data_2k39_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k39 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 ttp . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 113.645 -3.074 . . . . 0.0 108.144 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -72.09 134.17 45.64 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 102.607 -3.108 . . . . 0.0 102.607 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -132.79 157.62 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 130.605 3.562 . . . . 0.0 105.749 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -120.96 151.02 40.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 129.129 2.972 . . . . 0.0 107.771 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.17 135.34 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 167.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -103.62 120.3 40.62 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 126.648 2.468 . . . . 0.0 110.612 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -97.33 137.23 36.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.414 38.0 mt -27.04 -43.12 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.568 1 C-N-CA 132.996 4.518 . . . . 0.0 111.611 172.044 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.351 80.9 p -83.03 -16.32 47.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.086 -1.634 . . . . 0.0 110.438 -168.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.22 -4.48 23.65 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.477 -1.179 . . . . 0.0 112.116 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -80.61 132.62 35.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 129.449 3.1 . . . . 0.0 113.224 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -105.14 128.31 53.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 102.103 -3.295 . . . . 0.0 102.103 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.4 mt -129.44 135.3 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 -174.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.456 1.8 t -127.18 147.03 50.2 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -143.23 129.93 20.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 118.167 -2.833 . . . . 0.0 107.21 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -75.53 123.74 25.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 165.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -137.24 173.81 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 125.996 2.808 . . . . 0.0 104.847 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.49 154.37 39.14 Favored Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 102.149 -3.278 . . . . 0.0 102.149 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.06 -29.36 22.57 Favored 'Trans proline' 0 N--CA 1.447 -1.23 1 C-N-CA 130.228 7.285 . . . . 0.0 114.352 170.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.3 m -71.89 -16.6 62.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 122.456 2.389 . . . . 0.0 115.693 173.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -65.37 132.92 50.22 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 122.644 2.474 . . . . 0.0 107.817 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.295 70.6 p -43.75 149.23 0.31 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 156.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -66.42 -39.69 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 O-C-N 121.439 -0.788 . . . . 0.0 108.953 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.324 63.4 tt0 -54.92 -37.93 67.02 Favored 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 134.272 5.029 . . . . 0.0 115.229 177.42 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -53.69 -49.29 68.36 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 161.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.35 -13.94 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 126.755 2.022 . . . . 0.0 112.578 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -78.16 -32.45 50.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.749 2.82 . . . . 0.0 108.362 168.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.94 -29.21 22.24 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 117.361 -3.337 . . . . 0.0 110.242 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -63.6 -32.2 73.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 114.612 -2.613 . . . . 0.0 108.33 168.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.361 17.6 mt -65.97 -28.72 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 124.825 3.466 . . . . 0.0 112.315 166.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -73.94 -38.74 64.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 122.054 2.206 . . . . 0.0 106.89 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -52.91 -48.82 66.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 131.203 3.801 . . . . 0.0 113.463 165.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -88.99 -37.15 15.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 126.765 2.54 . . . . 0.0 116.156 -170.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -136.76 -14.71 1.62 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.699 1.714 . . . . 0.0 110.646 -162.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.06 8.34 34.08 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 155.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.258 13.7 mt -101.59 133.08 21.04 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-N 123.367 3.583 . . . . 0.0 107.924 -162.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.21 150.92 37.95 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 CA-C-N 123.027 2.117 . . . . 0.0 114.223 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -46.85 -40.16 24.86 Favored 'Trans proline' 0 N--CA 1.443 -1.499 1 C-N-CA 126.861 5.041 . . . . 0.0 119.73 166.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.3 -44.42 88.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 128.504 3.627 . . . . 0.0 116.27 -170.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.301 74.0 mm-40 -100.37 -1.41 36.12 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 113.457 -1.701 . . . . 0.0 112.103 -173.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -95.65 125.76 40.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 126.571 2.419 . . . . 0.0 113.081 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.348 31.4 ttm105 -124.26 132.84 53.61 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 128.509 2.724 . . . . 0.0 108.579 172.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.81 151.21 29.31 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 117.498 -1.239 . . . . 0.0 108.89 -172.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.409 34.8 mt -129.95 131.53 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.912 1.685 . . . . 0.0 106.988 -167.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -142.31 118.42 10.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 130.67 3.588 . . . . 0.0 110.666 169.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.58 27.12 11.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.101 2.16 . . . . 0.0 110.228 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.53 -20.45 44.36 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.108 -1.62 . . . . 0.0 113.101 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.362 45.2 mtmt -94.71 143.41 26.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -165.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -71.35 137.4 48.41 Favored 'General case' 0 C--O 1.223 -0.294 0 O-C-N 121.644 -0.66 . . . . 0.0 110.992 159.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.2 mt -104.62 140.44 38.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -128.98 157.26 42.18 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 -147.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.256 5.9 p-10 -59.2 140.19 56.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.124 172.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.13 -47.1 1.05 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 105.673 -2.971 . . . . 0.0 105.673 162.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.86 175.92 5.46 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.225 -1.488 . . . . 0.0 111.053 -165.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 p -122.52 161.41 23.68 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.163 2.585 . . . . 0.0 113.496 -164.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mt -55.02 -35.45 64.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.5 t -57.75 -46.23 84.78 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 128.79 2.836 . . . . 0.0 109.825 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -59.91 -37.4 79.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 119.892 -1.755 . . . . 0.0 114.294 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -90.11 15.13 10.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 115.091 -2.385 . . . . 0.0 115.008 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 m120 71.52 10.87 6.54 Favored 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 132.89 4.476 . . . . 0.0 110.246 161.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.0 mt -52.61 134.54 14.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 1 C-N-CA 133.864 4.866 . . . . 0.0 110.179 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -145.06 -177.55 5.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 130.822 3.649 . . . . 0.0 111.331 -159.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.378 72.6 tttt -51.81 104.83 0.09 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 129.999 3.32 . . . . 0.0 114.278 170.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 70.92 21.49 5.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 118.143 -2.848 . . . . 0.0 113.565 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 m -58.16 119.79 7.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 121.915 2.143 . . . . 0.0 107.059 173.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.5 m -92.89 122.5 35.33 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 129.407 3.083 . . . . 0.0 107.769 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -113.82 170.99 7.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 125.279 1.612 . . . . 0.0 109.103 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.22 144.33 44.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.154 2.182 . . . . 0.0 111.128 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.06 103.2 7.32 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -160.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 m -87.54 128.6 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 124.875 2.274 . . . . 0.0 109.86 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.307 31.8 tp . . . . . 0 N--CA 1.446 -0.64 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -98.64 133.56 42.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 121.051 1.751 . . . . 0.0 109.029 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.284 1.1 pt -129.6 168.09 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.27 161.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -132.24 146.45 52.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.89 94.92 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 1 N-CA-C 98.661 -4.57 . . . . 0.0 98.661 -161.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -77.53 137.9 38.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 124.857 2.265 . . . . 0.0 110.891 170.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -94.61 168.52 10.8 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 124.375 2.035 . . . . 0.0 106.667 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.18 -16.53 62.53 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 118.431 -2.668 . . . . 0.0 111.137 163.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.0 p -91.23 -7.15 52.11 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 115.724 -2.084 . . . . 0.0 113.344 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.99 -17.71 17.12 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.408 1.48 . . . . 0.0 115.953 161.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -76.93 145.63 38.07 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.413 2.285 . . . . 0.0 107.674 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.2 p -105.82 121.86 44.91 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.51 2.724 . . . . 0.0 108.982 172.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.273 35.6 mm -89.26 146.82 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 173.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 22.1 m -109.52 137.64 47.06 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 119.826 -1.796 . . . . 0.0 109.86 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.87 100.13 6.74 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -160.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.5 106.35 17.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.944 3.697 . . . . 0.0 109.195 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -158.88 161.07 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 120.777 1.626 . . . . 0.0 112.26 -160.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -97.42 152.95 38.51 Favored Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 118.466 -2.646 . . . . 0.0 110.143 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.309 2.7 Cg_exo -51.77 -30.42 37.75 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 N-CA-C 119.355 2.791 . . . . 0.0 119.355 167.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 p -88.16 2.39 52.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.997 2.119 . . . . 0.0 112.019 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -81.39 140.93 34.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 120.021 1.282 . . . . 0.0 109.361 166.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -80.41 159.58 25.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.994 2.518 . . . . 0.0 109.604 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.293 8.7 mt -72.08 -14.23 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 126.219 1.808 . . . . 0.0 115.011 170.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -87.06 -18.48 30.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 170.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.279 13.3 t30 -66.56 -45.58 78.86 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 111.591 -2.549 . . . . 0.0 106.466 165.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.1 t -56.8 -40.76 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 1 C-N-CA 132.205 4.202 . . . . 0.0 108.805 170.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.579 ' HZ1' ' CG ' ' A' ' 52' ' ' ASP . 90.6 mttt -73.46 -38.76 65.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 116.42 -2.112 . . . . 0.0 110.185 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -31.57 72.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -57.43 -44.72 84.91 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 125.003 1.44 . . . . 0.0 112.933 163.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.416 21.7 mt -55.88 -45.27 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 127.914 2.486 . . . . 0.0 114.703 -176.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -48.83 -67.11 0.3 Allowed 'General case' 0 C--N 1.33 -0.24 1 O-C-N 129.493 4.245 . . . . 0.0 113.815 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -50.3 -32.04 15.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -87.02 -58.27 2.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.173 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.284 18.2 tp10 -112.45 -8.66 13.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 121.105 3.743 . . . . 0.0 121.105 -166.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.56 1.2 55.44 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 117.146 -1.919 . . . . 0.0 111.749 162.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.6 mt -98.42 110.45 56.61 Favored Pre-proline 0 N--CA 1.452 -0.359 0 C-N-CA 125.284 1.434 . . . . 0.0 110.073 -171.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -56.77 142.97 91.84 Favored 'Trans proline' 0 C--N 1.323 -0.776 1 CA-C-O 110.438 -4.068 . . . . 0.0 118.062 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.277 28.7 Cg_exo -45.1 -31.23 5.54 Favored 'Trans proline' 0 N--CA 1.452 -0.915 1 O-C-N 129.638 4.494 . . . . 0.0 119.543 -178.737 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.68 -35.2 72.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.289 79.7 mt-30 -90.07 13.37 15.11 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.652 -1.613 . . . . 0.0 113.363 -177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -106.13 156.9 17.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 172.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -138.68 116.52 11.54 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 127.271 2.228 . . . . 0.0 112.093 149.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.93 107.23 19.61 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 131.19 3.796 . . . . 0.0 105.946 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 pt -110.52 158.18 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 129.235 3.014 . . . . 0.0 109.5 169.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -115.62 -0.57 12.97 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 130.263 3.425 . . . . 0.0 108.9 161.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.552 . . -142.43 -110.68 0.13 Allowed 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 119.135 -2.228 . . . . 0.0 114.617 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.06 -19.8 2.88 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 122.473 2.397 . . . . 0.0 110.629 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -117.54 154.8 30.88 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 127.552 2.56 . . . . 0.0 112.361 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.05 165.25 11.4 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 124.122 0.889 . . . . 0.0 108.855 -172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.314 38.6 mt -96.25 128.08 42.84 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 110.954 -2.839 . . . . 0.0 106.744 164.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -69.18 125.14 25.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 116.306 -1.807 . . . . 0.0 115.551 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.579 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS 0.278 0.0 OUTLIER -46.27 -28.66 1.35 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 128.824 3.828 . . . . 0.0 117.789 -170.538 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.11 10.87 60.27 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 125.57 1.794 . . . . 0.0 116.548 -168.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -111.33 179.83 3.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.949 1.699 . . . . 0.0 107.504 168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -120.45 172.09 8.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 104.583 -2.376 . . . . 0.0 104.583 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.392 6.9 mp -40.21 -51.55 2.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 130.919 3.688 . . . . 0.0 110.309 157.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 p -63.02 -37.92 89.12 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.843 2.057 . . . . 0.0 114.868 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.43 -46.42 66.81 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.835 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -79.15 -5.3 53.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 125.952 2.787 . . . . 0.0 114.699 -175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.65 44.43 17.46 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 117.977 -2.952 . . . . 0.0 115.937 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.7 mm -91.2 98.06 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -77.87 166.49 22.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.304 2.642 . . . . 0.0 109.556 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.36 129.79 1.76 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 167.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 70.79 38.83 1.15 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.455 2.302 . . . . 0.0 113.367 167.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.4 m -92.03 130.42 37.77 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 130.639 3.575 . . . . 0.0 108.449 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.3 m -88.36 111.95 22.32 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 127.435 2.959 . . . . 0.0 109.189 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.9 mt -94.85 136.43 35.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.927 1.291 . . . . 0.0 108.678 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -95.2 125.44 39.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.298 -1.501 . . . . 0.0 110.551 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.0 tp -101.01 108.96 20.8 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.179 1.792 . . . . 0.0 108.123 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.6 147.76 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 123.343 1.544 . . . . 0.0 109.502 153.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 N--CA 1.449 -0.516 0 C-N-CA 127.943 2.497 . . . . 0.0 111.355 -171.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 53.8 ttp . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 117.459 -1.258 . . . . 0.0 107.756 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -77.42 134.52 38.39 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 126.244 2.215 . . . . 0.0 114.494 168.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -137.43 161.6 34.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.5 3.52 . . . . 0.0 102.337 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -112.54 144.25 42.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 111.015 -2.811 . . . . 0.0 114.764 168.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -132.77 112.78 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 O-C-N 125.738 1.899 . . . . 0.0 108.053 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -72.57 125.19 26.84 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 114.106 -2.854 . . . . 0.0 106.434 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -90.12 162.98 15.04 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 114.948 -2.453 . . . . 0.0 114.686 155.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pp -77.54 -12.37 59.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 125.283 1.614 . . . . 0.0 110.092 171.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -79.31 -10.4 59.8 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 129.937 3.295 . . . . 0.0 112.188 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.34 10.06 37.14 Favored Glycine 0 CA--C 1.539 1.554 0 O-C-N 117.991 -2.943 . . . . 0.0 114.275 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -104.51 140.97 37.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -115.16 100.83 8.44 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.934 2.894 . . . . 0.0 103.339 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.3 mt -81.16 123.66 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.8 m -104.84 123.74 48.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 121.401 1.91 . . . . 0.0 107.525 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.4 mt -126.23 130.41 50.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.117 2.567 . . . . 0.0 111.811 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.26 116.45 12.71 Favored 'General case' 0 C--N 1.327 -0.377 1 O-C-N 130.072 4.607 . . . . 0.0 109.137 154.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.0 172.72 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 113.29 -3.243 . . . . 0.0 114.793 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -97.11 144.65 28.25 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 124.37 3.259 . . . . 0.0 105.214 159.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -52.77 -28.38 38.01 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 CA-C-N 127.301 3.643 . . . . 0.0 115.475 163.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.9 p -81.46 4.32 21.48 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 127.493 2.996 . . . . 0.0 116.191 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -70.75 156.75 39.12 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.564 1.146 . . . . 0.0 108.268 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -111.42 166.56 11.02 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.352 1.861 . . . . 0.0 110.499 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.465 ' H ' HG12 ' A' ' 23' ' ' ILE . 4.0 mm -52.79 -42.64 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 127.722 2.409 . . . . 0.0 111.651 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -49.49 -34.98 18.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 115.358 -2.258 . . . . 0.0 116.322 171.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -85.0 -15.31 44.62 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 126.809 2.568 . . . . 0.0 109.089 -167.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -81.44 -52.52 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 126.307 2.956 . . . . 0.0 103.59 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -62.66 -33.17 74.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 131.058 3.743 . . . . 0.0 110.949 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.8 66.6 Favored 'General case' 0 N--CA 1.443 -0.786 1 O-C-N 114.529 -5.107 . . . . 0.0 109.377 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -67.11 -29.04 68.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 113.922 -2.942 . . . . 0.0 110.505 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.259 42.0 mt -72.44 -42.06 64.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 123.751 2.978 . . . . 0.0 104.722 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -53.95 -40.18 66.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 118.602 -2.561 . . . . 0.0 116.294 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.261 2.3 t70 -67.88 -19.89 65.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 116.232 -1.842 . . . . 0.0 112.171 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -94.22 -61.81 1.45 Allowed 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 124.61 1.194 . . . . 0.0 111.351 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -91.92 -28.51 17.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.443 2.697 . . . . 0.0 113.431 -166.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.22 -24.58 24.31 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 121.046 -1.034 . . . . 0.0 112.5 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 mt -60.32 118.18 31.14 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 111.737 -2.232 . . . . 0.0 107.097 -169.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.263 98.0 Cg_endo -67.74 158.04 59.05 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 CA-C-N 122.446 1.909 . . . . 0.0 116.563 175.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.312 14.9 Cg_exo -57.27 -33.11 95.49 Favored 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 128.635 6.223 . . . . 0.0 112.954 -179.282 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -86.53 -9.89 55.2 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 122.561 2.437 . . . . 0.0 111.581 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -94.77 -23.3 17.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.517 1.136 . . . . 0.0 113.724 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.46 122.15 21.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 113.722 -3.037 . . . . 0.0 108.751 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -100.4 119.47 38.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 121.428 1.922 . . . . 0.0 107.888 164.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 tp -121.18 104.06 9.47 Favored 'General case' 0 N--CA 1.445 -0.719 1 C-N-CA 132.458 4.303 . . . . 0.0 109.912 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.297 47.8 mm -96.6 151.18 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 128.359 3.537 . . . . 0.0 112.067 174.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -150.47 108.74 3.76 Favored 'General case' 0 CA--C 1.535 0.382 1 C-N-CA 132.038 4.135 . . . . 0.0 111.669 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.27 29.5 3.63 Favored 'General case' 0 C--N 1.325 -0.47 1 C-N-CA 132.269 4.228 . . . . 0.0 117.168 157.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.24 -10.11 20.18 Favored Glycine 0 CA--C 1.527 0.833 1 C-N-CA 133.765 5.459 . . . . 0.0 107.607 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -123.44 162.99 21.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 121.752 2.776 . . . . 0.0 105.908 -168.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -79.71 149.6 31.13 Favored 'General case' 0 N--CA 1.449 -0.488 1 C-N-CA 132.986 4.514 . . . . 0.0 108.588 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.0 mt -112.86 104.87 12.87 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.599 1.56 . . . . 0.0 108.479 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -94.35 149.82 20.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 102.181 -3.266 . . . . 0.0 102.181 -171.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -76.49 152.42 36.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 127.01 2.124 . . . . 0.0 114.195 -165.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.33 -23.04 33.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 119.457 2.543 . . . . 0.0 119.457 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -70.57 162.48 28.8 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 p -100.79 165.06 11.56 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.117 -1.615 . . . . 0.0 107.146 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.7 mt -60.9 -47.37 86.69 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 113.053 -1.885 . . . . 0.0 115.709 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.4 p -43.06 -45.23 5.17 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 129.081 2.952 . . . . 0.0 114.854 162.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.81 -52.5 59.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 131.416 3.886 . . . . 0.0 110.448 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -74.12 -14.3 60.95 Favored 'General case' 0 N--CA 1.449 -0.494 1 C-N-CA 132.465 4.306 . . . . 0.0 111.802 172.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.48 19.5 t30 87.37 20.74 0.06 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 165.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.9 mt -78.44 144.07 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -168.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -142.64 172.54 12.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.285 1.834 . . . . 0.0 108.996 -155.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -62.54 119.76 9.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 125.591 1.807 . . . . 0.0 109.85 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.506 15.2 mt-10 85.29 15.26 0.16 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -176.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -71.68 141.17 49.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.704 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.3 m -108.56 117.57 34.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.13 142.15 32.0 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.376 2.271 . . . . 0.0 109.304 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -108.69 125.48 51.94 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 125.275 2.464 . . . . 0.0 111.936 169.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -96.16 132.96 41.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 110.341 -3.118 . . . . 0.0 109.307 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.12 158.14 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 131.001 3.72 . . . . 0.0 108.138 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.303 83.3 mt . . . . . 0 N--CA 1.441 -0.882 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.935 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 117.348 -1.31 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -89.14 140.86 29.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.424 1.489 . . . . 0.0 113.348 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.8 pt -134.45 161.02 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 127.35 2.26 . . . . 0.0 107.742 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.476 ' CE1' HG21 ' A' ' 14' ' ' THR . 57.3 m-85 -123.46 112.37 17.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 119.783 -1.823 . . . . 0.0 109.809 -169.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.75 128.8 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 100.201 -4.0 . . . . 0.0 100.201 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -90.29 136.1 33.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 110.949 -2.841 . . . . 0.0 107.004 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.255 26.8 p -114.86 132.3 56.56 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 124.465 1.103 . . . . 0.0 109.77 167.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.4 mt -72.86 -3.98 28.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 116.995 -3.566 . . . . 0.0 113.958 -151.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.5 p -76.65 -5.91 49.87 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 121.874 2.125 . . . . 0.0 115.935 159.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.6 -6.12 7.05 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 118.426 -2.671 . . . . 0.0 110.805 160.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -85.37 127.36 34.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 104.138 -2.541 . . . . 0.0 104.138 -165.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -96.2 101.4 13.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 126.629 2.456 . . . . 0.0 111.448 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.41 114.41 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 125.84 2.733 . . . . 0.0 105.305 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.476 HG21 ' CE1' ' A' ' 4' ' ' PHE . 11.2 m -99.29 113.61 26.0 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 mt -105.95 154.21 20.9 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.932 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -93.55 137.34 32.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.591 1.663 . . . . 0.0 106.677 165.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.309 11.8 m -145.05 175.78 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 128.466 2.706 . . . . 0.0 111.968 -174.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -139.3 152.99 70.58 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 128.823 2.849 . . . . 0.0 109.613 164.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.37 -30.3 92.37 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.493 2.795 . . . . 0.0 117.055 -173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 p -91.77 20.66 5.39 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 121.72 2.055 . . . . 0.0 110.752 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -100.82 140.75 34.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 119.728 -1.858 . . . . 0.0 109.046 -169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.2 p -70.24 157.91 36.81 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 127.951 3.282 . . . . 0.0 110.937 -168.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.286 26.9 mt -61.67 -27.97 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 116.487 -1.72 . . . . 0.0 111.654 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.252 9.4 tp10 -62.06 -47.59 84.04 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 123.248 2.749 . . . . 0.0 106.052 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -68.71 -38.09 79.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 123.011 2.641 . . . . 0.0 111.645 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -55.62 -58.34 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 127.332 2.253 . . . . 0.0 114.389 166.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -53.38 -35.44 60.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 128.423 2.689 . . . . 0.0 110.096 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.24 -32.34 70.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 125.157 2.408 . . . . 0.0 112.028 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.64 -7.18 58.98 Favored 'General case' 0 N--CA 1.451 -0.388 1 O-C-N 115.614 -4.428 . . . . 0.0 107.987 -170.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.2 mt -87.5 -33.41 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 119.649 1.113 . . . . 0.0 108.264 170.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -64.47 -39.1 93.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.23 -51.1 65.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.66 1.584 . . . . 0.0 114.536 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -83.22 -52.45 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -95.17 -15.63 23.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 119.834 3.272 . . . . 0.0 119.834 -171.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.33 4.46 62.61 Favored Glycine 0 CA--C 1.531 1.046 1 O-C-N 130.132 4.645 . . . . 0.0 116.035 170.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.3 mt -86.98 123.16 70.73 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 121.485 2.642 . . . . 0.0 105.653 -155.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -62.65 133.43 42.3 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 CA-C-O 115.982 -1.758 . . . . 0.0 111.401 169.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.4 35.1 Cg_exo -41.55 -24.42 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 1 C-N-CA 128.664 6.243 . . . . 0.0 121.318 175.806 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -52.53 -50.43 62.86 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.971 1.708 . . . . 0.0 114.974 165.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -83.93 -18.25 37.97 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.162 2.985 . . . . 0.0 110.368 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -76.83 99.36 5.14 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.939 1.696 . . . . 0.0 110.526 169.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -102.47 107.81 18.91 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 119.693 -1.88 . . . . 0.0 107.988 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.2 mt -73.77 60.43 0.71 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 129.921 3.288 . . . . 0.0 110.184 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mm -87.79 107.68 17.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 115.646 -2.121 . . . . 0.0 108.732 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.379 23.3 t80 -133.3 118.85 19.02 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 129.467 3.107 . . . . 0.0 111.187 -168.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.86 43.88 26.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 129.163 2.985 . . . . 0.0 116.274 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.23 -28.9 9.6 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.034 2.254 . . . . 0.0 114.865 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.301 54.6 mttt -92.21 164.77 13.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -171.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -81.32 117.84 22.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 151.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.24 143.62 26.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.345 8.5 mt-10 -96.31 164.92 12.45 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 125.789 3.904 . . . . 0.0 111.635 -163.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -72.54 145.4 47.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 129.404 3.082 . . . . 0.0 110.325 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.75 6.5 12.79 Favored Glycine 0 CA--C 1.523 0.536 0 O-C-N 118.183 -2.823 . . . . 0.0 115.473 158.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -122.67 170.12 10.36 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.319 1.848 . . . . 0.0 110.226 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.4 p -99.7 165.3 11.67 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 130.959 3.703 . . . . 0.0 109.875 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.325 37.6 mt -41.21 -45.9 2.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.657 2.783 . . . . 0.0 113.623 170.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.4 m -84.45 -21.8 30.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 122.545 2.429 . . . . 0.0 112.281 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.263 20.0 m-20 -68.4 -18.59 64.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 115.981 -1.961 . . . . 0.0 113.457 173.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -108.33 11.7 26.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 126.564 2.415 . . . . 0.0 113.012 164.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 10.7 p30 64.47 28.04 13.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 167.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mt -78.6 131.29 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 121.025 -1.047 . . . . 0.0 110.647 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -106.88 163.83 12.63 Favored 'General case' 0 N--CA 1.444 -0.742 1 C-N-CA 132.078 4.151 . . . . 0.0 108.586 -177.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -53.67 144.32 18.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 111.209 -2.723 . . . . 0.0 113.237 171.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.433 44.9 mt-10 57.81 10.82 1.19 Allowed 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 118.393 -2.692 . . . . 0.0 117.432 -172.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 m -73.03 147.65 44.89 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.7 m -105.69 139.57 40.07 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 129.405 3.082 . . . . 0.0 107.969 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.84 179.97 8.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 114.657 -2.592 . . . . 0.0 111.365 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -125.41 131.13 52.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 127.29 2.869 . . . . 0.0 111.981 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 tp -102.43 147.08 27.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.379 1.872 . . . . 0.0 106.695 167.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -121.42 151.04 24.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 125.299 2.476 . . . . 0.0 108.897 168.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.45 -0.434 0 CA-C-N 108.804 -3.816 . . . . 0.0 110.755 176.271 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.584 0.707 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -100.25 145.54 27.96 Favored 'General case' 0 N--CA 1.442 -0.83 2 O-C-N 113.477 -5.764 . . . . 0.0 107.722 -171.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 pt -127.85 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 1 O-C-N 115.78 -4.325 . . . . 0.0 107.526 151.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -88.55 136.67 32.88 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.075 -1.421 . . . . 0.0 107.697 166.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.25 10.9 t -123.59 122.33 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 117.3 -3.375 . . . . 0.0 109.448 170.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -94.01 107.14 19.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.4 6.2 p -56.41 160.45 3.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 128.196 3.435 . . . . 0.0 117.386 170.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -74.63 -24.18 58.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.395 1.078 . . . . 0.0 109.032 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.67 -1.92 56.78 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 123.144 1.449 . . . . 0.0 114.174 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.44 -26.79 15.35 Favored Glycine 0 CA--C 1.526 0.761 0 O-C-N 119.371 -2.081 . . . . 0.0 115.762 165.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -70.01 130.25 41.67 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 116.929 -3.689 . . . . 0.0 107.731 -172.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.5 m -88.77 109.94 20.6 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 118.895 -2.378 . . . . 0.0 108.089 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 pt -93.31 141.48 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 124.291 1.037 . . . . 0.0 112.551 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 t -81.95 143.94 31.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 161.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.09 121.14 22.23 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 131.543 3.937 . . . . 0.0 107.363 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.31 13.1 mp0 -86.12 134.39 33.81 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 117.598 -1.641 . . . . 0.0 110.375 172.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.274 27.4 m -137.38 170.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 116.471 -1.728 . . . . 0.0 109.37 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -112.94 158.88 36.52 Favored Pre-proline 0 N--CA 1.444 -0.739 0 C-N-CA 128.668 2.787 . . . . 0.0 105.258 162.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.79 -28.35 25.23 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.935 2.423 . . . . 0.0 117.21 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -76.85 4.22 10.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 126.127 2.142 . . . . 0.0 116.596 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -84.43 141.15 31.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.361 1.864 . . . . 0.0 107.853 -164.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -78.86 140.09 38.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.336 1.455 . . . . 0.0 110.235 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.29 8.3 mt -47.09 -35.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 119.979 -1.701 . . . . 0.0 114.939 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -53.79 -49.31 68.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.306 2.242 . . . . 0.0 111.095 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -64.78 -43.25 93.84 Favored 'General case' 0 N--CA 1.441 -0.91 1 C-N-CA 132.665 4.386 . . . . 0.0 111.752 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.12 -50.63 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 115.208 -2.33 . . . . 0.0 113.351 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -61.6 -41.19 97.09 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 127.261 2.224 . . . . 0.0 112.259 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.73 -40.53 84.03 Favored 'General case' 0 N--CA 1.448 -0.543 1 C-N-CA 132.165 4.186 . . . . 0.0 109.235 177.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.32 79.8 mttt -79.33 -19.46 50.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 119.043 -2.286 . . . . 0.0 114.794 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mt -76.82 -32.34 20.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 118.887 -2.383 . . . . 0.0 107.413 172.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.82 -38.46 86.48 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 116.667 -3.77 . . . . 0.0 114.005 163.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -67.14 -23.03 65.75 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 113.007 -3.378 . . . . 0.0 109.641 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -98.55 -66.94 0.87 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 121.455 1.934 . . . . 0.0 113.733 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -111.32 -9.78 14.27 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 117.108 -3.495 . . . . 0.0 109.235 -164.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.53 2.37 50.26 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.145 -1.364 . . . . 0.0 114.479 158.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -77.0 125.13 87.26 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 125.02 1.328 . . . . 0.0 107.782 -171.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.59 129.55 19.09 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.826 3.684 . . . . 0.0 115.637 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -41.85 -33.07 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 1 C-N-CA 127.55 5.5 . . . . 0.0 117.502 175.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -51.11 -64.17 0.9 Allowed 'General case' 0 N--CA 1.445 -0.678 1 C-N-CA 132.174 4.189 . . . . 0.0 112.925 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -73.18 -26.27 61.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 128.661 2.784 . . . . 0.0 117.524 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -73.22 128.4 35.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.104 2.562 . . . . 0.0 107.351 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 ttm105 -120.73 129.37 53.61 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.977 1.711 . . . . 0.0 108.468 158.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -97.48 161.94 13.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.365 -1.779 . . . . 0.0 110.822 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -136.07 138.0 47.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 126.428 2.33 . . . . 0.0 108.062 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -130.8 116.53 18.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.602 2.361 . . . . 0.0 107.518 162.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.293 . . 57.86 34.15 24.03 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 129.034 2.934 . . . . 0.0 114.106 168.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.1 10.81 84.24 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 129.253 3.311 . . . . 0.0 117.778 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -98.61 134.63 41.28 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.917 2.487 . . . . 0.0 106.957 173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -84.63 124.71 31.77 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.99 130.19 38.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 116.222 -1.847 . . . . 0.0 109.839 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.93 126.01 36.85 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.949 1.704 . . . . 0.0 109.273 -166.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -46.18 115.34 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 129.831 3.252 . . . . 0.0 111.836 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.24 -9.85 31.19 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 116.762 -2.132 . . . . 0.0 112.962 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.352 17.7 mmt180 -86.26 154.13 21.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 121.075 2.437 . . . . 0.0 111.383 174.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 p -71.57 161.2 31.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 160.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.49 -21.32 66.18 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 122.257 2.299 . . . . 0.0 113.796 169.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 t -77.53 -16.56 58.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 117.217 -3.427 . . . . 0.0 108.226 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -76.66 4.16 10.06 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 123.192 2.724 . . . . 0.0 113.336 167.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -138.45 9.33 2.68 Favored 'General case' 0 C--N 1.327 -0.405 1 O-C-N 115.085 -4.759 . . . . 0.0 112.523 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 t30 62.3 26.92 16.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 130.054 3.342 . . . . 0.0 116.679 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.36 128.42 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -124.32 -160.07 0.91 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.171 -1.377 . . . . 0.0 107.461 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.66 135.57 51.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -165.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 81.96 10.08 0.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 129.013 2.925 . . . . 0.0 115.12 163.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -70.06 152.19 44.66 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 126.049 2.093 . . . . 0.0 113.432 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.7 m -110.39 125.46 53.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.87 155.47 20.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 169.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -110.92 150.75 28.77 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.663 1.985 . . . . 0.0 106.999 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -125.9 135.55 52.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.705 2.402 . . . . 0.0 109.841 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.2 m -135.58 140.45 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 127.928 2.491 . . . . 0.0 108.043 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.277 1.1 pp . . . . . 0 C--N 1.325 -0.474 0 C-N-CA 128.107 2.563 . . . . 0.0 112.087 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttp . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -104.67 128.92 52.88 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 101.537 -3.505 . . . . 0.0 101.537 -169.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 pt -138.14 170.97 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 129.727 3.211 . . . . 0.0 106.84 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -114.4 149.3 36.38 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -121.8 121.4 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.271 1.828 . . . . 0.0 106.206 161.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -110.1 178.49 4.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 109.248 -3.614 . . . . 0.0 110.465 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -138.08 155.96 48.26 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 128.238 2.615 . . . . 0.0 108.538 -168.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.4 mt -75.76 -14.52 60.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 112.939 -3.41 . . . . 0.0 111.245 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -92.95 -4.03 53.44 Favored 'General case' 0 C--N 1.324 -0.525 1 CA-C-N 126.255 4.116 . . . . 0.0 108.86 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.12 7.13 31.27 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 120.313 2.885 . . . . 0.0 120.313 162.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -60.76 154.26 22.17 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 118.595 -2.709 . . . . 0.0 108.82 169.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.281 4.3 m -141.92 107.0 4.94 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.427 1.891 . . . . 0.0 108.743 170.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mm -100.43 142.24 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 111.997 -2.365 . . . . 0.0 106.315 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -94.42 143.2 26.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.643 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.6 123.44 37.65 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 122.604 2.456 . . . . 0.0 107.853 -173.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -99.43 109.56 22.13 Favored 'General case' 0 C--N 1.329 -0.283 1 N-CA-C 97.181 -5.118 . . . . 0.0 97.181 175.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 m -118.76 150.21 21.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 119.711 -1.868 . . . . 0.0 108.009 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -89.45 161.29 40.09 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 116.479 -1.724 . . . . 0.0 111.078 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.02 -19.76 13.55 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.504 2.803 . . . . 0.0 111.664 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 p -73.06 -17.93 61.37 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 128.709 2.804 . . . . 0.0 111.7 173.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -69.86 123.94 22.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 124.934 2.302 . . . . 0.0 112.02 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.6 p -76.67 166.11 23.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 111.893 -2.412 . . . . 0.0 110.098 162.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.2 -21.51 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 O-C-N 124.945 1.403 . . . . 0.0 108.641 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -73.59 -28.88 62.06 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.34 -29.82 53.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -83.18 -27.88 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 119.969 -1.707 . . . . 0.0 107.505 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -69.19 -42.22 76.1 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.78 -38.49 78.64 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 133.056 4.542 . . . . 0.0 114.158 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -77.36 -38.5 50.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 127.369 3.462 . . . . 0.0 114.877 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.1 mt -61.11 -35.81 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 1 O-C-N 113.05 -6.031 . . . . 0.0 105.788 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -32.96 71.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.184 1.794 . . . . 0.0 109.756 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.03 -32.19 73.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.99 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -91.65 -36.67 13.5 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.56 1.944 . . . . 0.0 113.943 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -129.16 -23.53 2.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -173.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.04 2.03 57.06 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 126.996 2.685 . . . . 0.0 116.611 165.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.2 mm -72.8 121.42 84.97 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 120.095 1.948 . . . . 0.0 111.048 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -39.27 129.11 1.56 Allowed 'Trans proline' 0 N--CA 1.443 -1.498 0 N-CA-C 119.225 2.74 . . . . 0.0 119.225 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.29 26.4 Cg_exo -47.76 -29.99 12.17 Favored 'Trans proline' 0 N--CA 1.453 -0.901 1 C-N-CA 129.227 6.618 . . . . 0.0 115.825 178.296 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -79.28 -4.27 49.93 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 128.0 2.52 . . . . 0.0 112.381 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -118.36 -15.67 9.68 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.486 1.915 . . . . 0.0 110.349 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.304 79.9 mt-30 -90.05 115.22 27.15 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 116.317 -2.153 . . . . 0.0 108.235 -170.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -103.96 129.55 51.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 100.712 -3.81 . . . . 0.0 100.712 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 mt -132.63 93.78 3.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.423 -2.673 . . . . 0.0 106.278 -162.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -89.56 128.16 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -128.86 107.71 9.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 128.728 2.811 . . . . 0.0 106.398 166.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.331 . . 60.71 16.53 6.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 130.52 3.528 . . . . 0.0 117.706 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.82 -13.47 57.73 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.314 1.912 . . . . 0.0 110.722 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.54 105.45 14.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.998 2.119 . . . . 0.0 105.568 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -61.05 107.64 0.76 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 111.742 -2.481 . . . . 0.0 114.652 152.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.6 mt -65.7 123.06 18.73 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 128.115 3.384 . . . . 0.0 107.974 -172.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.19 131.27 34.8 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 126.884 2.615 . . . . 0.0 111.267 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.97 119.39 4.24 Favored 'General case' 0 N--CA 1.449 -0.485 1 CA-C-O 129.272 4.367 . . . . 0.0 111.849 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.18 -19.74 31.76 Favored Glycine 0 CA--C 1.523 0.559 1 O-C-N 115.195 -4.691 . . . . 0.0 119.234 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -83.56 175.83 9.48 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 118.473 -1.291 . . . . 0.0 111.433 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.3 p -114.16 162.06 17.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 121.216 1.825 . . . . 0.0 110.842 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mt -36.71 -50.56 0.83 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.104 2.962 . . . . 0.0 116.654 172.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 p -81.29 0.27 37.73 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 109.485 -3.507 . . . . 0.0 112.995 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -97.04 -18.77 19.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 116.647 -3.783 . . . . 0.0 109.249 170.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -98.99 -17.4 18.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 118.588 -2.57 . . . . 0.0 116.832 167.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 74.72 42.59 0.28 Allowed 'General case' 0 N--CA 1.452 -0.349 1 C-N-CA 132.456 4.303 . . . . 0.0 108.517 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.9 mt -68.21 106.3 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 O-C-N 119.892 -1.755 . . . . 0.0 107.853 156.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -76.88 169.9 17.47 Favored 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 133.628 4.771 . . . . 0.0 112.254 166.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.268 17.9 pttm -69.1 148.94 49.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 174.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 73.2 mt-10 57.34 13.72 1.87 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.7 m -81.58 169.6 16.86 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.467 2.307 . . . . 0.0 108.298 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -143.51 131.51 21.69 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.233 -153.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.22 145.64 35.87 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.158 -1.589 . . . . 0.0 111.159 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.281 24.6 m80 -97.1 117.91 32.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -170.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.31 128.43 34.69 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.602 1.961 . . . . 0.0 110.668 169.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.06 146.96 30.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 1 C-N-CA 131.795 4.038 . . . . 0.0 108.688 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.291 1.2 mm? . . . . . 0 C--N 1.32 -0.694 0 O-C-N 118.961 -2.337 . . . . 0.0 109.394 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -84.68 152.1 23.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 125.027 2.346 . . . . 0.0 114.235 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -134.16 137.14 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 129.783 3.233 . . . . 0.0 104.633 165.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -94.56 121.35 36.03 Favored 'General case' 0 N--CA 1.449 -0.504 1 C-N-CA 132.196 4.198 . . . . 0.0 105.219 166.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.56 130.8 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 101.306 -3.59 . . . . 0.0 101.306 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 23.2 mttm -90.9 116.57 28.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 129.547 3.139 . . . . 0.0 106.866 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 p -74.96 162.85 28.23 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 120.252 1.387 . . . . 0.0 110.176 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -70.56 -36.9 73.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.198 1.399 . . . . 0.0 107.823 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.8 p -80.71 -2.65 47.69 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.958 2.103 . . . . 0.0 116.273 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.49 20.34 8.24 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 161.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -107.35 158.07 17.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 126.47 3.033 . . . . 0.0 106.403 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.258 10.9 m -129.49 91.85 3.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 131.538 3.935 . . . . 0.0 108.854 -172.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mm -79.69 111.96 17.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 O-C-N 128.623 3.702 . . . . 0.0 104.71 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.257 85.1 m -86.52 107.73 18.23 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.816 1.647 . . . . 0.0 112.903 173.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mp -97.9 164.82 12.21 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 126.15 2.156 . . . . 0.0 112.888 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -113.08 146.59 38.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 127.196 3.379 . . . . 0.0 107.79 162.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.48 178.8 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 131.035 3.734 . . . . 0.0 107.5 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -120.9 150.42 52.99 Favored Pre-proline 0 N--CA 1.45 -0.432 0 C-N-CA 130.969 3.708 . . . . 0.0 103.109 154.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -47.02 -19.47 0.85 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 120.396 3.191 . . . . 0.0 120.396 164.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.7 m -58.92 -33.17 70.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 130.61 3.564 . . . . 0.0 114.276 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.09 126.49 20.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.891 2.476 . . . . 0.0 107.052 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.5 p -79.89 147.51 31.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 127.609 3.068 . . . . 0.0 104.809 162.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -46.4 -51.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 111.921 -2.399 . . . . 0.0 114.439 169.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -35.78 -42.15 0.25 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 160.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -74.31 -35.42 63.66 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 117.491 -3.255 . . . . 0.0 115.371 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.85 -42.69 79.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 120.079 -1.638 . . . . 0.0 109.006 170.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -56.72 -36.98 70.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 123.686 1.708 . . . . 0.0 113.543 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.67 -34.02 62.6 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 130.665 3.586 . . . . 0.0 111.05 -175.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -75.44 -44.02 46.63 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 128.578 2.751 . . . . 0.0 106.924 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 mt -60.83 -33.71 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 119.352 -2.092 . . . . 0.0 113.553 162.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.262 12.8 tt0 -60.1 -38.64 83.56 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 123.048 1.404 . . . . 0.0 112.58 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.75 -61.45 2.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 119.492 3.145 . . . . 0.0 119.492 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -63.65 -43.78 95.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 108.452 -3.977 . . . . 0.0 110.443 -168.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -119.46 -18.32 8.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 120.238 1.381 . . . . 0.0 112.336 -167.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.75 -8.66 54.72 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 117.418 -1.768 . . . . 0.0 111.224 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -67.4 115.0 22.02 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 120.196 1.998 . . . . 0.0 111.207 -164.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -74.36 156.65 45.87 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.466 2.11 . . . . 0.0 108.592 -168.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -68.57 -35.46 17.17 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 117.079 1.915 . . . . 0.0 117.079 -172.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.02 -27.06 68.61 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 118.806 2.891 . . . . 0.0 118.806 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -83.73 -30.58 26.58 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 119.236 -2.165 . . . . 0.0 112.746 173.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -67.32 133.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 123.075 1.417 . . . . 0.0 113.719 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -128.19 141.55 51.44 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 130.505 3.522 . . . . 0.0 103.376 161.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.67 136.4 53.94 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 129.488 3.115 . . . . 0.0 106.337 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.2 mt -123.75 156.58 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 110.023 -3.262 . . . . 0.0 112.699 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -158.19 127.53 5.77 Favored 'General case' 0 N--CA 1.45 -0.453 1 O-C-N 129.355 4.16 . . . . 0.0 102.984 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.08 26.27 11.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 165.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.64 -9.6 41.13 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 128.7 3.048 . . . . 0.0 113.331 169.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -121.37 142.54 49.89 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 126.744 2.085 . . . . 0.0 111.371 -166.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -90.44 116.67 28.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 128.236 2.614 . . . . 0.0 107.978 -172.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.68 136.02 34.87 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.416 1.487 . . . . 0.0 107.99 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.253 4.3 mm-40 -92.33 124.29 36.28 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 110.667 -2.97 . . . . 0.0 107.915 -163.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -22.18 9.6 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 119.38 3.104 . . . . 0.0 119.38 -160.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.74 -5.39 55.3 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 128.567 2.984 . . . . 0.0 119.197 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -90.15 156.39 18.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.935 1.694 . . . . 0.0 108.045 173.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -95.98 167.16 11.4 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.75 2.82 . . . . 0.0 108.704 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -70.38 -31.21 68.35 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 125.854 2.74 . . . . 0.0 108.663 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.353 14.1 t -50.71 -38.68 48.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 112.815 -3.469 . . . . 0.0 115.5 164.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.263 0.4 OUTLIER -74.03 -26.84 60.63 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 126.564 2.415 . . . . 0.0 109.578 -168.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.522 40.8 m-85 -102.08 10.15 39.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 125.279 1.612 . . . . 0.0 114.328 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.412 3.7 p-10 60.86 33.25 20.02 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 128.028 2.531 . . . . 0.0 116.563 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.7 mt -90.52 114.48 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.291 0.3 OUTLIER -143.86 81.35 1.69 Allowed 'General case' 0 N--CA 1.45 -0.47 1 C-N-CA 131.724 4.01 . . . . 0.0 117.011 -177.106 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.406 22.3 ttpt 84.51 131.95 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.799 3.64 . . . . 0.0 117.73 171.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 72.53 41.38 0.58 Allowed 'General case' 0 N--CA 1.443 -0.785 1 C-N-CA 134.504 5.122 . . . . 0.0 109.306 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.0 m -85.93 144.36 27.69 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 130.753 3.621 . . . . 0.0 111.439 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.9 m -100.33 109.63 21.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.127 2.571 . . . . 0.0 105.748 164.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -111.94 151.09 29.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.107 -1.901 . . . . 0.0 109.911 171.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -120.79 140.54 51.56 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 131.276 3.83 . . . . 0.0 112.06 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -98.67 135.61 39.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 116.053 -1.927 . . . . 0.0 110.954 157.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.33 148.52 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 1 O-C-N 129.345 4.153 . . . . 0.0 109.248 160.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 N--CA 1.447 -0.592 0 O-C-N 117.767 -3.083 . . . . 0.0 108.054 -173.031 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 123.284 1.516 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -134.26 150.22 51.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 108.729 -3.85 . . . . 0.0 116.608 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -136.46 144.69 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 112.8 -2.0 . . . . 0.0 113.454 166.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -90.08 122.24 32.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 116.906 -3.621 . . . . 0.0 109.138 163.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.8 t -82.82 125.24 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 101.244 -3.613 . . . . 0.0 101.244 157.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -103.98 104.58 14.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 110.14 -3.209 . . . . 0.0 104.914 162.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -72.48 137.93 46.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.645 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.36 -39.58 46.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 119.728 3.233 . . . . 0.0 119.728 -171.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.389 2.0 t -35.46 -30.76 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.704 1 C-N-CA 133.465 4.706 . . . . 0.0 117.044 156.75 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.99 -20.22 7.21 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 124.935 2.408 . . . . 0.0 110.444 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.26 73.4 tttt -71.35 139.48 49.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 119.304 -2.292 . . . . 0.0 108.712 -168.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 m -118.15 111.95 19.52 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 126.016 2.073 . . . . 0.0 114.562 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.263 13.8 mm -104.71 131.36 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.002 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.308 2.8 m -94.01 123.58 37.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 117.786 -3.071 . . . . 0.0 108.816 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mp -111.14 132.26 54.43 Favored 'General case' 0 C--O 1.217 -0.605 0 O-C-N 119.629 -1.92 . . . . 0.0 107.795 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -82.98 131.66 35.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 170.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -144.25 -174.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.807 0.843 . . . . 0.0 112.848 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -140.28 143.58 33.99 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 127.672 3.108 . . . . 0.0 108.916 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.68 -15.4 24.28 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 CA-C-N 125.105 2.859 . . . . 0.0 115.625 -167.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -75.32 1.8 12.81 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 117.41 -3.306 . . . . 0.0 116.938 165.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -93.76 150.77 20.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.499 2.319 . . . . 0.0 109.057 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.542 ' HB ' ' H ' ' A' ' 24' ' ' GLU . 7.4 p -71.36 161.0 31.78 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -175.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.305 16.5 mm -49.76 -41.93 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 131.677 3.991 . . . . 0.0 111.174 146.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.542 ' H ' ' HB ' ' A' ' 22' ' ' THR . 27.8 tt0 -59.35 -45.82 90.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 116.232 -2.187 . . . . 0.0 113.159 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -71.8 -23.3 61.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.472 1.107 . . . . 0.0 113.459 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.294 91.7 t -48.88 -62.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 150.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -68.64 -38.16 80.26 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.927 -1.733 . . . . 0.0 115.086 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.82 -38.26 75.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 129.591 3.157 . . . . 0.0 116.233 172.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -50.26 -37.64 36.84 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 163.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -69.84 -12.92 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 O-C-N 119.837 -1.789 . . . . 0.0 107.675 -172.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -62.45 -43.38 98.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 116.591 -3.818 . . . . 0.0 112.895 171.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -83.32 -32.87 26.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.382 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -75.05 -67.55 0.64 Allowed 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 119.515 -1.991 . . . . 0.0 108.663 168.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -103.58 -23.58 13.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 116.902 -3.624 . . . . 0.0 115.814 -155.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.63 25.74 10.51 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 116.83 -2.095 . . . . 0.0 108.569 172.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 mm -107.68 129.39 24.26 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.36 165.63 31.02 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.292 1.995 . . . . 0.0 111.767 170.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.63 -38.02 6.39 Favored 'Trans proline' 0 N--CA 1.453 -0.897 1 C-N-CA 127.551 5.501 . . . . 0.0 117.007 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.86 -21.11 26.83 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.922 2.489 . . . . 0.0 113.968 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -95.51 -9.53 32.22 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.928 2.891 . . . . 0.0 116.297 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -95.88 133.51 39.97 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 115.193 -2.337 . . . . 0.0 108.793 -172.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -119.13 104.39 10.4 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.702 2.001 . . . . 0.0 107.953 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tt -98.37 118.75 35.73 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 126.499 2.374 . . . . 0.0 105.487 -171.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -117.35 149.91 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -170.76 137.73 1.32 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 124.057 1.884 . . . . 0.0 107.725 166.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.36 28.95 11.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 117.434 2.383 . . . . 0.0 117.434 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.84 -5.39 69.23 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 116.454 -2.303 . . . . 0.0 114.061 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -125.76 147.36 49.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 127.404 2.473 . . . . 0.0 112.613 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -68.04 135.02 51.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.36 1.864 . . . . 0.0 113.46 163.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.47 101.45 13.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.16 -16.63 59.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -173.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.594 26.5 t0 103.72 145.67 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 127.623 2.369 . . . . 0.0 112.136 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.3 -8.02 2.89 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 172.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.347 48.3 mtp180 -145.17 152.53 40.16 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.782 1.277 . . . . 0.0 109.812 -168.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.7 p -83.08 168.48 16.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 112.777 -2.01 . . . . 0.0 114.835 -168.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.5 mt -47.56 -40.69 19.66 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.3 p -60.1 -56.09 25.84 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.899 2.48 . . . . 0.0 116.594 167.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -46.01 -57.59 4.3 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.512 1.925 . . . . 0.0 114.117 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -74.82 -16.69 60.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 126.901 2.081 . . . . 0.0 115.168 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.274 25.5 t-20 90.33 64.28 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 129.951 3.3 . . . . 0.0 111.498 164.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -118.85 131.0 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.275 73.7 mm-40 -128.06 165.19 20.81 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 126.09 2.119 . . . . 0.0 106.606 -160.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -60.67 147.57 41.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 116.876 -1.535 . . . . 0.0 110.524 -167.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 59.92 19.62 8.62 Favored 'General case' 0 N--CA 1.444 -0.736 1 C-N-CA 131.957 4.103 . . . . 0.0 111.73 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.4 m -81.04 149.66 29.16 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 123.146 2.703 . . . . 0.0 113.287 170.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.3 m -93.08 131.76 37.81 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.879 2.872 . . . . 0.0 107.376 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.9 mt -103.52 130.03 50.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.63 2.772 . . . . 0.0 111.865 159.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -90.6 139.4 30.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.285 43.2 tp -122.29 129.58 52.32 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 117.129 -1.829 . . . . 0.0 109.116 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.254 83.6 t -95.45 139.33 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 126.354 2.284 . . . . 0.0 105.085 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 121.869 0.842 . . . . 0.0 111.813 176.095 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 112.891 -3.433 . . . . 0.0 107.742 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -91.38 134.51 34.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.386 3.074 . . . . 0.0 112.376 167.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 pt -125.19 167.51 19.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 124.836 2.255 . . . . 0.0 106.915 160.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -106.35 144.43 33.05 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.409 2.284 . . . . 0.0 108.037 162.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.42 108.34 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 168.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -86.19 132.36 34.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 123.236 1.494 . . . . 0.0 111.443 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.7 p -98.08 159.2 15.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 117.189 -3.445 . . . . 0.0 106.079 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -58.7 -45.64 89.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.218 2.207 . . . . 0.0 109.077 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -73.43 3.04 6.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 130.569 3.548 . . . . 0.0 115.772 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.06 -8.99 50.27 Favored Glycine 0 N--CA 1.442 -0.901 2 O-C-N 114.099 -5.376 . . . . 0.0 113.102 162.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -79.15 150.6 31.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 121.73 2.765 . . . . 0.0 111.797 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 p -105.87 131.35 53.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 126.345 2.278 . . . . 0.0 111.643 161.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 pt -104.28 162.74 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 1 O-C-N 114.611 -5.055 . . . . 0.0 105.469 168.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.53 110.27 14.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.635 2.374 . . . . 0.0 106.011 -172.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.282 0.4 OUTLIER -104.48 138.93 40.12 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 128.316 2.646 . . . . 0.0 109.803 -173.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.45 ' CD ' ' HZ3' ' A' ' 33' ' ' LYS . 20.1 pm0 -90.15 135.81 33.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 126.821 2.576 . . . . 0.0 108.769 159.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 m -150.37 149.41 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.15 3.38 . . . . 0.0 107.418 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -101.87 141.88 23.47 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 127.939 2.496 . . . . 0.0 105.249 163.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -39.04 -42.76 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 N-CA-C 119.759 2.946 . . . . 0.0 119.759 167.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 p -88.15 14.75 8.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.422 2.689 . . . . 0.0 109.934 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -88.71 150.92 22.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 124.987 2.327 . . . . 0.0 105.661 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -86.99 146.74 26.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 110.442 -3.072 . . . . 0.0 110.206 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.5 mt -57.17 -24.81 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 124.864 1.353 . . . . 0.0 112.145 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.64 -34.16 73.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 128.239 2.616 . . . . 0.0 110.336 172.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -72.04 -31.85 66.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 114.103 -2.856 . . . . 0.0 107.305 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.4 t -79.46 -33.63 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 123.895 3.043 . . . . 0.0 107.68 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -54.85 -49.59 70.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 112.519 -3.61 . . . . 0.0 110.576 168.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.45 -52.33 6.11 Favored 'General case' 0 CA--C 1.537 0.468 1 CA-C-N 126.396 4.18 . . . . 0.0 119.426 156.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -74.09 -22.8 59.35 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 117.038 -3.539 . . . . 0.0 116.511 -169.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.0 mt -66.44 -39.0 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 130.951 3.701 . . . . 0.0 113.373 158.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.44 -26.82 64.79 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 122.841 2.564 . . . . 0.0 109.171 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.49 -42.38 74.87 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 128.436 3.585 . . . . 0.0 110.11 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 32.9 mmtt -76.39 -42.63 43.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 176.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 13.8 tp10 -130.19 5.77 4.9 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.491 -1.38 . . . . 0.0 109.972 -159.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.09 -0.93 35.99 Favored Glycine 0 CA--C 1.532 1.109 1 N-CA-C 123.598 4.199 . . . . 0.0 123.598 165.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 mt -78.05 114.97 46.76 Favored Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 129.696 3.198 . . . . 0.0 105.325 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.264 4.9 Cg_exo -48.52 134.67 26.72 Favored 'Trans proline' 0 N--CA 1.455 -0.768 1 C-N-CA 125.413 4.076 . . . . 0.0 111.554 172.517 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.21 -37.01 26.28 Favored 'Trans proline' 0 N--CA 1.44 -1.656 1 C-N-CA 129.156 6.571 . . . . 0.0 115.15 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -39.49 -31.89 0.11 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 129.65 3.18 . . . . 0.0 115.756 159.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.387 85.5 mt-30 -98.26 -13.42 20.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 118.989 -2.319 . . . . 0.0 114.78 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -81.6 143.08 32.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.2 ttp-105 -127.77 129.66 47.43 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 155.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.4 mt -96.23 132.98 41.11 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 116.672 -3.767 . . . . 0.0 107.297 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mt -125.44 149.57 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -113.64 -25.84 8.52 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 118.203 -2.811 . . . . 0.0 113.076 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.683 . . -143.43 -123.86 0.09 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 112.266 -2.243 . . . . 0.0 110.773 -170.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.93 18.41 19.22 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.666 0.592 . . . . 0.0 112.436 -166.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -151.65 154.77 37.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 118.182 -2.952 . . . . 0.0 110.383 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -57.73 156.33 8.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.802 1.641 . . . . 0.0 112.537 166.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.19 162.72 18.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 118.811 -2.43 . . . . 0.0 108.195 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -104.62 140.86 37.4 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.95 1.357 . . . . 0.0 109.132 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.97 -24.2 65.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 130.01 3.324 . . . . 0.0 114.594 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.12 40.77 2.43 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.479 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 11.1 mtt180 -130.37 151.17 51.16 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 165.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -96.6 162.27 13.53 Favored 'General case' 0 N--CA 1.45 -0.428 1 O-C-N 116.253 -4.03 . . . . 0.0 111.424 -167.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -54.67 -44.0 72.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.034 1.733 . . . . 0.0 110.617 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -61.27 -40.98 96.13 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 170.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -54.17 -33.13 57.32 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 131.296 3.838 . . . . 0.0 114.807 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 97.1 m-85 -100.13 0.04 39.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.276 -1.515 . . . . 0.0 111.732 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.7 t30 56.63 36.19 27.26 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 129.28 3.032 . . . . 0.0 117.588 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mt -79.28 116.21 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 103.204 -2.888 . . . . 0.0 103.204 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -103.44 169.35 8.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.598 1.959 . . . . 0.0 109.204 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.385 53.7 pttt -50.22 133.4 23.7 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.343 1.857 . . . . 0.0 113.42 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 24.0 mt-10 72.12 12.35 5.93 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 130.339 3.455 . . . . 0.0 115.488 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.9 m -60.86 145.31 50.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 113.97 -2.919 . . . . 0.0 112.864 162.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -102.39 131.26 49.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 127.698 3.124 . . . . 0.0 105.154 170.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.75 151.73 25.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.634 -2.541 . . . . 0.0 108.621 161.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -109.47 128.48 55.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 117.917 -2.99 . . . . 0.0 105.595 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.0 tp -106.21 103.07 12.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 112.11 -2.313 . . . . 0.0 109.673 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.1 t -83.23 137.17 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 124.498 2.095 . . . . 0.0 110.574 169.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 126.313 1.845 . . . . 0.0 107.274 -157.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.32 135.83 33.17 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 119.547 -1.971 . . . . 0.0 106.81 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.44 164.08 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 123.961 0.904 . . . . 0.0 112.018 166.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -90.57 129.94 36.65 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 126.092 1.757 . . . . 0.0 110.347 155.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.03 110.51 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 150.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -99.1 134.12 42.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 127.222 3.391 . . . . 0.0 110.926 170.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 p -89.15 141.36 28.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 111.706 -2.497 . . . . 0.0 108.759 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.06 -11.08 35.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 163.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -78.91 -15.55 58.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 118.212 -2.805 . . . . 0.0 115.069 169.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.19 -12.09 6.09 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 120.211 1.369 . . . . 0.0 113.64 159.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -82.95 137.19 34.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.522 1.529 . . . . 0.0 110.612 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -97.67 125.97 42.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 125.201 2.429 . . . . 0.0 106.507 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 mm -112.8 106.06 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 1 O-C-N 115.646 -4.409 . . . . 0.0 101.567 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.4 m -59.91 137.11 58.15 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 122.868 1.318 . . . . 0.0 111.618 158.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.29 140.54 43.47 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 128.584 2.754 . . . . 0.0 109.168 177.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -111.66 121.71 45.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.0 162.54 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 128.864 2.866 . . . . 0.0 104.787 -177.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -111.3 162.53 20.5 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 160.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -88.72 -21.71 1.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 121.735 1.623 . . . . 0.0 109.386 -164.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -69.09 -6.13 26.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 159.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -71.57 137.24 47.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 119.82 -1.8 . . . . 0.0 112.593 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.315 42.7 p -60.44 142.71 54.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 128.414 2.685 . . . . 0.0 112.74 169.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.444 62.6 mt -46.79 -29.58 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 163.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -53.83 -56.27 19.14 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 131.699 4.0 . . . . 0.0 108.013 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -74.75 -28.47 60.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 116.527 -1.701 . . . . 0.0 112.018 -171.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 t -71.01 -51.13 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 128.381 2.672 . . . . 0.0 111.743 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -55.37 -45.37 76.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 113.456 -3.164 . . . . 0.0 113.317 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.5 -17.03 63.5 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 131.291 3.837 . . . . 0.0 115.324 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -77.55 -32.54 53.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 112.946 -3.407 . . . . 0.0 107.317 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.51 -21.81 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 O-C-N 127.062 2.726 . . . . 0.0 108.097 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -67.57 -35.64 79.42 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 128.534 2.734 . . . . 0.0 112.864 164.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.66 -33.13 60.4 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.277 1.031 . . . . 0.0 111.646 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -81.55 -77.33 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 119.725 -1.86 . . . . 0.0 109.391 -172.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.269 15.9 mm-40 -100.9 -15.4 17.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 115.034 -2.412 . . . . 0.0 114.604 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.05 -1.72 40.95 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 121.749 2.068 . . . . 0.0 110.331 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -76.22 130.63 77.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 114.953 -2.451 . . . . 0.0 106.641 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.53 149.73 16.69 Favored 'Trans proline' 0 N--CA 1.446 -1.319 1 C-N-CA 125.991 4.461 . . . . 0.0 111.317 -174.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -40.01 -37.42 1.68 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 N-CA-C 119.475 2.837 . . . . 0.0 119.475 165.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -45.7 -49.06 14.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.153 1.781 . . . . 0.0 114.292 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -99.72 -3.4 32.99 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 127.47 2.308 . . . . 0.0 116.976 -169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -80.23 127.56 32.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 125.144 2.402 . . . . 0.0 108.979 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.488 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 36.4 mtm180 -112.79 127.06 56.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 119.418 -2.051 . . . . 0.0 105.824 165.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.02 124.8 50.72 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 131.331 3.852 . . . . 0.0 107.577 -163.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 mm -124.89 128.82 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 117.12 -3.488 . . . . 0.0 109.445 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -153.68 136.99 15.73 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 118.529 -2.607 . . . . 0.0 109.701 163.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.385 . . 66.35 32.07 7.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 124.339 2.019 . . . . 0.0 115.123 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 -12.33 32.6 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 112.38 -2.191 . . . . 0.0 116.199 -174.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.261 9.9 ttpt -100.84 136.63 40.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.45 -1.617 . . . . 0.0 109.175 -167.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -92.82 116.47 29.06 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 171.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 mt -81.09 143.19 32.62 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 126.446 2.341 . . . . 0.0 105.239 -163.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.98 150.43 29.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.018 2.927 . . . . 0.0 109.356 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.67 155.33 33.47 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 117.988 -2.945 . . . . 0.0 111.361 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.77 48.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 127.111 2.291 . . . . 0.0 114.821 162.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -94.71 160.62 14.53 Favored 'General case' 0 N--CA 1.446 -0.664 1 C-N-CA 135.444 5.498 . . . . 0.0 113.878 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.4 p -103.91 170.8 7.71 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -72.51 -18.3 61.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 123.828 1.775 . . . . 0.0 108.305 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -78.68 -22.45 46.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.316 -2.115 . . . . 0.0 112.118 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -83.98 4.22 30.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -118.33 -7.38 10.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 118.091 -2.88 . . . . 0.0 108.529 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 10.8 p30 59.71 37.65 22.12 Favored 'General case' 0 N--CA 1.449 -0.511 1 C-N-CA 134.402 5.081 . . . . 0.0 114.149 -172.224 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -69.49 137.46 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 O-C-N 120.646 -1.284 . . . . 0.0 112.298 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -127.74 169.87 13.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.323 3.049 . . . . 0.0 109.48 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -42.33 131.89 3.56 Favored 'General case' 0 N--CA 1.45 -0.437 1 C-N-CA 136.415 5.886 . . . . 0.0 107.938 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.328 2.2 tt0 69.37 12.97 8.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 172.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.5 m -65.27 149.21 50.34 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.786 2.435 . . . . 0.0 108.145 166.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.4 m -101.63 120.84 40.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.238 -3.414 . . . . 0.0 102.557 166.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.37 37.8 mt -101.35 158.48 16.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.053 1.406 . . . . 0.0 110.435 162.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.301 79.2 m80 -117.41 133.5 55.9 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 119.279 -2.138 . . . . 0.0 108.947 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.28 120.18 39.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 124.876 2.274 . . . . 0.0 107.089 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.488 HG11 ' CZ ' ' A' ' 42' ' ' ARG . 96.4 t -99.99 136.76 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.498 171.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.1 tp . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 101.062 -3.681 . . . . 0.0 101.062 -177.159 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 ttp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 102.016 -3.327 . . . . 0.0 102.016 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -99.47 145.32 27.58 Favored 'General case' 0 N--CA 1.444 -0.738 2 CA-C-O 111.552 -4.071 . . . . 0.0 108.103 170.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -120.33 159.02 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 115.653 -2.118 . . . . 0.0 110.956 150.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -99.41 132.01 45.03 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 128.719 3.762 . . . . 0.0 107.298 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.45 145.36 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 O-C-N 126.674 2.484 . . . . 0.0 105.257 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -114.56 140.32 48.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 127.904 2.481 . . . . 0.0 108.616 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -100.27 170.63 8.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 125.995 2.807 . . . . 0.0 105.116 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.5 mt -57.07 -32.11 65.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.126 -2.306 . . . . 0.0 109.918 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.0 p -86.6 -9.36 56.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 117.575 -3.203 . . . . 0.0 110.343 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.75 11.31 38.13 Favored Glycine 0 CA--C 1.532 1.134 1 C-N-CA 135.108 6.099 . . . . 0.0 114.762 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -82.54 129.26 34.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 -162.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 48.1 m -96.47 126.06 41.39 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.088 0.955 . . . . 0.0 110.718 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -120.03 151.46 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 119.605 -1.934 . . . . 0.0 106.574 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.271 4.8 m -118.0 91.21 3.51 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 128.021 2.528 . . . . 0.0 106.579 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -83.0 150.19 26.51 Favored 'General case' 0 N--CA 1.444 -0.736 1 CA-C-N 107.991 -4.186 . . . . 0.0 112.053 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.88 108.07 18.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.446 1.898 . . . . 0.0 108.121 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.61 -176.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 1 C-N-CA 134.168 4.987 . . . . 0.0 116.492 173.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -152.12 159.83 32.34 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 103.007 -2.96 . . . . 0.0 103.007 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 75.1 Cg_exo -41.89 -24.42 0.29 Allowed 'Trans proline' 0 N--CA 1.443 -1.498 1 C-N-CA 128.004 5.803 . . . . 0.0 121.697 174.824 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.9 p -78.6 1.92 21.05 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 129.853 3.261 . . . . 0.0 115.182 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.45 130.01 45.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -76.98 178.71 6.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 113.916 -2.945 . . . . 0.0 112.298 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 mm -76.19 -24.62 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 113.956 -2.926 . . . . 0.0 109.197 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -72.99 -41.6 64.16 Favored 'General case' 0 C--O 1.242 0.691 1 C-N-CA 132.697 4.399 . . . . 0.0 105.062 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -65.29 -30.41 71.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.684 -2.51 . . . . 0.0 115.623 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -87.71 -35.9 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 1 CA-C-O 108.545 -5.502 . . . . 0.0 108.219 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.03 -29.57 70.48 Favored 'General case' 0 C--N 1.324 -0.51 1 CA-C-N 126.71 4.323 . . . . 0.0 114.45 169.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.87 80.78 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 125.502 2.572 . . . . 0.0 114.079 167.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -72.9 -37.2 67.33 Favored 'General case' 0 C--N 1.326 -0.414 1 O-C-N 115.117 -4.739 . . . . 0.0 108.967 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.2 mt -50.81 -65.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 128.019 2.528 . . . . 0.0 114.459 160.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -35.99 -43.58 0.33 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.206 2.202 . . . . 0.0 112.423 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -60.32 -42.02 94.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.918 3.287 . . . . 0.0 118.219 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -102.61 -29.31 11.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.011 -2.359 . . . . 0.0 114.776 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -119.08 -13.01 9.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 118.299 2.704 . . . . 0.0 118.299 -169.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.79 -12.56 68.47 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 114.278 -3.512 . . . . 0.0 118.655 162.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mt -73.12 123.2 89.29 Favored Pre-proline 0 N--CA 1.451 -0.403 1 O-C-N 130.414 4.244 . . . . 0.0 104.957 -162.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.14 145.72 33.29 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 123.79 2.994 . . . . 0.0 113.786 170.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.06 -30.33 21.06 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 N-CA-C 117.033 1.897 . . . . 0.0 117.033 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.23 -35.34 36.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 124.156 1.932 . . . . 0.0 109.109 -158.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -80.53 -19.38 45.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.83 144.98 31.65 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 117.994 -1.003 . . . . 0.0 111.542 -172.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -142.01 150.94 41.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 114.165 -2.826 . . . . 0.0 111.449 172.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.45 121.07 41.62 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 128.277 3.486 . . . . 0.0 108.084 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.4 mm -103.36 141.58 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 1 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -139.11 127.55 22.94 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 100.94 -3.726 . . . . 0.0 100.94 171.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.71 46.13 17.81 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 129.5 3.12 . . . . 0.0 107.831 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.07 -12.44 1.69 Allowed Glycine 0 CA--C 1.535 1.343 0 O-C-N 116.73 -3.731 . . . . 0.0 120.577 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -97.46 137.35 36.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.219 2.608 . . . . 0.0 108.711 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.13 140.08 57.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.909 1.381 . . . . 0.0 108.269 165.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.8 mt -81.42 109.75 16.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 131.052 3.741 . . . . 0.0 104.548 164.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -94.45 136.68 34.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.459 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -47.77 141.26 5.69 Favored 'General case' 0 C--N 1.328 -0.347 1 C-N-CA 132.846 4.459 . . . . 0.0 116.241 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.66 -30.66 7.95 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.498 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -100.78 161.82 13.33 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 117.092 -3.593 . . . . 0.0 107.542 -173.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -102.65 -176.17 3.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.535 -1.666 . . . . 0.0 108.009 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.97 -34.25 77.98 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 119.041 -2.287 . . . . 0.0 113.155 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.5 m -62.39 -37.51 86.02 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -62.92 -20.06 64.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.619 1.968 . . . . 0.0 116.055 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -114.87 -5.34 12.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.143 2.177 . . . . 0.0 111.904 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 t30 55.53 54.54 8.32 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.799 1.937 . . . . 0.0 114.684 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.0 mt -88.8 132.38 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.8 0.809 . . . . 0.0 109.168 -176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -98.32 150.89 21.09 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.383 2.273 . . . . 0.0 109.317 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.556 ' HZ1' ' CD ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -46.13 135.2 7.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 127.795 3.184 . . . . 0.0 109.799 154.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.556 ' CD ' ' HZ1' ' A' ' 63' ' ' LYS 0.417 0.0 OUTLIER 84.6 -6.21 0.99 Allowed 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 125.877 1.986 . . . . 0.0 115.207 166.228 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 t -88.17 140.2 29.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 128.004 3.315 . . . . 0.0 108.085 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.1 m -92.89 129.35 38.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -164.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.08 128.97 54.85 Favored 'General case' 0 N--CA 1.447 -0.621 1 C-N-CA 133.744 4.818 . . . . 0.0 111.659 171.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.14 141.0 29.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 123.999 3.091 . . . . 0.0 107.669 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -116.02 92.17 3.82 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 126.762 3.173 . . . . 0.0 103.154 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -93.46 158.25 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 112.653 -2.067 . . . . 0.0 110.435 170.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 129.805 3.242 . . . . 0.0 106.482 169.554 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 ttp . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.264 19.2 tm0? -109.78 123.91 50.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 125.732 2.682 . . . . 0.0 107.397 -172.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 pt -110.46 155.47 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 129.144 2.977 . . . . 0.0 108.261 155.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -110.81 160.55 16.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 125.088 2.375 . . . . 0.0 106.652 171.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 t -123.17 134.35 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 110.087 -3.233 . . . . 0.0 108.505 166.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 tttt -115.83 157.4 24.47 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 127.894 3.246 . . . . 0.0 110.406 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.312 7.9 t -147.72 161.06 41.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.754 2.821 . . . . 0.0 108.751 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -28.13 -45.94 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.445 1 C-N-CA 135.863 5.665 . . . . 0.0 119.859 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -79.33 -16.89 55.61 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.708 2.803 . . . . 0.0 114.24 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.61 -12.17 58.05 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 117.489 -1.728 . . . . 0.0 113.673 -171.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -55.33 150.34 11.55 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.336 22.7 p -130.44 149.91 51.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 117.801 -3.062 . . . . 0.0 115.3 168.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.38 117.55 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 100.818 -3.771 . . . . 0.0 100.818 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.283 9.0 t -106.07 122.23 45.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.151 3.38 . . . . 0.0 107.954 170.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.285 42.1 mt -113.29 134.95 54.34 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.292 3.037 . . . . 0.0 108.306 162.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -81.17 109.89 16.14 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 100.887 -3.746 . . . . 0.0 100.887 168.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -114.8 145.21 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 125.746 2.689 . . . . 0.0 111.713 -172.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.296 3.8 tt0 -103.35 116.87 61.44 Favored Pre-proline 0 C--N 1.324 -0.532 1 C-N-CA 131.745 4.018 . . . . 0.0 106.451 -176.033 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.318 50.5 Cg_exo -32.6 -42.56 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 1 N-CA-C 122.762 4.101 . . . . 0.0 122.762 -178.283 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.6 p -80.14 -7.74 59.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 131.1 3.76 . . . . 0.0 120.357 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -68.72 126.71 30.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 124.383 1.052 . . . . 0.0 113.204 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.4 p -70.28 146.83 50.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.346 20.2 mm -51.84 -31.18 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.462 1.905 . . . . 0.0 112.439 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.69 -33.63 18.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 123.15 1.452 . . . . 0.0 109.711 -170.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.18 -36.27 83.51 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 118.923 -2.361 . . . . 0.0 117.009 165.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.0 t -63.55 -49.01 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 116.646 -1.645 . . . . 0.0 111.466 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -57.75 -29.05 64.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 118.374 2.731 . . . . 0.0 118.374 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.63 -18.09 30.41 Favored 'General case' 0 CA--C 1.537 0.456 1 C-N-CA 132.257 4.223 . . . . 0.0 108.309 -176.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -90.44 -26.94 19.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.374 1.443 . . . . 0.0 110.646 169.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -71.0 -31.37 45.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 129.491 3.117 . . . . 0.0 108.114 172.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -56.42 -44.54 80.48 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 126.896 2.622 . . . . 0.0 113.705 172.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.39 -47.7 84.95 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.105 2.162 . . . . 0.0 109.958 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -67.84 -69.18 0.33 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 128.167 2.587 . . . . 0.0 108.646 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -88.08 -32.83 18.53 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 121.176 3.769 . . . . 0.0 121.176 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.27 5.05 35.08 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 127.79 2.614 . . . . 0.0 114.384 172.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -93.63 135.07 25.54 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 101.289 -3.597 . . . . 0.0 101.289 -174.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.89 148.01 21.87 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 O-C-N 125.122 2.117 . . . . 0.0 110.817 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -53.99 -30.37 58.83 Favored 'Trans proline' 0 N--CA 1.447 -1.263 1 C-N-CA 128.597 6.198 . . . . 0.0 118.427 -170.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -61.77 -27.01 68.43 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 130.585 3.554 . . . . 0.0 110.105 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -91.34 -12.95 33.47 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 117.159 -1.4 . . . . 0.0 113.008 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -89.12 121.71 31.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 122.722 2.51 . . . . 0.0 111.703 -174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -88.15 110.06 20.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 151.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.7 mt -91.92 92.01 8.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 153.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mt -96.88 137.02 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 128.914 2.886 . . . . 0.0 105.23 -173.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -116.56 -149.85 0.45 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 115.214 -2.327 . . . . 0.0 107.764 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 66.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 131.233 3.813 . . . . 0.0 115.465 171.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.99 -22.51 0.75 Allowed Glycine 0 CA--C 1.533 1.171 1 C-N-CA 130.906 4.098 . . . . 0.0 117.343 -164.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -82.92 128.93 34.9 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 120.718 -1.46 . . . . 0.0 113.494 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.306 19.9 mp0 -90.73 107.99 19.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 126.078 2.111 . . . . 0.0 105.711 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.61 107.44 1.4 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.913 2.485 . . . . 0.0 113.123 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.45 142.18 32.12 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.966 2.906 . . . . 0.0 110.884 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -67.92 109.94 3.65 Favored 'General case' 0 N--CA 1.45 -0.466 1 C-N-CA 133.431 4.692 . . . . 0.0 109.616 -172.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.43 -8.59 58.7 Favored Glycine 0 CA--C 1.528 0.845 1 CA-C-O 112.669 -4.406 . . . . 0.0 113.039 -171.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.72 153.65 38.75 Favored 'General case' 0 C--N 1.323 -0.553 1 CA-C-N 125.18 4.49 . . . . 0.0 110.258 165.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.259 67.7 p -77.38 -178.56 5.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 124.253 1.977 . . . . 0.0 106.475 169.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.293 26.0 mt -77.15 -38.46 51.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.383 164.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.8 t -62.42 -23.24 66.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 112.191 -3.766 . . . . 0.0 111.609 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.96 -35.43 74.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 122.011 2.187 . . . . 0.0 109.215 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -100.66 8.4 43.37 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 128.327 2.651 . . . . 0.0 108.911 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.32 2.3 p-10 52.96 46.32 27.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.152 1.781 . . . . 0.0 115.614 170.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.251 24.9 mt -92.46 117.52 35.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 123.662 1.696 . . . . 0.0 110.06 -167.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -98.85 169.01 9.76 Favored 'General case' 0 N--CA 1.45 -0.448 1 O-C-N 116.138 -4.101 . . . . 0.0 112.776 -176.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.291 20.6 pttt -37.88 152.18 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 115.512 -2.185 . . . . 0.0 115.283 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 77.05 -9.91 1.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.3 m -62.58 132.09 51.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 119.406 -2.059 . . . . 0.0 116.184 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.4 m -109.31 111.13 22.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.462 ' N ' HD11 ' A' ' 67' ' ' LEU . 5.8 mp -83.53 146.39 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.622 3.569 . . . . 0.0 107.825 170.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.265 50.0 t60 -103.75 111.03 23.36 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 117.364 -3.335 . . . . 0.0 111.975 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.3 1.3 tt -90.78 131.43 36.44 Favored 'General case' 0 N--CA 1.45 -0.468 1 O-C-N 131.093 5.246 . . . . 0.0 104.907 -175.402 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.343 16.7 m -147.19 169.28 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 128.515 2.726 . . . . 0.0 111.236 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.284 10.9 tp . . . . . 0 N--CA 1.446 -0.646 0 C-N-CA 128.931 2.892 . . . . 0.0 107.42 -172.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -113.82 140.29 48.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 124.082 1.896 . . . . 0.0 108.528 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 pt -146.44 160.01 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 100.428 -3.915 . . . . 0.0 100.428 172.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.387 31.3 m-85 -105.36 134.74 47.97 Favored 'General case' 0 N--CA 1.445 -0.694 1 CA-C-N 107.749 -4.296 . . . . 0.0 105.13 -173.116 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 t -106.45 132.09 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 119.706 -1.872 . . . . 0.0 107.549 166.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -84.78 123.69 30.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 159.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.0 p -80.27 167.74 19.91 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.675 2.39 . . . . 0.0 116.297 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -60.67 -10.97 6.02 Favored 'General case' 0 C--N 1.321 -0.646 1 C-N-CA 133.211 4.605 . . . . 0.0 113.742 175.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -122.62 2.41 9.54 Favored 'General case' 0 C--N 1.33 -0.249 1 O-C-N 114.033 -5.417 . . . . 0.0 117.205 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.24 -14.02 28.33 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 117.9 1.92 . . . . 0.0 117.9 166.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -82.28 167.18 18.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.591 2.356 . . . . 0.0 110.471 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.5 m -111.98 121.38 44.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 129.728 3.211 . . . . 0.0 105.476 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.31 19.4 pt -103.57 146.19 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 128.786 2.834 . . . . 0.0 103.987 163.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 m -78.54 153.3 31.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 129.074 2.95 . . . . 0.0 109.963 149.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.83 159.63 43.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 126.87 3.224 . . . . 0.0 105.755 161.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.66 112.56 19.03 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 126.782 3.182 . . . . 0.0 107.513 -171.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.41 165.19 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 116.774 -3.704 . . . . 0.0 107.648 -173.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.283 1.6 tm-20 -103.85 149.29 37.01 Favored Pre-proline 0 N--CA 1.44 -0.967 0 O-C-N 118.387 -2.695 . . . . 0.0 108.613 161.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -53.64 -18.65 12.35 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 125.191 3.927 . . . . 0.0 114.344 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.9 p -77.22 -7.77 56.45 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 119.321 3.082 . . . . 0.0 119.321 170.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.36 126.97 29.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.601 1.191 . . . . 0.0 110.833 164.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.5 p -89.41 163.91 15.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 117.331 -1.748 . . . . 0.0 108.953 170.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.325 0.9 OUTLIER -34.77 -51.53 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 113.09 -3.338 . . . . 0.0 113.481 173.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.262 3.5 tp10 -67.07 -23.71 65.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 129.34 3.056 . . . . 0.0 114.696 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -74.11 -40.33 62.75 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 166.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.51 -40.89 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 O-C-N 118.716 -2.49 . . . . 0.0 106.11 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -43.28 -45.69 5.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 129.471 3.109 . . . . 0.0 118.173 172.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.81 -37.48 48.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.769 2.028 . . . . 0.0 109.828 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.371 78.0 mttt -61.2 -43.6 98.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 124.85 2.262 . . . . 0.0 111.475 177.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.45 -53.3 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 127.94 2.496 . . . . 0.0 107.262 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -49.35 -48.55 46.53 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 117.632 -3.168 . . . . 0.0 116.003 165.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.12 -33.4 70.81 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 116.834 -1.555 . . . . 0.0 110.888 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -97.29 -51.47 4.17 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 123.449 2.84 . . . . 0.0 107.648 -172.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -102.81 -31.08 10.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 127.561 2.344 . . . . 0.0 113.347 -167.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.76 9.87 24.0 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 163.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mt -90.11 127.11 54.78 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 118.756 1.278 . . . . 0.0 107.997 -162.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.75 130.22 33.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 125.289 3.992 . . . . 0.0 114.42 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.25 2.4 Cg_endo -72.63 -2.82 12.41 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.239 1.959 . . . . 0.0 113.564 173.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -79.42 -14.17 59.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 160.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -98.6 -25.97 14.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.212 1.805 . . . . 0.0 108.551 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -86.05 111.56 20.43 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 115.476 -2.202 . . . . 0.0 108.89 -172.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -105.5 148.5 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 128.164 3.415 . . . . 0.0 106.489 154.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.56 113.68 26.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 131.308 3.843 . . . . 0.0 110.597 157.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mm -122.49 119.85 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -143.32 111.53 6.19 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.898 -1.955 . . . . 0.0 107.501 -167.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 73.49 24.87 2.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 129.583 3.153 . . . . 0.0 112.408 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.65 7.58 50.78 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-O 115.347 -2.919 . . . . 0.0 114.797 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -138.69 150.72 46.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 123.686 3.743 . . . . 0.0 108.216 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -66.16 135.49 54.6 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 111.237 -2.71 . . . . 0.0 111.793 161.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.4 mt -91.62 149.54 21.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 117.638 -1.173 . . . . 0.0 107.96 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.254 10.1 tp10 -142.07 166.78 23.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.39 2.276 . . . . 0.0 115.378 -149.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.72 122.61 18.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.265 2.226 . . . . 0.0 115.053 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.71 -21.9 17.85 Favored Glycine 0 CA--C 1.537 1.418 0 O-C-N 120.337 -1.477 . . . . 0.0 111.289 163.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.319 0.3 OUTLIER -78.69 138.31 38.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.841 1.656 . . . . 0.0 108.038 169.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.8 p -84.1 156.79 21.98 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.2 mt -42.94 -39.54 2.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 160.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.416 3.8 p -54.49 -46.33 73.41 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 117.426 -3.296 . . . . 0.0 117.223 161.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -65.04 -13.24 57.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 122.665 2.484 . . . . 0.0 114.029 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -104.5 10.0 35.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 119.527 -1.983 . . . . 0.0 111.681 172.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 60.46 18.74 8.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 130.312 3.445 . . . . 0.0 115.77 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.9 mt -72.92 122.63 26.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -115.5 143.5 45.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.147 3.379 . . . . 0.0 112.474 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -30.2 131.73 0.08 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.441 2.697 . . . . 0.0 116.116 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 78.57 23.74 0.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.963 2.905 . . . . 0.0 111.128 164.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.6 m -97.97 161.06 13.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 129.137 2.975 . . . . 0.0 113.301 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -102.9 118.56 37.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 112.751 -3.5 . . . . 0.0 111.017 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 mt -93.17 162.86 13.85 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 125.806 1.941 . . . . 0.0 108.138 160.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -125.54 158.74 33.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.972 2.509 . . . . 0.0 109.097 171.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.316 4.8 tt -115.08 149.57 37.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 131.356 3.862 . . . . 0.0 112.244 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.4 t -124.89 118.2 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 116.51 -1.709 . . . . 0.0 111.844 171.032 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttp . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 116.739 -1.6 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -100.49 134.17 43.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 -154.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.3 pt -117.32 150.01 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.93 158.07 15.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 118.667 -2.521 . . . . 0.0 108.835 162.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -140.34 138.25 36.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 173.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -112.13 128.23 56.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.546 2.338 . . . . 0.0 104.72 172.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.284 21.8 m -94.89 140.21 30.24 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 111.215 -2.721 . . . . 0.0 104.573 169.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tt -24.14 -39.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 131.204 3.802 . . . . 0.0 118.952 165.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -67.32 -10.55 51.99 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 118.913 -2.367 . . . . 0.0 117.122 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.78 14.41 55.17 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 118.908 -2.37 . . . . 0.0 109.193 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -90.9 121.44 32.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 130.755 3.622 . . . . 0.0 106.062 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.2 m -103.72 138.94 39.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.066 2.546 . . . . 0.0 105.312 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.1 172.27 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 128.313 2.645 . . . . 0.0 104.661 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 t -139.8 139.66 36.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 118.137 -2.852 . . . . 0.0 112.864 172.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 mp -132.08 132.55 43.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 128.275 3.484 . . . . 0.0 105.749 -177.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -76.55 122.71 24.98 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 127.455 2.302 . . . . 0.0 109.456 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.34 -174.88 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -128.05 160.14 63.16 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 165.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.93 -39.01 94.55 Favored 'Trans proline' 0 N--CA 1.445 -1.343 1 C-N-CA 126.355 4.703 . . . . 0.0 112.593 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.3 m -78.91 6.78 8.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -78.29 129.04 34.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 117.271 -3.393 . . . . 0.0 107.61 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -52.55 151.48 4.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 129.269 3.028 . . . . 0.0 110.832 168.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -54.91 -39.43 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.717 2.407 . . . . 0.0 111.664 158.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -50.24 -53.23 29.65 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.531 1.932 . . . . 0.0 114.405 171.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -54.62 -35.67 63.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 165.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -75.75 -42.11 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 119.707 -1.87 . . . . 0.0 111.977 -175.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -63.81 -35.75 81.64 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 125.724 1.89 . . . . 0.0 113.655 168.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.43 58.14 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.702 1.601 . . . . 0.0 107.133 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -83.48 -44.2 14.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 118.347 -2.721 . . . . 0.0 109.847 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.374 82.3 mt -42.46 -44.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 129.975 3.31 . . . . 0.0 114.59 164.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -57.24 -43.57 83.05 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.683 1.993 . . . . 0.0 116.226 172.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.19 -41.51 63.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -63.98 -49.08 73.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 131.696 3.998 . . . . 0.0 115.674 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -144.13 -7.15 0.72 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -171.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.12 -1.15 21.01 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 119.054 -2.279 . . . . 0.0 115.313 164.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.9 mt -78.86 118.88 74.99 Favored Pre-proline 0 C--O 1.22 -0.472 0 CA-C-O 114.385 -2.721 . . . . 0.0 108.024 -162.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.7 149.19 78.83 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 O-C-N 125.783 2.465 . . . . 0.0 114.985 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.24 -32.36 1.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.447 1.432 . . . . 0.0 113.835 -165.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -86.05 7.02 26.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 129.62 3.168 . . . . 0.0 111.587 -169.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -132.38 -9.24 3.3 Favored 'General case' 0 C--N 1.325 -0.488 1 C-N-CA 132.103 4.161 . . . . 0.0 111.759 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.269 4.5 tt0 -103.03 139.24 38.84 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 128.43 2.692 . . . . 0.0 107.29 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -146.6 132.19 18.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 101.94 -3.355 . . . . 0.0 101.94 -171.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp -114.68 141.64 47.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.796 -163.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.278 77.7 mt -128.96 138.67 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 1 C-N-CA 133.049 4.54 . . . . 0.0 109.784 -178.605 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -150.61 111.14 4.22 Favored 'General case' 0 N--CA 1.448 -0.566 1 C-N-CA 131.739 4.015 . . . . 0.0 109.309 176.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.312 . . 68.56 31.06 4.91 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.85 -23.34 9.25 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.32 1.438 . . . . 0.0 111.526 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -74.3 126.67 31.15 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 110.65 6.75 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 129.304 3.042 . . . . 0.0 106.717 160.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.9 mt -82.41 128.87 34.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -78.15 159.41 28.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.578 1.551 . . . . 0.0 111.31 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -73.91 133.19 43.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.493 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.59 -15.48 55.82 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 115.11 -3.05 . . . . 0.0 111.733 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -77.21 159.7 29.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 123.043 3.421 . . . . 0.0 114.692 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -106.44 -177.77 3.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 127.935 3.272 . . . . 0.0 110.785 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.34 -18.21 46.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 128.58 2.752 . . . . 0.0 109.095 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.83 -28.41 50.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.788 2.035 . . . . 0.0 110.815 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -64.6 -31.11 72.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 126.445 3.021 . . . . 0.0 115.675 172.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.96 8.61 13.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 124.636 2.16 . . . . 0.0 115.46 -173.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.291 36.3 m-20 67.16 39.16 3.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 120.906 3.669 . . . . 0.0 120.906 163.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.2 mt -88.75 128.24 41.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.596 -164.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -98.23 165.12 12.02 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 124.824 2.25 . . . . 0.0 115.314 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -63.88 127.8 33.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.96 -2.963 . . . . 0.0 107.491 -168.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.468 0.0 OUTLIER 93.28 3.98 0.06 Allowed 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 126.297 2.248 . . . . 0.0 113.666 175.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.9 m -61.05 144.02 54.26 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 117.029 -3.544 . . . . 0.0 109.854 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -92.55 117.34 29.85 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 118.441 -2.662 . . . . 0.0 114.047 170.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.25 23.4 tp -107.12 134.42 50.27 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 125.131 1.519 . . . . 0.0 109.094 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -107.73 152.47 24.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.9 155.23 42.73 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 126.021 2.819 . . . . 0.0 107.575 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.93 137.44 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 131.439 3.896 . . . . 0.0 103.471 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.447 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 114.839 -2.505 . . . . 0.0 111.391 176.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 ttp . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 101.966 -3.346 . . . . 0.0 101.966 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -88.5 135.96 33.22 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 121.701 2.046 . . . . 0.0 114.27 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.279 44.4 pt -119.42 148.02 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 128.626 2.77 . . . . 0.0 113.771 168.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -99.55 115.89 30.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.701 2.4 . . . . 0.0 111.365 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.277 6.5 t -89.1 100.29 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 129.086 2.954 . . . . 0.0 103.053 172.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -74.11 156.83 36.98 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.242 -1.536 . . . . 0.0 114.721 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.445 13.0 t -150.71 164.46 36.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.57 171.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 tp -46.23 -39.98 10.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 121.37 3.841 . . . . 0.0 121.37 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.8 p -82.15 -1.26 48.28 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 123.849 1.785 . . . . 0.0 111.425 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.37 8.94 55.95 Favored Glycine 0 N--CA 1.443 -0.852 0 O-C-N 116.71 -3.744 . . . . 0.0 116.539 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -76.32 132.45 39.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.027 2.931 . . . . 0.0 106.733 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 p -112.94 132.6 55.28 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 108.832 -3.803 . . . . 0.0 103.261 161.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 mt -102.03 135.12 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 159.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 t -81.88 115.89 21.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 125.587 1.804 . . . . 0.0 111.511 160.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.3 tp -116.81 129.68 56.24 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -80.4 143.94 33.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.786 1.755 . . . . 0.0 110.754 170.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.97 167.86 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 128.554 2.742 . . . . 0.0 109.822 164.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.263 9.0 tt0 -105.55 147.45 34.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 110.277 -3.147 . . . . 0.0 105.713 153.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -74.88 -25.21 12.34 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.075 1.85 . . . . 0.0 110.533 -172.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -63.97 -9.34 15.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 173.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -68.04 164.03 21.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 130.036 3.334 . . . . 0.0 111.286 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 p -124.09 148.09 47.39 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 128.822 2.849 . . . . 0.0 104.949 -164.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.92 -48.41 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 110.584 -3.007 . . . . 0.0 112.988 -171.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -67.17 -36.93 82.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -66.48 -39.71 88.91 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.27 86.9 t -70.47 -39.52 76.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 125.707 1.603 . . . . 0.0 110.405 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -56.67 -29.28 62.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 168.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.82 -41.21 62.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 166.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -64.49 -31.88 73.28 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 119.861 -1.774 . . . . 0.0 109.42 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.325 55.1 mt -62.48 -35.03 67.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.313 3.445 . . . . 0.0 110.614 165.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.26 -38.86 65.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 115.071 -2.395 . . . . 0.0 106.642 -174.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.45 1.5 t70 -37.95 -41.59 0.56 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.992 2.96 . . . . 0.0 118.992 166.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -81.46 -72.16 0.44 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.072 -1.876 . . . . 0.0 115.153 171.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -84.62 -19.87 32.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 116.535 -1.697 . . . . 0.0 115.179 -170.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.08 -9.47 56.42 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 116.867 -2.074 . . . . 0.0 111.036 159.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.09 137.31 37.47 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 123.001 1.381 . . . . 0.0 108.891 -169.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -55.95 139.96 85.26 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.292 2.661 . . . . 0.0 113.579 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.63 -26.47 12.92 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.067 2.512 . . . . 0.0 117.527 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -45.0 -38.65 4.91 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 130.812 3.645 . . . . 0.0 113.607 174.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.09 -4.11 36.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.25 2.22 . . . . 0.0 109.877 -171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -98.17 117.82 33.39 Favored 'General case' 0 N--CA 1.451 -0.393 1 O-C-N 115.656 -4.403 . . . . 0.0 114.837 -170.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.258 16.4 ttm-85 -112.39 113.94 26.4 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.172 1.789 . . . . 0.0 110.881 163.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -83.21 143.51 30.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 120.59 -1.319 . . . . 0.0 109.473 163.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 tt -133.73 143.67 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 119.531 -1.981 . . . . 0.0 106.04 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -136.99 84.3 2.06 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -170.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 84.37 24.87 0.1 Allowed 'General case' 0 N--CA 1.448 -0.547 1 C-N-CA 133.205 4.602 . . . . 0.0 113.984 165.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.12 -1.85 26.92 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 119.184 -2.198 . . . . 0.0 113.674 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.353 40.8 ttmt -121.43 137.14 54.84 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.097 2.159 . . . . 0.0 107.017 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -73.04 128.09 34.46 Favored 'General case' 0 N--CA 1.442 -0.826 1 C-N-CA 135.108 5.363 . . . . 0.0 108.618 177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -93.41 132.27 37.81 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 168.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -134.42 145.86 49.29 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 131.101 3.761 . . . . 0.0 109.532 -162.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.29 144.93 29.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.075 -2.329 . . . . 0.0 110.418 -163.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.52 4.59 23.28 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 116.951 -2.027 . . . . 0.0 116.194 -166.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.337 11.7 mtm180 -125.51 177.5 6.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.004 1.402 . . . . 0.0 113.367 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.3 p -95.95 175.25 6.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 119.339 -2.101 . . . . 0.0 110.927 158.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -57.91 -30.98 66.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 159.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 t -66.75 -25.67 66.61 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 113.093 -3.337 . . . . 0.0 114.115 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.73 -19.99 54.26 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 127.39 2.931 . . . . 0.0 109.494 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.295 23.3 m-85 -108.04 6.74 27.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.11 -2.244 . . . . 0.0 110.548 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.397 0.4 OUTLIER 68.86 30.73 4.59 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.849 2.059 . . . . 0.0 112.698 163.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mt -79.16 122.47 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 O-C-N 119.293 -2.13 . . . . 0.0 110.075 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -111.62 165.57 11.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.176 1.79 . . . . 0.0 112.607 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -46.85 143.96 2.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 119.643 -1.911 . . . . 0.0 115.719 171.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 63.72 21.44 12.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 128.981 2.912 . . . . 0.0 112.254 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 m -82.89 152.67 25.46 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.12 1.768 . . . . 0.0 107.476 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.6 m -109.91 105.84 15.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 127.714 3.134 . . . . 0.0 107.862 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -82.79 154.78 24.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 163.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -117.63 148.08 42.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 118.502 -2.624 . . . . 0.0 108.436 166.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.3 tp -109.28 147.55 32.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 124.829 2.252 . . . . 0.0 105.256 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.85 175.25 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 113.683 -3.056 . . . . 0.0 107.044 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.25 13.3 tp . . . . . 0 N--CA 1.45 -0.447 0 O-C-N 128.402 3.564 . . . . 0.0 103.813 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 ttp . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -94.48 144.82 25.25 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 115.279 -2.296 . . . . 0.0 106.689 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 pt -146.57 172.66 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.842 2.457 . . . . 0.0 106.193 165.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -135.26 118.6 16.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 128.057 3.348 . . . . 0.0 107.987 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.27 129.1 44.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 131.199 3.799 . . . . 0.0 101.975 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -126.2 125.45 42.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 126.241 2.924 . . . . 0.0 111.812 172.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.3 p -84.55 151.56 24.47 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.301 80.7 mt -56.65 -10.34 0.98 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 131.105 3.762 . . . . 0.0 115.984 175.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 p -93.4 -24.3 18.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 128.724 2.81 . . . . 0.0 109.269 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.06 43.18 1.81 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.148 1.832 . . . . 0.0 116.276 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -115.56 110.11 18.76 Favored 'General case' 0 C--N 1.321 -0.641 2 C-N-CA 132.118 4.167 . . . . 0.0 110.727 169.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.6 m -85.72 111.94 20.59 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 124.44 2.067 . . . . 0.0 110.281 173.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.0 mt -100.02 116.15 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 128.089 3.804 . . . . 0.0 101.741 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.325 52.7 m -91.46 134.05 34.96 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 102.274 -3.232 . . . . 0.0 102.274 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tp -130.47 155.28 46.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.112 2.965 . . . . 0.0 110.116 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 126.31 53.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -134.53 163.77 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -101.17 148.17 34.76 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 114.305 -2.76 . . . . 0.0 106.575 174.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.95 6.77 3.98 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 CA-C-N 126.251 3.268 . . . . 0.0 113.675 -171.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -118.05 -2.95 11.16 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 114.595 -2.621 . . . . 0.0 105.666 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.97 122.87 11.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.636 2.774 . . . . 0.0 105.942 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -66.77 158.38 30.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 127.784 3.178 . . . . 0.0 116.61 161.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mm -58.46 -33.44 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 123.341 2.791 . . . . 0.0 114.36 171.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -45.29 -49.59 12.55 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 164.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -70.76 -39.06 73.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.368 71.1 t -52.3 -37.84 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 127.59 2.356 . . . . 0.0 114.021 169.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -66.92 -31.38 71.93 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 116.791 -3.693 . . . . 0.0 115.832 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.47 -36.78 32.99 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.851 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.77 -29.7 70.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 116.801 -1.571 . . . . 0.0 114.833 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.99 -43.78 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 116.398 -1.763 . . . . 0.0 111.478 166.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -59.7 -39.66 85.33 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 114.125 -2.845 . . . . 0.0 110.583 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.14 -21.48 22.78 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.515 1.134 . . . . 0.0 113.72 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.251 18.3 mmtm -109.54 -49.91 3.05 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 117.358 -3.339 . . . . 0.0 107.025 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -103.24 -9.67 19.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 113.788 -3.006 . . . . 0.0 113.661 -165.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.98 -17.7 49.32 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 121.701 2.046 . . . . 0.0 112.69 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 pt -81.2 140.22 49.18 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 117.408 0.604 . . . . 0.0 111.184 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.41 140.85 30.82 Favored 'Trans proline' 0 N--CA 1.453 -0.882 1 C-N-CA 126.731 4.954 . . . . 0.0 114.971 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -40.81 -31.08 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.316 1 C-N-CA 127.373 5.382 . . . . 0.0 119.453 173.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.83 -54.81 42.13 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 131.471 3.908 . . . . 0.0 113.839 -174.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -80.02 -7.18 58.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 126.323 2.963 . . . . 0.0 114.549 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.62 145.78 25.01 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 117.573 -3.205 . . . . 0.0 111.103 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -123.67 130.95 53.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.503 1.521 . . . . 0.0 108.814 151.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -89.54 130.88 35.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -122.34 123.93 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 112.398 -2.183 . . . . 0.0 115.424 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -147.47 144.38 28.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 130.008 3.323 . . . . 0.0 113.848 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.62 24.68 14.04 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.938 2.495 . . . . 0.0 112.816 168.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.98 -2.32 69.02 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 114.909 0.723 . . . . 0.0 114.909 -177.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -134.64 155.82 49.82 Favored 'General case' 0 N--CA 1.447 -0.619 2 O-C-N 115.031 -4.805 . . . . 0.0 112.906 -170.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -79.12 133.6 36.75 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 125.435 2.541 . . . . 0.0 106.052 164.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 mt -80.47 136.39 36.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.769 -2.014 . . . . 0.0 114.565 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -76.89 144.05 39.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 116.884 -1.926 . . . . 0.0 111.464 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -66.67 -33.07 74.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.236 -168.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.28 -5.0 49.96 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 126.33 1.919 . . . . 0.0 111.564 -165.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.306 11.4 mmt180 -74.18 149.56 40.86 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.772 2.029 . . . . 0.0 114.616 161.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -103.87 159.76 15.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 127.215 3.388 . . . . 0.0 109.489 -172.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.2 mt -48.28 -47.45 36.35 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 110.025 -3.261 . . . . 0.0 111.915 162.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -59.8 -49.88 76.0 Favored 'General case' 0 N--CA 1.443 -0.805 1 O-C-N 129.694 4.371 . . . . 0.0 119.952 167.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 50.6 m-20 -50.06 -43.72 51.26 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 121.408 3.855 . . . . 0.0 121.408 165.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -93.28 1.28 57.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 73.57 50.8 0.12 Allowed 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 119.113 -2.242 . . . . 0.0 104.976 168.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.1 69.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 118.459 -2.65 . . . . 0.0 104.932 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -127.52 72.97 1.41 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.357 -147.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.416 10.9 tmtt? 89.03 90.87 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 O-C-N 125.285 1.616 . . . . 0.0 112.363 171.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 86.41 47.3 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 110.665 -2.971 . . . . 0.0 110.693 158.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 p -117.05 159.06 23.12 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.746 1.26 . . . . 0.0 108.733 171.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.5 m -108.8 137.46 46.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 125.495 2.569 . . . . 0.0 109.118 -172.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.256 0.9 OUTLIER -113.84 143.57 44.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 111.711 -2.495 . . . . 0.0 107.306 -173.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -90.49 136.85 32.8 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 130.481 3.512 . . . . 0.0 107.47 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.3 tp -121.32 113.9 20.57 Favored 'General case' 0 N--CA 1.451 -0.405 1 C-N-CA 131.754 4.022 . . . . 0.0 107.486 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -117.56 133.16 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 129.288 3.035 . . . . 0.0 104.388 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 125.811 2.72 . . . . 0.0 111.454 -166.939 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 113.788 -3.006 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.253 59.2 tt0 -104.57 164.82 11.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 125.586 1.804 . . . . 0.0 109.522 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -145.51 164.91 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 1 C-N-CA 134.746 5.219 . . . . 0.0 107.053 168.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.2 147.08 41.79 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 118.922 -2.361 . . . . 0.0 111.782 175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.68 113.66 28.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 113.333 -3.222 . . . . 0.0 106.558 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -87.74 143.73 27.0 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 126.522 2.388 . . . . 0.0 110.123 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -117.09 158.73 23.7 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 126.192 2.182 . . . . 0.0 109.49 -171.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.6 mt -50.44 -50.29 52.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 116.826 -3.671 . . . . 0.0 116.973 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -138.11 34.14 2.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.21 -123.84 2.52 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 -172.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -138.47 -167.85 2.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.677 1.991 . . . . 0.0 111.204 -166.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 p -89.75 119.99 30.62 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.083 0.856 . . . . 0.0 110.909 149.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.2 mt -80.55 143.45 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 167.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.264 71.9 p -114.68 122.31 46.06 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 113.931 -2.937 . . . . 0.0 108.221 -169.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.419 HD23 HG12 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -128.68 134.22 48.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 122.3 2.318 . . . . 0.0 104.906 174.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.85 118.91 37.8 Favored 'General case' 0 N--CA 1.44 -0.962 1 N-CA-C 99.909 -4.108 . . . . 0.0 99.909 172.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.45 149.64 33.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 130.102 3.361 . . . . 0.0 107.478 -167.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -74.19 137.02 75.47 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -62.64 -5.48 7.26 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 CA-C-O 115.817 -1.826 . . . . 0.0 115.921 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.4 p -115.18 23.45 12.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -81.36 160.92 23.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 126.717 2.51 . . . . 0.0 115.498 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 p -102.28 140.79 36.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 131.595 3.958 . . . . 0.0 107.23 -162.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.3 mt -47.96 -47.1 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 125.803 1.641 . . . . 0.0 112.979 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.75 -38.59 89.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.989 1.722 . . . . 0.0 112.025 -173.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -72.45 -12.73 61.22 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.114 2.166 . . . . 0.0 110.797 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 t -99.42 -27.39 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 1 CA-C-O 110.642 -4.504 . . . . 0.0 106.288 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -56.73 -42.97 80.17 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 128.28 3.488 . . . . 0.0 109.907 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.17 -42.41 77.03 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.717 3.607 . . . . 0.0 112.001 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -64.26 -35.36 80.58 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.419 HG12 HD23 ' A' ' 15' ' ' LEU . 61.5 mt -72.91 -28.07 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.461 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -52.49 35.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 117.105 -3.497 . . . . 0.0 114.681 166.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.94 -30.17 63.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -101.31 -33.16 10.15 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.401 1.455 . . . . 0.0 112.647 -173.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.327 78.8 mm-40 -125.28 -19.14 5.17 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.12 2.73 51.55 Favored Glycine 0 N--CA 1.44 -1.098 0 O-C-N 117.559 -3.213 . . . . 0.0 115.719 170.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.3 mt -77.66 120.67 82.32 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 122.584 3.192 . . . . 0.0 109.945 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.47 159.11 49.34 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 N-CA-C 118.037 2.283 . . . . 0.0 118.037 169.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.47 -19.83 11.34 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 124.556 3.504 . . . . 0.0 114.529 -169.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -82.4 -12.2 58.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -76.41 -42.84 42.89 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.647 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -74.77 110.73 9.31 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 127.917 3.261 . . . . 0.0 107.934 -156.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -108.54 112.1 24.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 100.388 -3.93 . . . . 0.0 100.388 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.38 124.3 44.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.538 0.0 OUTLIER -127.3 137.31 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 117.637 -3.164 . . . . 0.0 113.259 -175.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.275 24.9 t80 -149.59 108.15 3.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.817 -1.538 . . . . 0.0 109.207 -165.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.4 23.34 6.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 127.043 3.306 . . . . 0.0 115.172 164.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.02 -17.86 47.54 Favored Glycine 0 CA--C 1.531 1.09 1 C-N-CA 136.234 6.635 . . . . 0.0 111.628 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -80.6 120.0 23.98 Favored 'General case' 0 N--CA 1.447 -0.607 1 C-N-CA 131.808 4.043 . . . . 0.0 107.824 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -73.06 131.59 42.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 115.417 -2.23 . . . . 0.0 114.604 159.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.364 39.2 mt -110.45 132.64 54.0 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 125.892 2.758 . . . . 0.0 107.264 -163.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -105.46 124.96 50.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 111.399 -2.637 . . . . 0.0 113.33 -169.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.267 0.0 OUTLIER -61.43 139.88 58.14 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 111.908 -2.405 . . . . 0.0 110.619 -172.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.81 -38.18 2.09 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 104.243 -3.543 . . . . 0.0 104.243 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -94.38 -178.37 4.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 -175.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.257 46.7 p -119.68 -175.84 3.04 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.753 -166.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.2 -41.87 96.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.154 1.381 . . . . 0.0 114.278 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 t -71.93 -32.91 67.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 131.011 3.725 . . . . 0.0 107.681 -170.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -71.46 -13.36 61.8 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 130.824 3.65 . . . . 0.0 112.698 -172.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -128.97 0.97 5.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.069 2.547 . . . . 0.0 111.466 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t30 57.41 53.89 7.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 128.815 2.846 . . . . 0.0 110.401 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mt -92.46 112.57 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 100.395 -3.928 . . . . 0.0 100.395 168.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -130.86 171.41 13.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.39 -167.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.74 113.79 0.92 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 129.237 3.015 . . . . 0.0 112.218 -170.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 67.88 25.17 7.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 118.201 -2.812 . . . . 0.0 117.337 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.1 m -64.32 135.22 55.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 118.233 -2.792 . . . . 0.0 117.829 156.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.267 96.5 m -110.49 128.0 55.42 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 124.479 1.112 . . . . 0.0 108.563 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.261 1.2 mp -109.67 168.73 9.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 173.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -112.35 138.37 49.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.965 3.306 . . . . 0.0 107.668 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tp -126.79 114.76 18.38 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.908 1.683 . . . . 0.0 108.138 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 m -106.1 142.56 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.3 mt . . . . . 0 N--CA 1.445 -0.718 0 CA-C-O 116.005 -1.95 . . . . 0.0 111.649 179.777 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 123.544 1.64 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -105.13 130.18 53.36 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.725 3.21 . . . . 0.0 110.977 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.293 17.6 pt -133.04 140.85 46.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 1 C-N-CA 133.731 4.812 . . . . 0.0 113.345 177.596 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.409 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 49.3 m-85 -93.21 148.88 21.65 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 125.89 2.757 . . . . 0.0 112.226 170.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.55 126.57 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 118.812 -2.43 . . . . 0.0 105.304 170.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -87.2 112.29 21.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 115.687 -2.102 . . . . 0.0 114.796 171.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 p -62.68 155.62 25.85 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 119.748 1.158 . . . . 0.0 113.03 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.62 -36.26 80.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.17 2.588 . . . . 0.0 111.242 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -93.01 0.01 57.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.824 1.193 . . . . 0.0 112.682 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.93 20.51 6.01 Favored Glycine 0 N--CA 1.445 -0.719 0 O-C-N 118.484 -2.635 . . . . 0.0 116.212 142.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -84.89 152.58 23.45 Favored 'General case' 0 CA--C 1.538 0.503 1 C-N-CA 136.016 5.726 . . . . 0.0 107.247 171.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -112.38 137.07 51.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.351 1.2 pt -115.01 131.64 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 176.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.375 32.6 m -90.95 130.51 36.87 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 166.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tp -117.25 137.29 52.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 104.446 -2.428 . . . . 0.0 104.446 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -94.16 144.5 25.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -158.96 -177.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.257 2.223 . . . . 0.0 106.763 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -133.06 153.15 80.77 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 129.119 2.967 . . . . 0.0 106.394 166.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.34 0.1 OUTLIER -49.4 -24.33 8.6 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 N-CA-C 119.214 2.736 . . . . 0.0 119.214 167.107 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.9 p -84.57 -11.06 56.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 113.578 -3.106 . . . . 0.0 110.619 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -68.35 131.72 45.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 129.746 3.218 . . . . 0.0 113.593 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 69.6 p -82.45 164.62 20.85 Favored 'General case' 0 N--CA 1.449 -0.476 1 O-C-N 129.542 4.276 . . . . 0.0 111.879 178.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -59.64 -31.29 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 112.541 -2.118 . . . . 0.0 112.013 172.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -74.21 -16.64 60.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 124.468 2.08 . . . . 0.0 112.584 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -98.45 -28.59 13.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.12 2.568 . . . . 0.0 110.485 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.267 62.8 t -52.52 -59.48 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.823 2.449 . . . . 0.0 112.291 168.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.343 17.4 ptpt -53.87 -41.78 67.9 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 128.184 3.428 . . . . 0.0 113.456 177.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.05 -40.56 70.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 126.244 2.215 . . . . 0.0 113.013 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -77.34 -28.1 52.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.609 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.55 -34.73 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 O-C-N 119.614 -1.929 . . . . 0.0 112.261 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -58.88 -42.89 90.54 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 119.225 0.92 . . . . 0.0 113.163 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.69 -47.06 42.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.257 2.223 . . . . 0.0 112.784 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -68.46 -38.65 81.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.422 64.3 mm-40 -129.21 -18.56 3.64 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 130.093 3.357 . . . . 0.0 115.675 -154.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.77 -22.28 41.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.66 2.076 . . . . 0.0 114.686 163.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mt -86.48 119.04 71.19 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 125.883 1.673 . . . . 0.0 109.638 -163.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -45.94 149.26 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.644 1 C-N-CA 127.615 5.543 . . . . 0.0 115.73 175.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -68.02 -32.51 28.05 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 124.535 3.49 . . . . 0.0 109.995 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.258 19.7 t70 -49.96 -35.92 26.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 117.042 -1.456 . . . . 0.0 114.144 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -101.55 -5.73 24.78 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 128.679 2.791 . . . . 0.0 107.325 -160.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -85.66 141.34 29.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 119.22 -2.175 . . . . 0.0 115.772 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -128.17 95.85 4.29 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.49 111.09 18.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 114.544 -2.646 . . . . 0.0 114.472 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mt -118.77 144.24 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 125.163 3.619 . . . . 0.0 110.383 -172.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -140.37 123.18 16.41 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 163.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.83 33.12 0.92 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 111.713 -2.494 . . . . 0.0 114.022 169.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.95 -33.88 4.99 Favored Glycine 0 C--O 1.221 -0.671 0 O-C-N 118.63 -2.543 . . . . 0.0 112.898 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -79.04 121.66 25.23 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 128.199 2.941 . . . . 0.0 112.171 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -79.51 111.38 15.72 Favored 'General case' 0 N--CA 1.454 -0.251 1 N-CA-C 100.023 -4.066 . . . . 0.0 100.023 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.67 123.01 24.83 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 127.826 2.45 . . . . 0.0 108.691 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -94.85 151.12 19.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 124.927 2.299 . . . . 0.0 108.389 -163.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.94 139.32 33.43 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 109.796 -3.365 . . . . 0.0 110.524 -168.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.47 -20.09 38.0 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.738 2.59 . . . . 0.0 116.291 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.8 mmm-85 -73.38 145.05 46.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 117.759 -3.201 . . . . 0.0 109.49 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 11.5 p -75.64 144.18 41.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.447 2.699 . . . . 0.0 107.026 167.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.0 mt -47.18 -37.67 10.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 166.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -67.91 -30.74 70.15 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -77.62 -36.9 51.23 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 126.262 1.825 . . . . 0.0 110.022 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.43 -20.98 64.68 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 115.742 -2.075 . . . . 0.0 115.839 170.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.341 29.5 m120 74.58 27.01 1.39 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 120.272 3.434 . . . . 0.0 120.272 -170.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -81.18 112.52 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 O-C-N 117.863 -3.023 . . . . 0.0 109.065 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.254 78.0 mm-40 -83.25 155.71 23.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.938 2.895 . . . . 0.0 114.319 177.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.55 127.38 15.41 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 131.343 3.857 . . . . 0.0 114.762 170.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 1.5 pt-20 65.2 33.13 9.55 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 125.685 2.659 . . . . 0.0 116.048 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -74.59 155.44 37.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 124.899 2.285 . . . . 0.0 111.746 160.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 20.6 m -116.21 104.39 11.47 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 111.537 -2.574 . . . . 0.0 105.516 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -94.86 159.77 14.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 130.77 3.628 . . . . 0.0 108.721 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.347 70.7 m80 -109.35 136.61 48.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 115.465 -2.207 . . . . 0.0 114.198 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.261 31.4 tp -108.94 117.5 34.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 126.006 2.066 . . . . 0.0 106.322 173.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -112.0 145.44 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 111.818 -2.446 . . . . 0.0 105.246 169.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 130.034 3.333 . . . . 0.0 110.538 168.032 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pm0 -96.66 143.03 28.0 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.405 3.082 . . . . 0.0 109.509 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -132.72 158.09 43.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 1 C-N-CA 132.152 4.181 . . . . 0.0 105.976 152.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -100.66 138.94 37.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.596 1.958 . . . . 0.0 108.327 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.49 110.37 31.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 172.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -107.06 113.22 26.56 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 126.876 3.227 . . . . 0.0 106.28 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -79.19 148.1 32.4 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 117.399 -3.313 . . . . 0.0 105.527 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.53 -21.23 66.16 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 118.908 -2.37 . . . . 0.0 112.836 168.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 p -79.0 -1.32 34.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.003 1.721 . . . . 0.0 112.334 167.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.68 -27.09 22.12 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 115.867 -2.629 . . . . 0.0 112.251 160.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.402 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 66.7 tttt -64.32 139.6 58.78 Favored 'General case' 0 C--N 1.328 -0.352 1 C-N-CA 132.21 4.204 . . . . 0.0 108.179 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.9 m -117.26 112.72 21.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 124.524 2.107 . . . . 0.0 105.934 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.7 mt -101.16 138.03 26.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 1 C-N-CA 131.832 4.053 . . . . 0.0 106.646 176.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m -101.63 129.76 47.82 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 128.375 2.67 . . . . 0.0 107.297 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.299 62.0 mt -103.18 168.35 9.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.24 169.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.95 115.74 10.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 128.371 3.545 . . . . 0.0 101.811 169.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.52 167.55 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 103.876 -2.639 . . . . 0.0 103.876 -161.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 4.7 mm-40 -97.91 162.02 23.66 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 169.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.81 -6.24 18.3 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 124.213 3.275 . . . . 0.0 116.194 163.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.6 p -94.17 -0.64 55.1 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.477 1.911 . . . . 0.0 110.066 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -78.47 121.15 24.18 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -65.74 145.64 55.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.387 2.675 . . . . 0.0 112.342 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -66.46 88.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 123.322 1.534 . . . . 0.0 112.421 165.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 178.42 -54.48 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 131.11 3.764 . . . . 0.0 104.69 -177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.308 22.6 t-20 -52.11 -55.76 18.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 -174.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.322 40.9 t -72.6 -20.08 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 128.456 2.702 . . . . 0.0 110.996 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -71.38 -30.21 65.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 122.995 2.634 . . . . 0.0 108.507 172.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.66 -19.57 41.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 116.357 -1.782 . . . . 0.0 113.695 171.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -76.98 -35.72 56.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 116.564 -1.684 . . . . 0.0 109.342 163.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.2 mm -65.05 -38.47 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 124.644 2.164 . . . . 0.0 111.698 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -46.45 -61.49 1.78 Allowed 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 117.732 -3.105 . . . . 0.0 110.109 164.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.8 -37.66 84.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -78.65 -59.15 2.9 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 62.7 mm-40 -106.89 -0.36 23.29 Favored 'General case' 0 C--O 1.222 -0.351 0 O-C-N 125.691 1.869 . . . . 0.0 111.326 -162.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.18 13.7 76.35 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 129.8 3.571 . . . . 0.0 117.985 162.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.81 113.56 64.58 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -49.74 126.3 16.18 Favored 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 128.387 6.058 . . . . 0.0 113.767 167.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -41.76 -27.84 0.61 Allowed 'Trans proline' 0 C--N 1.323 -0.81 1 C-N-CA 125.685 4.257 . . . . 0.0 117.751 -177.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.81 -22.78 65.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 171.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -98.69 4.02 47.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.381 2.672 . . . . 0.0 114.708 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -95.81 113.28 24.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 113.835 -2.983 . . . . 0.0 105.133 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -95.71 141.48 29.14 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 123.763 2.983 . . . . 0.0 112.515 150.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.29 0.8 OUTLIER -157.52 117.46 3.4 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 116.603 -1.665 . . . . 0.0 108.811 -148.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mp -145.51 144.29 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 126.487 2.367 . . . . 0.0 106.43 -150.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -131.62 -37.98 1.18 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.27 3.028 . . . . 0.0 115.155 172.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.363 . . -148.11 56.68 1.07 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 129.177 2.991 . . . . 0.0 111.163 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.98 -3.54 77.27 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-O 113.809 -3.773 . . . . 0.0 119.499 168.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -146.06 176.27 9.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 120.466 2.133 . . . . 0.0 110.052 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.06 130.29 39.04 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.029 -1.896 . . . . 0.0 107.911 174.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -77.56 120.6 22.76 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.027 1.731 . . . . 0.0 109.349 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -67.02 123.87 21.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 125.947 2.784 . . . . 0.0 109.876 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.92 115.68 3.89 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.269 2.228 . . . . 0.0 110.751 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.79 -23.55 11.73 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 115.411 -2.883 . . . . 0.0 110.23 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -77.65 148.82 34.85 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -78.34 174.51 11.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.767 2.027 . . . . 0.0 111.956 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.1 -24.78 64.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.399 1.48 . . . . 0.0 112.095 167.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -66.33 -33.84 76.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.052 2.541 . . . . 0.0 113.216 172.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -75.87 -34.84 60.03 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 115.085 -2.388 . . . . 0.0 109.833 -175.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.7 1.92 51.5 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 128.784 3.803 . . . . 0.0 113.484 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 t30 60.45 39.66 18.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.797 2.039 . . . . 0.0 110.421 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -90.84 137.67 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 102.14 -3.281 . . . . 0.0 102.14 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.93 170.11 16.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -168.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -58.51 138.4 56.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 120.717 3.599 . . . . 0.0 120.717 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 4.8 tt0 75.35 22.21 1.71 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.547 2.739 . . . . 0.0 108.749 160.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.413 27.4 m -99.61 158.54 15.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 124.909 2.29 . . . . 0.0 109.149 174.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.9 m -62.44 130.9 47.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 116.508 -3.87 . . . . 0.0 111.709 161.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -117.16 143.29 46.0 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 159.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -109.23 143.19 39.01 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.708 2.403 . . . . 0.0 111.935 -169.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -128.52 128.81 45.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 129.426 3.091 . . . . 0.0 107.167 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.3 4.3 t -122.03 136.09 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 115.596 -2.145 . . . . 0.0 106.947 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 129.071 2.948 . . . . 0.0 115.303 -171.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttp . . . . . 0 N--CA 1.474 0.764 0 CA-C-O 122.092 0.948 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -115.88 145.23 43.05 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 117.335 -1.746 . . . . 0.0 106.389 -169.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -132.27 177.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 126.591 1.956 . . . . 0.0 108.902 171.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -124.36 149.4 46.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.93 111.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -72.43 115.14 11.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.298 2.239 . . . . 0.0 113.409 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.405 ' H ' ' HG1' ' A' ' 7' ' ' THR . 46.9 p -94.11 170.32 9.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 124.085 1.898 . . . . 0.0 107.301 -169.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.7 -15.79 62.22 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -164.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -73.46 -31.51 63.83 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 128.247 2.619 . . . . 0.0 111.244 165.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.63 2.6 27.31 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 129.031 3.205 . . . . 0.0 110.605 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -66.75 146.41 54.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 121.328 2.564 . . . . 0.0 114.478 171.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.0 m -116.33 106.75 14.0 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 114.012 -2.899 . . . . 0.0 104.164 -165.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mm -98.59 140.65 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -79.21 136.8 37.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 124.355 2.026 . . . . 0.0 109.77 167.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.64 135.85 32.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 -169.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.27 131.02 50.66 Favored 'General case' 0 C--O 1.238 0.448 1 CA-C-O 129.62 4.533 . . . . 0.0 108.138 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.14 -165.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 129.77 3.228 . . . . 0.0 118.481 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -149.65 139.28 13.13 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 167.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -61.21 -22.87 75.9 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 124.16 3.24 . . . . 0.0 118.477 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 m -90.98 -25.14 19.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 118.863 2.912 . . . . 0.0 118.863 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.85 106.28 4.12 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 130.08 3.352 . . . . 0.0 109.841 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -48.97 148.66 2.18 Favored 'General case' 0 N--CA 1.45 -0.436 1 C-N-CA 134.346 5.058 . . . . 0.0 113.139 -155.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.24 -39.62 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.157 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -47.18 -52.18 16.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.86 1.664 . . . . 0.0 111.387 170.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -69.69 -24.93 63.65 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.393 2.277 . . . . 0.0 114.27 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.275 99.4 t -56.82 -55.36 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 1 O-C-N 113.328 -5.858 . . . . 0.0 112.586 167.261 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -43.66 -42.61 5.37 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 127.443 2.297 . . . . 0.0 115.601 167.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.9 -32.44 73.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.734 3.213 . . . . 0.0 112.43 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.12 -31.86 70.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 124.819 2.247 . . . . 0.0 114.276 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -73.22 -40.19 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 127.37 2.268 . . . . 0.0 115.114 169.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.29 -37.76 49.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 127.78 2.432 . . . . 0.0 112.63 162.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -72.07 -38.19 69.48 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.034 0.533 . . . . 0.0 111.958 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -75.78 -51.88 11.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 129.069 2.948 . . . . 0.0 111.815 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -133.63 -0.16 3.22 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.246 1.498 . . . . 0.0 111.402 -160.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.87 -23.17 35.48 Favored Glycine 0 N--CA 1.44 -1.063 0 O-C-N 117.421 -3.299 . . . . 0.0 114.482 161.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.42 120.01 78.16 Favored Pre-proline 0 N--CA 1.441 -0.891 0 O-C-N 117.058 -3.613 . . . . 0.0 112.17 -171.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -72.23 142.24 37.29 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.007 3.138 . . . . 0.0 110.719 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -35.49 -42.87 0.49 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 123.88 3.053 . . . . 0.0 119.12 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.05 -18.17 32.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -119.54 1.25 11.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.372 -170.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -86.3 151.27 23.73 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 172.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -132.54 128.91 38.29 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.562 1.545 . . . . 0.0 108.875 151.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.6 mt -108.19 129.21 55.2 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 3.2 mt -112.24 128.59 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 129.215 3.006 . . . . 0.0 109.175 165.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -81.43 -36.3 29.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 119.039 -2.288 . . . . 0.0 106.535 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.08 -67.35 0.36 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.55 -24.78 1.21 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.247 1.88 . . . . 0.0 113.766 164.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -94.26 141.21 28.83 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.88 2.472 . . . . 0.0 106.595 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -70.63 140.27 51.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.224 3.01 . . . . 0.0 113.95 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 mt -93.15 100.37 12.77 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 126.191 1.796 . . . . 0.0 108.332 171.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -93.16 142.13 27.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 126.304 2.954 . . . . 0.0 106.39 -156.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.69 132.85 55.18 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 130.881 3.672 . . . . 0.0 108.492 172.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.15 -15.16 8.83 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 128.69 3.043 . . . . 0.0 115.4 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -124.47 179.61 4.87 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 128.808 2.843 . . . . 0.0 110.958 -163.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -115.65 164.62 14.07 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 118.53 -2.607 . . . . 0.0 109.409 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.2 mt -72.46 -14.43 61.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.545 -0.722 . . . . 0.0 111.476 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -72.61 -35.39 67.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 129.21 3.004 . . . . 0.0 106.921 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.369 21.3 m-20 -51.4 -36.88 45.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.849 2.46 . . . . 0.0 113.696 172.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -103.91 3.52 33.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 112.903 -3.427 . . . . 0.0 110.162 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.27 0.5 OUTLIER 33.95 63.85 0.38 Allowed 'General case' 0 N--CA 1.45 -0.464 1 C-N-CA 134.333 5.053 . . . . 0.0 114.73 -176.081 . . . . . . . . 4 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.4 mm -77.6 135.9 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.206 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -100.27 171.66 7.64 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.316 1.446 . . . . 0.0 107.231 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -66.73 146.06 54.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 126.211 2.194 . . . . 0.0 108.456 -170.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 65.73 17.44 10.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.354 1.888 . . . . 0.0 113.765 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -62.99 148.16 48.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 162.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -100.11 106.7 18.46 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.446 2.698 . . . . 0.0 108.399 -176.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.2 159.9 14.65 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.85 0.75 . . . . 0.0 111.275 169.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.46 154.91 29.51 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.636 1.974 . . . . 0.0 108.043 170.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.342 4.3 pp -127.93 155.28 44.46 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 130.392 3.477 . . . . 0.0 116.238 177.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.23 148.2 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 130.304 3.442 . . . . 0.0 108.783 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 N--CA 1.448 -0.548 0 C-N-CA 130.572 3.549 . . . . 0.0 114.32 168.475 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ptt? . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -93.95 155.9 16.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 173.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.33 18.1 pt -133.15 158.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.922 2.489 . . . . 0.0 107.167 161.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -116.94 127.04 53.84 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 118.837 -2.414 . . . . 0.0 109.525 176.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.293 3.2 t -107.74 96.68 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 174.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -93.33 127.14 38.81 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 118.942 -2.349 . . . . 0.0 116.986 -171.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.54 150.23 44.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 130.429 3.492 . . . . 0.0 109.288 174.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.86 -25.77 64.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 116.038 -1.935 . . . . 0.0 107.713 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -80.42 2.92 23.09 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 131.165 3.786 . . . . 0.0 116.241 174.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.61 6.19 53.06 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.296 2.379 . . . . 0.0 108.829 154.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -97.48 156.48 16.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 121.575 2.687 . . . . 0.0 106.188 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -125.56 129.28 49.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 126.52 2.388 . . . . 0.0 114.328 -178.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.66 116.78 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 1 N-CA-C 98.173 -4.751 . . . . 0.0 98.173 169.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -95.0 116.96 29.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.3 0.64 . . . . 0.0 109.664 170.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.325 32.4 mt -92.24 151.49 20.31 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.754 2.022 . . . . 0.0 106.912 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -108.23 83.03 1.72 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.098 2.959 . . . . 0.0 108.458 -173.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.13 164.47 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 119.219 -2.175 . . . . 0.0 110.77 -168.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -108.28 160.09 28.31 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 130.564 3.546 . . . . 0.0 111.903 162.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.28 -20.89 27.46 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 CA-C-N 122.833 2.047 . . . . 0.0 114.126 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.2 p -94.09 1.33 56.17 Favored 'General case' 0 N--CA 1.447 -0.586 1 C-N-CA 133.659 4.784 . . . . 0.0 112.649 -176.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -61.62 139.85 58.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.312 2.245 . . . . 0.0 107.7 161.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.4 p -95.77 178.88 5.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.314 2.246 . . . . 0.0 106.462 170.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.9 mm -65.11 -34.85 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 1 C-N-CA 132.433 4.293 . . . . 0.0 106.055 170.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -64.95 -42.0 95.0 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 117.26 -3.4 . . . . 0.0 109.564 176.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -76.74 -41.51 44.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.958 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.54 -29.43 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 124.964 3.529 . . . . 0.0 111.869 176.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -52.19 -46.39 65.55 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.928 2.491 . . . . 0.0 116.557 165.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.55 -44.05 71.69 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 112.366 -2.197 . . . . 0.0 111.984 171.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -72.84 -33.19 65.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.525 -1.36 . . . . 0.0 112.082 -169.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -66.89 -41.84 88.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 120.359 -1.463 . . . . 0.0 109.311 171.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.76 84.3 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 124.868 1.355 . . . . 0.0 110.174 177.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.64 -38.53 80.56 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 119.778 -1.826 . . . . 0.0 114.021 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -68.66 -43.86 75.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 115.824 -2.036 . . . . 0.0 111.253 169.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.293 18.4 tp10 -136.21 12.04 3.3 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 117.231 -1.788 . . . . 0.0 110.453 -147.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 29.03 40.98 0.03 OUTLIER Glycine 0 CA--C 1.53 1.01 1 C-N-CA 132.848 5.023 . . . . 0.0 114.775 175.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -91.74 120.28 68.12 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 115.492 -2.194 . . . . 0.0 105.609 157.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.291 1.7 Cg_endo -45.87 144.62 5.6 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 O-C-N 125.693 2.417 . . . . 0.0 118.357 171.482 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.76 -10.66 10.55 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 O-C-N 125.844 2.497 . . . . 0.0 112.258 -163.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.87 -16.25 54.16 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 128.699 2.8 . . . . 0.0 111.5 173.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -74.5 -27.55 60.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.954 2.501 . . . . 0.0 112.673 174.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -95.36 147.69 23.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 129.349 3.06 . . . . 0.0 114.677 -168.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -115.59 117.2 29.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 172.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.0 mt -97.11 98.13 9.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 -166.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.304 74.1 mt -100.66 145.9 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 128.81 2.844 . . . . 0.0 113.673 -175.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -153.62 123.24 6.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 116.383 -3.948 . . . . 0.0 106.02 166.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.499 . . 74.73 25.25 1.53 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 170.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.94 7.78 67.91 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 130.049 3.69 . . . . 0.0 113.151 -174.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -134.6 150.02 50.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 123.549 3.674 . . . . 0.0 105.396 -166.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -87.86 127.82 35.35 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 128.567 2.747 . . . . 0.0 107.683 176.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.52 133.64 49.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 121.581 1.991 . . . . 0.0 113.386 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -83.24 124.74 30.86 Favored 'General case' 0 N--CA 1.447 -0.604 1 C-N-CA 133.867 4.867 . . . . 0.0 107.004 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.22 123.21 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 111.992 -2.367 . . . . 0.0 108.005 -175.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.16 31.12 3.4 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 114.924 -3.153 . . . . 0.0 115.7 -177.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -139.62 146.11 39.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 122.245 3.022 . . . . 0.0 108.555 170.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.8 p -79.46 155.7 28.18 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.6 mt -46.74 -64.05 0.87 Allowed 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.6 m -66.98 -41.7 86.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.392 1.877 . . . . 0.0 115.857 -172.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.265 11.0 t70 -51.34 -46.91 62.84 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 119.349 -2.094 . . . . 0.0 113.608 170.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.98 8.12 1.72 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 129.86 3.264 . . . . 0.0 114.857 174.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.372 3.4 t30 82.31 4.83 1.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 178.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.293 1.9 mt -94.27 91.21 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 123.177 1.465 . . . . 0.0 111.33 -178.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.251 46.6 mm-40 -96.52 -167.14 1.52 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 112.623 -2.081 . . . . 0.0 109.08 -175.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -68.48 131.52 45.41 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.865 -175.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.347 24.9 mt-10 76.96 36.53 0.32 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 130.51 3.524 . . . . 0.0 108.864 165.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.264 37.9 m -96.25 138.48 33.79 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 -170.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.2 m -96.5 118.76 33.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -178.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp -106.94 155.72 19.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.748 2.419 . . . . 0.0 105.708 159.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.23 139.86 46.27 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 126.415 2.322 . . . . 0.0 110.488 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 tp -82.86 121.85 27.47 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 126.371 2.295 . . . . 0.0 105.911 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -136.02 136.41 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 128.191 2.596 . . . . 0.0 104.68 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.442 -0.859 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.032 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.1 ttm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 117.224 -1.369 . . . . 0.0 107.754 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -98.55 137.64 36.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 125.374 1.671 . . . . 0.0 114.649 -174.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -133.29 177.43 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 120.134 -1.604 . . . . 0.0 113.17 171.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -125.23 133.51 52.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 130.178 3.391 . . . . 0.0 109.752 173.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.9 t -117.48 131.76 69.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 109.836 -3.347 . . . . 0.0 103.002 165.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -77.66 129.71 35.91 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 116.331 -1.795 . . . . 0.0 113.461 151.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -82.63 149.5 27.36 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.293 2.637 . . . . 0.0 104.41 172.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.22 -21.02 66.7 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.168 2.587 . . . . 0.0 111.404 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -70.73 -13.62 62.13 Favored 'General case' 0 C--N 1.326 -0.44 1 C-N-CA 132.056 4.142 . . . . 0.0 112.861 165.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.28 1.02 56.89 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.934 1.243 . . . . 0.0 115.301 165.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 155.16 18.96 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.195 -2.356 . . . . 0.0 110.435 166.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.6 m -98.07 152.39 19.36 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 100.448 -3.908 . . . . 0.0 100.448 -176.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.81 144.79 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 165.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -93.75 145.22 24.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 123.237 1.494 . . . . 0.0 107.203 165.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.414 2.1 pt? -148.25 159.5 43.91 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 120.276 3.436 . . . . 0.0 120.276 166.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -108.49 139.91 42.57 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 124.282 3.219 . . . . 0.0 109.89 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.266 7.5 p -138.21 178.95 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 127.967 3.292 . . . . 0.0 110.363 -177.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -134.14 138.29 30.15 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 -177.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -44.34 -37.21 10.2 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 N-CA-C 119.559 2.869 . . . . 0.0 119.559 175.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.295 13.5 p -95.08 3.34 54.92 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 113.422 -3.18 . . . . 0.0 111.2 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -73.87 160.45 31.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 123.61 2.914 . . . . 0.0 105.355 169.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -102.94 155.2 18.52 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 119.311 -2.118 . . . . 0.0 112.181 -177.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.6 mm -63.88 -57.69 10.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 130.061 3.345 . . . . 0.0 111.777 -168.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.555 1.9 tt0 -44.57 -48.54 10.33 Favored 'General case' 0 C--O 1.222 -0.349 1 C-N-CA 132.632 4.373 . . . . 0.0 114.83 176.733 . . . . . . . . 3 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.284 26.3 t30 -49.06 -61.12 2.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 130.139 3.376 . . . . 0.0 111.666 -178.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -74.06 -39.55 50.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 128.742 2.817 . . . . 0.0 106.225 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -62.38 -28.35 69.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 112.716 -3.516 . . . . 0.0 112.196 -178.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.03 -14.39 31.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.87 2.577 . . . . 0.0 116.434 178.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -54.85 -27.34 41.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.466 2.307 . . . . 0.0 113.576 177.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tp -48.03 -22.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 1 C-N-CA 135.654 5.581 . . . . 0.0 117.382 -175.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -61.8 3.08 0.16 Allowed 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 170.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.513 32.9 t70 -19.15 -55.28 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 2 C-N-CA 135.112 5.365 . . . . 0.0 122.067 158.021 . . . . . . . . 3 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.254 1.6 pptp? -149.15 -19.52 0.29 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 122.265 2.302 . . . . 0.0 112.22 -160.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.413 1.1 pm0 -124.85 169.3 12.18 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 147.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.81 62.11 0.33 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 105.602 -2.999 . . . . 0.0 105.602 -175.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.8 pt -86.64 148.98 47.62 Favored Pre-proline 0 N--CA 1.448 -0.572 0 C-N-CA 130.196 3.398 . . . . 0.0 109.793 178.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -76.27 136.42 17.88 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.742 2.294 . . . . 0.0 113.661 171.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -77.29 -16.1 15.61 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.997 3.131 . . . . 0.0 112.099 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.3 -15.4 62.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 124.0 3.091 . . . . 0.0 108.136 178.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -90.73 17.32 7.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.986 2.114 . . . . 0.0 115.439 176.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -142.33 160.09 40.94 Favored 'General case' 0 N--CA 1.446 -0.633 1 C-N-CA 136.984 6.114 . . . . 0.0 113.022 173.221 . . . . . . . . 4 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -149.8 146.97 27.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 131.341 3.857 . . . . 0.0 111.534 -178.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.57 121.81 38.8 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.959 3.304 . . . . 0.0 113.265 177.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.3 mt -91.96 144.58 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 156.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CG ' ' N ' ' A' ' 46' ' ' ALA 0.303 4.7 p90 -111.91 -76.37 0.6 Allowed 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 169.747 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' N ' ' CG ' ' A' ' 45' ' ' PHE . . . -130.5 82.93 2.08 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 100.854 -3.758 . . . . 0.0 100.854 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.24 61.33 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 112.444 -2.162 . . . . 0.0 117.084 165.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -147.83 172.79 13.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 129.21 3.004 . . . . 0.0 113.862 -171.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 142.89 35.95 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 128.214 2.606 . . . . 0.0 112.836 -170.177 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.9 mt -74.34 165.9 24.4 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 129.492 3.117 . . . . 0.0 113.06 169.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -151.97 150.85 30.47 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 129.719 3.208 . . . . 0.0 116.59 175.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -43.8 132.48 5.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.28 -26.24 7.1 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.221 1.391 . . . . 0.0 112.979 173.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 163.64 12.47 Favored 'General case' 0 N--CA 1.444 -0.731 1 C-N-CA 133.426 4.69 . . . . 0.0 108.295 -164.916 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 p -103.68 173.17 6.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 113.545 -1.662 . . . . 0.0 106.536 167.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.45 -34.18 74.98 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.364 175.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -78.81 -8.95 59.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.123 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -69.2 -31.62 70.34 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 125.494 1.747 . . . . 0.0 109.842 160.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -110.93 11.47 22.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.424 16.1 m120 83.4 -6.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 163.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -69.92 135.24 28.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -157.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.4 -166.79 2.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 114.183 -2.818 . . . . 0.0 110.536 -162.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.36 110.69 0.33 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 165.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 78.1 mt-10 73.35 31.79 1.33 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 131.02 3.728 . . . . 0.0 115.177 175.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 m -70.14 121.91 18.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 128.014 2.526 . . . . 0.0 107.07 172.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.4 m -97.58 114.35 26.25 Favored 'General case' 0 C--N 1.32 -0.683 1 N-CA-C 97.522 -4.992 . . . . 0.0 97.522 -178.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.71 151.52 19.28 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 130.453 3.501 . . . . 0.0 107.453 171.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -118.98 134.7 55.02 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 126.581 2.426 . . . . 0.0 112.775 168.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 tp -100.93 124.88 47.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -174.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.42 ' CG2' ' H ' ' A' ' 71' ' ' LEU 0.353 7.5 p -140.18 -146.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 126.198 1.799 . . . . 0.0 112.027 173.959 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.42 ' H ' ' CG2' ' A' ' 70' ' ' VAL 0.542 1.8 pt? . . . . . 0 N--CA 1.45 -0.446 1 C-N-CA 132.0 4.12 . . . . 0.0 111.26 179.953 . . . . . . . . 3 2 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 117.646 -1.169 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -74.37 121.2 21.02 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -170.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -136.15 174.95 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 123.606 2.912 . . . . 0.0 113.756 170.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -123.73 155.14 38.41 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.843 2.457 . . . . 0.0 113.65 169.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.2 130.9 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 O-C-N 118.195 -2.816 . . . . 0.0 105.945 161.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.272 64.8 tttt -111.49 131.35 55.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 118.829 -2.419 . . . . 0.0 104.529 176.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.8 p -98.79 168.95 9.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.516 2.726 . . . . 0.0 105.48 -166.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.9 mt -93.16 -0.02 57.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 130.887 3.675 . . . . 0.0 112.346 175.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 p -102.59 -23.63 13.85 Favored 'General case' 0 N--CA 1.444 -0.762 1 C-N-CA 134.187 4.995 . . . . 0.0 109.942 172.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.09 -6.71 11.97 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 116.635 -2.203 . . . . 0.0 110.594 147.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -61.45 149.92 37.13 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 157.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -112.45 117.84 33.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 163.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mt -101.46 133.15 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 101.756 -3.424 . . . . 0.0 101.756 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -94.46 146.78 23.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.473 1.909 . . . . 0.0 110.624 177.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.9 -177.21 3.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -176.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -149.88 117.48 6.17 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 116.536 -1.697 . . . . 0.0 107.987 170.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -131.32 148.26 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 C-N-CA 133.112 4.565 . . . . 0.0 107.237 -176.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -81.99 141.53 47.26 Favored Pre-proline 0 N--CA 1.443 -0.785 0 CA-C-O 115.747 -2.073 . . . . 0.0 107.56 172.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -45.12 -35.16 10.35 Favored 'Trans proline' 0 N--CA 1.45 -1.071 1 C-N-CA 127.821 5.681 . . . . 0.0 114.169 173.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.7 p -77.07 -19.46 57.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.611 2.764 . . . . 0.0 113.918 176.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.75 126.53 28.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.704 2.047 . . . . 0.0 109.053 -173.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -70.44 150.99 45.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.1 0.96 . . . . 0.0 112.496 170.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 15.8 mm -55.13 -26.98 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 127.901 2.481 . . . . 0.0 114.777 -178.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.259 8.4 pt-20 -61.71 -33.94 74.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 166.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -92.53 -33.14 14.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -167.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.284 75.4 t -39.85 -42.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 130.631 3.573 . . . . 0.0 113.256 158.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -74.02 -16.21 61.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.97 -37.65 54.8 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 126.856 2.062 . . . . 0.0 105.52 -173.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -75.86 -26.16 56.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 130.013 3.325 . . . . 0.0 109.047 -175.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -77.68 -22.84 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 126.795 2.559 . . . . 0.0 111.441 173.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -69.17 -43.09 74.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.977 1.311 . . . . 0.0 110.994 -175.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.429 21.8 t70 -56.93 -36.19 69.92 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 129.908 3.283 . . . . 0.0 116.161 -179.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -103.46 -27.93 12.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 109.426 -3.534 . . . . 0.0 115.402 -173.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -116.75 -13.78 10.77 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 124.812 2.244 . . . . 0.0 116.201 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.8 -0.96 56.57 Favored Glycine 0 CA--C 1.526 0.753 0 O-C-N 117.642 -3.161 . . . . 0.0 110.594 165.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.75 130.24 23.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 129.396 3.078 . . . . 0.0 111.569 -156.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.92 162.11 20.93 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 121.022 1.148 . . . . 0.0 110.223 -173.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -52.49 -21.86 15.1 Favored 'Trans proline' 0 N--CA 1.449 -1.109 1 C-N-CA 126.07 4.513 . . . . 0.0 117.718 170.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -57.32 -26.92 61.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 126.996 2.685 . . . . 0.0 117.935 164.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -97.79 -28.81 13.7 Favored 'General case' 0 C--O 1.221 -0.417 1 C-N-CA 131.848 4.059 . . . . 0.0 113.093 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.74 93.83 2.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.037 2.135 . . . . 0.0 107.522 -177.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 mtp85 -110.74 100.84 9.53 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.083 1.753 . . . . 0.0 114.667 167.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.3 mt -100.17 139.9 35.17 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 110.753 -2.931 . . . . 0.0 109.789 -165.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.48 160.72 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 174.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -149.62 124.1 9.68 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.985 2.914 . . . . 0.0 103.536 168.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.75 28.31 6.19 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 128.657 2.783 . . . . 0.0 115.664 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.29 3.23 90.62 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 128.194 3.433 . . . . 0.0 114.49 -175.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -92.2 147.55 22.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 122.771 3.286 . . . . 0.0 106.335 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.33 93.31 5.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 102.696 -3.075 . . . . 0.0 102.696 -176.131 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.21 115.28 1.98 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 130.785 3.634 . . . . 0.0 109.041 176.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.266 40.0 tt0 -81.44 134.7 35.58 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 102.58 -3.118 . . . . 0.0 102.58 -165.645 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.58 119.76 7.63 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 128.086 2.554 . . . . 0.0 106.472 167.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.49 -5.97 57.35 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 119.832 -1.792 . . . . 0.0 112.654 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -94.75 176.67 6.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 116.07 -1.919 . . . . 0.0 108.986 163.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 77.0 p -115.23 176.99 4.82 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.029 1.456 . . . . 0.0 112.012 176.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.97 -28.69 69.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 116.729 -1.605 . . . . 0.0 113.453 167.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.7 t -64.6 -36.34 83.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.785 2.434 . . . . 0.0 109.161 174.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.402 16.4 m-20 -57.4 -25.42 59.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 116.545 -3.847 . . . . 0.0 119.759 169.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -112.25 3.79 17.35 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 116.374 -1.774 . . . . 0.0 109.715 177.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.554 8.8 p30 57.2 31.71 20.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 129.302 3.041 . . . . 0.0 116.631 -173.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -81.38 118.34 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 -176.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -99.67 173.74 6.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.707 2.403 . . . . 0.0 112.958 -173.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -39.1 134.36 1.08 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.71 2.804 . . . . 0.0 113.11 174.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 62.67 46.14 5.53 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 128.097 2.559 . . . . 0.0 109.659 175.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -104.4 125.47 50.64 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 123.182 2.719 . . . . 0.0 104.21 172.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.8 m -85.7 134.47 33.96 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 114.649 -2.596 . . . . 0.0 108.607 178.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -107.77 154.33 21.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 101.546 -3.501 . . . . 0.0 101.546 -179.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -102.34 134.76 45.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.217 2.607 . . . . 0.0 105.639 176.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 1.7 mt -97.56 129.5 44.69 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.165 2.186 . . . . 0.0 106.267 176.018 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -100.24 117.71 45.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 159.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tp . . . . . 0 N--CA 1.447 -0.621 0 C-N-CA 127.786 2.434 . . . . 0.0 110.108 176.127 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 115.47 -2.205 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.274 27.7 mt-30 -99.78 154.53 18.25 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 121.323 1.874 . . . . 0.0 113.879 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -145.67 153.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -124.77 107.64 11.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 115.387 -2.244 . . . . 0.0 105.967 -161.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.25 115.72 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 119.883 1.219 . . . . 0.0 108.378 179.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -84.56 142.37 30.04 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 125.438 2.542 . . . . 0.0 108.372 176.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -127.82 148.38 50.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 110.026 -3.261 . . . . 0.0 108.879 162.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.4 mt -48.17 -17.99 0.17 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 128.053 2.541 . . . . 0.0 116.765 174.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -77.78 -37.48 48.81 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 125.516 2.579 . . . . 0.0 114.453 -169.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.73 -16.49 10.33 Favored Glycine 0 CA--C 1.538 1.502 0 O-C-N 117.04 -3.538 . . . . 0.0 108.438 -170.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -77.58 138.8 39.35 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 130.007 3.323 . . . . 0.0 106.81 174.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 m -141.3 117.93 10.96 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.731 3.212 . . . . 0.0 106.632 -171.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mm -91.09 117.47 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.344 1.857 . . . . 0.0 106.636 -173.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.9 m -83.04 118.92 23.86 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.549 1.94 . . . . 0.0 109.232 176.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -120.76 134.78 55.27 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.307 1.843 . . . . 0.0 106.547 172.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -88.25 124.63 34.06 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 128.77 3.794 . . . . 0.0 109.102 157.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.8 169.89 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 1 CA-C-N 107.66 -4.336 . . . . 0.0 105.156 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -119.76 162.76 31.23 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 128.911 2.884 . . . . 0.0 111.397 158.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.65 -23.47 15.28 Favored 'Trans proline' 0 N--CA 1.447 -1.237 1 C-N-CA 126.158 4.572 . . . . 0.0 119.687 177.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -88.3 1.58 54.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 115.848 -2.025 . . . . 0.0 113.423 175.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.01 115.41 3.13 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 122.039 2.2 . . . . 0.0 113.394 -175.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.2 p -71.88 160.11 33.12 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 118.358 -2.714 . . . . 0.0 112.893 172.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 23' ' ' ILE 0.272 53.7 mt -49.17 -36.94 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 115.369 -2.253 . . . . 0.0 113.974 167.624 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -58.9 -31.29 68.49 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 131.397 3.879 . . . . 0.0 113.435 164.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -84.68 -32.55 23.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 121.971 2.168 . . . . 0.0 110.04 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.94 -50.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 115.284 -2.294 . . . . 0.0 109.076 169.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -43.33 -47.95 6.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.695 1.598 . . . . 0.0 114.612 177.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.8 -24.13 61.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 124.304 2.002 . . . . 0.0 116.148 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -86.08 -42.37 13.99 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 114.119 -2.848 . . . . 0.0 104.808 -173.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.257 78.1 mt -49.06 -59.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 112.623 -3.56 . . . . 0.0 106.337 168.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -47.24 -51.53 18.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 127.977 3.298 . . . . 0.0 117.348 171.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.37 -35.96 82.13 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.332 0.653 . . . . 0.0 112.279 -174.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -82.27 -76.03 0.28 Allowed 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 125.706 1.879 . . . . 0.0 109.902 173.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -91.54 -21.57 20.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.265 -159.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.02 -0.23 60.38 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 116.159 -2.467 . . . . 0.0 113.745 164.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -66.98 127.04 93.38 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 120.407 2.103 . . . . 0.0 109.167 165.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.44 140.26 21.47 Favored 'Trans proline' 0 N--CA 1.445 -1.358 1 C-N-CA 126.608 4.872 . . . . 0.0 110.254 175.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.257 87.3 Cg_exo -41.45 -34.4 1.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 1 C-N-CA 131.83 8.353 . . . . 0.0 118.818 169.333 . . . . . . . . 3 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.58 -29.0 68.96 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 125.72 1.887 . . . . 0.0 113.476 171.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -84.5 -2.79 57.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 122.346 2.339 . . . . 0.0 111.726 -170.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 26.9 mt-30 -113.83 134.4 54.81 Favored 'General case' 0 C--N 1.325 -0.495 1 CA-C-O 111.257 -4.211 . . . . 0.0 118.744 -166.694 . . . . . . . . 3 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -110.63 141.02 44.42 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 128.986 3.929 . . . . 0.0 102.05 163.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.5 mt -135.38 128.78 32.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.561 1.144 . . . . 0.0 109.396 -174.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 4.2 mt -122.42 150.77 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.083 2.553 . . . . 0.0 104.451 -174.132 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.65 -82.6 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 102.391 -3.188 . . . . 0.0 102.391 165.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.86 -52.97 1.43 Allowed 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.15 -1.594 . . . . 0.0 108.894 173.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.14 -30.68 0.78 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 106.054 -2.818 . . . . 0.0 106.054 -175.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -82.89 110.42 17.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 -175.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -60.38 127.58 32.45 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 116.526 -1.702 . . . . 0.0 111.333 159.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -75.11 151.5 38.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 125.464 2.554 . . . . 0.0 112.56 -178.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -112.66 144.86 41.45 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 119.924 -1.735 . . . . 0.0 109.833 175.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.73 153.88 42.98 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 127.257 2.848 . . . . 0.0 114.98 -172.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.85 13.03 44.85 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 128.071 2.748 . . . . 0.0 114.136 169.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.3 mtt85 -125.63 151.71 46.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.229 1.966 . . . . 0.0 108.544 -167.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.411 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 52.0 p -92.43 174.95 7.02 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.397 1.57 . . . . 0.0 110.799 -177.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.58 -28.26 65.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 111.833 -2.44 . . . . 0.0 111.726 174.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -71.67 -37.76 70.72 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.378 -1.451 . . . . 0.0 114.645 173.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 39.1 m-20 -63.94 -42.02 97.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.102 0.961 . . . . 0.0 113.386 178.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.57 4.0 45.38 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 123.488 1.613 . . . . 0.0 113.01 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.316 42.7 m-80 76.49 26.77 0.86 Allowed 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 172.016 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.5 mt -99.49 107.86 21.48 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-O 125.518 2.58 . . . . 0.0 104.117 -170.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -93.34 165.11 12.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 165.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.472 39.7 pttt -30.97 125.68 0.19 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 164.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 88.43 1.98 0.32 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 130.044 3.338 . . . . 0.0 113.982 176.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -62.17 141.29 58.26 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 117.104 -3.497 . . . . 0.0 113.311 176.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.3 m -90.82 137.67 32.18 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 125.407 1.692 . . . . 0.0 108.361 170.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -119.74 172.87 7.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 164.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -136.15 110.95 8.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 126.01 2.069 . . . . 0.0 110.176 -167.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.52 126.73 42.98 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 125.383 2.516 . . . . 0.0 110.193 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.49 122.02 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 O-C-N 116.965 -3.585 . . . . 0.0 106.487 170.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.4 mt . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 129.709 3.204 . . . . 0.0 111.582 178.756 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -98.21 139.08 34.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -173.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.5 pt -121.91 161.58 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.99 2.116 . . . . 0.0 106.334 166.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -105.31 129.4 53.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 159.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.77 125.99 54.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 160.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -115.21 158.35 22.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 128.315 2.646 . . . . 0.0 105.651 178.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -135.43 167.94 20.14 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 118.125 -2.859 . . . . 0.0 105.565 -170.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -69.16 -27.55 65.63 Favored 'General case' 0 N--CA 1.451 -0.387 1 O-C-N 116.093 -4.129 . . . . 0.0 113.839 176.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.1 p -85.12 3.89 36.87 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 119.077 -2.264 . . . . 0.0 110.043 171.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.9 -24.19 32.19 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 117.87 -3.018 . . . . 0.0 106.961 156.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -50.23 118.79 3.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.719 3.608 . . . . 0.0 106.29 -177.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -118.76 117.06 27.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.052 0.842 . . . . 0.0 109.408 -174.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.3 mt -84.15 136.09 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 1 C-N-CA 132.471 4.308 . . . . 0.0 107.944 168.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -93.39 133.62 36.46 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 163.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.14 142.06 51.6 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 129.507 3.123 . . . . 0.0 112.436 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -113.89 136.01 53.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 168.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 m -153.76 -178.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.84 1 C-N-CA 134.695 5.198 . . . . 0.0 112.07 -165.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -139.79 147.91 53.33 Favored Pre-proline 0 N--CA 1.448 -0.542 0 O-C-N 117.979 -2.95 . . . . 0.0 110.701 175.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -49.75 -41.67 45.67 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 123.566 2.844 . . . . 0.0 114.337 -177.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 p -51.05 -26.26 6.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 165.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -70.18 126.81 30.76 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 122.517 2.417 . . . . 0.0 108.257 -170.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.8 p -66.14 149.77 49.78 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.984 1.714 . . . . 0.0 113.796 -178.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 mm -84.6 89.56 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 1 N-CA-C 99.4 -4.296 . . . . 0.0 99.4 159.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -175.08 -60.91 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 130.325 3.45 . . . . 0.0 103.695 173.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -70.46 -39.51 74.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 114.853 -2.499 . . . . 0.0 116.454 -175.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.15 -44.35 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.692 1.997 . . . . 0.0 114.317 160.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.22 -16.49 62.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 112.318 -3.706 . . . . 0.0 111.407 -176.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.36 -35.88 30.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 123.888 3.04 . . . . 0.0 105.266 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -68.55 -35.92 78.09 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 125.076 2.369 . . . . 0.0 110.491 -176.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 mm -70.36 -46.91 69.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.276 176.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -56.11 -45.82 79.32 Favored 'General case' 0 N--CA 1.453 -0.296 1 O-C-N 116.274 -4.016 . . . . 0.0 107.223 -178.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.371 4.9 t70 -47.82 -55.9 8.68 Favored 'General case' 0 N--CA 1.444 -0.742 1 C-N-CA 133.901 4.88 . . . . 0.0 112.491 169.235 . . . . . . . . 3 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -65.97 -47.63 73.93 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 124.651 1.22 . . . . 0.0 109.925 176.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -125.14 -15.84 6.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 117.936 -2.978 . . . . 0.0 116.259 -148.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.21 6.57 53.44 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 153.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.7 mt -99.47 121.53 54.62 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-O 114.39 -2.719 . . . . 0.0 105.455 -163.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.77 135.33 62.98 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-N 124.63 2.689 . . . . 0.0 113.755 173.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.292 67.4 Cg_exo -33.1 -37.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.56 1 C-N-CA 129.644 6.896 . . . . 0.0 118.246 174.476 . . . . . . . . 3 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -80.69 -31.85 36.09 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 117.985 -2.947 . . . . 0.0 106.752 -172.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -90.94 -10.91 40.69 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 115.206 -2.331 . . . . 0.0 105.11 -172.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -77.87 94.79 4.6 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 130.687 3.595 . . . . 0.0 104.545 169.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -91.26 120.55 32.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.685 176.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mt -126.5 123.97 39.0 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -163.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -138.34 133.87 43.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -164.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.361 0.3 OUTLIER -124.6 -28.25 3.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.082 -2.327 . . . . 0.0 115.287 159.662 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.291 . . -153.02 43.59 0.63 Allowed 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 125.405 1.691 . . . . 0.0 108.912 -166.217 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.96 -7.67 49.04 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 128.709 3.052 . . . . 0.0 117.921 159.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.44 32.0 pttt -151.97 147.49 26.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 131.488 3.915 . . . . 0.0 110.918 -170.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.7 139.95 48.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.151 1.78 . . . . 0.0 112.705 173.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 mt -82.11 136.35 35.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 114.949 -2.453 . . . . 0.0 107.884 -174.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -82.68 139.84 33.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 126.237 2.211 . . . . 0.0 110.371 -170.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -45.3 113.78 0.63 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 118.679 2.844 . . . . 0.0 118.679 169.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.09 -7.19 40.67 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 164.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.259 13.3 mmp_? -93.69 142.12 27.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -172.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.9 p -86.47 163.86 17.3 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.333 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -41.05 -52.89 3.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 124.798 3.454 . . . . 0.0 115.704 163.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 t -51.84 -37.64 52.72 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 114.115 -2.85 . . . . 0.0 115.156 168.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -68.0 -18.57 64.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 178.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -97.36 -13.49 21.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 114.132 -2.842 . . . . 0.0 112.308 161.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.8 t30 72.14 31.8 1.87 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 125.626 3.83 . . . . 0.0 113.104 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -70.55 112.84 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 1 O-C-N 115.927 -4.233 . . . . 0.0 109.845 -175.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.291 22.9 mt-30 -94.03 162.68 13.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.269 1.428 . . . . 0.0 110.539 -165.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.266 26.8 pttt -42.16 115.26 0.66 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 117.168 2.284 . . . . 0.0 117.168 161.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.5 2.6 tt0 87.16 30.35 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.785 170.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.31 68.6 m -90.01 132.69 35.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 172.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -82.27 125.82 31.41 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.433 2.293 . . . . 0.0 112.456 169.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mp -116.36 124.36 49.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 172.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.285 11.8 t60 -83.64 120.09 25.56 Favored 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 131.876 4.07 . . . . 0.0 112.275 165.508 . . . . . . . . 3 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -94.5 130.59 40.83 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 117.373 -3.329 . . . . 0.0 108.337 174.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.79 153.01 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 O-C-N 117.98 -2.95 . . . . 0.0 114.125 170.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.518 -0.272 1 N-CA-C 98.125 -4.769 . . . . 0.0 98.125 -161.43 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pm0 -104.92 140.72 37.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.543 1.937 . . . . 0.0 107.93 178.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -124.72 151.8 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 128.644 2.777 . . . . 0.0 106.607 165.272 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.253 60.3 m-85 -93.11 151.58 19.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 122.577 1.179 . . . . 0.0 113.217 168.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.1 144.67 28.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 114.293 -2.765 . . . . 0.0 107.245 167.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 52.3 tttt -126.48 127.46 45.4 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 128.75 3.781 . . . . 0.0 118.196 170.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 p -82.36 166.18 19.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.743 2.417 . . . . 0.0 111.448 -169.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.35 -37.0 66.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 129.974 3.31 . . . . 0.0 116.604 172.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.8 p -73.89 -33.25 63.95 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.589 2.756 . . . . 0.0 113.967 173.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.17 16.43 7.23 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 116.518 1.367 . . . . 0.0 116.518 177.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -86.47 134.99 33.64 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.898 1.679 . . . . 0.0 106.984 178.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -100.59 113.24 25.89 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 130.091 3.357 . . . . 0.0 105.315 -176.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -100.38 114.51 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 100.666 -3.827 . . . . 0.0 100.666 174.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -66.25 131.75 46.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.954 -2.966 . . . . 0.0 109.261 154.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.14 128.45 38.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 119.418 -2.051 . . . . 0.0 108.297 -172.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -91.92 115.79 28.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 125.696 1.872 . . . . 0.0 110.26 178.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.51 22.6 m -121.07 -68.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 113.45 -3.166 . . . . 0.0 118.052 -163.271 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 80.48 131.74 0.04 OUTLIER Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 129.709 3.204 . . . . 0.0 107.176 -155.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.3 -16.81 15.21 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 CA-C-N 120.316 1.149 . . . . 0.0 114.976 -175.294 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 m -86.23 18.03 3.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 172.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -76.79 152.63 35.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.056 1.342 . . . . 0.0 110.002 158.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -88.71 148.5 23.95 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.999 1.319 . . . . 0.0 107.952 174.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.279 5.8 mm -46.13 -37.63 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 127.546 2.338 . . . . 0.0 113.477 174.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -82.27 -14.18 55.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 116.506 -3.871 . . . . 0.0 113.343 -175.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -94.86 -24.94 16.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 123.805 1.764 . . . . 0.0 110.692 174.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.45 -41.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 1 O-C-N 115.452 -4.53 . . . . 0.0 108.857 167.343 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -69.83 -34.05 73.14 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 124.525 1.141 . . . . 0.0 112.811 176.106 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.255 . . -77.45 -13.27 59.96 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 120.604 1.547 . . . . 0.0 110.808 173.126 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -69.1 -37.06 78.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 118.314 -2.742 . . . . 0.0 111.13 172.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 mm -69.15 -31.39 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 127.572 2.349 . . . . 0.0 108.291 175.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.58 -37.12 76.82 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 172.326 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.12 -51.2 40.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.254 -1.529 . . . . 0.0 114.152 172.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -87.57 -27.65 22.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -171.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -122.89 -21.23 5.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 115.282 -2.294 . . . . 0.0 115.441 175.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.63 -14.6 42.12 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 116.446 -2.308 . . . . 0.0 111.558 172.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.5 mt -78.38 121.23 83.49 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 120.394 2.097 . . . . 0.0 109.238 -154.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -55.27 143.27 76.51 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 CA-C-N 123.214 2.184 . . . . 0.0 117.029 -174.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.43 -28.86 3.33 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 O-C-N 116.965 -2.177 . . . . 0.0 116.396 -166.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 0.0 OUTLIER -51.92 -29.21 19.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 121.291 3.811 . . . . 0.0 121.291 172.127 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -92.7 -18.47 22.94 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 128.492 3.62 . . . . 0.0 111.723 -177.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -83.24 129.41 35.01 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 126.168 2.167 . . . . 0.0 116.282 -175.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -103.47 119.64 39.28 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 114.488 -2.673 . . . . 0.0 105.048 160.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -88.6 120.8 30.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.788 1.631 . . . . 0.0 109.075 168.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mm -114.57 135.28 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 126.52 1.928 . . . . 0.0 112.635 -177.025 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.262 49.5 t80 -148.61 113.33 5.38 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 128.383 2.673 . . . . 0.0 109.103 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.92 50.71 0.81 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 128.159 2.583 . . . . 0.0 111.451 163.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.15 4.5 66.63 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 117.82 -2.134 . . . . 0.0 117.264 174.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -161.2 144.75 12.97 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -160.391 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -87.92 140.32 29.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 125.352 2.501 . . . . 0.0 107.648 173.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.61 113.2 24.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 118.84 -2.413 . . . . 0.0 108.514 179.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -79.2 137.22 37.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 118.395 -2.691 . . . . 0.0 111.634 -163.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -45.65 112.38 0.45 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 129.146 2.978 . . . . 0.0 114.733 156.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.62 -15.6 9.76 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 128.972 3.177 . . . . 0.0 113.896 -173.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -105.69 178.26 4.61 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 120.84 2.32 . . . . 0.0 105.797 -175.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -110.7 170.0 8.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 118.473 -2.642 . . . . 0.0 108.545 176.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.46 -35.72 63.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 117.195 -1.802 . . . . 0.0 109.983 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 p -53.95 -27.75 33.07 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 128.2 2.6 . . . . 0.0 112.91 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -58.68 -26.35 63.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 167.158 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -120.33 23.04 11.1 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 118.209 -2.807 . . . . 0.0 108.287 -170.132 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.344 13.5 m120 78.73 10.01 1.82 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 126.379 2.299 . . . . 0.0 111.978 171.12 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -77.81 120.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 121.124 1.784 . . . . 0.0 111.544 -160.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -106.37 -177.4 3.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.643 1.211 . . . . 0.0 111.185 176.13 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -69.49 126.48 29.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.074 2.149 . . . . 0.0 110.46 -178.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 61.85 29.68 17.98 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 129.392 3.077 . . . . 0.0 114.34 -176.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.5 m -62.34 126.79 28.56 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.613 2.365 . . . . 0.0 111.963 154.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -82.97 119.98 25.12 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 127.141 2.177 . . . . 0.0 107.219 173.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -89.74 154.89 19.58 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.438 -2.164 . . . . 0.0 107.607 159.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -119.24 139.72 51.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -112.41 132.3 55.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 124.564 2.126 . . . . 0.0 110.559 -167.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 m -130.53 133.07 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 113.09 -1.868 . . . . 0.0 110.04 175.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.448 -0.571 0 O-C-N 126.234 2.209 . . . . 0.0 107.499 -177.567 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 mtt . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 116.59 -1.671 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 149.17 23.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 121.29 1.859 . . . . 0.0 107.43 177.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -136.06 -177.33 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 C-N-CA 127.931 2.493 . . . . 0.0 107.986 160.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -128.44 138.63 52.4 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 119.21 -2.181 . . . . 0.0 113.064 174.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.9 t -110.73 114.84 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 164.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 83.8 tttt -104.26 140.31 38.04 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.296 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.4 p -102.35 117.53 34.92 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 118.165 -2.835 . . . . 0.0 104.654 166.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.09 -32.69 7.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 117.184 -3.448 . . . . 0.0 117.681 177.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 p -88.0 -9.68 52.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.903 2.881 . . . . 0.0 109.072 -176.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.73 -111.86 1.07 Allowed Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.276 -1.291 . . . . 0.0 113.233 -170.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.353 7.4 pttp -142.66 164.1 31.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.305 1.842 . . . . 0.0 115.387 -168.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.313 0.6 OUTLIER -81.3 115.16 20.54 Favored 'General case' 0 C--N 1.325 -0.473 1 C-N-CA 134.0 4.92 . . . . 0.0 109.603 -179.836 . . . . . . . . 4 3 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 mt -108.94 124.72 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -173.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 p -72.34 124.69 25.64 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 112.71 -2.041 . . . . 0.0 111.678 -179.027 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.261 1.7 tm? -130.06 152.22 49.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.082 -2.261 . . . . 0.0 109.907 -175.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -129.75 123.33 30.78 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 123.873 1.797 . . . . 0.0 107.936 -170.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.73 152.63 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 131.37 3.868 . . . . 0.0 113.206 178.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -93.73 156.98 38.97 Favored Pre-proline 0 N--CA 1.446 -0.66 0 C-N-CA 127.048 2.139 . . . . 0.0 105.611 171.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.14 -7.93 18.69 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 N-CA-C 118.44 2.438 . . . . 0.0 118.44 -171.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.6 p -108.16 5.26 25.7 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 130.95 3.7 . . . . 0.0 117.49 176.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.03 139.73 36.83 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 126.213 2.196 . . . . 0.0 107.736 -167.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -87.21 166.6 14.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 125.427 1.704 . . . . 0.0 108.588 174.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mp -69.02 -40.3 80.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 130.079 3.352 . . . . 0.0 108.049 -176.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -53.16 -34.76 58.26 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 113.431 -3.176 . . . . 0.0 112.75 168.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -82.76 -13.38 56.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 125.147 1.529 . . . . 0.0 109.752 -174.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.3 t -70.9 -57.89 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 131.127 3.771 . . . . 0.0 106.727 168.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.316 38.7 mtmt -53.51 -38.66 63.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 125.281 2.467 . . . . 0.0 116.953 173.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -43.77 65.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 112.406 -2.179 . . . . 0.0 111.189 175.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -55.66 -51.92 65.59 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 118.79 -2.444 . . . . 0.0 109.1 171.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.9 mt -51.78 -31.56 13.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 122.535 2.425 . . . . 0.0 109.587 169.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -78.55 -48.66 14.77 Favored 'General case' 0 N--CA 1.447 -0.61 1 O-C-N 113.851 -5.53 . . . . 0.0 108.148 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.383 18.3 t70 -46.95 -33.48 4.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 128.957 2.903 . . . . 0.0 117.841 165.614 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -100.46 -53.68 3.04 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 118.079 -2.888 . . . . 0.0 114.238 -174.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -108.47 -27.81 9.71 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -173.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.85 19.79 60.78 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 125.625 2.792 . . . . 0.0 117.269 175.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.9 mt -77.18 109.67 9.89 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-O 113.067 -3.349 . . . . 0.0 105.663 179.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -64.58 148.35 90.44 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 CA-C-N 126.912 3.504 . . . . 0.0 107.853 -166.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.84 -23.85 74.35 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 118.626 2.51 . . . . 0.0 118.626 -172.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -94.65 -12.23 27.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 115.461 -2.209 . . . . 0.0 111.913 -172.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -86.81 -19.41 29.04 Favored 'General case' 0 N--CA 1.448 -0.56 1 C-N-CA 132.536 4.334 . . . . 0.0 111.724 173.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -80.97 144.99 31.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 -179.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.334 70.5 mtm180 -119.79 153.14 36.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 117.126 -3.484 . . . . 0.0 104.809 144.059 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.9 mt -119.35 140.98 49.46 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 114.303 -2.761 . . . . 0.0 107.255 176.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.497 0.0 OUTLIER -136.96 146.45 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 125.169 3.622 . . . . 0.0 110.778 172.482 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -159.09 110.47 2.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 116.542 -1.695 . . . . 0.0 108.875 -169.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.34 21.2 5.84 Favored 'General case' 0 N--CA 1.449 -0.487 1 O-C-N 129.525 4.265 . . . . 0.0 115.643 168.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.0 -18.16 29.01 Favored Glycine 0 CA--C 1.532 1.145 0 O-C-N 118.077 -2.89 . . . . 0.0 116.531 -169.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 126.71 52.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 129.465 3.685 . . . . 0.0 112.535 -162.361 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.78 97.6 0.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 129.2 3.0 . . . . 0.0 110.009 173.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -67.63 118.69 11.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 127.757 2.423 . . . . 0.0 109.641 -178.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.51 128.96 55.26 Favored 'General case' 0 N--CA 1.451 -0.391 1 O-C-N 130.676 4.985 . . . . 0.0 112.19 175.109 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -52.85 131.46 35.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 119.255 -2.153 . . . . 0.0 112.466 156.44 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.74 2.14 14.68 Favored Glycine 0 CA--C 1.53 1.023 1 CA-C-O 110.766 -5.463 . . . . 0.0 113.367 -171.03 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -129.21 163.08 26.37 Favored 'General case' 0 N--CA 1.449 -0.506 1 CA-C-N 124.287 4.044 . . . . 0.0 107.577 -176.37 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 p -88.26 159.71 17.99 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 101.707 -3.442 . . . . 0.0 101.707 -176.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tt -34.23 -53.52 0.49 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 129.834 3.254 . . . . 0.0 111.138 153.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.6 m -72.27 -14.78 61.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 128.433 2.693 . . . . 0.0 115.233 -173.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.268 17.6 m-20 -65.09 -41.25 95.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 164.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -107.63 -28.46 9.73 Favored 'General case' 0 C--N 1.324 -0.504 1 O-C-N 114.891 -4.881 . . . . 0.0 108.136 -170.262 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.494 20.2 t30 96.06 41.72 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.324 2.25 . . . . 0.0 115.745 -175.024 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.1 mt -84.35 89.6 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 125.49 1.744 . . . . 0.0 110.191 176.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -91.09 175.13 7.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 125.82 1.95 . . . . 0.0 108.203 -168.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 149.06 30.07 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 170.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 64.78 2.96 1.85 Allowed 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 125.784 1.928 . . . . 0.0 114.421 177.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -69.06 156.17 39.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.026 -1.671 . . . . 0.0 111.442 176.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.3 m -125.17 132.27 53.08 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 117.334 -3.354 . . . . 0.0 104.746 -174.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.53 137.4 47.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -85.72 143.34 28.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.841 -1.787 . . . . 0.0 106.343 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tp -107.42 131.5 54.21 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 168.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.85 89.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.941 2.096 . . . . 0.0 114.419 -163.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.323 -0.572 0 O-C-N 119.403 -2.06 . . . . 0.0 109.062 -147.89 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 117.464 -1.255 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.274 50.0 mt-30 -95.43 125.87 40.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 127.324 3.44 . . . . 0.0 107.031 -175.57 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -113.07 144.71 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.315 171.083 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -100.7 106.5 17.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.267 -178.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.3 t -88.34 106.81 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 124.028 1.871 . . . . 0.0 110.487 170.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.294 5.4 tppt? -84.75 135.76 33.99 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.029 -1.669 . . . . 0.0 109.469 173.131 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -78.17 165.19 24.24 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.967 1.707 . . . . 0.0 115.107 165.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.35 0.4 OUTLIER -83.1 -12.49 57.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.581 163.665 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -66.65 -41.58 88.02 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 171.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.82 38.23 1.31 Allowed Glycine 0 CA--C 1.536 1.397 0 O-C-N 118.081 -2.887 . . . . 0.0 110.218 -172.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.283 59.4 pttt -130.76 168.77 16.67 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.525 2.33 . . . . 0.0 105.593 167.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.305 1.8 m -115.3 171.21 7.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 159.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 pt -138.61 145.69 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 131.411 3.885 . . . . 0.0 109.091 161.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 m -107.58 105.88 15.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 118.787 -2.446 . . . . 0.0 110.623 -175.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.21 131.73 40.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 115.185 -2.341 . . . . 0.0 109.209 176.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -74.66 119.62 19.1 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.04 2.536 . . . . 0.0 109.041 156.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.22 157.59 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 177.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.301 1.7 tm-20 -85.53 153.04 58.33 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 169.7 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.96 -22.98 75.33 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.482 1.455 . . . . 0.0 115.846 168.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.0 p -94.86 11.68 30.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 119.021 -2.3 . . . . 0.0 113.314 171.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.22 134.96 48.57 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 124.518 3.327 . . . . 0.0 107.819 159.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p -89.51 155.17 19.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 112.519 -2.128 . . . . 0.0 114.029 174.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 mm -40.23 -56.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.418 2.287 . . . . 0.0 114.996 -172.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -39.66 65.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -69.87 -33.25 71.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.164 -1.585 . . . . 0.0 110.613 176.184 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 t -59.71 -45.27 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 O-C-N 116.633 -3.792 . . . . 0.0 108.129 171.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -53.78 -49.74 67.6 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 125.426 1.704 . . . . 0.0 108.448 175.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.43 -34.95 78.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 126.828 3.204 . . . . 0.0 114.099 -178.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -78.44 -24.53 46.06 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 117.309 -3.369 . . . . 0.0 108.791 177.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 mt -70.24 -40.36 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 123.544 2.884 . . . . 0.0 108.935 162.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -67.92 -39.38 83.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 114.467 -2.682 . . . . 0.0 112.097 -168.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -53.66 -39.54 65.15 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 127.487 2.315 . . . . 0.0 115.112 165.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.311 65.8 mmtt -89.7 -44.86 9.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 117.755 -1.578 . . . . 0.0 113.007 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -97.87 -19.88 17.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 116.124 -1.893 . . . . 0.0 113.055 -173.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.3 -15.26 63.35 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 173.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.0 mt -70.94 113.3 17.79 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-O 114.343 -2.741 . . . . 0.0 110.043 -177.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -65.35 153.77 76.7 Favored 'Trans proline' 0 N--CA 1.449 -1.116 1 C-N-CA 126.238 4.625 . . . . 0.0 110.385 -173.764 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.47 -34.16 97.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.825 3.017 . . . . 0.0 113.991 -178.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -60.52 -2.91 0.57 Allowed 'General case' 0 N--CA 1.445 -0.683 1 C-N-CA 133.883 4.873 . . . . 0.0 115.85 172.899 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.39 0.0 OUTLIER -135.59 14.93 3.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 169.289 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -105.79 161.35 14.5 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 171.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.295 15.9 ttm180 -157.62 139.27 13.92 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 131.386 3.874 . . . . 0.0 108.454 169.448 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.9 118.23 22.32 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.486 2.314 . . . . 0.0 109.985 -162.569 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.4 mm -101.75 139.33 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.689 1.596 . . . . 0.0 109.173 -174.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -148.03 140.48 24.43 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 115.82 -2.038 . . . . 0.0 110.376 158.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.301 . . 69.97 8.09 6.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 -177.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.89 -13.84 22.03 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.189 1.852 . . . . 0.0 108.786 171.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -112.45 163.86 13.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 116.497 -3.943 . . . . 0.0 111.776 -174.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -79.1 118.44 21.08 Favored 'General case' 0 N--CA 1.441 -0.913 1 C-N-CA 132.018 4.127 . . . . 0.0 111.315 166.524 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.85 129.12 34.36 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 127.53 3.019 . . . . 0.0 106.769 169.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -92.23 156.32 17.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 130.529 3.531 . . . . 0.0 114.004 -171.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -49.11 130.69 19.09 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.447 2.299 . . . . 0.0 111.545 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.73 -27.53 14.68 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.088 1.804 . . . . 0.0 116.418 163.358 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.81 149.98 26.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 120.537 2.169 . . . . 0.0 108.178 176.403 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -79.31 164.99 23.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 128.909 2.884 . . . . 0.0 109.285 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.1 mt -67.64 -27.0 66.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.665 170.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.257 1.2 p -72.32 -20.36 61.5 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 112.281 -3.723 . . . . 0.0 115.402 163.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.61 -17.63 62.27 Favored 'General case' 0 N--CA 1.447 -0.615 1 CA-C-O 129.295 4.379 . . . . 0.0 109.225 178.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.264 50.2 m-85 -112.05 1.67 16.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 117.649 -3.157 . . . . 0.0 110.931 177.596 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.4 t30 53.57 44.43 29.83 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.8 2.44 . . . . 0.0 115.16 168.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.275 2.9 mt -66.56 131.57 32.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 1 C-N-CA 133.825 4.85 . . . . 0.0 112.875 160.636 . . . . . . . . 3 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.0 169.29 12.26 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 114.837 -2.506 . . . . 0.0 113.537 171.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.14 127.17 3.47 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 119.452 3.13 . . . . 0.0 119.452 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 65.45 30.61 10.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.358 2.263 . . . . 0.0 115.392 174.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -81.87 151.02 27.5 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.2 m -97.48 116.71 30.21 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 119.615 -1.928 . . . . 0.0 107.565 -174.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -100.43 145.14 28.59 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 128.513 2.725 . . . . 0.0 111.49 171.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -112.55 107.5 16.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 124.39 2.043 . . . . 0.0 110.202 -167.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tp -80.49 134.75 36.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 119.214 -2.179 . . . . 0.0 109.22 -173.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.5 t -125.01 136.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.911 -1.118 . . . . 0.0 111.099 174.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.45 -0.446 0 C-N-CA 130.533 3.533 . . . . 0.0 106.875 176.92 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -102.1 150.78 22.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 118.294 -2.754 . . . . 0.0 105.847 176.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.374 16.4 pt -140.56 157.51 24.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 131.203 3.801 . . . . 0.0 106.693 164.585 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -112.05 139.83 47.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -175.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 t -115.08 126.31 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 128.276 2.631 . . . . 0.0 107.83 166.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -93.29 125.59 37.97 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 127.925 3.266 . . . . 0.0 110.838 169.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.271 72.5 p -79.11 -165.18 0.71 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -179.632 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mt -77.28 -43.21 34.08 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 118.042 -2.911 . . . . 0.0 111.898 163.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.7 p -74.74 -6.28 47.99 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -169.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.59 0.87 43.23 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 117.253 1.661 . . . . 0.0 117.253 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -84.59 147.88 26.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.909 1.283 . . . . 0.0 111.713 173.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.6 m -110.52 109.29 19.57 Favored 'General case' 0 C--N 1.326 -0.441 1 C-N-CA 132.416 4.286 . . . . 0.0 100.314 173.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -95.31 142.42 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 127.257 2.223 . . . . 0.0 106.246 166.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.5 m -96.2 133.31 40.67 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -117.63 140.36 49.74 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -177.149 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -101.86 130.88 48.43 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 100.666 -3.828 . . . . 0.0 100.666 -177.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.34 163.14 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.177 176.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.366 71.2 mm-40 -116.48 145.83 36.09 Favored Pre-proline 0 N--CA 1.445 -0.675 0 N-CA-C 101.758 -3.423 . . . . 0.0 101.758 163.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -73.01 -3.6 13.92 Favored 'Trans proline' 0 N--CA 1.447 -1.261 1 C-N-CA 125.964 4.442 . . . . 0.0 113.911 -174.343 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 p -80.5 -20.91 42.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 128.755 2.822 . . . . 0.0 115.615 164.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -61.6 141.58 57.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.441 1.591 . . . . 0.0 113.565 175.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -70.56 159.12 34.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.1 1.76 . . . . 0.0 109.459 167.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 mm -45.24 -39.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 130.131 3.372 . . . . 0.0 113.973 162.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -76.61 -34.83 58.36 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.358 0.981 . . . . 0.0 110.761 179.533 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.288 18.8 m-80 -53.33 -44.29 68.32 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 116.722 -1.608 . . . . 0.0 112.014 174.381 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.28 1.9 t -51.55 -49.37 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 167.133 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -54.65 -52.15 63.21 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 125.586 1.804 . . . . 0.0 115.145 175.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.8 -39.02 4.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 131.306 3.842 . . . . 0.0 119.661 166.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -86.26 -38.92 17.07 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 110.867 -2.879 . . . . 0.0 105.841 -179.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.304 83.6 mt -54.47 -37.03 36.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 O-C-N 117.806 -3.059 . . . . 0.0 114.05 166.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -44.83 66.89 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 128.053 2.541 . . . . 0.0 115.718 175.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.39 -51.94 67.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.348 1.859 . . . . 0.0 111.637 168.089 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -82.67 -16.86 46.58 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 118.444 2.757 . . . . 0.0 118.444 -168.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -154.79 2.37 0.2 Allowed 'General case' 0 N--CA 1.449 -0.52 1 O-C-N 115.962 -4.211 . . . . 0.0 109.405 -173.594 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.37 -20.09 48.52 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 117.598 -3.189 . . . . 0.0 114.933 161.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mt -83.25 131.55 52.93 Favored Pre-proline 0 N--CA 1.442 -0.854 0 O-C-N 119.258 -2.319 . . . . 0.0 107.671 -167.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -59.92 151.06 74.38 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 118.824 2.586 . . . . 0.0 118.824 165.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.396 29.9 Cg_exo -47.17 -40.91 27.44 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 124.685 3.59 . . . . 0.0 117.718 173.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.27 2.76 38.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 124.811 1.319 . . . . 0.0 110.295 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -118.93 6.08 11.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 123.388 2.813 . . . . 0.0 112.494 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 70.1 mt-30 -99.2 156.24 17.07 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 118.704 0.684 . . . . 0.0 109.768 175.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -129.84 114.92 16.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 101.56 -3.496 . . . . 0.0 101.56 160.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 mt -86.66 146.45 26.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 125.735 3.88 . . . . 0.0 109.151 176.467 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.27 20.3 mm -135.14 156.17 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 129.722 3.209 . . . . 0.0 106.418 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -159.55 147.55 17.34 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 127.001 2.688 . . . . 0.0 109.789 159.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.347 . . 52.59 20.11 1.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 131.117 3.767 . . . . 0.0 112.51 175.354 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.29 -0.06 59.92 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 128.659 3.028 . . . . 0.0 110.168 175.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.275 28.3 mttm -100.66 148.06 25.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 116.127 -1.892 . . . . 0.0 112.689 -178.713 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.41 132.38 42.93 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 161.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 118.67 5.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.501 172.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.95 99.36 3.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.177 2.191 . . . . 0.0 111.25 174.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -39.3 135.07 1.08 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 151.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.96 2.53 7.82 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.132 -1.371 . . . . 0.0 116.412 171.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -129.25 -167.57 1.81 Allowed 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 127.371 2.453 . . . . 0.0 111.193 -163.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -125.21 165.18 18.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.824 1.65 . . . . 0.0 110.19 161.183 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.4 -40.09 81.43 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 118.081 -2.887 . . . . 0.0 111.042 -176.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.0 t -64.48 -33.45 75.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.719 2.008 . . . . 0.0 109.797 175.467 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.251 28.1 t70 -82.37 -32.36 29.26 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 117.667 -3.146 . . . . 0.0 115.07 -176.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -91.51 -2.75 57.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 116.012 -1.947 . . . . 0.0 109.177 173.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 71.74 40.04 0.81 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 129.988 3.315 . . . . 0.0 114.47 169.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.4 mt -79.88 109.81 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 102.003 -3.332 . . . . 0.0 102.003 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -83.51 164.98 19.5 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.274 1.83 . . . . 0.0 112.193 172.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.74 156.78 39.08 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.346 2.659 . . . . 0.0 108.951 -177.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 62.75 7.2 2.42 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.386 2.274 . . . . 0.0 112.278 175.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -74.61 148.44 40.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.2 -2.188 . . . . 0.0 111.385 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.2 m -108.4 111.91 24.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 118.361 -1.336 . . . . 0.0 112.741 -178.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -88.62 176.02 7.3 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 129.905 3.282 . . . . 0.0 109.944 171.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -134.36 154.03 51.57 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 116.619 -3.801 . . . . 0.0 110.811 -175.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.321 0.7 OUTLIER -118.16 150.57 39.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.11 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.65 147.74 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 130.735 3.614 . . . . 0.0 105.597 163.02 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.9 tp . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.625 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -96.75 166.7 11.52 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -164.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 pt -114.68 134.41 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 153.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -87.12 112.06 21.56 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.53 1.532 . . . . 0.0 113.41 165.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.48 117.46 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 113.379 -3.201 . . . . 0.0 108.182 -176.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -119.29 152.28 36.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 130.005 3.322 . . . . 0.0 107.322 -169.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -155.45 170.57 21.63 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.933 1.693 . . . . 0.0 112.817 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 -23.34 48.34 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 128.608 3.693 . . . . 0.0 114.588 -165.5 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -76.67 -7.42 55.27 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 169.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.3 -23.5 8.05 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 118.026 -2.921 . . . . 0.0 114.108 167.113 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -59.55 133.05 55.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 118.06 2.615 . . . . 0.0 118.06 -175.853 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 m -112.86 103.67 11.66 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 170.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 mt -96.85 115.3 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 129.589 3.156 . . . . 0.0 106.484 175.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.8 p -89.6 109.94 20.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 114.046 -2.883 . . . . 0.0 111.932 168.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -112.21 140.11 47.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 125.076 3.58 . . . . 0.0 105.028 172.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -88.64 135.76 33.34 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.19 2.196 . . . . 0.0 107.599 176.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.51 173.6 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 127.879 2.472 . . . . 0.0 110.991 -161.623 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 44.7 mm-40 -132.88 166.56 28.33 Favored Pre-proline 0 N--CA 1.441 -0.925 1 O-C-N 129.572 4.295 . . . . 0.0 108.517 151.648 . . . . . . . . 3 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -37.74 -21.63 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 124.324 3.349 . . . . 0.0 120.229 163.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.7 p -94.07 -20.59 19.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.914 2.886 . . . . 0.0 113.667 -173.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -69.1 145.3 53.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.188 0.994 . . . . 0.0 112.502 176.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.5 p -90.0 165.25 14.16 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.93 -1.941 . . . . 0.0 112.108 -173.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -74.08 -49.72 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 114.902 -2.475 . . . . 0.0 110.382 170.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -58.62 -10.28 2.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 125.705 3.866 . . . . 0.0 119.605 172.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -74.91 -38.66 61.77 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 119.628 1.104 . . . . 0.0 112.26 161.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -71.89 -34.63 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 O-C-N 116.817 -3.677 . . . . 0.0 109.419 -168.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -71.43 -39.53 70.98 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.692 1.997 . . . . 0.0 109.251 -175.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.73 89.32 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.983 3.313 . . . . 0.0 116.505 161.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -82.79 -21.04 34.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 125.62 1.825 . . . . 0.0 113.729 -177.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -55.76 -50.67 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.646 2.378 . . . . 0.0 109.252 161.111 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -67.35 -28.52 68.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -173.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.334 36.5 t70 -52.41 -46.43 66.32 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 130.882 3.673 . . . . 0.0 117.093 162.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -92.08 -48.62 6.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.688 -1.596 . . . . 0.0 108.907 -175.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.46 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS 0.318 20.8 tp10 -108.13 -15.79 14.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 128.065 2.546 . . . . 0.0 116.37 -166.78 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.26 -26.01 26.0 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 124.497 3.317 . . . . 0.0 111.949 158.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 tp -67.95 127.91 93.33 Favored Pre-proline 0 C--O 1.223 -0.33 0 CA-C-O 113.917 -2.944 . . . . 0.0 107.782 -170.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.67 137.07 17.76 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 124.519 3.48 . . . . 0.0 118.137 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -34.53 -37.95 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.441 3.427 . . . . 0.0 117.623 178.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.481 13.1 t70 -44.07 -40.47 4.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 171.214 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -108.23 12.39 26.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 112.836 -1.984 . . . . 0.0 111.426 -176.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -100.95 135.86 41.72 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.195 1.798 . . . . 0.0 107.88 174.06 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -130.26 140.07 50.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 128.09 2.556 . . . . 0.0 111.816 172.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.03 118.79 30.7 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 126.542 2.401 . . . . 0.0 108.666 -160.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.3 mm -120.03 138.35 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 127.599 2.359 . . . . 0.0 111.197 -173.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -133.55 100.67 4.87 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.226 2.211 . . . . 0.0 112.232 171.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.49 -94.36 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.386 -162.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.08 4.57 9.0 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 115.973 -2.57 . . . . 0.0 114.437 168.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -87.3 131.23 34.32 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 120.703 2.252 . . . . 0.0 105.067 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -85.0 124.27 31.5 Favored 'General case' 0 N--CA 1.442 -0.842 1 C-N-CA 134.445 5.098 . . . . 0.0 105.599 176.241 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 mt -101.27 157.27 16.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 125.46 1.725 . . . . 0.0 109.879 -173.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -130.18 134.04 47.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.468 1.507 . . . . 0.0 107.313 170.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.256 3.1 p30 -70.12 -168.62 0.23 Allowed 'General case' 0 C--O 1.221 -0.402 0 O-C-N 128.684 3.74 . . . . 0.0 112.141 -174.153 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.55 1.75 58.92 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 120.89 3.116 . . . . 0.0 120.89 -175.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.3 mtt-85 -147.86 159.34 43.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 128.586 2.754 . . . . 0.0 110.747 -150.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.3 p -83.19 176.73 8.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 129.972 3.309 . . . . 0.0 111.036 -179.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.66 -33.49 76.01 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 129.36 3.064 . . . . 0.0 111.232 168.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 41.1 t -85.49 -10.52 55.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 119.39 -2.069 . . . . 0.0 112.115 176.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.03 -28.46 68.88 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 125.612 1.82 . . . . 0.0 109.979 169.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.287 41.3 m-85 -122.73 17.15 10.28 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 119.53 -1.981 . . . . 0.0 113.562 -175.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 t30 53.8 40.61 31.72 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -174.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.2 mt -85.62 80.58 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 173.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -102.77 36.55 2.16 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.613 2.365 . . . . 0.0 111.428 -161.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm 96.45 132.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 1 C-N-CA 132.212 4.205 . . . . 0.0 105.774 156.069 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.435 9.9 mp0 73.49 23.53 2.46 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 130.6 3.56 . . . . 0.0 109.87 176.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.9 m -69.48 142.27 53.78 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 129.045 2.938 . . . . 0.0 109.308 171.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.5 m -94.86 119.08 32.84 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 126.103 2.127 . . . . 0.0 106.105 168.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.38 137.12 47.72 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 175.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -104.9 120.57 41.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.569 2.348 . . . . 0.0 107.253 178.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -92.49 115.52 28.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 110.71 -2.95 . . . . 0.0 109.089 166.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.8 t -74.38 109.87 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 159.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.218 -0.576 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 165.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 115.765 -2.064 . . . . 0.0 107.739 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -86.5 140.44 29.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -167.803 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.398 7.4 pt -131.77 172.97 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 128.686 2.794 . . . . 0.0 115.561 162.576 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -126.85 135.45 51.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 127.164 2.79 . . . . 0.0 103.679 -175.317 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.275 79.6 t -126.92 121.47 58.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.978 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.255 35.1 tttp -97.47 156.05 16.66 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 129.583 3.153 . . . . 0.0 103.8 -172.918 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -134.48 146.2 49.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.183 -178.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.7 mt -68.52 -22.59 64.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 117.906 -2.996 . . . . 0.0 111.403 -176.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 p -82.04 -18.49 43.04 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.504 2.322 . . . . 0.0 109.002 -172.654 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.47 31.45 0.78 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-O 116.624 -2.209 . . . . 0.0 112.981 151.14 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.311 41.5 pttt -133.43 160.87 36.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.039 3.336 . . . . 0.0 110.212 -179.399 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -122.08 135.53 54.82 Favored 'General case' 0 N--CA 1.449 -0.514 1 N-CA-C 99.739 -4.171 . . . . 0.0 99.739 164.73 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 pt -97.99 152.43 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 118.806 -2.434 . . . . 0.0 105.165 168.616 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.1 m -96.83 150.14 21.06 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 128.741 3.776 . . . . 0.0 107.656 166.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.85 157.36 46.94 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.009 2.123 . . . . 0.0 107.288 179.816 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -134.27 101.4 5.0 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.475 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.44 145.31 25.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 129.458 3.103 . . . . 0.0 112.646 -172.773 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -85.29 135.18 39.31 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.768 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.83 -37.62 2.45 Favored 'Trans proline' 0 N--CA 1.454 -0.841 1 C-N-CA 126.971 5.114 . . . . 0.0 117.639 -178.334 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 p -103.13 9.61 38.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 119.566 3.172 . . . . 0.0 119.566 -179.494 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -72.55 137.71 46.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 118.138 -2.851 . . . . 0.0 104.035 170.194 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -75.95 162.03 28.44 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 129.693 3.197 . . . . 0.0 113.809 172.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.1 mm -53.12 -36.45 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.258 2.223 . . . . 0.0 113.891 -174.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.305 4.8 tp10 -55.89 -38.6 70.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.83 2.052 . . . . 0.0 115.526 173.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -66.99 -43.66 82.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 125.932 2.02 . . . . 0.0 112.756 176.225 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.263 22.8 t -52.84 -52.76 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.836 2.054 . . . . 0.0 110.2 174.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -58.79 -42.08 88.22 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 125.667 1.854 . . . . 0.0 111.916 -179.228 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.48 72.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 116.462 -1.732 . . . . 0.0 112.572 177.371 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -76.41 -33.48 58.82 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 122.784 2.538 . . . . 0.0 111.457 178.586 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.58 -43.43 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 129.895 3.278 . . . . 0.0 110.698 174.394 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.48 -52.9 62.59 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 125.309 1.443 . . . . 0.0 112.416 175.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -52.71 -39.43 62.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 131.237 3.815 . . . . 0.0 111.977 -179.082 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -87.83 -50.69 6.29 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 127.688 3.117 . . . . 0.0 115.808 -178.894 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.3 -6.29 12.96 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 128.075 2.55 . . . . 0.0 115.357 -166.237 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.0 -16.6 35.98 Favored Glycine 0 CA--C 1.533 1.158 1 C-N-CA 130.821 4.058 . . . . 0.0 110.181 156.453 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.08 121.94 86.34 Favored Pre-proline 0 N--CA 1.444 -0.763 0 O-C-N 119.468 -2.195 . . . . 0.0 110.388 -164.089 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.26 148.94 56.54 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 122.994 2.463 . . . . 0.0 111.244 179.164 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.68 -32.14 95.33 Favored 'Trans proline' 0 N--CA 1.447 -1.238 1 C-N-CA 125.363 4.042 . . . . 0.0 116.614 -163.065 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.253 51.3 m-20 -73.18 -4.34 32.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.007 2.123 . . . . 0.0 115.49 176.165 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -108.82 -12.16 14.94 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 171.613 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.83 162.37 21.66 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.699 -0.8 . . . . 0.0 113.027 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.276 0.1 OUTLIER -151.71 102.93 2.9 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 118.308 -2.745 . . . . 0.0 106.475 175.21 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.2 mt -87.04 113.55 22.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 127.576 3.048 . . . . 0.0 114.732 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.8 mt -120.56 138.89 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 131.551 3.941 . . . . 0.0 106.558 -168.102 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -155.34 -176.68 6.07 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.098 -2.876 . . . . 0.0 105.97 -172.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.04 112.67 1.41 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 124.638 2.161 . . . . 0.0 110.026 -168.693 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.82 -78.54 0.3 Allowed Glycine 0 CA--C 1.532 1.137 0 N-CA-C 107.03 -2.428 . . . . 0.0 107.03 -175.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -165.74 -171.99 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.965 2.506 . . . . 0.0 104.959 -161.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.81 148.85 45.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 130.994 3.718 . . . . 0.0 110.034 -177.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.37 147.39 22.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 122.863 1.316 . . . . 0.0 111.907 176.148 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -111.55 157.72 20.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 111.663 -2.517 . . . . 0.0 115.556 -175.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -72.98 135.53 44.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 130.84 3.656 . . . . 0.0 112.381 -171.68 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.5 -28.35 10.96 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 169.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -71.74 159.26 34.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 116.605 -1.664 . . . . 0.0 110.36 -179.006 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 p -113.28 -178.46 3.38 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.358 2.263 . . . . 0.0 109.567 171.148 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.0 -31.25 68.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 125.192 1.557 . . . . 0.0 114.255 179.197 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.3 p -77.42 -33.31 54.97 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.15 -37.83 75.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 124.508 1.13 . . . . 0.0 110.883 177.261 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.73 -0.58 57.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.026 -1.046 . . . . 0.0 113.627 -175.076 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 77.94 42.83 0.1 Allowed 'General case' 0 C--N 1.324 -0.51 1 C-N-CA 134.045 4.938 . . . . 0.0 109.072 167.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -100.03 95.35 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 103.258 -2.868 . . . . 0.0 103.258 -175.34 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.66 163.74 26.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.624 -1.298 . . . . 0.0 110.162 160.459 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -45.41 147.3 0.83 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 131.095 3.758 . . . . 0.0 114.04 175.37 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 59.41 33.84 22.5 Favored 'General case' 0 N--CA 1.448 -0.566 1 C-N-CA 132.847 4.459 . . . . 0.0 106.901 172.29 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -93.68 152.21 19.13 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 117.511 -3.243 . . . . 0.0 106.861 175.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.6 m -99.67 130.28 45.88 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.932 1.395 . . . . 0.0 110.56 175.177 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mp -102.78 161.49 13.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 102.088 -3.301 . . . . 0.0 102.088 163.434 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 123.42 49.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 172.752 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -90.14 122.0 32.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 118.677 -2.514 . . . . 0.0 111.57 167.302 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.67 156.4 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.925 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.268 16.0 mt . . . . . 0 N--CA 1.444 -0.739 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.399 -169.807 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptt? . . . . . 0 C--O 1.223 -0.317 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -88.45 148.69 24.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 117.518 -3.239 . . . . 0.0 105.705 -177.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -127.2 143.29 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 128.925 2.89 . . . . 0.0 107.268 159.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -104.07 134.41 47.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.197 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.23 126.93 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 117.74 -1.124 . . . . 0.0 109.413 -168.047 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -116.68 116.45 27.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 122.162 2.256 . . . . 0.0 112.853 -165.703 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 p -74.06 158.59 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.201 1.4 . . . . 0.0 109.98 -178.88 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.5 tp -59.78 -40.47 88.37 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.682 1.993 . . . . 0.0 107.223 -166.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.6 p -80.7 2.2 26.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.89 -3.007 . . . . 0.0 118.607 176.408 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.91 -7.7 16.96 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 119.157 2.423 . . . . 0.0 119.157 152.815 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -75.67 122.86 24.61 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.281 1.433 . . . . 0.0 107.251 -177.086 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.321 73.1 m -81.86 138.16 35.11 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.19 0.995 . . . . 0.0 109.754 170.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -122.12 141.86 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 129.807 3.243 . . . . 0.0 103.379 172.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 m -96.88 120.05 36.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.943 2.497 . . . . 0.0 112.307 170.165 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.2 mt -106.17 136.27 46.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.084 1.754 . . . . 0.0 110.437 171.158 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -92.17 140.28 29.78 Favored 'General case' 0 CA--C 1.535 0.401 1 O-C-N 129.863 4.477 . . . . 0.0 104.235 172.058 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -153.9 168.66 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 129.256 3.022 . . . . 0.0 105.278 -174.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -116.45 159.69 39.08 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 129.094 2.958 . . . . 0.0 107.81 172.769 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.297 86.7 Cg_endo -57.86 -29.58 86.69 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.568 3.512 . . . . 0.0 116.515 172.237 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -95.88 11.18 34.67 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 130.769 3.628 . . . . 0.0 108.398 -166.889 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.29 2.6 m-20 -92.92 146.8 23.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 115.835 -2.031 . . . . 0.0 111.533 -176.038 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 t -86.13 151.83 23.35 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 120.338 1.427 . . . . 0.0 112.262 173.72 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.258 62.6 mt -65.12 -31.24 53.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 118.367 -2.708 . . . . 0.0 108.826 -171.069 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.15 -40.44 97.57 Favored 'General case' 0 N--CA 1.452 -0.366 2 O-C-N 114.325 -5.234 . . . . 0.0 113.824 176.515 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -68.44 -31.0 70.01 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 128.532 2.733 . . . . 0.0 111.8 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 t -59.64 -51.94 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 122.496 2.407 . . . . 0.0 110.278 163.448 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -68.03 -40.55 82.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.973 2.909 . . . . 0.0 112.051 -164.053 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -17.94 64.8 Favored 'General case' 0 N--CA 1.446 -0.655 1 C-N-CA 132.765 4.426 . . . . 0.0 113.982 177.45 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -65.08 -31.64 72.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 130.554 3.542 . . . . 0.0 110.661 176.399 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 mm -74.05 -16.74 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 O-C-N 124.948 1.405 . . . . 0.0 114.164 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.281 6.1 tp60 -66.89 -38.12 85.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 117.251 -3.406 . . . . 0.0 111.441 169.723 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.66 -47.67 74.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.811 1.244 . . . . 0.0 110.708 168.612 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.85 -75.33 0.16 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 115.577 -2.154 . . . . 0.0 114.498 -175.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -101.24 -20.06 15.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 127.944 3.278 . . . . 0.0 115.171 -161.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.96 6.34 26.34 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 130.345 3.831 . . . . 0.0 114.51 162.811 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.59 124.02 54.32 Favored Pre-proline 0 N--CA 1.448 -0.555 0 O-C-N 126.728 2.075 . . . . 0.0 105.854 -164.176 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -68.24 172.81 10.49 Favored 'Trans proline' 0 N--CA 1.451 -1.003 1 C-N-CA 126.424 4.75 . . . . 0.0 116.16 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.85 -42.59 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 1 C-N-CA 126.943 5.096 . . . . 0.0 107.622 177.266 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.88 -15.32 62.62 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 130.725 3.61 . . . . 0.0 115.978 -174.57 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.257 38.0 tt0 -103.59 -34.57 8.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 118.101 -1.439 . . . . 0.0 113.887 171.572 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.05 135.01 21.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.745 1.618 . . . . 0.0 115.329 169.017 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -136.14 158.34 44.65 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 119.158 -2.214 . . . . 0.0 107.702 168.44 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.8 mt -129.63 152.24 49.36 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 127.87 3.231 . . . . 0.0 108.952 -167.602 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 mt -135.94 129.49 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 127.797 2.439 . . . . 0.0 107.142 169.871 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -120.28 118.33 30.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 130.359 3.464 . . . . 0.0 105.338 173.205 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.87 50.64 11.09 Favored 'General case' 0 C--O 1.22 -0.472 1 C-N-CA 133.797 4.839 . . . . 0.0 111.568 170.983 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.46 -13.92 60.93 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.787 -1.007 . . . . 0.0 111.591 173.344 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -105.93 119.75 39.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 130.988 3.715 . . . . 0.0 109.06 -172.812 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -76.36 151.83 36.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 128.526 2.731 . . . . 0.0 104.559 172.164 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.282 0.8 OUTLIER -140.15 132.3 28.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.669 2.787 . . . . 0.0 111.11 177.768 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.258 71.9 mm-40 -87.61 162.3 17.23 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 125.188 2.423 . . . . 0.0 110.116 172.222 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.35 162.06 18.37 Favored 'General case' 0 N--CA 1.45 -0.468 1 C-N-CA 134.882 5.273 . . . . 0.0 109.02 173.898 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.57 14.46 32.28 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 119.687 2.635 . . . . 0.0 119.687 173.591 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -157.55 163.95 37.84 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.876 2.07 . . . . 0.0 111.958 177.797 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.6 p -85.47 149.43 25.4 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 130.354 3.462 . . . . 0.0 108.456 -173.106 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.0 mt -65.2 -34.93 79.55 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.522 1.529 . . . . 0.0 109.556 -171.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.29 66.5 p -36.59 -56.98 0.8 Allowed 'General case' 0 N--CA 1.449 -0.513 1 C-N-CA 133.966 4.906 . . . . 0.0 113.8 173.944 . . . . . . . . 3 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.86 -27.25 66.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 130.713 3.605 . . . . 0.0 116.156 -177.563 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -101.14 2.73 40.49 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.412 2.285 . . . . 0.0 110.846 179.603 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.362 24.3 p30 69.13 29.43 4.7 Favored 'General case' 0 N--CA 1.444 -0.772 1 C-N-CA 131.819 4.047 . . . . 0.0 113.161 168.332 . . . . . . . . 3 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.8 mt -83.68 127.14 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.446 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -115.57 178.83 4.16 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 130.255 3.422 . . . . 0.0 107.304 -174.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.56 135.26 46.39 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 128.689 2.796 . . . . 0.0 111.261 168.132 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 61.49 27.6 17.11 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 129.552 3.141 . . . . 0.0 116.683 176.766 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -62.98 147.86 49.33 Favored 'General case' 0 C--N 1.328 -0.369 1 O-C-N 115.423 -4.548 . . . . 0.0 109.959 171.608 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.8 p -113.69 108.3 16.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.554 1.941 . . . . 0.0 107.383 -176.688 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.57 150.64 28.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 123.817 1.77 . . . . 0.0 112.738 177.894 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -87.77 139.95 30.01 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 128.956 2.902 . . . . 0.0 104.654 169.281 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.68 120.9 40.06 Favored 'General case' 0 C--N 1.325 -0.493 1 N-CA-C 96.73 -5.285 . . . . 0.0 96.73 170.544 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 m -132.67 165.97 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 128.222 2.609 . . . . 0.0 108.367 170.176 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 C--N 1.324 -0.539 0 C-N-CA 127.805 2.442 . . . . 0.0 116.025 -174.491 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttm . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.77 144.9 40.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.233 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.372 34.2 pt -132.37 162.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 130.189 3.396 . . . . 0.0 116.57 169.376 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -107.89 131.58 54.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.647 1.979 . . . . 0.0 109.858 178.41 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -100.32 118.0 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 129.031 2.933 . . . . 0.0 105.866 159.724 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.391 71.9 tttt -112.48 123.25 49.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 -174.437 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -88.74 151.56 22.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 110.113 -3.221 . . . . 0.0 107.968 174.652 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mt -67.88 -24.21 65.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 127.172 2.795 . . . . 0.0 109.869 172.37 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -81.24 -18.43 46.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 118.526 -2.609 . . . . 0.0 111.104 -171.332 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.31 -6.17 7.18 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 128.129 2.776 . . . . 0.0 115.11 156.427 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU 0.251 17.1 pttt -82.36 143.21 31.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.349 1.46 . . . . 0.0 111.203 -175.743 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 p -97.26 143.42 28.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 125.796 2.712 . . . . 0.0 107.671 164.629 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.6 mt -122.75 143.03 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 110.347 -3.115 . . . . 0.0 103.171 172.804 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 m -100.22 132.64 45.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.081 2.552 . . . . 0.0 110.875 172.996 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -120.38 133.08 55.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.222 3.009 . . . . 0.0 110.406 170.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -93.75 112.73 24.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.278 1.831 . . . . 0.0 109.063 170.287 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.79 175.64 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 127.975 2.51 . . . . 0.0 109.627 -176.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -132.13 159.33 72.61 Favored Pre-proline 0 N--CA 1.451 -0.399 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 159.178 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.93 -8.94 20.62 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 123.214 2.609 . . . . 0.0 114.228 -170.652 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 p -68.64 -31.35 70.42 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.884 2.873 . . . . 0.0 114.627 167.577 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.9 131.93 41.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 117.181 -3.449 . . . . 0.0 113.978 174.489 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.0 p -73.06 157.37 37.46 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 127.085 2.154 . . . . 0.0 112.301 173.406 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.295 1.9 mp -36.2 -42.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 129.414 3.086 . . . . 0.0 115.202 154.804 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -73.03 -37.68 66.81 Favored 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 133.557 4.743 . . . . 0.0 116.561 169.517 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -63.18 -36.38 83.44 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.794 2.088 . . . . 0.0 110.89 165.862 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.1 t -69.65 -39.4 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 1 O-C-N 115.034 -4.791 . . . . 0.0 114.292 178.134 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -61.04 -38.71 87.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.914 1.686 . . . . 0.0 115.058 168.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.25 -54.51 14.37 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 130.626 3.571 . . . . 0.0 107.581 174.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -55.35 -42.38 73.79 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.1 mt -64.08 -43.95 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.512 1.125 . . . . 0.0 111.173 169.205 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -58.59 -32.61 69.12 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.965 2.506 . . . . 0.0 112.446 178.3 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.268 0.9 OUTLIER -58.21 -37.79 75.52 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 119.536 -1.977 . . . . 0.0 111.357 169.941 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -87.5 -45.41 10.51 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.151 2.581 . . . . 0.0 106.833 -169.854 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.446 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 13.8 mm-40 -111.16 -17.51 13.2 Favored 'General case' 0 N--CA 1.451 -0.4 1 N-CA-C 124.846 5.128 . . . . 0.0 124.846 -174.516 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.79 -2.09 81.06 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 125.534 1.54 . . . . 0.0 114.489 172.693 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.7 mt -76.04 138.49 68.91 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 127.446 2.298 . . . . 0.0 109.846 -174.554 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.36 133.73 41.7 Favored 'Trans proline' 0 N--CA 1.45 -1.061 1 C-N-CA 126.363 4.709 . . . . 0.0 116.611 179.117 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -43.54 -44.74 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.698 1 C-N-CA 131.883 8.389 . . . . 0.0 111.502 173.825 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.358 2.4 t70 -38.7 -44.12 0.97 Allowed 'General case' 0 C--O 1.234 0.275 1 C-N-CA 133.826 4.85 . . . . 0.0 113.087 169.117 . . . . . . . . 3 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -96.66 -25.71 15.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.649 1.98 . . . . 0.0 108.926 -171.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -81.41 111.75 18.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -166.181 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -102.81 124.94 49.28 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 100.94 -3.726 . . . . 0.0 100.94 177.812 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.57 120.06 34.72 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 127.23 2.831 . . . . 0.0 107.435 175.032 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mt -122.35 154.12 27.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 126.273 2.233 . . . . 0.0 105.347 -169.064 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.283 67.8 t80 -143.32 128.21 18.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 115.26 -2.305 . . . . 0.0 110.472 160.716 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.36 20.3 6.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.145 2.178 . . . . 0.0 112.674 167.778 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.02 -8.6 63.22 Favored Glycine 0 CA--C 1.526 0.741 1 O-C-N 115.853 -4.279 . . . . 0.0 111.667 -178.59 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -102.66 155.23 18.44 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 124.988 2.328 . . . . 0.0 115.357 173.388 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -94.04 129.81 40.41 Favored 'General case' 0 N--CA 1.446 -0.643 1 N-CA-C 100.123 -4.028 . . . . 0.0 100.123 174.759 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.58 133.88 53.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 127.074 2.15 . . . . 0.0 107.701 167.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -69.86 134.62 48.67 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 115.298 -2.287 . . . . 0.0 112.796 177.836 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.294 5.6 t0 -93.21 132.99 36.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 126.224 2.916 . . . . 0.0 109.135 168.569 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.58 8.06 23.3 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 119.059 -2.275 . . . . 0.0 112.925 -159.721 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt-85 -136.98 178.19 7.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 120.476 2.138 . . . . 0.0 106.677 -177.575 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.8 p -110.78 172.42 6.88 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 129.808 3.243 . . . . 0.0 112.509 -176.901 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.4 mt -61.32 -46.78 88.87 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 119.178 -2.202 . . . . 0.0 109.113 168.164 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -56.32 -31.58 63.85 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 174.441 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.71 -29.72 70.29 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.87 2.068 . . . . 0.0 109.885 -178.323 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -102.16 12.23 37.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 124.106 1.908 . . . . 0.0 112.827 177.13 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.338 0.6 OUTLIER 84.14 1.7 0.9 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.728 2.011 . . . . 0.0 113.982 172.039 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.14 71.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.98 2.112 . . . . 0.0 108.8 179.28 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -81.07 -32.51 33.95 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.997 2.519 . . . . 0.0 113.902 166.565 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -149.54 118.45 6.67 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 118.779 -2.45 . . . . 0.0 114.022 -179.798 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 47.47 99.92 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.891 1 C-N-CA 135.198 5.399 . . . . 0.0 113.295 157.579 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -143.17 174.39 10.74 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 117.06 -3.525 . . . . 0.0 108.942 -177.235 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -121.81 147.88 45.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 116.758 -3.714 . . . . 0.0 104.527 171.78 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.5 mt -115.11 144.01 44.32 Favored 'General case' 0 N--CA 1.447 -0.578 1 C-N-CA 131.976 4.11 . . . . 0.0 111.354 174.42 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -100.89 117.08 34.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 101.069 -3.678 . . . . 0.0 101.069 -175.711 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.5 tp -100.87 129.48 46.74 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.463 1.105 . . . . 0.0 108.997 167.58 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.405 0.2 OUTLIER -131.02 156.94 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 O-C-N 125.996 2.06 . . . . 0.0 109.284 165.547 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 tp . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 127.297 3.427 . . . . 0.0 107.495 174.769 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 123.52 1.629 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -94.79 124.73 39.0 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 117.584 -3.197 . . . . 0.0 106.051 175.57 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -108.08 161.88 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 102.981 -2.97 . . . . 0.0 102.981 164.542 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -101.9 141.75 34.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 116.0 -1.952 . . . . 0.0 114.073 157.777 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 t -110.31 115.36 49.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 163.746 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -83.16 107.0 15.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.227 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.285 1.2 p -74.0 156.13 37.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.768 2.827 . . . . 0.0 109.476 174.748 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.5 tp -54.62 -37.67 65.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 130.152 3.381 . . . . 0.0 116.449 -159.986 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -66.62 -24.05 66.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 113.006 -3.378 . . . . 0.0 115.235 177.303 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.22 -35.25 3.01 Favored Glycine 0 CA--C 1.531 1.036 1 CA-C-O 112.101 -4.722 . . . . 0.0 111.415 -164.397 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.21 139.01 58.72 Favored 'General case' 0 N--CA 1.448 -0.566 1 O-C-N 131.292 4.76 . . . . 0.0 104.679 -175.423 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -116.65 129.73 56.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 128.165 2.586 . . . . 0.0 109.255 173.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 pt -113.77 143.78 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.503 167.472 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.9 m -90.65 130.38 36.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 128.337 2.655 . . . . 0.0 106.68 176.373 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.35 109.57 18.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.985 2.114 . . . . 0.0 106.871 179.086 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -71.84 112.45 7.95 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 128.945 3.903 . . . . 0.0 107.832 168.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 m -135.4 166.25 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 128.231 2.612 . . . . 0.0 109.085 -177.197 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -116.48 161.57 31.06 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 116.456 -1.735 . . . . 0.0 108.762 168.674 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -65.13 -19.49 63.03 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 124.682 3.588 . . . . 0.0 113.224 178.333 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.6 p -69.8 -26.16 64.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 113.379 -3.2 . . . . 0.0 112.3 172.068 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.93 133.85 26.42 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 128.948 2.899 . . . . 0.0 112.222 -177.717 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 p -83.61 148.65 27.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 116.055 -1.926 . . . . 0.0 111.509 175.375 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 mm -48.11 -42.77 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 125.388 3.722 . . . . 0.0 111.274 168.404 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -40.98 -65.76 0.4 Allowed 'General case' 0 N--CA 1.445 -0.686 1 C-N-CA 131.703 4.001 . . . . 0.0 112.884 163.107 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -35.43 80.23 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 123.239 0.337 . . . . 0.0 110.613 179.653 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.29 68.7 t -57.04 -48.34 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 116.79 -1.576 . . . . 0.0 115.153 168.908 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -46.71 -34.37 5.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 125.559 3.8 . . . . 0.0 117.543 161.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -28.04 59.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 123.792 1.758 . . . . 0.0 112.725 177.628 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -79.7 -44.45 20.8 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 118.564 -2.585 . . . . 0.0 112.709 172.479 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mt -48.67 -49.17 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 120.732 1.605 . . . . 0.0 111.25 170.5 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -54.98 -53.77 51.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 167.2 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.88 -41.28 91.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 123.229 2.74 . . . . 0.0 109.65 -175.164 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -76.17 -27.78 57.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 118.34 2.719 . . . . 0.0 118.34 179.916 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.294 21.0 mm-40 -140.11 2.96 1.95 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 122.903 2.592 . . . . 0.0 109.97 -175.734 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.42 -3.54 86.44 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 117.937 -2.977 . . . . 0.0 116.495 162.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.61 146.65 61.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 115.568 -2.158 . . . . 0.0 107.136 -167.396 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -78.11 132.27 11.44 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.062 3.175 . . . . 0.0 103.932 -178.081 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.77 -18.34 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 CA-C-N 124.098 2.499 . . . . 0.0 112.84 -170.413 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.34 -22.42 44.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 118.006 -1.477 . . . . 0.0 114.831 -170.111 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -82.76 -16.67 47.02 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.633 1.973 . . . . 0.0 114.432 172.396 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -73.87 130.22 39.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.623 1.969 . . . . 0.0 111.967 174.418 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -96.16 144.81 26.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.927 2.491 . . . . 0.0 107.323 155.585 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.1 tp -142.93 115.03 8.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 130.538 3.535 . . . . 0.0 111.088 -164.946 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 46.5 pt -134.74 142.83 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 1 C-N-CA 132.336 4.254 . . . . 0.0 114.045 -159.052 . . . . . . . . 3 2 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -138.02 96.55 3.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.199 2.6 . . . . 0.0 105.79 178.451 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 77.25 21.66 1.05 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.12 -1.612 . . . . 0.0 107.716 162.064 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.36 -40.4 2.46 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 119.642 -1.266 . . . . 0.0 113.883 -175.157 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.319 51.1 mttm -82.04 132.53 35.25 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 119.257 -2.319 . . . . 0.0 110.916 -171.883 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -82.01 128.27 33.93 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.296 0.953 . . . . 0.0 109.422 170.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -82.19 115.92 21.51 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 178.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -75.96 135.95 40.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.143 -3.473 . . . . 0.0 107.511 -177.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.0 119.9 7.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.24 2.216 . . . . 0.0 111.652 178.363 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.47 6.51 41.28 Favored Glycine 0 CA--C 1.525 0.685 1 C-N-CA 130.906 4.098 . . . . 0.0 114.617 171.146 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -86.32 154.11 21.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 125.423 1.307 . . . . 0.0 110.421 169.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.7 p -76.86 145.02 38.62 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 127.027 2.704 . . . . 0.0 115.522 171.438 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.6 mt -59.51 -29.96 68.25 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.947 2.499 . . . . 0.0 112.473 172.602 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.7 t -52.44 -59.04 4.91 Favored 'General case' 0 N--CA 1.446 -0.626 1 C-N-CA 132.821 4.448 . . . . 0.0 110.515 168.503 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -50.55 -41.69 54.38 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 118.827 2.899 . . . . 0.0 118.827 170.093 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -88.53 -0.62 57.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.136 0.88 . . . . 0.0 109.951 -179.859 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m120 62.26 39.1 12.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 129.316 3.046 . . . . 0.0 115.155 -175.442 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 mm -85.81 121.84 37.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -171.425 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -103.75 169.01 8.77 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 111.593 -2.549 . . . . 0.0 114.556 -176.179 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -58.73 135.1 57.35 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 112.37 -3.681 . . . . 0.0 113.065 -176.333 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.1 19.12 11.73 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.521 3.129 . . . . 0.0 116.253 -178.559 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -70.17 141.66 52.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.725 3.21 . . . . 0.0 109.485 160.729 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.3 m -107.52 129.33 54.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 175.804 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -97.69 154.18 17.74 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 129.525 3.13 . . . . 0.0 106.846 171.049 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -125.27 163.85 21.61 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.801 2.04 . . . . 0.0 110.861 -175.158 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.43 ' HG ' ' H ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -134.72 160.09 39.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.103 -2.317 . . . . 0.0 116.326 -176.216 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.43 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 23.0 t -151.83 150.68 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 128.387 3.554 . . . . 0.0 105.982 166.512 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.259 53.2 mt . . . . . 0 N--CA 1.443 -0.811 0 O-C-N 119.121 -2.237 . . . . 0.0 111.453 176.483 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.402 ' N ' ' OE2' ' A' ' 16' ' ' GLU 0.251 45.7 ttp . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -81.55 156.68 25.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 178.535 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 pt -146.24 174.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 1 O-C-N 129.204 4.065 . . . . 0.0 105.944 174.173 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -131.06 153.38 49.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 117.167 -1.397 . . . . 0.0 110.309 164.024 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -130.12 114.74 30.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 101.699 -3.445 . . . . 0.0 101.699 172.001 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -80.99 133.96 35.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.166 2.186 . . . . 0.0 106.244 174.452 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 p -75.13 175.48 8.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 129.977 3.311 . . . . 0.0 111.772 164.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.88 -9.21 49.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 118.151 -2.843 . . . . 0.0 110.671 172.044 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 p -99.57 4.31 45.79 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.777 -179.441 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.74 -25.34 7.64 Favored Glycine 0 CA--C 1.531 1.061 1 C-N-CA 131.902 4.573 . . . . 0.0 109.389 159.148 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 pttt -82.71 134.0 35.15 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 -153.502 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 m -95.36 110.63 22.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.275 1.83 . . . . 0.0 114.55 -178.333 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.74 120.82 35.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 118.648 -2.532 . . . . 0.0 105.738 -176.39 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -77.47 121.24 23.56 Favored 'General case' 0 C--N 1.324 -0.519 1 O-C-N 114.558 -5.089 . . . . 0.0 103.508 175.91 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.299 69.3 mt -125.02 152.58 44.06 Favored 'General case' 0 N--CA 1.446 -0.645 1 CA-C-N 126.294 4.134 . . . . 0.0 108.059 169.97 . . . . . . . . 3 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' OE2' ' N ' ' A' ' 1' ' ' MET . 32.0 tp10 -99.88 132.43 45.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 173.353 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.77 167.0 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 127.426 3.489 . . . . 0.0 105.72 172.512 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.41 140.13 28.71 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 110.747 -2.933 . . . . 0.0 106.408 155.518 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.363 46.3 Cg_endo -59.93 -4.48 2.88 Favored 'Trans proline' 0 N--CA 1.45 -1.032 1 C-N-CA 126.742 4.961 . . . . 0.0 117.005 -173.052 . . . . . . . . 3 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 p -88.58 -6.34 57.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 113.239 -3.267 . . . . 0.0 114.591 165.468 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.47 140.44 55.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 125.971 2.045 . . . . 0.0 106.777 179.691 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.6 p -73.93 163.37 28.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 116.527 -1.701 . . . . 0.0 109.631 170.891 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.0 mm -60.93 -37.14 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 124.211 1.958 . . . . 0.0 107.086 175.508 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.395 0.0 OUTLIER -46.2 -45.03 16.63 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 118.322 -2.736 . . . . 0.0 115.348 171.357 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -67.88 -33.89 75.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.041 2.536 . . . . 0.0 109.126 -179.909 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.258 89.0 t -67.88 -52.92 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 126.169 1.787 . . . . 0.0 113.079 166.707 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -48.67 -41.14 30.51 Favored 'General case' 0 N--CA 1.442 -0.842 1 N-CA-C 122.123 4.119 . . . . 0.0 122.123 171.398 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.25 -35.32 66.21 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.721 2.008 . . . . 0.0 112.506 176.429 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.3 mttt -67.56 -30.8 70.52 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 176.784 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -70.92 -43.49 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 130.359 3.464 . . . . 0.0 109.655 170.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -51.83 -55.34 20.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 125.806 2.717 . . . . 0.0 113.566 168.114 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.19 -27.49 62.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.552 3.141 . . . . 0.0 113.925 -173.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -97.7 -66.52 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 119.45 -2.032 . . . . 0.0 110.993 172.51 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -92.01 -17.85 24.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 120.935 1.698 . . . . 0.0 113.392 -165.381 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.83 -10.95 32.3 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 116.765 -3.709 . . . . 0.0 119.33 172.276 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.6 mt -86.07 129.39 54.18 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 117.541 -3.329 . . . . 0.0 112.043 -160.428 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -76.95 137.96 18.03 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 125.281 3.987 . . . . 0.0 111.719 -166.761 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -39.56 -53.47 2.23 Favored 'Trans proline' 0 N--CA 1.446 -1.318 1 C-N-CA 126.863 5.042 . . . . 0.0 111.985 172.408 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.37 10.06 2.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 124.558 3.344 . . . . 0.0 113.464 -172.335 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -103.85 -28.8 11.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.602 1.191 . . . . 0.0 113.367 162.318 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.38 149.74 30.09 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 120.295 -1.503 . . . . 0.0 113.658 -168.13 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -135.04 118.91 17.29 Favored 'General case' 0 N--CA 1.451 -0.388 1 C-N-CA 132.164 4.186 . . . . 0.0 109.131 164.552 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.266 59.9 mt -100.0 132.16 45.52 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.692 0.797 . . . . 0.0 112.462 167.597 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.2 mm -109.63 124.75 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 101.068 -3.678 . . . . 0.0 101.068 -175.586 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -117.79 113.89 22.48 Favored 'General case' 0 N--CA 1.444 -0.761 1 N-CA-C 98.63 -4.582 . . . . 0.0 98.63 174.557 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.22 52.36 8.68 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 111.353 -2.658 . . . . 0.0 117.376 170.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -0.88 81.22 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 116.883 -2.065 . . . . 0.0 111.673 167.183 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -126.96 154.12 44.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.0 1.32 . . . . 0.0 111.166 177.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -91.89 118.47 30.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 110.137 -3.21 . . . . 0.0 105.001 -175.077 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -67.18 123.91 21.6 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.202 2.201 . . . . 0.0 107.472 172.719 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -85.65 143.19 28.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -71.66 155.66 40.25 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 126.107 2.129 . . . . 0.0 110.635 -171.299 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.29 -2.98 85.48 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 128.187 2.803 . . . . 0.0 114.507 174.414 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.376 0.9 OUTLIER -99.8 164.76 11.9 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.506 1.522 . . . . 0.0 109.615 173.893 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 64.8 p -99.66 171.49 7.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 126.852 3.215 . . . . 0.0 110.371 169.473 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mp -42.73 -51.98 5.12 Favored 'General case' 0 N--CA 1.446 -0.657 1 C-N-CA 131.772 4.029 . . . . 0.0 114.951 163.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 p -75.17 -12.44 60.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.498 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -80.85 -42.33 21.74 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 119.224 -2.172 . . . . 0.0 107.339 172.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.29 10.12 41.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.557 1.943 . . . . 0.0 112.705 -166.352 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.362 71.0 m-80 91.1 12.08 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.192 1.797 . . . . 0.0 114.612 159.843 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.27 55.3 mt -71.33 135.73 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 -171.198 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.523 0.4 OUTLIER -122.86 162.91 21.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.568 2.347 . . . . 0.0 114.404 175.175 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -49.6 126.84 14.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 121.468 1.94 . . . . 0.0 114.46 171.547 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.355 16.3 tt0 81.78 0.42 1.52 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 130.985 3.714 . . . . 0.0 113.212 176.94 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -61.55 145.74 51.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 119.719 -1.863 . . . . 0.0 113.638 166.823 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.3 m -125.79 109.27 12.34 Favored 'General case' 0 N--CA 1.451 -0.417 1 O-C-N 132.394 6.059 . . . . 0.0 110.614 -160.525 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.326 10.9 mp -106.04 170.71 7.75 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 -176.622 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -121.92 142.39 50.33 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.407 3.083 . . . . 0.0 105.641 177.487 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.6 tp -102.51 128.42 49.16 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 -178.043 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -111.88 150.7 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 124.407 1.067 . . . . 0.0 109.204 163.626 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.444 -0.75 0 O-C-N 117.054 -3.529 . . . . 0.0 114.928 168.984 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 103.593 -2.744 . . . . 0.0 103.593 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -90.47 128.23 36.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 115.658 -2.115 . . . . 0.0 110.241 -172.316 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -116.25 148.74 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 1 CA-C-N 126.012 4.006 . . . . 0.0 109.262 168.596 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -105.76 113.32 26.8 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -172.48 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.8 t -95.14 115.65 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 1 N-CA-C 99.574 -4.232 . . . . 0.0 99.574 168.308 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -99.19 133.03 44.06 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.904 174.111 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p -121.47 140.2 52.49 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -171.882 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 mt -62.66 -40.9 98.5 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.577 2.351 . . . . 0.0 109.994 171.253 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.265 23.8 p -71.53 8.63 1.03 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 176.453 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.58 18.02 2.27 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 117.112 -1.938 . . . . 0.0 112.424 118.581 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -138.42 153.92 48.88 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 129.373 3.069 . . . . 0.0 111.458 -176.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.2 p -99.61 106.16 18.09 Favored 'General case' 0 N--CA 1.446 -0.653 1 C-N-CA 135.148 5.379 . . . . 0.0 109.799 174.935 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 mt -101.84 105.76 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 2 N-CA-C 98.685 -4.561 . . . . 0.0 98.685 -167.75 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 p -92.96 89.25 6.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 119.377 -2.077 . . . . 0.0 113.015 -176.469 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tp -73.54 133.86 43.67 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 131.603 3.961 . . . . 0.0 104.063 -178.211 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -96.33 122.45 39.23 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 129.375 3.07 . . . . 0.0 104.515 168.336 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.3 135.59 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 128.805 2.842 . . . . 0.0 115.761 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.59 149.11 90.71 Favored Pre-proline 0 N--CA 1.45 -0.469 0 O-C-N 119.535 -1.978 . . . . 0.0 106.884 175.532 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.03 15.77 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.87 2.38 . . . . 0.0 113.123 -172.455 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.268 67.4 p -135.41 18.11 3.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 120.867 1.667 . . . . 0.0 113.58 175.575 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -81.04 118.03 22.14 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.747 -167.026 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -88.01 148.4 24.55 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 122.084 2.22 . . . . 0.0 107.427 -165.034 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.429 6.0 mt -45.03 -39.92 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 113.405 -3.188 . . . . 0.0 118.175 -174.395 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.95 -45.08 93.8 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 125.508 1.755 . . . . 0.0 112.739 170.82 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -71.75 -9.16 57.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.848 1.659 . . . . 0.0 110.594 -176.736 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.89 -29.07 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 127.104 2.161 . . . . 0.0 111.88 172.584 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -68.85 -32.36 71.98 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 118.91 -2.369 . . . . 0.0 113.854 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.01 -21.1 47.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 111.982 -2.372 . . . . 0.0 108.519 -176.055 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.31 -39.24 17.91 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 113.039 -3.362 . . . . 0.0 105.925 174.29 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 mt -58.36 -34.46 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 1 CA-C-N 127.394 4.633 . . . . 0.0 115.288 169.358 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -83.6 -3.31 57.59 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.935 2.494 . . . . 0.0 110.018 -176.521 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -101.63 -45.25 5.32 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.184 1.793 . . . . 0.0 106.691 166.164 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.27 48.5 tptt -74.46 -37.58 63.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 117.137 -1.411 . . . . 0.0 110.519 -167.361 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -121.41 -24.85 5.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 123.679 2.945 . . . . 0.0 108.787 -179.923 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.02 14.01 65.36 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 121.994 2.179 . . . . 0.0 110.901 175.025 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -74.04 131.84 80.68 Favored Pre-proline 0 N--CA 1.44 -0.949 0 C-N-CA 128.482 2.713 . . . . 0.0 108.329 169.487 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -78.2 162.65 28.39 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 N-CA-C 116.549 1.711 . . . . 0.0 116.549 -177.492 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.47 -16.54 47.66 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 N-CA-C 119.364 2.794 . . . . 0.0 119.364 -177.084 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -95.95 -2.89 46.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.435 -179.559 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -117.26 -15.39 10.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 112.467 -3.635 . . . . 0.0 115.038 177.517 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -67.55 138.03 56.19 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 130.536 3.534 . . . . 0.0 108.694 174.457 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -127.63 150.96 49.51 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 146.939 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.401 0.8 OUTLIER -139.8 133.78 30.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 173.675 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.55 144.4 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 -165.981 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -125.28 137.9 54.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.019 162.211 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.289 . . 56.92 28.45 14.67 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 169.084 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.71 -17.64 58.74 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 128.919 3.152 . . . . 0.0 112.707 -171.499 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -103.87 122.27 44.8 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 121.522 2.661 . . . . 0.0 109.717 -161.351 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.419 HE21 ' C ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -69.55 113.12 6.55 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.421 1.889 . . . . 0.0 107.781 166.0 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.3 mt -71.27 131.55 43.64 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 131.692 3.997 . . . . 0.0 108.198 -172.194 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -106.33 129.35 54.36 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 112.545 -3.597 . . . . 0.0 109.587 176.453 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.66 146.8 24.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 127.405 2.94 . . . . 0.0 109.316 179.029 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.31 -21.01 22.66 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 128.073 2.749 . . . . 0.0 114.762 173.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -88.99 153.77 20.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.418 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.4 p -86.25 175.8 8.28 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 126.251 2.22 . . . . 0.0 112.282 168.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.48 -39.9 81.23 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.48 2.712 . . . . 0.0 111.108 176.757 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.3 t -53.05 -51.41 61.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.308 1.843 . . . . 0.0 112.241 179.65 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -46.39 -34.53 4.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 129.546 3.138 . . . . 0.0 115.285 -179.065 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -111.77 -12.42 13.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 125.32 1.638 . . . . 0.0 108.284 -170.989 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' HE21 ' A' ' 62' ' ' GLN . 14.1 t-20 82.77 46.11 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.671 1 C-N-CA 131.951 4.1 . . . . 0.0 108.404 166.568 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.262 19.8 mt -98.63 91.54 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 174.617 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.418 HE21 ' HA ' ' A' ' 60' ' ' ASN . 91.1 mm-40 -98.96 -4.12 33.43 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 114.652 -2.594 . . . . 0.0 112.11 -169.762 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER 134.42 161.06 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.862 1 C-N-CA 134.338 5.055 . . . . 0.0 105.702 176.948 . . . . . . . . 4 3 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 71.57 -31.71 0.23 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 114.964 -2.446 . . . . 0.0 113.505 172.29 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.8 m -27.3 133.24 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.547 1 C-N-CA 135.366 5.466 . . . . 0.0 111.872 173.928 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.2 m -89.64 108.52 19.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.613 -1.305 . . . . 0.0 111.159 172.457 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -87.86 154.72 20.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.04 2.536 . . . . 0.0 114.838 162.967 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -125.14 121.17 33.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.817 2.047 . . . . 0.0 106.421 -179.566 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tp -86.96 136.86 32.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 115.872 -2.013 . . . . 0.0 109.522 171.596 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.24 166.59 19.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 126.463 2.352 . . . . 0.0 108.13 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.238 0.456 0 CA-C-N 119.995 1.27 . . . . 0.0 113.655 174.293 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 115.24 -2.314 . . . . 0.0 107.819 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.62 125.56 36.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 128.34 3.525 . . . . 0.0 110.104 179.926 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -122.03 136.87 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 119.422 -2.048 . . . . 0.0 111.935 158.433 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -90.53 133.13 35.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 172.235 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.55 110.64 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 174.269 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -97.77 143.65 28.18 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 128.115 3.384 . . . . 0.0 106.136 -177.572 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -112.97 149.51 33.16 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 129.166 2.987 . . . . 0.0 114.428 177.254 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.87 -34.81 1.02 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.612 2.765 . . . . 0.0 117.869 -171.519 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -74.3 -24.83 59.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 125.329 1.643 . . . . 0.0 112.969 179.398 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.85 -7.68 15.09 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.362 2.41 . . . . 0.0 118.362 -175.172 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 75.1 tttt -64.77 145.54 56.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.749 2.02 . . . . 0.0 106.481 173.863 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 m -137.19 132.68 34.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 112.63 -2.077 . . . . 0.0 105.679 -172.079 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mt -93.41 109.42 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 129.904 3.282 . . . . 0.0 107.717 162.494 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -74.75 119.42 18.92 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 128.171 2.588 . . . . 0.0 106.603 162.743 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -128.17 158.43 38.08 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -177.156 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -124.96 121.12 33.53 Favored 'General case' 0 C--O 1.221 -0.424 1 N-CA-C 99.756 -4.164 . . . . 0.0 99.756 -178.009 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -152.18 147.9 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.572 1.949 . . . . 0.0 108.585 -165.325 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.263 1.6 tm-20 -84.3 135.94 40.97 Favored Pre-proline 0 C--O 1.219 -0.516 0 O-C-N 125.817 1.948 . . . . 0.0 107.342 173.142 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -56.37 -26.81 64.4 Favored 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 126.384 4.722 . . . . 0.0 110.92 179.386 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.2 p -95.34 6.47 48.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 116.503 -3.873 . . . . 0.0 114.083 -177.497 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -68.18 132.35 47.01 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 111.662 -2.517 . . . . 0.0 111.248 160.704 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -95.52 157.4 15.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 116.635 -1.65 . . . . 0.0 107.335 -173.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.3 mm -36.62 -54.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 112.243 -3.742 . . . . 0.0 109.863 173.786 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -68.93 -23.13 64.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 125.611 3.823 . . . . 0.0 111.248 -170.713 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -77.7 -44.64 27.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 128.185 2.594 . . . . 0.0 110.722 -179.748 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.35 -46.59 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 170.511 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 38' ' ' PRO 0.361 37.9 mtpt -46.73 -49.79 19.05 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 112.912 -1.949 . . . . 0.0 116.105 173.363 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.68 68.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 129.042 2.937 . . . . 0.0 113.223 175.742 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -67.82 -37.51 82.03 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.545 1.938 . . . . 0.0 109.354 173.257 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.91 -30.31 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 121.842 2.11 . . . . 0.0 110.254 168.042 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.72 -35.56 75.14 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 116.769 -1.972 . . . . 0.0 111.705 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.26 -43.85 76.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.565 2.346 . . . . 0.0 109.334 178.787 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.324 12.6 mmtt -66.09 -42.04 89.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 117.037 -3.539 . . . . 0.0 115.451 178.532 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.47 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 5.0 mm-40 -140.87 -19.49 0.82 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 116.632 -1.652 . . . . 0.0 113.278 -156.372 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.79 5.89 83.41 Favored Glycine 0 CA--C 1.524 0.654 1 CA-C-O 112.78 -4.344 . . . . 0.0 109.314 172.515 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.2 mt -69.08 128.25 92.74 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 123.445 3.623 . . . . 0.0 108.771 174.41 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -54.59 144.87 61.71 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.57 2.18 . . . . 0.0 113.911 173.138 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' CB ' ' HB3' ' A' ' 27' ' ' LYS . 36.7 Cg_endo -72.35 -55.2 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 CA-C-N 123.423 2.258 . . . . 0.0 109.381 -170.006 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.16 -29.64 23.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.621 2.368 . . . . 0.0 112.17 -176.341 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -68.31 -31.86 71.59 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 114.432 -2.699 . . . . 0.0 110.223 179.182 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -73.81 138.9 44.78 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 123.597 2.908 . . . . 0.0 112.474 -173.055 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.42 52.6 mtt180 -104.73 134.08 48.48 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 119.563 -1.961 . . . . 0.0 112.557 141.691 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mp -88.28 114.23 24.68 Favored 'General case' 0 N--CA 1.443 -0.8 1 C-N-CA 134.14 4.976 . . . . 0.0 107.134 174.237 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.8 mt -111.76 140.09 32.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 126.602 1.961 . . . . 0.0 111.551 168.331 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -152.06 148.24 27.45 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 131.421 3.888 . . . . 0.0 105.635 160.829 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.398 . . 69.48 30.28 4.12 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 130.382 3.473 . . . . 0.0 112.773 163.689 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.64 12.9 60.31 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-N 109.678 -3.419 . . . . 0.0 116.148 168.43 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -148.29 164.53 33.73 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 -168.257 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -76.25 130.87 38.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 124.936 2.303 . . . . 0.0 105.726 162.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.45 147.62 35.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.288 -1.778 . . . . 0.0 106.792 165.748 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.82 136.63 43.95 Favored 'General case' 0 C--N 1.324 -0.538 1 C-N-CA 134.624 5.17 . . . . 0.0 110.798 -178.185 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.55 126.16 26.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 130.789 3.635 . . . . 0.0 116.653 -179.361 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.32 -24.89 7.18 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 119.337 -2.102 . . . . 0.0 113.295 -178.288 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -95.09 140.57 29.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 -172.866 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.6 p -70.2 157.15 38.16 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 167.841 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.3 mt -54.57 -33.67 60.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 116.88 -1.533 . . . . 0.0 112.881 168.892 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 p -64.21 -37.59 88.01 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.244 2.218 . . . . 0.0 111.957 174.523 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.66 -29.39 70.39 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.678 2.791 . . . . 0.0 109.723 179.052 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.93 -5.77 30.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.361 1.465 . . . . 0.0 112.852 -173.74 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.378 68.1 m-80 97.31 9.82 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 O-C-N 127.029 2.706 . . . . 0.0 110.738 165.791 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.9 mt -85.83 117.57 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 118.906 -2.371 . . . . 0.0 106.926 -154.171 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.41 23.4 tt0 -90.29 172.27 8.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 112.317 -2.22 . . . . 0.0 111.77 175.569 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.95 140.03 2.83 Favored 'General case' 0 N--CA 1.445 -0.685 1 O-C-N 129.467 4.229 . . . . 0.0 114.603 174.739 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 56.57 38.85 29.93 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.796 2.838 . . . . 0.0 111.696 170.61 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 m -81.69 139.17 35.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 110.044 -3.253 . . . . 0.0 103.263 169.687 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.4 m -103.98 112.46 25.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 114.786 -2.531 . . . . 0.0 105.363 174.662 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.57 159.41 24.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.67 3.188 . . . . 0.0 110.865 -177.041 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -116.82 152.99 33.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -156.485 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tp -137.68 136.47 37.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 119.936 1.243 . . . . 0.0 110.29 179.307 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.1 t -123.31 119.26 57.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 126.244 1.818 . . . . 0.0 109.991 174.583 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 CA--C 1.53 0.195 0 O-C-N 118.946 -2.346 . . . . 0.0 105.089 -179.231 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptt? . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -88.14 154.72 20.23 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 119.691 -1.88 . . . . 0.0 110.412 171.766 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 pt -139.53 159.19 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 130.681 3.592 . . . . 0.0 109.786 160.873 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.51 116.61 29.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 118.486 -2.634 . . . . 0.0 108.42 174.61 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -92.91 136.08 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.798 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -117.8 112.61 20.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.953 1.701 . . . . 0.0 109.564 -173.741 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -62.65 175.68 0.77 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 124.542 2.115 . . . . 0.0 109.176 -178.321 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tt -70.0 -31.69 69.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 117.785 -3.072 . . . . 0.0 114.004 174.519 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.317 18.4 p -81.09 -16.52 52.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 129.845 3.258 . . . . 0.0 109.506 -178.493 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.92 -1.16 30.17 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 117.076 -3.515 . . . . 0.0 111.285 167.259 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.257 70.8 tttt -69.05 156.25 38.97 Favored 'General case' 0 N--CA 1.45 -0.47 2 C-N-CA 132.308 4.243 . . . . 0.0 108.009 173.275 . . . . . . . . 3 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -133.01 130.77 39.89 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 113.632 -3.08 . . . . 0.0 111.339 -170.902 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.1 pt -131.93 139.28 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 129.548 3.139 . . . . 0.0 106.972 173.243 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.4 m -89.51 114.21 25.7 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 173.381 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -95.19 153.7 17.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 126.235 2.209 . . . . 0.0 105.599 167.643 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -116.44 132.29 56.72 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 113.395 -3.193 . . . . 0.0 111.078 169.39 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -153.34 -178.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 102.887 -3.005 . . . . 0.0 102.887 -162.266 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -144.28 156.49 57.55 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 131.218 3.807 . . . . 0.0 102.676 166.542 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -49.14 -28.48 14.4 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 116.147 1.557 . . . . 0.0 116.147 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 p -68.82 -18.98 64.26 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 128.816 2.846 . . . . 0.0 115.726 178.414 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.275 2.0 m-20 -51.29 121.93 7.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 122.567 2.439 . . . . 0.0 112.637 173.386 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 p -65.97 156.49 33.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.632 3.173 . . . . 0.0 109.465 168.684 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.2 mm -61.83 -40.6 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 O-C-N 125.034 1.459 . . . . 0.0 110.637 171.902 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.36 -25.83 60.76 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 122.25 2.295 . . . . 0.0 109.039 -172.771 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.267 16.8 t-20 -71.77 -44.33 64.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 117.168 -3.458 . . . . 0.0 109.501 173.909 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -68.25 -27.58 37.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 O-C-N 117.585 -3.197 . . . . 0.0 110.738 179.439 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -66.09 -24.45 66.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 122.575 1.179 . . . . 0.0 114.072 169.07 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.8 -38.42 58.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 115.151 -2.357 . . . . 0.0 111.019 167.595 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -64.26 -42.87 96.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 129.897 3.279 . . . . 0.0 110.558 178.85 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.63 -27.88 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 O-C-N 126.268 2.23 . . . . 0.0 109.112 177.114 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -74.17 -44.94 51.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 124.273 1.987 . . . . 0.0 108.733 172.272 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.59 -40.14 74.76 Favored 'General case' 0 N--CA 1.446 -0.654 1 O-C-N 112.911 -6.118 . . . . 0.0 120.869 168.235 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -70.68 -53.32 16.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.497 2.319 . . . . 0.0 110.381 -178.178 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -133.63 6.12 3.74 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 117.627 -3.171 . . . . 0.0 112.895 -166.117 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.67 12.54 77.99 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 118.273 -2.767 . . . . 0.0 118.002 177.643 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.66 120.65 76.95 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 122.971 3.385 . . . . 0.0 112.301 174.19 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.32 147.77 94.67 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 106.208 -2.266 . . . . 0.0 106.208 -179.775 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.23 -48.73 7.84 Favored 'Trans proline' 0 N--CA 1.441 -1.601 1 C-N-CA 125.949 4.433 . . . . 0.0 117.601 170.879 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -77.02 -13.0 60.01 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -170.552 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -93.76 10.09 34.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.441 1.497 . . . . 0.0 113.225 -176.659 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -130.05 165.92 21.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 116.421 -3.925 . . . . 0.0 114.355 -176.557 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -143.84 129.7 19.4 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 125.376 1.673 . . . . 0.0 112.99 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.7 mt -110.92 145.26 38.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 113.381 -1.736 . . . . 0.0 115.126 -165.843 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 pt -147.71 143.87 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 1 N-CA-C 99.113 -4.403 . . . . 0.0 99.113 -157.735 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -165.63 126.16 1.84 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 161.728 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.56 36.32 13.88 Favored 'General case' 0 N--CA 1.444 -0.733 1 C-N-CA 132.827 4.451 . . . . 0.0 116.036 165.646 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.44 -11.5 65.1 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.558 -1.134 . . . . 0.0 113.513 175.348 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -111.61 133.52 53.81 Favored 'General case' 0 N--CA 1.449 -0.502 1 C-N-CA 133.682 4.793 . . . . 0.0 107.165 -173.616 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -84.82 124.58 31.74 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 128.396 3.56 . . . . 0.0 110.348 170.782 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.06 115.66 27.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 123.706 1.717 . . . . 0.0 112.61 -168.175 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.83 141.23 28.75 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 129.969 3.308 . . . . 0.0 115.033 -173.698 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -75.7 135.88 40.38 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 114.645 -2.598 . . . . 0.0 108.613 -173.921 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.96 -6.84 21.82 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 120.808 1.64 . . . . 0.0 111.225 -176.609 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -106.82 154.89 20.36 Favored 'General case' 0 N--CA 1.452 -0.367 1 C-N-CA 132.71 4.404 . . . . 0.0 107.862 177.32 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 p -101.93 162.14 13.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.865 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.5 mt -61.97 -26.76 68.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 128.252 2.621 . . . . 0.0 112.459 -172.084 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -71.25 -24.87 62.26 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.147 2.579 . . . . 0.0 110.199 179.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.47 -50.19 72.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.573 3.149 . . . . 0.0 109.378 -178.223 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.92 12.86 18.22 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 128.266 3.479 . . . . 0.0 113.274 178.382 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 55.16 37.99 29.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.737 2.815 . . . . 0.0 115.881 -178.277 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.01 121.36 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 122.651 2.478 . . . . 0.0 106.129 -175.198 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -88.1 164.93 15.48 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 124.378 2.037 . . . . 0.0 113.681 176.319 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.459 ' C ' ' H ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -65.92 163.81 16.29 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 119.975 -1.703 . . . . 0.0 110.329 -174.372 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 46.47 10.47 0.01 OUTLIER 'General case' 0 C--O 1.236 0.359 0 N-CA-C 120.354 3.465 . . . . 0.0 120.354 176.183 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 63' ' ' LYS 0.285 71.0 m -75.49 154.49 36.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 119.394 -2.066 . . . . 0.0 107.842 174.524 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 m -95.68 110.06 22.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 176.306 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.17 125.56 43.26 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 173.716 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -82.14 148.76 28.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.869 3.268 . . . . 0.0 109.196 174.027 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.307 1.6 pp -131.55 167.43 19.4 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 166.32 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t -123.88 140.66 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 -175.634 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 163.917 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -81.69 144.26 31.29 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 123.382 1.563 . . . . 0.0 112.322 -177.906 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 11.2 pt -132.56 157.45 43.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 115.026 -2.416 . . . . 0.0 107.251 166.897 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -98.52 144.0 28.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 114.939 -2.458 . . . . 0.0 106.617 165.177 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.14 122.71 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 100.431 -3.914 . . . . 0.0 100.431 176.443 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -123.66 117.83 25.89 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 -170.799 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -80.66 144.86 31.96 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 118.644 -2.535 . . . . 0.0 106.208 -175.016 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.27 -34.43 0.49 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 118.033 2.605 . . . . 0.0 118.033 172.981 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -50.59 -37.87 42.36 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 118.239 -2.788 . . . . 0.0 116.841 164.811 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.85 9.68 8.11 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 127.188 2.328 . . . . 0.0 109.503 176.652 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -84.24 103.12 13.17 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.908 2.483 . . . . 0.0 104.725 -170.765 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.2 m -96.37 119.59 35.14 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.269 1.827 . . . . 0.0 112.874 -178.612 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mm -130.79 145.78 35.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 111.238 -2.71 . . . . 0.0 109.826 -169.334 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.5 p -81.57 165.73 20.87 Favored 'General case' 0 C--O 1.237 0.42 1 O-C-N 114.777 -4.952 . . . . 0.0 114.922 172.929 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.265 2.4 tp -152.65 142.81 22.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.132 2.973 . . . . 0.0 109.441 172.042 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -95.23 117.52 30.4 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.282 2.633 . . . . 0.0 109.528 166.687 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.272 13.9 m -120.75 148.85 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.236 2.215 . . . . 0.0 108.909 179.136 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -91.45 136.14 27.19 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 179.666 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.262 71.5 Cg_exo -41.4 -30.88 0.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 1 N-CA-C 124.084 4.609 . . . . 0.0 124.084 166.53 . . . . . . . . 3 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -103.64 14.34 31.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.992 1.717 . . . . 0.0 113.678 176.241 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.279 24.5 m-20 -66.91 139.77 57.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 128.704 2.802 . . . . 0.0 110.99 170.886 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -73.05 154.54 40.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.091 2.556 . . . . 0.0 107.124 168.185 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mp -69.73 -29.61 41.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 130.252 3.421 . . . . 0.0 105.344 175.466 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -67.71 -36.48 80.7 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 116.85 -3.656 . . . . 0.0 112.989 164.574 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -67.92 -19.07 64.95 Favored 'General case' 0 N--CA 1.444 -0.774 1 CA-C-N 128.254 5.024 . . . . 0.0 113.14 164.285 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.76 -34.68 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 126.048 2.832 . . . . 0.0 114.633 172.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -70.18 -35.33 73.9 Favored 'General case' 0 CA--C 1.537 0.451 1 O-C-N 115.931 -4.231 . . . . 0.0 107.273 174.024 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -33.05 71.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 169.046 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -79.52 -27.54 41.35 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 116.02 -1.943 . . . . 0.0 108.658 179.765 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -77.54 -38.74 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 125.046 1.467 . . . . 0.0 109.216 171.87 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -59.89 -30.29 68.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 118.524 -2.61 . . . . 0.0 111.291 176.535 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.429 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . 29.4 t70 -53.04 -37.41 61.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 127.041 2.136 . . . . 0.0 108.149 174.603 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HD2' ' HB3' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -115.36 -44.64 2.97 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.982 1.713 . . . . 0.0 107.326 -169.336 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -94.34 -23.52 17.77 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 118.005 -2.934 . . . . 0.0 112.143 -172.521 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.07 27.9 47.66 Favored Glycine 0 CA--C 1.525 0.685 0 O-C-N 119.569 -1.957 . . . . 0.0 113.935 175.892 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.84 124.25 37.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 113.728 -3.034 . . . . 0.0 107.45 -176.921 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.16 137.92 64.11 Favored 'Trans proline' 0 N--CA 1.451 -1.025 1 C-N-CA 125.582 4.188 . . . . 0.0 116.236 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -45.28 -30.48 5.34 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 O-C-N 125.553 2.344 . . . . 0.0 117.834 177.766 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.374 5.8 t70 -46.92 -43.31 18.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 119.09 -2.256 . . . . 0.0 116.075 178.276 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -110.24 -13.35 14.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.315 2.246 . . . . 0.0 105.558 -161.43 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -66.69 139.25 57.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.018 -1.676 . . . . 0.0 112.91 161.29 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -121.63 150.87 41.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.332 1.453 . . . . 0.0 113.217 157.612 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.356 5.8 mt -127.08 138.33 53.18 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 116.634 -3.791 . . . . 0.0 112.733 -179.283 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.366 98.4 mt -139.4 128.36 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 127.18 2.8 . . . . 0.0 112.07 -157.678 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -150.1 147.54 27.91 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.513 1.133 . . . . 0.0 108.945 152.995 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.365 . . 65.87 21.15 11.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 130.28 3.432 . . . . 0.0 112.537 177.478 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.35 -3.84 85.35 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.004 1.288 . . . . 0.0 113.477 -173.819 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -99.98 159.27 15.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 119.899 1.85 . . . . 0.0 107.229 -176.45 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.9 135.39 54.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 101.689 -3.448 . . . . 0.0 101.689 -178.072 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.7 mt -89.42 159.36 17.34 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 119.22 -2.175 . . . . 0.0 114.349 -179.058 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -104.01 141.2 36.61 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 119.219 -2.175 . . . . 0.0 107.068 -165.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.283 11.2 m-20 -72.27 123.51 23.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 126.247 2.927 . . . . 0.0 115.221 167.798 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.81 -28.61 9.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 129.496 3.427 . . . . 0.0 113.369 -177.876 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -69.43 167.73 15.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.476 -2.191 . . . . 0.0 112.543 170.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -115.0 166.46 11.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -163.722 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 mt -54.29 -44.87 72.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.328 1.451 . . . . 0.0 111.023 164.01 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -63.75 -27.65 69.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.944 1.702 . . . . 0.0 109.766 -174.002 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.37 -37.88 88.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.764 1.626 . . . . 0.0 109.696 -171.263 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -99.08 -5.0 31.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 111.723 -2.49 . . . . 0.0 107.236 -176.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 71.96 23.46 3.51 Favored 'General case' 0 N--CA 1.442 -0.845 1 O-C-N 114.643 -5.036 . . . . 0.0 116.408 165.221 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -90.68 130.66 39.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 130.54 3.536 . . . . 0.0 107.949 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -115.65 -173.83 2.41 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 131.143 3.777 . . . . 0.0 109.993 -167.673 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -74.17 133.26 42.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 129.577 3.151 . . . . 0.0 106.315 -159.887 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.301 35.7 mt-10 76.03 26.63 0.98 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.045 2.538 . . . . 0.0 113.28 -179.524 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.4 p -84.01 145.84 28.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.308 170.11 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.7 m -103.01 118.77 37.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 -177.23 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 tp -100.07 151.04 21.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 173.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -113.07 119.7 38.77 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 128.557 2.743 . . . . 0.0 109.69 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -89.16 137.05 32.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 128.642 3.714 . . . . 0.0 107.111 -176.569 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 t -105.41 116.51 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.832 166.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 125.7 1.6 . . . . 0.0 107.217 -169.681 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -89.8 112.41 23.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 128.657 2.783 . . . . 0.0 108.074 -170.29 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -109.66 143.09 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 169.121 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 66' ' ' THR . 47.8 m-85 -87.97 150.95 23.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.061 0.944 . . . . 0.0 111.79 161.919 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.4 121.14 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 130.296 3.438 . . . . 0.0 108.309 168.641 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -108.95 133.73 52.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.766 2.427 . . . . 0.0 113.889 176.434 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -105.87 173.4 6.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 117.55 -3.218 . . . . 0.0 109.856 -170.963 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tt -91.84 -35.68 13.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 131.535 3.934 . . . . 0.0 111.667 -176.57 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.7 p -65.03 -6.3 8.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 166.011 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.04 -28.77 5.76 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 117.006 1.562 . . . . 0.0 117.006 160.658 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 76.2 tttt -79.21 138.35 37.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 116.197 -1.859 . . . . 0.0 111.836 -172.182 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -99.51 118.92 37.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 113.798 -3.001 . . . . 0.0 104.522 172.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.9 mt -96.91 152.92 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 126.663 2.477 . . . . 0.0 107.121 179.302 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -125.14 142.03 51.74 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 165.357 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 131.47 49.78 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 111.656 -2.52 . . . . 0.0 113.162 -178.311 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -99.46 110.73 23.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 115.824 -2.036 . . . . 0.0 106.636 174.806 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 1.7 m -131.99 -174.84 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 119.748 1.158 . . . . 0.0 108.844 175.947 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -111.88 156.09 42.24 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 125.111 1.364 . . . . 0.0 109.887 174.713 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.08 -6.96 12.18 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-O 114.249 -2.479 . . . . 0.0 113.821 -171.704 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m -106.02 2.94 27.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 121.338 1.881 . . . . 0.0 110.64 179.992 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -75.72 152.74 37.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 118.646 -2.534 . . . . 0.0 111.724 170.478 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.333 74.8 p -94.33 169.52 10.16 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.253 1.021 . . . . 0.0 109.97 -165.547 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -71.6 -22.88 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 115.946 -1.978 . . . . 0.0 106.661 -178.47 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -69.19 -19.69 63.99 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 125.072 3.578 . . . . 0.0 107.204 173.537 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -73.94 -48.05 33.29 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 119.144 0.884 . . . . 0.0 111.23 -178.101 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -67.33 -44.37 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 111.997 -2.365 . . . . 0.0 113.404 175.306 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.29 30.1 mtpt -48.64 -36.56 16.16 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 119.898 3.296 . . . . 0.0 119.898 160.15 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.83 -39.87 42.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 120.912 1.687 . . . . 0.0 110.519 -179.572 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -69.88 -33.04 71.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.109 2.163 . . . . 0.0 111.232 178.753 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.22 -46.13 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 113.139 -3.315 . . . . 0.0 114.18 162.788 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -58.44 -45.86 87.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 123.056 2.662 . . . . 0.0 115.451 168.23 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.444 24.1 t70 -47.67 -64.5 0.77 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.006 1.722 . . . . 0.0 114.431 173.326 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -98.81 -20.69 16.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -165.191 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 60.2 mm-40 -127.46 13.01 7.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.185 2.194 . . . . 0.0 113.894 -176.539 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.06 20.58 62.77 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.078 2.275 . . . . 0.0 117.462 159.184 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mt -91.91 132.8 31.84 Favored Pre-proline 0 N--CA 1.444 -0.752 0 O-C-N 118.275 -2.897 . . . . 0.0 105.365 -172.491 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.84 112.13 2.14 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 114.694 -2.294 . . . . 0.0 114.581 169.627 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.66 -10.59 23.63 Favored 'Trans proline' 0 N--CA 1.457 -0.626 1 C-N-CA 125.447 4.098 . . . . 0.0 114.305 -167.625 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.361 25.7 t0 -65.3 -27.85 68.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 125.528 2.585 . . . . 0.0 111.904 167.504 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -114.97 51.61 0.9 Allowed 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 116.893 -3.63 . . . . 0.0 103.257 -167.432 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HB2' HE21 ' A' ' 41' ' ' GLN . 5.4 tt0 -160.64 147.12 15.29 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.997 2.119 . . . . 0.0 105.839 -170.736 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -149.65 126.26 10.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 102.173 -3.269 . . . . 0.0 102.173 172.183 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.334 78.2 mt -93.46 150.14 20.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 125.052 2.358 . . . . 0.0 109.518 169.695 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.7 mt -126.61 135.07 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 1 C-N-CA 133.249 4.62 . . . . 0.0 111.471 -177.219 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 65' ' ' SER . 52.8 t80 -150.66 133.17 15.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 118.7 -2.5 . . . . 0.0 111.853 178.115 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.22 21.31 1.59 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 118.831 2.9 . . . . 0.0 118.831 -178.583 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.65 -5.35 47.56 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 127.571 2.51 . . . . 0.0 113.038 -176.681 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -119.56 123.05 42.99 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.574 2.75 . . . . 0.0 109.239 -161.246 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -54.18 124.11 14.75 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 118.669 -2.519 . . . . 0.0 110.963 164.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -71.51 108.46 4.91 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.853 2.061 . . . . 0.0 109.645 174.359 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.287 29.8 tt0 -91.31 151.04 21.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -166.472 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -73.83 128.4 35.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.67 2.388 . . . . 0.0 106.773 -174.66 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.97 18.16 12.88 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 128.659 3.028 . . . . 0.0 116.709 175.217 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -121.86 168.11 12.25 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.876 1.67 . . . . 0.0 107.978 -177.472 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.4 p -124.32 146.21 48.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 -173.219 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.285 5.7 mt -48.15 -41.76 27.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.936 1.694 . . . . 0.0 112.053 -171.936 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -36.61 -44.96 0.48 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 129.846 3.258 . . . . 0.0 117.342 161.493 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -73.07 -7.65 52.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.761 2.024 . . . . 0.0 112.701 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -117.01 -12.56 10.65 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.35 1.86 . . . . 0.0 112.72 170.331 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.1 t30 78.05 33.7 0.33 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.8 2.04 . . . . 0.0 111.003 171.861 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.9 mt -69.14 119.15 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 127.118 2.167 . . . . 0.0 106.211 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.277 4.0 pp0? -119.65 175.48 5.84 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 128.943 2.897 . . . . 0.0 108.71 -168.25 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -48.56 111.33 0.44 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 117.007 -3.558 . . . . 0.0 115.452 -175.338 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 73.46 29.32 1.62 Allowed 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 119.294 -2.128 . . . . 0.0 109.658 176.284 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.402 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 73.4 m -84.25 125.77 32.54 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 117.108 -3.495 . . . . 0.0 103.263 175.225 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 60.1 m -95.41 110.1 22.18 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 116.946 -3.596 . . . . 0.0 108.426 -169.191 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -79.75 157.26 27.16 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 130.766 3.626 . . . . 0.0 110.4 174.736 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -121.39 142.4 50.04 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 129.533 3.133 . . . . 0.0 104.448 -177.808 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.22 127.29 48.4 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 131.242 3.817 . . . . 0.0 105.057 -173.223 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.31 142.37 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 118.761 -2.462 . . . . 0.0 113.506 163.74 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.674 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 -170.113 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 CA--C 1.534 0.361 1 CA-C-O 129.783 4.611 . . . . 0.0 105.297 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -71.02 144.58 50.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 110.671 -2.968 . . . . 0.0 113.389 -173.786 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.3 pt -146.12 174.95 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 116.441 -1.742 . . . . 0.0 106.691 177.998 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -128.31 117.35 21.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.063 2.545 . . . . 0.0 108.178 172.121 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.438 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 16.2 t -82.29 116.55 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 118.946 -2.346 . . . . 0.0 105.665 158.446 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -95.06 146.77 24.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 115.417 -2.23 . . . . 0.0 111.735 160.903 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -95.54 159.8 14.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 129.386 3.074 . . . . 0.0 104.697 164.62 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 tp -63.5 -21.41 66.31 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 111.526 -2.579 . . . . 0.0 110.534 177.037 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.1 p -95.63 -6.79 39.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 127.674 3.109 . . . . 0.0 112.708 178.134 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.5 -24.94 6.06 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.198 -1.334 . . . . 0.0 112.704 158.472 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -55.58 118.53 4.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 129.228 3.011 . . . . 0.0 109.086 -177.573 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.0 m -100.34 132.89 45.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 126.83 2.581 . . . . 0.0 109.711 179.084 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.438 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 10.0 mm -109.05 130.41 62.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.589 1.955 . . . . 0.0 106.911 173.614 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.7 m -85.36 144.1 28.24 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.907 2.483 . . . . 0.0 105.17 174.631 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.68 151.63 49.49 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 120.267 -1.521 . . . . 0.0 107.675 171.615 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -103.3 125.67 50.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 153.79 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -137.79 171.25 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 131.496 3.919 . . . . 0.0 112.677 163.73 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -130.14 144.29 52.55 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -178.411 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -57.81 -28.71 83.38 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 CA-C-O 111.843 -3.482 . . . . 0.0 115.286 -169.598 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.9 p -77.2 2.4 15.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 124.81 3.459 . . . . 0.0 115.52 172.25 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -77.83 148.78 34.55 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 118.968 -2.332 . . . . 0.0 107.358 -179.443 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.3 p -78.4 155.1 30.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 116.739 -1.601 . . . . 0.0 112.648 -172.12 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.254 10.6 mm -81.9 50.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 125.327 2.489 . . . . 0.0 109.794 161.175 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -153.72 -54.66 0.11 Allowed 'General case' 0 CA--C 1.532 0.288 0 O-C-N 117.39 -3.319 . . . . 0.0 109.066 -173.44 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -59.71 -57.37 13.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 120.698 1.59 . . . . 0.0 113.517 -175.394 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.37 -8.03 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.65 2.38 . . . . 0.0 111.188 -163.568 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -49.01 -40.29 30.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.322 2.649 . . . . 0.0 116.291 162.338 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.91 -27.69 8.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 119.722 -1.861 . . . . 0.0 115.527 172.033 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -89.01 -2.26 58.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 118.541 -1.263 . . . . 0.0 111.511 -172.096 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.9 mm -89.71 -37.75 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 127.67 2.388 . . . . 0.0 108.581 165.543 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.08 -43.24 99.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.361 -1.291 . . . . 0.0 114.225 176.476 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.25 -16.34 8.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.816 2.447 . . . . 0.0 115.704 170.934 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -108.94 -52.26 2.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.566 1.546 . . . . 0.0 110.979 -173.246 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -115.01 -19.06 11.07 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 118.801 -2.437 . . . . 0.0 112.331 -173.628 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.27 15.79 20.39 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 115.161 -3.022 . . . . 0.0 112.41 177.908 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -90.75 121.63 67.93 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 121.773 2.787 . . . . 0.0 112.172 -176.987 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.4 158.06 59.18 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.538 2.159 . . . . 0.0 113.656 179.028 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.36 -40.17 60.61 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.273 2.649 . . . . 0.0 115.465 -173.614 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -41.6 -54.87 3.09 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 131.225 3.81 . . . . 0.0 114.015 166.144 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -80.23 -13.23 59.39 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.607 2.363 . . . . 0.0 113.868 -170.481 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -83.91 106.44 15.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 129.482 3.113 . . . . 0.0 106.676 -179.058 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -113.28 137.28 51.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.728 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.284 1.7 pt? -134.02 131.37 38.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 120.707 1.594 . . . . 0.0 112.497 -172.378 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.8 mt -109.68 132.22 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 -174.533 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -131.74 -85.4 0.49 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 130.546 3.538 . . . . 0.0 114.233 168.528 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.61 55.01 0.69 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 125.961 3.982 . . . . 0.0 114.584 -170.474 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.71 -9.48 48.06 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 161.805 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -139.33 156.01 47.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 119.764 3.246 . . . . 0.0 119.764 176.536 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.86 116.17 18.16 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.988 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.5 mt -58.68 135.53 57.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.769 -2.457 . . . . 0.0 113.932 -175.251 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -84.07 143.77 29.51 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.531 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.54 132.92 46.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.323 1.449 . . . . 0.0 112.261 169.937 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.23 -24.44 10.6 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 124.671 2.262 . . . . 0.0 112.241 171.565 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -73.61 166.87 22.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 111.978 -2.111 . . . . 0.0 105.316 -179.903 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.9 p -100.81 163.59 12.24 Favored 'General case' 0 N--CA 1.45 -0.436 1 O-C-N 115.583 -4.448 . . . . 0.0 108.269 169.013 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -51.59 -36.98 47.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.233 2.213 . . . . 0.0 113.439 171.501 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -79.6 -17.84 52.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 177.235 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -62.97 -17.33 61.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 121.294 1.861 . . . . 0.0 109.411 164.847 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -118.05 7.18 12.17 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 130.389 3.476 . . . . 0.0 112.484 -178.212 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 62.96 32.39 15.61 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 131.453 3.901 . . . . 0.0 112.0 174.291 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.89 132.0 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 126.607 1.963 . . . . 0.0 105.84 -172.002 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -127.34 165.77 19.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.319 2.248 . . . . 0.0 111.678 -179.902 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -48.03 137.28 10.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 131.286 3.835 . . . . 0.0 112.494 179.577 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 84.67 4.15 0.67 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.461 1.905 . . . . 0.0 108.454 165.541 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 m -83.61 142.69 30.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 175.374 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.8 m -97.29 129.52 44.58 Favored 'General case' 0 N--CA 1.451 -0.408 1 C-N-CA 132.431 4.292 . . . . 0.0 112.749 179.485 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.62 143.18 50.71 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -169.99 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -115.1 102.68 10.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 101.621 -3.474 . . . . 0.0 101.621 -160.72 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -71.07 144.45 50.34 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 128.843 2.857 . . . . 0.0 108.649 166.1 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.85 156.29 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 130.134 3.373 . . . . 0.0 106.66 170.414 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.28 48.1 mt . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 126.55 3.072 . . . . 0.0 108.89 -178.483 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttp . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -125.13 139.59 53.63 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.007 2.523 . . . . 0.0 114.18 -175.983 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.296 45.6 pt -133.55 -179.48 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 128.893 2.877 . . . . 0.0 104.869 173.935 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -133.17 160.65 36.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 167.291 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.6 t -129.52 141.04 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 166.694 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -109.16 127.05 53.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.129 1.771 . . . . 0.0 106.638 176.814 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.5 p -79.74 173.14 12.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 124.154 1.931 . . . . 0.0 112.305 165.852 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.7 mt -78.71 -31.45 46.47 Favored 'General case' 0 C--O 1.24 0.602 0 O-C-N 118.188 -2.82 . . . . 0.0 111.921 173.708 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 t -64.0 -21.11 66.36 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 167.642 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.54 6.63 40.92 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 125.825 1.953 . . . . 0.0 109.275 168.769 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -65.77 119.06 10.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 122.377 3.088 . . . . 0.0 109.113 167.998 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.5 m -102.46 94.83 5.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 122.948 2.613 . . . . 0.0 104.652 -178.914 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.86 144.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 1 C-N-CA 132.212 4.205 . . . . 0.0 109.41 170.11 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.9 m -103.22 142.42 34.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.752 1.621 . . . . 0.0 109.912 169.109 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -125.12 132.53 53.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 157.819 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.84 128.4 35.48 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 154.638 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.67 157.99 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 120.402 -1.436 . . . . 0.0 111.403 -178.056 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.76 149.55 38.6 Favored Pre-proline 0 N--CA 1.442 -0.869 0 C-N-CA 127.016 2.127 . . . . 0.0 106.382 174.882 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.295 52.8 Cg_endo -70.41 -15.17 34.6 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 124.767 3.645 . . . . 0.0 116.476 -179.254 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -98.52 1.27 46.43 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.986 2.514 . . . . 0.0 113.632 -178.643 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -77.64 153.63 32.97 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.394 -1.441 . . . . 0.0 111.539 -169.863 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.5 p -89.42 158.14 17.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 128.047 2.539 . . . . 0.0 106.005 177.256 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.11 -29.74 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 114.049 -2.882 . . . . 0.0 107.59 175.964 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -59.63 -38.04 80.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 124.629 3.377 . . . . 0.0 108.316 168.921 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -76.38 -21.54 55.91 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 118.368 -2.707 . . . . 0.0 109.604 176.309 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.29 -37.02 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 124.609 3.368 . . . . 0.0 111.7 172.933 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -64.64 -30.07 71.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.484 1.914 . . . . 0.0 111.971 176.566 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.265 . . -75.25 -30.24 60.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.621 2.368 . . . . 0.0 111.928 179.867 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -79.51 -25.43 41.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 125.108 2.385 . . . . 0.0 112.014 174.707 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.34 32.1 mm -82.3 -33.68 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 113.412 -1.722 . . . . 0.0 108.883 173.241 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -36.32 66.5 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 123.013 2.642 . . . . 0.0 114.063 161.595 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.05 -59.85 2.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 128.433 2.693 . . . . 0.0 106.531 177.718 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.322 68.1 mmtt -51.39 -64.94 0.65 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.695 2.398 . . . . 0.0 110.567 -177.309 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -120.49 -9.88 9.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 112.914 -3.422 . . . . 0.0 107.437 -150.451 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.49 -1.9 62.42 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 127.875 3.234 . . . . 0.0 116.826 166.933 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.3 mm -95.09 132.14 28.67 Favored Pre-proline 0 N--CA 1.452 -0.368 0 O-C-N 117.335 -3.45 . . . . 0.0 111.722 -159.231 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -47.44 122.95 7.31 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 126.914 5.076 . . . . 0.0 108.657 168.352 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -35.36 -47.43 0.81 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 1 C-N-CA 129.698 6.932 . . . . 0.0 118.52 174.711 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.5 -16.3 64.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 114.913 -2.47 . . . . 0.0 115.422 -178.697 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.24 -7.36 42.29 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 126.186 2.179 . . . . 0.0 109.125 179.542 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -86.91 130.19 34.56 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 128.338 2.655 . . . . 0.0 109.269 179.906 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -116.86 141.06 48.72 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 128.868 2.867 . . . . 0.0 107.334 179.823 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.9 mt -119.44 111.18 17.82 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.551 2.34 . . . . 0.0 110.797 173.886 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.3 mt -105.12 118.6 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 161.23 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -126.69 130.79 51.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 175.212 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.42 19.5 10.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.658 169.514 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.17 -17.55 59.08 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 128.453 2.93 . . . . 0.0 115.678 -169.728 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.288 11.6 mmmt -93.19 146.48 23.65 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 119.404 1.602 . . . . 0.0 111.971 -176.931 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -94.54 112.47 24.23 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 130.892 3.677 . . . . 0.0 105.07 -176.246 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.448 ' HG ' ' CD1' ' A' ' 59' ' ' TYR . 6.2 mp -80.2 111.2 16.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 114.455 -2.688 . . . . 0.0 105.778 -179.259 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -83.83 -15.05 49.73 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 126.769 2.543 . . . . 0.0 115.705 -173.052 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.298 5.3 t0 93.64 153.66 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 128.694 2.798 . . . . 0.0 111.49 -175.932 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.01 30.98 5.82 Favored Glycine 0 N--CA 1.438 -1.21 0 O-C-N 117.394 -3.316 . . . . 0.0 114.335 161.322 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -153.4 160.48 42.63 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 131.586 3.954 . . . . 0.0 106.83 172.276 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.6 p -98.34 176.66 5.62 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 117.013 -3.555 . . . . 0.0 111.506 -167.269 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.53 -37.13 84.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 126.312 1.845 . . . . 0.0 111.96 -173.82 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 p -64.39 -33.6 76.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.017 1.727 . . . . 0.0 115.12 166.189 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -71.74 -56.44 5.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.99 2.116 . . . . 0.0 107.416 179.634 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.448 ' CD1' ' HG ' ' A' ' 50' ' ' LEU 0.277 42.9 m-85 -64.52 0.99 0.89 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 130.548 3.539 . . . . 0.0 116.312 -178.756 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.311 1.5 t-20 78.42 18.32 1.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 124.131 3.15 . . . . 0.0 113.836 163.659 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.8 mt -94.01 105.02 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 117.306 -3.371 . . . . 0.0 106.409 179.92 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -99.83 -170.79 1.94 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 116.601 -3.812 . . . . 0.0 101.483 -166.541 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -64.99 120.23 12.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 114.669 -2.586 . . . . 0.0 112.125 -170.044 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.555 2.4 mp0 77.59 24.77 0.75 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 117.427 2.381 . . . . 0.0 117.427 179.144 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.9 m -71.23 148.02 47.65 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 112.42 -2.173 . . . . 0.0 106.157 175.221 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.321 99.1 m -114.83 128.9 56.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 169.579 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.1 mt -92.65 151.24 20.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 108.824 -3.807 . . . . 0.0 107.811 170.305 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -98.68 127.35 44.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.904 0.882 . . . . 0.0 113.374 162.112 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -107.46 118.46 36.79 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 -178.396 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.52 160.78 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.306 1.842 . . . . 0.0 110.253 172.992 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.1 mt . . . . . 0 N--CA 1.448 -0.53 0 O-C-N 118.868 -2.395 . . . . 0.0 112.623 176.523 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ttt . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 116.409 -1.758 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -77.82 131.53 37.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 123.716 2.962 . . . . 0.0 112.309 173.629 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.4 pt -130.37 136.9 57.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 126.88 2.613 . . . . 0.0 107.202 170.457 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.52 123.01 35.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 172.045 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -96.27 124.88 49.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 166.682 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.261 49.3 tttm -106.87 121.31 44.15 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -174.292 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.294 5.1 p -113.13 -171.34 1.85 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 128.009 2.523 . . . . 0.0 108.099 175.466 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.301 74.3 mt -82.26 -28.41 31.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 126.625 3.107 . . . . 0.0 113.649 176.006 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 p -123.87 68.02 1.04 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.87 3.268 . . . . 0.0 107.024 -175.848 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.53 101.67 1.22 Allowed Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 104.198 -3.561 . . . . 0.0 104.198 178.653 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -79.06 -33.23 44.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 129.014 3.42 . . . . 0.0 111.363 -179.425 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m -117.71 59.57 0.78 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 126.44 3.019 . . . . 0.0 106.396 -167.634 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.81 116.01 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 118.558 -2.589 . . . . 0.0 106.613 170.102 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.86 119.59 39.23 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 118.293 -2.754 . . . . 0.0 105.902 -169.986 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -115.81 136.15 53.32 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 129.744 3.218 . . . . 0.0 108.746 172.657 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.259 10.1 tp10 -92.17 114.41 26.94 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 167.169 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -108.75 -167.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 126.18 1.792 . . . . 0.0 110.854 168.999 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -139.47 140.65 26.12 Favored Pre-proline 0 N--CA 1.45 -0.462 1 C-N-CA 131.92 4.088 . . . . 0.0 107.578 171.62 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -43.54 -47.4 9.39 Favored 'Trans proline' 0 N--CA 1.445 -1.334 1 C-N-CA 126.079 4.519 . . . . 0.0 118.876 171.282 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.264 77.9 p -91.75 18.72 7.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.304 1.842 . . . . 0.0 107.2 -176.828 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -79.0 144.94 34.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 123.439 2.836 . . . . 0.0 114.102 169.978 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -92.77 153.48 18.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 117.421 -3.299 . . . . 0.0 111.038 -178.884 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mm -57.99 -26.1 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 118.675 -2.516 . . . . 0.0 114.713 -176.046 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -82.22 -18.31 43.03 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.787 1.635 . . . . 0.0 108.31 -170.395 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -83.78 -35.28 24.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.582 2.353 . . . . 0.0 107.948 178.905 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.95 -51.63 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 128.495 2.718 . . . . 0.0 107.538 177.288 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -59.01 -39.28 81.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 120.075 3.361 . . . . 0.0 120.075 173.526 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -26.9 68.5 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.705 3.602 . . . . 0.0 113.331 160.792 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -77.58 -47.49 19.28 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 121.681 2.037 . . . . 0.0 113.011 172.768 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.321 92.1 mt -54.15 -46.19 66.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 131.009 3.723 . . . . 0.0 112.811 174.264 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -60.25 -20.23 58.09 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 118.753 -2.467 . . . . 0.0 116.138 -177.75 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.278 3.7 t70 -94.2 -36.89 11.83 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 -178.546 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -70.95 -55.1 9.09 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.506 178.364 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -117.47 -21.43 8.63 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 118.355 -2.716 . . . . 0.0 108.662 -166.352 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.4 10.7 28.87 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 117.183 -3.448 . . . . 0.0 114.014 164.379 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.92 120.89 57.54 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 -165.709 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -77.98 154.19 29.41 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 O-C-N 116.322 -2.515 . . . . 0.0 112.402 -173.119 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -73.98 -33.27 6.28 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.076 1.851 . . . . 0.0 112.557 -153.921 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -73.91 -19.7 60.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 124.739 1.274 . . . . 0.0 112.932 177.532 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -90.89 -16.49 28.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.638 2.375 . . . . 0.0 110.572 -179.404 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -89.11 129.45 35.72 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 129.124 2.969 . . . . 0.0 112.452 -179.704 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -119.78 155.78 31.86 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 173.791 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.06 144.33 51.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 120.15 -1.594 . . . . 0.0 111.739 178.074 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -131.43 143.76 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 122.844 2.565 . . . . 0.0 113.881 176.048 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -151.9 123.58 7.93 Favored 'General case' 0 N--CA 1.451 -0.388 1 C-N-CA 132.087 4.155 . . . . 0.0 113.461 171.541 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.27 37.56 4.21 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 119.651 3.204 . . . . 0.0 119.651 -175.784 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.75 -0.24 57.84 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 117.038 -3.539 . . . . 0.0 112.607 171.425 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -113.53 138.72 49.73 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 122.976 3.388 . . . . 0.0 105.15 -178.767 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.293 24.3 tt0 -98.0 125.07 42.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.308 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.14 131.14 44.87 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.89 -168.392 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -104.31 154.72 19.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 127.008 3.29 . . . . 0.0 113.726 -172.93 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -45.75 127.75 8.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 117.438 -3.289 . . . . 0.0 115.505 177.509 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.16 -2.38 61.33 Favored Glycine 0 CA--C 1.536 1.368 1 CA-C-N 127.362 4.619 . . . . 0.0 112.485 163.636 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.263 25.9 mmt-85 -100.06 172.88 6.92 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 127.188 3.375 . . . . 0.0 106.931 -173.138 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -119.69 -178.63 3.67 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 116.551 -3.843 . . . . 0.0 113.02 168.394 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.83 -44.42 59.32 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 131.032 3.733 . . . . 0.0 112.825 162.811 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.5 m -72.22 -33.68 67.77 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.367 2.667 . . . . 0.0 111.404 -170.897 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -66.98 -38.9 86.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 124.731 2.205 . . . . 0.0 111.34 -178.264 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -91.15 0.62 57.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 117.146 -3.471 . . . . 0.0 116.042 176.425 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.256 13.3 m120 71.52 53.13 0.23 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 130.383 3.473 . . . . 0.0 110.638 -178.206 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.9 mt -103.03 140.41 21.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 -174.306 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -106.84 149.0 27.85 Favored 'General case' 0 N--CA 1.451 -0.397 1 C-N-CA 131.936 4.094 . . . . 0.0 115.674 -169.074 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.77 128.53 30.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 124.351 1.032 . . . . 0.0 112.705 162.065 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.277 29.3 tt0 87.05 21.89 0.06 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.839 2.856 . . . . 0.0 110.209 174.253 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.9 m -71.63 141.84 49.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.216 1.806 . . . . 0.0 114.475 175.716 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.279 97.6 m -100.69 126.74 47.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 115.279 -2.296 . . . . 0.0 104.89 165.58 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.08 173.47 13.36 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 130.781 3.632 . . . . 0.0 107.2 177.651 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -127.45 134.13 49.87 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.443 2.297 . . . . 0.0 112.991 -156.548 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 tt -108.29 139.28 43.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 125.336 2.493 . . . . 0.0 107.752 173.621 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 t -130.55 134.53 62.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 129.846 3.258 . . . . 0.0 106.722 -178.144 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.438 -1.063 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 172.338 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.374 0.6 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 . . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -91.82 129.28 37.81 Favored 'General case' 0 N--CA 1.447 -0.591 1 C-N-CA 133.927 4.891 . . . . 0.0 107.213 -179.622 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -119.08 156.69 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 128.01 3.319 . . . . 0.0 106.167 154.01 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -95.35 133.86 38.8 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.579 1.552 . . . . 0.0 107.239 166.279 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.57 125.55 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 1 N-CA-C 97.321 -5.066 . . . . 0.0 97.321 175.293 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -103.04 127.05 50.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 127.059 3.314 . . . . 0.0 107.707 173.977 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -89.76 145.03 25.48 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 126.021 2.82 . . . . 0.0 106.102 -176.178 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.35 -27.89 68.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.706 -2.043 . . . . 0.0 116.241 178.561 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 p -76.72 -7.47 55.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.081 2.553 . . . . 0.0 116.94 173.274 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.05 10.15 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 129.922 3.629 . . . . 0.0 114.694 166.303 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 47.1 tttt -70.39 149.57 47.16 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 121.939 2.869 . . . . 0.0 110.758 -178.556 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.1 m -104.24 141.75 35.74 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.717 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.401 0.1 OUTLIER -125.08 135.17 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 126.516 3.055 . . . . 0.0 112.789 163.173 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 m -75.66 137.5 40.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 117.65 -3.156 . . . . 0.0 104.482 174.085 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -138.41 120.14 15.22 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 175.833 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.286 25.4 mt-10 -70.39 131.92 44.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 126.949 2.656 . . . . 0.0 111.724 170.527 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 m -148.99 164.34 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 127.886 2.474 . . . . 0.0 106.787 -173.794 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -123.47 155.99 64.78 Favored Pre-proline 0 N--CA 1.449 -0.52 0 O-C-N 117.624 -3.173 . . . . 0.0 109.419 165.49 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.72 -37.67 35.67 Favored 'Trans proline' 0 N--CA 1.451 -0.997 1 C-N-CA 127.152 5.235 . . . . 0.0 116.008 179.203 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.8 p -81.27 -13.46 58.45 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 112.563 -2.108 . . . . 0.0 112.757 -179.624 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -67.02 155.84 37.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 121.103 1.774 . . . . 0.0 109.951 170.663 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -121.8 139.86 53.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 130.287 3.435 . . . . 0.0 111.248 -161.178 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -46.23 -24.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 O-C-N 116.595 -3.816 . . . . 0.0 116.895 176.243 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -68.74 -54.4 16.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.904 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -62.42 -37.43 85.79 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 119.593 3.183 . . . . 0.0 119.593 -173.353 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.282 76.1 t -50.71 -43.98 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 129.498 3.119 . . . . 0.0 113.804 170.605 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.355 40.0 mtmt -50.78 -43.69 58.59 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.766 2.027 . . . . 0.0 112.598 172.251 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.32 -33.65 28.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 125.982 2.051 . . . . 0.0 114.649 -176.619 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -55.41 -31.9 62.23 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 125.334 2.492 . . . . 0.0 115.215 173.003 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.402 ' HB ' HE22 ' A' ' 41' ' ' GLN . 70.8 mt -75.63 -21.11 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 113.421 -1.718 . . . . 0.0 113.156 172.147 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -70.56 -43.34 69.68 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 122.572 2.442 . . . . 0.0 107.715 173.225 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.53 -29.04 67.61 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 118.926 -2.358 . . . . 0.0 112.417 176.942 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -97.19 -57.21 2.32 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 175.617 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 11' ' ' LYS . 28.6 mm-40 -92.64 -22.7 19.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.151 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.62 -18.39 22.54 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 130.672 3.987 . . . . 0.0 112.326 171.426 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.3 mt -71.2 122.98 88.59 Favored Pre-proline 0 N--CA 1.445 -0.686 0 C-N-CA 127.882 2.473 . . . . 0.0 106.185 -159.604 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.0 137.8 27.22 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.872 2.382 . . . . 0.0 109.973 172.423 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -40.73 -45.29 4.76 Favored 'Trans proline' 0 N--CA 1.454 -0.804 1 C-N-CA 126.442 4.761 . . . . 0.0 114.786 -175.654 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.257 12.6 t70 -31.76 -41.75 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 127.104 2.752 . . . . 0.0 117.943 170.762 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -96.84 -16.76 20.6 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -170.349 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.402 HE22 ' HB ' ' A' ' 30' ' ' ILE . 9.2 pt20 -97.49 140.88 31.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 127.479 2.987 . . . . 0.0 111.746 -178.593 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -125.23 128.21 47.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 116.74 -1.6 . . . . 0.0 108.325 174.146 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.78 140.82 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.085 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.3 pt -141.91 144.36 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 131.587 3.955 . . . . 0.0 111.114 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -146.16 130.34 17.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 111.566 -2.561 . . . . 0.0 107.627 172.265 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.79 17.91 8.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.264 1.826 . . . . 0.0 115.308 168.694 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.39 -26.66 12.76 Favored Glycine 0 CA--C 1.528 0.88 1 C-N-CA 131.95 4.595 . . . . 0.0 112.501 -169.253 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.303 38.4 mttt -68.24 129.89 41.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.807 0.804 . . . . 0.0 111.278 -170.982 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.316 78.0 mt-30 -66.06 115.05 5.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 163.708 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.97 121.96 29.34 Favored 'General case' 0 C--O 1.239 0.52 1 O-C-N 116.156 -4.09 . . . . 0.0 110.139 -175.746 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.47 148.15 24.31 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 129.702 3.201 . . . . 0.0 111.293 -165.08 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -74.93 123.72 25.61 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.667 2.387 . . . . 0.0 108.323 -166.606 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.06 60.33 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 128.814 3.102 . . . . 0.0 116.215 174.1 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -80.58 143.61 33.05 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 128.214 2.606 . . . . 0.0 109.511 173.663 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -77.0 151.81 35.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 128.589 2.755 . . . . 0.0 110.655 177.977 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -59.71 -25.29 64.68 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 127.522 2.329 . . . . 0.0 114.678 161.546 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -74.46 -23.05 58.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 130.2 3.4 . . . . 0.0 112.812 166.229 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -89.53 -16.92 29.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 121.655 2.025 . . . . 0.0 109.387 178.806 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.44 ' HB2' HD11 ' A' ' 61' ' ' ILE . 68.1 m-85 -96.81 -3.51 42.08 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 115.886 -2.007 . . . . 0.0 111.512 171.731 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 t30 62.35 37.86 13.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 171.835 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 59' ' ' TYR . 50.7 mt -94.57 127.99 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 -172.19 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -99.44 175.56 5.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.789 2.036 . . . . 0.0 111.224 -176.247 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 144.0 57.45 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 130.97 3.708 . . . . 0.0 110.708 179.057 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.323 3.0 pt-20 60.68 13.17 4.12 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 131.562 3.945 . . . . 0.0 116.874 -179.374 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.0 m -67.33 144.77 55.67 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 126.709 2.506 . . . . 0.0 111.701 166.084 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.0 m -86.31 108.81 18.58 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.257 1.423 . . . . 0.0 109.074 174.788 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.89 150.43 25.72 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 123.029 1.395 . . . . 0.0 113.36 156.785 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.265 75.2 m80 -104.02 144.07 32.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.443 -1.411 . . . . 0.0 111.303 176.714 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 tt -128.55 120.99 27.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 113.61 -3.09 . . . . 0.0 109.51 -177.813 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.99 133.34 44.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 127.782 2.433 . . . . 0.0 106.718 -175.532 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.274 73.6 mt . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 125.841 1.657 . . . . 0.0 111.678 171.895 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ttt . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 116.021 1.859 . . . . 0.0 116.021 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -106.61 165.96 10.91 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.103 1.761 . . . . 0.0 113.241 -176.831 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -122.75 165.02 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 127.531 2.332 . . . . 0.0 108.858 152.662 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -112.18 125.44 54.14 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 126.646 2.466 . . . . 0.0 112.414 -172.253 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.74 91.35 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 101.664 -3.458 . . . . 0.0 101.664 176.869 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -68.27 145.8 53.91 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 114.277 -2.773 . . . . 0.0 112.855 167.32 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -155.06 171.5 19.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 124.963 3.528 . . . . 0.0 111.792 170.526 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 mt -68.75 -17.49 64.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 130.057 3.343 . . . . 0.0 116.913 -164.585 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.6 p -74.14 -7.77 53.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 173.588 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.71 -20.81 44.71 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 116.674 1.43 . . . . 0.0 116.674 -179.147 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -76.9 152.71 35.26 Favored 'General case' 0 N--CA 1.447 -0.585 1 C-N-CA 132.25 4.22 . . . . 0.0 104.348 -176.21 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.289 75.7 m -122.68 147.79 46.05 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 118.937 -2.352 . . . . 0.0 112.3 161.765 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mt -120.88 154.39 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 131.685 3.994 . . . . 0.0 107.056 -178.013 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 p -127.47 135.9 51.03 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 128.174 2.59 . . . . 0.0 110.721 -165.682 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.7 mt -130.6 117.43 19.52 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 126.418 2.324 . . . . 0.0 107.679 -179.668 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -90.66 108.77 20.02 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.131 2.172 . . . . 0.0 106.26 169.117 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.0 161.33 32.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 1 C-N-CA 134.413 5.085 . . . . 0.0 108.77 -170.326 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -126.16 152.32 73.25 Favored Pre-proline 0 N--CA 1.442 -0.867 0 C-N-CA 131.589 3.956 . . . . 0.0 110.045 175.486 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -47.35 -48.97 13.91 Favored 'Trans proline' 0 N--CA 1.456 -0.685 1 C-N-CA 126.523 4.815 . . . . 0.0 114.232 -167.368 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -61.66 -15.77 42.87 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 119.104 3.001 . . . . 0.0 119.104 -176.879 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.42 120.58 9.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.942 170.797 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 p -65.79 136.28 55.99 Favored 'General case' 0 N--CA 1.447 -0.578 1 C-N-CA 135.521 5.528 . . . . 0.0 110.266 161.377 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mm -59.99 -31.7 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 114.882 -2.485 . . . . 0.0 114.527 -174.71 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -48.7 -36.48 16.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.103 2.561 . . . . 0.0 114.73 169.743 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -82.79 -39.28 21.98 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 125.343 1.652 . . . . 0.0 108.937 -172.866 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.32 4.5 t -67.95 -36.58 76.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 112.982 -3.39 . . . . 0.0 115.678 172.705 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -58.94 -46.84 87.02 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 129.6 3.16 . . . . 0.0 107.301 177.889 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.91 -18.69 61.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.867 3.267 . . . . 0.0 118.184 172.351 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -49.57 63.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 118.24 -2.787 . . . . 0.0 113.112 160.551 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -68.32 -38.66 79.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 127.832 2.453 . . . . 0.0 107.397 -169.667 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.41 -65.61 0.53 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.489 1.115 . . . . 0.0 111.071 160.529 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.253 35.0 t70 -43.28 -38.29 2.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 129.612 3.165 . . . . 0.0 114.086 179.68 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -80.28 -45.64 17.54 Favored 'General case' 0 CA--C 1.535 0.39 1 C-N-CA 131.964 4.106 . . . . 0.0 120.658 171.619 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -123.69 -20.43 5.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 126.057 2.837 . . . . 0.0 112.988 -166.468 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.73 28.8 22.99 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 118.035 -2.916 . . . . 0.0 115.983 170.035 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 tt -106.27 111.6 64.2 Favored Pre-proline 0 N--CA 1.446 -0.654 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 -175.213 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.32 151.87 23.34 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 125.163 3.909 . . . . 0.0 109.512 -174.789 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -47.86 -38.2 30.12 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 112.135 -3.36 . . . . 0.0 115.182 -166.795 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -13.91 2.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 127.676 3.11 . . . . 0.0 116.579 175.919 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -116.72 -7.4 11.52 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.039 2.535 . . . . 0.0 110.418 -176.2 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.277 80.0 mt-30 -87.67 145.36 26.2 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 117.866 -3.021 . . . . 0.0 105.656 175.709 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -124.64 128.13 48.39 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 129.037 2.935 . . . . 0.0 106.747 161.711 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -119.92 104.57 10.29 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 112.405 -3.664 . . . . 0.0 110.002 -160.941 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.65 131.52 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 1 CA-C-N 126.011 4.005 . . . . 0.0 108.798 -163.26 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -111.43 113.41 25.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.435 1.894 . . . . 0.0 112.202 164.207 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.8 -92.1 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 131.051 3.74 . . . . 0.0 110.51 -166.068 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.16 1.63 5.4 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 113.85 -1.523 . . . . 0.0 116.044 169.961 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -95.98 128.87 43.26 Favored 'General case' 0 CA--C 1.541 0.6 1 C-N-CA 132.031 4.132 . . . . 0.0 104.951 -174.168 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.371 18.6 mp0 -77.77 138.87 39.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.451 3.901 . . . . 0.0 107.903 178.178 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.467 ' HG ' ' CE2' ' A' ' 59' ' ' TYR . 8.1 mp -94.42 153.98 17.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.317 2.008 . . . . 0.0 107.315 172.544 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -135.23 144.25 46.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 112.257 -2.247 . . . . 0.0 108.648 164.555 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -49.15 146.88 3.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.671 2.388 . . . . 0.0 115.649 169.468 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.94 16.49 28.1 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-O 116.092 -2.504 . . . . 0.0 111.292 -169.289 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -145.92 158.26 43.87 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 127.512 3.53 . . . . 0.0 102.759 171.599 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -103.21 173.99 6.06 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 116.671 -3.768 . . . . 0.0 110.27 177.678 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.98 -36.46 83.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 117.994 -2.941 . . . . 0.0 106.83 176.59 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 t -64.91 -45.18 86.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.691 0.62 . . . . 0.0 112.444 175.95 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.63 -46.43 70.48 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.809 178.239 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.467 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 39.7 m-85 -75.41 -10.51 59.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 123.454 1.597 . . . . 0.0 113.629 -175.894 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.4 t30 66.32 45.95 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.516 3.526 . . . . 0.0 114.412 -173.069 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -90.21 142.82 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 O-C-N 126.577 2.423 . . . . 0.0 106.469 -178.264 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -137.12 177.99 7.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 178.196 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -49.03 116.85 1.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.665 2.386 . . . . 0.0 112.547 -176.0 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.457 21.4 mp0 79.74 23.52 0.47 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 130.298 3.439 . . . . 0.0 112.759 168.732 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 m -71.19 150.05 45.72 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.225 1.81 . . . . 0.0 111.012 169.175 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 m -98.9 130.52 45.3 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 119.161 -2.212 . . . . 0.0 109.429 162.386 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -109.62 141.05 42.7 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 114.914 -2.47 . . . . 0.0 108.876 167.441 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.355 23.2 t60 -100.94 164.06 12.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 121.603 2.001 . . . . 0.0 115.711 178.67 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.253 0.4 OUTLIER -141.11 136.7 32.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 129.14 2.976 . . . . 0.0 107.544 -175.841 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.65 118.69 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 O-C-N 126.791 2.557 . . . . 0.0 105.717 -176.492 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.663 0 O-C-N 128.682 3.738 . . . . 0.0 108.222 171.886 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.259 9.5 ptt? . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -74.36 146.31 43.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 118.45 -2.656 . . . . 0.0 117.196 169.187 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.336 44.5 pt -130.85 133.92 62.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 115.256 -2.307 . . . . 0.0 107.846 166.788 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -117.64 107.83 14.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -177.644 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.28 120.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.972 2.509 . . . . 0.0 105.046 -170.132 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -96.08 150.12 20.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 128.67 3.731 . . . . 0.0 112.502 178.327 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -113.96 138.14 50.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 160.667 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -53.37 -36.13 61.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -174.864 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.9 p -73.48 -11.4 60.44 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 130.038 3.335 . . . . 0.0 113.263 -175.587 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.92 54.08 0.32 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 126.992 2.234 . . . . 0.0 113.973 168.872 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -141.27 143.93 34.38 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 121.372 2.586 . . . . 0.0 111.052 166.355 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -123.97 117.07 23.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 167.323 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.9 mm -80.74 118.23 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 160.779 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -92.36 128.39 38.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 164.368 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -125.07 140.32 53.0 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.066 -2.271 . . . . 0.0 107.327 178.488 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -92.75 131.36 37.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 126.898 2.624 . . . . 0.0 110.905 162.112 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.5 m -134.97 160.02 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 127.522 2.329 . . . . 0.0 111.153 179.25 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.281 20.5 mm-40 -76.18 149.34 82.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 115.778 -2.058 . . . . 0.0 111.869 156.465 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -24.56 72.26 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 CA-C-N 123.915 2.434 . . . . 0.0 114.796 176.418 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -101.61 20.85 15.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.871 2.868 . . . . 0.0 112.354 177.617 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.48 ' CG ' HD21 ' A' ' 25' ' ' ASN 0.27 11.2 t0 -82.92 155.35 24.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 118.117 -2.864 . . . . 0.0 110.699 169.142 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 p -81.01 152.74 27.79 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.966 -169.744 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.9 mm -67.11 -12.68 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 120.483 -1.386 . . . . 0.0 111.2 167.843 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -71.22 -45.89 62.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 120.725 -1.234 . . . . 0.0 111.374 169.398 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.48 HD21 ' CG ' ' A' ' 21' ' ' ASP . 18.9 t30 -53.17 -34.05 55.21 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 175.403 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.95 -40.57 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 117.827 -1.083 . . . . 0.0 108.543 179.242 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -70.63 -37.87 73.83 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 121.867 2.121 . . . . 0.0 111.12 -179.91 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.52 87.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 115.265 -2.303 . . . . 0.0 111.814 178.153 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.372 54.6 mttm -76.83 -31.21 56.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.472 1.509 . . . . 0.0 113.056 172.925 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mt -70.77 -37.89 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 1 O-C-N 115.737 -4.352 . . . . 0.0 109.292 174.117 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -54.56 -37.8 65.88 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 122.759 2.527 . . . . 0.0 117.744 160.572 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.44 -39.75 94.42 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.16 -2.291 . . . . 0.0 115.416 -179.95 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -86.68 -69.11 0.7 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.38 2.272 . . . . 0.0 107.157 -174.225 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -83.42 -15.82 48.24 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 125.945 2.028 . . . . 0.0 114.341 -161.554 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.25 8.62 68.3 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 117.276 -3.39 . . . . 0.0 115.8 175.708 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 pt -99.8 123.61 46.94 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-O 113.426 -3.178 . . . . 0.0 112.455 -168.844 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.72 137.27 71.99 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 127.587 3.745 . . . . 0.0 110.968 -179.136 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -64.78 -8.91 19.1 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.801 2.334 . . . . 0.0 113.608 177.683 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -75.73 -12.5 60.2 Favored 'General case' 0 N--CA 1.452 -0.341 1 CA-C-N 127.09 4.495 . . . . 0.0 109.086 172.246 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -87.99 -22.02 24.5 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 127.661 2.384 . . . . 0.0 112.909 -178.85 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -95.81 131.47 42.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 130.717 3.607 . . . . 0.0 103.232 -165.234 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.287 17.1 mtp180 -126.46 111.01 13.93 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.915 2.086 . . . . 0.0 108.432 170.993 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -94.4 133.16 38.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 117.205 -3.434 . . . . 0.0 114.698 -172.652 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 tt -144.37 136.74 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 128.768 2.827 . . . . 0.0 110.254 -155.288 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -140.79 138.23 33.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.631 1.832 . . . . 0.0 112.24 172.832 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.59 35.01 7.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.049 2.939 . . . . 0.0 115.276 170.184 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.42 -23.88 31.71 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.875 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -103.07 125.11 49.65 Favored 'General case' 0 C--N 1.324 -0.52 1 O-C-N 115.655 -4.438 . . . . 0.0 109.026 -160.849 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -85.04 126.65 33.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 127.291 2.87 . . . . 0.0 105.644 174.929 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -96.25 128.05 42.81 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 125.565 1.791 . . . . 0.0 109.463 -163.062 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -72.46 130.23 40.2 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -178.29 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -62.12 123.57 18.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 129.797 3.239 . . . . 0.0 112.299 -173.362 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.97 -6.06 51.05 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 112.117 -2.31 . . . . 0.0 114.807 173.239 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -72.77 163.81 27.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.25 1.025 . . . . 0.0 112.539 167.003 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -99.43 154.09 18.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 123.848 1.785 . . . . 0.0 114.433 174.311 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.375 11.5 mt -53.99 -48.87 69.95 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 116.775 -3.703 . . . . 0.0 110.53 -173.953 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.279 33.0 t -57.62 -47.07 83.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.782 2.033 . . . . 0.0 110.401 -177.719 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -70.37 -22.59 62.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.141 0.976 . . . . 0.0 110.733 -169.976 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.29 -3.09 54.17 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 131.131 3.772 . . . . 0.0 113.631 170.06 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.443 11.8 m120 80.94 21.86 0.38 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 130.191 3.396 . . . . 0.0 116.314 173.695 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.9 mt -83.07 112.73 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 117.02 -3.55 . . . . 0.0 106.949 171.757 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.84 178.57 5.73 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.563 2.745 . . . . 0.0 112.646 -178.692 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -54.63 137.13 44.44 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.929 1.292 . . . . 0.0 111.995 171.048 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 69.12 23.1 6.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 131.694 3.998 . . . . 0.0 112.521 175.575 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.3 m -82.63 138.14 34.28 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 117.332 -3.355 . . . . 0.0 105.804 -169.38 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.74 133.36 42.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.469 -179.664 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.3 0.0 OUTLIER -149.77 -155.54 0.64 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.556 1.071 . . . . 0.0 110.538 172.603 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -158.17 170.21 22.79 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -168.912 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.2 tp -129.32 144.81 51.37 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 128.541 3.65 . . . . 0.0 105.059 -178.173 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -119.58 124.39 72.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 127.961 3.288 . . . . 0.0 109.691 168.591 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 mt . . . . . 0 C--N 1.322 -0.59 0 C-N-CA 126.8 2.04 . . . . 0.0 108.506 172.209 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.1 ttp . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 113.298 -3.239 . . . . 0.0 107.17 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.18 133.04 52.99 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 126.357 2.285 . . . . 0.0 114.266 170.552 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.54 -176.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 119.162 -2.211 . . . . 0.0 109.083 159.109 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -135.38 162.93 31.22 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.107 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 t -134.57 112.44 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 130.023 3.329 . . . . 0.0 106.228 -176.319 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -94.98 120.97 36.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 171.186 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -67.82 167.18 13.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 112.65 -2.068 . . . . 0.0 110.816 172.645 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.572 HD22 ' H ' ' A' ' 71' ' ' LEU . 4.3 mp -64.57 -35.42 80.92 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 119.297 -2.127 . . . . 0.0 113.76 176.891 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.319 17.7 p -67.73 -51.14 52.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.433 2.293 . . . . 0.0 109.383 173.544 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.89 31.15 0.6 Allowed Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.333 -1.26 . . . . 0.0 115.364 174.7 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -86.21 131.51 34.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 122.736 3.268 . . . . 0.0 109.929 160.883 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -105.1 85.47 2.28 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.104 1.361 . . . . 0.0 108.862 -175.458 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.275 3.9 mt -87.48 141.13 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 -174.216 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 m -74.63 143.4 44.35 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 169.987 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -125.52 127.76 46.93 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 118.057 -2.902 . . . . 0.0 104.636 -175.089 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -80.86 115.05 20.15 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 130.974 3.71 . . . . 0.0 107.829 172.465 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.9 172.77 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.669 1.188 . . . . 0.0 108.58 -176.446 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.407 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 70.3 mm-40 -133.05 148.7 70.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 131.5 3.92 . . . . 0.0 113.75 148.895 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.32 93.5 Cg_endo -51.03 -15.78 2.17 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 O-C-N 124.904 2.002 . . . . 0.0 116.324 -177.444 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -92.4 -1.82 56.75 Favored 'General case' 0 N--CA 1.452 -0.336 1 O-C-N 115.539 -4.476 . . . . 0.0 115.599 174.327 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.407 ' OD2' ' N ' ' A' ' 18' ' ' GLU 0.253 72.0 m-20 -81.05 131.18 35.29 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.176 -1.41 . . . . 0.0 111.451 177.176 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -69.51 160.33 31.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.838 0.855 . . . . 0.0 111.044 179.664 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mm -61.08 -34.74 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 129.036 2.934 . . . . 0.0 106.766 175.99 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.81 -58.98 5.53 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 127.969 2.508 . . . . 0.0 111.499 175.224 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -51.77 -45.93 63.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.712 2.508 . . . . 0.0 113.931 169.367 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.58 -48.07 88.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 O-C-N 124.988 1.43 . . . . 0.0 112.838 174.644 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt -57.43 -35.6 70.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.858 -3.026 . . . . 0.0 113.678 170.282 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.57 81.29 Favored 'General case' 0 N--CA 1.452 -0.355 1 CA-C-O 111.302 -4.19 . . . . 0.0 109.976 174.433 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -67.59 -29.76 69.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 124.042 3.11 . . . . 0.0 111.568 -179.834 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 mt -81.48 -16.21 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 126.928 2.091 . . . . 0.0 110.912 -175.67 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -70.01 -49.0 55.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 117.52 -3.238 . . . . 0.0 115.488 156.525 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -49.17 -61.29 2.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.573 1.949 . . . . 0.0 115.785 170.374 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -63.23 -46.27 87.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 130.388 3.475 . . . . 0.0 114.758 -177.189 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -138.87 -21.82 0.97 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.079 1.752 . . . . 0.0 111.019 -154.99 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.99 1.34 54.96 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 122.091 2.223 . . . . 0.0 109.458 166.972 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -81.55 117.27 67.55 Favored Pre-proline 0 N--CA 1.445 -0.675 0 O-C-N 117.163 -3.551 . . . . 0.0 103.909 179.887 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -74.13 164.29 34.67 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.433 2.089 . . . . 0.0 112.0 -172.023 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.252 37.9 Cg_endo -73.67 -37.94 2.73 Favored 'Trans proline' 0 N--CA 1.446 -1.309 1 C-N-CA 126.275 4.65 . . . . 0.0 109.835 -177.401 . . . . . . . . 3 2 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -80.12 143.75 33.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.501 2.321 . . . . 0.0 108.873 170.518 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 90.05 -31.04 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.206 1.002 . . . . 0.0 109.247 179.304 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -91.1 141.63 28.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.07 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -119.95 129.69 54.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 128.134 2.573 . . . . 0.0 110.989 172.243 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.1 mt -99.24 151.09 21.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 117.656 -3.152 . . . . 0.0 111.341 164.854 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mt -127.11 156.2 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 170.302 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -126.07 136.97 53.56 Favored 'General case' 0 N--CA 1.447 -0.625 1 C-N-CA 133.836 4.855 . . . . 0.0 108.789 157.043 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.49 -100.49 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 128.904 3.877 . . . . 0.0 108.776 179.021 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.37 -2.07 3.38 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 105.704 -2.958 . . . . 0.0 105.704 168.691 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -79.93 114.98 19.26 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 118.208 -2.936 . . . . 0.0 105.134 -173.348 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -64.93 126.36 27.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 122.982 1.372 . . . . 0.0 109.08 159.907 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.9 mt -90.79 141.8 28.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 124.167 1.937 . . . . 0.0 109.846 177.152 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -91.74 143.59 26.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.975 2.51 . . . . 0.0 109.342 170.75 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -49.51 -44.05 45.97 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 129.732 3.213 . . . . 0.0 112.836 -172.619 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.21 4.25 40.99 Favored Glycine 0 CA--C 1.531 1.062 1 O-C-N 115.423 -4.548 . . . . 0.0 112.788 -163.837 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -76.84 160.17 29.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 120.176 1.988 . . . . 0.0 112.103 164.096 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -97.93 162.35 13.29 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 127.174 2.796 . . . . 0.0 104.811 175.007 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.7 mt -42.5 -42.9 3.47 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.651 1.98 . . . . 0.0 109.721 157.736 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.3 t -69.02 -28.14 66.3 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 127.455 2.302 . . . . 0.0 110.035 -169.989 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -75.9 -9.07 58.3 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 175.127 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -118.9 11.74 12.65 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.416 1.886 . . . . 0.0 114.052 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.91 29.02 18.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.808 2.043 . . . . 0.0 115.679 179.9 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.2 mt -96.33 105.04 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 124.25 1.976 . . . . 0.0 108.541 -170.077 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -89.43 178.55 6.29 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 120.01 -1.681 . . . . 0.0 113.074 163.482 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -60.46 161.45 7.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 129.936 3.295 . . . . 0.0 115.999 -167.426 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 74.96 2.89 4.09 Favored 'General case' 0 N--CA 1.443 -0.815 1 C-N-CA 133.559 4.743 . . . . 0.0 112.946 175.931 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -71.31 132.46 44.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.149 1.78 . . . . 0.0 113.232 -177.093 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 p -97.95 113.0 24.72 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 125.443 1.714 . . . . 0.0 108.343 -176.74 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.82 156.2 20.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.967 1.307 . . . . 0.0 110.66 173.193 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -127.19 119.72 27.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 124.389 2.043 . . . . 0.0 106.166 -174.581 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tt -91.2 120.31 32.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.518 3.127 . . . . 0.0 103.871 -174.728 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.32 131.02 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 112.302 -2.227 . . . . 0.0 106.371 170.459 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.572 ' H ' HD22 ' A' ' 8' ' ' LEU . 12.3 mt . . . . . 0 C--N 1.329 -0.287 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 175.181 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 116.482 -1.723 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -65.77 132.38 48.6 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 125.01 1.444 . . . . 0.0 113.14 -171.487 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 pt -135.56 171.34 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 O-C-N 118.876 -2.39 . . . . 0.0 109.144 174.282 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -114.29 126.06 54.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 126.073 2.108 . . . . 0.0 109.156 170.848 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -110.26 147.61 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 163.777 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.274 62.4 tttt -126.6 125.02 41.24 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 131.439 3.896 . . . . 0.0 113.849 -174.286 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -102.74 162.79 12.64 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.81 1.644 . . . . 0.0 108.589 -173.599 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.754 HD11 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -77.83 -16.16 58.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 129.756 3.222 . . . . 0.0 116.891 -167.598 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 p -83.81 -0.9 52.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 164.035 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.3 27.4 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 127.432 2.444 . . . . 0.0 111.609 171.097 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -67.62 136.2 54.05 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 123.377 3.588 . . . . 0.0 115.935 -173.55 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 m -113.57 147.89 37.16 Favored 'General case' 0 C--N 1.325 -0.462 1 CA-C-O 129.069 4.271 . . . . 0.0 104.029 174.829 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.276 19.2 pt -127.64 114.8 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 109.367 -3.561 . . . . 0.0 110.102 178.451 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.4 p -84.94 108.84 17.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 101.807 -3.405 . . . . 0.0 101.807 177.283 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 pp -139.78 154.52 47.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 123.409 1.576 . . . . 0.0 111.28 170.011 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -84.47 133.57 34.47 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.518 2.327 . . . . 0.0 112.467 177.958 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.16 -153.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 168.399 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -151.08 158.83 34.5 Favored Pre-proline 0 N--CA 1.443 -0.794 0 C-N-CA 127.418 2.287 . . . . 0.0 106.556 -173.002 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.81 -32.91 35.69 Favored 'Trans proline' 0 N--CA 1.445 -1.333 1 C-N-CA 126.298 4.665 . . . . 0.0 115.951 174.871 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -99.11 3.99 46.8 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.885 2.874 . . . . 0.0 112.124 -171.981 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.64 145.73 29.5 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 121.311 1.869 . . . . 0.0 110.761 -179.081 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.7 p -85.6 162.68 18.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.577 2.351 . . . . 0.0 111.034 169.295 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.334 81.2 mt -53.16 -44.03 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 O-C-N 127.253 2.845 . . . . 0.0 115.871 178.501 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -49.67 -36.11 23.86 Favored 'General case' 0 C--N 1.33 -0.275 1 C-N-CA 132.255 4.222 . . . . 0.0 115.003 166.974 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -82.92 -11.97 57.73 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 126.462 1.905 . . . . 0.0 114.275 176.407 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -98.79 -41.07 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.006 1.322 . . . . 0.0 111.392 174.648 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -53.68 -45.01 70.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 128.991 2.916 . . . . 0.0 109.56 173.793 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.79 89.19 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 126.428 3.014 . . . . 0.0 111.78 -175.845 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -60.14 -44.33 95.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 131.629 3.972 . . . . 0.0 112.8 177.171 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.12 -37.56 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 179.764 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -65.35 -38.95 91.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 124.171 3.169 . . . . 0.0 112.919 179.43 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -59.53 -26.3 65.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 112.923 -3.418 . . . . 0.0 115.017 171.241 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -115.18 -28.18 7.03 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 122.117 2.235 . . . . 0.0 111.255 -163.191 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -126.06 -19.28 4.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.719 2.408 . . . . 0.0 114.605 -177.215 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.91 16.34 61.46 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 115.909 -2.606 . . . . 0.0 114.362 178.94 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.6 mt -87.73 123.7 68.75 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 123.066 3.433 . . . . 0.0 109.469 -163.213 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -73.31 127.63 12.09 Favored 'Trans proline' 0 N--CA 1.453 -0.901 1 O-C-N 128.871 4.09 . . . . 0.0 111.334 -176.523 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.36 -19.05 6.79 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.16 2.573 . . . . 0.0 115.047 -157.249 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.85 -28.28 65.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 115.829 -2.034 . . . . 0.0 110.858 176.604 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.77 9.39 16.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 127.77 3.169 . . . . 0.0 107.453 -164.577 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -110.9 142.34 43.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 123.394 1.569 . . . . 0.0 109.476 -170.403 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -126.67 122.36 34.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 130.593 3.557 . . . . 0.0 109.786 162.35 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.8 mt -110.05 115.59 30.04 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.643 3.177 . . . . 0.0 107.074 -168.399 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.88 129.35 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 127.823 2.449 . . . . 0.0 115.123 -178.653 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.257 63.8 t80 -143.41 128.68 18.82 Favored 'General case' 0 C--N 1.327 -0.394 1 O-C-N 114.484 -5.135 . . . . 0.0 110.428 168.945 . . . . . . . . 3 2 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.1 38.5 24.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 165.457 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.53 -11.39 7.99 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 116.762 -2.132 . . . . 0.0 115.016 164.069 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -149.47 170.98 17.33 Favored 'General case' 0 C--N 1.324 -0.513 1 C-N-CA 131.865 4.066 . . . . 0.0 114.466 -176.119 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.61 132.73 45.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 128.91 2.884 . . . . 0.0 107.498 154.275 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 tp -66.75 138.44 57.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 112.067 -2.333 . . . . 0.0 106.394 165.787 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -51.13 145.92 7.13 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.438 1.895 . . . . 0.0 110.659 163.192 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -103.02 109.49 21.05 Favored 'General case' 0 N--CA 1.448 -0.568 1 N-CA-C 96.562 -5.347 . . . . 0.0 96.562 170.504 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.62 35.07 1.94 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.783 2.611 . . . . 0.0 116.694 178.707 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -133.09 132.74 42.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 115.927 -1.987 . . . . 0.0 110.043 171.014 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.0 p -75.67 150.57 37.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 125.154 2.406 . . . . 0.0 113.351 168.165 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -56.74 -35.68 68.87 Favored 'General case' 0 N--CA 1.441 -0.907 1 O-C-N 115.774 -4.329 . . . . 0.0 118.005 -159.428 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -75.85 -4.93 43.5 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 129.946 3.298 . . . . 0.0 112.628 176.64 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -77.11 -11.0 59.75 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 120.948 1.704 . . . . 0.0 111.758 169.774 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -113.09 159.12 19.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 129.296 3.038 . . . . 0.0 105.04 168.134 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -80.5 55.36 2.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.61 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -73.1 104.97 2.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 159.51 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.265 71.1 mm-40 -96.37 169.8 9.68 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 125.604 1.815 . . . . 0.0 114.35 170.49 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -46.84 130.88 12.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 119.946 -1.721 . . . . 0.0 112.372 166.251 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.31 8.1 mt-10 77.54 18.85 1.28 Allowed 'General case' 0 N--CA 1.451 -0.383 1 C-N-CA 133.484 4.714 . . . . 0.0 112.185 170.417 . . . . . . . . 3 2 . 1 . 048 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -74.26 148.03 41.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.958 179.165 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.9 m -95.9 104.44 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 102.183 -3.265 . . . . 0.0 102.183 -168.22 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.2 143.69 27.17 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.314 2.646 . . . . 0.0 108.057 166.944 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -124.29 136.65 54.29 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -174.878 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.93 121.59 45.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.908 2.083 . . . . 0.0 105.41 178.863 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 t -108.15 146.97 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.487 2.315 . . . . 0.0 106.443 170.984 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 tp . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 -175.11 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 122.407 1.098 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -79.12 135.24 36.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.528 -2.124 . . . . 0.0 110.517 -178.999 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -128.46 172.7 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.964 2.905 . . . . 0.0 109.709 173.636 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -116.79 153.37 32.55 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.363 2.665 . . . . 0.0 108.32 173.228 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.508 9.1 p -133.36 133.88 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 C-N-CA 129.045 2.938 . . . . 0.0 107.454 177.863 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -88.0 118.81 27.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 156.458 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -64.79 162.54 15.87 Favored 'General case' 0 C--N 1.324 -0.542 1 C-N-CA 132.924 4.49 . . . . 0.0 107.788 167.545 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.98 -11.56 60.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 123.749 1.738 . . . . 0.0 114.248 -173.141 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -91.99 -14.69 29.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.288 1.435 . . . . 0.0 111.575 173.753 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.62 -2.3 15.55 Favored Glycine 0 CA--C 1.535 1.31 1 O-C-N 113.447 -5.783 . . . . 0.0 111.491 165.994 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -88.27 134.39 33.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.744 2.418 . . . . 0.0 108.611 -172.682 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.09 146.91 52.25 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.34 166.083 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.533 57.2 mt -125.81 130.77 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 O-C-N 126.595 2.434 . . . . 0.0 109.223 152.901 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 90.8 m -83.73 130.57 34.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 171.845 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.1 tp -135.77 142.35 44.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 115.912 -1.994 . . . . 0.0 113.95 -174.42 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -94.28 128.23 40.63 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 131.211 3.804 . . . . 0.0 106.904 175.244 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -139.52 144.22 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 O-C-N 120.089 -1.632 . . . . 0.0 111.902 172.362 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.452 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -76.56 148.74 80.35 Favored Pre-proline 0 N--CA 1.447 -0.601 0 C-N-CA 126.305 1.842 . . . . 0.0 109.583 173.217 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.52 -41.82 18.61 Favored 'Trans proline' 0 N--CA 1.447 -1.215 1 C-N-CA 128.543 6.162 . . . . 0.0 109.731 159.057 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.9 p -66.54 -5.91 13.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.566 2.746 . . . . 0.0 117.898 170.668 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.452 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 3.0 t0 -88.61 145.94 25.4 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 117.434 -3.291 . . . . 0.0 105.097 -175.841 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -98.67 145.56 26.76 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.628 2.371 . . . . 0.0 115.901 -177.625 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.331 44.6 mm -42.0 -49.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 -176.575 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -75.87 -31.34 59.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 126.456 3.027 . . . . 0.0 114.306 -175.997 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.68 -35.37 65.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 116.499 -3.876 . . . . 0.0 113.085 172.637 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.0 t -72.21 -36.07 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 1 CA-C-O 111.127 -4.273 . . . . 0.0 112.252 169.817 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -61.47 -29.06 69.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 124.184 3.175 . . . . 0.0 114.39 162.68 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.334 . . -68.61 -31.21 70.22 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 126.77 2.544 . . . . 0.0 110.526 175.249 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -74.25 -19.32 60.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 122.458 2.39 . . . . 0.0 114.573 174.322 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.4 mm -76.71 -27.89 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 125.767 1.627 . . . . 0.0 114.047 161.629 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -63.28 -37.82 88.73 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -176.378 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.34 -53.9 3.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.477 1.511 . . . . 0.0 113.495 166.273 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -91.04 -46.32 8.2 Favored 'General case' 0 N--CA 1.45 -0.449 1 O-C-N 129.138 4.024 . . . . 0.0 107.038 -159.482 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -96.11 -32.63 12.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 119.092 -2.255 . . . . 0.0 113.503 -172.754 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.13 -31.33 8.67 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 116.857 -2.08 . . . . 0.0 108.654 175.264 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.271 8.3 mm -47.98 116.76 4.97 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 175.38 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.8 152.2 81.7 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 CA-C-N 124.032 2.476 . . . . 0.0 108.223 176.784 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.67 -36.61 72.87 Favored 'Trans proline' 0 N--CA 1.453 -0.864 1 C-N-CA 128.596 6.197 . . . . 0.0 116.023 175.274 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.18 -17.59 58.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.831 2.852 . . . . 0.0 113.938 177.804 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.265 9.3 mm-40 -91.64 -9.72 42.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 115.641 -2.123 . . . . 0.0 112.722 166.539 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -108.81 130.13 55.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -167.244 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -118.2 -176.18 3.01 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 119.863 -1.773 . . . . 0.0 109.242 156.365 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.87 123.63 3.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 177.216 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mm -108.86 122.4 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 -176.917 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -138.66 108.39 6.26 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.434 3.894 . . . . 0.0 109.434 -167.407 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.07 27.2 7.05 Favored 'General case' 0 N--CA 1.443 -0.821 1 C-N-CA 131.743 4.017 . . . . 0.0 115.972 177.665 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.37 17.13 20.79 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 106.448 -2.661 . . . . 0.0 106.448 170.05 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.302 65.6 pttt -150.71 159.46 44.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.911 2.084 . . . . 0.0 115.687 -171.698 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -79.62 148.2 31.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 131.344 3.858 . . . . 0.0 116.711 162.593 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.9 mt -100.24 118.45 36.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 128.354 3.534 . . . . 0.0 101.728 174.237 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.283 7.8 tp10 -87.3 157.15 19.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.226 -0.921 . . . . 0.0 109.052 -175.621 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.07 155.31 39.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.984 2.114 . . . . 0.0 110.675 -177.626 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.11 -14.38 57.48 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.991 175.229 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -90.65 149.34 22.13 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -176.342 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.8 p -79.19 174.29 11.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 117.326 -3.359 . . . . 0.0 109.154 167.135 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mp -76.61 -22.88 53.58 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 117.039 -3.538 . . . . 0.0 112.587 174.309 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 t -70.26 -29.14 65.85 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 127.517 2.327 . . . . 0.0 112.689 171.321 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.47 -32.32 73.86 Favored 'General case' 0 C--N 1.322 -0.6 1 O-C-N 115.843 -4.286 . . . . 0.0 111.934 173.174 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.86 6.21 21.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 119.841 -1.787 . . . . 0.0 106.738 -169.687 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.361 1.6 p-10 57.21 41.44 26.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 124.701 2.191 . . . . 0.0 113.878 167.838 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 mt -90.56 122.38 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 129.991 3.316 . . . . 0.0 106.241 -176.599 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.287 21.3 mm-40 -115.27 -176.6 2.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 130.537 3.535 . . . . 0.0 116.22 176.242 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -51.42 161.88 0.41 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 123.277 2.762 . . . . 0.0 116.065 159.83 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 85.16 1.37 0.74 Allowed 'General case' 0 C--N 1.325 -0.496 1 C-N-CA 133.301 4.64 . . . . 0.0 111.214 171.136 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -82.04 107.46 14.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 -177.373 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -84.37 110.66 18.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.553 2.341 . . . . 0.0 111.279 157.158 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.1 mt -76.46 162.67 27.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.118 -1.614 . . . . 0.0 115.16 170.019 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -119.94 147.56 44.6 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.961 2.104 . . . . 0.0 110.369 150.687 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.68 149.4 21.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 129.104 2.962 . . . . 0.0 111.947 171.317 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -133.74 155.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 O-C-N 117.839 -3.038 . . . . 0.0 115.452 168.722 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.5 mt . . . . . 0 N--CA 1.452 -0.365 0 CA-C-N 122.633 2.47 . . . . 0.0 105.712 -170.923 . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 ttp . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 100.425 -3.917 . . . . 0.0 100.425 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -72.14 137.46 47.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 111.648 -2.524 . . . . 0.0 110.999 -175.108 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.305 10.9 pt -141.17 170.74 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 O-C-N 125.678 1.861 . . . . 0.0 111.268 173.106 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -122.37 138.95 54.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 107.132 177.428 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.64 117.66 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 101.875 -3.38 . . . . 0.0 101.875 173.298 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -78.87 135.38 37.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 125.327 2.489 . . . . 0.0 112.838 165.395 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 p -80.16 -169.43 2.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 118.746 -2.471 . . . . 0.0 110.023 -179.398 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.5 mt -61.82 -40.41 95.2 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -165.909 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.8 p -103.04 9.01 38.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 111.338 -2.665 . . . . 0.0 112.739 -176.266 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.64 -0.73 59.67 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 128.655 3.026 . . . . 0.0 117.841 170.469 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -73.4 129.29 37.69 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 119.949 1.874 . . . . 0.0 110.771 177.199 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 t -81.04 136.37 35.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.785 2.034 . . . . 0.0 113.72 -177.945 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 pt -114.15 120.14 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 102.671 -3.085 . . . . 0.0 102.671 168.681 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.8 m -86.66 112.88 22.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.04 2.536 . . . . 0.0 108.86 -179.836 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.83 170.07 8.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.153 2.981 . . . . 0.0 104.346 -170.698 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.484 1.1 pm0 -132.79 124.39 27.94 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 131.297 3.839 . . . . 0.0 118.965 162.99 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.334 0.0 OUTLIER -143.85 154.14 15.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 113.909 -1.496 . . . . 0.0 113.898 -175.345 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -88.97 151.08 46.63 Favored Pre-proline 0 N--CA 1.452 -0.367 0 O-C-N 119.67 -1.894 . . . . 0.0 108.828 176.919 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.29 -30.09 10.54 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 124.907 3.738 . . . . 0.0 117.53 165.835 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.303 16.8 p -96.99 12.84 31.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 129.201 3.001 . . . . 0.0 112.714 170.799 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.81 142.35 31.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 123.421 2.828 . . . . 0.0 108.104 167.513 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -81.8 177.9 8.62 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 131.565 3.946 . . . . 0.0 111.285 -177.573 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -89.21 -18.96 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 O-C-N 116.575 -3.828 . . . . 0.0 111.321 -170.803 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.76 -37.66 74.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.102 157.432 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -85.11 5.26 30.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 123.71 1.719 . . . . 0.0 110.425 -172.616 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.25 -37.41 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 O-C-N 118.08 -2.887 . . . . 0.0 110.06 156.475 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -56.78 -52.65 64.21 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 116.571 -3.831 . . . . 0.0 110.083 174.846 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.3 46.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 118.086 2.625 . . . . 0.0 118.086 179.502 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -83.18 -26.54 30.77 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 111.553 -2.567 . . . . 0.0 116.126 178.443 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.0 mt -68.38 -38.96 80.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 115.758 -2.067 . . . . 0.0 108.838 160.666 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.15 -34.19 77.51 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 117.832 -1.08 . . . . 0.0 109.921 174.457 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.44 -34.67 77.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -179.091 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -102.24 -25.21 13.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 127.651 3.094 . . . . 0.0 117.937 -176.713 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -141.15 -16.24 0.85 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.627 2.371 . . . . 0.0 112.352 -171.599 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.06 -3.89 67.31 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 120.217 -1.552 . . . . 0.0 113.699 152.157 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.3 mt -73.3 132.65 81.65 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 114.055 -2.879 . . . . 0.0 106.037 -176.953 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.6 132.56 22.21 Favored 'Trans proline' 0 N--CA 1.454 -0.81 1 C-N-CA 127.118 5.212 . . . . 0.0 106.856 -171.274 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -40.2 -30.68 0.46 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 1 C-N-CA 130.445 7.43 . . . . 0.0 119.604 177.503 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.76 -39.07 84.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.448 2.299 . . . . 0.0 113.725 175.744 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.32 -16.15 55.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 115.248 -2.311 . . . . 0.0 112.64 -175.707 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.46 130.89 35.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.76 2.824 . . . . 0.0 111.638 -172.696 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -121.47 131.93 54.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 103.354 -2.832 . . . . 0.0 103.354 168.688 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 mt -103.0 137.82 40.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 119.914 1.234 . . . . 0.0 110.488 166.649 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mm -122.61 148.66 26.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 129.925 3.29 . . . . 0.0 107.862 177.341 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -153.88 127.58 8.75 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.177 1.791 . . . . 0.0 110.038 173.919 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.37 40.39 10.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.048 2.139 . . . . 0.0 115.08 -172.536 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.64 -13.08 68.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 117.638 1.815 . . . . 0.0 117.638 177.559 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.399 55.3 pttt -123.78 148.34 46.75 Favored 'General case' 0 C--N 1.326 -0.437 1 C-N-CA 133.353 4.661 . . . . 0.0 108.212 -161.691 . . . . . . . . 3 2 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -71.3 155.33 40.8 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 118.388 -2.695 . . . . 0.0 109.245 -169.277 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -136.23 114.08 11.2 Favored 'General case' 0 N--CA 1.451 -0.388 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 177.885 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -123.31 155.49 37.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 126.335 2.969 . . . . 0.0 111.895 -169.186 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.26 145.28 55.34 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.013 -2.929 . . . . 0.0 108.668 -178.246 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.07 -6.7 19.43 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 127.148 2.78 . . . . 0.0 113.977 -173.756 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -135.35 -175.56 3.98 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.414 1.486 . . . . 0.0 113.032 -179.509 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.6 p -128.39 175.17 8.71 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.288 1.035 . . . . 0.0 109.787 -178.856 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -55.05 -36.44 65.56 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.532 1.933 . . . . 0.0 113.703 171.423 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.328 13.0 m -75.6 -25.61 57.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 115.622 -2.431 . . . . 0.0 113.6 177.159 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -70.46 -41.61 72.54 Favored 'General case' 0 N--CA 1.45 -0.451 2 CA-C-N 126.516 4.235 . . . . 0.0 112.817 173.196 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -82.09 -12.63 58.12 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 124.742 1.276 . . . . 0.0 110.8 -176.212 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.5 m120 72.76 58.91 0.12 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.554 3.542 . . . . 0.0 114.984 175.836 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -100.69 159.05 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 112.504 -2.134 . . . . 0.0 109.814 -177.933 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -130.52 -151.73 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.684 1.194 . . . . 0.0 112.188 -176.614 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -90.34 144.64 25.64 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.427 2.291 . . . . 0.0 107.444 175.874 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 77.01 19.75 1.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 125.213 2.435 . . . . 0.0 111.073 161.895 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.7 m -87.78 133.42 33.87 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.97 2.508 . . . . 0.0 115.278 -178.025 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.1 m -111.93 125.36 53.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 123.608 2.913 . . . . 0.0 104.24 -170.787 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mt -103.05 166.32 10.51 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.313 2.245 . . . . 0.0 111.281 173.518 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -109.43 134.01 52.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 118.669 -2.52 . . . . 0.0 105.282 164.99 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 1.5 tm? -90.01 140.22 29.85 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.088 1.355 . . . . 0.0 109.696 154.033 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.92 156.22 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 128.869 2.868 . . . . 0.0 111.616 164.012 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 125.908 1.683 . . . . 0.0 108.812 171.529 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 123.732 1.729 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 051 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -103.4 120.45 40.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 119.613 -1.93 . . . . 0.0 107.175 178.3 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -121.92 131.22 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.056 170.42 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -86.86 81.44 8.15 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.629 2.372 . . . . 0.0 109.166 -174.358 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -65.41 132.54 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 125.981 1.713 . . . . 0.0 108.682 169.246 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -123.24 152.78 40.97 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 119.972 -1.705 . . . . 0.0 109.562 172.923 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -117.73 -177.44 3.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 126.478 3.037 . . . . 0.0 109.585 -165.296 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.68 -42.4 34.71 Favored 'General case' 0 N--CA 1.446 -0.656 1 O-C-N 115.899 -4.251 . . . . 0.0 104.669 174.38 . . . . . . . . 3 3 . 1 . 051 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -69.89 -19.08 63.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 123.22 2.736 . . . . 0.0 112.772 -176.316 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.38 32.16 2.62 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.044 0.83 . . . . 0.0 113.112 156.982 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -110.68 146.27 36.52 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 114.22 -2.8 . . . . 0.0 110.088 -167.113 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.261 43.1 m -99.57 89.71 4.24 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 173.802 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mm -52.47 -57.93 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 120.757 1.617 . . . . 0.0 112.209 -173.848 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.317 75.5 m 79.3 81.91 0.06 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -178.675 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 tp -99.15 138.65 35.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 124.984 2.326 . . . . 0.0 106.61 -178.877 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -91.35 121.52 33.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.223 -1.548 . . . . 0.0 107.916 170.896 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.401 4.8 t -121.56 152.24 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 103.831 -2.655 . . . . 0.0 103.831 -175.547 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -104.36 136.0 19.25 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-O 114.624 -2.608 . . . . 0.0 109.384 170.909 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -57.7 -18.09 31.94 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 N-CA-C 118.609 2.503 . . . . 0.0 118.609 -174.773 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.7 p -74.08 -15.07 61.07 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.655 2.382 . . . . 0.0 114.427 168.93 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -66.39 129.01 38.39 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 122.72 2.509 . . . . 0.0 110.698 -176.026 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.6 p -85.37 174.67 9.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.971 1.714 . . . . 0.0 108.389 163.243 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.255 27.4 mm -46.7 -39.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 128.707 2.803 . . . . 0.0 115.899 176.592 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -59.02 -43.27 91.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 115.716 -2.088 . . . . 0.0 111.058 174.996 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -73.23 -36.06 66.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 127.476 2.31 . . . . 0.0 109.561 -172.513 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.29 -55.13 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 124.467 1.107 . . . . 0.0 110.512 172.989 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.263 78.7 mttt -43.5 -44.47 6.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.239 2.216 . . . . 0.0 113.512 169.718 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.22 -53.26 59.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.298 2.239 . . . . 0.0 110.097 177.506 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -62.37 -33.26 74.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 179.976 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -68.02 -44.72 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 126.946 2.654 . . . . 0.0 109.873 165.878 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -46.15 91.84 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 125.368 1.667 . . . . 0.0 114.106 -178.977 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.446 27.8 t70 -34.45 -61.32 0.39 Allowed 'General case' 0 N--CA 1.448 -0.549 1 N-CA-C 124.403 4.964 . . . . 0.0 124.403 152.451 . . . . . . . . 3 2 . 1 . 051 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -95.19 -30.23 14.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 119.892 -1.755 . . . . 0.0 111.405 -156.764 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -109.25 -27.79 9.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 128.806 2.843 . . . . 0.0 110.709 -179.978 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.58 -3.15 61.0 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 121.428 3.331 . . . . 0.0 121.428 167.674 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.508 ' H ' HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -85.15 145.19 42.5 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 114.054 -2.879 . . . . 0.0 109.715 -179.88 . . . . . . . . 3 3 . 1 . 051 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.23 161.59 33.48 Favored 'Trans proline' 0 N--CA 1.45 -1.039 1 C-N-CA 126.781 4.987 . . . . 0.0 109.986 174.039 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.82 -13.07 8.28 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.724 3.616 . . . . 0.0 115.242 -171.949 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.55 -36.21 63.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 160.586 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.447 HE21 ' HB2' ' A' ' 40' ' ' GLN . 2.5 tt0 -67.78 -23.48 65.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.286 -1.34 . . . . 0.0 113.508 179.57 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -85.23 129.1 34.87 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 113.839 -2.981 . . . . 0.0 106.042 -168.484 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -110.68 160.05 17.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 155.165 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.519 0.2 OUTLIER -136.44 135.51 38.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 119.112 -2.243 . . . . 0.0 114.98 176.686 . . . . . . . . 3 3 . 1 . 051 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 mt -127.47 108.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -159.469 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -124.19 130.98 53.46 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.858 1.663 . . . . 0.0 110.369 171.787 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.09 50.54 13.96 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 130.398 3.479 . . . . 0.0 110.68 175.304 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.1 -34.3 3.99 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.841 2.162 . . . . 0.0 117.173 178.839 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -89.04 132.05 34.94 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -164.134 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.259 24.5 mt-30 -88.71 104.31 16.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 123.835 1.778 . . . . 0.0 108.949 168.373 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 50' ' ' LEU . 7.5 mt -55.86 138.35 48.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 110.426 -3.079 . . . . 0.0 113.298 -166.529 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -88.64 152.49 21.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 116.423 -1.751 . . . . 0.0 106.851 -172.121 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.59 134.76 50.46 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 114.58 -2.629 . . . . 0.0 114.885 -173.671 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.83 16.92 80.35 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 117.384 1.713 . . . . 0.0 117.384 172.614 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.0 mmm-85 -99.21 176.98 5.35 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.887 2.075 . . . . 0.0 107.583 178.448 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.5 p -100.05 141.24 33.14 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 102.371 -3.196 . . . . 0.0 102.371 -172.622 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.26 -30.81 71.32 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 127.529 2.332 . . . . 0.0 113.071 179.661 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.3 m -87.17 -22.13 25.5 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.321 -166.802 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.02 -15.89 60.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 124.864 1.352 . . . . 0.0 114.314 173.658 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -92.84 5.62 50.62 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.847 2.059 . . . . 0.0 109.299 168.135 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 75.94 21.74 1.54 Allowed 'General case' 0 N--CA 1.444 -0.765 1 C-N-CA 134.007 4.923 . . . . 0.0 118.322 170.164 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 mt -82.33 103.69 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 C-N-CA 128.144 2.578 . . . . 0.0 107.543 -169.069 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -89.5 170.44 10.5 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.059 2.143 . . . . 0.0 109.63 177.084 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -66.76 159.01 28.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 116.991 -1.48 . . . . 0.0 113.586 159.632 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 68.35 18.88 9.07 Favored 'General case' 0 N--CA 1.453 -0.318 1 C-N-CA 132.913 4.485 . . . . 0.0 111.032 179.359 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.1 t -95.94 178.39 5.44 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 128.731 3.769 . . . . 0.0 112.182 -176.433 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.2 p -131.85 133.71 44.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 125.798 1.936 . . . . 0.0 111.072 -171.971 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.19 150.91 51.94 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 126.279 2.237 . . . . 0.0 105.468 -171.704 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -108.2 119.67 40.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 117.942 -2.974 . . . . 0.0 110.953 171.663 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.3 tp -82.4 133.78 35.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 173.43 . . . . . . . . 1 1 . 1 . 051 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.291 68.7 t -108.61 141.28 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 125.149 3.613 . . . . 0.0 107.495 163.257 . . . . . . . . 2 2 . 1 . 051 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 167.113 . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 ttp . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 116.627 -1.654 . . . . 0.0 108.069 . . . . . . . . . 0 0 . 1 . 052 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -73.12 133.1 44.0 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 122.407 2.367 . . . . 0.0 115.765 176.167 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -122.3 155.3 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 115.647 -2.12 . . . . 0.0 112.551 165.084 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -102.5 128.37 49.17 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 126.046 2.091 . . . . 0.0 105.658 179.262 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -100.54 109.6 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 118.047 -2.908 . . . . 0.0 103.383 166.066 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -102.95 150.3 23.67 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.447 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.283 14.8 t -145.48 160.32 41.77 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 125.27 2.462 . . . . 0.0 109.217 158.243 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mp -67.71 -39.71 84.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 109.114 -3.675 . . . . 0.0 114.365 -161.914 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 p -52.48 -5.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 1 C-N-CA 133.435 4.694 . . . . 0.0 115.728 171.486 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.27 2.09 54.11 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 119.911 -1.743 . . . . 0.0 112.772 167.228 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -79.7 126.46 30.96 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.185 1.993 . . . . 0.0 110.096 164.308 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 m -128.2 101.96 6.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 103.244 -2.872 . . . . 0.0 103.244 171.031 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.266 2.8 mp -80.26 150.07 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 130.741 3.616 . . . . 0.0 110.457 -177.462 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 t -135.91 122.1 20.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.636 1.575 . . . . 0.0 108.241 -175.885 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -123.14 147.52 46.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.773 1.229 . . . . 0.0 113.845 175.221 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -97.43 121.23 39.09 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 131.093 3.757 . . . . 0.0 105.605 177.162 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -131.04 166.72 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 118.494 -2.629 . . . . 0.0 114.481 178.474 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -95.69 156.71 37.08 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 155.65 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.28 -20.04 69.68 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.64 2.893 . . . . 0.0 113.15 -179.891 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 13.6 p -91.78 0.33 57.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.945 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -66.33 142.85 57.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 176.562 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.33 147.49 26.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 125.216 2.436 . . . . 0.0 109.043 178.356 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.2 mt -55.75 -26.46 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 118.903 -2.373 . . . . 0.0 113.149 179.603 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.287 31.9 mt-10 -74.07 -42.66 59.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 109.422 -178.535 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.01 -50.4 70.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.513 175.499 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.1 t -55.57 -31.1 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 115.612 -2.137 . . . . 0.0 111.835 166.029 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -76.71 -17.56 59.03 Favored 'General case' 0 N--CA 1.442 -0.834 2 CA-C-N 128.092 4.951 . . . . 0.0 109.66 -177.267 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.42 -19.99 22.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.516 1.126 . . . . 0.0 113.215 172.273 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -73.76 -29.72 62.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 170.785 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.9 mt -64.79 -30.78 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 128.834 2.854 . . . . 0.0 115.148 160.309 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -65.71 -53.51 39.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.62 1.1 . . . . 0.0 111.776 173.094 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.401 22.9 t70 -36.99 -34.16 0.07 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 131.514 3.926 . . . . 0.0 112.485 168.283 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -93.78 -57.99 2.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 120.582 1.537 . . . . 0.0 115.038 171.816 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.26 -21.14 23.35 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -161.268 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.99 1.95 62.81 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 119.312 2.485 . . . . 0.0 119.312 -174.905 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.0 mt -95.86 140.87 22.49 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 128.191 2.596 . . . . 0.0 110.874 -163.234 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.59 136.53 10.98 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.765 2.977 . . . . 0.0 115.604 172.774 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -66.47 -21.21 53.62 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 124.562 3.508 . . . . 0.0 116.093 -158.047 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.31 4.78 9.91 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 117.907 -2.996 . . . . 0.0 110.94 -176.884 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -95.36 -18.96 20.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 113.172 -3.299 . . . . 0.0 109.083 168.062 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.284 13.4 mm-40 -98.0 125.05 42.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 124.678 3.399 . . . . 0.0 112.319 -160.835 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 127.5 42.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 100.635 -3.839 . . . . 0.0 100.635 -178.772 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.7 mt -101.89 134.78 44.54 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 128.683 2.793 . . . . 0.0 115.096 179.688 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -128.74 156.65 41.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 126.458 1.903 . . . . 0.0 107.209 167.753 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.368 6.7 t80 -126.61 -126.65 0.23 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 109.711 -3.404 . . . . 0.0 107.945 -157.76 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.75 44.57 1.07 Allowed 'General case' 0 C--N 1.324 -0.54 1 C-N-CA 132.243 4.217 . . . . 0.0 110.777 169.994 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.9 -22.22 34.13 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 128.328 2.87 . . . . 0.0 114.493 -177.715 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.93 126.01 34.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -171.268 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -76.21 119.86 20.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.123 0.963 . . . . 0.0 108.78 171.967 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.23 127.43 37.71 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -169.957 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.91 149.5 34.21 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 123.399 1.571 . . . . 0.0 114.872 174.005 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -64.6 126.75 28.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 129.619 3.168 . . . . 0.0 109.748 178.115 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.1 -20.08 51.59 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 116.705 -2.664 . . . . 0.0 114.847 172.279 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.32 156.35 38.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.72 1.26 . . . . 0.0 110.091 159.394 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.1 p -87.94 -179.95 6.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 119.327 -2.108 . . . . 0.0 109.152 -175.668 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.08 -22.39 52.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 116.772 -1.585 . . . . 0.0 110.443 165.618 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.2 t -64.82 -41.02 96.09 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 117.608 2.448 . . . . 0.0 117.608 168.492 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -51.88 -53.83 36.21 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.703 -178.26 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -94.67 3.33 55.2 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.697 1.999 . . . . 0.0 110.824 -171.124 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.49 1.3 p-10 64.68 28.73 13.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 118.711 2.856 . . . . 0.0 118.711 175.11 . . . . . . . . 2 2 . 1 . 052 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.6 mt -75.16 131.37 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.343 170.023 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -124.17 176.7 6.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 125.929 2.018 . . . . 0.0 108.936 -168.254 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -52.99 127.27 23.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.418 1.487 . . . . 0.0 108.555 175.148 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 62.95 15.52 8.43 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 120.372 3.471 . . . . 0.0 120.372 -171.373 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -76.72 123.41 26.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 116.888 -3.633 . . . . 0.0 106.402 168.496 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -87.15 129.34 34.98 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.698 2.799 . . . . 0.0 108.523 179.469 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.97 134.15 44.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.547 2.339 . . . . 0.0 109.363 163.72 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -86.03 151.29 23.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 103.552 -2.758 . . . . 0.0 103.552 164.657 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -134.23 112.8 11.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 127.871 2.468 . . . . 0.0 109.824 -173.774 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.84 -177.58 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.179 2.591 . . . . 0.0 110.965 -178.347 . . . . . . . . 1 1 . 1 . 052 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.445 -0.691 0 CA-C-O 113.737 -3.03 . . . . 0.0 110.637 -177.088 . . . . . . . . 0 0 . 1 . 053 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 . . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.457 HE21 ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -80.36 144.02 33.06 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.491 1.916 . . . . 0.0 112.536 -175.148 . . . . . . . . 3 3 . 1 . 053 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.481 HG21 ' H ' ' A' ' 65' ' ' SER . 22.9 pt -127.44 161.33 35.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 120.237 -1.539 . . . . 0.0 111.073 155.764 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -92.27 163.57 13.85 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 172.739 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.32 155.67 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 129.436 3.094 . . . . 0.0 110.608 148.422 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -152.12 142.39 22.42 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 122.858 2.572 . . . . 0.0 105.233 -162.308 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.27 66.7 p -100.19 170.75 8.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.049 1.34 . . . . 0.0 110.965 179.284 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 mt -93.0 18.88 8.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 117.856 -3.027 . . . . 0.0 110.22 177.324 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.371 0.6 OUTLIER -153.46 22.37 0.54 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 125.563 3.801 . . . . 0.0 109.412 -164.442 . . . . . . . . 3 3 . 1 . 053 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.88 -11.36 29.68 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 122.688 3.835 . . . . 0.0 122.688 164.752 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -112.73 170.69 8.01 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 121.159 2.479 . . . . 0.0 109.193 -171.001 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.4 p -140.03 169.2 18.13 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.52 3.128 . . . . 0.0 110.503 170.579 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.7 mm -140.99 132.86 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 126.097 2.123 . . . . 0.0 110.377 168.851 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 m -80.88 116.53 20.91 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 126.621 2.45 . . . . 0.0 110.125 168.399 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.8 mt -102.74 146.08 28.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 123.773 1.749 . . . . 0.0 113.304 179.041 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.9 107.88 10.49 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.877 168.881 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -142.58 -41.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.837 1.655 . . . . 0.0 111.441 -157.067 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 75.74 140.97 0.08 OUTLIER Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 131.07 3.748 . . . . 0.0 110.726 -171.339 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.58 -24.08 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 124.474 3.449 . . . . 0.0 119.979 172.308 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 p -64.07 -34.21 77.5 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 116.365 -3.959 . . . . 0.0 113.178 174.931 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.98 144.87 11.02 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -177.846 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.257 10.7 t -117.56 130.68 56.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 116.84 -1.552 . . . . 0.0 108.483 -165.514 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.409 24.7 mm -40.69 -43.72 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 129.774 3.23 . . . . 0.0 114.755 -159.6 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -65.48 -29.47 70.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 121.214 1.825 . . . . 0.0 113.19 179.648 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.77 -16.61 28.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 -176.825 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.43 -40.33 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 114.809 -2.519 . . . . 0.0 105.518 172.702 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -71.5 -30.04 65.5 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 125.035 1.459 . . . . 0.0 112.235 175.324 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.25 -18.65 60.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.53 2.332 . . . . 0.0 115.869 173.74 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.28 -18.41 55.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 119.724 3.231 . . . . 0.0 119.724 161.416 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.6 mt -87.97 -38.19 11.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 127.27 2.856 . . . . 0.0 107.733 170.655 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.295 38.6 tt0 -45.9 -56.28 5.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 162.01 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -51.56 -38.2 53.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 111.397 -2.638 . . . . 0.0 110.704 171.363 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -87.7 -53.71 4.63 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -179.991 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -103.46 -21.56 13.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 -170.932 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.76 -17.09 28.06 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 116.42 -2.322 . . . . 0.0 110.394 175.156 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.79 120.19 78.62 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 129.288 3.035 . . . . 0.0 110.292 -174.127 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -77.23 148.72 27.38 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 C-N-CA 123.924 3.083 . . . . 0.0 110.973 -171.146 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.293 47.2 Cg_exo -47.53 -37.39 26.21 Favored 'Trans proline' 0 N--CA 1.442 -1.532 1 C-N-CA 126.382 4.721 . . . . 0.0 116.096 -176.814 . . . . . . . . 3 2 . 1 . 053 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.75 -13.71 61.0 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -171.737 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.317 20.2 mt-30 -100.88 -7.82 23.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 178.715 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -89.23 95.03 10.13 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.247 2.219 . . . . 0.0 115.996 173.353 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.291 51.4 ttt180 -88.44 105.7 17.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.293 -1.504 . . . . 0.0 107.639 172.821 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.295 97.1 mt -97.07 120.11 36.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.984 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.0 mt -110.85 126.24 68.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 130.179 3.392 . . . . 0.0 105.91 -172.53 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.261 89.9 t80 -119.95 -138.27 0.34 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.869 2.868 . . . . 0.0 105.019 -172.422 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.26 57.19 4.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.302 2.641 . . . . 0.0 114.146 -163.284 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.78 -3.17 80.99 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 127.198 2.333 . . . . 0.0 114.449 -166.679 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -123.96 141.01 52.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.37 2.268 . . . . 0.0 110.98 -170.381 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -77.44 140.04 39.77 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.656 -0.687 . . . . 0.0 110.989 153.309 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.97 123.5 20.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 126.232 2.208 . . . . 0.0 109.156 174.01 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -85.09 138.93 32.1 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 126.554 2.409 . . . . 0.0 107.519 -177.376 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.276 96.8 m-20 -73.56 127.27 32.29 Favored 'General case' 0 N--CA 1.445 -0.724 1 CA-C-N 107.303 -4.498 . . . . 0.0 104.707 171.74 . . . . . . . . 3 2 . 1 . 053 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.32 -19.79 26.46 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.708 1.255 . . . . 0.0 116.148 -173.147 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -100.02 163.3 12.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 124.1 1.905 . . . . 0.0 110.007 176.136 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -92.87 164.8 13.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 117.377 -3.327 . . . . 0.0 111.667 179.492 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.2 mt -62.11 -45.07 95.1 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 117.31 -3.369 . . . . 0.0 113.482 171.644 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.535 47.5 t -29.95 -36.12 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.215 1 C-N-CA 134.838 5.255 . . . . 0.0 120.511 156.203 . . . . . . . . 3 2 . 1 . 053 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.318 34.5 m-20 -80.49 -10.03 59.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 114.38 -2.724 . . . . 0.0 110.738 177.184 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -104.86 -7.71 19.2 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 126.864 2.602 . . . . 0.0 114.199 168.15 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 7.0 t-20 55.08 59.42 4.03 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.253 2.221 . . . . 0.0 113.232 -171.909 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -101.16 126.94 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 1 O-C-N 114.621 -5.05 . . . . 0.0 103.599 179.468 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -109.9 -170.28 1.62 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.918 1.687 . . . . 0.0 112.347 -168.827 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -50.83 139.15 17.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.047 -1.033 . . . . 0.0 113.01 171.269 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.278 4.4 tt0 70.56 32.26 2.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 128.879 3.862 . . . . 0.0 109.923 163.395 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.481 ' H ' HG21 ' A' ' 3' ' ' ILE . 69.6 m -83.1 153.23 24.96 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 117.777 -3.077 . . . . 0.0 114.509 -178.335 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m -113.52 137.82 51.01 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 125.234 2.445 . . . . 0.0 111.018 168.902 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.69 125.86 27.91 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 176.468 . . . . . . . . 2 2 . 1 . 053 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -92.09 143.86 26.02 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 127.619 3.075 . . . . 0.0 108.491 177.584 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tt -115.64 122.23 44.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.159 -172.724 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.7 t -100.91 141.82 16.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 127.981 2.512 . . . . 0.0 108.347 176.529 . . . . . . . . 1 1 . 1 . 053 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 126.355 2.979 . . . . 0.0 109.492 -174.118 . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.9 ttp . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 115.818 -2.039 . . . . 0.0 107.086 . . . . . . . . . 0 0 . 1 . 054 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -90.87 146.17 24.14 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 126.036 2.085 . . . . 0.0 109.469 -169.134 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 6.0 pt -145.88 164.78 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 175.376 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -127.53 145.39 50.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 124.385 2.041 . . . . 0.0 107.937 -174.917 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -137.53 106.87 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 1 O-C-N 115.246 -4.659 . . . . 0.0 104.382 -177.908 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -77.34 126.67 31.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 124.567 2.127 . . . . 0.0 112.991 162.896 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -78.48 156.8 29.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.511 1.924 . . . . 0.0 109.266 177.468 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mt -50.47 -34.65 25.71 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 164.467 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.2 p -78.66 -11.91 59.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.735 2.014 . . . . 0.0 112.713 -176.086 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.25 -8.39 26.83 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 115.657 -2.746 . . . . 0.0 111.087 174.243 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -91.73 159.66 15.73 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.29 1.436 . . . . 0.0 109.765 -174.947 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -126.17 136.41 52.82 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 -178.127 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mt -102.79 159.81 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 1 C-N-CA 132.337 4.255 . . . . 0.0 106.647 163.956 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.33 3.3 t -135.4 149.98 49.78 Favored 'General case' 0 C--N 1.328 -0.34 1 C-N-CA 134.117 4.967 . . . . 0.0 112.526 168.831 . . . . . . . . 3 2 . 1 . 054 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mp -141.27 144.35 34.61 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -173.342 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.274 4.0 tp10 -99.71 128.04 45.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 125.322 1.639 . . . . 0.0 108.613 161.559 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.72 173.3 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 129.216 3.007 . . . . 0.0 114.976 173.05 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -103.2 148.19 35.29 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 128.148 2.579 . . . . 0.0 106.796 151.812 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -64.63 -14.13 42.83 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-O 116.499 -1.542 . . . . 0.0 112.006 172.457 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.5 m -86.98 1.53 52.47 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 127.782 3.176 . . . . 0.0 111.194 177.817 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -89.97 143.76 26.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 126.203 2.189 . . . . 0.0 106.959 175.075 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -82.76 162.56 21.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 126.245 2.926 . . . . 0.0 104.174 -168.548 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.27 -45.85 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 120.002 -1.686 . . . . 0.0 109.109 168.622 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.8 -33.58 10.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 124.266 1.984 . . . . 0.0 114.209 173.518 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.89 -34.96 67.0 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 117.106 -3.497 . . . . 0.0 112.282 176.174 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.62 -37.18 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 O-C-N 120.54 -1.35 . . . . 0.0 111.136 169.682 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -68.03 -39.8 83.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.766 -1.833 . . . . 0.0 113.449 172.922 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.35 77.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 172.689 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -72.32 -33.91 67.7 Favored 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 131.806 4.042 . . . . 0.0 111.756 175.457 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.6 mt -80.09 -39.82 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 118.502 -2.624 . . . . 0.0 116.582 169.1 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -44.03 -47.39 8.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 119.39 -2.068 . . . . 0.0 114.955 150.725 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -53.97 -45.0 71.26 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 178.085 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -107.58 -49.99 3.15 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 126.245 2.216 . . . . 0.0 107.924 -160.31 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -90.01 -38.35 13.67 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.099 1.76 . . . . 0.0 112.04 -174.172 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.2 9.38 24.06 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 116.622 -2.21 . . . . 0.0 112.865 169.641 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.64 124.53 69.28 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 119.99 1.895 . . . . 0.0 112.687 -170.722 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -54.19 135.78 65.84 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 124.316 3.344 . . . . 0.0 109.828 175.509 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.262 71.6 Cg_exo -41.59 -52.5 3.73 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.132 2.555 . . . . 0.0 117.858 170.083 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -40.82 -17.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 129.658 3.183 . . . . 0.0 114.834 167.39 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -136.04 30.71 3.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -167.068 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.297 13.1 pt20 -141.23 138.12 33.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 130.711 3.604 . . . . 0.0 110.648 168.671 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -138.34 120.92 16.19 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 118.377 -2.702 . . . . 0.0 104.282 175.507 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.59 150.35 23.1 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 119.835 -1.791 . . . . 0.0 109.706 177.037 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.8 mt -137.33 128.0 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -179.412 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -131.5 118.91 20.81 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 127.279 2.862 . . . . 0.0 108.214 179.107 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.21 13.34 7.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 130.754 3.622 . . . . 0.0 118.588 167.4 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.87 3.39 36.66 Favored Glycine 0 CA--C 1.536 1.379 1 C-N-CA 130.881 4.086 . . . . 0.0 114.581 -171.65 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -106.83 100.98 10.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 113.211 -3.28 . . . . 0.0 111.037 -177.517 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -63.29 108.56 1.33 Allowed 'General case' 0 C--N 1.325 -0.479 1 O-C-N 129.695 4.372 . . . . 0.0 106.445 169.122 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.14 147.88 46.21 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 125.789 1.931 . . . . 0.0 112.054 179.399 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 54' ' ' ARG . 3.8 mt-10 -116.39 137.61 52.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.04 2.136 . . . . 0.0 105.657 -178.502 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -43.89 136.46 3.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 138.179 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.44 -10.34 33.14 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 129.845 3.593 . . . . 0.0 115.832 -176.023 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.497 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 39.8 mtt-85 -123.58 -177.72 3.81 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 127.21 2.359 . . . . 0.0 109.385 -178.805 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -128.73 168.34 15.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.277 -175.174 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.5 mt -59.02 -29.29 67.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -178.873 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -65.45 -47.19 77.0 Favored 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 135.489 5.515 . . . . 0.0 115.659 172.736 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -47.13 -25.56 0.9 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 120.053 3.353 . . . . 0.0 120.053 170.855 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.497 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 72.3 m-85 -117.17 1.73 12.53 Favored 'General case' 0 C--O 1.238 0.473 1 C-N-CA 132.866 4.466 . . . . 0.0 115.291 177.958 . . . . . . . . 3 3 . 1 . 054 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.374 4.0 t30 66.89 49.13 1.21 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.375 1.47 . . . . 0.0 113.377 176.782 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mt -101.3 125.39 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 118.243 -2.786 . . . . 0.0 104.568 177.043 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -115.02 -166.7 1.14 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.243 -2.253 . . . . 0.0 111.152 172.635 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.257 58.9 tttt -41.84 125.78 2.95 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 118.939 2.941 . . . . 0.0 118.939 170.496 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.45 44.4 mt-10 75.84 18.1 2.16 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 165.776 . . . . . . . . 2 2 . 1 . 054 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 m -83.67 147.04 27.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.53 1.132 . . . . 0.0 108.782 -175.832 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -120.67 131.75 54.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 -174.466 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -111.7 162.09 15.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.084 2.553 . . . . 0.0 109.608 171.87 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -115.01 142.49 46.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 124.462 2.077 . . . . 0.0 110.496 162.537 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.3 133.52 52.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 119.374 -2.079 . . . . 0.0 106.232 -178.703 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.76 153.86 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.356 1.862 . . . . 0.0 110.897 161.507 . . . . . . . . 1 1 . 1 . 054 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.856 0 CA-C-O 116.735 -1.602 . . . . 0.0 107.975 -173.778 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttm . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 . . . . . . . . . 0 0 . 1 . 055 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -91.39 136.82 32.84 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.629 0.771 . . . . 0.0 111.639 175.382 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -117.41 170.01 7.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 119.895 -1.753 . . . . 0.0 110.799 145.539 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.77 138.21 48.66 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 164.824 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 t -121.91 124.76 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 O-C-N 120.922 -1.111 . . . . 0.0 109.397 168.133 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -88.45 115.69 26.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.268 1.027 . . . . 0.0 111.89 -179.482 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 34.9 p -78.71 161.02 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 125.528 2.585 . . . . 0.0 109.378 171.675 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.04 -27.74 66.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.576 1.95 . . . . 0.0 113.634 -171.853 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p -69.0 -8.86 48.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 119.692 -1.88 . . . . 0.0 114.687 168.459 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.28 -6.09 30.27 Favored Glycine 0 N--CA 1.44 -1.039 0 O-C-N 120.179 -1.576 . . . . 0.0 112.106 172.197 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -73.85 125.28 27.8 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.36 2.264 . . . . 0.0 114.61 -176.423 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.3 57.0 m -95.69 106.19 18.26 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 101.029 -3.693 . . . . 0.0 101.029 176.906 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.9 mt -87.16 130.65 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 125.385 1.474 . . . . 0.0 110.265 173.036 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -90.26 105.63 17.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 127.697 3.123 . . . . 0.0 107.835 176.411 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.252 7.7 tp -108.51 152.31 24.9 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.827 2.051 . . . . 0.0 111.71 -178.147 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -95.93 143.15 27.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 163.3 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.05 150.94 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 129.586 3.154 . . . . 0.0 107.198 166.23 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.271 12.7 tp10 -89.39 141.92 29.3 Favored Pre-proline 0 N--CA 1.446 -0.649 0 O-C-N 127.649 3.093 . . . . 0.0 105.287 154.024 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.26 -19.73 6.91 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 N-CA-C 121.033 3.436 . . . . 0.0 121.033 170.837 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.276 20.7 p -99.2 1.57 44.97 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.664 -174.391 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -85.74 144.83 27.56 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 179.939 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.3 p -90.86 162.6 14.74 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.587 -2.571 . . . . 0.0 115.026 -174.278 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mm -52.69 -53.54 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 128.847 2.859 . . . . 0.0 107.89 -165.035 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -79.58 -21.12 45.44 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 114.129 -2.843 . . . . 0.0 112.053 -169.316 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -66.67 -47.68 71.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 123.52 2.873 . . . . 0.0 111.924 166.354 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.24 -34.52 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 130.889 3.676 . . . . 0.0 110.04 177.015 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -67.78 -35.67 79.09 Favored 'General case' 0 N--CA 1.451 -0.387 1 O-C-N 114.435 -5.166 . . . . 0.0 113.23 169.053 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.7 -22.22 46.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 130.408 3.483 . . . . 0.0 110.424 -179.22 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -64.46 -20.65 66.31 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 118.45 -2.656 . . . . 0.0 109.168 173.096 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mm -68.78 -19.71 24.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 117.361 -3.337 . . . . 0.0 117.243 167.279 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -74.65 -35.81 62.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 113.664 -3.065 . . . . 0.0 107.911 -165.175 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.307 27.9 t70 -30.69 -53.58 0.19 Allowed 'General case' 0 N--CA 1.441 -0.902 1 C-N-CA 132.099 4.159 . . . . 0.0 110.421 154.715 . . . . . . . . 3 2 . 1 . 055 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -89.02 -48.17 7.61 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 127.294 2.871 . . . . 0.0 116.842 -178.066 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -102.79 -36.03 8.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 125.221 1.576 . . . . 0.0 108.617 -160.891 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.15 13.47 58.79 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 115.21 -2.994 . . . . 0.0 117.529 171.28 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mm -97.55 142.55 24.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 112.516 -3.611 . . . . 0.0 108.411 -172.985 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -60.6 139.38 85.64 Favored 'Trans proline' 0 N--CA 1.453 -0.897 1 C-N-CA 126.522 4.815 . . . . 0.0 116.853 170.153 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.76 -27.81 37.5 Favored 'Trans proline' 0 N--CA 1.456 -0.729 1 C-N-CA 126.544 4.829 . . . . 0.0 113.31 -172.978 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.18 -38.23 82.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 119.916 -1.74 . . . . 0.0 115.052 166.167 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -73.99 -29.67 62.09 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 118.178 -2.826 . . . . 0.0 117.029 176.886 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -75.44 149.44 38.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.106 2.562 . . . . 0.0 114.557 164.173 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.444 ' CZ ' ' HG2' ' A' ' 49' ' ' GLN . 16.4 ttt180 -131.44 150.01 52.31 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 128.234 2.614 . . . . 0.0 104.661 157.05 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.465 0.4 OUTLIER -120.46 148.62 43.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 124.327 2.013 . . . . 0.0 112.73 158.66 . . . . . . . . 3 3 . 1 . 055 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -104.62 154.29 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 1 C-N-CA 134.504 5.122 . . . . 0.0 108.924 176.601 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -162.6 135.0 5.55 Favored 'General case' 0 C--N 1.321 -0.638 1 C-N-CA 132.313 4.245 . . . . 0.0 103.589 163.015 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 76.37 43.21 0.15 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.012 1.325 . . . . 0.0 109.554 163.504 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.51 22.63 46.23 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 129.754 3.55 . . . . 0.0 118.481 -176.655 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.322 37.4 pttt -162.06 170.13 19.76 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.658 1.583 . . . . 0.0 112.128 -179.397 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 42' ' ' ARG 0.306 27.2 mp0 -93.77 139.73 30.5 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.386 -161.563 . . . . . . . . 3 3 . 1 . 055 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.2 mt -94.46 162.14 13.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.639 1.975 . . . . 0.0 109.513 179.01 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -150.93 151.3 31.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 119.294 -2.128 . . . . 0.0 110.366 -173.374 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -44.77 133.98 5.82 Favored 'General case' 0 C--N 1.327 -0.413 1 C-N-CA 134.039 4.936 . . . . 0.0 112.267 -177.341 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.35 -19.94 28.61 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 114.084 -3.62 . . . . 0.0 111.354 151.718 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -94.07 155.86 16.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 127.572 2.572 . . . . 0.0 107.518 172.361 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -76.2 163.98 26.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.801 2.44 . . . . 0.0 112.739 -178.514 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.9 mt -43.85 -43.47 6.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 130.178 3.391 . . . . 0.0 109.229 159.897 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -71.35 -37.67 71.67 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 118.701 -2.5 . . . . 0.0 114.889 -175.525 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -59.71 -36.19 76.05 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 127.139 2.176 . . . . 0.0 107.877 178.891 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.282 13.9 m-85 -97.83 11.94 35.59 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.591 1.556 . . . . 0.0 110.995 175.907 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.623 0.1 OUTLIER 67.56 25.97 8.22 Favored 'General case' 0 C--O 1.222 -0.374 1 O-C-N 115.566 -4.458 . . . . 0.0 121.512 165.016 . . . . . . . . 4 3 . 1 . 055 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -76.61 93.29 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 128.628 2.771 . . . . 0.0 104.973 174.305 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.302 8.3 mm-40 -99.4 -169.67 1.79 Allowed 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 128.089 3.368 . . . . 0.0 102.344 174.938 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.419 16.1 ptpt -43.64 122.23 2.63 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 130.808 3.643 . . . . 0.0 116.729 169.601 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 4.2 tp10 83.13 33.98 0.06 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.946 2.099 . . . . 0.0 112.493 175.198 . . . . . . . . 2 2 . 1 . 055 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -96.91 138.38 34.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.125 2.97 . . . . 0.0 108.237 -176.6 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -118.26 141.19 48.77 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 173.865 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.0 158.82 16.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 116.9 -3.625 . . . . 0.0 111.718 166.171 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -135.07 136.11 41.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 175.195 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 mt -86.64 154.7 20.82 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 178.106 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 t -141.39 133.55 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 128.713 2.805 . . . . 0.0 106.525 -178.734 . . . . . . . . 1 1 . 1 . 055 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.446 -0.67 0 CA-C-N 123.027 2.649 . . . . 0.0 108.438 -179.637 . . . . . . . . 0 0 . 1 . 056 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.309 14.2 ptt? . . . . . 0 N--CA 1.471 0.579 0 CA-C-O 117.872 -1.061 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -79.3 153.25 30.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 115.739 -2.077 . . . . 0.0 111.602 163.896 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.291 31.4 pt -134.22 -177.39 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 129.292 3.037 . . . . 0.0 103.934 164.417 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -142.0 139.44 32.39 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 128.631 2.773 . . . . 0.0 104.544 170.954 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.29 109.31 25.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 131.266 3.826 . . . . 0.0 101.59 179.45 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -87.51 122.29 31.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 101.057 -3.683 . . . . 0.0 101.057 170.221 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.5 p -65.72 160.26 23.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 128.384 2.673 . . . . 0.0 111.119 161.967 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tt -44.84 -39.55 5.43 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 120.169 3.396 . . . . 0.0 120.169 172.941 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 p -90.87 -9.69 45.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.811 2.044 . . . . 0.0 111.715 -176.075 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.72 7.39 17.89 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.775 0.702 . . . . 0.0 111.675 165.847 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -76.5 130.92 38.63 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.808 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -112.87 146.76 38.35 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.625 2.37 . . . . 0.0 106.023 -174.071 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 pt -143.89 146.6 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 127.091 2.745 . . . . 0.0 105.737 173.158 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.9 m -89.14 132.59 34.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 129.702 3.201 . . . . 0.0 104.635 168.876 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 mt -108.86 153.27 23.76 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.047 1.739 . . . . 0.0 109.659 151.966 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -103.21 111.57 24.01 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 111.684 -2.507 . . . . 0.0 111.47 164.873 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.23 138.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.512 1.525 . . . . 0.0 106.89 -174.944 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -77.77 147.01 73.64 Favored Pre-proline 0 N--CA 1.446 -0.645 0 O-C-N 118.753 -2.467 . . . . 0.0 109.61 154.361 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.06 -22.35 74.43 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 N-CA-C 119.651 2.904 . . . . 0.0 119.651 -174.25 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 0.3 OUTLIER -81.18 -12.5 59.17 Favored 'General case' 0 N--CA 1.442 -0.861 1 C-N-CA 131.792 4.037 . . . . 0.0 112.226 177.889 . . . . . . . . 4 3 . 1 . 056 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.06 119.65 17.59 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 119.614 -1.929 . . . . 0.0 107.196 -172.65 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.5 p -66.3 167.83 9.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 121.524 1.965 . . . . 0.0 106.245 -167.797 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -54.18 -37.72 36.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -177.876 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -71.02 -28.66 64.57 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.182 0.992 . . . . 0.0 112.626 -174.92 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.41 -22.35 66.77 Favored 'General case' 0 N--CA 1.451 -0.416 1 CA-C-O 110.544 -4.55 . . . . 0.0 112.802 175.855 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.39 -45.32 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 131.139 3.776 . . . . 0.0 109.749 177.622 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.286 37.5 pttt -75.34 -23.65 57.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 123.904 1.811 . . . . 0.0 113.332 -178.504 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -34.2 75.3 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.159 2.584 . . . . 0.0 108.337 -179.549 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -73.58 -53.87 9.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 127.777 3.173 . . . . 0.0 107.277 176.011 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.43 65.4 mt -38.81 -54.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 125.807 2.718 . . . . 0.0 117.821 -179.675 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -65.08 -20.72 66.61 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 118.586 -2.571 . . . . 0.0 116.253 -179.385 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.256 36.0 t70 -90.37 -24.87 20.69 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 121.672 2.033 . . . . 0.0 107.517 175.492 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -97.33 -50.64 4.47 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 113.646 -3.073 . . . . 0.0 107.371 -164.17 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -129.18 12.21 6.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 115.647 -2.12 . . . . 0.0 109.929 -179.929 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.74 -3.19 86.08 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 126.674 2.083 . . . . 0.0 116.523 154.292 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -72.69 107.64 3.37 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 130.347 3.459 . . . . 0.0 106.439 177.352 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.97 160.61 36.8 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.47 2.113 . . . . 0.0 116.545 -177.711 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.317 5.6 Cg_endo -50.69 -35.34 47.12 Favored 'Trans proline' 0 N--CA 1.44 -1.668 1 C-N-CA 130.13 7.22 . . . . 0.0 114.027 167.845 . . . . . . . . 3 2 . 1 . 056 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.67 -18.98 63.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 116.185 1.921 . . . . 0.0 116.185 175.312 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -123.38 14.32 9.6 Favored 'General case' 0 N--CA 1.443 -0.791 1 O-C-N 115.598 -4.439 . . . . 0.0 110.037 -176.083 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.343 0.3 OUTLIER -101.85 126.29 48.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 118.814 -2.429 . . . . 0.0 107.364 -161.967 . . . . . . . . 3 3 . 1 . 056 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -131.74 108.02 9.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 168.657 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.8 mt -93.21 126.66 38.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.002 -1.475 . . . . 0.0 108.392 179.572 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 pt -128.9 144.25 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 119.454 1.025 . . . . 0.0 113.046 -178.004 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -137.08 133.74 35.72 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 169.116 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.11 20.59 11.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 120.873 1.67 . . . . 0.0 111.488 166.681 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.49 -21.12 42.58 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.305 0.957 . . . . 0.0 112.723 -174.483 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -80.63 146.16 31.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -176.324 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -99.99 123.99 44.84 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 175.822 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mt -71.4 115.82 11.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 124.663 2.173 . . . . 0.0 109.951 -171.022 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -82.84 133.31 35.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.421 2.688 . . . . 0.0 112.767 175.317 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -41.89 143.29 0.56 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 130.893 3.677 . . . . 0.0 115.474 174.009 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.96 50.27 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 111.789 -2.459 . . . . 0.0 112.809 164.729 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -74.35 140.45 44.82 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 118.367 -2.843 . . . . 0.0 107.28 175.206 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -68.43 139.47 55.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 126.503 2.377 . . . . 0.0 109.048 160.947 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.2 mt -53.11 -30.08 34.57 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.666 1.586 . . . . 0.0 113.974 174.451 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 t -74.68 -35.82 62.78 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.911 2.085 . . . . 0.0 112.383 -176.992 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -60.35 -17.77 45.62 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 167.799 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.06 12.66 35.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 120.037 3.347 . . . . 0.0 120.037 167.434 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 73.64 21.22 2.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 124.811 2.243 . . . . 0.0 115.375 169.542 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.2 mm -78.32 135.01 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -179.517 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -112.89 170.54 8.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.008 178.347 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.3 140.4 17.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 118.469 -2.644 . . . . 0.0 111.246 169.364 . . . . . . . . 2 2 . 1 . 056 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.494 0.6 OUTLIER 68.89 1.29 3.07 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 117.122 2.268 . . . . 0.0 117.122 163.708 . . . . . . . . 3 3 . 1 . 056 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -54.98 146.04 18.8 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 118.853 2.908 . . . . 0.0 118.853 169.048 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.5 m -102.24 105.66 16.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -179.547 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.69 162.19 13.16 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.121 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -113.24 132.87 55.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 127.542 3.026 . . . . 0.0 109.116 -178.383 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -105.59 110.97 23.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 129.044 2.938 . . . . 0.0 104.979 169.716 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.38 118.82 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 O-C-N 118.74 -2.475 . . . . 0.0 104.744 172.6 . . . . . . . . 1 1 . 1 . 056 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.7 mt . . . . . 0 N--CA 1.445 -0.691 0 C-N-CA 128.629 2.772 . . . . 0.0 110.861 163.728 . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 057 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -102.1 141.29 35.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.775 2.43 . . . . 0.0 111.343 176.26 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 pt -133.38 144.62 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 110.964 -2.834 . . . . 0.0 108.305 164.506 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -93.84 141.03 28.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 173.556 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.1 t -120.99 122.66 68.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 123.067 2.667 . . . . 0.0 105.039 170.165 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -89.17 124.49 34.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 122.146 2.248 . . . . 0.0 106.941 176.891 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.328 82.7 p -99.59 -166.84 1.39 Allowed 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 118.201 -2.812 . . . . 0.0 114.715 -172.855 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.457 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 7.5 mp -43.27 -33.62 1.01 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 119.695 3.22 . . . . 0.0 119.695 -177.745 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -110.26 -4.82 15.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.175 2.19 . . . . 0.0 112.493 -178.549 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.34 -1.72 67.28 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 179.585 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.59 127.44 31.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 129.305 3.042 . . . . 0.0 104.616 173.352 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -90.76 131.91 36.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.943 1.402 . . . . 0.0 108.236 -179.841 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.1 pt -117.49 136.07 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 123.739 1.733 . . . . 0.0 107.038 170.302 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.9 m -88.81 112.02 22.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 113.07 -3.348 . . . . 0.0 111.376 179.895 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.03 129.27 49.76 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 101.725 -3.435 . . . . 0.0 101.725 -175.987 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -82.93 133.68 35.1 Favored 'General case' 0 C--O 1.222 -0.361 1 C-N-CA 132.324 4.25 . . . . 0.0 103.925 164.262 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.91 169.06 8.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 109.832 -3.349 . . . . 0.0 108.687 -176.739 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -128.27 157.65 73.78 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.858 169.401 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -69.45 -6.73 19.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 125.115 3.876 . . . . 0.0 114.953 -174.629 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.7 p -86.31 -13.41 46.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 129.006 2.922 . . . . 0.0 112.804 167.223 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -69.29 131.72 45.31 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 122.419 2.372 . . . . 0.0 115.069 -179.149 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 p -91.36 169.2 11.0 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.066 1.746 . . . . 0.0 113.285 172.003 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.2 -17.78 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.733 178.531 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -62.75 -47.08 85.09 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 118.146 -2.846 . . . . 0.0 112.756 160.91 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -70.03 -26.12 63.89 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.786 -178.459 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -90.49 -33.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 113.02 -3.372 . . . . 0.0 107.399 -172.656 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -43.0 -44.55 4.72 Favored 'General case' 0 C--N 1.322 -0.629 1 C-N-CA 132.681 4.392 . . . . 0.0 112.841 167.795 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.08 -17.39 55.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 114.788 -2.529 . . . . 0.0 115.727 178.295 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -90.64 -22.47 21.18 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 121.54 1.973 . . . . 0.0 107.554 172.27 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.7 mt -67.21 -37.96 80.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.432 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -42.8 61.08 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.581 2.752 . . . . 0.0 114.509 169.746 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.61 -55.24 25.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 163.982 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -80.77 -17.91 49.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -170.643 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.427 25.7 tp10 -135.62 -8.7 2.17 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 121.61 3.93 . . . . 0.0 121.61 171.361 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.69 7.68 68.56 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 116.496 -3.877 . . . . 0.0 117.208 173.842 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mm -91.37 123.45 63.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 C-N-CA 130.051 3.34 . . . . 0.0 106.524 -170.985 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.324 72.9 Cg_endo -67.32 154.0 75.32 Favored 'Trans proline' 0 N--CA 1.454 -0.852 1 C-N-CA 128.095 5.863 . . . . 0.0 109.725 170.663 . . . . . . . . 3 2 . 1 . 057 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.18 -22.59 53.78 Favored 'Trans proline' 0 N--CA 1.448 -1.192 1 C-N-CA 125.313 4.009 . . . . 0.0 115.833 -164.046 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.02 -8.0 52.61 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 124.405 1.066 . . . . 0.0 110.317 -164.061 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -110.41 -9.85 14.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 118.128 -2.858 . . . . 0.0 113.573 -172.33 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.263 73.4 mt-30 -88.17 121.75 30.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.829 1.652 . . . . 0.0 106.869 -172.222 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -102.59 100.21 10.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 112.632 -2.076 . . . . 0.0 108.594 170.395 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.6 mt -90.63 126.31 35.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 119.589 -1.944 . . . . 0.0 111.842 177.443 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.1 mt -132.35 139.7 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.217 2.207 . . . . 0.0 110.853 -168.382 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -162.65 112.8 1.45 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 129.316 3.046 . . . . 0.0 112.39 -174.242 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.09 36.19 14.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 128.426 3.965 . . . . 0.0 118.496 177.292 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.08 -10.12 43.6 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 108.508 -3.951 . . . . 0.0 109.638 167.233 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -92.41 120.06 32.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 130.351 3.46 . . . . 0.0 111.448 -178.749 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -79.16 119.27 22.02 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.997 2.519 . . . . 0.0 109.055 165.028 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -79.01 129.18 34.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -158.86 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -82.77 153.44 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -172.425 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -80.47 126.57 31.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.475 170.982 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.35 -3.97 18.07 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-O 115.722 -2.71 . . . . 0.0 110.433 -172.507 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -103.14 155.85 18.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 120.652 2.226 . . . . 0.0 108.547 -167.931 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.2 p -95.98 141.43 29.4 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.61 2.364 . . . . 0.0 109.346 168.017 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.4 mt -51.23 -38.56 53.19 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 129.919 3.288 . . . . 0.0 111.696 -178.567 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -74.83 -20.44 59.76 Favored 'General case' 0 C--O 1.217 -0.624 0 O-C-N 120.103 -1.623 . . . . 0.0 111.573 -176.666 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -79.8 -25.47 40.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.371 2.268 . . . . 0.0 110.001 -178.463 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -85.86 -17.67 34.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 123.204 1.478 . . . . 0.0 114.895 166.453 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 83.17 48.45 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.867 1.667 . . . . 0.0 111.112 173.923 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.9 mt -107.18 102.97 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 1 N-CA-C 99.844 -4.132 . . . . 0.0 99.844 -174.943 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.94 154.39 24.57 Favored 'General case' 0 CA--C 1.54 0.592 1 O-C-N 130.168 4.667 . . . . 0.0 113.28 167.136 . . . . . . . . 3 3 . 1 . 057 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.397 0.0 OUTLIER -38.15 133.36 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 130.896 3.678 . . . . 0.0 118.069 170.438 . . . . . . . . 3 3 . 1 . 057 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.449 15.0 mt-10 80.58 1.49 1.86 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 125.331 3.696 . . . . 0.0 112.381 -179.866 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.2 m -67.81 145.42 54.68 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 126.284 2.24 . . . . 0.0 112.385 172.428 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -108.51 114.83 28.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 101.673 -3.454 . . . . 0.0 101.673 179.132 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -98.56 155.14 17.43 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.435 1.494 . . . . 0.0 108.009 177.136 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -105.83 146.57 29.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 114.817 -2.516 . . . . 0.0 108.467 178.767 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -125.81 134.73 51.59 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.011 1.725 . . . . 0.0 108.745 177.065 . . . . . . . . 1 1 . 1 . 057 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -129.59 164.46 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 1 C-N-CA 132.445 4.298 . . . . 0.0 105.642 179.719 . . . . . . . . 2 2 . 1 . 057 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 114.271 -2.776 . . . . 0.0 105.85 -171.35 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptt? . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 . . . . . . . . . 0 0 . 1 . 058 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -104.12 137.03 42.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 118.553 -2.592 . . . . 0.0 106.825 177.2 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 pt -132.41 155.11 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 129.898 3.279 . . . . 0.0 105.908 174.709 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -118.77 143.89 46.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.296 2.238 . . . . 0.0 111.737 176.8 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -126.94 115.83 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 112.069 -3.824 . . . . 0.0 108.64 178.529 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -90.78 120.91 32.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 113.596 -3.097 . . . . 0.0 114.031 175.704 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.8 p -80.99 160.91 24.46 Favored 'General case' 0 N--CA 1.448 -0.552 1 O-C-N 129.15 4.031 . . . . 0.0 112.815 164.039 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -45.21 93.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 -172.53 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.261 55.7 p -59.49 -17.18 29.45 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 166.931 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.07 -0.99 6.68 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.291 1.9 . . . . 0.0 108.88 154.048 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -74.58 141.67 44.72 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 119.272 -2.311 . . . . 0.0 111.31 -167.727 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.9 m -120.11 121.63 39.26 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 125.343 1.652 . . . . 0.0 111.019 -166.437 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.65 156.63 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 114.847 -2.502 . . . . 0.0 108.284 175.055 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.388 6.6 t -126.17 124.99 41.73 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 127.47 2.981 . . . . 0.0 111.095 174.693 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.84 150.11 43.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 124.441 2.067 . . . . 0.0 106.269 -171.676 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -106.82 110.98 23.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.012 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.9 136.69 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 109.16 -3.655 . . . . 0.0 109.902 -173.114 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -95.38 139.35 21.95 Favored Pre-proline 0 N--CA 1.445 -0.714 0 CA-C-O 113.78 -3.009 . . . . 0.0 106.323 169.844 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.258 23.5 Cg_exo -53.75 -29.93 54.34 Favored 'Trans proline' 0 N--CA 1.454 -0.837 1 C-N-CA 125.63 4.22 . . . . 0.0 115.103 -173.325 . . . . . . . . 3 2 . 1 . 058 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -78.94 -4.05 47.92 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 123.314 2.779 . . . . 0.0 112.627 177.873 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.61 147.13 39.82 Favored 'General case' 0 C--N 1.328 -0.354 1 O-C-N 114.749 -4.97 . . . . 0.0 110.999 -175.585 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -92.03 162.17 14.48 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.346 1.058 . . . . 0.0 108.635 -171.195 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 mm -56.52 -26.72 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 O-C-N 126.684 2.49 . . . . 0.0 113.821 -174.589 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.367 9.4 pt-20 -65.32 -34.76 79.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.375 2.67 . . . . 0.0 114.463 172.663 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -77.95 -29.49 49.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 125.545 2.593 . . . . 0.0 108.866 -176.271 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.357 31.2 m -82.47 -35.11 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 O-C-N 116.738 -3.727 . . . . 0.0 106.934 178.622 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -55.26 -46.19 76.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 116.548 -3.845 . . . . 0.0 114.0 170.816 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.281 . . -77.27 -18.77 57.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 126.382 2.991 . . . . 0.0 114.279 -174.62 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -82.35 -43.62 17.2 Favored 'General case' 0 C--N 1.322 -0.625 1 O-C-N 116.11 -4.119 . . . . 0.0 107.257 -179.476 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.423 12.1 mt -45.51 -46.78 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 128.076 2.55 . . . . 0.0 113.205 160.389 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -59.69 -50.23 74.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 117.901 -2.999 . . . . 0.0 116.794 172.71 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.452 34.7 t70 -53.08 -33.03 50.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.706 2.802 . . . . 0.0 110.721 178.099 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -80.74 -65.71 0.98 Allowed 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 113.204 -3.284 . . . . 0.0 113.621 172.707 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -97.45 -27.15 14.58 Favored 'General case' 0 N--CA 1.445 -0.724 1 O-C-N 129.645 4.34 . . . . 0.0 118.965 -165.757 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.24 7.65 59.31 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 128.531 2.967 . . . . 0.0 114.962 -179.539 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 mm -82.1 122.35 79.56 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 116.999 -3.647 . . . . 0.0 110.474 -174.394 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -70.88 120.9 7.41 Favored 'Trans proline' 0 N--CA 1.443 -1.494 1 C-N-CA 128.6 6.2 . . . . 0.0 113.346 -174.95 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.278 77.5 Cg_exo -34.49 -46.79 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.688 1 C-N-CA 128.468 6.112 . . . . 0.0 116.037 -169.545 . . . . . . . . 3 2 . 1 . 058 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.289 0.5 OUTLIER -55.63 -42.59 75.16 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 116.306 -3.996 . . . . 0.0 116.258 178.609 . . . . . . . . 3 3 . 1 . 058 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -79.45 -2.88 43.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.233 0.613 . . . . 0.0 112.63 -177.196 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -85.97 141.71 29.33 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 116.662 -3.774 . . . . 0.0 108.852 173.427 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -145.29 104.6 3.95 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 111.18 -2.736 . . . . 0.0 106.071 -172.375 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -96.43 112.37 24.14 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 119.31 -2.119 . . . . 0.0 107.561 -173.373 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mt -85.47 141.9 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.011 -1.681 . . . . 0.0 110.82 168.905 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -147.1 119.01 8.12 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 102.253 -3.24 . . . . 0.0 102.253 164.035 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.2 22.43 11.0 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 120.957 3.688 . . . . 0.0 120.957 164.056 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.41 -22.7 38.8 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 127.414 2.435 . . . . 0.0 112.581 -175.065 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -97.1 147.26 24.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 118.189 -2.948 . . . . 0.0 107.866 -177.559 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.38 133.32 35.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 126.762 2.539 . . . . 0.0 104.216 163.674 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -70.11 109.9 4.85 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 118.189 -2.819 . . . . 0.0 114.801 168.862 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -74.02 147.23 43.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.297 2.639 . . . . 0.0 112.234 -176.754 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -81.26 147.96 29.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 126.8 2.562 . . . . 0.0 104.585 -166.23 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.46 -36.79 3.94 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 116.739 -2.145 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -76.26 169.99 17.18 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 127.057 3.313 . . . . 0.0 107.939 -174.849 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -103.25 174.75 5.73 Favored 'General case' 0 N--CA 1.452 -0.349 2 O-C-N 112.911 -6.118 . . . . 0.0 113.141 163.003 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.36 -29.04 41.98 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.865 1.666 . . . . 0.0 110.273 -177.336 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -71.13 -32.6 69.18 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 117.526 -1.226 . . . . 0.0 110.009 -177.579 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.09 -22.79 55.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 115.364 -2.255 . . . . 0.0 110.537 174.85 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -86.9 0.32 55.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.056 171.974 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t30 28.62 61.95 0.12 Allowed 'General case' 0 N--CA 1.445 -0.723 1 C-N-CA 138.845 6.858 . . . . 0.0 112.253 175.114 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.8 mt -98.55 -34.96 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 128.348 2.659 . . . . 0.0 105.433 -170.707 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.463 13.1 mm-40 82.12 -158.77 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.531 1.133 . . . . 0.0 112.608 178.109 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -81.65 158.33 24.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.311 3.045 . . . . 0.0 115.14 -176.077 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.309 4.1 tt0 66.52 11.75 8.28 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 128.634 2.774 . . . . 0.0 118.457 161.254 . . . . . . . . 2 2 . 1 . 058 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -105.23 144.47 31.97 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 116.979 -1.486 . . . . 0.0 112.155 -162.515 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -103.41 106.72 17.3 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 122.228 2.286 . . . . 0.0 108.229 -166.726 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -75.64 153.68 37.08 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.264 164.864 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -117.3 95.05 4.8 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 129.102 2.961 . . . . 0.0 107.707 -172.096 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -63.85 118.16 7.97 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.253 2.221 . . . . 0.0 106.918 166.645 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -125.66 150.9 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 167.21 . . . . . . . . 1 1 . 1 . 058 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--N 1.324 -0.5 0 CA-C-O 117.017 -1.468 . . . . 0.0 110.871 -172.051 . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttp . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 . . . . . . . . . 0 0 . 1 . 059 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -96.18 142.17 28.68 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.854 2.462 . . . . 0.0 108.598 -174.744 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.5 pt -130.82 177.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 128.748 2.819 . . . . 0.0 111.32 161.944 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -100.71 144.68 29.39 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.253 1.421 . . . . 0.0 109.618 163.177 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.9 t -116.76 150.47 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 121.765 2.075 . . . . 0.0 105.494 158.791 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -137.85 145.87 42.77 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 128.476 2.71 . . . . 0.0 111.438 -178.363 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -106.85 163.84 12.62 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 126.797 2.561 . . . . 0.0 112.197 173.183 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.55 -33.77 75.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 122.071 2.214 . . . . 0.0 110.964 171.351 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -75.2 -17.09 60.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 121.721 2.055 . . . . 0.0 111.553 167.153 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.68 36.45 6.46 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 118.145 2.018 . . . . 0.0 118.145 156.129 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -77.54 116.65 18.27 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 117.604 -3.292 . . . . 0.0 104.116 158.93 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.257 12.8 m -93.93 157.86 15.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 114.548 -2.644 . . . . 0.0 111.298 167.939 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -154.68 152.66 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 126.076 2.11 . . . . 0.0 113.34 177.508 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.9 m -83.28 131.47 35.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 130.581 3.552 . . . . 0.0 107.113 166.033 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.86 121.53 21.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 119.065 -2.272 . . . . 0.0 110.309 -177.362 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.348 3.5 tt0 -99.35 128.8 45.5 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 -172.06 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.2 t -140.82 137.09 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 114.138 -2.839 . . . . 0.0 107.414 -171.446 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -90.32 138.47 27.11 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 126.745 2.528 . . . . 0.0 106.383 171.644 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.264 94.2 Cg_exo -45.09 -23.1 0.91 Allowed 'Trans proline' 0 N--CA 1.439 -1.703 1 C-N-CA 126.001 4.467 . . . . 0.0 120.906 167.303 . . . . . . . . 3 2 . 1 . 059 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 15.2 m -77.52 -13.84 59.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.77 1.628 . . . . 0.0 111.413 176.324 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.2 130.89 34.94 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 120.763 1.619 . . . . 0.0 107.82 179.265 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -69.73 174.73 4.81 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.94 162.369 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.25 24.7 mt -61.42 -44.76 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 128.426 2.69 . . . . 0.0 109.62 169.731 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.81 -38.33 64.45 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 128.858 2.863 . . . . 0.0 110.212 175.997 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -73.15 -34.6 66.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 116.422 -1.751 . . . . 0.0 113.276 177.165 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 57.9 t -62.29 -37.42 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 125.185 3.63 . . . . 0.0 108.79 168.683 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -66.1 -40.61 90.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.507 1.754 . . . . 0.0 115.158 171.41 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.4 87.53 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.554 1.942 . . . . 0.0 112.88 171.251 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 48.9 mttp -67.81 -41.49 83.04 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 123.628 1.68 . . . . 0.0 111.041 173.567 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.273 94.2 mt -55.55 -58.07 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 1 O-C-N 115.622 -4.424 . . . . 0.0 110.141 168.526 . . . . . . . . 3 2 . 1 . 059 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -45.37 -37.61 5.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 165.278 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.13 -45.14 42.92 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.727 2.011 . . . . 0.0 113.786 177.504 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 mmtm -107.51 -35.03 6.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -166.214 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.3 -30.56 18.36 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.868 2.867 . . . . 0.0 110.411 179.495 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.13 52.73 6.6 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 125.885 1.707 . . . . 0.0 111.479 174.012 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.62 145.43 33.86 Favored Pre-proline 0 N--CA 1.447 -0.595 0 C-N-CA 129.913 3.285 . . . . 0.0 112.31 -178.782 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.09 128.29 12.1 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 124.92 3.747 . . . . 0.0 116.788 162.572 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -75.33 -46.9 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.791 3.661 . . . . 0.0 108.734 -165.522 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.261 23.6 t70 -34.25 -33.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.452 1 C-N-CA 132.391 4.276 . . . . 0.0 119.518 -176.256 . . . . . . . . 3 2 . 1 . 059 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -85.89 -22.27 27.59 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.028 1.731 . . . . 0.0 114.26 175.418 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -98.82 145.79 26.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -160.627 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -118.16 154.39 32.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 118.244 -2.785 . . . . 0.0 110.296 172.625 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mp -108.29 135.45 49.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 167.056 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.1 mm -122.41 129.41 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 128.304 2.641 . . . . 0.0 106.51 175.457 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.539 ' CE1' HG12 ' A' ' 61' ' ' ILE . 44.6 t80 -138.44 131.3 29.57 Favored 'General case' 0 C--O 1.221 -0.421 1 C-N-CA 132.371 4.268 . . . . 0.0 108.057 172.365 . . . . . . . . 3 3 . 1 . 059 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.78 31.96 21.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 130.115 3.366 . . . . 0.0 115.404 -166.895 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.79 15.0 81.01 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 128.419 2.914 . . . . 0.0 111.413 179.204 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -144.37 156.66 44.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 124.112 3.956 . . . . 0.0 113.565 -171.496 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.83 120.35 20.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 126.077 2.846 . . . . 0.0 104.369 -173.345 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.45 66.9 mt -86.05 157.2 20.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 111.366 -2.652 . . . . 0.0 108.769 -178.6 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -91.79 132.99 36.02 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.274 -1.517 . . . . 0.0 107.653 -168.899 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.01 114.57 14.8 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.738 -1.226 . . . . 0.0 109.926 -166.961 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.83 -6.75 11.15 Favored Glycine 0 CA--C 1.522 0.483 0 O-C-N 117.968 -2.958 . . . . 0.0 110.47 -173.733 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -79.21 161.42 26.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 124.509 2.1 . . . . 0.0 112.31 174.67 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.4 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 17.3 p -91.25 176.87 6.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 114.012 -2.899 . . . . 0.0 112.747 167.472 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.3 tp -75.05 -28.88 60.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.613 2.365 . . . . 0.0 111.542 -173.743 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -80.11 -23.84 40.95 Favored 'General case' 0 N--CA 1.449 -0.501 1 O-C-N 115.822 -4.299 . . . . 0.0 117.138 174.2 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.4 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 70.0 m-20 -67.44 -26.07 66.22 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 172.221 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -93.76 -9.22 38.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.72 2.008 . . . . 0.0 112.647 159.185 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 p30 50.99 51.7 16.53 Favored 'General case' 0 N--CA 1.45 -0.468 1 C-N-CA 131.82 4.048 . . . . 0.0 112.019 -177.997 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.539 HG12 ' CE1' ' A' ' 45' ' ' PHE . 21.5 mt -71.25 110.43 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 127.912 2.485 . . . . 0.0 109.675 162.067 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -96.34 174.41 6.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.866 -1.97 . . . . 0.0 107.981 -171.744 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -37.46 137.97 0.37 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 120.077 3.362 . . . . 0.0 120.077 162.825 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 9.4 tt0 57.25 35.01 25.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.908 3.283 . . . . 0.0 114.461 179.755 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -91.07 158.96 16.37 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.451 1.5 . . . . 0.0 111.31 174.595 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.6 m -112.35 115.63 29.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 123.036 1.398 . . . . 0.0 110.026 171.991 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.43 141.32 28.67 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 127.152 3.358 . . . . 0.0 102.848 162.187 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -108.1 136.56 47.58 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 -177.819 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.292 13.7 tp -115.17 95.3 5.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.206 -172.997 . . . . . . . . 2 2 . 1 . 059 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.13 110.22 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 126.81 2.044 . . . . 0.0 108.203 171.171 . . . . . . . . 1 1 . 1 . 059 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.299 2.9 mm? . . . . . 0 N--CA 1.448 -0.539 0 CA-C-N 121.108 1.776 . . . . 0.0 109.237 179.327 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -82.52 146.45 29.21 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.003 2.121 . . . . 0.0 107.154 -174.812 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -142.23 161.7 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 121.798 2.09 . . . . 0.0 108.702 166.553 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -100.85 144.1 30.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.981 1.426 . . . . 0.0 113.757 162.305 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.9 t -110.19 115.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 159.091 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -89.32 137.04 32.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 155.358 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -86.9 146.66 26.09 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 165.089 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.19 4.7 0.12 Allowed 'General case' 0 N--CA 1.445 -0.68 1 C-N-CA 132.463 4.305 . . . . 0.0 112.936 165.814 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -106.46 12.1 30.02 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 119.373 -2.079 . . . . 0.0 113.693 171.489 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.4 -20.19 35.42 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 115.645 -2.753 . . . . 0.0 116.281 169.118 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.315 74.9 tttt -101.0 130.59 47.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 126.635 3.112 . . . . 0.0 105.373 -166.203 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 m -107.91 125.25 51.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 124.717 2.198 . . . . 0.0 108.932 177.781 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.8 mt -110.31 120.75 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 -172.288 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 m -97.19 131.3 44.07 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 118.027 -2.92 . . . . 0.0 106.932 -178.682 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.29 154.06 35.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.965 2.906 . . . . 0.0 111.501 -176.412 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -109.4 137.85 46.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 123.424 1.583 . . . . 0.0 108.148 161.944 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.325 21.0 m -128.02 149.78 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 119.946 3.313 . . . . 0.0 119.946 -178.582 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -85.26 156.54 59.85 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 128.069 2.548 . . . . 0.0 105.807 172.785 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.356 60.0 Cg_endo -70.19 -33.94 14.05 Favored 'Trans proline' 0 N--CA 1.447 -1.207 2 C-N-CA 129.276 6.65 . . . . 0.0 114.165 -179.915 . . . . . . . . 3 2 . 1 . 060 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.6 m -115.73 17.44 16.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 118.674 -2.516 . . . . 0.0 104.311 -167.935 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -84.01 161.27 20.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 125.322 2.487 . . . . 0.0 109.336 178.923 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.41 49.8 p -93.6 147.86 22.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 -163.146 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.305 12.4 mm -44.44 -43.92 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 121.569 3.914 . . . . 0.0 121.569 165.478 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 pm0 -79.69 -15.95 56.6 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 113.434 -3.175 . . . . 0.0 108.571 -174.239 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -74.45 -33.15 62.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 122.412 2.369 . . . . 0.0 106.921 172.299 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG21 ' H ' ' A' ' 26' ' ' VAL . 39.2 t -49.97 -48.4 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 124.378 3.263 . . . . 0.0 114.373 167.77 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -64.5 -37.35 87.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 114.704 -2.57 . . . . 0.0 111.906 -176.519 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.06 70.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 128.082 2.553 . . . . 0.0 111.358 171.502 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -80.75 -25.69 37.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.677 -1.89 . . . . 0.0 110.497 -176.65 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.264 30.3 mm -65.94 -45.49 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 116.351 -1.785 . . . . 0.0 106.832 169.858 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -62.3 -50.52 71.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 121.504 1.956 . . . . 0.0 114.89 -179.713 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -39.74 -39.66 0.82 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.299 2.24 . . . . 0.0 114.549 172.934 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.2 tttt -98.04 -41.48 7.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 117.845 -3.034 . . . . 0.0 108.006 177.34 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -113.05 -23.03 10.26 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 124.463 3.302 . . . . 0.0 111.869 -149.639 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.96 -1.63 85.12 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-O 116.799 -2.112 . . . . 0.0 116.603 174.709 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.0 mm -78.99 118.92 75.21 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 121.8 2.8 . . . . 0.0 104.303 176.342 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.69 165.35 16.12 Favored 'Trans proline' 0 N--CA 1.45 -1.053 1 C-N-CA 126.543 4.829 . . . . 0.0 113.934 179.106 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.53 -27.27 39.47 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.608 2.205 . . . . 0.0 115.246 178.53 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -69.77 1.4 4.35 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 117.466 -3.271 . . . . 0.0 111.57 -178.634 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -121.04 -14.91 8.34 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 128.598 2.759 . . . . 0.0 109.214 -169.989 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -106.47 114.07 27.96 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 128.575 3.672 . . . . 0.0 106.825 -172.198 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -108.87 141.23 41.23 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.661 2.785 . . . . 0.0 108.17 161.248 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.28 1.5 mp -116.08 139.97 49.75 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -177.51 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 mt -112.24 151.57 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 O-C-N 127.23 2.831 . . . . 0.0 103.63 169.54 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -128.16 124.41 36.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 161.451 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.326 . . 58.57 -81.88 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 128.796 2.838 . . . . 0.0 115.467 -172.743 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.63 1.34 4.35 Favored Glycine 0 CA--C 1.533 1.176 2 O-C-N 130.294 4.747 . . . . 0.0 112.534 171.565 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -122.37 151.33 41.31 Favored 'General case' 0 C--N 1.322 -0.606 1 CA-C-N 125.352 4.576 . . . . 0.0 106.643 -169.542 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 22.8 mt-30 -72.56 138.35 46.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.533 -174.601 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -95.98 120.91 37.1 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 117.079 -1.848 . . . . 0.0 112.695 171.059 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -92.63 154.02 18.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -176.446 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.87 154.9 29.38 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 131.576 3.95 . . . . 0.0 110.625 178.976 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.89 0.34 83.63 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 122.773 1.207 . . . . 0.0 115.505 171.786 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -124.75 145.85 49.5 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 131.403 3.881 . . . . 0.0 105.731 -167.006 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.41 30.5 p -79.94 159.47 26.31 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 112.225 -2.261 . . . . 0.0 115.389 -171.745 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -51.9 14.13 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 126.672 2.483 . . . . 0.0 109.919 -172.104 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -78.0 -0.37 27.56 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.431 2.692 . . . . 0.0 106.41 -168.347 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.4 -31.01 70.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 124.639 2.161 . . . . 0.0 107.127 175.576 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.353 8.3 m-85 -107.84 -179.44 3.9 Favored 'General case' 0 N--CA 1.449 -0.505 1 O-C-N 115.998 -4.189 . . . . 0.0 107.87 175.572 . . . . . . . . 3 2 . 1 . 060 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -92.9 45.68 1.19 Allowed 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 118.179 -2.826 . . . . 0.0 116.137 175.633 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.07 138.85 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 117.753 -1.117 . . . . 0.0 108.88 166.428 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -154.12 -178.46 7.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.541 1.937 . . . . 0.0 109.779 -164.438 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -50.3 115.57 1.5 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.177 1.791 . . . . 0.0 109.301 171.478 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 55.78 33.57 21.71 Favored 'General case' 0 N--CA 1.452 -0.337 1 C-N-CA 133.619 4.768 . . . . 0.0 113.491 -178.064 . . . . . . . . 2 2 . 1 . 060 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 138.8 56.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.313 1.845 . . . . 0.0 108.812 158.046 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.4 m -103.93 136.61 43.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.628 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.97 139.54 42.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 130.251 3.42 . . . . 0.0 116.771 156.202 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -97.34 124.26 41.43 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 113.219 -3.277 . . . . 0.0 107.145 -175.552 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.7 tp -93.87 124.14 37.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 128.242 3.464 . . . . 0.0 109.664 -179.248 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.2 116.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 130.194 3.398 . . . . 0.0 106.26 -177.563 . . . . . . . . 1 1 . 1 . 060 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 87.4 mt . . . . . 0 C--N 1.324 -0.536 0 O-C-N 126.116 2.135 . . . . 0.0 111.736 -166.854 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.625 0 CA-C-O 117.73 -1.128 . . . . 0.0 109.155 . . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -88.65 125.72 34.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.19 2.196 . . . . 0.0 113.676 -179.494 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -109.76 164.12 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 124.13 3.15 . . . . 0.0 111.054 177.984 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -117.83 145.56 44.49 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 117.53 -3.231 . . . . 0.0 110.07 170.66 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.3 t -122.18 127.51 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 174.055 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -73.78 111.76 9.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 111.671 -2.513 . . . . 0.0 106.422 168.896 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 m -108.61 126.97 53.54 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -178.755 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.661 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -55.14 -6.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 1 N-CA-C 122.133 4.123 . . . . 0.0 122.133 178.124 . . . . . . . . 4 4 . 1 . 061 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -83.01 3.35 30.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 123.878 0.736 . . . . 0.0 109.589 175.9 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.62 21.81 30.49 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 123.705 1.725 . . . . 0.0 114.793 -178.704 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -123.78 135.56 53.88 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 116.645 -1.645 . . . . 0.0 109.102 -162.665 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.9 m -114.79 85.09 2.18 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.981 1.848 . . . . 0.0 111.32 177.695 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 pt -77.11 161.63 4.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 O-C-N 119.1 -2.25 . . . . 0.0 106.812 -167.031 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -128.5 136.41 50.76 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 125.308 1.63 . . . . 0.0 109.774 178.582 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.331 0.3 OUTLIER -141.04 146.84 37.73 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 129.866 3.266 . . . . 0.0 114.036 -179.778 . . . . . . . . 3 3 . 1 . 061 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -92.6 120.03 32.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 129.464 3.106 . . . . 0.0 105.599 -171.05 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 16.0 m -127.37 162.85 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 116.364 -3.96 . . . . 0.0 109.732 177.756 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.61 159.96 69.53 Favored Pre-proline 0 N--CA 1.451 -0.414 1 O-C-N 115.485 -4.509 . . . . 0.0 107.053 164.882 . . . . . . . . 3 3 . 1 . 061 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -53.48 -46.84 30.85 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 N-CA-C 118.595 2.498 . . . . 0.0 118.595 -167.172 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.1 m -79.0 5.55 11.44 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 128.653 2.781 . . . . 0.0 112.56 -169.051 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.266 89.9 m-20 -77.66 140.61 39.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.73 -1.231 . . . . 0.0 109.494 176.658 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -86.0 146.62 26.59 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 129.08 3.988 . . . . 0.0 107.605 -179.522 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.77 -23.9 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 128.646 2.779 . . . . 0.0 111.762 -175.544 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -61.82 -38.83 89.64 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.974 2.91 . . . . 0.0 111.452 166.963 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.13 -35.61 78.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 125.756 2.693 . . . . 0.0 113.421 179.81 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -82.7 -37.71 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 112.44 -2.164 . . . . 0.0 109.3 176.425 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.363 61.8 mttt -48.72 -50.27 34.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.031 2.933 . . . . 0.0 111.665 168.143 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.3 56.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 116.056 -1.926 . . . . 0.0 109.928 -173.292 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -63.58 -45.2 91.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 122.474 2.397 . . . . 0.0 116.89 165.955 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -55.51 -40.54 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 114.822 -2.513 . . . . 0.0 110.223 167.713 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -61.5 -42.12 98.32 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 113.535 -3.126 . . . . 0.0 112.906 171.302 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.444 29.9 t70 -57.08 -27.83 62.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 122.627 2.467 . . . . 0.0 116.292 173.124 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -94.58 -55.7 3.05 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 126.485 2.366 . . . . 0.0 111.039 -174.298 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -117.31 -21.34 8.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.465 1.506 . . . . 0.0 113.835 -165.087 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.63 12.03 45.51 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 115.67 -2.739 . . . . 0.0 111.668 168.296 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.3 mt -82.95 132.24 51.59 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 118.87 1.335 . . . . 0.0 112.608 171.434 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.21 121.79 8.61 Favored 'Trans proline' 0 N--CA 1.456 -0.692 1 C-N-CA 129.153 6.569 . . . . 0.0 113.758 178.222 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.297 32.3 Cg_exo -40.78 -35.23 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 1 C-N-CA 126.296 4.664 . . . . 0.0 117.43 170.908 . . . . . . . . 3 2 . 1 . 061 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.75 -35.09 78.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 -175.871 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -77.62 -42.11 36.11 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 130.48 3.512 . . . . 0.0 115.387 170.049 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.27 146.97 53.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.612 1.165 . . . . 0.0 114.029 -173.723 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -141.98 154.34 44.96 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 131.693 3.997 . . . . 0.0 109.88 -177.143 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.7 mt -130.11 159.61 36.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 116.72 -3.737 . . . . 0.0 115.865 177.532 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.03 136.51 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 130.004 3.322 . . . . 0.0 115.74 165.01 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 65' ' ' SER . 91.3 t80 -140.18 145.59 37.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 167.672 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.21 33.09 19.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.705 2.802 . . . . 0.0 112.086 168.007 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.26 -24.19 12.46 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.851 -1.527 . . . . 0.0 113.978 -175.033 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -87.41 141.74 28.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 121.499 2.65 . . . . 0.0 105.461 -169.889 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.61 122.68 27.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 166.05 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -75.47 137.74 41.14 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -173.983 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -89.43 159.78 17.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 125.228 1.58 . . . . 0.0 106.91 176.607 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.11 121.89 30.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 126.203 2.189 . . . . 0.0 107.234 172.746 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.32 -33.24 3.06 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-O 124.523 2.18 . . . . 0.0 113.165 -178.398 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -82.52 167.87 17.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 112.777 -1.711 . . . . 0.0 112.698 177.821 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.0 p -109.64 167.75 9.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -176.747 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.4 mt -56.11 -48.96 75.17 Favored 'General case' 0 N--CA 1.45 -0.44 1 C-N-CA 131.98 4.112 . . . . 0.0 105.885 172.833 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -43.98 17.01 Favored 'General case' 0 N--CA 1.444 -0.765 1 C-N-CA 131.747 4.019 . . . . 0.0 108.518 174.052 . . . . . . . . 3 3 . 1 . 061 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.69 -16.38 48.47 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 124.365 3.257 . . . . 0.0 114.067 178.962 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -114.17 2.66 14.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 114.803 -2.522 . . . . 0.0 111.544 -174.661 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.305 67.3 m-80 74.85 16.33 2.99 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.794 2.438 . . . . 0.0 111.686 173.655 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -68.39 128.05 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 O-C-N 117.521 -3.237 . . . . 0.0 113.905 -174.22 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -123.41 -163.45 1.12 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.152 2.581 . . . . 0.0 107.64 -178.854 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -50.81 119.26 3.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 123.375 1.56 . . . . 0.0 113.768 169.899 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.321 50.8 mt-10 74.94 21.38 2.03 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.024 -1.672 . . . . 0.0 111.576 163.171 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.414 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 45.8 m -53.7 126.28 21.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 115.96 -1.971 . . . . 0.0 110.223 160.663 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -97.38 112.38 24.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.163 2.185 . . . . 0.0 109.314 171.856 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.314 8.7 mp -97.82 167.26 11.04 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.399 1.88 . . . . 0.0 108.864 176.144 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -116.59 124.17 49.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.822 2.849 . . . . 0.0 104.605 -176.118 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -97.78 132.19 43.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.978 2.911 . . . . 0.0 110.574 -177.229 . . . . . . . . 1 1 . 1 . 061 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.292 4.1 m -142.32 171.29 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 112.921 -1.945 . . . . 0.0 110.752 -176.538 . . . . . . . . 2 2 . 1 . 061 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 172.519 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 ptt? . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 116.878 -1.534 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 062 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.411 49.4 mm-40 -109.15 146.39 34.18 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 116.717 -1.611 . . . . 0.0 108.166 -170.609 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 pt -145.33 156.86 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 121.208 1.822 . . . . 0.0 109.038 170.473 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -99.84 141.29 32.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 178.668 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.58 133.71 51.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 156.513 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -91.34 117.6 29.8 Favored 'General case' 0 C--N 1.325 -0.474 1 C-N-CA 132.743 4.417 . . . . 0.0 110.26 170.298 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -82.65 162.46 21.84 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.342 1.857 . . . . 0.0 110.07 176.821 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pp -78.76 -24.47 44.7 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 127.384 2.274 . . . . 0.0 110.179 172.024 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -87.84 -18.02 30.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 119.867 -1.77 . . . . 0.0 114.136 -178.275 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.17 7.67 3.16 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 128.506 2.955 . . . . 0.0 115.903 144.576 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -90.62 163.34 14.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 125.36 2.505 . . . . 0.0 107.71 174.817 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.3 m -128.29 117.23 21.11 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.942 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.32 129.75 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 128.458 2.703 . . . . 0.0 103.837 -167.426 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -91.57 107.73 19.41 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -177.033 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.316 48.7 mt -102.91 152.52 21.2 Favored 'General case' 0 N--CA 1.449 -0.517 1 CA-C-N 126.341 4.155 . . . . 0.0 107.935 175.581 . . . . . . . . 3 2 . 1 . 062 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -113.78 119.93 39.04 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 114.68 -2.581 . . . . 0.0 106.15 175.313 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -124.7 149.68 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 125.003 1.439 . . . . 0.0 114.661 -175.309 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -81.61 130.61 60.81 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-O 114.991 -2.433 . . . . 0.0 104.556 167.309 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -38.71 -25.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.379 1 N-CA-C 123.163 4.255 . . . . 0.0 123.163 165.69 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.1 p -115.06 18.54 16.26 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 126.147 2.154 . . . . 0.0 114.466 178.99 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -59.46 111.33 1.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 128.822 2.849 . . . . 0.0 112.636 156.806 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -72.06 169.53 15.8 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 123.256 2.753 . . . . 0.0 111.192 -177.528 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.321 18.7 mm -51.11 -32.16 11.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 125.773 1.629 . . . . 0.0 113.782 -179.916 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -87.15 -20.86 26.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 122.179 2.263 . . . . 0.0 106.893 -175.314 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -79.39 -39.18 33.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.622 1.169 . . . . 0.0 112.482 179.839 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.3 t -43.07 -39.13 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 128.497 2.719 . . . . 0.0 113.157 161.884 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -75.01 -37.66 61.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 119.512 -1.992 . . . . 0.0 112.939 -171.818 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.285 . . -68.28 -16.69 64.05 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.974 2.509 . . . . 0.0 114.444 172.298 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.25 -38.42 17.59 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.572 2.349 . . . . 0.0 112.316 171.329 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.19 -42.41 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 114.449 -2.691 . . . . 0.0 114.451 157.445 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -48.63 -62.87 1.28 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.193 2.197 . . . . 0.0 112.471 165.283 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -33.0 -40.59 0.06 Allowed 'General case' 0 N--CA 1.448 -0.57 1 CA-C-O 111.589 -4.053 . . . . 0.0 119.709 170.656 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.48 -53.1 3.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 128.202 3.439 . . . . 0.0 111.473 176.865 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -112.97 -3.75 14.01 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -167.657 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.0 -8.94 77.54 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 116.895 -2.058 . . . . 0.0 115.683 160.5 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HB ' HE21 ' A' ' 41' ' ' GLN . 6.7 mt -66.21 130.0 94.25 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 129.045 2.938 . . . . 0.0 109.035 -172.454 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -71.22 143.15 43.2 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 N-CA-C 107.975 -1.587 . . . . 0.0 107.975 172.599 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.3 46.7 Cg_exo -28.86 -60.74 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 1 C-N-CA 126.369 4.712 . . . . 0.0 117.741 163.593 . . . . . . . . 3 2 . 1 . 062 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -55.41 -25.49 36.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 122.082 2.219 . . . . 0.0 115.568 -172.463 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -89.89 -9.89 47.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 176.211 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.416 HE21 ' HB ' ' A' ' 36' ' ' ILE . 72.0 mt-30 -94.75 154.76 17.14 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 131.599 3.96 . . . . 0.0 107.085 -175.838 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -143.47 152.38 41.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 113.853 -2.975 . . . . 0.0 104.821 163.634 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.267 76.5 mt -123.79 119.64 30.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.5 1.955 . . . . 0.0 107.385 -173.106 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -107.52 143.13 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 127.758 2.423 . . . . 0.0 110.005 -179.131 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -155.29 143.97 20.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.421 2.288 . . . . 0.0 109.304 172.343 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.66 31.88 13.52 Favored 'General case' 0 C--N 1.328 -0.331 3 O-C-N 114.566 -5.084 . . . . 0.0 114.217 161.483 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.27 2.56 62.01 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.645 2.069 . . . . 0.0 116.449 171.386 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.338 41.5 pttt -136.1 150.4 49.1 Favored 'General case' 0 N--CA 1.445 -0.717 1 C-N-CA 133.225 4.61 . . . . 0.0 114.966 -169.271 . . . . . . . . 3 2 . 1 . 062 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 48.8 tt0 -76.54 140.73 41.24 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.704 2.002 . . . . 0.0 106.996 162.455 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 mt -71.6 129.49 38.86 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 114.764 -2.541 . . . . 0.0 112.992 171.714 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.82 139.68 30.22 Favored 'General case' 0 N--CA 1.447 -0.581 1 C-N-CA 131.814 4.046 . . . . 0.0 105.057 -173.446 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.83 117.86 24.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 127.628 2.371 . . . . 0.0 115.856 -174.126 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.46 11.44 1.73 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.391 1.948 . . . . 0.0 112.836 179.684 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -141.11 163.65 32.39 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -174.058 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -123.73 -179.29 4.31 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 119.226 -2.171 . . . . 0.0 109.728 -162.994 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -58.84 -33.75 70.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 118.464 -2.648 . . . . 0.0 114.601 172.192 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 p -76.27 -34.61 59.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 120.94 1.7 . . . . 0.0 107.056 179.582 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -74.08 -42.61 59.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 125.5 1.75 . . . . 0.0 109.537 -173.237 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -76.44 4.04 9.93 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 118.762 -2.461 . . . . 0.0 115.215 166.892 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 75.8 18.0 2.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 131.529 3.932 . . . . 0.0 114.483 168.268 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.4 mt -69.97 132.98 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 O-C-N 119.295 -2.128 . . . . 0.0 108.681 -174.233 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -124.27 153.4 41.75 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 112.859 -3.448 . . . . 0.0 109.98 -173.861 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.27 135.02 27.17 Favored 'General case' 0 N--CA 1.443 -0.802 1 O-C-N 129.111 4.007 . . . . 0.0 113.049 -177.048 . . . . . . . . 3 3 . 1 . 062 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.588 80.8 mt-10 84.93 11.17 0.31 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 128.247 2.619 . . . . 0.0 116.505 172.645 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.308 27.9 m -86.65 159.9 19.06 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 116.229 -1.843 . . . . 0.0 110.964 170.978 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.8 m -130.95 113.34 13.88 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.276 1.83 . . . . 0.0 107.143 -158.948 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.7 163.32 12.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 130.575 3.55 . . . . 0.0 113.906 -179.885 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -122.17 154.86 36.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -161.31 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.257 39.1 tp -145.58 117.93 8.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 125.619 2.628 . . . . 0.0 105.913 -167.853 . . . . . . . . 2 2 . 1 . 062 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 t -110.17 119.39 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 110.588 -3.006 . . . . 0.0 108.142 169.433 . . . . . . . . 1 1 . 1 . 062 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 C--N 1.326 -0.426 0 O-C-N 119.427 -2.045 . . . . 0.0 110.294 167.157 . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttm . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 063 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -87.31 117.5 26.12 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.93 2.892 . . . . 0.0 112.728 -175.513 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.57 167.5 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.428 1.491 . . . . 0.0 109.742 170.961 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -140.6 115.21 9.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 125.327 2.489 . . . . 0.0 105.651 -168.912 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 t -101.55 109.23 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.663 -2.062 . . . . 0.0 111.807 -179.239 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -93.99 121.11 35.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 115.549 -2.167 . . . . 0.0 113.489 -174.528 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.0 p -73.48 179.32 4.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 128.246 2.618 . . . . 0.0 111.259 -177.453 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.52 -32.16 60.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.19 2.196 . . . . 0.0 108.274 172.2 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.42 -21.71 59.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.155 2.182 . . . . 0.0 109.852 179.741 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.11 -4.56 58.86 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 117.244 -1.865 . . . . 0.0 114.92 177.511 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -65.92 143.9 57.13 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.9 1.0 . . . . 0.0 110.889 170.615 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -138.15 99.93 4.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.137 -2.227 . . . . 0.0 106.011 -158.844 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.5 mm -95.72 131.78 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.226 -169.946 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 m -94.75 105.49 17.43 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 119.628 -1.92 . . . . 0.0 107.64 -171.486 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 mt -93.98 127.23 39.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 125.143 2.402 . . . . 0.0 105.594 179.401 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -95.79 110.47 22.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 119.786 -1.821 . . . . 0.0 107.506 174.071 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.14 170.57 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.598 2.759 . . . . 0.0 107.596 -174.68 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -114.39 162.41 23.49 Favored Pre-proline 0 N--CA 1.449 -0.509 1 O-C-N 129.19 4.056 . . . . 0.0 108.892 150.195 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -57.88 -14.62 18.78 Favored 'Trans proline' 0 N--CA 1.447 -1.252 1 C-N-CA 125.716 4.277 . . . . 0.0 115.486 -175.555 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.1 p -90.74 0.32 57.47 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 116.912 -3.617 . . . . 0.0 114.853 -179.383 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.74 137.91 44.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 127.983 3.302 . . . . 0.0 106.396 -176.57 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -83.39 170.69 14.26 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.171 1.35 . . . . 0.0 112.512 173.264 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mt -58.7 -42.82 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 129.26 3.024 . . . . 0.0 108.018 170.816 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -49.57 -46.99 49.53 Favored 'General case' 0 C--N 1.329 -0.294 1 C-N-CA 132.535 4.334 . . . . 0.0 109.854 166.909 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -73.61 -45.65 51.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 120.448 1.476 . . . . 0.0 110.067 -177.925 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -53.57 -48.87 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 117.315 -1.326 . . . . 0.0 108.497 171.181 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -67.39 -36.28 81.0 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 120.086 1.312 . . . . 0.0 110.368 -178.668 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.53 -40.37 78.64 Favored 'General case' 0 C--O 1.217 -0.624 1 O-C-N 115.923 -4.235 . . . . 0.0 110.703 171.238 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.319 39.2 mttp -62.14 -49.74 74.66 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.253 3.421 . . . . 0.0 117.432 -179.389 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.92 -33.94 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 128.683 3.739 . . . . 0.0 110.462 164.479 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -75.34 -37.89 60.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 121.599 2.0 . . . . 0.0 115.014 -178.903 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -55.21 -37.99 67.85 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 126.89 2.076 . . . . 0.0 113.842 172.849 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -80.99 -83.1 0.11 Allowed 'General case' 0 N--CA 1.442 -0.87 1 C-N-CA 132.108 4.163 . . . . 0.0 114.022 -176.966 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -92.37 -0.27 57.39 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 116.884 -1.531 . . . . 0.0 110.975 -174.922 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.23 11.58 82.05 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 122.652 2.478 . . . . 0.0 114.239 175.961 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.9 mm -67.77 126.8 93.08 Favored Pre-proline 0 N--CA 1.446 -0.628 1 C-N-CA 132.313 4.245 . . . . 0.0 110.808 -177.103 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -64.14 149.39 90.46 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.542 3.494 . . . . 0.0 113.4 171.519 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -68.44 -55.69 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.212 2.608 . . . . 0.0 114.422 178.044 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -52.44 -25.21 9.4 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 127.305 2.878 . . . . 0.0 113.066 -173.12 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -79.2 -10.91 59.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.077 178.857 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -111.85 152.91 27.39 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 130.206 3.402 . . . . 0.0 116.609 -168.398 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -137.96 138.69 39.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 118.712 -2.493 . . . . 0.0 106.295 166.473 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.2 mt -107.63 148.5 29.26 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.244 3.018 . . . . 0.0 112.026 -171.819 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.4 mt -147.74 118.69 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 126.811 2.044 . . . . 0.0 107.757 -164.982 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -146.56 140.69 26.31 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 126.018 1.727 . . . . 0.0 106.997 169.993 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 74.9 21.07 2.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.987 2.515 . . . . 0.0 116.123 169.542 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.75 3.01 61.07 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 120.413 -1.43 . . . . 0.0 112.299 179.705 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.315 16.7 ptpt -127.96 133.93 49.25 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -171.406 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -75.21 132.76 41.34 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 102.029 -3.322 . . . . 0.0 102.029 163.539 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.4 mt -86.29 137.91 32.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 112.94 -1.936 . . . . 0.0 108.415 -179.69 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -111.86 147.41 35.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -178.877 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.01 139.78 58.8 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 128.802 2.841 . . . . 0.0 111.635 -162.9 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.48 20.74 10.56 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.373 1.463 . . . . 0.0 114.486 178.701 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -131.99 147.35 52.45 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 123.923 1.82 . . . . 0.0 109.755 175.386 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -95.46 154.08 17.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 111.283 -2.69 . . . . 0.0 111.767 179.264 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.9 mt -51.41 -33.64 31.28 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 119.229 -2.169 . . . . 0.0 115.683 -179.105 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -10.52 59.53 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 120.415 -1.428 . . . . 0.0 114.319 177.195 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -77.76 -27.93 50.49 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.586 175.18 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.366 67.8 m-85 -104.96 -0.04 27.32 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 130.986 3.714 . . . . 0.0 113.878 170.585 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.338 0.7 OUTLIER 59.06 39.82 22.84 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 128.813 2.845 . . . . 0.0 113.962 -179.079 . . . . . . . . 3 3 . 1 . 063 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.0 mt -70.31 112.08 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 118.758 0.708 . . . . 0.0 109.811 168.634 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -112.37 -170.12 1.6 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 113.187 -1.824 . . . . 0.0 112.751 -170.813 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.443 36.1 pttt -50.65 120.18 4.49 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 120.378 3.473 . . . . 0.0 120.378 179.674 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 67.77 54.15 0.65 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.855 2.862 . . . . 0.0 109.241 177.731 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.7 m -107.43 141.31 39.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.309 175.238 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.276 36.3 m -108.9 144.95 36.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 126.233 2.921 . . . . 0.0 107.651 168.393 . . . . . . . . 2 2 . 1 . 063 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.11 -178.03 4.72 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 103.355 -2.832 . . . . 0.0 103.355 173.976 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -151.68 -179.59 7.56 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 111.986 -2.37 . . . . 0.0 105.155 -171.898 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 pp -147.15 168.46 21.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 123.345 1.545 . . . . 0.0 112.923 175.865 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.0 p -128.74 133.42 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 131.574 3.95 . . . . 0.0 110.057 -178.225 . . . . . . . . 1 1 . 1 . 063 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 164.394 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 ttp . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 115.691 -2.1 . . . . 0.0 106.17 . . . . . . . . . 0 0 . 1 . 064 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.253 27.0 mp0 -97.0 131.24 44.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -175.127 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -114.63 177.64 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 116.955 -3.59 . . . . 0.0 105.577 158.926 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -127.25 141.76 51.64 Favored 'General case' 0 N--CA 1.447 -0.618 1 C-N-CA 131.978 4.111 . . . . 0.0 108.515 175.904 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.2 106.36 17.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 -178.344 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -89.37 166.53 13.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 117.762 -3.086 . . . . 0.0 104.489 166.695 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -127.5 149.34 50.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 109.38 -3.554 . . . . 0.0 104.04 176.08 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.21 1.68 20.69 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 128.003 3.315 . . . . 0.0 112.607 175.274 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -102.84 -21.32 14.04 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.645 2.378 . . . . 0.0 116.68 167.275 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.5 13.16 9.03 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-O 113.567 -3.907 . . . . 0.0 110.805 153.721 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -72.23 131.62 42.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 123.291 3.546 . . . . 0.0 112.597 155.182 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.8 m -108.22 133.17 52.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 172.714 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.6 mt -115.24 144.0 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 129.308 3.043 . . . . 0.0 106.784 167.884 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.293 28.4 m -107.31 130.63 54.75 Favored 'General case' 0 N--CA 1.448 -0.532 1 N-CA-C 97.453 -5.017 . . . . 0.0 97.453 164.708 . . . . . . . . 3 2 . 1 . 064 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tp -130.56 138.37 50.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.857 1.348 . . . . 0.0 111.603 179.288 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.27 118.16 35.99 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 -173.225 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.289 17.1 m -120.94 160.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 122.548 1.166 . . . . 0.0 109.574 -176.095 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -96.58 141.34 22.95 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 113.305 -3.236 . . . . 0.0 113.26 173.581 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -45.0 -50.9 8.21 Favored 'Trans proline' 0 N--CA 1.444 -1.385 1 C-N-CA 131.593 8.195 . . . . 0.0 108.245 169.102 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -60.24 -15.46 24.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.703 2.001 . . . . 0.0 112.101 -179.299 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -68.94 127.95 34.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 122.469 2.395 . . . . 0.0 114.505 -168.832 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.1 p -68.33 138.49 55.47 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 125.391 1.682 . . . . 0.0 107.065 160.845 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mm -53.45 -19.83 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -177.406 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.67 -36.24 80.26 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 122.225 2.284 . . . . 0.0 112.821 166.261 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -78.42 -10.14 59.57 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 123.271 2.76 . . . . 0.0 110.19 -178.814 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -92.88 -28.82 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 118.163 -2.836 . . . . 0.0 106.447 174.383 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -84.43 -20.31 32.02 Favored 'General case' 0 CA--C 1.539 0.523 1 O-C-N 114.977 -4.827 . . . . 0.0 110.062 177.83 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.69 -26.38 59.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 117.537 -1.22 . . . . 0.0 113.5 159.752 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -78.38 -17.02 57.04 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 171.772 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.2 mt -80.18 -34.51 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 114.309 -2.758 . . . . 0.0 110.685 162.952 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -50.69 -35.81 32.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 123.078 2.672 . . . . 0.0 116.019 168.656 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.253 27.5 t70 -91.74 -5.37 53.72 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 119.148 -2.22 . . . . 0.0 111.321 -172.631 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -121.99 -36.57 2.98 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 113.175 -3.297 . . . . 0.0 111.233 -169.511 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -125.65 -26.44 3.53 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 123.648 2.931 . . . . 0.0 109.195 176.901 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.72 17.35 12.16 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 117.016 -3.553 . . . . 0.0 112.746 174.588 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mt -86.82 125.94 65.15 Favored Pre-proline 0 N--CA 1.445 -0.711 0 N-CA-C 100.821 -3.77 . . . . 0.0 100.821 -175.735 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.47 144.49 25.65 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 CA-C-O 115.47 -1.971 . . . . 0.0 112.742 165.785 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -9.71 26.89 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 124.471 3.447 . . . . 0.0 114.754 -162.994 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.77 -17.01 64.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 123.429 2.831 . . . . 0.0 117.334 169.291 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -119.82 27.19 8.85 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 117.134 -3.479 . . . . 0.0 116.285 -162.157 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -113.56 165.66 12.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.257 2.623 . . . . 0.0 111.892 178.675 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -127.15 150.79 49.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.012 3.725 . . . . 0.0 102.983 141.902 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.67 105.59 11.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 112.317 -2.219 . . . . 0.0 110.946 165.114 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.97 134.77 27.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 125.688 2.661 . . . . 0.0 105.206 174.301 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -140.76 115.08 9.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 108.603 -3.908 . . . . 0.0 112.532 176.905 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.69 37.84 1.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 128.687 2.795 . . . . 0.0 112.75 -175.052 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.6 -35.34 4.78 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 121.253 -0.905 . . . . 0.0 113.075 171.173 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.313 97.7 mttt -83.57 165.09 19.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.971 2.908 . . . . 0.0 107.247 -173.947 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -116.5 119.72 36.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.685 2.394 . . . . 0.0 108.779 177.497 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.1 mt -80.59 124.38 28.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 123.379 1.561 . . . . 0.0 109.057 -161.125 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.21 130.84 35.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 -174.38 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.95 -37.11 30.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 127.59 3.056 . . . . 0.0 118.704 -170.952 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.19 5.02 41.4 Favored Glycine 0 CA--C 1.526 0.777 1 O-C-N 116.079 -4.138 . . . . 0.0 115.026 -170.381 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -88.57 146.72 24.97 Favored 'General case' 0 C--N 1.327 -0.413 1 O-C-N 116.226 -4.103 . . . . 0.0 107.024 170.195 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -86.47 134.64 33.67 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 127.858 3.224 . . . . 0.0 111.573 -173.678 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.309 10.8 tp -22.42 -76.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 1 C-N-CA 134.036 4.935 . . . . 0.0 114.243 177.656 . . . . . . . . 3 2 . 1 . 064 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.1 -37.29 85.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 125.397 2.522 . . . . 0.0 110.217 -170.135 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.3 -21.26 42.78 Favored 'General case' 0 CA--C 1.536 0.43 1 O-C-N 113.793 -5.567 . . . . 0.0 113.201 178.584 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -22.37 66.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 162.913 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.809 6.5 t-20 105.85 24.13 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 129.534 3.134 . . . . 0.0 117.96 175.512 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -99.82 73.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 126.708 2.003 . . . . 0.0 109.672 -177.524 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -89.84 169.79 10.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 124.72 2.2 . . . . 0.0 105.955 -179.506 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -31.54 115.79 0.16 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.283 2.697 . . . . 0.0 118.283 -174.298 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 77.51 29.8 0.52 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 129.067 2.947 . . . . 0.0 113.427 174.945 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -72.44 148.47 45.12 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 126.165 2.888 . . . . 0.0 114.133 169.986 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 m -104.73 107.48 18.45 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 117.062 -3.524 . . . . 0.0 105.811 -173.288 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.36 149.17 25.22 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 128.084 3.365 . . . . 0.0 108.649 162.275 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -107.59 110.84 22.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 127.971 3.294 . . . . 0.0 114.609 155.821 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.273 6.4 tt -74.19 139.41 44.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.083 -1.636 . . . . 0.0 107.635 168.763 . . . . . . . . 2 2 . 1 . 064 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.02 145.99 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 164.97 . . . . . . . . 1 1 . 1 . 064 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mp . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 -177.573 . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptt? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 117.392 -1.29 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 065 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -100.2 161.61 13.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 169.272 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.9 pt -146.74 158.46 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 130.322 3.449 . . . . 0.0 103.137 168.71 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -107.11 140.31 40.15 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 127.057 2.143 . . . . 0.0 107.734 174.075 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -121.05 117.79 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 127.258 3.409 . . . . 0.0 105.808 170.009 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -78.79 114.93 18.14 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 116.455 -3.903 . . . . 0.0 105.182 167.069 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.4 p -86.22 159.25 19.53 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 127.996 3.31 . . . . 0.0 108.469 168.544 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.76 -30.72 71.74 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.265 -1.789 . . . . 0.0 114.009 178.834 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.4 p -72.79 4.52 3.99 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.759 2.424 . . . . 0.0 114.806 165.913 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.86 17.08 77.92 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 114.045 -3.642 . . . . 0.0 113.839 173.013 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -85.42 121.32 27.97 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 122.819 3.309 . . . . 0.0 104.844 173.607 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.3 m -85.86 63.68 8.18 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.791 2.436 . . . . 0.0 107.194 173.447 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mm -50.72 120.9 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 126.702 2.001 . . . . 0.0 111.948 173.82 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.9 m -88.67 136.66 32.88 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 174.346 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 mt -121.65 139.6 53.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.034 1.733 . . . . 0.0 106.992 177.629 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -86.97 129.22 34.97 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 167.418 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.381 18.5 m -140.75 154.48 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 128.936 2.894 . . . . 0.0 114.165 -179.416 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -117.4 171.42 4.97 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-O 114.186 -2.816 . . . . 0.0 110.596 171.63 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.97 -27.73 3.64 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 N-CA-C 118.393 2.42 . . . . 0.0 118.393 -170.171 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -86.61 -5.96 59.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 119.056 -2.277 . . . . 0.0 116.463 178.661 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.16 122.65 11.49 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 127.605 2.362 . . . . 0.0 108.996 178.224 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 p -85.87 169.77 13.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 117.222 -3.424 . . . . 0.0 110.883 -179.402 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 mt -61.79 -27.81 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 O-C-N 126.299 2.249 . . . . 0.0 111.049 179.253 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.94 -43.36 79.29 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.491 -1.38 . . . . 0.0 107.372 174.326 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.315 30.0 m-20 -54.36 -41.53 69.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 118.736 -2.477 . . . . 0.0 117.344 168.6 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.5 t -73.56 -52.81 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 125.107 1.504 . . . . 0.0 109.082 176.135 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -44.64 -37.44 3.65 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 117.556 -3.215 . . . . 0.0 117.348 168.095 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.65 -37.86 55.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 126.826 2.579 . . . . 0.0 111.766 177.037 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -56.72 -50.15 73.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 127.424 2.952 . . . . 0.0 110.376 175.929 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.61 -31.29 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 117.469 -1.253 . . . . 0.0 109.322 -178.509 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -68.29 -48.63 64.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 121.104 1.775 . . . . 0.0 110.706 174.357 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.279 32.2 t70 -43.72 -40.77 4.45 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 128.624 3.703 . . . . 0.0 114.117 169.261 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -77.88 -60.1 2.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.459 1.904 . . . . 0.0 114.714 172.464 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -101.3 -21.19 14.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -162.071 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.0 -11.4 65.92 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 117.079 1.592 . . . . 0.0 117.079 -177.4 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.281 73.5 mt -77.58 126.33 84.68 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 123.915 3.857 . . . . 0.0 112.584 -174.875 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.98 168.37 24.95 Favored 'Trans proline' 0 N--CA 1.44 -1.638 0 N-CA-C 116.731 1.781 . . . . 0.0 116.731 -174.007 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.26 -22.78 9.42 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 CA-C-O 124.999 2.0 . . . . 0.0 115.817 -162.88 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.56 -20.36 59.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 111.983 -3.865 . . . . 0.0 110.58 179.778 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.64 -16.62 44.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 128.773 3.796 . . . . 0.0 109.001 -174.737 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -98.84 137.63 37.14 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.994 1.854 . . . . 0.0 113.472 -171.493 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -116.15 141.91 47.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 153.13 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.82 138.85 48.68 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.081 0.943 . . . . 0.0 108.636 179.893 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -129.09 135.04 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 124.002 0.921 . . . . 0.0 109.564 -168.693 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -90.66 -175.94 4.57 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.365 2.266 . . . . 0.0 107.598 176.521 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -20.34 -57.22 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 1 C-N-CA 138.361 6.664 . . . . 0.0 111.826 -176.537 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.89 9.69 1.81 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.333 -1.815 . . . . 0.0 114.823 172.759 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -141.82 129.6 21.69 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -165.313 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -75.35 139.82 42.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 126.22 2.2 . . . . 0.0 109.053 179.926 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -97.59 157.88 15.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 121.202 1.819 . . . . 0.0 110.692 179.003 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -148.64 138.96 22.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 123.013 1.387 . . . . 0.0 108.627 -176.517 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -59.42 144.3 47.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.008 2.923 . . . . 0.0 112.969 -163.526 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.6 11.88 11.11 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 126.366 2.291 . . . . 0.0 117.011 168.205 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -136.47 159.24 42.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.684 2.794 . . . . 0.0 109.072 179.487 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.0 p -85.96 176.68 7.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 124.854 2.264 . . . . 0.0 110.709 177.016 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.5 mt -62.94 -47.99 80.83 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 119.293 -2.13 . . . . 0.0 109.331 169.904 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -46.58 -38.17 9.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.892 2.877 . . . . 0.0 114.399 173.505 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -78.17 -31.61 49.72 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 115.051 -2.405 . . . . 0.0 104.803 -174.575 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -95.12 -1.38 52.09 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.817 1.323 . . . . 0.0 107.749 -173.361 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 60.0 m-80 77.83 27.72 0.57 Allowed 'General case' 0 N--CA 1.45 -0.471 1 O-C-N 115.429 -4.545 . . . . 0.0 117.931 171.605 . . . . . . . . 3 2 . 1 . 065 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -103.15 123.21 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 -170.249 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -123.28 171.0 9.71 Favored 'General case' 0 N--CA 1.445 -0.679 1 C-N-CA 131.737 4.015 . . . . 0.0 113.317 176.126 . . . . . . . . 2 2 . 1 . 065 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -57.78 135.65 56.83 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 128.155 2.582 . . . . 0.0 111.478 -168.092 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.337 0.7 OUTLIER 81.51 7.24 1.13 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.656 2.782 . . . . 0.0 118.178 -177.896 . . . . . . . . 3 3 . 1 . 065 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -68.67 139.61 55.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 124.83 2.252 . . . . 0.0 110.579 169.849 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.0 m -97.08 125.78 41.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 111.182 -2.735 . . . . 0.0 106.831 170.72 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.3 mt -96.36 150.51 20.5 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 128.759 2.824 . . . . 0.0 106.809 166.913 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -126.38 130.91 51.67 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 129.098 2.959 . . . . 0.0 110.703 171.685 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tp -86.4 141.84 28.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.685 1.994 . . . . 0.0 111.865 -178.543 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -130.91 133.02 63.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 101.872 -3.381 . . . . 0.0 101.872 177.098 . . . . . . . . 1 1 . 1 . 065 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.1 mt . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 119.042 2.979 . . . . 0.0 119.042 175.668 . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 113.855 -2.974 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 066 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -98.7 149.88 22.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 121.111 1.778 . . . . 0.0 107.267 -176.997 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 pt -152.01 157.02 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.184 1.793 . . . . 0.0 107.934 174.129 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -110.1 142.86 40.99 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 130.275 3.43 . . . . 0.0 105.79 -175.176 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t -113.97 138.46 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 168.873 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -100.96 144.72 29.57 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 118.134 -2.854 . . . . 0.0 110.757 162.348 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.1 m -113.63 142.37 46.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.523 2.729 . . . . 0.0 104.956 -175.951 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 3.2 tm? -47.35 -49.28 24.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.33 2.252 . . . . 0.0 111.569 -171.769 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.3 p -80.29 5.7 14.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 -177.871 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.34 -9.83 10.89 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 121.723 3.449 . . . . 0.0 121.723 157.47 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -79.61 149.0 31.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.883 1.673 . . . . 0.0 109.736 -179.544 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m -119.09 124.29 46.52 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 129.612 3.165 . . . . 0.0 108.572 178.811 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.286 1.5 pp -119.33 -173.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.095 1.358 . . . . 0.0 111.559 176.049 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 t -154.2 144.17 21.88 Favored 'General case' 0 C--N 1.321 -0.647 1 O-C-N 116.0 -4.187 . . . . 0.0 110.345 177.267 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.34 0.3 OUTLIER -138.42 150.97 47.03 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.77 2.828 . . . . 0.0 109.168 -175.159 . . . . . . . . 3 3 . 1 . 066 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.371 13.1 mp0 -97.49 119.89 36.87 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 126.66 2.475 . . . . 0.0 111.233 175.444 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.275 34.2 m -142.89 -179.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -163.145 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -141.84 143.37 28.48 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 127.568 2.347 . . . . 0.0 111.788 174.409 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.258 2.2 Cg_endo -58.73 -28.18 85.8 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 CA-C-N 127.279 3.635 . . . . 0.0 116.318 -175.073 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.9 m -85.2 19.59 2.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 112.375 -3.678 . . . . 0.0 109.144 178.524 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -88.18 148.54 24.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 -178.982 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -87.47 154.08 20.92 Favored 'General case' 0 N--CA 1.446 -0.642 1 O-C-N 130.604 4.94 . . . . 0.0 113.244 177.489 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mm -53.17 -30.93 17.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 123.108 2.685 . . . . 0.0 118.069 -175.187 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.29 10.5 tt0 -70.62 -41.52 72.14 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 116.769 -1.586 . . . . 0.0 109.812 -176.315 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -72.95 -20.56 61.03 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 128.425 2.69 . . . . 0.0 112.152 -174.125 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -79.14 -50.06 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 128.054 2.541 . . . . 0.0 110.796 165.128 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -62.02 -24.06 66.83 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 120.745 1.612 . . . . 0.0 114.992 174.984 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.94 -37.57 53.21 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 128.67 2.788 . . . . 0.0 113.54 170.701 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -81.56 -23.35 37.25 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 126.038 2.086 . . . . 0.0 112.879 -176.649 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.85 -42.63 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 129.072 2.949 . . . . 0.0 104.357 179.669 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -51.03 -54.17 27.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.09 2.556 . . . . 0.0 113.83 164.294 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.66 -44.02 85.4 Favored 'General case' 0 N--CA 1.44 -0.96 1 C-N-CA 131.962 4.105 . . . . 0.0 117.54 -178.364 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -78.15 -81.85 0.1 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.646 1.979 . . . . 0.0 110.128 168.617 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -76.85 -35.11 57.72 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 127.015 2.697 . . . . 0.0 116.596 -162.663 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.85 11.1 23.47 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 119.19 -2.194 . . . . 0.0 117.139 177.024 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mt -88.72 134.54 33.68 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 116.258 -1.83 . . . . 0.0 106.548 -177.125 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -70.38 142.97 46.5 Favored 'Trans proline' 0 N--CA 1.447 -1.241 1 C-N-CA 125.454 4.103 . . . . 0.0 112.646 174.217 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.85 -20.31 68.17 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.698 1.599 . . . . 0.0 112.167 174.815 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -72.0 -5.52 35.58 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 118.231 -2.793 . . . . 0.0 112.179 172.478 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -126.01 0.71 7.25 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.827 2.451 . . . . 0.0 116.312 -176.607 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.262 50.6 mt-30 -101.72 149.01 24.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 122.256 2.298 . . . . 0.0 105.026 -175.219 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -133.06 130.96 40.06 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 158.998 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.8 mt -98.47 133.82 42.31 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.831 2.853 . . . . 0.0 107.019 175.255 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.35 148.07 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 176.319 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -156.7 119.4 4.04 Favored 'General case' 0 C--O 1.24 0.568 1 C-N-CA 132.212 4.205 . . . . 0.0 110.869 167.437 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 74.5 13.67 3.68 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.541 1.936 . . . . 0.0 115.205 177.724 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.9 -28.11 7.16 Favored Glycine 0 CA--C 1.531 1.065 1 CA-C-O 112.282 -4.621 . . . . 0.0 107.272 179.907 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -99.85 134.04 43.33 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 128.022 2.837 . . . . 0.0 110.937 -157.224 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.93 129.99 42.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.384 1.053 . . . . 0.0 109.289 163.908 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.78 111.84 6.53 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 125.41 1.484 . . . . 0.0 111.828 171.224 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.473 15.9 tt0 -91.85 148.03 22.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -172.51 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.75 142.77 35.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 120.481 1.491 . . . . 0.0 112.365 -164.877 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.34 -33.94 5.43 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 125.803 2.891 . . . . 0.0 112.86 -177.629 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -80.43 170.69 16.04 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 111.514 -2.343 . . . . 0.0 111.053 -175.886 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -115.38 159.28 21.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.994 2.518 . . . . 0.0 108.769 -172.368 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.1 -26.43 68.29 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 116.393 -3.942 . . . . 0.0 109.756 179.566 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.0 t -54.23 -50.89 66.12 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.799 2.44 . . . . 0.0 113.353 175.317 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -48.09 -16.56 0.09 Allowed 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 127.476 2.31 . . . . 0.0 117.145 173.535 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -124.96 -4.28 7.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 118.058 -2.901 . . . . 0.0 111.95 179.689 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 93.17 31.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 125.573 1.795 . . . . 0.0 108.073 163.442 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.6 121.2 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 -172.397 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -113.37 176.16 5.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 112.902 -1.953 . . . . 0.0 112.066 -175.675 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -39.14 124.54 1.49 Allowed 'General case' 0 CA--C 1.536 0.42 1 C-N-CA 132.47 4.308 . . . . 0.0 111.643 164.526 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 80.14 0.22 2.03 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.997 3.719 . . . . 0.0 113.808 175.559 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -62.44 135.26 57.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 121.591 1.996 . . . . 0.0 108.733 -171.709 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.9 m -95.72 118.63 32.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.439 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -92.19 155.74 17.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 129.028 2.931 . . . . 0.0 108.067 177.394 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -105.68 133.08 50.99 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 163.607 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.7 tp -101.39 130.94 47.7 Favored 'General case' 0 C--N 1.322 -0.62 1 C-N-CA 132.633 4.373 . . . . 0.0 115.286 162.424 . . . . . . . . 2 2 . 1 . 066 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.5 t -127.24 130.27 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 131.237 3.815 . . . . 0.0 104.041 -179.43 . . . . . . . . 1 1 . 1 . 066 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.445 -0.684 0 CA-C-O 115.249 -2.31 . . . . 0.0 113.163 -177.687 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttp . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 . . . . . . . . . 0 0 . 1 . 067 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -87.09 131.91 33.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.188 0.995 . . . . 0.0 108.411 -175.064 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.268 30.6 pt -110.67 142.21 23.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 154.322 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -88.24 129.72 35.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 160.783 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.19 115.63 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 O-C-N 127.705 3.128 . . . . 0.0 112.812 161.241 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -67.04 118.22 10.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 127.721 2.408 . . . . 0.0 111.415 173.208 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.8 p -86.59 163.95 17.14 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 120.004 3.335 . . . . 0.0 120.004 170.918 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 mp -84.86 -18.14 35.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 129.076 2.951 . . . . 0.0 112.776 179.344 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.93 -37.07 86.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 128.228 2.611 . . . . 0.0 111.804 172.756 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.1 -159.81 24.45 Favored Glycine 0 CA--C 1.533 1.186 1 C-N-CA 132.357 4.789 . . . . 0.0 108.356 -163.165 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 mttt 41.14 -163.47 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 1 N-CA-C 123.397 4.591 . . . . 0.0 123.397 167.28 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.0 p -128.76 157.75 40.57 Favored 'General case' 0 N--CA 1.444 -0.738 2 O-C-N 115.511 -4.493 . . . . 0.0 110.106 164.079 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.8 mm -95.73 130.91 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 161.434 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 m -94.55 120.68 35.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.556 1.17 . . . . 0.0 108.945 163.027 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -100.18 144.53 29.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 131.078 3.751 . . . . 0.0 106.418 -178.455 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.92 141.21 28.67 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 121.521 1.964 . . . . 0.0 108.76 152.908 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.24 153.98 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 O-C-N 124.697 1.248 . . . . 0.0 108.782 172.582 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -90.36 156.94 45.48 Favored Pre-proline 0 C--N 1.322 -0.619 0 O-C-N 118.005 -2.934 . . . . 0.0 104.209 163.542 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.7 -4.34 13.42 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 O-C-N 116.843 -2.241 . . . . 0.0 112.336 -176.776 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.8 p -97.71 7.47 46.37 Favored 'General case' 0 N--CA 1.448 -0.56 1 C-N-CA 135.67 5.588 . . . . 0.0 116.808 173.992 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -82.05 158.13 23.89 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 165.234 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -90.76 161.96 15.08 Favored 'General case' 0 C--N 1.326 -0.435 1 C-N-CA 132.218 4.207 . . . . 0.0 109.524 171.187 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mt -69.28 -20.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 127.572 2.349 . . . . 0.0 110.144 175.556 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.19 -26.14 65.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.088 -1.633 . . . . 0.0 114.009 164.999 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -34.93 69.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 120.858 1.663 . . . . 0.0 111.379 164.558 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.67 -54.45 32.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 122.767 2.53 . . . . 0.0 109.09 174.238 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -48.24 -50.83 28.08 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 118.799 -2.438 . . . . 0.0 115.569 177.788 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.27 -11.24 59.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 116.444 -1.741 . . . . 0.0 113.394 -176.438 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -81.62 -35.25 30.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 122.022 2.192 . . . . 0.0 111.416 166.7 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.24 -44.3 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 126.204 1.802 . . . . 0.0 109.183 169.045 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.32 44.6 tt0 -69.25 -40.05 78.1 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 117.372 -3.33 . . . . 0.0 110.018 -175.907 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -52.25 -49.46 63.99 Favored 'General case' 0 N--CA 1.445 -0.7 1 C-N-CA 134.669 5.187 . . . . 0.0 110.27 169.092 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.275 35.3 mttm -76.03 -57.9 3.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 114.023 -2.894 . . . . 0.0 110.345 177.804 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -113.07 -12.87 13.13 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 121.674 2.034 . . . . 0.0 106.564 -157.992 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.45 1.49 60.61 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 125.369 3.713 . . . . 0.0 114.934 160.732 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.9 mm -74.49 133.77 76.92 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 125.897 1.587 . . . . 0.0 108.545 -174.519 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -66.92 144.85 72.16 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 N-CA-C 116.432 1.666 . . . . 0.0 116.432 176.393 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.16 -25.31 13.84 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 CA-C-O 116.247 -1.647 . . . . 0.0 110.784 -162.467 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.63 -12.06 59.95 Favored 'General case' 0 N--CA 1.442 -0.836 1 C-N-CA 133.298 4.639 . . . . 0.0 105.47 -176.358 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -104.59 -15.13 15.4 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 125.305 1.628 . . . . 0.0 112.321 174.159 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -83.53 95.48 8.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 116.624 -3.797 . . . . 0.0 109.642 -178.597 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -87.89 92.75 9.24 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 121.919 2.145 . . . . 0.0 108.437 175.824 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.57 130.35 34.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 112.085 -2.325 . . . . 0.0 109.606 -179.021 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.9 mt -116.45 143.33 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 111.47 -2.604 . . . . 0.0 108.348 -170.452 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -144.16 129.85 19.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.107 1.363 . . . . 0.0 110.362 161.56 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.286 . . 57.15 15.88 2.7 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 119.613 3.19 . . . . 0.0 119.613 174.752 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.72 -32.88 5.78 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 117.989 -1.45 . . . . 0.0 112.279 -172.552 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.8 tttm -92.47 127.93 38.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.793 1.797 . . . . 0.0 108.121 -170.784 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 104.94 13.39 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 128.85 3.844 . . . . 0.0 106.348 168.095 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -71.84 125.19 26.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 111.438 -2.619 . . . . 0.0 113.964 -157.632 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.59 161.57 29.02 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 124.704 2.192 . . . . 0.0 105.25 -166.368 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.93 154.73 31.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.06 1.744 . . . . 0.0 112.836 163.541 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.81 -4.81 24.27 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.303 2.382 . . . . 0.0 114.949 165.466 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -136.1 168.93 18.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -171.66 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.8 p -107.44 173.76 6.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 119.324 -2.11 . . . . 0.0 113.163 -175.353 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mt -76.64 -18.34 58.65 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 116.867 -3.645 . . . . 0.0 108.527 -164.312 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.2 t -76.93 -31.27 56.52 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 129.398 3.079 . . . . 0.0 105.644 177.782 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 35.0 m-20 -78.22 -44.25 26.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 102.41 -3.181 . . . . 0.0 102.41 -173.809 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -72.64 1.93 7.43 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 127.539 2.336 . . . . 0.0 114.832 174.556 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t30 72.15 5.46 5.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.73 2.012 . . . . 0.0 113.042 171.199 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.4 mt -70.54 129.61 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 125.004 3.547 . . . . 0.0 106.701 -168.814 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.325 95.6 mm-40 -103.69 166.58 10.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 125.958 2.036 . . . . 0.0 108.9 174.466 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -42.65 123.1 2.53 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 130.725 3.61 . . . . 0.0 114.744 170.772 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.404 8.0 mp0 85.66 8.28 0.35 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 129.446 3.098 . . . . 0.0 112.87 170.161 . . . . . . . . 2 2 . 1 . 067 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -64.86 137.72 57.94 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 119.756 -1.84 . . . . 0.0 110.22 177.034 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -93.74 107.38 19.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 119.688 -1.883 . . . . 0.0 109.475 174.094 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.95 148.82 23.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 100.378 -3.934 . . . . 0.0 100.378 178.226 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -92.52 141.23 28.73 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 116.341 -3.975 . . . . 0.0 109.008 171.509 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.355 14.1 tp -107.77 131.35 54.55 Favored 'General case' 0 N--CA 1.451 -0.413 1 N-CA-C 98.36 -4.682 . . . . 0.0 98.36 158.05 . . . . . . . . 3 2 . 1 . 067 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.66 139.55 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 126.598 2.436 . . . . 0.0 105.387 169.465 . . . . . . . . 1 1 . 1 . 067 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.2 mt . . . . . 0 N--CA 1.451 -0.42 0 CA-C-N 111.982 -2.372 . . . . 0.0 105.905 176.576 . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 ttp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 0 0 . 1 . 068 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -87.15 152.08 22.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 102.842 -3.021 . . . . 0.0 102.842 -175.032 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 pt -150.65 164.33 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 131.538 3.935 . . . . 0.0 107.04 169.689 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -118.04 141.15 48.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 130.379 3.472 . . . . 0.0 112.351 166.568 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m -104.4 151.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 111.464 -2.607 . . . . 0.0 108.671 162.134 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -140.67 156.42 46.24 Favored 'General case' 0 C--N 1.327 -0.377 1 O-C-N 115.266 -4.646 . . . . 0.0 106.848 176.679 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.347 4.8 t -142.21 152.5 43.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.475 2.71 . . . . 0.0 107.512 -176.671 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.97 -8.26 4.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 130.825 3.65 . . . . 0.0 118.388 -170.962 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.2 p -79.61 -20.0 47.9 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 123.891 3.041 . . . . 0.0 108.492 166.675 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.35 -1.17 23.75 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 128.676 3.036 . . . . 0.0 112.562 -175.733 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.269 75.3 tttt -72.78 143.45 47.92 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 118.449 -2.795 . . . . 0.0 110.318 -173.828 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.4 p -135.27 143.43 46.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.859 2.064 . . . . 0.0 114.344 179.727 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -139.19 143.35 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 1 C-N-CA 131.71 4.004 . . . . 0.0 109.963 -178.916 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 t -101.74 139.89 36.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.611 1.82 . . . . 0.0 113.215 171.015 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mt -129.85 151.25 50.62 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.235 1.414 . . . . 0.0 109.219 177.667 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -109.19 118.06 35.73 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.833 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.43 139.37 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -170.039 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -76.62 142.72 70.79 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-O 124.37 2.033 . . . . 0.0 106.195 177.044 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -58.81 -36.49 96.93 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 125.016 3.811 . . . . 0.0 116.546 178.051 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 p -72.72 -12.99 61.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.495 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -72.09 140.75 49.08 Favored 'General case' 0 N--CA 1.45 -0.455 1 O-C-N 115.303 -4.623 . . . . 0.0 113.026 -176.831 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.3 p -73.14 134.98 44.64 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 179.447 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.251 26.6 mm -47.34 -38.24 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 129.704 3.202 . . . . 0.0 110.48 179.431 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -36.35 76.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 172.05 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -77.2 -40.52 44.83 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 129.249 3.02 . . . . 0.0 107.3 -177.777 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -70.94 -31.04 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 130.565 3.546 . . . . 0.0 112.331 -177.75 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP . 23.0 ttmt -64.86 -32.66 74.47 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 116.709 -3.744 . . . . 0.0 108.559 179.39 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.37 69.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 117.232 -3.417 . . . . 0.0 113.138 172.502 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -74.54 -5.98 45.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 119.859 1.209 . . . . 0.0 111.666 -171.186 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.21 -35.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 123.695 1.712 . . . . 0.0 114.432 156.454 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -72.72 -38.0 67.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 118.232 -2.792 . . . . 0.0 110.053 -166.818 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.67 -36.81 83.42 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.09 171.055 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -90.14 -33.57 16.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 113.982 -2.913 . . . . 0.0 112.084 -175.35 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -126.25 -30.25 2.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 122.037 2.199 . . . . 0.0 112.373 -171.999 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.81 -8.35 42.84 Favored Glycine 0 CA--C 1.522 0.507 1 CA-C-O 112.157 -4.691 . . . . 0.0 113.153 176.935 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -74.21 125.58 89.88 Favored Pre-proline 0 C--N 1.328 -0.347 1 O-C-N 131.361 4.8 . . . . 0.0 108.025 -175.914 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.06 138.28 43.36 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 N-CA-C 117.525 2.086 . . . . 0.0 117.525 166.007 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.42 -31.95 88.64 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.901 3.067 . . . . 0.0 115.521 -170.656 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.61 -17.93 64.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 111.911 -3.899 . . . . 0.0 108.293 -171.467 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.09 -13.22 59.95 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 117.97 2.581 . . . . 0.0 117.97 172.151 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -116.13 151.46 35.6 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 120.328 -1.482 . . . . 0.0 111.344 -154.27 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -141.33 123.67 15.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 116.556 -3.84 . . . . 0.0 113.283 175.616 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.3 148.6 28.24 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 117.132 -3.48 . . . . 0.0 115.862 171.807 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.32 45.7 mt -131.11 138.6 53.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 127.955 2.502 . . . . 0.0 110.481 179.528 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -135.85 -176.98 4.48 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 179.52 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.41 85.75 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.226 3.01 . . . . 0.0 116.565 -164.931 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.41 -36.46 3.96 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 118.806 -2.434 . . . . 0.0 117.359 -174.492 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.355 86.1 tttt -151.87 159.6 43.8 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 125.955 2.788 . . . . 0.0 111.081 -160.401 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -80.61 144.31 32.46 Favored 'General case' 0 C--N 1.323 -0.545 1 CA-C-N 107.405 -4.452 . . . . 0.0 108.202 178.723 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.3 mt -94.72 133.23 38.63 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 115.812 -2.355 . . . . 0.0 109.91 -175.397 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.2 132.13 48.3 Favored 'General case' 0 C--N 1.326 -0.454 1 O-C-N 115.694 -4.378 . . . . 0.0 118.624 168.229 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 70.5 m-20 -76.46 93.28 3.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 128.7 3.75 . . . . 0.0 111.021 -168.649 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.55 -0.23 2.74 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 118.495 2.158 . . . . 0.0 118.495 -170.919 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -102.81 175.15 5.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.065 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.333 78.8 p -105.38 164.13 12.09 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.651 2.781 . . . . 0.0 110.56 -172.033 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -41.04 -51.66 3.28 Favored 'General case' 0 N--CA 1.446 -0.644 1 C-N-CA 132.109 4.164 . . . . 0.0 110.699 164.646 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 m -86.04 -6.96 58.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.253 -164.787 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -69.24 -38.62 78.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 124.911 2.291 . . . . 0.0 112.21 171.115 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.55 -5.18 22.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 128.121 2.568 . . . . 0.0 112.812 -175.559 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.521 0.7 OUTLIER 75.61 37.62 0.41 Allowed 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 128.098 3.374 . . . . 0.0 113.584 175.539 . . . . . . . . 3 3 . 1 . 068 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -70.81 137.28 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 173.129 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -131.69 -178.06 4.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.147 -168.797 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -42.21 110.62 0.18 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.926 2.491 . . . . 0.0 113.77 176.274 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 73.88 25.24 1.95 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.514 1.926 . . . . 0.0 111.829 172.458 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.14 128.76 37.65 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 119.182 -2.199 . . . . 0.0 110.262 179.722 . . . . . . . . 2 2 . 1 . 068 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.9 m -91.12 107.6 19.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.216 1.006 . . . . 0.0 111.017 172.486 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.5 mt -97.01 147.56 23.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.432 1.893 . . . . 0.0 107.23 179.481 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -101.55 147.83 25.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 117.117 -1.42 . . . . 0.0 107.595 -174.181 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.19 142.97 46.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 125.095 2.379 . . . . 0.0 107.983 -179.631 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -138.42 159.59 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 O-C-N 119.353 -2.092 . . . . 0.0 105.468 173.191 . . . . . . . . 1 1 . 1 . 068 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 112.528 -3.606 . . . . 0.0 118.151 151.24 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttp . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 . . . . . . . . . 0 0 . 1 . 069 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -101.41 137.27 39.96 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 -177.369 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.492 9.7 pt -142.67 149.79 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 1 C-N-CA 133.08 4.552 . . . . 0.0 110.259 174.913 . . . . . . . . 3 2 . 1 . 069 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -108.96 141.35 41.19 Favored 'General case' 0 C--O 1.223 -0.312 1 N-CA-C 99.909 -4.108 . . . . 0.0 99.909 -175.602 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.15 119.57 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 124.249 1.02 . . . . 0.0 113.526 156.689 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -91.5 111.3 22.75 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 -178.971 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -65.95 162.55 18.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 124.644 2.164 . . . . 0.0 115.26 171.758 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.508 ' H ' HD21 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -68.53 -7.0 28.49 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 118.515 -2.615 . . . . 0.0 115.832 176.882 . . . . . . . . 3 3 . 1 . 069 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -123.08 14.01 9.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 118.668 -2.52 . . . . 0.0 109.671 -176.826 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.16 -31.87 7.53 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 115.772 -2.682 . . . . 0.0 112.49 154.492 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -61.85 147.49 46.4 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 179.257 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.9 m -105.39 149.1 26.4 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 115.483 -2.199 . . . . 0.0 112.98 175.236 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.23 124.91 72.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 100.647 -3.834 . . . . 0.0 100.647 -179.623 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -78.14 134.18 37.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 117.227 -3.421 . . . . 0.0 110.525 162.612 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.4 mt -115.17 132.23 56.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 125.268 1.605 . . . . 0.0 109.141 167.892 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -97.38 117.21 31.09 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 127.42 2.95 . . . . 0.0 105.298 168.017 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.41 -171.52 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 125.054 1.342 . . . . 0.0 112.167 -175.32 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -136.88 146.8 56.55 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-O 115.673 -2.108 . . . . 0.0 108.246 -165.175 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.53 -29.05 83.55 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.645 2.897 . . . . 0.0 118.425 178.346 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.4 p -92.76 1.13 57.44 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 127.614 3.071 . . . . 0.0 114.248 -175.692 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.73 118.34 22.18 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -173.273 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.286 17.0 p -52.03 142.68 15.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 117.658 -3.151 . . . . 0.0 116.181 164.108 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.358 2.5 mm -31.23 -56.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 128.001 2.52 . . . . 0.0 114.977 174.405 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.252 12.9 mm-40 -53.71 -43.77 69.29 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.035 2.534 . . . . 0.0 117.573 172.588 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.417 6.6 m120 -59.95 -14.67 16.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 118.503 2.779 . . . . 0.0 118.503 165.296 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.352 61.7 t -97.7 -33.36 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.159 1.784 . . . . 0.0 110.18 174.696 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -75.55 -27.72 58.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.346 -1.788 . . . . 0.0 109.997 178.68 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.93 -56.67 18.64 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 129.578 3.151 . . . . 0.0 112.414 167.643 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.297 88.5 mttt -44.19 -29.92 0.71 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 164.272 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -77.72 -28.69 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 O-C-N 118.407 -2.683 . . . . 0.0 112.018 171.037 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -77.2 -35.02 56.08 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 122.576 2.443 . . . . 0.0 107.392 -174.388 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.57 -31.86 66.57 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 126.005 2.066 . . . . 0.0 108.886 177.735 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -92.85 -50.56 5.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 113.113 -3.327 . . . . 0.0 110.844 -177.136 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -112.54 -19.05 12.25 Favored 'General case' 0 N--CA 1.439 -0.983 1 O-C-N 130.346 4.779 . . . . 0.0 111.129 -155.806 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.34 -4.63 58.56 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 125.631 1.832 . . . . 0.0 116.183 174.083 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.54 112.89 35.18 Favored Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 130.926 3.691 . . . . 0.0 111.06 -172.642 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.57 150.77 87.67 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 O-C-N 123.377 1.198 . . . . 0.0 111.711 -173.677 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.422 50.8 Cg_exo -41.58 -50.67 4.65 Favored 'Trans proline' 0 N--CA 1.457 -0.639 1 C-N-CA 125.648 4.232 . . . . 0.0 116.939 167.833 . . . . . . . . 3 2 . 1 . 069 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.271 33.9 t70 -56.67 -22.92 38.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -178.681 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -95.52 -13.15 24.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 117.542 -3.224 . . . . 0.0 110.222 -173.807 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.261 77.7 mt-30 -94.19 136.26 34.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.957 -164.282 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.553 ' HG2' HE22 ' A' ' 49' ' ' GLN . 70.9 mtp180 -115.67 127.42 55.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 102.237 -3.245 . . . . 0.0 102.237 165.408 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.1 mt -102.62 119.79 39.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 124.525 1.141 . . . . 0.0 113.216 168.006 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.6 mm -114.63 152.72 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 128.947 2.899 . . . . 0.0 105.715 -170.016 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -168.0 127.04 1.25 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 112.013 -2.358 . . . . 0.0 106.556 176.532 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.417 . . 75.78 15.28 2.59 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 122.398 2.363 . . . . 0.0 116.044 167.068 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.49 17.44 31.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.856 2.646 . . . . 0.0 118.318 177.793 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 pttt -160.66 149.49 16.74 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -156.801 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.553 HE22 ' HG2' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -75.1 143.04 43.56 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 125.309 1.631 . . . . 0.0 108.021 178.094 . . . . . . . . 3 3 . 1 . 069 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.45 117.2 18.69 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.462 -1.399 . . . . 0.0 107.757 169.755 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -81.57 150.92 27.94 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 131.145 3.778 . . . . 0.0 113.657 -166.422 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -64.86 120.56 12.76 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.781 2.033 . . . . 0.0 107.647 -171.956 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.56 15.25 3.7 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.394 1.949 . . . . 0.0 113.172 165.139 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.337 20.1 mtt180 -133.68 146.71 51.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 123.071 1.415 . . . . 0.0 113.881 -161.438 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -107.85 149.86 27.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 124.077 1.894 . . . . 0.0 107.505 178.043 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 mt -34.19 -48.09 0.31 Allowed 'General case' 0 N--CA 1.448 -0.525 1 C-N-CA 132.419 4.288 . . . . 0.0 116.124 176.778 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.4 p -83.88 -6.39 59.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -179.432 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.352 31.1 t0 -101.17 -10.7 20.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.765 2.026 . . . . 0.0 107.713 176.372 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.88 -14.36 17.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 129.412 3.085 . . . . 0.0 111.703 173.974 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 73.23 39.58 0.59 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 127.238 2.836 . . . . 0.0 110.578 -175.412 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.6 mt -87.05 96.64 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 121.988 2.176 . . . . 0.0 111.075 172.062 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.84 169.51 17.77 Favored 'General case' 0 C--N 1.325 -0.498 1 C-N-CA 134.848 5.259 . . . . 0.0 112.442 177.32 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.291 0.0 OUTLIER -51.3 140.19 17.5 Favored 'General case' 0 N--CA 1.439 -0.988 1 C-N-CA 131.739 4.016 . . . . 0.0 111.539 175.915 . . . . . . . . 4 3 . 1 . 069 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 37.34 43.58 0.39 Allowed 'General case' 0 C--N 1.324 -0.518 1 C-N-CA 133.654 4.781 . . . . 0.0 112.699 -176.917 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -59.6 147.51 36.97 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.97 1.708 . . . . 0.0 113.34 154.964 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.4 m -112.61 126.04 54.94 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 128.387 3.554 . . . . 0.0 103.798 169.7 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.64 160.05 29.36 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 127.696 3.123 . . . . 0.0 106.173 171.355 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -126.54 113.39 16.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 101.696 -3.446 . . . . 0.0 101.696 -155.523 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.3 tp -92.22 120.95 33.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 111.893 -2.412 . . . . 0.0 111.22 175.733 . . . . . . . . 1 1 . 1 . 069 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.27 12.1 m -127.32 154.52 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 127.172 2.189 . . . . 0.0 107.818 173.435 . . . . . . . . 2 2 . 1 . 069 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.258 2.3 pp . . . . . 0 N--CA 1.451 -0.418 0 CA-C-N 120.372 1.442 . . . . 0.0 112.505 -172.282 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.527 ' H2 ' ' CD ' ' A' ' 16' ' ' GLU . 26.2 ptt? . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 . . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -86.64 131.16 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.008 1.323 . . . . 0.0 111.481 -172.174 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.4 pt -125.59 150.32 30.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 -175.536 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.273 2.2 m-85 -92.32 130.57 37.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.276 1.43 . . . . 0.0 108.764 168.29 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.37 96.93 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 O-C-N 127.639 3.087 . . . . 0.0 105.67 -177.093 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -85.22 123.69 31.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.01 -2.931 . . . . 0.0 104.499 -170.835 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -76.23 150.31 37.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 165.192 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.8 tp -59.88 -24.51 64.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -173.707 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -89.16 0.28 56.87 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 120.391 -1.443 . . . . 0.0 113.182 -179.696 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.5 -5.93 18.89 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 115.093 -3.06 . . . . 0.0 117.967 166.149 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -86.14 131.73 34.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 128.339 3.023 . . . . 0.0 106.633 -174.534 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -113.66 104.1 11.89 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.062 -172.274 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.2 mt -88.09 126.38 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -172.555 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 9.5 m -93.06 121.33 34.3 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 177.326 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.281 55.8 tp -144.61 144.24 31.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 119.991 -1.693 . . . . 0.0 111.16 -165.511 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.527 ' CD ' ' H2 ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -99.5 134.45 42.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 122.073 0.939 . . . . 0.0 109.103 -177.341 . . . . . . . . 3 3 . 1 . 070 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.34 169.2 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 174.251 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -109.9 160.98 26.07 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 127.641 2.376 . . . . 0.0 110.374 164.531 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.64 -23.31 17.08 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 125.194 3.929 . . . . 0.0 115.283 -176.353 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -83.91 -1.21 54.07 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.856 -2.403 . . . . 0.0 114.644 -179.731 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -79.62 121.14 24.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.727 2.011 . . . . 0.0 107.306 -177.618 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.4 p -48.63 148.49 2.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 164.616 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.393 8.6 mm -38.3 -15.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 130.089 3.355 . . . . 0.0 118.382 173.46 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -94.21 -49.8 5.57 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 123.695 2.952 . . . . 0.0 107.4 -159.256 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -51.33 -32.7 26.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.898 2.079 . . . . 0.0 114.677 -155.239 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -73.03 -21.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 1 CA-C-O 129.67 4.557 . . . . 0.0 119.359 -178.993 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -69.81 -40.31 76.02 Favored 'General case' 0 N--CA 1.442 -0.85 1 O-C-N 114.41 -5.181 . . . . 0.0 115.091 -171.413 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.58 -23.34 49.99 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 112.453 -3.641 . . . . 0.0 111.34 170.764 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -63.18 -48.39 78.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.458 2.349 . . . . 0.0 113.382 166.087 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 mm -62.23 -42.12 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 126.28 1.832 . . . . 0.0 112.309 173.204 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -47.86 -43.75 28.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 166.996 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.42 -47.2 50.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.652 -173.836 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.28 -30.11 16.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 127.317 2.886 . . . . 0.0 115.706 -176.565 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -120.99 -0.73 9.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 121.682 2.037 . . . . 0.0 110.329 179.676 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.85 -0.05 87.7 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 118.258 -2.776 . . . . 0.0 116.494 166.692 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.6 mt -99.65 128.54 31.06 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 -170.768 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.84 155.0 58.59 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 121.818 3.738 . . . . 0.0 121.818 175.898 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -59.4 -32.17 96.08 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 124.868 3.712 . . . . 0.0 117.083 176.104 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.46 1.6 t0 -52.51 -21.48 3.83 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 163.311 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -106.28 -18.42 14.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.705 2.002 . . . . 0.0 111.755 -179.519 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -98.94 100.87 12.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 116.774 -3.704 . . . . 0.0 103.264 -172.321 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -108.73 138.6 44.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 110.352 -3.113 . . . . 0.0 104.135 166.672 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -148.51 161.72 41.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 121.654 2.025 . . . . 0.0 114.81 -168.612 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mp -129.28 131.54 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 1 C-N-CA 134.667 5.187 . . . . 0.0 112.31 -169.822 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -98.35 -50.06 4.46 Favored 'General case' 0 N--CA 1.449 -0.475 1 CA-C-O 111.577 -4.059 . . . . 0.0 114.574 161.613 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -162.35 43.36 0.13 Allowed 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 128.158 3.411 . . . . 0.0 108.054 -161.217 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.43 -69.85 0.49 Allowed Glycine 0 CA--C 1.531 1.048 0 CA-C-O 124.002 1.89 . . . . 0.0 116.686 163.778 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -54.66 132.93 46.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 162.011 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -59.28 145.58 42.58 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 116.737 -1.985 . . . . 0.0 111.955 154.933 . . . . . . . . 3 3 . 1 . 070 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.451 HD21 ' CE2' ' A' ' 59' ' ' TYR . 23.2 mt -91.08 116.98 29.23 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 123.567 1.651 . . . . 0.0 113.297 -175.498 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.271 32.1 tt0 -84.49 156.37 21.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 112.437 -2.165 . . . . 0.0 116.156 -167.67 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -65.59 141.89 58.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.281 1.832 . . . . 0.0 109.689 175.083 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.58 -42.44 1.91 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-O 115.474 -2.848 . . . . 0.0 111.585 -178.181 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 mmp_? -72.98 173.5 9.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 121.67 2.735 . . . . 0.0 117.111 -173.289 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -120.71 155.82 33.09 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 126.67 2.481 . . . . 0.0 104.925 174.868 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.7 mt -59.37 -29.86 68.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 125.382 2.515 . . . . 0.0 113.071 -176.882 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -47.57 -46.05 27.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 118.373 -2.704 . . . . 0.0 116.228 163.905 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -68.32 -12.32 60.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.406 -175.622 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.451 ' CE2' HD21 ' A' ' 50' ' ' LEU . 55.8 m-85 -106.67 1.37 25.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 128.169 2.587 . . . . 0.0 112.742 178.746 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 1.7 t30 66.14 39.16 4.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.173 1.389 . . . . 0.0 110.262 175.24 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -88.33 131.28 36.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 120.75 1.614 . . . . 0.0 110.289 -176.708 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.44 -176.14 3.12 Favored 'General case' 0 C--O 1.221 -0.406 1 O-C-N 116.235 -4.04 . . . . 0.0 110.403 -176.982 . . . . . . . . 3 3 . 1 . 070 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -55.8 146.7 20.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.617 1.967 . . . . 0.0 112.084 149.837 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 66.1 14.82 9.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.062 1.745 . . . . 0.0 112.317 176.418 . . . . . . . . 2 2 . 1 . 070 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.0 m -71.02 155.85 40.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.508 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.6 m -113.5 120.87 42.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 129.461 3.105 . . . . 0.0 105.371 176.871 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.86 140.73 45.07 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 114.274 -2.774 . . . . 0.0 106.089 170.481 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -129.49 138.95 51.67 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.224 1.81 . . . . 0.0 106.484 -174.691 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.59 151.51 22.26 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.819 177.53 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -105.85 109.49 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 131.388 3.875 . . . . 0.0 102.287 170.432 . . . . . . . . 1 1 . 1 . 070 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 C-N-CA 129.929 3.292 . . . . 0.0 104.446 -179.972 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 116.714 -1.612 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -109.03 139.44 43.9 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.032 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.11 152.19 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 128.461 2.704 . . . . 0.0 106.624 -172.76 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -105.51 140.98 37.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 124.531 2.11 . . . . 0.0 110.657 179.012 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.309 1.7 p -145.76 107.79 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.146 -178.823 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -84.23 137.2 33.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 126.038 2.086 . . . . 0.0 113.404 -173.395 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -78.91 170.68 16.3 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 113.803 -2.999 . . . . 0.0 111.615 -176.303 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.43 -13.78 15.4 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 126.936 2.648 . . . . 0.0 118.041 -175.759 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 p -107.74 -6.34 16.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.997 1.319 . . . . 0.0 110.808 -178.681 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.0 1.81 31.8 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 120.379 -1.451 . . . . 0.0 112.745 168.161 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 tttt -84.32 119.86 25.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 130.113 3.365 . . . . 0.0 102.127 -168.343 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 3.4 m -88.71 134.89 33.77 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 -167.104 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.5 mt -120.48 152.89 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.808 2.043 . . . . 0.0 110.061 169.254 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.286 1.5 m -118.58 123.1 44.22 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 169.955 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.9 mt -116.6 140.86 48.92 Favored 'General case' 0 N--CA 1.447 -0.59 1 C-N-CA 133.587 4.755 . . . . 0.0 111.348 -176.622 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.326 0.4 OUTLIER -99.27 120.01 38.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 101.387 -3.561 . . . . 0.0 101.387 167.228 . . . . . . . . 3 3 . 1 . 071 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.88 -19.45 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 113.473 -3.156 . . . . 0.0 110.666 -168.769 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 0.1 OUTLIER 90.81 127.54 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-O 115.557 -2.163 . . . . 0.0 106.651 177.426 . . . . . . . . 3 3 . 1 . 071 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -74.72 -29.26 8.92 Favored 'Trans proline' 0 N--CA 1.452 -0.966 1 C-N-CA 125.688 4.259 . . . . 0.0 113.514 178.345 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -84.54 -7.73 59.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.448 3.099 . . . . 0.0 110.606 -178.342 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.5 -177.86 3.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 122.372 2.351 . . . . 0.0 109.355 178.645 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -130.43 167.79 18.03 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -173.321 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' CG2' ' HB3' ' A' ' 50' ' ' LEU . 2.8 mm -66.57 -38.02 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.636 1.575 . . . . 0.0 110.479 -164.735 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -56.66 -34.66 67.57 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 122.132 2.242 . . . . 0.0 109.902 -178.272 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -82.38 -2.11 52.01 Favored 'General case' 0 N--CA 1.445 -0.688 1 O-C-N 114.061 -5.4 . . . . 0.0 115.166 -178.498 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -88.98 -46.37 15.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 176.632 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HA ' HD13 ' A' ' 30' ' ' ILE . 58.1 mtmt -65.97 -29.77 70.21 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.169 0.988 . . . . 0.0 112.717 177.86 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.81 -41.11 79.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.932 2.493 . . . . 0.0 107.885 174.279 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -72.98 -30.08 63.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 173.958 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 27' ' ' LYS . 16.2 mt -67.48 -46.86 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 122.279 2.309 . . . . 0.0 111.533 169.019 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -49.75 -51.85 36.01 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 117.478 -3.264 . . . . 0.0 119.062 169.831 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -53.26 -38.05 62.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 128.602 2.761 . . . . 0.0 117.117 168.854 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -57.03 -62.81 1.49 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.46 1.504 . . . . 0.0 111.836 172.917 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.309 5.9 mm-40 -131.56 -8.7 3.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 125.493 2.568 . . . . 0.0 113.778 -157.361 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.82 32.85 6.32 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 119.955 -1.716 . . . . 0.0 115.993 178.022 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mm -82.58 130.04 60.29 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 127.889 2.476 . . . . 0.0 107.975 -167.495 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.88 127.9 15.16 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.312 2.008 . . . . 0.0 112.062 172.923 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.91 -34.99 7.88 Favored 'Trans proline' 0 N--CA 1.447 -1.219 1 C-N-CA 127.391 5.394 . . . . 0.0 112.518 -169.315 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -68.73 -19.97 64.37 Favored 'General case' 0 C--N 1.321 -0.633 1 C-N-CA 135.418 5.487 . . . . 0.0 110.244 -172.869 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -94.97 -3.74 47.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.893 1.677 . . . . 0.0 108.495 -176.914 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 10.2 mm100 -96.1 107.49 19.8 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 130.261 3.424 . . . . 0.0 111.446 -172.296 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -94.16 101.66 13.67 Favored 'General case' 0 N--CA 1.444 -0.761 1 C-N-CA 132.759 4.424 . . . . 0.0 107.24 167.919 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 41' ' ' GLN . 11.2 mp -103.5 101.93 11.82 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 127.536 2.334 . . . . 0.0 111.4 -174.332 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.6 mm -108.69 142.3 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 123.704 1.716 . . . . 0.0 107.225 179.209 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -124.79 105.17 9.07 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 112.529 -2.123 . . . . 0.0 109.508 173.671 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.84 42.1 15.45 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 127.12 3.343 . . . . 0.0 117.048 176.791 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.9 -14.5 52.65 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 109.401 -3.545 . . . . 0.0 118.735 178.325 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.25 77.3 mttt -115.1 130.34 56.9 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -166.374 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.33 48.3 tt0 -48.33 142.34 5.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 121.345 3.832 . . . . 0.0 121.345 162.319 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 23' ' ' ILE . 87.8 mt -98.02 105.49 17.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 172.481 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -88.07 140.81 29.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 -175.706 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -81.09 141.64 34.11 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 124.161 3.164 . . . . 0.0 103.047 173.269 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.16 -29.67 6.66 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -175.664 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.39 150.4 23.83 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 127.31 2.418 . . . . 0.0 113.202 176.475 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.452 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 34.2 p -77.9 156.92 30.03 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.398 -1.273 . . . . 0.0 109.537 166.151 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.4 mt -74.6 -31.94 62.19 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.553 1.941 . . . . 0.0 109.589 -178.033 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.1 t -75.33 -12.67 60.32 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 120.414 -1.428 . . . . 0.0 112.572 175.917 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.452 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 53.9 m-20 -66.05 -34.32 77.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 123.679 2.945 . . . . 0.0 112.65 169.518 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -91.59 7.08 43.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 127.234 2.834 . . . . 0.0 116.283 172.889 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.368 81.1 m-20 76.53 36.2 0.38 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.977 1.711 . . . . 0.0 113.304 171.285 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.4 mt -82.03 99.32 5.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 171.019 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -110.07 -172.92 2.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 129.978 3.311 . . . . 0.0 113.926 179.48 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.05 140.86 0.99 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 128.317 2.647 . . . . 0.0 117.202 173.71 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 6.7 tm-20 73.62 4.19 4.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 122.439 2.382 . . . . 0.0 114.449 162.823 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.2 m -72.54 132.14 43.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.572 -1.649 . . . . 0.0 107.913 -173.217 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.0 p -105.68 142.36 35.55 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 125.071 1.482 . . . . 0.0 108.109 167.198 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.29 165.91 26.18 Favored 'General case' 0 N--CA 1.446 -0.636 1 C-N-CA 131.838 4.055 . . . . 0.0 105.692 167.261 . . . . . . . . 2 2 . 1 . 071 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -99.54 161.58 13.53 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 126.022 2.82 . . . . 0.0 104.486 165.894 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.2 tp -148.11 132.56 17.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 118.762 -2.461 . . . . 0.0 110.224 -179.56 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -68.34 89.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 127.023 3.296 . . . . 0.0 104.529 163.812 . . . . . . . . 1 1 . 1 . 071 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 N--CA 1.443 -0.812 1 N-CA-C 98.601 -4.592 . . . . 0.0 98.601 175.427 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ttp . . . . . 0 C--O 1.24 0.568 1 N-CA-C 99.492 -4.262 . . . . 0.0 99.492 . . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -94.37 136.15 34.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 123.082 2.674 . . . . 0.0 110.694 167.966 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.27 161.25 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 102.902 -2.999 . . . . 0.0 102.902 170.401 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -117.25 149.76 39.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.045 1.738 . . . . 0.0 113.481 -171.67 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.343 16.3 m -141.69 165.0 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 128.681 2.792 . . . . 0.0 112.41 169.062 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -149.78 142.17 24.29 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -169.367 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -136.72 -145.21 0.21 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 129.08 2.952 . . . . 0.0 108.604 175.246 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -96.29 -55.01 3.08 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 121.357 1.889 . . . . 0.0 108.254 -169.036 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -84.98 -27.1 26.71 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.295 1.838 . . . . 0.0 114.276 -179.917 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.94 123.95 7.15 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 106.505 -2.638 . . . . 0.0 106.505 175.269 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -102.86 -29.04 11.69 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.011 2.524 . . . . 0.0 107.383 -174.683 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -137.28 96.37 3.26 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 114.283 -2.77 . . . . 0.0 104.497 -177.233 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.9 mt -103.29 109.32 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 1 N-CA-C 98.541 -4.614 . . . . 0.0 98.541 165.009 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.271 62.8 p -86.77 131.48 34.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 173.922 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -128.61 120.72 27.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.436 -2.802 . . . . 0.0 103.436 -175.603 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -96.01 120.39 36.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.611 3.564 . . . . 0.0 105.681 -178.435 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 m -143.4 159.01 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 O-C-N 117.482 -3.261 . . . . 0.0 108.057 -170.07 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.71 151.29 37.37 Favored Pre-proline 0 N--CA 1.447 -0.606 1 C-N-CA 132.618 4.367 . . . . 0.0 100.764 163.644 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.281 73.1 Cg_endo -64.47 8.7 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.966 2.444 . . . . 0.0 116.443 -179.927 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.3 p -128.34 16.87 6.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 129.345 3.058 . . . . 0.0 115.93 168.753 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.263 1.0 OUTLIER -41.0 117.21 0.82 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 158.813 . . . . . . . . 3 3 . 1 . 072 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 p -73.68 151.18 40.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.947 2.899 . . . . 0.0 108.823 179.687 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.31 1.1 mm -50.77 -41.03 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 126.779 2.032 . . . . 0.0 109.501 176.438 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -57.9 -41.48 82.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 171.143 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -65.15 -50.42 66.07 Favored 'General case' 0 N--CA 1.45 -0.452 1 O-C-N 116.159 -4.088 . . . . 0.0 113.962 171.342 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.84 -54.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 122.684 2.493 . . . . 0.0 112.426 168.649 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -53.04 -47.57 68.29 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.029 2.932 . . . . 0.0 115.904 170.68 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.47 -52.96 33.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 117.141 -3.474 . . . . 0.0 118.791 159.012 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -62.05 -33.36 74.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 128.882 2.873 . . . . 0.0 110.268 -176.508 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.4 mt -76.39 -48.55 27.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 129.014 2.926 . . . . 0.0 106.842 173.227 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -49.85 -49.5 49.0 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 128.94 2.896 . . . . 0.0 113.144 176.94 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -49.3 -31.95 10.08 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 128.919 2.888 . . . . 0.0 114.883 -174.054 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -105.0 -64.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 127.782 3.176 . . . . 0.0 111.196 178.353 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -81.45 -27.87 34.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -159.118 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.61 0.65 43.1 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 170.797 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.5 mm -80.61 122.05 81.92 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 120.869 2.335 . . . . 0.0 107.764 -170.806 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.562 ' HD2' HE21 ' A' ' 40' ' ' GLN . 18.6 Cg_endo -76.53 156.02 36.16 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 CA-C-O 114.356 -2.435 . . . . 0.0 112.95 175.402 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.26 -21.42 1.18 Allowed 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 122.522 2.148 . . . . 0.0 115.525 170.915 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -81.26 -22.14 38.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 117.845 -3.034 . . . . 0.0 116.814 -175.623 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.562 HE21 ' HD2' ' A' ' 37' ' ' PRO . 9.3 tt0 -105.61 3.43 29.18 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -166.525 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -128.47 128.9 45.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.346 2.258 . . . . 0.0 105.052 -171.237 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 mtt85 -90.41 170.22 10.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 124.952 2.311 . . . . 0.0 105.121 158.006 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.386 30.7 tp -138.19 112.02 8.35 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 112.71 -2.041 . . . . 0.0 107.783 176.606 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.31 140.99 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 127.445 3.498 . . . . 0.0 105.189 173.714 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.54 145.17 22.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 119.247 -2.158 . . . . 0.0 105.41 151.592 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.67 22.46 5.36 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 125.778 1.924 . . . . 0.0 111.3 175.43 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.8 -12.89 61.0 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 116.414 -2.325 . . . . 0.0 108.325 174.408 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -108.69 127.35 53.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 120.849 2.324 . . . . 0.0 106.157 -159.04 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -61.58 93.58 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.907 2.883 . . . . 0.0 105.069 165.713 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.8 mt -64.94 130.51 43.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 119.389 -2.069 . . . . 0.0 113.571 172.3 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -86.65 146.45 26.31 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 125.718 1.886 . . . . 0.0 114.562 -176.732 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.305 14.5 m-20 -68.33 112.85 5.45 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 126.975 2.672 . . . . 0.0 115.103 168.703 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.15 -23.59 2.41 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.253 -1.304 . . . . 0.0 114.862 -169.559 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -110.06 162.57 14.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 -161.796 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -101.73 165.98 10.92 Favored 'General case' 0 N--CA 1.448 -0.561 1 C-N-CA 132.583 4.353 . . . . 0.0 113.313 168.525 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.9 mt -42.03 -45.51 3.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 116.237 -1.84 . . . . 0.0 113.909 168.833 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -64.68 -14.95 60.48 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 130.199 3.4 . . . . 0.0 113.972 -176.532 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -75.92 -35.47 59.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.711 0.404 . . . . 0.0 110.518 172.809 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -114.26 12.5 17.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 -173.193 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 9.2 m120 65.27 28.94 11.86 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 126.665 1.986 . . . . 0.0 115.306 161.977 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -93.29 137.43 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 128.496 3.998 . . . . 0.0 103.841 -160.384 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -111.4 -168.75 1.35 Allowed 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 116.928 -3.608 . . . . 0.0 109.993 176.97 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -78.48 149.86 33.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 118.876 -2.39 . . . . 0.0 113.18 -170.233 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 31.4 mt-10 66.52 9.35 6.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 130.75 3.62 . . . . 0.0 112.963 174.889 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -72.51 165.75 24.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.919 1.688 . . . . 0.0 108.075 174.81 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 m -121.86 130.26 53.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.067 2.947 . . . . 0.0 109.683 176.414 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 mp -104.8 169.48 8.43 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 119.543 -1.973 . . . . 0.0 111.26 158.057 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -119.77 126.5 51.2 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.6 2.36 . . . . 0.0 113.623 177.088 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 3.9 tt -98.85 131.39 44.99 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -177.131 . . . . . . . . 2 2 . 1 . 072 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.9 123.9 71.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 174.893 . . . . . . . . 1 1 . 1 . 072 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 mt . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 127.774 2.43 . . . . 0.0 110.148 179.42 . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptm . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 124.935 2.302 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 073 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -85.84 121.87 29.1 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 117.603 -3.186 . . . . 0.0 109.268 170.054 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pt -137.44 117.93 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 128.338 2.655 . . . . 0.0 104.59 170.871 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -83.16 112.92 20.27 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 117.803 -3.061 . . . . 0.0 109.213 -173.259 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.4 t -85.05 100.55 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 O-C-N 117.999 -2.938 . . . . 0.0 106.89 170.797 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -103.5 119.52 39.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.3 1.44 . . . . 0.0 107.245 -167.955 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m -81.57 144.6 31.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.245 1.818 . . . . 0.0 109.437 174.89 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -37.8 -51.11 1.27 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -178.648 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 p -62.07 -10.49 10.27 Favored 'General case' 0 N--CA 1.444 -0.728 1 O-C-N 129.366 4.166 . . . . 0.0 114.751 -178.057 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.2 -24.14 16.86 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.755 1.862 . . . . 0.0 117.755 179.752 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -62.59 123.02 17.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 127.329 2.252 . . . . 0.0 109.374 -177.253 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.278 8.4 m -114.8 113.28 24.04 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.976 2.11 . . . . 0.0 115.652 -174.108 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.7 mt -90.44 148.0 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 O-C-N 126.495 2.372 . . . . 0.0 106.528 -172.445 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.318 4.7 t -155.19 100.04 2.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 -163.906 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -140.78 127.98 20.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.635 -2.075 . . . . 0.0 110.653 -161.101 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.79 93.61 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.456 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -125.84 169.81 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 126.689 1.995 . . . . 0.0 107.815 169.799 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -138.17 158.9 70.16 Favored Pre-proline 0 N--CA 1.445 -0.713 1 C-N-CA 132.035 4.134 . . . . 0.0 107.068 -176.24 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.16 -9.03 14.12 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 O-C-N 125.58 2.358 . . . . 0.0 117.992 -168.605 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 t -92.74 4.42 53.79 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.455 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -73.18 134.23 44.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 117.267 -3.396 . . . . 0.0 111.428 175.902 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -76.29 157.25 32.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 125.03 2.348 . . . . 0.0 112.926 175.902 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.268 2.7 mm -64.52 -31.5 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 O-C-N 117.207 -3.433 . . . . 0.0 118.315 -172.12 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.03 -35.85 25.45 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.926 2.091 . . . . 0.0 111.557 178.137 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.367 10.3 t-20 -51.72 -48.94 63.4 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 127.037 2.711 . . . . 0.0 113.669 158.651 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.87 -40.43 85.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 121.898 2.136 . . . . 0.0 113.067 171.681 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.261 44.7 mtpt -64.84 -36.33 83.99 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.153 1.781 . . . . 0.0 110.833 -178.376 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.14 -14.25 62.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.449 2.299 . . . . 0.0 112.527 -176.308 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -83.13 -27.81 29.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 123.633 0.583 . . . . 0.0 111.594 173.953 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.3 mt -82.57 -18.65 10.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.907 -164.967 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -77.26 -30.14 54.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 125.14 1.525 . . . . 0.0 112.484 176.362 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -70.91 -57.41 4.62 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 119.367 -2.083 . . . . 0.0 110.979 165.886 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -82.66 -28.59 30.56 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.157 1.783 . . . . 0.0 114.327 -161.438 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -118.23 -5.99 10.86 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 124.403 1.064 . . . . 0.0 110.601 178.733 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.22 -0.08 26.09 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 129.733 3.54 . . . . 0.0 117.923 -175.677 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.6 mm -82.8 138.88 43.34 Favored Pre-proline 0 N--CA 1.447 -0.597 1 O-C-N 115.376 -4.602 . . . . 0.0 104.165 -172.275 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -86.03 167.29 9.56 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 125.027 3.818 . . . . 0.0 105.589 176.254 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.61 ' HA ' HE21 ' A' ' 41' ' ' GLN . 73.2 Cg_endo -81.98 -22.16 5.32 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.64 2.227 . . . . 0.0 116.237 168.507 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.37 0.0 OUTLIER -54.52 -49.73 69.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 129.747 3.219 . . . . 0.0 109.668 -179.459 . . . . . . . . 3 3 . 1 . 073 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.29 71.0 mm-40 -78.8 -22.26 46.55 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 120.458 1.481 . . . . 0.0 114.943 178.116 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.61 HE21 ' HA ' ' A' ' 38' ' ' PRO 0.307 7.1 tt0 -86.21 154.46 21.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.488 1.915 . . . . 0.0 113.542 -156.527 . . . . . . . . 3 3 . 1 . 073 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.319 23.6 ttm105 -153.35 140.4 19.32 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 128.381 2.672 . . . . 0.0 112.75 -178.247 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.3 mt -125.0 131.96 53.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 116.85 -1.548 . . . . 0.0 111.708 -177.937 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.53 120.67 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.282 1.833 . . . . 0.0 112.742 179.234 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.294 22.6 t80 -120.7 119.84 33.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 115.992 -1.956 . . . . 0.0 108.078 176.908 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.46 25.41 9.63 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 126.239 2.212 . . . . 0.0 116.928 -178.967 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.27 -15.28 63.29 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.739 1.637 . . . . 0.0 112.406 -174.73 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.13 113.76 26.11 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 124.025 3.912 . . . . 0.0 105.494 -173.444 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -66.77 136.7 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 126.338 2.97 . . . . 0.0 107.77 168.189 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -84.97 134.95 34.23 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 118.608 -2.558 . . . . 0.0 113.168 179.134 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.24 158.27 16.68 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -178.733 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -73.16 155.08 39.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.984 2.514 . . . . 0.0 111.902 177.829 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.13 -15.56 62.61 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.767 2.127 . . . . 0.0 116.303 171.213 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -91.21 161.0 15.25 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -167.821 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -84.77 166.78 16.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.923 0.868 . . . . 0.0 108.945 170.499 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.0 -41.37 91.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 118.978 -2.326 . . . . 0.0 116.905 168.088 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 t -53.92 -23.91 14.49 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 130.04 3.336 . . . . 0.0 116.069 170.307 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -74.27 -18.06 60.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 115.38 -2.248 . . . . 0.0 115.23 172.266 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -103.45 5.83 37.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.243 1.383 . . . . 0.0 110.979 172.401 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 73.72 33.73 1.0 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.119 1.368 . . . . 0.0 110.007 175.137 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -90.57 136.91 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 119.342 -2.099 . . . . 0.0 112.071 -170.608 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -130.69 174.05 10.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.013 1.725 . . . . 0.0 112.669 -162.786 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -58.26 121.23 10.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.154 2.181 . . . . 0.0 111.56 -177.995 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.368 12.4 mt-10 61.57 34.03 18.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 130.807 3.643 . . . . 0.0 113.77 178.454 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.258 24.4 m -83.76 157.72 22.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 159.481 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -126.4 135.46 51.45 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.468 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.254 3.9 mp -98.68 143.1 29.43 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 128.332 2.653 . . . . 0.0 107.51 172.081 . . . . . . . . 2 2 . 1 . 073 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -72.43 148.87 44.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 124.674 2.178 . . . . 0.0 109.405 159.534 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -135.23 131.16 36.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.422 169.376 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.37 152.65 36.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 128.336 2.654 . . . . 0.0 110.922 170.49 . . . . . . . . 1 1 . 1 . 073 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.445 -0.685 0 C-N-CA 130.309 3.444 . . . . 0.0 109.496 178.489 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttp . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 . . . . . . . . . 0 0 . 1 . 074 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -95.08 140.87 29.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.514 -1.675 . . . . 0.0 110.111 -178.49 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -145.09 159.58 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 128.075 2.55 . . . . 0.0 107.174 167.313 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -106.43 153.3 22.46 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 117.409 -3.307 . . . . 0.0 105.946 171.806 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.8 t -118.85 130.01 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 166.827 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -111.01 138.35 47.52 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.418 1.087 . . . . 0.0 108.128 173.789 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.7 p -88.35 140.51 29.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 164.557 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -60.47 -17.76 47.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 117.03 -3.544 . . . . 0.0 115.88 -177.15 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -80.49 -5.84 57.25 Favored 'General case' 0 C--N 1.322 -0.589 2 C-N-CA 131.97 4.108 . . . . 0.0 112.716 165.724 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.37 -7.95 43.86 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 118.306 2.082 . . . . 0.0 118.306 165.142 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -58.15 152.27 17.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 117.916 -3.108 . . . . 0.0 112.547 163.583 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.0 p -134.15 161.31 35.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.628 1.204 . . . . 0.0 109.776 161.948 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.42 154.8 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 102.173 -3.269 . . . . 0.0 102.173 169.385 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -97.54 126.38 42.79 Favored 'General case' 0 N--CA 1.444 -0.773 1 C-N-CA 132.116 4.167 . . . . 0.0 103.36 -175.038 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.15 101.35 8.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 131.386 3.874 . . . . 0.0 111.687 -176.8 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.3 pm0 -76.47 126.16 30.5 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 127.174 2.796 . . . . 0.0 105.473 163.539 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.432 31.5 m -135.84 165.01 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 1 C-N-CA 133.368 4.667 . . . . 0.0 116.468 -175.674 . . . . . . . . 3 2 . 1 . 074 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.67 159.78 37.42 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 125.879 1.671 . . . . 0.0 111.124 166.686 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.352 97.7 Cg_endo -58.62 -40.59 72.22 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 N-CA-C 120.26 3.139 . . . . 0.0 120.26 177.256 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -73.15 -14.74 61.43 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 130.24 3.416 . . . . 0.0 109.89 -171.644 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -65.55 127.3 31.31 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 124.98 2.324 . . . . 0.0 112.74 -175.725 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.9 p -70.06 156.09 39.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.376 175.244 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.76 -37.0 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.577 1.151 . . . . 0.0 111.506 166.101 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -48.06 -48.61 33.22 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.691 1.996 . . . . 0.0 114.338 166.749 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -73.32 -43.3 61.12 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 118.006 -2.934 . . . . 0.0 112.774 174.59 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.315 29.9 t -58.57 -31.47 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 118.012 -2.93 . . . . 0.0 112.022 170.653 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -64.95 -39.27 93.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 123.145 2.702 . . . . 0.0 111.339 169.302 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.46 -31.36 53.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 111.944 -3.884 . . . . 0.0 114.704 175.491 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -62.95 -50.97 68.7 Favored 'General case' 0 N--CA 1.452 -0.357 1 O-C-N 132.857 6.348 . . . . 0.0 109.659 167.443 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mt -53.05 -46.18 53.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 1 O-C-N 115.517 -4.489 . . . . 0.0 109.424 173.442 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -34.64 77.8 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 112.741 -3.504 . . . . 0.0 111.51 -179.964 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.67 -32.37 69.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 128.457 3.598 . . . . 0.0 109.851 176.058 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -78.43 -34.48 47.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 121.754 2.07 . . . . 0.0 113.5 173.759 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -145.98 -19.46 0.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -151.818 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.39 -4.68 54.73 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 128.374 2.892 . . . . 0.0 114.003 158.279 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mt -65.19 115.48 21.77 Favored Pre-proline 0 N--CA 1.445 -0.701 0 O-C-N 119.027 -2.455 . . . . 0.0 111.979 173.942 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.1 153.42 62.69 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 CA-C-O 112.085 -3.381 . . . . 0.0 117.425 -178.198 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.68 -34.96 55.72 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 125.134 3.889 . . . . 0.0 118.727 -166.7 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.01 -23.81 35.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.464 0.649 . . . . 0.0 109.846 -168.338 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.397 12.3 mm100 -87.01 -0.69 57.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.922 2.489 . . . . 0.0 111.203 178.748 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -95.22 145.67 24.89 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.482 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -138.3 134.61 34.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.547 2.739 . . . . 0.0 104.359 161.232 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mt -114.89 139.02 50.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 113.401 -3.19 . . . . 0.0 107.943 -177.234 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mm -129.87 131.88 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 129.623 3.169 . . . . 0.0 106.516 -174.718 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -113.11 -38.0 4.6 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 158.767 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.257 . . -124.95 -120.34 0.27 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 118.034 -2.916 . . . . 0.0 107.831 -172.641 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.52 13.96 42.8 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 125.982 3.992 . . . . 0.0 111.668 -177.014 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -145.01 -175.86 4.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 115.098 -2.382 . . . . 0.0 109.742 -176.967 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -78.73 156.32 28.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 126.187 2.179 . . . . 0.0 111.831 169.946 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.8 mt -95.45 144.52 25.88 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 163.836 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.92 129.21 46.74 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.211 2.204 . . . . 0.0 110.825 -168.941 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -42.52 -52.62 4.66 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 120.822 3.638 . . . . 0.0 120.822 -171.161 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.71 5.19 73.13 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 114.091 -3.616 . . . . 0.0 111.131 -175.212 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -92.6 150.8 20.49 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 119.866 1.833 . . . . 0.0 111.287 159.813 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.342 7.1 p -91.1 156.73 17.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 129.622 3.169 . . . . 0.0 113.389 -177.764 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -43.11 -49.22 6.35 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.55 3.14 . . . . 0.0 112.516 164.761 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.378 45.3 p -55.91 -40.36 72.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 172.895 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -58.52 -47.72 83.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 118.348 -2.72 . . . . 0.0 110.762 -176.091 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.393 40.3 m-85 -90.06 4.14 51.15 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.061 177.887 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 t30 74.8 33.84 0.75 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.306 2.242 . . . . 0.0 114.017 156.51 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.1 mm -72.23 127.81 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 100.902 -3.74 . . . . 0.0 100.902 -171.802 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -92.34 155.66 17.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.063 1.745 . . . . 0.0 107.354 175.761 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.03 146.12 2.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.74 2.416 . . . . 0.0 115.372 173.892 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.373 1.6 tt0 58.0 19.1 5.62 Favored 'General case' 0 N--CA 1.443 -0.793 1 C-N-CA 133.112 4.565 . . . . 0.0 118.534 -174.741 . . . . . . . . 3 2 . 1 . 074 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.9 m -70.57 145.14 50.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.392 2.368 . . . . 0.0 117.392 169.216 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 m -90.26 140.27 29.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 103.186 -2.894 . . . . 0.0 103.186 179.157 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.4 mt -108.78 145.53 35.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 128.393 2.677 . . . . 0.0 110.525 154.699 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -104.73 137.92 41.81 Favored 'General case' 0 N--CA 1.45 -0.466 1 N-CA-C 100.091 -4.04 . . . . 0.0 100.091 174.992 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.4 tp -124.53 113.54 18.23 Favored 'General case' 0 N--CA 1.445 -0.677 1 C-N-CA 134.757 5.223 . . . . 0.0 107.436 -174.459 . . . . . . . . 2 2 . 1 . 074 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.7 t -78.07 129.61 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 102.284 -3.228 . . . . 0.0 102.284 163.032 . . . . . . . . 1 1 . 1 . 074 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 124.405 2.05 . . . . 0.0 106.195 171.768 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ptt? . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 116.628 -1.653 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 075 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -112.67 145.53 40.28 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 123.516 2.871 . . . . 0.0 113.75 -177.835 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -135.53 155.19 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 128.03 2.532 . . . . 0.0 109.299 167.524 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -111.86 132.05 54.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 131.315 3.846 . . . . 0.0 108.787 -176.901 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 67' ' ' LEU . 93.3 t -121.67 128.79 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 172.732 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.324 59.2 mmtt -97.98 140.94 31.57 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 117.596 -3.19 . . . . 0.0 110.464 163.436 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.5 p -86.67 -176.72 5.92 Favored 'General case' 0 N--CA 1.44 -0.936 1 C-N-CA 131.914 4.086 . . . . 0.0 105.069 179.911 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.08 -46.4 57.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.236 2.615 . . . . 0.0 105.262 -178.701 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -78.58 -12.24 60.01 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.678 1.591 . . . . 0.0 112.29 -173.189 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.77 9.23 26.95 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 106.116 -2.794 . . . . 0.0 106.116 160.532 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -71.48 136.28 47.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 121.85 2.825 . . . . 0.0 110.223 170.54 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.2 m -97.23 119.76 36.34 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 128.054 3.346 . . . . 0.0 106.705 179.349 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mt -103.32 125.14 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 O-C-N 126.532 2.395 . . . . 0.0 106.915 178.358 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.2 p -109.81 124.56 51.5 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 119.948 1.249 . . . . 0.0 109.268 170.608 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.24 150.67 28.36 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.441 1.897 . . . . 0.0 107.23 175.741 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -85.37 109.4 18.38 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 131.022 3.729 . . . . 0.0 102.83 166.962 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.24 159.76 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 175.451 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -121.48 159.59 49.71 Favored Pre-proline 0 N--CA 1.45 -0.457 0 C-N-CA 131.58 3.952 . . . . 0.0 111.903 166.34 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.263 22.5 Cg_exo -61.15 -19.37 63.19 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 N-CA-C 118.019 2.276 . . . . 0.0 118.019 -172.459 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.27 0.2 OUTLIER -90.57 -2.36 57.88 Favored 'General case' 0 N--CA 1.446 -0.653 1 C-N-CA 131.877 4.071 . . . . 0.0 115.328 178.724 . . . . . . . . 4 3 . 1 . 075 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -71.43 135.37 47.18 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 118.639 -2.538 . . . . 0.0 112.549 168.675 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.1 p -82.07 164.6 21.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 177.464 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.8 mm -56.81 -36.82 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 116.878 -3.639 . . . . 0.0 113.341 -178.41 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.253 13.1 tp10 -67.63 -37.54 82.6 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 127.106 2.754 . . . . 0.0 111.188 178.395 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.09 -48.65 79.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.352 2.261 . . . . 0.0 111.658 177.833 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 t -60.39 -38.9 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 127.056 2.723 . . . . 0.0 112.271 178.156 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -80.69 -20.78 42.18 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 118.717 -2.49 . . . . 0.0 110.207 -177.551 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.91 -29.67 39.86 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 115.207 -2.33 . . . . 0.0 111.485 172.986 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -72.97 -23.74 60.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 168.317 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -73.28 -42.8 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 129.833 3.253 . . . . 0.0 111.03 170.286 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -64.42 -42.34 96.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 116.636 -1.649 . . . . 0.0 109.692 172.704 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.59 -56.2 24.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 121.827 2.103 . . . . 0.0 113.254 173.306 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -77.54 -31.97 53.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 112.993 -1.912 . . . . 0.0 115.597 -172.989 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -142.9 -7.41 0.83 Allowed 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 117.947 -2.971 . . . . 0.0 110.977 -167.51 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.95 13.07 54.43 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 126.553 2.025 . . . . 0.0 112.405 156.212 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.9 mt -88.76 127.05 57.62 Favored Pre-proline 0 N--CA 1.446 -0.646 0 O-C-N 117.704 -3.233 . . . . 0.0 108.955 -178.616 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.73 154.97 20.57 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 N-CA-C 106.945 -1.983 . . . . 0.0 106.945 -165.612 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -68.97 -29.62 27.41 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 CA-C-O 115.359 -2.017 . . . . 0.0 112.34 176.553 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.43 118.17 9.01 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 113.731 -3.033 . . . . 0.0 115.014 171.527 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 81.45 1.63 1.57 Allowed 'General case' 0 C--N 1.321 -0.634 1 C-N-CA 132.116 4.166 . . . . 0.0 112.955 179.414 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -99.49 121.31 40.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 100.797 -3.779 . . . . 0.0 100.797 173.191 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -105.04 152.05 23.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 111.866 -2.424 . . . . 0.0 107.42 169.796 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -121.28 110.93 16.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 126.917 2.636 . . . . 0.0 113.188 174.661 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.2 mt -94.27 148.07 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 124.892 2.282 . . . . 0.0 110.01 173.427 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -126.83 107.45 10.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 100.426 -3.916 . . . . 0.0 100.426 173.108 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 76.0 -104.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 101.916 -3.364 . . . . 0.0 101.916 178.969 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.97 8.5 6.78 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 129.419 3.39 . . . . 0.0 112.707 173.617 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -86.23 105.59 16.71 Favored 'General case' 0 C--N 1.325 -0.471 1 C-N-CA 132.9 4.48 . . . . 0.0 112.056 173.204 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -66.32 134.02 51.73 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 115.421 -2.228 . . . . 0.0 114.044 158.784 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.8 mt -107.01 111.18 23.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 127.65 3.094 . . . . 0.0 109.45 -162.755 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -68.06 123.26 20.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 130.92 3.688 . . . . 0.0 111.955 176.991 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.2 -18.11 3.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 119.644 3.201 . . . . 0.0 119.644 -157.057 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.87 -1.22 56.21 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 -175.583 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -92.81 166.69 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.933 2.093 . . . . 0.0 113.898 -173.475 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -109.75 166.3 11.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 124.816 1.323 . . . . 0.0 110.11 178.84 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mt -61.93 -34.87 76.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.415 1.486 . . . . 0.0 110.426 167.656 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.7 t -53.32 -41.26 65.52 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 117.728 -3.107 . . . . 0.0 117.898 160.823 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -75.84 -41.36 52.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 112.872 -3.442 . . . . 0.0 114.255 -178.206 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -86.68 -21.0 26.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 122.013 2.188 . . . . 0.0 106.787 -174.414 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 38.6 t30 81.07 62.24 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 119.005 -2.31 . . . . 0.0 108.181 179.718 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mt -110.08 110.01 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 100.25 -3.981 . . . . 0.0 100.25 177.935 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -104.13 165.15 11.24 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 127.597 2.359 . . . . 0.0 110.66 -168.241 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.447 7.7 pttp -44.52 125.16 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 118.449 -2.657 . . . . 0.0 115.971 172.395 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.409 2.7 tt0 84.18 9.2 0.49 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 119.12 3.008 . . . . 0.0 119.12 179.34 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -59.46 147.17 37.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.454 -3.279 . . . . 0.0 114.66 172.502 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.5 p -123.94 110.69 15.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 127.093 2.746 . . . . 0.0 106.384 -171.064 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.473 ' HB2' HG23 ' A' ' 5' ' ' VAL . 5.7 mp -111.48 158.81 18.7 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 128.798 2.839 . . . . 0.0 109.178 -173.042 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -121.55 139.37 53.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.994 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -104.11 132.63 50.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.561 -2.755 . . . . 0.0 103.561 177.875 . . . . . . . . 1 1 . 1 . 075 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.331 76.7 t -113.77 132.31 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 129.504 3.121 . . . . 0.0 111.298 174.928 . . . . . . . . 2 2 . 1 . 075 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.449 -0.48 0 O-C-N 126.115 2.134 . . . . 0.0 107.932 168.391 . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 101.213 -3.625 . . . . 0.0 101.213 . . . . . . . . . 0 0 . 1 . 076 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.307 8.5 mt-30 -104.51 156.3 18.07 Favored 'General case' 0 N--CA 1.455 -0.205 1 O-C-N 112.643 -6.286 . . . . 0.0 105.895 175.256 . . . . . . . . 3 2 . 1 . 076 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -125.8 140.5 48.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 110.942 -2.845 . . . . 0.0 110.541 156.143 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -81.17 138.73 35.84 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 101.044 -3.687 . . . . 0.0 101.044 171.648 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.12 123.3 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 166.385 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -86.22 131.65 34.18 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 -178.149 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -93.67 167.24 11.79 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.674 -1.266 . . . . 0.0 111.738 179.662 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.54 -24.36 61.93 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.427 2.691 . . . . 0.0 108.977 172.067 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.2 p -94.39 3.47 55.14 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 121.974 2.17 . . . . 0.0 110.39 -177.273 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.02 -38.94 2.53 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 158.928 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -83.54 158.78 21.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.167 -1.196 . . . . 0.0 111.008 -167.742 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -106.82 101.24 10.7 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 128.542 2.737 . . . . 0.0 103.969 177.453 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 pt -68.16 140.54 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.268 163.194 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 m -97.65 121.02 39.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 118.011 -2.93 . . . . 0.0 105.486 173.067 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.23 145.34 26.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 122.003 2.183 . . . . 0.0 105.649 166.752 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -100.65 113.18 25.81 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.078 2.151 . . . . 0.0 109.309 169.891 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.252 11.9 m -136.76 154.08 31.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 117.735 -3.103 . . . . 0.0 114.137 -164.722 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -118.24 149.31 45.55 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 127.914 2.486 . . . . 0.0 110.786 172.749 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.383 36.6 Cg_endo -57.18 -40.35 83.61 Favored 'Trans proline' 0 N--CA 1.447 -1.239 2 C-N-CA 127.461 5.441 . . . . 0.0 123.098 -174.886 . . . . . . . . 3 2 . 1 . 076 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.288 23.0 p -80.17 -2.08 43.16 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 178.836 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.69 138.97 37.51 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.831 -174.95 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -84.76 126.97 33.88 Favored 'General case' 0 C--N 1.323 -0.544 1 C-N-CA 132.134 4.174 . . . . 0.0 106.761 -171.645 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.262 5.4 mm -30.59 -41.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 120.897 3.665 . . . . 0.0 120.897 174.427 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -61.72 -34.42 75.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 114.972 -2.442 . . . . 0.0 110.693 172.669 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -72.8 -15.87 61.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 125.424 3.738 . . . . 0.0 113.119 171.116 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.2 t -86.28 -35.3 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 115.907 -1.996 . . . . 0.0 110.612 175.975 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -62.76 -45.25 93.56 Favored 'General case' 0 N--CA 1.447 -0.623 1 O-C-N 129.548 4.28 . . . . 0.0 109.667 171.362 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.56 -33.9 68.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 167.077 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -73.77 -40.82 63.19 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 116.403 -1.761 . . . . 0.0 109.815 -178.843 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.52 -33.83 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 126.682 1.993 . . . . 0.0 114.972 171.956 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -69.5 -44.92 70.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 101.887 -3.375 . . . . 0.0 101.887 177.843 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.357 2.5 t70 -63.59 -5.34 3.8 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 130.321 3.448 . . . . 0.0 114.689 179.075 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -116.85 -75.44 0.58 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.846 2.858 . . . . 0.0 111.33 178.491 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -95.91 -1.96 48.21 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.267 1.827 . . . . 0.0 114.046 -174.721 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.93 3.5 68.06 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 123.401 2.818 . . . . 0.0 114.982 164.98 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.2 mt -76.45 111.71 17.21 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 126.673 1.989 . . . . 0.0 110.216 -176.822 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -51.86 131.32 37.82 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 CA-C-O 115.696 -1.877 . . . . 0.0 113.825 168.97 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -38.58 -35.95 0.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 124.983 3.789 . . . . 0.0 119.816 175.625 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.49 -12.98 62.1 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.885 0.85 . . . . 0.0 113.129 -178.285 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -92.12 -5.7 52.21 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 117.243 -3.41 . . . . 0.0 112.161 172.423 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 65.6 mt-30 -108.3 107.38 17.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 119.439 -2.038 . . . . 0.0 108.975 -171.423 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -92.06 133.43 35.75 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 125.584 1.803 . . . . 0.0 106.668 156.492 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.3 mt -113.4 144.81 42.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.837 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.268 11.3 mm -132.12 136.43 56.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 112.062 -2.335 . . . . 0.0 105.948 -165.767 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 61' ' ' ILE . 75.8 t80 -145.35 117.4 8.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 127.097 2.748 . . . . 0.0 106.322 177.152 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.327 . . 63.76 -98.6 0.07 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.812 1.245 . . . . 0.0 111.38 -160.191 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.19 11.23 5.32 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 127.231 2.832 . . . . 0.0 119.37 161.844 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -87.03 127.04 35.11 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.417 2.687 . . . . 0.0 105.728 -163.421 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -75.12 102.94 5.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 118.967 -2.333 . . . . 0.0 108.322 170.329 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.466 HD21 ' CD2' ' A' ' 59' ' ' TYR . 65.0 mt -62.46 117.99 6.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.401 3.08 . . . . 0.0 109.309 177.632 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -89.74 145.49 25.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 117.512 -3.242 . . . . 0.0 114.39 -174.571 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.98 118.12 16.57 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 126.551 3.072 . . . . 0.0 112.902 176.267 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.1 -17.42 19.63 Favored Glycine 0 CA--C 1.524 0.625 1 C-N-CA 132.24 4.733 . . . . 0.0 111.429 -178.431 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -86.98 149.47 24.75 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 122.089 2.944 . . . . 0.0 109.68 176.026 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.6 p -95.78 169.27 10.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 126.511 3.053 . . . . 0.0 112.964 -178.685 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.78 -36.1 80.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 116.5 -3.875 . . . . 0.0 111.384 173.638 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -67.84 -37.77 82.3 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 118.709 -2.494 . . . . 0.0 108.336 -178.775 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.4 -48.83 77.99 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 126.228 2.205 . . . . 0.0 110.789 176.742 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.466 ' CD2' HD21 ' A' ' 50' ' ' LEU . 53.9 m-85 -81.65 7.85 11.31 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.617 3.167 . . . . 0.0 118.572 170.71 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 63.03 21.31 12.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.406 1.882 . . . . 0.0 110.789 170.489 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.431 HG12 ' CE2' ' A' ' 45' ' ' PHE . 47.1 mt -76.8 145.11 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 124.124 1.916 . . . . 0.0 108.521 175.018 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -134.44 -177.38 4.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.41 1.484 . . . . 0.0 110.631 -167.248 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -57.13 132.56 53.33 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 114.455 -2.688 . . . . 0.0 114.36 173.763 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 70.44 48.1 0.48 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 126.11 2.862 . . . . 0.0 115.825 172.888 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -117.88 152.74 34.8 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 118.698 -2.502 . . . . 0.0 106.77 -178.548 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.4 m -108.34 117.01 33.05 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 129.242 3.017 . . . . 0.0 108.746 -176.514 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.311 7.6 mp -105.63 158.33 16.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 167.541 . . . . . . . . 2 2 . 1 . 076 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -103.27 123.87 47.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 129.762 3.225 . . . . 0.0 109.868 168.3 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 tp -81.71 113.63 19.83 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 129.411 3.084 . . . . 0.0 107.921 164.101 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.85 150.71 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 128.161 2.584 . . . . 0.0 112.684 -176.977 . . . . . . . . 1 1 . 1 . 076 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.44 -0.965 0 C-N-CA 129.48 3.112 . . . . 0.0 103.173 -178.984 . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 tmm? . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 117.166 -1.397 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 077 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -75.82 133.7 40.57 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.261 1.824 . . . . 0.0 110.064 -177.708 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -147.29 173.26 2.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 122.554 2.434 . . . . 0.0 113.353 162.508 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.69 148.62 39.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 128.678 2.791 . . . . 0.0 104.236 -177.951 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.06 125.08 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 126.946 2.099 . . . . 0.0 105.384 169.185 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.51 140.12 40.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.6 171.966 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.419 ' HG1' ' H ' ' A' ' 11' ' ' LYS . 3.8 p -111.62 145.54 39.0 Favored 'General case' 0 C--N 1.327 -0.394 1 O-C-N 129.289 4.118 . . . . 0.0 112.636 177.965 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 tp -77.34 -13.29 59.96 Favored 'General case' 0 C--O 1.239 0.549 1 O-C-N 115.821 -4.299 . . . . 0.0 109.1 -177.269 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -88.04 -16.76 32.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 113.642 -3.075 . . . . 0.0 113.037 171.54 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.6 17.17 2.39 Favored Glycine 0 CA--C 1.54 1.633 0 O-C-N 128.892 3.87 . . . . 0.0 112.348 142.872 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.419 ' H ' ' HG1' ' A' ' 7' ' ' THR . 64.8 tttt -96.86 147.65 23.74 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.64 3.576 . . . . 0.0 107.552 178.808 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 m -125.07 147.24 49.07 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 122.127 2.239 . . . . 0.0 108.134 164.933 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 pt -129.51 153.83 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 126.614 1.965 . . . . 0.0 108.497 173.958 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 140.32 29.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 150.963 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.6 tp -137.8 166.12 24.78 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 129.818 3.247 . . . . 0.0 106.782 -173.638 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -132.3 128.85 38.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 100.624 -3.843 . . . . 0.0 100.624 173.122 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 m -127.21 166.23 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 128.521 2.728 . . . . 0.0 105.921 175.075 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -86.12 155.58 57.75 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 101.443 -3.54 . . . . 0.0 101.443 166.726 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -59.75 -33.27 96.39 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 CA-C-N 122.176 1.813 . . . . 0.0 114.358 157.581 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 m -93.5 19.64 8.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 109.898 -3.319 . . . . 0.0 107.568 -168.252 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -82.66 133.04 35.17 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.729 1.212 . . . . 0.0 108.57 160.927 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.357 20.3 p -77.22 163.53 26.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.794 1.238 . . . . 0.0 111.59 165.458 . . . . . . . . 3 3 . 1 . 077 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 24.9 mm -38.62 -51.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 128.374 2.67 . . . . 0.0 112.307 166.411 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.58 -39.41 91.09 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 118.184 2.661 . . . . 0.0 118.184 174.67 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -83.22 -26.62 30.61 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 114.091 -2.861 . . . . 0.0 110.535 -178.608 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.0 t -44.47 -76.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 130.74 3.616 . . . . 0.0 109.958 156.991 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -31.47 -38.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 1 C-N-CA 133.693 4.797 . . . . 0.0 114.52 170.743 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.55 -22.12 61.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 128.366 2.666 . . . . 0.0 114.652 -175.615 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -101.55 -16.09 16.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.499 1.92 . . . . 0.0 109.996 -176.114 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -80.68 -25.42 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 119.297 -2.127 . . . . 0.0 114.203 158.934 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -67.53 -47.12 70.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.625 1.57 . . . . 0.0 109.707 -176.487 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -48.75 -48.59 40.7 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 127.261 2.224 . . . . 0.0 111.383 168.783 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.22 -24.26 54.61 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 119.441 -2.037 . . . . 0.0 109.265 -171.314 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.513 6.7 tp10 -128.09 -34.5 2.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 -159.024 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.79 -4.78 79.2 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 123.088 2.676 . . . . 0.0 118.249 -170.21 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.7 mt -84.3 124.31 74.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.245 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.28 153.11 45.42 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.656 3.571 . . . . 0.0 105.165 173.691 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -57.31 -42.35 63.27 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.808 3.005 . . . . 0.0 115.542 -174.128 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -49.98 -20.99 1.06 Allowed 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 119.075 2.991 . . . . 0.0 119.075 168.895 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -108.09 -9.34 15.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 122.387 2.358 . . . . 0.0 111.13 176.77 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -78.11 137.1 38.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.524 1.14 . . . . 0.0 110.806 172.237 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -126.74 111.2 13.96 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 174.932 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.8 mt -100.41 122.61 43.44 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 125.713 1.883 . . . . 0.0 108.205 -178.797 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.59 139.56 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 125.965 2.04 . . . . 0.0 112.622 171.722 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -147.77 120.96 8.9 Favored 'General case' 0 N--CA 1.448 -0.543 1 C-N-CA 131.823 4.049 . . . . 0.0 113.519 175.182 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.91 33.53 14.71 Favored 'General case' 0 N--CA 1.443 -0.801 1 C-N-CA 133.162 4.585 . . . . 0.0 111.999 -178.137 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.5 -17.63 56.42 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 128.235 2.826 . . . . 0.0 117.923 173.63 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -92.52 135.77 33.78 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 116.439 -1.744 . . . . 0.0 113.719 173.39 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 133.4 45.02 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 126.87 2.606 . . . . 0.0 110.349 156.091 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.0 mt -99.21 155.04 17.69 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 118.472 -2.642 . . . . 0.0 109.972 -155.971 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -92.63 139.12 30.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 175.968 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.266 17.0 m-20 -43.08 -58.45 2.45 Favored 'General case' 0 N--CA 1.447 -0.609 1 C-N-CA 137.54 6.336 . . . . 0.0 109.173 -160.199 . . . . . . . . 3 2 . 1 . 077 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.74 18.82 43.03 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 117.594 1.798 . . . . 0.0 117.594 -159.763 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.321 22.0 mmm180 -101.49 143.06 31.96 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 179.478 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.8 p -72.24 165.03 25.25 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.374 2.269 . . . . 0.0 106.401 -179.099 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.4 mt -65.51 -22.61 66.74 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 116.42 -3.925 . . . . 0.0 117.452 168.751 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -72.17 -24.92 61.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 167.485 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -72.47 -21.6 61.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 117.97 -2.957 . . . . 0.0 116.474 166.083 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -98.72 -2.85 37.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.051 1.341 . . . . 0.0 111.88 172.834 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 73.55 29.04 1.62 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.368 1.867 . . . . 0.0 113.905 176.82 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.0 mt -92.47 113.49 27.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.012 1.725 . . . . 0.0 109.231 -175.572 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.263 57.5 tp60 -142.63 83.55 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.933 2.093 . . . . 0.0 109.834 -171.739 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.369 3.9 tmtt? 91.39 108.54 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 O-C-N 116.774 -3.703 . . . . 0.0 113.538 139.523 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.69 26.4 mt-10 78.41 17.12 1.15 Allowed 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 117.595 -3.191 . . . . 0.0 118.901 -178.108 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.266 19.2 p -85.71 155.95 20.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -178.839 . . . . . . . . 2 2 . 1 . 077 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.4 m -109.86 110.39 21.35 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 174.217 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.68 130.29 35.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.553 1.941 . . . . 0.0 109.405 168.64 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -94.44 128.53 41.05 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 115.471 -2.492 . . . . 0.0 104.861 -168.906 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -109.61 123.53 49.6 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -171.071 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.34 164.08 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 125.431 1.492 . . . . 0.0 107.818 174.7 . . . . . . . . 1 1 . 1 . 077 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 123.64 1.686 . . . . 0.0 106.608 -169.961 . . . . . . . . 0 0 . 1 . 078 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 37.7 ttp . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 . . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -86.3 144.73 27.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 118.8 -2.438 . . . . 0.0 114.455 170.449 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.3 pt -132.21 165.5 31.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 117.163 -3.461 . . . . 0.0 107.026 169.538 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -112.49 140.13 47.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.509 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.398 60.9 t -124.84 84.39 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 129.571 3.149 . . . . 0.0 109.686 -172.272 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -75.16 121.82 22.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 121.211 -0.93 . . . . 0.0 111.582 -179.159 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 32.1 m -90.18 154.88 19.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 118.461 -2.649 . . . . 0.0 110.783 -175.471 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.287 3.0 tm? -33.46 -38.84 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 117.221 -3.425 . . . . 0.0 118.886 168.931 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.2 p -77.71 -18.17 56.85 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.344 3.458 . . . . 0.0 114.014 179.594 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.38 14.47 38.27 Favored Glycine 0 CA--C 1.523 0.574 1 C-N-CA 132.568 4.889 . . . . 0.0 109.612 177.254 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -79.48 116.88 19.96 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.563 -1.551 . . . . 0.0 109.394 173.811 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.5 m -75.07 109.55 8.64 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.664 1.986 . . . . 0.0 107.547 163.826 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.254 86.1 mt -90.58 148.14 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 1 N-CA-C 97.05 -5.167 . . . . 0.0 97.05 165.045 . . . . . . . . 3 2 . 1 . 078 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -135.78 139.25 43.38 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 117.217 -3.427 . . . . 0.0 108.781 163.97 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.53 149.52 42.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.432 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -83.62 136.97 34.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.969 1.308 . . . . 0.0 109.642 167.325 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.46 165.2 30.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 130.765 3.626 . . . . 0.0 108.447 173.487 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -96.67 156.42 36.64 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-O 116.75 -1.595 . . . . 0.0 113.859 167.614 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.3 -43.34 59.6 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 N-CA-C 121.755 3.714 . . . . 0.0 121.755 175.408 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -10.38 57.9 Favored 'General case' 0 N--CA 1.452 -0.337 1 N-CA-C 122.145 4.128 . . . . 0.0 122.145 -178.506 . . . . . . . . 3 3 . 1 . 078 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -49.22 139.47 11.07 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 128.056 2.543 . . . . 0.0 114.532 177.552 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -97.03 141.85 29.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 110.323 -3.126 . . . . 0.0 105.08 -174.155 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.09 -28.61 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 118.282 -2.761 . . . . 0.0 112.402 -166.325 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.31 -26.3 65.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 173.852 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -78.89 -24.71 44.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 118.762 -2.461 . . . . 0.0 107.038 -177.724 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.4 -33.86 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 122.888 2.586 . . . . 0.0 113.045 -177.345 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -68.39 -39.09 81.81 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.819 2.447 . . . . 0.0 109.548 -177.801 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.29 -28.72 68.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.761 -2.462 . . . . 0.0 112.789 176.315 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -84.58 -30.64 24.86 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 124.825 1.328 . . . . 0.0 110.893 -174.242 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mt -71.95 -41.16 68.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 127.032 2.707 . . . . 0.0 104.706 171.234 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.38 -43.14 96.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 119.009 -2.307 . . . . 0.0 108.379 176.966 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -64.99 -45.12 86.94 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 121.212 1.824 . . . . 0.0 113.789 -178.561 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -99.02 -25.33 14.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 111.895 -3.907 . . . . 0.0 111.624 -167.874 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -117.33 -22.98 7.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 123.214 2.734 . . . . 0.0 111.679 177.035 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.3 42.43 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 128.418 2.913 . . . . 0.0 113.799 166.088 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.2 mt -90.69 120.47 68.84 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 127.578 2.351 . . . . 0.0 107.133 -179.115 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -58.09 154.76 37.57 Favored 'Trans proline' 0 N--CA 1.444 -1.409 1 C-N-CA 128.009 5.806 . . . . 0.0 112.251 -179.972 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -78.52 -18.07 12.39 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 122.469 2.113 . . . . 0.0 116.531 -162.986 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.09 -10.88 51.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 167.673 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -93.7 -15.82 24.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.715 1.606 . . . . 0.0 111.229 -171.992 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -98.11 143.81 28.25 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.184 1.794 . . . . 0.0 111.451 170.24 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.88 128.64 42.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 129.003 2.921 . . . . 0.0 106.096 166.373 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -95.37 123.24 38.79 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.704 1.24 . . . . 0.0 109.993 179.413 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.463 10.3 mt -108.64 124.48 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 130.209 3.404 . . . . 0.0 114.16 178.096 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -139.6 133.97 31.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 115.763 -2.065 . . . . 0.0 112.614 171.124 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.71 36.37 23.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.938 2.095 . . . . 0.0 115.218 173.934 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.26 -16.24 30.02 Favored Glycine 0 N--CA 1.442 -0.933 1 CA-C-O 112.271 -4.627 . . . . 0.0 113.476 -171.771 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -89.48 138.63 31.28 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 122.19 2.995 . . . . 0.0 105.361 -171.208 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.38 136.26 33.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.919 -1.946 . . . . 0.0 109.355 157.119 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.441 HD21 ' CG ' ' A' ' 59' ' ' TYR 0.269 15.5 mt -90.38 139.71 30.41 Favored 'General case' 0 C--O 1.221 -0.432 1 CA-C-O 111.415 -4.136 . . . . 0.0 108.858 -165.222 . . . . . . . . 4 3 . 1 . 078 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -99.99 145.65 27.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 124.246 3.203 . . . . 0.0 113.345 173.77 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.94 139.18 52.86 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 125.083 1.489 . . . . 0.0 108.626 162.61 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.18 11.39 13.71 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 103.777 -3.729 . . . . 0.0 103.777 -179.249 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -139.5 176.8 8.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 123.572 1.653 . . . . 0.0 108.62 176.754 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.4 p -108.46 177.56 4.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.542 1.537 . . . . 0.0 112.178 178.089 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.307 85.2 mt -50.36 -55.84 13.93 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.667 3.187 . . . . 0.0 110.66 164.079 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -67.03 -24.56 66.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -173.663 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -57.39 -40.1 77.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 128.833 2.853 . . . . 0.0 112.361 176.639 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.441 ' CG ' HD21 ' A' ' 50' ' ' LEU . 44.4 m-85 -103.82 0.7 30.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.654 1.982 . . . . 0.0 112.551 -177.469 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.9 m120 81.23 32.71 0.12 Allowed 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 125.038 1.461 . . . . 0.0 113.348 168.262 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -95.19 94.97 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 125.856 1.972 . . . . 0.0 106.811 -177.915 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -101.76 -158.87 0.7 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.005 0.431 . . . . 0.0 111.319 172.923 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -58.7 134.7 57.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.284 -2.135 . . . . 0.0 111.684 168.87 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 25.0 tt0 85.11 40.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.061 -1.025 . . . . 0.0 110.058 170.364 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -120.36 137.8 54.08 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.565 1.946 . . . . 0.0 108.215 -179.936 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -120.23 123.47 43.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 115.993 -1.956 . . . . 0.0 108.67 176.739 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.23 160.82 15.06 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -178.209 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -118.66 139.35 51.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 125.002 1.439 . . . . 0.0 108.226 176.711 . . . . . . . . 1 1 . 1 . 078 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.332 4.0 tt -125.24 119.71 29.24 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 101.787 -3.412 . . . . 0.0 101.787 -166.764 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.282 20.9 m -111.23 144.25 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 101.74 -3.43 . . . . 0.0 101.74 174.417 . . . . . . . . 2 2 . 1 . 078 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 N--CA 1.447 -0.586 0 CA-C-N 109.307 -3.588 . . . . 0.0 107.185 174.792 . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptt? . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 079 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.377 26.7 mt-30 -97.44 124.23 41.57 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.665 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.4 160.21 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 127.715 2.406 . . . . 0.0 112.82 170.239 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -113.51 136.47 52.77 Favored 'General case' 0 N--CA 1.452 -0.344 1 O-C-N 112.289 -6.507 . . . . 0.0 114.416 -176.086 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.9 t -111.25 121.64 64.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 128.171 2.588 . . . . 0.0 110.387 164.512 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -100.95 117.0 34.12 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 101.479 -3.526 . . . . 0.0 101.479 -172.21 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -73.38 155.67 39.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.977 2.511 . . . . 0.0 111.962 172.542 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.99 -30.82 68.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 124.855 2.265 . . . . 0.0 115.108 170.914 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 p -75.15 0.76 15.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 128.039 2.535 . . . . 0.0 112.881 177.293 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.57 -18.35 25.02 Favored Glycine 0 CA--C 1.526 0.778 1 C-N-CA 131.402 4.334 . . . . 0.0 118.689 166.345 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -94.54 155.05 17.09 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.827 2.451 . . . . 0.0 109.907 -160.142 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.3 m -114.04 132.55 55.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 124.724 2.202 . . . . 0.0 110.888 -176.182 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.37 126.59 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 1 O-C-N 116.219 -4.051 . . . . 0.0 106.609 178.357 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -90.2 128.49 36.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -171.065 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.97 123.95 51.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 116.468 -1.729 . . . . 0.0 106.816 -179.107 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -103.59 101.73 11.59 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 130.524 3.53 . . . . 0.0 110.977 177.797 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.39 166.35 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 N-CA-C 99.921 -4.103 . . . . 0.0 99.921 -157.204 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.358 48.7 mm-40 -108.08 167.99 8.52 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 115.576 -2.154 . . . . 0.0 106.3 158.951 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.15 -6.48 18.01 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 CA-C-N 123.32 2.221 . . . . 0.0 110.239 179.031 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.6 p -96.32 13.5 27.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 131.209 3.804 . . . . 0.0 113.737 177.875 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.81 135.7 38.93 Favored 'General case' 0 C--N 1.32 -0.687 1 C-N-CA 133.299 4.64 . . . . 0.0 102.684 174.036 . . . . . . . . 3 3 . 1 . 079 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -77.24 172.63 12.96 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.039 0.935 . . . . 0.0 110.856 166.915 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.288 1.4 mp -59.29 -42.09 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 125.767 1.627 . . . . 0.0 108.886 163.97 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -65.56 -39.83 92.12 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 125.647 1.842 . . . . 0.0 109.067 -172.909 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -64.45 -40.68 96.18 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.119 1.368 . . . . 0.0 107.403 177.52 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 t -69.5 -39.96 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 O-C-N 117.752 -3.093 . . . . 0.0 117.872 174.845 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -66.98 -29.51 69.37 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.905 -2.372 . . . . 0.0 114.493 168.724 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.08 59.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 170.97 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -59.11 -32.0 69.42 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.889 173.428 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.8 mt -65.14 -47.45 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 121.884 2.129 . . . . 0.0 109.37 169.386 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -74.89 -39.09 61.69 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.688 1.595 . . . . 0.0 107.912 -168.886 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.74 -31.15 72.24 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 122.866 2.576 . . . . 0.0 109.203 177.28 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -87.87 -66.94 0.86 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 115.355 -2.259 . . . . 0.0 107.927 177.633 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -96.79 -20.6 18.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 120.372 1.442 . . . . 0.0 110.568 -156.534 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.73 -19.12 21.72 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 168.718 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.1 mt -69.14 139.06 89.88 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 127.64 2.376 . . . . 0.0 113.265 -170.573 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -75.06 147.73 34.11 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 CA-C-O 113.412 -2.828 . . . . 0.0 115.209 -179.778 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.32 -45.41 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.276 3.317 . . . . 0.0 115.066 -158.046 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.24 -3.6 11.29 Favored 'General case' 0 N--CA 1.452 -0.354 1 C-N-CA 132.999 4.52 . . . . 0.0 116.641 178.087 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -87.76 -23.57 24.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 126.275 2.234 . . . . 0.0 107.728 173.324 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -90.56 115.97 28.1 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.119 -3.488 . . . . 0.0 110.87 -169.289 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -99.51 126.13 45.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 123.473 1.606 . . . . 0.0 107.706 161.8 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.62 110.15 22.27 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.798 2.439 . . . . 0.0 110.767 -175.866 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.1 mt -105.03 145.96 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 O-C-N 119.823 -1.798 . . . . 0.0 111.233 -179.211 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -160.46 139.61 10.65 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.1 1.76 . . . . 0.0 112.998 165.687 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.58 28.49 15.71 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 130.763 3.625 . . . . 0.0 112.246 168.144 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.69 1.49 58.81 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 116.724 -2.153 . . . . 0.0 113.122 176.223 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -120.94 151.97 39.07 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 131.391 3.877 . . . . 0.0 114.767 176.632 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -94.93 116.65 28.98 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 128.509 3.631 . . . . 0.0 107.398 168.382 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.92 112.88 3.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.293 -2.754 . . . . 0.0 112.401 -178.905 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.272 74.4 tt0 -89.01 147.3 24.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 114.904 -2.475 . . . . 0.0 106.922 -164.619 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.92 132.86 50.49 Favored 'General case' 0 C--N 1.326 -0.423 1 O-C-N 130.442 4.839 . . . . 0.0 114.551 175.565 . . . . . . . . 2 2 . 1 . 079 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.06 -9.29 54.66 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 128.196 2.808 . . . . 0.0 117.003 -176.682 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.7 mtt-85 -101.83 157.53 16.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.383 2.673 . . . . 0.0 108.27 -174.488 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.8 p -102.69 155.41 18.32 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 102.216 -3.254 . . . . 0.0 102.216 173.23 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.6 mt -35.54 -36.44 0.07 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 129.564 3.146 . . . . 0.0 118.619 162.134 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.6 t -64.6 -21.93 66.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 111.564 -2.562 . . . . 0.0 115.791 179.343 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.45 -22.88 46.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 120.531 -1.356 . . . . 0.0 111.705 -178.324 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -106.96 -0.83 22.82 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.169 2.188 . . . . 0.0 106.507 -176.262 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 m120 56.28 50.56 13.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 126.063 2.839 . . . . 0.0 112.816 173.998 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.0 mt -80.15 115.82 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 112.483 -2.144 . . . . 0.0 108.112 -178.613 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -76.57 167.02 22.57 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 165.91 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -54.09 143.81 21.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 118.633 2.827 . . . . 0.0 118.633 159.57 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 73.89 6.56 4.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 115.318 -2.277 . . . . 0.0 113.367 172.971 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -66.39 154.96 38.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.965 3.706 . . . . 0.0 111.272 172.084 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -114.47 111.72 21.86 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -177.342 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.43 169.64 8.57 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 179.917 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -130.62 141.67 50.44 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 119.708 1.14 . . . . 0.0 109.247 -163.383 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -114.85 129.47 56.71 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 126.22 2.2 . . . . 0.0 115.661 167.106 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.0 t -132.31 136.15 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 170.629 . . . . . . . . 1 1 . 1 . 079 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.2 mt . . . . . 0 N--CA 1.453 -0.309 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.097 -171.665 . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 ttp . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 115.348 -2.263 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 080 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.28 92.9 mt-30 -108.51 133.53 52.54 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 125.055 3.57 . . . . 0.0 110.559 -171.241 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -127.44 174.67 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 155.113 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -117.42 156.52 27.8 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.012 1.725 . . . . 0.0 108.693 172.614 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.72 130.06 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.9 157.59 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -90.73 130.13 36.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 112.173 -2.285 . . . . 0.0 111.801 173.567 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -98.63 136.86 38.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 167.853 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.31 -0.02 1.14 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.268 1.827 . . . . 0.0 114.667 -156.323 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.8 p -86.43 -25.89 25.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 129.969 3.308 . . . . 0.0 105.68 -178.805 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.81 3.17 18.45 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.636 1.112 . . . . 0.0 113.889 -178.685 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -79.48 135.13 36.57 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.711 3.204 . . . . 0.0 109.42 170.722 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.4 p -123.48 136.25 54.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.919 1.688 . . . . 0.0 111.229 -170.041 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mt -118.7 113.0 40.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.352 -2.832 . . . . 0.0 103.352 179.833 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -67.86 119.13 12.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 162.317 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.267 0.2 OUTLIER -114.62 126.97 55.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -171.126 . . . . . . . . 3 3 . 1 . 080 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -104.56 115.04 29.66 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.223 1.809 . . . . 0.0 109.844 -164.101 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.305 34.1 m -129.82 -177.83 2.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 C-N-CA 123.914 0.886 . . . . 0.0 112.351 -171.29 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.43 163.02 51.66 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-O 114.831 -2.509 . . . . 0.0 106.786 148.083 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -48.14 -16.86 0.7 Allowed 'Trans proline' 0 N--CA 1.442 -1.531 0 N-CA-C 122.149 3.865 . . . . 0.0 122.149 -176.337 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.1 m -88.15 -8.7 55.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 114.112 -2.851 . . . . 0.0 113.542 178.697 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.53 121.24 12.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.04 2.136 . . . . 0.0 106.558 -175.479 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -77.17 137.5 38.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.075 2.95 . . . . 0.0 107.874 176.274 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.285 1.5 mp -54.79 -30.93 23.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 127.637 2.375 . . . . 0.0 113.61 179.454 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -71.77 -22.49 61.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 121.54 1.973 . . . . 0.0 109.643 174.721 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.6 -31.0 21.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 115.126 -2.369 . . . . 0.0 105.969 178.987 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.48 -41.5 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 126.291 2.244 . . . . 0.0 106.931 178.129 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -56.8 -37.99 71.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 115.821 -2.037 . . . . 0.0 113.085 174.16 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.57 85.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 121.719 2.054 . . . . 0.0 111.461 175.78 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -65.78 -33.77 76.63 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 130.182 3.393 . . . . 0.0 111.933 177.723 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.5 mt -71.96 -40.74 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 115.315 -2.278 . . . . 0.0 106.25 169.607 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -60.11 -40.43 89.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 124.273 3.215 . . . . 0.0 109.694 171.193 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.87 -30.44 67.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.062 2.545 . . . . 0.0 116.1 179.789 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -93.75 -57.04 2.68 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 128.743 2.817 . . . . 0.0 111.172 -174.707 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -118.05 -13.1 9.99 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -164.549 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.14 -11.7 55.42 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 115.339 -2.923 . . . . 0.0 117.111 156.579 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.19 123.15 87.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 111.713 -3.994 . . . . 0.0 107.687 -172.377 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -63.48 138.28 64.43 Favored 'Trans proline' 0 N--CA 1.449 -1.142 1 O-C-N 129.198 4.262 . . . . 0.0 111.565 -179.855 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -59.85 -21.91 66.1 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 120.603 3.27 . . . . 0.0 120.603 -164.724 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.39 -13.36 58.48 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 124.917 1.385 . . . . 0.0 114.089 -175.304 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -98.11 -7.5 29.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.116 1.766 . . . . 0.0 113.768 175.652 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.39 147.86 33.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.519 1.528 . . . . 0.0 112.677 165.897 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.372 35.9 ttm105 -134.83 132.42 38.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 114.511 -2.661 . . . . 0.0 107.685 161.913 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.37 107.04 14.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.619 2.768 . . . . 0.0 107.162 -179.118 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.0 mt -122.34 144.69 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 1 O-C-N 115.509 -4.494 . . . . 0.0 107.349 171.234 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.498 ' CD1' HD13 ' A' ' 50' ' ' LEU 0.38 0.1 OUTLIER -142.08 110.89 6.21 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 132.898 4.479 . . . . 0.0 114.988 167.967 . . . . . . . . 5 4 . 1 . 080 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.34 32.44 3.53 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.717 2.807 . . . . 0.0 111.337 177.582 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 -19.36 23.98 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 128.35 2.881 . . . . 0.0 116.222 -177.322 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -76.98 117.51 18.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.649 2.38 . . . . 0.0 107.996 177.165 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -77.33 122.03 24.56 Favored 'General case' 0 N--CA 1.445 -0.722 1 C-N-CA 133.986 4.914 . . . . 0.0 108.399 175.241 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.498 HD13 ' CD1' ' A' ' 45' ' ' PHE . 6.4 mp -87.1 120.84 28.79 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 126.271 2.232 . . . . 0.0 108.646 -176.922 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.46 151.16 22.63 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.516 -156.392 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.8 104.0 1.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 131.01 3.724 . . . . 0.0 108.782 -174.15 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.88 -14.6 26.57 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.277 174.211 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -71.09 147.38 48.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 122.787 3.293 . . . . 0.0 106.971 160.451 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -105.91 -178.2 3.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 118.98 -2.325 . . . . 0.0 108.408 -173.951 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -66.1 -33.37 75.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 113.829 -2.986 . . . . 0.0 108.209 175.286 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.355 21.3 m -72.59 -29.4 63.49 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 127.455 2.972 . . . . 0.0 109.378 -179.105 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -67.22 -34.95 78.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.96 1.413 . . . . 0.0 113.725 173.573 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 55.2 m-85 -97.67 9.38 42.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.48 2.312 . . . . 0.0 112.085 -178.704 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.39 74.5 m-20 73.17 13.81 4.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 173.0 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.8 mm -91.94 114.98 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 -159.298 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -88.57 168.44 12.56 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 111.67 -2.514 . . . . 0.0 112.183 163.482 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.289 30.5 pttt -29.27 137.79 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 121.345 3.831 . . . . 0.0 121.345 169.867 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.273 4.9 tt0 71.76 4.28 4.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 164.867 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -62.2 158.71 16.38 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 118.639 -2.538 . . . . 0.0 112.615 159.986 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.306 15.2 t -129.4 137.18 50.77 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 129.084 3.99 . . . . 0.0 108.764 -175.129 . . . . . . . . 2 2 . 1 . 080 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -120.62 135.08 55.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 121.555 1.98 . . . . 0.0 111.998 -176.131 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -96.55 137.68 35.26 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 115.173 -2.346 . . . . 0.0 110.018 170.536 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -117.53 166.33 12.49 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 127.678 3.111 . . . . 0.0 111.212 173.489 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.95 147.22 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 O-C-N 127.477 2.985 . . . . 0.0 107.544 165.148 . . . . . . . . 1 1 . 1 . 080 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.1 mt . . . . . 0 N--CA 1.445 -0.707 1 C-N-CA 134.567 5.147 . . . . 0.0 110.553 170.595 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 ttp . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 . . . . . . . . . 0 0 . 1 . 081 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -96.18 155.47 16.75 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 119.569 -1.957 . . . . 0.0 106.735 -177.796 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 pt -135.84 160.29 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 129.236 3.014 . . . . 0.0 113.127 165.369 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -101.59 151.95 21.38 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 125.534 1.771 . . . . 0.0 108.509 162.338 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.5 t -125.7 132.19 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 166.368 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -89.95 119.68 30.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 117.862 -3.024 . . . . 0.0 105.593 157.954 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -100.48 136.34 40.51 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -178.137 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -44.12 -42.53 6.37 Favored 'General case' 0 C--N 1.324 -0.514 1 O-C-N 130.515 4.884 . . . . 0.0 113.53 -174.48 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.1 p -58.72 -12.08 3.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 130.859 3.664 . . . . 0.0 117.095 174.208 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.07 -16.27 10.1 Favored Glycine 0 CA--C 1.527 0.804 1 C-N-CA 130.731 4.015 . . . . 0.0 110.843 176.071 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 95.3 mttt -80.73 142.07 34.2 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 120.473 2.137 . . . . 0.0 112.117 -165.361 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.6 m -96.91 130.0 44.28 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 164.071 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.269 43.9 pt -135.69 153.97 33.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 127.623 2.369 . . . . 0.0 106.289 -177.55 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.256 11.8 t -129.03 133.05 47.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 112.657 -3.545 . . . . 0.0 110.632 -177.915 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -130.82 151.44 51.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 122.74 2.518 . . . . 0.0 111.181 -172.309 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -97.16 117.4 31.27 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 131.338 3.855 . . . . 0.0 106.394 172.882 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.18 171.81 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 1 N-CA-C 100.093 -4.04 . . . . 0.0 100.093 179.714 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -111.36 142.85 27.26 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 131.273 3.829 . . . . 0.0 101.357 159.574 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -63.07 -13.89 38.19 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.086 3.19 . . . . 0.0 114.078 174.475 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -86.38 -7.81 58.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 126.962 3.268 . . . . 0.0 112.736 176.939 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -74.5 132.69 42.08 Favored 'General case' 0 N--CA 1.451 -0.405 1 O-C-N 114.552 -5.092 . . . . 0.0 109.361 179.521 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -63.32 162.87 11.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.343 2.657 . . . . 0.0 113.695 169.955 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mm -66.14 -36.4 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.207 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -19.55 64.59 Favored 'General case' 0 N--CA 1.449 -0.504 1 O-C-N 115.003 -4.811 . . . . 0.0 116.972 172.878 . . . . . . . . 3 3 . 1 . 081 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -80.25 -24.44 40.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 125.473 1.733 . . . . 0.0 109.579 174.024 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 t -73.58 -30.89 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.662 1.185 . . . . 0.0 108.755 168.111 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -73.29 -41.11 63.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 118.168 -2.833 . . . . 0.0 113.99 175.958 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.9 -47.12 43.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 129.985 3.314 . . . . 0.0 113.372 170.162 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -73.76 -30.19 62.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 114.823 -2.513 . . . . 0.0 112.54 179.085 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -75.36 -39.89 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 O-C-N 125.821 1.95 . . . . 0.0 109.316 168.854 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -50.02 -46.36 52.78 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 128.152 2.581 . . . . 0.0 110.642 174.875 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.254 5.6 t70 -58.51 -44.18 89.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.388 1.875 . . . . 0.0 114.571 175.58 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -85.85 -51.3 6.49 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 115.91 -1.995 . . . . 0.0 110.25 -176.166 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.42 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 68.3 mm-40 -99.91 -23.04 15.06 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 114.131 -2.842 . . . . 0.0 111.572 -164.58 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.17 -12.98 28.79 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 128.65 3.719 . . . . 0.0 117.696 172.724 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.305 70.8 mt -75.27 132.13 76.86 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 113.715 -3.041 . . . . 0.0 111.067 -163.327 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.86 146.1 82.24 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 O-C-N 126.608 2.899 . . . . 0.0 114.206 173.014 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.56 -34.18 43.22 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 CA-C-N 120.959 1.378 . . . . 0.0 115.119 176.27 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.308 0.1 OUTLIER -42.19 -37.79 1.56 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.054 2.542 . . . . 0.0 113.853 174.793 . . . . . . . . 3 3 . 1 . 081 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -108.88 -8.45 15.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.396 1.879 . . . . 0.0 111.915 -171.182 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -104.78 119.03 38.02 Favored 'General case' 0 N--CA 1.452 -0.334 1 C-N-CA 134.203 5.001 . . . . 0.0 113.343 -169.434 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -127.38 133.46 50.02 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 177.43 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.274 3.8 mt -104.42 152.4 22.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.974 1.71 . . . . 0.0 110.969 -169.302 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mt -137.04 146.09 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 1 C-N-CA 132.929 4.492 . . . . 0.0 107.324 -169.397 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -152.41 123.8 7.72 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 131.638 3.975 . . . . 0.0 107.918 169.358 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.4 38.05 25.76 Favored 'General case' 0 N--CA 1.445 -0.687 1 C-N-CA 132.355 4.262 . . . . 0.0 112.302 166.507 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.28 -14.89 63.1 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 120.149 -1.594 . . . . 0.0 116.925 -179.382 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -107.1 125.89 51.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 -171.785 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.92 127.81 32.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 169.704 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.11 137.46 34.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.289 1.859 . . . . 0.0 106.613 -168.683 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -82.21 123.63 29.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 109.55 -3.477 . . . . 0.0 105.333 -164.563 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -69.96 112.18 6.18 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 127.726 2.41 . . . . 0.0 106.033 -167.814 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.89 0.04 22.87 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 115.77 -2.683 . . . . 0.0 117.594 -157.722 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -114.16 178.71 4.18 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.981 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -125.59 160.42 29.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.958 2.503 . . . . 0.0 107.411 -174.264 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.45 -41.27 98.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.579 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.2 t -53.03 -38.71 62.61 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.285 -1.509 . . . . 0.0 110.227 175.575 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.47 -48.5 81.41 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 116.266 -1.826 . . . . 0.0 112.343 -173.171 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -84.95 11.89 8.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 121.503 1.956 . . . . 0.0 115.187 172.406 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.36 4.1 t-20 76.84 33.33 0.47 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 123.179 1.466 . . . . 0.0 108.566 160.363 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.99 120.09 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 118.7 -2.5 . . . . 0.0 111.345 -177.95 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -99.72 172.0 7.54 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.225 2.21 . . . . 0.0 111.642 173.414 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -59.69 133.33 55.99 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.928 2.491 . . . . 0.0 115.661 179.911 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 4.2 tt0 75.19 20.95 1.98 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.359 2.664 . . . . 0.0 115.772 -175.314 . . . . . . . . 2 2 . 1 . 081 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -63.5 136.84 57.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 131.407 3.883 . . . . 0.0 109.595 165.439 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.6 m -101.05 107.0 18.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 124.781 1.301 . . . . 0.0 112.662 169.23 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.94 162.0 20.62 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.477 1.911 . . . . 0.0 110.94 172.938 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -135.41 117.06 14.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 130.381 3.472 . . . . 0.0 105.755 -168.616 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tp -98.52 140.46 32.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 115.456 -2.212 . . . . 0.0 110.925 -174.002 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.29 163.71 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 127.179 2.191 . . . . 0.0 108.657 171.908 . . . . . . . . 1 1 . 1 . 081 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.485 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.588 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -173.193 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 . . . . . . . . . 0 0 . 1 . 082 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -91.91 145.19 24.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 -172.324 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.85 163.54 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 128.842 2.857 . . . . 0.0 109.147 162.731 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -104.38 151.12 23.87 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 114.638 -2.601 . . . . 0.0 105.002 177.01 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.9 105.15 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 1 C-N-CA 132.69 4.396 . . . . 0.0 104.328 172.272 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -97.91 107.36 19.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.312 2.245 . . . . 0.0 111.263 -173.905 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 p -86.11 166.49 15.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -168.422 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -86.63 -20.76 27.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.528 -2.177 . . . . 0.0 115.923 166.905 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 p -69.44 -23.76 63.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 125.32 1.638 . . . . 0.0 113.321 176.154 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.53 -14.09 5.33 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 119.494 -2.004 . . . . 0.0 115.746 156.145 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -80.6 172.54 13.62 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 120.075 -1.838 . . . . 0.0 112.892 173.556 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 m -136.67 132.1 34.49 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 117.544 -3.222 . . . . 0.0 107.2 177.297 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.22 148.1 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.63 1.572 . . . . 0.0 107.807 172.881 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 p -97.22 131.35 44.03 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.978 2.911 . . . . 0.0 110.178 165.762 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.82 133.6 53.06 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 115.411 -2.233 . . . . 0.0 111.073 -172.527 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -84.23 125.8 32.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 101.256 -3.609 . . . . 0.0 101.256 164.837 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.38 147.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 176.035 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 2.1 tm-20 -97.59 135.8 21.52 Favored Pre-proline 0 N--CA 1.448 -0.526 0 O-C-N 119.274 -2.141 . . . . 0.0 108.608 158.027 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.82 -24.81 2.26 Favored 'Trans proline' 0 N--CA 1.443 -1.451 1 C-N-CA 126.817 5.012 . . . . 0.0 116.317 173.951 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -98.29 1.55 47.25 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 129.796 3.238 . . . . 0.0 109.991 177.194 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -72.03 140.46 49.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 121.799 2.09 . . . . 0.0 106.935 167.731 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.0 p -90.58 178.92 5.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 118.916 -2.365 . . . . 0.0 108.381 -175.928 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -67.24 -33.23 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 120.01 1.277 . . . . 0.0 113.457 179.469 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.69 -37.27 83.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.752 2.821 . . . . 0.0 116.672 168.293 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -77.58 -35.44 53.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 115.629 -2.129 . . . . 0.0 107.233 -179.722 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 t -65.8 -48.52 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 124.856 3.48 . . . . 0.0 111.606 170.992 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -50.99 -49.99 59.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 169.719 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.05 -49.46 41.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.946 2.098 . . . . 0.0 114.889 165.157 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -65.14 -25.46 67.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 119.606 -1.934 . . . . 0.0 110.574 -179.864 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -80.92 -13.76 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 O-C-N 119.276 -2.14 . . . . 0.0 114.677 175.269 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -76.59 -41.9 44.5 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 118.593 -2.567 . . . . 0.0 110.255 168.034 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -57.72 -43.38 85.2 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 127.248 2.219 . . . . 0.0 112.314 178.903 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -69.19 -55.03 11.85 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 115.268 -2.301 . . . . 0.0 115.255 174.198 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -122.94 -19.59 6.07 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 125.837 1.96 . . . . 0.0 111.65 -155.638 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.1 9.53 63.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.282 1.896 . . . . 0.0 111.716 167.679 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mt -67.52 130.45 93.27 Favored Pre-proline 0 N--CA 1.444 -0.744 0 O-C-N 118.924 -2.515 . . . . 0.0 112.841 171.754 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -79.14 123.17 5.52 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.862 3.041 . . . . 0.0 109.108 -176.467 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.458 17.4 Cg_exo -25.93 -43.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.123 1 C-N-CA 129.736 6.957 . . . . 0.0 121.94 -177.91 . . . . . . . . 3 2 . 1 . 082 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.97 -15.19 63.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 113.602 -3.094 . . . . 0.0 113.389 177.403 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -86.71 -15.0 40.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 124.034 3.106 . . . . 0.0 109.673 177.574 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -90.11 153.03 20.85 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -166.753 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -142.32 120.13 11.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 121.85 2.114 . . . . 0.0 109.32 170.084 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.4 mt -89.45 144.0 26.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 125.034 3.561 . . . . 0.0 107.27 -178.059 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mm -127.41 153.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 125.69 2.662 . . . . 0.0 106.634 169.522 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -150.46 108.67 3.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.004 2.522 . . . . 0.0 108.985 174.725 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.02 22.21 12.92 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 131.567 3.947 . . . . 0.0 112.207 167.261 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.95 -4.01 25.7 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 119.239 -2.163 . . . . 0.0 116.977 178.409 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.22 143.98 48.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 172.225 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -91.89 135.17 34.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -172.618 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -89.99 138.39 31.54 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.23 -1.544 . . . . 0.0 108.925 176.733 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -145.58 140.68 27.58 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -159.889 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -35.85 128.9 0.65 Allowed 'General case' 0 N--CA 1.452 -0.326 1 C-N-CA 134.633 5.173 . . . . 0.0 113.65 -179.371 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.69 -16.25 23.78 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 118.092 -2.88 . . . . 0.0 117.223 167.253 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.334 32.9 mtt85 -100.49 166.77 10.77 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 125.713 2.673 . . . . 0.0 107.065 167.766 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -87.83 167.63 13.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 119.509 -1.994 . . . . 0.0 108.755 173.115 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.306 22.2 mt -59.93 -38.43 82.36 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 172.7 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.7 p -69.03 -27.75 65.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.413 1.885 . . . . 0.0 112.917 -179.254 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.53 -44.26 96.26 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.581 1.952 . . . . 0.0 108.278 171.803 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -81.4 10.55 5.52 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 128.341 2.656 . . . . 0.0 114.142 175.488 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.268 1.9 t-20 65.87 24.1 11.31 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 172.934 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 mt -86.69 132.62 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 O-C-N 120.194 -1.567 . . . . 0.0 106.941 -173.8 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -114.05 -179.56 3.67 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 127.073 2.733 . . . . 0.0 112.121 170.224 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 138.24 24.91 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.08 0.952 . . . . 0.0 111.201 175.253 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 42.6 mt-10 74.84 13.59 3.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 125.349 1.655 . . . . 0.0 109.735 163.603 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.4 m -54.52 157.53 2.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 157.252 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.93 105.25 14.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 111.51 -2.586 . . . . 0.0 106.084 177.102 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -102.08 138.89 38.43 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 176.535 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.257 41.4 m80 -95.88 135.77 37.18 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.637 1.575 . . . . 0.0 112.254 175.766 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.23 100.91 10.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 179.426 . . . . . . . . 2 2 . 1 . 082 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -96.51 151.91 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.031 . . . . . . . . 1 1 . 1 . 082 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.5 mt . . . . . 0 N--CA 1.446 -0.652 1 C-N-CA 135.776 5.631 . . . . 0.0 117.857 174.726 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 ttp . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 115.309 -2.281 . . . . 0.0 106.214 . . . . . . . . . 0 0 . 1 . 083 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -104.53 130.53 52.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.855 2.57 . . . . 0.0 111.388 -179.933 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.293 20.4 pt -119.22 122.03 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 114.25 -2.786 . . . . 0.0 109.617 165.336 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -73.77 151.97 40.47 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 124.15 3.159 . . . . 0.0 108.434 178.243 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -126.44 155.16 36.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 1 O-C-N 129.301 4.126 . . . . 0.0 106.794 161.438 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.25 42.3 tttt -120.63 152.87 37.61 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 128.909 2.884 . . . . 0.0 113.342 169.205 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.3 p -107.23 159.06 16.63 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 130.591 3.556 . . . . 0.0 106.422 -170.573 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 mt -63.64 -19.97 65.31 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.608 1.563 . . . . 0.0 111.895 -179.163 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.5 p -85.31 -15.25 43.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 176.235 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.63 5.59 41.95 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 113.777 -3.79 . . . . 0.0 114.129 177.695 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -82.58 132.67 35.19 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 121.885 2.843 . . . . 0.0 110.381 176.911 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.6 m -90.0 124.59 34.88 Favored 'General case' 0 C--N 1.325 -0.463 1 C-N-CA 134.339 5.055 . . . . 0.0 104.799 176.227 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -113.59 139.4 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 130.93 3.692 . . . . 0.0 107.809 -179.34 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.4 m -96.73 130.66 43.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 121.886 2.13 . . . . 0.0 112.128 170.854 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.2 mt -107.63 129.54 54.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.559 2.344 . . . . 0.0 113.004 173.805 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -80.37 118.7 22.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 123.69 1.71 . . . . 0.0 108.646 169.983 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.04 156.46 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 O-C-N 117.537 -3.227 . . . . 0.0 115.243 173.882 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 20' ' ' SER . 73.2 mm-40 -74.61 154.29 87.5 Favored Pre-proline 0 N--CA 1.451 -0.404 0 O-C-N 117.843 -3.036 . . . . 0.0 108.979 162.826 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -76.81 15.84 1.03 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 1 C-N-CA 125.568 4.179 . . . . 0.0 114.543 179.648 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 18' ' ' GLU . 10.8 p -131.38 3.16 4.24 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 129.288 3.035 . . . . 0.0 117.786 171.914 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.54 137.93 57.86 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 126.588 2.43 . . . . 0.0 107.941 179.506 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.298 44.6 p -102.56 170.47 8.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 126.957 3.265 . . . . 0.0 107.709 -174.09 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mm -66.01 -30.72 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 1 O-C-N 114.642 -5.036 . . . . 0.0 115.506 -173.962 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.14 -26.25 68.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 121.031 1.741 . . . . 0.0 111.648 175.661 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.05 -28.12 29.8 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.441 2.296 . . . . 0.0 112.652 176.429 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.8 t -81.58 -29.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 122.382 2.355 . . . . 0.0 108.275 178.732 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -51.45 -49.39 61.82 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.251 2.22 . . . . 0.0 115.347 160.062 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.11 -46.11 68.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.677 1.591 . . . . 0.0 108.563 -178.695 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.254 57.2 mttm -52.09 -50.11 62.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 172.633 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.335 91.5 mt -54.52 -38.07 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 123.61 1.671 . . . . 0.0 114.992 171.902 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.88 -42.62 94.65 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 117.165 -3.459 . . . . 0.0 111.233 170.846 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -52.45 -42.5 64.22 Favored 'General case' 0 N--CA 1.445 -0.702 1 O-C-N 116.206 -4.059 . . . . 0.0 114.278 172.007 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -90.51 -47.34 7.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -167.538 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -120.15 -15.15 8.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 124.803 2.24 . . . . 0.0 113.528 -157.26 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.34 1.42 44.19 Favored Glycine 0 CA--C 1.522 0.518 1 C-N-CA 134.309 5.719 . . . . 0.0 117.352 166.818 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -88.99 119.98 69.89 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 128.181 2.592 . . . . 0.0 104.667 -153.2 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.3 142.84 55.75 Favored 'Trans proline' 0 N--CA 1.447 -1.229 1 C-N-CA 126.459 4.772 . . . . 0.0 114.659 178.164 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.02 -46.78 7.64 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 124.603 3.535 . . . . 0.0 111.267 -177.789 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.439 0.0 OUTLIER -32.95 -40.4 0.05 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 118.608 2.818 . . . . 0.0 118.608 167.49 . . . . . . . . 3 3 . 1 . 083 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.302 11.5 mm-40 -101.34 -5.25 25.65 Favored 'General case' 0 N--CA 1.448 -0.556 1 C-N-CA 132.312 4.245 . . . . 0.0 114.626 -161.56 . . . . . . . . 3 2 . 1 . 083 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -99.7 157.21 16.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.931 2.093 . . . . 0.0 106.929 -178.664 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -142.59 129.13 20.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 130.017 3.327 . . . . 0.0 110.364 160.14 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -117.04 120.26 37.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 120.357 1.435 . . . . 0.0 107.428 174.784 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mm -106.32 152.75 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 130.148 3.379 . . . . 0.0 107.801 -177.329 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -152.08 107.16 3.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 130.161 3.384 . . . . 0.0 105.582 178.271 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.439 . . 72.25 23.23 3.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 127.887 3.708 . . . . 0.0 117.679 169.383 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.03 -12.75 45.12 Favored Glycine 0 CA--C 1.529 0.958 1 O-C-N 114.574 -5.079 . . . . 0.0 110.086 171.901 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -112.69 142.24 45.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.559 3.544 . . . . 0.0 111.963 -179.969 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -91.65 141.89 28.21 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 110.473 -3.058 . . . . 0.0 105.218 -175.765 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -88.18 113.91 24.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 130.217 3.407 . . . . 0.0 106.824 -175.285 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -103.28 164.66 11.5 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 129.832 3.253 . . . . 0.0 113.346 -169.904 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -68.42 132.03 46.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 128.81 3.819 . . . . 0.0 112.745 -177.297 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.8 0.88 58.83 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.694 1.616 . . . . 0.0 112.647 173.769 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -88.81 164.53 15.18 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.866 2.066 . . . . 0.0 108.678 177.001 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -111.71 161.68 16.03 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 169.399 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -55.67 -39.41 70.91 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.675 1.19 . . . . 0.0 110.762 176.538 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 m -61.31 -34.1 74.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 116.113 -1.898 . . . . 0.0 115.214 177.885 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -60.85 -38.54 85.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 116.211 -1.852 . . . . 0.0 114.852 172.237 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -97.95 14.68 26.43 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 116.717 -1.611 . . . . 0.0 110.943 173.894 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.363 12.6 p30 74.54 14.95 3.44 Favored 'General case' 0 N--CA 1.439 -0.978 1 C-N-CA 135.111 5.364 . . . . 0.0 114.208 166.608 . . . . . . . . 3 2 . 1 . 083 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -72.33 111.57 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.181 2.192 . . . . 0.0 109.297 -170.414 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -96.57 164.84 12.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 127.019 2.699 . . . . 0.0 107.811 -173.18 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -48.26 117.76 2.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.961 3.704 . . . . 0.0 110.483 179.27 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.722 2.1 mp0 78.01 18.97 1.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 117.898 2.555 . . . . 0.0 117.898 -178.707 . . . . . . . . 2 2 . 1 . 083 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.6 m -77.27 154.11 33.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 170.466 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.2 m -107.21 129.26 54.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.205 1.802 . . . . 0.0 106.949 173.232 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -99.81 156.1 17.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 163.622 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -98.94 149.38 23.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 115.496 -2.193 . . . . 0.0 108.352 160.281 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 pp -97.37 151.89 19.48 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 124.752 1.283 . . . . 0.0 110.866 164.157 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.6 t -142.72 125.35 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -179.203 . . . . . . . . 1 1 . 1 . 083 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 N--CA 1.449 -0.487 0 O-C-N 119.795 -1.815 . . . . 0.0 110.249 -176.002 . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 . . . . . . . . . 0 0 . 1 . 084 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -97.04 144.79 26.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 -178.201 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.382 0.9 OUTLIER -125.54 157.55 34.76 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 C-N-CA 129.469 3.108 . . . . 0.0 107.158 167.428 . . . . . . . . 3 3 . 1 . 084 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -113.17 139.39 48.8 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.739 2.015 . . . . 0.0 105.746 179.757 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.9 t -117.25 113.45 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 171.077 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -102.16 135.14 44.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 173.084 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -83.48 164.28 19.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 118.007 -2.933 . . . . 0.0 112.105 172.394 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.3 -27.75 67.55 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.699 2.0 . . . . 0.0 108.67 179.577 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -14.44 58.93 Favored 'General case' 0 N--CA 1.448 -0.567 1 C-N-CA 134.362 5.065 . . . . 0.0 115.558 176.794 . . . . . . . . 3 3 . 1 . 084 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.8 -9.0 37.19 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 118.736 -2.478 . . . . 0.0 113.047 166.448 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.262 79.0 tttt -89.95 128.25 36.2 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 -177.106 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.3 m -117.83 120.2 37.19 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 110.857 -2.883 . . . . 0.0 112.116 -174.681 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -112.54 155.51 13.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 126.895 3.236 . . . . 0.0 110.337 174.795 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.3 6.8 m -103.1 120.53 40.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.538 -1.976 . . . . 0.0 107.396 -173.785 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -115.2 126.71 54.89 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.259 2.224 . . . . 0.0 109.898 -168.177 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -90.39 114.24 26.31 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 125.099 1.499 . . . . 0.0 108.29 -176.655 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.47 165.32 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 126.308 1.843 . . . . 0.0 114.465 179.908 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -125.34 153.15 72.09 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 114.921 -2.466 . . . . 0.0 109.408 165.505 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.17 -30.85 26.78 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.449 3.433 . . . . 0.0 117.921 -177.521 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -75.97 -1.47 25.79 Favored 'General case' 0 N--CA 1.446 -0.652 1 C-N-CA 135.424 5.489 . . . . 0.0 117.707 178.534 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.65 137.71 33.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 117.246 -3.409 . . . . 0.0 109.023 -175.155 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -84.63 159.14 20.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 122.004 2.184 . . . . 0.0 113.528 175.356 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -65.76 -21.41 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.098 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.74 -36.0 81.61 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 130.396 3.479 . . . . 0.0 112.23 174.736 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -73.82 -34.42 64.57 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 125.373 1.671 . . . . 0.0 110.27 175.683 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -80.72 -42.63 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.83 2.452 . . . . 0.0 111.578 -175.093 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -53.92 -46.51 71.51 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 121.231 3.789 . . . . 0.0 121.231 161.929 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.76 -43.03 98.51 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 126.883 2.614 . . . . 0.0 113.08 174.48 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -52.02 -39.44 59.49 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 115.022 -2.418 . . . . 0.0 112.73 174.737 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.7 mt -57.12 -46.46 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 125.456 1.722 . . . . 0.0 109.599 179.292 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -66.61 -45.94 77.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.298 1.839 . . . . 0.0 108.777 178.254 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -55.38 -43.49 75.2 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 117.568 -3.208 . . . . 0.0 115.266 177.065 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.94 -80.74 0.14 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 130.055 3.342 . . . . 0.0 113.937 174.976 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -89.19 -10.17 48.11 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 122.024 2.193 . . . . 0.0 115.069 -170.214 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.71 40.61 37.03 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 119.946 2.738 . . . . 0.0 119.946 -177.753 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 mt -119.18 95.82 49.59 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 119.957 -1.908 . . . . 0.0 109.86 178.407 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -69.13 158.03 59.32 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 O-C-N 122.805 0.898 . . . . 0.0 111.735 -177.953 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.292 63.1 Cg_exo -42.09 -34.88 2.94 Favored 'Trans proline' 0 N--CA 1.444 -1.407 1 C-N-CA 126.269 4.646 . . . . 0.0 120.186 176.858 . . . . . . . . 3 2 . 1 . 084 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.97 -35.55 0.54 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 129.488 3.115 . . . . 0.0 112.997 163.942 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -110.08 -7.69 14.89 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.208 1.803 . . . . 0.0 110.851 -170.618 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.253 81.1 mt-30 -100.06 155.09 17.91 Favored 'General case' 0 C--O 1.226 -0.141 0 O-C-N 118.945 -2.347 . . . . 0.0 112.266 179.256 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -150.08 105.61 3.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 100.962 -3.718 . . . . 0.0 100.962 169.052 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.69 72.74 8.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.565 1.546 . . . . 0.0 109.905 165.301 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 tt -71.24 92.95 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.226 154.843 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -73.26 -28.71 62.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -172.252 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.62 -80.93 0.12 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 114.882 -2.485 . . . . 0.0 108.401 175.1 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.67 -12.88 9.12 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 115.3 -2.945 . . . . 0.0 110.042 -179.315 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -136.28 163.46 30.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 121.253 2.526 . . . . 0.0 105.077 -169.478 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.02 155.64 32.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.333 -1.479 . . . . 0.0 113.662 172.14 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.8 mt -68.61 152.24 45.63 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 124.62 1.2 . . . . 0.0 109.793 172.346 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -108.64 129.78 55.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 120.811 1.642 . . . . 0.0 109.114 178.791 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -45.59 105.25 0.06 Allowed 'General case' 0 N--CA 1.444 -0.739 1 C-N-CA 132.717 4.407 . . . . 0.0 116.109 166.419 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.51 -3.96 13.5 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.659 2.552 . . . . 0.0 116.373 174.961 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -98.4 158.87 15.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 -177.525 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -111.65 169.65 8.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 110.208 -3.178 . . . . 0.0 103.778 -179.925 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 3.5 mp -52.59 -34.32 50.14 Favored 'General case' 0 N--CA 1.445 -0.714 1 C-N-CA 132.111 4.164 . . . . 0.0 112.445 172.0 . . . . . . . . 3 3 . 1 . 084 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.9 m -72.15 -21.24 61.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 175.407 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -72.89 -30.62 64.08 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.443 1.497 . . . . 0.0 113.713 169.97 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -101.85 2.15 37.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.529 1.532 . . . . 0.0 111.164 173.767 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 49.1 m-80 67.94 14.55 9.4 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 117.794 -3.066 . . . . 0.0 118.726 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.0 mt -65.85 154.27 7.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -163.188 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -128.39 179.16 5.79 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 130.98 3.712 . . . . 0.0 114.319 -170.165 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 tttt -65.16 135.43 55.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 113.818 -2.992 . . . . 0.0 109.725 -177.833 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.351 15.4 mt-10 78.72 0.55 2.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.515 2.726 . . . . 0.0 113.187 167.904 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.62 141.63 54.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.936 2.494 . . . . 0.0 112.047 178.656 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.1 m -109.81 132.27 54.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -177.412 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.6 mt -114.7 152.34 32.15 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 125.61 1.819 . . . . 0.0 108.743 173.738 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.368 15.4 m80 -105.1 149.3 25.97 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.038 2.135 . . . . 0.0 107.092 -168.274 . . . . . . . . 2 2 . 1 . 084 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -129.9 136.81 49.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 121.168 1.804 . . . . 0.0 112.631 169.598 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.0 t -124.57 139.07 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 129.768 3.227 . . . . 0.0 107.72 -176.326 . . . . . . . . 1 1 . 1 . 084 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 tp . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 -158.142 . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 ttp . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 085 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -75.11 132.95 41.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 126.928 2.643 . . . . 0.0 113.644 170.275 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 pt -130.54 146.56 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 1 C-N-CA 131.757 4.023 . . . . 0.0 106.917 160.414 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.29 141.53 34.03 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 129.112 2.965 . . . . 0.0 105.733 171.548 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -128.7 126.34 64.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 115.954 -1.974 . . . . 0.0 105.758 163.923 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -84.41 114.15 21.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 127.425 2.953 . . . . 0.0 110.908 174.722 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -64.13 160.67 17.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 128.5 4.0 . . . . 0.0 111.711 170.657 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -60.46 -12.59 10.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 117.274 -3.391 . . . . 0.0 118.571 -176.663 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 p -95.04 -8.0 38.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 109.894 -3.321 . . . . 0.0 111.222 175.766 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.82 -20.15 36.97 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 124.072 3.124 . . . . 0.0 112.827 -179.88 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -78.35 141.57 38.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 113.619 -3.086 . . . . 0.0 114.767 -176.219 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 p -92.77 132.05 37.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 125.926 3.966 . . . . 0.0 116.871 168.8 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.9 pt -102.91 129.37 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.536 161.005 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.2 m -88.54 129.14 35.54 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 103.452 -2.795 . . . . 0.0 103.452 -175.001 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.7 mt -114.89 131.16 56.95 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 178.624 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.15 98.72 9.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.553 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -112.98 167.99 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 124.662 2.172 . . . . 0.0 113.173 -176.221 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.371 26.4 mm-40 -93.46 149.25 36.95 Favored Pre-proline 0 N--CA 1.449 -0.511 0 O-C-N 118.204 -2.81 . . . . 0.0 105.593 167.104 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.28 15.4 Cg_endo -73.02 -16.03 25.77 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.952 2.434 . . . . 0.0 115.192 -176.61 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 p -86.61 -5.65 59.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.697 2.399 . . . . 0.0 112.07 -179.353 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -75.27 153.83 37.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -173.32 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.8 p -97.34 173.15 7.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 117.942 -2.974 . . . . 0.0 110.932 176.219 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.7 mm -85.97 -24.64 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 127.805 2.442 . . . . 0.0 109.121 -164.112 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -68.25 -30.58 69.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 129.929 3.292 . . . . 0.0 109.211 174.632 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -86.04 -17.67 34.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 124.319 3.236 . . . . 0.0 113.225 170.422 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.91 -50.93 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 102.75 -3.056 . . . . 0.0 102.75 168.908 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.22 -30.0 61.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 121.101 1.773 . . . . 0.0 108.756 -171.134 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.24 -27.4 67.94 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 117.497 -3.252 . . . . 0.0 115.465 168.317 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -67.02 -38.13 85.4 Favored 'General case' 0 C--N 1.325 -0.494 1 O-C-N 115.862 -4.274 . . . . 0.0 116.733 169.604 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.4 mt -74.3 -20.25 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 O-C-N 126.89 2.619 . . . . 0.0 113.173 171.433 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -66.61 -30.77 71.13 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 119.635 -1.915 . . . . 0.0 115.663 154.659 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -83.79 -57.71 3.1 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 121.496 1.953 . . . . 0.0 106.106 -174.765 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.323 64.7 mttm -45.04 -71.47 0.08 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 119.53 3.159 . . . . 0.0 119.53 168.073 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -102.77 -28.52 12.04 Favored 'General case' 0 N--CA 1.448 -0.526 1 CA-C-O 128.901 4.191 . . . . 0.0 115.979 -164.7 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.11 -9.12 50.18 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 118.777 -2.452 . . . . 0.0 118.955 167.211 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.4 mm -82.5 124.62 77.62 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 129.347 3.059 . . . . 0.0 104.825 -167.556 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.27 147.05 36.78 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 123.822 3.015 . . . . 0.0 112.829 -173.134 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -67.19 -13.19 38.74 Favored 'Trans proline' 0 N--CA 1.442 -1.507 1 C-N-CA 126.953 5.102 . . . . 0.0 114.072 -171.672 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -83.46 -5.7 59.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 118.213 -1.395 . . . . 0.0 113.927 173.688 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.431 2.5 tp-100 -108.98 -8.45 15.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.266 1.826 . . . . 0.0 111.408 168.885 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -92.91 123.74 36.39 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 126.859 3.219 . . . . 0.0 107.687 179.498 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.354 32.2 mtt180 -126.0 138.77 53.76 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 111.61 -2.541 . . . . 0.0 108.157 172.292 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -105.49 150.96 24.85 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 174.176 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.286 68.4 mt -100.53 143.84 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 1 C-N-CA 133.383 4.673 . . . . 0.0 109.685 152.219 . . . . . . . . 3 2 . 1 . 085 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -151.59 119.68 6.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 111.025 -2.807 . . . . 0.0 115.055 162.635 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.8 39.07 24.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.758 2.423 . . . . 0.0 115.08 176.677 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.43 -10.39 16.88 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 163.15 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -134.09 136.23 43.78 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -159.867 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.359 6.0 tt0 -73.99 130.37 39.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 162.525 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -73.92 133.6 43.09 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -172.787 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.22 -39.31 94.26 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.585 1.954 . . . . 0.0 112.125 175.182 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.391 24.8 t0 106.38 160.31 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 131.701 4.0 . . . . 0.0 113.419 170.585 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.98 21.94 12.94 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 128.609 3.004 . . . . 0.0 114.518 153.608 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -113.62 176.37 5.06 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 124.724 2.202 . . . . 0.0 106.666 175.034 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.2 p -90.41 154.22 19.83 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.274 -2.141 . . . . 0.0 108.438 172.623 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.346 8.0 mp -41.79 -61.25 1.15 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 110.261 -3.154 . . . . 0.0 115.686 175.596 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -45.24 -52.88 9.01 Favored 'General case' 0 N--CA 1.448 -0.536 1 C-N-CA 132.921 4.488 . . . . 0.0 112.601 176.103 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -64.45 -43.66 93.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.66 178.216 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.75 -14.4 60.71 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 119.359 -2.088 . . . . 0.0 111.733 -173.402 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.475 0.9 OUTLIER 91.61 24.03 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 130.801 3.641 . . . . 0.0 115.643 179.323 . . . . . . . . 3 3 . 1 . 085 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.7 mt -95.59 115.47 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 119.934 1.243 . . . . 0.0 111.99 176.139 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.436 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 9.5 mp0 -116.2 -156.49 0.62 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.831 1.652 . . . . 0.0 114.344 -178.876 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.436 ' H ' ' HB3' ' A' ' 62' ' ' GLN . 52.4 tttm -56.28 112.11 1.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 127.416 2.286 . . . . 0.0 112.997 178.407 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 76.52 21.96 1.27 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.065 2.146 . . . . 0.0 108.968 168.461 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -63.68 127.31 30.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 117.195 -1.383 . . . . 0.0 108.471 175.297 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 13.5 m -90.16 111.61 22.82 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 121.33 1.877 . . . . 0.0 111.687 169.664 . . . . . . . . 2 2 . 1 . 085 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.3 mt -91.87 152.19 20.2 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.823 1.249 . . . . 0.0 110.263 166.673 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -107.96 141.25 39.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 173.164 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -104.35 145.46 30.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -179.556 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 m -142.72 153.11 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 129.146 2.978 . . . . 0.0 107.095 -178.023 . . . . . . . . 1 1 . 1 . 085 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 mt . . . . . 0 C--N 1.323 -0.549 0 C-N-CA 127.094 2.158 . . . . 0.0 108.393 167.131 . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 115.401 -2.238 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 086 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -72.42 152.58 41.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 129.525 3.13 . . . . 0.0 108.926 177.595 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pp -145.29 158.95 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 160.63 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -119.22 117.82 29.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.463 1.505 . . . . 0.0 108.989 -174.085 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 t -100.88 117.52 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 1 N-CA-C 99.253 -4.351 . . . . 0.0 99.253 175.886 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -109.42 136.52 48.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 125.465 1.728 . . . . 0.0 109.624 -171.917 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -84.97 174.27 9.9 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.125 -1.609 . . . . 0.0 108.969 -177.137 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.5 mt -91.64 0.65 57.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 116.84 -1.552 . . . . 0.0 107.085 179.595 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -107.19 0.89 23.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.305 1.842 . . . . 0.0 110.481 174.453 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.99 -27.48 8.6 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 115.049 -3.084 . . . . 0.0 111.912 154.625 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -62.6 144.31 56.32 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 129.826 3.898 . . . . 0.0 108.906 179.066 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -118.52 123.0 44.02 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 127.683 3.114 . . . . 0.0 103.791 -169.057 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mt -94.24 134.36 32.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 117.039 -1.457 . . . . 0.0 108.329 174.602 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.6 m -103.07 110.23 22.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 114.296 -2.764 . . . . 0.0 110.716 177.848 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -107.6 160.37 15.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 127.152 2.782 . . . . 0.0 109.648 167.668 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.394 0.0 OUTLIER -127.87 116.06 19.56 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.732 3.213 . . . . 0.0 110.568 -178.017 . . . . . . . . 3 3 . 1 . 086 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.19 162.61 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 O-C-N 117.725 -3.109 . . . . 0.0 106.974 -169.387 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -102.07 154.56 37.28 Favored Pre-proline 0 N--CA 1.441 -0.901 0 O-C-N 118.975 -2.328 . . . . 0.0 106.815 164.638 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.251 67.0 Cg_endo -66.77 -29.32 42.58 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 124.496 3.464 . . . . 0.0 115.765 175.757 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.256 27.9 p -63.05 -2.28 1.21 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 114.927 -2.463 . . . . 0.0 117.366 160.814 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -70.1 136.14 49.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 123.484 2.856 . . . . 0.0 108.542 -175.517 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 p -77.99 170.83 15.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.76 2.424 . . . . 0.0 109.128 170.241 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.3 mt -72.66 -46.07 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -177.987 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -41.72 -44.1 3.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 122.668 2.485 . . . . 0.0 116.024 162.561 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -63.96 -42.97 97.13 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 124.687 1.242 . . . . 0.0 109.87 179.461 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 t -79.83 -27.88 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.353 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -68.69 -34.07 75.04 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 114.607 -2.616 . . . . 0.0 114.445 167.541 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.35 -26.12 42.15 Favored 'General case' 0 N--CA 1.45 -0.445 1 CA-C-N 126.881 4.401 . . . . 0.0 115.057 169.382 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -71.55 -39.61 70.55 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 124.688 1.242 . . . . 0.0 109.777 172.271 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.8 mt -73.36 -37.76 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 O-C-N 116.664 -3.773 . . . . 0.0 113.695 173.406 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -45.49 88.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 119.999 1.272 . . . . 0.0 112.623 175.551 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.09 -35.51 69.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.766 2.426 . . . . 0.0 111.495 -179.612 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -86.73 -39.04 16.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -177.312 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -120.53 -25.31 5.59 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.311 1.844 . . . . 0.0 111.466 -172.259 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.77 -11.97 67.72 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 114.641 -3.311 . . . . 0.0 116.138 -178.682 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.6 mt -64.84 118.52 49.46 Favored Pre-proline 0 N--CA 1.45 -0.456 1 CA-C-N 124.434 4.117 . . . . 0.0 115.678 177.469 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -76.44 141.49 22.67 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 CA-C-N 124.533 2.655 . . . . 0.0 118.035 -173.767 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -30.21 -50.33 0.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 N-CA-C 121.089 3.457 . . . . 0.0 121.089 177.839 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.93 -40.74 63.83 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 117.446 -3.284 . . . . 0.0 114.591 172.93 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -84.51 -25.79 28.55 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 118.535 -1.266 . . . . 0.0 113.733 -174.376 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -63.81 121.48 14.13 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 128.218 2.607 . . . . 0.0 108.117 171.882 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -101.54 131.83 47.5 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 123.316 2.78 . . . . 0.0 109.65 147.739 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.9 mt -104.95 139.09 40.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 125.846 1.966 . . . . 0.0 108.222 167.72 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mt -129.37 125.93 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 110.793 -2.912 . . . . 0.0 108.148 -173.912 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.362 33.1 t80 -149.54 131.18 14.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.654 1.115 . . . . 0.0 108.908 176.086 . . . . . . . . 2 2 . 1 . 086 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.38 34.51 15.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -178.711 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.01 -23.05 5.42 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 119.233 2.453 . . . . 0.0 119.233 -173.05 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -79.2 139.23 38.01 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 127.566 2.568 . . . . 0.0 111.405 -174.724 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -87.67 124.83 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 164.352 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.95 135.61 33.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 126.169 1.788 . . . . 0.0 113.395 -162.175 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -83.4 134.72 34.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 116.822 -3.674 . . . . 0.0 113.437 176.643 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.92 141.48 51.14 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 127.523 3.014 . . . . 0.0 111.173 -174.577 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.76 -16.16 26.12 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 111.725 -2.489 . . . . 0.0 114.141 177.854 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -87.25 145.82 26.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.886 2.074 . . . . 0.0 112.189 177.037 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 p -85.69 157.81 20.21 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 126.037 2.086 . . . . 0.0 111.904 179.02 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -53.62 -53.97 44.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.883 2.073 . . . . 0.0 114.464 177.23 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.252 22.1 t -39.68 -35.05 0.28 Allowed 'General case' 0 C--N 1.326 -0.437 1 N-CA-C 122.927 4.417 . . . . 0.0 122.927 165.925 . . . . . . . . 3 2 . 1 . 086 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -70.28 -44.25 68.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.224 2.61 . . . . 0.0 114.858 176.739 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -94.93 6.28 49.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 111.795 -2.457 . . . . 0.0 106.642 -173.286 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.9 t30 86.11 21.39 0.08 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 126.482 3.039 . . . . 0.0 113.065 151.976 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.297 82.3 mt -77.84 98.37 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 1 O-C-N 115.782 -4.324 . . . . 0.0 102.542 -178.316 . . . . . . . . 3 2 . 1 . 086 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -82.03 161.88 22.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 130.523 3.529 . . . . 0.0 107.51 -179.9 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -49.14 133.69 18.55 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 126.179 2.174 . . . . 0.0 112.913 176.242 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 65.05 20.92 12.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.125 2.97 . . . . 0.0 118.876 169.305 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -65.97 149.9 49.5 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 112.045 -3.836 . . . . 0.0 115.965 174.518 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 m -107.32 128.48 54.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 128.438 3.586 . . . . 0.0 110.265 170.332 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.251 0.7 OUTLIER -144.56 -177.9 5.72 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.361 2.264 . . . . 0.0 108.376 -170.771 . . . . . . . . 3 3 . 1 . 086 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.629 2.1 p80 -128.96 167.12 17.9 Favored 'General case' 0 N--CA 1.448 -0.537 1 C-N-CA 134.144 4.977 . . . . 0.0 118.117 177.79 . . . . . . . . 3 2 . 1 . 086 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 tp -135.86 126.72 27.54 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 110.6 -3.0 . . . . 0.0 115.713 175.267 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.14 104.77 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 130.44 3.496 . . . . 0.0 108.346 -179.303 . . . . . . . . 1 1 . 1 . 086 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 N--CA 1.448 -0.563 0 C-N-CA 130.958 3.703 . . . . 0.0 108.863 165.528 . . . . . . . . 0 0 . 1 . 087 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 . . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.95 139.16 44.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 116.833 -1.556 . . . . 0.0 112.728 158.913 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -128.75 173.79 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 167.509 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.19 160.41 37.33 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 125.612 1.82 . . . . 0.0 109.421 179.946 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.9 t -136.37 116.22 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 127.654 2.382 . . . . 0.0 109.256 172.671 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -76.3 130.67 38.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 121.277 1.853 . . . . 0.0 111.196 156.588 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 p -100.73 168.17 9.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 116.168 -1.872 . . . . 0.0 114.592 -174.71 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 mt -58.6 -32.93 69.44 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 127.181 2.192 . . . . 0.0 113.089 -175.87 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -71.57 -22.62 61.71 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.679 1.991 . . . . 0.0 115.363 174.418 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.56 -18.22 13.41 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 128.925 3.155 . . . . 0.0 108.658 -176.793 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 86.8 tttt -66.68 148.09 52.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 113.839 -2.981 . . . . 0.0 109.111 -172.738 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.3 m -120.52 130.94 54.46 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 125.853 1.971 . . . . 0.0 112.429 174.966 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 mm -103.69 147.65 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 128.591 2.756 . . . . 0.0 105.597 179.471 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.3 m -106.84 122.9 47.32 Favored 'General case' 0 N--CA 1.452 -0.337 1 N-CA-C 99.472 -4.27 . . . . 0.0 99.472 174.743 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.14 160.69 25.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.87 1.668 . . . . 0.0 109.302 173.436 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -114.01 125.91 54.53 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.39 -1.732 . . . . 0.0 115.167 166.224 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.42 161.99 13.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 O-C-N 119.613 -1.929 . . . . 0.0 112.135 176.152 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -107.57 160.57 26.17 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 127.456 2.302 . . . . 0.0 107.335 161.304 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -40.38 -42.16 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.891 1 C-N-CA 127.477 5.451 . . . . 0.0 114.815 175.218 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 p -77.57 -3.01 38.58 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.772 -3.08 . . . . 0.0 117.005 -172.88 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.25 123.81 29.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 123.641 1.686 . . . . 0.0 109.841 -178.631 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.3 p -81.71 179.85 7.66 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 129.319 3.048 . . . . 0.0 106.399 -179.403 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.2 mm -64.77 -35.89 76.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 115.941 -1.98 . . . . 0.0 109.376 179.325 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -55.24 -47.15 75.82 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 126.458 1.903 . . . . 0.0 114.318 173.771 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -64.81 -34.95 79.57 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.899 3.679 . . . . 0.0 109.474 177.236 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.0 t -71.05 -42.5 76.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.454 1.902 . . . . 0.0 107.0 177.177 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -73.0 -31.08 64.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 119.24 -2.162 . . . . 0.0 115.61 -178.019 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.29 78.03 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.766 3.226 . . . . 0.0 112.492 170.053 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -74.46 -30.09 61.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.323 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.7 mt -73.39 -35.96 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 128.982 2.913 . . . . 0.0 109.916 -176.957 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -61.94 -42.74 99.45 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 119.133 -2.229 . . . . 0.0 109.515 172.931 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -61.67 -19.28 62.15 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 119.671 3.212 . . . . 0.0 119.671 178.358 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -101.11 -40.36 7.23 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 116.874 -1.536 . . . . 0.0 109.095 172.404 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS 0.328 16.8 tp10 -125.05 -4.68 7.44 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.529 -1.357 . . . . 0.0 114.023 -157.616 . . . . . . . . 3 3 . 1 . 087 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.23 9.23 28.64 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 119.176 2.43 . . . . 0.0 119.176 174.762 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.2 mt -75.89 133.12 73.22 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 130.655 3.582 . . . . 0.0 105.484 174.842 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.55 145.67 59.1 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 CA-C-O 113.926 -2.614 . . . . 0.0 114.285 -175.193 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.08 -39.17 19.43 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.504 2.803 . . . . 0.0 119.29 -177.469 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 38.4 t70 -48.64 -48.79 39.29 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 130.378 3.471 . . . . 0.0 114.145 179.73 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -72.22 -25.62 61.71 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 131.092 3.757 . . . . 0.0 113.278 173.3 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.84 128.76 35.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 123.759 2.981 . . . . 0.0 109.945 -175.014 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -109.98 161.8 15.15 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 118.862 -2.399 . . . . 0.0 108.675 165.49 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -124.81 106.65 10.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 164.111 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -92.77 128.65 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 101.008 -3.701 . . . . 0.0 101.008 164.641 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -157.13 117.67 3.56 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 128.29 2.636 . . . . 0.0 110.277 -173.727 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.94 28.74 18.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.217 2.607 . . . . 0.0 110.652 -172.427 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.23 -25.49 28.05 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 125.413 1.696 . . . . 0.0 109.861 177.678 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 tttt -92.62 135.01 34.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.988 -0.713 . . . . 0.0 111.227 -162.804 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.67 119.51 14.92 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 115.885 -2.007 . . . . 0.0 109.115 171.824 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.2 mt -81.36 123.82 28.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -177.953 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -81.29 137.59 35.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.457 -1.402 . . . . 0.0 110.365 -175.414 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.73 114.71 5.21 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.486 169.747 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.24 -21.32 2.95 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 130.327 3.822 . . . . 0.0 112.752 177.932 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mtp85 -97.31 155.67 16.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -176.861 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.448 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 42.0 p -94.74 171.05 9.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.364 1.866 . . . . 0.0 108.09 177.619 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.13 -47.24 77.79 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.962 1.305 . . . . 0.0 111.41 176.085 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.5 p -44.89 -40.26 6.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 118.591 2.812 . . . . 0.0 118.591 159.863 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 70.8 m-20 -61.57 -34.17 75.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 124.218 1.961 . . . . 0.0 116.133 168.654 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.94 11.16 21.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.033 -2.292 . . . . 0.0 115.927 168.813 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.451 8.5 p30 54.36 46.6 24.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 124.442 2.067 . . . . 0.0 111.662 177.515 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -103.85 108.25 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 128.662 2.785 . . . . 0.0 109.158 173.599 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -105.27 169.28 8.54 Favored 'General case' 0 C--N 1.325 -0.482 1 O-C-N 130.147 4.654 . . . . 0.0 112.749 -173.875 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.325 51.7 tttm -12.52 107.0 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 129.372 3.069 . . . . 0.0 117.446 168.969 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 76.49 17.87 1.85 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 129.386 3.074 . . . . 0.0 115.013 168.694 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -67.93 139.12 56.42 Favored 'General case' 0 CA--C 1.532 0.283 1 O-C-N 115.567 -4.458 . . . . 0.0 113.512 171.109 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.1 m -98.08 112.06 24.15 Favored 'General case' 0 N--CA 1.449 -0.48 1 C-N-CA 133.641 4.776 . . . . 0.0 103.579 178.137 . . . . . . . . 2 2 . 1 . 087 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -87.09 161.51 18.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 128.824 2.85 . . . . 0.0 109.538 169.21 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -123.15 118.7 28.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 130.12 3.368 . . . . 0.0 111.348 -172.73 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.1 tp -89.77 111.09 21.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 116.32 -1.8 . . . . 0.0 114.649 -166.167 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.95 165.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 125.142 1.526 . . . . 0.0 107.875 -179.539 . . . . . . . . 1 1 . 1 . 087 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tp . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 125.921 1.688 . . . . 0.0 109.045 -176.469 . . . . . . . . 0 0 . 1 . 088 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -72.19 134.78 45.87 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.299 1.84 . . . . 0.0 112.864 171.592 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.5 pt -147.04 141.04 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.489 2.316 . . . . 0.0 107.958 168.935 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.04 151.28 25.07 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 119.125 -2.234 . . . . 0.0 107.54 -179.223 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -110.88 129.39 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 117.733 -3.104 . . . . 0.0 104.33 160.61 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -109.07 120.36 42.31 Favored 'General case' 0 N--CA 1.45 -0.433 1 O-C-N 116.268 -4.02 . . . . 0.0 101.406 167.707 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -85.95 126.79 34.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 158.547 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.307 6.0 mp -88.83 -12.65 41.35 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 125.318 1.636 . . . . 0.0 108.88 -167.686 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.5 p -90.33 -14.02 33.98 Favored 'General case' 0 N--CA 1.442 -0.869 1 O-C-N 115.919 -4.238 . . . . 0.0 113.198 164.281 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.64 -104.89 1.28 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.319 1.914 . . . . 0.0 108.532 -156.0 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -159.67 151.73 20.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 117.85 -3.147 . . . . 0.0 108.884 -159.071 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.4 p -70.96 127.19 31.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.553 -2.112 . . . . 0.0 110.222 161.336 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.98 137.6 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 131.324 3.85 . . . . 0.0 102.779 -175.386 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.3 p -92.51 112.55 24.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.227 -1.351 . . . . 0.0 107.662 173.935 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.35 171.74 7.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 174.533 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -141.8 127.36 18.98 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 103.147 -2.908 . . . . 0.0 103.147 -175.823 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.2 m -132.8 177.78 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 O-C-N 119.295 -2.128 . . . . 0.0 111.833 177.666 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -97.27 143.18 25.71 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 125.581 1.552 . . . . 0.0 109.605 178.611 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -63.73 -24.34 68.96 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-O 115.727 -1.864 . . . . 0.0 115.44 172.911 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.3 p -99.75 10.45 41.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 130.016 3.326 . . . . 0.0 114.132 -178.398 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.71 145.97 48.48 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 125.764 1.915 . . . . 0.0 107.187 -179.339 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.1 p -91.94 150.63 20.92 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 115.582 -2.151 . . . . 0.0 113.677 164.809 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -54.46 -34.07 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 123.868 3.031 . . . . 0.0 116.49 -176.172 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.33 -39.54 76.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 124.53 3.332 . . . . 0.0 115.963 172.974 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -83.16 -26.17 31.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.897 2.079 . . . . 0.0 115.675 175.4 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.287 99.3 t -50.47 -52.69 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 O-C-N 119.007 -2.308 . . . . 0.0 115.109 157.712 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -60.41 -34.48 74.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 126.46 2.35 . . . . 0.0 115.444 174.691 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.1 63.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 131.311 3.844 . . . . 0.0 113.04 165.561 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.289 49.1 mttp -59.33 -41.28 88.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.662 1.585 . . . . 0.0 111.592 -178.784 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.296 18.0 mt -78.22 -23.15 13.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 127.597 2.359 . . . . 0.0 110.996 -176.939 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 31' ' ' GLN . 0.9 OUTLIER -73.81 -43.16 59.67 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 165.444 . . . . . . . . 3 3 . 1 . 088 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.296 25.8 t70 -69.08 -36.96 78.19 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 125.735 2.683 . . . . 0.0 116.675 -178.416 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -36.8 65.48 Favored 'General case' 0 CA--C 1.536 0.433 1 O-C-N 113.395 -5.816 . . . . 0.0 115.982 177.296 . . . . . . . . 3 3 . 1 . 088 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -128.98 -10.43 4.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 117.372 2.36 . . . . 0.0 117.372 -168.189 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.22 10.39 77.97 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 129.794 3.569 . . . . 0.0 112.97 179.804 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.9 mt -81.92 129.1 66.0 Favored Pre-proline 0 N--CA 1.443 -0.814 1 CA-C-N 124.701 4.251 . . . . 0.0 110.288 -166.426 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.02 144.58 64.48 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 123.491 2.794 . . . . 0.0 118.084 -170.887 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -74.62 -30.06 8.26 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.411 2.741 . . . . 0.0 117.735 -168.978 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -70.89 -17.15 62.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.266 1.031 . . . . 0.0 110.196 172.446 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -102.85 -8.76 20.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 117.869 -3.02 . . . . 0.0 113.398 -171.683 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -83.33 135.39 34.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 122.074 2.215 . . . . 0.0 107.876 -178.764 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -120.05 112.73 19.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 119.414 -2.054 . . . . 0.0 107.585 148.306 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mt -84.84 147.1 26.98 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 126.128 2.142 . . . . 0.0 109.393 170.37 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.296 0.0 OUTLIER -143.36 131.99 19.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 115.45 -2.214 . . . . 0.0 111.79 -174.288 . . . . . . . . 3 3 . 1 . 088 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -137.16 121.74 18.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 102.726 -3.065 . . . . 0.0 102.726 175.393 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 79.56 2.39 2.21 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 127.768 3.167 . . . . 0.0 113.719 165.671 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.75 -17.87 20.13 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 118.07 -2.894 . . . . 0.0 108.519 -174.622 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -85.82 109.56 18.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.167 2.187 . . . . 0.0 108.955 179.993 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.7 119.87 13.15 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.042 166.83 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -91.16 116.92 29.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 117.935 -2.978 . . . . 0.0 106.361 -151.222 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -92.84 145.98 23.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 123.252 1.501 . . . . 0.0 107.045 -166.642 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.24 145.19 43.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 112.375 -2.193 . . . . 0.0 107.67 171.131 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.38 -26.03 25.0 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.783 2.135 . . . . 0.0 112.635 175.169 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -96.49 168.61 10.44 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.552 2.341 . . . . 0.0 114.955 179.2 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.7 p -119.14 176.72 5.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 112.792 -2.003 . . . . 0.0 112.256 -166.752 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.2 mt -77.21 -28.98 54.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.905 -179.782 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.2 t -76.21 -25.76 55.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 115.128 -2.368 . . . . 0.0 110.03 177.76 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -59.78 -61.66 2.45 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 131.058 3.743 . . . . 0.0 105.41 176.622 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -89.67 -7.28 54.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 128.341 2.656 . . . . 0.0 111.908 -169.596 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.384 2.3 t-20 86.03 31.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.226 2.61 . . . . 0.0 111.954 166.01 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.252 5.4 mt -80.24 107.99 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 126.247 1.819 . . . . 0.0 111.002 -174.744 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -100.7 -179.86 4.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 127.215 2.822 . . . . 0.0 112.731 179.13 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -61.86 129.93 43.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 129.712 3.205 . . . . 0.0 112.391 -176.135 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.535 1.1 tt0 79.2 4.59 2.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 159.764 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.9 p -57.12 157.58 5.92 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 127.512 3.007 . . . . 0.0 115.893 158.423 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 m -102.77 126.56 49.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 119.821 -1.8 . . . . 0.0 111.952 156.27 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 mp -91.26 146.69 23.61 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 120.721 -1.237 . . . . 0.0 107.705 160.173 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -94.66 145.93 24.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 117.108 -1.425 . . . . 0.0 108.188 177.73 . . . . . . . . 1 1 . 1 . 088 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.13 122.02 40.09 Favored 'General case' 0 C--N 1.322 -0.589 1 C-N-CA 132.547 4.339 . . . . 0.0 104.908 177.544 . . . . . . . . 3 3 . 1 . 088 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.326 2.8 m -121.11 115.61 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 109.074 -3.694 . . . . 0.0 101.427 -178.274 . . . . . . . . 2 2 . 1 . 088 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 N--CA 1.451 -0.378 1 O-C-N 115.94 -4.225 . . . . 0.0 113.4 -174.844 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 ttp . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 101.511 -3.514 . . . . 0.0 101.511 . . . . . . . . . 0 0 . 1 . 089 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -89.63 150.91 22.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.857 1.263 . . . . 0.0 110.432 161.676 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.294 47.4 pt -135.13 175.06 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 129.778 3.231 . . . . 0.0 109.978 163.264 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.291 97.9 m-85 -116.38 126.17 53.1 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.101 2.96 . . . . 0.0 110.93 163.732 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.19 140.34 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 151.807 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -118.97 146.73 44.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 126.85 2.594 . . . . 0.0 105.54 167.564 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.2 p -98.65 161.21 13.78 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.49 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt -50.6 -29.64 11.38 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 118.892 -2.38 . . . . 0.0 116.09 -175.223 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.2 p -104.77 9.47 34.93 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.544 2.737 . . . . 0.0 108.749 -162.909 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.85 -23.68 30.38 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 119.605 -1.934 . . . . 0.0 116.231 164.981 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -69.76 126.2 29.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 125.753 1.502 . . . . 0.0 108.503 -179.939 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 p -106.47 150.73 25.79 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.304 1.841 . . . . 0.0 108.654 175.658 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.7 pt -129.75 131.67 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 1 C-N-CA 133.477 4.711 . . . . 0.0 113.8 168.999 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -87.95 118.58 27.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.854 2.061 . . . . 0.0 106.875 177.893 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.63 134.2 50.14 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 129.183 2.993 . . . . 0.0 112.164 178.796 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.66 138.24 36.12 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.533 1.933 . . . . 0.0 113.171 172.419 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.306 7.0 m -157.16 142.99 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-O 117.295 -1.336 . . . . 0.0 107.625 -163.229 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -91.96 148.01 36.05 Favored Pre-proline 0 C--O 1.221 -0.401 0 C-N-CA 124.783 1.233 . . . . 0.0 110.814 -178.296 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 31.8 Cg_exo -47.06 -0.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.434 1 N-CA-C 122.616 4.045 . . . . 0.0 122.616 170.627 . . . . . . . . 3 2 . 1 . 089 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 p -134.32 16.24 3.75 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 118.782 -2.449 . . . . 0.0 111.715 -174.154 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.487 ' CG ' HD21 ' A' ' 25' ' ' ASN . 22.3 m-20 -85.93 150.79 24.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -179.53 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -102.34 149.98 23.79 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 128.457 2.703 . . . . 0.0 106.369 177.509 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -49.65 -27.25 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.605 2.362 . . . . 0.0 114.546 177.269 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -50.42 -44.31 55.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.882 2.073 . . . . 0.0 115.103 161.376 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.487 HD21 ' CG ' ' A' ' 21' ' ' ASP . 49.2 t30 -62.1 -42.1 98.87 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 128.425 2.69 . . . . 0.0 110.891 177.735 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -58.81 -38.45 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 176.936 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -66.51 -40.44 89.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 128.484 2.714 . . . . 0.0 114.25 175.246 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.06 80.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 117.739 -1.124 . . . . 0.0 110.714 176.03 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.437 25.1 mttt -53.82 -45.58 70.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 175.538 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.279 50.8 mt -52.67 -49.4 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 117.019 -1.467 . . . . 0.0 112.686 170.565 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -42.87 -55.21 3.8 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 129.36 3.064 . . . . 0.0 111.578 167.32 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.98 -29.86 62.2 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.002 -1.475 . . . . 0.0 111.134 -171.651 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -83.66 -47.56 11.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 120.697 1.589 . . . . 0.0 112.267 172.107 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -116.41 -20.66 9.6 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 115.575 -2.155 . . . . 0.0 113.829 -159.154 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.15 0.24 25.32 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 125.135 1.522 . . . . 0.0 115.152 172.599 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.0 mt -96.26 136.68 21.86 Favored Pre-proline 0 N--CA 1.45 -0.429 0 O-C-N 126.573 1.984 . . . . 0.0 109.607 -160.365 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 40' ' ' GLN . 9.5 Cg_endo -89.31 142.19 4.3 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 124.726 2.723 . . . . 0.0 111.471 -163.422 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.07 -45.77 36.83 Favored 'Trans proline' 0 N--CA 1.452 -0.95 1 C-N-CA 126.607 4.871 . . . . 0.0 114.778 -177.95 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -48.49 -23.3 0.92 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 130.13 3.372 . . . . 0.0 115.774 171.271 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.411 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 41.8 mt-30 -120.93 14.15 11.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 127.504 3.002 . . . . 0.0 112.941 -176.171 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 72.8 mt-30 -102.86 162.39 12.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 169.891 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.3 ttp-105 -144.52 131.88 20.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 131.209 3.804 . . . . 0.0 105.637 162.74 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.1 mt -111.25 134.76 52.6 Favored 'General case' 0 N--CA 1.444 -0.759 1 O-C-N 115.85 -4.281 . . . . 0.0 110.241 -174.747 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 41.7 mt -126.8 149.52 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 118.293 -2.755 . . . . 0.0 108.841 179.201 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -112.9 -44.11 3.34 Favored 'General case' 0 C--N 1.325 -0.48 1 C-N-CA 132.031 4.132 . . . . 0.0 111.118 161.374 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.09 -103.98 0.29 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 -175.685 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.48 -32.55 0.52 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 118.254 2.062 . . . . 0.0 118.254 -150.196 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -93.14 -178.91 4.92 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 130.125 3.37 . . . . 0.0 112.56 153.394 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -97.12 151.96 19.26 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.651 1.58 . . . . 0.0 109.725 177.475 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.23 135.74 40.99 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.34 1.856 . . . . 0.0 109.365 -177.2 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -77.58 112.65 14.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.033 -2.917 . . . . 0.0 109.448 169.16 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.92 -19.84 46.28 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 129.982 3.313 . . . . 0.0 119.132 -165.788 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.56 14.43 35.52 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.789 2.138 . . . . 0.0 110.05 -177.482 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -90.85 166.57 13.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 124.349 2.023 . . . . 0.0 108.496 157.51 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -90.53 166.02 13.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.663 -1.608 . . . . 0.0 113.687 173.758 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.409 11.8 mt -45.08 -31.86 1.53 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 129.086 2.955 . . . . 0.0 118.371 163.994 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.7 p -93.05 -11.66 32.5 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 119.474 -2.016 . . . . 0.0 111.183 179.143 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -90.59 -4.95 56.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 114.838 -2.506 . . . . 0.0 109.257 177.603 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -118.7 -10.01 10.09 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 166.555 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t30 87.0 40.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 119.479 -2.013 . . . . 0.0 111.334 171.973 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.5 mm -87.55 106.95 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 113.088 -1.869 . . . . 0.0 108.103 175.514 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -87.03 179.88 6.6 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 131.337 3.855 . . . . 0.0 106.532 -172.939 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.3 51.2 pttt -58.4 136.54 57.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 166.794 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 58.9 26.74 15.28 Favored 'General case' 0 N--CA 1.45 -0.472 1 C-N-CA 133.506 4.722 . . . . 0.0 112.344 169.03 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 m -73.8 149.96 41.35 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 129.96 3.304 . . . . 0.0 113.587 -176.844 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -98.45 119.29 36.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 178.26 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -100.23 154.19 18.66 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.397 152.735 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -116.1 119.61 36.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.794 1.638 . . . . 0.0 107.896 -172.167 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.262 52.2 tp -98.94 122.79 42.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 124.118 1.913 . . . . 0.0 113.158 -179.112 . . . . . . . . 2 2 . 1 . 089 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.88 145.06 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 126.513 1.925 . . . . 0.0 110.107 161.52 . . . . . . . . 1 1 . 1 . 089 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 127.982 2.513 . . . . 0.0 110.651 172.898 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 . . . . . . . . . 0 0 . 1 . 090 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -83.24 139.63 32.99 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 129.512 3.125 . . . . 0.0 105.162 -175.747 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.266 30.0 pt -141.53 149.33 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 127.124 2.17 . . . . 0.0 111.968 -176.37 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -89.13 146.43 24.81 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.224 164.036 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.76 118.09 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 126.838 2.586 . . . . 0.0 106.133 169.656 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -94.83 116.81 29.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -177.993 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.2 p -70.75 164.9 24.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 124.441 2.067 . . . . 0.0 112.955 174.982 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.25 -37.82 60.84 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 120.528 -1.358 . . . . 0.0 112.094 -177.45 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 p -54.56 -29.86 52.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 130.993 3.717 . . . . 0.0 116.242 161.844 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.68 -19.77 5.84 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 119.677 -1.889 . . . . 0.0 113.146 161.843 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -73.5 136.57 44.14 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.965 2.506 . . . . 0.0 111.024 175.059 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m -112.32 130.11 56.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 125.265 1.603 . . . . 0.0 110.019 178.273 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.3 pt -110.9 177.61 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 112.376 -2.193 . . . . 0.0 108.592 -178.513 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 t -140.83 141.64 34.68 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.404 1.881 . . . . 0.0 107.077 170.36 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.6 mt -129.11 159.02 37.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.647 2.779 . . . . 0.0 107.051 177.754 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -91.58 138.12 31.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 157.31 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.01 175.76 8.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 CA-C-N 122.416 2.371 . . . . 0.0 107.448 170.113 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -111.87 156.68 41.31 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 162.146 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -58.65 -28.17 85.35 Favored 'Trans proline' 0 N--CA 1.444 -1.412 1 C-N-CA 126.186 4.591 . . . . 0.0 120.538 173.042 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -98.1 21.92 10.14 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 124.939 1.399 . . . . 0.0 112.321 173.97 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.83 153.86 38.54 Favored 'General case' 0 N--CA 1.453 -0.32 1 O-C-N 115.085 -4.759 . . . . 0.0 108.089 174.319 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.293 86.7 m -100.24 157.81 16.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.27 2.228 . . . . 0.0 108.272 168.823 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.1 mm -58.47 -9.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 119.261 3.06 . . . . 0.0 119.261 -178.835 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -87.46 -4.72 59.0 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 118.832 -2.417 . . . . 0.0 113.136 -178.422 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -91.78 -34.63 14.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.717 -2.038 . . . . 0.0 111.717 164.977 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.26 -51.52 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 O-C-N 119.638 -1.914 . . . . 0.0 108.625 179.773 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -51.05 -56.14 14.05 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 128.921 3.888 . . . . 0.0 113.075 -178.532 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.97 80.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.269 2.628 . . . . 0.0 117.034 176.738 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -68.44 -40.52 81.11 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 173.044 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.357 75.8 mt -47.65 -49.29 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 128.811 2.844 . . . . 0.0 112.692 160.665 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -63.61 -45.89 88.26 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.61 2.364 . . . . 0.0 112.556 -179.259 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.51 -64.6 0.79 Allowed 'General case' 0 C--O 1.238 0.46 1 C-N-CA 132.487 4.315 . . . . 0.0 107.222 173.167 . . . . . . . . 3 3 . 1 . 090 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -63.51 -57.03 11.48 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 128.094 3.371 . . . . 0.0 118.22 -174.254 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.279 22.2 mm-40 -111.94 -2.07 15.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.176 2.19 . . . . 0.0 113.741 -168.173 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.85 -19.41 41.3 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 117.543 -3.223 . . . . 0.0 113.132 160.635 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -83.56 127.3 68.6 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 117.962 -3.081 . . . . 0.0 112.506 -157.483 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.22 133.85 31.93 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 CA-C-N 123.885 2.423 . . . . 0.0 113.112 168.653 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.337 17.9 Cg_endo -58.94 -30.31 92.84 Favored 'Trans proline' 0 N--CA 1.452 -0.959 1 C-N-CA 127.691 5.594 . . . . 0.0 117.211 -171.255 . . . . . . . . 3 2 . 1 . 090 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.286 26.6 t70 -76.3 -26.47 55.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 119.967 -1.708 . . . . 0.0 111.327 -163.728 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -73.14 -7.84 53.13 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 172.033 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.455 1.2 pp0? -132.63 162.22 31.89 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.964 1.364 . . . . 0.0 113.428 -179.532 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -126.0 148.89 49.17 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 128.573 2.749 . . . . 0.0 111.512 171.343 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mt -99.37 118.73 36.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.802 2.841 . . . . 0.0 105.475 -178.357 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 mm -107.71 144.66 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 128.613 2.765 . . . . 0.0 104.922 179.18 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -141.82 132.57 25.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 125.221 1.576 . . . . 0.0 108.506 162.087 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.07 22.77 0.15 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 129.891 3.276 . . . . 0.0 114.644 -177.216 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.44 -7.07 36.62 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 119.398 -2.064 . . . . 0.0 112.948 177.398 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -113.29 141.01 47.52 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 121.564 -0.962 . . . . 0.0 113.298 -168.033 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -63.61 137.01 57.94 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 126.667 2.479 . . . . 0.0 115.565 171.975 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -105.54 108.53 20.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.673 3.189 . . . . 0.0 106.679 179.716 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -91.61 166.45 12.81 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 120.567 1.531 . . . . 0.0 112.38 -168.608 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.31 129.19 37.33 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.371 2.668 . . . . 0.0 107.803 171.107 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.93 -20.19 29.3 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 130.009 3.671 . . . . 0.0 114.933 165.086 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -89.45 153.08 21.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.077 2.551 . . . . 0.0 106.404 179.753 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -104.18 142.19 34.95 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 129.163 2.985 . . . . 0.0 111.276 -169.642 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.28 -55.35 25.33 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 126.906 2.628 . . . . 0.0 117.342 -170.042 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.331 41.2 t -65.0 -18.94 65.73 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 118.335 -2.728 . . . . 0.0 110.255 -172.913 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -78.69 -22.41 46.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 131.377 3.871 . . . . 0.0 115.817 171.333 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -81.37 -10.07 59.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.985 1.714 . . . . 0.0 113.14 163.665 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.349 58.8 t30 80.32 47.69 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 131.546 3.938 . . . . 0.0 108.349 173.882 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.3 mt -104.76 146.52 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 C-N-CA 125.814 1.646 . . . . 0.0 107.357 171.652 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -139.52 -158.86 0.9 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 129.663 3.185 . . . . 0.0 112.656 -179.175 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.11 135.34 36.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.873 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 70.69 30.31 3.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 129.509 3.124 . . . . 0.0 106.506 177.979 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.1 m -74.46 149.9 40.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 117.858 -3.026 . . . . 0.0 106.347 160.403 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.8 m -113.21 101.01 9.02 Favored 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 133.336 4.655 . . . . 0.0 101.481 179.166 . . . . . . . . 2 2 . 1 . 090 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 157.08 16.53 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 118.847 -2.408 . . . . 0.0 106.311 166.374 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -123.47 148.58 46.06 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 116.486 -1.721 . . . . 0.0 106.693 -175.644 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tt -103.02 139.35 38.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 103.155 -2.905 . . . . 0.0 103.155 177.096 . . . . . . . . 1 1 . 1 . 090 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.351 29.1 m -134.27 137.73 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 1 C-N-CA 132.77 4.428 . . . . 0.0 112.479 175.782 . . . . . . . . 3 2 . 1 . 090 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 116.824 -1.56 . . . . 0.0 108.371 168.368 . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptt? . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 091 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -80.02 146.19 32.11 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 124.933 1.396 . . . . 0.0 110.529 -174.23 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.418 2.4 pt -142.63 128.77 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 130.385 3.474 . . . . 0.0 108.974 175.642 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.259 62.1 m-85 -98.78 67.13 1.68 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 131.21 3.804 . . . . 0.0 110.57 -159.463 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.267 24.2 t -62.96 113.71 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.772 2 O-C-N 115.669 -4.395 . . . . 0.0 108.651 174.721 . . . . . . . . 3 2 . 1 . 091 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.273 11.8 tppt? -102.45 139.93 37.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 101.987 -3.338 . . . . 0.0 101.987 -170.868 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -106.84 169.88 8.27 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 124.219 0.949 . . . . 0.0 109.04 167.741 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.25 -41.45 63.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 118.825 -2.422 . . . . 0.0 110.345 167.386 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.292 52.7 p -50.84 -34.25 27.08 Favored 'General case' 0 N--CA 1.448 -0.549 1 C-N-CA 131.796 4.039 . . . . 0.0 116.526 174.991 . . . . . . . . 3 2 . 1 . 091 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.66 27.48 3.28 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 128.958 3.171 . . . . 0.0 116.482 157.613 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU 0.383 56.7 mttt -100.5 128.69 46.48 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 167.775 . . . . . . . . 3 3 . 1 . 091 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.2 m -89.28 101.95 14.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 166.285 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.9 mm -53.75 -48.69 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 116.44 -1.743 . . . . 0.0 115.076 -177.052 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.6 m 74.4 50.42 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 129.459 3.103 . . . . 0.0 108.265 176.45 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tp -75.65 126.86 31.84 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -169.598 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -81.16 115.43 20.57 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 125.171 2.415 . . . . 0.0 110.854 163.171 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -108.9 162.17 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 1 C-N-CA 132.679 4.392 . . . . 0.0 113.387 176.853 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -116.07 155.38 48.11 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.98 166.215 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -78.37 -3.63 13.54 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 O-C-N 117.228 -2.038 . . . . 0.0 112.647 -172.923 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 p -81.66 -14.78 56.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.845 2.058 . . . . 0.0 111.694 167.426 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -65.33 122.67 17.67 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.234 2.214 . . . . 0.0 106.918 -179.818 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -85.65 158.09 20.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 172.918 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 21.8 mm -43.19 -43.6 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 O-C-N 118.069 -2.894 . . . . 0.0 113.941 177.438 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.13 -37.09 83.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 125.301 2.476 . . . . 0.0 114.52 176.642 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.58 -34.95 53.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.971 -179.671 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.353 41.0 t -59.48 -44.47 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 118.037 -2.914 . . . . 0.0 108.078 168.829 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -64.71 -38.83 92.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.318 -2.114 . . . . 0.0 113.458 -177.506 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -51.68 66.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 127.136 2.174 . . . . 0.0 113.016 166.569 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -60.15 -26.24 66.14 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 127.929 2.492 . . . . 0.0 113.9 172.602 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.8 mt -86.97 -42.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 120.979 1.718 . . . . 0.0 111.084 171.29 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.44 -24.76 61.08 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.16 1.784 . . . . 0.0 111.797 -175.78 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -52.98 -53.89 43.23 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 130.079 3.352 . . . . 0.0 110.184 165.52 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -85.46 -48.51 8.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 115.855 -2.021 . . . . 0.0 110.503 -170.973 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.509 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 38.9 mm-40 -110.18 -19.13 13.13 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 128.46 2.704 . . . . 0.0 115.202 -162.409 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.94 -10.57 73.68 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 121.789 3.476 . . . . 0.0 121.789 162.308 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.57 121.13 73.59 Favored Pre-proline 0 N--CA 1.442 -0.839 0 C-N-CA 129.893 3.277 . . . . 0.0 110.384 -163.201 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -63.45 141.89 82.75 Favored 'Trans proline' 0 N--CA 1.452 -0.931 1 C-N-CA 126.152 4.568 . . . . 0.0 113.969 179.596 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.263 50.0 Cg_exo -48.47 -41.65 36.09 Favored 'Trans proline' 0 N--CA 1.448 -1.162 1 C-N-CA 127.759 5.639 . . . . 0.0 117.458 -170.524 . . . . . . . . 3 2 . 1 . 091 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.76 -30.97 40.9 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.524 2.73 . . . . 0.0 107.709 179.908 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -72.12 -3.38 22.85 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.347 2.259 . . . . 0.0 116.233 173.374 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.55 122.77 41.32 Favored 'General case' 0 N--CA 1.446 -0.659 1 C-N-CA 133.736 4.814 . . . . 0.0 110.826 -173.492 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -134.82 137.61 43.48 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 128.324 2.65 . . . . 0.0 105.654 175.431 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.63 112.63 24.29 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 128.129 2.572 . . . . 0.0 108.314 -174.308 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.53 139.52 20.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.45 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.362 59.1 t80 -144.78 92.5 2.29 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 129.693 3.197 . . . . 0.0 109.777 -166.246 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.28 24.79 2.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 121.415 3.857 . . . . 0.0 121.415 176.277 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.58 -12.73 46.99 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 128.293 2.854 . . . . 0.0 114.57 -173.017 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.282 38.9 ttmt -120.07 139.55 52.38 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 126.206 1.768 . . . . 0.0 109.995 -163.698 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 24.3 mt-30 -80.96 130.94 35.27 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.727 2.011 . . . . 0.0 106.315 170.99 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -84.5 136.52 33.78 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.65 177.891 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.33 144.05 36.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 125.743 2.687 . . . . 0.0 106.988 -171.487 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -87.52 145.83 26.07 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.072 -2.892 . . . . 0.0 110.004 -166.629 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.23 -21.56 37.2 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 124.173 1.985 . . . . 0.0 113.909 -175.002 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -89.7 -177.08 5.18 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -162.451 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 p -107.47 168.07 9.49 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.96 171.737 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.74 -24.4 62.61 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 128.568 2.747 . . . . 0.0 109.381 165.831 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 m -75.54 -15.22 60.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.165 -1.834 . . . . 0.0 112.995 177.137 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.35 -36.53 71.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.348 1.859 . . . . 0.0 111.27 -177.065 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -100.18 -9.77 22.13 Favored 'General case' 0 N--CA 1.442 -0.857 1 C-N-CA 135.133 5.373 . . . . 0.0 110.692 -176.97 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.487 13.6 t30 82.86 18.25 0.28 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 119.685 3.217 . . . . 0.0 119.685 177.291 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mt -72.16 121.53 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.329 1.851 . . . . 0.0 107.193 -172.786 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -122.58 177.69 5.32 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 128.697 2.799 . . . . 0.0 112.027 170.734 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -46.11 136.9 6.42 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 130.732 3.613 . . . . 0.0 111.075 -164.462 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.434 2.8 tt0 85.41 15.69 0.15 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 113.935 -2.936 . . . . 0.0 114.558 170.416 . . . . . . . . 2 2 . 1 . 091 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 t -93.58 133.5 36.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 130.589 3.555 . . . . 0.0 110.76 -179.573 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.4 p -92.89 135.69 33.91 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 174.526 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.51 -176.24 2.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 164.756 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -138.6 139.75 38.71 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 128.025 2.53 . . . . 0.0 107.014 179.269 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.1 tt -111.35 123.39 50.12 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 124.466 1.104 . . . . 0.0 108.341 -174.676 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 m -124.5 137.44 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.472 -179.112 . . . . . . . . 1 1 . 1 . 091 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.259 5.0 mt . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 102.687 -3.079 . . . . 0.0 102.687 -172.613 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 092 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -105.89 140.74 38.45 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.206 -2.183 . . . . 0.0 110.025 -160.046 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.8 pt -139.67 160.67 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 128.167 2.587 . . . . 0.0 108.596 178.517 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -108.93 159.45 16.8 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.468 1.907 . . . . 0.0 106.296 175.578 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.92 150.69 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 158.513 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -87.26 149.76 24.35 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.966 2.906 . . . . 0.0 114.568 155.89 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.256 9.0 t -138.24 151.93 48.12 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.959 1.304 . . . . 0.0 108.315 173.171 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.282 4.8 tp -70.44 0.04 7.41 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 127.98 2.512 . . . . 0.0 116.191 -163.679 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.0 p -85.43 -20.07 30.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.418 -2.676 . . . . 0.0 109.738 165.61 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.63 -6.21 26.18 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 129.082 3.229 . . . . 0.0 117.804 176.884 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.82 157.46 27.68 Favored 'General case' 0 C--O 1.235 0.318 1 O-C-N 132.577 5.516 . . . . 0.0 111.812 179.269 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.554 36.1 p -123.35 107.21 11.39 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 129.04 2.936 . . . . 0.0 114.088 -177.351 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 mt -104.99 136.21 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 130.042 3.337 . . . . 0.0 108.127 -171.128 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 t -108.25 121.34 44.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.865 3.266 . . . . 0.0 106.516 -178.621 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -110.95 156.02 21.82 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 129.003 2.921 . . . . 0.0 110.736 -176.15 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -118.61 116.75 27.27 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 130.831 3.653 . . . . 0.0 108.562 174.683 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -136.81 166.55 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 131.198 3.799 . . . . 0.0 110.323 -169.944 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -125.44 159.62 59.39 Favored Pre-proline 0 C--N 1.322 -0.629 0 O-C-N 118.907 -2.371 . . . . 0.0 105.993 161.828 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.42 -46.03 28.15 Favored 'Trans proline' 0 N--CA 1.452 -0.943 1 C-N-CA 125.353 4.036 . . . . 0.0 118.759 175.5 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 p -69.77 1.74 4.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 176.884 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.71 134.62 45.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 116.104 -1.903 . . . . 0.0 114.838 179.533 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.4 p -83.37 148.75 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 123.687 2.949 . . . . 0.0 112.467 -179.406 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -50.01 -37.27 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 126.258 1.823 . . . . 0.0 113.826 178.356 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.18 -39.48 79.02 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 121.201 1.819 . . . . 0.0 114.258 170.221 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -68.78 -36.46 78.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 126.821 2.576 . . . . 0.0 109.777 172.611 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.03 -57.18 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 121.383 1.902 . . . . 0.0 106.723 173.107 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP 0.294 86.7 mttt -38.55 -40.65 0.6 Allowed 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 130.495 3.518 . . . . 0.0 116.809 171.661 . . . . . . . . 3 3 . 1 . 092 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.48 -20.64 33.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.188 -2.278 . . . . 0.0 111.28 -175.006 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -87.58 -14.21 40.77 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.942 1.297 . . . . 0.0 109.777 176.881 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.31 -51.79 22.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 126.418 1.887 . . . . 0.0 107.904 162.407 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -65.4 -25.64 67.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 131.107 3.763 . . . . 0.0 109.567 -175.928 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.4 -46.1 62.74 Favored 'General case' 0 CA--C 1.533 0.307 1 C-N-CA 132.103 4.161 . . . . 0.0 113.514 170.023 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -114.16 -32.17 6.09 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 127.556 3.035 . . . . 0.0 114.798 -174.309 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -91.91 -33.28 14.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -179.291 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.18 11.32 64.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 113.583 -3.898 . . . . 0.0 113.398 171.375 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -92.15 139.31 24.25 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 100.975 -3.713 . . . . 0.0 100.975 -172.046 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.93 160.39 21.09 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 120.67 0.914 . . . . 0.0 112.552 -173.787 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.26 56.7 Cg_endo -57.9 -40.89 74.55 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 N-CA-C 117.895 2.229 . . . . 0.0 117.895 -170.868 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.92 -11.07 60.59 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.141 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -93.68 -17.43 23.24 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 172.265 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -89.39 143.13 27.06 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 123.21 1.481 . . . . 0.0 109.09 -174.644 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.26 96.29 2.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 -171.551 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.76 131.57 46.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 115.779 -2.058 . . . . 0.0 107.463 -169.389 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.48 145.21 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 129.762 3.225 . . . . 0.0 110.689 -174.424 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -128.47 -169.03 2.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.887 3.275 . . . . 0.0 110.291 179.456 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.59 49.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.481 2 C-N-CA 132.558 4.343 . . . . 0.0 121.941 -177.055 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.11 -12.97 19.55 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 127.305 2.383 . . . . 0.0 109.063 -179.403 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.403 85.4 mttt -109.29 126.41 53.33 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.346 2.258 . . . . 0.0 116.171 -176.62 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -85.19 129.53 34.79 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 130.36 3.464 . . . . 0.0 106.512 167.867 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.6 mt -107.19 127.76 53.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 111.799 -3.953 . . . . 0.0 106.165 -162.349 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -104.21 137.0 42.77 Favored 'General case' 0 C--N 1.324 -0.52 1 O-C-N 130.847 5.092 . . . . 0.0 110.54 -173.084 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.48 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS 0.344 1.2 m-20 -27.91 -45.9 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.408 2 N-CA-C 123.723 4.712 . . . . 0.0 123.723 173.983 . . . . . . . . 4 3 . 1 . 092 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.84 33.94 4.56 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 117.545 -3.222 . . . . 0.0 111.681 -169.828 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -122.03 162.82 20.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.841 2.857 . . . . 0.0 105.595 165.169 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -85.17 158.24 20.43 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.553 2.341 . . . . 0.0 114.762 178.069 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.4 mt -57.76 -28.36 63.88 Favored 'General case' 0 C--N 1.326 -0.447 1 O-C-N 114.569 -5.082 . . . . 0.0 114.963 165.269 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.412 0.2 OUTLIER -61.16 -39.63 90.82 Favored 'General case' 0 N--CA 1.448 -0.546 1 C-N-CA 132.125 4.17 . . . . 0.0 113.848 163.87 . . . . . . . . 4 3 . 1 . 092 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -69.43 -11.12 60.56 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 118.269 -2.77 . . . . 0.0 111.434 170.796 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -110.41 5.92 21.83 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 114.149 -2.834 . . . . 0.0 114.753 164.105 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.347 3.9 p-10 34.76 58.27 0.71 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.182 2.993 . . . . 0.0 112.732 -171.113 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mm -67.56 131.62 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 131.674 3.99 . . . . 0.0 111.967 174.986 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.388 26.9 mt-30 -102.6 152.46 21.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 127.266 2.226 . . . . 0.0 108.098 -179.678 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -48.97 150.62 1.48 Allowed 'General case' 0 C--N 1.325 -0.492 1 O-C-N 115.444 -4.535 . . . . 0.0 116.247 176.132 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.319 7.6 tt0 70.84 8.56 6.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.768 2.827 . . . . 0.0 116.237 176.495 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 m -63.31 138.69 58.62 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.682 1.593 . . . . 0.0 108.531 178.248 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.268 16.6 m -103.82 138.84 39.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 118.567 -2.583 . . . . 0.0 104.741 165.316 . . . . . . . . 2 2 . 1 . 092 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.78 148.1 22.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 130.404 3.482 . . . . 0.0 105.506 175.609 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -88.68 125.7 34.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 117.075 -3.516 . . . . 0.0 110.767 168.401 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tt -121.02 133.4 55.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 118.359 -2.713 . . . . 0.0 104.978 -171.609 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -132.34 -173.92 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.918 1.287 . . . . 0.0 112.48 163.583 . . . . . . . . 1 1 . 1 . 092 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.3 tp . . . . . 0 N--CA 1.445 -0.7 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.912 168.819 . . . . . . . . 0 0 . 1 . 093 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 ttp . . . . . 0 CA--C 1.537 0.472 1 N-CA-C 99.49 -4.263 . . . . 0.0 99.49 . . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -96.99 137.44 36.07 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 123.786 2.993 . . . . 0.0 107.226 164.794 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -107.49 170.3 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 129.817 3.247 . . . . 0.0 110.74 161.21 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -116.9 156.82 26.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 118.305 -2.747 . . . . 0.0 106.704 152.326 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.81 133.79 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 1 C-N-CA 132.517 4.327 . . . . 0.0 102.722 156.713 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -122.36 122.83 39.95 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -179.848 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 99.9 m -83.77 124.82 31.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 160.284 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.264 0.0 OUTLIER -63.2 -8.69 8.68 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 119.596 3.184 . . . . 0.0 119.596 -162.839 . . . . . . . . 3 3 . 1 . 093 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -84.85 -3.6 58.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.349 2.26 . . . . 0.0 112.331 -179.529 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 32.93 0.78 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 123.396 1.553 . . . . 0.0 115.017 154.249 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -128.36 123.28 33.5 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.09 2.156 . . . . 0.0 109.964 -171.965 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 m -113.21 127.85 56.3 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.493 1.117 . . . . 0.0 108.3 -178.727 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.66 133.46 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 127.311 2.245 . . . . 0.0 106.15 164.161 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -109.66 125.42 52.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.859 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.1 tp -133.94 139.81 46.38 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.273 -0.892 . . . . 0.0 111.725 -178.171 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.7 mp0 -95.93 116.57 29.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 131.46 3.904 . . . . 0.0 102.266 179.508 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -146.66 159.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 114.507 -2.664 . . . . 0.0 105.053 -163.141 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -111.63 145.94 33.67 Favored Pre-proline 0 N--CA 1.452 -0.349 0 O-C-N 128.747 3.78 . . . . 0.0 108.024 171.925 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.88 -29.23 14.69 Favored 'Trans proline' 0 N--CA 1.452 -0.958 1 C-N-CA 129.97 7.113 . . . . 0.0 115.687 -178.59 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t -90.16 6.9 40.67 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 117.849 -3.032 . . . . 0.0 116.109 -179.758 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -78.72 149.5 32.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.332 -1.318 . . . . 0.0 110.78 -175.436 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.9 p -87.45 155.27 20.09 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 124.67 2.176 . . . . 0.0 111.089 -175.875 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.66 -27.43 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 173.379 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -85.54 -38.35 18.62 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -168.733 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -60.75 -38.93 86.83 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 115.707 -2.092 . . . . 0.0 111.379 164.063 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.324 28.2 t -55.99 -58.42 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 123.521 2.873 . . . . 0.0 117.776 167.32 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.313 37.8 ttmt -68.36 -18.01 64.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.338 1.455 . . . . 0.0 114.849 -173.267 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.12 -35.66 21.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 125.182 1.552 . . . . 0.0 111.526 170.219 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -71.56 -24.08 61.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.091 -1.044 . . . . 0.0 113.21 -175.828 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.07 -20.64 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 125.762 1.914 . . . . 0.0 110.392 170.187 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -82.01 -38.99 24.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 116.862 -3.649 . . . . 0.0 107.761 179.564 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.63 -41.5 83.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.687 2.795 . . . . 0.0 111.792 178.605 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -96.69 -22.12 17.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 130.122 3.369 . . . . 0.0 112.945 -169.565 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.492 2.3 mm-40 -136.83 -23.02 1.2 Allowed 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 118.69 -2.506 . . . . 0.0 112.228 -169.235 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.39 1.9 40.96 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 165.558 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.21 125.68 33.66 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 114.915 -2.469 . . . . 0.0 108.192 -170.522 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.07 149.09 76.64 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.906 3.071 . . . . 0.0 114.991 175.972 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.39 -38.27 54.5 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 O-C-N 126.292 2.733 . . . . 0.0 113.545 179.726 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -41.91 -42.25 2.7 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 173.226 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -94.62 -2.29 51.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 131.242 3.817 . . . . 0.0 115.062 -179.488 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -111.18 114.83 28.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.029 -3.544 . . . . 0.0 104.858 -162.627 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 ttm105 -102.24 128.47 48.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 128.607 2.763 . . . . 0.0 109.242 165.765 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 mt -115.51 137.24 52.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 111.65 -2.523 . . . . 0.0 105.8 -177.042 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.6 mt -115.22 129.43 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 128.421 2.688 . . . . 0.0 109.025 -174.521 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -132.47 134.07 44.6 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 115.231 -2.587 . . . . 0.0 111.202 156.632 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.28 0.2 3.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 172.913 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.22 -11.69 19.7 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 129.887 3.613 . . . . 0.0 108.13 -175.367 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -95.8 125.57 40.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 126.001 1.648 . . . . 0.0 110.318 -174.34 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.17 111.24 1.88 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.383 2.273 . . . . 0.0 108.115 167.866 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.254 45.6 mt -87.09 131.3 34.17 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 115.035 -2.666 . . . . 0.0 113.549 -167.715 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -119.39 156.47 30.06 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 129.96 3.304 . . . . 0.0 110.097 -179.035 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.66 142.38 35.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 130.482 3.513 . . . . 0.0 113.146 177.306 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.02 -25.61 7.82 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 126.917 2.636 . . . . 0.0 113.272 -159.231 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -121.77 133.88 54.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.435 1.894 . . . . 0.0 106.22 176.042 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.5 p -81.26 -175.31 5.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 123.86 1.79 . . . . 0.0 113.837 172.305 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.2 -38.31 90.58 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 118.532 -2.605 . . . . 0.0 110.656 176.082 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 m -63.9 -47.21 81.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 171.23 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -47.03 -39.02 11.9 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 117.11 -3.494 . . . . 0.0 117.1 166.539 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -91.12 -3.81 56.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 123.283 2.765 . . . . 0.0 117.861 170.24 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 48.0 m-80 81.92 38.29 0.06 Allowed 'General case' 0 N--CA 1.445 -0.721 1 C-N-CA 133.933 4.893 . . . . 0.0 113.082 170.846 . . . . . . . . 3 2 . 1 . 093 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.5 mt -91.29 142.65 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 -167.481 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -138.66 -169.66 2.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.436 -154.474 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -59.54 124.79 21.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.377 1.071 . . . . 0.0 111.248 173.042 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 70.96 8.98 6.69 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.297 -2.752 . . . . 0.0 115.185 172.496 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -85.29 148.0 26.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 116.953 -3.592 . . . . 0.0 106.402 -171.39 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.4 m -122.94 124.33 42.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 -173.27 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.01 141.32 28.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 130.793 3.637 . . . . 0.0 104.708 178.487 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.28 58.2 m80 -101.65 115.6 30.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 113.693 -3.051 . . . . 0.0 107.498 -177.607 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 tt -90.29 125.16 35.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 171.057 . . . . . . . . 1 1 . 1 . 093 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.78 104.57 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.102 -0.999 . . . . 0.0 112.695 170.17 . . . . . . . . 2 2 . 1 . 093 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.296 56.4 tp . . . . . 0 N--CA 1.448 -0.547 1 O-C-N 114.282 -5.262 . . . . 0.0 111.49 -170.12 . . . . . . . . 2 1 . 1 . 094 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 123.335 1.54 . . . . 0.0 107.203 . . . . . . . . . 0 0 . 1 . 094 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.257 20.9 mt-30 -104.34 149.5 25.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 111.965 -2.38 . . . . 0.0 109.59 174.527 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 pt -137.33 156.03 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 126.092 2.12 . . . . 0.0 110.056 170.727 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -107.25 132.29 53.25 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.396 172.7 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.42 116.86 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 128.406 2.682 . . . . 0.0 112.95 175.159 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -92.83 138.69 31.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.942 1.829 . . . . 0.0 108.939 -179.055 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -88.61 167.4 13.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 108.623 -3.899 . . . . 0.0 108.955 177.33 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.437 HD22 ' H ' ' A' ' 8' ' ' LEU . 2.4 pt? -69.34 -23.46 63.78 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 119.127 -2.233 . . . . 0.0 113.189 160.991 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -90.1 -13.81 35.02 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 115.951 -1.976 . . . . 0.0 113.806 -175.343 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.37 -0.26 8.78 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 121.423 1.919 . . . . 0.0 113.042 163.695 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -92.62 149.64 21.21 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.051 1.425 . . . . 0.0 110.592 177.522 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -106.47 115.85 30.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 130.767 3.627 . . . . 0.0 104.513 165.442 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.0 mt -97.45 140.22 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 1 N-CA-C 97.95 -4.833 . . . . 0.0 97.95 177.858 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.3 m -101.41 98.73 9.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -179.639 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.09 156.12 18.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 117.409 -3.307 . . . . 0.0 109.445 175.001 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -121.16 119.87 33.62 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 130.742 3.617 . . . . 0.0 108.722 172.864 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 m -152.68 154.87 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 129.591 3.156 . . . . 0.0 104.887 175.545 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.351 76.0 mm-40 -100.41 166.73 12.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 111.348 -2.66 . . . . 0.0 112.371 174.279 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.288 2.6 Cg_exo -49.67 -34.02 33.65 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.043 3.162 . . . . 0.0 119.669 -178.848 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -85.91 -5.57 59.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 119.35 -2.094 . . . . 0.0 112.688 -172.814 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.395 65.7 m-20 -85.13 142.72 29.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 125.097 1.498 . . . . 0.0 109.092 -167.348 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.3 p -79.03 161.19 26.76 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 115.599 -2.143 . . . . 0.0 109.894 175.989 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.8 mm -42.22 -34.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 130.468 3.507 . . . . 0.0 111.172 165.499 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -66.75 -21.65 66.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 124.308 3.231 . . . . 0.0 111.908 -174.876 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -72.13 -52.01 18.68 Favored 'General case' 0 N--CA 1.44 -0.938 1 C-N-CA 131.809 4.044 . . . . 0.0 114.768 169.13 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.9 t -53.46 -59.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 126.428 1.891 . . . . 0.0 111.563 174.37 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -56.03 -33.71 65.19 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 127.455 2.972 . . . . 0.0 107.98 -179.855 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.76 -39.19 57.52 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 124.08 3.127 . . . . 0.0 118.665 -175.904 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -63.7 -40.3 96.45 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.644 1.978 . . . . 0.0 114.795 162.338 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.1 mt -59.21 -42.99 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 116.626 -1.654 . . . . 0.0 109.246 174.917 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -44.96 91.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 128.984 3.927 . . . . 0.0 113.976 171.977 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.41 -19.21 60.5 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 121.323 1.874 . . . . 0.0 112.594 -175.514 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -98.91 -53.08 3.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.084 1.754 . . . . 0.0 111.135 -166.885 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.254 36.5 tp10 -112.91 -3.48 14.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.846 -173.773 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.76 28.62 20.9 Favored Glycine 0 CA--C 1.527 0.829 1 CA-C-O 128.371 4.317 . . . . 0.0 115.093 163.836 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -105.22 118.0 56.99 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 109.983 -3.108 . . . . 0.0 111.675 -165.437 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -72.73 133.01 19.51 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 CA-C-O 111.724 -3.532 . . . . 0.0 112.692 -175.725 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -74.76 -19.62 18.3 Favored 'Trans proline' 0 N--CA 1.448 -1.169 1 O-C-N 130.087 4.73 . . . . 0.0 112.202 -163.167 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -82.46 -14.6 54.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 121.852 2.115 . . . . 0.0 108.306 177.139 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.45 -15.33 35.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.356 2.262 . . . . 0.0 109.485 178.385 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -88.18 154.94 20.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 120.64 1.564 . . . . 0.0 110.994 -177.837 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -148.22 122.95 9.9 Favored 'General case' 0 C--N 1.324 -0.521 1 C-N-CA 132.985 4.514 . . . . 0.0 104.149 -175.028 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mp -122.13 131.59 54.04 Favored 'General case' 0 N--CA 1.446 -0.664 1 C-N-CA 132.281 4.232 . . . . 0.0 114.109 -165.231 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.421 1.8 tt -134.63 144.66 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 126.315 2.26 . . . . 0.0 111.851 -172.309 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -156.34 142.45 18.15 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 126.552 3.072 . . . . 0.0 104.007 165.018 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 29.37 2.88 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 109.33 -3.577 . . . . 0.0 118.08 175.394 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.41 -17.67 36.61 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 127.149 2.78 . . . . 0.0 113.68 175.572 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -103.27 120.04 40.01 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 130.921 3.689 . . . . 0.0 110.979 -168.871 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -72.74 135.4 45.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.243 1.417 . . . . 0.0 107.23 164.873 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.1 mt -92.61 121.09 33.69 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.877 -163.266 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -81.5 124.8 29.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 125.729 1.893 . . . . 0.0 108.187 -169.497 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.76 108.22 2.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.271 3.028 . . . . 0.0 111.144 173.448 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.75 4.65 12.85 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 126.205 2.19 . . . . 0.0 115.615 177.2 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -105.89 144.84 32.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 116.47 -3.959 . . . . 0.0 109.92 168.418 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.6 p -84.79 145.07 28.07 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 127.123 2.764 . . . . 0.0 112.155 176.059 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 tp -41.71 -48.7 4.22 Favored 'General case' 0 N--CA 1.448 -0.538 1 C-N-CA 131.905 4.082 . . . . 0.0 109.149 179.537 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -54.25 -31.85 54.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 130.852 3.661 . . . . 0.0 113.171 176.349 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -67.53 -32.33 73.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.81 0.844 . . . . 0.0 112.955 177.139 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -88.46 -7.23 56.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 115.572 -2.156 . . . . 0.0 109.534 175.385 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 51.17 40.14 25.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 125.914 3.961 . . . . 0.0 112.971 -178.121 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.97 134.48 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.538 -2.119 . . . . 0.0 105.426 166.937 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -119.57 169.62 9.91 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 -173.834 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -49.13 126.37 12.52 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 131.687 3.995 . . . . 0.0 113.493 178.93 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 71.02 5.54 5.52 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 114.649 -2.596 . . . . 0.0 116.608 -178.887 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.5 m -59.3 128.96 39.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 164.78 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -83.22 123.77 29.9 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.337 1.055 . . . . 0.0 110.335 -177.949 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -124.23 156.59 36.56 Favored 'General case' 0 N--CA 1.452 -0.374 1 C-N-CA 134.213 5.005 . . . . 0.0 108.191 -177.549 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -124.49 148.15 47.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 120.835 -1.166 . . . . 0.0 111.934 -168.867 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tp -117.76 127.73 54.19 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.225 2.21 . . . . 0.0 108.855 -174.208 . . . . . . . . 1 1 . 1 . 094 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.594 35.3 m -119.92 165.07 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 129.385 3.074 . . . . 0.0 112.493 169.847 . . . . . . . . 2 2 . 1 . 094 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.0 mt . . . . . 0 N--CA 1.442 -0.843 0 O-C-N 119.794 -1.816 . . . . 0.0 106.723 175.908 . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttp . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 . . . . . . . . . 0 0 . 1 . 095 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -78.59 148.39 33.32 Favored 'General case' 0 C--N 1.324 -0.537 1 O-C-N 115.481 -4.512 . . . . 0.0 110.262 169.598 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -136.88 163.71 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 101.93 -3.359 . . . . 0.0 101.93 164.988 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -121.51 151.2 40.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 124.338 2.018 . . . . 0.0 110.165 -178.34 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 t -127.1 130.02 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 O-C-N 119.156 -2.215 . . . . 0.0 110.58 171.741 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -85.74 167.74 14.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.008 1.723 . . . . 0.0 111.978 157.875 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -126.06 177.2 6.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.728 1.268 . . . . 0.0 111.388 -176.58 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.83 -34.42 78.1 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 115.608 1.706 . . . . 0.0 115.608 174.468 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -63.25 -50.69 69.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.662 2.385 . . . . 0.0 112.45 165.84 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.54 13.54 8.04 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 116.686 -2.174 . . . . 0.0 111.113 168.238 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -69.31 135.4 50.36 Favored 'General case' 0 N--CA 1.451 -0.398 1 C-N-CA 135.718 5.607 . . . . 0.0 102.815 174.254 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 47.6 m -89.28 140.79 29.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 113.928 -1.487 . . . . 0.0 107.785 -174.741 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -116.59 148.92 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 130.16 3.384 . . . . 0.0 106.854 164.111 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 t -134.6 139.59 45.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 128.128 3.393 . . . . 0.0 108.973 170.798 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mt -141.72 160.94 39.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 125.255 2.455 . . . . 0.0 105.759 -171.711 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -109.9 127.04 54.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 125.884 2.754 . . . . 0.0 110.065 162.358 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.6 -178.65 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 131.548 3.939 . . . . 0.0 109.925 -177.107 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.275 6.1 mt-10 -130.89 148.82 71.72 Favored Pre-proline 0 N--CA 1.444 -0.731 0 O-C-N 116.359 -3.963 . . . . 0.0 112.068 168.824 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.51 -43.98 31.54 Favored 'Trans proline' 0 N--CA 1.453 -0.863 1 C-N-CA 125.488 4.125 . . . . 0.0 118.58 -169.968 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 t -86.29 8.48 21.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.655 -2.066 . . . . 0.0 116.449 -179.587 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.93 154.19 31.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.305 2.253 . . . . 0.0 116.505 173.827 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.305 81.1 p -92.64 149.55 21.26 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 125.128 1.518 . . . . 0.0 108.144 178.346 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.9 mm -45.55 -44.06 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 126.632 1.973 . . . . 0.0 115.874 176.787 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -51.19 -53.97 29.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 128.77 2.828 . . . . 0.0 112.897 173.383 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -63.59 -30.39 71.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.94 1.352 . . . . 0.0 111.846 -172.142 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.47 -40.01 76.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 127.236 2.214 . . . . 0.0 109.778 169.949 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -68.98 -28.0 66.22 Favored 'General case' 0 C--N 1.328 -0.34 1 O-C-N 115.054 -4.779 . . . . 0.0 111.324 -173.797 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -31.86 66.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.576 -1.647 . . . . 0.0 112.536 172.833 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -75.08 -41.02 59.66 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -178.556 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.74 -28.97 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 119.789 1.177 . . . . 0.0 113.026 175.565 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -62.45 -44.62 95.98 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 127.84 2.456 . . . . 0.0 113.111 171.736 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -72.63 -16.55 61.71 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.091 -2.255 . . . . 0.0 113.112 -175.586 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -107.75 -53.47 2.62 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 -172.674 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -112.93 -9.32 13.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 114.471 -2.681 . . . . 0.0 112.232 -173.602 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.21 39.28 72.07 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 115.014 -3.103 . . . . 0.0 113.007 -177.181 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.2 mt -96.16 116.31 66.11 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 178.235 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.67 145.9 65.15 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 N-CA-C 118.422 2.432 . . . . 0.0 118.422 -179.032 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.297 39.7 Cg_endo -70.89 -21.41 28.27 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 125.198 3.932 . . . . 0.0 118.696 -160.045 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.49 -30.95 16.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 123.844 3.02 . . . . 0.0 110.527 -179.036 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -71.14 -37.01 72.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 177.978 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -63.74 125.02 22.96 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 112.67 -3.538 . . . . 0.0 116.487 179.262 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.281 32.4 ttm105 -128.33 121.46 29.25 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 122.872 2.578 . . . . 0.0 108.906 176.235 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.5 132.72 41.78 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 128.049 2.54 . . . . 0.0 107.625 -179.156 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.1 mt -119.87 161.14 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.742 2.017 . . . . 0.0 110.408 167.648 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -158.83 128.6 5.72 Favored 'General case' 0 N--CA 1.449 -0.494 1 N-CA-C 98.241 -4.726 . . . . 0.0 98.241 173.157 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.92 23.34 13.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.455 2.302 . . . . 0.0 113.542 162.369 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.1 0.01 54.64 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 178.03 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -120.78 129.65 53.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -167.643 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -70.77 151.82 44.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 166.221 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.93 113.95 27.37 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 101.601 -3.481 . . . . 0.0 101.601 -179.772 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -101.12 139.42 36.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 125.086 1.491 . . . . 0.0 108.428 -173.564 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -28.8 129.2 0.08 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 129.325 3.05 . . . . 0.0 116.982 167.911 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.49 -11.35 71.63 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 159.687 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -103.68 156.12 18.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.504 1.922 . . . . 0.0 106.435 -178.164 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.7 p -111.81 149.83 31.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.964 2.506 . . . . 0.0 115.778 -164.577 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.4 mt -60.81 -46.35 90.85 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 112.72 -2.037 . . . . 0.0 114.871 -164.974 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -75.8 -33.31 60.12 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.462 -171.165 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.54 -31.85 71.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 112.881 -3.438 . . . . 0.0 118.817 166.32 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -73.54 -21.92 60.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 127.916 3.26 . . . . 0.0 112.486 164.789 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t30 89.58 45.04 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.446 2 C-N-CA 134.076 4.951 . . . . 0.0 107.895 175.558 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mm -79.36 145.87 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 118.027 -2.921 . . . . 0.0 104.564 172.63 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -132.76 -178.48 4.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 121.946 2.157 . . . . 0.0 106.742 178.347 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -72.87 112.8 9.23 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 130.793 3.637 . . . . 0.0 109.036 -171.784 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 75.85 31.82 0.69 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 130.236 3.414 . . . . 0.0 111.95 -172.937 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -70.5 140.75 51.94 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 115.97 -1.967 . . . . 0.0 112.008 166.581 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.8 m -102.37 129.89 48.97 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -179.218 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.71 154.2 31.01 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.893 3.277 . . . . 0.0 108.46 -177.993 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.268 20.8 t-160 -109.04 118.28 36.38 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.013 0.925 . . . . 0.0 109.877 -171.256 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tt -93.83 127.75 39.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.224 1.81 . . . . 0.0 109.248 173.498 . . . . . . . . 1 1 . 1 . 095 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.34 138.59 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 1 O-C-N 129.103 4.002 . . . . 0.0 104.039 162.399 . . . . . . . . 2 2 . 1 . 095 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 tt . . . . . 0 N--CA 1.448 -0.566 0 O-C-N 118.639 -2.538 . . . . 0.0 109.669 167.339 . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 C--O 1.236 0.381 0 N-CA-C 110.88 -0.044 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 096 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.49 133.91 51.29 Favored 'General case' 0 N--CA 1.448 -0.54 1 C-N-CA 131.997 4.119 . . . . 0.0 108.242 -179.029 . . . . . . . . 3 3 . 1 . 096 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.286 0.9 OUTLIER -129.93 169.9 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 117.217 -1.373 . . . . 0.0 112.114 163.701 . . . . . . . . 3 3 . 1 . 096 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -110.03 152.16 26.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 125.139 3.609 . . . . 0.0 105.632 172.149 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.292 2.6 t -135.34 113.88 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 128.883 2.873 . . . . 0.0 107.148 172.1 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -97.31 126.04 42.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 129.931 3.292 . . . . 0.0 106.137 -177.789 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.0 p -86.41 178.03 7.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.247 1.819 . . . . 0.0 114.117 160.54 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -79.03 -33.8 44.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 117.144 -1.408 . . . . 0.0 110.696 -169.904 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -93.18 0.99 57.31 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -178.873 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.42 -8.31 5.92 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 126.53 2.014 . . . . 0.0 111.188 151.97 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -71.04 110.55 5.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -171.717 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -87.35 113.34 22.98 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 101.728 -3.434 . . . . 0.0 101.728 172.927 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.0 mt -86.34 126.69 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 N-CA-C 99.625 -4.213 . . . . 0.0 99.625 166.905 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.5 m -99.82 109.06 21.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 129.339 3.056 . . . . 0.0 105.16 173.891 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 tp -105.39 135.23 47.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -161.688 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.285 31.1 tt0 -86.12 134.71 33.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 110.823 -2.899 . . . . 0.0 113.142 160.351 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.2 164.44 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 123.807 1.765 . . . . 0.0 107.672 174.278 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -95.69 160.01 31.24 Favored Pre-proline 0 N--CA 1.444 -0.729 2 C-N-CA 133.018 4.527 . . . . 0.0 109.884 145.825 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.89 -25.16 74.29 Favored 'Trans proline' 0 N--CA 1.45 -1.03 1 C-N-CA 125.715 4.277 . . . . 0.0 113.487 -173.657 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -83.03 -11.03 58.43 Favored 'General case' 0 N--CA 1.444 -0.747 1 C-N-CA 137.275 6.23 . . . . 0.0 110.214 -175.175 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.03 114.7 8.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.734 2.014 . . . . 0.0 107.438 160.18 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.253 71.3 p -89.57 -162.54 0.89 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 115.793 -2.051 . . . . 0.0 114.857 -170.725 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.4 mm -60.9 -33.9 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 122.722 2.51 . . . . 0.0 113.811 172.262 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -78.56 -45.68 21.24 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 129.47 3.108 . . . . 0.0 114.801 174.466 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -67.6 -25.24 65.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 113.759 -3.176 . . . . 0.0 112.577 -179.517 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.5 t -57.5 -58.05 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.712 2.405 . . . . 0.0 116.841 157.06 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -58.51 -26.13 63.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 174.82 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.33 -37.81 43.69 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 127.078 3.323 . . . . 0.0 117.409 170.979 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -60.11 -39.18 85.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 117.092 -3.505 . . . . 0.0 113.635 164.249 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.0 mt -53.42 -47.91 58.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 129.166 2.986 . . . . 0.0 111.569 172.678 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -60.94 -50.57 72.86 Favored 'General case' 0 N--CA 1.45 -0.446 1 C-N-CA 132.121 4.169 . . . . 0.0 109.819 177.39 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.0 -48.05 61.47 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 171.364 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -84.82 -52.83 5.75 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 115.788 -2.053 . . . . 0.0 112.868 -171.988 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -123.4 -2.85 8.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 122.041 2.2 . . . . 0.0 110.237 -155.502 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.17 7.89 67.26 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.901 1.715 . . . . 0.0 112.328 163.104 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -73.27 124.18 90.28 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 129.347 3.059 . . . . 0.0 106.675 -170.589 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.76 110.51 1.63 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 125.002 3.802 . . . . 0.0 113.16 173.425 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.36 -15.06 12.8 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 N-CA-C 118.754 2.559 . . . . 0.0 118.754 -167.898 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.365 0.0 OUTLIER -25.54 -35.26 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 130.697 3.599 . . . . 0.0 120.252 174.778 . . . . . . . . 3 3 . 1 . 096 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -126.79 25.41 6.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.502 1.921 . . . . 0.0 111.21 -165.837 . . . . . . . . 3 3 . 1 . 096 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -131.24 126.88 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.272 1.829 . . . . 0.0 111.096 -168.634 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -123.68 157.56 33.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 109.586 -3.461 . . . . 0.0 109.701 176.455 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.11 138.59 53.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 114.133 -2.841 . . . . 0.0 108.659 -166.253 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mm -110.04 148.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 127.952 3.283 . . . . 0.0 115.568 165.272 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -149.24 125.64 10.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 114.687 -2.578 . . . . 0.0 105.519 166.565 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.57 15.24 10.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 130.471 3.508 . . . . 0.0 113.539 172.637 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.47 -34.93 5.38 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 128.654 3.026 . . . . 0.0 108.737 -169.425 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -78.11 136.02 37.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 122.133 2.967 . . . . 0.0 108.339 -156.946 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -80.27 106.13 12.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 113.611 -3.09 . . . . 0.0 113.31 164.572 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.3 136.96 57.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 128.098 3.374 . . . . 0.0 115.155 -178.014 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -91.98 116.07 28.6 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.166 2.186 . . . . 0.0 105.106 -165.43 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.49 116.27 3.86 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 115.298 -2.287 . . . . 0.0 112.607 -177.271 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.28 3.96 7.85 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 129.908 3.623 . . . . 0.0 112.896 -178.331 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -109.36 159.13 17.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 122.008 2.904 . . . . 0.0 108.93 -170.932 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.6 p -90.6 173.13 8.22 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 129.859 3.264 . . . . 0.0 110.551 176.981 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.78 -18.09 59.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.197 -0.939 . . . . 0.0 110.591 173.647 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.0 m -70.05 -20.52 63.23 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.43 -1.419 . . . . 0.0 112.841 177.367 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -86.12 -6.29 59.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.485 2.714 . . . . 0.0 112.154 -177.073 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -130.44 -7.21 4.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 114.495 -2.669 . . . . 0.0 113.196 178.954 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.1 t30 57.05 51.07 10.97 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 127.084 2.74 . . . . 0.0 112.733 178.807 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.46 125.86 62.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 -178.417 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -114.09 -166.66 1.12 Allowed 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 112.284 -2.235 . . . . 0.0 108.502 177.88 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -65.25 149.74 49.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 129.116 2.966 . . . . 0.0 112.219 -170.004 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.542 12.6 pt-20 73.45 16.89 3.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.541 170.056 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 m -84.26 155.65 22.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.221 1.808 . . . . 0.0 111.173 -177.015 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.9 m -116.78 137.47 52.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.798 -2.439 . . . . 0.0 111.884 174.576 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -105.0 149.53 25.69 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 156.224 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -102.97 133.58 47.84 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 169.338 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.351 1.8 tm? -96.97 144.88 26.45 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 115.142 -2.361 . . . . 0.0 111.458 -178.23 . . . . . . . . 2 2 . 1 . 096 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.83 133.14 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 128.696 2.798 . . . . 0.0 107.567 179.074 . . . . . . . . 1 1 . 1 . 096 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 130.289 3.435 . . . . 0.0 107.745 173.207 . . . . . . . . 0 0 . 1 . 097 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.252 9.2 tpp . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 124.011 1.862 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.348 4.9 tt0 -85.54 156.85 20.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 118.203 -2.811 . . . . 0.0 115.284 177.089 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.332 17.1 pt -133.06 134.9 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 117.067 -3.521 . . . . 0.0 106.799 162.349 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -94.13 144.55 25.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.583 166.116 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.458 HG13 HD13 ' A' ' 30' ' ' ILE . 3.8 t -128.3 133.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 127.403 2.281 . . . . 0.0 106.368 -179.975 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -133.11 145.87 51.11 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 -176.076 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -129.23 -90.75 0.48 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 116.353 -1.784 . . . . 0.0 110.704 159.847 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -142.54 -42.44 0.32 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 128.239 2.616 . . . . 0.0 114.282 169.088 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.57 114.02 21.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.116 1.366 . . . . 0.0 108.232 174.721 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.12 142.37 10.52 Favored Glycine 0 CA--C 1.536 1.392 0 N-CA-C 106.69 -2.564 . . . . 0.0 106.69 -169.426 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -54.51 -67.37 0.27 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.967 2.107 . . . . 0.0 110.267 156.402 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 p -155.57 174.53 15.14 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.916 2.486 . . . . 0.0 106.575 178.674 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.09 144.4 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 C-N-CA 127.226 2.21 . . . . 0.0 105.297 164.418 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.8 p -104.53 129.11 52.6 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.337 1.455 . . . . 0.0 112.352 -175.32 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 mt -123.42 145.98 48.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 117.349 -3.344 . . . . 0.0 108.024 176.681 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.03 121.17 37.49 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 126.132 2.145 . . . . 0.0 110.073 162.602 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -122.5 -161.6 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 O-C-N 120.223 -1.548 . . . . 0.0 112.936 -178.693 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.278 4.3 tm-20 -142.52 147.78 44.29 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 164.244 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -65.47 -21.56 60.18 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 CA-C-O 115.124 -2.115 . . . . 0.0 115.328 -178.642 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.75 14.81 6.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 120.798 1.635 . . . . 0.0 114.449 173.548 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -75.09 121.68 22.41 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 127.496 2.318 . . . . 0.0 107.124 167.233 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.8 p -66.6 155.28 38.25 Favored 'General case' 0 N--CA 1.449 -0.491 1 O-C-N 129.17 4.044 . . . . 0.0 109.028 160.782 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 80.5 mt -68.04 -27.94 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 124.249 1.976 . . . . 0.0 111.917 178.736 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -47.15 -41.39 17.59 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 112.741 -2.027 . . . . 0.0 111.689 170.517 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -75.15 -38.48 60.96 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.236 1.414 . . . . 0.0 112.351 178.56 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.71 -31.28 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 126.448 2.343 . . . . 0.0 112.712 179.03 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -51.94 -37.4 52.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 173.053 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.312 . . -79.2 -32.01 43.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 125.739 2.685 . . . . 0.0 111.163 -176.144 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -56.04 -53.09 61.14 Favored 'General case' 0 N--CA 1.452 -0.372 1 O-C-N 115.686 -4.384 . . . . 0.0 112.371 164.2 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.458 HD13 HG13 ' A' ' 5' ' ' VAL . 46.2 mm -59.27 -39.54 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 119.576 -1.952 . . . . 0.0 109.82 -178.301 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -51.95 -49.34 63.37 Favored 'General case' 0 N--CA 1.452 -0.34 1 N-CA-C 122.622 4.304 . . . . 0.0 122.622 161.899 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.09 -34.91 74.11 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 170.685 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.31 -23.98 14.99 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.881 1.672 . . . . 0.0 114.437 -174.869 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -143.09 -12.43 0.73 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 124.812 2.244 . . . . 0.0 115.252 -165.954 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.81 -17.4 32.82 Favored Glycine 0 CA--C 1.536 1.373 1 O-C-N 115.282 -4.636 . . . . 0.0 114.137 159.715 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mt -74.32 126.31 89.09 Favored Pre-proline 0 N--CA 1.45 -0.447 0 O-C-N 120.023 -1.869 . . . . 0.0 112.714 -170.52 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -64.88 141.06 69.57 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 CA-C-O 114.846 -2.231 . . . . 0.0 117.864 173.031 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -43.87 -41.4 11.94 Favored 'Trans proline' 0 N--CA 1.449 -1.111 1 C-N-CA 125.301 4.001 . . . . 0.0 116.98 178.934 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.98 -26.1 59.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.191 2.996 . . . . 0.0 111.471 179.341 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -97.25 -15.29 20.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 127.058 2.143 . . . . 0.0 115.024 -173.761 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -90.58 132.57 35.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -169.728 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -114.24 111.9 22.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 129.23 3.012 . . . . 0.0 109.511 169.111 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -97.36 109.64 22.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.139 -1.601 . . . . 0.0 108.345 -176.855 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mt -119.08 136.66 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 1 N-CA-C 98.267 -4.716 . . . . 0.0 98.267 -174.991 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -168.66 143.16 3.24 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.997 2.519 . . . . 0.0 107.366 173.341 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.303 . . 65.51 27.21 11.69 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.261 2.224 . . . . 0.0 113.208 173.77 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.3 -8.74 59.01 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 129.016 3.198 . . . . 0.0 108.3 163.817 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -129.24 147.01 51.04 Favored 'General case' 0 C--O 1.241 0.641 0 O-C-N 116.928 -3.689 . . . . 0.0 113.194 176.82 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -60.89 104.94 0.41 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.87 3.268 . . . . 0.0 111.79 165.306 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -60.16 144.42 49.95 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -173.082 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -77.36 134.52 38.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 125.188 1.555 . . . . 0.0 110.55 161.988 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.04 -31.76 68.3 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 131.204 3.802 . . . . 0.0 117.587 -166.101 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.83 9.56 56.85 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 126.943 2.652 . . . . 0.0 110.026 -175.286 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 159.29 16.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 123.813 1.768 . . . . 0.0 110.696 162.398 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.3 p -102.2 163.96 11.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 111.678 -2.51 . . . . 0.0 109.923 -171.5 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.08 -59.12 4.73 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.213 2.205 . . . . 0.0 108.539 172.642 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 82.3 p -44.2 -46.12 8.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.236 2.614 . . . . 0.0 115.655 171.923 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -51.38 -34.09 32.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.486 1.514 . . . . 0.0 114.812 173.244 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -104.27 0.01 28.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.559 -1.338 . . . . 0.0 112.555 -175.151 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m120 81.75 23.47 0.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.849 2.059 . . . . 0.0 111.689 -176.056 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.0 mt -84.59 102.89 11.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -174.169 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -70.8 162.3 29.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 172.958 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -42.17 138.31 1.68 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.895 2.078 . . . . 0.0 114.005 155.8 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.257 7.6 mm-40 77.07 17.91 1.55 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 129.028 2.931 . . . . 0.0 111.84 170.302 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -96.44 155.81 16.61 Favored 'General case' 0 CA--C 1.537 0.454 1 CA-C-O 130.108 4.766 . . . . 0.0 109.333 -177.053 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.4 m -96.92 140.84 30.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 110.001 -3.272 . . . . 0.0 106.51 176.704 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.54 162.7 13.89 Favored 'General case' 0 CA--C 1.537 0.465 1 N-CA-C 98.586 -4.598 . . . . 0.0 98.586 157.602 . . . . . . . . 2 2 . 1 . 097 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -120.01 141.79 49.39 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 167.401 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tp -116.89 148.79 41.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 130.584 3.553 . . . . 0.0 112.808 -172.509 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.92 130.36 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 130.304 3.441 . . . . 0.0 109.931 -176.294 . . . . . . . . 1 1 . 1 . 097 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--N 1.327 -0.405 0 O-C-N 120.06 -1.65 . . . . 0.0 107.362 164.99 . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttp . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 098 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -82.78 122.76 28.62 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.387 1.875 . . . . 0.0 113.723 172.452 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -112.52 163.39 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 1 C-N-CA 132.779 4.431 . . . . 0.0 103.914 167.632 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -117.06 153.85 32.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.507 1.523 . . . . 0.0 108.497 168.151 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.97 136.24 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.216 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.365 14.9 ttmt -133.49 151.35 51.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.51 1.924 . . . . 0.0 113.596 172.632 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -110.42 151.01 28.0 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.867 1.317 . . . . 0.0 108.053 178.9 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.311 27.7 mt -61.25 -31.02 70.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.75 -2.469 . . . . 0.0 113.11 179.727 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.1 p -70.49 -3.35 17.41 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 131.466 3.906 . . . . 0.0 114.41 172.107 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.28 29.1 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 124.978 1.424 . . . . 0.0 113.024 153.211 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -62.83 127.25 30.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 118.893 -2.534 . . . . 0.0 111.603 176.966 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 m -116.85 144.41 44.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.511 2.724 . . . . 0.0 107.659 177.522 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.8 tt -146.05 132.8 14.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -175.735 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -70.04 150.27 46.8 Favored 'General case' 0 C--N 1.327 -0.388 1 O-C-N 115.693 -4.38 . . . . 0.0 108.156 166.192 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -133.11 155.62 48.92 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 172.211 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -112.38 129.78 56.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 119.64 -1.913 . . . . 0.0 107.751 172.194 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -146.77 154.81 11.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 130.11 3.364 . . . . 0.0 109.471 -174.346 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -102.11 143.52 26.77 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 171.245 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.53 -16.1 49.85 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.837 3.024 . . . . 0.0 116.214 -173.069 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.5 p -85.6 -7.31 58.92 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 121.586 1.994 . . . . 0.0 116.35 165.126 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -58.61 142.99 47.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 117.575 -3.203 . . . . 0.0 110.345 173.361 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.469 ' O ' HG21 ' A' ' 26' ' ' VAL . 44.7 p -80.11 157.05 26.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.869 2.067 . . . . 0.0 112.193 174.684 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.2 -29.57 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.355 1.462 . . . . 0.0 107.768 -178.143 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -64.72 -48.82 73.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.55 1.14 . . . . 0.0 108.346 172.734 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.35 -37.09 64.53 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 120.273 -1.517 . . . . 0.0 113.798 166.316 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 22' ' ' THR 0.257 3.5 t -64.34 -30.58 50.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 118.904 -2.372 . . . . 0.0 114.808 172.224 . . . . . . . . 3 3 . 1 . 098 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -76.82 -28.34 55.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 168.934 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.34 -36.0 63.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 122.424 1.107 . . . . 0.0 110.398 -179.248 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -68.01 -25.31 65.34 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.183 -1.573 . . . . 0.0 113.108 171.604 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -80.7 -38.04 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 171.562 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -30.51 4.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 116.389 -3.945 . . . . 0.0 111.396 176.922 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -73.8 -29.45 62.17 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.702 1.601 . . . . 0.0 111.969 179.338 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -103.02 -50.99 3.36 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 117.17 -3.457 . . . . 0.0 110.324 -169.12 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -122.25 -2.93 9.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.435 1.894 . . . . 0.0 113.054 -168.345 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.4 -32.16 6.75 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 114.235 -3.536 . . . . 0.0 115.251 155.493 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.5 mt -55.3 128.75 67.5 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 128.729 2.811 . . . . 0.0 110.708 -170.722 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.86 139.99 64.85 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 128.253 5.969 . . . . 0.0 109.213 179.84 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -38.23 -40.99 1.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 1 C-N-CA 130.329 7.353 . . . . 0.0 115.821 176.648 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -61.6 -30.4 70.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 117.773 -3.08 . . . . 0.0 115.348 176.706 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -83.02 -26.65 31.01 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.377 1.444 . . . . 0.0 110.677 -176.738 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.274 77.5 mt-30 -91.37 137.26 32.51 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.966 1.416 . . . . 0.0 109.848 -178.526 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.262 3.8 mtt85 -107.42 146.26 31.91 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 111.208 -2.723 . . . . 0.0 110.773 155.439 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.97 120.5 42.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.868 1.213 . . . . 0.0 108.156 167.174 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.44 146.99 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 125.22 1.575 . . . . 0.0 108.599 -179.041 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -139.86 127.46 21.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.701 2.8 . . . . 0.0 104.078 166.112 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.252 . . 61.73 33.44 17.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 119.804 -1.81 . . . . 0.0 111.948 170.765 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.85 -19.58 11.49 Favored Glycine 0 CA--C 1.538 1.517 0 O-C-N 118.495 -2.628 . . . . 0.0 111.776 -179.662 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -76.98 113.64 14.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 123.571 3.685 . . . . 0.0 107.032 -177.771 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.41 110.73 8.94 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 104.06 -2.57 . . . . 0.0 104.06 162.276 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.6 mt -59.36 129.25 41.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.839 1.656 . . . . 0.0 108.608 168.485 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -92.32 138.95 31.09 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.891 0.876 . . . . 0.0 110.464 -179.998 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -64.73 138.14 58.21 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 125.873 1.983 . . . . 0.0 110.466 -175.306 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.79 -30.81 6.65 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 127.929 2.681 . . . . 0.0 115.989 -175.784 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -91.69 147.93 22.63 Favored 'General case' 0 CA--C 1.535 0.394 1 C-N-CA 132.889 4.475 . . . . 0.0 110.731 -178.209 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 p -102.03 170.49 8.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 125.145 1.528 . . . . 0.0 112.513 -171.438 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -51.88 -42.91 63.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 128.618 3.699 . . . . 0.0 109.196 170.033 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -79.65 -28.16 40.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 120.02 -1.675 . . . . 0.0 114.645 -171.23 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -78.33 -40.06 37.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.045 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -83.07 0.19 46.12 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 117.852 -3.03 . . . . 0.0 109.951 -179.046 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.421 5.2 p-10 46.08 64.52 1.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.391 2.276 . . . . 0.0 113.161 -179.326 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 mm -83.89 -43.99 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 118.563 -1.255 . . . . 0.0 109.875 -166.176 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.415 52.9 mm-40 97.04 153.81 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.689 2.395 . . . . 0.0 111.774 166.747 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.39 131.51 45.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 119.044 -2.285 . . . . 0.0 108.008 177.07 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.282 3.4 mp0 81.41 10.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 127.194 2.809 . . . . 0.0 110.063 166.684 . . . . . . . . 2 2 . 1 . 098 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.8 t -75.2 139.1 42.4 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 130.817 3.647 . . . . 0.0 107.82 172.992 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -100.15 126.72 46.45 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 103.031 -2.952 . . . . 0.0 103.031 -177.302 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mp -101.11 147.27 26.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.795 164.617 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -88.31 127.23 35.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.209 2.604 . . . . 0.0 107.537 -176.781 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.3 tp -114.22 123.82 50.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 -175.711 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.3 135.59 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -175.617 . . . . . . . . 1 1 . 1 . 098 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 125.228 2.442 . . . . 0.0 106.633 -163.159 . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttp . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 099 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -79.66 133.93 36.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 173.975 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.9 pt -138.1 171.73 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 169.818 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -115.69 122.11 44.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 118.07 -2.894 . . . . 0.0 113.36 175.625 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -93.72 102.99 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 122.786 2.539 . . . . 0.0 111.193 166.701 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 21.3 tptt -80.49 122.98 27.67 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 128.039 2.535 . . . . 0.0 111.846 165.216 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.8 p -102.99 156.63 17.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.747 -176.256 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.647 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -53.77 -26.19 22.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 130.068 3.347 . . . . 0.0 118.267 -175.946 . . . . . . . . 3 3 . 1 . 099 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -86.78 -10.65 53.07 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 127.245 2.841 . . . . 0.0 112.144 -177.8 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.89 -3.99 57.46 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 130.275 3.798 . . . . 0.0 117.761 -178.992 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -71.69 143.0 49.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 120.147 1.973 . . . . 0.0 111.411 175.402 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 154.17 33.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.002 173.538 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -135.23 143.18 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 129.341 3.056 . . . . 0.0 108.682 -176.826 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -119.73 102.02 8.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.313 179.949 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.2 mt -96.02 170.05 9.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 -177.203 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -121.57 90.94 3.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 123.265 1.507 . . . . 0.0 112.149 167.926 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -99.49 172.5 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 117.595 -3.191 . . . . 0.0 109.912 -177.536 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -131.94 130.8 22.29 Favored Pre-proline 0 N--CA 1.447 -0.624 2 O-C-N 114.672 -5.017 . . . . 0.0 107.223 -164.39 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -42.94 -29.82 1.65 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 1 CA-C-N 129.146 4.302 . . . . 0.0 116.937 167.408 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -75.73 -13.99 60.32 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 129.0 2.92 . . . . 0.0 114.869 176.871 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 56' ' ' LEU . 66.1 m-20 -79.87 129.29 34.36 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 124.47 2.081 . . . . 0.0 109.989 -170.682 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -73.21 163.04 28.68 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 125.482 2.563 . . . . 0.0 105.57 177.896 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -55.28 -36.23 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 117.82 -3.05 . . . . 0.0 112.631 172.028 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.48 -30.38 69.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 117.494 -3.254 . . . . 0.0 113.346 169.568 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -59.82 -43.76 94.37 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 170.63 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -52.74 -50.09 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 O-C-N 127.707 3.13 . . . . 0.0 114.279 174.591 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -54.01 -46.37 71.78 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 129.075 3.984 . . . . 0.0 109.229 172.609 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.16 93.62 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.827 2.051 . . . . 0.0 115.386 174.252 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -58.23 -41.82 84.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.353 2.261 . . . . 0.0 116.032 165.423 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -67.09 -45.52 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 120.388 -1.445 . . . . 0.0 110.976 176.56 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -45.26 -59.79 2.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 127.51 3.006 . . . . 0.0 111.761 173.099 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -52.42 -34.95 50.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.786 -175.059 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -98.17 -37.57 9.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 126.17 2.168 . . . . 0.0 116.687 -168.682 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -128.3 6.15 5.82 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.291 2.237 . . . . 0.0 116.07 -173.606 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.8 11.51 63.07 Favored Glycine 0 CA--C 1.532 1.142 1 O-C-N 116.178 -4.076 . . . . 0.0 119.887 174.678 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.3 mt -83.4 130.66 55.56 Favored Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-N 120.734 2.267 . . . . 0.0 105.238 177.274 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.264 73.7 Cg_endo -80.66 159.45 21.92 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 O-C-N 116.098 -2.632 . . . . 0.0 113.371 174.103 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.83 -40.63 16.33 Favored 'Trans proline' 0 N--CA 1.443 -1.467 1 C-N-CA 125.395 4.063 . . . . 0.0 110.559 -170.882 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.26 24.7 t70 -55.96 -22.57 27.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 113.335 -3.221 . . . . 0.0 116.379 176.622 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -86.34 -10.09 55.11 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 128.401 3.563 . . . . 0.0 110.009 -178.142 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -100.49 161.15 13.79 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.791 1.636 . . . . 0.0 107.136 -157.389 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -157.04 126.19 5.96 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 125.351 2.5 . . . . 0.0 107.713 162.142 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -99.59 126.02 45.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.74 -2.475 . . . . 0.0 106.738 -174.757 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.2 mm -111.45 143.64 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 129.879 3.271 . . . . 0.0 110.267 179.469 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -146.81 137.12 23.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.27 3.028 . . . . 0.0 108.666 166.626 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.281 . . 53.33 42.0 32.08 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 131.186 3.794 . . . . 0.0 112.454 172.648 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.27 10.18 85.72 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 114.429 -3.428 . . . . 0.0 114.708 -174.864 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -147.98 163.0 38.19 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 123.723 3.761 . . . . 0.0 115.305 179.172 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -63.64 133.78 54.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 131.655 3.982 . . . . 0.0 110.316 171.017 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 mt -99.31 126.73 45.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 163.609 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.93 156.85 20.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 126.324 2.265 . . . . 0.0 113.315 -174.007 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.19 155.28 11.6 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.567 -169.075 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.85 0.04 48.67 Favored Glycine 0 CA--C 1.525 0.665 1 O-C-N 130.388 4.805 . . . . 0.0 113.266 150.438 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -120.17 169.5 10.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 131.008 3.723 . . . . 0.0 112.321 179.336 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 p -105.92 163.87 12.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 116.557 -1.687 . . . . 0.0 113.916 -173.504 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 21' ' ' ASP . 5.9 mp -41.72 -37.83 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 112.645 -3.55 . . . . 0.0 115.108 156.94 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -71.58 -38.37 70.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 124.721 3.419 . . . . 0.0 117.94 170.531 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.95 -29.37 66.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 122.163 2.256 . . . . 0.0 115.319 173.761 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -87.68 8.84 23.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 118.68 -2.512 . . . . 0.0 108.132 173.112 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 63.26 24.47 14.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 124.211 3.187 . . . . 0.0 117.183 171.32 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.6 mt -76.87 127.71 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 118.636 -2.54 . . . . 0.0 116.749 -175.217 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.278 4.3 tp-100 -110.6 165.16 12.04 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.835 2.454 . . . . 0.0 109.896 -170.335 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.2 155.83 2.51 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 117.086 -3.509 . . . . 0.0 115.556 178.532 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 57.06 1.03 0.09 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.434 2.294 . . . . 0.0 116.509 170.435 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -60.12 151.31 27.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 130.48 3.512 . . . . 0.0 110.5 173.893 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.9 m -103.47 115.69 31.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 177.632 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.38 148.01 24.45 Favored 'General case' 0 N--CA 1.445 -0.68 1 C-N-CA 132.618 4.367 . . . . 0.0 107.784 160.402 . . . . . . . . 2 2 . 1 . 099 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -113.68 148.4 36.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 122.312 2.324 . . . . 0.0 109.597 176.467 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -119.28 136.63 54.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.259 2.623 . . . . 0.0 107.274 178.996 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.97 167.99 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 O-C-N 125.222 1.576 . . . . 0.0 111.476 157.048 . . . . . . . . 1 1 . 1 . 099 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.593 1.1 pp . . . . . 0 N--CA 1.447 -0.598 0 CA-C-N 120.573 1.533 . . . . 0.0 113.821 171.176 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 ttp . . . . . 0 C--O 1.234 0.248 0 CA-C-O 115.737 -2.078 . . . . 0.0 106.554 . . . . . . . . . 0 0 . 1 . 100 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.58 HE21 HG22 ' A' ' 14' ' ' THR . 57.9 tt0 -90.75 138.96 31.17 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 121.383 1.901 . . . . 0.0 108.748 173.331 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 pt -125.96 159.76 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 130.081 3.352 . . . . 0.0 109.372 159.908 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.279 73.4 m-85 -95.47 144.0 26.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 165.726 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.8 t -116.14 149.07 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 127.878 2.471 . . . . 0.0 108.768 163.987 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -136.79 150.07 48.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 130.488 3.515 . . . . 0.0 104.243 177.721 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.5 p -106.79 -170.97 1.8 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 111.731 -2.486 . . . . 0.0 106.189 -179.786 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.1 mt -106.67 -11.75 15.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 126.548 3.071 . . . . 0.0 112.951 -176.318 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -89.15 -6.02 57.3 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 119.077 -2.265 . . . . 0.0 110.994 173.859 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.8 -28.47 5.43 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 129.263 3.316 . . . . 0.0 111.107 171.572 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.441 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 47.3 tttt -73.12 142.48 47.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.067 -158.509 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.5 p -113.02 136.73 52.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.465 1.906 . . . . 0.0 109.897 -179.171 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 pt -117.78 143.6 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 131.4 3.88 . . . . 0.0 102.191 168.297 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.58 HG22 HE21 ' A' ' 2' ' ' GLN 0.427 78.5 m -97.58 141.23 30.88 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 169.559 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.291 0.0 OUTLIER -131.23 125.28 32.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.068 2.147 . . . . 0.0 109.042 -176.649 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.4 132.2 37.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 129.238 3.015 . . . . 0.0 112.203 156.162 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.99 160.35 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 127.235 2.214 . . . . 0.0 111.689 -177.81 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -121.19 154.87 58.73 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 100.724 -3.806 . . . . 0.0 100.724 173.976 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.82 -17.91 17.44 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.775 1.65 . . . . 0.0 115.865 -171.575 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 p -84.42 5.14 28.42 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 117.381 -1.295 . . . . 0.0 111.642 -175.064 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.03 139.51 39.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.431 2.693 . . . . 0.0 114.646 178.903 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 p -94.61 134.88 36.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.265 2.226 . . . . 0.0 114.664 -177.067 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.442 5.0 mt -42.14 -40.61 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -177.006 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.39 -13.95 59.61 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 117.156 -3.465 . . . . 0.0 113.5 176.429 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -89.64 -23.32 21.93 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 116.158 -1.877 . . . . 0.0 114.056 162.815 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.84 -36.18 73.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 116.343 -1.789 . . . . 0.0 110.129 168.034 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -60.2 -39.69 87.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 122.457 2.389 . . . . 0.0 113.487 170.078 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -36.5 79.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 115.583 -2.151 . . . . 0.0 113.664 169.694 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 tttt -61.81 -38.05 86.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 123.379 2.809 . . . . 0.0 110.349 169.606 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.366 66.4 mt -62.19 -32.66 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 O-C-N 117.7 -3.125 . . . . 0.0 117.416 169.96 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -27.24 68.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.708 1.203 . . . . 0.0 113.774 175.947 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -84.11 -33.98 24.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 126.139 2.15 . . . . 0.0 107.371 -176.726 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -73.75 -43.45 59.02 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 177.469 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.441 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS 0.302 47.8 tp10 -142.02 -5.2 1.01 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 123.383 1.563 . . . . 0.0 108.135 -152.855 . . . . . . . . 3 3 . 1 . 100 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.24 -9.17 69.81 Favored Glycine 0 N--CA 1.443 -0.877 1 O-C-N 115.975 -4.203 . . . . 0.0 122.558 162.497 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.449 HG23 ' HG3' ' A' ' 41' ' ' GLN . 68.0 mt -79.03 124.02 84.83 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-O 114.389 -2.719 . . . . 0.0 105.241 -171.2 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.303 58.9 Cg_endo -54.48 149.78 37.26 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.46 2.107 . . . . 0.0 115.394 172.221 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -84.29 -25.62 2.08 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 107.28 -1.854 . . . . 0.0 107.28 -162.165 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -48.84 -47.62 42.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 177.73 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -95.78 13.65 25.87 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.497 1.519 . . . . 0.0 108.029 -175.51 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.449 ' HG3' HG23 ' A' ' 36' ' ' ILE . 30.9 mt-30 -92.78 145.44 24.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 122.144 2.247 . . . . 0.0 109.919 171.192 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -147.63 124.23 11.1 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 130.005 3.322 . . . . 0.0 109.015 -177.261 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mp -101.39 139.01 37.64 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.875 1.67 . . . . 0.0 110.823 -177.161 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.9 mt -121.84 140.67 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 131.372 3.869 . . . . 0.0 110.292 168.761 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -116.54 -32.02 5.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 119.245 -2.159 . . . . 0.0 113.917 166.254 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.7 -107.16 0.38 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-O 115.43 -2.224 . . . . 0.0 106.312 175.961 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.95 2.77 13.19 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 117.931 1.932 . . . . 0.0 117.931 166.569 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -113.11 151.62 30.59 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 118.999 -2.471 . . . . 0.0 107.495 -160.707 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -66.41 144.65 56.39 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.676 163.912 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.4 mt -98.05 147.41 24.56 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.873 2.469 . . . . 0.0 106.534 172.729 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -66.96 114.59 5.88 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 157.677 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -53.35 -30.32 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 119.915 3.302 . . . . 0.0 119.915 -176.38 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.68 18.44 52.95 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -168.753 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -94.02 168.69 10.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 125.572 1.395 . . . . 0.0 109.913 167.232 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.1 p -96.08 166.93 11.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 130.628 3.571 . . . . 0.0 116.53 175.29 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.79 -38.41 69.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 114.492 -2.671 . . . . 0.0 115.538 168.6 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 p -76.1 -31.27 58.6 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.555 2.742 . . . . 0.0 106.702 -171.397 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -57.42 -35.01 69.53 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 120.083 1.311 . . . . 0.0 111.809 173.999 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -108.39 -3.57 18.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -170.741 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.419 36.9 t-20 67.16 53.47 0.79 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 127.324 2.89 . . . . 0.0 111.904 178.8 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.1 mm -79.11 115.68 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 127.94 2.496 . . . . 0.0 104.491 168.494 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -93.15 156.88 16.58 Favored 'General case' 0 N--CA 1.448 -0.534 1 C-N-CA 132.014 4.126 . . . . 0.0 111.438 177.047 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -67.4 149.01 50.84 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 119.645 -1.91 . . . . 0.0 111.78 -177.245 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.393 19.2 mt-10 80.67 -2.4 1.86 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 114.09 -2.862 . . . . 0.0 113.219 172.78 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.8 m -66.58 159.63 27.03 Favored 'General case' 0 N--CA 1.449 -0.494 1 O-C-N 130.016 4.573 . . . . 0.0 112.616 -177.229 . . . . . . . . 2 2 . 1 . 100 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.5 m -103.74 121.29 42.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 175.083 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 tt -110.31 154.45 23.46 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 117.803 -3.061 . . . . 0.0 106.486 -179.347 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -120.95 119.77 33.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 116.507 -3.871 . . . . 0.0 110.415 -167.826 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.1 tp -98.4 142.57 29.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.582 2.353 . . . . 0.0 110.178 178.983 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -124.3 162.98 24.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 129.187 2.995 . . . . 0.0 109.687 177.217 . . . . . . . . 1 1 . 1 . 100 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 122.455 1.121 . . . . 0.0 109.227 177.685 . . . . . . . . 0 0 . 1 . 101 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.4 ttm . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 116.982 -1.485 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 101 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -106.11 122.49 46.29 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -166.209 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -132.8 174.1 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 O-C-N 125.723 1.889 . . . . 0.0 109.086 167.832 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.404 ' HB3' ' HA ' ' A' ' 14' ' ' THR 0.283 7.6 p90 -150.62 149.06 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 117.033 -3.542 . . . . 0.0 109.509 -171.457 . . . . . . . . 3 3 . 1 . 101 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.58 150.42 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 179.909 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -109.26 123.42 49.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 175.624 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -68.51 172.88 5.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 128.538 2.735 . . . . 0.0 110.584 176.861 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.76 -26.5 66.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.805 167.43 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -88.92 -4.27 58.5 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 179.978 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.91 -4.29 57.55 Favored Glycine 0 CA--C 1.528 0.898 1 CA-C-O 112.379 -4.567 . . . . 0.0 111.823 166.128 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -84.62 141.5 30.61 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 123.922 3.861 . . . . 0.0 110.885 178.139 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.276 53.9 m -104.15 148.62 26.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 121.658 2.026 . . . . 0.0 105.906 -168.433 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mt -128.48 121.08 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.824 2.05 . . . . 0.0 107.936 176.951 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.404 ' HA ' ' HB3' ' A' ' 4' ' ' PHE . 91.8 m -92.67 129.77 38.5 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.561 1.945 . . . . 0.0 106.63 -177.244 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.91 139.4 47.43 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 127.147 2.779 . . . . 0.0 106.403 -175.48 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.294 22.3 tp10 -96.22 127.18 42.0 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 118.442 -2.661 . . . . 0.0 107.211 159.635 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.63 161.81 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 103.503 -2.776 . . . . 0.0 103.503 177.823 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -107.85 121.56 43.61 Favored Pre-proline 0 N--CA 1.446 -0.667 1 C-N-CA 133.366 4.666 . . . . 0.0 104.877 160.63 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 10.4 Cg_endo -65.19 -2.57 5.99 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 127.188 5.258 . . . . 0.0 117.483 -160.22 . . . . . . . . 3 2 . 1 . 101 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -96.85 3.4 52.21 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.86 -177.331 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.12 157.04 31.23 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.694 1.597 . . . . 0.0 111.523 174.932 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -100.53 149.93 23.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 -172.338 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.452 HG12 ' H ' ' A' ' 23' ' ' ILE . 5.5 mm -51.96 -31.86 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 112.609 -3.567 . . . . 0.0 116.477 -178.005 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -65.38 -26.54 68.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 123.079 2.672 . . . . 0.0 113.136 174.188 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -81.69 -21.24 38.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.506 1.503 . . . . 0.0 112.744 178.495 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 t -71.4 -52.53 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 1 C-N-CA 133.804 4.842 . . . . 0.0 110.082 167.716 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -53.6 -34.13 57.35 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 116.555 -3.84 . . . . 0.0 118.12 168.299 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.74 -18.85 39.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 120.395 -1.441 . . . . 0.0 112.06 -178.439 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -69.95 -17.23 63.3 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 116.844 -3.66 . . . . 0.0 117.026 167.293 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mm -84.83 -35.56 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 116.736 -1.602 . . . . 0.0 108.733 -174.743 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -52.14 -43.41 64.03 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 129.618 3.167 . . . . 0.0 111.863 -166.783 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.85 -29.3 65.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 122.767 2.53 . . . . 0.0 113.272 179.701 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -75.18 -56.77 4.4 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.393 -2.692 . . . . 0.0 109.914 173.294 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -134.29 137.63 44.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 -165.524 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.48 40.87 2.32 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 -149.71 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 mt -91.93 119.66 68.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 130.066 3.347 . . . . 0.0 113.807 -174.781 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.97 138.94 23.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 121.273 1.49 . . . . 0.0 113.024 -168.273 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.08 -18.75 7.66 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-O 111.452 -3.645 . . . . 0.0 116.18 177.59 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -88.61 12.15 15.42 Favored 'General case' 0 C--O 1.238 0.491 1 CA-C-N 127.076 4.489 . . . . 0.0 112.314 175.078 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.336 8.2 tt0 -127.01 -18.86 4.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.511 -1.993 . . . . 0.0 111.222 -176.858 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 77.3 mt-30 -92.66 156.64 16.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.254 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -144.8 147.69 33.18 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.212 -2.885 . . . . 0.0 103.212 170.49 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.8 mt -117.76 136.06 53.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.526 2.331 . . . . 0.0 110.078 -176.591 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.2 mt -122.15 143.18 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 172.892 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -118.03 106.45 12.92 Favored 'General case' 0 C--N 1.33 -0.273 2 CA-C-N 105.312 -5.404 . . . . 0.0 112.332 154.675 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.462 . . 87.18 4.22 0.36 Allowed 'General case' 0 CA--C 1.532 0.265 1 O-C-N 111.987 -6.696 . . . . 0.0 116.69 157.537 . . . . . . . . 3 2 . 1 . 101 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.7 2.22 46.47 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.714 -171.794 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -92.23 124.07 36.03 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 128.349 2.659 . . . . 0.0 111.276 165.012 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -77.18 128.46 34.42 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 168.788 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.279 11.9 mt -68.15 126.54 29.84 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 118.336 2.717 . . . . 0.0 118.336 170.388 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -98.75 139.09 34.95 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -173.625 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.45 142.83 57.7 Favored 'General case' 0 C--O 1.22 -0.457 0 O-C-N 117.996 -2.94 . . . . 0.0 109.013 176.787 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.68 -19.04 56.34 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 119.108 -2.245 . . . . 0.0 108.126 171.519 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -81.09 157.97 25.2 Favored 'General case' 0 N--CA 1.453 -0.319 1 O-C-N 115.072 -4.781 . . . . 0.0 106.538 173.123 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.1 p -92.03 165.93 12.94 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 120.558 -1.339 . . . . 0.0 109.967 165.689 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 mt -51.7 -45.79 63.65 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.451 2.7 . . . . 0.0 113.286 163.075 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -53.45 -28.84 32.51 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 170.082 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.01 -23.65 48.2 Favored 'General case' 0 N--CA 1.447 -0.597 1 O-C-N 115.068 -4.77 . . . . 0.0 115.857 178.356 . . . . . . . . 3 3 . 1 . 101 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.28 45.9 m-85 -97.99 -9.05 26.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.309 1.444 . . . . 0.0 114.303 172.497 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.377 26.5 t30 72.54 47.18 0.26 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 130.324 3.45 . . . . 0.0 111.405 -178.233 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -82.57 103.58 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.943 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -90.09 -175.06 4.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 130.02 3.328 . . . . 0.0 115.901 170.458 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.76 138.58 41.85 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.613 3.165 . . . . 0.0 112.933 173.498 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.454 62.8 tt0 83.93 2.24 0.91 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 126.867 2.067 . . . . 0.0 114.657 167.53 . . . . . . . . 2 2 . 1 . 101 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -77.88 134.1 38.0 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.23 -1.544 . . . . 0.0 111.104 -169.195 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -85.19 115.55 23.04 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 126.662 2.476 . . . . 0.0 104.733 174.44 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.3 mt -94.83 171.03 9.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 128.208 3.443 . . . . 0.0 107.262 161.839 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -130.96 139.13 50.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.721 -179.029 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -101.95 120.87 41.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 -171.006 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.37 172.95 13.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 127.497 2.319 . . . . 0.0 105.973 -175.287 . . . . . . . . 1 1 . 1 . 101 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mp . . . . . 0 N--CA 1.443 -0.818 0 C-N-CA 122.816 0.446 . . . . 0.0 110.687 -165.576 . . . . . . . . 0 0 . 1 . 102 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttp . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 116.654 -1.641 . . . . 0.0 107.281 . . . . . . . . . 0 0 . 1 . 102 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -93.95 138.59 31.9 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 124.041 1.877 . . . . 0.0 111.164 170.842 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -136.74 167.71 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.704 2.001 . . . . 0.0 107.897 162.289 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -119.87 135.2 54.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -177.144 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.0 t -121.43 89.58 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 126.674 2.484 . . . . 0.0 104.907 178.747 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -77.83 121.32 23.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.456 3.902 . . . . 0.0 107.018 -175.542 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.8 p -84.61 155.05 22.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 175.373 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 mt -50.44 -16.81 0.39 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 131.415 3.886 . . . . 0.0 115.664 176.558 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -97.81 6.35 47.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.18 0.992 . . . . 0.0 111.731 172.706 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.08 -36.32 4.47 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 120.007 -1.683 . . . . 0.0 109.951 167.515 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -60.24 127.68 33.0 Favored 'General case' 0 C--N 1.33 -0.255 1 C-N-CA 132.369 4.268 . . . . 0.0 106.69 -174.718 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.253 20.6 m -119.19 123.81 45.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.102 2.561 . . . . 0.0 109.071 -166.014 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mm -82.48 120.37 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 168.235 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.8 m -74.35 134.8 42.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.88 1.363 . . . . 0.0 109.27 166.735 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.44 129.91 50.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 120.645 1.566 . . . . 0.0 113.259 179.593 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.48 90.77 7.69 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.133 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -98.99 164.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.321 177.996 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.265 30.5 tp10 -107.81 156.21 38.49 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-O 113.612 -3.09 . . . . 0.0 105.017 162.3 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -59.93 -25.07 78.49 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 124.127 3.218 . . . . 0.0 118.073 170.557 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -88.57 1.65 54.53 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 119.439 3.125 . . . . 0.0 119.439 -179.732 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -72.43 149.18 44.47 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 114.439 -2.696 . . . . 0.0 115.891 -177.605 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 p -65.95 151.67 46.26 Favored 'General case' 0 C--N 1.325 -0.459 1 O-C-N 129.62 4.325 . . . . 0.0 110.475 167.04 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -61.02 -29.01 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 116.591 -1.671 . . . . 0.0 110.412 173.251 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -70.3 -50.61 37.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.045 2.538 . . . . 0.0 111.379 -173.056 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.3 -45.04 54.3 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.132 2.573 . . . . 0.0 112.629 170.93 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.4 -45.85 67.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.856 1.662 . . . . 0.0 108.158 -176.28 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -63.61 -31.19 72.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.251 1.42 . . . . 0.0 114.397 178.101 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.71 -14.87 35.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.38 3.472 . . . . 0.0 113.56 177.084 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.04 -31.2 27.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 119.119 -2.238 . . . . 0.0 107.083 174.571 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.2 mm -81.51 -6.99 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 117.348 -1.31 . . . . 0.0 109.961 176.907 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -76.54 -28.99 56.51 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 118.104 -2.873 . . . . 0.0 109.102 163.37 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.55 -47.21 12.41 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -163.292 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -73.18 -73.77 0.2 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.332 2.653 . . . . 0.0 112.214 178.437 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -85.45 -16.57 39.24 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.736 2.414 . . . . 0.0 117.183 -166.942 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.97 -7.84 67.53 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 117.142 -1.921 . . . . 0.0 112.786 -179.777 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.261 37.9 mm -80.29 115.03 51.91 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 123.141 3.471 . . . . 0.0 112.248 -163.485 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -55.67 160.22 9.91 Favored 'Trans proline' 0 N--CA 1.445 -1.354 1 C-N-CA 126.126 4.551 . . . . 0.0 113.941 171.011 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.63 5.82 3.59 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 N-CA-C 120.028 3.049 . . . . 0.0 120.028 -176.509 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.378 82.8 m-20 -104.72 -6.37 20.43 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 126.312 2.958 . . . . 0.0 117.929 174.451 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -97.82 -6.47 32.55 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 119.304 -2.122 . . . . 0.0 114.703 160.992 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -85.25 85.93 7.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 169.51 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -93.85 97.22 10.25 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 -171.421 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 mt -93.06 139.15 30.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -163.654 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mt -136.47 135.55 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.31 1.844 . . . . 0.0 110.039 177.754 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -129.38 107.13 9.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.07 3.348 . . . . 0.0 105.465 -178.465 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.39 42.0 31.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.426 2.291 . . . . 0.0 115.176 167.634 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.2 -25.29 28.81 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 119.707 -1.87 . . . . 0.0 114.199 -178.449 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -93.77 114.22 26.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 -171.227 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.292 7.8 tt0 -82.28 140.78 33.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 169.1 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.56 135.75 40.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 130.576 3.551 . . . . 0.0 109.362 -174.159 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -104.5 -4.01 23.22 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.203 2.601 . . . . 0.0 109.113 -172.013 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.323 7.5 m-20 84.38 168.35 0.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.278 170.247 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.62 -16.89 36.93 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 123.812 0.695 . . . . 0.0 113.881 169.232 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -120.98 -171.69 2.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.976 2.111 . . . . 0.0 105.366 -171.05 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.261 7.0 p -111.66 167.66 10.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.233 -0.917 . . . . 0.0 110.894 -165.463 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.284 9.3 mp -56.32 -28.86 60.28 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 169.249 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -77.06 -34.33 57.11 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 116.572 -2.051 . . . . 0.0 114.489 179.087 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.64 -40.39 76.54 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 127.924 3.265 . . . . 0.0 113.143 -177.685 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -79.44 0.56 28.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 117.519 -3.238 . . . . 0.0 109.341 171.045 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.366 1.6 t-20 70.6 49.13 0.42 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 126.277 2.942 . . . . 0.0 115.647 169.903 . . . . . . . . 2 2 . 1 . 102 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -101.79 123.45 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 112.538 -2.119 . . . . 0.0 107.336 -174.736 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -111.72 -164.96 0.95 Allowed 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 124.96 1.413 . . . . 0.0 113.696 -168.104 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -69.97 114.72 8.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 119.44 -2.037 . . . . 0.0 107.619 174.611 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.312 5.7 tt0 89.4 12.3 0.07 Allowed 'General case' 0 C--O 1.236 0.374 1 O-C-N 115.915 -4.241 . . . . 0.0 112.746 167.307 . . . . . . . . 3 2 . 1 . 102 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -49.76 152.23 1.55 Allowed 'General case' 0 C--N 1.327 -0.381 0 O-C-N 117.661 -3.149 . . . . 0.0 112.179 167.953 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.1 m -116.15 130.54 56.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.637 167.928 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.92 123.56 46.05 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.078 1.751 . . . . 0.0 112.4 166.13 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -84.65 110.32 18.65 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 173.004 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.1 tp -89.2 103.76 16.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.727 2.411 . . . . 0.0 108.933 172.413 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 t -81.36 116.75 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 127.63 2.372 . . . . 0.0 109.292 163.502 . . . . . . . . 1 1 . 1 . 102 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 115.112 -2.375 . . . . 0.0 104.682 175.202 . . . . . . . . 0 0 . 1 . 103 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tmm? . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 . . . . . . . . . 0 0 . 1 . 103 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -94.01 154.31 17.72 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -174.665 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 pt -135.74 144.26 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 171.421 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -102.96 94.29 5.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 111.207 -2.724 . . . . 0.0 104.439 -179.235 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.4 t -80.88 112.68 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.598 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -96.14 127.91 42.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -170.142 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -95.49 136.83 35.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.317 2.247 . . . . 0.0 109.087 160.055 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.12 -32.33 71.65 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 113.871 -2.966 . . . . 0.0 112.575 166.997 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.276 33.1 p -76.37 -16.52 59.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 114.707 -2.568 . . . . 0.0 109.456 -178.805 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.36 48.15 0.09 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 117.052 -2.499 . . . . 0.0 113.665 123.301 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.304 0.6 OUTLIER -139.19 153.05 47.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.76 1.267 . . . . 0.0 108.84 164.555 . . . . . . . . 3 3 . 1 . 103 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -95.35 129.98 42.29 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.157 2.183 . . . . 0.0 107.03 164.585 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.2 mt -108.92 132.68 56.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 128.975 2.91 . . . . 0.0 106.322 177.625 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.5 m -93.78 126.33 38.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 167.133 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.87 138.17 50.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 125.944 2.028 . . . . 0.0 106.845 166.634 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.74 137.04 39.66 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 173.048 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 m -150.44 179.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.571 1 C-N-CA 132.866 4.467 . . . . 0.0 106.165 -166.779 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.262 48.4 mm-40 -130.89 159.35 71.77 Favored Pre-proline 0 N--CA 1.446 -0.658 0 C-N-CA 127.824 2.45 . . . . 0.0 105.345 155.167 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -61.47 -9.15 12.4 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.026 2.484 . . . . 0.0 116.82 179.543 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.269 26.4 p -88.58 -3.73 58.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.665 -1.16 . . . . 0.0 113.27 173.98 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.67 126.81 28.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.794 0.725 . . . . 0.0 110.457 171.147 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.398 4.7 p -67.05 155.07 39.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 173.775 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.4 -35.67 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 131.176 3.79 . . . . 0.0 107.629 171.395 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.46 -40.45 50.4 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 119.454 -2.029 . . . . 0.0 110.774 -174.204 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -56.56 -59.66 4.68 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 124.994 1.434 . . . . 0.0 113.419 168.38 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.321 96.6 t -51.72 -51.25 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 O-C-N 116.705 -3.747 . . . . 0.0 115.849 -177.387 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -48.8 -44.09 38.75 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 127.456 2.973 . . . . 0.0 116.433 169.927 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.24 -34.2 23.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 129.772 3.229 . . . . 0.0 110.361 -179.425 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -62.06 -33.54 74.58 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 125.853 1.971 . . . . 0.0 110.862 169.256 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.2 mt -63.95 -50.38 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 127.77 2.428 . . . . 0.0 113.239 165.965 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -41.34 82.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.92 2.088 . . . . 0.0 112.856 -175.984 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -54.37 -26.22 28.89 Favored 'General case' 0 N--CA 1.447 -0.594 1 C-N-CA 131.811 4.045 . . . . 0.0 113.741 173.601 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -98.78 -62.25 1.26 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 120.645 1.566 . . . . 0.0 113.514 -178.874 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -106.78 -17.41 14.22 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 126.368 2.292 . . . . 0.0 114.265 -167.523 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.95 1.43 42.18 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 117.696 -3.127 . . . . 0.0 118.053 168.049 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mt -80.75 130.16 65.24 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 123.279 3.54 . . . . 0.0 115.511 -172.43 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.285 36.9 Cg_endo -68.3 135.37 33.95 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.996 2.464 . . . . 0.0 110.745 179.419 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -43.79 -40.63 11.36 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.532 2.821 . . . . 0.0 116.556 175.925 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -55.75 -30.28 60.97 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.698 1.199 . . . . 0.0 112.986 -176.139 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -101.15 -12.5 18.72 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 128.314 2.646 . . . . 0.0 115.216 -171.606 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.26 73.3 mt-30 -81.14 152.61 27.69 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 111.932 -2.394 . . . . 0.0 108.419 179.413 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -132.45 126.83 33.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.847 2.459 . . . . 0.0 108.246 157.13 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 mt -115.96 131.2 57.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 177.684 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.72 143.11 32.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 110.789 -2.914 . . . . 0.0 108.085 -173.031 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -139.38 118.02 12.26 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.566 2.347 . . . . 0.0 109.011 160.083 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.65 48.87 6.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 128.36 3.538 . . . . 0.0 109.688 170.152 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.66 -19.94 51.14 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.578 1.085 . . . . 0.0 112.019 166.631 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.262 74.5 mttt -96.83 144.81 26.44 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.083 1.942 . . . . 0.0 114.447 -174.568 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.319 77.8 mm-40 -76.88 169.1 18.93 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 116.895 -1.922 . . . . 0.0 109.131 160.908 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.457 HD21 ' CG ' ' A' ' 59' ' ' TYR 0.25 43.4 mt -120.34 119.35 32.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 117.84 -3.038 . . . . 0.0 106.141 -170.571 . . . . . . . . 3 3 . 1 . 103 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -86.08 146.65 26.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 123.194 1.473 . . . . 0.0 113.274 -170.243 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -68.44 122.39 18.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 111.97 -2.377 . . . . 0.0 104.916 -175.403 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.07 9.25 10.83 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 127.581 3.051 . . . . 0.0 119.336 179.698 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.277 90.2 mtt-85 -132.35 179.34 6.18 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.953 2.101 . . . . 0.0 107.244 -172.579 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -126.46 178.62 5.75 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.113 -171.184 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -73.62 -28.93 62.06 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 127.45 2.969 . . . . 0.0 110.909 175.389 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.1 t -59.81 -27.58 66.71 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 129.521 3.129 . . . . 0.0 110.692 172.49 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.89 -44.16 27.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.748 2.419 . . . . 0.0 108.796 178.528 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.457 ' CG ' HD21 ' A' ' 50' ' ' LEU . 96.0 m-85 -99.99 20.93 13.5 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -179.622 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 3.9 t-20 83.7 25.38 0.11 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 119.147 3.017 . . . . 0.0 119.147 164.169 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mt -104.04 81.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -172.679 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -92.28 -23.49 19.28 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 129.09 2.956 . . . . 0.0 114.491 -170.362 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -168.39 130.13 1.36 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.881 1.672 . . . . 0.0 109.535 -170.881 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 7.99 86.95 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 130.906 3.683 . . . . 0.0 116.944 167.049 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.284 5.3 t -143.98 -160.52 1.13 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 115.115 -2.374 . . . . 0.0 107.301 173.788 . . . . . . . . 2 2 . 1 . 103 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.5 m -125.7 132.07 52.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 122.074 2.215 . . . . 0.0 106.334 -167.265 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.77 143.54 29.01 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 156.373 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -89.96 128.84 36.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 119.521 -1.987 . . . . 0.0 109.114 166.904 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 tp -92.45 117.67 30.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 131.69 3.996 . . . . 0.0 103.511 176.833 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.5 143.69 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -176.968 . . . . . . . . 1 1 . 1 . 103 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.625 0 O-C-N 119.3 -2.125 . . . . 0.0 111.044 -171.097 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ptt? . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 . . . . . . . . . 0 0 . 1 . 104 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -82.71 152.32 25.84 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 115.208 -2.33 . . . . 0.0 112.678 -179.701 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.8 pt -139.82 149.5 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 121.777 2.08 . . . . 0.0 109.449 162.539 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -105.27 126.22 51.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 -172.355 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.272 93.0 t -99.4 112.14 30.9 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 C-N-CA 127.979 2.511 . . . . 0.0 108.076 171.929 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -70.32 148.8 48.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 111.565 -2.561 . . . . 0.0 111.314 166.352 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -120.75 -167.07 1.41 Allowed 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.083 -1.635 . . . . 0.0 109.534 176.442 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.495 HD22 ' HE2' ' A' ' 68' ' ' HIS . 0.5 OUTLIER -143.14 42.17 1.53 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 164.294 . . . . . . . . 3 3 . 1 . 104 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -139.74 26.54 2.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.715 2.406 . . . . 0.0 107.786 176.985 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.98 16.52 35.4 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 116.865 -3.647 . . . . 0.0 117.883 152.997 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -154.49 171.73 18.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 124.427 2.061 . . . . 0.0 110.116 177.664 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.5 m -112.89 127.57 56.23 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 131.313 3.845 . . . . 0.0 108.918 175.887 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 87.3 mt -106.47 129.37 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 O-C-N 126.78 2.55 . . . . 0.0 107.011 175.018 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.1 m -107.04 136.9 46.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 102.411 -3.181 . . . . 0.0 102.411 169.829 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tp -129.57 160.83 32.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 128.314 2.645 . . . . 0.0 105.496 -179.665 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -102.19 139.27 38.03 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 130.653 3.581 . . . . 0.0 103.19 172.968 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -151.03 166.36 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 119.314 -2.116 . . . . 0.0 108.644 -178.903 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -138.27 142.71 36.16 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 126.152 1.781 . . . . 0.0 108.469 -173.189 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.343 11.5 Cg_exo -50.72 -34.83 45.59 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 N-CA-C 121.369 3.565 . . . . 0.0 121.369 -179.887 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.5 p -93.43 -2.27 54.77 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 127.47 2.981 . . . . 0.0 112.134 -174.24 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -74.33 141.14 45.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 125.868 2.747 . . . . 0.0 109.091 170.327 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 p -76.32 172.81 12.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 119.221 -2.174 . . . . 0.0 111.408 175.933 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -53.15 -46.96 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 C-N-CA 133.875 4.87 . . . . 0.0 113.397 171.097 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -47.47 -42.16 22.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 113.295 -3.24 . . . . 0.0 112.33 170.089 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.281 4.7 m120 -59.14 -32.13 69.59 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.536 2.734 . . . . 0.0 116.135 175.392 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.79 -54.62 25.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 120.121 -1.612 . . . . 0.0 110.769 165.419 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -71.81 -23.88 61.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 125.675 2.655 . . . . 0.0 113.637 -171.952 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.6 -46.98 51.55 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 118.785 -2.447 . . . . 0.0 110.043 173.534 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.68 -27.91 60.61 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.729 2.412 . . . . 0.0 109.757 -176.487 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.36 -47.92 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 O-C-N 118.933 -2.355 . . . . 0.0 106.463 169.77 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -50.86 -51.86 47.29 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 124.426 3.284 . . . . 0.0 107.851 175.924 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.301 5.1 t70 -46.56 -50.03 17.91 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 179.094 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -83.64 -48.99 9.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 128.905 3.878 . . . . 0.0 108.55 -173.195 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -106.26 -14.74 15.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 123.493 2.861 . . . . 0.0 110.012 -161.754 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.21 0.99 84.63 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 129.851 3.595 . . . . 0.0 118.976 -178.623 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -83.86 126.42 70.58 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 119.855 1.827 . . . . 0.0 111.817 -165.827 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.09 145.92 31.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 O-C-N 124.245 1.655 . . . . 0.0 110.394 -175.063 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.27 38.0 Cg_endo -72.94 -16.23 25.93 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.494 3.463 . . . . 0.0 119.823 -163.6 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -72.07 -26.73 62.28 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 125.461 1.726 . . . . 0.0 110.337 174.335 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -83.02 -30.24 28.26 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.41 1.484 . . . . 0.0 112.507 -174.355 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -80.87 142.54 33.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 129.459 3.104 . . . . 0.0 109.375 175.747 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -145.62 119.36 9.22 Favored 'General case' 0 N--CA 1.449 -0.502 1 N-CA-C 99.217 -4.364 . . . . 0.0 99.217 175.733 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.14 124.53 29.95 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 114.64 -2.6 . . . . 0.0 115.81 177.062 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mm -102.17 129.13 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 101.197 -3.631 . . . . 0.0 101.197 173.552 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -137.31 125.98 23.81 Favored 'General case' 0 N--CA 1.451 -0.405 1 N-CA-C 97.139 -5.134 . . . . 0.0 97.139 175.607 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.75 24.18 14.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.864 2.866 . . . . 0.0 114.822 160.577 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.81 -25.92 25.8 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.873 -1.515 . . . . 0.0 112.566 -175.349 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -99.29 164.43 12.13 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 128.079 2.552 . . . . 0.0 109.159 -171.577 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.28 7.3 mt-30 -118.64 145.79 45.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.537 1.935 . . . . 0.0 106.339 166.445 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.44 139.26 30.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.77 -166.58 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.267 7.7 tp10 -85.44 140.34 30.8 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 131.671 3.989 . . . . 0.0 107.174 167.581 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -73.98 136.06 43.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 114.134 -2.841 . . . . 0.0 112.917 -177.667 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.01 -14.16 26.37 Favored Glycine 0 CA--C 1.535 1.327 1 CA-C-N 127.707 4.776 . . . . 0.0 113.775 166.028 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.295 3.1 mpt_? -81.06 161.05 24.34 Favored 'General case' 0 C--N 1.322 -0.624 1 O-C-N 130.925 4.544 . . . . 0.0 105.553 176.385 . . . . . . . . 3 2 . 1 . 104 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -89.59 172.69 8.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 125.282 1.614 . . . . 0.0 109.056 -177.457 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mt -63.04 -52.64 62.07 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 128.932 2.893 . . . . 0.0 110.443 169.961 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.0 p -41.96 -41.27 2.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 117.222 2.305 . . . . 0.0 117.222 162.501 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -62.14 -24.29 67.08 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 118.317 -2.739 . . . . 0.0 116.704 177.34 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -99.52 -6.86 26.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.738 3.215 . . . . 0.0 117.78 179.387 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.308 0.7 OUTLIER 69.85 48.13 0.58 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 130.491 3.517 . . . . 0.0 113.413 174.509 . . . . . . . . 3 3 . 1 . 104 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -93.25 139.69 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -172.998 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.274 7.0 tp60 -148.97 156.36 42.16 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 112.334 -2.212 . . . . 0.0 107.791 -176.18 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.374 23.9 ttpp -31.98 114.43 0.14 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.553 2.741 . . . . 0.0 113.541 -179.974 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 83.4 21.65 0.17 Allowed 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 128.148 3.405 . . . . 0.0 115.007 176.357 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 m -65.65 134.67 53.75 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.688 171.77 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.1 m -94.71 122.4 37.28 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -178.989 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.77 160.24 26.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.227 1.011 . . . . 0.0 109.398 166.21 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.495 ' HE2' HD22 ' A' ' 8' ' ' LEU . 12.0 t-80 -127.88 124.36 37.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 118.493 -2.63 . . . . 0.0 111.979 -175.547 . . . . . . . . 2 2 . 1 . 104 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.4 tp -82.57 101.45 10.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 115.337 -2.268 . . . . 0.0 111.086 -179.861 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.31 151.7 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 O-C-N 125.42 1.7 . . . . 0.0 107.326 163.545 . . . . . . . . 1 1 . 1 . 104 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 126.633 1.973 . . . . 0.0 111.3 178.77 . . . . . . . . 0 0 . 1 . 105 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptt? . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 . . . . . . . . . 0 0 . 1 . 105 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -60.7 125.16 22.66 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 117.553 -1.213 . . . . 0.0 113.248 174.231 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.365 26.8 pt -128.91 166.48 26.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 O-C-N 125.209 1.568 . . . . 0.0 112.127 162.253 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -112.38 154.11 26.26 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.567 2.747 . . . . 0.0 106.916 176.674 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.87 130.66 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 168.682 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -101.72 128.32 48.1 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 122.835 2.561 . . . . 0.0 109.285 167.708 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.6 p -91.59 163.75 14.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.855 2.462 . . . . 0.0 108.386 -173.19 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.41 -47.71 47.7 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 128.286 2.634 . . . . 0.0 109.076 176.22 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.9 p -68.58 -16.94 64.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 128.011 2.524 . . . . 0.0 111.575 -174.743 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.01 -14.06 37.46 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 125.044 3.566 . . . . 0.0 115.498 169.652 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -69.73 147.26 50.75 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.794 1.637 . . . . 0.0 115.074 172.481 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -93.28 137.8 32.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.597 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.3 mt -119.68 137.88 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 170.269 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.4 t -100.86 142.0 32.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.328 1.851 . . . . 0.0 109.941 166.198 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 mt -135.73 142.93 45.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 171.134 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -88.03 115.48 25.54 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 161.787 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 t -123.93 132.41 71.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 127.75 2.42 . . . . 0.0 108.583 -174.985 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -91.3 148.6 38.05 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 114.866 -2.492 . . . . 0.0 110.0 -172.811 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -43.17 -46.0 9.4 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 123.596 2.864 . . . . 0.0 114.955 171.957 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -91.99 15.68 12.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.095 0.861 . . . . 0.0 112.624 -178.428 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -78.46 132.98 37.5 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 118.601 -2.562 . . . . 0.0 105.241 162.818 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.8 p -84.97 179.32 7.32 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 109.86 177.564 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.323 1.1 mp -71.15 -37.36 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 124.192 1.949 . . . . 0.0 108.989 -178.062 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -57.1 -39.01 74.21 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 117.456 -3.278 . . . . 0.0 114.332 173.03 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -53.17 -50.85 63.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 126.007 2.067 . . . . 0.0 115.158 177.739 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 t -65.85 -48.03 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 1 C-N-CA 132.377 4.271 . . . . 0.0 111.094 171.123 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -64.86 -35.94 82.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 115.998 -1.953 . . . . 0.0 111.731 179.11 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.83 -37.03 70.67 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.035 2.134 . . . . 0.0 114.164 174.987 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -84.51 -29.74 25.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 111.068 -2.787 . . . . 0.0 103.67 -170.676 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.8 mt -73.91 -46.24 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 121.503 1.956 . . . . 0.0 112.562 165.368 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -52.98 -48.42 67.46 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 129.532 3.133 . . . . 0.0 110.557 -178.571 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -56.28 -42.63 77.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 169.854 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -86.8 -55.06 4.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -175.867 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -100.01 -18.53 16.99 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 129.532 3.133 . . . . 0.0 113.289 -171.583 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.09 -1.51 70.44 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 114.829 0.692 . . . . 0.0 114.829 155.641 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.63 136.1 71.23 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-O 115.252 -2.309 . . . . 0.0 112.845 173.43 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -70.29 166.32 28.64 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 O-C-N 125.513 2.323 . . . . 0.0 116.449 173.421 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.42 -33.21 5.65 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 CA-C-O 114.901 -2.208 . . . . 0.0 111.228 -166.666 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.94 -21.8 58.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 123.712 2.96 . . . . 0.0 113.241 173.574 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -111.14 -1.08 16.33 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 128.497 2.719 . . . . 0.0 112.078 -169.454 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -96.83 109.24 21.97 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 127.717 2.407 . . . . 0.0 107.145 172.756 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -110.33 89.2 2.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -175.816 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.304 12.8 mt -79.07 127.9 32.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 129.597 3.159 . . . . 0.0 109.221 -179.918 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 8.2 mt -126.2 135.41 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 O-C-N 126.996 2.685 . . . . 0.0 113.561 -175.466 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -147.35 124.3 11.33 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.213 2.205 . . . . 0.0 112.112 172.568 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.36 44.08 9.94 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.882 2.073 . . . . 0.0 111.586 169.009 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.99 4.81 64.65 Favored Glycine 0 CA--C 1.537 1.407 1 CA-C-O 111.949 -4.806 . . . . 0.0 110.393 164.449 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -133.67 141.46 47.6 Favored 'General case' 0 N--CA 1.448 -0.565 1 O-C-N 131.147 4.675 . . . . 0.0 107.509 -170.932 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -70.05 127.67 33.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 123.927 1.822 . . . . 0.0 108.957 160.381 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -83.29 125.29 31.46 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 171.068 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -90.33 136.69 32.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.754 1.622 . . . . 0.0 110.008 -166.163 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -53.83 99.58 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.604 1 C-N-CA 132.29 4.236 . . . . 0.0 117.209 172.207 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.13 -3.46 6.81 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 119.221 2.448 . . . . 0.0 119.221 169.044 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.449 ' HD2' ' CE2' ' A' ' 59' ' ' TYR . 50.3 mtt180 -86.84 -167.66 1.96 Allowed 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 118.824 -2.574 . . . . 0.0 104.463 172.611 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 69.5 p -106.7 165.77 11.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.58 178.321 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -27.77 69.57 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 123.504 1.621 . . . . 0.0 114.626 169.013 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -67.52 -36.1 80.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.454 -1.703 . . . . 0.0 115.042 172.286 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.11 -21.41 66.17 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.702 1.601 . . . . 0.0 114.426 179.235 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.449 ' CE2' ' HD2' ' A' ' 54' ' ' ARG . 32.3 m-85 -112.52 -2.17 14.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 116.868 2.174 . . . . 0.0 116.868 -167.264 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 44.28 46.6 7.66 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 171.343 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -83.98 -35.26 10.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 128.032 3.333 . . . . 0.0 113.905 -173.922 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 75.51 152.28 0.13 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 129.317 3.047 . . . . 0.0 113.357 164.413 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.95 135.88 35.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 127.031 2.133 . . . . 0.0 113.992 173.461 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.344 9.2 tt0 89.05 -1.38 0.37 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 111.311 -2.677 . . . . 0.0 111.479 173.421 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -85.77 162.69 18.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 117.863 -3.023 . . . . 0.0 109.348 -171.082 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.268 36.9 m -121.5 122.83 40.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.176 2.59 . . . . 0.0 106.641 -171.864 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.299 72.9 mt -89.44 145.36 25.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 119.424 -2.047 . . . . 0.0 107.315 167.318 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.276 74.2 m-70 -100.72 121.39 41.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.447 2.699 . . . . 0.0 108.231 174.114 . . . . . . . . 2 2 . 1 . 105 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.1 tp -99.21 118.29 35.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 126.605 2.441 . . . . 0.0 105.277 -179.262 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.48 135.06 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.0 . . . . . . . . 1 1 . 1 . 105 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 112.99 -3.386 . . . . 0.0 107.312 169.68 . . . . . . . . 0 0 . 1 . 106 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 117.566 -1.206 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 106 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.258 77.4 mm-40 -115.7 129.35 56.44 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.431 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.8 pt -100.4 155.14 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 116.866 -1.54 . . . . 0.0 111.066 165.608 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -103.71 121.66 43.43 Favored 'General case' 0 C--O 1.219 -0.532 0 O-C-N 127.395 2.934 . . . . 0.0 105.168 178.16 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 t -115.22 123.59 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 117.213 -3.43 . . . . 0.0 107.886 -177.629 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -119.57 99.66 6.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.599 -1.313 . . . . 0.0 113.294 -173.709 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.2 p -85.04 161.37 19.74 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 119.788 -1.82 . . . . 0.0 112.62 -174.592 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.386 0.0 OUTLIER -17.39 -72.78 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 1 C-N-CA 133.592 4.757 . . . . 0.0 119.711 -172.382 . . . . . . . . 4 3 . 1 . 106 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.0 p -61.21 -10.28 6.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.469 -1.696 . . . . 0.0 114.073 171.827 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.67 -5.17 34.83 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 127.222 3.679 . . . . 0.0 117.64 176.673 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.03 110.77 1.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 129.071 2.948 . . . . 0.0 108.678 -177.894 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.1 m -99.06 139.24 35.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 127.382 2.926 . . . . 0.0 107.559 -161.519 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.4 mt -123.23 141.46 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 177.387 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 m -98.51 105.88 18.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 127.994 3.309 . . . . 0.0 110.054 153.198 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tp -99.07 133.62 43.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 -179.365 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.266 83.6 tt0 -86.27 141.57 29.18 Favored 'General case' 0 N--CA 1.45 -0.427 1 O-C-N 129.363 4.165 . . . . 0.0 106.561 174.712 . . . . . . . . 3 2 . 1 . 106 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.29 179.24 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 126.691 3.138 . . . . 0.0 109.562 174.396 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -107.79 152.99 41.8 Favored Pre-proline 0 N--CA 1.45 -0.458 0 O-C-N 116.793 -3.692 . . . . 0.0 106.491 148.578 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.5 -25.19 25.45 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 O-C-N 116.714 -2.308 . . . . 0.0 113.294 -176.575 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.2 p -77.51 -0.81 27.6 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 129.052 2.941 . . . . 0.0 114.899 174.069 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -77.34 148.96 35.33 Favored 'General case' 0 C--O 1.22 -0.457 0 O-C-N 126.256 2.222 . . . . 0.0 110.226 173.279 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -109.16 144.33 37.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 111.437 -2.619 . . . . 0.0 105.581 -163.447 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -54.07 -30.29 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 1 CA-C-O 110.342 -4.647 . . . . 0.0 115.005 -171.022 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -65.73 -33.83 76.77 Favored 'General case' 0 N--CA 1.451 -0.401 1 CA-C-N 126.006 4.003 . . . . 0.0 113.067 172.532 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -80.66 -16.42 54.07 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 126.824 2.578 . . . . 0.0 107.577 -175.741 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.25 -53.55 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 127.216 2.206 . . . . 0.0 110.649 171.244 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -60.71 -37.83 83.02 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.278 1.831 . . . . 0.0 112.26 176.611 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.59 -10.08 59.13 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 115.236 -2.316 . . . . 0.0 109.88 178.898 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -91.34 -36.93 13.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.55 2.74 . . . . 0.0 108.996 178.925 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.4 mt -65.54 -40.17 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 128.785 2.834 . . . . 0.0 108.718 170.791 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.466 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 38.5 tt0 -52.53 -47.43 66.71 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.32 -2.737 . . . . 0.0 116.282 167.061 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.58 -41.42 92.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 120.937 1.699 . . . . 0.0 115.171 172.175 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -78.01 -37.17 47.69 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.675 1.234 . . . . 0.0 112.837 -176.726 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.35 28.8 mm-40 -124.37 -33.72 3.0 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 -169.197 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.97 39.71 1.95 Allowed Glycine 0 CA--C 1.527 0.841 1 O-C-N 115.279 -4.638 . . . . 0.0 116.127 162.709 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.466 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 8.4 mt -123.36 135.72 26.34 Favored Pre-proline 0 N--CA 1.451 -0.424 0 O-C-N 118.316 -2.873 . . . . 0.0 108.592 179.159 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.89 137.16 17.38 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 O-C-N 125.42 2.274 . . . . 0.0 113.249 -177.967 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -44.9 -30.24 4.3 Favored 'Trans proline' 0 N--CA 1.446 -1.292 1 C-N-CA 126.161 4.574 . . . . 0.0 118.903 -177.204 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.2 -10.83 56.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -168.151 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -98.21 -3.19 38.03 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 129.476 3.111 . . . . 0.0 112.596 175.639 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.255 64.6 mt-30 -107.94 132.9 53.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 123.63 2.923 . . . . 0.0 104.332 -172.191 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -113.96 129.95 56.56 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 119.921 -1.737 . . . . 0.0 109.842 149.965 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.5 mt -101.36 120.58 40.48 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.586 1.955 . . . . 0.0 108.128 170.262 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mm -97.63 131.59 44.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 113.076 -3.345 . . . . 0.0 109.832 172.959 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -111.89 136.38 51.27 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 124.638 3.381 . . . . 0.0 104.795 152.897 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.0 -99.95 0.1 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.205 1.402 . . . . 0.0 112.228 -169.98 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.84 25.08 3.77 Favored Glycine 0 CA--C 1.523 0.558 1 C-N-CA 131.581 4.42 . . . . 0.0 113.341 159.646 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -93.82 111.35 23.03 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 118.144 -2.974 . . . . 0.0 107.563 175.82 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -76.17 97.17 4.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 127.693 3.121 . . . . 0.0 112.857 175.818 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.81 127.92 33.51 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 126.819 2.575 . . . . 0.0 113.234 -171.384 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -104.77 132.08 51.46 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 131.358 3.863 . . . . 0.0 113.748 -169.915 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.6 123.01 17.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 130.775 3.63 . . . . 0.0 109.116 -179.128 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.72 -6.87 20.12 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 120.359 1.436 . . . . 0.0 111.475 -177.1 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -122.16 173.62 7.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 170.821 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -115.37 175.63 5.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 117.894 -3.004 . . . . 0.0 113.635 -168.886 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.1 mt -75.6 -30.3 59.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 123.258 1.504 . . . . 0.0 111.864 172.401 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -58.98 -36.2 74.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.905 1.336 . . . . 0.0 112.288 170.727 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -69.9 -41.98 74.0 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 119.252 -2.155 . . . . 0.0 108.788 -174.179 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -84.85 10.89 10.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 175.552 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 58.96 35.58 24.16 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 129.058 2.943 . . . . 0.0 111.418 172.051 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.2 mt -88.78 142.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 -173.816 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.304 3.4 pm0 -137.63 -166.22 1.91 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.811 2.045 . . . . 0.0 114.104 -162.677 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -60.81 131.83 51.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 128.861 2.864 . . . . 0.0 110.392 174.255 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.397 0.8 OUTLIER 86.36 17.06 0.11 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 127.614 3.578 . . . . 0.0 115.648 175.926 . . . . . . . . 3 3 . 1 . 106 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.8 p -83.58 127.94 34.13 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 118.216 -2.803 . . . . 0.0 112.099 -178.346 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.1 m -107.1 114.65 28.86 Favored 'General case' 0 N--CA 1.445 -0.716 1 C-N-CA 132.383 4.273 . . . . 0.0 108.697 172.724 . . . . . . . . 2 2 . 1 . 106 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -100.48 130.26 46.54 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.627 1.571 . . . . 0.0 109.016 174.895 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -102.3 127.97 49.05 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 128.852 2.861 . . . . 0.0 107.155 -170.399 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -93.69 150.72 20.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 122.22 2.282 . . . . 0.0 105.889 175.321 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.4 p -141.32 141.61 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 130.088 3.355 . . . . 0.0 107.37 163.894 . . . . . . . . 1 1 . 1 . 106 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.448 -0.559 0 CA-C-N 121.092 1.769 . . . . 0.0 110.615 175.358 . . . . . . . . 0 0 . 1 . 107 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 123.465 1.602 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 107 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -101.32 134.45 44.36 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.922 -1.111 . . . . 0.0 113.823 163.753 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.312 2.1 pp -124.82 146.96 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.774 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -105.73 133.83 49.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 123.797 1.76 . . . . 0.0 108.898 177.004 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.09 133.97 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 174.632 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -108.38 122.24 46.6 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 111.848 -2.433 . . . . 0.0 109.843 178.026 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -80.42 153.25 28.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 123.557 1.646 . . . . 0.0 110.161 179.627 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.36 -25.66 63.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.45 2.3 . . . . 0.0 112.383 -174.738 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.3 p -100.63 19.64 16.59 Favored 'General case' 0 CA--C 1.538 0.494 1 C-N-CA 132.943 4.497 . . . . 0.0 115.692 173.374 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.93 21.61 11.83 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-O 115.136 -3.036 . . . . 0.0 117.535 137.457 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.353 55.2 mttt -103.78 171.11 7.53 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 128.356 2.663 . . . . 0.0 115.966 169.623 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -128.22 103.92 7.45 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 130.366 3.466 . . . . 0.0 108.92 169.931 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.4 mm -81.11 117.51 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 128.629 2.771 . . . . 0.0 112.469 177.469 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.269 22.9 m -93.97 105.52 17.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.102 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -88.78 159.33 17.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 172.183 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -107.35 133.89 51.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 124.422 2.058 . . . . 0.0 107.224 165.253 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 m -139.51 -179.09 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 119.895 -1.753 . . . . 0.0 110.795 178.537 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -140.05 155.11 70.86 Favored Pre-proline 0 N--CA 1.451 -0.407 0 C-N-CA 130.208 3.403 . . . . 0.0 104.195 171.955 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.47 -38.33 53.22 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-O 115.538 -1.942 . . . . 0.0 116.39 -175.851 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -77.75 -9.42 59.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 124.542 1.151 . . . . 0.0 111.494 -170.877 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.67 135.9 52.09 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 125.041 2.353 . . . . 0.0 109.743 179.304 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -78.38 153.94 31.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 129.737 3.215 . . . . 0.0 111.257 -168.22 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.3 -17.59 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.33 -0.856 . . . . 0.0 108.934 -178.54 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -78.04 -44.15 27.26 Favored 'General case' 0 N--CA 1.448 -0.549 1 O-C-N 116.254 -4.029 . . . . 0.0 108.021 -179.506 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -62.86 -50.26 71.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 112.93 -3.414 . . . . 0.0 114.552 166.351 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -52.99 -40.65 37.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 121.828 2.104 . . . . 0.0 111.375 177.032 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -42.04 -35.78 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 115.98 1.845 . . . . 0.0 115.98 166.182 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.73 -28.06 14.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 120.363 1.438 . . . . 0.0 108.69 -177.207 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -60.92 -31.69 71.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 117.887 -3.008 . . . . 0.0 118.29 168.264 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.285 1.5 tt -70.87 -40.76 76.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 167.993 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.26 -36.41 75.45 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 175.54 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -74.19 -10.69 59.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.902 0.774 . . . . 0.0 112.626 -170.928 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -77.7 0.22 Allowed 'General case' 0 C--O 1.235 0.338 1 C-N-CA 132.385 4.274 . . . . 0.0 116.603 159.699 . . . . . . . . 3 3 . 1 . 107 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -98.54 -3.38 36.56 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.265 -0.897 . . . . 0.0 113.259 -162.777 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.01 7.95 86.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 117.906 -2.092 . . . . 0.0 117.36 171.14 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.5 mt -74.71 120.65 82.58 Favored Pre-proline 0 N--CA 1.454 -0.237 1 C-N-CA 132.704 4.402 . . . . 0.0 109.206 178.65 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -74.51 141.0 27.61 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 CA-C-O 115.164 -2.098 . . . . 0.0 112.989 -175.203 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.23 -7.14 20.47 Favored 'Trans proline' 0 N--CA 1.447 -1.264 1 C-N-CA 127.443 5.429 . . . . 0.0 116.531 -178.408 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -74.34 -9.82 58.98 Favored 'General case' 0 N--CA 1.446 -0.644 1 O-C-N 115.13 -4.731 . . . . 0.0 113.424 168.779 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -119.47 -8.49 10.01 Favored 'General case' 0 C--N 1.323 -0.56 1 C-N-CA 134.56 5.144 . . . . 0.0 114.146 -175.468 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 11.4 mt-30 -90.35 152.79 20.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 119.989 -1.694 . . . . 0.0 111.598 168.638 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttp-105 -128.05 122.09 31.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 115.028 -2.415 . . . . 0.0 109.849 156.794 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.84 115.51 20.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.635 1.561 . . . . 0.0 106.949 172.117 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.3 mt -116.26 134.85 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 116.418 -1.754 . . . . 0.0 106.7 167.299 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -88.29 -49.88 6.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.277 1.399 . . . . 0.0 108.299 -175.653 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.51 -44.32 0.1 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.221 -1.371 . . . . 0.0 114.566 -177.213 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.3 -11.21 4.75 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 118.685 2.234 . . . . 0.0 118.685 152.443 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -143.18 160.22 40.85 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.961 1.304 . . . . 0.0 112.686 -161.85 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -78.96 142.87 36.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 125.462 1.726 . . . . 0.0 113.646 -159.366 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 mp -85.83 109.32 18.61 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.174 -3.454 . . . . 0.0 106.652 170.496 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -71.44 128.55 36.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.592 2.757 . . . . 0.0 111.126 -175.438 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -52.68 122.42 9.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 124.836 2.255 . . . . 0.0 112.647 166.328 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.1 19.48 5.92 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 118.683 -2.51 . . . . 0.0 110.815 173.848 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.323 26.8 mtt-85 -127.21 170.89 11.94 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 130.643 3.577 . . . . 0.0 113.992 -179.652 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -118.03 162.9 17.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 130.051 3.341 . . . . 0.0 117.893 174.939 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.69 -41.69 56.12 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 122.659 2.481 . . . . 0.0 113.012 173.974 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 t -60.82 -22.24 63.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 118.502 2.778 . . . . 0.0 118.502 -178.739 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -69.23 -37.93 78.25 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 120.792 -1.192 . . . . 0.0 113.677 168.999 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -98.54 -1.38 41.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.972 2.109 . . . . 0.0 112.564 -175.264 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 74.31 14.19 3.74 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 129.454 3.102 . . . . 0.0 112.149 168.217 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.267 90.1 mt -55.41 125.45 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 124.082 0.953 . . . . 0.0 113.102 178.743 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -131.89 167.49 19.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.794 2.838 . . . . 0.0 112.271 -176.191 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.326 41.3 pttt -34.57 119.03 0.43 Allowed 'General case' 0 N--CA 1.447 -0.605 1 C-N-CA 132.999 4.52 . . . . 0.0 116.114 -178.122 . . . . . . . . 3 2 . 1 . 107 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 63.94 25.44 13.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 179.507 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 m -70.46 121.41 17.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 115.305 -2.283 . . . . 0.0 107.752 160.189 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -95.87 119.37 34.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 125.725 1.891 . . . . 0.0 107.532 174.896 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.21 147.0 26.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 128.683 2.793 . . . . 0.0 105.574 179.858 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -95.49 154.37 17.24 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 101.374 -3.565 . . . . 0.0 101.374 174.557 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.82 114.55 20.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 125.37 2.51 . . . . 0.0 112.875 161.35 . . . . . . . . 2 2 . 1 . 107 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.7 t -79.86 152.47 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 129.905 3.282 . . . . 0.0 111.391 165.724 . . . . . . . . 1 1 . 1 . 107 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 124.022 1.868 . . . . 0.0 106.848 -174.062 . . . . . . . . 0 0 . 1 . 108 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptt? . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 . . . . . . . . . 0 0 . 1 . 108 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -86.5 157.4 19.79 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 124.404 1.065 . . . . 0.0 110.487 166.294 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.24 158.64 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 128.504 2.722 . . . . 0.0 106.531 155.142 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -113.54 138.13 50.59 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.694 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.4 115.75 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 1 C-N-CA 133.857 4.863 . . . . 0.0 107.738 170.08 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -84.56 135.32 34.26 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.563 1.545 . . . . 0.0 108.863 170.997 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -82.55 169.08 16.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 126.93 2.644 . . . . 0.0 108.118 158.615 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.99 -21.25 24.94 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.062 2.145 . . . . 0.0 109.569 178.848 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 p -68.9 -30.92 69.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 116.329 -3.982 . . . . 0.0 114.764 163.285 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.11 5.96 5.5 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 125.723 3.874 . . . . 0.0 113.639 161.653 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -88.85 130.32 35.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 117.79 -3.182 . . . . 0.0 107.391 175.353 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.8 m -89.17 128.52 35.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 124.962 2.315 . . . . 0.0 107.85 160.997 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.71 135.31 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 1 O-C-N 114.751 -4.968 . . . . 0.0 103.004 173.836 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.4 m -99.9 138.1 37.44 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 127.926 3.266 . . . . 0.0 104.023 176.18 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -131.28 142.38 50.11 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.652 1.981 . . . . 0.0 110.432 178.005 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -124.5 110.6 14.68 Favored 'General case' 0 C--N 1.322 -0.622 2 O-C-N 115.748 -4.345 . . . . 0.0 110.35 -170.601 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.44 158.82 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 110.424 -3.08 . . . . 0.0 114.485 -163.022 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -96.39 153.5 38.91 Favored Pre-proline 0 N--CA 1.447 -0.598 0 O-C-N 127.53 3.019 . . . . 0.0 106.946 160.334 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -76.46 -6.66 17.27 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 118.72 2.546 . . . . 0.0 118.72 -170.616 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 m -94.44 7.14 46.57 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.484 1.514 . . . . 0.0 107.624 174.405 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CG ' HD21 ' A' ' 25' ' ' ASN . 16.4 t0 -80.95 137.37 36.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 116.986 -3.571 . . . . 0.0 109.76 171.829 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -92.13 149.41 21.5 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 118.185 -2.822 . . . . 0.0 106.839 -156.351 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mp -46.86 -31.92 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 127.684 2.394 . . . . 0.0 114.569 169.673 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.27 -28.29 66.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.495 -1.378 . . . . 0.0 111.342 179.676 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.455 HD21 ' CG ' ' A' ' 21' ' ' ASP . 63.6 t30 -81.32 -33.82 32.28 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 119.534 -1.979 . . . . 0.0 114.42 170.451 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.301 39.5 t -59.24 -44.98 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 116.592 -1.67 . . . . 0.0 108.518 170.117 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -50.66 -38.74 48.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.176 2.658 . . . . 0.0 118.176 172.793 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.9 -23.89 31.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 123.623 0.577 . . . . 0.0 112.096 -168.507 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 30.9 mttm -73.08 -29.43 62.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 118.96 -2.338 . . . . 0.0 111.698 175.441 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -70.64 -52.69 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 129.512 3.125 . . . . 0.0 105.943 178.301 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.372 1.1 tp-100 -34.23 -45.24 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 1 O-C-N 115.008 -4.807 . . . . 0.0 119.386 162.088 . . . . . . . . 3 2 . 1 . 108 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -73.71 -44.96 54.99 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 131.289 3.836 . . . . 0.0 109.953 -178.584 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -74.02 -47.35 37.56 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 119.833 3.272 . . . . 0.0 119.833 -177.275 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -135.6 11.8 3.45 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 117.906 -1.045 . . . . 0.0 113.701 -177.205 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.71 -8.38 75.74 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 157.485 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.6 mt -58.71 131.74 85.97 Favored Pre-proline 0 N--CA 1.449 -0.497 1 C-N-CA 134.744 5.218 . . . . 0.0 107.404 173.544 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -80.3 150.51 19.91 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.947 1.098 . . . . 0.0 112.392 -178.574 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.18 -30.83 10.14 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 124.211 3.274 . . . . 0.0 116.985 -175.997 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.38 -3.58 31.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -166.549 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -99.99 -31.15 11.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -173.483 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -75.76 118.01 18.11 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.699 1.6 . . . . 0.0 112.631 -159.407 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -102.11 113.43 26.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 130.77 3.628 . . . . 0.0 105.976 158.407 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.82 150.36 24.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 121.615 2.007 . . . . 0.0 106.932 166.929 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.28 15.2 mt -126.63 139.62 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.905 176.187 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -139.82 115.73 10.27 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 128.101 2.56 . . . . 0.0 109.412 177.659 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 74.56 20.86 2.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.961 2.504 . . . . 0.0 108.262 167.587 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.84 -3.17 73.67 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 130.323 3.821 . . . . 0.0 110.413 -175.141 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -96.66 134.2 40.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 121.516 2.658 . . . . 0.0 106.54 -170.411 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.5 pm0 -80.56 132.07 35.61 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 126.356 2.285 . . . . 0.0 108.843 172.312 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.426 HD21 ' CD2' ' A' ' 59' ' ' TYR . 25.6 mt -95.57 155.42 16.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 125.206 2.432 . . . . 0.0 112.209 -172.921 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -118.16 157.01 27.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 112.784 -2.007 . . . . 0.0 109.088 -178.215 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -77.59 137.97 38.87 Favored 'General case' 0 N--CA 1.444 -0.726 1 O-C-N 129.996 4.56 . . . . 0.0 112.589 -172.804 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.67 -21.23 46.97 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 177.905 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 54' ' ' ARG . 8.1 mmp_? -84.78 169.93 13.71 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 127.179 2.191 . . . . 0.0 112.239 168.83 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.406 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 52.7 p -110.55 163.52 13.63 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.179 1.792 . . . . 0.0 110.461 -162.159 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 5.7 mt -43.48 -47.51 7.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.867 1.667 . . . . 0.0 111.937 152.899 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -63.78 -38.95 93.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.532 1.933 . . . . 0.0 113.109 -170.682 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 74.4 m-20 -64.53 -45.15 88.42 Favored 'General case' 0 C--N 1.327 -0.376 1 C-N-CA 133.589 4.756 . . . . 0.0 109.123 -178.992 . . . . . . . . 3 3 . 1 . 108 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.426 ' CD2' HD21 ' A' ' 50' ' ' LEU . 35.5 m-85 -96.26 12.13 32.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 124.157 1.932 . . . . 0.0 109.328 -174.654 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.19 42.62 27.9 Favored 'General case' 0 N--CA 1.444 -0.739 2 C-N-CA 132.492 4.317 . . . . 0.0 114.903 175.858 . . . . . . . . 3 3 . 1 . 108 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 mt -93.71 101.7 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 -172.349 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -94.77 177.93 5.75 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.166 -1.379 . . . . 0.0 113.54 -176.604 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -49.01 142.04 7.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.306 3.042 . . . . 0.0 117.136 -174.77 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 88.3 mt-10 63.76 11.38 5.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 120.17 3.396 . . . . 0.0 120.17 179.005 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -73.52 143.77 46.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.445 -177.586 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.8 m -92.29 139.34 30.71 Favored 'General case' 0 N--CA 1.442 -0.848 1 C-N-CA 132.193 4.197 . . . . 0.0 108.194 178.043 . . . . . . . . 2 2 . 1 . 108 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.68 158.05 42.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 130.236 3.415 . . . . 0.0 111.56 169.215 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -126.01 148.54 49.26 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 128.231 2.612 . . . . 0.0 109.409 163.618 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 0.6 OUTLIER -98.41 130.37 45.04 Favored 'General case' 0 N--CA 1.451 -0.378 1 C-N-CA 132.329 4.252 . . . . 0.0 109.494 167.383 . . . . . . . . 4 3 . 1 . 108 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -103.44 136.37 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.045 164.749 . . . . . . . . 1 1 . 1 . 108 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.446 -0.64 0 C-N-CA 129.682 3.193 . . . . 0.0 110.638 178.506 . . . . . . . . 0 0 . 1 . 109 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 . . . . . . . . . 0 0 . 1 . 109 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.298 8.8 tt0 -88.62 144.15 26.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 125.718 2.675 . . . . 0.0 108.393 -175.092 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.26 149.38 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 111.214 -2.721 . . . . 0.0 108.848 -179.154 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -88.66 144.15 26.47 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 127.843 2.457 . . . . 0.0 113.965 168.102 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.09 99.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 118.187 -2.821 . . . . 0.0 104.147 -174.154 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -77.05 99.62 5.39 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 167.789 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.4 p -72.04 173.15 8.83 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 126.553 2.408 . . . . 0.0 114.47 166.447 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -40.19 -40.68 1.16 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 129.494 3.118 . . . . 0.0 118.815 -168.352 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.1 p -80.83 -6.43 58.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 171.864 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.71 0.6 60.54 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 123.85 1.806 . . . . 0.0 113.764 -170.369 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -69.22 106.58 2.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.919 -1.641 . . . . 0.0 108.014 -173.848 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.7 m -79.39 112.38 16.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 110.19 -3.187 . . . . 0.0 111.844 -178.304 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mt -110.75 137.27 43.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 1 CA-C-N 106.954 -4.657 . . . . 0.0 109.485 173.214 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.8 m -100.41 125.09 46.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 179.912 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tp -133.73 159.94 39.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 128.665 2.786 . . . . 0.0 110.408 -172.845 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -128.46 155.72 44.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 175.247 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.22 151.3 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 O-C-N 126.336 2.273 . . . . 0.0 107.599 -175.02 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -100.13 136.78 20.02 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 100.953 -3.721 . . . . 0.0 100.953 173.189 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -34.36 -42.01 0.27 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 1 C-N-CA 128.003 5.802 . . . . 0.0 119.326 174.228 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 p -79.3 -13.24 59.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 114.257 -2.782 . . . . 0.0 116.036 179.562 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -47.94 125.52 9.08 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.796 2.038 . . . . 0.0 112.354 -179.468 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -69.39 151.7 45.82 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.911 2.485 . . . . 0.0 111.917 163.067 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.6 mm -63.31 -32.72 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 124.029 3.104 . . . . 0.0 119.151 -174.445 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -54.9 -33.05 61.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.057 2.143 . . . . 0.0 113.339 158.104 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -79.56 -15.67 57.27 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.662 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -82.72 -48.92 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 118.941 -2.349 . . . . 0.0 109.364 169.159 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -60.29 -27.93 67.69 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.275 0.984 . . . . 0.0 113.575 176.309 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.37 -23.43 43.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 118.786 -2.446 . . . . 0.0 116.963 176.699 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -78.24 -47.4 18.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.151 175.725 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.263 26.2 mt -51.02 -40.45 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 O-C-N 128.45 3.594 . . . . 0.0 109.977 169.367 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.62 -62.43 1.86 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.623 1.969 . . . . 0.0 114.024 179.441 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -43.38 -23.7 0.07 Allowed 'General case' 0 N--CA 1.45 -0.436 1 C-N-CA 136.039 5.735 . . . . 0.0 116.699 -178.385 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -96.78 -12.23 23.93 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 131.526 3.931 . . . . 0.0 117.513 179.194 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -160.16 -16.83 0.06 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 122.948 2.613 . . . . 0.0 110.346 -179.082 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.66 11.87 22.19 Favored Glycine 0 CA--C 1.524 0.644 1 C-N-CA 113.679 -4.105 . . . . 0.0 111.401 162.477 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.59 127.61 28.16 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 121.35 2.575 . . . . 0.0 108.457 -170.352 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -68.13 147.3 72.81 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 CA-C-O 114.644 -2.315 . . . . 0.0 111.792 -172.154 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.252 71.3 Cg_exo -44.67 -38.4 12.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 O-C-N 126.711 2.953 . . . . 0.0 117.409 167.887 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.98 -24.79 55.96 Favored 'General case' 0 C--N 1.325 -0.469 1 C-N-CA 131.896 4.078 . . . . 0.0 113.433 179.439 . . . . . . . . 3 3 . 1 . 109 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -110.29 -28.38 8.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 125.709 1.881 . . . . 0.0 110.136 -178.258 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -60.49 104.58 0.35 Allowed 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 119.942 -1.724 . . . . 0.0 111.557 177.668 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -110.56 128.57 55.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 130.205 3.402 . . . . 0.0 102.689 179.885 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 99.29 3.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -157.929 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.8 mm -99.2 128.04 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 -166.153 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.412 ' CE2' HG12 ' A' ' 61' ' ' ILE . 61.7 t80 -146.5 109.66 4.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 -177.928 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 79.99 35.21 0.15 Allowed 'General case' 0 CA--C 1.53 0.178 0 O-C-N 125.496 1.748 . . . . 0.0 109.779 178.355 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.67 -10.51 70.68 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 114.784 -3.579 . . . . 0.0 109.572 169.46 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.259 19.6 pttt -143.89 145.36 32.24 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.723 -2.633 . . . . 0.0 106.208 -161.796 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -72.2 135.25 46.05 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.701 2.4 . . . . 0.0 107.632 -175.977 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.76 107.65 19.07 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.842 1.657 . . . . 0.0 110.464 -179.445 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -114.75 161.57 17.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.412 -2.055 . . . . 0.0 105.862 -159.751 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.0 149.94 30.58 Favored 'General case' 0 N--CA 1.447 -0.61 1 C-N-CA 133.458 4.703 . . . . 0.0 107.423 -178.216 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.86 -21.71 31.39 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 169.584 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -101.49 157.58 16.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.715 2.806 . . . . 0.0 108.577 -172.513 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.0 p -113.83 174.94 5.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.991 0.9 . . . . 0.0 109.43 163.662 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.0 mt -53.27 -38.01 62.66 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 176.753 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -60.82 -22.98 64.73 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 167.915 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -86.71 -0.23 55.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 118.446 -2.659 . . . . 0.0 113.94 -178.557 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -138.0 -6.54 1.64 Allowed 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 117.867 -3.021 . . . . 0.0 110.976 172.735 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 67.12 71.37 0.37 Allowed 'General case' 0 N--CA 1.442 -0.855 1 C-N-CA 133.467 4.707 . . . . 0.0 110.3 -177.987 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.412 HG12 ' CE2' ' A' ' 45' ' ' PHE . 70.4 mt -120.18 135.54 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 -177.95 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.264 11.9 pt20 -152.27 -166.61 2.53 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 126.005 2.066 . . . . 0.0 109.936 173.15 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -50.53 142.13 11.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.787 1.635 . . . . 0.0 114.034 -174.373 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 11.4 tp10 89.15 -8.35 0.43 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.543 1.537 . . . . 0.0 114.004 164.404 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -62.84 151.55 38.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 118.24 2.682 . . . . 0.0 118.24 170.128 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -106.8 118.01 35.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 171.802 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.5 mt -89.5 143.93 26.43 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 128.53 2.732 . . . . 0.0 105.592 167.596 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.37 25.6 p80 -133.78 135.76 44.08 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 116.261 -1.828 . . . . 0.0 109.274 -174.457 . . . . . . . . 2 2 . 1 . 109 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.5 154.51 40.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 124.566 1.166 . . . . 0.0 112.561 -164.727 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.48 -179.8 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 131.422 3.889 . . . . 0.0 110.358 169.013 . . . . . . . . 1 1 . 1 . 109 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.311 4.4 mp . . . . . 0 C--O 1.239 0.516 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.288 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 115.283 -2.294 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 110 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -81.46 142.22 33.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 123.538 1.637 . . . . 0.0 107.079 167.401 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pt -127.91 152.63 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 116.268 -1.825 . . . . 0.0 107.466 161.675 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -94.11 142.71 27.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 115.627 -2.429 . . . . 0.0 111.897 172.648 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.29 53.1 t -114.68 83.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 1 C-N-CA 132.829 4.452 . . . . 0.0 108.204 169.2 . . . . . . . . 3 2 . 1 . 110 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -64.03 130.83 45.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 110.071 -3.24 . . . . 0.0 109.812 172.255 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -132.65 154.26 50.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.783 0.833 . . . . 0.0 110.306 -176.868 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.469 HD11 ' H ' ' A' ' 8' ' ' LEU . 5.8 mp -42.2 -27.2 0.13 Allowed 'General case' 0 N--CA 1.444 -0.74 1 C-N-CA 133.295 4.638 . . . . 0.0 121.031 -170.271 . . . . . . . . 3 3 . 1 . 110 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 39.1 p -119.17 17.01 13.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.229 -161.147 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.33 24.56 23.9 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 130.312 3.815 . . . . 0.0 112.217 171.127 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -105.4 160.2 15.32 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.932 1.366 . . . . 0.0 107.604 173.62 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -127.89 113.86 16.44 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.515 2.326 . . . . 0.0 113.493 174.681 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -90.67 133.86 31.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 116.466 -3.896 . . . . 0.0 103.843 -179.137 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 t -141.72 83.09 1.84 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 127.508 3.528 . . . . 0.0 112.698 -170.534 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.57 150.38 20.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.011 -2.359 . . . . 0.0 111.488 179.216 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -94.93 118.55 31.99 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 101.88 -3.378 . . . . 0.0 101.88 179.015 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -135.18 152.21 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 123.713 0.805 . . . . 0.0 109.085 -176.146 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -106.51 160.0 27.82 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 173.343 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.328 40.9 Cg_endo -66.92 -24.38 46.1 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.388 2.726 . . . . 0.0 115.269 -168.186 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.1 p -84.57 -4.97 59.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 120.608 3.558 . . . . 0.0 120.608 -174.483 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -69.77 132.25 45.79 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 126.414 2.321 . . . . 0.0 109.624 176.727 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -69.82 147.92 49.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 126.857 3.218 . . . . 0.0 105.996 171.727 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mm -59.58 -34.42 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 110.059 -3.246 . . . . 0.0 114.208 179.8 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.65 -30.66 65.99 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 121.897 2.135 . . . . 0.0 111.16 178.605 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -74.81 -26.54 59.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 125.469 1.731 . . . . 0.0 113.736 174.026 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.5 t -78.42 -24.83 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 121.251 1.841 . . . . 0.0 108.399 173.149 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -67.6 -39.8 84.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 123.562 2.892 . . . . 0.0 112.146 164.896 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.64 -31.7 70.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.71 2.004 . . . . 0.0 110.907 179.244 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -71.04 -10.72 60.24 Favored 'General case' 0 N--CA 1.451 -0.42 1 C-N-CA 134.574 5.149 . . . . 0.0 114.183 176.026 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.1 -27.61 4.36 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 127.563 2.345 . . . . 0.0 108.664 176.375 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -54.74 -27.09 38.43 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 123.064 2.666 . . . . 0.0 115.072 174.287 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -33.82 65.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 123.94 1.829 . . . . 0.0 108.474 179.078 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mmtm -96.49 -51.63 4.27 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.547 2.739 . . . . 0.0 107.085 -164.268 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -113.79 -12.17 12.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -173.45 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.42 -16.45 58.97 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 120.562 1.528 . . . . 0.0 111.584 173.11 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.2 mt -87.51 123.21 69.94 Favored Pre-proline 0 N--CA 1.449 -0.521 0 O-C-N 117.328 -3.454 . . . . 0.0 109.191 -159.209 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.03 154.78 38.0 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 O-C-N 116.349 -2.501 . . . . 0.0 108.057 179.206 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -44.73 -34.21 8.0 Favored 'Trans proline' 0 N--CA 1.441 -1.598 1 C-N-CA 126.738 4.959 . . . . 0.0 119.364 177.174 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.11 -38.26 76.13 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.62 2.768 . . . . 0.0 115.223 178.743 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.8 -8.77 57.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 103.914 -2.625 . . . . 0.0 103.914 -172.967 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -100.75 163.7 12.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 123.28 2.764 . . . . 0.0 112.356 178.324 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -144.7 160.45 41.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 109.989 -3.278 . . . . 0.0 108.547 158.338 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 mt -118.48 126.42 52.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.521 2.328 . . . . 0.0 111.623 169.748 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.4 mm -100.76 139.64 21.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 130.788 3.635 . . . . 0.0 106.952 168.296 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.558 ' CE2' HG12 ' A' ' 61' ' ' ILE . 12.2 t80 -122.89 -146.12 0.36 Allowed 'General case' 0 C--N 1.332 -0.196 0 O-C-N 126.705 2.503 . . . . 0.0 110.466 173.654 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.11 54.18 1.58 Allowed 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.32 -1.488 . . . . 0.0 110.227 -171.543 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.64 -19.04 19.45 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 117.498 -1.723 . . . . 0.0 110.987 178.451 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -112.8 138.76 49.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 126.559 3.076 . . . . 0.0 107.063 -168.831 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -88.75 123.35 33.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.04 -1.891 . . . . 0.0 108.26 165.281 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 mt -82.22 141.09 33.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 120.9 -1.125 . . . . 0.0 113.201 -174.532 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -98.25 147.62 24.44 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.774 -0.578 . . . . 0.0 110.756 -176.488 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.04 123.52 29.55 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 125.153 1.533 . . . . 0.0 106.909 -177.71 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.1 -29.65 4.08 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 128.178 2.799 . . . . 0.0 114.194 -179.692 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -84.43 154.73 22.61 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 128.408 3.064 . . . . 0.0 106.395 172.484 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -78.6 169.82 17.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 112.226 -2.261 . . . . 0.0 110.918 175.888 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.8 -17.28 63.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 119.793 -1.817 . . . . 0.0 111.467 168.684 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.5 t -92.23 -13.93 29.73 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 118.377 -2.702 . . . . 0.0 111.472 -169.653 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -50.19 -46.04 54.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 130.988 3.715 . . . . 0.0 106.217 168.413 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -101.21 16.47 25.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 123.383 1.563 . . . . 0.0 111.016 -172.159 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.342 10.9 p-10 52.21 40.84 29.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 129.338 3.055 . . . . 0.0 114.183 177.943 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.558 HG12 ' CE2' ' A' ' 45' ' ' PHE . 19.0 mt -76.72 128.64 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 125.599 2.619 . . . . 0.0 106.786 -177.619 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.07 167.64 9.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 109.073 -3.694 . . . . 0.0 111.013 -177.064 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.283 36.0 pttt -40.62 129.68 2.49 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 118.719 2.859 . . . . 0.0 118.719 162.965 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 58.65 3.03 0.26 Allowed 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 126.782 2.551 . . . . 0.0 117.71 173.189 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 t -63.16 152.9 36.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.029 1.732 . . . . 0.0 114.009 174.723 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -102.14 120.41 40.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -160.995 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.83 152.68 22.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.509 2.724 . . . . 0.0 106.502 164.477 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -123.93 137.4 54.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 126.029 2.081 . . . . 0.0 109.638 -175.472 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -118.71 132.77 56.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 119.732 -1.855 . . . . 0.0 108.006 -159.838 . . . . . . . . 1 1 . 1 . 110 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 m -137.64 165.2 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 1 CA-C-N 126.181 4.082 . . . . 0.0 107.384 -170.438 . . . . . . . . 2 2 . 1 . 110 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 124.027 1.87 . . . . 0.0 109.619 -179.818 . . . . . . . . 0 0 . 1 . 111 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 . . . . . . . . . 0 0 . 1 . 111 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -77.09 143.9 38.91 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 122.725 2.512 . . . . 0.0 112.973 -179.975 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.263 46.7 pt -140.13 168.49 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 125.756 1.91 . . . . 0.0 106.997 173.045 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.94 133.52 31.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 118.326 -2.734 . . . . 0.0 110.569 159.429 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.4 t -93.04 105.58 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 101.194 -3.632 . . . . 0.0 101.194 174.117 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -97.65 104.11 16.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 118.631 -2.543 . . . . 0.0 110.198 171.542 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -86.47 146.58 26.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 126.464 3.03 . . . . 0.0 113.74 -162.876 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.64 -28.74 65.04 Favored 'General case' 0 N--CA 1.446 -0.64 1 O-C-N 113.3 -5.875 . . . . 0.0 109.443 179.145 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.358 30.2 p -62.52 -7.46 4.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 119.667 3.21 . . . . 0.0 119.667 162.282 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.96 -5.63 11.25 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-O 114.685 -3.286 . . . . 0.0 118.4 150.489 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -120.66 160.59 22.97 Favored 'General case' 0 N--CA 1.446 -0.661 1 CA-C-N 125.422 4.611 . . . . 0.0 111.259 -177.568 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -100.39 136.9 39.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 125.441 1.713 . . . . 0.0 109.591 177.174 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mt -113.59 119.09 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.278 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -75.85 126.73 31.56 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 130.652 3.581 . . . . 0.0 106.099 169.948 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.26 160.85 39.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 124.177 1.942 . . . . 0.0 105.904 -173.481 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -125.87 131.47 52.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.076 2.151 . . . . 0.0 109.244 -178.184 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 m -137.27 169.83 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 O-C-N 127.382 2.926 . . . . 0.0 110.715 178.238 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.283 0.7 OUTLIER -112.08 146.72 35.41 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 168.382 . . . . . . . . 3 3 . 1 . 111 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -47.99 -33.39 20.29 Favored 'Trans proline' 0 N--CA 1.447 -1.233 1 C-N-CA 129.3 6.667 . . . . 0.0 115.37 158.632 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.9 p -74.47 -6.81 50.45 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 119.516 3.154 . . . . 0.0 119.516 174.279 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -73.02 130.53 40.53 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 129.204 3.002 . . . . 0.0 104.378 179.714 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -77.28 155.85 31.79 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 111.962 -2.381 . . . . 0.0 112.852 163.376 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.367 35.5 mm -49.88 -38.1 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -178.359 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.29 -29.85 62.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.216 2.606 . . . . 0.0 113.632 177.934 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -75.94 -34.62 59.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 114.562 -2.637 . . . . 0.0 108.342 172.565 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.11 -42.69 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 120.673 1.579 . . . . 0.0 111.029 175.058 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -63.59 -27.09 69.01 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 118.441 -2.662 . . . . 0.0 111.755 179.484 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.32 . . -80.21 -22.09 42.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 116.312 -1.804 . . . . 0.0 111.727 179.962 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -80.08 -23.09 41.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 113.99 -2.909 . . . . 0.0 104.903 173.617 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -74.6 -37.4 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 166.717 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.356 51.1 tt0 -63.66 -32.29 73.73 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -178.412 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -70.65 -32.31 69.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.391 -2.186 . . . . 0.0 112.187 -177.626 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -98.7 -49.76 4.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 -169.738 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -105.43 -17.6 14.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 120.721 -1.237 . . . . 0.0 107.839 -165.148 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.52 4.73 57.1 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 120.769 -1.207 . . . . 0.0 114.178 171.208 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.1 mm -91.4 124.41 61.21 Favored Pre-proline 0 C--O 1.236 0.384 0 O-C-N 119.51 -2.171 . . . . 0.0 110.83 -169.904 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -66.5 141.69 62.18 Favored 'Trans proline' 0 N--CA 1.446 -1.274 1 C-N-CA 128.618 6.212 . . . . 0.0 107.077 -175.202 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.42 -35.48 39.26 Favored 'Trans proline' 0 N--CA 1.445 -1.379 1 C-N-CA 129.286 6.657 . . . . 0.0 108.884 -174.089 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -41.55 -46.83 3.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 166.032 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -79.28 -34.38 42.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 125.891 1.994 . . . . 0.0 113.893 -178.678 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -69.79 145.24 52.31 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 -179.027 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.09 150.82 39.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.022 -1.942 . . . . 0.0 110.008 165.814 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.0 tp -117.75 123.51 46.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 124.351 3.25 . . . . 0.0 103.916 -177.977 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mm -125.25 129.34 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 -168.462 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.294 64.8 t80 -151.14 109.78 3.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 116.153 -1.88 . . . . 0.0 115.608 172.112 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.529 . . 90.52 42.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 124.772 2.225 . . . . 0.0 113.033 171.903 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.88 -0.09 89.11 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 117.097 -3.502 . . . . 0.0 119.261 179.458 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -142.58 150.13 39.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 110.598 -2.801 . . . . 0.0 113.135 -165.127 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 0.0 OUTLIER -73.94 126.77 31.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 115.267 -2.301 . . . . 0.0 110.958 170.136 . . . . . . . . 3 3 . 1 . 111 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -78.04 126.48 30.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.462 2.705 . . . . 0.0 104.874 167.246 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -103.35 156.95 17.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 110.793 -2.912 . . . . 0.0 111.495 -170.706 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.39 161.24 20.19 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.407 2.283 . . . . 0.0 113.671 -178.286 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.14 -33.29 6.57 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 130.184 3.754 . . . . 0.0 112.359 173.038 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.279 88.6 mtt180 -98.59 153.4 18.69 Favored 'General case' 0 N--CA 1.451 -0.418 1 C-N-CA 135.343 5.457 . . . . 0.0 106.318 -164.037 . . . . . . . . 3 2 . 1 . 111 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.1 p -100.24 163.59 12.33 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 125.739 1.9 . . . . 0.0 108.094 175.763 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mt -49.46 -31.18 9.38 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.029 2.532 . . . . 0.0 117.632 157.25 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.7 p -71.56 -33.64 69.28 Favored 'General case' 0 N--CA 1.449 -0.494 1 O-C-N 114.955 -4.841 . . . . 0.0 107.694 175.186 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -76.46 -32.94 58.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 123.821 3.01 . . . . 0.0 107.042 -176.235 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -79.32 -19.76 49.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 115.156 -2.354 . . . . 0.0 109.147 170.178 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 72.6 43.13 0.48 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.287 2.635 . . . . 0.0 107.464 176.043 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -80.91 143.62 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 117.63 -3.169 . . . . 0.0 111.021 175.797 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -133.74 159.71 39.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 129.117 2.967 . . . . 0.0 115.66 -178.196 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.16 139.25 1.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 120.124 3.379 . . . . 0.0 120.124 -175.647 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 32.5 mt-10 69.76 28.11 4.46 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 129.574 3.15 . . . . 0.0 115.731 174.164 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.26 70.9 m -81.66 154.08 26.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 111.92 -2.4 . . . . 0.0 106.382 170.047 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.7 p -98.86 131.91 44.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 126.222 2.915 . . . . 0.0 103.32 166.915 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.03 150.52 38.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 129.654 3.181 . . . . 0.0 102.813 175.979 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.32 140.47 52.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 121.586 1.994 . . . . 0.0 113.412 -166.87 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 5.9 mt -91.19 139.87 30.33 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 118.76 -2.462 . . . . 0.0 112.422 165.937 . . . . . . . . 2 2 . 1 . 111 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.25 145.04 33.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 129.291 3.036 . . . . 0.0 106.635 163.229 . . . . . . . . 1 1 . 1 . 111 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.452 -0.361 1 C-N-CA 132.559 4.343 . . . . 0.0 108.916 -167.522 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 125.78 2.705 . . . . 0.0 114.836 . . . . . . . . . 0 0 . 1 . 112 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.266 12.4 mt-30 -85.49 152.79 22.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 119.549 -1.969 . . . . 0.0 110.925 167.769 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.252 18.2 pt -134.24 167.42 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 101.007 -3.701 . . . . 0.0 101.007 162.979 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -131.8 93.4 3.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.429 1.492 . . . . 0.0 108.94 -167.678 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t -90.75 110.47 22.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 101.605 -3.48 . . . . 0.0 101.605 -172.057 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -109.34 137.63 46.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.45 2.3 . . . . 0.0 112.841 177.669 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -86.14 152.45 22.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 103.228 -2.879 . . . . 0.0 103.228 179.291 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -55.06 -19.05 6.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.517 2.727 . . . . 0.0 113.357 174.514 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -94.88 2.22 55.4 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 115.548 -2.168 . . . . 0.0 115.625 170.337 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.84 -12.37 57.74 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 120.769 1.622 . . . . 0.0 114.202 163.861 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -81.45 134.44 35.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -176.234 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -125.99 122.81 36.97 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 119.803 -1.81 . . . . 0.0 108.192 -159.283 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mt -95.39 122.6 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 120.229 -1.544 . . . . 0.0 110.04 169.014 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.6 m -96.55 112.68 24.33 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 125.04 2.352 . . . . 0.0 105.613 -178.242 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.52 116.42 31.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.982 1.713 . . . . 0.0 109.242 -170.244 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -77.02 127.92 33.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 127.302 2.877 . . . . 0.0 110.129 160.785 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.262 34.5 m -138.86 157.73 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 1 C-N-CA 133.454 4.702 . . . . 0.0 115.419 -178.393 . . . . . . . . 3 2 . 1 . 112 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.285 27.1 mm-40 -112.56 158.13 38.28 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 102.844 -3.021 . . . . 0.0 102.844 156.551 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -60.6 -23.08 74.73 Favored 'Trans proline' 0 N--CA 1.447 -1.225 1 C-N-CA 126.873 5.049 . . . . 0.0 116.845 -175.919 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -83.05 -2.58 55.69 Favored 'General case' 0 N--CA 1.44 -0.944 1 C-N-CA 132.062 4.145 . . . . 0.0 113.484 -175.146 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.67 136.2 38.18 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 -174.156 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.4 p -88.89 172.64 9.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.466 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.3 mm -70.63 -34.42 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 117.5 -1.238 . . . . 0.0 108.204 -178.616 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -42.52 -46.42 4.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.838 3.255 . . . . 0.0 113.652 170.911 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -70.95 -40.31 72.07 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.984 2.113 . . . . 0.0 116.207 173.833 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -82.36 -21.54 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 O-C-N 117.974 -2.954 . . . . 0.0 108.667 -176.016 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -69.39 -42.22 75.43 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 118.749 -2.469 . . . . 0.0 115.769 170.283 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -35.21 58.22 Favored 'General case' 0 CA--C 1.535 0.403 1 O-C-N 132.228 5.955 . . . . 0.0 113.1 -179.009 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -60.28 -52.44 65.27 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 125.721 1.888 . . . . 0.0 110.403 165.594 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.344 35.9 mt -59.29 -46.13 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 114.993 -2.432 . . . . 0.0 112.917 175.969 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.377 0.0 OUTLIER -40.07 -63.05 0.65 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 126.296 2.951 . . . . 0.0 115.243 166.3 . . . . . . . . 3 3 . 1 . 112 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.296 37.0 t70 -46.86 -47.46 21.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 110.396 -3.093 . . . . 0.0 118.584 173.314 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -84.56 -39.42 18.79 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.546 1.938 . . . . 0.0 111.29 -165.574 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.63 -14.21 6.33 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 128.301 3.501 . . . . 0.0 115.735 -166.187 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.96 22.05 40.16 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.971 2.7 . . . . 0.0 112.373 176.19 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -97.35 130.53 29.3 Favored Pre-proline 0 N--CA 1.442 -0.852 0 CA-C-N 120.488 2.144 . . . . 0.0 109.83 -178.286 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -76.36 165.12 29.83 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.738 2.292 . . . . 0.0 110.23 -173.845 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.52 -47.24 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 N-CA-C 116.41 1.658 . . . . 0.0 116.41 -174.86 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -61.28 -5.07 1.41 Allowed 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 117.946 2.573 . . . . 0.0 117.946 -175.58 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -99.62 -16.68 18.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.886 1.274 . . . . 0.0 110.245 -169.919 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -88.84 132.07 34.81 Favored 'General case' 0 N--CA 1.44 -0.934 1 C-N-CA 133.171 4.588 . . . . 0.0 110.034 -166.151 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -135.93 147.75 48.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 118.003 -2.936 . . . . 0.0 105.87 163.045 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.1 mt -104.88 128.1 52.97 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 130.668 3.587 . . . . 0.0 110.958 169.768 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 mt -124.78 130.11 73.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 128.151 2.58 . . . . 0.0 107.552 165.423 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -142.46 113.46 7.56 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 119.084 -2.26 . . . . 0.0 105.928 174.331 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.17 36.02 1.16 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 120.431 1.469 . . . . 0.0 110.536 157.872 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.88 -47.18 1.41 Allowed Glycine 0 CA--C 1.523 0.571 0 CA-C-O 126.131 3.073 . . . . 0.0 116.095 -167.146 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -76.64 126.63 31.32 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 120.159 -1.789 . . . . 0.0 113.097 -166.995 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -71.52 132.83 45.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 124.928 2.299 . . . . 0.0 106.94 154.961 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.291 0.2 OUTLIER -91.92 124.88 36.36 Favored 'General case' 0 C--O 1.237 0.414 1 O-C-N 115.824 -4.297 . . . . 0.0 108.056 172.213 . . . . . . . . 4 3 . 1 . 112 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -78.15 156.19 30.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.397 2.279 . . . . 0.0 115.58 174.582 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.376 26.6 m-20 -71.44 133.49 45.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 124.345 2.021 . . . . 0.0 113.106 167.921 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.3 -11.38 39.92 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 128.544 2.973 . . . . 0.0 114.019 176.398 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -71.52 153.09 42.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 126.202 1.766 . . . . 0.0 112.217 170.78 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -99.74 143.42 29.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.291 1.837 . . . . 0.0 107.332 170.278 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.57 -33.67 76.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 -166.395 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -84.31 -23.33 30.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.008 -1.472 . . . . 0.0 114.485 -173.47 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -54.01 -36.78 63.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 126.077 2.846 . . . . 0.0 112.55 168.695 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -85.59 -6.6 59.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 128.745 2.818 . . . . 0.0 114.769 176.595 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.489 17.2 m120 89.81 15.18 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.613 1 C-N-CA 132.994 4.518 . . . . 0.0 118.116 177.719 . . . . . . . . 3 2 . 1 . 112 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.8 mt -81.96 112.82 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 116.174 -2.21 . . . . 0.0 108.296 -177.298 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -124.1 170.84 10.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 124.733 1.271 . . . . 0.0 108.144 -167.589 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.327 44.4 pttt -43.03 122.02 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.902 2.481 . . . . 0.0 115.668 -169.126 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 66.97 24.72 9.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 178.285 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.275 56.7 m -75.71 125.27 28.73 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 124.017 1.865 . . . . 0.0 110.56 170.258 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 m -84.81 131.59 34.52 Favored 'General case' 0 C--N 1.323 -0.562 1 C-N-CA 132.158 4.183 . . . . 0.0 100.831 173.487 . . . . . . . . 2 2 . 1 . 112 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -142.61 112.41 6.89 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 -164.911 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -46.13 103.52 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 113.746 -3.026 . . . . 0.0 115.407 159.446 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -96.1 102.5 14.3 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 121.531 1.969 . . . . 0.0 112.43 176.392 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.7 t -69.08 109.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 128.578 2.751 . . . . 0.0 108.909 -176.433 . . . . . . . . 1 1 . 1 . 112 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.566 . . . . . . . . 0 0 . 1 . 113 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptm . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 113 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -84.5 134.81 34.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 114.602 -2.618 . . . . 0.0 106.643 179.117 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.314 28.0 pt -125.86 171.53 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 1 O-C-N 129.138 4.024 . . . . 0.0 108.134 173.774 . . . . . . . . 3 2 . 1 . 113 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -132.75 143.1 49.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 163.04 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.44 113.28 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 126.307 1.843 . . . . 0.0 108.878 169.268 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -83.02 134.38 35.05 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -177.437 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.29 36.9 m -87.11 149.89 24.37 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 116.765 -1.588 . . . . 0.0 112.279 168.427 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -19.6 16.49 Favored 'General case' 0 C--N 1.324 -0.527 1 C-N-CA 132.772 4.429 . . . . 0.0 112.469 -174.734 . . . . . . . . 3 3 . 1 . 113 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 p -81.54 -15.78 53.78 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.493 1.917 . . . . 0.0 115.428 166.45 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.25 -9.86 10.96 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 114.289 -3.506 . . . . 0.0 107.302 175.821 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -80.32 122.59 27.1 Favored 'General case' 0 N--CA 1.45 -0.447 1 CA-C-N 124.951 4.375 . . . . 0.0 110.859 -175.044 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -84.7 107.65 17.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 175.96 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.07 126.76 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 120.188 -1.57 . . . . 0.0 110.37 179.093 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.3 p -89.67 133.31 34.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 121.485 1.948 . . . . 0.0 108.09 -179.544 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.5 tp -149.06 136.87 20.54 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.759 2.824 . . . . 0.0 106.444 -165.817 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -116.17 132.8 56.56 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.225 2.21 . . . . 0.0 105.56 -177.824 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -137.44 -177.96 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 129.346 3.058 . . . . 0.0 111.862 -178.745 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -119.24 153.14 53.23 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 124.97 1.308 . . . . 0.0 109.711 163.275 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.297 28.4 Cg_endo -55.52 -34.62 90.33 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 N-CA-C 121.452 3.597 . . . . 0.0 121.452 -179.929 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -75.28 -8.65 57.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 112.588 -2.097 . . . . 0.0 115.716 173.507 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.77 120.42 7.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 120.645 1.566 . . . . 0.0 110.345 174.369 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -61.76 150.26 37.44 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 120.126 -1.609 . . . . 0.0 108.511 161.711 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -59.99 -19.02 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.79 2.036 . . . . 0.0 112.99 179.731 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.14 -23.49 41.09 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.711 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -89.87 -22.11 22.2 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.085 0.954 . . . . 0.0 109.381 178.547 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.78 -40.91 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 O-C-N 126.912 2.632 . . . . 0.0 108.733 166.57 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -69.16 -20.76 64.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 114.048 -2.882 . . . . 0.0 112.77 172.093 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.82 -40.47 47.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 131.541 3.936 . . . . 0.0 111.415 174.611 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -71.34 -28.67 64.24 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.657 3.583 . . . . 0.0 109.708 178.106 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.83 -65.03 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 113.247 -3.264 . . . . 0.0 110.854 157.232 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -46.0 -31.41 2.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 126.563 2.414 . . . . 0.0 115.851 -179.457 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.72 -32.6 43.88 Favored 'General case' 0 C--N 1.329 -0.322 1 C-N-CA 131.79 4.036 . . . . 0.0 111.036 178.23 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -116.27 -39.2 3.43 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -176.823 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -83.56 -31.16 26.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 116.973 -3.579 . . . . 0.0 117.052 -169.953 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.96 -6.5 83.63 Favored Glycine 0 CA--C 1.531 1.094 0 O-C-N 120.944 -1.097 . . . . 0.0 111.126 171.478 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.251 77.1 mt -98.2 129.05 31.64 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-O 115.104 -2.379 . . . . 0.0 105.924 -175.072 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.56 155.69 68.12 Favored 'Trans proline' 0 N--CA 1.449 -1.104 1 C-N-CA 127.153 5.235 . . . . 0.0 117.807 -174.745 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.303 51.3 Cg_exo -42.21 -35.28 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.567 3.511 . . . . 0.0 117.319 170.026 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -43.17 -41.2 3.63 Favored 'General case' 0 CA--C 1.535 0.4 1 O-C-N 114.003 -5.435 . . . . 0.0 117.723 168.555 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -96.55 -6.44 36.96 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 118.244 -2.785 . . . . 0.0 114.363 -170.098 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -102.01 122.93 45.02 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.408 2.683 . . . . 0.0 110.321 175.03 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -120.49 131.42 54.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 173.153 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -118.76 129.07 55.05 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 128.716 2.807 . . . . 0.0 110.364 -175.532 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.36 148.19 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 127.689 2.396 . . . . 0.0 116.144 163.582 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -141.06 114.28 8.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 127.781 3.176 . . . . 0.0 107.509 172.925 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.71 41.37 12.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.789 -1.101 . . . . 0.0 109.626 176.891 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.75 -16.86 34.03 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 117.976 1.95 . . . . 0.0 117.976 177.118 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.365 69.1 mttt -94.5 129.17 41.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.886 1.327 . . . . 0.0 108.301 179.55 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.54 87.49 7.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 131.443 3.897 . . . . 0.0 102.444 178.887 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.5 mt -50.05 136.5 18.84 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 128.346 2.659 . . . . 0.0 115.186 -165.208 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -65.12 114.51 4.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 125.013 1.446 . . . . 0.0 112.89 171.798 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.349 0.0 OUTLIER -66.7 -4.53 9.13 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.972 2.109 . . . . 0.0 116.168 -172.942 . . . . . . . . 3 3 . 1 . 113 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.16 -0.09 16.76 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.221 1.391 . . . . 0.0 111.666 178.434 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -93.23 160.04 15.01 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 159.382 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.8 p -107.28 171.23 7.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 125.166 2.412 . . . . 0.0 108.053 -172.555 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.04 -30.54 62.46 Favored 'General case' 0 C--N 1.326 -0.45 1 O-C-N 114.698 -5.001 . . . . 0.0 109.316 -178.059 . . . . . . . . 3 3 . 1 . 113 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 t -67.06 -33.26 75.12 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 173.561 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -71.93 -23.02 61.4 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.958 2.503 . . . . 0.0 111.515 178.098 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -91.54 -3.79 56.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 170.755 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 t30 58.71 36.57 24.99 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 131.589 3.956 . . . . 0.0 114.77 179.784 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -77.08 125.33 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 O-C-N 124.955 1.409 . . . . 0.0 114.506 -173.889 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -98.51 176.24 5.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 125.082 2.372 . . . . 0.0 107.852 -170.769 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.94 117.05 3.89 Favored 'General case' 0 N--CA 1.441 -0.897 1 C-N-CA 131.708 4.003 . . . . 0.0 110.055 -177.787 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 68.79 44.23 1.15 Allowed 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 127.593 3.058 . . . . 0.0 111.944 163.491 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.1 p -100.27 157.7 16.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 125.708 2.67 . . . . 0.0 111.652 160.695 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -106.73 127.02 53.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 116.43 -3.919 . . . . 0.0 110.33 -166.766 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.36 172.38 8.79 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 129.294 3.037 . . . . 0.0 104.295 164.918 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -133.64 136.72 44.98 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.731 2.012 . . . . 0.0 109.169 -179.199 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -127.09 108.11 10.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 101.452 -3.536 . . . . 0.0 101.452 -163.907 . . . . . . . . 1 1 . 1 . 113 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.34 116.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 1 O-C-N 130.375 4.797 . . . . 0.0 110.656 163.639 . . . . . . . . 2 2 . 1 . 113 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 101.498 -3.519 . . . . 0.0 101.498 177.37 . . . . . . . . 0 0 . 1 . 114 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 123.322 1.534 . . . . 0.0 108.764 . . . . . . . . . 0 0 . 1 . 114 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.256 43.6 mt-30 -113.76 128.72 56.53 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 111.373 -2.649 . . . . 0.0 112.859 -179.046 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.358 17.2 pt -144.7 138.36 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 128.286 3.491 . . . . 0.0 110.084 -175.39 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -106.28 121.23 43.79 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 127.377 2.923 . . . . 0.0 110.781 -163.823 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.65 87.46 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 172.202 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -86.88 149.0 25.12 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 117.338 -3.351 . . . . 0.0 107.268 -172.462 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.277 42.4 m -103.7 140.29 37.8 Favored 'General case' 0 N--CA 1.447 -0.595 1 C-N-CA 133.097 4.559 . . . . 0.0 105.565 175.863 . . . . . . . . 3 2 . 1 . 114 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.309 0.4 OUTLIER -46.29 -24.76 0.52 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 120.006 3.336 . . . . 0.0 120.006 -179.423 . . . . . . . . 3 3 . 1 . 114 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.29 6.9 p -94.82 5.72 51.07 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.836 2.454 . . . . 0.0 108.395 -174.982 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.19 0.18 44.3 Favored Glycine 0 CA--C 1.531 1.049 1 C-N-CA 134.76 5.933 . . . . 0.0 111.172 158.292 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -65.83 138.79 58.14 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 116.488 -3.948 . . . . 0.0 111.275 170.997 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.353 12.0 m -124.31 112.1 16.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.975 2.11 . . . . 0.0 111.553 -170.258 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 mm -100.99 148.87 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 173.313 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.353 7.1 p -129.22 128.88 44.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 111.641 -2.527 . . . . 0.0 111.151 -164.084 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -106.38 125.56 51.15 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.849 1.26 . . . . 0.0 111.114 176.656 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -88.51 93.03 9.41 Favored 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 132.886 4.474 . . . . 0.0 107.235 162.943 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.18 162.18 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 O-C-N 118.364 -2.71 . . . . 0.0 111.06 -176.184 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.265 3.4 tp10 -115.91 135.36 22.72 Favored Pre-proline 0 N--CA 1.447 -0.6 0 N-CA-C 101.286 -3.598 . . . . 0.0 101.286 176.119 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -34.16 -40.55 0.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 1 C-N-CA 128.135 5.89 . . . . 0.0 115.148 -176.918 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -80.06 -1.37 39.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.323 2.249 . . . . 0.0 114.585 -171.505 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -65.25 135.9 55.95 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 130.746 3.618 . . . . 0.0 107.73 174.707 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -65.03 159.69 22.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.029 2.932 . . . . 0.0 112.902 171.771 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mm -74.39 -31.84 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 124.777 1.298 . . . . 0.0 110.392 178.456 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.79 -30.5 71.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 128.496 2.718 . . . . 0.0 112.203 172.965 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -80.9 -24.56 38.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 119.367 -2.083 . . . . 0.0 109.611 173.101 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 1.0 OUTLIER -72.28 -20.11 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 122.5 1.143 . . . . 0.0 111.913 175.978 . . . . . . . . 3 3 . 1 . 114 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -73.4 -43.89 59.57 Favored 'General case' 0 C--N 1.323 -0.553 1 C-N-CA 133.335 4.654 . . . . 0.0 114.031 173.854 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.62 89.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.213 2.205 . . . . 0.0 111.908 174.384 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -69.3 -10.32 57.33 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.354 2.661 . . . . 0.0 116.8 173.434 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.27 58.1 mt -94.24 -40.45 11.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 O-C-N 127.509 3.005 . . . . 0.0 109.809 163.859 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -61.48 -62.93 1.47 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 130.567 3.547 . . . . 0.0 110.333 -174.917 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -41.72 -37.92 1.32 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.109 2.564 . . . . 0.0 116.673 170.307 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -79.16 -70.6 0.49 Allowed 'General case' 0 C--N 1.32 -0.683 0 O-C-N 128.32 3.513 . . . . 0.0 118.88 167.349 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -98.24 -5.5 33.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.432 -161.342 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.11 0.32 74.37 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 126.56 2.029 . . . . 0.0 114.814 166.995 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.1 mt -79.6 133.38 59.43 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-O 113.15 -3.309 . . . . 0.0 106.41 -165.283 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.83 162.65 23.86 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 CA-C-N 126.691 3.425 . . . . 0.0 111.538 -173.586 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.83 -51.46 0.38 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 123.876 3.051 . . . . 0.0 116.573 -166.034 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.95 -11.23 55.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 126.39 2.995 . . . . 0.0 113.914 -163.984 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -96.57 -17.59 20.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 113.689 -3.053 . . . . 0.0 110.165 -172.483 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.25 139.2 30.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 126.161 2.886 . . . . 0.0 107.72 -176.332 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.26 71.2 mtt180 -131.42 142.01 49.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 128.67 2.788 . . . . 0.0 112.985 162.028 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.55 0.6 OUTLIER -133.99 139.95 46.41 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 -164.755 . . . . . . . . 3 3 . 1 . 114 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.297 68.1 mt -132.52 130.14 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.209 1.804 . . . . 0.0 109.707 -160.988 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -159.27 133.88 7.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.077 2.151 . . . . 0.0 112.609 179.037 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.53 34.61 15.88 Favored 'General case' 0 N--CA 1.439 -0.986 1 C-N-CA 133.398 4.679 . . . . 0.0 112.78 -176.916 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.48 -30.05 7.51 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 115.514 -2.826 . . . . 0.0 112.21 174.478 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -120.12 148.04 44.12 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 120.502 2.151 . . . . 0.0 111.002 -159.939 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -71.83 129.28 38.24 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.998 2.119 . . . . 0.0 108.04 171.151 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 59' ' ' TYR . 10.8 mp -75.05 109.69 8.73 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 129.826 3.25 . . . . 0.0 108.853 -176.295 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -73.25 130.06 39.39 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 129.635 3.174 . . . . 0.0 110.217 -172.927 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.293 73.4 m-20 -46.24 129.7 10.3 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 129.394 3.078 . . . . 0.0 112.991 166.811 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.54 20.49 47.82 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 124.963 2.424 . . . . 0.0 111.317 172.733 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.23 177.18 4.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.598 2.359 . . . . 0.0 113.672 170.161 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -118.29 163.83 16.11 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 125.209 2.433 . . . . 0.0 110.503 162.561 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.9 mt -53.93 -37.67 64.09 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 117.128 -3.482 . . . . 0.0 113.899 169.87 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.2 t -58.45 -31.97 68.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 124.725 2.202 . . . . 0.0 114.073 172.173 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -63.46 -30.22 71.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 119.329 -2.107 . . . . 0.0 115.291 177.426 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 10.7 m-85 -96.78 7.57 46.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 130.615 3.566 . . . . 0.0 109.245 178.456 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.8 t30 35.7 47.61 0.4 Allowed 'General case' 0 N--CA 1.448 -0.53 2 O-C-N 113.535 -5.728 . . . . 0.0 114.558 -172.51 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -88.91 110.75 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 128.114 2.566 . . . . 0.0 106.844 178.677 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -111.31 170.01 8.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.853 3.261 . . . . 0.0 112.682 -173.738 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -49.89 131.61 22.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 112.457 -177.475 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.453 5.4 pt-20 65.98 39.09 4.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.048 2.939 . . . . 0.0 118.146 178.511 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.7 p -87.18 140.73 29.25 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.411 1.884 . . . . 0.0 107.292 165.454 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 79.7 m -96.22 130.82 43.2 Favored 'General case' 0 N--CA 1.442 -0.858 2 C-N-CA 133.509 4.723 . . . . 0.0 107.108 164.333 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -123.67 175.49 6.81 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.941 1.696 . . . . 0.0 108.743 -176.7 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -111.38 149.88 30.57 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 118.457 -2.652 . . . . 0.0 112.335 178.21 . . . . . . . . 1 1 . 1 . 114 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -121.85 138.55 54.34 Favored 'General case' 0 N--CA 1.448 -0.529 1 C-N-CA 134.395 5.078 . . . . 0.0 109.907 178.995 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 t -133.41 104.12 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 1 CA-C-O 130.104 4.764 . . . . 0.0 104.937 176.913 . . . . . . . . 2 2 . 1 . 114 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 N--CA 1.451 -0.406 1 O-C-N 113.14 -5.975 . . . . 0.0 105.495 179.286 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.2 ttp . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 113.947 -2.93 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 115 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -88.11 130.28 35.06 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 124.175 1.941 . . . . 0.0 115.491 -179.387 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 pt -115.42 174.86 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 111.421 -2.627 . . . . 0.0 111.222 155.391 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.278 52.0 p90 -147.33 143.4 28.02 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 169.143 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.63 99.04 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 130.398 3.479 . . . . 0.0 105.395 -156.487 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -83.7 133.07 34.82 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.975 2.11 . . . . 0.0 105.513 176.236 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.283 45.1 p -99.77 -171.56 2.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.043 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.77 -6.61 57.62 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 130.602 3.561 . . . . 0.0 115.325 170.373 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -117.11 -163.9 0.95 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 112.214 -2.266 . . . . 0.0 106.984 -179.723 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.03 50.7 0.77 Allowed Glycine 0 CA--C 1.524 0.656 0 O-C-N 124.757 1.285 . . . . 0.0 112.139 -178.087 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.343 66.9 tttt -119.69 139.1 52.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.48 3.912 . . . . 0.0 106.853 167.696 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.6 m -131.71 117.88 19.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 115.563 -2.161 . . . . 0.0 106.896 179.888 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.6 mt -100.46 129.32 51.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 -170.448 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -92.86 146.65 23.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 177.117 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.92 127.03 27.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 -170.801 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -108.18 98.05 7.65 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 126.407 3.003 . . . . 0.0 114.291 175.424 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.3 164.08 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 117.606 -3.184 . . . . 0.0 114.515 -166.411 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.98 137.09 31.62 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 117.085 -1.436 . . . . 0.0 110.028 171.587 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -85.01 -3.92 9.68 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.516 2.811 . . . . 0.0 113.682 -172.822 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.4 p -80.72 -2.11 45.53 Favored 'General case' 0 C--N 1.33 -0.264 1 CA-C-O 108.846 -5.359 . . . . 0.0 112.523 167.435 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.404 ' CG ' HD21 ' A' ' 25' ' ' ASN . 8.9 t0 -89.1 152.81 21.44 Favored 'General case' 0 N--CA 1.447 -0.59 1 O-C-N 130.172 4.67 . . . . 0.0 110.709 177.45 . . . . . . . . 3 3 . 1 . 115 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -83.42 151.35 25.53 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.98 1.712 . . . . 0.0 107.427 -175.718 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.8 mm -53.62 -33.39 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.812 174.639 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -62.41 -52.08 64.98 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 129.387 3.075 . . . . 0.0 108.243 -173.63 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.404 HD21 ' CG ' ' A' ' 21' ' ' ASP . 26.7 t30 -77.57 -23.2 50.06 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 109.441 -3.527 . . . . 0.0 113.572 -174.323 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.34 35.2 t -58.4 -50.34 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 129.952 3.301 . . . . 0.0 110.916 162.452 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -67.15 -38.46 85.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 127.203 2.814 . . . . 0.0 114.182 175.452 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.68 -4.58 16.2 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 117.841 -3.037 . . . . 0.0 117.404 163.329 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -92.82 -42.67 9.42 Favored 'General case' 0 C--N 1.328 -0.351 1 O-C-N 115.691 -4.381 . . . . 0.0 105.093 175.407 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -49.2 -39.48 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 1 C-N-CA 132.228 4.211 . . . . 0.0 114.267 165.6 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.257 46.3 tt0 -46.1 -45.11 16.17 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.309 2.243 . . . . 0.0 116.752 175.288 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.34 -41.25 98.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 112.858 -1.974 . . . . 0.0 111.077 173.585 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -76.4 -54.17 7.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.079 -169.787 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -101.77 -5.33 25.02 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 126.251 2.219 . . . . 0.0 114.657 -172.659 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.21 6.16 89.02 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 121.487 3.355 . . . . 0.0 121.487 165.293 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.266 4.0 tp -100.61 141.62 23.03 Favored Pre-proline 0 N--CA 1.454 -0.273 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -167.085 . . . . . . . . 3 2 . 1 . 115 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.6 161.11 47.21 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.969 2.446 . . . . 0.0 113.909 169.565 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.88 -9.43 10.85 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 N-CA-C 117.795 2.19 . . . . 0.0 117.795 -162.198 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -95.55 8.15 44.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 117.731 -3.105 . . . . 0.0 113.188 -178.175 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -119.89 -4.15 10.17 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 112.384 -2.189 . . . . 0.0 115.614 -175.207 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.302 78.4 mt-30 -99.59 138.0 37.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 128.454 2.702 . . . . 0.0 104.618 175.182 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -129.99 102.95 6.5 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 103.184 -2.895 . . . . 0.0 103.184 174.146 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.7 mt -81.61 128.41 33.9 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 119.899 -1.751 . . . . 0.0 107.47 169.119 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mt -113.46 119.89 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 1 C-N-CA 132.275 4.23 . . . . 0.0 106.963 175.894 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -105.18 128.86 53.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 101.082 -3.673 . . . . 0.0 101.082 153.152 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 73.0 -108.28 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 129.071 2.948 . . . . 0.0 110.495 171.166 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.54 22.69 4.11 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.159 1.361 . . . . 0.0 112.111 164.689 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -98.23 108.37 21.06 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.208 3.003 . . . . 0.0 109.929 166.723 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -80.88 108.7 14.77 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 173.86 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.8 mt -67.29 146.3 54.27 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.05 -159.914 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -101.39 134.5 44.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.691 1.596 . . . . 0.0 108.539 -168.299 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.33 -37.69 72.93 Favored 'General case' 0 N--CA 1.442 -0.852 1 C-N-CA 132.58 4.352 . . . . 0.0 115.25 -155.489 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.01 -13.72 24.53 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 119.018 -2.301 . . . . 0.0 112.051 -169.38 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -69.7 152.8 44.25 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 118.998 -2.472 . . . . 0.0 107.948 166.832 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.4 p -78.5 179.3 7.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 127.362 2.265 . . . . 0.0 111.902 171.319 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.7 mt -84.51 -26.6 27.99 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 120.165 -1.584 . . . . 0.0 109.273 166.273 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.8 p -69.84 -22.64 63.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 130.203 3.401 . . . . 0.0 110.427 173.923 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -75.88 -29.6 58.56 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 121.783 2.083 . . . . 0.0 111.116 168.954 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -90.85 -2.63 57.74 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.249 1.42 . . . . 0.0 107.912 178.549 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 5.0 t-20 59.53 38.39 22.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.99 2.916 . . . . 0.0 116.087 -179.705 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.6 mm -76.63 105.48 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 126.848 2.059 . . . . 0.0 108.624 -176.643 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -84.67 166.77 16.79 Favored 'General case' 0 C--O 1.238 0.481 1 C-N-CA 133.517 4.727 . . . . 0.0 109.811 178.478 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttt -61.6 135.68 57.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 115.684 -2.103 . . . . 0.0 110.245 -173.346 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 68.79 26.76 5.94 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 131.445 3.898 . . . . 0.0 115.087 177.577 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 m -79.54 115.5 19.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 102.242 -3.244 . . . . 0.0 102.242 -177.966 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -73.36 137.62 44.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 129.23 3.012 . . . . 0.0 107.904 173.49 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.83 176.97 8.23 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 167.234 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -122.65 122.63 39.27 Favored 'General case' 0 N--CA 1.45 -0.474 1 O-C-N 116.165 -4.085 . . . . 0.0 106.301 -173.634 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.471 ' CD2' HD21 ' A' ' 71' ' ' LEU . 55.0 tp -97.91 133.06 42.9 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 124.154 1.93 . . . . 0.0 107.019 171.747 . . . . . . . . 2 2 . 1 . 115 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.34 128.77 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 163.944 . . . . . . . . 1 1 . 1 . 115 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.471 HD21 ' CD2' ' A' ' 69' ' ' LEU . 2.5 pt? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 121.675 2.034 . . . . 0.0 109.167 165.701 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 . . . . . . . . . 0 0 . 1 . 116 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.84 151.67 19.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 124.076 0.86 . . . . 0.0 110.403 -177.207 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.303 49.2 pt -141.61 155.62 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 1 C-N-CA 131.802 4.041 . . . . 0.0 110.996 162.278 . . . . . . . . 3 2 . 1 . 116 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -110.93 156.42 21.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 127.664 3.102 . . . . 0.0 110.902 179.058 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.328 82.0 t -136.67 128.13 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 100.763 -3.792 . . . . 0.0 100.763 174.246 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -82.41 125.58 31.22 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 118.404 -2.685 . . . . 0.0 105.63 161.496 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -80.68 167.87 19.52 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.158 1.456 . . . . 0.0 110.213 168.321 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.96 -29.96 69.95 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 117.855 -3.028 . . . . 0.0 113.278 -178.696 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 p -77.54 -25.07 49.85 Favored 'General case' 0 N--CA 1.447 -0.597 1 C-N-CA 132.877 4.471 . . . . 0.0 115.559 171.076 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.46 -2.09 9.54 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 126.799 2.562 . . . . 0.0 110.633 154.301 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -78.37 137.1 37.85 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.503 2.721 . . . . 0.0 105.795 -179.485 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -92.96 123.1 35.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.112 2.165 . . . . 0.0 107.085 -174.422 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.7 mm -111.27 129.61 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 127.863 2.465 . . . . 0.0 105.963 -174.376 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -95.58 120.57 36.06 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.676 2.79 . . . . 0.0 110.564 172.039 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -112.28 131.76 55.33 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.169 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -96.33 116.03 28.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 129.0 3.938 . . . . 0.0 110.008 160.598 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.38 160.7 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 131.511 3.925 . . . . 0.0 109.247 -165.378 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -71.23 152.75 94.43 Favored Pre-proline 0 N--CA 1.446 -0.668 0 O-C-N 117.408 -3.307 . . . . 0.0 108.163 163.197 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -71.11 -18.68 30.59 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 121.703 1.602 . . . . 0.0 112.339 173.793 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.377 63.6 p -125.54 36.44 4.55 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 127.031 2.132 . . . . 0.0 113.748 176.547 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.92 157.6 37.13 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.346 1.458 . . . . 0.0 108.845 173.486 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.259 40.8 p -99.49 168.06 10.21 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 126.782 2.551 . . . . 0.0 109.993 172.941 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.257 33.5 mm -76.88 -15.09 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 119.546 -1.971 . . . . 0.0 110.55 -178.541 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.4 -60.6 2.6 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 127.382 2.273 . . . . 0.0 112.738 174.112 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.95 -31.18 72.3 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 179.501 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.293 78.9 t -53.64 -41.69 47.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 115.373 -2.251 . . . . 0.0 113.415 163.445 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -55.02 -42.55 72.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 123.244 2.747 . . . . 0.0 109.963 176.811 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.75 -37.75 76.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 123.687 1.708 . . . . 0.0 111.635 -177.918 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -71.15 -31.12 67.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.483 -2.011 . . . . 0.0 108.498 176.562 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.303 86.3 mt -74.81 -32.86 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 1 O-C-N 115.756 -4.34 . . . . 0.0 110.842 177.605 . . . . . . . . 3 2 . 1 . 116 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -64.28 -53.2 52.64 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 130.738 3.615 . . . . 0.0 107.638 171.413 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -55.23 -51.7 65.74 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 118.783 2.882 . . . . 0.0 118.783 174.534 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -66.24 -43.48 86.46 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 115.083 -2.389 . . . . 0.0 111.482 177.679 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.342 69.3 mm-40 -128.98 -15.96 4.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 114.563 -2.637 . . . . 0.0 116.338 -166.819 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.58 -22.49 7.35 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 125.628 1.83 . . . . 0.0 111.348 156.192 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mt -73.39 124.79 90.83 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 126.375 1.87 . . . . 0.0 108.728 -162.186 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -70.04 157.51 59.61 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.25 1.967 . . . . 0.0 109.621 173.247 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.17 -29.03 22.54 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 124.805 3.67 . . . . 0.0 111.279 -168.355 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.267 5.4 t70 -40.11 -55.59 2.07 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 126.28 2.943 . . . . 0.0 117.743 158.141 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -81.66 -6.71 59.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 111.774 -2.466 . . . . 0.0 111.66 -175.392 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -89.06 166.76 13.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 124.184 3.174 . . . . 0.0 113.871 174.972 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.367 6.7 ptt180 -154.66 128.87 8.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 128.112 2.565 . . . . 0.0 108.213 164.594 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 mt -102.57 91.93 4.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 129.656 3.182 . . . . 0.0 110.022 174.781 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.1 mm -96.09 120.86 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 127.156 2.785 . . . . 0.0 105.168 -175.836 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -130.91 116.12 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 130.245 3.418 . . . . 0.0 109.217 -176.116 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.75 42.16 11.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 128.503 2.721 . . . . 0.0 112.516 -176.343 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.01 -2.78 55.43 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.058 1.313 . . . . 0.0 114.515 166.417 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -132.98 158.29 43.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.815 0.846 . . . . 0.0 110.769 -179.476 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.16 130.28 35.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 126.747 3.165 . . . . 0.0 114.761 173.811 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.53 128.29 35.98 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 116.865 -3.647 . . . . 0.0 109.886 163.1 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -117.38 -179.07 3.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 119.512 -1.992 . . . . 0.0 114.08 -171.031 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.28 129.6 35.85 Favored 'General case' 0 N--CA 1.449 -0.52 1 C-N-CA 133.725 4.81 . . . . 0.0 113.026 165.255 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.81 -28.41 7.38 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 118.269 -2.769 . . . . 0.0 110.518 151.18 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.256 75.1 mtt85 -97.77 124.45 42.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.905 2.082 . . . . 0.0 106.709 171.359 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.3 p -62.56 174.3 1.03 Allowed 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 125.254 1.597 . . . . 0.0 114.624 170.23 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -42.07 -53.34 3.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 176.579 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 t -64.69 -29.77 70.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.138 1.375 . . . . 0.0 111.165 -173.632 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -91.21 2.03 56.66 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 119.274 -2.141 . . . . 0.0 110.297 -176.159 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -101.9 20.36 16.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 123.057 2.662 . . . . 0.0 109.419 156.29 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.361 19.4 p30 59.19 22.32 10.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -176.727 . . . . . . . . 2 2 . 1 . 116 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.8 mt -75.7 123.56 31.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 O-C-N 118.18 -2.825 . . . . 0.0 111.292 178.233 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -106.82 -176.01 2.96 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -173.559 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -67.76 125.15 25.33 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.778 1.631 . . . . 0.0 108.203 177.996 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 69.79 20.94 6.63 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 126.208 2.192 . . . . 0.0 114.025 178.016 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.7 m -73.16 140.04 46.76 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 131.163 3.785 . . . . 0.0 114.108 177.173 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.8 m -105.13 143.87 32.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.035 -1.666 . . . . 0.0 111.376 -172.521 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.3 mt -121.84 157.8 30.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.124 1.37 . . . . 0.0 113.834 172.016 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -109.71 155.03 22.06 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 177.441 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -128.53 124.64 36.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 110.426 -3.079 . . . . 0.0 107.35 -179.619 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.25 148.24 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 128.268 2.627 . . . . 0.0 107.055 162.727 . . . . . . . . 1 1 . 1 . 116 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 O-C-N 127.284 2.865 . . . . 0.0 110.552 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 ttp . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 113.645 -3.074 . . . . 0.0 108.144 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -72.09 134.17 45.64 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 102.607 -3.108 . . . . 0.0 102.607 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -132.79 157.62 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 130.605 3.562 . . . . 0.0 105.749 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -120.96 151.02 40.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 129.129 2.972 . . . . 0.0 107.771 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.17 135.34 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 167.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -103.62 120.3 40.62 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 126.648 2.468 . . . . 0.0 110.612 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -97.33 137.23 36.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.414 38.0 mt -27.04 -43.12 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.568 1 C-N-CA 132.996 4.518 . . . . 0.0 111.611 172.044 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.351 80.9 p -83.03 -16.32 47.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.086 -1.634 . . . . 0.0 110.438 -168.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.22 -4.48 23.65 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.477 -1.179 . . . . 0.0 112.116 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -80.61 132.62 35.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 129.449 3.1 . . . . 0.0 113.224 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -105.14 128.31 53.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 102.103 -3.295 . . . . 0.0 102.103 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.4 mt -129.44 135.3 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 -174.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.456 1.8 t -127.18 147.03 50.2 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -143.23 129.93 20.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 118.167 -2.833 . . . . 0.0 107.21 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -75.53 123.74 25.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 165.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -137.24 173.81 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 125.996 2.808 . . . . 0.0 104.847 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.49 154.37 39.14 Favored Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 102.149 -3.278 . . . . 0.0 102.149 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.06 -29.36 22.57 Favored 'Trans proline' 0 N--CA 1.447 -1.23 1 C-N-CA 130.228 7.285 . . . . 0.0 114.352 170.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.3 m -71.89 -16.6 62.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 122.456 2.389 . . . . 0.0 115.693 173.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -65.37 132.92 50.22 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 122.644 2.474 . . . . 0.0 107.817 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.295 70.6 p -43.75 149.23 0.31 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 156.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -66.42 -39.69 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 O-C-N 121.439 -0.788 . . . . 0.0 108.953 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.324 63.4 tt0 -54.92 -37.93 67.02 Favored 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 134.272 5.029 . . . . 0.0 115.229 177.42 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -53.69 -49.29 68.36 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 161.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.35 -13.94 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 126.755 2.022 . . . . 0.0 112.578 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -78.16 -32.45 50.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.749 2.82 . . . . 0.0 108.362 168.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.94 -29.21 22.24 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 117.361 -3.337 . . . . 0.0 110.242 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -63.6 -32.2 73.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 114.612 -2.613 . . . . 0.0 108.33 168.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.361 17.6 mt -65.97 -28.72 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 124.825 3.466 . . . . 0.0 112.315 166.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -73.94 -38.74 64.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 122.054 2.206 . . . . 0.0 106.89 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -52.91 -48.82 66.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 131.203 3.801 . . . . 0.0 113.463 165.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -88.99 -37.15 15.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 126.765 2.54 . . . . 0.0 116.156 -170.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -136.76 -14.71 1.62 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.699 1.714 . . . . 0.0 110.646 -162.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.06 8.34 34.08 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 155.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.258 13.7 mt -101.59 133.08 21.04 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-N 123.367 3.583 . . . . 0.0 107.924 -162.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.21 150.92 37.95 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 CA-C-N 123.027 2.117 . . . . 0.0 114.223 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -46.85 -40.16 24.86 Favored 'Trans proline' 0 N--CA 1.443 -1.499 1 C-N-CA 126.861 5.041 . . . . 0.0 119.73 166.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.3 -44.42 88.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 128.504 3.627 . . . . 0.0 116.27 -170.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.301 74.0 mm-40 -100.37 -1.41 36.12 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 113.457 -1.701 . . . . 0.0 112.103 -173.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -95.65 125.76 40.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 126.571 2.419 . . . . 0.0 113.081 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.348 31.4 ttm105 -124.26 132.84 53.61 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 128.509 2.724 . . . . 0.0 108.579 172.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.81 151.21 29.31 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 117.498 -1.239 . . . . 0.0 108.89 -172.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.409 34.8 mt -129.95 131.53 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.912 1.685 . . . . 0.0 106.988 -167.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -142.31 118.42 10.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 130.67 3.588 . . . . 0.0 110.666 169.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.58 27.12 11.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.101 2.16 . . . . 0.0 110.228 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.53 -20.45 44.36 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.108 -1.62 . . . . 0.0 113.101 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.362 45.2 mtmt -94.71 143.41 26.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -165.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -71.35 137.4 48.41 Favored 'General case' 0 C--O 1.223 -0.294 0 O-C-N 121.644 -0.66 . . . . 0.0 110.992 159.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.2 mt -104.62 140.44 38.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -128.98 157.26 42.18 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 -147.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.256 5.9 p-10 -59.2 140.19 56.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.124 172.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.13 -47.1 1.05 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 105.673 -2.971 . . . . 0.0 105.673 162.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.86 175.92 5.46 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.225 -1.488 . . . . 0.0 111.053 -165.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 p -122.52 161.41 23.68 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.163 2.585 . . . . 0.0 113.496 -164.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mt -55.02 -35.45 64.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.5 t -57.75 -46.23 84.78 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 128.79 2.836 . . . . 0.0 109.825 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -59.91 -37.4 79.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 119.892 -1.755 . . . . 0.0 114.294 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -90.11 15.13 10.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 115.091 -2.385 . . . . 0.0 115.008 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 m120 71.52 10.87 6.54 Favored 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 132.89 4.476 . . . . 0.0 110.246 161.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.0 mt -52.61 134.54 14.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 1 C-N-CA 133.864 4.866 . . . . 0.0 110.179 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -145.06 -177.55 5.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 130.822 3.649 . . . . 0.0 111.331 -159.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.378 72.6 tttt -51.81 104.83 0.09 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 129.999 3.32 . . . . 0.0 114.278 170.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 70.92 21.49 5.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 118.143 -2.848 . . . . 0.0 113.565 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 m -58.16 119.79 7.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 121.915 2.143 . . . . 0.0 107.059 173.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.5 m -92.89 122.5 35.33 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 129.407 3.083 . . . . 0.0 107.769 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -113.82 170.99 7.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 125.279 1.612 . . . . 0.0 109.103 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.22 144.33 44.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.154 2.182 . . . . 0.0 111.128 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.06 103.2 7.32 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -160.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 m -87.54 128.6 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 124.875 2.274 . . . . 0.0 109.86 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.307 31.8 tp -93.43 114.0 26.29 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.304 37.6 ttt85 80.42 -52.65 0.35 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 129.162 2.985 . . . . 0.0 115.408 162.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.44 138.46 47.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.714 2.806 . . . . 0.0 105.375 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.282 40.5 ttt-85 -110.6 134.31 52.53 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 102.297 -3.223 . . . . 0.0 102.297 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.0 -122.56 6.2 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 116.566 -2.731 . . . . 0.0 107.36 -164.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 115.531 -2.816 . . . . 0.0 112.164 -175.574 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -98.64 133.56 42.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 121.051 1.751 . . . . 0.0 109.029 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.284 1.1 pt -129.6 168.09 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.27 161.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -132.24 146.45 52.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.89 94.92 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 1 N-CA-C 98.661 -4.57 . . . . 0.0 98.661 -161.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -77.53 137.9 38.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 124.857 2.265 . . . . 0.0 110.891 170.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.5 p -94.61 168.52 10.8 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 124.375 2.035 . . . . 0.0 106.667 178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.18 -16.53 62.53 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 118.431 -2.668 . . . . 0.0 111.137 163.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.0 p -91.23 -7.15 52.11 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 115.724 -2.084 . . . . 0.0 113.344 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.99 -17.71 17.12 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.408 1.48 . . . . 0.0 115.953 161.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -76.93 145.63 38.07 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.413 2.285 . . . . 0.0 107.674 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.2 p -105.82 121.86 44.91 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.51 2.724 . . . . 0.0 108.982 172.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.273 35.6 mm -89.26 146.82 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 173.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 22.1 m -109.52 137.64 47.06 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 119.826 -1.796 . . . . 0.0 109.86 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.87 100.13 6.74 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -160.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.5 106.35 17.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.944 3.697 . . . . 0.0 109.195 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -158.88 161.07 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 120.777 1.626 . . . . 0.0 112.26 -160.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -97.42 152.95 38.51 Favored Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 118.466 -2.646 . . . . 0.0 110.143 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.309 2.7 Cg_exo -51.77 -30.42 37.75 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 N-CA-C 119.355 2.791 . . . . 0.0 119.355 167.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 p -88.16 2.39 52.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.997 2.119 . . . . 0.0 112.019 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -81.39 140.93 34.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 120.021 1.282 . . . . 0.0 109.361 166.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -80.41 159.58 25.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.994 2.518 . . . . 0.0 109.604 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.293 8.7 mt -72.08 -14.23 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 126.219 1.808 . . . . 0.0 115.011 170.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -87.06 -18.48 30.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 170.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.279 13.3 t30 -66.56 -45.58 78.86 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 111.591 -2.549 . . . . 0.0 106.466 165.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.1 t -56.8 -40.76 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 1 C-N-CA 132.205 4.202 . . . . 0.0 108.805 170.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.579 ' HZ1' ' CG ' ' A' ' 52' ' ' ASP . 90.6 mttt -73.46 -38.76 65.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 116.42 -2.112 . . . . 0.0 110.185 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -31.57 72.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -57.43 -44.72 84.91 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 125.003 1.44 . . . . 0.0 112.933 163.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.416 21.7 mt -55.88 -45.27 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 127.914 2.486 . . . . 0.0 114.703 -176.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -48.83 -67.11 0.3 Allowed 'General case' 0 C--N 1.33 -0.24 1 O-C-N 129.493 4.245 . . . . 0.0 113.815 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -50.3 -32.04 15.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -87.02 -58.27 2.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.173 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.284 18.2 tp10 -112.45 -8.66 13.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 121.105 3.743 . . . . 0.0 121.105 -166.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.56 1.2 55.44 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 117.146 -1.919 . . . . 0.0 111.749 162.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.6 mt -98.42 110.45 56.61 Favored Pre-proline 0 N--CA 1.452 -0.359 0 C-N-CA 125.284 1.434 . . . . 0.0 110.073 -171.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -56.77 142.97 91.84 Favored 'Trans proline' 0 C--N 1.323 -0.776 1 CA-C-O 110.438 -4.068 . . . . 0.0 118.062 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.277 28.7 Cg_exo -45.1 -31.23 5.54 Favored 'Trans proline' 0 N--CA 1.452 -0.915 1 O-C-N 129.638 4.494 . . . . 0.0 119.543 -178.737 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.68 -35.2 72.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.289 79.7 mt-30 -90.07 13.37 15.11 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.652 -1.613 . . . . 0.0 113.363 -177.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -106.13 156.9 17.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 172.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -138.68 116.52 11.54 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 127.271 2.228 . . . . 0.0 112.093 149.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.93 107.23 19.61 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 131.19 3.796 . . . . 0.0 105.946 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 pt -110.52 158.18 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 129.235 3.014 . . . . 0.0 109.5 169.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -115.62 -0.57 12.97 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 130.263 3.425 . . . . 0.0 108.9 161.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.552 . . -142.43 -110.68 0.13 Allowed 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 119.135 -2.228 . . . . 0.0 114.617 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.06 -19.8 2.88 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 122.473 2.397 . . . . 0.0 110.629 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -117.54 154.8 30.88 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 127.552 2.56 . . . . 0.0 112.361 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.05 165.25 11.4 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 124.122 0.889 . . . . 0.0 108.855 -172.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.314 38.6 mt -96.25 128.08 42.84 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 110.954 -2.839 . . . . 0.0 106.744 164.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -69.18 125.14 25.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 116.306 -1.807 . . . . 0.0 115.551 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.579 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS 0.278 0.0 OUTLIER -46.27 -28.66 1.35 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 128.824 3.828 . . . . 0.0 117.789 -170.538 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.11 10.87 60.27 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 125.57 1.794 . . . . 0.0 116.548 -168.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -111.33 179.83 3.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.949 1.699 . . . . 0.0 107.504 168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -120.45 172.09 8.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 104.583 -2.376 . . . . 0.0 104.583 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.392 6.9 mp -40.21 -51.55 2.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 130.919 3.688 . . . . 0.0 110.309 157.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 p -63.02 -37.92 89.12 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.843 2.057 . . . . 0.0 114.868 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.43 -46.42 66.81 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.835 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -79.15 -5.3 53.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 125.952 2.787 . . . . 0.0 114.699 -175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.65 44.43 17.46 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 117.977 -2.952 . . . . 0.0 115.937 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.7 mm -91.2 98.06 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -77.87 166.49 22.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.304 2.642 . . . . 0.0 109.556 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.36 129.79 1.76 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 167.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 70.79 38.83 1.15 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.455 2.302 . . . . 0.0 113.367 167.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.4 m -92.03 130.42 37.77 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 130.639 3.575 . . . . 0.0 108.449 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.3 m -88.36 111.95 22.32 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 127.435 2.959 . . . . 0.0 109.189 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.9 mt -94.85 136.43 35.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.927 1.291 . . . . 0.0 108.678 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -95.2 125.44 39.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.298 -1.501 . . . . 0.0 110.551 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.0 tp -101.01 108.96 20.8 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.179 1.792 . . . . 0.0 108.123 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.6 147.76 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 123.343 1.544 . . . . 0.0 109.502 153.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 pp -138.18 141.05 40.06 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.943 2.497 . . . . 0.0 111.355 -171.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.8 mtm105 -91.34 12.45 20.4 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 174.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.264 2.0 pp -122.74 37.27 4.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 128.044 3.34 . . . . 0.0 111.77 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -63.76 -43.43 96.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.255 3.422 . . . . 0.0 113.887 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.02 23.53 7.69 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 130.244 3.783 . . . . 0.0 114.117 -166.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 115.624 -2.765 . . . . 0.0 106.935 167.797 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 53.8 ttp . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 117.459 -1.258 . . . . 0.0 107.756 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -77.42 134.52 38.39 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 126.244 2.215 . . . . 0.0 114.494 168.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -137.43 161.6 34.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.5 3.52 . . . . 0.0 102.337 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -112.54 144.25 42.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 111.015 -2.811 . . . . 0.0 114.764 168.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -132.77 112.78 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 O-C-N 125.738 1.899 . . . . 0.0 108.053 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -72.57 125.19 26.84 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 114.106 -2.854 . . . . 0.0 106.434 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -90.12 162.98 15.04 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 114.948 -2.453 . . . . 0.0 114.686 155.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pp -77.54 -12.37 59.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 125.283 1.614 . . . . 0.0 110.092 171.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -79.31 -10.4 59.8 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 129.937 3.295 . . . . 0.0 112.188 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.34 10.06 37.14 Favored Glycine 0 CA--C 1.539 1.554 0 O-C-N 117.991 -2.943 . . . . 0.0 114.275 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -104.51 140.97 37.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -115.16 100.83 8.44 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.934 2.894 . . . . 0.0 103.339 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.3 mt -81.16 123.66 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.8 m -104.84 123.74 48.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 121.401 1.91 . . . . 0.0 107.525 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.4 mt -126.23 130.41 50.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.117 2.567 . . . . 0.0 111.811 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.26 116.45 12.71 Favored 'General case' 0 C--N 1.327 -0.377 1 O-C-N 130.072 4.607 . . . . 0.0 109.137 154.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.0 172.72 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 113.29 -3.243 . . . . 0.0 114.793 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -97.11 144.65 28.25 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 124.37 3.259 . . . . 0.0 105.214 159.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -52.77 -28.38 38.01 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 CA-C-N 127.301 3.643 . . . . 0.0 115.475 163.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.9 p -81.46 4.32 21.48 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 127.493 2.996 . . . . 0.0 116.191 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -70.75 156.75 39.12 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.564 1.146 . . . . 0.0 108.268 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -111.42 166.56 11.02 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.352 1.861 . . . . 0.0 110.499 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.465 ' H ' HG12 ' A' ' 23' ' ' ILE . 4.0 mm -52.79 -42.64 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 127.722 2.409 . . . . 0.0 111.651 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -49.49 -34.98 18.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 115.358 -2.258 . . . . 0.0 116.322 171.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -85.0 -15.31 44.62 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 126.809 2.568 . . . . 0.0 109.089 -167.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -81.44 -52.52 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 126.307 2.956 . . . . 0.0 103.59 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -62.66 -33.17 74.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 131.058 3.743 . . . . 0.0 110.949 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.8 66.6 Favored 'General case' 0 N--CA 1.443 -0.786 1 O-C-N 114.529 -5.107 . . . . 0.0 109.377 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -67.11 -29.04 68.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 113.922 -2.942 . . . . 0.0 110.505 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.259 42.0 mt -72.44 -42.06 64.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 123.751 2.978 . . . . 0.0 104.722 176.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -53.95 -40.18 66.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 118.602 -2.561 . . . . 0.0 116.294 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.261 2.3 t70 -67.88 -19.89 65.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 116.232 -1.842 . . . . 0.0 112.171 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -94.22 -61.81 1.45 Allowed 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 124.61 1.194 . . . . 0.0 111.351 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -91.92 -28.51 17.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.443 2.697 . . . . 0.0 113.431 -166.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.22 -24.58 24.31 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 121.046 -1.034 . . . . 0.0 112.5 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 mt -60.32 118.18 31.14 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 111.737 -2.232 . . . . 0.0 107.097 -169.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.263 98.0 Cg_endo -67.74 158.04 59.05 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 CA-C-N 122.446 1.909 . . . . 0.0 116.563 175.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.312 14.9 Cg_exo -57.27 -33.11 95.49 Favored 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 128.635 6.223 . . . . 0.0 112.954 -179.282 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -86.53 -9.89 55.2 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 122.561 2.437 . . . . 0.0 111.581 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -94.77 -23.3 17.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.517 1.136 . . . . 0.0 113.724 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.46 122.15 21.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 113.722 -3.037 . . . . 0.0 108.751 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -100.4 119.47 38.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 121.428 1.922 . . . . 0.0 107.888 164.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 tp -121.18 104.06 9.47 Favored 'General case' 0 N--CA 1.445 -0.719 1 C-N-CA 132.458 4.303 . . . . 0.0 109.912 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.297 47.8 mm -96.6 151.18 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 128.359 3.537 . . . . 0.0 112.067 174.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -150.47 108.74 3.76 Favored 'General case' 0 CA--C 1.535 0.382 1 C-N-CA 132.038 4.135 . . . . 0.0 111.669 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.27 29.5 3.63 Favored 'General case' 0 C--N 1.325 -0.47 1 C-N-CA 132.269 4.228 . . . . 0.0 117.168 157.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.24 -10.11 20.18 Favored Glycine 0 CA--C 1.527 0.833 1 C-N-CA 133.765 5.459 . . . . 0.0 107.607 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -123.44 162.99 21.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 121.752 2.776 . . . . 0.0 105.908 -168.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -79.71 149.6 31.13 Favored 'General case' 0 N--CA 1.449 -0.488 1 C-N-CA 132.986 4.514 . . . . 0.0 108.588 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.0 mt -112.86 104.87 12.87 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.599 1.56 . . . . 0.0 108.479 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -94.35 149.82 20.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 102.181 -3.266 . . . . 0.0 102.181 -171.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -76.49 152.42 36.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 127.01 2.124 . . . . 0.0 114.195 -165.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.33 -23.04 33.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 119.457 2.543 . . . . 0.0 119.457 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -70.57 162.48 28.8 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 p -100.79 165.06 11.56 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.117 -1.615 . . . . 0.0 107.146 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.7 mt -60.9 -47.37 86.69 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 113.053 -1.885 . . . . 0.0 115.709 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.4 p -43.06 -45.23 5.17 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 129.081 2.952 . . . . 0.0 114.854 162.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.81 -52.5 59.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 131.416 3.886 . . . . 0.0 110.448 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -74.12 -14.3 60.95 Favored 'General case' 0 N--CA 1.449 -0.494 1 C-N-CA 132.465 4.306 . . . . 0.0 111.802 172.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.48 19.5 t30 87.37 20.74 0.06 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 165.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.9 mt -78.44 144.07 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -168.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -142.64 172.54 12.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.285 1.834 . . . . 0.0 108.996 -155.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -62.54 119.76 9.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 125.591 1.807 . . . . 0.0 109.85 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.506 15.2 mt-10 85.29 15.26 0.16 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -176.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -71.68 141.17 49.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.704 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.3 m -108.56 117.57 34.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.13 142.15 32.0 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.376 2.271 . . . . 0.0 109.304 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -108.69 125.48 51.94 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 125.275 2.464 . . . . 0.0 111.936 169.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.1 tp -96.16 132.96 41.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 110.341 -3.118 . . . . 0.0 109.307 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.12 158.14 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 131.001 3.72 . . . . 0.0 108.138 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.303 83.3 mt -101.34 143.86 30.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.935 162.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -84.79 134.76 34.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 129.121 2.969 . . . . 0.0 107.605 150.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.6 mt -114.67 133.86 55.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.365 18.0 ptt180 -137.23 -9.12 1.74 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -165.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.35 -40.77 1.75 Allowed Glycine 0 CA--C 1.528 0.859 0 O-C-N 128.34 3.525 . . . . 0.0 114.474 -165.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.748 0 C-N-CA 126.049 1.785 . . . . 0.0 109.19 -169.112 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 117.348 -1.31 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -89.14 140.86 29.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.424 1.489 . . . . 0.0 113.348 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.8 pt -134.45 161.02 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 127.35 2.26 . . . . 0.0 107.742 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.476 ' CE1' HG21 ' A' ' 14' ' ' THR . 57.3 m-85 -123.46 112.37 17.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 119.783 -1.823 . . . . 0.0 109.809 -169.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.75 128.8 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 100.201 -4.0 . . . . 0.0 100.201 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -90.29 136.1 33.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 110.949 -2.841 . . . . 0.0 107.004 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.255 26.8 p -114.86 132.3 56.56 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 124.465 1.103 . . . . 0.0 109.77 167.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.4 mt -72.86 -3.98 28.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 116.995 -3.566 . . . . 0.0 113.958 -151.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.5 p -76.65 -5.91 49.87 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 121.874 2.125 . . . . 0.0 115.935 159.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.6 -6.12 7.05 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 118.426 -2.671 . . . . 0.0 110.805 160.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -85.37 127.36 34.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 104.138 -2.541 . . . . 0.0 104.138 -165.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -96.2 101.4 13.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 126.629 2.456 . . . . 0.0 111.448 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.41 114.41 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 125.84 2.733 . . . . 0.0 105.305 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.476 HG21 ' CE1' ' A' ' 4' ' ' PHE . 11.2 m -99.29 113.61 26.0 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 mt -105.95 154.21 20.9 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.932 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -93.55 137.34 32.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.591 1.663 . . . . 0.0 106.677 165.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.309 11.8 m -145.05 175.78 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 128.466 2.706 . . . . 0.0 111.968 -174.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -139.3 152.99 70.58 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 128.823 2.849 . . . . 0.0 109.613 164.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.37 -30.3 92.37 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.493 2.795 . . . . 0.0 117.055 -173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 p -91.77 20.66 5.39 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 121.72 2.055 . . . . 0.0 110.752 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -100.82 140.75 34.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 119.728 -1.858 . . . . 0.0 109.046 -169.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.2 p -70.24 157.91 36.81 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 127.951 3.282 . . . . 0.0 110.937 -168.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.286 26.9 mt -61.67 -27.97 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 116.487 -1.72 . . . . 0.0 111.654 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.252 9.4 tp10 -62.06 -47.59 84.04 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 123.248 2.749 . . . . 0.0 106.052 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -68.71 -38.09 79.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 123.011 2.641 . . . . 0.0 111.645 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -55.62 -58.34 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 127.332 2.253 . . . . 0.0 114.389 166.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -53.38 -35.44 60.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 128.423 2.689 . . . . 0.0 110.096 172.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.24 -32.34 70.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 125.157 2.408 . . . . 0.0 112.028 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.64 -7.18 58.98 Favored 'General case' 0 N--CA 1.451 -0.388 1 O-C-N 115.614 -4.428 . . . . 0.0 107.987 -170.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.2 mt -87.5 -33.41 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 119.649 1.113 . . . . 0.0 108.264 170.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -64.47 -39.1 93.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.23 -51.1 65.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.66 1.584 . . . . 0.0 114.536 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -83.22 -52.45 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -95.17 -15.63 23.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 119.834 3.272 . . . . 0.0 119.834 -171.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.33 4.46 62.61 Favored Glycine 0 CA--C 1.531 1.046 1 O-C-N 130.132 4.645 . . . . 0.0 116.035 170.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 41.3 mt -86.98 123.16 70.73 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 121.485 2.642 . . . . 0.0 105.653 -155.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -62.65 133.43 42.3 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 CA-C-O 115.982 -1.758 . . . . 0.0 111.401 169.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.4 35.1 Cg_exo -41.55 -24.42 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 1 C-N-CA 128.664 6.243 . . . . 0.0 121.318 175.806 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -52.53 -50.43 62.86 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.971 1.708 . . . . 0.0 114.974 165.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -83.93 -18.25 37.97 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.162 2.985 . . . . 0.0 110.368 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -76.83 99.36 5.14 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.939 1.696 . . . . 0.0 110.526 169.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -102.47 107.81 18.91 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 119.693 -1.88 . . . . 0.0 107.988 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.2 mt -73.77 60.43 0.71 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 129.921 3.288 . . . . 0.0 110.184 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mm -87.79 107.68 17.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 115.646 -2.121 . . . . 0.0 108.732 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.379 23.3 t80 -133.3 118.85 19.02 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 129.467 3.107 . . . . 0.0 111.187 -168.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.86 43.88 26.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 129.163 2.985 . . . . 0.0 116.274 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.23 -28.9 9.6 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.034 2.254 . . . . 0.0 114.865 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.301 54.6 mttt -92.21 164.77 13.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -171.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -81.32 117.84 22.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 151.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.24 143.62 26.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.345 8.5 mt-10 -96.31 164.92 12.45 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 125.789 3.904 . . . . 0.0 111.635 -163.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -72.54 145.4 47.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 129.404 3.082 . . . . 0.0 110.325 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.75 6.5 12.79 Favored Glycine 0 CA--C 1.523 0.536 0 O-C-N 118.183 -2.823 . . . . 0.0 115.473 158.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -122.67 170.12 10.36 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.319 1.848 . . . . 0.0 110.226 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.4 p -99.7 165.3 11.67 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 130.959 3.703 . . . . 0.0 109.875 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.325 37.6 mt -41.21 -45.9 2.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.657 2.783 . . . . 0.0 113.623 170.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.4 m -84.45 -21.8 30.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 122.545 2.429 . . . . 0.0 112.281 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.263 20.0 m-20 -68.4 -18.59 64.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 115.981 -1.961 . . . . 0.0 113.457 173.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -108.33 11.7 26.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 126.564 2.415 . . . . 0.0 113.012 164.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 10.7 p30 64.47 28.04 13.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 167.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mt -78.6 131.29 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 121.025 -1.047 . . . . 0.0 110.647 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -106.88 163.83 12.63 Favored 'General case' 0 N--CA 1.444 -0.742 1 C-N-CA 132.078 4.151 . . . . 0.0 108.586 -177.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -53.67 144.32 18.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 111.209 -2.723 . . . . 0.0 113.237 171.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.433 44.9 mt-10 57.81 10.82 1.19 Allowed 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 118.393 -2.692 . . . . 0.0 117.432 -172.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 m -73.03 147.65 44.89 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.7 m -105.69 139.57 40.07 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 129.405 3.082 . . . . 0.0 107.969 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.84 179.97 8.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 114.657 -2.592 . . . . 0.0 111.365 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -125.41 131.13 52.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 127.29 2.869 . . . . 0.0 111.981 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 tp -102.43 147.08 27.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.379 1.872 . . . . 0.0 106.695 167.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -121.42 151.04 24.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 125.299 2.476 . . . . 0.0 108.897 168.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -111.57 143.75 41.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 108.804 -3.816 . . . . 0.0 110.755 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -58.89 124.61 20.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.92 2.488 . . . . 0.0 110.036 156.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.29 136.39 33.14 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 130.587 3.555 . . . . 0.0 109.858 -176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -80.01 -20.05 46.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 112.473 -3.632 . . . . 0.0 112.254 -170.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.03 40.99 1.25 Allowed Glycine 0 CA--C 1.538 1.509 0 CA-C-N 122.125 2.239 . . . . 0.0 113.406 -165.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 N-CA-C 103.31 -3.916 . . . . 0.0 103.31 177.26 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.584 0.707 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -100.25 145.54 27.96 Favored 'General case' 0 N--CA 1.442 -0.83 2 O-C-N 113.477 -5.764 . . . . 0.0 107.722 -171.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.1 pt -127.85 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 1 O-C-N 115.78 -4.325 . . . . 0.0 107.526 151.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -88.55 136.67 32.88 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.075 -1.421 . . . . 0.0 107.697 166.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.25 10.9 t -123.59 122.33 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 117.3 -3.375 . . . . 0.0 109.448 170.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -94.01 107.14 19.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.4 6.2 p -56.41 160.45 3.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 128.196 3.435 . . . . 0.0 117.386 170.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -74.63 -24.18 58.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.395 1.078 . . . . 0.0 109.032 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.67 -1.92 56.78 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 123.144 1.449 . . . . 0.0 114.174 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.44 -26.79 15.35 Favored Glycine 0 CA--C 1.526 0.761 0 O-C-N 119.371 -2.081 . . . . 0.0 115.762 165.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -70.01 130.25 41.67 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 116.929 -3.689 . . . . 0.0 107.731 -172.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.5 m -88.77 109.94 20.6 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 118.895 -2.378 . . . . 0.0 108.089 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 pt -93.31 141.48 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 124.291 1.037 . . . . 0.0 112.551 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 t -81.95 143.94 31.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 161.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.09 121.14 22.23 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 131.543 3.937 . . . . 0.0 107.363 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.31 13.1 mp0 -86.12 134.39 33.81 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 117.598 -1.641 . . . . 0.0 110.375 172.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.274 27.4 m -137.38 170.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 116.471 -1.728 . . . . 0.0 109.37 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -112.94 158.88 36.52 Favored Pre-proline 0 N--CA 1.444 -0.739 0 C-N-CA 128.668 2.787 . . . . 0.0 105.258 162.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.79 -28.35 25.23 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.935 2.423 . . . . 0.0 117.21 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -76.85 4.22 10.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 126.127 2.142 . . . . 0.0 116.596 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -84.43 141.15 31.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.361 1.864 . . . . 0.0 107.853 -164.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -78.86 140.09 38.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.336 1.455 . . . . 0.0 110.235 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.29 8.3 mt -47.09 -35.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 119.979 -1.701 . . . . 0.0 114.939 171.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -53.79 -49.31 68.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.306 2.242 . . . . 0.0 111.095 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -64.78 -43.25 93.84 Favored 'General case' 0 N--CA 1.441 -0.91 1 C-N-CA 132.665 4.386 . . . . 0.0 111.752 176.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.12 -50.63 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 115.208 -2.33 . . . . 0.0 113.351 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -61.6 -41.19 97.09 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 127.261 2.224 . . . . 0.0 112.259 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.73 -40.53 84.03 Favored 'General case' 0 N--CA 1.448 -0.543 1 C-N-CA 132.165 4.186 . . . . 0.0 109.235 177.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.32 79.8 mttt -79.33 -19.46 50.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 119.043 -2.286 . . . . 0.0 114.794 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mt -76.82 -32.34 20.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 118.887 -2.383 . . . . 0.0 107.413 172.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.82 -38.46 86.48 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 116.667 -3.77 . . . . 0.0 114.005 163.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -67.14 -23.03 65.75 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 113.007 -3.378 . . . . 0.0 109.641 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -98.55 -66.94 0.87 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 121.455 1.934 . . . . 0.0 113.733 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -111.32 -9.78 14.27 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 117.108 -3.495 . . . . 0.0 109.235 -164.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.53 2.37 50.26 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.145 -1.364 . . . . 0.0 114.479 158.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -77.0 125.13 87.26 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 125.02 1.328 . . . . 0.0 107.782 -171.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.59 129.55 19.09 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.826 3.684 . . . . 0.0 115.637 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -41.85 -33.07 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 1 C-N-CA 127.55 5.5 . . . . 0.0 117.502 175.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -51.11 -64.17 0.9 Allowed 'General case' 0 N--CA 1.445 -0.678 1 C-N-CA 132.174 4.189 . . . . 0.0 112.925 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -73.18 -26.27 61.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 128.661 2.784 . . . . 0.0 117.524 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -73.22 128.4 35.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.104 2.562 . . . . 0.0 107.351 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 ttm105 -120.73 129.37 53.61 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.977 1.711 . . . . 0.0 108.468 158.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -97.48 161.94 13.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.365 -1.779 . . . . 0.0 110.822 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -136.07 138.0 47.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 126.428 2.33 . . . . 0.0 108.062 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -130.8 116.53 18.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.602 2.361 . . . . 0.0 107.518 162.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.293 . . 57.86 34.15 24.03 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 129.034 2.934 . . . . 0.0 114.106 168.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.1 10.81 84.24 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 129.253 3.311 . . . . 0.0 117.778 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -98.61 134.63 41.28 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.917 2.487 . . . . 0.0 106.957 173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -84.63 124.71 31.77 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.99 130.19 38.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 116.222 -1.847 . . . . 0.0 109.839 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -91.93 126.01 36.85 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.949 1.704 . . . . 0.0 109.273 -166.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -46.18 115.34 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 129.831 3.252 . . . . 0.0 111.836 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.24 -9.85 31.19 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 116.762 -2.132 . . . . 0.0 112.962 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.352 17.7 mmt180 -86.26 154.13 21.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 121.075 2.437 . . . . 0.0 111.383 174.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 p -71.57 161.2 31.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 160.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.49 -21.32 66.18 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 122.257 2.299 . . . . 0.0 113.796 169.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 t -77.53 -16.56 58.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 117.217 -3.427 . . . . 0.0 108.226 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -76.66 4.16 10.06 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 123.192 2.724 . . . . 0.0 113.336 167.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -138.45 9.33 2.68 Favored 'General case' 0 C--N 1.327 -0.405 1 O-C-N 115.085 -4.759 . . . . 0.0 112.523 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 t30 62.3 26.92 16.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 130.054 3.342 . . . . 0.0 116.679 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.36 128.42 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -124.32 -160.07 0.91 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.171 -1.377 . . . . 0.0 107.461 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.66 135.57 51.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -165.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 81.96 10.08 0.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 129.013 2.925 . . . . 0.0 115.12 163.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -70.06 152.19 44.66 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 126.049 2.093 . . . . 0.0 113.432 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.7 m -110.39 125.46 53.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.87 155.47 20.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 169.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -110.92 150.75 28.77 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.663 1.985 . . . . 0.0 106.999 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -125.9 135.55 52.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.705 2.402 . . . . 0.0 109.841 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.2 m -135.58 140.45 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 127.928 2.491 . . . . 0.0 108.043 -176.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.277 1.1 pp -136.83 178.48 7.04 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.107 2.563 . . . . 0.0 112.087 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 73.42 -53.36 0.7 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.697 2.399 . . . . 0.0 113.342 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.352 0.8 OUTLIER -131.71 151.22 51.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 -175.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.7 ttt-85 -72.39 112.74 8.72 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.93 -2.356 . . . . 0.0 107.16 171.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.04 172.76 14.54 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 115.737 -2.702 . . . . 0.0 111.061 163.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 127.078 3.599 . . . . 0.0 109.124 -156.683 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttp . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -104.67 128.92 52.88 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 101.537 -3.505 . . . . 0.0 101.537 -169.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 pt -138.14 170.97 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 129.727 3.211 . . . . 0.0 106.84 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -114.4 149.3 36.38 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -121.8 121.4 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.271 1.828 . . . . 0.0 106.206 161.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -110.1 178.49 4.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 109.248 -3.614 . . . . 0.0 110.465 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -138.08 155.96 48.26 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 128.238 2.615 . . . . 0.0 108.538 -168.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.4 mt -75.76 -14.52 60.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 112.939 -3.41 . . . . 0.0 111.245 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -92.95 -4.03 53.44 Favored 'General case' 0 C--N 1.324 -0.525 1 CA-C-N 126.255 4.116 . . . . 0.0 108.86 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.12 7.13 31.27 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 120.313 2.885 . . . . 0.0 120.313 162.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -60.76 154.26 22.17 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 118.595 -2.709 . . . . 0.0 108.82 169.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.281 4.3 m -141.92 107.0 4.94 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.427 1.891 . . . . 0.0 108.743 170.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mm -100.43 142.24 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 111.997 -2.365 . . . . 0.0 106.315 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -94.42 143.2 26.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.643 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.6 123.44 37.65 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 122.604 2.456 . . . . 0.0 107.853 -173.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -99.43 109.56 22.13 Favored 'General case' 0 C--N 1.329 -0.283 1 N-CA-C 97.181 -5.118 . . . . 0.0 97.181 175.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 m -118.76 150.21 21.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 119.711 -1.868 . . . . 0.0 108.009 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -89.45 161.29 40.09 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 116.479 -1.724 . . . . 0.0 111.078 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.02 -19.76 13.55 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.504 2.803 . . . . 0.0 111.664 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 p -73.06 -17.93 61.37 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 128.709 2.804 . . . . 0.0 111.7 173.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -69.86 123.94 22.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 124.934 2.302 . . . . 0.0 112.02 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.6 p -76.67 166.11 23.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 111.893 -2.412 . . . . 0.0 110.098 162.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.2 -21.51 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 O-C-N 124.945 1.403 . . . . 0.0 108.641 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -73.59 -28.88 62.06 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.34 -29.82 53.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -83.18 -27.88 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 119.969 -1.707 . . . . 0.0 107.505 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -69.19 -42.22 76.1 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.78 -38.49 78.64 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 133.056 4.542 . . . . 0.0 114.158 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -77.36 -38.5 50.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 127.369 3.462 . . . . 0.0 114.877 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.1 mt -61.11 -35.81 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 1 O-C-N 113.05 -6.031 . . . . 0.0 105.788 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -32.96 71.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.184 1.794 . . . . 0.0 109.756 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.03 -32.19 73.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.99 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -91.65 -36.67 13.5 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.56 1.944 . . . . 0.0 113.943 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -129.16 -23.53 2.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -173.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.04 2.03 57.06 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 126.996 2.685 . . . . 0.0 116.611 165.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.2 mm -72.8 121.42 84.97 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 120.095 1.948 . . . . 0.0 111.048 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -39.27 129.11 1.56 Allowed 'Trans proline' 0 N--CA 1.443 -1.498 0 N-CA-C 119.225 2.74 . . . . 0.0 119.225 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.29 26.4 Cg_exo -47.76 -29.99 12.17 Favored 'Trans proline' 0 N--CA 1.453 -0.901 1 C-N-CA 129.227 6.618 . . . . 0.0 115.825 178.296 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -79.28 -4.27 49.93 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 128.0 2.52 . . . . 0.0 112.381 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -118.36 -15.67 9.68 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.486 1.915 . . . . 0.0 110.349 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.304 79.9 mt-30 -90.05 115.22 27.15 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 116.317 -2.153 . . . . 0.0 108.235 -170.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -103.96 129.55 51.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 100.712 -3.81 . . . . 0.0 100.712 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 mt -132.63 93.78 3.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.423 -2.673 . . . . 0.0 106.278 -162.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -89.56 128.16 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -128.86 107.71 9.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 128.728 2.811 . . . . 0.0 106.398 166.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.331 . . 60.71 16.53 6.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 130.52 3.528 . . . . 0.0 117.706 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.82 -13.47 57.73 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.314 1.912 . . . . 0.0 110.722 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.54 105.45 14.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.998 2.119 . . . . 0.0 105.568 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -61.05 107.64 0.76 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 111.742 -2.481 . . . . 0.0 114.652 152.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.6 mt -65.7 123.06 18.73 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 128.115 3.384 . . . . 0.0 107.974 -172.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.19 131.27 34.8 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 126.884 2.615 . . . . 0.0 111.267 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.97 119.39 4.24 Favored 'General case' 0 N--CA 1.449 -0.485 1 CA-C-O 129.272 4.367 . . . . 0.0 111.849 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.18 -19.74 31.76 Favored Glycine 0 CA--C 1.523 0.559 1 O-C-N 115.195 -4.691 . . . . 0.0 119.234 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -83.56 175.83 9.48 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 118.473 -1.291 . . . . 0.0 111.433 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.3 p -114.16 162.06 17.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 121.216 1.825 . . . . 0.0 110.842 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mt -36.71 -50.56 0.83 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.104 2.962 . . . . 0.0 116.654 172.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 p -81.29 0.27 37.73 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 109.485 -3.507 . . . . 0.0 112.995 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -97.04 -18.77 19.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 116.647 -3.783 . . . . 0.0 109.249 170.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -98.99 -17.4 18.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 118.588 -2.57 . . . . 0.0 116.832 167.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 74.72 42.59 0.28 Allowed 'General case' 0 N--CA 1.452 -0.349 1 C-N-CA 132.456 4.303 . . . . 0.0 108.517 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.9 mt -68.21 106.3 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 O-C-N 119.892 -1.755 . . . . 0.0 107.853 156.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -76.88 169.9 17.47 Favored 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 133.628 4.771 . . . . 0.0 112.254 166.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.268 17.9 pttm -69.1 148.94 49.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 174.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 73.2 mt-10 57.34 13.72 1.87 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.7 m -81.58 169.6 16.86 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.467 2.307 . . . . 0.0 108.298 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -143.51 131.51 21.69 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.233 -153.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.22 145.64 35.87 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.158 -1.589 . . . . 0.0 111.159 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.281 24.6 m80 -97.1 117.91 32.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -170.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.31 128.43 34.69 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.602 1.961 . . . . 0.0 110.668 169.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.06 146.96 30.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 1 C-N-CA 131.795 4.038 . . . . 0.0 108.688 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.291 1.2 mm? -84.72 126.56 33.5 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 118.961 -2.337 . . . . 0.0 109.394 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -148.79 105.59 3.58 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 119.438 -2.039 . . . . 0.0 106.55 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.78 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.336 3.054 . . . . 0.0 103.107 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -150.97 121.56 7.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 124.754 2.216 . . . . 0.0 110.153 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.63 -0.99 9.19 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 113.175 -1.83 . . . . 0.0 114.906 -175.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 C-N-CA 127.965 2.698 . . . . 0.0 110.004 173.276 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -84.68 152.1 23.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 125.027 2.346 . . . . 0.0 114.235 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.1 pt -134.16 137.14 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 129.783 3.233 . . . . 0.0 104.633 165.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -94.56 121.35 36.03 Favored 'General case' 0 N--CA 1.449 -0.504 1 C-N-CA 132.196 4.198 . . . . 0.0 105.219 166.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.56 130.8 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 101.306 -3.59 . . . . 0.0 101.306 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 23.2 mttm -90.9 116.57 28.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 129.547 3.139 . . . . 0.0 106.866 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 p -74.96 162.85 28.23 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 120.252 1.387 . . . . 0.0 110.176 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -70.56 -36.9 73.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.198 1.399 . . . . 0.0 107.823 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.8 p -80.71 -2.65 47.69 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.958 2.103 . . . . 0.0 116.273 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.49 20.34 8.24 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 161.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -107.35 158.07 17.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 126.47 3.033 . . . . 0.0 106.403 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.258 10.9 m -129.49 91.85 3.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 131.538 3.935 . . . . 0.0 108.854 -172.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mm -79.69 111.96 17.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 O-C-N 128.623 3.702 . . . . 0.0 104.71 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.257 85.1 m -86.52 107.73 18.23 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.816 1.647 . . . . 0.0 112.903 173.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mp -97.9 164.82 12.21 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 126.15 2.156 . . . . 0.0 112.888 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -113.08 146.59 38.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 127.196 3.379 . . . . 0.0 107.79 162.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.48 178.8 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 131.035 3.734 . . . . 0.0 107.5 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -120.9 150.42 52.99 Favored Pre-proline 0 N--CA 1.45 -0.432 0 C-N-CA 130.969 3.708 . . . . 0.0 103.109 154.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -47.02 -19.47 0.85 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 120.396 3.191 . . . . 0.0 120.396 164.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.7 m -58.92 -33.17 70.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 130.61 3.564 . . . . 0.0 114.276 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.09 126.49 20.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.891 2.476 . . . . 0.0 107.052 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.5 p -79.89 147.51 31.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 127.609 3.068 . . . . 0.0 104.809 162.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.2 mm -46.4 -51.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 111.921 -2.399 . . . . 0.0 114.439 169.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -35.78 -42.15 0.25 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 160.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -74.31 -35.42 63.66 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 117.491 -3.255 . . . . 0.0 115.371 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.85 -42.69 79.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 120.079 -1.638 . . . . 0.0 109.006 170.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -56.72 -36.98 70.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 123.686 1.708 . . . . 0.0 113.543 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.67 -34.02 62.6 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 130.665 3.586 . . . . 0.0 111.05 -175.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -75.44 -44.02 46.63 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 128.578 2.751 . . . . 0.0 106.924 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 mt -60.83 -33.71 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 119.352 -2.092 . . . . 0.0 113.553 162.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.262 12.8 tt0 -60.1 -38.64 83.56 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 123.048 1.404 . . . . 0.0 112.58 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.75 -61.45 2.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 119.492 3.145 . . . . 0.0 119.492 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -63.65 -43.78 95.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 108.452 -3.977 . . . . 0.0 110.443 -168.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -119.46 -18.32 8.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 120.238 1.381 . . . . 0.0 112.336 -167.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.75 -8.66 54.72 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 117.418 -1.768 . . . . 0.0 111.224 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -67.4 115.0 22.02 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 120.196 1.998 . . . . 0.0 111.207 -164.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -74.36 156.65 45.87 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.466 2.11 . . . . 0.0 108.592 -168.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -68.57 -35.46 17.17 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 117.079 1.915 . . . . 0.0 117.079 -172.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.02 -27.06 68.61 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 118.806 2.891 . . . . 0.0 118.806 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -83.73 -30.58 26.58 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 119.236 -2.165 . . . . 0.0 112.746 173.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -67.32 133.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 123.075 1.417 . . . . 0.0 113.719 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -128.19 141.55 51.44 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 130.505 3.522 . . . . 0.0 103.376 161.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.67 136.4 53.94 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 129.488 3.115 . . . . 0.0 106.337 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.2 mt -123.75 156.58 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 110.023 -3.262 . . . . 0.0 112.699 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -158.19 127.53 5.77 Favored 'General case' 0 N--CA 1.45 -0.453 1 O-C-N 129.355 4.16 . . . . 0.0 102.984 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.08 26.27 11.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 165.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.64 -9.6 41.13 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 128.7 3.048 . . . . 0.0 113.331 169.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -121.37 142.54 49.89 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 126.744 2.085 . . . . 0.0 111.371 -166.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -90.44 116.67 28.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 128.236 2.614 . . . . 0.0 107.978 -172.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.68 136.02 34.87 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.416 1.487 . . . . 0.0 107.99 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.253 4.3 mm-40 -92.33 124.29 36.28 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 110.667 -2.97 . . . . 0.0 107.915 -163.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -22.18 9.6 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 119.38 3.104 . . . . 0.0 119.38 -160.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.74 -5.39 55.3 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 128.567 2.984 . . . . 0.0 119.197 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -90.15 156.39 18.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.935 1.694 . . . . 0.0 108.045 173.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -95.98 167.16 11.4 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.75 2.82 . . . . 0.0 108.704 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -70.38 -31.21 68.35 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 125.854 2.74 . . . . 0.0 108.663 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.353 14.1 t -50.71 -38.68 48.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 112.815 -3.469 . . . . 0.0 115.5 164.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.263 0.4 OUTLIER -74.03 -26.84 60.63 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 126.564 2.415 . . . . 0.0 109.578 -168.198 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.522 40.8 m-85 -102.08 10.15 39.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 125.279 1.612 . . . . 0.0 114.328 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.412 3.7 p-10 60.86 33.25 20.02 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 128.028 2.531 . . . . 0.0 116.563 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.7 mt -90.52 114.48 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.291 0.3 OUTLIER -143.86 81.35 1.69 Allowed 'General case' 0 N--CA 1.45 -0.47 1 C-N-CA 131.724 4.01 . . . . 0.0 117.011 -177.106 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.406 22.3 ttpt 84.51 131.95 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.799 3.64 . . . . 0.0 117.73 171.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 72.53 41.38 0.58 Allowed 'General case' 0 N--CA 1.443 -0.785 1 C-N-CA 134.504 5.122 . . . . 0.0 109.306 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.0 m -85.93 144.36 27.69 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 130.753 3.621 . . . . 0.0 111.439 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.9 m -100.33 109.63 21.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.127 2.571 . . . . 0.0 105.748 164.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -111.94 151.09 29.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.107 -1.901 . . . . 0.0 109.911 171.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -120.79 140.54 51.56 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 131.276 3.83 . . . . 0.0 112.06 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -98.67 135.61 39.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 116.053 -1.927 . . . . 0.0 110.954 157.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.33 148.52 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 1 O-C-N 129.345 4.153 . . . . 0.0 109.248 160.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -165.31 -174.6 3.27 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 117.767 -3.083 . . . . 0.0 108.054 -173.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -107.56 123.0 47.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.524 2.73 . . . . 0.0 107.201 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.57 153.45 49.85 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 123.541 1.639 . . . . 0.0 110.988 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -104.91 146.82 28.49 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 171.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.69 165.24 18.96 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 127.978 2.704 . . . . 0.0 111.75 171.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 168.88 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 123.284 1.516 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -134.26 150.22 51.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 108.729 -3.85 . . . . 0.0 116.608 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -136.46 144.69 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 112.8 -2.0 . . . . 0.0 113.454 166.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -90.08 122.24 32.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 116.906 -3.621 . . . . 0.0 109.138 163.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.8 t -82.82 125.24 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 101.244 -3.613 . . . . 0.0 101.244 157.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -103.98 104.58 14.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 110.14 -3.209 . . . . 0.0 104.914 162.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -72.48 137.93 46.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.645 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.36 -39.58 46.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 119.728 3.233 . . . . 0.0 119.728 -171.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.389 2.0 t -35.46 -30.76 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.704 1 C-N-CA 133.465 4.706 . . . . 0.0 117.044 156.75 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.99 -20.22 7.21 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 124.935 2.408 . . . . 0.0 110.444 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.26 73.4 tttt -71.35 139.48 49.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 119.304 -2.292 . . . . 0.0 108.712 -168.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 m -118.15 111.95 19.52 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 126.016 2.073 . . . . 0.0 114.562 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.263 13.8 mm -104.71 131.36 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.002 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.308 2.8 m -94.01 123.58 37.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 117.786 -3.071 . . . . 0.0 108.816 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mp -111.14 132.26 54.43 Favored 'General case' 0 C--O 1.217 -0.605 0 O-C-N 119.629 -1.92 . . . . 0.0 107.795 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -82.98 131.66 35.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 170.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -144.25 -174.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.807 0.843 . . . . 0.0 112.848 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -140.28 143.58 33.99 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 127.672 3.108 . . . . 0.0 108.916 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.68 -15.4 24.28 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 CA-C-N 125.105 2.859 . . . . 0.0 115.625 -167.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -75.32 1.8 12.81 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 117.41 -3.306 . . . . 0.0 116.938 165.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -93.76 150.77 20.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.499 2.319 . . . . 0.0 109.057 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.542 ' HB ' ' H ' ' A' ' 24' ' ' GLU . 7.4 p -71.36 161.0 31.78 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -175.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.305 16.5 mm -49.76 -41.93 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 131.677 3.991 . . . . 0.0 111.174 146.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.542 ' H ' ' HB ' ' A' ' 22' ' ' THR . 27.8 tt0 -59.35 -45.82 90.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 116.232 -2.187 . . . . 0.0 113.159 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -71.8 -23.3 61.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.472 1.107 . . . . 0.0 113.459 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.294 91.7 t -48.88 -62.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 150.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -68.64 -38.16 80.26 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.927 -1.733 . . . . 0.0 115.086 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.82 -38.26 75.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 129.591 3.157 . . . . 0.0 116.233 172.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -50.26 -37.64 36.84 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 163.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -69.84 -12.92 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 O-C-N 119.837 -1.789 . . . . 0.0 107.675 -172.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -62.45 -43.38 98.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 116.591 -3.818 . . . . 0.0 112.895 171.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -83.32 -32.87 26.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.382 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -75.05 -67.55 0.64 Allowed 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 119.515 -1.991 . . . . 0.0 108.663 168.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -103.58 -23.58 13.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 116.902 -3.624 . . . . 0.0 115.814 -155.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.63 25.74 10.51 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 116.83 -2.095 . . . . 0.0 108.569 172.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 mm -107.68 129.39 24.26 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.36 165.63 31.02 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.292 1.995 . . . . 0.0 111.767 170.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.63 -38.02 6.39 Favored 'Trans proline' 0 N--CA 1.453 -0.897 1 C-N-CA 127.551 5.501 . . . . 0.0 117.007 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.86 -21.11 26.83 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.922 2.489 . . . . 0.0 113.968 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -95.51 -9.53 32.22 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.928 2.891 . . . . 0.0 116.297 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -95.88 133.51 39.97 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 115.193 -2.337 . . . . 0.0 108.793 -172.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -119.13 104.39 10.4 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.702 2.001 . . . . 0.0 107.953 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.4 tt -98.37 118.75 35.73 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 126.499 2.374 . . . . 0.0 105.487 -171.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -117.35 149.91 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -170.76 137.73 1.32 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 124.057 1.884 . . . . 0.0 107.725 166.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.36 28.95 11.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 117.434 2.383 . . . . 0.0 117.434 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.84 -5.39 69.23 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 116.454 -2.303 . . . . 0.0 114.061 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -125.76 147.36 49.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 127.404 2.473 . . . . 0.0 112.613 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -68.04 135.02 51.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.36 1.864 . . . . 0.0 113.46 163.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.9 mp -93.47 101.45 13.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.16 -16.63 59.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -173.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.594 26.5 t0 103.72 145.67 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 127.623 2.369 . . . . 0.0 112.136 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.3 -8.02 2.89 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 172.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.347 48.3 mtp180 -145.17 152.53 40.16 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.782 1.277 . . . . 0.0 109.812 -168.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.7 p -83.08 168.48 16.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 112.777 -2.01 . . . . 0.0 114.835 -168.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.5 mt -47.56 -40.69 19.66 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.3 p -60.1 -56.09 25.84 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.899 2.48 . . . . 0.0 116.594 167.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -46.01 -57.59 4.3 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.512 1.925 . . . . 0.0 114.117 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -74.82 -16.69 60.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 126.901 2.081 . . . . 0.0 115.168 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.274 25.5 t-20 90.33 64.28 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 129.951 3.3 . . . . 0.0 111.498 164.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -118.85 131.0 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.275 73.7 mm-40 -128.06 165.19 20.81 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 126.09 2.119 . . . . 0.0 106.606 -160.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -60.67 147.57 41.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 116.876 -1.535 . . . . 0.0 110.524 -167.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 59.92 19.62 8.62 Favored 'General case' 0 N--CA 1.444 -0.736 1 C-N-CA 131.957 4.103 . . . . 0.0 111.73 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.4 m -81.04 149.66 29.16 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 123.146 2.703 . . . . 0.0 113.287 170.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.3 m -93.08 131.76 37.81 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.879 2.872 . . . . 0.0 107.376 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.9 mt -103.52 130.03 50.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.63 2.772 . . . . 0.0 111.865 159.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -90.6 139.4 30.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.285 43.2 tp -122.29 129.58 52.32 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 117.129 -1.829 . . . . 0.0 109.116 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.254 83.6 t -95.45 139.33 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 126.354 2.284 . . . . 0.0 105.085 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mp -115.01 148.77 38.41 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.869 0.842 . . . . 0.0 111.813 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -112.24 163.24 14.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 124.275 1.988 . . . . 0.0 106.202 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -102.17 22.43 13.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.363 2.265 . . . . 0.0 111.615 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -163.87 154.14 15.21 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.099 -2.25 . . . . 0.0 107.584 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.88 94.2 0.36 Allowed Glycine 0 N--CA 1.444 -0.817 1 C-N-CA 131.382 4.325 . . . . 0.0 110.691 155.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.984 0 CA-C-O 115.564 -2.798 . . . . 0.0 112.665 -171.566 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 112.891 -3.433 . . . . 0.0 107.742 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -91.38 134.51 34.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.386 3.074 . . . . 0.0 112.376 167.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 pt -125.19 167.51 19.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 124.836 2.255 . . . . 0.0 106.915 160.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -106.35 144.43 33.05 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.409 2.284 . . . . 0.0 108.037 162.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.42 108.34 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 168.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -86.19 132.36 34.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 123.236 1.494 . . . . 0.0 111.443 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.7 p -98.08 159.2 15.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 117.189 -3.445 . . . . 0.0 106.079 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -58.7 -45.64 89.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.218 2.207 . . . . 0.0 109.077 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -73.43 3.04 6.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 130.569 3.548 . . . . 0.0 115.772 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.06 -8.99 50.27 Favored Glycine 0 N--CA 1.442 -0.901 2 O-C-N 114.099 -5.376 . . . . 0.0 113.102 162.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -79.15 150.6 31.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 121.73 2.765 . . . . 0.0 111.797 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 p -105.87 131.35 53.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 126.345 2.278 . . . . 0.0 111.643 161.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.9 pt -104.28 162.74 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 1 O-C-N 114.611 -5.055 . . . . 0.0 105.469 168.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.53 110.27 14.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.635 2.374 . . . . 0.0 106.011 -172.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.282 0.4 OUTLIER -104.48 138.93 40.12 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 128.316 2.646 . . . . 0.0 109.803 -173.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.45 ' CD ' ' HZ3' ' A' ' 33' ' ' LYS . 20.1 pm0 -90.15 135.81 33.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 126.821 2.576 . . . . 0.0 108.769 159.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 m -150.37 149.41 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.15 3.38 . . . . 0.0 107.418 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -101.87 141.88 23.47 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 127.939 2.496 . . . . 0.0 105.249 163.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -39.04 -42.76 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 N-CA-C 119.759 2.946 . . . . 0.0 119.759 167.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 p -88.15 14.75 8.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.422 2.689 . . . . 0.0 109.934 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -88.71 150.92 22.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 124.987 2.327 . . . . 0.0 105.661 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -86.99 146.74 26.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 110.442 -3.072 . . . . 0.0 110.206 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.5 mt -57.17 -24.81 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 124.864 1.353 . . . . 0.0 112.145 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -69.64 -34.16 73.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 128.239 2.616 . . . . 0.0 110.336 172.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -72.04 -31.85 66.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 114.103 -2.856 . . . . 0.0 107.305 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.4 t -79.46 -33.63 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 123.895 3.043 . . . . 0.0 107.68 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -54.85 -49.59 70.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 112.519 -3.61 . . . . 0.0 110.576 168.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.45 -52.33 6.11 Favored 'General case' 0 CA--C 1.537 0.468 1 CA-C-N 126.396 4.18 . . . . 0.0 119.426 156.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -74.09 -22.8 59.35 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 117.038 -3.539 . . . . 0.0 116.511 -169.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.0 mt -66.44 -39.0 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 130.951 3.701 . . . . 0.0 113.373 158.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.44 -26.82 64.79 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 122.841 2.564 . . . . 0.0 109.171 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.49 -42.38 74.87 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 128.436 3.585 . . . . 0.0 110.11 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HZ3' ' CD ' ' A' ' 16' ' ' GLU . 32.9 mmtt -76.39 -42.63 43.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 176.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 13.8 tp10 -130.19 5.77 4.9 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.491 -1.38 . . . . 0.0 109.972 -159.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.09 -0.93 35.99 Favored Glycine 0 CA--C 1.532 1.109 1 N-CA-C 123.598 4.199 . . . . 0.0 123.598 165.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 mt -78.05 114.97 46.76 Favored Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 129.696 3.198 . . . . 0.0 105.325 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.264 4.9 Cg_exo -48.52 134.67 26.72 Favored 'Trans proline' 0 N--CA 1.455 -0.768 1 C-N-CA 125.413 4.076 . . . . 0.0 111.554 172.517 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.21 -37.01 26.28 Favored 'Trans proline' 0 N--CA 1.44 -1.656 1 C-N-CA 129.156 6.571 . . . . 0.0 115.15 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -39.49 -31.89 0.11 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 129.65 3.18 . . . . 0.0 115.756 159.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.387 85.5 mt-30 -98.26 -13.42 20.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 118.989 -2.319 . . . . 0.0 114.78 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -81.6 143.08 32.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.2 ttp-105 -127.77 129.66 47.43 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 155.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.4 mt -96.23 132.98 41.11 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 116.672 -3.767 . . . . 0.0 107.297 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mt -125.44 149.57 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -113.64 -25.84 8.52 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 118.203 -2.811 . . . . 0.0 113.076 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.683 . . -143.43 -123.86 0.09 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 112.266 -2.243 . . . . 0.0 110.773 -170.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.93 18.41 19.22 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.666 0.592 . . . . 0.0 112.436 -166.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -151.65 154.77 37.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 118.182 -2.952 . . . . 0.0 110.383 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -57.73 156.33 8.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.802 1.641 . . . . 0.0 112.537 166.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.19 162.72 18.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 118.811 -2.43 . . . . 0.0 108.195 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -104.62 140.86 37.4 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.95 1.357 . . . . 0.0 109.132 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -67.97 -24.2 65.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 130.01 3.324 . . . . 0.0 114.594 -175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.12 40.77 2.43 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.479 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 11.1 mtt180 -130.37 151.17 51.16 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 165.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -96.6 162.27 13.53 Favored 'General case' 0 N--CA 1.45 -0.428 1 O-C-N 116.253 -4.03 . . . . 0.0 111.424 -167.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -54.67 -44.0 72.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.034 1.733 . . . . 0.0 110.617 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -61.27 -40.98 96.13 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 170.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -54.17 -33.13 57.32 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 131.296 3.838 . . . . 0.0 114.807 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 97.1 m-85 -100.13 0.04 39.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.276 -1.515 . . . . 0.0 111.732 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.7 t30 56.63 36.19 27.26 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 129.28 3.032 . . . . 0.0 117.588 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mt -79.28 116.21 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 103.204 -2.888 . . . . 0.0 103.204 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -103.44 169.35 8.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.598 1.959 . . . . 0.0 109.204 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.385 53.7 pttt -50.22 133.4 23.7 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.343 1.857 . . . . 0.0 113.42 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 24.0 mt-10 72.12 12.35 5.93 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 130.339 3.455 . . . . 0.0 115.488 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.9 m -60.86 145.31 50.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 113.97 -2.919 . . . . 0.0 112.864 162.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -102.39 131.26 49.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 127.698 3.124 . . . . 0.0 105.154 170.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.75 151.73 25.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.634 -2.541 . . . . 0.0 108.621 161.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -109.47 128.48 55.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 117.917 -2.99 . . . . 0.0 105.595 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.0 tp -106.21 103.07 12.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 112.11 -2.313 . . . . 0.0 109.673 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.1 t -83.23 137.17 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 124.498 2.095 . . . . 0.0 110.574 169.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.62 149.68 51.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.313 1.845 . . . . 0.0 107.274 -157.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 mtm105 -108.78 55.32 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 129.139 2.975 . . . . 0.0 113.65 166.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.488 1.0 OUTLIER -138.09 15.16 2.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 117.434 2.383 . . . . 0.0 117.434 163.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -45.23 48.52 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 127.518 2.327 . . . . 0.0 113.76 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.98 7.03 23.92 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 127.109 2.29 . . . . 0.0 111.599 171.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 O-C-N 120.267 -1.725 . . . . 0.0 109.855 -157.495 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.32 135.83 33.17 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 119.547 -1.971 . . . . 0.0 106.81 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.44 164.08 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 123.961 0.904 . . . . 0.0 112.018 166.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -90.57 129.94 36.65 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 126.092 1.757 . . . . 0.0 110.347 155.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.03 110.51 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 150.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -99.1 134.12 42.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 127.222 3.391 . . . . 0.0 110.926 170.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 p -89.15 141.36 28.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 111.706 -2.497 . . . . 0.0 108.759 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.06 -11.08 35.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 163.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -78.91 -15.55 58.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 118.212 -2.805 . . . . 0.0 115.069 169.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.19 -12.09 6.09 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 120.211 1.369 . . . . 0.0 113.64 159.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -82.95 137.19 34.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.522 1.529 . . . . 0.0 110.612 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -97.67 125.97 42.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 125.201 2.429 . . . . 0.0 106.507 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 mm -112.8 106.06 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 1 O-C-N 115.646 -4.409 . . . . 0.0 101.567 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.4 m -59.91 137.11 58.15 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 122.868 1.318 . . . . 0.0 111.618 158.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.29 140.54 43.47 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 128.584 2.754 . . . . 0.0 109.168 177.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -111.66 121.71 45.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.0 162.54 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 128.864 2.866 . . . . 0.0 104.787 -177.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -111.3 162.53 20.5 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 160.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -88.72 -21.71 1.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 121.735 1.623 . . . . 0.0 109.386 -164.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -69.09 -6.13 26.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 159.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -71.57 137.24 47.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 119.82 -1.8 . . . . 0.0 112.593 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.315 42.7 p -60.44 142.71 54.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 128.414 2.685 . . . . 0.0 112.74 169.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.444 62.6 mt -46.79 -29.58 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 163.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -53.83 -56.27 19.14 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 131.699 4.0 . . . . 0.0 108.013 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -74.75 -28.47 60.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 116.527 -1.701 . . . . 0.0 112.018 -171.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 t -71.01 -51.13 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 128.381 2.672 . . . . 0.0 111.743 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -55.37 -45.37 76.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 113.456 -3.164 . . . . 0.0 113.317 168.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.5 -17.03 63.5 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 131.291 3.837 . . . . 0.0 115.324 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -77.55 -32.54 53.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 112.946 -3.407 . . . . 0.0 107.317 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.51 -21.81 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 O-C-N 127.062 2.726 . . . . 0.0 108.097 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -67.57 -35.64 79.42 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 128.534 2.734 . . . . 0.0 112.864 164.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.66 -33.13 60.4 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.277 1.031 . . . . 0.0 111.646 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -81.55 -77.33 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 119.725 -1.86 . . . . 0.0 109.391 -172.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.269 15.9 mm-40 -100.9 -15.4 17.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 115.034 -2.412 . . . . 0.0 114.604 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.05 -1.72 40.95 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 121.749 2.068 . . . . 0.0 110.331 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -76.22 130.63 77.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 114.953 -2.451 . . . . 0.0 106.641 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.53 149.73 16.69 Favored 'Trans proline' 0 N--CA 1.446 -1.319 1 C-N-CA 125.991 4.461 . . . . 0.0 111.317 -174.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -40.01 -37.42 1.68 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 N-CA-C 119.475 2.837 . . . . 0.0 119.475 165.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -45.7 -49.06 14.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.153 1.781 . . . . 0.0 114.292 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -99.72 -3.4 32.99 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 127.47 2.308 . . . . 0.0 116.976 -169.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -80.23 127.56 32.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 125.144 2.402 . . . . 0.0 108.979 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.488 ' CZ ' HG11 ' A' ' 70' ' ' VAL . 36.4 mtm180 -112.79 127.06 56.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 119.418 -2.051 . . . . 0.0 105.824 165.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.02 124.8 50.72 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 131.331 3.852 . . . . 0.0 107.577 -163.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 mm -124.89 128.82 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 117.12 -3.488 . . . . 0.0 109.445 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -153.68 136.99 15.73 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 118.529 -2.607 . . . . 0.0 109.701 163.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.385 . . 66.35 32.07 7.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 124.339 2.019 . . . . 0.0 115.123 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 -12.33 32.6 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 112.38 -2.191 . . . . 0.0 116.199 -174.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.261 9.9 ttpt -100.84 136.63 40.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.45 -1.617 . . . . 0.0 109.175 -167.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -92.82 116.47 29.06 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 171.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 mt -81.09 143.19 32.62 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 126.446 2.341 . . . . 0.0 105.239 -163.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.98 150.43 29.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.018 2.927 . . . . 0.0 109.356 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.67 155.33 33.47 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 117.988 -2.945 . . . . 0.0 111.361 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.77 48.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 127.111 2.291 . . . . 0.0 114.821 162.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -94.71 160.62 14.53 Favored 'General case' 0 N--CA 1.446 -0.664 1 C-N-CA 135.444 5.498 . . . . 0.0 113.878 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.4 p -103.91 170.8 7.71 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -72.51 -18.3 61.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 123.828 1.775 . . . . 0.0 108.305 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -78.68 -22.45 46.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.316 -2.115 . . . . 0.0 112.118 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -83.98 4.22 30.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -118.33 -7.38 10.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 118.091 -2.88 . . . . 0.0 108.529 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 10.8 p30 59.71 37.65 22.12 Favored 'General case' 0 N--CA 1.449 -0.511 1 C-N-CA 134.402 5.081 . . . . 0.0 114.149 -172.224 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -69.49 137.46 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 O-C-N 120.646 -1.284 . . . . 0.0 112.298 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -127.74 169.87 13.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.323 3.049 . . . . 0.0 109.48 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -42.33 131.89 3.56 Favored 'General case' 0 N--CA 1.45 -0.437 1 C-N-CA 136.415 5.886 . . . . 0.0 107.938 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.328 2.2 tt0 69.37 12.97 8.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 172.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.5 m -65.27 149.21 50.34 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.786 2.435 . . . . 0.0 108.145 166.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.4 m -101.63 120.84 40.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.238 -3.414 . . . . 0.0 102.557 166.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.37 37.8 mt -101.35 158.48 16.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.053 1.406 . . . . 0.0 110.435 162.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.301 79.2 m80 -117.41 133.5 55.9 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 119.279 -2.138 . . . . 0.0 108.947 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.28 120.18 39.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 124.876 2.274 . . . . 0.0 107.089 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.488 HG11 ' CZ ' ' A' ' 42' ' ' ARG . 96.4 t -99.99 136.76 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.498 171.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.01 155.62 16.65 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 101.062 -3.681 . . . . 0.0 101.062 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -87.98 104.27 16.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 128.876 2.87 . . . . 0.0 108.125 167.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mt -95.72 -176.01 3.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -106.52 12.77 29.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.95 -173.95 13.85 Favored Glycine 0 CA--C 1.528 0.87 1 C-N-CA 130.862 4.077 . . . . 0.0 105.885 167.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 C-N-CA 129.591 3.472 . . . . 0.0 109.603 179.244 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 ttp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 102.016 -3.327 . . . . 0.0 102.016 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -99.47 145.32 27.58 Favored 'General case' 0 N--CA 1.444 -0.738 2 CA-C-O 111.552 -4.071 . . . . 0.0 108.103 170.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -120.33 159.02 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 115.653 -2.118 . . . . 0.0 110.956 150.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -99.41 132.01 45.03 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 128.719 3.762 . . . . 0.0 107.298 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.45 145.36 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 O-C-N 126.674 2.484 . . . . 0.0 105.257 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -114.56 140.32 48.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 127.904 2.481 . . . . 0.0 108.616 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -100.27 170.63 8.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 125.995 2.807 . . . . 0.0 105.116 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.5 mt -57.07 -32.11 65.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.126 -2.306 . . . . 0.0 109.918 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.0 p -86.6 -9.36 56.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 117.575 -3.203 . . . . 0.0 110.343 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.75 11.31 38.13 Favored Glycine 0 CA--C 1.532 1.134 1 C-N-CA 135.108 6.099 . . . . 0.0 114.762 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -82.54 129.26 34.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 -162.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 48.1 m -96.47 126.06 41.39 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.088 0.955 . . . . 0.0 110.718 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -120.03 151.46 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 119.605 -1.934 . . . . 0.0 106.574 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.271 4.8 m -118.0 91.21 3.51 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 128.021 2.528 . . . . 0.0 106.579 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -83.0 150.19 26.51 Favored 'General case' 0 N--CA 1.444 -0.736 1 CA-C-N 107.991 -4.186 . . . . 0.0 112.053 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.88 108.07 18.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.446 1.898 . . . . 0.0 108.121 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.61 -176.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 1 C-N-CA 134.168 4.987 . . . . 0.0 116.492 173.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -152.12 159.83 32.34 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 103.007 -2.96 . . . . 0.0 103.007 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 75.1 Cg_exo -41.89 -24.42 0.29 Allowed 'Trans proline' 0 N--CA 1.443 -1.498 1 C-N-CA 128.004 5.803 . . . . 0.0 121.697 174.824 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.9 p -78.6 1.92 21.05 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 129.853 3.261 . . . . 0.0 115.182 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.45 130.01 45.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -76.98 178.71 6.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 113.916 -2.945 . . . . 0.0 112.298 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 mm -76.19 -24.62 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 113.956 -2.926 . . . . 0.0 109.197 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -72.99 -41.6 64.16 Favored 'General case' 0 C--O 1.242 0.691 1 C-N-CA 132.697 4.399 . . . . 0.0 105.062 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -65.29 -30.41 71.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.684 -2.51 . . . . 0.0 115.623 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -87.71 -35.9 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 1 CA-C-O 108.545 -5.502 . . . . 0.0 108.219 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.03 -29.57 70.48 Favored 'General case' 0 C--N 1.324 -0.51 1 CA-C-N 126.71 4.323 . . . . 0.0 114.45 169.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.87 80.78 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 125.502 2.572 . . . . 0.0 114.079 167.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -72.9 -37.2 67.33 Favored 'General case' 0 C--N 1.326 -0.414 1 O-C-N 115.117 -4.739 . . . . 0.0 108.967 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.2 mt -50.81 -65.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 128.019 2.528 . . . . 0.0 114.459 160.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -35.99 -43.58 0.33 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.206 2.202 . . . . 0.0 112.423 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -60.32 -42.02 94.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.918 3.287 . . . . 0.0 118.219 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -102.61 -29.31 11.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.011 -2.359 . . . . 0.0 114.776 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -119.08 -13.01 9.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 118.299 2.704 . . . . 0.0 118.299 -169.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.79 -12.56 68.47 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 114.278 -3.512 . . . . 0.0 118.655 162.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mt -73.12 123.2 89.29 Favored Pre-proline 0 N--CA 1.451 -0.403 1 O-C-N 130.414 4.244 . . . . 0.0 104.957 -162.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.14 145.72 33.29 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 123.79 2.994 . . . . 0.0 113.786 170.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.06 -30.33 21.06 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 N-CA-C 117.033 1.897 . . . . 0.0 117.033 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.23 -35.34 36.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 124.156 1.932 . . . . 0.0 109.109 -158.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -80.53 -19.38 45.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.83 144.98 31.65 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 117.994 -1.003 . . . . 0.0 111.542 -172.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -142.01 150.94 41.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 114.165 -2.826 . . . . 0.0 111.449 172.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.45 121.07 41.62 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 128.277 3.486 . . . . 0.0 108.084 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.4 mm -103.36 141.58 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 1 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -139.11 127.55 22.94 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 100.94 -3.726 . . . . 0.0 100.94 171.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.71 46.13 17.81 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 129.5 3.12 . . . . 0.0 107.831 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.07 -12.44 1.69 Allowed Glycine 0 CA--C 1.535 1.343 0 O-C-N 116.73 -3.731 . . . . 0.0 120.577 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -97.46 137.35 36.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.219 2.608 . . . . 0.0 108.711 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.13 140.08 57.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.909 1.381 . . . . 0.0 108.269 165.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 92.8 mt -81.42 109.75 16.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 131.052 3.741 . . . . 0.0 104.548 164.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -94.45 136.68 34.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.459 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -47.77 141.26 5.69 Favored 'General case' 0 C--N 1.328 -0.347 1 C-N-CA 132.846 4.459 . . . . 0.0 116.241 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.66 -30.66 7.95 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.498 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -100.78 161.82 13.33 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 117.092 -3.593 . . . . 0.0 107.542 -173.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -102.65 -176.17 3.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.535 -1.666 . . . . 0.0 108.009 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.97 -34.25 77.98 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 119.041 -2.287 . . . . 0.0 113.155 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.5 m -62.39 -37.51 86.02 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -62.92 -20.06 64.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.619 1.968 . . . . 0.0 116.055 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -114.87 -5.34 12.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.143 2.177 . . . . 0.0 111.904 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 t30 55.53 54.54 8.32 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.799 1.937 . . . . 0.0 114.684 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.0 mt -88.8 132.38 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.8 0.809 . . . . 0.0 109.168 -176.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -98.32 150.89 21.09 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.383 2.273 . . . . 0.0 109.317 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.556 ' HZ1' ' CD ' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -46.13 135.2 7.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 127.795 3.184 . . . . 0.0 109.799 154.128 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.556 ' CD ' ' HZ1' ' A' ' 63' ' ' LYS 0.417 0.0 OUTLIER 84.6 -6.21 0.99 Allowed 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 125.877 1.986 . . . . 0.0 115.207 166.228 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 t -88.17 140.2 29.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 128.004 3.315 . . . . 0.0 108.085 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.1 m -92.89 129.35 38.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -164.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.08 128.97 54.85 Favored 'General case' 0 N--CA 1.447 -0.621 1 C-N-CA 133.744 4.818 . . . . 0.0 111.659 171.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.14 141.0 29.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 123.999 3.091 . . . . 0.0 107.669 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -116.02 92.17 3.82 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 126.762 3.173 . . . . 0.0 103.154 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -93.46 158.25 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 112.653 -2.067 . . . . 0.0 110.435 170.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.53 128.6 44.41 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.805 3.242 . . . . 0.0 106.482 169.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -68.78 -30.37 68.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 115.629 -2.129 . . . . 0.0 110.16 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.41 116.63 8.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 130.578 3.551 . . . . 0.0 101.667 174.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.85 -25.74 15.35 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 128.629 2.772 . . . . 0.0 109.784 -175.085 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.25 -105.07 2.43 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.878 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.395 0 C-N-CA 128.333 2.873 . . . . 0.0 106.023 161.396 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 ttp . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.264 19.2 tm0? -109.78 123.91 50.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 125.732 2.682 . . . . 0.0 107.397 -172.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 pt -110.46 155.47 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 129.144 2.977 . . . . 0.0 108.261 155.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -110.81 160.55 16.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 125.088 2.375 . . . . 0.0 106.652 171.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 t -123.17 134.35 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 110.087 -3.233 . . . . 0.0 108.505 166.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 tttt -115.83 157.4 24.47 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 127.894 3.246 . . . . 0.0 110.406 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.312 7.9 t -147.72 161.06 41.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.754 2.821 . . . . 0.0 108.751 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.6 mt -28.13 -45.94 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.445 1 C-N-CA 135.863 5.665 . . . . 0.0 119.859 -176.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -79.33 -16.89 55.61 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.708 2.803 . . . . 0.0 114.24 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.61 -12.17 58.05 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 117.489 -1.728 . . . . 0.0 113.673 -171.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -55.33 150.34 11.55 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.336 22.7 p -130.44 149.91 51.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 117.801 -3.062 . . . . 0.0 115.3 168.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.9 mt -118.38 117.55 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 100.818 -3.771 . . . . 0.0 100.818 -178.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.283 9.0 t -106.07 122.23 45.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.151 3.38 . . . . 0.0 107.954 170.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.285 42.1 mt -113.29 134.95 54.34 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.292 3.037 . . . . 0.0 108.306 162.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -81.17 109.89 16.14 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 100.887 -3.746 . . . . 0.0 100.887 168.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.4 m -114.8 145.21 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 125.746 2.689 . . . . 0.0 111.713 -172.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.296 3.8 tt0 -103.35 116.87 61.44 Favored Pre-proline 0 C--N 1.324 -0.532 1 C-N-CA 131.745 4.018 . . . . 0.0 106.451 -176.033 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.318 50.5 Cg_exo -32.6 -42.56 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 1 N-CA-C 122.762 4.101 . . . . 0.0 122.762 -178.283 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.6 p -80.14 -7.74 59.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 131.1 3.76 . . . . 0.0 120.357 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -68.72 126.71 30.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 124.383 1.052 . . . . 0.0 113.204 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.4 p -70.28 146.83 50.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.346 20.2 mm -51.84 -31.18 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.462 1.905 . . . . 0.0 112.439 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.69 -33.63 18.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 123.15 1.452 . . . . 0.0 109.711 -170.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.18 -36.27 83.51 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 118.923 -2.361 . . . . 0.0 117.009 165.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.0 t -63.55 -49.01 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 116.646 -1.645 . . . . 0.0 111.466 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -57.75 -29.05 64.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 118.374 2.731 . . . . 0.0 118.374 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.63 -18.09 30.41 Favored 'General case' 0 CA--C 1.537 0.456 1 C-N-CA 132.257 4.223 . . . . 0.0 108.309 -176.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -90.44 -26.94 19.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.374 1.443 . . . . 0.0 110.646 169.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.1 mt -71.0 -31.37 45.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 129.491 3.117 . . . . 0.0 108.114 172.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -56.42 -44.54 80.48 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 126.896 2.622 . . . . 0.0 113.705 172.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.39 -47.7 84.95 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.105 2.162 . . . . 0.0 109.958 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -67.84 -69.18 0.33 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 128.167 2.587 . . . . 0.0 108.646 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -88.08 -32.83 18.53 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 121.176 3.769 . . . . 0.0 121.176 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.27 5.05 35.08 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 127.79 2.614 . . . . 0.0 114.384 172.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -93.63 135.07 25.54 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 101.289 -3.597 . . . . 0.0 101.289 -174.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.89 148.01 21.87 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 O-C-N 125.122 2.117 . . . . 0.0 110.817 174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -53.99 -30.37 58.83 Favored 'Trans proline' 0 N--CA 1.447 -1.263 1 C-N-CA 128.597 6.198 . . . . 0.0 118.427 -170.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -61.77 -27.01 68.43 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 130.585 3.554 . . . . 0.0 110.105 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -91.34 -12.95 33.47 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 117.159 -1.4 . . . . 0.0 113.008 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -89.12 121.71 31.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 122.722 2.51 . . . . 0.0 111.703 -174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -88.15 110.06 20.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 151.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.7 mt -91.92 92.01 8.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 153.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mt -96.88 137.02 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 128.914 2.886 . . . . 0.0 105.23 -173.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -116.56 -149.85 0.45 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 115.214 -2.327 . . . . 0.0 107.764 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 66.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 131.233 3.813 . . . . 0.0 115.465 171.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.99 -22.51 0.75 Allowed Glycine 0 CA--C 1.533 1.171 1 C-N-CA 130.906 4.098 . . . . 0.0 117.343 -164.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -82.92 128.93 34.9 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 120.718 -1.46 . . . . 0.0 113.494 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.306 19.9 mp0 -90.73 107.99 19.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 126.078 2.111 . . . . 0.0 105.711 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.61 107.44 1.4 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.913 2.485 . . . . 0.0 113.123 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.45 142.18 32.12 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.966 2.906 . . . . 0.0 110.884 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -67.92 109.94 3.65 Favored 'General case' 0 N--CA 1.45 -0.466 1 C-N-CA 133.431 4.692 . . . . 0.0 109.616 -172.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.43 -8.59 58.7 Favored Glycine 0 CA--C 1.528 0.845 1 CA-C-O 112.669 -4.406 . . . . 0.0 113.039 -171.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.72 153.65 38.75 Favored 'General case' 0 C--N 1.323 -0.553 1 CA-C-N 125.18 4.49 . . . . 0.0 110.258 165.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.259 67.7 p -77.38 -178.56 5.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 124.253 1.977 . . . . 0.0 106.475 169.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.293 26.0 mt -77.15 -38.46 51.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.383 164.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.8 t -62.42 -23.24 66.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 112.191 -3.766 . . . . 0.0 111.609 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.96 -35.43 74.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 122.011 2.187 . . . . 0.0 109.215 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -100.66 8.4 43.37 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 128.327 2.651 . . . . 0.0 108.911 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.32 2.3 p-10 52.96 46.32 27.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.152 1.781 . . . . 0.0 115.614 170.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.251 24.9 mt -92.46 117.52 35.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 123.662 1.696 . . . . 0.0 110.06 -167.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -98.85 169.01 9.76 Favored 'General case' 0 N--CA 1.45 -0.448 1 O-C-N 116.138 -4.101 . . . . 0.0 112.776 -176.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.291 20.6 pttt -37.88 152.18 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 115.512 -2.185 . . . . 0.0 115.283 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 77.05 -9.91 1.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.3 m -62.58 132.09 51.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 119.406 -2.059 . . . . 0.0 116.184 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.4 m -109.31 111.13 22.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.462 ' N ' HD11 ' A' ' 67' ' ' LEU . 5.8 mp -83.53 146.39 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.622 3.569 . . . . 0.0 107.825 170.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.265 50.0 t60 -103.75 111.03 23.36 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 117.364 -3.335 . . . . 0.0 111.975 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.3 1.3 tt -90.78 131.43 36.44 Favored 'General case' 0 N--CA 1.45 -0.468 1 O-C-N 131.093 5.246 . . . . 0.0 104.907 -175.402 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.343 16.7 m -147.19 169.28 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 128.515 2.726 . . . . 0.0 111.236 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.284 10.9 tp -92.79 129.49 38.7 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.931 2.892 . . . . 0.0 107.42 -172.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -69.46 97.04 0.95 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 130.414 3.486 . . . . 0.0 106.567 174.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.6 mt -96.42 102.2 13.95 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 152.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.409 27.2 ttt180 91.57 -64.4 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 128.991 2.916 . . . . 0.0 108.12 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.54 -174.17 44.61 Favored Glycine 0 CA--C 1.526 0.754 1 C-N-CA 132.338 4.78 . . . . 0.0 112.625 174.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.479 2 N-CA-C 101.356 -4.698 . . . . 0.0 101.356 -172.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -113.82 140.29 48.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 124.082 1.896 . . . . 0.0 108.528 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 pt -146.44 160.01 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 100.428 -3.915 . . . . 0.0 100.428 172.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.387 31.3 m-85 -105.36 134.74 47.97 Favored 'General case' 0 N--CA 1.445 -0.694 1 CA-C-N 107.749 -4.296 . . . . 0.0 105.13 -173.116 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 t -106.45 132.09 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 119.706 -1.872 . . . . 0.0 107.549 166.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -84.78 123.69 30.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 159.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.0 p -80.27 167.74 19.91 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.675 2.39 . . . . 0.0 116.297 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -60.67 -10.97 6.02 Favored 'General case' 0 C--N 1.321 -0.646 1 C-N-CA 133.211 4.605 . . . . 0.0 113.742 175.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -122.62 2.41 9.54 Favored 'General case' 0 C--N 1.33 -0.249 1 O-C-N 114.033 -5.417 . . . . 0.0 117.205 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.24 -14.02 28.33 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 117.9 1.92 . . . . 0.0 117.9 166.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -82.28 167.18 18.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.591 2.356 . . . . 0.0 110.471 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.5 m -111.98 121.38 44.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 129.728 3.211 . . . . 0.0 105.476 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.31 19.4 pt -103.57 146.19 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 128.786 2.834 . . . . 0.0 103.987 163.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 m -78.54 153.3 31.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 129.074 2.95 . . . . 0.0 109.963 149.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.83 159.63 43.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 126.87 3.224 . . . . 0.0 105.755 161.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.66 112.56 19.03 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 126.782 3.182 . . . . 0.0 107.513 -171.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.41 165.19 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 116.774 -3.704 . . . . 0.0 107.648 -173.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.283 1.6 tm-20 -103.85 149.29 37.01 Favored Pre-proline 0 N--CA 1.44 -0.967 0 O-C-N 118.387 -2.695 . . . . 0.0 108.613 161.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -53.64 -18.65 12.35 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 125.191 3.927 . . . . 0.0 114.344 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.9 p -77.22 -7.77 56.45 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 119.321 3.082 . . . . 0.0 119.321 170.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.36 126.97 29.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.601 1.191 . . . . 0.0 110.833 164.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.5 p -89.41 163.91 15.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 117.331 -1.748 . . . . 0.0 108.953 170.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.325 0.9 OUTLIER -34.77 -51.53 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 113.09 -3.338 . . . . 0.0 113.481 173.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.262 3.5 tp10 -67.07 -23.71 65.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 129.34 3.056 . . . . 0.0 114.696 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -74.11 -40.33 62.75 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 166.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.51 -40.89 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 O-C-N 118.716 -2.49 . . . . 0.0 106.11 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -43.28 -45.69 5.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 129.471 3.109 . . . . 0.0 118.173 172.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.81 -37.48 48.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.769 2.028 . . . . 0.0 109.828 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.371 78.0 mttt -61.2 -43.6 98.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 124.85 2.262 . . . . 0.0 111.475 177.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.45 -53.3 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 127.94 2.496 . . . . 0.0 107.262 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -49.35 -48.55 46.53 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 117.632 -3.168 . . . . 0.0 116.003 165.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.12 -33.4 70.81 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 116.834 -1.555 . . . . 0.0 110.888 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -97.29 -51.47 4.17 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 123.449 2.84 . . . . 0.0 107.648 -172.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -102.81 -31.08 10.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 127.561 2.344 . . . . 0.0 113.347 -167.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.76 9.87 24.0 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 163.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mt -90.11 127.11 54.78 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 118.756 1.278 . . . . 0.0 107.997 -162.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.75 130.22 33.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 125.289 3.992 . . . . 0.0 114.42 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.25 2.4 Cg_endo -72.63 -2.82 12.41 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.239 1.959 . . . . 0.0 113.564 173.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -79.42 -14.17 59.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 160.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -98.6 -25.97 14.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.212 1.805 . . . . 0.0 108.551 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -86.05 111.56 20.43 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 115.476 -2.202 . . . . 0.0 108.89 -172.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -105.5 148.5 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 128.164 3.415 . . . . 0.0 106.489 154.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.56 113.68 26.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 131.308 3.843 . . . . 0.0 110.597 157.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mm -122.49 119.85 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -143.32 111.53 6.19 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.898 -1.955 . . . . 0.0 107.501 -167.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 73.49 24.87 2.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 129.583 3.153 . . . . 0.0 112.408 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.65 7.58 50.78 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-O 115.347 -2.919 . . . . 0.0 114.797 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -138.69 150.72 46.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 123.686 3.743 . . . . 0.0 108.216 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -66.16 135.49 54.6 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 111.237 -2.71 . . . . 0.0 111.793 161.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.4 mt -91.62 149.54 21.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 117.638 -1.173 . . . . 0.0 107.96 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.254 10.1 tp10 -142.07 166.78 23.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.39 2.276 . . . . 0.0 115.378 -149.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.72 122.61 18.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.265 2.226 . . . . 0.0 115.053 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.71 -21.9 17.85 Favored Glycine 0 CA--C 1.537 1.418 0 O-C-N 120.337 -1.477 . . . . 0.0 111.289 163.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.319 0.3 OUTLIER -78.69 138.31 38.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.841 1.656 . . . . 0.0 108.038 169.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.8 p -84.1 156.79 21.98 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.2 mt -42.94 -39.54 2.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 160.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.416 3.8 p -54.49 -46.33 73.41 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 117.426 -3.296 . . . . 0.0 117.223 161.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -65.04 -13.24 57.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 122.665 2.484 . . . . 0.0 114.029 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -104.5 10.0 35.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 119.527 -1.983 . . . . 0.0 111.681 172.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 60.46 18.74 8.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 130.312 3.445 . . . . 0.0 115.77 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.9 mt -72.92 122.63 26.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -115.5 143.5 45.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.147 3.379 . . . . 0.0 112.474 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -30.2 131.73 0.08 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.441 2.697 . . . . 0.0 116.116 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 78.57 23.74 0.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.963 2.905 . . . . 0.0 111.128 164.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.6 m -97.97 161.06 13.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 129.137 2.975 . . . . 0.0 113.301 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -102.9 118.56 37.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 112.751 -3.5 . . . . 0.0 111.017 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 mt -93.17 162.86 13.85 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 125.806 1.941 . . . . 0.0 108.138 160.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -125.54 158.74 33.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.972 2.509 . . . . 0.0 109.097 171.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.316 4.8 tt -115.08 149.57 37.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 131.356 3.862 . . . . 0.0 112.244 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.4 t -124.89 118.2 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.02 155.02 41.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 116.51 -1.709 . . . . 0.0 111.844 171.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -103.17 148.95 25.14 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 124.021 3.101 . . . . 0.0 104.927 148.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.6 34.63 2.37 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 -164.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttp85 -89.61 118.91 29.58 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 123.029 2.65 . . . . 0.0 107.67 161.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.35 -137.06 13.33 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 118.661 -2.525 . . . . 0.0 107.799 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 115.77 -2.683 . . . . 0.0 106.918 -177.063 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttp . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 116.739 -1.6 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -100.49 134.17 43.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 -154.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.3 pt -117.32 150.01 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.93 158.07 15.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 118.667 -2.521 . . . . 0.0 108.835 162.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -140.34 138.25 36.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 173.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -112.13 128.23 56.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.546 2.338 . . . . 0.0 104.72 172.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.284 21.8 m -94.89 140.21 30.24 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 111.215 -2.721 . . . . 0.0 104.573 169.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tt -24.14 -39.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 131.204 3.802 . . . . 0.0 118.952 165.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -67.32 -10.55 51.99 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 118.913 -2.367 . . . . 0.0 117.122 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.78 14.41 55.17 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 118.908 -2.37 . . . . 0.0 109.193 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -90.9 121.44 32.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 130.755 3.622 . . . . 0.0 106.062 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.2 m -103.72 138.94 39.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.066 2.546 . . . . 0.0 105.312 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.1 172.27 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 128.313 2.645 . . . . 0.0 104.661 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 t -139.8 139.66 36.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 118.137 -2.852 . . . . 0.0 112.864 172.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 mp -132.08 132.55 43.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 128.275 3.484 . . . . 0.0 105.749 -177.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -76.55 122.71 24.98 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 127.455 2.302 . . . . 0.0 109.456 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.34 -174.88 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -128.05 160.14 63.16 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 165.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.93 -39.01 94.55 Favored 'Trans proline' 0 N--CA 1.445 -1.343 1 C-N-CA 126.355 4.703 . . . . 0.0 112.593 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.3 m -78.91 6.78 8.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -78.29 129.04 34.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 117.271 -3.393 . . . . 0.0 107.61 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -52.55 151.48 4.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 129.269 3.028 . . . . 0.0 110.832 168.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -54.91 -39.43 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.717 2.407 . . . . 0.0 111.664 158.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -50.24 -53.23 29.65 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.531 1.932 . . . . 0.0 114.405 171.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -54.62 -35.67 63.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 165.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -75.75 -42.11 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 119.707 -1.87 . . . . 0.0 111.977 -175.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -63.81 -35.75 81.64 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 125.724 1.89 . . . . 0.0 113.655 168.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.43 58.14 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.702 1.601 . . . . 0.0 107.133 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -83.48 -44.2 14.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 118.347 -2.721 . . . . 0.0 109.847 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.374 82.3 mt -42.46 -44.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 129.975 3.31 . . . . 0.0 114.59 164.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -57.24 -43.57 83.05 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.683 1.993 . . . . 0.0 116.226 172.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.19 -41.51 63.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -63.98 -49.08 73.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 131.696 3.998 . . . . 0.0 115.674 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -144.13 -7.15 0.72 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -171.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.12 -1.15 21.01 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 119.054 -2.279 . . . . 0.0 115.313 164.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.9 mt -78.86 118.88 74.99 Favored Pre-proline 0 C--O 1.22 -0.472 0 CA-C-O 114.385 -2.721 . . . . 0.0 108.024 -162.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.7 149.19 78.83 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 O-C-N 125.783 2.465 . . . . 0.0 114.985 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.24 -32.36 1.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.447 1.432 . . . . 0.0 113.835 -165.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -86.05 7.02 26.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 129.62 3.168 . . . . 0.0 111.587 -169.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -132.38 -9.24 3.3 Favored 'General case' 0 C--N 1.325 -0.488 1 C-N-CA 132.103 4.161 . . . . 0.0 111.759 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.269 4.5 tt0 -103.03 139.24 38.84 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 128.43 2.692 . . . . 0.0 107.29 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -146.6 132.19 18.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 101.94 -3.355 . . . . 0.0 101.94 -171.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mp -114.68 141.64 47.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.796 -163.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.278 77.7 mt -128.96 138.67 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 1 C-N-CA 133.049 4.54 . . . . 0.0 109.784 -178.605 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -150.61 111.14 4.22 Favored 'General case' 0 N--CA 1.448 -0.566 1 C-N-CA 131.739 4.015 . . . . 0.0 109.309 176.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.312 . . 68.56 31.06 4.91 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.85 -23.34 9.25 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.32 1.438 . . . . 0.0 111.526 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -74.3 126.67 31.15 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 110.65 6.75 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 129.304 3.042 . . . . 0.0 106.717 160.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.9 mt -82.41 128.87 34.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -78.15 159.41 28.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.578 1.551 . . . . 0.0 111.31 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -73.91 133.19 43.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.493 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.59 -15.48 55.82 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 115.11 -3.05 . . . . 0.0 111.733 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -77.21 159.7 29.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 123.043 3.421 . . . . 0.0 114.692 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -106.44 -177.77 3.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 127.935 3.272 . . . . 0.0 110.785 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.34 -18.21 46.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 128.58 2.752 . . . . 0.0 109.095 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.83 -28.41 50.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.788 2.035 . . . . 0.0 110.815 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -64.6 -31.11 72.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 126.445 3.021 . . . . 0.0 115.675 172.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.96 8.61 13.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 124.636 2.16 . . . . 0.0 115.46 -173.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.291 36.3 m-20 67.16 39.16 3.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 120.906 3.669 . . . . 0.0 120.906 163.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.2 mt -88.75 128.24 41.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.596 -164.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -98.23 165.12 12.02 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 124.824 2.25 . . . . 0.0 115.314 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -63.88 127.8 33.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.96 -2.963 . . . . 0.0 107.491 -168.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.468 0.0 OUTLIER 93.28 3.98 0.06 Allowed 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 126.297 2.248 . . . . 0.0 113.666 175.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.9 m -61.05 144.02 54.26 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 117.029 -3.544 . . . . 0.0 109.854 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -92.55 117.34 29.85 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 118.441 -2.662 . . . . 0.0 114.047 170.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.25 23.4 tp -107.12 134.42 50.27 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 125.131 1.519 . . . . 0.0 109.094 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -107.73 152.47 24.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.9 155.23 42.73 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 126.021 2.819 . . . . 0.0 107.575 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.93 137.44 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 131.439 3.896 . . . . 0.0 103.471 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.447 0.7 OUTLIER -119.8 125.3 48.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 114.839 -2.505 . . . . 0.0 111.391 176.097 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.411 3.6 ttt180 96.72 -4.4 0.06 Allowed 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 127.375 2.922 . . . . 0.0 115.289 164.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -143.03 158.67 43.39 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.713 1.605 . . . . 0.0 108.842 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -76.37 90.79 3.23 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.25 157.34 15.17 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 116.482 -2.288 . . . . 0.0 116.132 171.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 O-C-N 127.744 2.673 . . . . 0.0 106.769 -168.367 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 ttp . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 101.966 -3.346 . . . . 0.0 101.966 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -88.5 135.96 33.22 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 121.701 2.046 . . . . 0.0 114.27 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.279 44.4 pt -119.42 148.02 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 128.626 2.77 . . . . 0.0 113.771 168.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -99.55 115.89 30.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.701 2.4 . . . . 0.0 111.365 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.277 6.5 t -89.1 100.29 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 129.086 2.954 . . . . 0.0 103.053 172.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -74.11 156.83 36.98 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.242 -1.536 . . . . 0.0 114.721 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.445 13.0 t -150.71 164.46 36.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.57 171.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 tp -46.23 -39.98 10.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 121.37 3.841 . . . . 0.0 121.37 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.8 p -82.15 -1.26 48.28 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 123.849 1.785 . . . . 0.0 111.425 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.37 8.94 55.95 Favored Glycine 0 N--CA 1.443 -0.852 0 O-C-N 116.71 -3.744 . . . . 0.0 116.539 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -76.32 132.45 39.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.027 2.931 . . . . 0.0 106.733 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 p -112.94 132.6 55.28 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 108.832 -3.803 . . . . 0.0 103.261 161.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 mt -102.03 135.12 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 159.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 t -81.88 115.89 21.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 125.587 1.804 . . . . 0.0 111.511 160.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.3 tp -116.81 129.68 56.24 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -80.4 143.94 33.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.786 1.755 . . . . 0.0 110.754 170.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.97 167.86 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 128.554 2.742 . . . . 0.0 109.822 164.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.263 9.0 tt0 -105.55 147.45 34.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 110.277 -3.147 . . . . 0.0 105.713 153.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -74.88 -25.21 12.34 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.075 1.85 . . . . 0.0 110.533 -172.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -63.97 -9.34 15.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 173.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -68.04 164.03 21.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 130.036 3.334 . . . . 0.0 111.286 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 p -124.09 148.09 47.39 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 128.822 2.849 . . . . 0.0 104.949 -164.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.92 -48.41 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 110.584 -3.007 . . . . 0.0 112.988 -171.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -67.17 -36.93 82.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -66.48 -39.71 88.91 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.27 86.9 t -70.47 -39.52 76.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 125.707 1.603 . . . . 0.0 110.405 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -56.67 -29.28 62.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 168.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.82 -41.21 62.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 166.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -64.49 -31.88 73.28 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 119.861 -1.774 . . . . 0.0 109.42 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.325 55.1 mt -62.48 -35.03 67.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.313 3.445 . . . . 0.0 110.614 165.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.26 -38.86 65.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 115.071 -2.395 . . . . 0.0 106.642 -174.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.45 1.5 t70 -37.95 -41.59 0.56 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.992 2.96 . . . . 0.0 118.992 166.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -81.46 -72.16 0.44 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.072 -1.876 . . . . 0.0 115.153 171.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -84.62 -19.87 32.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 116.535 -1.697 . . . . 0.0 115.179 -170.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.08 -9.47 56.42 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 116.867 -2.074 . . . . 0.0 111.036 159.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.09 137.31 37.47 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 123.001 1.381 . . . . 0.0 108.891 -169.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -55.95 139.96 85.26 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.292 2.661 . . . . 0.0 113.579 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.63 -26.47 12.92 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.067 2.512 . . . . 0.0 117.527 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -45.0 -38.65 4.91 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 130.812 3.645 . . . . 0.0 113.607 174.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.09 -4.11 36.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.25 2.22 . . . . 0.0 109.877 -171.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -98.17 117.82 33.39 Favored 'General case' 0 N--CA 1.451 -0.393 1 O-C-N 115.656 -4.403 . . . . 0.0 114.837 -170.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.258 16.4 ttm-85 -112.39 113.94 26.4 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.172 1.789 . . . . 0.0 110.881 163.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -83.21 143.51 30.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 120.59 -1.319 . . . . 0.0 109.473 163.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 tt -133.73 143.67 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 119.531 -1.981 . . . . 0.0 106.04 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -136.99 84.3 2.06 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -170.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 84.37 24.87 0.1 Allowed 'General case' 0 N--CA 1.448 -0.547 1 C-N-CA 133.205 4.602 . . . . 0.0 113.984 165.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.12 -1.85 26.92 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 119.184 -2.198 . . . . 0.0 113.674 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.353 40.8 ttmt -121.43 137.14 54.84 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.097 2.159 . . . . 0.0 107.017 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -73.04 128.09 34.46 Favored 'General case' 0 N--CA 1.442 -0.826 1 C-N-CA 135.108 5.363 . . . . 0.0 108.618 177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.2 mt -93.41 132.27 37.81 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 168.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -134.42 145.86 49.29 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 131.101 3.761 . . . . 0.0 109.532 -162.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.29 144.93 29.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.075 -2.329 . . . . 0.0 110.418 -163.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.52 4.59 23.28 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 116.951 -2.027 . . . . 0.0 116.194 -166.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.337 11.7 mtm180 -125.51 177.5 6.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.004 1.402 . . . . 0.0 113.367 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.3 p -95.95 175.25 6.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 119.339 -2.101 . . . . 0.0 110.927 158.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -57.91 -30.98 66.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 159.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 t -66.75 -25.67 66.61 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 113.093 -3.337 . . . . 0.0 114.115 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.73 -19.99 54.26 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 127.39 2.931 . . . . 0.0 109.494 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.295 23.3 m-85 -108.04 6.74 27.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.11 -2.244 . . . . 0.0 110.548 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.397 0.4 OUTLIER 68.86 30.73 4.59 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.849 2.059 . . . . 0.0 112.698 163.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mt -79.16 122.47 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 O-C-N 119.293 -2.13 . . . . 0.0 110.075 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -111.62 165.57 11.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.176 1.79 . . . . 0.0 112.607 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -46.85 143.96 2.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 119.643 -1.911 . . . . 0.0 115.719 171.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 63.72 21.44 12.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 128.981 2.912 . . . . 0.0 112.254 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 m -82.89 152.67 25.46 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.12 1.768 . . . . 0.0 107.476 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.6 m -109.91 105.84 15.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 127.714 3.134 . . . . 0.0 107.862 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -82.79 154.78 24.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 163.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -117.63 148.08 42.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 118.502 -2.624 . . . . 0.0 108.436 166.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.3 tp -109.28 147.55 32.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 124.829 2.252 . . . . 0.0 105.256 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.85 175.25 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 113.683 -3.056 . . . . 0.0 107.044 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.25 13.3 tp -106.73 149.35 27.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 128.402 3.564 . . . . 0.0 103.813 -170.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -116.89 87.2 2.65 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 -167.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.8 mt -96.8 131.07 43.9 Favored 'General case' 0 C--O 1.24 0.571 0 O-C-N 119.317 -2.114 . . . . 0.0 106.7 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 82.84 -32.26 0.09 Allowed 'General case' 0 N--CA 1.444 -0.747 1 C-N-CA 136.215 5.806 . . . . 0.0 112.15 148.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.23 -171.47 15.29 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 128.374 2.892 . . . . 0.0 106.825 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.198 0 CA-C-N 112.56 -1.82 . . . . 0.0 112.318 177.753 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 ttp . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -94.48 144.82 25.25 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 115.279 -2.296 . . . . 0.0 106.689 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 pt -146.57 172.66 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.842 2.457 . . . . 0.0 106.193 165.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -135.26 118.6 16.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 128.057 3.348 . . . . 0.0 107.987 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.27 129.1 44.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 131.199 3.799 . . . . 0.0 101.975 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -126.2 125.45 42.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 126.241 2.924 . . . . 0.0 111.812 172.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.3 p -84.55 151.56 24.47 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.301 80.7 mt -56.65 -10.34 0.98 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 131.105 3.762 . . . . 0.0 115.984 175.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 p -93.4 -24.3 18.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 128.724 2.81 . . . . 0.0 109.269 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.06 43.18 1.81 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.148 1.832 . . . . 0.0 116.276 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -115.56 110.11 18.76 Favored 'General case' 0 C--N 1.321 -0.641 2 C-N-CA 132.118 4.167 . . . . 0.0 110.727 169.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.6 m -85.72 111.94 20.59 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 124.44 2.067 . . . . 0.0 110.281 173.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.0 mt -100.02 116.15 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 128.089 3.804 . . . . 0.0 101.741 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.325 52.7 m -91.46 134.05 34.96 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 102.274 -3.232 . . . . 0.0 102.274 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tp -130.47 155.28 46.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.112 2.965 . . . . 0.0 110.116 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 126.31 53.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.6 m -134.53 163.77 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 -176.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -101.17 148.17 34.76 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 114.305 -2.76 . . . . 0.0 106.575 174.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.95 6.77 3.98 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 CA-C-N 126.251 3.268 . . . . 0.0 113.675 -171.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -118.05 -2.95 11.16 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 114.595 -2.621 . . . . 0.0 105.666 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.97 122.87 11.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.636 2.774 . . . . 0.0 105.942 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -66.77 158.38 30.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 127.784 3.178 . . . . 0.0 116.61 161.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mm -58.46 -33.44 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 123.341 2.791 . . . . 0.0 114.36 171.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -45.29 -49.59 12.55 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 164.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -70.76 -39.06 73.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.368 71.1 t -52.3 -37.84 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 127.59 2.356 . . . . 0.0 114.021 169.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -66.92 -31.38 71.93 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 116.791 -3.693 . . . . 0.0 115.832 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.47 -36.78 32.99 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.851 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.77 -29.7 70.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 116.801 -1.571 . . . . 0.0 114.833 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.99 -43.78 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 116.398 -1.763 . . . . 0.0 111.478 166.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -59.7 -39.66 85.33 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 114.125 -2.845 . . . . 0.0 110.583 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.14 -21.48 22.78 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.515 1.134 . . . . 0.0 113.72 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.251 18.3 mmtm -109.54 -49.91 3.05 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 117.358 -3.339 . . . . 0.0 107.025 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -103.24 -9.67 19.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 113.788 -3.006 . . . . 0.0 113.661 -165.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.98 -17.7 49.32 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 121.701 2.046 . . . . 0.0 112.69 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 pt -81.2 140.22 49.18 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 117.408 0.604 . . . . 0.0 111.184 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.41 140.85 30.82 Favored 'Trans proline' 0 N--CA 1.453 -0.882 1 C-N-CA 126.731 4.954 . . . . 0.0 114.971 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -40.81 -31.08 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.316 1 C-N-CA 127.373 5.382 . . . . 0.0 119.453 173.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.83 -54.81 42.13 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 131.471 3.908 . . . . 0.0 113.839 -174.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -80.02 -7.18 58.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 126.323 2.963 . . . . 0.0 114.549 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.62 145.78 25.01 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 117.573 -3.205 . . . . 0.0 111.103 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -123.67 130.95 53.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.503 1.521 . . . . 0.0 108.814 151.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -89.54 130.88 35.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -122.34 123.93 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 112.398 -2.183 . . . . 0.0 115.424 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -147.47 144.38 28.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 130.008 3.323 . . . . 0.0 113.848 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.62 24.68 14.04 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.938 2.495 . . . . 0.0 112.816 168.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.98 -2.32 69.02 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 114.909 0.723 . . . . 0.0 114.909 -177.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -134.64 155.82 49.82 Favored 'General case' 0 N--CA 1.447 -0.619 2 O-C-N 115.031 -4.805 . . . . 0.0 112.906 -170.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -79.12 133.6 36.75 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 125.435 2.541 . . . . 0.0 106.052 164.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 mt -80.47 136.39 36.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.769 -2.014 . . . . 0.0 114.565 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -76.89 144.05 39.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 116.884 -1.926 . . . . 0.0 111.464 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -66.67 -33.07 74.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.236 -168.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.28 -5.0 49.96 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 126.33 1.919 . . . . 0.0 111.564 -165.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.306 11.4 mmt180 -74.18 149.56 40.86 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.772 2.029 . . . . 0.0 114.616 161.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -103.87 159.76 15.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 127.215 3.388 . . . . 0.0 109.489 -172.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.2 mt -48.28 -47.45 36.35 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 110.025 -3.261 . . . . 0.0 111.915 162.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -59.8 -49.88 76.0 Favored 'General case' 0 N--CA 1.443 -0.805 1 O-C-N 129.694 4.371 . . . . 0.0 119.952 167.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 50.6 m-20 -50.06 -43.72 51.26 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 121.408 3.855 . . . . 0.0 121.408 165.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -93.28 1.28 57.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 73.57 50.8 0.12 Allowed 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 119.113 -2.242 . . . . 0.0 104.976 168.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.1 69.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 118.459 -2.65 . . . . 0.0 104.932 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -127.52 72.97 1.41 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.357 -147.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.416 10.9 tmtt? 89.03 90.87 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 O-C-N 125.285 1.616 . . . . 0.0 112.363 171.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 86.41 47.3 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 110.665 -2.971 . . . . 0.0 110.693 158.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 p -117.05 159.06 23.12 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.746 1.26 . . . . 0.0 108.733 171.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.5 m -108.8 137.46 46.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 125.495 2.569 . . . . 0.0 109.118 -172.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.256 0.9 OUTLIER -113.84 143.57 44.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 111.711 -2.495 . . . . 0.0 107.306 -173.923 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -90.49 136.85 32.8 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 130.481 3.512 . . . . 0.0 107.47 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.3 tp -121.32 113.9 20.57 Favored 'General case' 0 N--CA 1.451 -0.405 1 C-N-CA 131.754 4.022 . . . . 0.0 107.486 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -117.56 133.16 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 129.288 3.035 . . . . 0.0 104.388 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mp -122.38 150.43 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 125.811 2.72 . . . . 0.0 111.454 -166.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.269 34.8 ttt180 -92.69 44.27 1.15 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 127.767 2.427 . . . . 0.0 108.606 -176.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.302 2.3 pp -143.18 155.48 44.55 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.198 0.999 . . . . 0.0 108.374 -177.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -86.05 118.16 25.34 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 128.156 3.41 . . . . 0.0 107.216 -170.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.82 86.18 1.77 Allowed Glycine 0 CA--C 1.528 0.889 0 CA-C-N 123.123 2.692 . . . . 0.0 109.937 -159.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.314 0 CA-C-O 116.821 -2.099 . . . . 0.0 108.619 -174.392 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 113.788 -3.006 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.253 59.2 tt0 -104.57 164.82 11.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 125.586 1.804 . . . . 0.0 109.522 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -145.51 164.91 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 1 C-N-CA 134.746 5.219 . . . . 0.0 107.053 168.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.2 147.08 41.79 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 118.922 -2.361 . . . . 0.0 111.782 175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.68 113.66 28.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 113.333 -3.222 . . . . 0.0 106.558 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -87.74 143.73 27.0 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 126.522 2.388 . . . . 0.0 110.123 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -117.09 158.73 23.7 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 126.192 2.182 . . . . 0.0 109.49 -171.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 74.6 mt -50.44 -50.29 52.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 116.826 -3.671 . . . . 0.0 116.973 -175.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -138.11 34.14 2.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.21 -123.84 2.52 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 -172.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -138.47 -167.85 2.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.677 1.991 . . . . 0.0 111.204 -166.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 p -89.75 119.99 30.62 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.083 0.856 . . . . 0.0 110.909 149.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.2 mt -80.55 143.45 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 167.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.264 71.9 p -114.68 122.31 46.06 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 113.931 -2.937 . . . . 0.0 108.221 -169.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.419 HD23 HG12 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -128.68 134.22 48.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 122.3 2.318 . . . . 0.0 104.906 174.119 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.85 118.91 37.8 Favored 'General case' 0 N--CA 1.44 -0.962 1 N-CA-C 99.909 -4.108 . . . . 0.0 99.909 172.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.45 149.64 33.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 130.102 3.361 . . . . 0.0 107.478 -167.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -74.19 137.02 75.47 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -62.64 -5.48 7.26 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 CA-C-O 115.817 -1.826 . . . . 0.0 115.921 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.4 p -115.18 23.45 12.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -81.36 160.92 23.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 126.717 2.51 . . . . 0.0 115.498 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 p -102.28 140.79 36.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 131.595 3.958 . . . . 0.0 107.23 -162.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.3 mt -47.96 -47.1 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 125.803 1.641 . . . . 0.0 112.979 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.75 -38.59 89.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.989 1.722 . . . . 0.0 112.025 -173.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -72.45 -12.73 61.22 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.114 2.166 . . . . 0.0 110.797 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 t -99.42 -27.39 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 1 CA-C-O 110.642 -4.504 . . . . 0.0 106.288 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -56.73 -42.97 80.17 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 128.28 3.488 . . . . 0.0 109.907 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.17 -42.41 77.03 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.717 3.607 . . . . 0.0 112.001 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -64.26 -35.36 80.58 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.419 HG12 HD23 ' A' ' 15' ' ' LEU . 61.5 mt -72.91 -28.07 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.461 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -52.49 35.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 117.105 -3.497 . . . . 0.0 114.681 166.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.94 -30.17 63.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -101.31 -33.16 10.15 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.401 1.455 . . . . 0.0 112.647 -173.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.327 78.8 mm-40 -125.28 -19.14 5.17 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.12 2.73 51.55 Favored Glycine 0 N--CA 1.44 -1.098 0 O-C-N 117.559 -3.213 . . . . 0.0 115.719 170.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.3 mt -77.66 120.67 82.32 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 122.584 3.192 . . . . 0.0 109.945 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.47 159.11 49.34 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 N-CA-C 118.037 2.283 . . . . 0.0 118.037 169.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.47 -19.83 11.34 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 124.556 3.504 . . . . 0.0 114.529 -169.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -82.4 -12.2 58.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -76.41 -42.84 42.89 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.647 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -74.77 110.73 9.31 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 127.917 3.261 . . . . 0.0 107.934 -156.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -108.54 112.1 24.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 100.388 -3.93 . . . . 0.0 100.388 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.38 124.3 44.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.538 0.0 OUTLIER -127.3 137.31 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 117.637 -3.164 . . . . 0.0 113.259 -175.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.275 24.9 t80 -149.59 108.15 3.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.817 -1.538 . . . . 0.0 109.207 -165.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.4 23.34 6.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 127.043 3.306 . . . . 0.0 115.172 164.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.02 -17.86 47.54 Favored Glycine 0 CA--C 1.531 1.09 1 C-N-CA 136.234 6.635 . . . . 0.0 111.628 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -80.6 120.0 23.98 Favored 'General case' 0 N--CA 1.447 -0.607 1 C-N-CA 131.808 4.043 . . . . 0.0 107.824 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -73.06 131.59 42.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 115.417 -2.23 . . . . 0.0 114.604 159.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.364 39.2 mt -110.45 132.64 54.0 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 125.892 2.758 . . . . 0.0 107.264 -163.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -105.46 124.96 50.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 111.399 -2.637 . . . . 0.0 113.33 -169.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.267 0.0 OUTLIER -61.43 139.88 58.14 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 111.908 -2.405 . . . . 0.0 110.619 -172.435 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.81 -38.18 2.09 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 104.243 -3.543 . . . . 0.0 104.243 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -94.38 -178.37 4.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 -175.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.257 46.7 p -119.68 -175.84 3.04 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.753 -166.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.2 -41.87 96.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.154 1.381 . . . . 0.0 114.278 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 t -71.93 -32.91 67.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 131.011 3.725 . . . . 0.0 107.681 -170.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -71.46 -13.36 61.8 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 130.824 3.65 . . . . 0.0 112.698 -172.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -128.97 0.97 5.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.069 2.547 . . . . 0.0 111.466 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t30 57.41 53.89 7.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 128.815 2.846 . . . . 0.0 110.401 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.0 mt -92.46 112.57 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 100.395 -3.928 . . . . 0.0 100.395 168.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -130.86 171.41 13.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.39 -167.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.74 113.79 0.92 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 129.237 3.015 . . . . 0.0 112.218 -170.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 67.88 25.17 7.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 118.201 -2.812 . . . . 0.0 117.337 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.1 m -64.32 135.22 55.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 118.233 -2.792 . . . . 0.0 117.829 156.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.267 96.5 m -110.49 128.0 55.42 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 124.479 1.112 . . . . 0.0 108.563 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.261 1.2 mp -109.67 168.73 9.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 173.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -112.35 138.37 49.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.965 3.306 . . . . 0.0 107.668 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tp -126.79 114.76 18.38 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.908 1.683 . . . . 0.0 108.138 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.1 m -106.1 142.56 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.3 mt -101.19 150.91 22.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 116.005 -1.95 . . . . 0.0 111.649 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.469 HH11 ' HD3' ' A' ' 72' ' ' ARG . 17.6 ttt-85 -103.86 101.97 11.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 129.114 2.966 . . . . 0.0 103.35 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 mt -118.3 -23.14 7.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 130.166 3.387 . . . . 0.0 114.655 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.36 4.97 17.94 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 -169.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.09 -27.65 19.44 Favored Glycine 0 CA--C 1.53 0.985 1 C-N-CA 132.011 4.624 . . . . 0.0 110.784 169.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.58 -2.233 . . . . 0.0 111.107 157.276 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 123.544 1.64 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -105.13 130.18 53.36 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.725 3.21 . . . . 0.0 110.977 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.293 17.6 pt -133.04 140.85 46.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 1 C-N-CA 133.731 4.812 . . . . 0.0 113.345 177.596 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.409 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 49.3 m-85 -93.21 148.88 21.65 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 125.89 2.757 . . . . 0.0 112.226 170.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.55 126.57 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 118.812 -2.43 . . . . 0.0 105.304 170.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -87.2 112.29 21.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 115.687 -2.102 . . . . 0.0 114.796 171.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 p -62.68 155.62 25.85 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 119.748 1.158 . . . . 0.0 113.03 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.62 -36.26 80.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.17 2.588 . . . . 0.0 111.242 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -93.01 0.01 57.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.824 1.193 . . . . 0.0 112.682 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.93 20.51 6.01 Favored Glycine 0 N--CA 1.445 -0.719 0 O-C-N 118.484 -2.635 . . . . 0.0 116.212 142.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -84.89 152.58 23.45 Favored 'General case' 0 CA--C 1.538 0.503 1 C-N-CA 136.016 5.726 . . . . 0.0 107.247 171.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -112.38 137.07 51.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.351 1.2 pt -115.01 131.64 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 176.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.375 32.6 m -90.95 130.51 36.87 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 166.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tp -117.25 137.29 52.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 104.446 -2.428 . . . . 0.0 104.446 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -94.16 144.5 25.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 m -158.96 -177.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.257 2.223 . . . . 0.0 106.763 -177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -133.06 153.15 80.77 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 129.119 2.967 . . . . 0.0 106.394 166.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.34 0.1 OUTLIER -49.4 -24.33 8.6 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 N-CA-C 119.214 2.736 . . . . 0.0 119.214 167.107 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.9 p -84.57 -11.06 56.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 113.578 -3.106 . . . . 0.0 110.619 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -68.35 131.72 45.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 129.746 3.218 . . . . 0.0 113.593 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 69.6 p -82.45 164.62 20.85 Favored 'General case' 0 N--CA 1.449 -0.476 1 O-C-N 129.542 4.276 . . . . 0.0 111.879 178.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -59.64 -31.29 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 112.541 -2.118 . . . . 0.0 112.013 172.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -74.21 -16.64 60.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 124.468 2.08 . . . . 0.0 112.584 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -98.45 -28.59 13.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.12 2.568 . . . . 0.0 110.485 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.267 62.8 t -52.52 -59.48 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.823 2.449 . . . . 0.0 112.291 168.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.343 17.4 ptpt -53.87 -41.78 67.9 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 128.184 3.428 . . . . 0.0 113.456 177.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.05 -40.56 70.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 126.244 2.215 . . . . 0.0 113.013 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -77.34 -28.1 52.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.609 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.55 -34.73 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 O-C-N 119.614 -1.929 . . . . 0.0 112.261 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -58.88 -42.89 90.54 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 119.225 0.92 . . . . 0.0 113.163 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.69 -47.06 42.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.257 2.223 . . . . 0.0 112.784 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -68.46 -38.65 81.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.422 64.3 mm-40 -129.21 -18.56 3.64 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 130.093 3.357 . . . . 0.0 115.675 -154.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.77 -22.28 41.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.66 2.076 . . . . 0.0 114.686 163.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.4 mt -86.48 119.04 71.19 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 125.883 1.673 . . . . 0.0 109.638 -163.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -45.94 149.26 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.644 1 C-N-CA 127.615 5.543 . . . . 0.0 115.73 175.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -68.02 -32.51 28.05 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 124.535 3.49 . . . . 0.0 109.995 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.258 19.7 t70 -49.96 -35.92 26.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 117.042 -1.456 . . . . 0.0 114.144 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -101.55 -5.73 24.78 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 128.679 2.791 . . . . 0.0 107.325 -160.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -85.66 141.34 29.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 119.22 -2.175 . . . . 0.0 115.772 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -128.17 95.85 4.29 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.49 111.09 18.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 114.544 -2.646 . . . . 0.0 114.472 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mt -118.77 144.24 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 125.163 3.619 . . . . 0.0 110.383 -172.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -140.37 123.18 16.41 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 163.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.83 33.12 0.92 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 111.713 -2.494 . . . . 0.0 114.022 169.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.95 -33.88 4.99 Favored Glycine 0 C--O 1.221 -0.671 0 O-C-N 118.63 -2.543 . . . . 0.0 112.898 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -79.04 121.66 25.23 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 128.199 2.941 . . . . 0.0 112.171 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -79.51 111.38 15.72 Favored 'General case' 0 N--CA 1.454 -0.251 1 N-CA-C 100.023 -4.066 . . . . 0.0 100.023 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.67 123.01 24.83 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 127.826 2.45 . . . . 0.0 108.691 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -94.85 151.12 19.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 124.927 2.299 . . . . 0.0 108.389 -163.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.94 139.32 33.43 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 109.796 -3.365 . . . . 0.0 110.524 -168.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.47 -20.09 38.0 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.738 2.59 . . . . 0.0 116.291 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.8 mmm-85 -73.38 145.05 46.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 117.759 -3.201 . . . . 0.0 109.49 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 11.5 p -75.64 144.18 41.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.447 2.699 . . . . 0.0 107.026 167.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.0 mt -47.18 -37.67 10.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 166.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -67.91 -30.74 70.15 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -77.62 -36.9 51.23 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 126.262 1.825 . . . . 0.0 110.022 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -68.43 -20.98 64.68 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 115.742 -2.075 . . . . 0.0 115.839 170.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.341 29.5 m120 74.58 27.01 1.39 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 120.272 3.434 . . . . 0.0 120.272 -170.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 39.7 mm -81.18 112.52 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 O-C-N 117.863 -3.023 . . . . 0.0 109.065 -179.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.254 78.0 mm-40 -83.25 155.71 23.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.938 2.895 . . . . 0.0 114.319 177.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.55 127.38 15.41 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 131.343 3.857 . . . . 0.0 114.762 170.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 1.5 pt-20 65.2 33.13 9.55 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 125.685 2.659 . . . . 0.0 116.048 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -74.59 155.44 37.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 124.899 2.285 . . . . 0.0 111.746 160.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.409 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 20.6 m -116.21 104.39 11.47 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 111.537 -2.574 . . . . 0.0 105.516 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -94.86 159.77 14.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 130.77 3.628 . . . . 0.0 108.721 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.347 70.7 m80 -109.35 136.61 48.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 115.465 -2.207 . . . . 0.0 114.198 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.261 31.4 tp -108.94 117.5 34.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 126.006 2.066 . . . . 0.0 106.322 173.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -112.0 145.44 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 111.818 -2.446 . . . . 0.0 105.246 169.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.78 121.04 24.27 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 130.034 3.333 . . . . 0.0 110.538 168.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -68.07 -19.14 64.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.318 2.647 . . . . 0.0 111.033 172.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.336 0.0 OUTLIER -144.68 159.4 42.9 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 122.778 2.535 . . . . 0.0 116.689 157.158 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -123.38 -26.42 4.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.365 1.466 . . . . 0.0 111.708 166.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.9 147.16 7.9 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 162.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.653 1 CA-C-O 112.987 -4.229 . . . . 0.0 111.904 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pm0 -96.66 143.03 28.0 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.405 3.082 . . . . 0.0 109.509 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -132.72 158.09 43.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 1 C-N-CA 132.152 4.181 . . . . 0.0 105.976 152.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -100.66 138.94 37.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.596 1.958 . . . . 0.0 108.327 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.49 110.37 31.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 172.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -107.06 113.22 26.56 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 126.876 3.227 . . . . 0.0 106.28 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -79.19 148.1 32.4 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 117.399 -3.313 . . . . 0.0 105.527 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.53 -21.23 66.16 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 118.908 -2.37 . . . . 0.0 112.836 168.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 p -79.0 -1.32 34.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.003 1.721 . . . . 0.0 112.334 167.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.68 -27.09 22.12 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 115.867 -2.629 . . . . 0.0 112.251 160.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.402 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 66.7 tttt -64.32 139.6 58.78 Favored 'General case' 0 C--N 1.328 -0.352 1 C-N-CA 132.21 4.204 . . . . 0.0 108.179 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.9 m -117.26 112.72 21.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 124.524 2.107 . . . . 0.0 105.934 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.7 mt -101.16 138.03 26.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 1 C-N-CA 131.832 4.053 . . . . 0.0 106.646 176.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m -101.63 129.76 47.82 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 128.375 2.67 . . . . 0.0 107.297 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.299 62.0 mt -103.18 168.35 9.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.24 169.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.95 115.74 10.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 128.371 3.545 . . . . 0.0 101.811 169.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.52 167.55 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 103.876 -2.639 . . . . 0.0 103.876 -161.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 4.7 mm-40 -97.91 162.02 23.66 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 169.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.81 -6.24 18.3 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 124.213 3.275 . . . . 0.0 116.194 163.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.6 p -94.17 -0.64 55.1 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.477 1.911 . . . . 0.0 110.066 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -78.47 121.15 24.18 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -65.74 145.64 55.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.387 2.675 . . . . 0.0 112.342 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -66.46 88.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 123.322 1.534 . . . . 0.0 112.421 165.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 178.42 -54.48 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 131.11 3.764 . . . . 0.0 104.69 -177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.308 22.6 t-20 -52.11 -55.76 18.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 -174.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.322 40.9 t -72.6 -20.08 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 128.456 2.702 . . . . 0.0 110.996 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -71.38 -30.21 65.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 122.995 2.634 . . . . 0.0 108.507 172.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.66 -19.57 41.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 116.357 -1.782 . . . . 0.0 113.695 171.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -76.98 -35.72 56.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 116.564 -1.684 . . . . 0.0 109.342 163.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.2 mm -65.05 -38.47 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 124.644 2.164 . . . . 0.0 111.698 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -46.45 -61.49 1.78 Allowed 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 117.732 -3.105 . . . . 0.0 110.109 164.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.8 -37.66 84.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -78.65 -59.15 2.9 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 62.7 mm-40 -106.89 -0.36 23.29 Favored 'General case' 0 C--O 1.222 -0.351 0 O-C-N 125.691 1.869 . . . . 0.0 111.326 -162.026 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.18 13.7 76.35 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 129.8 3.571 . . . . 0.0 117.985 162.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.81 113.56 64.58 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -49.74 126.3 16.18 Favored 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 128.387 6.058 . . . . 0.0 113.767 167.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -41.76 -27.84 0.61 Allowed 'Trans proline' 0 C--N 1.323 -0.81 1 C-N-CA 125.685 4.257 . . . . 0.0 117.751 -177.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.81 -22.78 65.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 171.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -98.69 4.02 47.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.381 2.672 . . . . 0.0 114.708 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -95.81 113.28 24.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 113.835 -2.983 . . . . 0.0 105.133 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -95.71 141.48 29.14 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 123.763 2.983 . . . . 0.0 112.515 150.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.29 0.8 OUTLIER -157.52 117.46 3.4 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 116.603 -1.665 . . . . 0.0 108.811 -148.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mp -145.51 144.29 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 126.487 2.367 . . . . 0.0 106.43 -150.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 37.4 t80 -131.62 -37.98 1.18 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.27 3.028 . . . . 0.0 115.155 172.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.363 . . -148.11 56.68 1.07 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 129.177 2.991 . . . . 0.0 111.163 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.98 -3.54 77.27 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-O 113.809 -3.773 . . . . 0.0 119.499 168.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -146.06 176.27 9.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 120.466 2.133 . . . . 0.0 110.052 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.06 130.29 39.04 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.029 -1.896 . . . . 0.0 107.911 174.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -77.56 120.6 22.76 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.027 1.731 . . . . 0.0 109.349 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -67.02 123.87 21.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 125.947 2.784 . . . . 0.0 109.876 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.92 115.68 3.89 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.269 2.228 . . . . 0.0 110.751 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.79 -23.55 11.73 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 115.411 -2.883 . . . . 0.0 110.23 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -77.65 148.82 34.85 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -78.34 174.51 11.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.767 2.027 . . . . 0.0 111.956 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.1 -24.78 64.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.399 1.48 . . . . 0.0 112.095 167.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -66.33 -33.84 76.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.052 2.541 . . . . 0.0 113.216 172.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -75.87 -34.84 60.03 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 115.085 -2.388 . . . . 0.0 109.833 -175.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.7 1.92 51.5 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 128.784 3.803 . . . . 0.0 113.484 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 t30 60.45 39.66 18.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.797 2.039 . . . . 0.0 110.421 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.9 mt -90.84 137.67 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 102.14 -3.281 . . . . 0.0 102.14 -178.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.93 170.11 16.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -168.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -58.51 138.4 56.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 120.717 3.599 . . . . 0.0 120.717 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 4.8 tt0 75.35 22.21 1.71 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.547 2.739 . . . . 0.0 108.749 160.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.413 27.4 m -99.61 158.54 15.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 124.909 2.29 . . . . 0.0 109.149 174.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.9 m -62.44 130.9 47.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 116.508 -3.87 . . . . 0.0 111.709 161.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -117.16 143.29 46.0 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 159.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -109.23 143.19 39.01 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.708 2.403 . . . . 0.0 111.935 -169.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -128.52 128.81 45.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 129.426 3.091 . . . . 0.0 107.167 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.3 4.3 t -122.03 136.09 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 115.596 -2.145 . . . . 0.0 106.947 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.02 121.48 45.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.071 2.948 . . . . 0.0 115.303 -171.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 40.76 -28.25 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.891 1 C-N-CA 135.623 5.569 . . . . 0.0 119.899 -174.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.3 mt -117.58 149.48 40.59 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 101.528 -3.508 . . . . 0.0 101.528 -168.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.63 135.14 56.67 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 128.431 2.692 . . . . 0.0 111.572 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.31 47.26 1.04 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 127.442 2.449 . . . . 0.0 114.352 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.486 0 CA-C-O 114.492 -3.393 . . . . 0.0 110.805 -168.586 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttp . . . . . 0 N--CA 1.474 0.764 0 CA-C-O 122.092 0.948 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -115.88 145.23 43.05 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 117.335 -1.746 . . . . 0.0 106.389 -169.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -132.27 177.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 126.591 1.956 . . . . 0.0 108.902 171.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -124.36 149.4 46.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.93 111.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -72.43 115.14 11.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.298 2.239 . . . . 0.0 113.409 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.405 ' H ' ' HG1' ' A' ' 7' ' ' THR . 46.9 p -94.11 170.32 9.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 124.085 1.898 . . . . 0.0 107.301 -169.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.7 -15.79 62.22 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -164.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -73.46 -31.51 63.83 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 128.247 2.619 . . . . 0.0 111.244 165.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.63 2.6 27.31 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 129.031 3.205 . . . . 0.0 110.605 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -66.75 146.41 54.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 121.328 2.564 . . . . 0.0 114.478 171.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.0 m -116.33 106.75 14.0 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 114.012 -2.899 . . . . 0.0 104.164 -165.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mm -98.59 140.65 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -79.21 136.8 37.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 124.355 2.026 . . . . 0.0 109.77 167.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.64 135.85 32.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 -169.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.27 131.02 50.66 Favored 'General case' 0 C--O 1.238 0.448 1 CA-C-O 129.62 4.533 . . . . 0.0 108.138 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.14 -165.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 129.77 3.228 . . . . 0.0 118.481 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -149.65 139.28 13.13 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 167.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -61.21 -22.87 75.9 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 124.16 3.24 . . . . 0.0 118.477 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 m -90.98 -25.14 19.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 118.863 2.912 . . . . 0.0 118.863 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.85 106.28 4.12 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 130.08 3.352 . . . . 0.0 109.841 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -48.97 148.66 2.18 Favored 'General case' 0 N--CA 1.45 -0.436 1 C-N-CA 134.346 5.058 . . . . 0.0 113.139 -155.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.24 -39.62 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.157 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -47.18 -52.18 16.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.86 1.664 . . . . 0.0 111.387 170.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -69.69 -24.93 63.65 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.393 2.277 . . . . 0.0 114.27 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.275 99.4 t -56.82 -55.36 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 1 O-C-N 113.328 -5.858 . . . . 0.0 112.586 167.261 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -43.66 -42.61 5.37 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 127.443 2.297 . . . . 0.0 115.601 167.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.9 -32.44 73.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.734 3.213 . . . . 0.0 112.43 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.12 -31.86 70.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 124.819 2.247 . . . . 0.0 114.276 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -73.22 -40.19 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 127.37 2.268 . . . . 0.0 115.114 169.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.29 -37.76 49.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 127.78 2.432 . . . . 0.0 112.63 162.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -72.07 -38.19 69.48 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.034 0.533 . . . . 0.0 111.958 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -75.78 -51.88 11.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 129.069 2.948 . . . . 0.0 111.815 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -133.63 -0.16 3.22 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.246 1.498 . . . . 0.0 111.402 -160.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.87 -23.17 35.48 Favored Glycine 0 N--CA 1.44 -1.063 0 O-C-N 117.421 -3.299 . . . . 0.0 114.482 161.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.42 120.01 78.16 Favored Pre-proline 0 N--CA 1.441 -0.891 0 O-C-N 117.058 -3.613 . . . . 0.0 112.17 -171.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -72.23 142.24 37.29 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.007 3.138 . . . . 0.0 110.719 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -35.49 -42.87 0.49 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 123.88 3.053 . . . . 0.0 119.12 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.05 -18.17 32.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -119.54 1.25 11.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.372 -170.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -86.3 151.27 23.73 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 172.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -132.54 128.91 38.29 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.562 1.545 . . . . 0.0 108.875 151.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.6 mt -108.19 129.21 55.2 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 3.2 mt -112.24 128.59 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 129.215 3.006 . . . . 0.0 109.175 165.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -81.43 -36.3 29.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 119.039 -2.288 . . . . 0.0 106.535 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.08 -67.35 0.36 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.55 -24.78 1.21 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.247 1.88 . . . . 0.0 113.766 164.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -94.26 141.21 28.83 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.88 2.472 . . . . 0.0 106.595 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -70.63 140.27 51.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.224 3.01 . . . . 0.0 113.95 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 mt -93.15 100.37 12.77 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 126.191 1.796 . . . . 0.0 108.332 171.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -93.16 142.13 27.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 126.304 2.954 . . . . 0.0 106.39 -156.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.69 132.85 55.18 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 130.881 3.672 . . . . 0.0 108.492 172.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.15 -15.16 8.83 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 128.69 3.043 . . . . 0.0 115.4 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -124.47 179.61 4.87 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 128.808 2.843 . . . . 0.0 110.958 -163.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -115.65 164.62 14.07 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 118.53 -2.607 . . . . 0.0 109.409 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.2 mt -72.46 -14.43 61.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.545 -0.722 . . . . 0.0 111.476 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -72.61 -35.39 67.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 129.21 3.004 . . . . 0.0 106.921 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.369 21.3 m-20 -51.4 -36.88 45.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.849 2.46 . . . . 0.0 113.696 172.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -103.91 3.52 33.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 112.903 -3.427 . . . . 0.0 110.162 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.27 0.5 OUTLIER 33.95 63.85 0.38 Allowed 'General case' 0 N--CA 1.45 -0.464 1 C-N-CA 134.333 5.053 . . . . 0.0 114.73 -176.081 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.4 mm -77.6 135.9 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.206 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -100.27 171.66 7.64 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.316 1.446 . . . . 0.0 107.231 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -66.73 146.06 54.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 126.211 2.194 . . . . 0.0 108.456 -170.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 65.73 17.44 10.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.354 1.888 . . . . 0.0 113.765 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -62.99 148.16 48.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 162.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -100.11 106.7 18.46 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.446 2.698 . . . . 0.0 108.399 -176.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.2 159.9 14.65 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.85 0.75 . . . . 0.0 111.275 169.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.46 154.91 29.51 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.636 1.974 . . . . 0.0 108.043 170.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.342 4.3 pp -127.93 155.28 44.46 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 130.392 3.477 . . . . 0.0 116.238 177.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.23 148.2 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 130.304 3.442 . . . . 0.0 108.783 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.8 mt -54.13 129.3 34.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 130.572 3.549 . . . . 0.0 114.32 168.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -108.44 52.22 0.72 Allowed 'General case' 0 CA--C 1.534 0.332 0 O-C-N 125.526 1.766 . . . . 0.0 108.268 163.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.35 -176.11 2.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 117.731 -1.588 . . . . 0.0 114.257 152.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.6 ttm105 -146.53 -26.22 0.42 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 122.814 2.552 . . . . 0.0 109.12 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.56 165.78 24.39 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 124.541 2.189 . . . . 0.0 112.688 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 1 CA-C-O 111.623 -4.987 . . . . 0.0 113.405 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 ptt? . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -93.95 155.9 16.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 173.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.33 18.1 pt -133.15 158.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.922 2.489 . . . . 0.0 107.167 161.187 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -116.94 127.04 53.84 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 118.837 -2.414 . . . . 0.0 109.525 176.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.293 3.2 t -107.74 96.68 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 174.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -93.33 127.14 38.81 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 118.942 -2.349 . . . . 0.0 116.986 -171.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.54 150.23 44.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 130.429 3.492 . . . . 0.0 109.288 174.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.86 -25.77 64.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 116.038 -1.935 . . . . 0.0 107.713 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -80.42 2.92 23.09 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 131.165 3.786 . . . . 0.0 116.241 174.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.61 6.19 53.06 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.296 2.379 . . . . 0.0 108.829 154.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.4 mtmt -97.48 156.48 16.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 121.575 2.687 . . . . 0.0 106.188 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -125.56 129.28 49.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 126.52 2.388 . . . . 0.0 114.328 -178.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.66 116.78 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 1 N-CA-C 98.173 -4.751 . . . . 0.0 98.173 169.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -95.0 116.96 29.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.3 0.64 . . . . 0.0 109.664 170.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.325 32.4 mt -92.24 151.49 20.31 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.754 2.022 . . . . 0.0 106.912 -179.983 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -108.23 83.03 1.72 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.098 2.959 . . . . 0.0 108.458 -173.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.13 164.47 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 119.219 -2.175 . . . . 0.0 110.77 -168.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -108.28 160.09 28.31 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 130.564 3.546 . . . . 0.0 111.903 162.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.28 -20.89 27.46 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 CA-C-N 122.833 2.047 . . . . 0.0 114.126 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.2 p -94.09 1.33 56.17 Favored 'General case' 0 N--CA 1.447 -0.586 1 C-N-CA 133.659 4.784 . . . . 0.0 112.649 -176.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -61.62 139.85 58.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.312 2.245 . . . . 0.0 107.7 161.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.4 p -95.77 178.88 5.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.314 2.246 . . . . 0.0 106.462 170.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.9 mm -65.11 -34.85 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 1 C-N-CA 132.433 4.293 . . . . 0.0 106.055 170.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -64.95 -42.0 95.0 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 117.26 -3.4 . . . . 0.0 109.564 176.007 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -76.74 -41.51 44.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.958 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.54 -29.43 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 124.964 3.529 . . . . 0.0 111.869 176.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -52.19 -46.39 65.55 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.928 2.491 . . . . 0.0 116.557 165.339 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.55 -44.05 71.69 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 112.366 -2.197 . . . . 0.0 111.984 171.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -72.84 -33.19 65.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.525 -1.36 . . . . 0.0 112.082 -169.426 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -66.89 -41.84 88.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 120.359 -1.463 . . . . 0.0 109.311 171.229 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.76 84.3 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 124.868 1.355 . . . . 0.0 110.174 177.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.64 -38.53 80.56 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 119.778 -1.826 . . . . 0.0 114.021 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -68.66 -43.86 75.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 115.824 -2.036 . . . . 0.0 111.253 169.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.293 18.4 tp10 -136.21 12.04 3.3 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 117.231 -1.788 . . . . 0.0 110.453 -147.645 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 29.03 40.98 0.03 OUTLIER Glycine 0 CA--C 1.53 1.01 1 C-N-CA 132.848 5.023 . . . . 0.0 114.775 175.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -91.74 120.28 68.12 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 115.492 -2.194 . . . . 0.0 105.609 157.771 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.291 1.7 Cg_endo -45.87 144.62 5.6 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 O-C-N 125.693 2.417 . . . . 0.0 118.357 171.482 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.76 -10.66 10.55 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 O-C-N 125.844 2.497 . . . . 0.0 112.258 -163.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.87 -16.25 54.16 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 128.699 2.8 . . . . 0.0 111.5 173.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -74.5 -27.55 60.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.954 2.501 . . . . 0.0 112.673 174.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -95.36 147.69 23.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 129.349 3.06 . . . . 0.0 114.677 -168.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -115.59 117.2 29.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 172.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.0 mt -97.11 98.13 9.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 -166.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.304 74.1 mt -100.66 145.9 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 128.81 2.844 . . . . 0.0 113.673 -175.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -153.62 123.24 6.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 116.383 -3.948 . . . . 0.0 106.02 166.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.499 . . 74.73 25.25 1.53 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 170.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.94 7.78 67.91 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 130.049 3.69 . . . . 0.0 113.151 -174.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -134.6 150.02 50.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 123.549 3.674 . . . . 0.0 105.396 -166.19 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -87.86 127.82 35.35 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 128.567 2.747 . . . . 0.0 107.683 176.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.52 133.64 49.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 121.581 1.991 . . . . 0.0 113.386 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -83.24 124.74 30.86 Favored 'General case' 0 N--CA 1.447 -0.604 1 C-N-CA 133.867 4.867 . . . . 0.0 107.004 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.22 123.21 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 111.992 -2.367 . . . . 0.0 108.005 -175.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.16 31.12 3.4 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 114.924 -3.153 . . . . 0.0 115.7 -177.3 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -139.62 146.11 39.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 122.245 3.022 . . . . 0.0 108.555 170.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.8 p -79.46 155.7 28.18 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.6 mt -46.74 -64.05 0.87 Allowed 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.6 m -66.98 -41.7 86.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.392 1.877 . . . . 0.0 115.857 -172.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.265 11.0 t70 -51.34 -46.91 62.84 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 119.349 -2.094 . . . . 0.0 113.608 170.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.98 8.12 1.72 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 129.86 3.264 . . . . 0.0 114.857 174.66 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.372 3.4 t30 82.31 4.83 1.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 178.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.293 1.9 mt -94.27 91.21 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 123.177 1.465 . . . . 0.0 111.33 -178.304 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.251 46.6 mm-40 -96.52 -167.14 1.52 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 112.623 -2.081 . . . . 0.0 109.08 -175.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -68.48 131.52 45.41 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.865 -175.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.347 24.9 mt-10 76.96 36.53 0.32 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 130.51 3.524 . . . . 0.0 108.864 165.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.264 37.9 m -96.25 138.48 33.79 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 -170.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.2 m -96.5 118.76 33.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -178.758 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.6 mp -106.94 155.72 19.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.748 2.419 . . . . 0.0 105.708 159.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.23 139.86 46.27 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 126.415 2.322 . . . . 0.0 110.488 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 tp -82.86 121.85 27.47 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 126.371 2.295 . . . . 0.0 105.911 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -136.02 136.41 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 128.191 2.596 . . . . 0.0 104.68 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.18 163.66 15.64 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.26 43.6 ttt-85 -137.22 131.9 33.08 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.7 2.8 . . . . 0.0 107.684 170.482 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.267 34.1 mt -84.43 28.85 0.62 Allowed 'General case' 0 N--CA 1.454 -0.244 1 C-N-CA 135.294 5.437 . . . . 0.0 113.568 -168.783 . . . . . . . . 3 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -153.94 131.35 11.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.391 2.676 . . . . 0.0 108.037 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.88 -24.21 7.41 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-N 111.121 -2.763 . . . . 0.0 117.738 -174.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 129.997 3.665 . . . . 0.0 104.131 175.851 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.1 ttm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 117.224 -1.369 . . . . 0.0 107.754 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -98.55 137.64 36.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 125.374 1.671 . . . . 0.0 114.649 -174.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -133.29 177.43 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 120.134 -1.604 . . . . 0.0 113.17 171.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -125.23 133.51 52.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 130.178 3.391 . . . . 0.0 109.752 173.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.9 t -117.48 131.76 69.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 109.836 -3.347 . . . . 0.0 103.002 165.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -77.66 129.71 35.91 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 116.331 -1.795 . . . . 0.0 113.461 151.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -82.63 149.5 27.36 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.293 2.637 . . . . 0.0 104.41 172.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.22 -21.02 66.7 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.168 2.587 . . . . 0.0 111.404 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -70.73 -13.62 62.13 Favored 'General case' 0 C--N 1.326 -0.44 1 C-N-CA 132.056 4.142 . . . . 0.0 112.861 165.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.28 1.02 56.89 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.934 1.243 . . . . 0.0 115.301 165.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 155.16 18.96 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.195 -2.356 . . . . 0.0 110.435 166.848 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.6 m -98.07 152.39 19.36 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 100.448 -3.908 . . . . 0.0 100.448 -176.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.81 144.79 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 165.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -93.75 145.22 24.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 123.237 1.494 . . . . 0.0 107.203 165.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.414 2.1 pt? -148.25 159.5 43.91 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 120.276 3.436 . . . . 0.0 120.276 166.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -108.49 139.91 42.57 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 124.282 3.219 . . . . 0.0 109.89 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.266 7.5 p -138.21 178.95 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 127.967 3.292 . . . . 0.0 110.363 -177.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.9 tp10 -134.14 138.29 30.15 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 -177.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -44.34 -37.21 10.2 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 N-CA-C 119.559 2.869 . . . . 0.0 119.559 175.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.295 13.5 p -95.08 3.34 54.92 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 113.422 -3.18 . . . . 0.0 111.2 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -73.87 160.45 31.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 123.61 2.914 . . . . 0.0 105.355 169.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -102.94 155.2 18.52 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 119.311 -2.118 . . . . 0.0 112.181 -177.519 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.6 mm -63.88 -57.69 10.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 130.061 3.345 . . . . 0.0 111.777 -168.334 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.555 1.9 tt0 -44.57 -48.54 10.33 Favored 'General case' 0 C--O 1.222 -0.349 1 C-N-CA 132.632 4.373 . . . . 0.0 114.83 176.733 . . . . . . . . 3 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.284 26.3 t30 -49.06 -61.12 2.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 130.139 3.376 . . . . 0.0 111.666 -178.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -74.06 -39.55 50.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 128.742 2.817 . . . . 0.0 106.225 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -62.38 -28.35 69.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 112.716 -3.516 . . . . 0.0 112.196 -178.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.03 -14.39 31.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.87 2.577 . . . . 0.0 116.434 178.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -54.85 -27.34 41.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.466 2.307 . . . . 0.0 113.576 177.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tp -48.03 -22.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 1 C-N-CA 135.654 5.581 . . . . 0.0 117.382 -175.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -61.8 3.08 0.16 Allowed 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 170.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.513 32.9 t70 -19.15 -55.28 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 2 C-N-CA 135.112 5.365 . . . . 0.0 122.067 158.021 . . . . . . . . 3 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.254 1.6 pptp? -149.15 -19.52 0.29 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 122.265 2.302 . . . . 0.0 112.22 -160.135 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.413 1.1 pm0 -124.85 169.3 12.18 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 147.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.81 62.11 0.33 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 105.602 -2.999 . . . . 0.0 105.602 -175.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.8 pt -86.64 148.98 47.62 Favored Pre-proline 0 N--CA 1.448 -0.572 0 C-N-CA 130.196 3.398 . . . . 0.0 109.793 178.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -76.27 136.42 17.88 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.742 2.294 . . . . 0.0 113.661 171.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -77.29 -16.1 15.61 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.997 3.131 . . . . 0.0 112.099 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.3 -15.4 62.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 124.0 3.091 . . . . 0.0 108.136 178.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -90.73 17.32 7.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.986 2.114 . . . . 0.0 115.439 176.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -142.33 160.09 40.94 Favored 'General case' 0 N--CA 1.446 -0.633 1 C-N-CA 136.984 6.114 . . . . 0.0 113.022 173.221 . . . . . . . . 4 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -149.8 146.97 27.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 131.341 3.857 . . . . 0.0 111.534 -178.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.57 121.81 38.8 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.959 3.304 . . . . 0.0 113.265 177.049 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.3 mt -91.96 144.58 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 156.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CG ' ' N ' ' A' ' 46' ' ' ALA 0.303 4.7 p90 -111.91 -76.37 0.6 Allowed 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 169.747 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' N ' ' CG ' ' A' ' 45' ' ' PHE . . . -130.5 82.93 2.08 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 100.854 -3.758 . . . . 0.0 100.854 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.24 61.33 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 112.444 -2.162 . . . . 0.0 117.084 165.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -147.83 172.79 13.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 129.21 3.004 . . . . 0.0 113.862 -171.22 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 142.89 35.95 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 128.214 2.606 . . . . 0.0 112.836 -170.177 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.9 mt -74.34 165.9 24.4 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 129.492 3.117 . . . . 0.0 113.06 169.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -151.97 150.85 30.47 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 129.719 3.208 . . . . 0.0 116.59 175.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -43.8 132.48 5.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.28 -26.24 7.1 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.221 1.391 . . . . 0.0 112.979 173.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 163.64 12.47 Favored 'General case' 0 N--CA 1.444 -0.731 1 C-N-CA 133.426 4.69 . . . . 0.0 108.295 -164.916 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 p -103.68 173.17 6.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 113.545 -1.662 . . . . 0.0 106.536 167.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.45 -34.18 74.98 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.364 175.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -78.81 -8.95 59.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.123 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -69.2 -31.62 70.34 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 125.494 1.747 . . . . 0.0 109.842 160.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -110.93 11.47 22.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.424 16.1 m120 83.4 -6.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 163.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -69.92 135.24 28.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -157.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.4 -166.79 2.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 114.183 -2.818 . . . . 0.0 110.536 -162.478 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.36 110.69 0.33 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 165.015 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 78.1 mt-10 73.35 31.79 1.33 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 131.02 3.728 . . . . 0.0 115.177 175.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 m -70.14 121.91 18.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 128.014 2.526 . . . . 0.0 107.07 172.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.4 m -97.58 114.35 26.25 Favored 'General case' 0 C--N 1.32 -0.683 1 N-CA-C 97.522 -4.992 . . . . 0.0 97.522 -178.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.2 mp -95.71 151.52 19.28 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 130.453 3.501 . . . . 0.0 107.453 171.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -118.98 134.7 55.02 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 126.581 2.426 . . . . 0.0 112.775 168.795 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 tp -100.93 124.88 47.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -174.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.42 ' CG2' ' H ' ' A' ' 71' ' ' LEU 0.353 7.5 p -140.18 -146.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 126.198 1.799 . . . . 0.0 112.027 173.959 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.42 ' H ' ' CG2' ' A' ' 70' ' ' VAL 0.542 1.8 pt? -150.09 165.75 31.86 Favored 'General case' 0 N--CA 1.45 -0.446 1 C-N-CA 132.0 4.12 . . . . 0.0 111.26 179.953 . . . . . . . . 4 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -67.66 121.0 14.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.388 177.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.349 5.2 mp -122.19 51.62 1.35 Allowed 'General case' 0 CA--C 1.534 0.341 1 C-N-CA 132.705 4.402 . . . . 0.0 108.307 179.777 . . . . . . . . 3 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -144.34 131.39 20.5 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 127.613 3.071 . . . . 0.0 105.119 173.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.75 -8.93 19.97 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 130.13 3.729 . . . . 0.0 109.402 -178.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 N-CA-C 105.525 -3.03 . . . . 0.0 105.525 164.968 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 117.646 -1.169 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -74.37 121.2 21.02 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -170.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -136.15 174.95 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 123.606 2.912 . . . . 0.0 113.756 170.682 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -123.73 155.14 38.41 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.843 2.457 . . . . 0.0 113.65 169.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.2 130.9 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 O-C-N 118.195 -2.816 . . . . 0.0 105.945 161.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.272 64.8 tttt -111.49 131.35 55.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 118.829 -2.419 . . . . 0.0 104.529 176.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.8 p -98.79 168.95 9.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.516 2.726 . . . . 0.0 105.48 -166.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.9 mt -93.16 -0.02 57.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 130.887 3.675 . . . . 0.0 112.346 175.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 p -102.59 -23.63 13.85 Favored 'General case' 0 N--CA 1.444 -0.762 1 C-N-CA 134.187 4.995 . . . . 0.0 109.942 172.707 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.09 -6.71 11.97 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 116.635 -2.203 . . . . 0.0 110.594 147.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -61.45 149.92 37.13 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 157.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -112.45 117.84 33.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 163.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mt -101.46 133.15 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 101.756 -3.424 . . . . 0.0 101.756 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -94.46 146.78 23.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.473 1.909 . . . . 0.0 110.624 177.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.9 -177.21 3.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -176.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -149.88 117.48 6.17 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 116.536 -1.697 . . . . 0.0 107.987 170.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -131.32 148.26 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 C-N-CA 133.112 4.565 . . . . 0.0 107.237 -176.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -81.99 141.53 47.26 Favored Pre-proline 0 N--CA 1.443 -0.785 0 CA-C-O 115.747 -2.073 . . . . 0.0 107.56 172.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -45.12 -35.16 10.35 Favored 'Trans proline' 0 N--CA 1.45 -1.071 1 C-N-CA 127.821 5.681 . . . . 0.0 114.169 173.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.7 p -77.07 -19.46 57.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.611 2.764 . . . . 0.0 113.918 176.71 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.75 126.53 28.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.704 2.047 . . . . 0.0 109.053 -173.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -70.44 150.99 45.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.1 0.96 . . . . 0.0 112.496 170.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 15.8 mm -55.13 -26.98 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 127.901 2.481 . . . . 0.0 114.777 -178.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.259 8.4 pt-20 -61.71 -33.94 74.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 166.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -92.53 -33.14 14.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -167.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.284 75.4 t -39.85 -42.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 130.631 3.573 . . . . 0.0 113.256 158.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -74.02 -16.21 61.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.97 -37.65 54.8 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 126.856 2.062 . . . . 0.0 105.52 -173.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -75.86 -26.16 56.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 130.013 3.325 . . . . 0.0 109.047 -175.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -77.68 -22.84 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 126.795 2.559 . . . . 0.0 111.441 173.236 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -69.17 -43.09 74.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.977 1.311 . . . . 0.0 110.994 -175.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.429 21.8 t70 -56.93 -36.19 69.92 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 129.908 3.283 . . . . 0.0 116.161 -179.373 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -103.46 -27.93 12.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 109.426 -3.534 . . . . 0.0 115.402 -173.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -116.75 -13.78 10.77 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 124.812 2.244 . . . . 0.0 116.201 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.8 -0.96 56.57 Favored Glycine 0 CA--C 1.526 0.753 0 O-C-N 117.642 -3.161 . . . . 0.0 110.594 165.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.75 130.24 23.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 129.396 3.078 . . . . 0.0 111.569 -156.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.92 162.11 20.93 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 121.022 1.148 . . . . 0.0 110.223 -173.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -52.49 -21.86 15.1 Favored 'Trans proline' 0 N--CA 1.449 -1.109 1 C-N-CA 126.07 4.513 . . . . 0.0 117.718 170.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -57.32 -26.92 61.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 126.996 2.685 . . . . 0.0 117.935 164.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -97.79 -28.81 13.7 Favored 'General case' 0 C--O 1.221 -0.417 1 C-N-CA 131.848 4.059 . . . . 0.0 113.093 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.74 93.83 2.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.037 2.135 . . . . 0.0 107.522 -177.279 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 mtp85 -110.74 100.84 9.53 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.083 1.753 . . . . 0.0 114.667 167.734 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.3 mt -100.17 139.9 35.17 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 110.753 -2.931 . . . . 0.0 109.789 -165.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.48 160.72 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 174.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -149.62 124.1 9.68 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.985 2.914 . . . . 0.0 103.536 168.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.75 28.31 6.19 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 128.657 2.783 . . . . 0.0 115.664 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.29 3.23 90.62 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 128.194 3.433 . . . . 0.0 114.49 -175.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -92.2 147.55 22.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 122.771 3.286 . . . . 0.0 106.335 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.33 93.31 5.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 102.696 -3.075 . . . . 0.0 102.696 -176.131 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.2 mt -54.21 115.28 1.98 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 130.785 3.634 . . . . 0.0 109.041 176.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.266 40.0 tt0 -81.44 134.7 35.58 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 102.58 -3.118 . . . . 0.0 102.58 -165.645 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.58 119.76 7.63 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 128.086 2.554 . . . . 0.0 106.472 167.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.49 -5.97 57.35 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 119.832 -1.792 . . . . 0.0 112.654 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -94.75 176.67 6.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 116.07 -1.919 . . . . 0.0 108.986 163.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 77.0 p -115.23 176.99 4.82 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.029 1.456 . . . . 0.0 112.012 176.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.97 -28.69 69.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 116.729 -1.605 . . . . 0.0 113.453 167.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.7 t -64.6 -36.34 83.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.785 2.434 . . . . 0.0 109.161 174.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.402 16.4 m-20 -57.4 -25.42 59.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 116.545 -3.847 . . . . 0.0 119.759 169.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -112.25 3.79 17.35 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 116.374 -1.774 . . . . 0.0 109.715 177.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.554 8.8 p30 57.2 31.71 20.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 129.302 3.041 . . . . 0.0 116.631 -173.212 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -81.38 118.34 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 -176.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -99.67 173.74 6.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.707 2.403 . . . . 0.0 112.958 -173.104 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -39.1 134.36 1.08 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.71 2.804 . . . . 0.0 113.11 174.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 62.67 46.14 5.53 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 128.097 2.559 . . . . 0.0 109.659 175.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -104.4 125.47 50.64 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 123.182 2.719 . . . . 0.0 104.21 172.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.8 m -85.7 134.47 33.96 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 114.649 -2.596 . . . . 0.0 108.607 178.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -107.77 154.33 21.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 101.546 -3.501 . . . . 0.0 101.546 -179.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -102.34 134.76 45.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.217 2.607 . . . . 0.0 105.639 176.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 1.7 mt -97.56 129.5 44.69 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.165 2.186 . . . . 0.0 106.267 176.018 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -100.24 117.71 45.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 159.386 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.1 tp -119.04 168.82 10.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.786 2.434 . . . . 0.0 110.108 176.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -124.01 113.39 18.36 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 129.604 3.162 . . . . 0.0 112.123 155.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.253 0.2 OUTLIER -134.52 -158.41 0.88 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 117.382 -3.324 . . . . 0.0 105.995 158.625 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.4 mtm-85 -63.45 -64.51 0.88 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 130.246 3.418 . . . . 0.0 108.559 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.98 -10.26 3.9 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 107.501 -2.239 . . . . 0.0 107.501 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 C-N-CA 127.239 2.352 . . . . 0.0 108.338 -178.3 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 115.47 -2.205 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.274 27.7 mt-30 -99.78 154.53 18.25 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 121.323 1.874 . . . . 0.0 113.879 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -145.67 153.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -124.77 107.64 11.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 115.387 -2.244 . . . . 0.0 105.967 -161.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.25 115.72 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 119.883 1.219 . . . . 0.0 108.378 179.42 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -84.56 142.37 30.04 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 125.438 2.542 . . . . 0.0 108.372 176.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -127.82 148.38 50.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 110.026 -3.261 . . . . 0.0 108.879 162.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.4 mt -48.17 -17.99 0.17 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 128.053 2.541 . . . . 0.0 116.765 174.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -77.78 -37.48 48.81 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 125.516 2.579 . . . . 0.0 114.453 -169.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.73 -16.49 10.33 Favored Glycine 0 CA--C 1.538 1.502 0 O-C-N 117.04 -3.538 . . . . 0.0 108.438 -170.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -77.58 138.8 39.35 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 130.007 3.323 . . . . 0.0 106.81 174.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 m -141.3 117.93 10.96 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.731 3.212 . . . . 0.0 106.632 -171.106 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mm -91.09 117.47 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.344 1.857 . . . . 0.0 106.636 -173.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.9 m -83.04 118.92 23.86 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.549 1.94 . . . . 0.0 109.232 176.391 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -120.76 134.78 55.27 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.307 1.843 . . . . 0.0 106.547 172.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -88.25 124.63 34.06 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 128.77 3.794 . . . . 0.0 109.102 157.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.8 169.89 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 1 CA-C-N 107.66 -4.336 . . . . 0.0 105.156 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -119.76 162.76 31.23 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 128.911 2.884 . . . . 0.0 111.397 158.185 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.65 -23.47 15.28 Favored 'Trans proline' 0 N--CA 1.447 -1.237 1 C-N-CA 126.158 4.572 . . . . 0.0 119.687 177.625 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -88.3 1.58 54.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 115.848 -2.025 . . . . 0.0 113.423 175.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.01 115.41 3.13 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 122.039 2.2 . . . . 0.0 113.394 -175.055 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.2 p -71.88 160.11 33.12 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 118.358 -2.714 . . . . 0.0 112.893 172.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.403 ' H ' HG13 ' A' ' 23' ' ' ILE 0.272 53.7 mt -49.17 -36.94 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 115.369 -2.253 . . . . 0.0 113.974 167.624 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -58.9 -31.29 68.49 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 131.397 3.879 . . . . 0.0 113.435 164.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -84.68 -32.55 23.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 121.971 2.168 . . . . 0.0 110.04 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.94 -50.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 115.284 -2.294 . . . . 0.0 109.076 169.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -43.33 -47.95 6.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.695 1.598 . . . . 0.0 114.612 177.06 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.8 -24.13 61.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 124.304 2.002 . . . . 0.0 116.148 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -86.08 -42.37 13.99 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 114.119 -2.848 . . . . 0.0 104.808 -173.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.257 78.1 mt -49.06 -59.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 112.623 -3.56 . . . . 0.0 106.337 168.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -47.24 -51.53 18.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 127.977 3.298 . . . . 0.0 117.348 171.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.37 -35.96 82.13 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.332 0.653 . . . . 0.0 112.279 -174.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -82.27 -76.03 0.28 Allowed 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 125.706 1.879 . . . . 0.0 109.902 173.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -91.54 -21.57 20.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.265 -159.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.02 -0.23 60.38 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 116.159 -2.467 . . . . 0.0 113.745 164.865 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -66.98 127.04 93.38 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 120.407 2.103 . . . . 0.0 109.167 165.129 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.44 140.26 21.47 Favored 'Trans proline' 0 N--CA 1.445 -1.358 1 C-N-CA 126.608 4.872 . . . . 0.0 110.254 175.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.257 87.3 Cg_exo -41.45 -34.4 1.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 1 C-N-CA 131.83 8.353 . . . . 0.0 118.818 169.333 . . . . . . . . 3 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.58 -29.0 68.96 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 125.72 1.887 . . . . 0.0 113.476 171.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -84.5 -2.79 57.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 122.346 2.339 . . . . 0.0 111.726 -170.613 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 26.9 mt-30 -113.83 134.4 54.81 Favored 'General case' 0 C--N 1.325 -0.495 1 CA-C-O 111.257 -4.211 . . . . 0.0 118.744 -166.694 . . . . . . . . 3 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -110.63 141.02 44.42 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 128.986 3.929 . . . . 0.0 102.05 163.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.5 mt -135.38 128.78 32.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.561 1.144 . . . . 0.0 109.396 -174.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 4.2 mt -122.42 150.77 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.083 2.553 . . . . 0.0 104.451 -174.132 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.65 -82.6 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 102.391 -3.188 . . . . 0.0 102.391 165.324 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.86 -52.97 1.43 Allowed 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.15 -1.594 . . . . 0.0 108.894 173.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.14 -30.68 0.78 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 106.054 -2.818 . . . . 0.0 106.054 -175.314 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -82.89 110.42 17.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 -175.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -60.38 127.58 32.45 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 116.526 -1.702 . . . . 0.0 111.333 159.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -75.11 151.5 38.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 125.464 2.554 . . . . 0.0 112.56 -178.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -112.66 144.86 41.45 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 119.924 -1.735 . . . . 0.0 109.833 175.04 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.73 153.88 42.98 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 127.257 2.848 . . . . 0.0 114.98 -172.336 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.85 13.03 44.85 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 128.071 2.748 . . . . 0.0 114.136 169.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.3 mtt85 -125.63 151.71 46.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.229 1.966 . . . . 0.0 108.544 -167.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.411 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 52.0 p -92.43 174.95 7.02 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.397 1.57 . . . . 0.0 110.799 -177.316 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.58 -28.26 65.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 111.833 -2.44 . . . . 0.0 111.726 174.611 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -71.67 -37.76 70.72 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.378 -1.451 . . . . 0.0 114.645 173.311 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.411 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 39.1 m-20 -63.94 -42.02 97.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.102 0.961 . . . . 0.0 113.386 178.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.57 4.0 45.38 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 123.488 1.613 . . . . 0.0 113.01 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.316 42.7 m-80 76.49 26.77 0.86 Allowed 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 172.016 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.5 mt -99.49 107.86 21.48 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-O 125.518 2.58 . . . . 0.0 104.117 -170.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -93.34 165.11 12.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 165.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.472 39.7 pttt -30.97 125.68 0.19 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 164.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 88.43 1.98 0.32 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 130.044 3.338 . . . . 0.0 113.982 176.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -62.17 141.29 58.26 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 117.104 -3.497 . . . . 0.0 113.311 176.766 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.3 m -90.82 137.67 32.18 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 125.407 1.692 . . . . 0.0 108.361 170.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -119.74 172.87 7.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 164.472 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -136.15 110.95 8.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 126.01 2.069 . . . . 0.0 110.176 -167.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.52 126.73 42.98 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 125.383 2.516 . . . . 0.0 110.193 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.49 122.02 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 O-C-N 116.965 -3.585 . . . . 0.0 106.487 170.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.4 mt -70.01 145.9 51.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.709 3.204 . . . . 0.0 111.582 178.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -82.48 48.11 1.25 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.702 2.401 . . . . 0.0 116.583 173.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.1 mt -54.94 130.67 42.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 109.156 -3.656 . . . . 0.0 114.01 174.275 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.265 5.2 mpt_? -108.08 123.61 48.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.159 177.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.73 158.38 23.03 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 105.361 -3.096 . . . . 0.0 105.361 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.682 0 CA-C-O 115.39 -2.894 . . . . 0.0 107.285 164.165 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -98.21 139.08 34.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -173.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.5 pt -121.91 161.58 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.99 2.116 . . . . 0.0 106.334 166.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -105.31 129.4 53.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 159.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.77 125.99 54.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 160.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -115.21 158.35 22.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 128.315 2.646 . . . . 0.0 105.651 178.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -135.43 167.94 20.14 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 118.125 -2.859 . . . . 0.0 105.565 -170.028 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -69.16 -27.55 65.63 Favored 'General case' 0 N--CA 1.451 -0.387 1 O-C-N 116.093 -4.129 . . . . 0.0 113.839 176.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.1 p -85.12 3.89 36.87 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 119.077 -2.264 . . . . 0.0 110.043 171.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.9 -24.19 32.19 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 117.87 -3.018 . . . . 0.0 106.961 156.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -50.23 118.79 3.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.719 3.608 . . . . 0.0 106.29 -177.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -118.76 117.06 27.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.052 0.842 . . . . 0.0 109.408 -174.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.3 mt -84.15 136.09 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 1 C-N-CA 132.471 4.308 . . . . 0.0 107.944 168.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -93.39 133.62 36.46 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 163.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.14 142.06 51.6 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 129.507 3.123 . . . . 0.0 112.436 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -113.89 136.01 53.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 168.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 m -153.76 -178.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.84 1 C-N-CA 134.695 5.198 . . . . 0.0 112.07 -165.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -139.79 147.91 53.33 Favored Pre-proline 0 N--CA 1.448 -0.542 0 O-C-N 117.979 -2.95 . . . . 0.0 110.701 175.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -49.75 -41.67 45.67 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 123.566 2.844 . . . . 0.0 114.337 -177.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 p -51.05 -26.26 6.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 165.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -70.18 126.81 30.76 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 122.517 2.417 . . . . 0.0 108.257 -170.502 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.8 p -66.14 149.77 49.78 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.984 1.714 . . . . 0.0 113.796 -178.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 mm -84.6 89.56 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 1 N-CA-C 99.4 -4.296 . . . . 0.0 99.4 159.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -175.08 -60.91 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 130.325 3.45 . . . . 0.0 103.695 173.144 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -70.46 -39.51 74.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 114.853 -2.499 . . . . 0.0 116.454 -175.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.15 -44.35 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.692 1.997 . . . . 0.0 114.317 160.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.22 -16.49 62.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 112.318 -3.706 . . . . 0.0 111.407 -176.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.36 -35.88 30.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 123.888 3.04 . . . . 0.0 105.266 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -68.55 -35.92 78.09 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 125.076 2.369 . . . . 0.0 110.491 -176.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 mm -70.36 -46.91 69.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.276 176.297 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -56.11 -45.82 79.32 Favored 'General case' 0 N--CA 1.453 -0.296 1 O-C-N 116.274 -4.016 . . . . 0.0 107.223 -178.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.371 4.9 t70 -47.82 -55.9 8.68 Favored 'General case' 0 N--CA 1.444 -0.742 1 C-N-CA 133.901 4.88 . . . . 0.0 112.491 169.235 . . . . . . . . 3 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -65.97 -47.63 73.93 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 124.651 1.22 . . . . 0.0 109.925 176.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -125.14 -15.84 6.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 117.936 -2.978 . . . . 0.0 116.259 -148.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.21 6.57 53.44 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 153.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.7 mt -99.47 121.53 54.62 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-O 114.39 -2.719 . . . . 0.0 105.455 -163.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.77 135.33 62.98 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-N 124.63 2.689 . . . . 0.0 113.755 173.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.292 67.4 Cg_exo -33.1 -37.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.56 1 C-N-CA 129.644 6.896 . . . . 0.0 118.246 174.476 . . . . . . . . 3 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -80.69 -31.85 36.09 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 117.985 -2.947 . . . . 0.0 106.752 -172.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -90.94 -10.91 40.69 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 115.206 -2.331 . . . . 0.0 105.11 -172.192 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -77.87 94.79 4.6 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 130.687 3.595 . . . . 0.0 104.545 169.563 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -91.26 120.55 32.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.685 176.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mt -126.5 123.97 39.0 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -163.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -138.34 133.87 43.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -164.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.361 0.3 OUTLIER -124.6 -28.25 3.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.082 -2.327 . . . . 0.0 115.287 159.662 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.291 . . -153.02 43.59 0.63 Allowed 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 125.405 1.691 . . . . 0.0 108.912 -166.217 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.96 -7.67 49.04 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 128.709 3.052 . . . . 0.0 117.921 159.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.44 32.0 pttt -151.97 147.49 26.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 131.488 3.915 . . . . 0.0 110.918 -170.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.7 139.95 48.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.151 1.78 . . . . 0.0 112.705 173.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 mt -82.11 136.35 35.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 114.949 -2.453 . . . . 0.0 107.884 -174.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -82.68 139.84 33.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 126.237 2.211 . . . . 0.0 110.371 -170.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -45.3 113.78 0.63 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 118.679 2.844 . . . . 0.0 118.679 169.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.09 -7.19 40.67 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 164.448 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.259 13.3 mmp_? -93.69 142.12 27.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -172.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.9 p -86.47 163.86 17.3 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.333 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -41.05 -52.89 3.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 124.798 3.454 . . . . 0.0 115.704 163.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 t -51.84 -37.64 52.72 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 114.115 -2.85 . . . . 0.0 115.156 168.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -68.0 -18.57 64.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 178.627 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -97.36 -13.49 21.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 114.132 -2.842 . . . . 0.0 112.308 161.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.8 t30 72.14 31.8 1.87 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 125.626 3.83 . . . . 0.0 113.104 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -70.55 112.84 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 1 O-C-N 115.927 -4.233 . . . . 0.0 109.845 -175.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.291 22.9 mt-30 -94.03 162.68 13.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.269 1.428 . . . . 0.0 110.539 -165.605 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.266 26.8 pttt -42.16 115.26 0.66 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 117.168 2.284 . . . . 0.0 117.168 161.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.5 2.6 tt0 87.16 30.35 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.785 170.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.31 68.6 m -90.01 132.69 35.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 172.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -82.27 125.82 31.41 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.433 2.293 . . . . 0.0 112.456 169.566 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mp -116.36 124.36 49.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 172.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.285 11.8 t60 -83.64 120.09 25.56 Favored 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 131.876 4.07 . . . . 0.0 112.275 165.508 . . . . . . . . 3 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -94.5 130.59 40.83 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 117.373 -3.329 . . . . 0.0 108.337 174.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.79 153.01 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 O-C-N 117.98 -2.95 . . . . 0.0 114.125 170.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.73 95.28 3.02 Favored 'General case' 0 CA--C 1.518 -0.272 1 N-CA-C 98.125 -4.769 . . . . 0.0 98.125 -161.43 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 73.52 11.66 4.76 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 117.456 -3.277 . . . . 0.0 114.487 168.086 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -110.63 139.39 45.94 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 129.032 2.933 . . . . 0.0 103.885 176.202 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -93.04 163.39 13.67 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 126.707 3.146 . . . . 0.0 111.472 166.835 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.01 49.74 0.84 Allowed Glycine 0 CA--C 1.536 1.372 0 O-C-N 118.37 -2.706 . . . . 0.0 107.896 178.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 128.997 3.189 . . . . 0.0 106.415 -176.706 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pm0 -104.92 140.72 37.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.543 1.937 . . . . 0.0 107.93 178.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -124.72 151.8 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 128.644 2.777 . . . . 0.0 106.607 165.272 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.253 60.3 m-85 -93.11 151.58 19.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 122.577 1.179 . . . . 0.0 113.217 168.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.1 144.67 28.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 114.293 -2.765 . . . . 0.0 107.245 167.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 52.3 tttt -126.48 127.46 45.4 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 128.75 3.781 . . . . 0.0 118.196 170.091 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 p -82.36 166.18 19.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.743 2.417 . . . . 0.0 111.448 -169.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.35 -37.0 66.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 129.974 3.31 . . . . 0.0 116.604 172.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.8 p -73.89 -33.25 63.95 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.589 2.756 . . . . 0.0 113.967 173.607 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.17 16.43 7.23 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 116.518 1.367 . . . . 0.0 116.518 177.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -86.47 134.99 33.64 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.898 1.679 . . . . 0.0 106.984 178.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -100.59 113.24 25.89 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 130.091 3.357 . . . . 0.0 105.315 -176.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -100.38 114.51 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 100.666 -3.827 . . . . 0.0 100.666 174.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -66.25 131.75 46.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.954 -2.966 . . . . 0.0 109.261 154.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.14 128.45 38.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 119.418 -2.051 . . . . 0.0 108.297 -172.29 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -91.92 115.79 28.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 125.696 1.872 . . . . 0.0 110.26 178.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.51 22.6 m -121.07 -68.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 113.45 -3.166 . . . . 0.0 118.052 -163.271 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 80.48 131.74 0.04 OUTLIER Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 129.709 3.204 . . . . 0.0 107.176 -155.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.3 -16.81 15.21 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 CA-C-N 120.316 1.149 . . . . 0.0 114.976 -175.294 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 m -86.23 18.03 3.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 172.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -76.79 152.63 35.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.056 1.342 . . . . 0.0 110.002 158.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -88.71 148.5 23.95 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.999 1.319 . . . . 0.0 107.952 174.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.279 5.8 mm -46.13 -37.63 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 127.546 2.338 . . . . 0.0 113.477 174.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -82.27 -14.18 55.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 116.506 -3.871 . . . . 0.0 113.343 -175.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -94.86 -24.94 16.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 123.805 1.764 . . . . 0.0 110.692 174.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.45 -41.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 1 O-C-N 115.452 -4.53 . . . . 0.0 108.857 167.343 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -69.83 -34.05 73.14 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 124.525 1.141 . . . . 0.0 112.811 176.106 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.255 . . -77.45 -13.27 59.96 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 120.604 1.547 . . . . 0.0 110.808 173.126 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -69.1 -37.06 78.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 118.314 -2.742 . . . . 0.0 111.13 172.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 mm -69.15 -31.39 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 127.572 2.349 . . . . 0.0 108.291 175.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.58 -37.12 76.82 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 172.326 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.12 -51.2 40.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.254 -1.529 . . . . 0.0 114.152 172.092 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -87.57 -27.65 22.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -171.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -122.89 -21.23 5.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 115.282 -2.294 . . . . 0.0 115.441 175.119 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.63 -14.6 42.12 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 116.446 -2.308 . . . . 0.0 111.558 172.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.5 mt -78.38 121.23 83.49 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 120.394 2.097 . . . . 0.0 109.238 -154.348 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -55.27 143.27 76.51 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 CA-C-N 123.214 2.184 . . . . 0.0 117.029 -174.848 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.43 -28.86 3.33 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 O-C-N 116.965 -2.177 . . . . 0.0 116.396 -166.628 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 0.0 OUTLIER -51.92 -29.21 19.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 121.291 3.811 . . . . 0.0 121.291 172.127 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -92.7 -18.47 22.94 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 128.492 3.62 . . . . 0.0 111.723 -177.103 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -83.24 129.41 35.01 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 126.168 2.167 . . . . 0.0 116.282 -175.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -103.47 119.64 39.28 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 114.488 -2.673 . . . . 0.0 105.048 160.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -88.6 120.8 30.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.788 1.631 . . . . 0.0 109.075 168.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mm -114.57 135.28 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 126.52 1.928 . . . . 0.0 112.635 -177.025 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.262 49.5 t80 -148.61 113.33 5.38 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 128.383 2.673 . . . . 0.0 109.103 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.92 50.71 0.81 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 128.159 2.583 . . . . 0.0 111.451 163.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.15 4.5 66.63 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 117.82 -2.134 . . . . 0.0 117.264 174.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -161.2 144.75 12.97 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -160.391 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -87.92 140.32 29.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 125.352 2.501 . . . . 0.0 107.648 173.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.61 113.2 24.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 118.84 -2.413 . . . . 0.0 108.514 179.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -79.2 137.22 37.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 118.395 -2.691 . . . . 0.0 111.634 -163.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -45.65 112.38 0.45 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 129.146 2.978 . . . . 0.0 114.733 156.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.62 -15.6 9.76 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 128.972 3.177 . . . . 0.0 113.896 -173.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -105.69 178.26 4.61 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 120.84 2.32 . . . . 0.0 105.797 -175.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -110.7 170.0 8.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 118.473 -2.642 . . . . 0.0 108.545 176.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.46 -35.72 63.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 117.195 -1.802 . . . . 0.0 109.983 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 p -53.95 -27.75 33.07 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 128.2 2.6 . . . . 0.0 112.91 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -58.68 -26.35 63.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 167.158 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -120.33 23.04 11.1 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 118.209 -2.807 . . . . 0.0 108.287 -170.132 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.344 13.5 m120 78.73 10.01 1.82 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 126.379 2.299 . . . . 0.0 111.978 171.12 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -77.81 120.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 121.124 1.784 . . . . 0.0 111.544 -160.361 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -106.37 -177.4 3.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.643 1.211 . . . . 0.0 111.185 176.13 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -69.49 126.48 29.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.074 2.149 . . . . 0.0 110.46 -178.174 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 61.85 29.68 17.98 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 129.392 3.077 . . . . 0.0 114.34 -176.583 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.5 m -62.34 126.79 28.56 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.613 2.365 . . . . 0.0 111.963 154.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -82.97 119.98 25.12 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 127.141 2.177 . . . . 0.0 107.219 173.586 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -89.74 154.89 19.58 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.438 -2.164 . . . . 0.0 107.607 159.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -119.24 139.72 51.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -112.41 132.3 55.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 124.564 2.126 . . . . 0.0 110.559 -167.374 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 m -130.53 133.07 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 113.09 -1.868 . . . . 0.0 110.04 175.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -94.97 133.78 38.35 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 126.234 2.209 . . . . 0.0 107.499 -177.567 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -123.93 119.88 30.9 Favored 'General case' 0 N--CA 1.448 -0.534 1 CA-C-O 111.281 -4.199 . . . . 0.0 109.505 -172.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -104.12 143.56 32.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 123.365 2.802 . . . . 0.0 104.682 171.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.252 25.6 ttp85 86.53 -96.8 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.185 2.594 . . . . 0.0 107.588 170.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.31 -166.91 11.4 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.153 2.787 . . . . 0.0 110.012 167.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.874 0 CA-C-N 123.962 3.881 . . . . 0.0 115.792 -171.415 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 mtt . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 116.59 -1.671 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 149.17 23.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 121.29 1.859 . . . . 0.0 107.43 177.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -136.06 -177.33 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 C-N-CA 127.931 2.493 . . . . 0.0 107.986 160.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -128.44 138.63 52.4 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 119.21 -2.181 . . . . 0.0 113.064 174.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.9 t -110.73 114.84 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 164.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 83.8 tttt -104.26 140.31 38.04 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.296 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.4 p -102.35 117.53 34.92 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 118.165 -2.835 . . . . 0.0 104.654 166.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.09 -32.69 7.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 117.184 -3.448 . . . . 0.0 117.681 177.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 p -88.0 -9.68 52.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.903 2.881 . . . . 0.0 109.072 -176.61 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.73 -111.86 1.07 Allowed Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.276 -1.291 . . . . 0.0 113.233 -170.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.353 7.4 pttp -142.66 164.1 31.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.305 1.842 . . . . 0.0 115.387 -168.158 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.313 0.6 OUTLIER -81.3 115.16 20.54 Favored 'General case' 0 C--N 1.325 -0.473 1 C-N-CA 134.0 4.92 . . . . 0.0 109.603 -179.836 . . . . . . . . 4 3 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 mt -108.94 124.72 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -173.642 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 p -72.34 124.69 25.64 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 112.71 -2.041 . . . . 0.0 111.678 -179.027 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.261 1.7 tm? -130.06 152.22 49.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.082 -2.261 . . . . 0.0 109.907 -175.66 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 68.1 tt0 -129.75 123.33 30.78 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 123.873 1.797 . . . . 0.0 107.936 -170.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.73 152.63 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 131.37 3.868 . . . . 0.0 113.206 178.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -93.73 156.98 38.97 Favored Pre-proline 0 N--CA 1.446 -0.66 0 C-N-CA 127.048 2.139 . . . . 0.0 105.611 171.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.14 -7.93 18.69 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 N-CA-C 118.44 2.438 . . . . 0.0 118.44 -171.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.6 p -108.16 5.26 25.7 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 130.95 3.7 . . . . 0.0 117.49 176.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.03 139.73 36.83 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 126.213 2.196 . . . . 0.0 107.736 -167.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -87.21 166.6 14.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 125.427 1.704 . . . . 0.0 108.588 174.809 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mp -69.02 -40.3 80.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 130.079 3.352 . . . . 0.0 108.049 -176.473 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -53.16 -34.76 58.26 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 113.431 -3.176 . . . . 0.0 112.75 168.315 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -82.76 -13.38 56.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 125.147 1.529 . . . . 0.0 109.752 -174.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.3 t -70.9 -57.89 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 131.127 3.771 . . . . 0.0 106.727 168.535 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.316 38.7 mtmt -53.51 -38.66 63.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 125.281 2.467 . . . . 0.0 116.953 173.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -43.77 65.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 112.406 -2.179 . . . . 0.0 111.189 175.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -55.66 -51.92 65.59 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 118.79 -2.444 . . . . 0.0 109.1 171.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.9 mt -51.78 -31.56 13.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 122.535 2.425 . . . . 0.0 109.587 169.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -78.55 -48.66 14.77 Favored 'General case' 0 N--CA 1.447 -0.61 1 O-C-N 113.851 -5.53 . . . . 0.0 108.148 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.383 18.3 t70 -46.95 -33.48 4.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 128.957 2.903 . . . . 0.0 117.841 165.614 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -100.46 -53.68 3.04 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 118.079 -2.888 . . . . 0.0 114.238 -174.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -108.47 -27.81 9.71 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -173.295 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.85 19.79 60.78 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 125.625 2.792 . . . . 0.0 117.269 175.363 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 49.9 mt -77.18 109.67 9.89 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-O 113.067 -3.349 . . . . 0.0 105.663 179.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -64.58 148.35 90.44 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 CA-C-N 126.912 3.504 . . . . 0.0 107.853 -166.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.84 -23.85 74.35 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 118.626 2.51 . . . . 0.0 118.626 -172.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -94.65 -12.23 27.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 115.461 -2.209 . . . . 0.0 111.913 -172.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -86.81 -19.41 29.04 Favored 'General case' 0 N--CA 1.448 -0.56 1 C-N-CA 132.536 4.334 . . . . 0.0 111.724 173.746 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -80.97 144.99 31.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 -179.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.334 70.5 mtm180 -119.79 153.14 36.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 117.126 -3.484 . . . . 0.0 104.809 144.059 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.9 mt -119.35 140.98 49.46 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 114.303 -2.761 . . . . 0.0 107.255 176.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.497 0.0 OUTLIER -136.96 146.45 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 125.169 3.622 . . . . 0.0 110.778 172.482 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -159.09 110.47 2.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 116.542 -1.695 . . . . 0.0 108.875 -169.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.34 21.2 5.84 Favored 'General case' 0 N--CA 1.449 -0.487 1 O-C-N 129.525 4.265 . . . . 0.0 115.643 168.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.0 -18.16 29.01 Favored Glycine 0 CA--C 1.532 1.145 0 O-C-N 118.077 -2.89 . . . . 0.0 116.531 -169.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 126.71 52.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 129.465 3.685 . . . . 0.0 112.535 -162.361 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.78 97.6 0.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 129.2 3.0 . . . . 0.0 110.009 173.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.9 mt -67.63 118.69 11.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 127.757 2.423 . . . . 0.0 109.641 -178.704 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.51 128.96 55.26 Favored 'General case' 0 N--CA 1.451 -0.391 1 O-C-N 130.676 4.985 . . . . 0.0 112.19 175.109 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -52.85 131.46 35.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 119.255 -2.153 . . . . 0.0 112.466 156.44 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.74 2.14 14.68 Favored Glycine 0 CA--C 1.53 1.023 1 CA-C-O 110.766 -5.463 . . . . 0.0 113.367 -171.03 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -129.21 163.08 26.37 Favored 'General case' 0 N--CA 1.449 -0.506 1 CA-C-N 124.287 4.044 . . . . 0.0 107.577 -176.37 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 p -88.26 159.71 17.99 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 101.707 -3.442 . . . . 0.0 101.707 -176.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tt -34.23 -53.52 0.49 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 129.834 3.254 . . . . 0.0 111.138 153.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.6 m -72.27 -14.78 61.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 128.433 2.693 . . . . 0.0 115.233 -173.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.268 17.6 m-20 -65.09 -41.25 95.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 164.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -107.63 -28.46 9.73 Favored 'General case' 0 C--N 1.324 -0.504 1 O-C-N 114.891 -4.881 . . . . 0.0 108.136 -170.262 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.494 20.2 t30 96.06 41.72 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.324 2.25 . . . . 0.0 115.745 -175.024 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.1 mt -84.35 89.6 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 125.49 1.744 . . . . 0.0 110.191 176.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -91.09 175.13 7.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 125.82 1.95 . . . . 0.0 108.203 -168.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 149.06 30.07 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 170.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 64.78 2.96 1.85 Allowed 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 125.784 1.928 . . . . 0.0 114.421 177.606 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -69.06 156.17 39.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.026 -1.671 . . . . 0.0 111.442 176.484 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.3 m -125.17 132.27 53.08 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 117.334 -3.354 . . . . 0.0 104.746 -174.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.53 137.4 47.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -85.72 143.34 28.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.841 -1.787 . . . . 0.0 106.343 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tp -107.42 131.5 54.21 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 168.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.85 89.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.941 2.096 . . . . 0.0 114.419 -163.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mp -80.14 156.66 26.89 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 119.403 -2.06 . . . . 0.0 109.062 -147.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 mtt-85 -94.09 87.0 5.15 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 163.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.259 18.7 mt -91.87 -45.87 8.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.709 -0.663 . . . . 0.0 110.45 168.458 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -82.18 -38.23 24.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.774 1.23 . . . . 0.0 112.756 169.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.8 12.1 8.07 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 126.244 2.215 . . . . 0.0 116.218 -172.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 115.172 -3.016 . . . . 0.0 112.132 -166.803 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 117.464 -1.255 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.274 50.0 mt-30 -95.43 125.87 40.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 127.324 3.44 . . . . 0.0 107.031 -175.57 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -113.07 144.71 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.315 171.083 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -100.7 106.5 17.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.267 -178.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.3 t -88.34 106.81 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 124.028 1.871 . . . . 0.0 110.487 170.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.294 5.4 tppt? -84.75 135.76 33.99 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.029 -1.669 . . . . 0.0 109.469 173.131 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -78.17 165.19 24.24 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.967 1.707 . . . . 0.0 115.107 165.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.35 0.4 OUTLIER -83.1 -12.49 57.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.581 163.665 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -66.65 -41.58 88.02 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 171.43 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.82 38.23 1.31 Allowed Glycine 0 CA--C 1.536 1.397 0 O-C-N 118.081 -2.887 . . . . 0.0 110.218 -172.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.283 59.4 pttt -130.76 168.77 16.67 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.525 2.33 . . . . 0.0 105.593 167.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.305 1.8 m -115.3 171.21 7.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 159.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 pt -138.61 145.69 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 131.411 3.885 . . . . 0.0 109.091 161.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 m -107.58 105.88 15.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 118.787 -2.446 . . . . 0.0 110.623 -175.88 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.21 131.73 40.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 115.185 -2.341 . . . . 0.0 109.209 176.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -74.66 119.62 19.1 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.04 2.536 . . . . 0.0 109.041 156.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.22 157.59 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 177.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.301 1.7 tm-20 -85.53 153.04 58.33 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 169.7 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.96 -22.98 75.33 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.482 1.455 . . . . 0.0 115.846 168.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.0 p -94.86 11.68 30.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 119.021 -2.3 . . . . 0.0 113.314 171.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.22 134.96 48.57 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 124.518 3.327 . . . . 0.0 107.819 159.181 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p -89.51 155.17 19.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 112.519 -2.128 . . . . 0.0 114.029 174.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.7 mm -40.23 -56.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.418 2.287 . . . . 0.0 114.996 -172.222 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -39.66 65.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -69.87 -33.25 71.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.164 -1.585 . . . . 0.0 110.613 176.184 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 t -59.71 -45.27 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 O-C-N 116.633 -3.792 . . . . 0.0 108.129 171.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -53.78 -49.74 67.6 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 125.426 1.704 . . . . 0.0 108.448 175.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.43 -34.95 78.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 126.828 3.204 . . . . 0.0 114.099 -178.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -78.44 -24.53 46.06 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 117.309 -3.369 . . . . 0.0 108.791 177.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 mt -70.24 -40.36 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 123.544 2.884 . . . . 0.0 108.935 162.54 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -67.92 -39.38 83.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 114.467 -2.682 . . . . 0.0 112.097 -168.391 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -53.66 -39.54 65.15 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 127.487 2.315 . . . . 0.0 115.112 165.478 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.311 65.8 mmtt -89.7 -44.86 9.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 117.755 -1.578 . . . . 0.0 113.007 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -97.87 -19.88 17.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 116.124 -1.893 . . . . 0.0 113.055 -173.747 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.3 -15.26 63.35 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 173.601 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.0 mt -70.94 113.3 17.79 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-O 114.343 -2.741 . . . . 0.0 110.043 -177.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -65.35 153.77 76.7 Favored 'Trans proline' 0 N--CA 1.449 -1.116 1 C-N-CA 126.238 4.625 . . . . 0.0 110.385 -173.764 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.47 -34.16 97.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.825 3.017 . . . . 0.0 113.991 -178.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -60.52 -2.91 0.57 Allowed 'General case' 0 N--CA 1.445 -0.683 1 C-N-CA 133.883 4.873 . . . . 0.0 115.85 172.899 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.39 0.0 OUTLIER -135.59 14.93 3.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 169.289 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -105.79 161.35 14.5 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 171.477 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.295 15.9 ttm180 -157.62 139.27 13.92 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 131.386 3.874 . . . . 0.0 108.454 169.448 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.9 118.23 22.32 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.486 2.314 . . . . 0.0 109.985 -162.569 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.4 mm -101.75 139.33 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.689 1.596 . . . . 0.0 109.173 -174.418 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -148.03 140.48 24.43 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 115.82 -2.038 . . . . 0.0 110.376 158.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.301 . . 69.97 8.09 6.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 -177.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.89 -13.84 22.03 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.189 1.852 . . . . 0.0 108.786 171.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -112.45 163.86 13.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 116.497 -3.943 . . . . 0.0 111.776 -174.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -79.1 118.44 21.08 Favored 'General case' 0 N--CA 1.441 -0.913 1 C-N-CA 132.018 4.127 . . . . 0.0 111.315 166.524 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.85 129.12 34.36 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 127.53 3.019 . . . . 0.0 106.769 169.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -92.23 156.32 17.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 130.529 3.531 . . . . 0.0 114.004 -171.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -49.11 130.69 19.09 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.447 2.299 . . . . 0.0 111.545 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.73 -27.53 14.68 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.088 1.804 . . . . 0.0 116.418 163.358 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.81 149.98 26.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 120.537 2.169 . . . . 0.0 108.178 176.403 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -79.31 164.99 23.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 128.909 2.884 . . . . 0.0 109.285 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.1 mt -67.64 -27.0 66.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.665 170.179 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.257 1.2 p -72.32 -20.36 61.5 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 112.281 -3.723 . . . . 0.0 115.402 163.579 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.61 -17.63 62.27 Favored 'General case' 0 N--CA 1.447 -0.615 1 CA-C-O 129.295 4.379 . . . . 0.0 109.225 178.527 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.264 50.2 m-85 -112.05 1.67 16.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 117.649 -3.157 . . . . 0.0 110.931 177.596 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.4 t30 53.57 44.43 29.83 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.8 2.44 . . . . 0.0 115.16 168.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.275 2.9 mt -66.56 131.57 32.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 1 C-N-CA 133.825 4.85 . . . . 0.0 112.875 160.636 . . . . . . . . 3 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.0 169.29 12.26 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 114.837 -2.506 . . . . 0.0 113.537 171.998 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.14 127.17 3.47 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 119.452 3.13 . . . . 0.0 119.452 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 65.45 30.61 10.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.358 2.263 . . . . 0.0 115.392 174.784 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -81.87 151.02 27.5 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.2 m -97.48 116.71 30.21 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 119.615 -1.928 . . . . 0.0 107.565 -174.259 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -100.43 145.14 28.59 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 128.513 2.725 . . . . 0.0 111.49 171.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -112.55 107.5 16.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 124.39 2.043 . . . . 0.0 110.202 -167.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tp -80.49 134.75 36.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 119.214 -2.179 . . . . 0.0 109.22 -173.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.5 t -125.01 136.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.911 -1.118 . . . . 0.0 111.099 174.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -93.42 134.92 35.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 130.533 3.533 . . . . 0.0 106.875 176.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 mtp-105 -120.38 175.08 6.15 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 102.447 -3.168 . . . . 0.0 102.447 159.305 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.8 mt -84.04 162.97 20.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.947 2.899 . . . . 0.0 111.694 168.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.475 6.1 ttp180 108.8 78.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 130.484 3.514 . . . . 0.0 109.994 -177.89 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.03 -145.46 15.94 Favored Glycine 0 CA--C 1.536 1.368 1 C-N-CA 131.084 4.183 . . . . 0.0 109.021 173.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.774 0 C-N-CA 128.772 3.082 . . . . 0.0 111.536 -172.654 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -102.1 150.78 22.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 118.294 -2.754 . . . . 0.0 105.847 176.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.374 16.4 pt -140.56 157.51 24.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 131.203 3.801 . . . . 0.0 106.693 164.585 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -112.05 139.83 47.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -175.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 t -115.08 126.31 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 128.276 2.631 . . . . 0.0 107.83 166.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -93.29 125.59 37.97 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 127.925 3.266 . . . . 0.0 110.838 169.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.271 72.5 p -79.11 -165.18 0.71 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -179.632 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mt -77.28 -43.21 34.08 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 118.042 -2.911 . . . . 0.0 111.898 163.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.7 p -74.74 -6.28 47.99 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -169.614 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.59 0.87 43.23 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 117.253 1.661 . . . . 0.0 117.253 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -84.59 147.88 26.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.909 1.283 . . . . 0.0 111.713 173.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.6 m -110.52 109.29 19.57 Favored 'General case' 0 C--N 1.326 -0.441 1 C-N-CA 132.416 4.286 . . . . 0.0 100.314 173.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -95.31 142.42 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 127.257 2.223 . . . . 0.0 106.246 166.552 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.5 m -96.2 133.31 40.67 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -117.63 140.36 49.74 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -177.149 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -101.86 130.88 48.43 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 100.666 -3.828 . . . . 0.0 100.666 -177.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -137.34 163.14 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.177 176.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.366 71.2 mm-40 -116.48 145.83 36.09 Favored Pre-proline 0 N--CA 1.445 -0.675 0 N-CA-C 101.758 -3.423 . . . . 0.0 101.758 163.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -73.01 -3.6 13.92 Favored 'Trans proline' 0 N--CA 1.447 -1.261 1 C-N-CA 125.964 4.442 . . . . 0.0 113.911 -174.343 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 p -80.5 -20.91 42.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 128.755 2.822 . . . . 0.0 115.615 164.836 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -61.6 141.58 57.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.441 1.591 . . . . 0.0 113.565 175.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -70.56 159.12 34.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.1 1.76 . . . . 0.0 109.459 167.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 mm -45.24 -39.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 130.131 3.372 . . . . 0.0 113.973 162.593 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -76.61 -34.83 58.36 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.358 0.981 . . . . 0.0 110.761 179.533 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.288 18.8 m-80 -53.33 -44.29 68.32 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 116.722 -1.608 . . . . 0.0 112.014 174.381 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.28 1.9 t -51.55 -49.37 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 167.133 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -54.65 -52.15 63.21 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 125.586 1.804 . . . . 0.0 115.145 175.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.8 -39.02 4.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 131.306 3.842 . . . . 0.0 119.661 166.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -86.26 -38.92 17.07 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 110.867 -2.879 . . . . 0.0 105.841 -179.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.304 83.6 mt -54.47 -37.03 36.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 O-C-N 117.806 -3.059 . . . . 0.0 114.05 166.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -44.83 66.89 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 128.053 2.541 . . . . 0.0 115.718 175.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.39 -51.94 67.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.348 1.859 . . . . 0.0 111.637 168.089 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -82.67 -16.86 46.58 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 118.444 2.757 . . . . 0.0 118.444 -168.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -154.79 2.37 0.2 Allowed 'General case' 0 N--CA 1.449 -0.52 1 O-C-N 115.962 -4.211 . . . . 0.0 109.405 -173.594 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.37 -20.09 48.52 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 117.598 -3.189 . . . . 0.0 114.933 161.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mt -83.25 131.55 52.93 Favored Pre-proline 0 N--CA 1.442 -0.854 0 O-C-N 119.258 -2.319 . . . . 0.0 107.671 -167.11 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -59.92 151.06 74.38 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 118.824 2.586 . . . . 0.0 118.824 165.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.396 29.9 Cg_exo -47.17 -40.91 27.44 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 124.685 3.59 . . . . 0.0 117.718 173.488 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.27 2.76 38.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 124.811 1.319 . . . . 0.0 110.295 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -118.93 6.08 11.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 123.388 2.813 . . . . 0.0 112.494 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 70.1 mt-30 -99.2 156.24 17.07 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 118.704 0.684 . . . . 0.0 109.768 175.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -129.84 114.92 16.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 101.56 -3.496 . . . . 0.0 101.56 160.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 mt -86.66 146.45 26.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 125.735 3.88 . . . . 0.0 109.151 176.467 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.27 20.3 mm -135.14 156.17 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 129.722 3.209 . . . . 0.0 106.418 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -159.55 147.55 17.34 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 127.001 2.688 . . . . 0.0 109.789 159.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.347 . . 52.59 20.11 1.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 131.117 3.767 . . . . 0.0 112.51 175.354 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.29 -0.06 59.92 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 128.659 3.028 . . . . 0.0 110.168 175.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.275 28.3 mttm -100.66 148.06 25.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 116.127 -1.892 . . . . 0.0 112.689 -178.713 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.41 132.38 42.93 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 161.425 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 118.67 5.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.501 172.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.95 99.36 3.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.177 2.191 . . . . 0.0 111.25 174.463 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -39.3 135.07 1.08 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 151.782 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.96 2.53 7.82 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.132 -1.371 . . . . 0.0 116.412 171.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -129.25 -167.57 1.81 Allowed 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 127.371 2.453 . . . . 0.0 111.193 -163.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -125.21 165.18 18.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.824 1.65 . . . . 0.0 110.19 161.183 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.4 -40.09 81.43 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 118.081 -2.887 . . . . 0.0 111.042 -176.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.0 t -64.48 -33.45 75.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.719 2.008 . . . . 0.0 109.797 175.467 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.251 28.1 t70 -82.37 -32.36 29.26 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 117.667 -3.146 . . . . 0.0 115.07 -176.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -91.51 -2.75 57.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 116.012 -1.947 . . . . 0.0 109.177 173.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 71.74 40.04 0.81 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 129.988 3.315 . . . . 0.0 114.47 169.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.4 mt -79.88 109.81 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 102.003 -3.332 . . . . 0.0 102.003 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -83.51 164.98 19.5 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.274 1.83 . . . . 0.0 112.193 172.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.74 156.78 39.08 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.346 2.659 . . . . 0.0 108.951 -177.07 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 62.75 7.2 2.42 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.386 2.274 . . . . 0.0 112.278 175.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -74.61 148.44 40.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.2 -2.188 . . . . 0.0 111.385 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.2 m -108.4 111.91 24.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 118.361 -1.336 . . . . 0.0 112.741 -178.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -88.62 176.02 7.3 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 129.905 3.282 . . . . 0.0 109.944 171.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -134.36 154.03 51.57 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 116.619 -3.801 . . . . 0.0 110.811 -175.263 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.321 0.7 OUTLIER -118.16 150.57 39.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.11 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.65 147.74 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 130.735 3.614 . . . . 0.0 105.597 163.02 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.9 tp -92.5 140.83 29.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.625 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -149.79 113.04 4.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 100.519 -3.882 . . . . 0.0 100.519 174.865 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 49.7 mt -86.75 53.81 2.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 179.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -160.84 131.8 5.45 Favored 'General case' 0 N--CA 1.45 -0.47 1 C-N-CA 134.872 5.269 . . . . 0.0 106.715 178.292 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.51 6.19 16.58 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 125.864 2.924 . . . . 0.0 110.767 -178.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.029 0 O-C-N 118.191 -2.946 . . . . 0.0 111.205 -177.083 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -96.75 166.7 11.52 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -164.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 pt -114.68 134.41 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 153.61 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -87.12 112.06 21.56 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.53 1.532 . . . . 0.0 113.41 165.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.48 117.46 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 113.379 -3.201 . . . . 0.0 108.182 -176.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -119.29 152.28 36.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 130.005 3.322 . . . . 0.0 107.322 -169.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -155.45 170.57 21.63 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.933 1.693 . . . . 0.0 112.817 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 -23.34 48.34 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 128.608 3.693 . . . . 0.0 114.588 -165.5 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -76.67 -7.42 55.27 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 169.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.3 -23.5 8.05 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 118.026 -2.921 . . . . 0.0 114.108 167.113 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -59.55 133.05 55.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 118.06 2.615 . . . . 0.0 118.06 -175.853 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 m -112.86 103.67 11.66 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 170.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 mt -96.85 115.3 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 129.589 3.156 . . . . 0.0 106.484 175.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.8 p -89.6 109.94 20.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 114.046 -2.883 . . . . 0.0 111.932 168.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -112.21 140.11 47.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 125.076 3.58 . . . . 0.0 105.028 172.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -88.64 135.76 33.34 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.19 2.196 . . . . 0.0 107.599 176.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.51 173.6 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 127.879 2.472 . . . . 0.0 110.991 -161.623 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 44.7 mm-40 -132.88 166.56 28.33 Favored Pre-proline 0 N--CA 1.441 -0.925 1 O-C-N 129.572 4.295 . . . . 0.0 108.517 151.648 . . . . . . . . 3 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -37.74 -21.63 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 124.324 3.349 . . . . 0.0 120.229 163.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.7 p -94.07 -20.59 19.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.914 2.886 . . . . 0.0 113.667 -173.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -69.1 145.3 53.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.188 0.994 . . . . 0.0 112.502 176.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.5 p -90.0 165.25 14.16 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.93 -1.941 . . . . 0.0 112.108 -173.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -74.08 -49.72 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 114.902 -2.475 . . . . 0.0 110.382 170.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -58.62 -10.28 2.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 125.705 3.866 . . . . 0.0 119.605 172.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -74.91 -38.66 61.77 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 119.628 1.104 . . . . 0.0 112.26 161.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 t -71.89 -34.63 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 O-C-N 116.817 -3.677 . . . . 0.0 109.419 -168.67 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -71.43 -39.53 70.98 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.692 1.997 . . . . 0.0 109.251 -175.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.73 89.32 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.983 3.313 . . . . 0.0 116.505 161.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -82.79 -21.04 34.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 125.62 1.825 . . . . 0.0 113.729 -177.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -55.76 -50.67 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.646 2.378 . . . . 0.0 109.252 161.111 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -67.35 -28.52 68.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -173.506 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.334 36.5 t70 -52.41 -46.43 66.32 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 130.882 3.673 . . . . 0.0 117.093 162.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -92.08 -48.62 6.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.688 -1.596 . . . . 0.0 108.907 -175.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.46 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS 0.318 20.8 tp10 -108.13 -15.79 14.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 128.065 2.546 . . . . 0.0 116.37 -166.78 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.26 -26.01 26.0 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 124.497 3.317 . . . . 0.0 111.949 158.061 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 tp -67.95 127.91 93.33 Favored Pre-proline 0 C--O 1.223 -0.33 0 CA-C-O 113.917 -2.944 . . . . 0.0 107.782 -170.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.67 137.07 17.76 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 124.519 3.48 . . . . 0.0 118.137 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -34.53 -37.95 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.441 3.427 . . . . 0.0 117.623 178.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.481 13.1 t70 -44.07 -40.47 4.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 171.214 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -108.23 12.39 26.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 112.836 -1.984 . . . . 0.0 111.426 -176.265 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -100.95 135.86 41.72 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.195 1.798 . . . . 0.0 107.88 174.06 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -130.26 140.07 50.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 128.09 2.556 . . . . 0.0 111.816 172.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.03 118.79 30.7 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 126.542 2.401 . . . . 0.0 108.666 -160.262 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.3 mm -120.03 138.35 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 127.599 2.359 . . . . 0.0 111.197 -173.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -133.55 100.67 4.87 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.226 2.211 . . . . 0.0 112.232 171.447 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.49 -94.36 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.386 -162.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.08 4.57 9.0 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 115.973 -2.57 . . . . 0.0 114.437 168.643 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -87.3 131.23 34.32 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 120.703 2.252 . . . . 0.0 105.067 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -85.0 124.27 31.5 Favored 'General case' 0 N--CA 1.442 -0.842 1 C-N-CA 134.445 5.098 . . . . 0.0 105.599 176.241 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 mt -101.27 157.27 16.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 125.46 1.725 . . . . 0.0 109.879 -173.011 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -130.18 134.04 47.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.468 1.507 . . . . 0.0 107.313 170.261 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.256 3.1 p30 -70.12 -168.62 0.23 Allowed 'General case' 0 C--O 1.221 -0.402 0 O-C-N 128.684 3.74 . . . . 0.0 112.141 -174.153 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.55 1.75 58.92 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 120.89 3.116 . . . . 0.0 120.89 -175.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.3 mtt-85 -147.86 159.34 43.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 128.586 2.754 . . . . 0.0 110.747 -150.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.3 p -83.19 176.73 8.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 129.972 3.309 . . . . 0.0 111.036 -179.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.66 -33.49 76.01 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 129.36 3.064 . . . . 0.0 111.232 168.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 41.1 t -85.49 -10.52 55.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 119.39 -2.069 . . . . 0.0 112.115 176.634 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.03 -28.46 68.88 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 125.612 1.82 . . . . 0.0 109.979 169.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.287 41.3 m-85 -122.73 17.15 10.28 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 119.53 -1.981 . . . . 0.0 113.562 -175.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 t30 53.8 40.61 31.72 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -174.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.2 mt -85.62 80.58 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 173.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -102.77 36.55 2.16 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.613 2.365 . . . . 0.0 111.428 -161.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm 96.45 132.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 1 C-N-CA 132.212 4.205 . . . . 0.0 105.774 156.069 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.435 9.9 mp0 73.49 23.53 2.46 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 130.6 3.56 . . . . 0.0 109.87 176.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.9 m -69.48 142.27 53.78 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 129.045 2.938 . . . . 0.0 109.308 171.339 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.5 m -94.86 119.08 32.84 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 126.103 2.127 . . . . 0.0 106.105 168.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.38 137.12 47.72 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 175.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -104.9 120.57 41.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.569 2.348 . . . . 0.0 107.253 178.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -92.49 115.52 28.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 110.71 -2.95 . . . . 0.0 109.089 166.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 82.8 t -74.38 109.87 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 159.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.02 136.43 37.94 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 165.84 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -76.57 120.82 22.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 125.819 1.95 . . . . 0.0 109.547 172.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.8 mt -144.01 140.06 29.37 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.935 3.294 . . . . 0.0 106.707 -171.695 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.9 ttm105 -95.85 -27.9 14.98 Favored 'General case' 0 C--N 1.325 -0.472 1 CA-C-O 129.008 4.242 . . . . 0.0 110.35 179.055 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.24 -124.36 3.17 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 110.036 -3.257 . . . . 0.0 108.111 168.507 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 130.075 3.702 . . . . 0.0 110.318 -164.437 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 115.765 -2.064 . . . . 0.0 107.739 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -86.5 140.44 29.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -167.803 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.398 7.4 pt -131.77 172.97 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 128.686 2.794 . . . . 0.0 115.561 162.576 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -126.85 135.45 51.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 127.164 2.79 . . . . 0.0 103.679 -175.317 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.275 79.6 t -126.92 121.47 58.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.978 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.255 35.1 tttp -97.47 156.05 16.66 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 129.583 3.153 . . . . 0.0 103.8 -172.918 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -134.48 146.2 49.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.183 -178.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.7 mt -68.52 -22.59 64.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 117.906 -2.996 . . . . 0.0 111.403 -176.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 p -82.04 -18.49 43.04 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.504 2.322 . . . . 0.0 109.002 -172.654 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.47 31.45 0.78 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-O 116.624 -2.209 . . . . 0.0 112.981 151.14 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.311 41.5 pttt -133.43 160.87 36.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.039 3.336 . . . . 0.0 110.212 -179.399 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -122.08 135.53 54.82 Favored 'General case' 0 N--CA 1.449 -0.514 1 N-CA-C 99.739 -4.171 . . . . 0.0 99.739 164.73 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 pt -97.99 152.43 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 118.806 -2.434 . . . . 0.0 105.165 168.616 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.1 m -96.83 150.14 21.06 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 128.741 3.776 . . . . 0.0 107.656 166.428 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.85 157.36 46.94 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.009 2.123 . . . . 0.0 107.288 179.816 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -134.27 101.4 5.0 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.475 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.44 145.31 25.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 129.458 3.103 . . . . 0.0 112.646 -172.773 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -85.29 135.18 39.31 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.768 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.83 -37.62 2.45 Favored 'Trans proline' 0 N--CA 1.454 -0.841 1 C-N-CA 126.971 5.114 . . . . 0.0 117.639 -178.334 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 p -103.13 9.61 38.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 119.566 3.172 . . . . 0.0 119.566 -179.494 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -72.55 137.71 46.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 118.138 -2.851 . . . . 0.0 104.035 170.194 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -75.95 162.03 28.44 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 129.693 3.197 . . . . 0.0 113.809 172.714 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.1 mm -53.12 -36.45 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.258 2.223 . . . . 0.0 113.891 -174.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.305 4.8 tp10 -55.89 -38.6 70.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.83 2.052 . . . . 0.0 115.526 173.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -66.99 -43.66 82.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 125.932 2.02 . . . . 0.0 112.756 176.225 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.263 22.8 t -52.84 -52.76 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.836 2.054 . . . . 0.0 110.2 174.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -58.79 -42.08 88.22 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 125.667 1.854 . . . . 0.0 111.916 -179.228 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.48 72.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 116.462 -1.732 . . . . 0.0 112.572 177.371 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -76.41 -33.48 58.82 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 122.784 2.538 . . . . 0.0 111.457 178.586 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.58 -43.43 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 129.895 3.278 . . . . 0.0 110.698 174.394 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.48 -52.9 62.59 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 125.309 1.443 . . . . 0.0 112.416 175.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -52.71 -39.43 62.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 131.237 3.815 . . . . 0.0 111.977 -179.082 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -87.83 -50.69 6.29 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 127.688 3.117 . . . . 0.0 115.808 -178.894 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.3 -6.29 12.96 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 128.075 2.55 . . . . 0.0 115.357 -166.237 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.0 -16.6 35.98 Favored Glycine 0 CA--C 1.533 1.158 1 C-N-CA 130.821 4.058 . . . . 0.0 110.181 156.453 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.08 121.94 86.34 Favored Pre-proline 0 N--CA 1.444 -0.763 0 O-C-N 119.468 -2.195 . . . . 0.0 110.388 -164.089 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.26 148.94 56.54 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 122.994 2.463 . . . . 0.0 111.244 179.164 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.68 -32.14 95.33 Favored 'Trans proline' 0 N--CA 1.447 -1.238 1 C-N-CA 125.363 4.042 . . . . 0.0 116.614 -163.065 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.253 51.3 m-20 -73.18 -4.34 32.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.007 2.123 . . . . 0.0 115.49 176.165 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -108.82 -12.16 14.94 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 171.613 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.83 162.37 21.66 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.699 -0.8 . . . . 0.0 113.027 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.276 0.1 OUTLIER -151.71 102.93 2.9 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 118.308 -2.745 . . . . 0.0 106.475 175.21 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.2 mt -87.04 113.55 22.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 127.576 3.048 . . . . 0.0 114.732 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.8 mt -120.56 138.89 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 131.551 3.941 . . . . 0.0 106.558 -168.102 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -155.34 -176.68 6.07 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.098 -2.876 . . . . 0.0 105.97 -172.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.04 112.67 1.41 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 124.638 2.161 . . . . 0.0 110.026 -168.693 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.82 -78.54 0.3 Allowed Glycine 0 CA--C 1.532 1.137 0 N-CA-C 107.03 -2.428 . . . . 0.0 107.03 -175.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -165.74 -171.99 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.965 2.506 . . . . 0.0 104.959 -161.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.81 148.85 45.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 130.994 3.718 . . . . 0.0 110.034 -177.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.37 147.39 22.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 122.863 1.316 . . . . 0.0 111.907 176.148 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -111.55 157.72 20.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 111.663 -2.517 . . . . 0.0 115.556 -175.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -72.98 135.53 44.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 130.84 3.656 . . . . 0.0 112.381 -171.68 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.5 -28.35 10.96 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 169.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -71.74 159.26 34.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 116.605 -1.664 . . . . 0.0 110.36 -179.006 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 p -113.28 -178.46 3.38 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.358 2.263 . . . . 0.0 109.567 171.148 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.0 -31.25 68.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 125.192 1.557 . . . . 0.0 114.255 179.197 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.3 p -77.42 -33.31 54.97 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.15 -37.83 75.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 124.508 1.13 . . . . 0.0 110.883 177.261 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.73 -0.58 57.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.026 -1.046 . . . . 0.0 113.627 -175.076 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 77.94 42.83 0.1 Allowed 'General case' 0 C--N 1.324 -0.51 1 C-N-CA 134.045 4.938 . . . . 0.0 109.072 167.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -100.03 95.35 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 103.258 -2.868 . . . . 0.0 103.258 -175.34 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.66 163.74 26.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.624 -1.298 . . . . 0.0 110.162 160.459 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -45.41 147.3 0.83 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 131.095 3.758 . . . . 0.0 114.04 175.37 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 59.41 33.84 22.5 Favored 'General case' 0 N--CA 1.448 -0.566 1 C-N-CA 132.847 4.459 . . . . 0.0 106.901 172.29 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -93.68 152.21 19.13 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 117.511 -3.243 . . . . 0.0 106.861 175.739 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.6 m -99.67 130.28 45.88 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.932 1.395 . . . . 0.0 110.56 175.177 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mp -102.78 161.49 13.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 102.088 -3.301 . . . . 0.0 102.088 163.434 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.83 123.42 49.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 172.752 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -90.14 122.0 32.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 118.677 -2.514 . . . . 0.0 111.57 167.302 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.67 156.4 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.925 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.268 16.0 mt -114.84 147.92 39.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.399 -169.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -95.03 160.86 14.37 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 127.986 3.304 . . . . 0.0 108.779 156.449 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -95.26 115.54 27.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 165.994 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.265 21.7 ttt180 -140.05 -80.86 0.28 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 112.952 -1.931 . . . . 0.0 106.416 177.305 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.29 -179.68 16.45 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 178.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.551 1 N-CA-C 102.321 -4.312 . . . . 0.0 102.321 168.54 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptt? . . . . . 0 C--O 1.223 -0.317 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -88.45 148.69 24.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 117.518 -3.239 . . . . 0.0 105.705 -177.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -127.2 143.29 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 128.925 2.89 . . . . 0.0 107.268 159.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -104.07 134.41 47.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.197 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.23 126.93 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 117.74 -1.124 . . . . 0.0 109.413 -168.047 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -116.68 116.45 27.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 122.162 2.256 . . . . 0.0 112.853 -165.703 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 p -74.06 158.59 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.201 1.4 . . . . 0.0 109.98 -178.88 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.5 tp -59.78 -40.47 88.37 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.682 1.993 . . . . 0.0 107.223 -166.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.6 p -80.7 2.2 26.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.89 -3.007 . . . . 0.0 118.607 176.408 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.91 -7.7 16.96 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 119.157 2.423 . . . . 0.0 119.157 152.815 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -75.67 122.86 24.61 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.281 1.433 . . . . 0.0 107.251 -177.086 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.321 73.1 m -81.86 138.16 35.11 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.19 0.995 . . . . 0.0 109.754 170.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -122.12 141.86 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 129.807 3.243 . . . . 0.0 103.379 172.917 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 m -96.88 120.05 36.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.943 2.497 . . . . 0.0 112.307 170.165 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.2 mt -106.17 136.27 46.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.084 1.754 . . . . 0.0 110.437 171.158 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -92.17 140.28 29.78 Favored 'General case' 0 CA--C 1.535 0.401 1 O-C-N 129.863 4.477 . . . . 0.0 104.235 172.058 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -153.9 168.66 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 129.256 3.022 . . . . 0.0 105.278 -174.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -116.45 159.69 39.08 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 129.094 2.958 . . . . 0.0 107.81 172.769 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.297 86.7 Cg_endo -57.86 -29.58 86.69 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.568 3.512 . . . . 0.0 116.515 172.237 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -95.88 11.18 34.67 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 130.769 3.628 . . . . 0.0 108.398 -166.889 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.29 2.6 m-20 -92.92 146.8 23.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 115.835 -2.031 . . . . 0.0 111.533 -176.038 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 t -86.13 151.83 23.35 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 120.338 1.427 . . . . 0.0 112.262 173.72 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.258 62.6 mt -65.12 -31.24 53.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 118.367 -2.708 . . . . 0.0 108.826 -171.069 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.15 -40.44 97.57 Favored 'General case' 0 N--CA 1.452 -0.366 2 O-C-N 114.325 -5.234 . . . . 0.0 113.824 176.515 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -68.44 -31.0 70.01 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 128.532 2.733 . . . . 0.0 111.8 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 t -59.64 -51.94 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 122.496 2.407 . . . . 0.0 110.278 163.448 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -68.03 -40.55 82.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.973 2.909 . . . . 0.0 112.051 -164.053 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -17.94 64.8 Favored 'General case' 0 N--CA 1.446 -0.655 1 C-N-CA 132.765 4.426 . . . . 0.0 113.982 177.45 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -65.08 -31.64 72.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 130.554 3.542 . . . . 0.0 110.661 176.399 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 mm -74.05 -16.74 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 O-C-N 124.948 1.405 . . . . 0.0 114.164 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.281 6.1 tp60 -66.89 -38.12 85.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 117.251 -3.406 . . . . 0.0 111.441 169.723 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.66 -47.67 74.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.811 1.244 . . . . 0.0 110.708 168.612 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.85 -75.33 0.16 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 115.577 -2.154 . . . . 0.0 114.498 -175.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -101.24 -20.06 15.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 127.944 3.278 . . . . 0.0 115.171 -161.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.96 6.34 26.34 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 130.345 3.831 . . . . 0.0 114.51 162.811 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.59 124.02 54.32 Favored Pre-proline 0 N--CA 1.448 -0.555 0 O-C-N 126.728 2.075 . . . . 0.0 105.854 -164.176 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -68.24 172.81 10.49 Favored 'Trans proline' 0 N--CA 1.451 -1.003 1 C-N-CA 126.424 4.75 . . . . 0.0 116.16 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.85 -42.59 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 1 C-N-CA 126.943 5.096 . . . . 0.0 107.622 177.266 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.88 -15.32 62.62 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 130.725 3.61 . . . . 0.0 115.978 -174.57 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.257 38.0 tt0 -103.59 -34.57 8.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 118.101 -1.439 . . . . 0.0 113.887 171.572 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.05 135.01 21.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.745 1.618 . . . . 0.0 115.329 169.017 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -136.14 158.34 44.65 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 119.158 -2.214 . . . . 0.0 107.702 168.44 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.8 mt -129.63 152.24 49.36 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 127.87 3.231 . . . . 0.0 108.952 -167.602 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 mt -135.94 129.49 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 127.797 2.439 . . . . 0.0 107.142 169.871 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -120.28 118.33 30.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 130.359 3.464 . . . . 0.0 105.338 173.205 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.87 50.64 11.09 Favored 'General case' 0 C--O 1.22 -0.472 1 C-N-CA 133.797 4.839 . . . . 0.0 111.568 170.983 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.46 -13.92 60.93 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.787 -1.007 . . . . 0.0 111.591 173.344 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 mtmt -105.93 119.75 39.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 130.988 3.715 . . . . 0.0 109.06 -172.812 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -76.36 151.83 36.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 128.526 2.731 . . . . 0.0 104.559 172.164 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.282 0.8 OUTLIER -140.15 132.3 28.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.669 2.787 . . . . 0.0 111.11 177.768 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.258 71.9 mm-40 -87.61 162.3 17.23 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 125.188 2.423 . . . . 0.0 110.116 172.222 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.35 162.06 18.37 Favored 'General case' 0 N--CA 1.45 -0.468 1 C-N-CA 134.882 5.273 . . . . 0.0 109.02 173.898 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.57 14.46 32.28 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 119.687 2.635 . . . . 0.0 119.687 173.591 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -157.55 163.95 37.84 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.876 2.07 . . . . 0.0 111.958 177.797 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.6 p -85.47 149.43 25.4 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 130.354 3.462 . . . . 0.0 108.456 -173.106 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.0 mt -65.2 -34.93 79.55 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.522 1.529 . . . . 0.0 109.556 -171.334 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.29 66.5 p -36.59 -56.98 0.8 Allowed 'General case' 0 N--CA 1.449 -0.513 1 C-N-CA 133.966 4.906 . . . . 0.0 113.8 173.944 . . . . . . . . 3 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.86 -27.25 66.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 130.713 3.605 . . . . 0.0 116.156 -177.563 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -101.14 2.73 40.49 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.412 2.285 . . . . 0.0 110.846 179.603 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.362 24.3 p30 69.13 29.43 4.7 Favored 'General case' 0 N--CA 1.444 -0.772 1 C-N-CA 131.819 4.047 . . . . 0.0 113.161 168.332 . . . . . . . . 3 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 25.8 mt -83.68 127.14 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.446 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -115.57 178.83 4.16 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 130.255 3.422 . . . . 0.0 107.304 -174.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.56 135.26 46.39 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 128.689 2.796 . . . . 0.0 111.261 168.132 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 61.49 27.6 17.11 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 129.552 3.141 . . . . 0.0 116.683 176.766 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -62.98 147.86 49.33 Favored 'General case' 0 C--N 1.328 -0.369 1 O-C-N 115.423 -4.548 . . . . 0.0 109.959 171.608 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.8 p -113.69 108.3 16.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.554 1.941 . . . . 0.0 107.383 -176.688 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.57 150.64 28.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 123.817 1.77 . . . . 0.0 112.738 177.894 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -87.77 139.95 30.01 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 128.956 2.902 . . . . 0.0 104.654 169.281 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.68 120.9 40.06 Favored 'General case' 0 C--N 1.325 -0.493 1 N-CA-C 96.73 -5.285 . . . . 0.0 96.73 170.544 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 m -132.67 165.97 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 128.222 2.609 . . . . 0.0 108.367 170.176 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.83 137.64 45.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.805 2.442 . . . . 0.0 116.025 -174.491 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -84.78 119.31 25.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 100.662 -3.829 . . . . 0.0 100.662 165.176 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.9 mt -95.98 114.26 25.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.3 2.64 . . . . 0.0 112.904 167.066 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -104.9 144.25 32.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 131.494 3.917 . . . . 0.0 113.238 -173.083 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.78 51.64 0.81 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 122.902 1.279 . . . . 0.0 111.756 166.964 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.472 0 C-N-CA 128.083 2.754 . . . . 0.0 110.576 -175.106 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttm . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.77 144.9 40.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.233 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.372 34.2 pt -132.37 162.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 130.189 3.396 . . . . 0.0 116.57 169.376 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -107.89 131.58 54.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.647 1.979 . . . . 0.0 109.858 178.41 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.2 t -100.32 118.0 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 129.031 2.933 . . . . 0.0 105.866 159.724 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.391 71.9 tttt -112.48 123.25 49.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 -174.437 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -88.74 151.56 22.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 110.113 -3.221 . . . . 0.0 107.968 174.652 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mt -67.88 -24.21 65.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 127.172 2.795 . . . . 0.0 109.869 172.37 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -81.24 -18.43 46.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 118.526 -2.609 . . . . 0.0 111.104 -171.332 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.31 -6.17 7.18 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 128.129 2.776 . . . . 0.0 115.11 156.427 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' HZ3' ' CD ' ' A' ' 34' ' ' GLU 0.251 17.1 pttt -82.36 143.21 31.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.349 1.46 . . . . 0.0 111.203 -175.743 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 p -97.26 143.42 28.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 125.796 2.712 . . . . 0.0 107.671 164.629 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.6 mt -122.75 143.03 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 110.347 -3.115 . . . . 0.0 103.171 172.804 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 m -100.22 132.64 45.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.081 2.552 . . . . 0.0 110.875 172.996 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -120.38 133.08 55.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.222 3.009 . . . . 0.0 110.406 170.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -93.75 112.73 24.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.278 1.831 . . . . 0.0 109.063 170.287 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.79 175.64 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 127.975 2.51 . . . . 0.0 109.627 -176.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -132.13 159.33 72.61 Favored Pre-proline 0 N--CA 1.451 -0.399 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 159.178 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.93 -8.94 20.62 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 123.214 2.609 . . . . 0.0 114.228 -170.652 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 p -68.64 -31.35 70.42 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.884 2.873 . . . . 0.0 114.627 167.577 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.9 131.93 41.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 117.181 -3.449 . . . . 0.0 113.978 174.489 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.0 p -73.06 157.37 37.46 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 127.085 2.154 . . . . 0.0 112.301 173.406 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.295 1.9 mp -36.2 -42.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 129.414 3.086 . . . . 0.0 115.202 154.804 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -73.03 -37.68 66.81 Favored 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 133.557 4.743 . . . . 0.0 116.561 169.517 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -63.18 -36.38 83.44 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.794 2.088 . . . . 0.0 110.89 165.862 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.1 t -69.65 -39.4 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 1 O-C-N 115.034 -4.791 . . . . 0.0 114.292 178.134 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -61.04 -38.71 87.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.914 1.686 . . . . 0.0 115.058 168.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.25 -54.51 14.37 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 130.626 3.571 . . . . 0.0 107.581 174.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -55.35 -42.38 73.79 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.1 mt -64.08 -43.95 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.512 1.125 . . . . 0.0 111.173 169.205 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -58.59 -32.61 69.12 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.965 2.506 . . . . 0.0 112.446 178.3 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.268 0.9 OUTLIER -58.21 -37.79 75.52 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 119.536 -1.977 . . . . 0.0 111.357 169.941 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -87.5 -45.41 10.51 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.151 2.581 . . . . 0.0 106.833 -169.854 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.446 ' CD ' ' HZ3' ' A' ' 11' ' ' LYS . 13.8 mm-40 -111.16 -17.51 13.2 Favored 'General case' 0 N--CA 1.451 -0.4 1 N-CA-C 124.846 5.128 . . . . 0.0 124.846 -174.516 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.79 -2.09 81.06 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 125.534 1.54 . . . . 0.0 114.489 172.693 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.7 mt -76.04 138.49 68.91 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 127.446 2.298 . . . . 0.0 109.846 -174.554 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.36 133.73 41.7 Favored 'Trans proline' 0 N--CA 1.45 -1.061 1 C-N-CA 126.363 4.709 . . . . 0.0 116.611 179.117 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -43.54 -44.74 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.698 1 C-N-CA 131.883 8.389 . . . . 0.0 111.502 173.825 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.358 2.4 t70 -38.7 -44.12 0.97 Allowed 'General case' 0 C--O 1.234 0.275 1 C-N-CA 133.826 4.85 . . . . 0.0 113.087 169.117 . . . . . . . . 3 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -96.66 -25.71 15.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.649 1.98 . . . . 0.0 108.926 -171.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -81.41 111.75 18.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -166.181 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -102.81 124.94 49.28 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 100.94 -3.726 . . . . 0.0 100.94 177.812 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.57 120.06 34.72 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 127.23 2.831 . . . . 0.0 107.435 175.032 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mt -122.35 154.12 27.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 126.273 2.233 . . . . 0.0 105.347 -169.064 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.283 67.8 t80 -143.32 128.21 18.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 115.26 -2.305 . . . . 0.0 110.472 160.716 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.36 20.3 6.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.145 2.178 . . . . 0.0 112.674 167.778 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.02 -8.6 63.22 Favored Glycine 0 CA--C 1.526 0.741 1 O-C-N 115.853 -4.279 . . . . 0.0 111.667 -178.59 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -102.66 155.23 18.44 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 124.988 2.328 . . . . 0.0 115.357 173.388 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -94.04 129.81 40.41 Favored 'General case' 0 N--CA 1.446 -0.643 1 N-CA-C 100.123 -4.028 . . . . 0.0 100.123 174.759 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.58 133.88 53.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 127.074 2.15 . . . . 0.0 107.701 167.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -69.86 134.62 48.67 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 115.298 -2.287 . . . . 0.0 112.796 177.836 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.294 5.6 t0 -93.21 132.99 36.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 126.224 2.916 . . . . 0.0 109.135 168.569 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.58 8.06 23.3 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 119.059 -2.275 . . . . 0.0 112.925 -159.721 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt-85 -136.98 178.19 7.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 120.476 2.138 . . . . 0.0 106.677 -177.575 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.8 p -110.78 172.42 6.88 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 129.808 3.243 . . . . 0.0 112.509 -176.901 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.4 mt -61.32 -46.78 88.87 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 119.178 -2.202 . . . . 0.0 109.113 168.164 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -56.32 -31.58 63.85 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 174.441 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.71 -29.72 70.29 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.87 2.068 . . . . 0.0 109.885 -178.323 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -102.16 12.23 37.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 124.106 1.908 . . . . 0.0 112.827 177.13 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.338 0.6 OUTLIER 84.14 1.7 0.9 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.728 2.011 . . . . 0.0 113.982 172.039 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.14 71.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.98 2.112 . . . . 0.0 108.8 179.28 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -81.07 -32.51 33.95 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.997 2.519 . . . . 0.0 113.902 166.565 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -149.54 118.45 6.67 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 118.779 -2.45 . . . . 0.0 114.022 -179.798 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 47.47 99.92 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.891 1 C-N-CA 135.198 5.399 . . . . 0.0 113.295 157.579 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -143.17 174.39 10.74 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 117.06 -3.525 . . . . 0.0 108.942 -177.235 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -121.81 147.88 45.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 116.758 -3.714 . . . . 0.0 104.527 171.78 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.5 mt -115.11 144.01 44.32 Favored 'General case' 0 N--CA 1.447 -0.578 1 C-N-CA 131.976 4.11 . . . . 0.0 111.354 174.42 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -100.89 117.08 34.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 101.069 -3.678 . . . . 0.0 101.069 -175.711 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.5 tp -100.87 129.48 46.74 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.463 1.105 . . . . 0.0 108.997 167.58 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.405 0.2 OUTLIER -131.02 156.94 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 O-C-N 125.996 2.06 . . . . 0.0 109.284 165.547 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 tp -85.77 -160.03 0.5 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 127.297 3.427 . . . . 0.0 107.495 174.769 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.88 -20.69 17.97 Favored 'General case' 0 N--CA 1.45 -0.451 1 O-C-N 114.544 -5.097 . . . . 0.0 108.477 176.936 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.9 mt -118.49 161.68 19.61 Favored 'General case' 0 N--CA 1.455 -0.18 1 C-N-CA 132.657 4.383 . . . . 0.0 104.444 -174.594 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.09 126.75 51.45 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 125.07 2.367 . . . . 0.0 105.475 170.294 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.35 -151.36 20.08 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 106.841 -2.504 . . . . 0.0 106.841 -168.671 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 116.357 -2.357 . . . . 0.0 114.535 179.861 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 123.52 1.629 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -94.79 124.73 39.0 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 117.584 -3.197 . . . . 0.0 106.051 175.57 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -108.08 161.88 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 102.981 -2.97 . . . . 0.0 102.981 164.542 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -101.9 141.75 34.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 116.0 -1.952 . . . . 0.0 114.073 157.777 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 t -110.31 115.36 49.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 163.746 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -83.16 107.0 15.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.227 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.285 1.2 p -74.0 156.13 37.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.768 2.827 . . . . 0.0 109.476 174.748 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.5 tp -54.62 -37.67 65.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 130.152 3.381 . . . . 0.0 116.449 -159.986 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -66.62 -24.05 66.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 113.006 -3.378 . . . . 0.0 115.235 177.303 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.22 -35.25 3.01 Favored Glycine 0 CA--C 1.531 1.036 1 CA-C-O 112.101 -4.722 . . . . 0.0 111.415 -164.397 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.21 139.01 58.72 Favored 'General case' 0 N--CA 1.448 -0.566 1 O-C-N 131.292 4.76 . . . . 0.0 104.679 -175.423 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -116.65 129.73 56.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 128.165 2.586 . . . . 0.0 109.255 173.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 pt -113.77 143.78 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.503 167.472 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.9 m -90.65 130.38 36.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 128.337 2.655 . . . . 0.0 106.68 176.373 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.35 109.57 18.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.985 2.114 . . . . 0.0 106.871 179.086 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -71.84 112.45 7.95 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 128.945 3.903 . . . . 0.0 107.832 168.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 m -135.4 166.25 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 128.231 2.612 . . . . 0.0 109.085 -177.197 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -116.48 161.57 31.06 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 116.456 -1.735 . . . . 0.0 108.762 168.674 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -65.13 -19.49 63.03 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 124.682 3.588 . . . . 0.0 113.224 178.333 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.6 p -69.8 -26.16 64.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 113.379 -3.2 . . . . 0.0 112.3 172.068 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.93 133.85 26.42 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 128.948 2.899 . . . . 0.0 112.222 -177.717 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 p -83.61 148.65 27.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 116.055 -1.926 . . . . 0.0 111.509 175.375 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.0 mm -48.11 -42.77 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 125.388 3.722 . . . . 0.0 111.274 168.404 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -40.98 -65.76 0.4 Allowed 'General case' 0 N--CA 1.445 -0.686 1 C-N-CA 131.703 4.001 . . . . 0.0 112.884 163.107 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -35.43 80.23 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 123.239 0.337 . . . . 0.0 110.613 179.653 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.29 68.7 t -57.04 -48.34 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 116.79 -1.576 . . . . 0.0 115.153 168.908 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -46.71 -34.37 5.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 125.559 3.8 . . . . 0.0 117.543 161.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -28.04 59.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 123.792 1.758 . . . . 0.0 112.725 177.628 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -79.7 -44.45 20.8 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 118.564 -2.585 . . . . 0.0 112.709 172.479 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mt -48.67 -49.17 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 120.732 1.605 . . . . 0.0 111.25 170.5 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -54.98 -53.77 51.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 167.2 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.88 -41.28 91.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 123.229 2.74 . . . . 0.0 109.65 -175.164 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -76.17 -27.78 57.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 118.34 2.719 . . . . 0.0 118.34 179.916 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.294 21.0 mm-40 -140.11 2.96 1.95 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 122.903 2.592 . . . . 0.0 109.97 -175.734 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.42 -3.54 86.44 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 117.937 -2.977 . . . . 0.0 116.495 162.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.61 146.65 61.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 115.568 -2.158 . . . . 0.0 107.136 -167.396 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -78.11 132.27 11.44 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.062 3.175 . . . . 0.0 103.932 -178.081 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.77 -18.34 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 CA-C-N 124.098 2.499 . . . . 0.0 112.84 -170.413 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.34 -22.42 44.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 118.006 -1.477 . . . . 0.0 114.831 -170.111 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -82.76 -16.67 47.02 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.633 1.973 . . . . 0.0 114.432 172.396 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -73.87 130.22 39.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.623 1.969 . . . . 0.0 111.967 174.418 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -96.16 144.81 26.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.927 2.491 . . . . 0.0 107.323 155.585 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.1 tp -142.93 115.03 8.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 130.538 3.535 . . . . 0.0 111.088 -164.946 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 46.5 pt -134.74 142.83 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 1 C-N-CA 132.336 4.254 . . . . 0.0 114.045 -159.052 . . . . . . . . 3 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -138.02 96.55 3.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.199 2.6 . . . . 0.0 105.79 178.451 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 77.25 21.66 1.05 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.12 -1.612 . . . . 0.0 107.716 162.064 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.36 -40.4 2.46 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 119.642 -1.266 . . . . 0.0 113.883 -175.157 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.319 51.1 mttm -82.04 132.53 35.25 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 119.257 -2.319 . . . . 0.0 110.916 -171.883 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -82.01 128.27 33.93 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.296 0.953 . . . . 0.0 109.422 170.992 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -82.19 115.92 21.51 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 178.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -75.96 135.95 40.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.143 -3.473 . . . . 0.0 107.511 -177.902 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.0 119.9 7.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.24 2.216 . . . . 0.0 111.652 178.363 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.47 6.51 41.28 Favored Glycine 0 CA--C 1.525 0.685 1 C-N-CA 130.906 4.098 . . . . 0.0 114.617 171.146 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -86.32 154.11 21.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 125.423 1.307 . . . . 0.0 110.421 169.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.7 p -76.86 145.02 38.62 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 127.027 2.704 . . . . 0.0 115.522 171.438 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.6 mt -59.51 -29.96 68.25 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.947 2.499 . . . . 0.0 112.473 172.602 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.7 t -52.44 -59.04 4.91 Favored 'General case' 0 N--CA 1.446 -0.626 1 C-N-CA 132.821 4.448 . . . . 0.0 110.515 168.503 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -50.55 -41.69 54.38 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 118.827 2.899 . . . . 0.0 118.827 170.093 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -88.53 -0.62 57.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.136 0.88 . . . . 0.0 109.951 -179.859 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m120 62.26 39.1 12.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 129.316 3.046 . . . . 0.0 115.155 -175.442 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 mm -85.81 121.84 37.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -171.425 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -103.75 169.01 8.77 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 111.593 -2.549 . . . . 0.0 114.556 -176.179 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -58.73 135.1 57.35 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 112.37 -3.681 . . . . 0.0 113.065 -176.333 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.1 19.12 11.73 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.521 3.129 . . . . 0.0 116.253 -178.559 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -70.17 141.66 52.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.725 3.21 . . . . 0.0 109.485 160.729 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.3 m -107.52 129.33 54.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 175.804 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -97.69 154.18 17.74 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 129.525 3.13 . . . . 0.0 106.846 171.049 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -125.27 163.85 21.61 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.801 2.04 . . . . 0.0 110.861 -175.158 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.43 ' HG ' ' H ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -134.72 160.09 39.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.103 -2.317 . . . . 0.0 116.326 -176.216 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.43 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 23.0 t -151.83 150.68 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 128.387 3.554 . . . . 0.0 105.982 166.512 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.259 53.2 mt -107.11 151.35 25.5 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 119.121 -2.237 . . . . 0.0 111.453 176.483 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -46.19 -52.42 12.37 Favored 'General case' 0 C--N 1.325 -0.497 1 CA-C-O 129.833 4.635 . . . . 0.0 109.511 175.556 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.4 147.35 36.05 Favored 'General case' 0 N--CA 1.447 -0.61 2 C-N-CA 134.39 5.076 . . . . 0.0 110.555 170.366 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -110.81 -30.98 7.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.47 1.908 . . . . 0.0 110.695 164.215 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.55 126.23 4.6 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 127.118 2.761 . . . . 0.0 109.571 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 CA-C-O 116.372 -2.349 . . . . 0.0 108.911 172.434 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' N ' ' OE2' ' A' ' 16' ' ' GLU 0.251 45.7 ttp . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -81.55 156.68 25.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 178.535 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 pt -146.24 174.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 1 O-C-N 129.204 4.065 . . . . 0.0 105.944 174.173 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -131.06 153.38 49.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 117.167 -1.397 . . . . 0.0 110.309 164.024 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -130.12 114.74 30.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 101.699 -3.445 . . . . 0.0 101.699 172.001 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -80.99 133.96 35.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.166 2.186 . . . . 0.0 106.244 174.452 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 p -75.13 175.48 8.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 129.977 3.311 . . . . 0.0 111.772 164.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.88 -9.21 49.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 118.151 -2.843 . . . . 0.0 110.671 172.044 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 p -99.57 4.31 45.79 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.777 -179.441 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.74 -25.34 7.64 Favored Glycine 0 CA--C 1.531 1.061 1 C-N-CA 131.902 4.573 . . . . 0.0 109.389 159.148 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 pttt -82.71 134.0 35.15 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 -153.502 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 m -95.36 110.63 22.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.275 1.83 . . . . 0.0 114.55 -178.333 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.74 120.82 35.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 118.648 -2.532 . . . . 0.0 105.738 -176.39 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -77.47 121.24 23.56 Favored 'General case' 0 C--N 1.324 -0.519 1 O-C-N 114.558 -5.089 . . . . 0.0 103.508 175.91 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.299 69.3 mt -125.02 152.58 44.06 Favored 'General case' 0 N--CA 1.446 -0.645 1 CA-C-N 126.294 4.134 . . . . 0.0 108.059 169.97 . . . . . . . . 3 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' OE2' ' N ' ' A' ' 1' ' ' MET . 32.0 tp10 -99.88 132.43 45.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 173.353 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.77 167.0 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 127.426 3.489 . . . . 0.0 105.72 172.512 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.41 140.13 28.71 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 110.747 -2.933 . . . . 0.0 106.408 155.518 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.363 46.3 Cg_endo -59.93 -4.48 2.88 Favored 'Trans proline' 0 N--CA 1.45 -1.032 1 C-N-CA 126.742 4.961 . . . . 0.0 117.005 -173.052 . . . . . . . . 3 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 p -88.58 -6.34 57.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 113.239 -3.267 . . . . 0.0 114.591 165.468 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.47 140.44 55.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 125.971 2.045 . . . . 0.0 106.777 179.691 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.6 p -73.93 163.37 28.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 116.527 -1.701 . . . . 0.0 109.631 170.891 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.0 mm -60.93 -37.14 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 124.211 1.958 . . . . 0.0 107.086 175.508 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.395 0.0 OUTLIER -46.2 -45.03 16.63 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 118.322 -2.736 . . . . 0.0 115.348 171.357 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -67.88 -33.89 75.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.041 2.536 . . . . 0.0 109.126 -179.909 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.258 89.0 t -67.88 -52.92 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 126.169 1.787 . . . . 0.0 113.079 166.707 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -48.67 -41.14 30.51 Favored 'General case' 0 N--CA 1.442 -0.842 1 N-CA-C 122.123 4.119 . . . . 0.0 122.123 171.398 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.25 -35.32 66.21 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.721 2.008 . . . . 0.0 112.506 176.429 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.3 mttt -67.56 -30.8 70.52 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 176.784 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -70.92 -43.49 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 130.359 3.464 . . . . 0.0 109.655 170.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -51.83 -55.34 20.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 125.806 2.717 . . . . 0.0 113.566 168.114 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.19 -27.49 62.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.552 3.141 . . . . 0.0 113.925 -173.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -97.7 -66.52 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 119.45 -2.032 . . . . 0.0 110.993 172.51 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -92.01 -17.85 24.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 120.935 1.698 . . . . 0.0 113.392 -165.381 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.83 -10.95 32.3 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 116.765 -3.709 . . . . 0.0 119.33 172.276 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 73.6 mt -86.07 129.39 54.18 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 117.541 -3.329 . . . . 0.0 112.043 -160.428 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -76.95 137.96 18.03 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 125.281 3.987 . . . . 0.0 111.719 -166.761 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -39.56 -53.47 2.23 Favored 'Trans proline' 0 N--CA 1.446 -1.318 1 C-N-CA 126.863 5.042 . . . . 0.0 111.985 172.408 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.37 10.06 2.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 124.558 3.344 . . . . 0.0 113.464 -172.335 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -103.85 -28.8 11.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.602 1.191 . . . . 0.0 113.367 162.318 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.38 149.74 30.09 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 120.295 -1.503 . . . . 0.0 113.658 -168.13 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -135.04 118.91 17.29 Favored 'General case' 0 N--CA 1.451 -0.388 1 C-N-CA 132.164 4.186 . . . . 0.0 109.131 164.552 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.266 59.9 mt -100.0 132.16 45.52 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.692 0.797 . . . . 0.0 112.462 167.597 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.2 mm -109.63 124.75 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 101.068 -3.678 . . . . 0.0 101.068 -175.586 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -117.79 113.89 22.48 Favored 'General case' 0 N--CA 1.444 -0.761 1 N-CA-C 98.63 -4.582 . . . . 0.0 98.63 174.557 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.22 52.36 8.68 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 111.353 -2.658 . . . . 0.0 117.376 170.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -0.88 81.22 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 116.883 -2.065 . . . . 0.0 111.673 167.183 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -126.96 154.12 44.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.0 1.32 . . . . 0.0 111.166 177.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -91.89 118.47 30.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 110.137 -3.21 . . . . 0.0 105.001 -175.077 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -67.18 123.91 21.6 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.202 2.201 . . . . 0.0 107.472 172.719 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -85.65 143.19 28.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -71.66 155.66 40.25 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 126.107 2.129 . . . . 0.0 110.635 -171.299 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.29 -2.98 85.48 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 128.187 2.803 . . . . 0.0 114.507 174.414 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.376 0.9 OUTLIER -99.8 164.76 11.9 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.506 1.522 . . . . 0.0 109.615 173.893 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 64.8 p -99.66 171.49 7.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 126.852 3.215 . . . . 0.0 110.371 169.473 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mp -42.73 -51.98 5.12 Favored 'General case' 0 N--CA 1.446 -0.657 1 C-N-CA 131.772 4.029 . . . . 0.0 114.951 163.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 p -75.17 -12.44 60.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.498 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -80.85 -42.33 21.74 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 119.224 -2.172 . . . . 0.0 107.339 172.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.29 10.12 41.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.557 1.943 . . . . 0.0 112.705 -166.352 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.362 71.0 m-80 91.1 12.08 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.192 1.797 . . . . 0.0 114.612 159.843 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.27 55.3 mt -71.33 135.73 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 -171.198 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.523 0.4 OUTLIER -122.86 162.91 21.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.568 2.347 . . . . 0.0 114.404 175.175 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -49.6 126.84 14.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 121.468 1.94 . . . . 0.0 114.46 171.547 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.355 16.3 tt0 81.78 0.42 1.52 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 130.985 3.714 . . . . 0.0 113.212 176.94 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -61.55 145.74 51.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 119.719 -1.863 . . . . 0.0 113.638 166.823 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.3 m -125.79 109.27 12.34 Favored 'General case' 0 N--CA 1.451 -0.417 1 O-C-N 132.394 6.059 . . . . 0.0 110.614 -160.525 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.326 10.9 mp -106.04 170.71 7.75 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 -176.622 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -121.92 142.39 50.33 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.407 3.083 . . . . 0.0 105.641 177.487 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.6 tp -102.51 128.42 49.16 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 -178.043 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -111.88 150.7 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 124.407 1.067 . . . . 0.0 109.204 163.626 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.6 mt -113.47 157.38 22.05 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 117.054 -3.529 . . . . 0.0 114.928 168.984 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 -95.92 155.89 16.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.54 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.46 132.72 33.86 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.528 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.258 42.8 ttt85 -134.6 -48.91 0.76 Allowed 'General case' 0 CA--C 1.534 0.338 0 O-C-N 127.122 2.764 . . . . 0.0 112.663 -174.653 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.87 9.17 7.66 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.923 1.725 . . . . 0.0 113.044 164.862 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.197 0 CA-C-O 118.022 -1.432 . . . . 0.0 113.692 179.228 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 103.593 -2.744 . . . . 0.0 103.593 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -90.47 128.23 36.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 115.658 -2.115 . . . . 0.0 110.241 -172.316 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -116.25 148.74 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 1 CA-C-N 126.012 4.006 . . . . 0.0 109.262 168.596 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -105.76 113.32 26.8 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -172.48 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.8 t -95.14 115.65 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 1 N-CA-C 99.574 -4.232 . . . . 0.0 99.574 168.308 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -99.19 133.03 44.06 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.904 174.111 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p -121.47 140.2 52.49 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -171.882 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 mt -62.66 -40.9 98.5 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.577 2.351 . . . . 0.0 109.994 171.253 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.265 23.8 p -71.53 8.63 1.03 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 176.453 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.58 18.02 2.27 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 117.112 -1.938 . . . . 0.0 112.424 118.581 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -138.42 153.92 48.88 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 129.373 3.069 . . . . 0.0 111.458 -176.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.2 p -99.61 106.16 18.09 Favored 'General case' 0 N--CA 1.446 -0.653 1 C-N-CA 135.148 5.379 . . . . 0.0 109.799 174.935 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 mt -101.84 105.76 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 2 N-CA-C 98.685 -4.561 . . . . 0.0 98.685 -167.75 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 p -92.96 89.25 6.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 119.377 -2.077 . . . . 0.0 113.015 -176.469 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tp -73.54 133.86 43.67 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 131.603 3.961 . . . . 0.0 104.063 -178.211 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -96.33 122.45 39.23 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 129.375 3.07 . . . . 0.0 104.515 168.336 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.3 135.59 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 128.805 2.842 . . . . 0.0 115.761 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.59 149.11 90.71 Favored Pre-proline 0 N--CA 1.45 -0.469 0 O-C-N 119.535 -1.978 . . . . 0.0 106.884 175.532 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.03 15.77 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.87 2.38 . . . . 0.0 113.123 -172.455 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.268 67.4 p -135.41 18.11 3.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 120.867 1.667 . . . . 0.0 113.58 175.575 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -81.04 118.03 22.14 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.747 -167.026 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -88.01 148.4 24.55 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 122.084 2.22 . . . . 0.0 107.427 -165.034 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.429 6.0 mt -45.03 -39.92 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 113.405 -3.188 . . . . 0.0 118.175 -174.395 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.95 -45.08 93.8 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 125.508 1.755 . . . . 0.0 112.739 170.82 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -71.75 -9.16 57.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.848 1.659 . . . . 0.0 110.594 -176.736 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.89 -29.07 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 127.104 2.161 . . . . 0.0 111.88 172.584 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -68.85 -32.36 71.98 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 118.91 -2.369 . . . . 0.0 113.854 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.01 -21.1 47.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 111.982 -2.372 . . . . 0.0 108.519 -176.055 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.31 -39.24 17.91 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 113.039 -3.362 . . . . 0.0 105.925 174.29 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 mt -58.36 -34.46 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 1 CA-C-N 127.394 4.633 . . . . 0.0 115.288 169.358 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -83.6 -3.31 57.59 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.935 2.494 . . . . 0.0 110.018 -176.521 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -101.63 -45.25 5.32 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.184 1.793 . . . . 0.0 106.691 166.164 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.27 48.5 tptt -74.46 -37.58 63.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 117.137 -1.411 . . . . 0.0 110.519 -167.361 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -121.41 -24.85 5.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 123.679 2.945 . . . . 0.0 108.787 -179.923 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.02 14.01 65.36 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 121.994 2.179 . . . . 0.0 110.901 175.025 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -74.04 131.84 80.68 Favored Pre-proline 0 N--CA 1.44 -0.949 0 C-N-CA 128.482 2.713 . . . . 0.0 108.329 169.487 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -78.2 162.65 28.39 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 N-CA-C 116.549 1.711 . . . . 0.0 116.549 -177.492 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.47 -16.54 47.66 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 N-CA-C 119.364 2.794 . . . . 0.0 119.364 -177.084 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -95.95 -2.89 46.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.435 -179.559 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -117.26 -15.39 10.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 112.467 -3.635 . . . . 0.0 115.038 177.517 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -67.55 138.03 56.19 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 130.536 3.534 . . . . 0.0 108.694 174.457 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -127.63 150.96 49.51 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 146.939 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.401 0.8 OUTLIER -139.8 133.78 30.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 173.675 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.55 144.4 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 -165.981 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -125.28 137.9 54.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.019 162.211 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.289 . . 56.92 28.45 14.67 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 169.084 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.71 -17.64 58.74 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 128.919 3.152 . . . . 0.0 112.707 -171.499 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -103.87 122.27 44.8 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 121.522 2.661 . . . . 0.0 109.717 -161.351 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.419 HE21 ' C ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -69.55 113.12 6.55 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.421 1.889 . . . . 0.0 107.781 166.0 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.3 mt -71.27 131.55 43.64 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 131.692 3.997 . . . . 0.0 108.198 -172.194 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -106.33 129.35 54.36 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 112.545 -3.597 . . . . 0.0 109.587 176.453 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.66 146.8 24.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 127.405 2.94 . . . . 0.0 109.316 179.029 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.31 -21.01 22.66 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 128.073 2.749 . . . . 0.0 114.762 173.798 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -88.99 153.77 20.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.418 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.4 p -86.25 175.8 8.28 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 126.251 2.22 . . . . 0.0 112.282 168.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.48 -39.9 81.23 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.48 2.712 . . . . 0.0 111.108 176.757 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.3 t -53.05 -51.41 61.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.308 1.843 . . . . 0.0 112.241 179.65 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -46.39 -34.53 4.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 129.546 3.138 . . . . 0.0 115.285 -179.065 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -111.77 -12.42 13.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 125.32 1.638 . . . . 0.0 108.284 -170.989 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' HE21 ' A' ' 62' ' ' GLN . 14.1 t-20 82.77 46.11 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.671 1 C-N-CA 131.951 4.1 . . . . 0.0 108.404 166.568 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.262 19.8 mt -98.63 91.54 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 174.617 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.418 HE21 ' HA ' ' A' ' 60' ' ' ASN . 91.1 mm-40 -98.96 -4.12 33.43 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 114.652 -2.594 . . . . 0.0 112.11 -169.762 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER 134.42 161.06 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.862 1 C-N-CA 134.338 5.055 . . . . 0.0 105.702 176.948 . . . . . . . . 4 3 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 71.57 -31.71 0.23 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 114.964 -2.446 . . . . 0.0 113.505 172.29 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.8 m -27.3 133.24 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.547 1 C-N-CA 135.366 5.466 . . . . 0.0 111.872 173.928 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.2 m -89.64 108.52 19.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.613 -1.305 . . . . 0.0 111.159 172.457 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -87.86 154.72 20.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.04 2.536 . . . . 0.0 114.838 162.967 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -125.14 121.17 33.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.817 2.047 . . . . 0.0 106.421 -179.566 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tp -86.96 136.86 32.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 115.872 -2.013 . . . . 0.0 109.522 171.596 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.24 166.59 19.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 126.463 2.352 . . . . 0.0 108.13 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.14 149.15 23.83 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.995 1.27 . . . . 0.0 113.655 174.293 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -76.93 84.43 3.48 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.789 2.436 . . . . 0.0 109.018 173.04 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 mt -86.04 -2.33 58.21 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 124.866 2.27 . . . . 0.0 115.743 -165.197 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -139.04 -56.51 0.6 Allowed 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 117.241 -3.412 . . . . 0.0 110.527 -167.262 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.07 48.78 0.56 Allowed Glycine 0 CA--C 1.532 1.097 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 -176.753 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 N-CA-C 104.046 -3.622 . . . . 0.0 104.046 -174.524 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 115.24 -2.314 . . . . 0.0 107.819 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.62 125.56 36.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 128.34 3.525 . . . . 0.0 110.104 179.926 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -122.03 136.87 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 119.422 -2.048 . . . . 0.0 111.935 158.433 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -90.53 133.13 35.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 172.235 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.55 110.64 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 174.269 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -97.77 143.65 28.18 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 128.115 3.384 . . . . 0.0 106.136 -177.572 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -112.97 149.51 33.16 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 129.166 2.987 . . . . 0.0 114.428 177.254 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.87 -34.81 1.02 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.612 2.765 . . . . 0.0 117.869 -171.519 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -74.3 -24.83 59.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 125.329 1.643 . . . . 0.0 112.969 179.398 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.85 -7.68 15.09 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.362 2.41 . . . . 0.0 118.362 -175.172 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 75.1 tttt -64.77 145.54 56.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.749 2.02 . . . . 0.0 106.481 173.863 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 m -137.19 132.68 34.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 112.63 -2.077 . . . . 0.0 105.679 -172.079 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mt -93.41 109.42 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 129.904 3.282 . . . . 0.0 107.717 162.494 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -74.75 119.42 18.92 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 128.171 2.588 . . . . 0.0 106.603 162.743 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -128.17 158.43 38.08 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -177.156 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -124.96 121.12 33.53 Favored 'General case' 0 C--O 1.221 -0.424 1 N-CA-C 99.756 -4.164 . . . . 0.0 99.756 -178.009 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -152.18 147.9 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.572 1.949 . . . . 0.0 108.585 -165.325 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.263 1.6 tm-20 -84.3 135.94 40.97 Favored Pre-proline 0 C--O 1.219 -0.516 0 O-C-N 125.817 1.948 . . . . 0.0 107.342 173.142 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -56.37 -26.81 64.4 Favored 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 126.384 4.722 . . . . 0.0 110.92 179.386 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.2 p -95.34 6.47 48.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 116.503 -3.873 . . . . 0.0 114.083 -177.497 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -68.18 132.35 47.01 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 111.662 -2.517 . . . . 0.0 111.248 160.704 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -95.52 157.4 15.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 116.635 -1.65 . . . . 0.0 107.335 -173.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.3 mm -36.62 -54.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 112.243 -3.742 . . . . 0.0 109.863 173.786 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -68.93 -23.13 64.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 125.611 3.823 . . . . 0.0 111.248 -170.713 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -77.7 -44.64 27.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 128.185 2.594 . . . . 0.0 110.722 -179.748 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.35 -46.59 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 170.511 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 38' ' ' PRO 0.361 37.9 mtpt -46.73 -49.79 19.05 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 112.912 -1.949 . . . . 0.0 116.105 173.363 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.68 68.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 129.042 2.937 . . . . 0.0 113.223 175.742 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -67.82 -37.51 82.03 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.545 1.938 . . . . 0.0 109.354 173.257 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.91 -30.31 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 121.842 2.11 . . . . 0.0 110.254 168.042 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.72 -35.56 75.14 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 116.769 -1.972 . . . . 0.0 111.705 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.26 -43.85 76.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.565 2.346 . . . . 0.0 109.334 178.787 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.324 12.6 mmtt -66.09 -42.04 89.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 117.037 -3.539 . . . . 0.0 115.451 178.532 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.47 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 5.0 mm-40 -140.87 -19.49 0.82 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 116.632 -1.652 . . . . 0.0 113.278 -156.372 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.79 5.89 83.41 Favored Glycine 0 CA--C 1.524 0.654 1 CA-C-O 112.78 -4.344 . . . . 0.0 109.314 172.515 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.2 mt -69.08 128.25 92.74 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 123.445 3.623 . . . . 0.0 108.771 174.41 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -54.59 144.87 61.71 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.57 2.18 . . . . 0.0 113.911 173.138 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' CB ' ' HB3' ' A' ' 27' ' ' LYS . 36.7 Cg_endo -72.35 -55.2 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 CA-C-N 123.423 2.258 . . . . 0.0 109.381 -170.006 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.16 -29.64 23.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.621 2.368 . . . . 0.0 112.17 -176.341 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -68.31 -31.86 71.59 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 114.432 -2.699 . . . . 0.0 110.223 179.182 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -73.81 138.9 44.78 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 123.597 2.908 . . . . 0.0 112.474 -173.055 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.42 52.6 mtt180 -104.73 134.08 48.48 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 119.563 -1.961 . . . . 0.0 112.557 141.691 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mp -88.28 114.23 24.68 Favored 'General case' 0 N--CA 1.443 -0.8 1 C-N-CA 134.14 4.976 . . . . 0.0 107.134 174.237 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.8 mt -111.76 140.09 32.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 126.602 1.961 . . . . 0.0 111.551 168.331 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -152.06 148.24 27.45 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 131.421 3.888 . . . . 0.0 105.635 160.829 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.398 . . 69.48 30.28 4.12 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 130.382 3.473 . . . . 0.0 112.773 163.689 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.64 12.9 60.31 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-N 109.678 -3.419 . . . . 0.0 116.148 168.43 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -148.29 164.53 33.73 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 -168.257 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -76.25 130.87 38.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 124.936 2.303 . . . . 0.0 105.726 162.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.45 147.62 35.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.288 -1.778 . . . . 0.0 106.792 165.748 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.82 136.63 43.95 Favored 'General case' 0 C--N 1.324 -0.538 1 C-N-CA 134.624 5.17 . . . . 0.0 110.798 -178.185 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.55 126.16 26.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 130.789 3.635 . . . . 0.0 116.653 -179.361 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.32 -24.89 7.18 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 119.337 -2.102 . . . . 0.0 113.295 -178.288 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -95.09 140.57 29.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 -172.866 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.6 p -70.2 157.15 38.16 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 167.841 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.3 mt -54.57 -33.67 60.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 116.88 -1.533 . . . . 0.0 112.881 168.892 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 p -64.21 -37.59 88.01 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.244 2.218 . . . . 0.0 111.957 174.523 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.66 -29.39 70.39 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.678 2.791 . . . . 0.0 109.723 179.052 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.93 -5.77 30.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.361 1.465 . . . . 0.0 112.852 -173.74 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.378 68.1 m-80 97.31 9.82 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 O-C-N 127.029 2.706 . . . . 0.0 110.738 165.791 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.9 mt -85.83 117.57 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 118.906 -2.371 . . . . 0.0 106.926 -154.171 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.41 23.4 tt0 -90.29 172.27 8.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 112.317 -2.22 . . . . 0.0 111.77 175.569 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.95 140.03 2.83 Favored 'General case' 0 N--CA 1.445 -0.685 1 O-C-N 129.467 4.229 . . . . 0.0 114.603 174.739 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 56.57 38.85 29.93 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.796 2.838 . . . . 0.0 111.696 170.61 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 m -81.69 139.17 35.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 110.044 -3.253 . . . . 0.0 103.263 169.687 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.4 m -103.98 112.46 25.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 114.786 -2.531 . . . . 0.0 105.363 174.662 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.57 159.41 24.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.67 3.188 . . . . 0.0 110.865 -177.041 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -116.82 152.99 33.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -156.485 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tp -137.68 136.47 37.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 119.936 1.243 . . . . 0.0 110.29 179.307 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.1 t -123.31 119.26 57.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 126.244 1.818 . . . . 0.0 109.991 174.583 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.0 mt -89.73 126.42 35.65 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 118.946 -2.346 . . . . 0.0 105.089 -179.231 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -83.31 -176.07 6.14 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 128.494 2.718 . . . . 0.0 108.206 177.292 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 74' ' ' ARG . 44.3 mt -97.32 132.02 43.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 116.606 -3.809 . . . . 0.0 110.465 168.871 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.444 ' CB ' ' O ' ' A' ' 73' ' ' LEU . 39.4 ttp180 124.68 106.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 1 C-N-CA 134.245 5.018 . . . . 0.0 108.828 -174.186 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.46 148.66 8.78 Favored Glycine 0 CA--C 1.526 0.763 2 C-N-CA 132.619 4.914 . . . . 0.0 113.444 -168.478 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.755 1 N-CA-C 101.034 -4.826 . . . . 0.0 101.034 169.651 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptt? . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -88.14 154.72 20.23 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 119.691 -1.88 . . . . 0.0 110.412 171.766 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 pt -139.53 159.19 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 130.681 3.592 . . . . 0.0 109.786 160.873 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.51 116.61 29.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 118.486 -2.634 . . . . 0.0 108.42 174.61 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -92.91 136.08 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.798 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -117.8 112.61 20.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.953 1.701 . . . . 0.0 109.564 -173.741 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -62.65 175.68 0.77 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 124.542 2.115 . . . . 0.0 109.176 -178.321 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tt -70.0 -31.69 69.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 117.785 -3.072 . . . . 0.0 114.004 174.519 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.317 18.4 p -81.09 -16.52 52.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 129.845 3.258 . . . . 0.0 109.506 -178.493 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.92 -1.16 30.17 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 117.076 -3.515 . . . . 0.0 111.285 167.259 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.257 70.8 tttt -69.05 156.25 38.97 Favored 'General case' 0 N--CA 1.45 -0.47 2 C-N-CA 132.308 4.243 . . . . 0.0 108.009 173.275 . . . . . . . . 3 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -133.01 130.77 39.89 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 113.632 -3.08 . . . . 0.0 111.339 -170.902 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.1 pt -131.93 139.28 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 129.548 3.139 . . . . 0.0 106.972 173.243 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.4 m -89.51 114.21 25.7 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 173.381 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -95.19 153.7 17.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 126.235 2.209 . . . . 0.0 105.599 167.643 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -116.44 132.29 56.72 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 113.395 -3.193 . . . . 0.0 111.078 169.39 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -153.34 -178.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 102.887 -3.005 . . . . 0.0 102.887 -162.266 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -144.28 156.49 57.55 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 131.218 3.807 . . . . 0.0 102.676 166.542 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -49.14 -28.48 14.4 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 116.147 1.557 . . . . 0.0 116.147 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 p -68.82 -18.98 64.26 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 128.816 2.846 . . . . 0.0 115.726 178.414 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.275 2.0 m-20 -51.29 121.93 7.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 122.567 2.439 . . . . 0.0 112.637 173.386 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 p -65.97 156.49 33.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.632 3.173 . . . . 0.0 109.465 168.684 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.2 mm -61.83 -40.6 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 O-C-N 125.034 1.459 . . . . 0.0 110.637 171.902 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.36 -25.83 60.76 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 122.25 2.295 . . . . 0.0 109.039 -172.771 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.267 16.8 t-20 -71.77 -44.33 64.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 117.168 -3.458 . . . . 0.0 109.501 173.909 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -68.25 -27.58 37.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 O-C-N 117.585 -3.197 . . . . 0.0 110.738 179.439 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -66.09 -24.45 66.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 122.575 1.179 . . . . 0.0 114.072 169.07 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.8 -38.42 58.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 115.151 -2.357 . . . . 0.0 111.019 167.595 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -64.26 -42.87 96.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 129.897 3.279 . . . . 0.0 110.558 178.85 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.63 -27.88 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 O-C-N 126.268 2.23 . . . . 0.0 109.112 177.114 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -74.17 -44.94 51.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 124.273 1.987 . . . . 0.0 108.733 172.272 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.59 -40.14 74.76 Favored 'General case' 0 N--CA 1.446 -0.654 1 O-C-N 112.911 -6.118 . . . . 0.0 120.869 168.235 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -70.68 -53.32 16.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.497 2.319 . . . . 0.0 110.381 -178.178 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -133.63 6.12 3.74 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 117.627 -3.171 . . . . 0.0 112.895 -166.117 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.67 12.54 77.99 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 118.273 -2.767 . . . . 0.0 118.002 177.643 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.66 120.65 76.95 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 122.971 3.385 . . . . 0.0 112.301 174.19 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.32 147.77 94.67 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 106.208 -2.266 . . . . 0.0 106.208 -179.775 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.23 -48.73 7.84 Favored 'Trans proline' 0 N--CA 1.441 -1.601 1 C-N-CA 125.949 4.433 . . . . 0.0 117.601 170.879 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -77.02 -13.0 60.01 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -170.552 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -93.76 10.09 34.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.441 1.497 . . . . 0.0 113.225 -176.659 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -130.05 165.92 21.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 116.421 -3.925 . . . . 0.0 114.355 -176.557 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -143.84 129.7 19.4 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 125.376 1.673 . . . . 0.0 112.99 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.7 mt -110.92 145.26 38.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 113.381 -1.736 . . . . 0.0 115.126 -165.843 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 pt -147.71 143.87 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 1 N-CA-C 99.113 -4.403 . . . . 0.0 99.113 -157.735 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -165.63 126.16 1.84 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 161.728 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.56 36.32 13.88 Favored 'General case' 0 N--CA 1.444 -0.733 1 C-N-CA 132.827 4.451 . . . . 0.0 116.036 165.646 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.44 -11.5 65.1 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.558 -1.134 . . . . 0.0 113.513 175.348 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -111.61 133.52 53.81 Favored 'General case' 0 N--CA 1.449 -0.502 1 C-N-CA 133.682 4.793 . . . . 0.0 107.165 -173.616 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -84.82 124.58 31.74 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 128.396 3.56 . . . . 0.0 110.348 170.782 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.06 115.66 27.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 123.706 1.717 . . . . 0.0 112.61 -168.175 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.83 141.23 28.75 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 129.969 3.308 . . . . 0.0 115.033 -173.698 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -75.7 135.88 40.38 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 114.645 -2.598 . . . . 0.0 108.613 -173.921 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.96 -6.84 21.82 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 120.808 1.64 . . . . 0.0 111.225 -176.609 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -106.82 154.89 20.36 Favored 'General case' 0 N--CA 1.452 -0.367 1 C-N-CA 132.71 4.404 . . . . 0.0 107.862 177.32 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 p -101.93 162.14 13.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.865 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.5 mt -61.97 -26.76 68.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 128.252 2.621 . . . . 0.0 112.459 -172.084 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -71.25 -24.87 62.26 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.147 2.579 . . . . 0.0 110.199 179.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.47 -50.19 72.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.573 3.149 . . . . 0.0 109.378 -178.223 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.92 12.86 18.22 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 128.266 3.479 . . . . 0.0 113.274 178.382 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 55.16 37.99 29.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.737 2.815 . . . . 0.0 115.881 -178.277 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.01 121.36 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 122.651 2.478 . . . . 0.0 106.129 -175.198 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -88.1 164.93 15.48 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 124.378 2.037 . . . . 0.0 113.681 176.319 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.459 ' C ' ' H ' ' A' ' 65' ' ' SER . 0.0 OUTLIER -65.92 163.81 16.29 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 119.975 -1.703 . . . . 0.0 110.329 -174.372 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 46.47 10.47 0.01 OUTLIER 'General case' 0 C--O 1.236 0.359 0 N-CA-C 120.354 3.465 . . . . 0.0 120.354 176.183 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 63' ' ' LYS 0.285 71.0 m -75.49 154.49 36.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 119.394 -2.066 . . . . 0.0 107.842 174.524 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 m -95.68 110.06 22.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 176.306 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.17 125.56 43.26 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 173.716 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -82.14 148.76 28.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.869 3.268 . . . . 0.0 109.196 174.027 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.307 1.6 pp -131.55 167.43 19.4 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 166.32 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t -123.88 140.66 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 -175.634 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp -86.68 121.22 28.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 163.917 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -72.12 -21.42 61.48 Favored 'General case' 0 N--CA 1.446 -0.668 1 C-N-CA 132.375 4.27 . . . . 0.0 111.411 -170.427 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.18 145.82 34.59 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 117.514 -3.241 . . . . 0.0 103.507 170.899 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -144.34 111.72 6.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.598 1.159 . . . . 0.0 112.684 170.243 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.77 121.7 2.33 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 118.05 -2.024 . . . . 0.0 113.957 -175.26 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 1 C-N-CA 133.185 5.183 . . . . 0.0 110.668 171.461 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -81.69 144.26 31.29 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 123.382 1.563 . . . . 0.0 112.322 -177.906 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 11.2 pt -132.56 157.45 43.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 115.026 -2.416 . . . . 0.0 107.251 166.897 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -98.52 144.0 28.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 114.939 -2.458 . . . . 0.0 106.617 165.177 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.14 122.71 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 100.431 -3.914 . . . . 0.0 100.431 176.443 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -123.66 117.83 25.89 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 -170.799 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -80.66 144.86 31.96 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 118.644 -2.535 . . . . 0.0 106.208 -175.016 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.27 -34.43 0.49 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 118.033 2.605 . . . . 0.0 118.033 172.981 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -50.59 -37.87 42.36 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 118.239 -2.788 . . . . 0.0 116.841 164.811 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.85 9.68 8.11 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 127.188 2.328 . . . . 0.0 109.503 176.652 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -84.24 103.12 13.17 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.908 2.483 . . . . 0.0 104.725 -170.765 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.2 m -96.37 119.59 35.14 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.269 1.827 . . . . 0.0 112.874 -178.612 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mm -130.79 145.78 35.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 111.238 -2.71 . . . . 0.0 109.826 -169.334 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.5 p -81.57 165.73 20.87 Favored 'General case' 0 C--O 1.237 0.42 1 O-C-N 114.777 -4.952 . . . . 0.0 114.922 172.929 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.265 2.4 tp -152.65 142.81 22.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.132 2.973 . . . . 0.0 109.441 172.042 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -95.23 117.52 30.4 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.282 2.633 . . . . 0.0 109.528 166.687 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.272 13.9 m -120.75 148.85 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.236 2.215 . . . . 0.0 108.909 179.136 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -91.45 136.14 27.19 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 179.666 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.262 71.5 Cg_exo -41.4 -30.88 0.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 1 N-CA-C 124.084 4.609 . . . . 0.0 124.084 166.53 . . . . . . . . 3 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -103.64 14.34 31.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.992 1.717 . . . . 0.0 113.678 176.241 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.279 24.5 m-20 -66.91 139.77 57.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 128.704 2.802 . . . . 0.0 110.99 170.886 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -73.05 154.54 40.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.091 2.556 . . . . 0.0 107.124 168.185 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mp -69.73 -29.61 41.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 130.252 3.421 . . . . 0.0 105.344 175.466 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -67.71 -36.48 80.7 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 116.85 -3.656 . . . . 0.0 112.989 164.574 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -67.92 -19.07 64.95 Favored 'General case' 0 N--CA 1.444 -0.774 1 CA-C-N 128.254 5.024 . . . . 0.0 113.14 164.285 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.76 -34.68 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 126.048 2.832 . . . . 0.0 114.633 172.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -70.18 -35.33 73.9 Favored 'General case' 0 CA--C 1.537 0.451 1 O-C-N 115.931 -4.231 . . . . 0.0 107.273 174.024 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -33.05 71.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 169.046 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -79.52 -27.54 41.35 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 116.02 -1.943 . . . . 0.0 108.658 179.765 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -77.54 -38.74 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 125.046 1.467 . . . . 0.0 109.216 171.87 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -59.89 -30.29 68.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 118.524 -2.61 . . . . 0.0 111.291 176.535 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . 29.4 t70 -53.04 -37.41 61.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 127.041 2.136 . . . . 0.0 108.149 174.603 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.429 ' HD2' ' HB3' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -115.36 -44.64 2.97 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.982 1.713 . . . . 0.0 107.326 -169.336 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -94.34 -23.52 17.77 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 118.005 -2.934 . . . . 0.0 112.143 -172.521 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.07 27.9 47.66 Favored Glycine 0 CA--C 1.525 0.685 0 O-C-N 119.569 -1.957 . . . . 0.0 113.935 175.892 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.84 124.25 37.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 113.728 -3.034 . . . . 0.0 107.45 -176.921 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.16 137.92 64.11 Favored 'Trans proline' 0 N--CA 1.451 -1.025 1 C-N-CA 125.582 4.188 . . . . 0.0 116.236 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -45.28 -30.48 5.34 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 O-C-N 125.553 2.344 . . . . 0.0 117.834 177.766 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.374 5.8 t70 -46.92 -43.31 18.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 119.09 -2.256 . . . . 0.0 116.075 178.276 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -110.24 -13.35 14.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.315 2.246 . . . . 0.0 105.558 -161.43 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -66.69 139.25 57.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.018 -1.676 . . . . 0.0 112.91 161.29 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -121.63 150.87 41.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.332 1.453 . . . . 0.0 113.217 157.612 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.356 5.8 mt -127.08 138.33 53.18 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 116.634 -3.791 . . . . 0.0 112.733 -179.283 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.366 98.4 mt -139.4 128.36 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 127.18 2.8 . . . . 0.0 112.07 -157.678 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -150.1 147.54 27.91 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.513 1.133 . . . . 0.0 108.945 152.995 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.365 . . 65.87 21.15 11.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 130.28 3.432 . . . . 0.0 112.537 177.478 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.35 -3.84 85.35 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.004 1.288 . . . . 0.0 113.477 -173.819 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -99.98 159.27 15.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 119.899 1.85 . . . . 0.0 107.229 -176.45 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.9 135.39 54.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 101.689 -3.448 . . . . 0.0 101.689 -178.072 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.7 mt -89.42 159.36 17.34 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 119.22 -2.175 . . . . 0.0 114.349 -179.058 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -104.01 141.2 36.61 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 119.219 -2.175 . . . . 0.0 107.068 -165.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.283 11.2 m-20 -72.27 123.51 23.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 126.247 2.927 . . . . 0.0 115.221 167.798 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.81 -28.61 9.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 129.496 3.427 . . . . 0.0 113.369 -177.876 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -69.43 167.73 15.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.476 -2.191 . . . . 0.0 112.543 170.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -115.0 166.46 11.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -163.722 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 mt -54.29 -44.87 72.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.328 1.451 . . . . 0.0 111.023 164.01 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -63.75 -27.65 69.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.944 1.702 . . . . 0.0 109.766 -174.002 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.37 -37.88 88.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.764 1.626 . . . . 0.0 109.696 -171.263 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -99.08 -5.0 31.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 111.723 -2.49 . . . . 0.0 107.236 -176.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 71.96 23.46 3.51 Favored 'General case' 0 N--CA 1.442 -0.845 1 O-C-N 114.643 -5.036 . . . . 0.0 116.408 165.221 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -90.68 130.66 39.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 130.54 3.536 . . . . 0.0 107.949 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -115.65 -173.83 2.41 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 131.143 3.777 . . . . 0.0 109.993 -167.673 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -74.17 133.26 42.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 129.577 3.151 . . . . 0.0 106.315 -159.887 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.301 35.7 mt-10 76.03 26.63 0.98 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.045 2.538 . . . . 0.0 113.28 -179.524 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.4 p -84.01 145.84 28.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.308 170.11 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.7 m -103.01 118.77 37.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 -177.23 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 tp -100.07 151.04 21.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 173.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -113.07 119.7 38.77 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 128.557 2.743 . . . . 0.0 109.69 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -89.16 137.05 32.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 128.642 3.714 . . . . 0.0 107.111 -176.569 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 t -105.41 116.51 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.832 166.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.31 142.84 28.22 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.7 1.6 . . . . 0.0 107.217 -169.681 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -132.38 138.54 47.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 114.601 -2.619 . . . . 0.0 110.492 160.416 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -158.0 164.9 36.31 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 127.349 2.905 . . . . 0.0 104.916 178.005 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -116.61 -28.07 6.51 Favored 'General case' 0 N--CA 1.452 -0.341 1 C-N-CA 133.187 4.595 . . . . 0.0 108.13 -174.399 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.07 -119.48 6.48 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 128.965 3.916 . . . . 0.0 114.306 -171.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 O-C-N 119.342 -2.269 . . . . 0.0 112.31 -173.659 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -89.8 112.41 23.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 128.657 2.783 . . . . 0.0 108.074 -170.29 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -109.66 143.09 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 169.121 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 66' ' ' THR . 47.8 m-85 -87.97 150.95 23.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.061 0.944 . . . . 0.0 111.79 161.919 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.4 121.14 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 130.296 3.438 . . . . 0.0 108.309 168.641 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -108.95 133.73 52.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.766 2.427 . . . . 0.0 113.889 176.434 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -105.87 173.4 6.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 117.55 -3.218 . . . . 0.0 109.856 -170.963 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tt -91.84 -35.68 13.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 131.535 3.934 . . . . 0.0 111.667 -176.57 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.7 p -65.03 -6.3 8.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 166.011 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.04 -28.77 5.76 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 117.006 1.562 . . . . 0.0 117.006 160.658 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.415 ' HZ2' ' CD ' ' A' ' 34' ' ' GLU . 76.2 tttt -79.21 138.35 37.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 116.197 -1.859 . . . . 0.0 111.836 -172.182 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -99.51 118.92 37.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 113.798 -3.001 . . . . 0.0 104.522 172.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.9 mt -96.91 152.92 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 126.663 2.477 . . . . 0.0 107.121 179.302 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -125.14 142.03 51.74 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 165.357 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 131.47 49.78 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 111.656 -2.52 . . . . 0.0 113.162 -178.311 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -99.46 110.73 23.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 115.824 -2.036 . . . . 0.0 106.636 174.806 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 1.7 m -131.99 -174.84 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 119.748 1.158 . . . . 0.0 108.844 175.947 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -111.88 156.09 42.24 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 125.111 1.364 . . . . 0.0 109.887 174.713 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.08 -6.96 12.18 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-O 114.249 -2.479 . . . . 0.0 113.821 -171.704 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m -106.02 2.94 27.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 121.338 1.881 . . . . 0.0 110.64 179.992 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -75.72 152.74 37.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 118.646 -2.534 . . . . 0.0 111.724 170.478 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.333 74.8 p -94.33 169.52 10.16 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.253 1.021 . . . . 0.0 109.97 -165.547 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -71.6 -22.88 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 115.946 -1.978 . . . . 0.0 106.661 -178.47 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -69.19 -19.69 63.99 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 125.072 3.578 . . . . 0.0 107.204 173.537 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -73.94 -48.05 33.29 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 119.144 0.884 . . . . 0.0 111.23 -178.101 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -67.33 -44.37 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 111.997 -2.365 . . . . 0.0 113.404 175.306 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.29 30.1 mtpt -48.64 -36.56 16.16 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 119.898 3.296 . . . . 0.0 119.898 160.15 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.83 -39.87 42.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 120.912 1.687 . . . . 0.0 110.519 -179.572 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -69.88 -33.04 71.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.109 2.163 . . . . 0.0 111.232 178.753 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.22 -46.13 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 113.139 -3.315 . . . . 0.0 114.18 162.788 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -58.44 -45.86 87.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 123.056 2.662 . . . . 0.0 115.451 168.23 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.444 24.1 t70 -47.67 -64.5 0.77 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.006 1.722 . . . . 0.0 114.431 173.326 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -98.81 -20.69 16.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -165.191 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' CD ' ' HZ2' ' A' ' 11' ' ' LYS . 60.2 mm-40 -127.46 13.01 7.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.185 2.194 . . . . 0.0 113.894 -176.539 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.06 20.58 62.77 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.078 2.275 . . . . 0.0 117.462 159.184 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mt -91.91 132.8 31.84 Favored Pre-proline 0 N--CA 1.444 -0.752 0 O-C-N 118.275 -2.897 . . . . 0.0 105.365 -172.491 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.84 112.13 2.14 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 114.694 -2.294 . . . . 0.0 114.581 169.627 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.66 -10.59 23.63 Favored 'Trans proline' 0 N--CA 1.457 -0.626 1 C-N-CA 125.447 4.098 . . . . 0.0 114.305 -167.625 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.361 25.7 t0 -65.3 -27.85 68.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 125.528 2.585 . . . . 0.0 111.904 167.504 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -114.97 51.61 0.9 Allowed 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 116.893 -3.63 . . . . 0.0 103.257 -167.432 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HB2' HE21 ' A' ' 41' ' ' GLN . 5.4 tt0 -160.64 147.12 15.29 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.997 2.119 . . . . 0.0 105.839 -170.736 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -149.65 126.26 10.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 102.173 -3.269 . . . . 0.0 102.173 172.183 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.334 78.2 mt -93.46 150.14 20.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 125.052 2.358 . . . . 0.0 109.518 169.695 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.7 mt -126.61 135.07 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 1 C-N-CA 133.249 4.62 . . . . 0.0 111.471 -177.219 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 65' ' ' SER . 52.8 t80 -150.66 133.17 15.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 118.7 -2.5 . . . . 0.0 111.853 178.115 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.22 21.31 1.59 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 118.831 2.9 . . . . 0.0 118.831 -178.583 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.65 -5.35 47.56 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 127.571 2.51 . . . . 0.0 113.038 -176.681 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -119.56 123.05 42.99 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.574 2.75 . . . . 0.0 109.239 -161.246 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -54.18 124.11 14.75 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 118.669 -2.519 . . . . 0.0 110.963 164.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -71.51 108.46 4.91 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.853 2.061 . . . . 0.0 109.645 174.359 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.287 29.8 tt0 -91.31 151.04 21.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -166.472 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -73.83 128.4 35.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.67 2.388 . . . . 0.0 106.773 -174.66 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.97 18.16 12.88 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 128.659 3.028 . . . . 0.0 116.709 175.217 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -121.86 168.11 12.25 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.876 1.67 . . . . 0.0 107.978 -177.472 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.4 p -124.32 146.21 48.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 -173.219 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.285 5.7 mt -48.15 -41.76 27.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.936 1.694 . . . . 0.0 112.053 -171.936 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -36.61 -44.96 0.48 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 129.846 3.258 . . . . 0.0 117.342 161.493 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -73.07 -7.65 52.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.761 2.024 . . . . 0.0 112.701 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -117.01 -12.56 10.65 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.35 1.86 . . . . 0.0 112.72 170.331 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.1 t30 78.05 33.7 0.33 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.8 2.04 . . . . 0.0 111.003 171.861 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.9 mt -69.14 119.15 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 127.118 2.167 . . . . 0.0 106.211 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.277 4.0 pp0? -119.65 175.48 5.84 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 128.943 2.897 . . . . 0.0 108.71 -168.25 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -48.56 111.33 0.44 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 117.007 -3.558 . . . . 0.0 115.452 -175.338 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 73.46 29.32 1.62 Allowed 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 119.294 -2.128 . . . . 0.0 109.658 176.284 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.402 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 73.4 m -84.25 125.77 32.54 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 117.108 -3.495 . . . . 0.0 103.263 175.225 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 4' ' ' PHE . 60.1 m -95.41 110.1 22.18 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 116.946 -3.596 . . . . 0.0 108.426 -169.191 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -79.75 157.26 27.16 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 130.766 3.626 . . . . 0.0 110.4 174.736 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -121.39 142.4 50.04 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 129.533 3.133 . . . . 0.0 104.448 -177.808 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.22 127.29 48.4 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 131.242 3.817 . . . . 0.0 105.057 -173.223 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.31 142.37 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 118.761 -2.462 . . . . 0.0 113.506 163.74 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.425 ' C ' ' H ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -93.98 114.91 27.2 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 -170.113 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 55.5 -25.03 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.099 2.16 . . . . 0.0 116.771 -179.158 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.425 ' H ' ' C ' ' A' ' 71' ' ' LEU . 2.2 mt -51.05 139.87 16.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 131.127 3.771 . . . . 0.0 112.848 -176.652 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.258 42.5 ttt180 -86.95 137.94 31.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.232 -173.287 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.6 -156.23 11.94 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 128.868 3.128 . . . . 0.0 118.713 -178.005 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.811 0 C-N-CA 126.467 1.984 . . . . 0.0 108.271 171.365 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 CA--C 1.534 0.361 1 CA-C-O 129.783 4.611 . . . . 0.0 105.297 . . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -71.02 144.58 50.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 110.671 -2.968 . . . . 0.0 113.389 -173.786 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.3 pt -146.12 174.95 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 116.441 -1.742 . . . . 0.0 106.691 177.998 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -128.31 117.35 21.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.063 2.545 . . . . 0.0 108.178 172.121 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.438 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 16.2 t -82.29 116.55 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 118.946 -2.346 . . . . 0.0 105.665 158.446 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -95.06 146.77 24.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 115.417 -2.23 . . . . 0.0 111.735 160.903 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -95.54 159.8 14.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 129.386 3.074 . . . . 0.0 104.697 164.62 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 tp -63.5 -21.41 66.31 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 111.526 -2.579 . . . . 0.0 110.534 177.037 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.1 p -95.63 -6.79 39.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 127.674 3.109 . . . . 0.0 112.708 178.134 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.5 -24.94 6.06 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.198 -1.334 . . . . 0.0 112.704 158.472 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -55.58 118.53 4.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 129.228 3.011 . . . . 0.0 109.086 -177.573 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.0 m -100.34 132.89 45.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 126.83 2.581 . . . . 0.0 109.711 179.084 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.438 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 10.0 mm -109.05 130.41 62.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.589 1.955 . . . . 0.0 106.911 173.614 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.7 m -85.36 144.1 28.24 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.907 2.483 . . . . 0.0 105.17 174.631 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.68 151.63 49.49 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 120.267 -1.521 . . . . 0.0 107.675 171.615 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -103.3 125.67 50.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 153.79 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -137.79 171.25 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 131.496 3.919 . . . . 0.0 112.677 163.73 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -130.14 144.29 52.55 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -178.411 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -57.81 -28.71 83.38 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 CA-C-O 111.843 -3.482 . . . . 0.0 115.286 -169.598 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.9 p -77.2 2.4 15.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 124.81 3.459 . . . . 0.0 115.52 172.25 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -77.83 148.78 34.55 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 118.968 -2.332 . . . . 0.0 107.358 -179.443 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.3 p -78.4 155.1 30.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 116.739 -1.601 . . . . 0.0 112.648 -172.12 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.254 10.6 mm -81.9 50.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 125.327 2.489 . . . . 0.0 109.794 161.175 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -153.72 -54.66 0.11 Allowed 'General case' 0 CA--C 1.532 0.288 0 O-C-N 117.39 -3.319 . . . . 0.0 109.066 -173.44 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -59.71 -57.37 13.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 120.698 1.59 . . . . 0.0 113.517 -175.394 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.37 -8.03 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.65 2.38 . . . . 0.0 111.188 -163.568 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -49.01 -40.29 30.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.322 2.649 . . . . 0.0 116.291 162.338 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.91 -27.69 8.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 119.722 -1.861 . . . . 0.0 115.527 172.033 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -89.01 -2.26 58.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 118.541 -1.263 . . . . 0.0 111.511 -172.096 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.9 mm -89.71 -37.75 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 127.67 2.388 . . . . 0.0 108.581 165.543 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.08 -43.24 99.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.361 -1.291 . . . . 0.0 114.225 176.476 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.25 -16.34 8.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.816 2.447 . . . . 0.0 115.704 170.934 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -108.94 -52.26 2.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.566 1.546 . . . . 0.0 110.979 -173.246 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -115.01 -19.06 11.07 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 118.801 -2.437 . . . . 0.0 112.331 -173.628 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.27 15.79 20.39 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 115.161 -3.022 . . . . 0.0 112.41 177.908 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -90.75 121.63 67.93 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 121.773 2.787 . . . . 0.0 112.172 -176.987 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.4 158.06 59.18 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.538 2.159 . . . . 0.0 113.656 179.028 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.36 -40.17 60.61 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.273 2.649 . . . . 0.0 115.465 -173.614 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -41.6 -54.87 3.09 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 131.225 3.81 . . . . 0.0 114.015 166.144 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -80.23 -13.23 59.39 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.607 2.363 . . . . 0.0 113.868 -170.481 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -83.91 106.44 15.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 129.482 3.113 . . . . 0.0 106.676 -179.058 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -113.28 137.28 51.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.728 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.284 1.7 pt? -134.02 131.37 38.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 120.707 1.594 . . . . 0.0 112.497 -172.378 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.8 mt -109.68 132.22 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 -174.533 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -131.74 -85.4 0.49 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 130.546 3.538 . . . . 0.0 114.233 168.528 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.61 55.01 0.69 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 125.961 3.982 . . . . 0.0 114.584 -170.474 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.71 -9.48 48.06 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 161.805 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -139.33 156.01 47.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 119.764 3.246 . . . . 0.0 119.764 176.536 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.86 116.17 18.16 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.988 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.5 mt -58.68 135.53 57.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.769 -2.457 . . . . 0.0 113.932 -175.251 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -84.07 143.77 29.51 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.531 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.54 132.92 46.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.323 1.449 . . . . 0.0 112.261 169.937 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.23 -24.44 10.6 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 124.671 2.262 . . . . 0.0 112.241 171.565 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -73.61 166.87 22.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 111.978 -2.111 . . . . 0.0 105.316 -179.903 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.9 p -100.81 163.59 12.24 Favored 'General case' 0 N--CA 1.45 -0.436 1 O-C-N 115.583 -4.448 . . . . 0.0 108.269 169.013 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -51.59 -36.98 47.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.233 2.213 . . . . 0.0 113.439 171.501 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -79.6 -17.84 52.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 177.235 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -62.97 -17.33 61.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 121.294 1.861 . . . . 0.0 109.411 164.847 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -118.05 7.18 12.17 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 130.389 3.476 . . . . 0.0 112.484 -178.212 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 62.96 32.39 15.61 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 131.453 3.901 . . . . 0.0 112.0 174.291 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.89 132.0 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 126.607 1.963 . . . . 0.0 105.84 -172.002 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -127.34 165.77 19.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.319 2.248 . . . . 0.0 111.678 -179.902 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -48.03 137.28 10.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 131.286 3.835 . . . . 0.0 112.494 179.577 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 84.67 4.15 0.67 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.461 1.905 . . . . 0.0 108.454 165.541 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 m -83.61 142.69 30.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 175.374 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.8 m -97.29 129.52 44.58 Favored 'General case' 0 N--CA 1.451 -0.408 1 C-N-CA 132.431 4.292 . . . . 0.0 112.749 179.485 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.62 143.18 50.71 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -169.99 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -115.1 102.68 10.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 101.621 -3.474 . . . . 0.0 101.621 -160.72 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -71.07 144.45 50.34 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 128.843 2.857 . . . . 0.0 108.649 166.1 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.85 156.29 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 130.134 3.373 . . . . 0.0 106.66 170.414 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.28 48.1 mt -108.05 126.77 53.13 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 126.55 3.072 . . . . 0.0 108.89 -178.483 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.438 5.4 ttt180 93.39 -54.81 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 131.209 3.804 . . . . 0.0 118.255 164.12 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 mt -110.51 146.08 36.61 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 110.55 -3.023 . . . . 0.0 105.645 -161.539 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.3 ttp180 -65.68 145.95 55.4 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.972 2.909 . . . . 0.0 111.309 171.059 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.6 117.66 3.68 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 125.406 1.691 . . . . 0.0 111.347 163.881 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.385 0 CA-C-O 124.481 2.156 . . . . 0.0 115.256 -172.099 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttp . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -125.13 139.59 53.63 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.007 2.523 . . . . 0.0 114.18 -175.983 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.296 45.6 pt -133.55 -179.48 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 128.893 2.877 . . . . 0.0 104.869 173.935 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -133.17 160.65 36.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 167.291 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.6 t -129.52 141.04 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 166.694 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -109.16 127.05 53.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.129 1.771 . . . . 0.0 106.638 176.814 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.5 p -79.74 173.14 12.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 124.154 1.931 . . . . 0.0 112.305 165.852 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.7 mt -78.71 -31.45 46.47 Favored 'General case' 0 C--O 1.24 0.602 0 O-C-N 118.188 -2.82 . . . . 0.0 111.921 173.708 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 t -64.0 -21.11 66.36 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 167.642 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.54 6.63 40.92 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 125.825 1.953 . . . . 0.0 109.275 168.769 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -65.77 119.06 10.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 122.377 3.088 . . . . 0.0 109.113 167.998 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.5 m -102.46 94.83 5.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 122.948 2.613 . . . . 0.0 104.652 -178.914 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.86 144.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 1 C-N-CA 132.212 4.205 . . . . 0.0 109.41 170.11 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.9 m -103.22 142.42 34.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.752 1.621 . . . . 0.0 109.912 169.109 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -125.12 132.53 53.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 157.819 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.84 128.4 35.48 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 154.638 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.67 157.99 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 120.402 -1.436 . . . . 0.0 111.403 -178.056 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.76 149.55 38.6 Favored Pre-proline 0 N--CA 1.442 -0.869 0 C-N-CA 127.016 2.127 . . . . 0.0 106.382 174.882 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.295 52.8 Cg_endo -70.41 -15.17 34.6 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 124.767 3.645 . . . . 0.0 116.476 -179.254 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -98.52 1.27 46.43 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.986 2.514 . . . . 0.0 113.632 -178.643 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -77.64 153.63 32.97 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.394 -1.441 . . . . 0.0 111.539 -169.863 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.5 p -89.42 158.14 17.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 128.047 2.539 . . . . 0.0 106.005 177.256 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.11 -29.74 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 114.049 -2.882 . . . . 0.0 107.59 175.964 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -59.63 -38.04 80.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 124.629 3.377 . . . . 0.0 108.316 168.921 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -76.38 -21.54 55.91 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 118.368 -2.707 . . . . 0.0 109.604 176.309 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.29 -37.02 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 124.609 3.368 . . . . 0.0 111.7 172.933 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -64.64 -30.07 71.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.484 1.914 . . . . 0.0 111.971 176.566 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.265 . . -75.25 -30.24 60.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.621 2.368 . . . . 0.0 111.928 179.867 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -79.51 -25.43 41.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 125.108 2.385 . . . . 0.0 112.014 174.707 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.34 32.1 mm -82.3 -33.68 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 113.412 -1.722 . . . . 0.0 108.883 173.241 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -36.32 66.5 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 123.013 2.642 . . . . 0.0 114.063 161.595 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.05 -59.85 2.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 128.433 2.693 . . . . 0.0 106.531 177.718 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.322 68.1 mmtt -51.39 -64.94 0.65 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.695 2.398 . . . . 0.0 110.567 -177.309 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -120.49 -9.88 9.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 112.914 -3.422 . . . . 0.0 107.437 -150.451 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.49 -1.9 62.42 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 127.875 3.234 . . . . 0.0 116.826 166.933 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.3 mm -95.09 132.14 28.67 Favored Pre-proline 0 N--CA 1.452 -0.368 0 O-C-N 117.335 -3.45 . . . . 0.0 111.722 -159.231 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -47.44 122.95 7.31 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 126.914 5.076 . . . . 0.0 108.657 168.352 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -35.36 -47.43 0.81 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 1 C-N-CA 129.698 6.932 . . . . 0.0 118.52 174.711 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.5 -16.3 64.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 114.913 -2.47 . . . . 0.0 115.422 -178.697 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.24 -7.36 42.29 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 126.186 2.179 . . . . 0.0 109.125 179.542 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -86.91 130.19 34.56 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 128.338 2.655 . . . . 0.0 109.269 179.906 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -116.86 141.06 48.72 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 128.868 2.867 . . . . 0.0 107.334 179.823 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.9 mt -119.44 111.18 17.82 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.551 2.34 . . . . 0.0 110.797 173.886 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.3 mt -105.12 118.6 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 161.23 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -126.69 130.79 51.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 175.212 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.42 19.5 10.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.658 169.514 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.17 -17.55 59.08 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 128.453 2.93 . . . . 0.0 115.678 -169.728 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.288 11.6 mmmt -93.19 146.48 23.65 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 119.404 1.602 . . . . 0.0 111.971 -176.931 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -94.54 112.47 24.23 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 130.892 3.677 . . . . 0.0 105.07 -176.246 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.448 ' HG ' ' CD1' ' A' ' 59' ' ' TYR . 6.2 mp -80.2 111.2 16.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 114.455 -2.688 . . . . 0.0 105.778 -179.259 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -83.83 -15.05 49.73 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 126.769 2.543 . . . . 0.0 115.705 -173.052 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.298 5.3 t0 93.64 153.66 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 128.694 2.798 . . . . 0.0 111.49 -175.932 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.01 30.98 5.82 Favored Glycine 0 N--CA 1.438 -1.21 0 O-C-N 117.394 -3.316 . . . . 0.0 114.335 161.322 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -153.4 160.48 42.63 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 131.586 3.954 . . . . 0.0 106.83 172.276 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.6 p -98.34 176.66 5.62 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 117.013 -3.555 . . . . 0.0 111.506 -167.269 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.53 -37.13 84.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 126.312 1.845 . . . . 0.0 111.96 -173.82 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 p -64.39 -33.6 76.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.017 1.727 . . . . 0.0 115.12 166.189 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -71.74 -56.44 5.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.99 2.116 . . . . 0.0 107.416 179.634 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.448 ' CD1' ' HG ' ' A' ' 50' ' ' LEU 0.277 42.9 m-85 -64.52 0.99 0.89 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 130.548 3.539 . . . . 0.0 116.312 -178.756 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.311 1.5 t-20 78.42 18.32 1.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 124.131 3.15 . . . . 0.0 113.836 163.659 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.8 mt -94.01 105.02 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 117.306 -3.371 . . . . 0.0 106.409 179.92 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -99.83 -170.79 1.94 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 116.601 -3.812 . . . . 0.0 101.483 -166.541 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -64.99 120.23 12.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 114.669 -2.586 . . . . 0.0 112.125 -170.044 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.555 2.4 mp0 77.59 24.77 0.75 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 117.427 2.381 . . . . 0.0 117.427 179.144 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.9 m -71.23 148.02 47.65 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 112.42 -2.173 . . . . 0.0 106.157 175.221 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.321 99.1 m -114.83 128.9 56.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 169.579 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.1 mt -92.65 151.24 20.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 108.824 -3.807 . . . . 0.0 107.811 170.305 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -98.68 127.35 44.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.904 0.882 . . . . 0.0 113.374 162.112 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -107.46 118.46 36.79 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 -178.396 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.52 160.78 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.306 1.842 . . . . 0.0 110.253 172.992 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.1 mt -92.55 153.39 19.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 118.868 -2.395 . . . . 0.0 112.623 176.523 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.7 mtt-85 -91.51 146.1 24.07 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.91 2.484 . . . . 0.0 108.002 150.514 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 mt -93.67 -22.38 18.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 126.779 3.181 . . . . 0.0 111.806 170.319 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.4 tpt85 -149.32 135.66 19.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 129.753 3.221 . . . . 0.0 116.223 -177.5 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.08 149.98 16.68 Favored Glycine 0 CA--C 1.533 1.176 1 O-C-N 115.459 -4.526 . . . . 0.0 104.939 168.89 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 127.731 2.586 . . . . 0.0 108.467 -175.33 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ttt . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 116.409 -1.758 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -77.82 131.53 37.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 123.716 2.962 . . . . 0.0 112.309 173.629 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.4 pt -130.37 136.9 57.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 126.88 2.613 . . . . 0.0 107.202 170.457 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.52 123.01 35.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 172.045 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.6 t -96.27 124.88 49.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 166.682 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.261 49.3 tttm -106.87 121.31 44.15 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -174.292 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.294 5.1 p -113.13 -171.34 1.85 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 128.009 2.523 . . . . 0.0 108.099 175.466 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.301 74.3 mt -82.26 -28.41 31.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 126.625 3.107 . . . . 0.0 113.649 176.006 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 p -123.87 68.02 1.04 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.87 3.268 . . . . 0.0 107.024 -175.848 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.53 101.67 1.22 Allowed Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 104.198 -3.561 . . . . 0.0 104.198 178.653 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -79.06 -33.23 44.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 129.014 3.42 . . . . 0.0 111.363 -179.425 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m -117.71 59.57 0.78 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 126.44 3.019 . . . . 0.0 106.396 -167.634 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.81 116.01 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 118.558 -2.589 . . . . 0.0 106.613 170.102 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.86 119.59 39.23 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 118.293 -2.754 . . . . 0.0 105.902 -169.986 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -115.81 136.15 53.32 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 129.744 3.218 . . . . 0.0 108.746 172.657 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.259 10.1 tp10 -92.17 114.41 26.94 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 167.169 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.1 m -108.75 -167.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 126.18 1.792 . . . . 0.0 110.854 168.999 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -139.47 140.65 26.12 Favored Pre-proline 0 N--CA 1.45 -0.462 1 C-N-CA 131.92 4.088 . . . . 0.0 107.578 171.62 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -43.54 -47.4 9.39 Favored 'Trans proline' 0 N--CA 1.445 -1.334 1 C-N-CA 126.079 4.519 . . . . 0.0 118.876 171.282 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.264 77.9 p -91.75 18.72 7.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.304 1.842 . . . . 0.0 107.2 -176.828 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -79.0 144.94 34.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 123.439 2.836 . . . . 0.0 114.102 169.978 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -92.77 153.48 18.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 117.421 -3.299 . . . . 0.0 111.038 -178.884 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mm -57.99 -26.1 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 118.675 -2.516 . . . . 0.0 114.713 -176.046 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -82.22 -18.31 43.03 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.787 1.635 . . . . 0.0 108.31 -170.395 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -83.78 -35.28 24.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.582 2.353 . . . . 0.0 107.948 178.905 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.95 -51.63 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 128.495 2.718 . . . . 0.0 107.538 177.288 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -59.01 -39.28 81.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 120.075 3.361 . . . . 0.0 120.075 173.526 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -26.9 68.5 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.705 3.602 . . . . 0.0 113.331 160.792 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -77.58 -47.49 19.28 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 121.681 2.037 . . . . 0.0 113.011 172.768 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.321 92.1 mt -54.15 -46.19 66.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 131.009 3.723 . . . . 0.0 112.811 174.264 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -60.25 -20.23 58.09 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 118.753 -2.467 . . . . 0.0 116.138 -177.75 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.278 3.7 t70 -94.2 -36.89 11.83 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 -178.546 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -70.95 -55.1 9.09 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.506 178.364 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -117.47 -21.43 8.63 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 118.355 -2.716 . . . . 0.0 108.662 -166.352 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.4 10.7 28.87 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 117.183 -3.448 . . . . 0.0 114.014 164.379 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.92 120.89 57.54 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 -165.709 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -77.98 154.19 29.41 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 O-C-N 116.322 -2.515 . . . . 0.0 112.402 -173.119 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -73.98 -33.27 6.28 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.076 1.851 . . . . 0.0 112.557 -153.921 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -73.91 -19.7 60.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 124.739 1.274 . . . . 0.0 112.932 177.532 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -90.89 -16.49 28.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.638 2.375 . . . . 0.0 110.572 -179.404 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -89.11 129.45 35.72 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 129.124 2.969 . . . . 0.0 112.452 -179.704 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -119.78 155.78 31.86 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 173.791 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.06 144.33 51.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 120.15 -1.594 . . . . 0.0 111.739 178.074 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.9 mt -131.43 143.76 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 122.844 2.565 . . . . 0.0 113.881 176.048 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -151.9 123.58 7.93 Favored 'General case' 0 N--CA 1.451 -0.388 1 C-N-CA 132.087 4.155 . . . . 0.0 113.461 171.541 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.27 37.56 4.21 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 119.651 3.204 . . . . 0.0 119.651 -175.784 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.75 -0.24 57.84 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 117.038 -3.539 . . . . 0.0 112.607 171.425 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -113.53 138.72 49.73 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 122.976 3.388 . . . . 0.0 105.15 -178.767 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.293 24.3 tt0 -98.0 125.07 42.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.308 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.14 131.14 44.87 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.89 -168.392 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -104.31 154.72 19.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 127.008 3.29 . . . . 0.0 113.726 -172.93 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -45.75 127.75 8.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 117.438 -3.289 . . . . 0.0 115.505 177.509 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.16 -2.38 61.33 Favored Glycine 0 CA--C 1.536 1.368 1 CA-C-N 127.362 4.619 . . . . 0.0 112.485 163.636 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.263 25.9 mmt-85 -100.06 172.88 6.92 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 127.188 3.375 . . . . 0.0 106.931 -173.138 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -119.69 -178.63 3.67 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 116.551 -3.843 . . . . 0.0 113.02 168.394 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.83 -44.42 59.32 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 131.032 3.733 . . . . 0.0 112.825 162.811 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.5 m -72.22 -33.68 67.77 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.367 2.667 . . . . 0.0 111.404 -170.897 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -66.98 -38.9 86.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 124.731 2.205 . . . . 0.0 111.34 -178.264 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -91.15 0.62 57.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 117.146 -3.471 . . . . 0.0 116.042 176.425 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.256 13.3 m120 71.52 53.13 0.23 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 130.383 3.473 . . . . 0.0 110.638 -178.206 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.9 mt -103.03 140.41 21.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 -174.306 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -106.84 149.0 27.85 Favored 'General case' 0 N--CA 1.451 -0.397 1 C-N-CA 131.936 4.094 . . . . 0.0 115.674 -169.074 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.77 128.53 30.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 124.351 1.032 . . . . 0.0 112.705 162.065 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.277 29.3 tt0 87.05 21.89 0.06 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.839 2.856 . . . . 0.0 110.209 174.253 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.9 m -71.63 141.84 49.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.216 1.806 . . . . 0.0 114.475 175.716 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.279 97.6 m -100.69 126.74 47.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 115.279 -2.296 . . . . 0.0 104.89 165.58 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.08 173.47 13.36 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 130.781 3.632 . . . . 0.0 107.2 177.651 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -127.45 134.13 49.87 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.443 2.297 . . . . 0.0 112.991 -156.548 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.6 tt -108.29 139.28 43.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 125.336 2.493 . . . . 0.0 107.752 173.621 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 t -130.55 134.53 62.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 129.846 3.258 . . . . 0.0 106.722 -178.144 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -97.14 134.43 40.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 172.338 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -95.7 81.19 3.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 125.812 2.72 . . . . 0.0 109.807 -174.761 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.11 -22.81 22.69 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 109.864 -3.335 . . . . 0.0 113.77 167.575 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.1 ptt-85 -136.57 167.13 21.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.411 1.884 . . . . 0.0 115.038 167.874 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.25 169.19 14.35 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 128.637 3.711 . . . . 0.0 110.066 167.541 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 1 CA-C-O 112.726 -4.374 . . . . 0.0 116.905 165.6 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.374 0.6 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 . . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -91.82 129.28 37.81 Favored 'General case' 0 N--CA 1.447 -0.591 1 C-N-CA 133.927 4.891 . . . . 0.0 107.213 -179.622 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -119.08 156.69 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 128.01 3.319 . . . . 0.0 106.167 154.01 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -95.35 133.86 38.8 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.579 1.552 . . . . 0.0 107.239 166.279 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.57 125.55 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 1 N-CA-C 97.321 -5.066 . . . . 0.0 97.321 175.293 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -103.04 127.05 50.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 127.059 3.314 . . . . 0.0 107.707 173.977 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -89.76 145.03 25.48 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 126.021 2.82 . . . . 0.0 106.102 -176.178 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.35 -27.89 68.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.706 -2.043 . . . . 0.0 116.241 178.561 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 p -76.72 -7.47 55.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.081 2.553 . . . . 0.0 116.94 173.274 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.05 10.15 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 129.922 3.629 . . . . 0.0 114.694 166.303 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 47.1 tttt -70.39 149.57 47.16 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 121.939 2.869 . . . . 0.0 110.758 -178.556 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.1 m -104.24 141.75 35.74 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.717 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.401 0.1 OUTLIER -125.08 135.17 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 126.516 3.055 . . . . 0.0 112.789 163.173 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 m -75.66 137.5 40.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 117.65 -3.156 . . . . 0.0 104.482 174.085 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -138.41 120.14 15.22 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 175.833 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.286 25.4 mt-10 -70.39 131.92 44.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 126.949 2.656 . . . . 0.0 111.724 170.527 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 m -148.99 164.34 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 127.886 2.474 . . . . 0.0 106.787 -173.794 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -123.47 155.99 64.78 Favored Pre-proline 0 N--CA 1.449 -0.52 0 O-C-N 117.624 -3.173 . . . . 0.0 109.419 165.49 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.72 -37.67 35.67 Favored 'Trans proline' 0 N--CA 1.451 -0.997 1 C-N-CA 127.152 5.235 . . . . 0.0 116.008 179.203 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.8 p -81.27 -13.46 58.45 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 112.563 -2.108 . . . . 0.0 112.757 -179.624 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -67.02 155.84 37.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 121.103 1.774 . . . . 0.0 109.951 170.663 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -121.8 139.86 53.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 130.287 3.435 . . . . 0.0 111.248 -161.178 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -46.23 -24.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 O-C-N 116.595 -3.816 . . . . 0.0 116.895 176.243 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -68.74 -54.4 16.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.904 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -62.42 -37.43 85.79 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 119.593 3.183 . . . . 0.0 119.593 -173.353 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.282 76.1 t -50.71 -43.98 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 129.498 3.119 . . . . 0.0 113.804 170.605 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.355 40.0 mtmt -50.78 -43.69 58.59 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.766 2.027 . . . . 0.0 112.598 172.251 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.32 -33.65 28.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 125.982 2.051 . . . . 0.0 114.649 -176.619 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -55.41 -31.9 62.23 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 125.334 2.492 . . . . 0.0 115.215 173.003 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.402 ' HB ' HE22 ' A' ' 41' ' ' GLN . 70.8 mt -75.63 -21.11 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 113.421 -1.718 . . . . 0.0 113.156 172.147 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -70.56 -43.34 69.68 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 122.572 2.442 . . . . 0.0 107.715 173.225 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.53 -29.04 67.61 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 118.926 -2.358 . . . . 0.0 112.417 176.942 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -97.19 -57.21 2.32 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 175.617 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 11' ' ' LYS . 28.6 mm-40 -92.64 -22.7 19.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.151 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.62 -18.39 22.54 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 130.672 3.987 . . . . 0.0 112.326 171.426 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.3 mt -71.2 122.98 88.59 Favored Pre-proline 0 N--CA 1.445 -0.686 0 C-N-CA 127.882 2.473 . . . . 0.0 106.185 -159.604 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.0 137.8 27.22 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.872 2.382 . . . . 0.0 109.973 172.423 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -40.73 -45.29 4.76 Favored 'Trans proline' 0 N--CA 1.454 -0.804 1 C-N-CA 126.442 4.761 . . . . 0.0 114.786 -175.654 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.257 12.6 t70 -31.76 -41.75 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 127.104 2.752 . . . . 0.0 117.943 170.762 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -96.84 -16.76 20.6 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -170.349 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.402 HE22 ' HB ' ' A' ' 30' ' ' ILE . 9.2 pt20 -97.49 140.88 31.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 127.479 2.987 . . . . 0.0 111.746 -178.593 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -125.23 128.21 47.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 116.74 -1.6 . . . . 0.0 108.325 174.146 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.78 140.82 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.085 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.3 pt -141.91 144.36 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 131.587 3.955 . . . . 0.0 111.114 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -146.16 130.34 17.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 111.566 -2.561 . . . . 0.0 107.627 172.265 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.79 17.91 8.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.264 1.826 . . . . 0.0 115.308 168.694 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.39 -26.66 12.76 Favored Glycine 0 CA--C 1.528 0.88 1 C-N-CA 131.95 4.595 . . . . 0.0 112.501 -169.253 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.303 38.4 mttt -68.24 129.89 41.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.807 0.804 . . . . 0.0 111.278 -170.982 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.316 78.0 mt-30 -66.06 115.05 5.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 163.708 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.97 121.96 29.34 Favored 'General case' 0 C--O 1.239 0.52 1 O-C-N 116.156 -4.09 . . . . 0.0 110.139 -175.746 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.47 148.15 24.31 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 129.702 3.201 . . . . 0.0 111.293 -165.08 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -74.93 123.72 25.61 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.667 2.387 . . . . 0.0 108.323 -166.606 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.06 60.33 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 128.814 3.102 . . . . 0.0 116.215 174.1 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -80.58 143.61 33.05 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 128.214 2.606 . . . . 0.0 109.511 173.663 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -77.0 151.81 35.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 128.589 2.755 . . . . 0.0 110.655 177.977 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -59.71 -25.29 64.68 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 127.522 2.329 . . . . 0.0 114.678 161.546 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -74.46 -23.05 58.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 130.2 3.4 . . . . 0.0 112.812 166.229 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -89.53 -16.92 29.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 121.655 2.025 . . . . 0.0 109.387 178.806 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.44 ' HB2' HD11 ' A' ' 61' ' ' ILE . 68.1 m-85 -96.81 -3.51 42.08 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 115.886 -2.007 . . . . 0.0 111.512 171.731 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 t30 62.35 37.86 13.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 171.835 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 59' ' ' TYR . 50.7 mt -94.57 127.99 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 -172.19 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -99.44 175.56 5.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.789 2.036 . . . . 0.0 111.224 -176.247 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 144.0 57.45 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 130.97 3.708 . . . . 0.0 110.708 179.057 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.323 3.0 pt-20 60.68 13.17 4.12 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 131.562 3.945 . . . . 0.0 116.874 -179.374 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.0 m -67.33 144.77 55.67 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 126.709 2.506 . . . . 0.0 111.701 166.084 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.0 m -86.31 108.81 18.58 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.257 1.423 . . . . 0.0 109.074 174.788 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -83.89 150.43 25.72 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 123.029 1.395 . . . . 0.0 113.36 156.785 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.265 75.2 m80 -104.02 144.07 32.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.443 -1.411 . . . . 0.0 111.303 176.714 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 tt -128.55 120.99 27.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 113.61 -3.09 . . . . 0.0 109.51 -177.813 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.99 133.34 44.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 127.782 2.433 . . . . 0.0 106.718 -175.532 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.274 73.6 mt -80.63 148.92 30.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.841 1.657 . . . . 0.0 111.678 171.895 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -81.52 -15.29 55.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 115.122 -2.37 . . . . 0.0 108.762 171.106 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.82 147.95 39.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 123.026 2.648 . . . . 0.0 110.888 -175.681 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.82 -54.46 0.93 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 121.329 1.877 . . . . 0.0 107.077 169.272 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.72 136.66 6.46 Favored Glycine 0 CA--C 1.531 1.068 1 C-N-CA 130.986 4.136 . . . . 0.0 109.781 -166.228 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.083 0 C-N-CA 120.182 -1.008 . . . . 0.0 111.404 176.13 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ttt . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 116.021 1.859 . . . . 0.0 116.021 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -106.61 165.96 10.91 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.103 1.761 . . . . 0.0 113.241 -176.831 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -122.75 165.02 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 127.531 2.332 . . . . 0.0 108.858 152.662 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -112.18 125.44 54.14 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 126.646 2.466 . . . . 0.0 112.414 -172.253 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.74 91.35 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 101.664 -3.458 . . . . 0.0 101.664 176.869 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -68.27 145.8 53.91 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 114.277 -2.773 . . . . 0.0 112.855 167.32 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -155.06 171.5 19.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 124.963 3.528 . . . . 0.0 111.792 170.526 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 mt -68.75 -17.49 64.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 130.057 3.343 . . . . 0.0 116.913 -164.585 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.6 p -74.14 -7.77 53.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 173.588 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.71 -20.81 44.71 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 116.674 1.43 . . . . 0.0 116.674 -179.147 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -76.9 152.71 35.26 Favored 'General case' 0 N--CA 1.447 -0.585 1 C-N-CA 132.25 4.22 . . . . 0.0 104.348 -176.21 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.289 75.7 m -122.68 147.79 46.05 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 118.937 -2.352 . . . . 0.0 112.3 161.765 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mt -120.88 154.39 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 131.685 3.994 . . . . 0.0 107.056 -178.013 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 p -127.47 135.9 51.03 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 128.174 2.59 . . . . 0.0 110.721 -165.682 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.7 mt -130.6 117.43 19.52 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 126.418 2.324 . . . . 0.0 107.679 -179.668 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.5 mp0 -90.66 108.77 20.02 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.131 2.172 . . . . 0.0 106.26 169.117 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.0 161.33 32.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 1 C-N-CA 134.413 5.085 . . . . 0.0 108.77 -170.326 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -126.16 152.32 73.25 Favored Pre-proline 0 N--CA 1.442 -0.867 0 C-N-CA 131.589 3.956 . . . . 0.0 110.045 175.486 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -47.35 -48.97 13.91 Favored 'Trans proline' 0 N--CA 1.456 -0.685 1 C-N-CA 126.523 4.815 . . . . 0.0 114.232 -167.368 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -61.66 -15.77 42.87 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 119.104 3.001 . . . . 0.0 119.104 -176.879 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.42 120.58 9.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.942 170.797 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 p -65.79 136.28 55.99 Favored 'General case' 0 N--CA 1.447 -0.578 1 C-N-CA 135.521 5.528 . . . . 0.0 110.266 161.377 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mm -59.99 -31.7 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 114.882 -2.485 . . . . 0.0 114.527 -174.71 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -48.7 -36.48 16.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.103 2.561 . . . . 0.0 114.73 169.743 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -82.79 -39.28 21.98 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 125.343 1.652 . . . . 0.0 108.937 -172.866 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.32 4.5 t -67.95 -36.58 76.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 112.982 -3.39 . . . . 0.0 115.678 172.705 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -58.94 -46.84 87.02 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 129.6 3.16 . . . . 0.0 107.301 177.889 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.91 -18.69 61.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.867 3.267 . . . . 0.0 118.184 172.351 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -49.57 63.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 118.24 -2.787 . . . . 0.0 113.112 160.551 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -68.32 -38.66 79.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 127.832 2.453 . . . . 0.0 107.397 -169.667 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.41 -65.61 0.53 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.489 1.115 . . . . 0.0 111.071 160.529 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.253 35.0 t70 -43.28 -38.29 2.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 129.612 3.165 . . . . 0.0 114.086 179.68 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -80.28 -45.64 17.54 Favored 'General case' 0 CA--C 1.535 0.39 1 C-N-CA 131.964 4.106 . . . . 0.0 120.658 171.619 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -123.69 -20.43 5.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 126.057 2.837 . . . . 0.0 112.988 -166.468 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.73 28.8 22.99 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 118.035 -2.916 . . . . 0.0 115.983 170.035 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 tt -106.27 111.6 64.2 Favored Pre-proline 0 N--CA 1.446 -0.654 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 -175.213 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.32 151.87 23.34 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 125.163 3.909 . . . . 0.0 109.512 -174.789 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -47.86 -38.2 30.12 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 112.135 -3.36 . . . . 0.0 115.182 -166.795 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -13.91 2.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 127.676 3.11 . . . . 0.0 116.579 175.919 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -116.72 -7.4 11.52 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.039 2.535 . . . . 0.0 110.418 -176.2 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.277 80.0 mt-30 -87.67 145.36 26.2 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 117.866 -3.021 . . . . 0.0 105.656 175.709 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -124.64 128.13 48.39 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 129.037 2.935 . . . . 0.0 106.747 161.711 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -119.92 104.57 10.29 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 112.405 -3.664 . . . . 0.0 110.002 -160.941 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.65 131.52 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 1 CA-C-N 126.011 4.005 . . . . 0.0 108.798 -163.26 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -111.43 113.41 25.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.435 1.894 . . . . 0.0 112.202 164.207 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.8 -92.1 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 131.051 3.74 . . . . 0.0 110.51 -166.068 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.16 1.63 5.4 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 113.85 -1.523 . . . . 0.0 116.044 169.961 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -95.98 128.87 43.26 Favored 'General case' 0 CA--C 1.541 0.6 1 C-N-CA 132.031 4.132 . . . . 0.0 104.951 -174.168 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.371 18.6 mp0 -77.77 138.87 39.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.451 3.901 . . . . 0.0 107.903 178.178 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.467 ' HG ' ' CE2' ' A' ' 59' ' ' TYR . 8.1 mp -94.42 153.98 17.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.317 2.008 . . . . 0.0 107.315 172.544 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -135.23 144.25 46.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 112.257 -2.247 . . . . 0.0 108.648 164.555 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -49.15 146.88 3.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.671 2.388 . . . . 0.0 115.649 169.468 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.94 16.49 28.1 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-O 116.092 -2.504 . . . . 0.0 111.292 -169.289 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -145.92 158.26 43.87 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 127.512 3.53 . . . . 0.0 102.759 171.599 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -103.21 173.99 6.06 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 116.671 -3.768 . . . . 0.0 110.27 177.678 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.98 -36.46 83.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 117.994 -2.941 . . . . 0.0 106.83 176.59 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 t -64.91 -45.18 86.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.691 0.62 . . . . 0.0 112.444 175.95 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.63 -46.43 70.48 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.809 178.239 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.467 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 39.7 m-85 -75.41 -10.51 59.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 123.454 1.597 . . . . 0.0 113.629 -175.894 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.4 t30 66.32 45.95 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.516 3.526 . . . . 0.0 114.412 -173.069 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -90.21 142.82 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 O-C-N 126.577 2.423 . . . . 0.0 106.469 -178.264 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -137.12 177.99 7.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 178.196 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -49.03 116.85 1.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.665 2.386 . . . . 0.0 112.547 -176.0 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.457 21.4 mp0 79.74 23.52 0.47 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 130.298 3.439 . . . . 0.0 112.759 168.732 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 m -71.19 150.05 45.72 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.225 1.81 . . . . 0.0 111.012 169.175 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 m -98.9 130.52 45.3 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 119.161 -2.212 . . . . 0.0 109.429 162.386 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -109.62 141.05 42.7 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 114.914 -2.47 . . . . 0.0 108.876 167.441 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.355 23.2 t60 -100.94 164.06 12.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 121.603 2.001 . . . . 0.0 115.711 178.67 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.253 0.4 OUTLIER -141.11 136.7 32.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 129.14 2.976 . . . . 0.0 107.544 -175.841 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.65 118.69 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 O-C-N 126.791 2.557 . . . . 0.0 105.717 -176.492 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.89 145.03 26.84 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 128.682 3.738 . . . . 0.0 108.222 171.886 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -77.59 119.15 20.74 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 126.609 2.443 . . . . 0.0 105.876 171.257 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.8 163.98 20.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 178.252 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -104.36 -37.69 7.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.866 -171.775 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.42 -168.94 15.58 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 126.337 2.273 . . . . 0.0 110.363 -177.683 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 N-CA-C 107.852 -2.099 . . . . 0.0 107.852 -166.417 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.259 9.5 ptt? . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 . . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -74.36 146.31 43.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 118.45 -2.656 . . . . 0.0 117.196 169.187 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.336 44.5 pt -130.85 133.92 62.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 115.256 -2.307 . . . . 0.0 107.846 166.788 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -117.64 107.83 14.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -177.644 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -108.28 120.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.972 2.509 . . . . 0.0 105.046 -170.132 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -96.08 150.12 20.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 128.67 3.731 . . . . 0.0 112.502 178.327 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -113.96 138.14 50.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 160.667 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -53.37 -36.13 61.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -174.864 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.9 p -73.48 -11.4 60.44 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 130.038 3.335 . . . . 0.0 113.263 -175.587 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.92 54.08 0.32 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 126.992 2.234 . . . . 0.0 113.973 168.872 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -141.27 143.93 34.38 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 121.372 2.586 . . . . 0.0 111.052 166.355 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -123.97 117.07 23.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 167.323 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.9 mm -80.74 118.23 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 160.779 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -92.36 128.39 38.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 164.368 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -125.07 140.32 53.0 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.066 -2.271 . . . . 0.0 107.327 178.488 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -92.75 131.36 37.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 126.898 2.624 . . . . 0.0 110.905 162.112 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.5 m -134.97 160.02 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 127.522 2.329 . . . . 0.0 111.153 179.25 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.281 20.5 mm-40 -76.18 149.34 82.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 115.778 -2.058 . . . . 0.0 111.869 156.465 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -24.56 72.26 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 CA-C-N 123.915 2.434 . . . . 0.0 114.796 176.418 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -101.61 20.85 15.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.871 2.868 . . . . 0.0 112.354 177.617 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.48 ' CG ' HD21 ' A' ' 25' ' ' ASN 0.27 11.2 t0 -82.92 155.35 24.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 118.117 -2.864 . . . . 0.0 110.699 169.142 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 p -81.01 152.74 27.79 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.966 -169.744 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.9 mm -67.11 -12.68 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 120.483 -1.386 . . . . 0.0 111.2 167.843 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -71.22 -45.89 62.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 120.725 -1.234 . . . . 0.0 111.374 169.398 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.48 HD21 ' CG ' ' A' ' 21' ' ' ASP . 18.9 t30 -53.17 -34.05 55.21 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 175.403 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.95 -40.57 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 117.827 -1.083 . . . . 0.0 108.543 179.242 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -70.63 -37.87 73.83 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 121.867 2.121 . . . . 0.0 111.12 -179.91 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.52 87.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 115.265 -2.303 . . . . 0.0 111.814 178.153 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.372 54.6 mttm -76.83 -31.21 56.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.472 1.509 . . . . 0.0 113.056 172.925 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.8 mt -70.77 -37.89 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 1 O-C-N 115.737 -4.352 . . . . 0.0 109.292 174.117 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -54.56 -37.8 65.88 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 122.759 2.527 . . . . 0.0 117.744 160.572 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.44 -39.75 94.42 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.16 -2.291 . . . . 0.0 115.416 -179.95 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -86.68 -69.11 0.7 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.38 2.272 . . . . 0.0 107.157 -174.225 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -83.42 -15.82 48.24 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 125.945 2.028 . . . . 0.0 114.341 -161.554 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.25 8.62 68.3 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 117.276 -3.39 . . . . 0.0 115.8 175.708 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 pt -99.8 123.61 46.94 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-O 113.426 -3.178 . . . . 0.0 112.455 -168.844 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.72 137.27 71.99 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 127.587 3.745 . . . . 0.0 110.968 -179.136 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -64.78 -8.91 19.1 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.801 2.334 . . . . 0.0 113.608 177.683 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -75.73 -12.5 60.2 Favored 'General case' 0 N--CA 1.452 -0.341 1 CA-C-N 127.09 4.495 . . . . 0.0 109.086 172.246 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -87.99 -22.02 24.5 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 127.661 2.384 . . . . 0.0 112.909 -178.85 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -95.81 131.47 42.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 130.717 3.607 . . . . 0.0 103.232 -165.234 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.287 17.1 mtp180 -126.46 111.01 13.93 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.915 2.086 . . . . 0.0 108.432 170.993 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -94.4 133.16 38.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 117.205 -3.434 . . . . 0.0 114.698 -172.652 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 tt -144.37 136.74 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 128.768 2.827 . . . . 0.0 110.254 -155.288 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -140.79 138.23 33.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.631 1.832 . . . . 0.0 112.24 172.832 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.59 35.01 7.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.049 2.939 . . . . 0.0 115.276 170.184 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.42 -23.88 31.71 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.875 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -103.07 125.11 49.65 Favored 'General case' 0 C--N 1.324 -0.52 1 O-C-N 115.655 -4.438 . . . . 0.0 109.026 -160.849 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -85.04 126.65 33.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 127.291 2.87 . . . . 0.0 105.644 174.929 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -96.25 128.05 42.81 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 125.565 1.791 . . . . 0.0 109.463 -163.062 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -72.46 130.23 40.2 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -178.29 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -62.12 123.57 18.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 129.797 3.239 . . . . 0.0 112.299 -173.362 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.97 -6.06 51.05 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 112.117 -2.31 . . . . 0.0 114.807 173.239 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -72.77 163.81 27.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.25 1.025 . . . . 0.0 112.539 167.003 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -99.43 154.09 18.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 123.848 1.785 . . . . 0.0 114.433 174.311 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.375 11.5 mt -53.99 -48.87 69.95 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 116.775 -3.703 . . . . 0.0 110.53 -173.953 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.279 33.0 t -57.62 -47.07 83.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.782 2.033 . . . . 0.0 110.401 -177.719 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -70.37 -22.59 62.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.141 0.976 . . . . 0.0 110.733 -169.976 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.29 -3.09 54.17 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 131.131 3.772 . . . . 0.0 113.631 170.06 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.443 11.8 m120 80.94 21.86 0.38 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 130.191 3.396 . . . . 0.0 116.314 173.695 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.9 mt -83.07 112.73 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 117.02 -3.55 . . . . 0.0 106.949 171.757 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.84 178.57 5.73 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.563 2.745 . . . . 0.0 112.646 -178.692 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -54.63 137.13 44.44 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.929 1.292 . . . . 0.0 111.995 171.048 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 69.12 23.1 6.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 131.694 3.998 . . . . 0.0 112.521 175.575 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.3 m -82.63 138.14 34.28 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 117.332 -3.355 . . . . 0.0 105.804 -169.38 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.74 133.36 42.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.469 -179.664 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.3 0.0 OUTLIER -149.77 -155.54 0.64 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.556 1.071 . . . . 0.0 110.538 172.603 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -158.17 170.21 22.79 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -168.912 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.2 tp -129.32 144.81 51.37 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 128.541 3.65 . . . . 0.0 105.059 -178.173 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -119.58 124.39 72.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 127.961 3.288 . . . . 0.0 109.691 168.591 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 mt -87.32 128.18 35.18 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.8 2.04 . . . . 0.0 108.506 172.209 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.251 18.6 tpt180 -158.02 126.93 5.65 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 130.158 3.383 . . . . 0.0 108.425 -166.315 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.2 tp -83.77 144.86 29.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.292 2.237 . . . . 0.0 106.254 171.65 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.1 ttm105 -77.54 145.39 36.95 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.636 2.774 . . . . 0.0 110.115 175.787 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.02 -153.1 15.32 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 118.404 -2.685 . . . . 0.0 110.271 -178.081 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.883 0 C-N-CA 118.205 -1.95 . . . . 0.0 109.003 -179.666 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.1 ttp . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 113.298 -3.239 . . . . 0.0 107.17 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.18 133.04 52.99 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 126.357 2.285 . . . . 0.0 114.266 170.552 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.54 -176.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 119.162 -2.211 . . . . 0.0 109.083 159.109 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -135.38 162.93 31.22 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.107 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.3 t -134.57 112.44 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 130.023 3.329 . . . . 0.0 106.228 -176.319 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -94.98 120.97 36.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 171.186 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -67.82 167.18 13.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 112.65 -2.068 . . . . 0.0 110.816 172.645 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.572 HD22 ' H ' ' A' ' 71' ' ' LEU . 4.3 mp -64.57 -35.42 80.92 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 119.297 -2.127 . . . . 0.0 113.76 176.891 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.319 17.7 p -67.73 -51.14 52.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.433 2.293 . . . . 0.0 109.383 173.544 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.89 31.15 0.6 Allowed Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.333 -1.26 . . . . 0.0 115.364 174.7 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -86.21 131.51 34.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 122.736 3.268 . . . . 0.0 109.929 160.883 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -105.1 85.47 2.28 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.104 1.361 . . . . 0.0 108.862 -175.458 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.275 3.9 mt -87.48 141.13 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 -174.216 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 m -74.63 143.4 44.35 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 169.987 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -125.52 127.76 46.93 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 118.057 -2.902 . . . . 0.0 104.636 -175.089 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -80.86 115.05 20.15 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 130.974 3.71 . . . . 0.0 107.829 172.465 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.9 172.77 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.669 1.188 . . . . 0.0 108.58 -176.446 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.407 ' N ' ' OD2' ' A' ' 21' ' ' ASP . 70.3 mm-40 -133.05 148.7 70.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 131.5 3.92 . . . . 0.0 113.75 148.895 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.32 93.5 Cg_endo -51.03 -15.78 2.17 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 O-C-N 124.904 2.002 . . . . 0.0 116.324 -177.444 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -92.4 -1.82 56.75 Favored 'General case' 0 N--CA 1.452 -0.336 1 O-C-N 115.539 -4.476 . . . . 0.0 115.599 174.327 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.407 ' OD2' ' N ' ' A' ' 18' ' ' GLU 0.253 72.0 m-20 -81.05 131.18 35.29 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.176 -1.41 . . . . 0.0 111.451 177.176 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -69.51 160.33 31.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.838 0.855 . . . . 0.0 111.044 179.664 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.6 mm -61.08 -34.74 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 129.036 2.934 . . . . 0.0 106.766 175.99 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.81 -58.98 5.53 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 127.969 2.508 . . . . 0.0 111.499 175.224 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -51.77 -45.93 63.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.712 2.508 . . . . 0.0 113.931 169.367 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.58 -48.07 88.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 O-C-N 124.988 1.43 . . . . 0.0 112.838 174.644 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt -57.43 -35.6 70.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.858 -3.026 . . . . 0.0 113.678 170.282 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.57 81.29 Favored 'General case' 0 N--CA 1.452 -0.355 1 CA-C-O 111.302 -4.19 . . . . 0.0 109.976 174.433 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -67.59 -29.76 69.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 124.042 3.11 . . . . 0.0 111.568 -179.834 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 mt -81.48 -16.21 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 126.928 2.091 . . . . 0.0 110.912 -175.67 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -70.01 -49.0 55.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 117.52 -3.238 . . . . 0.0 115.488 156.525 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -49.17 -61.29 2.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.573 1.949 . . . . 0.0 115.785 170.374 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -63.23 -46.27 87.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 130.388 3.475 . . . . 0.0 114.758 -177.189 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -138.87 -21.82 0.97 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.079 1.752 . . . . 0.0 111.019 -154.99 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.99 1.34 54.96 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 122.091 2.223 . . . . 0.0 109.458 166.972 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -81.55 117.27 67.55 Favored Pre-proline 0 N--CA 1.445 -0.675 0 O-C-N 117.163 -3.551 . . . . 0.0 103.909 179.887 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -74.13 164.29 34.67 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.433 2.089 . . . . 0.0 112.0 -172.023 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.252 37.9 Cg_endo -73.67 -37.94 2.73 Favored 'Trans proline' 0 N--CA 1.446 -1.309 1 C-N-CA 126.275 4.65 . . . . 0.0 109.835 -177.401 . . . . . . . . 3 2 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -80.12 143.75 33.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.501 2.321 . . . . 0.0 108.873 170.518 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 90.05 -31.04 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.206 1.002 . . . . 0.0 109.247 179.304 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -91.1 141.63 28.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.07 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -119.95 129.69 54.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 128.134 2.573 . . . . 0.0 110.989 172.243 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 94.1 mt -99.24 151.09 21.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 117.656 -3.152 . . . . 0.0 111.341 164.854 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mt -127.11 156.2 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 170.302 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -126.07 136.97 53.56 Favored 'General case' 0 N--CA 1.447 -0.625 1 C-N-CA 133.836 4.855 . . . . 0.0 108.789 157.043 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.49 -100.49 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 128.904 3.877 . . . . 0.0 108.776 179.021 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.37 -2.07 3.38 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 105.704 -2.958 . . . . 0.0 105.704 168.691 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -79.93 114.98 19.26 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 118.208 -2.936 . . . . 0.0 105.134 -173.348 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -64.93 126.36 27.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 122.982 1.372 . . . . 0.0 109.08 159.907 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.9 mt -90.79 141.8 28.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 124.167 1.937 . . . . 0.0 109.846 177.152 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -91.74 143.59 26.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.975 2.51 . . . . 0.0 109.342 170.75 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -49.51 -44.05 45.97 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 129.732 3.213 . . . . 0.0 112.836 -172.619 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.21 4.25 40.99 Favored Glycine 0 CA--C 1.531 1.062 1 O-C-N 115.423 -4.548 . . . . 0.0 112.788 -163.837 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -76.84 160.17 29.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 120.176 1.988 . . . . 0.0 112.103 164.096 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -97.93 162.35 13.29 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 127.174 2.796 . . . . 0.0 104.811 175.007 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.7 mt -42.5 -42.9 3.47 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.651 1.98 . . . . 0.0 109.721 157.736 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.3 t -69.02 -28.14 66.3 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 127.455 2.302 . . . . 0.0 110.035 -169.989 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -75.9 -9.07 58.3 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 175.127 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -118.9 11.74 12.65 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.416 1.886 . . . . 0.0 114.052 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.91 29.02 18.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.808 2.043 . . . . 0.0 115.679 179.9 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.2 mt -96.33 105.04 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 124.25 1.976 . . . . 0.0 108.541 -170.077 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -89.43 178.55 6.29 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 120.01 -1.681 . . . . 0.0 113.074 163.482 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -60.46 161.45 7.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 129.936 3.295 . . . . 0.0 115.999 -167.426 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 74.96 2.89 4.09 Favored 'General case' 0 N--CA 1.443 -0.815 1 C-N-CA 133.559 4.743 . . . . 0.0 112.946 175.931 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -71.31 132.46 44.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.149 1.78 . . . . 0.0 113.232 -177.093 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 p -97.95 113.0 24.72 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 125.443 1.714 . . . . 0.0 108.343 -176.74 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.82 156.2 20.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.967 1.307 . . . . 0.0 110.66 173.193 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -127.19 119.72 27.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 124.389 2.043 . . . . 0.0 106.166 -174.581 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tt -91.2 120.31 32.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.518 3.127 . . . . 0.0 103.871 -174.728 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.32 131.02 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 112.302 -2.227 . . . . 0.0 106.371 170.459 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.572 ' H ' HD22 ' A' ' 8' ' ' LEU . 12.3 mt -98.33 126.26 43.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 175.181 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -63.4 -48.72 76.65 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 128.69 2.796 . . . . 0.0 113.759 172.448 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.0 mt -145.04 173.5 11.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 130.05 3.34 . . . . 0.0 105.816 177.833 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -69.33 134.99 49.77 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.087 1.755 . . . . 0.0 107.451 178.076 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.49 -34.8 0.48 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 115.565 -2.797 . . . . 0.0 111.999 179.693 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 116.407 -2.329 . . . . 0.0 114.604 179.393 . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 116.482 -1.723 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -65.77 132.38 48.6 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 125.01 1.444 . . . . 0.0 113.14 -171.487 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 pt -135.56 171.34 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 O-C-N 118.876 -2.39 . . . . 0.0 109.144 174.282 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -114.29 126.06 54.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 126.073 2.108 . . . . 0.0 109.156 170.848 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -110.26 147.61 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 163.777 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.274 62.4 tttt -126.6 125.02 41.24 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 131.439 3.896 . . . . 0.0 113.849 -174.286 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -102.74 162.79 12.64 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.81 1.644 . . . . 0.0 108.589 -173.599 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.754 HD11 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -77.83 -16.16 58.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 129.756 3.222 . . . . 0.0 116.891 -167.598 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 p -83.81 -0.9 52.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 164.035 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.3 27.4 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 127.432 2.444 . . . . 0.0 111.609 171.097 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -67.62 136.2 54.05 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 123.377 3.588 . . . . 0.0 115.935 -173.55 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 m -113.57 147.89 37.16 Favored 'General case' 0 C--N 1.325 -0.462 1 CA-C-O 129.069 4.271 . . . . 0.0 104.029 174.829 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.276 19.2 pt -127.64 114.8 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 109.367 -3.561 . . . . 0.0 110.102 178.451 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.4 p -84.94 108.84 17.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 101.807 -3.405 . . . . 0.0 101.807 177.283 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 pp -139.78 154.52 47.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 123.409 1.576 . . . . 0.0 111.28 170.011 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -84.47 133.57 34.47 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.518 2.327 . . . . 0.0 112.467 177.958 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.16 -153.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 168.399 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -151.08 158.83 34.5 Favored Pre-proline 0 N--CA 1.443 -0.794 0 C-N-CA 127.418 2.287 . . . . 0.0 106.556 -173.002 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.81 -32.91 35.69 Favored 'Trans proline' 0 N--CA 1.445 -1.333 1 C-N-CA 126.298 4.665 . . . . 0.0 115.951 174.871 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -99.11 3.99 46.8 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.885 2.874 . . . . 0.0 112.124 -171.981 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.64 145.73 29.5 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 121.311 1.869 . . . . 0.0 110.761 -179.081 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.7 p -85.6 162.68 18.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.577 2.351 . . . . 0.0 111.034 169.295 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.334 81.2 mt -53.16 -44.03 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 O-C-N 127.253 2.845 . . . . 0.0 115.871 178.501 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -49.67 -36.11 23.86 Favored 'General case' 0 C--N 1.33 -0.275 1 C-N-CA 132.255 4.222 . . . . 0.0 115.003 166.974 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -82.92 -11.97 57.73 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 126.462 1.905 . . . . 0.0 114.275 176.407 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -98.79 -41.07 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.006 1.322 . . . . 0.0 111.392 174.648 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -53.68 -45.01 70.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 128.991 2.916 . . . . 0.0 109.56 173.793 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.79 89.19 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 126.428 3.014 . . . . 0.0 111.78 -175.845 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -60.14 -44.33 95.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 131.629 3.972 . . . . 0.0 112.8 177.171 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.12 -37.56 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 179.764 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -65.35 -38.95 91.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 124.171 3.169 . . . . 0.0 112.919 179.43 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -59.53 -26.3 65.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 112.923 -3.418 . . . . 0.0 115.017 171.241 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -115.18 -28.18 7.03 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 122.117 2.235 . . . . 0.0 111.255 -163.191 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -126.06 -19.28 4.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.719 2.408 . . . . 0.0 114.605 -177.215 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.91 16.34 61.46 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 115.909 -2.606 . . . . 0.0 114.362 178.94 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.6 mt -87.73 123.7 68.75 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 123.066 3.433 . . . . 0.0 109.469 -163.213 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -73.31 127.63 12.09 Favored 'Trans proline' 0 N--CA 1.453 -0.901 1 O-C-N 128.871 4.09 . . . . 0.0 111.334 -176.523 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.36 -19.05 6.79 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.16 2.573 . . . . 0.0 115.047 -157.249 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.85 -28.28 65.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 115.829 -2.034 . . . . 0.0 110.858 176.604 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.77 9.39 16.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 127.77 3.169 . . . . 0.0 107.453 -164.577 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -110.9 142.34 43.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 123.394 1.569 . . . . 0.0 109.476 -170.403 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -126.67 122.36 34.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 130.593 3.557 . . . . 0.0 109.786 162.35 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.8 mt -110.05 115.59 30.04 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.643 3.177 . . . . 0.0 107.074 -168.399 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.88 129.35 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 127.823 2.449 . . . . 0.0 115.123 -178.653 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.257 63.8 t80 -143.41 128.68 18.82 Favored 'General case' 0 C--N 1.327 -0.394 1 O-C-N 114.484 -5.135 . . . . 0.0 110.428 168.945 . . . . . . . . 3 2 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.1 38.5 24.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 165.457 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.53 -11.39 7.99 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 116.762 -2.132 . . . . 0.0 115.016 164.069 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -149.47 170.98 17.33 Favored 'General case' 0 C--N 1.324 -0.513 1 C-N-CA 131.865 4.066 . . . . 0.0 114.466 -176.119 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -54.61 132.73 45.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 128.91 2.884 . . . . 0.0 107.498 154.275 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 tp -66.75 138.44 57.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 112.067 -2.333 . . . . 0.0 106.394 165.787 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -51.13 145.92 7.13 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.438 1.895 . . . . 0.0 110.659 163.192 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -103.02 109.49 21.05 Favored 'General case' 0 N--CA 1.448 -0.568 1 N-CA-C 96.562 -5.347 . . . . 0.0 96.562 170.504 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.62 35.07 1.94 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.783 2.611 . . . . 0.0 116.694 178.707 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -133.09 132.74 42.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 115.927 -1.987 . . . . 0.0 110.043 171.014 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.0 p -75.67 150.57 37.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 125.154 2.406 . . . . 0.0 113.351 168.165 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -56.74 -35.68 68.87 Favored 'General case' 0 N--CA 1.441 -0.907 1 O-C-N 115.774 -4.329 . . . . 0.0 118.005 -159.428 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -75.85 -4.93 43.5 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 129.946 3.298 . . . . 0.0 112.628 176.64 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -77.11 -11.0 59.75 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 120.948 1.704 . . . . 0.0 111.758 169.774 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -113.09 159.12 19.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 129.296 3.038 . . . . 0.0 105.04 168.134 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -80.5 55.36 2.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.61 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -73.1 104.97 2.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 159.51 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.265 71.1 mm-40 -96.37 169.8 9.68 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 125.604 1.815 . . . . 0.0 114.35 170.49 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -46.84 130.88 12.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 119.946 -1.721 . . . . 0.0 112.372 166.251 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.31 8.1 mt-10 77.54 18.85 1.28 Allowed 'General case' 0 N--CA 1.451 -0.383 1 C-N-CA 133.484 4.714 . . . . 0.0 112.185 170.417 . . . . . . . . 3 2 . 1 . 048 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -74.26 148.03 41.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.958 179.165 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.9 m -95.9 104.44 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 102.183 -3.265 . . . . 0.0 102.183 -168.22 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.2 143.69 27.17 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.314 2.646 . . . . 0.0 108.057 166.944 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -124.29 136.65 54.29 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -174.878 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.93 121.59 45.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.908 2.083 . . . . 0.0 105.41 178.863 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 t -108.15 146.97 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.487 2.315 . . . . 0.0 106.443 170.984 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 tp -77.9 138.51 38.94 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 -175.11 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -90.28 113.62 25.5 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 119.732 -1.855 . . . . 0.0 107.361 163.846 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 2.7 pp -61.86 159.59 13.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.89 2.476 . . . . 0.0 111.158 -175.712 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.4 mmt-85 -123.47 48.87 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 124.632 2.158 . . . . 0.0 108.498 173.241 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.97 12.37 34.5 Favored Glycine 0 CA--C 1.532 1.111 1 C-N-CA 131.661 4.458 . . . . 0.0 111.536 172.008 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.487 0 CA-C-O 114.656 -3.302 . . . . 0.0 111.311 -163.252 . . . . . . . . 0 0 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 122.407 1.098 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -79.12 135.24 36.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.528 -2.124 . . . . 0.0 110.517 -178.999 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -128.46 172.7 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.964 2.905 . . . . 0.0 109.709 173.636 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -116.79 153.37 32.55 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.363 2.665 . . . . 0.0 108.32 173.228 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.508 9.1 p -133.36 133.88 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 C-N-CA 129.045 2.938 . . . . 0.0 107.454 177.863 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -88.0 118.81 27.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 156.458 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -64.79 162.54 15.87 Favored 'General case' 0 C--N 1.324 -0.542 1 C-N-CA 132.924 4.49 . . . . 0.0 107.788 167.545 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.98 -11.56 60.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 123.749 1.738 . . . . 0.0 114.248 -173.141 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -91.99 -14.69 29.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.288 1.435 . . . . 0.0 111.575 173.753 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.62 -2.3 15.55 Favored Glycine 0 CA--C 1.535 1.31 1 O-C-N 113.447 -5.783 . . . . 0.0 111.491 165.994 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -88.27 134.39 33.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.744 2.418 . . . . 0.0 108.611 -172.682 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.09 146.91 52.25 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.34 166.083 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.533 57.2 mt -125.81 130.77 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 O-C-N 126.595 2.434 . . . . 0.0 109.223 152.901 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 90.8 m -83.73 130.57 34.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 171.845 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.1 tp -135.77 142.35 44.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 115.912 -1.994 . . . . 0.0 113.95 -174.42 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -94.28 128.23 40.63 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 131.211 3.804 . . . . 0.0 106.904 175.244 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -139.52 144.22 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 O-C-N 120.089 -1.632 . . . . 0.0 111.902 172.362 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.452 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -76.56 148.74 80.35 Favored Pre-proline 0 N--CA 1.447 -0.601 0 C-N-CA 126.305 1.842 . . . . 0.0 109.583 173.217 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.52 -41.82 18.61 Favored 'Trans proline' 0 N--CA 1.447 -1.215 1 C-N-CA 128.543 6.162 . . . . 0.0 109.731 159.057 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.9 p -66.54 -5.91 13.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.566 2.746 . . . . 0.0 117.898 170.668 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.452 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 3.0 t0 -88.61 145.94 25.4 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 117.434 -3.291 . . . . 0.0 105.097 -175.841 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -98.67 145.56 26.76 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.628 2.371 . . . . 0.0 115.901 -177.625 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.331 44.6 mm -42.0 -49.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 -176.575 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -75.87 -31.34 59.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 126.456 3.027 . . . . 0.0 114.306 -175.997 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.68 -35.37 65.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 116.499 -3.876 . . . . 0.0 113.085 172.637 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.0 t -72.21 -36.07 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 1 CA-C-O 111.127 -4.273 . . . . 0.0 112.252 169.817 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -61.47 -29.06 69.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 124.184 3.175 . . . . 0.0 114.39 162.68 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.334 . . -68.61 -31.21 70.22 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 126.77 2.544 . . . . 0.0 110.526 175.249 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -74.25 -19.32 60.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 122.458 2.39 . . . . 0.0 114.573 174.322 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.4 mm -76.71 -27.89 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 125.767 1.627 . . . . 0.0 114.047 161.629 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -63.28 -37.82 88.73 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -176.378 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.34 -53.9 3.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.477 1.511 . . . . 0.0 113.495 166.273 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -91.04 -46.32 8.2 Favored 'General case' 0 N--CA 1.45 -0.449 1 O-C-N 129.138 4.024 . . . . 0.0 107.038 -159.482 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -96.11 -32.63 12.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 119.092 -2.255 . . . . 0.0 113.503 -172.754 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.13 -31.33 8.67 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 116.857 -2.08 . . . . 0.0 108.654 175.264 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.271 8.3 mm -47.98 116.76 4.97 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 175.38 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.8 152.2 81.7 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 CA-C-N 124.032 2.476 . . . . 0.0 108.223 176.784 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.67 -36.61 72.87 Favored 'Trans proline' 0 N--CA 1.453 -0.864 1 C-N-CA 128.596 6.197 . . . . 0.0 116.023 175.274 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.18 -17.59 58.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.831 2.852 . . . . 0.0 113.938 177.804 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.265 9.3 mm-40 -91.64 -9.72 42.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 115.641 -2.123 . . . . 0.0 112.722 166.539 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -108.81 130.13 55.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -167.244 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -118.2 -176.18 3.01 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 119.863 -1.773 . . . . 0.0 109.242 156.365 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.87 123.63 3.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 177.216 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mm -108.86 122.4 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 -176.917 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -138.66 108.39 6.26 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.434 3.894 . . . . 0.0 109.434 -167.407 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.07 27.2 7.05 Favored 'General case' 0 N--CA 1.443 -0.821 1 C-N-CA 131.743 4.017 . . . . 0.0 115.972 177.665 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.37 17.13 20.79 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 106.448 -2.661 . . . . 0.0 106.448 170.05 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.302 65.6 pttt -150.71 159.46 44.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.911 2.084 . . . . 0.0 115.687 -171.698 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -79.62 148.2 31.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 131.344 3.858 . . . . 0.0 116.711 162.593 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.9 mt -100.24 118.45 36.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 128.354 3.534 . . . . 0.0 101.728 174.237 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.283 7.8 tp10 -87.3 157.15 19.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.226 -0.921 . . . . 0.0 109.052 -175.621 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.07 155.31 39.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.984 2.114 . . . . 0.0 110.675 -177.626 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.11 -14.38 57.48 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.991 175.229 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -90.65 149.34 22.13 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -176.342 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.8 p -79.19 174.29 11.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 117.326 -3.359 . . . . 0.0 109.154 167.135 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mp -76.61 -22.88 53.58 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 117.039 -3.538 . . . . 0.0 112.587 174.309 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 t -70.26 -29.14 65.85 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 127.517 2.327 . . . . 0.0 112.689 171.321 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.47 -32.32 73.86 Favored 'General case' 0 C--N 1.322 -0.6 1 O-C-N 115.843 -4.286 . . . . 0.0 111.934 173.174 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.86 6.21 21.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 119.841 -1.787 . . . . 0.0 106.738 -169.687 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.361 1.6 p-10 57.21 41.44 26.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 124.701 2.191 . . . . 0.0 113.878 167.838 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 mt -90.56 122.38 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 129.991 3.316 . . . . 0.0 106.241 -176.599 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.287 21.3 mm-40 -115.27 -176.6 2.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 130.537 3.535 . . . . 0.0 116.22 176.242 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -51.42 161.88 0.41 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 123.277 2.762 . . . . 0.0 116.065 159.83 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 85.16 1.37 0.74 Allowed 'General case' 0 C--N 1.325 -0.496 1 C-N-CA 133.301 4.64 . . . . 0.0 111.214 171.136 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -82.04 107.46 14.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 -177.373 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -84.37 110.66 18.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.553 2.341 . . . . 0.0 111.279 157.158 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.1 mt -76.46 162.67 27.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.118 -1.614 . . . . 0.0 115.16 170.019 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -119.94 147.56 44.6 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.961 2.104 . . . . 0.0 110.369 150.687 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.68 149.4 21.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 129.104 2.962 . . . . 0.0 111.947 171.317 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -133.74 155.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 O-C-N 117.839 -3.038 . . . . 0.0 115.452 168.722 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.5 mt -99.2 141.46 31.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 122.633 2.47 . . . . 0.0 105.712 -170.923 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -84.81 153.87 22.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 125.447 3.749 . . . . 0.0 111.709 149.578 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.256 18.8 tp -84.38 -44.53 13.66 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 118.286 -2.759 . . . . 0.0 113.994 166.906 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -77.85 144.12 37.27 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.504 2.322 . . . . 0.0 107.748 -174.331 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.81 -127.77 4.21 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 174.004 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 124.997 2.443 . . . . 0.0 112.097 -168.349 . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 ttp . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 100.425 -3.917 . . . . 0.0 100.425 . . . . . . . . . 0 0 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -72.14 137.46 47.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 111.648 -2.524 . . . . 0.0 110.999 -175.108 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.305 10.9 pt -141.17 170.74 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 O-C-N 125.678 1.861 . . . . 0.0 111.268 173.106 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -122.37 138.95 54.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 107.132 177.428 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.64 117.66 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 101.875 -3.38 . . . . 0.0 101.875 173.298 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -78.87 135.38 37.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 125.327 2.489 . . . . 0.0 112.838 165.395 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 p -80.16 -169.43 2.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 118.746 -2.471 . . . . 0.0 110.023 -179.398 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.5 mt -61.82 -40.41 95.2 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -165.909 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.8 p -103.04 9.01 38.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 111.338 -2.665 . . . . 0.0 112.739 -176.266 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.64 -0.73 59.67 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 128.655 3.026 . . . . 0.0 117.841 170.469 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -73.4 129.29 37.69 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 119.949 1.874 . . . . 0.0 110.771 177.199 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 t -81.04 136.37 35.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.785 2.034 . . . . 0.0 113.72 -177.945 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 pt -114.15 120.14 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 102.671 -3.085 . . . . 0.0 102.671 168.681 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.8 m -86.66 112.88 22.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.04 2.536 . . . . 0.0 108.86 -179.836 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.83 170.07 8.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.153 2.981 . . . . 0.0 104.346 -170.698 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.484 1.1 pm0 -132.79 124.39 27.94 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 131.297 3.839 . . . . 0.0 118.965 162.99 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.334 0.0 OUTLIER -143.85 154.14 15.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 113.909 -1.496 . . . . 0.0 113.898 -175.345 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -88.97 151.08 46.63 Favored Pre-proline 0 N--CA 1.452 -0.367 0 O-C-N 119.67 -1.894 . . . . 0.0 108.828 176.919 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.29 -30.09 10.54 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 124.907 3.738 . . . . 0.0 117.53 165.835 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.303 16.8 p -96.99 12.84 31.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 129.201 3.001 . . . . 0.0 112.714 170.799 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.81 142.35 31.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 123.421 2.828 . . . . 0.0 108.104 167.513 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -81.8 177.9 8.62 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 131.565 3.946 . . . . 0.0 111.285 -177.573 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -89.21 -18.96 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 O-C-N 116.575 -3.828 . . . . 0.0 111.321 -170.803 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.76 -37.66 74.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.102 157.432 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -85.11 5.26 30.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 123.71 1.719 . . . . 0.0 110.425 -172.616 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.25 -37.41 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 O-C-N 118.08 -2.887 . . . . 0.0 110.06 156.475 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -56.78 -52.65 64.21 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 116.571 -3.831 . . . . 0.0 110.083 174.846 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.3 46.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 118.086 2.625 . . . . 0.0 118.086 179.502 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -83.18 -26.54 30.77 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 111.553 -2.567 . . . . 0.0 116.126 178.443 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.0 mt -68.38 -38.96 80.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 115.758 -2.067 . . . . 0.0 108.838 160.666 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.15 -34.19 77.51 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 117.832 -1.08 . . . . 0.0 109.921 174.457 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.44 -34.67 77.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -179.091 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -102.24 -25.21 13.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 127.651 3.094 . . . . 0.0 117.937 -176.713 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -141.15 -16.24 0.85 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.627 2.371 . . . . 0.0 112.352 -171.599 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.06 -3.89 67.31 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 120.217 -1.552 . . . . 0.0 113.699 152.157 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.3 mt -73.3 132.65 81.65 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 114.055 -2.879 . . . . 0.0 106.037 -176.953 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.6 132.56 22.21 Favored 'Trans proline' 0 N--CA 1.454 -0.81 1 C-N-CA 127.118 5.212 . . . . 0.0 106.856 -171.274 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -40.2 -30.68 0.46 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 1 C-N-CA 130.445 7.43 . . . . 0.0 119.604 177.503 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.76 -39.07 84.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.448 2.299 . . . . 0.0 113.725 175.744 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.32 -16.15 55.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 115.248 -2.311 . . . . 0.0 112.64 -175.707 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.46 130.89 35.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.76 2.824 . . . . 0.0 111.638 -172.696 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -121.47 131.93 54.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 103.354 -2.832 . . . . 0.0 103.354 168.688 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 mt -103.0 137.82 40.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 119.914 1.234 . . . . 0.0 110.488 166.649 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mm -122.61 148.66 26.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 129.925 3.29 . . . . 0.0 107.862 177.341 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -153.88 127.58 8.75 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.177 1.791 . . . . 0.0 110.038 173.919 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.37 40.39 10.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.048 2.139 . . . . 0.0 115.08 -172.536 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.64 -13.08 68.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 117.638 1.815 . . . . 0.0 117.638 177.559 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.399 55.3 pttt -123.78 148.34 46.75 Favored 'General case' 0 C--N 1.326 -0.437 1 C-N-CA 133.353 4.661 . . . . 0.0 108.212 -161.691 . . . . . . . . 3 2 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -71.3 155.33 40.8 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 118.388 -2.695 . . . . 0.0 109.245 -169.277 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -136.23 114.08 11.2 Favored 'General case' 0 N--CA 1.451 -0.388 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 177.885 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -123.31 155.49 37.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 126.335 2.969 . . . . 0.0 111.895 -169.186 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.26 145.28 55.34 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.013 -2.929 . . . . 0.0 108.668 -178.246 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.07 -6.7 19.43 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 127.148 2.78 . . . . 0.0 113.977 -173.756 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -135.35 -175.56 3.98 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.414 1.486 . . . . 0.0 113.032 -179.509 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.6 p -128.39 175.17 8.71 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.288 1.035 . . . . 0.0 109.787 -178.856 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -55.05 -36.44 65.56 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.532 1.933 . . . . 0.0 113.703 171.423 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.328 13.0 m -75.6 -25.61 57.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 115.622 -2.431 . . . . 0.0 113.6 177.159 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -70.46 -41.61 72.54 Favored 'General case' 0 N--CA 1.45 -0.451 2 CA-C-N 126.516 4.235 . . . . 0.0 112.817 173.196 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -82.09 -12.63 58.12 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 124.742 1.276 . . . . 0.0 110.8 -176.212 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.5 m120 72.76 58.91 0.12 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.554 3.542 . . . . 0.0 114.984 175.836 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -100.69 159.05 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 112.504 -2.134 . . . . 0.0 109.814 -177.933 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -130.52 -151.73 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.684 1.194 . . . . 0.0 112.188 -176.614 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -90.34 144.64 25.64 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.427 2.291 . . . . 0.0 107.444 175.874 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 77.01 19.75 1.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 125.213 2.435 . . . . 0.0 111.073 161.895 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.7 m -87.78 133.42 33.87 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.97 2.508 . . . . 0.0 115.278 -178.025 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.1 m -111.93 125.36 53.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 123.608 2.913 . . . . 0.0 104.24 -170.787 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mt -103.05 166.32 10.51 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.313 2.245 . . . . 0.0 111.281 173.518 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -109.43 134.01 52.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 118.669 -2.52 . . . . 0.0 105.282 164.99 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 1.5 tm? -90.01 140.22 29.85 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.088 1.355 . . . . 0.0 109.696 154.033 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.92 156.22 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 128.869 2.868 . . . . 0.0 111.616 164.012 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.0 124.77 30.07 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.908 1.683 . . . . 0.0 108.812 171.529 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -173.44 97.88 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 111.63 -2.532 . . . . 0.0 109.865 -176.148 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.66 112.63 4.27 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 118.242 -2.786 . . . . 0.0 106.719 179.663 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.35 -55.4 0.44 Allowed 'General case' 0 N--CA 1.452 -0.372 1 N-CA-C 97.11 -5.144 . . . . 0.0 97.11 170.814 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.06 -142.24 15.56 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 117.302 -3.374 . . . . 0.0 111.538 -175.905 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.863 0 CA-C-N 121.397 2.598 . . . . 0.0 110.686 -174.149 . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 123.732 1.729 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 051 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -103.4 120.45 40.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 119.613 -1.93 . . . . 0.0 107.175 178.3 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -121.92 131.22 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.056 170.42 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -86.86 81.44 8.15 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.629 2.372 . . . . 0.0 109.166 -174.358 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -65.41 132.54 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 125.981 1.713 . . . . 0.0 108.682 169.246 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -123.24 152.78 40.97 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 119.972 -1.705 . . . . 0.0 109.562 172.923 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -117.73 -177.44 3.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 126.478 3.037 . . . . 0.0 109.585 -165.296 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.68 -42.4 34.71 Favored 'General case' 0 N--CA 1.446 -0.656 1 O-C-N 115.899 -4.251 . . . . 0.0 104.669 174.38 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -69.89 -19.08 63.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 123.22 2.736 . . . . 0.0 112.772 -176.316 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.38 32.16 2.62 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.044 0.83 . . . . 0.0 113.112 156.982 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -110.68 146.27 36.52 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 114.22 -2.8 . . . . 0.0 110.088 -167.113 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.261 43.1 m -99.57 89.71 4.24 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 173.802 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mm -52.47 -57.93 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 120.757 1.617 . . . . 0.0 112.209 -173.848 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.317 75.5 m 79.3 81.91 0.06 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -178.675 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 tp -99.15 138.65 35.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 124.984 2.326 . . . . 0.0 106.61 -178.877 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -91.35 121.52 33.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.223 -1.548 . . . . 0.0 107.916 170.896 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.401 4.8 t -121.56 152.24 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 103.831 -2.655 . . . . 0.0 103.831 -175.547 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -104.36 136.0 19.25 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-O 114.624 -2.608 . . . . 0.0 109.384 170.909 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -57.7 -18.09 31.94 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 N-CA-C 118.609 2.503 . . . . 0.0 118.609 -174.773 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.7 p -74.08 -15.07 61.07 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.655 2.382 . . . . 0.0 114.427 168.93 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -66.39 129.01 38.39 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 122.72 2.509 . . . . 0.0 110.698 -176.026 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.6 p -85.37 174.67 9.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.971 1.714 . . . . 0.0 108.389 163.243 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.255 27.4 mm -46.7 -39.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 128.707 2.803 . . . . 0.0 115.899 176.592 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -59.02 -43.27 91.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 115.716 -2.088 . . . . 0.0 111.058 174.996 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -73.23 -36.06 66.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 127.476 2.31 . . . . 0.0 109.561 -172.513 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.29 -55.13 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 124.467 1.107 . . . . 0.0 110.512 172.989 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.263 78.7 mttt -43.5 -44.47 6.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.239 2.216 . . . . 0.0 113.512 169.718 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.22 -53.26 59.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.298 2.239 . . . . 0.0 110.097 177.506 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -62.37 -33.26 74.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 179.976 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -68.02 -44.72 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 126.946 2.654 . . . . 0.0 109.873 165.878 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -46.15 91.84 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 125.368 1.667 . . . . 0.0 114.106 -178.977 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.446 27.8 t70 -34.45 -61.32 0.39 Allowed 'General case' 0 N--CA 1.448 -0.549 1 N-CA-C 124.403 4.964 . . . . 0.0 124.403 152.451 . . . . . . . . 3 2 . 1 . 051 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -95.19 -30.23 14.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 119.892 -1.755 . . . . 0.0 111.405 -156.764 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -109.25 -27.79 9.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 128.806 2.843 . . . . 0.0 110.709 -179.978 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.58 -3.15 61.0 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 121.428 3.331 . . . . 0.0 121.428 167.674 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.508 ' H ' HD11 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -85.15 145.19 42.5 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 114.054 -2.879 . . . . 0.0 109.715 -179.88 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.23 161.59 33.48 Favored 'Trans proline' 0 N--CA 1.45 -1.039 1 C-N-CA 126.781 4.987 . . . . 0.0 109.986 174.039 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.82 -13.07 8.28 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.724 3.616 . . . . 0.0 115.242 -171.949 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.55 -36.21 63.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 160.586 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.447 HE21 ' HB2' ' A' ' 40' ' ' GLN . 2.5 tt0 -67.78 -23.48 65.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.286 -1.34 . . . . 0.0 113.508 179.57 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -85.23 129.1 34.87 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 113.839 -2.981 . . . . 0.0 106.042 -168.484 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -110.68 160.05 17.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 155.165 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.519 0.2 OUTLIER -136.44 135.51 38.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 119.112 -2.243 . . . . 0.0 114.98 176.686 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 mt -127.47 108.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -159.469 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -124.19 130.98 53.46 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.858 1.663 . . . . 0.0 110.369 171.787 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.09 50.54 13.96 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 130.398 3.479 . . . . 0.0 110.68 175.304 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.1 -34.3 3.99 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.841 2.162 . . . . 0.0 117.173 178.839 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -89.04 132.05 34.94 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -164.134 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.259 24.5 mt-30 -88.71 104.31 16.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 123.835 1.778 . . . . 0.0 108.949 168.373 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 50' ' ' LEU . 7.5 mt -55.86 138.35 48.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 110.426 -3.079 . . . . 0.0 113.298 -166.529 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -88.64 152.49 21.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 116.423 -1.751 . . . . 0.0 106.851 -172.121 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.59 134.76 50.46 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 114.58 -2.629 . . . . 0.0 114.885 -173.671 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.83 16.92 80.35 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 117.384 1.713 . . . . 0.0 117.384 172.614 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.0 mmm-85 -99.21 176.98 5.35 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.887 2.075 . . . . 0.0 107.583 178.448 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.5 p -100.05 141.24 33.14 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 102.371 -3.196 . . . . 0.0 102.371 -172.622 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.7 mt -66.26 -30.81 71.32 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 127.529 2.332 . . . . 0.0 113.071 179.661 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.3 m -87.17 -22.13 25.5 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.321 -166.802 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.02 -15.89 60.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 124.864 1.352 . . . . 0.0 114.314 173.658 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -92.84 5.62 50.62 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.847 2.059 . . . . 0.0 109.299 168.135 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 75.94 21.74 1.54 Allowed 'General case' 0 N--CA 1.444 -0.765 1 C-N-CA 134.007 4.923 . . . . 0.0 118.322 170.164 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 mt -82.33 103.69 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 C-N-CA 128.144 2.578 . . . . 0.0 107.543 -169.069 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -89.5 170.44 10.5 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.059 2.143 . . . . 0.0 109.63 177.084 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -66.76 159.01 28.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 116.991 -1.48 . . . . 0.0 113.586 159.632 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 68.35 18.88 9.07 Favored 'General case' 0 N--CA 1.453 -0.318 1 C-N-CA 132.913 4.485 . . . . 0.0 111.032 179.359 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.1 t -95.94 178.39 5.44 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 128.731 3.769 . . . . 0.0 112.182 -176.433 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.2 p -131.85 133.71 44.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 125.798 1.936 . . . . 0.0 111.072 -171.971 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.19 150.91 51.94 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 126.279 2.237 . . . . 0.0 105.468 -171.704 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -108.2 119.67 40.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 117.942 -2.974 . . . . 0.0 110.953 171.663 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.3 tp -82.4 133.78 35.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 173.43 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.291 68.7 t -108.61 141.28 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 125.149 3.613 . . . . 0.0 107.495 163.257 . . . . . . . . 2 2 . 1 . 051 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mp -83.8 149.02 26.69 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 167.113 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.36 0.0 OUTLIER -58.02 -7.82 0.88 Allowed 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 129.972 3.309 . . . . 0.0 116.259 171.235 . . . . . . . . 3 3 . 1 . 051 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.24 155.77 19.57 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.655 1.982 . . . . 0.0 109.971 177.354 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -99.41 130.99 45.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 125.471 2.558 . . . . 0.0 105.99 -167.963 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.18 -172.31 16.61 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.49 179.63 . . . . . . . . 1 1 . 1 . 051 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 113.405 -3.997 . . . . 0.0 106.835 174.511 . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 ttp . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 116.627 -1.654 . . . . 0.0 108.069 . . . . . . . . . 0 0 . 1 . 052 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -73.12 133.1 44.0 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 122.407 2.367 . . . . 0.0 115.765 176.167 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -122.3 155.3 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 115.647 -2.12 . . . . 0.0 112.551 165.084 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -102.5 128.37 49.17 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 126.046 2.091 . . . . 0.0 105.658 179.262 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -100.54 109.6 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 118.047 -2.908 . . . . 0.0 103.383 166.066 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -102.95 150.3 23.67 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.447 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.283 14.8 t -145.48 160.32 41.77 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 125.27 2.462 . . . . 0.0 109.217 158.243 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mp -67.71 -39.71 84.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 109.114 -3.675 . . . . 0.0 114.365 -161.914 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 p -52.48 -5.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 1 C-N-CA 133.435 4.694 . . . . 0.0 115.728 171.486 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.27 2.09 54.11 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 119.911 -1.743 . . . . 0.0 112.772 167.228 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -79.7 126.46 30.96 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.185 1.993 . . . . 0.0 110.096 164.308 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 m -128.2 101.96 6.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 103.244 -2.872 . . . . 0.0 103.244 171.031 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.266 2.8 mp -80.26 150.07 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 130.741 3.616 . . . . 0.0 110.457 -177.462 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 t -135.91 122.1 20.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.636 1.575 . . . . 0.0 108.241 -175.885 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -123.14 147.52 46.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.773 1.229 . . . . 0.0 113.845 175.221 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -97.43 121.23 39.09 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 131.093 3.757 . . . . 0.0 105.605 177.162 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -131.04 166.72 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 118.494 -2.629 . . . . 0.0 114.481 178.474 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -95.69 156.71 37.08 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 155.65 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.28 -20.04 69.68 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.64 2.893 . . . . 0.0 113.15 -179.891 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 13.6 p -91.78 0.33 57.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.945 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -66.33 142.85 57.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 176.562 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.33 147.49 26.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 125.216 2.436 . . . . 0.0 109.043 178.356 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.2 mt -55.75 -26.46 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 118.903 -2.373 . . . . 0.0 113.149 179.603 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.287 31.9 mt-10 -74.07 -42.66 59.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 109.422 -178.535 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.01 -50.4 70.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.513 175.499 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.1 t -55.57 -31.1 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 115.612 -2.137 . . . . 0.0 111.835 166.029 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -76.71 -17.56 59.03 Favored 'General case' 0 N--CA 1.442 -0.834 2 CA-C-N 128.092 4.951 . . . . 0.0 109.66 -177.267 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.42 -19.99 22.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.516 1.126 . . . . 0.0 113.215 172.273 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -73.76 -29.72 62.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 170.785 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 56.9 mt -64.79 -30.78 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 128.834 2.854 . . . . 0.0 115.148 160.309 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -65.71 -53.51 39.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.62 1.1 . . . . 0.0 111.776 173.094 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.401 22.9 t70 -36.99 -34.16 0.07 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 131.514 3.926 . . . . 0.0 112.485 168.283 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -93.78 -57.99 2.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 120.582 1.537 . . . . 0.0 115.038 171.816 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.26 -21.14 23.35 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -161.268 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.99 1.95 62.81 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 119.312 2.485 . . . . 0.0 119.312 -174.905 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.0 mt -95.86 140.87 22.49 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 128.191 2.596 . . . . 0.0 110.874 -163.234 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.59 136.53 10.98 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.765 2.977 . . . . 0.0 115.604 172.774 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -66.47 -21.21 53.62 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 124.562 3.508 . . . . 0.0 116.093 -158.047 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.31 4.78 9.91 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 117.907 -2.996 . . . . 0.0 110.94 -176.884 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -95.36 -18.96 20.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 113.172 -3.299 . . . . 0.0 109.083 168.062 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.284 13.4 mm-40 -98.0 125.05 42.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 124.678 3.399 . . . . 0.0 112.319 -160.835 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 127.5 42.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 100.635 -3.839 . . . . 0.0 100.635 -178.772 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.7 mt -101.89 134.78 44.54 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 128.683 2.793 . . . . 0.0 115.096 179.688 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -128.74 156.65 41.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 126.458 1.903 . . . . 0.0 107.209 167.753 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.368 6.7 t80 -126.61 -126.65 0.23 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 109.711 -3.404 . . . . 0.0 107.945 -157.76 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.75 44.57 1.07 Allowed 'General case' 0 C--N 1.324 -0.54 1 C-N-CA 132.243 4.217 . . . . 0.0 110.777 169.994 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.9 -22.22 34.13 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 128.328 2.87 . . . . 0.0 114.493 -177.715 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.93 126.01 34.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -171.268 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -76.21 119.86 20.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.123 0.963 . . . . 0.0 108.78 171.967 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -92.23 127.43 37.71 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -169.957 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.91 149.5 34.21 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 123.399 1.571 . . . . 0.0 114.872 174.005 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -64.6 126.75 28.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 129.619 3.168 . . . . 0.0 109.748 178.115 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.1 -20.08 51.59 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 116.705 -2.664 . . . . 0.0 114.847 172.279 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.32 156.35 38.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.72 1.26 . . . . 0.0 110.091 159.394 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.1 p -87.94 -179.95 6.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 119.327 -2.108 . . . . 0.0 109.152 -175.668 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.8 mt -77.08 -22.39 52.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 116.772 -1.585 . . . . 0.0 110.443 165.618 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.2 t -64.82 -41.02 96.09 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 117.608 2.448 . . . . 0.0 117.608 168.492 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -51.88 -53.83 36.21 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.703 -178.26 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -94.67 3.33 55.2 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.697 1.999 . . . . 0.0 110.824 -171.124 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.49 1.3 p-10 64.68 28.73 13.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 118.711 2.856 . . . . 0.0 118.711 175.11 . . . . . . . . 2 2 . 1 . 052 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.6 mt -75.16 131.37 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.343 170.023 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -124.17 176.7 6.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 125.929 2.018 . . . . 0.0 108.936 -168.254 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -52.99 127.27 23.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.418 1.487 . . . . 0.0 108.555 175.148 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 62.95 15.52 8.43 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 120.372 3.471 . . . . 0.0 120.372 -171.373 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -76.72 123.41 26.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 116.888 -3.633 . . . . 0.0 106.402 168.496 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -87.15 129.34 34.98 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.698 2.799 . . . . 0.0 108.523 179.469 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -100.97 134.15 44.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.547 2.339 . . . . 0.0 109.363 163.72 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -86.03 151.29 23.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 103.552 -2.758 . . . . 0.0 103.552 164.657 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -134.23 112.8 11.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 127.871 2.468 . . . . 0.0 109.824 -173.774 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.84 -177.58 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.179 2.591 . . . . 0.0 110.965 -178.347 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.8 mt -87.47 138.87 31.11 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 113.737 -3.03 . . . . 0.0 110.637 -177.088 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -76.81 124.91 28.4 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 120.959 1.709 . . . . 0.0 107.866 174.59 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.2 mt -126.55 91.84 3.44 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 122.828 1.299 . . . . 0.0 111.74 -173.898 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 88.02 -74.88 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.794 2.437 . . . . 0.0 109.618 -175.81 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.64 -179.37 15.84 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.953 -0.915 . . . . 0.0 112.11 -177.011 . . . . . . . . 1 1 . 1 . 052 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.837 0 CA-C-O 117.961 -1.466 . . . . 0.0 109.708 172.454 . . . . . . . . 0 0 . 1 . 053 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 . . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.457 HE21 ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -80.36 144.02 33.06 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.491 1.916 . . . . 0.0 112.536 -175.148 . . . . . . . . 3 3 . 1 . 053 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.481 HG21 ' H ' ' A' ' 65' ' ' SER . 22.9 pt -127.44 161.33 35.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 120.237 -1.539 . . . . 0.0 111.073 155.764 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -92.27 163.57 13.85 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 172.739 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.32 155.67 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 129.436 3.094 . . . . 0.0 110.608 148.422 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -152.12 142.39 22.42 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 122.858 2.572 . . . . 0.0 105.233 -162.308 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.27 66.7 p -100.19 170.75 8.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.049 1.34 . . . . 0.0 110.965 179.284 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 43.8 mt -93.0 18.88 8.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 117.856 -3.027 . . . . 0.0 110.22 177.324 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.371 0.6 OUTLIER -153.46 22.37 0.54 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 125.563 3.801 . . . . 0.0 109.412 -164.442 . . . . . . . . 3 3 . 1 . 053 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.88 -11.36 29.68 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 122.688 3.835 . . . . 0.0 122.688 164.752 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -112.73 170.69 8.01 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 121.159 2.479 . . . . 0.0 109.193 -171.001 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.4 p -140.03 169.2 18.13 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.52 3.128 . . . . 0.0 110.503 170.579 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.7 mm -140.99 132.86 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 126.097 2.123 . . . . 0.0 110.377 168.851 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 m -80.88 116.53 20.91 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 126.621 2.45 . . . . 0.0 110.125 168.399 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.8 mt -102.74 146.08 28.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 123.773 1.749 . . . . 0.0 113.304 179.041 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.9 107.88 10.49 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.877 168.881 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -142.58 -41.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.837 1.655 . . . . 0.0 111.441 -157.067 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 75.74 140.97 0.08 OUTLIER Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 131.07 3.748 . . . . 0.0 110.726 -171.339 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -46.58 -24.08 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 124.474 3.449 . . . . 0.0 119.979 172.308 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 p -64.07 -34.21 77.5 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 116.365 -3.959 . . . . 0.0 113.178 174.931 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.98 144.87 11.02 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -177.846 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.257 10.7 t -117.56 130.68 56.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 116.84 -1.552 . . . . 0.0 108.483 -165.514 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.409 24.7 mm -40.69 -43.72 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 129.774 3.23 . . . . 0.0 114.755 -159.6 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -65.48 -29.47 70.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 121.214 1.825 . . . . 0.0 113.19 179.648 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.77 -16.61 28.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 -176.825 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.43 -40.33 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 114.809 -2.519 . . . . 0.0 105.518 172.702 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -71.5 -30.04 65.5 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 125.035 1.459 . . . . 0.0 112.235 175.324 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.25 -18.65 60.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.53 2.332 . . . . 0.0 115.869 173.74 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.28 -18.41 55.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 119.724 3.231 . . . . 0.0 119.724 161.416 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.6 mt -87.97 -38.19 11.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 127.27 2.856 . . . . 0.0 107.733 170.655 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.295 38.6 tt0 -45.9 -56.28 5.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 162.01 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -51.56 -38.2 53.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 111.397 -2.638 . . . . 0.0 110.704 171.363 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -87.7 -53.71 4.63 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -179.991 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -103.46 -21.56 13.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 -170.932 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.76 -17.09 28.06 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 116.42 -2.322 . . . . 0.0 110.394 175.156 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.79 120.19 78.62 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 129.288 3.035 . . . . 0.0 110.292 -174.127 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -77.23 148.72 27.38 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 C-N-CA 123.924 3.083 . . . . 0.0 110.973 -171.146 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.293 47.2 Cg_exo -47.53 -37.39 26.21 Favored 'Trans proline' 0 N--CA 1.442 -1.532 1 C-N-CA 126.382 4.721 . . . . 0.0 116.096 -176.814 . . . . . . . . 3 2 . 1 . 053 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.75 -13.71 61.0 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -171.737 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.317 20.2 mt-30 -100.88 -7.82 23.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 178.715 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -89.23 95.03 10.13 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.247 2.219 . . . . 0.0 115.996 173.353 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.291 51.4 ttt180 -88.44 105.7 17.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.293 -1.504 . . . . 0.0 107.639 172.821 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.295 97.1 mt -97.07 120.11 36.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.984 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.0 mt -110.85 126.24 68.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 130.179 3.392 . . . . 0.0 105.91 -172.53 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.261 89.9 t80 -119.95 -138.27 0.34 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.869 2.868 . . . . 0.0 105.019 -172.422 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.26 57.19 4.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.302 2.641 . . . . 0.0 114.146 -163.284 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.78 -3.17 80.99 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 127.198 2.333 . . . . 0.0 114.449 -166.679 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -123.96 141.01 52.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.37 2.268 . . . . 0.0 110.98 -170.381 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -77.44 140.04 39.77 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.656 -0.687 . . . . 0.0 110.989 153.309 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 73.4 mt -67.97 123.5 20.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 126.232 2.208 . . . . 0.0 109.156 174.01 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -85.09 138.93 32.1 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 126.554 2.409 . . . . 0.0 107.519 -177.376 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.276 96.8 m-20 -73.56 127.27 32.29 Favored 'General case' 0 N--CA 1.445 -0.724 1 CA-C-N 107.303 -4.498 . . . . 0.0 104.707 171.74 . . . . . . . . 3 2 . 1 . 053 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.32 -19.79 26.46 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.708 1.255 . . . . 0.0 116.148 -173.147 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -100.02 163.3 12.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 124.1 1.905 . . . . 0.0 110.007 176.136 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -92.87 164.8 13.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 117.377 -3.327 . . . . 0.0 111.667 179.492 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 18.2 mt -62.11 -45.07 95.1 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 117.31 -3.369 . . . . 0.0 113.482 171.644 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.535 47.5 t -29.95 -36.12 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.215 1 C-N-CA 134.838 5.255 . . . . 0.0 120.511 156.203 . . . . . . . . 3 2 . 1 . 053 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.318 34.5 m-20 -80.49 -10.03 59.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 114.38 -2.724 . . . . 0.0 110.738 177.184 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -104.86 -7.71 19.2 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 126.864 2.602 . . . . 0.0 114.199 168.15 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 7.0 t-20 55.08 59.42 4.03 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.253 2.221 . . . . 0.0 113.232 -171.909 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -101.16 126.94 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 1 O-C-N 114.621 -5.05 . . . . 0.0 103.599 179.468 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -109.9 -170.28 1.62 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.918 1.687 . . . . 0.0 112.347 -168.827 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -50.83 139.15 17.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.047 -1.033 . . . . 0.0 113.01 171.269 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.278 4.4 tt0 70.56 32.26 2.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 128.879 3.862 . . . . 0.0 109.923 163.395 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.481 ' H ' HG21 ' A' ' 3' ' ' ILE . 69.6 m -83.1 153.23 24.96 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 117.777 -3.077 . . . . 0.0 114.509 -178.335 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m -113.52 137.82 51.01 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 125.234 2.445 . . . . 0.0 111.018 168.902 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.69 125.86 27.91 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 176.468 . . . . . . . . 2 2 . 1 . 053 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -92.09 143.86 26.02 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 127.619 3.075 . . . . 0.0 108.491 177.584 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tt -115.64 122.23 44.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.159 -172.724 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.7 t -100.91 141.82 16.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 127.981 2.512 . . . . 0.0 108.347 176.529 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt -89.92 149.35 22.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 126.355 2.979 . . . . 0.0 109.492 -174.118 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.4 ptt180 -154.85 -179.39 7.98 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 131.428 3.891 . . . . 0.0 105.497 174.421 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -134.38 118.69 17.73 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 100.758 -3.793 . . . . 0.0 100.758 151.259 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -81.23 -34.45 32.16 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.827 1.251 . . . . 0.0 110.464 171.756 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.56 4.9 6.14 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 117.875 -2.107 . . . . 0.0 114.189 177.072 . . . . . . . . 1 1 . 1 . 053 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 C-N-CA 125.68 1.61 . . . . 0.0 113.824 -151.936 . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.9 ttp . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 115.818 -2.039 . . . . 0.0 107.086 . . . . . . . . . 0 0 . 1 . 054 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -90.87 146.17 24.14 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 126.036 2.085 . . . . 0.0 109.469 -169.134 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 6.0 pt -145.88 164.78 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 175.376 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -127.53 145.39 50.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 124.385 2.041 . . . . 0.0 107.937 -174.917 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -137.53 106.87 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 1 O-C-N 115.246 -4.659 . . . . 0.0 104.382 -177.908 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -77.34 126.67 31.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 124.567 2.127 . . . . 0.0 112.991 162.896 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -78.48 156.8 29.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.511 1.924 . . . . 0.0 109.266 177.468 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mt -50.47 -34.65 25.71 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 164.467 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.2 p -78.66 -11.91 59.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.735 2.014 . . . . 0.0 112.713 -176.086 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.25 -8.39 26.83 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 115.657 -2.746 . . . . 0.0 111.087 174.243 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -91.73 159.66 15.73 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.29 1.436 . . . . 0.0 109.765 -174.947 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -126.17 136.41 52.82 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 -178.127 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mt -102.79 159.81 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 1 C-N-CA 132.337 4.255 . . . . 0.0 106.647 163.956 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.33 3.3 t -135.4 149.98 49.78 Favored 'General case' 0 C--N 1.328 -0.34 1 C-N-CA 134.117 4.967 . . . . 0.0 112.526 168.831 . . . . . . . . 3 2 . 1 . 054 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mp -141.27 144.35 34.61 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -173.342 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.274 4.0 tp10 -99.71 128.04 45.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 125.322 1.639 . . . . 0.0 108.613 161.559 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.72 173.3 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 129.216 3.007 . . . . 0.0 114.976 173.05 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -103.2 148.19 35.29 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 128.148 2.579 . . . . 0.0 106.796 151.812 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -64.63 -14.13 42.83 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-O 116.499 -1.542 . . . . 0.0 112.006 172.457 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.5 m -86.98 1.53 52.47 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 127.782 3.176 . . . . 0.0 111.194 177.817 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -89.97 143.76 26.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 126.203 2.189 . . . . 0.0 106.959 175.075 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -82.76 162.56 21.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 126.245 2.926 . . . . 0.0 104.174 -168.548 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.27 -45.85 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 120.002 -1.686 . . . . 0.0 109.109 168.622 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.8 -33.58 10.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 124.266 1.984 . . . . 0.0 114.209 173.518 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.89 -34.96 67.0 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 117.106 -3.497 . . . . 0.0 112.282 176.174 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.62 -37.18 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 O-C-N 120.54 -1.35 . . . . 0.0 111.136 169.682 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -68.03 -39.8 83.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.766 -1.833 . . . . 0.0 113.449 172.922 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.35 77.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 172.689 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -72.32 -33.91 67.7 Favored 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 131.806 4.042 . . . . 0.0 111.756 175.457 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.6 mt -80.09 -39.82 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 118.502 -2.624 . . . . 0.0 116.582 169.1 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -44.03 -47.39 8.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 119.39 -2.068 . . . . 0.0 114.955 150.725 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -53.97 -45.0 71.26 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 178.085 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -107.58 -49.99 3.15 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 126.245 2.216 . . . . 0.0 107.924 -160.31 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -90.01 -38.35 13.67 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.099 1.76 . . . . 0.0 112.04 -174.172 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.2 9.38 24.06 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 116.622 -2.21 . . . . 0.0 112.865 169.641 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.64 124.53 69.28 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 119.99 1.895 . . . . 0.0 112.687 -170.722 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -54.19 135.78 65.84 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 124.316 3.344 . . . . 0.0 109.828 175.509 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.262 71.6 Cg_exo -41.59 -52.5 3.73 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.132 2.555 . . . . 0.0 117.858 170.083 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -40.82 -17.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 129.658 3.183 . . . . 0.0 114.834 167.39 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -136.04 30.71 3.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -167.068 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.297 13.1 pt20 -141.23 138.12 33.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 130.711 3.604 . . . . 0.0 110.648 168.671 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -138.34 120.92 16.19 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 118.377 -2.702 . . . . 0.0 104.282 175.507 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.59 150.35 23.1 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 119.835 -1.791 . . . . 0.0 109.706 177.037 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.8 mt -137.33 128.0 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -179.412 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -131.5 118.91 20.81 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 127.279 2.862 . . . . 0.0 108.214 179.107 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.21 13.34 7.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 130.754 3.622 . . . . 0.0 118.588 167.4 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.87 3.39 36.66 Favored Glycine 0 CA--C 1.536 1.379 1 C-N-CA 130.881 4.086 . . . . 0.0 114.581 -171.65 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -106.83 100.98 10.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 113.211 -3.28 . . . . 0.0 111.037 -177.517 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -63.29 108.56 1.33 Allowed 'General case' 0 C--N 1.325 -0.479 1 O-C-N 129.695 4.372 . . . . 0.0 106.445 169.122 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.14 147.88 46.21 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 125.789 1.931 . . . . 0.0 112.054 179.399 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' CD ' HH21 ' A' ' 54' ' ' ARG . 3.8 mt-10 -116.39 137.61 52.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.04 2.136 . . . . 0.0 105.657 -178.502 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -43.89 136.46 3.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 138.179 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.44 -10.34 33.14 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 129.845 3.593 . . . . 0.0 115.832 -176.023 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.497 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 39.8 mtt-85 -123.58 -177.72 3.81 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 127.21 2.359 . . . . 0.0 109.385 -178.805 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -128.73 168.34 15.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.277 -175.174 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.5 mt -59.02 -29.29 67.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -178.873 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -65.45 -47.19 77.0 Favored 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 135.489 5.515 . . . . 0.0 115.659 172.736 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -47.13 -25.56 0.9 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 120.053 3.353 . . . . 0.0 120.053 170.855 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.497 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 72.3 m-85 -117.17 1.73 12.53 Favored 'General case' 0 C--O 1.238 0.473 1 C-N-CA 132.866 4.466 . . . . 0.0 115.291 177.958 . . . . . . . . 3 3 . 1 . 054 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.374 4.0 t30 66.89 49.13 1.21 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.375 1.47 . . . . 0.0 113.377 176.782 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mt -101.3 125.39 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 118.243 -2.786 . . . . 0.0 104.568 177.043 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -115.02 -166.7 1.14 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.243 -2.253 . . . . 0.0 111.152 172.635 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.257 58.9 tttt -41.84 125.78 2.95 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 118.939 2.941 . . . . 0.0 118.939 170.496 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.45 44.4 mt-10 75.84 18.1 2.16 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 165.776 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 m -83.67 147.04 27.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.53 1.132 . . . . 0.0 108.782 -175.832 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -120.67 131.75 54.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 -174.466 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -111.7 162.09 15.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.084 2.553 . . . . 0.0 109.608 171.87 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -115.01 142.49 46.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 124.462 2.077 . . . . 0.0 110.496 162.537 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.3 133.52 52.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 119.374 -2.079 . . . . 0.0 106.232 -178.703 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.519 HG13 ' H ' ' A' ' 75' ' ' GLY . 29.6 m -114.76 153.86 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.356 1.862 . . . . 0.0 110.897 161.507 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.35 110.14 11.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 116.735 -1.602 . . . . 0.0 107.975 -173.778 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 70.54 -49.69 0.66 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.735 2.814 . . . . 0.0 117.685 177.51 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.85 148.79 21.74 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 128.693 2.797 . . . . 0.0 108.203 165.183 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -93.72 139.41 30.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 112.691 -2.05 . . . . 0.0 110.126 171.947 . . . . . . . . 1 1 . 1 . 054 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.519 ' H ' HG13 ' A' ' 70' ' ' VAL . . . -123.95 108.28 1.15 Allowed Glycine 0 CA--C 1.528 0.89 0 O-C-N 119.731 -1.855 . . . . 0.0 114.552 163.787 . . . . . . . . 2 2 . 1 . 054 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.655 1 C-N-CA 134.629 5.871 . . . . 0.0 103.226 163.1 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttm . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 . . . . . . . . . 0 0 . 1 . 055 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -91.39 136.82 32.84 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.629 0.771 . . . . 0.0 111.639 175.382 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -117.41 170.01 7.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 119.895 -1.753 . . . . 0.0 110.799 145.539 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.77 138.21 48.66 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 164.824 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 t -121.91 124.76 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 O-C-N 120.922 -1.111 . . . . 0.0 109.397 168.133 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -88.45 115.69 26.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.268 1.027 . . . . 0.0 111.89 -179.482 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 34.9 p -78.71 161.02 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 125.528 2.585 . . . . 0.0 109.378 171.675 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.04 -27.74 66.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.576 1.95 . . . . 0.0 113.634 -171.853 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p -69.0 -8.86 48.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 119.692 -1.88 . . . . 0.0 114.687 168.459 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.28 -6.09 30.27 Favored Glycine 0 N--CA 1.44 -1.039 0 O-C-N 120.179 -1.576 . . . . 0.0 112.106 172.197 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -73.85 125.28 27.8 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.36 2.264 . . . . 0.0 114.61 -176.423 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.3 57.0 m -95.69 106.19 18.26 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 101.029 -3.693 . . . . 0.0 101.029 176.906 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.9 mt -87.16 130.65 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 125.385 1.474 . . . . 0.0 110.265 173.036 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -90.26 105.63 17.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 127.697 3.123 . . . . 0.0 107.835 176.411 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.252 7.7 tp -108.51 152.31 24.9 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.827 2.051 . . . . 0.0 111.71 -178.147 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -95.93 143.15 27.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 163.3 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.0 m -134.05 150.94 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 129.586 3.154 . . . . 0.0 107.198 166.23 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.271 12.7 tp10 -89.39 141.92 29.3 Favored Pre-proline 0 N--CA 1.446 -0.649 0 O-C-N 127.649 3.093 . . . . 0.0 105.287 154.024 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.26 -19.73 6.91 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 N-CA-C 121.033 3.436 . . . . 0.0 121.033 170.837 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.276 20.7 p -99.2 1.57 44.97 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.664 -174.391 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -85.74 144.83 27.56 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 179.939 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.3 p -90.86 162.6 14.74 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.587 -2.571 . . . . 0.0 115.026 -174.278 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mm -52.69 -53.54 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 128.847 2.859 . . . . 0.0 107.89 -165.035 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -79.58 -21.12 45.44 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 114.129 -2.843 . . . . 0.0 112.053 -169.316 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -66.67 -47.68 71.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 123.52 2.873 . . . . 0.0 111.924 166.354 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.24 -34.52 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 130.889 3.676 . . . . 0.0 110.04 177.015 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -67.78 -35.67 79.09 Favored 'General case' 0 N--CA 1.451 -0.387 1 O-C-N 114.435 -5.166 . . . . 0.0 113.23 169.053 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.7 -22.22 46.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 130.408 3.483 . . . . 0.0 110.424 -179.22 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -64.46 -20.65 66.31 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 118.45 -2.656 . . . . 0.0 109.168 173.096 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mm -68.78 -19.71 24.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 117.361 -3.337 . . . . 0.0 117.243 167.279 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -74.65 -35.81 62.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 113.664 -3.065 . . . . 0.0 107.911 -165.175 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.307 27.9 t70 -30.69 -53.58 0.19 Allowed 'General case' 0 N--CA 1.441 -0.902 1 C-N-CA 132.099 4.159 . . . . 0.0 110.421 154.715 . . . . . . . . 3 2 . 1 . 055 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -89.02 -48.17 7.61 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 127.294 2.871 . . . . 0.0 116.842 -178.066 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -102.79 -36.03 8.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 125.221 1.576 . . . . 0.0 108.617 -160.891 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.15 13.47 58.79 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 115.21 -2.994 . . . . 0.0 117.529 171.28 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mm -97.55 142.55 24.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 112.516 -3.611 . . . . 0.0 108.411 -172.985 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -60.6 139.38 85.64 Favored 'Trans proline' 0 N--CA 1.453 -0.897 1 C-N-CA 126.522 4.815 . . . . 0.0 116.853 170.153 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.76 -27.81 37.5 Favored 'Trans proline' 0 N--CA 1.456 -0.729 1 C-N-CA 126.544 4.829 . . . . 0.0 113.31 -172.978 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.18 -38.23 82.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 119.916 -1.74 . . . . 0.0 115.052 166.167 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -73.99 -29.67 62.09 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 118.178 -2.826 . . . . 0.0 117.029 176.886 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -75.44 149.44 38.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.106 2.562 . . . . 0.0 114.557 164.173 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.444 ' CZ ' ' HG2' ' A' ' 49' ' ' GLN . 16.4 ttt180 -131.44 150.01 52.31 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 128.234 2.614 . . . . 0.0 104.661 157.05 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.465 0.4 OUTLIER -120.46 148.62 43.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 124.327 2.013 . . . . 0.0 112.73 158.66 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -104.62 154.29 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 1 C-N-CA 134.504 5.122 . . . . 0.0 108.924 176.601 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -162.6 135.0 5.55 Favored 'General case' 0 C--N 1.321 -0.638 1 C-N-CA 132.313 4.245 . . . . 0.0 103.589 163.015 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 76.37 43.21 0.15 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.012 1.325 . . . . 0.0 109.554 163.504 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.51 22.63 46.23 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 129.754 3.55 . . . . 0.0 118.481 -176.655 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.322 37.4 pttt -162.06 170.13 19.76 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.658 1.583 . . . . 0.0 112.128 -179.397 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HG2' ' CZ ' ' A' ' 42' ' ' ARG 0.306 27.2 mp0 -93.77 139.73 30.5 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.386 -161.563 . . . . . . . . 3 3 . 1 . 055 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.2 mt -94.46 162.14 13.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.639 1.975 . . . . 0.0 109.513 179.01 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -150.93 151.3 31.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 119.294 -2.128 . . . . 0.0 110.366 -173.374 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -44.77 133.98 5.82 Favored 'General case' 0 C--N 1.327 -0.413 1 C-N-CA 134.039 4.936 . . . . 0.0 112.267 -177.341 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.35 -19.94 28.61 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 114.084 -3.62 . . . . 0.0 111.354 151.718 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -94.07 155.86 16.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 127.572 2.572 . . . . 0.0 107.518 172.361 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -76.2 163.98 26.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.801 2.44 . . . . 0.0 112.739 -178.514 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.9 mt -43.85 -43.47 6.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 130.178 3.391 . . . . 0.0 109.229 159.897 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -71.35 -37.67 71.67 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 118.701 -2.5 . . . . 0.0 114.889 -175.525 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -59.71 -36.19 76.05 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 127.139 2.176 . . . . 0.0 107.877 178.891 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.282 13.9 m-85 -97.83 11.94 35.59 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.591 1.556 . . . . 0.0 110.995 175.907 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.623 0.1 OUTLIER 67.56 25.97 8.22 Favored 'General case' 0 C--O 1.222 -0.374 1 O-C-N 115.566 -4.458 . . . . 0.0 121.512 165.016 . . . . . . . . 4 3 . 1 . 055 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -76.61 93.29 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 128.628 2.771 . . . . 0.0 104.973 174.305 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.302 8.3 mm-40 -99.4 -169.67 1.79 Allowed 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 128.089 3.368 . . . . 0.0 102.344 174.938 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.419 16.1 ptpt -43.64 122.23 2.63 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 130.808 3.643 . . . . 0.0 116.729 169.601 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 4.2 tp10 83.13 33.98 0.06 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.946 2.099 . . . . 0.0 112.493 175.198 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -96.91 138.38 34.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.125 2.97 . . . . 0.0 108.237 -176.6 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -118.26 141.19 48.77 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 173.865 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.0 158.82 16.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 116.9 -3.625 . . . . 0.0 111.718 166.171 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -135.07 136.11 41.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 175.195 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 mt -86.64 154.7 20.82 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 178.106 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 t -141.39 133.55 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 128.713 2.805 . . . . 0.0 106.525 -178.734 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt -92.09 136.21 33.36 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 123.027 2.649 . . . . 0.0 108.438 -179.637 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -93.27 113.61 25.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 103.114 -2.921 . . . . 0.0 103.114 163.924 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.8 mt -99.48 58.38 1.07 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.001 2.52 . . . . 0.0 104.961 -167.481 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.25 13.6 mmm180 -104.07 164.86 11.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.009 -1.905 . . . . 0.0 112.591 -177.134 . . . . . . . . 2 2 . 1 . 055 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.41 -136.1 6.16 Favored Glycine 0 CA--C 1.536 1.363 0 N-CA-C 104.197 -3.561 . . . . 0.0 104.197 -176.155 . . . . . . . . 1 1 . 1 . 055 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.723 0 N-CA-C 103.36 -3.896 . . . . 0.0 103.36 -175.618 . . . . . . . . 0 0 . 1 . 056 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.309 14.2 ptt? . . . . . 0 N--CA 1.471 0.579 0 CA-C-O 117.872 -1.061 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -79.3 153.25 30.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 115.739 -2.077 . . . . 0.0 111.602 163.896 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.291 31.4 pt -134.22 -177.39 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 129.292 3.037 . . . . 0.0 103.934 164.417 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -142.0 139.44 32.39 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 128.631 2.773 . . . . 0.0 104.544 170.954 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.29 109.31 25.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 131.266 3.826 . . . . 0.0 101.59 179.45 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -87.51 122.29 31.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 101.057 -3.683 . . . . 0.0 101.057 170.221 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.5 p -65.72 160.26 23.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 128.384 2.673 . . . . 0.0 111.119 161.967 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tt -44.84 -39.55 5.43 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 120.169 3.396 . . . . 0.0 120.169 172.941 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 p -90.87 -9.69 45.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.811 2.044 . . . . 0.0 111.715 -176.075 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.72 7.39 17.89 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.775 0.702 . . . . 0.0 111.675 165.847 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -76.5 130.92 38.63 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.808 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -112.87 146.76 38.35 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.625 2.37 . . . . 0.0 106.023 -174.071 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 pt -143.89 146.6 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 127.091 2.745 . . . . 0.0 105.737 173.158 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.9 m -89.14 132.59 34.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 129.702 3.201 . . . . 0.0 104.635 168.876 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 mt -108.86 153.27 23.76 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.047 1.739 . . . . 0.0 109.659 151.966 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -103.21 111.57 24.01 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 111.684 -2.507 . . . . 0.0 111.47 164.873 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.23 138.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.512 1.525 . . . . 0.0 106.89 -174.944 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -77.77 147.01 73.64 Favored Pre-proline 0 N--CA 1.446 -0.645 0 O-C-N 118.753 -2.467 . . . . 0.0 109.61 154.361 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.06 -22.35 74.43 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 N-CA-C 119.651 2.904 . . . . 0.0 119.651 -174.25 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 0.3 OUTLIER -81.18 -12.5 59.17 Favored 'General case' 0 N--CA 1.442 -0.861 1 C-N-CA 131.792 4.037 . . . . 0.0 112.226 177.889 . . . . . . . . 4 3 . 1 . 056 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.06 119.65 17.59 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 119.614 -1.929 . . . . 0.0 107.196 -172.65 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.5 p -66.3 167.83 9.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 121.524 1.965 . . . . 0.0 106.245 -167.797 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -54.18 -37.72 36.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -177.876 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -71.02 -28.66 64.57 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.182 0.992 . . . . 0.0 112.626 -174.92 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.41 -22.35 66.77 Favored 'General case' 0 N--CA 1.451 -0.416 1 CA-C-O 110.544 -4.55 . . . . 0.0 112.802 175.855 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.39 -45.32 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 131.139 3.776 . . . . 0.0 109.749 177.622 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.286 37.5 pttt -75.34 -23.65 57.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 123.904 1.811 . . . . 0.0 113.332 -178.504 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -34.2 75.3 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.159 2.584 . . . . 0.0 108.337 -179.549 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -73.58 -53.87 9.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 127.777 3.173 . . . . 0.0 107.277 176.011 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.43 65.4 mt -38.81 -54.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 125.807 2.718 . . . . 0.0 117.821 -179.675 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -65.08 -20.72 66.61 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 118.586 -2.571 . . . . 0.0 116.253 -179.385 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.256 36.0 t70 -90.37 -24.87 20.69 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 121.672 2.033 . . . . 0.0 107.517 175.492 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -97.33 -50.64 4.47 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 113.646 -3.073 . . . . 0.0 107.371 -164.17 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -129.18 12.21 6.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 115.647 -2.12 . . . . 0.0 109.929 -179.929 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.74 -3.19 86.08 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 126.674 2.083 . . . . 0.0 116.523 154.292 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -72.69 107.64 3.37 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 130.347 3.459 . . . . 0.0 106.439 177.352 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.97 160.61 36.8 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.47 2.113 . . . . 0.0 116.545 -177.711 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.317 5.6 Cg_endo -50.69 -35.34 47.12 Favored 'Trans proline' 0 N--CA 1.44 -1.668 1 C-N-CA 130.13 7.22 . . . . 0.0 114.027 167.845 . . . . . . . . 3 2 . 1 . 056 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.67 -18.98 63.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 116.185 1.921 . . . . 0.0 116.185 175.312 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -123.38 14.32 9.6 Favored 'General case' 0 N--CA 1.443 -0.791 1 O-C-N 115.598 -4.439 . . . . 0.0 110.037 -176.083 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.343 0.3 OUTLIER -101.85 126.29 48.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 118.814 -2.429 . . . . 0.0 107.364 -161.967 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -131.74 108.02 9.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 168.657 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.8 mt -93.21 126.66 38.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.002 -1.475 . . . . 0.0 108.392 179.572 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 pt -128.9 144.25 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 119.454 1.025 . . . . 0.0 113.046 -178.004 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -137.08 133.74 35.72 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 169.116 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.11 20.59 11.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 120.873 1.67 . . . . 0.0 111.488 166.681 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.49 -21.12 42.58 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.305 0.957 . . . . 0.0 112.723 -174.483 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -80.63 146.16 31.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -176.324 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -99.99 123.99 44.84 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 175.822 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mt -71.4 115.82 11.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 124.663 2.173 . . . . 0.0 109.951 -171.022 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -82.84 133.31 35.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.421 2.688 . . . . 0.0 112.767 175.317 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -41.89 143.29 0.56 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 130.893 3.677 . . . . 0.0 115.474 174.009 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.96 50.27 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 111.789 -2.459 . . . . 0.0 112.809 164.729 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -74.35 140.45 44.82 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 118.367 -2.843 . . . . 0.0 107.28 175.206 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -68.43 139.47 55.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 126.503 2.377 . . . . 0.0 109.048 160.947 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.2 mt -53.11 -30.08 34.57 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.666 1.586 . . . . 0.0 113.974 174.451 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 t -74.68 -35.82 62.78 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.911 2.085 . . . . 0.0 112.383 -176.992 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -60.35 -17.77 45.62 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 167.799 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.06 12.66 35.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 120.037 3.347 . . . . 0.0 120.037 167.434 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 73.64 21.22 2.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 124.811 2.243 . . . . 0.0 115.375 169.542 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.2 mm -78.32 135.01 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -179.517 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -112.89 170.54 8.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.008 178.347 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.3 140.4 17.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 118.469 -2.644 . . . . 0.0 111.246 169.364 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.494 0.6 OUTLIER 68.89 1.29 3.07 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 117.122 2.268 . . . . 0.0 117.122 163.708 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -54.98 146.04 18.8 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 118.853 2.908 . . . . 0.0 118.853 169.048 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.5 m -102.24 105.66 16.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -179.547 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.69 162.19 13.16 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.121 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -113.24 132.87 55.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 127.542 3.026 . . . . 0.0 109.116 -178.383 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -105.59 110.97 23.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 129.044 2.938 . . . . 0.0 104.979 169.716 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.38 118.82 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 O-C-N 118.74 -2.475 . . . . 0.0 104.744 172.6 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.7 mt -67.12 99.08 0.64 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.629 2.772 . . . . 0.0 110.861 163.728 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -75.24 -16.12 60.49 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.823 2.849 . . . . 0.0 110.917 -157.221 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.366 0.0 OUTLIER -138.38 174.14 10.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 119.986 -1.696 . . . . 0.0 113.051 153.584 . . . . . . . . 3 3 . 1 . 056 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.506 23.1 ttt180 -139.67 -69.32 0.41 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 126.477 3.037 . . . . 0.0 114.262 -178.054 . . . . . . . . 2 2 . 1 . 056 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.82 148.17 8.84 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 109.12 -3.673 . . . . 0.0 108.29 -165.207 . . . . . . . . 1 1 . 1 . 056 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.295 0 O-C-N 117.742 -3.211 . . . . 0.0 120.088 178.799 . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 057 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -102.1 141.29 35.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.775 2.43 . . . . 0.0 111.343 176.26 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 pt -133.38 144.62 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 110.964 -2.834 . . . . 0.0 108.305 164.506 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -93.84 141.03 28.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 173.556 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.1 t -120.99 122.66 68.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 123.067 2.667 . . . . 0.0 105.039 170.165 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -89.17 124.49 34.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 122.146 2.248 . . . . 0.0 106.941 176.891 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.328 82.7 p -99.59 -166.84 1.39 Allowed 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 118.201 -2.812 . . . . 0.0 114.715 -172.855 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.457 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 7.5 mp -43.27 -33.62 1.01 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 119.695 3.22 . . . . 0.0 119.695 -177.745 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -110.26 -4.82 15.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.175 2.19 . . . . 0.0 112.493 -178.549 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.34 -1.72 67.28 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 179.585 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.59 127.44 31.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 129.305 3.042 . . . . 0.0 104.616 173.352 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -90.76 131.91 36.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.943 1.402 . . . . 0.0 108.236 -179.841 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.1 pt -117.49 136.07 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 123.739 1.733 . . . . 0.0 107.038 170.302 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.9 m -88.81 112.02 22.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 113.07 -3.348 . . . . 0.0 111.376 179.895 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.03 129.27 49.76 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 101.725 -3.435 . . . . 0.0 101.725 -175.987 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -82.93 133.68 35.1 Favored 'General case' 0 C--O 1.222 -0.361 1 C-N-CA 132.324 4.25 . . . . 0.0 103.925 164.262 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.91 169.06 8.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 109.832 -3.349 . . . . 0.0 108.687 -176.739 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -128.27 157.65 73.78 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.858 169.401 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -69.45 -6.73 19.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 125.115 3.876 . . . . 0.0 114.953 -174.629 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.7 p -86.31 -13.41 46.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 129.006 2.922 . . . . 0.0 112.804 167.223 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -69.29 131.72 45.31 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 122.419 2.372 . . . . 0.0 115.069 -179.149 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 p -91.36 169.2 11.0 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.066 1.746 . . . . 0.0 113.285 172.003 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.2 -17.78 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.733 178.531 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -62.75 -47.08 85.09 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 118.146 -2.846 . . . . 0.0 112.756 160.91 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -70.03 -26.12 63.89 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.786 -178.459 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -90.49 -33.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 113.02 -3.372 . . . . 0.0 107.399 -172.656 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -43.0 -44.55 4.72 Favored 'General case' 0 C--N 1.322 -0.629 1 C-N-CA 132.681 4.392 . . . . 0.0 112.841 167.795 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.08 -17.39 55.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 114.788 -2.529 . . . . 0.0 115.727 178.295 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -90.64 -22.47 21.18 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 121.54 1.973 . . . . 0.0 107.554 172.27 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.7 mt -67.21 -37.96 80.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.432 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -42.8 61.08 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.581 2.752 . . . . 0.0 114.509 169.746 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.61 -55.24 25.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 163.982 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -80.77 -17.91 49.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -170.643 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.427 25.7 tp10 -135.62 -8.7 2.17 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 121.61 3.93 . . . . 0.0 121.61 171.361 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.69 7.68 68.56 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 116.496 -3.877 . . . . 0.0 117.208 173.842 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mm -91.37 123.45 63.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 C-N-CA 130.051 3.34 . . . . 0.0 106.524 -170.985 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.324 72.9 Cg_endo -67.32 154.0 75.32 Favored 'Trans proline' 0 N--CA 1.454 -0.852 1 C-N-CA 128.095 5.863 . . . . 0.0 109.725 170.663 . . . . . . . . 3 2 . 1 . 057 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.18 -22.59 53.78 Favored 'Trans proline' 0 N--CA 1.448 -1.192 1 C-N-CA 125.313 4.009 . . . . 0.0 115.833 -164.046 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.02 -8.0 52.61 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 124.405 1.066 . . . . 0.0 110.317 -164.061 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -110.41 -9.85 14.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 118.128 -2.858 . . . . 0.0 113.573 -172.33 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.263 73.4 mt-30 -88.17 121.75 30.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.829 1.652 . . . . 0.0 106.869 -172.222 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -102.59 100.21 10.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 112.632 -2.076 . . . . 0.0 108.594 170.395 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.6 mt -90.63 126.31 35.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 119.589 -1.944 . . . . 0.0 111.842 177.443 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.1 mt -132.35 139.7 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.217 2.207 . . . . 0.0 110.853 -168.382 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -162.65 112.8 1.45 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 129.316 3.046 . . . . 0.0 112.39 -174.242 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.09 36.19 14.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 128.426 3.965 . . . . 0.0 118.496 177.292 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.08 -10.12 43.6 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 108.508 -3.951 . . . . 0.0 109.638 167.233 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -92.41 120.06 32.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 130.351 3.46 . . . . 0.0 111.448 -178.749 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -79.16 119.27 22.02 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.997 2.519 . . . . 0.0 109.055 165.028 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -79.01 129.18 34.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -158.86 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -82.77 153.44 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -172.425 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -80.47 126.57 31.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.475 170.982 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.35 -3.97 18.07 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-O 115.722 -2.71 . . . . 0.0 110.433 -172.507 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -103.14 155.85 18.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 120.652 2.226 . . . . 0.0 108.547 -167.931 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.2 p -95.98 141.43 29.4 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.61 2.364 . . . . 0.0 109.346 168.017 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.4 mt -51.23 -38.56 53.19 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 129.919 3.288 . . . . 0.0 111.696 -178.567 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -74.83 -20.44 59.76 Favored 'General case' 0 C--O 1.217 -0.624 0 O-C-N 120.103 -1.623 . . . . 0.0 111.573 -176.666 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -79.8 -25.47 40.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.371 2.268 . . . . 0.0 110.001 -178.463 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -85.86 -17.67 34.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 123.204 1.478 . . . . 0.0 114.895 166.453 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 83.17 48.45 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.867 1.667 . . . . 0.0 111.112 173.923 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.9 mt -107.18 102.97 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 1 N-CA-C 99.844 -4.132 . . . . 0.0 99.844 -174.943 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.94 154.39 24.57 Favored 'General case' 0 CA--C 1.54 0.592 1 O-C-N 130.168 4.667 . . . . 0.0 113.28 167.136 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.397 0.0 OUTLIER -38.15 133.36 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 130.896 3.678 . . . . 0.0 118.069 170.438 . . . . . . . . 3 3 . 1 . 057 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.449 15.0 mt-10 80.58 1.49 1.86 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 125.331 3.696 . . . . 0.0 112.381 -179.866 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.2 m -67.81 145.42 54.68 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 126.284 2.24 . . . . 0.0 112.385 172.428 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -108.51 114.83 28.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 101.673 -3.454 . . . . 0.0 101.673 179.132 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -98.56 155.14 17.43 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.435 1.494 . . . . 0.0 108.009 177.136 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -105.83 146.57 29.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 114.817 -2.516 . . . . 0.0 108.467 178.767 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -125.81 134.73 51.59 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.011 1.725 . . . . 0.0 108.745 177.065 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -129.59 164.46 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 1 C-N-CA 132.445 4.298 . . . . 0.0 105.642 179.719 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.84 126.43 50.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 114.271 -2.776 . . . . 0.0 105.85 -171.35 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -142.53 121.86 13.12 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 128.793 3.808 . . . . 0.0 108.415 165.532 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -79.11 124.06 27.95 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 133.498 4.719 . . . . 0.0 106.793 167.916 . . . . . . . . 2 2 . 1 . 057 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -154.99 100.81 2.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 102.059 -3.311 . . . . 0.0 102.059 171.756 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.99 116.07 1.68 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 128.565 2.983 . . . . 0.0 110.37 178.732 . . . . . . . . 1 1 . 1 . 057 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 116.129 -2.484 . . . . 0.0 117.924 162.978 . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptt? . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 . . . . . . . . . 0 0 . 1 . 058 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -104.12 137.03 42.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 118.553 -2.592 . . . . 0.0 106.825 177.2 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.2 pt -132.41 155.11 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 129.898 3.279 . . . . 0.0 105.908 174.709 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -118.77 143.89 46.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.296 2.238 . . . . 0.0 111.737 176.8 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -126.94 115.83 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 112.069 -3.824 . . . . 0.0 108.64 178.529 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -90.78 120.91 32.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 113.596 -3.097 . . . . 0.0 114.031 175.704 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.8 p -80.99 160.91 24.46 Favored 'General case' 0 N--CA 1.448 -0.552 1 O-C-N 129.15 4.031 . . . . 0.0 112.815 164.039 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -45.21 93.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 -172.53 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.261 55.7 p -59.49 -17.18 29.45 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 166.931 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.07 -0.99 6.68 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.291 1.9 . . . . 0.0 108.88 154.048 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -74.58 141.67 44.72 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 119.272 -2.311 . . . . 0.0 111.31 -167.727 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.9 m -120.11 121.63 39.26 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 125.343 1.652 . . . . 0.0 111.019 -166.437 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.65 156.63 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 114.847 -2.502 . . . . 0.0 108.284 175.055 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.388 6.6 t -126.17 124.99 41.73 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 127.47 2.981 . . . . 0.0 111.095 174.693 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.84 150.11 43.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 124.441 2.067 . . . . 0.0 106.269 -171.676 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -106.82 110.98 23.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.012 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.9 136.69 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 109.16 -3.655 . . . . 0.0 109.902 -173.114 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -95.38 139.35 21.95 Favored Pre-proline 0 N--CA 1.445 -0.714 0 CA-C-O 113.78 -3.009 . . . . 0.0 106.323 169.844 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.258 23.5 Cg_exo -53.75 -29.93 54.34 Favored 'Trans proline' 0 N--CA 1.454 -0.837 1 C-N-CA 125.63 4.22 . . . . 0.0 115.103 -173.325 . . . . . . . . 3 2 . 1 . 058 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -78.94 -4.05 47.92 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 123.314 2.779 . . . . 0.0 112.627 177.873 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.61 147.13 39.82 Favored 'General case' 0 C--N 1.328 -0.354 1 O-C-N 114.749 -4.97 . . . . 0.0 110.999 -175.585 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -92.03 162.17 14.48 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.346 1.058 . . . . 0.0 108.635 -171.195 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 mm -56.52 -26.72 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 O-C-N 126.684 2.49 . . . . 0.0 113.821 -174.589 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.367 9.4 pt-20 -65.32 -34.76 79.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.375 2.67 . . . . 0.0 114.463 172.663 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -77.95 -29.49 49.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 125.545 2.593 . . . . 0.0 108.866 -176.271 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.357 31.2 m -82.47 -35.11 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 O-C-N 116.738 -3.727 . . . . 0.0 106.934 178.622 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -55.26 -46.19 76.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 116.548 -3.845 . . . . 0.0 114.0 170.816 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.281 . . -77.27 -18.77 57.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 126.382 2.991 . . . . 0.0 114.279 -174.62 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -82.35 -43.62 17.2 Favored 'General case' 0 C--N 1.322 -0.625 1 O-C-N 116.11 -4.119 . . . . 0.0 107.257 -179.476 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.423 12.1 mt -45.51 -46.78 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 128.076 2.55 . . . . 0.0 113.205 160.389 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -59.69 -50.23 74.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 117.901 -2.999 . . . . 0.0 116.794 172.71 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.452 34.7 t70 -53.08 -33.03 50.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.706 2.802 . . . . 0.0 110.721 178.099 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -80.74 -65.71 0.98 Allowed 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 113.204 -3.284 . . . . 0.0 113.621 172.707 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -97.45 -27.15 14.58 Favored 'General case' 0 N--CA 1.445 -0.724 1 O-C-N 129.645 4.34 . . . . 0.0 118.965 -165.757 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.24 7.65 59.31 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 128.531 2.967 . . . . 0.0 114.962 -179.539 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 mm -82.1 122.35 79.56 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 116.999 -3.647 . . . . 0.0 110.474 -174.394 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -70.88 120.9 7.41 Favored 'Trans proline' 0 N--CA 1.443 -1.494 1 C-N-CA 128.6 6.2 . . . . 0.0 113.346 -174.95 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.278 77.5 Cg_exo -34.49 -46.79 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.688 1 C-N-CA 128.468 6.112 . . . . 0.0 116.037 -169.545 . . . . . . . . 3 2 . 1 . 058 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.289 0.5 OUTLIER -55.63 -42.59 75.16 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 116.306 -3.996 . . . . 0.0 116.258 178.609 . . . . . . . . 3 3 . 1 . 058 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -79.45 -2.88 43.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.233 0.613 . . . . 0.0 112.63 -177.196 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -85.97 141.71 29.33 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 116.662 -3.774 . . . . 0.0 108.852 173.427 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -145.29 104.6 3.95 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 111.18 -2.736 . . . . 0.0 106.071 -172.375 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -96.43 112.37 24.14 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 119.31 -2.119 . . . . 0.0 107.561 -173.373 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mt -85.47 141.9 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.011 -1.681 . . . . 0.0 110.82 168.905 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -147.1 119.01 8.12 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 102.253 -3.24 . . . . 0.0 102.253 164.035 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.2 22.43 11.0 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 120.957 3.688 . . . . 0.0 120.957 164.056 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.41 -22.7 38.8 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 127.414 2.435 . . . . 0.0 112.581 -175.065 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -97.1 147.26 24.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 118.189 -2.948 . . . . 0.0 107.866 -177.559 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.38 133.32 35.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 126.762 2.539 . . . . 0.0 104.216 163.674 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -70.11 109.9 4.85 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 118.189 -2.819 . . . . 0.0 114.801 168.862 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -74.02 147.23 43.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.297 2.639 . . . . 0.0 112.234 -176.754 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -81.26 147.96 29.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 126.8 2.562 . . . . 0.0 104.585 -166.23 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.46 -36.79 3.94 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 116.739 -2.145 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -76.26 169.99 17.18 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 127.057 3.313 . . . . 0.0 107.939 -174.849 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -103.25 174.75 5.73 Favored 'General case' 0 N--CA 1.452 -0.349 2 O-C-N 112.911 -6.118 . . . . 0.0 113.141 163.003 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.36 -29.04 41.98 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.865 1.666 . . . . 0.0 110.273 -177.336 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -71.13 -32.6 69.18 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 117.526 -1.226 . . . . 0.0 110.009 -177.579 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.09 -22.79 55.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 115.364 -2.255 . . . . 0.0 110.537 174.85 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -86.9 0.32 55.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.056 171.974 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t30 28.62 61.95 0.12 Allowed 'General case' 0 N--CA 1.445 -0.723 1 C-N-CA 138.845 6.858 . . . . 0.0 112.253 175.114 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.8 mt -98.55 -34.96 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 128.348 2.659 . . . . 0.0 105.433 -170.707 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.463 13.1 mm-40 82.12 -158.77 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.531 1.133 . . . . 0.0 112.608 178.109 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -81.65 158.33 24.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.311 3.045 . . . . 0.0 115.14 -176.077 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.309 4.1 tt0 66.52 11.75 8.28 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 128.634 2.774 . . . . 0.0 118.457 161.254 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -105.23 144.47 31.97 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 116.979 -1.486 . . . . 0.0 112.155 -162.515 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -103.41 106.72 17.3 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 122.228 2.286 . . . . 0.0 108.229 -166.726 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -75.64 153.68 37.08 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.264 164.864 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -117.3 95.05 4.8 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 129.102 2.961 . . . . 0.0 107.707 -172.096 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -63.85 118.16 7.97 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.253 2.221 . . . . 0.0 106.918 166.645 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -125.66 150.9 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 167.21 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mp -100.61 160.81 14.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 117.017 -1.468 . . . . 0.0 110.871 -172.051 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -110.1 104.73 13.64 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.584 1.177 . . . . 0.0 113.941 169.086 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -94.9 122.27 37.36 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.207 -3.257 . . . . 0.0 102.207 -178.349 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.443 51.0 mtp180 89.79 -84.28 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 125.071 2.367 . . . . 0.0 109.062 164.635 . . . . . . . . 2 2 . 1 . 058 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.1 -29.26 0.74 Allowed Glycine 0 CA--C 1.533 1.21 0 CA-C-O 116.847 -2.085 . . . . 0.0 116.091 -178.034 . . . . . . . . 1 1 . 1 . 058 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 N-CA-C 107.846 -2.101 . . . . 0.0 107.846 -169.244 . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttp . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 . . . . . . . . . 0 0 . 1 . 059 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -96.18 142.17 28.68 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.854 2.462 . . . . 0.0 108.598 -174.744 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.5 pt -130.82 177.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 128.748 2.819 . . . . 0.0 111.32 161.944 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -100.71 144.68 29.39 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.253 1.421 . . . . 0.0 109.618 163.177 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.9 t -116.76 150.47 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 121.765 2.075 . . . . 0.0 105.494 158.791 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -137.85 145.87 42.77 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 128.476 2.71 . . . . 0.0 111.438 -178.363 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -106.85 163.84 12.62 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 126.797 2.561 . . . . 0.0 112.197 173.183 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.55 -33.77 75.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 122.071 2.214 . . . . 0.0 110.964 171.351 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -75.2 -17.09 60.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 121.721 2.055 . . . . 0.0 111.553 167.153 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.68 36.45 6.46 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 118.145 2.018 . . . . 0.0 118.145 156.129 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -77.54 116.65 18.27 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 117.604 -3.292 . . . . 0.0 104.116 158.93 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.257 12.8 m -93.93 157.86 15.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 114.548 -2.644 . . . . 0.0 111.298 167.939 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -154.68 152.66 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 126.076 2.11 . . . . 0.0 113.34 177.508 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.9 m -83.28 131.47 35.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 130.581 3.552 . . . . 0.0 107.113 166.033 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.86 121.53 21.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 119.065 -2.272 . . . . 0.0 110.309 -177.362 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.348 3.5 tt0 -99.35 128.8 45.5 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 -172.06 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.2 t -140.82 137.09 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 114.138 -2.839 . . . . 0.0 107.414 -171.446 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -90.32 138.47 27.11 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 126.745 2.528 . . . . 0.0 106.383 171.644 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.264 94.2 Cg_exo -45.09 -23.1 0.91 Allowed 'Trans proline' 0 N--CA 1.439 -1.703 1 C-N-CA 126.001 4.467 . . . . 0.0 120.906 167.303 . . . . . . . . 3 2 . 1 . 059 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 15.2 m -77.52 -13.84 59.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.77 1.628 . . . . 0.0 111.413 176.324 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.2 130.89 34.94 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 120.763 1.619 . . . . 0.0 107.82 179.265 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -69.73 174.73 4.81 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.94 162.369 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.25 24.7 mt -61.42 -44.76 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 128.426 2.69 . . . . 0.0 109.62 169.731 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.81 -38.33 64.45 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 128.858 2.863 . . . . 0.0 110.212 175.997 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -73.15 -34.6 66.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 116.422 -1.751 . . . . 0.0 113.276 177.165 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 57.9 t -62.29 -37.42 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 125.185 3.63 . . . . 0.0 108.79 168.683 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -66.1 -40.61 90.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.507 1.754 . . . . 0.0 115.158 171.41 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.4 87.53 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.554 1.942 . . . . 0.0 112.88 171.251 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 48.9 mttp -67.81 -41.49 83.04 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 123.628 1.68 . . . . 0.0 111.041 173.567 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.273 94.2 mt -55.55 -58.07 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 1 O-C-N 115.622 -4.424 . . . . 0.0 110.141 168.526 . . . . . . . . 3 2 . 1 . 059 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -45.37 -37.61 5.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 165.278 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.13 -45.14 42.92 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.727 2.011 . . . . 0.0 113.786 177.504 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 mmtm -107.51 -35.03 6.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -166.214 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.3 -30.56 18.36 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.868 2.867 . . . . 0.0 110.411 179.495 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.13 52.73 6.6 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 125.885 1.707 . . . . 0.0 111.479 174.012 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.62 145.43 33.86 Favored Pre-proline 0 N--CA 1.447 -0.595 0 C-N-CA 129.913 3.285 . . . . 0.0 112.31 -178.782 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.09 128.29 12.1 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 124.92 3.747 . . . . 0.0 116.788 162.572 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -75.33 -46.9 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.791 3.661 . . . . 0.0 108.734 -165.522 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.261 23.6 t70 -34.25 -33.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.452 1 C-N-CA 132.391 4.276 . . . . 0.0 119.518 -176.256 . . . . . . . . 3 2 . 1 . 059 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -85.89 -22.27 27.59 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.028 1.731 . . . . 0.0 114.26 175.418 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -98.82 145.79 26.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -160.627 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -118.16 154.39 32.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 118.244 -2.785 . . . . 0.0 110.296 172.625 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mp -108.29 135.45 49.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 167.056 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.1 mm -122.41 129.41 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 128.304 2.641 . . . . 0.0 106.51 175.457 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.539 ' CE1' HG12 ' A' ' 61' ' ' ILE . 44.6 t80 -138.44 131.3 29.57 Favored 'General case' 0 C--O 1.221 -0.421 1 C-N-CA 132.371 4.268 . . . . 0.0 108.057 172.365 . . . . . . . . 3 3 . 1 . 059 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.78 31.96 21.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 130.115 3.366 . . . . 0.0 115.404 -166.895 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.79 15.0 81.01 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 128.419 2.914 . . . . 0.0 111.413 179.204 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -144.37 156.66 44.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 124.112 3.956 . . . . 0.0 113.565 -171.496 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.83 120.35 20.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 126.077 2.846 . . . . 0.0 104.369 -173.345 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.45 66.9 mt -86.05 157.2 20.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 111.366 -2.652 . . . . 0.0 108.769 -178.6 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -91.79 132.99 36.02 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.274 -1.517 . . . . 0.0 107.653 -168.899 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.01 114.57 14.8 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.738 -1.226 . . . . 0.0 109.926 -166.961 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.83 -6.75 11.15 Favored Glycine 0 CA--C 1.522 0.483 0 O-C-N 117.968 -2.958 . . . . 0.0 110.47 -173.733 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -79.21 161.42 26.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 124.509 2.1 . . . . 0.0 112.31 174.67 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.4 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 17.3 p -91.25 176.87 6.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 114.012 -2.899 . . . . 0.0 112.747 167.472 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.3 tp -75.05 -28.88 60.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.613 2.365 . . . . 0.0 111.542 -173.743 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -80.11 -23.84 40.95 Favored 'General case' 0 N--CA 1.449 -0.501 1 O-C-N 115.822 -4.299 . . . . 0.0 117.138 174.2 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 70.0 m-20 -67.44 -26.07 66.22 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 172.221 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -93.76 -9.22 38.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.72 2.008 . . . . 0.0 112.647 159.185 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 p30 50.99 51.7 16.53 Favored 'General case' 0 N--CA 1.45 -0.468 1 C-N-CA 131.82 4.048 . . . . 0.0 112.019 -177.997 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.539 HG12 ' CE1' ' A' ' 45' ' ' PHE . 21.5 mt -71.25 110.43 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 127.912 2.485 . . . . 0.0 109.675 162.067 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -96.34 174.41 6.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.866 -1.97 . . . . 0.0 107.981 -171.744 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -37.46 137.97 0.37 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 120.077 3.362 . . . . 0.0 120.077 162.825 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 9.4 tt0 57.25 35.01 25.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.908 3.283 . . . . 0.0 114.461 179.755 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -91.07 158.96 16.37 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.451 1.5 . . . . 0.0 111.31 174.595 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.6 m -112.35 115.63 29.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 123.036 1.398 . . . . 0.0 110.026 171.991 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 tp -89.43 141.32 28.67 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 127.152 3.358 . . . . 0.0 102.848 162.187 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -108.1 136.56 47.58 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 -177.819 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.292 13.7 tp -115.17 95.3 5.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.206 -172.997 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.13 110.22 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 126.81 2.044 . . . . 0.0 108.203 171.171 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.299 2.9 mm? -93.33 155.42 17.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 121.108 1.776 . . . . 0.0 109.237 179.327 . . . . . . . . 2 2 . 1 . 059 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -145.94 114.18 6.64 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 103.139 -2.911 . . . . 0.0 103.139 165.416 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -122.33 127.48 49.85 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.937 2.095 . . . . 0.0 110.114 -171.984 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.8 ttp-105 -94.0 -45.67 7.49 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 116.628 -3.795 . . . . 0.0 104.856 178.0 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.06 170.47 26.17 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 122.435 2.379 . . . . 0.0 108.939 173.818 . . . . . . . . 1 1 . 1 . 059 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 C-N-CA 126.418 1.961 . . . . 0.0 110.145 173.463 . . . . . . . . 0 0 . 1 . 060 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -82.52 146.45 29.21 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.003 2.121 . . . . 0.0 107.154 -174.812 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -142.23 161.7 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 121.798 2.09 . . . . 0.0 108.702 166.553 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -100.85 144.1 30.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.981 1.426 . . . . 0.0 113.757 162.305 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.9 t -110.19 115.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 159.091 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -89.32 137.04 32.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 155.358 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -86.9 146.66 26.09 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 165.089 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.19 4.7 0.12 Allowed 'General case' 0 N--CA 1.445 -0.68 1 C-N-CA 132.463 4.305 . . . . 0.0 112.936 165.814 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -106.46 12.1 30.02 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 119.373 -2.079 . . . . 0.0 113.693 171.489 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.4 -20.19 35.42 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 115.645 -2.753 . . . . 0.0 116.281 169.118 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.315 74.9 tttt -101.0 130.59 47.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 126.635 3.112 . . . . 0.0 105.373 -166.203 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 m -107.91 125.25 51.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 124.717 2.198 . . . . 0.0 108.932 177.781 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.8 mt -110.31 120.75 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 -172.288 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 m -97.19 131.3 44.07 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 118.027 -2.92 . . . . 0.0 106.932 -178.682 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.29 154.06 35.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.965 2.906 . . . . 0.0 111.501 -176.412 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -109.4 137.85 46.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 123.424 1.583 . . . . 0.0 108.148 161.944 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.325 21.0 m -128.02 149.78 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 119.946 3.313 . . . . 0.0 119.946 -178.582 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -85.26 156.54 59.85 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 128.069 2.548 . . . . 0.0 105.807 172.785 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.356 60.0 Cg_endo -70.19 -33.94 14.05 Favored 'Trans proline' 0 N--CA 1.447 -1.207 2 C-N-CA 129.276 6.65 . . . . 0.0 114.165 -179.915 . . . . . . . . 3 2 . 1 . 060 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.6 m -115.73 17.44 16.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 118.674 -2.516 . . . . 0.0 104.311 -167.935 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -84.01 161.27 20.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 125.322 2.487 . . . . 0.0 109.336 178.923 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.41 49.8 p -93.6 147.86 22.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 -163.146 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.305 12.4 mm -44.44 -43.92 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 121.569 3.914 . . . . 0.0 121.569 165.478 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 pm0 -79.69 -15.95 56.6 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 113.434 -3.175 . . . . 0.0 108.571 -174.239 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -74.45 -33.15 62.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 122.412 2.369 . . . . 0.0 106.921 172.299 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG21 ' H ' ' A' ' 26' ' ' VAL . 39.2 t -49.97 -48.4 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 124.378 3.263 . . . . 0.0 114.373 167.77 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -64.5 -37.35 87.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 114.704 -2.57 . . . . 0.0 111.906 -176.519 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.06 70.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 128.082 2.553 . . . . 0.0 111.358 171.502 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -80.75 -25.69 37.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.677 -1.89 . . . . 0.0 110.497 -176.65 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.264 30.3 mm -65.94 -45.49 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 116.351 -1.785 . . . . 0.0 106.832 169.858 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -62.3 -50.52 71.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 121.504 1.956 . . . . 0.0 114.89 -179.713 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -39.74 -39.66 0.82 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.299 2.24 . . . . 0.0 114.549 172.934 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.2 tttt -98.04 -41.48 7.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 117.845 -3.034 . . . . 0.0 108.006 177.34 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -113.05 -23.03 10.26 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 124.463 3.302 . . . . 0.0 111.869 -149.639 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.96 -1.63 85.12 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-O 116.799 -2.112 . . . . 0.0 116.603 174.709 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.0 mm -78.99 118.92 75.21 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 121.8 2.8 . . . . 0.0 104.303 176.342 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.69 165.35 16.12 Favored 'Trans proline' 0 N--CA 1.45 -1.053 1 C-N-CA 126.543 4.829 . . . . 0.0 113.934 179.106 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.53 -27.27 39.47 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.608 2.205 . . . . 0.0 115.246 178.53 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -69.77 1.4 4.35 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 117.466 -3.271 . . . . 0.0 111.57 -178.634 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -121.04 -14.91 8.34 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 128.598 2.759 . . . . 0.0 109.214 -169.989 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -106.47 114.07 27.96 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 128.575 3.672 . . . . 0.0 106.825 -172.198 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -108.87 141.23 41.23 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.661 2.785 . . . . 0.0 108.17 161.248 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.28 1.5 mp -116.08 139.97 49.75 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -177.51 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 mt -112.24 151.57 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 O-C-N 127.23 2.831 . . . . 0.0 103.63 169.54 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -128.16 124.41 36.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 161.451 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.326 . . 58.57 -81.88 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 128.796 2.838 . . . . 0.0 115.467 -172.743 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.63 1.34 4.35 Favored Glycine 0 CA--C 1.533 1.176 2 O-C-N 130.294 4.747 . . . . 0.0 112.534 171.565 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -122.37 151.33 41.31 Favored 'General case' 0 C--N 1.322 -0.606 1 CA-C-N 125.352 4.576 . . . . 0.0 106.643 -169.542 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 22.8 mt-30 -72.56 138.35 46.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.533 -174.601 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 82.3 mt -95.98 120.91 37.1 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 117.079 -1.848 . . . . 0.0 112.695 171.059 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -92.63 154.02 18.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -176.446 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.87 154.9 29.38 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 131.576 3.95 . . . . 0.0 110.625 178.976 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.89 0.34 83.63 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 122.773 1.207 . . . . 0.0 115.505 171.786 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -124.75 145.85 49.5 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 131.403 3.881 . . . . 0.0 105.731 -167.006 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.41 30.5 p -79.94 159.47 26.31 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 112.225 -2.261 . . . . 0.0 115.389 -171.745 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -51.9 14.13 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 126.672 2.483 . . . . 0.0 109.919 -172.104 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -78.0 -0.37 27.56 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.431 2.692 . . . . 0.0 106.41 -168.347 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.4 -31.01 70.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 124.639 2.161 . . . . 0.0 107.127 175.576 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.353 8.3 m-85 -107.84 -179.44 3.9 Favored 'General case' 0 N--CA 1.449 -0.505 1 O-C-N 115.998 -4.189 . . . . 0.0 107.87 175.572 . . . . . . . . 3 2 . 1 . 060 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -92.9 45.68 1.19 Allowed 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 118.179 -2.826 . . . . 0.0 116.137 175.633 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.07 138.85 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 117.753 -1.117 . . . . 0.0 108.88 166.428 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -154.12 -178.46 7.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.541 1.937 . . . . 0.0 109.779 -164.438 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -50.3 115.57 1.5 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.177 1.791 . . . . 0.0 109.301 171.478 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 55.78 33.57 21.71 Favored 'General case' 0 N--CA 1.452 -0.337 1 C-N-CA 133.619 4.768 . . . . 0.0 113.491 -178.064 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 138.8 56.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.313 1.845 . . . . 0.0 108.812 158.046 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.4 m -103.93 136.61 43.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.628 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -107.97 139.54 42.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 130.251 3.42 . . . . 0.0 116.771 156.202 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -97.34 124.26 41.43 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 113.219 -3.277 . . . . 0.0 107.145 -175.552 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.7 tp -93.87 124.14 37.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 128.242 3.464 . . . . 0.0 109.664 -179.248 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.2 116.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 130.194 3.398 . . . . 0.0 106.26 -177.563 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 87.4 mt -95.78 -12.21 25.7 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 126.116 2.135 . . . . 0.0 111.736 -166.854 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.296 6.6 tmm_? 95.66 -21.57 0.05 Allowed 'General case' 0 N--CA 1.454 -0.263 1 C-N-CA 134.554 5.141 . . . . 0.0 114.025 -173.287 . . . . . . . . 3 2 . 1 . 060 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.45 120.2 38.75 Favored 'General case' 0 N--CA 1.448 -0.55 1 CA-C-O 129.537 4.494 . . . . 0.0 110.113 179.677 . . . . . . . . 2 2 . 1 . 060 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -154.25 161.33 41.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 101.518 -3.512 . . . . 0.0 101.518 160.208 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.82 35.22 4.28 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 120.324 1.42 . . . . 0.0 114.031 -177.862 . . . . . . . . 1 1 . 1 . 060 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.412 0 CA-C-O 115.663 -2.743 . . . . 0.0 111.669 -168.379 . . . . . . . . 0 0 . 1 . 061 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.625 0 CA-C-O 117.73 -1.128 . . . . 0.0 109.155 . . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -88.65 125.72 34.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.19 2.196 . . . . 0.0 113.676 -179.494 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -109.76 164.12 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 124.13 3.15 . . . . 0.0 111.054 177.984 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -117.83 145.56 44.49 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 117.53 -3.231 . . . . 0.0 110.07 170.66 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.3 t -122.18 127.51 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 174.055 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -73.78 111.76 9.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 111.671 -2.513 . . . . 0.0 106.422 168.896 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 m -108.61 126.97 53.54 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -178.755 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.661 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -55.14 -6.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 1 N-CA-C 122.133 4.123 . . . . 0.0 122.133 178.124 . . . . . . . . 4 4 . 1 . 061 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -83.01 3.35 30.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 123.878 0.736 . . . . 0.0 109.589 175.9 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.62 21.81 30.49 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 123.705 1.725 . . . . 0.0 114.793 -178.704 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -123.78 135.56 53.88 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 116.645 -1.645 . . . . 0.0 109.102 -162.665 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.9 m -114.79 85.09 2.18 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.981 1.848 . . . . 0.0 111.32 177.695 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.6 pt -77.11 161.63 4.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 O-C-N 119.1 -2.25 . . . . 0.0 106.812 -167.031 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -128.5 136.41 50.76 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 125.308 1.63 . . . . 0.0 109.774 178.582 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.331 0.3 OUTLIER -141.04 146.84 37.73 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 129.866 3.266 . . . . 0.0 114.036 -179.778 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -92.6 120.03 32.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 129.464 3.106 . . . . 0.0 105.599 -171.05 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 16.0 m -127.37 162.85 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 116.364 -3.96 . . . . 0.0 109.732 177.756 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.61 159.96 69.53 Favored Pre-proline 0 N--CA 1.451 -0.414 1 O-C-N 115.485 -4.509 . . . . 0.0 107.053 164.882 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -53.48 -46.84 30.85 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 N-CA-C 118.595 2.498 . . . . 0.0 118.595 -167.172 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.1 m -79.0 5.55 11.44 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 128.653 2.781 . . . . 0.0 112.56 -169.051 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.266 89.9 m-20 -77.66 140.61 39.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.73 -1.231 . . . . 0.0 109.494 176.658 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -86.0 146.62 26.59 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 129.08 3.988 . . . . 0.0 107.605 -179.522 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.77 -23.9 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 128.646 2.779 . . . . 0.0 111.762 -175.544 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -61.82 -38.83 89.64 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.974 2.91 . . . . 0.0 111.452 166.963 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.13 -35.61 78.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 125.756 2.693 . . . . 0.0 113.421 179.81 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -82.7 -37.71 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 112.44 -2.164 . . . . 0.0 109.3 176.425 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.363 61.8 mttt -48.72 -50.27 34.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.031 2.933 . . . . 0.0 111.665 168.143 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.3 56.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 116.056 -1.926 . . . . 0.0 109.928 -173.292 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -63.58 -45.2 91.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 122.474 2.397 . . . . 0.0 116.89 165.955 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -55.51 -40.54 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 114.822 -2.513 . . . . 0.0 110.223 167.713 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -61.5 -42.12 98.32 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 113.535 -3.126 . . . . 0.0 112.906 171.302 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.444 29.9 t70 -57.08 -27.83 62.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 122.627 2.467 . . . . 0.0 116.292 173.124 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -94.58 -55.7 3.05 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 126.485 2.366 . . . . 0.0 111.039 -174.298 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -117.31 -21.34 8.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.465 1.506 . . . . 0.0 113.835 -165.087 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.63 12.03 45.51 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 115.67 -2.739 . . . . 0.0 111.668 168.296 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.3 mt -82.95 132.24 51.59 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 118.87 1.335 . . . . 0.0 112.608 171.434 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.21 121.79 8.61 Favored 'Trans proline' 0 N--CA 1.456 -0.692 1 C-N-CA 129.153 6.569 . . . . 0.0 113.758 178.222 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.297 32.3 Cg_exo -40.78 -35.23 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 1 C-N-CA 126.296 4.664 . . . . 0.0 117.43 170.908 . . . . . . . . 3 2 . 1 . 061 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.75 -35.09 78.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 -175.871 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -77.62 -42.11 36.11 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 130.48 3.512 . . . . 0.0 115.387 170.049 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.27 146.97 53.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.612 1.165 . . . . 0.0 114.029 -173.723 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -141.98 154.34 44.96 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 131.693 3.997 . . . . 0.0 109.88 -177.143 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.7 mt -130.11 159.61 36.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 116.72 -3.737 . . . . 0.0 115.865 177.532 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.03 136.51 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 130.004 3.322 . . . . 0.0 115.74 165.01 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 65' ' ' SER . 91.3 t80 -140.18 145.59 37.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 167.672 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.21 33.09 19.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.705 2.802 . . . . 0.0 112.086 168.007 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.26 -24.19 12.46 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.851 -1.527 . . . . 0.0 113.978 -175.033 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -87.41 141.74 28.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 121.499 2.65 . . . . 0.0 105.461 -169.889 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.61 122.68 27.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 166.05 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -75.47 137.74 41.14 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -173.983 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -89.43 159.78 17.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 125.228 1.58 . . . . 0.0 106.91 176.607 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.11 121.89 30.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 126.203 2.189 . . . . 0.0 107.234 172.746 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.32 -33.24 3.06 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-O 124.523 2.18 . . . . 0.0 113.165 -178.398 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 mtt-85 -82.52 167.87 17.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 112.777 -1.711 . . . . 0.0 112.698 177.821 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.0 p -109.64 167.75 9.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -176.747 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.4 mt -56.11 -48.96 75.17 Favored 'General case' 0 N--CA 1.45 -0.44 1 C-N-CA 131.98 4.112 . . . . 0.0 105.885 172.833 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -43.98 17.01 Favored 'General case' 0 N--CA 1.444 -0.765 1 C-N-CA 131.747 4.019 . . . . 0.0 108.518 174.052 . . . . . . . . 3 3 . 1 . 061 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.69 -16.38 48.47 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 124.365 3.257 . . . . 0.0 114.067 178.962 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -114.17 2.66 14.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 114.803 -2.522 . . . . 0.0 111.544 -174.661 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.305 67.3 m-80 74.85 16.33 2.99 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.794 2.438 . . . . 0.0 111.686 173.655 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -68.39 128.05 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 O-C-N 117.521 -3.237 . . . . 0.0 113.905 -174.22 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -123.41 -163.45 1.12 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.152 2.581 . . . . 0.0 107.64 -178.854 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -50.81 119.26 3.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 123.375 1.56 . . . . 0.0 113.768 169.899 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.321 50.8 mt-10 74.94 21.38 2.03 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.024 -1.672 . . . . 0.0 111.576 163.171 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.414 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 45.8 m -53.7 126.28 21.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 115.96 -1.971 . . . . 0.0 110.223 160.663 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -97.38 112.38 24.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.163 2.185 . . . . 0.0 109.314 171.856 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.314 8.7 mp -97.82 167.26 11.04 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.399 1.88 . . . . 0.0 108.864 176.144 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -116.59 124.17 49.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.822 2.849 . . . . 0.0 104.605 -176.118 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -97.78 132.19 43.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.978 2.911 . . . . 0.0 110.574 -177.229 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.292 4.1 m -142.32 171.29 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 112.921 -1.945 . . . . 0.0 110.752 -176.538 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.65 138.65 22.28 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 172.519 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.416 14.8 ttt85 85.97 -54.72 0.07 Allowed 'General case' 0 C--N 1.321 -0.658 1 C-N-CA 132.14 4.176 . . . . 0.0 113.016 164.903 . . . . . . . . 3 2 . 1 . 061 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.4 mt -95.97 144.66 26.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 128.275 2.63 . . . . 0.0 112.167 -160.667 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.3 135.88 39.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 124.242 0.964 . . . . 0.0 112.0 -176.852 . . . . . . . . 2 2 . 1 . 061 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.13 169.32 18.08 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 128.651 3.024 . . . . 0.0 109.303 176.853 . . . . . . . . 1 1 . 1 . 061 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.515 0 CA-C-O 115.848 -2.64 . . . . 0.0 110.419 178.064 . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 ptt? . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 116.878 -1.534 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 062 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.411 49.4 mm-40 -109.15 146.39 34.18 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 116.717 -1.611 . . . . 0.0 108.166 -170.609 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 pt -145.33 156.86 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 121.208 1.822 . . . . 0.0 109.038 170.473 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -99.84 141.29 32.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 178.668 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.58 133.71 51.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 156.513 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -91.34 117.6 29.8 Favored 'General case' 0 C--N 1.325 -0.474 1 C-N-CA 132.743 4.417 . . . . 0.0 110.26 170.298 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -82.65 162.46 21.84 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.342 1.857 . . . . 0.0 110.07 176.821 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pp -78.76 -24.47 44.7 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 127.384 2.274 . . . . 0.0 110.179 172.024 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -87.84 -18.02 30.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 119.867 -1.77 . . . . 0.0 114.136 -178.275 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.17 7.67 3.16 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 128.506 2.955 . . . . 0.0 115.903 144.576 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -90.62 163.34 14.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 125.36 2.505 . . . . 0.0 107.71 174.817 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.3 m -128.29 117.23 21.11 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.942 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.32 129.75 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 128.458 2.703 . . . . 0.0 103.837 -167.426 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -91.57 107.73 19.41 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -177.033 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.316 48.7 mt -102.91 152.52 21.2 Favored 'General case' 0 N--CA 1.449 -0.517 1 CA-C-N 126.341 4.155 . . . . 0.0 107.935 175.581 . . . . . . . . 3 2 . 1 . 062 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -113.78 119.93 39.04 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 114.68 -2.581 . . . . 0.0 106.15 175.313 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -124.7 149.68 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 125.003 1.439 . . . . 0.0 114.661 -175.309 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -81.61 130.61 60.81 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-O 114.991 -2.433 . . . . 0.0 104.556 167.309 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -38.71 -25.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.379 1 N-CA-C 123.163 4.255 . . . . 0.0 123.163 165.69 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.1 p -115.06 18.54 16.26 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 126.147 2.154 . . . . 0.0 114.466 178.99 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -59.46 111.33 1.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 128.822 2.849 . . . . 0.0 112.636 156.806 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -72.06 169.53 15.8 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 123.256 2.753 . . . . 0.0 111.192 -177.528 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.321 18.7 mm -51.11 -32.16 11.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 125.773 1.629 . . . . 0.0 113.782 -179.916 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -87.15 -20.86 26.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 122.179 2.263 . . . . 0.0 106.893 -175.314 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -79.39 -39.18 33.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.622 1.169 . . . . 0.0 112.482 179.839 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.3 t -43.07 -39.13 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 128.497 2.719 . . . . 0.0 113.157 161.884 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -75.01 -37.66 61.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 119.512 -1.992 . . . . 0.0 112.939 -171.818 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.285 . . -68.28 -16.69 64.05 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.974 2.509 . . . . 0.0 114.444 172.298 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.25 -38.42 17.59 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.572 2.349 . . . . 0.0 112.316 171.329 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.19 -42.41 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 114.449 -2.691 . . . . 0.0 114.451 157.445 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -48.63 -62.87 1.28 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.193 2.197 . . . . 0.0 112.471 165.283 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -33.0 -40.59 0.06 Allowed 'General case' 0 N--CA 1.448 -0.57 1 CA-C-O 111.589 -4.053 . . . . 0.0 119.709 170.656 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.48 -53.1 3.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 128.202 3.439 . . . . 0.0 111.473 176.865 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -112.97 -3.75 14.01 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -167.657 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.0 -8.94 77.54 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 116.895 -2.058 . . . . 0.0 115.683 160.5 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.416 ' HB ' HE21 ' A' ' 41' ' ' GLN . 6.7 mt -66.21 130.0 94.25 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 129.045 2.938 . . . . 0.0 109.035 -172.454 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -71.22 143.15 43.2 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 N-CA-C 107.975 -1.587 . . . . 0.0 107.975 172.599 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.3 46.7 Cg_exo -28.86 -60.74 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 1 C-N-CA 126.369 4.712 . . . . 0.0 117.741 163.593 . . . . . . . . 3 2 . 1 . 062 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -55.41 -25.49 36.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 122.082 2.219 . . . . 0.0 115.568 -172.463 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -89.89 -9.89 47.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 176.211 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.416 HE21 ' HB ' ' A' ' 36' ' ' ILE . 72.0 mt-30 -94.75 154.76 17.14 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 131.599 3.96 . . . . 0.0 107.085 -175.838 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -143.47 152.38 41.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 113.853 -2.975 . . . . 0.0 104.821 163.634 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.267 76.5 mt -123.79 119.64 30.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.5 1.955 . . . . 0.0 107.385 -173.106 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -107.52 143.13 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 127.758 2.423 . . . . 0.0 110.005 -179.131 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -155.29 143.97 20.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.421 2.288 . . . . 0.0 109.304 172.343 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.66 31.88 13.52 Favored 'General case' 0 C--N 1.328 -0.331 3 O-C-N 114.566 -5.084 . . . . 0.0 114.217 161.483 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.27 2.56 62.01 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.645 2.069 . . . . 0.0 116.449 171.386 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.338 41.5 pttt -136.1 150.4 49.1 Favored 'General case' 0 N--CA 1.445 -0.717 1 C-N-CA 133.225 4.61 . . . . 0.0 114.966 -169.271 . . . . . . . . 3 2 . 1 . 062 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 48.8 tt0 -76.54 140.73 41.24 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.704 2.002 . . . . 0.0 106.996 162.455 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 mt -71.6 129.49 38.86 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 114.764 -2.541 . . . . 0.0 112.992 171.714 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.82 139.68 30.22 Favored 'General case' 0 N--CA 1.447 -0.581 1 C-N-CA 131.814 4.046 . . . . 0.0 105.057 -173.446 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.83 117.86 24.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 127.628 2.371 . . . . 0.0 115.856 -174.126 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.46 11.44 1.73 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.391 1.948 . . . . 0.0 112.836 179.684 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -141.11 163.65 32.39 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -174.058 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -123.73 -179.29 4.31 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 119.226 -2.171 . . . . 0.0 109.728 -162.994 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -58.84 -33.75 70.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 118.464 -2.648 . . . . 0.0 114.601 172.192 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 p -76.27 -34.61 59.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 120.94 1.7 . . . . 0.0 107.056 179.582 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -74.08 -42.61 59.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 125.5 1.75 . . . . 0.0 109.537 -173.237 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -76.44 4.04 9.93 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 118.762 -2.461 . . . . 0.0 115.215 166.892 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 75.8 18.0 2.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 131.529 3.932 . . . . 0.0 114.483 168.268 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.4 mt -69.97 132.98 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 O-C-N 119.295 -2.128 . . . . 0.0 108.681 -174.233 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -124.27 153.4 41.75 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 112.859 -3.448 . . . . 0.0 109.98 -173.861 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.27 135.02 27.17 Favored 'General case' 0 N--CA 1.443 -0.802 1 O-C-N 129.111 4.007 . . . . 0.0 113.049 -177.048 . . . . . . . . 3 3 . 1 . 062 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.588 80.8 mt-10 84.93 11.17 0.31 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 128.247 2.619 . . . . 0.0 116.505 172.645 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.308 27.9 m -86.65 159.9 19.06 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 116.229 -1.843 . . . . 0.0 110.964 170.978 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.8 m -130.95 113.34 13.88 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.276 1.83 . . . . 0.0 107.143 -158.948 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.7 163.32 12.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 130.575 3.55 . . . . 0.0 113.906 -179.885 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -122.17 154.86 36.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -161.31 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.257 39.1 tp -145.58 117.93 8.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 125.619 2.628 . . . . 0.0 105.913 -167.853 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 t -110.17 119.39 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 110.588 -3.006 . . . . 0.0 108.142 169.433 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.84 145.49 40.57 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 119.427 -2.045 . . . . 0.0 110.294 167.157 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -100.42 173.5 6.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 102.009 -3.33 . . . . 0.0 102.009 177.197 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.6 mt -73.86 175.2 7.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.566 -1.334 . . . . 0.0 113.49 165.646 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 65.1 121.89 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.828 1 C-N-CA 134.207 5.003 . . . . 0.0 117.331 -167.342 . . . . . . . . 2 2 . 1 . 062 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.25 144.5 6.78 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.016 -1.991 . . . . 0.0 110.852 179.903 . . . . . . . . 1 1 . 1 . 062 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.122 0 CA-C-O 113.799 -3.778 . . . . 0.0 111.946 -161.174 . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttm . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 063 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -87.31 117.5 26.12 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.93 2.892 . . . . 0.0 112.728 -175.513 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.57 167.5 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.428 1.491 . . . . 0.0 109.742 170.961 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -140.6 115.21 9.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 125.327 2.489 . . . . 0.0 105.651 -168.912 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 t -101.55 109.23 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.663 -2.062 . . . . 0.0 111.807 -179.239 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -93.99 121.11 35.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 115.549 -2.167 . . . . 0.0 113.489 -174.528 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.0 p -73.48 179.32 4.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 128.246 2.618 . . . . 0.0 111.259 -177.453 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.52 -32.16 60.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.19 2.196 . . . . 0.0 108.274 172.2 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.42 -21.71 59.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.155 2.182 . . . . 0.0 109.852 179.741 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.11 -4.56 58.86 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 117.244 -1.865 . . . . 0.0 114.92 177.511 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -65.92 143.9 57.13 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.9 1.0 . . . . 0.0 110.889 170.615 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -138.15 99.93 4.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.137 -2.227 . . . . 0.0 106.011 -158.844 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.5 mm -95.72 131.78 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.226 -169.946 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 m -94.75 105.49 17.43 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 119.628 -1.92 . . . . 0.0 107.64 -171.486 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 mt -93.98 127.23 39.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 125.143 2.402 . . . . 0.0 105.594 179.401 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -95.79 110.47 22.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 119.786 -1.821 . . . . 0.0 107.506 174.071 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.14 170.57 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.598 2.759 . . . . 0.0 107.596 -174.68 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -114.39 162.41 23.49 Favored Pre-proline 0 N--CA 1.449 -0.509 1 O-C-N 129.19 4.056 . . . . 0.0 108.892 150.195 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -57.88 -14.62 18.78 Favored 'Trans proline' 0 N--CA 1.447 -1.252 1 C-N-CA 125.716 4.277 . . . . 0.0 115.486 -175.555 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.1 p -90.74 0.32 57.47 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 116.912 -3.617 . . . . 0.0 114.853 -179.383 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.74 137.91 44.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 127.983 3.302 . . . . 0.0 106.396 -176.57 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -83.39 170.69 14.26 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.171 1.35 . . . . 0.0 112.512 173.264 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mt -58.7 -42.82 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 129.26 3.024 . . . . 0.0 108.018 170.816 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -49.57 -46.99 49.53 Favored 'General case' 0 C--N 1.329 -0.294 1 C-N-CA 132.535 4.334 . . . . 0.0 109.854 166.909 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -73.61 -45.65 51.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 120.448 1.476 . . . . 0.0 110.067 -177.925 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -53.57 -48.87 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 117.315 -1.326 . . . . 0.0 108.497 171.181 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -67.39 -36.28 81.0 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 120.086 1.312 . . . . 0.0 110.368 -178.668 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.53 -40.37 78.64 Favored 'General case' 0 C--O 1.217 -0.624 1 O-C-N 115.923 -4.235 . . . . 0.0 110.703 171.238 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.319 39.2 mttp -62.14 -49.74 74.66 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.253 3.421 . . . . 0.0 117.432 -179.389 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.92 -33.94 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 128.683 3.739 . . . . 0.0 110.462 164.479 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -75.34 -37.89 60.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 121.599 2.0 . . . . 0.0 115.014 -178.903 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -55.21 -37.99 67.85 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 126.89 2.076 . . . . 0.0 113.842 172.849 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -80.99 -83.1 0.11 Allowed 'General case' 0 N--CA 1.442 -0.87 1 C-N-CA 132.108 4.163 . . . . 0.0 114.022 -176.966 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -92.37 -0.27 57.39 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 116.884 -1.531 . . . . 0.0 110.975 -174.922 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.23 11.58 82.05 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 122.652 2.478 . . . . 0.0 114.239 175.961 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.9 mm -67.77 126.8 93.08 Favored Pre-proline 0 N--CA 1.446 -0.628 1 C-N-CA 132.313 4.245 . . . . 0.0 110.808 -177.103 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -64.14 149.39 90.46 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.542 3.494 . . . . 0.0 113.4 171.519 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -68.44 -55.69 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.212 2.608 . . . . 0.0 114.422 178.044 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -52.44 -25.21 9.4 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 127.305 2.878 . . . . 0.0 113.066 -173.12 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -79.2 -10.91 59.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.077 178.857 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -111.85 152.91 27.39 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 130.206 3.402 . . . . 0.0 116.609 -168.398 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -137.96 138.69 39.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 118.712 -2.493 . . . . 0.0 106.295 166.473 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 41.2 mt -107.63 148.5 29.26 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.244 3.018 . . . . 0.0 112.026 -171.819 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.4 mt -147.74 118.69 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 126.811 2.044 . . . . 0.0 107.757 -164.982 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -146.56 140.69 26.31 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 126.018 1.727 . . . . 0.0 106.997 169.993 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 74.9 21.07 2.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.987 2.515 . . . . 0.0 116.123 169.542 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.75 3.01 61.07 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 120.413 -1.43 . . . . 0.0 112.299 179.705 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.315 16.7 ptpt -127.96 133.93 49.25 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -171.406 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -75.21 132.76 41.34 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 102.029 -3.322 . . . . 0.0 102.029 163.539 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 29.4 mt -86.29 137.91 32.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 112.94 -1.936 . . . . 0.0 108.415 -179.69 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -111.86 147.41 35.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -178.877 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.01 139.78 58.8 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 128.802 2.841 . . . . 0.0 111.635 -162.9 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.48 20.74 10.56 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.373 1.463 . . . . 0.0 114.486 178.701 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -131.99 147.35 52.45 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 123.923 1.82 . . . . 0.0 109.755 175.386 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -95.46 154.08 17.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 111.283 -2.69 . . . . 0.0 111.767 179.264 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.9 mt -51.41 -33.64 31.28 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 119.229 -2.169 . . . . 0.0 115.683 -179.105 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -10.52 59.53 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 120.415 -1.428 . . . . 0.0 114.319 177.195 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -77.76 -27.93 50.49 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.586 175.18 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.366 67.8 m-85 -104.96 -0.04 27.32 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 130.986 3.714 . . . . 0.0 113.878 170.585 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.338 0.7 OUTLIER 59.06 39.82 22.84 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 128.813 2.845 . . . . 0.0 113.962 -179.079 . . . . . . . . 3 3 . 1 . 063 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.0 mt -70.31 112.08 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 118.758 0.708 . . . . 0.0 109.811 168.634 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -112.37 -170.12 1.6 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 113.187 -1.824 . . . . 0.0 112.751 -170.813 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.443 36.1 pttt -50.65 120.18 4.49 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 120.378 3.473 . . . . 0.0 120.378 179.674 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 67.77 54.15 0.65 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.855 2.862 . . . . 0.0 109.241 177.731 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.7 m -107.43 141.31 39.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.309 175.238 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.276 36.3 m -108.9 144.95 36.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 126.233 2.921 . . . . 0.0 107.651 168.393 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.11 -178.03 4.72 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 103.355 -2.832 . . . . 0.0 103.355 173.976 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -151.68 -179.59 7.56 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 111.986 -2.37 . . . . 0.0 105.155 -171.898 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.5 pp -147.15 168.46 21.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 123.345 1.545 . . . . 0.0 112.923 175.865 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.0 p -128.74 133.42 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 131.574 3.95 . . . . 0.0 110.057 -178.225 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -47.05 136.59 8.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 164.394 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.318 3.9 ttm180 -122.78 129.55 51.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.902 2.881 . . . . 0.0 105.701 171.087 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.3 mt -95.86 -26.31 15.67 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 127.48 2.987 . . . . 0.0 113.124 -157.339 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -97.34 140.06 32.37 Favored 'General case' 0 CA--C 1.535 0.367 1 C-N-CA 132.81 4.444 . . . . 0.0 103.765 176.939 . . . . . . . . 2 2 . 1 . 063 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.73 124.11 3.36 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 127.74 2.591 . . . . 0.0 115.127 175.401 . . . . . . . . 1 1 . 1 . 063 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 N-CA-C 104.534 -3.426 . . . . 0.0 104.534 -175.978 . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 ttp . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 115.691 -2.1 . . . . 0.0 106.17 . . . . . . . . . 0 0 . 1 . 064 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.253 27.0 mp0 -97.0 131.24 44.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -175.127 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -114.63 177.64 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 116.955 -3.59 . . . . 0.0 105.577 158.926 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -127.25 141.76 51.64 Favored 'General case' 0 N--CA 1.447 -0.618 1 C-N-CA 131.978 4.111 . . . . 0.0 108.515 175.904 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.2 106.36 17.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 -178.344 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -89.37 166.53 13.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 117.762 -3.086 . . . . 0.0 104.489 166.695 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -127.5 149.34 50.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 109.38 -3.554 . . . . 0.0 104.04 176.08 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.21 1.68 20.69 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 128.003 3.315 . . . . 0.0 112.607 175.274 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -102.84 -21.32 14.04 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.645 2.378 . . . . 0.0 116.68 167.275 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.5 13.16 9.03 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-O 113.567 -3.907 . . . . 0.0 110.805 153.721 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -72.23 131.62 42.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 123.291 3.546 . . . . 0.0 112.597 155.182 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.8 m -108.22 133.17 52.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 172.714 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.6 mt -115.24 144.0 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 129.308 3.043 . . . . 0.0 106.784 167.884 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.293 28.4 m -107.31 130.63 54.75 Favored 'General case' 0 N--CA 1.448 -0.532 1 N-CA-C 97.453 -5.017 . . . . 0.0 97.453 164.708 . . . . . . . . 3 2 . 1 . 064 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tp -130.56 138.37 50.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.857 1.348 . . . . 0.0 111.603 179.288 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.27 118.16 35.99 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 -173.225 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.289 17.1 m -120.94 160.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 122.548 1.166 . . . . 0.0 109.574 -176.095 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -96.58 141.34 22.95 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 113.305 -3.236 . . . . 0.0 113.26 173.581 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -45.0 -50.9 8.21 Favored 'Trans proline' 0 N--CA 1.444 -1.385 1 C-N-CA 131.593 8.195 . . . . 0.0 108.245 169.102 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -60.24 -15.46 24.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.703 2.001 . . . . 0.0 112.101 -179.299 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -68.94 127.95 34.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 122.469 2.395 . . . . 0.0 114.505 -168.832 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.1 p -68.33 138.49 55.47 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 125.391 1.682 . . . . 0.0 107.065 160.845 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mm -53.45 -19.83 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -177.406 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.67 -36.24 80.26 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 122.225 2.284 . . . . 0.0 112.821 166.261 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -78.42 -10.14 59.57 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 123.271 2.76 . . . . 0.0 110.19 -178.814 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -92.88 -28.82 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 118.163 -2.836 . . . . 0.0 106.447 174.383 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -84.43 -20.31 32.02 Favored 'General case' 0 CA--C 1.539 0.523 1 O-C-N 114.977 -4.827 . . . . 0.0 110.062 177.83 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.69 -26.38 59.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 117.537 -1.22 . . . . 0.0 113.5 159.752 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -78.38 -17.02 57.04 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 171.772 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.2 mt -80.18 -34.51 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 114.309 -2.758 . . . . 0.0 110.685 162.952 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -50.69 -35.81 32.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 123.078 2.672 . . . . 0.0 116.019 168.656 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.253 27.5 t70 -91.74 -5.37 53.72 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 119.148 -2.22 . . . . 0.0 111.321 -172.631 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -121.99 -36.57 2.98 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 113.175 -3.297 . . . . 0.0 111.233 -169.511 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -125.65 -26.44 3.53 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 123.648 2.931 . . . . 0.0 109.195 176.901 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.72 17.35 12.16 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 117.016 -3.553 . . . . 0.0 112.746 174.588 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mt -86.82 125.94 65.15 Favored Pre-proline 0 N--CA 1.445 -0.711 0 N-CA-C 100.821 -3.77 . . . . 0.0 100.821 -175.735 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.47 144.49 25.65 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 CA-C-O 115.47 -1.971 . . . . 0.0 112.742 165.785 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -9.71 26.89 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 124.471 3.447 . . . . 0.0 114.754 -162.994 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.77 -17.01 64.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 123.429 2.831 . . . . 0.0 117.334 169.291 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -119.82 27.19 8.85 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 117.134 -3.479 . . . . 0.0 116.285 -162.157 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -113.56 165.66 12.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.257 2.623 . . . . 0.0 111.892 178.675 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -127.15 150.79 49.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.012 3.725 . . . . 0.0 102.983 141.902 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.67 105.59 11.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 112.317 -2.219 . . . . 0.0 110.946 165.114 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.97 134.77 27.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 125.688 2.661 . . . . 0.0 105.206 174.301 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -140.76 115.08 9.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 108.603 -3.908 . . . . 0.0 112.532 176.905 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.69 37.84 1.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 128.687 2.795 . . . . 0.0 112.75 -175.052 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.6 -35.34 4.78 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 121.253 -0.905 . . . . 0.0 113.075 171.173 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.313 97.7 mttt -83.57 165.09 19.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.971 2.908 . . . . 0.0 107.247 -173.947 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -116.5 119.72 36.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.685 2.394 . . . . 0.0 108.779 177.497 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.1 mt -80.59 124.38 28.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 123.379 1.561 . . . . 0.0 109.057 -161.125 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.21 130.84 35.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 -174.38 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.95 -37.11 30.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 127.59 3.056 . . . . 0.0 118.704 -170.952 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.19 5.02 41.4 Favored Glycine 0 CA--C 1.526 0.777 1 O-C-N 116.079 -4.138 . . . . 0.0 115.026 -170.381 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -88.57 146.72 24.97 Favored 'General case' 0 C--N 1.327 -0.413 1 O-C-N 116.226 -4.103 . . . . 0.0 107.024 170.195 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -86.47 134.64 33.67 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 127.858 3.224 . . . . 0.0 111.573 -173.678 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.309 10.8 tp -22.42 -76.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 1 C-N-CA 134.036 4.935 . . . . 0.0 114.243 177.656 . . . . . . . . 3 2 . 1 . 064 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.1 -37.29 85.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 125.397 2.522 . . . . 0.0 110.217 -170.135 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.3 -21.26 42.78 Favored 'General case' 0 CA--C 1.536 0.43 1 O-C-N 113.793 -5.567 . . . . 0.0 113.201 178.584 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -22.37 66.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 162.913 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.809 6.5 t-20 105.85 24.13 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 129.534 3.134 . . . . 0.0 117.96 175.512 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -99.82 73.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 126.708 2.003 . . . . 0.0 109.672 -177.524 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -89.84 169.79 10.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 124.72 2.2 . . . . 0.0 105.955 -179.506 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -31.54 115.79 0.16 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.283 2.697 . . . . 0.0 118.283 -174.298 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 77.51 29.8 0.52 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 129.067 2.947 . . . . 0.0 113.427 174.945 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -72.44 148.47 45.12 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 126.165 2.888 . . . . 0.0 114.133 169.986 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 m -104.73 107.48 18.45 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 117.062 -3.524 . . . . 0.0 105.811 -173.288 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.36 149.17 25.22 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 128.084 3.365 . . . . 0.0 108.649 162.275 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -107.59 110.84 22.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 127.971 3.294 . . . . 0.0 114.609 155.821 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.273 6.4 tt -74.19 139.41 44.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.083 -1.636 . . . . 0.0 107.635 168.763 . . . . . . . . 2 2 . 1 . 064 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.02 145.99 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 164.97 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 mp -97.84 123.48 41.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 -177.573 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -79.27 69.49 5.5 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 171.442 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.494 0.5 OUTLIER -155.49 -82.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.904 2.482 . . . . 0.0 108.858 171.444 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.31 139.28 22.02 Favored 'General case' 0 N--CA 1.449 -0.525 1 C-N-CA 132.433 4.293 . . . . 0.0 102.131 171.389 . . . . . . . . 3 3 . 1 . 064 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.42 106.22 2.38 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 104.832 -3.307 . . . . 0.0 104.832 179.78 . . . . . . . . 1 1 . 1 . 064 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.499 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -154.423 . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptt? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 117.392 -1.29 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 065 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -100.2 161.61 13.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 169.272 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.9 pt -146.74 158.46 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 130.322 3.449 . . . . 0.0 103.137 168.71 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -107.11 140.31 40.15 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 127.057 2.143 . . . . 0.0 107.734 174.075 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -121.05 117.79 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 127.258 3.409 . . . . 0.0 105.808 170.009 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.9 tptt -78.79 114.93 18.14 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 116.455 -3.903 . . . . 0.0 105.182 167.069 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.4 p -86.22 159.25 19.53 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 127.996 3.31 . . . . 0.0 108.469 168.544 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.76 -30.72 71.74 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.265 -1.789 . . . . 0.0 114.009 178.834 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.4 p -72.79 4.52 3.99 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.759 2.424 . . . . 0.0 114.806 165.913 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.86 17.08 77.92 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 114.045 -3.642 . . . . 0.0 113.839 173.013 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -85.42 121.32 27.97 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 122.819 3.309 . . . . 0.0 104.844 173.607 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.3 m -85.86 63.68 8.18 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.791 2.436 . . . . 0.0 107.194 173.447 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mm -50.72 120.9 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 126.702 2.001 . . . . 0.0 111.948 173.82 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.9 m -88.67 136.66 32.88 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 174.346 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 mt -121.65 139.6 53.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.034 1.733 . . . . 0.0 106.992 177.629 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -86.97 129.22 34.97 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 167.418 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.381 18.5 m -140.75 154.48 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 128.936 2.894 . . . . 0.0 114.165 -179.416 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -117.4 171.42 4.97 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-O 114.186 -2.816 . . . . 0.0 110.596 171.63 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.97 -27.73 3.64 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 N-CA-C 118.393 2.42 . . . . 0.0 118.393 -170.171 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -86.61 -5.96 59.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 119.056 -2.277 . . . . 0.0 116.463 178.661 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.16 122.65 11.49 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 127.605 2.362 . . . . 0.0 108.996 178.224 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 p -85.87 169.77 13.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 117.222 -3.424 . . . . 0.0 110.883 -179.402 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.4 mt -61.79 -27.81 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 O-C-N 126.299 2.249 . . . . 0.0 111.049 179.253 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.94 -43.36 79.29 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.491 -1.38 . . . . 0.0 107.372 174.326 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.315 30.0 m-20 -54.36 -41.53 69.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 118.736 -2.477 . . . . 0.0 117.344 168.6 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.5 t -73.56 -52.81 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 125.107 1.504 . . . . 0.0 109.082 176.135 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -44.64 -37.44 3.65 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 117.556 -3.215 . . . . 0.0 117.348 168.095 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.65 -37.86 55.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 126.826 2.579 . . . . 0.0 111.766 177.037 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -56.72 -50.15 73.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 127.424 2.952 . . . . 0.0 110.376 175.929 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.61 -31.29 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 117.469 -1.253 . . . . 0.0 109.322 -178.509 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -68.29 -48.63 64.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 121.104 1.775 . . . . 0.0 110.706 174.357 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.279 32.2 t70 -43.72 -40.77 4.45 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 128.624 3.703 . . . . 0.0 114.117 169.261 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -77.88 -60.1 2.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.459 1.904 . . . . 0.0 114.714 172.464 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -101.3 -21.19 14.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -162.071 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.0 -11.4 65.92 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 117.079 1.592 . . . . 0.0 117.079 -177.4 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.281 73.5 mt -77.58 126.33 84.68 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 123.915 3.857 . . . . 0.0 112.584 -174.875 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.98 168.37 24.95 Favored 'Trans proline' 0 N--CA 1.44 -1.638 0 N-CA-C 116.731 1.781 . . . . 0.0 116.731 -174.007 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.26 -22.78 9.42 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 CA-C-O 124.999 2.0 . . . . 0.0 115.817 -162.88 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.56 -20.36 59.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 111.983 -3.865 . . . . 0.0 110.58 179.778 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.64 -16.62 44.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 128.773 3.796 . . . . 0.0 109.001 -174.737 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -98.84 137.63 37.14 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.994 1.854 . . . . 0.0 113.472 -171.493 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -116.15 141.91 47.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 153.13 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.82 138.85 48.68 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.081 0.943 . . . . 0.0 108.636 179.893 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -129.09 135.04 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 124.002 0.921 . . . . 0.0 109.564 -168.693 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -90.66 -175.94 4.57 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.365 2.266 . . . . 0.0 107.598 176.521 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -20.34 -57.22 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 1 C-N-CA 138.361 6.664 . . . . 0.0 111.826 -176.537 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.89 9.69 1.81 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.333 -1.815 . . . . 0.0 114.823 172.759 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -141.82 129.6 21.69 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -165.313 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -75.35 139.82 42.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 126.22 2.2 . . . . 0.0 109.053 179.926 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -97.59 157.88 15.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 121.202 1.819 . . . . 0.0 110.692 179.003 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -148.64 138.96 22.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 123.013 1.387 . . . . 0.0 108.627 -176.517 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -59.42 144.3 47.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.008 2.923 . . . . 0.0 112.969 -163.526 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.6 11.88 11.11 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 126.366 2.291 . . . . 0.0 117.011 168.205 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -136.47 159.24 42.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.684 2.794 . . . . 0.0 109.072 179.487 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.0 p -85.96 176.68 7.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 124.854 2.264 . . . . 0.0 110.709 177.016 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.5 mt -62.94 -47.99 80.83 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 119.293 -2.13 . . . . 0.0 109.331 169.904 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -46.58 -38.17 9.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.892 2.877 . . . . 0.0 114.399 173.505 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -78.17 -31.61 49.72 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 115.051 -2.405 . . . . 0.0 104.803 -174.575 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -95.12 -1.38 52.09 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.817 1.323 . . . . 0.0 107.749 -173.361 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 60.0 m-80 77.83 27.72 0.57 Allowed 'General case' 0 N--CA 1.45 -0.471 1 O-C-N 115.429 -4.545 . . . . 0.0 117.931 171.605 . . . . . . . . 3 2 . 1 . 065 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -103.15 123.21 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 -170.249 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -123.28 171.0 9.71 Favored 'General case' 0 N--CA 1.445 -0.679 1 C-N-CA 131.737 4.015 . . . . 0.0 113.317 176.126 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -57.78 135.65 56.83 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 128.155 2.582 . . . . 0.0 111.478 -168.092 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.337 0.7 OUTLIER 81.51 7.24 1.13 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.656 2.782 . . . . 0.0 118.178 -177.896 . . . . . . . . 3 3 . 1 . 065 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -68.67 139.61 55.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 124.83 2.252 . . . . 0.0 110.579 169.849 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.0 m -97.08 125.78 41.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 111.182 -2.735 . . . . 0.0 106.831 170.72 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.3 mt -96.36 150.51 20.5 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 128.759 2.824 . . . . 0.0 106.809 166.913 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -126.38 130.91 51.67 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 129.098 2.959 . . . . 0.0 110.703 171.685 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tp -86.4 141.84 28.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.685 1.994 . . . . 0.0 111.865 -178.543 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -130.91 133.02 63.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 101.872 -3.381 . . . . 0.0 101.872 177.098 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.1 mt -103.03 129.67 49.88 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 119.042 2.979 . . . . 0.0 119.042 175.668 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -82.94 90.33 6.97 Favored 'General case' 0 C--N 1.323 -0.572 1 O-C-N 130.1 4.625 . . . . 0.0 105.341 -176.763 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.53 141.19 30.89 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 131.446 3.898 . . . . 0.0 108.941 173.915 . . . . . . . . 2 2 . 1 . 065 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -113.27 141.45 46.98 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 103.398 -2.815 . . . . 0.0 103.398 -166.68 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.66 -94.06 0.17 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 127.883 2.659 . . . . 0.0 112.778 163.906 . . . . . . . . 1 1 . 1 . 065 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 174.41 . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 113.855 -2.974 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 066 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -98.7 149.88 22.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 121.111 1.778 . . . . 0.0 107.267 -176.997 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 pt -152.01 157.02 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.184 1.793 . . . . 0.0 107.934 174.129 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -110.1 142.86 40.99 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 130.275 3.43 . . . . 0.0 105.79 -175.176 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t -113.97 138.46 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 168.873 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -100.96 144.72 29.57 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 118.134 -2.854 . . . . 0.0 110.757 162.348 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.1 m -113.63 142.37 46.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.523 2.729 . . . . 0.0 104.956 -175.951 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 3.2 tm? -47.35 -49.28 24.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.33 2.252 . . . . 0.0 111.569 -171.769 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.3 p -80.29 5.7 14.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 -177.871 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.34 -9.83 10.89 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 121.723 3.449 . . . . 0.0 121.723 157.47 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -79.61 149.0 31.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.883 1.673 . . . . 0.0 109.736 -179.544 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m -119.09 124.29 46.52 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 129.612 3.165 . . . . 0.0 108.572 178.811 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.286 1.5 pp -119.33 -173.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.095 1.358 . . . . 0.0 111.559 176.049 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 t -154.2 144.17 21.88 Favored 'General case' 0 C--N 1.321 -0.647 1 O-C-N 116.0 -4.187 . . . . 0.0 110.345 177.267 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.34 0.3 OUTLIER -138.42 150.97 47.03 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.77 2.828 . . . . 0.0 109.168 -175.159 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.371 13.1 mp0 -97.49 119.89 36.87 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 126.66 2.475 . . . . 0.0 111.233 175.444 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.275 34.2 m -142.89 -179.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -163.145 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -141.84 143.37 28.48 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 127.568 2.347 . . . . 0.0 111.788 174.409 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.258 2.2 Cg_endo -58.73 -28.18 85.8 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 CA-C-N 127.279 3.635 . . . . 0.0 116.318 -175.073 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.9 m -85.2 19.59 2.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 112.375 -3.678 . . . . 0.0 109.144 178.524 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -88.18 148.54 24.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 -178.982 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -87.47 154.08 20.92 Favored 'General case' 0 N--CA 1.446 -0.642 1 O-C-N 130.604 4.94 . . . . 0.0 113.244 177.489 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mm -53.17 -30.93 17.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 123.108 2.685 . . . . 0.0 118.069 -175.187 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.29 10.5 tt0 -70.62 -41.52 72.14 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 116.769 -1.586 . . . . 0.0 109.812 -176.315 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -72.95 -20.56 61.03 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 128.425 2.69 . . . . 0.0 112.152 -174.125 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.2 t -79.14 -50.06 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 128.054 2.541 . . . . 0.0 110.796 165.128 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -62.02 -24.06 66.83 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 120.745 1.612 . . . . 0.0 114.992 174.984 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.94 -37.57 53.21 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 128.67 2.788 . . . . 0.0 113.54 170.701 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -81.56 -23.35 37.25 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 126.038 2.086 . . . . 0.0 112.879 -176.649 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.85 -42.63 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 129.072 2.949 . . . . 0.0 104.357 179.669 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -51.03 -54.17 27.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.09 2.556 . . . . 0.0 113.83 164.294 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.66 -44.02 85.4 Favored 'General case' 0 N--CA 1.44 -0.96 1 C-N-CA 131.962 4.105 . . . . 0.0 117.54 -178.364 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -78.15 -81.85 0.1 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.646 1.979 . . . . 0.0 110.128 168.617 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -76.85 -35.11 57.72 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 127.015 2.697 . . . . 0.0 116.596 -162.663 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.85 11.1 23.47 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 119.19 -2.194 . . . . 0.0 117.139 177.024 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mt -88.72 134.54 33.68 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 116.258 -1.83 . . . . 0.0 106.548 -177.125 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -70.38 142.97 46.5 Favored 'Trans proline' 0 N--CA 1.447 -1.241 1 C-N-CA 125.454 4.103 . . . . 0.0 112.646 174.217 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.85 -20.31 68.17 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.698 1.599 . . . . 0.0 112.167 174.815 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -72.0 -5.52 35.58 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 118.231 -2.793 . . . . 0.0 112.179 172.478 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -126.01 0.71 7.25 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.827 2.451 . . . . 0.0 116.312 -176.607 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.262 50.6 mt-30 -101.72 149.01 24.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 122.256 2.298 . . . . 0.0 105.026 -175.219 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -133.06 130.96 40.06 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 158.998 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.8 mt -98.47 133.82 42.31 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.831 2.853 . . . . 0.0 107.019 175.255 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.35 148.07 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 176.319 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -156.7 119.4 4.04 Favored 'General case' 0 C--O 1.24 0.568 1 C-N-CA 132.212 4.205 . . . . 0.0 110.869 167.437 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 74.5 13.67 3.68 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.541 1.936 . . . . 0.0 115.205 177.724 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.9 -28.11 7.16 Favored Glycine 0 CA--C 1.531 1.065 1 CA-C-O 112.282 -4.621 . . . . 0.0 107.272 179.907 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -99.85 134.04 43.33 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 128.022 2.837 . . . . 0.0 110.937 -157.224 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.93 129.99 42.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.384 1.053 . . . . 0.0 109.289 163.908 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.78 111.84 6.53 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 125.41 1.484 . . . . 0.0 111.828 171.224 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.473 15.9 tt0 -91.85 148.03 22.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -172.51 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.75 142.77 35.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 120.481 1.491 . . . . 0.0 112.365 -164.877 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.34 -33.94 5.43 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 125.803 2.891 . . . . 0.0 112.86 -177.629 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -80.43 170.69 16.04 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 111.514 -2.343 . . . . 0.0 111.053 -175.886 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -115.38 159.28 21.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.994 2.518 . . . . 0.0 108.769 -172.368 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.1 -26.43 68.29 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 116.393 -3.942 . . . . 0.0 109.756 179.566 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.0 t -54.23 -50.89 66.12 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.799 2.44 . . . . 0.0 113.353 175.317 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -48.09 -16.56 0.09 Allowed 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 127.476 2.31 . . . . 0.0 117.145 173.535 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -124.96 -4.28 7.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 118.058 -2.901 . . . . 0.0 111.95 179.689 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 93.17 31.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 125.573 1.795 . . . . 0.0 108.073 163.442 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -89.6 121.2 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 -172.397 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -113.37 176.16 5.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 112.902 -1.953 . . . . 0.0 112.066 -175.675 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -39.14 124.54 1.49 Allowed 'General case' 0 CA--C 1.536 0.42 1 C-N-CA 132.47 4.308 . . . . 0.0 111.643 164.526 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 80.14 0.22 2.03 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.997 3.719 . . . . 0.0 113.808 175.559 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -62.44 135.26 57.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 121.591 1.996 . . . . 0.0 108.733 -171.709 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.9 m -95.72 118.63 32.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.439 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -92.19 155.74 17.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 129.028 2.931 . . . . 0.0 108.067 177.394 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -105.68 133.08 50.99 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 163.607 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.7 tp -101.39 130.94 47.7 Favored 'General case' 0 C--N 1.322 -0.62 1 C-N-CA 132.633 4.373 . . . . 0.0 115.286 162.424 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.5 t -127.24 130.27 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 131.237 3.815 . . . . 0.0 104.041 -179.43 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.421 ' C ' ' H ' ' A' ' 73' ' ' LEU . 0.3 OUTLIER -124.48 160.68 27.71 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 115.249 -2.31 . . . . 0.0 113.163 -177.687 . . . . . . . . 3 3 . 1 . 066 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 74.77 -25.75 0.2 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 127.087 2.742 . . . . 0.0 109.392 164.486 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 71' ' ' LEU . 3.0 pp -128.85 172.03 11.7 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 169.481 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt-85 -82.05 146.3 29.75 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.737 1.215 . . . . 0.0 109.709 -173.325 . . . . . . . . 1 1 . 1 . 066 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -137.7 121.13 2.19 Favored Glycine 0 CA--C 1.531 1.047 1 CA-C-O 113.097 -4.168 . . . . 0.0 103.835 -168.391 . . . . . . . . 2 2 . 1 . 066 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.505 0 N-CA-C 104.237 -3.545 . . . . 0.0 104.237 -170.972 . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttp . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 . . . . . . . . . 0 0 . 1 . 067 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -87.09 131.91 33.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.188 0.995 . . . . 0.0 108.411 -175.064 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.268 30.6 pt -110.67 142.21 23.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 154.322 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -88.24 129.72 35.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 160.783 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.19 115.63 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 O-C-N 127.705 3.128 . . . . 0.0 112.812 161.241 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -67.04 118.22 10.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 127.721 2.408 . . . . 0.0 111.415 173.208 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.8 p -86.59 163.95 17.14 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 120.004 3.335 . . . . 0.0 120.004 170.918 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 mp -84.86 -18.14 35.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 129.076 2.951 . . . . 0.0 112.776 179.344 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.93 -37.07 86.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 128.228 2.611 . . . . 0.0 111.804 172.756 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.1 -159.81 24.45 Favored Glycine 0 CA--C 1.533 1.186 1 C-N-CA 132.357 4.789 . . . . 0.0 108.356 -163.165 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 mttt 41.14 -163.47 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 1 N-CA-C 123.397 4.591 . . . . 0.0 123.397 167.28 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.0 p -128.76 157.75 40.57 Favored 'General case' 0 N--CA 1.444 -0.738 2 O-C-N 115.511 -4.493 . . . . 0.0 110.106 164.079 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.8 mm -95.73 130.91 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 161.434 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 m -94.55 120.68 35.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.556 1.17 . . . . 0.0 108.945 163.027 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -100.18 144.53 29.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 131.078 3.751 . . . . 0.0 106.418 -178.455 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.92 141.21 28.67 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 121.521 1.964 . . . . 0.0 108.76 152.908 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.24 153.98 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 O-C-N 124.697 1.248 . . . . 0.0 108.782 172.582 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -90.36 156.94 45.48 Favored Pre-proline 0 C--N 1.322 -0.619 0 O-C-N 118.005 -2.934 . . . . 0.0 104.209 163.542 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.7 -4.34 13.42 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 O-C-N 116.843 -2.241 . . . . 0.0 112.336 -176.776 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.8 p -97.71 7.47 46.37 Favored 'General case' 0 N--CA 1.448 -0.56 1 C-N-CA 135.67 5.588 . . . . 0.0 116.808 173.992 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -82.05 158.13 23.89 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 165.234 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -90.76 161.96 15.08 Favored 'General case' 0 C--N 1.326 -0.435 1 C-N-CA 132.218 4.207 . . . . 0.0 109.524 171.187 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mt -69.28 -20.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 127.572 2.349 . . . . 0.0 110.144 175.556 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.19 -26.14 65.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.088 -1.633 . . . . 0.0 114.009 164.999 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -34.93 69.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 120.858 1.663 . . . . 0.0 111.379 164.558 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.67 -54.45 32.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 122.767 2.53 . . . . 0.0 109.09 174.238 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -48.24 -50.83 28.08 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 118.799 -2.438 . . . . 0.0 115.569 177.788 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.27 -11.24 59.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 116.444 -1.741 . . . . 0.0 113.394 -176.438 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -81.62 -35.25 30.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 122.022 2.192 . . . . 0.0 111.416 166.7 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.24 -44.3 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 126.204 1.802 . . . . 0.0 109.183 169.045 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.32 44.6 tt0 -69.25 -40.05 78.1 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 117.372 -3.33 . . . . 0.0 110.018 -175.907 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -52.25 -49.46 63.99 Favored 'General case' 0 N--CA 1.445 -0.7 1 C-N-CA 134.669 5.187 . . . . 0.0 110.27 169.092 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.275 35.3 mttm -76.03 -57.9 3.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 114.023 -2.894 . . . . 0.0 110.345 177.804 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -113.07 -12.87 13.13 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 121.674 2.034 . . . . 0.0 106.564 -157.992 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.45 1.49 60.61 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 125.369 3.713 . . . . 0.0 114.934 160.732 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.9 mm -74.49 133.77 76.92 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 125.897 1.587 . . . . 0.0 108.545 -174.519 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -66.92 144.85 72.16 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 N-CA-C 116.432 1.666 . . . . 0.0 116.432 176.393 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.16 -25.31 13.84 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 CA-C-O 116.247 -1.647 . . . . 0.0 110.784 -162.467 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.63 -12.06 59.95 Favored 'General case' 0 N--CA 1.442 -0.836 1 C-N-CA 133.298 4.639 . . . . 0.0 105.47 -176.358 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -104.59 -15.13 15.4 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 125.305 1.628 . . . . 0.0 112.321 174.159 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -83.53 95.48 8.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 116.624 -3.797 . . . . 0.0 109.642 -178.597 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -87.89 92.75 9.24 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 121.919 2.145 . . . . 0.0 108.437 175.824 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.57 130.35 34.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 112.085 -2.325 . . . . 0.0 109.606 -179.021 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.9 mt -116.45 143.33 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 111.47 -2.604 . . . . 0.0 108.348 -170.452 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -144.16 129.85 19.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.107 1.363 . . . . 0.0 110.362 161.56 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.286 . . 57.15 15.88 2.7 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 119.613 3.19 . . . . 0.0 119.613 174.752 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.72 -32.88 5.78 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 117.989 -1.45 . . . . 0.0 112.279 -172.552 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.8 tttm -92.47 127.93 38.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.793 1.797 . . . . 0.0 108.121 -170.784 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 104.94 13.39 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 128.85 3.844 . . . . 0.0 106.348 168.095 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.1 mt -71.84 125.19 26.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 111.438 -2.619 . . . . 0.0 113.964 -157.632 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.59 161.57 29.02 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 124.704 2.192 . . . . 0.0 105.25 -166.368 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.93 154.73 31.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.06 1.744 . . . . 0.0 112.836 163.541 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.81 -4.81 24.27 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.303 2.382 . . . . 0.0 114.949 165.466 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -136.1 168.93 18.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -171.66 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.8 p -107.44 173.76 6.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 119.324 -2.11 . . . . 0.0 113.163 -175.353 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mt -76.64 -18.34 58.65 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 116.867 -3.645 . . . . 0.0 108.527 -164.312 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.2 t -76.93 -31.27 56.52 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 129.398 3.079 . . . . 0.0 105.644 177.782 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 35.0 m-20 -78.22 -44.25 26.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 102.41 -3.181 . . . . 0.0 102.41 -173.809 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -72.64 1.93 7.43 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 127.539 2.336 . . . . 0.0 114.832 174.556 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t30 72.15 5.46 5.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.73 2.012 . . . . 0.0 113.042 171.199 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.4 mt -70.54 129.61 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 125.004 3.547 . . . . 0.0 106.701 -168.814 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.325 95.6 mm-40 -103.69 166.58 10.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 125.958 2.036 . . . . 0.0 108.9 174.466 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -42.65 123.1 2.53 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 130.725 3.61 . . . . 0.0 114.744 170.772 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.404 8.0 mp0 85.66 8.28 0.35 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 129.446 3.098 . . . . 0.0 112.87 170.161 . . . . . . . . 2 2 . 1 . 067 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -64.86 137.72 57.94 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 119.756 -1.84 . . . . 0.0 110.22 177.034 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -93.74 107.38 19.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 119.688 -1.883 . . . . 0.0 109.475 174.094 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.95 148.82 23.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 100.378 -3.934 . . . . 0.0 100.378 178.226 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -92.52 141.23 28.73 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 116.341 -3.975 . . . . 0.0 109.008 171.509 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.355 14.1 tp -107.77 131.35 54.55 Favored 'General case' 0 N--CA 1.451 -0.413 1 N-CA-C 98.36 -4.682 . . . . 0.0 98.36 158.05 . . . . . . . . 3 2 . 1 . 067 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.66 139.55 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 126.598 2.436 . . . . 0.0 105.387 169.465 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.2 mt -102.72 150.4 23.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 111.982 -2.372 . . . . 0.0 105.905 176.576 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -119.47 77.74 1.24 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.272 -1.331 . . . . 0.0 113.437 172.49 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 mt -76.5 -27.11 55.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 125.228 1.58 . . . . 0.0 113.462 -158.39 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -91.32 -57.92 2.62 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 116.71 -3.743 . . . . 0.0 111.288 171.233 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.91 -131.58 10.71 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 116.071 -2.516 . . . . 0.0 110.958 -173.675 . . . . . . . . 1 1 . 1 . 067 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 1 CA-C-N 124.847 4.323 . . . . 0.0 111.031 176.089 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 ttp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 0 0 . 1 . 068 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -87.15 152.08 22.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 102.842 -3.021 . . . . 0.0 102.842 -175.032 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 pt -150.65 164.33 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 131.538 3.935 . . . . 0.0 107.04 169.689 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -118.04 141.15 48.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 130.379 3.472 . . . . 0.0 112.351 166.568 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m -104.4 151.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 111.464 -2.607 . . . . 0.0 108.671 162.134 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -140.67 156.42 46.24 Favored 'General case' 0 C--N 1.327 -0.377 1 O-C-N 115.266 -4.646 . . . . 0.0 106.848 176.679 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.347 4.8 t -142.21 152.5 43.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.475 2.71 . . . . 0.0 107.512 -176.671 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.97 -8.26 4.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 130.825 3.65 . . . . 0.0 118.388 -170.962 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.2 p -79.61 -20.0 47.9 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 123.891 3.041 . . . . 0.0 108.492 166.675 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.35 -1.17 23.75 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 128.676 3.036 . . . . 0.0 112.562 -175.733 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.269 75.3 tttt -72.78 143.45 47.92 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 118.449 -2.795 . . . . 0.0 110.318 -173.828 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.4 p -135.27 143.43 46.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.859 2.064 . . . . 0.0 114.344 179.727 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -139.19 143.35 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 1 C-N-CA 131.71 4.004 . . . . 0.0 109.963 -178.916 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 t -101.74 139.89 36.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.611 1.82 . . . . 0.0 113.215 171.015 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mt -129.85 151.25 50.62 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.235 1.414 . . . . 0.0 109.219 177.667 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -109.19 118.06 35.73 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.833 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.43 139.37 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -170.039 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -76.62 142.72 70.79 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-O 124.37 2.033 . . . . 0.0 106.195 177.044 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -58.81 -36.49 96.93 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 125.016 3.811 . . . . 0.0 116.546 178.051 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 p -72.72 -12.99 61.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.495 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -72.09 140.75 49.08 Favored 'General case' 0 N--CA 1.45 -0.455 1 O-C-N 115.303 -4.623 . . . . 0.0 113.026 -176.831 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.3 p -73.14 134.98 44.64 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 179.447 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.251 26.6 mm -47.34 -38.24 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 129.704 3.202 . . . . 0.0 110.48 179.431 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -36.35 76.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 172.05 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -77.2 -40.52 44.83 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 129.249 3.02 . . . . 0.0 107.3 -177.777 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.0 t -70.94 -31.04 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 130.565 3.546 . . . . 0.0 112.331 -177.75 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP . 23.0 ttmt -64.86 -32.66 74.47 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 116.709 -3.744 . . . . 0.0 108.559 179.39 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.37 69.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 117.232 -3.417 . . . . 0.0 113.138 172.502 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -74.54 -5.98 45.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 119.859 1.209 . . . . 0.0 111.666 -171.186 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.21 -35.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 123.695 1.712 . . . . 0.0 114.432 156.454 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -72.72 -38.0 67.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 118.232 -2.792 . . . . 0.0 110.053 -166.818 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.67 -36.81 83.42 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.09 171.055 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -90.14 -33.57 16.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 113.982 -2.913 . . . . 0.0 112.084 -175.35 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -126.25 -30.25 2.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 122.037 2.199 . . . . 0.0 112.373 -171.999 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.81 -8.35 42.84 Favored Glycine 0 CA--C 1.522 0.507 1 CA-C-O 112.157 -4.691 . . . . 0.0 113.153 176.935 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -74.21 125.58 89.88 Favored Pre-proline 0 C--N 1.328 -0.347 1 O-C-N 131.361 4.8 . . . . 0.0 108.025 -175.914 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.06 138.28 43.36 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 N-CA-C 117.525 2.086 . . . . 0.0 117.525 166.007 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -61.42 -31.95 88.64 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.901 3.067 . . . . 0.0 115.521 -170.656 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.61 -17.93 64.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 111.911 -3.899 . . . . 0.0 108.293 -171.467 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.09 -13.22 59.95 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 117.97 2.581 . . . . 0.0 117.97 172.151 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -116.13 151.46 35.6 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 120.328 -1.482 . . . . 0.0 111.344 -154.27 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -141.33 123.67 15.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 116.556 -3.84 . . . . 0.0 113.283 175.616 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.3 148.6 28.24 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 117.132 -3.48 . . . . 0.0 115.862 171.807 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.32 45.7 mt -131.11 138.6 53.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 127.955 2.502 . . . . 0.0 110.481 179.528 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -135.85 -176.98 4.48 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 179.52 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.41 85.75 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.226 3.01 . . . . 0.0 116.565 -164.931 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.41 -36.46 3.96 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 118.806 -2.434 . . . . 0.0 117.359 -174.492 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.355 86.1 tttt -151.87 159.6 43.8 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 125.955 2.788 . . . . 0.0 111.081 -160.401 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -80.61 144.31 32.46 Favored 'General case' 0 C--N 1.323 -0.545 1 CA-C-N 107.405 -4.452 . . . . 0.0 108.202 178.723 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.3 mt -94.72 133.23 38.63 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 115.812 -2.355 . . . . 0.0 109.91 -175.397 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.2 132.13 48.3 Favored 'General case' 0 C--N 1.326 -0.454 1 O-C-N 115.694 -4.378 . . . . 0.0 118.624 168.229 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS . 70.5 m-20 -76.46 93.28 3.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 128.7 3.75 . . . . 0.0 111.021 -168.649 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.55 -0.23 2.74 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 118.495 2.158 . . . . 0.0 118.495 -170.919 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -102.81 175.15 5.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.065 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.333 78.8 p -105.38 164.13 12.09 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.651 2.781 . . . . 0.0 110.56 -172.033 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -41.04 -51.66 3.28 Favored 'General case' 0 N--CA 1.446 -0.644 1 C-N-CA 132.109 4.164 . . . . 0.0 110.699 164.646 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 m -86.04 -6.96 58.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.253 -164.787 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -69.24 -38.62 78.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 124.911 2.291 . . . . 0.0 112.21 171.115 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -103.55 -5.18 22.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 128.121 2.568 . . . . 0.0 112.812 -175.559 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.521 0.7 OUTLIER 75.61 37.62 0.41 Allowed 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 128.098 3.374 . . . . 0.0 113.584 175.539 . . . . . . . . 3 3 . 1 . 068 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.0 mt -70.81 137.28 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 173.129 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -131.69 -178.06 4.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.147 -168.797 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -42.21 110.62 0.18 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.926 2.491 . . . . 0.0 113.77 176.274 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 73.88 25.24 1.95 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.514 1.926 . . . . 0.0 111.829 172.458 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -62.14 128.76 37.65 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 119.182 -2.199 . . . . 0.0 110.262 179.722 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.9 m -91.12 107.6 19.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.216 1.006 . . . . 0.0 111.017 172.486 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.5 mt -97.01 147.56 23.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.432 1.893 . . . . 0.0 107.23 179.481 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -101.55 147.83 25.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 117.117 -1.42 . . . . 0.0 107.595 -174.181 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.19 142.97 46.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 125.095 2.379 . . . . 0.0 107.983 -179.631 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -138.42 159.59 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 O-C-N 119.353 -2.092 . . . . 0.0 105.468 173.191 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.85 134.78 57.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 112.528 -3.606 . . . . 0.0 118.151 151.24 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -82.54 128.81 34.65 Favored 'General case' 0 N--CA 1.448 -0.554 2 C-N-CA 132.93 4.492 . . . . 0.0 106.663 168.861 . . . . . . . . 2 2 . 1 . 068 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 mt -108.2 30.41 6.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 131.008 3.723 . . . . 0.0 112.708 -170.646 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.272 7.5 ttt180 86.93 34.66 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.33 1 C-N-CA 135.64 5.576 . . . . 0.0 108.008 166.071 . . . . . . . . 3 2 . 1 . 068 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.18 -173.16 13.24 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.441 170.644 . . . . . . . . 1 1 . 1 . 068 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 CA-C-O 116.923 -2.043 . . . . 0.0 115.168 174.875 . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttp . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 . . . . . . . . . 0 0 . 1 . 069 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -101.41 137.27 39.96 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 -177.369 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.492 9.7 pt -142.67 149.79 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 1 C-N-CA 133.08 4.552 . . . . 0.0 110.259 174.913 . . . . . . . . 3 2 . 1 . 069 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -108.96 141.35 41.19 Favored 'General case' 0 C--O 1.223 -0.312 1 N-CA-C 99.909 -4.108 . . . . 0.0 99.909 -175.602 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.15 119.57 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 124.249 1.02 . . . . 0.0 113.526 156.689 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -91.5 111.3 22.75 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 -178.971 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -65.95 162.55 18.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 124.644 2.164 . . . . 0.0 115.26 171.758 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.508 ' H ' HD21 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -68.53 -7.0 28.49 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 118.515 -2.615 . . . . 0.0 115.832 176.882 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -123.08 14.01 9.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 118.668 -2.52 . . . . 0.0 109.671 -176.826 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.16 -31.87 7.53 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 115.772 -2.682 . . . . 0.0 112.49 154.492 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -61.85 147.49 46.4 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 179.257 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.9 m -105.39 149.1 26.4 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 115.483 -2.199 . . . . 0.0 112.98 175.236 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.23 124.91 72.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 100.647 -3.834 . . . . 0.0 100.647 -179.623 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -78.14 134.18 37.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 117.227 -3.421 . . . . 0.0 110.525 162.612 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.4 mt -115.17 132.23 56.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 125.268 1.605 . . . . 0.0 109.141 167.892 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -97.38 117.21 31.09 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 127.42 2.95 . . . . 0.0 105.298 168.017 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -141.41 -171.52 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 125.054 1.342 . . . . 0.0 112.167 -175.32 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -136.88 146.8 56.55 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-O 115.673 -2.108 . . . . 0.0 108.246 -165.175 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.53 -29.05 83.55 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.645 2.897 . . . . 0.0 118.425 178.346 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.4 p -92.76 1.13 57.44 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 127.614 3.071 . . . . 0.0 114.248 -175.692 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.73 118.34 22.18 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -173.273 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.286 17.0 p -52.03 142.68 15.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 117.658 -3.151 . . . . 0.0 116.181 164.108 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.358 2.5 mm -31.23 -56.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 128.001 2.52 . . . . 0.0 114.977 174.405 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.252 12.9 mm-40 -53.71 -43.77 69.29 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.035 2.534 . . . . 0.0 117.573 172.588 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.417 6.6 m120 -59.95 -14.67 16.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 118.503 2.779 . . . . 0.0 118.503 165.296 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.352 61.7 t -97.7 -33.36 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.159 1.784 . . . . 0.0 110.18 174.696 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -75.55 -27.72 58.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.346 -1.788 . . . . 0.0 109.997 178.68 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.93 -56.67 18.64 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 129.578 3.151 . . . . 0.0 112.414 167.643 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.297 88.5 mttt -44.19 -29.92 0.71 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 164.272 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -77.72 -28.69 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 O-C-N 118.407 -2.683 . . . . 0.0 112.018 171.037 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -77.2 -35.02 56.08 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 122.576 2.443 . . . . 0.0 107.392 -174.388 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.57 -31.86 66.57 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 126.005 2.066 . . . . 0.0 108.886 177.735 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -92.85 -50.56 5.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 113.113 -3.327 . . . . 0.0 110.844 -177.136 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -112.54 -19.05 12.25 Favored 'General case' 0 N--CA 1.439 -0.983 1 O-C-N 130.346 4.779 . . . . 0.0 111.129 -155.806 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.34 -4.63 58.56 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 125.631 1.832 . . . . 0.0 116.183 174.083 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.54 112.89 35.18 Favored Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 130.926 3.691 . . . . 0.0 111.06 -172.642 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.57 150.77 87.67 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 O-C-N 123.377 1.198 . . . . 0.0 111.711 -173.677 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.422 50.8 Cg_exo -41.58 -50.67 4.65 Favored 'Trans proline' 0 N--CA 1.457 -0.639 1 C-N-CA 125.648 4.232 . . . . 0.0 116.939 167.833 . . . . . . . . 3 2 . 1 . 069 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.271 33.9 t70 -56.67 -22.92 38.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -178.681 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -95.52 -13.15 24.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 117.542 -3.224 . . . . 0.0 110.222 -173.807 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.261 77.7 mt-30 -94.19 136.26 34.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.957 -164.282 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.553 ' HG2' HE22 ' A' ' 49' ' ' GLN . 70.9 mtp180 -115.67 127.42 55.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 102.237 -3.245 . . . . 0.0 102.237 165.408 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.1 mt -102.62 119.79 39.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 124.525 1.141 . . . . 0.0 113.216 168.006 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.6 mm -114.63 152.72 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 128.947 2.899 . . . . 0.0 105.715 -170.016 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -168.0 127.04 1.25 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 112.013 -2.358 . . . . 0.0 106.556 176.532 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.417 . . 75.78 15.28 2.59 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 122.398 2.363 . . . . 0.0 116.044 167.068 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.49 17.44 31.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.856 2.646 . . . . 0.0 118.318 177.793 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 pttt -160.66 149.49 16.74 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -156.801 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.553 HE22 ' HG2' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -75.1 143.04 43.56 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 125.309 1.631 . . . . 0.0 108.021 178.094 . . . . . . . . 3 3 . 1 . 069 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.45 117.2 18.69 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.462 -1.399 . . . . 0.0 107.757 169.755 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -81.57 150.92 27.94 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 131.145 3.778 . . . . 0.0 113.657 -166.422 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -64.86 120.56 12.76 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.781 2.033 . . . . 0.0 107.647 -171.956 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.56 15.25 3.7 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.394 1.949 . . . . 0.0 113.172 165.139 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.337 20.1 mtt180 -133.68 146.71 51.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 123.071 1.415 . . . . 0.0 113.881 -161.438 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -107.85 149.86 27.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 124.077 1.894 . . . . 0.0 107.505 178.043 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 mt -34.19 -48.09 0.31 Allowed 'General case' 0 N--CA 1.448 -0.525 1 C-N-CA 132.419 4.288 . . . . 0.0 116.124 176.778 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.4 p -83.88 -6.39 59.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -179.432 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.352 31.1 t0 -101.17 -10.7 20.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.765 2.026 . . . . 0.0 107.713 176.372 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.88 -14.36 17.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 129.412 3.085 . . . . 0.0 111.703 173.974 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 73.23 39.58 0.59 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 127.238 2.836 . . . . 0.0 110.578 -175.412 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.6 mt -87.05 96.64 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 121.988 2.176 . . . . 0.0 111.075 172.062 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.84 169.51 17.77 Favored 'General case' 0 C--N 1.325 -0.498 1 C-N-CA 134.848 5.259 . . . . 0.0 112.442 177.32 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.291 0.0 OUTLIER -51.3 140.19 17.5 Favored 'General case' 0 N--CA 1.439 -0.988 1 C-N-CA 131.739 4.016 . . . . 0.0 111.539 175.915 . . . . . . . . 4 3 . 1 . 069 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 37.34 43.58 0.39 Allowed 'General case' 0 C--N 1.324 -0.518 1 C-N-CA 133.654 4.781 . . . . 0.0 112.699 -176.917 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -59.6 147.51 36.97 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.97 1.708 . . . . 0.0 113.34 154.964 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.4 m -112.61 126.04 54.94 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 128.387 3.554 . . . . 0.0 103.798 169.7 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.64 160.05 29.36 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 127.696 3.123 . . . . 0.0 106.173 171.355 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -126.54 113.39 16.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 101.696 -3.446 . . . . 0.0 101.696 -155.523 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.3 tp -92.22 120.95 33.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 111.893 -2.412 . . . . 0.0 111.22 175.733 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.27 12.1 m -127.32 154.52 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 127.172 2.189 . . . . 0.0 107.818 173.435 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.258 2.3 pp -125.48 148.58 48.8 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 120.372 1.442 . . . . 0.0 112.505 -172.282 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -87.08 -171.49 3.53 Favored 'General case' 0 N--CA 1.445 -0.692 1 C-N-CA 132.056 4.142 . . . . 0.0 111.168 172.683 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.2 mt -81.61 178.66 8.21 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.139 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.376 25.1 ttp-105 91.0 36.87 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 127.63 2.372 . . . . 0.0 112.163 175.858 . . . . . . . . 2 2 . 1 . 069 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.36 -0.1 5.88 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 122.702 1.168 . . . . 0.0 111.73 165.226 . . . . . . . . 1 1 . 1 . 069 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 O-C-N 117.918 -3.107 . . . . 0.0 109.999 -155.803 . . . . . . . . 0 0 . 1 . 070 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.527 ' H2 ' ' CD ' ' A' ' 16' ' ' GLU . 26.2 ptt? . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 . . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -86.64 131.16 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.008 1.323 . . . . 0.0 111.481 -172.174 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.4 pt -125.59 150.32 30.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 -175.536 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.273 2.2 m-85 -92.32 130.57 37.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.276 1.43 . . . . 0.0 108.764 168.29 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.37 96.93 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 O-C-N 127.639 3.087 . . . . 0.0 105.67 -177.093 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -85.22 123.69 31.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.01 -2.931 . . . . 0.0 104.499 -170.835 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -76.23 150.31 37.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 165.192 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.8 tp -59.88 -24.51 64.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -173.707 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -89.16 0.28 56.87 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 120.391 -1.443 . . . . 0.0 113.182 -179.696 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.5 -5.93 18.89 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 115.093 -3.06 . . . . 0.0 117.967 166.149 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -86.14 131.73 34.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 128.339 3.023 . . . . 0.0 106.633 -174.534 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -113.66 104.1 11.89 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.062 -172.274 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.2 mt -88.09 126.38 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -172.555 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 9.5 m -93.06 121.33 34.3 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 177.326 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.281 55.8 tp -144.61 144.24 31.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 119.991 -1.693 . . . . 0.0 111.16 -165.511 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.527 ' CD ' ' H2 ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -99.5 134.45 42.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 122.073 0.939 . . . . 0.0 109.103 -177.341 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.34 169.2 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 174.251 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -109.9 160.98 26.07 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 127.641 2.376 . . . . 0.0 110.374 164.531 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.64 -23.31 17.08 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 125.194 3.929 . . . . 0.0 115.283 -176.353 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -83.91 -1.21 54.07 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.856 -2.403 . . . . 0.0 114.644 -179.731 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -79.62 121.14 24.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.727 2.011 . . . . 0.0 107.306 -177.618 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.4 p -48.63 148.49 2.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 164.616 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.393 8.6 mm -38.3 -15.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 130.089 3.355 . . . . 0.0 118.382 173.46 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -94.21 -49.8 5.57 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 123.695 2.952 . . . . 0.0 107.4 -159.256 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -51.33 -32.7 26.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.898 2.079 . . . . 0.0 114.677 -155.239 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -73.03 -21.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 1 CA-C-O 129.67 4.557 . . . . 0.0 119.359 -178.993 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -69.81 -40.31 76.02 Favored 'General case' 0 N--CA 1.442 -0.85 1 O-C-N 114.41 -5.181 . . . . 0.0 115.091 -171.413 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.58 -23.34 49.99 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 112.453 -3.641 . . . . 0.0 111.34 170.764 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -63.18 -48.39 78.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.458 2.349 . . . . 0.0 113.382 166.087 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 mm -62.23 -42.12 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 126.28 1.832 . . . . 0.0 112.309 173.204 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -47.86 -43.75 28.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 166.996 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.42 -47.2 50.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.652 -173.836 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.28 -30.11 16.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 127.317 2.886 . . . . 0.0 115.706 -176.565 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -120.99 -0.73 9.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 121.682 2.037 . . . . 0.0 110.329 179.676 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.85 -0.05 87.7 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 118.258 -2.776 . . . . 0.0 116.494 166.692 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.6 mt -99.65 128.54 31.06 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 -170.768 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.84 155.0 58.59 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 121.818 3.738 . . . . 0.0 121.818 175.898 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -59.4 -32.17 96.08 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 124.868 3.712 . . . . 0.0 117.083 176.104 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.46 1.6 t0 -52.51 -21.48 3.83 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 163.311 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -106.28 -18.42 14.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.705 2.002 . . . . 0.0 111.755 -179.519 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -98.94 100.87 12.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 116.774 -3.704 . . . . 0.0 103.264 -172.321 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -108.73 138.6 44.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 110.352 -3.113 . . . . 0.0 104.135 166.672 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -148.51 161.72 41.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 121.654 2.025 . . . . 0.0 114.81 -168.612 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mp -129.28 131.54 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 1 C-N-CA 134.667 5.187 . . . . 0.0 112.31 -169.822 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -98.35 -50.06 4.46 Favored 'General case' 0 N--CA 1.449 -0.475 1 CA-C-O 111.577 -4.059 . . . . 0.0 114.574 161.613 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -162.35 43.36 0.13 Allowed 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 128.158 3.411 . . . . 0.0 108.054 -161.217 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.43 -69.85 0.49 Allowed Glycine 0 CA--C 1.531 1.048 0 CA-C-O 124.002 1.89 . . . . 0.0 116.686 163.778 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -54.66 132.93 46.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 162.011 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.431 HE21 ' HB3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -59.28 145.58 42.58 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 116.737 -1.985 . . . . 0.0 111.955 154.933 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.451 HD21 ' CE2' ' A' ' 59' ' ' TYR . 23.2 mt -91.08 116.98 29.23 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 123.567 1.651 . . . . 0.0 113.297 -175.498 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.271 32.1 tt0 -84.49 156.37 21.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 112.437 -2.165 . . . . 0.0 116.156 -167.67 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -65.59 141.89 58.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.281 1.832 . . . . 0.0 109.689 175.083 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.58 -42.44 1.91 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-O 115.474 -2.848 . . . . 0.0 111.585 -178.181 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 mmp_? -72.98 173.5 9.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 121.67 2.735 . . . . 0.0 117.111 -173.289 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -120.71 155.82 33.09 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 126.67 2.481 . . . . 0.0 104.925 174.868 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 49.7 mt -59.37 -29.86 68.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 125.382 2.515 . . . . 0.0 113.071 -176.882 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -47.57 -46.05 27.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 118.373 -2.704 . . . . 0.0 116.228 163.905 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -68.32 -12.32 60.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.406 -175.622 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.451 ' CE2' HD21 ' A' ' 50' ' ' LEU . 55.8 m-85 -106.67 1.37 25.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 128.169 2.587 . . . . 0.0 112.742 178.746 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 1.7 t30 66.14 39.16 4.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.173 1.389 . . . . 0.0 110.262 175.24 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -88.33 131.28 36.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 120.75 1.614 . . . . 0.0 110.289 -176.708 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.44 -176.14 3.12 Favored 'General case' 0 C--O 1.221 -0.406 1 O-C-N 116.235 -4.04 . . . . 0.0 110.403 -176.982 . . . . . . . . 3 3 . 1 . 070 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -55.8 146.7 20.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.617 1.967 . . . . 0.0 112.084 149.837 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 66.1 14.82 9.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.062 1.745 . . . . 0.0 112.317 176.418 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.0 m -71.02 155.85 40.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.508 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.6 m -113.5 120.87 42.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 129.461 3.105 . . . . 0.0 105.371 176.871 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.9 mp -110.86 140.73 45.07 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 114.274 -2.774 . . . . 0.0 106.089 170.481 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -129.49 138.95 51.67 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.224 1.81 . . . . 0.0 106.484 -174.691 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.59 151.51 22.26 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.819 177.53 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -105.85 109.49 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 131.388 3.875 . . . . 0.0 102.287 170.432 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.23 96.4 7.24 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 129.929 3.292 . . . . 0.0 104.446 -179.972 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 90.98 -71.28 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 131.102 3.761 . . . . 0.0 108.541 162.757 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mt -144.35 158.58 43.67 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 127.6 3.062 . . . . 0.0 105.071 -178.528 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -74.63 143.26 44.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.588 175.321 . . . . . . . . 1 1 . 1 . 070 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.7 79.81 0.31 Allowed Glycine 0 CA--C 1.534 1.234 1 C-N-CA 134.143 5.639 . . . . 0.0 109.407 -177.014 . . . . . . . . 2 2 . 1 . 070 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.991 2 C-N-CA 130.963 4.125 . . . . 0.0 105.42 -163.778 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 116.714 -1.612 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -109.03 139.44 43.9 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.032 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.11 152.19 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 128.461 2.704 . . . . 0.0 106.624 -172.76 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -105.51 140.98 37.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 124.531 2.11 . . . . 0.0 110.657 179.012 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.309 1.7 p -145.76 107.79 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.146 -178.823 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -84.23 137.2 33.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 126.038 2.086 . . . . 0.0 113.404 -173.395 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -78.91 170.68 16.3 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 113.803 -2.999 . . . . 0.0 111.615 -176.303 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tp -60.43 -13.78 15.4 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 126.936 2.648 . . . . 0.0 118.041 -175.759 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 p -107.74 -6.34 16.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.997 1.319 . . . . 0.0 110.808 -178.681 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.0 1.81 31.8 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 120.379 -1.451 . . . . 0.0 112.745 168.161 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 tttt -84.32 119.86 25.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 130.113 3.365 . . . . 0.0 102.127 -168.343 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 3.4 m -88.71 134.89 33.77 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 -167.104 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.5 mt -120.48 152.89 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.808 2.043 . . . . 0.0 110.061 169.254 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.286 1.5 m -118.58 123.1 44.22 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 169.955 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.9 mt -116.6 140.86 48.92 Favored 'General case' 0 N--CA 1.447 -0.59 1 C-N-CA 133.587 4.755 . . . . 0.0 111.348 -176.622 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.326 0.4 OUTLIER -99.27 120.01 38.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 101.387 -3.561 . . . . 0.0 101.387 167.228 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.88 -19.45 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 113.473 -3.156 . . . . 0.0 110.666 -168.769 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 0.1 OUTLIER 90.81 127.54 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-O 115.557 -2.163 . . . . 0.0 106.651 177.426 . . . . . . . . 3 3 . 1 . 071 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -74.72 -29.26 8.92 Favored 'Trans proline' 0 N--CA 1.452 -0.966 1 C-N-CA 125.688 4.259 . . . . 0.0 113.514 178.345 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -84.54 -7.73 59.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.448 3.099 . . . . 0.0 110.606 -178.342 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.5 -177.86 3.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 122.372 2.351 . . . . 0.0 109.355 178.645 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -130.43 167.79 18.03 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -173.321 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' CG2' ' HB3' ' A' ' 50' ' ' LEU . 2.8 mm -66.57 -38.02 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.636 1.575 . . . . 0.0 110.479 -164.735 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -56.66 -34.66 67.57 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 122.132 2.242 . . . . 0.0 109.902 -178.272 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -82.38 -2.11 52.01 Favored 'General case' 0 N--CA 1.445 -0.688 1 O-C-N 114.061 -5.4 . . . . 0.0 115.166 -178.498 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -88.98 -46.37 15.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 176.632 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HA ' HD13 ' A' ' 30' ' ' ILE . 58.1 mtmt -65.97 -29.77 70.21 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.169 0.988 . . . . 0.0 112.717 177.86 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.81 -41.11 79.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.932 2.493 . . . . 0.0 107.885 174.279 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -72.98 -30.08 63.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 173.958 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 27' ' ' LYS . 16.2 mt -67.48 -46.86 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 122.279 2.309 . . . . 0.0 111.533 169.019 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -49.75 -51.85 36.01 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 117.478 -3.264 . . . . 0.0 119.062 169.831 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -53.26 -38.05 62.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 128.602 2.761 . . . . 0.0 117.117 168.854 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -57.03 -62.81 1.49 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.46 1.504 . . . . 0.0 111.836 172.917 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.309 5.9 mm-40 -131.56 -8.7 3.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 125.493 2.568 . . . . 0.0 113.778 -157.361 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.82 32.85 6.32 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 119.955 -1.716 . . . . 0.0 115.993 178.022 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mm -82.58 130.04 60.29 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 127.889 2.476 . . . . 0.0 107.975 -167.495 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.88 127.9 15.16 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.312 2.008 . . . . 0.0 112.062 172.923 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.91 -34.99 7.88 Favored 'Trans proline' 0 N--CA 1.447 -1.219 1 C-N-CA 127.391 5.394 . . . . 0.0 112.518 -169.315 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -68.73 -19.97 64.37 Favored 'General case' 0 C--N 1.321 -0.633 1 C-N-CA 135.418 5.487 . . . . 0.0 110.244 -172.869 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -94.97 -3.74 47.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.893 1.677 . . . . 0.0 108.495 -176.914 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 10.2 mm100 -96.1 107.49 19.8 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 130.261 3.424 . . . . 0.0 111.446 -172.296 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -94.16 101.66 13.67 Favored 'General case' 0 N--CA 1.444 -0.761 1 C-N-CA 132.759 4.424 . . . . 0.0 107.24 167.919 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 41' ' ' GLN . 11.2 mp -103.5 101.93 11.82 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 127.536 2.334 . . . . 0.0 111.4 -174.332 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.6 mm -108.69 142.3 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 123.704 1.716 . . . . 0.0 107.225 179.209 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -124.79 105.17 9.07 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 112.529 -2.123 . . . . 0.0 109.508 173.671 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.84 42.1 15.45 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 127.12 3.343 . . . . 0.0 117.048 176.791 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.9 -14.5 52.65 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 109.401 -3.545 . . . . 0.0 118.735 178.325 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.25 77.3 mttt -115.1 130.34 56.9 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -166.374 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.33 48.3 tt0 -48.33 142.34 5.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 121.345 3.832 . . . . 0.0 121.345 162.319 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.407 ' HB3' ' CG2' ' A' ' 23' ' ' ILE . 87.8 mt -98.02 105.49 17.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 172.481 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -88.07 140.81 29.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 -175.706 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -81.09 141.64 34.11 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 124.161 3.164 . . . . 0.0 103.047 173.269 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.16 -29.67 6.66 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -175.664 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.39 150.4 23.83 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 127.31 2.418 . . . . 0.0 113.202 176.475 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.452 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 34.2 p -77.9 156.92 30.03 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.398 -1.273 . . . . 0.0 109.537 166.151 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.4 mt -74.6 -31.94 62.19 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.553 1.941 . . . . 0.0 109.589 -178.033 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.1 t -75.33 -12.67 60.32 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 120.414 -1.428 . . . . 0.0 112.572 175.917 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.452 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 53.9 m-20 -66.05 -34.32 77.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 123.679 2.945 . . . . 0.0 112.65 169.518 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -91.59 7.08 43.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 127.234 2.834 . . . . 0.0 116.283 172.889 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.368 81.1 m-20 76.53 36.2 0.38 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.977 1.711 . . . . 0.0 113.304 171.285 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.4 mt -82.03 99.32 5.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 171.019 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -110.07 -172.92 2.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 129.978 3.311 . . . . 0.0 113.926 179.48 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.05 140.86 0.99 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 128.317 2.647 . . . . 0.0 117.202 173.71 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 6.7 tm-20 73.62 4.19 4.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 122.439 2.382 . . . . 0.0 114.449 162.823 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.2 m -72.54 132.14 43.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.572 -1.649 . . . . 0.0 107.913 -173.217 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.0 p -105.68 142.36 35.55 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 125.071 1.482 . . . . 0.0 108.109 167.198 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.29 165.91 26.18 Favored 'General case' 0 N--CA 1.446 -0.636 1 C-N-CA 131.838 4.055 . . . . 0.0 105.692 167.261 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -99.54 161.58 13.53 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 126.022 2.82 . . . . 0.0 104.486 165.894 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.2 tp -148.11 132.56 17.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 118.762 -2.461 . . . . 0.0 110.224 -179.56 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -68.34 89.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 127.023 3.296 . . . . 0.0 104.529 163.812 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp -153.72 148.93 26.96 Favored 'General case' 0 N--CA 1.443 -0.812 1 N-CA-C 98.601 -4.592 . . . . 0.0 98.601 175.427 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -77.75 157.46 30.02 Favored 'General case' 0 N--CA 1.441 -0.9 1 C-N-CA 133.251 4.621 . . . . 0.0 107.367 -175.1 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -12.28 61.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 125.774 2.702 . . . . 0.0 115.468 -176.004 . . . . . . . . 2 2 . 1 . 071 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -82.62 100.81 10.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 118.964 -2.335 . . . . 0.0 110.057 -175.651 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.73 -73.09 0.21 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 127.875 2.655 . . . . 0.0 111.841 161.348 . . . . . . . . 1 1 . 1 . 071 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 N-CA-C 103.23 -3.948 . . . . 0.0 103.23 169.059 . . . . . . . . 0 0 . 1 . 072 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ttp . . . . . 0 C--O 1.24 0.568 1 N-CA-C 99.492 -4.262 . . . . 0.0 99.492 . . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -94.37 136.15 34.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 123.082 2.674 . . . . 0.0 110.694 167.966 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.27 161.25 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 102.902 -2.999 . . . . 0.0 102.902 170.401 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -117.25 149.76 39.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.045 1.738 . . . . 0.0 113.481 -171.67 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.343 16.3 m -141.69 165.0 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 128.681 2.792 . . . . 0.0 112.41 169.062 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -149.78 142.17 24.29 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -169.367 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -136.72 -145.21 0.21 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 129.08 2.952 . . . . 0.0 108.604 175.246 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -96.29 -55.01 3.08 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 121.357 1.889 . . . . 0.0 108.254 -169.036 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -84.98 -27.1 26.71 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.295 1.838 . . . . 0.0 114.276 -179.917 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.94 123.95 7.15 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 106.505 -2.638 . . . . 0.0 106.505 175.269 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -102.86 -29.04 11.69 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.011 2.524 . . . . 0.0 107.383 -174.683 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -137.28 96.37 3.26 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 114.283 -2.77 . . . . 0.0 104.497 -177.233 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.9 mt -103.29 109.32 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 1 N-CA-C 98.541 -4.614 . . . . 0.0 98.541 165.009 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.271 62.8 p -86.77 131.48 34.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 173.922 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -128.61 120.72 27.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.436 -2.802 . . . . 0.0 103.436 -175.603 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -96.01 120.39 36.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.611 3.564 . . . . 0.0 105.681 -178.435 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 m -143.4 159.01 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 O-C-N 117.482 -3.261 . . . . 0.0 108.057 -170.07 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.71 151.29 37.37 Favored Pre-proline 0 N--CA 1.447 -0.606 1 C-N-CA 132.618 4.367 . . . . 0.0 100.764 163.644 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.281 73.1 Cg_endo -64.47 8.7 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.966 2.444 . . . . 0.0 116.443 -179.927 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.3 p -128.34 16.87 6.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 129.345 3.058 . . . . 0.0 115.93 168.753 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.263 1.0 OUTLIER -41.0 117.21 0.82 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 158.813 . . . . . . . . 3 3 . 1 . 072 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 p -73.68 151.18 40.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.947 2.899 . . . . 0.0 108.823 179.687 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.31 1.1 mm -50.77 -41.03 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 126.779 2.032 . . . . 0.0 109.501 176.438 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -57.9 -41.48 82.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 171.143 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -65.15 -50.42 66.07 Favored 'General case' 0 N--CA 1.45 -0.452 1 O-C-N 116.159 -4.088 . . . . 0.0 113.962 171.342 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.84 -54.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 122.684 2.493 . . . . 0.0 112.426 168.649 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -53.04 -47.57 68.29 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.029 2.932 . . . . 0.0 115.904 170.68 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.47 -52.96 33.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 117.141 -3.474 . . . . 0.0 118.791 159.012 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -62.05 -33.36 74.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 128.882 2.873 . . . . 0.0 110.268 -176.508 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.4 mt -76.39 -48.55 27.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 129.014 2.926 . . . . 0.0 106.842 173.227 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -49.85 -49.5 49.0 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 128.94 2.896 . . . . 0.0 113.144 176.94 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -49.3 -31.95 10.08 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 128.919 2.888 . . . . 0.0 114.883 -174.054 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -105.0 -64.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 127.782 3.176 . . . . 0.0 111.196 178.353 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -81.45 -27.87 34.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -159.118 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.61 0.65 43.1 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 170.797 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.5 mm -80.61 122.05 81.92 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 120.869 2.335 . . . . 0.0 107.764 -170.806 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.562 ' HD2' HE21 ' A' ' 40' ' ' GLN . 18.6 Cg_endo -76.53 156.02 36.16 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 CA-C-O 114.356 -2.435 . . . . 0.0 112.95 175.402 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.26 -21.42 1.18 Allowed 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 122.522 2.148 . . . . 0.0 115.525 170.915 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -81.26 -22.14 38.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 117.845 -3.034 . . . . 0.0 116.814 -175.623 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.562 HE21 ' HD2' ' A' ' 37' ' ' PRO . 9.3 tt0 -105.61 3.43 29.18 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -166.525 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -128.47 128.9 45.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.346 2.258 . . . . 0.0 105.052 -171.237 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 mtt85 -90.41 170.22 10.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 124.952 2.311 . . . . 0.0 105.121 158.006 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.386 30.7 tp -138.19 112.02 8.35 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 112.71 -2.041 . . . . 0.0 107.783 176.606 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.31 140.99 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 127.445 3.498 . . . . 0.0 105.189 173.714 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.54 145.17 22.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 119.247 -2.158 . . . . 0.0 105.41 151.592 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.67 22.46 5.36 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 125.778 1.924 . . . . 0.0 111.3 175.43 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.8 -12.89 61.0 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 116.414 -2.325 . . . . 0.0 108.325 174.408 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -108.69 127.35 53.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 120.849 2.324 . . . . 0.0 106.157 -159.04 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -61.58 93.58 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.907 2.883 . . . . 0.0 105.069 165.713 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.8 mt -64.94 130.51 43.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 119.389 -2.069 . . . . 0.0 113.571 172.3 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -86.65 146.45 26.31 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 125.718 1.886 . . . . 0.0 114.562 -176.732 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.305 14.5 m-20 -68.33 112.85 5.45 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 126.975 2.672 . . . . 0.0 115.103 168.703 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.15 -23.59 2.41 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.253 -1.304 . . . . 0.0 114.862 -169.559 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -110.06 162.57 14.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 -161.796 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -101.73 165.98 10.92 Favored 'General case' 0 N--CA 1.448 -0.561 1 C-N-CA 132.583 4.353 . . . . 0.0 113.313 168.525 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.9 mt -42.03 -45.51 3.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 116.237 -1.84 . . . . 0.0 113.909 168.833 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -64.68 -14.95 60.48 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 130.199 3.4 . . . . 0.0 113.972 -176.532 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -75.92 -35.47 59.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.711 0.404 . . . . 0.0 110.518 172.809 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -114.26 12.5 17.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 -173.193 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 9.2 m120 65.27 28.94 11.86 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 126.665 1.986 . . . . 0.0 115.306 161.977 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -93.29 137.43 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 128.496 3.998 . . . . 0.0 103.841 -160.384 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -111.4 -168.75 1.35 Allowed 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 116.928 -3.608 . . . . 0.0 109.993 176.97 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -78.48 149.86 33.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 118.876 -2.39 . . . . 0.0 113.18 -170.233 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 31.4 mt-10 66.52 9.35 6.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 130.75 3.62 . . . . 0.0 112.963 174.889 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -72.51 165.75 24.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.919 1.688 . . . . 0.0 108.075 174.81 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 m -121.86 130.26 53.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.067 2.947 . . . . 0.0 109.683 176.414 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 mp -104.8 169.48 8.43 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 119.543 -1.973 . . . . 0.0 111.26 158.057 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -119.77 126.5 51.2 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.6 2.36 . . . . 0.0 113.623 177.088 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 3.9 tt -98.85 131.39 44.99 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -177.131 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.9 123.9 71.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 174.893 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 mt -89.23 164.95 14.74 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.774 2.43 . . . . 0.0 110.148 179.42 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -120.62 50.87 1.28 Allowed 'General case' 0 N--CA 1.447 -0.625 1 C-N-CA 135.714 5.605 . . . . 0.0 109.33 177.968 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.3 mt -80.76 -34.71 34.06 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.659 1.983 . . . . 0.0 106.546 167.168 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.274 34.1 ptt85 -154.54 116.36 4.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.348 2.659 . . . . 0.0 108.285 179.427 . . . . . . . . 2 2 . 1 . 072 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.77 -144.37 8.17 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 123.735 1.742 . . . . 0.0 116.058 -175.202 . . . . . . . . 1 1 . 1 . 072 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 C-N-CA 128.627 3.013 . . . . 0.0 112.335 -174.971 . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptm . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 124.935 2.302 . . . . 0.0 109.786 . . . . . . . . . 0 0 . 1 . 073 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -85.84 121.87 29.1 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 117.603 -3.186 . . . . 0.0 109.268 170.054 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pt -137.44 117.93 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 128.338 2.655 . . . . 0.0 104.59 170.871 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -83.16 112.92 20.27 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 117.803 -3.061 . . . . 0.0 109.213 -173.259 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.4 t -85.05 100.55 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 O-C-N 117.999 -2.938 . . . . 0.0 106.89 170.797 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -103.5 119.52 39.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.3 1.44 . . . . 0.0 107.245 -167.955 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m -81.57 144.6 31.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.245 1.818 . . . . 0.0 109.437 174.89 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -37.8 -51.11 1.27 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -178.648 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 p -62.07 -10.49 10.27 Favored 'General case' 0 N--CA 1.444 -0.728 1 O-C-N 129.366 4.166 . . . . 0.0 114.751 -178.057 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.2 -24.14 16.86 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.755 1.862 . . . . 0.0 117.755 179.752 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -62.59 123.02 17.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 127.329 2.252 . . . . 0.0 109.374 -177.253 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.278 8.4 m -114.8 113.28 24.04 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.976 2.11 . . . . 0.0 115.652 -174.108 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.7 mt -90.44 148.0 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 O-C-N 126.495 2.372 . . . . 0.0 106.528 -172.445 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.318 4.7 t -155.19 100.04 2.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 -163.906 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -140.78 127.98 20.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.635 -2.075 . . . . 0.0 110.653 -161.101 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.79 93.61 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.456 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -125.84 169.81 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 126.689 1.995 . . . . 0.0 107.815 169.799 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -138.17 158.9 70.16 Favored Pre-proline 0 N--CA 1.445 -0.713 1 C-N-CA 132.035 4.134 . . . . 0.0 107.068 -176.24 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.16 -9.03 14.12 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 O-C-N 125.58 2.358 . . . . 0.0 117.992 -168.605 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 t -92.74 4.42 53.79 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.455 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -73.18 134.23 44.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 117.267 -3.396 . . . . 0.0 111.428 175.902 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -76.29 157.25 32.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 125.03 2.348 . . . . 0.0 112.926 175.902 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.268 2.7 mm -64.52 -31.5 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 O-C-N 117.207 -3.433 . . . . 0.0 118.315 -172.12 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.03 -35.85 25.45 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.926 2.091 . . . . 0.0 111.557 178.137 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.367 10.3 t-20 -51.72 -48.94 63.4 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 127.037 2.711 . . . . 0.0 113.669 158.651 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.87 -40.43 85.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 121.898 2.136 . . . . 0.0 113.067 171.681 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.261 44.7 mtpt -64.84 -36.33 83.99 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.153 1.781 . . . . 0.0 110.833 -178.376 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.14 -14.25 62.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.449 2.299 . . . . 0.0 112.527 -176.308 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -83.13 -27.81 29.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 123.633 0.583 . . . . 0.0 111.594 173.953 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.3 mt -82.57 -18.65 10.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.907 -164.967 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -77.26 -30.14 54.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 125.14 1.525 . . . . 0.0 112.484 176.362 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -70.91 -57.41 4.62 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 119.367 -2.083 . . . . 0.0 110.979 165.886 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -82.66 -28.59 30.56 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.157 1.783 . . . . 0.0 114.327 -161.438 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -118.23 -5.99 10.86 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 124.403 1.064 . . . . 0.0 110.601 178.733 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.22 -0.08 26.09 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 129.733 3.54 . . . . 0.0 117.923 -175.677 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.6 mm -82.8 138.88 43.34 Favored Pre-proline 0 N--CA 1.447 -0.597 1 O-C-N 115.376 -4.602 . . . . 0.0 104.165 -172.275 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -86.03 167.29 9.56 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 125.027 3.818 . . . . 0.0 105.589 176.254 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.61 ' HA ' HE21 ' A' ' 41' ' ' GLN . 73.2 Cg_endo -81.98 -22.16 5.32 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.64 2.227 . . . . 0.0 116.237 168.507 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.37 0.0 OUTLIER -54.52 -49.73 69.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 129.747 3.219 . . . . 0.0 109.668 -179.459 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.29 71.0 mm-40 -78.8 -22.26 46.55 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 120.458 1.481 . . . . 0.0 114.943 178.116 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.61 HE21 ' HA ' ' A' ' 38' ' ' PRO 0.307 7.1 tt0 -86.21 154.46 21.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.488 1.915 . . . . 0.0 113.542 -156.527 . . . . . . . . 3 3 . 1 . 073 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.319 23.6 ttm105 -153.35 140.4 19.32 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 128.381 2.672 . . . . 0.0 112.75 -178.247 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.3 mt -125.0 131.96 53.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 116.85 -1.548 . . . . 0.0 111.708 -177.937 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.53 120.67 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.282 1.833 . . . . 0.0 112.742 179.234 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.294 22.6 t80 -120.7 119.84 33.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 115.992 -1.956 . . . . 0.0 108.078 176.908 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.46 25.41 9.63 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 126.239 2.212 . . . . 0.0 116.928 -178.967 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.27 -15.28 63.29 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.739 1.637 . . . . 0.0 112.406 -174.73 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.13 113.76 26.11 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 124.025 3.912 . . . . 0.0 105.494 -173.444 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -66.77 136.7 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 126.338 2.97 . . . . 0.0 107.77 168.189 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -84.97 134.95 34.23 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 118.608 -2.558 . . . . 0.0 113.168 179.134 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.24 158.27 16.68 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -178.733 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -73.16 155.08 39.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.984 2.514 . . . . 0.0 111.902 177.829 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.13 -15.56 62.61 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.767 2.127 . . . . 0.0 116.303 171.213 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -91.21 161.0 15.25 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -167.821 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -84.77 166.78 16.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.923 0.868 . . . . 0.0 108.945 170.499 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.0 -41.37 91.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 118.978 -2.326 . . . . 0.0 116.905 168.088 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 t -53.92 -23.91 14.49 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 130.04 3.336 . . . . 0.0 116.069 170.307 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -74.27 -18.06 60.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 115.38 -2.248 . . . . 0.0 115.23 172.266 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -103.45 5.83 37.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.243 1.383 . . . . 0.0 110.979 172.401 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 73.72 33.73 1.0 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.119 1.368 . . . . 0.0 110.007 175.137 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -90.57 136.91 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 119.342 -2.099 . . . . 0.0 112.071 -170.608 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -130.69 174.05 10.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.013 1.725 . . . . 0.0 112.669 -162.786 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -58.26 121.23 10.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.154 2.181 . . . . 0.0 111.56 -177.995 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.368 12.4 mt-10 61.57 34.03 18.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 130.807 3.643 . . . . 0.0 113.77 178.454 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.258 24.4 m -83.76 157.72 22.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 159.481 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -126.4 135.46 51.45 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.468 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.254 3.9 mp -98.68 143.1 29.43 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 128.332 2.653 . . . . 0.0 107.51 172.081 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -72.43 148.87 44.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 124.674 2.178 . . . . 0.0 109.405 159.534 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -135.23 131.16 36.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.422 169.376 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.37 152.65 36.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 128.336 2.654 . . . . 0.0 110.922 170.49 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.41 120.88 33.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 130.309 3.444 . . . . 0.0 109.496 178.489 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.646 14.2 ttt85 93.36 -10.07 0.15 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.12 2.168 . . . . 0.0 116.227 162.918 . . . . . . . . 2 2 . 1 . 073 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.384 4.6 pp -140.18 156.05 46.68 Favored 'General case' 0 N--CA 1.448 -0.535 1 CA-C-O 111.54 -4.076 . . . . 0.0 116.875 -177.955 . . . . . . . . 3 2 . 1 . 073 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -108.56 64.46 0.61 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 127.711 3.132 . . . . 0.0 115.801 -177.71 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.28 127.9 5.63 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 127.948 2.689 . . . . 0.0 107.939 178.868 . . . . . . . . 1 1 . 1 . 073 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.684 1 N-CA-C 101.457 -4.657 . . . . 0.0 101.457 158.621 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttp . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 . . . . . . . . . 0 0 . 1 . 074 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -95.08 140.87 29.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.514 -1.675 . . . . 0.0 110.111 -178.49 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -145.09 159.58 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 128.075 2.55 . . . . 0.0 107.174 167.313 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -106.43 153.3 22.46 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 117.409 -3.307 . . . . 0.0 105.946 171.806 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.8 t -118.85 130.01 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 166.827 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -111.01 138.35 47.52 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.418 1.087 . . . . 0.0 108.128 173.789 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.7 p -88.35 140.51 29.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 164.557 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -60.47 -17.76 47.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 117.03 -3.544 . . . . 0.0 115.88 -177.15 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -80.49 -5.84 57.25 Favored 'General case' 0 C--N 1.322 -0.589 2 C-N-CA 131.97 4.108 . . . . 0.0 112.716 165.724 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.37 -7.95 43.86 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 118.306 2.082 . . . . 0.0 118.306 165.142 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -58.15 152.27 17.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 117.916 -3.108 . . . . 0.0 112.547 163.583 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.0 p -134.15 161.31 35.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.628 1.204 . . . . 0.0 109.776 161.948 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -142.42 154.8 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 102.173 -3.269 . . . . 0.0 102.173 169.385 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -97.54 126.38 42.79 Favored 'General case' 0 N--CA 1.444 -0.773 1 C-N-CA 132.116 4.167 . . . . 0.0 103.36 -175.038 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.15 101.35 8.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 131.386 3.874 . . . . 0.0 111.687 -176.8 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.3 pm0 -76.47 126.16 30.5 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 127.174 2.796 . . . . 0.0 105.473 163.539 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.432 31.5 m -135.84 165.01 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 1 C-N-CA 133.368 4.667 . . . . 0.0 116.468 -175.674 . . . . . . . . 3 2 . 1 . 074 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.67 159.78 37.42 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 125.879 1.671 . . . . 0.0 111.124 166.686 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.352 97.7 Cg_endo -58.62 -40.59 72.22 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 N-CA-C 120.26 3.139 . . . . 0.0 120.26 177.256 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -73.15 -14.74 61.43 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 130.24 3.416 . . . . 0.0 109.89 -171.644 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -65.55 127.3 31.31 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 124.98 2.324 . . . . 0.0 112.74 -175.725 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.9 p -70.06 156.09 39.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.376 175.244 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.76 -37.0 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.577 1.151 . . . . 0.0 111.506 166.101 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -48.06 -48.61 33.22 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.691 1.996 . . . . 0.0 114.338 166.749 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -73.32 -43.3 61.12 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 118.006 -2.934 . . . . 0.0 112.774 174.59 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.315 29.9 t -58.57 -31.47 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 118.012 -2.93 . . . . 0.0 112.022 170.653 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -64.95 -39.27 93.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 123.145 2.702 . . . . 0.0 111.339 169.302 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.46 -31.36 53.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 111.944 -3.884 . . . . 0.0 114.704 175.491 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -62.95 -50.97 68.7 Favored 'General case' 0 N--CA 1.452 -0.357 1 O-C-N 132.857 6.348 . . . . 0.0 109.659 167.443 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mt -53.05 -46.18 53.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 1 O-C-N 115.517 -4.489 . . . . 0.0 109.424 173.442 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -34.64 77.8 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 112.741 -3.504 . . . . 0.0 111.51 -179.964 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.67 -32.37 69.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 128.457 3.598 . . . . 0.0 109.851 176.058 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -78.43 -34.48 47.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 121.754 2.07 . . . . 0.0 113.5 173.759 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -145.98 -19.46 0.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -151.818 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.39 -4.68 54.73 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 128.374 2.892 . . . . 0.0 114.003 158.279 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mt -65.19 115.48 21.77 Favored Pre-proline 0 N--CA 1.445 -0.701 0 O-C-N 119.027 -2.455 . . . . 0.0 111.979 173.942 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.1 153.42 62.69 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 CA-C-O 112.085 -3.381 . . . . 0.0 117.425 -178.198 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.68 -34.96 55.72 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 125.134 3.889 . . . . 0.0 118.727 -166.7 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.01 -23.81 35.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.464 0.649 . . . . 0.0 109.846 -168.338 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.397 12.3 mm100 -87.01 -0.69 57.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.922 2.489 . . . . 0.0 111.203 178.748 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -95.22 145.67 24.89 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.482 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -138.3 134.61 34.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.547 2.739 . . . . 0.0 104.359 161.232 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mt -114.89 139.02 50.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 113.401 -3.19 . . . . 0.0 107.943 -177.234 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mm -129.87 131.88 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 129.623 3.169 . . . . 0.0 106.516 -174.718 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -113.11 -38.0 4.6 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 158.767 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.257 . . -124.95 -120.34 0.27 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 118.034 -2.916 . . . . 0.0 107.831 -172.641 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.52 13.96 42.8 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 125.982 3.992 . . . . 0.0 111.668 -177.014 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -145.01 -175.86 4.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 115.098 -2.382 . . . . 0.0 109.742 -176.967 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -78.73 156.32 28.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 126.187 2.179 . . . . 0.0 111.831 169.946 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.8 mt -95.45 144.52 25.88 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 163.836 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.92 129.21 46.74 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.211 2.204 . . . . 0.0 110.825 -168.941 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -42.52 -52.62 4.66 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 120.822 3.638 . . . . 0.0 120.822 -171.161 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.71 5.19 73.13 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 114.091 -3.616 . . . . 0.0 111.131 -175.212 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -92.6 150.8 20.49 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 119.866 1.833 . . . . 0.0 111.287 159.813 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.342 7.1 p -91.1 156.73 17.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 129.622 3.169 . . . . 0.0 113.389 -177.764 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -43.11 -49.22 6.35 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.55 3.14 . . . . 0.0 112.516 164.761 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.378 45.3 p -55.91 -40.36 72.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 172.895 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -58.52 -47.72 83.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 118.348 -2.72 . . . . 0.0 110.762 -176.091 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.393 40.3 m-85 -90.06 4.14 51.15 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.061 177.887 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 t30 74.8 33.84 0.75 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.306 2.242 . . . . 0.0 114.017 156.51 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.1 mm -72.23 127.81 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 100.902 -3.74 . . . . 0.0 100.902 -171.802 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -92.34 155.66 17.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.063 1.745 . . . . 0.0 107.354 175.761 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.03 146.12 2.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.74 2.416 . . . . 0.0 115.372 173.892 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.373 1.6 tt0 58.0 19.1 5.62 Favored 'General case' 0 N--CA 1.443 -0.793 1 C-N-CA 133.112 4.565 . . . . 0.0 118.534 -174.741 . . . . . . . . 3 2 . 1 . 074 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.9 m -70.57 145.14 50.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.392 2.368 . . . . 0.0 117.392 169.216 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 m -90.26 140.27 29.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 103.186 -2.894 . . . . 0.0 103.186 179.157 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.4 mt -108.78 145.53 35.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 128.393 2.677 . . . . 0.0 110.525 154.699 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -104.73 137.92 41.81 Favored 'General case' 0 N--CA 1.45 -0.466 1 N-CA-C 100.091 -4.04 . . . . 0.0 100.091 174.992 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.4 tp -124.53 113.54 18.23 Favored 'General case' 0 N--CA 1.445 -0.677 1 C-N-CA 134.757 5.223 . . . . 0.0 107.436 -174.459 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.7 t -78.07 129.61 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 102.284 -3.228 . . . . 0.0 102.284 163.032 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.27 112.22 14.24 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 124.405 2.05 . . . . 0.0 106.195 171.768 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 mtm105 -80.23 48.75 1.04 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 117.641 2.459 . . . . 0.0 117.641 -170.482 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -153.34 19.36 0.56 Allowed 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 127.953 3.283 . . . . 0.0 114.567 -176.256 . . . . . . . . 1 1 . 1 . 074 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -42.46 19.6 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 117.497 -1.239 . . . . 0.0 108.682 -179.686 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.08 -14.1 19.18 Favored Glycine 0 CA--C 1.528 0.898 1 C-N-CA 131.783 4.516 . . . . 0.0 115.437 176.078 . . . . . . . . 2 2 . 1 . 074 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.333 0 N-CA-C 104.87 -3.292 . . . . 0.0 104.87 -172.403 . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ptt? . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 116.628 -1.653 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 075 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -112.67 145.53 40.28 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 123.516 2.871 . . . . 0.0 113.75 -177.835 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -135.53 155.19 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 128.03 2.532 . . . . 0.0 109.299 167.524 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -111.86 132.05 54.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 131.315 3.846 . . . . 0.0 108.787 -176.901 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 67' ' ' LEU . 93.3 t -121.67 128.79 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 172.732 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.324 59.2 mmtt -97.98 140.94 31.57 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 117.596 -3.19 . . . . 0.0 110.464 163.436 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.5 p -86.67 -176.72 5.92 Favored 'General case' 0 N--CA 1.44 -0.936 1 C-N-CA 131.914 4.086 . . . . 0.0 105.069 179.911 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.08 -46.4 57.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.236 2.615 . . . . 0.0 105.262 -178.701 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -78.58 -12.24 60.01 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.678 1.591 . . . . 0.0 112.29 -173.189 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.77 9.23 26.95 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 106.116 -2.794 . . . . 0.0 106.116 160.532 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -71.48 136.28 47.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 121.85 2.825 . . . . 0.0 110.223 170.54 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.2 m -97.23 119.76 36.34 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 128.054 3.346 . . . . 0.0 106.705 179.349 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mt -103.32 125.14 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 O-C-N 126.532 2.395 . . . . 0.0 106.915 178.358 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.2 p -109.81 124.56 51.5 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 119.948 1.249 . . . . 0.0 109.268 170.608 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.24 150.67 28.36 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.441 1.897 . . . . 0.0 107.23 175.741 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -85.37 109.4 18.38 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 131.022 3.729 . . . . 0.0 102.83 166.962 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.24 159.76 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 175.451 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -121.48 159.59 49.71 Favored Pre-proline 0 N--CA 1.45 -0.457 0 C-N-CA 131.58 3.952 . . . . 0.0 111.903 166.34 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.263 22.5 Cg_exo -61.15 -19.37 63.19 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 N-CA-C 118.019 2.276 . . . . 0.0 118.019 -172.459 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.27 0.2 OUTLIER -90.57 -2.36 57.88 Favored 'General case' 0 N--CA 1.446 -0.653 1 C-N-CA 131.877 4.071 . . . . 0.0 115.328 178.724 . . . . . . . . 4 3 . 1 . 075 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -71.43 135.37 47.18 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 118.639 -2.538 . . . . 0.0 112.549 168.675 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.1 p -82.07 164.6 21.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 177.464 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.8 mm -56.81 -36.82 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 116.878 -3.639 . . . . 0.0 113.341 -178.41 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.253 13.1 tp10 -67.63 -37.54 82.6 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 127.106 2.754 . . . . 0.0 111.188 178.395 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.09 -48.65 79.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.352 2.261 . . . . 0.0 111.658 177.833 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 t -60.39 -38.9 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 127.056 2.723 . . . . 0.0 112.271 178.156 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -80.69 -20.78 42.18 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 118.717 -2.49 . . . . 0.0 110.207 -177.551 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.91 -29.67 39.86 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 115.207 -2.33 . . . . 0.0 111.485 172.986 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -72.97 -23.74 60.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 168.317 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -73.28 -42.8 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 129.833 3.253 . . . . 0.0 111.03 170.286 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -64.42 -42.34 96.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 116.636 -1.649 . . . . 0.0 109.692 172.704 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.59 -56.2 24.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 121.827 2.103 . . . . 0.0 113.254 173.306 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -77.54 -31.97 53.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 112.993 -1.912 . . . . 0.0 115.597 -172.989 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -142.9 -7.41 0.83 Allowed 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 117.947 -2.971 . . . . 0.0 110.977 -167.51 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.95 13.07 54.43 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 126.553 2.025 . . . . 0.0 112.405 156.212 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.9 mt -88.76 127.05 57.62 Favored Pre-proline 0 N--CA 1.446 -0.646 0 O-C-N 117.704 -3.233 . . . . 0.0 108.955 -178.616 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.73 154.97 20.57 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 N-CA-C 106.945 -1.983 . . . . 0.0 106.945 -165.612 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -68.97 -29.62 27.41 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 CA-C-O 115.359 -2.017 . . . . 0.0 112.34 176.553 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.43 118.17 9.01 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 113.731 -3.033 . . . . 0.0 115.014 171.527 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 81.45 1.63 1.57 Allowed 'General case' 0 C--N 1.321 -0.634 1 C-N-CA 132.116 4.166 . . . . 0.0 112.955 179.414 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -99.49 121.31 40.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 100.797 -3.779 . . . . 0.0 100.797 173.191 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -105.04 152.05 23.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 111.866 -2.424 . . . . 0.0 107.42 169.796 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -121.28 110.93 16.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 126.917 2.636 . . . . 0.0 113.188 174.661 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.2 mt -94.27 148.07 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 124.892 2.282 . . . . 0.0 110.01 173.427 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -126.83 107.45 10.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 100.426 -3.916 . . . . 0.0 100.426 173.108 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 76.0 -104.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 101.916 -3.364 . . . . 0.0 101.916 178.969 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.97 8.5 6.78 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 129.419 3.39 . . . . 0.0 112.707 173.617 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -86.23 105.59 16.71 Favored 'General case' 0 C--N 1.325 -0.471 1 C-N-CA 132.9 4.48 . . . . 0.0 112.056 173.204 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -66.32 134.02 51.73 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 115.421 -2.228 . . . . 0.0 114.044 158.784 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.8 mt -107.01 111.18 23.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 127.65 3.094 . . . . 0.0 109.45 -162.755 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -68.06 123.26 20.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 130.92 3.688 . . . . 0.0 111.955 176.991 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.2 -18.11 3.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 119.644 3.201 . . . . 0.0 119.644 -157.057 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.87 -1.22 56.21 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 -175.583 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -92.81 166.69 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.933 2.093 . . . . 0.0 113.898 -173.475 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -109.75 166.3 11.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 124.816 1.323 . . . . 0.0 110.11 178.84 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mt -61.93 -34.87 76.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.415 1.486 . . . . 0.0 110.426 167.656 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.7 t -53.32 -41.26 65.52 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 117.728 -3.107 . . . . 0.0 117.898 160.823 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -75.84 -41.36 52.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 112.872 -3.442 . . . . 0.0 114.255 -178.206 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -86.68 -21.0 26.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 122.013 2.188 . . . . 0.0 106.787 -174.414 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 38.6 t30 81.07 62.24 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 119.005 -2.31 . . . . 0.0 108.181 179.718 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mt -110.08 110.01 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 100.25 -3.981 . . . . 0.0 100.25 177.935 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -104.13 165.15 11.24 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 127.597 2.359 . . . . 0.0 110.66 -168.241 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.447 7.7 pttp -44.52 125.16 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 118.449 -2.657 . . . . 0.0 115.971 172.395 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.409 2.7 tt0 84.18 9.2 0.49 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 119.12 3.008 . . . . 0.0 119.12 179.34 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -59.46 147.17 37.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.454 -3.279 . . . . 0.0 114.66 172.502 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.5 p -123.94 110.69 15.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 127.093 2.746 . . . . 0.0 106.384 -171.064 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.473 ' HB2' HG23 ' A' ' 5' ' ' VAL . 5.7 mp -111.48 158.81 18.7 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 128.798 2.839 . . . . 0.0 109.178 -173.042 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -121.55 139.37 53.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.994 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -104.11 132.63 50.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.561 -2.755 . . . . 0.0 103.561 177.875 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.331 76.7 t -113.77 132.31 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 129.504 3.121 . . . . 0.0 111.298 174.928 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.5 mt -91.01 113.95 26.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 126.115 2.134 . . . . 0.0 107.932 168.391 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -12.5 60.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.214 3.006 . . . . 0.0 111.149 179.408 . . . . . . . . 2 2 . 1 . 075 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 tp -150.72 158.37 44.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 117.192 -3.443 . . . . 0.0 104.2 158.234 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -68.68 165.4 19.49 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 121.111 1.778 . . . . 0.0 112.787 -174.948 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.73 21.21 23.66 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 129.605 3.478 . . . . 0.0 119.102 166.212 . . . . . . . . 1 1 . 1 . 075 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 1 C-N-CA 132.806 5.003 . . . . 0.0 117.415 -166.915 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 101.213 -3.625 . . . . 0.0 101.213 . . . . . . . . . 0 0 . 1 . 076 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.307 8.5 mt-30 -104.51 156.3 18.07 Favored 'General case' 0 N--CA 1.455 -0.205 1 O-C-N 112.643 -6.286 . . . . 0.0 105.895 175.256 . . . . . . . . 3 2 . 1 . 076 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -125.8 140.5 48.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 110.942 -2.845 . . . . 0.0 110.541 156.143 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -81.17 138.73 35.84 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 101.044 -3.687 . . . . 0.0 101.044 171.648 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.5 t -123.12 123.3 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 166.385 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -86.22 131.65 34.18 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 -178.149 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -93.67 167.24 11.79 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.674 -1.266 . . . . 0.0 111.738 179.662 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.54 -24.36 61.93 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.427 2.691 . . . . 0.0 108.977 172.067 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.2 p -94.39 3.47 55.14 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 121.974 2.17 . . . . 0.0 110.39 -177.273 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.02 -38.94 2.53 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 158.928 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -83.54 158.78 21.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.167 -1.196 . . . . 0.0 111.008 -167.742 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -106.82 101.24 10.7 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 128.542 2.737 . . . . 0.0 103.969 177.453 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 pt -68.16 140.54 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.268 163.194 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 m -97.65 121.02 39.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 118.011 -2.93 . . . . 0.0 105.486 173.067 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -87.23 145.34 26.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 122.003 2.183 . . . . 0.0 105.649 166.752 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -100.65 113.18 25.81 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.078 2.151 . . . . 0.0 109.309 169.891 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.252 11.9 m -136.76 154.08 31.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 117.735 -3.103 . . . . 0.0 114.137 -164.722 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -118.24 149.31 45.55 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 127.914 2.486 . . . . 0.0 110.786 172.749 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.383 36.6 Cg_endo -57.18 -40.35 83.61 Favored 'Trans proline' 0 N--CA 1.447 -1.239 2 C-N-CA 127.461 5.441 . . . . 0.0 123.098 -174.886 . . . . . . . . 3 2 . 1 . 076 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.288 23.0 p -80.17 -2.08 43.16 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 178.836 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.69 138.97 37.51 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.831 -174.95 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -84.76 126.97 33.88 Favored 'General case' 0 C--N 1.323 -0.544 1 C-N-CA 132.134 4.174 . . . . 0.0 106.761 -171.645 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.262 5.4 mm -30.59 -41.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 120.897 3.665 . . . . 0.0 120.897 174.427 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -61.72 -34.42 75.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 114.972 -2.442 . . . . 0.0 110.693 172.669 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -72.8 -15.87 61.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 125.424 3.738 . . . . 0.0 113.119 171.116 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.2 t -86.28 -35.3 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 115.907 -1.996 . . . . 0.0 110.612 175.975 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -62.76 -45.25 93.56 Favored 'General case' 0 N--CA 1.447 -0.623 1 O-C-N 129.548 4.28 . . . . 0.0 109.667 171.362 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.56 -33.9 68.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 167.077 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -73.77 -40.82 63.19 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 116.403 -1.761 . . . . 0.0 109.815 -178.843 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.52 -33.83 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 126.682 1.993 . . . . 0.0 114.972 171.956 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -69.5 -44.92 70.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 101.887 -3.375 . . . . 0.0 101.887 177.843 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.357 2.5 t70 -63.59 -5.34 3.8 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 130.321 3.448 . . . . 0.0 114.689 179.075 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -116.85 -75.44 0.58 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.846 2.858 . . . . 0.0 111.33 178.491 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -95.91 -1.96 48.21 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.267 1.827 . . . . 0.0 114.046 -174.721 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.93 3.5 68.06 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 123.401 2.818 . . . . 0.0 114.982 164.98 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.2 mt -76.45 111.71 17.21 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 126.673 1.989 . . . . 0.0 110.216 -176.822 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -51.86 131.32 37.82 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 CA-C-O 115.696 -1.877 . . . . 0.0 113.825 168.97 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -38.58 -35.95 0.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 124.983 3.789 . . . . 0.0 119.816 175.625 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.49 -12.98 62.1 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.885 0.85 . . . . 0.0 113.129 -178.285 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -92.12 -5.7 52.21 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 117.243 -3.41 . . . . 0.0 112.161 172.423 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 65.6 mt-30 -108.3 107.38 17.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 119.439 -2.038 . . . . 0.0 108.975 -171.423 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -92.06 133.43 35.75 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 125.584 1.803 . . . . 0.0 106.668 156.492 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.3 mt -113.4 144.81 42.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.837 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.268 11.3 mm -132.12 136.43 56.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 112.062 -2.335 . . . . 0.0 105.948 -165.767 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.431 ' CE2' HG12 ' A' ' 61' ' ' ILE . 75.8 t80 -145.35 117.4 8.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 127.097 2.748 . . . . 0.0 106.322 177.152 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.327 . . 63.76 -98.6 0.07 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.812 1.245 . . . . 0.0 111.38 -160.191 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.19 11.23 5.32 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 127.231 2.832 . . . . 0.0 119.37 161.844 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -87.03 127.04 35.11 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.417 2.687 . . . . 0.0 105.728 -163.421 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -75.12 102.94 5.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 118.967 -2.333 . . . . 0.0 108.322 170.329 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.466 HD21 ' CD2' ' A' ' 59' ' ' TYR . 65.0 mt -62.46 117.99 6.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.401 3.08 . . . . 0.0 109.309 177.632 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -89.74 145.49 25.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 117.512 -3.242 . . . . 0.0 114.39 -174.571 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.98 118.12 16.57 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 126.551 3.072 . . . . 0.0 112.902 176.267 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.1 -17.42 19.63 Favored Glycine 0 CA--C 1.524 0.625 1 C-N-CA 132.24 4.733 . . . . 0.0 111.429 -178.431 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -86.98 149.47 24.75 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 122.089 2.944 . . . . 0.0 109.68 176.026 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.6 p -95.78 169.27 10.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 126.511 3.053 . . . . 0.0 112.964 -178.685 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.78 -36.1 80.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 116.5 -3.875 . . . . 0.0 111.384 173.638 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -67.84 -37.77 82.3 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 118.709 -2.494 . . . . 0.0 108.336 -178.775 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.4 -48.83 77.99 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 126.228 2.205 . . . . 0.0 110.789 176.742 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.466 ' CD2' HD21 ' A' ' 50' ' ' LEU . 53.9 m-85 -81.65 7.85 11.31 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.617 3.167 . . . . 0.0 118.572 170.71 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 63.03 21.31 12.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.406 1.882 . . . . 0.0 110.789 170.489 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.431 HG12 ' CE2' ' A' ' 45' ' ' PHE . 47.1 mt -76.8 145.11 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 124.124 1.916 . . . . 0.0 108.521 175.018 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -134.44 -177.38 4.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.41 1.484 . . . . 0.0 110.631 -167.248 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -57.13 132.56 53.33 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 114.455 -2.688 . . . . 0.0 114.36 173.763 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 70.44 48.1 0.48 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 126.11 2.862 . . . . 0.0 115.825 172.888 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -117.88 152.74 34.8 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 118.698 -2.502 . . . . 0.0 106.77 -178.548 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.4 m -108.34 117.01 33.05 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 129.242 3.017 . . . . 0.0 108.746 -176.514 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.311 7.6 mp -105.63 158.33 16.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 167.541 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -103.27 123.87 47.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 129.762 3.225 . . . . 0.0 109.868 168.3 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 tp -81.71 113.63 19.83 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 129.411 3.084 . . . . 0.0 107.921 164.101 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.85 150.71 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 128.161 2.584 . . . . 0.0 112.684 -176.977 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.2 mt -78.16 135.39 37.64 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 129.48 3.112 . . . . 0.0 103.173 -178.984 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -91.63 135.67 33.71 Favored 'General case' 0 N--CA 1.446 -0.668 1 C-N-CA 135.221 5.409 . . . . 0.0 104.596 148.083 . . . . . . . . 2 2 . 1 . 076 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -125.93 -13.83 6.24 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.395 1.684 . . . . 0.0 110.292 -168.939 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -124.7 118.89 27.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.722 2.009 . . . . 0.0 111.925 164.787 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.59 157.36 17.16 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 104.42 -3.472 . . . . 0.0 104.42 -168.957 . . . . . . . . 1 1 . 1 . 076 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 1 O-C-N 115.495 -4.532 . . . . 0.0 106.875 -176.62 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 tmm? . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 117.166 -1.397 . . . . 0.0 108.952 . . . . . . . . . 0 0 . 1 . 077 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -75.82 133.7 40.57 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.261 1.824 . . . . 0.0 110.064 -177.708 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -147.29 173.26 2.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 122.554 2.434 . . . . 0.0 113.353 162.508 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.69 148.62 39.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 128.678 2.791 . . . . 0.0 104.236 -177.951 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.06 125.08 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 126.946 2.099 . . . . 0.0 105.384 169.185 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.51 140.12 40.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.6 171.966 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.419 ' HG1' ' H ' ' A' ' 11' ' ' LYS . 3.8 p -111.62 145.54 39.0 Favored 'General case' 0 C--N 1.327 -0.394 1 O-C-N 129.289 4.118 . . . . 0.0 112.636 177.965 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 tp -77.34 -13.29 59.96 Favored 'General case' 0 C--O 1.239 0.549 1 O-C-N 115.821 -4.299 . . . . 0.0 109.1 -177.269 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -88.04 -16.76 32.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 113.642 -3.075 . . . . 0.0 113.037 171.54 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.6 17.17 2.39 Favored Glycine 0 CA--C 1.54 1.633 0 O-C-N 128.892 3.87 . . . . 0.0 112.348 142.872 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.419 ' H ' ' HG1' ' A' ' 7' ' ' THR . 64.8 tttt -96.86 147.65 23.74 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.64 3.576 . . . . 0.0 107.552 178.808 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 m -125.07 147.24 49.07 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 122.127 2.239 . . . . 0.0 108.134 164.933 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 pt -129.51 153.83 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 126.614 1.965 . . . . 0.0 108.497 173.958 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 140.32 29.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 150.963 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.6 tp -137.8 166.12 24.78 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 129.818 3.247 . . . . 0.0 106.782 -173.638 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -132.3 128.85 38.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 100.624 -3.843 . . . . 0.0 100.624 173.122 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 m -127.21 166.23 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 128.521 2.728 . . . . 0.0 105.921 175.075 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -86.12 155.58 57.75 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 101.443 -3.54 . . . . 0.0 101.443 166.726 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -59.75 -33.27 96.39 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 CA-C-N 122.176 1.813 . . . . 0.0 114.358 157.581 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 m -93.5 19.64 8.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 109.898 -3.319 . . . . 0.0 107.568 -168.252 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -82.66 133.04 35.17 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.729 1.212 . . . . 0.0 108.57 160.927 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 55' ' ' THR 0.357 20.3 p -77.22 163.53 26.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.794 1.238 . . . . 0.0 111.59 165.458 . . . . . . . . 3 3 . 1 . 077 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 24.9 mm -38.62 -51.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 128.374 2.67 . . . . 0.0 112.307 166.411 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.58 -39.41 91.09 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 118.184 2.661 . . . . 0.0 118.184 174.67 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -83.22 -26.62 30.61 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 114.091 -2.861 . . . . 0.0 110.535 -178.608 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 64.0 t -44.47 -76.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 130.74 3.616 . . . . 0.0 109.958 156.991 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -31.47 -38.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 1 C-N-CA 133.693 4.797 . . . . 0.0 114.52 170.743 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.55 -22.12 61.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 128.366 2.666 . . . . 0.0 114.652 -175.615 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -101.55 -16.09 16.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.499 1.92 . . . . 0.0 109.996 -176.114 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -80.68 -25.42 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 119.297 -2.127 . . . . 0.0 114.203 158.934 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -67.53 -47.12 70.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.625 1.57 . . . . 0.0 109.707 -176.487 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -48.75 -48.59 40.7 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 127.261 2.224 . . . . 0.0 111.383 168.783 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.22 -24.26 54.61 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 119.441 -2.037 . . . . 0.0 109.265 -171.314 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.513 6.7 tp10 -128.09 -34.5 2.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 -159.024 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.79 -4.78 79.2 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 123.088 2.676 . . . . 0.0 118.249 -170.21 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.7 mt -84.3 124.31 74.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.245 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.28 153.11 45.42 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.656 3.571 . . . . 0.0 105.165 173.691 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -57.31 -42.35 63.27 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.808 3.005 . . . . 0.0 115.542 -174.128 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -49.98 -20.99 1.06 Allowed 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 119.075 2.991 . . . . 0.0 119.075 168.895 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -108.09 -9.34 15.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 122.387 2.358 . . . . 0.0 111.13 176.77 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -78.11 137.1 38.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.524 1.14 . . . . 0.0 110.806 172.237 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -126.74 111.2 13.96 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 174.932 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.8 mt -100.41 122.61 43.44 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 125.713 1.883 . . . . 0.0 108.205 -178.797 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.59 139.56 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 125.965 2.04 . . . . 0.0 112.622 171.722 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -147.77 120.96 8.9 Favored 'General case' 0 N--CA 1.448 -0.543 1 C-N-CA 131.823 4.049 . . . . 0.0 113.519 175.182 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.91 33.53 14.71 Favored 'General case' 0 N--CA 1.443 -0.801 1 C-N-CA 133.162 4.585 . . . . 0.0 111.999 -178.137 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.5 -17.63 56.42 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 128.235 2.826 . . . . 0.0 117.923 173.63 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -92.52 135.77 33.78 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 116.439 -1.744 . . . . 0.0 113.719 173.39 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 133.4 45.02 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 126.87 2.606 . . . . 0.0 110.349 156.091 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.0 mt -99.21 155.04 17.69 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 118.472 -2.642 . . . . 0.0 109.972 -155.971 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -92.63 139.12 30.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 175.968 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.266 17.0 m-20 -43.08 -58.45 2.45 Favored 'General case' 0 N--CA 1.447 -0.609 1 C-N-CA 137.54 6.336 . . . . 0.0 109.173 -160.199 . . . . . . . . 3 2 . 1 . 077 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.74 18.82 43.03 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 117.594 1.798 . . . . 0.0 117.594 -159.763 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.321 22.0 mmm180 -101.49 143.06 31.96 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 179.478 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 70.8 p -72.24 165.03 25.25 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.374 2.269 . . . . 0.0 106.401 -179.099 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.4 mt -65.51 -22.61 66.74 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 116.42 -3.925 . . . . 0.0 117.452 168.751 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -72.17 -24.92 61.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 167.485 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -72.47 -21.6 61.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 117.97 -2.957 . . . . 0.0 116.474 166.083 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -98.72 -2.85 37.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.051 1.341 . . . . 0.0 111.88 172.834 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 73.55 29.04 1.62 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.368 1.867 . . . . 0.0 113.905 176.82 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.0 mt -92.47 113.49 27.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.012 1.725 . . . . 0.0 109.231 -175.572 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.263 57.5 tp60 -142.63 83.55 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.933 2.093 . . . . 0.0 109.834 -171.739 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.369 3.9 tmtt? 91.39 108.54 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 O-C-N 116.774 -3.703 . . . . 0.0 113.538 139.523 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.69 26.4 mt-10 78.41 17.12 1.15 Allowed 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 117.595 -3.191 . . . . 0.0 118.901 -178.108 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.266 19.2 p -85.71 155.95 20.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -178.839 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.4 m -109.86 110.39 21.35 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 174.217 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.68 130.29 35.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.553 1.941 . . . . 0.0 109.405 168.64 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -94.44 128.53 41.05 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 115.471 -2.492 . . . . 0.0 104.861 -168.906 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -109.61 123.53 49.6 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -171.071 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.34 164.08 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 125.431 1.492 . . . . 0.0 107.818 174.7 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -105.99 132.47 52.05 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 123.64 1.686 . . . . 0.0 106.608 -169.961 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -78.01 85.43 4.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 125.502 2.572 . . . . 0.0 104.754 -157.693 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.09 -174.59 4.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 129.053 2.941 . . . . 0.0 103.433 175.159 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -59.61 51.06 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 129.09 2.956 . . . . 0.0 114.638 173.367 . . . . . . . . 1 1 . 1 . 077 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.94 -179.56 16.52 Favored Glycine 0 CA--C 1.533 1.18 1 C-N-CA 133.864 5.507 . . . . 0.0 111.033 174.173 . . . . . . . . 2 2 . 1 . 077 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.508 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 -163.826 . . . . . . . . 0 0 . 1 . 078 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 37.7 ttp . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 . . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -86.3 144.73 27.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 118.8 -2.438 . . . . 0.0 114.455 170.449 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.3 pt -132.21 165.5 31.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 117.163 -3.461 . . . . 0.0 107.026 169.538 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -112.49 140.13 47.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.509 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.398 60.9 t -124.84 84.39 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 129.571 3.149 . . . . 0.0 109.686 -172.272 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -75.16 121.82 22.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 121.211 -0.93 . . . . 0.0 111.582 -179.159 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 32.1 m -90.18 154.88 19.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 118.461 -2.649 . . . . 0.0 110.783 -175.471 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.287 3.0 tm? -33.46 -38.84 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 117.221 -3.425 . . . . 0.0 118.886 168.931 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.2 p -77.71 -18.17 56.85 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.344 3.458 . . . . 0.0 114.014 179.594 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.38 14.47 38.27 Favored Glycine 0 CA--C 1.523 0.574 1 C-N-CA 132.568 4.889 . . . . 0.0 109.612 177.254 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -79.48 116.88 19.96 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.563 -1.551 . . . . 0.0 109.394 173.811 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.5 m -75.07 109.55 8.64 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.664 1.986 . . . . 0.0 107.547 163.826 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.254 86.1 mt -90.58 148.14 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 1 N-CA-C 97.05 -5.167 . . . . 0.0 97.05 165.045 . . . . . . . . 3 2 . 1 . 078 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -135.78 139.25 43.38 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 117.217 -3.427 . . . . 0.0 108.781 163.97 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.53 149.52 42.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.432 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -83.62 136.97 34.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.969 1.308 . . . . 0.0 109.642 167.325 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.46 165.2 30.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 130.765 3.626 . . . . 0.0 108.447 173.487 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -96.67 156.42 36.64 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-O 116.75 -1.595 . . . . 0.0 113.859 167.614 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.3 -43.34 59.6 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 N-CA-C 121.755 3.714 . . . . 0.0 121.755 175.408 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -10.38 57.9 Favored 'General case' 0 N--CA 1.452 -0.337 1 N-CA-C 122.145 4.128 . . . . 0.0 122.145 -178.506 . . . . . . . . 3 3 . 1 . 078 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -49.22 139.47 11.07 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 128.056 2.543 . . . . 0.0 114.532 177.552 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -97.03 141.85 29.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 110.323 -3.126 . . . . 0.0 105.08 -174.155 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.09 -28.61 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 118.282 -2.761 . . . . 0.0 112.402 -166.325 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.31 -26.3 65.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 173.852 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -78.89 -24.71 44.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 118.762 -2.461 . . . . 0.0 107.038 -177.724 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.4 -33.86 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 122.888 2.586 . . . . 0.0 113.045 -177.345 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -68.39 -39.09 81.81 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.819 2.447 . . . . 0.0 109.548 -177.801 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.29 -28.72 68.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.761 -2.462 . . . . 0.0 112.789 176.315 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -84.58 -30.64 24.86 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 124.825 1.328 . . . . 0.0 110.893 -174.242 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mt -71.95 -41.16 68.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 127.032 2.707 . . . . 0.0 104.706 171.234 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.38 -43.14 96.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 119.009 -2.307 . . . . 0.0 108.379 176.966 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -64.99 -45.12 86.94 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 121.212 1.824 . . . . 0.0 113.789 -178.561 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -99.02 -25.33 14.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 111.895 -3.907 . . . . 0.0 111.624 -167.874 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -117.33 -22.98 7.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 123.214 2.734 . . . . 0.0 111.679 177.035 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.3 42.43 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 128.418 2.913 . . . . 0.0 113.799 166.088 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.2 mt -90.69 120.47 68.84 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 127.578 2.351 . . . . 0.0 107.133 -179.115 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -58.09 154.76 37.57 Favored 'Trans proline' 0 N--CA 1.444 -1.409 1 C-N-CA 128.009 5.806 . . . . 0.0 112.251 -179.972 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -78.52 -18.07 12.39 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 122.469 2.113 . . . . 0.0 116.531 -162.986 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.09 -10.88 51.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 167.673 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -93.7 -15.82 24.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.715 1.606 . . . . 0.0 111.229 -171.992 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -98.11 143.81 28.25 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.184 1.794 . . . . 0.0 111.451 170.24 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.88 128.64 42.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 129.003 2.921 . . . . 0.0 106.096 166.373 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -95.37 123.24 38.79 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.704 1.24 . . . . 0.0 109.993 179.413 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.463 10.3 mt -108.64 124.48 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 130.209 3.404 . . . . 0.0 114.16 178.096 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -139.6 133.97 31.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 115.763 -2.065 . . . . 0.0 112.614 171.124 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.71 36.37 23.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.938 2.095 . . . . 0.0 115.218 173.934 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.26 -16.24 30.02 Favored Glycine 0 N--CA 1.442 -0.933 1 CA-C-O 112.271 -4.627 . . . . 0.0 113.476 -171.771 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -89.48 138.63 31.28 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 122.19 2.995 . . . . 0.0 105.361 -171.208 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.38 136.26 33.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.919 -1.946 . . . . 0.0 109.355 157.119 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.441 HD21 ' CG ' ' A' ' 59' ' ' TYR 0.269 15.5 mt -90.38 139.71 30.41 Favored 'General case' 0 C--O 1.221 -0.432 1 CA-C-O 111.415 -4.136 . . . . 0.0 108.858 -165.222 . . . . . . . . 4 3 . 1 . 078 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -99.99 145.65 27.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 124.246 3.203 . . . . 0.0 113.345 173.77 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.94 139.18 52.86 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 125.083 1.489 . . . . 0.0 108.626 162.61 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.18 11.39 13.71 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 103.777 -3.729 . . . . 0.0 103.777 -179.249 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -139.5 176.8 8.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 123.572 1.653 . . . . 0.0 108.62 176.754 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.4 p -108.46 177.56 4.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.542 1.537 . . . . 0.0 112.178 178.089 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.307 85.2 mt -50.36 -55.84 13.93 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.667 3.187 . . . . 0.0 110.66 164.079 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -67.03 -24.56 66.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -173.663 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -57.39 -40.1 77.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 128.833 2.853 . . . . 0.0 112.361 176.639 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.441 ' CG ' HD21 ' A' ' 50' ' ' LEU . 44.4 m-85 -103.82 0.7 30.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.654 1.982 . . . . 0.0 112.551 -177.469 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.9 m120 81.23 32.71 0.12 Allowed 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 125.038 1.461 . . . . 0.0 113.348 168.262 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -95.19 94.97 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 125.856 1.972 . . . . 0.0 106.811 -177.915 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -101.76 -158.87 0.7 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.005 0.431 . . . . 0.0 111.319 172.923 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -58.7 134.7 57.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.284 -2.135 . . . . 0.0 111.684 168.87 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 25.0 tt0 85.11 40.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.061 -1.025 . . . . 0.0 110.058 170.364 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -120.36 137.8 54.08 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.565 1.946 . . . . 0.0 108.215 -179.936 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -120.23 123.47 43.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 115.993 -1.956 . . . . 0.0 108.67 176.739 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.23 160.82 15.06 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -178.209 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -118.66 139.35 51.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 125.002 1.439 . . . . 0.0 108.226 176.711 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.332 4.0 tt -125.24 119.71 29.24 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 101.787 -3.412 . . . . 0.0 101.787 -166.764 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.282 20.9 m -111.23 144.25 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 101.74 -3.43 . . . . 0.0 101.74 174.417 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.2 mt -101.52 141.74 33.94 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 109.307 -3.588 . . . . 0.0 107.185 174.792 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.493 3.7 tpt180 71.93 -37.75 0.4 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 118.827 2.899 . . . . 0.0 118.827 174.102 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.331 1.3 pt? -148.47 167.34 25.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 118.74 -2.475 . . . . 0.0 110.687 -164.46 . . . . . . . . 2 2 . 1 . 078 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -96.06 77.78 3.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.309 1.844 . . . . 0.0 107.202 -174.812 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.08 -128.43 3.31 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.767 1.651 . . . . 0.0 114.275 173.812 . . . . . . . . 1 1 . 1 . 078 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -168.04 . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptt? . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 079 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.377 26.7 mt-30 -97.44 124.23 41.57 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.665 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.4 160.21 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 127.715 2.406 . . . . 0.0 112.82 170.239 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -113.51 136.47 52.77 Favored 'General case' 0 N--CA 1.452 -0.344 1 O-C-N 112.289 -6.507 . . . . 0.0 114.416 -176.086 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.9 t -111.25 121.64 64.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 128.171 2.588 . . . . 0.0 110.387 164.512 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -100.95 117.0 34.12 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 101.479 -3.526 . . . . 0.0 101.479 -172.21 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -73.38 155.67 39.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.977 2.511 . . . . 0.0 111.962 172.542 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.99 -30.82 68.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 124.855 2.265 . . . . 0.0 115.108 170.914 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 p -75.15 0.76 15.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 128.039 2.535 . . . . 0.0 112.881 177.293 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.57 -18.35 25.02 Favored Glycine 0 CA--C 1.526 0.778 1 C-N-CA 131.402 4.334 . . . . 0.0 118.689 166.345 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -94.54 155.05 17.09 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.827 2.451 . . . . 0.0 109.907 -160.142 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.3 m -114.04 132.55 55.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 124.724 2.202 . . . . 0.0 110.888 -176.182 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.37 126.59 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 1 O-C-N 116.219 -4.051 . . . . 0.0 106.609 178.357 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 98.8 m -90.2 128.49 36.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -171.065 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.97 123.95 51.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 116.468 -1.729 . . . . 0.0 106.816 -179.107 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -103.59 101.73 11.59 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 130.524 3.53 . . . . 0.0 110.977 177.797 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.39 166.35 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 N-CA-C 99.921 -4.103 . . . . 0.0 99.921 -157.204 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.358 48.7 mm-40 -108.08 167.99 8.52 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 115.576 -2.154 . . . . 0.0 106.3 158.951 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.15 -6.48 18.01 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 CA-C-N 123.32 2.221 . . . . 0.0 110.239 179.031 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.6 p -96.32 13.5 27.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 131.209 3.804 . . . . 0.0 113.737 177.875 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.81 135.7 38.93 Favored 'General case' 0 C--N 1.32 -0.687 1 C-N-CA 133.299 4.64 . . . . 0.0 102.684 174.036 . . . . . . . . 3 3 . 1 . 079 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -77.24 172.63 12.96 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.039 0.935 . . . . 0.0 110.856 166.915 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.288 1.4 mp -59.29 -42.09 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 125.767 1.627 . . . . 0.0 108.886 163.97 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -65.56 -39.83 92.12 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 125.647 1.842 . . . . 0.0 109.067 -172.909 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -64.45 -40.68 96.18 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.119 1.368 . . . . 0.0 107.403 177.52 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 t -69.5 -39.96 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 O-C-N 117.752 -3.093 . . . . 0.0 117.872 174.845 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -66.98 -29.51 69.37 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.905 -2.372 . . . . 0.0 114.493 168.724 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.08 59.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 170.97 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -59.11 -32.0 69.42 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.889 173.428 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.8 mt -65.14 -47.45 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 121.884 2.129 . . . . 0.0 109.37 169.386 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -74.89 -39.09 61.69 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.688 1.595 . . . . 0.0 107.912 -168.886 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.74 -31.15 72.24 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 122.866 2.576 . . . . 0.0 109.203 177.28 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -87.87 -66.94 0.86 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 115.355 -2.259 . . . . 0.0 107.927 177.633 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -96.79 -20.6 18.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 120.372 1.442 . . . . 0.0 110.568 -156.534 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.73 -19.12 21.72 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 168.718 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.1 mt -69.14 139.06 89.88 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 127.64 2.376 . . . . 0.0 113.265 -170.573 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -75.06 147.73 34.11 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 CA-C-O 113.412 -2.828 . . . . 0.0 115.209 -179.778 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.32 -45.41 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.276 3.317 . . . . 0.0 115.066 -158.046 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.24 -3.6 11.29 Favored 'General case' 0 N--CA 1.452 -0.354 1 C-N-CA 132.999 4.52 . . . . 0.0 116.641 178.087 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -87.76 -23.57 24.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 126.275 2.234 . . . . 0.0 107.728 173.324 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -90.56 115.97 28.1 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.119 -3.488 . . . . 0.0 110.87 -169.289 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -99.51 126.13 45.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 123.473 1.606 . . . . 0.0 107.706 161.8 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.62 110.15 22.27 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.798 2.439 . . . . 0.0 110.767 -175.866 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.1 mt -105.03 145.96 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 O-C-N 119.823 -1.798 . . . . 0.0 111.233 -179.211 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -160.46 139.61 10.65 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.1 1.76 . . . . 0.0 112.998 165.687 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.58 28.49 15.71 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 130.763 3.625 . . . . 0.0 112.246 168.144 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.69 1.49 58.81 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 116.724 -2.153 . . . . 0.0 113.122 176.223 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -120.94 151.97 39.07 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 131.391 3.877 . . . . 0.0 114.767 176.632 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -94.93 116.65 28.98 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 128.509 3.631 . . . . 0.0 107.398 168.382 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.92 112.88 3.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.293 -2.754 . . . . 0.0 112.401 -178.905 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.272 74.4 tt0 -89.01 147.3 24.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 114.904 -2.475 . . . . 0.0 106.922 -164.619 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.92 132.86 50.49 Favored 'General case' 0 C--N 1.326 -0.423 1 O-C-N 130.442 4.839 . . . . 0.0 114.551 175.565 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.06 -9.29 54.66 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 128.196 2.808 . . . . 0.0 117.003 -176.682 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.7 mtt-85 -101.83 157.53 16.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.383 2.673 . . . . 0.0 108.27 -174.488 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.8 p -102.69 155.41 18.32 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 102.216 -3.254 . . . . 0.0 102.216 173.23 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.6 mt -35.54 -36.44 0.07 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 129.564 3.146 . . . . 0.0 118.619 162.134 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.6 t -64.6 -21.93 66.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 111.564 -2.562 . . . . 0.0 115.791 179.343 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.45 -22.88 46.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 120.531 -1.356 . . . . 0.0 111.705 -178.324 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -106.96 -0.83 22.82 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.169 2.188 . . . . 0.0 106.507 -176.262 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 m120 56.28 50.56 13.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 126.063 2.839 . . . . 0.0 112.816 173.998 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.0 mt -80.15 115.82 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 112.483 -2.144 . . . . 0.0 108.112 -178.613 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -76.57 167.02 22.57 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 165.91 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -54.09 143.81 21.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 118.633 2.827 . . . . 0.0 118.633 159.57 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 73.89 6.56 4.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 115.318 -2.277 . . . . 0.0 113.367 172.971 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -66.39 154.96 38.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.965 3.706 . . . . 0.0 111.272 172.084 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -114.47 111.72 21.86 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -177.342 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.43 169.64 8.57 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 179.917 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -130.62 141.67 50.44 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 119.708 1.14 . . . . 0.0 109.247 -163.383 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -114.85 129.47 56.71 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 126.22 2.2 . . . . 0.0 115.661 167.106 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.0 t -132.31 136.15 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 170.629 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.2 mt -97.97 159.49 14.9 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.097 -171.665 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -153.92 129.84 10.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -174.347 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.21 69.31 1.01 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.911 2.885 . . . . 0.0 110.094 -174.483 . . . . . . . . 2 2 . 1 . 079 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -131.81 159.32 38.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 101.909 -3.367 . . . . 0.0 101.909 171.472 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.45 63.09 0.62 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 130.365 3.84 . . . . 0.0 111.311 177.43 . . . . . . . . 1 1 . 1 . 079 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 104.247 -3.541 . . . . 0.0 104.247 177.261 . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 ttp . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 115.348 -2.263 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 080 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.28 92.9 mt-30 -108.51 133.53 52.54 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 125.055 3.57 . . . . 0.0 110.559 -171.241 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -127.44 174.67 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 155.113 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -117.42 156.52 27.8 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.012 1.725 . . . . 0.0 108.693 172.614 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.72 130.06 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.9 157.59 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -90.73 130.13 36.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 112.173 -2.285 . . . . 0.0 111.801 173.567 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -98.63 136.86 38.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 167.853 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.31 -0.02 1.14 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.268 1.827 . . . . 0.0 114.667 -156.323 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.8 p -86.43 -25.89 25.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 129.969 3.308 . . . . 0.0 105.68 -178.805 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.81 3.17 18.45 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.636 1.112 . . . . 0.0 113.889 -178.685 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -79.48 135.13 36.57 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.711 3.204 . . . . 0.0 109.42 170.722 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.4 p -123.48 136.25 54.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.919 1.688 . . . . 0.0 111.229 -170.041 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mt -118.7 113.0 40.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.352 -2.832 . . . . 0.0 103.352 179.833 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -67.86 119.13 12.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 162.317 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.267 0.2 OUTLIER -114.62 126.97 55.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -171.126 . . . . . . . . 3 3 . 1 . 080 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -104.56 115.04 29.66 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.223 1.809 . . . . 0.0 109.844 -164.101 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.305 34.1 m -129.82 -177.83 2.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 C-N-CA 123.914 0.886 . . . . 0.0 112.351 -171.29 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.43 163.02 51.66 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-O 114.831 -2.509 . . . . 0.0 106.786 148.083 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -48.14 -16.86 0.7 Allowed 'Trans proline' 0 N--CA 1.442 -1.531 0 N-CA-C 122.149 3.865 . . . . 0.0 122.149 -176.337 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.1 m -88.15 -8.7 55.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 114.112 -2.851 . . . . 0.0 113.542 178.697 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.53 121.24 12.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.04 2.136 . . . . 0.0 106.558 -175.479 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -77.17 137.5 38.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.075 2.95 . . . . 0.0 107.874 176.274 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.285 1.5 mp -54.79 -30.93 23.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 127.637 2.375 . . . . 0.0 113.61 179.454 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -71.77 -22.49 61.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 121.54 1.973 . . . . 0.0 109.643 174.721 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.6 -31.0 21.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 115.126 -2.369 . . . . 0.0 105.969 178.987 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.48 -41.5 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 126.291 2.244 . . . . 0.0 106.931 178.129 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -56.8 -37.99 71.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 115.821 -2.037 . . . . 0.0 113.085 174.16 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.57 85.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 121.719 2.054 . . . . 0.0 111.461 175.78 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -65.78 -33.77 76.63 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 130.182 3.393 . . . . 0.0 111.933 177.723 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 20.5 mt -71.96 -40.74 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 115.315 -2.278 . . . . 0.0 106.25 169.607 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -60.11 -40.43 89.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 124.273 3.215 . . . . 0.0 109.694 171.193 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.87 -30.44 67.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.062 2.545 . . . . 0.0 116.1 179.789 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -93.75 -57.04 2.68 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 128.743 2.817 . . . . 0.0 111.172 -174.707 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -118.05 -13.1 9.99 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -164.549 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.14 -11.7 55.42 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 115.339 -2.923 . . . . 0.0 117.111 156.579 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.5 mp -77.19 123.15 87.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 111.713 -3.994 . . . . 0.0 107.687 -172.377 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -63.48 138.28 64.43 Favored 'Trans proline' 0 N--CA 1.449 -1.142 1 O-C-N 129.198 4.262 . . . . 0.0 111.565 -179.855 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -59.85 -21.91 66.1 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 120.603 3.27 . . . . 0.0 120.603 -164.724 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.39 -13.36 58.48 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 124.917 1.385 . . . . 0.0 114.089 -175.304 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -98.11 -7.5 29.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.116 1.766 . . . . 0.0 113.768 175.652 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.39 147.86 33.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.519 1.528 . . . . 0.0 112.677 165.897 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.372 35.9 ttm105 -134.83 132.42 38.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 114.511 -2.661 . . . . 0.0 107.685 161.913 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.37 107.04 14.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.619 2.768 . . . . 0.0 107.162 -179.118 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.0 mt -122.34 144.69 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 1 O-C-N 115.509 -4.494 . . . . 0.0 107.349 171.234 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.498 ' CD1' HD13 ' A' ' 50' ' ' LEU 0.38 0.1 OUTLIER -142.08 110.89 6.21 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 132.898 4.479 . . . . 0.0 114.988 167.967 . . . . . . . . 5 4 . 1 . 080 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.34 32.44 3.53 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.717 2.807 . . . . 0.0 111.337 177.582 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 -19.36 23.98 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 128.35 2.881 . . . . 0.0 116.222 -177.322 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -76.98 117.51 18.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.649 2.38 . . . . 0.0 107.996 177.165 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -77.33 122.03 24.56 Favored 'General case' 0 N--CA 1.445 -0.722 1 C-N-CA 133.986 4.914 . . . . 0.0 108.399 175.241 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.498 HD13 ' CD1' ' A' ' 45' ' ' PHE . 6.4 mp -87.1 120.84 28.79 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 126.271 2.232 . . . . 0.0 108.646 -176.922 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.46 151.16 22.63 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.516 -156.392 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.8 104.0 1.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 131.01 3.724 . . . . 0.0 108.782 -174.15 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.88 -14.6 26.57 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.277 174.211 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -71.09 147.38 48.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 122.787 3.293 . . . . 0.0 106.971 160.451 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -105.91 -178.2 3.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 118.98 -2.325 . . . . 0.0 108.408 -173.951 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -66.1 -33.37 75.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 113.829 -2.986 . . . . 0.0 108.209 175.286 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.355 21.3 m -72.59 -29.4 63.49 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 127.455 2.972 . . . . 0.0 109.378 -179.105 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -67.22 -34.95 78.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.96 1.413 . . . . 0.0 113.725 173.573 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 55.2 m-85 -97.67 9.38 42.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.48 2.312 . . . . 0.0 112.085 -178.704 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.39 74.5 m-20 73.17 13.81 4.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 173.0 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.8 mm -91.94 114.98 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 -159.298 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -88.57 168.44 12.56 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 111.67 -2.514 . . . . 0.0 112.183 163.482 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.289 30.5 pttt -29.27 137.79 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 121.345 3.831 . . . . 0.0 121.345 169.867 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.273 4.9 tt0 71.76 4.28 4.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 164.867 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -62.2 158.71 16.38 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 118.639 -2.538 . . . . 0.0 112.615 159.986 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.306 15.2 t -129.4 137.18 50.77 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 129.084 3.99 . . . . 0.0 108.764 -175.129 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -120.62 135.08 55.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 121.555 1.98 . . . . 0.0 111.998 -176.131 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -96.55 137.68 35.26 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 115.173 -2.346 . . . . 0.0 110.018 170.536 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -117.53 166.33 12.49 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 127.678 3.111 . . . . 0.0 111.212 173.489 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.95 147.22 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 O-C-N 127.477 2.985 . . . . 0.0 107.544 165.148 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.1 mt -112.5 123.83 51.17 Favored 'General case' 0 N--CA 1.445 -0.707 1 C-N-CA 134.567 5.147 . . . . 0.0 110.553 170.595 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -91.89 -11.19 37.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 127.583 3.052 . . . . 0.0 111.334 -167.744 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -107.88 117.04 33.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.826 1.648 . . . . 0.0 113.972 167.759 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.288 29.1 ttp180 81.02 50.58 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.26 2.224 . . . . 0.0 110.212 -174.174 . . . . . . . . 2 2 . 1 . 080 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.8 157.43 17.37 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 126.067 3.037 . . . . 0.0 111.382 174.419 . . . . . . . . 1 1 . 1 . 080 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.364 0 C-N-CA 127.364 2.411 . . . . 0.0 109.667 167.431 . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 ttp . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 . . . . . . . . . 0 0 . 1 . 081 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -96.18 155.47 16.75 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 119.569 -1.957 . . . . 0.0 106.735 -177.796 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 pt -135.84 160.29 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 129.236 3.014 . . . . 0.0 113.127 165.369 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -101.59 151.95 21.38 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 125.534 1.771 . . . . 0.0 108.509 162.338 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.5 t -125.7 132.19 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 166.368 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -89.95 119.68 30.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 117.862 -3.024 . . . . 0.0 105.593 157.954 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -100.48 136.34 40.51 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -178.137 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -44.12 -42.53 6.37 Favored 'General case' 0 C--N 1.324 -0.514 1 O-C-N 130.515 4.884 . . . . 0.0 113.53 -174.48 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.1 p -58.72 -12.08 3.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 130.859 3.664 . . . . 0.0 117.095 174.208 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.07 -16.27 10.1 Favored Glycine 0 CA--C 1.527 0.804 1 C-N-CA 130.731 4.015 . . . . 0.0 110.843 176.071 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.42 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 95.3 mttt -80.73 142.07 34.2 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 120.473 2.137 . . . . 0.0 112.117 -165.361 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.6 m -96.91 130.0 44.28 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 164.071 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.269 43.9 pt -135.69 153.97 33.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 127.623 2.369 . . . . 0.0 106.289 -177.55 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.256 11.8 t -129.03 133.05 47.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 112.657 -3.545 . . . . 0.0 110.632 -177.915 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -130.82 151.44 51.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 122.74 2.518 . . . . 0.0 111.181 -172.309 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -97.16 117.4 31.27 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 131.338 3.855 . . . . 0.0 106.394 172.882 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.18 171.81 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 1 N-CA-C 100.093 -4.04 . . . . 0.0 100.093 179.714 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -111.36 142.85 27.26 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 131.273 3.829 . . . . 0.0 101.357 159.574 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -63.07 -13.89 38.19 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.086 3.19 . . . . 0.0 114.078 174.475 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -86.38 -7.81 58.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 126.962 3.268 . . . . 0.0 112.736 176.939 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -74.5 132.69 42.08 Favored 'General case' 0 N--CA 1.451 -0.405 1 O-C-N 114.552 -5.092 . . . . 0.0 109.361 179.521 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -63.32 162.87 11.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.343 2.657 . . . . 0.0 113.695 169.955 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mm -66.14 -36.4 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.207 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -19.55 64.59 Favored 'General case' 0 N--CA 1.449 -0.504 1 O-C-N 115.003 -4.811 . . . . 0.0 116.972 172.878 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -80.25 -24.44 40.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 125.473 1.733 . . . . 0.0 109.579 174.024 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 t -73.58 -30.89 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.662 1.185 . . . . 0.0 108.755 168.111 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -73.29 -41.11 63.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 118.168 -2.833 . . . . 0.0 113.99 175.958 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.9 -47.12 43.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 129.985 3.314 . . . . 0.0 113.372 170.162 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -73.76 -30.19 62.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 114.823 -2.513 . . . . 0.0 112.54 179.085 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -75.36 -39.89 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 O-C-N 125.821 1.95 . . . . 0.0 109.316 168.854 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -50.02 -46.36 52.78 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 128.152 2.581 . . . . 0.0 110.642 174.875 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.254 5.6 t70 -58.51 -44.18 89.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.388 1.875 . . . . 0.0 114.571 175.58 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -85.85 -51.3 6.49 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 115.91 -1.995 . . . . 0.0 110.25 -176.166 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.42 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 68.3 mm-40 -99.91 -23.04 15.06 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 114.131 -2.842 . . . . 0.0 111.572 -164.58 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.17 -12.98 28.79 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 128.65 3.719 . . . . 0.0 117.696 172.724 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.305 70.8 mt -75.27 132.13 76.86 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 113.715 -3.041 . . . . 0.0 111.067 -163.327 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.86 146.1 82.24 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 O-C-N 126.608 2.899 . . . . 0.0 114.206 173.014 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.56 -34.18 43.22 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 CA-C-N 120.959 1.378 . . . . 0.0 115.119 176.27 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.308 0.1 OUTLIER -42.19 -37.79 1.56 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.054 2.542 . . . . 0.0 113.853 174.793 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -108.88 -8.45 15.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.396 1.879 . . . . 0.0 111.915 -171.182 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -104.78 119.03 38.02 Favored 'General case' 0 N--CA 1.452 -0.334 1 C-N-CA 134.203 5.001 . . . . 0.0 113.343 -169.434 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -127.38 133.46 50.02 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 177.43 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.274 3.8 mt -104.42 152.4 22.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.974 1.71 . . . . 0.0 110.969 -169.302 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mt -137.04 146.09 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 1 C-N-CA 132.929 4.492 . . . . 0.0 107.324 -169.397 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -152.41 123.8 7.72 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 131.638 3.975 . . . . 0.0 107.918 169.358 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.4 38.05 25.76 Favored 'General case' 0 N--CA 1.445 -0.687 1 C-N-CA 132.355 4.262 . . . . 0.0 112.302 166.507 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.28 -14.89 63.1 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 120.149 -1.594 . . . . 0.0 116.925 -179.382 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -107.1 125.89 51.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 -171.785 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.92 127.81 32.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 169.704 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.11 137.46 34.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.289 1.859 . . . . 0.0 106.613 -168.683 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -82.21 123.63 29.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 109.55 -3.477 . . . . 0.0 105.333 -164.563 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -69.96 112.18 6.18 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 127.726 2.41 . . . . 0.0 106.033 -167.814 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.89 0.04 22.87 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 115.77 -2.683 . . . . 0.0 117.594 -157.722 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -114.16 178.71 4.18 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.981 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -125.59 160.42 29.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.958 2.503 . . . . 0.0 107.411 -174.264 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.45 -41.27 98.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.579 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.2 t -53.03 -38.71 62.61 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.285 -1.509 . . . . 0.0 110.227 175.575 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.47 -48.5 81.41 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 116.266 -1.826 . . . . 0.0 112.343 -173.171 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -84.95 11.89 8.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 121.503 1.956 . . . . 0.0 115.187 172.406 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.36 4.1 t-20 76.84 33.33 0.47 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 123.179 1.466 . . . . 0.0 108.566 160.363 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.99 120.09 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 118.7 -2.5 . . . . 0.0 111.345 -177.95 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -99.72 172.0 7.54 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.225 2.21 . . . . 0.0 111.642 173.414 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -59.69 133.33 55.99 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.928 2.491 . . . . 0.0 115.661 179.911 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 4.2 tt0 75.19 20.95 1.98 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.359 2.664 . . . . 0.0 115.772 -175.314 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -63.5 136.84 57.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 131.407 3.883 . . . . 0.0 109.595 165.439 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.6 m -101.05 107.0 18.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 124.781 1.301 . . . . 0.0 112.662 169.23 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.94 162.0 20.62 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.477 1.911 . . . . 0.0 110.94 172.938 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -135.41 117.06 14.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 130.381 3.472 . . . . 0.0 105.755 -168.616 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tp -98.52 140.46 32.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 115.456 -2.212 . . . . 0.0 110.925 -174.002 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.29 163.71 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 127.179 2.191 . . . . 0.0 108.657 171.908 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.485 0.7 OUTLIER -144.08 146.15 32.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -173.193 . . . . . . . . 3 3 . 1 . 081 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 82.63 -13.12 0.85 Allowed 'General case' 0 N--CA 1.45 -0.473 1 C-N-CA 132.545 4.338 . . . . 0.0 114.589 -179.036 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.486 3.5 pp -149.85 156.86 42.52 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.918 2.887 . . . . 0.0 116.137 -170.416 . . . . . . . . 2 2 . 1 . 081 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -78.43 129.01 34.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 113.515 -1.675 . . . . 0.0 107.947 157.874 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.55 158.87 14.59 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 114.275 -3.514 . . . . 0.0 114.499 155.935 . . . . . . . . 1 1 . 1 . 081 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.91 0 CA-C-N 122.145 2.972 . . . . 0.0 109.533 178.403 . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 . . . . . . . . . 0 0 . 1 . 082 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -91.91 145.19 24.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 -172.324 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.85 163.54 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 128.842 2.857 . . . . 0.0 109.147 162.731 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -104.38 151.12 23.87 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 114.638 -2.601 . . . . 0.0 105.002 177.01 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.9 105.15 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 1 C-N-CA 132.69 4.396 . . . . 0.0 104.328 172.272 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -97.91 107.36 19.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.312 2.245 . . . . 0.0 111.263 -173.905 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 p -86.11 166.49 15.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -168.422 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -86.63 -20.76 27.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.528 -2.177 . . . . 0.0 115.923 166.905 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 p -69.44 -23.76 63.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 125.32 1.638 . . . . 0.0 113.321 176.154 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.53 -14.09 5.33 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 119.494 -2.004 . . . . 0.0 115.746 156.145 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -80.6 172.54 13.62 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 120.075 -1.838 . . . . 0.0 112.892 173.556 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 m -136.67 132.1 34.49 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 117.544 -3.222 . . . . 0.0 107.2 177.297 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.22 148.1 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.63 1.572 . . . . 0.0 107.807 172.881 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 p -97.22 131.35 44.03 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.978 2.911 . . . . 0.0 110.178 165.762 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.82 133.6 53.06 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 115.411 -2.233 . . . . 0.0 111.073 -172.527 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -84.23 125.8 32.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 101.256 -3.609 . . . . 0.0 101.256 164.837 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -132.38 147.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 176.035 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 2.1 tm-20 -97.59 135.8 21.52 Favored Pre-proline 0 N--CA 1.448 -0.526 0 O-C-N 119.274 -2.141 . . . . 0.0 108.608 158.027 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.82 -24.81 2.26 Favored 'Trans proline' 0 N--CA 1.443 -1.451 1 C-N-CA 126.817 5.012 . . . . 0.0 116.317 173.951 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -98.29 1.55 47.25 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 129.796 3.238 . . . . 0.0 109.991 177.194 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -72.03 140.46 49.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 121.799 2.09 . . . . 0.0 106.935 167.731 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.0 p -90.58 178.92 5.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 118.916 -2.365 . . . . 0.0 108.381 -175.928 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.0 mm -67.24 -33.23 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 120.01 1.277 . . . . 0.0 113.457 179.469 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.69 -37.27 83.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.752 2.821 . . . . 0.0 116.672 168.293 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -77.58 -35.44 53.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 115.629 -2.129 . . . . 0.0 107.233 -179.722 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.9 t -65.8 -48.52 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 124.856 3.48 . . . . 0.0 111.606 170.992 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -50.99 -49.99 59.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 169.719 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.05 -49.46 41.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.946 2.098 . . . . 0.0 114.889 165.157 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -65.14 -25.46 67.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 119.606 -1.934 . . . . 0.0 110.574 -179.864 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -80.92 -13.76 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 O-C-N 119.276 -2.14 . . . . 0.0 114.677 175.269 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -76.59 -41.9 44.5 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 118.593 -2.567 . . . . 0.0 110.255 168.034 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -57.72 -43.38 85.2 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 127.248 2.219 . . . . 0.0 112.314 178.903 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -69.19 -55.03 11.85 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 115.268 -2.301 . . . . 0.0 115.255 174.198 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -122.94 -19.59 6.07 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 125.837 1.96 . . . . 0.0 111.65 -155.638 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.1 9.53 63.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.282 1.896 . . . . 0.0 111.716 167.679 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mt -67.52 130.45 93.27 Favored Pre-proline 0 N--CA 1.444 -0.744 0 O-C-N 118.924 -2.515 . . . . 0.0 112.841 171.754 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -79.14 123.17 5.52 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.862 3.041 . . . . 0.0 109.108 -176.467 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.458 17.4 Cg_exo -25.93 -43.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.123 1 C-N-CA 129.736 6.957 . . . . 0.0 121.94 -177.91 . . . . . . . . 3 2 . 1 . 082 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.97 -15.19 63.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 113.602 -3.094 . . . . 0.0 113.389 177.403 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -86.71 -15.0 40.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 124.034 3.106 . . . . 0.0 109.673 177.574 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -90.11 153.03 20.85 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -166.753 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -142.32 120.13 11.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 121.85 2.114 . . . . 0.0 109.32 170.084 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.4 mt -89.45 144.0 26.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 125.034 3.561 . . . . 0.0 107.27 -178.059 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mm -127.41 153.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 125.69 2.662 . . . . 0.0 106.634 169.522 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -150.46 108.67 3.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.004 2.522 . . . . 0.0 108.985 174.725 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.02 22.21 12.92 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 131.567 3.947 . . . . 0.0 112.207 167.261 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.95 -4.01 25.7 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 119.239 -2.163 . . . . 0.0 116.977 178.409 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.22 143.98 48.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 172.225 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -91.89 135.17 34.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -172.618 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -89.99 138.39 31.54 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.23 -1.544 . . . . 0.0 108.925 176.733 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -145.58 140.68 27.58 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -159.889 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -35.85 128.9 0.65 Allowed 'General case' 0 N--CA 1.452 -0.326 1 C-N-CA 134.633 5.173 . . . . 0.0 113.65 -179.371 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.69 -16.25 23.78 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 118.092 -2.88 . . . . 0.0 117.223 167.253 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.334 32.9 mtt85 -100.49 166.77 10.77 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 125.713 2.673 . . . . 0.0 107.065 167.766 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -87.83 167.63 13.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 119.509 -1.994 . . . . 0.0 108.755 173.115 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.306 22.2 mt -59.93 -38.43 82.36 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 172.7 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.7 p -69.03 -27.75 65.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.413 1.885 . . . . 0.0 112.917 -179.254 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.53 -44.26 96.26 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.581 1.952 . . . . 0.0 108.278 171.803 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -81.4 10.55 5.52 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 128.341 2.656 . . . . 0.0 114.142 175.488 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.268 1.9 t-20 65.87 24.1 11.31 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 172.934 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 mt -86.69 132.62 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 O-C-N 120.194 -1.567 . . . . 0.0 106.941 -173.8 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -114.05 -179.56 3.67 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 127.073 2.733 . . . . 0.0 112.121 170.224 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 138.24 24.91 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.08 0.952 . . . . 0.0 111.201 175.253 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 42.6 mt-10 74.84 13.59 3.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 125.349 1.655 . . . . 0.0 109.735 163.603 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.4 m -54.52 157.53 2.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 157.252 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.93 105.25 14.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 111.51 -2.586 . . . . 0.0 106.084 177.102 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -102.08 138.89 38.43 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 176.535 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.257 41.4 m80 -95.88 135.77 37.18 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.637 1.575 . . . . 0.0 112.254 175.766 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.23 100.91 10.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 179.426 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -96.51 151.91 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.031 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.41 148.0 26.43 Favored 'General case' 0 N--CA 1.446 -0.652 1 C-N-CA 135.776 5.631 . . . . 0.0 117.857 174.726 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.407 ' HB3' ' H ' ' A' ' 73' ' ' LEU . 67.4 mtp180 -112.18 -174.74 2.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.427 2.691 . . . . 0.0 105.767 173.501 . . . . . . . . 2 2 . 1 . 082 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.407 ' H ' ' HB3' ' A' ' 72' ' ' ARG . 0.8 OUTLIER -102.46 160.69 14.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 102.199 -3.26 . . . . 0.0 102.199 160.755 . . . . . . . . 3 3 . 1 . 082 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.325 2.4 ttp180 91.61 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.528 1 C-N-CA 133.705 4.802 . . . . 0.0 106.114 172.525 . . . . . . . . 3 2 . 1 . 082 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.78 -150.28 21.84 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 127.991 2.71 . . . . 0.0 117.098 179.794 . . . . . . . . 1 1 . 1 . 082 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.923 1 N-CA-C 101.707 -4.557 . . . . 0.0 101.707 -170.894 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 ttp . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 115.309 -2.281 . . . . 0.0 106.214 . . . . . . . . . 0 0 . 1 . 083 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -104.53 130.53 52.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.855 2.57 . . . . 0.0 111.388 -179.933 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.293 20.4 pt -119.22 122.03 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 114.25 -2.786 . . . . 0.0 109.617 165.336 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -73.77 151.97 40.47 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 124.15 3.159 . . . . 0.0 108.434 178.243 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -126.44 155.16 36.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 1 O-C-N 129.301 4.126 . . . . 0.0 106.794 161.438 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.25 42.3 tttt -120.63 152.87 37.61 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 128.909 2.884 . . . . 0.0 113.342 169.205 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.3 p -107.23 159.06 16.63 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 130.591 3.556 . . . . 0.0 106.422 -170.573 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 mt -63.64 -19.97 65.31 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.608 1.563 . . . . 0.0 111.895 -179.163 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.5 p -85.31 -15.25 43.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 176.235 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.63 5.59 41.95 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 113.777 -3.79 . . . . 0.0 114.129 177.695 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -82.58 132.67 35.19 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 121.885 2.843 . . . . 0.0 110.381 176.911 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.6 m -90.0 124.59 34.88 Favored 'General case' 0 C--N 1.325 -0.463 1 C-N-CA 134.339 5.055 . . . . 0.0 104.799 176.227 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -113.59 139.4 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 130.93 3.692 . . . . 0.0 107.809 -179.34 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.4 m -96.73 130.66 43.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 121.886 2.13 . . . . 0.0 112.128 170.854 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.2 mt -107.63 129.54 54.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.559 2.344 . . . . 0.0 113.004 173.805 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -80.37 118.7 22.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 123.69 1.71 . . . . 0.0 108.646 169.983 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.04 156.46 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 O-C-N 117.537 -3.227 . . . . 0.0 115.243 173.882 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.488 ' C ' ' H ' ' A' ' 20' ' ' SER . 73.2 mm-40 -74.61 154.29 87.5 Favored Pre-proline 0 N--CA 1.451 -0.404 0 O-C-N 117.843 -3.036 . . . . 0.0 108.979 162.826 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -76.81 15.84 1.03 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 1 C-N-CA 125.568 4.179 . . . . 0.0 114.543 179.648 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 18' ' ' GLU . 10.8 p -131.38 3.16 4.24 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 129.288 3.035 . . . . 0.0 117.786 171.914 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.54 137.93 57.86 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 126.588 2.43 . . . . 0.0 107.941 179.506 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.298 44.6 p -102.56 170.47 8.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 126.957 3.265 . . . . 0.0 107.709 -174.09 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mm -66.01 -30.72 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 1 O-C-N 114.642 -5.036 . . . . 0.0 115.506 -173.962 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.14 -26.25 68.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 121.031 1.741 . . . . 0.0 111.648 175.661 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.05 -28.12 29.8 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.441 2.296 . . . . 0.0 112.652 176.429 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.8 t -81.58 -29.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 122.382 2.355 . . . . 0.0 108.275 178.732 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -51.45 -49.39 61.82 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.251 2.22 . . . . 0.0 115.347 160.062 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.11 -46.11 68.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.677 1.591 . . . . 0.0 108.563 -178.695 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.254 57.2 mttm -52.09 -50.11 62.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 172.633 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.335 91.5 mt -54.52 -38.07 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 123.61 1.671 . . . . 0.0 114.992 171.902 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.88 -42.62 94.65 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 117.165 -3.459 . . . . 0.0 111.233 170.846 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -52.45 -42.5 64.22 Favored 'General case' 0 N--CA 1.445 -0.702 1 O-C-N 116.206 -4.059 . . . . 0.0 114.278 172.007 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -90.51 -47.34 7.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -167.538 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -120.15 -15.15 8.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 124.803 2.24 . . . . 0.0 113.528 -157.26 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.34 1.42 44.19 Favored Glycine 0 CA--C 1.522 0.518 1 C-N-CA 134.309 5.719 . . . . 0.0 117.352 166.818 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -88.99 119.98 69.89 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 128.181 2.592 . . . . 0.0 104.667 -153.2 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.3 142.84 55.75 Favored 'Trans proline' 0 N--CA 1.447 -1.229 1 C-N-CA 126.459 4.772 . . . . 0.0 114.659 178.164 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.02 -46.78 7.64 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 124.603 3.535 . . . . 0.0 111.267 -177.789 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.439 0.0 OUTLIER -32.95 -40.4 0.05 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 118.608 2.818 . . . . 0.0 118.608 167.49 . . . . . . . . 3 3 . 1 . 083 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.302 11.5 mm-40 -101.34 -5.25 25.65 Favored 'General case' 0 N--CA 1.448 -0.556 1 C-N-CA 132.312 4.245 . . . . 0.0 114.626 -161.56 . . . . . . . . 3 2 . 1 . 083 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -99.7 157.21 16.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.931 2.093 . . . . 0.0 106.929 -178.664 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -142.59 129.13 20.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 130.017 3.327 . . . . 0.0 110.364 160.14 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -117.04 120.26 37.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 120.357 1.435 . . . . 0.0 107.428 174.784 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mm -106.32 152.75 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 130.148 3.379 . . . . 0.0 107.801 -177.329 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -152.08 107.16 3.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 130.161 3.384 . . . . 0.0 105.582 178.271 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.439 . . 72.25 23.23 3.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 127.887 3.708 . . . . 0.0 117.679 169.383 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.03 -12.75 45.12 Favored Glycine 0 CA--C 1.529 0.958 1 O-C-N 114.574 -5.079 . . . . 0.0 110.086 171.901 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -112.69 142.24 45.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.559 3.544 . . . . 0.0 111.963 -179.969 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -91.65 141.89 28.21 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 110.473 -3.058 . . . . 0.0 105.218 -175.765 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -88.18 113.91 24.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 130.217 3.407 . . . . 0.0 106.824 -175.285 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -103.28 164.66 11.5 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 129.832 3.253 . . . . 0.0 113.346 -169.904 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -68.42 132.03 46.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 128.81 3.819 . . . . 0.0 112.745 -177.297 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.8 0.88 58.83 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.694 1.616 . . . . 0.0 112.647 173.769 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -88.81 164.53 15.18 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.866 2.066 . . . . 0.0 108.678 177.001 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -111.71 161.68 16.03 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 169.399 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -55.67 -39.41 70.91 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.675 1.19 . . . . 0.0 110.762 176.538 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 m -61.31 -34.1 74.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 116.113 -1.898 . . . . 0.0 115.214 177.885 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -60.85 -38.54 85.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 116.211 -1.852 . . . . 0.0 114.852 172.237 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -97.95 14.68 26.43 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 116.717 -1.611 . . . . 0.0 110.943 173.894 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.363 12.6 p30 74.54 14.95 3.44 Favored 'General case' 0 N--CA 1.439 -0.978 1 C-N-CA 135.111 5.364 . . . . 0.0 114.208 166.608 . . . . . . . . 3 2 . 1 . 083 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -72.33 111.57 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.181 2.192 . . . . 0.0 109.297 -170.414 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -96.57 164.84 12.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 127.019 2.699 . . . . 0.0 107.811 -173.18 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -48.26 117.76 2.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.961 3.704 . . . . 0.0 110.483 179.27 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.722 2.1 mp0 78.01 18.97 1.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 117.898 2.555 . . . . 0.0 117.898 -178.707 . . . . . . . . 2 2 . 1 . 083 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.6 m -77.27 154.11 33.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 170.466 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.2 m -107.21 129.26 54.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.205 1.802 . . . . 0.0 106.949 173.232 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -99.81 156.1 17.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 163.622 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -98.94 149.38 23.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 115.496 -2.193 . . . . 0.0 108.352 160.281 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 pp -97.37 151.89 19.48 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 124.752 1.283 . . . . 0.0 110.866 164.157 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.6 t -142.72 125.35 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -179.203 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 98.6 mt -80.32 173.04 13.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.795 -1.815 . . . . 0.0 110.249 -176.002 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 -66.95 126.67 29.84 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.956 152.567 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.5 mt -126.85 143.89 51.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.626 173.322 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -73.6 145.52 45.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.221 1.808 . . . . 0.0 110.351 162.733 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.02 13.38 45.09 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 116.435 -2.314 . . . . 0.0 117.018 -157.857 . . . . . . . . 1 1 . 1 . 083 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 O-C-N 126.762 2.095 . . . . 0.0 110.116 -163.009 . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 . . . . . . . . . 0 0 . 1 . 084 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -97.04 144.79 26.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 -178.201 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.382 0.9 OUTLIER -125.54 157.55 34.76 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 C-N-CA 129.469 3.108 . . . . 0.0 107.158 167.428 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -113.17 139.39 48.8 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.739 2.015 . . . . 0.0 105.746 179.757 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.9 t -117.25 113.45 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 171.077 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -102.16 135.14 44.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 173.084 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -83.48 164.28 19.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 118.007 -2.933 . . . . 0.0 112.105 172.394 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.3 -27.75 67.55 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.699 2.0 . . . . 0.0 108.67 179.577 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -14.44 58.93 Favored 'General case' 0 N--CA 1.448 -0.567 1 C-N-CA 134.362 5.065 . . . . 0.0 115.558 176.794 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.8 -9.0 37.19 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 118.736 -2.478 . . . . 0.0 113.047 166.448 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.262 79.0 tttt -89.95 128.25 36.2 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 -177.106 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.3 m -117.83 120.2 37.19 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 110.857 -2.883 . . . . 0.0 112.116 -174.681 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -112.54 155.51 13.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 126.895 3.236 . . . . 0.0 110.337 174.795 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.3 6.8 m -103.1 120.53 40.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.538 -1.976 . . . . 0.0 107.396 -173.785 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -115.2 126.71 54.89 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.259 2.224 . . . . 0.0 109.898 -168.177 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -90.39 114.24 26.31 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 125.099 1.499 . . . . 0.0 108.29 -176.655 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.47 165.32 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 126.308 1.843 . . . . 0.0 114.465 179.908 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -125.34 153.15 72.09 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 114.921 -2.466 . . . . 0.0 109.408 165.505 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.17 -30.85 26.78 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.449 3.433 . . . . 0.0 117.921 -177.521 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -75.97 -1.47 25.79 Favored 'General case' 0 N--CA 1.446 -0.652 1 C-N-CA 135.424 5.489 . . . . 0.0 117.707 178.534 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.65 137.71 33.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 117.246 -3.409 . . . . 0.0 109.023 -175.155 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -84.63 159.14 20.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 122.004 2.184 . . . . 0.0 113.528 175.356 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -65.76 -21.41 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.098 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.74 -36.0 81.61 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 130.396 3.479 . . . . 0.0 112.23 174.736 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -73.82 -34.42 64.57 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 125.373 1.671 . . . . 0.0 110.27 175.683 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -80.72 -42.63 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.83 2.452 . . . . 0.0 111.578 -175.093 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -53.92 -46.51 71.51 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 121.231 3.789 . . . . 0.0 121.231 161.929 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.76 -43.03 98.51 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 126.883 2.614 . . . . 0.0 113.08 174.48 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -52.02 -39.44 59.49 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 115.022 -2.418 . . . . 0.0 112.73 174.737 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.7 mt -57.12 -46.46 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 125.456 1.722 . . . . 0.0 109.599 179.292 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -66.61 -45.94 77.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.298 1.839 . . . . 0.0 108.777 178.254 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -55.38 -43.49 75.2 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 117.568 -3.208 . . . . 0.0 115.266 177.065 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.94 -80.74 0.14 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 130.055 3.342 . . . . 0.0 113.937 174.976 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -89.19 -10.17 48.11 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 122.024 2.193 . . . . 0.0 115.069 -170.214 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.71 40.61 37.03 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 119.946 2.738 . . . . 0.0 119.946 -177.753 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 mt -119.18 95.82 49.59 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 119.957 -1.908 . . . . 0.0 109.86 178.407 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -69.13 158.03 59.32 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 O-C-N 122.805 0.898 . . . . 0.0 111.735 -177.953 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.292 63.1 Cg_exo -42.09 -34.88 2.94 Favored 'Trans proline' 0 N--CA 1.444 -1.407 1 C-N-CA 126.269 4.646 . . . . 0.0 120.186 176.858 . . . . . . . . 3 2 . 1 . 084 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.97 -35.55 0.54 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 129.488 3.115 . . . . 0.0 112.997 163.942 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -110.08 -7.69 14.89 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.208 1.803 . . . . 0.0 110.851 -170.618 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.253 81.1 mt-30 -100.06 155.09 17.91 Favored 'General case' 0 C--O 1.226 -0.141 0 O-C-N 118.945 -2.347 . . . . 0.0 112.266 179.256 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -150.08 105.61 3.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 100.962 -3.718 . . . . 0.0 100.962 169.052 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.69 72.74 8.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.565 1.546 . . . . 0.0 109.905 165.301 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 tt -71.24 92.95 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.226 154.843 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -73.26 -28.71 62.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -172.252 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.62 -80.93 0.12 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 114.882 -2.485 . . . . 0.0 108.401 175.1 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.67 -12.88 9.12 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 115.3 -2.945 . . . . 0.0 110.042 -179.315 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -136.28 163.46 30.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 121.253 2.526 . . . . 0.0 105.077 -169.478 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.02 155.64 32.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.333 -1.479 . . . . 0.0 113.662 172.14 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 39.8 mt -68.61 152.24 45.63 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 124.62 1.2 . . . . 0.0 109.793 172.346 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -108.64 129.78 55.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 120.811 1.642 . . . . 0.0 109.114 178.791 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -45.59 105.25 0.06 Allowed 'General case' 0 N--CA 1.444 -0.739 1 C-N-CA 132.717 4.407 . . . . 0.0 116.109 166.419 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.51 -3.96 13.5 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.659 2.552 . . . . 0.0 116.373 174.961 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -98.4 158.87 15.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 -177.525 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -111.65 169.65 8.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 110.208 -3.178 . . . . 0.0 103.778 -179.925 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 3.5 mp -52.59 -34.32 50.14 Favored 'General case' 0 N--CA 1.445 -0.714 1 C-N-CA 132.111 4.164 . . . . 0.0 112.445 172.0 . . . . . . . . 3 3 . 1 . 084 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.9 m -72.15 -21.24 61.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 175.407 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -72.89 -30.62 64.08 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.443 1.497 . . . . 0.0 113.713 169.97 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -101.85 2.15 37.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.529 1.532 . . . . 0.0 111.164 173.767 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 49.1 m-80 67.94 14.55 9.4 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 117.794 -3.066 . . . . 0.0 118.726 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.0 mt -65.85 154.27 7.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -163.188 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -128.39 179.16 5.79 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 130.98 3.712 . . . . 0.0 114.319 -170.165 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 tttt -65.16 135.43 55.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 113.818 -2.992 . . . . 0.0 109.725 -177.833 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.351 15.4 mt-10 78.72 0.55 2.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.515 2.726 . . . . 0.0 113.187 167.904 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.62 141.63 54.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.936 2.494 . . . . 0.0 112.047 178.656 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.1 m -109.81 132.27 54.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -177.412 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 67.6 mt -114.7 152.34 32.15 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 125.61 1.819 . . . . 0.0 108.743 173.738 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.368 15.4 m80 -105.1 149.3 25.97 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.038 2.135 . . . . 0.0 107.092 -168.274 . . . . . . . . 2 2 . 1 . 084 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -129.9 136.81 49.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 121.168 1.804 . . . . 0.0 112.631 169.598 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.0 t -124.57 139.07 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 129.768 3.227 . . . . 0.0 107.72 -176.326 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 tp -104.25 119.26 38.57 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 -158.142 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -67.68 126.87 30.73 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 127.366 2.916 . . . . 0.0 110.847 166.218 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.1 tp -107.15 135.38 48.79 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 174.616 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -61.08 150.21 34.67 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.605 2.762 . . . . 0.0 110.238 -176.612 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.55 -178.66 15.97 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 125.989 1.757 . . . . 0.0 112.125 -161.964 . . . . . . . . 1 1 . 1 . 084 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.986 0 C-N-CA 129.312 3.339 . . . . 0.0 109.86 -174.054 . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 ttp . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 085 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -75.11 132.95 41.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 126.928 2.643 . . . . 0.0 113.644 170.275 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 pt -130.54 146.56 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 1 C-N-CA 131.757 4.023 . . . . 0.0 106.917 160.414 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.29 141.53 34.03 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 129.112 2.965 . . . . 0.0 105.733 171.548 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -128.7 126.34 64.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 115.954 -1.974 . . . . 0.0 105.758 163.923 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -84.41 114.15 21.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 127.425 2.953 . . . . 0.0 110.908 174.722 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -64.13 160.67 17.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 128.5 4.0 . . . . 0.0 111.711 170.657 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -60.46 -12.59 10.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 117.274 -3.391 . . . . 0.0 118.571 -176.663 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 p -95.04 -8.0 38.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 109.894 -3.321 . . . . 0.0 111.222 175.766 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.82 -20.15 36.97 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 124.072 3.124 . . . . 0.0 112.827 -179.88 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -78.35 141.57 38.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 113.619 -3.086 . . . . 0.0 114.767 -176.219 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 p -92.77 132.05 37.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 125.926 3.966 . . . . 0.0 116.871 168.8 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.9 pt -102.91 129.37 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.536 161.005 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.2 m -88.54 129.14 35.54 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 103.452 -2.795 . . . . 0.0 103.452 -175.001 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.7 mt -114.89 131.16 56.95 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 178.624 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.15 98.72 9.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.553 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -112.98 167.99 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 124.662 2.172 . . . . 0.0 113.173 -176.221 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.371 26.4 mm-40 -93.46 149.25 36.95 Favored Pre-proline 0 N--CA 1.449 -0.511 0 O-C-N 118.204 -2.81 . . . . 0.0 105.593 167.104 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.28 15.4 Cg_endo -73.02 -16.03 25.77 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.952 2.434 . . . . 0.0 115.192 -176.61 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 p -86.61 -5.65 59.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.697 2.399 . . . . 0.0 112.07 -179.353 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -75.27 153.83 37.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -173.32 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.8 p -97.34 173.15 7.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 117.942 -2.974 . . . . 0.0 110.932 176.219 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.7 mm -85.97 -24.64 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 127.805 2.442 . . . . 0.0 109.121 -164.112 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -68.25 -30.58 69.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 129.929 3.292 . . . . 0.0 109.211 174.632 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -86.04 -17.67 34.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 124.319 3.236 . . . . 0.0 113.225 170.422 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.91 -50.93 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 102.75 -3.056 . . . . 0.0 102.75 168.908 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.22 -30.0 61.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 121.101 1.773 . . . . 0.0 108.756 -171.134 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.24 -27.4 67.94 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 117.497 -3.252 . . . . 0.0 115.465 168.317 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -67.02 -38.13 85.4 Favored 'General case' 0 C--N 1.325 -0.494 1 O-C-N 115.862 -4.274 . . . . 0.0 116.733 169.604 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.4 mt -74.3 -20.25 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 O-C-N 126.89 2.619 . . . . 0.0 113.173 171.433 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -66.61 -30.77 71.13 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 119.635 -1.915 . . . . 0.0 115.663 154.659 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -83.79 -57.71 3.1 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 121.496 1.953 . . . . 0.0 106.106 -174.765 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.323 64.7 mttm -45.04 -71.47 0.08 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 119.53 3.159 . . . . 0.0 119.53 168.073 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -102.77 -28.52 12.04 Favored 'General case' 0 N--CA 1.448 -0.526 1 CA-C-O 128.901 4.191 . . . . 0.0 115.979 -164.7 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.11 -9.12 50.18 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 118.777 -2.452 . . . . 0.0 118.955 167.211 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.4 mm -82.5 124.62 77.62 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 129.347 3.059 . . . . 0.0 104.825 -167.556 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.27 147.05 36.78 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 123.822 3.015 . . . . 0.0 112.829 -173.134 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -67.19 -13.19 38.74 Favored 'Trans proline' 0 N--CA 1.442 -1.507 1 C-N-CA 126.953 5.102 . . . . 0.0 114.072 -171.672 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -83.46 -5.7 59.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 118.213 -1.395 . . . . 0.0 113.927 173.688 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.431 2.5 tp-100 -108.98 -8.45 15.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.266 1.826 . . . . 0.0 111.408 168.885 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -92.91 123.74 36.39 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 126.859 3.219 . . . . 0.0 107.687 179.498 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.354 32.2 mtt180 -126.0 138.77 53.76 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 111.61 -2.541 . . . . 0.0 108.157 172.292 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.5 mt -105.49 150.96 24.85 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 174.176 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.286 68.4 mt -100.53 143.84 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 1 C-N-CA 133.383 4.673 . . . . 0.0 109.685 152.219 . . . . . . . . 3 2 . 1 . 085 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -151.59 119.68 6.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 111.025 -2.807 . . . . 0.0 115.055 162.635 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.8 39.07 24.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.758 2.423 . . . . 0.0 115.08 176.677 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.43 -10.39 16.88 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 163.15 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -134.09 136.23 43.78 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -159.867 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.359 6.0 tt0 -73.99 130.37 39.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 162.525 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -73.92 133.6 43.09 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -172.787 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.22 -39.31 94.26 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.585 1.954 . . . . 0.0 112.125 175.182 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.391 24.8 t0 106.38 160.31 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 131.701 4.0 . . . . 0.0 113.419 170.585 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.98 21.94 12.94 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 128.609 3.004 . . . . 0.0 114.518 153.608 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -113.62 176.37 5.06 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 124.724 2.202 . . . . 0.0 106.666 175.034 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.2 p -90.41 154.22 19.83 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.274 -2.141 . . . . 0.0 108.438 172.623 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.346 8.0 mp -41.79 -61.25 1.15 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 110.261 -3.154 . . . . 0.0 115.686 175.596 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -45.24 -52.88 9.01 Favored 'General case' 0 N--CA 1.448 -0.536 1 C-N-CA 132.921 4.488 . . . . 0.0 112.601 176.103 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -64.45 -43.66 93.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.66 178.216 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.75 -14.4 60.71 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 119.359 -2.088 . . . . 0.0 111.733 -173.402 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.475 0.9 OUTLIER 91.61 24.03 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 130.801 3.641 . . . . 0.0 115.643 179.323 . . . . . . . . 3 3 . 1 . 085 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.7 mt -95.59 115.47 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 119.934 1.243 . . . . 0.0 111.99 176.139 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.436 ' HB3' ' H ' ' A' ' 63' ' ' LYS . 9.5 mp0 -116.2 -156.49 0.62 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.831 1.652 . . . . 0.0 114.344 -178.876 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.436 ' H ' ' HB3' ' A' ' 62' ' ' GLN . 52.4 tttm -56.28 112.11 1.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 127.416 2.286 . . . . 0.0 112.997 178.407 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 76.52 21.96 1.27 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.065 2.146 . . . . 0.0 108.968 168.461 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -63.68 127.31 30.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 117.195 -1.383 . . . . 0.0 108.471 175.297 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 13.5 m -90.16 111.61 22.82 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 121.33 1.877 . . . . 0.0 111.687 169.664 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.3 mt -91.87 152.19 20.2 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.823 1.249 . . . . 0.0 110.263 166.673 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -107.96 141.25 39.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 173.164 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -104.35 145.46 30.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -179.556 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 m -142.72 153.11 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 129.146 2.978 . . . . 0.0 107.095 -178.023 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 mt -97.82 155.41 17.06 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 127.094 2.158 . . . . 0.0 108.393 167.131 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -96.06 79.4 3.21 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 120.896 1.68 . . . . 0.0 108.691 167.89 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.343 12.5 mt -88.68 -33.94 17.39 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 -174.084 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.8 ttm105 -91.59 -42.81 10.01 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 115.735 -2.386 . . . . 0.0 113.815 -165.795 . . . . . . . . 1 1 . 1 . 085 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.72 -141.19 11.41 Favored Glycine 0 CA--C 1.534 1.28 1 C-N-CA 131.343 4.306 . . . . 0.0 104.401 -158.486 . . . . . . . . 2 2 . 1 . 085 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.322 0 N-CA-C 104.787 -3.325 . . . . 0.0 104.787 165.599 . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 115.401 -2.238 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 086 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -72.42 152.58 41.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 129.525 3.13 . . . . 0.0 108.926 177.595 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pp -145.29 158.95 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 160.63 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -119.22 117.82 29.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.463 1.505 . . . . 0.0 108.989 -174.085 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 t -100.88 117.52 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 1 N-CA-C 99.253 -4.351 . . . . 0.0 99.253 175.886 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -109.42 136.52 48.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 125.465 1.728 . . . . 0.0 109.624 -171.917 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -84.97 174.27 9.9 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.125 -1.609 . . . . 0.0 108.969 -177.137 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.5 mt -91.64 0.65 57.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 116.84 -1.552 . . . . 0.0 107.085 179.595 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -107.19 0.89 23.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.305 1.842 . . . . 0.0 110.481 174.453 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.99 -27.48 8.6 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 115.049 -3.084 . . . . 0.0 111.912 154.625 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -62.6 144.31 56.32 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 129.826 3.898 . . . . 0.0 108.906 179.066 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -118.52 123.0 44.02 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 127.683 3.114 . . . . 0.0 103.791 -169.057 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mt -94.24 134.36 32.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 117.039 -1.457 . . . . 0.0 108.329 174.602 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.6 m -103.07 110.23 22.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 114.296 -2.764 . . . . 0.0 110.716 177.848 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -107.6 160.37 15.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 127.152 2.782 . . . . 0.0 109.648 167.668 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.394 0.0 OUTLIER -127.87 116.06 19.56 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.732 3.213 . . . . 0.0 110.568 -178.017 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.19 162.61 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 O-C-N 117.725 -3.109 . . . . 0.0 106.974 -169.387 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -102.07 154.56 37.28 Favored Pre-proline 0 N--CA 1.441 -0.901 0 O-C-N 118.975 -2.328 . . . . 0.0 106.815 164.638 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.251 67.0 Cg_endo -66.77 -29.32 42.58 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 124.496 3.464 . . . . 0.0 115.765 175.757 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.256 27.9 p -63.05 -2.28 1.21 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 114.927 -2.463 . . . . 0.0 117.366 160.814 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -70.1 136.14 49.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 123.484 2.856 . . . . 0.0 108.542 -175.517 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 p -77.99 170.83 15.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.76 2.424 . . . . 0.0 109.128 170.241 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.3 mt -72.66 -46.07 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -177.987 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -41.72 -44.1 3.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 122.668 2.485 . . . . 0.0 116.024 162.561 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -63.96 -42.97 97.13 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 124.687 1.242 . . . . 0.0 109.87 179.461 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 t -79.83 -27.88 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.353 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -68.69 -34.07 75.04 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 114.607 -2.616 . . . . 0.0 114.445 167.541 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.35 -26.12 42.15 Favored 'General case' 0 N--CA 1.45 -0.445 1 CA-C-N 126.881 4.401 . . . . 0.0 115.057 169.382 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -71.55 -39.61 70.55 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 124.688 1.242 . . . . 0.0 109.777 172.271 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.8 mt -73.36 -37.76 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 O-C-N 116.664 -3.773 . . . . 0.0 113.695 173.406 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -45.49 88.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 119.999 1.272 . . . . 0.0 112.623 175.551 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.09 -35.51 69.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.766 2.426 . . . . 0.0 111.495 -179.612 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -86.73 -39.04 16.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -177.312 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -120.53 -25.31 5.59 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.311 1.844 . . . . 0.0 111.466 -172.259 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.77 -11.97 67.72 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 114.641 -3.311 . . . . 0.0 116.138 -178.682 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.6 mt -64.84 118.52 49.46 Favored Pre-proline 0 N--CA 1.45 -0.456 1 CA-C-N 124.434 4.117 . . . . 0.0 115.678 177.469 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -76.44 141.49 22.67 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 CA-C-N 124.533 2.655 . . . . 0.0 118.035 -173.767 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -30.21 -50.33 0.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 N-CA-C 121.089 3.457 . . . . 0.0 121.089 177.839 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.93 -40.74 63.83 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 117.446 -3.284 . . . . 0.0 114.591 172.93 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -84.51 -25.79 28.55 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 118.535 -1.266 . . . . 0.0 113.733 -174.376 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -63.81 121.48 14.13 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 128.218 2.607 . . . . 0.0 108.117 171.882 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -101.54 131.83 47.5 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 123.316 2.78 . . . . 0.0 109.65 147.739 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.9 mt -104.95 139.09 40.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 125.846 1.966 . . . . 0.0 108.222 167.72 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.7 mt -129.37 125.93 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 110.793 -2.912 . . . . 0.0 108.148 -173.912 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.362 33.1 t80 -149.54 131.18 14.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.654 1.115 . . . . 0.0 108.908 176.086 . . . . . . . . 2 2 . 1 . 086 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.38 34.51 15.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -178.711 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.01 -23.05 5.42 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 119.233 2.453 . . . . 0.0 119.233 -173.05 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -79.2 139.23 38.01 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 127.566 2.568 . . . . 0.0 111.405 -174.724 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -87.67 124.83 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 164.352 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.95 135.61 33.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 126.169 1.788 . . . . 0.0 113.395 -162.175 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -83.4 134.72 34.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 116.822 -3.674 . . . . 0.0 113.437 176.643 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.92 141.48 51.14 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 127.523 3.014 . . . . 0.0 111.173 -174.577 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.76 -16.16 26.12 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 111.725 -2.489 . . . . 0.0 114.141 177.854 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -87.25 145.82 26.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.886 2.074 . . . . 0.0 112.189 177.037 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 p -85.69 157.81 20.21 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 126.037 2.086 . . . . 0.0 111.904 179.02 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -53.62 -53.97 44.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.883 2.073 . . . . 0.0 114.464 177.23 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.252 22.1 t -39.68 -35.05 0.28 Allowed 'General case' 0 C--N 1.326 -0.437 1 N-CA-C 122.927 4.417 . . . . 0.0 122.927 165.925 . . . . . . . . 3 2 . 1 . 086 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -70.28 -44.25 68.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.224 2.61 . . . . 0.0 114.858 176.739 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -94.93 6.28 49.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 111.795 -2.457 . . . . 0.0 106.642 -173.286 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.9 t30 86.11 21.39 0.08 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 126.482 3.039 . . . . 0.0 113.065 151.976 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.297 82.3 mt -77.84 98.37 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 1 O-C-N 115.782 -4.324 . . . . 0.0 102.542 -178.316 . . . . . . . . 3 2 . 1 . 086 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -82.03 161.88 22.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 130.523 3.529 . . . . 0.0 107.51 -179.9 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -49.14 133.69 18.55 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 126.179 2.174 . . . . 0.0 112.913 176.242 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 65.05 20.92 12.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.125 2.97 . . . . 0.0 118.876 169.305 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -65.97 149.9 49.5 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 112.045 -3.836 . . . . 0.0 115.965 174.518 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 m -107.32 128.48 54.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 128.438 3.586 . . . . 0.0 110.265 170.332 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.251 0.7 OUTLIER -144.56 -177.9 5.72 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.361 2.264 . . . . 0.0 108.376 -170.771 . . . . . . . . 3 3 . 1 . 086 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.629 2.1 p80 -128.96 167.12 17.9 Favored 'General case' 0 N--CA 1.448 -0.537 1 C-N-CA 134.144 4.977 . . . . 0.0 118.117 177.79 . . . . . . . . 3 2 . 1 . 086 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 tp -135.86 126.72 27.54 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 110.6 -3.0 . . . . 0.0 115.713 175.267 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.14 104.77 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 130.44 3.496 . . . . 0.0 108.346 -179.303 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.53 78.06 0.07 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 130.958 3.703 . . . . 0.0 108.863 165.528 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -74.6 76.04 2.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 125.325 3.693 . . . . 0.0 112.767 165.201 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -80.61 12.49 3.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 129.368 3.067 . . . . 0.0 114.365 -177.165 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -90.61 133.18 35.3 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 102.094 -3.298 . . . . 0.0 102.094 157.694 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.2 83.13 0.35 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -165.616 . . . . . . . . 1 1 . 1 . 086 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.829 0 CA-C-O 115.168 -3.018 . . . . 0.0 108.113 179.629 . . . . . . . . 0 0 . 1 . 087 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 . . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.95 139.16 44.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 116.833 -1.556 . . . . 0.0 112.728 158.913 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -128.75 173.79 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 167.509 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.19 160.41 37.33 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 125.612 1.82 . . . . 0.0 109.421 179.946 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.9 t -136.37 116.22 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 127.654 2.382 . . . . 0.0 109.256 172.671 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -76.3 130.67 38.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 121.277 1.853 . . . . 0.0 111.196 156.588 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 p -100.73 168.17 9.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 116.168 -1.872 . . . . 0.0 114.592 -174.71 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 mt -58.6 -32.93 69.44 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 127.181 2.192 . . . . 0.0 113.089 -175.87 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -71.57 -22.62 61.71 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.679 1.991 . . . . 0.0 115.363 174.418 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.56 -18.22 13.41 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 128.925 3.155 . . . . 0.0 108.658 -176.793 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 86.8 tttt -66.68 148.09 52.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 113.839 -2.981 . . . . 0.0 109.111 -172.738 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.3 m -120.52 130.94 54.46 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 125.853 1.971 . . . . 0.0 112.429 174.966 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 mm -103.69 147.65 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 128.591 2.756 . . . . 0.0 105.597 179.471 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.3 m -106.84 122.9 47.32 Favored 'General case' 0 N--CA 1.452 -0.337 1 N-CA-C 99.472 -4.27 . . . . 0.0 99.472 174.743 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.14 160.69 25.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.87 1.668 . . . . 0.0 109.302 173.436 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -114.01 125.91 54.53 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.39 -1.732 . . . . 0.0 115.167 166.224 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.42 161.99 13.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 O-C-N 119.613 -1.929 . . . . 0.0 112.135 176.152 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -107.57 160.57 26.17 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 127.456 2.302 . . . . 0.0 107.335 161.304 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -40.38 -42.16 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.891 1 C-N-CA 127.477 5.451 . . . . 0.0 114.815 175.218 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 p -77.57 -3.01 38.58 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.772 -3.08 . . . . 0.0 117.005 -172.88 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.25 123.81 29.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 123.641 1.686 . . . . 0.0 109.841 -178.631 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.3 p -81.71 179.85 7.66 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 129.319 3.048 . . . . 0.0 106.399 -179.403 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.2 mm -64.77 -35.89 76.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 115.941 -1.98 . . . . 0.0 109.376 179.325 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -55.24 -47.15 75.82 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 126.458 1.903 . . . . 0.0 114.318 173.771 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -64.81 -34.95 79.57 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.899 3.679 . . . . 0.0 109.474 177.236 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.0 t -71.05 -42.5 76.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.454 1.902 . . . . 0.0 107.0 177.177 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -73.0 -31.08 64.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 119.24 -2.162 . . . . 0.0 115.61 -178.019 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.29 78.03 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.766 3.226 . . . . 0.0 112.492 170.053 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -74.46 -30.09 61.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.323 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.7 mt -73.39 -35.96 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 128.982 2.913 . . . . 0.0 109.916 -176.957 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -61.94 -42.74 99.45 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 119.133 -2.229 . . . . 0.0 109.515 172.931 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -61.67 -19.28 62.15 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 119.671 3.212 . . . . 0.0 119.671 178.358 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -101.11 -40.36 7.23 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 116.874 -1.536 . . . . 0.0 109.095 172.404 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS 0.328 16.8 tp10 -125.05 -4.68 7.44 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.529 -1.357 . . . . 0.0 114.023 -157.616 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.23 9.23 28.64 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 119.176 2.43 . . . . 0.0 119.176 174.762 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.2 mt -75.89 133.12 73.22 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 130.655 3.582 . . . . 0.0 105.484 174.842 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.55 145.67 59.1 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 CA-C-O 113.926 -2.614 . . . . 0.0 114.285 -175.193 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.08 -39.17 19.43 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.504 2.803 . . . . 0.0 119.29 -177.469 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.47 ' CG ' HH12 ' A' ' 72' ' ' ARG 0.265 38.4 t70 -48.64 -48.79 39.29 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 130.378 3.471 . . . . 0.0 114.145 179.73 . . . . . . . . 3 3 . 1 . 087 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -72.22 -25.62 61.71 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 131.092 3.757 . . . . 0.0 113.278 173.3 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.84 128.76 35.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 123.759 2.981 . . . . 0.0 109.945 -175.014 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -109.98 161.8 15.15 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 118.862 -2.399 . . . . 0.0 108.675 165.49 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -124.81 106.65 10.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 164.111 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -92.77 128.65 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 101.008 -3.701 . . . . 0.0 101.008 164.641 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -157.13 117.67 3.56 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 128.29 2.636 . . . . 0.0 110.277 -173.727 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.94 28.74 18.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.217 2.607 . . . . 0.0 110.652 -172.427 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.23 -25.49 28.05 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 125.413 1.696 . . . . 0.0 109.861 177.678 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 tttt -92.62 135.01 34.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.988 -0.713 . . . . 0.0 111.227 -162.804 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.67 119.51 14.92 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 115.885 -2.007 . . . . 0.0 109.115 171.824 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.2 mt -81.36 123.82 28.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -177.953 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -81.29 137.59 35.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.457 -1.402 . . . . 0.0 110.365 -175.414 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.73 114.71 5.21 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.486 169.747 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.24 -21.32 2.95 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 130.327 3.822 . . . . 0.0 112.752 177.932 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mtp85 -97.31 155.67 16.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -176.861 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.448 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 42.0 p -94.74 171.05 9.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.364 1.866 . . . . 0.0 108.09 177.619 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.13 -47.24 77.79 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.962 1.305 . . . . 0.0 111.41 176.085 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.5 p -44.89 -40.26 6.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 118.591 2.812 . . . . 0.0 118.591 159.863 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 70.8 m-20 -61.57 -34.17 75.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 124.218 1.961 . . . . 0.0 116.133 168.654 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.94 11.16 21.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.033 -2.292 . . . . 0.0 115.927 168.813 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.451 8.5 p30 54.36 46.6 24.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 124.442 2.067 . . . . 0.0 111.662 177.515 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -103.85 108.25 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 128.662 2.785 . . . . 0.0 109.158 173.599 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -105.27 169.28 8.54 Favored 'General case' 0 C--N 1.325 -0.482 1 O-C-N 130.147 4.654 . . . . 0.0 112.749 -173.875 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.325 51.7 tttm -12.52 107.0 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 129.372 3.069 . . . . 0.0 117.446 168.969 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 76.49 17.87 1.85 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 129.386 3.074 . . . . 0.0 115.013 168.694 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -67.93 139.12 56.42 Favored 'General case' 0 CA--C 1.532 0.283 1 O-C-N 115.567 -4.458 . . . . 0.0 113.512 171.109 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.1 m -98.08 112.06 24.15 Favored 'General case' 0 N--CA 1.449 -0.48 1 C-N-CA 133.641 4.776 . . . . 0.0 103.579 178.137 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -87.09 161.51 18.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 128.824 2.85 . . . . 0.0 109.538 169.21 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -123.15 118.7 28.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 130.12 3.368 . . . . 0.0 111.348 -172.73 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.1 tp -89.77 111.09 21.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 116.32 -1.8 . . . . 0.0 114.649 -166.167 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.95 165.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 125.142 1.526 . . . . 0.0 107.875 -179.539 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tp -112.37 162.59 15.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.921 1.688 . . . . 0.0 109.045 -176.469 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.47 HH12 ' CG ' ' A' ' 39' ' ' ASP . 51.0 ttp180 -85.51 124.16 31.76 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 127.139 2.176 . . . . 0.0 108.078 178.602 . . . . . . . . 2 2 . 1 . 087 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.97 163.2 13.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.885 2.874 . . . . 0.0 106.991 172.327 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.374 5.1 ptp180 -147.33 152.59 38.47 Favored 'General case' 0 N--CA 1.452 -0.335 1 C-N-CA 132.664 4.385 . . . . 0.0 109.991 -176.78 . . . . . . . . 3 2 . 1 . 087 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.62 -116.18 2.4 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 103.916 -3.674 . . . . 0.0 103.916 154.488 . . . . . . . . 1 1 . 1 . 087 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.698 0 C-N-CA 129.002 3.191 . . . . 0.0 109.502 -176.604 . . . . . . . . 0 0 . 1 . 088 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -72.19 134.78 45.87 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.299 1.84 . . . . 0.0 112.864 171.592 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.5 pt -147.04 141.04 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.489 2.316 . . . . 0.0 107.958 168.935 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.04 151.28 25.07 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 119.125 -2.234 . . . . 0.0 107.54 -179.223 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -110.88 129.39 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 117.733 -3.104 . . . . 0.0 104.33 160.61 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -109.07 120.36 42.31 Favored 'General case' 0 N--CA 1.45 -0.433 1 O-C-N 116.268 -4.02 . . . . 0.0 101.406 167.707 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -85.95 126.79 34.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 158.547 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.307 6.0 mp -88.83 -12.65 41.35 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 125.318 1.636 . . . . 0.0 108.88 -167.686 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.5 p -90.33 -14.02 33.98 Favored 'General case' 0 N--CA 1.442 -0.869 1 O-C-N 115.919 -4.238 . . . . 0.0 113.198 164.281 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.64 -104.89 1.28 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.319 1.914 . . . . 0.0 108.532 -156.0 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -159.67 151.73 20.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 117.85 -3.147 . . . . 0.0 108.884 -159.071 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.4 p -70.96 127.19 31.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.553 -2.112 . . . . 0.0 110.222 161.336 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.98 137.6 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 131.324 3.85 . . . . 0.0 102.779 -175.386 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.3 p -92.51 112.55 24.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.227 -1.351 . . . . 0.0 107.662 173.935 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.35 171.74 7.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 174.533 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -141.8 127.36 18.98 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 103.147 -2.908 . . . . 0.0 103.147 -175.823 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.2 m -132.8 177.78 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 O-C-N 119.295 -2.128 . . . . 0.0 111.833 177.666 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -97.27 143.18 25.71 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 125.581 1.552 . . . . 0.0 109.605 178.611 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -63.73 -24.34 68.96 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-O 115.727 -1.864 . . . . 0.0 115.44 172.911 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.3 p -99.75 10.45 41.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 130.016 3.326 . . . . 0.0 114.132 -178.398 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.71 145.97 48.48 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 125.764 1.915 . . . . 0.0 107.187 -179.339 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.1 p -91.94 150.63 20.92 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 115.582 -2.151 . . . . 0.0 113.677 164.809 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -54.46 -34.07 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 123.868 3.031 . . . . 0.0 116.49 -176.172 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.33 -39.54 76.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 124.53 3.332 . . . . 0.0 115.963 172.974 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -83.16 -26.17 31.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.897 2.079 . . . . 0.0 115.675 175.4 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.287 99.3 t -50.47 -52.69 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 O-C-N 119.007 -2.308 . . . . 0.0 115.109 157.712 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -60.41 -34.48 74.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 126.46 2.35 . . . . 0.0 115.444 174.691 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.1 63.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 131.311 3.844 . . . . 0.0 113.04 165.561 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.289 49.1 mttp -59.33 -41.28 88.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.662 1.585 . . . . 0.0 111.592 -178.784 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.296 18.0 mt -78.22 -23.15 13.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 127.597 2.359 . . . . 0.0 110.996 -176.939 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 31' ' ' GLN . 0.9 OUTLIER -73.81 -43.16 59.67 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 165.444 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.296 25.8 t70 -69.08 -36.96 78.19 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 125.735 2.683 . . . . 0.0 116.675 -178.416 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -36.8 65.48 Favored 'General case' 0 CA--C 1.536 0.433 1 O-C-N 113.395 -5.816 . . . . 0.0 115.982 177.296 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -128.98 -10.43 4.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 117.372 2.36 . . . . 0.0 117.372 -168.189 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.22 10.39 77.97 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 129.794 3.569 . . . . 0.0 112.97 179.804 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.9 mt -81.92 129.1 66.0 Favored Pre-proline 0 N--CA 1.443 -0.814 1 CA-C-N 124.701 4.251 . . . . 0.0 110.288 -166.426 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.02 144.58 64.48 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 123.491 2.794 . . . . 0.0 118.084 -170.887 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -74.62 -30.06 8.26 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.411 2.741 . . . . 0.0 117.735 -168.978 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -70.89 -17.15 62.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.266 1.031 . . . . 0.0 110.196 172.446 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -102.85 -8.76 20.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 117.869 -3.02 . . . . 0.0 113.398 -171.683 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -83.33 135.39 34.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 122.074 2.215 . . . . 0.0 107.876 -178.764 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -120.05 112.73 19.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 119.414 -2.054 . . . . 0.0 107.585 148.306 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mt -84.84 147.1 26.98 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 126.128 2.142 . . . . 0.0 109.393 170.37 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.296 0.0 OUTLIER -143.36 131.99 19.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 115.45 -2.214 . . . . 0.0 111.79 -174.288 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -137.16 121.74 18.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 102.726 -3.065 . . . . 0.0 102.726 175.393 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 79.56 2.39 2.21 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 127.768 3.167 . . . . 0.0 113.719 165.671 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.75 -17.87 20.13 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 118.07 -2.894 . . . . 0.0 108.519 -174.622 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -85.82 109.56 18.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.167 2.187 . . . . 0.0 108.955 179.993 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.7 119.87 13.15 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.042 166.83 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -91.16 116.92 29.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 117.935 -2.978 . . . . 0.0 106.361 -151.222 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -92.84 145.98 23.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 123.252 1.501 . . . . 0.0 107.045 -166.642 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.24 145.19 43.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 112.375 -2.193 . . . . 0.0 107.67 171.131 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.38 -26.03 25.0 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.783 2.135 . . . . 0.0 112.635 175.169 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -96.49 168.61 10.44 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.552 2.341 . . . . 0.0 114.955 179.2 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.7 p -119.14 176.72 5.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 112.792 -2.003 . . . . 0.0 112.256 -166.752 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.2 mt -77.21 -28.98 54.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.905 -179.782 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.2 t -76.21 -25.76 55.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 115.128 -2.368 . . . . 0.0 110.03 177.76 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -59.78 -61.66 2.45 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 131.058 3.743 . . . . 0.0 105.41 176.622 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -89.67 -7.28 54.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 128.341 2.656 . . . . 0.0 111.908 -169.596 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.384 2.3 t-20 86.03 31.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.226 2.61 . . . . 0.0 111.954 166.01 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.252 5.4 mt -80.24 107.99 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 126.247 1.819 . . . . 0.0 111.002 -174.744 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -100.7 -179.86 4.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 127.215 2.822 . . . . 0.0 112.731 179.13 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -61.86 129.93 43.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 129.712 3.205 . . . . 0.0 112.391 -176.135 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.535 1.1 tt0 79.2 4.59 2.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 159.764 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.9 p -57.12 157.58 5.92 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 127.512 3.007 . . . . 0.0 115.893 158.423 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 m -102.77 126.56 49.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 119.821 -1.8 . . . . 0.0 111.952 156.27 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 mp -91.26 146.69 23.61 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 120.721 -1.237 . . . . 0.0 107.705 160.173 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -94.66 145.93 24.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 117.108 -1.425 . . . . 0.0 108.188 177.73 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.13 122.02 40.09 Favored 'General case' 0 C--N 1.322 -0.589 1 C-N-CA 132.547 4.339 . . . . 0.0 104.908 177.544 . . . . . . . . 3 3 . 1 . 088 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.326 2.8 m -121.11 115.61 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 109.074 -3.694 . . . . 0.0 101.427 -178.274 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.1 mt -77.69 119.3 21.03 Favored 'General case' 0 N--CA 1.451 -0.378 1 O-C-N 115.94 -4.225 . . . . 0.0 113.4 -174.844 . . . . . . . . 2 2 . 1 . 088 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.1 ttt-85 -81.19 74.78 8.18 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 119.993 -1.692 . . . . 0.0 107.564 176.652 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.5 mt -78.45 -31.03 47.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -169.19 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -106.09 -22.35 12.89 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 127.828 3.205 . . . . 0.0 107.246 -171.838 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.71 42.26 2.17 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 115.578 -2.79 . . . . 0.0 112.721 -172.762 . . . . . . . . 1 1 . 1 . 088 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.331 0 O-C-N 125.164 1.155 . . . . 0.0 112.93 179.873 . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 ttp . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 101.511 -3.514 . . . . 0.0 101.511 . . . . . . . . . 0 0 . 1 . 089 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -89.63 150.91 22.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.857 1.263 . . . . 0.0 110.432 161.676 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.294 47.4 pt -135.13 175.06 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 129.778 3.231 . . . . 0.0 109.978 163.264 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.291 97.9 m-85 -116.38 126.17 53.1 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.101 2.96 . . . . 0.0 110.93 163.732 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.19 140.34 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 151.807 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -118.97 146.73 44.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 126.85 2.594 . . . . 0.0 105.54 167.564 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.2 p -98.65 161.21 13.78 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.49 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt -50.6 -29.64 11.38 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 118.892 -2.38 . . . . 0.0 116.09 -175.223 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.2 p -104.77 9.47 34.93 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.544 2.737 . . . . 0.0 108.749 -162.909 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.85 -23.68 30.38 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 119.605 -1.934 . . . . 0.0 116.231 164.981 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -69.76 126.2 29.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 125.753 1.502 . . . . 0.0 108.503 -179.939 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 p -106.47 150.73 25.79 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.304 1.841 . . . . 0.0 108.654 175.658 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.7 pt -129.75 131.67 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 1 C-N-CA 133.477 4.711 . . . . 0.0 113.8 168.999 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -87.95 118.58 27.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.854 2.061 . . . . 0.0 106.875 177.893 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.63 134.2 50.14 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 129.183 2.993 . . . . 0.0 112.164 178.796 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.66 138.24 36.12 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.533 1.933 . . . . 0.0 113.171 172.419 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.306 7.0 m -157.16 142.99 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-O 117.295 -1.336 . . . . 0.0 107.625 -163.229 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -91.96 148.01 36.05 Favored Pre-proline 0 C--O 1.221 -0.401 0 C-N-CA 124.783 1.233 . . . . 0.0 110.814 -178.296 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 31.8 Cg_exo -47.06 -0.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.434 1 N-CA-C 122.616 4.045 . . . . 0.0 122.616 170.627 . . . . . . . . 3 2 . 1 . 089 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 p -134.32 16.24 3.75 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 118.782 -2.449 . . . . 0.0 111.715 -174.154 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.487 ' CG ' HD21 ' A' ' 25' ' ' ASN . 22.3 m-20 -85.93 150.79 24.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -179.53 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -102.34 149.98 23.79 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 128.457 2.703 . . . . 0.0 106.369 177.509 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -49.65 -27.25 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.605 2.362 . . . . 0.0 114.546 177.269 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -50.42 -44.31 55.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.882 2.073 . . . . 0.0 115.103 161.376 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.487 HD21 ' CG ' ' A' ' 21' ' ' ASP . 49.2 t30 -62.1 -42.1 98.87 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 128.425 2.69 . . . . 0.0 110.891 177.735 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.0 t -58.81 -38.45 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 176.936 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -66.51 -40.44 89.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 128.484 2.714 . . . . 0.0 114.25 175.246 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -40.06 80.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 117.739 -1.124 . . . . 0.0 110.714 176.03 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.437 25.1 mttt -53.82 -45.58 70.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 175.538 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.279 50.8 mt -52.67 -49.4 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 117.019 -1.467 . . . . 0.0 112.686 170.565 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -42.87 -55.21 3.8 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 129.36 3.064 . . . . 0.0 111.578 167.32 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.98 -29.86 62.2 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.002 -1.475 . . . . 0.0 111.134 -171.651 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -83.66 -47.56 11.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 120.697 1.589 . . . . 0.0 112.267 172.107 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -116.41 -20.66 9.6 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 115.575 -2.155 . . . . 0.0 113.829 -159.154 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.15 0.24 25.32 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 125.135 1.522 . . . . 0.0 115.152 172.599 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.0 mt -96.26 136.68 21.86 Favored Pre-proline 0 N--CA 1.45 -0.429 0 O-C-N 126.573 1.984 . . . . 0.0 109.607 -160.365 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HG2' ' HB2' ' A' ' 40' ' ' GLN . 9.5 Cg_endo -89.31 142.19 4.3 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 124.726 2.723 . . . . 0.0 111.471 -163.422 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.07 -45.77 36.83 Favored 'Trans proline' 0 N--CA 1.452 -0.95 1 C-N-CA 126.607 4.871 . . . . 0.0 114.778 -177.95 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -48.49 -23.3 0.92 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 130.13 3.372 . . . . 0.0 115.774 171.271 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.411 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 41.8 mt-30 -120.93 14.15 11.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 127.504 3.002 . . . . 0.0 112.941 -176.171 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 72.8 mt-30 -102.86 162.39 12.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 169.891 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.3 ttp-105 -144.52 131.88 20.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 131.209 3.804 . . . . 0.0 105.637 162.74 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.1 mt -111.25 134.76 52.6 Favored 'General case' 0 N--CA 1.444 -0.759 1 O-C-N 115.85 -4.281 . . . . 0.0 110.241 -174.747 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 41.7 mt -126.8 149.52 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 118.293 -2.755 . . . . 0.0 108.841 179.201 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -112.9 -44.11 3.34 Favored 'General case' 0 C--N 1.325 -0.48 1 C-N-CA 132.031 4.132 . . . . 0.0 111.118 161.374 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.09 -103.98 0.29 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 -175.685 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.48 -32.55 0.52 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 118.254 2.062 . . . . 0.0 118.254 -150.196 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -93.14 -178.91 4.92 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 130.125 3.37 . . . . 0.0 112.56 153.394 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -97.12 151.96 19.26 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.651 1.58 . . . . 0.0 109.725 177.475 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.23 135.74 40.99 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.34 1.856 . . . . 0.0 109.365 -177.2 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -77.58 112.65 14.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.033 -2.917 . . . . 0.0 109.448 169.16 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.92 -19.84 46.28 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 129.982 3.313 . . . . 0.0 119.132 -165.788 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.56 14.43 35.52 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.789 2.138 . . . . 0.0 110.05 -177.482 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -90.85 166.57 13.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 124.349 2.023 . . . . 0.0 108.496 157.51 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -90.53 166.02 13.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.663 -1.608 . . . . 0.0 113.687 173.758 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.409 11.8 mt -45.08 -31.86 1.53 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 129.086 2.955 . . . . 0.0 118.371 163.994 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.7 p -93.05 -11.66 32.5 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 119.474 -2.016 . . . . 0.0 111.183 179.143 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -90.59 -4.95 56.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 114.838 -2.506 . . . . 0.0 109.257 177.603 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -118.7 -10.01 10.09 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 166.555 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t30 87.0 40.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 119.479 -2.013 . . . . 0.0 111.334 171.973 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.5 mm -87.55 106.95 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 113.088 -1.869 . . . . 0.0 108.103 175.514 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -87.03 179.88 6.6 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 131.337 3.855 . . . . 0.0 106.532 -172.939 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.3 51.2 pttt -58.4 136.54 57.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 166.794 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 58.9 26.74 15.28 Favored 'General case' 0 N--CA 1.45 -0.472 1 C-N-CA 133.506 4.722 . . . . 0.0 112.344 169.03 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 m -73.8 149.96 41.35 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 129.96 3.304 . . . . 0.0 113.587 -176.844 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -98.45 119.29 36.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 178.26 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -100.23 154.19 18.66 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.397 152.735 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -116.1 119.61 36.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.794 1.638 . . . . 0.0 107.896 -172.167 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.262 52.2 tp -98.94 122.79 42.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 124.118 1.913 . . . . 0.0 113.158 -179.112 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.88 145.06 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 126.513 1.925 . . . . 0.0 110.107 161.52 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.26 136.37 41.62 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 127.982 2.513 . . . . 0.0 110.651 172.898 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.2 mtm105 -101.84 24.83 9.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.335 -175.83 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.67 79.07 1.24 Allowed 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 119.392 -2.067 . . . . 0.0 105.491 177.049 . . . . . . . . 2 2 . 1 . 089 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -153.2 -52.95 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -174.293 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.83 44.14 0.21 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 128.173 2.797 . . . . 0.0 111.369 173.384 . . . . . . . . 1 1 . 1 . 089 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.428 0 CA-C-O 115.956 -2.58 . . . . 0.0 109.452 -158.946 . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 . . . . . . . . . 0 0 . 1 . 090 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -83.24 139.63 32.99 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 129.512 3.125 . . . . 0.0 105.162 -175.747 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.266 30.0 pt -141.53 149.33 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 127.124 2.17 . . . . 0.0 111.968 -176.37 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -89.13 146.43 24.81 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.224 164.036 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -127.76 118.09 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 126.838 2.586 . . . . 0.0 106.133 169.656 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -94.83 116.81 29.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -177.993 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.2 p -70.75 164.9 24.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 124.441 2.067 . . . . 0.0 112.955 174.982 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.25 -37.82 60.84 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 120.528 -1.358 . . . . 0.0 112.094 -177.45 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 p -54.56 -29.86 52.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 130.993 3.717 . . . . 0.0 116.242 161.844 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.68 -19.77 5.84 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 119.677 -1.889 . . . . 0.0 113.146 161.843 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -73.5 136.57 44.14 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.965 2.506 . . . . 0.0 111.024 175.059 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m -112.32 130.11 56.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 125.265 1.603 . . . . 0.0 110.019 178.273 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.3 pt -110.9 177.61 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 112.376 -2.193 . . . . 0.0 108.592 -178.513 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 t -140.83 141.64 34.68 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.404 1.881 . . . . 0.0 107.077 170.36 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.6 mt -129.11 159.02 37.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.647 2.779 . . . . 0.0 107.051 177.754 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -91.58 138.12 31.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 157.31 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.01 175.76 8.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 CA-C-N 122.416 2.371 . . . . 0.0 107.448 170.113 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -111.87 156.68 41.31 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 162.146 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -58.65 -28.17 85.35 Favored 'Trans proline' 0 N--CA 1.444 -1.412 1 C-N-CA 126.186 4.591 . . . . 0.0 120.538 173.042 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -98.1 21.92 10.14 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 124.939 1.399 . . . . 0.0 112.321 173.97 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.83 153.86 38.54 Favored 'General case' 0 N--CA 1.453 -0.32 1 O-C-N 115.085 -4.759 . . . . 0.0 108.089 174.319 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.293 86.7 m -100.24 157.81 16.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.27 2.228 . . . . 0.0 108.272 168.823 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.1 mm -58.47 -9.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 119.261 3.06 . . . . 0.0 119.261 -178.835 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -87.46 -4.72 59.0 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 118.832 -2.417 . . . . 0.0 113.136 -178.422 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -91.78 -34.63 14.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.717 -2.038 . . . . 0.0 111.717 164.977 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.26 -51.52 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 O-C-N 119.638 -1.914 . . . . 0.0 108.625 179.773 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -51.05 -56.14 14.05 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 128.921 3.888 . . . . 0.0 113.075 -178.532 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.97 80.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.269 2.628 . . . . 0.0 117.034 176.738 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -68.44 -40.52 81.11 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 173.044 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.357 75.8 mt -47.65 -49.29 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 128.811 2.844 . . . . 0.0 112.692 160.665 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -63.61 -45.89 88.26 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.61 2.364 . . . . 0.0 112.556 -179.259 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.51 -64.6 0.79 Allowed 'General case' 0 C--O 1.238 0.46 1 C-N-CA 132.487 4.315 . . . . 0.0 107.222 173.167 . . . . . . . . 3 3 . 1 . 090 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -63.51 -57.03 11.48 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 128.094 3.371 . . . . 0.0 118.22 -174.254 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.279 22.2 mm-40 -111.94 -2.07 15.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.176 2.19 . . . . 0.0 113.741 -168.173 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.85 -19.41 41.3 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 117.543 -3.223 . . . . 0.0 113.132 160.635 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -83.56 127.3 68.6 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 117.962 -3.081 . . . . 0.0 112.506 -157.483 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.22 133.85 31.93 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 CA-C-N 123.885 2.423 . . . . 0.0 113.112 168.653 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.337 17.9 Cg_endo -58.94 -30.31 92.84 Favored 'Trans proline' 0 N--CA 1.452 -0.959 1 C-N-CA 127.691 5.594 . . . . 0.0 117.211 -171.255 . . . . . . . . 3 2 . 1 . 090 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.286 26.6 t70 -76.3 -26.47 55.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 119.967 -1.708 . . . . 0.0 111.327 -163.728 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -73.14 -7.84 53.13 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 172.033 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.455 1.2 pp0? -132.63 162.22 31.89 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.964 1.364 . . . . 0.0 113.428 -179.532 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -126.0 148.89 49.17 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 128.573 2.749 . . . . 0.0 111.512 171.343 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mt -99.37 118.73 36.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.802 2.841 . . . . 0.0 105.475 -178.357 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 mm -107.71 144.66 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 128.613 2.765 . . . . 0.0 104.922 179.18 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -141.82 132.57 25.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 125.221 1.576 . . . . 0.0 108.506 162.087 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.07 22.77 0.15 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 129.891 3.276 . . . . 0.0 114.644 -177.216 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.44 -7.07 36.62 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 119.398 -2.064 . . . . 0.0 112.948 177.398 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -113.29 141.01 47.52 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 121.564 -0.962 . . . . 0.0 113.298 -168.033 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -63.61 137.01 57.94 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 126.667 2.479 . . . . 0.0 115.565 171.975 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -105.54 108.53 20.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.673 3.189 . . . . 0.0 106.679 179.716 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -91.61 166.45 12.81 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 120.567 1.531 . . . . 0.0 112.38 -168.608 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.31 129.19 37.33 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.371 2.668 . . . . 0.0 107.803 171.107 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.93 -20.19 29.3 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 130.009 3.671 . . . . 0.0 114.933 165.086 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -89.45 153.08 21.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.077 2.551 . . . . 0.0 106.404 179.753 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -104.18 142.19 34.95 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 129.163 2.985 . . . . 0.0 111.276 -169.642 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.28 -55.35 25.33 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 126.906 2.628 . . . . 0.0 117.342 -170.042 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.331 41.2 t -65.0 -18.94 65.73 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 118.335 -2.728 . . . . 0.0 110.255 -172.913 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -78.69 -22.41 46.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 131.377 3.871 . . . . 0.0 115.817 171.333 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -81.37 -10.07 59.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.985 1.714 . . . . 0.0 113.14 163.665 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.349 58.8 t30 80.32 47.69 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 131.546 3.938 . . . . 0.0 108.349 173.882 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.3 mt -104.76 146.52 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 C-N-CA 125.814 1.646 . . . . 0.0 107.357 171.652 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -139.52 -158.86 0.9 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 129.663 3.185 . . . . 0.0 112.656 -179.175 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.11 135.34 36.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.873 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 70.69 30.31 3.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 129.509 3.124 . . . . 0.0 106.506 177.979 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.1 m -74.46 149.9 40.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 117.858 -3.026 . . . . 0.0 106.347 160.403 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.8 m -113.21 101.01 9.02 Favored 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 133.336 4.655 . . . . 0.0 101.481 179.166 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.92 157.08 16.53 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 118.847 -2.408 . . . . 0.0 106.311 166.374 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -123.47 148.58 46.06 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 116.486 -1.721 . . . . 0.0 106.693 -175.644 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tt -103.02 139.35 38.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 103.155 -2.905 . . . . 0.0 103.155 177.096 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.351 29.1 m -134.27 137.73 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 1 C-N-CA 132.77 4.428 . . . . 0.0 112.479 175.782 . . . . . . . . 3 2 . 1 . 090 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.6 mp -104.37 145.89 29.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 116.824 -1.56 . . . . 0.0 108.371 168.368 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 61.17 -34.36 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 1 N-CA-C 122.182 4.142 . . . . 0.0 122.182 173.466 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.61 152.83 35.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 129.77 3.228 . . . . 0.0 114.45 -171.274 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.279 44.6 ttt-85 -123.07 134.87 54.23 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 -176.303 . . . . . . . . 2 2 . 1 . 090 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.95 72.49 0.21 Allowed Glycine 0 N--CA 1.441 -1.014 0 CA-C-O 126.149 3.083 . . . . 0.0 108.753 166.87 . . . . . . . . 1 1 . 1 . 090 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.285 0 C-N-CA 127.683 2.564 . . . . 0.0 109.789 -161.63 . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptt? . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 091 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -80.02 146.19 32.11 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 124.933 1.396 . . . . 0.0 110.529 -174.23 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.418 2.4 pt -142.63 128.77 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 130.385 3.474 . . . . 0.0 108.974 175.642 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.259 62.1 m-85 -98.78 67.13 1.68 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 131.21 3.804 . . . . 0.0 110.57 -159.463 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.267 24.2 t -62.96 113.71 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.772 2 O-C-N 115.669 -4.395 . . . . 0.0 108.651 174.721 . . . . . . . . 3 2 . 1 . 091 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.273 11.8 tppt? -102.45 139.93 37.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 101.987 -3.338 . . . . 0.0 101.987 -170.868 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -106.84 169.88 8.27 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 124.219 0.949 . . . . 0.0 109.04 167.741 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.25 -41.45 63.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 118.825 -2.422 . . . . 0.0 110.345 167.386 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.292 52.7 p -50.84 -34.25 27.08 Favored 'General case' 0 N--CA 1.448 -0.549 1 C-N-CA 131.796 4.039 . . . . 0.0 116.526 174.991 . . . . . . . . 3 2 . 1 . 091 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.66 27.48 3.28 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 128.958 3.171 . . . . 0.0 116.482 157.613 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.509 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU 0.383 56.7 mttt -100.5 128.69 46.48 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 167.775 . . . . . . . . 3 3 . 1 . 091 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.2 m -89.28 101.95 14.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 166.285 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.9 mm -53.75 -48.69 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 116.44 -1.743 . . . . 0.0 115.076 -177.052 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.6 m 74.4 50.42 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 129.459 3.103 . . . . 0.0 108.265 176.45 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tp -75.65 126.86 31.84 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -169.598 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -81.16 115.43 20.57 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 125.171 2.415 . . . . 0.0 110.854 163.171 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -108.9 162.17 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 1 C-N-CA 132.679 4.392 . . . . 0.0 113.387 176.853 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -116.07 155.38 48.11 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.98 166.215 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -78.37 -3.63 13.54 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 O-C-N 117.228 -2.038 . . . . 0.0 112.647 -172.923 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 p -81.66 -14.78 56.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.845 2.058 . . . . 0.0 111.694 167.426 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -65.33 122.67 17.67 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.234 2.214 . . . . 0.0 106.918 -179.818 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -85.65 158.09 20.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 172.918 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 21.8 mm -43.19 -43.6 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 O-C-N 118.069 -2.894 . . . . 0.0 113.941 177.438 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.13 -37.09 83.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 125.301 2.476 . . . . 0.0 114.52 176.642 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.58 -34.95 53.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.971 -179.671 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.353 41.0 t -59.48 -44.47 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 118.037 -2.914 . . . . 0.0 108.078 168.829 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -64.71 -38.83 92.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.318 -2.114 . . . . 0.0 113.458 -177.506 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -51.68 66.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 127.136 2.174 . . . . 0.0 113.016 166.569 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -60.15 -26.24 66.14 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 127.929 2.492 . . . . 0.0 113.9 172.602 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.8 mt -86.97 -42.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 120.979 1.718 . . . . 0.0 111.084 171.29 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.44 -24.76 61.08 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.16 1.784 . . . . 0.0 111.797 -175.78 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -52.98 -53.89 43.23 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 130.079 3.352 . . . . 0.0 110.184 165.52 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -85.46 -48.51 8.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 115.855 -2.021 . . . . 0.0 110.503 -170.973 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.509 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS . 38.9 mm-40 -110.18 -19.13 13.13 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 128.46 2.704 . . . . 0.0 115.202 -162.409 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.94 -10.57 73.68 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 121.789 3.476 . . . . 0.0 121.789 162.308 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.57 121.13 73.59 Favored Pre-proline 0 N--CA 1.442 -0.839 0 C-N-CA 129.893 3.277 . . . . 0.0 110.384 -163.201 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -63.45 141.89 82.75 Favored 'Trans proline' 0 N--CA 1.452 -0.931 1 C-N-CA 126.152 4.568 . . . . 0.0 113.969 179.596 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.263 50.0 Cg_exo -48.47 -41.65 36.09 Favored 'Trans proline' 0 N--CA 1.448 -1.162 1 C-N-CA 127.759 5.639 . . . . 0.0 117.458 -170.524 . . . . . . . . 3 2 . 1 . 091 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.76 -30.97 40.9 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.524 2.73 . . . . 0.0 107.709 179.908 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -72.12 -3.38 22.85 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.347 2.259 . . . . 0.0 116.233 173.374 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.55 122.77 41.32 Favored 'General case' 0 N--CA 1.446 -0.659 1 C-N-CA 133.736 4.814 . . . . 0.0 110.826 -173.492 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -134.82 137.61 43.48 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 128.324 2.65 . . . . 0.0 105.654 175.431 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.63 112.63 24.29 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 128.129 2.572 . . . . 0.0 108.314 -174.308 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.53 139.52 20.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.45 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.362 59.1 t80 -144.78 92.5 2.29 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 129.693 3.197 . . . . 0.0 109.777 -166.246 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.28 24.79 2.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 121.415 3.857 . . . . 0.0 121.415 176.277 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.58 -12.73 46.99 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 128.293 2.854 . . . . 0.0 114.57 -173.017 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.282 38.9 ttmt -120.07 139.55 52.38 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 126.206 1.768 . . . . 0.0 109.995 -163.698 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 24.3 mt-30 -80.96 130.94 35.27 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.727 2.011 . . . . 0.0 106.315 170.99 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -84.5 136.52 33.78 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.65 177.891 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.33 144.05 36.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 125.743 2.687 . . . . 0.0 106.988 -171.487 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -87.52 145.83 26.07 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.072 -2.892 . . . . 0.0 110.004 -166.629 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.23 -21.56 37.2 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 124.173 1.985 . . . . 0.0 113.909 -175.002 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -89.7 -177.08 5.18 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -162.451 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 p -107.47 168.07 9.49 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.96 171.737 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.74 -24.4 62.61 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 128.568 2.747 . . . . 0.0 109.381 165.831 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 m -75.54 -15.22 60.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.165 -1.834 . . . . 0.0 112.995 177.137 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.35 -36.53 71.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.348 1.859 . . . . 0.0 111.27 -177.065 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -100.18 -9.77 22.13 Favored 'General case' 0 N--CA 1.442 -0.857 1 C-N-CA 135.133 5.373 . . . . 0.0 110.692 -176.97 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.487 13.6 t30 82.86 18.25 0.28 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 119.685 3.217 . . . . 0.0 119.685 177.291 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mt -72.16 121.53 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.329 1.851 . . . . 0.0 107.193 -172.786 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -122.58 177.69 5.32 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 128.697 2.799 . . . . 0.0 112.027 170.734 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -46.11 136.9 6.42 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 130.732 3.613 . . . . 0.0 111.075 -164.462 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.434 2.8 tt0 85.41 15.69 0.15 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 113.935 -2.936 . . . . 0.0 114.558 170.416 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 t -93.58 133.5 36.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 130.589 3.555 . . . . 0.0 110.76 -179.573 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.4 p -92.89 135.69 33.91 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 174.526 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.51 -176.24 2.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 164.756 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -138.6 139.75 38.71 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 128.025 2.53 . . . . 0.0 107.014 179.269 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.1 tt -111.35 123.39 50.12 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 124.466 1.104 . . . . 0.0 108.341 -174.676 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 m -124.5 137.44 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.472 -179.112 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.259 5.0 mt -88.65 160.42 17.39 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 102.687 -3.079 . . . . 0.0 102.687 -172.613 . . . . . . . . 2 2 . 1 . 091 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -72.63 -42.75 64.1 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 124.239 1.971 . . . . 0.0 107.195 -165.993 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -82.86 114.93 21.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.299 -2.751 . . . . 0.0 112.403 178.105 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 mtp-105 -73.35 153.5 40.47 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -171.506 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.44 -157.19 15.39 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 170.312 . . . . . . . . 1 1 . 1 . 091 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.349 1 C-N-CA 131.535 4.398 . . . . 0.0 110.707 -176.397 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 092 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -105.89 140.74 38.45 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.206 -2.183 . . . . 0.0 110.025 -160.046 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.8 pt -139.67 160.67 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 128.167 2.587 . . . . 0.0 108.596 178.517 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -108.93 159.45 16.8 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.468 1.907 . . . . 0.0 106.296 175.578 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.92 150.69 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 158.513 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -87.26 149.76 24.35 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.966 2.906 . . . . 0.0 114.568 155.89 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.256 9.0 t -138.24 151.93 48.12 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.959 1.304 . . . . 0.0 108.315 173.171 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.282 4.8 tp -70.44 0.04 7.41 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 127.98 2.512 . . . . 0.0 116.191 -163.679 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.0 p -85.43 -20.07 30.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.418 -2.676 . . . . 0.0 109.738 165.61 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.63 -6.21 26.18 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 129.082 3.229 . . . . 0.0 117.804 176.884 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.82 157.46 27.68 Favored 'General case' 0 C--O 1.235 0.318 1 O-C-N 132.577 5.516 . . . . 0.0 111.812 179.269 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.554 36.1 p -123.35 107.21 11.39 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 129.04 2.936 . . . . 0.0 114.088 -177.351 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 mt -104.99 136.21 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 130.042 3.337 . . . . 0.0 108.127 -171.128 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 t -108.25 121.34 44.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.865 3.266 . . . . 0.0 106.516 -178.621 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -110.95 156.02 21.82 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 129.003 2.921 . . . . 0.0 110.736 -176.15 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -118.61 116.75 27.27 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 130.831 3.653 . . . . 0.0 108.562 174.683 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -136.81 166.55 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 131.198 3.799 . . . . 0.0 110.323 -169.944 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -125.44 159.62 59.39 Favored Pre-proline 0 C--N 1.322 -0.629 0 O-C-N 118.907 -2.371 . . . . 0.0 105.993 161.828 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.42 -46.03 28.15 Favored 'Trans proline' 0 N--CA 1.452 -0.943 1 C-N-CA 125.353 4.036 . . . . 0.0 118.759 175.5 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 p -69.77 1.74 4.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 176.884 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.71 134.62 45.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 116.104 -1.903 . . . . 0.0 114.838 179.533 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.4 p -83.37 148.75 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 123.687 2.949 . . . . 0.0 112.467 -179.406 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -50.01 -37.27 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 126.258 1.823 . . . . 0.0 113.826 178.356 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.18 -39.48 79.02 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 121.201 1.819 . . . . 0.0 114.258 170.221 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -68.78 -36.46 78.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 126.821 2.576 . . . . 0.0 109.777 172.611 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.03 -57.18 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 121.383 1.902 . . . . 0.0 106.723 173.107 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HZ3' ' CG ' ' A' ' 52' ' ' ASP 0.294 86.7 mttt -38.55 -40.65 0.6 Allowed 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 130.495 3.518 . . . . 0.0 116.809 171.661 . . . . . . . . 3 3 . 1 . 092 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.48 -20.64 33.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.188 -2.278 . . . . 0.0 111.28 -175.006 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -87.58 -14.21 40.77 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.942 1.297 . . . . 0.0 109.777 176.881 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.31 -51.79 22.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 126.418 1.887 . . . . 0.0 107.904 162.407 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -65.4 -25.64 67.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 131.107 3.763 . . . . 0.0 109.567 -175.928 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.4 -46.1 62.74 Favored 'General case' 0 CA--C 1.533 0.307 1 C-N-CA 132.103 4.161 . . . . 0.0 113.514 170.023 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -114.16 -32.17 6.09 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 127.556 3.035 . . . . 0.0 114.798 -174.309 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -91.91 -33.28 14.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -179.291 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.18 11.32 64.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 113.583 -3.898 . . . . 0.0 113.398 171.375 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -92.15 139.31 24.25 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 100.975 -3.713 . . . . 0.0 100.975 -172.046 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.93 160.39 21.09 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 120.67 0.914 . . . . 0.0 112.552 -173.787 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.26 56.7 Cg_endo -57.9 -40.89 74.55 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 N-CA-C 117.895 2.229 . . . . 0.0 117.895 -170.868 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.92 -11.07 60.59 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.141 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -93.68 -17.43 23.24 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 172.265 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -89.39 143.13 27.06 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 123.21 1.481 . . . . 0.0 109.09 -174.644 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.26 96.29 2.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 -171.551 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.76 131.57 46.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 115.779 -2.058 . . . . 0.0 107.463 -169.389 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.48 145.21 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 129.762 3.225 . . . . 0.0 110.689 -174.424 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -128.47 -169.03 2.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.887 3.275 . . . . 0.0 110.291 179.456 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.59 49.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.481 2 C-N-CA 132.558 4.343 . . . . 0.0 121.941 -177.055 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.11 -12.97 19.55 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 127.305 2.383 . . . . 0.0 109.063 -179.403 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.403 85.4 mttt -109.29 126.41 53.33 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.346 2.258 . . . . 0.0 116.171 -176.62 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -85.19 129.53 34.79 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 130.36 3.464 . . . . 0.0 106.512 167.867 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 69.6 mt -107.19 127.76 53.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 111.799 -3.953 . . . . 0.0 106.165 -162.349 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -104.21 137.0 42.77 Favored 'General case' 0 C--N 1.324 -0.52 1 O-C-N 130.847 5.092 . . . . 0.0 110.54 -173.084 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.48 ' CG ' ' HZ3' ' A' ' 27' ' ' LYS 0.344 1.2 m-20 -27.91 -45.9 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.408 2 N-CA-C 123.723 4.712 . . . . 0.0 123.723 173.983 . . . . . . . . 4 3 . 1 . 092 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.84 33.94 4.56 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 117.545 -3.222 . . . . 0.0 111.681 -169.828 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -122.03 162.82 20.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.841 2.857 . . . . 0.0 105.595 165.169 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -85.17 158.24 20.43 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.553 2.341 . . . . 0.0 114.762 178.069 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.4 mt -57.76 -28.36 63.88 Favored 'General case' 0 C--N 1.326 -0.447 1 O-C-N 114.569 -5.082 . . . . 0.0 114.963 165.269 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.412 0.2 OUTLIER -61.16 -39.63 90.82 Favored 'General case' 0 N--CA 1.448 -0.546 1 C-N-CA 132.125 4.17 . . . . 0.0 113.848 163.87 . . . . . . . . 4 3 . 1 . 092 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -69.43 -11.12 60.56 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 118.269 -2.77 . . . . 0.0 111.434 170.796 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -110.41 5.92 21.83 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 114.149 -2.834 . . . . 0.0 114.753 164.105 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.347 3.9 p-10 34.76 58.27 0.71 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.182 2.993 . . . . 0.0 112.732 -171.113 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mm -67.56 131.62 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 131.674 3.99 . . . . 0.0 111.967 174.986 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.388 26.9 mt-30 -102.6 152.46 21.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 127.266 2.226 . . . . 0.0 108.098 -179.678 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -48.97 150.62 1.48 Allowed 'General case' 0 C--N 1.325 -0.492 1 O-C-N 115.444 -4.535 . . . . 0.0 116.247 176.132 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.319 7.6 tt0 70.84 8.56 6.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.768 2.827 . . . . 0.0 116.237 176.495 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 m -63.31 138.69 58.62 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.682 1.593 . . . . 0.0 108.531 178.248 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.268 16.6 m -103.82 138.84 39.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 118.567 -2.583 . . . . 0.0 104.741 165.316 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.6 mt -95.78 148.1 22.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 130.404 3.482 . . . . 0.0 105.506 175.609 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -88.68 125.7 34.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 117.075 -3.516 . . . . 0.0 110.767 168.401 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tt -121.02 133.4 55.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 118.359 -2.713 . . . . 0.0 104.978 -171.609 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -132.34 -173.92 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.918 1.287 . . . . 0.0 112.48 163.583 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.3 tp -85.12 144.24 28.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.912 168.819 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -78.18 115.87 18.22 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.226 -1.546 . . . . 0.0 110.842 166.802 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.4 mt -107.23 88.13 2.66 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 112.572 -2.104 . . . . 0.0 106.448 176.463 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.355 30.2 ttt85 78.81 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 112.239 -3.743 . . . . 0.0 113.885 -173.824 . . . . . . . . 2 2 . 1 . 092 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.0 155.33 20.94 Favored Glycine 0 CA--C 1.522 0.517 0 O-C-N 127.869 3.23 . . . . 0.0 109.525 -166.67 . . . . . . . . 1 1 . 1 . 092 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 1 C-N-CA 130.866 4.079 . . . . 0.0 107.139 175.344 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 ttp . . . . . 0 CA--C 1.537 0.472 1 N-CA-C 99.49 -4.263 . . . . 0.0 99.49 . . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -96.99 137.44 36.07 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 123.786 2.993 . . . . 0.0 107.226 164.794 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -107.49 170.3 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 129.817 3.247 . . . . 0.0 110.74 161.21 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -116.9 156.82 26.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 118.305 -2.747 . . . . 0.0 106.704 152.326 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.81 133.79 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 1 C-N-CA 132.517 4.327 . . . . 0.0 102.722 156.713 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -122.36 122.83 39.95 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -179.848 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 99.9 m -83.77 124.82 31.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 160.284 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.264 0.0 OUTLIER -63.2 -8.69 8.68 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 119.596 3.184 . . . . 0.0 119.596 -162.839 . . . . . . . . 3 3 . 1 . 093 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -84.85 -3.6 58.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.349 2.26 . . . . 0.0 112.331 -179.529 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 32.93 0.78 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 123.396 1.553 . . . . 0.0 115.017 154.249 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -128.36 123.28 33.5 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.09 2.156 . . . . 0.0 109.964 -171.965 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 m -113.21 127.85 56.3 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.493 1.117 . . . . 0.0 108.3 -178.727 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.66 133.46 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 127.311 2.245 . . . . 0.0 106.15 164.161 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -109.66 125.42 52.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.859 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.1 tp -133.94 139.81 46.38 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.273 -0.892 . . . . 0.0 111.725 -178.171 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.7 mp0 -95.93 116.57 29.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 131.46 3.904 . . . . 0.0 102.266 179.508 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -146.66 159.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 114.507 -2.664 . . . . 0.0 105.053 -163.141 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -111.63 145.94 33.67 Favored Pre-proline 0 N--CA 1.452 -0.349 0 O-C-N 128.747 3.78 . . . . 0.0 108.024 171.925 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.88 -29.23 14.69 Favored 'Trans proline' 0 N--CA 1.452 -0.958 1 C-N-CA 129.97 7.113 . . . . 0.0 115.687 -178.59 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t -90.16 6.9 40.67 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 117.849 -3.032 . . . . 0.0 116.109 -179.758 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -78.72 149.5 32.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.332 -1.318 . . . . 0.0 110.78 -175.436 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.9 p -87.45 155.27 20.09 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 124.67 2.176 . . . . 0.0 111.089 -175.875 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.66 -27.43 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 173.379 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -85.54 -38.35 18.62 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -168.733 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -60.75 -38.93 86.83 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 115.707 -2.092 . . . . 0.0 111.379 164.063 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.324 28.2 t -55.99 -58.42 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 123.521 2.873 . . . . 0.0 117.776 167.32 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.313 37.8 ttmt -68.36 -18.01 64.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.338 1.455 . . . . 0.0 114.849 -173.267 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.12 -35.66 21.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 125.182 1.552 . . . . 0.0 111.526 170.219 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -71.56 -24.08 61.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.091 -1.044 . . . . 0.0 113.21 -175.828 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.07 -20.64 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 125.762 1.914 . . . . 0.0 110.392 170.187 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -82.01 -38.99 24.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 116.862 -3.649 . . . . 0.0 107.761 179.564 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.63 -41.5 83.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.687 2.795 . . . . 0.0 111.792 178.605 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -96.69 -22.12 17.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 130.122 3.369 . . . . 0.0 112.945 -169.565 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.492 2.3 mm-40 -136.83 -23.02 1.2 Allowed 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 118.69 -2.506 . . . . 0.0 112.228 -169.235 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.39 1.9 40.96 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 165.558 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.21 125.68 33.66 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 114.915 -2.469 . . . . 0.0 108.192 -170.522 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.07 149.09 76.64 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.906 3.071 . . . . 0.0 114.991 175.972 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.39 -38.27 54.5 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 O-C-N 126.292 2.733 . . . . 0.0 113.545 179.726 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -41.91 -42.25 2.7 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 173.226 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -94.62 -2.29 51.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 131.242 3.817 . . . . 0.0 115.062 -179.488 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -111.18 114.83 28.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.029 -3.544 . . . . 0.0 104.858 -162.627 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 ttm105 -102.24 128.47 48.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 128.607 2.763 . . . . 0.0 109.242 165.765 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 mt -115.51 137.24 52.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 111.65 -2.523 . . . . 0.0 105.8 -177.042 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.6 mt -115.22 129.43 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 128.421 2.688 . . . . 0.0 109.025 -174.521 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -132.47 134.07 44.6 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 115.231 -2.587 . . . . 0.0 111.202 156.632 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.28 0.2 3.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 172.913 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.22 -11.69 19.7 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 129.887 3.613 . . . . 0.0 108.13 -175.367 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -95.8 125.57 40.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 126.001 1.648 . . . . 0.0 110.318 -174.34 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.17 111.24 1.88 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.383 2.273 . . . . 0.0 108.115 167.866 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.254 45.6 mt -87.09 131.3 34.17 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 115.035 -2.666 . . . . 0.0 113.549 -167.715 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -119.39 156.47 30.06 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 129.96 3.304 . . . . 0.0 110.097 -179.035 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.66 142.38 35.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 130.482 3.513 . . . . 0.0 113.146 177.306 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.02 -25.61 7.82 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 126.917 2.636 . . . . 0.0 113.272 -159.231 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -121.77 133.88 54.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.435 1.894 . . . . 0.0 106.22 176.042 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.5 p -81.26 -175.31 5.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 123.86 1.79 . . . . 0.0 113.837 172.305 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.2 -38.31 90.58 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 118.532 -2.605 . . . . 0.0 110.656 176.082 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 m -63.9 -47.21 81.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 171.23 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -47.03 -39.02 11.9 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 117.11 -3.494 . . . . 0.0 117.1 166.539 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -91.12 -3.81 56.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 123.283 2.765 . . . . 0.0 117.861 170.24 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 48.0 m-80 81.92 38.29 0.06 Allowed 'General case' 0 N--CA 1.445 -0.721 1 C-N-CA 133.933 4.893 . . . . 0.0 113.082 170.846 . . . . . . . . 3 2 . 1 . 093 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.5 mt -91.29 142.65 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 -167.481 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -138.66 -169.66 2.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.436 -154.474 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -59.54 124.79 21.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.377 1.071 . . . . 0.0 111.248 173.042 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 70.96 8.98 6.69 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.297 -2.752 . . . . 0.0 115.185 172.496 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -85.29 148.0 26.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 116.953 -3.592 . . . . 0.0 106.402 -171.39 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.4 m -122.94 124.33 42.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 -173.27 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.01 141.32 28.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 130.793 3.637 . . . . 0.0 104.708 178.487 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.28 58.2 m80 -101.65 115.6 30.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 113.693 -3.051 . . . . 0.0 107.498 -177.607 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 tt -90.29 125.16 35.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 171.057 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -125.78 104.57 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.102 -0.999 . . . . 0.0 112.695 170.17 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.296 56.4 tp -79.32 128.0 32.78 Favored 'General case' 0 N--CA 1.448 -0.547 1 O-C-N 114.282 -5.262 . . . . 0.0 111.49 -170.12 . . . . . . . . 3 2 . 1 . 093 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.284 22.6 ttt180 62.91 -46.33 0.2 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 130.609 3.564 . . . . 0.0 117.001 178.146 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.55 149.82 48.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 128.765 2.826 . . . . 0.0 109.772 -172.583 . . . . . . . . 2 2 . 1 . 093 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -79.47 126.24 30.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.617 -1.302 . . . . 0.0 111.43 -172.684 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.1 176.59 17.73 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 129.464 3.411 . . . . 0.0 105.622 175.284 . . . . . . . . 1 1 . 1 . 093 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.475 0 CA-C-O 114.972 -3.127 . . . . 0.0 111.832 -163.843 . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 123.335 1.54 . . . . 0.0 107.203 . . . . . . . . . 0 0 . 1 . 094 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.257 20.9 mt-30 -104.34 149.5 25.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 111.965 -2.38 . . . . 0.0 109.59 174.527 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 pt -137.33 156.03 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 126.092 2.12 . . . . 0.0 110.056 170.727 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -107.25 132.29 53.25 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.396 172.7 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.42 116.86 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 128.406 2.682 . . . . 0.0 112.95 175.159 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -92.83 138.69 31.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.942 1.829 . . . . 0.0 108.939 -179.055 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -88.61 167.4 13.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 108.623 -3.899 . . . . 0.0 108.955 177.33 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.437 HD22 ' H ' ' A' ' 8' ' ' LEU . 2.4 pt? -69.34 -23.46 63.78 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 119.127 -2.233 . . . . 0.0 113.189 160.991 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -90.1 -13.81 35.02 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 115.951 -1.976 . . . . 0.0 113.806 -175.343 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.37 -0.26 8.78 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 121.423 1.919 . . . . 0.0 113.042 163.695 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -92.62 149.64 21.21 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.051 1.425 . . . . 0.0 110.592 177.522 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -106.47 115.85 30.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 130.767 3.627 . . . . 0.0 104.513 165.442 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.0 mt -97.45 140.22 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 1 N-CA-C 97.95 -4.833 . . . . 0.0 97.95 177.858 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.3 m -101.41 98.73 9.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -179.639 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.09 156.12 18.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 117.409 -3.307 . . . . 0.0 109.445 175.001 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -121.16 119.87 33.62 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 130.742 3.617 . . . . 0.0 108.722 172.864 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 m -152.68 154.87 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 129.591 3.156 . . . . 0.0 104.887 175.545 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.351 76.0 mm-40 -100.41 166.73 12.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 111.348 -2.66 . . . . 0.0 112.371 174.279 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.288 2.6 Cg_exo -49.67 -34.02 33.65 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.043 3.162 . . . . 0.0 119.669 -178.848 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -85.91 -5.57 59.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 119.35 -2.094 . . . . 0.0 112.688 -172.814 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.395 65.7 m-20 -85.13 142.72 29.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 125.097 1.498 . . . . 0.0 109.092 -167.348 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.3 p -79.03 161.19 26.76 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 115.599 -2.143 . . . . 0.0 109.894 175.989 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.8 mm -42.22 -34.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 130.468 3.507 . . . . 0.0 111.172 165.499 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -66.75 -21.65 66.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 124.308 3.231 . . . . 0.0 111.908 -174.876 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -72.13 -52.01 18.68 Favored 'General case' 0 N--CA 1.44 -0.938 1 C-N-CA 131.809 4.044 . . . . 0.0 114.768 169.13 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.9 t -53.46 -59.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 126.428 1.891 . . . . 0.0 111.563 174.37 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -56.03 -33.71 65.19 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 127.455 2.972 . . . . 0.0 107.98 -179.855 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.76 -39.19 57.52 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 124.08 3.127 . . . . 0.0 118.665 -175.904 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -63.7 -40.3 96.45 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.644 1.978 . . . . 0.0 114.795 162.338 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.1 mt -59.21 -42.99 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 116.626 -1.654 . . . . 0.0 109.246 174.917 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -44.96 91.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 128.984 3.927 . . . . 0.0 113.976 171.977 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.41 -19.21 60.5 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 121.323 1.874 . . . . 0.0 112.594 -175.514 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -98.91 -53.08 3.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.084 1.754 . . . . 0.0 111.135 -166.885 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.254 36.5 tp10 -112.91 -3.48 14.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.846 -173.773 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.76 28.62 20.9 Favored Glycine 0 CA--C 1.527 0.829 1 CA-C-O 128.371 4.317 . . . . 0.0 115.093 163.836 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -105.22 118.0 56.99 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 109.983 -3.108 . . . . 0.0 111.675 -165.437 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -72.73 133.01 19.51 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 CA-C-O 111.724 -3.532 . . . . 0.0 112.692 -175.725 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -74.76 -19.62 18.3 Favored 'Trans proline' 0 N--CA 1.448 -1.169 1 O-C-N 130.087 4.73 . . . . 0.0 112.202 -163.167 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -82.46 -14.6 54.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 121.852 2.115 . . . . 0.0 108.306 177.139 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.45 -15.33 35.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.356 2.262 . . . . 0.0 109.485 178.385 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -88.18 154.94 20.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 120.64 1.564 . . . . 0.0 110.994 -177.837 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -148.22 122.95 9.9 Favored 'General case' 0 C--N 1.324 -0.521 1 C-N-CA 132.985 4.514 . . . . 0.0 104.149 -175.028 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mp -122.13 131.59 54.04 Favored 'General case' 0 N--CA 1.446 -0.664 1 C-N-CA 132.281 4.232 . . . . 0.0 114.109 -165.231 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.421 1.8 tt -134.63 144.66 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 126.315 2.26 . . . . 0.0 111.851 -172.309 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -156.34 142.45 18.15 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 126.552 3.072 . . . . 0.0 104.007 165.018 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 29.37 2.88 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 109.33 -3.577 . . . . 0.0 118.08 175.394 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.41 -17.67 36.61 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 127.149 2.78 . . . . 0.0 113.68 175.572 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -103.27 120.04 40.01 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 130.921 3.689 . . . . 0.0 110.979 -168.871 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -72.74 135.4 45.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.243 1.417 . . . . 0.0 107.23 164.873 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.1 mt -92.61 121.09 33.69 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.877 -163.266 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -81.5 124.8 29.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 125.729 1.893 . . . . 0.0 108.187 -169.497 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.76 108.22 2.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.271 3.028 . . . . 0.0 111.144 173.448 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.75 4.65 12.85 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 126.205 2.19 . . . . 0.0 115.615 177.2 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -105.89 144.84 32.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 116.47 -3.959 . . . . 0.0 109.92 168.418 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.6 p -84.79 145.07 28.07 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 127.123 2.764 . . . . 0.0 112.155 176.059 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 tp -41.71 -48.7 4.22 Favored 'General case' 0 N--CA 1.448 -0.538 1 C-N-CA 131.905 4.082 . . . . 0.0 109.149 179.537 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -54.25 -31.85 54.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 130.852 3.661 . . . . 0.0 113.171 176.349 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -67.53 -32.33 73.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.81 0.844 . . . . 0.0 112.955 177.139 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -88.46 -7.23 56.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 115.572 -2.156 . . . . 0.0 109.534 175.385 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 51.17 40.14 25.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 125.914 3.961 . . . . 0.0 112.971 -178.121 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.97 134.48 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.538 -2.119 . . . . 0.0 105.426 166.937 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -119.57 169.62 9.91 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 -173.834 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -49.13 126.37 12.52 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 131.687 3.995 . . . . 0.0 113.493 178.93 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 71.02 5.54 5.52 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 114.649 -2.596 . . . . 0.0 116.608 -178.887 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.5 m -59.3 128.96 39.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 164.78 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -83.22 123.77 29.9 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.337 1.055 . . . . 0.0 110.335 -177.949 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -124.23 156.59 36.56 Favored 'General case' 0 N--CA 1.452 -0.374 1 C-N-CA 134.213 5.005 . . . . 0.0 108.191 -177.549 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -124.49 148.15 47.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 120.835 -1.166 . . . . 0.0 111.934 -168.867 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tp -117.76 127.73 54.19 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.225 2.21 . . . . 0.0 108.855 -174.208 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.594 35.3 m -119.92 165.07 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 129.385 3.074 . . . . 0.0 112.493 169.847 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.0 mt -99.74 141.12 32.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 119.794 -1.816 . . . . 0.0 106.723 175.908 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.5 ttt-85 -152.76 119.04 5.54 Favored 'General case' 0 N--CA 1.443 -0.783 1 N-CA-C 99.683 -4.191 . . . . 0.0 99.683 165.128 . . . . . . . . 2 2 . 1 . 094 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 mp -92.38 54.94 2.41 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.286 -1.779 . . . . 0.0 106.273 -172.088 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -169.12 130.85 1.18 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 119.772 -1.83 . . . . 0.0 106.519 -163.953 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.36 84.72 0.37 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.404 1.954 . . . . 0.0 112.918 171.669 . . . . . . . . 1 1 . 1 . 094 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 175.243 . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttp . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 . . . . . . . . . 0 0 . 1 . 095 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -78.59 148.39 33.32 Favored 'General case' 0 C--N 1.324 -0.537 1 O-C-N 115.481 -4.512 . . . . 0.0 110.262 169.598 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -136.88 163.71 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 101.93 -3.359 . . . . 0.0 101.93 164.988 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -121.51 151.2 40.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 124.338 2.018 . . . . 0.0 110.165 -178.34 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 t -127.1 130.02 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 O-C-N 119.156 -2.215 . . . . 0.0 110.58 171.741 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -85.74 167.74 14.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.008 1.723 . . . . 0.0 111.978 157.875 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -126.06 177.2 6.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.728 1.268 . . . . 0.0 111.388 -176.58 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.83 -34.42 78.1 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 115.608 1.706 . . . . 0.0 115.608 174.468 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -63.25 -50.69 69.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.662 2.385 . . . . 0.0 112.45 165.84 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.54 13.54 8.04 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 116.686 -2.174 . . . . 0.0 111.113 168.238 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -69.31 135.4 50.36 Favored 'General case' 0 N--CA 1.451 -0.398 1 C-N-CA 135.718 5.607 . . . . 0.0 102.815 174.254 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 47.6 m -89.28 140.79 29.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 113.928 -1.487 . . . . 0.0 107.785 -174.741 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -116.59 148.92 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 130.16 3.384 . . . . 0.0 106.854 164.111 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 t -134.6 139.59 45.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 128.128 3.393 . . . . 0.0 108.973 170.798 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mt -141.72 160.94 39.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 125.255 2.455 . . . . 0.0 105.759 -171.711 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -109.9 127.04 54.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 125.884 2.754 . . . . 0.0 110.065 162.358 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.6 -178.65 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 131.548 3.939 . . . . 0.0 109.925 -177.107 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.275 6.1 mt-10 -130.89 148.82 71.72 Favored Pre-proline 0 N--CA 1.444 -0.731 0 O-C-N 116.359 -3.963 . . . . 0.0 112.068 168.824 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.51 -43.98 31.54 Favored 'Trans proline' 0 N--CA 1.453 -0.863 1 C-N-CA 125.488 4.125 . . . . 0.0 118.58 -169.968 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 t -86.29 8.48 21.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.655 -2.066 . . . . 0.0 116.449 -179.587 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.93 154.19 31.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.305 2.253 . . . . 0.0 116.505 173.827 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.305 81.1 p -92.64 149.55 21.26 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 125.128 1.518 . . . . 0.0 108.144 178.346 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.9 mm -45.55 -44.06 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 126.632 1.973 . . . . 0.0 115.874 176.787 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -51.19 -53.97 29.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 128.77 2.828 . . . . 0.0 112.897 173.383 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -63.59 -30.39 71.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.94 1.352 . . . . 0.0 111.846 -172.142 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.47 -40.01 76.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 127.236 2.214 . . . . 0.0 109.778 169.949 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -68.98 -28.0 66.22 Favored 'General case' 0 C--N 1.328 -0.34 1 O-C-N 115.054 -4.779 . . . . 0.0 111.324 -173.797 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -31.86 66.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.576 -1.647 . . . . 0.0 112.536 172.833 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -75.08 -41.02 59.66 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -178.556 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.74 -28.97 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 119.789 1.177 . . . . 0.0 113.026 175.565 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -62.45 -44.62 95.98 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 127.84 2.456 . . . . 0.0 113.111 171.736 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -72.63 -16.55 61.71 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.091 -2.255 . . . . 0.0 113.112 -175.586 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -107.75 -53.47 2.62 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 -172.674 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -112.93 -9.32 13.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 114.471 -2.681 . . . . 0.0 112.232 -173.602 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.21 39.28 72.07 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 115.014 -3.103 . . . . 0.0 113.007 -177.181 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.2 mt -96.16 116.31 66.11 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 178.235 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.67 145.9 65.15 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 N-CA-C 118.422 2.432 . . . . 0.0 118.422 -179.032 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.297 39.7 Cg_endo -70.89 -21.41 28.27 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 125.198 3.932 . . . . 0.0 118.696 -160.045 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.49 -30.95 16.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 123.844 3.02 . . . . 0.0 110.527 -179.036 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -71.14 -37.01 72.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 177.978 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -63.74 125.02 22.96 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 112.67 -3.538 . . . . 0.0 116.487 179.262 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.281 32.4 ttm105 -128.33 121.46 29.25 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 122.872 2.578 . . . . 0.0 108.906 176.235 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.5 132.72 41.78 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 128.049 2.54 . . . . 0.0 107.625 -179.156 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.1 mt -119.87 161.14 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.742 2.017 . . . . 0.0 110.408 167.648 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -158.83 128.6 5.72 Favored 'General case' 0 N--CA 1.449 -0.494 1 N-CA-C 98.241 -4.726 . . . . 0.0 98.241 173.157 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.92 23.34 13.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.455 2.302 . . . . 0.0 113.542 162.369 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.1 0.01 54.64 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 178.03 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -120.78 129.65 53.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -167.643 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -70.77 151.82 44.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 166.221 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.93 113.95 27.37 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 101.601 -3.481 . . . . 0.0 101.601 -179.772 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -101.12 139.42 36.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 125.086 1.491 . . . . 0.0 108.428 -173.564 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -28.8 129.2 0.08 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 129.325 3.05 . . . . 0.0 116.982 167.911 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.49 -11.35 71.63 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 159.687 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -103.68 156.12 18.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.504 1.922 . . . . 0.0 106.435 -178.164 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.7 p -111.81 149.83 31.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.964 2.506 . . . . 0.0 115.778 -164.577 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.4 mt -60.81 -46.35 90.85 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 112.72 -2.037 . . . . 0.0 114.871 -164.974 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -75.8 -33.31 60.12 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.462 -171.165 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.54 -31.85 71.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 112.881 -3.438 . . . . 0.0 118.817 166.32 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -73.54 -21.92 60.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 127.916 3.26 . . . . 0.0 112.486 164.789 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t30 89.58 45.04 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.446 2 C-N-CA 134.076 4.951 . . . . 0.0 107.895 175.558 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mm -79.36 145.87 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 118.027 -2.921 . . . . 0.0 104.564 172.63 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -132.76 -178.48 4.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 121.946 2.157 . . . . 0.0 106.742 178.347 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -72.87 112.8 9.23 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 130.793 3.637 . . . . 0.0 109.036 -171.784 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 75.85 31.82 0.69 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 130.236 3.414 . . . . 0.0 111.95 -172.937 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -70.5 140.75 51.94 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 115.97 -1.967 . . . . 0.0 112.008 166.581 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.8 m -102.37 129.89 48.97 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -179.218 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.71 154.2 31.01 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.893 3.277 . . . . 0.0 108.46 -177.993 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.268 20.8 t-160 -109.04 118.28 36.38 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.013 0.925 . . . . 0.0 109.877 -171.256 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tt -93.83 127.75 39.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.224 1.81 . . . . 0.0 109.248 173.498 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.34 138.59 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 1 O-C-N 129.103 4.002 . . . . 0.0 104.039 162.399 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 tt -101.75 122.61 44.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 118.639 -2.538 . . . . 0.0 109.669 167.339 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.548 54.7 ttt180 77.02 -35.44 0.23 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 124.985 2.326 . . . . 0.0 115.58 171.861 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.25 88.1 mt -57.71 150.83 18.74 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 117.578 -3.201 . . . . 0.0 114.67 -179.204 . . . . . . . . 2 2 . 1 . 095 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -72.15 140.68 48.94 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 129.319 3.048 . . . . 0.0 107.843 -175.535 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.43 1.27 6.51 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 111.423 -2.626 . . . . 0.0 114.056 179.912 . . . . . . . . 1 1 . 1 . 095 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.373 0 N-CA-C 104.976 -3.249 . . . . 0.0 104.976 -154.354 . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 C--O 1.236 0.381 0 N-CA-C 110.88 -0.044 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 096 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.49 133.91 51.29 Favored 'General case' 0 N--CA 1.448 -0.54 1 C-N-CA 131.997 4.119 . . . . 0.0 108.242 -179.029 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.286 0.9 OUTLIER -129.93 169.9 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 117.217 -1.373 . . . . 0.0 112.114 163.701 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -110.03 152.16 26.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 125.139 3.609 . . . . 0.0 105.632 172.149 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.292 2.6 t -135.34 113.88 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 128.883 2.873 . . . . 0.0 107.148 172.1 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -97.31 126.04 42.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 129.931 3.292 . . . . 0.0 106.137 -177.789 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.0 p -86.41 178.03 7.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.247 1.819 . . . . 0.0 114.117 160.54 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -79.03 -33.8 44.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 117.144 -1.408 . . . . 0.0 110.696 -169.904 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -93.18 0.99 57.31 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -178.873 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.42 -8.31 5.92 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 126.53 2.014 . . . . 0.0 111.188 151.97 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -71.04 110.55 5.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -171.717 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -87.35 113.34 22.98 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 101.728 -3.434 . . . . 0.0 101.728 172.927 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.0 mt -86.34 126.69 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 N-CA-C 99.625 -4.213 . . . . 0.0 99.625 166.905 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.5 m -99.82 109.06 21.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 129.339 3.056 . . . . 0.0 105.16 173.891 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 tp -105.39 135.23 47.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -161.688 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.285 31.1 tt0 -86.12 134.71 33.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 110.823 -2.899 . . . . 0.0 113.142 160.351 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -148.2 164.44 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 123.807 1.765 . . . . 0.0 107.672 174.278 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -95.69 160.01 31.24 Favored Pre-proline 0 N--CA 1.444 -0.729 2 C-N-CA 133.018 4.527 . . . . 0.0 109.884 145.825 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.89 -25.16 74.29 Favored 'Trans proline' 0 N--CA 1.45 -1.03 1 C-N-CA 125.715 4.277 . . . . 0.0 113.487 -173.657 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -83.03 -11.03 58.43 Favored 'General case' 0 N--CA 1.444 -0.747 1 C-N-CA 137.275 6.23 . . . . 0.0 110.214 -175.175 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.03 114.7 8.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.734 2.014 . . . . 0.0 107.438 160.18 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.253 71.3 p -89.57 -162.54 0.89 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 115.793 -2.051 . . . . 0.0 114.857 -170.725 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.4 mm -60.9 -33.9 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 122.722 2.51 . . . . 0.0 113.811 172.262 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -78.56 -45.68 21.24 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 129.47 3.108 . . . . 0.0 114.801 174.466 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -67.6 -25.24 65.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 113.759 -3.176 . . . . 0.0 112.577 -179.517 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.5 t -57.5 -58.05 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.712 2.405 . . . . 0.0 116.841 157.06 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -58.51 -26.13 63.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 174.82 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.33 -37.81 43.69 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 127.078 3.323 . . . . 0.0 117.409 170.979 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -60.11 -39.18 85.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 117.092 -3.505 . . . . 0.0 113.635 164.249 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.0 mt -53.42 -47.91 58.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 129.166 2.986 . . . . 0.0 111.569 172.678 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -60.94 -50.57 72.86 Favored 'General case' 0 N--CA 1.45 -0.446 1 C-N-CA 132.121 4.169 . . . . 0.0 109.819 177.39 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.0 -48.05 61.47 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 171.364 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -84.82 -52.83 5.75 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 115.788 -2.053 . . . . 0.0 112.868 -171.988 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -123.4 -2.85 8.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 122.041 2.2 . . . . 0.0 110.237 -155.502 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.17 7.89 67.26 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.901 1.715 . . . . 0.0 112.328 163.104 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -73.27 124.18 90.28 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 129.347 3.059 . . . . 0.0 106.675 -170.589 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.76 110.51 1.63 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 125.002 3.802 . . . . 0.0 113.16 173.425 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.36 -15.06 12.8 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 N-CA-C 118.754 2.559 . . . . 0.0 118.754 -167.898 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.365 0.0 OUTLIER -25.54 -35.26 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 130.697 3.599 . . . . 0.0 120.252 174.778 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -126.79 25.41 6.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.502 1.921 . . . . 0.0 111.21 -165.837 . . . . . . . . 3 3 . 1 . 096 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -131.24 126.88 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.272 1.829 . . . . 0.0 111.096 -168.634 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -123.68 157.56 33.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 109.586 -3.461 . . . . 0.0 109.701 176.455 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.11 138.59 53.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 114.133 -2.841 . . . . 0.0 108.659 -166.253 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mm -110.04 148.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 127.952 3.283 . . . . 0.0 115.568 165.272 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -149.24 125.64 10.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 114.687 -2.578 . . . . 0.0 105.519 166.565 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.57 15.24 10.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 130.471 3.508 . . . . 0.0 113.539 172.637 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.47 -34.93 5.38 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 128.654 3.026 . . . . 0.0 108.737 -169.425 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -78.11 136.02 37.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 122.133 2.967 . . . . 0.0 108.339 -156.946 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -80.27 106.13 12.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 113.611 -3.09 . . . . 0.0 113.31 164.572 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.3 136.96 57.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 128.098 3.374 . . . . 0.0 115.155 -178.014 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -91.98 116.07 28.6 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.166 2.186 . . . . 0.0 105.106 -165.43 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.49 116.27 3.86 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 115.298 -2.287 . . . . 0.0 112.607 -177.271 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.28 3.96 7.85 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 129.908 3.623 . . . . 0.0 112.896 -178.331 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -109.36 159.13 17.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 122.008 2.904 . . . . 0.0 108.93 -170.932 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.6 p -90.6 173.13 8.22 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 129.859 3.264 . . . . 0.0 110.551 176.981 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.78 -18.09 59.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.197 -0.939 . . . . 0.0 110.591 173.647 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.0 m -70.05 -20.52 63.23 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.43 -1.419 . . . . 0.0 112.841 177.367 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -86.12 -6.29 59.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.485 2.714 . . . . 0.0 112.154 -177.073 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -130.44 -7.21 4.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 114.495 -2.669 . . . . 0.0 113.196 178.954 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.1 t30 57.05 51.07 10.97 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 127.084 2.74 . . . . 0.0 112.733 178.807 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.46 125.86 62.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 -178.417 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -114.09 -166.66 1.12 Allowed 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 112.284 -2.235 . . . . 0.0 108.502 177.88 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -65.25 149.74 49.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 129.116 2.966 . . . . 0.0 112.219 -170.004 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.542 12.6 pt-20 73.45 16.89 3.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.541 170.056 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 m -84.26 155.65 22.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.221 1.808 . . . . 0.0 111.173 -177.015 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.9 m -116.78 137.47 52.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.798 -2.439 . . . . 0.0 111.884 174.576 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -105.0 149.53 25.69 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 156.224 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -102.97 133.58 47.84 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 169.338 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.351 1.8 tm? -96.97 144.88 26.45 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 115.142 -2.361 . . . . 0.0 111.458 -178.23 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.83 133.14 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 128.696 2.798 . . . . 0.0 107.567 179.074 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mp -88.47 137.95 31.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 130.289 3.435 . . . . 0.0 107.745 173.207 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -73.14 -24.74 60.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 176.455 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.11 135.14 54.2 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.406 -168.89 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.359 57.3 ttt-85 -116.09 -35.16 4.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 115.629 -2.129 . . . . 0.0 115.575 167.687 . . . . . . . . 2 2 . 1 . 096 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.44 -176.56 16.16 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 120.035 2.774 . . . . 0.0 120.035 167.678 . . . . . . . . 1 1 . 1 . 096 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.431 0 N-CA-C 103.464 -3.855 . . . . 0.0 103.464 -177.039 . . . . . . . . 0 0 . 1 . 097 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.252 9.2 tpp . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 124.011 1.862 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.348 4.9 tt0 -85.54 156.85 20.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 118.203 -2.811 . . . . 0.0 115.284 177.089 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.332 17.1 pt -133.06 134.9 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 117.067 -3.521 . . . . 0.0 106.799 162.349 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -94.13 144.55 25.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.583 166.116 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.458 HG13 HD13 ' A' ' 30' ' ' ILE . 3.8 t -128.3 133.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 127.403 2.281 . . . . 0.0 106.368 -179.975 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -133.11 145.87 51.11 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 -176.076 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -129.23 -90.75 0.48 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 116.353 -1.784 . . . . 0.0 110.704 159.847 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -142.54 -42.44 0.32 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 128.239 2.616 . . . . 0.0 114.282 169.088 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.57 114.02 21.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.116 1.366 . . . . 0.0 108.232 174.721 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.12 142.37 10.52 Favored Glycine 0 CA--C 1.536 1.392 0 N-CA-C 106.69 -2.564 . . . . 0.0 106.69 -169.426 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -54.51 -67.37 0.27 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.967 2.107 . . . . 0.0 110.267 156.402 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 p -155.57 174.53 15.14 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.916 2.486 . . . . 0.0 106.575 178.674 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.09 144.4 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 C-N-CA 127.226 2.21 . . . . 0.0 105.297 164.418 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.8 p -104.53 129.11 52.6 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.337 1.455 . . . . 0.0 112.352 -175.32 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 mt -123.42 145.98 48.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 117.349 -3.344 . . . . 0.0 108.024 176.681 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.03 121.17 37.49 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 126.132 2.145 . . . . 0.0 110.073 162.602 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -122.5 -161.6 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 O-C-N 120.223 -1.548 . . . . 0.0 112.936 -178.693 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.278 4.3 tm-20 -142.52 147.78 44.29 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 164.244 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -65.47 -21.56 60.18 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 CA-C-O 115.124 -2.115 . . . . 0.0 115.328 -178.642 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.75 14.81 6.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 120.798 1.635 . . . . 0.0 114.449 173.548 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -75.09 121.68 22.41 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 127.496 2.318 . . . . 0.0 107.124 167.233 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.8 p -66.6 155.28 38.25 Favored 'General case' 0 N--CA 1.449 -0.491 1 O-C-N 129.17 4.044 . . . . 0.0 109.028 160.782 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 80.5 mt -68.04 -27.94 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 124.249 1.976 . . . . 0.0 111.917 178.736 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -47.15 -41.39 17.59 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 112.741 -2.027 . . . . 0.0 111.689 170.517 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -75.15 -38.48 60.96 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.236 1.414 . . . . 0.0 112.351 178.56 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.71 -31.28 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 126.448 2.343 . . . . 0.0 112.712 179.03 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -51.94 -37.4 52.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 173.053 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.312 . . -79.2 -32.01 43.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 125.739 2.685 . . . . 0.0 111.163 -176.144 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -56.04 -53.09 61.14 Favored 'General case' 0 N--CA 1.452 -0.372 1 O-C-N 115.686 -4.384 . . . . 0.0 112.371 164.2 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.458 HD13 HG13 ' A' ' 5' ' ' VAL . 46.2 mm -59.27 -39.54 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 119.576 -1.952 . . . . 0.0 109.82 -178.301 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -51.95 -49.34 63.37 Favored 'General case' 0 N--CA 1.452 -0.34 1 N-CA-C 122.622 4.304 . . . . 0.0 122.622 161.899 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.09 -34.91 74.11 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 170.685 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.31 -23.98 14.99 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.881 1.672 . . . . 0.0 114.437 -174.869 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -143.09 -12.43 0.73 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 124.812 2.244 . . . . 0.0 115.252 -165.954 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.81 -17.4 32.82 Favored Glycine 0 CA--C 1.536 1.373 1 O-C-N 115.282 -4.636 . . . . 0.0 114.137 159.715 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mt -74.32 126.31 89.09 Favored Pre-proline 0 N--CA 1.45 -0.447 0 O-C-N 120.023 -1.869 . . . . 0.0 112.714 -170.52 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -64.88 141.06 69.57 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 CA-C-O 114.846 -2.231 . . . . 0.0 117.864 173.031 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -43.87 -41.4 11.94 Favored 'Trans proline' 0 N--CA 1.449 -1.111 1 C-N-CA 125.301 4.001 . . . . 0.0 116.98 178.934 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.98 -26.1 59.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.191 2.996 . . . . 0.0 111.471 179.341 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -97.25 -15.29 20.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 127.058 2.143 . . . . 0.0 115.024 -173.761 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -90.58 132.57 35.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -169.728 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -114.24 111.9 22.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 129.23 3.012 . . . . 0.0 109.511 169.111 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -97.36 109.64 22.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.139 -1.601 . . . . 0.0 108.345 -176.855 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mt -119.08 136.66 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 1 N-CA-C 98.267 -4.716 . . . . 0.0 98.267 -174.991 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -168.66 143.16 3.24 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.997 2.519 . . . . 0.0 107.366 173.341 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.303 . . 65.51 27.21 11.69 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.261 2.224 . . . . 0.0 113.208 173.77 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.3 -8.74 59.01 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 129.016 3.198 . . . . 0.0 108.3 163.817 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -129.24 147.01 51.04 Favored 'General case' 0 C--O 1.241 0.641 0 O-C-N 116.928 -3.689 . . . . 0.0 113.194 176.82 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -60.89 104.94 0.41 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.87 3.268 . . . . 0.0 111.79 165.306 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -60.16 144.42 49.95 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -173.082 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -77.36 134.52 38.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 125.188 1.555 . . . . 0.0 110.55 161.988 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.04 -31.76 68.3 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 131.204 3.802 . . . . 0.0 117.587 -166.101 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.83 9.56 56.85 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 126.943 2.652 . . . . 0.0 110.026 -175.286 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 159.29 16.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 123.813 1.768 . . . . 0.0 110.696 162.398 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.3 p -102.2 163.96 11.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 111.678 -2.51 . . . . 0.0 109.923 -171.5 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.08 -59.12 4.73 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.213 2.205 . . . . 0.0 108.539 172.642 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 82.3 p -44.2 -46.12 8.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.236 2.614 . . . . 0.0 115.655 171.923 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -51.38 -34.09 32.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.486 1.514 . . . . 0.0 114.812 173.244 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -104.27 0.01 28.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.559 -1.338 . . . . 0.0 112.555 -175.151 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m120 81.75 23.47 0.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.849 2.059 . . . . 0.0 111.689 -176.056 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.0 mt -84.59 102.89 11.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -174.169 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -70.8 162.3 29.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 172.958 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -42.17 138.31 1.68 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.895 2.078 . . . . 0.0 114.005 155.8 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.257 7.6 mm-40 77.07 17.91 1.55 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 129.028 2.931 . . . . 0.0 111.84 170.302 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -96.44 155.81 16.61 Favored 'General case' 0 CA--C 1.537 0.454 1 CA-C-O 130.108 4.766 . . . . 0.0 109.333 -177.053 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.4 m -96.92 140.84 30.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 110.001 -3.272 . . . . 0.0 106.51 176.704 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.54 162.7 13.89 Favored 'General case' 0 CA--C 1.537 0.465 1 N-CA-C 98.586 -4.598 . . . . 0.0 98.586 157.602 . . . . . . . . 2 2 . 1 . 097 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -120.01 141.79 49.39 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 167.401 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.5 tp -116.89 148.79 41.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 130.584 3.553 . . . . 0.0 112.808 -172.509 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.92 130.36 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 130.304 3.441 . . . . 0.0 109.931 -176.294 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.75 144.13 41.63 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 120.06 -1.65 . . . . 0.0 107.362 164.99 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -88.08 -34.13 18.05 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.477 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.2 mt -141.5 168.22 20.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 126.668 2.48 . . . . 0.0 109.938 168.148 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -91.54 -15.06 29.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 115.516 -2.183 . . . . 0.0 113.51 -178.296 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.05 -177.03 28.42 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 128.389 2.9 . . . . 0.0 107.119 177.929 . . . . . . . . 1 1 . 1 . 097 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.361 0 CA-C-O 114.887 -3.174 . . . . 0.0 110.877 -160.086 . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttp . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 098 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -82.78 122.76 28.62 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.387 1.875 . . . . 0.0 113.723 172.452 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -112.52 163.39 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 1 C-N-CA 132.779 4.431 . . . . 0.0 103.914 167.632 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -117.06 153.85 32.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.507 1.523 . . . . 0.0 108.497 168.151 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.97 136.24 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.216 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.365 14.9 ttmt -133.49 151.35 51.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.51 1.924 . . . . 0.0 113.596 172.632 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -110.42 151.01 28.0 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.867 1.317 . . . . 0.0 108.053 178.9 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.311 27.7 mt -61.25 -31.02 70.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.75 -2.469 . . . . 0.0 113.11 179.727 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.1 p -70.49 -3.35 17.41 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 131.466 3.906 . . . . 0.0 114.41 172.107 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.28 29.1 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 124.978 1.424 . . . . 0.0 113.024 153.211 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -62.83 127.25 30.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 118.893 -2.534 . . . . 0.0 111.603 176.966 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 m -116.85 144.41 44.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.511 2.724 . . . . 0.0 107.659 177.522 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.8 tt -146.05 132.8 14.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -175.735 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -70.04 150.27 46.8 Favored 'General case' 0 C--N 1.327 -0.388 1 O-C-N 115.693 -4.38 . . . . 0.0 108.156 166.192 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -133.11 155.62 48.92 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 172.211 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -112.38 129.78 56.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 119.64 -1.913 . . . . 0.0 107.751 172.194 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -146.77 154.81 11.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 130.11 3.364 . . . . 0.0 109.471 -174.346 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -102.11 143.52 26.77 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 171.245 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.53 -16.1 49.85 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.837 3.024 . . . . 0.0 116.214 -173.069 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.5 p -85.6 -7.31 58.92 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 121.586 1.994 . . . . 0.0 116.35 165.126 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -58.61 142.99 47.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 117.575 -3.203 . . . . 0.0 110.345 173.361 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.469 ' O ' HG21 ' A' ' 26' ' ' VAL . 44.7 p -80.11 157.05 26.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.869 2.067 . . . . 0.0 112.193 174.684 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.2 -29.57 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.355 1.462 . . . . 0.0 107.768 -178.143 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -64.72 -48.82 73.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.55 1.14 . . . . 0.0 108.346 172.734 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.35 -37.09 64.53 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 120.273 -1.517 . . . . 0.0 113.798 166.316 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 22' ' ' THR 0.257 3.5 t -64.34 -30.58 50.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 118.904 -2.372 . . . . 0.0 114.808 172.224 . . . . . . . . 3 3 . 1 . 098 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -76.82 -28.34 55.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 168.934 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.34 -36.0 63.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 122.424 1.107 . . . . 0.0 110.398 -179.248 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -68.01 -25.31 65.34 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.183 -1.573 . . . . 0.0 113.108 171.604 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -80.7 -38.04 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 171.562 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -30.51 4.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 116.389 -3.945 . . . . 0.0 111.396 176.922 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -73.8 -29.45 62.17 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.702 1.601 . . . . 0.0 111.969 179.338 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -103.02 -50.99 3.36 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 117.17 -3.457 . . . . 0.0 110.324 -169.12 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -122.25 -2.93 9.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.435 1.894 . . . . 0.0 113.054 -168.345 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.4 -32.16 6.75 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 114.235 -3.536 . . . . 0.0 115.251 155.493 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.5 mt -55.3 128.75 67.5 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 128.729 2.811 . . . . 0.0 110.708 -170.722 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.86 139.99 64.85 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 128.253 5.969 . . . . 0.0 109.213 179.84 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -38.23 -40.99 1.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 1 C-N-CA 130.329 7.353 . . . . 0.0 115.821 176.648 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -61.6 -30.4 70.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 117.773 -3.08 . . . . 0.0 115.348 176.706 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -83.02 -26.65 31.01 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.377 1.444 . . . . 0.0 110.677 -176.738 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.274 77.5 mt-30 -91.37 137.26 32.51 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.966 1.416 . . . . 0.0 109.848 -178.526 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.262 3.8 mtt85 -107.42 146.26 31.91 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 111.208 -2.723 . . . . 0.0 110.773 155.439 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.97 120.5 42.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.868 1.213 . . . . 0.0 108.156 167.174 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.44 146.99 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 125.22 1.575 . . . . 0.0 108.599 -179.041 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -139.86 127.46 21.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.701 2.8 . . . . 0.0 104.078 166.112 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.252 . . 61.73 33.44 17.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 119.804 -1.81 . . . . 0.0 111.948 170.765 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.85 -19.58 11.49 Favored Glycine 0 CA--C 1.538 1.517 0 O-C-N 118.495 -2.628 . . . . 0.0 111.776 -179.662 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -76.98 113.64 14.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 123.571 3.685 . . . . 0.0 107.032 -177.771 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.41 110.73 8.94 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 104.06 -2.57 . . . . 0.0 104.06 162.276 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.6 mt -59.36 129.25 41.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.839 1.656 . . . . 0.0 108.608 168.485 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -92.32 138.95 31.09 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.891 0.876 . . . . 0.0 110.464 -179.998 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -64.73 138.14 58.21 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 125.873 1.983 . . . . 0.0 110.466 -175.306 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.79 -30.81 6.65 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 127.929 2.681 . . . . 0.0 115.989 -175.784 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -91.69 147.93 22.63 Favored 'General case' 0 CA--C 1.535 0.394 1 C-N-CA 132.889 4.475 . . . . 0.0 110.731 -178.209 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 p -102.03 170.49 8.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 125.145 1.528 . . . . 0.0 112.513 -171.438 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -51.88 -42.91 63.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 128.618 3.699 . . . . 0.0 109.196 170.033 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -79.65 -28.16 40.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 120.02 -1.675 . . . . 0.0 114.645 -171.23 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -78.33 -40.06 37.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.045 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -83.07 0.19 46.12 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 117.852 -3.03 . . . . 0.0 109.951 -179.046 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.421 5.2 p-10 46.08 64.52 1.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.391 2.276 . . . . 0.0 113.161 -179.326 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 mm -83.89 -43.99 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 118.563 -1.255 . . . . 0.0 109.875 -166.176 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.415 52.9 mm-40 97.04 153.81 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.689 2.395 . . . . 0.0 111.774 166.747 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.39 131.51 45.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 119.044 -2.285 . . . . 0.0 108.008 177.07 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.282 3.4 mp0 81.41 10.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 127.194 2.809 . . . . 0.0 110.063 166.684 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.8 t -75.2 139.1 42.4 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 130.817 3.647 . . . . 0.0 107.82 172.992 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -100.15 126.72 46.45 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 103.031 -2.952 . . . . 0.0 103.031 -177.302 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.2 mp -101.11 147.27 26.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.795 164.617 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -88.31 127.23 35.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.209 2.604 . . . . 0.0 107.537 -176.781 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.3 tp -114.22 123.82 50.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 -175.711 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.3 135.59 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -175.617 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.5 mt -89.48 158.69 17.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 125.228 2.442 . . . . 0.0 106.633 -163.159 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 ttt-85 -144.2 104.7 4.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.731 -2.031 . . . . 0.0 107.251 156.265 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.337 8.5 mp 88.76 148.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 1 C-N-CA 134.538 5.135 . . . . 0.0 111.621 179.683 . . . . . . . . 3 2 . 1 . 098 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.289 23.9 ttt180 -130.58 -52.2 1.08 Allowed 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 126.765 2.54 . . . . 0.0 108.96 177.36 . . . . . . . . 2 2 . 1 . 098 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.17 148.56 10.77 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 104.643 -3.383 . . . . 0.0 104.643 -172.965 . . . . . . . . 1 1 . 1 . 098 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -174.451 . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttp . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 099 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -79.66 133.93 36.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 173.975 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.9 pt -138.1 171.73 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 169.818 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -115.69 122.11 44.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 118.07 -2.894 . . . . 0.0 113.36 175.625 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -93.72 102.99 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 122.786 2.539 . . . . 0.0 111.193 166.701 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 21.3 tptt -80.49 122.98 27.67 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 128.039 2.535 . . . . 0.0 111.846 165.216 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.8 p -102.99 156.63 17.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.747 -176.256 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.647 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -53.77 -26.19 22.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 130.068 3.347 . . . . 0.0 118.267 -175.946 . . . . . . . . 3 3 . 1 . 099 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -86.78 -10.65 53.07 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 127.245 2.841 . . . . 0.0 112.144 -177.8 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.89 -3.99 57.46 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 130.275 3.798 . . . . 0.0 117.761 -178.992 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -71.69 143.0 49.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 120.147 1.973 . . . . 0.0 111.411 175.402 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 154.17 33.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.002 173.538 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -135.23 143.18 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 129.341 3.056 . . . . 0.0 108.682 -176.826 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -119.73 102.02 8.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.313 179.949 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.2 mt -96.02 170.05 9.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 -177.203 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -121.57 90.94 3.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 123.265 1.507 . . . . 0.0 112.149 167.926 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -99.49 172.5 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 117.595 -3.191 . . . . 0.0 109.912 -177.536 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -131.94 130.8 22.29 Favored Pre-proline 0 N--CA 1.447 -0.624 2 O-C-N 114.672 -5.017 . . . . 0.0 107.223 -164.39 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -42.94 -29.82 1.65 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 1 CA-C-N 129.146 4.302 . . . . 0.0 116.937 167.408 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -75.73 -13.99 60.32 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 129.0 2.92 . . . . 0.0 114.869 176.871 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' HB2' HD11 ' A' ' 56' ' ' LEU . 66.1 m-20 -79.87 129.29 34.36 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 124.47 2.081 . . . . 0.0 109.989 -170.682 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -73.21 163.04 28.68 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 125.482 2.563 . . . . 0.0 105.57 177.896 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -55.28 -36.23 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 117.82 -3.05 . . . . 0.0 112.631 172.028 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.48 -30.38 69.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 117.494 -3.254 . . . . 0.0 113.346 169.568 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -59.82 -43.76 94.37 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 170.63 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -52.74 -50.09 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 O-C-N 127.707 3.13 . . . . 0.0 114.279 174.591 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -54.01 -46.37 71.78 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 129.075 3.984 . . . . 0.0 109.229 172.609 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.73 -39.16 93.62 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.827 2.051 . . . . 0.0 115.386 174.252 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -58.23 -41.82 84.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.353 2.261 . . . . 0.0 116.032 165.423 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -67.09 -45.52 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 120.388 -1.445 . . . . 0.0 110.976 176.56 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -45.26 -59.79 2.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 127.51 3.006 . . . . 0.0 111.761 173.099 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -52.42 -34.95 50.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.786 -175.059 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -98.17 -37.57 9.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 126.17 2.168 . . . . 0.0 116.687 -168.682 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -128.3 6.15 5.82 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.291 2.237 . . . . 0.0 116.07 -173.606 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.8 11.51 63.07 Favored Glycine 0 CA--C 1.532 1.142 1 O-C-N 116.178 -4.076 . . . . 0.0 119.887 174.678 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.3 mt -83.4 130.66 55.56 Favored Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-N 120.734 2.267 . . . . 0.0 105.238 177.274 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.264 73.7 Cg_endo -80.66 159.45 21.92 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 O-C-N 116.098 -2.632 . . . . 0.0 113.371 174.103 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.83 -40.63 16.33 Favored 'Trans proline' 0 N--CA 1.443 -1.467 1 C-N-CA 125.395 4.063 . . . . 0.0 110.559 -170.882 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.26 24.7 t70 -55.96 -22.57 27.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 113.335 -3.221 . . . . 0.0 116.379 176.622 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -86.34 -10.09 55.11 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 128.401 3.563 . . . . 0.0 110.009 -178.142 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -100.49 161.15 13.79 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.791 1.636 . . . . 0.0 107.136 -157.389 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -157.04 126.19 5.96 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 125.351 2.5 . . . . 0.0 107.713 162.142 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -99.59 126.02 45.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.74 -2.475 . . . . 0.0 106.738 -174.757 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.2 mm -111.45 143.64 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 129.879 3.271 . . . . 0.0 110.267 179.469 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -146.81 137.12 23.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.27 3.028 . . . . 0.0 108.666 166.626 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.281 . . 53.33 42.0 32.08 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 131.186 3.794 . . . . 0.0 112.454 172.648 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.27 10.18 85.72 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 114.429 -3.428 . . . . 0.0 114.708 -174.864 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -147.98 163.0 38.19 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 123.723 3.761 . . . . 0.0 115.305 179.172 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -63.64 133.78 54.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 131.655 3.982 . . . . 0.0 110.316 171.017 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 mt -99.31 126.73 45.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 163.609 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.93 156.85 20.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 126.324 2.265 . . . . 0.0 113.315 -174.007 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.19 155.28 11.6 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.567 -169.075 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.85 0.04 48.67 Favored Glycine 0 CA--C 1.525 0.665 1 O-C-N 130.388 4.805 . . . . 0.0 113.266 150.438 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -120.17 169.5 10.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 131.008 3.723 . . . . 0.0 112.321 179.336 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 p -105.92 163.87 12.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 116.557 -1.687 . . . . 0.0 113.916 -173.504 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.423 HD11 ' HB2' ' A' ' 21' ' ' ASP . 5.9 mp -41.72 -37.83 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 112.645 -3.55 . . . . 0.0 115.108 156.94 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -71.58 -38.37 70.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 124.721 3.419 . . . . 0.0 117.94 170.531 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.95 -29.37 66.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 122.163 2.256 . . . . 0.0 115.319 173.761 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -87.68 8.84 23.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 118.68 -2.512 . . . . 0.0 108.132 173.112 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 63.26 24.47 14.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 124.211 3.187 . . . . 0.0 117.183 171.32 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.6 mt -76.87 127.71 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 118.636 -2.54 . . . . 0.0 116.749 -175.217 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.278 4.3 tp-100 -110.6 165.16 12.04 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.835 2.454 . . . . 0.0 109.896 -170.335 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.2 155.83 2.51 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 117.086 -3.509 . . . . 0.0 115.556 178.532 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 57.06 1.03 0.09 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.434 2.294 . . . . 0.0 116.509 170.435 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -60.12 151.31 27.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 130.48 3.512 . . . . 0.0 110.5 173.893 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.9 m -103.47 115.69 31.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 177.632 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.38 148.01 24.45 Favored 'General case' 0 N--CA 1.445 -0.68 1 C-N-CA 132.618 4.367 . . . . 0.0 107.784 160.402 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -113.68 148.4 36.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 122.312 2.324 . . . . 0.0 109.597 176.467 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -119.28 136.63 54.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.259 2.623 . . . . 0.0 107.274 178.996 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.97 167.99 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 O-C-N 125.222 1.576 . . . . 0.0 111.476 157.048 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.593 1.1 pp -127.41 137.28 52.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 120.573 1.533 . . . . 0.0 113.821 171.176 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -89.32 -171.96 3.44 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 111.757 -2.474 . . . . 0.0 108.796 178.319 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mt -90.68 164.56 14.11 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.381 2.673 . . . . 0.0 112.568 169.899 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.44 36.7 ttp180 81.36 127.02 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 128.179 2.591 . . . . 0.0 111.839 -177.079 . . . . . . . . 2 2 . 1 . 099 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.98 157.09 10.49 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 104.698 -3.361 . . . . 0.0 104.698 178.715 . . . . . . . . 1 1 . 1 . 099 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.349 0 N-CA-C 106.953 -2.459 . . . . 0.0 106.953 -179.815 . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 ttp . . . . . 0 C--O 1.234 0.248 0 CA-C-O 115.737 -2.078 . . . . 0.0 106.554 . . . . . . . . . 0 0 . 1 . 100 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.58 HE21 HG22 ' A' ' 14' ' ' THR . 57.9 tt0 -90.75 138.96 31.17 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 121.383 1.901 . . . . 0.0 108.748 173.331 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 pt -125.96 159.76 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 130.081 3.352 . . . . 0.0 109.372 159.908 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.279 73.4 m-85 -95.47 144.0 26.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 165.726 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.8 t -116.14 149.07 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 127.878 2.471 . . . . 0.0 108.768 163.987 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -136.79 150.07 48.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 130.488 3.515 . . . . 0.0 104.243 177.721 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.5 p -106.79 -170.97 1.8 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 111.731 -2.486 . . . . 0.0 106.189 -179.786 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.1 mt -106.67 -11.75 15.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 126.548 3.071 . . . . 0.0 112.951 -176.318 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -89.15 -6.02 57.3 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 119.077 -2.265 . . . . 0.0 110.994 173.859 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.8 -28.47 5.43 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 129.263 3.316 . . . . 0.0 111.107 171.572 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.441 ' HZ1' ' CD ' ' A' ' 34' ' ' GLU . 47.3 tttt -73.12 142.48 47.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.067 -158.509 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.5 p -113.02 136.73 52.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.465 1.906 . . . . 0.0 109.897 -179.171 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 pt -117.78 143.6 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 131.4 3.88 . . . . 0.0 102.191 168.297 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.58 HG22 HE21 ' A' ' 2' ' ' GLN 0.427 78.5 m -97.58 141.23 30.88 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 169.559 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.291 0.0 OUTLIER -131.23 125.28 32.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.068 2.147 . . . . 0.0 109.042 -176.649 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.4 132.2 37.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 129.238 3.015 . . . . 0.0 112.203 156.162 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.99 160.35 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 127.235 2.214 . . . . 0.0 111.689 -177.81 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -121.19 154.87 58.73 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 100.724 -3.806 . . . . 0.0 100.724 173.976 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.82 -17.91 17.44 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.775 1.65 . . . . 0.0 115.865 -171.575 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 p -84.42 5.14 28.42 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 117.381 -1.295 . . . . 0.0 111.642 -175.064 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.03 139.51 39.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.431 2.693 . . . . 0.0 114.646 178.903 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 p -94.61 134.88 36.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.265 2.226 . . . . 0.0 114.664 -177.067 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.442 5.0 mt -42.14 -40.61 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -177.006 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.39 -13.95 59.61 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 117.156 -3.465 . . . . 0.0 113.5 176.429 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -89.64 -23.32 21.93 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 116.158 -1.877 . . . . 0.0 114.056 162.815 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.84 -36.18 73.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 116.343 -1.789 . . . . 0.0 110.129 168.034 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -60.2 -39.69 87.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 122.457 2.389 . . . . 0.0 113.487 170.078 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -36.5 79.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 115.583 -2.151 . . . . 0.0 113.664 169.694 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 tttt -61.81 -38.05 86.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 123.379 2.809 . . . . 0.0 110.349 169.606 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.366 66.4 mt -62.19 -32.66 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 O-C-N 117.7 -3.125 . . . . 0.0 117.416 169.96 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -27.24 68.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.708 1.203 . . . . 0.0 113.774 175.947 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -84.11 -33.98 24.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 126.139 2.15 . . . . 0.0 107.371 -176.726 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -73.75 -43.45 59.02 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 177.469 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.441 ' CD ' ' HZ1' ' A' ' 11' ' ' LYS 0.302 47.8 tp10 -142.02 -5.2 1.01 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 123.383 1.563 . . . . 0.0 108.135 -152.855 . . . . . . . . 3 3 . 1 . 100 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.24 -9.17 69.81 Favored Glycine 0 N--CA 1.443 -0.877 1 O-C-N 115.975 -4.203 . . . . 0.0 122.558 162.497 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.449 HG23 ' HG3' ' A' ' 41' ' ' GLN . 68.0 mt -79.03 124.02 84.83 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-O 114.389 -2.719 . . . . 0.0 105.241 -171.2 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.303 58.9 Cg_endo -54.48 149.78 37.26 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.46 2.107 . . . . 0.0 115.394 172.221 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -84.29 -25.62 2.08 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 107.28 -1.854 . . . . 0.0 107.28 -162.165 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -48.84 -47.62 42.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 177.73 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -95.78 13.65 25.87 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.497 1.519 . . . . 0.0 108.029 -175.51 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.449 ' HG3' HG23 ' A' ' 36' ' ' ILE . 30.9 mt-30 -92.78 145.44 24.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 122.144 2.247 . . . . 0.0 109.919 171.192 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -147.63 124.23 11.1 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 130.005 3.322 . . . . 0.0 109.015 -177.261 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mp -101.39 139.01 37.64 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.875 1.67 . . . . 0.0 110.823 -177.161 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.9 mt -121.84 140.67 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 131.372 3.869 . . . . 0.0 110.292 168.761 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -116.54 -32.02 5.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 119.245 -2.159 . . . . 0.0 113.917 166.254 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.7 -107.16 0.38 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-O 115.43 -2.224 . . . . 0.0 106.312 175.961 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.95 2.77 13.19 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 117.931 1.932 . . . . 0.0 117.931 166.569 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -113.11 151.62 30.59 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 118.999 -2.471 . . . . 0.0 107.495 -160.707 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -66.41 144.65 56.39 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.676 163.912 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.4 mt -98.05 147.41 24.56 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.873 2.469 . . . . 0.0 106.534 172.729 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -66.96 114.59 5.88 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 157.677 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -53.35 -30.32 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 119.915 3.302 . . . . 0.0 119.915 -176.38 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.68 18.44 52.95 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -168.753 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -94.02 168.69 10.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 125.572 1.395 . . . . 0.0 109.913 167.232 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.1 p -96.08 166.93 11.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 130.628 3.571 . . . . 0.0 116.53 175.29 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.79 -38.41 69.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 114.492 -2.671 . . . . 0.0 115.538 168.6 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 p -76.1 -31.27 58.6 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.555 2.742 . . . . 0.0 106.702 -171.397 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -57.42 -35.01 69.53 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 120.083 1.311 . . . . 0.0 111.809 173.999 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -108.39 -3.57 18.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -170.741 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.419 36.9 t-20 67.16 53.47 0.79 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 127.324 2.89 . . . . 0.0 111.904 178.8 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.1 mm -79.11 115.68 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 127.94 2.496 . . . . 0.0 104.491 168.494 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -93.15 156.88 16.58 Favored 'General case' 0 N--CA 1.448 -0.534 1 C-N-CA 132.014 4.126 . . . . 0.0 111.438 177.047 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -67.4 149.01 50.84 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 119.645 -1.91 . . . . 0.0 111.78 -177.245 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.393 19.2 mt-10 80.67 -2.4 1.86 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 114.09 -2.862 . . . . 0.0 113.219 172.78 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.8 m -66.58 159.63 27.03 Favored 'General case' 0 N--CA 1.449 -0.494 1 O-C-N 130.016 4.573 . . . . 0.0 112.616 -177.229 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.5 m -103.74 121.29 42.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 175.083 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 tt -110.31 154.45 23.46 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 117.803 -3.061 . . . . 0.0 106.486 -179.347 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -120.95 119.77 33.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 116.507 -3.871 . . . . 0.0 110.415 -167.826 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.1 tp -98.4 142.57 29.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.582 2.353 . . . . 0.0 110.178 178.983 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -124.3 162.98 24.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 129.187 2.995 . . . . 0.0 109.687 177.217 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -153.46 163.58 39.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.455 1.121 . . . . 0.0 109.227 177.685 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.3 mtm105 -126.94 52.96 1.74 Allowed 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 118.848 -2.407 . . . . 0.0 108.802 -173.104 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.47 4.2 pp -135.05 -2.64 2.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 120.059 1.3 . . . . 0.0 109.72 -179.755 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.499 ' HE ' ' C ' ' A' ' 76' ' ' GLY . 2.8 tmm_? -94.44 -28.1 15.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -168.026 . . . . . . . . 2 2 . 1 . 100 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.66 18.32 5.72 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 121.591 1.996 . . . . 0.0 112.911 -171.358 . . . . . . . . 1 1 . 1 . 100 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.499 ' C ' ' HE ' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 129.69 3.519 . . . . 0.0 104.939 -167.633 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.4 ttm . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 116.982 -1.485 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 101 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -106.11 122.49 46.29 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -166.209 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -132.8 174.1 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 O-C-N 125.723 1.889 . . . . 0.0 109.086 167.832 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.404 ' HB3' ' HA ' ' A' ' 14' ' ' THR 0.283 7.6 p90 -150.62 149.06 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 117.033 -3.542 . . . . 0.0 109.509 -171.457 . . . . . . . . 3 3 . 1 . 101 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 m -114.58 150.42 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 179.909 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -109.26 123.42 49.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 175.624 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -68.51 172.88 5.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 128.538 2.735 . . . . 0.0 110.584 176.861 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.76 -26.5 66.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.805 167.43 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -88.92 -4.27 58.5 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 179.978 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.91 -4.29 57.55 Favored Glycine 0 CA--C 1.528 0.898 1 CA-C-O 112.379 -4.567 . . . . 0.0 111.823 166.128 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -84.62 141.5 30.61 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 123.922 3.861 . . . . 0.0 110.885 178.139 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.276 53.9 m -104.15 148.62 26.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 121.658 2.026 . . . . 0.0 105.906 -168.433 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mt -128.48 121.08 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.824 2.05 . . . . 0.0 107.936 176.951 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.404 ' HA ' ' HB3' ' A' ' 4' ' ' PHE . 91.8 m -92.67 129.77 38.5 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.561 1.945 . . . . 0.0 106.63 -177.244 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.91 139.4 47.43 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 127.147 2.779 . . . . 0.0 106.403 -175.48 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.294 22.3 tp10 -96.22 127.18 42.0 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 118.442 -2.661 . . . . 0.0 107.211 159.635 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.63 161.81 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 103.503 -2.776 . . . . 0.0 103.503 177.823 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -107.85 121.56 43.61 Favored Pre-proline 0 N--CA 1.446 -0.667 1 C-N-CA 133.366 4.666 . . . . 0.0 104.877 160.63 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 10.4 Cg_endo -65.19 -2.57 5.99 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 127.188 5.258 . . . . 0.0 117.483 -160.22 . . . . . . . . 3 2 . 1 . 101 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -96.85 3.4 52.21 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.86 -177.331 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.12 157.04 31.23 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.694 1.597 . . . . 0.0 111.523 174.932 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -100.53 149.93 23.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 -172.338 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.452 HG12 ' H ' ' A' ' 23' ' ' ILE . 5.5 mm -51.96 -31.86 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 112.609 -3.567 . . . . 0.0 116.477 -178.005 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -65.38 -26.54 68.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 123.079 2.672 . . . . 0.0 113.136 174.188 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -81.69 -21.24 38.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.506 1.503 . . . . 0.0 112.744 178.495 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 t -71.4 -52.53 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 1 C-N-CA 133.804 4.842 . . . . 0.0 110.082 167.716 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -53.6 -34.13 57.35 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 116.555 -3.84 . . . . 0.0 118.12 168.299 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.74 -18.85 39.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 120.395 -1.441 . . . . 0.0 112.06 -178.439 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -69.95 -17.23 63.3 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 116.844 -3.66 . . . . 0.0 117.026 167.293 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mm -84.83 -35.56 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 116.736 -1.602 . . . . 0.0 108.733 -174.743 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -52.14 -43.41 64.03 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 129.618 3.167 . . . . 0.0 111.863 -166.783 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.85 -29.3 65.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 122.767 2.53 . . . . 0.0 113.272 179.701 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -75.18 -56.77 4.4 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.393 -2.692 . . . . 0.0 109.914 173.294 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -134.29 137.63 44.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 -165.524 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.48 40.87 2.32 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 -149.71 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 mt -91.93 119.66 68.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 130.066 3.347 . . . . 0.0 113.807 -174.781 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.97 138.94 23.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 121.273 1.49 . . . . 0.0 113.024 -168.273 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.08 -18.75 7.66 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-O 111.452 -3.645 . . . . 0.0 116.18 177.59 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -88.61 12.15 15.42 Favored 'General case' 0 C--O 1.238 0.491 1 CA-C-N 127.076 4.489 . . . . 0.0 112.314 175.078 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.336 8.2 tt0 -127.01 -18.86 4.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.511 -1.993 . . . . 0.0 111.222 -176.858 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 77.3 mt-30 -92.66 156.64 16.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.254 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -144.8 147.69 33.18 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.212 -2.885 . . . . 0.0 103.212 170.49 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.8 mt -117.76 136.06 53.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.526 2.331 . . . . 0.0 110.078 -176.591 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 56.2 mt -122.15 143.18 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 172.892 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -118.03 106.45 12.92 Favored 'General case' 0 C--N 1.33 -0.273 2 CA-C-N 105.312 -5.404 . . . . 0.0 112.332 154.675 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.462 . . 87.18 4.22 0.36 Allowed 'General case' 0 CA--C 1.532 0.265 1 O-C-N 111.987 -6.696 . . . . 0.0 116.69 157.537 . . . . . . . . 3 2 . 1 . 101 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.7 2.22 46.47 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.714 -171.794 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -92.23 124.07 36.03 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 128.349 2.659 . . . . 0.0 111.276 165.012 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -77.18 128.46 34.42 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 168.788 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.279 11.9 mt -68.15 126.54 29.84 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 118.336 2.717 . . . . 0.0 118.336 170.388 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -98.75 139.09 34.95 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -173.625 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.45 142.83 57.7 Favored 'General case' 0 C--O 1.22 -0.457 0 O-C-N 117.996 -2.94 . . . . 0.0 109.013 176.787 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.68 -19.04 56.34 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 119.108 -2.245 . . . . 0.0 108.126 171.519 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -81.09 157.97 25.2 Favored 'General case' 0 N--CA 1.453 -0.319 1 O-C-N 115.072 -4.781 . . . . 0.0 106.538 173.123 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.1 p -92.03 165.93 12.94 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 120.558 -1.339 . . . . 0.0 109.967 165.689 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 mt -51.7 -45.79 63.65 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.451 2.7 . . . . 0.0 113.286 163.075 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -53.45 -28.84 32.51 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 170.082 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.01 -23.65 48.2 Favored 'General case' 0 N--CA 1.447 -0.597 1 O-C-N 115.068 -4.77 . . . . 0.0 115.857 178.356 . . . . . . . . 3 3 . 1 . 101 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.28 45.9 m-85 -97.99 -9.05 26.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.309 1.444 . . . . 0.0 114.303 172.497 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.377 26.5 t30 72.54 47.18 0.26 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 130.324 3.45 . . . . 0.0 111.405 -178.233 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -82.57 103.58 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.943 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -90.09 -175.06 4.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 130.02 3.328 . . . . 0.0 115.901 170.458 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.76 138.58 41.85 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.613 3.165 . . . . 0.0 112.933 173.498 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.454 62.8 tt0 83.93 2.24 0.91 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 126.867 2.067 . . . . 0.0 114.657 167.53 . . . . . . . . 2 2 . 1 . 101 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -77.88 134.1 38.0 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.23 -1.544 . . . . 0.0 111.104 -169.195 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -85.19 115.55 23.04 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 126.662 2.476 . . . . 0.0 104.733 174.44 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 51.3 mt -94.83 171.03 9.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 128.208 3.443 . . . . 0.0 107.262 161.839 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -130.96 139.13 50.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.721 -179.029 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -101.95 120.87 41.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 -171.006 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.37 172.95 13.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 127.497 2.319 . . . . 0.0 105.973 -175.287 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 mp -129.0 142.78 50.81 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 122.816 0.446 . . . . 0.0 110.687 -165.576 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 ttt85 -161.11 114.1 1.94 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 130.096 3.358 . . . . 0.0 105.846 174.218 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.7 mt -51.86 126.61 18.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 161.635 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -66.19 134.18 52.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 130.932 3.693 . . . . 0.0 109.174 178.689 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.37 22.16 11.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 116.259 -2.412 . . . . 0.0 118.231 176.704 . . . . . . . . 1 1 . 1 . 101 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 N-CA-C 106.564 -2.614 . . . . 0.0 106.564 -176.501 . . . . . . . . 0 0 . 1 . 102 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttp . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 116.654 -1.641 . . . . 0.0 107.281 . . . . . . . . . 0 0 . 1 . 102 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -93.95 138.59 31.9 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 124.041 1.877 . . . . 0.0 111.164 170.842 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -136.74 167.71 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.704 2.001 . . . . 0.0 107.897 162.289 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -119.87 135.2 54.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -177.144 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.0 t -121.43 89.58 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 126.674 2.484 . . . . 0.0 104.907 178.747 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -77.83 121.32 23.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.456 3.902 . . . . 0.0 107.018 -175.542 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.8 p -84.61 155.05 22.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 175.373 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 mt -50.44 -16.81 0.39 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 131.415 3.886 . . . . 0.0 115.664 176.558 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -97.81 6.35 47.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.18 0.992 . . . . 0.0 111.731 172.706 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.08 -36.32 4.47 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 120.007 -1.683 . . . . 0.0 109.951 167.515 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -60.24 127.68 33.0 Favored 'General case' 0 C--N 1.33 -0.255 1 C-N-CA 132.369 4.268 . . . . 0.0 106.69 -174.718 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.253 20.6 m -119.19 123.81 45.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.102 2.561 . . . . 0.0 109.071 -166.014 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mm -82.48 120.37 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 168.235 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.8 m -74.35 134.8 42.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.88 1.363 . . . . 0.0 109.27 166.735 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.3 mt -125.44 129.91 50.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 120.645 1.566 . . . . 0.0 113.259 179.593 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.48 90.77 7.69 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.133 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -98.99 164.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.321 177.996 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.265 30.5 tp10 -107.81 156.21 38.49 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-O 113.612 -3.09 . . . . 0.0 105.017 162.3 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -59.93 -25.07 78.49 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 124.127 3.218 . . . . 0.0 118.073 170.557 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -88.57 1.65 54.53 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 119.439 3.125 . . . . 0.0 119.439 -179.732 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -72.43 149.18 44.47 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 114.439 -2.696 . . . . 0.0 115.891 -177.605 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 p -65.95 151.67 46.26 Favored 'General case' 0 C--N 1.325 -0.459 1 O-C-N 129.62 4.325 . . . . 0.0 110.475 167.04 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -61.02 -29.01 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 116.591 -1.671 . . . . 0.0 110.412 173.251 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -70.3 -50.61 37.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.045 2.538 . . . . 0.0 111.379 -173.056 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.3 -45.04 54.3 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.132 2.573 . . . . 0.0 112.629 170.93 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.4 -45.85 67.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.856 1.662 . . . . 0.0 108.158 -176.28 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -63.61 -31.19 72.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.251 1.42 . . . . 0.0 114.397 178.101 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.71 -14.87 35.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.38 3.472 . . . . 0.0 113.56 177.084 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.04 -31.2 27.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 119.119 -2.238 . . . . 0.0 107.083 174.571 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.2 mm -81.51 -6.99 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 117.348 -1.31 . . . . 0.0 109.961 176.907 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -76.54 -28.99 56.51 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 118.104 -2.873 . . . . 0.0 109.102 163.37 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.55 -47.21 12.41 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -163.292 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -73.18 -73.77 0.2 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.332 2.653 . . . . 0.0 112.214 178.437 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -85.45 -16.57 39.24 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.736 2.414 . . . . 0.0 117.183 -166.942 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.97 -7.84 67.53 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 117.142 -1.921 . . . . 0.0 112.786 -179.777 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.261 37.9 mm -80.29 115.03 51.91 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 123.141 3.471 . . . . 0.0 112.248 -163.485 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -55.67 160.22 9.91 Favored 'Trans proline' 0 N--CA 1.445 -1.354 1 C-N-CA 126.126 4.551 . . . . 0.0 113.941 171.011 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.63 5.82 3.59 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 N-CA-C 120.028 3.049 . . . . 0.0 120.028 -176.509 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.378 82.8 m-20 -104.72 -6.37 20.43 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 126.312 2.958 . . . . 0.0 117.929 174.451 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -97.82 -6.47 32.55 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 119.304 -2.122 . . . . 0.0 114.703 160.992 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -85.25 85.93 7.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 169.51 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -93.85 97.22 10.25 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 -171.421 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 mt -93.06 139.15 30.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -163.654 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mt -136.47 135.55 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.31 1.844 . . . . 0.0 110.039 177.754 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -129.38 107.13 9.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.07 3.348 . . . . 0.0 105.465 -178.465 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.39 42.0 31.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.426 2.291 . . . . 0.0 115.176 167.634 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.2 -25.29 28.81 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 119.707 -1.87 . . . . 0.0 114.199 -178.449 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -93.77 114.22 26.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 -171.227 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.292 7.8 tt0 -82.28 140.78 33.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 169.1 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.56 135.75 40.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 130.576 3.551 . . . . 0.0 109.362 -174.159 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -104.5 -4.01 23.22 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.203 2.601 . . . . 0.0 109.113 -172.013 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.323 7.5 m-20 84.38 168.35 0.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.278 170.247 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.62 -16.89 36.93 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 123.812 0.695 . . . . 0.0 113.881 169.232 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -120.98 -171.69 2.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.976 2.111 . . . . 0.0 105.366 -171.05 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.261 7.0 p -111.66 167.66 10.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.233 -0.917 . . . . 0.0 110.894 -165.463 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.284 9.3 mp -56.32 -28.86 60.28 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 169.249 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -77.06 -34.33 57.11 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 116.572 -2.051 . . . . 0.0 114.489 179.087 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.64 -40.39 76.54 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 127.924 3.265 . . . . 0.0 113.143 -177.685 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -79.44 0.56 28.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 117.519 -3.238 . . . . 0.0 109.341 171.045 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.366 1.6 t-20 70.6 49.13 0.42 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 126.277 2.942 . . . . 0.0 115.647 169.903 . . . . . . . . 2 2 . 1 . 102 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -101.79 123.45 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 112.538 -2.119 . . . . 0.0 107.336 -174.736 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -111.72 -164.96 0.95 Allowed 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 124.96 1.413 . . . . 0.0 113.696 -168.104 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -69.97 114.72 8.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 119.44 -2.037 . . . . 0.0 107.619 174.611 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.312 5.7 tt0 89.4 12.3 0.07 Allowed 'General case' 0 C--O 1.236 0.374 1 O-C-N 115.915 -4.241 . . . . 0.0 112.746 167.307 . . . . . . . . 3 2 . 1 . 102 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -49.76 152.23 1.55 Allowed 'General case' 0 C--N 1.327 -0.381 0 O-C-N 117.661 -3.149 . . . . 0.0 112.179 167.953 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.1 m -116.15 130.54 56.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.637 167.928 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.92 123.56 46.05 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.078 1.751 . . . . 0.0 112.4 166.13 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -84.65 110.32 18.65 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 173.004 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.1 tp -89.2 103.76 16.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.727 2.411 . . . . 0.0 108.933 172.413 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 t -81.36 116.75 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 127.63 2.372 . . . . 0.0 109.292 163.502 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.5 116.38 26.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 115.112 -2.375 . . . . 0.0 104.682 175.202 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -72.11 146.65 47.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 127.754 3.159 . . . . 0.0 109.503 159.798 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 mt -94.49 13.43 23.99 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 165.699 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -148.27 -163.71 1.84 Allowed 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 128.323 3.514 . . . . 0.0 103.681 -175.335 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.43 159.6 13.93 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 115.618 -2.768 . . . . 0.0 110.015 174.515 . . . . . . . . 1 1 . 1 . 102 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.952 0 O-C-N 129.257 3.563 . . . . 0.0 111.497 172.411 . . . . . . . . 0 0 . 1 . 103 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tmm? . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 . . . . . . . . . 0 0 . 1 . 103 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -94.01 154.31 17.72 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -174.665 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 pt -135.74 144.26 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 171.421 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -102.96 94.29 5.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 111.207 -2.724 . . . . 0.0 104.439 -179.235 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.4 t -80.88 112.68 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.598 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -96.14 127.91 42.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -170.142 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -95.49 136.83 35.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.317 2.247 . . . . 0.0 109.087 160.055 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.12 -32.33 71.65 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 113.871 -2.966 . . . . 0.0 112.575 166.997 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.276 33.1 p -76.37 -16.52 59.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 114.707 -2.568 . . . . 0.0 109.456 -178.805 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.36 48.15 0.09 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 117.052 -2.499 . . . . 0.0 113.665 123.301 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.304 0.6 OUTLIER -139.19 153.05 47.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.76 1.267 . . . . 0.0 108.84 164.555 . . . . . . . . 3 3 . 1 . 103 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -95.35 129.98 42.29 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.157 2.183 . . . . 0.0 107.03 164.585 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.2 mt -108.92 132.68 56.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 128.975 2.91 . . . . 0.0 106.322 177.625 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.5 m -93.78 126.33 38.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 167.133 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.87 138.17 50.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 125.944 2.028 . . . . 0.0 106.845 166.634 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.74 137.04 39.66 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 173.048 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 m -150.44 179.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.571 1 C-N-CA 132.866 4.467 . . . . 0.0 106.165 -166.779 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.262 48.4 mm-40 -130.89 159.35 71.77 Favored Pre-proline 0 N--CA 1.446 -0.658 0 C-N-CA 127.824 2.45 . . . . 0.0 105.345 155.167 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -61.47 -9.15 12.4 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.026 2.484 . . . . 0.0 116.82 179.543 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.269 26.4 p -88.58 -3.73 58.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.665 -1.16 . . . . 0.0 113.27 173.98 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.67 126.81 28.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.794 0.725 . . . . 0.0 110.457 171.147 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.398 4.7 p -67.05 155.07 39.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 173.775 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.4 -35.67 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 131.176 3.79 . . . . 0.0 107.629 171.395 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.46 -40.45 50.4 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 119.454 -2.029 . . . . 0.0 110.774 -174.204 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -56.56 -59.66 4.68 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 124.994 1.434 . . . . 0.0 113.419 168.38 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.321 96.6 t -51.72 -51.25 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 O-C-N 116.705 -3.747 . . . . 0.0 115.849 -177.387 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -48.8 -44.09 38.75 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 127.456 2.973 . . . . 0.0 116.433 169.927 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.24 -34.2 23.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 129.772 3.229 . . . . 0.0 110.361 -179.425 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -62.06 -33.54 74.58 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 125.853 1.971 . . . . 0.0 110.862 169.256 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.2 mt -63.95 -50.38 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 127.77 2.428 . . . . 0.0 113.239 165.965 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -41.34 82.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.92 2.088 . . . . 0.0 112.856 -175.984 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -54.37 -26.22 28.89 Favored 'General case' 0 N--CA 1.447 -0.594 1 C-N-CA 131.811 4.045 . . . . 0.0 113.741 173.601 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -98.78 -62.25 1.26 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 120.645 1.566 . . . . 0.0 113.514 -178.874 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -106.78 -17.41 14.22 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 126.368 2.292 . . . . 0.0 114.265 -167.523 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.95 1.43 42.18 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 117.696 -3.127 . . . . 0.0 118.053 168.049 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mt -80.75 130.16 65.24 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 123.279 3.54 . . . . 0.0 115.511 -172.43 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.285 36.9 Cg_endo -68.3 135.37 33.95 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.996 2.464 . . . . 0.0 110.745 179.419 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -43.79 -40.63 11.36 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.532 2.821 . . . . 0.0 116.556 175.925 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -55.75 -30.28 60.97 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.698 1.199 . . . . 0.0 112.986 -176.139 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -101.15 -12.5 18.72 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 128.314 2.646 . . . . 0.0 115.216 -171.606 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.26 73.3 mt-30 -81.14 152.61 27.69 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 111.932 -2.394 . . . . 0.0 108.419 179.413 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -132.45 126.83 33.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.847 2.459 . . . . 0.0 108.246 157.13 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 mt -115.96 131.2 57.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 177.684 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.72 143.11 32.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 110.789 -2.914 . . . . 0.0 108.085 -173.031 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -139.38 118.02 12.26 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.566 2.347 . . . . 0.0 109.011 160.083 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.65 48.87 6.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 128.36 3.538 . . . . 0.0 109.688 170.152 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.66 -19.94 51.14 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.578 1.085 . . . . 0.0 112.019 166.631 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.262 74.5 mttt -96.83 144.81 26.44 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.083 1.942 . . . . 0.0 114.447 -174.568 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.319 77.8 mm-40 -76.88 169.1 18.93 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 116.895 -1.922 . . . . 0.0 109.131 160.908 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.457 HD21 ' CG ' ' A' ' 59' ' ' TYR 0.25 43.4 mt -120.34 119.35 32.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 117.84 -3.038 . . . . 0.0 106.141 -170.571 . . . . . . . . 3 3 . 1 . 103 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -86.08 146.65 26.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 123.194 1.473 . . . . 0.0 113.274 -170.243 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -68.44 122.39 18.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 111.97 -2.377 . . . . 0.0 104.916 -175.403 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.07 9.25 10.83 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 127.581 3.051 . . . . 0.0 119.336 179.698 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.277 90.2 mtt-85 -132.35 179.34 6.18 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.953 2.101 . . . . 0.0 107.244 -172.579 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -126.46 178.62 5.75 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.113 -171.184 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -73.62 -28.93 62.06 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 127.45 2.969 . . . . 0.0 110.909 175.389 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.1 t -59.81 -27.58 66.71 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 129.521 3.129 . . . . 0.0 110.692 172.49 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.89 -44.16 27.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.748 2.419 . . . . 0.0 108.796 178.528 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.457 ' CG ' HD21 ' A' ' 50' ' ' LEU . 96.0 m-85 -99.99 20.93 13.5 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -179.622 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 3.9 t-20 83.7 25.38 0.11 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 119.147 3.017 . . . . 0.0 119.147 164.169 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mt -104.04 81.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -172.679 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -92.28 -23.49 19.28 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 129.09 2.956 . . . . 0.0 114.491 -170.362 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -168.39 130.13 1.36 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.881 1.672 . . . . 0.0 109.535 -170.881 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 7.99 86.95 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 130.906 3.683 . . . . 0.0 116.944 167.049 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.284 5.3 t -143.98 -160.52 1.13 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 115.115 -2.374 . . . . 0.0 107.301 173.788 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.5 m -125.7 132.07 52.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 122.074 2.215 . . . . 0.0 106.334 -167.265 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.77 143.54 29.01 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 156.373 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -89.96 128.84 36.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 119.521 -1.987 . . . . 0.0 109.114 166.904 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 tp -92.45 117.67 30.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 131.69 3.996 . . . . 0.0 103.511 176.833 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.5 143.69 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -176.968 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.28 124.04 31.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 119.3 -2.125 . . . . 0.0 111.044 -171.097 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.49 -29.61 66.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 114.393 -2.718 . . . . 0.0 112.854 178.95 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.296 50.7 tp -72.46 123.21 22.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 128.842 3.838 . . . . 0.0 109.085 171.395 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.323 1.2 ttp85 -84.14 125.67 32.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 102.921 -2.992 . . . . 0.0 102.921 -174.023 . . . . . . . . 2 2 . 1 . 103 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.83 -92.96 0.53 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 130.065 3.698 . . . . 0.0 106.524 -175.9 . . . . . . . . 1 1 . 1 . 103 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 C-N-CA 129.617 3.484 . . . . 0.0 110.609 -170.423 . . . . . . . . 0 0 . 1 . 104 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ptt? . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 . . . . . . . . . 0 0 . 1 . 104 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -82.71 152.32 25.84 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 115.208 -2.33 . . . . 0.0 112.678 -179.701 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.8 pt -139.82 149.5 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 121.777 2.08 . . . . 0.0 109.449 162.539 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -105.27 126.22 51.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 -172.355 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.272 93.0 t -99.4 112.14 30.9 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 C-N-CA 127.979 2.511 . . . . 0.0 108.076 171.929 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -70.32 148.8 48.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 111.565 -2.561 . . . . 0.0 111.314 166.352 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -120.75 -167.07 1.41 Allowed 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.083 -1.635 . . . . 0.0 109.534 176.442 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.495 HD22 ' HE2' ' A' ' 68' ' ' HIS . 0.5 OUTLIER -143.14 42.17 1.53 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 164.294 . . . . . . . . 3 3 . 1 . 104 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -139.74 26.54 2.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.715 2.406 . . . . 0.0 107.786 176.985 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.98 16.52 35.4 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 116.865 -3.647 . . . . 0.0 117.883 152.997 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -154.49 171.73 18.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 124.427 2.061 . . . . 0.0 110.116 177.664 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.5 m -112.89 127.57 56.23 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 131.313 3.845 . . . . 0.0 108.918 175.887 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 87.3 mt -106.47 129.37 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 O-C-N 126.78 2.55 . . . . 0.0 107.011 175.018 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.1 m -107.04 136.9 46.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 102.411 -3.181 . . . . 0.0 102.411 169.829 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tp -129.57 160.83 32.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 128.314 2.645 . . . . 0.0 105.496 -179.665 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -102.19 139.27 38.03 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 130.653 3.581 . . . . 0.0 103.19 172.968 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -151.03 166.36 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 119.314 -2.116 . . . . 0.0 108.644 -178.903 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -138.27 142.71 36.16 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 126.152 1.781 . . . . 0.0 108.469 -173.189 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.343 11.5 Cg_exo -50.72 -34.83 45.59 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 N-CA-C 121.369 3.565 . . . . 0.0 121.369 -179.887 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.5 p -93.43 -2.27 54.77 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 127.47 2.981 . . . . 0.0 112.134 -174.24 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -74.33 141.14 45.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 125.868 2.747 . . . . 0.0 109.091 170.327 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 p -76.32 172.81 12.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 119.221 -2.174 . . . . 0.0 111.408 175.933 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -53.15 -46.96 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 C-N-CA 133.875 4.87 . . . . 0.0 113.397 171.097 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -47.47 -42.16 22.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 113.295 -3.24 . . . . 0.0 112.33 170.089 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.281 4.7 m120 -59.14 -32.13 69.59 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.536 2.734 . . . . 0.0 116.135 175.392 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.79 -54.62 25.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 120.121 -1.612 . . . . 0.0 110.769 165.419 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -71.81 -23.88 61.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 125.675 2.655 . . . . 0.0 113.637 -171.952 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.6 -46.98 51.55 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 118.785 -2.447 . . . . 0.0 110.043 173.534 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.68 -27.91 60.61 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.729 2.412 . . . . 0.0 109.757 -176.487 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.36 -47.92 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 O-C-N 118.933 -2.355 . . . . 0.0 106.463 169.77 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -50.86 -51.86 47.29 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 124.426 3.284 . . . . 0.0 107.851 175.924 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.301 5.1 t70 -46.56 -50.03 17.91 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 179.094 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -83.64 -48.99 9.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 128.905 3.878 . . . . 0.0 108.55 -173.195 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -106.26 -14.74 15.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 123.493 2.861 . . . . 0.0 110.012 -161.754 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.21 0.99 84.63 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 129.851 3.595 . . . . 0.0 118.976 -178.623 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -83.86 126.42 70.58 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 119.855 1.827 . . . . 0.0 111.817 -165.827 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.09 145.92 31.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 O-C-N 124.245 1.655 . . . . 0.0 110.394 -175.063 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.27 38.0 Cg_endo -72.94 -16.23 25.93 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.494 3.463 . . . . 0.0 119.823 -163.6 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -72.07 -26.73 62.28 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 125.461 1.726 . . . . 0.0 110.337 174.335 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -83.02 -30.24 28.26 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.41 1.484 . . . . 0.0 112.507 -174.355 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -80.87 142.54 33.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 129.459 3.104 . . . . 0.0 109.375 175.747 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -145.62 119.36 9.22 Favored 'General case' 0 N--CA 1.449 -0.502 1 N-CA-C 99.217 -4.364 . . . . 0.0 99.217 175.733 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.14 124.53 29.95 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 114.64 -2.6 . . . . 0.0 115.81 177.062 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mm -102.17 129.13 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 101.197 -3.631 . . . . 0.0 101.197 173.552 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -137.31 125.98 23.81 Favored 'General case' 0 N--CA 1.451 -0.405 1 N-CA-C 97.139 -5.134 . . . . 0.0 97.139 175.607 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.75 24.18 14.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.864 2.866 . . . . 0.0 114.822 160.577 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.81 -25.92 25.8 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.873 -1.515 . . . . 0.0 112.566 -175.349 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -99.29 164.43 12.13 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 128.079 2.552 . . . . 0.0 109.159 -171.577 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.28 7.3 mt-30 -118.64 145.79 45.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.537 1.935 . . . . 0.0 106.339 166.445 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.44 139.26 30.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.77 -166.58 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.267 7.7 tp10 -85.44 140.34 30.8 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 131.671 3.989 . . . . 0.0 107.174 167.581 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -73.98 136.06 43.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 114.134 -2.841 . . . . 0.0 112.917 -177.667 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.01 -14.16 26.37 Favored Glycine 0 CA--C 1.535 1.327 1 CA-C-N 127.707 4.776 . . . . 0.0 113.775 166.028 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.295 3.1 mpt_? -81.06 161.05 24.34 Favored 'General case' 0 C--N 1.322 -0.624 1 O-C-N 130.925 4.544 . . . . 0.0 105.553 176.385 . . . . . . . . 3 2 . 1 . 104 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -89.59 172.69 8.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 125.282 1.614 . . . . 0.0 109.056 -177.457 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mt -63.04 -52.64 62.07 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 128.932 2.893 . . . . 0.0 110.443 169.961 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.0 p -41.96 -41.27 2.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 117.222 2.305 . . . . 0.0 117.222 162.501 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -62.14 -24.29 67.08 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 118.317 -2.739 . . . . 0.0 116.704 177.34 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -99.52 -6.86 26.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.738 3.215 . . . . 0.0 117.78 179.387 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.308 0.7 OUTLIER 69.85 48.13 0.58 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 130.491 3.517 . . . . 0.0 113.413 174.509 . . . . . . . . 3 3 . 1 . 104 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -93.25 139.69 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -172.998 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.274 7.0 tp60 -148.97 156.36 42.16 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 112.334 -2.212 . . . . 0.0 107.791 -176.18 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.374 23.9 ttpp -31.98 114.43 0.14 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.553 2.741 . . . . 0.0 113.541 -179.974 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 83.4 21.65 0.17 Allowed 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 128.148 3.405 . . . . 0.0 115.007 176.357 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 m -65.65 134.67 53.75 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.688 171.77 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 85.1 m -94.71 122.4 37.28 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -178.989 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 mp -122.77 160.24 26.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.227 1.011 . . . . 0.0 109.398 166.21 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.495 ' HE2' HD22 ' A' ' 8' ' ' LEU . 12.0 t-80 -127.88 124.36 37.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 118.493 -2.63 . . . . 0.0 111.979 -175.547 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.4 tp -82.57 101.45 10.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 115.337 -2.268 . . . . 0.0 111.086 -179.861 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.31 151.7 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 O-C-N 125.42 1.7 . . . . 0.0 107.326 163.545 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 mt -109.24 153.01 24.44 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.633 1.973 . . . . 0.0 111.3 178.77 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -80.93 146.59 30.69 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.646 154.697 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.8 141.92 30.2 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 126.831 3.205 . . . . 0.0 105.911 168.77 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -155.64 -40.71 0.08 Allowed 'General case' 0 C--O 1.234 0.264 0 O-C-N 117.479 -3.263 . . . . 0.0 113.243 -166.255 . . . . . . . . 1 1 . 1 . 104 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.25 130.91 4.89 Favored Glycine 0 CA--C 1.531 1.041 1 C-N-CA 131.273 4.273 . . . . 0.0 116.389 176.224 . . . . . . . . 2 2 . 1 . 104 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.528 0 O-C-N 125.811 1.536 . . . . 0.0 109.542 -170.824 . . . . . . . . 0 0 . 1 . 105 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptt? . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 . . . . . . . . . 0 0 . 1 . 105 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -60.7 125.16 22.66 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 117.553 -1.213 . . . . 0.0 113.248 174.231 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.365 26.8 pt -128.91 166.48 26.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 O-C-N 125.209 1.568 . . . . 0.0 112.127 162.253 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -112.38 154.11 26.26 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.567 2.747 . . . . 0.0 106.916 176.674 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.87 130.66 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 168.682 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -101.72 128.32 48.1 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 122.835 2.561 . . . . 0.0 109.285 167.708 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.6 p -91.59 163.75 14.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.855 2.462 . . . . 0.0 108.386 -173.19 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.41 -47.71 47.7 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 128.286 2.634 . . . . 0.0 109.076 176.22 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.9 p -68.58 -16.94 64.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 128.011 2.524 . . . . 0.0 111.575 -174.743 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.01 -14.06 37.46 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 125.044 3.566 . . . . 0.0 115.498 169.652 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -69.73 147.26 50.75 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.794 1.637 . . . . 0.0 115.074 172.481 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -93.28 137.8 32.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.597 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.3 mt -119.68 137.88 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 170.269 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.4 t -100.86 142.0 32.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.328 1.851 . . . . 0.0 109.941 166.198 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 mt -135.73 142.93 45.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 171.134 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -88.03 115.48 25.54 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 161.787 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 t -123.93 132.41 71.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 127.75 2.42 . . . . 0.0 108.583 -174.985 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -91.3 148.6 38.05 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 114.866 -2.492 . . . . 0.0 110.0 -172.811 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -43.17 -46.0 9.4 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 123.596 2.864 . . . . 0.0 114.955 171.957 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -91.99 15.68 12.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.095 0.861 . . . . 0.0 112.624 -178.428 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -78.46 132.98 37.5 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 118.601 -2.562 . . . . 0.0 105.241 162.818 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.8 p -84.97 179.32 7.32 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 109.86 177.564 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.323 1.1 mp -71.15 -37.36 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 124.192 1.949 . . . . 0.0 108.989 -178.062 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -57.1 -39.01 74.21 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 117.456 -3.278 . . . . 0.0 114.332 173.03 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -53.17 -50.85 63.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 126.007 2.067 . . . . 0.0 115.158 177.739 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 t -65.85 -48.03 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 1 C-N-CA 132.377 4.271 . . . . 0.0 111.094 171.123 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -64.86 -35.94 82.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 115.998 -1.953 . . . . 0.0 111.731 179.11 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.83 -37.03 70.67 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.035 2.134 . . . . 0.0 114.164 174.987 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -84.51 -29.74 25.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 111.068 -2.787 . . . . 0.0 103.67 -170.676 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.8 mt -73.91 -46.24 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 121.503 1.956 . . . . 0.0 112.562 165.368 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -52.98 -48.42 67.46 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 129.532 3.133 . . . . 0.0 110.557 -178.571 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -56.28 -42.63 77.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 169.854 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -86.8 -55.06 4.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -175.867 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -100.01 -18.53 16.99 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 129.532 3.133 . . . . 0.0 113.289 -171.583 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.09 -1.51 70.44 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 114.829 0.692 . . . . 0.0 114.829 155.641 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.63 136.1 71.23 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-O 115.252 -2.309 . . . . 0.0 112.845 173.43 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -70.29 166.32 28.64 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 O-C-N 125.513 2.323 . . . . 0.0 116.449 173.421 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.42 -33.21 5.65 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 CA-C-O 114.901 -2.208 . . . . 0.0 111.228 -166.666 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.94 -21.8 58.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 123.712 2.96 . . . . 0.0 113.241 173.574 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -111.14 -1.08 16.33 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 128.497 2.719 . . . . 0.0 112.078 -169.454 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -96.83 109.24 21.97 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 127.717 2.407 . . . . 0.0 107.145 172.756 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -110.33 89.2 2.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -175.816 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.304 12.8 mt -79.07 127.9 32.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 129.597 3.159 . . . . 0.0 109.221 -179.918 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 8.2 mt -126.2 135.41 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 O-C-N 126.996 2.685 . . . . 0.0 113.561 -175.466 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -147.35 124.3 11.33 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.213 2.205 . . . . 0.0 112.112 172.568 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.36 44.08 9.94 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.882 2.073 . . . . 0.0 111.586 169.009 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.99 4.81 64.65 Favored Glycine 0 CA--C 1.537 1.407 1 CA-C-O 111.949 -4.806 . . . . 0.0 110.393 164.449 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -133.67 141.46 47.6 Favored 'General case' 0 N--CA 1.448 -0.565 1 O-C-N 131.147 4.675 . . . . 0.0 107.509 -170.932 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -70.05 127.67 33.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 123.927 1.822 . . . . 0.0 108.957 160.381 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -83.29 125.29 31.46 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 171.068 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -90.33 136.69 32.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.754 1.622 . . . . 0.0 110.008 -166.163 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -53.83 99.58 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.604 1 C-N-CA 132.29 4.236 . . . . 0.0 117.209 172.207 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.13 -3.46 6.81 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 119.221 2.448 . . . . 0.0 119.221 169.044 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.449 ' HD2' ' CE2' ' A' ' 59' ' ' TYR . 50.3 mtt180 -86.84 -167.66 1.96 Allowed 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 118.824 -2.574 . . . . 0.0 104.463 172.611 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 69.5 p -106.7 165.77 11.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.58 178.321 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -27.77 69.57 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 123.504 1.621 . . . . 0.0 114.626 169.013 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -67.52 -36.1 80.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.454 -1.703 . . . . 0.0 115.042 172.286 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.11 -21.41 66.17 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.702 1.601 . . . . 0.0 114.426 179.235 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.449 ' CE2' ' HD2' ' A' ' 54' ' ' ARG . 32.3 m-85 -112.52 -2.17 14.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 116.868 2.174 . . . . 0.0 116.868 -167.264 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 44.28 46.6 7.66 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 171.343 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -83.98 -35.26 10.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 128.032 3.333 . . . . 0.0 113.905 -173.922 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 75.51 152.28 0.13 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 129.317 3.047 . . . . 0.0 113.357 164.413 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.95 135.88 35.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 127.031 2.133 . . . . 0.0 113.992 173.461 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.344 9.2 tt0 89.05 -1.38 0.37 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 111.311 -2.677 . . . . 0.0 111.479 173.421 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -85.77 162.69 18.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 117.863 -3.023 . . . . 0.0 109.348 -171.082 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.268 36.9 m -121.5 122.83 40.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.176 2.59 . . . . 0.0 106.641 -171.864 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.299 72.9 mt -89.44 145.36 25.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 119.424 -2.047 . . . . 0.0 107.315 167.318 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.276 74.2 m-70 -100.72 121.39 41.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.447 2.699 . . . . 0.0 108.231 174.114 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.1 tp -99.21 118.29 35.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 126.605 2.441 . . . . 0.0 105.277 -179.262 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.48 135.06 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.0 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt -72.84 122.01 20.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 112.99 -3.386 . . . . 0.0 107.312 169.68 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -69.23 83.4 0.36 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 122.957 2.617 . . . . 0.0 111.596 167.325 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.39 125.5 54.32 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.747 -177.937 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 64.2 161.47 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 1 C-N-CA 135.773 5.629 . . . . 0.0 113.181 -156.142 . . . . . . . . 2 2 . 1 . 105 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.15 -42.25 2.44 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 110.194 -3.184 . . . . 0.0 108.84 170.023 . . . . . . . . 1 1 . 1 . 105 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.448 0 O-C-N 118.383 -2.833 . . . . 0.0 111.629 169.455 . . . . . . . . 0 0 . 1 . 106 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 117.566 -1.206 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 106 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.258 77.4 mm-40 -115.7 129.35 56.44 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.431 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.8 pt -100.4 155.14 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 116.866 -1.54 . . . . 0.0 111.066 165.608 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -103.71 121.66 43.43 Favored 'General case' 0 C--O 1.219 -0.532 0 O-C-N 127.395 2.934 . . . . 0.0 105.168 178.16 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 t -115.22 123.59 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 117.213 -3.43 . . . . 0.0 107.886 -177.629 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -119.57 99.66 6.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.599 -1.313 . . . . 0.0 113.294 -173.709 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.2 p -85.04 161.37 19.74 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 119.788 -1.82 . . . . 0.0 112.62 -174.592 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.386 0.0 OUTLIER -17.39 -72.78 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 1 C-N-CA 133.592 4.757 . . . . 0.0 119.711 -172.382 . . . . . . . . 4 3 . 1 . 106 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.0 p -61.21 -10.28 6.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.469 -1.696 . . . . 0.0 114.073 171.827 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.67 -5.17 34.83 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 127.222 3.679 . . . . 0.0 117.64 176.673 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.03 110.77 1.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 129.071 2.948 . . . . 0.0 108.678 -177.894 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.1 m -99.06 139.24 35.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 127.382 2.926 . . . . 0.0 107.559 -161.519 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.4 mt -123.23 141.46 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 177.387 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 m -98.51 105.88 18.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 127.994 3.309 . . . . 0.0 110.054 153.198 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tp -99.07 133.62 43.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 -179.365 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.266 83.6 tt0 -86.27 141.57 29.18 Favored 'General case' 0 N--CA 1.45 -0.427 1 O-C-N 129.363 4.165 . . . . 0.0 106.561 174.712 . . . . . . . . 3 2 . 1 . 106 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.29 179.24 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 126.691 3.138 . . . . 0.0 109.562 174.396 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -107.79 152.99 41.8 Favored Pre-proline 0 N--CA 1.45 -0.458 0 O-C-N 116.793 -3.692 . . . . 0.0 106.491 148.578 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.5 -25.19 25.45 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 O-C-N 116.714 -2.308 . . . . 0.0 113.294 -176.575 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.2 p -77.51 -0.81 27.6 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 129.052 2.941 . . . . 0.0 114.899 174.069 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -77.34 148.96 35.33 Favored 'General case' 0 C--O 1.22 -0.457 0 O-C-N 126.256 2.222 . . . . 0.0 110.226 173.279 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -109.16 144.33 37.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 111.437 -2.619 . . . . 0.0 105.581 -163.447 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -54.07 -30.29 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 1 CA-C-O 110.342 -4.647 . . . . 0.0 115.005 -171.022 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -65.73 -33.83 76.77 Favored 'General case' 0 N--CA 1.451 -0.401 1 CA-C-N 126.006 4.003 . . . . 0.0 113.067 172.532 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -80.66 -16.42 54.07 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 126.824 2.578 . . . . 0.0 107.577 -175.741 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.25 -53.55 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 127.216 2.206 . . . . 0.0 110.649 171.244 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -60.71 -37.83 83.02 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.278 1.831 . . . . 0.0 112.26 176.611 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.59 -10.08 59.13 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 115.236 -2.316 . . . . 0.0 109.88 178.898 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -91.34 -36.93 13.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.55 2.74 . . . . 0.0 108.996 178.925 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.4 mt -65.54 -40.17 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 128.785 2.834 . . . . 0.0 108.718 170.791 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.466 ' HA ' ' H ' ' A' ' 36' ' ' ILE . 38.5 tt0 -52.53 -47.43 66.71 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.32 -2.737 . . . . 0.0 116.282 167.061 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.58 -41.42 92.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 120.937 1.699 . . . . 0.0 115.171 172.175 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -78.01 -37.17 47.69 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.675 1.234 . . . . 0.0 112.837 -176.726 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.35 28.8 mm-40 -124.37 -33.72 3.0 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 -169.197 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.97 39.71 1.95 Allowed Glycine 0 CA--C 1.527 0.841 1 O-C-N 115.279 -4.638 . . . . 0.0 116.127 162.709 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.466 ' H ' ' HA ' ' A' ' 31' ' ' GLN . 8.4 mt -123.36 135.72 26.34 Favored Pre-proline 0 N--CA 1.451 -0.424 0 O-C-N 118.316 -2.873 . . . . 0.0 108.592 179.159 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -76.89 137.16 17.38 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 O-C-N 125.42 2.274 . . . . 0.0 113.249 -177.967 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -44.9 -30.24 4.3 Favored 'Trans proline' 0 N--CA 1.446 -1.292 1 C-N-CA 126.161 4.574 . . . . 0.0 118.903 -177.204 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.2 -10.83 56.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -168.151 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -98.21 -3.19 38.03 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 129.476 3.111 . . . . 0.0 112.596 175.639 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.255 64.6 mt-30 -107.94 132.9 53.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 123.63 2.923 . . . . 0.0 104.332 -172.191 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -113.96 129.95 56.56 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 119.921 -1.737 . . . . 0.0 109.842 149.965 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.5 mt -101.36 120.58 40.48 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.586 1.955 . . . . 0.0 108.128 170.262 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mm -97.63 131.59 44.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 113.076 -3.345 . . . . 0.0 109.832 172.959 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -111.89 136.38 51.27 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 124.638 3.381 . . . . 0.0 104.795 152.897 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.0 -99.95 0.1 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.205 1.402 . . . . 0.0 112.228 -169.98 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.84 25.08 3.77 Favored Glycine 0 CA--C 1.523 0.558 1 C-N-CA 131.581 4.42 . . . . 0.0 113.341 159.646 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -93.82 111.35 23.03 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 118.144 -2.974 . . . . 0.0 107.563 175.82 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -76.17 97.17 4.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 127.693 3.121 . . . . 0.0 112.857 175.818 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.81 127.92 33.51 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 126.819 2.575 . . . . 0.0 113.234 -171.384 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -104.77 132.08 51.46 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 131.358 3.863 . . . . 0.0 113.748 -169.915 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.6 123.01 17.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 130.775 3.63 . . . . 0.0 109.116 -179.128 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.72 -6.87 20.12 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 120.359 1.436 . . . . 0.0 111.475 -177.1 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -122.16 173.62 7.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 170.821 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -115.37 175.63 5.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 117.894 -3.004 . . . . 0.0 113.635 -168.886 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.1 mt -75.6 -30.3 59.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 123.258 1.504 . . . . 0.0 111.864 172.401 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -58.98 -36.2 74.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.905 1.336 . . . . 0.0 112.288 170.727 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -69.9 -41.98 74.0 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 119.252 -2.155 . . . . 0.0 108.788 -174.179 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -84.85 10.89 10.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 175.552 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 58.96 35.58 24.16 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 129.058 2.943 . . . . 0.0 111.418 172.051 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.2 mt -88.78 142.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 -173.816 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.304 3.4 pm0 -137.63 -166.22 1.91 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.811 2.045 . . . . 0.0 114.104 -162.677 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -60.81 131.83 51.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 128.861 2.864 . . . . 0.0 110.392 174.255 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.397 0.8 OUTLIER 86.36 17.06 0.11 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 127.614 3.578 . . . . 0.0 115.648 175.926 . . . . . . . . 3 3 . 1 . 106 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.8 p -83.58 127.94 34.13 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 118.216 -2.803 . . . . 0.0 112.099 -178.346 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.1 m -107.1 114.65 28.86 Favored 'General case' 0 N--CA 1.445 -0.716 1 C-N-CA 132.383 4.273 . . . . 0.0 108.697 172.724 . . . . . . . . 2 2 . 1 . 106 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -100.48 130.26 46.54 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.627 1.571 . . . . 0.0 109.016 174.895 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -102.3 127.97 49.05 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 128.852 2.861 . . . . 0.0 107.155 -170.399 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -93.69 150.72 20.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 122.22 2.282 . . . . 0.0 105.889 175.321 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.4 p -141.32 141.61 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 130.088 3.355 . . . . 0.0 107.37 163.894 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt -77.4 154.95 32.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 121.092 1.769 . . . . 0.0 110.615 175.358 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -97.57 117.97 33.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 103.044 -2.947 . . . . 0.0 103.044 168.714 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.7 mt -135.82 -5.19 2.19 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 125.176 1.547 . . . . 0.0 114.249 -171.267 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -153.25 136.55 15.75 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.844 3.257 . . . . 0.0 117.96 168.083 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.17 -168.36 14.76 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 106.248 -2.741 . . . . 0.0 106.248 175.318 . . . . . . . . 1 1 . 1 . 106 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.463 1 O-C-N 116.177 -4.131 . . . . 0.0 103.5 168.166 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 123.465 1.602 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 107 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -101.32 134.45 44.36 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.922 -1.111 . . . . 0.0 113.823 163.753 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.312 2.1 pp -124.82 146.96 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.774 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -105.73 133.83 49.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 123.797 1.76 . . . . 0.0 108.898 177.004 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.09 133.97 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 174.632 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -108.38 122.24 46.6 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 111.848 -2.433 . . . . 0.0 109.843 178.026 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -80.42 153.25 28.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 123.557 1.646 . . . . 0.0 110.161 179.627 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.36 -25.66 63.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.45 2.3 . . . . 0.0 112.383 -174.738 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.3 p -100.63 19.64 16.59 Favored 'General case' 0 CA--C 1.538 0.494 1 C-N-CA 132.943 4.497 . . . . 0.0 115.692 173.374 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.93 21.61 11.83 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-O 115.136 -3.036 . . . . 0.0 117.535 137.457 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.353 55.2 mttt -103.78 171.11 7.53 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 128.356 2.663 . . . . 0.0 115.966 169.623 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -128.22 103.92 7.45 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 130.366 3.466 . . . . 0.0 108.92 169.931 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.4 mm -81.11 117.51 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 128.629 2.771 . . . . 0.0 112.469 177.469 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.269 22.9 m -93.97 105.52 17.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.102 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -88.78 159.33 17.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 172.183 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -107.35 133.89 51.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 124.422 2.058 . . . . 0.0 107.224 165.253 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 m -139.51 -179.09 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 119.895 -1.753 . . . . 0.0 110.795 178.537 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -140.05 155.11 70.86 Favored Pre-proline 0 N--CA 1.451 -0.407 0 C-N-CA 130.208 3.403 . . . . 0.0 104.195 171.955 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.47 -38.33 53.22 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-O 115.538 -1.942 . . . . 0.0 116.39 -175.851 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -77.75 -9.42 59.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 124.542 1.151 . . . . 0.0 111.494 -170.877 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.67 135.9 52.09 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 125.041 2.353 . . . . 0.0 109.743 179.304 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.0 p -78.38 153.94 31.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 129.737 3.215 . . . . 0.0 111.257 -168.22 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.3 -17.59 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.33 -0.856 . . . . 0.0 108.934 -178.54 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -78.04 -44.15 27.26 Favored 'General case' 0 N--CA 1.448 -0.549 1 O-C-N 116.254 -4.029 . . . . 0.0 108.021 -179.506 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -62.86 -50.26 71.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 112.93 -3.414 . . . . 0.0 114.552 166.351 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.9 t -52.99 -40.65 37.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 121.828 2.104 . . . . 0.0 111.375 177.032 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -42.04 -35.78 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 115.98 1.845 . . . . 0.0 115.98 166.182 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.73 -28.06 14.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 120.363 1.438 . . . . 0.0 108.69 -177.207 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -60.92 -31.69 71.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 117.887 -3.008 . . . . 0.0 118.29 168.264 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.285 1.5 tt -70.87 -40.76 76.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 167.993 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.26 -36.41 75.45 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 175.54 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -74.19 -10.69 59.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.902 0.774 . . . . 0.0 112.626 -170.928 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -77.7 0.22 Allowed 'General case' 0 C--O 1.235 0.338 1 C-N-CA 132.385 4.274 . . . . 0.0 116.603 159.699 . . . . . . . . 3 3 . 1 . 107 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -98.54 -3.38 36.56 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.265 -0.897 . . . . 0.0 113.259 -162.777 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.01 7.95 86.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 117.906 -2.092 . . . . 0.0 117.36 171.14 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.5 mt -74.71 120.65 82.58 Favored Pre-proline 0 N--CA 1.454 -0.237 1 C-N-CA 132.704 4.402 . . . . 0.0 109.206 178.65 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -74.51 141.0 27.61 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 CA-C-O 115.164 -2.098 . . . . 0.0 112.989 -175.203 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.23 -7.14 20.47 Favored 'Trans proline' 0 N--CA 1.447 -1.264 1 C-N-CA 127.443 5.429 . . . . 0.0 116.531 -178.408 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -74.34 -9.82 58.98 Favored 'General case' 0 N--CA 1.446 -0.644 1 O-C-N 115.13 -4.731 . . . . 0.0 113.424 168.779 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -119.47 -8.49 10.01 Favored 'General case' 0 C--N 1.323 -0.56 1 C-N-CA 134.56 5.144 . . . . 0.0 114.146 -175.468 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 11.4 mt-30 -90.35 152.79 20.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 119.989 -1.694 . . . . 0.0 111.598 168.638 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttp-105 -128.05 122.09 31.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 115.028 -2.415 . . . . 0.0 109.849 156.794 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.84 115.51 20.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.635 1.561 . . . . 0.0 106.949 172.117 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.3 mt -116.26 134.85 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 116.418 -1.754 . . . . 0.0 106.7 167.299 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -88.29 -49.88 6.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.277 1.399 . . . . 0.0 108.299 -175.653 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.51 -44.32 0.1 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.221 -1.371 . . . . 0.0 114.566 -177.213 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.3 -11.21 4.75 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 118.685 2.234 . . . . 0.0 118.685 152.443 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -143.18 160.22 40.85 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.961 1.304 . . . . 0.0 112.686 -161.85 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -78.96 142.87 36.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 125.462 1.726 . . . . 0.0 113.646 -159.366 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.8 mp -85.83 109.32 18.61 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.174 -3.454 . . . . 0.0 106.652 170.496 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -71.44 128.55 36.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.592 2.757 . . . . 0.0 111.126 -175.438 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -52.68 122.42 9.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 124.836 2.255 . . . . 0.0 112.647 166.328 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.1 19.48 5.92 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 118.683 -2.51 . . . . 0.0 110.815 173.848 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.323 26.8 mtt-85 -127.21 170.89 11.94 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 130.643 3.577 . . . . 0.0 113.992 -179.652 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -118.03 162.9 17.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 130.051 3.341 . . . . 0.0 117.893 174.939 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.69 -41.69 56.12 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 122.659 2.481 . . . . 0.0 113.012 173.974 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 t -60.82 -22.24 63.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 118.502 2.778 . . . . 0.0 118.502 -178.739 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -69.23 -37.93 78.25 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 120.792 -1.192 . . . . 0.0 113.677 168.999 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -98.54 -1.38 41.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.972 2.109 . . . . 0.0 112.564 -175.264 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 74.31 14.19 3.74 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 129.454 3.102 . . . . 0.0 112.149 168.217 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.267 90.1 mt -55.41 125.45 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 124.082 0.953 . . . . 0.0 113.102 178.743 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -131.89 167.49 19.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.794 2.838 . . . . 0.0 112.271 -176.191 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.326 41.3 pttt -34.57 119.03 0.43 Allowed 'General case' 0 N--CA 1.447 -0.605 1 C-N-CA 132.999 4.52 . . . . 0.0 116.114 -178.122 . . . . . . . . 3 2 . 1 . 107 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 63.94 25.44 13.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 179.507 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 m -70.46 121.41 17.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 115.305 -2.283 . . . . 0.0 107.752 160.189 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -95.87 119.37 34.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 125.725 1.891 . . . . 0.0 107.532 174.896 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.21 147.0 26.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 128.683 2.793 . . . . 0.0 105.574 179.858 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -95.49 154.37 17.24 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 101.374 -3.565 . . . . 0.0 101.374 174.557 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.82 114.55 20.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 125.37 2.51 . . . . 0.0 112.875 161.35 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.7 t -79.86 152.47 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 129.905 3.282 . . . . 0.0 111.391 165.724 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -116.21 147.22 41.66 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 124.022 1.868 . . . . 0.0 106.848 -174.062 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -72.09 115.86 11.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.109 -1.86 . . . . 0.0 108.77 166.148 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.306 30.0 tp -143.47 140.89 30.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 118.406 -2.684 . . . . 0.0 104.881 -173.738 . . . . . . . . 2 2 . 1 . 107 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -107.7 133.77 51.64 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.709 2.404 . . . . 0.0 112.8 179.422 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.47 177.42 25.92 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 130.138 3.732 . . . . 0.0 109.592 175.703 . . . . . . . . 1 1 . 1 . 107 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.804 1 C-N-CA 134.239 5.685 . . . . 0.0 108.779 172.67 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptt? . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 . . . . . . . . . 0 0 . 1 . 108 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -86.5 157.4 19.79 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 124.404 1.065 . . . . 0.0 110.487 166.294 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.24 158.64 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 128.504 2.722 . . . . 0.0 106.531 155.142 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -113.54 138.13 50.59 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.694 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.4 115.75 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 1 C-N-CA 133.857 4.863 . . . . 0.0 107.738 170.08 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -84.56 135.32 34.26 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.563 1.545 . . . . 0.0 108.863 170.997 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -82.55 169.08 16.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 126.93 2.644 . . . . 0.0 108.118 158.615 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.99 -21.25 24.94 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.062 2.145 . . . . 0.0 109.569 178.848 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 p -68.9 -30.92 69.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 116.329 -3.982 . . . . 0.0 114.764 163.285 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.11 5.96 5.5 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 125.723 3.874 . . . . 0.0 113.639 161.653 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -88.85 130.32 35.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 117.79 -3.182 . . . . 0.0 107.391 175.353 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.8 m -89.17 128.52 35.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 124.962 2.315 . . . . 0.0 107.85 160.997 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.71 135.31 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 1 O-C-N 114.751 -4.968 . . . . 0.0 103.004 173.836 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.4 m -99.9 138.1 37.44 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 127.926 3.266 . . . . 0.0 104.023 176.18 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 53.9 mt -131.28 142.38 50.11 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.652 1.981 . . . . 0.0 110.432 178.005 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -124.5 110.6 14.68 Favored 'General case' 0 C--N 1.322 -0.622 2 O-C-N 115.748 -4.345 . . . . 0.0 110.35 -170.601 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.44 158.82 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 110.424 -3.08 . . . . 0.0 114.485 -163.022 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -96.39 153.5 38.91 Favored Pre-proline 0 N--CA 1.447 -0.598 0 O-C-N 127.53 3.019 . . . . 0.0 106.946 160.334 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -76.46 -6.66 17.27 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 118.72 2.546 . . . . 0.0 118.72 -170.616 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 m -94.44 7.14 46.57 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.484 1.514 . . . . 0.0 107.624 174.405 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CG ' HD21 ' A' ' 25' ' ' ASN . 16.4 t0 -80.95 137.37 36.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 116.986 -3.571 . . . . 0.0 109.76 171.829 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -92.13 149.41 21.5 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 118.185 -2.822 . . . . 0.0 106.839 -156.351 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mp -46.86 -31.92 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 127.684 2.394 . . . . 0.0 114.569 169.673 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.27 -28.29 66.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.495 -1.378 . . . . 0.0 111.342 179.676 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.455 HD21 ' CG ' ' A' ' 21' ' ' ASP . 63.6 t30 -81.32 -33.82 32.28 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 119.534 -1.979 . . . . 0.0 114.42 170.451 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.301 39.5 t -59.24 -44.98 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 116.592 -1.67 . . . . 0.0 108.518 170.117 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.9 mttt -50.66 -38.74 48.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.176 2.658 . . . . 0.0 118.176 172.793 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.9 -23.89 31.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 123.623 0.577 . . . . 0.0 112.096 -168.507 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 30.9 mttm -73.08 -29.43 62.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 118.96 -2.338 . . . . 0.0 111.698 175.441 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -70.64 -52.69 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 129.512 3.125 . . . . 0.0 105.943 178.301 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.372 1.1 tp-100 -34.23 -45.24 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 1 O-C-N 115.008 -4.807 . . . . 0.0 119.386 162.088 . . . . . . . . 3 2 . 1 . 108 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -73.71 -44.96 54.99 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 131.289 3.836 . . . . 0.0 109.953 -178.584 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -74.02 -47.35 37.56 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 119.833 3.272 . . . . 0.0 119.833 -177.275 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -135.6 11.8 3.45 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 117.906 -1.045 . . . . 0.0 113.701 -177.205 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.71 -8.38 75.74 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 157.485 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.6 mt -58.71 131.74 85.97 Favored Pre-proline 0 N--CA 1.449 -0.497 1 C-N-CA 134.744 5.218 . . . . 0.0 107.404 173.544 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -80.3 150.51 19.91 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.947 1.098 . . . . 0.0 112.392 -178.574 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.18 -30.83 10.14 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 124.211 3.274 . . . . 0.0 116.985 -175.997 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.38 -3.58 31.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -166.549 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -99.99 -31.15 11.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -173.483 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -75.76 118.01 18.11 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.699 1.6 . . . . 0.0 112.631 -159.407 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -102.11 113.43 26.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 130.77 3.628 . . . . 0.0 105.976 158.407 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.82 150.36 24.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 121.615 2.007 . . . . 0.0 106.932 166.929 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.28 15.2 mt -126.63 139.62 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.905 176.187 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -139.82 115.73 10.27 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 128.101 2.56 . . . . 0.0 109.412 177.659 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 74.56 20.86 2.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.961 2.504 . . . . 0.0 108.262 167.587 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.84 -3.17 73.67 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 130.323 3.821 . . . . 0.0 110.413 -175.141 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -96.66 134.2 40.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 121.516 2.658 . . . . 0.0 106.54 -170.411 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.5 pm0 -80.56 132.07 35.61 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 126.356 2.285 . . . . 0.0 108.843 172.312 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.426 HD21 ' CD2' ' A' ' 59' ' ' TYR . 25.6 mt -95.57 155.42 16.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 125.206 2.432 . . . . 0.0 112.209 -172.921 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -118.16 157.01 27.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 112.784 -2.007 . . . . 0.0 109.088 -178.215 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -77.59 137.97 38.87 Favored 'General case' 0 N--CA 1.444 -0.726 1 O-C-N 129.996 4.56 . . . . 0.0 112.589 -172.804 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.67 -21.23 46.97 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 177.905 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.41 ' CZ ' ' HA ' ' A' ' 54' ' ' ARG . 8.1 mmp_? -84.78 169.93 13.71 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 127.179 2.191 . . . . 0.0 112.239 168.83 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.406 ' HG1' ' CG ' ' A' ' 58' ' ' ASP . 52.7 p -110.55 163.52 13.63 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.179 1.792 . . . . 0.0 110.461 -162.159 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.435 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 5.7 mt -43.48 -47.51 7.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.867 1.667 . . . . 0.0 111.937 152.899 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -63.78 -38.95 93.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.532 1.933 . . . . 0.0 113.109 -170.682 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' CG ' ' HG1' ' A' ' 55' ' ' THR . 74.4 m-20 -64.53 -45.15 88.42 Favored 'General case' 0 C--N 1.327 -0.376 1 C-N-CA 133.589 4.756 . . . . 0.0 109.123 -178.992 . . . . . . . . 3 3 . 1 . 108 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.426 ' CD2' HD21 ' A' ' 50' ' ' LEU . 35.5 m-85 -96.26 12.13 32.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 124.157 1.932 . . . . 0.0 109.328 -174.654 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.19 42.62 27.9 Favored 'General case' 0 N--CA 1.444 -0.739 2 C-N-CA 132.492 4.317 . . . . 0.0 114.903 175.858 . . . . . . . . 3 3 . 1 . 108 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 mt -93.71 101.7 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 -172.349 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -94.77 177.93 5.75 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.166 -1.379 . . . . 0.0 113.54 -176.604 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -49.01 142.04 7.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.306 3.042 . . . . 0.0 117.136 -174.77 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 88.3 mt-10 63.76 11.38 5.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 120.17 3.396 . . . . 0.0 120.17 179.005 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -73.52 143.77 46.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.445 -177.586 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.8 m -92.29 139.34 30.71 Favored 'General case' 0 N--CA 1.442 -0.848 1 C-N-CA 132.193 4.197 . . . . 0.0 108.194 178.043 . . . . . . . . 2 2 . 1 . 108 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.68 158.05 42.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 130.236 3.415 . . . . 0.0 111.56 169.215 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -126.01 148.54 49.26 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 128.231 2.612 . . . . 0.0 109.409 163.618 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 0.6 OUTLIER -98.41 130.37 45.04 Favored 'General case' 0 N--CA 1.451 -0.378 1 C-N-CA 132.329 4.252 . . . . 0.0 109.494 167.383 . . . . . . . . 4 3 . 1 . 108 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -103.44 136.37 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.045 164.749 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 mt -93.67 122.97 36.67 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 129.682 3.193 . . . . 0.0 110.638 178.506 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -161.24 112.73 1.79 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.997 172.513 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.76 147.21 39.45 Favored 'General case' 0 CA--C 1.535 0.381 1 C-N-CA 132.185 4.194 . . . . 0.0 109.683 177.062 . . . . . . . . 3 3 . 1 . 108 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.4 ttm105 -72.77 113.09 9.41 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 127.837 2.455 . . . . 0.0 112.228 -175.779 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.67 158.52 14.24 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 118.738 -2.476 . . . . 0.0 109.855 175.868 . . . . . . . . 1 1 . 1 . 108 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.327 0 CA-C-O 114.499 -3.389 . . . . 0.0 104.687 -175.493 . . . . . . . . 0 0 . 1 . 109 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 . . . . . . . . . 0 0 . 1 . 109 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.298 8.8 tt0 -88.62 144.15 26.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 125.718 2.675 . . . . 0.0 108.393 -175.092 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.26 149.38 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 111.214 -2.721 . . . . 0.0 108.848 -179.154 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -88.66 144.15 26.47 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 127.843 2.457 . . . . 0.0 113.965 168.102 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.09 99.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 118.187 -2.821 . . . . 0.0 104.147 -174.154 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -77.05 99.62 5.39 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 167.789 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.4 p -72.04 173.15 8.83 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 126.553 2.408 . . . . 0.0 114.47 166.447 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -40.19 -40.68 1.16 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 129.494 3.118 . . . . 0.0 118.815 -168.352 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.1 p -80.83 -6.43 58.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 171.864 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.71 0.6 60.54 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 123.85 1.806 . . . . 0.0 113.764 -170.369 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -69.22 106.58 2.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.919 -1.641 . . . . 0.0 108.014 -173.848 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.7 m -79.39 112.38 16.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 110.19 -3.187 . . . . 0.0 111.844 -178.304 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mt -110.75 137.27 43.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 1 CA-C-N 106.954 -4.657 . . . . 0.0 109.485 173.214 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.8 m -100.41 125.09 46.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 179.912 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tp -133.73 159.94 39.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 128.665 2.786 . . . . 0.0 110.408 -172.845 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -128.46 155.72 44.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 175.247 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.22 151.3 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 O-C-N 126.336 2.273 . . . . 0.0 107.599 -175.02 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -100.13 136.78 20.02 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 100.953 -3.721 . . . . 0.0 100.953 173.189 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -34.36 -42.01 0.27 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 1 C-N-CA 128.003 5.802 . . . . 0.0 119.326 174.228 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 p -79.3 -13.24 59.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 114.257 -2.782 . . . . 0.0 116.036 179.562 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -47.94 125.52 9.08 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.796 2.038 . . . . 0.0 112.354 -179.468 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.9 p -69.39 151.7 45.82 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.911 2.485 . . . . 0.0 111.917 163.067 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.6 mm -63.31 -32.72 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 124.029 3.104 . . . . 0.0 119.151 -174.445 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -54.9 -33.05 61.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.057 2.143 . . . . 0.0 113.339 158.104 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -79.56 -15.67 57.27 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.662 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -82.72 -48.92 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 118.941 -2.349 . . . . 0.0 109.364 169.159 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -60.29 -27.93 67.69 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.275 0.984 . . . . 0.0 113.575 176.309 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.37 -23.43 43.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 118.786 -2.446 . . . . 0.0 116.963 176.699 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -78.24 -47.4 18.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.151 175.725 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.263 26.2 mt -51.02 -40.45 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 O-C-N 128.45 3.594 . . . . 0.0 109.977 169.367 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.62 -62.43 1.86 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.623 1.969 . . . . 0.0 114.024 179.441 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -43.38 -23.7 0.07 Allowed 'General case' 0 N--CA 1.45 -0.436 1 C-N-CA 136.039 5.735 . . . . 0.0 116.699 -178.385 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -96.78 -12.23 23.93 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 131.526 3.931 . . . . 0.0 117.513 179.194 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -160.16 -16.83 0.06 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 122.948 2.613 . . . . 0.0 110.346 -179.082 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.66 11.87 22.19 Favored Glycine 0 CA--C 1.524 0.644 1 C-N-CA 113.679 -4.105 . . . . 0.0 111.401 162.477 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.59 127.61 28.16 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 121.35 2.575 . . . . 0.0 108.457 -170.352 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -68.13 147.3 72.81 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 CA-C-O 114.644 -2.315 . . . . 0.0 111.792 -172.154 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.252 71.3 Cg_exo -44.67 -38.4 12.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 O-C-N 126.711 2.953 . . . . 0.0 117.409 167.887 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.98 -24.79 55.96 Favored 'General case' 0 C--N 1.325 -0.469 1 C-N-CA 131.896 4.078 . . . . 0.0 113.433 179.439 . . . . . . . . 3 3 . 1 . 109 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -110.29 -28.38 8.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 125.709 1.881 . . . . 0.0 110.136 -178.258 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -60.49 104.58 0.35 Allowed 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 119.942 -1.724 . . . . 0.0 111.557 177.668 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -110.56 128.57 55.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 130.205 3.402 . . . . 0.0 102.689 179.885 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 99.29 3.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -157.929 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.8 mm -99.2 128.04 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 -166.153 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.412 ' CE2' HG12 ' A' ' 61' ' ' ILE . 61.7 t80 -146.5 109.66 4.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 -177.928 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 79.99 35.21 0.15 Allowed 'General case' 0 CA--C 1.53 0.178 0 O-C-N 125.496 1.748 . . . . 0.0 109.779 178.355 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.67 -10.51 70.68 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 114.784 -3.579 . . . . 0.0 109.572 169.46 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.259 19.6 pttt -143.89 145.36 32.24 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.723 -2.633 . . . . 0.0 106.208 -161.796 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -72.2 135.25 46.05 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.701 2.4 . . . . 0.0 107.632 -175.977 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.76 107.65 19.07 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.842 1.657 . . . . 0.0 110.464 -179.445 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -114.75 161.57 17.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.412 -2.055 . . . . 0.0 105.862 -159.751 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.0 149.94 30.58 Favored 'General case' 0 N--CA 1.447 -0.61 1 C-N-CA 133.458 4.703 . . . . 0.0 107.423 -178.216 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.86 -21.71 31.39 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 169.584 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -101.49 157.58 16.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.715 2.806 . . . . 0.0 108.577 -172.513 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.0 p -113.83 174.94 5.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.991 0.9 . . . . 0.0 109.43 163.662 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.0 mt -53.27 -38.01 62.66 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 176.753 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -60.82 -22.98 64.73 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 167.915 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -86.71 -0.23 55.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 118.446 -2.659 . . . . 0.0 113.94 -178.557 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -138.0 -6.54 1.64 Allowed 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 117.867 -3.021 . . . . 0.0 110.976 172.735 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 67.12 71.37 0.37 Allowed 'General case' 0 N--CA 1.442 -0.855 1 C-N-CA 133.467 4.707 . . . . 0.0 110.3 -177.987 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.412 HG12 ' CE2' ' A' ' 45' ' ' PHE . 70.4 mt -120.18 135.54 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 -177.95 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.264 11.9 pt20 -152.27 -166.61 2.53 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 126.005 2.066 . . . . 0.0 109.936 173.15 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -50.53 142.13 11.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.787 1.635 . . . . 0.0 114.034 -174.373 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 11.4 tp10 89.15 -8.35 0.43 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.543 1.537 . . . . 0.0 114.004 164.404 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -62.84 151.55 38.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 118.24 2.682 . . . . 0.0 118.24 170.128 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -106.8 118.01 35.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 171.802 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.5 mt -89.5 143.93 26.43 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 128.53 2.732 . . . . 0.0 105.592 167.596 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.37 25.6 p80 -133.78 135.76 44.08 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 116.261 -1.828 . . . . 0.0 109.274 -174.457 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.5 154.51 40.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 124.566 1.166 . . . . 0.0 112.561 -164.727 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.48 -179.8 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 131.422 3.889 . . . . 0.0 110.358 169.013 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.311 4.4 mp -93.92 144.17 25.69 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.288 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -89.65 129.81 36.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.405 163.618 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.5 mt -136.39 37.25 2.71 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 -169.824 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -136.97 -74.29 0.43 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 -179.348 . . . . . . . . 1 1 . 1 . 109 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.3 152.8 8.85 Favored Glycine 0 CA--C 1.525 0.681 1 C-N-CA 130.845 4.069 . . . . 0.0 112.01 -177.973 . . . . . . . . 2 2 . 1 . 109 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.329 0 C-N-CA 126.279 1.895 . . . . 0.0 112.252 -172.762 . . . . . . . . 0 0 . 1 . 110 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 115.283 -2.294 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 110 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -81.46 142.22 33.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 123.538 1.637 . . . . 0.0 107.079 167.401 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pt -127.91 152.63 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 116.268 -1.825 . . . . 0.0 107.466 161.675 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -94.11 142.71 27.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 115.627 -2.429 . . . . 0.0 111.897 172.648 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.29 53.1 t -114.68 83.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 1 C-N-CA 132.829 4.452 . . . . 0.0 108.204 169.2 . . . . . . . . 3 2 . 1 . 110 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -64.03 130.83 45.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 110.071 -3.24 . . . . 0.0 109.812 172.255 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -132.65 154.26 50.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.783 0.833 . . . . 0.0 110.306 -176.868 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.469 HD11 ' H ' ' A' ' 8' ' ' LEU . 5.8 mp -42.2 -27.2 0.13 Allowed 'General case' 0 N--CA 1.444 -0.74 1 C-N-CA 133.295 4.638 . . . . 0.0 121.031 -170.271 . . . . . . . . 3 3 . 1 . 110 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 39.1 p -119.17 17.01 13.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.229 -161.147 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.33 24.56 23.9 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 130.312 3.815 . . . . 0.0 112.217 171.127 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -105.4 160.2 15.32 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.932 1.366 . . . . 0.0 107.604 173.62 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -127.89 113.86 16.44 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.515 2.326 . . . . 0.0 113.493 174.681 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -90.67 133.86 31.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 116.466 -3.896 . . . . 0.0 103.843 -179.137 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 t -141.72 83.09 1.84 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 127.508 3.528 . . . . 0.0 112.698 -170.534 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.57 150.38 20.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.011 -2.359 . . . . 0.0 111.488 179.216 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -94.93 118.55 31.99 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 101.88 -3.378 . . . . 0.0 101.88 179.015 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -135.18 152.21 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 123.713 0.805 . . . . 0.0 109.085 -176.146 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -106.51 160.0 27.82 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 173.343 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.328 40.9 Cg_endo -66.92 -24.38 46.1 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.388 2.726 . . . . 0.0 115.269 -168.186 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.1 p -84.57 -4.97 59.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 120.608 3.558 . . . . 0.0 120.608 -174.483 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -69.77 132.25 45.79 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 126.414 2.321 . . . . 0.0 109.624 176.727 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -69.82 147.92 49.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 126.857 3.218 . . . . 0.0 105.996 171.727 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mm -59.58 -34.42 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 110.059 -3.246 . . . . 0.0 114.208 179.8 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.65 -30.66 65.99 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 121.897 2.135 . . . . 0.0 111.16 178.605 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -74.81 -26.54 59.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 125.469 1.731 . . . . 0.0 113.736 174.026 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.5 t -78.42 -24.83 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 121.251 1.841 . . . . 0.0 108.399 173.149 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -67.6 -39.8 84.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 123.562 2.892 . . . . 0.0 112.146 164.896 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.64 -31.7 70.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.71 2.004 . . . . 0.0 110.907 179.244 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -71.04 -10.72 60.24 Favored 'General case' 0 N--CA 1.451 -0.42 1 C-N-CA 134.574 5.149 . . . . 0.0 114.183 176.026 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.1 -27.61 4.36 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 127.563 2.345 . . . . 0.0 108.664 176.375 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -54.74 -27.09 38.43 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 123.064 2.666 . . . . 0.0 115.072 174.287 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -33.82 65.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 123.94 1.829 . . . . 0.0 108.474 179.078 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mmtm -96.49 -51.63 4.27 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.547 2.739 . . . . 0.0 107.085 -164.268 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -113.79 -12.17 12.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -173.45 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.42 -16.45 58.97 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 120.562 1.528 . . . . 0.0 111.584 173.11 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.2 mt -87.51 123.21 69.94 Favored Pre-proline 0 N--CA 1.449 -0.521 0 O-C-N 117.328 -3.454 . . . . 0.0 109.191 -159.209 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.03 154.78 38.0 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 O-C-N 116.349 -2.501 . . . . 0.0 108.057 179.206 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -44.73 -34.21 8.0 Favored 'Trans proline' 0 N--CA 1.441 -1.598 1 C-N-CA 126.738 4.959 . . . . 0.0 119.364 177.174 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.11 -38.26 76.13 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.62 2.768 . . . . 0.0 115.223 178.743 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.8 -8.77 57.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 103.914 -2.625 . . . . 0.0 103.914 -172.967 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -100.75 163.7 12.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 123.28 2.764 . . . . 0.0 112.356 178.324 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -144.7 160.45 41.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 109.989 -3.278 . . . . 0.0 108.547 158.338 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 mt -118.48 126.42 52.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.521 2.328 . . . . 0.0 111.623 169.748 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.4 mm -100.76 139.64 21.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 130.788 3.635 . . . . 0.0 106.952 168.296 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.558 ' CE2' HG12 ' A' ' 61' ' ' ILE . 12.2 t80 -122.89 -146.12 0.36 Allowed 'General case' 0 C--N 1.332 -0.196 0 O-C-N 126.705 2.503 . . . . 0.0 110.466 173.654 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.11 54.18 1.58 Allowed 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.32 -1.488 . . . . 0.0 110.227 -171.543 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.64 -19.04 19.45 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 117.498 -1.723 . . . . 0.0 110.987 178.451 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -112.8 138.76 49.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 126.559 3.076 . . . . 0.0 107.063 -168.831 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -88.75 123.35 33.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.04 -1.891 . . . . 0.0 108.26 165.281 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 mt -82.22 141.09 33.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 120.9 -1.125 . . . . 0.0 113.201 -174.532 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -98.25 147.62 24.44 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.774 -0.578 . . . . 0.0 110.756 -176.488 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.04 123.52 29.55 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 125.153 1.533 . . . . 0.0 106.909 -177.71 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.1 -29.65 4.08 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 128.178 2.799 . . . . 0.0 114.194 -179.692 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -84.43 154.73 22.61 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 128.408 3.064 . . . . 0.0 106.395 172.484 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -78.6 169.82 17.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 112.226 -2.261 . . . . 0.0 110.918 175.888 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.8 -17.28 63.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 119.793 -1.817 . . . . 0.0 111.467 168.684 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.5 t -92.23 -13.93 29.73 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 118.377 -2.702 . . . . 0.0 111.472 -169.653 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -50.19 -46.04 54.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 130.988 3.715 . . . . 0.0 106.217 168.413 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -101.21 16.47 25.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 123.383 1.563 . . . . 0.0 111.016 -172.159 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.342 10.9 p-10 52.21 40.84 29.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 129.338 3.055 . . . . 0.0 114.183 177.943 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.558 HG12 ' CE2' ' A' ' 45' ' ' PHE . 19.0 mt -76.72 128.64 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 125.599 2.619 . . . . 0.0 106.786 -177.619 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.07 167.64 9.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 109.073 -3.694 . . . . 0.0 111.013 -177.064 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.283 36.0 pttt -40.62 129.68 2.49 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 118.719 2.859 . . . . 0.0 118.719 162.965 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 58.65 3.03 0.26 Allowed 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 126.782 2.551 . . . . 0.0 117.71 173.189 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 t -63.16 152.9 36.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.029 1.732 . . . . 0.0 114.009 174.723 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -102.14 120.41 40.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -160.995 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.83 152.68 22.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.509 2.724 . . . . 0.0 106.502 164.477 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -123.93 137.4 54.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 126.029 2.081 . . . . 0.0 109.638 -175.472 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -118.71 132.77 56.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 119.732 -1.855 . . . . 0.0 108.006 -159.838 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 m -137.64 165.2 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 1 CA-C-N 126.181 4.082 . . . . 0.0 107.384 -170.438 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.1 tp -86.82 134.48 33.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 124.027 1.87 . . . . 0.0 109.619 -179.818 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.281 40.0 ttt180 -102.74 140.0 37.58 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 116.363 -3.96 . . . . 0.0 102.89 -179.994 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.1 mt -124.91 49.25 1.88 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 129.764 3.226 . . . . 0.0 111.492 -170.334 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 90.41 2.45 0.17 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 130.874 3.67 . . . . 0.0 105.93 167.491 . . . . . . . . 1 1 . 1 . 110 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.05 136.63 9.97 Favored Glycine 0 CA--C 1.536 1.394 1 O-C-N 115.286 -4.634 . . . . 0.0 106.634 -167.852 . . . . . . . . 2 2 . 1 . 110 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.369 1 C-N-CA 130.972 4.129 . . . . 0.0 114.823 -167.441 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 . . . . . . . . . 0 0 . 1 . 111 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -77.09 143.9 38.91 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 122.725 2.512 . . . . 0.0 112.973 -179.975 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.263 46.7 pt -140.13 168.49 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 125.756 1.91 . . . . 0.0 106.997 173.045 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.94 133.52 31.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 118.326 -2.734 . . . . 0.0 110.569 159.429 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.4 t -93.04 105.58 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 101.194 -3.632 . . . . 0.0 101.194 174.117 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -97.65 104.11 16.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 118.631 -2.543 . . . . 0.0 110.198 171.542 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -86.47 146.58 26.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 126.464 3.03 . . . . 0.0 113.74 -162.876 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.64 -28.74 65.04 Favored 'General case' 0 N--CA 1.446 -0.64 1 O-C-N 113.3 -5.875 . . . . 0.0 109.443 179.145 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.358 30.2 p -62.52 -7.46 4.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 119.667 3.21 . . . . 0.0 119.667 162.282 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.96 -5.63 11.25 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-O 114.685 -3.286 . . . . 0.0 118.4 150.489 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -120.66 160.59 22.97 Favored 'General case' 0 N--CA 1.446 -0.661 1 CA-C-N 125.422 4.611 . . . . 0.0 111.259 -177.568 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -100.39 136.9 39.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 125.441 1.713 . . . . 0.0 109.591 177.174 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mt -113.59 119.09 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.278 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -75.85 126.73 31.56 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 130.652 3.581 . . . . 0.0 106.099 169.948 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.26 160.85 39.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 124.177 1.942 . . . . 0.0 105.904 -173.481 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -125.87 131.47 52.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.076 2.151 . . . . 0.0 109.244 -178.184 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 m -137.27 169.83 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 O-C-N 127.382 2.926 . . . . 0.0 110.715 178.238 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.283 0.7 OUTLIER -112.08 146.72 35.41 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 168.382 . . . . . . . . 3 3 . 1 . 111 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -47.99 -33.39 20.29 Favored 'Trans proline' 0 N--CA 1.447 -1.233 1 C-N-CA 129.3 6.667 . . . . 0.0 115.37 158.632 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.9 p -74.47 -6.81 50.45 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 119.516 3.154 . . . . 0.0 119.516 174.279 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -73.02 130.53 40.53 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 129.204 3.002 . . . . 0.0 104.378 179.714 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -77.28 155.85 31.79 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 111.962 -2.381 . . . . 0.0 112.852 163.376 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.367 35.5 mm -49.88 -38.1 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -178.359 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.29 -29.85 62.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.216 2.606 . . . . 0.0 113.632 177.934 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -75.94 -34.62 59.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 114.562 -2.637 . . . . 0.0 108.342 172.565 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.11 -42.69 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 120.673 1.579 . . . . 0.0 111.029 175.058 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -63.59 -27.09 69.01 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 118.441 -2.662 . . . . 0.0 111.755 179.484 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.32 . . -80.21 -22.09 42.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 116.312 -1.804 . . . . 0.0 111.727 179.962 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -80.08 -23.09 41.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 113.99 -2.909 . . . . 0.0 104.903 173.617 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.2 mt -74.6 -37.4 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 166.717 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.356 51.1 tt0 -63.66 -32.29 73.73 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -178.412 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -70.65 -32.31 69.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.391 -2.186 . . . . 0.0 112.187 -177.626 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -98.7 -49.76 4.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 -169.738 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -105.43 -17.6 14.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 120.721 -1.237 . . . . 0.0 107.839 -165.148 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.52 4.73 57.1 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 120.769 -1.207 . . . . 0.0 114.178 171.208 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.1 mm -91.4 124.41 61.21 Favored Pre-proline 0 C--O 1.236 0.384 0 O-C-N 119.51 -2.171 . . . . 0.0 110.83 -169.904 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -66.5 141.69 62.18 Favored 'Trans proline' 0 N--CA 1.446 -1.274 1 C-N-CA 128.618 6.212 . . . . 0.0 107.077 -175.202 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.42 -35.48 39.26 Favored 'Trans proline' 0 N--CA 1.445 -1.379 1 C-N-CA 129.286 6.657 . . . . 0.0 108.884 -174.089 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -41.55 -46.83 3.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 166.032 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -79.28 -34.38 42.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 125.891 1.994 . . . . 0.0 113.893 -178.678 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -69.79 145.24 52.31 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 -179.027 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.09 150.82 39.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.022 -1.942 . . . . 0.0 110.008 165.814 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.0 tp -117.75 123.51 46.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 124.351 3.25 . . . . 0.0 103.916 -177.977 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mm -125.25 129.34 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 -168.462 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.294 64.8 t80 -151.14 109.78 3.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 116.153 -1.88 . . . . 0.0 115.608 172.112 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.529 . . 90.52 42.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 124.772 2.225 . . . . 0.0 113.033 171.903 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.88 -0.09 89.11 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 117.097 -3.502 . . . . 0.0 119.261 179.458 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -142.58 150.13 39.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 110.598 -2.801 . . . . 0.0 113.135 -165.127 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 0.0 OUTLIER -73.94 126.77 31.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 115.267 -2.301 . . . . 0.0 110.958 170.136 . . . . . . . . 3 3 . 1 . 111 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.6 mt -78.04 126.48 30.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.462 2.705 . . . . 0.0 104.874 167.246 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -103.35 156.95 17.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 110.793 -2.912 . . . . 0.0 111.495 -170.706 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.39 161.24 20.19 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.407 2.283 . . . . 0.0 113.671 -178.286 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.14 -33.29 6.57 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 130.184 3.754 . . . . 0.0 112.359 173.038 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.279 88.6 mtt180 -98.59 153.4 18.69 Favored 'General case' 0 N--CA 1.451 -0.418 1 C-N-CA 135.343 5.457 . . . . 0.0 106.318 -164.037 . . . . . . . . 3 2 . 1 . 111 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.1 p -100.24 163.59 12.33 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 125.739 1.9 . . . . 0.0 108.094 175.763 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mt -49.46 -31.18 9.38 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.029 2.532 . . . . 0.0 117.632 157.25 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.7 p -71.56 -33.64 69.28 Favored 'General case' 0 N--CA 1.449 -0.494 1 O-C-N 114.955 -4.841 . . . . 0.0 107.694 175.186 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -76.46 -32.94 58.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 123.821 3.01 . . . . 0.0 107.042 -176.235 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -79.32 -19.76 49.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 115.156 -2.354 . . . . 0.0 109.147 170.178 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 72.6 43.13 0.48 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.287 2.635 . . . . 0.0 107.464 176.043 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -80.91 143.62 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 117.63 -3.169 . . . . 0.0 111.021 175.797 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -133.74 159.71 39.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 129.117 2.967 . . . . 0.0 115.66 -178.196 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.16 139.25 1.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 120.124 3.379 . . . . 0.0 120.124 -175.647 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 32.5 mt-10 69.76 28.11 4.46 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 129.574 3.15 . . . . 0.0 115.731 174.164 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.26 70.9 m -81.66 154.08 26.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 111.92 -2.4 . . . . 0.0 106.382 170.047 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.7 p -98.86 131.91 44.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 126.222 2.915 . . . . 0.0 103.32 166.915 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.03 150.52 38.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 129.654 3.181 . . . . 0.0 102.813 175.979 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.32 140.47 52.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 121.586 1.994 . . . . 0.0 113.412 -166.87 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.287 5.9 mt -91.19 139.87 30.33 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 118.76 -2.462 . . . . 0.0 112.422 165.937 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.25 145.04 33.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 129.291 3.036 . . . . 0.0 106.635 163.229 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -116.42 119.28 35.15 Favored 'General case' 0 N--CA 1.452 -0.361 1 C-N-CA 132.559 4.343 . . . . 0.0 108.916 -167.522 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -72.71 168.2 19.23 Favored 'General case' 0 C--N 1.326 -0.448 1 C-N-CA 132.293 4.237 . . . . 0.0 106.137 172.146 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.0 mt -83.75 140.07 32.32 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 111.234 -2.712 . . . . 0.0 104.263 164.33 . . . . . . . . 1 1 . 1 . 111 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 91.8 130.95 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 1 C-N-CA 132.72 4.408 . . . . 0.0 109.138 -172.88 . . . . . . . . 3 3 . 1 . 111 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.61 166.55 20.07 Favored Glycine 0 CA--C 1.522 0.516 1 C-N-CA 134.183 5.658 . . . . 0.0 108.758 -177.858 . . . . . . . . 2 2 . 1 . 111 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.262 0 CA-C-O 116.678 -2.179 . . . . 0.0 109.694 -179.568 . . . . . . . . 0 0 . 1 . 112 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 125.78 2.705 . . . . 0.0 114.836 . . . . . . . . . 0 0 . 1 . 112 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.266 12.4 mt-30 -85.49 152.79 22.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 119.549 -1.969 . . . . 0.0 110.925 167.769 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.252 18.2 pt -134.24 167.42 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 101.007 -3.701 . . . . 0.0 101.007 162.979 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -131.8 93.4 3.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.429 1.492 . . . . 0.0 108.94 -167.678 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t -90.75 110.47 22.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 101.605 -3.48 . . . . 0.0 101.605 -172.057 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -109.34 137.63 46.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.45 2.3 . . . . 0.0 112.841 177.669 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -86.14 152.45 22.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 103.228 -2.879 . . . . 0.0 103.228 179.291 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -55.06 -19.05 6.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.517 2.727 . . . . 0.0 113.357 174.514 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -94.88 2.22 55.4 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 115.548 -2.168 . . . . 0.0 115.625 170.337 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.84 -12.37 57.74 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 120.769 1.622 . . . . 0.0 114.202 163.861 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -81.45 134.44 35.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -176.234 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -125.99 122.81 36.97 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 119.803 -1.81 . . . . 0.0 108.192 -159.283 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mt -95.39 122.6 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 120.229 -1.544 . . . . 0.0 110.04 169.014 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.6 m -96.55 112.68 24.33 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 125.04 2.352 . . . . 0.0 105.613 -178.242 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.52 116.42 31.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.982 1.713 . . . . 0.0 109.242 -170.244 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -77.02 127.92 33.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 127.302 2.877 . . . . 0.0 110.129 160.785 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.262 34.5 m -138.86 157.73 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 1 C-N-CA 133.454 4.702 . . . . 0.0 115.419 -178.393 . . . . . . . . 3 2 . 1 . 112 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.285 27.1 mm-40 -112.56 158.13 38.28 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 102.844 -3.021 . . . . 0.0 102.844 156.551 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -60.6 -23.08 74.73 Favored 'Trans proline' 0 N--CA 1.447 -1.225 1 C-N-CA 126.873 5.049 . . . . 0.0 116.845 -175.919 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -83.05 -2.58 55.69 Favored 'General case' 0 N--CA 1.44 -0.944 1 C-N-CA 132.062 4.145 . . . . 0.0 113.484 -175.146 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.67 136.2 38.18 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 -174.156 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.4 p -88.89 172.64 9.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.466 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.3 mm -70.63 -34.42 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 117.5 -1.238 . . . . 0.0 108.204 -178.616 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -42.52 -46.42 4.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.838 3.255 . . . . 0.0 113.652 170.911 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -70.95 -40.31 72.07 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.984 2.113 . . . . 0.0 116.207 173.833 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -82.36 -21.54 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 O-C-N 117.974 -2.954 . . . . 0.0 108.667 -176.016 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -69.39 -42.22 75.43 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 118.749 -2.469 . . . . 0.0 115.769 170.283 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -35.21 58.22 Favored 'General case' 0 CA--C 1.535 0.403 1 O-C-N 132.228 5.955 . . . . 0.0 113.1 -179.009 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -60.28 -52.44 65.27 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 125.721 1.888 . . . . 0.0 110.403 165.594 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.344 35.9 mt -59.29 -46.13 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 114.993 -2.432 . . . . 0.0 112.917 175.969 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.377 0.0 OUTLIER -40.07 -63.05 0.65 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 126.296 2.951 . . . . 0.0 115.243 166.3 . . . . . . . . 3 3 . 1 . 112 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.296 37.0 t70 -46.86 -47.46 21.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 110.396 -3.093 . . . . 0.0 118.584 173.314 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -84.56 -39.42 18.79 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.546 1.938 . . . . 0.0 111.29 -165.574 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.63 -14.21 6.33 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 128.301 3.501 . . . . 0.0 115.735 -166.187 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.96 22.05 40.16 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.971 2.7 . . . . 0.0 112.373 176.19 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -97.35 130.53 29.3 Favored Pre-proline 0 N--CA 1.442 -0.852 0 CA-C-N 120.488 2.144 . . . . 0.0 109.83 -178.286 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -76.36 165.12 29.83 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.738 2.292 . . . . 0.0 110.23 -173.845 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.52 -47.24 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 N-CA-C 116.41 1.658 . . . . 0.0 116.41 -174.86 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -61.28 -5.07 1.41 Allowed 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 117.946 2.573 . . . . 0.0 117.946 -175.58 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -99.62 -16.68 18.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.886 1.274 . . . . 0.0 110.245 -169.919 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -88.84 132.07 34.81 Favored 'General case' 0 N--CA 1.44 -0.934 1 C-N-CA 133.171 4.588 . . . . 0.0 110.034 -166.151 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -135.93 147.75 48.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 118.003 -2.936 . . . . 0.0 105.87 163.045 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.1 mt -104.88 128.1 52.97 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 130.668 3.587 . . . . 0.0 110.958 169.768 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 mt -124.78 130.11 73.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 128.151 2.58 . . . . 0.0 107.552 165.423 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -142.46 113.46 7.56 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 119.084 -2.26 . . . . 0.0 105.928 174.331 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.17 36.02 1.16 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 120.431 1.469 . . . . 0.0 110.536 157.872 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.88 -47.18 1.41 Allowed Glycine 0 CA--C 1.523 0.571 0 CA-C-O 126.131 3.073 . . . . 0.0 116.095 -167.146 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -76.64 126.63 31.32 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 120.159 -1.789 . . . . 0.0 113.097 -166.995 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -71.52 132.83 45.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 124.928 2.299 . . . . 0.0 106.94 154.961 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.291 0.2 OUTLIER -91.92 124.88 36.36 Favored 'General case' 0 C--O 1.237 0.414 1 O-C-N 115.824 -4.297 . . . . 0.0 108.056 172.213 . . . . . . . . 4 3 . 1 . 112 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -78.15 156.19 30.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.397 2.279 . . . . 0.0 115.58 174.582 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.376 26.6 m-20 -71.44 133.49 45.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 124.345 2.021 . . . . 0.0 113.106 167.921 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.3 -11.38 39.92 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 128.544 2.973 . . . . 0.0 114.019 176.398 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -71.52 153.09 42.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 126.202 1.766 . . . . 0.0 112.217 170.78 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -99.74 143.42 29.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.291 1.837 . . . . 0.0 107.332 170.278 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.57 -33.67 76.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 -166.395 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -84.31 -23.33 30.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.008 -1.472 . . . . 0.0 114.485 -173.47 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -54.01 -36.78 63.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 126.077 2.846 . . . . 0.0 112.55 168.695 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -85.59 -6.6 59.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 128.745 2.818 . . . . 0.0 114.769 176.595 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.489 17.2 m120 89.81 15.18 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.613 1 C-N-CA 132.994 4.518 . . . . 0.0 118.116 177.719 . . . . . . . . 3 2 . 1 . 112 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.8 mt -81.96 112.82 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 116.174 -2.21 . . . . 0.0 108.296 -177.298 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -124.1 170.84 10.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 124.733 1.271 . . . . 0.0 108.144 -167.589 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.327 44.4 pttt -43.03 122.02 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.902 2.481 . . . . 0.0 115.668 -169.126 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 66.97 24.72 9.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 178.285 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.275 56.7 m -75.71 125.27 28.73 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 124.017 1.865 . . . . 0.0 110.56 170.258 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 m -84.81 131.59 34.52 Favored 'General case' 0 C--N 1.323 -0.562 1 C-N-CA 132.158 4.183 . . . . 0.0 100.831 173.487 . . . . . . . . 2 2 . 1 . 112 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -142.61 112.41 6.89 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 -164.911 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -46.13 103.52 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 113.746 -3.026 . . . . 0.0 115.407 159.446 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -96.1 102.5 14.3 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 121.531 1.969 . . . . 0.0 112.43 176.392 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.7 t -69.08 109.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 128.578 2.751 . . . . 0.0 108.909 -176.433 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 mt -81.71 110.24 16.87 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.566 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -111.41 136.48 50.5 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 130.302 3.441 . . . . 0.0 108.998 177.828 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -90.4 4.01 52.15 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -176.963 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -144.58 157.65 44.12 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 131.273 3.829 . . . . 0.0 106.917 -178.198 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.02 -12.84 11.67 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 111.842 -2.435 . . . . 0.0 111.054 -173.969 . . . . . . . . 1 1 . 1 . 112 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 1 C-N-CA 133.5 5.333 . . . . 0.0 103.546 -177.877 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptm . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 113 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -84.5 134.81 34.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 114.602 -2.618 . . . . 0.0 106.643 179.117 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.314 28.0 pt -125.86 171.53 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 1 O-C-N 129.138 4.024 . . . . 0.0 108.134 173.774 . . . . . . . . 3 2 . 1 . 113 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -132.75 143.1 49.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 163.04 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.44 113.28 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 126.307 1.843 . . . . 0.0 108.878 169.268 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -83.02 134.38 35.05 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -177.437 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.29 36.9 m -87.11 149.89 24.37 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 116.765 -1.588 . . . . 0.0 112.279 168.427 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -19.6 16.49 Favored 'General case' 0 C--N 1.324 -0.527 1 C-N-CA 132.772 4.429 . . . . 0.0 112.469 -174.734 . . . . . . . . 3 3 . 1 . 113 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 p -81.54 -15.78 53.78 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.493 1.917 . . . . 0.0 115.428 166.45 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.25 -9.86 10.96 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 114.289 -3.506 . . . . 0.0 107.302 175.821 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -80.32 122.59 27.1 Favored 'General case' 0 N--CA 1.45 -0.447 1 CA-C-N 124.951 4.375 . . . . 0.0 110.859 -175.044 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -84.7 107.65 17.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 175.96 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.07 126.76 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 120.188 -1.57 . . . . 0.0 110.37 179.093 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.3 p -89.67 133.31 34.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 121.485 1.948 . . . . 0.0 108.09 -179.544 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.5 tp -149.06 136.87 20.54 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.759 2.824 . . . . 0.0 106.444 -165.817 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -116.17 132.8 56.56 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.225 2.21 . . . . 0.0 105.56 -177.824 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -137.44 -177.96 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 129.346 3.058 . . . . 0.0 111.862 -178.745 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -119.24 153.14 53.23 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 124.97 1.308 . . . . 0.0 109.711 163.275 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.297 28.4 Cg_endo -55.52 -34.62 90.33 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 N-CA-C 121.452 3.597 . . . . 0.0 121.452 -179.929 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -75.28 -8.65 57.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 112.588 -2.097 . . . . 0.0 115.716 173.507 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.77 120.42 7.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 120.645 1.566 . . . . 0.0 110.345 174.369 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -61.76 150.26 37.44 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 120.126 -1.609 . . . . 0.0 108.511 161.711 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -59.99 -19.02 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.79 2.036 . . . . 0.0 112.99 179.731 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.14 -23.49 41.09 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.711 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -89.87 -22.11 22.2 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.085 0.954 . . . . 0.0 109.381 178.547 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.78 -40.91 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 O-C-N 126.912 2.632 . . . . 0.0 108.733 166.57 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -69.16 -20.76 64.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 114.048 -2.882 . . . . 0.0 112.77 172.093 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.82 -40.47 47.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 131.541 3.936 . . . . 0.0 111.415 174.611 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -71.34 -28.67 64.24 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.657 3.583 . . . . 0.0 109.708 178.106 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.83 -65.03 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 113.247 -3.264 . . . . 0.0 110.854 157.232 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -46.0 -31.41 2.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 126.563 2.414 . . . . 0.0 115.851 -179.457 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.72 -32.6 43.88 Favored 'General case' 0 C--N 1.329 -0.322 1 C-N-CA 131.79 4.036 . . . . 0.0 111.036 178.23 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -116.27 -39.2 3.43 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -176.823 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -83.56 -31.16 26.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 116.973 -3.579 . . . . 0.0 117.052 -169.953 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.96 -6.5 83.63 Favored Glycine 0 CA--C 1.531 1.094 0 O-C-N 120.944 -1.097 . . . . 0.0 111.126 171.478 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.251 77.1 mt -98.2 129.05 31.64 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-O 115.104 -2.379 . . . . 0.0 105.924 -175.072 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.56 155.69 68.12 Favored 'Trans proline' 0 N--CA 1.449 -1.104 1 C-N-CA 127.153 5.235 . . . . 0.0 117.807 -174.745 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.303 51.3 Cg_exo -42.21 -35.28 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.567 3.511 . . . . 0.0 117.319 170.026 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -43.17 -41.2 3.63 Favored 'General case' 0 CA--C 1.535 0.4 1 O-C-N 114.003 -5.435 . . . . 0.0 117.723 168.555 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -96.55 -6.44 36.96 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 118.244 -2.785 . . . . 0.0 114.363 -170.098 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -102.01 122.93 45.02 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.408 2.683 . . . . 0.0 110.321 175.03 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -120.49 131.42 54.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 173.153 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -118.76 129.07 55.05 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 128.716 2.807 . . . . 0.0 110.364 -175.532 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.36 148.19 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 127.689 2.396 . . . . 0.0 116.144 163.582 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -141.06 114.28 8.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 127.781 3.176 . . . . 0.0 107.509 172.925 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.71 41.37 12.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.789 -1.101 . . . . 0.0 109.626 176.891 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.75 -16.86 34.03 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 117.976 1.95 . . . . 0.0 117.976 177.118 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.365 69.1 mttt -94.5 129.17 41.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.886 1.327 . . . . 0.0 108.301 179.55 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.54 87.49 7.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 131.443 3.897 . . . . 0.0 102.444 178.887 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.5 mt -50.05 136.5 18.84 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 128.346 2.659 . . . . 0.0 115.186 -165.208 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -65.12 114.51 4.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 125.013 1.446 . . . . 0.0 112.89 171.798 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.349 0.0 OUTLIER -66.7 -4.53 9.13 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.972 2.109 . . . . 0.0 116.168 -172.942 . . . . . . . . 3 3 . 1 . 113 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.16 -0.09 16.76 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.221 1.391 . . . . 0.0 111.666 178.434 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -93.23 160.04 15.01 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 159.382 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.8 p -107.28 171.23 7.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 125.166 2.412 . . . . 0.0 108.053 -172.555 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.04 -30.54 62.46 Favored 'General case' 0 C--N 1.326 -0.45 1 O-C-N 114.698 -5.001 . . . . 0.0 109.316 -178.059 . . . . . . . . 3 3 . 1 . 113 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 t -67.06 -33.26 75.12 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 173.561 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -71.93 -23.02 61.4 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.958 2.503 . . . . 0.0 111.515 178.098 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -91.54 -3.79 56.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 170.755 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 t30 58.71 36.57 24.99 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 131.589 3.956 . . . . 0.0 114.77 179.784 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -77.08 125.33 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 O-C-N 124.955 1.409 . . . . 0.0 114.506 -173.889 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -98.51 176.24 5.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 125.082 2.372 . . . . 0.0 107.852 -170.769 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.94 117.05 3.89 Favored 'General case' 0 N--CA 1.441 -0.897 1 C-N-CA 131.708 4.003 . . . . 0.0 110.055 -177.787 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 68.79 44.23 1.15 Allowed 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 127.593 3.058 . . . . 0.0 111.944 163.491 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.1 p -100.27 157.7 16.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 125.708 2.67 . . . . 0.0 111.652 160.695 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -106.73 127.02 53.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 116.43 -3.919 . . . . 0.0 110.33 -166.766 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.36 172.38 8.79 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 129.294 3.037 . . . . 0.0 104.295 164.918 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -133.64 136.72 44.98 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.731 2.012 . . . . 0.0 109.169 -179.199 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -127.09 108.11 10.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 101.452 -3.536 . . . . 0.0 101.452 -163.907 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.34 116.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 1 O-C-N 130.375 4.797 . . . . 0.0 110.656 163.639 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -103.87 154.77 19.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 101.498 -3.519 . . . . 0.0 101.498 177.37 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.266 7.5 ttp180 -94.16 67.0 3.55 Favored 'General case' 0 C--N 1.328 -0.367 1 CA-C-N 108.209 -4.087 . . . . 0.0 101.945 159.109 . . . . . . . . 3 2 . 1 . 113 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.4 ' H ' ' CD2' ' A' ' 73' ' ' LEU 0.334 1.8 pt? -57.93 93.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 118.601 -2.562 . . . . 0.0 116.679 -170.534 . . . . . . . . 3 3 . 1 . 113 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.96 -33.15 0.42 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.869 1.267 . . . . 0.0 113.788 173.886 . . . . . . . . 2 2 . 1 . 113 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.41 -177.31 17.53 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 118.13 2.012 . . . . 0.0 118.13 175.116 . . . . . . . . 1 1 . 1 . 113 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.329 0 C-N-CA 128.112 2.768 . . . . 0.0 106.473 -178.716 . . . . . . . . 0 0 . 1 . 114 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 123.322 1.534 . . . . 0.0 108.764 . . . . . . . . . 0 0 . 1 . 114 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.256 43.6 mt-30 -113.76 128.72 56.53 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 111.373 -2.649 . . . . 0.0 112.859 -179.046 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.358 17.2 pt -144.7 138.36 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 128.286 3.491 . . . . 0.0 110.084 -175.39 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -106.28 121.23 43.79 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 127.377 2.923 . . . . 0.0 110.781 -163.823 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.65 87.46 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 172.202 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -86.88 149.0 25.12 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 117.338 -3.351 . . . . 0.0 107.268 -172.462 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.277 42.4 m -103.7 140.29 37.8 Favored 'General case' 0 N--CA 1.447 -0.595 1 C-N-CA 133.097 4.559 . . . . 0.0 105.565 175.863 . . . . . . . . 3 2 . 1 . 114 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.309 0.4 OUTLIER -46.29 -24.76 0.52 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 120.006 3.336 . . . . 0.0 120.006 -179.423 . . . . . . . . 3 3 . 1 . 114 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.29 6.9 p -94.82 5.72 51.07 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.836 2.454 . . . . 0.0 108.395 -174.982 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.19 0.18 44.3 Favored Glycine 0 CA--C 1.531 1.049 1 C-N-CA 134.76 5.933 . . . . 0.0 111.172 158.292 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -65.83 138.79 58.14 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 116.488 -3.948 . . . . 0.0 111.275 170.997 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.353 12.0 m -124.31 112.1 16.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.975 2.11 . . . . 0.0 111.553 -170.258 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 mm -100.99 148.87 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 173.313 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.353 7.1 p -129.22 128.88 44.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 111.641 -2.527 . . . . 0.0 111.151 -164.084 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.7 mt -106.38 125.56 51.15 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.849 1.26 . . . . 0.0 111.114 176.656 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -88.51 93.03 9.41 Favored 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 132.886 4.474 . . . . 0.0 107.235 162.943 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.18 162.18 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 O-C-N 118.364 -2.71 . . . . 0.0 111.06 -176.184 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.265 3.4 tp10 -115.91 135.36 22.72 Favored Pre-proline 0 N--CA 1.447 -0.6 0 N-CA-C 101.286 -3.598 . . . . 0.0 101.286 176.119 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -34.16 -40.55 0.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 1 C-N-CA 128.135 5.89 . . . . 0.0 115.148 -176.918 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -80.06 -1.37 39.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.323 2.249 . . . . 0.0 114.585 -171.505 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -65.25 135.9 55.95 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 130.746 3.618 . . . . 0.0 107.73 174.707 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -65.03 159.69 22.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.029 2.932 . . . . 0.0 112.902 171.771 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mm -74.39 -31.84 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 124.777 1.298 . . . . 0.0 110.392 178.456 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.79 -30.5 71.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 128.496 2.718 . . . . 0.0 112.203 172.965 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -80.9 -24.56 38.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 119.367 -2.083 . . . . 0.0 109.611 173.101 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 1.0 OUTLIER -72.28 -20.11 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 122.5 1.143 . . . . 0.0 111.913 175.978 . . . . . . . . 3 3 . 1 . 114 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -73.4 -43.89 59.57 Favored 'General case' 0 C--N 1.323 -0.553 1 C-N-CA 133.335 4.654 . . . . 0.0 114.031 173.854 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.62 89.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.213 2.205 . . . . 0.0 111.908 174.384 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -69.3 -10.32 57.33 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.354 2.661 . . . . 0.0 116.8 173.434 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.27 58.1 mt -94.24 -40.45 11.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 O-C-N 127.509 3.005 . . . . 0.0 109.809 163.859 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -61.48 -62.93 1.47 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 130.567 3.547 . . . . 0.0 110.333 -174.917 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -41.72 -37.92 1.32 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.109 2.564 . . . . 0.0 116.673 170.307 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -79.16 -70.6 0.49 Allowed 'General case' 0 C--N 1.32 -0.683 0 O-C-N 128.32 3.513 . . . . 0.0 118.88 167.349 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -98.24 -5.5 33.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.432 -161.342 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.11 0.32 74.37 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 126.56 2.029 . . . . 0.0 114.814 166.995 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.1 mt -79.6 133.38 59.43 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-O 113.15 -3.309 . . . . 0.0 106.41 -165.283 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.83 162.65 23.86 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 CA-C-N 126.691 3.425 . . . . 0.0 111.538 -173.586 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.83 -51.46 0.38 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 123.876 3.051 . . . . 0.0 116.573 -166.034 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.95 -11.23 55.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 126.39 2.995 . . . . 0.0 113.914 -163.984 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -96.57 -17.59 20.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 113.689 -3.053 . . . . 0.0 110.165 -172.483 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.25 139.2 30.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 126.161 2.886 . . . . 0.0 107.72 -176.332 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.26 71.2 mtt180 -131.42 142.01 49.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 128.67 2.788 . . . . 0.0 112.985 162.028 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.55 0.6 OUTLIER -133.99 139.95 46.41 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 -164.755 . . . . . . . . 3 3 . 1 . 114 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.297 68.1 mt -132.52 130.14 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.209 1.804 . . . . 0.0 109.707 -160.988 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -159.27 133.88 7.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.077 2.151 . . . . 0.0 112.609 179.037 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.53 34.61 15.88 Favored 'General case' 0 N--CA 1.439 -0.986 1 C-N-CA 133.398 4.679 . . . . 0.0 112.78 -176.916 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.48 -30.05 7.51 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 115.514 -2.826 . . . . 0.0 112.21 174.478 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -120.12 148.04 44.12 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 120.502 2.151 . . . . 0.0 111.002 -159.939 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -71.83 129.28 38.24 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.998 2.119 . . . . 0.0 108.04 171.151 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 59' ' ' TYR . 10.8 mp -75.05 109.69 8.73 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 129.826 3.25 . . . . 0.0 108.853 -176.295 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -73.25 130.06 39.39 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 129.635 3.174 . . . . 0.0 110.217 -172.927 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.293 73.4 m-20 -46.24 129.7 10.3 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 129.394 3.078 . . . . 0.0 112.991 166.811 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.54 20.49 47.82 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 124.963 2.424 . . . . 0.0 111.317 172.733 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.23 177.18 4.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.598 2.359 . . . . 0.0 113.672 170.161 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -118.29 163.83 16.11 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 125.209 2.433 . . . . 0.0 110.503 162.561 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.9 mt -53.93 -37.67 64.09 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 117.128 -3.482 . . . . 0.0 113.899 169.87 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.2 t -58.45 -31.97 68.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 124.725 2.202 . . . . 0.0 114.073 172.173 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -63.46 -30.22 71.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 119.329 -2.107 . . . . 0.0 115.291 177.426 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 10.7 m-85 -96.78 7.57 46.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 130.615 3.566 . . . . 0.0 109.245 178.456 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.8 t30 35.7 47.61 0.4 Allowed 'General case' 0 N--CA 1.448 -0.53 2 O-C-N 113.535 -5.728 . . . . 0.0 114.558 -172.51 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -88.91 110.75 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 128.114 2.566 . . . . 0.0 106.844 178.677 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -111.31 170.01 8.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.853 3.261 . . . . 0.0 112.682 -173.738 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -49.89 131.61 22.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 112.457 -177.475 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.453 5.4 pt-20 65.98 39.09 4.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.048 2.939 . . . . 0.0 118.146 178.511 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.7 p -87.18 140.73 29.25 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.411 1.884 . . . . 0.0 107.292 165.454 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 79.7 m -96.22 130.82 43.2 Favored 'General case' 0 N--CA 1.442 -0.858 2 C-N-CA 133.509 4.723 . . . . 0.0 107.108 164.333 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -123.67 175.49 6.81 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.941 1.696 . . . . 0.0 108.743 -176.7 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -111.38 149.88 30.57 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 118.457 -2.652 . . . . 0.0 112.335 178.21 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -121.85 138.55 54.34 Favored 'General case' 0 N--CA 1.448 -0.529 1 C-N-CA 134.395 5.078 . . . . 0.0 109.907 178.995 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 t -133.41 104.12 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 1 CA-C-O 130.104 4.764 . . . . 0.0 104.937 176.913 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.99 142.94 28.35 Favored 'General case' 0 N--CA 1.451 -0.406 1 O-C-N 113.14 -5.975 . . . . 0.0 105.495 179.286 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -94.67 167.76 11.26 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 131.633 3.973 . . . . 0.0 109.304 150.758 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.07 151.32 48.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 119.184 -2.198 . . . . 0.0 107.068 171.394 . . . . . . . . 2 2 . 1 . 114 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -108.11 -19.54 13.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 130.642 3.577 . . . . 0.0 110.097 177.582 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.04 128.99 5.22 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 128.255 2.836 . . . . 0.0 106.902 176.365 . . . . . . . . 1 1 . 1 . 114 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.844 1 N-CA-C 99.904 -5.278 . . . . 0.0 99.904 -157.565 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.2 ttp . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 113.947 -2.93 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 115 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -88.11 130.28 35.06 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 124.175 1.941 . . . . 0.0 115.491 -179.387 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 pt -115.42 174.86 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 111.421 -2.627 . . . . 0.0 111.222 155.391 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.278 52.0 p90 -147.33 143.4 28.02 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 169.143 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.63 99.04 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 130.398 3.479 . . . . 0.0 105.395 -156.487 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -83.7 133.07 34.82 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.975 2.11 . . . . 0.0 105.513 176.236 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.283 45.1 p -99.77 -171.56 2.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.043 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.77 -6.61 57.62 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 130.602 3.561 . . . . 0.0 115.325 170.373 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -117.11 -163.9 0.95 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 112.214 -2.266 . . . . 0.0 106.984 -179.723 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.03 50.7 0.77 Allowed Glycine 0 CA--C 1.524 0.656 0 O-C-N 124.757 1.285 . . . . 0.0 112.139 -178.087 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.343 66.9 tttt -119.69 139.1 52.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.48 3.912 . . . . 0.0 106.853 167.696 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.6 m -131.71 117.88 19.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 115.563 -2.161 . . . . 0.0 106.896 179.888 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.6 mt -100.46 129.32 51.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 -170.448 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -92.86 146.65 23.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 177.117 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.92 127.03 27.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 -170.801 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -108.18 98.05 7.65 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 126.407 3.003 . . . . 0.0 114.291 175.424 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.3 164.08 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 117.606 -3.184 . . . . 0.0 114.515 -166.411 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.98 137.09 31.62 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 117.085 -1.436 . . . . 0.0 110.028 171.587 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -85.01 -3.92 9.68 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.516 2.811 . . . . 0.0 113.682 -172.822 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.4 p -80.72 -2.11 45.53 Favored 'General case' 0 C--N 1.33 -0.264 1 CA-C-O 108.846 -5.359 . . . . 0.0 112.523 167.435 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.404 ' CG ' HD21 ' A' ' 25' ' ' ASN . 8.9 t0 -89.1 152.81 21.44 Favored 'General case' 0 N--CA 1.447 -0.59 1 O-C-N 130.172 4.67 . . . . 0.0 110.709 177.45 . . . . . . . . 3 3 . 1 . 115 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -83.42 151.35 25.53 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.98 1.712 . . . . 0.0 107.427 -175.718 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.8 mm -53.62 -33.39 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.812 174.639 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -62.41 -52.08 64.98 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 129.387 3.075 . . . . 0.0 108.243 -173.63 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.404 HD21 ' CG ' ' A' ' 21' ' ' ASP . 26.7 t30 -77.57 -23.2 50.06 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 109.441 -3.527 . . . . 0.0 113.572 -174.323 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.34 35.2 t -58.4 -50.34 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 129.952 3.301 . . . . 0.0 110.916 162.452 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -67.15 -38.46 85.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 127.203 2.814 . . . . 0.0 114.182 175.452 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.68 -4.58 16.2 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 117.841 -3.037 . . . . 0.0 117.404 163.329 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -92.82 -42.67 9.42 Favored 'General case' 0 C--N 1.328 -0.351 1 O-C-N 115.691 -4.381 . . . . 0.0 105.093 175.407 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -49.2 -39.48 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 1 C-N-CA 132.228 4.211 . . . . 0.0 114.267 165.6 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.257 46.3 tt0 -46.1 -45.11 16.17 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.309 2.243 . . . . 0.0 116.752 175.288 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.34 -41.25 98.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 112.858 -1.974 . . . . 0.0 111.077 173.585 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -76.4 -54.17 7.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.079 -169.787 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -101.77 -5.33 25.02 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 126.251 2.219 . . . . 0.0 114.657 -172.659 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.21 6.16 89.02 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 121.487 3.355 . . . . 0.0 121.487 165.293 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.266 4.0 tp -100.61 141.62 23.03 Favored Pre-proline 0 N--CA 1.454 -0.273 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -167.085 . . . . . . . . 3 2 . 1 . 115 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -70.6 161.11 47.21 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.969 2.446 . . . . 0.0 113.909 169.565 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.88 -9.43 10.85 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 N-CA-C 117.795 2.19 . . . . 0.0 117.795 -162.198 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -95.55 8.15 44.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 117.731 -3.105 . . . . 0.0 113.188 -178.175 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -119.89 -4.15 10.17 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 112.384 -2.189 . . . . 0.0 115.614 -175.207 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.302 78.4 mt-30 -99.59 138.0 37.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 128.454 2.702 . . . . 0.0 104.618 175.182 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -129.99 102.95 6.5 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 103.184 -2.895 . . . . 0.0 103.184 174.146 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.7 mt -81.61 128.41 33.9 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 119.899 -1.751 . . . . 0.0 107.47 169.119 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mt -113.46 119.89 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 1 C-N-CA 132.275 4.23 . . . . 0.0 106.963 175.894 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -105.18 128.86 53.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 101.082 -3.673 . . . . 0.0 101.082 153.152 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 73.0 -108.28 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 129.071 2.948 . . . . 0.0 110.495 171.166 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.54 22.69 4.11 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.159 1.361 . . . . 0.0 112.111 164.689 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -98.23 108.37 21.06 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.208 3.003 . . . . 0.0 109.929 166.723 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -80.88 108.7 14.77 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 173.86 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.8 mt -67.29 146.3 54.27 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.05 -159.914 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -101.39 134.5 44.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.691 1.596 . . . . 0.0 108.539 -168.299 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.33 -37.69 72.93 Favored 'General case' 0 N--CA 1.442 -0.852 1 C-N-CA 132.58 4.352 . . . . 0.0 115.25 -155.489 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.01 -13.72 24.53 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 119.018 -2.301 . . . . 0.0 112.051 -169.38 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -69.7 152.8 44.25 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 118.998 -2.472 . . . . 0.0 107.948 166.832 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.4 p -78.5 179.3 7.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 127.362 2.265 . . . . 0.0 111.902 171.319 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 43.7 mt -84.51 -26.6 27.99 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 120.165 -1.584 . . . . 0.0 109.273 166.273 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.8 p -69.84 -22.64 63.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 130.203 3.401 . . . . 0.0 110.427 173.923 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -75.88 -29.6 58.56 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 121.783 2.083 . . . . 0.0 111.116 168.954 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -90.85 -2.63 57.74 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.249 1.42 . . . . 0.0 107.912 178.549 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 5.0 t-20 59.53 38.39 22.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.99 2.916 . . . . 0.0 116.087 -179.705 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.6 mm -76.63 105.48 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 126.848 2.059 . . . . 0.0 108.624 -176.643 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -84.67 166.77 16.79 Favored 'General case' 0 C--O 1.238 0.481 1 C-N-CA 133.517 4.727 . . . . 0.0 109.811 178.478 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 20.5 pttt -61.6 135.68 57.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 115.684 -2.103 . . . . 0.0 110.245 -173.346 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 68.79 26.76 5.94 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 131.445 3.898 . . . . 0.0 115.087 177.577 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 m -79.54 115.5 19.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 102.242 -3.244 . . . . 0.0 102.242 -177.966 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -73.36 137.62 44.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 129.23 3.012 . . . . 0.0 107.904 173.49 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.83 176.97 8.23 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 167.234 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -122.65 122.63 39.27 Favored 'General case' 0 N--CA 1.45 -0.474 1 O-C-N 116.165 -4.085 . . . . 0.0 106.301 -173.634 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.471 ' CD2' HD21 ' A' ' 71' ' ' LEU . 55.0 tp -97.91 133.06 42.9 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 124.154 1.93 . . . . 0.0 107.019 171.747 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.34 128.77 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 163.944 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.471 HD21 ' CD2' ' A' ' 69' ' ' LEU . 2.5 pt? -141.07 173.18 11.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.675 2.034 . . . . 0.0 109.167 165.701 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.456 ' H ' ' HB2' ' A' ' 71' ' ' LEU . 22.9 ttt180 -84.98 149.17 25.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 100.416 -3.92 . . . . 0.0 100.416 175.185 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.4 mt -110.25 157.05 19.87 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 125.141 2.4 . . . . 0.0 112.85 155.39 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.32 -35.97 6.14 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 128.017 2.527 . . . . 0.0 109.651 167.576 . . . . . . . . 2 2 . 1 . 115 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.55 -148.12 17.7 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 107.965 -2.054 . . . . 0.0 107.965 -177.546 . . . . . . . . 1 1 . 1 . 115 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 C-N-CA 124.888 1.232 . . . . 0.0 110.249 -179.383 . . . . . . . . 0 0 . 1 . 116 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 . . . . . . . . . 0 0 . 1 . 116 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.84 151.67 19.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 124.076 0.86 . . . . 0.0 110.403 -177.207 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.303 49.2 pt -141.61 155.62 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 1 C-N-CA 131.802 4.041 . . . . 0.0 110.996 162.278 . . . . . . . . 3 2 . 1 . 116 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -110.93 156.42 21.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 127.664 3.102 . . . . 0.0 110.902 179.058 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.328 82.0 t -136.67 128.13 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 100.763 -3.792 . . . . 0.0 100.763 174.246 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -82.41 125.58 31.22 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 118.404 -2.685 . . . . 0.0 105.63 161.496 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -80.68 167.87 19.52 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.158 1.456 . . . . 0.0 110.213 168.321 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.96 -29.96 69.95 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 117.855 -3.028 . . . . 0.0 113.278 -178.696 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 p -77.54 -25.07 49.85 Favored 'General case' 0 N--CA 1.447 -0.597 1 C-N-CA 132.877 4.471 . . . . 0.0 115.559 171.076 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.46 -2.09 9.54 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 126.799 2.562 . . . . 0.0 110.633 154.301 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -78.37 137.1 37.85 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.503 2.721 . . . . 0.0 105.795 -179.485 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -92.96 123.1 35.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.112 2.165 . . . . 0.0 107.085 -174.422 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.7 mm -111.27 129.61 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 127.863 2.465 . . . . 0.0 105.963 -174.376 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -95.58 120.57 36.06 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.676 2.79 . . . . 0.0 110.564 172.039 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -112.28 131.76 55.33 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.169 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -96.33 116.03 28.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 129.0 3.938 . . . . 0.0 110.008 160.598 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.38 160.7 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 131.511 3.925 . . . . 0.0 109.247 -165.378 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -71.23 152.75 94.43 Favored Pre-proline 0 N--CA 1.446 -0.668 0 O-C-N 117.408 -3.307 . . . . 0.0 108.163 163.197 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -71.11 -18.68 30.59 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 121.703 1.602 . . . . 0.0 112.339 173.793 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.377 63.6 p -125.54 36.44 4.55 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 127.031 2.132 . . . . 0.0 113.748 176.547 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.92 157.6 37.13 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.346 1.458 . . . . 0.0 108.845 173.486 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.259 40.8 p -99.49 168.06 10.21 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 126.782 2.551 . . . . 0.0 109.993 172.941 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.257 33.5 mm -76.88 -15.09 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 119.546 -1.971 . . . . 0.0 110.55 -178.541 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.4 -60.6 2.6 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 127.382 2.273 . . . . 0.0 112.738 174.112 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.95 -31.18 72.3 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 179.501 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.293 78.9 t -53.64 -41.69 47.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 115.373 -2.251 . . . . 0.0 113.415 163.445 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -55.02 -42.55 72.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 123.244 2.747 . . . . 0.0 109.963 176.811 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.75 -37.75 76.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 123.687 1.708 . . . . 0.0 111.635 -177.918 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -71.15 -31.12 67.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.483 -2.011 . . . . 0.0 108.498 176.562 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.303 86.3 mt -74.81 -32.86 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 1 O-C-N 115.756 -4.34 . . . . 0.0 110.842 177.605 . . . . . . . . 3 2 . 1 . 116 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -64.28 -53.2 52.64 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 130.738 3.615 . . . . 0.0 107.638 171.413 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -55.23 -51.7 65.74 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 118.783 2.882 . . . . 0.0 118.783 174.534 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -66.24 -43.48 86.46 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 115.083 -2.389 . . . . 0.0 111.482 177.679 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.342 69.3 mm-40 -128.98 -15.96 4.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 114.563 -2.637 . . . . 0.0 116.338 -166.819 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.58 -22.49 7.35 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 125.628 1.83 . . . . 0.0 111.348 156.192 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mt -73.39 124.79 90.83 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 126.375 1.87 . . . . 0.0 108.728 -162.186 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -70.04 157.51 59.61 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.25 1.967 . . . . 0.0 109.621 173.247 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.17 -29.03 22.54 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 124.805 3.67 . . . . 0.0 111.279 -168.355 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.267 5.4 t70 -40.11 -55.59 2.07 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 126.28 2.943 . . . . 0.0 117.743 158.141 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -81.66 -6.71 59.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 111.774 -2.466 . . . . 0.0 111.66 -175.392 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -89.06 166.76 13.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 124.184 3.174 . . . . 0.0 113.871 174.972 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.367 6.7 ptt180 -154.66 128.87 8.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 128.112 2.565 . . . . 0.0 108.213 164.594 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 mt -102.57 91.93 4.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 129.656 3.182 . . . . 0.0 110.022 174.781 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.1 mm -96.09 120.86 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 127.156 2.785 . . . . 0.0 105.168 -175.836 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -130.91 116.12 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 130.245 3.418 . . . . 0.0 109.217 -176.116 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.75 42.16 11.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 128.503 2.721 . . . . 0.0 112.516 -176.343 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.01 -2.78 55.43 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.058 1.313 . . . . 0.0 114.515 166.417 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -132.98 158.29 43.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.815 0.846 . . . . 0.0 110.769 -179.476 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.16 130.28 35.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 126.747 3.165 . . . . 0.0 114.761 173.811 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.53 128.29 35.98 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 116.865 -3.647 . . . . 0.0 109.886 163.1 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -117.38 -179.07 3.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 119.512 -1.992 . . . . 0.0 114.08 -171.031 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.28 129.6 35.85 Favored 'General case' 0 N--CA 1.449 -0.52 1 C-N-CA 133.725 4.81 . . . . 0.0 113.026 165.255 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.81 -28.41 7.38 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 118.269 -2.769 . . . . 0.0 110.518 151.18 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.256 75.1 mtt85 -97.77 124.45 42.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.905 2.082 . . . . 0.0 106.709 171.359 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.3 p -62.56 174.3 1.03 Allowed 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 125.254 1.597 . . . . 0.0 114.624 170.23 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -42.07 -53.34 3.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 176.579 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 t -64.69 -29.77 70.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.138 1.375 . . . . 0.0 111.165 -173.632 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -91.21 2.03 56.66 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 119.274 -2.141 . . . . 0.0 110.297 -176.159 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -101.9 20.36 16.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 123.057 2.662 . . . . 0.0 109.419 156.29 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.361 19.4 p30 59.19 22.32 10.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -176.727 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.8 mt -75.7 123.56 31.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 O-C-N 118.18 -2.825 . . . . 0.0 111.292 178.233 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -106.82 -176.01 2.96 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -173.559 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -67.76 125.15 25.33 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.778 1.631 . . . . 0.0 108.203 177.996 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 69.79 20.94 6.63 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 126.208 2.192 . . . . 0.0 114.025 178.016 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.7 m -73.16 140.04 46.76 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 131.163 3.785 . . . . 0.0 114.108 177.173 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.8 m -105.13 143.87 32.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.035 -1.666 . . . . 0.0 111.376 -172.521 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.3 mt -121.84 157.8 30.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.124 1.37 . . . . 0.0 113.834 172.016 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -109.71 155.03 22.06 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 177.441 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -128.53 124.64 36.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 110.426 -3.079 . . . . 0.0 107.35 -179.619 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.25 148.24 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 128.268 2.627 . . . . 0.0 107.055 162.727 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.37 152.4 51.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 127.284 2.865 . . . . 0.0 110.552 -177.642 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -71.28 124.88 25.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 126.776 3.179 . . . . 0.0 106.242 176.017 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.0 mt -134.72 173.26 11.88 Favored 'General case' 0 N--CA 1.447 -0.609 1 C-N-CA 133.86 4.864 . . . . 0.0 107.972 175.827 . . . . . . . . 2 2 . 1 . 116 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -98.47 142.29 30.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 154.596 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.81 -95.64 2.07 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 156.7 . . . . . . . . 1 1 . 1 . 116 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.263 0 C-N-CA 129.887 3.613 . . . . 0.0 111.521 -173.836 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 ttp . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 113.645 -3.074 . . . . 0.0 108.144 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -72.09 134.17 45.64 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 102.607 -3.108 . . . . 0.0 102.607 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -132.79 157.62 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 130.605 3.562 . . . . 0.0 105.749 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -120.96 151.02 40.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 129.129 2.972 . . . . 0.0 107.771 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.17 135.34 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 167.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -103.62 120.3 40.62 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 126.648 2.468 . . . . 0.0 110.612 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -97.33 137.23 36.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.414 38.0 mt -27.04 -43.12 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.568 1 C-N-CA 132.996 4.518 . . . . 0.0 111.611 172.044 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.351 80.9 p -83.03 -16.32 47.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.086 -1.634 . . . . 0.0 110.438 -168.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.22 -4.48 23.65 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.477 -1.179 . . . . 0.0 112.116 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -80.61 132.62 35.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 129.449 3.1 . . . . 0.0 113.224 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -105.14 128.31 53.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 102.103 -3.295 . . . . 0.0 102.103 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 13' ' ' ILE . 59.4 mt -129.44 135.3 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 -174.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.456 1.8 t -127.18 147.03 50.2 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -143.23 129.93 20.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 118.167 -2.833 . . . . 0.0 107.21 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 16' ' ' GLU . 14.7 mp0 -75.53 123.74 25.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 165.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -137.24 173.81 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 125.996 2.808 . . . . 0.0 104.847 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.49 154.37 39.14 Favored Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 102.149 -3.278 . . . . 0.0 102.149 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.06 -29.36 22.57 Favored 'Trans proline' 0 N--CA 1.447 -1.23 1 C-N-CA 130.228 7.285 . . . . 0.0 114.352 170.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.3 m -71.89 -16.6 62.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 122.456 2.389 . . . . 0.0 115.693 173.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -65.37 132.92 50.22 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 122.644 2.474 . . . . 0.0 107.817 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.295 70.6 p -43.75 149.23 0.31 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 156.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -66.42 -39.69 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 O-C-N 121.439 -0.788 . . . . 0.0 108.953 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.324 63.4 tt0 -54.92 -37.93 67.02 Favored 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 134.272 5.029 . . . . 0.0 115.229 177.42 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -53.69 -49.29 68.36 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 161.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.35 -13.94 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 126.755 2.022 . . . . 0.0 112.578 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -78.16 -32.45 50.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.749 2.82 . . . . 0.0 108.362 168.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.94 -29.21 22.24 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 117.361 -3.337 . . . . 0.0 110.242 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -63.6 -32.2 73.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 114.612 -2.613 . . . . 0.0 108.33 168.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.361 17.6 mt -65.97 -28.72 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 124.825 3.466 . . . . 0.0 112.315 166.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -73.94 -38.74 64.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 122.054 2.206 . . . . 0.0 106.89 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -52.91 -48.82 66.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 131.203 3.801 . . . . 0.0 113.463 165.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -88.99 -37.15 15.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 126.765 2.54 . . . . 0.0 116.156 -170.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -136.76 -14.71 1.62 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.699 1.714 . . . . 0.0 110.646 -162.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.06 8.34 34.08 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 155.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.258 13.7 mt -101.59 133.08 21.04 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-N 123.367 3.583 . . . . 0.0 107.924 -162.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.21 150.92 37.95 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 CA-C-N 123.027 2.117 . . . . 0.0 114.223 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -46.85 -40.16 24.86 Favored 'Trans proline' 0 N--CA 1.443 -1.499 1 C-N-CA 126.861 5.041 . . . . 0.0 119.73 166.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.3 -44.42 88.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 128.504 3.627 . . . . 0.0 116.27 -170.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.301 74.0 mm-40 -100.37 -1.41 36.12 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 113.457 -1.701 . . . . 0.0 112.103 -173.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -95.65 125.76 40.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 126.571 2.419 . . . . 0.0 113.081 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.348 31.4 ttm105 -124.26 132.84 53.61 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 128.509 2.724 . . . . 0.0 108.579 172.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.81 151.21 29.31 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 117.498 -1.239 . . . . 0.0 108.89 -172.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.409 34.8 mt -129.95 131.53 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.912 1.685 . . . . 0.0 106.988 -167.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -142.31 118.42 10.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 130.67 3.588 . . . . 0.0 110.666 169.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.58 27.12 11.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.101 2.16 . . . . 0.0 110.228 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.53 -20.45 44.36 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.108 -1.62 . . . . 0.0 113.101 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.362 45.2 mtmt -94.71 143.41 26.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -165.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -71.35 137.4 48.41 Favored 'General case' 0 C--O 1.223 -0.294 0 O-C-N 121.644 -0.66 . . . . 0.0 110.992 159.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.2 mt -104.62 140.44 38.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -128.98 157.26 42.18 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 -147.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.256 5.9 p-10 -59.2 140.19 56.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.124 172.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.13 -47.1 1.05 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 105.673 -2.971 . . . . 0.0 105.673 162.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.86 175.92 5.46 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.225 -1.488 . . . . 0.0 111.053 -165.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 p -122.52 161.41 23.68 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.163 2.585 . . . . 0.0 113.496 -164.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mt -55.02 -35.45 64.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.5 t -57.75 -46.23 84.78 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 128.79 2.836 . . . . 0.0 109.825 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -59.91 -37.4 79.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 119.892 -1.755 . . . . 0.0 114.294 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -90.11 15.13 10.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 115.091 -2.385 . . . . 0.0 115.008 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 m120 71.52 10.87 6.54 Favored 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 132.89 4.476 . . . . 0.0 110.246 161.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.0 mt -52.61 134.54 14.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 1 C-N-CA 133.864 4.866 . . . . 0.0 110.179 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -145.06 -177.55 5.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 130.822 3.649 . . . . 0.0 111.331 -159.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.378 72.6 tttt -51.81 104.83 0.09 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 129.999 3.32 . . . . 0.0 114.278 170.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 70.92 21.49 5.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 118.143 -2.848 . . . . 0.0 113.565 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 m -58.16 119.79 7.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 121.915 2.143 . . . . 0.0 107.059 173.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.5 m -92.89 122.5 35.33 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 129.407 3.083 . . . . 0.0 107.769 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -113.82 170.99 7.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 125.279 1.612 . . . . 0.0 109.103 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.22 144.33 44.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.154 2.182 . . . . 0.0 111.128 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.06 103.2 7.32 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -160.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 m -87.54 128.6 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 124.875 2.274 . . . . 0.0 109.86 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.307 31.8 tp . . . . . 0 N--CA 1.446 -0.64 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -98.64 133.56 42.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 121.051 1.751 . . . . 0.0 109.029 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.284 1.1 pt -129.6 168.09 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.27 161.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -132.24 146.45 52.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.89 94.92 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 1 N-CA-C 98.661 -4.57 . . . . 0.0 98.661 -161.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -77.53 137.9 38.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 124.857 2.265 . . . . 0.0 110.891 170.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.582 HG22 HD23 ' A' ' 69' ' ' LEU . 44.5 p -94.61 168.52 10.8 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 124.375 2.035 . . . . 0.0 106.667 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.18 -16.53 62.53 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 118.431 -2.668 . . . . 0.0 111.137 163.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.0 p -91.23 -7.15 52.11 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 115.724 -2.084 . . . . 0.0 113.344 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.99 -17.71 17.12 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.408 1.48 . . . . 0.0 115.953 161.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -76.93 145.63 38.07 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.413 2.285 . . . . 0.0 107.674 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.2 p -105.82 121.86 44.91 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.51 2.724 . . . . 0.0 108.982 172.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.273 35.6 mm -89.26 146.82 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 173.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 22.1 m -109.52 137.64 47.06 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 119.826 -1.796 . . . . 0.0 109.86 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -122.87 100.13 6.74 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -160.24 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.5 106.35 17.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.944 3.697 . . . . 0.0 109.195 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -158.88 161.07 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 120.777 1.626 . . . . 0.0 112.26 -160.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -97.42 152.95 38.51 Favored Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 118.466 -2.646 . . . . 0.0 110.143 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.309 2.7 Cg_exo -51.77 -30.42 37.75 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 N-CA-C 119.355 2.791 . . . . 0.0 119.355 167.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 p -88.16 2.39 52.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.997 2.119 . . . . 0.0 112.019 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -81.39 140.93 34.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 120.021 1.282 . . . . 0.0 109.361 166.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -80.41 159.58 25.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.994 2.518 . . . . 0.0 109.604 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 54' ' ' ARG 0.293 8.7 mt -72.08 -14.23 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 126.219 1.808 . . . . 0.0 115.011 170.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -87.06 -18.48 30.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 170.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.279 13.3 t30 -66.56 -45.58 78.86 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 111.591 -2.549 . . . . 0.0 106.466 165.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.1 t -56.8 -40.76 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 1 C-N-CA 132.205 4.202 . . . . 0.0 108.805 170.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 90.6 mttt -73.46 -38.76 65.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 116.42 -2.112 . . . . 0.0 110.185 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -31.57 72.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -57.43 -44.72 84.91 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 125.003 1.44 . . . . 0.0 112.933 163.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.416 21.7 mt -55.88 -45.27 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 127.914 2.486 . . . . 0.0 114.703 -176.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -48.83 -67.11 0.3 Allowed 'General case' 0 C--N 1.33 -0.24 1 O-C-N 129.493 4.245 . . . . 0.0 113.815 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -50.3 -32.04 15.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -87.02 -58.27 2.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.173 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.284 18.2 tp10 -112.45 -8.66 13.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 121.105 3.743 . . . . 0.0 121.105 -166.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.56 1.2 55.44 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 117.146 -1.919 . . . . 0.0 111.749 162.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 36' ' ' ILE . 18.6 mt -98.42 110.45 56.61 Favored Pre-proline 0 N--CA 1.452 -0.359 0 C-N-CA 125.284 1.434 . . . . 0.0 110.073 -171.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -56.77 142.97 91.84 Favored 'Trans proline' 0 C--N 1.323 -0.776 1 CA-C-O 110.438 -4.068 . . . . 0.0 118.062 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HB3' ' HB3' ' A' ' 27' ' ' LYS 0.277 28.7 Cg_exo -45.1 -31.23 5.54 Favored 'Trans proline' 0 N--CA 1.452 -0.915 1 O-C-N 129.638 4.494 . . . . 0.0 119.543 -178.737 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.68 -35.2 72.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.289 79.7 mt-30 -90.07 13.37 15.11 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.652 -1.613 . . . . 0.0 113.363 -177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -106.13 156.9 17.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 172.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -138.68 116.52 11.54 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 127.271 2.228 . . . . 0.0 112.093 149.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.93 107.23 19.61 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 131.19 3.796 . . . . 0.0 105.946 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 pt -110.52 158.18 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 129.235 3.014 . . . . 0.0 109.5 169.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -115.62 -0.57 12.97 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 130.263 3.425 . . . . 0.0 108.9 161.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.552 . . -142.43 -110.68 0.13 Allowed 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 119.135 -2.228 . . . . 0.0 114.617 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.06 -19.8 2.88 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 122.473 2.397 . . . . 0.0 110.629 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -117.54 154.8 30.88 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 127.552 2.56 . . . . 0.0 112.361 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.05 165.25 11.4 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 124.122 0.889 . . . . 0.0 108.855 -172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.314 38.6 mt -96.25 128.08 42.84 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 110.954 -2.839 . . . . 0.0 106.744 164.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -69.18 125.14 25.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 116.306 -1.807 . . . . 0.0 115.551 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.278 0.0 OUTLIER -46.27 -28.66 1.35 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 128.824 3.828 . . . . 0.0 117.789 -170.538 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.11 10.87 60.27 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 125.57 1.794 . . . . 0.0 116.548 -168.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.511 ' O ' HD12 ' A' ' 23' ' ' ILE . 50.5 mtt180 -111.33 179.83 3.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.949 1.699 . . . . 0.0 107.504 168.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -120.45 172.09 8.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 104.583 -2.376 . . . . 0.0 104.583 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.392 6.9 mp -40.21 -51.55 2.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 130.919 3.688 . . . . 0.0 110.309 157.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 p -63.02 -37.92 89.12 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.843 2.057 . . . . 0.0 114.868 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.43 -46.42 66.81 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.835 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -79.15 -5.3 53.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 125.952 2.787 . . . . 0.0 114.699 -175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.65 44.43 17.46 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 117.977 -2.952 . . . . 0.0 115.937 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.7 mm -91.2 98.06 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -77.87 166.49 22.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.304 2.642 . . . . 0.0 109.556 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.36 129.79 1.76 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 167.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 70.79 38.83 1.15 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.455 2.302 . . . . 0.0 113.367 167.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.4 m -92.03 130.42 37.77 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 130.639 3.575 . . . . 0.0 108.449 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.3 m -88.36 111.95 22.32 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 127.435 2.959 . . . . 0.0 109.189 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.9 mt -94.85 136.43 35.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.927 1.291 . . . . 0.0 108.678 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -95.2 125.44 39.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.298 -1.501 . . . . 0.0 110.551 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.582 HD23 HG22 ' A' ' 7' ' ' THR . 27.0 tp -101.01 108.96 20.8 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.179 1.792 . . . . 0.0 108.123 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.6 147.76 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 123.343 1.544 . . . . 0.0 109.502 153.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 N--CA 1.449 -0.516 0 C-N-CA 127.943 2.497 . . . . 0.0 111.355 -171.951 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 53.8 ttp . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 117.459 -1.258 . . . . 0.0 107.756 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -77.42 134.52 38.39 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 126.244 2.215 . . . . 0.0 114.494 168.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -137.43 161.6 34.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.5 3.52 . . . . 0.0 102.337 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -112.54 144.25 42.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 111.015 -2.811 . . . . 0.0 114.764 168.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -132.77 112.78 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 O-C-N 125.738 1.899 . . . . 0.0 108.053 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -72.57 125.19 26.84 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 114.106 -2.854 . . . . 0.0 106.434 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -90.12 162.98 15.04 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 114.948 -2.453 . . . . 0.0 114.686 155.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pp -77.54 -12.37 59.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 125.283 1.614 . . . . 0.0 110.092 171.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -79.31 -10.4 59.8 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 129.937 3.295 . . . . 0.0 112.188 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.34 10.06 37.14 Favored Glycine 0 CA--C 1.539 1.554 0 O-C-N 117.991 -2.943 . . . . 0.0 114.275 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -104.51 140.97 37.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -115.16 100.83 8.44 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.934 2.894 . . . . 0.0 103.339 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.3 mt -81.16 123.66 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.8 m -104.84 123.74 48.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 121.401 1.91 . . . . 0.0 107.525 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.4 mt -126.23 130.41 50.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.117 2.567 . . . . 0.0 111.811 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.26 116.45 12.71 Favored 'General case' 0 C--N 1.327 -0.377 1 O-C-N 130.072 4.607 . . . . 0.0 109.137 154.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.0 172.72 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 113.29 -3.243 . . . . 0.0 114.793 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -97.11 144.65 28.25 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 124.37 3.259 . . . . 0.0 105.214 159.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -52.77 -28.38 38.01 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 CA-C-N 127.301 3.643 . . . . 0.0 115.475 163.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.9 p -81.46 4.32 21.48 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 127.493 2.996 . . . . 0.0 116.191 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -70.75 156.75 39.12 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.564 1.146 . . . . 0.0 108.268 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -111.42 166.56 11.02 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.352 1.861 . . . . 0.0 110.499 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.437 HG12 ' H ' ' A' ' 23' ' ' ILE . 4.0 mm -52.79 -42.64 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 127.722 2.409 . . . . 0.0 111.651 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -49.49 -34.98 18.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 115.358 -2.258 . . . . 0.0 116.322 171.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -85.0 -15.31 44.62 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 126.809 2.568 . . . . 0.0 109.089 -167.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -81.44 -52.52 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 126.307 2.956 . . . . 0.0 103.59 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -62.66 -33.17 74.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 131.058 3.743 . . . . 0.0 110.949 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.8 66.6 Favored 'General case' 0 N--CA 1.443 -0.786 1 O-C-N 114.529 -5.107 . . . . 0.0 109.377 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -67.11 -29.04 68.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 113.922 -2.942 . . . . 0.0 110.505 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 69' ' ' LEU 0.259 42.0 mt -72.44 -42.06 64.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 123.751 2.978 . . . . 0.0 104.722 176.034 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -53.95 -40.18 66.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 118.602 -2.561 . . . . 0.0 116.294 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.261 2.3 t70 -67.88 -19.89 65.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 116.232 -1.842 . . . . 0.0 112.171 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -94.22 -61.81 1.45 Allowed 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 124.61 1.194 . . . . 0.0 111.351 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -91.92 -28.51 17.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.443 2.697 . . . . 0.0 113.431 -166.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.22 -24.58 24.31 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 121.046 -1.034 . . . . 0.0 112.5 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 mt -60.32 118.18 31.14 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 111.737 -2.232 . . . . 0.0 107.097 -169.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.263 98.0 Cg_endo -67.74 158.04 59.05 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 CA-C-N 122.446 1.909 . . . . 0.0 116.563 175.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.312 14.9 Cg_exo -57.27 -33.11 95.49 Favored 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 128.635 6.223 . . . . 0.0 112.954 -179.282 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -86.53 -9.89 55.2 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 122.561 2.437 . . . . 0.0 111.581 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -94.77 -23.3 17.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.517 1.136 . . . . 0.0 113.724 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.46 122.15 21.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 113.722 -3.037 . . . . 0.0 108.751 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -100.4 119.47 38.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 121.428 1.922 . . . . 0.0 107.888 164.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 tp -121.18 104.06 9.47 Favored 'General case' 0 N--CA 1.445 -0.719 1 C-N-CA 132.458 4.303 . . . . 0.0 109.912 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.297 47.8 mm -96.6 151.18 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 128.359 3.537 . . . . 0.0 112.067 174.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -150.47 108.74 3.76 Favored 'General case' 0 CA--C 1.535 0.382 1 C-N-CA 132.038 4.135 . . . . 0.0 111.669 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.27 29.5 3.63 Favored 'General case' 0 C--N 1.325 -0.47 1 C-N-CA 132.269 4.228 . . . . 0.0 117.168 157.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.24 -10.11 20.18 Favored Glycine 0 CA--C 1.527 0.833 1 C-N-CA 133.765 5.459 . . . . 0.0 107.607 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -123.44 162.99 21.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 121.752 2.776 . . . . 0.0 105.908 -168.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -79.71 149.6 31.13 Favored 'General case' 0 N--CA 1.449 -0.488 1 C-N-CA 132.986 4.514 . . . . 0.0 108.588 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.0 mt -112.86 104.87 12.87 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.599 1.56 . . . . 0.0 108.479 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -94.35 149.82 20.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 102.181 -3.266 . . . . 0.0 102.181 -171.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -76.49 152.42 36.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 127.01 2.124 . . . . 0.0 114.195 -165.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.33 -23.04 33.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 119.457 2.543 . . . . 0.0 119.457 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -70.57 162.48 28.8 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 p -100.79 165.06 11.56 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.117 -1.615 . . . . 0.0 107.146 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.7 mt -60.9 -47.37 86.69 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 113.053 -1.885 . . . . 0.0 115.709 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.4 p -43.06 -45.23 5.17 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 129.081 2.952 . . . . 0.0 114.854 162.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.81 -52.5 59.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 131.416 3.886 . . . . 0.0 110.448 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -74.12 -14.3 60.95 Favored 'General case' 0 N--CA 1.449 -0.494 1 C-N-CA 132.465 4.306 . . . . 0.0 111.802 172.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.48 19.5 t30 87.37 20.74 0.06 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 165.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.9 mt -78.44 144.07 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -168.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -142.64 172.54 12.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.285 1.834 . . . . 0.0 108.996 -155.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -62.54 119.76 9.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 125.591 1.807 . . . . 0.0 109.85 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.506 15.2 mt-10 85.29 15.26 0.16 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -176.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -71.68 141.17 49.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.704 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.3 m -108.56 117.57 34.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.13 142.15 32.0 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.376 2.271 . . . . 0.0 109.304 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -108.69 125.48 51.94 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 125.275 2.464 . . . . 0.0 111.936 169.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.442 HD21 HG21 ' A' ' 30' ' ' ILE . 23.1 tp -96.16 132.96 41.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 110.341 -3.118 . . . . 0.0 109.307 174.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.12 158.14 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 131.001 3.72 . . . . 0.0 108.138 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.303 83.3 mt . . . . . 0 N--CA 1.441 -0.882 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.935 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 117.348 -1.31 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -89.14 140.86 29.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.424 1.489 . . . . 0.0 113.348 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.8 pt -134.45 161.02 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 127.35 2.26 . . . . 0.0 107.742 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.527 ' CE1' HG23 ' A' ' 14' ' ' THR . 57.3 m-85 -123.46 112.37 17.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 119.783 -1.823 . . . . 0.0 109.809 -169.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.75 128.8 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 100.201 -4.0 . . . . 0.0 100.201 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -90.29 136.1 33.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 110.949 -2.841 . . . . 0.0 107.004 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.255 26.8 p -114.86 132.3 56.56 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 124.465 1.103 . . . . 0.0 109.77 167.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.4 mt -72.86 -3.98 28.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 116.995 -3.566 . . . . 0.0 113.958 -151.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.5 p -76.65 -5.91 49.87 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 121.874 2.125 . . . . 0.0 115.935 159.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.6 -6.12 7.05 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 118.426 -2.671 . . . . 0.0 110.805 160.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -85.37 127.36 34.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 104.138 -2.541 . . . . 0.0 104.138 -165.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -96.2 101.4 13.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 126.629 2.456 . . . . 0.0 111.448 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.41 114.41 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 125.84 2.733 . . . . 0.0 105.305 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.527 HG23 ' CE1' ' A' ' 4' ' ' PHE . 11.2 m -99.29 113.61 26.0 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.492 HD11 HG13 ' A' ' 30' ' ' ILE . 46.7 mt -105.95 154.21 20.9 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.932 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -93.55 137.34 32.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.591 1.663 . . . . 0.0 106.677 165.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.309 11.8 m -145.05 175.78 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 128.466 2.706 . . . . 0.0 111.968 -174.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -139.3 152.99 70.58 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 128.823 2.849 . . . . 0.0 109.613 164.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.37 -30.3 92.37 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.493 2.795 . . . . 0.0 117.055 -173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 p -91.77 20.66 5.39 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 121.72 2.055 . . . . 0.0 110.752 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -100.82 140.75 34.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 119.728 -1.858 . . . . 0.0 109.046 -169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.2 p -70.24 157.91 36.81 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 127.951 3.282 . . . . 0.0 110.937 -168.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.439 HG22 ' HD2' ' A' ' 27' ' ' LYS 0.286 26.9 mt -61.67 -27.97 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 116.487 -1.72 . . . . 0.0 111.654 165.2 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.252 9.4 tp10 -62.06 -47.59 84.04 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 123.248 2.749 . . . . 0.0 106.052 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -68.71 -38.09 79.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 123.011 2.641 . . . . 0.0 111.645 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -55.62 -58.34 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 127.332 2.253 . . . . 0.0 114.389 166.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HE3' HD11 ' A' ' 43' ' ' LEU . 14.0 mttt -53.38 -35.44 60.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 128.423 2.689 . . . . 0.0 110.096 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.24 -32.34 70.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 125.157 2.408 . . . . 0.0 112.028 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.64 -7.18 58.98 Favored 'General case' 0 N--CA 1.451 -0.388 1 O-C-N 115.614 -4.428 . . . . 0.0 107.987 -170.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.492 HG13 HD11 ' A' ' 15' ' ' LEU . 35.2 mt -87.5 -33.41 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 119.649 1.113 . . . . 0.0 108.264 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -64.47 -39.1 93.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.23 -51.1 65.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.66 1.584 . . . . 0.0 114.536 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -83.22 -52.45 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -95.17 -15.63 23.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 119.834 3.272 . . . . 0.0 119.834 -171.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.33 4.46 62.61 Favored Glycine 0 CA--C 1.531 1.046 1 O-C-N 130.132 4.645 . . . . 0.0 116.035 170.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 36' ' ' ILE . 41.3 mt -86.98 123.16 70.73 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 121.485 2.642 . . . . 0.0 105.653 -155.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -62.65 133.43 42.3 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 CA-C-O 115.982 -1.758 . . . . 0.0 111.401 169.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.4 35.1 Cg_exo -41.55 -24.42 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 1 C-N-CA 128.664 6.243 . . . . 0.0 121.318 175.806 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -52.53 -50.43 62.86 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.971 1.708 . . . . 0.0 114.974 165.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -83.93 -18.25 37.97 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.162 2.985 . . . . 0.0 110.368 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -76.83 99.36 5.14 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.939 1.696 . . . . 0.0 110.526 169.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -102.47 107.81 18.91 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 119.693 -1.88 . . . . 0.0 107.988 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.466 HD11 ' HE3' ' A' ' 27' ' ' LYS . 19.2 mt -73.77 60.43 0.71 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 129.921 3.288 . . . . 0.0 110.184 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mm -87.79 107.68 17.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 115.646 -2.121 . . . . 0.0 108.732 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.379 23.3 t80 -133.3 118.85 19.02 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 129.467 3.107 . . . . 0.0 111.187 -168.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.86 43.88 26.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 129.163 2.985 . . . . 0.0 116.274 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.23 -28.9 9.6 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.034 2.254 . . . . 0.0 114.865 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.301 54.6 mttt -92.21 164.77 13.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -171.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -81.32 117.84 22.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 151.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.24 143.62 26.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.345 8.5 mt-10 -96.31 164.92 12.45 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 125.789 3.904 . . . . 0.0 111.635 -163.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -72.54 145.4 47.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 129.404 3.082 . . . . 0.0 110.325 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.75 6.5 12.79 Favored Glycine 0 CA--C 1.523 0.536 0 O-C-N 118.183 -2.823 . . . . 0.0 115.473 158.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -122.67 170.12 10.36 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.319 1.848 . . . . 0.0 110.226 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.4 p -99.7 165.3 11.67 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 130.959 3.703 . . . . 0.0 109.875 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.325 37.6 mt -41.21 -45.9 2.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.657 2.783 . . . . 0.0 113.623 170.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.4 m -84.45 -21.8 30.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 122.545 2.429 . . . . 0.0 112.281 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.263 20.0 m-20 -68.4 -18.59 64.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 115.981 -1.961 . . . . 0.0 113.457 173.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -108.33 11.7 26.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 126.564 2.415 . . . . 0.0 113.012 164.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 10.7 p30 64.47 28.04 13.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 167.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mt -78.6 131.29 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 121.025 -1.047 . . . . 0.0 110.647 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -106.88 163.83 12.63 Favored 'General case' 0 N--CA 1.444 -0.742 1 C-N-CA 132.078 4.151 . . . . 0.0 108.586 -177.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -53.67 144.32 18.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 111.209 -2.723 . . . . 0.0 113.237 171.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.433 44.9 mt-10 57.81 10.82 1.19 Allowed 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 118.393 -2.692 . . . . 0.0 117.432 -172.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 m -73.03 147.65 44.89 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.7 m -105.69 139.57 40.07 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 129.405 3.082 . . . . 0.0 107.969 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.84 179.97 8.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 114.657 -2.592 . . . . 0.0 111.365 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -125.41 131.13 52.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 127.29 2.869 . . . . 0.0 111.981 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 tp -102.43 147.08 27.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.379 1.872 . . . . 0.0 106.695 167.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -121.42 151.04 24.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 125.299 2.476 . . . . 0.0 108.897 168.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.45 -0.434 0 CA-C-N 108.804 -3.816 . . . . 0.0 110.755 176.271 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.584 0.707 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -100.25 145.54 27.96 Favored 'General case' 0 N--CA 1.442 -0.83 2 O-C-N 113.477 -5.764 . . . . 0.0 107.722 -171.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 3' ' ' ILE . 8.1 pt -127.85 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 1 O-C-N 115.78 -4.325 . . . . 0.0 107.526 151.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -88.55 136.67 32.88 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.075 -1.421 . . . . 0.0 107.697 166.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.25 10.9 t -123.59 122.33 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 117.3 -3.375 . . . . 0.0 109.448 170.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -94.01 107.14 19.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.4 6.2 p -56.41 160.45 3.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 128.196 3.435 . . . . 0.0 117.386 170.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 70' ' ' VAL . 2.0 tm? -74.63 -24.18 58.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.395 1.078 . . . . 0.0 109.032 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.67 -1.92 56.78 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 123.144 1.449 . . . . 0.0 114.174 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.44 -26.79 15.35 Favored Glycine 0 CA--C 1.526 0.761 0 O-C-N 119.371 -2.081 . . . . 0.0 115.762 165.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -70.01 130.25 41.67 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 116.929 -3.689 . . . . 0.0 107.731 -172.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.5 m -88.77 109.94 20.6 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 118.895 -2.378 . . . . 0.0 108.089 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 pt -93.31 141.48 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 124.291 1.037 . . . . 0.0 112.551 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 t -81.95 143.94 31.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 161.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.09 121.14 22.23 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 131.543 3.937 . . . . 0.0 107.363 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.31 13.1 mp0 -86.12 134.39 33.81 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 117.598 -1.641 . . . . 0.0 110.375 172.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.274 27.4 m -137.38 170.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 116.471 -1.728 . . . . 0.0 109.37 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -112.94 158.88 36.52 Favored Pre-proline 0 N--CA 1.444 -0.739 0 C-N-CA 128.668 2.787 . . . . 0.0 105.258 162.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.79 -28.35 25.23 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.935 2.423 . . . . 0.0 117.21 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -76.85 4.22 10.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 126.127 2.142 . . . . 0.0 116.596 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -84.43 141.15 31.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.361 1.864 . . . . 0.0 107.853 -164.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -78.86 140.09 38.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.336 1.455 . . . . 0.0 110.235 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.441 HD12 ' HB2' ' A' ' 54' ' ' ARG 0.29 8.3 mt -47.09 -35.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 119.979 -1.701 . . . . 0.0 114.939 171.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -53.79 -49.31 68.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.306 2.242 . . . . 0.0 111.095 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 7.9 t-20 -64.78 -43.25 93.84 Favored 'General case' 0 N--CA 1.441 -0.91 1 C-N-CA 132.665 4.386 . . . . 0.0 111.752 176.323 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.12 -50.63 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 115.208 -2.33 . . . . 0.0 113.351 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -61.6 -41.19 97.09 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 127.261 2.224 . . . . 0.0 112.259 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.73 -40.53 84.03 Favored 'General case' 0 N--CA 1.448 -0.543 1 C-N-CA 132.165 4.186 . . . . 0.0 109.235 177.363 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.32 79.8 mttt -79.33 -19.46 50.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 119.043 -2.286 . . . . 0.0 114.794 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mt -76.82 -32.34 20.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 118.887 -2.383 . . . . 0.0 107.413 172.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.82 -38.46 86.48 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 116.667 -3.77 . . . . 0.0 114.005 163.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -67.14 -23.03 65.75 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 113.007 -3.378 . . . . 0.0 109.641 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -98.55 -66.94 0.87 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 121.455 1.934 . . . . 0.0 113.733 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -111.32 -9.78 14.27 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 117.108 -3.495 . . . . 0.0 109.235 -164.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.53 2.37 50.26 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.145 -1.364 . . . . 0.0 114.479 158.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -77.0 125.13 87.26 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 125.02 1.328 . . . . 0.0 107.782 -171.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.59 129.55 19.09 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.826 3.684 . . . . 0.0 115.637 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -41.85 -33.07 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 1 C-N-CA 127.55 5.5 . . . . 0.0 117.502 175.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -51.11 -64.17 0.9 Allowed 'General case' 0 N--CA 1.445 -0.678 1 C-N-CA 132.174 4.189 . . . . 0.0 112.925 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -73.18 -26.27 61.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 128.661 2.784 . . . . 0.0 117.524 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -73.22 128.4 35.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.104 2.562 . . . . 0.0 107.351 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 ttm105 -120.73 129.37 53.61 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.977 1.711 . . . . 0.0 108.468 158.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -97.48 161.94 13.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.365 -1.779 . . . . 0.0 110.822 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -136.07 138.0 47.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 126.428 2.33 . . . . 0.0 108.062 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -130.8 116.53 18.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.602 2.361 . . . . 0.0 107.518 162.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.293 . . 57.86 34.15 24.03 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 129.034 2.934 . . . . 0.0 114.106 168.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.1 10.81 84.24 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 129.253 3.311 . . . . 0.0 117.778 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -98.61 134.63 41.28 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.917 2.487 . . . . 0.0 106.957 173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -84.63 124.71 31.77 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.99 130.19 38.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 116.222 -1.847 . . . . 0.0 109.839 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' OE1' ' NE ' ' A' ' 54' ' ' ARG . 1.1 tt0 -91.93 126.01 36.85 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.949 1.704 . . . . 0.0 109.273 -166.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -46.18 115.34 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 129.831 3.252 . . . . 0.0 111.836 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.24 -9.85 31.19 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 116.762 -2.132 . . . . 0.0 112.962 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HB2' HD12 ' A' ' 23' ' ' ILE 0.352 17.7 mmt180 -86.26 154.13 21.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 121.075 2.437 . . . . 0.0 111.383 174.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 p -71.57 161.2 31.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 160.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.49 -21.32 66.18 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 122.257 2.299 . . . . 0.0 113.796 169.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 t -77.53 -16.56 58.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 117.217 -3.427 . . . . 0.0 108.226 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -76.66 4.16 10.06 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 123.192 2.724 . . . . 0.0 113.336 167.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -138.45 9.33 2.68 Favored 'General case' 0 C--N 1.327 -0.405 1 O-C-N 115.085 -4.759 . . . . 0.0 112.523 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 t30 62.3 26.92 16.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 130.054 3.342 . . . . 0.0 116.679 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.36 128.42 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -124.32 -160.07 0.91 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.171 -1.377 . . . . 0.0 107.461 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.66 135.57 51.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -165.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 81.96 10.08 0.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 129.013 2.925 . . . . 0.0 115.12 163.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -70.06 152.19 44.66 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 126.049 2.093 . . . . 0.0 113.432 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.7 m -110.39 125.46 53.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.87 155.47 20.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 169.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -110.92 150.75 28.77 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.663 1.985 . . . . 0.0 106.999 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -125.9 135.55 52.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.705 2.402 . . . . 0.0 109.841 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.408 ' HA ' HD23 ' A' ' 8' ' ' LEU . 19.2 m -135.58 140.45 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 127.928 2.491 . . . . 0.0 108.043 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.277 1.1 pp . . . . . 0 C--N 1.325 -0.474 0 C-N-CA 128.107 2.563 . . . . 0.0 112.087 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttp . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.459 HE22 ' HG3' ' A' ' 16' ' ' GLU . 8.6 tp60 -104.67 128.92 52.88 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 101.537 -3.505 . . . . 0.0 101.537 -169.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 pt -138.14 170.97 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 129.727 3.211 . . . . 0.0 106.84 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -114.4 149.3 36.38 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -121.8 121.4 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.271 1.828 . . . . 0.0 106.206 161.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -110.1 178.49 4.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 109.248 -3.614 . . . . 0.0 110.465 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -138.08 155.96 48.26 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 128.238 2.615 . . . . 0.0 108.538 -168.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.4 mt -75.76 -14.52 60.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 112.939 -3.41 . . . . 0.0 111.245 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -92.95 -4.03 53.44 Favored 'General case' 0 C--N 1.324 -0.525 1 CA-C-N 126.255 4.116 . . . . 0.0 108.86 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.12 7.13 31.27 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 120.313 2.885 . . . . 0.0 120.313 162.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -60.76 154.26 22.17 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 118.595 -2.709 . . . . 0.0 108.82 169.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.281 4.3 m -141.92 107.0 4.94 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.427 1.891 . . . . 0.0 108.743 170.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mm -100.43 142.24 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 111.997 -2.365 . . . . 0.0 106.315 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -94.42 143.2 26.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.643 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.6 123.44 37.65 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 122.604 2.456 . . . . 0.0 107.853 -173.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.459 ' HG3' HE22 ' A' ' 2' ' ' GLN . 26.0 mp0 -99.43 109.56 22.13 Favored 'General case' 0 C--N 1.329 -0.283 1 N-CA-C 97.181 -5.118 . . . . 0.0 97.181 175.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 m -118.76 150.21 21.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 119.711 -1.868 . . . . 0.0 108.009 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -89.45 161.29 40.09 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 116.479 -1.724 . . . . 0.0 111.078 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.02 -19.76 13.55 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.504 2.803 . . . . 0.0 111.664 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 p -73.06 -17.93 61.37 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 128.709 2.804 . . . . 0.0 111.7 173.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -69.86 123.94 22.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 124.934 2.302 . . . . 0.0 112.02 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.6 p -76.67 166.11 23.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 111.893 -2.412 . . . . 0.0 110.098 162.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.2 -21.51 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 O-C-N 124.945 1.403 . . . . 0.0 108.641 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -73.59 -28.88 62.06 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.34 -29.82 53.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -83.18 -27.88 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 119.969 -1.707 . . . . 0.0 107.505 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -69.19 -42.22 76.1 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.78 -38.49 78.64 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 133.056 4.542 . . . . 0.0 114.158 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -77.36 -38.5 50.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 127.369 3.462 . . . . 0.0 114.877 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.1 mt -61.11 -35.81 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 1 O-C-N 113.05 -6.031 . . . . 0.0 105.788 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -32.96 71.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.184 1.794 . . . . 0.0 109.756 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.03 -32.19 73.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.99 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -91.65 -36.67 13.5 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.56 1.944 . . . . 0.0 113.943 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -129.16 -23.53 2.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -173.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.04 2.03 57.06 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 126.996 2.685 . . . . 0.0 116.611 165.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.2 mm -72.8 121.42 84.97 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 120.095 1.948 . . . . 0.0 111.048 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -39.27 129.11 1.56 Allowed 'Trans proline' 0 N--CA 1.443 -1.498 0 N-CA-C 119.225 2.74 . . . . 0.0 119.225 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.29 26.4 Cg_exo -47.76 -29.99 12.17 Favored 'Trans proline' 0 N--CA 1.453 -0.901 1 C-N-CA 129.227 6.618 . . . . 0.0 115.825 178.296 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -79.28 -4.27 49.93 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 128.0 2.52 . . . . 0.0 112.381 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -118.36 -15.67 9.68 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.486 1.915 . . . . 0.0 110.349 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.304 79.9 mt-30 -90.05 115.22 27.15 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 116.317 -2.153 . . . . 0.0 108.235 -170.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -103.96 129.55 51.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 100.712 -3.81 . . . . 0.0 100.712 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 mt -132.63 93.78 3.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.423 -2.673 . . . . 0.0 106.278 -162.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -89.56 128.16 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -128.86 107.71 9.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 128.728 2.811 . . . . 0.0 106.398 166.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.331 . . 60.71 16.53 6.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 130.52 3.528 . . . . 0.0 117.706 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.82 -13.47 57.73 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.314 1.912 . . . . 0.0 110.722 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.54 105.45 14.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.998 2.119 . . . . 0.0 105.568 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -61.05 107.64 0.76 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 111.742 -2.481 . . . . 0.0 114.652 152.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.6 mt -65.7 123.06 18.73 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 128.115 3.384 . . . . 0.0 107.974 -172.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.19 131.27 34.8 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 126.884 2.615 . . . . 0.0 111.267 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.97 119.39 4.24 Favored 'General case' 0 N--CA 1.449 -0.485 1 CA-C-O 129.272 4.367 . . . . 0.0 111.849 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.18 -19.74 31.76 Favored Glycine 0 CA--C 1.523 0.559 1 O-C-N 115.195 -4.691 . . . . 0.0 119.234 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -83.56 175.83 9.48 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 118.473 -1.291 . . . . 0.0 111.433 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.3 p -114.16 162.06 17.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 121.216 1.825 . . . . 0.0 110.842 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 8.9 mt -36.71 -50.56 0.83 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.104 2.962 . . . . 0.0 116.654 172.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 p -81.29 0.27 37.73 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 109.485 -3.507 . . . . 0.0 112.995 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -97.04 -18.77 19.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 116.647 -3.783 . . . . 0.0 109.249 170.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -98.99 -17.4 18.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 118.588 -2.57 . . . . 0.0 116.832 167.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 74.72 42.59 0.28 Allowed 'General case' 0 N--CA 1.452 -0.349 1 C-N-CA 132.456 4.303 . . . . 0.0 108.517 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.9 mt -68.21 106.3 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 O-C-N 119.892 -1.755 . . . . 0.0 107.853 156.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -76.88 169.9 17.47 Favored 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 133.628 4.771 . . . . 0.0 112.254 166.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.268 17.9 pttm -69.1 148.94 49.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 174.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 73.2 mt-10 57.34 13.72 1.87 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.7 m -81.58 169.6 16.86 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.467 2.307 . . . . 0.0 108.298 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -143.51 131.51 21.69 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.233 -153.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.22 145.64 35.87 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.158 -1.589 . . . . 0.0 111.159 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.281 24.6 m80 -97.1 117.91 32.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -170.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.31 128.43 34.69 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.602 1.961 . . . . 0.0 110.668 169.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.06 146.96 30.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 1 C-N-CA 131.795 4.038 . . . . 0.0 108.688 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.291 1.2 mm? . . . . . 0 C--N 1.32 -0.694 0 O-C-N 118.961 -2.337 . . . . 0.0 109.394 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -84.68 152.1 23.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 125.027 2.346 . . . . 0.0 114.235 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 3' ' ' ILE . 42.1 pt -134.16 137.14 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 129.783 3.233 . . . . 0.0 104.633 165.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -94.56 121.35 36.03 Favored 'General case' 0 N--CA 1.449 -0.504 1 C-N-CA 132.196 4.198 . . . . 0.0 105.219 166.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.56 130.8 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 101.306 -3.59 . . . . 0.0 101.306 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 23.2 mttm -90.9 116.57 28.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 129.547 3.139 . . . . 0.0 106.866 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 p -74.96 162.85 28.23 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 120.252 1.387 . . . . 0.0 110.176 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -70.56 -36.9 73.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.198 1.399 . . . . 0.0 107.823 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.8 p -80.71 -2.65 47.69 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.958 2.103 . . . . 0.0 116.273 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.49 20.34 8.24 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 161.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -107.35 158.07 17.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 126.47 3.033 . . . . 0.0 106.403 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.258 10.9 m -129.49 91.85 3.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 131.538 3.935 . . . . 0.0 108.854 -172.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mm -79.69 111.96 17.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 O-C-N 128.623 3.702 . . . . 0.0 104.71 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.257 85.1 m -86.52 107.73 18.23 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.816 1.647 . . . . 0.0 112.903 173.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mp -97.9 164.82 12.21 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 126.15 2.156 . . . . 0.0 112.888 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -113.08 146.59 38.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 127.196 3.379 . . . . 0.0 107.79 162.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.48 178.8 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 131.035 3.734 . . . . 0.0 107.5 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -120.9 150.42 52.99 Favored Pre-proline 0 N--CA 1.45 -0.432 0 C-N-CA 130.969 3.708 . . . . 0.0 103.109 154.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -47.02 -19.47 0.85 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 120.396 3.191 . . . . 0.0 120.396 164.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.7 m -58.92 -33.17 70.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 130.61 3.564 . . . . 0.0 114.276 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.09 126.49 20.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.891 2.476 . . . . 0.0 107.052 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.5 p -79.89 147.51 31.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 127.609 3.068 . . . . 0.0 104.809 162.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 8.2 mm -46.4 -51.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 111.921 -2.399 . . . . 0.0 114.439 169.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -35.78 -42.15 0.25 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 160.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -74.31 -35.42 63.66 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 117.491 -3.255 . . . . 0.0 115.371 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.85 -42.69 79.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 120.079 -1.638 . . . . 0.0 109.006 170.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -56.72 -36.98 70.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 123.686 1.708 . . . . 0.0 113.543 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.67 -34.02 62.6 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 130.665 3.586 . . . . 0.0 111.05 -175.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -75.44 -44.02 46.63 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 128.578 2.751 . . . . 0.0 106.924 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 mt -60.83 -33.71 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 119.352 -2.092 . . . . 0.0 113.553 162.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.262 12.8 tt0 -60.1 -38.64 83.56 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 123.048 1.404 . . . . 0.0 112.58 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.75 -61.45 2.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 119.492 3.145 . . . . 0.0 119.492 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -63.65 -43.78 95.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 108.452 -3.977 . . . . 0.0 110.443 -168.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -119.46 -18.32 8.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 120.238 1.381 . . . . 0.0 112.336 -167.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.75 -8.66 54.72 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 117.418 -1.768 . . . . 0.0 111.224 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -67.4 115.0 22.02 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 120.196 1.998 . . . . 0.0 111.207 -164.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -74.36 156.65 45.87 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.466 2.11 . . . . 0.0 108.592 -168.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -68.57 -35.46 17.17 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 117.079 1.915 . . . . 0.0 117.079 -172.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.02 -27.06 68.61 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 118.806 2.891 . . . . 0.0 118.806 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -83.73 -30.58 26.58 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 119.236 -2.165 . . . . 0.0 112.746 173.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -67.32 133.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 123.075 1.417 . . . . 0.0 113.719 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -128.19 141.55 51.44 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 130.505 3.522 . . . . 0.0 103.376 161.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.67 136.4 53.94 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 129.488 3.115 . . . . 0.0 106.337 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.2 mt -123.75 156.58 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 110.023 -3.262 . . . . 0.0 112.699 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -158.19 127.53 5.77 Favored 'General case' 0 N--CA 1.45 -0.453 1 O-C-N 129.355 4.16 . . . . 0.0 102.984 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.08 26.27 11.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 165.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.64 -9.6 41.13 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 128.7 3.048 . . . . 0.0 113.331 169.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -121.37 142.54 49.89 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 126.744 2.085 . . . . 0.0 111.371 -166.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -90.44 116.67 28.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 128.236 2.614 . . . . 0.0 107.978 -172.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.68 136.02 34.87 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.416 1.487 . . . . 0.0 107.99 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.253 4.3 mm-40 -92.33 124.29 36.28 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 110.667 -2.97 . . . . 0.0 107.915 -163.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -53.93 -22.18 9.6 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 119.38 3.104 . . . . 0.0 119.38 -160.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.74 -5.39 55.3 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 128.567 2.984 . . . . 0.0 119.197 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -90.15 156.39 18.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.935 1.694 . . . . 0.0 108.045 173.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -95.98 167.16 11.4 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.75 2.82 . . . . 0.0 108.704 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -70.38 -31.21 68.35 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 125.854 2.74 . . . . 0.0 108.663 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.353 14.1 t -50.71 -38.68 48.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 112.815 -3.469 . . . . 0.0 115.5 164.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.263 0.4 OUTLIER -74.03 -26.84 60.63 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 126.564 2.415 . . . . 0.0 109.578 -168.198 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.522 40.8 m-85 -102.08 10.15 39.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 125.279 1.612 . . . . 0.0 114.328 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.412 3.7 p-10 60.86 33.25 20.02 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 128.028 2.531 . . . . 0.0 116.563 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.7 mt -90.52 114.48 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.291 0.3 OUTLIER -143.86 81.35 1.69 Allowed 'General case' 0 N--CA 1.45 -0.47 1 C-N-CA 131.724 4.01 . . . . 0.0 117.011 -177.106 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.406 22.3 ttpt 84.51 131.95 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.799 3.64 . . . . 0.0 117.73 171.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 72.53 41.38 0.58 Allowed 'General case' 0 N--CA 1.443 -0.785 1 C-N-CA 134.504 5.122 . . . . 0.0 109.306 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.0 m -85.93 144.36 27.69 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 130.753 3.621 . . . . 0.0 111.439 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.9 m -100.33 109.63 21.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.127 2.571 . . . . 0.0 105.748 164.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -111.94 151.09 29.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.107 -1.901 . . . . 0.0 109.911 171.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -120.79 140.54 51.56 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 131.276 3.83 . . . . 0.0 112.06 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -98.67 135.61 39.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 116.053 -1.927 . . . . 0.0 110.954 157.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.33 148.52 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 1 O-C-N 129.345 4.153 . . . . 0.0 109.248 160.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 N--CA 1.447 -0.592 0 O-C-N 117.767 -3.083 . . . . 0.0 108.054 -173.031 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 123.284 1.516 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -134.26 150.22 51.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 108.729 -3.85 . . . . 0.0 116.608 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -136.46 144.69 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 112.8 -2.0 . . . . 0.0 113.454 166.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -90.08 122.24 32.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 116.906 -3.621 . . . . 0.0 109.138 163.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.8 t -82.82 125.24 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 101.244 -3.613 . . . . 0.0 101.244 157.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -103.98 104.58 14.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 110.14 -3.209 . . . . 0.0 104.914 162.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -72.48 137.93 46.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.645 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.36 -39.58 46.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 119.728 3.233 . . . . 0.0 119.728 -171.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.389 2.0 t -35.46 -30.76 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.704 1 C-N-CA 133.465 4.706 . . . . 0.0 117.044 156.75 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.99 -20.22 7.21 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 124.935 2.408 . . . . 0.0 110.444 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.26 73.4 tttt -71.35 139.48 49.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 119.304 -2.292 . . . . 0.0 108.712 -168.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 m -118.15 111.95 19.52 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 126.016 2.073 . . . . 0.0 114.562 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.263 13.8 mm -104.71 131.36 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.002 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.308 2.8 m -94.01 123.58 37.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 117.786 -3.071 . . . . 0.0 108.816 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mp -111.14 132.26 54.43 Favored 'General case' 0 C--O 1.217 -0.605 0 O-C-N 119.629 -1.92 . . . . 0.0 107.795 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -82.98 131.66 35.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 170.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -144.25 -174.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.807 0.843 . . . . 0.0 112.848 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -140.28 143.58 33.99 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 127.672 3.108 . . . . 0.0 108.916 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.68 -15.4 24.28 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 CA-C-N 125.105 2.859 . . . . 0.0 115.625 -167.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -75.32 1.8 12.81 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 117.41 -3.306 . . . . 0.0 116.938 165.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -93.76 150.77 20.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.499 2.319 . . . . 0.0 109.057 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 24' ' ' GLU . 7.4 p -71.36 161.0 31.78 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -175.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.63 HG23 HD13 ' A' ' 43' ' ' LEU 0.305 16.5 mm -49.76 -41.93 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 131.677 3.991 . . . . 0.0 111.174 146.197 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' H ' ' HB ' ' A' ' 22' ' ' THR . 27.8 tt0 -59.35 -45.82 90.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 116.232 -2.187 . . . . 0.0 113.159 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -71.8 -23.3 61.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.472 1.107 . . . . 0.0 113.459 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.294 91.7 t -48.88 -62.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 150.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -68.64 -38.16 80.26 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.927 -1.733 . . . . 0.0 115.086 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.82 -38.26 75.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 129.591 3.157 . . . . 0.0 116.233 172.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -50.26 -37.64 36.84 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 163.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -69.84 -12.92 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 O-C-N 119.837 -1.789 . . . . 0.0 107.675 -172.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -62.45 -43.38 98.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 116.591 -3.818 . . . . 0.0 112.895 171.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -83.32 -32.87 26.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.382 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -75.05 -67.55 0.64 Allowed 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 119.515 -1.991 . . . . 0.0 108.663 168.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -103.58 -23.58 13.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 116.902 -3.624 . . . . 0.0 115.814 -155.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.63 25.74 10.51 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 116.83 -2.095 . . . . 0.0 108.569 172.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 mm -107.68 129.39 24.26 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.36 165.63 31.02 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.292 1.995 . . . . 0.0 111.767 170.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.63 -38.02 6.39 Favored 'Trans proline' 0 N--CA 1.453 -0.897 1 C-N-CA 127.551 5.501 . . . . 0.0 117.007 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.86 -21.11 26.83 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.922 2.489 . . . . 0.0 113.968 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -95.51 -9.53 32.22 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.928 2.891 . . . . 0.0 116.297 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -95.88 133.51 39.97 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 115.193 -2.337 . . . . 0.0 108.793 -172.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -119.13 104.39 10.4 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.702 2.001 . . . . 0.0 107.953 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.63 HD13 HG23 ' A' ' 23' ' ' ILE . 1.4 tt -98.37 118.75 35.73 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 126.499 2.374 . . . . 0.0 105.487 -171.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -117.35 149.91 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -170.76 137.73 1.32 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 124.057 1.884 . . . . 0.0 107.725 166.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.36 28.95 11.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 117.434 2.383 . . . . 0.0 117.434 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.84 -5.39 69.23 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 116.454 -2.303 . . . . 0.0 114.061 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -125.76 147.36 49.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 127.404 2.473 . . . . 0.0 112.613 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -68.04 135.02 51.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.36 1.864 . . . . 0.0 113.46 163.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.625 HD22 HD22 ' A' ' 43' ' ' LEU . 9.9 mp -93.47 101.45 13.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.16 -16.63 59.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -173.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.594 26.5 t0 103.72 145.67 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 127.623 2.369 . . . . 0.0 112.136 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.3 -8.02 2.89 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 172.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.347 48.3 mtp180 -145.17 152.53 40.16 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.782 1.277 . . . . 0.0 109.812 -168.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.7 p -83.08 168.48 16.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 112.777 -2.01 . . . . 0.0 114.835 -168.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.5 mt -47.56 -40.69 19.66 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.3 p -60.1 -56.09 25.84 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.899 2.48 . . . . 0.0 116.594 167.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -46.01 -57.59 4.3 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.512 1.925 . . . . 0.0 114.117 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -74.82 -16.69 60.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 126.901 2.081 . . . . 0.0 115.168 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.274 25.5 t-20 90.33 64.28 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 129.951 3.3 . . . . 0.0 111.498 164.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -118.85 131.0 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.275 73.7 mm-40 -128.06 165.19 20.81 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 126.09 2.119 . . . . 0.0 106.606 -160.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -60.67 147.57 41.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 116.876 -1.535 . . . . 0.0 110.524 -167.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 59.92 19.62 8.62 Favored 'General case' 0 N--CA 1.444 -0.736 1 C-N-CA 131.957 4.103 . . . . 0.0 111.73 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.4 m -81.04 149.66 29.16 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 123.146 2.703 . . . . 0.0 113.287 170.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.3 m -93.08 131.76 37.81 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.879 2.872 . . . . 0.0 107.376 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.9 mt -103.52 130.03 50.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.63 2.772 . . . . 0.0 111.865 159.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -90.6 139.4 30.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.285 43.2 tp -122.29 129.58 52.32 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 117.129 -1.829 . . . . 0.0 109.116 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.254 83.6 t -95.45 139.33 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 126.354 2.284 . . . . 0.0 105.085 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 121.869 0.842 . . . . 0.0 111.813 176.095 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 112.891 -3.433 . . . . 0.0 107.742 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -91.38 134.51 34.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.386 3.074 . . . . 0.0 112.376 167.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 pt -125.19 167.51 19.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 124.836 2.255 . . . . 0.0 106.915 160.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -106.35 144.43 33.05 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.409 2.284 . . . . 0.0 108.037 162.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.486 HG21 HD11 ' A' ' 30' ' ' ILE . 43.8 t -118.42 108.34 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 168.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -86.19 132.36 34.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 123.236 1.494 . . . . 0.0 111.443 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.7 p -98.08 159.2 15.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 117.189 -3.445 . . . . 0.0 106.079 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -58.7 -45.64 89.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.218 2.207 . . . . 0.0 109.077 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -73.43 3.04 6.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 130.569 3.548 . . . . 0.0 115.772 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.06 -8.99 50.27 Favored Glycine 0 N--CA 1.442 -0.901 2 O-C-N 114.099 -5.376 . . . . 0.0 113.102 162.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -79.15 150.6 31.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 121.73 2.765 . . . . 0.0 111.797 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 p -105.87 131.35 53.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 126.345 2.278 . . . . 0.0 111.643 161.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.455 HG13 ' HB ' ' A' ' 5' ' ' VAL . 1.9 pt -104.28 162.74 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 1 O-C-N 114.611 -5.055 . . . . 0.0 105.469 168.234 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.53 110.27 14.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.635 2.374 . . . . 0.0 106.011 -172.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.282 0.4 OUTLIER -104.48 138.93 40.12 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 128.316 2.646 . . . . 0.0 109.803 -173.464 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 pm0 -90.15 135.81 33.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 126.821 2.576 . . . . 0.0 108.769 159.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 m -150.37 149.41 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.15 3.38 . . . . 0.0 107.418 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -101.87 141.88 23.47 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 127.939 2.496 . . . . 0.0 105.249 163.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -39.04 -42.76 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 N-CA-C 119.759 2.946 . . . . 0.0 119.759 167.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 p -88.15 14.75 8.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.422 2.689 . . . . 0.0 109.934 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -88.71 150.92 22.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 124.987 2.327 . . . . 0.0 105.661 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -86.99 146.74 26.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 110.442 -3.072 . . . . 0.0 110.206 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 23' ' ' ILE . 69.5 mt -57.17 -24.81 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 124.864 1.353 . . . . 0.0 112.145 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 6.9 tt0 -69.64 -34.16 73.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 128.239 2.616 . . . . 0.0 110.336 172.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.04 -31.85 66.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 114.103 -2.856 . . . . 0.0 107.305 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.4 t -79.46 -33.63 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 123.895 3.043 . . . . 0.0 107.68 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -54.85 -49.59 70.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 112.519 -3.61 . . . . 0.0 110.576 168.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.45 -52.33 6.11 Favored 'General case' 0 CA--C 1.537 0.468 1 CA-C-N 126.396 4.18 . . . . 0.0 119.426 156.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -74.09 -22.8 59.35 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 117.038 -3.539 . . . . 0.0 116.511 -169.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.486 HD11 HG21 ' A' ' 5' ' ' VAL . 14.0 mt -66.44 -39.0 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 130.951 3.701 . . . . 0.0 113.373 158.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -69.44 -26.82 64.79 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 122.841 2.564 . . . . 0.0 109.171 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.49 -42.38 74.87 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 128.436 3.585 . . . . 0.0 110.11 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -76.39 -42.63 43.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 176.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 13.8 tp10 -130.19 5.77 4.9 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.491 -1.38 . . . . 0.0 109.972 -159.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.09 -0.93 35.99 Favored Glycine 0 CA--C 1.532 1.109 1 N-CA-C 123.598 4.199 . . . . 0.0 123.598 165.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 mt -78.05 114.97 46.76 Favored Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 129.696 3.198 . . . . 0.0 105.325 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.264 4.9 Cg_exo -48.52 134.67 26.72 Favored 'Trans proline' 0 N--CA 1.455 -0.768 1 C-N-CA 125.413 4.076 . . . . 0.0 111.554 172.517 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.21 -37.01 26.28 Favored 'Trans proline' 0 N--CA 1.44 -1.656 1 C-N-CA 129.156 6.571 . . . . 0.0 115.15 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -39.49 -31.89 0.11 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 129.65 3.18 . . . . 0.0 115.756 159.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.387 85.5 mt-30 -98.26 -13.42 20.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 118.989 -2.319 . . . . 0.0 114.78 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -81.6 143.08 32.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.2 ttp-105 -127.77 129.66 47.43 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 155.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.4 mt -96.23 132.98 41.11 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 116.672 -3.767 . . . . 0.0 107.297 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mt -125.44 149.57 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -113.64 -25.84 8.52 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 118.203 -2.811 . . . . 0.0 113.076 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.683 . . -143.43 -123.86 0.09 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 112.266 -2.243 . . . . 0.0 110.773 -170.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.93 18.41 19.22 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.666 0.592 . . . . 0.0 112.436 -166.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -151.65 154.77 37.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 118.182 -2.952 . . . . 0.0 110.383 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -57.73 156.33 8.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.802 1.641 . . . . 0.0 112.537 166.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.19 162.72 18.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 118.811 -2.43 . . . . 0.0 108.195 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -104.62 140.86 37.4 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.95 1.357 . . . . 0.0 109.132 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 6.1 m-20 -67.97 -24.2 65.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 130.01 3.324 . . . . 0.0 114.594 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.12 40.77 2.43 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.539 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 11.1 mtt180 -130.37 151.17 51.16 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 165.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -96.6 162.27 13.53 Favored 'General case' 0 N--CA 1.45 -0.428 1 O-C-N 116.253 -4.03 . . . . 0.0 111.424 -167.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -54.67 -44.0 72.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.034 1.733 . . . . 0.0 110.617 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -61.27 -40.98 96.13 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 170.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -54.17 -33.13 57.32 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 131.296 3.838 . . . . 0.0 114.807 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 97.1 m-85 -100.13 0.04 39.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.276 -1.515 . . . . 0.0 111.732 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.7 t30 56.63 36.19 27.26 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 129.28 3.032 . . . . 0.0 117.588 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mt -79.28 116.21 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 103.204 -2.888 . . . . 0.0 103.204 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -103.44 169.35 8.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.598 1.959 . . . . 0.0 109.204 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.385 53.7 pttt -50.22 133.4 23.7 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.343 1.857 . . . . 0.0 113.42 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 24.0 mt-10 72.12 12.35 5.93 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 130.339 3.455 . . . . 0.0 115.488 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.9 m -60.86 145.31 50.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 113.97 -2.919 . . . . 0.0 112.864 162.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -102.39 131.26 49.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 127.698 3.124 . . . . 0.0 105.154 170.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.75 151.73 25.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.634 -2.541 . . . . 0.0 108.621 161.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -109.47 128.48 55.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 117.917 -2.99 . . . . 0.0 105.595 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.0 tp -106.21 103.07 12.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 112.11 -2.313 . . . . 0.0 109.673 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.1 t -83.23 137.17 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 124.498 2.095 . . . . 0.0 110.574 169.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 126.313 1.845 . . . . 0.0 107.274 -157.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.32 135.83 33.17 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 119.547 -1.971 . . . . 0.0 106.81 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.44 164.08 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 123.961 0.904 . . . . 0.0 112.018 166.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -90.57 129.94 36.65 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 126.092 1.757 . . . . 0.0 110.347 155.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.03 110.51 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 150.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -99.1 134.12 42.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 127.222 3.391 . . . . 0.0 110.926 170.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 p -89.15 141.36 28.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 111.706 -2.497 . . . . 0.0 108.759 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.06 -11.08 35.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 163.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -78.91 -15.55 58.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 118.212 -2.805 . . . . 0.0 115.069 169.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.19 -12.09 6.09 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 120.211 1.369 . . . . 0.0 113.64 159.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -82.95 137.19 34.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.522 1.529 . . . . 0.0 110.612 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -97.67 125.97 42.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 125.201 2.429 . . . . 0.0 106.507 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 mm -112.8 106.06 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 1 O-C-N 115.646 -4.409 . . . . 0.0 101.567 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.4 m -59.91 137.11 58.15 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 122.868 1.318 . . . . 0.0 111.618 158.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.29 140.54 43.47 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 128.584 2.754 . . . . 0.0 109.168 177.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -111.66 121.71 45.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.0 162.54 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 128.864 2.866 . . . . 0.0 104.787 -177.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -111.3 162.53 20.5 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 160.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -88.72 -21.71 1.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 121.735 1.623 . . . . 0.0 109.386 -164.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -69.09 -6.13 26.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 159.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -71.57 137.24 47.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 119.82 -1.8 . . . . 0.0 112.593 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.315 42.7 p -60.44 142.71 54.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 128.414 2.685 . . . . 0.0 112.74 169.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.444 62.6 mt -46.79 -29.58 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 163.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -53.83 -56.27 19.14 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 131.699 4.0 . . . . 0.0 108.013 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -74.75 -28.47 60.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 116.527 -1.701 . . . . 0.0 112.018 -171.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 t -71.01 -51.13 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 128.381 2.672 . . . . 0.0 111.743 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 38' ' ' PRO . 76.3 mttt -55.37 -45.37 76.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 113.456 -3.164 . . . . 0.0 113.317 168.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.5 -17.03 63.5 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 131.291 3.837 . . . . 0.0 115.324 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -77.55 -32.54 53.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 112.946 -3.407 . . . . 0.0 107.317 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.51 -21.81 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 O-C-N 127.062 2.726 . . . . 0.0 108.097 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -67.57 -35.64 79.42 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 128.534 2.734 . . . . 0.0 112.864 164.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.66 -33.13 60.4 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.277 1.031 . . . . 0.0 111.646 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -81.55 -77.33 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 119.725 -1.86 . . . . 0.0 109.391 -172.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.269 15.9 mm-40 -100.9 -15.4 17.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 115.034 -2.412 . . . . 0.0 114.604 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.05 -1.72 40.95 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 121.749 2.068 . . . . 0.0 110.331 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -76.22 130.63 77.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 114.953 -2.451 . . . . 0.0 106.641 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.53 149.73 16.69 Favored 'Trans proline' 0 N--CA 1.446 -1.319 1 C-N-CA 125.991 4.461 . . . . 0.0 111.317 -174.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 19.5 Cg_exo -40.01 -37.42 1.68 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 N-CA-C 119.475 2.837 . . . . 0.0 119.475 165.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -45.7 -49.06 14.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.153 1.781 . . . . 0.0 114.292 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -99.72 -3.4 32.99 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 127.47 2.308 . . . . 0.0 116.976 -169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -80.23 127.56 32.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 125.144 2.402 . . . . 0.0 108.979 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.533 ' CZ ' HG12 ' A' ' 70' ' ' VAL . 36.4 mtm180 -112.79 127.06 56.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 119.418 -2.051 . . . . 0.0 105.824 165.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.02 124.8 50.72 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 131.331 3.852 . . . . 0.0 107.577 -163.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 mm -124.89 128.82 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 117.12 -3.488 . . . . 0.0 109.445 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -153.68 136.99 15.73 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 118.529 -2.607 . . . . 0.0 109.701 163.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.385 . . 66.35 32.07 7.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 124.339 2.019 . . . . 0.0 115.123 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 -12.33 32.6 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 112.38 -2.191 . . . . 0.0 116.199 -174.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.261 9.9 ttpt -100.84 136.63 40.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.45 -1.617 . . . . 0.0 109.175 -167.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -92.82 116.47 29.06 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 171.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 mt -81.09 143.19 32.62 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 126.446 2.341 . . . . 0.0 105.239 -163.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.98 150.43 29.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.018 2.927 . . . . 0.0 109.356 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.67 155.33 33.47 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 117.988 -2.945 . . . . 0.0 111.361 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.77 48.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 127.111 2.291 . . . . 0.0 114.821 162.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -94.71 160.62 14.53 Favored 'General case' 0 N--CA 1.446 -0.664 1 C-N-CA 135.444 5.498 . . . . 0.0 113.878 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.4 p -103.91 170.8 7.71 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -72.51 -18.3 61.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 123.828 1.775 . . . . 0.0 108.305 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -78.68 -22.45 46.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.316 -2.115 . . . . 0.0 112.118 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -83.98 4.22 30.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -118.33 -7.38 10.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 118.091 -2.88 . . . . 0.0 108.529 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 0.3 OUTLIER 59.71 37.65 22.12 Favored 'General case' 0 N--CA 1.449 -0.511 1 C-N-CA 134.402 5.081 . . . . 0.0 114.149 -172.224 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -69.49 137.46 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 O-C-N 120.646 -1.284 . . . . 0.0 112.298 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -127.74 169.87 13.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.323 3.049 . . . . 0.0 109.48 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -42.33 131.89 3.56 Favored 'General case' 0 N--CA 1.45 -0.437 1 C-N-CA 136.415 5.886 . . . . 0.0 107.938 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.328 2.2 tt0 69.37 12.97 8.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 172.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.5 m -65.27 149.21 50.34 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.786 2.435 . . . . 0.0 108.145 166.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.4 m -101.63 120.84 40.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.238 -3.414 . . . . 0.0 102.557 166.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.37 37.8 mt -101.35 158.48 16.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.053 1.406 . . . . 0.0 110.435 162.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.301 79.2 m80 -117.41 133.5 55.9 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 119.279 -2.138 . . . . 0.0 108.947 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.28 120.18 39.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 124.876 2.274 . . . . 0.0 107.089 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.533 HG12 ' CZ ' ' A' ' 42' ' ' ARG . 96.4 t -99.99 136.76 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.498 171.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.1 tp . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 101.062 -3.681 . . . . 0.0 101.062 -177.159 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 ttp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 102.016 -3.327 . . . . 0.0 102.016 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -99.47 145.32 27.58 Favored 'General case' 0 N--CA 1.444 -0.738 2 CA-C-O 111.552 -4.071 . . . . 0.0 108.103 170.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -120.33 159.02 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 115.653 -2.118 . . . . 0.0 110.956 150.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -99.41 132.01 45.03 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 128.719 3.762 . . . . 0.0 107.298 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.45 145.36 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 O-C-N 126.674 2.484 . . . . 0.0 105.257 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -114.56 140.32 48.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 127.904 2.481 . . . . 0.0 108.616 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -100.27 170.63 8.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 125.995 2.807 . . . . 0.0 105.116 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.5 mt -57.07 -32.11 65.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.126 -2.306 . . . . 0.0 109.918 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.0 p -86.6 -9.36 56.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 117.575 -3.203 . . . . 0.0 110.343 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.75 11.31 38.13 Favored Glycine 0 CA--C 1.532 1.134 1 C-N-CA 135.108 6.099 . . . . 0.0 114.762 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -82.54 129.26 34.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 -162.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 48.1 m -96.47 126.06 41.39 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.088 0.955 . . . . 0.0 110.718 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -120.03 151.46 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 119.605 -1.934 . . . . 0.0 106.574 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.271 4.8 m -118.0 91.21 3.51 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 128.021 2.528 . . . . 0.0 106.579 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -83.0 150.19 26.51 Favored 'General case' 0 N--CA 1.444 -0.736 1 CA-C-N 107.991 -4.186 . . . . 0.0 112.053 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.88 108.07 18.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.446 1.898 . . . . 0.0 108.121 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.61 -176.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 1 C-N-CA 134.168 4.987 . . . . 0.0 116.492 173.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -152.12 159.83 32.34 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 103.007 -2.96 . . . . 0.0 103.007 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 75.1 Cg_exo -41.89 -24.42 0.29 Allowed 'Trans proline' 0 N--CA 1.443 -1.498 1 C-N-CA 128.004 5.803 . . . . 0.0 121.697 174.824 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.9 p -78.6 1.92 21.05 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 129.853 3.261 . . . . 0.0 115.182 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.45 130.01 45.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -76.98 178.71 6.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 113.916 -2.945 . . . . 0.0 112.298 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 mm -76.19 -24.62 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 113.956 -2.926 . . . . 0.0 109.197 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -72.99 -41.6 64.16 Favored 'General case' 0 C--O 1.242 0.691 1 C-N-CA 132.697 4.399 . . . . 0.0 105.062 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -65.29 -30.41 71.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.684 -2.51 . . . . 0.0 115.623 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -87.71 -35.9 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 1 CA-C-O 108.545 -5.502 . . . . 0.0 108.219 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.03 -29.57 70.48 Favored 'General case' 0 C--N 1.324 -0.51 1 CA-C-N 126.71 4.323 . . . . 0.0 114.45 169.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.87 80.78 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 125.502 2.572 . . . . 0.0 114.079 167.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -72.9 -37.2 67.33 Favored 'General case' 0 C--N 1.326 -0.414 1 O-C-N 115.117 -4.739 . . . . 0.0 108.967 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.2 mt -50.81 -65.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 128.019 2.528 . . . . 0.0 114.459 160.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -35.99 -43.58 0.33 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.206 2.202 . . . . 0.0 112.423 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -60.32 -42.02 94.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.918 3.287 . . . . 0.0 118.219 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -102.61 -29.31 11.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.011 -2.359 . . . . 0.0 114.776 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -119.08 -13.01 9.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 118.299 2.704 . . . . 0.0 118.299 -169.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.79 -12.56 68.47 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 114.278 -3.512 . . . . 0.0 118.655 162.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mt -73.12 123.2 89.29 Favored Pre-proline 0 N--CA 1.451 -0.403 1 O-C-N 130.414 4.244 . . . . 0.0 104.957 -162.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.14 145.72 33.29 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 123.79 2.994 . . . . 0.0 113.786 170.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.06 -30.33 21.06 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 N-CA-C 117.033 1.897 . . . . 0.0 117.033 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.23 -35.34 36.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 124.156 1.932 . . . . 0.0 109.109 -158.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -80.53 -19.38 45.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.83 144.98 31.65 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 117.994 -1.003 . . . . 0.0 111.542 -172.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -142.01 150.94 41.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 114.165 -2.826 . . . . 0.0 111.449 172.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.45 121.07 41.62 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 128.277 3.486 . . . . 0.0 108.084 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.4 mm -103.36 141.58 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 1 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' HB3' HD21 ' A' ' 50' ' ' LEU . 36.9 t80 -139.11 127.55 22.94 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 100.94 -3.726 . . . . 0.0 100.94 171.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.71 46.13 17.81 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 129.5 3.12 . . . . 0.0 107.831 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.07 -12.44 1.69 Allowed Glycine 0 CA--C 1.535 1.343 0 O-C-N 116.73 -3.731 . . . . 0.0 120.577 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -97.46 137.35 36.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.219 2.608 . . . . 0.0 108.711 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.13 140.08 57.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.909 1.381 . . . . 0.0 108.269 165.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 45' ' ' PHE . 92.8 mt -81.42 109.75 16.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 131.052 3.741 . . . . 0.0 104.548 164.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -94.45 136.68 34.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.459 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -47.77 141.26 5.69 Favored 'General case' 0 C--N 1.328 -0.347 1 C-N-CA 132.846 4.459 . . . . 0.0 116.241 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.66 -30.66 7.95 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.498 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -100.78 161.82 13.33 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 117.092 -3.593 . . . . 0.0 107.542 -173.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -102.65 -176.17 3.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.535 -1.666 . . . . 0.0 108.009 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.97 -34.25 77.98 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 119.041 -2.287 . . . . 0.0 113.155 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.5 m -62.39 -37.51 86.02 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -62.92 -20.06 64.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.619 1.968 . . . . 0.0 116.055 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -114.87 -5.34 12.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.143 2.177 . . . . 0.0 111.904 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 t30 55.53 54.54 8.32 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.799 1.937 . . . . 0.0 114.684 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.0 mt -88.8 132.38 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.8 0.809 . . . . 0.0 109.168 -176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -98.32 150.89 21.09 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.383 2.273 . . . . 0.0 109.317 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -46.13 135.2 7.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 127.795 3.184 . . . . 0.0 109.799 154.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.417 0.0 OUTLIER 84.6 -6.21 0.99 Allowed 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 125.877 1.986 . . . . 0.0 115.207 166.228 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 t -88.17 140.2 29.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 128.004 3.315 . . . . 0.0 108.085 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.1 m -92.89 129.35 38.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -164.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.08 128.97 54.85 Favored 'General case' 0 N--CA 1.447 -0.621 1 C-N-CA 133.744 4.818 . . . . 0.0 111.659 171.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.14 141.0 29.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 123.999 3.091 . . . . 0.0 107.669 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -116.02 92.17 3.82 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 126.762 3.173 . . . . 0.0 103.154 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -93.46 158.25 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 112.653 -2.067 . . . . 0.0 110.435 170.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 129.805 3.242 . . . . 0.0 106.482 169.554 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 ttp . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.264 19.2 tm0? -109.78 123.91 50.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 125.732 2.682 . . . . 0.0 107.397 -172.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 pt -110.46 155.47 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 129.144 2.977 . . . . 0.0 108.261 155.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -110.81 160.55 16.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 125.088 2.375 . . . . 0.0 106.652 171.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 t -123.17 134.35 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 110.087 -3.233 . . . . 0.0 108.505 166.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 tttt -115.83 157.4 24.47 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 127.894 3.246 . . . . 0.0 110.406 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.312 7.9 t -147.72 161.06 41.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.754 2.821 . . . . 0.0 108.751 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 7.6 mt -28.13 -45.94 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.445 1 C-N-CA 135.863 5.665 . . . . 0.0 119.859 -176.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -79.33 -16.89 55.61 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.708 2.803 . . . . 0.0 114.24 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.61 -12.17 58.05 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 117.489 -1.728 . . . . 0.0 113.673 -171.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -55.33 150.34 11.55 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.336 22.7 p -130.44 149.91 51.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 117.801 -3.062 . . . . 0.0 115.3 168.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.403 HD11 ' OE2' ' A' ' 34' ' ' GLU . 61.9 mt -118.38 117.55 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 100.818 -3.771 . . . . 0.0 100.818 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.283 9.0 t -106.07 122.23 45.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.151 3.38 . . . . 0.0 107.954 170.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.285 42.1 mt -113.29 134.95 54.34 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.292 3.037 . . . . 0.0 108.306 162.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -81.17 109.89 16.14 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 100.887 -3.746 . . . . 0.0 100.887 168.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 56' ' ' LEU . 5.4 m -114.8 145.21 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 125.746 2.689 . . . . 0.0 111.713 -172.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.296 3.8 tt0 -103.35 116.87 61.44 Favored Pre-proline 0 C--N 1.324 -0.532 1 C-N-CA 131.745 4.018 . . . . 0.0 106.451 -176.033 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.318 50.5 Cg_exo -32.6 -42.56 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 1 N-CA-C 122.762 4.101 . . . . 0.0 122.762 -178.283 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.6 p -80.14 -7.74 59.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 131.1 3.76 . . . . 0.0 120.357 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -68.72 126.71 30.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 124.383 1.052 . . . . 0.0 113.204 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.4 p -70.28 146.83 50.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.346 20.2 mm -51.84 -31.18 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.462 1.905 . . . . 0.0 112.439 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.69 -33.63 18.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 123.15 1.452 . . . . 0.0 109.711 -170.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.18 -36.27 83.51 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 118.923 -2.361 . . . . 0.0 117.009 165.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.0 t -63.55 -49.01 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 116.646 -1.645 . . . . 0.0 111.466 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -57.75 -29.05 64.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 118.374 2.731 . . . . 0.0 118.374 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.63 -18.09 30.41 Favored 'General case' 0 CA--C 1.537 0.456 1 C-N-CA 132.257 4.223 . . . . 0.0 108.309 -176.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -90.44 -26.94 19.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.374 1.443 . . . . 0.0 110.646 169.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 30' ' ' ILE . 95.1 mt -71.0 -31.37 45.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 129.491 3.117 . . . . 0.0 108.114 172.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -56.42 -44.54 80.48 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 126.896 2.622 . . . . 0.0 113.705 172.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.39 -47.7 84.95 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.105 2.162 . . . . 0.0 109.958 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -67.84 -69.18 0.33 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 128.167 2.587 . . . . 0.0 108.646 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.403 ' OE2' HD11 ' A' ' 13' ' ' ILE . 44.6 mm-40 -88.08 -32.83 18.53 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 121.176 3.769 . . . . 0.0 121.176 -172.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.27 5.05 35.08 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 127.79 2.614 . . . . 0.0 114.384 172.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -93.63 135.07 25.54 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 101.289 -3.597 . . . . 0.0 101.289 -174.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.8 Cg_endo -78.89 148.01 21.87 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 O-C-N 125.122 2.117 . . . . 0.0 110.817 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 47.0 Cg_exo -53.99 -30.37 58.83 Favored 'Trans proline' 0 N--CA 1.447 -1.263 1 C-N-CA 128.597 6.198 . . . . 0.0 118.427 -170.466 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -61.77 -27.01 68.43 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 130.585 3.554 . . . . 0.0 110.105 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -91.34 -12.95 33.47 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 117.159 -1.4 . . . . 0.0 113.008 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -89.12 121.71 31.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 122.722 2.51 . . . . 0.0 111.703 -174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -88.15 110.06 20.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 151.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.7 mt -91.92 92.01 8.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 153.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mt -96.88 137.02 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 128.914 2.886 . . . . 0.0 105.23 -173.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -116.56 -149.85 0.45 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 115.214 -2.327 . . . . 0.0 107.764 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 66.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 131.233 3.813 . . . . 0.0 115.465 171.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.99 -22.51 0.75 Allowed Glycine 0 CA--C 1.533 1.171 1 C-N-CA 130.906 4.098 . . . . 0.0 117.343 -164.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -82.92 128.93 34.9 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 120.718 -1.46 . . . . 0.0 113.494 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.306 19.9 mp0 -90.73 107.99 19.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 126.078 2.111 . . . . 0.0 105.711 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.61 107.44 1.4 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.913 2.485 . . . . 0.0 113.123 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.45 142.18 32.12 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.966 2.906 . . . . 0.0 110.884 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -67.92 109.94 3.65 Favored 'General case' 0 N--CA 1.45 -0.466 1 C-N-CA 133.431 4.692 . . . . 0.0 109.616 -172.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.43 -8.59 58.7 Favored Glycine 0 CA--C 1.528 0.845 1 CA-C-O 112.669 -4.406 . . . . 0.0 113.039 -171.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.72 153.65 38.75 Favored 'General case' 0 C--N 1.323 -0.553 1 CA-C-N 125.18 4.49 . . . . 0.0 110.258 165.262 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.259 67.7 p -77.38 -178.56 5.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 124.253 1.977 . . . . 0.0 106.475 169.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.428 HD11 ' HB ' ' A' ' 17' ' ' VAL 0.293 26.0 mt -77.15 -38.46 51.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.383 164.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.8 t -62.42 -23.24 66.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 112.191 -3.766 . . . . 0.0 111.609 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.96 -35.43 74.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 122.011 2.187 . . . . 0.0 109.215 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -100.66 8.4 43.37 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 128.327 2.651 . . . . 0.0 108.911 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.32 2.3 p-10 52.96 46.32 27.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.152 1.781 . . . . 0.0 115.614 170.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.447 HG21 HD13 ' A' ' 61' ' ' ILE 0.251 24.9 mt -92.46 117.52 35.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 123.662 1.696 . . . . 0.0 110.06 -167.664 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -98.85 169.01 9.76 Favored 'General case' 0 N--CA 1.45 -0.448 1 O-C-N 116.138 -4.101 . . . . 0.0 112.776 -176.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.291 20.6 pttt -37.88 152.18 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 115.512 -2.185 . . . . 0.0 115.283 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 77.05 -9.91 1.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.3 m -62.58 132.09 51.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 119.406 -2.059 . . . . 0.0 116.184 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.4 m -109.31 111.13 22.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.8 mp -83.53 146.39 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.622 3.569 . . . . 0.0 107.825 170.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.265 50.0 t60 -103.75 111.03 23.36 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 117.364 -3.335 . . . . 0.0 111.975 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.3 1.3 tt -90.78 131.43 36.44 Favored 'General case' 0 N--CA 1.45 -0.468 1 O-C-N 131.093 5.246 . . . . 0.0 104.907 -175.402 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.343 16.7 m -147.19 169.28 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 128.515 2.726 . . . . 0.0 111.236 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.284 10.9 tp . . . . . 0 N--CA 1.446 -0.646 0 C-N-CA 128.931 2.892 . . . . 0.0 107.42 -172.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -113.82 140.29 48.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 124.082 1.896 . . . . 0.0 108.528 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 pt -146.44 160.01 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 100.428 -3.915 . . . . 0.0 100.428 172.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.387 31.3 m-85 -105.36 134.74 47.97 Favored 'General case' 0 N--CA 1.445 -0.694 1 CA-C-N 107.749 -4.296 . . . . 0.0 105.13 -173.116 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 t -106.45 132.09 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 119.706 -1.872 . . . . 0.0 107.549 166.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -84.78 123.69 30.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 159.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.0 p -80.27 167.74 19.91 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.675 2.39 . . . . 0.0 116.297 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.414 ' HB3' HD22 ' A' ' 69' ' ' LEU . 1.4 pt? -60.67 -10.97 6.02 Favored 'General case' 0 C--N 1.321 -0.646 1 C-N-CA 133.211 4.605 . . . . 0.0 113.742 175.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -122.62 2.41 9.54 Favored 'General case' 0 C--N 1.33 -0.249 1 O-C-N 114.033 -5.417 . . . . 0.0 117.205 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.24 -14.02 28.33 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 117.9 1.92 . . . . 0.0 117.9 166.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -82.28 167.18 18.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.591 2.356 . . . . 0.0 110.471 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.5 m -111.98 121.38 44.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 129.728 3.211 . . . . 0.0 105.476 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.31 19.4 pt -103.57 146.19 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 128.786 2.834 . . . . 0.0 103.987 163.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 m -78.54 153.3 31.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 129.074 2.95 . . . . 0.0 109.963 149.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.83 159.63 43.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 126.87 3.224 . . . . 0.0 105.755 161.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.66 112.56 19.03 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 126.782 3.182 . . . . 0.0 107.513 -171.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.41 165.19 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 116.774 -3.704 . . . . 0.0 107.648 -173.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.283 1.6 tm-20 -103.85 149.29 37.01 Favored Pre-proline 0 N--CA 1.44 -0.967 0 O-C-N 118.387 -2.695 . . . . 0.0 108.613 161.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -53.64 -18.65 12.35 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 125.191 3.927 . . . . 0.0 114.344 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.9 p -77.22 -7.77 56.45 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 119.321 3.082 . . . . 0.0 119.321 170.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -60.36 126.97 29.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.601 1.191 . . . . 0.0 110.833 164.262 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.5 p -89.41 163.91 15.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 117.331 -1.748 . . . . 0.0 108.953 170.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.325 0.9 OUTLIER -34.77 -51.53 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 113.09 -3.338 . . . . 0.0 113.481 173.538 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.262 3.5 tp10 -67.07 -23.71 65.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 129.34 3.056 . . . . 0.0 114.696 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -74.11 -40.33 62.75 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 166.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.51 -40.89 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 O-C-N 118.716 -2.49 . . . . 0.0 106.11 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -43.28 -45.69 5.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 129.471 3.109 . . . . 0.0 118.173 172.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.81 -37.48 48.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.769 2.028 . . . . 0.0 109.828 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP 0.371 78.0 mttt -61.2 -43.6 98.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 124.85 2.262 . . . . 0.0 111.475 177.221 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.45 -53.3 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 127.94 2.496 . . . . 0.0 107.262 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -49.35 -48.55 46.53 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 117.632 -3.168 . . . . 0.0 116.003 165.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.12 -33.4 70.81 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 116.834 -1.555 . . . . 0.0 110.888 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -97.29 -51.47 4.17 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 123.449 2.84 . . . . 0.0 107.648 -172.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -102.81 -31.08 10.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 127.561 2.344 . . . . 0.0 113.347 -167.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.76 9.87 24.0 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 163.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mt -90.11 127.11 54.78 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 118.756 1.278 . . . . 0.0 107.997 -162.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.75 130.22 33.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 125.289 3.992 . . . . 0.0 114.42 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.25 2.4 Cg_endo -72.63 -2.82 12.41 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.239 1.959 . . . . 0.0 113.564 173.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -79.42 -14.17 59.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 160.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -98.6 -25.97 14.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.212 1.805 . . . . 0.0 108.551 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -86.05 111.56 20.43 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 115.476 -2.202 . . . . 0.0 108.89 -172.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -105.5 148.5 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 128.164 3.415 . . . . 0.0 106.489 154.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.56 113.68 26.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 131.308 3.843 . . . . 0.0 110.597 157.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mm -122.49 119.85 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -143.32 111.53 6.19 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.898 -1.955 . . . . 0.0 107.501 -167.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 73.49 24.87 2.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 129.583 3.153 . . . . 0.0 112.408 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.65 7.58 50.78 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-O 115.347 -2.919 . . . . 0.0 114.797 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -138.69 150.72 46.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 123.686 3.743 . . . . 0.0 108.216 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -66.16 135.49 54.6 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 111.237 -2.71 . . . . 0.0 111.793 161.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.4 mt -91.62 149.54 21.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 117.638 -1.173 . . . . 0.0 107.96 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.254 10.1 tp10 -142.07 166.78 23.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.39 2.276 . . . . 0.0 115.378 -149.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.72 122.61 18.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.265 2.226 . . . . 0.0 115.053 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.71 -21.9 17.85 Favored Glycine 0 CA--C 1.537 1.418 0 O-C-N 120.337 -1.477 . . . . 0.0 111.289 163.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.535 ' H ' ' HD2' ' A' ' 54' ' ' ARG 0.319 0.3 OUTLIER -78.69 138.31 38.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.841 1.656 . . . . 0.0 108.038 169.163 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.8 p -84.1 156.79 21.98 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.2 mt -42.94 -39.54 2.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 160.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.416 3.8 p -54.49 -46.33 73.41 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 117.426 -3.296 . . . . 0.0 117.223 161.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -65.04 -13.24 57.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 122.665 2.484 . . . . 0.0 114.029 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -104.5 10.0 35.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 119.527 -1.983 . . . . 0.0 111.681 172.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 60.46 18.74 8.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 130.312 3.445 . . . . 0.0 115.77 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.9 mt -72.92 122.63 26.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -115.5 143.5 45.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.147 3.379 . . . . 0.0 112.474 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -30.2 131.73 0.08 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.441 2.697 . . . . 0.0 116.116 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 78.57 23.74 0.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.963 2.905 . . . . 0.0 111.128 164.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.6 m -97.97 161.06 13.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 129.137 2.975 . . . . 0.0 113.301 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -102.9 118.56 37.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 112.751 -3.5 . . . . 0.0 111.017 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 mt -93.17 162.86 13.85 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 125.806 1.941 . . . . 0.0 108.138 160.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -125.54 158.74 33.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.972 2.509 . . . . 0.0 109.097 171.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 8' ' ' LEU 0.316 4.8 tt -115.08 149.57 37.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 131.356 3.862 . . . . 0.0 112.244 176.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.4 t -124.89 118.2 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 116.51 -1.709 . . . . 0.0 111.844 171.032 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttp . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 116.739 -1.6 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -100.49 134.17 43.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 -154.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.3 pt -117.32 150.01 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.93 158.07 15.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 118.667 -2.521 . . . . 0.0 108.835 162.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 58.9 t -140.34 138.25 36.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -112.13 128.23 56.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.546 2.338 . . . . 0.0 104.72 172.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.284 21.8 m -94.89 140.21 30.24 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 111.215 -2.721 . . . . 0.0 104.573 169.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tt -24.14 -39.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 131.204 3.802 . . . . 0.0 118.952 165.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -67.32 -10.55 51.99 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 118.913 -2.367 . . . . 0.0 117.122 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.78 14.41 55.17 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 118.908 -2.37 . . . . 0.0 109.193 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -90.9 121.44 32.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 130.755 3.622 . . . . 0.0 106.062 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.2 m -103.72 138.94 39.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.066 2.546 . . . . 0.0 105.312 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.1 172.27 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 128.313 2.645 . . . . 0.0 104.661 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 t -139.8 139.66 36.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 118.137 -2.852 . . . . 0.0 112.864 172.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 mp -132.08 132.55 43.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 128.275 3.484 . . . . 0.0 105.749 -177.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -76.55 122.71 24.98 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 127.455 2.302 . . . . 0.0 109.456 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.34 -174.88 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -128.05 160.14 63.16 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 165.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.93 -39.01 94.55 Favored 'Trans proline' 0 N--CA 1.445 -1.343 1 C-N-CA 126.355 4.703 . . . . 0.0 112.593 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.3 m -78.91 6.78 8.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -78.29 129.04 34.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 117.271 -3.393 . . . . 0.0 107.61 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -52.55 151.48 4.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 129.269 3.028 . . . . 0.0 110.832 168.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -54.91 -39.43 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.717 2.407 . . . . 0.0 111.664 158.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -50.24 -53.23 29.65 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.531 1.932 . . . . 0.0 114.405 171.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -54.62 -35.67 63.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 165.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -75.75 -42.11 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 119.707 -1.87 . . . . 0.0 111.977 -175.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -63.81 -35.75 81.64 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 125.724 1.89 . . . . 0.0 113.655 168.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.43 58.14 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.702 1.601 . . . . 0.0 107.133 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -83.48 -44.2 14.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 118.347 -2.721 . . . . 0.0 109.847 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.374 82.3 mt -42.46 -44.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 129.975 3.31 . . . . 0.0 114.59 164.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -57.24 -43.57 83.05 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.683 1.993 . . . . 0.0 116.226 172.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.19 -41.51 63.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -63.98 -49.08 73.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 131.696 3.998 . . . . 0.0 115.674 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -144.13 -7.15 0.72 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -171.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.12 -1.15 21.01 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 119.054 -2.279 . . . . 0.0 115.313 164.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 36' ' ' ILE . 4.9 mt -78.86 118.88 74.99 Favored Pre-proline 0 C--O 1.22 -0.472 0 CA-C-O 114.385 -2.721 . . . . 0.0 108.024 -162.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.7 149.19 78.83 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 O-C-N 125.783 2.465 . . . . 0.0 114.985 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.24 -32.36 1.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.447 1.432 . . . . 0.0 113.835 -165.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -86.05 7.02 26.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 129.62 3.168 . . . . 0.0 111.587 -169.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -132.38 -9.24 3.3 Favored 'General case' 0 C--N 1.325 -0.488 1 C-N-CA 132.103 4.161 . . . . 0.0 111.759 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.269 4.5 tt0 -103.03 139.24 38.84 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 128.43 2.692 . . . . 0.0 107.29 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -146.6 132.19 18.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 101.94 -3.355 . . . . 0.0 101.94 -171.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 67' ' ' LEU . 11.2 mp -114.68 141.64 47.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.796 -163.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.278 77.7 mt -128.96 138.67 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 1 C-N-CA 133.049 4.54 . . . . 0.0 109.784 -178.605 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -150.61 111.14 4.22 Favored 'General case' 0 N--CA 1.448 -0.566 1 C-N-CA 131.739 4.015 . . . . 0.0 109.309 176.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.312 . . 68.56 31.06 4.91 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.85 -23.34 9.25 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.32 1.438 . . . . 0.0 111.526 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -74.3 126.67 31.15 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 110.65 6.75 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 129.304 3.042 . . . . 0.0 106.717 160.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.9 mt -82.41 128.87 34.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -78.15 159.41 28.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.578 1.551 . . . . 0.0 111.31 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -73.91 133.19 43.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.493 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.59 -15.48 55.82 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 115.11 -3.05 . . . . 0.0 111.733 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -77.21 159.7 29.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 123.043 3.421 . . . . 0.0 114.692 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -106.44 -177.77 3.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 127.935 3.272 . . . . 0.0 110.785 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.34 -18.21 46.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 128.58 2.752 . . . . 0.0 109.095 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.83 -28.41 50.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.788 2.035 . . . . 0.0 110.815 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -64.6 -31.11 72.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 126.445 3.021 . . . . 0.0 115.675 172.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.96 8.61 13.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 124.636 2.16 . . . . 0.0 115.46 -173.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.291 36.3 m-20 67.16 39.16 3.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 120.906 3.669 . . . . 0.0 120.906 163.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.2 mt -88.75 128.24 41.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.596 -164.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -98.23 165.12 12.02 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 124.824 2.25 . . . . 0.0 115.314 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -63.88 127.8 33.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.96 -2.963 . . . . 0.0 107.491 -168.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.468 0.0 OUTLIER 93.28 3.98 0.06 Allowed 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 126.297 2.248 . . . . 0.0 113.666 175.1 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.9 m -61.05 144.02 54.26 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 117.029 -3.544 . . . . 0.0 109.854 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -92.55 117.34 29.85 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 118.441 -2.662 . . . . 0.0 114.047 170.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.426 HD21 HD23 ' A' ' 43' ' ' LEU 0.25 23.4 tp -107.12 134.42 50.27 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 125.131 1.519 . . . . 0.0 109.094 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -107.73 152.47 24.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.9 155.23 42.73 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 126.021 2.819 . . . . 0.0 107.575 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.93 137.44 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 131.439 3.896 . . . . 0.0 103.471 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.447 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 114.839 -2.505 . . . . 0.0 111.391 176.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 ttp . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 101.966 -3.346 . . . . 0.0 101.966 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -88.5 135.96 33.22 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 121.701 2.046 . . . . 0.0 114.27 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 3' ' ' ILE 0.279 44.4 pt -119.42 148.02 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 128.626 2.77 . . . . 0.0 113.771 168.494 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -99.55 115.89 30.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.701 2.4 . . . . 0.0 111.365 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.277 6.5 t -89.1 100.29 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 129.086 2.954 . . . . 0.0 103.053 172.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -74.11 156.83 36.98 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.242 -1.536 . . . . 0.0 114.721 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.445 13.0 t -150.71 164.46 36.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.57 171.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 tp -46.23 -39.98 10.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 121.37 3.841 . . . . 0.0 121.37 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.8 p -82.15 -1.26 48.28 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 123.849 1.785 . . . . 0.0 111.425 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.37 8.94 55.95 Favored Glycine 0 N--CA 1.443 -0.852 0 O-C-N 116.71 -3.744 . . . . 0.0 116.539 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -76.32 132.45 39.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.027 2.931 . . . . 0.0 106.733 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 p -112.94 132.6 55.28 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 108.832 -3.803 . . . . 0.0 103.261 161.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 mt -102.03 135.12 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 159.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 t -81.88 115.89 21.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 125.587 1.804 . . . . 0.0 111.511 160.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.3 tp -116.81 129.68 56.24 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -80.4 143.94 33.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.786 1.755 . . . . 0.0 110.754 170.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.97 167.86 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 128.554 2.742 . . . . 0.0 109.822 164.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.263 9.0 tt0 -105.55 147.45 34.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 110.277 -3.147 . . . . 0.0 105.713 153.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -74.88 -25.21 12.34 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.075 1.85 . . . . 0.0 110.533 -172.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -63.97 -9.34 15.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 173.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -68.04 164.03 21.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 130.036 3.334 . . . . 0.0 111.286 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 p -124.09 148.09 47.39 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 128.822 2.849 . . . . 0.0 104.949 -164.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.92 -48.41 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 110.584 -3.007 . . . . 0.0 112.988 -171.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -67.17 -36.93 82.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -66.48 -39.71 88.91 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.27 86.9 t -70.47 -39.52 76.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 125.707 1.603 . . . . 0.0 110.405 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -56.67 -29.28 62.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 168.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.82 -41.21 62.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 166.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -64.49 -31.88 73.28 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 119.861 -1.774 . . . . 0.0 109.42 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.325 55.1 mt -62.48 -35.03 67.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.313 3.445 . . . . 0.0 110.614 165.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.26 -38.86 65.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 115.071 -2.395 . . . . 0.0 106.642 -174.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.45 1.5 t70 -37.95 -41.59 0.56 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.992 2.96 . . . . 0.0 118.992 166.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -81.46 -72.16 0.44 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.072 -1.876 . . . . 0.0 115.153 171.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -84.62 -19.87 32.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 116.535 -1.697 . . . . 0.0 115.179 -170.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.08 -9.47 56.42 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 116.867 -2.074 . . . . 0.0 111.036 159.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.09 137.31 37.47 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 123.001 1.381 . . . . 0.0 108.891 -169.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -55.95 139.96 85.26 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.292 2.661 . . . . 0.0 113.579 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.63 -26.47 12.92 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.067 2.512 . . . . 0.0 117.527 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -45.0 -38.65 4.91 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 130.812 3.645 . . . . 0.0 113.607 174.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.09 -4.11 36.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.25 2.22 . . . . 0.0 109.877 -171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -98.17 117.82 33.39 Favored 'General case' 0 N--CA 1.451 -0.393 1 O-C-N 115.656 -4.403 . . . . 0.0 114.837 -170.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.258 16.4 ttm-85 -112.39 113.94 26.4 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.172 1.789 . . . . 0.0 110.881 163.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -83.21 143.51 30.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 120.59 -1.319 . . . . 0.0 109.473 163.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 tt -133.73 143.67 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 119.531 -1.981 . . . . 0.0 106.04 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -136.99 84.3 2.06 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -170.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 84.37 24.87 0.1 Allowed 'General case' 0 N--CA 1.448 -0.547 1 C-N-CA 133.205 4.602 . . . . 0.0 113.984 165.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.12 -1.85 26.92 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 119.184 -2.198 . . . . 0.0 113.674 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.353 40.8 ttmt -121.43 137.14 54.84 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.097 2.159 . . . . 0.0 107.017 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -73.04 128.09 34.46 Favored 'General case' 0 N--CA 1.442 -0.826 1 C-N-CA 135.108 5.363 . . . . 0.0 108.618 177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.463 HD22 ' CG ' ' A' ' 59' ' ' TYR . 86.2 mt -93.41 132.27 37.81 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -134.42 145.86 49.29 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 131.101 3.761 . . . . 0.0 109.532 -162.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.29 144.93 29.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.075 -2.329 . . . . 0.0 110.418 -163.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.52 4.59 23.28 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 116.951 -2.027 . . . . 0.0 116.194 -166.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.337 11.7 mtm180 -125.51 177.5 6.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.004 1.402 . . . . 0.0 113.367 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.3 p -95.95 175.25 6.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 119.339 -2.101 . . . . 0.0 110.927 158.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -57.91 -30.98 66.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 159.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 t -66.75 -25.67 66.61 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 113.093 -3.337 . . . . 0.0 114.115 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.73 -19.99 54.26 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 127.39 2.931 . . . . 0.0 109.494 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CG ' HD22 ' A' ' 50' ' ' LEU 0.295 23.3 m-85 -108.04 6.74 27.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.11 -2.244 . . . . 0.0 110.548 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.397 0.4 OUTLIER 68.86 30.73 4.59 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.849 2.059 . . . . 0.0 112.698 163.813 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mt -79.16 122.47 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 O-C-N 119.293 -2.13 . . . . 0.0 110.075 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -111.62 165.57 11.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.176 1.79 . . . . 0.0 112.607 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -46.85 143.96 2.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 119.643 -1.911 . . . . 0.0 115.719 171.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 63.72 21.44 12.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 128.981 2.912 . . . . 0.0 112.254 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 m -82.89 152.67 25.46 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.12 1.768 . . . . 0.0 107.476 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.6 m -109.91 105.84 15.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 127.714 3.134 . . . . 0.0 107.862 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -82.79 154.78 24.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 163.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -117.63 148.08 42.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 118.502 -2.624 . . . . 0.0 108.436 166.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.3 tp -109.28 147.55 32.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 124.829 2.252 . . . . 0.0 105.256 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.85 175.25 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 113.683 -3.056 . . . . 0.0 107.044 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.25 13.3 tp . . . . . 0 N--CA 1.45 -0.447 0 O-C-N 128.402 3.564 . . . . 0.0 103.813 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 ttp . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -94.48 144.82 25.25 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 115.279 -2.296 . . . . 0.0 106.689 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.419 HD11 HG11 ' A' ' 17' ' ' VAL . 3.2 pt -146.57 172.66 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.842 2.457 . . . . 0.0 106.193 165.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -135.26 118.6 16.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 128.057 3.348 . . . . 0.0 107.987 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.27 129.1 44.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 131.199 3.799 . . . . 0.0 101.975 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -126.2 125.45 42.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 126.241 2.924 . . . . 0.0 111.812 172.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.3 p -84.55 151.56 24.47 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.301 80.7 mt -56.65 -10.34 0.98 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 131.105 3.762 . . . . 0.0 115.984 175.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 p -93.4 -24.3 18.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 128.724 2.81 . . . . 0.0 109.269 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.06 43.18 1.81 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.148 1.832 . . . . 0.0 116.276 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -115.56 110.11 18.76 Favored 'General case' 0 C--N 1.321 -0.641 2 C-N-CA 132.118 4.167 . . . . 0.0 110.727 169.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.6 m -85.72 111.94 20.59 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 124.44 2.067 . . . . 0.0 110.281 173.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.0 mt -100.02 116.15 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 128.089 3.804 . . . . 0.0 101.741 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.325 52.7 m -91.46 134.05 34.96 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 102.274 -3.232 . . . . 0.0 102.274 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tp -130.47 155.28 46.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.112 2.965 . . . . 0.0 110.116 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 126.31 53.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 3' ' ' ILE . 11.6 m -134.53 163.77 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -101.17 148.17 34.76 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 114.305 -2.76 . . . . 0.0 106.575 174.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.95 6.77 3.98 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 CA-C-N 126.251 3.268 . . . . 0.0 113.675 -171.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -118.05 -2.95 11.16 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 114.595 -2.621 . . . . 0.0 105.666 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.97 122.87 11.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.636 2.774 . . . . 0.0 105.942 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -66.77 158.38 30.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 127.784 3.178 . . . . 0.0 116.61 161.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mm -58.46 -33.44 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 123.341 2.791 . . . . 0.0 114.36 171.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -45.29 -49.59 12.55 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 164.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -70.76 -39.06 73.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.368 71.1 t -52.3 -37.84 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 127.59 2.356 . . . . 0.0 114.021 169.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -66.92 -31.38 71.93 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 116.791 -3.693 . . . . 0.0 115.832 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.47 -36.78 32.99 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.851 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.77 -29.7 70.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 116.801 -1.571 . . . . 0.0 114.833 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.99 -43.78 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 116.398 -1.763 . . . . 0.0 111.478 166.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -59.7 -39.66 85.33 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 114.125 -2.845 . . . . 0.0 110.583 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.14 -21.48 22.78 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.515 1.134 . . . . 0.0 113.72 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.251 18.3 mmtm -109.54 -49.91 3.05 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 117.358 -3.339 . . . . 0.0 107.025 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -103.24 -9.67 19.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 113.788 -3.006 . . . . 0.0 113.661 -165.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.98 -17.7 49.32 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 121.701 2.046 . . . . 0.0 112.69 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.41 HD13 HD21 ' A' ' 71' ' ' LEU . 1.8 pt -81.2 140.22 49.18 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 117.408 0.604 . . . . 0.0 111.184 -175.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.41 140.85 30.82 Favored 'Trans proline' 0 N--CA 1.453 -0.882 1 C-N-CA 126.731 4.954 . . . . 0.0 114.971 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -40.81 -31.08 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.316 1 C-N-CA 127.373 5.382 . . . . 0.0 119.453 173.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.83 -54.81 42.13 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 131.471 3.908 . . . . 0.0 113.839 -174.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -80.02 -7.18 58.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 126.323 2.963 . . . . 0.0 114.549 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.62 145.78 25.01 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 117.573 -3.205 . . . . 0.0 111.103 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -123.67 130.95 53.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.503 1.521 . . . . 0.0 108.814 151.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.669 HD12 HD22 ' A' ' 67' ' ' LEU . 1.7 mm? -89.54 130.88 35.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 172.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -122.34 123.93 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 112.398 -2.183 . . . . 0.0 115.424 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.456 ' HB2' HD23 ' A' ' 67' ' ' LEU . 87.0 t80 -147.47 144.38 28.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 130.008 3.323 . . . . 0.0 113.848 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.62 24.68 14.04 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.938 2.495 . . . . 0.0 112.816 168.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.98 -2.32 69.02 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 114.909 0.723 . . . . 0.0 114.909 -177.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -134.64 155.82 49.82 Favored 'General case' 0 N--CA 1.447 -0.619 2 O-C-N 115.031 -4.805 . . . . 0.0 112.906 -170.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -79.12 133.6 36.75 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 125.435 2.541 . . . . 0.0 106.052 164.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 mt -80.47 136.39 36.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.769 -2.014 . . . . 0.0 114.565 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -76.89 144.05 39.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 116.884 -1.926 . . . . 0.0 111.464 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -66.67 -33.07 74.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.236 -168.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.28 -5.0 49.96 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 126.33 1.919 . . . . 0.0 111.564 -165.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.306 11.4 mmt180 -74.18 149.56 40.86 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.772 2.029 . . . . 0.0 114.616 161.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -103.87 159.76 15.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 127.215 3.388 . . . . 0.0 109.489 -172.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.2 mt -48.28 -47.45 36.35 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 110.025 -3.261 . . . . 0.0 111.915 162.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -59.8 -49.88 76.0 Favored 'General case' 0 N--CA 1.443 -0.805 1 O-C-N 129.694 4.371 . . . . 0.0 119.952 167.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 50.6 m-20 -50.06 -43.72 51.26 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 121.408 3.855 . . . . 0.0 121.408 165.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -93.28 1.28 57.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 73.57 50.8 0.12 Allowed 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 119.113 -2.242 . . . . 0.0 104.976 168.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.1 69.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 118.459 -2.65 . . . . 0.0 104.932 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -127.52 72.97 1.41 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.357 -147.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.416 10.9 tmtt? 89.03 90.87 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 O-C-N 125.285 1.616 . . . . 0.0 112.363 171.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 86.41 47.3 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 110.665 -2.971 . . . . 0.0 110.693 158.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 p -117.05 159.06 23.12 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.746 1.26 . . . . 0.0 108.733 171.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.5 m -108.8 137.46 46.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 125.495 2.569 . . . . 0.0 109.118 -172.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.669 HD22 HD12 ' A' ' 43' ' ' LEU 0.256 0.9 OUTLIER -113.84 143.57 44.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 111.711 -2.495 . . . . 0.0 107.306 -173.923 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -90.49 136.85 32.8 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 130.481 3.512 . . . . 0.0 107.47 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.3 tp -121.32 113.9 20.57 Favored 'General case' 0 N--CA 1.451 -0.405 1 C-N-CA 131.754 4.022 . . . . 0.0 107.486 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -117.56 133.16 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 129.288 3.035 . . . . 0.0 104.388 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 36' ' ' ILE . 3.5 mp . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 125.811 2.72 . . . . 0.0 111.454 -166.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 113.788 -3.006 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.253 59.2 tt0 -104.57 164.82 11.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 125.586 1.804 . . . . 0.0 109.522 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -145.51 164.91 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 1 C-N-CA 134.746 5.219 . . . . 0.0 107.053 168.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.2 147.08 41.79 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 118.922 -2.361 . . . . 0.0 111.782 175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.68 113.66 28.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 113.333 -3.222 . . . . 0.0 106.558 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -87.74 143.73 27.0 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 126.522 2.388 . . . . 0.0 110.123 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -117.09 158.73 23.7 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 126.192 2.182 . . . . 0.0 109.49 -171.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.512 HD21 HG12 ' A' ' 70' ' ' VAL . 74.6 mt -50.44 -50.29 52.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 116.826 -3.671 . . . . 0.0 116.973 -175.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -138.11 34.14 2.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.21 -123.84 2.52 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 -172.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -138.47 -167.85 2.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.677 1.991 . . . . 0.0 111.204 -166.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 p -89.75 119.99 30.62 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.083 0.856 . . . . 0.0 110.909 149.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.2 mt -80.55 143.45 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 167.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.264 71.9 p -114.68 122.31 46.06 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 113.931 -2.937 . . . . 0.0 108.221 -169.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.4 HD21 HG12 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -128.68 134.22 48.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 122.3 2.318 . . . . 0.0 104.906 174.119 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.85 118.91 37.8 Favored 'General case' 0 N--CA 1.44 -0.962 1 N-CA-C 99.909 -4.108 . . . . 0.0 99.909 172.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.45 149.64 33.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 130.102 3.361 . . . . 0.0 107.478 -167.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -74.19 137.02 75.47 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -62.64 -5.48 7.26 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 CA-C-O 115.817 -1.826 . . . . 0.0 115.921 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.4 p -115.18 23.45 12.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -81.36 160.92 23.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 126.717 2.51 . . . . 0.0 115.498 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 p -102.28 140.79 36.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 131.595 3.958 . . . . 0.0 107.23 -162.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.3 mt -47.96 -47.1 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 125.803 1.641 . . . . 0.0 112.979 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.75 -38.59 89.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.989 1.722 . . . . 0.0 112.025 -173.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -72.45 -12.73 61.22 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.114 2.166 . . . . 0.0 110.797 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 t -99.42 -27.39 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 1 CA-C-O 110.642 -4.504 . . . . 0.0 106.288 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -56.73 -42.97 80.17 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 128.28 3.488 . . . . 0.0 109.907 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.17 -42.41 77.03 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.717 3.607 . . . . 0.0 112.001 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -64.26 -35.36 80.58 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.4 HG12 HD21 ' A' ' 15' ' ' LEU . 61.5 mt -72.91 -28.07 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.461 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -52.49 35.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 117.105 -3.497 . . . . 0.0 114.681 166.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.94 -30.17 63.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -101.31 -33.16 10.15 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.401 1.455 . . . . 0.0 112.647 -173.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.327 78.8 mm-40 -125.28 -19.14 5.17 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.12 2.73 51.55 Favored Glycine 0 N--CA 1.44 -1.098 0 O-C-N 117.559 -3.213 . . . . 0.0 115.719 170.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.3 mt -77.66 120.67 82.32 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 122.584 3.192 . . . . 0.0 109.945 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.47 159.11 49.34 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 N-CA-C 118.037 2.283 . . . . 0.0 118.037 169.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.47 -19.83 11.34 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 124.556 3.504 . . . . 0.0 114.529 -169.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -82.4 -12.2 58.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -76.41 -42.84 42.89 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.647 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -74.77 110.73 9.31 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 127.917 3.261 . . . . 0.0 107.934 -156.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -108.54 112.1 24.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 100.388 -3.93 . . . . 0.0 100.388 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.38 124.3 44.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.538 0.0 OUTLIER -127.3 137.31 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 117.637 -3.164 . . . . 0.0 113.259 -175.751 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.476 ' CE2' HG13 ' A' ' 61' ' ' ILE 0.275 24.9 t80 -149.59 108.15 3.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.817 -1.538 . . . . 0.0 109.207 -165.427 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.4 23.34 6.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 127.043 3.306 . . . . 0.0 115.172 164.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.02 -17.86 47.54 Favored Glycine 0 CA--C 1.531 1.09 1 C-N-CA 136.234 6.635 . . . . 0.0 111.628 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -80.6 120.0 23.98 Favored 'General case' 0 N--CA 1.447 -0.607 1 C-N-CA 131.808 4.043 . . . . 0.0 107.824 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -73.06 131.59 42.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 115.417 -2.23 . . . . 0.0 114.604 159.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.364 39.2 mt -110.45 132.64 54.0 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 125.892 2.758 . . . . 0.0 107.264 -163.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -105.46 124.96 50.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 111.399 -2.637 . . . . 0.0 113.33 -169.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.267 0.0 OUTLIER -61.43 139.88 58.14 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 111.908 -2.405 . . . . 0.0 110.619 -172.435 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.81 -38.18 2.09 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 104.243 -3.543 . . . . 0.0 104.243 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -94.38 -178.37 4.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 -175.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.257 46.7 p -119.68 -175.84 3.04 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.753 -166.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.2 -41.87 96.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.154 1.381 . . . . 0.0 114.278 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 t -71.93 -32.91 67.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 131.011 3.725 . . . . 0.0 107.681 -170.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -71.46 -13.36 61.8 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 130.824 3.65 . . . . 0.0 112.698 -172.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -128.97 0.97 5.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.069 2.547 . . . . 0.0 111.466 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t30 57.41 53.89 7.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 128.815 2.846 . . . . 0.0 110.401 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.476 HG13 ' CE2' ' A' ' 45' ' ' PHE . 5.0 mt -92.46 112.57 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 100.395 -3.928 . . . . 0.0 100.395 168.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -130.86 171.41 13.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.39 -167.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.74 113.79 0.92 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 129.237 3.015 . . . . 0.0 112.218 -170.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 67.88 25.17 7.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 118.201 -2.812 . . . . 0.0 117.337 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.1 m -64.32 135.22 55.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 118.233 -2.792 . . . . 0.0 117.829 156.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.267 96.5 m -110.49 128.0 55.42 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 124.479 1.112 . . . . 0.0 108.563 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.261 1.2 mp -109.67 168.73 9.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 173.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -112.35 138.37 49.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.965 3.306 . . . . 0.0 107.668 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tp -126.79 114.76 18.38 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.908 1.683 . . . . 0.0 108.138 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.512 HG12 HD21 ' A' ' 8' ' ' LEU . 25.1 m -106.1 142.56 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 175.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.3 mt . . . . . 0 N--CA 1.445 -0.718 0 CA-C-O 116.005 -1.95 . . . . 0.0 111.649 179.777 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 123.544 1.64 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -105.13 130.18 53.36 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.725 3.21 . . . . 0.0 110.977 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.293 17.6 pt -133.04 140.85 46.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 1 C-N-CA 133.731 4.812 . . . . 0.0 113.345 177.596 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 49.3 m-85 -93.21 148.88 21.65 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 125.89 2.757 . . . . 0.0 112.226 170.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.55 126.57 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 118.812 -2.43 . . . . 0.0 105.304 170.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -87.2 112.29 21.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 115.687 -2.102 . . . . 0.0 114.796 171.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 p -62.68 155.62 25.85 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 119.748 1.158 . . . . 0.0 113.03 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.62 -36.26 80.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.17 2.588 . . . . 0.0 111.242 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -93.01 0.01 57.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.824 1.193 . . . . 0.0 112.682 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.93 20.51 6.01 Favored Glycine 0 N--CA 1.445 -0.719 0 O-C-N 118.484 -2.635 . . . . 0.0 116.212 142.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -84.89 152.58 23.45 Favored 'General case' 0 CA--C 1.538 0.503 1 C-N-CA 136.016 5.726 . . . . 0.0 107.247 171.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -112.38 137.07 51.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.351 1.2 pt -115.01 131.64 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 176.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.375 32.6 m -90.95 130.51 36.87 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 166.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tp -117.25 137.29 52.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 104.446 -2.428 . . . . 0.0 104.446 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 17' ' ' VAL . 2.3 tp10 -94.16 144.5 25.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 16' ' ' GLU . 12.9 m -158.96 -177.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.257 2.223 . . . . 0.0 106.763 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -133.06 153.15 80.77 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 129.119 2.967 . . . . 0.0 106.394 166.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.34 0.1 OUTLIER -49.4 -24.33 8.6 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 N-CA-C 119.214 2.736 . . . . 0.0 119.214 167.107 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.9 p -84.57 -11.06 56.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 113.578 -3.106 . . . . 0.0 110.619 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -68.35 131.72 45.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 129.746 3.218 . . . . 0.0 113.593 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.6 p -82.45 164.62 20.85 Favored 'General case' 0 N--CA 1.449 -0.476 1 O-C-N 129.542 4.276 . . . . 0.0 111.879 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -59.64 -31.29 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 112.541 -2.118 . . . . 0.0 112.013 172.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -74.21 -16.64 60.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 124.468 2.08 . . . . 0.0 112.584 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -98.45 -28.59 13.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.12 2.568 . . . . 0.0 110.485 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.267 62.8 t -52.52 -59.48 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.823 2.449 . . . . 0.0 112.291 168.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.343 17.4 ptpt -53.87 -41.78 67.9 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 128.184 3.428 . . . . 0.0 113.456 177.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.05 -40.56 70.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 126.244 2.215 . . . . 0.0 113.013 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -77.34 -28.1 52.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.609 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.55 -34.73 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 O-C-N 119.614 -1.929 . . . . 0.0 112.261 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -58.88 -42.89 90.54 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 119.225 0.92 . . . . 0.0 113.163 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.69 -47.06 42.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.257 2.223 . . . . 0.0 112.784 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -68.46 -38.65 81.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.422 64.3 mm-40 -129.21 -18.56 3.64 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 130.093 3.357 . . . . 0.0 115.675 -154.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.77 -22.28 41.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.66 2.076 . . . . 0.0 114.686 163.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 36' ' ' ILE . 44.4 mt -86.48 119.04 71.19 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 125.883 1.673 . . . . 0.0 109.638 -163.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -45.94 149.26 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.644 1 C-N-CA 127.615 5.543 . . . . 0.0 115.73 175.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -68.02 -32.51 28.05 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 124.535 3.49 . . . . 0.0 109.995 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.258 19.7 t70 -49.96 -35.92 26.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 117.042 -1.456 . . . . 0.0 114.144 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -101.55 -5.73 24.78 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 128.679 2.791 . . . . 0.0 107.325 -160.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -85.66 141.34 29.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 119.22 -2.175 . . . . 0.0 115.772 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -128.17 95.85 4.29 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.49 111.09 18.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 114.544 -2.646 . . . . 0.0 114.472 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mt -118.77 144.24 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 125.163 3.619 . . . . 0.0 110.383 -172.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -140.37 123.18 16.41 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 163.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.83 33.12 0.92 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 111.713 -2.494 . . . . 0.0 114.022 169.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.95 -33.88 4.99 Favored Glycine 0 C--O 1.221 -0.671 0 O-C-N 118.63 -2.543 . . . . 0.0 112.898 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -79.04 121.66 25.23 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 128.199 2.941 . . . . 0.0 112.171 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -79.51 111.38 15.72 Favored 'General case' 0 N--CA 1.454 -0.251 1 N-CA-C 100.023 -4.066 . . . . 0.0 100.023 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.67 123.01 24.83 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 127.826 2.45 . . . . 0.0 108.691 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -94.85 151.12 19.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 124.927 2.299 . . . . 0.0 108.389 -163.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.94 139.32 33.43 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 109.796 -3.365 . . . . 0.0 110.524 -168.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.47 -20.09 38.0 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.738 2.59 . . . . 0.0 116.291 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.8 mmm-85 -73.38 145.05 46.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 117.759 -3.201 . . . . 0.0 109.49 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 p -75.64 144.18 41.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.447 2.699 . . . . 0.0 107.026 167.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.0 mt -47.18 -37.67 10.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 166.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -67.91 -30.74 70.15 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -77.62 -36.9 51.23 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 126.262 1.825 . . . . 0.0 110.022 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.561 ' HB3' HG12 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -68.43 -20.98 64.68 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 115.742 -2.075 . . . . 0.0 115.839 170.555 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.341 29.5 m120 74.58 27.01 1.39 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 120.272 3.434 . . . . 0.0 120.272 -170.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.561 HG12 ' HB3' ' A' ' 59' ' ' TYR . 39.7 mm -81.18 112.52 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 O-C-N 117.863 -3.023 . . . . 0.0 109.065 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.254 78.0 mm-40 -83.25 155.71 23.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.938 2.895 . . . . 0.0 114.319 177.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.55 127.38 15.41 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 131.343 3.857 . . . . 0.0 114.762 170.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 1.5 pt-20 65.2 33.13 9.55 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 125.685 2.659 . . . . 0.0 116.048 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -74.59 155.44 37.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 124.899 2.285 . . . . 0.0 111.746 160.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 20.6 m -116.21 104.39 11.47 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 111.537 -2.574 . . . . 0.0 105.516 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -94.86 159.77 14.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 130.77 3.628 . . . . 0.0 108.721 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.347 70.7 m80 -109.35 136.61 48.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 115.465 -2.207 . . . . 0.0 114.198 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.261 31.4 tp -108.94 117.5 34.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 126.006 2.066 . . . . 0.0 106.322 173.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -112.0 145.44 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 111.818 -2.446 . . . . 0.0 105.246 169.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 130.034 3.333 . . . . 0.0 110.538 168.032 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pm0 -96.66 143.03 28.0 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.405 3.082 . . . . 0.0 109.509 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.454 HG13 HD12 ' A' ' 15' ' ' LEU . 18.4 pt -132.72 158.09 43.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 1 C-N-CA 132.152 4.181 . . . . 0.0 105.976 152.596 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -100.66 138.94 37.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.596 1.958 . . . . 0.0 108.327 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.49 110.37 31.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 172.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -107.06 113.22 26.56 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 126.876 3.227 . . . . 0.0 106.28 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -79.19 148.1 32.4 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 117.399 -3.313 . . . . 0.0 105.527 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.53 -21.23 66.16 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 118.908 -2.37 . . . . 0.0 112.836 168.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 p -79.0 -1.32 34.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.003 1.721 . . . . 0.0 112.334 167.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.68 -27.09 22.12 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 115.867 -2.629 . . . . 0.0 112.251 160.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -64.32 139.6 58.78 Favored 'General case' 0 C--N 1.328 -0.352 1 C-N-CA 132.21 4.204 . . . . 0.0 108.179 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.9 m -117.26 112.72 21.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 124.524 2.107 . . . . 0.0 105.934 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.7 mt -101.16 138.03 26.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 1 C-N-CA 131.832 4.053 . . . . 0.0 106.646 176.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m -101.63 129.76 47.82 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 128.375 2.67 . . . . 0.0 107.297 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.454 HD12 HG13 ' A' ' 3' ' ' ILE 0.299 62.0 mt -103.18 168.35 9.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.24 169.781 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.95 115.74 10.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 128.371 3.545 . . . . 0.0 101.811 169.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.52 167.55 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 103.876 -2.639 . . . . 0.0 103.876 -161.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 4.7 mm-40 -97.91 162.02 23.66 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 169.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.81 -6.24 18.3 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 124.213 3.275 . . . . 0.0 116.194 163.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.6 p -94.17 -0.64 55.1 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.477 1.911 . . . . 0.0 110.066 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -78.47 121.15 24.18 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -65.74 145.64 55.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.387 2.675 . . . . 0.0 112.342 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -66.46 88.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 123.322 1.534 . . . . 0.0 112.421 165.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 178.42 -54.48 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 131.11 3.764 . . . . 0.0 104.69 -177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.308 22.6 t-20 -52.11 -55.76 18.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 -174.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.322 40.9 t -72.6 -20.08 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 128.456 2.702 . . . . 0.0 110.996 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -71.38 -30.21 65.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 122.995 2.634 . . . . 0.0 108.507 172.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.66 -19.57 41.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 116.357 -1.782 . . . . 0.0 113.695 171.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -76.98 -35.72 56.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 116.564 -1.684 . . . . 0.0 109.342 163.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.2 mm -65.05 -38.47 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 124.644 2.164 . . . . 0.0 111.698 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -46.45 -61.49 1.78 Allowed 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 117.732 -3.105 . . . . 0.0 110.109 164.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.8 -37.66 84.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -78.65 -59.15 2.9 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -106.89 -0.36 23.29 Favored 'General case' 0 C--O 1.222 -0.351 0 O-C-N 125.691 1.869 . . . . 0.0 111.326 -162.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.18 13.7 76.35 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 129.8 3.571 . . . . 0.0 117.985 162.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.81 113.56 64.58 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -49.74 126.3 16.18 Favored 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 128.387 6.058 . . . . 0.0 113.767 167.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -41.76 -27.84 0.61 Allowed 'Trans proline' 0 C--N 1.323 -0.81 1 C-N-CA 125.685 4.257 . . . . 0.0 117.751 -177.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.81 -22.78 65.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 171.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -98.69 4.02 47.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.381 2.672 . . . . 0.0 114.708 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -95.81 113.28 24.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 113.835 -2.983 . . . . 0.0 105.133 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -95.71 141.48 29.14 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 123.763 2.983 . . . . 0.0 112.515 150.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.29 0.8 OUTLIER -157.52 117.46 3.4 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 116.603 -1.665 . . . . 0.0 108.811 -148.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mp -145.51 144.29 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 126.487 2.367 . . . . 0.0 106.43 -150.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CD2' HG12 ' A' ' 61' ' ' ILE . 37.4 t80 -131.62 -37.98 1.18 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.27 3.028 . . . . 0.0 115.155 172.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.363 . . -148.11 56.68 1.07 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 129.177 2.991 . . . . 0.0 111.163 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.98 -3.54 77.27 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-O 113.809 -3.773 . . . . 0.0 119.499 168.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -146.06 176.27 9.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 120.466 2.133 . . . . 0.0 110.052 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.06 130.29 39.04 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.029 -1.896 . . . . 0.0 107.911 174.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -77.56 120.6 22.76 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.027 1.731 . . . . 0.0 109.349 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -67.02 123.87 21.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 125.947 2.784 . . . . 0.0 109.876 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.92 115.68 3.89 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.269 2.228 . . . . 0.0 110.751 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.79 -23.55 11.73 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 115.411 -2.883 . . . . 0.0 110.23 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -77.65 148.82 34.85 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -78.34 174.51 11.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.767 2.027 . . . . 0.0 111.956 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.1 -24.78 64.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.399 1.48 . . . . 0.0 112.095 167.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -66.33 -33.84 76.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.052 2.541 . . . . 0.0 113.216 172.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -75.87 -34.84 60.03 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 115.085 -2.388 . . . . 0.0 109.833 -175.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.7 1.92 51.5 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 128.784 3.803 . . . . 0.0 113.484 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 t30 60.45 39.66 18.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.797 2.039 . . . . 0.0 110.421 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 45' ' ' PHE . 67.9 mt -90.84 137.67 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 102.14 -3.281 . . . . 0.0 102.14 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -140.93 170.11 16.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -168.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -58.51 138.4 56.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 120.717 3.599 . . . . 0.0 120.717 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 4.8 tt0 75.35 22.21 1.71 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.547 2.739 . . . . 0.0 108.749 160.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.413 27.4 m -99.61 158.54 15.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 124.909 2.29 . . . . 0.0 109.149 174.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.9 m -62.44 130.9 47.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 116.508 -3.87 . . . . 0.0 111.709 161.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -117.16 143.29 46.0 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 159.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -109.23 143.19 39.01 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.708 2.403 . . . . 0.0 111.935 -169.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -128.52 128.81 45.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 129.426 3.091 . . . . 0.0 107.167 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.3 4.3 t -122.03 136.09 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 115.596 -2.145 . . . . 0.0 106.947 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 129.071 2.948 . . . . 0.0 115.303 -171.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttp . . . . . 0 N--CA 1.474 0.764 0 CA-C-O 122.092 0.948 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -115.88 145.23 43.05 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 117.335 -1.746 . . . . 0.0 106.389 -169.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -132.27 177.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 126.591 1.956 . . . . 0.0 108.902 171.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -124.36 149.4 46.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.93 111.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -72.43 115.14 11.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.298 2.239 . . . . 0.0 113.409 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.493 ' HA ' HD11 ' A' ' 69' ' ' LEU . 46.9 p -94.11 170.32 9.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 124.085 1.898 . . . . 0.0 107.301 -169.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.7 -15.79 62.22 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -164.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -73.46 -31.51 63.83 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 128.247 2.619 . . . . 0.0 111.244 165.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.63 2.6 27.31 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 129.031 3.205 . . . . 0.0 110.605 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -66.75 146.41 54.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 121.328 2.564 . . . . 0.0 114.478 171.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.0 m -116.33 106.75 14.0 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 114.012 -2.899 . . . . 0.0 104.164 -165.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mm -98.59 140.65 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -79.21 136.8 37.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 124.355 2.026 . . . . 0.0 109.77 167.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.64 135.85 32.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 -169.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.27 131.02 50.66 Favored 'General case' 0 C--O 1.238 0.448 1 CA-C-O 129.62 4.533 . . . . 0.0 108.138 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.14 -165.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 129.77 3.228 . . . . 0.0 118.481 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -149.65 139.28 13.13 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 167.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -61.21 -22.87 75.9 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 124.16 3.24 . . . . 0.0 118.477 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 m -90.98 -25.14 19.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 118.863 2.912 . . . . 0.0 118.863 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.85 106.28 4.12 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 130.08 3.352 . . . . 0.0 109.841 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -48.97 148.66 2.18 Favored 'General case' 0 N--CA 1.45 -0.436 1 C-N-CA 134.346 5.058 . . . . 0.0 113.139 -155.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.24 -39.62 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.157 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -47.18 -52.18 16.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.86 1.664 . . . . 0.0 111.387 170.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -69.69 -24.93 63.65 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.393 2.277 . . . . 0.0 114.27 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.275 99.4 t -56.82 -55.36 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 1 O-C-N 113.328 -5.858 . . . . 0.0 112.586 167.261 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -43.66 -42.61 5.37 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 127.443 2.297 . . . . 0.0 115.601 167.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.9 -32.44 73.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.734 3.213 . . . . 0.0 112.43 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.12 -31.86 70.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 124.819 2.247 . . . . 0.0 114.276 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -73.22 -40.19 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 127.37 2.268 . . . . 0.0 115.114 169.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.29 -37.76 49.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 127.78 2.432 . . . . 0.0 112.63 162.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -72.07 -38.19 69.48 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.034 0.533 . . . . 0.0 111.958 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -75.78 -51.88 11.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 129.069 2.948 . . . . 0.0 111.815 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -133.63 -0.16 3.22 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.246 1.498 . . . . 0.0 111.402 -160.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.87 -23.17 35.48 Favored Glycine 0 N--CA 1.44 -1.063 0 O-C-N 117.421 -3.299 . . . . 0.0 114.482 161.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.42 120.01 78.16 Favored Pre-proline 0 N--CA 1.441 -0.891 0 O-C-N 117.058 -3.613 . . . . 0.0 112.17 -171.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -72.23 142.24 37.29 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.007 3.138 . . . . 0.0 110.719 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -35.49 -42.87 0.49 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 123.88 3.053 . . . . 0.0 119.12 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.05 -18.17 32.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -119.54 1.25 11.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.372 -170.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -86.3 151.27 23.73 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 172.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -132.54 128.91 38.29 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.562 1.545 . . . . 0.0 108.875 151.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.6 mt -108.19 129.21 55.2 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 3.2 mt -112.24 128.59 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 129.215 3.006 . . . . 0.0 109.175 165.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -81.43 -36.3 29.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 119.039 -2.288 . . . . 0.0 106.535 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.08 -67.35 0.36 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.55 -24.78 1.21 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.247 1.88 . . . . 0.0 113.766 164.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -94.26 141.21 28.83 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.88 2.472 . . . . 0.0 106.595 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -70.63 140.27 51.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.224 3.01 . . . . 0.0 113.95 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 mt -93.15 100.37 12.77 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 126.191 1.796 . . . . 0.0 108.332 171.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -93.16 142.13 27.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 126.304 2.954 . . . . 0.0 106.39 -156.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.69 132.85 55.18 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 130.881 3.672 . . . . 0.0 108.492 172.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.15 -15.16 8.83 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 128.69 3.043 . . . . 0.0 115.4 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -124.47 179.61 4.87 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 128.808 2.843 . . . . 0.0 110.958 -163.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -115.65 164.62 14.07 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 118.53 -2.607 . . . . 0.0 109.409 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.2 mt -72.46 -14.43 61.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.545 -0.722 . . . . 0.0 111.476 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -72.61 -35.39 67.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 129.21 3.004 . . . . 0.0 106.921 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.369 21.3 m-20 -51.4 -36.88 45.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.849 2.46 . . . . 0.0 113.696 172.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -103.91 3.52 33.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 112.903 -3.427 . . . . 0.0 110.162 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.27 0.5 OUTLIER 33.95 63.85 0.38 Allowed 'General case' 0 N--CA 1.45 -0.464 1 C-N-CA 134.333 5.053 . . . . 0.0 114.73 -176.081 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.4 mm -77.6 135.9 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.206 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -100.27 171.66 7.64 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.316 1.446 . . . . 0.0 107.231 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -66.73 146.06 54.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 126.211 2.194 . . . . 0.0 108.456 -170.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 65.73 17.44 10.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.354 1.888 . . . . 0.0 113.765 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -62.99 148.16 48.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 162.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -100.11 106.7 18.46 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.446 2.698 . . . . 0.0 108.399 -176.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.2 159.9 14.65 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.85 0.75 . . . . 0.0 111.275 169.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.46 154.91 29.51 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.636 1.974 . . . . 0.0 108.043 170.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' A' ' 7' ' ' THR 0.342 4.3 pp -127.93 155.28 44.46 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 130.392 3.477 . . . . 0.0 116.238 177.201 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.23 148.2 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 130.304 3.442 . . . . 0.0 108.783 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 N--CA 1.448 -0.548 0 C-N-CA 130.572 3.549 . . . . 0.0 114.32 168.475 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.59 ' HG3' HG23 ' A' ' 17' ' ' VAL . 3.6 ptt? . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -93.95 155.9 16.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 173.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.33 18.1 pt -133.15 158.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.922 2.489 . . . . 0.0 107.167 161.187 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -116.94 127.04 53.84 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 118.837 -2.414 . . . . 0.0 109.525 176.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.568 HG21 HD11 ' A' ' 15' ' ' LEU 0.293 3.2 t -107.74 96.68 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 174.846 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -93.33 127.14 38.81 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 118.942 -2.349 . . . . 0.0 116.986 -171.1 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.54 150.23 44.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 130.429 3.492 . . . . 0.0 109.288 174.478 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.86 -25.77 64.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 116.038 -1.935 . . . . 0.0 107.713 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -80.42 2.92 23.09 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 131.165 3.786 . . . . 0.0 116.241 174.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.61 6.19 53.06 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.296 2.379 . . . . 0.0 108.829 154.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 7' ' ' THR . 47.4 mtmt -97.48 156.48 16.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 121.575 2.687 . . . . 0.0 106.188 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -125.56 129.28 49.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 126.52 2.388 . . . . 0.0 114.328 -178.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.66 116.78 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 1 N-CA-C 98.173 -4.751 . . . . 0.0 98.173 169.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -95.0 116.96 29.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.3 0.64 . . . . 0.0 109.664 170.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.568 HD11 HG21 ' A' ' 5' ' ' VAL 0.325 32.4 mt -92.24 151.49 20.31 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.754 2.022 . . . . 0.0 106.912 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -108.23 83.03 1.72 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.098 2.959 . . . . 0.0 108.458 -173.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' A' ' 1' ' ' MET . 27.0 m -103.13 164.47 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 119.219 -2.175 . . . . 0.0 110.77 -168.059 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -108.28 160.09 28.31 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 130.564 3.546 . . . . 0.0 111.903 162.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.28 -20.89 27.46 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 CA-C-N 122.833 2.047 . . . . 0.0 114.126 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.2 p -94.09 1.33 56.17 Favored 'General case' 0 N--CA 1.447 -0.586 1 C-N-CA 133.659 4.784 . . . . 0.0 112.649 -176.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -61.62 139.85 58.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.312 2.245 . . . . 0.0 107.7 161.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.4 p -95.77 178.88 5.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.314 2.246 . . . . 0.0 106.462 170.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.9 mm -65.11 -34.85 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 1 C-N-CA 132.433 4.293 . . . . 0.0 106.055 170.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -64.95 -42.0 95.0 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 117.26 -3.4 . . . . 0.0 109.564 176.007 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -76.74 -41.51 44.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.958 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.54 -29.43 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 124.964 3.529 . . . . 0.0 111.869 176.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -52.19 -46.39 65.55 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.928 2.491 . . . . 0.0 116.557 165.339 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.55 -44.05 71.69 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 112.366 -2.197 . . . . 0.0 111.984 171.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -72.84 -33.19 65.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.525 -1.36 . . . . 0.0 112.082 -169.426 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -66.89 -41.84 88.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 120.359 -1.463 . . . . 0.0 109.311 171.229 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -62.84 -36.76 84.3 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 124.868 1.355 . . . . 0.0 110.174 177.466 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.64 -38.53 80.56 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 119.778 -1.826 . . . . 0.0 114.021 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -68.66 -43.86 75.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 115.824 -2.036 . . . . 0.0 111.253 169.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 34' ' ' GLU 0.293 18.4 tp10 -136.21 12.04 3.3 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 117.231 -1.788 . . . . 0.0 110.453 -147.645 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 29.03 40.98 0.03 OUTLIER Glycine 0 CA--C 1.53 1.01 1 C-N-CA 132.848 5.023 . . . . 0.0 114.775 175.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -91.74 120.28 68.12 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 115.492 -2.194 . . . . 0.0 105.609 157.771 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 38' ' ' PRO 0.291 1.7 Cg_endo -45.87 144.62 5.6 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 O-C-N 125.693 2.417 . . . . 0.0 118.357 171.482 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.9 Cg_endo -82.76 -10.66 10.55 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 O-C-N 125.844 2.497 . . . . 0.0 112.258 -163.201 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.87 -16.25 54.16 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 128.699 2.8 . . . . 0.0 111.5 173.204 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -74.5 -27.55 60.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.954 2.501 . . . . 0.0 112.673 174.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -95.36 147.69 23.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 129.349 3.06 . . . . 0.0 114.677 -168.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -115.59 117.2 29.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 172.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.0 mt -97.11 98.13 9.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 -166.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.304 74.1 mt -100.66 145.9 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 128.81 2.844 . . . . 0.0 113.673 -175.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CE2' HG12 ' A' ' 61' ' ' ILE . 33.5 t80 -153.62 123.24 6.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 116.383 -3.948 . . . . 0.0 106.02 166.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.499 . . 74.73 25.25 1.53 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 170.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.94 7.78 67.91 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 130.049 3.69 . . . . 0.0 113.151 -174.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -134.6 150.02 50.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 123.549 3.674 . . . . 0.0 105.396 -166.19 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -87.86 127.82 35.35 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 128.567 2.747 . . . . 0.0 107.683 176.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.52 133.64 49.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 121.581 1.991 . . . . 0.0 113.386 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -83.24 124.74 30.86 Favored 'General case' 0 N--CA 1.447 -0.604 1 C-N-CA 133.867 4.867 . . . . 0.0 107.004 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.22 123.21 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 111.992 -2.367 . . . . 0.0 108.005 -175.217 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.16 31.12 3.4 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 114.924 -3.153 . . . . 0.0 115.7 -177.3 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -139.62 146.11 39.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 122.245 3.022 . . . . 0.0 108.555 170.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.8 p -79.46 155.7 28.18 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.6 mt -46.74 -64.05 0.87 Allowed 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.6 m -66.98 -41.7 86.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.392 1.877 . . . . 0.0 115.857 -172.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.265 11.0 t70 -51.34 -46.91 62.84 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 119.349 -2.094 . . . . 0.0 113.608 170.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.98 8.12 1.72 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 129.86 3.264 . . . . 0.0 114.857 174.66 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.372 3.4 t30 82.31 4.83 1.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 178.327 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.413 HG12 ' CE2' ' A' ' 45' ' ' PHE 0.293 1.9 mt -94.27 91.21 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 123.177 1.465 . . . . 0.0 111.33 -178.304 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.251 46.6 mm-40 -96.52 -167.14 1.52 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 112.623 -2.081 . . . . 0.0 109.08 -175.155 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -68.48 131.52 45.41 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.865 -175.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.347 24.9 mt-10 76.96 36.53 0.32 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 130.51 3.524 . . . . 0.0 108.864 165.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.264 37.9 m -96.25 138.48 33.79 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 -170.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.2 m -96.5 118.76 33.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -178.758 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 67' ' ' LEU . 3.6 mp -106.94 155.72 19.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.748 2.419 . . . . 0.0 105.708 159.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.23 139.86 46.27 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 126.415 2.322 . . . . 0.0 110.488 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 tp -82.86 121.85 27.47 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 126.371 2.295 . . . . 0.0 105.911 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -136.02 136.41 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 128.191 2.596 . . . . 0.0 104.68 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.442 -0.859 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.032 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.1 ttm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 117.224 -1.369 . . . . 0.0 107.754 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -98.55 137.64 36.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 125.374 1.671 . . . . 0.0 114.649 -174.413 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -133.29 177.43 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 120.134 -1.604 . . . . 0.0 113.17 171.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -125.23 133.51 52.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 130.178 3.391 . . . . 0.0 109.752 173.386 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.9 t -117.48 131.76 69.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 109.836 -3.347 . . . . 0.0 103.002 165.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -77.66 129.71 35.91 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 116.331 -1.795 . . . . 0.0 113.461 151.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -82.63 149.5 27.36 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.293 2.637 . . . . 0.0 104.41 172.518 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.22 -21.02 66.7 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.168 2.587 . . . . 0.0 111.404 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -70.73 -13.62 62.13 Favored 'General case' 0 C--N 1.326 -0.44 1 C-N-CA 132.056 4.142 . . . . 0.0 112.861 165.254 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.28 1.02 56.89 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.934 1.243 . . . . 0.0 115.301 165.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 155.16 18.96 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.195 -2.356 . . . . 0.0 110.435 166.848 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.6 m -98.07 152.39 19.36 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 100.448 -3.908 . . . . 0.0 100.448 -176.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.81 144.79 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 165.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -93.75 145.22 24.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 123.237 1.494 . . . . 0.0 107.203 165.291 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.414 2.1 pt? -148.25 159.5 43.91 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 120.276 3.436 . . . . 0.0 120.276 166.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -108.49 139.91 42.57 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 124.282 3.219 . . . . 0.0 109.89 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.577 HG22 ' H ' ' A' ' 18' ' ' GLU 0.266 7.5 p -138.21 178.95 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 127.967 3.292 . . . . 0.0 110.363 -177.872 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.577 ' H ' HG22 ' A' ' 17' ' ' VAL . 29.9 tp10 -134.14 138.29 30.15 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 -177.508 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -44.34 -37.21 10.2 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 N-CA-C 119.559 2.869 . . . . 0.0 119.559 175.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.295 13.5 p -95.08 3.34 54.92 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 113.422 -3.18 . . . . 0.0 111.2 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -73.87 160.45 31.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 123.61 2.914 . . . . 0.0 105.355 169.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -102.94 155.2 18.52 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 119.311 -2.118 . . . . 0.0 112.181 -177.519 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.415 HD13 HD12 ' A' ' 56' ' ' LEU . 16.6 mm -63.88 -57.69 10.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 130.061 3.345 . . . . 0.0 111.777 -168.334 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.555 1.9 tt0 -44.57 -48.54 10.33 Favored 'General case' 0 C--O 1.222 -0.349 1 C-N-CA 132.632 4.373 . . . . 0.0 114.83 176.733 . . . . . . . . 3 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.284 26.3 t30 -49.06 -61.12 2.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 130.139 3.376 . . . . 0.0 111.666 -178.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -74.06 -39.55 50.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 128.742 2.817 . . . . 0.0 106.225 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -62.38 -28.35 69.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 112.716 -3.516 . . . . 0.0 112.196 -178.413 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.03 -14.39 31.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.87 2.577 . . . . 0.0 116.434 178.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -54.85 -27.34 41.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.466 2.307 . . . . 0.0 113.576 177.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tp -48.03 -22.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 1 C-N-CA 135.654 5.581 . . . . 0.0 117.382 -175.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -61.8 3.08 0.16 Allowed 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 170.501 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.513 32.9 t70 -19.15 -55.28 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 2 C-N-CA 135.112 5.365 . . . . 0.0 122.067 158.021 . . . . . . . . 3 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.254 1.6 pptp? -149.15 -19.52 0.29 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 122.265 2.302 . . . . 0.0 112.22 -160.135 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.413 1.1 pm0 -124.85 169.3 12.18 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 147.19 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.81 62.11 0.33 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 105.602 -2.999 . . . . 0.0 105.602 -175.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.8 pt -86.64 148.98 47.62 Favored Pre-proline 0 N--CA 1.448 -0.572 0 C-N-CA 130.196 3.398 . . . . 0.0 109.793 178.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -76.27 136.42 17.88 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.742 2.294 . . . . 0.0 113.661 171.528 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -77.29 -16.1 15.61 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.997 3.131 . . . . 0.0 112.099 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.3 -15.4 62.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 124.0 3.091 . . . . 0.0 108.136 178.054 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -90.73 17.32 7.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.986 2.114 . . . . 0.0 115.439 176.445 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -142.33 160.09 40.94 Favored 'General case' 0 N--CA 1.446 -0.633 1 C-N-CA 136.984 6.114 . . . . 0.0 113.022 173.221 . . . . . . . . 4 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -149.8 146.97 27.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 131.341 3.857 . . . . 0.0 111.534 -178.27 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -96.57 121.81 38.8 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.959 3.304 . . . . 0.0 113.265 177.049 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.3 mt -91.96 144.58 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 156.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CG ' ' N ' ' A' ' 46' ' ' ALA 0.303 4.7 p90 -111.91 -76.37 0.6 Allowed 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 169.747 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' N ' ' CG ' ' A' ' 45' ' ' PHE . . . -130.5 82.93 2.08 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 100.854 -3.758 . . . . 0.0 100.854 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.24 61.33 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 112.444 -2.162 . . . . 0.0 117.084 165.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -147.83 172.79 13.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 129.21 3.004 . . . . 0.0 113.862 -171.22 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -107.04 142.89 35.95 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 128.214 2.606 . . . . 0.0 112.836 -170.177 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 43' ' ' LEU . 19.9 mt -74.34 165.9 24.4 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 129.492 3.117 . . . . 0.0 113.06 169.014 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -151.97 150.85 30.47 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 129.719 3.208 . . . . 0.0 116.59 175.098 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -43.8 132.48 5.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.28 -26.24 7.1 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.221 1.391 . . . . 0.0 112.979 173.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 163.64 12.47 Favored 'General case' 0 N--CA 1.444 -0.731 1 C-N-CA 133.426 4.69 . . . . 0.0 108.295 -164.916 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 p -103.68 173.17 6.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 113.545 -1.662 . . . . 0.0 106.536 167.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.415 HD12 HD13 ' A' ' 23' ' ' ILE . 3.0 mp -61.45 -34.18 74.98 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.364 175.55 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -78.81 -8.95 59.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.123 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -69.2 -31.62 70.34 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 125.494 1.747 . . . . 0.0 109.842 160.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -110.93 11.47 22.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.424 16.1 m120 83.4 -6.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 163.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -69.92 135.24 28.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -157.202 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.4 -166.79 2.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 114.183 -2.818 . . . . 0.0 110.536 -162.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.36 110.69 0.33 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 165.015 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 78.1 mt-10 73.35 31.79 1.33 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 131.02 3.728 . . . . 0.0 115.177 175.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 m -70.14 121.91 18.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 128.014 2.526 . . . . 0.0 107.07 172.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.4 m -97.58 114.35 26.25 Favored 'General case' 0 C--N 1.32 -0.683 1 N-CA-C 97.522 -4.992 . . . . 0.0 97.522 -178.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.465 ' HB3' HD12 ' A' ' 43' ' ' LEU . 8.2 mp -95.71 151.52 19.28 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 130.453 3.501 . . . . 0.0 107.453 171.629 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -118.98 134.7 55.02 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 126.581 2.426 . . . . 0.0 112.775 168.795 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 tp -100.93 124.88 47.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -174.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.639 HG22 ' H ' ' A' ' 71' ' ' LEU 0.353 7.5 p -140.18 -146.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 126.198 1.799 . . . . 0.0 112.027 173.959 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.639 ' H ' HG22 ' A' ' 70' ' ' VAL 0.542 1.8 pt? . . . . . 0 N--CA 1.45 -0.446 1 C-N-CA 132.0 4.12 . . . . 0.0 111.26 179.953 . . . . . . . . 3 2 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 117.646 -1.169 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.37 121.2 21.02 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -170.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -136.15 174.95 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 123.606 2.912 . . . . 0.0 113.756 170.682 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -123.73 155.14 38.41 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.843 2.457 . . . . 0.0 113.65 169.336 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.2 130.9 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 O-C-N 118.195 -2.816 . . . . 0.0 105.945 161.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.272 64.8 tttt -111.49 131.35 55.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 118.829 -2.419 . . . . 0.0 104.529 176.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.8 p -98.79 168.95 9.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.516 2.726 . . . . 0.0 105.48 -166.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 71' ' ' LEU . 15.9 mt -93.16 -0.02 57.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 130.887 3.675 . . . . 0.0 112.346 175.712 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 p -102.59 -23.63 13.85 Favored 'General case' 0 N--CA 1.444 -0.762 1 C-N-CA 134.187 4.995 . . . . 0.0 109.942 172.707 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.09 -6.71 11.97 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 116.635 -2.203 . . . . 0.0 110.594 147.265 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -61.45 149.92 37.13 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 157.071 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -112.45 117.84 33.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 163.232 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mt -101.46 133.15 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 101.756 -3.424 . . . . 0.0 101.756 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -94.46 146.78 23.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.473 1.909 . . . . 0.0 110.624 177.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.9 -177.21 3.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -176.364 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -149.88 117.48 6.17 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 116.536 -1.697 . . . . 0.0 107.987 170.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -131.32 148.26 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 C-N-CA 133.112 4.565 . . . . 0.0 107.237 -176.358 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -81.99 141.53 47.26 Favored Pre-proline 0 N--CA 1.443 -0.785 0 CA-C-O 115.747 -2.073 . . . . 0.0 107.56 172.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -45.12 -35.16 10.35 Favored 'Trans proline' 0 N--CA 1.45 -1.071 1 C-N-CA 127.821 5.681 . . . . 0.0 114.169 173.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.7 p -77.07 -19.46 57.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.611 2.764 . . . . 0.0 113.918 176.71 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.75 126.53 28.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.704 2.047 . . . . 0.0 109.053 -173.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -70.44 150.99 45.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.1 0.96 . . . . 0.0 112.496 170.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 15.8 mm -55.13 -26.98 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 127.901 2.481 . . . . 0.0 114.777 -178.437 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.259 8.4 pt-20 -61.71 -33.94 74.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 166.079 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -92.53 -33.14 14.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -167.527 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.284 75.4 t -39.85 -42.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 130.631 3.573 . . . . 0.0 113.256 158.479 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -74.02 -16.21 61.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.97 -37.65 54.8 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 126.856 2.062 . . . . 0.0 105.52 -173.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -75.86 -26.16 56.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 130.013 3.325 . . . . 0.0 109.047 -175.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -77.68 -22.84 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 126.795 2.559 . . . . 0.0 111.441 173.236 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -69.17 -43.09 74.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.977 1.311 . . . . 0.0 110.994 -175.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.429 21.8 t70 -56.93 -36.19 69.92 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 129.908 3.283 . . . . 0.0 116.161 -179.373 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -103.46 -27.93 12.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 109.426 -3.534 . . . . 0.0 115.402 -173.26 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -116.75 -13.78 10.77 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 124.812 2.244 . . . . 0.0 116.201 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.8 -0.96 56.57 Favored Glycine 0 CA--C 1.526 0.753 0 O-C-N 117.642 -3.161 . . . . 0.0 110.594 165.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.75 130.24 23.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 129.396 3.078 . . . . 0.0 111.569 -156.298 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.92 162.11 20.93 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 121.022 1.148 . . . . 0.0 110.223 -173.185 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -52.49 -21.86 15.1 Favored 'Trans proline' 0 N--CA 1.449 -1.109 1 C-N-CA 126.07 4.513 . . . . 0.0 117.718 170.715 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -57.32 -26.92 61.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 126.996 2.685 . . . . 0.0 117.935 164.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -97.79 -28.81 13.7 Favored 'General case' 0 C--O 1.221 -0.417 1 C-N-CA 131.848 4.059 . . . . 0.0 113.093 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.74 93.83 2.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.037 2.135 . . . . 0.0 107.522 -177.279 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 mtp85 -110.74 100.84 9.53 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.083 1.753 . . . . 0.0 114.667 167.734 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.3 mt -100.17 139.9 35.17 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 110.753 -2.931 . . . . 0.0 109.789 -165.023 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.48 160.72 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 174.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -149.62 124.1 9.68 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.985 2.914 . . . . 0.0 103.536 168.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.75 28.31 6.19 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 128.657 2.783 . . . . 0.0 115.664 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.29 3.23 90.62 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 128.194 3.433 . . . . 0.0 114.49 -175.842 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -92.2 147.55 22.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 122.771 3.286 . . . . 0.0 106.335 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -100.33 93.31 5.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 102.696 -3.075 . . . . 0.0 102.696 -176.131 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.422 ' HG ' ' H ' ' A' ' 50' ' ' LEU . 20.2 mt -54.21 115.28 1.98 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 130.785 3.634 . . . . 0.0 109.041 176.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.266 40.0 tt0 -81.44 134.7 35.58 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 102.58 -3.118 . . . . 0.0 102.58 -165.645 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.58 119.76 7.63 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 128.086 2.554 . . . . 0.0 106.472 167.08 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.49 -5.97 57.35 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 119.832 -1.792 . . . . 0.0 112.654 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -94.75 176.67 6.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 116.07 -1.919 . . . . 0.0 108.986 163.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 77.0 p -115.23 176.99 4.82 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.029 1.456 . . . . 0.0 112.012 176.237 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.97 -28.69 69.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 116.729 -1.605 . . . . 0.0 113.453 167.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.7 t -64.6 -36.34 83.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.785 2.434 . . . . 0.0 109.161 174.524 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.402 16.4 m-20 -57.4 -25.42 59.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 116.545 -3.847 . . . . 0.0 119.759 169.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -112.25 3.79 17.35 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 116.374 -1.774 . . . . 0.0 109.715 177.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.554 8.8 p30 57.2 31.71 20.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 129.302 3.041 . . . . 0.0 116.631 -173.212 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -81.38 118.34 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 -176.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -99.67 173.74 6.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.707 2.403 . . . . 0.0 112.958 -173.104 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -39.1 134.36 1.08 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.71 2.804 . . . . 0.0 113.11 174.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 62.67 46.14 5.53 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 128.097 2.559 . . . . 0.0 109.659 175.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -104.4 125.47 50.64 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 123.182 2.719 . . . . 0.0 104.21 172.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.8 m -85.7 134.47 33.96 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 114.649 -2.596 . . . . 0.0 108.607 178.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -107.77 154.33 21.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 101.546 -3.501 . . . . 0.0 101.546 -179.444 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -102.34 134.76 45.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.217 2.607 . . . . 0.0 105.639 176.298 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 1.7 mt -97.56 129.5 44.69 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.165 2.186 . . . . 0.0 106.267 176.018 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -100.24 117.71 45.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 159.386 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.437 ' H ' HD12 ' A' ' 8' ' ' LEU . 8.1 tp . . . . . 0 N--CA 1.447 -0.621 0 C-N-CA 127.786 2.434 . . . . 0.0 110.108 176.127 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 115.47 -2.205 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.274 87.1 mt-30 -99.78 154.53 18.25 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 121.323 1.874 . . . . 0.0 113.879 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -145.67 153.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -124.77 107.64 11.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 115.387 -2.244 . . . . 0.0 105.967 -161.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.25 115.72 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 119.883 1.219 . . . . 0.0 108.378 179.42 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -84.56 142.37 30.04 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 125.438 2.542 . . . . 0.0 108.372 176.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -127.82 148.38 50.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 110.026 -3.261 . . . . 0.0 108.879 162.382 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.4 mt -48.17 -17.99 0.17 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 128.053 2.541 . . . . 0.0 116.765 174.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -77.78 -37.48 48.81 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 125.516 2.579 . . . . 0.0 114.453 -169.107 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.73 -16.49 10.33 Favored Glycine 0 CA--C 1.538 1.502 0 O-C-N 117.04 -3.538 . . . . 0.0 108.438 -170.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -77.58 138.8 39.35 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 130.007 3.323 . . . . 0.0 106.81 174.54 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 m -141.3 117.93 10.96 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.731 3.212 . . . . 0.0 106.632 -171.106 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mm -91.09 117.47 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.344 1.857 . . . . 0.0 106.636 -173.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.9 m -83.04 118.92 23.86 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.549 1.94 . . . . 0.0 109.232 176.391 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -120.76 134.78 55.27 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.307 1.843 . . . . 0.0 106.547 172.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -88.25 124.63 34.06 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 128.77 3.794 . . . . 0.0 109.102 157.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.8 169.89 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 1 CA-C-N 107.66 -4.336 . . . . 0.0 105.156 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -119.76 162.76 31.23 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 128.911 2.884 . . . . 0.0 111.397 158.185 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.65 -23.47 15.28 Favored 'Trans proline' 0 N--CA 1.447 -1.237 1 C-N-CA 126.158 4.572 . . . . 0.0 119.687 177.625 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -88.3 1.58 54.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 115.848 -2.025 . . . . 0.0 113.423 175.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.01 115.41 3.13 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 122.039 2.2 . . . . 0.0 113.394 -175.055 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.2 p -71.88 160.11 33.12 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 118.358 -2.714 . . . . 0.0 112.893 172.43 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.272 53.7 mt -49.17 -36.94 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 115.369 -2.253 . . . . 0.0 113.974 167.624 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -58.9 -31.29 68.49 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 131.397 3.879 . . . . 0.0 113.435 164.27 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -84.68 -32.55 23.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 121.971 2.168 . . . . 0.0 110.04 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.94 -50.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 115.284 -2.294 . . . . 0.0 109.076 169.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 70.7 mttt -43.33 -47.95 6.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.695 1.598 . . . . 0.0 114.612 177.06 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.8 -24.13 61.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 124.304 2.002 . . . . 0.0 116.148 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -86.08 -42.37 13.99 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 114.119 -2.848 . . . . 0.0 104.808 -173.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.257 78.1 mt -49.06 -59.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 112.623 -3.56 . . . . 0.0 106.337 168.469 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -47.24 -51.53 18.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 127.977 3.298 . . . . 0.0 117.348 171.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.37 -35.96 82.13 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.332 0.653 . . . . 0.0 112.279 -174.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -82.27 -76.03 0.28 Allowed 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 125.706 1.879 . . . . 0.0 109.902 173.076 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -91.54 -21.57 20.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.265 -159.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.02 -0.23 60.38 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 116.159 -2.467 . . . . 0.0 113.745 164.865 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -66.98 127.04 93.38 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 120.407 2.103 . . . . 0.0 109.167 165.129 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.44 140.26 21.47 Favored 'Trans proline' 0 N--CA 1.445 -1.358 1 C-N-CA 126.608 4.872 . . . . 0.0 110.254 175.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HG3' ' HB3' ' A' ' 27' ' ' LYS 0.257 87.3 Cg_exo -41.45 -34.4 1.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 1 C-N-CA 131.83 8.353 . . . . 0.0 118.818 169.333 . . . . . . . . 4 3 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.58 -29.0 68.96 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 125.72 1.887 . . . . 0.0 113.476 171.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -84.5 -2.79 57.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 122.346 2.339 . . . . 0.0 111.726 -170.613 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 26.9 mt-30 -113.83 134.4 54.81 Favored 'General case' 0 C--N 1.325 -0.495 1 CA-C-O 111.257 -4.211 . . . . 0.0 118.744 -166.694 . . . . . . . . 3 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -110.63 141.02 44.42 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 128.986 3.929 . . . . 0.0 102.05 163.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.5 mt -135.38 128.78 32.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.561 1.144 . . . . 0.0 109.396 -174.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 4.2 mt -122.42 150.77 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.083 2.553 . . . . 0.0 104.451 -174.132 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.65 -82.6 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 102.391 -3.188 . . . . 0.0 102.391 165.324 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.86 -52.97 1.43 Allowed 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.15 -1.594 . . . . 0.0 108.894 173.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.14 -30.68 0.78 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 106.054 -2.818 . . . . 0.0 106.054 -175.314 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -82.89 110.42 17.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 -175.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -60.38 127.58 32.45 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 116.526 -1.702 . . . . 0.0 111.333 159.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -75.11 151.5 38.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 125.464 2.554 . . . . 0.0 112.56 -178.748 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -112.66 144.86 41.45 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 119.924 -1.735 . . . . 0.0 109.833 175.04 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.73 153.88 42.98 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 127.257 2.848 . . . . 0.0 114.98 -172.336 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.85 13.03 44.85 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 128.071 2.748 . . . . 0.0 114.136 169.206 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.3 mtt85 -125.63 151.71 46.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.229 1.966 . . . . 0.0 108.544 -167.26 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.0 p -92.43 174.95 7.02 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.397 1.57 . . . . 0.0 110.799 -177.316 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.58 -28.26 65.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 111.833 -2.44 . . . . 0.0 111.726 174.611 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -71.67 -37.76 70.72 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.378 -1.451 . . . . 0.0 114.645 173.311 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.94 -42.02 97.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.102 0.961 . . . . 0.0 113.386 178.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.57 4.0 45.38 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 123.488 1.613 . . . . 0.0 113.01 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.316 42.7 m-80 76.49 26.77 0.86 Allowed 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 172.016 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.5 mt -99.49 107.86 21.48 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-O 125.518 2.58 . . . . 0.0 104.117 -170.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -93.34 165.11 12.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 165.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.472 39.7 pttt -30.97 125.68 0.19 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 164.611 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 88.43 1.98 0.32 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 130.044 3.338 . . . . 0.0 113.982 176.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -62.17 141.29 58.26 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 117.104 -3.497 . . . . 0.0 113.311 176.766 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.3 m -90.82 137.67 32.18 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 125.407 1.692 . . . . 0.0 108.361 170.23 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -119.74 172.87 7.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 164.472 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -136.15 110.95 8.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 126.01 2.069 . . . . 0.0 110.176 -167.302 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.52 126.73 42.98 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 125.383 2.516 . . . . 0.0 110.193 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.49 122.02 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 O-C-N 116.965 -3.585 . . . . 0.0 106.487 170.387 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.4 mt . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 129.709 3.204 . . . . 0.0 111.582 178.756 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -98.21 139.08 34.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -173.083 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.5 pt -121.91 161.58 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.99 2.116 . . . . 0.0 106.334 166.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -105.31 129.4 53.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 159.234 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.77 125.99 54.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 160.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -115.21 158.35 22.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 128.315 2.646 . . . . 0.0 105.651 178.98 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -135.43 167.94 20.14 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 118.125 -2.859 . . . . 0.0 105.565 -170.028 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -69.16 -27.55 65.63 Favored 'General case' 0 N--CA 1.451 -0.387 1 O-C-N 116.093 -4.129 . . . . 0.0 113.839 176.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.1 p -85.12 3.89 36.87 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 119.077 -2.264 . . . . 0.0 110.043 171.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.9 -24.19 32.19 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 117.87 -3.018 . . . . 0.0 106.961 156.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -50.23 118.79 3.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.719 3.608 . . . . 0.0 106.29 -177.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -118.76 117.06 27.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.052 0.842 . . . . 0.0 109.408 -174.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.3 mt -84.15 136.09 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 1 C-N-CA 132.471 4.308 . . . . 0.0 107.944 168.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -93.39 133.62 36.46 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 163.27 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.14 142.06 51.6 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 129.507 3.123 . . . . 0.0 112.436 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -113.89 136.01 53.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 168.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 m -153.76 -178.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.84 1 C-N-CA 134.695 5.198 . . . . 0.0 112.07 -165.553 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -139.79 147.91 53.33 Favored Pre-proline 0 N--CA 1.448 -0.542 0 O-C-N 117.979 -2.95 . . . . 0.0 110.701 175.38 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -49.75 -41.67 45.67 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 123.566 2.844 . . . . 0.0 114.337 -177.175 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 p -51.05 -26.26 6.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 165.332 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -70.18 126.81 30.76 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 122.517 2.417 . . . . 0.0 108.257 -170.502 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.8 p -66.14 149.77 49.78 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.984 1.714 . . . . 0.0 113.796 -178.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 mm -84.6 89.56 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 1 N-CA-C 99.4 -4.296 . . . . 0.0 99.4 159.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -175.08 -60.91 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 130.325 3.45 . . . . 0.0 103.695 173.144 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -70.46 -39.51 74.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 114.853 -2.499 . . . . 0.0 116.454 -175.597 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.15 -44.35 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.692 1.997 . . . . 0.0 114.317 160.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.22 -16.49 62.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 112.318 -3.706 . . . . 0.0 111.407 -176.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.36 -35.88 30.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 123.888 3.04 . . . . 0.0 105.266 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -68.55 -35.92 78.09 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 125.076 2.369 . . . . 0.0 110.491 -176.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 mm -70.36 -46.91 69.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.276 176.297 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -56.11 -45.82 79.32 Favored 'General case' 0 N--CA 1.453 -0.296 1 O-C-N 116.274 -4.016 . . . . 0.0 107.223 -178.295 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.371 4.9 t70 -47.82 -55.9 8.68 Favored 'General case' 0 N--CA 1.444 -0.742 1 C-N-CA 133.901 4.88 . . . . 0.0 112.491 169.235 . . . . . . . . 3 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -65.97 -47.63 73.93 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 124.651 1.22 . . . . 0.0 109.925 176.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -125.14 -15.84 6.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 117.936 -2.978 . . . . 0.0 116.259 -148.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.21 6.57 53.44 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 153.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.7 mt -99.47 121.53 54.62 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-O 114.39 -2.719 . . . . 0.0 105.455 -163.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.77 135.33 62.98 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-N 124.63 2.689 . . . . 0.0 113.755 173.022 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.292 67.4 Cg_exo -33.1 -37.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.56 1 C-N-CA 129.644 6.896 . . . . 0.0 118.246 174.476 . . . . . . . . 3 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -80.69 -31.85 36.09 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 117.985 -2.947 . . . . 0.0 106.752 -172.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -90.94 -10.91 40.69 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 115.206 -2.331 . . . . 0.0 105.11 -172.192 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -77.87 94.79 4.6 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 130.687 3.595 . . . . 0.0 104.545 169.563 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -91.26 120.55 32.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.685 176.904 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mt -126.5 123.97 39.0 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -163.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -138.34 133.87 43.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -164.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.361 0.3 OUTLIER -124.6 -28.25 3.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.082 -2.327 . . . . 0.0 115.287 159.662 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.291 . . -153.02 43.59 0.63 Allowed 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 125.405 1.691 . . . . 0.0 108.912 -166.217 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.96 -7.67 49.04 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 128.709 3.052 . . . . 0.0 117.921 159.083 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.44 32.0 pttt -151.97 147.49 26.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 131.488 3.915 . . . . 0.0 110.918 -170.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.7 139.95 48.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.151 1.78 . . . . 0.0 112.705 173.573 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 mt -82.11 136.35 35.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 114.949 -2.453 . . . . 0.0 107.884 -174.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -82.68 139.84 33.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 126.237 2.211 . . . . 0.0 110.371 -170.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -45.3 113.78 0.63 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 118.679 2.844 . . . . 0.0 118.679 169.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.09 -7.19 40.67 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 164.448 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.259 13.3 mmp_? -93.69 142.12 27.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -172.057 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.9 p -86.47 163.86 17.3 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.333 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -41.05 -52.89 3.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 124.798 3.454 . . . . 0.0 115.704 163.587 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 t -51.84 -37.64 52.72 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 114.115 -2.85 . . . . 0.0 115.156 168.659 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -68.0 -18.57 64.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 178.627 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -97.36 -13.49 21.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 114.132 -2.842 . . . . 0.0 112.308 161.096 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.8 t30 72.14 31.8 1.87 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 125.626 3.83 . . . . 0.0 113.104 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -70.55 112.84 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 1 O-C-N 115.927 -4.233 . . . . 0.0 109.845 -175.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.291 22.9 mt-30 -94.03 162.68 13.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.269 1.428 . . . . 0.0 110.539 -165.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.266 26.8 pttt -42.16 115.26 0.66 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 117.168 2.284 . . . . 0.0 117.168 161.425 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.5 2.6 tt0 87.16 30.35 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.785 170.329 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.31 68.6 m -90.01 132.69 35.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 172.519 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -82.27 125.82 31.41 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.433 2.293 . . . . 0.0 112.456 169.566 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mp -116.36 124.36 49.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 172.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.285 11.8 t60 -83.64 120.09 25.56 Favored 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 131.876 4.07 . . . . 0.0 112.275 165.508 . . . . . . . . 3 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -94.5 130.59 40.83 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 117.373 -3.329 . . . . 0.0 108.337 174.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.79 153.01 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 O-C-N 117.98 -2.95 . . . . 0.0 114.125 170.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.518 -0.272 1 N-CA-C 98.125 -4.769 . . . . 0.0 98.125 -161.43 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pm0 -104.92 140.72 37.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.543 1.937 . . . . 0.0 107.93 178.103 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -124.72 151.8 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 128.644 2.777 . . . . 0.0 106.607 165.272 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.253 60.3 m-85 -93.11 151.58 19.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 122.577 1.179 . . . . 0.0 113.217 168.702 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.1 144.67 28.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 114.293 -2.765 . . . . 0.0 107.245 167.548 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 52.3 tttt -126.48 127.46 45.4 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 128.75 3.781 . . . . 0.0 118.196 170.091 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 p -82.36 166.18 19.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.743 2.417 . . . . 0.0 111.448 -169.265 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.35 -37.0 66.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 129.974 3.31 . . . . 0.0 116.604 172.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.8 p -73.89 -33.25 63.95 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.589 2.756 . . . . 0.0 113.967 173.607 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.17 16.43 7.23 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 116.518 1.367 . . . . 0.0 116.518 177.539 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -86.47 134.99 33.64 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.898 1.679 . . . . 0.0 106.984 178.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -100.59 113.24 25.89 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 130.091 3.357 . . . . 0.0 105.315 -176.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -100.38 114.51 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 100.666 -3.827 . . . . 0.0 100.666 174.647 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -66.25 131.75 46.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.954 -2.966 . . . . 0.0 109.261 154.637 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.14 128.45 38.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 119.418 -2.051 . . . . 0.0 108.297 -172.29 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -91.92 115.79 28.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 125.696 1.872 . . . . 0.0 110.26 178.265 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.51 22.6 m -121.07 -68.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 113.45 -3.166 . . . . 0.0 118.052 -163.271 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 80.48 131.74 0.04 OUTLIER Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 129.709 3.204 . . . . 0.0 107.176 -155.574 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.3 -16.81 15.21 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 CA-C-N 120.316 1.149 . . . . 0.0 114.976 -175.294 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 m -86.23 18.03 3.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 172.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -76.79 152.63 35.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.056 1.342 . . . . 0.0 110.002 158.359 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -88.71 148.5 23.95 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.999 1.319 . . . . 0.0 107.952 174.846 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.279 5.8 mm -46.13 -37.63 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 127.546 2.338 . . . . 0.0 113.477 174.872 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -82.27 -14.18 55.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 116.506 -3.871 . . . . 0.0 113.343 -175.045 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -94.86 -24.94 16.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 123.805 1.764 . . . . 0.0 110.692 174.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.45 -41.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 1 O-C-N 115.452 -4.53 . . . . 0.0 108.857 167.343 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -69.83 -34.05 73.14 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 124.525 1.141 . . . . 0.0 112.811 176.106 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.255 . . -77.45 -13.27 59.96 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 120.604 1.547 . . . . 0.0 110.808 173.126 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -69.1 -37.06 78.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 118.314 -2.742 . . . . 0.0 111.13 172.052 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 mm -69.15 -31.39 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 127.572 2.349 . . . . 0.0 108.291 175.533 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.58 -37.12 76.82 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 172.326 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.12 -51.2 40.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.254 -1.529 . . . . 0.0 114.152 172.092 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -87.57 -27.65 22.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -171.351 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -122.89 -21.23 5.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 115.282 -2.294 . . . . 0.0 115.441 175.119 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.63 -14.6 42.12 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 116.446 -2.308 . . . . 0.0 111.558 172.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.5 mt -78.38 121.23 83.49 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 120.394 2.097 . . . . 0.0 109.238 -154.348 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -55.27 143.27 76.51 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 CA-C-N 123.214 2.184 . . . . 0.0 117.029 -174.848 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.43 -28.86 3.33 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 O-C-N 116.965 -2.177 . . . . 0.0 116.396 -166.628 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 0.0 OUTLIER -51.92 -29.21 19.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 121.291 3.811 . . . . 0.0 121.291 172.127 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -92.7 -18.47 22.94 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 128.492 3.62 . . . . 0.0 111.723 -177.103 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -83.24 129.41 35.01 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 126.168 2.167 . . . . 0.0 116.282 -175.717 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -103.47 119.64 39.28 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 114.488 -2.673 . . . . 0.0 105.048 160.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -88.6 120.8 30.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.788 1.631 . . . . 0.0 109.075 168.993 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mm -114.57 135.28 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 126.52 1.928 . . . . 0.0 112.635 -177.025 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.262 49.5 t80 -148.61 113.33 5.38 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 128.383 2.673 . . . . 0.0 109.103 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.92 50.71 0.81 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 128.159 2.583 . . . . 0.0 111.451 163.555 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.15 4.5 66.63 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 117.82 -2.134 . . . . 0.0 117.264 174.148 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -161.2 144.75 12.97 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -160.391 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -87.92 140.32 29.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 125.352 2.501 . . . . 0.0 107.648 173.224 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.61 113.2 24.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 118.84 -2.413 . . . . 0.0 108.514 179.864 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -79.2 137.22 37.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 118.395 -2.691 . . . . 0.0 111.634 -163.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -45.65 112.38 0.45 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 129.146 2.978 . . . . 0.0 114.733 156.358 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.62 -15.6 9.76 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 128.972 3.177 . . . . 0.0 113.896 -173.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -105.69 178.26 4.61 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 120.84 2.32 . . . . 0.0 105.797 -175.827 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -110.7 170.0 8.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 118.473 -2.642 . . . . 0.0 108.545 176.389 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.46 -35.72 63.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 117.195 -1.802 . . . . 0.0 109.983 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 p -53.95 -27.75 33.07 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 128.2 2.6 . . . . 0.0 112.91 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -58.68 -26.35 63.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 167.158 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -120.33 23.04 11.1 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 118.209 -2.807 . . . . 0.0 108.287 -170.132 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.344 13.5 m120 78.73 10.01 1.82 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 126.379 2.299 . . . . 0.0 111.978 171.12 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -77.81 120.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 121.124 1.784 . . . . 0.0 111.544 -160.361 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -106.37 -177.4 3.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.643 1.211 . . . . 0.0 111.185 176.13 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -69.49 126.48 29.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.074 2.149 . . . . 0.0 110.46 -178.174 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 61.85 29.68 17.98 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 129.392 3.077 . . . . 0.0 114.34 -176.583 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.5 m -62.34 126.79 28.56 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.613 2.365 . . . . 0.0 111.963 154.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -82.97 119.98 25.12 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 127.141 2.177 . . . . 0.0 107.219 173.586 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -89.74 154.89 19.58 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.438 -2.164 . . . . 0.0 107.607 159.062 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -119.24 139.72 51.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -112.41 132.3 55.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 124.564 2.126 . . . . 0.0 110.559 -167.374 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 m -130.53 133.07 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 113.09 -1.868 . . . . 0.0 110.04 175.578 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.448 -0.571 0 O-C-N 126.234 2.209 . . . . 0.0 107.499 -177.567 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 mtt . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 116.59 -1.671 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 149.17 23.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 121.29 1.859 . . . . 0.0 107.43 177.803 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -136.06 -177.33 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 C-N-CA 127.931 2.493 . . . . 0.0 107.986 160.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -128.44 138.63 52.4 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 119.21 -2.181 . . . . 0.0 113.064 174.011 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.9 t -110.73 114.84 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 164.166 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 83.8 tttt -104.26 140.31 38.04 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.296 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.4 p -102.35 117.53 34.92 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 118.165 -2.835 . . . . 0.0 104.654 166.5 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.09 -32.69 7.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 117.184 -3.448 . . . . 0.0 117.681 177.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 p -88.0 -9.68 52.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.903 2.881 . . . . 0.0 109.072 -176.61 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.73 -111.86 1.07 Allowed Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.276 -1.291 . . . . 0.0 113.233 -170.35 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.353 7.4 pttp -142.66 164.1 31.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.305 1.842 . . . . 0.0 115.387 -168.158 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.313 0.6 OUTLIER -81.3 115.16 20.54 Favored 'General case' 0 C--N 1.325 -0.473 1 C-N-CA 134.0 4.92 . . . . 0.0 109.603 -179.836 . . . . . . . . 4 3 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 mt -108.94 124.72 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -173.642 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 p -72.34 124.69 25.64 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 112.71 -2.041 . . . . 0.0 111.678 -179.027 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 16' ' ' GLU 0.261 1.7 tm? -130.06 152.22 49.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.082 -2.261 . . . . 0.0 109.907 -175.66 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.521 ' H ' HD13 ' A' ' 15' ' ' LEU . 68.1 tt0 -129.75 123.33 30.78 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 123.873 1.797 . . . . 0.0 107.936 -170.801 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.73 152.63 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 131.37 3.868 . . . . 0.0 113.206 178.703 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -93.73 156.98 38.97 Favored Pre-proline 0 N--CA 1.446 -0.66 0 C-N-CA 127.048 2.139 . . . . 0.0 105.611 171.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.14 -7.93 18.69 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 N-CA-C 118.44 2.438 . . . . 0.0 118.44 -171.091 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.6 p -108.16 5.26 25.7 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 130.95 3.7 . . . . 0.0 117.49 176.59 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.03 139.73 36.83 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 126.213 2.196 . . . . 0.0 107.736 -167.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -87.21 166.6 14.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 125.427 1.704 . . . . 0.0 108.588 174.809 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mp -69.02 -40.3 80.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 130.079 3.352 . . . . 0.0 108.049 -176.473 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -53.16 -34.76 58.26 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 113.431 -3.176 . . . . 0.0 112.75 168.315 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -82.76 -13.38 56.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 125.147 1.529 . . . . 0.0 109.752 -174.397 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 30' ' ' ILE . 80.3 t -70.9 -57.89 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 131.127 3.771 . . . . 0.0 106.727 168.535 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.316 38.7 mtmt -53.51 -38.66 63.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 125.281 2.467 . . . . 0.0 116.953 173.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -43.77 65.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 112.406 -2.179 . . . . 0.0 111.189 175.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -55.66 -51.92 65.59 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 118.79 -2.444 . . . . 0.0 109.1 171.667 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 26' ' ' VAL . 62.9 mt -51.78 -31.56 13.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 122.535 2.425 . . . . 0.0 109.587 169.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -78.55 -48.66 14.77 Favored 'General case' 0 N--CA 1.447 -0.61 1 O-C-N 113.851 -5.53 . . . . 0.0 108.148 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.383 18.3 t70 -46.95 -33.48 4.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 128.957 2.903 . . . . 0.0 117.841 165.614 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -100.46 -53.68 3.04 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 118.079 -2.888 . . . . 0.0 114.238 -174.69 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -108.47 -27.81 9.71 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -173.295 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.85 19.79 60.78 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 125.625 2.792 . . . . 0.0 117.269 175.363 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.409 HG22 ' HG2' ' A' ' 41' ' ' GLN . 49.9 mt -77.18 109.67 9.89 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-O 113.067 -3.349 . . . . 0.0 105.663 179.319 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -64.58 148.35 90.44 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 CA-C-N 126.912 3.504 . . . . 0.0 107.853 -166.993 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.84 -23.85 74.35 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 118.626 2.51 . . . . 0.0 118.626 -172.747 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -94.65 -12.23 27.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 115.461 -2.209 . . . . 0.0 111.913 -172.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -86.81 -19.41 29.04 Favored 'General case' 0 N--CA 1.448 -0.56 1 C-N-CA 132.536 4.334 . . . . 0.0 111.724 173.746 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.409 ' HG2' HG22 ' A' ' 36' ' ' ILE . 74.8 mt-30 -80.97 144.99 31.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.334 70.5 mtm180 -119.79 153.14 36.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 117.126 -3.484 . . . . 0.0 104.809 144.059 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.9 mt -119.35 140.98 49.46 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 114.303 -2.761 . . . . 0.0 107.255 176.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.497 0.0 OUTLIER -136.96 146.45 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 125.169 3.622 . . . . 0.0 110.778 172.482 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -159.09 110.47 2.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 116.542 -1.695 . . . . 0.0 108.875 -169.626 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.34 21.2 5.84 Favored 'General case' 0 N--CA 1.449 -0.487 1 O-C-N 129.525 4.265 . . . . 0.0 115.643 168.85 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.0 -18.16 29.01 Favored Glycine 0 CA--C 1.532 1.145 0 O-C-N 118.077 -2.89 . . . . 0.0 116.531 -169.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 126.71 52.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 129.465 3.685 . . . . 0.0 112.535 -162.361 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -66.78 97.6 0.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 129.2 3.0 . . . . 0.0 110.009 173.313 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.467 HD22 HD11 ' A' ' 61' ' ' ILE . 17.9 mt -67.63 118.69 11.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 127.757 2.423 . . . . 0.0 109.641 -178.704 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.51 128.96 55.26 Favored 'General case' 0 N--CA 1.451 -0.391 1 O-C-N 130.676 4.985 . . . . 0.0 112.19 175.109 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -52.85 131.46 35.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 119.255 -2.153 . . . . 0.0 112.466 156.44 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.74 2.14 14.68 Favored Glycine 0 CA--C 1.53 1.023 1 CA-C-O 110.766 -5.463 . . . . 0.0 113.367 -171.03 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -129.21 163.08 26.37 Favored 'General case' 0 N--CA 1.449 -0.506 1 CA-C-N 124.287 4.044 . . . . 0.0 107.577 -176.37 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 p -88.26 159.71 17.99 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 101.707 -3.442 . . . . 0.0 101.707 -176.146 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 56' ' ' LEU . 6.6 tt -34.23 -53.52 0.49 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 129.834 3.254 . . . . 0.0 111.138 153.492 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.6 m -72.27 -14.78 61.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 128.433 2.693 . . . . 0.0 115.233 -173.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.268 17.6 m-20 -65.09 -41.25 95.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 164.313 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -107.63 -28.46 9.73 Favored 'General case' 0 C--N 1.324 -0.504 1 O-C-N 114.891 -4.881 . . . . 0.0 108.136 -170.262 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.494 20.2 t30 96.06 41.72 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.324 2.25 . . . . 0.0 115.745 -175.024 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.467 HD11 HD22 ' A' ' 50' ' ' LEU . 12.1 mt -84.35 89.6 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 125.49 1.744 . . . . 0.0 110.191 176.682 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -91.09 175.13 7.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 125.82 1.95 . . . . 0.0 108.203 -168.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 149.06 30.07 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 170.187 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 64.78 2.96 1.85 Allowed 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 125.784 1.928 . . . . 0.0 114.421 177.606 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -69.06 156.17 39.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.026 -1.671 . . . . 0.0 111.442 176.484 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.3 m -125.17 132.27 53.08 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 117.334 -3.354 . . . . 0.0 104.746 -174.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.53 137.4 47.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -85.72 143.34 28.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.841 -1.787 . . . . 0.0 106.343 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tp -107.42 131.5 54.21 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 168.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.85 89.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.941 2.096 . . . . 0.0 114.419 -163.057 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.323 -0.572 0 O-C-N 119.403 -2.06 . . . . 0.0 109.062 -147.89 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 117.464 -1.255 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.274 50.0 mt-30 -95.43 125.87 40.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 127.324 3.44 . . . . 0.0 107.031 -175.57 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -113.07 144.71 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.315 171.083 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -100.7 106.5 17.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.267 -178.666 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.3 t -88.34 106.81 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 124.028 1.871 . . . . 0.0 110.487 170.124 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.294 5.4 tppt? -84.75 135.76 33.99 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.029 -1.669 . . . . 0.0 109.469 173.131 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -78.17 165.19 24.24 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.967 1.707 . . . . 0.0 115.107 165.588 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.35 0.4 OUTLIER -83.1 -12.49 57.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.581 163.665 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -66.65 -41.58 88.02 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 171.43 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.82 38.23 1.31 Allowed Glycine 0 CA--C 1.536 1.397 0 O-C-N 118.081 -2.887 . . . . 0.0 110.218 -172.038 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.283 59.4 pttt -130.76 168.77 16.67 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.525 2.33 . . . . 0.0 105.593 167.668 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.305 1.8 m -115.3 171.21 7.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 159.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 pt -138.61 145.69 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 131.411 3.885 . . . . 0.0 109.091 161.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 m -107.58 105.88 15.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 118.787 -2.446 . . . . 0.0 110.623 -175.88 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.21 131.73 40.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 115.185 -2.341 . . . . 0.0 109.209 176.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -74.66 119.62 19.1 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.04 2.536 . . . . 0.0 109.041 156.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.22 157.59 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 177.135 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.301 1.7 tm-20 -85.53 153.04 58.33 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 169.7 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.96 -22.98 75.33 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.482 1.455 . . . . 0.0 115.846 168.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.0 p -94.86 11.68 30.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 119.021 -2.3 . . . . 0.0 113.314 171.109 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.22 134.96 48.57 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 124.518 3.327 . . . . 0.0 107.819 159.181 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p -89.51 155.17 19.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 112.519 -2.128 . . . . 0.0 114.029 174.492 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 23' ' ' ILE . 11.7 mm -40.23 -56.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.418 2.287 . . . . 0.0 114.996 -172.222 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -39.66 65.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -69.87 -33.25 71.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.164 -1.585 . . . . 0.0 110.613 176.184 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 t -59.71 -45.27 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 O-C-N 116.633 -3.792 . . . . 0.0 108.129 171.445 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -53.78 -49.74 67.6 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 125.426 1.704 . . . . 0.0 108.448 175.304 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.43 -34.95 78.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 126.828 3.204 . . . . 0.0 114.099 -178.158 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -78.44 -24.53 46.06 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 117.309 -3.369 . . . . 0.0 108.791 177.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 mt -70.24 -40.36 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 123.544 2.884 . . . . 0.0 108.935 162.54 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -67.92 -39.38 83.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 114.467 -2.682 . . . . 0.0 112.097 -168.391 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -53.66 -39.54 65.15 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 127.487 2.315 . . . . 0.0 115.112 165.478 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.311 65.8 mmtt -89.7 -44.86 9.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 117.755 -1.578 . . . . 0.0 113.007 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -97.87 -19.88 17.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 116.124 -1.893 . . . . 0.0 113.055 -173.747 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.3 -15.26 63.35 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 173.601 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.0 mt -70.94 113.3 17.79 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-O 114.343 -2.741 . . . . 0.0 110.043 -177.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -65.35 153.77 76.7 Favored 'Trans proline' 0 N--CA 1.449 -1.116 1 C-N-CA 126.238 4.625 . . . . 0.0 110.385 -173.764 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.47 -34.16 97.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.825 3.017 . . . . 0.0 113.991 -178.296 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -60.52 -2.91 0.57 Allowed 'General case' 0 N--CA 1.445 -0.683 1 C-N-CA 133.883 4.873 . . . . 0.0 115.85 172.899 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.39 0.0 OUTLIER -135.59 14.93 3.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 169.289 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -105.79 161.35 14.5 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 171.477 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.295 15.9 ttm180 -157.62 139.27 13.92 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 131.386 3.874 . . . . 0.0 108.454 169.448 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.9 118.23 22.32 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.486 2.314 . . . . 0.0 109.985 -162.569 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.4 mm -101.75 139.33 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.689 1.596 . . . . 0.0 109.173 -174.418 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -148.03 140.48 24.43 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 115.82 -2.038 . . . . 0.0 110.376 158.726 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.301 . . 69.97 8.09 6.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 -177.512 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.89 -13.84 22.03 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.189 1.852 . . . . 0.0 108.786 171.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -112.45 163.86 13.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 116.497 -3.943 . . . . 0.0 111.776 -174.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -79.1 118.44 21.08 Favored 'General case' 0 N--CA 1.441 -0.913 1 C-N-CA 132.018 4.127 . . . . 0.0 111.315 166.524 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.85 129.12 34.36 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 127.53 3.019 . . . . 0.0 106.769 169.782 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -92.23 156.32 17.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 130.529 3.531 . . . . 0.0 114.004 -171.668 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -49.11 130.69 19.09 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.447 2.299 . . . . 0.0 111.545 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.73 -27.53 14.68 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.088 1.804 . . . . 0.0 116.418 163.358 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.81 149.98 26.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 120.537 2.169 . . . . 0.0 108.178 176.403 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -79.31 164.99 23.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 128.909 2.884 . . . . 0.0 109.285 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 56' ' ' LEU . 80.1 mt -67.64 -27.0 66.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.665 170.179 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.257 1.2 p -72.32 -20.36 61.5 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 112.281 -3.723 . . . . 0.0 115.402 163.579 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.61 -17.63 62.27 Favored 'General case' 0 N--CA 1.447 -0.615 1 CA-C-O 129.295 4.379 . . . . 0.0 109.225 178.527 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.264 50.2 m-85 -112.05 1.67 16.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 117.649 -3.157 . . . . 0.0 110.931 177.596 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.4 t30 53.57 44.43 29.83 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.8 2.44 . . . . 0.0 115.16 168.466 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.275 2.9 mt -66.56 131.57 32.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 1 C-N-CA 133.825 4.85 . . . . 0.0 112.875 160.636 . . . . . . . . 3 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.0 169.29 12.26 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 114.837 -2.506 . . . . 0.0 113.537 171.998 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.14 127.17 3.47 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 119.452 3.13 . . . . 0.0 119.452 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 65.45 30.61 10.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.358 2.263 . . . . 0.0 115.392 174.784 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -81.87 151.02 27.5 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.2 m -97.48 116.71 30.21 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 119.615 -1.928 . . . . 0.0 107.565 -174.259 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -100.43 145.14 28.59 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 128.513 2.725 . . . . 0.0 111.49 171.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -112.55 107.5 16.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 124.39 2.043 . . . . 0.0 110.202 -167.205 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tp -80.49 134.75 36.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 119.214 -2.179 . . . . 0.0 109.22 -173.702 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.5 t -125.01 136.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.911 -1.118 . . . . 0.0 111.099 174.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.45 -0.446 0 C-N-CA 130.533 3.533 . . . . 0.0 106.875 176.92 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -102.1 150.78 22.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 118.294 -2.754 . . . . 0.0 105.847 176.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.374 16.4 pt -140.56 157.51 24.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 131.203 3.801 . . . . 0.0 106.693 164.585 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -112.05 139.83 47.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -175.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 t -115.08 126.31 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 128.276 2.631 . . . . 0.0 107.83 166.003 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -93.29 125.59 37.97 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 127.925 3.266 . . . . 0.0 110.838 169.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.271 72.5 p -79.11 -165.18 0.71 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -179.632 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mt -77.28 -43.21 34.08 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 118.042 -2.911 . . . . 0.0 111.898 163.401 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.7 p -74.74 -6.28 47.99 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -169.614 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.59 0.87 43.23 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 117.253 1.661 . . . . 0.0 117.253 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -84.59 147.88 26.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.909 1.283 . . . . 0.0 111.713 173.866 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.6 m -110.52 109.29 19.57 Favored 'General case' 0 C--N 1.326 -0.441 1 C-N-CA 132.416 4.286 . . . . 0.0 100.314 173.964 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -95.31 142.42 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 127.257 2.223 . . . . 0.0 106.246 166.552 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.5 m -96.2 133.31 40.67 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -117.63 140.36 49.74 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -177.149 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -101.86 130.88 48.43 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 100.666 -3.828 . . . . 0.0 100.666 -177.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.482 HG21 HD23 ' A' ' 56' ' ' LEU . 34.3 m -137.34 163.14 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.177 176.888 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.366 71.2 mm-40 -116.48 145.83 36.09 Favored Pre-proline 0 N--CA 1.445 -0.675 0 N-CA-C 101.758 -3.423 . . . . 0.0 101.758 163.425 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -73.01 -3.6 13.92 Favored 'Trans proline' 0 N--CA 1.447 -1.261 1 C-N-CA 125.964 4.442 . . . . 0.0 113.911 -174.343 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 p -80.5 -20.91 42.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 128.755 2.822 . . . . 0.0 115.615 164.836 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -61.6 141.58 57.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.441 1.591 . . . . 0.0 113.565 175.877 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -70.56 159.12 34.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.1 1.76 . . . . 0.0 109.459 167.776 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 mm -45.24 -39.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 130.131 3.372 . . . . 0.0 113.973 162.593 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -76.61 -34.83 58.36 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.358 0.981 . . . . 0.0 110.761 179.533 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.288 18.8 m-80 -53.33 -44.29 68.32 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 116.722 -1.608 . . . . 0.0 112.014 174.381 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.28 1.9 t -51.55 -49.37 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 167.133 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -54.65 -52.15 63.21 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 125.586 1.804 . . . . 0.0 115.145 175.72 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.8 -39.02 4.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 131.306 3.842 . . . . 0.0 119.661 166.171 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -86.26 -38.92 17.07 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 110.867 -2.879 . . . . 0.0 105.841 -179.177 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 30' ' ' ILE 0.304 83.6 mt -54.47 -37.03 36.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 O-C-N 117.806 -3.059 . . . . 0.0 114.05 166.745 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -44.83 66.89 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 128.053 2.541 . . . . 0.0 115.718 175.556 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.39 -51.94 67.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.348 1.859 . . . . 0.0 111.637 168.089 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -82.67 -16.86 46.58 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 118.444 2.757 . . . . 0.0 118.444 -168.731 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -154.79 2.37 0.2 Allowed 'General case' 0 N--CA 1.449 -0.52 1 O-C-N 115.962 -4.211 . . . . 0.0 109.405 -173.594 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.37 -20.09 48.52 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 117.598 -3.189 . . . . 0.0 114.933 161.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mt -83.25 131.55 52.93 Favored Pre-proline 0 N--CA 1.442 -0.854 0 O-C-N 119.258 -2.319 . . . . 0.0 107.671 -167.11 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -59.92 151.06 74.38 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 118.824 2.586 . . . . 0.0 118.824 165.868 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.396 29.9 Cg_exo -47.17 -40.91 27.44 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 124.685 3.59 . . . . 0.0 117.718 173.488 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.27 2.76 38.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 124.811 1.319 . . . . 0.0 110.295 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -118.93 6.08 11.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 123.388 2.813 . . . . 0.0 112.494 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 70.1 mt-30 -99.2 156.24 17.07 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 118.704 0.684 . . . . 0.0 109.768 175.373 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -129.84 114.92 16.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 101.56 -3.496 . . . . 0.0 101.56 160.013 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 mt -86.66 146.45 26.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 125.735 3.88 . . . . 0.0 109.151 176.467 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.27 20.3 mm -135.14 156.17 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 129.722 3.209 . . . . 0.0 106.418 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -159.55 147.55 17.34 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 127.001 2.688 . . . . 0.0 109.789 159.856 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.347 . . 52.59 20.11 1.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 131.117 3.767 . . . . 0.0 112.51 175.354 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.29 -0.06 59.92 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 128.659 3.028 . . . . 0.0 110.168 175.794 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.275 28.3 mttm -100.66 148.06 25.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 116.127 -1.892 . . . . 0.0 112.689 -178.713 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -73.41 132.38 42.93 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 161.425 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 118.67 5.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.501 172.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.95 99.36 3.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.177 2.191 . . . . 0.0 111.25 174.463 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -39.3 135.07 1.08 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 151.782 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.96 2.53 7.82 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.132 -1.371 . . . . 0.0 116.412 171.657 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -129.25 -167.57 1.81 Allowed 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 127.371 2.453 . . . . 0.0 111.193 -163.459 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -125.21 165.18 18.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.824 1.65 . . . . 0.0 110.19 161.183 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -58.4 -40.09 81.43 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 118.081 -2.887 . . . . 0.0 111.042 -176.535 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.0 t -64.48 -33.45 75.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.719 2.008 . . . . 0.0 109.797 175.467 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.251 28.1 t70 -82.37 -32.36 29.26 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 117.667 -3.146 . . . . 0.0 115.07 -176.77 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -91.51 -2.75 57.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 116.012 -1.947 . . . . 0.0 109.177 173.724 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 71.74 40.04 0.81 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 129.988 3.315 . . . . 0.0 114.47 169.038 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.4 mt -79.88 109.81 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 102.003 -3.332 . . . . 0.0 102.003 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -83.51 164.98 19.5 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.274 1.83 . . . . 0.0 112.193 172.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.74 156.78 39.08 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.346 2.659 . . . . 0.0 108.951 -177.07 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 62.75 7.2 2.42 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.386 2.274 . . . . 0.0 112.278 175.586 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -74.61 148.44 40.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.2 -2.188 . . . . 0.0 111.385 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.2 m -108.4 111.91 24.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 118.361 -1.336 . . . . 0.0 112.741 -178.913 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.3 mp -88.62 176.02 7.3 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 129.905 3.282 . . . . 0.0 109.944 171.547 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -134.36 154.03 51.57 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 116.619 -3.801 . . . . 0.0 110.811 -175.263 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.321 0.7 OUTLIER -118.16 150.57 39.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.11 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.65 147.74 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 130.735 3.614 . . . . 0.0 105.597 163.02 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.9 tp . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.625 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -96.75 166.7 11.52 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -164.63 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 pt -114.68 134.41 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 153.61 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -87.12 112.06 21.56 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.53 1.532 . . . . 0.0 113.41 165.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.48 117.46 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 113.379 -3.201 . . . . 0.0 108.182 -176.424 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -119.29 152.28 36.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 130.005 3.322 . . . . 0.0 107.322 -169.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -155.45 170.57 21.63 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.933 1.693 . . . . 0.0 112.817 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 -23.34 48.34 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 128.608 3.693 . . . . 0.0 114.588 -165.5 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -76.67 -7.42 55.27 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 169.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.3 -23.5 8.05 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 118.026 -2.921 . . . . 0.0 114.108 167.113 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -59.55 133.05 55.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 118.06 2.615 . . . . 0.0 118.06 -175.853 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 m -112.86 103.67 11.66 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 170.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 mt -96.85 115.3 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 129.589 3.156 . . . . 0.0 106.484 175.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.8 p -89.6 109.94 20.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 114.046 -2.883 . . . . 0.0 111.932 168.579 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -112.21 140.11 47.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 125.076 3.58 . . . . 0.0 105.028 172.826 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -88.64 135.76 33.34 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.19 2.196 . . . . 0.0 107.599 176.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.51 173.6 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 127.879 2.472 . . . . 0.0 110.991 -161.623 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 44.7 mm-40 -132.88 166.56 28.33 Favored Pre-proline 0 N--CA 1.441 -0.925 1 O-C-N 129.572 4.295 . . . . 0.0 108.517 151.648 . . . . . . . . 3 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -37.74 -21.63 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 124.324 3.349 . . . . 0.0 120.229 163.345 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.7 p -94.07 -20.59 19.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.914 2.886 . . . . 0.0 113.667 -173.414 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -69.1 145.3 53.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.188 0.994 . . . . 0.0 112.502 176.208 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.5 p -90.0 165.25 14.16 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.93 -1.941 . . . . 0.0 112.108 -173.167 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -74.08 -49.72 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 114.902 -2.475 . . . . 0.0 110.382 170.28 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -58.62 -10.28 2.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 125.705 3.866 . . . . 0.0 119.605 172.726 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -74.91 -38.66 61.77 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 119.628 1.104 . . . . 0.0 112.26 161.807 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 30' ' ' ILE . 22.7 t -71.89 -34.63 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 O-C-N 116.817 -3.677 . . . . 0.0 109.419 -168.67 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -71.43 -39.53 70.98 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.692 1.997 . . . . 0.0 109.251 -175.109 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.73 89.32 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.983 3.313 . . . . 0.0 116.505 161.675 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -82.79 -21.04 34.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 125.62 1.825 . . . . 0.0 113.729 -177.568 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 26' ' ' VAL . 96.2 mt -55.76 -50.67 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.646 2.378 . . . . 0.0 109.252 161.111 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -67.35 -28.52 68.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -173.506 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.334 36.5 t70 -52.41 -46.43 66.32 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 130.882 3.673 . . . . 0.0 117.093 162.544 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -92.08 -48.62 6.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.688 -1.596 . . . . 0.0 108.907 -175.673 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS 0.318 20.8 tp10 -108.13 -15.79 14.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 128.065 2.546 . . . . 0.0 116.37 -166.78 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.26 -26.01 26.0 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 124.497 3.317 . . . . 0.0 111.949 158.061 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 tp -67.95 127.91 93.33 Favored Pre-proline 0 C--O 1.223 -0.33 0 CA-C-O 113.917 -2.944 . . . . 0.0 107.782 -170.588 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.67 137.07 17.76 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 124.519 3.48 . . . . 0.0 118.137 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -34.53 -37.95 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.441 3.427 . . . . 0.0 117.623 178.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.481 13.1 t70 -44.07 -40.47 4.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 171.214 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -108.23 12.39 26.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 112.836 -1.984 . . . . 0.0 111.426 -176.265 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -100.95 135.86 41.72 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.195 1.798 . . . . 0.0 107.88 174.06 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -130.26 140.07 50.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 128.09 2.556 . . . . 0.0 111.816 172.451 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.03 118.79 30.7 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 126.542 2.401 . . . . 0.0 108.666 -160.262 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.444 HG12 HG23 ' A' ' 70' ' ' VAL . 38.3 mm -120.03 138.35 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 127.599 2.359 . . . . 0.0 111.197 -173.916 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -133.55 100.67 4.87 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.226 2.211 . . . . 0.0 112.232 171.447 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.49 -94.36 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.386 -162.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.08 4.57 9.0 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 115.973 -2.57 . . . . 0.0 114.437 168.643 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -87.3 131.23 34.32 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 120.703 2.252 . . . . 0.0 105.067 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -85.0 124.27 31.5 Favored 'General case' 0 N--CA 1.442 -0.842 1 C-N-CA 134.445 5.098 . . . . 0.0 105.599 176.241 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 mt -101.27 157.27 16.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 125.46 1.725 . . . . 0.0 109.879 -173.011 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -130.18 134.04 47.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.468 1.507 . . . . 0.0 107.313 170.261 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.256 3.1 p30 -70.12 -168.62 0.23 Allowed 'General case' 0 C--O 1.221 -0.402 0 O-C-N 128.684 3.74 . . . . 0.0 112.141 -174.153 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.55 1.75 58.92 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 120.89 3.116 . . . . 0.0 120.89 -175.084 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.3 mtt-85 -147.86 159.34 43.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 128.586 2.754 . . . . 0.0 110.747 -150.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.3 p -83.19 176.73 8.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 129.972 3.309 . . . . 0.0 111.036 -179.796 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.66 -33.49 76.01 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 129.36 3.064 . . . . 0.0 111.232 168.048 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 41.1 t -85.49 -10.52 55.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 119.39 -2.069 . . . . 0.0 112.115 176.634 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.03 -28.46 68.88 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 125.612 1.82 . . . . 0.0 109.979 169.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.287 41.3 m-85 -122.73 17.15 10.28 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 119.53 -1.981 . . . . 0.0 113.562 -175.914 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 t30 53.8 40.61 31.72 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -174.536 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.2 mt -85.62 80.58 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 173.157 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -102.77 36.55 2.16 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.613 2.365 . . . . 0.0 111.428 -161.851 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm 96.45 132.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 1 C-N-CA 132.212 4.205 . . . . 0.0 105.774 156.069 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.435 9.9 mp0 73.49 23.53 2.46 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 130.6 3.56 . . . . 0.0 109.87 176.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.9 m -69.48 142.27 53.78 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 129.045 2.938 . . . . 0.0 109.308 171.339 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.5 m -94.86 119.08 32.84 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 126.103 2.127 . . . . 0.0 106.105 168.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.38 137.12 47.72 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 175.611 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -104.9 120.57 41.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.569 2.348 . . . . 0.0 107.253 178.522 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -92.49 115.52 28.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 110.71 -2.95 . . . . 0.0 109.089 166.487 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.444 HG23 HG12 ' A' ' 44' ' ' ILE . 82.8 t -74.38 109.87 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 159.853 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.218 -0.576 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 165.84 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 115.765 -2.064 . . . . 0.0 107.739 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -86.5 140.44 29.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -167.803 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.398 7.4 pt -131.77 172.97 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 128.686 2.794 . . . . 0.0 115.561 162.576 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -126.85 135.45 51.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 127.164 2.79 . . . . 0.0 103.679 -175.317 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.275 79.6 t -126.92 121.47 58.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.978 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 68' ' ' HIS 0.255 35.1 tttp -97.47 156.05 16.66 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 129.583 3.153 . . . . 0.0 103.8 -172.918 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -134.48 146.2 49.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.183 -178.06 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.7 mt -68.52 -22.59 64.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 117.906 -2.996 . . . . 0.0 111.403 -176.996 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 p -82.04 -18.49 43.04 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.504 2.322 . . . . 0.0 109.002 -172.654 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.47 31.45 0.78 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-O 116.624 -2.209 . . . . 0.0 112.981 151.14 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.311 41.5 pttt -133.43 160.87 36.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.039 3.336 . . . . 0.0 110.212 -179.399 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -122.08 135.53 54.82 Favored 'General case' 0 N--CA 1.449 -0.514 1 N-CA-C 99.739 -4.171 . . . . 0.0 99.739 164.73 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 pt -97.99 152.43 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 118.806 -2.434 . . . . 0.0 105.165 168.616 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.1 m -96.83 150.14 21.06 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 128.741 3.776 . . . . 0.0 107.656 166.428 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.85 157.36 46.94 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.009 2.123 . . . . 0.0 107.288 179.816 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -134.27 101.4 5.0 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.475 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.44 145.31 25.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 129.458 3.103 . . . . 0.0 112.646 -172.773 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -85.29 135.18 39.31 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.768 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.83 -37.62 2.45 Favored 'Trans proline' 0 N--CA 1.454 -0.841 1 C-N-CA 126.971 5.114 . . . . 0.0 117.639 -178.334 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 p -103.13 9.61 38.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 119.566 3.172 . . . . 0.0 119.566 -179.494 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -72.55 137.71 46.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 118.138 -2.851 . . . . 0.0 104.035 170.194 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -75.95 162.03 28.44 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 129.693 3.197 . . . . 0.0 113.809 172.714 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.1 mm -53.12 -36.45 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.258 2.223 . . . . 0.0 113.891 -174.09 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.305 4.8 tp10 -55.89 -38.6 70.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.83 2.052 . . . . 0.0 115.526 173.945 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -66.99 -43.66 82.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 125.932 2.02 . . . . 0.0 112.756 176.225 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.263 22.8 t -52.84 -52.76 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.836 2.054 . . . . 0.0 110.2 174.873 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -58.79 -42.08 88.22 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 125.667 1.854 . . . . 0.0 111.916 -179.228 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.48 72.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 116.462 -1.732 . . . . 0.0 112.572 177.371 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -76.41 -33.48 58.82 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 122.784 2.538 . . . . 0.0 111.457 178.586 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.58 -43.43 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 129.895 3.278 . . . . 0.0 110.698 174.394 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.48 -52.9 62.59 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 125.309 1.443 . . . . 0.0 112.416 175.722 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -52.71 -39.43 62.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 131.237 3.815 . . . . 0.0 111.977 -179.082 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -87.83 -50.69 6.29 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 127.688 3.117 . . . . 0.0 115.808 -178.894 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.3 -6.29 12.96 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 128.075 2.55 . . . . 0.0 115.357 -166.237 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.0 -16.6 35.98 Favored Glycine 0 CA--C 1.533 1.158 1 C-N-CA 130.821 4.058 . . . . 0.0 110.181 156.453 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.08 121.94 86.34 Favored Pre-proline 0 N--CA 1.444 -0.763 0 O-C-N 119.468 -2.195 . . . . 0.0 110.388 -164.089 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.26 148.94 56.54 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 122.994 2.463 . . . . 0.0 111.244 179.164 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.68 -32.14 95.33 Favored 'Trans proline' 0 N--CA 1.447 -1.238 1 C-N-CA 125.363 4.042 . . . . 0.0 116.614 -163.065 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.253 51.3 m-20 -73.18 -4.34 32.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.007 2.123 . . . . 0.0 115.49 176.165 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -108.82 -12.16 14.94 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 171.613 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.83 162.37 21.66 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.699 -0.8 . . . . 0.0 113.027 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.276 0.1 OUTLIER -151.71 102.93 2.9 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 118.308 -2.745 . . . . 0.0 106.475 175.21 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.2 mt -87.04 113.55 22.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 127.576 3.048 . . . . 0.0 114.732 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.8 mt -120.56 138.89 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 131.551 3.941 . . . . 0.0 106.558 -168.102 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -155.34 -176.68 6.07 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.098 -2.876 . . . . 0.0 105.97 -172.951 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.04 112.67 1.41 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 124.638 2.161 . . . . 0.0 110.026 -168.693 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.82 -78.54 0.3 Allowed Glycine 0 CA--C 1.532 1.137 0 N-CA-C 107.03 -2.428 . . . . 0.0 107.03 -175.869 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -165.74 -171.99 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.965 2.506 . . . . 0.0 104.959 -161.959 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.81 148.85 45.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 130.994 3.718 . . . . 0.0 110.034 -177.437 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.37 147.39 22.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 122.863 1.316 . . . . 0.0 111.907 176.148 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -111.55 157.72 20.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 111.663 -2.517 . . . . 0.0 115.556 -175.956 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -72.98 135.53 44.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 130.84 3.656 . . . . 0.0 112.381 -171.68 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.5 -28.35 10.96 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 169.707 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -71.74 159.26 34.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 116.605 -1.664 . . . . 0.0 110.36 -179.006 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 p -113.28 -178.46 3.38 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.358 2.263 . . . . 0.0 109.567 171.148 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.0 -31.25 68.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 125.192 1.557 . . . . 0.0 114.255 179.197 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.3 p -77.42 -33.31 54.97 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.15 -37.83 75.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 124.508 1.13 . . . . 0.0 110.883 177.261 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.73 -0.58 57.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.026 -1.046 . . . . 0.0 113.627 -175.076 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 77.94 42.83 0.1 Allowed 'General case' 0 C--N 1.324 -0.51 1 C-N-CA 134.045 4.938 . . . . 0.0 109.072 167.78 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -100.03 95.35 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 103.258 -2.868 . . . . 0.0 103.258 -175.34 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -70.66 163.74 26.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.624 -1.298 . . . . 0.0 110.162 160.459 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -45.41 147.3 0.83 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 131.095 3.758 . . . . 0.0 114.04 175.37 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 59.41 33.84 22.5 Favored 'General case' 0 N--CA 1.448 -0.566 1 C-N-CA 132.847 4.459 . . . . 0.0 106.901 172.29 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -93.68 152.21 19.13 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 117.511 -3.243 . . . . 0.0 106.861 175.739 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.6 m -99.67 130.28 45.88 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.932 1.395 . . . . 0.0 110.56 175.177 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mp -102.78 161.49 13.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 102.088 -3.301 . . . . 0.0 102.088 163.434 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -114.83 123.42 49.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 172.752 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -90.14 122.0 32.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 118.677 -2.514 . . . . 0.0 111.57 167.302 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.67 156.4 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.925 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.268 16.0 mt . . . . . 0 N--CA 1.444 -0.739 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.399 -169.807 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptt? . . . . . 0 C--O 1.223 -0.317 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -88.45 148.69 24.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 117.518 -3.239 . . . . 0.0 105.705 -177.706 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -127.2 143.29 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 128.925 2.89 . . . . 0.0 107.268 159.902 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -104.07 134.41 47.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.197 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.23 126.93 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 117.74 -1.124 . . . . 0.0 109.413 -168.047 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -116.68 116.45 27.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 122.162 2.256 . . . . 0.0 112.853 -165.703 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 p -74.06 158.59 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.201 1.4 . . . . 0.0 109.98 -178.88 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.5 tp -59.78 -40.47 88.37 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.682 1.993 . . . . 0.0 107.223 -166.792 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.6 p -80.7 2.2 26.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.89 -3.007 . . . . 0.0 118.607 176.408 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.91 -7.7 16.96 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 119.157 2.423 . . . . 0.0 119.157 152.815 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -75.67 122.86 24.61 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.281 1.433 . . . . 0.0 107.251 -177.086 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.321 73.1 m -81.86 138.16 35.11 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.19 0.995 . . . . 0.0 109.754 170.865 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -122.12 141.86 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 129.807 3.243 . . . . 0.0 103.379 172.917 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 m -96.88 120.05 36.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.943 2.497 . . . . 0.0 112.307 170.165 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.2 mt -106.17 136.27 46.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.084 1.754 . . . . 0.0 110.437 171.158 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -92.17 140.28 29.78 Favored 'General case' 0 CA--C 1.535 0.401 1 O-C-N 129.863 4.477 . . . . 0.0 104.235 172.058 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -153.9 168.66 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 129.256 3.022 . . . . 0.0 105.278 -174.832 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.9 mt-10 -116.45 159.69 39.08 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 129.094 2.958 . . . . 0.0 107.81 172.769 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 18' ' ' GLU 0.297 86.7 Cg_endo -57.86 -29.58 86.69 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.568 3.512 . . . . 0.0 116.515 172.237 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -95.88 11.18 34.67 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 130.769 3.628 . . . . 0.0 108.398 -166.889 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.29 2.6 m-20 -92.92 146.8 23.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 115.835 -2.031 . . . . 0.0 111.533 -176.038 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 24' ' ' GLU . 2.4 t -86.13 151.83 23.35 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 120.338 1.427 . . . . 0.0 112.262 173.72 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.258 62.6 mt -65.12 -31.24 53.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 118.367 -2.708 . . . . 0.0 108.826 -171.069 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 22' ' ' THR . 1.0 OUTLIER -63.15 -40.44 97.57 Favored 'General case' 0 N--CA 1.452 -0.366 2 O-C-N 114.325 -5.234 . . . . 0.0 113.824 176.515 . . . . . . . . 4 4 . 1 . 032 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -68.44 -31.0 70.01 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 128.532 2.733 . . . . 0.0 111.8 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 t -59.64 -51.94 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 122.496 2.407 . . . . 0.0 110.278 163.448 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -68.03 -40.55 82.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.973 2.909 . . . . 0.0 112.051 -164.053 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -17.94 64.8 Favored 'General case' 0 N--CA 1.446 -0.655 1 C-N-CA 132.765 4.426 . . . . 0.0 113.982 177.45 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -65.08 -31.64 72.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 130.554 3.542 . . . . 0.0 110.661 176.399 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 mm -74.05 -16.74 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 O-C-N 124.948 1.405 . . . . 0.0 114.164 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.281 6.1 tp60 -66.89 -38.12 85.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 117.251 -3.406 . . . . 0.0 111.441 169.723 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.66 -47.67 74.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.811 1.244 . . . . 0.0 110.708 168.612 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.85 -75.33 0.16 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 115.577 -2.154 . . . . 0.0 114.498 -175.944 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -101.24 -20.06 15.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 127.944 3.278 . . . . 0.0 115.171 -161.906 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.96 6.34 26.34 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 130.345 3.831 . . . . 0.0 114.51 162.811 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.59 124.02 54.32 Favored Pre-proline 0 N--CA 1.448 -0.555 0 O-C-N 126.728 2.075 . . . . 0.0 105.854 -164.176 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -68.24 172.81 10.49 Favored 'Trans proline' 0 N--CA 1.451 -1.003 1 C-N-CA 126.424 4.75 . . . . 0.0 116.16 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.85 -42.59 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 1 C-N-CA 126.943 5.096 . . . . 0.0 107.622 177.266 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.88 -15.32 62.62 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 130.725 3.61 . . . . 0.0 115.978 -174.57 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.257 38.0 tt0 -103.59 -34.57 8.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 118.101 -1.439 . . . . 0.0 113.887 171.572 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.05 135.01 21.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.745 1.618 . . . . 0.0 115.329 169.017 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -136.14 158.34 44.65 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 119.158 -2.214 . . . . 0.0 107.702 168.44 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.8 mt -129.63 152.24 49.36 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 127.87 3.231 . . . . 0.0 108.952 -167.602 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 mt -135.94 129.49 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 127.797 2.439 . . . . 0.0 107.142 169.871 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -120.28 118.33 30.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 130.359 3.464 . . . . 0.0 105.338 173.205 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.87 50.64 11.09 Favored 'General case' 0 C--O 1.22 -0.472 1 C-N-CA 133.797 4.839 . . . . 0.0 111.568 170.983 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.46 -13.92 60.93 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.787 -1.007 . . . . 0.0 111.591 173.344 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 mtmt -105.93 119.75 39.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 130.988 3.715 . . . . 0.0 109.06 -172.812 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -76.36 151.83 36.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 128.526 2.731 . . . . 0.0 104.559 172.164 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.282 0.8 OUTLIER -140.15 132.3 28.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.669 2.787 . . . . 0.0 111.11 177.768 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.258 71.9 mm-40 -87.61 162.3 17.23 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 125.188 2.423 . . . . 0.0 110.116 172.222 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.35 162.06 18.37 Favored 'General case' 0 N--CA 1.45 -0.468 1 C-N-CA 134.882 5.273 . . . . 0.0 109.02 173.898 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.57 14.46 32.28 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 119.687 2.635 . . . . 0.0 119.687 173.591 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -157.55 163.95 37.84 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.876 2.07 . . . . 0.0 111.958 177.797 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.6 p -85.47 149.43 25.4 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 130.354 3.462 . . . . 0.0 108.456 -173.106 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.543 HD22 HD13 ' A' ' 61' ' ' ILE . 20.0 mt -65.2 -34.93 79.55 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.522 1.529 . . . . 0.0 109.556 -171.334 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.29 66.5 p -36.59 -56.98 0.8 Allowed 'General case' 0 N--CA 1.449 -0.513 1 C-N-CA 133.966 4.906 . . . . 0.0 113.8 173.944 . . . . . . . . 3 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.86 -27.25 66.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 130.713 3.605 . . . . 0.0 116.156 -177.563 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -101.14 2.73 40.49 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.412 2.285 . . . . 0.0 110.846 179.603 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.362 24.3 p30 69.13 29.43 4.7 Favored 'General case' 0 N--CA 1.444 -0.772 1 C-N-CA 131.819 4.047 . . . . 0.0 113.161 168.332 . . . . . . . . 3 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.543 HD13 HD22 ' A' ' 56' ' ' LEU . 25.8 mt -83.68 127.14 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.446 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -115.57 178.83 4.16 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 130.255 3.422 . . . . 0.0 107.304 -174.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.56 135.26 46.39 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 128.689 2.796 . . . . 0.0 111.261 168.132 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 61.49 27.6 17.11 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 129.552 3.141 . . . . 0.0 116.683 176.766 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -62.98 147.86 49.33 Favored 'General case' 0 C--N 1.328 -0.369 1 O-C-N 115.423 -4.548 . . . . 0.0 109.959 171.608 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.8 p -113.69 108.3 16.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.554 1.941 . . . . 0.0 107.383 -176.688 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.57 150.64 28.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 123.817 1.77 . . . . 0.0 112.738 177.894 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -87.77 139.95 30.01 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 128.956 2.902 . . . . 0.0 104.654 169.281 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.68 120.9 40.06 Favored 'General case' 0 C--N 1.325 -0.493 1 N-CA-C 96.73 -5.285 . . . . 0.0 96.73 170.544 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 m -132.67 165.97 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 128.222 2.609 . . . . 0.0 108.367 170.176 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 C--N 1.324 -0.539 0 C-N-CA 127.805 2.442 . . . . 0.0 116.025 -174.491 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttm . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -111.77 144.9 40.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.233 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.372 34.2 pt -132.37 162.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 130.189 3.396 . . . . 0.0 116.57 169.376 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -107.89 131.58 54.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.647 1.979 . . . . 0.0 109.858 178.41 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 30' ' ' ILE . 19.2 t -100.32 118.0 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 129.031 2.933 . . . . 0.0 105.866 159.724 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.391 71.9 tttt -112.48 123.25 49.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 -174.437 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -88.74 151.56 22.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 110.113 -3.221 . . . . 0.0 107.968 174.652 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mt -67.88 -24.21 65.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 127.172 2.795 . . . . 0.0 109.869 172.37 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -81.24 -18.43 46.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 118.526 -2.609 . . . . 0.0 111.104 -171.332 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.31 -6.17 7.18 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 128.129 2.776 . . . . 0.0 115.11 156.427 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.251 17.1 pttt -82.36 143.21 31.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.349 1.46 . . . . 0.0 111.203 -175.743 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 p -97.26 143.42 28.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 125.796 2.712 . . . . 0.0 107.671 164.629 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.6 mt -122.75 143.03 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 110.347 -3.115 . . . . 0.0 103.171 172.804 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 m -100.22 132.64 45.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.081 2.552 . . . . 0.0 110.875 172.996 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -120.38 133.08 55.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.222 3.009 . . . . 0.0 110.406 170.802 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -93.75 112.73 24.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.278 1.831 . . . . 0.0 109.063 170.287 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.79 175.64 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 127.975 2.51 . . . . 0.0 109.627 -176.784 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -132.13 159.33 72.61 Favored Pre-proline 0 N--CA 1.451 -0.399 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 159.178 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 46.0 Cg_endo -74.93 -8.94 20.62 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 123.214 2.609 . . . . 0.0 114.228 -170.652 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 p -68.64 -31.35 70.42 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.884 2.873 . . . . 0.0 114.627 167.577 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.9 131.93 41.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 117.181 -3.449 . . . . 0.0 113.978 174.489 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.0 p -73.06 157.37 37.46 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 127.085 2.154 . . . . 0.0 112.301 173.406 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.295 1.9 mp -36.2 -42.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 129.414 3.086 . . . . 0.0 115.202 154.804 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -73.03 -37.68 66.81 Favored 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 133.557 4.743 . . . . 0.0 116.561 169.517 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -63.18 -36.38 83.44 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.794 2.088 . . . . 0.0 110.89 165.862 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.1 t -69.65 -39.4 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 1 O-C-N 115.034 -4.791 . . . . 0.0 114.292 178.134 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -61.04 -38.71 87.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.914 1.686 . . . . 0.0 115.058 168.85 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.25 -54.51 14.37 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 130.626 3.571 . . . . 0.0 107.581 174.948 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -55.35 -42.38 73.79 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 5' ' ' VAL . 46.1 mt -64.08 -43.95 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.512 1.125 . . . . 0.0 111.173 169.205 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -58.59 -32.61 69.12 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.965 2.506 . . . . 0.0 112.446 178.3 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.268 0.9 OUTLIER -58.21 -37.79 75.52 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 119.536 -1.977 . . . . 0.0 111.357 169.941 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -87.5 -45.41 10.51 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.151 2.581 . . . . 0.0 106.833 -169.854 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.16 -17.51 13.2 Favored 'General case' 0 N--CA 1.451 -0.4 1 N-CA-C 124.846 5.128 . . . . 0.0 124.846 -174.516 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.79 -2.09 81.06 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 125.534 1.54 . . . . 0.0 114.489 172.693 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.7 mt -76.04 138.49 68.91 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 127.446 2.298 . . . . 0.0 109.846 -174.554 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.36 133.73 41.7 Favored 'Trans proline' 0 N--CA 1.45 -1.061 1 C-N-CA 126.363 4.709 . . . . 0.0 116.611 179.117 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -43.54 -44.74 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.698 1 C-N-CA 131.883 8.389 . . . . 0.0 111.502 173.825 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.358 2.4 t70 -38.7 -44.12 0.97 Allowed 'General case' 0 C--O 1.234 0.275 1 C-N-CA 133.826 4.85 . . . . 0.0 113.087 169.117 . . . . . . . . 3 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -96.66 -25.71 15.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.649 1.98 . . . . 0.0 108.926 -171.557 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -81.41 111.75 18.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -166.181 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -102.81 124.94 49.28 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 100.94 -3.726 . . . . 0.0 100.94 177.812 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.57 120.06 34.72 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 127.23 2.831 . . . . 0.0 107.435 175.032 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mt -122.35 154.12 27.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 126.273 2.233 . . . . 0.0 105.347 -169.064 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.283 67.8 t80 -143.32 128.21 18.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 115.26 -2.305 . . . . 0.0 110.472 160.716 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.36 20.3 6.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.145 2.178 . . . . 0.0 112.674 167.778 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.02 -8.6 63.22 Favored Glycine 0 CA--C 1.526 0.741 1 O-C-N 115.853 -4.279 . . . . 0.0 111.667 -178.59 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -102.66 155.23 18.44 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 124.988 2.328 . . . . 0.0 115.357 173.388 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -94.04 129.81 40.41 Favored 'General case' 0 N--CA 1.446 -0.643 1 N-CA-C 100.123 -4.028 . . . . 0.0 100.123 174.759 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.58 133.88 53.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 127.074 2.15 . . . . 0.0 107.701 167.98 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -69.86 134.62 48.67 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 115.298 -2.287 . . . . 0.0 112.796 177.836 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.294 5.6 t0 -93.21 132.99 36.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 126.224 2.916 . . . . 0.0 109.135 168.569 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.58 8.06 23.3 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 119.059 -2.275 . . . . 0.0 112.925 -159.721 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt-85 -136.98 178.19 7.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 120.476 2.138 . . . . 0.0 106.677 -177.575 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.8 p -110.78 172.42 6.88 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 129.808 3.243 . . . . 0.0 112.509 -176.901 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 5.4 mt -61.32 -46.78 88.87 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 119.178 -2.202 . . . . 0.0 109.113 168.164 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -56.32 -31.58 63.85 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 174.441 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.71 -29.72 70.29 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.87 2.068 . . . . 0.0 109.885 -178.323 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -102.16 12.23 37.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 124.106 1.908 . . . . 0.0 112.827 177.13 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.338 0.6 OUTLIER 84.14 1.7 0.9 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.728 2.011 . . . . 0.0 113.982 172.039 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.14 71.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.98 2.112 . . . . 0.0 108.8 179.28 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -81.07 -32.51 33.95 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.997 2.519 . . . . 0.0 113.902 166.565 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -149.54 118.45 6.67 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 118.779 -2.45 . . . . 0.0 114.022 -179.798 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 47.47 99.92 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.891 1 C-N-CA 135.198 5.399 . . . . 0.0 113.295 157.579 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -143.17 174.39 10.74 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 117.06 -3.525 . . . . 0.0 108.942 -177.235 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -121.81 147.88 45.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 116.758 -3.714 . . . . 0.0 104.527 171.78 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.5 mt -115.11 144.01 44.32 Favored 'General case' 0 N--CA 1.447 -0.578 1 C-N-CA 131.976 4.11 . . . . 0.0 111.354 174.42 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -100.89 117.08 34.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 101.069 -3.678 . . . . 0.0 101.069 -175.711 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.5 tp -100.87 129.48 46.74 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.463 1.105 . . . . 0.0 108.997 167.58 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.405 0.2 OUTLIER -131.02 156.94 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 O-C-N 125.996 2.06 . . . . 0.0 109.284 165.547 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 tp . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 127.297 3.427 . . . . 0.0 107.495 174.769 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 123.52 1.629 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -94.79 124.73 39.0 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 117.584 -3.197 . . . . 0.0 106.051 175.57 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -108.08 161.88 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 102.981 -2.97 . . . . 0.0 102.981 164.542 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -101.9 141.75 34.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 116.0 -1.952 . . . . 0.0 114.073 157.777 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 t -110.31 115.36 49.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 163.746 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -83.16 107.0 15.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.227 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.285 1.2 p -74.0 156.13 37.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.768 2.827 . . . . 0.0 109.476 174.748 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.5 tp -54.62 -37.67 65.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 130.152 3.381 . . . . 0.0 116.449 -159.986 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -66.62 -24.05 66.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 113.006 -3.378 . . . . 0.0 115.235 177.303 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.22 -35.25 3.01 Favored Glycine 0 CA--C 1.531 1.036 1 CA-C-O 112.101 -4.722 . . . . 0.0 111.415 -164.397 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.21 139.01 58.72 Favored 'General case' 0 N--CA 1.448 -0.566 1 O-C-N 131.292 4.76 . . . . 0.0 104.679 -175.423 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -116.65 129.73 56.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 128.165 2.586 . . . . 0.0 109.255 173.998 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 pt -113.77 143.78 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.503 167.472 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.9 m -90.65 130.38 36.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 128.337 2.655 . . . . 0.0 106.68 176.373 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.35 109.57 18.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.985 2.114 . . . . 0.0 106.871 179.086 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -71.84 112.45 7.95 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 128.945 3.903 . . . . 0.0 107.832 168.682 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 m -135.4 166.25 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 128.231 2.612 . . . . 0.0 109.085 -177.197 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -116.48 161.57 31.06 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 116.456 -1.735 . . . . 0.0 108.762 168.674 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -65.13 -19.49 63.03 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 124.682 3.588 . . . . 0.0 113.224 178.333 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.6 p -69.8 -26.16 64.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 113.379 -3.2 . . . . 0.0 112.3 172.068 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.93 133.85 26.42 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 128.948 2.899 . . . . 0.0 112.222 -177.717 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 p -83.61 148.65 27.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 116.055 -1.926 . . . . 0.0 111.509 175.375 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 23' ' ' ILE . 6.0 mm -48.11 -42.77 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 125.388 3.722 . . . . 0.0 111.274 168.404 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -40.98 -65.76 0.4 Allowed 'General case' 0 N--CA 1.445 -0.686 1 C-N-CA 131.703 4.001 . . . . 0.0 112.884 163.107 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -35.43 80.23 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 123.239 0.337 . . . . 0.0 110.613 179.653 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.29 68.7 t -57.04 -48.34 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 116.79 -1.576 . . . . 0.0 115.153 168.908 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -46.71 -34.37 5.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 125.559 3.8 . . . . 0.0 117.543 161.893 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -28.04 59.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 123.792 1.758 . . . . 0.0 112.725 177.628 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -79.7 -44.45 20.8 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 118.564 -2.585 . . . . 0.0 112.709 172.479 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mt -48.67 -49.17 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 120.732 1.605 . . . . 0.0 111.25 170.5 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -54.98 -53.77 51.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 167.2 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.88 -41.28 91.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 123.229 2.74 . . . . 0.0 109.65 -175.164 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -76.17 -27.78 57.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 118.34 2.719 . . . . 0.0 118.34 179.916 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.294 21.0 mm-40 -140.11 2.96 1.95 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 122.903 2.592 . . . . 0.0 109.97 -175.734 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.42 -3.54 86.44 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 117.937 -2.977 . . . . 0.0 116.495 162.925 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.61 146.65 61.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 115.568 -2.158 . . . . 0.0 107.136 -167.396 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -78.11 132.27 11.44 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.062 3.175 . . . . 0.0 103.932 -178.081 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.77 -18.34 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 CA-C-N 124.098 2.499 . . . . 0.0 112.84 -170.413 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.34 -22.42 44.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 118.006 -1.477 . . . . 0.0 114.831 -170.111 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -82.76 -16.67 47.02 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.633 1.973 . . . . 0.0 114.432 172.396 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -73.87 130.22 39.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.623 1.969 . . . . 0.0 111.967 174.418 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -96.16 144.81 26.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.927 2.491 . . . . 0.0 107.323 155.585 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.1 tp -142.93 115.03 8.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 130.538 3.535 . . . . 0.0 111.088 -164.946 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 46.5 pt -134.74 142.83 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 1 C-N-CA 132.336 4.254 . . . . 0.0 114.045 -159.052 . . . . . . . . 3 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -138.02 96.55 3.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.199 2.6 . . . . 0.0 105.79 178.451 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 77.25 21.66 1.05 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.12 -1.612 . . . . 0.0 107.716 162.064 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.36 -40.4 2.46 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 119.642 -1.266 . . . . 0.0 113.883 -175.157 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.319 51.1 mttm -82.04 132.53 35.25 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 119.257 -2.319 . . . . 0.0 110.916 -171.883 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -82.01 128.27 33.93 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.296 0.953 . . . . 0.0 109.422 170.992 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -82.19 115.92 21.51 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 178.911 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -75.96 135.95 40.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.143 -3.473 . . . . 0.0 107.511 -177.902 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.0 119.9 7.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.24 2.216 . . . . 0.0 111.652 178.363 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.47 6.51 41.28 Favored Glycine 0 CA--C 1.525 0.685 1 C-N-CA 130.906 4.098 . . . . 0.0 114.617 171.146 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -86.32 154.11 21.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 125.423 1.307 . . . . 0.0 110.421 169.617 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.7 p -76.86 145.02 38.62 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 127.027 2.704 . . . . 0.0 115.522 171.438 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.6 mt -59.51 -29.96 68.25 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.947 2.499 . . . . 0.0 112.473 172.602 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.7 t -52.44 -59.04 4.91 Favored 'General case' 0 N--CA 1.446 -0.626 1 C-N-CA 132.821 4.448 . . . . 0.0 110.515 168.503 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -50.55 -41.69 54.38 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 118.827 2.899 . . . . 0.0 118.827 170.093 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -88.53 -0.62 57.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.136 0.88 . . . . 0.0 109.951 -179.859 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m120 62.26 39.1 12.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 129.316 3.046 . . . . 0.0 115.155 -175.442 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 mm -85.81 121.84 37.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -171.425 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -103.75 169.01 8.77 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 111.593 -2.549 . . . . 0.0 114.556 -176.179 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -58.73 135.1 57.35 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 112.37 -3.681 . . . . 0.0 113.065 -176.333 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.1 19.12 11.73 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.521 3.129 . . . . 0.0 116.253 -178.559 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -70.17 141.66 52.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.725 3.21 . . . . 0.0 109.485 160.729 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.3 m -107.52 129.33 54.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 175.804 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -97.69 154.18 17.74 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 129.525 3.13 . . . . 0.0 106.846 171.049 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -125.27 163.85 21.61 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.801 2.04 . . . . 0.0 110.861 -175.158 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -134.72 160.09 39.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.103 -2.317 . . . . 0.0 116.326 -176.216 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.413 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 23.0 t -151.83 150.68 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 128.387 3.554 . . . . 0.0 105.982 166.512 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.259 53.2 mt . . . . . 0 N--CA 1.443 -0.811 0 O-C-N 119.121 -2.237 . . . . 0.0 111.453 176.483 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' OE2' ' A' ' 16' ' ' GLU 0.251 45.7 ttp . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -81.55 156.68 25.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 178.535 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 pt -146.24 174.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 1 O-C-N 129.204 4.065 . . . . 0.0 105.944 174.173 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -131.06 153.38 49.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 117.167 -1.397 . . . . 0.0 110.309 164.024 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -130.12 114.74 30.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 101.699 -3.445 . . . . 0.0 101.699 172.001 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -80.99 133.96 35.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.166 2.186 . . . . 0.0 106.244 174.452 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 p -75.13 175.48 8.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 129.977 3.311 . . . . 0.0 111.772 164.944 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.88 -9.21 49.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 118.151 -2.843 . . . . 0.0 110.671 172.044 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 p -99.57 4.31 45.79 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.777 -179.441 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.74 -25.34 7.64 Favored Glycine 0 CA--C 1.531 1.061 1 C-N-CA 131.902 4.573 . . . . 0.0 109.389 159.148 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 pttt -82.71 134.0 35.15 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 -153.502 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 m -95.36 110.63 22.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.275 1.83 . . . . 0.0 114.55 -178.333 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.74 120.82 35.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 118.648 -2.532 . . . . 0.0 105.738 -176.39 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -77.47 121.24 23.56 Favored 'General case' 0 C--N 1.324 -0.519 1 O-C-N 114.558 -5.089 . . . . 0.0 103.508 175.91 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.299 69.3 mt -125.02 152.58 44.06 Favored 'General case' 0 N--CA 1.446 -0.645 1 CA-C-N 126.294 4.134 . . . . 0.0 108.059 169.97 . . . . . . . . 3 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.444 ' OE2' ' N ' ' A' ' 1' ' ' MET . 32.0 tp10 -99.88 132.43 45.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 173.353 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.77 167.0 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 127.426 3.489 . . . . 0.0 105.72 172.512 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.41 140.13 28.71 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 110.747 -2.933 . . . . 0.0 106.408 155.518 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.363 46.3 Cg_endo -59.93 -4.48 2.88 Favored 'Trans proline' 0 N--CA 1.45 -1.032 1 C-N-CA 126.742 4.961 . . . . 0.0 117.005 -173.052 . . . . . . . . 3 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 p -88.58 -6.34 57.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 113.239 -3.267 . . . . 0.0 114.591 165.468 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.47 140.44 55.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 125.971 2.045 . . . . 0.0 106.777 179.691 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.6 p -73.93 163.37 28.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 116.527 -1.701 . . . . 0.0 109.631 170.891 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.0 mm -60.93 -37.14 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 124.211 1.958 . . . . 0.0 107.086 175.508 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.395 0.0 OUTLIER -46.2 -45.03 16.63 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 118.322 -2.736 . . . . 0.0 115.348 171.357 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -67.88 -33.89 75.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.041 2.536 . . . . 0.0 109.126 -179.909 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.258 89.0 t -67.88 -52.92 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 126.169 1.787 . . . . 0.0 113.079 166.707 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -48.67 -41.14 30.51 Favored 'General case' 0 N--CA 1.442 -0.842 1 N-CA-C 122.123 4.119 . . . . 0.0 122.123 171.398 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.25 -35.32 66.21 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.721 2.008 . . . . 0.0 112.506 176.429 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.3 mttt -67.56 -30.8 70.52 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 176.784 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -70.92 -43.49 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 130.359 3.464 . . . . 0.0 109.655 170.993 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -51.83 -55.34 20.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 125.806 2.717 . . . . 0.0 113.566 168.114 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.19 -27.49 62.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.552 3.141 . . . . 0.0 113.925 -173.737 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -97.7 -66.52 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 119.45 -2.032 . . . . 0.0 110.993 172.51 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -92.01 -17.85 24.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 120.935 1.698 . . . . 0.0 113.392 -165.381 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.83 -10.95 32.3 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 116.765 -3.709 . . . . 0.0 119.33 172.276 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 73.6 mt -86.07 129.39 54.18 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 117.541 -3.329 . . . . 0.0 112.043 -160.428 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 20.4 Cg_endo -76.95 137.96 18.03 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 125.281 3.987 . . . . 0.0 111.719 -166.761 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -39.56 -53.47 2.23 Favored 'Trans proline' 0 N--CA 1.446 -1.318 1 C-N-CA 126.863 5.042 . . . . 0.0 111.985 172.408 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.37 10.06 2.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 124.558 3.344 . . . . 0.0 113.464 -172.335 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -103.85 -28.8 11.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.602 1.191 . . . . 0.0 113.367 162.318 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.38 149.74 30.09 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 120.295 -1.503 . . . . 0.0 113.658 -168.13 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -135.04 118.91 17.29 Favored 'General case' 0 N--CA 1.451 -0.388 1 C-N-CA 132.164 4.186 . . . . 0.0 109.131 164.552 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.266 59.9 mt -100.0 132.16 45.52 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.692 0.797 . . . . 0.0 112.462 167.597 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.2 mm -109.63 124.75 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 101.068 -3.678 . . . . 0.0 101.068 -175.586 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -117.79 113.89 22.48 Favored 'General case' 0 N--CA 1.444 -0.761 1 N-CA-C 98.63 -4.582 . . . . 0.0 98.63 174.557 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.22 52.36 8.68 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 111.353 -2.658 . . . . 0.0 117.376 170.7 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -0.88 81.22 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 116.883 -2.065 . . . . 0.0 111.673 167.183 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -126.96 154.12 44.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.0 1.32 . . . . 0.0 111.166 177.996 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -91.89 118.47 30.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 110.137 -3.21 . . . . 0.0 105.001 -175.077 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -67.18 123.91 21.6 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.202 2.201 . . . . 0.0 107.472 172.719 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -85.65 143.19 28.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.446 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -71.66 155.66 40.25 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 126.107 2.129 . . . . 0.0 110.635 -171.299 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.29 -2.98 85.48 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 128.187 2.803 . . . . 0.0 114.507 174.414 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.376 0.9 OUTLIER -99.8 164.76 11.9 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.506 1.522 . . . . 0.0 109.615 173.893 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 64.8 p -99.66 171.49 7.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 126.852 3.215 . . . . 0.0 110.371 169.473 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mp -42.73 -51.98 5.12 Favored 'General case' 0 N--CA 1.446 -0.657 1 C-N-CA 131.772 4.029 . . . . 0.0 114.951 163.981 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 p -75.17 -12.44 60.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.498 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -80.85 -42.33 21.74 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 119.224 -2.172 . . . . 0.0 107.339 172.888 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.29 10.12 41.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.557 1.943 . . . . 0.0 112.705 -166.352 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.362 71.0 m-80 91.1 12.08 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.192 1.797 . . . . 0.0 114.612 159.843 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.27 55.3 mt -71.33 135.73 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 -171.198 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.523 0.4 OUTLIER -122.86 162.91 21.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.568 2.347 . . . . 0.0 114.404 175.175 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -49.6 126.84 14.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 121.468 1.94 . . . . 0.0 114.46 171.547 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.355 16.3 tt0 81.78 0.42 1.52 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 130.985 3.714 . . . . 0.0 113.212 176.94 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -61.55 145.74 51.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 119.719 -1.863 . . . . 0.0 113.638 166.823 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.3 m -125.79 109.27 12.34 Favored 'General case' 0 N--CA 1.451 -0.417 1 O-C-N 132.394 6.059 . . . . 0.0 110.614 -160.525 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.326 10.9 mp -106.04 170.71 7.75 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 -176.622 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -121.92 142.39 50.33 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.407 3.083 . . . . 0.0 105.641 177.487 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.6 tp -102.51 128.42 49.16 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 -178.043 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -111.88 150.7 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 124.407 1.067 . . . . 0.0 109.204 163.626 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.444 -0.75 0 O-C-N 117.054 -3.529 . . . . 0.0 114.928 168.984 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 103.593 -2.744 . . . . 0.0 103.593 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -90.47 128.23 36.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 115.658 -2.115 . . . . 0.0 110.241 -172.316 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -116.25 148.74 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 1 CA-C-N 126.012 4.006 . . . . 0.0 109.262 168.596 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -105.76 113.32 26.8 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -172.48 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.8 t -95.14 115.65 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 1 N-CA-C 99.574 -4.232 . . . . 0.0 99.574 168.308 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -99.19 133.03 44.06 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.904 174.111 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p -121.47 140.2 52.49 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -171.882 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 mt -62.66 -40.9 98.5 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.577 2.351 . . . . 0.0 109.994 171.253 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.265 23.8 p -71.53 8.63 1.03 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 176.453 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.58 18.02 2.27 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 117.112 -1.938 . . . . 0.0 112.424 118.581 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -138.42 153.92 48.88 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 129.373 3.069 . . . . 0.0 111.458 -176.921 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.2 p -99.61 106.16 18.09 Favored 'General case' 0 N--CA 1.446 -0.653 1 C-N-CA 135.148 5.379 . . . . 0.0 109.799 174.935 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 mt -101.84 105.76 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 2 N-CA-C 98.685 -4.561 . . . . 0.0 98.685 -167.75 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 p -92.96 89.25 6.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 119.377 -2.077 . . . . 0.0 113.015 -176.469 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tp -73.54 133.86 43.67 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 131.603 3.961 . . . . 0.0 104.063 -178.211 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -96.33 122.45 39.23 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 129.375 3.07 . . . . 0.0 104.515 168.336 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.3 135.59 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 128.805 2.842 . . . . 0.0 115.761 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.59 149.11 90.71 Favored Pre-proline 0 N--CA 1.45 -0.469 0 O-C-N 119.535 -1.978 . . . . 0.0 106.884 175.532 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.03 15.77 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.87 2.38 . . . . 0.0 113.123 -172.455 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.268 67.4 p -135.41 18.11 3.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 120.867 1.667 . . . . 0.0 113.58 175.575 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -81.04 118.03 22.14 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.747 -167.026 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -88.01 148.4 24.55 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 122.084 2.22 . . . . 0.0 107.427 -165.034 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.429 6.0 mt -45.03 -39.92 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 113.405 -3.188 . . . . 0.0 118.175 -174.395 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.95 -45.08 93.8 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 125.508 1.755 . . . . 0.0 112.739 170.82 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -71.75 -9.16 57.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.848 1.659 . . . . 0.0 110.594 -176.736 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.89 -29.07 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 127.104 2.161 . . . . 0.0 111.88 172.584 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -68.85 -32.36 71.98 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 118.91 -2.369 . . . . 0.0 113.854 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.01 -21.1 47.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 111.982 -2.372 . . . . 0.0 108.519 -176.055 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.31 -39.24 17.91 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 113.039 -3.362 . . . . 0.0 105.925 174.29 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 mt -58.36 -34.46 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 1 CA-C-N 127.394 4.633 . . . . 0.0 115.288 169.358 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -83.6 -3.31 57.59 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.935 2.494 . . . . 0.0 110.018 -176.521 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -101.63 -45.25 5.32 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.184 1.793 . . . . 0.0 106.691 166.164 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.27 48.5 tptt -74.46 -37.58 63.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 117.137 -1.411 . . . . 0.0 110.519 -167.361 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -121.41 -24.85 5.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 123.679 2.945 . . . . 0.0 108.787 -179.923 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.02 14.01 65.36 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 121.994 2.179 . . . . 0.0 110.901 175.025 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -74.04 131.84 80.68 Favored Pre-proline 0 N--CA 1.44 -0.949 0 C-N-CA 128.482 2.713 . . . . 0.0 108.329 169.487 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -78.2 162.65 28.39 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 N-CA-C 116.549 1.711 . . . . 0.0 116.549 -177.492 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.47 -16.54 47.66 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 N-CA-C 119.364 2.794 . . . . 0.0 119.364 -177.084 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -95.95 -2.89 46.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.435 -179.559 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -117.26 -15.39 10.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 112.467 -3.635 . . . . 0.0 115.038 177.517 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -67.55 138.03 56.19 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 130.536 3.534 . . . . 0.0 108.694 174.457 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -127.63 150.96 49.51 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 146.939 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.401 0.8 OUTLIER -139.8 133.78 30.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 173.675 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.55 144.4 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 -165.981 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -125.28 137.9 54.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.019 162.211 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.289 . . 56.92 28.45 14.67 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 169.084 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.71 -17.64 58.74 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 128.919 3.152 . . . . 0.0 112.707 -171.499 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -103.87 122.27 44.8 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 121.522 2.661 . . . . 0.0 109.717 -161.351 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 113.12 6.55 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.421 1.889 . . . . 0.0 107.781 166.0 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.3 mt -71.27 131.55 43.64 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 131.692 3.997 . . . . 0.0 108.198 -172.194 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -106.33 129.35 54.36 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 112.545 -3.597 . . . . 0.0 109.587 176.453 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.66 146.8 24.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 127.405 2.94 . . . . 0.0 109.316 179.029 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.31 -21.01 22.66 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 128.073 2.749 . . . . 0.0 114.762 173.798 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -88.99 153.77 20.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.418 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.4 p -86.25 175.8 8.28 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 126.251 2.22 . . . . 0.0 112.282 168.993 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.48 -39.9 81.23 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.48 2.712 . . . . 0.0 111.108 176.757 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.3 t -53.05 -51.41 61.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.308 1.843 . . . . 0.0 112.241 179.65 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -46.39 -34.53 4.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 129.546 3.138 . . . . 0.0 115.285 -179.065 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -111.77 -12.42 13.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 125.32 1.638 . . . . 0.0 108.284 -170.989 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 82.77 46.11 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.671 1 C-N-CA 131.951 4.1 . . . . 0.0 108.404 166.568 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.262 19.8 mt -98.63 91.54 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 174.617 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -98.96 -4.12 33.43 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 114.652 -2.594 . . . . 0.0 112.11 -169.762 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER 134.42 161.06 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.862 1 C-N-CA 134.338 5.055 . . . . 0.0 105.702 176.948 . . . . . . . . 4 3 . 1 . 036 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 71.57 -31.71 0.23 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 114.964 -2.446 . . . . 0.0 113.505 172.29 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.8 m -27.3 133.24 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.547 1 C-N-CA 135.366 5.466 . . . . 0.0 111.872 173.928 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.2 m -89.64 108.52 19.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.613 -1.305 . . . . 0.0 111.159 172.457 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -87.86 154.72 20.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.04 2.536 . . . . 0.0 114.838 162.967 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -125.14 121.17 33.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.817 2.047 . . . . 0.0 106.421 -179.566 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tp -86.96 136.86 32.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 115.872 -2.013 . . . . 0.0 109.522 171.596 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.24 166.59 19.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 126.463 2.352 . . . . 0.0 108.13 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.238 0.456 0 CA-C-N 119.995 1.27 . . . . 0.0 113.655 174.293 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 115.24 -2.314 . . . . 0.0 107.819 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.62 125.56 36.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 128.34 3.525 . . . . 0.0 110.104 179.926 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -122.03 136.87 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 119.422 -2.048 . . . . 0.0 111.935 158.433 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -90.53 133.13 35.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 172.235 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.55 110.64 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 174.269 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -97.77 143.65 28.18 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 128.115 3.384 . . . . 0.0 106.136 -177.572 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -112.97 149.51 33.16 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 129.166 2.987 . . . . 0.0 114.428 177.254 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.87 -34.81 1.02 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.612 2.765 . . . . 0.0 117.869 -171.519 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -74.3 -24.83 59.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 125.329 1.643 . . . . 0.0 112.969 179.398 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.85 -7.68 15.09 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.362 2.41 . . . . 0.0 118.362 -175.172 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.77 145.54 56.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.749 2.02 . . . . 0.0 106.481 173.863 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 m -137.19 132.68 34.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 112.63 -2.077 . . . . 0.0 105.679 -172.079 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mt -93.41 109.42 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 129.904 3.282 . . . . 0.0 107.717 162.494 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -74.75 119.42 18.92 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 128.171 2.588 . . . . 0.0 106.603 162.743 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -128.17 158.43 38.08 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -177.156 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -124.96 121.12 33.53 Favored 'General case' 0 C--O 1.221 -0.424 1 N-CA-C 99.756 -4.164 . . . . 0.0 99.756 -178.009 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -152.18 147.9 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.572 1.949 . . . . 0.0 108.585 -165.325 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' A' ' 21' ' ' ASP 0.263 1.6 tm-20 -84.3 135.94 40.97 Favored Pre-proline 0 C--O 1.219 -0.516 0 O-C-N 125.817 1.948 . . . . 0.0 107.342 173.142 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -56.37 -26.81 64.4 Favored 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 126.384 4.722 . . . . 0.0 110.92 179.386 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.2 p -95.34 6.47 48.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 116.503 -3.873 . . . . 0.0 114.083 -177.497 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 66.1 m-20 -68.18 132.35 47.01 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 111.662 -2.517 . . . . 0.0 111.248 160.704 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -95.52 157.4 15.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 116.635 -1.65 . . . . 0.0 107.335 -173.947 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.3 mm -36.62 -54.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 112.243 -3.742 . . . . 0.0 109.863 173.786 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -68.93 -23.13 64.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 125.611 3.823 . . . . 0.0 111.248 -170.713 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -77.7 -44.64 27.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 128.185 2.594 . . . . 0.0 110.722 -179.748 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.35 -46.59 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 170.511 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.361 37.9 mtpt -46.73 -49.79 19.05 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 112.912 -1.949 . . . . 0.0 116.105 173.363 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.68 68.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 129.042 2.937 . . . . 0.0 113.223 175.742 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -67.82 -37.51 82.03 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.545 1.938 . . . . 0.0 109.354 173.257 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.91 -30.31 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 121.842 2.11 . . . . 0.0 110.254 168.042 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.72 -35.56 75.14 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 116.769 -1.972 . . . . 0.0 111.705 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.26 -43.85 76.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.565 2.346 . . . . 0.0 109.334 178.787 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.324 12.6 mmtt -66.09 -42.04 89.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 117.037 -3.539 . . . . 0.0 115.451 178.532 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -140.87 -19.49 0.82 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 116.632 -1.652 . . . . 0.0 113.278 -156.372 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.79 5.89 83.41 Favored Glycine 0 CA--C 1.524 0.654 1 CA-C-O 112.78 -4.344 . . . . 0.0 109.314 172.515 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.2 mt -69.08 128.25 92.74 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 123.445 3.623 . . . . 0.0 108.771 174.41 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -54.59 144.87 61.71 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.57 2.18 . . . . 0.0 113.911 173.138 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -72.35 -55.2 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 CA-C-N 123.423 2.258 . . . . 0.0 109.381 -170.006 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.16 -29.64 23.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.621 2.368 . . . . 0.0 112.17 -176.341 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -68.31 -31.86 71.59 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 114.432 -2.699 . . . . 0.0 110.223 179.182 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -73.81 138.9 44.78 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 123.597 2.908 . . . . 0.0 112.474 -173.055 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.42 52.6 mtt180 -104.73 134.08 48.48 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 119.563 -1.961 . . . . 0.0 112.557 141.691 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mp -88.28 114.23 24.68 Favored 'General case' 0 N--CA 1.443 -0.8 1 C-N-CA 134.14 4.976 . . . . 0.0 107.134 174.237 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.8 mt -111.76 140.09 32.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 126.602 1.961 . . . . 0.0 111.551 168.331 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -152.06 148.24 27.45 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 131.421 3.888 . . . . 0.0 105.635 160.829 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.398 . . 69.48 30.28 4.12 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 130.382 3.473 . . . . 0.0 112.773 163.689 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.64 12.9 60.31 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-N 109.678 -3.419 . . . . 0.0 116.148 168.43 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -148.29 164.53 33.73 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 -168.257 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -76.25 130.87 38.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 124.936 2.303 . . . . 0.0 105.726 162.953 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.45 147.62 35.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.288 -1.778 . . . . 0.0 106.792 165.748 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.82 136.63 43.95 Favored 'General case' 0 C--N 1.324 -0.538 1 C-N-CA 134.624 5.17 . . . . 0.0 110.798 -178.185 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.55 126.16 26.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 130.789 3.635 . . . . 0.0 116.653 -179.361 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.32 -24.89 7.18 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 119.337 -2.102 . . . . 0.0 113.295 -178.288 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -95.09 140.57 29.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 -172.866 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.6 p -70.2 157.15 38.16 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 167.841 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.3 mt -54.57 -33.67 60.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 116.88 -1.533 . . . . 0.0 112.881 168.892 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 p -64.21 -37.59 88.01 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.244 2.218 . . . . 0.0 111.957 174.523 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.66 -29.39 70.39 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.678 2.791 . . . . 0.0 109.723 179.052 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.93 -5.77 30.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.361 1.465 . . . . 0.0 112.852 -173.74 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.378 68.1 m-80 97.31 9.82 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 O-C-N 127.029 2.706 . . . . 0.0 110.738 165.791 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.9 mt -85.83 117.57 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 118.906 -2.371 . . . . 0.0 106.926 -154.171 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.41 23.4 tt0 -90.29 172.27 8.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 112.317 -2.22 . . . . 0.0 111.77 175.569 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.95 140.03 2.83 Favored 'General case' 0 N--CA 1.445 -0.685 1 O-C-N 129.467 4.229 . . . . 0.0 114.603 174.739 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 56.57 38.85 29.93 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.796 2.838 . . . . 0.0 111.696 170.61 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 m -81.69 139.17 35.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 110.044 -3.253 . . . . 0.0 103.263 169.687 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.4 m -103.98 112.46 25.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 114.786 -2.531 . . . . 0.0 105.363 174.662 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.57 159.41 24.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.67 3.188 . . . . 0.0 110.865 -177.041 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -116.82 152.99 33.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -156.485 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tp -137.68 136.47 37.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 119.936 1.243 . . . . 0.0 110.29 179.307 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.1 t -123.31 119.26 57.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 126.244 1.818 . . . . 0.0 109.991 174.583 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 CA--C 1.53 0.195 0 O-C-N 118.946 -2.346 . . . . 0.0 105.089 -179.231 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptt? . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -88.14 154.72 20.23 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 119.691 -1.88 . . . . 0.0 110.412 171.766 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 pt -139.53 159.19 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 130.681 3.592 . . . . 0.0 109.786 160.873 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.51 116.61 29.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 118.486 -2.634 . . . . 0.0 108.42 174.61 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -92.91 136.08 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.798 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -117.8 112.61 20.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.953 1.701 . . . . 0.0 109.564 -173.741 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -62.65 175.68 0.77 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 124.542 2.115 . . . . 0.0 109.176 -178.321 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tt -70.0 -31.69 69.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 117.785 -3.072 . . . . 0.0 114.004 174.519 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.317 18.4 p -81.09 -16.52 52.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 129.845 3.258 . . . . 0.0 109.506 -178.493 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.92 -1.16 30.17 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 117.076 -3.515 . . . . 0.0 111.285 167.259 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.257 70.8 tttt -69.05 156.25 38.97 Favored 'General case' 0 N--CA 1.45 -0.47 2 C-N-CA 132.308 4.243 . . . . 0.0 108.009 173.275 . . . . . . . . 3 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -133.01 130.77 39.89 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 113.632 -3.08 . . . . 0.0 111.339 -170.902 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.1 pt -131.93 139.28 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 129.548 3.139 . . . . 0.0 106.972 173.243 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.4 m -89.51 114.21 25.7 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 173.381 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -95.19 153.7 17.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 126.235 2.209 . . . . 0.0 105.599 167.643 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -116.44 132.29 56.72 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 113.395 -3.193 . . . . 0.0 111.078 169.39 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -153.34 -178.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 102.887 -3.005 . . . . 0.0 102.887 -162.266 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -144.28 156.49 57.55 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 131.218 3.807 . . . . 0.0 102.676 166.542 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -49.14 -28.48 14.4 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 116.147 1.557 . . . . 0.0 116.147 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 p -68.82 -18.98 64.26 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 128.816 2.846 . . . . 0.0 115.726 178.414 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS 0.275 2.0 m-20 -51.29 121.93 7.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 122.567 2.439 . . . . 0.0 112.637 173.386 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 p -65.97 156.49 33.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.632 3.173 . . . . 0.0 109.465 168.684 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.2 mm -61.83 -40.6 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 O-C-N 125.034 1.459 . . . . 0.0 110.637 171.902 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.36 -25.83 60.76 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 122.25 2.295 . . . . 0.0 109.039 -172.771 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.267 16.8 t-20 -71.77 -44.33 64.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 117.168 -3.458 . . . . 0.0 109.501 173.909 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -68.25 -27.58 37.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 O-C-N 117.585 -3.197 . . . . 0.0 110.738 179.439 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -66.09 -24.45 66.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 122.575 1.179 . . . . 0.0 114.072 169.07 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.8 -38.42 58.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 115.151 -2.357 . . . . 0.0 111.019 167.595 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP . 43.1 mttp -64.26 -42.87 96.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 129.897 3.279 . . . . 0.0 110.558 178.85 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.63 -27.88 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 O-C-N 126.268 2.23 . . . . 0.0 109.112 177.114 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -74.17 -44.94 51.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 124.273 1.987 . . . . 0.0 108.733 172.272 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.59 -40.14 74.76 Favored 'General case' 0 N--CA 1.446 -0.654 1 O-C-N 112.911 -6.118 . . . . 0.0 120.869 168.235 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -70.68 -53.32 16.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.497 2.319 . . . . 0.0 110.381 -178.178 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -133.63 6.12 3.74 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 117.627 -3.171 . . . . 0.0 112.895 -166.117 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.67 12.54 77.99 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 118.273 -2.767 . . . . 0.0 118.002 177.643 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.66 120.65 76.95 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 122.971 3.385 . . . . 0.0 112.301 174.19 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.32 147.77 94.67 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 106.208 -2.266 . . . . 0.0 106.208 -179.775 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.23 -48.73 7.84 Favored 'Trans proline' 0 N--CA 1.441 -1.601 1 C-N-CA 125.949 4.433 . . . . 0.0 117.601 170.879 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -77.02 -13.0 60.01 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -170.552 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -93.76 10.09 34.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.441 1.497 . . . . 0.0 113.225 -176.659 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -130.05 165.92 21.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 116.421 -3.925 . . . . 0.0 114.355 -176.557 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -143.84 129.7 19.4 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 125.376 1.673 . . . . 0.0 112.99 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.7 mt -110.92 145.26 38.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 113.381 -1.736 . . . . 0.0 115.126 -165.843 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 pt -147.71 143.87 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 1 N-CA-C 99.113 -4.403 . . . . 0.0 99.113 -157.735 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -165.63 126.16 1.84 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 161.728 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.56 36.32 13.88 Favored 'General case' 0 N--CA 1.444 -0.733 1 C-N-CA 132.827 4.451 . . . . 0.0 116.036 165.646 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.44 -11.5 65.1 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.558 -1.134 . . . . 0.0 113.513 175.348 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -111.61 133.52 53.81 Favored 'General case' 0 N--CA 1.449 -0.502 1 C-N-CA 133.682 4.793 . . . . 0.0 107.165 -173.616 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -84.82 124.58 31.74 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 128.396 3.56 . . . . 0.0 110.348 170.782 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.06 115.66 27.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 123.706 1.717 . . . . 0.0 112.61 -168.175 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.83 141.23 28.75 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 129.969 3.308 . . . . 0.0 115.033 -173.698 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -75.7 135.88 40.38 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 114.645 -2.598 . . . . 0.0 108.613 -173.921 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.96 -6.84 21.82 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 120.808 1.64 . . . . 0.0 111.225 -176.609 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -106.82 154.89 20.36 Favored 'General case' 0 N--CA 1.452 -0.367 1 C-N-CA 132.71 4.404 . . . . 0.0 107.862 177.32 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 p -101.93 162.14 13.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.865 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.5 mt -61.97 -26.76 68.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 128.252 2.621 . . . . 0.0 112.459 -172.084 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -71.25 -24.87 62.26 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.147 2.579 . . . . 0.0 110.199 179.9 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.47 -50.19 72.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.573 3.149 . . . . 0.0 109.378 -178.223 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.92 12.86 18.22 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 128.266 3.479 . . . . 0.0 113.274 178.382 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 55.16 37.99 29.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.737 2.815 . . . . 0.0 115.881 -178.277 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.01 121.36 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 122.651 2.478 . . . . 0.0 106.129 -175.198 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -88.1 164.93 15.48 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 124.378 2.037 . . . . 0.0 113.681 176.319 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 163.81 16.29 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 119.975 -1.703 . . . . 0.0 110.329 -174.372 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 46.47 10.47 0.01 OUTLIER 'General case' 0 C--O 1.236 0.359 0 N-CA-C 120.354 3.465 . . . . 0.0 120.354 176.183 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.285 71.0 m -75.49 154.49 36.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 119.394 -2.066 . . . . 0.0 107.842 174.524 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 m -95.68 110.06 22.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 176.306 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.17 125.56 43.26 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 173.716 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -82.14 148.76 28.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.869 3.268 . . . . 0.0 109.196 174.027 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.307 1.6 pp -131.55 167.43 19.4 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 166.32 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t -123.88 140.66 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 -175.634 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 163.917 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -81.69 144.26 31.29 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 123.382 1.563 . . . . 0.0 112.322 -177.906 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 11.2 pt -132.56 157.45 43.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 115.026 -2.416 . . . . 0.0 107.251 166.897 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -98.52 144.0 28.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 114.939 -2.458 . . . . 0.0 106.617 165.177 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.14 122.71 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 100.431 -3.914 . . . . 0.0 100.431 176.443 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -123.66 117.83 25.89 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 -170.799 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -80.66 144.86 31.96 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 118.644 -2.535 . . . . 0.0 106.208 -175.016 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.27 -34.43 0.49 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 118.033 2.605 . . . . 0.0 118.033 172.981 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -50.59 -37.87 42.36 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 118.239 -2.788 . . . . 0.0 116.841 164.811 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.85 9.68 8.11 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 127.188 2.328 . . . . 0.0 109.503 176.652 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -84.24 103.12 13.17 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.908 2.483 . . . . 0.0 104.725 -170.765 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.2 m -96.37 119.59 35.14 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.269 1.827 . . . . 0.0 112.874 -178.612 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mm -130.79 145.78 35.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 111.238 -2.71 . . . . 0.0 109.826 -169.334 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.5 p -81.57 165.73 20.87 Favored 'General case' 0 C--O 1.237 0.42 1 O-C-N 114.777 -4.952 . . . . 0.0 114.922 172.929 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.265 2.4 tp -152.65 142.81 22.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.132 2.973 . . . . 0.0 109.441 172.042 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -95.23 117.52 30.4 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.282 2.633 . . . . 0.0 109.528 166.687 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.272 13.9 m -120.75 148.85 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.236 2.215 . . . . 0.0 108.909 179.136 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -91.45 136.14 27.19 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 179.666 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.262 71.5 Cg_exo -41.4 -30.88 0.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 1 N-CA-C 124.084 4.609 . . . . 0.0 124.084 166.53 . . . . . . . . 3 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -103.64 14.34 31.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.992 1.717 . . . . 0.0 113.678 176.241 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.408 ' OD1' ' ND2' ' A' ' 25' ' ' ASN 0.279 24.5 m-20 -66.91 139.77 57.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 128.704 2.802 . . . . 0.0 110.99 170.886 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -73.05 154.54 40.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.091 2.556 . . . . 0.0 107.124 168.185 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mp -69.73 -29.61 41.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 130.252 3.421 . . . . 0.0 105.344 175.466 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -67.71 -36.48 80.7 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 116.85 -3.656 . . . . 0.0 112.989 164.574 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.408 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 5.4 t30 -67.92 -19.07 64.95 Favored 'General case' 0 N--CA 1.444 -0.774 1 CA-C-N 128.254 5.024 . . . . 0.0 113.14 164.285 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.76 -34.68 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 126.048 2.832 . . . . 0.0 114.633 172.928 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -70.18 -35.33 73.9 Favored 'General case' 0 CA--C 1.537 0.451 1 O-C-N 115.931 -4.231 . . . . 0.0 107.273 174.024 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -33.05 71.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 169.046 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -79.52 -27.54 41.35 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 116.02 -1.943 . . . . 0.0 108.658 179.765 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -77.54 -38.74 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 125.046 1.467 . . . . 0.0 109.216 171.87 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -59.89 -30.29 68.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 118.524 -2.61 . . . . 0.0 111.291 176.535 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . 29.4 t70 -53.04 -37.41 61.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 127.041 2.136 . . . . 0.0 108.149 174.603 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.484 ' HD2' ' HB3' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -115.36 -44.64 2.97 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.982 1.713 . . . . 0.0 107.326 -169.336 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -94.34 -23.52 17.77 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 118.005 -2.934 . . . . 0.0 112.143 -172.521 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.07 27.9 47.66 Favored Glycine 0 CA--C 1.525 0.685 0 O-C-N 119.569 -1.957 . . . . 0.0 113.935 175.892 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.84 124.25 37.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 113.728 -3.034 . . . . 0.0 107.45 -176.921 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.16 137.92 64.11 Favored 'Trans proline' 0 N--CA 1.451 -1.025 1 C-N-CA 125.582 4.188 . . . . 0.0 116.236 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -45.28 -30.48 5.34 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 O-C-N 125.553 2.344 . . . . 0.0 117.834 177.766 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.374 5.8 t70 -46.92 -43.31 18.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 119.09 -2.256 . . . . 0.0 116.075 178.276 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -110.24 -13.35 14.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.315 2.246 . . . . 0.0 105.558 -161.43 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -66.69 139.25 57.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.018 -1.676 . . . . 0.0 112.91 161.29 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -121.63 150.87 41.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.332 1.453 . . . . 0.0 113.217 157.612 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.356 5.8 mt -127.08 138.33 53.18 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 116.634 -3.791 . . . . 0.0 112.733 -179.283 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.366 98.4 mt -139.4 128.36 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 127.18 2.8 . . . . 0.0 112.07 -157.678 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -150.1 147.54 27.91 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.513 1.133 . . . . 0.0 108.945 152.995 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.365 . . 65.87 21.15 11.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 130.28 3.432 . . . . 0.0 112.537 177.478 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.35 -3.84 85.35 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.004 1.288 . . . . 0.0 113.477 -173.819 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -99.98 159.27 15.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 119.899 1.85 . . . . 0.0 107.229 -176.45 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.9 135.39 54.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 101.689 -3.448 . . . . 0.0 101.689 -178.072 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.7 mt -89.42 159.36 17.34 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 119.22 -2.175 . . . . 0.0 114.349 -179.058 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -104.01 141.2 36.61 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 119.219 -2.175 . . . . 0.0 107.068 -165.561 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.283 11.2 m-20 -72.27 123.51 23.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 126.247 2.927 . . . . 0.0 115.221 167.798 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.81 -28.61 9.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 129.496 3.427 . . . . 0.0 113.369 -177.876 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -69.43 167.73 15.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.476 -2.191 . . . . 0.0 112.543 170.999 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -115.0 166.46 11.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -163.722 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 mt -54.29 -44.87 72.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.328 1.451 . . . . 0.0 111.023 164.01 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -63.75 -27.65 69.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.944 1.702 . . . . 0.0 109.766 -174.002 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.37 -37.88 88.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.764 1.626 . . . . 0.0 109.696 -171.263 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -99.08 -5.0 31.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 111.723 -2.49 . . . . 0.0 107.236 -176.888 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 71.96 23.46 3.51 Favored 'General case' 0 N--CA 1.442 -0.845 1 O-C-N 114.643 -5.036 . . . . 0.0 116.408 165.221 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -90.68 130.66 39.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 130.54 3.536 . . . . 0.0 107.949 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -115.65 -173.83 2.41 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 131.143 3.777 . . . . 0.0 109.993 -167.673 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -74.17 133.26 42.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 129.577 3.151 . . . . 0.0 106.315 -159.887 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.301 35.7 mt-10 76.03 26.63 0.98 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.045 2.538 . . . . 0.0 113.28 -179.524 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.4 p -84.01 145.84 28.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.308 170.11 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.7 m -103.01 118.77 37.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 -177.23 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 tp -100.07 151.04 21.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 173.947 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -113.07 119.7 38.77 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 128.557 2.743 . . . . 0.0 109.69 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -89.16 137.05 32.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 128.642 3.714 . . . . 0.0 107.111 -176.569 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 t -105.41 116.51 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.832 166.969 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 125.7 1.6 . . . . 0.0 107.217 -169.681 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -89.8 112.41 23.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 128.657 2.783 . . . . 0.0 108.074 -170.29 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -109.66 143.09 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 169.121 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -87.97 150.95 23.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.061 0.944 . . . . 0.0 111.79 161.919 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.4 121.14 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 130.296 3.438 . . . . 0.0 108.309 168.641 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -108.95 133.73 52.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.766 2.427 . . . . 0.0 113.889 176.434 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -105.87 173.4 6.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 117.55 -3.218 . . . . 0.0 109.856 -170.963 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tt -91.84 -35.68 13.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 131.535 3.934 . . . . 0.0 111.667 -176.57 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.7 p -65.03 -6.3 8.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 166.011 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.04 -28.77 5.76 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 117.006 1.562 . . . . 0.0 117.006 160.658 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -79.21 138.35 37.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 116.197 -1.859 . . . . 0.0 111.836 -172.182 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -99.51 118.92 37.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 113.798 -3.001 . . . . 0.0 104.522 172.543 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.9 mt -96.91 152.92 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 126.663 2.477 . . . . 0.0 107.121 179.302 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -125.14 142.03 51.74 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 165.357 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 131.47 49.78 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 111.656 -2.52 . . . . 0.0 113.162 -178.311 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -99.46 110.73 23.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 115.824 -2.036 . . . . 0.0 106.636 174.806 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 1.7 m -131.99 -174.84 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 119.748 1.158 . . . . 0.0 108.844 175.947 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -111.88 156.09 42.24 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 125.111 1.364 . . . . 0.0 109.887 174.713 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.08 -6.96 12.18 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-O 114.249 -2.479 . . . . 0.0 113.821 -171.704 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m -106.02 2.94 27.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 121.338 1.881 . . . . 0.0 110.64 179.992 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -75.72 152.74 37.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 118.646 -2.534 . . . . 0.0 111.724 170.478 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.333 74.8 p -94.33 169.52 10.16 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.253 1.021 . . . . 0.0 109.97 -165.547 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -71.6 -22.88 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 115.946 -1.978 . . . . 0.0 106.661 -178.47 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -69.19 -19.69 63.99 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 125.072 3.578 . . . . 0.0 107.204 173.537 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -73.94 -48.05 33.29 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 119.144 0.884 . . . . 0.0 111.23 -178.101 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -67.33 -44.37 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 111.997 -2.365 . . . . 0.0 113.404 175.306 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.29 30.1 mtpt -48.64 -36.56 16.16 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 119.898 3.296 . . . . 0.0 119.898 160.15 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.83 -39.87 42.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 120.912 1.687 . . . . 0.0 110.519 -179.572 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -69.88 -33.04 71.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.109 2.163 . . . . 0.0 111.232 178.753 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.22 -46.13 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 113.139 -3.315 . . . . 0.0 114.18 162.788 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -58.44 -45.86 87.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 123.056 2.662 . . . . 0.0 115.451 168.23 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.444 24.1 t70 -47.67 -64.5 0.77 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.006 1.722 . . . . 0.0 114.431 173.326 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -98.81 -20.69 16.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -165.191 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -127.46 13.01 7.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.185 2.194 . . . . 0.0 113.894 -176.539 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.06 20.58 62.77 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.078 2.275 . . . . 0.0 117.462 159.184 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mt -91.91 132.8 31.84 Favored Pre-proline 0 N--CA 1.444 -0.752 0 O-C-N 118.275 -2.897 . . . . 0.0 105.365 -172.491 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.84 112.13 2.14 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 114.694 -2.294 . . . . 0.0 114.581 169.627 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.66 -10.59 23.63 Favored 'Trans proline' 0 N--CA 1.457 -0.626 1 C-N-CA 125.447 4.098 . . . . 0.0 114.305 -167.625 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.361 25.7 t0 -65.3 -27.85 68.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 125.528 2.585 . . . . 0.0 111.904 167.504 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -114.97 51.61 0.9 Allowed 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 116.893 -3.63 . . . . 0.0 103.257 -167.432 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -160.64 147.12 15.29 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.997 2.119 . . . . 0.0 105.839 -170.736 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -149.65 126.26 10.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 102.173 -3.269 . . . . 0.0 102.173 172.183 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.334 78.2 mt -93.46 150.14 20.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 125.052 2.358 . . . . 0.0 109.518 169.695 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.7 mt -126.61 135.07 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 1 C-N-CA 133.249 4.62 . . . . 0.0 111.471 -177.219 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 65' ' ' SER . 52.8 t80 -150.66 133.17 15.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 118.7 -2.5 . . . . 0.0 111.853 178.115 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.22 21.31 1.59 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 118.831 2.9 . . . . 0.0 118.831 -178.583 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.65 -5.35 47.56 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 127.571 2.51 . . . . 0.0 113.038 -176.681 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -119.56 123.05 42.99 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.574 2.75 . . . . 0.0 109.239 -161.246 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -54.18 124.11 14.75 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 118.669 -2.519 . . . . 0.0 110.963 164.829 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -71.51 108.46 4.91 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.853 2.061 . . . . 0.0 109.645 174.359 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.287 29.8 tt0 -91.31 151.04 21.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -166.472 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -73.83 128.4 35.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.67 2.388 . . . . 0.0 106.773 -174.66 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.97 18.16 12.88 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 128.659 3.028 . . . . 0.0 116.709 175.217 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -121.86 168.11 12.25 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.876 1.67 . . . . 0.0 107.978 -177.472 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.4 p -124.32 146.21 48.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 -173.219 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 61' ' ' ILE 0.285 5.7 mt -48.15 -41.76 27.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.936 1.694 . . . . 0.0 112.053 -171.936 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -36.61 -44.96 0.48 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 129.846 3.258 . . . . 0.0 117.342 161.493 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -73.07 -7.65 52.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.761 2.024 . . . . 0.0 112.701 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -117.01 -12.56 10.65 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.35 1.86 . . . . 0.0 112.72 170.331 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.1 t30 78.05 33.7 0.33 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.8 2.04 . . . . 0.0 111.003 171.861 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 52.9 mt -69.14 119.15 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 127.118 2.167 . . . . 0.0 106.211 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.277 4.0 pp0? -119.65 175.48 5.84 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 128.943 2.897 . . . . 0.0 108.71 -168.25 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -48.56 111.33 0.44 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 117.007 -3.558 . . . . 0.0 115.452 -175.338 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 73.46 29.32 1.62 Allowed 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 119.294 -2.128 . . . . 0.0 109.658 176.284 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 73.4 m -84.25 125.77 32.54 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 117.108 -3.495 . . . . 0.0 103.263 175.225 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.1 m -95.41 110.1 22.18 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 116.946 -3.596 . . . . 0.0 108.426 -169.191 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -79.75 157.26 27.16 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 130.766 3.626 . . . . 0.0 110.4 174.736 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -121.39 142.4 50.04 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 129.533 3.133 . . . . 0.0 104.448 -177.808 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.22 127.29 48.4 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 131.242 3.817 . . . . 0.0 105.057 -173.223 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.31 142.37 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 118.761 -2.462 . . . . 0.0 113.506 163.74 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.674 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 -170.113 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 CA--C 1.534 0.361 1 CA-C-O 129.783 4.611 . . . . 0.0 105.297 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -71.02 144.58 50.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 110.671 -2.968 . . . . 0.0 113.389 -173.786 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.3 pt -146.12 174.95 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 116.441 -1.742 . . . . 0.0 106.691 177.998 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -128.31 117.35 21.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.063 2.545 . . . . 0.0 108.178 172.121 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -82.29 116.55 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 118.946 -2.346 . . . . 0.0 105.665 158.446 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -95.06 146.77 24.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 115.417 -2.23 . . . . 0.0 111.735 160.903 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -95.54 159.8 14.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 129.386 3.074 . . . . 0.0 104.697 164.62 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 tp -63.5 -21.41 66.31 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 111.526 -2.579 . . . . 0.0 110.534 177.037 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.1 p -95.63 -6.79 39.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 127.674 3.109 . . . . 0.0 112.708 178.134 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.5 -24.94 6.06 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.198 -1.334 . . . . 0.0 112.704 158.472 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -55.58 118.53 4.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 129.228 3.011 . . . . 0.0 109.086 -177.573 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.0 m -100.34 132.89 45.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 126.83 2.581 . . . . 0.0 109.711 179.084 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 mm -109.05 130.41 62.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.589 1.955 . . . . 0.0 106.911 173.614 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.7 m -85.36 144.1 28.24 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.907 2.483 . . . . 0.0 105.17 174.631 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.68 151.63 49.49 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 120.267 -1.521 . . . . 0.0 107.675 171.615 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -103.3 125.67 50.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 153.79 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -137.79 171.25 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 131.496 3.919 . . . . 0.0 112.677 163.73 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -130.14 144.29 52.55 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -178.411 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -57.81 -28.71 83.38 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 CA-C-O 111.843 -3.482 . . . . 0.0 115.286 -169.598 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.9 p -77.2 2.4 15.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 124.81 3.459 . . . . 0.0 115.52 172.25 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -77.83 148.78 34.55 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 118.968 -2.332 . . . . 0.0 107.358 -179.443 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.3 p -78.4 155.1 30.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 116.739 -1.601 . . . . 0.0 112.648 -172.12 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.254 10.6 mm -81.9 50.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 125.327 2.489 . . . . 0.0 109.794 161.175 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -153.72 -54.66 0.11 Allowed 'General case' 0 CA--C 1.532 0.288 0 O-C-N 117.39 -3.319 . . . . 0.0 109.066 -173.44 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -59.71 -57.37 13.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 120.698 1.59 . . . . 0.0 113.517 -175.394 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.37 -8.03 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.65 2.38 . . . . 0.0 111.188 -163.568 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -49.01 -40.29 30.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.322 2.649 . . . . 0.0 116.291 162.338 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.91 -27.69 8.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 119.722 -1.861 . . . . 0.0 115.527 172.033 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -89.01 -2.26 58.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 118.541 -1.263 . . . . 0.0 111.511 -172.096 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.9 mm -89.71 -37.75 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 127.67 2.388 . . . . 0.0 108.581 165.543 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.08 -43.24 99.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.361 -1.291 . . . . 0.0 114.225 176.476 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.25 -16.34 8.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.816 2.447 . . . . 0.0 115.704 170.934 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -108.94 -52.26 2.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.566 1.546 . . . . 0.0 110.979 -173.246 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -115.01 -19.06 11.07 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 118.801 -2.437 . . . . 0.0 112.331 -173.628 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.27 15.79 20.39 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 115.161 -3.022 . . . . 0.0 112.41 177.908 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -90.75 121.63 67.93 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 121.773 2.787 . . . . 0.0 112.172 -176.987 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.4 158.06 59.18 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.538 2.159 . . . . 0.0 113.656 179.028 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.36 -40.17 60.61 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.273 2.649 . . . . 0.0 115.465 -173.614 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -41.6 -54.87 3.09 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 131.225 3.81 . . . . 0.0 114.015 166.144 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -80.23 -13.23 59.39 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.607 2.363 . . . . 0.0 113.868 -170.481 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -83.91 106.44 15.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 129.482 3.113 . . . . 0.0 106.676 -179.058 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -113.28 137.28 51.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.728 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.284 1.7 pt? -134.02 131.37 38.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 120.707 1.594 . . . . 0.0 112.497 -172.378 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.8 mt -109.68 132.22 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 -174.533 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -131.74 -85.4 0.49 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 130.546 3.538 . . . . 0.0 114.233 168.528 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.61 55.01 0.69 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 125.961 3.982 . . . . 0.0 114.584 -170.474 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.71 -9.48 48.06 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 161.805 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -139.33 156.01 47.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 119.764 3.246 . . . . 0.0 119.764 176.536 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.86 116.17 18.16 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.988 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.5 mt -58.68 135.53 57.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.769 -2.457 . . . . 0.0 113.932 -175.251 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -84.07 143.77 29.51 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.531 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.54 132.92 46.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.323 1.449 . . . . 0.0 112.261 169.937 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.23 -24.44 10.6 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 124.671 2.262 . . . . 0.0 112.241 171.565 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -73.61 166.87 22.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 111.978 -2.111 . . . . 0.0 105.316 -179.903 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.9 p -100.81 163.59 12.24 Favored 'General case' 0 N--CA 1.45 -0.436 1 O-C-N 115.583 -4.448 . . . . 0.0 108.269 169.013 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -51.59 -36.98 47.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.233 2.213 . . . . 0.0 113.439 171.501 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -79.6 -17.84 52.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 177.235 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -62.97 -17.33 61.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 121.294 1.861 . . . . 0.0 109.411 164.847 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -118.05 7.18 12.17 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 130.389 3.476 . . . . 0.0 112.484 -178.212 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 62.96 32.39 15.61 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 131.453 3.901 . . . . 0.0 112.0 174.291 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.89 132.0 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 126.607 1.963 . . . . 0.0 105.84 -172.002 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -127.34 165.77 19.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.319 2.248 . . . . 0.0 111.678 -179.902 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -48.03 137.28 10.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 131.286 3.835 . . . . 0.0 112.494 179.577 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 84.67 4.15 0.67 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.461 1.905 . . . . 0.0 108.454 165.541 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 m -83.61 142.69 30.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 175.374 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.8 m -97.29 129.52 44.58 Favored 'General case' 0 N--CA 1.451 -0.408 1 C-N-CA 132.431 4.292 . . . . 0.0 112.749 179.485 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.62 143.18 50.71 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -169.99 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -115.1 102.68 10.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 101.621 -3.474 . . . . 0.0 101.621 -160.72 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -71.07 144.45 50.34 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 128.843 2.857 . . . . 0.0 108.649 166.1 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.85 156.29 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 130.134 3.373 . . . . 0.0 106.66 170.414 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.28 48.1 mt . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 126.55 3.072 . . . . 0.0 108.89 -178.483 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttp . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -125.13 139.59 53.63 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.007 2.523 . . . . 0.0 114.18 -175.983 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 3' ' ' ILE 0.296 45.6 pt -133.55 -179.48 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 128.893 2.877 . . . . 0.0 104.869 173.935 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -133.17 160.65 36.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 167.291 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.6 t -129.52 141.04 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 166.694 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -109.16 127.05 53.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.129 1.771 . . . . 0.0 106.638 176.814 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.5 p -79.74 173.14 12.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 124.154 1.931 . . . . 0.0 112.305 165.852 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.7 mt -78.71 -31.45 46.47 Favored 'General case' 0 C--O 1.24 0.602 0 O-C-N 118.188 -2.82 . . . . 0.0 111.921 173.708 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 t -64.0 -21.11 66.36 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 167.642 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.54 6.63 40.92 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 125.825 1.953 . . . . 0.0 109.275 168.769 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -65.77 119.06 10.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 122.377 3.088 . . . . 0.0 109.113 167.998 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.5 m -102.46 94.83 5.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 122.948 2.613 . . . . 0.0 104.652 -178.914 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.86 144.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 1 C-N-CA 132.212 4.205 . . . . 0.0 109.41 170.11 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.9 m -103.22 142.42 34.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.752 1.621 . . . . 0.0 109.912 169.109 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -125.12 132.53 53.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 157.819 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.84 128.4 35.48 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 154.638 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.67 157.99 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 120.402 -1.436 . . . . 0.0 111.403 -178.056 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.76 149.55 38.6 Favored Pre-proline 0 N--CA 1.442 -0.869 0 C-N-CA 127.016 2.127 . . . . 0.0 106.382 174.882 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.295 52.8 Cg_endo -70.41 -15.17 34.6 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 124.767 3.645 . . . . 0.0 116.476 -179.254 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -98.52 1.27 46.43 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.986 2.514 . . . . 0.0 113.632 -178.643 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -77.64 153.63 32.97 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.394 -1.441 . . . . 0.0 111.539 -169.863 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.5 p -89.42 158.14 17.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 128.047 2.539 . . . . 0.0 106.005 177.256 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.11 -29.74 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 114.049 -2.882 . . . . 0.0 107.59 175.964 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -59.63 -38.04 80.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 124.629 3.377 . . . . 0.0 108.316 168.921 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -76.38 -21.54 55.91 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 118.368 -2.707 . . . . 0.0 109.604 176.309 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.29 -37.02 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 124.609 3.368 . . . . 0.0 111.7 172.933 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -64.64 -30.07 71.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.484 1.914 . . . . 0.0 111.971 176.566 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.265 . . -75.25 -30.24 60.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.621 2.368 . . . . 0.0 111.928 179.867 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -79.51 -25.43 41.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 125.108 2.385 . . . . 0.0 112.014 174.707 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 30' ' ' ILE 0.34 32.1 mm -82.3 -33.68 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 113.412 -1.722 . . . . 0.0 108.883 173.241 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -55.48 -36.32 66.5 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 123.013 2.642 . . . . 0.0 114.063 161.595 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.05 -59.85 2.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 128.433 2.693 . . . . 0.0 106.531 177.718 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.322 68.1 mmtt -51.39 -64.94 0.65 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.695 2.398 . . . . 0.0 110.567 -177.309 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -120.49 -9.88 9.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 112.914 -3.422 . . . . 0.0 107.437 -150.451 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.49 -1.9 62.42 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 127.875 3.234 . . . . 0.0 116.826 166.933 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.3 mm -95.09 132.14 28.67 Favored Pre-proline 0 N--CA 1.452 -0.368 0 O-C-N 117.335 -3.45 . . . . 0.0 111.722 -159.231 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -47.44 122.95 7.31 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 126.914 5.076 . . . . 0.0 108.657 168.352 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -35.36 -47.43 0.81 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 1 C-N-CA 129.698 6.932 . . . . 0.0 118.52 174.711 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.5 -16.3 64.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 114.913 -2.47 . . . . 0.0 115.422 -178.697 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.24 -7.36 42.29 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 126.186 2.179 . . . . 0.0 109.125 179.542 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -86.91 130.19 34.56 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 128.338 2.655 . . . . 0.0 109.269 179.906 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -116.86 141.06 48.72 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 128.868 2.867 . . . . 0.0 107.334 179.823 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.9 mt -119.44 111.18 17.82 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.551 2.34 . . . . 0.0 110.797 173.886 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.3 mt -105.12 118.6 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 161.23 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -126.69 130.79 51.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 175.212 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.42 19.5 10.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.658 169.514 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.17 -17.55 59.08 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 128.453 2.93 . . . . 0.0 115.678 -169.728 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.288 11.6 mmmt -93.19 146.48 23.65 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 119.404 1.602 . . . . 0.0 111.971 -176.931 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -94.54 112.47 24.23 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 130.892 3.677 . . . . 0.0 105.07 -176.246 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HG ' ' CD1' ' A' ' 59' ' ' TYR . 6.2 mp -80.2 111.2 16.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 114.455 -2.688 . . . . 0.0 105.778 -179.259 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -83.83 -15.05 49.73 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 126.769 2.543 . . . . 0.0 115.705 -173.052 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.298 5.3 t0 93.64 153.66 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 128.694 2.798 . . . . 0.0 111.49 -175.932 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.01 30.98 5.82 Favored Glycine 0 N--CA 1.438 -1.21 0 O-C-N 117.394 -3.316 . . . . 0.0 114.335 161.322 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -153.4 160.48 42.63 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 131.586 3.954 . . . . 0.0 106.83 172.276 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.6 p -98.34 176.66 5.62 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 117.013 -3.555 . . . . 0.0 111.506 -167.269 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.53 -37.13 84.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 126.312 1.845 . . . . 0.0 111.96 -173.82 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 p -64.39 -33.6 76.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.017 1.727 . . . . 0.0 115.12 166.189 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -71.74 -56.44 5.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.99 2.116 . . . . 0.0 107.416 179.634 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.498 ' CD1' ' HG ' ' A' ' 50' ' ' LEU 0.277 42.9 m-85 -64.52 0.99 0.89 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 130.548 3.539 . . . . 0.0 116.312 -178.756 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.311 0.1 OUTLIER 78.42 18.32 1.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 124.131 3.15 . . . . 0.0 113.836 163.659 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.8 mt -94.01 105.02 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 117.306 -3.371 . . . . 0.0 106.409 179.92 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -99.83 -170.79 1.94 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 116.601 -3.812 . . . . 0.0 101.483 -166.541 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -64.99 120.23 12.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 114.669 -2.586 . . . . 0.0 112.125 -170.044 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.555 2.4 mp0 77.59 24.77 0.75 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 117.427 2.381 . . . . 0.0 117.427 179.144 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.9 m -71.23 148.02 47.65 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 112.42 -2.173 . . . . 0.0 106.157 175.221 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.321 99.1 m -114.83 128.9 56.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 169.579 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.1 mt -92.65 151.24 20.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 108.824 -3.807 . . . . 0.0 107.811 170.305 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -98.68 127.35 44.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.904 0.882 . . . . 0.0 113.374 162.112 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -107.46 118.46 36.79 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 -178.396 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.52 160.78 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.306 1.842 . . . . 0.0 110.253 172.992 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.1 mt . . . . . 0 N--CA 1.448 -0.53 0 O-C-N 118.868 -2.395 . . . . 0.0 112.623 176.523 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ttt . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 116.409 -1.758 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -77.82 131.53 37.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 123.716 2.962 . . . . 0.0 112.309 173.629 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 3' ' ' ILE . 46.4 pt -130.37 136.9 57.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 126.88 2.613 . . . . 0.0 107.202 170.457 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.52 123.01 35.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 172.045 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 46.6 t -96.27 124.88 49.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 166.682 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.261 49.3 tttm -106.87 121.31 44.15 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -174.292 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 69' ' ' LEU 0.294 5.1 p -113.13 -171.34 1.85 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 128.009 2.523 . . . . 0.0 108.099 175.466 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.301 74.3 mt -82.26 -28.41 31.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 126.625 3.107 . . . . 0.0 113.649 176.006 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 p -123.87 68.02 1.04 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.87 3.268 . . . . 0.0 107.024 -175.848 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.53 101.67 1.22 Allowed Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 104.198 -3.561 . . . . 0.0 104.198 178.653 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -79.06 -33.23 44.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 129.014 3.42 . . . . 0.0 111.363 -179.425 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m -117.71 59.57 0.78 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 126.44 3.019 . . . . 0.0 106.396 -167.634 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 2.2 mt -80.81 116.01 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 118.558 -2.589 . . . . 0.0 106.613 170.102 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.86 119.59 39.23 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 118.293 -2.754 . . . . 0.0 105.902 -169.986 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.447 HD23 ' CG1' ' A' ' 17' ' ' VAL . 8.7 tp -115.81 136.15 53.32 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 129.744 3.218 . . . . 0.0 108.746 172.657 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.259 10.1 tp10 -92.17 114.41 26.94 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 167.169 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG1' HD23 ' A' ' 15' ' ' LEU . 18.1 m -108.75 -167.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 126.18 1.792 . . . . 0.0 110.854 168.999 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -139.47 140.65 26.12 Favored Pre-proline 0 N--CA 1.45 -0.462 1 C-N-CA 131.92 4.088 . . . . 0.0 107.578 171.62 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -43.54 -47.4 9.39 Favored 'Trans proline' 0 N--CA 1.445 -1.334 1 C-N-CA 126.079 4.519 . . . . 0.0 118.876 171.282 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.264 77.9 p -91.75 18.72 7.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.304 1.842 . . . . 0.0 107.2 -176.828 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -79.0 144.94 34.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 123.439 2.836 . . . . 0.0 114.102 169.978 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -92.77 153.48 18.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 117.421 -3.299 . . . . 0.0 111.038 -178.884 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 6.3 mm -57.99 -26.1 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 118.675 -2.516 . . . . 0.0 114.713 -176.046 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -82.22 -18.31 43.03 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.787 1.635 . . . . 0.0 108.31 -170.395 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -83.78 -35.28 24.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.582 2.353 . . . . 0.0 107.948 178.905 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.95 -51.63 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 128.495 2.718 . . . . 0.0 107.538 177.288 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 38.4 mtmt -59.01 -39.28 81.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 120.075 3.361 . . . . 0.0 120.075 173.526 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -26.9 68.5 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.705 3.602 . . . . 0.0 113.331 160.792 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -77.58 -47.49 19.28 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 121.681 2.037 . . . . 0.0 113.011 172.768 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 30' ' ' ILE 0.321 92.1 mt -54.15 -46.19 66.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 131.009 3.723 . . . . 0.0 112.811 174.264 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -60.25 -20.23 58.09 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 118.753 -2.467 . . . . 0.0 116.138 -177.75 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.278 3.7 t70 -94.2 -36.89 11.83 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 -178.546 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -70.95 -55.1 9.09 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.506 178.364 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -117.47 -21.43 8.63 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 118.355 -2.716 . . . . 0.0 108.662 -166.352 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.4 10.7 28.87 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 117.183 -3.448 . . . . 0.0 114.014 164.379 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.92 120.89 57.54 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 -165.709 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -77.98 154.19 29.41 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 O-C-N 116.322 -2.515 . . . . 0.0 112.402 -173.119 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -73.98 -33.27 6.28 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.076 1.851 . . . . 0.0 112.557 -153.921 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -73.91 -19.7 60.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 124.739 1.274 . . . . 0.0 112.932 177.532 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -90.89 -16.49 28.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.638 2.375 . . . . 0.0 110.572 -179.404 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -89.11 129.45 35.72 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 129.124 2.969 . . . . 0.0 112.452 -179.704 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -119.78 155.78 31.86 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 173.791 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.06 144.33 51.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 120.15 -1.594 . . . . 0.0 111.739 178.074 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 44' ' ' ILE . 84.9 mt -131.43 143.76 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 122.844 2.565 . . . . 0.0 113.881 176.048 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -151.9 123.58 7.93 Favored 'General case' 0 N--CA 1.451 -0.388 1 C-N-CA 132.087 4.155 . . . . 0.0 113.461 171.541 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.27 37.56 4.21 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 119.651 3.204 . . . . 0.0 119.651 -175.784 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.75 -0.24 57.84 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 117.038 -3.539 . . . . 0.0 112.607 171.425 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -113.53 138.72 49.73 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 122.976 3.388 . . . . 0.0 105.15 -178.767 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.293 24.3 tt0 -98.0 125.07 42.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.308 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.14 131.14 44.87 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.89 -168.392 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -104.31 154.72 19.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 127.008 3.29 . . . . 0.0 113.726 -172.93 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -45.75 127.75 8.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 117.438 -3.289 . . . . 0.0 115.505 177.509 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.16 -2.38 61.33 Favored Glycine 0 CA--C 1.536 1.368 1 CA-C-N 127.362 4.619 . . . . 0.0 112.485 163.636 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.263 25.9 mmt-85 -100.06 172.88 6.92 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 127.188 3.375 . . . . 0.0 106.931 -173.138 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -119.69 -178.63 3.67 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 116.551 -3.843 . . . . 0.0 113.02 168.394 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD22 ' H ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -50.83 -44.42 59.32 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 131.032 3.733 . . . . 0.0 112.825 162.811 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.5 m -72.22 -33.68 67.77 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.367 2.667 . . . . 0.0 111.404 -170.897 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -66.98 -38.9 86.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 124.731 2.205 . . . . 0.0 111.34 -178.264 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -91.15 0.62 57.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 117.146 -3.471 . . . . 0.0 116.042 176.425 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.256 13.3 m120 71.52 53.13 0.23 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 130.383 3.473 . . . . 0.0 110.638 -178.206 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.9 mt -103.03 140.41 21.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 -174.306 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -106.84 149.0 27.85 Favored 'General case' 0 N--CA 1.451 -0.397 1 C-N-CA 131.936 4.094 . . . . 0.0 115.674 -169.074 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.77 128.53 30.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 124.351 1.032 . . . . 0.0 112.705 162.065 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.277 29.3 tt0 87.05 21.89 0.06 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.839 2.856 . . . . 0.0 110.209 174.253 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.9 m -71.63 141.84 49.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.216 1.806 . . . . 0.0 114.475 175.716 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.279 97.6 m -100.69 126.74 47.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 115.279 -2.296 . . . . 0.0 104.89 165.58 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.08 173.47 13.36 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 130.781 3.632 . . . . 0.0 107.2 177.651 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -127.45 134.13 49.87 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.443 2.297 . . . . 0.0 112.991 -156.548 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.425 ' HB3' HG22 ' A' ' 7' ' ' THR . 3.6 tt -108.29 139.28 43.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 125.336 2.493 . . . . 0.0 107.752 173.621 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 t -130.55 134.53 62.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 129.846 3.258 . . . . 0.0 106.722 -178.144 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.438 -1.063 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 172.338 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.374 0.6 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 . . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -91.82 129.28 37.81 Favored 'General case' 0 N--CA 1.447 -0.591 1 C-N-CA 133.927 4.891 . . . . 0.0 107.213 -179.622 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.629 HD12 HD22 ' A' ' 67' ' ' LEU . 28.5 pt -119.08 156.69 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 128.01 3.319 . . . . 0.0 106.167 154.01 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -95.35 133.86 38.8 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.579 1.552 . . . . 0.0 107.239 166.279 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.57 125.55 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 1 N-CA-C 97.321 -5.066 . . . . 0.0 97.321 175.293 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -103.04 127.05 50.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 127.059 3.314 . . . . 0.0 107.707 173.977 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -89.76 145.03 25.48 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 126.021 2.82 . . . . 0.0 106.102 -176.178 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.35 -27.89 68.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.706 -2.043 . . . . 0.0 116.241 178.561 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 p -76.72 -7.47 55.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.081 2.553 . . . . 0.0 116.94 173.274 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.05 10.15 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 129.922 3.629 . . . . 0.0 114.694 166.303 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 47.1 tttt -70.39 149.57 47.16 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 121.939 2.869 . . . . 0.0 110.758 -178.556 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.1 m -104.24 141.75 35.74 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.717 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.401 0.1 OUTLIER -125.08 135.17 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 126.516 3.055 . . . . 0.0 112.789 163.173 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 m -75.66 137.5 40.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 117.65 -3.156 . . . . 0.0 104.482 174.085 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -138.41 120.14 15.22 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 175.833 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.286 25.4 mt-10 -70.39 131.92 44.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 126.949 2.656 . . . . 0.0 111.724 170.527 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 m -148.99 164.34 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 127.886 2.474 . . . . 0.0 106.787 -173.794 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -123.47 155.99 64.78 Favored Pre-proline 0 N--CA 1.449 -0.52 0 O-C-N 117.624 -3.173 . . . . 0.0 109.419 165.49 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.72 -37.67 35.67 Favored 'Trans proline' 0 N--CA 1.451 -0.997 1 C-N-CA 127.152 5.235 . . . . 0.0 116.008 179.203 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.8 p -81.27 -13.46 58.45 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 112.563 -2.108 . . . . 0.0 112.757 -179.624 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -67.02 155.84 37.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 121.103 1.774 . . . . 0.0 109.951 170.663 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -121.8 139.86 53.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 130.287 3.435 . . . . 0.0 111.248 -161.178 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -46.23 -24.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 O-C-N 116.595 -3.816 . . . . 0.0 116.895 176.243 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -68.74 -54.4 16.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.904 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -62.42 -37.43 85.79 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 119.593 3.183 . . . . 0.0 119.593 -173.353 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.282 76.1 t -50.71 -43.98 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 129.498 3.119 . . . . 0.0 113.804 170.605 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.355 40.0 mtmt -50.78 -43.69 58.59 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.766 2.027 . . . . 0.0 112.598 172.251 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.32 -33.65 28.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 125.982 2.051 . . . . 0.0 114.649 -176.619 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -55.41 -31.9 62.23 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 125.334 2.492 . . . . 0.0 115.215 173.003 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.8 mt -75.63 -21.11 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 113.421 -1.718 . . . . 0.0 113.156 172.147 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -70.56 -43.34 69.68 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 122.572 2.442 . . . . 0.0 107.715 173.225 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.53 -29.04 67.61 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 118.926 -2.358 . . . . 0.0 112.417 176.942 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -97.19 -57.21 2.32 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 175.617 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 11' ' ' LYS . 28.6 mm-40 -92.64 -22.7 19.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.151 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.62 -18.39 22.54 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 130.672 3.987 . . . . 0.0 112.326 171.426 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.3 mt -71.2 122.98 88.59 Favored Pre-proline 0 N--CA 1.445 -0.686 0 C-N-CA 127.882 2.473 . . . . 0.0 106.185 -159.604 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.0 137.8 27.22 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.872 2.382 . . . . 0.0 109.973 172.423 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -40.73 -45.29 4.76 Favored 'Trans proline' 0 N--CA 1.454 -0.804 1 C-N-CA 126.442 4.761 . . . . 0.0 114.786 -175.654 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.257 12.6 t70 -31.76 -41.75 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 127.104 2.752 . . . . 0.0 117.943 170.762 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -96.84 -16.76 20.6 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -170.349 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -97.49 140.88 31.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 127.479 2.987 . . . . 0.0 111.746 -178.593 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -125.23 128.21 47.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 116.74 -1.6 . . . . 0.0 108.325 174.146 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.78 140.82 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.085 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.3 pt -141.91 144.36 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 131.587 3.955 . . . . 0.0 111.114 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -146.16 130.34 17.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 111.566 -2.561 . . . . 0.0 107.627 172.265 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.79 17.91 8.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.264 1.826 . . . . 0.0 115.308 168.694 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.39 -26.66 12.76 Favored Glycine 0 CA--C 1.528 0.88 1 C-N-CA 131.95 4.595 . . . . 0.0 112.501 -169.253 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.303 38.4 mttt -68.24 129.89 41.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.807 0.804 . . . . 0.0 111.278 -170.982 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.316 78.0 mt-30 -66.06 115.05 5.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 163.708 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.97 121.96 29.34 Favored 'General case' 0 C--O 1.239 0.52 1 O-C-N 116.156 -4.09 . . . . 0.0 110.139 -175.746 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.47 148.15 24.31 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 129.702 3.201 . . . . 0.0 111.293 -165.08 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -74.93 123.72 25.61 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.667 2.387 . . . . 0.0 108.323 -166.606 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.06 60.33 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 128.814 3.102 . . . . 0.0 116.215 174.1 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -80.58 143.61 33.05 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 128.214 2.606 . . . . 0.0 109.511 173.663 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -77.0 151.81 35.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 128.589 2.755 . . . . 0.0 110.655 177.977 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -59.71 -25.29 64.68 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 127.522 2.329 . . . . 0.0 114.678 161.546 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -74.46 -23.05 58.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 130.2 3.4 . . . . 0.0 112.812 166.229 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -89.53 -16.92 29.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 121.655 2.025 . . . . 0.0 109.387 178.806 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -96.81 -3.51 42.08 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 115.886 -2.007 . . . . 0.0 111.512 171.731 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 t30 62.35 37.86 13.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 171.835 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.7 mt -94.57 127.99 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 -172.19 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -99.44 175.56 5.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.789 2.036 . . . . 0.0 111.224 -176.247 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 144.0 57.45 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 130.97 3.708 . . . . 0.0 110.708 179.057 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.323 3.0 pt-20 60.68 13.17 4.12 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 131.562 3.945 . . . . 0.0 116.874 -179.374 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.0 m -67.33 144.77 55.67 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 126.709 2.506 . . . . 0.0 111.701 166.084 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.0 m -86.31 108.81 18.58 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.257 1.423 . . . . 0.0 109.074 174.788 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.629 HD22 HD12 ' A' ' 3' ' ' ILE . 11.0 mp -83.89 150.43 25.72 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 123.029 1.395 . . . . 0.0 113.36 156.785 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.265 75.2 m80 -104.02 144.07 32.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.443 -1.411 . . . . 0.0 111.303 176.714 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 tt -128.55 120.99 27.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 113.61 -3.09 . . . . 0.0 109.51 -177.813 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.99 133.34 44.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 127.782 2.433 . . . . 0.0 106.718 -175.532 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.274 73.6 mt . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 125.841 1.657 . . . . 0.0 111.678 171.895 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ttt . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 116.021 1.859 . . . . 0.0 116.021 . . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.426 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 96.1 mt-30 -106.61 165.96 10.91 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.103 1.761 . . . . 0.0 113.241 -176.831 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -122.75 165.02 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 127.531 2.332 . . . . 0.0 108.858 152.662 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -112.18 125.44 54.14 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 126.646 2.466 . . . . 0.0 112.414 -172.253 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.74 91.35 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 101.664 -3.458 . . . . 0.0 101.664 176.869 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -68.27 145.8 53.91 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 114.277 -2.773 . . . . 0.0 112.855 167.32 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -155.06 171.5 19.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 124.963 3.528 . . . . 0.0 111.792 170.526 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 mt -68.75 -17.49 64.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 130.057 3.343 . . . . 0.0 116.913 -164.585 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.6 p -74.14 -7.77 53.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 173.588 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.71 -20.81 44.71 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 116.674 1.43 . . . . 0.0 116.674 -179.147 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -76.9 152.71 35.26 Favored 'General case' 0 N--CA 1.447 -0.585 1 C-N-CA 132.25 4.22 . . . . 0.0 104.348 -176.21 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.289 75.7 m -122.68 147.79 46.05 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 118.937 -2.352 . . . . 0.0 112.3 161.765 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mt -120.88 154.39 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 131.685 3.994 . . . . 0.0 107.056 -178.013 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 p -127.47 135.9 51.03 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 128.174 2.59 . . . . 0.0 110.721 -165.682 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.7 mt -130.6 117.43 19.52 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 126.418 2.324 . . . . 0.0 107.679 -179.668 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HG3' ' HG2' ' A' ' 2' ' ' GLN . 31.5 mp0 -90.66 108.77 20.02 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.131 2.172 . . . . 0.0 106.26 169.117 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.0 161.33 32.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 1 C-N-CA 134.413 5.085 . . . . 0.0 108.77 -170.326 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 53.9 mm-40 -126.16 152.32 73.25 Favored Pre-proline 0 N--CA 1.442 -0.867 0 C-N-CA 131.589 3.956 . . . . 0.0 110.045 175.486 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 66.3 Cg_exo -47.35 -48.97 13.91 Favored 'Trans proline' 0 N--CA 1.456 -0.685 1 C-N-CA 126.523 4.815 . . . . 0.0 114.232 -167.368 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -61.66 -15.77 42.87 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 119.104 3.001 . . . . 0.0 119.104 -176.879 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.42 120.58 9.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.942 170.797 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 p -65.79 136.28 55.99 Favored 'General case' 0 N--CA 1.447 -0.578 1 C-N-CA 135.521 5.528 . . . . 0.0 110.266 161.377 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mm -59.99 -31.7 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 114.882 -2.485 . . . . 0.0 114.527 -174.71 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -48.7 -36.48 16.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.103 2.561 . . . . 0.0 114.73 169.743 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -82.79 -39.28 21.98 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 125.343 1.652 . . . . 0.0 108.937 -172.866 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.32 4.5 t -67.95 -36.58 76.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 112.982 -3.39 . . . . 0.0 115.678 172.705 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -58.94 -46.84 87.02 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 129.6 3.16 . . . . 0.0 107.301 177.889 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.91 -18.69 61.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.867 3.267 . . . . 0.0 118.184 172.351 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -49.57 63.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 118.24 -2.787 . . . . 0.0 113.112 160.551 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -68.32 -38.66 79.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 127.832 2.453 . . . . 0.0 107.397 -169.667 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.41 -65.61 0.53 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.489 1.115 . . . . 0.0 111.071 160.529 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.253 35.0 t70 -43.28 -38.29 2.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 129.612 3.165 . . . . 0.0 114.086 179.68 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -80.28 -45.64 17.54 Favored 'General case' 0 CA--C 1.535 0.39 1 C-N-CA 131.964 4.106 . . . . 0.0 120.658 171.619 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -123.69 -20.43 5.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 126.057 2.837 . . . . 0.0 112.988 -166.468 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.73 28.8 22.99 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 118.035 -2.916 . . . . 0.0 115.983 170.035 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 tt -106.27 111.6 64.2 Favored Pre-proline 0 N--CA 1.446 -0.654 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 -175.213 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.32 151.87 23.34 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 125.163 3.909 . . . . 0.0 109.512 -174.789 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -47.86 -38.2 30.12 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 112.135 -3.36 . . . . 0.0 115.182 -166.795 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -13.91 2.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 127.676 3.11 . . . . 0.0 116.579 175.919 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -116.72 -7.4 11.52 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.039 2.535 . . . . 0.0 110.418 -176.2 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.277 80.0 mt-30 -87.67 145.36 26.2 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 117.866 -3.021 . . . . 0.0 105.656 175.709 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -124.64 128.13 48.39 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 129.037 2.935 . . . . 0.0 106.747 161.711 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -119.92 104.57 10.29 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 112.405 -3.664 . . . . 0.0 110.002 -160.941 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.65 131.52 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 1 CA-C-N 126.011 4.005 . . . . 0.0 108.798 -163.26 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -111.43 113.41 25.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.435 1.894 . . . . 0.0 112.202 164.207 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.8 -92.1 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 131.051 3.74 . . . . 0.0 110.51 -166.068 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.16 1.63 5.4 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 113.85 -1.523 . . . . 0.0 116.044 169.961 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -95.98 128.87 43.26 Favored 'General case' 0 CA--C 1.541 0.6 1 C-N-CA 132.031 4.132 . . . . 0.0 104.951 -174.168 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.371 18.6 mp0 -77.77 138.87 39.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.451 3.901 . . . . 0.0 107.903 178.178 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.455 ' HG ' ' CE2' ' A' ' 59' ' ' TYR . 8.1 mp -94.42 153.98 17.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.317 2.008 . . . . 0.0 107.315 172.544 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -135.23 144.25 46.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 112.257 -2.247 . . . . 0.0 108.648 164.555 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -49.15 146.88 3.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.671 2.388 . . . . 0.0 115.649 169.468 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.94 16.49 28.1 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-O 116.092 -2.504 . . . . 0.0 111.292 -169.289 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -145.92 158.26 43.87 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 127.512 3.53 . . . . 0.0 102.759 171.599 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -103.21 173.99 6.06 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 116.671 -3.768 . . . . 0.0 110.27 177.678 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.98 -36.46 83.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 117.994 -2.941 . . . . 0.0 106.83 176.59 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 t -64.91 -45.18 86.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.691 0.62 . . . . 0.0 112.444 175.95 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.63 -46.43 70.48 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.809 178.239 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 39.7 m-85 -75.41 -10.51 59.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 123.454 1.597 . . . . 0.0 113.629 -175.894 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.4 t30 66.32 45.95 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.516 3.526 . . . . 0.0 114.412 -173.069 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -90.21 142.82 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 O-C-N 126.577 2.423 . . . . 0.0 106.469 -178.264 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -137.12 177.99 7.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 178.196 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -49.03 116.85 1.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.665 2.386 . . . . 0.0 112.547 -176.0 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.457 21.4 mp0 79.74 23.52 0.47 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 130.298 3.439 . . . . 0.0 112.759 168.732 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 m -71.19 150.05 45.72 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.225 1.81 . . . . 0.0 111.012 169.175 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 m -98.9 130.52 45.3 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 119.161 -2.212 . . . . 0.0 109.429 162.386 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -109.62 141.05 42.7 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 114.914 -2.47 . . . . 0.0 108.876 167.441 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.355 23.2 t60 -100.94 164.06 12.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 121.603 2.001 . . . . 0.0 115.711 178.67 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.253 0.4 OUTLIER -141.11 136.7 32.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 129.14 2.976 . . . . 0.0 107.544 -175.841 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.65 118.69 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 O-C-N 126.791 2.557 . . . . 0.0 105.717 -176.492 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.663 0 O-C-N 128.682 3.738 . . . . 0.0 108.222 171.886 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.259 9.5 ptt? . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -74.36 146.31 43.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 118.45 -2.656 . . . . 0.0 117.196 169.187 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.336 44.5 pt -130.85 133.92 62.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 115.256 -2.307 . . . . 0.0 107.846 166.788 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -117.64 107.83 14.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -177.644 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 67' ' ' LEU . 22.0 t -108.28 120.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.972 2.509 . . . . 0.0 105.046 -170.132 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -96.08 150.12 20.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 128.67 3.731 . . . . 0.0 112.502 178.327 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -113.96 138.14 50.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 160.667 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -53.37 -36.13 61.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -174.864 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.9 p -73.48 -11.4 60.44 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 130.038 3.335 . . . . 0.0 113.263 -175.587 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.92 54.08 0.32 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 126.992 2.234 . . . . 0.0 113.973 168.872 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -141.27 143.93 34.38 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 121.372 2.586 . . . . 0.0 111.052 166.355 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -123.97 117.07 23.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 167.323 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.9 mm -80.74 118.23 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 160.779 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -92.36 128.39 38.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 164.368 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -125.07 140.32 53.0 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.066 -2.271 . . . . 0.0 107.327 178.488 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -92.75 131.36 37.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 126.898 2.624 . . . . 0.0 110.905 162.112 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.5 m -134.97 160.02 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 127.522 2.329 . . . . 0.0 111.153 179.25 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.281 20.5 mm-40 -76.18 149.34 82.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 115.778 -2.058 . . . . 0.0 111.869 156.465 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -24.56 72.26 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 CA-C-N 123.915 2.434 . . . . 0.0 114.796 176.418 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -101.61 20.85 15.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.871 2.868 . . . . 0.0 112.354 177.617 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 11.2 t0 -82.92 155.35 24.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 118.117 -2.864 . . . . 0.0 110.699 169.142 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 p -81.01 152.74 27.79 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.966 -169.744 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.9 mm -67.11 -12.68 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 120.483 -1.386 . . . . 0.0 111.2 167.843 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -71.22 -45.89 62.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 120.725 -1.234 . . . . 0.0 111.374 169.398 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -53.17 -34.05 55.21 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 175.403 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.95 -40.57 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 117.827 -1.083 . . . . 0.0 108.543 179.242 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -70.63 -37.87 73.83 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 121.867 2.121 . . . . 0.0 111.12 -179.91 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.52 87.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 115.265 -2.303 . . . . 0.0 111.814 178.153 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.372 54.6 mttm -76.83 -31.21 56.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.472 1.509 . . . . 0.0 113.056 172.925 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.42 ' CG2' HD11 ' A' ' 36' ' ' ILE . 34.8 mt -70.77 -37.89 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 1 O-C-N 115.737 -4.352 . . . . 0.0 109.292 174.117 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -54.56 -37.8 65.88 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 122.759 2.527 . . . . 0.0 117.744 160.572 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.44 -39.75 94.42 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.16 -2.291 . . . . 0.0 115.416 -179.95 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -86.68 -69.11 0.7 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.38 2.272 . . . . 0.0 107.157 -174.225 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -83.42 -15.82 48.24 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 125.945 2.028 . . . . 0.0 114.341 -161.554 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.25 8.62 68.3 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 117.276 -3.39 . . . . 0.0 115.8 175.708 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.42 HD11 ' CG2' ' A' ' 30' ' ' ILE . 5.2 pt -99.8 123.61 46.94 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-O 113.426 -3.178 . . . . 0.0 112.455 -168.844 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.72 137.27 71.99 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 127.587 3.745 . . . . 0.0 110.968 -179.136 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -64.78 -8.91 19.1 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.801 2.334 . . . . 0.0 113.608 177.683 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -75.73 -12.5 60.2 Favored 'General case' 0 N--CA 1.452 -0.341 1 CA-C-N 127.09 4.495 . . . . 0.0 109.086 172.246 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -87.99 -22.02 24.5 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 127.661 2.384 . . . . 0.0 112.909 -178.85 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HB3' HD11 ' A' ' 69' ' ' LEU . 56.9 mt-30 -95.81 131.47 42.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 130.717 3.607 . . . . 0.0 103.232 -165.234 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.287 17.1 mtp180 -126.46 111.01 13.93 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.915 2.086 . . . . 0.0 108.432 170.993 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -94.4 133.16 38.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 117.205 -3.434 . . . . 0.0 114.698 -172.652 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 tt -144.37 136.74 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 128.768 2.827 . . . . 0.0 110.254 -155.288 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -140.79 138.23 33.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.631 1.832 . . . . 0.0 112.24 172.832 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.59 35.01 7.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.049 2.939 . . . . 0.0 115.276 170.184 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.42 -23.88 31.71 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.875 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -103.07 125.11 49.65 Favored 'General case' 0 C--N 1.324 -0.52 1 O-C-N 115.655 -4.438 . . . . 0.0 109.026 -160.849 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.446 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 2.4 pm0 -85.04 126.65 33.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 127.291 2.87 . . . . 0.0 105.644 174.929 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -96.25 128.05 42.81 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 125.565 1.791 . . . . 0.0 109.463 -163.062 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -72.46 130.23 40.2 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -178.29 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -62.12 123.57 18.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 129.797 3.239 . . . . 0.0 112.299 -173.362 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.97 -6.06 51.05 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 112.117 -2.31 . . . . 0.0 114.807 173.239 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -72.77 163.81 27.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.25 1.025 . . . . 0.0 112.539 167.003 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -99.43 154.09 18.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 123.848 1.785 . . . . 0.0 114.433 174.311 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.375 11.5 mt -53.99 -48.87 69.95 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 116.775 -3.703 . . . . 0.0 110.53 -173.953 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.279 33.0 t -57.62 -47.07 83.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.782 2.033 . . . . 0.0 110.401 -177.719 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -70.37 -22.59 62.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.141 0.976 . . . . 0.0 110.733 -169.976 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.29 -3.09 54.17 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 131.131 3.772 . . . . 0.0 113.631 170.06 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.443 11.8 m120 80.94 21.86 0.38 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 130.191 3.396 . . . . 0.0 116.314 173.695 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.9 mt -83.07 112.73 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 117.02 -3.55 . . . . 0.0 106.949 171.757 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.84 178.57 5.73 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.563 2.745 . . . . 0.0 112.646 -178.692 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -54.63 137.13 44.44 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.929 1.292 . . . . 0.0 111.995 171.048 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 69.12 23.1 6.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 131.694 3.998 . . . . 0.0 112.521 175.575 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.3 m -82.63 138.14 34.28 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 117.332 -3.355 . . . . 0.0 105.804 -169.38 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.74 133.36 42.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.469 -179.664 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' CD2' HG22 ' A' ' 5' ' ' VAL 0.3 0.0 OUTLIER -149.77 -155.54 0.64 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.556 1.071 . . . . 0.0 110.538 172.603 . . . . . . . . 4 4 . 1 . 046 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -158.17 170.21 22.79 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -168.912 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 41' ' ' GLN . 22.2 tp -129.32 144.81 51.37 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 128.541 3.65 . . . . 0.0 105.059 -178.173 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -119.58 124.39 72.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 127.961 3.288 . . . . 0.0 109.691 168.591 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 mt . . . . . 0 C--N 1.322 -0.59 0 C-N-CA 126.8 2.04 . . . . 0.0 108.506 172.209 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.1 ttp . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 113.298 -3.239 . . . . 0.0 107.17 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.18 133.04 52.99 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 126.357 2.285 . . . . 0.0 114.266 170.552 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.54 -176.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 119.162 -2.211 . . . . 0.0 109.083 159.109 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -135.38 162.93 31.22 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.107 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.457 ' HB ' HD23 ' A' ' 15' ' ' LEU . 12.3 t -134.57 112.44 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 130.023 3.329 . . . . 0.0 106.228 -176.319 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -94.98 120.97 36.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 171.186 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -67.82 167.18 13.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 112.65 -2.068 . . . . 0.0 110.816 172.645 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.611 HD21 ' H ' ' A' ' 71' ' ' LEU . 4.3 mp -64.57 -35.42 80.92 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 119.297 -2.127 . . . . 0.0 113.76 176.891 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.319 17.7 p -67.73 -51.14 52.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.433 2.293 . . . . 0.0 109.383 173.544 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.89 31.15 0.6 Allowed Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.333 -1.26 . . . . 0.0 115.364 174.7 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -86.21 131.51 34.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 122.736 3.268 . . . . 0.0 109.929 160.883 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -105.1 85.47 2.28 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.104 1.361 . . . . 0.0 108.862 -175.458 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.275 3.9 mt -87.48 141.13 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 -174.216 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 m -74.63 143.4 44.35 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 169.987 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.457 HD23 ' HB ' ' A' ' 5' ' ' VAL . 2.4 mm? -125.52 127.76 46.93 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 118.057 -2.902 . . . . 0.0 104.636 -175.089 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -80.86 115.05 20.15 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 130.974 3.71 . . . . 0.0 107.829 172.465 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.9 172.77 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.669 1.188 . . . . 0.0 108.58 -176.446 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -133.05 148.7 70.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 131.5 3.92 . . . . 0.0 113.75 148.895 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.32 93.5 Cg_endo -51.03 -15.78 2.17 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 O-C-N 124.904 2.002 . . . . 0.0 116.324 -177.444 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -92.4 -1.82 56.75 Favored 'General case' 0 N--CA 1.452 -0.336 1 O-C-N 115.539 -4.476 . . . . 0.0 115.599 174.327 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.253 72.0 m-20 -81.05 131.18 35.29 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.176 -1.41 . . . . 0.0 111.451 177.176 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -69.51 160.33 31.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.838 0.855 . . . . 0.0 111.044 179.664 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.512 HD12 HD13 ' A' ' 50' ' ' LEU . 17.6 mm -61.08 -34.74 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 129.036 2.934 . . . . 0.0 106.766 175.99 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.81 -58.98 5.53 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 127.969 2.508 . . . . 0.0 111.499 175.224 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -51.77 -45.93 63.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.712 2.508 . . . . 0.0 113.931 169.367 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.58 -48.07 88.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 O-C-N 124.988 1.43 . . . . 0.0 112.838 174.644 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HG3' HD12 ' A' ' 43' ' ' LEU . 20.1 mtmt -57.43 -35.6 70.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.858 -3.026 . . . . 0.0 113.678 170.282 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.57 81.29 Favored 'General case' 0 N--CA 1.452 -0.355 1 CA-C-O 111.302 -4.19 . . . . 0.0 109.976 174.433 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -67.59 -29.76 69.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 124.042 3.11 . . . . 0.0 111.568 -179.834 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 mt -81.48 -16.21 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 126.928 2.091 . . . . 0.0 110.912 -175.67 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -70.01 -49.0 55.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 117.52 -3.238 . . . . 0.0 115.488 156.525 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -49.17 -61.29 2.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.573 1.949 . . . . 0.0 115.785 170.374 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -63.23 -46.27 87.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 130.388 3.475 . . . . 0.0 114.758 -177.189 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -138.87 -21.82 0.97 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.079 1.752 . . . . 0.0 111.019 -154.99 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.99 1.34 54.96 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 122.091 2.223 . . . . 0.0 109.458 166.972 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -81.55 117.27 67.55 Favored Pre-proline 0 N--CA 1.445 -0.675 0 O-C-N 117.163 -3.551 . . . . 0.0 103.909 179.887 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -74.13 164.29 34.67 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.433 2.089 . . . . 0.0 112.0 -172.023 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.252 37.9 Cg_endo -73.67 -37.94 2.73 Favored 'Trans proline' 0 N--CA 1.446 -1.309 1 C-N-CA 126.275 4.65 . . . . 0.0 109.835 -177.401 . . . . . . . . 3 2 . 1 . 047 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 40' ' ' GLN . 48.2 t0 -80.12 143.75 33.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.501 2.321 . . . . 0.0 108.873 170.518 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 39' ' ' ASP . 4.1 mp0 90.05 -31.04 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.206 1.002 . . . . 0.0 109.247 179.304 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -91.1 141.63 28.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.07 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -119.95 129.69 54.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 128.134 2.573 . . . . 0.0 110.989 172.243 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.448 HD12 ' HG3' ' A' ' 27' ' ' LYS . 94.1 mt -99.24 151.09 21.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 117.656 -3.152 . . . . 0.0 111.341 164.854 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mt -127.11 156.2 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 170.302 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -126.07 136.97 53.56 Favored 'General case' 0 N--CA 1.447 -0.625 1 C-N-CA 133.836 4.855 . . . . 0.0 108.789 157.043 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.49 -100.49 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 128.904 3.877 . . . . 0.0 108.776 179.021 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.37 -2.07 3.38 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 105.704 -2.958 . . . . 0.0 105.704 168.691 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -79.93 114.98 19.26 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 118.208 -2.936 . . . . 0.0 105.134 -173.348 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -64.93 126.36 27.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 122.982 1.372 . . . . 0.0 109.08 159.907 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.512 HD13 HD12 ' A' ' 23' ' ' ILE . 16.9 mt -90.79 141.8 28.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 124.167 1.937 . . . . 0.0 109.846 177.152 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -91.74 143.59 26.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.975 2.51 . . . . 0.0 109.342 170.75 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -49.51 -44.05 45.97 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 129.732 3.213 . . . . 0.0 112.836 -172.619 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.21 4.25 40.99 Favored Glycine 0 CA--C 1.531 1.062 1 O-C-N 115.423 -4.548 . . . . 0.0 112.788 -163.837 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -76.84 160.17 29.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 120.176 1.988 . . . . 0.0 112.103 164.096 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -97.93 162.35 13.29 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 127.174 2.796 . . . . 0.0 104.811 175.007 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 18.7 mt -42.5 -42.9 3.47 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.651 1.98 . . . . 0.0 109.721 157.736 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.3 t -69.02 -28.14 66.3 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 127.455 2.302 . . . . 0.0 110.035 -169.989 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -75.9 -9.07 58.3 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 175.127 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -118.9 11.74 12.65 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.416 1.886 . . . . 0.0 114.052 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.91 29.02 18.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.808 2.043 . . . . 0.0 115.679 179.9 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.2 mt -96.33 105.04 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 124.25 1.976 . . . . 0.0 108.541 -170.077 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -89.43 178.55 6.29 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 120.01 -1.681 . . . . 0.0 113.074 163.482 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -60.46 161.45 7.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 129.936 3.295 . . . . 0.0 115.999 -167.426 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 74.96 2.89 4.09 Favored 'General case' 0 N--CA 1.443 -0.815 1 C-N-CA 133.559 4.743 . . . . 0.0 112.946 175.931 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -71.31 132.46 44.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.149 1.78 . . . . 0.0 113.232 -177.093 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 p -97.95 113.0 24.72 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 125.443 1.714 . . . . 0.0 108.343 -176.74 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.82 156.2 20.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.967 1.307 . . . . 0.0 110.66 173.193 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -127.19 119.72 27.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 124.389 2.043 . . . . 0.0 106.166 -174.581 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tt -91.2 120.31 32.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.518 3.127 . . . . 0.0 103.871 -174.728 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.32 131.02 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 112.302 -2.227 . . . . 0.0 106.371 170.459 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.611 ' H ' HD21 ' A' ' 8' ' ' LEU . 12.3 mt . . . . . 0 C--N 1.329 -0.287 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 175.181 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 116.482 -1.723 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -65.77 132.38 48.6 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 125.01 1.444 . . . . 0.0 113.14 -171.487 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 pt -135.56 171.34 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 O-C-N 118.876 -2.39 . . . . 0.0 109.144 174.282 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -114.29 126.06 54.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 126.073 2.108 . . . . 0.0 109.156 170.848 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -110.26 147.61 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 163.777 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.274 62.4 tttt -126.6 125.02 41.24 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 131.439 3.896 . . . . 0.0 113.849 -174.286 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -102.74 162.79 12.64 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.81 1.644 . . . . 0.0 108.589 -173.599 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.873 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -77.83 -16.16 58.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 129.756 3.222 . . . . 0.0 116.891 -167.598 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 p -83.81 -0.9 52.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 164.035 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.3 27.4 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 127.432 2.444 . . . . 0.0 111.609 171.097 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -67.62 136.2 54.05 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 123.377 3.588 . . . . 0.0 115.935 -173.55 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 m -113.57 147.89 37.16 Favored 'General case' 0 C--N 1.325 -0.462 1 CA-C-O 129.069 4.271 . . . . 0.0 104.029 174.829 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.276 19.2 pt -127.64 114.8 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 109.367 -3.561 . . . . 0.0 110.102 178.451 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.4 p -84.94 108.84 17.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 101.807 -3.405 . . . . 0.0 101.807 177.283 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 pp -139.78 154.52 47.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 123.409 1.576 . . . . 0.0 111.28 170.011 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -84.47 133.57 34.47 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.518 2.327 . . . . 0.0 112.467 177.958 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.16 -153.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 168.399 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -151.08 158.83 34.5 Favored Pre-proline 0 N--CA 1.443 -0.794 0 C-N-CA 127.418 2.287 . . . . 0.0 106.556 -173.002 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.81 -32.91 35.69 Favored 'Trans proline' 0 N--CA 1.445 -1.333 1 C-N-CA 126.298 4.665 . . . . 0.0 115.951 174.871 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -99.11 3.99 46.8 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.885 2.874 . . . . 0.0 112.124 -171.981 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.64 145.73 29.5 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 121.311 1.869 . . . . 0.0 110.761 -179.081 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.7 p -85.6 162.68 18.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.577 2.351 . . . . 0.0 111.034 169.295 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.334 81.2 mt -53.16 -44.03 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 O-C-N 127.253 2.845 . . . . 0.0 115.871 178.501 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -49.67 -36.11 23.86 Favored 'General case' 0 C--N 1.33 -0.275 1 C-N-CA 132.255 4.222 . . . . 0.0 115.003 166.974 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -82.92 -11.97 57.73 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 126.462 1.905 . . . . 0.0 114.275 176.407 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -98.79 -41.07 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.006 1.322 . . . . 0.0 111.392 174.648 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -53.68 -45.01 70.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 128.991 2.916 . . . . 0.0 109.56 173.793 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.79 89.19 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 126.428 3.014 . . . . 0.0 111.78 -175.845 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -60.14 -44.33 95.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 131.629 3.972 . . . . 0.0 112.8 177.171 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.12 -37.56 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 179.764 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -65.35 -38.95 91.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 124.171 3.169 . . . . 0.0 112.919 179.43 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -59.53 -26.3 65.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 112.923 -3.418 . . . . 0.0 115.017 171.241 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -115.18 -28.18 7.03 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 122.117 2.235 . . . . 0.0 111.255 -163.191 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -126.06 -19.28 4.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.719 2.408 . . . . 0.0 114.605 -177.215 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.91 16.34 61.46 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 115.909 -2.606 . . . . 0.0 114.362 178.94 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.6 mt -87.73 123.7 68.75 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 123.066 3.433 . . . . 0.0 109.469 -163.213 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 13.9 Cg_endo -73.31 127.63 12.09 Favored 'Trans proline' 0 N--CA 1.453 -0.901 1 O-C-N 128.871 4.09 . . . . 0.0 111.334 -176.523 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 98.6 Cg_endo -82.36 -19.05 6.79 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.16 2.573 . . . . 0.0 115.047 -157.249 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.85 -28.28 65.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 115.829 -2.034 . . . . 0.0 110.858 176.604 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.77 9.39 16.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 127.77 3.169 . . . . 0.0 107.453 -164.577 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -110.9 142.34 43.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 123.394 1.569 . . . . 0.0 109.476 -170.403 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -126.67 122.36 34.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 130.593 3.557 . . . . 0.0 109.786 162.35 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.8 mt -110.05 115.59 30.04 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.643 3.177 . . . . 0.0 107.074 -168.399 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 49' ' ' GLN . 30.5 mm -97.88 129.35 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 127.823 2.449 . . . . 0.0 115.123 -178.653 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.257 63.8 t80 -143.41 128.68 18.82 Favored 'General case' 0 C--N 1.327 -0.394 1 O-C-N 114.484 -5.135 . . . . 0.0 110.428 168.945 . . . . . . . . 3 2 . 1 . 048 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.1 38.5 24.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 165.457 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.53 -11.39 7.99 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 116.762 -2.132 . . . . 0.0 115.016 164.069 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -149.47 170.98 17.33 Favored 'General case' 0 C--N 1.324 -0.513 1 C-N-CA 131.865 4.066 . . . . 0.0 114.466 -176.119 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.485 ' HA ' HD13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -54.61 132.73 45.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 128.91 2.884 . . . . 0.0 107.498 154.275 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 tp -66.75 138.44 57.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 112.067 -2.333 . . . . 0.0 106.394 165.787 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -51.13 145.92 7.13 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.438 1.895 . . . . 0.0 110.659 163.192 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -103.02 109.49 21.05 Favored 'General case' 0 N--CA 1.448 -0.568 1 N-CA-C 96.562 -5.347 . . . . 0.0 96.562 170.504 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.62 35.07 1.94 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.783 2.611 . . . . 0.0 116.694 178.707 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -133.09 132.74 42.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 115.927 -1.987 . . . . 0.0 110.043 171.014 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.0 p -75.67 150.57 37.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 125.154 2.406 . . . . 0.0 113.351 168.165 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -56.74 -35.68 68.87 Favored 'General case' 0 N--CA 1.441 -0.907 1 O-C-N 115.774 -4.329 . . . . 0.0 118.005 -159.428 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -75.85 -4.93 43.5 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 129.946 3.298 . . . . 0.0 112.628 176.64 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -77.11 -11.0 59.75 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 120.948 1.704 . . . . 0.0 111.758 169.774 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -113.09 159.12 19.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 129.296 3.038 . . . . 0.0 105.04 168.134 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -80.5 55.36 2.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.61 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -73.1 104.97 2.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 159.51 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.265 71.1 mm-40 -96.37 169.8 9.68 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 125.604 1.815 . . . . 0.0 114.35 170.49 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -46.84 130.88 12.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 119.946 -1.721 . . . . 0.0 112.372 166.251 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.31 8.1 mt-10 77.54 18.85 1.28 Allowed 'General case' 0 N--CA 1.451 -0.383 1 C-N-CA 133.484 4.714 . . . . 0.0 112.185 170.417 . . . . . . . . 3 2 . 1 . 048 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -74.26 148.03 41.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.958 179.165 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.9 m -95.9 104.44 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 102.183 -3.265 . . . . 0.0 102.183 -168.22 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.2 143.69 27.17 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.314 2.646 . . . . 0.0 108.057 166.944 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -124.29 136.65 54.29 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -174.878 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.93 121.59 45.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.908 2.083 . . . . 0.0 105.41 178.863 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 t -108.15 146.97 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.487 2.315 . . . . 0.0 106.443 170.984 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 tp . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 -175.11 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 122.407 1.098 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -79.12 135.24 36.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.528 -2.124 . . . . 0.0 110.517 -178.999 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -128.46 172.7 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.964 2.905 . . . . 0.0 109.709 173.636 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -116.79 153.37 32.55 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.363 2.665 . . . . 0.0 108.32 173.228 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.508 9.1 p -133.36 133.88 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 C-N-CA 129.045 2.938 . . . . 0.0 107.454 177.863 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -88.0 118.81 27.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 156.458 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -64.79 162.54 15.87 Favored 'General case' 0 C--N 1.324 -0.542 1 C-N-CA 132.924 4.49 . . . . 0.0 107.788 167.545 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.98 -11.56 60.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 123.749 1.738 . . . . 0.0 114.248 -173.141 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -91.99 -14.69 29.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.288 1.435 . . . . 0.0 111.575 173.753 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.62 -2.3 15.55 Favored Glycine 0 CA--C 1.535 1.31 1 O-C-N 113.447 -5.783 . . . . 0.0 111.491 165.994 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -88.27 134.39 33.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.744 2.418 . . . . 0.0 108.611 -172.682 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.09 146.91 52.25 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.34 166.083 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.533 57.2 mt -125.81 130.77 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 O-C-N 126.595 2.434 . . . . 0.0 109.223 152.901 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 90.8 m -83.73 130.57 34.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 171.845 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.1 tp -135.77 142.35 44.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 115.912 -1.994 . . . . 0.0 113.95 -174.42 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -94.28 128.23 40.63 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 131.211 3.804 . . . . 0.0 106.904 175.244 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -139.52 144.22 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 O-C-N 120.089 -1.632 . . . . 0.0 111.902 172.362 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.439 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -76.56 148.74 80.35 Favored Pre-proline 0 N--CA 1.447 -0.601 0 C-N-CA 126.305 1.842 . . . . 0.0 109.583 173.217 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.52 -41.82 18.61 Favored 'Trans proline' 0 N--CA 1.447 -1.215 1 C-N-CA 128.543 6.162 . . . . 0.0 109.731 159.057 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.9 p -66.54 -5.91 13.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.566 2.746 . . . . 0.0 117.898 170.668 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 3.0 t0 -88.61 145.94 25.4 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 117.434 -3.291 . . . . 0.0 105.097 -175.841 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -98.67 145.56 26.76 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.628 2.371 . . . . 0.0 115.901 -177.625 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.331 44.6 mm -42.0 -49.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 -176.575 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -75.87 -31.34 59.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 126.456 3.027 . . . . 0.0 114.306 -175.997 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.68 -35.37 65.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 116.499 -3.876 . . . . 0.0 113.085 172.637 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.0 t -72.21 -36.07 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 1 CA-C-O 111.127 -4.273 . . . . 0.0 112.252 169.817 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -61.47 -29.06 69.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 124.184 3.175 . . . . 0.0 114.39 162.68 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.334 . . -68.61 -31.21 70.22 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 126.77 2.544 . . . . 0.0 110.526 175.249 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -74.25 -19.32 60.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 122.458 2.39 . . . . 0.0 114.573 174.322 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.4 mm -76.71 -27.89 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 125.767 1.627 . . . . 0.0 114.047 161.629 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -63.28 -37.82 88.73 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -176.378 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.34 -53.9 3.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.477 1.511 . . . . 0.0 113.495 166.273 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -91.04 -46.32 8.2 Favored 'General case' 0 N--CA 1.45 -0.449 1 O-C-N 129.138 4.024 . . . . 0.0 107.038 -159.482 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -96.11 -32.63 12.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 119.092 -2.255 . . . . 0.0 113.503 -172.754 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.13 -31.33 8.67 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 116.857 -2.08 . . . . 0.0 108.654 175.264 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.271 8.3 mm -47.98 116.76 4.97 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 175.38 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.8 152.2 81.7 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 CA-C-N 124.032 2.476 . . . . 0.0 108.223 176.784 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.67 -36.61 72.87 Favored 'Trans proline' 0 N--CA 1.453 -0.864 1 C-N-CA 128.596 6.197 . . . . 0.0 116.023 175.274 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.18 -17.59 58.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.831 2.852 . . . . 0.0 113.938 177.804 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.265 9.3 mm-40 -91.64 -9.72 42.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 115.641 -2.123 . . . . 0.0 112.722 166.539 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -108.81 130.13 55.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -167.244 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -118.2 -176.18 3.01 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 119.863 -1.773 . . . . 0.0 109.242 156.365 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.87 123.63 3.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 177.216 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mm -108.86 122.4 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 -176.917 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -138.66 108.39 6.26 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.434 3.894 . . . . 0.0 109.434 -167.407 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.07 27.2 7.05 Favored 'General case' 0 N--CA 1.443 -0.821 1 C-N-CA 131.743 4.017 . . . . 0.0 115.972 177.665 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.37 17.13 20.79 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 106.448 -2.661 . . . . 0.0 106.448 170.05 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.302 65.6 pttt -150.71 159.46 44.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.911 2.084 . . . . 0.0 115.687 -171.698 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -79.62 148.2 31.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 131.344 3.858 . . . . 0.0 116.711 162.593 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.9 mt -100.24 118.45 36.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 128.354 3.534 . . . . 0.0 101.728 174.237 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.283 7.8 tp10 -87.3 157.15 19.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.226 -0.921 . . . . 0.0 109.052 -175.621 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.07 155.31 39.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.984 2.114 . . . . 0.0 110.675 -177.626 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.11 -14.38 57.48 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.991 175.229 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -90.65 149.34 22.13 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -176.342 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.8 p -79.19 174.29 11.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 117.326 -3.359 . . . . 0.0 109.154 167.135 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mp -76.61 -22.88 53.58 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 117.039 -3.538 . . . . 0.0 112.587 174.309 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 t -70.26 -29.14 65.85 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 127.517 2.327 . . . . 0.0 112.689 171.321 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.47 -32.32 73.86 Favored 'General case' 0 C--N 1.322 -0.6 1 O-C-N 115.843 -4.286 . . . . 0.0 111.934 173.174 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.86 6.21 21.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 119.841 -1.787 . . . . 0.0 106.738 -169.687 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.361 1.6 p-10 57.21 41.44 26.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 124.701 2.191 . . . . 0.0 113.878 167.838 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 mt -90.56 122.38 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 129.991 3.316 . . . . 0.0 106.241 -176.599 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.287 21.3 mm-40 -115.27 -176.6 2.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 130.537 3.535 . . . . 0.0 116.22 176.242 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -51.42 161.88 0.41 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 123.277 2.762 . . . . 0.0 116.065 159.83 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 85.16 1.37 0.74 Allowed 'General case' 0 C--N 1.325 -0.496 1 C-N-CA 133.301 4.64 . . . . 0.0 111.214 171.136 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -82.04 107.46 14.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 -177.373 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -84.37 110.66 18.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.553 2.341 . . . . 0.0 111.279 157.158 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.1 mt -76.46 162.67 27.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.118 -1.614 . . . . 0.0 115.16 170.019 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -119.94 147.56 44.6 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.961 2.104 . . . . 0.0 110.369 150.687 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.68 149.4 21.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 129.104 2.962 . . . . 0.0 111.947 171.317 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -133.74 155.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 O-C-N 117.839 -3.038 . . . . 0.0 115.452 168.722 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.5 mt . . . . . 0 N--CA 1.452 -0.365 0 CA-C-N 122.633 2.47 . . . . 0.0 105.712 -170.923 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 ttp . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 100.425 -3.917 . . . . 0.0 100.425 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -72.14 137.46 47.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 111.648 -2.524 . . . . 0.0 110.999 -175.108 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.305 10.9 pt -141.17 170.74 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 O-C-N 125.678 1.861 . . . . 0.0 111.268 173.106 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -122.37 138.95 54.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 107.132 177.428 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.64 117.66 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 101.875 -3.38 . . . . 0.0 101.875 173.298 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -78.87 135.38 37.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 125.327 2.489 . . . . 0.0 112.838 165.395 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 p -80.16 -169.43 2.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 118.746 -2.471 . . . . 0.0 110.023 -179.398 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.5 mt -61.82 -40.41 95.2 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -165.909 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.8 p -103.04 9.01 38.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 111.338 -2.665 . . . . 0.0 112.739 -176.266 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.64 -0.73 59.67 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 128.655 3.026 . . . . 0.0 117.841 170.469 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -73.4 129.29 37.69 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 119.949 1.874 . . . . 0.0 110.771 177.199 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 t -81.04 136.37 35.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.785 2.034 . . . . 0.0 113.72 -177.945 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 pt -114.15 120.14 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 102.671 -3.085 . . . . 0.0 102.671 168.681 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.8 m -86.66 112.88 22.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.04 2.536 . . . . 0.0 108.86 -179.836 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.83 170.07 8.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.153 2.981 . . . . 0.0 104.346 -170.698 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.484 1.1 pm0 -132.79 124.39 27.94 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 131.297 3.839 . . . . 0.0 118.965 162.99 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.334 0.0 OUTLIER -143.85 154.14 15.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 113.909 -1.496 . . . . 0.0 113.898 -175.345 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -88.97 151.08 46.63 Favored Pre-proline 0 N--CA 1.452 -0.367 0 O-C-N 119.67 -1.894 . . . . 0.0 108.828 176.919 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.29 -30.09 10.54 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 124.907 3.738 . . . . 0.0 117.53 165.835 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.303 16.8 p -96.99 12.84 31.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 129.201 3.001 . . . . 0.0 112.714 170.799 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.81 142.35 31.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 123.421 2.828 . . . . 0.0 108.104 167.513 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -81.8 177.9 8.62 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 131.565 3.946 . . . . 0.0 111.285 -177.573 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -89.21 -18.96 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 O-C-N 116.575 -3.828 . . . . 0.0 111.321 -170.803 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.76 -37.66 74.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.102 157.432 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -85.11 5.26 30.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 123.71 1.719 . . . . 0.0 110.425 -172.616 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.25 -37.41 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 O-C-N 118.08 -2.887 . . . . 0.0 110.06 156.475 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -56.78 -52.65 64.21 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 116.571 -3.831 . . . . 0.0 110.083 174.846 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.3 46.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 118.086 2.625 . . . . 0.0 118.086 179.502 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -83.18 -26.54 30.77 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 111.553 -2.567 . . . . 0.0 116.126 178.443 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.0 mt -68.38 -38.96 80.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 115.758 -2.067 . . . . 0.0 108.838 160.666 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.15 -34.19 77.51 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 117.832 -1.08 . . . . 0.0 109.921 174.457 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.44 -34.67 77.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -179.091 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -102.24 -25.21 13.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 127.651 3.094 . . . . 0.0 117.937 -176.713 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -141.15 -16.24 0.85 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.627 2.371 . . . . 0.0 112.352 -171.599 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.06 -3.89 67.31 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 120.217 -1.552 . . . . 0.0 113.699 152.157 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.3 mt -73.3 132.65 81.65 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 114.055 -2.879 . . . . 0.0 106.037 -176.953 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.6 132.56 22.21 Favored 'Trans proline' 0 N--CA 1.454 -0.81 1 C-N-CA 127.118 5.212 . . . . 0.0 106.856 -171.274 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -40.2 -30.68 0.46 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 1 C-N-CA 130.445 7.43 . . . . 0.0 119.604 177.503 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.76 -39.07 84.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.448 2.299 . . . . 0.0 113.725 175.744 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.32 -16.15 55.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 115.248 -2.311 . . . . 0.0 112.64 -175.707 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.46 130.89 35.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.76 2.824 . . . . 0.0 111.638 -172.696 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -121.47 131.93 54.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 103.354 -2.832 . . . . 0.0 103.354 168.688 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 mt -103.0 137.82 40.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 119.914 1.234 . . . . 0.0 110.488 166.649 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mm -122.61 148.66 26.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 129.925 3.29 . . . . 0.0 107.862 177.341 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -153.88 127.58 8.75 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.177 1.791 . . . . 0.0 110.038 173.919 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.37 40.39 10.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.048 2.139 . . . . 0.0 115.08 -172.536 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.64 -13.08 68.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 117.638 1.815 . . . . 0.0 117.638 177.559 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.399 55.3 pttt -123.78 148.34 46.75 Favored 'General case' 0 C--N 1.326 -0.437 1 C-N-CA 133.353 4.661 . . . . 0.0 108.212 -161.691 . . . . . . . . 3 2 . 1 . 050 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -71.3 155.33 40.8 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 118.388 -2.695 . . . . 0.0 109.245 -169.277 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -136.23 114.08 11.2 Favored 'General case' 0 N--CA 1.451 -0.388 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 177.885 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -123.31 155.49 37.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 126.335 2.969 . . . . 0.0 111.895 -169.186 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.26 145.28 55.34 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.013 -2.929 . . . . 0.0 108.668 -178.246 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.07 -6.7 19.43 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 127.148 2.78 . . . . 0.0 113.977 -173.756 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -135.35 -175.56 3.98 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.414 1.486 . . . . 0.0 113.032 -179.509 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.6 p -128.39 175.17 8.71 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.288 1.035 . . . . 0.0 109.787 -178.856 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -55.05 -36.44 65.56 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.532 1.933 . . . . 0.0 113.703 171.423 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.328 13.0 m -75.6 -25.61 57.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 115.622 -2.431 . . . . 0.0 113.6 177.159 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -70.46 -41.61 72.54 Favored 'General case' 0 N--CA 1.45 -0.451 2 CA-C-N 126.516 4.235 . . . . 0.0 112.817 173.196 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -82.09 -12.63 58.12 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 124.742 1.276 . . . . 0.0 110.8 -176.212 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.5 m120 72.76 58.91 0.12 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.554 3.542 . . . . 0.0 114.984 175.836 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -100.69 159.05 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 112.504 -2.134 . . . . 0.0 109.814 -177.933 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -130.52 -151.73 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.684 1.194 . . . . 0.0 112.188 -176.614 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -90.34 144.64 25.64 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.427 2.291 . . . . 0.0 107.444 175.874 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 77.01 19.75 1.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 125.213 2.435 . . . . 0.0 111.073 161.895 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.7 m -87.78 133.42 33.87 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.97 2.508 . . . . 0.0 115.278 -178.025 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.1 m -111.93 125.36 53.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 123.608 2.913 . . . . 0.0 104.24 -170.787 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mt -103.05 166.32 10.51 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.313 2.245 . . . . 0.0 111.281 173.518 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -109.43 134.01 52.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 118.669 -2.52 . . . . 0.0 105.282 164.99 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 1.5 tm? -90.01 140.22 29.85 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.088 1.355 . . . . 0.0 109.696 154.033 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.92 156.22 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 128.869 2.868 . . . . 0.0 111.616 164.012 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 125.908 1.683 . . . . 0.0 108.812 171.529 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 123.732 1.729 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 051 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -103.4 120.45 40.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 119.613 -1.93 . . . . 0.0 107.175 178.3 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -121.92 131.22 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.056 170.42 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -86.86 81.44 8.15 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.629 2.372 . . . . 0.0 109.166 -174.358 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -65.41 132.54 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 125.981 1.713 . . . . 0.0 108.682 169.246 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -123.24 152.78 40.97 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 119.972 -1.705 . . . . 0.0 109.562 172.923 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -117.73 -177.44 3.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 126.478 3.037 . . . . 0.0 109.585 -165.296 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -77.68 -42.4 34.71 Favored 'General case' 0 N--CA 1.446 -0.656 1 O-C-N 115.899 -4.251 . . . . 0.0 104.669 174.38 . . . . . . . . 4 4 . 1 . 051 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -69.89 -19.08 63.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 123.22 2.736 . . . . 0.0 112.772 -176.316 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.38 32.16 2.62 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.044 0.83 . . . . 0.0 113.112 156.982 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -110.68 146.27 36.52 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 114.22 -2.8 . . . . 0.0 110.088 -167.113 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.261 43.1 m -99.57 89.71 4.24 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 173.802 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mm -52.47 -57.93 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 120.757 1.617 . . . . 0.0 112.209 -173.848 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.317 75.5 m 79.3 81.91 0.06 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -178.675 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 tp -99.15 138.65 35.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 124.984 2.326 . . . . 0.0 106.61 -178.877 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -91.35 121.52 33.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.223 -1.548 . . . . 0.0 107.916 170.896 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.401 4.8 t -121.56 152.24 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 103.831 -2.655 . . . . 0.0 103.831 -175.547 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -104.36 136.0 19.25 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-O 114.624 -2.608 . . . . 0.0 109.384 170.909 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -57.7 -18.09 31.94 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 N-CA-C 118.609 2.503 . . . . 0.0 118.609 -174.773 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.7 p -74.08 -15.07 61.07 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.655 2.382 . . . . 0.0 114.427 168.93 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 25' ' ' ASN . 92.8 m-20 -66.39 129.01 38.39 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 122.72 2.509 . . . . 0.0 110.698 -176.026 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.6 p -85.37 174.67 9.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.971 1.714 . . . . 0.0 108.389 163.243 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.255 27.4 mm -46.7 -39.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 128.707 2.803 . . . . 0.0 115.899 176.592 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -59.02 -43.27 91.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 115.716 -2.088 . . . . 0.0 111.058 174.996 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 29.7 m120 -73.23 -36.06 66.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 127.476 2.31 . . . . 0.0 109.561 -172.513 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.29 -55.13 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 124.467 1.107 . . . . 0.0 110.512 172.989 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.263 78.7 mttt -43.5 -44.47 6.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.239 2.216 . . . . 0.0 113.512 169.718 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.22 -53.26 59.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.298 2.239 . . . . 0.0 110.097 177.506 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -62.37 -33.26 74.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 179.976 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -68.02 -44.72 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 126.946 2.654 . . . . 0.0 109.873 165.878 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -46.15 91.84 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 125.368 1.667 . . . . 0.0 114.106 -178.977 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.446 27.8 t70 -34.45 -61.32 0.39 Allowed 'General case' 0 N--CA 1.448 -0.549 1 N-CA-C 124.403 4.964 . . . . 0.0 124.403 152.451 . . . . . . . . 3 2 . 1 . 051 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -95.19 -30.23 14.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 119.892 -1.755 . . . . 0.0 111.405 -156.764 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -109.25 -27.79 9.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 128.806 2.843 . . . . 0.0 110.709 -179.978 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.58 -3.15 61.0 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 121.428 3.331 . . . . 0.0 121.428 167.674 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -85.15 145.19 42.5 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 114.054 -2.879 . . . . 0.0 109.715 -179.88 . . . . . . . . 3 3 . 1 . 051 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.23 161.59 33.48 Favored 'Trans proline' 0 N--CA 1.45 -1.039 1 C-N-CA 126.781 4.987 . . . . 0.0 109.986 174.039 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.82 -13.07 8.28 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.724 3.616 . . . . 0.0 115.242 -171.949 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.55 -36.21 63.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 160.586 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -67.78 -23.48 65.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.286 -1.34 . . . . 0.0 113.508 179.57 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -85.23 129.1 34.87 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 113.839 -2.981 . . . . 0.0 106.042 -168.484 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -110.68 160.05 17.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 155.165 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.519 0.2 OUTLIER -136.44 135.51 38.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 119.112 -2.243 . . . . 0.0 114.98 176.686 . . . . . . . . 3 3 . 1 . 051 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 mt -127.47 108.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -159.469 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -124.19 130.98 53.46 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.858 1.663 . . . . 0.0 110.369 171.787 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.09 50.54 13.96 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 130.398 3.479 . . . . 0.0 110.68 175.304 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.1 -34.3 3.99 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.841 2.162 . . . . 0.0 117.173 178.839 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -89.04 132.05 34.94 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -164.134 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.259 80.1 mt-30 -88.71 104.31 16.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 123.835 1.778 . . . . 0.0 108.949 168.373 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 mt -55.86 138.35 48.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 110.426 -3.079 . . . . 0.0 113.298 -166.529 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -88.64 152.49 21.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 116.423 -1.751 . . . . 0.0 106.851 -172.121 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.59 134.76 50.46 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 114.58 -2.629 . . . . 0.0 114.885 -173.671 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.83 16.92 80.35 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 117.384 1.713 . . . . 0.0 117.384 172.614 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.0 mmm-85 -99.21 176.98 5.35 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.887 2.075 . . . . 0.0 107.583 178.448 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.5 p -100.05 141.24 33.14 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 102.371 -3.196 . . . . 0.0 102.371 -172.622 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 21.7 mt -66.26 -30.81 71.32 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 127.529 2.332 . . . . 0.0 113.071 179.661 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.3 m -87.17 -22.13 25.5 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.321 -166.802 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.02 -15.89 60.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 124.864 1.352 . . . . 0.0 114.314 173.658 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -92.84 5.62 50.62 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.847 2.059 . . . . 0.0 109.299 168.135 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 75.94 21.74 1.54 Allowed 'General case' 0 N--CA 1.444 -0.765 1 C-N-CA 134.007 4.923 . . . . 0.0 118.322 170.164 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 mt -82.33 103.69 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 C-N-CA 128.144 2.578 . . . . 0.0 107.543 -169.069 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -89.5 170.44 10.5 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.059 2.143 . . . . 0.0 109.63 177.084 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -66.76 159.01 28.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 116.991 -1.48 . . . . 0.0 113.586 159.632 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 68.35 18.88 9.07 Favored 'General case' 0 N--CA 1.453 -0.318 1 C-N-CA 132.913 4.485 . . . . 0.0 111.032 179.359 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.1 t -95.94 178.39 5.44 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 128.731 3.769 . . . . 0.0 112.182 -176.433 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.2 p -131.85 133.71 44.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 125.798 1.936 . . . . 0.0 111.072 -171.971 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.19 150.91 51.94 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 126.279 2.237 . . . . 0.0 105.468 -171.704 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -108.2 119.67 40.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 117.942 -2.974 . . . . 0.0 110.953 171.663 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.3 tp -82.4 133.78 35.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 173.43 . . . . . . . . 1 1 . 1 . 051 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.291 68.7 t -108.61 141.28 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 125.149 3.613 . . . . 0.0 107.495 163.257 . . . . . . . . 2 2 . 1 . 051 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.437 HD13 HD23 ' A' ' 8' ' ' LEU . 4.8 mp . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 167.113 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 ttp . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 116.627 -1.654 . . . . 0.0 108.069 . . . . . . . . . 0 0 . 1 . 052 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -73.12 133.1 44.0 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 122.407 2.367 . . . . 0.0 115.765 176.167 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.446 HD12 HD23 ' A' ' 67' ' ' LEU . 42.0 pt -122.3 155.3 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 115.647 -2.12 . . . . 0.0 112.551 165.084 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -102.5 128.37 49.17 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 126.046 2.091 . . . . 0.0 105.658 179.262 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -100.54 109.6 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 118.047 -2.908 . . . . 0.0 103.383 166.066 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -102.95 150.3 23.67 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.447 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.283 14.8 t -145.48 160.32 41.77 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 125.27 2.462 . . . . 0.0 109.217 158.243 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mp -67.71 -39.71 84.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 109.114 -3.675 . . . . 0.0 114.365 -161.914 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 p -52.48 -5.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 1 C-N-CA 133.435 4.694 . . . . 0.0 115.728 171.486 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.27 2.09 54.11 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 119.911 -1.743 . . . . 0.0 112.772 167.228 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -79.7 126.46 30.96 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.185 1.993 . . . . 0.0 110.096 164.308 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 m -128.2 101.96 6.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 103.244 -2.872 . . . . 0.0 103.244 171.031 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.266 2.8 mp -80.26 150.07 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 130.741 3.616 . . . . 0.0 110.457 -177.462 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 t -135.91 122.1 20.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.636 1.575 . . . . 0.0 108.241 -175.885 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -123.14 147.52 46.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.773 1.229 . . . . 0.0 113.845 175.221 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -97.43 121.23 39.09 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 131.093 3.757 . . . . 0.0 105.605 177.162 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -131.04 166.72 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 118.494 -2.629 . . . . 0.0 114.481 178.474 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -95.69 156.71 37.08 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 155.65 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.28 -20.04 69.68 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.64 2.893 . . . . 0.0 113.15 -179.891 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 13.6 p -91.78 0.33 57.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.945 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -66.33 142.85 57.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 176.562 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.33 147.49 26.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 125.216 2.436 . . . . 0.0 109.043 178.356 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.2 mt -55.75 -26.46 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 118.903 -2.373 . . . . 0.0 113.149 179.603 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.287 31.9 mt-10 -74.07 -42.66 59.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 109.422 -178.535 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.01 -50.4 70.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.513 175.499 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.1 t -55.57 -31.1 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 115.612 -2.137 . . . . 0.0 111.835 166.029 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -76.71 -17.56 59.03 Favored 'General case' 0 N--CA 1.442 -0.834 2 CA-C-N 128.092 4.951 . . . . 0.0 109.66 -177.267 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.42 -19.99 22.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.516 1.126 . . . . 0.0 113.215 172.273 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -73.76 -29.72 62.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 170.785 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 30' ' ' ILE . 56.9 mt -64.79 -30.78 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 128.834 2.854 . . . . 0.0 115.148 160.309 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -65.71 -53.51 39.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.62 1.1 . . . . 0.0 111.776 173.094 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.401 22.9 t70 -36.99 -34.16 0.07 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 131.514 3.926 . . . . 0.0 112.485 168.283 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -93.78 -57.99 2.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 120.582 1.537 . . . . 0.0 115.038 171.816 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.26 -21.14 23.35 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -161.268 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.99 1.95 62.81 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 119.312 2.485 . . . . 0.0 119.312 -174.905 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.0 mt -95.86 140.87 22.49 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 128.191 2.596 . . . . 0.0 110.874 -163.234 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.59 136.53 10.98 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.765 2.977 . . . . 0.0 115.604 172.774 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -66.47 -21.21 53.62 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 124.562 3.508 . . . . 0.0 116.093 -158.047 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.31 4.78 9.91 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 117.907 -2.996 . . . . 0.0 110.94 -176.884 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -95.36 -18.96 20.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 113.172 -3.299 . . . . 0.0 109.083 168.062 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.284 13.4 mm-40 -98.0 125.05 42.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 124.678 3.399 . . . . 0.0 112.319 -160.835 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 127.5 42.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 100.635 -3.839 . . . . 0.0 100.635 -178.772 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.7 mt -101.89 134.78 44.54 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 128.683 2.793 . . . . 0.0 115.096 179.688 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -128.74 156.65 41.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 126.458 1.903 . . . . 0.0 107.209 167.753 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.491 ' HB3' HD21 ' A' ' 50' ' ' LEU 0.368 6.7 t80 -126.61 -126.65 0.23 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 109.711 -3.404 . . . . 0.0 107.945 -157.76 . . . . . . . . 3 3 . 1 . 052 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.75 44.57 1.07 Allowed 'General case' 0 C--N 1.324 -0.54 1 C-N-CA 132.243 4.217 . . . . 0.0 110.777 169.994 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.9 -22.22 34.13 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 128.328 2.87 . . . . 0.0 114.493 -177.715 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.93 126.01 34.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -171.268 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -76.21 119.86 20.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.123 0.963 . . . . 0.0 108.78 171.967 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 45' ' ' PHE . 18.5 mt -92.23 127.43 37.71 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -169.957 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.91 149.5 34.21 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 123.399 1.571 . . . . 0.0 114.872 174.005 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -64.6 126.75 28.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 129.619 3.168 . . . . 0.0 109.748 178.115 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.1 -20.08 51.59 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 116.705 -2.664 . . . . 0.0 114.847 172.279 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.32 156.35 38.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.72 1.26 . . . . 0.0 110.091 159.394 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.1 p -87.94 -179.95 6.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 119.327 -2.108 . . . . 0.0 109.152 -175.668 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 12.8 mt -77.08 -22.39 52.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 116.772 -1.585 . . . . 0.0 110.443 165.618 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.2 t -64.82 -41.02 96.09 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 117.608 2.448 . . . . 0.0 117.608 168.492 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -51.88 -53.83 36.21 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.703 -178.26 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -94.67 3.33 55.2 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.697 1.999 . . . . 0.0 110.824 -171.124 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.49 1.3 p-10 64.68 28.73 13.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 118.711 2.856 . . . . 0.0 118.711 175.11 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.411 HD13 HD11 ' A' ' 67' ' ' LEU . 30.6 mt -75.16 131.37 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.343 170.023 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -124.17 176.7 6.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 125.929 2.018 . . . . 0.0 108.936 -168.254 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -52.99 127.27 23.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.418 1.487 . . . . 0.0 108.555 175.148 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 62.95 15.52 8.43 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 120.372 3.471 . . . . 0.0 120.372 -171.373 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -76.72 123.41 26.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 116.888 -3.633 . . . . 0.0 106.402 168.496 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -87.15 129.34 34.98 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.698 2.799 . . . . 0.0 108.523 179.469 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD23 HD12 ' A' ' 3' ' ' ILE . 2.5 mm? -100.97 134.15 44.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.547 2.339 . . . . 0.0 109.363 163.72 . . . . . . . . 2 2 . 1 . 052 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -86.03 151.29 23.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 103.552 -2.758 . . . . 0.0 103.552 164.657 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -134.23 112.8 11.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 127.871 2.468 . . . . 0.0 109.824 -173.774 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.84 -177.58 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.179 2.591 . . . . 0.0 110.965 -178.347 . . . . . . . . 1 1 . 1 . 052 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.445 -0.691 0 CA-C-O 113.737 -3.03 . . . . 0.0 110.637 -177.088 . . . . . . . . 0 0 . 1 . 053 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 . . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -80.36 144.02 33.06 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.491 1.916 . . . . 0.0 112.536 -175.148 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.611 HG22 ' H ' ' A' ' 65' ' ' SER . 22.9 pt -127.44 161.33 35.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 120.237 -1.539 . . . . 0.0 111.073 155.764 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -92.27 163.57 13.85 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 172.739 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.32 155.67 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 129.436 3.094 . . . . 0.0 110.608 148.422 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -152.12 142.39 22.42 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 122.858 2.572 . . . . 0.0 105.233 -162.308 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.27 66.7 p -100.19 170.75 8.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.049 1.34 . . . . 0.0 110.965 179.284 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.542 HD11 HG22 ' A' ' 70' ' ' VAL . 43.8 mt -93.0 18.88 8.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 117.856 -3.027 . . . . 0.0 110.22 177.324 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.371 0.6 OUTLIER -153.46 22.37 0.54 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 125.563 3.801 . . . . 0.0 109.412 -164.442 . . . . . . . . 3 3 . 1 . 053 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.88 -11.36 29.68 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 122.688 3.835 . . . . 0.0 122.688 164.752 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -112.73 170.69 8.01 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 121.159 2.479 . . . . 0.0 109.193 -171.001 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.4 p -140.03 169.2 18.13 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.52 3.128 . . . . 0.0 110.503 170.579 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.7 mm -140.99 132.86 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 126.097 2.123 . . . . 0.0 110.377 168.851 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 m -80.88 116.53 20.91 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 126.621 2.45 . . . . 0.0 110.125 168.399 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.8 mt -102.74 146.08 28.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 123.773 1.749 . . . . 0.0 113.304 179.041 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.9 107.88 10.49 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.877 168.881 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -142.58 -41.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.837 1.655 . . . . 0.0 111.441 -157.067 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 75.74 140.97 0.08 OUTLIER Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 131.07 3.748 . . . . 0.0 110.726 -171.339 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 87.3 Cg_exo -46.58 -24.08 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 124.474 3.449 . . . . 0.0 119.979 172.308 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 p -64.07 -34.21 77.5 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 116.365 -3.959 . . . . 0.0 113.178 174.931 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.98 144.87 11.02 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -177.846 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.257 10.7 t -117.56 130.68 56.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 116.84 -1.552 . . . . 0.0 108.483 -165.514 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.409 24.7 mm -40.69 -43.72 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 129.774 3.23 . . . . 0.0 114.755 -159.6 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -65.48 -29.47 70.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 121.214 1.825 . . . . 0.0 113.19 179.648 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.77 -16.61 28.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 -176.825 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.43 -40.33 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 114.809 -2.519 . . . . 0.0 105.518 172.702 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -71.5 -30.04 65.5 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 125.035 1.459 . . . . 0.0 112.235 175.324 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.25 -18.65 60.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.53 2.332 . . . . 0.0 115.869 173.74 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.28 -18.41 55.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 119.724 3.231 . . . . 0.0 119.724 161.416 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.6 mt -87.97 -38.19 11.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 127.27 2.856 . . . . 0.0 107.733 170.655 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.295 38.6 tt0 -45.9 -56.28 5.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 162.01 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -51.56 -38.2 53.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 111.397 -2.638 . . . . 0.0 110.704 171.363 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -87.7 -53.71 4.63 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -179.991 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -103.46 -21.56 13.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 -170.932 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.76 -17.09 28.06 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 116.42 -2.322 . . . . 0.0 110.394 175.156 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.79 120.19 78.62 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 129.288 3.035 . . . . 0.0 110.292 -174.127 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -77.23 148.72 27.38 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 C-N-CA 123.924 3.083 . . . . 0.0 110.973 -171.146 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.293 47.2 Cg_exo -47.53 -37.39 26.21 Favored 'Trans proline' 0 N--CA 1.442 -1.532 1 C-N-CA 126.382 4.721 . . . . 0.0 116.096 -176.814 . . . . . . . . 3 2 . 1 . 053 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.75 -13.71 61.0 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -171.737 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.317 20.2 mt-30 -100.88 -7.82 23.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 178.715 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -89.23 95.03 10.13 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.247 2.219 . . . . 0.0 115.996 173.353 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.291 51.4 ttt180 -88.44 105.7 17.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.293 -1.504 . . . . 0.0 107.639 172.821 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB3' HD12 ' A' ' 50' ' ' LEU 0.295 97.1 mt -97.07 120.11 36.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.984 . . . . . . . . 3 3 . 1 . 053 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.0 mt -110.85 126.24 68.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 130.179 3.392 . . . . 0.0 105.91 -172.53 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.261 89.9 t80 -119.95 -138.27 0.34 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.869 2.868 . . . . 0.0 105.019 -172.422 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.26 57.19 4.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.302 2.641 . . . . 0.0 114.146 -163.284 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.78 -3.17 80.99 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 127.198 2.333 . . . . 0.0 114.449 -166.679 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -123.96 141.01 52.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.37 2.268 . . . . 0.0 110.98 -170.381 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -77.44 140.04 39.77 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.656 -0.687 . . . . 0.0 110.989 153.309 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.443 HD12 ' HB3' ' A' ' 43' ' ' LEU . 73.4 mt -67.97 123.5 20.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 126.232 2.208 . . . . 0.0 109.156 174.01 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -85.09 138.93 32.1 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 126.554 2.409 . . . . 0.0 107.519 -177.376 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.276 96.8 m-20 -73.56 127.27 32.29 Favored 'General case' 0 N--CA 1.445 -0.724 1 CA-C-N 107.303 -4.498 . . . . 0.0 104.707 171.74 . . . . . . . . 3 2 . 1 . 053 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.32 -19.79 26.46 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.708 1.255 . . . . 0.0 116.148 -173.147 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -100.02 163.3 12.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 124.1 1.905 . . . . 0.0 110.007 176.136 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -92.87 164.8 13.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 117.377 -3.327 . . . . 0.0 111.667 179.492 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 18.2 mt -62.11 -45.07 95.1 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 117.31 -3.369 . . . . 0.0 113.482 171.644 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.535 47.5 t -29.95 -36.12 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.215 1 C-N-CA 134.838 5.255 . . . . 0.0 120.511 156.203 . . . . . . . . 3 2 . 1 . 053 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.318 34.5 m-20 -80.49 -10.03 59.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 114.38 -2.724 . . . . 0.0 110.738 177.184 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -104.86 -7.71 19.2 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 126.864 2.602 . . . . 0.0 114.199 168.15 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 7.0 t-20 55.08 59.42 4.03 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.253 2.221 . . . . 0.0 113.232 -171.909 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -101.16 126.94 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 1 O-C-N 114.621 -5.05 . . . . 0.0 103.599 179.468 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -109.9 -170.28 1.62 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.918 1.687 . . . . 0.0 112.347 -168.827 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -50.83 139.15 17.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.047 -1.033 . . . . 0.0 113.01 171.269 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.278 4.4 tt0 70.56 32.26 2.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 128.879 3.862 . . . . 0.0 109.923 163.395 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.611 ' H ' HG22 ' A' ' 3' ' ' ILE . 69.6 m -83.1 153.23 24.96 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 117.777 -3.077 . . . . 0.0 114.509 -178.335 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m -113.52 137.82 51.01 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 125.234 2.445 . . . . 0.0 111.018 168.902 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.69 125.86 27.91 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 176.468 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -92.09 143.86 26.02 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 127.619 3.075 . . . . 0.0 108.491 177.584 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tt -115.64 122.23 44.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.159 -172.724 . . . . . . . . 1 1 . 1 . 053 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.542 HG22 HD11 ' A' ' 8' ' ' LEU . 11.7 t -100.91 141.82 16.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 127.981 2.512 . . . . 0.0 108.347 176.529 . . . . . . . . 2 2 . 1 . 053 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 126.355 2.979 . . . . 0.0 109.492 -174.118 . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.9 ttp . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 115.818 -2.039 . . . . 0.0 107.086 . . . . . . . . . 0 0 . 1 . 054 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -90.87 146.17 24.14 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 126.036 2.085 . . . . 0.0 109.469 -169.134 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 6.0 pt -145.88 164.78 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 175.376 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -127.53 145.39 50.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 124.385 2.041 . . . . 0.0 107.937 -174.917 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -137.53 106.87 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 1 O-C-N 115.246 -4.659 . . . . 0.0 104.382 -177.908 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -77.34 126.67 31.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 124.567 2.127 . . . . 0.0 112.991 162.896 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -78.48 156.8 29.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.511 1.924 . . . . 0.0 109.266 177.468 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mt -50.47 -34.65 25.71 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 164.467 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.2 p -78.66 -11.91 59.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.735 2.014 . . . . 0.0 112.713 -176.086 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.25 -8.39 26.83 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 115.657 -2.746 . . . . 0.0 111.087 174.243 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -91.73 159.66 15.73 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.29 1.436 . . . . 0.0 109.765 -174.947 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -126.17 136.41 52.82 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 -178.127 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mt -102.79 159.81 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 1 C-N-CA 132.337 4.255 . . . . 0.0 106.647 163.956 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.33 3.3 t -135.4 149.98 49.78 Favored 'General case' 0 C--N 1.328 -0.34 1 C-N-CA 134.117 4.967 . . . . 0.0 112.526 168.831 . . . . . . . . 3 2 . 1 . 054 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mp -141.27 144.35 34.61 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -173.342 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.274 4.0 tp10 -99.71 128.04 45.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 125.322 1.639 . . . . 0.0 108.613 161.559 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.72 173.3 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 129.216 3.007 . . . . 0.0 114.976 173.05 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -103.2 148.19 35.29 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 128.148 2.579 . . . . 0.0 106.796 151.812 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -64.63 -14.13 42.83 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-O 116.499 -1.542 . . . . 0.0 112.006 172.457 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.5 m -86.98 1.53 52.47 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 127.782 3.176 . . . . 0.0 111.194 177.817 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -89.97 143.76 26.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 126.203 2.189 . . . . 0.0 106.959 175.075 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -82.76 162.56 21.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 126.245 2.926 . . . . 0.0 104.174 -168.548 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.27 -45.85 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 120.002 -1.686 . . . . 0.0 109.109 168.622 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.8 -33.58 10.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 124.266 1.984 . . . . 0.0 114.209 173.518 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.89 -34.96 67.0 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 117.106 -3.497 . . . . 0.0 112.282 176.174 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.62 -37.18 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 O-C-N 120.54 -1.35 . . . . 0.0 111.136 169.682 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -68.03 -39.8 83.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.766 -1.833 . . . . 0.0 113.449 172.922 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.35 77.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 172.689 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -72.32 -33.91 67.7 Favored 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 131.806 4.042 . . . . 0.0 111.756 175.457 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.6 mt -80.09 -39.82 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 118.502 -2.624 . . . . 0.0 116.582 169.1 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -44.03 -47.39 8.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 119.39 -2.068 . . . . 0.0 114.955 150.725 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -53.97 -45.0 71.26 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 178.085 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -107.58 -49.99 3.15 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 126.245 2.216 . . . . 0.0 107.924 -160.31 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -90.01 -38.35 13.67 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.099 1.76 . . . . 0.0 112.04 -174.172 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.2 9.38 24.06 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 116.622 -2.21 . . . . 0.0 112.865 169.641 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.64 124.53 69.28 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 119.99 1.895 . . . . 0.0 112.687 -170.722 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -54.19 135.78 65.84 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 124.316 3.344 . . . . 0.0 109.828 175.509 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.262 71.6 Cg_exo -41.59 -52.5 3.73 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.132 2.555 . . . . 0.0 117.858 170.083 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -40.82 -17.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 129.658 3.183 . . . . 0.0 114.834 167.39 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -136.04 30.71 3.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -167.068 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.297 13.1 pt20 -141.23 138.12 33.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 130.711 3.604 . . . . 0.0 110.648 168.671 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -138.34 120.92 16.19 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 118.377 -2.702 . . . . 0.0 104.282 175.507 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.59 150.35 23.1 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 119.835 -1.791 . . . . 0.0 109.706 177.037 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.8 mt -137.33 128.0 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -179.412 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -131.5 118.91 20.81 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 127.279 2.862 . . . . 0.0 108.214 179.107 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.21 13.34 7.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 130.754 3.622 . . . . 0.0 118.588 167.4 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.87 3.39 36.66 Favored Glycine 0 CA--C 1.536 1.379 1 C-N-CA 130.881 4.086 . . . . 0.0 114.581 -171.65 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -106.83 100.98 10.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 113.211 -3.28 . . . . 0.0 111.037 -177.517 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -63.29 108.56 1.33 Allowed 'General case' 0 C--N 1.325 -0.479 1 O-C-N 129.695 4.372 . . . . 0.0 106.445 169.122 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.14 147.88 46.21 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 125.789 1.931 . . . . 0.0 112.054 179.399 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 54' ' ' ARG . 3.8 mt-10 -116.39 137.61 52.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.04 2.136 . . . . 0.0 105.657 -178.502 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -43.89 136.46 3.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 138.179 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.44 -10.34 33.14 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 129.845 3.593 . . . . 0.0 115.832 -176.023 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 39.8 mtt-85 -123.58 -177.72 3.81 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 127.21 2.359 . . . . 0.0 109.385 -178.805 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -128.73 168.34 15.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.277 -175.174 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.5 mt -59.02 -29.29 67.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -178.873 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -65.45 -47.19 77.0 Favored 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 135.489 5.515 . . . . 0.0 115.659 172.736 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -47.13 -25.56 0.9 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 120.053 3.353 . . . . 0.0 120.053 170.855 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.466 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 72.3 m-85 -117.17 1.73 12.53 Favored 'General case' 0 C--O 1.238 0.473 1 C-N-CA 132.866 4.466 . . . . 0.0 115.291 177.958 . . . . . . . . 3 3 . 1 . 054 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.374 4.0 t30 66.89 49.13 1.21 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.375 1.47 . . . . 0.0 113.377 176.782 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mt -101.3 125.39 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 118.243 -2.786 . . . . 0.0 104.568 177.043 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -115.02 -166.7 1.14 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.243 -2.253 . . . . 0.0 111.152 172.635 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.257 58.9 tttt -41.84 125.78 2.95 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 118.939 2.941 . . . . 0.0 118.939 170.496 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.45 44.4 mt-10 75.84 18.1 2.16 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 165.776 . . . . . . . . 2 2 . 1 . 054 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 m -83.67 147.04 27.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.53 1.132 . . . . 0.0 108.782 -175.832 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -120.67 131.75 54.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 -174.466 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -111.7 162.09 15.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.084 2.553 . . . . 0.0 109.608 171.87 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -115.01 142.49 46.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 124.462 2.077 . . . . 0.0 110.496 162.537 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.3 133.52 52.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 119.374 -2.079 . . . . 0.0 106.232 -178.703 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.76 153.86 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.356 1.862 . . . . 0.0 110.897 161.507 . . . . . . . . 1 1 . 1 . 054 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.856 0 CA-C-O 116.735 -1.602 . . . . 0.0 107.975 -173.778 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttm . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 . . . . . . . . . 0 0 . 1 . 055 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -91.39 136.82 32.84 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.629 0.771 . . . . 0.0 111.639 175.382 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.478 HD11 HG11 ' A' ' 17' ' ' VAL . 16.6 pt -117.41 170.01 7.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 119.895 -1.753 . . . . 0.0 110.799 145.539 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.77 138.21 48.66 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 164.824 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 t -121.91 124.76 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 O-C-N 120.922 -1.111 . . . . 0.0 109.397 168.133 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -88.45 115.69 26.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.268 1.027 . . . . 0.0 111.89 -179.482 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 34.9 p -78.71 161.02 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 125.528 2.585 . . . . 0.0 109.378 171.675 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.04 -27.74 66.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.576 1.95 . . . . 0.0 113.634 -171.853 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p -69.0 -8.86 48.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 119.692 -1.88 . . . . 0.0 114.687 168.459 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.28 -6.09 30.27 Favored Glycine 0 N--CA 1.44 -1.039 0 O-C-N 120.179 -1.576 . . . . 0.0 112.106 172.197 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -73.85 125.28 27.8 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.36 2.264 . . . . 0.0 114.61 -176.423 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.3 57.0 m -95.69 106.19 18.26 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 101.029 -3.693 . . . . 0.0 101.029 176.906 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.9 mt -87.16 130.65 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 125.385 1.474 . . . . 0.0 110.265 173.036 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -90.26 105.63 17.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 127.697 3.123 . . . . 0.0 107.835 176.411 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.252 7.7 tp -108.51 152.31 24.9 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.827 2.051 . . . . 0.0 111.71 -178.147 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -95.93 143.15 27.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 163.3 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.478 HG11 HD11 ' A' ' 3' ' ' ILE . 16.0 m -134.05 150.94 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 129.586 3.154 . . . . 0.0 107.198 166.23 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.271 12.7 tp10 -89.39 141.92 29.3 Favored Pre-proline 0 N--CA 1.446 -0.649 0 O-C-N 127.649 3.093 . . . . 0.0 105.287 154.024 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.26 -19.73 6.91 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 N-CA-C 121.033 3.436 . . . . 0.0 121.033 170.837 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.276 20.7 p -99.2 1.57 44.97 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.664 -174.391 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 39.6 t0 -85.74 144.83 27.56 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 179.939 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.3 p -90.86 162.6 14.74 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.587 -2.571 . . . . 0.0 115.026 -174.278 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mm -52.69 -53.54 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 128.847 2.859 . . . . 0.0 107.89 -165.035 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -79.58 -21.12 45.44 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 114.129 -2.843 . . . . 0.0 112.053 -169.316 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -66.67 -47.68 71.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 123.52 2.873 . . . . 0.0 111.924 166.354 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.24 -34.52 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 130.889 3.676 . . . . 0.0 110.04 177.015 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -67.78 -35.67 79.09 Favored 'General case' 0 N--CA 1.451 -0.387 1 O-C-N 114.435 -5.166 . . . . 0.0 113.23 169.053 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.7 -22.22 46.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 130.408 3.483 . . . . 0.0 110.424 -179.22 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP . 43.9 mttp -64.46 -20.65 66.31 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 118.45 -2.656 . . . . 0.0 109.168 173.096 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mm -68.78 -19.71 24.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 117.361 -3.337 . . . . 0.0 117.243 167.279 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -74.65 -35.81 62.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 113.664 -3.065 . . . . 0.0 107.911 -165.175 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.307 27.9 t70 -30.69 -53.58 0.19 Allowed 'General case' 0 N--CA 1.441 -0.902 1 C-N-CA 132.099 4.159 . . . . 0.0 110.421 154.715 . . . . . . . . 3 2 . 1 . 055 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -89.02 -48.17 7.61 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 127.294 2.871 . . . . 0.0 116.842 -178.066 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -102.79 -36.03 8.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 125.221 1.576 . . . . 0.0 108.617 -160.891 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.15 13.47 58.79 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 115.21 -2.994 . . . . 0.0 117.529 171.28 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mm -97.55 142.55 24.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 112.516 -3.611 . . . . 0.0 108.411 -172.985 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -60.6 139.38 85.64 Favored 'Trans proline' 0 N--CA 1.453 -0.897 1 C-N-CA 126.522 4.815 . . . . 0.0 116.853 170.153 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.76 -27.81 37.5 Favored 'Trans proline' 0 N--CA 1.456 -0.729 1 C-N-CA 126.544 4.829 . . . . 0.0 113.31 -172.978 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.18 -38.23 82.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 119.916 -1.74 . . . . 0.0 115.052 166.167 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -73.99 -29.67 62.09 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 118.178 -2.826 . . . . 0.0 117.029 176.886 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -75.44 149.44 38.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.106 2.562 . . . . 0.0 114.557 164.173 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -131.44 150.01 52.31 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 128.234 2.614 . . . . 0.0 104.661 157.05 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.496 ' CD1' HD12 ' A' ' 50' ' ' LEU 0.465 0.4 OUTLIER -120.46 148.62 43.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 124.327 2.013 . . . . 0.0 112.73 158.66 . . . . . . . . 4 4 . 1 . 055 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -104.62 154.29 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 1 C-N-CA 134.504 5.122 . . . . 0.0 108.924 176.601 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -162.6 135.0 5.55 Favored 'General case' 0 C--N 1.321 -0.638 1 C-N-CA 132.313 4.245 . . . . 0.0 103.589 163.015 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 76.37 43.21 0.15 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.012 1.325 . . . . 0.0 109.554 163.504 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.51 22.63 46.23 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 129.754 3.55 . . . . 0.0 118.481 -176.655 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.322 37.4 pttt -162.06 170.13 19.76 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.658 1.583 . . . . 0.0 112.128 -179.397 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.306 27.2 mp0 -93.77 139.73 30.5 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.386 -161.563 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.496 HD12 ' CD1' ' A' ' 43' ' ' LEU . 14.2 mt -94.46 162.14 13.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.639 1.975 . . . . 0.0 109.513 179.01 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -150.93 151.3 31.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 119.294 -2.128 . . . . 0.0 110.366 -173.374 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -44.77 133.98 5.82 Favored 'General case' 0 C--N 1.327 -0.413 1 C-N-CA 134.039 4.936 . . . . 0.0 112.267 -177.341 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.35 -19.94 28.61 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 114.084 -3.62 . . . . 0.0 111.354 151.718 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -94.07 155.86 16.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 127.572 2.572 . . . . 0.0 107.518 172.361 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -76.2 163.98 26.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.801 2.44 . . . . 0.0 112.739 -178.514 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.9 mt -43.85 -43.47 6.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 130.178 3.391 . . . . 0.0 109.229 159.897 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -71.35 -37.67 71.67 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 118.701 -2.5 . . . . 0.0 114.889 -175.525 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -59.71 -36.19 76.05 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 127.139 2.176 . . . . 0.0 107.877 178.891 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.282 13.9 m-85 -97.83 11.94 35.59 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.591 1.556 . . . . 0.0 110.995 175.907 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.623 0.1 OUTLIER 67.56 25.97 8.22 Favored 'General case' 0 C--O 1.222 -0.374 1 O-C-N 115.566 -4.458 . . . . 0.0 121.512 165.016 . . . . . . . . 4 3 . 1 . 055 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -76.61 93.29 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 128.628 2.771 . . . . 0.0 104.973 174.305 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.302 8.3 mm-40 -99.4 -169.67 1.79 Allowed 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 128.089 3.368 . . . . 0.0 102.344 174.938 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.419 16.1 ptpt -43.64 122.23 2.63 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 130.808 3.643 . . . . 0.0 116.729 169.601 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 4.2 tp10 83.13 33.98 0.06 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.946 2.099 . . . . 0.0 112.493 175.198 . . . . . . . . 2 2 . 1 . 055 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -96.91 138.38 34.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.125 2.97 . . . . 0.0 108.237 -176.6 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -118.26 141.19 48.77 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 173.865 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.0 158.82 16.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 116.9 -3.625 . . . . 0.0 111.718 166.171 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -135.07 136.11 41.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 175.195 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 mt -86.64 154.7 20.82 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 178.106 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 t -141.39 133.55 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 128.713 2.805 . . . . 0.0 106.525 -178.734 . . . . . . . . 1 1 . 1 . 055 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.446 -0.67 0 CA-C-N 123.027 2.649 . . . . 0.0 108.438 -179.637 . . . . . . . . 0 0 . 1 . 056 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.309 14.2 ptt? . . . . . 0 N--CA 1.471 0.579 0 CA-C-O 117.872 -1.061 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -79.3 153.25 30.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 115.739 -2.077 . . . . 0.0 111.602 163.896 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.291 31.4 pt -134.22 -177.39 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 129.292 3.037 . . . . 0.0 103.934 164.417 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -142.0 139.44 32.39 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 128.631 2.773 . . . . 0.0 104.544 170.954 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.29 109.31 25.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 131.266 3.826 . . . . 0.0 101.59 179.45 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -87.51 122.29 31.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 101.057 -3.683 . . . . 0.0 101.057 170.221 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.5 p -65.72 160.26 23.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 128.384 2.673 . . . . 0.0 111.119 161.967 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tt -44.84 -39.55 5.43 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 120.169 3.396 . . . . 0.0 120.169 172.941 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 p -90.87 -9.69 45.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.811 2.044 . . . . 0.0 111.715 -176.075 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.72 7.39 17.89 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.775 0.702 . . . . 0.0 111.675 165.847 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -76.5 130.92 38.63 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.808 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -112.87 146.76 38.35 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.625 2.37 . . . . 0.0 106.023 -174.071 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 pt -143.89 146.6 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 127.091 2.745 . . . . 0.0 105.737 173.158 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.9 m -89.14 132.59 34.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 129.702 3.201 . . . . 0.0 104.635 168.876 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 mt -108.86 153.27 23.76 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.047 1.739 . . . . 0.0 109.659 151.966 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -103.21 111.57 24.01 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 111.684 -2.507 . . . . 0.0 111.47 164.873 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.23 138.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.512 1.525 . . . . 0.0 106.89 -174.944 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -77.77 147.01 73.64 Favored Pre-proline 0 N--CA 1.446 -0.645 0 O-C-N 118.753 -2.467 . . . . 0.0 109.61 154.361 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.06 -22.35 74.43 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 N-CA-C 119.651 2.904 . . . . 0.0 119.651 -174.25 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 0.3 OUTLIER -81.18 -12.5 59.17 Favored 'General case' 0 N--CA 1.442 -0.861 1 C-N-CA 131.792 4.037 . . . . 0.0 112.226 177.889 . . . . . . . . 4 3 . 1 . 056 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.06 119.65 17.59 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 119.614 -1.929 . . . . 0.0 107.196 -172.65 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.5 p -66.3 167.83 9.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 121.524 1.965 . . . . 0.0 106.245 -167.797 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -54.18 -37.72 36.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -177.876 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -71.02 -28.66 64.57 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.182 0.992 . . . . 0.0 112.626 -174.92 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.41 -22.35 66.77 Favored 'General case' 0 N--CA 1.451 -0.416 1 CA-C-O 110.544 -4.55 . . . . 0.0 112.802 175.855 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.39 -45.32 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 131.139 3.776 . . . . 0.0 109.749 177.622 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.286 37.5 pttt -75.34 -23.65 57.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 123.904 1.811 . . . . 0.0 113.332 -178.504 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -34.2 75.3 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.159 2.584 . . . . 0.0 108.337 -179.549 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -73.58 -53.87 9.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 127.777 3.173 . . . . 0.0 107.277 176.011 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.43 65.4 mt -38.81 -54.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 125.807 2.718 . . . . 0.0 117.821 -179.675 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -65.08 -20.72 66.61 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 118.586 -2.571 . . . . 0.0 116.253 -179.385 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.256 36.0 t70 -90.37 -24.87 20.69 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 121.672 2.033 . . . . 0.0 107.517 175.492 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -97.33 -50.64 4.47 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 113.646 -3.073 . . . . 0.0 107.371 -164.17 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -129.18 12.21 6.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 115.647 -2.12 . . . . 0.0 109.929 -179.929 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.74 -3.19 86.08 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 126.674 2.083 . . . . 0.0 116.523 154.292 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -72.69 107.64 3.37 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 130.347 3.459 . . . . 0.0 106.439 177.352 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.97 160.61 36.8 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.47 2.113 . . . . 0.0 116.545 -177.711 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.317 5.6 Cg_endo -50.69 -35.34 47.12 Favored 'Trans proline' 0 N--CA 1.44 -1.668 1 C-N-CA 130.13 7.22 . . . . 0.0 114.027 167.845 . . . . . . . . 3 2 . 1 . 056 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.67 -18.98 63.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 116.185 1.921 . . . . 0.0 116.185 175.312 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -123.38 14.32 9.6 Favored 'General case' 0 N--CA 1.443 -0.791 1 O-C-N 115.598 -4.439 . . . . 0.0 110.037 -176.083 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.343 0.3 OUTLIER -101.85 126.29 48.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 118.814 -2.429 . . . . 0.0 107.364 -161.967 . . . . . . . . 3 3 . 1 . 056 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -131.74 108.02 9.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 168.657 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.8 mt -93.21 126.66 38.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.002 -1.475 . . . . 0.0 108.392 179.572 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 pt -128.9 144.25 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 119.454 1.025 . . . . 0.0 113.046 -178.004 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -137.08 133.74 35.72 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 169.116 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.11 20.59 11.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 120.873 1.67 . . . . 0.0 111.488 166.681 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.49 -21.12 42.58 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.305 0.957 . . . . 0.0 112.723 -174.483 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -80.63 146.16 31.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -176.324 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -99.99 123.99 44.84 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 175.822 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mt -71.4 115.82 11.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 124.663 2.173 . . . . 0.0 109.951 -171.022 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -82.84 133.31 35.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.421 2.688 . . . . 0.0 112.767 175.317 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -41.89 143.29 0.56 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 130.893 3.677 . . . . 0.0 115.474 174.009 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.96 50.27 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 111.789 -2.459 . . . . 0.0 112.809 164.729 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -74.35 140.45 44.82 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 118.367 -2.843 . . . . 0.0 107.28 175.206 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -68.43 139.47 55.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 126.503 2.377 . . . . 0.0 109.048 160.947 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.2 mt -53.11 -30.08 34.57 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.666 1.586 . . . . 0.0 113.974 174.451 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 t -74.68 -35.82 62.78 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.911 2.085 . . . . 0.0 112.383 -176.992 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -60.35 -17.77 45.62 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 167.799 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.06 12.66 35.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 120.037 3.347 . . . . 0.0 120.037 167.434 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 73.64 21.22 2.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 124.811 2.243 . . . . 0.0 115.375 169.542 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.2 mm -78.32 135.01 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -179.517 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -112.89 170.54 8.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.008 178.347 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.3 140.4 17.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 118.469 -2.644 . . . . 0.0 111.246 169.364 . . . . . . . . 2 2 . 1 . 056 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.494 0.6 OUTLIER 68.89 1.29 3.07 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 117.122 2.268 . . . . 0.0 117.122 163.708 . . . . . . . . 3 3 . 1 . 056 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -54.98 146.04 18.8 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 118.853 2.908 . . . . 0.0 118.853 169.048 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.5 m -102.24 105.66 16.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -179.547 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.69 162.19 13.16 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.121 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -113.24 132.87 55.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 127.542 3.026 . . . . 0.0 109.116 -178.383 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -105.59 110.97 23.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 129.044 2.938 . . . . 0.0 104.979 169.716 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.38 118.82 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 O-C-N 118.74 -2.475 . . . . 0.0 104.744 172.6 . . . . . . . . 1 1 . 1 . 056 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.7 mt . . . . . 0 N--CA 1.445 -0.691 0 C-N-CA 128.629 2.772 . . . . 0.0 110.861 163.728 . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 057 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -102.1 141.29 35.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.775 2.43 . . . . 0.0 111.343 176.26 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 pt -133.38 144.62 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 110.964 -2.834 . . . . 0.0 108.305 164.506 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -93.84 141.03 28.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 173.556 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.1 t -120.99 122.66 68.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 123.067 2.667 . . . . 0.0 105.039 170.165 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -89.17 124.49 34.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 122.146 2.248 . . . . 0.0 106.941 176.891 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.328 82.7 p -99.59 -166.84 1.39 Allowed 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 118.201 -2.812 . . . . 0.0 114.715 -172.855 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.443 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 7.5 mp -43.27 -33.62 1.01 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 119.695 3.22 . . . . 0.0 119.695 -177.745 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -110.26 -4.82 15.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.175 2.19 . . . . 0.0 112.493 -178.549 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.34 -1.72 67.28 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 179.585 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.59 127.44 31.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 129.305 3.042 . . . . 0.0 104.616 173.352 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -90.76 131.91 36.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.943 1.402 . . . . 0.0 108.236 -179.841 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.577 HD13 ' HB2' ' A' ' 34' ' ' GLU . 12.1 pt -117.49 136.07 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 123.739 1.733 . . . . 0.0 107.038 170.302 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.9 m -88.81 112.02 22.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 113.07 -3.348 . . . . 0.0 111.376 179.895 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.03 129.27 49.76 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 101.725 -3.435 . . . . 0.0 101.725 -175.987 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -82.93 133.68 35.1 Favored 'General case' 0 C--O 1.222 -0.361 1 C-N-CA 132.324 4.25 . . . . 0.0 103.925 164.262 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.91 169.06 8.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 109.832 -3.349 . . . . 0.0 108.687 -176.739 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -128.27 157.65 73.78 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.858 169.401 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -69.45 -6.73 19.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 125.115 3.876 . . . . 0.0 114.953 -174.629 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.7 p -86.31 -13.41 46.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 129.006 2.922 . . . . 0.0 112.804 167.223 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -69.29 131.72 45.31 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 122.419 2.372 . . . . 0.0 115.069 -179.149 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 p -91.36 169.2 11.0 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.066 1.746 . . . . 0.0 113.285 172.003 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.2 -17.78 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.733 178.531 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -62.75 -47.08 85.09 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 118.146 -2.846 . . . . 0.0 112.756 160.91 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -70.03 -26.12 63.89 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.786 -178.459 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -90.49 -33.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 113.02 -3.372 . . . . 0.0 107.399 -172.656 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -43.0 -44.55 4.72 Favored 'General case' 0 C--N 1.322 -0.629 1 C-N-CA 132.681 4.392 . . . . 0.0 112.841 167.795 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.08 -17.39 55.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 114.788 -2.529 . . . . 0.0 115.727 178.295 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -90.64 -22.47 21.18 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 121.54 1.973 . . . . 0.0 107.554 172.27 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.7 mt -67.21 -37.96 80.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.432 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -51.17 -42.8 61.08 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.581 2.752 . . . . 0.0 114.509 169.746 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.61 -55.24 25.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 163.982 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -80.77 -17.91 49.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -170.643 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.577 ' HB2' HD13 ' A' ' 13' ' ' ILE 0.427 25.7 tp10 -135.62 -8.7 2.17 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 121.61 3.93 . . . . 0.0 121.61 171.361 . . . . . . . . 3 3 . 1 . 057 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.69 7.68 68.56 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 116.496 -3.877 . . . . 0.0 117.208 173.842 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mm -91.37 123.45 63.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 C-N-CA 130.051 3.34 . . . . 0.0 106.524 -170.985 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.324 72.9 Cg_endo -67.32 154.0 75.32 Favored 'Trans proline' 0 N--CA 1.454 -0.852 1 C-N-CA 128.095 5.863 . . . . 0.0 109.725 170.663 . . . . . . . . 3 2 . 1 . 057 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.18 -22.59 53.78 Favored 'Trans proline' 0 N--CA 1.448 -1.192 1 C-N-CA 125.313 4.009 . . . . 0.0 115.833 -164.046 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.02 -8.0 52.61 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 124.405 1.066 . . . . 0.0 110.317 -164.061 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -110.41 -9.85 14.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 118.128 -2.858 . . . . 0.0 113.573 -172.33 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.263 73.4 mt-30 -88.17 121.75 30.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.829 1.652 . . . . 0.0 106.869 -172.222 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -102.59 100.21 10.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 112.632 -2.076 . . . . 0.0 108.594 170.395 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.6 mt -90.63 126.31 35.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 119.589 -1.944 . . . . 0.0 111.842 177.443 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.1 mt -132.35 139.7 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.217 2.207 . . . . 0.0 110.853 -168.382 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -162.65 112.8 1.45 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 129.316 3.046 . . . . 0.0 112.39 -174.242 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.09 36.19 14.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 128.426 3.965 . . . . 0.0 118.496 177.292 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.08 -10.12 43.6 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 108.508 -3.951 . . . . 0.0 109.638 167.233 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -92.41 120.06 32.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 130.351 3.46 . . . . 0.0 111.448 -178.749 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -79.16 119.27 22.02 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.997 2.519 . . . . 0.0 109.055 165.028 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -79.01 129.18 34.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -158.86 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -82.77 153.44 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -172.425 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -80.47 126.57 31.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.475 170.982 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.35 -3.97 18.07 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-O 115.722 -2.71 . . . . 0.0 110.433 -172.507 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -103.14 155.85 18.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 120.652 2.226 . . . . 0.0 108.547 -167.931 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.2 p -95.98 141.43 29.4 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.61 2.364 . . . . 0.0 109.346 168.017 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.4 mt -51.23 -38.56 53.19 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 129.919 3.288 . . . . 0.0 111.696 -178.567 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -74.83 -20.44 59.76 Favored 'General case' 0 C--O 1.217 -0.624 0 O-C-N 120.103 -1.623 . . . . 0.0 111.573 -176.666 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -79.8 -25.47 40.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.371 2.268 . . . . 0.0 110.001 -178.463 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -85.86 -17.67 34.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 123.204 1.478 . . . . 0.0 114.895 166.453 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 83.17 48.45 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.867 1.667 . . . . 0.0 111.112 173.923 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.9 mt -107.18 102.97 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 1 N-CA-C 99.844 -4.132 . . . . 0.0 99.844 -174.943 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.94 154.39 24.57 Favored 'General case' 0 CA--C 1.54 0.592 1 O-C-N 130.168 4.667 . . . . 0.0 113.28 167.136 . . . . . . . . 3 3 . 1 . 057 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.397 0.0 OUTLIER -38.15 133.36 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 130.896 3.678 . . . . 0.0 118.069 170.438 . . . . . . . . 3 3 . 1 . 057 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.449 15.0 mt-10 80.58 1.49 1.86 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 125.331 3.696 . . . . 0.0 112.381 -179.866 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.2 m -67.81 145.42 54.68 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 126.284 2.24 . . . . 0.0 112.385 172.428 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -108.51 114.83 28.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 101.673 -3.454 . . . . 0.0 101.673 179.132 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -98.56 155.14 17.43 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.435 1.494 . . . . 0.0 108.009 177.136 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -105.83 146.57 29.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 114.817 -2.516 . . . . 0.0 108.467 178.767 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -125.81 134.73 51.59 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.011 1.725 . . . . 0.0 108.745 177.065 . . . . . . . . 1 1 . 1 . 057 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -129.59 164.46 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 1 C-N-CA 132.445 4.298 . . . . 0.0 105.642 179.719 . . . . . . . . 2 2 . 1 . 057 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 114.271 -2.776 . . . . 0.0 105.85 -171.35 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptt? . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 . . . . . . . . . 0 0 . 1 . 058 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -104.12 137.03 42.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 118.553 -2.592 . . . . 0.0 106.825 177.2 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 3' ' ' ILE . 4.2 pt -132.41 155.11 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 129.898 3.279 . . . . 0.0 105.908 174.709 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -118.77 143.89 46.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.296 2.238 . . . . 0.0 111.737 176.8 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -126.94 115.83 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 112.069 -3.824 . . . . 0.0 108.64 178.529 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -90.78 120.91 32.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 113.596 -3.097 . . . . 0.0 114.031 175.704 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.758 HG22 HD12 ' A' ' 69' ' ' LEU . 81.8 p -80.99 160.91 24.46 Favored 'General case' 0 N--CA 1.448 -0.552 1 O-C-N 129.15 4.031 . . . . 0.0 112.815 164.039 . . . . . . . . 3 3 . 1 . 058 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -45.21 93.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 -172.53 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.261 55.7 p -59.49 -17.18 29.45 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 166.931 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.07 -0.99 6.68 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.291 1.9 . . . . 0.0 108.88 154.048 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -74.58 141.67 44.72 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 119.272 -2.311 . . . . 0.0 111.31 -167.727 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.9 m -120.11 121.63 39.26 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 125.343 1.652 . . . . 0.0 111.019 -166.437 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.65 156.63 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 114.847 -2.502 . . . . 0.0 108.284 175.055 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.388 6.6 t -126.17 124.99 41.73 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 127.47 2.981 . . . . 0.0 111.095 174.693 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.84 150.11 43.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 124.441 2.067 . . . . 0.0 106.269 -171.676 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -106.82 110.98 23.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.012 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.9 136.69 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 109.16 -3.655 . . . . 0.0 109.902 -173.114 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -95.38 139.35 21.95 Favored Pre-proline 0 N--CA 1.445 -0.714 0 CA-C-O 113.78 -3.009 . . . . 0.0 106.323 169.844 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.258 23.5 Cg_exo -53.75 -29.93 54.34 Favored 'Trans proline' 0 N--CA 1.454 -0.837 1 C-N-CA 125.63 4.22 . . . . 0.0 115.103 -173.325 . . . . . . . . 3 2 . 1 . 058 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -78.94 -4.05 47.92 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 123.314 2.779 . . . . 0.0 112.627 177.873 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.61 147.13 39.82 Favored 'General case' 0 C--N 1.328 -0.354 1 O-C-N 114.749 -4.97 . . . . 0.0 110.999 -175.585 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -92.03 162.17 14.48 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.346 1.058 . . . . 0.0 108.635 -171.195 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 mm -56.52 -26.72 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 O-C-N 126.684 2.49 . . . . 0.0 113.821 -174.589 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.367 9.4 pt-20 -65.32 -34.76 79.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.375 2.67 . . . . 0.0 114.463 172.663 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -77.95 -29.49 49.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 125.545 2.593 . . . . 0.0 108.866 -176.271 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.357 31.2 m -82.47 -35.11 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 O-C-N 116.738 -3.727 . . . . 0.0 106.934 178.622 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -55.26 -46.19 76.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 116.548 -3.845 . . . . 0.0 114.0 170.816 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.281 . . -77.27 -18.77 57.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 126.382 2.991 . . . . 0.0 114.279 -174.62 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -82.35 -43.62 17.2 Favored 'General case' 0 C--N 1.322 -0.625 1 O-C-N 116.11 -4.119 . . . . 0.0 107.257 -179.476 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.423 12.1 mt -45.51 -46.78 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 128.076 2.55 . . . . 0.0 113.205 160.389 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -59.69 -50.23 74.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 117.901 -2.999 . . . . 0.0 116.794 172.71 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.452 34.7 t70 -53.08 -33.03 50.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.706 2.802 . . . . 0.0 110.721 178.099 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -80.74 -65.71 0.98 Allowed 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 113.204 -3.284 . . . . 0.0 113.621 172.707 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -97.45 -27.15 14.58 Favored 'General case' 0 N--CA 1.445 -0.724 1 O-C-N 129.645 4.34 . . . . 0.0 118.965 -165.757 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.24 7.65 59.31 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 128.531 2.967 . . . . 0.0 114.962 -179.539 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.529 HD12 HD21 ' A' ' 71' ' ' LEU . 10.7 mm -82.1 122.35 79.56 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 116.999 -3.647 . . . . 0.0 110.474 -174.394 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 96.8 Cg_endo -70.88 120.9 7.41 Favored 'Trans proline' 0 N--CA 1.443 -1.494 1 C-N-CA 128.6 6.2 . . . . 0.0 113.346 -174.95 . . . . . . . . 3 3 . 1 . 058 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 37' ' ' PRO 0.278 77.5 Cg_exo -34.49 -46.79 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.688 1 C-N-CA 128.468 6.112 . . . . 0.0 116.037 -169.545 . . . . . . . . 4 3 . 1 . 058 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.289 0.5 OUTLIER -55.63 -42.59 75.16 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 116.306 -3.996 . . . . 0.0 116.258 178.609 . . . . . . . . 3 3 . 1 . 058 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -79.45 -2.88 43.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.233 0.613 . . . . 0.0 112.63 -177.196 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -85.97 141.71 29.33 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 116.662 -3.774 . . . . 0.0 108.852 173.427 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -145.29 104.6 3.95 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 111.18 -2.736 . . . . 0.0 106.071 -172.375 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -96.43 112.37 24.14 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 119.31 -2.119 . . . . 0.0 107.561 -173.373 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mt -85.47 141.9 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.011 -1.681 . . . . 0.0 110.82 168.905 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.482 ' CE2' HG23 ' A' ' 61' ' ' ILE . 14.1 t80 -147.1 119.01 8.12 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 102.253 -3.24 . . . . 0.0 102.253 164.035 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.2 22.43 11.0 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 120.957 3.688 . . . . 0.0 120.957 164.056 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.41 -22.7 38.8 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 127.414 2.435 . . . . 0.0 112.581 -175.065 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -97.1 147.26 24.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 118.189 -2.948 . . . . 0.0 107.866 -177.559 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -92.38 133.32 35.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 126.762 2.539 . . . . 0.0 104.216 163.674 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -70.11 109.9 4.85 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 118.189 -2.819 . . . . 0.0 114.801 168.862 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -74.02 147.23 43.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.297 2.639 . . . . 0.0 112.234 -176.754 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -81.26 147.96 29.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 126.8 2.562 . . . . 0.0 104.585 -166.23 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.46 -36.79 3.94 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 116.739 -2.145 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -76.26 169.99 17.18 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 127.057 3.313 . . . . 0.0 107.939 -174.849 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -103.25 174.75 5.73 Favored 'General case' 0 N--CA 1.452 -0.349 2 O-C-N 112.911 -6.118 . . . . 0.0 113.141 163.003 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.36 -29.04 41.98 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.865 1.666 . . . . 0.0 110.273 -177.336 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -71.13 -32.6 69.18 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 117.526 -1.226 . . . . 0.0 110.009 -177.579 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.09 -22.79 55.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 115.364 -2.255 . . . . 0.0 110.537 174.85 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -86.9 0.32 55.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.056 171.974 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t30 28.62 61.95 0.12 Allowed 'General case' 0 N--CA 1.445 -0.723 1 C-N-CA 138.845 6.858 . . . . 0.0 112.253 175.114 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.482 HG23 ' CE2' ' A' ' 45' ' ' PHE . 13.8 mt -98.55 -34.96 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 128.348 2.659 . . . . 0.0 105.433 -170.707 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.463 13.1 mm-40 82.12 -158.77 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.531 1.133 . . . . 0.0 112.608 178.109 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -81.65 158.33 24.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.311 3.045 . . . . 0.0 115.14 -176.077 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.309 4.1 tt0 66.52 11.75 8.28 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 128.634 2.774 . . . . 0.0 118.457 161.254 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -105.23 144.47 31.97 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 116.979 -1.486 . . . . 0.0 112.155 -162.515 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -103.41 106.72 17.3 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 122.228 2.286 . . . . 0.0 108.229 -166.726 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -75.64 153.68 37.08 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.264 164.864 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -117.3 95.05 4.8 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 129.102 2.961 . . . . 0.0 107.707 -172.096 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 7' ' ' THR . 1.2 tm? -63.85 118.16 7.97 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.253 2.221 . . . . 0.0 106.918 166.645 . . . . . . . . 2 2 . 1 . 058 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -125.66 150.9 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 167.21 . . . . . . . . 1 1 . 1 . 058 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.529 HD21 HD12 ' A' ' 36' ' ' ILE . 2.4 mp . . . . . 0 C--N 1.324 -0.5 0 CA-C-O 117.017 -1.468 . . . . 0.0 110.871 -172.051 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttp . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 . . . . . . . . . 0 0 . 1 . 059 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -96.18 142.17 28.68 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.854 2.462 . . . . 0.0 108.598 -174.744 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.5 pt -130.82 177.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 128.748 2.819 . . . . 0.0 111.32 161.944 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -100.71 144.68 29.39 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.253 1.421 . . . . 0.0 109.618 163.177 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.9 t -116.76 150.47 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 121.765 2.075 . . . . 0.0 105.494 158.791 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -137.85 145.87 42.77 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 128.476 2.71 . . . . 0.0 111.438 -178.363 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -106.85 163.84 12.62 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 126.797 2.561 . . . . 0.0 112.197 173.183 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.55 -33.77 75.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 122.071 2.214 . . . . 0.0 110.964 171.351 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -75.2 -17.09 60.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 121.721 2.055 . . . . 0.0 111.553 167.153 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.68 36.45 6.46 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 118.145 2.018 . . . . 0.0 118.145 156.129 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -77.54 116.65 18.27 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 117.604 -3.292 . . . . 0.0 104.116 158.93 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.257 12.8 m -93.93 157.86 15.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 114.548 -2.644 . . . . 0.0 111.298 167.939 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -154.68 152.66 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 126.076 2.11 . . . . 0.0 113.34 177.508 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.9 m -83.28 131.47 35.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 130.581 3.552 . . . . 0.0 107.113 166.033 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.86 121.53 21.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 119.065 -2.272 . . . . 0.0 110.309 -177.362 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.348 3.5 tt0 -99.35 128.8 45.5 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 -172.06 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.2 t -140.82 137.09 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 114.138 -2.839 . . . . 0.0 107.414 -171.446 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -90.32 138.47 27.11 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 126.745 2.528 . . . . 0.0 106.383 171.644 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.264 94.2 Cg_exo -45.09 -23.1 0.91 Allowed 'Trans proline' 0 N--CA 1.439 -1.703 1 C-N-CA 126.001 4.467 . . . . 0.0 120.906 167.303 . . . . . . . . 3 2 . 1 . 059 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 15.2 m -77.52 -13.84 59.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.77 1.628 . . . . 0.0 111.413 176.324 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.2 130.89 34.94 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 120.763 1.619 . . . . 0.0 107.82 179.265 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -69.73 174.73 4.81 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.94 162.369 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 23' ' ' ILE 0.25 24.7 mt -61.42 -44.76 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 128.426 2.69 . . . . 0.0 109.62 169.731 . . . . . . . . 3 3 . 1 . 059 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.81 -38.33 64.45 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 128.858 2.863 . . . . 0.0 110.212 175.997 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -73.15 -34.6 66.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 116.422 -1.751 . . . . 0.0 113.276 177.165 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 57.9 t -62.29 -37.42 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 125.185 3.63 . . . . 0.0 108.79 168.683 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 74.5 mttt -66.1 -40.61 90.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.507 1.754 . . . . 0.0 115.158 171.41 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.4 87.53 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.554 1.942 . . . . 0.0 112.88 171.251 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 48.9 mttp -67.81 -41.49 83.04 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 123.628 1.68 . . . . 0.0 111.041 173.567 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.273 94.2 mt -55.55 -58.07 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 1 O-C-N 115.622 -4.424 . . . . 0.0 110.141 168.526 . . . . . . . . 3 2 . 1 . 059 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -45.37 -37.61 5.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 165.278 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.13 -45.14 42.92 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.727 2.011 . . . . 0.0 113.786 177.504 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 mmtm -107.51 -35.03 6.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -166.214 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.3 -30.56 18.36 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.868 2.867 . . . . 0.0 110.411 179.495 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.13 52.73 6.6 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 125.885 1.707 . . . . 0.0 111.479 174.012 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.62 145.43 33.86 Favored Pre-proline 0 N--CA 1.447 -0.595 0 C-N-CA 129.913 3.285 . . . . 0.0 112.31 -178.782 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.09 128.29 12.1 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 124.92 3.747 . . . . 0.0 116.788 162.572 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 4.9 Cg_endo -75.33 -46.9 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.791 3.661 . . . . 0.0 108.734 -165.522 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.261 23.6 t70 -34.25 -33.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.452 1 C-N-CA 132.391 4.276 . . . . 0.0 119.518 -176.256 . . . . . . . . 3 2 . 1 . 059 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -85.89 -22.27 27.59 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.028 1.731 . . . . 0.0 114.26 175.418 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -98.82 145.79 26.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -160.627 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -118.16 154.39 32.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 118.244 -2.785 . . . . 0.0 110.296 172.625 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HB3' HD11 ' A' ' 67' ' ' LEU . 2.3 mp -108.29 135.45 49.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 167.056 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.1 mm -122.41 129.41 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 128.304 2.641 . . . . 0.0 106.51 175.457 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.497 ' CE1' HG12 ' A' ' 61' ' ' ILE . 44.6 t80 -138.44 131.3 29.57 Favored 'General case' 0 C--O 1.221 -0.421 1 C-N-CA 132.371 4.268 . . . . 0.0 108.057 172.365 . . . . . . . . 3 3 . 1 . 059 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.78 31.96 21.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 130.115 3.366 . . . . 0.0 115.404 -166.895 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.79 15.0 81.01 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 128.419 2.914 . . . . 0.0 111.413 179.204 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -144.37 156.66 44.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 124.112 3.956 . . . . 0.0 113.565 -171.496 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.83 120.35 20.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 126.077 2.846 . . . . 0.0 104.369 -173.345 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.45 66.9 mt -86.05 157.2 20.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 111.366 -2.652 . . . . 0.0 108.769 -178.6 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -91.79 132.99 36.02 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.274 -1.517 . . . . 0.0 107.653 -168.899 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.01 114.57 14.8 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.738 -1.226 . . . . 0.0 109.926 -166.961 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.83 -6.75 11.15 Favored Glycine 0 CA--C 1.522 0.483 0 O-C-N 117.968 -2.958 . . . . 0.0 110.47 -173.733 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -79.21 161.42 26.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 124.509 2.1 . . . . 0.0 112.31 174.67 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 p -91.25 176.87 6.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 114.012 -2.899 . . . . 0.0 112.747 167.472 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.3 tp -75.05 -28.88 60.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.613 2.365 . . . . 0.0 111.542 -173.743 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -80.11 -23.84 40.95 Favored 'General case' 0 N--CA 1.449 -0.501 1 O-C-N 115.822 -4.299 . . . . 0.0 117.138 174.2 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -67.44 -26.07 66.22 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 172.221 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -93.76 -9.22 38.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.72 2.008 . . . . 0.0 112.647 159.185 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 p30 50.99 51.7 16.53 Favored 'General case' 0 N--CA 1.45 -0.468 1 C-N-CA 131.82 4.048 . . . . 0.0 112.019 -177.997 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.497 HG12 ' CE1' ' A' ' 45' ' ' PHE . 21.5 mt -71.25 110.43 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 127.912 2.485 . . . . 0.0 109.675 162.067 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -96.34 174.41 6.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.866 -1.97 . . . . 0.0 107.981 -171.744 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -37.46 137.97 0.37 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 120.077 3.362 . . . . 0.0 120.077 162.825 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 9.4 tt0 57.25 35.01 25.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.908 3.283 . . . . 0.0 114.461 179.755 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -91.07 158.96 16.37 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.451 1.5 . . . . 0.0 111.31 174.595 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.6 m -112.35 115.63 29.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 123.036 1.398 . . . . 0.0 110.026 171.991 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.461 HD11 ' HB3' ' A' ' 43' ' ' LEU . 19.3 tp -89.43 141.32 28.67 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 127.152 3.358 . . . . 0.0 102.848 162.187 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -108.1 136.56 47.58 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 -177.819 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.292 13.7 tp -115.17 95.3 5.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.206 -172.997 . . . . . . . . 2 2 . 1 . 059 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.13 110.22 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 126.81 2.044 . . . . 0.0 108.203 171.171 . . . . . . . . 1 1 . 1 . 059 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.299 2.9 mm? . . . . . 0 N--CA 1.448 -0.539 0 CA-C-N 121.108 1.776 . . . . 0.0 109.237 179.327 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -82.52 146.45 29.21 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.003 2.121 . . . . 0.0 107.154 -174.812 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -142.23 161.7 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 121.798 2.09 . . . . 0.0 108.702 166.553 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -100.85 144.1 30.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.981 1.426 . . . . 0.0 113.757 162.305 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.9 t -110.19 115.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 159.091 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -89.32 137.04 32.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 155.358 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -86.9 146.66 26.09 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 165.089 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 8' ' ' LEU . 2.6 mm? -62.19 4.7 0.12 Allowed 'General case' 0 N--CA 1.445 -0.68 1 C-N-CA 132.463 4.305 . . . . 0.0 112.936 165.814 . . . . . . . . 3 3 . 1 . 060 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -106.46 12.1 30.02 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 119.373 -2.079 . . . . 0.0 113.693 171.489 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.4 -20.19 35.42 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 115.645 -2.753 . . . . 0.0 116.281 169.118 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.315 74.9 tttt -101.0 130.59 47.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 126.635 3.112 . . . . 0.0 105.373 -166.203 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 m -107.91 125.25 51.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 124.717 2.198 . . . . 0.0 108.932 177.781 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.8 mt -110.31 120.75 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 -172.288 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 m -97.19 131.3 44.07 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 118.027 -2.92 . . . . 0.0 106.932 -178.682 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.29 154.06 35.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.965 2.906 . . . . 0.0 111.501 -176.412 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -109.4 137.85 46.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 123.424 1.583 . . . . 0.0 108.148 161.944 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.325 21.0 m -128.02 149.78 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 119.946 3.313 . . . . 0.0 119.946 -178.582 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -85.26 156.54 59.85 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 128.069 2.548 . . . . 0.0 105.807 172.785 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.356 60.0 Cg_endo -70.19 -33.94 14.05 Favored 'Trans proline' 0 N--CA 1.447 -1.207 2 C-N-CA 129.276 6.65 . . . . 0.0 114.165 -179.915 . . . . . . . . 3 2 . 1 . 060 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.6 m -115.73 17.44 16.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 118.674 -2.516 . . . . 0.0 104.311 -167.935 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -84.01 161.27 20.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 125.322 2.487 . . . . 0.0 109.336 178.923 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.41 49.8 p -93.6 147.86 22.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 -163.146 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.305 12.4 mm -44.44 -43.92 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 121.569 3.914 . . . . 0.0 121.569 165.478 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 pm0 -79.69 -15.95 56.6 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 113.434 -3.175 . . . . 0.0 108.571 -174.239 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -74.45 -33.15 62.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 122.412 2.369 . . . . 0.0 106.921 172.299 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.431 ' H ' HG23 ' A' ' 26' ' ' VAL . 39.2 t -49.97 -48.4 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 124.378 3.263 . . . . 0.0 114.373 167.77 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -64.5 -37.35 87.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 114.704 -2.57 . . . . 0.0 111.906 -176.519 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.06 70.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 128.082 2.553 . . . . 0.0 111.358 171.502 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -80.75 -25.69 37.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.677 -1.89 . . . . 0.0 110.497 -176.65 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 30' ' ' ILE 0.264 30.3 mm -65.94 -45.49 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 116.351 -1.785 . . . . 0.0 106.832 169.858 . . . . . . . . 3 3 . 1 . 060 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -62.3 -50.52 71.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 121.504 1.956 . . . . 0.0 114.89 -179.713 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -39.74 -39.66 0.82 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.299 2.24 . . . . 0.0 114.549 172.934 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.2 tttt -98.04 -41.48 7.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 117.845 -3.034 . . . . 0.0 108.006 177.34 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -113.05 -23.03 10.26 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 124.463 3.302 . . . . 0.0 111.869 -149.639 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.96 -1.63 85.12 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-O 116.799 -2.112 . . . . 0.0 116.603 174.709 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.0 mm -78.99 118.92 75.21 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 121.8 2.8 . . . . 0.0 104.303 176.342 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.69 165.35 16.12 Favored 'Trans proline' 0 N--CA 1.45 -1.053 1 C-N-CA 126.543 4.829 . . . . 0.0 113.934 179.106 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.53 -27.27 39.47 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.608 2.205 . . . . 0.0 115.246 178.53 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -69.77 1.4 4.35 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 117.466 -3.271 . . . . 0.0 111.57 -178.634 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -121.04 -14.91 8.34 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 128.598 2.759 . . . . 0.0 109.214 -169.989 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -106.47 114.07 27.96 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 128.575 3.672 . . . . 0.0 106.825 -172.198 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -108.87 141.23 41.23 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.661 2.785 . . . . 0.0 108.17 161.248 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.28 1.5 mp -116.08 139.97 49.75 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -177.51 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 mt -112.24 151.57 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 O-C-N 127.23 2.831 . . . . 0.0 103.63 169.54 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -128.16 124.41 36.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 161.451 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.326 . . 58.57 -81.88 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 128.796 2.838 . . . . 0.0 115.467 -172.743 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.63 1.34 4.35 Favored Glycine 0 CA--C 1.533 1.176 2 O-C-N 130.294 4.747 . . . . 0.0 112.534 171.565 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -122.37 151.33 41.31 Favored 'General case' 0 C--N 1.322 -0.606 1 CA-C-N 125.352 4.576 . . . . 0.0 106.643 -169.542 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 74.9 mt-30 -72.56 138.35 46.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.533 -174.601 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.53 HD11 HD12 ' A' ' 67' ' ' LEU . 82.3 mt -95.98 120.91 37.1 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 117.079 -1.848 . . . . 0.0 112.695 171.059 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -92.63 154.02 18.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -176.446 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.87 154.9 29.38 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 131.576 3.95 . . . . 0.0 110.625 178.976 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.89 0.34 83.63 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 122.773 1.207 . . . . 0.0 115.505 171.786 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -124.75 145.85 49.5 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 131.403 3.881 . . . . 0.0 105.731 -167.006 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.41 30.5 p -79.94 159.47 26.31 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 112.225 -2.261 . . . . 0.0 115.389 -171.745 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -51.9 14.13 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 126.672 2.483 . . . . 0.0 109.919 -172.104 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -78.0 -0.37 27.56 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.431 2.692 . . . . 0.0 106.41 -168.347 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.4 -31.01 70.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 124.639 2.161 . . . . 0.0 107.127 175.576 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.353 8.3 m-85 -107.84 -179.44 3.9 Favored 'General case' 0 N--CA 1.449 -0.505 1 O-C-N 115.998 -4.189 . . . . 0.0 107.87 175.572 . . . . . . . . 3 2 . 1 . 060 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -92.9 45.68 1.19 Allowed 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 118.179 -2.826 . . . . 0.0 116.137 175.633 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.07 138.85 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 117.753 -1.117 . . . . 0.0 108.88 166.428 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -154.12 -178.46 7.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.541 1.937 . . . . 0.0 109.779 -164.438 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -50.3 115.57 1.5 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.177 1.791 . . . . 0.0 109.301 171.478 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 55.78 33.57 21.71 Favored 'General case' 0 N--CA 1.452 -0.337 1 C-N-CA 133.619 4.768 . . . . 0.0 113.491 -178.064 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 138.8 56.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.313 1.845 . . . . 0.0 108.812 158.046 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.4 m -103.93 136.61 43.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.628 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.53 HD12 HD11 ' A' ' 50' ' ' LEU . 2.4 mm? -107.97 139.54 42.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 130.251 3.42 . . . . 0.0 116.771 156.202 . . . . . . . . 2 2 . 1 . 060 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -97.34 124.26 41.43 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 113.219 -3.277 . . . . 0.0 107.145 -175.552 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.7 tp -93.87 124.14 37.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 128.242 3.464 . . . . 0.0 109.664 -179.248 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.2 116.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 130.194 3.398 . . . . 0.0 106.26 -177.563 . . . . . . . . 1 1 . 1 . 060 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 87.4 mt . . . . . 0 C--N 1.324 -0.536 0 O-C-N 126.116 2.135 . . . . 0.0 111.736 -166.854 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.625 0 CA-C-O 117.73 -1.128 . . . . 0.0 109.155 . . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -88.65 125.72 34.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.19 2.196 . . . . 0.0 113.676 -179.494 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -109.76 164.12 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 124.13 3.15 . . . . 0.0 111.054 177.984 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -117.83 145.56 44.49 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 117.53 -3.231 . . . . 0.0 110.07 170.66 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.3 t -122.18 127.51 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 174.055 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -73.78 111.76 9.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 111.671 -2.513 . . . . 0.0 106.422 168.896 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 m -108.61 126.97 53.54 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -178.755 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.651 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -55.14 -6.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 1 N-CA-C 122.133 4.123 . . . . 0.0 122.133 178.124 . . . . . . . . 4 4 . 1 . 061 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -83.01 3.35 30.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 123.878 0.736 . . . . 0.0 109.589 175.9 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.62 21.81 30.49 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 123.705 1.725 . . . . 0.0 114.793 -178.704 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -123.78 135.56 53.88 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 116.645 -1.645 . . . . 0.0 109.102 -162.665 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.9 m -114.79 85.09 2.18 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.981 1.848 . . . . 0.0 111.32 177.695 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 13' ' ' ILE . 9.6 pt -77.11 161.63 4.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 O-C-N 119.1 -2.25 . . . . 0.0 106.812 -167.031 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -128.5 136.41 50.76 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 125.308 1.63 . . . . 0.0 109.774 178.582 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.331 0.3 OUTLIER -141.04 146.84 37.73 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 129.866 3.266 . . . . 0.0 114.036 -179.778 . . . . . . . . 3 3 . 1 . 061 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -92.6 120.03 32.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 129.464 3.106 . . . . 0.0 105.599 -171.05 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 16.0 m -127.37 162.85 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 116.364 -3.96 . . . . 0.0 109.732 177.756 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.61 159.96 69.53 Favored Pre-proline 0 N--CA 1.451 -0.414 1 O-C-N 115.485 -4.509 . . . . 0.0 107.053 164.882 . . . . . . . . 3 3 . 1 . 061 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -53.48 -46.84 30.85 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 N-CA-C 118.595 2.498 . . . . 0.0 118.595 -167.172 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.1 m -79.0 5.55 11.44 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 128.653 2.781 . . . . 0.0 112.56 -169.051 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.266 89.9 m-20 -77.66 140.61 39.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.73 -1.231 . . . . 0.0 109.494 176.658 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -86.0 146.62 26.59 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 129.08 3.988 . . . . 0.0 107.605 -179.522 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.77 -23.9 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 128.646 2.779 . . . . 0.0 111.762 -175.544 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -61.82 -38.83 89.64 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.974 2.91 . . . . 0.0 111.452 166.963 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.13 -35.61 78.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 125.756 2.693 . . . . 0.0 113.421 179.81 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -82.7 -37.71 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 112.44 -2.164 . . . . 0.0 109.3 176.425 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.363 61.8 mttt -48.72 -50.27 34.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.031 2.933 . . . . 0.0 111.665 168.143 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.3 56.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 116.056 -1.926 . . . . 0.0 109.928 -173.292 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -63.58 -45.2 91.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 122.474 2.397 . . . . 0.0 116.89 165.955 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -55.51 -40.54 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 114.822 -2.513 . . . . 0.0 110.223 167.713 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -61.5 -42.12 98.32 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 113.535 -3.126 . . . . 0.0 112.906 171.302 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.444 29.9 t70 -57.08 -27.83 62.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 122.627 2.467 . . . . 0.0 116.292 173.124 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -94.58 -55.7 3.05 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 126.485 2.366 . . . . 0.0 111.039 -174.298 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -117.31 -21.34 8.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.465 1.506 . . . . 0.0 113.835 -165.087 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.63 12.03 45.51 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 115.67 -2.739 . . . . 0.0 111.668 168.296 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 36' ' ' ILE . 39.3 mt -82.95 132.24 51.59 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 118.87 1.335 . . . . 0.0 112.608 171.434 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.21 121.79 8.61 Favored 'Trans proline' 0 N--CA 1.456 -0.692 1 C-N-CA 129.153 6.569 . . . . 0.0 113.758 178.222 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.297 32.3 Cg_exo -40.78 -35.23 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 1 C-N-CA 126.296 4.664 . . . . 0.0 117.43 170.908 . . . . . . . . 3 2 . 1 . 061 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.75 -35.09 78.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 -175.871 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -77.62 -42.11 36.11 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 130.48 3.512 . . . . 0.0 115.387 170.049 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.27 146.97 53.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.612 1.165 . . . . 0.0 114.029 -173.723 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.429 ' HB3' HG23 ' A' ' 70' ' ' VAL . 2.4 ttt180 -141.98 154.34 44.96 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 131.693 3.997 . . . . 0.0 109.88 -177.143 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.7 mt -130.11 159.61 36.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 116.72 -3.737 . . . . 0.0 115.865 177.532 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.03 136.51 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 130.004 3.322 . . . . 0.0 115.74 165.01 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 65' ' ' SER . 91.3 t80 -140.18 145.59 37.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 167.672 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.21 33.09 19.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.705 2.802 . . . . 0.0 112.086 168.007 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.26 -24.19 12.46 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.851 -1.527 . . . . 0.0 113.978 -175.033 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -87.41 141.74 28.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 121.499 2.65 . . . . 0.0 105.461 -169.889 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.61 122.68 27.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 166.05 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -75.47 137.74 41.14 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -173.983 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.437 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 2.5 mp0 -89.43 159.78 17.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 125.228 1.58 . . . . 0.0 106.91 176.607 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.11 121.89 30.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 126.203 2.189 . . . . 0.0 107.234 172.746 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.32 -33.24 3.06 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-O 124.523 2.18 . . . . 0.0 113.165 -178.398 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.437 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 4.1 mtt-85 -82.52 167.87 17.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 112.777 -1.711 . . . . 0.0 112.698 177.821 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.0 p -109.64 167.75 9.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -176.747 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.411 HD23 HD12 ' A' ' 61' ' ' ILE . 83.4 mt -56.11 -48.96 75.17 Favored 'General case' 0 N--CA 1.45 -0.44 1 C-N-CA 131.98 4.112 . . . . 0.0 105.885 172.833 . . . . . . . . 3 3 . 1 . 061 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -43.98 17.01 Favored 'General case' 0 N--CA 1.444 -0.765 1 C-N-CA 131.747 4.019 . . . . 0.0 108.518 174.052 . . . . . . . . 3 3 . 1 . 061 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.69 -16.38 48.47 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 124.365 3.257 . . . . 0.0 114.067 178.962 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -114.17 2.66 14.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 114.803 -2.522 . . . . 0.0 111.544 -174.661 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.305 67.3 m-80 74.85 16.33 2.99 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.794 2.438 . . . . 0.0 111.686 173.655 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.411 HD12 HD23 ' A' ' 56' ' ' LEU . 74.8 mt -68.39 128.05 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 O-C-N 117.521 -3.237 . . . . 0.0 113.905 -174.22 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -123.41 -163.45 1.12 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.152 2.581 . . . . 0.0 107.64 -178.854 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -50.81 119.26 3.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 123.375 1.56 . . . . 0.0 113.768 169.899 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.321 50.8 mt-10 74.94 21.38 2.03 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.024 -1.672 . . . . 0.0 111.576 163.171 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 45.8 m -53.7 126.28 21.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 115.96 -1.971 . . . . 0.0 110.223 160.663 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -97.38 112.38 24.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.163 2.185 . . . . 0.0 109.314 171.856 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.314 8.7 mp -97.82 167.26 11.04 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.399 1.88 . . . . 0.0 108.864 176.144 . . . . . . . . 2 2 . 1 . 061 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -116.59 124.17 49.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.822 2.849 . . . . 0.0 104.605 -176.118 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -97.78 132.19 43.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.978 2.911 . . . . 0.0 110.574 -177.229 . . . . . . . . 1 1 . 1 . 061 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 42' ' ' ARG 0.292 4.1 m -142.32 171.29 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 112.921 -1.945 . . . . 0.0 110.752 -176.538 . . . . . . . . 3 3 . 1 . 061 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 172.519 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 ptt? . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 116.878 -1.534 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 062 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.411 49.4 mm-40 -109.15 146.39 34.18 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 116.717 -1.611 . . . . 0.0 108.166 -170.609 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 pt -145.33 156.86 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 121.208 1.822 . . . . 0.0 109.038 170.473 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -99.84 141.29 32.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 178.668 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 30' ' ' ILE . 52.9 t -107.58 133.71 51.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 156.513 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -91.34 117.6 29.8 Favored 'General case' 0 C--N 1.325 -0.474 1 C-N-CA 132.743 4.417 . . . . 0.0 110.26 170.298 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -82.65 162.46 21.84 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.342 1.857 . . . . 0.0 110.07 176.821 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pp -78.76 -24.47 44.7 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 127.384 2.274 . . . . 0.0 110.179 172.024 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -87.84 -18.02 30.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 119.867 -1.77 . . . . 0.0 114.136 -178.275 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.17 7.67 3.16 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 128.506 2.955 . . . . 0.0 115.903 144.576 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -90.62 163.34 14.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 125.36 2.505 . . . . 0.0 107.71 174.817 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.3 m -128.29 117.23 21.11 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.942 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.32 129.75 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 128.458 2.703 . . . . 0.0 103.837 -167.426 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -91.57 107.73 19.41 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -177.033 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.316 48.7 mt -102.91 152.52 21.2 Favored 'General case' 0 N--CA 1.449 -0.517 1 CA-C-N 126.341 4.155 . . . . 0.0 107.935 175.581 . . . . . . . . 3 2 . 1 . 062 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -113.78 119.93 39.04 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 114.68 -2.581 . . . . 0.0 106.15 175.313 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -124.7 149.68 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 125.003 1.439 . . . . 0.0 114.661 -175.309 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -81.61 130.61 60.81 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-O 114.991 -2.433 . . . . 0.0 104.556 167.309 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -38.71 -25.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.379 1 N-CA-C 123.163 4.255 . . . . 0.0 123.163 165.69 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.1 p -115.06 18.54 16.26 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 126.147 2.154 . . . . 0.0 114.466 178.99 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -59.46 111.33 1.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 128.822 2.849 . . . . 0.0 112.636 156.806 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -72.06 169.53 15.8 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 123.256 2.753 . . . . 0.0 111.192 -177.528 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.321 18.7 mm -51.11 -32.16 11.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 125.773 1.629 . . . . 0.0 113.782 -179.916 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -87.15 -20.86 26.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 122.179 2.263 . . . . 0.0 106.893 -175.314 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -79.39 -39.18 33.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.622 1.169 . . . . 0.0 112.482 179.839 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.3 t -43.07 -39.13 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 128.497 2.719 . . . . 0.0 113.157 161.884 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -75.01 -37.66 61.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 119.512 -1.992 . . . . 0.0 112.939 -171.818 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.285 . . -68.28 -16.69 64.05 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.974 2.509 . . . . 0.0 114.444 172.298 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.25 -38.42 17.59 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.572 2.349 . . . . 0.0 112.316 171.329 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 5' ' ' VAL . 71.9 mt -58.19 -42.41 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 114.449 -2.691 . . . . 0.0 114.451 157.445 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -48.63 -62.87 1.28 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.193 2.197 . . . . 0.0 112.471 165.283 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -33.0 -40.59 0.06 Allowed 'General case' 0 N--CA 1.448 -0.57 1 CA-C-O 111.589 -4.053 . . . . 0.0 119.709 170.656 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.48 -53.1 3.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 128.202 3.439 . . . . 0.0 111.473 176.865 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -112.97 -3.75 14.01 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -167.657 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.0 -8.94 77.54 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 116.895 -2.058 . . . . 0.0 115.683 160.5 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -66.21 130.0 94.25 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 129.045 2.938 . . . . 0.0 109.035 -172.454 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -71.22 143.15 43.2 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 N-CA-C 107.975 -1.587 . . . . 0.0 107.975 172.599 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.3 46.7 Cg_exo -28.86 -60.74 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 1 C-N-CA 126.369 4.712 . . . . 0.0 117.741 163.593 . . . . . . . . 3 2 . 1 . 062 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -55.41 -25.49 36.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 122.082 2.219 . . . . 0.0 115.568 -172.463 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -89.89 -9.89 47.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 176.211 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -94.75 154.76 17.14 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 131.599 3.96 . . . . 0.0 107.085 -175.838 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -143.47 152.38 41.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 113.853 -2.975 . . . . 0.0 104.821 163.634 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.267 76.5 mt -123.79 119.64 30.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.5 1.955 . . . . 0.0 107.385 -173.106 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -107.52 143.13 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 127.758 2.423 . . . . 0.0 110.005 -179.131 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -155.29 143.97 20.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.421 2.288 . . . . 0.0 109.304 172.343 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.66 31.88 13.52 Favored 'General case' 0 C--N 1.328 -0.331 3 O-C-N 114.566 -5.084 . . . . 0.0 114.217 161.483 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.27 2.56 62.01 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.645 2.069 . . . . 0.0 116.449 171.386 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.338 41.5 pttt -136.1 150.4 49.1 Favored 'General case' 0 N--CA 1.445 -0.717 1 C-N-CA 133.225 4.61 . . . . 0.0 114.966 -169.271 . . . . . . . . 3 2 . 1 . 062 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 48.8 tt0 -76.54 140.73 41.24 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.704 2.002 . . . . 0.0 106.996 162.455 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 mt -71.6 129.49 38.86 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 114.764 -2.541 . . . . 0.0 112.992 171.714 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.82 139.68 30.22 Favored 'General case' 0 N--CA 1.447 -0.581 1 C-N-CA 131.814 4.046 . . . . 0.0 105.057 -173.446 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.83 117.86 24.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 127.628 2.371 . . . . 0.0 115.856 -174.126 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.46 11.44 1.73 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.391 1.948 . . . . 0.0 112.836 179.684 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -141.11 163.65 32.39 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -174.058 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -123.73 -179.29 4.31 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 119.226 -2.171 . . . . 0.0 109.728 -162.994 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -58.84 -33.75 70.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 118.464 -2.648 . . . . 0.0 114.601 172.192 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 p -76.27 -34.61 59.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 120.94 1.7 . . . . 0.0 107.056 179.582 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -74.08 -42.61 59.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 125.5 1.75 . . . . 0.0 109.537 -173.237 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -76.44 4.04 9.93 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 118.762 -2.461 . . . . 0.0 115.215 166.892 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 75.8 18.0 2.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 131.529 3.932 . . . . 0.0 114.483 168.268 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.4 mt -69.97 132.98 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 O-C-N 119.295 -2.128 . . . . 0.0 108.681 -174.233 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -124.27 153.4 41.75 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 112.859 -3.448 . . . . 0.0 109.98 -173.861 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.27 135.02 27.17 Favored 'General case' 0 N--CA 1.443 -0.802 1 O-C-N 129.111 4.007 . . . . 0.0 113.049 -177.048 . . . . . . . . 3 3 . 1 . 062 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.588 80.8 mt-10 84.93 11.17 0.31 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 128.247 2.619 . . . . 0.0 116.505 172.645 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.308 27.9 m -86.65 159.9 19.06 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 116.229 -1.843 . . . . 0.0 110.964 170.978 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.8 m -130.95 113.34 13.88 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.276 1.83 . . . . 0.0 107.143 -158.948 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.7 163.32 12.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 130.575 3.55 . . . . 0.0 113.906 -179.885 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -122.17 154.86 36.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -161.31 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.257 39.1 tp -145.58 117.93 8.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 125.619 2.628 . . . . 0.0 105.913 -167.853 . . . . . . . . 2 2 . 1 . 062 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 t -110.17 119.39 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 110.588 -3.006 . . . . 0.0 108.142 169.433 . . . . . . . . 1 1 . 1 . 062 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 C--N 1.326 -0.426 0 O-C-N 119.427 -2.045 . . . . 0.0 110.294 167.157 . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttm . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 063 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -87.31 117.5 26.12 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.93 2.892 . . . . 0.0 112.728 -175.513 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.57 167.5 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.428 1.491 . . . . 0.0 109.742 170.961 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -140.6 115.21 9.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 125.327 2.489 . . . . 0.0 105.651 -168.912 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 15' ' ' LEU . 15.5 t -101.55 109.23 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.663 -2.062 . . . . 0.0 111.807 -179.239 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -93.99 121.11 35.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 115.549 -2.167 . . . . 0.0 113.489 -174.528 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.0 p -73.48 179.32 4.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 128.246 2.618 . . . . 0.0 111.259 -177.453 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.52 -32.16 60.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.19 2.196 . . . . 0.0 108.274 172.2 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.42 -21.71 59.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.155 2.182 . . . . 0.0 109.852 179.741 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.11 -4.56 58.86 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 117.244 -1.865 . . . . 0.0 114.92 177.511 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -65.92 143.9 57.13 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.9 1.0 . . . . 0.0 110.889 170.615 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -138.15 99.93 4.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.137 -2.227 . . . . 0.0 106.011 -158.844 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.5 mm -95.72 131.78 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.226 -169.946 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 m -94.75 105.49 17.43 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 119.628 -1.92 . . . . 0.0 107.64 -171.486 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.542 HD12 HG21 ' A' ' 5' ' ' VAL . 47.8 mt -93.98 127.23 39.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 125.143 2.402 . . . . 0.0 105.594 179.401 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -95.79 110.47 22.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 119.786 -1.821 . . . . 0.0 107.506 174.071 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.14 170.57 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.598 2.759 . . . . 0.0 107.596 -174.68 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -114.39 162.41 23.49 Favored Pre-proline 0 N--CA 1.449 -0.509 1 O-C-N 129.19 4.056 . . . . 0.0 108.892 150.195 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -57.88 -14.62 18.78 Favored 'Trans proline' 0 N--CA 1.447 -1.252 1 C-N-CA 125.716 4.277 . . . . 0.0 115.486 -175.555 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.1 p -90.74 0.32 57.47 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 116.912 -3.617 . . . . 0.0 114.853 -179.383 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.74 137.91 44.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 127.983 3.302 . . . . 0.0 106.396 -176.57 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -83.39 170.69 14.26 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.171 1.35 . . . . 0.0 112.512 173.264 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 50' ' ' LEU . 47.1 mt -58.7 -42.82 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 129.26 3.024 . . . . 0.0 108.018 170.816 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -49.57 -46.99 49.53 Favored 'General case' 0 C--N 1.329 -0.294 1 C-N-CA 132.535 4.334 . . . . 0.0 109.854 166.909 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -73.61 -45.65 51.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 120.448 1.476 . . . . 0.0 110.067 -177.925 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -53.57 -48.87 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 117.315 -1.326 . . . . 0.0 108.497 171.181 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -67.39 -36.28 81.0 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 120.086 1.312 . . . . 0.0 110.368 -178.668 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.53 -40.37 78.64 Favored 'General case' 0 C--O 1.217 -0.624 1 O-C-N 115.923 -4.235 . . . . 0.0 110.703 171.238 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.319 39.2 mttp -62.14 -49.74 74.66 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.253 3.421 . . . . 0.0 117.432 -179.389 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.92 -33.94 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 128.683 3.739 . . . . 0.0 110.462 164.479 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -75.34 -37.89 60.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 121.599 2.0 . . . . 0.0 115.014 -178.903 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -55.21 -37.99 67.85 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 126.89 2.076 . . . . 0.0 113.842 172.849 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -80.99 -83.1 0.11 Allowed 'General case' 0 N--CA 1.442 -0.87 1 C-N-CA 132.108 4.163 . . . . 0.0 114.022 -176.966 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -92.37 -0.27 57.39 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 116.884 -1.531 . . . . 0.0 110.975 -174.922 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.23 11.58 82.05 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 122.652 2.478 . . . . 0.0 114.239 175.961 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.9 mm -67.77 126.8 93.08 Favored Pre-proline 0 N--CA 1.446 -0.628 1 C-N-CA 132.313 4.245 . . . . 0.0 110.808 -177.103 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -64.14 149.39 90.46 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.542 3.494 . . . . 0.0 113.4 171.519 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -68.44 -55.69 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.212 2.608 . . . . 0.0 114.422 178.044 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -52.44 -25.21 9.4 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 127.305 2.878 . . . . 0.0 113.066 -173.12 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -79.2 -10.91 59.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.077 178.857 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -111.85 152.91 27.39 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 130.206 3.402 . . . . 0.0 116.609 -168.398 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -137.96 138.69 39.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 118.712 -2.493 . . . . 0.0 106.295 166.473 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 69' ' ' LEU . 41.2 mt -107.63 148.5 29.26 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.244 3.018 . . . . 0.0 112.026 -171.819 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.4 mt -147.74 118.69 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 126.811 2.044 . . . . 0.0 107.757 -164.982 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CD1' HG12 ' A' ' 61' ' ' ILE . 45.3 t80 -146.56 140.69 26.31 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 126.018 1.727 . . . . 0.0 106.997 169.993 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 74.9 21.07 2.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.987 2.515 . . . . 0.0 116.123 169.542 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.75 3.01 61.07 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 120.413 -1.43 . . . . 0.0 112.299 179.705 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.315 16.7 ptpt -127.96 133.93 49.25 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -171.406 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -75.21 132.76 41.34 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 102.029 -3.322 . . . . 0.0 102.029 163.539 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.447 ' HB3' HD11 ' A' ' 23' ' ' ILE . 29.4 mt -86.29 137.91 32.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 112.94 -1.936 . . . . 0.0 108.415 -179.69 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -111.86 147.41 35.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -178.877 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.01 139.78 58.8 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 128.802 2.841 . . . . 0.0 111.635 -162.9 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.48 20.74 10.56 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.373 1.463 . . . . 0.0 114.486 178.701 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -131.99 147.35 52.45 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 123.923 1.82 . . . . 0.0 109.755 175.386 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -95.46 154.08 17.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 111.283 -2.69 . . . . 0.0 111.767 179.264 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 53.9 mt -51.41 -33.64 31.28 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 119.229 -2.169 . . . . 0.0 115.683 -179.105 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -10.52 59.53 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 120.415 -1.428 . . . . 0.0 114.319 177.195 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -77.76 -27.93 50.49 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.586 175.18 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.366 67.8 m-85 -104.96 -0.04 27.32 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 130.986 3.714 . . . . 0.0 113.878 170.585 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.338 0.7 OUTLIER 59.06 39.82 22.84 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 128.813 2.845 . . . . 0.0 113.962 -179.079 . . . . . . . . 3 3 . 1 . 063 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 90.0 mt -70.31 112.08 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 118.758 0.708 . . . . 0.0 109.811 168.634 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -112.37 -170.12 1.6 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 113.187 -1.824 . . . . 0.0 112.751 -170.813 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.443 36.1 pttt -50.65 120.18 4.49 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 120.378 3.473 . . . . 0.0 120.378 179.674 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 67.77 54.15 0.65 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.855 2.862 . . . . 0.0 109.241 177.731 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.7 m -107.43 141.31 39.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.309 175.238 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.276 36.3 m -108.9 144.95 36.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 126.233 2.921 . . . . 0.0 107.651 168.393 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.11 -178.03 4.72 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 103.355 -2.832 . . . . 0.0 103.355 173.976 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -151.68 -179.59 7.56 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 111.986 -2.37 . . . . 0.0 105.155 -171.898 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.429 ' HB3' HD23 ' A' ' 43' ' ' LEU . 1.5 pp -147.15 168.46 21.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 123.345 1.545 . . . . 0.0 112.923 175.865 . . . . . . . . 2 2 . 1 . 063 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.0 p -128.74 133.42 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 131.574 3.95 . . . . 0.0 110.057 -178.225 . . . . . . . . 1 1 . 1 . 063 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.572 ' O ' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 164.394 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 ttp . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 115.691 -2.1 . . . . 0.0 106.17 . . . . . . . . . 0 0 . 1 . 064 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.253 27.0 mp0 -97.0 131.24 44.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -175.127 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -114.63 177.64 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 116.955 -3.59 . . . . 0.0 105.577 158.926 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -127.25 141.76 51.64 Favored 'General case' 0 N--CA 1.447 -0.618 1 C-N-CA 131.978 4.111 . . . . 0.0 108.515 175.904 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.2 106.36 17.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 -178.344 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -89.37 166.53 13.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 117.762 -3.086 . . . . 0.0 104.489 166.695 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -127.5 149.34 50.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 109.38 -3.554 . . . . 0.0 104.04 176.08 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.21 1.68 20.69 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 128.003 3.315 . . . . 0.0 112.607 175.274 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -102.84 -21.32 14.04 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.645 2.378 . . . . 0.0 116.68 167.275 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.5 13.16 9.03 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-O 113.567 -3.907 . . . . 0.0 110.805 153.721 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -72.23 131.62 42.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 123.291 3.546 . . . . 0.0 112.597 155.182 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.8 m -108.22 133.17 52.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 172.714 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.6 mt -115.24 144.0 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 129.308 3.043 . . . . 0.0 106.784 167.884 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.293 28.4 m -107.31 130.63 54.75 Favored 'General case' 0 N--CA 1.448 -0.532 1 N-CA-C 97.453 -5.017 . . . . 0.0 97.453 164.708 . . . . . . . . 3 2 . 1 . 064 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tp -130.56 138.37 50.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.857 1.348 . . . . 0.0 111.603 179.288 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.27 118.16 35.99 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 -173.225 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.289 17.1 m -120.94 160.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 122.548 1.166 . . . . 0.0 109.574 -176.095 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -96.58 141.34 22.95 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 113.305 -3.236 . . . . 0.0 113.26 173.581 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -45.0 -50.9 8.21 Favored 'Trans proline' 0 N--CA 1.444 -1.385 1 C-N-CA 131.593 8.195 . . . . 0.0 108.245 169.102 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -60.24 -15.46 24.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.703 2.001 . . . . 0.0 112.101 -179.299 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -68.94 127.95 34.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 122.469 2.395 . . . . 0.0 114.505 -168.832 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.1 p -68.33 138.49 55.47 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 125.391 1.682 . . . . 0.0 107.065 160.845 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mm -53.45 -19.83 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -177.406 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.67 -36.24 80.26 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 122.225 2.284 . . . . 0.0 112.821 166.261 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -78.42 -10.14 59.57 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 123.271 2.76 . . . . 0.0 110.19 -178.814 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -92.88 -28.82 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 118.163 -2.836 . . . . 0.0 106.447 174.383 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -84.43 -20.31 32.02 Favored 'General case' 0 CA--C 1.539 0.523 1 O-C-N 114.977 -4.827 . . . . 0.0 110.062 177.83 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.69 -26.38 59.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 117.537 -1.22 . . . . 0.0 113.5 159.752 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -78.38 -17.02 57.04 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 171.772 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.2 mt -80.18 -34.51 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 114.309 -2.758 . . . . 0.0 110.685 162.952 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -50.69 -35.81 32.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 123.078 2.672 . . . . 0.0 116.019 168.656 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.253 27.5 t70 -91.74 -5.37 53.72 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 119.148 -2.22 . . . . 0.0 111.321 -172.631 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -121.99 -36.57 2.98 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 113.175 -3.297 . . . . 0.0 111.233 -169.511 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -125.65 -26.44 3.53 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 123.648 2.931 . . . . 0.0 109.195 176.901 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.72 17.35 12.16 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 117.016 -3.553 . . . . 0.0 112.746 174.588 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mt -86.82 125.94 65.15 Favored Pre-proline 0 N--CA 1.445 -0.711 0 N-CA-C 100.821 -3.77 . . . . 0.0 100.821 -175.735 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.47 144.49 25.65 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 CA-C-O 115.47 -1.971 . . . . 0.0 112.742 165.785 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -9.71 26.89 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 124.471 3.447 . . . . 0.0 114.754 -162.994 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.77 -17.01 64.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 123.429 2.831 . . . . 0.0 117.334 169.291 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -119.82 27.19 8.85 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 117.134 -3.479 . . . . 0.0 116.285 -162.157 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -113.56 165.66 12.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.257 2.623 . . . . 0.0 111.892 178.675 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -127.15 150.79 49.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.012 3.725 . . . . 0.0 102.983 141.902 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.67 105.59 11.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 112.317 -2.219 . . . . 0.0 110.946 165.114 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.97 134.77 27.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 125.688 2.661 . . . . 0.0 105.206 174.301 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -140.76 115.08 9.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 108.603 -3.908 . . . . 0.0 112.532 176.905 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.69 37.84 1.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 128.687 2.795 . . . . 0.0 112.75 -175.052 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.6 -35.34 4.78 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 121.253 -0.905 . . . . 0.0 113.075 171.173 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.313 97.7 mttt -83.57 165.09 19.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.971 2.908 . . . . 0.0 107.247 -173.947 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -116.5 119.72 36.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.685 2.394 . . . . 0.0 108.779 177.497 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.1 mt -80.59 124.38 28.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 123.379 1.561 . . . . 0.0 109.057 -161.125 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.21 130.84 35.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 -174.38 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.95 -37.11 30.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 127.59 3.056 . . . . 0.0 118.704 -170.952 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.19 5.02 41.4 Favored Glycine 0 CA--C 1.526 0.777 1 O-C-N 116.079 -4.138 . . . . 0.0 115.026 -170.381 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -88.57 146.72 24.97 Favored 'General case' 0 C--N 1.327 -0.413 1 O-C-N 116.226 -4.103 . . . . 0.0 107.024 170.195 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -86.47 134.64 33.67 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 127.858 3.224 . . . . 0.0 111.573 -173.678 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.309 10.8 tp -22.42 -76.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 1 C-N-CA 134.036 4.935 . . . . 0.0 114.243 177.656 . . . . . . . . 3 2 . 1 . 064 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.1 -37.29 85.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 125.397 2.522 . . . . 0.0 110.217 -170.135 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.3 -21.26 42.78 Favored 'General case' 0 CA--C 1.536 0.43 1 O-C-N 113.793 -5.567 . . . . 0.0 113.201 178.584 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -22.37 66.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 162.913 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.809 6.5 t-20 105.85 24.13 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 129.534 3.134 . . . . 0.0 117.96 175.512 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -99.82 73.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 126.708 2.003 . . . . 0.0 109.672 -177.524 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -89.84 169.79 10.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 124.72 2.2 . . . . 0.0 105.955 -179.506 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -31.54 115.79 0.16 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.283 2.697 . . . . 0.0 118.283 -174.298 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 77.51 29.8 0.52 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 129.067 2.947 . . . . 0.0 113.427 174.945 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -72.44 148.47 45.12 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 126.165 2.888 . . . . 0.0 114.133 169.986 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 m -104.73 107.48 18.45 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 117.062 -3.524 . . . . 0.0 105.811 -173.288 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.36 149.17 25.22 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 128.084 3.365 . . . . 0.0 108.649 162.275 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -107.59 110.84 22.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 127.971 3.294 . . . . 0.0 114.609 155.821 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.273 6.4 tt -74.19 139.41 44.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.083 -1.636 . . . . 0.0 107.635 168.763 . . . . . . . . 2 2 . 1 . 064 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.02 145.99 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 164.97 . . . . . . . . 1 1 . 1 . 064 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 71' ' ' LEU . 5.6 mp . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 -177.573 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptt? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 117.392 -1.29 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 065 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -100.2 161.61 13.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 169.272 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.9 pt -146.74 158.46 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 130.322 3.449 . . . . 0.0 103.137 168.71 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -107.11 140.31 40.15 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 127.057 2.143 . . . . 0.0 107.734 174.075 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -121.05 117.79 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 127.258 3.409 . . . . 0.0 105.808 170.009 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HZ2' ' HG1' ' A' ' 12' ' ' THR . 13.9 tptt -78.79 114.93 18.14 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 116.455 -3.903 . . . . 0.0 105.182 167.069 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.4 p -86.22 159.25 19.53 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 127.996 3.31 . . . . 0.0 108.469 168.544 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.76 -30.72 71.74 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.265 -1.789 . . . . 0.0 114.009 178.834 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.4 p -72.79 4.52 3.99 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.759 2.424 . . . . 0.0 114.806 165.913 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.86 17.08 77.92 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 114.045 -3.642 . . . . 0.0 113.839 173.013 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -85.42 121.32 27.97 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 122.819 3.309 . . . . 0.0 104.844 173.607 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.416 ' HG1' ' HZ2' ' A' ' 6' ' ' LYS . 11.3 m -85.86 63.68 8.18 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.791 2.436 . . . . 0.0 107.194 173.447 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mm -50.72 120.9 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 126.702 2.001 . . . . 0.0 111.948 173.82 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.9 m -88.67 136.66 32.88 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 174.346 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 mt -121.65 139.6 53.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.034 1.733 . . . . 0.0 106.992 177.629 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -86.97 129.22 34.97 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 167.418 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.381 18.5 m -140.75 154.48 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 128.936 2.894 . . . . 0.0 114.165 -179.416 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -117.4 171.42 4.97 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-O 114.186 -2.816 . . . . 0.0 110.596 171.63 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.97 -27.73 3.64 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 N-CA-C 118.393 2.42 . . . . 0.0 118.393 -170.171 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -86.61 -5.96 59.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 119.056 -2.277 . . . . 0.0 116.463 178.661 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.16 122.65 11.49 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 127.605 2.362 . . . . 0.0 108.996 178.224 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 p -85.87 169.77 13.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 117.222 -3.424 . . . . 0.0 110.883 -179.402 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 52' ' ' ASP . 18.4 mt -61.79 -27.81 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 O-C-N 126.299 2.249 . . . . 0.0 111.049 179.253 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.94 -43.36 79.29 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.491 -1.38 . . . . 0.0 107.372 174.326 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.315 30.0 m-20 -54.36 -41.53 69.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 118.736 -2.477 . . . . 0.0 117.344 168.6 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.5 t -73.56 -52.81 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 125.107 1.504 . . . . 0.0 109.082 176.135 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -44.64 -37.44 3.65 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 117.556 -3.215 . . . . 0.0 117.348 168.095 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.65 -37.86 55.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 126.826 2.579 . . . . 0.0 111.766 177.037 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -56.72 -50.15 73.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 127.424 2.952 . . . . 0.0 110.376 175.929 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.61 -31.29 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 117.469 -1.253 . . . . 0.0 109.322 -178.509 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -68.29 -48.63 64.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 121.104 1.775 . . . . 0.0 110.706 174.357 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.279 32.2 t70 -43.72 -40.77 4.45 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 128.624 3.703 . . . . 0.0 114.117 169.261 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -77.88 -60.1 2.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.459 1.904 . . . . 0.0 114.714 172.464 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -101.3 -21.19 14.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -162.071 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.0 -11.4 65.92 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 117.079 1.592 . . . . 0.0 117.079 -177.4 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.281 73.5 mt -77.58 126.33 84.68 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 123.915 3.857 . . . . 0.0 112.584 -174.875 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.98 168.37 24.95 Favored 'Trans proline' 0 N--CA 1.44 -1.638 0 N-CA-C 116.731 1.781 . . . . 0.0 116.731 -174.007 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.26 -22.78 9.42 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 CA-C-O 124.999 2.0 . . . . 0.0 115.817 -162.88 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.56 -20.36 59.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 111.983 -3.865 . . . . 0.0 110.58 179.778 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.64 -16.62 44.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 128.773 3.796 . . . . 0.0 109.001 -174.737 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -98.84 137.63 37.14 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.994 1.854 . . . . 0.0 113.472 -171.493 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -116.15 141.91 47.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 153.13 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.82 138.85 48.68 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.081 0.943 . . . . 0.0 108.636 179.893 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.453 HG13 ' HG3' ' A' ' 49' ' ' GLN . 3.7 mt -129.09 135.04 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 124.002 0.921 . . . . 0.0 109.564 -168.693 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -90.66 -175.94 4.57 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.365 2.266 . . . . 0.0 107.598 176.521 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -20.34 -57.22 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 1 C-N-CA 138.361 6.664 . . . . 0.0 111.826 -176.537 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.89 9.69 1.81 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.333 -1.815 . . . . 0.0 114.823 172.759 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -141.82 129.6 21.69 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -165.313 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.453 ' HG3' HG13 ' A' ' 44' ' ' ILE . 42.0 tt0 -75.35 139.82 42.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 126.22 2.2 . . . . 0.0 109.053 179.926 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -97.59 157.88 15.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 121.202 1.819 . . . . 0.0 110.692 179.003 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -148.64 138.96 22.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 123.013 1.387 . . . . 0.0 108.627 -176.517 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HA ' HD12 ' A' ' 23' ' ' ILE . 16.3 m-20 -59.42 144.3 47.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.008 2.923 . . . . 0.0 112.969 -163.526 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.6 11.88 11.11 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 126.366 2.291 . . . . 0.0 117.011 168.205 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -136.47 159.24 42.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.684 2.794 . . . . 0.0 109.072 179.487 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.0 p -85.96 176.68 7.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 124.854 2.264 . . . . 0.0 110.709 177.016 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.5 mt -62.94 -47.99 80.83 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 119.293 -2.13 . . . . 0.0 109.331 169.904 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -46.58 -38.17 9.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.892 2.877 . . . . 0.0 114.399 173.505 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -78.17 -31.61 49.72 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 115.051 -2.405 . . . . 0.0 104.803 -174.575 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -95.12 -1.38 52.09 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.817 1.323 . . . . 0.0 107.749 -173.361 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 60.0 m-80 77.83 27.72 0.57 Allowed 'General case' 0 N--CA 1.45 -0.471 1 O-C-N 115.429 -4.545 . . . . 0.0 117.931 171.605 . . . . . . . . 3 2 . 1 . 065 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -103.15 123.21 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 -170.249 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -123.28 171.0 9.71 Favored 'General case' 0 N--CA 1.445 -0.679 1 C-N-CA 131.737 4.015 . . . . 0.0 113.317 176.126 . . . . . . . . 2 2 . 1 . 065 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -57.78 135.65 56.83 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 128.155 2.582 . . . . 0.0 111.478 -168.092 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.337 0.7 OUTLIER 81.51 7.24 1.13 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.656 2.782 . . . . 0.0 118.178 -177.896 . . . . . . . . 3 3 . 1 . 065 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -68.67 139.61 55.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 124.83 2.252 . . . . 0.0 110.579 169.849 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.0 m -97.08 125.78 41.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 111.182 -2.735 . . . . 0.0 106.831 170.72 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.3 mt -96.36 150.51 20.5 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 128.759 2.824 . . . . 0.0 106.809 166.913 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -126.38 130.91 51.67 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 129.098 2.959 . . . . 0.0 110.703 171.685 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tp -86.4 141.84 28.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.685 1.994 . . . . 0.0 111.865 -178.543 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -130.91 133.02 63.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 101.872 -3.381 . . . . 0.0 101.872 177.098 . . . . . . . . 1 1 . 1 . 065 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.1 mt . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 119.042 2.979 . . . . 0.0 119.042 175.668 . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 113.855 -2.974 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 066 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -98.7 149.88 22.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 121.111 1.778 . . . . 0.0 107.267 -176.997 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 pt -152.01 157.02 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.184 1.793 . . . . 0.0 107.934 174.129 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -110.1 142.86 40.99 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 130.275 3.43 . . . . 0.0 105.79 -175.176 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t -113.97 138.46 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 168.873 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -100.96 144.72 29.57 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 118.134 -2.854 . . . . 0.0 110.757 162.348 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.1 m -113.63 142.37 46.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.523 2.729 . . . . 0.0 104.956 -175.951 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 3.2 tm? -47.35 -49.28 24.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.33 2.252 . . . . 0.0 111.569 -171.769 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.3 p -80.29 5.7 14.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 -177.871 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.34 -9.83 10.89 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 121.723 3.449 . . . . 0.0 121.723 157.47 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -79.61 149.0 31.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.883 1.673 . . . . 0.0 109.736 -179.544 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m -119.09 124.29 46.52 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 129.612 3.165 . . . . 0.0 108.572 178.811 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.286 1.5 pp -119.33 -173.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.095 1.358 . . . . 0.0 111.559 176.049 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 t -154.2 144.17 21.88 Favored 'General case' 0 C--N 1.321 -0.647 1 O-C-N 116.0 -4.187 . . . . 0.0 110.345 177.267 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.34 0.3 OUTLIER -138.42 150.97 47.03 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.77 2.828 . . . . 0.0 109.168 -175.159 . . . . . . . . 3 3 . 1 . 066 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.371 13.1 mp0 -97.49 119.89 36.87 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 126.66 2.475 . . . . 0.0 111.233 175.444 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.275 34.2 m -142.89 -179.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -163.145 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -141.84 143.37 28.48 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 127.568 2.347 . . . . 0.0 111.788 174.409 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.258 2.2 Cg_endo -58.73 -28.18 85.8 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 CA-C-N 127.279 3.635 . . . . 0.0 116.318 -175.073 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.9 m -85.2 19.59 2.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 112.375 -3.678 . . . . 0.0 109.144 178.524 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 55' ' ' THR . 12.0 m-20 -88.18 148.54 24.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 -178.982 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -87.47 154.08 20.92 Favored 'General case' 0 N--CA 1.446 -0.642 1 O-C-N 130.604 4.94 . . . . 0.0 113.244 177.489 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mm -53.17 -30.93 17.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 123.108 2.685 . . . . 0.0 118.069 -175.187 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.29 10.5 tt0 -70.62 -41.52 72.14 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 116.769 -1.586 . . . . 0.0 109.812 -176.315 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -72.95 -20.56 61.03 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 128.425 2.69 . . . . 0.0 112.152 -174.125 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.488 HG21 HD21 ' A' ' 56' ' ' LEU . 61.2 t -79.14 -50.06 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 128.054 2.541 . . . . 0.0 110.796 165.128 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -62.02 -24.06 66.83 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 120.745 1.612 . . . . 0.0 114.992 174.984 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.94 -37.57 53.21 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 128.67 2.788 . . . . 0.0 113.54 170.701 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -81.56 -23.35 37.25 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 126.038 2.086 . . . . 0.0 112.879 -176.649 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.85 -42.63 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 129.072 2.949 . . . . 0.0 104.357 179.669 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -51.03 -54.17 27.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.09 2.556 . . . . 0.0 113.83 164.294 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.66 -44.02 85.4 Favored 'General case' 0 N--CA 1.44 -0.96 1 C-N-CA 131.962 4.105 . . . . 0.0 117.54 -178.364 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -78.15 -81.85 0.1 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.646 1.979 . . . . 0.0 110.128 168.617 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -76.85 -35.11 57.72 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 127.015 2.697 . . . . 0.0 116.596 -162.663 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.85 11.1 23.47 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 119.19 -2.194 . . . . 0.0 117.139 177.024 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mt -88.72 134.54 33.68 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 116.258 -1.83 . . . . 0.0 106.548 -177.125 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -70.38 142.97 46.5 Favored 'Trans proline' 0 N--CA 1.447 -1.241 1 C-N-CA 125.454 4.103 . . . . 0.0 112.646 174.217 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.85 -20.31 68.17 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.698 1.599 . . . . 0.0 112.167 174.815 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -72.0 -5.52 35.58 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 118.231 -2.793 . . . . 0.0 112.179 172.478 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -126.01 0.71 7.25 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.827 2.451 . . . . 0.0 116.312 -176.607 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.262 50.6 mt-30 -101.72 149.01 24.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 122.256 2.298 . . . . 0.0 105.026 -175.219 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -133.06 130.96 40.06 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 158.998 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.8 mt -98.47 133.82 42.31 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.831 2.853 . . . . 0.0 107.019 175.255 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.35 148.07 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 176.319 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -156.7 119.4 4.04 Favored 'General case' 0 C--O 1.24 0.568 1 C-N-CA 132.212 4.205 . . . . 0.0 110.869 167.437 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 74.5 13.67 3.68 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.541 1.936 . . . . 0.0 115.205 177.724 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.9 -28.11 7.16 Favored Glycine 0 CA--C 1.531 1.065 1 CA-C-O 112.282 -4.621 . . . . 0.0 107.272 179.907 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -99.85 134.04 43.33 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 128.022 2.837 . . . . 0.0 110.937 -157.224 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -62.93 129.99 42.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.384 1.053 . . . . 0.0 109.289 163.908 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.78 111.84 6.53 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 125.41 1.484 . . . . 0.0 111.828 171.224 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.473 15.9 tt0 -91.85 148.03 22.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -172.51 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.75 142.77 35.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 120.481 1.491 . . . . 0.0 112.365 -164.877 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.34 -33.94 5.43 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 125.803 2.891 . . . . 0.0 112.86 -177.629 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -80.43 170.69 16.04 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 111.514 -2.343 . . . . 0.0 111.053 -175.886 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 21' ' ' ASP . 70.6 p -115.38 159.28 21.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.994 2.518 . . . . 0.0 108.769 -172.368 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 26' ' ' VAL . 77.2 mt -62.1 -26.43 68.29 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 116.393 -3.942 . . . . 0.0 109.756 179.566 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.0 t -54.23 -50.89 66.12 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.799 2.44 . . . . 0.0 113.353 175.317 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -48.09 -16.56 0.09 Allowed 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 127.476 2.31 . . . . 0.0 117.145 173.535 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -124.96 -4.28 7.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 118.058 -2.901 . . . . 0.0 111.95 179.689 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 93.17 31.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 125.573 1.795 . . . . 0.0 108.073 163.442 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 63.5 mt -89.6 121.2 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 -172.397 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -113.37 176.16 5.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 112.902 -1.953 . . . . 0.0 112.066 -175.675 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -39.14 124.54 1.49 Allowed 'General case' 0 CA--C 1.536 0.42 1 C-N-CA 132.47 4.308 . . . . 0.0 111.643 164.526 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 80.14 0.22 2.03 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.997 3.719 . . . . 0.0 113.808 175.559 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -62.44 135.26 57.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 121.591 1.996 . . . . 0.0 108.733 -171.709 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.9 m -95.72 118.63 32.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.439 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -92.19 155.74 17.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 129.028 2.931 . . . . 0.0 108.067 177.394 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -105.68 133.08 50.99 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 163.607 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.7 tp -101.39 130.94 47.7 Favored 'General case' 0 C--N 1.322 -0.62 1 C-N-CA 132.633 4.373 . . . . 0.0 115.286 162.424 . . . . . . . . 2 2 . 1 . 066 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.5 t -127.24 130.27 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 131.237 3.815 . . . . 0.0 104.041 -179.43 . . . . . . . . 1 1 . 1 . 066 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.445 -0.684 0 CA-C-O 115.249 -2.31 . . . . 0.0 113.163 -177.687 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttp . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 . . . . . . . . . 0 0 . 1 . 067 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -87.09 131.91 33.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.188 0.995 . . . . 0.0 108.411 -175.064 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.268 30.6 pt -110.67 142.21 23.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 154.322 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -88.24 129.72 35.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 160.783 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.19 115.63 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 O-C-N 127.705 3.128 . . . . 0.0 112.812 161.241 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -67.04 118.22 10.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 127.721 2.408 . . . . 0.0 111.415 173.208 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.8 p -86.59 163.95 17.14 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 120.004 3.335 . . . . 0.0 120.004 170.918 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 mp -84.86 -18.14 35.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 129.076 2.951 . . . . 0.0 112.776 179.344 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.93 -37.07 86.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 128.228 2.611 . . . . 0.0 111.804 172.756 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.1 -159.81 24.45 Favored Glycine 0 CA--C 1.533 1.186 1 C-N-CA 132.357 4.789 . . . . 0.0 108.356 -163.165 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 mttt 41.14 -163.47 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 1 N-CA-C 123.397 4.591 . . . . 0.0 123.397 167.28 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.0 p -128.76 157.75 40.57 Favored 'General case' 0 N--CA 1.444 -0.738 2 O-C-N 115.511 -4.493 . . . . 0.0 110.106 164.079 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.8 mm -95.73 130.91 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 161.434 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 m -94.55 120.68 35.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.556 1.17 . . . . 0.0 108.945 163.027 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -100.18 144.53 29.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 131.078 3.751 . . . . 0.0 106.418 -178.455 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.92 141.21 28.67 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 121.521 1.964 . . . . 0.0 108.76 152.908 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.24 153.98 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 O-C-N 124.697 1.248 . . . . 0.0 108.782 172.582 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -90.36 156.94 45.48 Favored Pre-proline 0 C--N 1.322 -0.619 0 O-C-N 118.005 -2.934 . . . . 0.0 104.209 163.542 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.7 -4.34 13.42 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 O-C-N 116.843 -2.241 . . . . 0.0 112.336 -176.776 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.8 p -97.71 7.47 46.37 Favored 'General case' 0 N--CA 1.448 -0.56 1 C-N-CA 135.67 5.588 . . . . 0.0 116.808 173.992 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -82.05 158.13 23.89 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 165.234 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -90.76 161.96 15.08 Favored 'General case' 0 C--N 1.326 -0.435 1 C-N-CA 132.218 4.207 . . . . 0.0 109.524 171.187 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mt -69.28 -20.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 127.572 2.349 . . . . 0.0 110.144 175.556 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.19 -26.14 65.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.088 -1.633 . . . . 0.0 114.009 164.999 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -34.93 69.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 120.858 1.663 . . . . 0.0 111.379 164.558 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.67 -54.45 32.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 122.767 2.53 . . . . 0.0 109.09 174.238 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -48.24 -50.83 28.08 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 118.799 -2.438 . . . . 0.0 115.569 177.788 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.27 -11.24 59.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 116.444 -1.741 . . . . 0.0 113.394 -176.438 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -81.62 -35.25 30.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 122.022 2.192 . . . . 0.0 111.416 166.7 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.24 -44.3 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 126.204 1.802 . . . . 0.0 109.183 169.045 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.32 44.6 tt0 -69.25 -40.05 78.1 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 117.372 -3.33 . . . . 0.0 110.018 -175.907 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -52.25 -49.46 63.99 Favored 'General case' 0 N--CA 1.445 -0.7 1 C-N-CA 134.669 5.187 . . . . 0.0 110.27 169.092 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.275 35.3 mttm -76.03 -57.9 3.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 114.023 -2.894 . . . . 0.0 110.345 177.804 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -113.07 -12.87 13.13 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 121.674 2.034 . . . . 0.0 106.564 -157.992 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.45 1.49 60.61 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 125.369 3.713 . . . . 0.0 114.934 160.732 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.9 mm -74.49 133.77 76.92 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 125.897 1.587 . . . . 0.0 108.545 -174.519 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -66.92 144.85 72.16 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 N-CA-C 116.432 1.666 . . . . 0.0 116.432 176.393 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.16 -25.31 13.84 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 CA-C-O 116.247 -1.647 . . . . 0.0 110.784 -162.467 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.63 -12.06 59.95 Favored 'General case' 0 N--CA 1.442 -0.836 1 C-N-CA 133.298 4.639 . . . . 0.0 105.47 -176.358 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.1 tp60 -104.59 -15.13 15.4 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 125.305 1.628 . . . . 0.0 112.321 174.159 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -83.53 95.48 8.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 116.624 -3.797 . . . . 0.0 109.642 -178.597 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -87.89 92.75 9.24 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 121.919 2.145 . . . . 0.0 108.437 175.824 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.57 130.35 34.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 112.085 -2.325 . . . . 0.0 109.606 -179.021 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.9 mt -116.45 143.33 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 111.47 -2.604 . . . . 0.0 108.348 -170.452 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -144.16 129.85 19.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.107 1.363 . . . . 0.0 110.362 161.56 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.286 . . 57.15 15.88 2.7 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 119.613 3.19 . . . . 0.0 119.613 174.752 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.72 -32.88 5.78 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 117.989 -1.45 . . . . 0.0 112.279 -172.552 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.8 tttm -92.47 127.93 38.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.793 1.797 . . . . 0.0 108.121 -170.784 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 104.94 13.39 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 128.85 3.844 . . . . 0.0 106.348 168.095 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 50' ' ' LEU . 44.1 mt -71.84 125.19 26.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 111.438 -2.619 . . . . 0.0 113.964 -157.632 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.59 161.57 29.02 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 124.704 2.192 . . . . 0.0 105.25 -166.368 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.93 154.73 31.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.06 1.744 . . . . 0.0 112.836 163.541 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.81 -4.81 24.27 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.303 2.382 . . . . 0.0 114.949 165.466 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -136.1 168.93 18.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -171.66 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.8 p -107.44 173.76 6.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 119.324 -2.11 . . . . 0.0 113.163 -175.353 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mt -76.64 -18.34 58.65 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 116.867 -3.645 . . . . 0.0 108.527 -164.312 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.2 t -76.93 -31.27 56.52 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 129.398 3.079 . . . . 0.0 105.644 177.782 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 35.0 m-20 -78.22 -44.25 26.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 102.41 -3.181 . . . . 0.0 102.41 -173.809 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -72.64 1.93 7.43 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 127.539 2.336 . . . . 0.0 114.832 174.556 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t30 72.15 5.46 5.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.73 2.012 . . . . 0.0 113.042 171.199 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.417 HD13 HD21 ' A' ' 67' ' ' LEU . 5.4 mt -70.54 129.61 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 125.004 3.547 . . . . 0.0 106.701 -168.814 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.325 95.6 mm-40 -103.69 166.58 10.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 125.958 2.036 . . . . 0.0 108.9 174.466 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -42.65 123.1 2.53 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 130.725 3.61 . . . . 0.0 114.744 170.772 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.404 8.0 mp0 85.66 8.28 0.35 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 129.446 3.098 . . . . 0.0 112.87 170.161 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -64.86 137.72 57.94 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 119.756 -1.84 . . . . 0.0 110.22 177.034 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -93.74 107.38 19.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 119.688 -1.883 . . . . 0.0 109.475 174.094 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.417 HD21 HD13 ' A' ' 61' ' ' ILE . 9.5 mp -98.95 148.82 23.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 100.378 -3.934 . . . . 0.0 100.378 178.226 . . . . . . . . 2 2 . 1 . 067 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -92.52 141.23 28.73 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 116.341 -3.975 . . . . 0.0 109.008 171.509 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.355 14.1 tp -107.77 131.35 54.55 Favored 'General case' 0 N--CA 1.451 -0.413 1 N-CA-C 98.36 -4.682 . . . . 0.0 98.36 158.05 . . . . . . . . 3 2 . 1 . 067 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.66 139.55 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 126.598 2.436 . . . . 0.0 105.387 169.465 . . . . . . . . 1 1 . 1 . 067 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.2 mt . . . . . 0 N--CA 1.451 -0.42 0 CA-C-N 111.982 -2.372 . . . . 0.0 105.905 176.576 . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 ttp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 0 0 . 1 . 068 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -87.15 152.08 22.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 102.842 -3.021 . . . . 0.0 102.842 -175.032 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 pt -150.65 164.33 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 131.538 3.935 . . . . 0.0 107.04 169.689 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -118.04 141.15 48.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 130.379 3.472 . . . . 0.0 112.351 166.568 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m -104.4 151.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 111.464 -2.607 . . . . 0.0 108.671 162.134 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -140.67 156.42 46.24 Favored 'General case' 0 C--N 1.327 -0.377 1 O-C-N 115.266 -4.646 . . . . 0.0 106.848 176.679 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.347 4.8 t -142.21 152.5 43.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.475 2.71 . . . . 0.0 107.512 -176.671 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.97 -8.26 4.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 130.825 3.65 . . . . 0.0 118.388 -170.962 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.2 p -79.61 -20.0 47.9 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 123.891 3.041 . . . . 0.0 108.492 166.675 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.35 -1.17 23.75 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 128.676 3.036 . . . . 0.0 112.562 -175.733 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.269 75.3 tttt -72.78 143.45 47.92 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 118.449 -2.795 . . . . 0.0 110.318 -173.828 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.4 p -135.27 143.43 46.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.859 2.064 . . . . 0.0 114.344 179.727 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -139.19 143.35 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 1 C-N-CA 131.71 4.004 . . . . 0.0 109.963 -178.916 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 t -101.74 139.89 36.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.611 1.82 . . . . 0.0 113.215 171.015 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mt -129.85 151.25 50.62 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.235 1.414 . . . . 0.0 109.219 177.667 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -109.19 118.06 35.73 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.833 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.43 139.37 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -170.039 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -76.62 142.72 70.79 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-O 124.37 2.033 . . . . 0.0 106.195 177.044 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -58.81 -36.49 96.93 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 125.016 3.811 . . . . 0.0 116.546 178.051 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 p -72.72 -12.99 61.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.495 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -72.09 140.75 49.08 Favored 'General case' 0 N--CA 1.45 -0.455 1 O-C-N 115.303 -4.623 . . . . 0.0 113.026 -176.831 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 26' ' ' VAL . 77.3 p -73.14 134.98 44.64 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 179.447 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.251 26.6 mm -47.34 -38.24 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 129.704 3.202 . . . . 0.0 110.48 179.431 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -36.35 76.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 172.05 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -77.2 -40.52 44.83 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 129.249 3.02 . . . . 0.0 107.3 -177.777 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 22' ' ' THR . 44.0 t -70.94 -31.04 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 130.565 3.546 . . . . 0.0 112.331 -177.75 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -64.86 -32.66 74.47 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 116.709 -3.744 . . . . 0.0 108.559 179.39 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.37 69.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 117.232 -3.417 . . . . 0.0 113.138 172.502 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -74.54 -5.98 45.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 119.859 1.209 . . . . 0.0 111.666 -171.186 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.21 -35.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 123.695 1.712 . . . . 0.0 114.432 156.454 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -72.72 -38.0 67.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 118.232 -2.792 . . . . 0.0 110.053 -166.818 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.67 -36.81 83.42 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.09 171.055 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -90.14 -33.57 16.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 113.982 -2.913 . . . . 0.0 112.084 -175.35 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -126.25 -30.25 2.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 122.037 2.199 . . . . 0.0 112.373 -171.999 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.81 -8.35 42.84 Favored Glycine 0 CA--C 1.522 0.507 1 CA-C-O 112.157 -4.691 . . . . 0.0 113.153 176.935 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -74.21 125.58 89.88 Favored Pre-proline 0 C--N 1.328 -0.347 1 O-C-N 131.361 4.8 . . . . 0.0 108.025 -175.914 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 83.3 Cg_endo -68.06 138.28 43.36 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 N-CA-C 117.525 2.086 . . . . 0.0 117.525 166.007 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 9.3 Cg_endo -61.42 -31.95 88.64 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.901 3.067 . . . . 0.0 115.521 -170.656 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.61 -17.93 64.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 111.911 -3.899 . . . . 0.0 108.293 -171.467 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -78.09 -13.22 59.95 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 117.97 2.581 . . . . 0.0 117.97 172.151 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -116.13 151.46 35.6 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 120.328 -1.482 . . . . 0.0 111.344 -154.27 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -141.33 123.67 15.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 116.556 -3.84 . . . . 0.0 113.283 175.616 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.3 148.6 28.24 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 117.132 -3.48 . . . . 0.0 115.862 171.807 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.32 45.7 mt -131.11 138.6 53.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 127.955 2.502 . . . . 0.0 110.481 179.528 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' HB3' HD21 ' A' ' 50' ' ' LEU . 36.0 t80 -135.85 -176.98 4.48 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 179.52 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.41 85.75 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.226 3.01 . . . . 0.0 116.565 -164.931 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.41 -36.46 3.96 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 118.806 -2.434 . . . . 0.0 117.359 -174.492 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.355 86.1 tttt -151.87 159.6 43.8 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 125.955 2.788 . . . . 0.0 111.081 -160.401 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -80.61 144.31 32.46 Favored 'General case' 0 C--N 1.323 -0.545 1 CA-C-N 107.405 -4.452 . . . . 0.0 108.202 178.723 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 45' ' ' PHE . 18.3 mt -94.72 133.23 38.63 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 115.812 -2.355 . . . . 0.0 109.91 -175.397 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.2 132.13 48.3 Favored 'General case' 0 C--N 1.326 -0.454 1 O-C-N 115.694 -4.378 . . . . 0.0 118.624 168.229 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -76.46 93.28 3.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 128.7 3.75 . . . . 0.0 111.021 -168.649 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.55 -0.23 2.74 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 118.495 2.158 . . . . 0.0 118.495 -170.919 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -102.81 175.15 5.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.065 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.333 78.8 p -105.38 164.13 12.09 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.651 2.781 . . . . 0.0 110.56 -172.033 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -41.04 -51.66 3.28 Favored 'General case' 0 N--CA 1.446 -0.644 1 C-N-CA 132.109 4.164 . . . . 0.0 110.699 164.646 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 m -86.04 -6.96 58.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.253 -164.787 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -69.24 -38.62 78.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 124.911 2.291 . . . . 0.0 112.21 171.115 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.444 ' CD2' HD22 ' A' ' 50' ' ' LEU . 75.5 m-85 -103.55 -5.18 22.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 128.121 2.568 . . . . 0.0 112.812 -175.559 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.521 0.7 OUTLIER 75.61 37.62 0.41 Allowed 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 128.098 3.374 . . . . 0.0 113.584 175.539 . . . . . . . . 3 3 . 1 . 068 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.402 HG23 ' CB ' ' A' ' 65' ' ' SER . 85.0 mt -70.81 137.28 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 173.129 . . . . . . . . 2 2 . 1 . 068 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -131.69 -178.06 4.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.147 -168.797 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -42.21 110.62 0.18 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.926 2.491 . . . . 0.0 113.77 176.274 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 73.88 25.24 1.95 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.514 1.926 . . . . 0.0 111.829 172.458 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.402 ' CB ' HG23 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -62.14 128.76 37.65 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 119.182 -2.199 . . . . 0.0 110.262 179.722 . . . . . . . . 3 3 . 1 . 068 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.9 m -91.12 107.6 19.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.216 1.006 . . . . 0.0 111.017 172.486 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.5 mt -97.01 147.56 23.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.432 1.893 . . . . 0.0 107.23 179.481 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -101.55 147.83 25.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 117.117 -1.42 . . . . 0.0 107.595 -174.181 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.19 142.97 46.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 125.095 2.379 . . . . 0.0 107.983 -179.631 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -138.42 159.59 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 O-C-N 119.353 -2.092 . . . . 0.0 105.468 173.191 . . . . . . . . 1 1 . 1 . 068 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 112.528 -3.606 . . . . 0.0 118.151 151.24 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttp . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 . . . . . . . . . 0 0 . 1 . 069 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -101.41 137.27 39.96 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 -177.369 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.492 9.7 pt -142.67 149.79 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 1 C-N-CA 133.08 4.552 . . . . 0.0 110.259 174.913 . . . . . . . . 3 2 . 1 . 069 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -108.96 141.35 41.19 Favored 'General case' 0 C--O 1.223 -0.312 1 N-CA-C 99.909 -4.108 . . . . 0.0 99.909 -175.602 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.15 119.57 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 124.249 1.02 . . . . 0.0 113.526 156.689 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -91.5 111.3 22.75 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 -178.971 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -65.95 162.55 18.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 124.644 2.164 . . . . 0.0 115.26 171.758 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -68.53 -7.0 28.49 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 118.515 -2.615 . . . . 0.0 115.832 176.882 . . . . . . . . 3 3 . 1 . 069 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -123.08 14.01 9.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 118.668 -2.52 . . . . 0.0 109.671 -176.826 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.16 -31.87 7.53 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 115.772 -2.682 . . . . 0.0 112.49 154.492 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -61.85 147.49 46.4 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 179.257 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.9 m -105.39 149.1 26.4 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 115.483 -2.199 . . . . 0.0 112.98 175.236 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.23 124.91 72.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 100.647 -3.834 . . . . 0.0 100.647 -179.623 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -78.14 134.18 37.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 117.227 -3.421 . . . . 0.0 110.525 162.612 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.4 mt -115.17 132.23 56.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 125.268 1.605 . . . . 0.0 109.141 167.892 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -97.38 117.21 31.09 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 127.42 2.95 . . . . 0.0 105.298 168.017 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.46 ' HB ' ' H ' ' A' ' 18' ' ' GLU . 16.3 m -141.41 -171.52 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 125.054 1.342 . . . . 0.0 112.167 -175.32 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' H ' ' HB ' ' A' ' 17' ' ' VAL . 1.2 tm-20 -136.88 146.8 56.55 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-O 115.673 -2.108 . . . . 0.0 108.246 -165.175 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.53 -29.05 83.55 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.645 2.897 . . . . 0.0 118.425 178.346 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.4 p -92.76 1.13 57.44 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 127.614 3.071 . . . . 0.0 114.248 -175.692 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.73 118.34 22.18 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -173.273 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.286 17.0 p -52.03 142.68 15.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 117.658 -3.151 . . . . 0.0 116.181 164.108 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.358 2.5 mm -31.23 -56.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 128.001 2.52 . . . . 0.0 114.977 174.405 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.252 12.9 mm-40 -53.71 -43.77 69.29 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.035 2.534 . . . . 0.0 117.573 172.588 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.417 6.6 m120 -59.95 -14.67 16.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 118.503 2.779 . . . . 0.0 118.503 165.296 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.352 61.7 t -97.7 -33.36 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.159 1.784 . . . . 0.0 110.18 174.696 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -75.55 -27.72 58.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.346 -1.788 . . . . 0.0 109.997 178.68 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.93 -56.67 18.64 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 129.578 3.151 . . . . 0.0 112.414 167.643 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.297 88.5 mttt -44.19 -29.92 0.71 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 164.272 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -77.72 -28.69 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 O-C-N 118.407 -2.683 . . . . 0.0 112.018 171.037 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -77.2 -35.02 56.08 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 122.576 2.443 . . . . 0.0 107.392 -174.388 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.57 -31.86 66.57 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 126.005 2.066 . . . . 0.0 108.886 177.735 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -92.85 -50.56 5.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 113.113 -3.327 . . . . 0.0 110.844 -177.136 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -112.54 -19.05 12.25 Favored 'General case' 0 N--CA 1.439 -0.983 1 O-C-N 130.346 4.779 . . . . 0.0 111.129 -155.806 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.34 -4.63 58.56 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 125.631 1.832 . . . . 0.0 116.183 174.083 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.54 112.89 35.18 Favored Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 130.926 3.691 . . . . 0.0 111.06 -172.642 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.57 150.77 87.67 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 O-C-N 123.377 1.198 . . . . 0.0 111.711 -173.677 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.422 50.8 Cg_exo -41.58 -50.67 4.65 Favored 'Trans proline' 0 N--CA 1.457 -0.639 1 C-N-CA 125.648 4.232 . . . . 0.0 116.939 167.833 . . . . . . . . 3 2 . 1 . 069 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.271 33.9 t70 -56.67 -22.92 38.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -178.681 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -95.52 -13.15 24.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 117.542 -3.224 . . . . 0.0 110.222 -173.807 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.261 77.7 mt-30 -94.19 136.26 34.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.957 -164.282 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.617 ' HG2' HE22 ' A' ' 49' ' ' GLN . 70.9 mtp180 -115.67 127.42 55.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 102.237 -3.245 . . . . 0.0 102.237 165.408 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.1 mt -102.62 119.79 39.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 124.525 1.141 . . . . 0.0 113.216 168.006 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 17.6 mm -114.63 152.72 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 128.947 2.899 . . . . 0.0 105.715 -170.016 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -168.0 127.04 1.25 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 112.013 -2.358 . . . . 0.0 106.556 176.532 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.417 . . 75.78 15.28 2.59 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 122.398 2.363 . . . . 0.0 116.044 167.068 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.49 17.44 31.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.856 2.646 . . . . 0.0 118.318 177.793 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 pttt -160.66 149.49 16.74 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -156.801 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.617 HE22 ' HG2' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -75.1 143.04 43.56 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 125.309 1.631 . . . . 0.0 108.021 178.094 . . . . . . . . 3 3 . 1 . 069 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.45 117.2 18.69 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.462 -1.399 . . . . 0.0 107.757 169.755 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -81.57 150.92 27.94 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 131.145 3.778 . . . . 0.0 113.657 -166.422 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -64.86 120.56 12.76 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.781 2.033 . . . . 0.0 107.647 -171.956 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.56 15.25 3.7 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.394 1.949 . . . . 0.0 113.172 165.139 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.337 20.1 mtt180 -133.68 146.71 51.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 123.071 1.415 . . . . 0.0 113.881 -161.438 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -107.85 149.86 27.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 124.077 1.894 . . . . 0.0 107.505 178.043 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 mt -34.19 -48.09 0.31 Allowed 'General case' 0 N--CA 1.448 -0.525 1 C-N-CA 132.419 4.288 . . . . 0.0 116.124 176.778 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.4 p -83.88 -6.39 59.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -179.432 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.352 31.1 t0 -101.17 -10.7 20.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.765 2.026 . . . . 0.0 107.713 176.372 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.88 -14.36 17.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 129.412 3.085 . . . . 0.0 111.703 173.974 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 73.23 39.58 0.59 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 127.238 2.836 . . . . 0.0 110.578 -175.412 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.66 HD13 HD21 ' A' ' 67' ' ' LEU . 8.6 mt -87.05 96.64 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 121.988 2.176 . . . . 0.0 111.075 172.062 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.84 169.51 17.77 Favored 'General case' 0 C--N 1.325 -0.498 1 C-N-CA 134.848 5.259 . . . . 0.0 112.442 177.32 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.291 0.0 OUTLIER -51.3 140.19 17.5 Favored 'General case' 0 N--CA 1.439 -0.988 1 C-N-CA 131.739 4.016 . . . . 0.0 111.539 175.915 . . . . . . . . 4 3 . 1 . 069 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 37.34 43.58 0.39 Allowed 'General case' 0 C--N 1.324 -0.518 1 C-N-CA 133.654 4.781 . . . . 0.0 112.699 -176.917 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -59.6 147.51 36.97 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.97 1.708 . . . . 0.0 113.34 154.964 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.4 m -112.61 126.04 54.94 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 128.387 3.554 . . . . 0.0 103.798 169.7 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -124.64 160.05 29.36 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 127.696 3.123 . . . . 0.0 106.173 171.355 . . . . . . . . 3 3 . 1 . 069 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 28.0 m80 -126.54 113.39 16.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 101.696 -3.446 . . . . 0.0 101.696 -155.523 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.3 tp -92.22 120.95 33.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 111.893 -2.412 . . . . 0.0 111.22 175.733 . . . . . . . . 1 1 . 1 . 069 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.27 12.1 m -127.32 154.52 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 127.172 2.189 . . . . 0.0 107.818 173.435 . . . . . . . . 2 2 . 1 . 069 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.258 2.3 pp . . . . . 0 N--CA 1.451 -0.418 0 CA-C-N 120.372 1.442 . . . . 0.0 112.505 -172.282 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 . . . . . . . . . 0 0 . 1 . 070 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -86.64 131.16 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.008 1.323 . . . . 0.0 111.481 -172.174 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.566 HD12 HD13 ' A' ' 67' ' ' LEU . 19.4 pt -125.59 150.32 30.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 -175.536 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.273 2.2 m-85 -92.32 130.57 37.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.276 1.43 . . . . 0.0 108.764 168.29 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.37 96.93 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 O-C-N 127.639 3.087 . . . . 0.0 105.67 -177.093 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -85.22 123.69 31.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.01 -2.931 . . . . 0.0 104.499 -170.835 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -76.23 150.31 37.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 165.192 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.8 tp -59.88 -24.51 64.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -173.707 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -89.16 0.28 56.87 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 120.391 -1.443 . . . . 0.0 113.182 -179.696 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.5 -5.93 18.89 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 115.093 -3.06 . . . . 0.0 117.967 166.149 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -86.14 131.73 34.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 128.339 3.023 . . . . 0.0 106.633 -174.534 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -113.66 104.1 11.89 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.062 -172.274 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.2 mt -88.09 126.38 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -172.555 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 9.5 m -93.06 121.33 34.3 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 177.326 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.281 55.8 tp -144.61 144.24 31.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 119.991 -1.693 . . . . 0.0 111.16 -165.511 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.5 134.45 42.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 122.073 0.939 . . . . 0.0 109.103 -177.341 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.34 169.2 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 174.251 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -109.9 160.98 26.07 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 127.641 2.376 . . . . 0.0 110.374 164.531 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.64 -23.31 17.08 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 125.194 3.929 . . . . 0.0 115.283 -176.353 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -83.91 -1.21 54.07 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.856 -2.403 . . . . 0.0 114.644 -179.731 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -79.62 121.14 24.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.727 2.011 . . . . 0.0 107.306 -177.618 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.4 p -48.63 148.49 2.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 164.616 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' CD1' HD23 ' A' ' 56' ' ' LEU 0.393 8.6 mm -38.3 -15.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 130.089 3.355 . . . . 0.0 118.382 173.46 . . . . . . . . 3 3 . 1 . 070 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -94.21 -49.8 5.57 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 123.695 2.952 . . . . 0.0 107.4 -159.256 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -51.33 -32.7 26.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.898 2.079 . . . . 0.0 114.677 -155.239 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -73.03 -21.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 1 CA-C-O 129.67 4.557 . . . . 0.0 119.359 -178.993 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -69.81 -40.31 76.02 Favored 'General case' 0 N--CA 1.442 -0.85 1 O-C-N 114.41 -5.181 . . . . 0.0 115.091 -171.413 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.58 -23.34 49.99 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 112.453 -3.641 . . . . 0.0 111.34 170.764 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -63.18 -48.39 78.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.458 2.349 . . . . 0.0 113.382 166.087 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 mm -62.23 -42.12 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 126.28 1.832 . . . . 0.0 112.309 173.204 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -47.86 -43.75 28.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 166.996 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.42 -47.2 50.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.652 -173.836 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.28 -30.11 16.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 127.317 2.886 . . . . 0.0 115.706 -176.565 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -120.99 -0.73 9.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 121.682 2.037 . . . . 0.0 110.329 179.676 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.85 -0.05 87.7 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 118.258 -2.776 . . . . 0.0 116.494 166.692 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 71' ' ' LEU . 11.6 mt -99.65 128.54 31.06 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 -170.768 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.84 155.0 58.59 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 121.818 3.738 . . . . 0.0 121.818 175.898 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -59.4 -32.17 96.08 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 124.868 3.712 . . . . 0.0 117.083 176.104 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.46 1.6 t0 -52.51 -21.48 3.83 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 163.311 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -106.28 -18.42 14.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.705 2.002 . . . . 0.0 111.755 -179.519 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -98.94 100.87 12.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 116.774 -3.704 . . . . 0.0 103.264 -172.321 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -108.73 138.6 44.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 110.352 -3.113 . . . . 0.0 104.135 166.672 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -148.51 161.72 41.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 121.654 2.025 . . . . 0.0 114.81 -168.612 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mp -129.28 131.54 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 1 C-N-CA 134.667 5.187 . . . . 0.0 112.31 -169.822 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -98.35 -50.06 4.46 Favored 'General case' 0 N--CA 1.449 -0.475 1 CA-C-O 111.577 -4.059 . . . . 0.0 114.574 161.613 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -162.35 43.36 0.13 Allowed 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 128.158 3.411 . . . . 0.0 108.054 -161.217 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.43 -69.85 0.49 Allowed Glycine 0 CA--C 1.531 1.048 0 CA-C-O 124.002 1.89 . . . . 0.0 116.686 163.778 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -54.66 132.93 46.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 162.011 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 145.58 42.58 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 116.737 -1.985 . . . . 0.0 111.955 154.933 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 59' ' ' TYR . 23.2 mt -91.08 116.98 29.23 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 123.567 1.651 . . . . 0.0 113.297 -175.498 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.271 32.1 tt0 -84.49 156.37 21.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 112.437 -2.165 . . . . 0.0 116.156 -167.67 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -65.59 141.89 58.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.281 1.832 . . . . 0.0 109.689 175.083 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.58 -42.44 1.91 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-O 115.474 -2.848 . . . . 0.0 111.585 -178.181 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 mmp_? -72.98 173.5 9.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 121.67 2.735 . . . . 0.0 117.111 -173.289 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -120.71 155.82 33.09 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 126.67 2.481 . . . . 0.0 104.925 174.868 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 ' CD1' ' A' ' 23' ' ' ILE . 49.7 mt -59.37 -29.86 68.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 125.382 2.515 . . . . 0.0 113.071 -176.882 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -47.57 -46.05 27.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 118.373 -2.704 . . . . 0.0 116.228 163.905 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -68.32 -12.32 60.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.406 -175.622 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.479 ' CE2' HD22 ' A' ' 50' ' ' LEU . 55.8 m-85 -106.67 1.37 25.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 128.169 2.587 . . . . 0.0 112.742 178.746 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 2.4 t-20 66.14 39.16 4.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.173 1.389 . . . . 0.0 110.262 175.24 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -88.33 131.28 36.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 120.75 1.614 . . . . 0.0 110.289 -176.708 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -100.44 -176.14 3.12 Favored 'General case' 0 C--O 1.221 -0.406 1 O-C-N 116.235 -4.04 . . . . 0.0 110.403 -176.982 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -55.8 146.7 20.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.617 1.967 . . . . 0.0 112.084 149.837 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 66.1 14.82 9.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.062 1.745 . . . . 0.0 112.317 176.418 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.0 m -71.02 155.85 40.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.508 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.6 m -113.5 120.87 42.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 129.461 3.105 . . . . 0.0 105.371 176.871 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.566 HD13 HD12 ' A' ' 3' ' ' ILE . 4.9 mp -110.86 140.73 45.07 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 114.274 -2.774 . . . . 0.0 106.089 170.481 . . . . . . . . 2 2 . 1 . 070 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -129.49 138.95 51.67 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.224 1.81 . . . . 0.0 106.484 -174.691 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.59 151.51 22.26 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.819 177.53 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -105.85 109.49 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 131.388 3.875 . . . . 0.0 102.287 170.432 . . . . . . . . 1 1 . 1 . 070 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 36' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 C-N-CA 129.929 3.292 . . . . 0.0 104.446 -179.972 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 116.714 -1.612 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -109.03 139.44 43.9 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.032 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.11 152.19 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 128.461 2.704 . . . . 0.0 106.624 -172.76 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -105.51 140.98 37.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 124.531 2.11 . . . . 0.0 110.657 179.012 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.309 1.7 p -145.76 107.79 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.146 -178.823 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -84.23 137.2 33.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 126.038 2.086 . . . . 0.0 113.404 -173.395 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -78.91 170.68 16.3 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 113.803 -2.999 . . . . 0.0 111.615 -176.303 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 9.4 tp -60.43 -13.78 15.4 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 126.936 2.648 . . . . 0.0 118.041 -175.759 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 p -107.74 -6.34 16.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.997 1.319 . . . . 0.0 110.808 -178.681 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.0 1.81 31.8 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 120.379 -1.451 . . . . 0.0 112.745 168.161 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 tttt -84.32 119.86 25.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 130.113 3.365 . . . . 0.0 102.127 -168.343 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 3.4 m -88.71 134.89 33.77 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 -167.104 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.5 mt -120.48 152.89 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.808 2.043 . . . . 0.0 110.061 169.254 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.286 1.5 m -118.58 123.1 44.22 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 169.955 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.9 mt -116.6 140.86 48.92 Favored 'General case' 0 N--CA 1.447 -0.59 1 C-N-CA 133.587 4.755 . . . . 0.0 111.348 -176.622 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.326 0.4 OUTLIER -99.27 120.01 38.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 101.387 -3.561 . . . . 0.0 101.387 167.228 . . . . . . . . 3 3 . 1 . 071 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.88 -19.45 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 113.473 -3.156 . . . . 0.0 110.666 -168.769 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 0.1 OUTLIER 90.81 127.54 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-O 115.557 -2.163 . . . . 0.0 106.651 177.426 . . . . . . . . 3 3 . 1 . 071 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -74.72 -29.26 8.92 Favored 'Trans proline' 0 N--CA 1.452 -0.966 1 C-N-CA 125.688 4.259 . . . . 0.0 113.514 178.345 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -84.54 -7.73 59.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.448 3.099 . . . . 0.0 110.606 -178.342 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.5 -177.86 3.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 122.372 2.351 . . . . 0.0 109.355 178.645 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -130.43 167.79 18.03 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -173.321 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -66.57 -38.02 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.636 1.575 . . . . 0.0 110.479 -164.735 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -56.66 -34.66 67.57 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 122.132 2.242 . . . . 0.0 109.902 -178.272 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -82.38 -2.11 52.01 Favored 'General case' 0 N--CA 1.445 -0.688 1 O-C-N 114.061 -5.4 . . . . 0.0 115.166 -178.498 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -88.98 -46.37 15.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 176.632 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HA ' HD12 ' A' ' 30' ' ' ILE . 58.1 mtmt -65.97 -29.77 70.21 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.169 0.988 . . . . 0.0 112.717 177.86 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.81 -41.11 79.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.932 2.493 . . . . 0.0 107.885 174.279 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -72.98 -30.08 63.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 173.958 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 27' ' ' LYS . 16.2 mt -67.48 -46.86 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 122.279 2.309 . . . . 0.0 111.533 169.019 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -49.75 -51.85 36.01 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 117.478 -3.264 . . . . 0.0 119.062 169.831 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -53.26 -38.05 62.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 128.602 2.761 . . . . 0.0 117.117 168.854 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -57.03 -62.81 1.49 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.46 1.504 . . . . 0.0 111.836 172.917 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.309 5.9 mm-40 -131.56 -8.7 3.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 125.493 2.568 . . . . 0.0 113.778 -157.361 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.82 32.85 6.32 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 119.955 -1.716 . . . . 0.0 115.993 178.022 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mm -82.58 130.04 60.29 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 127.889 2.476 . . . . 0.0 107.975 -167.495 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.88 127.9 15.16 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.312 2.008 . . . . 0.0 112.062 172.923 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.91 -34.99 7.88 Favored 'Trans proline' 0 N--CA 1.447 -1.219 1 C-N-CA 127.391 5.394 . . . . 0.0 112.518 -169.315 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -68.73 -19.97 64.37 Favored 'General case' 0 C--N 1.321 -0.633 1 C-N-CA 135.418 5.487 . . . . 0.0 110.244 -172.869 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -94.97 -3.74 47.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.893 1.677 . . . . 0.0 108.495 -176.914 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 10.2 mm100 -96.1 107.49 19.8 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 130.261 3.424 . . . . 0.0 111.446 -172.296 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -94.16 101.66 13.67 Favored 'General case' 0 N--CA 1.444 -0.761 1 C-N-CA 132.759 4.424 . . . . 0.0 107.24 167.919 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.488 ' CD1' ' HB3' ' A' ' 41' ' ' GLN . 11.2 mp -103.5 101.93 11.82 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 127.536 2.334 . . . . 0.0 111.4 -174.332 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.6 mm -108.69 142.3 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 123.704 1.716 . . . . 0.0 107.225 179.209 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -124.79 105.17 9.07 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 112.529 -2.123 . . . . 0.0 109.508 173.671 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.84 42.1 15.45 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 127.12 3.343 . . . . 0.0 117.048 176.791 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.9 -14.5 52.65 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 109.401 -3.545 . . . . 0.0 118.735 178.325 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.25 77.3 mttt -115.1 130.34 56.9 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -166.374 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.33 48.3 tt0 -48.33 142.34 5.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 121.345 3.832 . . . . 0.0 121.345 162.319 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 50' ' ' LEU . 87.8 mt -98.02 105.49 17.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 172.481 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -88.07 140.81 29.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 -175.706 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -81.09 141.64 34.11 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 124.161 3.164 . . . . 0.0 103.047 173.269 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.16 -29.67 6.66 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -175.664 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.39 150.4 23.83 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 127.31 2.418 . . . . 0.0 113.202 176.475 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -77.9 156.92 30.03 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.398 -1.273 . . . . 0.0 109.537 166.151 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.4 mt -74.6 -31.94 62.19 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.553 1.941 . . . . 0.0 109.589 -178.033 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.1 t -75.33 -12.67 60.32 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 120.414 -1.428 . . . . 0.0 112.572 175.917 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -66.05 -34.32 77.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 123.679 2.945 . . . . 0.0 112.65 169.518 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -91.59 7.08 43.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 127.234 2.834 . . . . 0.0 116.283 172.889 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.368 81.1 m-20 76.53 36.2 0.38 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.977 1.711 . . . . 0.0 113.304 171.285 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.4 mt -82.03 99.32 5.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 171.019 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -110.07 -172.92 2.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 129.978 3.311 . . . . 0.0 113.926 179.48 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.05 140.86 0.99 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 128.317 2.647 . . . . 0.0 117.202 173.71 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 6.7 tm-20 73.62 4.19 4.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 122.439 2.382 . . . . 0.0 114.449 162.823 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.2 m -72.54 132.14 43.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.572 -1.649 . . . . 0.0 107.913 -173.217 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.0 p -105.68 142.36 35.55 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 125.071 1.482 . . . . 0.0 108.109 167.198 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.29 165.91 26.18 Favored 'General case' 0 N--CA 1.446 -0.636 1 C-N-CA 131.838 4.055 . . . . 0.0 105.692 167.261 . . . . . . . . 2 2 . 1 . 071 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -99.54 161.58 13.53 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 126.022 2.82 . . . . 0.0 104.486 165.894 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.2 tp -148.11 132.56 17.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 118.762 -2.461 . . . . 0.0 110.224 -179.56 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -68.34 89.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 127.023 3.296 . . . . 0.0 104.529 163.812 . . . . . . . . 1 1 . 1 . 071 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 N--CA 1.443 -0.812 1 N-CA-C 98.601 -4.592 . . . . 0.0 98.601 175.427 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ttp . . . . . 0 C--O 1.24 0.568 1 N-CA-C 99.492 -4.262 . . . . 0.0 99.492 . . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -94.37 136.15 34.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 123.082 2.674 . . . . 0.0 110.694 167.966 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.27 161.25 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 102.902 -2.999 . . . . 0.0 102.902 170.401 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -117.25 149.76 39.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.045 1.738 . . . . 0.0 113.481 -171.67 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' HB2' ' A' ' 67' ' ' LEU 0.343 16.3 m -141.69 165.0 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 128.681 2.792 . . . . 0.0 112.41 169.062 . . . . . . . . 3 3 . 1 . 072 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -149.78 142.17 24.29 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -169.367 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -136.72 -145.21 0.21 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 129.08 2.952 . . . . 0.0 108.604 175.246 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -96.29 -55.01 3.08 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 121.357 1.889 . . . . 0.0 108.254 -169.036 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -84.98 -27.1 26.71 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.295 1.838 . . . . 0.0 114.276 -179.917 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.94 123.95 7.15 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 106.505 -2.638 . . . . 0.0 106.505 175.269 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -102.86 -29.04 11.69 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.011 2.524 . . . . 0.0 107.383 -174.683 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -137.28 96.37 3.26 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 114.283 -2.77 . . . . 0.0 104.497 -177.233 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.9 mt -103.29 109.32 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 1 N-CA-C 98.541 -4.614 . . . . 0.0 98.541 165.009 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.271 62.8 p -86.77 131.48 34.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 173.922 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -128.61 120.72 27.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.436 -2.802 . . . . 0.0 103.436 -175.603 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -96.01 120.39 36.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.611 3.564 . . . . 0.0 105.681 -178.435 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 m -143.4 159.01 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 O-C-N 117.482 -3.261 . . . . 0.0 108.057 -170.07 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.71 151.29 37.37 Favored Pre-proline 0 N--CA 1.447 -0.606 1 C-N-CA 132.618 4.367 . . . . 0.0 100.764 163.644 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.281 73.1 Cg_endo -64.47 8.7 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.966 2.444 . . . . 0.0 116.443 -179.927 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.3 p -128.34 16.87 6.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 129.345 3.058 . . . . 0.0 115.93 168.753 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.263 1.0 OUTLIER -41.0 117.21 0.82 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 158.813 . . . . . . . . 3 3 . 1 . 072 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 p -73.68 151.18 40.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.947 2.899 . . . . 0.0 108.823 179.687 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.31 1.1 mm -50.77 -41.03 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 126.779 2.032 . . . . 0.0 109.501 176.438 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -57.9 -41.48 82.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 171.143 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -65.15 -50.42 66.07 Favored 'General case' 0 N--CA 1.45 -0.452 1 O-C-N 116.159 -4.088 . . . . 0.0 113.962 171.342 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.84 -54.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 122.684 2.493 . . . . 0.0 112.426 168.649 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -53.04 -47.57 68.29 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.029 2.932 . . . . 0.0 115.904 170.68 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.47 -52.96 33.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 117.141 -3.474 . . . . 0.0 118.791 159.012 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -62.05 -33.36 74.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 128.882 2.873 . . . . 0.0 110.268 -176.508 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.4 mt -76.39 -48.55 27.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 129.014 2.926 . . . . 0.0 106.842 173.227 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -49.85 -49.5 49.0 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 128.94 2.896 . . . . 0.0 113.144 176.94 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -49.3 -31.95 10.08 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 128.919 2.888 . . . . 0.0 114.883 -174.054 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -105.0 -64.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 127.782 3.176 . . . . 0.0 111.196 178.353 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -81.45 -27.87 34.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -159.118 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.61 0.65 43.1 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 170.797 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.5 mm -80.61 122.05 81.92 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 120.869 2.335 . . . . 0.0 107.764 -170.806 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.53 156.02 36.16 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 CA-C-O 114.356 -2.435 . . . . 0.0 112.95 175.402 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.26 -21.42 1.18 Allowed 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 122.522 2.148 . . . . 0.0 115.525 170.915 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -81.26 -22.14 38.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 117.845 -3.034 . . . . 0.0 116.814 -175.623 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -105.61 3.43 29.18 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -166.525 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.537 ' HB2' HD21 ' A' ' 69' ' ' LEU . 19.5 pt20 -128.47 128.9 45.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.346 2.258 . . . . 0.0 105.052 -171.237 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 mtt85 -90.41 170.22 10.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 124.952 2.311 . . . . 0.0 105.121 158.006 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.386 30.7 tp -138.19 112.02 8.35 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 112.71 -2.041 . . . . 0.0 107.783 176.606 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.31 140.99 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 127.445 3.498 . . . . 0.0 105.189 173.714 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.54 145.17 22.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 119.247 -2.158 . . . . 0.0 105.41 151.592 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.67 22.46 5.36 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 125.778 1.924 . . . . 0.0 111.3 175.43 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.8 -12.89 61.0 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 116.414 -2.325 . . . . 0.0 108.325 174.408 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -108.69 127.35 53.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 120.849 2.324 . . . . 0.0 106.157 -159.04 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -61.58 93.58 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.907 2.883 . . . . 0.0 105.069 165.713 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.8 mt -64.94 130.51 43.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 119.389 -2.069 . . . . 0.0 113.571 172.3 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -86.65 146.45 26.31 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 125.718 1.886 . . . . 0.0 114.562 -176.732 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.305 14.5 m-20 -68.33 112.85 5.45 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 126.975 2.672 . . . . 0.0 115.103 168.703 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.15 -23.59 2.41 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.253 -1.304 . . . . 0.0 114.862 -169.559 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -110.06 162.57 14.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 -161.796 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -101.73 165.98 10.92 Favored 'General case' 0 N--CA 1.448 -0.561 1 C-N-CA 132.583 4.353 . . . . 0.0 113.313 168.525 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.9 mt -42.03 -45.51 3.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 116.237 -1.84 . . . . 0.0 113.909 168.833 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -64.68 -14.95 60.48 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 130.199 3.4 . . . . 0.0 113.972 -176.532 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -75.92 -35.47 59.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.711 0.404 . . . . 0.0 110.518 172.809 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -114.26 12.5 17.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 -173.193 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 9.2 m120 65.27 28.94 11.86 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 126.665 1.986 . . . . 0.0 115.306 161.977 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -93.29 137.43 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 128.496 3.998 . . . . 0.0 103.841 -160.384 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -111.4 -168.75 1.35 Allowed 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 116.928 -3.608 . . . . 0.0 109.993 176.97 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -78.48 149.86 33.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 118.876 -2.39 . . . . 0.0 113.18 -170.233 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 31.4 mt-10 66.52 9.35 6.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 130.75 3.62 . . . . 0.0 112.963 174.889 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -72.51 165.75 24.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.919 1.688 . . . . 0.0 108.075 174.81 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 m -121.86 130.26 53.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.067 2.947 . . . . 0.0 109.683 176.414 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 67' ' ' LEU . 3.1 mp -104.8 169.48 8.43 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 119.543 -1.973 . . . . 0.0 111.26 158.057 . . . . . . . . 2 2 . 1 . 072 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -119.77 126.5 51.2 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.6 2.36 . . . . 0.0 113.623 177.088 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 41' ' ' GLN 0.288 3.9 tt -98.85 131.39 44.99 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -177.131 . . . . . . . . 3 3 . 1 . 072 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.9 123.9 71.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 174.893 . . . . . . . . 1 1 . 1 . 072 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 mt . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 127.774 2.43 . . . . 0.0 110.148 179.42 . . . . . . . . 0 0 . 1 . 073 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 6.4 ptm . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 124.935 2.302 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -85.84 121.87 29.1 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 117.603 -3.186 . . . . 0.0 109.268 170.054 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pt -137.44 117.93 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 128.338 2.655 . . . . 0.0 104.59 170.871 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -83.16 112.92 20.27 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 117.803 -3.061 . . . . 0.0 109.213 -173.259 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.4 t -85.05 100.55 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 O-C-N 117.999 -2.938 . . . . 0.0 106.89 170.797 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -103.5 119.52 39.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.3 1.44 . . . . 0.0 107.245 -167.955 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m -81.57 144.6 31.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.245 1.818 . . . . 0.0 109.437 174.89 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -37.8 -51.11 1.27 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -178.648 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 p -62.07 -10.49 10.27 Favored 'General case' 0 N--CA 1.444 -0.728 1 O-C-N 129.366 4.166 . . . . 0.0 114.751 -178.057 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.2 -24.14 16.86 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.755 1.862 . . . . 0.0 117.755 179.752 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -62.59 123.02 17.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 127.329 2.252 . . . . 0.0 109.374 -177.253 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.278 8.4 m -114.8 113.28 24.04 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.976 2.11 . . . . 0.0 115.652 -174.108 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.7 mt -90.44 148.0 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 O-C-N 126.495 2.372 . . . . 0.0 106.528 -172.445 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.318 4.7 t -155.19 100.04 2.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 -163.906 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -140.78 127.98 20.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.635 -2.075 . . . . 0.0 110.653 -161.101 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.79 93.61 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.456 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -125.84 169.81 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 126.689 1.995 . . . . 0.0 107.815 169.799 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' OE2' ' HB3' ' A' ' 1' ' ' MET . 26.7 mm-40 -138.17 158.9 70.16 Favored Pre-proline 0 N--CA 1.445 -0.713 1 C-N-CA 132.035 4.134 . . . . 0.0 107.068 -176.24 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.16 -9.03 14.12 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 O-C-N 125.58 2.358 . . . . 0.0 117.992 -168.605 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 t -92.74 4.42 53.79 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.455 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -73.18 134.23 44.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 117.267 -3.396 . . . . 0.0 111.428 175.902 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -76.29 157.25 32.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 125.03 2.348 . . . . 0.0 112.926 175.902 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.268 2.7 mm -64.52 -31.5 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 O-C-N 117.207 -3.433 . . . . 0.0 118.315 -172.12 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.03 -35.85 25.45 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.926 2.091 . . . . 0.0 111.557 178.137 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.367 10.3 t-20 -51.72 -48.94 63.4 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 127.037 2.711 . . . . 0.0 113.669 158.651 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.87 -40.43 85.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 121.898 2.136 . . . . 0.0 113.067 171.681 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.261 44.7 mtpt -64.84 -36.33 83.99 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.153 1.781 . . . . 0.0 110.833 -178.376 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.14 -14.25 62.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.449 2.299 . . . . 0.0 112.527 -176.308 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -83.13 -27.81 29.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 123.633 0.583 . . . . 0.0 111.594 173.953 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 30' ' ' ILE . 75.3 mt -82.57 -18.65 10.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.907 -164.967 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -77.26 -30.14 54.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 125.14 1.525 . . . . 0.0 112.484 176.362 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -70.91 -57.41 4.62 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 119.367 -2.083 . . . . 0.0 110.979 165.886 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -82.66 -28.59 30.56 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.157 1.783 . . . . 0.0 114.327 -161.438 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -118.23 -5.99 10.86 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 124.403 1.064 . . . . 0.0 110.601 178.733 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.22 -0.08 26.09 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 129.733 3.54 . . . . 0.0 117.923 -175.677 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.6 mm -82.8 138.88 43.34 Favored Pre-proline 0 N--CA 1.447 -0.597 1 O-C-N 115.376 -4.602 . . . . 0.0 104.165 -172.275 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -86.03 167.29 9.56 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 125.027 3.818 . . . . 0.0 105.589 176.254 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.98 -22.16 5.32 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.64 2.227 . . . . 0.0 116.237 168.507 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.37 0.0 OUTLIER -54.52 -49.73 69.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 129.747 3.219 . . . . 0.0 109.668 -179.459 . . . . . . . . 3 3 . 1 . 073 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.29 71.0 mm-40 -78.8 -22.26 46.55 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 120.458 1.481 . . . . 0.0 114.943 178.116 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.307 62.4 tt0 -86.21 154.46 21.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.488 1.915 . . . . 0.0 113.542 -156.527 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.319 23.6 ttm105 -153.35 140.4 19.32 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 128.381 2.672 . . . . 0.0 112.75 -178.247 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.3 mt -125.0 131.96 53.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 116.85 -1.548 . . . . 0.0 111.708 -177.937 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.53 120.67 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.282 1.833 . . . . 0.0 112.742 179.234 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.294 22.6 t80 -120.7 119.84 33.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 115.992 -1.956 . . . . 0.0 108.078 176.908 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.46 25.41 9.63 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 126.239 2.212 . . . . 0.0 116.928 -178.967 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.27 -15.28 63.29 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.739 1.637 . . . . 0.0 112.406 -174.73 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.13 113.76 26.11 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 124.025 3.912 . . . . 0.0 105.494 -173.444 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -66.77 136.7 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 126.338 2.97 . . . . 0.0 107.77 168.189 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -84.97 134.95 34.23 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 118.608 -2.558 . . . . 0.0 113.168 179.134 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.24 158.27 16.68 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -178.733 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -73.16 155.08 39.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.984 2.514 . . . . 0.0 111.902 177.829 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.13 -15.56 62.61 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.767 2.127 . . . . 0.0 116.303 171.213 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -91.21 161.0 15.25 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -167.821 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -84.77 166.78 16.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.923 0.868 . . . . 0.0 108.945 170.499 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.0 -41.37 91.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 118.978 -2.326 . . . . 0.0 116.905 168.088 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 t -53.92 -23.91 14.49 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 130.04 3.336 . . . . 0.0 116.069 170.307 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -74.27 -18.06 60.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 115.38 -2.248 . . . . 0.0 115.23 172.266 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -103.45 5.83 37.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.243 1.383 . . . . 0.0 110.979 172.401 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 73.72 33.73 1.0 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.119 1.368 . . . . 0.0 110.007 175.137 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -90.57 136.91 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 119.342 -2.099 . . . . 0.0 112.071 -170.608 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -130.69 174.05 10.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.013 1.725 . . . . 0.0 112.669 -162.786 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -58.26 121.23 10.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.154 2.181 . . . . 0.0 111.56 -177.995 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.368 12.4 mt-10 61.57 34.03 18.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 130.807 3.643 . . . . 0.0 113.77 178.454 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.258 24.4 m -83.76 157.72 22.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 159.481 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -126.4 135.46 51.45 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.468 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.254 3.9 mp -98.68 143.1 29.43 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 128.332 2.653 . . . . 0.0 107.51 172.081 . . . . . . . . 2 2 . 1 . 073 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -72.43 148.87 44.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 124.674 2.178 . . . . 0.0 109.405 159.534 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -135.23 131.16 36.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.422 169.376 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.37 152.65 36.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 128.336 2.654 . . . . 0.0 110.922 170.49 . . . . . . . . 1 1 . 1 . 073 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.445 -0.685 0 C-N-CA 130.309 3.444 . . . . 0.0 109.496 178.489 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttp . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 . . . . . . . . . 0 0 . 1 . 074 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -95.08 140.87 29.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.514 -1.675 . . . . 0.0 110.111 -178.49 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -145.09 159.58 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 128.075 2.55 . . . . 0.0 107.174 167.313 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -106.43 153.3 22.46 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 117.409 -3.307 . . . . 0.0 105.946 171.806 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.8 t -118.85 130.01 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 166.827 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -111.01 138.35 47.52 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.418 1.087 . . . . 0.0 108.128 173.789 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.7 p -88.35 140.51 29.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 164.557 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -60.47 -17.76 47.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 117.03 -3.544 . . . . 0.0 115.88 -177.15 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -80.49 -5.84 57.25 Favored 'General case' 0 C--N 1.322 -0.589 2 C-N-CA 131.97 4.108 . . . . 0.0 112.716 165.724 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.37 -7.95 43.86 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 118.306 2.082 . . . . 0.0 118.306 165.142 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -58.15 152.27 17.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 117.916 -3.108 . . . . 0.0 112.547 163.583 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.0 p -134.15 161.31 35.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.628 1.204 . . . . 0.0 109.776 161.948 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.54 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -142.42 154.8 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 102.173 -3.269 . . . . 0.0 102.173 169.385 . . . . . . . . 3 3 . 1 . 074 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -97.54 126.38 42.79 Favored 'General case' 0 N--CA 1.444 -0.773 1 C-N-CA 132.116 4.167 . . . . 0.0 103.36 -175.038 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.15 101.35 8.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 131.386 3.874 . . . . 0.0 111.687 -176.8 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.3 pm0 -76.47 126.16 30.5 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 127.174 2.796 . . . . 0.0 105.473 163.539 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.432 31.5 m -135.84 165.01 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 1 C-N-CA 133.368 4.667 . . . . 0.0 116.468 -175.674 . . . . . . . . 3 2 . 1 . 074 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.67 159.78 37.42 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 125.879 1.671 . . . . 0.0 111.124 166.686 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.352 97.7 Cg_endo -58.62 -40.59 72.22 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 N-CA-C 120.26 3.139 . . . . 0.0 120.26 177.256 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -73.15 -14.74 61.43 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 130.24 3.416 . . . . 0.0 109.89 -171.644 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -65.55 127.3 31.31 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 124.98 2.324 . . . . 0.0 112.74 -175.725 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.9 p -70.06 156.09 39.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.376 175.244 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.76 -37.0 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.577 1.151 . . . . 0.0 111.506 166.101 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -48.06 -48.61 33.22 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.691 1.996 . . . . 0.0 114.338 166.749 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -73.32 -43.3 61.12 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 118.006 -2.934 . . . . 0.0 112.774 174.59 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.315 29.9 t -58.57 -31.47 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 118.012 -2.93 . . . . 0.0 112.022 170.653 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -64.95 -39.27 93.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 123.145 2.702 . . . . 0.0 111.339 169.302 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.46 -31.36 53.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 111.944 -3.884 . . . . 0.0 114.704 175.491 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -62.95 -50.97 68.7 Favored 'General case' 0 N--CA 1.452 -0.357 1 O-C-N 132.857 6.348 . . . . 0.0 109.659 167.443 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mt -53.05 -46.18 53.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 1 O-C-N 115.517 -4.489 . . . . 0.0 109.424 173.442 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -34.64 77.8 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 112.741 -3.504 . . . . 0.0 111.51 -179.964 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.67 -32.37 69.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 128.457 3.598 . . . . 0.0 109.851 176.058 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -78.43 -34.48 47.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 121.754 2.07 . . . . 0.0 113.5 173.759 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -145.98 -19.46 0.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -151.818 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.39 -4.68 54.73 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 128.374 2.892 . . . . 0.0 114.003 158.279 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mt -65.19 115.48 21.77 Favored Pre-proline 0 N--CA 1.445 -0.701 0 O-C-N 119.027 -2.455 . . . . 0.0 111.979 173.942 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.1 153.42 62.69 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 CA-C-O 112.085 -3.381 . . . . 0.0 117.425 -178.198 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.68 -34.96 55.72 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 125.134 3.889 . . . . 0.0 118.727 -166.7 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.01 -23.81 35.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.464 0.649 . . . . 0.0 109.846 -168.338 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.397 12.3 mm100 -87.01 -0.69 57.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.922 2.489 . . . . 0.0 111.203 178.748 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -95.22 145.67 24.89 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.482 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -138.3 134.61 34.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.547 2.739 . . . . 0.0 104.359 161.232 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mt -114.89 139.02 50.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 113.401 -3.19 . . . . 0.0 107.943 -177.234 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mm -129.87 131.88 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 129.623 3.169 . . . . 0.0 106.516 -174.718 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -113.11 -38.0 4.6 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 158.767 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.257 . . -124.95 -120.34 0.27 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 118.034 -2.916 . . . . 0.0 107.831 -172.641 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.52 13.96 42.8 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 125.982 3.992 . . . . 0.0 111.668 -177.014 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -145.01 -175.86 4.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 115.098 -2.382 . . . . 0.0 109.742 -176.967 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -78.73 156.32 28.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 126.187 2.179 . . . . 0.0 111.831 169.946 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.8 mt -95.45 144.52 25.88 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 163.836 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.92 129.21 46.74 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.211 2.204 . . . . 0.0 110.825 -168.941 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -42.52 -52.62 4.66 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 120.822 3.638 . . . . 0.0 120.822 -171.161 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.71 5.19 73.13 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 114.091 -3.616 . . . . 0.0 111.131 -175.212 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 54' ' ' ARG . 14.7 mtt180 -92.6 150.8 20.49 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 119.866 1.833 . . . . 0.0 111.287 159.813 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.342 7.1 p -91.1 156.73 17.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 129.622 3.169 . . . . 0.0 113.389 -177.764 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -43.11 -49.22 6.35 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.55 3.14 . . . . 0.0 112.516 164.761 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.378 45.3 p -55.91 -40.36 72.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 172.895 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -58.52 -47.72 83.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 118.348 -2.72 . . . . 0.0 110.762 -176.091 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.393 40.3 m-85 -90.06 4.14 51.15 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.061 177.887 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 74.8 33.84 0.75 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.306 2.242 . . . . 0.0 114.017 156.51 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.1 mm -72.23 127.81 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 100.902 -3.74 . . . . 0.0 100.902 -171.802 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -92.34 155.66 17.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.063 1.745 . . . . 0.0 107.354 175.761 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.03 146.12 2.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.74 2.416 . . . . 0.0 115.372 173.892 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.373 1.6 tt0 58.0 19.1 5.62 Favored 'General case' 0 N--CA 1.443 -0.793 1 C-N-CA 133.112 4.565 . . . . 0.0 118.534 -174.741 . . . . . . . . 3 2 . 1 . 074 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.9 m -70.57 145.14 50.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.392 2.368 . . . . 0.0 117.392 169.216 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 m -90.26 140.27 29.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 103.186 -2.894 . . . . 0.0 103.186 179.157 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.4 mt -108.78 145.53 35.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 128.393 2.677 . . . . 0.0 110.525 154.699 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -104.73 137.92 41.81 Favored 'General case' 0 N--CA 1.45 -0.466 1 N-CA-C 100.091 -4.04 . . . . 0.0 100.091 174.992 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.4 tp -124.53 113.54 18.23 Favored 'General case' 0 N--CA 1.445 -0.677 1 C-N-CA 134.757 5.223 . . . . 0.0 107.436 -174.459 . . . . . . . . 2 2 . 1 . 074 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.7 t -78.07 129.61 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 102.284 -3.228 . . . . 0.0 102.284 163.032 . . . . . . . . 1 1 . 1 . 074 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 124.405 2.05 . . . . 0.0 106.195 171.768 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ptt? . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 116.628 -1.653 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 075 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -112.67 145.53 40.28 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 123.516 2.871 . . . . 0.0 113.75 -177.835 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -135.53 155.19 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 128.03 2.532 . . . . 0.0 109.299 167.524 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -111.86 132.05 54.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 131.315 3.846 . . . . 0.0 108.787 -176.901 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 67' ' ' LEU . 93.3 t -121.67 128.79 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 172.732 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.324 59.2 mmtt -97.98 140.94 31.57 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 117.596 -3.19 . . . . 0.0 110.464 163.436 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.5 p -86.67 -176.72 5.92 Favored 'General case' 0 N--CA 1.44 -0.936 1 C-N-CA 131.914 4.086 . . . . 0.0 105.069 179.911 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.08 -46.4 57.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.236 2.615 . . . . 0.0 105.262 -178.701 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -78.58 -12.24 60.01 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.678 1.591 . . . . 0.0 112.29 -173.189 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.77 9.23 26.95 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 106.116 -2.794 . . . . 0.0 106.116 160.532 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -71.48 136.28 47.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 121.85 2.825 . . . . 0.0 110.223 170.54 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.2 m -97.23 119.76 36.34 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 128.054 3.346 . . . . 0.0 106.705 179.349 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mt -103.32 125.14 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 O-C-N 126.532 2.395 . . . . 0.0 106.915 178.358 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.2 p -109.81 124.56 51.5 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 119.948 1.249 . . . . 0.0 109.268 170.608 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.24 150.67 28.36 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.441 1.897 . . . . 0.0 107.23 175.741 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -85.37 109.4 18.38 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 131.022 3.729 . . . . 0.0 102.83 166.962 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.24 159.76 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 175.451 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -121.48 159.59 49.71 Favored Pre-proline 0 N--CA 1.45 -0.457 0 C-N-CA 131.58 3.952 . . . . 0.0 111.903 166.34 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.263 22.5 Cg_exo -61.15 -19.37 63.19 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 N-CA-C 118.019 2.276 . . . . 0.0 118.019 -172.459 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.27 0.2 OUTLIER -90.57 -2.36 57.88 Favored 'General case' 0 N--CA 1.446 -0.653 1 C-N-CA 131.877 4.071 . . . . 0.0 115.328 178.724 . . . . . . . . 4 3 . 1 . 075 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -71.43 135.37 47.18 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 118.639 -2.538 . . . . 0.0 112.549 168.675 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.1 p -82.07 164.6 21.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 177.464 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.8 mm -56.81 -36.82 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 116.878 -3.639 . . . . 0.0 113.341 -178.41 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.253 13.1 tp10 -67.63 -37.54 82.6 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 127.106 2.754 . . . . 0.0 111.188 178.395 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.09 -48.65 79.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.352 2.261 . . . . 0.0 111.658 177.833 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 t -60.39 -38.9 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 127.056 2.723 . . . . 0.0 112.271 178.156 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -80.69 -20.78 42.18 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 118.717 -2.49 . . . . 0.0 110.207 -177.551 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.91 -29.67 39.86 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 115.207 -2.33 . . . . 0.0 111.485 172.986 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -72.97 -23.74 60.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 168.317 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -73.28 -42.8 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 129.833 3.253 . . . . 0.0 111.03 170.286 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -64.42 -42.34 96.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 116.636 -1.649 . . . . 0.0 109.692 172.704 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.59 -56.2 24.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 121.827 2.103 . . . . 0.0 113.254 173.306 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -77.54 -31.97 53.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 112.993 -1.912 . . . . 0.0 115.597 -172.989 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -142.9 -7.41 0.83 Allowed 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 117.947 -2.971 . . . . 0.0 110.977 -167.51 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.95 13.07 54.43 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 126.553 2.025 . . . . 0.0 112.405 156.212 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 36' ' ' ILE . 16.9 mt -88.76 127.05 57.62 Favored Pre-proline 0 N--CA 1.446 -0.646 0 O-C-N 117.704 -3.233 . . . . 0.0 108.955 -178.616 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.73 154.97 20.57 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 N-CA-C 106.945 -1.983 . . . . 0.0 106.945 -165.612 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -68.97 -29.62 27.41 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 CA-C-O 115.359 -2.017 . . . . 0.0 112.34 176.553 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.43 118.17 9.01 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 113.731 -3.033 . . . . 0.0 115.014 171.527 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 81.45 1.63 1.57 Allowed 'General case' 0 C--N 1.321 -0.634 1 C-N-CA 132.116 4.166 . . . . 0.0 112.955 179.414 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -99.49 121.31 40.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 100.797 -3.779 . . . . 0.0 100.797 173.191 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -105.04 152.05 23.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 111.866 -2.424 . . . . 0.0 107.42 169.796 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -121.28 110.93 16.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 126.917 2.636 . . . . 0.0 113.188 174.661 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.2 mt -94.27 148.07 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 124.892 2.282 . . . . 0.0 110.01 173.427 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -126.83 107.45 10.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 100.426 -3.916 . . . . 0.0 100.426 173.108 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 76.0 -104.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 101.916 -3.364 . . . . 0.0 101.916 178.969 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.97 8.5 6.78 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 129.419 3.39 . . . . 0.0 112.707 173.617 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -86.23 105.59 16.71 Favored 'General case' 0 C--N 1.325 -0.471 1 C-N-CA 132.9 4.48 . . . . 0.0 112.056 173.204 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -66.32 134.02 51.73 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 115.421 -2.228 . . . . 0.0 114.044 158.784 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.8 mt -107.01 111.18 23.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 127.65 3.094 . . . . 0.0 109.45 -162.755 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -68.06 123.26 20.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 130.92 3.688 . . . . 0.0 111.955 176.991 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.2 -18.11 3.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 119.644 3.201 . . . . 0.0 119.644 -157.057 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.87 -1.22 56.21 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 -175.583 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -92.81 166.69 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.933 2.093 . . . . 0.0 113.898 -173.475 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -109.75 166.3 11.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 124.816 1.323 . . . . 0.0 110.11 178.84 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mt -61.93 -34.87 76.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.415 1.486 . . . . 0.0 110.426 167.656 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.7 t -53.32 -41.26 65.52 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 117.728 -3.107 . . . . 0.0 117.898 160.823 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -75.84 -41.36 52.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 112.872 -3.442 . . . . 0.0 114.255 -178.206 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -86.68 -21.0 26.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 122.013 2.188 . . . . 0.0 106.787 -174.414 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 38.6 t30 81.07 62.24 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 119.005 -2.31 . . . . 0.0 108.181 179.718 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mt -110.08 110.01 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 100.25 -3.981 . . . . 0.0 100.25 177.935 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -104.13 165.15 11.24 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 127.597 2.359 . . . . 0.0 110.66 -168.241 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.447 7.7 pttp -44.52 125.16 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 118.449 -2.657 . . . . 0.0 115.971 172.395 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.409 2.7 tt0 84.18 9.2 0.49 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 119.12 3.008 . . . . 0.0 119.12 179.34 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -59.46 147.17 37.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.454 -3.279 . . . . 0.0 114.66 172.502 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.5 p -123.94 110.69 15.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 127.093 2.746 . . . . 0.0 106.384 -171.064 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 5' ' ' VAL . 5.7 mp -111.48 158.81 18.7 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 128.798 2.839 . . . . 0.0 109.178 -173.042 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -121.55 139.37 53.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.994 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -104.11 132.63 50.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.561 -2.755 . . . . 0.0 103.561 177.875 . . . . . . . . 1 1 . 1 . 075 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.331 76.7 t -113.77 132.31 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 129.504 3.121 . . . . 0.0 111.298 174.928 . . . . . . . . 2 2 . 1 . 075 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.449 -0.48 0 O-C-N 126.115 2.134 . . . . 0.0 107.932 168.391 . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 101.213 -3.625 . . . . 0.0 101.213 . . . . . . . . . 0 0 . 1 . 076 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.307 8.5 mt-30 -104.51 156.3 18.07 Favored 'General case' 0 N--CA 1.455 -0.205 1 O-C-N 112.643 -6.286 . . . . 0.0 105.895 175.256 . . . . . . . . 3 2 . 1 . 076 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.559 HD12 HD13 ' A' ' 67' ' ' LEU . 16.9 pt -125.8 140.5 48.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 110.942 -2.845 . . . . 0.0 110.541 156.143 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -81.17 138.73 35.84 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 101.044 -3.687 . . . . 0.0 101.044 171.648 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' CG2' HD23 ' A' ' 15' ' ' LEU . 39.5 t -123.12 123.3 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 166.385 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -86.22 131.65 34.18 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 -178.149 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -93.67 167.24 11.79 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.674 -1.266 . . . . 0.0 111.738 179.662 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.54 -24.36 61.93 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.427 2.691 . . . . 0.0 108.977 172.067 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.2 p -94.39 3.47 55.14 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 121.974 2.17 . . . . 0.0 110.39 -177.273 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.02 -38.94 2.53 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 158.928 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -83.54 158.78 21.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.167 -1.196 . . . . 0.0 111.008 -167.742 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -106.82 101.24 10.7 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 128.542 2.737 . . . . 0.0 103.969 177.453 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 pt -68.16 140.54 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.268 163.194 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 m -97.65 121.02 39.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 118.011 -2.93 . . . . 0.0 105.486 173.067 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD23 ' CG2' ' A' ' 5' ' ' VAL . 3.8 mm? -87.23 145.34 26.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 122.003 2.183 . . . . 0.0 105.649 166.752 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -100.65 113.18 25.81 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.078 2.151 . . . . 0.0 109.309 169.891 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.252 11.9 m -136.76 154.08 31.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 117.735 -3.103 . . . . 0.0 114.137 -164.722 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -118.24 149.31 45.55 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 127.914 2.486 . . . . 0.0 110.786 172.749 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.383 36.6 Cg_endo -57.18 -40.35 83.61 Favored 'Trans proline' 0 N--CA 1.447 -1.239 2 C-N-CA 127.461 5.441 . . . . 0.0 123.098 -174.886 . . . . . . . . 3 2 . 1 . 076 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.288 23.0 p -80.17 -2.08 43.16 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 178.836 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.69 138.97 37.51 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.831 -174.95 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -84.76 126.97 33.88 Favored 'General case' 0 C--N 1.323 -0.544 1 C-N-CA 132.134 4.174 . . . . 0.0 106.761 -171.645 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 50' ' ' LEU 0.262 5.4 mm -30.59 -41.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 120.897 3.665 . . . . 0.0 120.897 174.427 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -61.72 -34.42 75.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 114.972 -2.442 . . . . 0.0 110.693 172.669 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -72.8 -15.87 61.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 125.424 3.738 . . . . 0.0 113.119 171.116 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.2 t -86.28 -35.3 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 115.907 -1.996 . . . . 0.0 110.612 175.975 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -62.76 -45.25 93.56 Favored 'General case' 0 N--CA 1.447 -0.623 1 O-C-N 129.548 4.28 . . . . 0.0 109.667 171.362 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.56 -33.9 68.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 167.077 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -73.77 -40.82 63.19 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 116.403 -1.761 . . . . 0.0 109.815 -178.843 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.52 -33.83 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 126.682 1.993 . . . . 0.0 114.972 171.956 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -69.5 -44.92 70.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 101.887 -3.375 . . . . 0.0 101.887 177.843 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.357 2.5 t70 -63.59 -5.34 3.8 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 130.321 3.448 . . . . 0.0 114.689 179.075 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -116.85 -75.44 0.58 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.846 2.858 . . . . 0.0 111.33 178.491 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -95.91 -1.96 48.21 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.267 1.827 . . . . 0.0 114.046 -174.721 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.93 3.5 68.06 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 123.401 2.818 . . . . 0.0 114.982 164.98 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.2 mt -76.45 111.71 17.21 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 126.673 1.989 . . . . 0.0 110.216 -176.822 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -51.86 131.32 37.82 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 CA-C-O 115.696 -1.877 . . . . 0.0 113.825 168.97 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -38.58 -35.95 0.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 124.983 3.789 . . . . 0.0 119.816 175.625 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.49 -12.98 62.1 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.885 0.85 . . . . 0.0 113.129 -178.285 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -92.12 -5.7 52.21 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 117.243 -3.41 . . . . 0.0 112.161 172.423 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 65.6 mt-30 -108.3 107.38 17.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 119.439 -2.038 . . . . 0.0 108.975 -171.423 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -92.06 133.43 35.75 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 125.584 1.803 . . . . 0.0 106.668 156.492 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 69' ' ' LEU . 93.3 mt -113.4 144.81 42.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.837 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.268 11.3 mm -132.12 136.43 56.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 112.062 -2.335 . . . . 0.0 105.948 -165.767 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.423 ' CE2' HG12 ' A' ' 61' ' ' ILE . 75.8 t80 -145.35 117.4 8.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 127.097 2.748 . . . . 0.0 106.322 177.152 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.327 . . 63.76 -98.6 0.07 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.812 1.245 . . . . 0.0 111.38 -160.191 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.19 11.23 5.32 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 127.231 2.832 . . . . 0.0 119.37 161.844 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -87.03 127.04 35.11 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.417 2.687 . . . . 0.0 105.728 -163.421 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -75.12 102.94 5.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 118.967 -2.333 . . . . 0.0 108.322 170.329 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 23' ' ' ILE . 65.0 mt -62.46 117.99 6.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.401 3.08 . . . . 0.0 109.309 177.632 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -89.74 145.49 25.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 117.512 -3.242 . . . . 0.0 114.39 -174.571 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.98 118.12 16.57 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 126.551 3.072 . . . . 0.0 112.902 176.267 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.1 -17.42 19.63 Favored Glycine 0 CA--C 1.524 0.625 1 C-N-CA 132.24 4.733 . . . . 0.0 111.429 -178.431 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -86.98 149.47 24.75 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 122.089 2.944 . . . . 0.0 109.68 176.026 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.6 p -95.78 169.27 10.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 126.511 3.053 . . . . 0.0 112.964 -178.685 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.78 -36.1 80.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 116.5 -3.875 . . . . 0.0 111.384 173.638 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -67.84 -37.77 82.3 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 118.709 -2.494 . . . . 0.0 108.336 -178.775 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.4 -48.83 77.99 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 126.228 2.205 . . . . 0.0 110.789 176.742 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -81.65 7.85 11.31 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.617 3.167 . . . . 0.0 118.572 170.71 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 63.03 21.31 12.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.406 1.882 . . . . 0.0 110.789 170.489 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.423 HG12 ' CE2' ' A' ' 45' ' ' PHE . 47.1 mt -76.8 145.11 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 124.124 1.916 . . . . 0.0 108.521 175.018 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -134.44 -177.38 4.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.41 1.484 . . . . 0.0 110.631 -167.248 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -57.13 132.56 53.33 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 114.455 -2.688 . . . . 0.0 114.36 173.763 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 70.44 48.1 0.48 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 126.11 2.862 . . . . 0.0 115.825 172.888 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -117.88 152.74 34.8 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 118.698 -2.502 . . . . 0.0 106.77 -178.548 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.4 m -108.34 117.01 33.05 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 129.242 3.017 . . . . 0.0 108.746 -176.514 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.559 HD13 HD12 ' A' ' 3' ' ' ILE 0.311 7.6 mp -105.63 158.33 16.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 167.541 . . . . . . . . 3 3 . 1 . 076 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -103.27 123.87 47.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 129.762 3.225 . . . . 0.0 109.868 168.3 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 43' ' ' LEU . 36.8 tp -81.71 113.63 19.83 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 129.411 3.084 . . . . 0.0 107.921 164.101 . . . . . . . . 2 2 . 1 . 076 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.85 150.71 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 128.161 2.584 . . . . 0.0 112.684 -176.977 . . . . . . . . 1 1 . 1 . 076 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.44 -0.965 0 C-N-CA 129.48 3.112 . . . . 0.0 103.173 -178.984 . . . . . . . . 0 0 . 1 . 077 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.426 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 4.3 tmm? . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 117.166 -1.397 . . . . 0.0 108.952 . . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -75.82 133.7 40.57 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.261 1.824 . . . . 0.0 110.064 -177.708 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -147.29 173.26 2.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 122.554 2.434 . . . . 0.0 113.353 162.508 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.69 148.62 39.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 128.678 2.791 . . . . 0.0 104.236 -177.951 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.06 125.08 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 126.946 2.099 . . . . 0.0 105.384 169.185 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.51 140.12 40.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.6 171.966 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -111.62 145.54 39.0 Favored 'General case' 0 C--N 1.327 -0.394 1 O-C-N 129.289 4.118 . . . . 0.0 112.636 177.965 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 tp -77.34 -13.29 59.96 Favored 'General case' 0 C--O 1.239 0.549 1 O-C-N 115.821 -4.299 . . . . 0.0 109.1 -177.269 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -88.04 -16.76 32.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 113.642 -3.075 . . . . 0.0 113.037 171.54 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.6 17.17 2.39 Favored Glycine 0 CA--C 1.54 1.633 0 O-C-N 128.892 3.87 . . . . 0.0 112.348 142.872 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -96.86 147.65 23.74 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.64 3.576 . . . . 0.0 107.552 178.808 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 m -125.07 147.24 49.07 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 122.127 2.239 . . . . 0.0 108.134 164.933 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 pt -129.51 153.83 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 126.614 1.965 . . . . 0.0 108.497 173.958 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 140.32 29.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 150.963 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.6 tp -137.8 166.12 24.78 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 129.818 3.247 . . . . 0.0 106.782 -173.638 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -132.3 128.85 38.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 100.624 -3.843 . . . . 0.0 100.624 173.122 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.514 HG21 ' CD1' ' A' ' 56' ' ' LEU . 3.5 m -127.21 166.23 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 128.521 2.728 . . . . 0.0 105.921 175.075 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.553 ' HG3' ' H ' ' A' ' 20' ' ' SER . 14.6 tp10 -86.12 155.58 57.75 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 101.443 -3.54 . . . . 0.0 101.443 166.726 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 50.7 Cg_endo -59.75 -33.27 96.39 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 CA-C-N 122.176 1.813 . . . . 0.0 114.358 157.581 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.553 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 2.9 m -93.5 19.64 8.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 109.898 -3.319 . . . . 0.0 107.568 -168.252 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -82.66 133.04 35.17 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.729 1.212 . . . . 0.0 108.57 160.927 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 54' ' ' ARG 0.357 20.3 p -77.22 163.53 26.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.794 1.238 . . . . 0.0 111.59 165.458 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 24.9 mm -38.62 -51.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 128.374 2.67 . . . . 0.0 112.307 166.411 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.58 -39.41 91.09 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 118.184 2.661 . . . . 0.0 118.184 174.67 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -83.22 -26.62 30.61 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 114.091 -2.861 . . . . 0.0 110.535 -178.608 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 22' ' ' THR . 64.0 t -44.47 -76.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 130.74 3.616 . . . . 0.0 109.958 156.991 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -31.47 -38.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 1 C-N-CA 133.693 4.797 . . . . 0.0 114.52 170.743 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.55 -22.12 61.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 128.366 2.666 . . . . 0.0 114.652 -175.615 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -101.55 -16.09 16.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.499 1.92 . . . . 0.0 109.996 -176.114 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -80.68 -25.42 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 119.297 -2.127 . . . . 0.0 114.203 158.934 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -67.53 -47.12 70.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.625 1.57 . . . . 0.0 109.707 -176.487 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -48.75 -48.59 40.7 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 127.261 2.224 . . . . 0.0 111.383 168.783 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.22 -24.26 54.61 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 119.441 -2.037 . . . . 0.0 109.265 -171.314 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.513 6.7 tp10 -128.09 -34.5 2.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 -159.024 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.79 -4.78 79.2 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 123.088 2.676 . . . . 0.0 118.249 -170.21 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.7 mt -84.3 124.31 74.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.245 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.28 153.11 45.42 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.656 3.571 . . . . 0.0 105.165 173.691 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -57.31 -42.35 63.27 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.808 3.005 . . . . 0.0 115.542 -174.128 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -49.98 -20.99 1.06 Allowed 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 119.075 2.991 . . . . 0.0 119.075 168.895 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -108.09 -9.34 15.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 122.387 2.358 . . . . 0.0 111.13 176.77 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -78.11 137.1 38.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.524 1.14 . . . . 0.0 110.806 172.237 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -126.74 111.2 13.96 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 174.932 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.8 mt -100.41 122.61 43.44 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 125.713 1.883 . . . . 0.0 108.205 -178.797 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.59 139.56 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 125.965 2.04 . . . . 0.0 112.622 171.722 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -147.77 120.96 8.9 Favored 'General case' 0 N--CA 1.448 -0.543 1 C-N-CA 131.823 4.049 . . . . 0.0 113.519 175.182 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.91 33.53 14.71 Favored 'General case' 0 N--CA 1.443 -0.801 1 C-N-CA 133.162 4.585 . . . . 0.0 111.999 -178.137 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.5 -17.63 56.42 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 128.235 2.826 . . . . 0.0 117.923 173.63 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -92.52 135.77 33.78 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 116.439 -1.744 . . . . 0.0 113.719 173.39 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.27 133.4 45.02 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 126.87 2.606 . . . . 0.0 110.349 156.091 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.0 mt -99.21 155.04 17.69 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 118.472 -2.642 . . . . 0.0 109.972 -155.971 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -92.63 139.12 30.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 175.968 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.266 17.0 m-20 -43.08 -58.45 2.45 Favored 'General case' 0 N--CA 1.447 -0.609 1 C-N-CA 137.54 6.336 . . . . 0.0 109.173 -160.199 . . . . . . . . 3 2 . 1 . 077 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.74 18.82 43.03 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 117.594 1.798 . . . . 0.0 117.594 -159.763 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 22' ' ' THR 0.321 22.0 mmm180 -101.49 143.06 31.96 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 179.478 . . . . . . . . 3 3 . 1 . 077 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -72.24 165.03 25.25 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.374 2.269 . . . . 0.0 106.401 -179.099 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.514 ' CD1' HG21 ' A' ' 17' ' ' VAL . 73.4 mt -65.51 -22.61 66.74 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 116.42 -3.925 . . . . 0.0 117.452 168.751 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -72.17 -24.92 61.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 167.485 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -72.47 -21.6 61.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 117.97 -2.957 . . . . 0.0 116.474 166.083 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -98.72 -2.85 37.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.051 1.341 . . . . 0.0 111.88 172.834 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 73.55 29.04 1.62 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.368 1.867 . . . . 0.0 113.905 176.82 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 11.0 mt -92.47 113.49 27.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.012 1.725 . . . . 0.0 109.231 -175.572 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.263 57.5 tp60 -142.63 83.55 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.933 2.093 . . . . 0.0 109.834 -171.739 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.369 3.9 tmtt? 91.39 108.54 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 O-C-N 116.774 -3.703 . . . . 0.0 113.538 139.523 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.69 26.4 mt-10 78.41 17.12 1.15 Allowed 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 117.595 -3.191 . . . . 0.0 118.901 -178.108 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.266 19.2 p -85.71 155.95 20.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -178.839 . . . . . . . . 2 2 . 1 . 077 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.4 m -109.86 110.39 21.35 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 174.217 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.68 130.29 35.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.553 1.941 . . . . 0.0 109.405 168.64 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -94.44 128.53 41.05 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 115.471 -2.492 . . . . 0.0 104.861 -168.906 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -109.61 123.53 49.6 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -171.071 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.34 164.08 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 125.431 1.492 . . . . 0.0 107.818 174.7 . . . . . . . . 1 1 . 1 . 077 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 123.64 1.686 . . . . 0.0 106.608 -169.961 . . . . . . . . 0 0 . 1 . 078 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 37.7 ttp . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 . . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -86.3 144.73 27.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 118.8 -2.438 . . . . 0.0 114.455 170.449 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 3' ' ' ILE . 42.3 pt -132.21 165.5 31.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 117.163 -3.461 . . . . 0.0 107.026 169.538 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -112.49 140.13 47.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.509 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.398 60.9 t -124.84 84.39 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 129.571 3.149 . . . . 0.0 109.686 -172.272 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -75.16 121.82 22.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 121.211 -0.93 . . . . 0.0 111.582 -179.159 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 32.1 m -90.18 154.88 19.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 118.461 -2.649 . . . . 0.0 110.783 -175.471 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.287 3.0 tm? -33.46 -38.84 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 117.221 -3.425 . . . . 0.0 118.886 168.931 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.2 p -77.71 -18.17 56.85 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.344 3.458 . . . . 0.0 114.014 179.594 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.38 14.47 38.27 Favored Glycine 0 CA--C 1.523 0.574 1 C-N-CA 132.568 4.889 . . . . 0.0 109.612 177.254 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -79.48 116.88 19.96 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.563 -1.551 . . . . 0.0 109.394 173.811 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.5 m -75.07 109.55 8.64 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.664 1.986 . . . . 0.0 107.547 163.826 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.504 HD13 HG21 ' A' ' 13' ' ' ILE 0.254 86.1 mt -90.58 148.14 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 1 N-CA-C 97.05 -5.167 . . . . 0.0 97.05 165.045 . . . . . . . . 4 3 . 1 . 078 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -135.78 139.25 43.38 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 117.217 -3.427 . . . . 0.0 108.781 163.97 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.53 149.52 42.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.432 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -83.62 136.97 34.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.969 1.308 . . . . 0.0 109.642 167.325 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.46 165.2 30.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 130.765 3.626 . . . . 0.0 108.447 173.487 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -96.67 156.42 36.64 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-O 116.75 -1.595 . . . . 0.0 113.859 167.614 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.3 -43.34 59.6 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 N-CA-C 121.755 3.714 . . . . 0.0 121.755 175.408 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -10.38 57.9 Favored 'General case' 0 N--CA 1.452 -0.337 1 N-CA-C 122.145 4.128 . . . . 0.0 122.145 -178.506 . . . . . . . . 3 3 . 1 . 078 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -49.22 139.47 11.07 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 128.056 2.543 . . . . 0.0 114.532 177.552 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -97.03 141.85 29.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 110.323 -3.126 . . . . 0.0 105.08 -174.155 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.09 -28.61 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 118.282 -2.761 . . . . 0.0 112.402 -166.325 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.31 -26.3 65.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 173.852 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -78.89 -24.71 44.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 118.762 -2.461 . . . . 0.0 107.038 -177.724 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.4 -33.86 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 122.888 2.586 . . . . 0.0 113.045 -177.345 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -68.39 -39.09 81.81 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.819 2.447 . . . . 0.0 109.548 -177.801 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.29 -28.72 68.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.761 -2.462 . . . . 0.0 112.789 176.315 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -84.58 -30.64 24.86 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 124.825 1.328 . . . . 0.0 110.893 -174.242 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mt -71.95 -41.16 68.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 127.032 2.707 . . . . 0.0 104.706 171.234 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.38 -43.14 96.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 119.009 -2.307 . . . . 0.0 108.379 176.966 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -64.99 -45.12 86.94 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 121.212 1.824 . . . . 0.0 113.789 -178.561 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -99.02 -25.33 14.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 111.895 -3.907 . . . . 0.0 111.624 -167.874 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -117.33 -22.98 7.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 123.214 2.734 . . . . 0.0 111.679 177.035 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.3 42.43 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 128.418 2.913 . . . . 0.0 113.799 166.088 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.2 mt -90.69 120.47 68.84 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 127.578 2.351 . . . . 0.0 107.133 -179.115 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -58.09 154.76 37.57 Favored 'Trans proline' 0 N--CA 1.444 -1.409 1 C-N-CA 128.009 5.806 . . . . 0.0 112.251 -179.972 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -78.52 -18.07 12.39 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 122.469 2.113 . . . . 0.0 116.531 -162.986 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.09 -10.88 51.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 167.673 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -93.7 -15.82 24.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.715 1.606 . . . . 0.0 111.229 -171.992 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 41' ' ' GLN . 18.5 pt20 -98.11 143.81 28.25 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.184 1.794 . . . . 0.0 111.451 170.24 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.88 128.64 42.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 129.003 2.921 . . . . 0.0 106.096 166.373 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -95.37 123.24 38.79 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.704 1.24 . . . . 0.0 109.993 179.413 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.463 10.3 mt -108.64 124.48 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 130.209 3.404 . . . . 0.0 114.16 178.096 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -139.6 133.97 31.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 115.763 -2.065 . . . . 0.0 112.614 171.124 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.71 36.37 23.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.938 2.095 . . . . 0.0 115.218 173.934 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.26 -16.24 30.02 Favored Glycine 0 N--CA 1.442 -0.933 1 CA-C-O 112.271 -4.627 . . . . 0.0 113.476 -171.771 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -89.48 138.63 31.28 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 122.19 2.995 . . . . 0.0 105.361 -171.208 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.38 136.26 33.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.919 -1.946 . . . . 0.0 109.355 157.119 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.493 HD22 ' CG ' ' A' ' 59' ' ' TYR 0.269 15.5 mt -90.38 139.71 30.41 Favored 'General case' 0 C--O 1.221 -0.432 1 CA-C-O 111.415 -4.136 . . . . 0.0 108.858 -165.222 . . . . . . . . 4 3 . 1 . 078 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -99.99 145.65 27.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 124.246 3.203 . . . . 0.0 113.345 173.77 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.94 139.18 52.86 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 125.083 1.489 . . . . 0.0 108.626 162.61 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.18 11.39 13.71 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 103.777 -3.729 . . . . 0.0 103.777 -179.249 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -139.5 176.8 8.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 123.572 1.653 . . . . 0.0 108.62 176.754 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.4 p -108.46 177.56 4.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.542 1.537 . . . . 0.0 112.178 178.089 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.307 85.2 mt -50.36 -55.84 13.93 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.667 3.187 . . . . 0.0 110.66 164.079 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -67.03 -24.56 66.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -173.663 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -57.39 -40.1 77.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 128.833 2.853 . . . . 0.0 112.361 176.639 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CG ' HD22 ' A' ' 50' ' ' LEU . 44.4 m-85 -103.82 0.7 30.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.654 1.982 . . . . 0.0 112.551 -177.469 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.9 m120 81.23 32.71 0.12 Allowed 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 125.038 1.461 . . . . 0.0 113.348 168.262 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -95.19 94.97 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 125.856 1.972 . . . . 0.0 106.811 -177.915 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -101.76 -158.87 0.7 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.005 0.431 . . . . 0.0 111.319 172.923 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -58.7 134.7 57.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.284 -2.135 . . . . 0.0 111.684 168.87 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 25.0 tt0 85.11 40.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.061 -1.025 . . . . 0.0 110.058 170.364 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -120.36 137.8 54.08 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.565 1.946 . . . . 0.0 108.215 -179.936 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -120.23 123.47 43.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 115.993 -1.956 . . . . 0.0 108.67 176.739 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.23 160.82 15.06 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -178.209 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -118.66 139.35 51.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 125.002 1.439 . . . . 0.0 108.226 176.711 . . . . . . . . 1 1 . 1 . 078 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.332 4.0 tt -125.24 119.71 29.24 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 101.787 -3.412 . . . . 0.0 101.787 -166.764 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.282 20.9 m -111.23 144.25 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 101.74 -3.43 . . . . 0.0 101.74 174.417 . . . . . . . . 2 2 . 1 . 078 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 N--CA 1.447 -0.586 0 CA-C-N 109.307 -3.588 . . . . 0.0 107.185 174.792 . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptt? . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 079 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.377 84.2 mt-30 -97.44 124.23 41.57 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.665 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.4 160.21 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 127.715 2.406 . . . . 0.0 112.82 170.239 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -113.51 136.47 52.77 Favored 'General case' 0 N--CA 1.452 -0.344 1 O-C-N 112.289 -6.507 . . . . 0.0 114.416 -176.086 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.9 t -111.25 121.64 64.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 128.171 2.588 . . . . 0.0 110.387 164.512 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -100.95 117.0 34.12 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 101.479 -3.526 . . . . 0.0 101.479 -172.21 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -73.38 155.67 39.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.977 2.511 . . . . 0.0 111.962 172.542 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.99 -30.82 68.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 124.855 2.265 . . . . 0.0 115.108 170.914 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 p -75.15 0.76 15.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 128.039 2.535 . . . . 0.0 112.881 177.293 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.57 -18.35 25.02 Favored Glycine 0 CA--C 1.526 0.778 1 C-N-CA 131.402 4.334 . . . . 0.0 118.689 166.345 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -94.54 155.05 17.09 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.827 2.451 . . . . 0.0 109.907 -160.142 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.3 m -114.04 132.55 55.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 124.724 2.202 . . . . 0.0 110.888 -176.182 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.37 126.59 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 1 O-C-N 116.219 -4.051 . . . . 0.0 106.609 178.357 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.412 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 98.8 m -90.2 128.49 36.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -171.065 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.97 123.95 51.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 116.468 -1.729 . . . . 0.0 106.816 -179.107 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -103.59 101.73 11.59 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 130.524 3.53 . . . . 0.0 110.977 177.797 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.39 166.35 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 N-CA-C 99.921 -4.103 . . . . 0.0 99.921 -157.204 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.358 48.7 mm-40 -108.08 167.99 8.52 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 115.576 -2.154 . . . . 0.0 106.3 158.951 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.15 -6.48 18.01 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 CA-C-N 123.32 2.221 . . . . 0.0 110.239 179.031 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.6 p -96.32 13.5 27.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 131.209 3.804 . . . . 0.0 113.737 177.875 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.81 135.7 38.93 Favored 'General case' 0 C--N 1.32 -0.687 1 C-N-CA 133.299 4.64 . . . . 0.0 102.684 174.036 . . . . . . . . 3 3 . 1 . 079 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -77.24 172.63 12.96 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.039 0.935 . . . . 0.0 110.856 166.915 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.288 1.4 mp -59.29 -42.09 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 125.767 1.627 . . . . 0.0 108.886 163.97 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -65.56 -39.83 92.12 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 125.647 1.842 . . . . 0.0 109.067 -172.909 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -64.45 -40.68 96.18 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.119 1.368 . . . . 0.0 107.403 177.52 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 t -69.5 -39.96 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 O-C-N 117.752 -3.093 . . . . 0.0 117.872 174.845 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -66.98 -29.51 69.37 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.905 -2.372 . . . . 0.0 114.493 168.724 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.08 59.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 170.97 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -59.11 -32.0 69.42 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.889 173.428 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.8 mt -65.14 -47.45 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 121.884 2.129 . . . . 0.0 109.37 169.386 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -74.89 -39.09 61.69 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.688 1.595 . . . . 0.0 107.912 -168.886 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.74 -31.15 72.24 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 122.866 2.576 . . . . 0.0 109.203 177.28 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 14' ' ' THR . 82.0 mttt -87.87 -66.94 0.86 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 115.355 -2.259 . . . . 0.0 107.927 177.633 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -96.79 -20.6 18.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 120.372 1.442 . . . . 0.0 110.568 -156.534 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.73 -19.12 21.72 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 168.718 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 36' ' ' ILE . 28.1 mt -69.14 139.06 89.88 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 127.64 2.376 . . . . 0.0 113.265 -170.573 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -75.06 147.73 34.11 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 CA-C-O 113.412 -2.828 . . . . 0.0 115.209 -179.778 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.32 -45.41 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.276 3.317 . . . . 0.0 115.066 -158.046 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.24 -3.6 11.29 Favored 'General case' 0 N--CA 1.452 -0.354 1 C-N-CA 132.999 4.52 . . . . 0.0 116.641 178.087 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -87.76 -23.57 24.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 126.275 2.234 . . . . 0.0 107.728 173.324 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -90.56 115.97 28.1 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.119 -3.488 . . . . 0.0 110.87 -169.289 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -99.51 126.13 45.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 123.473 1.606 . . . . 0.0 107.706 161.8 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.62 110.15 22.27 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.798 2.439 . . . . 0.0 110.767 -175.866 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.1 mt -105.03 145.96 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 O-C-N 119.823 -1.798 . . . . 0.0 111.233 -179.211 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -160.46 139.61 10.65 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.1 1.76 . . . . 0.0 112.998 165.687 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.58 28.49 15.71 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 130.763 3.625 . . . . 0.0 112.246 168.144 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.69 1.49 58.81 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 116.724 -2.153 . . . . 0.0 113.122 176.223 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -120.94 151.97 39.07 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 131.391 3.877 . . . . 0.0 114.767 176.632 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -94.93 116.65 28.98 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 128.509 3.631 . . . . 0.0 107.398 168.382 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.92 112.88 3.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.293 -2.754 . . . . 0.0 112.401 -178.905 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.272 74.4 tt0 -89.01 147.3 24.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 114.904 -2.475 . . . . 0.0 106.922 -164.619 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.92 132.86 50.49 Favored 'General case' 0 C--N 1.326 -0.423 1 O-C-N 130.442 4.839 . . . . 0.0 114.551 175.565 . . . . . . . . 2 2 . 1 . 079 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.06 -9.29 54.66 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 128.196 2.808 . . . . 0.0 117.003 -176.682 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.7 mtt-85 -101.83 157.53 16.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.383 2.673 . . . . 0.0 108.27 -174.488 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.8 p -102.69 155.41 18.32 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 102.216 -3.254 . . . . 0.0 102.216 173.23 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.6 mt -35.54 -36.44 0.07 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 129.564 3.146 . . . . 0.0 118.619 162.134 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.6 t -64.6 -21.93 66.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 111.564 -2.562 . . . . 0.0 115.791 179.343 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.45 -22.88 46.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 120.531 -1.356 . . . . 0.0 111.705 -178.324 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -106.96 -0.83 22.82 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.169 2.188 . . . . 0.0 106.507 -176.262 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 m120 56.28 50.56 13.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 126.063 2.839 . . . . 0.0 112.816 173.998 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.0 mt -80.15 115.82 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 112.483 -2.144 . . . . 0.0 108.112 -178.613 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -76.57 167.02 22.57 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 165.91 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -54.09 143.81 21.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 118.633 2.827 . . . . 0.0 118.633 159.57 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 73.89 6.56 4.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 115.318 -2.277 . . . . 0.0 113.367 172.971 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -66.39 154.96 38.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.965 3.706 . . . . 0.0 111.272 172.084 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -114.47 111.72 21.86 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -177.342 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.43 169.64 8.57 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 179.917 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -130.62 141.67 50.44 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 119.708 1.14 . . . . 0.0 109.247 -163.383 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -114.85 129.47 56.71 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 126.22 2.2 . . . . 0.0 115.661 167.106 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.0 t -132.31 136.15 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 170.629 . . . . . . . . 1 1 . 1 . 079 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.2 mt . . . . . 0 N--CA 1.453 -0.309 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.097 -171.665 . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 ttp . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 115.348 -2.263 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 080 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.28 92.9 mt-30 -108.51 133.53 52.54 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 125.055 3.57 . . . . 0.0 110.559 -171.241 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -127.44 174.67 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 155.113 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -117.42 156.52 27.8 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.012 1.725 . . . . 0.0 108.693 172.614 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.72 130.06 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.9 157.59 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -90.73 130.13 36.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 112.173 -2.285 . . . . 0.0 111.801 173.567 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -98.63 136.86 38.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 167.853 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.31 -0.02 1.14 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.268 1.827 . . . . 0.0 114.667 -156.323 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.8 p -86.43 -25.89 25.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 129.969 3.308 . . . . 0.0 105.68 -178.805 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.81 3.17 18.45 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.636 1.112 . . . . 0.0 113.889 -178.685 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -79.48 135.13 36.57 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.711 3.204 . . . . 0.0 109.42 170.722 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.4 p -123.48 136.25 54.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.919 1.688 . . . . 0.0 111.229 -170.041 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mt -118.7 113.0 40.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.352 -2.832 . . . . 0.0 103.352 179.833 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -67.86 119.13 12.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 162.317 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.267 0.2 OUTLIER -114.62 126.97 55.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -171.126 . . . . . . . . 3 3 . 1 . 080 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -104.56 115.04 29.66 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.223 1.809 . . . . 0.0 109.844 -164.101 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.305 34.1 m -129.82 -177.83 2.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 C-N-CA 123.914 0.886 . . . . 0.0 112.351 -171.29 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.43 163.02 51.66 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-O 114.831 -2.509 . . . . 0.0 106.786 148.083 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -48.14 -16.86 0.7 Allowed 'Trans proline' 0 N--CA 1.442 -1.531 0 N-CA-C 122.149 3.865 . . . . 0.0 122.149 -176.337 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.1 m -88.15 -8.7 55.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 114.112 -2.851 . . . . 0.0 113.542 178.697 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.53 121.24 12.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.04 2.136 . . . . 0.0 106.558 -175.479 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -77.17 137.5 38.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.075 2.95 . . . . 0.0 107.874 176.274 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.285 1.5 mp -54.79 -30.93 23.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 127.637 2.375 . . . . 0.0 113.61 179.454 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -71.77 -22.49 61.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 121.54 1.973 . . . . 0.0 109.643 174.721 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.6 -31.0 21.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 115.126 -2.369 . . . . 0.0 105.969 178.987 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.48 -41.5 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 126.291 2.244 . . . . 0.0 106.931 178.129 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 30' ' ' ILE . 27.8 mtmt -56.8 -37.99 71.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 115.821 -2.037 . . . . 0.0 113.085 174.16 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.57 85.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 121.719 2.054 . . . . 0.0 111.461 175.78 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -65.78 -33.77 76.63 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 130.182 3.393 . . . . 0.0 111.933 177.723 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 27' ' ' LYS . 20.5 mt -71.96 -40.74 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 115.315 -2.278 . . . . 0.0 106.25 169.607 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -60.11 -40.43 89.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 124.273 3.215 . . . . 0.0 109.694 171.193 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.87 -30.44 67.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.062 2.545 . . . . 0.0 116.1 179.789 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -93.75 -57.04 2.68 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 128.743 2.817 . . . . 0.0 111.172 -174.707 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -118.05 -13.1 9.99 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -164.549 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.14 -11.7 55.42 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 115.339 -2.923 . . . . 0.0 117.111 156.579 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 36' ' ' ILE . 2.5 mp -77.19 123.15 87.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 111.713 -3.994 . . . . 0.0 107.687 -172.377 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -63.48 138.28 64.43 Favored 'Trans proline' 0 N--CA 1.449 -1.142 1 O-C-N 129.198 4.262 . . . . 0.0 111.565 -179.855 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -59.85 -21.91 66.1 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 120.603 3.27 . . . . 0.0 120.603 -164.724 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.39 -13.36 58.48 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 124.917 1.385 . . . . 0.0 114.089 -175.304 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -98.11 -7.5 29.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.116 1.766 . . . . 0.0 113.768 175.652 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.39 147.86 33.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.519 1.528 . . . . 0.0 112.677 165.897 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.372 35.9 ttm105 -134.83 132.42 38.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 114.511 -2.661 . . . . 0.0 107.685 161.913 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.37 107.04 14.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.619 2.768 . . . . 0.0 107.162 -179.118 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.0 mt -122.34 144.69 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 1 O-C-N 115.509 -4.494 . . . . 0.0 107.349 171.234 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.465 ' CD1' HD11 ' A' ' 50' ' ' LEU 0.38 0.1 OUTLIER -142.08 110.89 6.21 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 132.898 4.479 . . . . 0.0 114.988 167.967 . . . . . . . . 5 4 . 1 . 080 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.34 32.44 3.53 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.717 2.807 . . . . 0.0 111.337 177.582 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 -19.36 23.98 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 128.35 2.881 . . . . 0.0 116.222 -177.322 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -76.98 117.51 18.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.649 2.38 . . . . 0.0 107.996 177.165 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -77.33 122.03 24.56 Favored 'General case' 0 N--CA 1.445 -0.722 1 C-N-CA 133.986 4.914 . . . . 0.0 108.399 175.241 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.465 HD11 ' CD1' ' A' ' 45' ' ' PHE . 6.4 mp -87.1 120.84 28.79 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 126.271 2.232 . . . . 0.0 108.646 -176.922 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.46 151.16 22.63 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.516 -156.392 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.8 104.0 1.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 131.01 3.724 . . . . 0.0 108.782 -174.15 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.88 -14.6 26.57 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.277 174.211 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -71.09 147.38 48.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 122.787 3.293 . . . . 0.0 106.971 160.451 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -105.91 -178.2 3.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 118.98 -2.325 . . . . 0.0 108.408 -173.951 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -66.1 -33.37 75.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 113.829 -2.986 . . . . 0.0 108.209 175.286 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.355 21.3 m -72.59 -29.4 63.49 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 127.455 2.972 . . . . 0.0 109.378 -179.105 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -67.22 -34.95 78.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.96 1.413 . . . . 0.0 113.725 173.573 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 55.2 m-85 -97.67 9.38 42.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.48 2.312 . . . . 0.0 112.085 -178.704 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.39 74.5 m-20 73.17 13.81 4.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 173.0 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.8 mm -91.94 114.98 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 -159.298 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -88.57 168.44 12.56 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 111.67 -2.514 . . . . 0.0 112.183 163.482 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.289 30.5 pttt -29.27 137.79 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 121.345 3.831 . . . . 0.0 121.345 169.867 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.273 4.9 tt0 71.76 4.28 4.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 164.867 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -62.2 158.71 16.38 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 118.639 -2.538 . . . . 0.0 112.615 159.986 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.306 15.2 t -129.4 137.18 50.77 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 129.084 3.99 . . . . 0.0 108.764 -175.129 . . . . . . . . 2 2 . 1 . 080 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -120.62 135.08 55.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 121.555 1.98 . . . . 0.0 111.998 -176.131 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -96.55 137.68 35.26 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 115.173 -2.346 . . . . 0.0 110.018 170.536 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -117.53 166.33 12.49 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 127.678 3.111 . . . . 0.0 111.212 173.489 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.95 147.22 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 O-C-N 127.477 2.985 . . . . 0.0 107.544 165.148 . . . . . . . . 1 1 . 1 . 080 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 36' ' ' ILE . 32.1 mt . . . . . 0 N--CA 1.445 -0.707 1 C-N-CA 134.567 5.147 . . . . 0.0 110.553 170.595 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 ttp . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 . . . . . . . . . 0 0 . 1 . 081 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -96.18 155.47 16.75 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 119.569 -1.957 . . . . 0.0 106.735 -177.796 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 pt -135.84 160.29 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 129.236 3.014 . . . . 0.0 113.127 165.369 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -101.59 151.95 21.38 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 125.534 1.771 . . . . 0.0 108.509 162.338 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.5 t -125.7 132.19 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 166.368 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -89.95 119.68 30.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 117.862 -3.024 . . . . 0.0 105.593 157.954 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -100.48 136.34 40.51 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -178.137 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -44.12 -42.53 6.37 Favored 'General case' 0 C--N 1.324 -0.514 1 O-C-N 130.515 4.884 . . . . 0.0 113.53 -174.48 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.1 p -58.72 -12.08 3.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 130.859 3.664 . . . . 0.0 117.095 174.208 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.07 -16.27 10.1 Favored Glycine 0 CA--C 1.527 0.804 1 C-N-CA 130.731 4.015 . . . . 0.0 110.843 176.071 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -80.73 142.07 34.2 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 120.473 2.137 . . . . 0.0 112.117 -165.361 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.6 m -96.91 130.0 44.28 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 164.071 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.269 43.9 pt -135.69 153.97 33.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 127.623 2.369 . . . . 0.0 106.289 -177.55 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.256 11.8 t -129.03 133.05 47.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 112.657 -3.545 . . . . 0.0 110.632 -177.915 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -130.82 151.44 51.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 122.74 2.518 . . . . 0.0 111.181 -172.309 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -97.16 117.4 31.27 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 131.338 3.855 . . . . 0.0 106.394 172.882 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.18 171.81 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 1 N-CA-C 100.093 -4.04 . . . . 0.0 100.093 179.714 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -111.36 142.85 27.26 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 131.273 3.829 . . . . 0.0 101.357 159.574 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 57' ' ' SER . 53.6 Cg_endo -63.07 -13.89 38.19 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.086 3.19 . . . . 0.0 114.078 174.475 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -86.38 -7.81 58.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 126.962 3.268 . . . . 0.0 112.736 176.939 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -74.5 132.69 42.08 Favored 'General case' 0 N--CA 1.451 -0.405 1 O-C-N 114.552 -5.092 . . . . 0.0 109.361 179.521 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -63.32 162.87 11.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.343 2.657 . . . . 0.0 113.695 169.955 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mm -66.14 -36.4 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.207 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -19.55 64.59 Favored 'General case' 0 N--CA 1.449 -0.504 1 O-C-N 115.003 -4.811 . . . . 0.0 116.972 172.878 . . . . . . . . 3 3 . 1 . 081 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -80.25 -24.44 40.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 125.473 1.733 . . . . 0.0 109.579 174.024 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 t -73.58 -30.89 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.662 1.185 . . . . 0.0 108.755 168.111 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -73.29 -41.11 63.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 118.168 -2.833 . . . . 0.0 113.99 175.958 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.9 -47.12 43.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 129.985 3.314 . . . . 0.0 113.372 170.162 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -73.76 -30.19 62.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 114.823 -2.513 . . . . 0.0 112.54 179.085 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -75.36 -39.89 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 O-C-N 125.821 1.95 . . . . 0.0 109.316 168.854 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -50.02 -46.36 52.78 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 128.152 2.581 . . . . 0.0 110.642 174.875 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.254 5.6 t70 -58.51 -44.18 89.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.388 1.875 . . . . 0.0 114.571 175.58 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -85.85 -51.3 6.49 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 115.91 -1.995 . . . . 0.0 110.25 -176.166 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -99.91 -23.04 15.06 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 114.131 -2.842 . . . . 0.0 111.572 -164.58 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.17 -12.98 28.79 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 128.65 3.719 . . . . 0.0 117.696 172.724 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.305 70.8 mt -75.27 132.13 76.86 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 113.715 -3.041 . . . . 0.0 111.067 -163.327 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.86 146.1 82.24 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 O-C-N 126.608 2.899 . . . . 0.0 114.206 173.014 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.56 -34.18 43.22 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 CA-C-N 120.959 1.378 . . . . 0.0 115.119 176.27 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.308 0.1 OUTLIER -42.19 -37.79 1.56 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.054 2.542 . . . . 0.0 113.853 174.793 . . . . . . . . 3 3 . 1 . 081 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -108.88 -8.45 15.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.396 1.879 . . . . 0.0 111.915 -171.182 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -104.78 119.03 38.02 Favored 'General case' 0 N--CA 1.452 -0.334 1 C-N-CA 134.203 5.001 . . . . 0.0 113.343 -169.434 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -127.38 133.46 50.02 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 177.43 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.274 3.8 mt -104.42 152.4 22.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.974 1.71 . . . . 0.0 110.969 -169.302 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mt -137.04 146.09 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 1 C-N-CA 132.929 4.492 . . . . 0.0 107.324 -169.397 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -152.41 123.8 7.72 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 131.638 3.975 . . . . 0.0 107.918 169.358 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.4 38.05 25.76 Favored 'General case' 0 N--CA 1.445 -0.687 1 C-N-CA 132.355 4.262 . . . . 0.0 112.302 166.507 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.28 -14.89 63.1 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 120.149 -1.594 . . . . 0.0 116.925 -179.382 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -107.1 125.89 51.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 -171.785 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.92 127.81 32.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 169.704 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.11 137.46 34.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.289 1.859 . . . . 0.0 106.613 -168.683 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -82.21 123.63 29.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 109.55 -3.477 . . . . 0.0 105.333 -164.563 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -69.96 112.18 6.18 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 127.726 2.41 . . . . 0.0 106.033 -167.814 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.89 0.04 22.87 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 115.77 -2.683 . . . . 0.0 117.594 -157.722 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -114.16 178.71 4.18 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.981 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -125.59 160.42 29.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.958 2.503 . . . . 0.0 107.411 -174.264 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.45 -41.27 98.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.579 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 42.2 t -53.03 -38.71 62.61 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.285 -1.509 . . . . 0.0 110.227 175.575 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.47 -48.5 81.41 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 116.266 -1.826 . . . . 0.0 112.343 -173.171 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -84.95 11.89 8.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 121.503 1.956 . . . . 0.0 115.187 172.406 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.36 4.1 t-20 76.84 33.33 0.47 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 123.179 1.466 . . . . 0.0 108.566 160.363 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.99 120.09 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 118.7 -2.5 . . . . 0.0 111.345 -177.95 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -99.72 172.0 7.54 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.225 2.21 . . . . 0.0 111.642 173.414 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -59.69 133.33 55.99 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.928 2.491 . . . . 0.0 115.661 179.911 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 4.2 tt0 75.19 20.95 1.98 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.359 2.664 . . . . 0.0 115.772 -175.314 . . . . . . . . 2 2 . 1 . 081 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -63.5 136.84 57.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 131.407 3.883 . . . . 0.0 109.595 165.439 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.6 m -101.05 107.0 18.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 124.781 1.301 . . . . 0.0 112.662 169.23 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.94 162.0 20.62 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.477 1.911 . . . . 0.0 110.94 172.938 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -135.41 117.06 14.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 130.381 3.472 . . . . 0.0 105.755 -168.616 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tp -98.52 140.46 32.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 115.456 -2.212 . . . . 0.0 110.925 -174.002 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.29 163.71 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 127.179 2.191 . . . . 0.0 108.657 171.908 . . . . . . . . 1 1 . 1 . 081 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.485 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.588 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -173.193 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 . . . . . . . . . 0 0 . 1 . 082 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -91.91 145.19 24.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 -172.324 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.85 163.54 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 128.842 2.857 . . . . 0.0 109.147 162.731 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -104.38 151.12 23.87 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 114.638 -2.601 . . . . 0.0 105.002 177.01 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.9 105.15 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 1 C-N-CA 132.69 4.396 . . . . 0.0 104.328 172.272 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -97.91 107.36 19.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.312 2.245 . . . . 0.0 111.263 -173.905 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 p -86.11 166.49 15.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -168.422 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -86.63 -20.76 27.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.528 -2.177 . . . . 0.0 115.923 166.905 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 p -69.44 -23.76 63.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 125.32 1.638 . . . . 0.0 113.321 176.154 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.53 -14.09 5.33 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 119.494 -2.004 . . . . 0.0 115.746 156.145 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -80.6 172.54 13.62 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 120.075 -1.838 . . . . 0.0 112.892 173.556 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 m -136.67 132.1 34.49 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 117.544 -3.222 . . . . 0.0 107.2 177.297 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.22 148.1 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.63 1.572 . . . . 0.0 107.807 172.881 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 p -97.22 131.35 44.03 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.978 2.911 . . . . 0.0 110.178 165.762 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.82 133.6 53.06 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 115.411 -2.233 . . . . 0.0 111.073 -172.527 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -84.23 125.8 32.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 101.256 -3.609 . . . . 0.0 101.256 164.837 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 26' ' ' VAL . 17.1 m -132.38 147.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 176.035 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 2.1 tm-20 -97.59 135.8 21.52 Favored Pre-proline 0 N--CA 1.448 -0.526 0 O-C-N 119.274 -2.141 . . . . 0.0 108.608 158.027 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.82 -24.81 2.26 Favored 'Trans proline' 0 N--CA 1.443 -1.451 1 C-N-CA 126.817 5.012 . . . . 0.0 116.317 173.951 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -98.29 1.55 47.25 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 129.796 3.238 . . . . 0.0 109.991 177.194 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -72.03 140.46 49.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 121.799 2.09 . . . . 0.0 106.935 167.731 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.0 p -90.58 178.92 5.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 118.916 -2.365 . . . . 0.0 108.381 -175.928 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.469 HG23 HD12 ' A' ' 43' ' ' LEU . 11.0 mm -67.24 -33.23 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 120.01 1.277 . . . . 0.0 113.457 179.469 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.69 -37.27 83.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.752 2.821 . . . . 0.0 116.672 168.293 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -77.58 -35.44 53.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 115.629 -2.129 . . . . 0.0 107.233 -179.722 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.449 HG22 HG12 ' A' ' 17' ' ' VAL . 8.9 t -65.8 -48.52 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 124.856 3.48 . . . . 0.0 111.606 170.992 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -50.99 -49.99 59.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 169.719 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.05 -49.46 41.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.946 2.098 . . . . 0.0 114.889 165.157 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -65.14 -25.46 67.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 119.606 -1.934 . . . . 0.0 110.574 -179.864 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -80.92 -13.76 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 O-C-N 119.276 -2.14 . . . . 0.0 114.677 175.269 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -76.59 -41.9 44.5 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 118.593 -2.567 . . . . 0.0 110.255 168.034 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -57.72 -43.38 85.2 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 127.248 2.219 . . . . 0.0 112.314 178.903 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -69.19 -55.03 11.85 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 115.268 -2.301 . . . . 0.0 115.255 174.198 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -122.94 -19.59 6.07 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 125.837 1.96 . . . . 0.0 111.65 -155.638 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.1 9.53 63.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.282 1.896 . . . . 0.0 111.716 167.679 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.433 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.8 mt -67.52 130.45 93.27 Favored Pre-proline 0 N--CA 1.444 -0.744 0 O-C-N 118.924 -2.515 . . . . 0.0 112.841 171.754 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -79.14 123.17 5.52 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.862 3.041 . . . . 0.0 109.108 -176.467 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.458 17.4 Cg_exo -25.93 -43.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.123 1 C-N-CA 129.736 6.957 . . . . 0.0 121.94 -177.91 . . . . . . . . 3 2 . 1 . 082 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.97 -15.19 63.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 113.602 -3.094 . . . . 0.0 113.389 177.403 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -86.71 -15.0 40.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 124.034 3.106 . . . . 0.0 109.673 177.574 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -90.11 153.03 20.85 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -166.753 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -142.32 120.13 11.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 121.85 2.114 . . . . 0.0 109.32 170.084 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.469 HD12 HG23 ' A' ' 23' ' ' ILE . 12.4 mt -89.45 144.0 26.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 125.034 3.561 . . . . 0.0 107.27 -178.059 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mm -127.41 153.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 125.69 2.662 . . . . 0.0 106.634 169.522 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.566 ' HB3' HD21 ' A' ' 50' ' ' LEU . 20.2 t80 -150.46 108.67 3.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.004 2.522 . . . . 0.0 108.985 174.725 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.02 22.21 12.92 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 131.567 3.947 . . . . 0.0 112.207 167.261 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.95 -4.01 25.7 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 119.239 -2.163 . . . . 0.0 116.977 178.409 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.22 143.98 48.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 172.225 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -91.89 135.17 34.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -172.618 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 45' ' ' PHE . 5.3 mt -89.99 138.39 31.54 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.23 -1.544 . . . . 0.0 108.925 176.733 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -145.58 140.68 27.58 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -159.889 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -35.85 128.9 0.65 Allowed 'General case' 0 N--CA 1.452 -0.326 1 C-N-CA 134.633 5.173 . . . . 0.0 113.65 -179.371 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.69 -16.25 23.78 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 118.092 -2.88 . . . . 0.0 117.223 167.253 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.334 32.9 mtt85 -100.49 166.77 10.77 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 125.713 2.673 . . . . 0.0 107.065 167.766 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -87.83 167.63 13.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 119.509 -1.994 . . . . 0.0 108.755 173.115 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.306 22.2 mt -59.93 -38.43 82.36 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 172.7 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.7 p -69.03 -27.75 65.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.413 1.885 . . . . 0.0 112.917 -179.254 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.53 -44.26 96.26 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.581 1.952 . . . . 0.0 108.278 171.803 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -81.4 10.55 5.52 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 128.341 2.656 . . . . 0.0 114.142 175.488 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.268 1.9 t-20 65.87 24.1 11.31 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 172.934 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 mt -86.69 132.62 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 O-C-N 120.194 -1.567 . . . . 0.0 106.941 -173.8 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -114.05 -179.56 3.67 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 127.073 2.733 . . . . 0.0 112.121 170.224 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 138.24 24.91 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.08 0.952 . . . . 0.0 111.201 175.253 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 42.6 mt-10 74.84 13.59 3.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 125.349 1.655 . . . . 0.0 109.735 163.603 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.4 m -54.52 157.53 2.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 157.252 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.93 105.25 14.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 111.51 -2.586 . . . . 0.0 106.084 177.102 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -102.08 138.89 38.43 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 176.535 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.257 41.4 m80 -95.88 135.77 37.18 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.637 1.575 . . . . 0.0 112.254 175.766 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.23 100.91 10.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 179.426 . . . . . . . . 2 2 . 1 . 082 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -96.51 151.91 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.031 . . . . . . . . 1 1 . 1 . 082 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.5 mt . . . . . 0 N--CA 1.446 -0.652 1 C-N-CA 135.776 5.631 . . . . 0.0 117.857 174.726 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 ttp . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 115.309 -2.281 . . . . 0.0 106.214 . . . . . . . . . 0 0 . 1 . 083 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -104.53 130.53 52.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.855 2.57 . . . . 0.0 111.388 -179.933 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.293 20.4 pt -119.22 122.03 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 114.25 -2.786 . . . . 0.0 109.617 165.336 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -73.77 151.97 40.47 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 124.15 3.159 . . . . 0.0 108.434 178.243 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -126.44 155.16 36.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 1 O-C-N 129.301 4.126 . . . . 0.0 106.794 161.438 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.25 42.3 tttt -120.63 152.87 37.61 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 128.909 2.884 . . . . 0.0 113.342 169.205 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.432 HG22 HD21 ' A' ' 69' ' ' LEU . 24.3 p -107.23 159.06 16.63 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 130.591 3.556 . . . . 0.0 106.422 -170.573 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 mt -63.64 -19.97 65.31 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.608 1.563 . . . . 0.0 111.895 -179.163 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.5 p -85.31 -15.25 43.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 176.235 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.63 5.59 41.95 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 113.777 -3.79 . . . . 0.0 114.129 177.695 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -82.58 132.67 35.19 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 121.885 2.843 . . . . 0.0 110.381 176.911 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.6 m -90.0 124.59 34.88 Favored 'General case' 0 C--N 1.325 -0.463 1 C-N-CA 134.339 5.055 . . . . 0.0 104.799 176.227 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -113.59 139.4 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 130.93 3.692 . . . . 0.0 107.809 -179.34 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.4 m -96.73 130.66 43.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 121.886 2.13 . . . . 0.0 112.128 170.854 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.2 mt -107.63 129.54 54.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.559 2.344 . . . . 0.0 113.004 173.805 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -80.37 118.7 22.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 123.69 1.71 . . . . 0.0 108.646 169.983 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.04 156.46 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 O-C-N 117.537 -3.227 . . . . 0.0 115.243 173.882 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -74.61 154.29 87.5 Favored Pre-proline 0 N--CA 1.451 -0.404 0 O-C-N 117.843 -3.036 . . . . 0.0 108.979 162.826 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -76.81 15.84 1.03 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 1 C-N-CA 125.568 4.179 . . . . 0.0 114.543 179.648 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 p -131.38 3.16 4.24 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 129.288 3.035 . . . . 0.0 117.786 171.914 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.54 137.93 57.86 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 126.588 2.43 . . . . 0.0 107.941 179.506 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.298 44.6 p -102.56 170.47 8.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 126.957 3.265 . . . . 0.0 107.709 -174.09 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mm -66.01 -30.72 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 1 O-C-N 114.642 -5.036 . . . . 0.0 115.506 -173.962 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.14 -26.25 68.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 121.031 1.741 . . . . 0.0 111.648 175.661 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.05 -28.12 29.8 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.441 2.296 . . . . 0.0 112.652 176.429 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.8 t -81.58 -29.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 122.382 2.355 . . . . 0.0 108.275 178.732 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -51.45 -49.39 61.82 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.251 2.22 . . . . 0.0 115.347 160.062 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.11 -46.11 68.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.677 1.591 . . . . 0.0 108.563 -178.695 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.254 57.2 mttm -52.09 -50.11 62.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 172.633 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.335 91.5 mt -54.52 -38.07 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 123.61 1.671 . . . . 0.0 114.992 171.902 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.88 -42.62 94.65 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 117.165 -3.459 . . . . 0.0 111.233 170.846 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -52.45 -42.5 64.22 Favored 'General case' 0 N--CA 1.445 -0.702 1 O-C-N 116.206 -4.059 . . . . 0.0 114.278 172.007 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -90.51 -47.34 7.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -167.538 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -120.15 -15.15 8.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 124.803 2.24 . . . . 0.0 113.528 -157.26 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.34 1.42 44.19 Favored Glycine 0 CA--C 1.522 0.518 1 C-N-CA 134.309 5.719 . . . . 0.0 117.352 166.818 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -88.99 119.98 69.89 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 128.181 2.592 . . . . 0.0 104.667 -153.2 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.3 142.84 55.75 Favored 'Trans proline' 0 N--CA 1.447 -1.229 1 C-N-CA 126.459 4.772 . . . . 0.0 114.659 178.164 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.02 -46.78 7.64 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 124.603 3.535 . . . . 0.0 111.267 -177.789 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.439 0.0 OUTLIER -32.95 -40.4 0.05 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 118.608 2.818 . . . . 0.0 118.608 167.49 . . . . . . . . 3 3 . 1 . 083 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.302 11.5 mm-40 -101.34 -5.25 25.65 Favored 'General case' 0 N--CA 1.448 -0.556 1 C-N-CA 132.312 4.245 . . . . 0.0 114.626 -161.56 . . . . . . . . 3 2 . 1 . 083 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -99.7 157.21 16.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.931 2.093 . . . . 0.0 106.929 -178.664 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -142.59 129.13 20.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 130.017 3.327 . . . . 0.0 110.364 160.14 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -117.04 120.26 37.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 120.357 1.435 . . . . 0.0 107.428 174.784 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mm -106.32 152.75 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 130.148 3.379 . . . . 0.0 107.801 -177.329 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -152.08 107.16 3.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 130.161 3.384 . . . . 0.0 105.582 178.271 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.439 . . 72.25 23.23 3.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 127.887 3.708 . . . . 0.0 117.679 169.383 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.03 -12.75 45.12 Favored Glycine 0 CA--C 1.529 0.958 1 O-C-N 114.574 -5.079 . . . . 0.0 110.086 171.901 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -112.69 142.24 45.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.559 3.544 . . . . 0.0 111.963 -179.969 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -91.65 141.89 28.21 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 110.473 -3.058 . . . . 0.0 105.218 -175.765 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -88.18 113.91 24.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 130.217 3.407 . . . . 0.0 106.824 -175.285 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -103.28 164.66 11.5 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 129.832 3.253 . . . . 0.0 113.346 -169.904 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -68.42 132.03 46.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 128.81 3.819 . . . . 0.0 112.745 -177.297 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.8 0.88 58.83 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.694 1.616 . . . . 0.0 112.647 173.769 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -88.81 164.53 15.18 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.866 2.066 . . . . 0.0 108.678 177.001 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -111.71 161.68 16.03 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 169.399 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -55.67 -39.41 70.91 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.675 1.19 . . . . 0.0 110.762 176.538 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 m -61.31 -34.1 74.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 116.113 -1.898 . . . . 0.0 115.214 177.885 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -60.85 -38.54 85.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 116.211 -1.852 . . . . 0.0 114.852 172.237 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -97.95 14.68 26.43 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 116.717 -1.611 . . . . 0.0 110.943 173.894 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.363 12.6 p30 74.54 14.95 3.44 Favored 'General case' 0 N--CA 1.439 -0.978 1 C-N-CA 135.111 5.364 . . . . 0.0 114.208 166.608 . . . . . . . . 3 2 . 1 . 083 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -72.33 111.57 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.181 2.192 . . . . 0.0 109.297 -170.414 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -96.57 164.84 12.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 127.019 2.699 . . . . 0.0 107.811 -173.18 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -48.26 117.76 2.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.961 3.704 . . . . 0.0 110.483 179.27 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.722 2.1 mp0 78.01 18.97 1.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 117.898 2.555 . . . . 0.0 117.898 -178.707 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.6 m -77.27 154.11 33.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 170.466 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.2 m -107.21 129.26 54.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.205 1.802 . . . . 0.0 106.949 173.232 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -99.81 156.1 17.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 163.622 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -98.94 149.38 23.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 115.496 -2.193 . . . . 0.0 108.352 160.281 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.432 HD21 HG22 ' A' ' 7' ' ' THR . 3.5 pp -97.37 151.89 19.48 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 124.752 1.283 . . . . 0.0 110.866 164.157 . . . . . . . . 2 2 . 1 . 083 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.6 t -142.72 125.35 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -179.203 . . . . . . . . 1 1 . 1 . 083 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 N--CA 1.449 -0.487 0 O-C-N 119.795 -1.815 . . . . 0.0 110.249 -176.002 . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 . . . . . . . . . 0 0 . 1 . 084 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -97.04 144.79 26.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 -178.201 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 67' ' ' LEU 0.382 0.9 OUTLIER -125.54 157.55 34.76 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 C-N-CA 129.469 3.108 . . . . 0.0 107.158 167.428 . . . . . . . . 4 4 . 1 . 084 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -113.17 139.39 48.8 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.739 2.015 . . . . 0.0 105.746 179.757 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.9 t -117.25 113.45 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 171.077 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -102.16 135.14 44.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 173.084 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -83.48 164.28 19.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 118.007 -2.933 . . . . 0.0 112.105 172.394 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 70' ' ' VAL . 1.2 mt -60.3 -27.75 67.55 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.699 2.0 . . . . 0.0 108.67 179.577 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -14.44 58.93 Favored 'General case' 0 N--CA 1.448 -0.567 1 C-N-CA 134.362 5.065 . . . . 0.0 115.558 176.794 . . . . . . . . 3 3 . 1 . 084 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.8 -9.0 37.19 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 118.736 -2.478 . . . . 0.0 113.047 166.448 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.262 79.0 tttt -89.95 128.25 36.2 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 -177.106 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.3 m -117.83 120.2 37.19 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 110.857 -2.883 . . . . 0.0 112.116 -174.681 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -112.54 155.51 13.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 126.895 3.236 . . . . 0.0 110.337 174.795 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.3 6.8 m -103.1 120.53 40.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.538 -1.976 . . . . 0.0 107.396 -173.785 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -115.2 126.71 54.89 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.259 2.224 . . . . 0.0 109.898 -168.177 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -90.39 114.24 26.31 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 125.099 1.499 . . . . 0.0 108.29 -176.655 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.47 165.32 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 126.308 1.843 . . . . 0.0 114.465 179.908 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -125.34 153.15 72.09 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 114.921 -2.466 . . . . 0.0 109.408 165.505 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.17 -30.85 26.78 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.449 3.433 . . . . 0.0 117.921 -177.521 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -75.97 -1.47 25.79 Favored 'General case' 0 N--CA 1.446 -0.652 1 C-N-CA 135.424 5.489 . . . . 0.0 117.707 178.534 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.65 137.71 33.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 117.246 -3.409 . . . . 0.0 109.023 -175.155 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -84.63 159.14 20.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 122.004 2.184 . . . . 0.0 113.528 175.356 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -65.76 -21.41 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.098 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.74 -36.0 81.61 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 130.396 3.479 . . . . 0.0 112.23 174.736 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -73.82 -34.42 64.57 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 125.373 1.671 . . . . 0.0 110.27 175.683 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -80.72 -42.63 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.83 2.452 . . . . 0.0 111.578 -175.093 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -53.92 -46.51 71.51 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 121.231 3.789 . . . . 0.0 121.231 161.929 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.76 -43.03 98.51 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 126.883 2.614 . . . . 0.0 113.08 174.48 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -52.02 -39.44 59.49 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 115.022 -2.418 . . . . 0.0 112.73 174.737 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.7 mt -57.12 -46.46 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 125.456 1.722 . . . . 0.0 109.599 179.292 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -66.61 -45.94 77.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.298 1.839 . . . . 0.0 108.777 178.254 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -55.38 -43.49 75.2 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 117.568 -3.208 . . . . 0.0 115.266 177.065 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.94 -80.74 0.14 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 130.055 3.342 . . . . 0.0 113.937 174.976 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -89.19 -10.17 48.11 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 122.024 2.193 . . . . 0.0 115.069 -170.214 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.71 40.61 37.03 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 119.946 2.738 . . . . 0.0 119.946 -177.753 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 mt -119.18 95.82 49.59 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 119.957 -1.908 . . . . 0.0 109.86 178.407 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -69.13 158.03 59.32 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 O-C-N 122.805 0.898 . . . . 0.0 111.735 -177.953 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.292 63.1 Cg_exo -42.09 -34.88 2.94 Favored 'Trans proline' 0 N--CA 1.444 -1.407 1 C-N-CA 126.269 4.646 . . . . 0.0 120.186 176.858 . . . . . . . . 3 2 . 1 . 084 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.97 -35.55 0.54 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 129.488 3.115 . . . . 0.0 112.997 163.942 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -110.08 -7.69 14.89 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.208 1.803 . . . . 0.0 110.851 -170.618 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.253 81.1 mt-30 -100.06 155.09 17.91 Favored 'General case' 0 C--O 1.226 -0.141 0 O-C-N 118.945 -2.347 . . . . 0.0 112.266 179.256 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -150.08 105.61 3.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 100.962 -3.718 . . . . 0.0 100.962 169.052 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD13 HD12 ' A' ' 50' ' ' LEU . 84.1 mt -81.69 72.74 8.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.565 1.546 . . . . 0.0 109.905 165.301 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 tt -71.24 92.95 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.226 154.843 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CD1' HD23 ' A' ' 50' ' ' LEU . 29.0 p90 -73.26 -28.71 62.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -172.252 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.62 -80.93 0.12 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 114.882 -2.485 . . . . 0.0 108.401 175.1 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.67 -12.88 9.12 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 115.3 -2.945 . . . . 0.0 110.042 -179.315 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -136.28 163.46 30.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 121.253 2.526 . . . . 0.0 105.077 -169.478 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -77.02 155.64 32.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.333 -1.479 . . . . 0.0 113.662 172.14 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.46 HD23 ' CD1' ' A' ' 45' ' ' PHE . 39.8 mt -68.61 152.24 45.63 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 124.62 1.2 . . . . 0.0 109.793 172.346 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -108.64 129.78 55.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 120.811 1.642 . . . . 0.0 109.114 178.791 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -45.59 105.25 0.06 Allowed 'General case' 0 N--CA 1.444 -0.739 1 C-N-CA 132.717 4.407 . . . . 0.0 116.109 166.419 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.51 -3.96 13.5 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.659 2.552 . . . . 0.0 116.373 174.961 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -98.4 158.87 15.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 -177.525 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -111.65 169.65 8.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 110.208 -3.178 . . . . 0.0 103.778 -179.925 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 3.5 mp -52.59 -34.32 50.14 Favored 'General case' 0 N--CA 1.445 -0.714 1 C-N-CA 132.111 4.164 . . . . 0.0 112.445 172.0 . . . . . . . . 3 3 . 1 . 084 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.9 m -72.15 -21.24 61.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 175.407 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -72.89 -30.62 64.08 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.443 1.497 . . . . 0.0 113.713 169.97 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -101.85 2.15 37.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.529 1.532 . . . . 0.0 111.164 173.767 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 49.1 m-80 67.94 14.55 9.4 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 117.794 -3.066 . . . . 0.0 118.726 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.0 mt -65.85 154.27 7.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -163.188 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -128.39 179.16 5.79 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 130.98 3.712 . . . . 0.0 114.319 -170.165 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 tttt -65.16 135.43 55.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 113.818 -2.992 . . . . 0.0 109.725 -177.833 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.351 15.4 mt-10 78.72 0.55 2.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.515 2.726 . . . . 0.0 113.187 167.904 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.62 141.63 54.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.936 2.494 . . . . 0.0 112.047 178.656 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.1 m -109.81 132.27 54.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -177.412 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.588 HD12 HD13 ' A' ' 3' ' ' ILE . 67.6 mt -114.7 152.34 32.15 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 125.61 1.819 . . . . 0.0 108.743 173.738 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.368 15.4 m80 -105.1 149.3 25.97 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.038 2.135 . . . . 0.0 107.092 -168.274 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -129.9 136.81 49.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 121.168 1.804 . . . . 0.0 112.631 169.598 . . . . . . . . 1 1 . 1 . 084 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.491 ' HA ' HD12 ' A' ' 8' ' ' LEU . 73.0 t -124.57 139.07 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 129.768 3.227 . . . . 0.0 107.72 -176.326 . . . . . . . . 2 2 . 1 . 084 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 tp . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 -158.142 . . . . . . . . 0 0 . 1 . 085 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 ttp . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 085 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -75.11 132.95 41.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 126.928 2.643 . . . . 0.0 113.644 170.275 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 3' ' ' ILE . 4.4 pt -130.54 146.56 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 1 C-N-CA 131.757 4.023 . . . . 0.0 106.917 160.414 . . . . . . . . 3 3 . 1 . 085 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.29 141.53 34.03 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 129.112 2.965 . . . . 0.0 105.733 171.548 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -128.7 126.34 64.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 115.954 -1.974 . . . . 0.0 105.758 163.923 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -84.41 114.15 21.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 127.425 2.953 . . . . 0.0 110.908 174.722 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -64.13 160.67 17.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 128.5 4.0 . . . . 0.0 111.711 170.657 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -60.46 -12.59 10.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 117.274 -3.391 . . . . 0.0 118.571 -176.663 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 p -95.04 -8.0 38.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 109.894 -3.321 . . . . 0.0 111.222 175.766 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.82 -20.15 36.97 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 124.072 3.124 . . . . 0.0 112.827 -179.88 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -78.35 141.57 38.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 113.619 -3.086 . . . . 0.0 114.767 -176.219 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 p -92.77 132.05 37.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 125.926 3.966 . . . . 0.0 116.871 168.8 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.9 pt -102.91 129.37 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.536 161.005 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.2 m -88.54 129.14 35.54 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 103.452 -2.795 . . . . 0.0 103.452 -175.001 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.7 mt -114.89 131.16 56.95 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 178.624 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.15 98.72 9.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.553 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -112.98 167.99 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 124.662 2.172 . . . . 0.0 113.173 -176.221 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.371 26.4 mm-40 -93.46 149.25 36.95 Favored Pre-proline 0 N--CA 1.449 -0.511 0 O-C-N 118.204 -2.81 . . . . 0.0 105.593 167.104 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.28 15.4 Cg_endo -73.02 -16.03 25.77 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.952 2.434 . . . . 0.0 115.192 -176.61 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 p -86.61 -5.65 59.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.697 2.399 . . . . 0.0 112.07 -179.353 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -75.27 153.83 37.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -173.32 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.8 p -97.34 173.15 7.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 117.942 -2.974 . . . . 0.0 110.932 176.219 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.7 mm -85.97 -24.64 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 127.805 2.442 . . . . 0.0 109.121 -164.112 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -68.25 -30.58 69.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 129.929 3.292 . . . . 0.0 109.211 174.632 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -86.04 -17.67 34.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 124.319 3.236 . . . . 0.0 113.225 170.422 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.91 -50.93 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 102.75 -3.056 . . . . 0.0 102.75 168.908 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.22 -30.0 61.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 121.101 1.773 . . . . 0.0 108.756 -171.134 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.24 -27.4 67.94 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 117.497 -3.252 . . . . 0.0 115.465 168.317 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -67.02 -38.13 85.4 Favored 'General case' 0 C--N 1.325 -0.494 1 O-C-N 115.862 -4.274 . . . . 0.0 116.733 169.604 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.4 mt -74.3 -20.25 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 O-C-N 126.89 2.619 . . . . 0.0 113.173 171.433 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -66.61 -30.77 71.13 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 119.635 -1.915 . . . . 0.0 115.663 154.659 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -83.79 -57.71 3.1 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 121.496 1.953 . . . . 0.0 106.106 -174.765 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.323 64.7 mttm -45.04 -71.47 0.08 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 119.53 3.159 . . . . 0.0 119.53 168.073 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -102.77 -28.52 12.04 Favored 'General case' 0 N--CA 1.448 -0.526 1 CA-C-O 128.901 4.191 . . . . 0.0 115.979 -164.7 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.11 -9.12 50.18 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 118.777 -2.452 . . . . 0.0 118.955 167.211 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.4 mm -82.5 124.62 77.62 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 129.347 3.059 . . . . 0.0 104.825 -167.556 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.27 147.05 36.78 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 123.822 3.015 . . . . 0.0 112.829 -173.134 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -67.19 -13.19 38.74 Favored 'Trans proline' 0 N--CA 1.442 -1.507 1 C-N-CA 126.953 5.102 . . . . 0.0 114.072 -171.672 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -83.46 -5.7 59.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 118.213 -1.395 . . . . 0.0 113.927 173.688 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.431 2.5 tp-100 -108.98 -8.45 15.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.266 1.826 . . . . 0.0 111.408 168.885 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -92.91 123.74 36.39 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 126.859 3.219 . . . . 0.0 107.687 179.498 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.354 32.2 mtt180 -126.0 138.77 53.76 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 111.61 -2.541 . . . . 0.0 108.157 172.292 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.405 HD13 HD13 ' A' ' 67' ' ' LEU . 16.5 mt -105.49 150.96 24.85 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 174.176 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.286 68.4 mt -100.53 143.84 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 1 C-N-CA 133.383 4.673 . . . . 0.0 109.685 152.219 . . . . . . . . 3 2 . 1 . 085 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -151.59 119.68 6.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 111.025 -2.807 . . . . 0.0 115.055 162.635 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.8 39.07 24.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.758 2.423 . . . . 0.0 115.08 176.677 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.43 -10.39 16.88 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 163.15 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -134.09 136.23 43.78 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -159.867 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.359 6.0 tt0 -73.99 130.37 39.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 162.525 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -73.92 133.6 43.09 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -172.787 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.22 -39.31 94.26 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.585 1.954 . . . . 0.0 112.125 175.182 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.391 24.8 t0 106.38 160.31 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 131.701 4.0 . . . . 0.0 113.419 170.585 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.98 21.94 12.94 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 128.609 3.004 . . . . 0.0 114.518 153.608 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -113.62 176.37 5.06 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 124.724 2.202 . . . . 0.0 106.666 175.034 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.2 p -90.41 154.22 19.83 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.274 -2.141 . . . . 0.0 108.438 172.623 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.346 8.0 mp -41.79 -61.25 1.15 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 110.261 -3.154 . . . . 0.0 115.686 175.596 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -45.24 -52.88 9.01 Favored 'General case' 0 N--CA 1.448 -0.536 1 C-N-CA 132.921 4.488 . . . . 0.0 112.601 176.103 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -64.45 -43.66 93.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.66 178.216 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.75 -14.4 60.71 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 119.359 -2.088 . . . . 0.0 111.733 -173.402 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.475 0.9 OUTLIER 91.61 24.03 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 130.801 3.641 . . . . 0.0 115.643 179.323 . . . . . . . . 3 3 . 1 . 085 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.7 mt -95.59 115.47 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 119.934 1.243 . . . . 0.0 111.99 176.139 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -116.2 -156.49 0.62 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.831 1.652 . . . . 0.0 114.344 -178.876 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -56.28 112.11 1.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 127.416 2.286 . . . . 0.0 112.997 178.407 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 76.52 21.96 1.27 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.065 2.146 . . . . 0.0 108.968 168.461 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -63.68 127.31 30.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 117.195 -1.383 . . . . 0.0 108.471 175.297 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 13.5 m -90.16 111.61 22.82 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 121.33 1.877 . . . . 0.0 111.687 169.664 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.405 HD13 HD13 ' A' ' 43' ' ' LEU . 31.3 mt -91.87 152.19 20.2 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.823 1.249 . . . . 0.0 110.263 166.673 . . . . . . . . 2 2 . 1 . 085 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -107.96 141.25 39.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 173.164 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -104.35 145.46 30.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -179.556 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 m -142.72 153.11 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 129.146 2.978 . . . . 0.0 107.095 -178.023 . . . . . . . . 1 1 . 1 . 085 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 mt . . . . . 0 C--N 1.323 -0.549 0 C-N-CA 127.094 2.158 . . . . 0.0 108.393 167.131 . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 115.401 -2.238 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 086 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -72.42 152.58 41.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 129.525 3.13 . . . . 0.0 108.926 177.595 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pp -145.29 158.95 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 160.63 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -119.22 117.82 29.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.463 1.505 . . . . 0.0 108.989 -174.085 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 t -100.88 117.52 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 1 N-CA-C 99.253 -4.351 . . . . 0.0 99.253 175.886 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -109.42 136.52 48.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 125.465 1.728 . . . . 0.0 109.624 -171.917 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -84.97 174.27 9.9 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.125 -1.609 . . . . 0.0 108.969 -177.137 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.5 mt -91.64 0.65 57.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 116.84 -1.552 . . . . 0.0 107.085 179.595 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -107.19 0.89 23.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.305 1.842 . . . . 0.0 110.481 174.453 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.99 -27.48 8.6 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 115.049 -3.084 . . . . 0.0 111.912 154.625 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -62.6 144.31 56.32 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 129.826 3.898 . . . . 0.0 108.906 179.066 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -118.52 123.0 44.02 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 127.683 3.114 . . . . 0.0 103.791 -169.057 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mt -94.24 134.36 32.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 117.039 -1.457 . . . . 0.0 108.329 174.602 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.6 m -103.07 110.23 22.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 114.296 -2.764 . . . . 0.0 110.716 177.848 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -107.6 160.37 15.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 127.152 2.782 . . . . 0.0 109.648 167.668 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.394 0.0 OUTLIER -127.87 116.06 19.56 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.732 3.213 . . . . 0.0 110.568 -178.017 . . . . . . . . 3 3 . 1 . 086 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.19 162.61 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 O-C-N 117.725 -3.109 . . . . 0.0 106.974 -169.387 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -102.07 154.56 37.28 Favored Pre-proline 0 N--CA 1.441 -0.901 0 O-C-N 118.975 -2.328 . . . . 0.0 106.815 164.638 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.251 67.0 Cg_endo -66.77 -29.32 42.58 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 124.496 3.464 . . . . 0.0 115.765 175.757 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.256 27.9 p -63.05 -2.28 1.21 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 114.927 -2.463 . . . . 0.0 117.366 160.814 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -70.1 136.14 49.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 123.484 2.856 . . . . 0.0 108.542 -175.517 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 p -77.99 170.83 15.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.76 2.424 . . . . 0.0 109.128 170.241 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.3 mt -72.66 -46.07 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -177.987 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -41.72 -44.1 3.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 122.668 2.485 . . . . 0.0 116.024 162.561 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -63.96 -42.97 97.13 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 124.687 1.242 . . . . 0.0 109.87 179.461 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.607 HG21 HD21 ' A' ' 56' ' ' LEU . 35.1 t -79.83 -27.88 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.353 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -68.69 -34.07 75.04 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 114.607 -2.616 . . . . 0.0 114.445 167.541 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.35 -26.12 42.15 Favored 'General case' 0 N--CA 1.45 -0.445 1 CA-C-N 126.881 4.401 . . . . 0.0 115.057 169.382 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -71.55 -39.61 70.55 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 124.688 1.242 . . . . 0.0 109.777 172.271 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.8 mt -73.36 -37.76 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 O-C-N 116.664 -3.773 . . . . 0.0 113.695 173.406 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -58.56 -45.49 88.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 119.999 1.272 . . . . 0.0 112.623 175.551 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.09 -35.51 69.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.766 2.426 . . . . 0.0 111.495 -179.612 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -86.73 -39.04 16.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -177.312 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -120.53 -25.31 5.59 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.311 1.844 . . . . 0.0 111.466 -172.259 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.77 -11.97 67.72 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 114.641 -3.311 . . . . 0.0 116.138 -178.682 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.6 mt -64.84 118.52 49.46 Favored Pre-proline 0 N--CA 1.45 -0.456 1 CA-C-N 124.434 4.117 . . . . 0.0 115.678 177.469 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -76.44 141.49 22.67 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 CA-C-N 124.533 2.655 . . . . 0.0 118.035 -173.767 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -30.21 -50.33 0.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 N-CA-C 121.089 3.457 . . . . 0.0 121.089 177.839 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.93 -40.74 63.83 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 117.446 -3.284 . . . . 0.0 114.591 172.93 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -84.51 -25.79 28.55 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 118.535 -1.266 . . . . 0.0 113.733 -174.376 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -63.81 121.48 14.13 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 128.218 2.607 . . . . 0.0 108.117 171.882 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -101.54 131.83 47.5 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 123.316 2.78 . . . . 0.0 109.65 147.739 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.9 mt -104.95 139.09 40.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 125.846 1.966 . . . . 0.0 108.222 167.72 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 44' ' ' ILE . 34.7 mt -129.37 125.93 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 110.793 -2.912 . . . . 0.0 108.148 -173.912 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.362 33.1 t80 -149.54 131.18 14.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.654 1.115 . . . . 0.0 108.908 176.086 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.38 34.51 15.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -178.711 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.01 -23.05 5.42 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 119.233 2.453 . . . . 0.0 119.233 -173.05 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -79.2 139.23 38.01 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 127.566 2.568 . . . . 0.0 111.405 -174.724 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -87.67 124.83 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 164.352 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.95 135.61 33.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 126.169 1.788 . . . . 0.0 113.395 -162.175 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -83.4 134.72 34.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 116.822 -3.674 . . . . 0.0 113.437 176.643 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.92 141.48 51.14 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 127.523 3.014 . . . . 0.0 111.173 -174.577 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.76 -16.16 26.12 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 111.725 -2.489 . . . . 0.0 114.141 177.854 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -87.25 145.82 26.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.886 2.074 . . . . 0.0 112.189 177.037 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 p -85.69 157.81 20.21 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 126.037 2.086 . . . . 0.0 111.904 179.02 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.607 HD21 HG21 ' A' ' 26' ' ' VAL . 60.2 mt -53.62 -53.97 44.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.883 2.073 . . . . 0.0 114.464 177.23 . . . . . . . . 2 2 . 1 . 086 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.252 22.1 t -39.68 -35.05 0.28 Allowed 'General case' 0 C--N 1.326 -0.437 1 N-CA-C 122.927 4.417 . . . . 0.0 122.927 165.925 . . . . . . . . 3 2 . 1 . 086 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -70.28 -44.25 68.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.224 2.61 . . . . 0.0 114.858 176.739 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -94.93 6.28 49.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 111.795 -2.457 . . . . 0.0 106.642 -173.286 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.9 t30 86.11 21.39 0.08 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 126.482 3.039 . . . . 0.0 113.065 151.976 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.297 82.3 mt -77.84 98.37 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 1 O-C-N 115.782 -4.324 . . . . 0.0 102.542 -178.316 . . . . . . . . 3 2 . 1 . 086 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -82.03 161.88 22.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 130.523 3.529 . . . . 0.0 107.51 -179.9 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -49.14 133.69 18.55 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 126.179 2.174 . . . . 0.0 112.913 176.242 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 65.05 20.92 12.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.125 2.97 . . . . 0.0 118.876 169.305 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -65.97 149.9 49.5 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 112.045 -3.836 . . . . 0.0 115.965 174.518 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 m -107.32 128.48 54.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 128.438 3.586 . . . . 0.0 110.265 170.332 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.251 0.7 OUTLIER -144.56 -177.9 5.72 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.361 2.264 . . . . 0.0 108.376 -170.771 . . . . . . . . 3 3 . 1 . 086 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.629 2.1 p80 -128.96 167.12 17.9 Favored 'General case' 0 N--CA 1.448 -0.537 1 C-N-CA 134.144 4.977 . . . . 0.0 118.117 177.79 . . . . . . . . 3 2 . 1 . 086 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 tp -135.86 126.72 27.54 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 110.6 -3.0 . . . . 0.0 115.713 175.267 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.14 104.77 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 130.44 3.496 . . . . 0.0 108.346 -179.303 . . . . . . . . 1 1 . 1 . 086 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 N--CA 1.448 -0.563 0 C-N-CA 130.958 3.703 . . . . 0.0 108.863 165.528 . . . . . . . . 0 0 . 1 . 087 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 . . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.95 139.16 44.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 116.833 -1.556 . . . . 0.0 112.728 158.913 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -128.75 173.79 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 167.509 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.19 160.41 37.33 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 125.612 1.82 . . . . 0.0 109.421 179.946 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.541 HG21 HD11 ' A' ' 30' ' ' ILE . 73.9 t -136.37 116.22 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 127.654 2.382 . . . . 0.0 109.256 172.671 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -76.3 130.67 38.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 121.277 1.853 . . . . 0.0 111.196 156.588 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 p -100.73 168.17 9.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 116.168 -1.872 . . . . 0.0 114.592 -174.71 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 mt -58.6 -32.93 69.44 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 127.181 2.192 . . . . 0.0 113.089 -175.87 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -71.57 -22.62 61.71 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.679 1.991 . . . . 0.0 115.363 174.418 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.56 -18.22 13.41 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 128.925 3.155 . . . . 0.0 108.658 -176.793 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.68 148.09 52.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 113.839 -2.981 . . . . 0.0 109.111 -172.738 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.3 m -120.52 130.94 54.46 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 125.853 1.971 . . . . 0.0 112.429 174.966 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 mm -103.69 147.65 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 128.591 2.756 . . . . 0.0 105.597 179.471 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.3 m -106.84 122.9 47.32 Favored 'General case' 0 N--CA 1.452 -0.337 1 N-CA-C 99.472 -4.27 . . . . 0.0 99.472 174.743 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.14 160.69 25.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.87 1.668 . . . . 0.0 109.302 173.436 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -114.01 125.91 54.53 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.39 -1.732 . . . . 0.0 115.167 166.224 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.42 161.99 13.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 O-C-N 119.613 -1.929 . . . . 0.0 112.135 176.152 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -107.57 160.57 26.17 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 127.456 2.302 . . . . 0.0 107.335 161.304 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -40.38 -42.16 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.891 1 C-N-CA 127.477 5.451 . . . . 0.0 114.815 175.218 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 p -77.57 -3.01 38.58 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.772 -3.08 . . . . 0.0 117.005 -172.88 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.25 123.81 29.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 123.641 1.686 . . . . 0.0 109.841 -178.631 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.3 p -81.71 179.85 7.66 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 129.319 3.048 . . . . 0.0 106.399 -179.403 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.583 HG22 ' HE2' ' A' ' 27' ' ' LYS . 9.2 mm -64.77 -35.89 76.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 115.941 -1.98 . . . . 0.0 109.376 179.325 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -55.24 -47.15 75.82 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 126.458 1.903 . . . . 0.0 114.318 173.771 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -64.81 -34.95 79.57 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.899 3.679 . . . . 0.0 109.474 177.236 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.0 t -71.05 -42.5 76.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.454 1.902 . . . . 0.0 107.0 177.177 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HE2' HG22 ' A' ' 23' ' ' ILE . 45.0 mtmt -73.0 -31.08 64.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 119.24 -2.162 . . . . 0.0 115.61 -178.019 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.29 78.03 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.766 3.226 . . . . 0.0 112.492 170.053 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -74.46 -30.09 61.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.323 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.541 HD11 HG21 ' A' ' 5' ' ' VAL . 64.7 mt -73.39 -35.96 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 128.982 2.913 . . . . 0.0 109.916 -176.957 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -61.94 -42.74 99.45 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 119.133 -2.229 . . . . 0.0 109.515 172.931 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -61.67 -19.28 62.15 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 119.671 3.212 . . . . 0.0 119.671 178.358 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -101.11 -40.36 7.23 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 116.874 -1.536 . . . . 0.0 109.095 172.404 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.328 16.8 tp10 -125.05 -4.68 7.44 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.529 -1.357 . . . . 0.0 114.023 -157.616 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.23 9.23 28.64 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 119.176 2.43 . . . . 0.0 119.176 174.762 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 36' ' ' ILE . 7.2 mt -75.89 133.12 73.22 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 130.655 3.582 . . . . 0.0 105.484 174.842 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.55 145.67 59.1 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 CA-C-O 113.926 -2.614 . . . . 0.0 114.285 -175.193 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.08 -39.17 19.43 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.504 2.803 . . . . 0.0 119.29 -177.469 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 38.4 t70 -48.64 -48.79 39.29 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 130.378 3.471 . . . . 0.0 114.145 179.73 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -72.22 -25.62 61.71 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 131.092 3.757 . . . . 0.0 113.278 173.3 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.84 128.76 35.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 123.759 2.981 . . . . 0.0 109.945 -175.014 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -109.98 161.8 15.15 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 118.862 -2.399 . . . . 0.0 108.675 165.49 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -124.81 106.65 10.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 164.111 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -92.77 128.65 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 101.008 -3.701 . . . . 0.0 101.008 164.641 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -157.13 117.67 3.56 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 128.29 2.636 . . . . 0.0 110.277 -173.727 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.94 28.74 18.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.217 2.607 . . . . 0.0 110.652 -172.427 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.23 -25.49 28.05 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 125.413 1.696 . . . . 0.0 109.861 177.678 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 tttt -92.62 135.01 34.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.988 -0.713 . . . . 0.0 111.227 -162.804 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.67 119.51 14.92 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 115.885 -2.007 . . . . 0.0 109.115 171.824 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.2 mt -81.36 123.82 28.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -177.953 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -81.29 137.59 35.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.457 -1.402 . . . . 0.0 110.365 -175.414 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.73 114.71 5.21 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.486 169.747 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.24 -21.32 2.95 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 130.327 3.822 . . . . 0.0 112.752 177.932 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mtp85 -97.31 155.67 16.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -176.861 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -94.74 171.05 9.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.364 1.866 . . . . 0.0 108.09 177.619 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.13 -47.24 77.79 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.962 1.305 . . . . 0.0 111.41 176.085 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.5 p -44.89 -40.26 6.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 118.591 2.812 . . . . 0.0 118.591 159.863 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -61.57 -34.17 75.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 124.218 1.961 . . . . 0.0 116.133 168.654 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.94 11.16 21.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.033 -2.292 . . . . 0.0 115.927 168.813 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.451 8.5 p30 54.36 46.6 24.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 124.442 2.067 . . . . 0.0 111.662 177.515 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -103.85 108.25 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 128.662 2.785 . . . . 0.0 109.158 173.599 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -105.27 169.28 8.54 Favored 'General case' 0 C--N 1.325 -0.482 1 O-C-N 130.147 4.654 . . . . 0.0 112.749 -173.875 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.325 51.7 tttm -12.52 107.0 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 129.372 3.069 . . . . 0.0 117.446 168.969 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 76.49 17.87 1.85 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 129.386 3.074 . . . . 0.0 115.013 168.694 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -67.93 139.12 56.42 Favored 'General case' 0 CA--C 1.532 0.283 1 O-C-N 115.567 -4.458 . . . . 0.0 113.512 171.109 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.1 m -98.08 112.06 24.15 Favored 'General case' 0 N--CA 1.449 -0.48 1 C-N-CA 133.641 4.776 . . . . 0.0 103.579 178.137 . . . . . . . . 2 2 . 1 . 087 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -87.09 161.51 18.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 128.824 2.85 . . . . 0.0 109.538 169.21 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -123.15 118.7 28.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 130.12 3.368 . . . . 0.0 111.348 -172.73 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.1 tp -89.77 111.09 21.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 116.32 -1.8 . . . . 0.0 114.649 -166.167 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.95 165.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 125.142 1.526 . . . . 0.0 107.875 -179.539 . . . . . . . . 1 1 . 1 . 087 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tp . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 125.921 1.688 . . . . 0.0 109.045 -176.469 . . . . . . . . 0 0 . 1 . 088 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -72.19 134.78 45.87 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.299 1.84 . . . . 0.0 112.864 171.592 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.5 pt -147.04 141.04 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.489 2.316 . . . . 0.0 107.958 168.935 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.04 151.28 25.07 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 119.125 -2.234 . . . . 0.0 107.54 -179.223 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -110.88 129.39 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 117.733 -3.104 . . . . 0.0 104.33 160.61 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -109.07 120.36 42.31 Favored 'General case' 0 N--CA 1.45 -0.433 1 O-C-N 116.268 -4.02 . . . . 0.0 101.406 167.707 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -85.95 126.79 34.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 158.547 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.307 6.0 mp -88.83 -12.65 41.35 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 125.318 1.636 . . . . 0.0 108.88 -167.686 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.5 p -90.33 -14.02 33.98 Favored 'General case' 0 N--CA 1.442 -0.869 1 O-C-N 115.919 -4.238 . . . . 0.0 113.198 164.281 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.64 -104.89 1.28 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.319 1.914 . . . . 0.0 108.532 -156.0 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -159.67 151.73 20.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 117.85 -3.147 . . . . 0.0 108.884 -159.071 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.4 p -70.96 127.19 31.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.553 -2.112 . . . . 0.0 110.222 161.336 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.98 137.6 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 131.324 3.85 . . . . 0.0 102.779 -175.386 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.3 p -92.51 112.55 24.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.227 -1.351 . . . . 0.0 107.662 173.935 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.35 171.74 7.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 174.533 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -141.8 127.36 18.98 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 103.147 -2.908 . . . . 0.0 103.147 -175.823 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.2 m -132.8 177.78 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 O-C-N 119.295 -2.128 . . . . 0.0 111.833 177.666 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -97.27 143.18 25.71 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 125.581 1.552 . . . . 0.0 109.605 178.611 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -63.73 -24.34 68.96 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-O 115.727 -1.864 . . . . 0.0 115.44 172.911 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.3 p -99.75 10.45 41.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 130.016 3.326 . . . . 0.0 114.132 -178.398 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.71 145.97 48.48 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 125.764 1.915 . . . . 0.0 107.187 -179.339 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.1 p -91.94 150.63 20.92 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 115.582 -2.151 . . . . 0.0 113.677 164.809 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -54.46 -34.07 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 123.868 3.031 . . . . 0.0 116.49 -176.172 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.33 -39.54 76.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 124.53 3.332 . . . . 0.0 115.963 172.974 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -83.16 -26.17 31.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.897 2.079 . . . . 0.0 115.675 175.4 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.287 99.3 t -50.47 -52.69 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 O-C-N 119.007 -2.308 . . . . 0.0 115.109 157.712 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -60.41 -34.48 74.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 126.46 2.35 . . . . 0.0 115.444 174.691 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.1 63.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 131.311 3.844 . . . . 0.0 113.04 165.561 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.289 49.1 mttp -59.33 -41.28 88.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.662 1.585 . . . . 0.0 111.592 -178.784 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.296 18.0 mt -78.22 -23.15 13.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 127.597 2.359 . . . . 0.0 110.996 -176.939 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -73.81 -43.16 59.67 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 165.444 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.296 25.8 t70 -69.08 -36.96 78.19 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 125.735 2.683 . . . . 0.0 116.675 -178.416 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -36.8 65.48 Favored 'General case' 0 CA--C 1.536 0.433 1 O-C-N 113.395 -5.816 . . . . 0.0 115.982 177.296 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -128.98 -10.43 4.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 117.372 2.36 . . . . 0.0 117.372 -168.189 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.22 10.39 77.97 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 129.794 3.569 . . . . 0.0 112.97 179.804 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.9 mt -81.92 129.1 66.0 Favored Pre-proline 0 N--CA 1.443 -0.814 1 CA-C-N 124.701 4.251 . . . . 0.0 110.288 -166.426 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.02 144.58 64.48 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 123.491 2.794 . . . . 0.0 118.084 -170.887 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -74.62 -30.06 8.26 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.411 2.741 . . . . 0.0 117.735 -168.978 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -70.89 -17.15 62.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.266 1.031 . . . . 0.0 110.196 172.446 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -102.85 -8.76 20.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 117.869 -3.02 . . . . 0.0 113.398 -171.683 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -83.33 135.39 34.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 122.074 2.215 . . . . 0.0 107.876 -178.764 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -120.05 112.73 19.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 119.414 -2.054 . . . . 0.0 107.585 148.306 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mt -84.84 147.1 26.98 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 126.128 2.142 . . . . 0.0 109.393 170.37 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 68' ' ' HIS 0.296 0.0 OUTLIER -143.36 131.99 19.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 115.45 -2.214 . . . . 0.0 111.79 -174.288 . . . . . . . . 4 4 . 1 . 088 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -137.16 121.74 18.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 102.726 -3.065 . . . . 0.0 102.726 175.393 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 79.56 2.39 2.21 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 127.768 3.167 . . . . 0.0 113.719 165.671 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.75 -17.87 20.13 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 118.07 -2.894 . . . . 0.0 108.519 -174.622 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -85.82 109.56 18.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.167 2.187 . . . . 0.0 108.955 179.993 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.7 119.87 13.15 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.042 166.83 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -91.16 116.92 29.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 117.935 -2.978 . . . . 0.0 106.361 -151.222 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -92.84 145.98 23.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 123.252 1.501 . . . . 0.0 107.045 -166.642 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.24 145.19 43.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 112.375 -2.193 . . . . 0.0 107.67 171.131 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.38 -26.03 25.0 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.783 2.135 . . . . 0.0 112.635 175.169 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -96.49 168.61 10.44 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.552 2.341 . . . . 0.0 114.955 179.2 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.7 p -119.14 176.72 5.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 112.792 -2.003 . . . . 0.0 112.256 -166.752 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.2 mt -77.21 -28.98 54.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.905 -179.782 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.2 t -76.21 -25.76 55.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 115.128 -2.368 . . . . 0.0 110.03 177.76 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -59.78 -61.66 2.45 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 131.058 3.743 . . . . 0.0 105.41 176.622 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -89.67 -7.28 54.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 128.341 2.656 . . . . 0.0 111.908 -169.596 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.384 2.3 t-20 86.03 31.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.226 2.61 . . . . 0.0 111.954 166.01 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.252 5.4 mt -80.24 107.99 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 126.247 1.819 . . . . 0.0 111.002 -174.744 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -100.7 -179.86 4.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 127.215 2.822 . . . . 0.0 112.731 179.13 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -61.86 129.93 43.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 129.712 3.205 . . . . 0.0 112.391 -176.135 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.535 1.1 tt0 79.2 4.59 2.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 159.764 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.9 p -57.12 157.58 5.92 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 127.512 3.007 . . . . 0.0 115.893 158.423 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 m -102.77 126.56 49.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 119.821 -1.8 . . . . 0.0 111.952 156.27 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 mp -91.26 146.69 23.61 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 120.721 -1.237 . . . . 0.0 107.705 160.173 . . . . . . . . 1 1 . 1 . 088 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.409 ' HB2' HG23 ' A' ' 44' ' ' ILE . 30.6 m170 -94.66 145.93 24.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 117.108 -1.425 . . . . 0.0 108.188 177.73 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.13 122.02 40.09 Favored 'General case' 0 C--N 1.322 -0.589 1 C-N-CA 132.547 4.339 . . . . 0.0 104.908 177.544 . . . . . . . . 3 3 . 1 . 088 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.326 2.8 m -121.11 115.61 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 109.074 -3.694 . . . . 0.0 101.427 -178.274 . . . . . . . . 2 2 . 1 . 088 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 N--CA 1.451 -0.378 1 O-C-N 115.94 -4.225 . . . . 0.0 113.4 -174.844 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 ttp . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 101.511 -3.514 . . . . 0.0 101.511 . . . . . . . . . 0 0 . 1 . 089 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -89.63 150.91 22.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.857 1.263 . . . . 0.0 110.432 161.676 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.294 47.4 pt -135.13 175.06 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 129.778 3.231 . . . . 0.0 109.978 163.264 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.417 ' HE1' ' HG1' ' A' ' 14' ' ' THR 0.291 97.9 m-85 -116.38 126.17 53.1 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.101 2.96 . . . . 0.0 110.93 163.732 . . . . . . . . 3 3 . 1 . 089 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.19 140.34 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 151.807 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -118.97 146.73 44.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 126.85 2.594 . . . . 0.0 105.54 167.564 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.2 p -98.65 161.21 13.78 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.49 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt -50.6 -29.64 11.38 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 118.892 -2.38 . . . . 0.0 116.09 -175.223 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.2 p -104.77 9.47 34.93 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.544 2.737 . . . . 0.0 108.749 -162.909 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.85 -23.68 30.38 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 119.605 -1.934 . . . . 0.0 116.231 164.981 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -69.76 126.2 29.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 125.753 1.502 . . . . 0.0 108.503 -179.939 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 p -106.47 150.73 25.79 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.304 1.841 . . . . 0.0 108.654 175.658 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.7 pt -129.75 131.67 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 1 C-N-CA 133.477 4.711 . . . . 0.0 113.8 168.999 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.417 ' HG1' ' HE1' ' A' ' 4' ' ' PHE . 2.6 m -87.95 118.58 27.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.854 2.061 . . . . 0.0 106.875 177.893 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.63 134.2 50.14 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 129.183 2.993 . . . . 0.0 112.164 178.796 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.66 138.24 36.12 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.533 1.933 . . . . 0.0 113.171 172.419 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.306 7.0 m -157.16 142.99 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-O 117.295 -1.336 . . . . 0.0 107.625 -163.229 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -91.96 148.01 36.05 Favored Pre-proline 0 C--O 1.221 -0.401 0 C-N-CA 124.783 1.233 . . . . 0.0 110.814 -178.296 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 31.8 Cg_exo -47.06 -0.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.434 1 N-CA-C 122.616 4.045 . . . . 0.0 122.616 170.627 . . . . . . . . 3 2 . 1 . 089 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 p -134.32 16.24 3.75 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 118.782 -2.449 . . . . 0.0 111.715 -174.154 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -85.93 150.79 24.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -179.53 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -102.34 149.98 23.79 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 128.457 2.703 . . . . 0.0 106.369 177.509 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -49.65 -27.25 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.605 2.362 . . . . 0.0 114.546 177.269 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -50.42 -44.31 55.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.882 2.073 . . . . 0.0 115.103 161.376 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -62.1 -42.1 98.87 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 128.425 2.69 . . . . 0.0 110.891 177.735 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 26' ' ' VAL . 2.0 t -58.81 -38.45 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 176.936 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -66.51 -40.44 89.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 128.484 2.714 . . . . 0.0 114.25 175.246 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -68.65 -40.06 80.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 117.739 -1.124 . . . . 0.0 110.714 176.03 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.437 25.1 mttt -53.82 -45.58 70.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 175.538 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.279 50.8 mt -52.67 -49.4 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 117.019 -1.467 . . . . 0.0 112.686 170.565 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 9.2 tm0? -42.87 -55.21 3.8 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 129.36 3.064 . . . . 0.0 111.578 167.32 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.98 -29.86 62.2 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.002 -1.475 . . . . 0.0 111.134 -171.651 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -83.66 -47.56 11.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 120.697 1.589 . . . . 0.0 112.267 172.107 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -116.41 -20.66 9.6 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 115.575 -2.155 . . . . 0.0 113.829 -159.154 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.15 0.24 25.32 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 125.135 1.522 . . . . 0.0 115.152 172.599 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.0 mt -96.26 136.68 21.86 Favored Pre-proline 0 N--CA 1.45 -0.429 0 O-C-N 126.573 1.984 . . . . 0.0 109.607 -160.365 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -89.31 142.19 4.3 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 124.726 2.723 . . . . 0.0 111.471 -163.422 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.07 -45.77 36.83 Favored 'Trans proline' 0 N--CA 1.452 -0.95 1 C-N-CA 126.607 4.871 . . . . 0.0 114.778 -177.95 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -48.49 -23.3 0.92 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 130.13 3.372 . . . . 0.0 115.774 171.271 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -120.93 14.15 11.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 127.504 3.002 . . . . 0.0 112.941 -176.171 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 72.8 mt-30 -102.86 162.39 12.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 169.891 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.3 ttp-105 -144.52 131.88 20.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 131.209 3.804 . . . . 0.0 105.637 162.74 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.1 mt -111.25 134.76 52.6 Favored 'General case' 0 N--CA 1.444 -0.759 1 O-C-N 115.85 -4.281 . . . . 0.0 110.241 -174.747 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 41.7 mt -126.8 149.52 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 118.293 -2.755 . . . . 0.0 108.841 179.201 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -112.9 -44.11 3.34 Favored 'General case' 0 C--N 1.325 -0.48 1 C-N-CA 132.031 4.132 . . . . 0.0 111.118 161.374 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.09 -103.98 0.29 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 -175.685 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.48 -32.55 0.52 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 118.254 2.062 . . . . 0.0 118.254 -150.196 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -93.14 -178.91 4.92 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 130.125 3.37 . . . . 0.0 112.56 153.394 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -97.12 151.96 19.26 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.651 1.58 . . . . 0.0 109.725 177.475 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.23 135.74 40.99 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.34 1.856 . . . . 0.0 109.365 -177.2 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -77.58 112.65 14.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.033 -2.917 . . . . 0.0 109.448 169.16 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.92 -19.84 46.28 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 129.982 3.313 . . . . 0.0 119.132 -165.788 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.56 14.43 35.52 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.789 2.138 . . . . 0.0 110.05 -177.482 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -90.85 166.57 13.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 124.349 2.023 . . . . 0.0 108.496 157.51 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -90.53 166.02 13.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.663 -1.608 . . . . 0.0 113.687 173.758 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.409 11.8 mt -45.08 -31.86 1.53 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 129.086 2.955 . . . . 0.0 118.371 163.994 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.7 p -93.05 -11.66 32.5 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 119.474 -2.016 . . . . 0.0 111.183 179.143 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -90.59 -4.95 56.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 114.838 -2.506 . . . . 0.0 109.257 177.603 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -118.7 -10.01 10.09 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 166.555 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t30 87.0 40.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 119.479 -2.013 . . . . 0.0 111.334 171.973 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.5 mm -87.55 106.95 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 113.088 -1.869 . . . . 0.0 108.103 175.514 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -87.03 179.88 6.6 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 131.337 3.855 . . . . 0.0 106.532 -172.939 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.3 51.2 pttt -58.4 136.54 57.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 166.794 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 58.9 26.74 15.28 Favored 'General case' 0 N--CA 1.45 -0.472 1 C-N-CA 133.506 4.722 . . . . 0.0 112.344 169.03 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 m -73.8 149.96 41.35 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 129.96 3.304 . . . . 0.0 113.587 -176.844 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -98.45 119.29 36.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 178.26 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -100.23 154.19 18.66 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.397 152.735 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -116.1 119.61 36.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.794 1.638 . . . . 0.0 107.896 -172.167 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.262 52.2 tp -98.94 122.79 42.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 124.118 1.913 . . . . 0.0 113.158 -179.112 . . . . . . . . 2 2 . 1 . 089 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.88 145.06 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 126.513 1.925 . . . . 0.0 110.107 161.52 . . . . . . . . 1 1 . 1 . 089 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 127.982 2.513 . . . . 0.0 110.651 172.898 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 . . . . . . . . . 0 0 . 1 . 090 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -83.24 139.63 32.99 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 129.512 3.125 . . . . 0.0 105.162 -175.747 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 14' ' ' THR 0.266 30.0 pt -141.53 149.33 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 127.124 2.17 . . . . 0.0 111.968 -176.37 . . . . . . . . 3 3 . 1 . 090 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -89.13 146.43 24.81 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.224 164.036 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD12 ' A' ' 15' ' ' LEU . 2.7 t -127.76 118.09 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 126.838 2.586 . . . . 0.0 106.133 169.656 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -94.83 116.81 29.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -177.993 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.2 p -70.75 164.9 24.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 124.441 2.067 . . . . 0.0 112.955 174.982 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.25 -37.82 60.84 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 120.528 -1.358 . . . . 0.0 112.094 -177.45 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 p -54.56 -29.86 52.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 130.993 3.717 . . . . 0.0 116.242 161.844 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.68 -19.77 5.84 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 119.677 -1.889 . . . . 0.0 113.146 161.843 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -73.5 136.57 44.14 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.965 2.506 . . . . 0.0 111.024 175.059 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m -112.32 130.11 56.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 125.265 1.603 . . . . 0.0 110.019 178.273 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.416 HD13 ' HG3' ' A' ' 34' ' ' GLU . 9.3 pt -110.9 177.61 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 112.376 -2.193 . . . . 0.0 108.592 -178.513 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 5.2 t -140.83 141.64 34.68 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.404 1.881 . . . . 0.0 107.077 170.36 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.471 HD12 HG21 ' A' ' 5' ' ' VAL . 22.6 mt -129.11 159.02 37.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.647 2.779 . . . . 0.0 107.051 177.754 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -91.58 138.12 31.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 157.31 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.01 175.76 8.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 CA-C-N 122.416 2.371 . . . . 0.0 107.448 170.113 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -111.87 156.68 41.31 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 162.146 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -58.65 -28.17 85.35 Favored 'Trans proline' 0 N--CA 1.444 -1.412 1 C-N-CA 126.186 4.591 . . . . 0.0 120.538 173.042 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -98.1 21.92 10.14 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 124.939 1.399 . . . . 0.0 112.321 173.97 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.83 153.86 38.54 Favored 'General case' 0 N--CA 1.453 -0.32 1 O-C-N 115.085 -4.759 . . . . 0.0 108.089 174.319 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.293 86.7 m -100.24 157.81 16.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.27 2.228 . . . . 0.0 108.272 168.823 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.1 mm -58.47 -9.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 119.261 3.06 . . . . 0.0 119.261 -178.835 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -87.46 -4.72 59.0 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 118.832 -2.417 . . . . 0.0 113.136 -178.422 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -91.78 -34.63 14.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.717 -2.038 . . . . 0.0 111.717 164.977 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.26 -51.52 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 O-C-N 119.638 -1.914 . . . . 0.0 108.625 179.773 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -51.05 -56.14 14.05 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 128.921 3.888 . . . . 0.0 113.075 -178.532 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.97 80.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.269 2.628 . . . . 0.0 117.034 176.738 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -68.44 -40.52 81.11 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 173.044 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.357 75.8 mt -47.65 -49.29 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 128.811 2.844 . . . . 0.0 112.692 160.665 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -63.61 -45.89 88.26 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.61 2.364 . . . . 0.0 112.556 -179.259 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.51 -64.6 0.79 Allowed 'General case' 0 C--O 1.238 0.46 1 C-N-CA 132.487 4.315 . . . . 0.0 107.222 173.167 . . . . . . . . 3 3 . 1 . 090 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -63.51 -57.03 11.48 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 128.094 3.371 . . . . 0.0 118.22 -174.254 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' HG3' HD13 ' A' ' 13' ' ' ILE 0.279 22.2 mm-40 -111.94 -2.07 15.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.176 2.19 . . . . 0.0 113.741 -168.173 . . . . . . . . 3 3 . 1 . 090 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.85 -19.41 41.3 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 117.543 -3.223 . . . . 0.0 113.132 160.635 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -83.56 127.3 68.6 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 117.962 -3.081 . . . . 0.0 112.506 -157.483 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.22 133.85 31.93 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 CA-C-N 123.885 2.423 . . . . 0.0 113.112 168.653 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.337 17.9 Cg_endo -58.94 -30.31 92.84 Favored 'Trans proline' 0 N--CA 1.452 -0.959 1 C-N-CA 127.691 5.594 . . . . 0.0 117.211 -171.255 . . . . . . . . 3 2 . 1 . 090 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.286 26.6 t70 -76.3 -26.47 55.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 119.967 -1.708 . . . . 0.0 111.327 -163.728 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -73.14 -7.84 53.13 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 172.033 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB3' HD12 ' A' ' 71' ' ' LEU 0.455 1.2 pp0? -132.63 162.22 31.89 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.964 1.364 . . . . 0.0 113.428 -179.532 . . . . . . . . 3 3 . 1 . 090 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -126.0 148.89 49.17 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 128.573 2.749 . . . . 0.0 111.512 171.343 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mt -99.37 118.73 36.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.802 2.841 . . . . 0.0 105.475 -178.357 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 mm -107.71 144.66 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 128.613 2.765 . . . . 0.0 104.922 179.18 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -141.82 132.57 25.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 125.221 1.576 . . . . 0.0 108.506 162.087 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.07 22.77 0.15 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 129.891 3.276 . . . . 0.0 114.644 -177.216 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.44 -7.07 36.62 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 119.398 -2.064 . . . . 0.0 112.948 177.398 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -113.29 141.01 47.52 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 121.564 -0.962 . . . . 0.0 113.298 -168.033 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -63.61 137.01 57.94 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 126.667 2.479 . . . . 0.0 115.565 171.975 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -105.54 108.53 20.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.673 3.189 . . . . 0.0 106.679 179.716 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -91.61 166.45 12.81 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 120.567 1.531 . . . . 0.0 112.38 -168.608 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.31 129.19 37.33 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.371 2.668 . . . . 0.0 107.803 171.107 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.93 -20.19 29.3 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 130.009 3.671 . . . . 0.0 114.933 165.086 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -89.45 153.08 21.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.077 2.551 . . . . 0.0 106.404 179.753 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -104.18 142.19 34.95 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 129.163 2.985 . . . . 0.0 111.276 -169.642 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.28 -55.35 25.33 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 126.906 2.628 . . . . 0.0 117.342 -170.042 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.331 41.2 t -65.0 -18.94 65.73 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 118.335 -2.728 . . . . 0.0 110.255 -172.913 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -78.69 -22.41 46.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 131.377 3.871 . . . . 0.0 115.817 171.333 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -81.37 -10.07 59.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.985 1.714 . . . . 0.0 113.14 163.665 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.349 58.8 t30 80.32 47.69 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 131.546 3.938 . . . . 0.0 108.349 173.882 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD13 HD21 ' A' ' 67' ' ' LEU . 14.3 mt -104.76 146.52 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 C-N-CA 125.814 1.646 . . . . 0.0 107.357 171.652 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -139.52 -158.86 0.9 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 129.663 3.185 . . . . 0.0 112.656 -179.175 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.11 135.34 36.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.873 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 70.69 30.31 3.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 129.509 3.124 . . . . 0.0 106.506 177.979 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.1 m -74.46 149.9 40.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 117.858 -3.026 . . . . 0.0 106.347 160.403 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.8 m -113.21 101.01 9.02 Favored 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 133.336 4.655 . . . . 0.0 101.481 179.166 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.415 HD21 HD13 ' A' ' 61' ' ' ILE . 7.8 mp -92.92 157.08 16.53 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 118.847 -2.408 . . . . 0.0 106.311 166.374 . . . . . . . . 2 2 . 1 . 090 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -123.47 148.58 46.06 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 116.486 -1.721 . . . . 0.0 106.693 -175.644 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tt -103.02 139.35 38.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 103.155 -2.905 . . . . 0.0 103.155 177.096 . . . . . . . . 1 1 . 1 . 090 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.351 29.1 m -134.27 137.73 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 1 C-N-CA 132.77 4.428 . . . . 0.0 112.479 175.782 . . . . . . . . 3 2 . 1 . 090 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 41' ' ' GLN . 10.6 mp . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 116.824 -1.56 . . . . 0.0 108.371 168.368 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptt? . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 091 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -80.02 146.19 32.11 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 124.933 1.396 . . . . 0.0 110.529 -174.23 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.515 HD12 HD13 ' A' ' 67' ' ' LEU 0.418 2.4 pt -142.63 128.77 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 130.385 3.474 . . . . 0.0 108.974 175.642 . . . . . . . . 3 3 . 1 . 091 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.259 62.1 m-85 -98.78 67.13 1.68 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 131.21 3.804 . . . . 0.0 110.57 -159.463 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.267 24.2 t -62.96 113.71 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.772 2 O-C-N 115.669 -4.395 . . . . 0.0 108.651 174.721 . . . . . . . . 3 2 . 1 . 091 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.273 11.8 tppt? -102.45 139.93 37.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 101.987 -3.338 . . . . 0.0 101.987 -170.868 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -106.84 169.88 8.27 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 124.219 0.949 . . . . 0.0 109.04 167.741 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.25 -41.45 63.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 118.825 -2.422 . . . . 0.0 110.345 167.386 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.292 52.7 p -50.84 -34.25 27.08 Favored 'General case' 0 N--CA 1.448 -0.549 1 C-N-CA 131.796 4.039 . . . . 0.0 116.526 174.991 . . . . . . . . 3 2 . 1 . 091 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.66 27.48 3.28 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 128.958 3.171 . . . . 0.0 116.482 157.613 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.383 56.7 mttt -100.5 128.69 46.48 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 167.775 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.2 m -89.28 101.95 14.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 166.285 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.9 mm -53.75 -48.69 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 116.44 -1.743 . . . . 0.0 115.076 -177.052 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.6 m 74.4 50.42 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 129.459 3.103 . . . . 0.0 108.265 176.45 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tp -75.65 126.86 31.84 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -169.598 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -81.16 115.43 20.57 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 125.171 2.415 . . . . 0.0 110.854 163.171 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -108.9 162.17 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 1 C-N-CA 132.679 4.392 . . . . 0.0 113.387 176.853 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -116.07 155.38 48.11 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.98 166.215 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -78.37 -3.63 13.54 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 O-C-N 117.228 -2.038 . . . . 0.0 112.647 -172.923 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 p -81.66 -14.78 56.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.845 2.058 . . . . 0.0 111.694 167.426 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -65.33 122.67 17.67 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.234 2.214 . . . . 0.0 106.918 -179.818 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -85.65 158.09 20.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 172.918 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 21.8 mm -43.19 -43.6 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 O-C-N 118.069 -2.894 . . . . 0.0 113.941 177.438 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.13 -37.09 83.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 125.301 2.476 . . . . 0.0 114.52 176.642 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.58 -34.95 53.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.971 -179.671 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.353 41.0 t -59.48 -44.47 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 118.037 -2.914 . . . . 0.0 108.078 168.829 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -64.71 -38.83 92.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.318 -2.114 . . . . 0.0 113.458 -177.506 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -51.68 66.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 127.136 2.174 . . . . 0.0 113.016 166.569 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -60.15 -26.24 66.14 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 127.929 2.492 . . . . 0.0 113.9 172.602 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.8 mt -86.97 -42.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 120.979 1.718 . . . . 0.0 111.084 171.29 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.44 -24.76 61.08 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.16 1.784 . . . . 0.0 111.797 -175.78 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -52.98 -53.89 43.23 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 130.079 3.352 . . . . 0.0 110.184 165.52 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -85.46 -48.51 8.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 115.855 -2.021 . . . . 0.0 110.503 -170.973 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -110.18 -19.13 13.13 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 128.46 2.704 . . . . 0.0 115.202 -162.409 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.94 -10.57 73.68 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 121.789 3.476 . . . . 0.0 121.789 162.308 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.57 121.13 73.59 Favored Pre-proline 0 N--CA 1.442 -0.839 0 C-N-CA 129.893 3.277 . . . . 0.0 110.384 -163.201 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -63.45 141.89 82.75 Favored 'Trans proline' 0 N--CA 1.452 -0.931 1 C-N-CA 126.152 4.568 . . . . 0.0 113.969 179.596 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.263 50.0 Cg_exo -48.47 -41.65 36.09 Favored 'Trans proline' 0 N--CA 1.448 -1.162 1 C-N-CA 127.759 5.639 . . . . 0.0 117.458 -170.524 . . . . . . . . 3 2 . 1 . 091 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.76 -30.97 40.9 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.524 2.73 . . . . 0.0 107.709 179.908 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -72.12 -3.38 22.85 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.347 2.259 . . . . 0.0 116.233 173.374 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.55 122.77 41.32 Favored 'General case' 0 N--CA 1.446 -0.659 1 C-N-CA 133.736 4.814 . . . . 0.0 110.826 -173.492 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -134.82 137.61 43.48 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 128.324 2.65 . . . . 0.0 105.654 175.431 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.63 112.63 24.29 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 128.129 2.572 . . . . 0.0 108.314 -174.308 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.53 139.52 20.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.45 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.362 59.1 t80 -144.78 92.5 2.29 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 129.693 3.197 . . . . 0.0 109.777 -166.246 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.28 24.79 2.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 121.415 3.857 . . . . 0.0 121.415 176.277 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.58 -12.73 46.99 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 128.293 2.854 . . . . 0.0 114.57 -173.017 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.282 38.9 ttmt -120.07 139.55 52.38 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 126.206 1.768 . . . . 0.0 109.995 -163.698 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 24.3 mt-30 -80.96 130.94 35.27 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.727 2.011 . . . . 0.0 106.315 170.99 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -84.5 136.52 33.78 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.65 177.891 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.33 144.05 36.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 125.743 2.687 . . . . 0.0 106.988 -171.487 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -87.52 145.83 26.07 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.072 -2.892 . . . . 0.0 110.004 -166.629 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.23 -21.56 37.2 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 124.173 1.985 . . . . 0.0 113.909 -175.002 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -89.7 -177.08 5.18 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -162.451 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 p -107.47 168.07 9.49 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.96 171.737 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.74 -24.4 62.61 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 128.568 2.747 . . . . 0.0 109.381 165.831 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 m -75.54 -15.22 60.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.165 -1.834 . . . . 0.0 112.995 177.137 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.35 -36.53 71.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.348 1.859 . . . . 0.0 111.27 -177.065 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -100.18 -9.77 22.13 Favored 'General case' 0 N--CA 1.442 -0.857 1 C-N-CA 135.133 5.373 . . . . 0.0 110.692 -176.97 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.487 13.6 t30 82.86 18.25 0.28 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 119.685 3.217 . . . . 0.0 119.685 177.291 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mt -72.16 121.53 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.329 1.851 . . . . 0.0 107.193 -172.786 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -122.58 177.69 5.32 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 128.697 2.799 . . . . 0.0 112.027 170.734 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -46.11 136.9 6.42 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 130.732 3.613 . . . . 0.0 111.075 -164.462 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.434 2.8 tt0 85.41 15.69 0.15 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 113.935 -2.936 . . . . 0.0 114.558 170.416 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 t -93.58 133.5 36.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 130.589 3.555 . . . . 0.0 110.76 -179.573 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.4 p -92.89 135.69 33.91 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 174.526 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.515 HD13 HD12 ' A' ' 3' ' ' ILE . 6.1 mp -115.51 -176.24 2.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 164.756 . . . . . . . . 2 2 . 1 . 091 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -138.6 139.75 38.71 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 128.025 2.53 . . . . 0.0 107.014 179.269 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.1 tt -111.35 123.39 50.12 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 124.466 1.104 . . . . 0.0 108.341 -174.676 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 m -124.5 137.44 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.472 -179.112 . . . . . . . . 1 1 . 1 . 091 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.259 5.0 mt . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 102.687 -3.079 . . . . 0.0 102.687 -172.613 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 092 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -105.89 140.74 38.45 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.206 -2.183 . . . . 0.0 110.025 -160.046 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.8 pt -139.67 160.67 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 128.167 2.587 . . . . 0.0 108.596 178.517 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -108.93 159.45 16.8 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.468 1.907 . . . . 0.0 106.296 175.578 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.92 150.69 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 158.513 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -87.26 149.76 24.35 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.966 2.906 . . . . 0.0 114.568 155.89 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.256 9.0 t -138.24 151.93 48.12 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.959 1.304 . . . . 0.0 108.315 173.171 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.282 4.8 tp -70.44 0.04 7.41 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 127.98 2.512 . . . . 0.0 116.191 -163.679 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.0 p -85.43 -20.07 30.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.418 -2.676 . . . . 0.0 109.738 165.61 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.63 -6.21 26.18 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 129.082 3.229 . . . . 0.0 117.804 176.884 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.82 157.46 27.68 Favored 'General case' 0 C--O 1.235 0.318 1 O-C-N 132.577 5.516 . . . . 0.0 111.812 179.269 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.554 36.1 p -123.35 107.21 11.39 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 129.04 2.936 . . . . 0.0 114.088 -177.351 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 mt -104.99 136.21 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 130.042 3.337 . . . . 0.0 108.127 -171.128 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 t -108.25 121.34 44.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.865 3.266 . . . . 0.0 106.516 -178.621 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -110.95 156.02 21.82 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 129.003 2.921 . . . . 0.0 110.736 -176.15 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -118.61 116.75 27.27 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 130.831 3.653 . . . . 0.0 108.562 174.683 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -136.81 166.55 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 131.198 3.799 . . . . 0.0 110.323 -169.944 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -125.44 159.62 59.39 Favored Pre-proline 0 C--N 1.322 -0.629 0 O-C-N 118.907 -2.371 . . . . 0.0 105.993 161.828 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.42 -46.03 28.15 Favored 'Trans proline' 0 N--CA 1.452 -0.943 1 C-N-CA 125.353 4.036 . . . . 0.0 118.759 175.5 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 p -69.77 1.74 4.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 176.884 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.71 134.62 45.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 116.104 -1.903 . . . . 0.0 114.838 179.533 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.4 p -83.37 148.75 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 123.687 2.949 . . . . 0.0 112.467 -179.406 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -50.01 -37.27 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 126.258 1.823 . . . . 0.0 113.826 178.356 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.18 -39.48 79.02 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 121.201 1.819 . . . . 0.0 114.258 170.221 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -68.78 -36.46 78.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 126.821 2.576 . . . . 0.0 109.777 172.611 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.03 -57.18 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 121.383 1.902 . . . . 0.0 106.723 173.107 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.294 86.7 mttt -38.55 -40.65 0.6 Allowed 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 130.495 3.518 . . . . 0.0 116.809 171.661 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.48 -20.64 33.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.188 -2.278 . . . . 0.0 111.28 -175.006 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -87.58 -14.21 40.77 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.942 1.297 . . . . 0.0 109.777 176.881 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.31 -51.79 22.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 126.418 1.887 . . . . 0.0 107.904 162.407 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -65.4 -25.64 67.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 131.107 3.763 . . . . 0.0 109.567 -175.928 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.4 -46.1 62.74 Favored 'General case' 0 CA--C 1.533 0.307 1 C-N-CA 132.103 4.161 . . . . 0.0 113.514 170.023 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -114.16 -32.17 6.09 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 127.556 3.035 . . . . 0.0 114.798 -174.309 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -91.91 -33.28 14.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -179.291 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.18 11.32 64.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 113.583 -3.898 . . . . 0.0 113.398 171.375 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -92.15 139.31 24.25 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 100.975 -3.713 . . . . 0.0 100.975 -172.046 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.93 160.39 21.09 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 120.67 0.914 . . . . 0.0 112.552 -173.787 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.26 56.7 Cg_endo -57.9 -40.89 74.55 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 N-CA-C 117.895 2.229 . . . . 0.0 117.895 -170.868 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.92 -11.07 60.59 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.141 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -93.68 -17.43 23.24 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 172.265 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -89.39 143.13 27.06 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 123.21 1.481 . . . . 0.0 109.09 -174.644 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.26 96.29 2.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 -171.551 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.76 131.57 46.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 115.779 -2.058 . . . . 0.0 107.463 -169.389 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.48 145.21 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 129.762 3.225 . . . . 0.0 110.689 -174.424 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -128.47 -169.03 2.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.887 3.275 . . . . 0.0 110.291 179.456 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.59 49.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.481 2 C-N-CA 132.558 4.343 . . . . 0.0 121.941 -177.055 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.11 -12.97 19.55 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 127.305 2.383 . . . . 0.0 109.063 -179.403 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.403 85.4 mttt -109.29 126.41 53.33 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.346 2.258 . . . . 0.0 116.171 -176.62 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -85.19 129.53 34.79 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 130.36 3.464 . . . . 0.0 106.512 167.867 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.423 HD11 HD22 ' A' ' 67' ' ' LEU . 69.6 mt -107.19 127.76 53.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 111.799 -3.953 . . . . 0.0 106.165 -162.349 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -104.21 137.0 42.77 Favored 'General case' 0 C--N 1.324 -0.52 1 O-C-N 130.847 5.092 . . . . 0.0 110.54 -173.084 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.344 1.2 m-20 -27.91 -45.9 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.408 2 N-CA-C 123.723 4.712 . . . . 0.0 123.723 173.983 . . . . . . . . 3 2 . 1 . 092 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.84 33.94 4.56 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 117.545 -3.222 . . . . 0.0 111.681 -169.828 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -122.03 162.82 20.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.841 2.857 . . . . 0.0 105.595 165.169 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -85.17 158.24 20.43 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.553 2.341 . . . . 0.0 114.762 178.069 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.4 mt -57.76 -28.36 63.88 Favored 'General case' 0 C--N 1.326 -0.447 1 O-C-N 114.569 -5.082 . . . . 0.0 114.963 165.269 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.412 0.2 OUTLIER -61.16 -39.63 90.82 Favored 'General case' 0 N--CA 1.448 -0.546 1 C-N-CA 132.125 4.17 . . . . 0.0 113.848 163.87 . . . . . . . . 4 3 . 1 . 092 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -69.43 -11.12 60.56 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 118.269 -2.77 . . . . 0.0 111.434 170.796 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -110.41 5.92 21.83 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 114.149 -2.834 . . . . 0.0 114.753 164.105 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.347 3.9 p-10 34.76 58.27 0.71 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.182 2.993 . . . . 0.0 112.732 -171.113 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mm -67.56 131.62 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 131.674 3.99 . . . . 0.0 111.967 174.986 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.388 26.9 mt-30 -102.6 152.46 21.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 127.266 2.226 . . . . 0.0 108.098 -179.678 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -48.97 150.62 1.48 Allowed 'General case' 0 C--N 1.325 -0.492 1 O-C-N 115.444 -4.535 . . . . 0.0 116.247 176.132 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.319 7.6 tt0 70.84 8.56 6.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.768 2.827 . . . . 0.0 116.237 176.495 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 m -63.31 138.69 58.62 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.682 1.593 . . . . 0.0 108.531 178.248 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.268 16.6 m -103.82 138.84 39.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 118.567 -2.583 . . . . 0.0 104.741 165.316 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.423 HD22 HD11 ' A' ' 50' ' ' LEU . 68.6 mt -95.78 148.1 22.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 130.404 3.482 . . . . 0.0 105.506 175.609 . . . . . . . . 2 2 . 1 . 092 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -88.68 125.7 34.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 117.075 -3.516 . . . . 0.0 110.767 168.401 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tt -121.02 133.4 55.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 118.359 -2.713 . . . . 0.0 104.978 -171.609 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -132.34 -173.92 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.918 1.287 . . . . 0.0 112.48 163.583 . . . . . . . . 1 1 . 1 . 092 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.3 tp . . . . . 0 N--CA 1.445 -0.7 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.912 168.819 . . . . . . . . 0 0 . 1 . 093 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 ttp . . . . . 0 CA--C 1.537 0.472 1 N-CA-C 99.49 -4.263 . . . . 0.0 99.49 . . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -96.99 137.44 36.07 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 123.786 2.993 . . . . 0.0 107.226 164.794 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -107.49 170.3 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 129.817 3.247 . . . . 0.0 110.74 161.21 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -116.9 156.82 26.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 118.305 -2.747 . . . . 0.0 106.704 152.326 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.81 133.79 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 1 C-N-CA 132.517 4.327 . . . . 0.0 102.722 156.713 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -122.36 122.83 39.95 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -179.848 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 99.9 m -83.77 124.82 31.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 160.284 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.264 0.0 OUTLIER -63.2 -8.69 8.68 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 119.596 3.184 . . . . 0.0 119.596 -162.839 . . . . . . . . 3 3 . 1 . 093 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -84.85 -3.6 58.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.349 2.26 . . . . 0.0 112.331 -179.529 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 32.93 0.78 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 123.396 1.553 . . . . 0.0 115.017 154.249 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -128.36 123.28 33.5 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.09 2.156 . . . . 0.0 109.964 -171.965 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 m -113.21 127.85 56.3 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.493 1.117 . . . . 0.0 108.3 -178.727 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.66 133.46 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 127.311 2.245 . . . . 0.0 106.15 164.161 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -109.66 125.42 52.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.859 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.1 tp -133.94 139.81 46.38 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.273 -0.892 . . . . 0.0 111.725 -178.171 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.7 mp0 -95.93 116.57 29.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 131.46 3.904 . . . . 0.0 102.266 179.508 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -146.66 159.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 114.507 -2.664 . . . . 0.0 105.053 -163.141 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -111.63 145.94 33.67 Favored Pre-proline 0 N--CA 1.452 -0.349 0 O-C-N 128.747 3.78 . . . . 0.0 108.024 171.925 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.88 -29.23 14.69 Favored 'Trans proline' 0 N--CA 1.452 -0.958 1 C-N-CA 129.97 7.113 . . . . 0.0 115.687 -178.59 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t -90.16 6.9 40.67 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 117.849 -3.032 . . . . 0.0 116.109 -179.758 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -78.72 149.5 32.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.332 -1.318 . . . . 0.0 110.78 -175.436 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.9 p -87.45 155.27 20.09 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 124.67 2.176 . . . . 0.0 111.089 -175.875 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.66 -27.43 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 173.379 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -85.54 -38.35 18.62 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -168.733 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -60.75 -38.93 86.83 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 115.707 -2.092 . . . . 0.0 111.379 164.063 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.324 28.2 t -55.99 -58.42 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 123.521 2.873 . . . . 0.0 117.776 167.32 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.313 37.8 ttmt -68.36 -18.01 64.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.338 1.455 . . . . 0.0 114.849 -173.267 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.12 -35.66 21.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 125.182 1.552 . . . . 0.0 111.526 170.219 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -71.56 -24.08 61.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.091 -1.044 . . . . 0.0 113.21 -175.828 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.07 -20.64 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 125.762 1.914 . . . . 0.0 110.392 170.187 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -82.01 -38.99 24.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 116.862 -3.649 . . . . 0.0 107.761 179.564 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.63 -41.5 83.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.687 2.795 . . . . 0.0 111.792 178.605 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -96.69 -22.12 17.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 130.122 3.369 . . . . 0.0 112.945 -169.565 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.492 2.3 mm-40 -136.83 -23.02 1.2 Allowed 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 118.69 -2.506 . . . . 0.0 112.228 -169.235 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.39 1.9 40.96 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 165.558 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.21 125.68 33.66 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 114.915 -2.469 . . . . 0.0 108.192 -170.522 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.07 149.09 76.64 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.906 3.071 . . . . 0.0 114.991 175.972 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.39 -38.27 54.5 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 O-C-N 126.292 2.733 . . . . 0.0 113.545 179.726 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -41.91 -42.25 2.7 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 173.226 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -94.62 -2.29 51.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 131.242 3.817 . . . . 0.0 115.062 -179.488 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -111.18 114.83 28.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.029 -3.544 . . . . 0.0 104.858 -162.627 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 ttm105 -102.24 128.47 48.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 128.607 2.763 . . . . 0.0 109.242 165.765 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 mt -115.51 137.24 52.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 111.65 -2.523 . . . . 0.0 105.8 -177.042 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.6 mt -115.22 129.43 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 128.421 2.688 . . . . 0.0 109.025 -174.521 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -132.47 134.07 44.6 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 115.231 -2.587 . . . . 0.0 111.202 156.632 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.28 0.2 3.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 172.913 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.22 -11.69 19.7 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 129.887 3.613 . . . . 0.0 108.13 -175.367 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -95.8 125.57 40.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 126.001 1.648 . . . . 0.0 110.318 -174.34 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.17 111.24 1.88 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.383 2.273 . . . . 0.0 108.115 167.866 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.254 45.6 mt -87.09 131.3 34.17 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 115.035 -2.666 . . . . 0.0 113.549 -167.715 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -119.39 156.47 30.06 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 129.96 3.304 . . . . 0.0 110.097 -179.035 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.66 142.38 35.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 130.482 3.513 . . . . 0.0 113.146 177.306 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.02 -25.61 7.82 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 126.917 2.636 . . . . 0.0 113.272 -159.231 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -121.77 133.88 54.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.435 1.894 . . . . 0.0 106.22 176.042 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.5 p -81.26 -175.31 5.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 123.86 1.79 . . . . 0.0 113.837 172.305 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.2 -38.31 90.58 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 118.532 -2.605 . . . . 0.0 110.656 176.082 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 m -63.9 -47.21 81.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 171.23 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -47.03 -39.02 11.9 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 117.11 -3.494 . . . . 0.0 117.1 166.539 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -91.12 -3.81 56.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 123.283 2.765 . . . . 0.0 117.861 170.24 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 48.0 m-80 81.92 38.29 0.06 Allowed 'General case' 0 N--CA 1.445 -0.721 1 C-N-CA 133.933 4.893 . . . . 0.0 113.082 170.846 . . . . . . . . 3 2 . 1 . 093 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.5 mt -91.29 142.65 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 -167.481 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -138.66 -169.66 2.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.436 -154.474 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -59.54 124.79 21.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.377 1.071 . . . . 0.0 111.248 173.042 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 70.96 8.98 6.69 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.297 -2.752 . . . . 0.0 115.185 172.496 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -85.29 148.0 26.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 116.953 -3.592 . . . . 0.0 106.402 -171.39 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.4 m -122.94 124.33 42.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 -173.27 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.01 141.32 28.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 130.793 3.637 . . . . 0.0 104.708 178.487 . . . . . . . . 1 1 . 1 . 093 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.28 58.2 m80 -101.65 115.6 30.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 113.693 -3.051 . . . . 0.0 107.498 -177.607 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 70' ' ' VAL . 4.5 tt -90.29 125.16 35.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 171.057 . . . . . . . . 2 2 . 1 . 093 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.471 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -125.78 104.57 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.102 -0.999 . . . . 0.0 112.695 170.17 . . . . . . . . 3 3 . 1 . 093 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.296 56.4 tp . . . . . 0 N--CA 1.448 -0.547 1 O-C-N 114.282 -5.262 . . . . 0.0 111.49 -170.12 . . . . . . . . 2 1 . 1 . 094 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 123.335 1.54 . . . . 0.0 107.203 . . . . . . . . . 0 0 . 1 . 094 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.257 72.1 mt-30 -104.34 149.5 25.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 111.965 -2.38 . . . . 0.0 109.59 174.527 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 pt -137.33 156.03 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 126.092 2.12 . . . . 0.0 110.056 170.727 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -107.25 132.29 53.25 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.396 172.7 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.42 116.86 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 128.406 2.682 . . . . 0.0 112.95 175.159 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -92.83 138.69 31.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.942 1.829 . . . . 0.0 108.939 -179.055 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -88.61 167.4 13.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 108.623 -3.899 . . . . 0.0 108.955 177.33 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.4 pt? -69.34 -23.46 63.78 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 119.127 -2.233 . . . . 0.0 113.189 160.991 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -90.1 -13.81 35.02 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 115.951 -1.976 . . . . 0.0 113.806 -175.343 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.37 -0.26 8.78 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 121.423 1.919 . . . . 0.0 113.042 163.695 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -92.62 149.64 21.21 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.051 1.425 . . . . 0.0 110.592 177.522 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -106.47 115.85 30.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 130.767 3.627 . . . . 0.0 104.513 165.442 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.0 mt -97.45 140.22 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 1 N-CA-C 97.95 -4.833 . . . . 0.0 97.95 177.858 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.3 m -101.41 98.73 9.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -179.639 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.09 156.12 18.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 117.409 -3.307 . . . . 0.0 109.445 175.001 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -121.16 119.87 33.62 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 130.742 3.617 . . . . 0.0 108.722 172.864 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 m -152.68 154.87 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 129.591 3.156 . . . . 0.0 104.887 175.545 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.351 76.0 mm-40 -100.41 166.73 12.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 111.348 -2.66 . . . . 0.0 112.371 174.279 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.288 2.6 Cg_exo -49.67 -34.02 33.65 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.043 3.162 . . . . 0.0 119.669 -178.848 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -85.91 -5.57 59.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 119.35 -2.094 . . . . 0.0 112.688 -172.814 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.395 65.7 m-20 -85.13 142.72 29.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 125.097 1.498 . . . . 0.0 109.092 -167.348 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.3 p -79.03 161.19 26.76 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 115.599 -2.143 . . . . 0.0 109.894 175.989 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.8 mm -42.22 -34.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 130.468 3.507 . . . . 0.0 111.172 165.499 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -66.75 -21.65 66.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 124.308 3.231 . . . . 0.0 111.908 -174.876 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -72.13 -52.01 18.68 Favored 'General case' 0 N--CA 1.44 -0.938 1 C-N-CA 131.809 4.044 . . . . 0.0 114.768 169.13 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.9 t -53.46 -59.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 126.428 1.891 . . . . 0.0 111.563 174.37 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -56.03 -33.71 65.19 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 127.455 2.972 . . . . 0.0 107.98 -179.855 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.76 -39.19 57.52 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 124.08 3.127 . . . . 0.0 118.665 -175.904 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -63.7 -40.3 96.45 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.644 1.978 . . . . 0.0 114.795 162.338 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.1 mt -59.21 -42.99 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 116.626 -1.654 . . . . 0.0 109.246 174.917 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -59.07 -44.96 91.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 128.984 3.927 . . . . 0.0 113.976 171.977 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.41 -19.21 60.5 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 121.323 1.874 . . . . 0.0 112.594 -175.514 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -98.91 -53.08 3.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.084 1.754 . . . . 0.0 111.135 -166.885 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.254 36.5 tp10 -112.91 -3.48 14.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.846 -173.773 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.76 28.62 20.9 Favored Glycine 0 CA--C 1.527 0.829 1 CA-C-O 128.371 4.317 . . . . 0.0 115.093 163.836 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -105.22 118.0 56.99 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 109.983 -3.108 . . . . 0.0 111.675 -165.437 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -72.73 133.01 19.51 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 CA-C-O 111.724 -3.532 . . . . 0.0 112.692 -175.725 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -74.76 -19.62 18.3 Favored 'Trans proline' 0 N--CA 1.448 -1.169 1 O-C-N 130.087 4.73 . . . . 0.0 112.202 -163.167 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -82.46 -14.6 54.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 121.852 2.115 . . . . 0.0 108.306 177.139 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.45 -15.33 35.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.356 2.262 . . . . 0.0 109.485 178.385 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -88.18 154.94 20.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 120.64 1.564 . . . . 0.0 110.994 -177.837 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.445 ' C ' HD12 ' A' ' 43' ' ' LEU . 12.3 ttm180 -148.22 122.95 9.9 Favored 'General case' 0 C--N 1.324 -0.521 1 C-N-CA 132.985 4.514 . . . . 0.0 104.149 -175.028 . . . . . . . . 3 3 . 1 . 094 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.445 HD12 ' C ' ' A' ' 42' ' ' ARG . 3.7 mp -122.13 131.59 54.04 Favored 'General case' 0 N--CA 1.446 -0.664 1 C-N-CA 132.281 4.232 . . . . 0.0 114.109 -165.231 . . . . . . . . 3 3 . 1 . 094 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.421 1.8 tt -134.63 144.66 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 126.315 2.26 . . . . 0.0 111.851 -172.309 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -156.34 142.45 18.15 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 126.552 3.072 . . . . 0.0 104.007 165.018 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 29.37 2.88 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 109.33 -3.577 . . . . 0.0 118.08 175.394 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.41 -17.67 36.61 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 127.149 2.78 . . . . 0.0 113.68 175.572 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -103.27 120.04 40.01 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 130.921 3.689 . . . . 0.0 110.979 -168.871 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -72.74 135.4 45.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.243 1.417 . . . . 0.0 107.23 164.873 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.1 mt -92.61 121.09 33.69 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.877 -163.266 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -81.5 124.8 29.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 125.729 1.893 . . . . 0.0 108.187 -169.497 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.76 108.22 2.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.271 3.028 . . . . 0.0 111.144 173.448 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.75 4.65 12.85 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 126.205 2.19 . . . . 0.0 115.615 177.2 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -105.89 144.84 32.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 116.47 -3.959 . . . . 0.0 109.92 168.418 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.6 p -84.79 145.07 28.07 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 127.123 2.764 . . . . 0.0 112.155 176.059 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 tp -41.71 -48.7 4.22 Favored 'General case' 0 N--CA 1.448 -0.538 1 C-N-CA 131.905 4.082 . . . . 0.0 109.149 179.537 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -54.25 -31.85 54.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 130.852 3.661 . . . . 0.0 113.171 176.349 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -67.53 -32.33 73.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.81 0.844 . . . . 0.0 112.955 177.139 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -88.46 -7.23 56.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 115.572 -2.156 . . . . 0.0 109.534 175.385 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 51.17 40.14 25.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 125.914 3.961 . . . . 0.0 112.971 -178.121 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.97 134.48 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.538 -2.119 . . . . 0.0 105.426 166.937 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -119.57 169.62 9.91 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 -173.834 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -49.13 126.37 12.52 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 131.687 3.995 . . . . 0.0 113.493 178.93 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 71.02 5.54 5.52 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 114.649 -2.596 . . . . 0.0 116.608 -178.887 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.5 m -59.3 128.96 39.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 164.78 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -83.22 123.77 29.9 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.337 1.055 . . . . 0.0 110.335 -177.949 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -124.23 156.59 36.56 Favored 'General case' 0 N--CA 1.452 -0.374 1 C-N-CA 134.213 5.005 . . . . 0.0 108.191 -177.549 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -124.49 148.15 47.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 120.835 -1.166 . . . . 0.0 111.934 -168.867 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tp -117.76 127.73 54.19 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.225 2.21 . . . . 0.0 108.855 -174.208 . . . . . . . . 1 1 . 1 . 094 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.594 35.3 m -119.92 165.07 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 129.385 3.074 . . . . 0.0 112.493 169.847 . . . . . . . . 2 2 . 1 . 094 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 71' ' ' LEU . 27.0 mt . . . . . 0 N--CA 1.442 -0.843 0 O-C-N 119.794 -1.816 . . . . 0.0 106.723 175.908 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttp . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 . . . . . . . . . 0 0 . 1 . 095 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -78.59 148.39 33.32 Favored 'General case' 0 C--N 1.324 -0.537 1 O-C-N 115.481 -4.512 . . . . 0.0 110.262 169.598 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 3' ' ' ILE . 37.5 pt -136.88 163.71 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 101.93 -3.359 . . . . 0.0 101.93 164.988 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -121.51 151.2 40.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 124.338 2.018 . . . . 0.0 110.165 -178.34 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 t -127.1 130.02 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 O-C-N 119.156 -2.215 . . . . 0.0 110.58 171.741 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -85.74 167.74 14.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.008 1.723 . . . . 0.0 111.978 157.875 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -126.06 177.2 6.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.728 1.268 . . . . 0.0 111.388 -176.58 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.83 -34.42 78.1 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 115.608 1.706 . . . . 0.0 115.608 174.468 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -63.25 -50.69 69.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.662 2.385 . . . . 0.0 112.45 165.84 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.54 13.54 8.04 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 116.686 -2.174 . . . . 0.0 111.113 168.238 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -69.31 135.4 50.36 Favored 'General case' 0 N--CA 1.451 -0.398 1 C-N-CA 135.718 5.607 . . . . 0.0 102.815 174.254 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 47.6 m -89.28 140.79 29.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 113.928 -1.487 . . . . 0.0 107.785 -174.741 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -116.59 148.92 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 130.16 3.384 . . . . 0.0 106.854 164.111 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 t -134.6 139.59 45.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 128.128 3.393 . . . . 0.0 108.973 170.798 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mt -141.72 160.94 39.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 125.255 2.455 . . . . 0.0 105.759 -171.711 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -109.9 127.04 54.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 125.884 2.754 . . . . 0.0 110.065 162.358 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.6 -178.65 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 131.548 3.939 . . . . 0.0 109.925 -177.107 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 19' ' ' PRO 0.275 6.1 mt-10 -130.89 148.82 71.72 Favored Pre-proline 0 N--CA 1.444 -0.731 0 O-C-N 116.359 -3.963 . . . . 0.0 112.068 168.824 . . . . . . . . 3 3 . 1 . 095 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 72.2 Cg_exo -48.51 -43.98 31.54 Favored 'Trans proline' 0 N--CA 1.453 -0.863 1 C-N-CA 125.488 4.125 . . . . 0.0 118.58 -169.968 . . . . . . . . 3 3 . 1 . 095 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 t -86.29 8.48 21.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.655 -2.066 . . . . 0.0 116.449 -179.587 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.93 154.19 31.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.305 2.253 . . . . 0.0 116.505 173.827 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.305 81.1 p -92.64 149.55 21.26 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 125.128 1.518 . . . . 0.0 108.144 178.346 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.9 mm -45.55 -44.06 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 126.632 1.973 . . . . 0.0 115.874 176.787 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -51.19 -53.97 29.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 128.77 2.828 . . . . 0.0 112.897 173.383 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -63.59 -30.39 71.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.94 1.352 . . . . 0.0 111.846 -172.142 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.47 -40.01 76.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 127.236 2.214 . . . . 0.0 109.778 169.949 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -68.98 -28.0 66.22 Favored 'General case' 0 C--N 1.328 -0.34 1 O-C-N 115.054 -4.779 . . . . 0.0 111.324 -173.797 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -31.86 66.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.576 -1.647 . . . . 0.0 112.536 172.833 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -75.08 -41.02 59.66 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -178.556 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.74 -28.97 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 119.789 1.177 . . . . 0.0 113.026 175.565 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -62.45 -44.62 95.98 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 127.84 2.456 . . . . 0.0 113.111 171.736 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -72.63 -16.55 61.71 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.091 -2.255 . . . . 0.0 113.112 -175.586 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -107.75 -53.47 2.62 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 -172.674 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -112.93 -9.32 13.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 114.471 -2.681 . . . . 0.0 112.232 -173.602 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.21 39.28 72.07 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 115.014 -3.103 . . . . 0.0 113.007 -177.181 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.2 mt -96.16 116.31 66.11 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 178.235 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.67 145.9 65.15 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 N-CA-C 118.422 2.432 . . . . 0.0 118.422 -179.032 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.297 39.7 Cg_endo -70.89 -21.41 28.27 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 125.198 3.932 . . . . 0.0 118.696 -160.045 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.49 -30.95 16.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 123.844 3.02 . . . . 0.0 110.527 -179.036 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -71.14 -37.01 72.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 177.978 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -63.74 125.02 22.96 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 112.67 -3.538 . . . . 0.0 116.487 179.262 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.281 32.4 ttm105 -128.33 121.46 29.25 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 122.872 2.578 . . . . 0.0 108.906 176.235 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.5 132.72 41.78 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 128.049 2.54 . . . . 0.0 107.625 -179.156 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.1 mt -119.87 161.14 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.742 2.017 . . . . 0.0 110.408 167.648 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -158.83 128.6 5.72 Favored 'General case' 0 N--CA 1.449 -0.494 1 N-CA-C 98.241 -4.726 . . . . 0.0 98.241 173.157 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.92 23.34 13.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.455 2.302 . . . . 0.0 113.542 162.369 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.1 0.01 54.64 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 178.03 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -120.78 129.65 53.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -167.643 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -70.77 151.82 44.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 166.221 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.93 113.95 27.37 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 101.601 -3.481 . . . . 0.0 101.601 -179.772 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -101.12 139.42 36.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 125.086 1.491 . . . . 0.0 108.428 -173.564 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -28.8 129.2 0.08 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 129.325 3.05 . . . . 0.0 116.982 167.911 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.49 -11.35 71.63 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 159.687 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -103.68 156.12 18.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.504 1.922 . . . . 0.0 106.435 -178.164 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.7 p -111.81 149.83 31.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.964 2.506 . . . . 0.0 115.778 -164.577 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.4 mt -60.81 -46.35 90.85 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 112.72 -2.037 . . . . 0.0 114.871 -164.974 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -75.8 -33.31 60.12 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.462 -171.165 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.54 -31.85 71.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 112.881 -3.438 . . . . 0.0 118.817 166.32 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -73.54 -21.92 60.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 127.916 3.26 . . . . 0.0 112.486 164.789 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t30 89.58 45.04 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.446 2 C-N-CA 134.076 4.951 . . . . 0.0 107.895 175.558 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mm -79.36 145.87 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 118.027 -2.921 . . . . 0.0 104.564 172.63 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -132.76 -178.48 4.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 121.946 2.157 . . . . 0.0 106.742 178.347 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -72.87 112.8 9.23 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 130.793 3.637 . . . . 0.0 109.036 -171.784 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 75.85 31.82 0.69 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 130.236 3.414 . . . . 0.0 111.95 -172.937 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -70.5 140.75 51.94 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 115.97 -1.967 . . . . 0.0 112.008 166.581 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.8 m -102.37 129.89 48.97 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -179.218 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.71 154.2 31.01 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.893 3.277 . . . . 0.0 108.46 -177.993 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.268 20.8 t-160 -109.04 118.28 36.38 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.013 0.925 . . . . 0.0 109.877 -171.256 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tt -93.83 127.75 39.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.224 1.81 . . . . 0.0 109.248 173.498 . . . . . . . . 1 1 . 1 . 095 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.34 138.59 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 1 O-C-N 129.103 4.002 . . . . 0.0 104.039 162.399 . . . . . . . . 2 2 . 1 . 095 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 tt . . . . . 0 N--CA 1.448 -0.566 0 O-C-N 118.639 -2.538 . . . . 0.0 109.669 167.339 . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 C--O 1.236 0.381 0 N-CA-C 110.88 -0.044 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 096 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.49 133.91 51.29 Favored 'General case' 0 N--CA 1.448 -0.54 1 C-N-CA 131.997 4.119 . . . . 0.0 108.242 -179.029 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.286 0.9 OUTLIER -129.93 169.9 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 117.217 -1.373 . . . . 0.0 112.114 163.701 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -110.03 152.16 26.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 125.139 3.609 . . . . 0.0 105.632 172.149 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.292 2.6 t -135.34 113.88 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 128.883 2.873 . . . . 0.0 107.148 172.1 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -97.31 126.04 42.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 129.931 3.292 . . . . 0.0 106.137 -177.789 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.0 p -86.41 178.03 7.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.247 1.819 . . . . 0.0 114.117 160.54 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -79.03 -33.8 44.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 117.144 -1.408 . . . . 0.0 110.696 -169.904 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -93.18 0.99 57.31 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -178.873 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.42 -8.31 5.92 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 126.53 2.014 . . . . 0.0 111.188 151.97 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -71.04 110.55 5.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -171.717 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -87.35 113.34 22.98 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 101.728 -3.434 . . . . 0.0 101.728 172.927 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.0 mt -86.34 126.69 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 N-CA-C 99.625 -4.213 . . . . 0.0 99.625 166.905 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.5 m -99.82 109.06 21.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 129.339 3.056 . . . . 0.0 105.16 173.891 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 tp -105.39 135.23 47.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -161.688 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 17' ' ' VAL 0.285 31.1 tt0 -86.12 134.71 33.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 110.823 -2.899 . . . . 0.0 113.142 160.351 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -148.2 164.44 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 123.807 1.765 . . . . 0.0 107.672 174.278 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -95.69 160.01 31.24 Favored Pre-proline 0 N--CA 1.444 -0.729 2 C-N-CA 133.018 4.527 . . . . 0.0 109.884 145.825 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.89 -25.16 74.29 Favored 'Trans proline' 0 N--CA 1.45 -1.03 1 C-N-CA 125.715 4.277 . . . . 0.0 113.487 -173.657 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -83.03 -11.03 58.43 Favored 'General case' 0 N--CA 1.444 -0.747 1 C-N-CA 137.275 6.23 . . . . 0.0 110.214 -175.175 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.03 114.7 8.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.734 2.014 . . . . 0.0 107.438 160.18 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.253 71.3 p -89.57 -162.54 0.89 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 115.793 -2.051 . . . . 0.0 114.857 -170.725 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.4 mm -60.9 -33.9 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 122.722 2.51 . . . . 0.0 113.811 172.262 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -78.56 -45.68 21.24 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 129.47 3.108 . . . . 0.0 114.801 174.466 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -67.6 -25.24 65.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 113.759 -3.176 . . . . 0.0 112.577 -179.517 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.5 t -57.5 -58.05 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.712 2.405 . . . . 0.0 116.841 157.06 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -58.51 -26.13 63.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 174.82 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.33 -37.81 43.69 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 127.078 3.323 . . . . 0.0 117.409 170.979 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -60.11 -39.18 85.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 117.092 -3.505 . . . . 0.0 113.635 164.249 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.0 mt -53.42 -47.91 58.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 129.166 2.986 . . . . 0.0 111.569 172.678 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -60.94 -50.57 72.86 Favored 'General case' 0 N--CA 1.45 -0.446 1 C-N-CA 132.121 4.169 . . . . 0.0 109.819 177.39 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.0 -48.05 61.47 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 171.364 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -84.82 -52.83 5.75 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 115.788 -2.053 . . . . 0.0 112.868 -171.988 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -123.4 -2.85 8.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 122.041 2.2 . . . . 0.0 110.237 -155.502 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.17 7.89 67.26 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.901 1.715 . . . . 0.0 112.328 163.104 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -73.27 124.18 90.28 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 129.347 3.059 . . . . 0.0 106.675 -170.589 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.76 110.51 1.63 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 125.002 3.802 . . . . 0.0 113.16 173.425 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.36 -15.06 12.8 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 N-CA-C 118.754 2.559 . . . . 0.0 118.754 -167.898 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.365 0.0 OUTLIER -25.54 -35.26 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 130.697 3.599 . . . . 0.0 120.252 174.778 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -126.79 25.41 6.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.502 1.921 . . . . 0.0 111.21 -165.837 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -131.24 126.88 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.272 1.829 . . . . 0.0 111.096 -168.634 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -123.68 157.56 33.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 109.586 -3.461 . . . . 0.0 109.701 176.455 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.11 138.59 53.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 114.133 -2.841 . . . . 0.0 108.659 -166.253 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mm -110.04 148.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 127.952 3.283 . . . . 0.0 115.568 165.272 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -149.24 125.64 10.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 114.687 -2.578 . . . . 0.0 105.519 166.565 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.57 15.24 10.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 130.471 3.508 . . . . 0.0 113.539 172.637 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.47 -34.93 5.38 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 128.654 3.026 . . . . 0.0 108.737 -169.425 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -78.11 136.02 37.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 122.133 2.967 . . . . 0.0 108.339 -156.946 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -80.27 106.13 12.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 113.611 -3.09 . . . . 0.0 113.31 164.572 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.3 136.96 57.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 128.098 3.374 . . . . 0.0 115.155 -178.014 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -91.98 116.07 28.6 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.166 2.186 . . . . 0.0 105.106 -165.43 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.49 116.27 3.86 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 115.298 -2.287 . . . . 0.0 112.607 -177.271 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.28 3.96 7.85 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 129.908 3.623 . . . . 0.0 112.896 -178.331 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -109.36 159.13 17.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 122.008 2.904 . . . . 0.0 108.93 -170.932 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.6 p -90.6 173.13 8.22 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 129.859 3.264 . . . . 0.0 110.551 176.981 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.78 -18.09 59.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.197 -0.939 . . . . 0.0 110.591 173.647 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.0 m -70.05 -20.52 63.23 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.43 -1.419 . . . . 0.0 112.841 177.367 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -86.12 -6.29 59.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.485 2.714 . . . . 0.0 112.154 -177.073 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -130.44 -7.21 4.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 114.495 -2.669 . . . . 0.0 113.196 178.954 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.05 51.07 10.97 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 127.084 2.74 . . . . 0.0 112.733 178.807 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.46 125.86 62.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 -178.417 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -114.09 -166.66 1.12 Allowed 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 112.284 -2.235 . . . . 0.0 108.502 177.88 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -65.25 149.74 49.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 129.116 2.966 . . . . 0.0 112.219 -170.004 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.542 12.6 pt-20 73.45 16.89 3.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.541 170.056 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 m -84.26 155.65 22.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.221 1.808 . . . . 0.0 111.173 -177.015 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.9 m -116.78 137.47 52.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.798 -2.439 . . . . 0.0 111.884 174.576 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -105.0 149.53 25.69 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 156.224 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -102.97 133.58 47.84 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 169.338 . . . . . . . . 1 1 . 1 . 096 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 70' ' ' VAL 0.351 1.8 tm? -96.97 144.88 26.45 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 115.142 -2.361 . . . . 0.0 111.458 -178.23 . . . . . . . . 3 3 . 1 . 096 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.429 ' N ' HD13 ' A' ' 69' ' ' LEU . 48.6 t -127.83 133.14 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 128.696 2.798 . . . . 0.0 107.567 179.074 . . . . . . . . 2 2 . 1 . 096 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 130.289 3.435 . . . . 0.0 107.745 173.207 . . . . . . . . 0 0 . 1 . 097 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.252 9.2 tpp . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 124.011 1.862 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.348 4.9 tt0 -85.54 156.85 20.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 118.203 -2.811 . . . . 0.0 115.284 177.089 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 3' ' ' ILE 0.332 17.1 pt -133.06 134.9 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 117.067 -3.521 . . . . 0.0 106.799 162.349 . . . . . . . . 3 3 . 1 . 097 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -94.13 144.55 25.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.583 166.116 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.416 HG11 HD12 ' A' ' 30' ' ' ILE . 3.8 t -128.3 133.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 127.403 2.281 . . . . 0.0 106.368 -179.975 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -133.11 145.87 51.11 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 -176.076 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -129.23 -90.75 0.48 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 116.353 -1.784 . . . . 0.0 110.704 159.847 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -142.54 -42.44 0.32 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 128.239 2.616 . . . . 0.0 114.282 169.088 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.57 114.02 21.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.116 1.366 . . . . 0.0 108.232 174.721 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.12 142.37 10.52 Favored Glycine 0 CA--C 1.536 1.392 0 N-CA-C 106.69 -2.564 . . . . 0.0 106.69 -169.426 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -54.51 -67.37 0.27 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.967 2.107 . . . . 0.0 110.267 156.402 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 p -155.57 174.53 15.14 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.916 2.486 . . . . 0.0 106.575 178.674 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.09 144.4 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 C-N-CA 127.226 2.21 . . . . 0.0 105.297 164.418 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.8 p -104.53 129.11 52.6 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.337 1.455 . . . . 0.0 112.352 -175.32 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 mt -123.42 145.98 48.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 117.349 -3.344 . . . . 0.0 108.024 176.681 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.03 121.17 37.49 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 126.132 2.145 . . . . 0.0 110.073 162.602 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -122.5 -161.6 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 O-C-N 120.223 -1.548 . . . . 0.0 112.936 -178.693 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.278 4.3 tm-20 -142.52 147.78 44.29 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 164.244 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -65.47 -21.56 60.18 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 CA-C-O 115.124 -2.115 . . . . 0.0 115.328 -178.642 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.75 14.81 6.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 120.798 1.635 . . . . 0.0 114.449 173.548 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -75.09 121.68 22.41 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 127.496 2.318 . . . . 0.0 107.124 167.233 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.8 p -66.6 155.28 38.25 Favored 'General case' 0 N--CA 1.449 -0.491 1 O-C-N 129.17 4.044 . . . . 0.0 109.028 160.782 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 80.5 mt -68.04 -27.94 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 124.249 1.976 . . . . 0.0 111.917 178.736 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -47.15 -41.39 17.59 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 112.741 -2.027 . . . . 0.0 111.689 170.517 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -75.15 -38.48 60.96 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.236 1.414 . . . . 0.0 112.351 178.56 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.71 -31.28 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 126.448 2.343 . . . . 0.0 112.712 179.03 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -51.94 -37.4 52.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 173.053 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.312 . . -79.2 -32.01 43.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 125.739 2.685 . . . . 0.0 111.163 -176.144 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -56.04 -53.09 61.14 Favored 'General case' 0 N--CA 1.452 -0.372 1 O-C-N 115.686 -4.384 . . . . 0.0 112.371 164.2 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.637 ' CG2' HD12 ' A' ' 36' ' ' ILE . 46.2 mm -59.27 -39.54 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 119.576 -1.952 . . . . 0.0 109.82 -178.301 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -51.95 -49.34 63.37 Favored 'General case' 0 N--CA 1.452 -0.34 1 N-CA-C 122.622 4.304 . . . . 0.0 122.622 161.899 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.09 -34.91 74.11 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 170.685 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.31 -23.98 14.99 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.881 1.672 . . . . 0.0 114.437 -174.869 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -143.09 -12.43 0.73 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 124.812 2.244 . . . . 0.0 115.252 -165.954 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.81 -17.4 32.82 Favored Glycine 0 CA--C 1.536 1.373 1 O-C-N 115.282 -4.636 . . . . 0.0 114.137 159.715 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.637 HD12 ' CG2' ' A' ' 30' ' ' ILE . 2.4 mt -74.32 126.31 89.09 Favored Pre-proline 0 N--CA 1.45 -0.447 0 O-C-N 120.023 -1.869 . . . . 0.0 112.714 -170.52 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -64.88 141.06 69.57 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 CA-C-O 114.846 -2.231 . . . . 0.0 117.864 173.031 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -43.87 -41.4 11.94 Favored 'Trans proline' 0 N--CA 1.449 -1.111 1 C-N-CA 125.301 4.001 . . . . 0.0 116.98 178.934 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.98 -26.1 59.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.191 2.996 . . . . 0.0 111.471 179.341 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -97.25 -15.29 20.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 127.058 2.143 . . . . 0.0 115.024 -173.761 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -90.58 132.57 35.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -169.728 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -114.24 111.9 22.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 129.23 3.012 . . . . 0.0 109.511 169.111 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -97.36 109.64 22.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.139 -1.601 . . . . 0.0 108.345 -176.855 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mt -119.08 136.66 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 1 N-CA-C 98.267 -4.716 . . . . 0.0 98.267 -174.991 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -168.66 143.16 3.24 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.997 2.519 . . . . 0.0 107.366 173.341 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.303 . . 65.51 27.21 11.69 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.261 2.224 . . . . 0.0 113.208 173.77 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.3 -8.74 59.01 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 129.016 3.198 . . . . 0.0 108.3 163.817 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -129.24 147.01 51.04 Favored 'General case' 0 C--O 1.241 0.641 0 O-C-N 116.928 -3.689 . . . . 0.0 113.194 176.82 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -60.89 104.94 0.41 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.87 3.268 . . . . 0.0 111.79 165.306 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -60.16 144.42 49.95 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -173.082 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -77.36 134.52 38.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 125.188 1.555 . . . . 0.0 110.55 161.988 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.04 -31.76 68.3 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 131.204 3.802 . . . . 0.0 117.587 -166.101 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.83 9.56 56.85 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 126.943 2.652 . . . . 0.0 110.026 -175.286 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 159.29 16.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 123.813 1.768 . . . . 0.0 110.696 162.398 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 37.3 p -102.2 163.96 11.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 111.678 -2.51 . . . . 0.0 109.923 -171.5 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.08 -59.12 4.73 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.213 2.205 . . . . 0.0 108.539 172.642 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 82.3 p -44.2 -46.12 8.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.236 2.614 . . . . 0.0 115.655 171.923 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 55' ' ' THR . 44.6 m-20 -51.38 -34.09 32.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.486 1.514 . . . . 0.0 114.812 173.244 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -104.27 0.01 28.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.559 -1.338 . . . . 0.0 112.555 -175.151 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m120 81.75 23.47 0.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.849 2.059 . . . . 0.0 111.689 -176.056 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.0 mt -84.59 102.89 11.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -174.169 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -70.8 162.3 29.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 172.958 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -42.17 138.31 1.68 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.895 2.078 . . . . 0.0 114.005 155.8 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.257 7.6 mm-40 77.07 17.91 1.55 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 129.028 2.931 . . . . 0.0 111.84 170.302 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -96.44 155.81 16.61 Favored 'General case' 0 CA--C 1.537 0.454 1 CA-C-O 130.108 4.766 . . . . 0.0 109.333 -177.053 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.4 m -96.92 140.84 30.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 110.001 -3.272 . . . . 0.0 106.51 176.704 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.54 162.7 13.89 Favored 'General case' 0 CA--C 1.537 0.465 1 N-CA-C 98.586 -4.598 . . . . 0.0 98.586 157.602 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -120.01 141.79 49.39 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 167.401 . . . . . . . . 1 1 . 1 . 097 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 70' ' ' VAL . 7.5 tp -116.89 148.79 41.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 130.584 3.553 . . . . 0.0 112.808 -172.509 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.523 ' H ' HD12 ' A' ' 69' ' ' LEU . 58.0 t -133.92 130.36 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 130.304 3.441 . . . . 0.0 109.931 -176.294 . . . . . . . . 2 2 . 1 . 097 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--N 1.327 -0.405 0 O-C-N 120.06 -1.65 . . . . 0.0 107.362 164.99 . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttp . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 098 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -82.78 122.76 28.62 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.387 1.875 . . . . 0.0 113.723 172.452 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -112.52 163.39 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 1 C-N-CA 132.779 4.431 . . . . 0.0 103.914 167.632 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -117.06 153.85 32.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.507 1.523 . . . . 0.0 108.497 168.151 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.97 136.24 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.216 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.365 14.9 ttmt -133.49 151.35 51.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.51 1.924 . . . . 0.0 113.596 172.632 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -110.42 151.01 28.0 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.867 1.317 . . . . 0.0 108.053 178.9 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.311 27.7 mt -61.25 -31.02 70.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.75 -2.469 . . . . 0.0 113.11 179.727 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.1 p -70.49 -3.35 17.41 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 131.466 3.906 . . . . 0.0 114.41 172.107 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.28 29.1 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 124.978 1.424 . . . . 0.0 113.024 153.211 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -62.83 127.25 30.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 118.893 -2.534 . . . . 0.0 111.603 176.966 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 m -116.85 144.41 44.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.511 2.724 . . . . 0.0 107.659 177.522 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.8 tt -146.05 132.8 14.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -175.735 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -70.04 150.27 46.8 Favored 'General case' 0 C--N 1.327 -0.388 1 O-C-N 115.693 -4.38 . . . . 0.0 108.156 166.192 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -133.11 155.62 48.92 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 172.211 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -112.38 129.78 56.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 119.64 -1.913 . . . . 0.0 107.751 172.194 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -146.77 154.81 11.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 130.11 3.364 . . . . 0.0 109.471 -174.346 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -102.11 143.52 26.77 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 171.245 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.53 -16.1 49.85 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.837 3.024 . . . . 0.0 116.214 -173.069 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.5 p -85.6 -7.31 58.92 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 121.586 1.994 . . . . 0.0 116.35 165.126 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -58.61 142.99 47.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 117.575 -3.203 . . . . 0.0 110.345 173.361 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 26' ' ' VAL . 44.7 p -80.11 157.05 26.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.869 2.067 . . . . 0.0 112.193 174.684 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.2 -29.57 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.355 1.462 . . . . 0.0 107.768 -178.143 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -64.72 -48.82 73.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.55 1.14 . . . . 0.0 108.346 172.734 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.35 -37.09 64.53 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 120.273 -1.517 . . . . 0.0 113.798 166.316 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 22' ' ' THR 0.257 3.5 t -64.34 -30.58 50.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 118.904 -2.372 . . . . 0.0 114.808 172.224 . . . . . . . . 3 3 . 1 . 098 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -76.82 -28.34 55.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 168.934 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.34 -36.0 63.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 122.424 1.107 . . . . 0.0 110.398 -179.248 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -68.01 -25.31 65.34 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.183 -1.573 . . . . 0.0 113.108 171.604 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -80.7 -38.04 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 171.562 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -30.51 4.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 116.389 -3.945 . . . . 0.0 111.396 176.922 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -73.8 -29.45 62.17 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.702 1.601 . . . . 0.0 111.969 179.338 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -103.02 -50.99 3.36 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 117.17 -3.457 . . . . 0.0 110.324 -169.12 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -122.25 -2.93 9.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.435 1.894 . . . . 0.0 113.054 -168.345 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.4 -32.16 6.75 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 114.235 -3.536 . . . . 0.0 115.251 155.493 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.5 mt -55.3 128.75 67.5 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 128.729 2.811 . . . . 0.0 110.708 -170.722 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.86 139.99 64.85 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 128.253 5.969 . . . . 0.0 109.213 179.84 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -38.23 -40.99 1.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 1 C-N-CA 130.329 7.353 . . . . 0.0 115.821 176.648 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -61.6 -30.4 70.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 117.773 -3.08 . . . . 0.0 115.348 176.706 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -83.02 -26.65 31.01 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.377 1.444 . . . . 0.0 110.677 -176.738 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.274 77.5 mt-30 -91.37 137.26 32.51 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.966 1.416 . . . . 0.0 109.848 -178.526 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.262 3.8 mtt85 -107.42 146.26 31.91 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 111.208 -2.723 . . . . 0.0 110.773 155.439 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.97 120.5 42.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.868 1.213 . . . . 0.0 108.156 167.174 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.44 146.99 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 125.22 1.575 . . . . 0.0 108.599 -179.041 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -139.86 127.46 21.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.701 2.8 . . . . 0.0 104.078 166.112 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.252 . . 61.73 33.44 17.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 119.804 -1.81 . . . . 0.0 111.948 170.765 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.85 -19.58 11.49 Favored Glycine 0 CA--C 1.538 1.517 0 O-C-N 118.495 -2.628 . . . . 0.0 111.776 -179.662 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -76.98 113.64 14.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 123.571 3.685 . . . . 0.0 107.032 -177.771 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -74.41 110.73 8.94 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 104.06 -2.57 . . . . 0.0 104.06 162.276 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.6 mt -59.36 129.25 41.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.839 1.656 . . . . 0.0 108.608 168.485 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -92.32 138.95 31.09 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.891 0.876 . . . . 0.0 110.464 -179.998 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -64.73 138.14 58.21 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 125.873 1.983 . . . . 0.0 110.466 -175.306 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.79 -30.81 6.65 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 127.929 2.681 . . . . 0.0 115.989 -175.784 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -91.69 147.93 22.63 Favored 'General case' 0 CA--C 1.535 0.394 1 C-N-CA 132.889 4.475 . . . . 0.0 110.731 -178.209 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 p -102.03 170.49 8.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 125.145 1.528 . . . . 0.0 112.513 -171.438 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -51.88 -42.91 63.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 128.618 3.699 . . . . 0.0 109.196 170.033 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -79.65 -28.16 40.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 120.02 -1.675 . . . . 0.0 114.645 -171.23 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -78.33 -40.06 37.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.045 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -83.07 0.19 46.12 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 117.852 -3.03 . . . . 0.0 109.951 -179.046 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.421 5.2 p-10 46.08 64.52 1.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.391 2.276 . . . . 0.0 113.161 -179.326 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 mm -83.89 -43.99 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 118.563 -1.255 . . . . 0.0 109.875 -166.176 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.415 52.9 mm-40 97.04 153.81 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.689 2.395 . . . . 0.0 111.774 166.747 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.39 131.51 45.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 119.044 -2.285 . . . . 0.0 108.008 177.07 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.282 3.4 mp0 81.41 10.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 127.194 2.809 . . . . 0.0 110.063 166.684 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.8 t -75.2 139.1 42.4 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 130.817 3.647 . . . . 0.0 107.82 172.992 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -100.15 126.72 46.45 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 103.031 -2.952 . . . . 0.0 103.031 -177.302 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 67' ' ' LEU . 2.2 mp -101.11 147.27 26.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.795 164.617 . . . . . . . . 2 2 . 1 . 098 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -88.31 127.23 35.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.209 2.604 . . . . 0.0 107.537 -176.781 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.3 tp -114.22 123.82 50.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 -175.711 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.3 135.59 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -175.617 . . . . . . . . 1 1 . 1 . 098 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 125.228 2.442 . . . . 0.0 106.633 -163.159 . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttp . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 099 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -79.66 133.93 36.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 173.975 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.9 pt -138.1 171.73 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 169.818 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -115.69 122.11 44.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 118.07 -2.894 . . . . 0.0 113.36 175.625 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -93.72 102.99 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 122.786 2.539 . . . . 0.0 111.193 166.701 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 21.3 tptt -80.49 122.98 27.67 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 128.039 2.535 . . . . 0.0 111.846 165.216 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.8 p -102.99 156.63 17.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.747 -176.256 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.781 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -53.77 -26.19 22.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 130.068 3.347 . . . . 0.0 118.267 -175.946 . . . . . . . . 3 3 . 1 . 099 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -86.78 -10.65 53.07 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 127.245 2.841 . . . . 0.0 112.144 -177.8 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.89 -3.99 57.46 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 130.275 3.798 . . . . 0.0 117.761 -178.992 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -71.69 143.0 49.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 120.147 1.973 . . . . 0.0 111.411 175.402 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 154.17 33.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.002 173.538 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -135.23 143.18 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 129.341 3.056 . . . . 0.0 108.682 -176.826 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -119.73 102.02 8.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.313 179.949 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.2 mt -96.02 170.05 9.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 -177.203 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -121.57 90.94 3.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 123.265 1.507 . . . . 0.0 112.149 167.926 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -99.49 172.5 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 117.595 -3.191 . . . . 0.0 109.912 -177.536 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -131.94 130.8 22.29 Favored Pre-proline 0 N--CA 1.447 -0.624 2 O-C-N 114.672 -5.017 . . . . 0.0 107.223 -164.39 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -42.94 -29.82 1.65 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 1 CA-C-N 129.146 4.302 . . . . 0.0 116.937 167.408 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -75.73 -13.99 60.32 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 129.0 2.92 . . . . 0.0 114.869 176.871 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.463 ' HB2' HD13 ' A' ' 56' ' ' LEU . 66.1 m-20 -79.87 129.29 34.36 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 124.47 2.081 . . . . 0.0 109.989 -170.682 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -73.21 163.04 28.68 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 125.482 2.563 . . . . 0.0 105.57 177.896 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -55.28 -36.23 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 117.82 -3.05 . . . . 0.0 112.631 172.028 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.48 -30.38 69.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 117.494 -3.254 . . . . 0.0 113.346 169.568 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 13.2 m120 -59.82 -43.76 94.37 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 170.63 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -52.74 -50.09 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 O-C-N 127.707 3.13 . . . . 0.0 114.279 174.591 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -54.01 -46.37 71.78 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 129.075 3.984 . . . . 0.0 109.229 172.609 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -63.73 -39.16 93.62 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.827 2.051 . . . . 0.0 115.386 174.252 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -58.23 -41.82 84.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.353 2.261 . . . . 0.0 116.032 165.423 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -67.09 -45.52 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 120.388 -1.445 . . . . 0.0 110.976 176.56 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -45.26 -59.79 2.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 127.51 3.006 . . . . 0.0 111.761 173.099 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -52.42 -34.95 50.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.786 -175.059 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -98.17 -37.57 9.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 126.17 2.168 . . . . 0.0 116.687 -168.682 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -128.3 6.15 5.82 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.291 2.237 . . . . 0.0 116.07 -173.606 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.8 11.51 63.07 Favored Glycine 0 CA--C 1.532 1.142 1 O-C-N 116.178 -4.076 . . . . 0.0 119.887 174.678 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.3 mt -83.4 130.66 55.56 Favored Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-N 120.734 2.267 . . . . 0.0 105.238 177.274 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 40' ' ' GLN 0.264 73.7 Cg_endo -80.66 159.45 21.92 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 O-C-N 116.098 -2.632 . . . . 0.0 113.371 174.103 . . . . . . . . 3 3 . 1 . 099 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.83 -40.63 16.33 Favored 'Trans proline' 0 N--CA 1.443 -1.467 1 C-N-CA 125.395 4.063 . . . . 0.0 110.559 -170.882 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.26 24.7 t70 -55.96 -22.57 27.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 113.335 -3.221 . . . . 0.0 116.379 176.622 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 37.6 tt0 -86.34 -10.09 55.11 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 128.401 3.563 . . . . 0.0 110.009 -178.142 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -100.49 161.15 13.79 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.791 1.636 . . . . 0.0 107.136 -157.389 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -157.04 126.19 5.96 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 125.351 2.5 . . . . 0.0 107.713 162.142 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -99.59 126.02 45.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.74 -2.475 . . . . 0.0 106.738 -174.757 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.2 mm -111.45 143.64 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 129.879 3.271 . . . . 0.0 110.267 179.469 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -146.81 137.12 23.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.27 3.028 . . . . 0.0 108.666 166.626 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.281 . . 53.33 42.0 32.08 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 131.186 3.794 . . . . 0.0 112.454 172.648 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.27 10.18 85.72 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 114.429 -3.428 . . . . 0.0 114.708 -174.864 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -147.98 163.0 38.19 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 123.723 3.761 . . . . 0.0 115.305 179.172 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -63.64 133.78 54.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 131.655 3.982 . . . . 0.0 110.316 171.017 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 mt -99.31 126.73 45.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 163.609 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.93 156.85 20.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 126.324 2.265 . . . . 0.0 113.315 -174.007 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.19 155.28 11.6 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.567 -169.075 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.85 0.04 48.67 Favored Glycine 0 CA--C 1.525 0.665 1 O-C-N 130.388 4.805 . . . . 0.0 113.266 150.438 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -120.17 169.5 10.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 131.008 3.723 . . . . 0.0 112.321 179.336 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 p -105.92 163.87 12.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 116.557 -1.687 . . . . 0.0 113.916 -173.504 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.506 HD12 ' H ' ' A' ' 56' ' ' LEU . 5.9 mp -41.72 -37.83 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 112.645 -3.55 . . . . 0.0 115.108 156.94 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -71.58 -38.37 70.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 124.721 3.419 . . . . 0.0 117.94 170.531 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.95 -29.37 66.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 122.163 2.256 . . . . 0.0 115.319 173.761 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -87.68 8.84 23.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 118.68 -2.512 . . . . 0.0 108.132 173.112 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 63.26 24.47 14.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 124.211 3.187 . . . . 0.0 117.183 171.32 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.6 mt -76.87 127.71 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 118.636 -2.54 . . . . 0.0 116.749 -175.217 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.278 4.3 tp-100 -110.6 165.16 12.04 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.835 2.454 . . . . 0.0 109.896 -170.335 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.2 155.83 2.51 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 117.086 -3.509 . . . . 0.0 115.556 178.532 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 57.06 1.03 0.09 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.434 2.294 . . . . 0.0 116.509 170.435 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -60.12 151.31 27.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 130.48 3.512 . . . . 0.0 110.5 173.893 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.9 m -103.47 115.69 31.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 177.632 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.38 148.01 24.45 Favored 'General case' 0 N--CA 1.445 -0.68 1 C-N-CA 132.618 4.367 . . . . 0.0 107.784 160.402 . . . . . . . . 2 2 . 1 . 099 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -113.68 148.4 36.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 122.312 2.324 . . . . 0.0 109.597 176.467 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -119.28 136.63 54.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.259 2.623 . . . . 0.0 107.274 178.996 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.97 167.99 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 O-C-N 125.222 1.576 . . . . 0.0 111.476 157.048 . . . . . . . . 1 1 . 1 . 099 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.593 1.1 pp . . . . . 0 N--CA 1.447 -0.598 0 CA-C-N 120.573 1.533 . . . . 0.0 113.821 171.176 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 ttp . . . . . 0 C--O 1.234 0.248 0 CA-C-O 115.737 -2.078 . . . . 0.0 106.554 . . . . . . . . . 0 0 . 1 . 100 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -90.75 138.96 31.17 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 121.383 1.901 . . . . 0.0 108.748 173.331 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 pt -125.96 159.76 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 130.081 3.352 . . . . 0.0 109.372 159.908 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.46 ' HB2' ' HA ' ' A' ' 66' ' ' THR 0.279 73.4 m-85 -95.47 144.0 26.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 165.726 . . . . . . . . 3 3 . 1 . 100 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.8 t -116.14 149.07 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 127.878 2.471 . . . . 0.0 108.768 163.987 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -136.79 150.07 48.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 130.488 3.515 . . . . 0.0 104.243 177.721 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.5 p -106.79 -170.97 1.8 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 111.731 -2.486 . . . . 0.0 106.189 -179.786 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.1 mt -106.67 -11.75 15.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 126.548 3.071 . . . . 0.0 112.951 -176.318 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -89.15 -6.02 57.3 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 119.077 -2.265 . . . . 0.0 110.994 173.859 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.8 -28.47 5.43 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 129.263 3.316 . . . . 0.0 111.107 171.572 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -73.12 142.48 47.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.067 -158.509 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.5 p -113.02 136.73 52.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.465 1.906 . . . . 0.0 109.897 -179.171 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 pt -117.78 143.6 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 131.4 3.88 . . . . 0.0 102.191 168.297 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.427 78.5 m -97.58 141.23 30.88 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 169.559 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.291 0.0 OUTLIER -131.23 125.28 32.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.068 2.147 . . . . 0.0 109.042 -176.649 . . . . . . . . 3 3 . 1 . 100 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.4 132.2 37.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 129.238 3.015 . . . . 0.0 112.203 156.162 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.99 160.35 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 127.235 2.214 . . . . 0.0 111.689 -177.81 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -121.19 154.87 58.73 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 100.724 -3.806 . . . . 0.0 100.724 173.976 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.82 -17.91 17.44 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.775 1.65 . . . . 0.0 115.865 -171.575 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 p -84.42 5.14 28.42 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 117.381 -1.295 . . . . 0.0 111.642 -175.064 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.03 139.51 39.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.431 2.693 . . . . 0.0 114.646 178.903 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 p -94.61 134.88 36.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.265 2.226 . . . . 0.0 114.664 -177.067 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.442 5.0 mt -42.14 -40.61 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -177.006 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.39 -13.95 59.61 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 117.156 -3.465 . . . . 0.0 113.5 176.429 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -89.64 -23.32 21.93 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 116.158 -1.877 . . . . 0.0 114.056 162.815 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.84 -36.18 73.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 116.343 -1.789 . . . . 0.0 110.129 168.034 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -60.2 -39.69 87.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 122.457 2.389 . . . . 0.0 113.487 170.078 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -36.5 79.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 115.583 -2.151 . . . . 0.0 113.664 169.694 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 tttt -61.81 -38.05 86.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 123.379 2.809 . . . . 0.0 110.349 169.606 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.366 66.4 mt -62.19 -32.66 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 O-C-N 117.7 -3.125 . . . . 0.0 117.416 169.96 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -65.29 -27.24 68.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.708 1.203 . . . . 0.0 113.774 175.947 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -84.11 -33.98 24.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 126.139 2.15 . . . . 0.0 107.371 -176.726 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -73.75 -43.45 59.02 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 177.469 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.302 47.8 tp10 -142.02 -5.2 1.01 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 123.383 1.563 . . . . 0.0 108.135 -152.855 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.24 -9.17 69.81 Favored Glycine 0 N--CA 1.443 -0.877 1 O-C-N 115.975 -4.203 . . . . 0.0 122.558 162.497 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -79.03 124.02 84.83 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-O 114.389 -2.719 . . . . 0.0 105.241 -171.2 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.303 58.9 Cg_endo -54.48 149.78 37.26 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.46 2.107 . . . . 0.0 115.394 172.221 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -84.29 -25.62 2.08 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 107.28 -1.854 . . . . 0.0 107.28 -162.165 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -48.84 -47.62 42.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 177.73 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -95.78 13.65 25.87 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.497 1.519 . . . . 0.0 108.029 -175.51 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -92.78 145.44 24.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 122.144 2.247 . . . . 0.0 109.919 171.192 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -147.63 124.23 11.1 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 130.005 3.322 . . . . 0.0 109.015 -177.261 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mp -101.39 139.01 37.64 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.875 1.67 . . . . 0.0 110.823 -177.161 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.9 mt -121.84 140.67 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 131.372 3.869 . . . . 0.0 110.292 168.761 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -116.54 -32.02 5.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 119.245 -2.159 . . . . 0.0 113.917 166.254 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.7 -107.16 0.38 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-O 115.43 -2.224 . . . . 0.0 106.312 175.961 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.95 2.77 13.19 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 117.931 1.932 . . . . 0.0 117.931 166.569 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -113.11 151.62 30.59 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 118.999 -2.471 . . . . 0.0 107.495 -160.707 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -66.41 144.65 56.39 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.676 163.912 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.4 mt -98.05 147.41 24.56 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.873 2.469 . . . . 0.0 106.534 172.729 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -66.96 114.59 5.88 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 157.677 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -53.35 -30.32 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 119.915 3.302 . . . . 0.0 119.915 -176.38 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.68 18.44 52.95 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -168.753 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -94.02 168.69 10.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 125.572 1.395 . . . . 0.0 109.913 167.232 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.1 p -96.08 166.93 11.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 130.628 3.571 . . . . 0.0 116.53 175.29 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.79 -38.41 69.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 114.492 -2.671 . . . . 0.0 115.538 168.6 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 p -76.1 -31.27 58.6 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.555 2.742 . . . . 0.0 106.702 -171.397 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -57.42 -35.01 69.53 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 120.083 1.311 . . . . 0.0 111.809 173.999 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -108.39 -3.57 18.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -170.741 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.419 36.9 t-20 67.16 53.47 0.79 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 127.324 2.89 . . . . 0.0 111.904 178.8 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.1 mm -79.11 115.68 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 127.94 2.496 . . . . 0.0 104.491 168.494 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -93.15 156.88 16.58 Favored 'General case' 0 N--CA 1.448 -0.534 1 C-N-CA 132.014 4.126 . . . . 0.0 111.438 177.047 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -67.4 149.01 50.84 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 119.645 -1.91 . . . . 0.0 111.78 -177.245 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.393 19.2 mt-10 80.67 -2.4 1.86 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 114.09 -2.862 . . . . 0.0 113.219 172.78 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.8 m -66.58 159.63 27.03 Favored 'General case' 0 N--CA 1.449 -0.494 1 O-C-N 130.016 4.573 . . . . 0.0 112.616 -177.229 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 53.5 m -103.74 121.29 42.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 175.083 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 tt -110.31 154.45 23.46 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 117.803 -3.061 . . . . 0.0 106.486 -179.347 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -120.95 119.77 33.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 116.507 -3.871 . . . . 0.0 110.415 -167.826 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.1 tp -98.4 142.57 29.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.582 2.353 . . . . 0.0 110.178 178.983 . . . . . . . . 1 1 . 1 . 100 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 71' ' ' LEU . 96.1 t -124.3 162.98 24.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 129.187 2.995 . . . . 0.0 109.687 177.217 . . . . . . . . 2 2 . 1 . 100 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.49 ' N ' HG12 ' A' ' 70' ' ' VAL . 2.4 pt? . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 122.455 1.121 . . . . 0.0 109.227 177.685 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.4 ttm . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 116.982 -1.485 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 101 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -106.11 122.49 46.29 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -166.209 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -132.8 174.1 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 O-C-N 125.723 1.889 . . . . 0.0 109.086 167.832 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.283 7.6 p90 -150.62 149.06 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 117.033 -3.542 . . . . 0.0 109.509 -171.457 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 67' ' ' LEU . 4.7 m -114.58 150.42 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 179.909 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -109.26 123.42 49.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 175.624 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -68.51 172.88 5.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 128.538 2.735 . . . . 0.0 110.584 176.861 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.76 -26.5 66.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.805 167.43 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -88.92 -4.27 58.5 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 179.978 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.91 -4.29 57.55 Favored Glycine 0 CA--C 1.528 0.898 1 CA-C-O 112.379 -4.567 . . . . 0.0 111.823 166.128 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -84.62 141.5 30.61 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 123.922 3.861 . . . . 0.0 110.885 178.139 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.276 53.9 m -104.15 148.62 26.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 121.658 2.026 . . . . 0.0 105.906 -168.433 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mt -128.48 121.08 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.824 2.05 . . . . 0.0 107.936 176.951 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.8 m -92.67 129.77 38.5 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.561 1.945 . . . . 0.0 106.63 -177.244 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.91 139.4 47.43 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 127.147 2.779 . . . . 0.0 106.403 -175.48 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.294 22.3 tp10 -96.22 127.18 42.0 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 118.442 -2.661 . . . . 0.0 107.211 159.635 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.63 161.81 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 103.503 -2.776 . . . . 0.0 103.503 177.823 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -107.85 121.56 43.61 Favored Pre-proline 0 N--CA 1.446 -0.667 1 C-N-CA 133.366 4.666 . . . . 0.0 104.877 160.63 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 10.4 Cg_endo -65.19 -2.57 5.99 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 127.188 5.258 . . . . 0.0 117.483 -160.22 . . . . . . . . 3 2 . 1 . 101 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -96.85 3.4 52.21 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.86 -177.331 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.12 157.04 31.23 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.694 1.597 . . . . 0.0 111.523 174.932 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -100.53 149.93 23.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 -172.338 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.443 ' H ' HG12 ' A' ' 23' ' ' ILE . 5.5 mm -51.96 -31.86 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 112.609 -3.567 . . . . 0.0 116.477 -178.005 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -65.38 -26.54 68.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 123.079 2.672 . . . . 0.0 113.136 174.188 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -81.69 -21.24 38.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.506 1.503 . . . . 0.0 112.744 178.495 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 t -71.4 -52.53 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 1 C-N-CA 133.804 4.842 . . . . 0.0 110.082 167.716 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -53.6 -34.13 57.35 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 116.555 -3.84 . . . . 0.0 118.12 168.299 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.74 -18.85 39.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 120.395 -1.441 . . . . 0.0 112.06 -178.439 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -69.95 -17.23 63.3 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 116.844 -3.66 . . . . 0.0 117.026 167.293 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mm -84.83 -35.56 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 116.736 -1.602 . . . . 0.0 108.733 -174.743 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -52.14 -43.41 64.03 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 129.618 3.167 . . . . 0.0 111.863 -166.783 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.85 -29.3 65.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 122.767 2.53 . . . . 0.0 113.272 179.701 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -75.18 -56.77 4.4 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.393 -2.692 . . . . 0.0 109.914 173.294 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -134.29 137.63 44.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 -165.524 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.48 40.87 2.32 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 -149.71 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 71' ' ' LEU . 43.6 mt -91.93 119.66 68.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 130.066 3.347 . . . . 0.0 113.807 -174.781 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.97 138.94 23.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 121.273 1.49 . . . . 0.0 113.024 -168.273 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.08 -18.75 7.66 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-O 111.452 -3.645 . . . . 0.0 116.18 177.59 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -88.61 12.15 15.42 Favored 'General case' 0 C--O 1.238 0.491 1 CA-C-N 127.076 4.489 . . . . 0.0 112.314 175.078 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.336 8.2 tt0 -127.01 -18.86 4.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.511 -1.993 . . . . 0.0 111.222 -176.858 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 77.3 mt-30 -92.66 156.64 16.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.254 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -144.8 147.69 33.18 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.212 -2.885 . . . . 0.0 103.212 170.49 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.8 mt -117.76 136.06 53.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.526 2.331 . . . . 0.0 110.078 -176.591 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 44' ' ' ILE . 56.2 mt -122.15 143.18 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 172.892 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -118.03 106.45 12.92 Favored 'General case' 0 C--N 1.33 -0.273 2 CA-C-N 105.312 -5.404 . . . . 0.0 112.332 154.675 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.462 . . 87.18 4.22 0.36 Allowed 'General case' 0 CA--C 1.532 0.265 1 O-C-N 111.987 -6.696 . . . . 0.0 116.69 157.537 . . . . . . . . 3 2 . 1 . 101 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.7 2.22 46.47 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.714 -171.794 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -92.23 124.07 36.03 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 128.349 2.659 . . . . 0.0 111.276 165.012 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -77.18 128.46 34.42 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 168.788 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.279 11.9 mt -68.15 126.54 29.84 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 118.336 2.717 . . . . 0.0 118.336 170.388 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -98.75 139.09 34.95 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -173.625 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.45 142.83 57.7 Favored 'General case' 0 C--O 1.22 -0.457 0 O-C-N 117.996 -2.94 . . . . 0.0 109.013 176.787 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.68 -19.04 56.34 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 119.108 -2.245 . . . . 0.0 108.126 171.519 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -81.09 157.97 25.2 Favored 'General case' 0 N--CA 1.453 -0.319 1 O-C-N 115.072 -4.781 . . . . 0.0 106.538 173.123 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.1 p -92.03 165.93 12.94 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 120.558 -1.339 . . . . 0.0 109.967 165.689 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 mt -51.7 -45.79 63.65 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.451 2.7 . . . . 0.0 113.286 163.075 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -53.45 -28.84 32.51 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 170.082 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.01 -23.65 48.2 Favored 'General case' 0 N--CA 1.447 -0.597 1 O-C-N 115.068 -4.77 . . . . 0.0 115.857 178.356 . . . . . . . . 3 3 . 1 . 101 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.28 45.9 m-85 -97.99 -9.05 26.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.309 1.444 . . . . 0.0 114.303 172.497 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.377 26.5 t30 72.54 47.18 0.26 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 130.324 3.45 . . . . 0.0 111.405 -178.233 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -82.57 103.58 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.943 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -90.09 -175.06 4.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 130.02 3.328 . . . . 0.0 115.901 170.458 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.76 138.58 41.85 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.613 3.165 . . . . 0.0 112.933 173.498 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.454 62.8 tt0 83.93 2.24 0.91 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 126.867 2.067 . . . . 0.0 114.657 167.53 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -77.88 134.1 38.0 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.23 -1.544 . . . . 0.0 111.104 -169.195 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -85.19 115.55 23.04 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 126.662 2.476 . . . . 0.0 104.733 174.44 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.469 ' HB2' HG12 ' A' ' 5' ' ' VAL . 51.3 mt -94.83 171.03 9.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 128.208 3.443 . . . . 0.0 107.262 161.839 . . . . . . . . 2 2 . 1 . 101 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -130.96 139.13 50.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.721 -179.029 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -101.95 120.87 41.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 -171.006 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.37 172.95 13.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 127.497 2.319 . . . . 0.0 105.973 -175.287 . . . . . . . . 1 1 . 1 . 101 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD11 HG21 ' A' ' 36' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.443 -0.818 0 C-N-CA 122.816 0.446 . . . . 0.0 110.687 -165.576 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttp . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 116.654 -1.641 . . . . 0.0 107.281 . . . . . . . . . 0 0 . 1 . 102 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -93.95 138.59 31.9 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 124.041 1.877 . . . . 0.0 111.164 170.842 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -136.74 167.71 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.704 2.001 . . . . 0.0 107.897 162.289 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -119.87 135.2 54.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -177.144 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 15' ' ' LEU . 88.0 t -121.43 89.58 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 126.674 2.484 . . . . 0.0 104.907 178.747 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -77.83 121.32 23.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.456 3.902 . . . . 0.0 107.018 -175.542 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.8 p -84.61 155.05 22.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 175.373 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 mt -50.44 -16.81 0.39 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 131.415 3.886 . . . . 0.0 115.664 176.558 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -97.81 6.35 47.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.18 0.992 . . . . 0.0 111.731 172.706 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.08 -36.32 4.47 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 120.007 -1.683 . . . . 0.0 109.951 167.515 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -60.24 127.68 33.0 Favored 'General case' 0 C--N 1.33 -0.255 1 C-N-CA 132.369 4.268 . . . . 0.0 106.69 -174.718 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.253 20.6 m -119.19 123.81 45.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.102 2.561 . . . . 0.0 109.071 -166.014 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mm -82.48 120.37 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 168.235 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.8 m -74.35 134.8 42.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.88 1.363 . . . . 0.0 109.27 166.735 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.468 HD12 HG21 ' A' ' 5' ' ' VAL . 2.3 mt -125.44 129.91 50.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 120.645 1.566 . . . . 0.0 113.259 179.593 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.48 90.77 7.69 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.133 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -98.99 164.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.321 177.996 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.265 30.5 tp10 -107.81 156.21 38.49 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-O 113.612 -3.09 . . . . 0.0 105.017 162.3 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -59.93 -25.07 78.49 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 124.127 3.218 . . . . 0.0 118.073 170.557 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -88.57 1.65 54.53 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 119.439 3.125 . . . . 0.0 119.439 -179.732 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -72.43 149.18 44.47 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 114.439 -2.696 . . . . 0.0 115.891 -177.605 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 p -65.95 151.67 46.26 Favored 'General case' 0 C--N 1.325 -0.459 1 O-C-N 129.62 4.325 . . . . 0.0 110.475 167.04 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -61.02 -29.01 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 116.591 -1.671 . . . . 0.0 110.412 173.251 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -70.3 -50.61 37.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.045 2.538 . . . . 0.0 111.379 -173.056 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -50.3 -45.04 54.3 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.132 2.573 . . . . 0.0 112.629 170.93 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.4 -45.85 67.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.856 1.662 . . . . 0.0 108.158 -176.28 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -63.61 -31.19 72.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.251 1.42 . . . . 0.0 114.397 178.101 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.71 -14.87 35.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.38 3.472 . . . . 0.0 113.56 177.084 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.04 -31.2 27.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 119.119 -2.238 . . . . 0.0 107.083 174.571 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.2 mm -81.51 -6.99 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 117.348 -1.31 . . . . 0.0 109.961 176.907 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -76.54 -28.99 56.51 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 118.104 -2.873 . . . . 0.0 109.102 163.37 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.55 -47.21 12.41 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -163.292 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -73.18 -73.77 0.2 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.332 2.653 . . . . 0.0 112.214 178.437 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -85.45 -16.57 39.24 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.736 2.414 . . . . 0.0 117.183 -166.942 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.97 -7.84 67.53 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 117.142 -1.921 . . . . 0.0 112.786 -179.777 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.261 37.9 mm -80.29 115.03 51.91 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 123.141 3.471 . . . . 0.0 112.248 -163.485 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -55.67 160.22 9.91 Favored 'Trans proline' 0 N--CA 1.445 -1.354 1 C-N-CA 126.126 4.551 . . . . 0.0 113.941 171.011 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.63 5.82 3.59 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 N-CA-C 120.028 3.049 . . . . 0.0 120.028 -176.509 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.378 82.8 m-20 -104.72 -6.37 20.43 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 126.312 2.958 . . . . 0.0 117.929 174.451 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -97.82 -6.47 32.55 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 119.304 -2.122 . . . . 0.0 114.703 160.992 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -85.25 85.93 7.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 169.51 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -93.85 97.22 10.25 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 -171.421 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 mt -93.06 139.15 30.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -163.654 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 44' ' ' ILE . 24.3 mt -136.47 135.55 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.31 1.844 . . . . 0.0 110.039 177.754 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -129.38 107.13 9.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.07 3.348 . . . . 0.0 105.465 -178.465 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.39 42.0 31.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.426 2.291 . . . . 0.0 115.176 167.634 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.2 -25.29 28.81 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 119.707 -1.87 . . . . 0.0 114.199 -178.449 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -93.77 114.22 26.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 -171.227 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.292 7.8 tt0 -82.28 140.78 33.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 169.1 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.56 135.75 40.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 130.576 3.551 . . . . 0.0 109.362 -174.159 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -104.5 -4.01 23.22 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.203 2.601 . . . . 0.0 109.113 -172.013 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.323 7.5 m-20 84.38 168.35 0.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.278 170.247 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.62 -16.89 36.93 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 123.812 0.695 . . . . 0.0 113.881 169.232 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -120.98 -171.69 2.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.976 2.111 . . . . 0.0 105.366 -171.05 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.261 7.0 p -111.66 167.66 10.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.233 -0.917 . . . . 0.0 110.894 -165.463 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.284 9.3 mp -56.32 -28.86 60.28 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 169.249 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -77.06 -34.33 57.11 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 116.572 -2.051 . . . . 0.0 114.489 179.087 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.64 -40.39 76.54 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 127.924 3.265 . . . . 0.0 113.143 -177.685 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -79.44 0.56 28.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 117.519 -3.238 . . . . 0.0 109.341 171.045 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.366 1.6 t-20 70.6 49.13 0.42 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 126.277 2.942 . . . . 0.0 115.647 169.903 . . . . . . . . 2 2 . 1 . 102 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -101.79 123.45 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 112.538 -2.119 . . . . 0.0 107.336 -174.736 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -111.72 -164.96 0.95 Allowed 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 124.96 1.413 . . . . 0.0 113.696 -168.104 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -69.97 114.72 8.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 119.44 -2.037 . . . . 0.0 107.619 174.611 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.312 5.7 tt0 89.4 12.3 0.07 Allowed 'General case' 0 C--O 1.236 0.374 1 O-C-N 115.915 -4.241 . . . . 0.0 112.746 167.307 . . . . . . . . 3 2 . 1 . 102 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -49.76 152.23 1.55 Allowed 'General case' 0 C--N 1.327 -0.381 0 O-C-N 117.661 -3.149 . . . . 0.0 112.179 167.953 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.1 m -116.15 130.54 56.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.637 167.928 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.92 123.56 46.05 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.078 1.751 . . . . 0.0 112.4 166.13 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -84.65 110.32 18.65 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 173.004 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.1 tp -89.2 103.76 16.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.727 2.411 . . . . 0.0 108.933 172.413 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 t -81.36 116.75 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 127.63 2.372 . . . . 0.0 109.292 163.502 . . . . . . . . 1 1 . 1 . 102 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 115.112 -2.375 . . . . 0.0 104.682 175.202 . . . . . . . . 0 0 . 1 . 103 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tmm? . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 . . . . . . . . . 0 0 . 1 . 103 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -94.01 154.31 17.72 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -174.665 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.461 HD13 HG21 ' A' ' 3' ' ' ILE . 4.8 pt -135.74 144.26 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 171.421 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -102.96 94.29 5.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 111.207 -2.724 . . . . 0.0 104.439 -179.235 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.4 t -80.88 112.68 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.598 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -96.14 127.91 42.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -170.142 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -95.49 136.83 35.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.317 2.247 . . . . 0.0 109.087 160.055 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.12 -32.33 71.65 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 113.871 -2.966 . . . . 0.0 112.575 166.997 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.276 33.1 p -76.37 -16.52 59.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 114.707 -2.568 . . . . 0.0 109.456 -178.805 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.36 48.15 0.09 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 117.052 -2.499 . . . . 0.0 113.665 123.301 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.304 0.6 OUTLIER -139.19 153.05 47.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.76 1.267 . . . . 0.0 108.84 164.555 . . . . . . . . 3 3 . 1 . 103 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -95.35 129.98 42.29 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.157 2.183 . . . . 0.0 107.03 164.585 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.2 mt -108.92 132.68 56.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 128.975 2.91 . . . . 0.0 106.322 177.625 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.5 m -93.78 126.33 38.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 167.133 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.87 138.17 50.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 125.944 2.028 . . . . 0.0 106.845 166.634 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.74 137.04 39.66 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 173.048 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 m -150.44 179.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.571 1 C-N-CA 132.866 4.467 . . . . 0.0 106.165 -166.779 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.262 48.4 mm-40 -130.89 159.35 71.77 Favored Pre-proline 0 N--CA 1.446 -0.658 0 C-N-CA 127.824 2.45 . . . . 0.0 105.345 155.167 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -61.47 -9.15 12.4 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.026 2.484 . . . . 0.0 116.82 179.543 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.269 26.4 p -88.58 -3.73 58.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.665 -1.16 . . . . 0.0 113.27 173.98 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.67 126.81 28.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.794 0.725 . . . . 0.0 110.457 171.147 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.398 4.7 p -67.05 155.07 39.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 173.775 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.4 -35.67 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 131.176 3.79 . . . . 0.0 107.629 171.395 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.46 -40.45 50.4 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 119.454 -2.029 . . . . 0.0 110.774 -174.204 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -56.56 -59.66 4.68 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 124.994 1.434 . . . . 0.0 113.419 168.38 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.321 96.6 t -51.72 -51.25 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 O-C-N 116.705 -3.747 . . . . 0.0 115.849 -177.387 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -48.8 -44.09 38.75 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 127.456 2.973 . . . . 0.0 116.433 169.927 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.24 -34.2 23.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 129.772 3.229 . . . . 0.0 110.361 -179.425 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -62.06 -33.54 74.58 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 125.853 1.971 . . . . 0.0 110.862 169.256 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.2 mt -63.95 -50.38 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 127.77 2.428 . . . . 0.0 113.239 165.965 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -57.91 -41.34 82.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.92 2.088 . . . . 0.0 112.856 -175.984 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -54.37 -26.22 28.89 Favored 'General case' 0 N--CA 1.447 -0.594 1 C-N-CA 131.811 4.045 . . . . 0.0 113.741 173.601 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -98.78 -62.25 1.26 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 120.645 1.566 . . . . 0.0 113.514 -178.874 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -106.78 -17.41 14.22 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 126.368 2.292 . . . . 0.0 114.265 -167.523 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.95 1.43 42.18 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 117.696 -3.127 . . . . 0.0 118.053 168.049 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mt -80.75 130.16 65.24 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 123.279 3.54 . . . . 0.0 115.511 -172.43 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.285 36.9 Cg_endo -68.3 135.37 33.95 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.996 2.464 . . . . 0.0 110.745 179.419 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -43.79 -40.63 11.36 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.532 2.821 . . . . 0.0 116.556 175.925 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -55.75 -30.28 60.97 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.698 1.199 . . . . 0.0 112.986 -176.139 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -101.15 -12.5 18.72 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 128.314 2.646 . . . . 0.0 115.216 -171.606 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.26 73.3 mt-30 -81.14 152.61 27.69 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 111.932 -2.394 . . . . 0.0 108.419 179.413 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -132.45 126.83 33.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.847 2.459 . . . . 0.0 108.246 157.13 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 mt -115.96 131.2 57.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 177.684 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.72 143.11 32.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 110.789 -2.914 . . . . 0.0 108.085 -173.031 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -139.38 118.02 12.26 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.566 2.347 . . . . 0.0 109.011 160.083 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.65 48.87 6.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 128.36 3.538 . . . . 0.0 109.688 170.152 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.66 -19.94 51.14 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.578 1.085 . . . . 0.0 112.019 166.631 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.262 74.5 mttt -96.83 144.81 26.44 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.083 1.942 . . . . 0.0 114.447 -174.568 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.319 77.8 mm-40 -76.88 169.1 18.93 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 116.895 -1.922 . . . . 0.0 109.131 160.908 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.25 43.4 mt -120.34 119.35 32.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 117.84 -3.038 . . . . 0.0 106.141 -170.571 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -86.08 146.65 26.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 123.194 1.473 . . . . 0.0 113.274 -170.243 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -68.44 122.39 18.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 111.97 -2.377 . . . . 0.0 104.916 -175.403 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.07 9.25 10.83 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 127.581 3.051 . . . . 0.0 119.336 179.698 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.277 90.2 mtt-85 -132.35 179.34 6.18 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.953 2.101 . . . . 0.0 107.244 -172.579 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -126.46 178.62 5.75 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.113 -171.184 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -73.62 -28.93 62.06 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 127.45 2.969 . . . . 0.0 110.909 175.389 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.1 t -59.81 -27.58 66.71 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 129.521 3.129 . . . . 0.0 110.692 172.49 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.89 -44.16 27.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.748 2.419 . . . . 0.0 108.796 178.528 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -99.99 20.93 13.5 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -179.622 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 3.9 t-20 83.7 25.38 0.11 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 119.147 3.017 . . . . 0.0 119.147 164.169 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mt -104.04 81.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -172.679 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -92.28 -23.49 19.28 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 129.09 2.956 . . . . 0.0 114.491 -170.362 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -168.39 130.13 1.36 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.881 1.672 . . . . 0.0 109.535 -170.881 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 7.99 86.95 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 130.906 3.683 . . . . 0.0 116.944 167.049 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.284 5.3 t -143.98 -160.52 1.13 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 115.115 -2.374 . . . . 0.0 107.301 173.788 . . . . . . . . 2 2 . 1 . 103 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.5 m -125.7 132.07 52.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 122.074 2.215 . . . . 0.0 106.334 -167.265 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.77 143.54 29.01 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 156.373 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -89.96 128.84 36.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 119.521 -1.987 . . . . 0.0 109.114 166.904 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 tp -92.45 117.67 30.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 131.69 3.996 . . . . 0.0 103.511 176.833 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.5 143.69 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -176.968 . . . . . . . . 1 1 . 1 . 103 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.625 0 O-C-N 119.3 -2.125 . . . . 0.0 111.044 -171.097 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ptt? . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 . . . . . . . . . 0 0 . 1 . 104 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -82.71 152.32 25.84 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 115.208 -2.33 . . . . 0.0 112.678 -179.701 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.8 pt -139.82 149.5 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 121.777 2.08 . . . . 0.0 109.449 162.539 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -105.27 126.22 51.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 -172.355 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.272 93.0 t -99.4 112.14 30.9 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 C-N-CA 127.979 2.511 . . . . 0.0 108.076 171.929 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -70.32 148.8 48.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 111.565 -2.561 . . . . 0.0 111.314 166.352 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -120.75 -167.07 1.41 Allowed 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.083 -1.635 . . . . 0.0 109.534 176.442 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.14 42.17 1.53 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 164.294 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -139.74 26.54 2.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.715 2.406 . . . . 0.0 107.786 176.985 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.98 16.52 35.4 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 116.865 -3.647 . . . . 0.0 117.883 152.997 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -154.49 171.73 18.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 124.427 2.061 . . . . 0.0 110.116 177.664 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.5 m -112.89 127.57 56.23 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 131.313 3.845 . . . . 0.0 108.918 175.887 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.439 HD13 HG21 ' A' ' 13' ' ' ILE . 87.3 mt -106.47 129.37 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 O-C-N 126.78 2.55 . . . . 0.0 107.011 175.018 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.1 m -107.04 136.9 46.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 102.411 -3.181 . . . . 0.0 102.411 169.829 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tp -129.57 160.83 32.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 128.314 2.645 . . . . 0.0 105.496 -179.665 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -102.19 139.27 38.03 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 130.653 3.581 . . . . 0.0 103.19 172.968 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -151.03 166.36 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 119.314 -2.116 . . . . 0.0 108.644 -178.903 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -138.27 142.71 36.16 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 126.152 1.781 . . . . 0.0 108.469 -173.189 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.343 11.5 Cg_exo -50.72 -34.83 45.59 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 N-CA-C 121.369 3.565 . . . . 0.0 121.369 -179.887 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.5 p -93.43 -2.27 54.77 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 127.47 2.981 . . . . 0.0 112.134 -174.24 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -74.33 141.14 45.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 125.868 2.747 . . . . 0.0 109.091 170.327 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 p -76.32 172.81 12.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 119.221 -2.174 . . . . 0.0 111.408 175.933 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -53.15 -46.96 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 C-N-CA 133.875 4.87 . . . . 0.0 113.397 171.097 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -47.47 -42.16 22.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 113.295 -3.24 . . . . 0.0 112.33 170.089 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.281 4.7 m120 -59.14 -32.13 69.59 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.536 2.734 . . . . 0.0 116.135 175.392 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.79 -54.62 25.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 120.121 -1.612 . . . . 0.0 110.769 165.419 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -71.81 -23.88 61.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 125.675 2.655 . . . . 0.0 113.637 -171.952 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.6 -46.98 51.55 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 118.785 -2.447 . . . . 0.0 110.043 173.534 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.68 -27.91 60.61 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.729 2.412 . . . . 0.0 109.757 -176.487 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.36 -47.92 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 O-C-N 118.933 -2.355 . . . . 0.0 106.463 169.77 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -50.86 -51.86 47.29 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 124.426 3.284 . . . . 0.0 107.851 175.924 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.301 5.1 t70 -46.56 -50.03 17.91 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 179.094 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -83.64 -48.99 9.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 128.905 3.878 . . . . 0.0 108.55 -173.195 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -106.26 -14.74 15.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 123.493 2.861 . . . . 0.0 110.012 -161.754 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.21 0.99 84.63 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 129.851 3.595 . . . . 0.0 118.976 -178.623 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -83.86 126.42 70.58 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 119.855 1.827 . . . . 0.0 111.817 -165.827 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.09 145.92 31.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 O-C-N 124.245 1.655 . . . . 0.0 110.394 -175.063 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.27 38.0 Cg_endo -72.94 -16.23 25.93 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.494 3.463 . . . . 0.0 119.823 -163.6 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -72.07 -26.73 62.28 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 125.461 1.726 . . . . 0.0 110.337 174.335 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -83.02 -30.24 28.26 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.41 1.484 . . . . 0.0 112.507 -174.355 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -80.87 142.54 33.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 129.459 3.104 . . . . 0.0 109.375 175.747 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -145.62 119.36 9.22 Favored 'General case' 0 N--CA 1.449 -0.502 1 N-CA-C 99.217 -4.364 . . . . 0.0 99.217 175.733 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.14 124.53 29.95 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 114.64 -2.6 . . . . 0.0 115.81 177.062 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mm -102.17 129.13 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 101.197 -3.631 . . . . 0.0 101.197 173.552 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -137.31 125.98 23.81 Favored 'General case' 0 N--CA 1.451 -0.405 1 N-CA-C 97.139 -5.134 . . . . 0.0 97.139 175.607 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.75 24.18 14.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.864 2.866 . . . . 0.0 114.822 160.577 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.81 -25.92 25.8 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.873 -1.515 . . . . 0.0 112.566 -175.349 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -99.29 164.43 12.13 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 128.079 2.552 . . . . 0.0 109.159 -171.577 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.28 7.3 mt-30 -118.64 145.79 45.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.537 1.935 . . . . 0.0 106.339 166.445 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.44 139.26 30.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.77 -166.58 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.267 7.7 tp10 -85.44 140.34 30.8 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 131.671 3.989 . . . . 0.0 107.174 167.581 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -73.98 136.06 43.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 114.134 -2.841 . . . . 0.0 112.917 -177.667 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.01 -14.16 26.37 Favored Glycine 0 CA--C 1.535 1.327 1 CA-C-N 127.707 4.776 . . . . 0.0 113.775 166.028 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.295 3.1 mpt_? -81.06 161.05 24.34 Favored 'General case' 0 C--N 1.322 -0.624 1 O-C-N 130.925 4.544 . . . . 0.0 105.553 176.385 . . . . . . . . 3 2 . 1 . 104 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -89.59 172.69 8.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 125.282 1.614 . . . . 0.0 109.056 -177.457 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mt -63.04 -52.64 62.07 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 128.932 2.893 . . . . 0.0 110.443 169.961 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.0 p -41.96 -41.27 2.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 117.222 2.305 . . . . 0.0 117.222 162.501 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -62.14 -24.29 67.08 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 118.317 -2.739 . . . . 0.0 116.704 177.34 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -99.52 -6.86 26.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.738 3.215 . . . . 0.0 117.78 179.387 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.308 0.7 OUTLIER 69.85 48.13 0.58 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 130.491 3.517 . . . . 0.0 113.413 174.509 . . . . . . . . 3 3 . 1 . 104 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -93.25 139.69 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -172.998 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.274 7.0 tp60 -148.97 156.36 42.16 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 112.334 -2.212 . . . . 0.0 107.791 -176.18 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.374 23.9 ttpp -31.98 114.43 0.14 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.553 2.741 . . . . 0.0 113.541 -179.974 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 83.4 21.65 0.17 Allowed 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 128.148 3.405 . . . . 0.0 115.007 176.357 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 m -65.65 134.67 53.75 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.688 171.77 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.406 ' C ' HD12 ' A' ' 67' ' ' LEU . 85.1 m -94.71 122.4 37.28 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -178.989 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.406 HD12 ' C ' ' A' ' 66' ' ' THR . 1.7 mp -122.77 160.24 26.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.227 1.011 . . . . 0.0 109.398 166.21 . . . . . . . . 2 2 . 1 . 104 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -127.88 124.36 37.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 118.493 -2.63 . . . . 0.0 111.979 -175.547 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.4 tp -82.57 101.45 10.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 115.337 -2.268 . . . . 0.0 111.086 -179.861 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.31 151.7 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 O-C-N 125.42 1.7 . . . . 0.0 107.326 163.545 . . . . . . . . 1 1 . 1 . 104 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 126.633 1.973 . . . . 0.0 111.3 178.77 . . . . . . . . 0 0 . 1 . 105 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptt? . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 . . . . . . . . . 0 0 . 1 . 105 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -60.7 125.16 22.66 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 117.553 -1.213 . . . . 0.0 113.248 174.231 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.365 26.8 pt -128.91 166.48 26.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 O-C-N 125.209 1.568 . . . . 0.0 112.127 162.253 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -112.38 154.11 26.26 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.567 2.747 . . . . 0.0 106.916 176.674 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.87 130.66 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 168.682 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -101.72 128.32 48.1 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 122.835 2.561 . . . . 0.0 109.285 167.708 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.6 p -91.59 163.75 14.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.855 2.462 . . . . 0.0 108.386 -173.19 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.41 -47.71 47.7 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 128.286 2.634 . . . . 0.0 109.076 176.22 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.9 p -68.58 -16.94 64.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 128.011 2.524 . . . . 0.0 111.575 -174.743 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.01 -14.06 37.46 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 125.044 3.566 . . . . 0.0 115.498 169.652 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -69.73 147.26 50.75 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.794 1.637 . . . . 0.0 115.074 172.481 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -93.28 137.8 32.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.597 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.3 mt -119.68 137.88 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 170.269 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.4 t -100.86 142.0 32.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.328 1.851 . . . . 0.0 109.941 166.198 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 mt -135.73 142.93 45.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 171.134 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -88.03 115.48 25.54 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 161.787 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 t -123.93 132.41 71.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 127.75 2.42 . . . . 0.0 108.583 -174.985 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -91.3 148.6 38.05 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 114.866 -2.492 . . . . 0.0 110.0 -172.811 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -43.17 -46.0 9.4 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 123.596 2.864 . . . . 0.0 114.955 171.957 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -91.99 15.68 12.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.095 0.861 . . . . 0.0 112.624 -178.428 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -78.46 132.98 37.5 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 118.601 -2.562 . . . . 0.0 105.241 162.818 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.8 p -84.97 179.32 7.32 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 109.86 177.564 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.323 1.1 mp -71.15 -37.36 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 124.192 1.949 . . . . 0.0 108.989 -178.062 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -57.1 -39.01 74.21 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 117.456 -3.278 . . . . 0.0 114.332 173.03 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -53.17 -50.85 63.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 126.007 2.067 . . . . 0.0 115.158 177.739 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 t -65.85 -48.03 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 1 C-N-CA 132.377 4.271 . . . . 0.0 111.094 171.123 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -64.86 -35.94 82.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 115.998 -1.953 . . . . 0.0 111.731 179.11 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.83 -37.03 70.67 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.035 2.134 . . . . 0.0 114.164 174.987 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -84.51 -29.74 25.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 111.068 -2.787 . . . . 0.0 103.67 -170.676 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.8 mt -73.91 -46.24 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 121.503 1.956 . . . . 0.0 112.562 165.368 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -52.98 -48.42 67.46 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 129.532 3.133 . . . . 0.0 110.557 -178.571 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -56.28 -42.63 77.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 169.854 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -86.8 -55.06 4.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -175.867 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -100.01 -18.53 16.99 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 129.532 3.133 . . . . 0.0 113.289 -171.583 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.09 -1.51 70.44 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 114.829 0.692 . . . . 0.0 114.829 155.641 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.63 136.1 71.23 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-O 115.252 -2.309 . . . . 0.0 112.845 173.43 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -70.29 166.32 28.64 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 O-C-N 125.513 2.323 . . . . 0.0 116.449 173.421 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.42 -33.21 5.65 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 CA-C-O 114.901 -2.208 . . . . 0.0 111.228 -166.666 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.94 -21.8 58.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 123.712 2.96 . . . . 0.0 113.241 173.574 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -111.14 -1.08 16.33 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 128.497 2.719 . . . . 0.0 112.078 -169.454 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -96.83 109.24 21.97 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 127.717 2.407 . . . . 0.0 107.145 172.756 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -110.33 89.2 2.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -175.816 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.304 12.8 mt -79.07 127.9 32.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 129.597 3.159 . . . . 0.0 109.221 -179.918 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 8.2 mt -126.2 135.41 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 O-C-N 126.996 2.685 . . . . 0.0 113.561 -175.466 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -147.35 124.3 11.33 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.213 2.205 . . . . 0.0 112.112 172.568 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.36 44.08 9.94 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.882 2.073 . . . . 0.0 111.586 169.009 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.99 4.81 64.65 Favored Glycine 0 CA--C 1.537 1.407 1 CA-C-O 111.949 -4.806 . . . . 0.0 110.393 164.449 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -133.67 141.46 47.6 Favored 'General case' 0 N--CA 1.448 -0.565 1 O-C-N 131.147 4.675 . . . . 0.0 107.509 -170.932 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.408 HE22 ' CD ' ' A' ' 51' ' ' GLU . 4.6 tm0? -70.05 127.67 33.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 123.927 1.822 . . . . 0.0 108.957 160.381 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -83.29 125.29 31.46 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 171.068 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' CD ' HE22 ' A' ' 49' ' ' GLN . 6.2 tp10 -90.33 136.69 32.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.754 1.622 . . . . 0.0 110.008 -166.163 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -53.83 99.58 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.604 1 C-N-CA 132.29 4.236 . . . . 0.0 117.209 172.207 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.13 -3.46 6.81 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 119.221 2.448 . . . . 0.0 119.221 169.044 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -86.84 -167.66 1.96 Allowed 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 118.824 -2.574 . . . . 0.0 104.463 172.611 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 69.5 p -106.7 165.77 11.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.58 178.321 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -27.77 69.57 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 123.504 1.621 . . . . 0.0 114.626 169.013 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -67.52 -36.1 80.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.454 -1.703 . . . . 0.0 115.042 172.286 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.11 -21.41 66.17 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.702 1.601 . . . . 0.0 114.426 179.235 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -112.52 -2.17 14.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 116.868 2.174 . . . . 0.0 116.868 -167.264 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 44.28 46.6 7.66 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 171.343 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -83.98 -35.26 10.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 128.032 3.333 . . . . 0.0 113.905 -173.922 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 75.51 152.28 0.13 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 129.317 3.047 . . . . 0.0 113.357 164.413 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.95 135.88 35.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 127.031 2.133 . . . . 0.0 113.992 173.461 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.344 9.2 tt0 89.05 -1.38 0.37 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 111.311 -2.677 . . . . 0.0 111.479 173.421 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -85.77 162.69 18.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 117.863 -3.023 . . . . 0.0 109.348 -171.082 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.268 36.9 m -121.5 122.83 40.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.176 2.59 . . . . 0.0 106.641 -171.864 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.299 72.9 mt -89.44 145.36 25.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 119.424 -2.047 . . . . 0.0 107.315 167.318 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.276 74.2 m-70 -100.72 121.39 41.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.447 2.699 . . . . 0.0 108.231 174.114 . . . . . . . . 2 2 . 1 . 105 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.1 tp -99.21 118.29 35.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 126.605 2.441 . . . . 0.0 105.277 -179.262 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.48 135.06 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.0 . . . . . . . . 1 1 . 1 . 105 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 112.99 -3.386 . . . . 0.0 107.312 169.68 . . . . . . . . 0 0 . 1 . 106 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 117.566 -1.206 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 106 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.258 77.4 mm-40 -115.7 129.35 56.44 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.431 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.8 pt -100.4 155.14 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 116.866 -1.54 . . . . 0.0 111.066 165.608 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -103.71 121.66 43.43 Favored 'General case' 0 C--O 1.219 -0.532 0 O-C-N 127.395 2.934 . . . . 0.0 105.168 178.16 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 t -115.22 123.59 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 117.213 -3.43 . . . . 0.0 107.886 -177.629 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -119.57 99.66 6.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.599 -1.313 . . . . 0.0 113.294 -173.709 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.2 p -85.04 161.37 19.74 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 119.788 -1.82 . . . . 0.0 112.62 -174.592 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.386 0.0 OUTLIER -17.39 -72.78 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 1 C-N-CA 133.592 4.757 . . . . 0.0 119.711 -172.382 . . . . . . . . 4 3 . 1 . 106 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.0 p -61.21 -10.28 6.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.469 -1.696 . . . . 0.0 114.073 171.827 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.67 -5.17 34.83 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 127.222 3.679 . . . . 0.0 117.64 176.673 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.03 110.77 1.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 129.071 2.948 . . . . 0.0 108.678 -177.894 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.1 m -99.06 139.24 35.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 127.382 2.926 . . . . 0.0 107.559 -161.519 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.4 mt -123.23 141.46 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 177.387 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 m -98.51 105.88 18.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 127.994 3.309 . . . . 0.0 110.054 153.198 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tp -99.07 133.62 43.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 -179.365 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.266 83.6 tt0 -86.27 141.57 29.18 Favored 'General case' 0 N--CA 1.45 -0.427 1 O-C-N 129.363 4.165 . . . . 0.0 106.561 174.712 . . . . . . . . 3 2 . 1 . 106 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.29 179.24 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 126.691 3.138 . . . . 0.0 109.562 174.396 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -107.79 152.99 41.8 Favored Pre-proline 0 N--CA 1.45 -0.458 0 O-C-N 116.793 -3.692 . . . . 0.0 106.491 148.578 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.5 -25.19 25.45 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 O-C-N 116.714 -2.308 . . . . 0.0 113.294 -176.575 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.2 p -77.51 -0.81 27.6 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 129.052 2.941 . . . . 0.0 114.899 174.069 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -77.34 148.96 35.33 Favored 'General case' 0 C--O 1.22 -0.457 0 O-C-N 126.256 2.222 . . . . 0.0 110.226 173.279 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -109.16 144.33 37.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 111.437 -2.619 . . . . 0.0 105.581 -163.447 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -54.07 -30.29 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 1 CA-C-O 110.342 -4.647 . . . . 0.0 115.005 -171.022 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -65.73 -33.83 76.77 Favored 'General case' 0 N--CA 1.451 -0.401 1 CA-C-N 126.006 4.003 . . . . 0.0 113.067 172.532 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -80.66 -16.42 54.07 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 126.824 2.578 . . . . 0.0 107.577 -175.741 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.25 -53.55 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 127.216 2.206 . . . . 0.0 110.649 171.244 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -60.71 -37.83 83.02 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.278 1.831 . . . . 0.0 112.26 176.611 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.59 -10.08 59.13 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 115.236 -2.316 . . . . 0.0 109.88 178.898 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -91.34 -36.93 13.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.55 2.74 . . . . 0.0 108.996 178.925 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.4 mt -65.54 -40.17 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 128.785 2.834 . . . . 0.0 108.718 170.791 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.53 -47.43 66.71 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.32 -2.737 . . . . 0.0 116.282 167.061 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.58 -41.42 92.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 120.937 1.699 . . . . 0.0 115.171 172.175 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -78.01 -37.17 47.69 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.675 1.234 . . . . 0.0 112.837 -176.726 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.35 28.8 mm-40 -124.37 -33.72 3.0 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 -169.197 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.97 39.71 1.95 Allowed Glycine 0 CA--C 1.527 0.841 1 O-C-N 115.279 -4.638 . . . . 0.0 116.127 162.709 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 mt -123.36 135.72 26.34 Favored Pre-proline 0 N--CA 1.451 -0.424 0 O-C-N 118.316 -2.873 . . . . 0.0 108.592 179.159 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 71.5 Cg_endo -76.89 137.16 17.38 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 O-C-N 125.42 2.274 . . . . 0.0 113.249 -177.967 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.2 Cg_exo -44.9 -30.24 4.3 Favored 'Trans proline' 0 N--CA 1.446 -1.292 1 C-N-CA 126.161 4.574 . . . . 0.0 118.903 -177.204 . . . . . . . . 3 3 . 1 . 106 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.2 -10.83 56.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -168.151 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -98.21 -3.19 38.03 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 129.476 3.111 . . . . 0.0 112.596 175.639 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.255 64.6 mt-30 -107.94 132.9 53.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 123.63 2.923 . . . . 0.0 104.332 -172.191 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -113.96 129.95 56.56 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 119.921 -1.737 . . . . 0.0 109.842 149.965 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.5 mt -101.36 120.58 40.48 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.586 1.955 . . . . 0.0 108.128 170.262 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mm -97.63 131.59 44.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 113.076 -3.345 . . . . 0.0 109.832 172.959 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -111.89 136.38 51.27 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 124.638 3.381 . . . . 0.0 104.795 152.897 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.0 -99.95 0.1 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.205 1.402 . . . . 0.0 112.228 -169.98 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.84 25.08 3.77 Favored Glycine 0 CA--C 1.523 0.558 1 C-N-CA 131.581 4.42 . . . . 0.0 113.341 159.646 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -93.82 111.35 23.03 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 118.144 -2.974 . . . . 0.0 107.563 175.82 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -76.17 97.17 4.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 127.693 3.121 . . . . 0.0 112.857 175.818 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.81 127.92 33.51 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 126.819 2.575 . . . . 0.0 113.234 -171.384 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -104.77 132.08 51.46 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 131.358 3.863 . . . . 0.0 113.748 -169.915 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.6 123.01 17.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 130.775 3.63 . . . . 0.0 109.116 -179.128 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.72 -6.87 20.12 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 120.359 1.436 . . . . 0.0 111.475 -177.1 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -122.16 173.62 7.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 170.821 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -115.37 175.63 5.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 117.894 -3.004 . . . . 0.0 113.635 -168.886 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.1 mt -75.6 -30.3 59.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 123.258 1.504 . . . . 0.0 111.864 172.401 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -58.98 -36.2 74.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.905 1.336 . . . . 0.0 112.288 170.727 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -69.9 -41.98 74.0 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 119.252 -2.155 . . . . 0.0 108.788 -174.179 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -84.85 10.89 10.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 175.552 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 58.96 35.58 24.16 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 129.058 2.943 . . . . 0.0 111.418 172.051 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.2 mt -88.78 142.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 -173.816 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.304 3.4 pm0 -137.63 -166.22 1.91 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.811 2.045 . . . . 0.0 114.104 -162.677 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -60.81 131.83 51.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 128.861 2.864 . . . . 0.0 110.392 174.255 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.397 0.8 OUTLIER 86.36 17.06 0.11 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 127.614 3.578 . . . . 0.0 115.648 175.926 . . . . . . . . 3 3 . 1 . 106 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.8 p -83.58 127.94 34.13 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 118.216 -2.803 . . . . 0.0 112.099 -178.346 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.1 m -107.1 114.65 28.86 Favored 'General case' 0 N--CA 1.445 -0.716 1 C-N-CA 132.383 4.273 . . . . 0.0 108.697 172.724 . . . . . . . . 2 2 . 1 . 106 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -100.48 130.26 46.54 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.627 1.571 . . . . 0.0 109.016 174.895 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -102.3 127.97 49.05 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 128.852 2.861 . . . . 0.0 107.155 -170.399 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -93.69 150.72 20.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 122.22 2.282 . . . . 0.0 105.889 175.321 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.4 p -141.32 141.61 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 130.088 3.355 . . . . 0.0 107.37 163.894 . . . . . . . . 1 1 . 1 . 106 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.448 -0.559 0 CA-C-N 121.092 1.769 . . . . 0.0 110.615 175.358 . . . . . . . . 0 0 . 1 . 107 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 123.465 1.602 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 107 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -101.32 134.45 44.36 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.922 -1.111 . . . . 0.0 113.823 163.753 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.312 2.1 pp -124.82 146.96 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.774 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -105.73 133.83 49.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 123.797 1.76 . . . . 0.0 108.898 177.004 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.09 133.97 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 174.632 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -108.38 122.24 46.6 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 111.848 -2.433 . . . . 0.0 109.843 178.026 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -80.42 153.25 28.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 123.557 1.646 . . . . 0.0 110.161 179.627 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.36 -25.66 63.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.45 2.3 . . . . 0.0 112.383 -174.738 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.3 p -100.63 19.64 16.59 Favored 'General case' 0 CA--C 1.538 0.494 1 C-N-CA 132.943 4.497 . . . . 0.0 115.692 173.374 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.93 21.61 11.83 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-O 115.136 -3.036 . . . . 0.0 117.535 137.457 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.353 55.2 mttt -103.78 171.11 7.53 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 128.356 2.663 . . . . 0.0 115.966 169.623 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -128.22 103.92 7.45 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 130.366 3.466 . . . . 0.0 108.92 169.931 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.4 mm -81.11 117.51 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 128.629 2.771 . . . . 0.0 112.469 177.469 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.269 22.9 m -93.97 105.52 17.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.102 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -88.78 159.33 17.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 172.183 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -107.35 133.89 51.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 124.422 2.058 . . . . 0.0 107.224 165.253 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 m -139.51 -179.09 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 119.895 -1.753 . . . . 0.0 110.795 178.537 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -140.05 155.11 70.86 Favored Pre-proline 0 N--CA 1.451 -0.407 0 C-N-CA 130.208 3.403 . . . . 0.0 104.195 171.955 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.47 -38.33 53.22 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-O 115.538 -1.942 . . . . 0.0 116.39 -175.851 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -77.75 -9.42 59.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 124.542 1.151 . . . . 0.0 111.494 -170.877 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.67 135.9 52.09 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 125.041 2.353 . . . . 0.0 109.743 179.304 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.0 p -78.38 153.94 31.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 129.737 3.215 . . . . 0.0 111.257 -168.22 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.3 -17.59 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.33 -0.856 . . . . 0.0 108.934 -178.54 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -78.04 -44.15 27.26 Favored 'General case' 0 N--CA 1.448 -0.549 1 O-C-N 116.254 -4.029 . . . . 0.0 108.021 -179.506 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -62.86 -50.26 71.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 112.93 -3.414 . . . . 0.0 114.552 166.351 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 22' ' ' THR . 70.9 t -52.99 -40.65 37.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 121.828 2.104 . . . . 0.0 111.375 177.032 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -42.04 -35.78 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 115.98 1.845 . . . . 0.0 115.98 166.182 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.73 -28.06 14.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 120.363 1.438 . . . . 0.0 108.69 -177.207 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -60.92 -31.69 71.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 117.887 -3.008 . . . . 0.0 118.29 168.264 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.285 1.5 tt -70.87 -40.76 76.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 167.993 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.26 -36.41 75.45 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 175.54 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -74.19 -10.69 59.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.902 0.774 . . . . 0.0 112.626 -170.928 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -77.7 0.22 Allowed 'General case' 0 C--O 1.235 0.338 1 C-N-CA 132.385 4.274 . . . . 0.0 116.603 159.699 . . . . . . . . 3 3 . 1 . 107 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -98.54 -3.38 36.56 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.265 -0.897 . . . . 0.0 113.259 -162.777 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.01 7.95 86.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 117.906 -2.092 . . . . 0.0 117.36 171.14 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.5 mt -74.71 120.65 82.58 Favored Pre-proline 0 N--CA 1.454 -0.237 1 C-N-CA 132.704 4.402 . . . . 0.0 109.206 178.65 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -74.51 141.0 27.61 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 CA-C-O 115.164 -2.098 . . . . 0.0 112.989 -175.203 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.23 -7.14 20.47 Favored 'Trans proline' 0 N--CA 1.447 -1.264 1 C-N-CA 127.443 5.429 . . . . 0.0 116.531 -178.408 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -74.34 -9.82 58.98 Favored 'General case' 0 N--CA 1.446 -0.644 1 O-C-N 115.13 -4.731 . . . . 0.0 113.424 168.779 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -119.47 -8.49 10.01 Favored 'General case' 0 C--N 1.323 -0.56 1 C-N-CA 134.56 5.144 . . . . 0.0 114.146 -175.468 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 11.4 mt-30 -90.35 152.79 20.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 119.989 -1.694 . . . . 0.0 111.598 168.638 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttp-105 -128.05 122.09 31.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 115.028 -2.415 . . . . 0.0 109.849 156.794 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.522 ' HB3' HD13 ' A' ' 50' ' ' LEU . 3.0 mm? -80.84 115.51 20.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.635 1.561 . . . . 0.0 106.949 172.117 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.3 mt -116.26 134.85 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 116.418 -1.754 . . . . 0.0 106.7 167.299 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -88.29 -49.88 6.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.277 1.399 . . . . 0.0 108.299 -175.653 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.51 -44.32 0.1 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.221 -1.371 . . . . 0.0 114.566 -177.213 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.3 -11.21 4.75 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 118.685 2.234 . . . . 0.0 118.685 152.443 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -143.18 160.22 40.85 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.961 1.304 . . . . 0.0 112.686 -161.85 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -78.96 142.87 36.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 125.462 1.726 . . . . 0.0 113.646 -159.366 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.522 HD13 ' HB3' ' A' ' 43' ' ' LEU . 6.8 mp -85.83 109.32 18.61 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.174 -3.454 . . . . 0.0 106.652 170.496 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -71.44 128.55 36.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.592 2.757 . . . . 0.0 111.126 -175.438 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -52.68 122.42 9.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 124.836 2.255 . . . . 0.0 112.647 166.328 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.1 19.48 5.92 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 118.683 -2.51 . . . . 0.0 110.815 173.848 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.323 26.8 mtt-85 -127.21 170.89 11.94 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 130.643 3.577 . . . . 0.0 113.992 -179.652 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -118.03 162.9 17.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 130.051 3.341 . . . . 0.0 117.893 174.939 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.69 -41.69 56.12 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 122.659 2.481 . . . . 0.0 113.012 173.974 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 t -60.82 -22.24 63.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 118.502 2.778 . . . . 0.0 118.502 -178.739 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -69.23 -37.93 78.25 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 120.792 -1.192 . . . . 0.0 113.677 168.999 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -98.54 -1.38 41.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.972 2.109 . . . . 0.0 112.564 -175.264 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 74.31 14.19 3.74 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 129.454 3.102 . . . . 0.0 112.149 168.217 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.267 90.1 mt -55.41 125.45 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 124.082 0.953 . . . . 0.0 113.102 178.743 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -131.89 167.49 19.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.794 2.838 . . . . 0.0 112.271 -176.191 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.326 41.3 pttt -34.57 119.03 0.43 Allowed 'General case' 0 N--CA 1.447 -0.605 1 C-N-CA 132.999 4.52 . . . . 0.0 116.114 -178.122 . . . . . . . . 3 2 . 1 . 107 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 63.94 25.44 13.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 179.507 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 m -70.46 121.41 17.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 115.305 -2.283 . . . . 0.0 107.752 160.189 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -95.87 119.37 34.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 125.725 1.891 . . . . 0.0 107.532 174.896 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.21 147.0 26.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 128.683 2.793 . . . . 0.0 105.574 179.858 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -95.49 154.37 17.24 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 101.374 -3.565 . . . . 0.0 101.374 174.557 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.82 114.55 20.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 125.37 2.51 . . . . 0.0 112.875 161.35 . . . . . . . . 2 2 . 1 . 107 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.7 t -79.86 152.47 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 129.905 3.282 . . . . 0.0 111.391 165.724 . . . . . . . . 1 1 . 1 . 107 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 124.022 1.868 . . . . 0.0 106.848 -174.062 . . . . . . . . 0 0 . 1 . 108 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptt? . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 . . . . . . . . . 0 0 . 1 . 108 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -86.5 157.4 19.79 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 124.404 1.065 . . . . 0.0 110.487 166.294 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.24 158.64 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 128.504 2.722 . . . . 0.0 106.531 155.142 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -113.54 138.13 50.59 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.694 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.4 115.75 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 1 C-N-CA 133.857 4.863 . . . . 0.0 107.738 170.08 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -84.56 135.32 34.26 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.563 1.545 . . . . 0.0 108.863 170.997 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -82.55 169.08 16.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 126.93 2.644 . . . . 0.0 108.118 158.615 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.99 -21.25 24.94 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.062 2.145 . . . . 0.0 109.569 178.848 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 p -68.9 -30.92 69.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 116.329 -3.982 . . . . 0.0 114.764 163.285 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.11 5.96 5.5 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 125.723 3.874 . . . . 0.0 113.639 161.653 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -88.85 130.32 35.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 117.79 -3.182 . . . . 0.0 107.391 175.353 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.8 m -89.17 128.52 35.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 124.962 2.315 . . . . 0.0 107.85 160.997 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.71 135.31 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 1 O-C-N 114.751 -4.968 . . . . 0.0 103.004 173.836 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.4 m -99.9 138.1 37.44 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 127.926 3.266 . . . . 0.0 104.023 176.18 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.441 HD13 HG13 ' A' ' 26' ' ' VAL . 53.9 mt -131.28 142.38 50.11 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.652 1.981 . . . . 0.0 110.432 178.005 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -124.5 110.6 14.68 Favored 'General case' 0 C--N 1.322 -0.622 2 O-C-N 115.748 -4.345 . . . . 0.0 110.35 -170.601 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.44 158.82 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 110.424 -3.08 . . . . 0.0 114.485 -163.022 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -96.39 153.5 38.91 Favored Pre-proline 0 N--CA 1.447 -0.598 0 O-C-N 127.53 3.019 . . . . 0.0 106.946 160.334 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -76.46 -6.66 17.27 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 118.72 2.546 . . . . 0.0 118.72 -170.616 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 m -94.44 7.14 46.57 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.484 1.514 . . . . 0.0 107.624 174.405 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.435 ' CG ' HD22 ' A' ' 25' ' ' ASN . 16.4 t0 -80.95 137.37 36.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 116.986 -3.571 . . . . 0.0 109.76 171.829 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -92.13 149.41 21.5 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 118.185 -2.822 . . . . 0.0 106.839 -156.351 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mp -46.86 -31.92 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 127.684 2.394 . . . . 0.0 114.569 169.673 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.27 -28.29 66.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.495 -1.378 . . . . 0.0 111.342 179.676 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.435 HD22 ' CG ' ' A' ' 21' ' ' ASP . 63.6 t30 -81.32 -33.82 32.28 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 119.534 -1.979 . . . . 0.0 114.42 170.451 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.441 HG13 HD13 ' A' ' 15' ' ' LEU 0.301 39.5 t -59.24 -44.98 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 116.592 -1.67 . . . . 0.0 108.518 170.117 . . . . . . . . 3 3 . 1 . 108 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HA ' HD12 ' A' ' 30' ' ' ILE . 69.9 mttt -50.66 -38.74 48.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.176 2.658 . . . . 0.0 118.176 172.793 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.9 -23.89 31.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 123.623 0.577 . . . . 0.0 112.096 -168.507 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 30.9 mttm -73.08 -29.43 62.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 118.96 -2.338 . . . . 0.0 111.698 175.441 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 27' ' ' LYS . 62.8 mt -70.64 -52.69 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 129.512 3.125 . . . . 0.0 105.943 178.301 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.372 1.1 tp-100 -34.23 -45.24 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 1 O-C-N 115.008 -4.807 . . . . 0.0 119.386 162.088 . . . . . . . . 3 2 . 1 . 108 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -73.71 -44.96 54.99 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 131.289 3.836 . . . . 0.0 109.953 -178.584 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -74.02 -47.35 37.56 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 119.833 3.272 . . . . 0.0 119.833 -177.275 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -135.6 11.8 3.45 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 117.906 -1.045 . . . . 0.0 113.701 -177.205 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.71 -8.38 75.74 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 157.485 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.6 mt -58.71 131.74 85.97 Favored Pre-proline 0 N--CA 1.449 -0.497 1 C-N-CA 134.744 5.218 . . . . 0.0 107.404 173.544 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -80.3 150.51 19.91 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.947 1.098 . . . . 0.0 112.392 -178.574 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.18 -30.83 10.14 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 124.211 3.274 . . . . 0.0 116.985 -175.997 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.38 -3.58 31.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -166.549 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -99.99 -31.15 11.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -173.483 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -75.76 118.01 18.11 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.699 1.6 . . . . 0.0 112.631 -159.407 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -102.11 113.43 26.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 130.77 3.628 . . . . 0.0 105.976 158.407 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.82 150.36 24.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 121.615 2.007 . . . . 0.0 106.932 166.929 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.28 15.2 mt -126.63 139.62 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.905 176.187 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -139.82 115.73 10.27 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 128.101 2.56 . . . . 0.0 109.412 177.659 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 74.56 20.86 2.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.961 2.504 . . . . 0.0 108.262 167.587 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.84 -3.17 73.67 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 130.323 3.821 . . . . 0.0 110.413 -175.141 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -96.66 134.2 40.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 121.516 2.658 . . . . 0.0 106.54 -170.411 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.5 pm0 -80.56 132.07 35.61 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 126.356 2.285 . . . . 0.0 108.843 172.312 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 59' ' ' TYR . 25.6 mt -95.57 155.42 16.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 125.206 2.432 . . . . 0.0 112.209 -172.921 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -118.16 157.01 27.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 112.784 -2.007 . . . . 0.0 109.088 -178.215 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -77.59 137.97 38.87 Favored 'General case' 0 N--CA 1.444 -0.726 1 O-C-N 129.996 4.56 . . . . 0.0 112.589 -172.804 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.67 -21.23 46.97 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 177.905 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -84.78 169.93 13.71 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 127.179 2.191 . . . . 0.0 112.239 168.83 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.7 p -110.55 163.52 13.63 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.179 1.792 . . . . 0.0 110.461 -162.159 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.418 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 5.7 mt -43.48 -47.51 7.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.867 1.667 . . . . 0.0 111.937 152.899 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -63.78 -38.95 93.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.532 1.933 . . . . 0.0 113.109 -170.682 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.53 -45.15 88.42 Favored 'General case' 0 C--N 1.327 -0.376 1 C-N-CA 133.589 4.756 . . . . 0.0 109.123 -178.992 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.421 ' CD2' HD22 ' A' ' 50' ' ' LEU . 35.5 m-85 -96.26 12.13 32.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 124.157 1.932 . . . . 0.0 109.328 -174.654 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.19 42.62 27.9 Favored 'General case' 0 N--CA 1.444 -0.739 2 C-N-CA 132.492 4.317 . . . . 0.0 114.903 175.858 . . . . . . . . 3 3 . 1 . 108 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 mt -93.71 101.7 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 -172.349 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -94.77 177.93 5.75 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.166 -1.379 . . . . 0.0 113.54 -176.604 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -49.01 142.04 7.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.306 3.042 . . . . 0.0 117.136 -174.77 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 88.3 mt-10 63.76 11.38 5.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 120.17 3.396 . . . . 0.0 120.17 179.005 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -73.52 143.77 46.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.445 -177.586 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.8 m -92.29 139.34 30.71 Favored 'General case' 0 N--CA 1.442 -0.848 1 C-N-CA 132.193 4.197 . . . . 0.0 108.194 178.043 . . . . . . . . 2 2 . 1 . 108 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.68 158.05 42.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 130.236 3.415 . . . . 0.0 111.56 169.215 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -126.01 148.54 49.26 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 128.231 2.612 . . . . 0.0 109.409 163.618 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 0.6 OUTLIER -98.41 130.37 45.04 Favored 'General case' 0 N--CA 1.451 -0.378 1 C-N-CA 132.329 4.252 . . . . 0.0 109.494 167.383 . . . . . . . . 4 3 . 1 . 108 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -103.44 136.37 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.045 164.749 . . . . . . . . 1 1 . 1 . 108 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.446 -0.64 0 C-N-CA 129.682 3.193 . . . . 0.0 110.638 178.506 . . . . . . . . 0 0 . 1 . 109 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 . . . . . . . . . 0 0 . 1 . 109 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.298 8.8 tt0 -88.62 144.15 26.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 125.718 2.675 . . . . 0.0 108.393 -175.092 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.26 149.38 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 111.214 -2.721 . . . . 0.0 108.848 -179.154 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -88.66 144.15 26.47 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 127.843 2.457 . . . . 0.0 113.965 168.102 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.09 99.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 118.187 -2.821 . . . . 0.0 104.147 -174.154 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -77.05 99.62 5.39 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 167.789 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.4 p -72.04 173.15 8.83 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 126.553 2.408 . . . . 0.0 114.47 166.447 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -40.19 -40.68 1.16 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 129.494 3.118 . . . . 0.0 118.815 -168.352 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.1 p -80.83 -6.43 58.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 171.864 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.71 0.6 60.54 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 123.85 1.806 . . . . 0.0 113.764 -170.369 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -69.22 106.58 2.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.919 -1.641 . . . . 0.0 108.014 -173.848 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.7 m -79.39 112.38 16.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 110.19 -3.187 . . . . 0.0 111.844 -178.304 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mt -110.75 137.27 43.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 1 CA-C-N 106.954 -4.657 . . . . 0.0 109.485 173.214 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.8 m -100.41 125.09 46.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 179.912 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tp -133.73 159.94 39.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 128.665 2.786 . . . . 0.0 110.408 -172.845 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -128.46 155.72 44.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 175.247 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.22 151.3 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 O-C-N 126.336 2.273 . . . . 0.0 107.599 -175.02 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -100.13 136.78 20.02 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 100.953 -3.721 . . . . 0.0 100.953 173.189 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -34.36 -42.01 0.27 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 1 C-N-CA 128.003 5.802 . . . . 0.0 119.326 174.228 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 p -79.3 -13.24 59.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 114.257 -2.782 . . . . 0.0 116.036 179.562 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -47.94 125.52 9.08 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.796 2.038 . . . . 0.0 112.354 -179.468 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.412 HG22 HG22 ' A' ' 55' ' ' THR . 81.9 p -69.39 151.7 45.82 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.911 2.485 . . . . 0.0 111.917 163.067 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.6 mm -63.31 -32.72 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 124.029 3.104 . . . . 0.0 119.151 -174.445 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -54.9 -33.05 61.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.057 2.143 . . . . 0.0 113.339 158.104 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -79.56 -15.67 57.27 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.662 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -82.72 -48.92 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 118.941 -2.349 . . . . 0.0 109.364 169.159 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -60.29 -27.93 67.69 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.275 0.984 . . . . 0.0 113.575 176.309 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.37 -23.43 43.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 118.786 -2.446 . . . . 0.0 116.963 176.699 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -78.24 -47.4 18.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.151 175.725 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.263 26.2 mt -51.02 -40.45 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 O-C-N 128.45 3.594 . . . . 0.0 109.977 169.367 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.62 -62.43 1.86 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.623 1.969 . . . . 0.0 114.024 179.441 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -43.38 -23.7 0.07 Allowed 'General case' 0 N--CA 1.45 -0.436 1 C-N-CA 136.039 5.735 . . . . 0.0 116.699 -178.385 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -96.78 -12.23 23.93 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 131.526 3.931 . . . . 0.0 117.513 179.194 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -160.16 -16.83 0.06 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 122.948 2.613 . . . . 0.0 110.346 -179.082 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.66 11.87 22.19 Favored Glycine 0 CA--C 1.524 0.644 1 C-N-CA 113.679 -4.105 . . . . 0.0 111.401 162.477 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.59 127.61 28.16 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 121.35 2.575 . . . . 0.0 108.457 -170.352 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -68.13 147.3 72.81 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 CA-C-O 114.644 -2.315 . . . . 0.0 111.792 -172.154 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.252 71.3 Cg_exo -44.67 -38.4 12.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 O-C-N 126.711 2.953 . . . . 0.0 117.409 167.887 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.98 -24.79 55.96 Favored 'General case' 0 C--N 1.325 -0.469 1 C-N-CA 131.896 4.078 . . . . 0.0 113.433 179.439 . . . . . . . . 3 3 . 1 . 109 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -110.29 -28.38 8.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 125.709 1.881 . . . . 0.0 110.136 -178.258 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -60.49 104.58 0.35 Allowed 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 119.942 -1.724 . . . . 0.0 111.557 177.668 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -110.56 128.57 55.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 130.205 3.402 . . . . 0.0 102.689 179.885 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 99.29 3.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -157.929 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.8 mm -99.2 128.04 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 -166.153 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.48 ' CE2' HG12 ' A' ' 61' ' ' ILE . 61.7 t80 -146.5 109.66 4.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 -177.928 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 79.99 35.21 0.15 Allowed 'General case' 0 CA--C 1.53 0.178 0 O-C-N 125.496 1.748 . . . . 0.0 109.779 178.355 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.67 -10.51 70.68 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 114.784 -3.579 . . . . 0.0 109.572 169.46 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.259 19.6 pttt -143.89 145.36 32.24 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.723 -2.633 . . . . 0.0 106.208 -161.796 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -72.2 135.25 46.05 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.701 2.4 . . . . 0.0 107.632 -175.977 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.76 107.65 19.07 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.842 1.657 . . . . 0.0 110.464 -179.445 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -114.75 161.57 17.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.412 -2.055 . . . . 0.0 105.862 -159.751 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.0 149.94 30.58 Favored 'General case' 0 N--CA 1.447 -0.61 1 C-N-CA 133.458 4.703 . . . . 0.0 107.423 -178.216 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.86 -21.71 31.39 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 169.584 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -101.49 157.58 16.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.715 2.806 . . . . 0.0 108.577 -172.513 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.412 HG22 HG22 ' A' ' 22' ' ' THR . 22.0 p -113.83 174.94 5.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.991 0.9 . . . . 0.0 109.43 163.662 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.0 mt -53.27 -38.01 62.66 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 176.753 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -60.82 -22.98 64.73 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 167.915 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -86.71 -0.23 55.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 118.446 -2.659 . . . . 0.0 113.94 -178.557 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -138.0 -6.54 1.64 Allowed 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 117.867 -3.021 . . . . 0.0 110.976 172.735 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 67.12 71.37 0.37 Allowed 'General case' 0 N--CA 1.442 -0.855 1 C-N-CA 133.467 4.707 . . . . 0.0 110.3 -177.987 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.48 HG12 ' CE2' ' A' ' 45' ' ' PHE . 70.4 mt -120.18 135.54 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 -177.95 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.264 11.9 pt20 -152.27 -166.61 2.53 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 126.005 2.066 . . . . 0.0 109.936 173.15 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -50.53 142.13 11.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.787 1.635 . . . . 0.0 114.034 -174.373 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 11.4 tp10 89.15 -8.35 0.43 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.543 1.537 . . . . 0.0 114.004 164.404 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -62.84 151.55 38.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 118.24 2.682 . . . . 0.0 118.24 170.128 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -106.8 118.01 35.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 171.802 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.5 mt -89.5 143.93 26.43 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 128.53 2.732 . . . . 0.0 105.592 167.596 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.37 25.6 p80 -133.78 135.76 44.08 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 116.261 -1.828 . . . . 0.0 109.274 -174.457 . . . . . . . . 2 2 . 1 . 109 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.5 154.51 40.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 124.566 1.166 . . . . 0.0 112.561 -164.727 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.48 -179.8 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 131.422 3.889 . . . . 0.0 110.358 169.013 . . . . . . . . 1 1 . 1 . 109 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.311 4.4 mp . . . . . 0 C--O 1.239 0.516 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.288 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 115.283 -2.294 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 110 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -81.46 142.22 33.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 123.538 1.637 . . . . 0.0 107.079 167.401 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pt -127.91 152.63 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 116.268 -1.825 . . . . 0.0 107.466 161.675 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -94.11 142.71 27.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 115.627 -2.429 . . . . 0.0 111.897 172.648 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.29 53.1 t -114.68 83.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 1 C-N-CA 132.829 4.452 . . . . 0.0 108.204 169.2 . . . . . . . . 3 2 . 1 . 110 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -64.03 130.83 45.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 110.071 -3.24 . . . . 0.0 109.812 172.255 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -132.65 154.26 50.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.783 0.833 . . . . 0.0 110.306 -176.868 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.571 HD12 ' H ' ' A' ' 8' ' ' LEU . 5.8 mp -42.2 -27.2 0.13 Allowed 'General case' 0 N--CA 1.444 -0.74 1 C-N-CA 133.295 4.638 . . . . 0.0 121.031 -170.271 . . . . . . . . 3 3 . 1 . 110 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 39.1 p -119.17 17.01 13.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.229 -161.147 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.33 24.56 23.9 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 130.312 3.815 . . . . 0.0 112.217 171.127 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -105.4 160.2 15.32 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.932 1.366 . . . . 0.0 107.604 173.62 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -127.89 113.86 16.44 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.515 2.326 . . . . 0.0 113.493 174.681 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -90.67 133.86 31.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 116.466 -3.896 . . . . 0.0 103.843 -179.137 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 t -141.72 83.09 1.84 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 127.508 3.528 . . . . 0.0 112.698 -170.534 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.57 150.38 20.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.011 -2.359 . . . . 0.0 111.488 179.216 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -94.93 118.55 31.99 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 101.88 -3.378 . . . . 0.0 101.88 179.015 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -135.18 152.21 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 123.713 0.805 . . . . 0.0 109.085 -176.146 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -106.51 160.0 27.82 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 173.343 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.328 40.9 Cg_endo -66.92 -24.38 46.1 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.388 2.726 . . . . 0.0 115.269 -168.186 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.1 p -84.57 -4.97 59.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 120.608 3.558 . . . . 0.0 120.608 -174.483 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -69.77 132.25 45.79 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 126.414 2.321 . . . . 0.0 109.624 176.727 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -69.82 147.92 49.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 126.857 3.218 . . . . 0.0 105.996 171.727 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mm -59.58 -34.42 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 110.059 -3.246 . . . . 0.0 114.208 179.8 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.65 -30.66 65.99 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 121.897 2.135 . . . . 0.0 111.16 178.605 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -74.81 -26.54 59.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 125.469 1.731 . . . . 0.0 113.736 174.026 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.5 t -78.42 -24.83 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 121.251 1.841 . . . . 0.0 108.399 173.149 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -67.6 -39.8 84.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 123.562 2.892 . . . . 0.0 112.146 164.896 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.64 -31.7 70.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.71 2.004 . . . . 0.0 110.907 179.244 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -71.04 -10.72 60.24 Favored 'General case' 0 N--CA 1.451 -0.42 1 C-N-CA 134.574 5.149 . . . . 0.0 114.183 176.026 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.1 -27.61 4.36 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 127.563 2.345 . . . . 0.0 108.664 176.375 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -54.74 -27.09 38.43 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 123.064 2.666 . . . . 0.0 115.072 174.287 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -33.82 65.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 123.94 1.829 . . . . 0.0 108.474 179.078 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mmtm -96.49 -51.63 4.27 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.547 2.739 . . . . 0.0 107.085 -164.268 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -113.79 -12.17 12.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -173.45 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.42 -16.45 58.97 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 120.562 1.528 . . . . 0.0 111.584 173.11 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.2 mt -87.51 123.21 69.94 Favored Pre-proline 0 N--CA 1.449 -0.521 0 O-C-N 117.328 -3.454 . . . . 0.0 109.191 -159.209 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.03 154.78 38.0 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 O-C-N 116.349 -2.501 . . . . 0.0 108.057 179.206 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -44.73 -34.21 8.0 Favored 'Trans proline' 0 N--CA 1.441 -1.598 1 C-N-CA 126.738 4.959 . . . . 0.0 119.364 177.174 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.11 -38.26 76.13 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.62 2.768 . . . . 0.0 115.223 178.743 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.8 -8.77 57.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 103.914 -2.625 . . . . 0.0 103.914 -172.967 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -100.75 163.7 12.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 123.28 2.764 . . . . 0.0 112.356 178.324 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -144.7 160.45 41.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 109.989 -3.278 . . . . 0.0 108.547 158.338 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 mt -118.48 126.42 52.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.521 2.328 . . . . 0.0 111.623 169.748 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.4 mm -100.76 139.64 21.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 130.788 3.635 . . . . 0.0 106.952 168.296 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 61' ' ' ILE . 12.2 t80 -122.89 -146.12 0.36 Allowed 'General case' 0 C--N 1.332 -0.196 0 O-C-N 126.705 2.503 . . . . 0.0 110.466 173.654 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.11 54.18 1.58 Allowed 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.32 -1.488 . . . . 0.0 110.227 -171.543 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.64 -19.04 19.45 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 117.498 -1.723 . . . . 0.0 110.987 178.451 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -112.8 138.76 49.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 126.559 3.076 . . . . 0.0 107.063 -168.831 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -88.75 123.35 33.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.04 -1.891 . . . . 0.0 108.26 165.281 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 mt -82.22 141.09 33.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 120.9 -1.125 . . . . 0.0 113.201 -174.532 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -98.25 147.62 24.44 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.774 -0.578 . . . . 0.0 110.756 -176.488 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.04 123.52 29.55 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 125.153 1.533 . . . . 0.0 106.909 -177.71 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.1 -29.65 4.08 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 128.178 2.799 . . . . 0.0 114.194 -179.692 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -84.43 154.73 22.61 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 128.408 3.064 . . . . 0.0 106.395 172.484 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -78.6 169.82 17.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 112.226 -2.261 . . . . 0.0 110.918 175.888 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.8 -17.28 63.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 119.793 -1.817 . . . . 0.0 111.467 168.684 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.5 t -92.23 -13.93 29.73 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 118.377 -2.702 . . . . 0.0 111.472 -169.653 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -50.19 -46.04 54.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 130.988 3.715 . . . . 0.0 106.217 168.413 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -101.21 16.47 25.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 123.383 1.563 . . . . 0.0 111.016 -172.159 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.342 10.9 p-10 52.21 40.84 29.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 129.338 3.055 . . . . 0.0 114.183 177.943 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.527 HG12 ' CE2' ' A' ' 45' ' ' PHE . 19.0 mt -76.72 128.64 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 125.599 2.619 . . . . 0.0 106.786 -177.619 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -105.07 167.64 9.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 109.073 -3.694 . . . . 0.0 111.013 -177.064 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.283 36.0 pttt -40.62 129.68 2.49 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 118.719 2.859 . . . . 0.0 118.719 162.965 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 58.65 3.03 0.26 Allowed 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 126.782 2.551 . . . . 0.0 117.71 173.189 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 t -63.16 152.9 36.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.029 1.732 . . . . 0.0 114.009 174.723 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -102.14 120.41 40.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -160.995 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.83 152.68 22.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.509 2.724 . . . . 0.0 106.502 164.477 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -123.93 137.4 54.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 126.029 2.081 . . . . 0.0 109.638 -175.472 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -118.71 132.77 56.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 119.732 -1.855 . . . . 0.0 108.006 -159.838 . . . . . . . . 1 1 . 1 . 110 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 m -137.64 165.2 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 1 CA-C-N 126.181 4.082 . . . . 0.0 107.384 -170.438 . . . . . . . . 2 2 . 1 . 110 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 124.027 1.87 . . . . 0.0 109.619 -179.818 . . . . . . . . 0 0 . 1 . 111 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 . . . . . . . . . 0 0 . 1 . 111 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -77.09 143.9 38.91 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 122.725 2.512 . . . . 0.0 112.973 -179.975 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.263 46.7 pt -140.13 168.49 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 125.756 1.91 . . . . 0.0 106.997 173.045 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.94 133.52 31.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 118.326 -2.734 . . . . 0.0 110.569 159.429 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.4 t -93.04 105.58 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 101.194 -3.632 . . . . 0.0 101.194 174.117 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -97.65 104.11 16.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 118.631 -2.543 . . . . 0.0 110.198 171.542 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -86.47 146.58 26.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 126.464 3.03 . . . . 0.0 113.74 -162.876 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 9' ' ' THR . 3.4 pp -70.64 -28.74 65.04 Favored 'General case' 0 N--CA 1.446 -0.64 1 O-C-N 113.3 -5.875 . . . . 0.0 109.443 179.145 . . . . . . . . 3 3 . 1 . 111 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.418 HG23 HD12 ' A' ' 8' ' ' LEU 0.358 30.2 p -62.52 -7.46 4.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 119.667 3.21 . . . . 0.0 119.667 162.282 . . . . . . . . 3 3 . 1 . 111 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.96 -5.63 11.25 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-O 114.685 -3.286 . . . . 0.0 118.4 150.489 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -120.66 160.59 22.97 Favored 'General case' 0 N--CA 1.446 -0.661 1 CA-C-N 125.422 4.611 . . . . 0.0 111.259 -177.568 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -100.39 136.9 39.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 125.441 1.713 . . . . 0.0 109.591 177.174 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mt -113.59 119.09 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.278 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -75.85 126.73 31.56 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 130.652 3.581 . . . . 0.0 106.099 169.948 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.26 160.85 39.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 124.177 1.942 . . . . 0.0 105.904 -173.481 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -125.87 131.47 52.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.076 2.151 . . . . 0.0 109.244 -178.184 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 m -137.27 169.83 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 O-C-N 127.382 2.926 . . . . 0.0 110.715 178.238 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.283 0.7 OUTLIER -112.08 146.72 35.41 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 168.382 . . . . . . . . 3 3 . 1 . 111 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -47.99 -33.39 20.29 Favored 'Trans proline' 0 N--CA 1.447 -1.233 1 C-N-CA 129.3 6.667 . . . . 0.0 115.37 158.632 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.9 p -74.47 -6.81 50.45 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 119.516 3.154 . . . . 0.0 119.516 174.279 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -73.02 130.53 40.53 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 129.204 3.002 . . . . 0.0 104.378 179.714 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -77.28 155.85 31.79 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 111.962 -2.381 . . . . 0.0 112.852 163.376 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.367 35.5 mm -49.88 -38.1 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -178.359 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.29 -29.85 62.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.216 2.606 . . . . 0.0 113.632 177.934 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -75.94 -34.62 59.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 114.562 -2.637 . . . . 0.0 108.342 172.565 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.11 -42.69 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 120.673 1.579 . . . . 0.0 111.029 175.058 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -63.59 -27.09 69.01 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 118.441 -2.662 . . . . 0.0 111.755 179.484 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.32 . . -80.21 -22.09 42.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 116.312 -1.804 . . . . 0.0 111.727 179.962 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -80.08 -23.09 41.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 113.99 -2.909 . . . . 0.0 104.903 173.617 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 69' ' ' LEU . 96.2 mt -74.6 -37.4 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 166.717 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.356 51.1 tt0 -63.66 -32.29 73.73 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -178.412 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -70.65 -32.31 69.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.391 -2.186 . . . . 0.0 112.187 -177.626 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -98.7 -49.76 4.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 -169.738 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -105.43 -17.6 14.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 120.721 -1.237 . . . . 0.0 107.839 -165.148 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.52 4.73 57.1 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 120.769 -1.207 . . . . 0.0 114.178 171.208 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.1 mm -91.4 124.41 61.21 Favored Pre-proline 0 C--O 1.236 0.384 0 O-C-N 119.51 -2.171 . . . . 0.0 110.83 -169.904 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -66.5 141.69 62.18 Favored 'Trans proline' 0 N--CA 1.446 -1.274 1 C-N-CA 128.618 6.212 . . . . 0.0 107.077 -175.202 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.42 -35.48 39.26 Favored 'Trans proline' 0 N--CA 1.445 -1.379 1 C-N-CA 129.286 6.657 . . . . 0.0 108.884 -174.089 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -41.55 -46.83 3.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 166.032 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -79.28 -34.38 42.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 125.891 1.994 . . . . 0.0 113.893 -178.678 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -69.79 145.24 52.31 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 -179.027 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.09 150.82 39.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.022 -1.942 . . . . 0.0 110.008 165.814 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.0 tp -117.75 123.51 46.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 124.351 3.25 . . . . 0.0 103.916 -177.977 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mm -125.25 129.34 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 -168.462 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.413 ' HB3' HD11 ' A' ' 50' ' ' LEU 0.294 64.8 t80 -151.14 109.78 3.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 116.153 -1.88 . . . . 0.0 115.608 172.112 . . . . . . . . 3 3 . 1 . 111 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.529 . . 90.52 42.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 124.772 2.225 . . . . 0.0 113.033 171.903 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.88 -0.09 89.11 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 117.097 -3.502 . . . . 0.0 119.261 179.458 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -142.58 150.13 39.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 110.598 -2.801 . . . . 0.0 113.135 -165.127 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 0.0 OUTLIER -73.94 126.77 31.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 115.267 -2.301 . . . . 0.0 110.958 170.136 . . . . . . . . 3 3 . 1 . 111 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 45' ' ' PHE . 31.6 mt -78.04 126.48 30.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.462 2.705 . . . . 0.0 104.874 167.246 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -103.35 156.95 17.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 110.793 -2.912 . . . . 0.0 111.495 -170.706 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.39 161.24 20.19 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.407 2.283 . . . . 0.0 113.671 -178.286 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.14 -33.29 6.57 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 130.184 3.754 . . . . 0.0 112.359 173.038 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.279 88.6 mtt180 -98.59 153.4 18.69 Favored 'General case' 0 N--CA 1.451 -0.418 1 C-N-CA 135.343 5.457 . . . . 0.0 106.318 -164.037 . . . . . . . . 3 2 . 1 . 111 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.1 p -100.24 163.59 12.33 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 125.739 1.9 . . . . 0.0 108.094 175.763 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mt -49.46 -31.18 9.38 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.029 2.532 . . . . 0.0 117.632 157.25 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.7 p -71.56 -33.64 69.28 Favored 'General case' 0 N--CA 1.449 -0.494 1 O-C-N 114.955 -4.841 . . . . 0.0 107.694 175.186 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -76.46 -32.94 58.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 123.821 3.01 . . . . 0.0 107.042 -176.235 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -79.32 -19.76 49.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 115.156 -2.354 . . . . 0.0 109.147 170.178 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 72.6 43.13 0.48 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.287 2.635 . . . . 0.0 107.464 176.043 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -80.91 143.62 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 117.63 -3.169 . . . . 0.0 111.021 175.797 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -133.74 159.71 39.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 129.117 2.967 . . . . 0.0 115.66 -178.196 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.16 139.25 1.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 120.124 3.379 . . . . 0.0 120.124 -175.647 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 32.5 mt-10 69.76 28.11 4.46 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 129.574 3.15 . . . . 0.0 115.731 174.164 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.26 70.9 m -81.66 154.08 26.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 111.92 -2.4 . . . . 0.0 106.382 170.047 . . . . . . . . 2 2 . 1 . 111 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.7 p -98.86 131.91 44.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 126.222 2.915 . . . . 0.0 103.32 166.915 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.03 150.52 38.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 129.654 3.181 . . . . 0.0 102.813 175.979 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.32 140.47 52.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 121.586 1.994 . . . . 0.0 113.412 -166.87 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 30' ' ' ILE 0.287 5.9 mt -91.19 139.87 30.33 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 118.76 -2.462 . . . . 0.0 112.422 165.937 . . . . . . . . 3 3 . 1 . 111 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.25 145.04 33.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 129.291 3.036 . . . . 0.0 106.635 163.229 . . . . . . . . 1 1 . 1 . 111 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.452 -0.361 1 C-N-CA 132.559 4.343 . . . . 0.0 108.916 -167.522 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 125.78 2.705 . . . . 0.0 114.836 . . . . . . . . . 0 0 . 1 . 112 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.266 12.4 mt-30 -85.49 152.79 22.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 119.549 -1.969 . . . . 0.0 110.925 167.769 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.252 18.2 pt -134.24 167.42 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 101.007 -3.701 . . . . 0.0 101.007 162.979 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -131.8 93.4 3.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.429 1.492 . . . . 0.0 108.94 -167.678 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t -90.75 110.47 22.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 101.605 -3.48 . . . . 0.0 101.605 -172.057 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -109.34 137.63 46.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.45 2.3 . . . . 0.0 112.841 177.669 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -86.14 152.45 22.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 103.228 -2.879 . . . . 0.0 103.228 179.291 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -55.06 -19.05 6.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.517 2.727 . . . . 0.0 113.357 174.514 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -94.88 2.22 55.4 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 115.548 -2.168 . . . . 0.0 115.625 170.337 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.84 -12.37 57.74 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 120.769 1.622 . . . . 0.0 114.202 163.861 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -81.45 134.44 35.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -176.234 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -125.99 122.81 36.97 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 119.803 -1.81 . . . . 0.0 108.192 -159.283 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mt -95.39 122.6 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 120.229 -1.544 . . . . 0.0 110.04 169.014 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.6 m -96.55 112.68 24.33 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 125.04 2.352 . . . . 0.0 105.613 -178.242 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.52 116.42 31.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.982 1.713 . . . . 0.0 109.242 -170.244 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -77.02 127.92 33.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 127.302 2.877 . . . . 0.0 110.129 160.785 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.262 34.5 m -138.86 157.73 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 1 C-N-CA 133.454 4.702 . . . . 0.0 115.419 -178.393 . . . . . . . . 3 2 . 1 . 112 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.285 27.1 mm-40 -112.56 158.13 38.28 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 102.844 -3.021 . . . . 0.0 102.844 156.551 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -60.6 -23.08 74.73 Favored 'Trans proline' 0 N--CA 1.447 -1.225 1 C-N-CA 126.873 5.049 . . . . 0.0 116.845 -175.919 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -83.05 -2.58 55.69 Favored 'General case' 0 N--CA 1.44 -0.944 1 C-N-CA 132.062 4.145 . . . . 0.0 113.484 -175.146 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.67 136.2 38.18 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 -174.156 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.4 p -88.89 172.64 9.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.466 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.431 HG22 ' HD2' ' A' ' 27' ' ' LYS . 19.3 mm -70.63 -34.42 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 117.5 -1.238 . . . . 0.0 108.204 -178.616 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -42.52 -46.42 4.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.838 3.255 . . . . 0.0 113.652 170.911 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -70.95 -40.31 72.07 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.984 2.113 . . . . 0.0 116.207 173.833 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -82.36 -21.54 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 O-C-N 117.974 -2.954 . . . . 0.0 108.667 -176.016 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HD2' HG22 ' A' ' 23' ' ' ILE . 30.0 mttt -69.39 -42.22 75.43 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 118.749 -2.469 . . . . 0.0 115.769 170.283 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -35.21 58.22 Favored 'General case' 0 CA--C 1.535 0.403 1 O-C-N 132.228 5.955 . . . . 0.0 113.1 -179.009 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -60.28 -52.44 65.27 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 125.721 1.888 . . . . 0.0 110.403 165.594 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.344 35.9 mt -59.29 -46.13 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 114.993 -2.432 . . . . 0.0 112.917 175.969 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.377 20.1 tm0? -40.07 -63.05 0.65 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 126.296 2.951 . . . . 0.0 115.243 166.3 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.296 37.0 t70 -46.86 -47.46 21.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 110.396 -3.093 . . . . 0.0 118.584 173.314 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -84.56 -39.42 18.79 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.546 1.938 . . . . 0.0 111.29 -165.574 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.63 -14.21 6.33 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 128.301 3.501 . . . . 0.0 115.735 -166.187 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.96 22.05 40.16 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.971 2.7 . . . . 0.0 112.373 176.19 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -97.35 130.53 29.3 Favored Pre-proline 0 N--CA 1.442 -0.852 0 CA-C-N 120.488 2.144 . . . . 0.0 109.83 -178.286 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -76.36 165.12 29.83 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.738 2.292 . . . . 0.0 110.23 -173.845 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.52 -47.24 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 N-CA-C 116.41 1.658 . . . . 0.0 116.41 -174.86 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -61.28 -5.07 1.41 Allowed 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 117.946 2.573 . . . . 0.0 117.946 -175.58 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -99.62 -16.68 18.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.886 1.274 . . . . 0.0 110.245 -169.919 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -88.84 132.07 34.81 Favored 'General case' 0 N--CA 1.44 -0.934 1 C-N-CA 133.171 4.588 . . . . 0.0 110.034 -166.151 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -135.93 147.75 48.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 118.003 -2.936 . . . . 0.0 105.87 163.045 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.1 mt -104.88 128.1 52.97 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 130.668 3.587 . . . . 0.0 110.958 169.768 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 mt -124.78 130.11 73.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 128.151 2.58 . . . . 0.0 107.552 165.423 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -142.46 113.46 7.56 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 119.084 -2.26 . . . . 0.0 105.928 174.331 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.17 36.02 1.16 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 120.431 1.469 . . . . 0.0 110.536 157.872 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.88 -47.18 1.41 Allowed Glycine 0 CA--C 1.523 0.571 0 CA-C-O 126.131 3.073 . . . . 0.0 116.095 -167.146 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -76.64 126.63 31.32 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 120.159 -1.789 . . . . 0.0 113.097 -166.995 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -71.52 132.83 45.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 124.928 2.299 . . . . 0.0 106.94 154.961 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.455 HD22 ' CD2' ' A' ' 59' ' ' TYR 0.291 0.2 OUTLIER -91.92 124.88 36.36 Favored 'General case' 0 C--O 1.237 0.414 1 O-C-N 115.824 -4.297 . . . . 0.0 108.056 172.213 . . . . . . . . 5 4 . 1 . 112 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -78.15 156.19 30.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.397 2.279 . . . . 0.0 115.58 174.582 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.376 26.6 m-20 -71.44 133.49 45.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 124.345 2.021 . . . . 0.0 113.106 167.921 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.3 -11.38 39.92 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 128.544 2.973 . . . . 0.0 114.019 176.398 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -71.52 153.09 42.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 126.202 1.766 . . . . 0.0 112.217 170.78 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -99.74 143.42 29.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.291 1.837 . . . . 0.0 107.332 170.278 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.57 -33.67 76.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 -166.395 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -84.31 -23.33 30.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.008 -1.472 . . . . 0.0 114.485 -173.47 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -54.01 -36.78 63.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 126.077 2.846 . . . . 0.0 112.55 168.695 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CD2' HD22 ' A' ' 50' ' ' LEU . 10.5 m-85 -85.59 -6.6 59.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 128.745 2.818 . . . . 0.0 114.769 176.595 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.489 17.2 m120 89.81 15.18 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.613 1 C-N-CA 132.994 4.518 . . . . 0.0 118.116 177.719 . . . . . . . . 3 2 . 1 . 112 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.8 mt -81.96 112.82 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 116.174 -2.21 . . . . 0.0 108.296 -177.298 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -124.1 170.84 10.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 124.733 1.271 . . . . 0.0 108.144 -167.589 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.327 44.4 pttt -43.03 122.02 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.902 2.481 . . . . 0.0 115.668 -169.126 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 66.97 24.72 9.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 178.285 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.275 56.7 m -75.71 125.27 28.73 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 124.017 1.865 . . . . 0.0 110.56 170.258 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 m -84.81 131.59 34.52 Favored 'General case' 0 C--N 1.323 -0.562 1 C-N-CA 132.158 4.183 . . . . 0.0 100.831 173.487 . . . . . . . . 2 2 . 1 . 112 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -142.61 112.41 6.89 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 -164.911 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -46.13 103.52 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 113.746 -3.026 . . . . 0.0 115.407 159.446 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -96.1 102.5 14.3 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 121.531 1.969 . . . . 0.0 112.43 176.392 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.7 t -69.08 109.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 128.578 2.751 . . . . 0.0 108.909 -176.433 . . . . . . . . 1 1 . 1 . 112 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.566 . . . . . . . . 0 0 . 1 . 113 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptm . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 113 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -84.5 134.81 34.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 114.602 -2.618 . . . . 0.0 106.643 179.117 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.314 28.0 pt -125.86 171.53 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 1 O-C-N 129.138 4.024 . . . . 0.0 108.134 173.774 . . . . . . . . 3 2 . 1 . 113 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -132.75 143.1 49.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 163.04 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.44 113.28 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 126.307 1.843 . . . . 0.0 108.878 169.268 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -83.02 134.38 35.05 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -177.437 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.29 36.9 m -87.11 149.89 24.37 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 116.765 -1.588 . . . . 0.0 112.279 168.427 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -19.6 16.49 Favored 'General case' 0 C--N 1.324 -0.527 1 C-N-CA 132.772 4.429 . . . . 0.0 112.469 -174.734 . . . . . . . . 3 3 . 1 . 113 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 p -81.54 -15.78 53.78 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.493 1.917 . . . . 0.0 115.428 166.45 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.25 -9.86 10.96 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 114.289 -3.506 . . . . 0.0 107.302 175.821 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -80.32 122.59 27.1 Favored 'General case' 0 N--CA 1.45 -0.447 1 CA-C-N 124.951 4.375 . . . . 0.0 110.859 -175.044 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -84.7 107.65 17.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 175.96 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.07 126.76 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 120.188 -1.57 . . . . 0.0 110.37 179.093 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.3 p -89.67 133.31 34.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 121.485 1.948 . . . . 0.0 108.09 -179.544 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.5 tp -149.06 136.87 20.54 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.759 2.824 . . . . 0.0 106.444 -165.817 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -116.17 132.8 56.56 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.225 2.21 . . . . 0.0 105.56 -177.824 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -137.44 -177.96 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 129.346 3.058 . . . . 0.0 111.862 -178.745 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -119.24 153.14 53.23 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 124.97 1.308 . . . . 0.0 109.711 163.275 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.297 28.4 Cg_endo -55.52 -34.62 90.33 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 N-CA-C 121.452 3.597 . . . . 0.0 121.452 -179.929 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -75.28 -8.65 57.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 112.588 -2.097 . . . . 0.0 115.716 173.507 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.77 120.42 7.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 120.645 1.566 . . . . 0.0 110.345 174.369 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -61.76 150.26 37.44 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 120.126 -1.609 . . . . 0.0 108.511 161.711 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -59.99 -19.02 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.79 2.036 . . . . 0.0 112.99 179.731 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.14 -23.49 41.09 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.711 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -89.87 -22.11 22.2 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.085 0.954 . . . . 0.0 109.381 178.547 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.78 -40.91 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 O-C-N 126.912 2.632 . . . . 0.0 108.733 166.57 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -69.16 -20.76 64.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 114.048 -2.882 . . . . 0.0 112.77 172.093 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.82 -40.47 47.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 131.541 3.936 . . . . 0.0 111.415 174.611 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -71.34 -28.67 64.24 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.657 3.583 . . . . 0.0 109.708 178.106 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.83 -65.03 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 113.247 -3.264 . . . . 0.0 110.854 157.232 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -46.0 -31.41 2.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 126.563 2.414 . . . . 0.0 115.851 -179.457 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.72 -32.6 43.88 Favored 'General case' 0 C--N 1.329 -0.322 1 C-N-CA 131.79 4.036 . . . . 0.0 111.036 178.23 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -116.27 -39.2 3.43 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -176.823 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -83.56 -31.16 26.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 116.973 -3.579 . . . . 0.0 117.052 -169.953 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.96 -6.5 83.63 Favored Glycine 0 CA--C 1.531 1.094 0 O-C-N 120.944 -1.097 . . . . 0.0 111.126 171.478 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.251 77.1 mt -98.2 129.05 31.64 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-O 115.104 -2.379 . . . . 0.0 105.924 -175.072 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.56 155.69 68.12 Favored 'Trans proline' 0 N--CA 1.449 -1.104 1 C-N-CA 127.153 5.235 . . . . 0.0 117.807 -174.745 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.303 51.3 Cg_exo -42.21 -35.28 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.567 3.511 . . . . 0.0 117.319 170.026 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -43.17 -41.2 3.63 Favored 'General case' 0 CA--C 1.535 0.4 1 O-C-N 114.003 -5.435 . . . . 0.0 117.723 168.555 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -96.55 -6.44 36.96 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 118.244 -2.785 . . . . 0.0 114.363 -170.098 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -102.01 122.93 45.02 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.408 2.683 . . . . 0.0 110.321 175.03 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -120.49 131.42 54.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 173.153 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -118.76 129.07 55.05 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 128.716 2.807 . . . . 0.0 110.364 -175.532 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.36 148.19 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 127.689 2.396 . . . . 0.0 116.144 163.582 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -141.06 114.28 8.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 127.781 3.176 . . . . 0.0 107.509 172.925 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.71 41.37 12.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.789 -1.101 . . . . 0.0 109.626 176.891 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.75 -16.86 34.03 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 117.976 1.95 . . . . 0.0 117.976 177.118 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.365 69.1 mttt -94.5 129.17 41.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.886 1.327 . . . . 0.0 108.301 179.55 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.54 87.49 7.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 131.443 3.897 . . . . 0.0 102.444 178.887 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.5 mt -50.05 136.5 18.84 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 128.346 2.659 . . . . 0.0 115.186 -165.208 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -65.12 114.51 4.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 125.013 1.446 . . . . 0.0 112.89 171.798 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.349 0.0 OUTLIER -66.7 -4.53 9.13 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.972 2.109 . . . . 0.0 116.168 -172.942 . . . . . . . . 3 3 . 1 . 113 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.16 -0.09 16.76 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.221 1.391 . . . . 0.0 111.666 178.434 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -93.23 160.04 15.01 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 159.382 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.8 p -107.28 171.23 7.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 125.166 2.412 . . . . 0.0 108.053 -172.555 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.04 -30.54 62.46 Favored 'General case' 0 C--N 1.326 -0.45 1 O-C-N 114.698 -5.001 . . . . 0.0 109.316 -178.059 . . . . . . . . 3 3 . 1 . 113 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 t -67.06 -33.26 75.12 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 173.561 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -71.93 -23.02 61.4 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.958 2.503 . . . . 0.0 111.515 178.098 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -91.54 -3.79 56.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 170.755 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 t30 58.71 36.57 24.99 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 131.589 3.956 . . . . 0.0 114.77 179.784 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -77.08 125.33 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 O-C-N 124.955 1.409 . . . . 0.0 114.506 -173.889 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -98.51 176.24 5.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 125.082 2.372 . . . . 0.0 107.852 -170.769 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.94 117.05 3.89 Favored 'General case' 0 N--CA 1.441 -0.897 1 C-N-CA 131.708 4.003 . . . . 0.0 110.055 -177.787 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 68.79 44.23 1.15 Allowed 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 127.593 3.058 . . . . 0.0 111.944 163.491 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.1 p -100.27 157.7 16.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 125.708 2.67 . . . . 0.0 111.652 160.695 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -106.73 127.02 53.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 116.43 -3.919 . . . . 0.0 110.33 -166.766 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.36 172.38 8.79 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 129.294 3.037 . . . . 0.0 104.295 164.918 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -133.64 136.72 44.98 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.731 2.012 . . . . 0.0 109.169 -179.199 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -127.09 108.11 10.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 101.452 -3.536 . . . . 0.0 101.452 -163.907 . . . . . . . . 1 1 . 1 . 113 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.34 116.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 1 O-C-N 130.375 4.797 . . . . 0.0 110.656 163.639 . . . . . . . . 2 2 . 1 . 113 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 101.498 -3.519 . . . . 0.0 101.498 177.37 . . . . . . . . 0 0 . 1 . 114 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 123.322 1.534 . . . . 0.0 108.764 . . . . . . . . . 0 0 . 1 . 114 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.256 43.6 mt-30 -113.76 128.72 56.53 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 111.373 -2.649 . . . . 0.0 112.859 -179.046 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.358 17.2 pt -144.7 138.36 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 128.286 3.491 . . . . 0.0 110.084 -175.39 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -106.28 121.23 43.79 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 127.377 2.923 . . . . 0.0 110.781 -163.823 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.65 87.46 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 172.202 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -86.88 149.0 25.12 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 117.338 -3.351 . . . . 0.0 107.268 -172.462 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.277 42.4 m -103.7 140.29 37.8 Favored 'General case' 0 N--CA 1.447 -0.595 1 C-N-CA 133.097 4.559 . . . . 0.0 105.565 175.863 . . . . . . . . 3 2 . 1 . 114 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.309 0.4 OUTLIER -46.29 -24.76 0.52 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 120.006 3.336 . . . . 0.0 120.006 -179.423 . . . . . . . . 3 3 . 1 . 114 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.29 6.9 p -94.82 5.72 51.07 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.836 2.454 . . . . 0.0 108.395 -174.982 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.19 0.18 44.3 Favored Glycine 0 CA--C 1.531 1.049 1 C-N-CA 134.76 5.933 . . . . 0.0 111.172 158.292 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -65.83 138.79 58.14 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 116.488 -3.948 . . . . 0.0 111.275 170.997 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.353 12.0 m -124.31 112.1 16.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.975 2.11 . . . . 0.0 111.553 -170.258 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 mm -100.99 148.87 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 173.313 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.353 7.1 p -129.22 128.88 44.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 111.641 -2.527 . . . . 0.0 111.151 -164.084 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.43 HD13 HG22 ' A' ' 26' ' ' VAL . 86.7 mt -106.38 125.56 51.15 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.849 1.26 . . . . 0.0 111.114 176.656 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -88.51 93.03 9.41 Favored 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 132.886 4.474 . . . . 0.0 107.235 162.943 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.18 162.18 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 O-C-N 118.364 -2.71 . . . . 0.0 111.06 -176.184 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.265 3.4 tp10 -115.91 135.36 22.72 Favored Pre-proline 0 N--CA 1.447 -0.6 0 N-CA-C 101.286 -3.598 . . . . 0.0 101.286 176.119 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -34.16 -40.55 0.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 1 C-N-CA 128.135 5.89 . . . . 0.0 115.148 -176.918 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -80.06 -1.37 39.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.323 2.249 . . . . 0.0 114.585 -171.505 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -65.25 135.9 55.95 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 130.746 3.618 . . . . 0.0 107.73 174.707 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -65.03 159.69 22.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.029 2.932 . . . . 0.0 112.902 171.771 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 23' ' ' ILE . 3.5 mm -74.39 -31.84 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 124.777 1.298 . . . . 0.0 110.392 178.456 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.79 -30.5 71.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 128.496 2.718 . . . . 0.0 112.203 172.965 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -80.9 -24.56 38.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 119.367 -2.083 . . . . 0.0 109.611 173.101 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG22 HD13 ' A' ' 15' ' ' LEU 0.255 1.0 OUTLIER -72.28 -20.11 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 122.5 1.143 . . . . 0.0 111.913 175.978 . . . . . . . . 4 4 . 1 . 114 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -73.4 -43.89 59.57 Favored 'General case' 0 C--N 1.323 -0.553 1 C-N-CA 133.335 4.654 . . . . 0.0 114.031 173.854 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.62 89.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.213 2.205 . . . . 0.0 111.908 174.384 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -69.3 -10.32 57.33 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.354 2.661 . . . . 0.0 116.8 173.434 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.27 58.1 mt -94.24 -40.45 11.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 O-C-N 127.509 3.005 . . . . 0.0 109.809 163.859 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -61.48 -62.93 1.47 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 130.567 3.547 . . . . 0.0 110.333 -174.917 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -41.72 -37.92 1.32 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.109 2.564 . . . . 0.0 116.673 170.307 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -79.16 -70.6 0.49 Allowed 'General case' 0 C--N 1.32 -0.683 0 O-C-N 128.32 3.513 . . . . 0.0 118.88 167.349 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -98.24 -5.5 33.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.432 -161.342 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.11 0.32 74.37 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 126.56 2.029 . . . . 0.0 114.814 166.995 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.1 mt -79.6 133.38 59.43 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-O 113.15 -3.309 . . . . 0.0 106.41 -165.283 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.83 162.65 23.86 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 CA-C-N 126.691 3.425 . . . . 0.0 111.538 -173.586 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.83 -51.46 0.38 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 123.876 3.051 . . . . 0.0 116.573 -166.034 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.95 -11.23 55.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 126.39 2.995 . . . . 0.0 113.914 -163.984 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -96.57 -17.59 20.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 113.689 -3.053 . . . . 0.0 110.165 -172.483 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.25 139.2 30.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 126.161 2.886 . . . . 0.0 107.72 -176.332 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.26 71.2 mtt180 -131.42 142.01 49.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 128.67 2.788 . . . . 0.0 112.985 162.028 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.55 0.6 OUTLIER -133.99 139.95 46.41 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 -164.755 . . . . . . . . 3 3 . 1 . 114 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.297 68.1 mt -132.52 130.14 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.209 1.804 . . . . 0.0 109.707 -160.988 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -159.27 133.88 7.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.077 2.151 . . . . 0.0 112.609 179.037 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.53 34.61 15.88 Favored 'General case' 0 N--CA 1.439 -0.986 1 C-N-CA 133.398 4.679 . . . . 0.0 112.78 -176.916 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.48 -30.05 7.51 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 115.514 -2.826 . . . . 0.0 112.21 174.478 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -120.12 148.04 44.12 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 120.502 2.151 . . . . 0.0 111.002 -159.939 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -71.83 129.28 38.24 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.998 2.119 . . . . 0.0 108.04 171.151 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mp -75.05 109.69 8.73 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 129.826 3.25 . . . . 0.0 108.853 -176.295 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -73.25 130.06 39.39 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 129.635 3.174 . . . . 0.0 110.217 -172.927 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.293 73.4 m-20 -46.24 129.7 10.3 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 129.394 3.078 . . . . 0.0 112.991 166.811 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.54 20.49 47.82 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 124.963 2.424 . . . . 0.0 111.317 172.733 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.23 177.18 4.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.598 2.359 . . . . 0.0 113.672 170.161 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.406 ' H ' ' CG ' ' A' ' 58' ' ' ASP . 43.5 p -118.29 163.83 16.11 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 125.209 2.433 . . . . 0.0 110.503 162.561 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.9 mt -53.93 -37.67 64.09 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 117.128 -3.482 . . . . 0.0 113.899 169.87 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.2 t -58.45 -31.97 68.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 124.725 2.202 . . . . 0.0 114.073 172.173 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 55' ' ' THR . 19.7 m-20 -63.46 -30.22 71.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 119.329 -2.107 . . . . 0.0 115.291 177.426 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -96.78 7.57 46.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 130.615 3.566 . . . . 0.0 109.245 178.456 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.8 t30 35.7 47.61 0.4 Allowed 'General case' 0 N--CA 1.448 -0.53 2 O-C-N 113.535 -5.728 . . . . 0.0 114.558 -172.51 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -88.91 110.75 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 128.114 2.566 . . . . 0.0 106.844 178.677 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -111.31 170.01 8.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.853 3.261 . . . . 0.0 112.682 -173.738 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -49.89 131.61 22.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 112.457 -177.475 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.453 5.4 pt-20 65.98 39.09 4.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.048 2.939 . . . . 0.0 118.146 178.511 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.7 p -87.18 140.73 29.25 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.411 1.884 . . . . 0.0 107.292 165.454 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 79.7 m -96.22 130.82 43.2 Favored 'General case' 0 N--CA 1.442 -0.858 2 C-N-CA 133.509 4.723 . . . . 0.0 107.108 164.333 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -123.67 175.49 6.81 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.941 1.696 . . . . 0.0 108.743 -176.7 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -111.38 149.88 30.57 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 118.457 -2.652 . . . . 0.0 112.335 178.21 . . . . . . . . 1 1 . 1 . 114 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -121.85 138.55 54.34 Favored 'General case' 0 N--CA 1.448 -0.529 1 C-N-CA 134.395 5.078 . . . . 0.0 109.907 178.995 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 t -133.41 104.12 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 1 CA-C-O 130.104 4.764 . . . . 0.0 104.937 176.913 . . . . . . . . 2 2 . 1 . 114 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 N--CA 1.451 -0.406 1 O-C-N 113.14 -5.975 . . . . 0.0 105.495 179.286 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.2 ttp . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 113.947 -2.93 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 115 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -88.11 130.28 35.06 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 124.175 1.941 . . . . 0.0 115.491 -179.387 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 pt -115.42 174.86 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 111.421 -2.627 . . . . 0.0 111.222 155.391 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.278 52.0 p90 -147.33 143.4 28.02 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 169.143 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.63 99.04 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 130.398 3.479 . . . . 0.0 105.395 -156.487 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -83.7 133.07 34.82 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.975 2.11 . . . . 0.0 105.513 176.236 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.283 45.1 p -99.77 -171.56 2.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.043 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.77 -6.61 57.62 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 130.602 3.561 . . . . 0.0 115.325 170.373 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -117.11 -163.9 0.95 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 112.214 -2.266 . . . . 0.0 106.984 -179.723 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.03 50.7 0.77 Allowed Glycine 0 CA--C 1.524 0.656 0 O-C-N 124.757 1.285 . . . . 0.0 112.139 -178.087 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.343 66.9 tttt -119.69 139.1 52.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.48 3.912 . . . . 0.0 106.853 167.696 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.6 m -131.71 117.88 19.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 115.563 -2.161 . . . . 0.0 106.896 179.888 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.6 mt -100.46 129.32 51.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 -170.448 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -92.86 146.65 23.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 177.117 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.92 127.03 27.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 -170.801 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -108.18 98.05 7.65 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 126.407 3.003 . . . . 0.0 114.291 175.424 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.3 164.08 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 117.606 -3.184 . . . . 0.0 114.515 -166.411 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.98 137.09 31.62 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 117.085 -1.436 . . . . 0.0 110.028 171.587 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -85.01 -3.92 9.68 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.516 2.811 . . . . 0.0 113.682 -172.822 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.4 p -80.72 -2.11 45.53 Favored 'General case' 0 C--N 1.33 -0.264 1 CA-C-O 108.846 -5.359 . . . . 0.0 112.523 167.435 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -89.1 152.81 21.44 Favored 'General case' 0 N--CA 1.447 -0.59 1 O-C-N 130.172 4.67 . . . . 0.0 110.709 177.45 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -83.42 151.35 25.53 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.98 1.712 . . . . 0.0 107.427 -175.718 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.496 HD11 HD23 ' A' ' 56' ' ' LEU . 22.8 mm -53.62 -33.39 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.812 174.639 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -62.41 -52.08 64.98 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 129.387 3.075 . . . . 0.0 108.243 -173.63 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -77.57 -23.2 50.06 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 109.441 -3.527 . . . . 0.0 113.572 -174.323 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.34 35.2 t -58.4 -50.34 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 129.952 3.301 . . . . 0.0 110.916 162.452 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HE2' HG22 ' A' ' 23' ' ' ILE . 55.1 mtmt -67.15 -38.46 85.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 127.203 2.814 . . . . 0.0 114.182 175.452 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.68 -4.58 16.2 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 117.841 -3.037 . . . . 0.0 117.404 163.329 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -92.82 -42.67 9.42 Favored 'General case' 0 C--N 1.328 -0.351 1 O-C-N 115.691 -4.381 . . . . 0.0 105.093 175.407 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -49.2 -39.48 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 1 C-N-CA 132.228 4.211 . . . . 0.0 114.267 165.6 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.257 46.3 tt0 -46.1 -45.11 16.17 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.309 2.243 . . . . 0.0 116.752 175.288 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.34 -41.25 98.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 112.858 -1.974 . . . . 0.0 111.077 173.585 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -76.4 -54.17 7.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.079 -169.787 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -101.77 -5.33 25.02 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 126.251 2.219 . . . . 0.0 114.657 -172.659 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.21 6.16 89.02 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 121.487 3.355 . . . . 0.0 121.487 165.293 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.473 HD12 ' HD2' ' A' ' 37' ' ' PRO 0.266 4.0 tp -100.61 141.62 23.03 Favored Pre-proline 0 N--CA 1.454 -0.273 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -167.085 . . . . . . . . 4 3 . 1 . 115 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HD2' HD12 ' A' ' 36' ' ' ILE . 97.6 Cg_endo -70.6 161.11 47.21 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.969 2.446 . . . . 0.0 113.909 169.565 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.88 -9.43 10.85 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 N-CA-C 117.795 2.19 . . . . 0.0 117.795 -162.198 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -95.55 8.15 44.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 117.731 -3.105 . . . . 0.0 113.188 -178.175 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -119.89 -4.15 10.17 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 112.384 -2.189 . . . . 0.0 115.614 -175.207 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.302 78.4 mt-30 -99.59 138.0 37.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 128.454 2.702 . . . . 0.0 104.618 175.182 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -129.99 102.95 6.5 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 103.184 -2.895 . . . . 0.0 103.184 174.146 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.7 mt -81.61 128.41 33.9 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 119.899 -1.751 . . . . 0.0 107.47 169.119 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mt -113.46 119.89 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 1 C-N-CA 132.275 4.23 . . . . 0.0 106.963 175.894 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -105.18 128.86 53.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 101.082 -3.673 . . . . 0.0 101.082 153.152 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 73.0 -108.28 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 129.071 2.948 . . . . 0.0 110.495 171.166 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.54 22.69 4.11 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.159 1.361 . . . . 0.0 112.111 164.689 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -98.23 108.37 21.06 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.208 3.003 . . . . 0.0 109.929 166.723 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -80.88 108.7 14.77 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 173.86 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.8 mt -67.29 146.3 54.27 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.05 -159.914 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -101.39 134.5 44.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.691 1.596 . . . . 0.0 108.539 -168.299 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 1.9 m-20 -57.33 -37.69 72.93 Favored 'General case' 0 N--CA 1.442 -0.852 1 C-N-CA 132.58 4.352 . . . . 0.0 115.25 -155.489 . . . . . . . . 3 3 . 1 . 115 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.01 -13.72 24.53 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 119.018 -2.301 . . . . 0.0 112.051 -169.38 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -69.7 152.8 44.25 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 118.998 -2.472 . . . . 0.0 107.948 166.832 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.4 p -78.5 179.3 7.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 127.362 2.265 . . . . 0.0 111.902 171.319 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.496 HD23 HD11 ' A' ' 23' ' ' ILE . 43.7 mt -84.51 -26.6 27.99 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 120.165 -1.584 . . . . 0.0 109.273 166.273 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.8 p -69.84 -22.64 63.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 130.203 3.401 . . . . 0.0 110.427 173.923 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -75.88 -29.6 58.56 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 121.783 2.083 . . . . 0.0 111.116 168.954 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -90.85 -2.63 57.74 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.249 1.42 . . . . 0.0 107.912 178.549 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 5.0 t-20 59.53 38.39 22.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.99 2.916 . . . . 0.0 116.087 -179.705 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.6 mm -76.63 105.48 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 126.848 2.059 . . . . 0.0 108.624 -176.643 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 63' ' ' LYS . 2.4 tp-100 -84.67 166.77 16.79 Favored 'General case' 0 C--O 1.238 0.481 1 C-N-CA 133.517 4.727 . . . . 0.0 109.811 178.478 . . . . . . . . 3 3 . 1 . 115 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' N ' ' HG3' ' A' ' 62' ' ' GLN . 20.5 pttt -61.6 135.68 57.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 115.684 -2.103 . . . . 0.0 110.245 -173.346 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 68.79 26.76 5.94 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 131.445 3.898 . . . . 0.0 115.087 177.577 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 m -79.54 115.5 19.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 102.242 -3.244 . . . . 0.0 102.242 -177.966 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -73.36 137.62 44.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 129.23 3.012 . . . . 0.0 107.904 173.49 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.83 176.97 8.23 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 167.234 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -122.65 122.63 39.27 Favored 'General case' 0 N--CA 1.45 -0.474 1 O-C-N 116.165 -4.085 . . . . 0.0 106.301 -173.634 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.451 ' CD2' HD22 ' A' ' 71' ' ' LEU . 55.0 tp -97.91 133.06 42.9 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 124.154 1.93 . . . . 0.0 107.019 171.747 . . . . . . . . 2 2 . 1 . 115 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.34 128.77 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 163.944 . . . . . . . . 1 1 . 1 . 115 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 69' ' ' LEU . 2.5 pt? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 121.675 2.034 . . . . 0.0 109.167 165.701 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 . . . . . . . . . 0 0 . 1 . 116 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.84 151.67 19.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 124.076 0.86 . . . . 0.0 110.403 -177.207 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.303 49.2 pt -141.61 155.62 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 1 C-N-CA 131.802 4.041 . . . . 0.0 110.996 162.278 . . . . . . . . 3 2 . 1 . 116 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -110.93 156.42 21.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 127.664 3.102 . . . . 0.0 110.902 179.058 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.328 82.0 t -136.67 128.13 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 100.763 -3.792 . . . . 0.0 100.763 174.246 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -82.41 125.58 31.22 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 118.404 -2.685 . . . . 0.0 105.63 161.496 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -80.68 167.87 19.52 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.158 1.456 . . . . 0.0 110.213 168.321 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.96 -29.96 69.95 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 117.855 -3.028 . . . . 0.0 113.278 -178.696 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 p -77.54 -25.07 49.85 Favored 'General case' 0 N--CA 1.447 -0.597 1 C-N-CA 132.877 4.471 . . . . 0.0 115.559 171.076 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.46 -2.09 9.54 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 126.799 2.562 . . . . 0.0 110.633 154.301 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -78.37 137.1 37.85 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.503 2.721 . . . . 0.0 105.795 -179.485 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -92.96 123.1 35.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.112 2.165 . . . . 0.0 107.085 -174.422 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.7 mm -111.27 129.61 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 127.863 2.465 . . . . 0.0 105.963 -174.376 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -95.58 120.57 36.06 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.676 2.79 . . . . 0.0 110.564 172.039 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -112.28 131.76 55.33 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.169 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -96.33 116.03 28.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 129.0 3.938 . . . . 0.0 110.008 160.598 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.38 160.7 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 131.511 3.925 . . . . 0.0 109.247 -165.378 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -71.23 152.75 94.43 Favored Pre-proline 0 N--CA 1.446 -0.668 0 O-C-N 117.408 -3.307 . . . . 0.0 108.163 163.197 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -71.11 -18.68 30.59 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 121.703 1.602 . . . . 0.0 112.339 173.793 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.377 63.6 p -125.54 36.44 4.55 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 127.031 2.132 . . . . 0.0 113.748 176.547 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.92 157.6 37.13 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.346 1.458 . . . . 0.0 108.845 173.486 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.259 40.8 p -99.49 168.06 10.21 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 126.782 2.551 . . . . 0.0 109.993 172.941 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.257 33.5 mm -76.88 -15.09 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 119.546 -1.971 . . . . 0.0 110.55 -178.541 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.4 -60.6 2.6 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 127.382 2.273 . . . . 0.0 112.738 174.112 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.95 -31.18 72.3 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 179.501 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.293 78.9 t -53.64 -41.69 47.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 115.373 -2.251 . . . . 0.0 113.415 163.445 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -55.02 -42.55 72.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 123.244 2.747 . . . . 0.0 109.963 176.811 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.75 -37.75 76.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 123.687 1.708 . . . . 0.0 111.635 -177.918 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -71.15 -31.12 67.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.483 -2.011 . . . . 0.0 108.498 176.562 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.303 86.3 mt -74.81 -32.86 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 1 O-C-N 115.756 -4.34 . . . . 0.0 110.842 177.605 . . . . . . . . 3 2 . 1 . 116 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -64.28 -53.2 52.64 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 130.738 3.615 . . . . 0.0 107.638 171.413 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -55.23 -51.7 65.74 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 118.783 2.882 . . . . 0.0 118.783 174.534 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -66.24 -43.48 86.46 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 115.083 -2.389 . . . . 0.0 111.482 177.679 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.342 69.3 mm-40 -128.98 -15.96 4.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 114.563 -2.637 . . . . 0.0 116.338 -166.819 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.58 -22.49 7.35 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 125.628 1.83 . . . . 0.0 111.348 156.192 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mt -73.39 124.79 90.83 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 126.375 1.87 . . . . 0.0 108.728 -162.186 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -70.04 157.51 59.61 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.25 1.967 . . . . 0.0 109.621 173.247 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.17 -29.03 22.54 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 124.805 3.67 . . . . 0.0 111.279 -168.355 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.267 5.4 t70 -40.11 -55.59 2.07 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 126.28 2.943 . . . . 0.0 117.743 158.141 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 82.0 mt-30 -81.66 -6.71 59.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 111.774 -2.466 . . . . 0.0 111.66 -175.392 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -89.06 166.76 13.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 124.184 3.174 . . . . 0.0 113.871 174.972 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.367 6.7 ptt180 -154.66 128.87 8.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 128.112 2.565 . . . . 0.0 108.213 164.594 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 mt -102.57 91.93 4.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 129.656 3.182 . . . . 0.0 110.022 174.781 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.1 mm -96.09 120.86 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 127.156 2.785 . . . . 0.0 105.168 -175.836 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -130.91 116.12 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 130.245 3.418 . . . . 0.0 109.217 -176.116 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.75 42.16 11.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 128.503 2.721 . . . . 0.0 112.516 -176.343 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.01 -2.78 55.43 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.058 1.313 . . . . 0.0 114.515 166.417 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -132.98 158.29 43.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.815 0.846 . . . . 0.0 110.769 -179.476 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.16 130.28 35.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 126.747 3.165 . . . . 0.0 114.761 173.811 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.53 128.29 35.98 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 116.865 -3.647 . . . . 0.0 109.886 163.1 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -117.38 -179.07 3.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 119.512 -1.992 . . . . 0.0 114.08 -171.031 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.28 129.6 35.85 Favored 'General case' 0 N--CA 1.449 -0.52 1 C-N-CA 133.725 4.81 . . . . 0.0 113.026 165.255 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.81 -28.41 7.38 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 118.269 -2.769 . . . . 0.0 110.518 151.18 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.256 75.1 mtt85 -97.77 124.45 42.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.905 2.082 . . . . 0.0 106.709 171.359 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.3 p -62.56 174.3 1.03 Allowed 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 125.254 1.597 . . . . 0.0 114.624 170.23 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -42.07 -53.34 3.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 176.579 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 t -64.69 -29.77 70.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.138 1.375 . . . . 0.0 111.165 -173.632 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -91.21 2.03 56.66 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 119.274 -2.141 . . . . 0.0 110.297 -176.159 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -101.9 20.36 16.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 123.057 2.662 . . . . 0.0 109.419 156.29 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.361 19.4 p30 59.19 22.32 10.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -176.727 . . . . . . . . 2 2 . 1 . 116 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.8 mt -75.7 123.56 31.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 O-C-N 118.18 -2.825 . . . . 0.0 111.292 178.233 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -106.82 -176.01 2.96 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -173.559 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -67.76 125.15 25.33 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.778 1.631 . . . . 0.0 108.203 177.996 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 69.79 20.94 6.63 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 126.208 2.192 . . . . 0.0 114.025 178.016 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.7 m -73.16 140.04 46.76 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 131.163 3.785 . . . . 0.0 114.108 177.173 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.8 m -105.13 143.87 32.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.035 -1.666 . . . . 0.0 111.376 -172.521 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.3 mt -121.84 157.8 30.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.124 1.37 . . . . 0.0 113.834 172.016 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -109.71 155.03 22.06 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 177.441 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -128.53 124.64 36.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 110.426 -3.079 . . . . 0.0 107.35 -179.619 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.25 148.24 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 128.268 2.627 . . . . 0.0 107.055 162.727 . . . . . . . . 1 1 . 1 . 116 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 O-C-N 127.284 2.865 . . . . 0.0 110.552 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 ttp . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 113.645 -3.074 . . . . 0.0 108.144 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -72.09 134.17 45.64 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 102.607 -3.108 . . . . 0.0 102.607 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -132.79 157.62 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 130.605 3.562 . . . . 0.0 105.749 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -120.96 151.02 40.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 129.129 2.972 . . . . 0.0 107.771 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.17 135.34 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 167.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -103.62 120.3 40.62 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 126.648 2.468 . . . . 0.0 110.612 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -97.33 137.23 36.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.414 38.0 mt -27.04 -43.12 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.568 1 C-N-CA 132.996 4.518 . . . . 0.0 111.611 172.044 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.351 80.9 p -83.03 -16.32 47.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.086 -1.634 . . . . 0.0 110.438 -168.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.22 -4.48 23.65 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.477 -1.179 . . . . 0.0 112.116 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -80.61 132.62 35.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 129.449 3.1 . . . . 0.0 113.224 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -105.14 128.31 53.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 102.103 -3.295 . . . . 0.0 102.103 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 13' ' ' ILE . 59.4 mt -129.44 135.3 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 -174.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.456 1.8 t -127.18 147.03 50.2 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -143.23 129.93 20.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 118.167 -2.833 . . . . 0.0 107.21 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 16' ' ' GLU . 14.7 mp0 -75.53 123.74 25.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 165.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -137.24 173.81 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 125.996 2.808 . . . . 0.0 104.847 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.49 154.37 39.14 Favored Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 102.149 -3.278 . . . . 0.0 102.149 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.06 -29.36 22.57 Favored 'Trans proline' 0 N--CA 1.447 -1.23 1 C-N-CA 130.228 7.285 . . . . 0.0 114.352 170.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.3 m -71.89 -16.6 62.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 122.456 2.389 . . . . 0.0 115.693 173.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -65.37 132.92 50.22 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 122.644 2.474 . . . . 0.0 107.817 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.295 70.6 p -43.75 149.23 0.31 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 156.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -66.42 -39.69 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 O-C-N 121.439 -0.788 . . . . 0.0 108.953 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.324 63.4 tt0 -54.92 -37.93 67.02 Favored 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 134.272 5.029 . . . . 0.0 115.229 177.42 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -53.69 -49.29 68.36 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 161.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.35 -13.94 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 126.755 2.022 . . . . 0.0 112.578 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -78.16 -32.45 50.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.749 2.82 . . . . 0.0 108.362 168.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.94 -29.21 22.24 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 117.361 -3.337 . . . . 0.0 110.242 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -63.6 -32.2 73.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 114.612 -2.613 . . . . 0.0 108.33 168.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.361 17.6 mt -65.97 -28.72 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 124.825 3.466 . . . . 0.0 112.315 166.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -73.94 -38.74 64.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 122.054 2.206 . . . . 0.0 106.89 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -52.91 -48.82 66.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 131.203 3.801 . . . . 0.0 113.463 165.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -88.99 -37.15 15.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 126.765 2.54 . . . . 0.0 116.156 -170.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -136.76 -14.71 1.62 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.699 1.714 . . . . 0.0 110.646 -162.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.06 8.34 34.08 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 155.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.258 13.7 mt -101.59 133.08 21.04 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-N 123.367 3.583 . . . . 0.0 107.924 -162.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.21 150.92 37.95 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 CA-C-N 123.027 2.117 . . . . 0.0 114.223 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -46.85 -40.16 24.86 Favored 'Trans proline' 0 N--CA 1.443 -1.499 1 C-N-CA 126.861 5.041 . . . . 0.0 119.73 166.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.3 -44.42 88.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 128.504 3.627 . . . . 0.0 116.27 -170.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.301 74.0 mm-40 -100.37 -1.41 36.12 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 113.457 -1.701 . . . . 0.0 112.103 -173.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -95.65 125.76 40.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 126.571 2.419 . . . . 0.0 113.081 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.348 31.4 ttm105 -124.26 132.84 53.61 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 128.509 2.724 . . . . 0.0 108.579 172.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.81 151.21 29.31 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 117.498 -1.239 . . . . 0.0 108.89 -172.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.409 34.8 mt -129.95 131.53 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.912 1.685 . . . . 0.0 106.988 -167.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -142.31 118.42 10.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 130.67 3.588 . . . . 0.0 110.666 169.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.58 27.12 11.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.101 2.16 . . . . 0.0 110.228 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.53 -20.45 44.36 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.108 -1.62 . . . . 0.0 113.101 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.362 45.2 mtmt -94.71 143.41 26.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -165.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -71.35 137.4 48.41 Favored 'General case' 0 C--O 1.223 -0.294 0 O-C-N 121.644 -0.66 . . . . 0.0 110.992 159.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.2 mt -104.62 140.44 38.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -128.98 157.26 42.18 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 -147.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.256 5.9 p-10 -59.2 140.19 56.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.124 172.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.13 -47.1 1.05 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 105.673 -2.971 . . . . 0.0 105.673 162.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.86 175.92 5.46 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.225 -1.488 . . . . 0.0 111.053 -165.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 p -122.52 161.41 23.68 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.163 2.585 . . . . 0.0 113.496 -164.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mt -55.02 -35.45 64.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.5 t -57.75 -46.23 84.78 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 128.79 2.836 . . . . 0.0 109.825 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -59.91 -37.4 79.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 119.892 -1.755 . . . . 0.0 114.294 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -90.11 15.13 10.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 115.091 -2.385 . . . . 0.0 115.008 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 m120 71.52 10.87 6.54 Favored 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 132.89 4.476 . . . . 0.0 110.246 161.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.0 mt -52.61 134.54 14.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 1 C-N-CA 133.864 4.866 . . . . 0.0 110.179 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -145.06 -177.55 5.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 130.822 3.649 . . . . 0.0 111.331 -159.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.378 72.6 tttt -51.81 104.83 0.09 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 129.999 3.32 . . . . 0.0 114.278 170.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 70.92 21.49 5.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 118.143 -2.848 . . . . 0.0 113.565 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 m -58.16 119.79 7.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 121.915 2.143 . . . . 0.0 107.059 173.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.5 m -92.89 122.5 35.33 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 129.407 3.083 . . . . 0.0 107.769 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -113.82 170.99 7.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 125.279 1.612 . . . . 0.0 109.103 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.22 144.33 44.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.154 2.182 . . . . 0.0 111.128 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.06 103.2 7.32 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -160.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 m -87.54 128.6 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 124.875 2.274 . . . . 0.0 109.86 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.307 31.8 tp -93.43 114.0 26.29 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.304 37.6 ttt85 80.42 -52.65 0.35 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 129.162 2.985 . . . . 0.0 115.408 162.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.44 138.46 47.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.714 2.806 . . . . 0.0 105.375 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.282 40.5 ttt-85 -110.6 134.31 52.53 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 102.297 -3.223 . . . . 0.0 102.297 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.0 -122.56 6.2 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 116.566 -2.731 . . . . 0.0 107.36 -164.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 115.531 -2.816 . . . . 0.0 112.164 -175.574 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -98.64 133.56 42.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 121.051 1.751 . . . . 0.0 109.029 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.284 1.1 pt -129.6 168.09 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.27 161.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -132.24 146.45 52.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.89 94.92 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 1 N-CA-C 98.661 -4.57 . . . . 0.0 98.661 -161.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -77.53 137.9 38.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 124.857 2.265 . . . . 0.0 110.891 170.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.582 HG22 HD23 ' A' ' 69' ' ' LEU . 44.5 p -94.61 168.52 10.8 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 124.375 2.035 . . . . 0.0 106.667 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.18 -16.53 62.53 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 118.431 -2.668 . . . . 0.0 111.137 163.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.0 p -91.23 -7.15 52.11 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 115.724 -2.084 . . . . 0.0 113.344 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.99 -17.71 17.12 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.408 1.48 . . . . 0.0 115.953 161.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -76.93 145.63 38.07 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.413 2.285 . . . . 0.0 107.674 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.2 p -105.82 121.86 44.91 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.51 2.724 . . . . 0.0 108.982 172.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.273 35.6 mm -89.26 146.82 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 173.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 22.1 m -109.52 137.64 47.06 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 119.826 -1.796 . . . . 0.0 109.86 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -122.87 100.13 6.74 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -160.24 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.5 106.35 17.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.944 3.697 . . . . 0.0 109.195 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -158.88 161.07 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 120.777 1.626 . . . . 0.0 112.26 -160.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -97.42 152.95 38.51 Favored Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 118.466 -2.646 . . . . 0.0 110.143 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.309 2.7 Cg_exo -51.77 -30.42 37.75 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 N-CA-C 119.355 2.791 . . . . 0.0 119.355 167.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 p -88.16 2.39 52.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.997 2.119 . . . . 0.0 112.019 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -81.39 140.93 34.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 120.021 1.282 . . . . 0.0 109.361 166.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -80.41 159.58 25.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.994 2.518 . . . . 0.0 109.604 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 54' ' ' ARG 0.293 8.7 mt -72.08 -14.23 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 126.219 1.808 . . . . 0.0 115.011 170.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -87.06 -18.48 30.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 170.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.279 13.3 t30 -66.56 -45.58 78.86 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 111.591 -2.549 . . . . 0.0 106.466 165.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.1 t -56.8 -40.76 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 1 C-N-CA 132.205 4.202 . . . . 0.0 108.805 170.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 90.6 mttt -73.46 -38.76 65.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 116.42 -2.112 . . . . 0.0 110.185 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -31.57 72.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -57.43 -44.72 84.91 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 125.003 1.44 . . . . 0.0 112.933 163.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.416 21.7 mt -55.88 -45.27 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 127.914 2.486 . . . . 0.0 114.703 -176.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -48.83 -67.11 0.3 Allowed 'General case' 0 C--N 1.33 -0.24 1 O-C-N 129.493 4.245 . . . . 0.0 113.815 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -50.3 -32.04 15.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -87.02 -58.27 2.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.173 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.284 18.2 tp10 -112.45 -8.66 13.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 121.105 3.743 . . . . 0.0 121.105 -166.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.56 1.2 55.44 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 117.146 -1.919 . . . . 0.0 111.749 162.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 36' ' ' ILE . 18.6 mt -98.42 110.45 56.61 Favored Pre-proline 0 N--CA 1.452 -0.359 0 C-N-CA 125.284 1.434 . . . . 0.0 110.073 -171.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -56.77 142.97 91.84 Favored 'Trans proline' 0 C--N 1.323 -0.776 1 CA-C-O 110.438 -4.068 . . . . 0.0 118.062 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HB3' ' HB3' ' A' ' 27' ' ' LYS 0.277 28.7 Cg_exo -45.1 -31.23 5.54 Favored 'Trans proline' 0 N--CA 1.452 -0.915 1 O-C-N 129.638 4.494 . . . . 0.0 119.543 -178.737 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.68 -35.2 72.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.289 79.7 mt-30 -90.07 13.37 15.11 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.652 -1.613 . . . . 0.0 113.363 -177.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -106.13 156.9 17.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 172.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -138.68 116.52 11.54 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 127.271 2.228 . . . . 0.0 112.093 149.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.93 107.23 19.61 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 131.19 3.796 . . . . 0.0 105.946 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 pt -110.52 158.18 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 129.235 3.014 . . . . 0.0 109.5 169.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -115.62 -0.57 12.97 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 130.263 3.425 . . . . 0.0 108.9 161.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.552 . . -142.43 -110.68 0.13 Allowed 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 119.135 -2.228 . . . . 0.0 114.617 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.06 -19.8 2.88 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 122.473 2.397 . . . . 0.0 110.629 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -117.54 154.8 30.88 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 127.552 2.56 . . . . 0.0 112.361 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.05 165.25 11.4 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 124.122 0.889 . . . . 0.0 108.855 -172.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.314 38.6 mt -96.25 128.08 42.84 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 110.954 -2.839 . . . . 0.0 106.744 164.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -69.18 125.14 25.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 116.306 -1.807 . . . . 0.0 115.551 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.278 0.0 OUTLIER -46.27 -28.66 1.35 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 128.824 3.828 . . . . 0.0 117.789 -170.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.11 10.87 60.27 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 125.57 1.794 . . . . 0.0 116.548 -168.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.511 ' O ' HD12 ' A' ' 23' ' ' ILE . 50.5 mtt180 -111.33 179.83 3.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.949 1.699 . . . . 0.0 107.504 168.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -120.45 172.09 8.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 104.583 -2.376 . . . . 0.0 104.583 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.392 6.9 mp -40.21 -51.55 2.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 130.919 3.688 . . . . 0.0 110.309 157.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 p -63.02 -37.92 89.12 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.843 2.057 . . . . 0.0 114.868 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.43 -46.42 66.81 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.835 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -79.15 -5.3 53.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 125.952 2.787 . . . . 0.0 114.699 -175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.65 44.43 17.46 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 117.977 -2.952 . . . . 0.0 115.937 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.7 mm -91.2 98.06 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -77.87 166.49 22.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.304 2.642 . . . . 0.0 109.556 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.36 129.79 1.76 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 167.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 70.79 38.83 1.15 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.455 2.302 . . . . 0.0 113.367 167.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.4 m -92.03 130.42 37.77 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 130.639 3.575 . . . . 0.0 108.449 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.3 m -88.36 111.95 22.32 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 127.435 2.959 . . . . 0.0 109.189 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.9 mt -94.85 136.43 35.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.927 1.291 . . . . 0.0 108.678 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -95.2 125.44 39.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.298 -1.501 . . . . 0.0 110.551 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.582 HD23 HG22 ' A' ' 7' ' ' THR . 27.0 tp -101.01 108.96 20.8 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.179 1.792 . . . . 0.0 108.123 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.6 147.76 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 123.343 1.544 . . . . 0.0 109.502 153.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 pp -138.18 141.05 40.06 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.943 2.497 . . . . 0.0 111.355 -171.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.8 mtm105 -91.34 12.45 20.4 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 174.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.264 2.0 pp -122.74 37.27 4.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 128.044 3.34 . . . . 0.0 111.77 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.403 HH21 ' C ' ' A' ' 76' ' ' GLY . 1.7 tmm_? -63.76 -43.43 96.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.255 3.422 . . . . 0.0 113.887 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.02 23.53 7.69 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 130.244 3.783 . . . . 0.0 114.117 -166.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.403 ' C ' HH21 ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 115.624 -2.765 . . . . 0.0 106.935 167.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 53.8 ttp . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 117.459 -1.258 . . . . 0.0 107.756 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -77.42 134.52 38.39 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 126.244 2.215 . . . . 0.0 114.494 168.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -137.43 161.6 34.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.5 3.52 . . . . 0.0 102.337 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -112.54 144.25 42.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 111.015 -2.811 . . . . 0.0 114.764 168.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -132.77 112.78 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 O-C-N 125.738 1.899 . . . . 0.0 108.053 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -72.57 125.19 26.84 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 114.106 -2.854 . . . . 0.0 106.434 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -90.12 162.98 15.04 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 114.948 -2.453 . . . . 0.0 114.686 155.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pp -77.54 -12.37 59.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 125.283 1.614 . . . . 0.0 110.092 171.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -79.31 -10.4 59.8 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 129.937 3.295 . . . . 0.0 112.188 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.34 10.06 37.14 Favored Glycine 0 CA--C 1.539 1.554 0 O-C-N 117.991 -2.943 . . . . 0.0 114.275 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -104.51 140.97 37.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -115.16 100.83 8.44 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.934 2.894 . . . . 0.0 103.339 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.3 mt -81.16 123.66 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.8 m -104.84 123.74 48.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 121.401 1.91 . . . . 0.0 107.525 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.4 mt -126.23 130.41 50.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.117 2.567 . . . . 0.0 111.811 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.26 116.45 12.71 Favored 'General case' 0 C--N 1.327 -0.377 1 O-C-N 130.072 4.607 . . . . 0.0 109.137 154.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.0 172.72 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 113.29 -3.243 . . . . 0.0 114.793 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -97.11 144.65 28.25 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 124.37 3.259 . . . . 0.0 105.214 159.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -52.77 -28.38 38.01 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 CA-C-N 127.301 3.643 . . . . 0.0 115.475 163.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.9 p -81.46 4.32 21.48 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 127.493 2.996 . . . . 0.0 116.191 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -70.75 156.75 39.12 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.564 1.146 . . . . 0.0 108.268 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -111.42 166.56 11.02 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.352 1.861 . . . . 0.0 110.499 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.437 HG12 ' H ' ' A' ' 23' ' ' ILE . 4.0 mm -52.79 -42.64 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 127.722 2.409 . . . . 0.0 111.651 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -49.49 -34.98 18.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 115.358 -2.258 . . . . 0.0 116.322 171.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -85.0 -15.31 44.62 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 126.809 2.568 . . . . 0.0 109.089 -167.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -81.44 -52.52 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 126.307 2.956 . . . . 0.0 103.59 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -62.66 -33.17 74.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 131.058 3.743 . . . . 0.0 110.949 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.8 66.6 Favored 'General case' 0 N--CA 1.443 -0.786 1 O-C-N 114.529 -5.107 . . . . 0.0 109.377 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -67.11 -29.04 68.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 113.922 -2.942 . . . . 0.0 110.505 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 69' ' ' LEU 0.259 42.0 mt -72.44 -42.06 64.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 123.751 2.978 . . . . 0.0 104.722 176.034 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -53.95 -40.18 66.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 118.602 -2.561 . . . . 0.0 116.294 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.261 2.3 t70 -67.88 -19.89 65.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 116.232 -1.842 . . . . 0.0 112.171 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -94.22 -61.81 1.45 Allowed 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 124.61 1.194 . . . . 0.0 111.351 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -91.92 -28.51 17.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.443 2.697 . . . . 0.0 113.431 -166.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.22 -24.58 24.31 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 121.046 -1.034 . . . . 0.0 112.5 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 mt -60.32 118.18 31.14 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 111.737 -2.232 . . . . 0.0 107.097 -169.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.263 98.0 Cg_endo -67.74 158.04 59.05 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 CA-C-N 122.446 1.909 . . . . 0.0 116.563 175.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.312 14.9 Cg_exo -57.27 -33.11 95.49 Favored 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 128.635 6.223 . . . . 0.0 112.954 -179.282 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -86.53 -9.89 55.2 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 122.561 2.437 . . . . 0.0 111.581 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -94.77 -23.3 17.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.517 1.136 . . . . 0.0 113.724 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.46 122.15 21.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 113.722 -3.037 . . . . 0.0 108.751 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -100.4 119.47 38.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 121.428 1.922 . . . . 0.0 107.888 164.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 tp -121.18 104.06 9.47 Favored 'General case' 0 N--CA 1.445 -0.719 1 C-N-CA 132.458 4.303 . . . . 0.0 109.912 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.297 47.8 mm -96.6 151.18 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 128.359 3.537 . . . . 0.0 112.067 174.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -150.47 108.74 3.76 Favored 'General case' 0 CA--C 1.535 0.382 1 C-N-CA 132.038 4.135 . . . . 0.0 111.669 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.27 29.5 3.63 Favored 'General case' 0 C--N 1.325 -0.47 1 C-N-CA 132.269 4.228 . . . . 0.0 117.168 157.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.24 -10.11 20.18 Favored Glycine 0 CA--C 1.527 0.833 1 C-N-CA 133.765 5.459 . . . . 0.0 107.607 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -123.44 162.99 21.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 121.752 2.776 . . . . 0.0 105.908 -168.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -79.71 149.6 31.13 Favored 'General case' 0 N--CA 1.449 -0.488 1 C-N-CA 132.986 4.514 . . . . 0.0 108.588 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.0 mt -112.86 104.87 12.87 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.599 1.56 . . . . 0.0 108.479 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -94.35 149.82 20.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 102.181 -3.266 . . . . 0.0 102.181 -171.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -76.49 152.42 36.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 127.01 2.124 . . . . 0.0 114.195 -165.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.33 -23.04 33.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 119.457 2.543 . . . . 0.0 119.457 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -70.57 162.48 28.8 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 p -100.79 165.06 11.56 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.117 -1.615 . . . . 0.0 107.146 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.7 mt -60.9 -47.37 86.69 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 113.053 -1.885 . . . . 0.0 115.709 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.4 p -43.06 -45.23 5.17 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 129.081 2.952 . . . . 0.0 114.854 162.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.81 -52.5 59.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 131.416 3.886 . . . . 0.0 110.448 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -74.12 -14.3 60.95 Favored 'General case' 0 N--CA 1.449 -0.494 1 C-N-CA 132.465 4.306 . . . . 0.0 111.802 172.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.48 19.5 t30 87.37 20.74 0.06 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 165.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.9 mt -78.44 144.07 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -168.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -142.64 172.54 12.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.285 1.834 . . . . 0.0 108.996 -155.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -62.54 119.76 9.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 125.591 1.807 . . . . 0.0 109.85 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.506 15.2 mt-10 85.29 15.26 0.16 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -176.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -71.68 141.17 49.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.704 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.3 m -108.56 117.57 34.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.13 142.15 32.0 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.376 2.271 . . . . 0.0 109.304 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -108.69 125.48 51.94 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 125.275 2.464 . . . . 0.0 111.936 169.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.442 HD21 HG21 ' A' ' 30' ' ' ILE . 23.1 tp -96.16 132.96 41.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 110.341 -3.118 . . . . 0.0 109.307 174.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.12 158.14 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 131.001 3.72 . . . . 0.0 108.138 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.303 83.3 mt -101.34 143.86 30.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.935 162.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -84.79 134.76 34.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 129.121 2.969 . . . . 0.0 107.605 150.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.6 mt -114.67 133.86 55.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.365 18.0 ptt180 -137.23 -9.12 1.74 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -165.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.35 -40.77 1.75 Allowed Glycine 0 CA--C 1.528 0.859 0 O-C-N 128.34 3.525 . . . . 0.0 114.474 -165.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.748 0 C-N-CA 126.049 1.785 . . . . 0.0 109.19 -169.112 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 117.348 -1.31 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -89.14 140.86 29.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.424 1.489 . . . . 0.0 113.348 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.8 pt -134.45 161.02 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 127.35 2.26 . . . . 0.0 107.742 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.527 ' CE1' HG23 ' A' ' 14' ' ' THR . 57.3 m-85 -123.46 112.37 17.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 119.783 -1.823 . . . . 0.0 109.809 -169.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.75 128.8 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 100.201 -4.0 . . . . 0.0 100.201 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -90.29 136.1 33.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 110.949 -2.841 . . . . 0.0 107.004 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.255 26.8 p -114.86 132.3 56.56 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 124.465 1.103 . . . . 0.0 109.77 167.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.4 mt -72.86 -3.98 28.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 116.995 -3.566 . . . . 0.0 113.958 -151.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.5 p -76.65 -5.91 49.87 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 121.874 2.125 . . . . 0.0 115.935 159.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.6 -6.12 7.05 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 118.426 -2.671 . . . . 0.0 110.805 160.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -85.37 127.36 34.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 104.138 -2.541 . . . . 0.0 104.138 -165.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -96.2 101.4 13.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 126.629 2.456 . . . . 0.0 111.448 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.41 114.41 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 125.84 2.733 . . . . 0.0 105.305 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.527 HG23 ' CE1' ' A' ' 4' ' ' PHE . 11.2 m -99.29 113.61 26.0 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.492 HD11 HG13 ' A' ' 30' ' ' ILE . 46.7 mt -105.95 154.21 20.9 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.932 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -93.55 137.34 32.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.591 1.663 . . . . 0.0 106.677 165.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.309 11.8 m -145.05 175.78 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 128.466 2.706 . . . . 0.0 111.968 -174.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -139.3 152.99 70.58 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 128.823 2.849 . . . . 0.0 109.613 164.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.37 -30.3 92.37 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.493 2.795 . . . . 0.0 117.055 -173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 p -91.77 20.66 5.39 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 121.72 2.055 . . . . 0.0 110.752 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -100.82 140.75 34.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 119.728 -1.858 . . . . 0.0 109.046 -169.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.2 p -70.24 157.91 36.81 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 127.951 3.282 . . . . 0.0 110.937 -168.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.439 HG22 ' HD2' ' A' ' 27' ' ' LYS 0.286 26.9 mt -61.67 -27.97 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 116.487 -1.72 . . . . 0.0 111.654 165.2 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.252 9.4 tp10 -62.06 -47.59 84.04 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 123.248 2.749 . . . . 0.0 106.052 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -68.71 -38.09 79.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 123.011 2.641 . . . . 0.0 111.645 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -55.62 -58.34 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 127.332 2.253 . . . . 0.0 114.389 166.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HE3' HD11 ' A' ' 43' ' ' LEU . 14.0 mttt -53.38 -35.44 60.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 128.423 2.689 . . . . 0.0 110.096 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.24 -32.34 70.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 125.157 2.408 . . . . 0.0 112.028 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.64 -7.18 58.98 Favored 'General case' 0 N--CA 1.451 -0.388 1 O-C-N 115.614 -4.428 . . . . 0.0 107.987 -170.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.492 HG13 HD11 ' A' ' 15' ' ' LEU . 35.2 mt -87.5 -33.41 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 119.649 1.113 . . . . 0.0 108.264 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -64.47 -39.1 93.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.23 -51.1 65.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.66 1.584 . . . . 0.0 114.536 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -83.22 -52.45 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -95.17 -15.63 23.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 119.834 3.272 . . . . 0.0 119.834 -171.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.33 4.46 62.61 Favored Glycine 0 CA--C 1.531 1.046 1 O-C-N 130.132 4.645 . . . . 0.0 116.035 170.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 36' ' ' ILE . 41.3 mt -86.98 123.16 70.73 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 121.485 2.642 . . . . 0.0 105.653 -155.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -62.65 133.43 42.3 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 CA-C-O 115.982 -1.758 . . . . 0.0 111.401 169.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.4 35.1 Cg_exo -41.55 -24.42 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 1 C-N-CA 128.664 6.243 . . . . 0.0 121.318 175.806 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -52.53 -50.43 62.86 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.971 1.708 . . . . 0.0 114.974 165.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -83.93 -18.25 37.97 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.162 2.985 . . . . 0.0 110.368 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -76.83 99.36 5.14 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.939 1.696 . . . . 0.0 110.526 169.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -102.47 107.81 18.91 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 119.693 -1.88 . . . . 0.0 107.988 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.466 HD11 ' HE3' ' A' ' 27' ' ' LYS . 19.2 mt -73.77 60.43 0.71 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 129.921 3.288 . . . . 0.0 110.184 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mm -87.79 107.68 17.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 115.646 -2.121 . . . . 0.0 108.732 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.379 23.3 t80 -133.3 118.85 19.02 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 129.467 3.107 . . . . 0.0 111.187 -168.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.86 43.88 26.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 129.163 2.985 . . . . 0.0 116.274 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.23 -28.9 9.6 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.034 2.254 . . . . 0.0 114.865 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.301 54.6 mttt -92.21 164.77 13.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -171.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -81.32 117.84 22.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 151.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.24 143.62 26.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.345 8.5 mt-10 -96.31 164.92 12.45 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 125.789 3.904 . . . . 0.0 111.635 -163.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -72.54 145.4 47.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 129.404 3.082 . . . . 0.0 110.325 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.75 6.5 12.79 Favored Glycine 0 CA--C 1.523 0.536 0 O-C-N 118.183 -2.823 . . . . 0.0 115.473 158.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -122.67 170.12 10.36 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.319 1.848 . . . . 0.0 110.226 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.4 p -99.7 165.3 11.67 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 130.959 3.703 . . . . 0.0 109.875 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.325 37.6 mt -41.21 -45.9 2.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.657 2.783 . . . . 0.0 113.623 170.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.4 m -84.45 -21.8 30.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 122.545 2.429 . . . . 0.0 112.281 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.263 20.0 m-20 -68.4 -18.59 64.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 115.981 -1.961 . . . . 0.0 113.457 173.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -108.33 11.7 26.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 126.564 2.415 . . . . 0.0 113.012 164.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 10.7 p30 64.47 28.04 13.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 167.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mt -78.6 131.29 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 121.025 -1.047 . . . . 0.0 110.647 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -106.88 163.83 12.63 Favored 'General case' 0 N--CA 1.444 -0.742 1 C-N-CA 132.078 4.151 . . . . 0.0 108.586 -177.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -53.67 144.32 18.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 111.209 -2.723 . . . . 0.0 113.237 171.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.433 44.9 mt-10 57.81 10.82 1.19 Allowed 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 118.393 -2.692 . . . . 0.0 117.432 -172.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 m -73.03 147.65 44.89 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.7 m -105.69 139.57 40.07 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 129.405 3.082 . . . . 0.0 107.969 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.84 179.97 8.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 114.657 -2.592 . . . . 0.0 111.365 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -125.41 131.13 52.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 127.29 2.869 . . . . 0.0 111.981 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 tp -102.43 147.08 27.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.379 1.872 . . . . 0.0 106.695 167.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -121.42 151.04 24.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 125.299 2.476 . . . . 0.0 108.897 168.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -111.57 143.75 41.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 108.804 -3.816 . . . . 0.0 110.755 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -58.89 124.61 20.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.92 2.488 . . . . 0.0 110.036 156.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.29 136.39 33.14 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 130.587 3.555 . . . . 0.0 109.858 -176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -80.01 -20.05 46.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 112.473 -3.632 . . . . 0.0 112.254 -170.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.03 40.99 1.25 Allowed Glycine 0 CA--C 1.538 1.509 0 CA-C-N 122.125 2.239 . . . . 0.0 113.406 -165.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 N-CA-C 103.31 -3.916 . . . . 0.0 103.31 177.26 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.584 0.707 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -100.25 145.54 27.96 Favored 'General case' 0 N--CA 1.442 -0.83 2 O-C-N 113.477 -5.764 . . . . 0.0 107.722 -171.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 3' ' ' ILE . 8.1 pt -127.85 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 1 O-C-N 115.78 -4.325 . . . . 0.0 107.526 151.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -88.55 136.67 32.88 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.075 -1.421 . . . . 0.0 107.697 166.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.25 10.9 t -123.59 122.33 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 117.3 -3.375 . . . . 0.0 109.448 170.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -94.01 107.14 19.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.4 6.2 p -56.41 160.45 3.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 128.196 3.435 . . . . 0.0 117.386 170.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 70' ' ' VAL . 2.0 tm? -74.63 -24.18 58.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.395 1.078 . . . . 0.0 109.032 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.67 -1.92 56.78 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 123.144 1.449 . . . . 0.0 114.174 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.44 -26.79 15.35 Favored Glycine 0 CA--C 1.526 0.761 0 O-C-N 119.371 -2.081 . . . . 0.0 115.762 165.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -70.01 130.25 41.67 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 116.929 -3.689 . . . . 0.0 107.731 -172.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.5 m -88.77 109.94 20.6 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 118.895 -2.378 . . . . 0.0 108.089 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 pt -93.31 141.48 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 124.291 1.037 . . . . 0.0 112.551 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 t -81.95 143.94 31.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 161.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.09 121.14 22.23 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 131.543 3.937 . . . . 0.0 107.363 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.31 13.1 mp0 -86.12 134.39 33.81 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 117.598 -1.641 . . . . 0.0 110.375 172.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.274 27.4 m -137.38 170.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 116.471 -1.728 . . . . 0.0 109.37 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -112.94 158.88 36.52 Favored Pre-proline 0 N--CA 1.444 -0.739 0 C-N-CA 128.668 2.787 . . . . 0.0 105.258 162.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.79 -28.35 25.23 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.935 2.423 . . . . 0.0 117.21 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -76.85 4.22 10.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 126.127 2.142 . . . . 0.0 116.596 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -84.43 141.15 31.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.361 1.864 . . . . 0.0 107.853 -164.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -78.86 140.09 38.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.336 1.455 . . . . 0.0 110.235 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.441 HD12 ' HB2' ' A' ' 54' ' ' ARG 0.29 8.3 mt -47.09 -35.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 119.979 -1.701 . . . . 0.0 114.939 171.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -53.79 -49.31 68.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.306 2.242 . . . . 0.0 111.095 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 7.9 t-20 -64.78 -43.25 93.84 Favored 'General case' 0 N--CA 1.441 -0.91 1 C-N-CA 132.665 4.386 . . . . 0.0 111.752 176.323 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.12 -50.63 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 115.208 -2.33 . . . . 0.0 113.351 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -61.6 -41.19 97.09 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 127.261 2.224 . . . . 0.0 112.259 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.73 -40.53 84.03 Favored 'General case' 0 N--CA 1.448 -0.543 1 C-N-CA 132.165 4.186 . . . . 0.0 109.235 177.363 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.32 79.8 mttt -79.33 -19.46 50.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 119.043 -2.286 . . . . 0.0 114.794 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mt -76.82 -32.34 20.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 118.887 -2.383 . . . . 0.0 107.413 172.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.82 -38.46 86.48 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 116.667 -3.77 . . . . 0.0 114.005 163.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -67.14 -23.03 65.75 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 113.007 -3.378 . . . . 0.0 109.641 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -98.55 -66.94 0.87 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 121.455 1.934 . . . . 0.0 113.733 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -111.32 -9.78 14.27 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 117.108 -3.495 . . . . 0.0 109.235 -164.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.53 2.37 50.26 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.145 -1.364 . . . . 0.0 114.479 158.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -77.0 125.13 87.26 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 125.02 1.328 . . . . 0.0 107.782 -171.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.59 129.55 19.09 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.826 3.684 . . . . 0.0 115.637 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -41.85 -33.07 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 1 C-N-CA 127.55 5.5 . . . . 0.0 117.502 175.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -51.11 -64.17 0.9 Allowed 'General case' 0 N--CA 1.445 -0.678 1 C-N-CA 132.174 4.189 . . . . 0.0 112.925 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -73.18 -26.27 61.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 128.661 2.784 . . . . 0.0 117.524 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -73.22 128.4 35.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.104 2.562 . . . . 0.0 107.351 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 ttm105 -120.73 129.37 53.61 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.977 1.711 . . . . 0.0 108.468 158.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -97.48 161.94 13.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.365 -1.779 . . . . 0.0 110.822 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -136.07 138.0 47.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 126.428 2.33 . . . . 0.0 108.062 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -130.8 116.53 18.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.602 2.361 . . . . 0.0 107.518 162.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.293 . . 57.86 34.15 24.03 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 129.034 2.934 . . . . 0.0 114.106 168.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.1 10.81 84.24 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 129.253 3.311 . . . . 0.0 117.778 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -98.61 134.63 41.28 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.917 2.487 . . . . 0.0 106.957 173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -84.63 124.71 31.77 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.99 130.19 38.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 116.222 -1.847 . . . . 0.0 109.839 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' OE1' ' NE ' ' A' ' 54' ' ' ARG . 1.1 tt0 -91.93 126.01 36.85 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.949 1.704 . . . . 0.0 109.273 -166.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -46.18 115.34 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 129.831 3.252 . . . . 0.0 111.836 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.24 -9.85 31.19 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 116.762 -2.132 . . . . 0.0 112.962 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HB2' HD12 ' A' ' 23' ' ' ILE 0.352 17.7 mmt180 -86.26 154.13 21.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 121.075 2.437 . . . . 0.0 111.383 174.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 p -71.57 161.2 31.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 160.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.49 -21.32 66.18 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 122.257 2.299 . . . . 0.0 113.796 169.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 t -77.53 -16.56 58.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 117.217 -3.427 . . . . 0.0 108.226 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -76.66 4.16 10.06 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 123.192 2.724 . . . . 0.0 113.336 167.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -138.45 9.33 2.68 Favored 'General case' 0 C--N 1.327 -0.405 1 O-C-N 115.085 -4.759 . . . . 0.0 112.523 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 t30 62.3 26.92 16.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 130.054 3.342 . . . . 0.0 116.679 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.36 128.42 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -124.32 -160.07 0.91 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.171 -1.377 . . . . 0.0 107.461 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.66 135.57 51.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -165.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 81.96 10.08 0.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 129.013 2.925 . . . . 0.0 115.12 163.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -70.06 152.19 44.66 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 126.049 2.093 . . . . 0.0 113.432 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.7 m -110.39 125.46 53.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.87 155.47 20.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 169.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -110.92 150.75 28.77 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.663 1.985 . . . . 0.0 106.999 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -125.9 135.55 52.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.705 2.402 . . . . 0.0 109.841 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.408 ' HA ' HD23 ' A' ' 8' ' ' LEU . 19.2 m -135.58 140.45 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 127.928 2.491 . . . . 0.0 108.043 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.277 1.1 pp -136.83 178.48 7.04 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.107 2.563 . . . . 0.0 112.087 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 73.42 -53.36 0.7 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.697 2.399 . . . . 0.0 113.342 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.352 0.8 OUTLIER -131.71 151.22 51.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 -175.104 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.7 ttt-85 -72.39 112.74 8.72 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.93 -2.356 . . . . 0.0 107.16 171.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.04 172.76 14.54 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 115.737 -2.702 . . . . 0.0 111.061 163.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 127.078 3.599 . . . . 0.0 109.124 -156.683 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttp . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.459 HE22 ' HG3' ' A' ' 16' ' ' GLU . 8.6 tp60 -104.67 128.92 52.88 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 101.537 -3.505 . . . . 0.0 101.537 -169.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 pt -138.14 170.97 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 129.727 3.211 . . . . 0.0 106.84 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -114.4 149.3 36.38 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -121.8 121.4 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.271 1.828 . . . . 0.0 106.206 161.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -110.1 178.49 4.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 109.248 -3.614 . . . . 0.0 110.465 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -138.08 155.96 48.26 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 128.238 2.615 . . . . 0.0 108.538 -168.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.4 mt -75.76 -14.52 60.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 112.939 -3.41 . . . . 0.0 111.245 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -92.95 -4.03 53.44 Favored 'General case' 0 C--N 1.324 -0.525 1 CA-C-N 126.255 4.116 . . . . 0.0 108.86 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.12 7.13 31.27 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 120.313 2.885 . . . . 0.0 120.313 162.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -60.76 154.26 22.17 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 118.595 -2.709 . . . . 0.0 108.82 169.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.281 4.3 m -141.92 107.0 4.94 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.427 1.891 . . . . 0.0 108.743 170.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mm -100.43 142.24 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 111.997 -2.365 . . . . 0.0 106.315 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -94.42 143.2 26.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.643 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.6 123.44 37.65 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 122.604 2.456 . . . . 0.0 107.853 -173.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.459 ' HG3' HE22 ' A' ' 2' ' ' GLN . 26.0 mp0 -99.43 109.56 22.13 Favored 'General case' 0 C--N 1.329 -0.283 1 N-CA-C 97.181 -5.118 . . . . 0.0 97.181 175.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 m -118.76 150.21 21.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 119.711 -1.868 . . . . 0.0 108.009 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -89.45 161.29 40.09 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 116.479 -1.724 . . . . 0.0 111.078 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.02 -19.76 13.55 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.504 2.803 . . . . 0.0 111.664 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 p -73.06 -17.93 61.37 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 128.709 2.804 . . . . 0.0 111.7 173.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -69.86 123.94 22.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 124.934 2.302 . . . . 0.0 112.02 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.6 p -76.67 166.11 23.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 111.893 -2.412 . . . . 0.0 110.098 162.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.2 -21.51 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 O-C-N 124.945 1.403 . . . . 0.0 108.641 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -73.59 -28.88 62.06 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.34 -29.82 53.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -83.18 -27.88 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 119.969 -1.707 . . . . 0.0 107.505 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -69.19 -42.22 76.1 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.78 -38.49 78.64 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 133.056 4.542 . . . . 0.0 114.158 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -77.36 -38.5 50.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 127.369 3.462 . . . . 0.0 114.877 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.1 mt -61.11 -35.81 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 1 O-C-N 113.05 -6.031 . . . . 0.0 105.788 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -32.96 71.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.184 1.794 . . . . 0.0 109.756 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.03 -32.19 73.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.99 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -91.65 -36.67 13.5 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.56 1.944 . . . . 0.0 113.943 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -129.16 -23.53 2.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -173.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.04 2.03 57.06 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 126.996 2.685 . . . . 0.0 116.611 165.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.2 mm -72.8 121.42 84.97 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 120.095 1.948 . . . . 0.0 111.048 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -39.27 129.11 1.56 Allowed 'Trans proline' 0 N--CA 1.443 -1.498 0 N-CA-C 119.225 2.74 . . . . 0.0 119.225 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.29 26.4 Cg_exo -47.76 -29.99 12.17 Favored 'Trans proline' 0 N--CA 1.453 -0.901 1 C-N-CA 129.227 6.618 . . . . 0.0 115.825 178.296 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -79.28 -4.27 49.93 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 128.0 2.52 . . . . 0.0 112.381 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -118.36 -15.67 9.68 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.486 1.915 . . . . 0.0 110.349 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.304 79.9 mt-30 -90.05 115.22 27.15 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 116.317 -2.153 . . . . 0.0 108.235 -170.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -103.96 129.55 51.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 100.712 -3.81 . . . . 0.0 100.712 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 mt -132.63 93.78 3.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.423 -2.673 . . . . 0.0 106.278 -162.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -89.56 128.16 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -128.86 107.71 9.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 128.728 2.811 . . . . 0.0 106.398 166.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.331 . . 60.71 16.53 6.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 130.52 3.528 . . . . 0.0 117.706 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.82 -13.47 57.73 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.314 1.912 . . . . 0.0 110.722 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.54 105.45 14.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.998 2.119 . . . . 0.0 105.568 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -61.05 107.64 0.76 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 111.742 -2.481 . . . . 0.0 114.652 152.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.6 mt -65.7 123.06 18.73 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 128.115 3.384 . . . . 0.0 107.974 -172.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.19 131.27 34.8 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 126.884 2.615 . . . . 0.0 111.267 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.97 119.39 4.24 Favored 'General case' 0 N--CA 1.449 -0.485 1 CA-C-O 129.272 4.367 . . . . 0.0 111.849 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.18 -19.74 31.76 Favored Glycine 0 CA--C 1.523 0.559 1 O-C-N 115.195 -4.691 . . . . 0.0 119.234 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -83.56 175.83 9.48 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 118.473 -1.291 . . . . 0.0 111.433 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.3 p -114.16 162.06 17.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 121.216 1.825 . . . . 0.0 110.842 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 8.9 mt -36.71 -50.56 0.83 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.104 2.962 . . . . 0.0 116.654 172.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 p -81.29 0.27 37.73 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 109.485 -3.507 . . . . 0.0 112.995 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -97.04 -18.77 19.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 116.647 -3.783 . . . . 0.0 109.249 170.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -98.99 -17.4 18.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 118.588 -2.57 . . . . 0.0 116.832 167.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 74.72 42.59 0.28 Allowed 'General case' 0 N--CA 1.452 -0.349 1 C-N-CA 132.456 4.303 . . . . 0.0 108.517 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.9 mt -68.21 106.3 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 O-C-N 119.892 -1.755 . . . . 0.0 107.853 156.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -76.88 169.9 17.47 Favored 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 133.628 4.771 . . . . 0.0 112.254 166.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.268 17.9 pttm -69.1 148.94 49.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 174.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 73.2 mt-10 57.34 13.72 1.87 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.7 m -81.58 169.6 16.86 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.467 2.307 . . . . 0.0 108.298 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -143.51 131.51 21.69 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.233 -153.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.22 145.64 35.87 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.158 -1.589 . . . . 0.0 111.159 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.281 24.6 m80 -97.1 117.91 32.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -170.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.31 128.43 34.69 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.602 1.961 . . . . 0.0 110.668 169.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.06 146.96 30.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 1 C-N-CA 131.795 4.038 . . . . 0.0 108.688 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.291 1.2 mm? -84.72 126.56 33.5 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 118.961 -2.337 . . . . 0.0 109.394 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -148.79 105.59 3.58 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 119.438 -2.039 . . . . 0.0 106.55 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.78 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.336 3.054 . . . . 0.0 103.107 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -150.97 121.56 7.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 124.754 2.216 . . . . 0.0 110.153 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.63 -0.99 9.19 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 113.175 -1.83 . . . . 0.0 114.906 -175.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 C-N-CA 127.965 2.698 . . . . 0.0 110.004 173.276 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -84.68 152.1 23.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 125.027 2.346 . . . . 0.0 114.235 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 3' ' ' ILE . 42.1 pt -134.16 137.14 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 129.783 3.233 . . . . 0.0 104.633 165.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -94.56 121.35 36.03 Favored 'General case' 0 N--CA 1.449 -0.504 1 C-N-CA 132.196 4.198 . . . . 0.0 105.219 166.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.56 130.8 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 101.306 -3.59 . . . . 0.0 101.306 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 23.2 mttm -90.9 116.57 28.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 129.547 3.139 . . . . 0.0 106.866 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 p -74.96 162.85 28.23 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 120.252 1.387 . . . . 0.0 110.176 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -70.56 -36.9 73.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.198 1.399 . . . . 0.0 107.823 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.8 p -80.71 -2.65 47.69 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.958 2.103 . . . . 0.0 116.273 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.49 20.34 8.24 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 161.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -107.35 158.07 17.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 126.47 3.033 . . . . 0.0 106.403 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.258 10.9 m -129.49 91.85 3.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 131.538 3.935 . . . . 0.0 108.854 -172.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mm -79.69 111.96 17.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 O-C-N 128.623 3.702 . . . . 0.0 104.71 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.257 85.1 m -86.52 107.73 18.23 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.816 1.647 . . . . 0.0 112.903 173.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mp -97.9 164.82 12.21 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 126.15 2.156 . . . . 0.0 112.888 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -113.08 146.59 38.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 127.196 3.379 . . . . 0.0 107.79 162.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.48 178.8 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 131.035 3.734 . . . . 0.0 107.5 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -120.9 150.42 52.99 Favored Pre-proline 0 N--CA 1.45 -0.432 0 C-N-CA 130.969 3.708 . . . . 0.0 103.109 154.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -47.02 -19.47 0.85 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 120.396 3.191 . . . . 0.0 120.396 164.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.7 m -58.92 -33.17 70.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 130.61 3.564 . . . . 0.0 114.276 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.09 126.49 20.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.891 2.476 . . . . 0.0 107.052 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.5 p -79.89 147.51 31.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 127.609 3.068 . . . . 0.0 104.809 162.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 8.2 mm -46.4 -51.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 111.921 -2.399 . . . . 0.0 114.439 169.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -35.78 -42.15 0.25 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 160.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -74.31 -35.42 63.66 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 117.491 -3.255 . . . . 0.0 115.371 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.85 -42.69 79.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 120.079 -1.638 . . . . 0.0 109.006 170.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -56.72 -36.98 70.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 123.686 1.708 . . . . 0.0 113.543 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.67 -34.02 62.6 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 130.665 3.586 . . . . 0.0 111.05 -175.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -75.44 -44.02 46.63 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 128.578 2.751 . . . . 0.0 106.924 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 mt -60.83 -33.71 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 119.352 -2.092 . . . . 0.0 113.553 162.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.262 12.8 tt0 -60.1 -38.64 83.56 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 123.048 1.404 . . . . 0.0 112.58 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.75 -61.45 2.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 119.492 3.145 . . . . 0.0 119.492 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -63.65 -43.78 95.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 108.452 -3.977 . . . . 0.0 110.443 -168.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -119.46 -18.32 8.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 120.238 1.381 . . . . 0.0 112.336 -167.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.75 -8.66 54.72 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 117.418 -1.768 . . . . 0.0 111.224 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -67.4 115.0 22.02 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 120.196 1.998 . . . . 0.0 111.207 -164.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -74.36 156.65 45.87 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.466 2.11 . . . . 0.0 108.592 -168.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -68.57 -35.46 17.17 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 117.079 1.915 . . . . 0.0 117.079 -172.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.02 -27.06 68.61 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 118.806 2.891 . . . . 0.0 118.806 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -83.73 -30.58 26.58 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 119.236 -2.165 . . . . 0.0 112.746 173.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -67.32 133.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 123.075 1.417 . . . . 0.0 113.719 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -128.19 141.55 51.44 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 130.505 3.522 . . . . 0.0 103.376 161.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.67 136.4 53.94 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 129.488 3.115 . . . . 0.0 106.337 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.2 mt -123.75 156.58 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 110.023 -3.262 . . . . 0.0 112.699 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -158.19 127.53 5.77 Favored 'General case' 0 N--CA 1.45 -0.453 1 O-C-N 129.355 4.16 . . . . 0.0 102.984 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.08 26.27 11.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 165.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.64 -9.6 41.13 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 128.7 3.048 . . . . 0.0 113.331 169.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -121.37 142.54 49.89 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 126.744 2.085 . . . . 0.0 111.371 -166.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 -90.44 116.67 28.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 128.236 2.614 . . . . 0.0 107.978 -172.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.68 136.02 34.87 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.416 1.487 . . . . 0.0 107.99 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.253 4.3 mm-40 -92.33 124.29 36.28 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 110.667 -2.97 . . . . 0.0 107.915 -163.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -53.93 -22.18 9.6 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 119.38 3.104 . . . . 0.0 119.38 -160.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.74 -5.39 55.3 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 128.567 2.984 . . . . 0.0 119.197 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -90.15 156.39 18.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.935 1.694 . . . . 0.0 108.045 173.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -95.98 167.16 11.4 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.75 2.82 . . . . 0.0 108.704 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -70.38 -31.21 68.35 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 125.854 2.74 . . . . 0.0 108.663 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.353 14.1 t -50.71 -38.68 48.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 112.815 -3.469 . . . . 0.0 115.5 164.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.263 0.4 OUTLIER -74.03 -26.84 60.63 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 126.564 2.415 . . . . 0.0 109.578 -168.198 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.522 40.8 m-85 -102.08 10.15 39.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 125.279 1.612 . . . . 0.0 114.328 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.412 3.7 p-10 60.86 33.25 20.02 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 128.028 2.531 . . . . 0.0 116.563 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.7 mt -90.52 114.48 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.291 0.3 OUTLIER -143.86 81.35 1.69 Allowed 'General case' 0 N--CA 1.45 -0.47 1 C-N-CA 131.724 4.01 . . . . 0.0 117.011 -177.106 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.406 22.3 ttpt 84.51 131.95 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.799 3.64 . . . . 0.0 117.73 171.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 72.53 41.38 0.58 Allowed 'General case' 0 N--CA 1.443 -0.785 1 C-N-CA 134.504 5.122 . . . . 0.0 109.306 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.0 m -85.93 144.36 27.69 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 130.753 3.621 . . . . 0.0 111.439 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.9 m -100.33 109.63 21.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.127 2.571 . . . . 0.0 105.748 164.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -111.94 151.09 29.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.107 -1.901 . . . . 0.0 109.911 171.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -120.79 140.54 51.56 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 131.276 3.83 . . . . 0.0 112.06 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -98.67 135.61 39.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 116.053 -1.927 . . . . 0.0 110.954 157.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.33 148.52 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 1 O-C-N 129.345 4.153 . . . . 0.0 109.248 160.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -165.31 -174.6 3.27 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 117.767 -3.083 . . . . 0.0 108.054 -173.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -107.56 123.0 47.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.524 2.73 . . . . 0.0 107.201 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.57 153.45 49.85 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 123.541 1.639 . . . . 0.0 110.988 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -104.91 146.82 28.49 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 171.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.69 165.24 18.96 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 127.978 2.704 . . . . 0.0 111.75 171.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 168.88 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 123.284 1.516 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -134.26 150.22 51.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 108.729 -3.85 . . . . 0.0 116.608 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -136.46 144.69 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 112.8 -2.0 . . . . 0.0 113.454 166.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -90.08 122.24 32.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 116.906 -3.621 . . . . 0.0 109.138 163.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.8 t -82.82 125.24 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 101.244 -3.613 . . . . 0.0 101.244 157.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -103.98 104.58 14.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 110.14 -3.209 . . . . 0.0 104.914 162.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -72.48 137.93 46.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.645 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.36 -39.58 46.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 119.728 3.233 . . . . 0.0 119.728 -171.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.389 2.0 t -35.46 -30.76 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.704 1 C-N-CA 133.465 4.706 . . . . 0.0 117.044 156.75 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.99 -20.22 7.21 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 124.935 2.408 . . . . 0.0 110.444 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.26 73.4 tttt -71.35 139.48 49.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 119.304 -2.292 . . . . 0.0 108.712 -168.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 m -118.15 111.95 19.52 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 126.016 2.073 . . . . 0.0 114.562 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.263 13.8 mm -104.71 131.36 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.002 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.308 2.8 m -94.01 123.58 37.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 117.786 -3.071 . . . . 0.0 108.816 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mp -111.14 132.26 54.43 Favored 'General case' 0 C--O 1.217 -0.605 0 O-C-N 119.629 -1.92 . . . . 0.0 107.795 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -82.98 131.66 35.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 170.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -144.25 -174.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.807 0.843 . . . . 0.0 112.848 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -140.28 143.58 33.99 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 127.672 3.108 . . . . 0.0 108.916 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.68 -15.4 24.28 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 CA-C-N 125.105 2.859 . . . . 0.0 115.625 -167.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -75.32 1.8 12.81 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 117.41 -3.306 . . . . 0.0 116.938 165.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -93.76 150.77 20.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.499 2.319 . . . . 0.0 109.057 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 24' ' ' GLU . 7.4 p -71.36 161.0 31.78 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -175.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.63 HG23 HD13 ' A' ' 43' ' ' LEU 0.305 16.5 mm -49.76 -41.93 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 131.677 3.991 . . . . 0.0 111.174 146.197 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' H ' ' HB ' ' A' ' 22' ' ' THR . 27.8 tt0 -59.35 -45.82 90.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 116.232 -2.187 . . . . 0.0 113.159 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -71.8 -23.3 61.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.472 1.107 . . . . 0.0 113.459 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.294 91.7 t -48.88 -62.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 150.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -68.64 -38.16 80.26 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.927 -1.733 . . . . 0.0 115.086 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.82 -38.26 75.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 129.591 3.157 . . . . 0.0 116.233 172.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -50.26 -37.64 36.84 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 163.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -69.84 -12.92 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 O-C-N 119.837 -1.789 . . . . 0.0 107.675 -172.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -62.45 -43.38 98.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 116.591 -3.818 . . . . 0.0 112.895 171.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -83.32 -32.87 26.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.382 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -75.05 -67.55 0.64 Allowed 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 119.515 -1.991 . . . . 0.0 108.663 168.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -103.58 -23.58 13.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 116.902 -3.624 . . . . 0.0 115.814 -155.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.63 25.74 10.51 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 116.83 -2.095 . . . . 0.0 108.569 172.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 mm -107.68 129.39 24.26 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.36 165.63 31.02 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.292 1.995 . . . . 0.0 111.767 170.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.63 -38.02 6.39 Favored 'Trans proline' 0 N--CA 1.453 -0.897 1 C-N-CA 127.551 5.501 . . . . 0.0 117.007 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.86 -21.11 26.83 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.922 2.489 . . . . 0.0 113.968 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -95.51 -9.53 32.22 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.928 2.891 . . . . 0.0 116.297 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -95.88 133.51 39.97 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 115.193 -2.337 . . . . 0.0 108.793 -172.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -119.13 104.39 10.4 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.702 2.001 . . . . 0.0 107.953 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.63 HD13 HG23 ' A' ' 23' ' ' ILE . 1.4 tt -98.37 118.75 35.73 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 126.499 2.374 . . . . 0.0 105.487 -171.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -117.35 149.91 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -170.76 137.73 1.32 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 124.057 1.884 . . . . 0.0 107.725 166.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.36 28.95 11.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 117.434 2.383 . . . . 0.0 117.434 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.84 -5.39 69.23 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 116.454 -2.303 . . . . 0.0 114.061 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -125.76 147.36 49.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 127.404 2.473 . . . . 0.0 112.613 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -68.04 135.02 51.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.36 1.864 . . . . 0.0 113.46 163.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.625 HD22 HD22 ' A' ' 43' ' ' LEU . 9.9 mp -93.47 101.45 13.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.16 -16.63 59.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -173.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.594 26.5 t0 103.72 145.67 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 127.623 2.369 . . . . 0.0 112.136 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.3 -8.02 2.89 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 172.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.347 48.3 mtp180 -145.17 152.53 40.16 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.782 1.277 . . . . 0.0 109.812 -168.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.7 p -83.08 168.48 16.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 112.777 -2.01 . . . . 0.0 114.835 -168.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.5 mt -47.56 -40.69 19.66 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.3 p -60.1 -56.09 25.84 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.899 2.48 . . . . 0.0 116.594 167.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -46.01 -57.59 4.3 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.512 1.925 . . . . 0.0 114.117 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -74.82 -16.69 60.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 126.901 2.081 . . . . 0.0 115.168 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.274 25.5 t-20 90.33 64.28 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 129.951 3.3 . . . . 0.0 111.498 164.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -118.85 131.0 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.275 73.7 mm-40 -128.06 165.19 20.81 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 126.09 2.119 . . . . 0.0 106.606 -160.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -60.67 147.57 41.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 116.876 -1.535 . . . . 0.0 110.524 -167.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 59.92 19.62 8.62 Favored 'General case' 0 N--CA 1.444 -0.736 1 C-N-CA 131.957 4.103 . . . . 0.0 111.73 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.4 m -81.04 149.66 29.16 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 123.146 2.703 . . . . 0.0 113.287 170.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.3 m -93.08 131.76 37.81 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.879 2.872 . . . . 0.0 107.376 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.9 mt -103.52 130.03 50.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.63 2.772 . . . . 0.0 111.865 159.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -90.6 139.4 30.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.285 43.2 tp -122.29 129.58 52.32 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 117.129 -1.829 . . . . 0.0 109.116 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.254 83.6 t -95.45 139.33 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 126.354 2.284 . . . . 0.0 105.085 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mp -115.01 148.77 38.41 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.869 0.842 . . . . 0.0 111.813 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -112.24 163.24 14.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 124.275 1.988 . . . . 0.0 106.202 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -102.17 22.43 13.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.363 2.265 . . . . 0.0 111.615 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -163.87 154.14 15.21 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.099 -2.25 . . . . 0.0 107.584 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.88 94.2 0.36 Allowed Glycine 0 N--CA 1.444 -0.817 1 C-N-CA 131.382 4.325 . . . . 0.0 110.691 155.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.984 0 CA-C-O 115.564 -2.798 . . . . 0.0 112.665 -171.566 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 112.891 -3.433 . . . . 0.0 107.742 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -91.38 134.51 34.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.386 3.074 . . . . 0.0 112.376 167.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 pt -125.19 167.51 19.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 124.836 2.255 . . . . 0.0 106.915 160.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -106.35 144.43 33.05 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.409 2.284 . . . . 0.0 108.037 162.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.486 HG21 HD11 ' A' ' 30' ' ' ILE . 43.8 t -118.42 108.34 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 168.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -86.19 132.36 34.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 123.236 1.494 . . . . 0.0 111.443 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.7 p -98.08 159.2 15.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 117.189 -3.445 . . . . 0.0 106.079 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -58.7 -45.64 89.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.218 2.207 . . . . 0.0 109.077 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -73.43 3.04 6.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 130.569 3.548 . . . . 0.0 115.772 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.06 -8.99 50.27 Favored Glycine 0 N--CA 1.442 -0.901 2 O-C-N 114.099 -5.376 . . . . 0.0 113.102 162.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -79.15 150.6 31.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 121.73 2.765 . . . . 0.0 111.797 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 p -105.87 131.35 53.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 126.345 2.278 . . . . 0.0 111.643 161.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.455 HG13 ' HB ' ' A' ' 5' ' ' VAL . 1.9 pt -104.28 162.74 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 1 O-C-N 114.611 -5.055 . . . . 0.0 105.469 168.234 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.53 110.27 14.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.635 2.374 . . . . 0.0 106.011 -172.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.282 0.4 OUTLIER -104.48 138.93 40.12 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 128.316 2.646 . . . . 0.0 109.803 -173.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 pm0 -90.15 135.81 33.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 126.821 2.576 . . . . 0.0 108.769 159.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 m -150.37 149.41 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.15 3.38 . . . . 0.0 107.418 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -101.87 141.88 23.47 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 127.939 2.496 . . . . 0.0 105.249 163.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -39.04 -42.76 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 N-CA-C 119.759 2.946 . . . . 0.0 119.759 167.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 p -88.15 14.75 8.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.422 2.689 . . . . 0.0 109.934 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -88.71 150.92 22.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 124.987 2.327 . . . . 0.0 105.661 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -86.99 146.74 26.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 110.442 -3.072 . . . . 0.0 110.206 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 23' ' ' ILE . 69.5 mt -57.17 -24.81 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 124.864 1.353 . . . . 0.0 112.145 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 6.9 tt0 -69.64 -34.16 73.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 128.239 2.616 . . . . 0.0 110.336 172.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -72.04 -31.85 66.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 114.103 -2.856 . . . . 0.0 107.305 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.4 t -79.46 -33.63 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 123.895 3.043 . . . . 0.0 107.68 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -54.85 -49.59 70.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 112.519 -3.61 . . . . 0.0 110.576 168.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.45 -52.33 6.11 Favored 'General case' 0 CA--C 1.537 0.468 1 CA-C-N 126.396 4.18 . . . . 0.0 119.426 156.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -74.09 -22.8 59.35 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 117.038 -3.539 . . . . 0.0 116.511 -169.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.486 HD11 HG21 ' A' ' 5' ' ' VAL . 14.0 mt -66.44 -39.0 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 130.951 3.701 . . . . 0.0 113.373 158.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.4 tm0? -69.44 -26.82 64.79 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 122.841 2.564 . . . . 0.0 109.171 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.49 -42.38 74.87 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 128.436 3.585 . . . . 0.0 110.11 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -76.39 -42.63 43.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 176.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 13.8 tp10 -130.19 5.77 4.9 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.491 -1.38 . . . . 0.0 109.972 -159.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.09 -0.93 35.99 Favored Glycine 0 CA--C 1.532 1.109 1 N-CA-C 123.598 4.199 . . . . 0.0 123.598 165.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 mt -78.05 114.97 46.76 Favored Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 129.696 3.198 . . . . 0.0 105.325 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.264 4.9 Cg_exo -48.52 134.67 26.72 Favored 'Trans proline' 0 N--CA 1.455 -0.768 1 C-N-CA 125.413 4.076 . . . . 0.0 111.554 172.517 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.21 -37.01 26.28 Favored 'Trans proline' 0 N--CA 1.44 -1.656 1 C-N-CA 129.156 6.571 . . . . 0.0 115.15 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -39.49 -31.89 0.11 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 129.65 3.18 . . . . 0.0 115.756 159.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.387 85.5 mt-30 -98.26 -13.42 20.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 118.989 -2.319 . . . . 0.0 114.78 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -81.6 143.08 32.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.2 ttp-105 -127.77 129.66 47.43 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 155.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.4 mt -96.23 132.98 41.11 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 116.672 -3.767 . . . . 0.0 107.297 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mt -125.44 149.57 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -113.64 -25.84 8.52 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 118.203 -2.811 . . . . 0.0 113.076 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.683 . . -143.43 -123.86 0.09 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 112.266 -2.243 . . . . 0.0 110.773 -170.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.93 18.41 19.22 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.666 0.592 . . . . 0.0 112.436 -166.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -151.65 154.77 37.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 118.182 -2.952 . . . . 0.0 110.383 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -57.73 156.33 8.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.802 1.641 . . . . 0.0 112.537 166.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.19 162.72 18.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 118.811 -2.43 . . . . 0.0 108.195 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -104.62 140.86 37.4 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.95 1.357 . . . . 0.0 109.132 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 6.1 m-20 -67.97 -24.2 65.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 130.01 3.324 . . . . 0.0 114.594 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.12 40.77 2.43 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.539 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 11.1 mtt180 -130.37 151.17 51.16 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 165.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -96.6 162.27 13.53 Favored 'General case' 0 N--CA 1.45 -0.428 1 O-C-N 116.253 -4.03 . . . . 0.0 111.424 -167.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -54.67 -44.0 72.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.034 1.733 . . . . 0.0 110.617 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -61.27 -40.98 96.13 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 170.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -54.17 -33.13 57.32 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 131.296 3.838 . . . . 0.0 114.807 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 97.1 m-85 -100.13 0.04 39.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.276 -1.515 . . . . 0.0 111.732 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.7 t30 56.63 36.19 27.26 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 129.28 3.032 . . . . 0.0 117.588 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mt -79.28 116.21 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 103.204 -2.888 . . . . 0.0 103.204 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.1 mm100 -103.44 169.35 8.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.598 1.959 . . . . 0.0 109.204 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.385 53.7 pttt -50.22 133.4 23.7 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.343 1.857 . . . . 0.0 113.42 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 24.0 mt-10 72.12 12.35 5.93 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 130.339 3.455 . . . . 0.0 115.488 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.9 m -60.86 145.31 50.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 113.97 -2.919 . . . . 0.0 112.864 162.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -102.39 131.26 49.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 127.698 3.124 . . . . 0.0 105.154 170.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.75 151.73 25.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.634 -2.541 . . . . 0.0 108.621 161.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -109.47 128.48 55.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 117.917 -2.99 . . . . 0.0 105.595 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.0 tp -106.21 103.07 12.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 112.11 -2.313 . . . . 0.0 109.673 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.1 t -83.23 137.17 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 124.498 2.095 . . . . 0.0 110.574 169.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.62 149.68 51.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.313 1.845 . . . . 0.0 107.274 -157.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 mtm105 -108.78 55.32 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 129.139 2.975 . . . . 0.0 113.65 166.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.488 1.0 OUTLIER -138.09 15.16 2.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 117.434 2.383 . . . . 0.0 117.434 163.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -45.23 48.52 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 127.518 2.327 . . . . 0.0 113.76 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.98 7.03 23.92 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 127.109 2.29 . . . . 0.0 111.599 171.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 O-C-N 120.267 -1.725 . . . . 0.0 109.855 -157.495 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.32 135.83 33.17 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 119.547 -1.971 . . . . 0.0 106.81 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.44 164.08 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 123.961 0.904 . . . . 0.0 112.018 166.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -90.57 129.94 36.65 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 126.092 1.757 . . . . 0.0 110.347 155.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.03 110.51 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 150.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -99.1 134.12 42.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 127.222 3.391 . . . . 0.0 110.926 170.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 p -89.15 141.36 28.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 111.706 -2.497 . . . . 0.0 108.759 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.06 -11.08 35.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 163.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -78.91 -15.55 58.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 118.212 -2.805 . . . . 0.0 115.069 169.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.19 -12.09 6.09 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 120.211 1.369 . . . . 0.0 113.64 159.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -82.95 137.19 34.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.522 1.529 . . . . 0.0 110.612 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -97.67 125.97 42.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 125.201 2.429 . . . . 0.0 106.507 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 mm -112.8 106.06 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 1 O-C-N 115.646 -4.409 . . . . 0.0 101.567 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.4 m -59.91 137.11 58.15 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 122.868 1.318 . . . . 0.0 111.618 158.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.29 140.54 43.47 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 128.584 2.754 . . . . 0.0 109.168 177.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -111.66 121.71 45.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.0 162.54 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 128.864 2.866 . . . . 0.0 104.787 -177.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -111.3 162.53 20.5 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 160.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -88.72 -21.71 1.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 121.735 1.623 . . . . 0.0 109.386 -164.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -69.09 -6.13 26.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 159.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -71.57 137.24 47.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 119.82 -1.8 . . . . 0.0 112.593 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.315 42.7 p -60.44 142.71 54.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 128.414 2.685 . . . . 0.0 112.74 169.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.444 62.6 mt -46.79 -29.58 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 163.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -53.83 -56.27 19.14 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 131.699 4.0 . . . . 0.0 108.013 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -74.75 -28.47 60.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 116.527 -1.701 . . . . 0.0 112.018 -171.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 t -71.01 -51.13 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 128.381 2.672 . . . . 0.0 111.743 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 38' ' ' PRO . 76.3 mttt -55.37 -45.37 76.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 113.456 -3.164 . . . . 0.0 113.317 168.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.5 -17.03 63.5 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 131.291 3.837 . . . . 0.0 115.324 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -77.55 -32.54 53.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 112.946 -3.407 . . . . 0.0 107.317 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.51 -21.81 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 O-C-N 127.062 2.726 . . . . 0.0 108.097 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -67.57 -35.64 79.42 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 128.534 2.734 . . . . 0.0 112.864 164.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.66 -33.13 60.4 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.277 1.031 . . . . 0.0 111.646 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -81.55 -77.33 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 119.725 -1.86 . . . . 0.0 109.391 -172.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.269 15.9 mm-40 -100.9 -15.4 17.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 115.034 -2.412 . . . . 0.0 114.604 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.05 -1.72 40.95 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 121.749 2.068 . . . . 0.0 110.331 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -76.22 130.63 77.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 114.953 -2.451 . . . . 0.0 106.641 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.53 149.73 16.69 Favored 'Trans proline' 0 N--CA 1.446 -1.319 1 C-N-CA 125.991 4.461 . . . . 0.0 111.317 -174.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 19.5 Cg_exo -40.01 -37.42 1.68 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 N-CA-C 119.475 2.837 . . . . 0.0 119.475 165.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -45.7 -49.06 14.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.153 1.781 . . . . 0.0 114.292 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -99.72 -3.4 32.99 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 127.47 2.308 . . . . 0.0 116.976 -169.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -80.23 127.56 32.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 125.144 2.402 . . . . 0.0 108.979 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.533 ' CZ ' HG12 ' A' ' 70' ' ' VAL . 36.4 mtm180 -112.79 127.06 56.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 119.418 -2.051 . . . . 0.0 105.824 165.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.02 124.8 50.72 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 131.331 3.852 . . . . 0.0 107.577 -163.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 mm -124.89 128.82 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 117.12 -3.488 . . . . 0.0 109.445 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -153.68 136.99 15.73 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 118.529 -2.607 . . . . 0.0 109.701 163.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.385 . . 66.35 32.07 7.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 124.339 2.019 . . . . 0.0 115.123 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 -12.33 32.6 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 112.38 -2.191 . . . . 0.0 116.199 -174.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.261 9.9 ttpt -100.84 136.63 40.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.45 -1.617 . . . . 0.0 109.175 -167.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -92.82 116.47 29.06 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 171.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 mt -81.09 143.19 32.62 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 126.446 2.341 . . . . 0.0 105.239 -163.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.98 150.43 29.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.018 2.927 . . . . 0.0 109.356 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.67 155.33 33.47 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 117.988 -2.945 . . . . 0.0 111.361 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.77 48.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 127.111 2.291 . . . . 0.0 114.821 162.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -94.71 160.62 14.53 Favored 'General case' 0 N--CA 1.446 -0.664 1 C-N-CA 135.444 5.498 . . . . 0.0 113.878 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.4 p -103.91 170.8 7.71 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -72.51 -18.3 61.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 123.828 1.775 . . . . 0.0 108.305 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -78.68 -22.45 46.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.316 -2.115 . . . . 0.0 112.118 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -83.98 4.22 30.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -118.33 -7.38 10.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 118.091 -2.88 . . . . 0.0 108.529 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 0.3 OUTLIER 59.71 37.65 22.12 Favored 'General case' 0 N--CA 1.449 -0.511 1 C-N-CA 134.402 5.081 . . . . 0.0 114.149 -172.224 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -69.49 137.46 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 O-C-N 120.646 -1.284 . . . . 0.0 112.298 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -127.74 169.87 13.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.323 3.049 . . . . 0.0 109.48 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -42.33 131.89 3.56 Favored 'General case' 0 N--CA 1.45 -0.437 1 C-N-CA 136.415 5.886 . . . . 0.0 107.938 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.328 2.2 tt0 69.37 12.97 8.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 172.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.5 m -65.27 149.21 50.34 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.786 2.435 . . . . 0.0 108.145 166.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.4 m -101.63 120.84 40.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.238 -3.414 . . . . 0.0 102.557 166.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.37 37.8 mt -101.35 158.48 16.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.053 1.406 . . . . 0.0 110.435 162.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.301 79.2 m80 -117.41 133.5 55.9 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 119.279 -2.138 . . . . 0.0 108.947 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.28 120.18 39.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 124.876 2.274 . . . . 0.0 107.089 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.533 HG12 ' CZ ' ' A' ' 42' ' ' ARG . 96.4 t -99.99 136.76 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.498 171.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.01 155.62 16.65 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 101.062 -3.681 . . . . 0.0 101.062 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -87.98 104.27 16.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 128.876 2.87 . . . . 0.0 108.125 167.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mt -95.72 -176.01 3.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -106.52 12.77 29.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.95 -173.95 13.85 Favored Glycine 0 CA--C 1.528 0.87 1 C-N-CA 130.862 4.077 . . . . 0.0 105.885 167.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 C-N-CA 129.591 3.472 . . . . 0.0 109.603 179.244 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 ttp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 102.016 -3.327 . . . . 0.0 102.016 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -99.47 145.32 27.58 Favored 'General case' 0 N--CA 1.444 -0.738 2 CA-C-O 111.552 -4.071 . . . . 0.0 108.103 170.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -120.33 159.02 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 115.653 -2.118 . . . . 0.0 110.956 150.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -99.41 132.01 45.03 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 128.719 3.762 . . . . 0.0 107.298 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.45 145.36 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 O-C-N 126.674 2.484 . . . . 0.0 105.257 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -114.56 140.32 48.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 127.904 2.481 . . . . 0.0 108.616 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -100.27 170.63 8.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 125.995 2.807 . . . . 0.0 105.116 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.5 mt -57.07 -32.11 65.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.126 -2.306 . . . . 0.0 109.918 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.0 p -86.6 -9.36 56.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 117.575 -3.203 . . . . 0.0 110.343 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.75 11.31 38.13 Favored Glycine 0 CA--C 1.532 1.134 1 C-N-CA 135.108 6.099 . . . . 0.0 114.762 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -82.54 129.26 34.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 -162.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 48.1 m -96.47 126.06 41.39 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.088 0.955 . . . . 0.0 110.718 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -120.03 151.46 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 119.605 -1.934 . . . . 0.0 106.574 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.271 4.8 m -118.0 91.21 3.51 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 128.021 2.528 . . . . 0.0 106.579 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -83.0 150.19 26.51 Favored 'General case' 0 N--CA 1.444 -0.736 1 CA-C-N 107.991 -4.186 . . . . 0.0 112.053 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.88 108.07 18.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.446 1.898 . . . . 0.0 108.121 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.61 -176.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 1 C-N-CA 134.168 4.987 . . . . 0.0 116.492 173.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -152.12 159.83 32.34 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 103.007 -2.96 . . . . 0.0 103.007 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 75.1 Cg_exo -41.89 -24.42 0.29 Allowed 'Trans proline' 0 N--CA 1.443 -1.498 1 C-N-CA 128.004 5.803 . . . . 0.0 121.697 174.824 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.9 p -78.6 1.92 21.05 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 129.853 3.261 . . . . 0.0 115.182 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.45 130.01 45.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -76.98 178.71 6.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 113.916 -2.945 . . . . 0.0 112.298 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 mm -76.19 -24.62 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 113.956 -2.926 . . . . 0.0 109.197 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -72.99 -41.6 64.16 Favored 'General case' 0 C--O 1.242 0.691 1 C-N-CA 132.697 4.399 . . . . 0.0 105.062 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -65.29 -30.41 71.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.684 -2.51 . . . . 0.0 115.623 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -87.71 -35.9 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 1 CA-C-O 108.545 -5.502 . . . . 0.0 108.219 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.03 -29.57 70.48 Favored 'General case' 0 C--N 1.324 -0.51 1 CA-C-N 126.71 4.323 . . . . 0.0 114.45 169.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.87 80.78 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 125.502 2.572 . . . . 0.0 114.079 167.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -72.9 -37.2 67.33 Favored 'General case' 0 C--N 1.326 -0.414 1 O-C-N 115.117 -4.739 . . . . 0.0 108.967 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.2 mt -50.81 -65.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 128.019 2.528 . . . . 0.0 114.459 160.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -35.99 -43.58 0.33 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.206 2.202 . . . . 0.0 112.423 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -60.32 -42.02 94.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.918 3.287 . . . . 0.0 118.219 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -102.61 -29.31 11.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.011 -2.359 . . . . 0.0 114.776 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -119.08 -13.01 9.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 118.299 2.704 . . . . 0.0 118.299 -169.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.79 -12.56 68.47 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 114.278 -3.512 . . . . 0.0 118.655 162.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mt -73.12 123.2 89.29 Favored Pre-proline 0 N--CA 1.451 -0.403 1 O-C-N 130.414 4.244 . . . . 0.0 104.957 -162.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.14 145.72 33.29 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 123.79 2.994 . . . . 0.0 113.786 170.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.06 -30.33 21.06 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 N-CA-C 117.033 1.897 . . . . 0.0 117.033 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.23 -35.34 36.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 124.156 1.932 . . . . 0.0 109.109 -158.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -80.53 -19.38 45.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.83 144.98 31.65 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 117.994 -1.003 . . . . 0.0 111.542 -172.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -142.01 150.94 41.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 114.165 -2.826 . . . . 0.0 111.449 172.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.45 121.07 41.62 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 128.277 3.486 . . . . 0.0 108.084 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.4 mm -103.36 141.58 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 1 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' HB3' HD21 ' A' ' 50' ' ' LEU . 36.9 t80 -139.11 127.55 22.94 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 100.94 -3.726 . . . . 0.0 100.94 171.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.71 46.13 17.81 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 129.5 3.12 . . . . 0.0 107.831 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.07 -12.44 1.69 Allowed Glycine 0 CA--C 1.535 1.343 0 O-C-N 116.73 -3.731 . . . . 0.0 120.577 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -97.46 137.35 36.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.219 2.608 . . . . 0.0 108.711 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.13 140.08 57.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.909 1.381 . . . . 0.0 108.269 165.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 45' ' ' PHE . 92.8 mt -81.42 109.75 16.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 131.052 3.741 . . . . 0.0 104.548 164.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -94.45 136.68 34.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.459 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -47.77 141.26 5.69 Favored 'General case' 0 C--N 1.328 -0.347 1 C-N-CA 132.846 4.459 . . . . 0.0 116.241 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.66 -30.66 7.95 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.498 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -100.78 161.82 13.33 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 117.092 -3.593 . . . . 0.0 107.542 -173.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -102.65 -176.17 3.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.535 -1.666 . . . . 0.0 108.009 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.97 -34.25 77.98 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 119.041 -2.287 . . . . 0.0 113.155 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.5 m -62.39 -37.51 86.02 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -62.92 -20.06 64.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.619 1.968 . . . . 0.0 116.055 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -114.87 -5.34 12.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.143 2.177 . . . . 0.0 111.904 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 t30 55.53 54.54 8.32 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.799 1.937 . . . . 0.0 114.684 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.0 mt -88.8 132.38 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.8 0.809 . . . . 0.0 109.168 -176.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -98.32 150.89 21.09 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.383 2.273 . . . . 0.0 109.317 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -46.13 135.2 7.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 127.795 3.184 . . . . 0.0 109.799 154.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.417 0.0 OUTLIER 84.6 -6.21 0.99 Allowed 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 125.877 1.986 . . . . 0.0 115.207 166.228 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 t -88.17 140.2 29.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 128.004 3.315 . . . . 0.0 108.085 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.1 m -92.89 129.35 38.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -164.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.08 128.97 54.85 Favored 'General case' 0 N--CA 1.447 -0.621 1 C-N-CA 133.744 4.818 . . . . 0.0 111.659 171.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.14 141.0 29.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 123.999 3.091 . . . . 0.0 107.669 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -116.02 92.17 3.82 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 126.762 3.173 . . . . 0.0 103.154 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -93.46 158.25 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 112.653 -2.067 . . . . 0.0 110.435 170.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.53 128.6 44.41 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.805 3.242 . . . . 0.0 106.482 169.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -68.78 -30.37 68.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 115.629 -2.129 . . . . 0.0 110.16 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.41 116.63 8.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 130.578 3.551 . . . . 0.0 101.667 174.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.85 -25.74 15.35 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 128.629 2.772 . . . . 0.0 109.784 -175.085 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.25 -105.07 2.43 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.878 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.395 0 C-N-CA 128.333 2.873 . . . . 0.0 106.023 161.396 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 ttp . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.264 19.2 tm0? -109.78 123.91 50.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 125.732 2.682 . . . . 0.0 107.397 -172.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 pt -110.46 155.47 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 129.144 2.977 . . . . 0.0 108.261 155.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -110.81 160.55 16.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 125.088 2.375 . . . . 0.0 106.652 171.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 t -123.17 134.35 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 110.087 -3.233 . . . . 0.0 108.505 166.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 tttt -115.83 157.4 24.47 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 127.894 3.246 . . . . 0.0 110.406 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.312 7.9 t -147.72 161.06 41.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.754 2.821 . . . . 0.0 108.751 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 7.6 mt -28.13 -45.94 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.445 1 C-N-CA 135.863 5.665 . . . . 0.0 119.859 -176.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -79.33 -16.89 55.61 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.708 2.803 . . . . 0.0 114.24 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.61 -12.17 58.05 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 117.489 -1.728 . . . . 0.0 113.673 -171.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -55.33 150.34 11.55 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.336 22.7 p -130.44 149.91 51.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 117.801 -3.062 . . . . 0.0 115.3 168.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.403 HD11 ' OE2' ' A' ' 34' ' ' GLU . 61.9 mt -118.38 117.55 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 100.818 -3.771 . . . . 0.0 100.818 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.283 9.0 t -106.07 122.23 45.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.151 3.38 . . . . 0.0 107.954 170.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.285 42.1 mt -113.29 134.95 54.34 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.292 3.037 . . . . 0.0 108.306 162.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -81.17 109.89 16.14 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 100.887 -3.746 . . . . 0.0 100.887 168.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 56' ' ' LEU . 5.4 m -114.8 145.21 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 125.746 2.689 . . . . 0.0 111.713 -172.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.296 3.8 tt0 -103.35 116.87 61.44 Favored Pre-proline 0 C--N 1.324 -0.532 1 C-N-CA 131.745 4.018 . . . . 0.0 106.451 -176.033 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.318 50.5 Cg_exo -32.6 -42.56 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 1 N-CA-C 122.762 4.101 . . . . 0.0 122.762 -178.283 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.6 p -80.14 -7.74 59.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 131.1 3.76 . . . . 0.0 120.357 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -68.72 126.71 30.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 124.383 1.052 . . . . 0.0 113.204 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.4 p -70.28 146.83 50.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.346 20.2 mm -51.84 -31.18 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.462 1.905 . . . . 0.0 112.439 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.69 -33.63 18.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 123.15 1.452 . . . . 0.0 109.711 -170.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.18 -36.27 83.51 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 118.923 -2.361 . . . . 0.0 117.009 165.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.0 t -63.55 -49.01 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 116.646 -1.645 . . . . 0.0 111.466 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -57.75 -29.05 64.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 118.374 2.731 . . . . 0.0 118.374 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.63 -18.09 30.41 Favored 'General case' 0 CA--C 1.537 0.456 1 C-N-CA 132.257 4.223 . . . . 0.0 108.309 -176.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -90.44 -26.94 19.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.374 1.443 . . . . 0.0 110.646 169.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 30' ' ' ILE . 95.1 mt -71.0 -31.37 45.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 129.491 3.117 . . . . 0.0 108.114 172.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -56.42 -44.54 80.48 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 126.896 2.622 . . . . 0.0 113.705 172.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.39 -47.7 84.95 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.105 2.162 . . . . 0.0 109.958 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -67.84 -69.18 0.33 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 128.167 2.587 . . . . 0.0 108.646 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.403 ' OE2' HD11 ' A' ' 13' ' ' ILE . 44.6 mm-40 -88.08 -32.83 18.53 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 121.176 3.769 . . . . 0.0 121.176 -172.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.27 5.05 35.08 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 127.79 2.614 . . . . 0.0 114.384 172.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -93.63 135.07 25.54 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 101.289 -3.597 . . . . 0.0 101.289 -174.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.8 Cg_endo -78.89 148.01 21.87 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 O-C-N 125.122 2.117 . . . . 0.0 110.817 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 47.0 Cg_exo -53.99 -30.37 58.83 Favored 'Trans proline' 0 N--CA 1.447 -1.263 1 C-N-CA 128.597 6.198 . . . . 0.0 118.427 -170.466 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -61.77 -27.01 68.43 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 130.585 3.554 . . . . 0.0 110.105 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -91.34 -12.95 33.47 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 117.159 -1.4 . . . . 0.0 113.008 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -89.12 121.71 31.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 122.722 2.51 . . . . 0.0 111.703 -174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -88.15 110.06 20.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 151.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.7 mt -91.92 92.01 8.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 153.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mt -96.88 137.02 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 128.914 2.886 . . . . 0.0 105.23 -173.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -116.56 -149.85 0.45 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 115.214 -2.327 . . . . 0.0 107.764 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 66.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 131.233 3.813 . . . . 0.0 115.465 171.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.99 -22.51 0.75 Allowed Glycine 0 CA--C 1.533 1.171 1 C-N-CA 130.906 4.098 . . . . 0.0 117.343 -164.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -82.92 128.93 34.9 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 120.718 -1.46 . . . . 0.0 113.494 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.306 19.9 mp0 -90.73 107.99 19.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 126.078 2.111 . . . . 0.0 105.711 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.61 107.44 1.4 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.913 2.485 . . . . 0.0 113.123 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.45 142.18 32.12 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.966 2.906 . . . . 0.0 110.884 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -67.92 109.94 3.65 Favored 'General case' 0 N--CA 1.45 -0.466 1 C-N-CA 133.431 4.692 . . . . 0.0 109.616 -172.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.43 -8.59 58.7 Favored Glycine 0 CA--C 1.528 0.845 1 CA-C-O 112.669 -4.406 . . . . 0.0 113.039 -171.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.72 153.65 38.75 Favored 'General case' 0 C--N 1.323 -0.553 1 CA-C-N 125.18 4.49 . . . . 0.0 110.258 165.262 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.259 67.7 p -77.38 -178.56 5.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 124.253 1.977 . . . . 0.0 106.475 169.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.428 HD11 ' HB ' ' A' ' 17' ' ' VAL 0.293 26.0 mt -77.15 -38.46 51.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.383 164.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.8 t -62.42 -23.24 66.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 112.191 -3.766 . . . . 0.0 111.609 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.96 -35.43 74.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 122.011 2.187 . . . . 0.0 109.215 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -100.66 8.4 43.37 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 128.327 2.651 . . . . 0.0 108.911 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.32 2.3 p-10 52.96 46.32 27.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.152 1.781 . . . . 0.0 115.614 170.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.447 HG21 HD13 ' A' ' 61' ' ' ILE 0.251 24.9 mt -92.46 117.52 35.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 123.662 1.696 . . . . 0.0 110.06 -167.664 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -98.85 169.01 9.76 Favored 'General case' 0 N--CA 1.45 -0.448 1 O-C-N 116.138 -4.101 . . . . 0.0 112.776 -176.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.291 20.6 pttt -37.88 152.18 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 115.512 -2.185 . . . . 0.0 115.283 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 77.05 -9.91 1.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.3 m -62.58 132.09 51.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 119.406 -2.059 . . . . 0.0 116.184 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.4 m -109.31 111.13 22.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.8 mp -83.53 146.39 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.622 3.569 . . . . 0.0 107.825 170.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.265 50.0 t60 -103.75 111.03 23.36 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 117.364 -3.335 . . . . 0.0 111.975 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.3 1.3 tt -90.78 131.43 36.44 Favored 'General case' 0 N--CA 1.45 -0.468 1 O-C-N 131.093 5.246 . . . . 0.0 104.907 -175.402 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.343 16.7 m -147.19 169.28 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 128.515 2.726 . . . . 0.0 111.236 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.284 10.9 tp -92.79 129.49 38.7 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.931 2.892 . . . . 0.0 107.42 -172.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -69.46 97.04 0.95 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 130.414 3.486 . . . . 0.0 106.567 174.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.6 mt -96.42 102.2 13.95 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 152.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.409 27.2 ttt180 91.57 -64.4 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 128.991 2.916 . . . . 0.0 108.12 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.54 -174.17 44.61 Favored Glycine 0 CA--C 1.526 0.754 1 C-N-CA 132.338 4.78 . . . . 0.0 112.625 174.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.479 2 N-CA-C 101.356 -4.698 . . . . 0.0 101.356 -172.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -113.82 140.29 48.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 124.082 1.896 . . . . 0.0 108.528 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 pt -146.44 160.01 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 100.428 -3.915 . . . . 0.0 100.428 172.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.387 31.3 m-85 -105.36 134.74 47.97 Favored 'General case' 0 N--CA 1.445 -0.694 1 CA-C-N 107.749 -4.296 . . . . 0.0 105.13 -173.116 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 t -106.45 132.09 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 119.706 -1.872 . . . . 0.0 107.549 166.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -84.78 123.69 30.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 159.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.0 p -80.27 167.74 19.91 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.675 2.39 . . . . 0.0 116.297 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.414 ' HB3' HD22 ' A' ' 69' ' ' LEU . 1.4 pt? -60.67 -10.97 6.02 Favored 'General case' 0 C--N 1.321 -0.646 1 C-N-CA 133.211 4.605 . . . . 0.0 113.742 175.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -122.62 2.41 9.54 Favored 'General case' 0 C--N 1.33 -0.249 1 O-C-N 114.033 -5.417 . . . . 0.0 117.205 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.24 -14.02 28.33 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 117.9 1.92 . . . . 0.0 117.9 166.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -82.28 167.18 18.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.591 2.356 . . . . 0.0 110.471 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.5 m -111.98 121.38 44.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 129.728 3.211 . . . . 0.0 105.476 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.31 19.4 pt -103.57 146.19 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 128.786 2.834 . . . . 0.0 103.987 163.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 m -78.54 153.3 31.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 129.074 2.95 . . . . 0.0 109.963 149.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.83 159.63 43.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 126.87 3.224 . . . . 0.0 105.755 161.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.66 112.56 19.03 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 126.782 3.182 . . . . 0.0 107.513 -171.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.41 165.19 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 116.774 -3.704 . . . . 0.0 107.648 -173.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.283 1.6 tm-20 -103.85 149.29 37.01 Favored Pre-proline 0 N--CA 1.44 -0.967 0 O-C-N 118.387 -2.695 . . . . 0.0 108.613 161.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -53.64 -18.65 12.35 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 125.191 3.927 . . . . 0.0 114.344 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.9 p -77.22 -7.77 56.45 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 119.321 3.082 . . . . 0.0 119.321 170.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -60.36 126.97 29.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.601 1.191 . . . . 0.0 110.833 164.262 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.5 p -89.41 163.91 15.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 117.331 -1.748 . . . . 0.0 108.953 170.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.325 0.9 OUTLIER -34.77 -51.53 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 113.09 -3.338 . . . . 0.0 113.481 173.538 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.262 3.5 tp10 -67.07 -23.71 65.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 129.34 3.056 . . . . 0.0 114.696 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -74.11 -40.33 62.75 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 166.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.51 -40.89 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 O-C-N 118.716 -2.49 . . . . 0.0 106.11 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -43.28 -45.69 5.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 129.471 3.109 . . . . 0.0 118.173 172.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.81 -37.48 48.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.769 2.028 . . . . 0.0 109.828 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP 0.371 78.0 mttt -61.2 -43.6 98.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 124.85 2.262 . . . . 0.0 111.475 177.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.45 -53.3 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 127.94 2.496 . . . . 0.0 107.262 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -49.35 -48.55 46.53 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 117.632 -3.168 . . . . 0.0 116.003 165.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.12 -33.4 70.81 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 116.834 -1.555 . . . . 0.0 110.888 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -97.29 -51.47 4.17 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 123.449 2.84 . . . . 0.0 107.648 -172.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -102.81 -31.08 10.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 127.561 2.344 . . . . 0.0 113.347 -167.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.76 9.87 24.0 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 163.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mt -90.11 127.11 54.78 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 118.756 1.278 . . . . 0.0 107.997 -162.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.75 130.22 33.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 125.289 3.992 . . . . 0.0 114.42 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.25 2.4 Cg_endo -72.63 -2.82 12.41 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.239 1.959 . . . . 0.0 113.564 173.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -79.42 -14.17 59.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 160.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -98.6 -25.97 14.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.212 1.805 . . . . 0.0 108.551 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -86.05 111.56 20.43 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 115.476 -2.202 . . . . 0.0 108.89 -172.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -105.5 148.5 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 128.164 3.415 . . . . 0.0 106.489 154.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.56 113.68 26.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 131.308 3.843 . . . . 0.0 110.597 157.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mm -122.49 119.85 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -143.32 111.53 6.19 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.898 -1.955 . . . . 0.0 107.501 -167.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 73.49 24.87 2.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 129.583 3.153 . . . . 0.0 112.408 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.65 7.58 50.78 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-O 115.347 -2.919 . . . . 0.0 114.797 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -138.69 150.72 46.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 123.686 3.743 . . . . 0.0 108.216 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -66.16 135.49 54.6 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 111.237 -2.71 . . . . 0.0 111.793 161.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.4 mt -91.62 149.54 21.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 117.638 -1.173 . . . . 0.0 107.96 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.254 10.1 tp10 -142.07 166.78 23.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.39 2.276 . . . . 0.0 115.378 -149.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.72 122.61 18.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.265 2.226 . . . . 0.0 115.053 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.71 -21.9 17.85 Favored Glycine 0 CA--C 1.537 1.418 0 O-C-N 120.337 -1.477 . . . . 0.0 111.289 163.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.535 ' H ' ' HD2' ' A' ' 54' ' ' ARG 0.319 0.3 OUTLIER -78.69 138.31 38.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.841 1.656 . . . . 0.0 108.038 169.163 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.8 p -84.1 156.79 21.98 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.2 mt -42.94 -39.54 2.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 160.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.416 3.8 p -54.49 -46.33 73.41 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 117.426 -3.296 . . . . 0.0 117.223 161.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -65.04 -13.24 57.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 122.665 2.484 . . . . 0.0 114.029 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -104.5 10.0 35.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 119.527 -1.983 . . . . 0.0 111.681 172.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 60.46 18.74 8.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 130.312 3.445 . . . . 0.0 115.77 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.9 mt -72.92 122.63 26.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -115.5 143.5 45.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.147 3.379 . . . . 0.0 112.474 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -30.2 131.73 0.08 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.441 2.697 . . . . 0.0 116.116 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 78.57 23.74 0.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.963 2.905 . . . . 0.0 111.128 164.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.6 m -97.97 161.06 13.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 129.137 2.975 . . . . 0.0 113.301 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -102.9 118.56 37.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 112.751 -3.5 . . . . 0.0 111.017 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 mt -93.17 162.86 13.85 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 125.806 1.941 . . . . 0.0 108.138 160.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -125.54 158.74 33.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.972 2.509 . . . . 0.0 109.097 171.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 8' ' ' LEU 0.316 4.8 tt -115.08 149.57 37.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 131.356 3.862 . . . . 0.0 112.244 176.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.4 t -124.89 118.2 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.02 155.02 41.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 116.51 -1.709 . . . . 0.0 111.844 171.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -103.17 148.95 25.14 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 124.021 3.101 . . . . 0.0 104.927 148.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.6 34.63 2.37 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 -164.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttp85 -89.61 118.91 29.58 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 123.029 2.65 . . . . 0.0 107.67 161.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.35 -137.06 13.33 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 118.661 -2.525 . . . . 0.0 107.799 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 115.77 -2.683 . . . . 0.0 106.918 -177.063 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttp . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 116.739 -1.6 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -100.49 134.17 43.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 -154.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.3 pt -117.32 150.01 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.93 158.07 15.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 118.667 -2.521 . . . . 0.0 108.835 162.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 58.9 t -140.34 138.25 36.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -112.13 128.23 56.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.546 2.338 . . . . 0.0 104.72 172.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.284 21.8 m -94.89 140.21 30.24 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 111.215 -2.721 . . . . 0.0 104.573 169.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tt -24.14 -39.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 131.204 3.802 . . . . 0.0 118.952 165.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -67.32 -10.55 51.99 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 118.913 -2.367 . . . . 0.0 117.122 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.78 14.41 55.17 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 118.908 -2.37 . . . . 0.0 109.193 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -90.9 121.44 32.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 130.755 3.622 . . . . 0.0 106.062 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.2 m -103.72 138.94 39.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.066 2.546 . . . . 0.0 105.312 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.1 172.27 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 128.313 2.645 . . . . 0.0 104.661 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 t -139.8 139.66 36.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 118.137 -2.852 . . . . 0.0 112.864 172.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 mp -132.08 132.55 43.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 128.275 3.484 . . . . 0.0 105.749 -177.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -76.55 122.71 24.98 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 127.455 2.302 . . . . 0.0 109.456 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.34 -174.88 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -128.05 160.14 63.16 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 165.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.93 -39.01 94.55 Favored 'Trans proline' 0 N--CA 1.445 -1.343 1 C-N-CA 126.355 4.703 . . . . 0.0 112.593 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.3 m -78.91 6.78 8.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -78.29 129.04 34.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 117.271 -3.393 . . . . 0.0 107.61 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -52.55 151.48 4.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 129.269 3.028 . . . . 0.0 110.832 168.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -54.91 -39.43 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.717 2.407 . . . . 0.0 111.664 158.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -50.24 -53.23 29.65 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.531 1.932 . . . . 0.0 114.405 171.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -54.62 -35.67 63.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 165.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -75.75 -42.11 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 119.707 -1.87 . . . . 0.0 111.977 -175.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -63.81 -35.75 81.64 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 125.724 1.89 . . . . 0.0 113.655 168.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.43 58.14 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.702 1.601 . . . . 0.0 107.133 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -83.48 -44.2 14.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 118.347 -2.721 . . . . 0.0 109.847 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.374 82.3 mt -42.46 -44.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 129.975 3.31 . . . . 0.0 114.59 164.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -57.24 -43.57 83.05 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.683 1.993 . . . . 0.0 116.226 172.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.19 -41.51 63.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -63.98 -49.08 73.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 131.696 3.998 . . . . 0.0 115.674 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -144.13 -7.15 0.72 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -171.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.12 -1.15 21.01 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 119.054 -2.279 . . . . 0.0 115.313 164.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 36' ' ' ILE . 4.9 mt -78.86 118.88 74.99 Favored Pre-proline 0 C--O 1.22 -0.472 0 CA-C-O 114.385 -2.721 . . . . 0.0 108.024 -162.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.7 149.19 78.83 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 O-C-N 125.783 2.465 . . . . 0.0 114.985 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.24 -32.36 1.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.447 1.432 . . . . 0.0 113.835 -165.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -86.05 7.02 26.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 129.62 3.168 . . . . 0.0 111.587 -169.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -132.38 -9.24 3.3 Favored 'General case' 0 C--N 1.325 -0.488 1 C-N-CA 132.103 4.161 . . . . 0.0 111.759 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.269 4.5 tt0 -103.03 139.24 38.84 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 128.43 2.692 . . . . 0.0 107.29 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -146.6 132.19 18.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 101.94 -3.355 . . . . 0.0 101.94 -171.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 67' ' ' LEU . 11.2 mp -114.68 141.64 47.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.796 -163.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.278 77.7 mt -128.96 138.67 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 1 C-N-CA 133.049 4.54 . . . . 0.0 109.784 -178.605 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -150.61 111.14 4.22 Favored 'General case' 0 N--CA 1.448 -0.566 1 C-N-CA 131.739 4.015 . . . . 0.0 109.309 176.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.312 . . 68.56 31.06 4.91 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.85 -23.34 9.25 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.32 1.438 . . . . 0.0 111.526 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -74.3 126.67 31.15 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 110.65 6.75 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 129.304 3.042 . . . . 0.0 106.717 160.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.9 mt -82.41 128.87 34.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -78.15 159.41 28.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.578 1.551 . . . . 0.0 111.31 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -73.91 133.19 43.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.493 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.59 -15.48 55.82 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 115.11 -3.05 . . . . 0.0 111.733 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -77.21 159.7 29.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 123.043 3.421 . . . . 0.0 114.692 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -106.44 -177.77 3.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 127.935 3.272 . . . . 0.0 110.785 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.34 -18.21 46.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 128.58 2.752 . . . . 0.0 109.095 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.83 -28.41 50.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.788 2.035 . . . . 0.0 110.815 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -64.6 -31.11 72.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 126.445 3.021 . . . . 0.0 115.675 172.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.96 8.61 13.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 124.636 2.16 . . . . 0.0 115.46 -173.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.291 36.3 m-20 67.16 39.16 3.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 120.906 3.669 . . . . 0.0 120.906 163.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.2 mt -88.75 128.24 41.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.596 -164.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -98.23 165.12 12.02 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 124.824 2.25 . . . . 0.0 115.314 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -63.88 127.8 33.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.96 -2.963 . . . . 0.0 107.491 -168.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.468 0.0 OUTLIER 93.28 3.98 0.06 Allowed 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 126.297 2.248 . . . . 0.0 113.666 175.1 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.9 m -61.05 144.02 54.26 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 117.029 -3.544 . . . . 0.0 109.854 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -92.55 117.34 29.85 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 118.441 -2.662 . . . . 0.0 114.047 170.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.426 HD21 HD23 ' A' ' 43' ' ' LEU 0.25 23.4 tp -107.12 134.42 50.27 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 125.131 1.519 . . . . 0.0 109.094 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -107.73 152.47 24.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.9 155.23 42.73 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 126.021 2.819 . . . . 0.0 107.575 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.93 137.44 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 131.439 3.896 . . . . 0.0 103.471 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.447 0.7 OUTLIER -119.8 125.3 48.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 114.839 -2.505 . . . . 0.0 111.391 176.097 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.411 3.6 ttt180 96.72 -4.4 0.06 Allowed 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 127.375 2.922 . . . . 0.0 115.289 164.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -143.03 158.67 43.39 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.713 1.605 . . . . 0.0 108.842 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -76.37 90.79 3.23 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.25 157.34 15.17 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 116.482 -2.288 . . . . 0.0 116.132 171.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 O-C-N 127.744 2.673 . . . . 0.0 106.769 -168.367 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 ttp . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 101.966 -3.346 . . . . 0.0 101.966 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -88.5 135.96 33.22 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 121.701 2.046 . . . . 0.0 114.27 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 3' ' ' ILE 0.279 44.4 pt -119.42 148.02 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 128.626 2.77 . . . . 0.0 113.771 168.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -99.55 115.89 30.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.701 2.4 . . . . 0.0 111.365 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.277 6.5 t -89.1 100.29 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 129.086 2.954 . . . . 0.0 103.053 172.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -74.11 156.83 36.98 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.242 -1.536 . . . . 0.0 114.721 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.445 13.0 t -150.71 164.46 36.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.57 171.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 tp -46.23 -39.98 10.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 121.37 3.841 . . . . 0.0 121.37 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.8 p -82.15 -1.26 48.28 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 123.849 1.785 . . . . 0.0 111.425 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.37 8.94 55.95 Favored Glycine 0 N--CA 1.443 -0.852 0 O-C-N 116.71 -3.744 . . . . 0.0 116.539 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -76.32 132.45 39.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.027 2.931 . . . . 0.0 106.733 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 p -112.94 132.6 55.28 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 108.832 -3.803 . . . . 0.0 103.261 161.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 mt -102.03 135.12 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 159.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 t -81.88 115.89 21.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 125.587 1.804 . . . . 0.0 111.511 160.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.3 tp -116.81 129.68 56.24 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -80.4 143.94 33.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.786 1.755 . . . . 0.0 110.754 170.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.97 167.86 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 128.554 2.742 . . . . 0.0 109.822 164.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.263 9.0 tt0 -105.55 147.45 34.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 110.277 -3.147 . . . . 0.0 105.713 153.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -74.88 -25.21 12.34 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.075 1.85 . . . . 0.0 110.533 -172.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -63.97 -9.34 15.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 173.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -68.04 164.03 21.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 130.036 3.334 . . . . 0.0 111.286 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 p -124.09 148.09 47.39 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 128.822 2.849 . . . . 0.0 104.949 -164.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.92 -48.41 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 110.584 -3.007 . . . . 0.0 112.988 -171.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -67.17 -36.93 82.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -66.48 -39.71 88.91 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.27 86.9 t -70.47 -39.52 76.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 125.707 1.603 . . . . 0.0 110.405 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -56.67 -29.28 62.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 168.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.82 -41.21 62.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 166.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -64.49 -31.88 73.28 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 119.861 -1.774 . . . . 0.0 109.42 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.325 55.1 mt -62.48 -35.03 67.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.313 3.445 . . . . 0.0 110.614 165.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.26 -38.86 65.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 115.071 -2.395 . . . . 0.0 106.642 -174.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.45 1.5 t70 -37.95 -41.59 0.56 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.992 2.96 . . . . 0.0 118.992 166.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -81.46 -72.16 0.44 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.072 -1.876 . . . . 0.0 115.153 171.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -84.62 -19.87 32.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 116.535 -1.697 . . . . 0.0 115.179 -170.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.08 -9.47 56.42 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 116.867 -2.074 . . . . 0.0 111.036 159.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.09 137.31 37.47 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 123.001 1.381 . . . . 0.0 108.891 -169.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -55.95 139.96 85.26 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.292 2.661 . . . . 0.0 113.579 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.63 -26.47 12.92 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.067 2.512 . . . . 0.0 117.527 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -45.0 -38.65 4.91 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 130.812 3.645 . . . . 0.0 113.607 174.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.09 -4.11 36.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.25 2.22 . . . . 0.0 109.877 -171.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -98.17 117.82 33.39 Favored 'General case' 0 N--CA 1.451 -0.393 1 O-C-N 115.656 -4.403 . . . . 0.0 114.837 -170.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.438 HH12 ' C ' ' A' ' 76' ' ' GLY 0.258 16.4 ttm-85 -112.39 113.94 26.4 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.172 1.789 . . . . 0.0 110.881 163.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -83.21 143.51 30.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 120.59 -1.319 . . . . 0.0 109.473 163.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 tt -133.73 143.67 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 119.531 -1.981 . . . . 0.0 106.04 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -136.99 84.3 2.06 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -170.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 84.37 24.87 0.1 Allowed 'General case' 0 N--CA 1.448 -0.547 1 C-N-CA 133.205 4.602 . . . . 0.0 113.984 165.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.12 -1.85 26.92 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 119.184 -2.198 . . . . 0.0 113.674 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.353 40.8 ttmt -121.43 137.14 54.84 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.097 2.159 . . . . 0.0 107.017 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -73.04 128.09 34.46 Favored 'General case' 0 N--CA 1.442 -0.826 1 C-N-CA 135.108 5.363 . . . . 0.0 108.618 177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.463 HD22 ' CG ' ' A' ' 59' ' ' TYR . 86.2 mt -93.41 132.27 37.81 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -134.42 145.86 49.29 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 131.101 3.761 . . . . 0.0 109.532 -162.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.29 144.93 29.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.075 -2.329 . . . . 0.0 110.418 -163.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.52 4.59 23.28 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 116.951 -2.027 . . . . 0.0 116.194 -166.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.337 11.7 mtm180 -125.51 177.5 6.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.004 1.402 . . . . 0.0 113.367 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.3 p -95.95 175.25 6.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 119.339 -2.101 . . . . 0.0 110.927 158.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -57.91 -30.98 66.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 159.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 t -66.75 -25.67 66.61 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 113.093 -3.337 . . . . 0.0 114.115 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.73 -19.99 54.26 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 127.39 2.931 . . . . 0.0 109.494 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CG ' HD22 ' A' ' 50' ' ' LEU 0.295 23.3 m-85 -108.04 6.74 27.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.11 -2.244 . . . . 0.0 110.548 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.397 0.4 OUTLIER 68.86 30.73 4.59 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.849 2.059 . . . . 0.0 112.698 163.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mt -79.16 122.47 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 O-C-N 119.293 -2.13 . . . . 0.0 110.075 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -111.62 165.57 11.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.176 1.79 . . . . 0.0 112.607 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -46.85 143.96 2.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 119.643 -1.911 . . . . 0.0 115.719 171.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 63.72 21.44 12.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 128.981 2.912 . . . . 0.0 112.254 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 m -82.89 152.67 25.46 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.12 1.768 . . . . 0.0 107.476 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.6 m -109.91 105.84 15.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 127.714 3.134 . . . . 0.0 107.862 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -82.79 154.78 24.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 163.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -117.63 148.08 42.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 118.502 -2.624 . . . . 0.0 108.436 166.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.3 tp -109.28 147.55 32.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 124.829 2.252 . . . . 0.0 105.256 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.85 175.25 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 113.683 -3.056 . . . . 0.0 107.044 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.25 13.3 tp -106.73 149.35 27.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 128.402 3.564 . . . . 0.0 103.813 -170.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -116.89 87.2 2.65 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 -167.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.8 mt -96.8 131.07 43.9 Favored 'General case' 0 C--O 1.24 0.571 0 O-C-N 119.317 -2.114 . . . . 0.0 106.7 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 82.84 -32.26 0.09 Allowed 'General case' 0 N--CA 1.444 -0.747 1 C-N-CA 136.215 5.806 . . . . 0.0 112.15 148.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.23 -171.47 15.29 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 128.374 2.892 . . . . 0.0 106.825 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.438 ' C ' HH12 ' A' ' 42' ' ' ARG . . . . . . . . 0 C--O 1.251 1.198 0 CA-C-N 112.56 -1.82 . . . . 0.0 112.318 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 ttp . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -94.48 144.82 25.25 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 115.279 -2.296 . . . . 0.0 106.689 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.419 HD11 HG11 ' A' ' 17' ' ' VAL . 3.2 pt -146.57 172.66 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.842 2.457 . . . . 0.0 106.193 165.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -135.26 118.6 16.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 128.057 3.348 . . . . 0.0 107.987 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.27 129.1 44.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 131.199 3.799 . . . . 0.0 101.975 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -126.2 125.45 42.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 126.241 2.924 . . . . 0.0 111.812 172.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.3 p -84.55 151.56 24.47 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.301 80.7 mt -56.65 -10.34 0.98 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 131.105 3.762 . . . . 0.0 115.984 175.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 p -93.4 -24.3 18.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 128.724 2.81 . . . . 0.0 109.269 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.06 43.18 1.81 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.148 1.832 . . . . 0.0 116.276 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -115.56 110.11 18.76 Favored 'General case' 0 C--N 1.321 -0.641 2 C-N-CA 132.118 4.167 . . . . 0.0 110.727 169.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.6 m -85.72 111.94 20.59 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 124.44 2.067 . . . . 0.0 110.281 173.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.0 mt -100.02 116.15 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 128.089 3.804 . . . . 0.0 101.741 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.325 52.7 m -91.46 134.05 34.96 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 102.274 -3.232 . . . . 0.0 102.274 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tp -130.47 155.28 46.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.112 2.965 . . . . 0.0 110.116 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 126.31 53.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 3' ' ' ILE . 11.6 m -134.53 163.77 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -101.17 148.17 34.76 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 114.305 -2.76 . . . . 0.0 106.575 174.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.95 6.77 3.98 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 CA-C-N 126.251 3.268 . . . . 0.0 113.675 -171.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -118.05 -2.95 11.16 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 114.595 -2.621 . . . . 0.0 105.666 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.97 122.87 11.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.636 2.774 . . . . 0.0 105.942 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -66.77 158.38 30.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 127.784 3.178 . . . . 0.0 116.61 161.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mm -58.46 -33.44 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 123.341 2.791 . . . . 0.0 114.36 171.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -45.29 -49.59 12.55 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 164.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -70.76 -39.06 73.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.368 71.1 t -52.3 -37.84 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 127.59 2.356 . . . . 0.0 114.021 169.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -66.92 -31.38 71.93 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 116.791 -3.693 . . . . 0.0 115.832 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.47 -36.78 32.99 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.851 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.77 -29.7 70.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 116.801 -1.571 . . . . 0.0 114.833 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.99 -43.78 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 116.398 -1.763 . . . . 0.0 111.478 166.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -59.7 -39.66 85.33 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 114.125 -2.845 . . . . 0.0 110.583 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.14 -21.48 22.78 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.515 1.134 . . . . 0.0 113.72 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.251 18.3 mmtm -109.54 -49.91 3.05 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 117.358 -3.339 . . . . 0.0 107.025 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -103.24 -9.67 19.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 113.788 -3.006 . . . . 0.0 113.661 -165.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.98 -17.7 49.32 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 121.701 2.046 . . . . 0.0 112.69 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.41 HD13 HD21 ' A' ' 71' ' ' LEU . 1.8 pt -81.2 140.22 49.18 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 117.408 0.604 . . . . 0.0 111.184 -175.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.41 140.85 30.82 Favored 'Trans proline' 0 N--CA 1.453 -0.882 1 C-N-CA 126.731 4.954 . . . . 0.0 114.971 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -40.81 -31.08 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.316 1 C-N-CA 127.373 5.382 . . . . 0.0 119.453 173.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.83 -54.81 42.13 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 131.471 3.908 . . . . 0.0 113.839 -174.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -80.02 -7.18 58.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 126.323 2.963 . . . . 0.0 114.549 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.62 145.78 25.01 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 117.573 -3.205 . . . . 0.0 111.103 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -123.67 130.95 53.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.503 1.521 . . . . 0.0 108.814 151.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.669 HD12 HD22 ' A' ' 67' ' ' LEU . 1.7 mm? -89.54 130.88 35.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 172.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -122.34 123.93 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 112.398 -2.183 . . . . 0.0 115.424 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.456 ' HB2' HD23 ' A' ' 67' ' ' LEU . 87.0 t80 -147.47 144.38 28.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 130.008 3.323 . . . . 0.0 113.848 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.62 24.68 14.04 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.938 2.495 . . . . 0.0 112.816 168.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.98 -2.32 69.02 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 114.909 0.723 . . . . 0.0 114.909 -177.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -134.64 155.82 49.82 Favored 'General case' 0 N--CA 1.447 -0.619 2 O-C-N 115.031 -4.805 . . . . 0.0 112.906 -170.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -79.12 133.6 36.75 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 125.435 2.541 . . . . 0.0 106.052 164.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 mt -80.47 136.39 36.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.769 -2.014 . . . . 0.0 114.565 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -76.89 144.05 39.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 116.884 -1.926 . . . . 0.0 111.464 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -66.67 -33.07 74.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.236 -168.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.28 -5.0 49.96 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 126.33 1.919 . . . . 0.0 111.564 -165.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.306 11.4 mmt180 -74.18 149.56 40.86 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.772 2.029 . . . . 0.0 114.616 161.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -103.87 159.76 15.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 127.215 3.388 . . . . 0.0 109.489 -172.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.2 mt -48.28 -47.45 36.35 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 110.025 -3.261 . . . . 0.0 111.915 162.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -59.8 -49.88 76.0 Favored 'General case' 0 N--CA 1.443 -0.805 1 O-C-N 129.694 4.371 . . . . 0.0 119.952 167.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 50.6 m-20 -50.06 -43.72 51.26 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 121.408 3.855 . . . . 0.0 121.408 165.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -93.28 1.28 57.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 73.57 50.8 0.12 Allowed 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 119.113 -2.242 . . . . 0.0 104.976 168.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.1 69.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 118.459 -2.65 . . . . 0.0 104.932 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -127.52 72.97 1.41 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.357 -147.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.416 10.9 tmtt? 89.03 90.87 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 O-C-N 125.285 1.616 . . . . 0.0 112.363 171.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 86.41 47.3 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 110.665 -2.971 . . . . 0.0 110.693 158.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 p -117.05 159.06 23.12 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.746 1.26 . . . . 0.0 108.733 171.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.5 m -108.8 137.46 46.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 125.495 2.569 . . . . 0.0 109.118 -172.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.669 HD22 HD12 ' A' ' 43' ' ' LEU 0.256 0.9 OUTLIER -113.84 143.57 44.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 111.711 -2.495 . . . . 0.0 107.306 -173.923 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -90.49 136.85 32.8 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 130.481 3.512 . . . . 0.0 107.47 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.3 tp -121.32 113.9 20.57 Favored 'General case' 0 N--CA 1.451 -0.405 1 C-N-CA 131.754 4.022 . . . . 0.0 107.486 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -117.56 133.16 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 129.288 3.035 . . . . 0.0 104.388 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 36' ' ' ILE . 3.5 mp -122.38 150.43 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 125.811 2.72 . . . . 0.0 111.454 -166.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.269 34.8 ttt180 -92.69 44.27 1.15 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 127.767 2.427 . . . . 0.0 108.606 -176.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.302 2.3 pp -143.18 155.48 44.55 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.198 0.999 . . . . 0.0 108.374 -177.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -86.05 118.16 25.34 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 128.156 3.41 . . . . 0.0 107.216 -170.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.82 86.18 1.77 Allowed Glycine 0 CA--C 1.528 0.889 0 CA-C-N 123.123 2.692 . . . . 0.0 109.937 -159.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.314 0 CA-C-O 116.821 -2.099 . . . . 0.0 108.619 -174.392 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 113.788 -3.006 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.253 59.2 tt0 -104.57 164.82 11.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 125.586 1.804 . . . . 0.0 109.522 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -145.51 164.91 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 1 C-N-CA 134.746 5.219 . . . . 0.0 107.053 168.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.2 147.08 41.79 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 118.922 -2.361 . . . . 0.0 111.782 175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.68 113.66 28.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 113.333 -3.222 . . . . 0.0 106.558 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -87.74 143.73 27.0 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 126.522 2.388 . . . . 0.0 110.123 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -117.09 158.73 23.7 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 126.192 2.182 . . . . 0.0 109.49 -171.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.512 HD21 HG12 ' A' ' 70' ' ' VAL . 74.6 mt -50.44 -50.29 52.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 116.826 -3.671 . . . . 0.0 116.973 -175.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -138.11 34.14 2.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.21 -123.84 2.52 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 -172.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -138.47 -167.85 2.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.677 1.991 . . . . 0.0 111.204 -166.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 p -89.75 119.99 30.62 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.083 0.856 . . . . 0.0 110.909 149.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.2 mt -80.55 143.45 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 167.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.264 71.9 p -114.68 122.31 46.06 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 113.931 -2.937 . . . . 0.0 108.221 -169.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.4 HD21 HG12 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -128.68 134.22 48.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 122.3 2.318 . . . . 0.0 104.906 174.119 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.85 118.91 37.8 Favored 'General case' 0 N--CA 1.44 -0.962 1 N-CA-C 99.909 -4.108 . . . . 0.0 99.909 172.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.45 149.64 33.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 130.102 3.361 . . . . 0.0 107.478 -167.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -74.19 137.02 75.47 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -62.64 -5.48 7.26 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 CA-C-O 115.817 -1.826 . . . . 0.0 115.921 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.4 p -115.18 23.45 12.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -81.36 160.92 23.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 126.717 2.51 . . . . 0.0 115.498 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 p -102.28 140.79 36.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 131.595 3.958 . . . . 0.0 107.23 -162.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.3 mt -47.96 -47.1 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 125.803 1.641 . . . . 0.0 112.979 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.75 -38.59 89.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.989 1.722 . . . . 0.0 112.025 -173.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -72.45 -12.73 61.22 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.114 2.166 . . . . 0.0 110.797 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 t -99.42 -27.39 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 1 CA-C-O 110.642 -4.504 . . . . 0.0 106.288 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -56.73 -42.97 80.17 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 128.28 3.488 . . . . 0.0 109.907 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.17 -42.41 77.03 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.717 3.607 . . . . 0.0 112.001 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -64.26 -35.36 80.58 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.4 HG12 HD21 ' A' ' 15' ' ' LEU . 61.5 mt -72.91 -28.07 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.461 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -52.49 35.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 117.105 -3.497 . . . . 0.0 114.681 166.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.94 -30.17 63.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -101.31 -33.16 10.15 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.401 1.455 . . . . 0.0 112.647 -173.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.327 78.8 mm-40 -125.28 -19.14 5.17 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.12 2.73 51.55 Favored Glycine 0 N--CA 1.44 -1.098 0 O-C-N 117.559 -3.213 . . . . 0.0 115.719 170.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.3 mt -77.66 120.67 82.32 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 122.584 3.192 . . . . 0.0 109.945 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.47 159.11 49.34 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 N-CA-C 118.037 2.283 . . . . 0.0 118.037 169.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.47 -19.83 11.34 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 124.556 3.504 . . . . 0.0 114.529 -169.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -82.4 -12.2 58.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -76.41 -42.84 42.89 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.647 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -74.77 110.73 9.31 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 127.917 3.261 . . . . 0.0 107.934 -156.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -108.54 112.1 24.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 100.388 -3.93 . . . . 0.0 100.388 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.38 124.3 44.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.538 0.0 OUTLIER -127.3 137.31 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 117.637 -3.164 . . . . 0.0 113.259 -175.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.476 ' CE2' HG13 ' A' ' 61' ' ' ILE 0.275 24.9 t80 -149.59 108.15 3.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.817 -1.538 . . . . 0.0 109.207 -165.427 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.4 23.34 6.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 127.043 3.306 . . . . 0.0 115.172 164.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.02 -17.86 47.54 Favored Glycine 0 CA--C 1.531 1.09 1 C-N-CA 136.234 6.635 . . . . 0.0 111.628 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -80.6 120.0 23.98 Favored 'General case' 0 N--CA 1.447 -0.607 1 C-N-CA 131.808 4.043 . . . . 0.0 107.824 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -73.06 131.59 42.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 115.417 -2.23 . . . . 0.0 114.604 159.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.364 39.2 mt -110.45 132.64 54.0 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 125.892 2.758 . . . . 0.0 107.264 -163.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -105.46 124.96 50.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 111.399 -2.637 . . . . 0.0 113.33 -169.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.267 0.0 OUTLIER -61.43 139.88 58.14 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 111.908 -2.405 . . . . 0.0 110.619 -172.435 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.81 -38.18 2.09 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 104.243 -3.543 . . . . 0.0 104.243 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -94.38 -178.37 4.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 -175.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.257 46.7 p -119.68 -175.84 3.04 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.753 -166.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.2 -41.87 96.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.154 1.381 . . . . 0.0 114.278 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 t -71.93 -32.91 67.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 131.011 3.725 . . . . 0.0 107.681 -170.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -71.46 -13.36 61.8 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 130.824 3.65 . . . . 0.0 112.698 -172.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -128.97 0.97 5.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.069 2.547 . . . . 0.0 111.466 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t30 57.41 53.89 7.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 128.815 2.846 . . . . 0.0 110.401 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.476 HG13 ' CE2' ' A' ' 45' ' ' PHE . 5.0 mt -92.46 112.57 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 100.395 -3.928 . . . . 0.0 100.395 168.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -130.86 171.41 13.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.39 -167.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.74 113.79 0.92 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 129.237 3.015 . . . . 0.0 112.218 -170.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 67.88 25.17 7.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 118.201 -2.812 . . . . 0.0 117.337 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.1 m -64.32 135.22 55.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 118.233 -2.792 . . . . 0.0 117.829 156.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.267 96.5 m -110.49 128.0 55.42 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 124.479 1.112 . . . . 0.0 108.563 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.261 1.2 mp -109.67 168.73 9.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 173.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -112.35 138.37 49.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.965 3.306 . . . . 0.0 107.668 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tp -126.79 114.76 18.38 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.908 1.683 . . . . 0.0 108.138 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.512 HG12 HD21 ' A' ' 8' ' ' LEU . 25.1 m -106.1 142.56 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 175.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.3 mt -101.19 150.91 22.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 116.005 -1.95 . . . . 0.0 111.649 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -103.86 101.97 11.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 129.114 2.966 . . . . 0.0 103.35 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 mt -118.3 -23.14 7.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 130.166 3.387 . . . . 0.0 114.655 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.36 4.97 17.94 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 -169.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.09 -27.65 19.44 Favored Glycine 0 CA--C 1.53 0.985 1 C-N-CA 132.011 4.624 . . . . 0.0 110.784 169.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.58 -2.233 . . . . 0.0 111.107 157.276 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 123.544 1.64 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -105.13 130.18 53.36 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.725 3.21 . . . . 0.0 110.977 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.293 17.6 pt -133.04 140.85 46.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 1 C-N-CA 133.731 4.812 . . . . 0.0 113.345 177.596 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 49.3 m-85 -93.21 148.88 21.65 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 125.89 2.757 . . . . 0.0 112.226 170.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.55 126.57 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 118.812 -2.43 . . . . 0.0 105.304 170.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -87.2 112.29 21.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 115.687 -2.102 . . . . 0.0 114.796 171.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 p -62.68 155.62 25.85 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 119.748 1.158 . . . . 0.0 113.03 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.62 -36.26 80.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.17 2.588 . . . . 0.0 111.242 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -93.01 0.01 57.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.824 1.193 . . . . 0.0 112.682 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.93 20.51 6.01 Favored Glycine 0 N--CA 1.445 -0.719 0 O-C-N 118.484 -2.635 . . . . 0.0 116.212 142.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -84.89 152.58 23.45 Favored 'General case' 0 CA--C 1.538 0.503 1 C-N-CA 136.016 5.726 . . . . 0.0 107.247 171.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -112.38 137.07 51.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.351 1.2 pt -115.01 131.64 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 176.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.375 32.6 m -90.95 130.51 36.87 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 166.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tp -117.25 137.29 52.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 104.446 -2.428 . . . . 0.0 104.446 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 17' ' ' VAL . 2.3 tp10 -94.16 144.5 25.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 16' ' ' GLU . 12.9 m -158.96 -177.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.257 2.223 . . . . 0.0 106.763 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -133.06 153.15 80.77 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 129.119 2.967 . . . . 0.0 106.394 166.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.34 0.1 OUTLIER -49.4 -24.33 8.6 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 N-CA-C 119.214 2.736 . . . . 0.0 119.214 167.107 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.9 p -84.57 -11.06 56.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 113.578 -3.106 . . . . 0.0 110.619 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -68.35 131.72 45.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 129.746 3.218 . . . . 0.0 113.593 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.6 p -82.45 164.62 20.85 Favored 'General case' 0 N--CA 1.449 -0.476 1 O-C-N 129.542 4.276 . . . . 0.0 111.879 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -59.64 -31.29 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 112.541 -2.118 . . . . 0.0 112.013 172.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -74.21 -16.64 60.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 124.468 2.08 . . . . 0.0 112.584 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -98.45 -28.59 13.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.12 2.568 . . . . 0.0 110.485 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.267 62.8 t -52.52 -59.48 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.823 2.449 . . . . 0.0 112.291 168.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.343 17.4 ptpt -53.87 -41.78 67.9 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 128.184 3.428 . . . . 0.0 113.456 177.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.05 -40.56 70.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 126.244 2.215 . . . . 0.0 113.013 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -77.34 -28.1 52.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.609 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.55 -34.73 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 O-C-N 119.614 -1.929 . . . . 0.0 112.261 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -58.88 -42.89 90.54 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 119.225 0.92 . . . . 0.0 113.163 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.69 -47.06 42.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.257 2.223 . . . . 0.0 112.784 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -68.46 -38.65 81.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.422 64.3 mm-40 -129.21 -18.56 3.64 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 130.093 3.357 . . . . 0.0 115.675 -154.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.77 -22.28 41.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.66 2.076 . . . . 0.0 114.686 163.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 36' ' ' ILE . 44.4 mt -86.48 119.04 71.19 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 125.883 1.673 . . . . 0.0 109.638 -163.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -45.94 149.26 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.644 1 C-N-CA 127.615 5.543 . . . . 0.0 115.73 175.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -68.02 -32.51 28.05 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 124.535 3.49 . . . . 0.0 109.995 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.258 19.7 t70 -49.96 -35.92 26.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 117.042 -1.456 . . . . 0.0 114.144 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -101.55 -5.73 24.78 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 128.679 2.791 . . . . 0.0 107.325 -160.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -85.66 141.34 29.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 119.22 -2.175 . . . . 0.0 115.772 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -128.17 95.85 4.29 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.49 111.09 18.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 114.544 -2.646 . . . . 0.0 114.472 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mt -118.77 144.24 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 125.163 3.619 . . . . 0.0 110.383 -172.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -140.37 123.18 16.41 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 163.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.83 33.12 0.92 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 111.713 -2.494 . . . . 0.0 114.022 169.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.95 -33.88 4.99 Favored Glycine 0 C--O 1.221 -0.671 0 O-C-N 118.63 -2.543 . . . . 0.0 112.898 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -79.04 121.66 25.23 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 128.199 2.941 . . . . 0.0 112.171 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -79.51 111.38 15.72 Favored 'General case' 0 N--CA 1.454 -0.251 1 N-CA-C 100.023 -4.066 . . . . 0.0 100.023 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.67 123.01 24.83 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 127.826 2.45 . . . . 0.0 108.691 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -94.85 151.12 19.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 124.927 2.299 . . . . 0.0 108.389 -163.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.94 139.32 33.43 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 109.796 -3.365 . . . . 0.0 110.524 -168.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.47 -20.09 38.0 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.738 2.59 . . . . 0.0 116.291 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.8 mmm-85 -73.38 145.05 46.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 117.759 -3.201 . . . . 0.0 109.49 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 p -75.64 144.18 41.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.447 2.699 . . . . 0.0 107.026 167.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.0 mt -47.18 -37.67 10.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 166.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -67.91 -30.74 70.15 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -77.62 -36.9 51.23 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 126.262 1.825 . . . . 0.0 110.022 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.561 ' HB3' HG12 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -68.43 -20.98 64.68 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 115.742 -2.075 . . . . 0.0 115.839 170.555 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.341 29.5 m120 74.58 27.01 1.39 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 120.272 3.434 . . . . 0.0 120.272 -170.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.561 HG12 ' HB3' ' A' ' 59' ' ' TYR . 39.7 mm -81.18 112.52 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 O-C-N 117.863 -3.023 . . . . 0.0 109.065 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.254 78.0 mm-40 -83.25 155.71 23.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.938 2.895 . . . . 0.0 114.319 177.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.55 127.38 15.41 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 131.343 3.857 . . . . 0.0 114.762 170.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 1.5 pt-20 65.2 33.13 9.55 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 125.685 2.659 . . . . 0.0 116.048 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -74.59 155.44 37.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 124.899 2.285 . . . . 0.0 111.746 160.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 20.6 m -116.21 104.39 11.47 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 111.537 -2.574 . . . . 0.0 105.516 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -94.86 159.77 14.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 130.77 3.628 . . . . 0.0 108.721 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.347 70.7 m80 -109.35 136.61 48.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 115.465 -2.207 . . . . 0.0 114.198 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.261 31.4 tp -108.94 117.5 34.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 126.006 2.066 . . . . 0.0 106.322 173.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -112.0 145.44 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 111.818 -2.446 . . . . 0.0 105.246 169.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.78 121.04 24.27 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 130.034 3.333 . . . . 0.0 110.538 168.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -68.07 -19.14 64.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.318 2.647 . . . . 0.0 111.033 172.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.336 0.0 OUTLIER -144.68 159.4 42.9 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 122.778 2.535 . . . . 0.0 116.689 157.158 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -123.38 -26.42 4.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.365 1.466 . . . . 0.0 111.708 166.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.9 147.16 7.9 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 162.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.653 1 CA-C-O 112.987 -4.229 . . . . 0.0 111.904 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pm0 -96.66 143.03 28.0 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.405 3.082 . . . . 0.0 109.509 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.454 HG13 HD12 ' A' ' 15' ' ' LEU . 18.4 pt -132.72 158.09 43.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 1 C-N-CA 132.152 4.181 . . . . 0.0 105.976 152.596 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -100.66 138.94 37.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.596 1.958 . . . . 0.0 108.327 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.49 110.37 31.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 172.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -107.06 113.22 26.56 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 126.876 3.227 . . . . 0.0 106.28 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -79.19 148.1 32.4 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 117.399 -3.313 . . . . 0.0 105.527 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.53 -21.23 66.16 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 118.908 -2.37 . . . . 0.0 112.836 168.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 p -79.0 -1.32 34.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.003 1.721 . . . . 0.0 112.334 167.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.68 -27.09 22.12 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 115.867 -2.629 . . . . 0.0 112.251 160.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -64.32 139.6 58.78 Favored 'General case' 0 C--N 1.328 -0.352 1 C-N-CA 132.21 4.204 . . . . 0.0 108.179 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.9 m -117.26 112.72 21.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 124.524 2.107 . . . . 0.0 105.934 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.7 mt -101.16 138.03 26.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 1 C-N-CA 131.832 4.053 . . . . 0.0 106.646 176.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m -101.63 129.76 47.82 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 128.375 2.67 . . . . 0.0 107.297 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.454 HD12 HG13 ' A' ' 3' ' ' ILE 0.299 62.0 mt -103.18 168.35 9.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.24 169.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.95 115.74 10.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 128.371 3.545 . . . . 0.0 101.811 169.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.52 167.55 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 103.876 -2.639 . . . . 0.0 103.876 -161.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 4.7 mm-40 -97.91 162.02 23.66 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 169.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.81 -6.24 18.3 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 124.213 3.275 . . . . 0.0 116.194 163.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.6 p -94.17 -0.64 55.1 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.477 1.911 . . . . 0.0 110.066 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -78.47 121.15 24.18 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -65.74 145.64 55.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.387 2.675 . . . . 0.0 112.342 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -66.46 88.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 123.322 1.534 . . . . 0.0 112.421 165.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 178.42 -54.48 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 131.11 3.764 . . . . 0.0 104.69 -177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.308 22.6 t-20 -52.11 -55.76 18.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 -174.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.322 40.9 t -72.6 -20.08 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 128.456 2.702 . . . . 0.0 110.996 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -71.38 -30.21 65.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 122.995 2.634 . . . . 0.0 108.507 172.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.66 -19.57 41.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 116.357 -1.782 . . . . 0.0 113.695 171.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -76.98 -35.72 56.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 116.564 -1.684 . . . . 0.0 109.342 163.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.2 mm -65.05 -38.47 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 124.644 2.164 . . . . 0.0 111.698 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -46.45 -61.49 1.78 Allowed 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 117.732 -3.105 . . . . 0.0 110.109 164.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.8 -37.66 84.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -78.65 -59.15 2.9 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -106.89 -0.36 23.29 Favored 'General case' 0 C--O 1.222 -0.351 0 O-C-N 125.691 1.869 . . . . 0.0 111.326 -162.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.18 13.7 76.35 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 129.8 3.571 . . . . 0.0 117.985 162.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.81 113.56 64.58 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -49.74 126.3 16.18 Favored 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 128.387 6.058 . . . . 0.0 113.767 167.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -41.76 -27.84 0.61 Allowed 'Trans proline' 0 C--N 1.323 -0.81 1 C-N-CA 125.685 4.257 . . . . 0.0 117.751 -177.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.81 -22.78 65.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 171.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -98.69 4.02 47.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.381 2.672 . . . . 0.0 114.708 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -95.81 113.28 24.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 113.835 -2.983 . . . . 0.0 105.133 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -95.71 141.48 29.14 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 123.763 2.983 . . . . 0.0 112.515 150.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.29 0.8 OUTLIER -157.52 117.46 3.4 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 116.603 -1.665 . . . . 0.0 108.811 -148.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mp -145.51 144.29 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 126.487 2.367 . . . . 0.0 106.43 -150.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CD2' HG12 ' A' ' 61' ' ' ILE . 37.4 t80 -131.62 -37.98 1.18 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.27 3.028 . . . . 0.0 115.155 172.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.363 . . -148.11 56.68 1.07 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 129.177 2.991 . . . . 0.0 111.163 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.98 -3.54 77.27 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-O 113.809 -3.773 . . . . 0.0 119.499 168.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -146.06 176.27 9.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 120.466 2.133 . . . . 0.0 110.052 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.06 130.29 39.04 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.029 -1.896 . . . . 0.0 107.911 174.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -77.56 120.6 22.76 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.027 1.731 . . . . 0.0 109.349 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -67.02 123.87 21.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 125.947 2.784 . . . . 0.0 109.876 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.92 115.68 3.89 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.269 2.228 . . . . 0.0 110.751 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.79 -23.55 11.73 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 115.411 -2.883 . . . . 0.0 110.23 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -77.65 148.82 34.85 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -78.34 174.51 11.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.767 2.027 . . . . 0.0 111.956 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.1 -24.78 64.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.399 1.48 . . . . 0.0 112.095 167.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -66.33 -33.84 76.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.052 2.541 . . . . 0.0 113.216 172.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -75.87 -34.84 60.03 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 115.085 -2.388 . . . . 0.0 109.833 -175.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.7 1.92 51.5 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 128.784 3.803 . . . . 0.0 113.484 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 t30 60.45 39.66 18.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.797 2.039 . . . . 0.0 110.421 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 45' ' ' PHE . 67.9 mt -90.84 137.67 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 102.14 -3.281 . . . . 0.0 102.14 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -140.93 170.11 16.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -168.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -58.51 138.4 56.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 120.717 3.599 . . . . 0.0 120.717 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 4.8 tt0 75.35 22.21 1.71 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.547 2.739 . . . . 0.0 108.749 160.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.413 27.4 m -99.61 158.54 15.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 124.909 2.29 . . . . 0.0 109.149 174.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.9 m -62.44 130.9 47.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 116.508 -3.87 . . . . 0.0 111.709 161.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -117.16 143.29 46.0 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 159.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -109.23 143.19 39.01 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.708 2.403 . . . . 0.0 111.935 -169.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -128.52 128.81 45.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 129.426 3.091 . . . . 0.0 107.167 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.3 4.3 t -122.03 136.09 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 115.596 -2.145 . . . . 0.0 106.947 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.02 121.48 45.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.071 2.948 . . . . 0.0 115.303 -171.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 40.76 -28.25 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.891 1 C-N-CA 135.623 5.569 . . . . 0.0 119.899 -174.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.3 mt -117.58 149.48 40.59 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 101.528 -3.508 . . . . 0.0 101.528 -168.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.63 135.14 56.67 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 128.431 2.692 . . . . 0.0 111.572 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.31 47.26 1.04 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 127.442 2.449 . . . . 0.0 114.352 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.486 0 CA-C-O 114.492 -3.393 . . . . 0.0 110.805 -168.586 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttp . . . . . 0 N--CA 1.474 0.764 0 CA-C-O 122.092 0.948 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -115.88 145.23 43.05 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 117.335 -1.746 . . . . 0.0 106.389 -169.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -132.27 177.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 126.591 1.956 . . . . 0.0 108.902 171.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -124.36 149.4 46.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.93 111.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -72.43 115.14 11.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.298 2.239 . . . . 0.0 113.409 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.493 ' HA ' HD11 ' A' ' 69' ' ' LEU . 46.9 p -94.11 170.32 9.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 124.085 1.898 . . . . 0.0 107.301 -169.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.7 -15.79 62.22 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -164.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -73.46 -31.51 63.83 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 128.247 2.619 . . . . 0.0 111.244 165.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.63 2.6 27.31 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 129.031 3.205 . . . . 0.0 110.605 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -66.75 146.41 54.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 121.328 2.564 . . . . 0.0 114.478 171.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.0 m -116.33 106.75 14.0 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 114.012 -2.899 . . . . 0.0 104.164 -165.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mm -98.59 140.65 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -79.21 136.8 37.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 124.355 2.026 . . . . 0.0 109.77 167.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.64 135.85 32.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 -169.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.27 131.02 50.66 Favored 'General case' 0 C--O 1.238 0.448 1 CA-C-O 129.62 4.533 . . . . 0.0 108.138 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.14 -165.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 129.77 3.228 . . . . 0.0 118.481 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -149.65 139.28 13.13 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 167.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -61.21 -22.87 75.9 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 124.16 3.24 . . . . 0.0 118.477 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 m -90.98 -25.14 19.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 118.863 2.912 . . . . 0.0 118.863 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.85 106.28 4.12 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 130.08 3.352 . . . . 0.0 109.841 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -48.97 148.66 2.18 Favored 'General case' 0 N--CA 1.45 -0.436 1 C-N-CA 134.346 5.058 . . . . 0.0 113.139 -155.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.24 -39.62 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.157 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -47.18 -52.18 16.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.86 1.664 . . . . 0.0 111.387 170.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -69.69 -24.93 63.65 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.393 2.277 . . . . 0.0 114.27 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.275 99.4 t -56.82 -55.36 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 1 O-C-N 113.328 -5.858 . . . . 0.0 112.586 167.261 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -43.66 -42.61 5.37 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 127.443 2.297 . . . . 0.0 115.601 167.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.9 -32.44 73.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.734 3.213 . . . . 0.0 112.43 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.12 -31.86 70.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 124.819 2.247 . . . . 0.0 114.276 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -73.22 -40.19 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 127.37 2.268 . . . . 0.0 115.114 169.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.29 -37.76 49.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 127.78 2.432 . . . . 0.0 112.63 162.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -72.07 -38.19 69.48 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.034 0.533 . . . . 0.0 111.958 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -75.78 -51.88 11.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 129.069 2.948 . . . . 0.0 111.815 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -133.63 -0.16 3.22 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.246 1.498 . . . . 0.0 111.402 -160.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.87 -23.17 35.48 Favored Glycine 0 N--CA 1.44 -1.063 0 O-C-N 117.421 -3.299 . . . . 0.0 114.482 161.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.42 120.01 78.16 Favored Pre-proline 0 N--CA 1.441 -0.891 0 O-C-N 117.058 -3.613 . . . . 0.0 112.17 -171.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -72.23 142.24 37.29 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.007 3.138 . . . . 0.0 110.719 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -35.49 -42.87 0.49 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 123.88 3.053 . . . . 0.0 119.12 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.05 -18.17 32.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -119.54 1.25 11.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.372 -170.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -86.3 151.27 23.73 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 172.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -132.54 128.91 38.29 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.562 1.545 . . . . 0.0 108.875 151.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.6 mt -108.19 129.21 55.2 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 3.2 mt -112.24 128.59 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 129.215 3.006 . . . . 0.0 109.175 165.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -81.43 -36.3 29.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 119.039 -2.288 . . . . 0.0 106.535 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.08 -67.35 0.36 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.55 -24.78 1.21 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.247 1.88 . . . . 0.0 113.766 164.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -94.26 141.21 28.83 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.88 2.472 . . . . 0.0 106.595 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -70.63 140.27 51.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.224 3.01 . . . . 0.0 113.95 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 mt -93.15 100.37 12.77 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 126.191 1.796 . . . . 0.0 108.332 171.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -93.16 142.13 27.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 126.304 2.954 . . . . 0.0 106.39 -156.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.69 132.85 55.18 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 130.881 3.672 . . . . 0.0 108.492 172.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.15 -15.16 8.83 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 128.69 3.043 . . . . 0.0 115.4 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -124.47 179.61 4.87 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 128.808 2.843 . . . . 0.0 110.958 -163.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -115.65 164.62 14.07 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 118.53 -2.607 . . . . 0.0 109.409 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.2 mt -72.46 -14.43 61.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.545 -0.722 . . . . 0.0 111.476 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -72.61 -35.39 67.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 129.21 3.004 . . . . 0.0 106.921 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.369 21.3 m-20 -51.4 -36.88 45.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.849 2.46 . . . . 0.0 113.696 172.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -103.91 3.52 33.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 112.903 -3.427 . . . . 0.0 110.162 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.27 0.5 OUTLIER 33.95 63.85 0.38 Allowed 'General case' 0 N--CA 1.45 -0.464 1 C-N-CA 134.333 5.053 . . . . 0.0 114.73 -176.081 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.4 mm -77.6 135.9 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.206 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -100.27 171.66 7.64 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.316 1.446 . . . . 0.0 107.231 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -66.73 146.06 54.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 126.211 2.194 . . . . 0.0 108.456 -170.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 65.73 17.44 10.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.354 1.888 . . . . 0.0 113.765 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -62.99 148.16 48.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 162.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -100.11 106.7 18.46 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.446 2.698 . . . . 0.0 108.399 -176.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.2 159.9 14.65 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.85 0.75 . . . . 0.0 111.275 169.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.46 154.91 29.51 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.636 1.974 . . . . 0.0 108.043 170.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' A' ' 7' ' ' THR 0.342 4.3 pp -127.93 155.28 44.46 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 130.392 3.477 . . . . 0.0 116.238 177.201 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.23 148.2 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 130.304 3.442 . . . . 0.0 108.783 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.8 mt -54.13 129.3 34.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 130.572 3.549 . . . . 0.0 114.32 168.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -108.44 52.22 0.72 Allowed 'General case' 0 CA--C 1.534 0.332 0 O-C-N 125.526 1.766 . . . . 0.0 108.268 163.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.35 -176.11 2.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 117.731 -1.588 . . . . 0.0 114.257 152.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.6 ttm105 -146.53 -26.22 0.42 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 122.814 2.552 . . . . 0.0 109.12 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.56 165.78 24.39 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 124.541 2.189 . . . . 0.0 112.688 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 1 CA-C-O 111.623 -4.987 . . . . 0.0 113.405 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.59 ' HG3' HG23 ' A' ' 17' ' ' VAL . 3.6 ptt? . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -93.95 155.9 16.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 173.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.33 18.1 pt -133.15 158.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.922 2.489 . . . . 0.0 107.167 161.187 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -116.94 127.04 53.84 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 118.837 -2.414 . . . . 0.0 109.525 176.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.568 HG21 HD11 ' A' ' 15' ' ' LEU 0.293 3.2 t -107.74 96.68 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 174.846 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -93.33 127.14 38.81 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 118.942 -2.349 . . . . 0.0 116.986 -171.1 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.54 150.23 44.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 130.429 3.492 . . . . 0.0 109.288 174.478 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.86 -25.77 64.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 116.038 -1.935 . . . . 0.0 107.713 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -80.42 2.92 23.09 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 131.165 3.786 . . . . 0.0 116.241 174.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.61 6.19 53.06 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.296 2.379 . . . . 0.0 108.829 154.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 7' ' ' THR . 47.4 mtmt -97.48 156.48 16.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 121.575 2.687 . . . . 0.0 106.188 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -125.56 129.28 49.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 126.52 2.388 . . . . 0.0 114.328 -178.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.66 116.78 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 1 N-CA-C 98.173 -4.751 . . . . 0.0 98.173 169.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -95.0 116.96 29.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.3 0.64 . . . . 0.0 109.664 170.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.568 HD11 HG21 ' A' ' 5' ' ' VAL 0.325 32.4 mt -92.24 151.49 20.31 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.754 2.022 . . . . 0.0 106.912 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -108.23 83.03 1.72 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.098 2.959 . . . . 0.0 108.458 -173.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' A' ' 1' ' ' MET . 27.0 m -103.13 164.47 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 119.219 -2.175 . . . . 0.0 110.77 -168.059 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -108.28 160.09 28.31 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 130.564 3.546 . . . . 0.0 111.903 162.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.28 -20.89 27.46 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 CA-C-N 122.833 2.047 . . . . 0.0 114.126 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.2 p -94.09 1.33 56.17 Favored 'General case' 0 N--CA 1.447 -0.586 1 C-N-CA 133.659 4.784 . . . . 0.0 112.649 -176.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -61.62 139.85 58.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.312 2.245 . . . . 0.0 107.7 161.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.4 p -95.77 178.88 5.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.314 2.246 . . . . 0.0 106.462 170.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.9 mm -65.11 -34.85 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 1 C-N-CA 132.433 4.293 . . . . 0.0 106.055 170.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -64.95 -42.0 95.0 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 117.26 -3.4 . . . . 0.0 109.564 176.007 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -76.74 -41.51 44.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.958 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.54 -29.43 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 124.964 3.529 . . . . 0.0 111.869 176.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -52.19 -46.39 65.55 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.928 2.491 . . . . 0.0 116.557 165.339 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.55 -44.05 71.69 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 112.366 -2.197 . . . . 0.0 111.984 171.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -72.84 -33.19 65.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.525 -1.36 . . . . 0.0 112.082 -169.426 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -66.89 -41.84 88.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 120.359 -1.463 . . . . 0.0 109.311 171.229 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.9 tm0? -62.84 -36.76 84.3 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 124.868 1.355 . . . . 0.0 110.174 177.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.64 -38.53 80.56 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 119.778 -1.826 . . . . 0.0 114.021 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -68.66 -43.86 75.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 115.824 -2.036 . . . . 0.0 111.253 169.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 34' ' ' GLU 0.293 18.4 tp10 -136.21 12.04 3.3 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 117.231 -1.788 . . . . 0.0 110.453 -147.645 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 29.03 40.98 0.03 OUTLIER Glycine 0 CA--C 1.53 1.01 1 C-N-CA 132.848 5.023 . . . . 0.0 114.775 175.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -91.74 120.28 68.12 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 115.492 -2.194 . . . . 0.0 105.609 157.771 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 38' ' ' PRO 0.291 1.7 Cg_endo -45.87 144.62 5.6 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 O-C-N 125.693 2.417 . . . . 0.0 118.357 171.482 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.9 Cg_endo -82.76 -10.66 10.55 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 O-C-N 125.844 2.497 . . . . 0.0 112.258 -163.201 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.87 -16.25 54.16 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 128.699 2.8 . . . . 0.0 111.5 173.204 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -74.5 -27.55 60.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.954 2.501 . . . . 0.0 112.673 174.297 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -95.36 147.69 23.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 129.349 3.06 . . . . 0.0 114.677 -168.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -115.59 117.2 29.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 172.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.0 mt -97.11 98.13 9.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 -166.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.304 74.1 mt -100.66 145.9 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 128.81 2.844 . . . . 0.0 113.673 -175.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CE2' HG12 ' A' ' 61' ' ' ILE . 33.5 t80 -153.62 123.24 6.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 116.383 -3.948 . . . . 0.0 106.02 166.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.499 . . 74.73 25.25 1.53 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 170.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.94 7.78 67.91 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 130.049 3.69 . . . . 0.0 113.151 -174.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -134.6 150.02 50.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 123.549 3.674 . . . . 0.0 105.396 -166.19 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -87.86 127.82 35.35 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 128.567 2.747 . . . . 0.0 107.683 176.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.52 133.64 49.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 121.581 1.991 . . . . 0.0 113.386 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -83.24 124.74 30.86 Favored 'General case' 0 N--CA 1.447 -0.604 1 C-N-CA 133.867 4.867 . . . . 0.0 107.004 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.22 123.21 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 111.992 -2.367 . . . . 0.0 108.005 -175.217 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.16 31.12 3.4 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 114.924 -3.153 . . . . 0.0 115.7 -177.3 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -139.62 146.11 39.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 122.245 3.022 . . . . 0.0 108.555 170.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.8 p -79.46 155.7 28.18 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.6 mt -46.74 -64.05 0.87 Allowed 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.6 m -66.98 -41.7 86.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.392 1.877 . . . . 0.0 115.857 -172.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.265 11.0 t70 -51.34 -46.91 62.84 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 119.349 -2.094 . . . . 0.0 113.608 170.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.98 8.12 1.72 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 129.86 3.264 . . . . 0.0 114.857 174.66 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.372 3.4 t30 82.31 4.83 1.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 178.327 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.413 HG12 ' CE2' ' A' ' 45' ' ' PHE 0.293 1.9 mt -94.27 91.21 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 123.177 1.465 . . . . 0.0 111.33 -178.304 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.251 46.6 mm-40 -96.52 -167.14 1.52 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 112.623 -2.081 . . . . 0.0 109.08 -175.155 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -68.48 131.52 45.41 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.865 -175.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.347 24.9 mt-10 76.96 36.53 0.32 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 130.51 3.524 . . . . 0.0 108.864 165.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.264 37.9 m -96.25 138.48 33.79 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 -170.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.2 m -96.5 118.76 33.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -178.758 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 67' ' ' LEU . 3.6 mp -106.94 155.72 19.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.748 2.419 . . . . 0.0 105.708 159.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.23 139.86 46.27 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 126.415 2.322 . . . . 0.0 110.488 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 tp -82.86 121.85 27.47 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 126.371 2.295 . . . . 0.0 105.911 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -136.02 136.41 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 128.191 2.596 . . . . 0.0 104.68 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.18 163.66 15.64 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.26 43.6 ttt-85 -137.22 131.9 33.08 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.7 2.8 . . . . 0.0 107.684 170.482 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.267 34.1 mt -84.43 28.85 0.62 Allowed 'General case' 0 N--CA 1.454 -0.244 1 C-N-CA 135.294 5.437 . . . . 0.0 113.568 -168.783 . . . . . . . . 3 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -153.94 131.35 11.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.391 2.676 . . . . 0.0 108.037 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.88 -24.21 7.41 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-N 111.121 -2.763 . . . . 0.0 117.738 -174.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 129.997 3.665 . . . . 0.0 104.131 175.851 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.1 ttm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 117.224 -1.369 . . . . 0.0 107.754 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -98.55 137.64 36.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 125.374 1.671 . . . . 0.0 114.649 -174.413 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -133.29 177.43 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 120.134 -1.604 . . . . 0.0 113.17 171.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -125.23 133.51 52.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 130.178 3.391 . . . . 0.0 109.752 173.386 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.9 t -117.48 131.76 69.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 109.836 -3.347 . . . . 0.0 103.002 165.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -77.66 129.71 35.91 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 116.331 -1.795 . . . . 0.0 113.461 151.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -82.63 149.5 27.36 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.293 2.637 . . . . 0.0 104.41 172.518 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.22 -21.02 66.7 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.168 2.587 . . . . 0.0 111.404 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -70.73 -13.62 62.13 Favored 'General case' 0 C--N 1.326 -0.44 1 C-N-CA 132.056 4.142 . . . . 0.0 112.861 165.254 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.28 1.02 56.89 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.934 1.243 . . . . 0.0 115.301 165.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 155.16 18.96 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.195 -2.356 . . . . 0.0 110.435 166.848 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.6 m -98.07 152.39 19.36 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 100.448 -3.908 . . . . 0.0 100.448 -176.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.81 144.79 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 165.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -93.75 145.22 24.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 123.237 1.494 . . . . 0.0 107.203 165.291 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.414 2.1 pt? -148.25 159.5 43.91 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 120.276 3.436 . . . . 0.0 120.276 166.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -108.49 139.91 42.57 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 124.282 3.219 . . . . 0.0 109.89 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.577 HG22 ' H ' ' A' ' 18' ' ' GLU 0.266 7.5 p -138.21 178.95 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 127.967 3.292 . . . . 0.0 110.363 -177.872 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.577 ' H ' HG22 ' A' ' 17' ' ' VAL . 29.9 tp10 -134.14 138.29 30.15 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 -177.508 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -44.34 -37.21 10.2 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 N-CA-C 119.559 2.869 . . . . 0.0 119.559 175.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.295 13.5 p -95.08 3.34 54.92 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 113.422 -3.18 . . . . 0.0 111.2 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -73.87 160.45 31.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 123.61 2.914 . . . . 0.0 105.355 169.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -102.94 155.2 18.52 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 119.311 -2.118 . . . . 0.0 112.181 -177.519 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.415 HD13 HD12 ' A' ' 56' ' ' LEU . 16.6 mm -63.88 -57.69 10.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 130.061 3.345 . . . . 0.0 111.777 -168.334 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.555 1.9 tt0 -44.57 -48.54 10.33 Favored 'General case' 0 C--O 1.222 -0.349 1 C-N-CA 132.632 4.373 . . . . 0.0 114.83 176.733 . . . . . . . . 3 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.284 26.3 t30 -49.06 -61.12 2.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 130.139 3.376 . . . . 0.0 111.666 -178.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -74.06 -39.55 50.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 128.742 2.817 . . . . 0.0 106.225 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -62.38 -28.35 69.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 112.716 -3.516 . . . . 0.0 112.196 -178.413 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.03 -14.39 31.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.87 2.577 . . . . 0.0 116.434 178.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -54.85 -27.34 41.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.466 2.307 . . . . 0.0 113.576 177.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tp -48.03 -22.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 1 C-N-CA 135.654 5.581 . . . . 0.0 117.382 -175.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -61.8 3.08 0.16 Allowed 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 170.501 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.513 32.9 t70 -19.15 -55.28 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 2 C-N-CA 135.112 5.365 . . . . 0.0 122.067 158.021 . . . . . . . . 3 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.254 1.6 pptp? -149.15 -19.52 0.29 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 122.265 2.302 . . . . 0.0 112.22 -160.135 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.413 1.1 pm0 -124.85 169.3 12.18 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 147.19 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.81 62.11 0.33 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 105.602 -2.999 . . . . 0.0 105.602 -175.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.8 pt -86.64 148.98 47.62 Favored Pre-proline 0 N--CA 1.448 -0.572 0 C-N-CA 130.196 3.398 . . . . 0.0 109.793 178.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -76.27 136.42 17.88 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.742 2.294 . . . . 0.0 113.661 171.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -77.29 -16.1 15.61 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.997 3.131 . . . . 0.0 112.099 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.3 -15.4 62.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 124.0 3.091 . . . . 0.0 108.136 178.054 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -90.73 17.32 7.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.986 2.114 . . . . 0.0 115.439 176.445 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -142.33 160.09 40.94 Favored 'General case' 0 N--CA 1.446 -0.633 1 C-N-CA 136.984 6.114 . . . . 0.0 113.022 173.221 . . . . . . . . 4 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -149.8 146.97 27.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 131.341 3.857 . . . . 0.0 111.534 -178.27 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -96.57 121.81 38.8 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.959 3.304 . . . . 0.0 113.265 177.049 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.3 mt -91.96 144.58 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 156.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CG ' ' N ' ' A' ' 46' ' ' ALA 0.303 4.7 p90 -111.91 -76.37 0.6 Allowed 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 169.747 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' N ' ' CG ' ' A' ' 45' ' ' PHE . . . -130.5 82.93 2.08 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 100.854 -3.758 . . . . 0.0 100.854 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.24 61.33 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 112.444 -2.162 . . . . 0.0 117.084 165.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -147.83 172.79 13.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 129.21 3.004 . . . . 0.0 113.862 -171.22 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -107.04 142.89 35.95 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 128.214 2.606 . . . . 0.0 112.836 -170.177 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 43' ' ' LEU . 19.9 mt -74.34 165.9 24.4 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 129.492 3.117 . . . . 0.0 113.06 169.014 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -151.97 150.85 30.47 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 129.719 3.208 . . . . 0.0 116.59 175.098 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -43.8 132.48 5.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.28 -26.24 7.1 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.221 1.391 . . . . 0.0 112.979 173.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 163.64 12.47 Favored 'General case' 0 N--CA 1.444 -0.731 1 C-N-CA 133.426 4.69 . . . . 0.0 108.295 -164.916 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 p -103.68 173.17 6.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 113.545 -1.662 . . . . 0.0 106.536 167.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.415 HD12 HD13 ' A' ' 23' ' ' ILE . 3.0 mp -61.45 -34.18 74.98 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.364 175.55 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -78.81 -8.95 59.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.123 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -69.2 -31.62 70.34 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 125.494 1.747 . . . . 0.0 109.842 160.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -110.93 11.47 22.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.424 16.1 m120 83.4 -6.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 163.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -69.92 135.24 28.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -157.202 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.4 -166.79 2.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 114.183 -2.818 . . . . 0.0 110.536 -162.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.36 110.69 0.33 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 165.015 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 78.1 mt-10 73.35 31.79 1.33 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 131.02 3.728 . . . . 0.0 115.177 175.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 m -70.14 121.91 18.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 128.014 2.526 . . . . 0.0 107.07 172.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.4 m -97.58 114.35 26.25 Favored 'General case' 0 C--N 1.32 -0.683 1 N-CA-C 97.522 -4.992 . . . . 0.0 97.522 -178.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.465 ' HB3' HD12 ' A' ' 43' ' ' LEU . 8.2 mp -95.71 151.52 19.28 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 130.453 3.501 . . . . 0.0 107.453 171.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -118.98 134.7 55.02 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 126.581 2.426 . . . . 0.0 112.775 168.795 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 tp -100.93 124.88 47.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -174.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.639 HG22 ' H ' ' A' ' 71' ' ' LEU 0.353 7.5 p -140.18 -146.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 126.198 1.799 . . . . 0.0 112.027 173.959 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.639 ' H ' HG22 ' A' ' 70' ' ' VAL 0.542 1.8 pt? -150.09 165.75 31.86 Favored 'General case' 0 N--CA 1.45 -0.446 1 C-N-CA 132.0 4.12 . . . . 0.0 111.26 179.953 . . . . . . . . 4 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -67.66 121.0 14.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.388 177.083 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.349 5.2 mp -122.19 51.62 1.35 Allowed 'General case' 0 CA--C 1.534 0.341 1 C-N-CA 132.705 4.402 . . . . 0.0 108.307 179.777 . . . . . . . . 3 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -144.34 131.39 20.5 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 127.613 3.071 . . . . 0.0 105.119 173.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.75 -8.93 19.97 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 130.13 3.729 . . . . 0.0 109.402 -178.005 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 N-CA-C 105.525 -3.03 . . . . 0.0 105.525 164.968 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 117.646 -1.169 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -74.37 121.2 21.02 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -170.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -136.15 174.95 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 123.606 2.912 . . . . 0.0 113.756 170.682 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -123.73 155.14 38.41 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.843 2.457 . . . . 0.0 113.65 169.336 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.2 130.9 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 O-C-N 118.195 -2.816 . . . . 0.0 105.945 161.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.272 64.8 tttt -111.49 131.35 55.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 118.829 -2.419 . . . . 0.0 104.529 176.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.8 p -98.79 168.95 9.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.516 2.726 . . . . 0.0 105.48 -166.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 71' ' ' LEU . 15.9 mt -93.16 -0.02 57.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 130.887 3.675 . . . . 0.0 112.346 175.712 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 p -102.59 -23.63 13.85 Favored 'General case' 0 N--CA 1.444 -0.762 1 C-N-CA 134.187 4.995 . . . . 0.0 109.942 172.707 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.09 -6.71 11.97 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 116.635 -2.203 . . . . 0.0 110.594 147.265 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -61.45 149.92 37.13 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 157.071 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -112.45 117.84 33.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 163.232 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mt -101.46 133.15 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 101.756 -3.424 . . . . 0.0 101.756 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -94.46 146.78 23.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.473 1.909 . . . . 0.0 110.624 177.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.9 -177.21 3.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -176.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -149.88 117.48 6.17 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 116.536 -1.697 . . . . 0.0 107.987 170.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -131.32 148.26 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 C-N-CA 133.112 4.565 . . . . 0.0 107.237 -176.358 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -81.99 141.53 47.26 Favored Pre-proline 0 N--CA 1.443 -0.785 0 CA-C-O 115.747 -2.073 . . . . 0.0 107.56 172.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -45.12 -35.16 10.35 Favored 'Trans proline' 0 N--CA 1.45 -1.071 1 C-N-CA 127.821 5.681 . . . . 0.0 114.169 173.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.7 p -77.07 -19.46 57.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.611 2.764 . . . . 0.0 113.918 176.71 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.75 126.53 28.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.704 2.047 . . . . 0.0 109.053 -173.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -70.44 150.99 45.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.1 0.96 . . . . 0.0 112.496 170.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 15.8 mm -55.13 -26.98 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 127.901 2.481 . . . . 0.0 114.777 -178.437 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.259 8.4 pt-20 -61.71 -33.94 74.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 166.079 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -92.53 -33.14 14.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -167.527 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.284 75.4 t -39.85 -42.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 130.631 3.573 . . . . 0.0 113.256 158.479 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -74.02 -16.21 61.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.97 -37.65 54.8 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 126.856 2.062 . . . . 0.0 105.52 -173.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -75.86 -26.16 56.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 130.013 3.325 . . . . 0.0 109.047 -175.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -77.68 -22.84 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 126.795 2.559 . . . . 0.0 111.441 173.236 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -69.17 -43.09 74.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.977 1.311 . . . . 0.0 110.994 -175.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.429 21.8 t70 -56.93 -36.19 69.92 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 129.908 3.283 . . . . 0.0 116.161 -179.373 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -103.46 -27.93 12.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 109.426 -3.534 . . . . 0.0 115.402 -173.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -116.75 -13.78 10.77 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 124.812 2.244 . . . . 0.0 116.201 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.8 -0.96 56.57 Favored Glycine 0 CA--C 1.526 0.753 0 O-C-N 117.642 -3.161 . . . . 0.0 110.594 165.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.75 130.24 23.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 129.396 3.078 . . . . 0.0 111.569 -156.298 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.92 162.11 20.93 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 121.022 1.148 . . . . 0.0 110.223 -173.185 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -52.49 -21.86 15.1 Favored 'Trans proline' 0 N--CA 1.449 -1.109 1 C-N-CA 126.07 4.513 . . . . 0.0 117.718 170.715 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -57.32 -26.92 61.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 126.996 2.685 . . . . 0.0 117.935 164.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -97.79 -28.81 13.7 Favored 'General case' 0 C--O 1.221 -0.417 1 C-N-CA 131.848 4.059 . . . . 0.0 113.093 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.74 93.83 2.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.037 2.135 . . . . 0.0 107.522 -177.279 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 mtp85 -110.74 100.84 9.53 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.083 1.753 . . . . 0.0 114.667 167.734 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.3 mt -100.17 139.9 35.17 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 110.753 -2.931 . . . . 0.0 109.789 -165.023 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.48 160.72 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 174.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -149.62 124.1 9.68 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.985 2.914 . . . . 0.0 103.536 168.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.75 28.31 6.19 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 128.657 2.783 . . . . 0.0 115.664 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.29 3.23 90.62 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 128.194 3.433 . . . . 0.0 114.49 -175.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -92.2 147.55 22.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 122.771 3.286 . . . . 0.0 106.335 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 -100.33 93.31 5.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 102.696 -3.075 . . . . 0.0 102.696 -176.131 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.422 ' HG ' ' H ' ' A' ' 50' ' ' LEU . 20.2 mt -54.21 115.28 1.98 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 130.785 3.634 . . . . 0.0 109.041 176.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.266 40.0 tt0 -81.44 134.7 35.58 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 102.58 -3.118 . . . . 0.0 102.58 -165.645 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.58 119.76 7.63 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 128.086 2.554 . . . . 0.0 106.472 167.08 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.49 -5.97 57.35 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 119.832 -1.792 . . . . 0.0 112.654 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -94.75 176.67 6.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 116.07 -1.919 . . . . 0.0 108.986 163.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 77.0 p -115.23 176.99 4.82 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.029 1.456 . . . . 0.0 112.012 176.237 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.97 -28.69 69.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 116.729 -1.605 . . . . 0.0 113.453 167.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.7 t -64.6 -36.34 83.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.785 2.434 . . . . 0.0 109.161 174.524 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.402 16.4 m-20 -57.4 -25.42 59.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 116.545 -3.847 . . . . 0.0 119.759 169.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -112.25 3.79 17.35 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 116.374 -1.774 . . . . 0.0 109.715 177.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.554 8.8 p30 57.2 31.71 20.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 129.302 3.041 . . . . 0.0 116.631 -173.212 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -81.38 118.34 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 -176.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -99.67 173.74 6.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.707 2.403 . . . . 0.0 112.958 -173.104 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -39.1 134.36 1.08 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.71 2.804 . . . . 0.0 113.11 174.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 62.67 46.14 5.53 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 128.097 2.559 . . . . 0.0 109.659 175.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -104.4 125.47 50.64 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 123.182 2.719 . . . . 0.0 104.21 172.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.8 m -85.7 134.47 33.96 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 114.649 -2.596 . . . . 0.0 108.607 178.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -107.77 154.33 21.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 101.546 -3.501 . . . . 0.0 101.546 -179.444 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -102.34 134.76 45.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.217 2.607 . . . . 0.0 105.639 176.298 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 1.7 mt -97.56 129.5 44.69 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.165 2.186 . . . . 0.0 106.267 176.018 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -100.24 117.71 45.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 159.386 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.437 ' H ' HD12 ' A' ' 8' ' ' LEU . 8.1 tp -119.04 168.82 10.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.786 2.434 . . . . 0.0 110.108 176.127 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -124.01 113.39 18.36 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 129.604 3.162 . . . . 0.0 112.123 155.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.253 0.2 OUTLIER -134.52 -158.41 0.88 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 117.382 -3.324 . . . . 0.0 105.995 158.625 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.4 mtm-85 -63.45 -64.51 0.88 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 130.246 3.418 . . . . 0.0 108.559 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.98 -10.26 3.9 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 107.501 -2.239 . . . . 0.0 107.501 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 C-N-CA 127.239 2.352 . . . . 0.0 108.338 -178.3 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 115.47 -2.205 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.274 87.1 mt-30 -99.78 154.53 18.25 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 121.323 1.874 . . . . 0.0 113.879 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -145.67 153.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -124.77 107.64 11.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 115.387 -2.244 . . . . 0.0 105.967 -161.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.25 115.72 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 119.883 1.219 . . . . 0.0 108.378 179.42 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -84.56 142.37 30.04 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 125.438 2.542 . . . . 0.0 108.372 176.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -127.82 148.38 50.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 110.026 -3.261 . . . . 0.0 108.879 162.382 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.4 mt -48.17 -17.99 0.17 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 128.053 2.541 . . . . 0.0 116.765 174.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -77.78 -37.48 48.81 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 125.516 2.579 . . . . 0.0 114.453 -169.107 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.73 -16.49 10.33 Favored Glycine 0 CA--C 1.538 1.502 0 O-C-N 117.04 -3.538 . . . . 0.0 108.438 -170.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -77.58 138.8 39.35 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 130.007 3.323 . . . . 0.0 106.81 174.54 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 m -141.3 117.93 10.96 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.731 3.212 . . . . 0.0 106.632 -171.106 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mm -91.09 117.47 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.344 1.857 . . . . 0.0 106.636 -173.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.9 m -83.04 118.92 23.86 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.549 1.94 . . . . 0.0 109.232 176.391 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -120.76 134.78 55.27 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.307 1.843 . . . . 0.0 106.547 172.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -88.25 124.63 34.06 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 128.77 3.794 . . . . 0.0 109.102 157.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.8 169.89 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 1 CA-C-N 107.66 -4.336 . . . . 0.0 105.156 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -119.76 162.76 31.23 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 128.911 2.884 . . . . 0.0 111.397 158.185 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.65 -23.47 15.28 Favored 'Trans proline' 0 N--CA 1.447 -1.237 1 C-N-CA 126.158 4.572 . . . . 0.0 119.687 177.625 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -88.3 1.58 54.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 115.848 -2.025 . . . . 0.0 113.423 175.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.01 115.41 3.13 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 122.039 2.2 . . . . 0.0 113.394 -175.055 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.2 p -71.88 160.11 33.12 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 118.358 -2.714 . . . . 0.0 112.893 172.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.272 53.7 mt -49.17 -36.94 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 115.369 -2.253 . . . . 0.0 113.974 167.624 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -58.9 -31.29 68.49 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 131.397 3.879 . . . . 0.0 113.435 164.27 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -84.68 -32.55 23.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 121.971 2.168 . . . . 0.0 110.04 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.94 -50.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 115.284 -2.294 . . . . 0.0 109.076 169.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 70.7 mttt -43.33 -47.95 6.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.695 1.598 . . . . 0.0 114.612 177.06 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.8 -24.13 61.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 124.304 2.002 . . . . 0.0 116.148 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -86.08 -42.37 13.99 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 114.119 -2.848 . . . . 0.0 104.808 -173.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.257 78.1 mt -49.06 -59.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 112.623 -3.56 . . . . 0.0 106.337 168.469 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -47.24 -51.53 18.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 127.977 3.298 . . . . 0.0 117.348 171.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.37 -35.96 82.13 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.332 0.653 . . . . 0.0 112.279 -174.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -82.27 -76.03 0.28 Allowed 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 125.706 1.879 . . . . 0.0 109.902 173.076 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -91.54 -21.57 20.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.265 -159.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.02 -0.23 60.38 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 116.159 -2.467 . . . . 0.0 113.745 164.865 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -66.98 127.04 93.38 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 120.407 2.103 . . . . 0.0 109.167 165.129 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.44 140.26 21.47 Favored 'Trans proline' 0 N--CA 1.445 -1.358 1 C-N-CA 126.608 4.872 . . . . 0.0 110.254 175.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HG3' ' HB3' ' A' ' 27' ' ' LYS 0.257 87.3 Cg_exo -41.45 -34.4 1.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 1 C-N-CA 131.83 8.353 . . . . 0.0 118.818 169.333 . . . . . . . . 4 3 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.58 -29.0 68.96 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 125.72 1.887 . . . . 0.0 113.476 171.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.1 tp60 -84.5 -2.79 57.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 122.346 2.339 . . . . 0.0 111.726 -170.613 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 26.9 mt-30 -113.83 134.4 54.81 Favored 'General case' 0 C--N 1.325 -0.495 1 CA-C-O 111.257 -4.211 . . . . 0.0 118.744 -166.694 . . . . . . . . 3 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -110.63 141.02 44.42 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 128.986 3.929 . . . . 0.0 102.05 163.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.5 mt -135.38 128.78 32.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.561 1.144 . . . . 0.0 109.396 -174.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 4.2 mt -122.42 150.77 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.083 2.553 . . . . 0.0 104.451 -174.132 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.65 -82.6 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 102.391 -3.188 . . . . 0.0 102.391 165.324 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.86 -52.97 1.43 Allowed 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.15 -1.594 . . . . 0.0 108.894 173.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.14 -30.68 0.78 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 106.054 -2.818 . . . . 0.0 106.054 -175.314 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -82.89 110.42 17.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 -175.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -60.38 127.58 32.45 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 116.526 -1.702 . . . . 0.0 111.333 159.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -75.11 151.5 38.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 125.464 2.554 . . . . 0.0 112.56 -178.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -112.66 144.86 41.45 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 119.924 -1.735 . . . . 0.0 109.833 175.04 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.73 153.88 42.98 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 127.257 2.848 . . . . 0.0 114.98 -172.336 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.85 13.03 44.85 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 128.071 2.748 . . . . 0.0 114.136 169.206 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.3 mtt85 -125.63 151.71 46.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.229 1.966 . . . . 0.0 108.544 -167.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.0 p -92.43 174.95 7.02 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.397 1.57 . . . . 0.0 110.799 -177.316 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.58 -28.26 65.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 111.833 -2.44 . . . . 0.0 111.726 174.611 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -71.67 -37.76 70.72 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.378 -1.451 . . . . 0.0 114.645 173.311 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.94 -42.02 97.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.102 0.961 . . . . 0.0 113.386 178.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.57 4.0 45.38 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 123.488 1.613 . . . . 0.0 113.01 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.316 42.7 m-80 76.49 26.77 0.86 Allowed 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 172.016 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.5 mt -99.49 107.86 21.48 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-O 125.518 2.58 . . . . 0.0 104.117 -170.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -93.34 165.11 12.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 165.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.472 39.7 pttt -30.97 125.68 0.19 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 164.611 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 88.43 1.98 0.32 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 130.044 3.338 . . . . 0.0 113.982 176.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -62.17 141.29 58.26 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 117.104 -3.497 . . . . 0.0 113.311 176.766 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.3 m -90.82 137.67 32.18 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 125.407 1.692 . . . . 0.0 108.361 170.23 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -119.74 172.87 7.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 164.472 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -136.15 110.95 8.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 126.01 2.069 . . . . 0.0 110.176 -167.302 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.52 126.73 42.98 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 125.383 2.516 . . . . 0.0 110.193 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.49 122.02 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 O-C-N 116.965 -3.585 . . . . 0.0 106.487 170.387 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.4 mt -70.01 145.9 51.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.709 3.204 . . . . 0.0 111.582 178.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -82.48 48.11 1.25 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.702 2.401 . . . . 0.0 116.583 173.578 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.1 mt -54.94 130.67 42.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 109.156 -3.656 . . . . 0.0 114.01 174.275 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.265 5.2 mpt_? -108.08 123.61 48.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.159 177.472 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.73 158.38 23.03 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 105.361 -3.096 . . . . 0.0 105.361 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.682 0 CA-C-O 115.39 -2.894 . . . . 0.0 107.285 164.165 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -98.21 139.08 34.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -173.083 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.5 pt -121.91 161.58 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.99 2.116 . . . . 0.0 106.334 166.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -105.31 129.4 53.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 159.234 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.77 125.99 54.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 160.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -115.21 158.35 22.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 128.315 2.646 . . . . 0.0 105.651 178.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -135.43 167.94 20.14 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 118.125 -2.859 . . . . 0.0 105.565 -170.028 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -69.16 -27.55 65.63 Favored 'General case' 0 N--CA 1.451 -0.387 1 O-C-N 116.093 -4.129 . . . . 0.0 113.839 176.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.1 p -85.12 3.89 36.87 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 119.077 -2.264 . . . . 0.0 110.043 171.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.9 -24.19 32.19 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 117.87 -3.018 . . . . 0.0 106.961 156.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -50.23 118.79 3.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.719 3.608 . . . . 0.0 106.29 -177.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -118.76 117.06 27.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.052 0.842 . . . . 0.0 109.408 -174.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.3 mt -84.15 136.09 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 1 C-N-CA 132.471 4.308 . . . . 0.0 107.944 168.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -93.39 133.62 36.46 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 163.27 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.14 142.06 51.6 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 129.507 3.123 . . . . 0.0 112.436 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -113.89 136.01 53.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 168.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 m -153.76 -178.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.84 1 C-N-CA 134.695 5.198 . . . . 0.0 112.07 -165.553 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -139.79 147.91 53.33 Favored Pre-proline 0 N--CA 1.448 -0.542 0 O-C-N 117.979 -2.95 . . . . 0.0 110.701 175.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -49.75 -41.67 45.67 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 123.566 2.844 . . . . 0.0 114.337 -177.175 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 p -51.05 -26.26 6.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 165.332 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -70.18 126.81 30.76 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 122.517 2.417 . . . . 0.0 108.257 -170.502 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.8 p -66.14 149.77 49.78 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.984 1.714 . . . . 0.0 113.796 -178.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 mm -84.6 89.56 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 1 N-CA-C 99.4 -4.296 . . . . 0.0 99.4 159.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -175.08 -60.91 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 130.325 3.45 . . . . 0.0 103.695 173.144 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -70.46 -39.51 74.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 114.853 -2.499 . . . . 0.0 116.454 -175.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.15 -44.35 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.692 1.997 . . . . 0.0 114.317 160.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.22 -16.49 62.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 112.318 -3.706 . . . . 0.0 111.407 -176.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.36 -35.88 30.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 123.888 3.04 . . . . 0.0 105.266 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -68.55 -35.92 78.09 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 125.076 2.369 . . . . 0.0 110.491 -176.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 mm -70.36 -46.91 69.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.276 176.297 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -56.11 -45.82 79.32 Favored 'General case' 0 N--CA 1.453 -0.296 1 O-C-N 116.274 -4.016 . . . . 0.0 107.223 -178.295 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.371 4.9 t70 -47.82 -55.9 8.68 Favored 'General case' 0 N--CA 1.444 -0.742 1 C-N-CA 133.901 4.88 . . . . 0.0 112.491 169.235 . . . . . . . . 3 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -65.97 -47.63 73.93 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 124.651 1.22 . . . . 0.0 109.925 176.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -125.14 -15.84 6.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 117.936 -2.978 . . . . 0.0 116.259 -148.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.21 6.57 53.44 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 153.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.7 mt -99.47 121.53 54.62 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-O 114.39 -2.719 . . . . 0.0 105.455 -163.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.77 135.33 62.98 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-N 124.63 2.689 . . . . 0.0 113.755 173.022 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.292 67.4 Cg_exo -33.1 -37.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.56 1 C-N-CA 129.644 6.896 . . . . 0.0 118.246 174.476 . . . . . . . . 3 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -80.69 -31.85 36.09 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 117.985 -2.947 . . . . 0.0 106.752 -172.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -90.94 -10.91 40.69 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 115.206 -2.331 . . . . 0.0 105.11 -172.192 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -77.87 94.79 4.6 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 130.687 3.595 . . . . 0.0 104.545 169.563 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -91.26 120.55 32.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.685 176.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mt -126.5 123.97 39.0 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -163.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -138.34 133.87 43.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -164.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.361 0.3 OUTLIER -124.6 -28.25 3.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.082 -2.327 . . . . 0.0 115.287 159.662 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.291 . . -153.02 43.59 0.63 Allowed 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 125.405 1.691 . . . . 0.0 108.912 -166.217 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.96 -7.67 49.04 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 128.709 3.052 . . . . 0.0 117.921 159.083 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.44 32.0 pttt -151.97 147.49 26.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 131.488 3.915 . . . . 0.0 110.918 -170.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.7 139.95 48.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.151 1.78 . . . . 0.0 112.705 173.573 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 mt -82.11 136.35 35.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 114.949 -2.453 . . . . 0.0 107.884 -174.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -82.68 139.84 33.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 126.237 2.211 . . . . 0.0 110.371 -170.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -45.3 113.78 0.63 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 118.679 2.844 . . . . 0.0 118.679 169.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.09 -7.19 40.67 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 164.448 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.259 13.3 mmp_? -93.69 142.12 27.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -172.057 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.9 p -86.47 163.86 17.3 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.333 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -41.05 -52.89 3.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 124.798 3.454 . . . . 0.0 115.704 163.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 t -51.84 -37.64 52.72 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 114.115 -2.85 . . . . 0.0 115.156 168.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -68.0 -18.57 64.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 178.627 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -97.36 -13.49 21.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 114.132 -2.842 . . . . 0.0 112.308 161.096 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.8 t30 72.14 31.8 1.87 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 125.626 3.83 . . . . 0.0 113.104 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -70.55 112.84 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 1 O-C-N 115.927 -4.233 . . . . 0.0 109.845 -175.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.291 22.9 mt-30 -94.03 162.68 13.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.269 1.428 . . . . 0.0 110.539 -165.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.266 26.8 pttt -42.16 115.26 0.66 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 117.168 2.284 . . . . 0.0 117.168 161.425 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.5 2.6 tt0 87.16 30.35 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.785 170.329 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.31 68.6 m -90.01 132.69 35.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 172.519 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -82.27 125.82 31.41 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.433 2.293 . . . . 0.0 112.456 169.566 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mp -116.36 124.36 49.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 172.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.285 11.8 t60 -83.64 120.09 25.56 Favored 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 131.876 4.07 . . . . 0.0 112.275 165.508 . . . . . . . . 3 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -94.5 130.59 40.83 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 117.373 -3.329 . . . . 0.0 108.337 174.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.79 153.01 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 O-C-N 117.98 -2.95 . . . . 0.0 114.125 170.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.73 95.28 3.02 Favored 'General case' 0 CA--C 1.518 -0.272 1 N-CA-C 98.125 -4.769 . . . . 0.0 98.125 -161.43 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 73.52 11.66 4.76 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 117.456 -3.277 . . . . 0.0 114.487 168.086 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -110.63 139.39 45.94 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 129.032 2.933 . . . . 0.0 103.885 176.202 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -93.04 163.39 13.67 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 126.707 3.146 . . . . 0.0 111.472 166.835 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.01 49.74 0.84 Allowed Glycine 0 CA--C 1.536 1.372 0 O-C-N 118.37 -2.706 . . . . 0.0 107.896 178.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 128.997 3.189 . . . . 0.0 106.415 -176.706 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pm0 -104.92 140.72 37.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.543 1.937 . . . . 0.0 107.93 178.103 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -124.72 151.8 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 128.644 2.777 . . . . 0.0 106.607 165.272 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.253 60.3 m-85 -93.11 151.58 19.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 122.577 1.179 . . . . 0.0 113.217 168.702 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.1 144.67 28.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 114.293 -2.765 . . . . 0.0 107.245 167.548 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 52.3 tttt -126.48 127.46 45.4 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 128.75 3.781 . . . . 0.0 118.196 170.091 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 p -82.36 166.18 19.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.743 2.417 . . . . 0.0 111.448 -169.265 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.35 -37.0 66.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 129.974 3.31 . . . . 0.0 116.604 172.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.8 p -73.89 -33.25 63.95 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.589 2.756 . . . . 0.0 113.967 173.607 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.17 16.43 7.23 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 116.518 1.367 . . . . 0.0 116.518 177.539 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -86.47 134.99 33.64 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.898 1.679 . . . . 0.0 106.984 178.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -100.59 113.24 25.89 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 130.091 3.357 . . . . 0.0 105.315 -176.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -100.38 114.51 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 100.666 -3.827 . . . . 0.0 100.666 174.647 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -66.25 131.75 46.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.954 -2.966 . . . . 0.0 109.261 154.637 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.14 128.45 38.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 119.418 -2.051 . . . . 0.0 108.297 -172.29 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -91.92 115.79 28.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 125.696 1.872 . . . . 0.0 110.26 178.265 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.51 22.6 m -121.07 -68.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 113.45 -3.166 . . . . 0.0 118.052 -163.271 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 80.48 131.74 0.04 OUTLIER Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 129.709 3.204 . . . . 0.0 107.176 -155.574 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.3 -16.81 15.21 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 CA-C-N 120.316 1.149 . . . . 0.0 114.976 -175.294 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 m -86.23 18.03 3.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 172.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -76.79 152.63 35.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.056 1.342 . . . . 0.0 110.002 158.359 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -88.71 148.5 23.95 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.999 1.319 . . . . 0.0 107.952 174.846 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.279 5.8 mm -46.13 -37.63 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 127.546 2.338 . . . . 0.0 113.477 174.872 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -82.27 -14.18 55.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 116.506 -3.871 . . . . 0.0 113.343 -175.045 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -94.86 -24.94 16.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 123.805 1.764 . . . . 0.0 110.692 174.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.45 -41.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 1 O-C-N 115.452 -4.53 . . . . 0.0 108.857 167.343 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -69.83 -34.05 73.14 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 124.525 1.141 . . . . 0.0 112.811 176.106 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.255 . . -77.45 -13.27 59.96 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 120.604 1.547 . . . . 0.0 110.808 173.126 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -69.1 -37.06 78.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 118.314 -2.742 . . . . 0.0 111.13 172.052 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 mm -69.15 -31.39 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 127.572 2.349 . . . . 0.0 108.291 175.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.58 -37.12 76.82 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 172.326 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.12 -51.2 40.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.254 -1.529 . . . . 0.0 114.152 172.092 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -87.57 -27.65 22.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -171.351 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -122.89 -21.23 5.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 115.282 -2.294 . . . . 0.0 115.441 175.119 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.63 -14.6 42.12 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 116.446 -2.308 . . . . 0.0 111.558 172.127 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.5 mt -78.38 121.23 83.49 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 120.394 2.097 . . . . 0.0 109.238 -154.348 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -55.27 143.27 76.51 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 CA-C-N 123.214 2.184 . . . . 0.0 117.029 -174.848 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.43 -28.86 3.33 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 O-C-N 116.965 -2.177 . . . . 0.0 116.396 -166.628 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 0.0 OUTLIER -51.92 -29.21 19.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 121.291 3.811 . . . . 0.0 121.291 172.127 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -92.7 -18.47 22.94 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 128.492 3.62 . . . . 0.0 111.723 -177.103 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -83.24 129.41 35.01 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 126.168 2.167 . . . . 0.0 116.282 -175.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -103.47 119.64 39.28 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 114.488 -2.673 . . . . 0.0 105.048 160.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -88.6 120.8 30.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.788 1.631 . . . . 0.0 109.075 168.993 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mm -114.57 135.28 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 126.52 1.928 . . . . 0.0 112.635 -177.025 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.262 49.5 t80 -148.61 113.33 5.38 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 128.383 2.673 . . . . 0.0 109.103 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.92 50.71 0.81 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 128.159 2.583 . . . . 0.0 111.451 163.555 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.15 4.5 66.63 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 117.82 -2.134 . . . . 0.0 117.264 174.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -161.2 144.75 12.97 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -160.391 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -87.92 140.32 29.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 125.352 2.501 . . . . 0.0 107.648 173.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.61 113.2 24.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 118.84 -2.413 . . . . 0.0 108.514 179.864 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -79.2 137.22 37.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 118.395 -2.691 . . . . 0.0 111.634 -163.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -45.65 112.38 0.45 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 129.146 2.978 . . . . 0.0 114.733 156.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.62 -15.6 9.76 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 128.972 3.177 . . . . 0.0 113.896 -173.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -105.69 178.26 4.61 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 120.84 2.32 . . . . 0.0 105.797 -175.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -110.7 170.0 8.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 118.473 -2.642 . . . . 0.0 108.545 176.389 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.46 -35.72 63.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 117.195 -1.802 . . . . 0.0 109.983 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 p -53.95 -27.75 33.07 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 128.2 2.6 . . . . 0.0 112.91 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -58.68 -26.35 63.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 167.158 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -120.33 23.04 11.1 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 118.209 -2.807 . . . . 0.0 108.287 -170.132 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.344 13.5 m120 78.73 10.01 1.82 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 126.379 2.299 . . . . 0.0 111.978 171.12 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -77.81 120.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 121.124 1.784 . . . . 0.0 111.544 -160.361 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -106.37 -177.4 3.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.643 1.211 . . . . 0.0 111.185 176.13 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -69.49 126.48 29.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.074 2.149 . . . . 0.0 110.46 -178.174 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 61.85 29.68 17.98 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 129.392 3.077 . . . . 0.0 114.34 -176.583 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.5 m -62.34 126.79 28.56 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.613 2.365 . . . . 0.0 111.963 154.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -82.97 119.98 25.12 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 127.141 2.177 . . . . 0.0 107.219 173.586 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -89.74 154.89 19.58 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.438 -2.164 . . . . 0.0 107.607 159.062 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -119.24 139.72 51.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -112.41 132.3 55.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 124.564 2.126 . . . . 0.0 110.559 -167.374 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 m -130.53 133.07 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 113.09 -1.868 . . . . 0.0 110.04 175.578 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -94.97 133.78 38.35 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 126.234 2.209 . . . . 0.0 107.499 -177.567 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -123.93 119.88 30.9 Favored 'General case' 0 N--CA 1.448 -0.534 1 CA-C-O 111.281 -4.199 . . . . 0.0 109.505 -172.686 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -104.12 143.56 32.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 123.365 2.802 . . . . 0.0 104.682 171.029 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.252 25.6 ttp85 86.53 -96.8 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.185 2.594 . . . . 0.0 107.588 170.601 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.31 -166.91 11.4 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.153 2.787 . . . . 0.0 110.012 167.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.874 0 CA-C-N 123.962 3.881 . . . . 0.0 115.792 -171.415 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 mtt . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 116.59 -1.671 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 149.17 23.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 121.29 1.859 . . . . 0.0 107.43 177.803 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -136.06 -177.33 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 C-N-CA 127.931 2.493 . . . . 0.0 107.986 160.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -128.44 138.63 52.4 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 119.21 -2.181 . . . . 0.0 113.064 174.011 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.9 t -110.73 114.84 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 164.166 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 83.8 tttt -104.26 140.31 38.04 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.296 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.4 p -102.35 117.53 34.92 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 118.165 -2.835 . . . . 0.0 104.654 166.5 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.09 -32.69 7.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 117.184 -3.448 . . . . 0.0 117.681 177.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 p -88.0 -9.68 52.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.903 2.881 . . . . 0.0 109.072 -176.61 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.73 -111.86 1.07 Allowed Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.276 -1.291 . . . . 0.0 113.233 -170.35 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.353 7.4 pttp -142.66 164.1 31.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.305 1.842 . . . . 0.0 115.387 -168.158 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.313 0.6 OUTLIER -81.3 115.16 20.54 Favored 'General case' 0 C--N 1.325 -0.473 1 C-N-CA 134.0 4.92 . . . . 0.0 109.603 -179.836 . . . . . . . . 4 3 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 mt -108.94 124.72 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -173.642 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 p -72.34 124.69 25.64 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 112.71 -2.041 . . . . 0.0 111.678 -179.027 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 16' ' ' GLU 0.261 1.7 tm? -130.06 152.22 49.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.082 -2.261 . . . . 0.0 109.907 -175.66 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.521 ' H ' HD13 ' A' ' 15' ' ' LEU . 68.1 tt0 -129.75 123.33 30.78 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 123.873 1.797 . . . . 0.0 107.936 -170.801 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.73 152.63 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 131.37 3.868 . . . . 0.0 113.206 178.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -93.73 156.98 38.97 Favored Pre-proline 0 N--CA 1.446 -0.66 0 C-N-CA 127.048 2.139 . . . . 0.0 105.611 171.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.14 -7.93 18.69 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 N-CA-C 118.44 2.438 . . . . 0.0 118.44 -171.091 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.6 p -108.16 5.26 25.7 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 130.95 3.7 . . . . 0.0 117.49 176.59 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.03 139.73 36.83 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 126.213 2.196 . . . . 0.0 107.736 -167.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -87.21 166.6 14.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 125.427 1.704 . . . . 0.0 108.588 174.809 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mp -69.02 -40.3 80.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 130.079 3.352 . . . . 0.0 108.049 -176.473 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -53.16 -34.76 58.26 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 113.431 -3.176 . . . . 0.0 112.75 168.315 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -82.76 -13.38 56.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 125.147 1.529 . . . . 0.0 109.752 -174.397 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 30' ' ' ILE . 80.3 t -70.9 -57.89 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 131.127 3.771 . . . . 0.0 106.727 168.535 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.316 38.7 mtmt -53.51 -38.66 63.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 125.281 2.467 . . . . 0.0 116.953 173.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -43.77 65.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 112.406 -2.179 . . . . 0.0 111.189 175.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -55.66 -51.92 65.59 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 118.79 -2.444 . . . . 0.0 109.1 171.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 26' ' ' VAL . 62.9 mt -51.78 -31.56 13.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 122.535 2.425 . . . . 0.0 109.587 169.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -78.55 -48.66 14.77 Favored 'General case' 0 N--CA 1.447 -0.61 1 O-C-N 113.851 -5.53 . . . . 0.0 108.148 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.383 18.3 t70 -46.95 -33.48 4.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 128.957 2.903 . . . . 0.0 117.841 165.614 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -100.46 -53.68 3.04 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 118.079 -2.888 . . . . 0.0 114.238 -174.69 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -108.47 -27.81 9.71 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -173.295 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.85 19.79 60.78 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 125.625 2.792 . . . . 0.0 117.269 175.363 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.409 HG22 ' HG2' ' A' ' 41' ' ' GLN . 49.9 mt -77.18 109.67 9.89 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-O 113.067 -3.349 . . . . 0.0 105.663 179.319 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -64.58 148.35 90.44 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 CA-C-N 126.912 3.504 . . . . 0.0 107.853 -166.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.84 -23.85 74.35 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 118.626 2.51 . . . . 0.0 118.626 -172.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -94.65 -12.23 27.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 115.461 -2.209 . . . . 0.0 111.913 -172.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -86.81 -19.41 29.04 Favored 'General case' 0 N--CA 1.448 -0.56 1 C-N-CA 132.536 4.334 . . . . 0.0 111.724 173.746 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.409 ' HG2' HG22 ' A' ' 36' ' ' ILE . 74.8 mt-30 -80.97 144.99 31.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.334 70.5 mtm180 -119.79 153.14 36.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 117.126 -3.484 . . . . 0.0 104.809 144.059 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.9 mt -119.35 140.98 49.46 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 114.303 -2.761 . . . . 0.0 107.255 176.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.497 0.0 OUTLIER -136.96 146.45 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 125.169 3.622 . . . . 0.0 110.778 172.482 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -159.09 110.47 2.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 116.542 -1.695 . . . . 0.0 108.875 -169.626 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.34 21.2 5.84 Favored 'General case' 0 N--CA 1.449 -0.487 1 O-C-N 129.525 4.265 . . . . 0.0 115.643 168.85 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.0 -18.16 29.01 Favored Glycine 0 CA--C 1.532 1.145 0 O-C-N 118.077 -2.89 . . . . 0.0 116.531 -169.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 126.71 52.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 129.465 3.685 . . . . 0.0 112.535 -162.361 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -66.78 97.6 0.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 129.2 3.0 . . . . 0.0 110.009 173.313 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD22 HD11 ' A' ' 61' ' ' ILE . 17.9 mt -67.63 118.69 11.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 127.757 2.423 . . . . 0.0 109.641 -178.704 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.51 128.96 55.26 Favored 'General case' 0 N--CA 1.451 -0.391 1 O-C-N 130.676 4.985 . . . . 0.0 112.19 175.109 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -52.85 131.46 35.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 119.255 -2.153 . . . . 0.0 112.466 156.44 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.74 2.14 14.68 Favored Glycine 0 CA--C 1.53 1.023 1 CA-C-O 110.766 -5.463 . . . . 0.0 113.367 -171.03 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -129.21 163.08 26.37 Favored 'General case' 0 N--CA 1.449 -0.506 1 CA-C-N 124.287 4.044 . . . . 0.0 107.577 -176.37 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 p -88.26 159.71 17.99 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 101.707 -3.442 . . . . 0.0 101.707 -176.146 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 56' ' ' LEU . 6.6 tt -34.23 -53.52 0.49 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 129.834 3.254 . . . . 0.0 111.138 153.492 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.6 m -72.27 -14.78 61.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 128.433 2.693 . . . . 0.0 115.233 -173.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.268 17.6 m-20 -65.09 -41.25 95.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 164.313 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -107.63 -28.46 9.73 Favored 'General case' 0 C--N 1.324 -0.504 1 O-C-N 114.891 -4.881 . . . . 0.0 108.136 -170.262 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.494 20.2 t30 96.06 41.72 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.324 2.25 . . . . 0.0 115.745 -175.024 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.467 HD11 HD22 ' A' ' 50' ' ' LEU . 12.1 mt -84.35 89.6 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 125.49 1.744 . . . . 0.0 110.191 176.682 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -91.09 175.13 7.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 125.82 1.95 . . . . 0.0 108.203 -168.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 149.06 30.07 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 170.187 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 64.78 2.96 1.85 Allowed 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 125.784 1.928 . . . . 0.0 114.421 177.606 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -69.06 156.17 39.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.026 -1.671 . . . . 0.0 111.442 176.484 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.3 m -125.17 132.27 53.08 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 117.334 -3.354 . . . . 0.0 104.746 -174.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.53 137.4 47.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -85.72 143.34 28.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.841 -1.787 . . . . 0.0 106.343 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tp -107.42 131.5 54.21 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 168.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.85 89.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.941 2.096 . . . . 0.0 114.419 -163.057 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mp -80.14 156.66 26.89 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 119.403 -2.06 . . . . 0.0 109.062 -147.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 mtt-85 -94.09 87.0 5.15 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 163.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.259 18.7 mt -91.87 -45.87 8.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.709 -0.663 . . . . 0.0 110.45 168.458 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -82.18 -38.23 24.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.774 1.23 . . . . 0.0 112.756 169.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.8 12.1 8.07 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 126.244 2.215 . . . . 0.0 116.218 -172.365 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 115.172 -3.016 . . . . 0.0 112.132 -166.803 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 117.464 -1.255 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.274 50.0 mt-30 -95.43 125.87 40.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 127.324 3.44 . . . . 0.0 107.031 -175.57 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -113.07 144.71 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.315 171.083 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -100.7 106.5 17.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.267 -178.666 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.3 t -88.34 106.81 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 124.028 1.871 . . . . 0.0 110.487 170.124 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.294 5.4 tppt? -84.75 135.76 33.99 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.029 -1.669 . . . . 0.0 109.469 173.131 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -78.17 165.19 24.24 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.967 1.707 . . . . 0.0 115.107 165.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.35 0.4 OUTLIER -83.1 -12.49 57.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.581 163.665 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -66.65 -41.58 88.02 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 171.43 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.82 38.23 1.31 Allowed Glycine 0 CA--C 1.536 1.397 0 O-C-N 118.081 -2.887 . . . . 0.0 110.218 -172.038 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.283 59.4 pttt -130.76 168.77 16.67 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.525 2.33 . . . . 0.0 105.593 167.668 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.305 1.8 m -115.3 171.21 7.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 159.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 pt -138.61 145.69 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 131.411 3.885 . . . . 0.0 109.091 161.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 m -107.58 105.88 15.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 118.787 -2.446 . . . . 0.0 110.623 -175.88 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.21 131.73 40.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 115.185 -2.341 . . . . 0.0 109.209 176.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -74.66 119.62 19.1 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.04 2.536 . . . . 0.0 109.041 156.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.22 157.59 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 177.135 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.301 1.7 tm-20 -85.53 153.04 58.33 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 169.7 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.96 -22.98 75.33 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.482 1.455 . . . . 0.0 115.846 168.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.0 p -94.86 11.68 30.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 119.021 -2.3 . . . . 0.0 113.314 171.109 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.22 134.96 48.57 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 124.518 3.327 . . . . 0.0 107.819 159.181 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p -89.51 155.17 19.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 112.519 -2.128 . . . . 0.0 114.029 174.492 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 23' ' ' ILE . 11.7 mm -40.23 -56.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.418 2.287 . . . . 0.0 114.996 -172.222 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -39.66 65.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -69.87 -33.25 71.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.164 -1.585 . . . . 0.0 110.613 176.184 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 t -59.71 -45.27 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 O-C-N 116.633 -3.792 . . . . 0.0 108.129 171.445 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -53.78 -49.74 67.6 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 125.426 1.704 . . . . 0.0 108.448 175.304 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.43 -34.95 78.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 126.828 3.204 . . . . 0.0 114.099 -178.158 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -78.44 -24.53 46.06 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 117.309 -3.369 . . . . 0.0 108.791 177.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 mt -70.24 -40.36 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 123.544 2.884 . . . . 0.0 108.935 162.54 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -67.92 -39.38 83.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 114.467 -2.682 . . . . 0.0 112.097 -168.391 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -53.66 -39.54 65.15 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 127.487 2.315 . . . . 0.0 115.112 165.478 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.311 65.8 mmtt -89.7 -44.86 9.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 117.755 -1.578 . . . . 0.0 113.007 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -97.87 -19.88 17.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 116.124 -1.893 . . . . 0.0 113.055 -173.747 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.3 -15.26 63.35 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 173.601 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.0 mt -70.94 113.3 17.79 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-O 114.343 -2.741 . . . . 0.0 110.043 -177.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -65.35 153.77 76.7 Favored 'Trans proline' 0 N--CA 1.449 -1.116 1 C-N-CA 126.238 4.625 . . . . 0.0 110.385 -173.764 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.47 -34.16 97.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.825 3.017 . . . . 0.0 113.991 -178.296 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -60.52 -2.91 0.57 Allowed 'General case' 0 N--CA 1.445 -0.683 1 C-N-CA 133.883 4.873 . . . . 0.0 115.85 172.899 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.39 0.0 OUTLIER -135.59 14.93 3.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 169.289 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -105.79 161.35 14.5 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 171.477 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.295 15.9 ttm180 -157.62 139.27 13.92 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 131.386 3.874 . . . . 0.0 108.454 169.448 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.9 118.23 22.32 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.486 2.314 . . . . 0.0 109.985 -162.569 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.4 mm -101.75 139.33 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.689 1.596 . . . . 0.0 109.173 -174.418 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -148.03 140.48 24.43 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 115.82 -2.038 . . . . 0.0 110.376 158.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.301 . . 69.97 8.09 6.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 -177.512 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.89 -13.84 22.03 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.189 1.852 . . . . 0.0 108.786 171.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -112.45 163.86 13.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 116.497 -3.943 . . . . 0.0 111.776 -174.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -79.1 118.44 21.08 Favored 'General case' 0 N--CA 1.441 -0.913 1 C-N-CA 132.018 4.127 . . . . 0.0 111.315 166.524 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.85 129.12 34.36 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 127.53 3.019 . . . . 0.0 106.769 169.782 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -92.23 156.32 17.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 130.529 3.531 . . . . 0.0 114.004 -171.668 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -49.11 130.69 19.09 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.447 2.299 . . . . 0.0 111.545 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.73 -27.53 14.68 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.088 1.804 . . . . 0.0 116.418 163.358 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.81 149.98 26.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 120.537 2.169 . . . . 0.0 108.178 176.403 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -79.31 164.99 23.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 128.909 2.884 . . . . 0.0 109.285 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 56' ' ' LEU . 80.1 mt -67.64 -27.0 66.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.665 170.179 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.257 1.2 p -72.32 -20.36 61.5 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 112.281 -3.723 . . . . 0.0 115.402 163.579 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.61 -17.63 62.27 Favored 'General case' 0 N--CA 1.447 -0.615 1 CA-C-O 129.295 4.379 . . . . 0.0 109.225 178.527 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.264 50.2 m-85 -112.05 1.67 16.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 117.649 -3.157 . . . . 0.0 110.931 177.596 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.4 t30 53.57 44.43 29.83 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.8 2.44 . . . . 0.0 115.16 168.466 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.275 2.9 mt -66.56 131.57 32.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 1 C-N-CA 133.825 4.85 . . . . 0.0 112.875 160.636 . . . . . . . . 3 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.0 169.29 12.26 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 114.837 -2.506 . . . . 0.0 113.537 171.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.14 127.17 3.47 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 119.452 3.13 . . . . 0.0 119.452 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 65.45 30.61 10.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.358 2.263 . . . . 0.0 115.392 174.784 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -81.87 151.02 27.5 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.2 m -97.48 116.71 30.21 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 119.615 -1.928 . . . . 0.0 107.565 -174.259 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -100.43 145.14 28.59 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 128.513 2.725 . . . . 0.0 111.49 171.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -112.55 107.5 16.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 124.39 2.043 . . . . 0.0 110.202 -167.205 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tp -80.49 134.75 36.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 119.214 -2.179 . . . . 0.0 109.22 -173.702 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.5 t -125.01 136.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.911 -1.118 . . . . 0.0 111.099 174.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -93.42 134.92 35.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 130.533 3.533 . . . . 0.0 106.875 176.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 mtp-105 -120.38 175.08 6.15 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 102.447 -3.168 . . . . 0.0 102.447 159.305 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.8 mt -84.04 162.97 20.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.947 2.899 . . . . 0.0 111.694 168.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.475 6.1 ttp180 108.8 78.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 130.484 3.514 . . . . 0.0 109.994 -177.89 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.03 -145.46 15.94 Favored Glycine 0 CA--C 1.536 1.368 1 C-N-CA 131.084 4.183 . . . . 0.0 109.021 173.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.774 0 C-N-CA 128.772 3.082 . . . . 0.0 111.536 -172.654 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -102.1 150.78 22.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 118.294 -2.754 . . . . 0.0 105.847 176.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.374 16.4 pt -140.56 157.51 24.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 131.203 3.801 . . . . 0.0 106.693 164.585 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -112.05 139.83 47.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -175.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 t -115.08 126.31 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 128.276 2.631 . . . . 0.0 107.83 166.003 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -93.29 125.59 37.97 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 127.925 3.266 . . . . 0.0 110.838 169.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.271 72.5 p -79.11 -165.18 0.71 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -179.632 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mt -77.28 -43.21 34.08 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 118.042 -2.911 . . . . 0.0 111.898 163.401 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.7 p -74.74 -6.28 47.99 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -169.614 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.59 0.87 43.23 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 117.253 1.661 . . . . 0.0 117.253 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -84.59 147.88 26.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.909 1.283 . . . . 0.0 111.713 173.866 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.6 m -110.52 109.29 19.57 Favored 'General case' 0 C--N 1.326 -0.441 1 C-N-CA 132.416 4.286 . . . . 0.0 100.314 173.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -95.31 142.42 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 127.257 2.223 . . . . 0.0 106.246 166.552 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.5 m -96.2 133.31 40.67 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -117.63 140.36 49.74 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -177.149 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -101.86 130.88 48.43 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 100.666 -3.828 . . . . 0.0 100.666 -177.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.482 HG21 HD23 ' A' ' 56' ' ' LEU . 34.3 m -137.34 163.14 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.177 176.888 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.366 71.2 mm-40 -116.48 145.83 36.09 Favored Pre-proline 0 N--CA 1.445 -0.675 0 N-CA-C 101.758 -3.423 . . . . 0.0 101.758 163.425 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -73.01 -3.6 13.92 Favored 'Trans proline' 0 N--CA 1.447 -1.261 1 C-N-CA 125.964 4.442 . . . . 0.0 113.911 -174.343 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 p -80.5 -20.91 42.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 128.755 2.822 . . . . 0.0 115.615 164.836 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -61.6 141.58 57.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.441 1.591 . . . . 0.0 113.565 175.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -70.56 159.12 34.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.1 1.76 . . . . 0.0 109.459 167.776 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 mm -45.24 -39.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 130.131 3.372 . . . . 0.0 113.973 162.593 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -76.61 -34.83 58.36 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.358 0.981 . . . . 0.0 110.761 179.533 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.288 18.8 m-80 -53.33 -44.29 68.32 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 116.722 -1.608 . . . . 0.0 112.014 174.381 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.28 1.9 t -51.55 -49.37 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 167.133 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -54.65 -52.15 63.21 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 125.586 1.804 . . . . 0.0 115.145 175.72 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.8 -39.02 4.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 131.306 3.842 . . . . 0.0 119.661 166.171 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -86.26 -38.92 17.07 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 110.867 -2.879 . . . . 0.0 105.841 -179.177 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 30' ' ' ILE 0.304 83.6 mt -54.47 -37.03 36.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 O-C-N 117.806 -3.059 . . . . 0.0 114.05 166.745 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -44.83 66.89 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 128.053 2.541 . . . . 0.0 115.718 175.556 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.39 -51.94 67.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.348 1.859 . . . . 0.0 111.637 168.089 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -82.67 -16.86 46.58 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 118.444 2.757 . . . . 0.0 118.444 -168.731 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -154.79 2.37 0.2 Allowed 'General case' 0 N--CA 1.449 -0.52 1 O-C-N 115.962 -4.211 . . . . 0.0 109.405 -173.594 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.37 -20.09 48.52 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 117.598 -3.189 . . . . 0.0 114.933 161.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mt -83.25 131.55 52.93 Favored Pre-proline 0 N--CA 1.442 -0.854 0 O-C-N 119.258 -2.319 . . . . 0.0 107.671 -167.11 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -59.92 151.06 74.38 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 118.824 2.586 . . . . 0.0 118.824 165.868 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.396 29.9 Cg_exo -47.17 -40.91 27.44 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 124.685 3.59 . . . . 0.0 117.718 173.488 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.27 2.76 38.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 124.811 1.319 . . . . 0.0 110.295 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.426 ' HB3' HD23 ' A' ' 73' ' ' LEU . 72.3 mt-30 -118.93 6.08 11.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 123.388 2.813 . . . . 0.0 112.494 170.671 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 70.1 mt-30 -99.2 156.24 17.07 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 118.704 0.684 . . . . 0.0 109.768 175.373 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -129.84 114.92 16.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 101.56 -3.496 . . . . 0.0 101.56 160.013 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 mt -86.66 146.45 26.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 125.735 3.88 . . . . 0.0 109.151 176.467 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.27 20.3 mm -135.14 156.17 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 129.722 3.209 . . . . 0.0 106.418 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -159.55 147.55 17.34 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 127.001 2.688 . . . . 0.0 109.789 159.856 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.347 . . 52.59 20.11 1.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 131.117 3.767 . . . . 0.0 112.51 175.354 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.29 -0.06 59.92 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 128.659 3.028 . . . . 0.0 110.168 175.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.275 28.3 mttm -100.66 148.06 25.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 116.127 -1.892 . . . . 0.0 112.689 -178.713 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 mp0 -73.41 132.38 42.93 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 161.425 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 118.67 5.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.501 172.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.95 99.36 3.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.177 2.191 . . . . 0.0 111.25 174.463 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -39.3 135.07 1.08 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 151.782 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.96 2.53 7.82 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.132 -1.371 . . . . 0.0 116.412 171.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -129.25 -167.57 1.81 Allowed 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 127.371 2.453 . . . . 0.0 111.193 -163.459 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -125.21 165.18 18.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.824 1.65 . . . . 0.0 110.19 161.183 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -58.4 -40.09 81.43 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 118.081 -2.887 . . . . 0.0 111.042 -176.535 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.0 t -64.48 -33.45 75.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.719 2.008 . . . . 0.0 109.797 175.467 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.251 28.1 t70 -82.37 -32.36 29.26 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 117.667 -3.146 . . . . 0.0 115.07 -176.77 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -91.51 -2.75 57.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 116.012 -1.947 . . . . 0.0 109.177 173.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 71.74 40.04 0.81 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 129.988 3.315 . . . . 0.0 114.47 169.038 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.4 mt -79.88 109.81 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 102.003 -3.332 . . . . 0.0 102.003 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -83.51 164.98 19.5 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.274 1.83 . . . . 0.0 112.193 172.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.74 156.78 39.08 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.346 2.659 . . . . 0.0 108.951 -177.07 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 62.75 7.2 2.42 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.386 2.274 . . . . 0.0 112.278 175.586 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -74.61 148.44 40.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.2 -2.188 . . . . 0.0 111.385 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.2 m -108.4 111.91 24.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 118.361 -1.336 . . . . 0.0 112.741 -178.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.3 mp -88.62 176.02 7.3 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 129.905 3.282 . . . . 0.0 109.944 171.547 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -134.36 154.03 51.57 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 116.619 -3.801 . . . . 0.0 110.811 -175.263 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.321 0.7 OUTLIER -118.16 150.57 39.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.11 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.65 147.74 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 130.735 3.614 . . . . 0.0 105.597 163.02 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.9 tp -92.5 140.83 29.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.625 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -149.79 113.04 4.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 100.519 -3.882 . . . . 0.0 100.519 174.865 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 40' ' ' GLN . 49.7 mt -86.75 53.81 2.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -160.84 131.8 5.45 Favored 'General case' 0 N--CA 1.45 -0.47 1 C-N-CA 134.872 5.269 . . . . 0.0 106.715 178.292 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.51 6.19 16.58 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 125.864 2.924 . . . . 0.0 110.767 -178.445 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.029 0 O-C-N 118.191 -2.946 . . . . 0.0 111.205 -177.083 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -96.75 166.7 11.52 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -164.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 pt -114.68 134.41 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 153.61 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -87.12 112.06 21.56 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.53 1.532 . . . . 0.0 113.41 165.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.48 117.46 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 113.379 -3.201 . . . . 0.0 108.182 -176.424 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -119.29 152.28 36.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 130.005 3.322 . . . . 0.0 107.322 -169.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -155.45 170.57 21.63 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.933 1.693 . . . . 0.0 112.817 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 -23.34 48.34 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 128.608 3.693 . . . . 0.0 114.588 -165.5 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -76.67 -7.42 55.27 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 169.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.3 -23.5 8.05 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 118.026 -2.921 . . . . 0.0 114.108 167.113 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -59.55 133.05 55.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 118.06 2.615 . . . . 0.0 118.06 -175.853 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 m -112.86 103.67 11.66 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 170.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 mt -96.85 115.3 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 129.589 3.156 . . . . 0.0 106.484 175.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.8 p -89.6 109.94 20.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 114.046 -2.883 . . . . 0.0 111.932 168.579 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -112.21 140.11 47.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 125.076 3.58 . . . . 0.0 105.028 172.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -88.64 135.76 33.34 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.19 2.196 . . . . 0.0 107.599 176.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.51 173.6 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 127.879 2.472 . . . . 0.0 110.991 -161.623 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 44.7 mm-40 -132.88 166.56 28.33 Favored Pre-proline 0 N--CA 1.441 -0.925 1 O-C-N 129.572 4.295 . . . . 0.0 108.517 151.648 . . . . . . . . 3 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -37.74 -21.63 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 124.324 3.349 . . . . 0.0 120.229 163.345 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.7 p -94.07 -20.59 19.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.914 2.886 . . . . 0.0 113.667 -173.414 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -69.1 145.3 53.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.188 0.994 . . . . 0.0 112.502 176.208 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.5 p -90.0 165.25 14.16 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.93 -1.941 . . . . 0.0 112.108 -173.167 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -74.08 -49.72 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 114.902 -2.475 . . . . 0.0 110.382 170.28 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -58.62 -10.28 2.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 125.705 3.866 . . . . 0.0 119.605 172.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -74.91 -38.66 61.77 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 119.628 1.104 . . . . 0.0 112.26 161.807 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 30' ' ' ILE . 22.7 t -71.89 -34.63 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 O-C-N 116.817 -3.677 . . . . 0.0 109.419 -168.67 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -71.43 -39.53 70.98 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.692 1.997 . . . . 0.0 109.251 -175.109 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.73 89.32 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.983 3.313 . . . . 0.0 116.505 161.675 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -82.79 -21.04 34.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 125.62 1.825 . . . . 0.0 113.729 -177.568 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 26' ' ' VAL . 96.2 mt -55.76 -50.67 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.646 2.378 . . . . 0.0 109.252 161.111 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -67.35 -28.52 68.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -173.506 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.334 36.5 t70 -52.41 -46.43 66.32 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 130.882 3.673 . . . . 0.0 117.093 162.544 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -92.08 -48.62 6.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.688 -1.596 . . . . 0.0 108.907 -175.673 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS 0.318 20.8 tp10 -108.13 -15.79 14.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 128.065 2.546 . . . . 0.0 116.37 -166.78 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.26 -26.01 26.0 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 124.497 3.317 . . . . 0.0 111.949 158.061 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 tp -67.95 127.91 93.33 Favored Pre-proline 0 C--O 1.223 -0.33 0 CA-C-O 113.917 -2.944 . . . . 0.0 107.782 -170.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.67 137.07 17.76 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 124.519 3.48 . . . . 0.0 118.137 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -34.53 -37.95 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.441 3.427 . . . . 0.0 117.623 178.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.481 13.1 t70 -44.07 -40.47 4.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 171.214 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -108.23 12.39 26.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 112.836 -1.984 . . . . 0.0 111.426 -176.265 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -100.95 135.86 41.72 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.195 1.798 . . . . 0.0 107.88 174.06 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -130.26 140.07 50.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 128.09 2.556 . . . . 0.0 111.816 172.451 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.03 118.79 30.7 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 126.542 2.401 . . . . 0.0 108.666 -160.262 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.444 HG12 HG23 ' A' ' 70' ' ' VAL . 38.3 mm -120.03 138.35 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 127.599 2.359 . . . . 0.0 111.197 -173.916 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -133.55 100.67 4.87 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.226 2.211 . . . . 0.0 112.232 171.447 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.49 -94.36 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.386 -162.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.08 4.57 9.0 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 115.973 -2.57 . . . . 0.0 114.437 168.643 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -87.3 131.23 34.32 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 120.703 2.252 . . . . 0.0 105.067 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -85.0 124.27 31.5 Favored 'General case' 0 N--CA 1.442 -0.842 1 C-N-CA 134.445 5.098 . . . . 0.0 105.599 176.241 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 mt -101.27 157.27 16.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 125.46 1.725 . . . . 0.0 109.879 -173.011 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -130.18 134.04 47.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.468 1.507 . . . . 0.0 107.313 170.261 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.256 3.1 p30 -70.12 -168.62 0.23 Allowed 'General case' 0 C--O 1.221 -0.402 0 O-C-N 128.684 3.74 . . . . 0.0 112.141 -174.153 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.55 1.75 58.92 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 120.89 3.116 . . . . 0.0 120.89 -175.084 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.3 mtt-85 -147.86 159.34 43.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 128.586 2.754 . . . . 0.0 110.747 -150.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.3 p -83.19 176.73 8.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 129.972 3.309 . . . . 0.0 111.036 -179.796 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.66 -33.49 76.01 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 129.36 3.064 . . . . 0.0 111.232 168.048 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 41.1 t -85.49 -10.52 55.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 119.39 -2.069 . . . . 0.0 112.115 176.634 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.03 -28.46 68.88 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 125.612 1.82 . . . . 0.0 109.979 169.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.287 41.3 m-85 -122.73 17.15 10.28 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 119.53 -1.981 . . . . 0.0 113.562 -175.914 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 t30 53.8 40.61 31.72 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -174.536 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.2 mt -85.62 80.58 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 173.157 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -102.77 36.55 2.16 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.613 2.365 . . . . 0.0 111.428 -161.851 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm 96.45 132.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 1 C-N-CA 132.212 4.205 . . . . 0.0 105.774 156.069 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.435 9.9 mp0 73.49 23.53 2.46 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 130.6 3.56 . . . . 0.0 109.87 176.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.9 m -69.48 142.27 53.78 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 129.045 2.938 . . . . 0.0 109.308 171.339 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.5 m -94.86 119.08 32.84 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 126.103 2.127 . . . . 0.0 106.105 168.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.38 137.12 47.72 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 175.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -104.9 120.57 41.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.569 2.348 . . . . 0.0 107.253 178.522 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -92.49 115.52 28.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 110.71 -2.95 . . . . 0.0 109.089 166.487 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.444 HG23 HG12 ' A' ' 44' ' ' ILE . 82.8 t -74.38 109.87 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 159.853 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.02 136.43 37.94 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 165.84 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -76.57 120.82 22.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 125.819 1.95 . . . . 0.0 109.547 172.192 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.8 mt -144.01 140.06 29.37 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.935 3.294 . . . . 0.0 106.707 -171.695 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.9 ttm105 -95.85 -27.9 14.98 Favored 'General case' 0 C--N 1.325 -0.472 1 CA-C-O 129.008 4.242 . . . . 0.0 110.35 179.055 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.24 -124.36 3.17 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 110.036 -3.257 . . . . 0.0 108.111 168.507 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 130.075 3.702 . . . . 0.0 110.318 -164.437 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 115.765 -2.064 . . . . 0.0 107.739 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -86.5 140.44 29.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -167.803 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.398 7.4 pt -131.77 172.97 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 128.686 2.794 . . . . 0.0 115.561 162.576 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -126.85 135.45 51.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 127.164 2.79 . . . . 0.0 103.679 -175.317 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.275 79.6 t -126.92 121.47 58.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.978 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 68' ' ' HIS 0.255 35.1 tttp -97.47 156.05 16.66 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 129.583 3.153 . . . . 0.0 103.8 -172.918 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -134.48 146.2 49.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.183 -178.06 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.7 mt -68.52 -22.59 64.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 117.906 -2.996 . . . . 0.0 111.403 -176.996 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 p -82.04 -18.49 43.04 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.504 2.322 . . . . 0.0 109.002 -172.654 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.47 31.45 0.78 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-O 116.624 -2.209 . . . . 0.0 112.981 151.14 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.311 41.5 pttt -133.43 160.87 36.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.039 3.336 . . . . 0.0 110.212 -179.399 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -122.08 135.53 54.82 Favored 'General case' 0 N--CA 1.449 -0.514 1 N-CA-C 99.739 -4.171 . . . . 0.0 99.739 164.73 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 pt -97.99 152.43 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 118.806 -2.434 . . . . 0.0 105.165 168.616 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.1 m -96.83 150.14 21.06 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 128.741 3.776 . . . . 0.0 107.656 166.428 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.85 157.36 46.94 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.009 2.123 . . . . 0.0 107.288 179.816 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -134.27 101.4 5.0 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.475 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.44 145.31 25.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 129.458 3.103 . . . . 0.0 112.646 -172.773 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -85.29 135.18 39.31 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.768 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.83 -37.62 2.45 Favored 'Trans proline' 0 N--CA 1.454 -0.841 1 C-N-CA 126.971 5.114 . . . . 0.0 117.639 -178.334 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 p -103.13 9.61 38.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 119.566 3.172 . . . . 0.0 119.566 -179.494 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -72.55 137.71 46.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 118.138 -2.851 . . . . 0.0 104.035 170.194 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -75.95 162.03 28.44 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 129.693 3.197 . . . . 0.0 113.809 172.714 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.1 mm -53.12 -36.45 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.258 2.223 . . . . 0.0 113.891 -174.09 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.305 4.8 tp10 -55.89 -38.6 70.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.83 2.052 . . . . 0.0 115.526 173.945 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -66.99 -43.66 82.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 125.932 2.02 . . . . 0.0 112.756 176.225 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.263 22.8 t -52.84 -52.76 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.836 2.054 . . . . 0.0 110.2 174.873 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -58.79 -42.08 88.22 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 125.667 1.854 . . . . 0.0 111.916 -179.228 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.48 72.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 116.462 -1.732 . . . . 0.0 112.572 177.371 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -76.41 -33.48 58.82 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 122.784 2.538 . . . . 0.0 111.457 178.586 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.58 -43.43 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 129.895 3.278 . . . . 0.0 110.698 174.394 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.48 -52.9 62.59 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 125.309 1.443 . . . . 0.0 112.416 175.722 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -52.71 -39.43 62.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 131.237 3.815 . . . . 0.0 111.977 -179.082 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -87.83 -50.69 6.29 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 127.688 3.117 . . . . 0.0 115.808 -178.894 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.3 -6.29 12.96 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 128.075 2.55 . . . . 0.0 115.357 -166.237 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.0 -16.6 35.98 Favored Glycine 0 CA--C 1.533 1.158 1 C-N-CA 130.821 4.058 . . . . 0.0 110.181 156.453 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.08 121.94 86.34 Favored Pre-proline 0 N--CA 1.444 -0.763 0 O-C-N 119.468 -2.195 . . . . 0.0 110.388 -164.089 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.26 148.94 56.54 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 122.994 2.463 . . . . 0.0 111.244 179.164 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.68 -32.14 95.33 Favored 'Trans proline' 0 N--CA 1.447 -1.238 1 C-N-CA 125.363 4.042 . . . . 0.0 116.614 -163.065 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.253 51.3 m-20 -73.18 -4.34 32.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.007 2.123 . . . . 0.0 115.49 176.165 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -108.82 -12.16 14.94 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 171.613 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.83 162.37 21.66 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.699 -0.8 . . . . 0.0 113.027 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.276 0.1 OUTLIER -151.71 102.93 2.9 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 118.308 -2.745 . . . . 0.0 106.475 175.21 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.2 mt -87.04 113.55 22.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 127.576 3.048 . . . . 0.0 114.732 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.8 mt -120.56 138.89 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 131.551 3.941 . . . . 0.0 106.558 -168.102 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -155.34 -176.68 6.07 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.098 -2.876 . . . . 0.0 105.97 -172.951 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.04 112.67 1.41 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 124.638 2.161 . . . . 0.0 110.026 -168.693 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.82 -78.54 0.3 Allowed Glycine 0 CA--C 1.532 1.137 0 N-CA-C 107.03 -2.428 . . . . 0.0 107.03 -175.869 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -165.74 -171.99 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.965 2.506 . . . . 0.0 104.959 -161.959 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.81 148.85 45.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 130.994 3.718 . . . . 0.0 110.034 -177.437 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.37 147.39 22.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 122.863 1.316 . . . . 0.0 111.907 176.148 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -111.55 157.72 20.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 111.663 -2.517 . . . . 0.0 115.556 -175.956 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -72.98 135.53 44.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 130.84 3.656 . . . . 0.0 112.381 -171.68 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.5 -28.35 10.96 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 169.707 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -71.74 159.26 34.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 116.605 -1.664 . . . . 0.0 110.36 -179.006 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 p -113.28 -178.46 3.38 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.358 2.263 . . . . 0.0 109.567 171.148 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.0 -31.25 68.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 125.192 1.557 . . . . 0.0 114.255 179.197 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.3 p -77.42 -33.31 54.97 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.15 -37.83 75.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 124.508 1.13 . . . . 0.0 110.883 177.261 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.73 -0.58 57.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.026 -1.046 . . . . 0.0 113.627 -175.076 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 77.94 42.83 0.1 Allowed 'General case' 0 C--N 1.324 -0.51 1 C-N-CA 134.045 4.938 . . . . 0.0 109.072 167.78 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -100.03 95.35 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 103.258 -2.868 . . . . 0.0 103.258 -175.34 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -70.66 163.74 26.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.624 -1.298 . . . . 0.0 110.162 160.459 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -45.41 147.3 0.83 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 131.095 3.758 . . . . 0.0 114.04 175.37 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 59.41 33.84 22.5 Favored 'General case' 0 N--CA 1.448 -0.566 1 C-N-CA 132.847 4.459 . . . . 0.0 106.901 172.29 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -93.68 152.21 19.13 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 117.511 -3.243 . . . . 0.0 106.861 175.739 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.6 m -99.67 130.28 45.88 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.932 1.395 . . . . 0.0 110.56 175.177 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mp -102.78 161.49 13.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 102.088 -3.301 . . . . 0.0 102.088 163.434 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -114.83 123.42 49.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 172.752 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -90.14 122.0 32.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 118.677 -2.514 . . . . 0.0 111.57 167.302 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.67 156.4 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.925 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.268 16.0 mt -114.84 147.92 39.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.399 -169.807 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -95.03 160.86 14.37 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 127.986 3.304 . . . . 0.0 108.779 156.449 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -95.26 115.54 27.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 165.994 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.265 21.7 ttt180 -140.05 -80.86 0.28 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 112.952 -1.931 . . . . 0.0 106.416 177.305 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.29 -179.68 16.45 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 178.985 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.551 1 N-CA-C 102.321 -4.312 . . . . 0.0 102.321 168.54 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptt? . . . . . 0 C--O 1.223 -0.317 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -88.45 148.69 24.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 117.518 -3.239 . . . . 0.0 105.705 -177.706 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -127.2 143.29 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 128.925 2.89 . . . . 0.0 107.268 159.902 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -104.07 134.41 47.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.197 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.23 126.93 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 117.74 -1.124 . . . . 0.0 109.413 -168.047 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -116.68 116.45 27.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 122.162 2.256 . . . . 0.0 112.853 -165.703 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 p -74.06 158.59 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.201 1.4 . . . . 0.0 109.98 -178.88 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.5 tp -59.78 -40.47 88.37 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.682 1.993 . . . . 0.0 107.223 -166.792 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.6 p -80.7 2.2 26.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.89 -3.007 . . . . 0.0 118.607 176.408 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.91 -7.7 16.96 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 119.157 2.423 . . . . 0.0 119.157 152.815 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -75.67 122.86 24.61 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.281 1.433 . . . . 0.0 107.251 -177.086 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.321 73.1 m -81.86 138.16 35.11 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.19 0.995 . . . . 0.0 109.754 170.865 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -122.12 141.86 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 129.807 3.243 . . . . 0.0 103.379 172.917 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 m -96.88 120.05 36.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.943 2.497 . . . . 0.0 112.307 170.165 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.2 mt -106.17 136.27 46.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.084 1.754 . . . . 0.0 110.437 171.158 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -92.17 140.28 29.78 Favored 'General case' 0 CA--C 1.535 0.401 1 O-C-N 129.863 4.477 . . . . 0.0 104.235 172.058 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -153.9 168.66 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 129.256 3.022 . . . . 0.0 105.278 -174.832 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.9 mt-10 -116.45 159.69 39.08 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 129.094 2.958 . . . . 0.0 107.81 172.769 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 18' ' ' GLU 0.297 86.7 Cg_endo -57.86 -29.58 86.69 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.568 3.512 . . . . 0.0 116.515 172.237 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -95.88 11.18 34.67 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 130.769 3.628 . . . . 0.0 108.398 -166.889 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.29 2.6 m-20 -92.92 146.8 23.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 115.835 -2.031 . . . . 0.0 111.533 -176.038 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 24' ' ' GLU . 2.4 t -86.13 151.83 23.35 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 120.338 1.427 . . . . 0.0 112.262 173.72 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.258 62.6 mt -65.12 -31.24 53.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 118.367 -2.708 . . . . 0.0 108.826 -171.069 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 22' ' ' THR . 1.0 OUTLIER -63.15 -40.44 97.57 Favored 'General case' 0 N--CA 1.452 -0.366 2 O-C-N 114.325 -5.234 . . . . 0.0 113.824 176.515 . . . . . . . . 4 4 . 1 . 032 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -68.44 -31.0 70.01 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 128.532 2.733 . . . . 0.0 111.8 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 t -59.64 -51.94 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 122.496 2.407 . . . . 0.0 110.278 163.448 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -68.03 -40.55 82.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.973 2.909 . . . . 0.0 112.051 -164.053 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -17.94 64.8 Favored 'General case' 0 N--CA 1.446 -0.655 1 C-N-CA 132.765 4.426 . . . . 0.0 113.982 177.45 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -65.08 -31.64 72.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 130.554 3.542 . . . . 0.0 110.661 176.399 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 mm -74.05 -16.74 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 O-C-N 124.948 1.405 . . . . 0.0 114.164 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.281 6.1 tp60 -66.89 -38.12 85.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 117.251 -3.406 . . . . 0.0 111.441 169.723 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.66 -47.67 74.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.811 1.244 . . . . 0.0 110.708 168.612 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.85 -75.33 0.16 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 115.577 -2.154 . . . . 0.0 114.498 -175.944 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -101.24 -20.06 15.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 127.944 3.278 . . . . 0.0 115.171 -161.906 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.96 6.34 26.34 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 130.345 3.831 . . . . 0.0 114.51 162.811 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.59 124.02 54.32 Favored Pre-proline 0 N--CA 1.448 -0.555 0 O-C-N 126.728 2.075 . . . . 0.0 105.854 -164.176 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -68.24 172.81 10.49 Favored 'Trans proline' 0 N--CA 1.451 -1.003 1 C-N-CA 126.424 4.75 . . . . 0.0 116.16 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.85 -42.59 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 1 C-N-CA 126.943 5.096 . . . . 0.0 107.622 177.266 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.88 -15.32 62.62 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 130.725 3.61 . . . . 0.0 115.978 -174.57 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.257 38.0 tt0 -103.59 -34.57 8.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 118.101 -1.439 . . . . 0.0 113.887 171.572 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.05 135.01 21.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.745 1.618 . . . . 0.0 115.329 169.017 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -136.14 158.34 44.65 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 119.158 -2.214 . . . . 0.0 107.702 168.44 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.8 mt -129.63 152.24 49.36 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 127.87 3.231 . . . . 0.0 108.952 -167.602 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 mt -135.94 129.49 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 127.797 2.439 . . . . 0.0 107.142 169.871 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -120.28 118.33 30.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 130.359 3.464 . . . . 0.0 105.338 173.205 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.87 50.64 11.09 Favored 'General case' 0 C--O 1.22 -0.472 1 C-N-CA 133.797 4.839 . . . . 0.0 111.568 170.983 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.46 -13.92 60.93 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.787 -1.007 . . . . 0.0 111.591 173.344 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 mtmt -105.93 119.75 39.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 130.988 3.715 . . . . 0.0 109.06 -172.812 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -76.36 151.83 36.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 128.526 2.731 . . . . 0.0 104.559 172.164 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.282 0.8 OUTLIER -140.15 132.3 28.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.669 2.787 . . . . 0.0 111.11 177.768 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.258 71.9 mm-40 -87.61 162.3 17.23 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 125.188 2.423 . . . . 0.0 110.116 172.222 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.35 162.06 18.37 Favored 'General case' 0 N--CA 1.45 -0.468 1 C-N-CA 134.882 5.273 . . . . 0.0 109.02 173.898 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.57 14.46 32.28 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 119.687 2.635 . . . . 0.0 119.687 173.591 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -157.55 163.95 37.84 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.876 2.07 . . . . 0.0 111.958 177.797 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.6 p -85.47 149.43 25.4 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 130.354 3.462 . . . . 0.0 108.456 -173.106 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.543 HD22 HD13 ' A' ' 61' ' ' ILE . 20.0 mt -65.2 -34.93 79.55 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.522 1.529 . . . . 0.0 109.556 -171.334 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.29 66.5 p -36.59 -56.98 0.8 Allowed 'General case' 0 N--CA 1.449 -0.513 1 C-N-CA 133.966 4.906 . . . . 0.0 113.8 173.944 . . . . . . . . 3 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.86 -27.25 66.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 130.713 3.605 . . . . 0.0 116.156 -177.563 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -101.14 2.73 40.49 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.412 2.285 . . . . 0.0 110.846 179.603 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.362 24.3 p30 69.13 29.43 4.7 Favored 'General case' 0 N--CA 1.444 -0.772 1 C-N-CA 131.819 4.047 . . . . 0.0 113.161 168.332 . . . . . . . . 3 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.543 HD13 HD22 ' A' ' 56' ' ' LEU . 25.8 mt -83.68 127.14 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.446 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.5 mm-40 -115.57 178.83 4.16 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 130.255 3.422 . . . . 0.0 107.304 -174.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.56 135.26 46.39 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 128.689 2.796 . . . . 0.0 111.261 168.132 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 61.49 27.6 17.11 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 129.552 3.141 . . . . 0.0 116.683 176.766 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -62.98 147.86 49.33 Favored 'General case' 0 C--N 1.328 -0.369 1 O-C-N 115.423 -4.548 . . . . 0.0 109.959 171.608 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.8 p -113.69 108.3 16.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.554 1.941 . . . . 0.0 107.383 -176.688 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.57 150.64 28.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 123.817 1.77 . . . . 0.0 112.738 177.894 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -87.77 139.95 30.01 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 128.956 2.902 . . . . 0.0 104.654 169.281 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.68 120.9 40.06 Favored 'General case' 0 C--N 1.325 -0.493 1 N-CA-C 96.73 -5.285 . . . . 0.0 96.73 170.544 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 m -132.67 165.97 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 128.222 2.609 . . . . 0.0 108.367 170.176 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.83 137.64 45.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.805 2.442 . . . . 0.0 116.025 -174.491 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -84.78 119.31 25.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 100.662 -3.829 . . . . 0.0 100.662 165.176 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.9 mt -95.98 114.26 25.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.3 2.64 . . . . 0.0 112.904 167.066 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -104.9 144.25 32.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 131.494 3.917 . . . . 0.0 113.238 -173.083 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.78 51.64 0.81 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 122.902 1.279 . . . . 0.0 111.756 166.964 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.472 0 C-N-CA 128.083 2.754 . . . . 0.0 110.576 -175.106 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttm . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -111.77 144.9 40.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.233 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.372 34.2 pt -132.37 162.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 130.189 3.396 . . . . 0.0 116.57 169.376 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -107.89 131.58 54.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.647 1.979 . . . . 0.0 109.858 178.41 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 30' ' ' ILE . 19.2 t -100.32 118.0 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 129.031 2.933 . . . . 0.0 105.866 159.724 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.391 71.9 tttt -112.48 123.25 49.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 -174.437 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -88.74 151.56 22.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 110.113 -3.221 . . . . 0.0 107.968 174.652 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mt -67.88 -24.21 65.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 127.172 2.795 . . . . 0.0 109.869 172.37 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -81.24 -18.43 46.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 118.526 -2.609 . . . . 0.0 111.104 -171.332 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.31 -6.17 7.18 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 128.129 2.776 . . . . 0.0 115.11 156.427 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.251 17.1 pttt -82.36 143.21 31.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.349 1.46 . . . . 0.0 111.203 -175.743 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 p -97.26 143.42 28.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 125.796 2.712 . . . . 0.0 107.671 164.629 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.6 mt -122.75 143.03 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 110.347 -3.115 . . . . 0.0 103.171 172.804 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 m -100.22 132.64 45.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.081 2.552 . . . . 0.0 110.875 172.996 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -120.38 133.08 55.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.222 3.009 . . . . 0.0 110.406 170.802 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -93.75 112.73 24.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.278 1.831 . . . . 0.0 109.063 170.287 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.79 175.64 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 127.975 2.51 . . . . 0.0 109.627 -176.784 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -132.13 159.33 72.61 Favored Pre-proline 0 N--CA 1.451 -0.399 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 159.178 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 46.0 Cg_endo -74.93 -8.94 20.62 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 123.214 2.609 . . . . 0.0 114.228 -170.652 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 p -68.64 -31.35 70.42 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.884 2.873 . . . . 0.0 114.627 167.577 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.9 131.93 41.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 117.181 -3.449 . . . . 0.0 113.978 174.489 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.0 p -73.06 157.37 37.46 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 127.085 2.154 . . . . 0.0 112.301 173.406 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.295 1.9 mp -36.2 -42.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 129.414 3.086 . . . . 0.0 115.202 154.804 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -73.03 -37.68 66.81 Favored 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 133.557 4.743 . . . . 0.0 116.561 169.517 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -63.18 -36.38 83.44 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.794 2.088 . . . . 0.0 110.89 165.862 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.1 t -69.65 -39.4 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 1 O-C-N 115.034 -4.791 . . . . 0.0 114.292 178.134 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -61.04 -38.71 87.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.914 1.686 . . . . 0.0 115.058 168.85 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.25 -54.51 14.37 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 130.626 3.571 . . . . 0.0 107.581 174.948 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -55.35 -42.38 73.79 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 5' ' ' VAL . 46.1 mt -64.08 -43.95 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.512 1.125 . . . . 0.0 111.173 169.205 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -58.59 -32.61 69.12 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.965 2.506 . . . . 0.0 112.446 178.3 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.268 0.9 OUTLIER -58.21 -37.79 75.52 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 119.536 -1.977 . . . . 0.0 111.357 169.941 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -87.5 -45.41 10.51 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.151 2.581 . . . . 0.0 106.833 -169.854 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.16 -17.51 13.2 Favored 'General case' 0 N--CA 1.451 -0.4 1 N-CA-C 124.846 5.128 . . . . 0.0 124.846 -174.516 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.79 -2.09 81.06 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 125.534 1.54 . . . . 0.0 114.489 172.693 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.7 mt -76.04 138.49 68.91 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 127.446 2.298 . . . . 0.0 109.846 -174.554 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.36 133.73 41.7 Favored 'Trans proline' 0 N--CA 1.45 -1.061 1 C-N-CA 126.363 4.709 . . . . 0.0 116.611 179.117 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -43.54 -44.74 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.698 1 C-N-CA 131.883 8.389 . . . . 0.0 111.502 173.825 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.358 2.4 t70 -38.7 -44.12 0.97 Allowed 'General case' 0 C--O 1.234 0.275 1 C-N-CA 133.826 4.85 . . . . 0.0 113.087 169.117 . . . . . . . . 3 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -96.66 -25.71 15.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.649 1.98 . . . . 0.0 108.926 -171.557 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -81.41 111.75 18.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -166.181 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -102.81 124.94 49.28 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 100.94 -3.726 . . . . 0.0 100.94 177.812 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.57 120.06 34.72 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 127.23 2.831 . . . . 0.0 107.435 175.032 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mt -122.35 154.12 27.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 126.273 2.233 . . . . 0.0 105.347 -169.064 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.283 67.8 t80 -143.32 128.21 18.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 115.26 -2.305 . . . . 0.0 110.472 160.716 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.36 20.3 6.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.145 2.178 . . . . 0.0 112.674 167.778 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.02 -8.6 63.22 Favored Glycine 0 CA--C 1.526 0.741 1 O-C-N 115.853 -4.279 . . . . 0.0 111.667 -178.59 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -102.66 155.23 18.44 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 124.988 2.328 . . . . 0.0 115.357 173.388 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -94.04 129.81 40.41 Favored 'General case' 0 N--CA 1.446 -0.643 1 N-CA-C 100.123 -4.028 . . . . 0.0 100.123 174.759 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.58 133.88 53.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 127.074 2.15 . . . . 0.0 107.701 167.98 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -69.86 134.62 48.67 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 115.298 -2.287 . . . . 0.0 112.796 177.836 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.294 5.6 t0 -93.21 132.99 36.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 126.224 2.916 . . . . 0.0 109.135 168.569 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.58 8.06 23.3 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 119.059 -2.275 . . . . 0.0 112.925 -159.721 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt-85 -136.98 178.19 7.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 120.476 2.138 . . . . 0.0 106.677 -177.575 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.8 p -110.78 172.42 6.88 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 129.808 3.243 . . . . 0.0 112.509 -176.901 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 5.4 mt -61.32 -46.78 88.87 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 119.178 -2.202 . . . . 0.0 109.113 168.164 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -56.32 -31.58 63.85 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 174.441 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.71 -29.72 70.29 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.87 2.068 . . . . 0.0 109.885 -178.323 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -102.16 12.23 37.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 124.106 1.908 . . . . 0.0 112.827 177.13 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.338 0.6 OUTLIER 84.14 1.7 0.9 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.728 2.011 . . . . 0.0 113.982 172.039 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.14 71.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.98 2.112 . . . . 0.0 108.8 179.28 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -81.07 -32.51 33.95 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.997 2.519 . . . . 0.0 113.902 166.565 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -149.54 118.45 6.67 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 118.779 -2.45 . . . . 0.0 114.022 -179.798 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 47.47 99.92 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.891 1 C-N-CA 135.198 5.399 . . . . 0.0 113.295 157.579 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -143.17 174.39 10.74 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 117.06 -3.525 . . . . 0.0 108.942 -177.235 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -121.81 147.88 45.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 116.758 -3.714 . . . . 0.0 104.527 171.78 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.5 mt -115.11 144.01 44.32 Favored 'General case' 0 N--CA 1.447 -0.578 1 C-N-CA 131.976 4.11 . . . . 0.0 111.354 174.42 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -100.89 117.08 34.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 101.069 -3.678 . . . . 0.0 101.069 -175.711 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.5 tp -100.87 129.48 46.74 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.463 1.105 . . . . 0.0 108.997 167.58 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.405 0.2 OUTLIER -131.02 156.94 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 O-C-N 125.996 2.06 . . . . 0.0 109.284 165.547 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 72' ' ' ARG . 5.1 tp -85.77 -160.03 0.5 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 127.297 3.427 . . . . 0.0 107.495 174.769 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.402 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -96.88 -20.69 17.97 Favored 'General case' 0 N--CA 1.45 -0.451 1 O-C-N 114.544 -5.097 . . . . 0.0 108.477 176.936 . . . . . . . . 4 4 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.9 mt -118.49 161.68 19.61 Favored 'General case' 0 N--CA 1.455 -0.18 1 C-N-CA 132.657 4.383 . . . . 0.0 104.444 -174.594 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.09 126.75 51.45 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 125.07 2.367 . . . . 0.0 105.475 170.294 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.35 -151.36 20.08 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 106.841 -2.504 . . . . 0.0 106.841 -168.671 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 116.357 -2.357 . . . . 0.0 114.535 179.861 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 123.52 1.629 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -94.79 124.73 39.0 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 117.584 -3.197 . . . . 0.0 106.051 175.57 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -108.08 161.88 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 102.981 -2.97 . . . . 0.0 102.981 164.542 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -101.9 141.75 34.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 116.0 -1.952 . . . . 0.0 114.073 157.777 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 t -110.31 115.36 49.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 163.746 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -83.16 107.0 15.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.227 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.285 1.2 p -74.0 156.13 37.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.768 2.827 . . . . 0.0 109.476 174.748 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.5 tp -54.62 -37.67 65.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 130.152 3.381 . . . . 0.0 116.449 -159.986 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -66.62 -24.05 66.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 113.006 -3.378 . . . . 0.0 115.235 177.303 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.22 -35.25 3.01 Favored Glycine 0 CA--C 1.531 1.036 1 CA-C-O 112.101 -4.722 . . . . 0.0 111.415 -164.397 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.21 139.01 58.72 Favored 'General case' 0 N--CA 1.448 -0.566 1 O-C-N 131.292 4.76 . . . . 0.0 104.679 -175.423 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -116.65 129.73 56.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 128.165 2.586 . . . . 0.0 109.255 173.998 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 pt -113.77 143.78 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.503 167.472 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.9 m -90.65 130.38 36.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 128.337 2.655 . . . . 0.0 106.68 176.373 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.35 109.57 18.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.985 2.114 . . . . 0.0 106.871 179.086 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -71.84 112.45 7.95 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 128.945 3.903 . . . . 0.0 107.832 168.682 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 m -135.4 166.25 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 128.231 2.612 . . . . 0.0 109.085 -177.197 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -116.48 161.57 31.06 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 116.456 -1.735 . . . . 0.0 108.762 168.674 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -65.13 -19.49 63.03 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 124.682 3.588 . . . . 0.0 113.224 178.333 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.6 p -69.8 -26.16 64.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 113.379 -3.2 . . . . 0.0 112.3 172.068 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.93 133.85 26.42 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 128.948 2.899 . . . . 0.0 112.222 -177.717 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 p -83.61 148.65 27.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 116.055 -1.926 . . . . 0.0 111.509 175.375 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 23' ' ' ILE . 6.0 mm -48.11 -42.77 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 125.388 3.722 . . . . 0.0 111.274 168.404 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -40.98 -65.76 0.4 Allowed 'General case' 0 N--CA 1.445 -0.686 1 C-N-CA 131.703 4.001 . . . . 0.0 112.884 163.107 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -35.43 80.23 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 123.239 0.337 . . . . 0.0 110.613 179.653 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.29 68.7 t -57.04 -48.34 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 116.79 -1.576 . . . . 0.0 115.153 168.908 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -46.71 -34.37 5.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 125.559 3.8 . . . . 0.0 117.543 161.893 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -28.04 59.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 123.792 1.758 . . . . 0.0 112.725 177.628 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -79.7 -44.45 20.8 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 118.564 -2.585 . . . . 0.0 112.709 172.479 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mt -48.67 -49.17 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 120.732 1.605 . . . . 0.0 111.25 170.5 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -54.98 -53.77 51.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 167.2 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.88 -41.28 91.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 123.229 2.74 . . . . 0.0 109.65 -175.164 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -76.17 -27.78 57.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 118.34 2.719 . . . . 0.0 118.34 179.916 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.294 21.0 mm-40 -140.11 2.96 1.95 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 122.903 2.592 . . . . 0.0 109.97 -175.734 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.42 -3.54 86.44 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 117.937 -2.977 . . . . 0.0 116.495 162.925 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.61 146.65 61.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 115.568 -2.158 . . . . 0.0 107.136 -167.396 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -78.11 132.27 11.44 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.062 3.175 . . . . 0.0 103.932 -178.081 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.77 -18.34 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 CA-C-N 124.098 2.499 . . . . 0.0 112.84 -170.413 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.34 -22.42 44.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 118.006 -1.477 . . . . 0.0 114.831 -170.111 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -82.76 -16.67 47.02 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.633 1.973 . . . . 0.0 114.432 172.396 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -73.87 130.22 39.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.623 1.969 . . . . 0.0 111.967 174.418 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -96.16 144.81 26.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.927 2.491 . . . . 0.0 107.323 155.585 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.1 tp -142.93 115.03 8.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 130.538 3.535 . . . . 0.0 111.088 -164.946 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 46.5 pt -134.74 142.83 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 1 C-N-CA 132.336 4.254 . . . . 0.0 114.045 -159.052 . . . . . . . . 3 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -138.02 96.55 3.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.199 2.6 . . . . 0.0 105.79 178.451 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 77.25 21.66 1.05 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.12 -1.612 . . . . 0.0 107.716 162.064 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.36 -40.4 2.46 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 119.642 -1.266 . . . . 0.0 113.883 -175.157 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.319 51.1 mttm -82.04 132.53 35.25 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 119.257 -2.319 . . . . 0.0 110.916 -171.883 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -82.01 128.27 33.93 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.296 0.953 . . . . 0.0 109.422 170.992 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -82.19 115.92 21.51 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 178.911 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -75.96 135.95 40.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.143 -3.473 . . . . 0.0 107.511 -177.902 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.0 119.9 7.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.24 2.216 . . . . 0.0 111.652 178.363 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.47 6.51 41.28 Favored Glycine 0 CA--C 1.525 0.685 1 C-N-CA 130.906 4.098 . . . . 0.0 114.617 171.146 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -86.32 154.11 21.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 125.423 1.307 . . . . 0.0 110.421 169.617 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.7 p -76.86 145.02 38.62 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 127.027 2.704 . . . . 0.0 115.522 171.438 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.6 mt -59.51 -29.96 68.25 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.947 2.499 . . . . 0.0 112.473 172.602 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.7 t -52.44 -59.04 4.91 Favored 'General case' 0 N--CA 1.446 -0.626 1 C-N-CA 132.821 4.448 . . . . 0.0 110.515 168.503 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -50.55 -41.69 54.38 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 118.827 2.899 . . . . 0.0 118.827 170.093 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -88.53 -0.62 57.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.136 0.88 . . . . 0.0 109.951 -179.859 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m120 62.26 39.1 12.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 129.316 3.046 . . . . 0.0 115.155 -175.442 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 mm -85.81 121.84 37.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -171.425 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -103.75 169.01 8.77 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 111.593 -2.549 . . . . 0.0 114.556 -176.179 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -58.73 135.1 57.35 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 112.37 -3.681 . . . . 0.0 113.065 -176.333 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.1 19.12 11.73 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.521 3.129 . . . . 0.0 116.253 -178.559 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -70.17 141.66 52.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.725 3.21 . . . . 0.0 109.485 160.729 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.3 m -107.52 129.33 54.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 175.804 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -97.69 154.18 17.74 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 129.525 3.13 . . . . 0.0 106.846 171.049 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -125.27 163.85 21.61 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.801 2.04 . . . . 0.0 110.861 -175.158 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -134.72 160.09 39.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.103 -2.317 . . . . 0.0 116.326 -176.216 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 23.0 t -151.83 150.68 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 128.387 3.554 . . . . 0.0 105.982 166.512 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.259 53.2 mt -107.11 151.35 25.5 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 119.121 -2.237 . . . . 0.0 111.453 176.483 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -46.19 -52.42 12.37 Favored 'General case' 0 C--N 1.325 -0.497 1 CA-C-O 129.833 4.635 . . . . 0.0 109.511 175.556 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.4 147.35 36.05 Favored 'General case' 0 N--CA 1.447 -0.61 2 C-N-CA 134.39 5.076 . . . . 0.0 110.555 170.366 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -110.81 -30.98 7.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.47 1.908 . . . . 0.0 110.695 164.215 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.55 126.23 4.6 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 127.118 2.761 . . . . 0.0 109.571 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 CA-C-O 116.372 -2.349 . . . . 0.0 108.911 172.434 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' OE2' ' A' ' 16' ' ' GLU 0.251 45.7 ttp . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -81.55 156.68 25.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 178.535 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 pt -146.24 174.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 1 O-C-N 129.204 4.065 . . . . 0.0 105.944 174.173 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -131.06 153.38 49.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 117.167 -1.397 . . . . 0.0 110.309 164.024 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -130.12 114.74 30.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 101.699 -3.445 . . . . 0.0 101.699 172.001 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -80.99 133.96 35.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.166 2.186 . . . . 0.0 106.244 174.452 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 p -75.13 175.48 8.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 129.977 3.311 . . . . 0.0 111.772 164.944 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.88 -9.21 49.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 118.151 -2.843 . . . . 0.0 110.671 172.044 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 p -99.57 4.31 45.79 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.777 -179.441 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.74 -25.34 7.64 Favored Glycine 0 CA--C 1.531 1.061 1 C-N-CA 131.902 4.573 . . . . 0.0 109.389 159.148 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 pttt -82.71 134.0 35.15 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 -153.502 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 m -95.36 110.63 22.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.275 1.83 . . . . 0.0 114.55 -178.333 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.74 120.82 35.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 118.648 -2.532 . . . . 0.0 105.738 -176.39 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -77.47 121.24 23.56 Favored 'General case' 0 C--N 1.324 -0.519 1 O-C-N 114.558 -5.089 . . . . 0.0 103.508 175.91 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.299 69.3 mt -125.02 152.58 44.06 Favored 'General case' 0 N--CA 1.446 -0.645 1 CA-C-N 126.294 4.134 . . . . 0.0 108.059 169.97 . . . . . . . . 3 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.444 ' OE2' ' N ' ' A' ' 1' ' ' MET . 32.0 tp10 -99.88 132.43 45.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 173.353 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.77 167.0 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 127.426 3.489 . . . . 0.0 105.72 172.512 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.41 140.13 28.71 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 110.747 -2.933 . . . . 0.0 106.408 155.518 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.363 46.3 Cg_endo -59.93 -4.48 2.88 Favored 'Trans proline' 0 N--CA 1.45 -1.032 1 C-N-CA 126.742 4.961 . . . . 0.0 117.005 -173.052 . . . . . . . . 3 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 p -88.58 -6.34 57.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 113.239 -3.267 . . . . 0.0 114.591 165.468 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.47 140.44 55.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 125.971 2.045 . . . . 0.0 106.777 179.691 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.6 p -73.93 163.37 28.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 116.527 -1.701 . . . . 0.0 109.631 170.891 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.0 mm -60.93 -37.14 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 124.211 1.958 . . . . 0.0 107.086 175.508 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.395 0.0 OUTLIER -46.2 -45.03 16.63 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 118.322 -2.736 . . . . 0.0 115.348 171.357 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -67.88 -33.89 75.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.041 2.536 . . . . 0.0 109.126 -179.909 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.258 89.0 t -67.88 -52.92 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 126.169 1.787 . . . . 0.0 113.079 166.707 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -48.67 -41.14 30.51 Favored 'General case' 0 N--CA 1.442 -0.842 1 N-CA-C 122.123 4.119 . . . . 0.0 122.123 171.398 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.25 -35.32 66.21 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.721 2.008 . . . . 0.0 112.506 176.429 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.3 mttt -67.56 -30.8 70.52 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 176.784 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -70.92 -43.49 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 130.359 3.464 . . . . 0.0 109.655 170.993 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -51.83 -55.34 20.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 125.806 2.717 . . . . 0.0 113.566 168.114 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.19 -27.49 62.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.552 3.141 . . . . 0.0 113.925 -173.737 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -97.7 -66.52 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 119.45 -2.032 . . . . 0.0 110.993 172.51 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -92.01 -17.85 24.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 120.935 1.698 . . . . 0.0 113.392 -165.381 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.83 -10.95 32.3 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 116.765 -3.709 . . . . 0.0 119.33 172.276 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 73.6 mt -86.07 129.39 54.18 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 117.541 -3.329 . . . . 0.0 112.043 -160.428 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 20.4 Cg_endo -76.95 137.96 18.03 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 125.281 3.987 . . . . 0.0 111.719 -166.761 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -39.56 -53.47 2.23 Favored 'Trans proline' 0 N--CA 1.446 -1.318 1 C-N-CA 126.863 5.042 . . . . 0.0 111.985 172.408 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.37 10.06 2.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 124.558 3.344 . . . . 0.0 113.464 -172.335 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -103.85 -28.8 11.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.602 1.191 . . . . 0.0 113.367 162.318 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.38 149.74 30.09 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 120.295 -1.503 . . . . 0.0 113.658 -168.13 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -135.04 118.91 17.29 Favored 'General case' 0 N--CA 1.451 -0.388 1 C-N-CA 132.164 4.186 . . . . 0.0 109.131 164.552 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.266 59.9 mt -100.0 132.16 45.52 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.692 0.797 . . . . 0.0 112.462 167.597 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.2 mm -109.63 124.75 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 101.068 -3.678 . . . . 0.0 101.068 -175.586 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -117.79 113.89 22.48 Favored 'General case' 0 N--CA 1.444 -0.761 1 N-CA-C 98.63 -4.582 . . . . 0.0 98.63 174.557 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.22 52.36 8.68 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 111.353 -2.658 . . . . 0.0 117.376 170.7 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -0.88 81.22 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 116.883 -2.065 . . . . 0.0 111.673 167.183 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -126.96 154.12 44.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.0 1.32 . . . . 0.0 111.166 177.996 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -91.89 118.47 30.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 110.137 -3.21 . . . . 0.0 105.001 -175.077 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -67.18 123.91 21.6 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.202 2.201 . . . . 0.0 107.472 172.719 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -85.65 143.19 28.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.446 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -71.66 155.66 40.25 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 126.107 2.129 . . . . 0.0 110.635 -171.299 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.29 -2.98 85.48 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 128.187 2.803 . . . . 0.0 114.507 174.414 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.376 0.9 OUTLIER -99.8 164.76 11.9 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.506 1.522 . . . . 0.0 109.615 173.893 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 64.8 p -99.66 171.49 7.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 126.852 3.215 . . . . 0.0 110.371 169.473 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mp -42.73 -51.98 5.12 Favored 'General case' 0 N--CA 1.446 -0.657 1 C-N-CA 131.772 4.029 . . . . 0.0 114.951 163.981 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 p -75.17 -12.44 60.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.498 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -80.85 -42.33 21.74 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 119.224 -2.172 . . . . 0.0 107.339 172.888 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.29 10.12 41.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.557 1.943 . . . . 0.0 112.705 -166.352 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.362 71.0 m-80 91.1 12.08 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.192 1.797 . . . . 0.0 114.612 159.843 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.27 55.3 mt -71.33 135.73 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 -171.198 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.523 0.4 OUTLIER -122.86 162.91 21.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.568 2.347 . . . . 0.0 114.404 175.175 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -49.6 126.84 14.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 121.468 1.94 . . . . 0.0 114.46 171.547 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.355 16.3 tt0 81.78 0.42 1.52 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 130.985 3.714 . . . . 0.0 113.212 176.94 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -61.55 145.74 51.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 119.719 -1.863 . . . . 0.0 113.638 166.823 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.3 m -125.79 109.27 12.34 Favored 'General case' 0 N--CA 1.451 -0.417 1 O-C-N 132.394 6.059 . . . . 0.0 110.614 -160.525 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.326 10.9 mp -106.04 170.71 7.75 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 -176.622 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -121.92 142.39 50.33 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.407 3.083 . . . . 0.0 105.641 177.487 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.6 tp -102.51 128.42 49.16 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 -178.043 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -111.88 150.7 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 124.407 1.067 . . . . 0.0 109.204 163.626 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.6 mt -113.47 157.38 22.05 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 117.054 -3.529 . . . . 0.0 114.928 168.984 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 -95.92 155.89 16.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.54 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.46 132.72 33.86 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.528 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.258 42.8 ttt85 -134.6 -48.91 0.76 Allowed 'General case' 0 CA--C 1.534 0.338 0 O-C-N 127.122 2.764 . . . . 0.0 112.663 -174.653 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.87 9.17 7.66 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.923 1.725 . . . . 0.0 113.044 164.862 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.197 0 CA-C-O 118.022 -1.432 . . . . 0.0 113.692 179.228 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 103.593 -2.744 . . . . 0.0 103.593 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -90.47 128.23 36.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 115.658 -2.115 . . . . 0.0 110.241 -172.316 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -116.25 148.74 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 1 CA-C-N 126.012 4.006 . . . . 0.0 109.262 168.596 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -105.76 113.32 26.8 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -172.48 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.8 t -95.14 115.65 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 1 N-CA-C 99.574 -4.232 . . . . 0.0 99.574 168.308 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -99.19 133.03 44.06 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.904 174.111 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p -121.47 140.2 52.49 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -171.882 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 mt -62.66 -40.9 98.5 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.577 2.351 . . . . 0.0 109.994 171.253 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.265 23.8 p -71.53 8.63 1.03 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 176.453 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.58 18.02 2.27 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 117.112 -1.938 . . . . 0.0 112.424 118.581 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -138.42 153.92 48.88 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 129.373 3.069 . . . . 0.0 111.458 -176.921 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.2 p -99.61 106.16 18.09 Favored 'General case' 0 N--CA 1.446 -0.653 1 C-N-CA 135.148 5.379 . . . . 0.0 109.799 174.935 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 mt -101.84 105.76 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 2 N-CA-C 98.685 -4.561 . . . . 0.0 98.685 -167.75 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 p -92.96 89.25 6.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 119.377 -2.077 . . . . 0.0 113.015 -176.469 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tp -73.54 133.86 43.67 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 131.603 3.961 . . . . 0.0 104.063 -178.211 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -96.33 122.45 39.23 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 129.375 3.07 . . . . 0.0 104.515 168.336 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.3 135.59 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 128.805 2.842 . . . . 0.0 115.761 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.59 149.11 90.71 Favored Pre-proline 0 N--CA 1.45 -0.469 0 O-C-N 119.535 -1.978 . . . . 0.0 106.884 175.532 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.03 15.77 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.87 2.38 . . . . 0.0 113.123 -172.455 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.268 67.4 p -135.41 18.11 3.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 120.867 1.667 . . . . 0.0 113.58 175.575 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -81.04 118.03 22.14 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.747 -167.026 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -88.01 148.4 24.55 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 122.084 2.22 . . . . 0.0 107.427 -165.034 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.429 6.0 mt -45.03 -39.92 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 113.405 -3.188 . . . . 0.0 118.175 -174.395 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.95 -45.08 93.8 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 125.508 1.755 . . . . 0.0 112.739 170.82 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -71.75 -9.16 57.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.848 1.659 . . . . 0.0 110.594 -176.736 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.89 -29.07 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 127.104 2.161 . . . . 0.0 111.88 172.584 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -68.85 -32.36 71.98 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 118.91 -2.369 . . . . 0.0 113.854 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.01 -21.1 47.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 111.982 -2.372 . . . . 0.0 108.519 -176.055 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.31 -39.24 17.91 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 113.039 -3.362 . . . . 0.0 105.925 174.29 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 mt -58.36 -34.46 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 1 CA-C-N 127.394 4.633 . . . . 0.0 115.288 169.358 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -83.6 -3.31 57.59 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.935 2.494 . . . . 0.0 110.018 -176.521 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -101.63 -45.25 5.32 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.184 1.793 . . . . 0.0 106.691 166.164 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.27 48.5 tptt -74.46 -37.58 63.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 117.137 -1.411 . . . . 0.0 110.519 -167.361 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -121.41 -24.85 5.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 123.679 2.945 . . . . 0.0 108.787 -179.923 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.02 14.01 65.36 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 121.994 2.179 . . . . 0.0 110.901 175.025 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -74.04 131.84 80.68 Favored Pre-proline 0 N--CA 1.44 -0.949 0 C-N-CA 128.482 2.713 . . . . 0.0 108.329 169.487 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -78.2 162.65 28.39 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 N-CA-C 116.549 1.711 . . . . 0.0 116.549 -177.492 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.47 -16.54 47.66 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 N-CA-C 119.364 2.794 . . . . 0.0 119.364 -177.084 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -95.95 -2.89 46.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.435 -179.559 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -117.26 -15.39 10.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 112.467 -3.635 . . . . 0.0 115.038 177.517 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -67.55 138.03 56.19 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 130.536 3.534 . . . . 0.0 108.694 174.457 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -127.63 150.96 49.51 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 146.939 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.401 0.8 OUTLIER -139.8 133.78 30.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 173.675 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.55 144.4 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 -165.981 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -125.28 137.9 54.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.019 162.211 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.289 . . 56.92 28.45 14.67 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 169.084 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.71 -17.64 58.74 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 128.919 3.152 . . . . 0.0 112.707 -171.499 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -103.87 122.27 44.8 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 121.522 2.661 . . . . 0.0 109.717 -161.351 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 113.12 6.55 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.421 1.889 . . . . 0.0 107.781 166.0 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.3 mt -71.27 131.55 43.64 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 131.692 3.997 . . . . 0.0 108.198 -172.194 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -106.33 129.35 54.36 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 112.545 -3.597 . . . . 0.0 109.587 176.453 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.66 146.8 24.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 127.405 2.94 . . . . 0.0 109.316 179.029 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.31 -21.01 22.66 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 128.073 2.749 . . . . 0.0 114.762 173.798 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -88.99 153.77 20.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.418 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.4 p -86.25 175.8 8.28 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 126.251 2.22 . . . . 0.0 112.282 168.993 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.48 -39.9 81.23 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.48 2.712 . . . . 0.0 111.108 176.757 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.3 t -53.05 -51.41 61.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.308 1.843 . . . . 0.0 112.241 179.65 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -46.39 -34.53 4.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 129.546 3.138 . . . . 0.0 115.285 -179.065 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -111.77 -12.42 13.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 125.32 1.638 . . . . 0.0 108.284 -170.989 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 82.77 46.11 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.671 1 C-N-CA 131.951 4.1 . . . . 0.0 108.404 166.568 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.262 19.8 mt -98.63 91.54 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 174.617 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -98.96 -4.12 33.43 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 114.652 -2.594 . . . . 0.0 112.11 -169.762 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER 134.42 161.06 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.862 1 C-N-CA 134.338 5.055 . . . . 0.0 105.702 176.948 . . . . . . . . 4 3 . 1 . 036 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 71.57 -31.71 0.23 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 114.964 -2.446 . . . . 0.0 113.505 172.29 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.8 m -27.3 133.24 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.547 1 C-N-CA 135.366 5.466 . . . . 0.0 111.872 173.928 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.2 m -89.64 108.52 19.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.613 -1.305 . . . . 0.0 111.159 172.457 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -87.86 154.72 20.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.04 2.536 . . . . 0.0 114.838 162.967 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -125.14 121.17 33.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.817 2.047 . . . . 0.0 106.421 -179.566 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tp -86.96 136.86 32.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 115.872 -2.013 . . . . 0.0 109.522 171.596 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.24 166.59 19.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 126.463 2.352 . . . . 0.0 108.13 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.14 149.15 23.83 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.995 1.27 . . . . 0.0 113.655 174.293 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -76.93 84.43 3.48 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.789 2.436 . . . . 0.0 109.018 173.04 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 mt -86.04 -2.33 58.21 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 124.866 2.27 . . . . 0.0 115.743 -165.197 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -139.04 -56.51 0.6 Allowed 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 117.241 -3.412 . . . . 0.0 110.527 -167.262 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.07 48.78 0.56 Allowed Glycine 0 CA--C 1.532 1.097 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 -176.753 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 N-CA-C 104.046 -3.622 . . . . 0.0 104.046 -174.524 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 115.24 -2.314 . . . . 0.0 107.819 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.62 125.56 36.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 128.34 3.525 . . . . 0.0 110.104 179.926 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -122.03 136.87 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 119.422 -2.048 . . . . 0.0 111.935 158.433 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -90.53 133.13 35.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 172.235 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.55 110.64 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 174.269 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -97.77 143.65 28.18 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 128.115 3.384 . . . . 0.0 106.136 -177.572 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -112.97 149.51 33.16 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 129.166 2.987 . . . . 0.0 114.428 177.254 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.87 -34.81 1.02 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.612 2.765 . . . . 0.0 117.869 -171.519 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -74.3 -24.83 59.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 125.329 1.643 . . . . 0.0 112.969 179.398 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.85 -7.68 15.09 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.362 2.41 . . . . 0.0 118.362 -175.172 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.77 145.54 56.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.749 2.02 . . . . 0.0 106.481 173.863 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 m -137.19 132.68 34.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 112.63 -2.077 . . . . 0.0 105.679 -172.079 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mt -93.41 109.42 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 129.904 3.282 . . . . 0.0 107.717 162.494 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -74.75 119.42 18.92 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 128.171 2.588 . . . . 0.0 106.603 162.743 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -128.17 158.43 38.08 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -177.156 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -124.96 121.12 33.53 Favored 'General case' 0 C--O 1.221 -0.424 1 N-CA-C 99.756 -4.164 . . . . 0.0 99.756 -178.009 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -152.18 147.9 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.572 1.949 . . . . 0.0 108.585 -165.325 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' A' ' 21' ' ' ASP 0.263 1.6 tm-20 -84.3 135.94 40.97 Favored Pre-proline 0 C--O 1.219 -0.516 0 O-C-N 125.817 1.948 . . . . 0.0 107.342 173.142 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -56.37 -26.81 64.4 Favored 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 126.384 4.722 . . . . 0.0 110.92 179.386 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.2 p -95.34 6.47 48.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 116.503 -3.873 . . . . 0.0 114.083 -177.497 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 66.1 m-20 -68.18 132.35 47.01 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 111.662 -2.517 . . . . 0.0 111.248 160.704 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -95.52 157.4 15.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 116.635 -1.65 . . . . 0.0 107.335 -173.947 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.3 mm -36.62 -54.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 112.243 -3.742 . . . . 0.0 109.863 173.786 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -68.93 -23.13 64.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 125.611 3.823 . . . . 0.0 111.248 -170.713 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -77.7 -44.64 27.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 128.185 2.594 . . . . 0.0 110.722 -179.748 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.35 -46.59 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 170.511 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.361 37.9 mtpt -46.73 -49.79 19.05 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 112.912 -1.949 . . . . 0.0 116.105 173.363 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.68 68.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 129.042 2.937 . . . . 0.0 113.223 175.742 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -67.82 -37.51 82.03 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.545 1.938 . . . . 0.0 109.354 173.257 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.91 -30.31 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 121.842 2.11 . . . . 0.0 110.254 168.042 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.72 -35.56 75.14 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 116.769 -1.972 . . . . 0.0 111.705 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.26 -43.85 76.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.565 2.346 . . . . 0.0 109.334 178.787 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.324 12.6 mmtt -66.09 -42.04 89.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 117.037 -3.539 . . . . 0.0 115.451 178.532 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -140.87 -19.49 0.82 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 116.632 -1.652 . . . . 0.0 113.278 -156.372 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.79 5.89 83.41 Favored Glycine 0 CA--C 1.524 0.654 1 CA-C-O 112.78 -4.344 . . . . 0.0 109.314 172.515 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.2 mt -69.08 128.25 92.74 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 123.445 3.623 . . . . 0.0 108.771 174.41 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -54.59 144.87 61.71 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.57 2.18 . . . . 0.0 113.911 173.138 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -72.35 -55.2 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 CA-C-N 123.423 2.258 . . . . 0.0 109.381 -170.006 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.16 -29.64 23.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.621 2.368 . . . . 0.0 112.17 -176.341 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -68.31 -31.86 71.59 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 114.432 -2.699 . . . . 0.0 110.223 179.182 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -73.81 138.9 44.78 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 123.597 2.908 . . . . 0.0 112.474 -173.055 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.42 52.6 mtt180 -104.73 134.08 48.48 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 119.563 -1.961 . . . . 0.0 112.557 141.691 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mp -88.28 114.23 24.68 Favored 'General case' 0 N--CA 1.443 -0.8 1 C-N-CA 134.14 4.976 . . . . 0.0 107.134 174.237 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.8 mt -111.76 140.09 32.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 126.602 1.961 . . . . 0.0 111.551 168.331 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -152.06 148.24 27.45 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 131.421 3.888 . . . . 0.0 105.635 160.829 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.398 . . 69.48 30.28 4.12 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 130.382 3.473 . . . . 0.0 112.773 163.689 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.64 12.9 60.31 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-N 109.678 -3.419 . . . . 0.0 116.148 168.43 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -148.29 164.53 33.73 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 -168.257 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -76.25 130.87 38.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 124.936 2.303 . . . . 0.0 105.726 162.953 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.45 147.62 35.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.288 -1.778 . . . . 0.0 106.792 165.748 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.82 136.63 43.95 Favored 'General case' 0 C--N 1.324 -0.538 1 C-N-CA 134.624 5.17 . . . . 0.0 110.798 -178.185 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.55 126.16 26.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 130.789 3.635 . . . . 0.0 116.653 -179.361 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.32 -24.89 7.18 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 119.337 -2.102 . . . . 0.0 113.295 -178.288 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -95.09 140.57 29.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 -172.866 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.6 p -70.2 157.15 38.16 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 167.841 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.3 mt -54.57 -33.67 60.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 116.88 -1.533 . . . . 0.0 112.881 168.892 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 p -64.21 -37.59 88.01 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.244 2.218 . . . . 0.0 111.957 174.523 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.66 -29.39 70.39 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.678 2.791 . . . . 0.0 109.723 179.052 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.93 -5.77 30.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.361 1.465 . . . . 0.0 112.852 -173.74 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.378 68.1 m-80 97.31 9.82 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 O-C-N 127.029 2.706 . . . . 0.0 110.738 165.791 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.9 mt -85.83 117.57 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 118.906 -2.371 . . . . 0.0 106.926 -154.171 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.41 23.4 tt0 -90.29 172.27 8.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 112.317 -2.22 . . . . 0.0 111.77 175.569 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.95 140.03 2.83 Favored 'General case' 0 N--CA 1.445 -0.685 1 O-C-N 129.467 4.229 . . . . 0.0 114.603 174.739 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 56.57 38.85 29.93 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.796 2.838 . . . . 0.0 111.696 170.61 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 m -81.69 139.17 35.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 110.044 -3.253 . . . . 0.0 103.263 169.687 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.4 m -103.98 112.46 25.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 114.786 -2.531 . . . . 0.0 105.363 174.662 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.57 159.41 24.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.67 3.188 . . . . 0.0 110.865 -177.041 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -116.82 152.99 33.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -156.485 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tp -137.68 136.47 37.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 119.936 1.243 . . . . 0.0 110.29 179.307 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.1 t -123.31 119.26 57.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 126.244 1.818 . . . . 0.0 109.991 174.583 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.0 mt -89.73 126.42 35.65 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 118.946 -2.346 . . . . 0.0 105.089 -179.231 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -83.31 -176.07 6.14 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 128.494 2.718 . . . . 0.0 108.206 177.292 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 74' ' ' ARG . 44.3 mt -97.32 132.02 43.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 116.606 -3.809 . . . . 0.0 110.465 168.871 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.444 ' CB ' ' O ' ' A' ' 73' ' ' LEU . 39.4 ttp180 124.68 106.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 1 C-N-CA 134.245 5.018 . . . . 0.0 108.828 -174.186 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.46 148.66 8.78 Favored Glycine 0 CA--C 1.526 0.763 2 C-N-CA 132.619 4.914 . . . . 0.0 113.444 -168.478 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.755 1 N-CA-C 101.034 -4.826 . . . . 0.0 101.034 169.651 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptt? . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -88.14 154.72 20.23 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 119.691 -1.88 . . . . 0.0 110.412 171.766 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 pt -139.53 159.19 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 130.681 3.592 . . . . 0.0 109.786 160.873 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.51 116.61 29.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 118.486 -2.634 . . . . 0.0 108.42 174.61 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -92.91 136.08 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.798 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -117.8 112.61 20.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.953 1.701 . . . . 0.0 109.564 -173.741 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -62.65 175.68 0.77 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 124.542 2.115 . . . . 0.0 109.176 -178.321 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tt -70.0 -31.69 69.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 117.785 -3.072 . . . . 0.0 114.004 174.519 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.317 18.4 p -81.09 -16.52 52.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 129.845 3.258 . . . . 0.0 109.506 -178.493 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.92 -1.16 30.17 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 117.076 -3.515 . . . . 0.0 111.285 167.259 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.257 70.8 tttt -69.05 156.25 38.97 Favored 'General case' 0 N--CA 1.45 -0.47 2 C-N-CA 132.308 4.243 . . . . 0.0 108.009 173.275 . . . . . . . . 3 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -133.01 130.77 39.89 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 113.632 -3.08 . . . . 0.0 111.339 -170.902 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.1 pt -131.93 139.28 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 129.548 3.139 . . . . 0.0 106.972 173.243 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.4 m -89.51 114.21 25.7 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 173.381 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -95.19 153.7 17.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 126.235 2.209 . . . . 0.0 105.599 167.643 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -116.44 132.29 56.72 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 113.395 -3.193 . . . . 0.0 111.078 169.39 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -153.34 -178.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 102.887 -3.005 . . . . 0.0 102.887 -162.266 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -144.28 156.49 57.55 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 131.218 3.807 . . . . 0.0 102.676 166.542 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -49.14 -28.48 14.4 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 116.147 1.557 . . . . 0.0 116.147 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 p -68.82 -18.98 64.26 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 128.816 2.846 . . . . 0.0 115.726 178.414 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS 0.275 2.0 m-20 -51.29 121.93 7.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 122.567 2.439 . . . . 0.0 112.637 173.386 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 p -65.97 156.49 33.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.632 3.173 . . . . 0.0 109.465 168.684 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.2 mm -61.83 -40.6 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 O-C-N 125.034 1.459 . . . . 0.0 110.637 171.902 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.36 -25.83 60.76 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 122.25 2.295 . . . . 0.0 109.039 -172.771 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.267 16.8 t-20 -71.77 -44.33 64.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 117.168 -3.458 . . . . 0.0 109.501 173.909 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -68.25 -27.58 37.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 O-C-N 117.585 -3.197 . . . . 0.0 110.738 179.439 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -66.09 -24.45 66.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 122.575 1.179 . . . . 0.0 114.072 169.07 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.8 -38.42 58.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 115.151 -2.357 . . . . 0.0 111.019 167.595 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP . 43.1 mttp -64.26 -42.87 96.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 129.897 3.279 . . . . 0.0 110.558 178.85 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.63 -27.88 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 O-C-N 126.268 2.23 . . . . 0.0 109.112 177.114 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -74.17 -44.94 51.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 124.273 1.987 . . . . 0.0 108.733 172.272 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.59 -40.14 74.76 Favored 'General case' 0 N--CA 1.446 -0.654 1 O-C-N 112.911 -6.118 . . . . 0.0 120.869 168.235 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -70.68 -53.32 16.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.497 2.319 . . . . 0.0 110.381 -178.178 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -133.63 6.12 3.74 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 117.627 -3.171 . . . . 0.0 112.895 -166.117 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.67 12.54 77.99 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 118.273 -2.767 . . . . 0.0 118.002 177.643 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.66 120.65 76.95 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 122.971 3.385 . . . . 0.0 112.301 174.19 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.32 147.77 94.67 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 106.208 -2.266 . . . . 0.0 106.208 -179.775 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.23 -48.73 7.84 Favored 'Trans proline' 0 N--CA 1.441 -1.601 1 C-N-CA 125.949 4.433 . . . . 0.0 117.601 170.879 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -77.02 -13.0 60.01 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -170.552 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -93.76 10.09 34.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.441 1.497 . . . . 0.0 113.225 -176.659 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -130.05 165.92 21.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 116.421 -3.925 . . . . 0.0 114.355 -176.557 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -143.84 129.7 19.4 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 125.376 1.673 . . . . 0.0 112.99 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.7 mt -110.92 145.26 38.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 113.381 -1.736 . . . . 0.0 115.126 -165.843 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 pt -147.71 143.87 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 1 N-CA-C 99.113 -4.403 . . . . 0.0 99.113 -157.735 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -165.63 126.16 1.84 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 161.728 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.56 36.32 13.88 Favored 'General case' 0 N--CA 1.444 -0.733 1 C-N-CA 132.827 4.451 . . . . 0.0 116.036 165.646 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.44 -11.5 65.1 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.558 -1.134 . . . . 0.0 113.513 175.348 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -111.61 133.52 53.81 Favored 'General case' 0 N--CA 1.449 -0.502 1 C-N-CA 133.682 4.793 . . . . 0.0 107.165 -173.616 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -84.82 124.58 31.74 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 128.396 3.56 . . . . 0.0 110.348 170.782 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.06 115.66 27.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 123.706 1.717 . . . . 0.0 112.61 -168.175 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.83 141.23 28.75 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 129.969 3.308 . . . . 0.0 115.033 -173.698 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -75.7 135.88 40.38 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 114.645 -2.598 . . . . 0.0 108.613 -173.921 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.96 -6.84 21.82 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 120.808 1.64 . . . . 0.0 111.225 -176.609 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -106.82 154.89 20.36 Favored 'General case' 0 N--CA 1.452 -0.367 1 C-N-CA 132.71 4.404 . . . . 0.0 107.862 177.32 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 p -101.93 162.14 13.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.865 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.5 mt -61.97 -26.76 68.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 128.252 2.621 . . . . 0.0 112.459 -172.084 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -71.25 -24.87 62.26 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.147 2.579 . . . . 0.0 110.199 179.9 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.47 -50.19 72.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.573 3.149 . . . . 0.0 109.378 -178.223 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.92 12.86 18.22 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 128.266 3.479 . . . . 0.0 113.274 178.382 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 55.16 37.99 29.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.737 2.815 . . . . 0.0 115.881 -178.277 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.01 121.36 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 122.651 2.478 . . . . 0.0 106.129 -175.198 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -88.1 164.93 15.48 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 124.378 2.037 . . . . 0.0 113.681 176.319 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 163.81 16.29 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 119.975 -1.703 . . . . 0.0 110.329 -174.372 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 46.47 10.47 0.01 OUTLIER 'General case' 0 C--O 1.236 0.359 0 N-CA-C 120.354 3.465 . . . . 0.0 120.354 176.183 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.285 71.0 m -75.49 154.49 36.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 119.394 -2.066 . . . . 0.0 107.842 174.524 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 m -95.68 110.06 22.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 176.306 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.17 125.56 43.26 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 173.716 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -82.14 148.76 28.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.869 3.268 . . . . 0.0 109.196 174.027 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.307 1.6 pp -131.55 167.43 19.4 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 166.32 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t -123.88 140.66 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 -175.634 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp -86.68 121.22 28.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 163.917 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -72.12 -21.42 61.48 Favored 'General case' 0 N--CA 1.446 -0.668 1 C-N-CA 132.375 4.27 . . . . 0.0 111.411 -170.427 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.573 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -142.18 145.82 34.59 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 117.514 -3.241 . . . . 0.0 103.507 170.899 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -144.34 111.72 6.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.598 1.159 . . . . 0.0 112.684 170.243 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.77 121.7 2.33 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 118.05 -2.024 . . . . 0.0 113.957 -175.26 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 1 C-N-CA 133.185 5.183 . . . . 0.0 110.668 171.461 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -81.69 144.26 31.29 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 123.382 1.563 . . . . 0.0 112.322 -177.906 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 11.2 pt -132.56 157.45 43.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 115.026 -2.416 . . . . 0.0 107.251 166.897 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -98.52 144.0 28.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 114.939 -2.458 . . . . 0.0 106.617 165.177 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.14 122.71 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 100.431 -3.914 . . . . 0.0 100.431 176.443 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -123.66 117.83 25.89 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 -170.799 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -80.66 144.86 31.96 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 118.644 -2.535 . . . . 0.0 106.208 -175.016 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.27 -34.43 0.49 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 118.033 2.605 . . . . 0.0 118.033 172.981 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -50.59 -37.87 42.36 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 118.239 -2.788 . . . . 0.0 116.841 164.811 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.85 9.68 8.11 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 127.188 2.328 . . . . 0.0 109.503 176.652 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -84.24 103.12 13.17 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.908 2.483 . . . . 0.0 104.725 -170.765 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.2 m -96.37 119.59 35.14 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.269 1.827 . . . . 0.0 112.874 -178.612 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mm -130.79 145.78 35.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 111.238 -2.71 . . . . 0.0 109.826 -169.334 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.5 p -81.57 165.73 20.87 Favored 'General case' 0 C--O 1.237 0.42 1 O-C-N 114.777 -4.952 . . . . 0.0 114.922 172.929 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.265 2.4 tp -152.65 142.81 22.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.132 2.973 . . . . 0.0 109.441 172.042 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -95.23 117.52 30.4 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.282 2.633 . . . . 0.0 109.528 166.687 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.272 13.9 m -120.75 148.85 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.236 2.215 . . . . 0.0 108.909 179.136 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -91.45 136.14 27.19 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 179.666 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.262 71.5 Cg_exo -41.4 -30.88 0.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 1 N-CA-C 124.084 4.609 . . . . 0.0 124.084 166.53 . . . . . . . . 3 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -103.64 14.34 31.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.992 1.717 . . . . 0.0 113.678 176.241 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.408 ' OD1' ' ND2' ' A' ' 25' ' ' ASN 0.279 24.5 m-20 -66.91 139.77 57.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 128.704 2.802 . . . . 0.0 110.99 170.886 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -73.05 154.54 40.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.091 2.556 . . . . 0.0 107.124 168.185 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mp -69.73 -29.61 41.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 130.252 3.421 . . . . 0.0 105.344 175.466 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -67.71 -36.48 80.7 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 116.85 -3.656 . . . . 0.0 112.989 164.574 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.408 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 5.4 t30 -67.92 -19.07 64.95 Favored 'General case' 0 N--CA 1.444 -0.774 1 CA-C-N 128.254 5.024 . . . . 0.0 113.14 164.285 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.76 -34.68 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 126.048 2.832 . . . . 0.0 114.633 172.928 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -70.18 -35.33 73.9 Favored 'General case' 0 CA--C 1.537 0.451 1 O-C-N 115.931 -4.231 . . . . 0.0 107.273 174.024 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -33.05 71.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 169.046 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -79.52 -27.54 41.35 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 116.02 -1.943 . . . . 0.0 108.658 179.765 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -77.54 -38.74 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 125.046 1.467 . . . . 0.0 109.216 171.87 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -59.89 -30.29 68.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 118.524 -2.61 . . . . 0.0 111.291 176.535 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . 29.4 t70 -53.04 -37.41 61.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 127.041 2.136 . . . . 0.0 108.149 174.603 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.484 ' HD2' ' HB3' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -115.36 -44.64 2.97 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.982 1.713 . . . . 0.0 107.326 -169.336 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -94.34 -23.52 17.77 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 118.005 -2.934 . . . . 0.0 112.143 -172.521 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.07 27.9 47.66 Favored Glycine 0 CA--C 1.525 0.685 0 O-C-N 119.569 -1.957 . . . . 0.0 113.935 175.892 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.84 124.25 37.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 113.728 -3.034 . . . . 0.0 107.45 -176.921 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.16 137.92 64.11 Favored 'Trans proline' 0 N--CA 1.451 -1.025 1 C-N-CA 125.582 4.188 . . . . 0.0 116.236 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -45.28 -30.48 5.34 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 O-C-N 125.553 2.344 . . . . 0.0 117.834 177.766 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.374 5.8 t70 -46.92 -43.31 18.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 119.09 -2.256 . . . . 0.0 116.075 178.276 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -110.24 -13.35 14.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.315 2.246 . . . . 0.0 105.558 -161.43 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -66.69 139.25 57.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.018 -1.676 . . . . 0.0 112.91 161.29 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -121.63 150.87 41.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.332 1.453 . . . . 0.0 113.217 157.612 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.356 5.8 mt -127.08 138.33 53.18 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 116.634 -3.791 . . . . 0.0 112.733 -179.283 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.366 98.4 mt -139.4 128.36 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 127.18 2.8 . . . . 0.0 112.07 -157.678 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -150.1 147.54 27.91 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.513 1.133 . . . . 0.0 108.945 152.995 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.365 . . 65.87 21.15 11.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 130.28 3.432 . . . . 0.0 112.537 177.478 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.35 -3.84 85.35 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.004 1.288 . . . . 0.0 113.477 -173.819 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -99.98 159.27 15.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 119.899 1.85 . . . . 0.0 107.229 -176.45 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.9 135.39 54.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 101.689 -3.448 . . . . 0.0 101.689 -178.072 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.7 mt -89.42 159.36 17.34 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 119.22 -2.175 . . . . 0.0 114.349 -179.058 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -104.01 141.2 36.61 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 119.219 -2.175 . . . . 0.0 107.068 -165.561 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.283 11.2 m-20 -72.27 123.51 23.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 126.247 2.927 . . . . 0.0 115.221 167.798 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.81 -28.61 9.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 129.496 3.427 . . . . 0.0 113.369 -177.876 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -69.43 167.73 15.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.476 -2.191 . . . . 0.0 112.543 170.999 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -115.0 166.46 11.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -163.722 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 mt -54.29 -44.87 72.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.328 1.451 . . . . 0.0 111.023 164.01 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -63.75 -27.65 69.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.944 1.702 . . . . 0.0 109.766 -174.002 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.37 -37.88 88.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.764 1.626 . . . . 0.0 109.696 -171.263 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -99.08 -5.0 31.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 111.723 -2.49 . . . . 0.0 107.236 -176.888 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 71.96 23.46 3.51 Favored 'General case' 0 N--CA 1.442 -0.845 1 O-C-N 114.643 -5.036 . . . . 0.0 116.408 165.221 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -90.68 130.66 39.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 130.54 3.536 . . . . 0.0 107.949 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -115.65 -173.83 2.41 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 131.143 3.777 . . . . 0.0 109.993 -167.673 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -74.17 133.26 42.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 129.577 3.151 . . . . 0.0 106.315 -159.887 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.301 35.7 mt-10 76.03 26.63 0.98 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.045 2.538 . . . . 0.0 113.28 -179.524 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.4 p -84.01 145.84 28.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.308 170.11 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.7 m -103.01 118.77 37.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 -177.23 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 tp -100.07 151.04 21.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 173.947 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -113.07 119.7 38.77 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 128.557 2.743 . . . . 0.0 109.69 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -89.16 137.05 32.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 128.642 3.714 . . . . 0.0 107.111 -176.569 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 t -105.41 116.51 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.832 166.969 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.31 142.84 28.22 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.7 1.6 . . . . 0.0 107.217 -169.681 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -132.38 138.54 47.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 114.601 -2.619 . . . . 0.0 110.492 160.416 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -158.0 164.9 36.31 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 127.349 2.905 . . . . 0.0 104.916 178.005 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -116.61 -28.07 6.51 Favored 'General case' 0 N--CA 1.452 -0.341 1 C-N-CA 133.187 4.595 . . . . 0.0 108.13 -174.399 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.07 -119.48 6.48 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 128.965 3.916 . . . . 0.0 114.306 -171.918 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 O-C-N 119.342 -2.269 . . . . 0.0 112.31 -173.659 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -89.8 112.41 23.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 128.657 2.783 . . . . 0.0 108.074 -170.29 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -109.66 143.09 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 169.121 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -87.97 150.95 23.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.061 0.944 . . . . 0.0 111.79 161.919 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.4 121.14 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 130.296 3.438 . . . . 0.0 108.309 168.641 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -108.95 133.73 52.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.766 2.427 . . . . 0.0 113.889 176.434 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -105.87 173.4 6.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 117.55 -3.218 . . . . 0.0 109.856 -170.963 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tt -91.84 -35.68 13.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 131.535 3.934 . . . . 0.0 111.667 -176.57 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.7 p -65.03 -6.3 8.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 166.011 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.04 -28.77 5.76 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 117.006 1.562 . . . . 0.0 117.006 160.658 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -79.21 138.35 37.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 116.197 -1.859 . . . . 0.0 111.836 -172.182 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -99.51 118.92 37.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 113.798 -3.001 . . . . 0.0 104.522 172.543 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.9 mt -96.91 152.92 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 126.663 2.477 . . . . 0.0 107.121 179.302 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -125.14 142.03 51.74 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 165.357 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 131.47 49.78 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 111.656 -2.52 . . . . 0.0 113.162 -178.311 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -99.46 110.73 23.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 115.824 -2.036 . . . . 0.0 106.636 174.806 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 1.7 m -131.99 -174.84 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 119.748 1.158 . . . . 0.0 108.844 175.947 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -111.88 156.09 42.24 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 125.111 1.364 . . . . 0.0 109.887 174.713 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.08 -6.96 12.18 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-O 114.249 -2.479 . . . . 0.0 113.821 -171.704 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m -106.02 2.94 27.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 121.338 1.881 . . . . 0.0 110.64 179.992 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -75.72 152.74 37.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 118.646 -2.534 . . . . 0.0 111.724 170.478 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.333 74.8 p -94.33 169.52 10.16 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.253 1.021 . . . . 0.0 109.97 -165.547 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -71.6 -22.88 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 115.946 -1.978 . . . . 0.0 106.661 -178.47 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -69.19 -19.69 63.99 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 125.072 3.578 . . . . 0.0 107.204 173.537 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -73.94 -48.05 33.29 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 119.144 0.884 . . . . 0.0 111.23 -178.101 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -67.33 -44.37 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 111.997 -2.365 . . . . 0.0 113.404 175.306 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.29 30.1 mtpt -48.64 -36.56 16.16 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 119.898 3.296 . . . . 0.0 119.898 160.15 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.83 -39.87 42.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 120.912 1.687 . . . . 0.0 110.519 -179.572 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -69.88 -33.04 71.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.109 2.163 . . . . 0.0 111.232 178.753 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.22 -46.13 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 113.139 -3.315 . . . . 0.0 114.18 162.788 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -58.44 -45.86 87.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 123.056 2.662 . . . . 0.0 115.451 168.23 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.444 24.1 t70 -47.67 -64.5 0.77 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.006 1.722 . . . . 0.0 114.431 173.326 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -98.81 -20.69 16.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -165.191 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -127.46 13.01 7.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.185 2.194 . . . . 0.0 113.894 -176.539 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.06 20.58 62.77 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.078 2.275 . . . . 0.0 117.462 159.184 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mt -91.91 132.8 31.84 Favored Pre-proline 0 N--CA 1.444 -0.752 0 O-C-N 118.275 -2.897 . . . . 0.0 105.365 -172.491 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.84 112.13 2.14 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 114.694 -2.294 . . . . 0.0 114.581 169.627 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.66 -10.59 23.63 Favored 'Trans proline' 0 N--CA 1.457 -0.626 1 C-N-CA 125.447 4.098 . . . . 0.0 114.305 -167.625 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.361 25.7 t0 -65.3 -27.85 68.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 125.528 2.585 . . . . 0.0 111.904 167.504 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -114.97 51.61 0.9 Allowed 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 116.893 -3.63 . . . . 0.0 103.257 -167.432 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -160.64 147.12 15.29 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.997 2.119 . . . . 0.0 105.839 -170.736 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -149.65 126.26 10.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 102.173 -3.269 . . . . 0.0 102.173 172.183 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.334 78.2 mt -93.46 150.14 20.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 125.052 2.358 . . . . 0.0 109.518 169.695 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.7 mt -126.61 135.07 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 1 C-N-CA 133.249 4.62 . . . . 0.0 111.471 -177.219 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 65' ' ' SER . 52.8 t80 -150.66 133.17 15.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 118.7 -2.5 . . . . 0.0 111.853 178.115 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.22 21.31 1.59 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 118.831 2.9 . . . . 0.0 118.831 -178.583 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.65 -5.35 47.56 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 127.571 2.51 . . . . 0.0 113.038 -176.681 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -119.56 123.05 42.99 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.574 2.75 . . . . 0.0 109.239 -161.246 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -54.18 124.11 14.75 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 118.669 -2.519 . . . . 0.0 110.963 164.829 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -71.51 108.46 4.91 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.853 2.061 . . . . 0.0 109.645 174.359 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.287 29.8 tt0 -91.31 151.04 21.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -166.472 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -73.83 128.4 35.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.67 2.388 . . . . 0.0 106.773 -174.66 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.97 18.16 12.88 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 128.659 3.028 . . . . 0.0 116.709 175.217 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -121.86 168.11 12.25 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.876 1.67 . . . . 0.0 107.978 -177.472 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.4 p -124.32 146.21 48.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 -173.219 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 61' ' ' ILE 0.285 5.7 mt -48.15 -41.76 27.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.936 1.694 . . . . 0.0 112.053 -171.936 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -36.61 -44.96 0.48 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 129.846 3.258 . . . . 0.0 117.342 161.493 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -73.07 -7.65 52.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.761 2.024 . . . . 0.0 112.701 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -117.01 -12.56 10.65 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.35 1.86 . . . . 0.0 112.72 170.331 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.1 t30 78.05 33.7 0.33 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.8 2.04 . . . . 0.0 111.003 171.861 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 52.9 mt -69.14 119.15 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 127.118 2.167 . . . . 0.0 106.211 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.277 4.0 pp0? -119.65 175.48 5.84 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 128.943 2.897 . . . . 0.0 108.71 -168.25 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -48.56 111.33 0.44 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 117.007 -3.558 . . . . 0.0 115.452 -175.338 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 73.46 29.32 1.62 Allowed 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 119.294 -2.128 . . . . 0.0 109.658 176.284 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 73.4 m -84.25 125.77 32.54 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 117.108 -3.495 . . . . 0.0 103.263 175.225 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.1 m -95.41 110.1 22.18 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 116.946 -3.596 . . . . 0.0 108.426 -169.191 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -79.75 157.26 27.16 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 130.766 3.626 . . . . 0.0 110.4 174.736 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -121.39 142.4 50.04 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 129.533 3.133 . . . . 0.0 104.448 -177.808 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.22 127.29 48.4 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 131.242 3.817 . . . . 0.0 105.057 -173.223 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.31 142.37 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 118.761 -2.462 . . . . 0.0 113.506 163.74 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.98 114.91 27.2 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 -170.113 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 55.5 -25.03 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.099 2.16 . . . . 0.0 116.771 -179.158 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mt -51.05 139.87 16.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 131.127 3.771 . . . . 0.0 112.848 -176.652 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.258 42.5 ttt180 -86.95 137.94 31.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.232 -173.287 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.6 -156.23 11.94 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 128.868 3.128 . . . . 0.0 118.713 -178.005 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.811 0 C-N-CA 126.467 1.984 . . . . 0.0 108.271 171.365 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 CA--C 1.534 0.361 1 CA-C-O 129.783 4.611 . . . . 0.0 105.297 . . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -71.02 144.58 50.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 110.671 -2.968 . . . . 0.0 113.389 -173.786 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.3 pt -146.12 174.95 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 116.441 -1.742 . . . . 0.0 106.691 177.998 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -128.31 117.35 21.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.063 2.545 . . . . 0.0 108.178 172.121 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -82.29 116.55 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 118.946 -2.346 . . . . 0.0 105.665 158.446 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -95.06 146.77 24.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 115.417 -2.23 . . . . 0.0 111.735 160.903 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -95.54 159.8 14.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 129.386 3.074 . . . . 0.0 104.697 164.62 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 tp -63.5 -21.41 66.31 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 111.526 -2.579 . . . . 0.0 110.534 177.037 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.1 p -95.63 -6.79 39.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 127.674 3.109 . . . . 0.0 112.708 178.134 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.5 -24.94 6.06 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.198 -1.334 . . . . 0.0 112.704 158.472 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -55.58 118.53 4.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 129.228 3.011 . . . . 0.0 109.086 -177.573 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.0 m -100.34 132.89 45.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 126.83 2.581 . . . . 0.0 109.711 179.084 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 mm -109.05 130.41 62.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.589 1.955 . . . . 0.0 106.911 173.614 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.7 m -85.36 144.1 28.24 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.907 2.483 . . . . 0.0 105.17 174.631 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.68 151.63 49.49 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 120.267 -1.521 . . . . 0.0 107.675 171.615 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -103.3 125.67 50.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 153.79 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -137.79 171.25 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 131.496 3.919 . . . . 0.0 112.677 163.73 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -130.14 144.29 52.55 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -178.411 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -57.81 -28.71 83.38 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 CA-C-O 111.843 -3.482 . . . . 0.0 115.286 -169.598 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.9 p -77.2 2.4 15.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 124.81 3.459 . . . . 0.0 115.52 172.25 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -77.83 148.78 34.55 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 118.968 -2.332 . . . . 0.0 107.358 -179.443 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.3 p -78.4 155.1 30.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 116.739 -1.601 . . . . 0.0 112.648 -172.12 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.254 10.6 mm -81.9 50.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 125.327 2.489 . . . . 0.0 109.794 161.175 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -153.72 -54.66 0.11 Allowed 'General case' 0 CA--C 1.532 0.288 0 O-C-N 117.39 -3.319 . . . . 0.0 109.066 -173.44 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -59.71 -57.37 13.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 120.698 1.59 . . . . 0.0 113.517 -175.394 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.37 -8.03 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.65 2.38 . . . . 0.0 111.188 -163.568 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -49.01 -40.29 30.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.322 2.649 . . . . 0.0 116.291 162.338 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.91 -27.69 8.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 119.722 -1.861 . . . . 0.0 115.527 172.033 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -89.01 -2.26 58.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 118.541 -1.263 . . . . 0.0 111.511 -172.096 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.9 mm -89.71 -37.75 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 127.67 2.388 . . . . 0.0 108.581 165.543 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.08 -43.24 99.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.361 -1.291 . . . . 0.0 114.225 176.476 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.25 -16.34 8.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.816 2.447 . . . . 0.0 115.704 170.934 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -108.94 -52.26 2.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.566 1.546 . . . . 0.0 110.979 -173.246 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -115.01 -19.06 11.07 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 118.801 -2.437 . . . . 0.0 112.331 -173.628 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.27 15.79 20.39 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 115.161 -3.022 . . . . 0.0 112.41 177.908 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -90.75 121.63 67.93 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 121.773 2.787 . . . . 0.0 112.172 -176.987 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.4 158.06 59.18 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.538 2.159 . . . . 0.0 113.656 179.028 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.36 -40.17 60.61 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.273 2.649 . . . . 0.0 115.465 -173.614 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -41.6 -54.87 3.09 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 131.225 3.81 . . . . 0.0 114.015 166.144 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -80.23 -13.23 59.39 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.607 2.363 . . . . 0.0 113.868 -170.481 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -83.91 106.44 15.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 129.482 3.113 . . . . 0.0 106.676 -179.058 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -113.28 137.28 51.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.728 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.284 1.7 pt? -134.02 131.37 38.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 120.707 1.594 . . . . 0.0 112.497 -172.378 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.8 mt -109.68 132.22 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 -174.533 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -131.74 -85.4 0.49 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 130.546 3.538 . . . . 0.0 114.233 168.528 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.61 55.01 0.69 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 125.961 3.982 . . . . 0.0 114.584 -170.474 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.71 -9.48 48.06 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 161.805 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -139.33 156.01 47.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 119.764 3.246 . . . . 0.0 119.764 176.536 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.86 116.17 18.16 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.988 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.5 mt -58.68 135.53 57.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.769 -2.457 . . . . 0.0 113.932 -175.251 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -84.07 143.77 29.51 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.531 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.54 132.92 46.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.323 1.449 . . . . 0.0 112.261 169.937 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.23 -24.44 10.6 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 124.671 2.262 . . . . 0.0 112.241 171.565 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -73.61 166.87 22.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 111.978 -2.111 . . . . 0.0 105.316 -179.903 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.9 p -100.81 163.59 12.24 Favored 'General case' 0 N--CA 1.45 -0.436 1 O-C-N 115.583 -4.448 . . . . 0.0 108.269 169.013 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -51.59 -36.98 47.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.233 2.213 . . . . 0.0 113.439 171.501 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -79.6 -17.84 52.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 177.235 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -62.97 -17.33 61.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 121.294 1.861 . . . . 0.0 109.411 164.847 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -118.05 7.18 12.17 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 130.389 3.476 . . . . 0.0 112.484 -178.212 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 62.96 32.39 15.61 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 131.453 3.901 . . . . 0.0 112.0 174.291 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.89 132.0 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 126.607 1.963 . . . . 0.0 105.84 -172.002 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -127.34 165.77 19.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.319 2.248 . . . . 0.0 111.678 -179.902 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -48.03 137.28 10.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 131.286 3.835 . . . . 0.0 112.494 179.577 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 84.67 4.15 0.67 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.461 1.905 . . . . 0.0 108.454 165.541 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 m -83.61 142.69 30.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 175.374 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.8 m -97.29 129.52 44.58 Favored 'General case' 0 N--CA 1.451 -0.408 1 C-N-CA 132.431 4.292 . . . . 0.0 112.749 179.485 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.62 143.18 50.71 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -169.99 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -115.1 102.68 10.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 101.621 -3.474 . . . . 0.0 101.621 -160.72 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -71.07 144.45 50.34 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 128.843 2.857 . . . . 0.0 108.649 166.1 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.85 156.29 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 130.134 3.373 . . . . 0.0 106.66 170.414 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.28 48.1 mt -108.05 126.77 53.13 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 126.55 3.072 . . . . 0.0 108.89 -178.483 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.438 5.4 ttt180 93.39 -54.81 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 131.209 3.804 . . . . 0.0 118.255 164.12 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 mt -110.51 146.08 36.61 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 110.55 -3.023 . . . . 0.0 105.645 -161.539 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 74' ' ' ARG . 23.3 ttp180 -65.68 145.95 55.4 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.972 2.909 . . . . 0.0 111.309 171.059 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.6 117.66 3.68 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 125.406 1.691 . . . . 0.0 111.347 163.881 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.385 0 CA-C-O 124.481 2.156 . . . . 0.0 115.256 -172.099 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttp . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -125.13 139.59 53.63 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.007 2.523 . . . . 0.0 114.18 -175.983 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 3' ' ' ILE 0.296 45.6 pt -133.55 -179.48 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 128.893 2.877 . . . . 0.0 104.869 173.935 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -133.17 160.65 36.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 167.291 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.6 t -129.52 141.04 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 166.694 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -109.16 127.05 53.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.129 1.771 . . . . 0.0 106.638 176.814 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.5 p -79.74 173.14 12.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 124.154 1.931 . . . . 0.0 112.305 165.852 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.7 mt -78.71 -31.45 46.47 Favored 'General case' 0 C--O 1.24 0.602 0 O-C-N 118.188 -2.82 . . . . 0.0 111.921 173.708 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 t -64.0 -21.11 66.36 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 167.642 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.54 6.63 40.92 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 125.825 1.953 . . . . 0.0 109.275 168.769 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -65.77 119.06 10.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 122.377 3.088 . . . . 0.0 109.113 167.998 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.5 m -102.46 94.83 5.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 122.948 2.613 . . . . 0.0 104.652 -178.914 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.86 144.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 1 C-N-CA 132.212 4.205 . . . . 0.0 109.41 170.11 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.9 m -103.22 142.42 34.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.752 1.621 . . . . 0.0 109.912 169.109 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -125.12 132.53 53.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 157.819 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.84 128.4 35.48 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 154.638 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.67 157.99 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 120.402 -1.436 . . . . 0.0 111.403 -178.056 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.76 149.55 38.6 Favored Pre-proline 0 N--CA 1.442 -0.869 0 C-N-CA 127.016 2.127 . . . . 0.0 106.382 174.882 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.295 52.8 Cg_endo -70.41 -15.17 34.6 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 124.767 3.645 . . . . 0.0 116.476 -179.254 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -98.52 1.27 46.43 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.986 2.514 . . . . 0.0 113.632 -178.643 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -77.64 153.63 32.97 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.394 -1.441 . . . . 0.0 111.539 -169.863 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.5 p -89.42 158.14 17.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 128.047 2.539 . . . . 0.0 106.005 177.256 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.11 -29.74 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 114.049 -2.882 . . . . 0.0 107.59 175.964 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -59.63 -38.04 80.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 124.629 3.377 . . . . 0.0 108.316 168.921 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -76.38 -21.54 55.91 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 118.368 -2.707 . . . . 0.0 109.604 176.309 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.29 -37.02 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 124.609 3.368 . . . . 0.0 111.7 172.933 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -64.64 -30.07 71.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.484 1.914 . . . . 0.0 111.971 176.566 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.265 . . -75.25 -30.24 60.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.621 2.368 . . . . 0.0 111.928 179.867 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -79.51 -25.43 41.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 125.108 2.385 . . . . 0.0 112.014 174.707 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 30' ' ' ILE 0.34 32.1 mm -82.3 -33.68 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 113.412 -1.722 . . . . 0.0 108.883 173.241 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -55.48 -36.32 66.5 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 123.013 2.642 . . . . 0.0 114.063 161.595 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.05 -59.85 2.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 128.433 2.693 . . . . 0.0 106.531 177.718 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.322 68.1 mmtt -51.39 -64.94 0.65 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.695 2.398 . . . . 0.0 110.567 -177.309 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -120.49 -9.88 9.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 112.914 -3.422 . . . . 0.0 107.437 -150.451 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.49 -1.9 62.42 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 127.875 3.234 . . . . 0.0 116.826 166.933 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.3 mm -95.09 132.14 28.67 Favored Pre-proline 0 N--CA 1.452 -0.368 0 O-C-N 117.335 -3.45 . . . . 0.0 111.722 -159.231 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -47.44 122.95 7.31 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 126.914 5.076 . . . . 0.0 108.657 168.352 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -35.36 -47.43 0.81 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 1 C-N-CA 129.698 6.932 . . . . 0.0 118.52 174.711 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.5 -16.3 64.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 114.913 -2.47 . . . . 0.0 115.422 -178.697 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.24 -7.36 42.29 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 126.186 2.179 . . . . 0.0 109.125 179.542 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -86.91 130.19 34.56 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 128.338 2.655 . . . . 0.0 109.269 179.906 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -116.86 141.06 48.72 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 128.868 2.867 . . . . 0.0 107.334 179.823 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.9 mt -119.44 111.18 17.82 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.551 2.34 . . . . 0.0 110.797 173.886 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.3 mt -105.12 118.6 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 161.23 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -126.69 130.79 51.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 175.212 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.42 19.5 10.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.658 169.514 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.17 -17.55 59.08 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 128.453 2.93 . . . . 0.0 115.678 -169.728 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.288 11.6 mmmt -93.19 146.48 23.65 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 119.404 1.602 . . . . 0.0 111.971 -176.931 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -94.54 112.47 24.23 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 130.892 3.677 . . . . 0.0 105.07 -176.246 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HG ' ' CD1' ' A' ' 59' ' ' TYR . 6.2 mp -80.2 111.2 16.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 114.455 -2.688 . . . . 0.0 105.778 -179.259 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -83.83 -15.05 49.73 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 126.769 2.543 . . . . 0.0 115.705 -173.052 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.298 5.3 t0 93.64 153.66 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 128.694 2.798 . . . . 0.0 111.49 -175.932 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.01 30.98 5.82 Favored Glycine 0 N--CA 1.438 -1.21 0 O-C-N 117.394 -3.316 . . . . 0.0 114.335 161.322 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -153.4 160.48 42.63 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 131.586 3.954 . . . . 0.0 106.83 172.276 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.6 p -98.34 176.66 5.62 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 117.013 -3.555 . . . . 0.0 111.506 -167.269 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.53 -37.13 84.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 126.312 1.845 . . . . 0.0 111.96 -173.82 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 p -64.39 -33.6 76.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.017 1.727 . . . . 0.0 115.12 166.189 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -71.74 -56.44 5.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.99 2.116 . . . . 0.0 107.416 179.634 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.498 ' CD1' ' HG ' ' A' ' 50' ' ' LEU 0.277 42.9 m-85 -64.52 0.99 0.89 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 130.548 3.539 . . . . 0.0 116.312 -178.756 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.311 0.1 OUTLIER 78.42 18.32 1.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 124.131 3.15 . . . . 0.0 113.836 163.659 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.8 mt -94.01 105.02 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 117.306 -3.371 . . . . 0.0 106.409 179.92 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -99.83 -170.79 1.94 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 116.601 -3.812 . . . . 0.0 101.483 -166.541 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -64.99 120.23 12.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 114.669 -2.586 . . . . 0.0 112.125 -170.044 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.555 2.4 mp0 77.59 24.77 0.75 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 117.427 2.381 . . . . 0.0 117.427 179.144 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.9 m -71.23 148.02 47.65 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 112.42 -2.173 . . . . 0.0 106.157 175.221 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.321 99.1 m -114.83 128.9 56.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 169.579 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.1 mt -92.65 151.24 20.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 108.824 -3.807 . . . . 0.0 107.811 170.305 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -98.68 127.35 44.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.904 0.882 . . . . 0.0 113.374 162.112 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -107.46 118.46 36.79 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 -178.396 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.52 160.78 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.306 1.842 . . . . 0.0 110.253 172.992 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.1 mt -92.55 153.39 19.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 118.868 -2.395 . . . . 0.0 112.623 176.523 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.7 mtt-85 -91.51 146.1 24.07 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.91 2.484 . . . . 0.0 108.002 150.514 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 mt -93.67 -22.38 18.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 126.779 3.181 . . . . 0.0 111.806 170.319 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.4 tpt85 -149.32 135.66 19.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 129.753 3.221 . . . . 0.0 116.223 -177.5 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.08 149.98 16.68 Favored Glycine 0 CA--C 1.533 1.176 1 O-C-N 115.459 -4.526 . . . . 0.0 104.939 168.89 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 127.731 2.586 . . . . 0.0 108.467 -175.33 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ttt . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 116.409 -1.758 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -77.82 131.53 37.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 123.716 2.962 . . . . 0.0 112.309 173.629 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 3' ' ' ILE . 46.4 pt -130.37 136.9 57.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 126.88 2.613 . . . . 0.0 107.202 170.457 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.52 123.01 35.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 172.045 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 46.6 t -96.27 124.88 49.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 166.682 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.261 49.3 tttm -106.87 121.31 44.15 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -174.292 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 69' ' ' LEU 0.294 5.1 p -113.13 -171.34 1.85 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 128.009 2.523 . . . . 0.0 108.099 175.466 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.301 74.3 mt -82.26 -28.41 31.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 126.625 3.107 . . . . 0.0 113.649 176.006 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 p -123.87 68.02 1.04 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.87 3.268 . . . . 0.0 107.024 -175.848 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.53 101.67 1.22 Allowed Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 104.198 -3.561 . . . . 0.0 104.198 178.653 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -79.06 -33.23 44.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 129.014 3.42 . . . . 0.0 111.363 -179.425 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m -117.71 59.57 0.78 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 126.44 3.019 . . . . 0.0 106.396 -167.634 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 2.2 mt -80.81 116.01 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 118.558 -2.589 . . . . 0.0 106.613 170.102 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.86 119.59 39.23 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 118.293 -2.754 . . . . 0.0 105.902 -169.986 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.447 HD23 ' CG1' ' A' ' 17' ' ' VAL . 8.7 tp -115.81 136.15 53.32 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 129.744 3.218 . . . . 0.0 108.746 172.657 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.259 10.1 tp10 -92.17 114.41 26.94 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 167.169 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG1' HD23 ' A' ' 15' ' ' LEU . 18.1 m -108.75 -167.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 126.18 1.792 . . . . 0.0 110.854 168.999 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -139.47 140.65 26.12 Favored Pre-proline 0 N--CA 1.45 -0.462 1 C-N-CA 131.92 4.088 . . . . 0.0 107.578 171.62 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -43.54 -47.4 9.39 Favored 'Trans proline' 0 N--CA 1.445 -1.334 1 C-N-CA 126.079 4.519 . . . . 0.0 118.876 171.282 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.264 77.9 p -91.75 18.72 7.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.304 1.842 . . . . 0.0 107.2 -176.828 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -79.0 144.94 34.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 123.439 2.836 . . . . 0.0 114.102 169.978 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -92.77 153.48 18.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 117.421 -3.299 . . . . 0.0 111.038 -178.884 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 6.3 mm -57.99 -26.1 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 118.675 -2.516 . . . . 0.0 114.713 -176.046 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -82.22 -18.31 43.03 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.787 1.635 . . . . 0.0 108.31 -170.395 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -83.78 -35.28 24.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.582 2.353 . . . . 0.0 107.948 178.905 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.95 -51.63 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 128.495 2.718 . . . . 0.0 107.538 177.288 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 38.4 mtmt -59.01 -39.28 81.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 120.075 3.361 . . . . 0.0 120.075 173.526 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -26.9 68.5 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.705 3.602 . . . . 0.0 113.331 160.792 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -77.58 -47.49 19.28 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 121.681 2.037 . . . . 0.0 113.011 172.768 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 30' ' ' ILE 0.321 92.1 mt -54.15 -46.19 66.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 131.009 3.723 . . . . 0.0 112.811 174.264 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -60.25 -20.23 58.09 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 118.753 -2.467 . . . . 0.0 116.138 -177.75 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.278 3.7 t70 -94.2 -36.89 11.83 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 -178.546 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -70.95 -55.1 9.09 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.506 178.364 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -117.47 -21.43 8.63 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 118.355 -2.716 . . . . 0.0 108.662 -166.352 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.4 10.7 28.87 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 117.183 -3.448 . . . . 0.0 114.014 164.379 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.92 120.89 57.54 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 -165.709 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -77.98 154.19 29.41 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 O-C-N 116.322 -2.515 . . . . 0.0 112.402 -173.119 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -73.98 -33.27 6.28 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.076 1.851 . . . . 0.0 112.557 -153.921 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -73.91 -19.7 60.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 124.739 1.274 . . . . 0.0 112.932 177.532 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -90.89 -16.49 28.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.638 2.375 . . . . 0.0 110.572 -179.404 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -89.11 129.45 35.72 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 129.124 2.969 . . . . 0.0 112.452 -179.704 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -119.78 155.78 31.86 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 173.791 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.06 144.33 51.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 120.15 -1.594 . . . . 0.0 111.739 178.074 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 44' ' ' ILE . 84.9 mt -131.43 143.76 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 122.844 2.565 . . . . 0.0 113.881 176.048 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -151.9 123.58 7.93 Favored 'General case' 0 N--CA 1.451 -0.388 1 C-N-CA 132.087 4.155 . . . . 0.0 113.461 171.541 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.27 37.56 4.21 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 119.651 3.204 . . . . 0.0 119.651 -175.784 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.75 -0.24 57.84 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 117.038 -3.539 . . . . 0.0 112.607 171.425 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -113.53 138.72 49.73 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 122.976 3.388 . . . . 0.0 105.15 -178.767 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.293 24.3 tt0 -98.0 125.07 42.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.308 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.14 131.14 44.87 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.89 -168.392 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -104.31 154.72 19.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 127.008 3.29 . . . . 0.0 113.726 -172.93 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -45.75 127.75 8.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 117.438 -3.289 . . . . 0.0 115.505 177.509 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.16 -2.38 61.33 Favored Glycine 0 CA--C 1.536 1.368 1 CA-C-N 127.362 4.619 . . . . 0.0 112.485 163.636 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.263 25.9 mmt-85 -100.06 172.88 6.92 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 127.188 3.375 . . . . 0.0 106.931 -173.138 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -119.69 -178.63 3.67 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 116.551 -3.843 . . . . 0.0 113.02 168.394 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD22 ' H ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -50.83 -44.42 59.32 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 131.032 3.733 . . . . 0.0 112.825 162.811 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.5 m -72.22 -33.68 67.77 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.367 2.667 . . . . 0.0 111.404 -170.897 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -66.98 -38.9 86.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 124.731 2.205 . . . . 0.0 111.34 -178.264 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -91.15 0.62 57.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 117.146 -3.471 . . . . 0.0 116.042 176.425 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.256 13.3 m120 71.52 53.13 0.23 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 130.383 3.473 . . . . 0.0 110.638 -178.206 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.9 mt -103.03 140.41 21.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 -174.306 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -106.84 149.0 27.85 Favored 'General case' 0 N--CA 1.451 -0.397 1 C-N-CA 131.936 4.094 . . . . 0.0 115.674 -169.074 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.77 128.53 30.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 124.351 1.032 . . . . 0.0 112.705 162.065 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.277 29.3 tt0 87.05 21.89 0.06 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.839 2.856 . . . . 0.0 110.209 174.253 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.9 m -71.63 141.84 49.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.216 1.806 . . . . 0.0 114.475 175.716 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.279 97.6 m -100.69 126.74 47.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 115.279 -2.296 . . . . 0.0 104.89 165.58 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.08 173.47 13.36 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 130.781 3.632 . . . . 0.0 107.2 177.651 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -127.45 134.13 49.87 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.443 2.297 . . . . 0.0 112.991 -156.548 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.425 ' HB3' HG22 ' A' ' 7' ' ' THR . 3.6 tt -108.29 139.28 43.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 125.336 2.493 . . . . 0.0 107.752 173.621 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 t -130.55 134.53 62.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 129.846 3.258 . . . . 0.0 106.722 -178.144 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -97.14 134.43 40.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 172.338 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -95.7 81.19 3.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 125.812 2.72 . . . . 0.0 109.807 -174.761 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.11 -22.81 22.69 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 109.864 -3.335 . . . . 0.0 113.77 167.575 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.1 ptt-85 -136.57 167.13 21.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.411 1.884 . . . . 0.0 115.038 167.874 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.25 169.19 14.35 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 128.637 3.711 . . . . 0.0 110.066 167.541 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 1 CA-C-O 112.726 -4.374 . . . . 0.0 116.905 165.6 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.374 0.6 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 . . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -91.82 129.28 37.81 Favored 'General case' 0 N--CA 1.447 -0.591 1 C-N-CA 133.927 4.891 . . . . 0.0 107.213 -179.622 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.629 HD12 HD22 ' A' ' 67' ' ' LEU . 28.5 pt -119.08 156.69 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 128.01 3.319 . . . . 0.0 106.167 154.01 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -95.35 133.86 38.8 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.579 1.552 . . . . 0.0 107.239 166.279 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.57 125.55 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 1 N-CA-C 97.321 -5.066 . . . . 0.0 97.321 175.293 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -103.04 127.05 50.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 127.059 3.314 . . . . 0.0 107.707 173.977 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -89.76 145.03 25.48 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 126.021 2.82 . . . . 0.0 106.102 -176.178 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.35 -27.89 68.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.706 -2.043 . . . . 0.0 116.241 178.561 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 p -76.72 -7.47 55.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.081 2.553 . . . . 0.0 116.94 173.274 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.05 10.15 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 129.922 3.629 . . . . 0.0 114.694 166.303 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 47.1 tttt -70.39 149.57 47.16 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 121.939 2.869 . . . . 0.0 110.758 -178.556 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.1 m -104.24 141.75 35.74 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.717 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.401 0.1 OUTLIER -125.08 135.17 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 126.516 3.055 . . . . 0.0 112.789 163.173 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 m -75.66 137.5 40.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 117.65 -3.156 . . . . 0.0 104.482 174.085 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -138.41 120.14 15.22 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 175.833 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.286 25.4 mt-10 -70.39 131.92 44.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 126.949 2.656 . . . . 0.0 111.724 170.527 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 m -148.99 164.34 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 127.886 2.474 . . . . 0.0 106.787 -173.794 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -123.47 155.99 64.78 Favored Pre-proline 0 N--CA 1.449 -0.52 0 O-C-N 117.624 -3.173 . . . . 0.0 109.419 165.49 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.72 -37.67 35.67 Favored 'Trans proline' 0 N--CA 1.451 -0.997 1 C-N-CA 127.152 5.235 . . . . 0.0 116.008 179.203 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.8 p -81.27 -13.46 58.45 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 112.563 -2.108 . . . . 0.0 112.757 -179.624 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -67.02 155.84 37.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 121.103 1.774 . . . . 0.0 109.951 170.663 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -121.8 139.86 53.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 130.287 3.435 . . . . 0.0 111.248 -161.178 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -46.23 -24.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 O-C-N 116.595 -3.816 . . . . 0.0 116.895 176.243 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -68.74 -54.4 16.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.904 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -62.42 -37.43 85.79 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 119.593 3.183 . . . . 0.0 119.593 -173.353 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.282 76.1 t -50.71 -43.98 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 129.498 3.119 . . . . 0.0 113.804 170.605 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.355 40.0 mtmt -50.78 -43.69 58.59 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.766 2.027 . . . . 0.0 112.598 172.251 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.32 -33.65 28.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 125.982 2.051 . . . . 0.0 114.649 -176.619 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -55.41 -31.9 62.23 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 125.334 2.492 . . . . 0.0 115.215 173.003 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.8 mt -75.63 -21.11 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 113.421 -1.718 . . . . 0.0 113.156 172.147 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -70.56 -43.34 69.68 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 122.572 2.442 . . . . 0.0 107.715 173.225 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.53 -29.04 67.61 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 118.926 -2.358 . . . . 0.0 112.417 176.942 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -97.19 -57.21 2.32 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 175.617 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 11' ' ' LYS . 28.6 mm-40 -92.64 -22.7 19.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.151 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.62 -18.39 22.54 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 130.672 3.987 . . . . 0.0 112.326 171.426 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.3 mt -71.2 122.98 88.59 Favored Pre-proline 0 N--CA 1.445 -0.686 0 C-N-CA 127.882 2.473 . . . . 0.0 106.185 -159.604 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.0 137.8 27.22 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.872 2.382 . . . . 0.0 109.973 172.423 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -40.73 -45.29 4.76 Favored 'Trans proline' 0 N--CA 1.454 -0.804 1 C-N-CA 126.442 4.761 . . . . 0.0 114.786 -175.654 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.257 12.6 t70 -31.76 -41.75 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 127.104 2.752 . . . . 0.0 117.943 170.762 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -96.84 -16.76 20.6 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -170.349 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -97.49 140.88 31.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 127.479 2.987 . . . . 0.0 111.746 -178.593 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -125.23 128.21 47.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 116.74 -1.6 . . . . 0.0 108.325 174.146 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.78 140.82 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.085 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.3 pt -141.91 144.36 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 131.587 3.955 . . . . 0.0 111.114 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -146.16 130.34 17.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 111.566 -2.561 . . . . 0.0 107.627 172.265 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.79 17.91 8.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.264 1.826 . . . . 0.0 115.308 168.694 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.39 -26.66 12.76 Favored Glycine 0 CA--C 1.528 0.88 1 C-N-CA 131.95 4.595 . . . . 0.0 112.501 -169.253 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.303 38.4 mttt -68.24 129.89 41.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.807 0.804 . . . . 0.0 111.278 -170.982 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.316 78.0 mt-30 -66.06 115.05 5.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 163.708 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.97 121.96 29.34 Favored 'General case' 0 C--O 1.239 0.52 1 O-C-N 116.156 -4.09 . . . . 0.0 110.139 -175.746 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.47 148.15 24.31 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 129.702 3.201 . . . . 0.0 111.293 -165.08 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -74.93 123.72 25.61 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.667 2.387 . . . . 0.0 108.323 -166.606 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.06 60.33 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 128.814 3.102 . . . . 0.0 116.215 174.1 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -80.58 143.61 33.05 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 128.214 2.606 . . . . 0.0 109.511 173.663 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -77.0 151.81 35.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 128.589 2.755 . . . . 0.0 110.655 177.977 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -59.71 -25.29 64.68 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 127.522 2.329 . . . . 0.0 114.678 161.546 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -74.46 -23.05 58.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 130.2 3.4 . . . . 0.0 112.812 166.229 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -89.53 -16.92 29.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 121.655 2.025 . . . . 0.0 109.387 178.806 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -96.81 -3.51 42.08 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 115.886 -2.007 . . . . 0.0 111.512 171.731 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 t30 62.35 37.86 13.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 171.835 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.7 mt -94.57 127.99 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 -172.19 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -99.44 175.56 5.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.789 2.036 . . . . 0.0 111.224 -176.247 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 144.0 57.45 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 130.97 3.708 . . . . 0.0 110.708 179.057 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.323 3.0 pt-20 60.68 13.17 4.12 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 131.562 3.945 . . . . 0.0 116.874 -179.374 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.0 m -67.33 144.77 55.67 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 126.709 2.506 . . . . 0.0 111.701 166.084 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.0 m -86.31 108.81 18.58 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.257 1.423 . . . . 0.0 109.074 174.788 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.629 HD22 HD12 ' A' ' 3' ' ' ILE . 11.0 mp -83.89 150.43 25.72 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 123.029 1.395 . . . . 0.0 113.36 156.785 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.265 75.2 m80 -104.02 144.07 32.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.443 -1.411 . . . . 0.0 111.303 176.714 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 tt -128.55 120.99 27.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 113.61 -3.09 . . . . 0.0 109.51 -177.813 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.99 133.34 44.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 127.782 2.433 . . . . 0.0 106.718 -175.532 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.274 73.6 mt -80.63 148.92 30.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.841 1.657 . . . . 0.0 111.678 171.895 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -81.52 -15.29 55.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 115.122 -2.37 . . . . 0.0 108.762 171.106 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.82 147.95 39.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 123.026 2.648 . . . . 0.0 110.888 -175.681 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.82 -54.46 0.93 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 121.329 1.877 . . . . 0.0 107.077 169.272 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.72 136.66 6.46 Favored Glycine 0 CA--C 1.531 1.068 1 C-N-CA 130.986 4.136 . . . . 0.0 109.781 -166.228 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.083 0 C-N-CA 120.182 -1.008 . . . . 0.0 111.404 176.13 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ttt . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 116.021 1.859 . . . . 0.0 116.021 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.426 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 96.1 mt-30 -106.61 165.96 10.91 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.103 1.761 . . . . 0.0 113.241 -176.831 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -122.75 165.02 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 127.531 2.332 . . . . 0.0 108.858 152.662 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -112.18 125.44 54.14 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 126.646 2.466 . . . . 0.0 112.414 -172.253 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.74 91.35 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 101.664 -3.458 . . . . 0.0 101.664 176.869 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -68.27 145.8 53.91 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 114.277 -2.773 . . . . 0.0 112.855 167.32 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -155.06 171.5 19.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 124.963 3.528 . . . . 0.0 111.792 170.526 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 mt -68.75 -17.49 64.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 130.057 3.343 . . . . 0.0 116.913 -164.585 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.6 p -74.14 -7.77 53.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 173.588 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.71 -20.81 44.71 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 116.674 1.43 . . . . 0.0 116.674 -179.147 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -76.9 152.71 35.26 Favored 'General case' 0 N--CA 1.447 -0.585 1 C-N-CA 132.25 4.22 . . . . 0.0 104.348 -176.21 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.289 75.7 m -122.68 147.79 46.05 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 118.937 -2.352 . . . . 0.0 112.3 161.765 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mt -120.88 154.39 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 131.685 3.994 . . . . 0.0 107.056 -178.013 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 p -127.47 135.9 51.03 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 128.174 2.59 . . . . 0.0 110.721 -165.682 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.7 mt -130.6 117.43 19.52 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 126.418 2.324 . . . . 0.0 107.679 -179.668 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HG3' ' HG2' ' A' ' 2' ' ' GLN . 31.5 mp0 -90.66 108.77 20.02 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.131 2.172 . . . . 0.0 106.26 169.117 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.0 161.33 32.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 1 C-N-CA 134.413 5.085 . . . . 0.0 108.77 -170.326 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 53.9 mm-40 -126.16 152.32 73.25 Favored Pre-proline 0 N--CA 1.442 -0.867 0 C-N-CA 131.589 3.956 . . . . 0.0 110.045 175.486 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 66.3 Cg_exo -47.35 -48.97 13.91 Favored 'Trans proline' 0 N--CA 1.456 -0.685 1 C-N-CA 126.523 4.815 . . . . 0.0 114.232 -167.368 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -61.66 -15.77 42.87 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 119.104 3.001 . . . . 0.0 119.104 -176.879 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.42 120.58 9.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.942 170.797 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 p -65.79 136.28 55.99 Favored 'General case' 0 N--CA 1.447 -0.578 1 C-N-CA 135.521 5.528 . . . . 0.0 110.266 161.377 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mm -59.99 -31.7 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 114.882 -2.485 . . . . 0.0 114.527 -174.71 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -48.7 -36.48 16.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.103 2.561 . . . . 0.0 114.73 169.743 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -82.79 -39.28 21.98 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 125.343 1.652 . . . . 0.0 108.937 -172.866 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.32 4.5 t -67.95 -36.58 76.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 112.982 -3.39 . . . . 0.0 115.678 172.705 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -58.94 -46.84 87.02 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 129.6 3.16 . . . . 0.0 107.301 177.889 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.91 -18.69 61.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.867 3.267 . . . . 0.0 118.184 172.351 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -49.57 63.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 118.24 -2.787 . . . . 0.0 113.112 160.551 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -68.32 -38.66 79.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 127.832 2.453 . . . . 0.0 107.397 -169.667 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.41 -65.61 0.53 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.489 1.115 . . . . 0.0 111.071 160.529 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.253 35.0 t70 -43.28 -38.29 2.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 129.612 3.165 . . . . 0.0 114.086 179.68 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -80.28 -45.64 17.54 Favored 'General case' 0 CA--C 1.535 0.39 1 C-N-CA 131.964 4.106 . . . . 0.0 120.658 171.619 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -123.69 -20.43 5.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 126.057 2.837 . . . . 0.0 112.988 -166.468 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.73 28.8 22.99 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 118.035 -2.916 . . . . 0.0 115.983 170.035 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 tt -106.27 111.6 64.2 Favored Pre-proline 0 N--CA 1.446 -0.654 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 -175.213 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.32 151.87 23.34 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 125.163 3.909 . . . . 0.0 109.512 -174.789 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -47.86 -38.2 30.12 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 112.135 -3.36 . . . . 0.0 115.182 -166.795 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -13.91 2.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 127.676 3.11 . . . . 0.0 116.579 175.919 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -116.72 -7.4 11.52 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.039 2.535 . . . . 0.0 110.418 -176.2 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.277 80.0 mt-30 -87.67 145.36 26.2 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 117.866 -3.021 . . . . 0.0 105.656 175.709 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -124.64 128.13 48.39 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 129.037 2.935 . . . . 0.0 106.747 161.711 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -119.92 104.57 10.29 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 112.405 -3.664 . . . . 0.0 110.002 -160.941 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.65 131.52 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 1 CA-C-N 126.011 4.005 . . . . 0.0 108.798 -163.26 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -111.43 113.41 25.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.435 1.894 . . . . 0.0 112.202 164.207 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.8 -92.1 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 131.051 3.74 . . . . 0.0 110.51 -166.068 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.16 1.63 5.4 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 113.85 -1.523 . . . . 0.0 116.044 169.961 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -95.98 128.87 43.26 Favored 'General case' 0 CA--C 1.541 0.6 1 C-N-CA 132.031 4.132 . . . . 0.0 104.951 -174.168 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.371 18.6 mp0 -77.77 138.87 39.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.451 3.901 . . . . 0.0 107.903 178.178 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.455 ' HG ' ' CE2' ' A' ' 59' ' ' TYR . 8.1 mp -94.42 153.98 17.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.317 2.008 . . . . 0.0 107.315 172.544 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -135.23 144.25 46.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 112.257 -2.247 . . . . 0.0 108.648 164.555 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -49.15 146.88 3.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.671 2.388 . . . . 0.0 115.649 169.468 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.94 16.49 28.1 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-O 116.092 -2.504 . . . . 0.0 111.292 -169.289 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -145.92 158.26 43.87 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 127.512 3.53 . . . . 0.0 102.759 171.599 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -103.21 173.99 6.06 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 116.671 -3.768 . . . . 0.0 110.27 177.678 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.98 -36.46 83.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 117.994 -2.941 . . . . 0.0 106.83 176.59 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 t -64.91 -45.18 86.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.691 0.62 . . . . 0.0 112.444 175.95 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.63 -46.43 70.48 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.809 178.239 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 39.7 m-85 -75.41 -10.51 59.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 123.454 1.597 . . . . 0.0 113.629 -175.894 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.4 t30 66.32 45.95 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.516 3.526 . . . . 0.0 114.412 -173.069 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -90.21 142.82 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 O-C-N 126.577 2.423 . . . . 0.0 106.469 -178.264 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -137.12 177.99 7.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 178.196 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -49.03 116.85 1.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.665 2.386 . . . . 0.0 112.547 -176.0 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.457 21.4 mp0 79.74 23.52 0.47 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 130.298 3.439 . . . . 0.0 112.759 168.732 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 m -71.19 150.05 45.72 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.225 1.81 . . . . 0.0 111.012 169.175 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 m -98.9 130.52 45.3 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 119.161 -2.212 . . . . 0.0 109.429 162.386 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -109.62 141.05 42.7 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 114.914 -2.47 . . . . 0.0 108.876 167.441 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.355 23.2 t60 -100.94 164.06 12.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 121.603 2.001 . . . . 0.0 115.711 178.67 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.253 0.4 OUTLIER -141.11 136.7 32.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 129.14 2.976 . . . . 0.0 107.544 -175.841 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.65 118.69 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 O-C-N 126.791 2.557 . . . . 0.0 105.717 -176.492 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.89 145.03 26.84 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 128.682 3.738 . . . . 0.0 108.222 171.886 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -77.59 119.15 20.74 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 126.609 2.443 . . . . 0.0 105.876 171.257 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.8 163.98 20.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 178.252 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -104.36 -37.69 7.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.866 -171.775 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.42 -168.94 15.58 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 126.337 2.273 . . . . 0.0 110.363 -177.683 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 N-CA-C 107.852 -2.099 . . . . 0.0 107.852 -166.417 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.259 9.5 ptt? . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -74.36 146.31 43.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 118.45 -2.656 . . . . 0.0 117.196 169.187 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.336 44.5 pt -130.85 133.92 62.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 115.256 -2.307 . . . . 0.0 107.846 166.788 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -117.64 107.83 14.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -177.644 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 67' ' ' LEU . 22.0 t -108.28 120.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.972 2.509 . . . . 0.0 105.046 -170.132 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -96.08 150.12 20.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 128.67 3.731 . . . . 0.0 112.502 178.327 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -113.96 138.14 50.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 160.667 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -53.37 -36.13 61.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -174.864 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.9 p -73.48 -11.4 60.44 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 130.038 3.335 . . . . 0.0 113.263 -175.587 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.92 54.08 0.32 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 126.992 2.234 . . . . 0.0 113.973 168.872 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -141.27 143.93 34.38 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 121.372 2.586 . . . . 0.0 111.052 166.355 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -123.97 117.07 23.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 167.323 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.9 mm -80.74 118.23 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 160.779 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -92.36 128.39 38.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 164.368 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -125.07 140.32 53.0 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.066 -2.271 . . . . 0.0 107.327 178.488 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -92.75 131.36 37.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 126.898 2.624 . . . . 0.0 110.905 162.112 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.5 m -134.97 160.02 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 127.522 2.329 . . . . 0.0 111.153 179.25 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.281 20.5 mm-40 -76.18 149.34 82.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 115.778 -2.058 . . . . 0.0 111.869 156.465 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -24.56 72.26 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 CA-C-N 123.915 2.434 . . . . 0.0 114.796 176.418 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -101.61 20.85 15.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.871 2.868 . . . . 0.0 112.354 177.617 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 11.2 t0 -82.92 155.35 24.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 118.117 -2.864 . . . . 0.0 110.699 169.142 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 p -81.01 152.74 27.79 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.966 -169.744 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.9 mm -67.11 -12.68 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 120.483 -1.386 . . . . 0.0 111.2 167.843 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -71.22 -45.89 62.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 120.725 -1.234 . . . . 0.0 111.374 169.398 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -53.17 -34.05 55.21 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 175.403 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.95 -40.57 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 117.827 -1.083 . . . . 0.0 108.543 179.242 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -70.63 -37.87 73.83 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 121.867 2.121 . . . . 0.0 111.12 -179.91 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.52 87.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 115.265 -2.303 . . . . 0.0 111.814 178.153 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.372 54.6 mttm -76.83 -31.21 56.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.472 1.509 . . . . 0.0 113.056 172.925 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.42 ' CG2' HD11 ' A' ' 36' ' ' ILE . 34.8 mt -70.77 -37.89 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 1 O-C-N 115.737 -4.352 . . . . 0.0 109.292 174.117 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -54.56 -37.8 65.88 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 122.759 2.527 . . . . 0.0 117.744 160.572 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.44 -39.75 94.42 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.16 -2.291 . . . . 0.0 115.416 -179.95 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -86.68 -69.11 0.7 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.38 2.272 . . . . 0.0 107.157 -174.225 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -83.42 -15.82 48.24 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 125.945 2.028 . . . . 0.0 114.341 -161.554 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.25 8.62 68.3 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 117.276 -3.39 . . . . 0.0 115.8 175.708 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.42 HD11 ' CG2' ' A' ' 30' ' ' ILE . 5.2 pt -99.8 123.61 46.94 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-O 113.426 -3.178 . . . . 0.0 112.455 -168.844 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.72 137.27 71.99 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 127.587 3.745 . . . . 0.0 110.968 -179.136 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -64.78 -8.91 19.1 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.801 2.334 . . . . 0.0 113.608 177.683 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -75.73 -12.5 60.2 Favored 'General case' 0 N--CA 1.452 -0.341 1 CA-C-N 127.09 4.495 . . . . 0.0 109.086 172.246 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -87.99 -22.02 24.5 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 127.661 2.384 . . . . 0.0 112.909 -178.85 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HB3' HD11 ' A' ' 69' ' ' LEU . 56.9 mt-30 -95.81 131.47 42.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 130.717 3.607 . . . . 0.0 103.232 -165.234 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.287 17.1 mtp180 -126.46 111.01 13.93 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.915 2.086 . . . . 0.0 108.432 170.993 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -94.4 133.16 38.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 117.205 -3.434 . . . . 0.0 114.698 -172.652 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 tt -144.37 136.74 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 128.768 2.827 . . . . 0.0 110.254 -155.288 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -140.79 138.23 33.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.631 1.832 . . . . 0.0 112.24 172.832 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.59 35.01 7.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.049 2.939 . . . . 0.0 115.276 170.184 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.42 -23.88 31.71 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.875 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -103.07 125.11 49.65 Favored 'General case' 0 C--N 1.324 -0.52 1 O-C-N 115.655 -4.438 . . . . 0.0 109.026 -160.849 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.446 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 2.4 pm0 -85.04 126.65 33.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 127.291 2.87 . . . . 0.0 105.644 174.929 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -96.25 128.05 42.81 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 125.565 1.791 . . . . 0.0 109.463 -163.062 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -72.46 130.23 40.2 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -178.29 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -62.12 123.57 18.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 129.797 3.239 . . . . 0.0 112.299 -173.362 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.97 -6.06 51.05 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 112.117 -2.31 . . . . 0.0 114.807 173.239 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -72.77 163.81 27.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.25 1.025 . . . . 0.0 112.539 167.003 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -99.43 154.09 18.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 123.848 1.785 . . . . 0.0 114.433 174.311 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.375 11.5 mt -53.99 -48.87 69.95 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 116.775 -3.703 . . . . 0.0 110.53 -173.953 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.279 33.0 t -57.62 -47.07 83.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.782 2.033 . . . . 0.0 110.401 -177.719 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -70.37 -22.59 62.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.141 0.976 . . . . 0.0 110.733 -169.976 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.29 -3.09 54.17 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 131.131 3.772 . . . . 0.0 113.631 170.06 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.443 11.8 m120 80.94 21.86 0.38 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 130.191 3.396 . . . . 0.0 116.314 173.695 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.9 mt -83.07 112.73 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 117.02 -3.55 . . . . 0.0 106.949 171.757 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.84 178.57 5.73 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.563 2.745 . . . . 0.0 112.646 -178.692 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -54.63 137.13 44.44 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.929 1.292 . . . . 0.0 111.995 171.048 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 69.12 23.1 6.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 131.694 3.998 . . . . 0.0 112.521 175.575 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.3 m -82.63 138.14 34.28 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 117.332 -3.355 . . . . 0.0 105.804 -169.38 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.74 133.36 42.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.469 -179.664 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' CD2' HG22 ' A' ' 5' ' ' VAL 0.3 0.0 OUTLIER -149.77 -155.54 0.64 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.556 1.071 . . . . 0.0 110.538 172.603 . . . . . . . . 4 4 . 1 . 046 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -158.17 170.21 22.79 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -168.912 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 41' ' ' GLN . 22.2 tp -129.32 144.81 51.37 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 128.541 3.65 . . . . 0.0 105.059 -178.173 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -119.58 124.39 72.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 127.961 3.288 . . . . 0.0 109.691 168.591 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 mt -87.32 128.18 35.18 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.8 2.04 . . . . 0.0 108.506 172.209 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.251 18.6 tpt180 -158.02 126.93 5.65 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 130.158 3.383 . . . . 0.0 108.425 -166.315 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.2 tp -83.77 144.86 29.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.292 2.237 . . . . 0.0 106.254 171.65 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.1 ttm105 -77.54 145.39 36.95 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.636 2.774 . . . . 0.0 110.115 175.787 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.02 -153.1 15.32 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 118.404 -2.685 . . . . 0.0 110.271 -178.081 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.883 0 C-N-CA 118.205 -1.95 . . . . 0.0 109.003 -179.666 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.1 ttp . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 113.298 -3.239 . . . . 0.0 107.17 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.18 133.04 52.99 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 126.357 2.285 . . . . 0.0 114.266 170.552 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.54 -176.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 119.162 -2.211 . . . . 0.0 109.083 159.109 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -135.38 162.93 31.22 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.107 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.457 ' HB ' HD23 ' A' ' 15' ' ' LEU . 12.3 t -134.57 112.44 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 130.023 3.329 . . . . 0.0 106.228 -176.319 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -94.98 120.97 36.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 171.186 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -67.82 167.18 13.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 112.65 -2.068 . . . . 0.0 110.816 172.645 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.611 HD21 ' H ' ' A' ' 71' ' ' LEU . 4.3 mp -64.57 -35.42 80.92 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 119.297 -2.127 . . . . 0.0 113.76 176.891 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.319 17.7 p -67.73 -51.14 52.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.433 2.293 . . . . 0.0 109.383 173.544 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.89 31.15 0.6 Allowed Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.333 -1.26 . . . . 0.0 115.364 174.7 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -86.21 131.51 34.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 122.736 3.268 . . . . 0.0 109.929 160.883 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -105.1 85.47 2.28 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.104 1.361 . . . . 0.0 108.862 -175.458 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.275 3.9 mt -87.48 141.13 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 -174.216 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 m -74.63 143.4 44.35 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 169.987 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.457 HD23 ' HB ' ' A' ' 5' ' ' VAL . 2.4 mm? -125.52 127.76 46.93 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 118.057 -2.902 . . . . 0.0 104.636 -175.089 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -80.86 115.05 20.15 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 130.974 3.71 . . . . 0.0 107.829 172.465 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.9 172.77 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.669 1.188 . . . . 0.0 108.58 -176.446 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -133.05 148.7 70.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 131.5 3.92 . . . . 0.0 113.75 148.895 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.32 93.5 Cg_endo -51.03 -15.78 2.17 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 O-C-N 124.904 2.002 . . . . 0.0 116.324 -177.444 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -92.4 -1.82 56.75 Favored 'General case' 0 N--CA 1.452 -0.336 1 O-C-N 115.539 -4.476 . . . . 0.0 115.599 174.327 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.253 72.0 m-20 -81.05 131.18 35.29 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.176 -1.41 . . . . 0.0 111.451 177.176 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -69.51 160.33 31.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.838 0.855 . . . . 0.0 111.044 179.664 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.512 HD12 HD13 ' A' ' 50' ' ' LEU . 17.6 mm -61.08 -34.74 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 129.036 2.934 . . . . 0.0 106.766 175.99 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.81 -58.98 5.53 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 127.969 2.508 . . . . 0.0 111.499 175.224 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -51.77 -45.93 63.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.712 2.508 . . . . 0.0 113.931 169.367 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.58 -48.07 88.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 O-C-N 124.988 1.43 . . . . 0.0 112.838 174.644 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HG3' HD12 ' A' ' 43' ' ' LEU . 20.1 mtmt -57.43 -35.6 70.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.858 -3.026 . . . . 0.0 113.678 170.282 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.57 81.29 Favored 'General case' 0 N--CA 1.452 -0.355 1 CA-C-O 111.302 -4.19 . . . . 0.0 109.976 174.433 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -67.59 -29.76 69.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 124.042 3.11 . . . . 0.0 111.568 -179.834 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 mt -81.48 -16.21 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 126.928 2.091 . . . . 0.0 110.912 -175.67 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -70.01 -49.0 55.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 117.52 -3.238 . . . . 0.0 115.488 156.525 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -49.17 -61.29 2.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.573 1.949 . . . . 0.0 115.785 170.374 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -63.23 -46.27 87.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 130.388 3.475 . . . . 0.0 114.758 -177.189 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -138.87 -21.82 0.97 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.079 1.752 . . . . 0.0 111.019 -154.99 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.99 1.34 54.96 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 122.091 2.223 . . . . 0.0 109.458 166.972 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -81.55 117.27 67.55 Favored Pre-proline 0 N--CA 1.445 -0.675 0 O-C-N 117.163 -3.551 . . . . 0.0 103.909 179.887 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -74.13 164.29 34.67 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.433 2.089 . . . . 0.0 112.0 -172.023 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.252 37.9 Cg_endo -73.67 -37.94 2.73 Favored 'Trans proline' 0 N--CA 1.446 -1.309 1 C-N-CA 126.275 4.65 . . . . 0.0 109.835 -177.401 . . . . . . . . 3 2 . 1 . 047 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 40' ' ' GLN . 48.2 t0 -80.12 143.75 33.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.501 2.321 . . . . 0.0 108.873 170.518 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 39' ' ' ASP . 4.1 mp0 90.05 -31.04 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.206 1.002 . . . . 0.0 109.247 179.304 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -91.1 141.63 28.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.07 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -119.95 129.69 54.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 128.134 2.573 . . . . 0.0 110.989 172.243 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.448 HD12 ' HG3' ' A' ' 27' ' ' LYS . 94.1 mt -99.24 151.09 21.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 117.656 -3.152 . . . . 0.0 111.341 164.854 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mt -127.11 156.2 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 170.302 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -126.07 136.97 53.56 Favored 'General case' 0 N--CA 1.447 -0.625 1 C-N-CA 133.836 4.855 . . . . 0.0 108.789 157.043 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.49 -100.49 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 128.904 3.877 . . . . 0.0 108.776 179.021 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.37 -2.07 3.38 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 105.704 -2.958 . . . . 0.0 105.704 168.691 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -79.93 114.98 19.26 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 118.208 -2.936 . . . . 0.0 105.134 -173.348 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -64.93 126.36 27.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 122.982 1.372 . . . . 0.0 109.08 159.907 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.512 HD13 HD12 ' A' ' 23' ' ' ILE . 16.9 mt -90.79 141.8 28.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 124.167 1.937 . . . . 0.0 109.846 177.152 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -91.74 143.59 26.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.975 2.51 . . . . 0.0 109.342 170.75 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -49.51 -44.05 45.97 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 129.732 3.213 . . . . 0.0 112.836 -172.619 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.21 4.25 40.99 Favored Glycine 0 CA--C 1.531 1.062 1 O-C-N 115.423 -4.548 . . . . 0.0 112.788 -163.837 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -76.84 160.17 29.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 120.176 1.988 . . . . 0.0 112.103 164.096 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -97.93 162.35 13.29 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 127.174 2.796 . . . . 0.0 104.811 175.007 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 18.7 mt -42.5 -42.9 3.47 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.651 1.98 . . . . 0.0 109.721 157.736 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.3 t -69.02 -28.14 66.3 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 127.455 2.302 . . . . 0.0 110.035 -169.989 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -75.9 -9.07 58.3 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 175.127 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -118.9 11.74 12.65 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.416 1.886 . . . . 0.0 114.052 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.91 29.02 18.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.808 2.043 . . . . 0.0 115.679 179.9 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.2 mt -96.33 105.04 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 124.25 1.976 . . . . 0.0 108.541 -170.077 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -89.43 178.55 6.29 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 120.01 -1.681 . . . . 0.0 113.074 163.482 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -60.46 161.45 7.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 129.936 3.295 . . . . 0.0 115.999 -167.426 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 74.96 2.89 4.09 Favored 'General case' 0 N--CA 1.443 -0.815 1 C-N-CA 133.559 4.743 . . . . 0.0 112.946 175.931 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -71.31 132.46 44.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.149 1.78 . . . . 0.0 113.232 -177.093 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 p -97.95 113.0 24.72 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 125.443 1.714 . . . . 0.0 108.343 -176.74 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.82 156.2 20.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.967 1.307 . . . . 0.0 110.66 173.193 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -127.19 119.72 27.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 124.389 2.043 . . . . 0.0 106.166 -174.581 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tt -91.2 120.31 32.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.518 3.127 . . . . 0.0 103.871 -174.728 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.32 131.02 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 112.302 -2.227 . . . . 0.0 106.371 170.459 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.611 ' H ' HD21 ' A' ' 8' ' ' LEU . 12.3 mt -98.33 126.26 43.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 175.181 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -63.4 -48.72 76.65 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 128.69 2.796 . . . . 0.0 113.759 172.448 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.0 mt -145.04 173.5 11.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 130.05 3.34 . . . . 0.0 105.816 177.833 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -69.33 134.99 49.77 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.087 1.755 . . . . 0.0 107.451 178.076 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.49 -34.8 0.48 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 115.565 -2.797 . . . . 0.0 111.999 179.693 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 116.407 -2.329 . . . . 0.0 114.604 179.393 . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 116.482 -1.723 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -65.77 132.38 48.6 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 125.01 1.444 . . . . 0.0 113.14 -171.487 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 pt -135.56 171.34 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 O-C-N 118.876 -2.39 . . . . 0.0 109.144 174.282 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -114.29 126.06 54.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 126.073 2.108 . . . . 0.0 109.156 170.848 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -110.26 147.61 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 163.777 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.274 62.4 tttt -126.6 125.02 41.24 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 131.439 3.896 . . . . 0.0 113.849 -174.286 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -102.74 162.79 12.64 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.81 1.644 . . . . 0.0 108.589 -173.599 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.873 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -77.83 -16.16 58.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 129.756 3.222 . . . . 0.0 116.891 -167.598 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 p -83.81 -0.9 52.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 164.035 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.3 27.4 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 127.432 2.444 . . . . 0.0 111.609 171.097 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -67.62 136.2 54.05 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 123.377 3.588 . . . . 0.0 115.935 -173.55 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 m -113.57 147.89 37.16 Favored 'General case' 0 C--N 1.325 -0.462 1 CA-C-O 129.069 4.271 . . . . 0.0 104.029 174.829 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.276 19.2 pt -127.64 114.8 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 109.367 -3.561 . . . . 0.0 110.102 178.451 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.4 p -84.94 108.84 17.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 101.807 -3.405 . . . . 0.0 101.807 177.283 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 pp -139.78 154.52 47.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 123.409 1.576 . . . . 0.0 111.28 170.011 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -84.47 133.57 34.47 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.518 2.327 . . . . 0.0 112.467 177.958 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.16 -153.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 168.399 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -151.08 158.83 34.5 Favored Pre-proline 0 N--CA 1.443 -0.794 0 C-N-CA 127.418 2.287 . . . . 0.0 106.556 -173.002 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.81 -32.91 35.69 Favored 'Trans proline' 0 N--CA 1.445 -1.333 1 C-N-CA 126.298 4.665 . . . . 0.0 115.951 174.871 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -99.11 3.99 46.8 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.885 2.874 . . . . 0.0 112.124 -171.981 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.64 145.73 29.5 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 121.311 1.869 . . . . 0.0 110.761 -179.081 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.7 p -85.6 162.68 18.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.577 2.351 . . . . 0.0 111.034 169.295 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.334 81.2 mt -53.16 -44.03 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 O-C-N 127.253 2.845 . . . . 0.0 115.871 178.501 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -49.67 -36.11 23.86 Favored 'General case' 0 C--N 1.33 -0.275 1 C-N-CA 132.255 4.222 . . . . 0.0 115.003 166.974 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -82.92 -11.97 57.73 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 126.462 1.905 . . . . 0.0 114.275 176.407 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -98.79 -41.07 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.006 1.322 . . . . 0.0 111.392 174.648 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -53.68 -45.01 70.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 128.991 2.916 . . . . 0.0 109.56 173.793 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.79 89.19 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 126.428 3.014 . . . . 0.0 111.78 -175.845 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -60.14 -44.33 95.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 131.629 3.972 . . . . 0.0 112.8 177.171 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.12 -37.56 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 179.764 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -65.35 -38.95 91.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 124.171 3.169 . . . . 0.0 112.919 179.43 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -59.53 -26.3 65.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 112.923 -3.418 . . . . 0.0 115.017 171.241 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -115.18 -28.18 7.03 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 122.117 2.235 . . . . 0.0 111.255 -163.191 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -126.06 -19.28 4.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.719 2.408 . . . . 0.0 114.605 -177.215 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.91 16.34 61.46 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 115.909 -2.606 . . . . 0.0 114.362 178.94 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.6 mt -87.73 123.7 68.75 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 123.066 3.433 . . . . 0.0 109.469 -163.213 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 13.9 Cg_endo -73.31 127.63 12.09 Favored 'Trans proline' 0 N--CA 1.453 -0.901 1 O-C-N 128.871 4.09 . . . . 0.0 111.334 -176.523 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 98.6 Cg_endo -82.36 -19.05 6.79 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.16 2.573 . . . . 0.0 115.047 -157.249 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.85 -28.28 65.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 115.829 -2.034 . . . . 0.0 110.858 176.604 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.77 9.39 16.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 127.77 3.169 . . . . 0.0 107.453 -164.577 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -110.9 142.34 43.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 123.394 1.569 . . . . 0.0 109.476 -170.403 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -126.67 122.36 34.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 130.593 3.557 . . . . 0.0 109.786 162.35 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.8 mt -110.05 115.59 30.04 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.643 3.177 . . . . 0.0 107.074 -168.399 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 49' ' ' GLN . 30.5 mm -97.88 129.35 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 127.823 2.449 . . . . 0.0 115.123 -178.653 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.257 63.8 t80 -143.41 128.68 18.82 Favored 'General case' 0 C--N 1.327 -0.394 1 O-C-N 114.484 -5.135 . . . . 0.0 110.428 168.945 . . . . . . . . 3 2 . 1 . 048 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.1 38.5 24.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 165.457 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.53 -11.39 7.99 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 116.762 -2.132 . . . . 0.0 115.016 164.069 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -149.47 170.98 17.33 Favored 'General case' 0 C--N 1.324 -0.513 1 C-N-CA 131.865 4.066 . . . . 0.0 114.466 -176.119 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.485 ' HA ' HD13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -54.61 132.73 45.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 128.91 2.884 . . . . 0.0 107.498 154.275 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 tp -66.75 138.44 57.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 112.067 -2.333 . . . . 0.0 106.394 165.787 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -51.13 145.92 7.13 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.438 1.895 . . . . 0.0 110.659 163.192 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -103.02 109.49 21.05 Favored 'General case' 0 N--CA 1.448 -0.568 1 N-CA-C 96.562 -5.347 . . . . 0.0 96.562 170.504 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.62 35.07 1.94 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.783 2.611 . . . . 0.0 116.694 178.707 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -133.09 132.74 42.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 115.927 -1.987 . . . . 0.0 110.043 171.014 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.0 p -75.67 150.57 37.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 125.154 2.406 . . . . 0.0 113.351 168.165 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -56.74 -35.68 68.87 Favored 'General case' 0 N--CA 1.441 -0.907 1 O-C-N 115.774 -4.329 . . . . 0.0 118.005 -159.428 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -75.85 -4.93 43.5 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 129.946 3.298 . . . . 0.0 112.628 176.64 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -77.11 -11.0 59.75 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 120.948 1.704 . . . . 0.0 111.758 169.774 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -113.09 159.12 19.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 129.296 3.038 . . . . 0.0 105.04 168.134 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -80.5 55.36 2.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.61 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -73.1 104.97 2.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 159.51 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.265 71.1 mm-40 -96.37 169.8 9.68 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 125.604 1.815 . . . . 0.0 114.35 170.49 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -46.84 130.88 12.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 119.946 -1.721 . . . . 0.0 112.372 166.251 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.31 8.1 mt-10 77.54 18.85 1.28 Allowed 'General case' 0 N--CA 1.451 -0.383 1 C-N-CA 133.484 4.714 . . . . 0.0 112.185 170.417 . . . . . . . . 3 2 . 1 . 048 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -74.26 148.03 41.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.958 179.165 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.9 m -95.9 104.44 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 102.183 -3.265 . . . . 0.0 102.183 -168.22 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.2 143.69 27.17 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.314 2.646 . . . . 0.0 108.057 166.944 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -124.29 136.65 54.29 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -174.878 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.93 121.59 45.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.908 2.083 . . . . 0.0 105.41 178.863 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 t -108.15 146.97 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.487 2.315 . . . . 0.0 106.443 170.984 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 tp -77.9 138.51 38.94 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 -175.11 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -90.28 113.62 25.5 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 119.732 -1.855 . . . . 0.0 107.361 163.846 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pp -61.86 159.59 13.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.89 2.476 . . . . 0.0 111.158 -175.712 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.4 mmt-85 -123.47 48.87 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 124.632 2.158 . . . . 0.0 108.498 173.241 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.97 12.37 34.5 Favored Glycine 0 CA--C 1.532 1.111 1 C-N-CA 131.661 4.458 . . . . 0.0 111.536 172.008 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.487 0 CA-C-O 114.656 -3.302 . . . . 0.0 111.311 -163.252 . . . . . . . . 0 0 . 1 . 049 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 122.407 1.098 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -79.12 135.24 36.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.528 -2.124 . . . . 0.0 110.517 -178.999 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -128.46 172.7 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.964 2.905 . . . . 0.0 109.709 173.636 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -116.79 153.37 32.55 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.363 2.665 . . . . 0.0 108.32 173.228 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.508 9.1 p -133.36 133.88 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 C-N-CA 129.045 2.938 . . . . 0.0 107.454 177.863 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -88.0 118.81 27.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 156.458 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -64.79 162.54 15.87 Favored 'General case' 0 C--N 1.324 -0.542 1 C-N-CA 132.924 4.49 . . . . 0.0 107.788 167.545 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.98 -11.56 60.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 123.749 1.738 . . . . 0.0 114.248 -173.141 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -91.99 -14.69 29.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.288 1.435 . . . . 0.0 111.575 173.753 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.62 -2.3 15.55 Favored Glycine 0 CA--C 1.535 1.31 1 O-C-N 113.447 -5.783 . . . . 0.0 111.491 165.994 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -88.27 134.39 33.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.744 2.418 . . . . 0.0 108.611 -172.682 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.09 146.91 52.25 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.34 166.083 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.533 57.2 mt -125.81 130.77 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 O-C-N 126.595 2.434 . . . . 0.0 109.223 152.901 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 90.8 m -83.73 130.57 34.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 171.845 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.1 tp -135.77 142.35 44.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 115.912 -1.994 . . . . 0.0 113.95 -174.42 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -94.28 128.23 40.63 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 131.211 3.804 . . . . 0.0 106.904 175.244 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -139.52 144.22 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 O-C-N 120.089 -1.632 . . . . 0.0 111.902 172.362 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.439 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -76.56 148.74 80.35 Favored Pre-proline 0 N--CA 1.447 -0.601 0 C-N-CA 126.305 1.842 . . . . 0.0 109.583 173.217 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.52 -41.82 18.61 Favored 'Trans proline' 0 N--CA 1.447 -1.215 1 C-N-CA 128.543 6.162 . . . . 0.0 109.731 159.057 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.9 p -66.54 -5.91 13.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.566 2.746 . . . . 0.0 117.898 170.668 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 3.0 t0 -88.61 145.94 25.4 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 117.434 -3.291 . . . . 0.0 105.097 -175.841 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -98.67 145.56 26.76 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.628 2.371 . . . . 0.0 115.901 -177.625 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.331 44.6 mm -42.0 -49.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 -176.575 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -75.87 -31.34 59.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 126.456 3.027 . . . . 0.0 114.306 -175.997 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.68 -35.37 65.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 116.499 -3.876 . . . . 0.0 113.085 172.637 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.0 t -72.21 -36.07 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 1 CA-C-O 111.127 -4.273 . . . . 0.0 112.252 169.817 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -61.47 -29.06 69.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 124.184 3.175 . . . . 0.0 114.39 162.68 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.334 . . -68.61 -31.21 70.22 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 126.77 2.544 . . . . 0.0 110.526 175.249 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -74.25 -19.32 60.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 122.458 2.39 . . . . 0.0 114.573 174.322 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.4 mm -76.71 -27.89 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 125.767 1.627 . . . . 0.0 114.047 161.629 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -63.28 -37.82 88.73 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -176.378 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.34 -53.9 3.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.477 1.511 . . . . 0.0 113.495 166.273 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -91.04 -46.32 8.2 Favored 'General case' 0 N--CA 1.45 -0.449 1 O-C-N 129.138 4.024 . . . . 0.0 107.038 -159.482 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -96.11 -32.63 12.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 119.092 -2.255 . . . . 0.0 113.503 -172.754 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.13 -31.33 8.67 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 116.857 -2.08 . . . . 0.0 108.654 175.264 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.271 8.3 mm -47.98 116.76 4.97 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 175.38 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.8 152.2 81.7 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 CA-C-N 124.032 2.476 . . . . 0.0 108.223 176.784 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.67 -36.61 72.87 Favored 'Trans proline' 0 N--CA 1.453 -0.864 1 C-N-CA 128.596 6.197 . . . . 0.0 116.023 175.274 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.18 -17.59 58.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.831 2.852 . . . . 0.0 113.938 177.804 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.265 9.3 mm-40 -91.64 -9.72 42.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 115.641 -2.123 . . . . 0.0 112.722 166.539 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -108.81 130.13 55.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -167.244 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -118.2 -176.18 3.01 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 119.863 -1.773 . . . . 0.0 109.242 156.365 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.87 123.63 3.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 177.216 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mm -108.86 122.4 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 -176.917 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -138.66 108.39 6.26 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.434 3.894 . . . . 0.0 109.434 -167.407 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.07 27.2 7.05 Favored 'General case' 0 N--CA 1.443 -0.821 1 C-N-CA 131.743 4.017 . . . . 0.0 115.972 177.665 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.37 17.13 20.79 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 106.448 -2.661 . . . . 0.0 106.448 170.05 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.302 65.6 pttt -150.71 159.46 44.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.911 2.084 . . . . 0.0 115.687 -171.698 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -79.62 148.2 31.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 131.344 3.858 . . . . 0.0 116.711 162.593 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.9 mt -100.24 118.45 36.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 128.354 3.534 . . . . 0.0 101.728 174.237 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.283 7.8 tp10 -87.3 157.15 19.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.226 -0.921 . . . . 0.0 109.052 -175.621 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.07 155.31 39.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.984 2.114 . . . . 0.0 110.675 -177.626 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.11 -14.38 57.48 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.991 175.229 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -90.65 149.34 22.13 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -176.342 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.8 p -79.19 174.29 11.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 117.326 -3.359 . . . . 0.0 109.154 167.135 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mp -76.61 -22.88 53.58 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 117.039 -3.538 . . . . 0.0 112.587 174.309 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 t -70.26 -29.14 65.85 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 127.517 2.327 . . . . 0.0 112.689 171.321 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.47 -32.32 73.86 Favored 'General case' 0 C--N 1.322 -0.6 1 O-C-N 115.843 -4.286 . . . . 0.0 111.934 173.174 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.86 6.21 21.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 119.841 -1.787 . . . . 0.0 106.738 -169.687 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.361 1.6 p-10 57.21 41.44 26.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 124.701 2.191 . . . . 0.0 113.878 167.838 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 mt -90.56 122.38 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 129.991 3.316 . . . . 0.0 106.241 -176.599 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.287 21.3 mm-40 -115.27 -176.6 2.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 130.537 3.535 . . . . 0.0 116.22 176.242 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -51.42 161.88 0.41 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 123.277 2.762 . . . . 0.0 116.065 159.83 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 85.16 1.37 0.74 Allowed 'General case' 0 C--N 1.325 -0.496 1 C-N-CA 133.301 4.64 . . . . 0.0 111.214 171.136 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -82.04 107.46 14.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 -177.373 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -84.37 110.66 18.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.553 2.341 . . . . 0.0 111.279 157.158 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.1 mt -76.46 162.67 27.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.118 -1.614 . . . . 0.0 115.16 170.019 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -119.94 147.56 44.6 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.961 2.104 . . . . 0.0 110.369 150.687 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.68 149.4 21.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 129.104 2.962 . . . . 0.0 111.947 171.317 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -133.74 155.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 O-C-N 117.839 -3.038 . . . . 0.0 115.452 168.722 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.5 mt -99.2 141.46 31.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 122.633 2.47 . . . . 0.0 105.712 -170.923 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -84.81 153.87 22.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 125.447 3.749 . . . . 0.0 111.709 149.578 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.256 18.8 tp -84.38 -44.53 13.66 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 118.286 -2.759 . . . . 0.0 113.994 166.906 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -77.85 144.12 37.27 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.504 2.322 . . . . 0.0 107.748 -174.331 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.81 -127.77 4.21 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 174.004 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 124.997 2.443 . . . . 0.0 112.097 -168.349 . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 ttp . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 100.425 -3.917 . . . . 0.0 100.425 . . . . . . . . . 0 0 . 1 . 050 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -72.14 137.46 47.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 111.648 -2.524 . . . . 0.0 110.999 -175.108 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.305 10.9 pt -141.17 170.74 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 O-C-N 125.678 1.861 . . . . 0.0 111.268 173.106 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -122.37 138.95 54.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 107.132 177.428 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.64 117.66 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 101.875 -3.38 . . . . 0.0 101.875 173.298 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -78.87 135.38 37.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 125.327 2.489 . . . . 0.0 112.838 165.395 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 p -80.16 -169.43 2.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 118.746 -2.471 . . . . 0.0 110.023 -179.398 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.5 mt -61.82 -40.41 95.2 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -165.909 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.8 p -103.04 9.01 38.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 111.338 -2.665 . . . . 0.0 112.739 -176.266 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.64 -0.73 59.67 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 128.655 3.026 . . . . 0.0 117.841 170.469 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -73.4 129.29 37.69 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 119.949 1.874 . . . . 0.0 110.771 177.199 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 t -81.04 136.37 35.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.785 2.034 . . . . 0.0 113.72 -177.945 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 pt -114.15 120.14 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 102.671 -3.085 . . . . 0.0 102.671 168.681 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.8 m -86.66 112.88 22.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.04 2.536 . . . . 0.0 108.86 -179.836 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.83 170.07 8.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.153 2.981 . . . . 0.0 104.346 -170.698 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.484 1.1 pm0 -132.79 124.39 27.94 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 131.297 3.839 . . . . 0.0 118.965 162.99 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.334 0.0 OUTLIER -143.85 154.14 15.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 113.909 -1.496 . . . . 0.0 113.898 -175.345 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -88.97 151.08 46.63 Favored Pre-proline 0 N--CA 1.452 -0.367 0 O-C-N 119.67 -1.894 . . . . 0.0 108.828 176.919 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.29 -30.09 10.54 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 124.907 3.738 . . . . 0.0 117.53 165.835 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.303 16.8 p -96.99 12.84 31.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 129.201 3.001 . . . . 0.0 112.714 170.799 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.81 142.35 31.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 123.421 2.828 . . . . 0.0 108.104 167.513 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -81.8 177.9 8.62 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 131.565 3.946 . . . . 0.0 111.285 -177.573 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -89.21 -18.96 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 O-C-N 116.575 -3.828 . . . . 0.0 111.321 -170.803 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.76 -37.66 74.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.102 157.432 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -85.11 5.26 30.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 123.71 1.719 . . . . 0.0 110.425 -172.616 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.25 -37.41 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 O-C-N 118.08 -2.887 . . . . 0.0 110.06 156.475 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -56.78 -52.65 64.21 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 116.571 -3.831 . . . . 0.0 110.083 174.846 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.3 46.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 118.086 2.625 . . . . 0.0 118.086 179.502 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -83.18 -26.54 30.77 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 111.553 -2.567 . . . . 0.0 116.126 178.443 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.0 mt -68.38 -38.96 80.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 115.758 -2.067 . . . . 0.0 108.838 160.666 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.15 -34.19 77.51 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 117.832 -1.08 . . . . 0.0 109.921 174.457 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.44 -34.67 77.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -179.091 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -102.24 -25.21 13.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 127.651 3.094 . . . . 0.0 117.937 -176.713 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -141.15 -16.24 0.85 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.627 2.371 . . . . 0.0 112.352 -171.599 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.06 -3.89 67.31 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 120.217 -1.552 . . . . 0.0 113.699 152.157 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.3 mt -73.3 132.65 81.65 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 114.055 -2.879 . . . . 0.0 106.037 -176.953 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.6 132.56 22.21 Favored 'Trans proline' 0 N--CA 1.454 -0.81 1 C-N-CA 127.118 5.212 . . . . 0.0 106.856 -171.274 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -40.2 -30.68 0.46 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 1 C-N-CA 130.445 7.43 . . . . 0.0 119.604 177.503 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.76 -39.07 84.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.448 2.299 . . . . 0.0 113.725 175.744 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.32 -16.15 55.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 115.248 -2.311 . . . . 0.0 112.64 -175.707 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.46 130.89 35.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.76 2.824 . . . . 0.0 111.638 -172.696 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -121.47 131.93 54.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 103.354 -2.832 . . . . 0.0 103.354 168.688 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 mt -103.0 137.82 40.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 119.914 1.234 . . . . 0.0 110.488 166.649 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mm -122.61 148.66 26.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 129.925 3.29 . . . . 0.0 107.862 177.341 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -153.88 127.58 8.75 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.177 1.791 . . . . 0.0 110.038 173.919 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.37 40.39 10.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.048 2.139 . . . . 0.0 115.08 -172.536 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.64 -13.08 68.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 117.638 1.815 . . . . 0.0 117.638 177.559 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.399 55.3 pttt -123.78 148.34 46.75 Favored 'General case' 0 C--N 1.326 -0.437 1 C-N-CA 133.353 4.661 . . . . 0.0 108.212 -161.691 . . . . . . . . 3 2 . 1 . 050 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -71.3 155.33 40.8 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 118.388 -2.695 . . . . 0.0 109.245 -169.277 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -136.23 114.08 11.2 Favored 'General case' 0 N--CA 1.451 -0.388 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 177.885 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -123.31 155.49 37.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 126.335 2.969 . . . . 0.0 111.895 -169.186 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.26 145.28 55.34 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.013 -2.929 . . . . 0.0 108.668 -178.246 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.07 -6.7 19.43 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 127.148 2.78 . . . . 0.0 113.977 -173.756 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -135.35 -175.56 3.98 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.414 1.486 . . . . 0.0 113.032 -179.509 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.6 p -128.39 175.17 8.71 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.288 1.035 . . . . 0.0 109.787 -178.856 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -55.05 -36.44 65.56 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.532 1.933 . . . . 0.0 113.703 171.423 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.328 13.0 m -75.6 -25.61 57.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 115.622 -2.431 . . . . 0.0 113.6 177.159 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -70.46 -41.61 72.54 Favored 'General case' 0 N--CA 1.45 -0.451 2 CA-C-N 126.516 4.235 . . . . 0.0 112.817 173.196 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -82.09 -12.63 58.12 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 124.742 1.276 . . . . 0.0 110.8 -176.212 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.5 m120 72.76 58.91 0.12 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.554 3.542 . . . . 0.0 114.984 175.836 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -100.69 159.05 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 112.504 -2.134 . . . . 0.0 109.814 -177.933 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -130.52 -151.73 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.684 1.194 . . . . 0.0 112.188 -176.614 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -90.34 144.64 25.64 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.427 2.291 . . . . 0.0 107.444 175.874 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 77.01 19.75 1.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 125.213 2.435 . . . . 0.0 111.073 161.895 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.7 m -87.78 133.42 33.87 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.97 2.508 . . . . 0.0 115.278 -178.025 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.1 m -111.93 125.36 53.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 123.608 2.913 . . . . 0.0 104.24 -170.787 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mt -103.05 166.32 10.51 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.313 2.245 . . . . 0.0 111.281 173.518 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -109.43 134.01 52.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 118.669 -2.52 . . . . 0.0 105.282 164.99 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 1.5 tm? -90.01 140.22 29.85 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.088 1.355 . . . . 0.0 109.696 154.033 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.92 156.22 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 128.869 2.868 . . . . 0.0 111.616 164.012 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.0 124.77 30.07 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.908 1.683 . . . . 0.0 108.812 171.529 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -173.44 97.88 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 111.63 -2.532 . . . . 0.0 109.865 -176.148 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.66 112.63 4.27 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 118.242 -2.786 . . . . 0.0 106.719 179.663 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.35 -55.4 0.44 Allowed 'General case' 0 N--CA 1.452 -0.372 1 N-CA-C 97.11 -5.144 . . . . 0.0 97.11 170.814 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.06 -142.24 15.56 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 117.302 -3.374 . . . . 0.0 111.538 -175.905 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.863 0 CA-C-N 121.397 2.598 . . . . 0.0 110.686 -174.149 . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 123.732 1.729 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 051 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -103.4 120.45 40.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 119.613 -1.93 . . . . 0.0 107.175 178.3 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -121.92 131.22 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.056 170.42 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -86.86 81.44 8.15 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.629 2.372 . . . . 0.0 109.166 -174.358 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -65.41 132.54 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 125.981 1.713 . . . . 0.0 108.682 169.246 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -123.24 152.78 40.97 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 119.972 -1.705 . . . . 0.0 109.562 172.923 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -117.73 -177.44 3.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 126.478 3.037 . . . . 0.0 109.585 -165.296 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -77.68 -42.4 34.71 Favored 'General case' 0 N--CA 1.446 -0.656 1 O-C-N 115.899 -4.251 . . . . 0.0 104.669 174.38 . . . . . . . . 4 4 . 1 . 051 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -69.89 -19.08 63.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 123.22 2.736 . . . . 0.0 112.772 -176.316 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.38 32.16 2.62 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.044 0.83 . . . . 0.0 113.112 156.982 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -110.68 146.27 36.52 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 114.22 -2.8 . . . . 0.0 110.088 -167.113 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.261 43.1 m -99.57 89.71 4.24 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 173.802 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mm -52.47 -57.93 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 120.757 1.617 . . . . 0.0 112.209 -173.848 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.317 75.5 m 79.3 81.91 0.06 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -178.675 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 tp -99.15 138.65 35.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 124.984 2.326 . . . . 0.0 106.61 -178.877 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -91.35 121.52 33.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.223 -1.548 . . . . 0.0 107.916 170.896 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.401 4.8 t -121.56 152.24 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 103.831 -2.655 . . . . 0.0 103.831 -175.547 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -104.36 136.0 19.25 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-O 114.624 -2.608 . . . . 0.0 109.384 170.909 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -57.7 -18.09 31.94 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 N-CA-C 118.609 2.503 . . . . 0.0 118.609 -174.773 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.7 p -74.08 -15.07 61.07 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.655 2.382 . . . . 0.0 114.427 168.93 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 25' ' ' ASN . 92.8 m-20 -66.39 129.01 38.39 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 122.72 2.509 . . . . 0.0 110.698 -176.026 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.6 p -85.37 174.67 9.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.971 1.714 . . . . 0.0 108.389 163.243 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.255 27.4 mm -46.7 -39.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 128.707 2.803 . . . . 0.0 115.899 176.592 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -59.02 -43.27 91.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 115.716 -2.088 . . . . 0.0 111.058 174.996 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 29.7 m120 -73.23 -36.06 66.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 127.476 2.31 . . . . 0.0 109.561 -172.513 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.29 -55.13 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 124.467 1.107 . . . . 0.0 110.512 172.989 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.263 78.7 mttt -43.5 -44.47 6.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.239 2.216 . . . . 0.0 113.512 169.718 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.22 -53.26 59.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.298 2.239 . . . . 0.0 110.097 177.506 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -62.37 -33.26 74.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 179.976 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -68.02 -44.72 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 126.946 2.654 . . . . 0.0 109.873 165.878 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -46.15 91.84 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 125.368 1.667 . . . . 0.0 114.106 -178.977 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.446 27.8 t70 -34.45 -61.32 0.39 Allowed 'General case' 0 N--CA 1.448 -0.549 1 N-CA-C 124.403 4.964 . . . . 0.0 124.403 152.451 . . . . . . . . 3 2 . 1 . 051 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -95.19 -30.23 14.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 119.892 -1.755 . . . . 0.0 111.405 -156.764 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -109.25 -27.79 9.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 128.806 2.843 . . . . 0.0 110.709 -179.978 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.58 -3.15 61.0 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 121.428 3.331 . . . . 0.0 121.428 167.674 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -85.15 145.19 42.5 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 114.054 -2.879 . . . . 0.0 109.715 -179.88 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.23 161.59 33.48 Favored 'Trans proline' 0 N--CA 1.45 -1.039 1 C-N-CA 126.781 4.987 . . . . 0.0 109.986 174.039 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.82 -13.07 8.28 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.724 3.616 . . . . 0.0 115.242 -171.949 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.55 -36.21 63.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 160.586 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -67.78 -23.48 65.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.286 -1.34 . . . . 0.0 113.508 179.57 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -85.23 129.1 34.87 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 113.839 -2.981 . . . . 0.0 106.042 -168.484 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -110.68 160.05 17.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 155.165 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.519 0.2 OUTLIER -136.44 135.51 38.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 119.112 -2.243 . . . . 0.0 114.98 176.686 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 mt -127.47 108.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -159.469 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -124.19 130.98 53.46 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.858 1.663 . . . . 0.0 110.369 171.787 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.09 50.54 13.96 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 130.398 3.479 . . . . 0.0 110.68 175.304 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.1 -34.3 3.99 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.841 2.162 . . . . 0.0 117.173 178.839 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -89.04 132.05 34.94 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -164.134 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.259 80.1 mt-30 -88.71 104.31 16.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 123.835 1.778 . . . . 0.0 108.949 168.373 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 mt -55.86 138.35 48.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 110.426 -3.079 . . . . 0.0 113.298 -166.529 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -88.64 152.49 21.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 116.423 -1.751 . . . . 0.0 106.851 -172.121 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.59 134.76 50.46 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 114.58 -2.629 . . . . 0.0 114.885 -173.671 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.83 16.92 80.35 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 117.384 1.713 . . . . 0.0 117.384 172.614 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.0 mmm-85 -99.21 176.98 5.35 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.887 2.075 . . . . 0.0 107.583 178.448 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.5 p -100.05 141.24 33.14 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 102.371 -3.196 . . . . 0.0 102.371 -172.622 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 21.7 mt -66.26 -30.81 71.32 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 127.529 2.332 . . . . 0.0 113.071 179.661 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.3 m -87.17 -22.13 25.5 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.321 -166.802 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.02 -15.89 60.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 124.864 1.352 . . . . 0.0 114.314 173.658 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -92.84 5.62 50.62 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.847 2.059 . . . . 0.0 109.299 168.135 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 75.94 21.74 1.54 Allowed 'General case' 0 N--CA 1.444 -0.765 1 C-N-CA 134.007 4.923 . . . . 0.0 118.322 170.164 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 mt -82.33 103.69 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 C-N-CA 128.144 2.578 . . . . 0.0 107.543 -169.069 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -89.5 170.44 10.5 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.059 2.143 . . . . 0.0 109.63 177.084 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -66.76 159.01 28.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 116.991 -1.48 . . . . 0.0 113.586 159.632 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 68.35 18.88 9.07 Favored 'General case' 0 N--CA 1.453 -0.318 1 C-N-CA 132.913 4.485 . . . . 0.0 111.032 179.359 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.1 t -95.94 178.39 5.44 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 128.731 3.769 . . . . 0.0 112.182 -176.433 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.2 p -131.85 133.71 44.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 125.798 1.936 . . . . 0.0 111.072 -171.971 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.19 150.91 51.94 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 126.279 2.237 . . . . 0.0 105.468 -171.704 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -108.2 119.67 40.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 117.942 -2.974 . . . . 0.0 110.953 171.663 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.3 tp -82.4 133.78 35.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 173.43 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.291 68.7 t -108.61 141.28 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 125.149 3.613 . . . . 0.0 107.495 163.257 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.437 HD13 HD23 ' A' ' 8' ' ' LEU . 4.8 mp -83.8 149.02 26.69 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 167.113 . . . . . . . . 2 2 . 1 . 051 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.36 0.0 OUTLIER -58.02 -7.82 0.88 Allowed 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 129.972 3.309 . . . . 0.0 116.259 171.235 . . . . . . . . 3 3 . 1 . 051 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.24 155.77 19.57 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.655 1.982 . . . . 0.0 109.971 177.354 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -99.41 130.99 45.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 125.471 2.558 . . . . 0.0 105.99 -167.963 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.18 -172.31 16.61 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.49 179.63 . . . . . . . . 1 1 . 1 . 051 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 113.405 -3.997 . . . . 0.0 106.835 174.511 . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 ttp . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 116.627 -1.654 . . . . 0.0 108.069 . . . . . . . . . 0 0 . 1 . 052 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -73.12 133.1 44.0 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 122.407 2.367 . . . . 0.0 115.765 176.167 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.446 HD12 HD23 ' A' ' 67' ' ' LEU . 42.0 pt -122.3 155.3 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 115.647 -2.12 . . . . 0.0 112.551 165.084 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -102.5 128.37 49.17 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 126.046 2.091 . . . . 0.0 105.658 179.262 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -100.54 109.6 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 118.047 -2.908 . . . . 0.0 103.383 166.066 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -102.95 150.3 23.67 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.447 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.283 14.8 t -145.48 160.32 41.77 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 125.27 2.462 . . . . 0.0 109.217 158.243 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 mp -67.71 -39.71 84.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 109.114 -3.675 . . . . 0.0 114.365 -161.914 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 p -52.48 -5.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 1 C-N-CA 133.435 4.694 . . . . 0.0 115.728 171.486 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.27 2.09 54.11 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 119.911 -1.743 . . . . 0.0 112.772 167.228 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -79.7 126.46 30.96 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.185 1.993 . . . . 0.0 110.096 164.308 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 m -128.2 101.96 6.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 103.244 -2.872 . . . . 0.0 103.244 171.031 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.266 2.8 mp -80.26 150.07 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 130.741 3.616 . . . . 0.0 110.457 -177.462 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 t -135.91 122.1 20.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.636 1.575 . . . . 0.0 108.241 -175.885 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -123.14 147.52 46.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.773 1.229 . . . . 0.0 113.845 175.221 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -97.43 121.23 39.09 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 131.093 3.757 . . . . 0.0 105.605 177.162 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -131.04 166.72 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 118.494 -2.629 . . . . 0.0 114.481 178.474 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -95.69 156.71 37.08 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 155.65 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.28 -20.04 69.68 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.64 2.893 . . . . 0.0 113.15 -179.891 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 13.6 p -91.78 0.33 57.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.945 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -66.33 142.85 57.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 176.562 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.33 147.49 26.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 125.216 2.436 . . . . 0.0 109.043 178.356 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.2 mt -55.75 -26.46 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 118.903 -2.373 . . . . 0.0 113.149 179.603 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.287 31.9 mt-10 -74.07 -42.66 59.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 109.422 -178.535 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.01 -50.4 70.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.513 175.499 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.1 t -55.57 -31.1 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 115.612 -2.137 . . . . 0.0 111.835 166.029 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -76.71 -17.56 59.03 Favored 'General case' 0 N--CA 1.442 -0.834 2 CA-C-N 128.092 4.951 . . . . 0.0 109.66 -177.267 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.42 -19.99 22.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.516 1.126 . . . . 0.0 113.215 172.273 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -73.76 -29.72 62.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 170.785 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 30' ' ' ILE . 56.9 mt -64.79 -30.78 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 128.834 2.854 . . . . 0.0 115.148 160.309 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -65.71 -53.51 39.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.62 1.1 . . . . 0.0 111.776 173.094 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.401 22.9 t70 -36.99 -34.16 0.07 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 131.514 3.926 . . . . 0.0 112.485 168.283 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -93.78 -57.99 2.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 120.582 1.537 . . . . 0.0 115.038 171.816 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.26 -21.14 23.35 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -161.268 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.99 1.95 62.81 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 119.312 2.485 . . . . 0.0 119.312 -174.905 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.0 mt -95.86 140.87 22.49 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 128.191 2.596 . . . . 0.0 110.874 -163.234 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.59 136.53 10.98 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.765 2.977 . . . . 0.0 115.604 172.774 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -66.47 -21.21 53.62 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 124.562 3.508 . . . . 0.0 116.093 -158.047 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.31 4.78 9.91 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 117.907 -2.996 . . . . 0.0 110.94 -176.884 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -95.36 -18.96 20.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 113.172 -3.299 . . . . 0.0 109.083 168.062 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.284 13.4 mm-40 -98.0 125.05 42.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 124.678 3.399 . . . . 0.0 112.319 -160.835 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 127.5 42.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 100.635 -3.839 . . . . 0.0 100.635 -178.772 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.7 mt -101.89 134.78 44.54 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 128.683 2.793 . . . . 0.0 115.096 179.688 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -128.74 156.65 41.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 126.458 1.903 . . . . 0.0 107.209 167.753 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.491 ' HB3' HD21 ' A' ' 50' ' ' LEU 0.368 6.7 t80 -126.61 -126.65 0.23 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 109.711 -3.404 . . . . 0.0 107.945 -157.76 . . . . . . . . 3 3 . 1 . 052 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.75 44.57 1.07 Allowed 'General case' 0 C--N 1.324 -0.54 1 C-N-CA 132.243 4.217 . . . . 0.0 110.777 169.994 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.9 -22.22 34.13 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 128.328 2.87 . . . . 0.0 114.493 -177.715 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.93 126.01 34.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -171.268 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -76.21 119.86 20.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.123 0.963 . . . . 0.0 108.78 171.967 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 45' ' ' PHE . 18.5 mt -92.23 127.43 37.71 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -169.957 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.91 149.5 34.21 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 123.399 1.571 . . . . 0.0 114.872 174.005 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -64.6 126.75 28.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 129.619 3.168 . . . . 0.0 109.748 178.115 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.1 -20.08 51.59 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 116.705 -2.664 . . . . 0.0 114.847 172.279 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.32 156.35 38.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.72 1.26 . . . . 0.0 110.091 159.394 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.1 p -87.94 -179.95 6.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 119.327 -2.108 . . . . 0.0 109.152 -175.668 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 12.8 mt -77.08 -22.39 52.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 116.772 -1.585 . . . . 0.0 110.443 165.618 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.2 t -64.82 -41.02 96.09 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 117.608 2.448 . . . . 0.0 117.608 168.492 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -51.88 -53.83 36.21 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.703 -178.26 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -94.67 3.33 55.2 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.697 1.999 . . . . 0.0 110.824 -171.124 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.49 1.3 p-10 64.68 28.73 13.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 118.711 2.856 . . . . 0.0 118.711 175.11 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.411 HD13 HD11 ' A' ' 67' ' ' LEU . 30.6 mt -75.16 131.37 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.343 170.023 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -124.17 176.7 6.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 125.929 2.018 . . . . 0.0 108.936 -168.254 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -52.99 127.27 23.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.418 1.487 . . . . 0.0 108.555 175.148 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 62.95 15.52 8.43 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 120.372 3.471 . . . . 0.0 120.372 -171.373 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -76.72 123.41 26.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 116.888 -3.633 . . . . 0.0 106.402 168.496 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -87.15 129.34 34.98 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.698 2.799 . . . . 0.0 108.523 179.469 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD23 HD12 ' A' ' 3' ' ' ILE . 2.5 mm? -100.97 134.15 44.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.547 2.339 . . . . 0.0 109.363 163.72 . . . . . . . . 2 2 . 1 . 052 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -86.03 151.29 23.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 103.552 -2.758 . . . . 0.0 103.552 164.657 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -134.23 112.8 11.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 127.871 2.468 . . . . 0.0 109.824 -173.774 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.84 -177.58 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.179 2.591 . . . . 0.0 110.965 -178.347 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.8 mt -87.47 138.87 31.11 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 113.737 -3.03 . . . . 0.0 110.637 -177.088 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -76.81 124.91 28.4 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 120.959 1.709 . . . . 0.0 107.866 174.59 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.2 mt -126.55 91.84 3.44 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 122.828 1.299 . . . . 0.0 111.74 -173.898 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 88.02 -74.88 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.794 2.437 . . . . 0.0 109.618 -175.81 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.64 -179.37 15.84 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.953 -0.915 . . . . 0.0 112.11 -177.011 . . . . . . . . 1 1 . 1 . 052 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.837 0 CA-C-O 117.961 -1.466 . . . . 0.0 109.708 172.454 . . . . . . . . 0 0 . 1 . 053 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 . . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -80.36 144.02 33.06 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.491 1.916 . . . . 0.0 112.536 -175.148 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.611 HG22 ' H ' ' A' ' 65' ' ' SER . 22.9 pt -127.44 161.33 35.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 120.237 -1.539 . . . . 0.0 111.073 155.764 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -92.27 163.57 13.85 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 172.739 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.32 155.67 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 129.436 3.094 . . . . 0.0 110.608 148.422 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -152.12 142.39 22.42 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 122.858 2.572 . . . . 0.0 105.233 -162.308 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.27 66.7 p -100.19 170.75 8.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.049 1.34 . . . . 0.0 110.965 179.284 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.542 HD11 HG22 ' A' ' 70' ' ' VAL . 43.8 mt -93.0 18.88 8.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 117.856 -3.027 . . . . 0.0 110.22 177.324 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.371 0.6 OUTLIER -153.46 22.37 0.54 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 125.563 3.801 . . . . 0.0 109.412 -164.442 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.88 -11.36 29.68 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 122.688 3.835 . . . . 0.0 122.688 164.752 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -112.73 170.69 8.01 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 121.159 2.479 . . . . 0.0 109.193 -171.001 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.4 p -140.03 169.2 18.13 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.52 3.128 . . . . 0.0 110.503 170.579 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.7 mm -140.99 132.86 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 126.097 2.123 . . . . 0.0 110.377 168.851 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 m -80.88 116.53 20.91 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 126.621 2.45 . . . . 0.0 110.125 168.399 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.8 mt -102.74 146.08 28.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 123.773 1.749 . . . . 0.0 113.304 179.041 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.9 107.88 10.49 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.877 168.881 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -142.58 -41.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.837 1.655 . . . . 0.0 111.441 -157.067 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 75.74 140.97 0.08 OUTLIER Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 131.07 3.748 . . . . 0.0 110.726 -171.339 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 87.3 Cg_exo -46.58 -24.08 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 124.474 3.449 . . . . 0.0 119.979 172.308 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 p -64.07 -34.21 77.5 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 116.365 -3.959 . . . . 0.0 113.178 174.931 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.98 144.87 11.02 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -177.846 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.257 10.7 t -117.56 130.68 56.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 116.84 -1.552 . . . . 0.0 108.483 -165.514 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.409 24.7 mm -40.69 -43.72 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 129.774 3.23 . . . . 0.0 114.755 -159.6 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -65.48 -29.47 70.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 121.214 1.825 . . . . 0.0 113.19 179.648 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.77 -16.61 28.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 -176.825 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.43 -40.33 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 114.809 -2.519 . . . . 0.0 105.518 172.702 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -71.5 -30.04 65.5 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 125.035 1.459 . . . . 0.0 112.235 175.324 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.25 -18.65 60.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.53 2.332 . . . . 0.0 115.869 173.74 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.28 -18.41 55.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 119.724 3.231 . . . . 0.0 119.724 161.416 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.6 mt -87.97 -38.19 11.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 127.27 2.856 . . . . 0.0 107.733 170.655 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.295 38.6 tt0 -45.9 -56.28 5.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 162.01 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -51.56 -38.2 53.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 111.397 -2.638 . . . . 0.0 110.704 171.363 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -87.7 -53.71 4.63 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -179.991 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -103.46 -21.56 13.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 -170.932 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.76 -17.09 28.06 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 116.42 -2.322 . . . . 0.0 110.394 175.156 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.79 120.19 78.62 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 129.288 3.035 . . . . 0.0 110.292 -174.127 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -77.23 148.72 27.38 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 C-N-CA 123.924 3.083 . . . . 0.0 110.973 -171.146 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.293 47.2 Cg_exo -47.53 -37.39 26.21 Favored 'Trans proline' 0 N--CA 1.442 -1.532 1 C-N-CA 126.382 4.721 . . . . 0.0 116.096 -176.814 . . . . . . . . 3 2 . 1 . 053 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.75 -13.71 61.0 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -171.737 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.404 ' HA ' ' HG3' ' A' ' 72' ' ' ARG 0.317 20.2 mt-30 -100.88 -7.82 23.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 178.715 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -89.23 95.03 10.13 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.247 2.219 . . . . 0.0 115.996 173.353 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.291 51.4 ttt180 -88.44 105.7 17.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.293 -1.504 . . . . 0.0 107.639 172.821 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB3' HD12 ' A' ' 50' ' ' LEU 0.295 97.1 mt -97.07 120.11 36.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.984 . . . . . . . . 3 3 . 1 . 053 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.0 mt -110.85 126.24 68.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 130.179 3.392 . . . . 0.0 105.91 -172.53 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.261 89.9 t80 -119.95 -138.27 0.34 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.869 2.868 . . . . 0.0 105.019 -172.422 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.26 57.19 4.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.302 2.641 . . . . 0.0 114.146 -163.284 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.78 -3.17 80.99 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 127.198 2.333 . . . . 0.0 114.449 -166.679 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -123.96 141.01 52.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.37 2.268 . . . . 0.0 110.98 -170.381 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -77.44 140.04 39.77 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.656 -0.687 . . . . 0.0 110.989 153.309 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.443 HD12 ' HB3' ' A' ' 43' ' ' LEU . 73.4 mt -67.97 123.5 20.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 126.232 2.208 . . . . 0.0 109.156 174.01 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -85.09 138.93 32.1 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 126.554 2.409 . . . . 0.0 107.519 -177.376 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.276 96.8 m-20 -73.56 127.27 32.29 Favored 'General case' 0 N--CA 1.445 -0.724 1 CA-C-N 107.303 -4.498 . . . . 0.0 104.707 171.74 . . . . . . . . 3 2 . 1 . 053 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.32 -19.79 26.46 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.708 1.255 . . . . 0.0 116.148 -173.147 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -100.02 163.3 12.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 124.1 1.905 . . . . 0.0 110.007 176.136 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -92.87 164.8 13.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 117.377 -3.327 . . . . 0.0 111.667 179.492 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 18.2 mt -62.11 -45.07 95.1 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 117.31 -3.369 . . . . 0.0 113.482 171.644 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.535 47.5 t -29.95 -36.12 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.215 1 C-N-CA 134.838 5.255 . . . . 0.0 120.511 156.203 . . . . . . . . 3 2 . 1 . 053 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.318 34.5 m-20 -80.49 -10.03 59.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 114.38 -2.724 . . . . 0.0 110.738 177.184 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -104.86 -7.71 19.2 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 126.864 2.602 . . . . 0.0 114.199 168.15 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 7.0 t-20 55.08 59.42 4.03 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.253 2.221 . . . . 0.0 113.232 -171.909 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -101.16 126.94 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 1 O-C-N 114.621 -5.05 . . . . 0.0 103.599 179.468 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -109.9 -170.28 1.62 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.918 1.687 . . . . 0.0 112.347 -168.827 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -50.83 139.15 17.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.047 -1.033 . . . . 0.0 113.01 171.269 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.278 4.4 tt0 70.56 32.26 2.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 128.879 3.862 . . . . 0.0 109.923 163.395 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.611 ' H ' HG22 ' A' ' 3' ' ' ILE . 69.6 m -83.1 153.23 24.96 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 117.777 -3.077 . . . . 0.0 114.509 -178.335 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m -113.52 137.82 51.01 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 125.234 2.445 . . . . 0.0 111.018 168.902 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.69 125.86 27.91 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 176.468 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -92.09 143.86 26.02 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 127.619 3.075 . . . . 0.0 108.491 177.584 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tt -115.64 122.23 44.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.159 -172.724 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.542 HG22 HD11 ' A' ' 8' ' ' LEU . 11.7 t -100.91 141.82 16.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 127.981 2.512 . . . . 0.0 108.347 176.529 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt -89.92 149.35 22.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 126.355 2.979 . . . . 0.0 109.492 -174.118 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HG3' ' HA ' ' A' ' 40' ' ' GLN . 22.4 ptt180 -154.85 -179.39 7.98 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 131.428 3.891 . . . . 0.0 105.497 174.421 . . . . . . . . 2 2 . 1 . 053 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -134.38 118.69 17.73 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 100.758 -3.793 . . . . 0.0 100.758 151.259 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -81.23 -34.45 32.16 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.827 1.251 . . . . 0.0 110.464 171.756 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.56 4.9 6.14 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 117.875 -2.107 . . . . 0.0 114.189 177.072 . . . . . . . . 1 1 . 1 . 053 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 C-N-CA 125.68 1.61 . . . . 0.0 113.824 -151.936 . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.9 ttp . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 115.818 -2.039 . . . . 0.0 107.086 . . . . . . . . . 0 0 . 1 . 054 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -90.87 146.17 24.14 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 126.036 2.085 . . . . 0.0 109.469 -169.134 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 6.0 pt -145.88 164.78 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 175.376 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -127.53 145.39 50.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 124.385 2.041 . . . . 0.0 107.937 -174.917 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -137.53 106.87 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 1 O-C-N 115.246 -4.659 . . . . 0.0 104.382 -177.908 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -77.34 126.67 31.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 124.567 2.127 . . . . 0.0 112.991 162.896 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -78.48 156.8 29.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.511 1.924 . . . . 0.0 109.266 177.468 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mt -50.47 -34.65 25.71 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 164.467 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.2 p -78.66 -11.91 59.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.735 2.014 . . . . 0.0 112.713 -176.086 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.25 -8.39 26.83 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 115.657 -2.746 . . . . 0.0 111.087 174.243 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -91.73 159.66 15.73 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.29 1.436 . . . . 0.0 109.765 -174.947 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -126.17 136.41 52.82 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 -178.127 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mt -102.79 159.81 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 1 C-N-CA 132.337 4.255 . . . . 0.0 106.647 163.956 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.33 3.3 t -135.4 149.98 49.78 Favored 'General case' 0 C--N 1.328 -0.34 1 C-N-CA 134.117 4.967 . . . . 0.0 112.526 168.831 . . . . . . . . 3 2 . 1 . 054 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mp -141.27 144.35 34.61 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -173.342 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.274 4.0 tp10 -99.71 128.04 45.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 125.322 1.639 . . . . 0.0 108.613 161.559 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.72 173.3 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 129.216 3.007 . . . . 0.0 114.976 173.05 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -103.2 148.19 35.29 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 128.148 2.579 . . . . 0.0 106.796 151.812 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -64.63 -14.13 42.83 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-O 116.499 -1.542 . . . . 0.0 112.006 172.457 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.5 m -86.98 1.53 52.47 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 127.782 3.176 . . . . 0.0 111.194 177.817 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -89.97 143.76 26.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 126.203 2.189 . . . . 0.0 106.959 175.075 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -82.76 162.56 21.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 126.245 2.926 . . . . 0.0 104.174 -168.548 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.27 -45.85 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 120.002 -1.686 . . . . 0.0 109.109 168.622 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.8 -33.58 10.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 124.266 1.984 . . . . 0.0 114.209 173.518 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.89 -34.96 67.0 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 117.106 -3.497 . . . . 0.0 112.282 176.174 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.62 -37.18 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 O-C-N 120.54 -1.35 . . . . 0.0 111.136 169.682 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -68.03 -39.8 83.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.766 -1.833 . . . . 0.0 113.449 172.922 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.35 77.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 172.689 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -72.32 -33.91 67.7 Favored 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 131.806 4.042 . . . . 0.0 111.756 175.457 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.6 mt -80.09 -39.82 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 118.502 -2.624 . . . . 0.0 116.582 169.1 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -44.03 -47.39 8.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 119.39 -2.068 . . . . 0.0 114.955 150.725 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -53.97 -45.0 71.26 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 178.085 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -107.58 -49.99 3.15 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 126.245 2.216 . . . . 0.0 107.924 -160.31 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -90.01 -38.35 13.67 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.099 1.76 . . . . 0.0 112.04 -174.172 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.2 9.38 24.06 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 116.622 -2.21 . . . . 0.0 112.865 169.641 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.64 124.53 69.28 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 119.99 1.895 . . . . 0.0 112.687 -170.722 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -54.19 135.78 65.84 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 124.316 3.344 . . . . 0.0 109.828 175.509 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.262 71.6 Cg_exo -41.59 -52.5 3.73 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.132 2.555 . . . . 0.0 117.858 170.083 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -40.82 -17.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 129.658 3.183 . . . . 0.0 114.834 167.39 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -136.04 30.71 3.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -167.068 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.297 13.1 pt20 -141.23 138.12 33.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 130.711 3.604 . . . . 0.0 110.648 168.671 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -138.34 120.92 16.19 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 118.377 -2.702 . . . . 0.0 104.282 175.507 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.59 150.35 23.1 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 119.835 -1.791 . . . . 0.0 109.706 177.037 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.8 mt -137.33 128.0 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -179.412 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -131.5 118.91 20.81 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 127.279 2.862 . . . . 0.0 108.214 179.107 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.21 13.34 7.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 130.754 3.622 . . . . 0.0 118.588 167.4 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.87 3.39 36.66 Favored Glycine 0 CA--C 1.536 1.379 1 C-N-CA 130.881 4.086 . . . . 0.0 114.581 -171.65 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -106.83 100.98 10.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 113.211 -3.28 . . . . 0.0 111.037 -177.517 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -63.29 108.56 1.33 Allowed 'General case' 0 C--N 1.325 -0.479 1 O-C-N 129.695 4.372 . . . . 0.0 106.445 169.122 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.14 147.88 46.21 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 125.789 1.931 . . . . 0.0 112.054 179.399 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 54' ' ' ARG . 3.8 mt-10 -116.39 137.61 52.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.04 2.136 . . . . 0.0 105.657 -178.502 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -43.89 136.46 3.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 138.179 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.44 -10.34 33.14 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 129.845 3.593 . . . . 0.0 115.832 -176.023 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 39.8 mtt-85 -123.58 -177.72 3.81 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 127.21 2.359 . . . . 0.0 109.385 -178.805 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -128.73 168.34 15.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.277 -175.174 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.5 mt -59.02 -29.29 67.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -178.873 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -65.45 -47.19 77.0 Favored 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 135.489 5.515 . . . . 0.0 115.659 172.736 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -47.13 -25.56 0.9 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 120.053 3.353 . . . . 0.0 120.053 170.855 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.466 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 72.3 m-85 -117.17 1.73 12.53 Favored 'General case' 0 C--O 1.238 0.473 1 C-N-CA 132.866 4.466 . . . . 0.0 115.291 177.958 . . . . . . . . 3 3 . 1 . 054 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.374 4.0 t30 66.89 49.13 1.21 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.375 1.47 . . . . 0.0 113.377 176.782 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mt -101.3 125.39 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 118.243 -2.786 . . . . 0.0 104.568 177.043 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -115.02 -166.7 1.14 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.243 -2.253 . . . . 0.0 111.152 172.635 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.257 58.9 tttt -41.84 125.78 2.95 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 118.939 2.941 . . . . 0.0 118.939 170.496 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.45 44.4 mt-10 75.84 18.1 2.16 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 165.776 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 m -83.67 147.04 27.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.53 1.132 . . . . 0.0 108.782 -175.832 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -120.67 131.75 54.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 -174.466 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -111.7 162.09 15.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.084 2.553 . . . . 0.0 109.608 171.87 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -115.01 142.49 46.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 124.462 2.077 . . . . 0.0 110.496 162.537 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.3 133.52 52.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 119.374 -2.079 . . . . 0.0 106.232 -178.703 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.76 153.86 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.356 1.862 . . . . 0.0 110.897 161.507 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.35 110.14 11.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 116.735 -1.602 . . . . 0.0 107.975 -173.778 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 70.54 -49.69 0.66 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.735 2.814 . . . . 0.0 117.685 177.51 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.85 148.79 21.74 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 128.693 2.797 . . . . 0.0 108.203 165.183 . . . . . . . . 2 2 . 1 . 054 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -93.72 139.41 30.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 112.691 -2.05 . . . . 0.0 110.126 171.947 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.95 108.28 1.15 Allowed Glycine 0 CA--C 1.528 0.89 0 O-C-N 119.731 -1.855 . . . . 0.0 114.552 163.787 . . . . . . . . 1 1 . 1 . 054 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.655 1 C-N-CA 134.629 5.871 . . . . 0.0 103.226 163.1 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttm . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 . . . . . . . . . 0 0 . 1 . 055 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -91.39 136.82 32.84 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.629 0.771 . . . . 0.0 111.639 175.382 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.478 HD11 HG11 ' A' ' 17' ' ' VAL . 16.6 pt -117.41 170.01 7.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 119.895 -1.753 . . . . 0.0 110.799 145.539 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.77 138.21 48.66 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 164.824 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 t -121.91 124.76 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 O-C-N 120.922 -1.111 . . . . 0.0 109.397 168.133 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -88.45 115.69 26.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.268 1.027 . . . . 0.0 111.89 -179.482 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 34.9 p -78.71 161.02 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 125.528 2.585 . . . . 0.0 109.378 171.675 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.04 -27.74 66.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.576 1.95 . . . . 0.0 113.634 -171.853 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p -69.0 -8.86 48.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 119.692 -1.88 . . . . 0.0 114.687 168.459 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.28 -6.09 30.27 Favored Glycine 0 N--CA 1.44 -1.039 0 O-C-N 120.179 -1.576 . . . . 0.0 112.106 172.197 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -73.85 125.28 27.8 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.36 2.264 . . . . 0.0 114.61 -176.423 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.3 57.0 m -95.69 106.19 18.26 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 101.029 -3.693 . . . . 0.0 101.029 176.906 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.9 mt -87.16 130.65 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 125.385 1.474 . . . . 0.0 110.265 173.036 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -90.26 105.63 17.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 127.697 3.123 . . . . 0.0 107.835 176.411 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.252 7.7 tp -108.51 152.31 24.9 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.827 2.051 . . . . 0.0 111.71 -178.147 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -95.93 143.15 27.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 163.3 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.478 HG11 HD11 ' A' ' 3' ' ' ILE . 16.0 m -134.05 150.94 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 129.586 3.154 . . . . 0.0 107.198 166.23 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.271 12.7 tp10 -89.39 141.92 29.3 Favored Pre-proline 0 N--CA 1.446 -0.649 0 O-C-N 127.649 3.093 . . . . 0.0 105.287 154.024 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.26 -19.73 6.91 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 N-CA-C 121.033 3.436 . . . . 0.0 121.033 170.837 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.276 20.7 p -99.2 1.57 44.97 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.664 -174.391 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 39.6 t0 -85.74 144.83 27.56 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 179.939 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.3 p -90.86 162.6 14.74 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.587 -2.571 . . . . 0.0 115.026 -174.278 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mm -52.69 -53.54 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 128.847 2.859 . . . . 0.0 107.89 -165.035 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -79.58 -21.12 45.44 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 114.129 -2.843 . . . . 0.0 112.053 -169.316 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -66.67 -47.68 71.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 123.52 2.873 . . . . 0.0 111.924 166.354 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.24 -34.52 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 130.889 3.676 . . . . 0.0 110.04 177.015 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -67.78 -35.67 79.09 Favored 'General case' 0 N--CA 1.451 -0.387 1 O-C-N 114.435 -5.166 . . . . 0.0 113.23 169.053 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.7 -22.22 46.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 130.408 3.483 . . . . 0.0 110.424 -179.22 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP . 43.9 mttp -64.46 -20.65 66.31 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 118.45 -2.656 . . . . 0.0 109.168 173.096 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mm -68.78 -19.71 24.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 117.361 -3.337 . . . . 0.0 117.243 167.279 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -74.65 -35.81 62.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 113.664 -3.065 . . . . 0.0 107.911 -165.175 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.307 27.9 t70 -30.69 -53.58 0.19 Allowed 'General case' 0 N--CA 1.441 -0.902 1 C-N-CA 132.099 4.159 . . . . 0.0 110.421 154.715 . . . . . . . . 3 2 . 1 . 055 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -89.02 -48.17 7.61 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 127.294 2.871 . . . . 0.0 116.842 -178.066 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -102.79 -36.03 8.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 125.221 1.576 . . . . 0.0 108.617 -160.891 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.15 13.47 58.79 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 115.21 -2.994 . . . . 0.0 117.529 171.28 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mm -97.55 142.55 24.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 112.516 -3.611 . . . . 0.0 108.411 -172.985 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -60.6 139.38 85.64 Favored 'Trans proline' 0 N--CA 1.453 -0.897 1 C-N-CA 126.522 4.815 . . . . 0.0 116.853 170.153 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.76 -27.81 37.5 Favored 'Trans proline' 0 N--CA 1.456 -0.729 1 C-N-CA 126.544 4.829 . . . . 0.0 113.31 -172.978 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.18 -38.23 82.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 119.916 -1.74 . . . . 0.0 115.052 166.167 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -73.99 -29.67 62.09 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 118.178 -2.826 . . . . 0.0 117.029 176.886 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -75.44 149.44 38.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.106 2.562 . . . . 0.0 114.557 164.173 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -131.44 150.01 52.31 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 128.234 2.614 . . . . 0.0 104.661 157.05 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.496 ' CD1' HD12 ' A' ' 50' ' ' LEU 0.465 0.4 OUTLIER -120.46 148.62 43.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 124.327 2.013 . . . . 0.0 112.73 158.66 . . . . . . . . 4 4 . 1 . 055 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -104.62 154.29 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 1 C-N-CA 134.504 5.122 . . . . 0.0 108.924 176.601 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -162.6 135.0 5.55 Favored 'General case' 0 C--N 1.321 -0.638 1 C-N-CA 132.313 4.245 . . . . 0.0 103.589 163.015 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 76.37 43.21 0.15 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.012 1.325 . . . . 0.0 109.554 163.504 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.51 22.63 46.23 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 129.754 3.55 . . . . 0.0 118.481 -176.655 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.322 37.4 pttt -162.06 170.13 19.76 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.658 1.583 . . . . 0.0 112.128 -179.397 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.306 27.2 mp0 -93.77 139.73 30.5 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.386 -161.563 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.496 HD12 ' CD1' ' A' ' 43' ' ' LEU . 14.2 mt -94.46 162.14 13.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.639 1.975 . . . . 0.0 109.513 179.01 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -150.93 151.3 31.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 119.294 -2.128 . . . . 0.0 110.366 -173.374 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -44.77 133.98 5.82 Favored 'General case' 0 C--N 1.327 -0.413 1 C-N-CA 134.039 4.936 . . . . 0.0 112.267 -177.341 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.35 -19.94 28.61 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 114.084 -3.62 . . . . 0.0 111.354 151.718 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -94.07 155.86 16.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 127.572 2.572 . . . . 0.0 107.518 172.361 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -76.2 163.98 26.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.801 2.44 . . . . 0.0 112.739 -178.514 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.9 mt -43.85 -43.47 6.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 130.178 3.391 . . . . 0.0 109.229 159.897 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -71.35 -37.67 71.67 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 118.701 -2.5 . . . . 0.0 114.889 -175.525 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -59.71 -36.19 76.05 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 127.139 2.176 . . . . 0.0 107.877 178.891 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.282 13.9 m-85 -97.83 11.94 35.59 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.591 1.556 . . . . 0.0 110.995 175.907 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.623 0.1 OUTLIER 67.56 25.97 8.22 Favored 'General case' 0 C--O 1.222 -0.374 1 O-C-N 115.566 -4.458 . . . . 0.0 121.512 165.016 . . . . . . . . 4 3 . 1 . 055 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -76.61 93.29 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 128.628 2.771 . . . . 0.0 104.973 174.305 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.302 8.3 mm-40 -99.4 -169.67 1.79 Allowed 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 128.089 3.368 . . . . 0.0 102.344 174.938 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.419 16.1 ptpt -43.64 122.23 2.63 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 130.808 3.643 . . . . 0.0 116.729 169.601 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 4.2 tp10 83.13 33.98 0.06 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.946 2.099 . . . . 0.0 112.493 175.198 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -96.91 138.38 34.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.125 2.97 . . . . 0.0 108.237 -176.6 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -118.26 141.19 48.77 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 173.865 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.0 158.82 16.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 116.9 -3.625 . . . . 0.0 111.718 166.171 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -135.07 136.11 41.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 175.195 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 mt -86.64 154.7 20.82 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 178.106 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 t -141.39 133.55 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 128.713 2.805 . . . . 0.0 106.525 -178.734 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt -92.09 136.21 33.36 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 123.027 2.649 . . . . 0.0 108.438 -179.637 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -93.27 113.61 25.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 103.114 -2.921 . . . . 0.0 103.114 163.924 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.8 mt -99.48 58.38 1.07 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.001 2.52 . . . . 0.0 104.961 -167.481 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.25 13.6 mmm180 -104.07 164.86 11.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.009 -1.905 . . . . 0.0 112.591 -177.134 . . . . . . . . 2 2 . 1 . 055 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.41 -136.1 6.16 Favored Glycine 0 CA--C 1.536 1.363 0 N-CA-C 104.197 -3.561 . . . . 0.0 104.197 -176.155 . . . . . . . . 1 1 . 1 . 055 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.723 0 N-CA-C 103.36 -3.896 . . . . 0.0 103.36 -175.618 . . . . . . . . 0 0 . 1 . 056 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.309 14.2 ptt? . . . . . 0 N--CA 1.471 0.579 0 CA-C-O 117.872 -1.061 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -79.3 153.25 30.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 115.739 -2.077 . . . . 0.0 111.602 163.896 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.291 31.4 pt -134.22 -177.39 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 129.292 3.037 . . . . 0.0 103.934 164.417 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -142.0 139.44 32.39 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 128.631 2.773 . . . . 0.0 104.544 170.954 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.29 109.31 25.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 131.266 3.826 . . . . 0.0 101.59 179.45 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -87.51 122.29 31.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 101.057 -3.683 . . . . 0.0 101.057 170.221 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.5 p -65.72 160.26 23.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 128.384 2.673 . . . . 0.0 111.119 161.967 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tt -44.84 -39.55 5.43 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 120.169 3.396 . . . . 0.0 120.169 172.941 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 p -90.87 -9.69 45.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.811 2.044 . . . . 0.0 111.715 -176.075 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.72 7.39 17.89 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.775 0.702 . . . . 0.0 111.675 165.847 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -76.5 130.92 38.63 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.808 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -112.87 146.76 38.35 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.625 2.37 . . . . 0.0 106.023 -174.071 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 pt -143.89 146.6 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 127.091 2.745 . . . . 0.0 105.737 173.158 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.9 m -89.14 132.59 34.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 129.702 3.201 . . . . 0.0 104.635 168.876 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 mt -108.86 153.27 23.76 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.047 1.739 . . . . 0.0 109.659 151.966 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -103.21 111.57 24.01 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 111.684 -2.507 . . . . 0.0 111.47 164.873 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.23 138.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.512 1.525 . . . . 0.0 106.89 -174.944 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -77.77 147.01 73.64 Favored Pre-proline 0 N--CA 1.446 -0.645 0 O-C-N 118.753 -2.467 . . . . 0.0 109.61 154.361 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.06 -22.35 74.43 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 N-CA-C 119.651 2.904 . . . . 0.0 119.651 -174.25 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 0.3 OUTLIER -81.18 -12.5 59.17 Favored 'General case' 0 N--CA 1.442 -0.861 1 C-N-CA 131.792 4.037 . . . . 0.0 112.226 177.889 . . . . . . . . 4 3 . 1 . 056 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.06 119.65 17.59 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 119.614 -1.929 . . . . 0.0 107.196 -172.65 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.5 p -66.3 167.83 9.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 121.524 1.965 . . . . 0.0 106.245 -167.797 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -54.18 -37.72 36.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -177.876 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -71.02 -28.66 64.57 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.182 0.992 . . . . 0.0 112.626 -174.92 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.41 -22.35 66.77 Favored 'General case' 0 N--CA 1.451 -0.416 1 CA-C-O 110.544 -4.55 . . . . 0.0 112.802 175.855 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.39 -45.32 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 131.139 3.776 . . . . 0.0 109.749 177.622 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.286 37.5 pttt -75.34 -23.65 57.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 123.904 1.811 . . . . 0.0 113.332 -178.504 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -34.2 75.3 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.159 2.584 . . . . 0.0 108.337 -179.549 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -73.58 -53.87 9.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 127.777 3.173 . . . . 0.0 107.277 176.011 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.43 65.4 mt -38.81 -54.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 125.807 2.718 . . . . 0.0 117.821 -179.675 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -65.08 -20.72 66.61 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 118.586 -2.571 . . . . 0.0 116.253 -179.385 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.256 36.0 t70 -90.37 -24.87 20.69 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 121.672 2.033 . . . . 0.0 107.517 175.492 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -97.33 -50.64 4.47 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 113.646 -3.073 . . . . 0.0 107.371 -164.17 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -129.18 12.21 6.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 115.647 -2.12 . . . . 0.0 109.929 -179.929 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.74 -3.19 86.08 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 126.674 2.083 . . . . 0.0 116.523 154.292 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -72.69 107.64 3.37 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 130.347 3.459 . . . . 0.0 106.439 177.352 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.97 160.61 36.8 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.47 2.113 . . . . 0.0 116.545 -177.711 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.317 5.6 Cg_endo -50.69 -35.34 47.12 Favored 'Trans proline' 0 N--CA 1.44 -1.668 1 C-N-CA 130.13 7.22 . . . . 0.0 114.027 167.845 . . . . . . . . 3 2 . 1 . 056 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.67 -18.98 63.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 116.185 1.921 . . . . 0.0 116.185 175.312 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -123.38 14.32 9.6 Favored 'General case' 0 N--CA 1.443 -0.791 1 O-C-N 115.598 -4.439 . . . . 0.0 110.037 -176.083 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.343 0.3 OUTLIER -101.85 126.29 48.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 118.814 -2.429 . . . . 0.0 107.364 -161.967 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -131.74 108.02 9.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 168.657 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.8 mt -93.21 126.66 38.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.002 -1.475 . . . . 0.0 108.392 179.572 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 pt -128.9 144.25 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 119.454 1.025 . . . . 0.0 113.046 -178.004 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -137.08 133.74 35.72 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 169.116 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.11 20.59 11.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 120.873 1.67 . . . . 0.0 111.488 166.681 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.49 -21.12 42.58 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.305 0.957 . . . . 0.0 112.723 -174.483 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -80.63 146.16 31.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -176.324 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -99.99 123.99 44.84 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 175.822 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mt -71.4 115.82 11.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 124.663 2.173 . . . . 0.0 109.951 -171.022 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -82.84 133.31 35.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.421 2.688 . . . . 0.0 112.767 175.317 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -41.89 143.29 0.56 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 130.893 3.677 . . . . 0.0 115.474 174.009 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.96 50.27 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 111.789 -2.459 . . . . 0.0 112.809 164.729 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -74.35 140.45 44.82 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 118.367 -2.843 . . . . 0.0 107.28 175.206 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -68.43 139.47 55.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 126.503 2.377 . . . . 0.0 109.048 160.947 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.2 mt -53.11 -30.08 34.57 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.666 1.586 . . . . 0.0 113.974 174.451 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 t -74.68 -35.82 62.78 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.911 2.085 . . . . 0.0 112.383 -176.992 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -60.35 -17.77 45.62 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 167.799 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.06 12.66 35.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 120.037 3.347 . . . . 0.0 120.037 167.434 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 73.64 21.22 2.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 124.811 2.243 . . . . 0.0 115.375 169.542 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.2 mm -78.32 135.01 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -179.517 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -112.89 170.54 8.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.008 178.347 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.3 140.4 17.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 118.469 -2.644 . . . . 0.0 111.246 169.364 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.494 0.6 OUTLIER 68.89 1.29 3.07 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 117.122 2.268 . . . . 0.0 117.122 163.708 . . . . . . . . 3 3 . 1 . 056 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -54.98 146.04 18.8 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 118.853 2.908 . . . . 0.0 118.853 169.048 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.5 m -102.24 105.66 16.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -179.547 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.69 162.19 13.16 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.121 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -113.24 132.87 55.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 127.542 3.026 . . . . 0.0 109.116 -178.383 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -105.59 110.97 23.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 129.044 2.938 . . . . 0.0 104.979 169.716 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.38 118.82 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 O-C-N 118.74 -2.475 . . . . 0.0 104.744 172.6 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.7 mt -67.12 99.08 0.64 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.629 2.772 . . . . 0.0 110.861 163.728 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -75.24 -16.12 60.49 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.823 2.849 . . . . 0.0 110.917 -157.221 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.404 ' N ' HD13 ' A' ' 73' ' ' LEU 0.366 0.0 OUTLIER -138.38 174.14 10.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 119.986 -1.696 . . . . 0.0 113.051 153.584 . . . . . . . . 4 4 . 1 . 056 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.506 23.1 ttt180 -139.67 -69.32 0.41 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 126.477 3.037 . . . . 0.0 114.262 -178.054 . . . . . . . . 2 2 . 1 . 056 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.82 148.17 8.84 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 109.12 -3.673 . . . . 0.0 108.29 -165.207 . . . . . . . . 1 1 . 1 . 056 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.295 0 O-C-N 117.742 -3.211 . . . . 0.0 120.088 178.799 . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 057 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -102.1 141.29 35.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.775 2.43 . . . . 0.0 111.343 176.26 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 pt -133.38 144.62 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 110.964 -2.834 . . . . 0.0 108.305 164.506 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -93.84 141.03 28.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 173.556 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.1 t -120.99 122.66 68.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 123.067 2.667 . . . . 0.0 105.039 170.165 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -89.17 124.49 34.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 122.146 2.248 . . . . 0.0 106.941 176.891 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.328 82.7 p -99.59 -166.84 1.39 Allowed 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 118.201 -2.812 . . . . 0.0 114.715 -172.855 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 7.5 mp -43.27 -33.62 1.01 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 119.695 3.22 . . . . 0.0 119.695 -177.745 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -110.26 -4.82 15.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.175 2.19 . . . . 0.0 112.493 -178.549 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.34 -1.72 67.28 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 179.585 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.59 127.44 31.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 129.305 3.042 . . . . 0.0 104.616 173.352 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -90.76 131.91 36.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.943 1.402 . . . . 0.0 108.236 -179.841 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.577 HD13 ' HB2' ' A' ' 34' ' ' GLU . 12.1 pt -117.49 136.07 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 123.739 1.733 . . . . 0.0 107.038 170.302 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.9 m -88.81 112.02 22.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 113.07 -3.348 . . . . 0.0 111.376 179.895 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.03 129.27 49.76 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 101.725 -3.435 . . . . 0.0 101.725 -175.987 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -82.93 133.68 35.1 Favored 'General case' 0 C--O 1.222 -0.361 1 C-N-CA 132.324 4.25 . . . . 0.0 103.925 164.262 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.91 169.06 8.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 109.832 -3.349 . . . . 0.0 108.687 -176.739 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -128.27 157.65 73.78 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.858 169.401 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -69.45 -6.73 19.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 125.115 3.876 . . . . 0.0 114.953 -174.629 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.7 p -86.31 -13.41 46.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 129.006 2.922 . . . . 0.0 112.804 167.223 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -69.29 131.72 45.31 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 122.419 2.372 . . . . 0.0 115.069 -179.149 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 p -91.36 169.2 11.0 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.066 1.746 . . . . 0.0 113.285 172.003 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.2 -17.78 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.733 178.531 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -62.75 -47.08 85.09 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 118.146 -2.846 . . . . 0.0 112.756 160.91 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -70.03 -26.12 63.89 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.786 -178.459 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -90.49 -33.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 113.02 -3.372 . . . . 0.0 107.399 -172.656 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -43.0 -44.55 4.72 Favored 'General case' 0 C--N 1.322 -0.629 1 C-N-CA 132.681 4.392 . . . . 0.0 112.841 167.795 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.08 -17.39 55.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 114.788 -2.529 . . . . 0.0 115.727 178.295 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -90.64 -22.47 21.18 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 121.54 1.973 . . . . 0.0 107.554 172.27 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.7 mt -67.21 -37.96 80.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.432 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -51.17 -42.8 61.08 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.581 2.752 . . . . 0.0 114.509 169.746 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.61 -55.24 25.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 163.982 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -80.77 -17.91 49.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -170.643 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.577 ' HB2' HD13 ' A' ' 13' ' ' ILE 0.427 25.7 tp10 -135.62 -8.7 2.17 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 121.61 3.93 . . . . 0.0 121.61 171.361 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.69 7.68 68.56 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 116.496 -3.877 . . . . 0.0 117.208 173.842 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mm -91.37 123.45 63.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 C-N-CA 130.051 3.34 . . . . 0.0 106.524 -170.985 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.324 72.9 Cg_endo -67.32 154.0 75.32 Favored 'Trans proline' 0 N--CA 1.454 -0.852 1 C-N-CA 128.095 5.863 . . . . 0.0 109.725 170.663 . . . . . . . . 3 2 . 1 . 057 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.18 -22.59 53.78 Favored 'Trans proline' 0 N--CA 1.448 -1.192 1 C-N-CA 125.313 4.009 . . . . 0.0 115.833 -164.046 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.02 -8.0 52.61 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 124.405 1.066 . . . . 0.0 110.317 -164.061 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -110.41 -9.85 14.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 118.128 -2.858 . . . . 0.0 113.573 -172.33 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.263 73.4 mt-30 -88.17 121.75 30.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.829 1.652 . . . . 0.0 106.869 -172.222 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -102.59 100.21 10.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 112.632 -2.076 . . . . 0.0 108.594 170.395 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.6 mt -90.63 126.31 35.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 119.589 -1.944 . . . . 0.0 111.842 177.443 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.1 mt -132.35 139.7 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.217 2.207 . . . . 0.0 110.853 -168.382 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -162.65 112.8 1.45 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 129.316 3.046 . . . . 0.0 112.39 -174.242 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.09 36.19 14.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 128.426 3.965 . . . . 0.0 118.496 177.292 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.08 -10.12 43.6 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 108.508 -3.951 . . . . 0.0 109.638 167.233 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -92.41 120.06 32.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 130.351 3.46 . . . . 0.0 111.448 -178.749 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -79.16 119.27 22.02 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.997 2.519 . . . . 0.0 109.055 165.028 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -79.01 129.18 34.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -158.86 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -82.77 153.44 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -172.425 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -80.47 126.57 31.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.475 170.982 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.35 -3.97 18.07 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-O 115.722 -2.71 . . . . 0.0 110.433 -172.507 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -103.14 155.85 18.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 120.652 2.226 . . . . 0.0 108.547 -167.931 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.2 p -95.98 141.43 29.4 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.61 2.364 . . . . 0.0 109.346 168.017 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.4 mt -51.23 -38.56 53.19 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 129.919 3.288 . . . . 0.0 111.696 -178.567 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -74.83 -20.44 59.76 Favored 'General case' 0 C--O 1.217 -0.624 0 O-C-N 120.103 -1.623 . . . . 0.0 111.573 -176.666 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -79.8 -25.47 40.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.371 2.268 . . . . 0.0 110.001 -178.463 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -85.86 -17.67 34.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 123.204 1.478 . . . . 0.0 114.895 166.453 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 83.17 48.45 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.867 1.667 . . . . 0.0 111.112 173.923 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.9 mt -107.18 102.97 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 1 N-CA-C 99.844 -4.132 . . . . 0.0 99.844 -174.943 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.94 154.39 24.57 Favored 'General case' 0 CA--C 1.54 0.592 1 O-C-N 130.168 4.667 . . . . 0.0 113.28 167.136 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.397 0.0 OUTLIER -38.15 133.36 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 130.896 3.678 . . . . 0.0 118.069 170.438 . . . . . . . . 3 3 . 1 . 057 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.449 15.0 mt-10 80.58 1.49 1.86 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 125.331 3.696 . . . . 0.0 112.381 -179.866 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.2 m -67.81 145.42 54.68 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 126.284 2.24 . . . . 0.0 112.385 172.428 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -108.51 114.83 28.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 101.673 -3.454 . . . . 0.0 101.673 179.132 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -98.56 155.14 17.43 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.435 1.494 . . . . 0.0 108.009 177.136 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -105.83 146.57 29.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 114.817 -2.516 . . . . 0.0 108.467 178.767 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -125.81 134.73 51.59 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.011 1.725 . . . . 0.0 108.745 177.065 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -129.59 164.46 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 1 C-N-CA 132.445 4.298 . . . . 0.0 105.642 179.719 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.84 126.43 50.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 114.271 -2.776 . . . . 0.0 105.85 -171.35 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -142.53 121.86 13.12 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 128.793 3.808 . . . . 0.0 108.415 165.532 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -79.11 124.06 27.95 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 133.498 4.719 . . . . 0.0 106.793 167.916 . . . . . . . . 2 2 . 1 . 057 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -154.99 100.81 2.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 102.059 -3.311 . . . . 0.0 102.059 171.756 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.99 116.07 1.68 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 128.565 2.983 . . . . 0.0 110.37 178.732 . . . . . . . . 1 1 . 1 . 057 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 116.129 -2.484 . . . . 0.0 117.924 162.978 . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptt? . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 . . . . . . . . . 0 0 . 1 . 058 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -104.12 137.03 42.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 118.553 -2.592 . . . . 0.0 106.825 177.2 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 3' ' ' ILE . 4.2 pt -132.41 155.11 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 129.898 3.279 . . . . 0.0 105.908 174.709 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -118.77 143.89 46.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.296 2.238 . . . . 0.0 111.737 176.8 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -126.94 115.83 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 112.069 -3.824 . . . . 0.0 108.64 178.529 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -90.78 120.91 32.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 113.596 -3.097 . . . . 0.0 114.031 175.704 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.758 HG22 HD12 ' A' ' 69' ' ' LEU . 81.8 p -80.99 160.91 24.46 Favored 'General case' 0 N--CA 1.448 -0.552 1 O-C-N 129.15 4.031 . . . . 0.0 112.815 164.039 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -45.21 93.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 -172.53 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.261 55.7 p -59.49 -17.18 29.45 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 166.931 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.07 -0.99 6.68 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.291 1.9 . . . . 0.0 108.88 154.048 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -74.58 141.67 44.72 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 119.272 -2.311 . . . . 0.0 111.31 -167.727 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.9 m -120.11 121.63 39.26 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 125.343 1.652 . . . . 0.0 111.019 -166.437 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.65 156.63 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 114.847 -2.502 . . . . 0.0 108.284 175.055 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.388 6.6 t -126.17 124.99 41.73 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 127.47 2.981 . . . . 0.0 111.095 174.693 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.84 150.11 43.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 124.441 2.067 . . . . 0.0 106.269 -171.676 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -106.82 110.98 23.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.012 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.9 136.69 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 109.16 -3.655 . . . . 0.0 109.902 -173.114 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -95.38 139.35 21.95 Favored Pre-proline 0 N--CA 1.445 -0.714 0 CA-C-O 113.78 -3.009 . . . . 0.0 106.323 169.844 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.258 23.5 Cg_exo -53.75 -29.93 54.34 Favored 'Trans proline' 0 N--CA 1.454 -0.837 1 C-N-CA 125.63 4.22 . . . . 0.0 115.103 -173.325 . . . . . . . . 3 2 . 1 . 058 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -78.94 -4.05 47.92 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 123.314 2.779 . . . . 0.0 112.627 177.873 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.61 147.13 39.82 Favored 'General case' 0 C--N 1.328 -0.354 1 O-C-N 114.749 -4.97 . . . . 0.0 110.999 -175.585 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -92.03 162.17 14.48 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.346 1.058 . . . . 0.0 108.635 -171.195 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 mm -56.52 -26.72 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 O-C-N 126.684 2.49 . . . . 0.0 113.821 -174.589 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.367 9.4 pt-20 -65.32 -34.76 79.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.375 2.67 . . . . 0.0 114.463 172.663 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -77.95 -29.49 49.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 125.545 2.593 . . . . 0.0 108.866 -176.271 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.357 31.2 m -82.47 -35.11 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 O-C-N 116.738 -3.727 . . . . 0.0 106.934 178.622 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -55.26 -46.19 76.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 116.548 -3.845 . . . . 0.0 114.0 170.816 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.281 . . -77.27 -18.77 57.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 126.382 2.991 . . . . 0.0 114.279 -174.62 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -82.35 -43.62 17.2 Favored 'General case' 0 C--N 1.322 -0.625 1 O-C-N 116.11 -4.119 . . . . 0.0 107.257 -179.476 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.423 12.1 mt -45.51 -46.78 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 128.076 2.55 . . . . 0.0 113.205 160.389 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -59.69 -50.23 74.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 117.901 -2.999 . . . . 0.0 116.794 172.71 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.452 34.7 t70 -53.08 -33.03 50.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.706 2.802 . . . . 0.0 110.721 178.099 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -80.74 -65.71 0.98 Allowed 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 113.204 -3.284 . . . . 0.0 113.621 172.707 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -97.45 -27.15 14.58 Favored 'General case' 0 N--CA 1.445 -0.724 1 O-C-N 129.645 4.34 . . . . 0.0 118.965 -165.757 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.24 7.65 59.31 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 128.531 2.967 . . . . 0.0 114.962 -179.539 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.529 HD12 HD21 ' A' ' 71' ' ' LEU . 10.7 mm -82.1 122.35 79.56 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 116.999 -3.647 . . . . 0.0 110.474 -174.394 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 96.8 Cg_endo -70.88 120.9 7.41 Favored 'Trans proline' 0 N--CA 1.443 -1.494 1 C-N-CA 128.6 6.2 . . . . 0.0 113.346 -174.95 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 37' ' ' PRO 0.278 77.5 Cg_exo -34.49 -46.79 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.688 1 C-N-CA 128.468 6.112 . . . . 0.0 116.037 -169.545 . . . . . . . . 4 3 . 1 . 058 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.289 0.5 OUTLIER -55.63 -42.59 75.16 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 116.306 -3.996 . . . . 0.0 116.258 178.609 . . . . . . . . 3 3 . 1 . 058 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -79.45 -2.88 43.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.233 0.613 . . . . 0.0 112.63 -177.196 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -85.97 141.71 29.33 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 116.662 -3.774 . . . . 0.0 108.852 173.427 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -145.29 104.6 3.95 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 111.18 -2.736 . . . . 0.0 106.071 -172.375 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -96.43 112.37 24.14 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 119.31 -2.119 . . . . 0.0 107.561 -173.373 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mt -85.47 141.9 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.011 -1.681 . . . . 0.0 110.82 168.905 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.482 ' CE2' HG23 ' A' ' 61' ' ' ILE . 14.1 t80 -147.1 119.01 8.12 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 102.253 -3.24 . . . . 0.0 102.253 164.035 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.2 22.43 11.0 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 120.957 3.688 . . . . 0.0 120.957 164.056 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.41 -22.7 38.8 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 127.414 2.435 . . . . 0.0 112.581 -175.065 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -97.1 147.26 24.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 118.189 -2.948 . . . . 0.0 107.866 -177.559 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -92.38 133.32 35.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 126.762 2.539 . . . . 0.0 104.216 163.674 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -70.11 109.9 4.85 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 118.189 -2.819 . . . . 0.0 114.801 168.862 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -74.02 147.23 43.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.297 2.639 . . . . 0.0 112.234 -176.754 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -81.26 147.96 29.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 126.8 2.562 . . . . 0.0 104.585 -166.23 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.46 -36.79 3.94 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 116.739 -2.145 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -76.26 169.99 17.18 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 127.057 3.313 . . . . 0.0 107.939 -174.849 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -103.25 174.75 5.73 Favored 'General case' 0 N--CA 1.452 -0.349 2 O-C-N 112.911 -6.118 . . . . 0.0 113.141 163.003 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.36 -29.04 41.98 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.865 1.666 . . . . 0.0 110.273 -177.336 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -71.13 -32.6 69.18 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 117.526 -1.226 . . . . 0.0 110.009 -177.579 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.09 -22.79 55.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 115.364 -2.255 . . . . 0.0 110.537 174.85 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -86.9 0.32 55.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.056 171.974 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t30 28.62 61.95 0.12 Allowed 'General case' 0 N--CA 1.445 -0.723 1 C-N-CA 138.845 6.858 . . . . 0.0 112.253 175.114 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.482 HG23 ' CE2' ' A' ' 45' ' ' PHE . 13.8 mt -98.55 -34.96 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 128.348 2.659 . . . . 0.0 105.433 -170.707 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.463 13.1 mm-40 82.12 -158.77 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.531 1.133 . . . . 0.0 112.608 178.109 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -81.65 158.33 24.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.311 3.045 . . . . 0.0 115.14 -176.077 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.309 4.1 tt0 66.52 11.75 8.28 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 128.634 2.774 . . . . 0.0 118.457 161.254 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -105.23 144.47 31.97 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 116.979 -1.486 . . . . 0.0 112.155 -162.515 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -103.41 106.72 17.3 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 122.228 2.286 . . . . 0.0 108.229 -166.726 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -75.64 153.68 37.08 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.264 164.864 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -117.3 95.05 4.8 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 129.102 2.961 . . . . 0.0 107.707 -172.096 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 7' ' ' THR . 1.2 tm? -63.85 118.16 7.97 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.253 2.221 . . . . 0.0 106.918 166.645 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -125.66 150.9 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 167.21 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.529 HD21 HD12 ' A' ' 36' ' ' ILE . 2.4 mp -100.61 160.81 14.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 117.017 -1.468 . . . . 0.0 110.871 -172.051 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -110.1 104.73 13.64 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.584 1.177 . . . . 0.0 113.941 169.086 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -94.9 122.27 37.36 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.207 -3.257 . . . . 0.0 102.207 -178.349 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.443 51.0 mtp180 89.79 -84.28 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 125.071 2.367 . . . . 0.0 109.062 164.635 . . . . . . . . 2 2 . 1 . 058 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.1 -29.26 0.74 Allowed Glycine 0 CA--C 1.533 1.21 0 CA-C-O 116.847 -2.085 . . . . 0.0 116.091 -178.034 . . . . . . . . 1 1 . 1 . 058 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 N-CA-C 107.846 -2.101 . . . . 0.0 107.846 -169.244 . . . . . . . . 0 0 . 1 . 059 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttp . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 . . . . . . . . . 0 0 . 1 . 059 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -96.18 142.17 28.68 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.854 2.462 . . . . 0.0 108.598 -174.744 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.5 pt -130.82 177.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 128.748 2.819 . . . . 0.0 111.32 161.944 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -100.71 144.68 29.39 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.253 1.421 . . . . 0.0 109.618 163.177 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.9 t -116.76 150.47 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 121.765 2.075 . . . . 0.0 105.494 158.791 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -137.85 145.87 42.77 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 128.476 2.71 . . . . 0.0 111.438 -178.363 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -106.85 163.84 12.62 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 126.797 2.561 . . . . 0.0 112.197 173.183 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.55 -33.77 75.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 122.071 2.214 . . . . 0.0 110.964 171.351 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -75.2 -17.09 60.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 121.721 2.055 . . . . 0.0 111.553 167.153 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.68 36.45 6.46 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 118.145 2.018 . . . . 0.0 118.145 156.129 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -77.54 116.65 18.27 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 117.604 -3.292 . . . . 0.0 104.116 158.93 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.257 12.8 m -93.93 157.86 15.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 114.548 -2.644 . . . . 0.0 111.298 167.939 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -154.68 152.66 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 126.076 2.11 . . . . 0.0 113.34 177.508 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.9 m -83.28 131.47 35.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 130.581 3.552 . . . . 0.0 107.113 166.033 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.86 121.53 21.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 119.065 -2.272 . . . . 0.0 110.309 -177.362 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.348 3.5 tt0 -99.35 128.8 45.5 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 -172.06 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.2 t -140.82 137.09 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 114.138 -2.839 . . . . 0.0 107.414 -171.446 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -90.32 138.47 27.11 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 126.745 2.528 . . . . 0.0 106.383 171.644 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.264 94.2 Cg_exo -45.09 -23.1 0.91 Allowed 'Trans proline' 0 N--CA 1.439 -1.703 1 C-N-CA 126.001 4.467 . . . . 0.0 120.906 167.303 . . . . . . . . 3 2 . 1 . 059 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 15.2 m -77.52 -13.84 59.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.77 1.628 . . . . 0.0 111.413 176.324 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.2 130.89 34.94 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 120.763 1.619 . . . . 0.0 107.82 179.265 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -69.73 174.73 4.81 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.94 162.369 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 23' ' ' ILE 0.25 24.7 mt -61.42 -44.76 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 128.426 2.69 . . . . 0.0 109.62 169.731 . . . . . . . . 3 3 . 1 . 059 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.81 -38.33 64.45 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 128.858 2.863 . . . . 0.0 110.212 175.997 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -73.15 -34.6 66.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 116.422 -1.751 . . . . 0.0 113.276 177.165 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 57.9 t -62.29 -37.42 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 125.185 3.63 . . . . 0.0 108.79 168.683 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 74.5 mttt -66.1 -40.61 90.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.507 1.754 . . . . 0.0 115.158 171.41 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.4 87.53 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.554 1.942 . . . . 0.0 112.88 171.251 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 48.9 mttp -67.81 -41.49 83.04 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 123.628 1.68 . . . . 0.0 111.041 173.567 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.273 94.2 mt -55.55 -58.07 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 1 O-C-N 115.622 -4.424 . . . . 0.0 110.141 168.526 . . . . . . . . 3 2 . 1 . 059 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -45.37 -37.61 5.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 165.278 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.13 -45.14 42.92 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.727 2.011 . . . . 0.0 113.786 177.504 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 mmtm -107.51 -35.03 6.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -166.214 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.3 -30.56 18.36 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.868 2.867 . . . . 0.0 110.411 179.495 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.13 52.73 6.6 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 125.885 1.707 . . . . 0.0 111.479 174.012 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.62 145.43 33.86 Favored Pre-proline 0 N--CA 1.447 -0.595 0 C-N-CA 129.913 3.285 . . . . 0.0 112.31 -178.782 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.09 128.29 12.1 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 124.92 3.747 . . . . 0.0 116.788 162.572 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 4.9 Cg_endo -75.33 -46.9 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.791 3.661 . . . . 0.0 108.734 -165.522 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.261 23.6 t70 -34.25 -33.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.452 1 C-N-CA 132.391 4.276 . . . . 0.0 119.518 -176.256 . . . . . . . . 3 2 . 1 . 059 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -85.89 -22.27 27.59 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.028 1.731 . . . . 0.0 114.26 175.418 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -98.82 145.79 26.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -160.627 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -118.16 154.39 32.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 118.244 -2.785 . . . . 0.0 110.296 172.625 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HB3' HD11 ' A' ' 67' ' ' LEU . 2.3 mp -108.29 135.45 49.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 167.056 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.1 mm -122.41 129.41 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 128.304 2.641 . . . . 0.0 106.51 175.457 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.497 ' CE1' HG12 ' A' ' 61' ' ' ILE . 44.6 t80 -138.44 131.3 29.57 Favored 'General case' 0 C--O 1.221 -0.421 1 C-N-CA 132.371 4.268 . . . . 0.0 108.057 172.365 . . . . . . . . 3 3 . 1 . 059 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.78 31.96 21.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 130.115 3.366 . . . . 0.0 115.404 -166.895 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.79 15.0 81.01 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 128.419 2.914 . . . . 0.0 111.413 179.204 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -144.37 156.66 44.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 124.112 3.956 . . . . 0.0 113.565 -171.496 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.83 120.35 20.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 126.077 2.846 . . . . 0.0 104.369 -173.345 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.45 66.9 mt -86.05 157.2 20.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 111.366 -2.652 . . . . 0.0 108.769 -178.6 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -91.79 132.99 36.02 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.274 -1.517 . . . . 0.0 107.653 -168.899 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.01 114.57 14.8 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.738 -1.226 . . . . 0.0 109.926 -166.961 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.83 -6.75 11.15 Favored Glycine 0 CA--C 1.522 0.483 0 O-C-N 117.968 -2.958 . . . . 0.0 110.47 -173.733 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -79.21 161.42 26.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 124.509 2.1 . . . . 0.0 112.31 174.67 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 p -91.25 176.87 6.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 114.012 -2.899 . . . . 0.0 112.747 167.472 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.3 tp -75.05 -28.88 60.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.613 2.365 . . . . 0.0 111.542 -173.743 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -80.11 -23.84 40.95 Favored 'General case' 0 N--CA 1.449 -0.501 1 O-C-N 115.822 -4.299 . . . . 0.0 117.138 174.2 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -67.44 -26.07 66.22 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 172.221 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -93.76 -9.22 38.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.72 2.008 . . . . 0.0 112.647 159.185 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 p30 50.99 51.7 16.53 Favored 'General case' 0 N--CA 1.45 -0.468 1 C-N-CA 131.82 4.048 . . . . 0.0 112.019 -177.997 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.497 HG12 ' CE1' ' A' ' 45' ' ' PHE . 21.5 mt -71.25 110.43 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 127.912 2.485 . . . . 0.0 109.675 162.067 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -96.34 174.41 6.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.866 -1.97 . . . . 0.0 107.981 -171.744 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -37.46 137.97 0.37 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 120.077 3.362 . . . . 0.0 120.077 162.825 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 9.4 tt0 57.25 35.01 25.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.908 3.283 . . . . 0.0 114.461 179.755 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -91.07 158.96 16.37 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.451 1.5 . . . . 0.0 111.31 174.595 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.6 m -112.35 115.63 29.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 123.036 1.398 . . . . 0.0 110.026 171.991 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.461 HD11 ' HB3' ' A' ' 43' ' ' LEU . 19.3 tp -89.43 141.32 28.67 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 127.152 3.358 . . . . 0.0 102.848 162.187 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -108.1 136.56 47.58 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 -177.819 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.292 13.7 tp -115.17 95.3 5.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.206 -172.997 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.13 110.22 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 126.81 2.044 . . . . 0.0 108.203 171.171 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.299 2.9 mm? -93.33 155.42 17.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 121.108 1.776 . . . . 0.0 109.237 179.327 . . . . . . . . 2 2 . 1 . 059 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -145.94 114.18 6.64 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 103.139 -2.911 . . . . 0.0 103.139 165.416 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -122.33 127.48 49.85 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.937 2.095 . . . . 0.0 110.114 -171.984 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.8 ttp-105 -94.0 -45.67 7.49 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 116.628 -3.795 . . . . 0.0 104.856 178.0 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.06 170.47 26.17 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 122.435 2.379 . . . . 0.0 108.939 173.818 . . . . . . . . 1 1 . 1 . 059 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 C-N-CA 126.418 1.961 . . . . 0.0 110.145 173.463 . . . . . . . . 0 0 . 1 . 060 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -82.52 146.45 29.21 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.003 2.121 . . . . 0.0 107.154 -174.812 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -142.23 161.7 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 121.798 2.09 . . . . 0.0 108.702 166.553 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -100.85 144.1 30.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.981 1.426 . . . . 0.0 113.757 162.305 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.9 t -110.19 115.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 159.091 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -89.32 137.04 32.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 155.358 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -86.9 146.66 26.09 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 165.089 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 8' ' ' LEU . 2.6 mm? -62.19 4.7 0.12 Allowed 'General case' 0 N--CA 1.445 -0.68 1 C-N-CA 132.463 4.305 . . . . 0.0 112.936 165.814 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -106.46 12.1 30.02 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 119.373 -2.079 . . . . 0.0 113.693 171.489 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.4 -20.19 35.42 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 115.645 -2.753 . . . . 0.0 116.281 169.118 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.315 74.9 tttt -101.0 130.59 47.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 126.635 3.112 . . . . 0.0 105.373 -166.203 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 m -107.91 125.25 51.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 124.717 2.198 . . . . 0.0 108.932 177.781 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.8 mt -110.31 120.75 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 -172.288 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 m -97.19 131.3 44.07 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 118.027 -2.92 . . . . 0.0 106.932 -178.682 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.29 154.06 35.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.965 2.906 . . . . 0.0 111.501 -176.412 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -109.4 137.85 46.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 123.424 1.583 . . . . 0.0 108.148 161.944 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.325 21.0 m -128.02 149.78 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 119.946 3.313 . . . . 0.0 119.946 -178.582 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -85.26 156.54 59.85 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 128.069 2.548 . . . . 0.0 105.807 172.785 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.356 60.0 Cg_endo -70.19 -33.94 14.05 Favored 'Trans proline' 0 N--CA 1.447 -1.207 2 C-N-CA 129.276 6.65 . . . . 0.0 114.165 -179.915 . . . . . . . . 3 2 . 1 . 060 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.6 m -115.73 17.44 16.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 118.674 -2.516 . . . . 0.0 104.311 -167.935 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -84.01 161.27 20.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 125.322 2.487 . . . . 0.0 109.336 178.923 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.41 49.8 p -93.6 147.86 22.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 -163.146 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.305 12.4 mm -44.44 -43.92 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 121.569 3.914 . . . . 0.0 121.569 165.478 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 pm0 -79.69 -15.95 56.6 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 113.434 -3.175 . . . . 0.0 108.571 -174.239 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -74.45 -33.15 62.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 122.412 2.369 . . . . 0.0 106.921 172.299 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.431 ' H ' HG23 ' A' ' 26' ' ' VAL . 39.2 t -49.97 -48.4 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 124.378 3.263 . . . . 0.0 114.373 167.77 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -64.5 -37.35 87.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 114.704 -2.57 . . . . 0.0 111.906 -176.519 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.06 70.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 128.082 2.553 . . . . 0.0 111.358 171.502 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -80.75 -25.69 37.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.677 -1.89 . . . . 0.0 110.497 -176.65 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 30' ' ' ILE 0.264 30.3 mm -65.94 -45.49 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 116.351 -1.785 . . . . 0.0 106.832 169.858 . . . . . . . . 3 3 . 1 . 060 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -62.3 -50.52 71.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 121.504 1.956 . . . . 0.0 114.89 -179.713 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -39.74 -39.66 0.82 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.299 2.24 . . . . 0.0 114.549 172.934 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.2 tttt -98.04 -41.48 7.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 117.845 -3.034 . . . . 0.0 108.006 177.34 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -113.05 -23.03 10.26 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 124.463 3.302 . . . . 0.0 111.869 -149.639 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.96 -1.63 85.12 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-O 116.799 -2.112 . . . . 0.0 116.603 174.709 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.0 mm -78.99 118.92 75.21 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 121.8 2.8 . . . . 0.0 104.303 176.342 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.69 165.35 16.12 Favored 'Trans proline' 0 N--CA 1.45 -1.053 1 C-N-CA 126.543 4.829 . . . . 0.0 113.934 179.106 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.53 -27.27 39.47 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.608 2.205 . . . . 0.0 115.246 178.53 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -69.77 1.4 4.35 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 117.466 -3.271 . . . . 0.0 111.57 -178.634 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -121.04 -14.91 8.34 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 128.598 2.759 . . . . 0.0 109.214 -169.989 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -106.47 114.07 27.96 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 128.575 3.672 . . . . 0.0 106.825 -172.198 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -108.87 141.23 41.23 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.661 2.785 . . . . 0.0 108.17 161.248 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.28 1.5 mp -116.08 139.97 49.75 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -177.51 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 mt -112.24 151.57 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 O-C-N 127.23 2.831 . . . . 0.0 103.63 169.54 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -128.16 124.41 36.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 161.451 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.326 . . 58.57 -81.88 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 128.796 2.838 . . . . 0.0 115.467 -172.743 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.63 1.34 4.35 Favored Glycine 0 CA--C 1.533 1.176 2 O-C-N 130.294 4.747 . . . . 0.0 112.534 171.565 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -122.37 151.33 41.31 Favored 'General case' 0 C--N 1.322 -0.606 1 CA-C-N 125.352 4.576 . . . . 0.0 106.643 -169.542 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 74.9 mt-30 -72.56 138.35 46.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.533 -174.601 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.53 HD11 HD12 ' A' ' 67' ' ' LEU . 82.3 mt -95.98 120.91 37.1 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 117.079 -1.848 . . . . 0.0 112.695 171.059 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -92.63 154.02 18.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -176.446 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.87 154.9 29.38 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 131.576 3.95 . . . . 0.0 110.625 178.976 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.89 0.34 83.63 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 122.773 1.207 . . . . 0.0 115.505 171.786 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -124.75 145.85 49.5 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 131.403 3.881 . . . . 0.0 105.731 -167.006 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.41 30.5 p -79.94 159.47 26.31 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 112.225 -2.261 . . . . 0.0 115.389 -171.745 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -51.9 14.13 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 126.672 2.483 . . . . 0.0 109.919 -172.104 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -78.0 -0.37 27.56 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.431 2.692 . . . . 0.0 106.41 -168.347 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.4 -31.01 70.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 124.639 2.161 . . . . 0.0 107.127 175.576 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.353 8.3 m-85 -107.84 -179.44 3.9 Favored 'General case' 0 N--CA 1.449 -0.505 1 O-C-N 115.998 -4.189 . . . . 0.0 107.87 175.572 . . . . . . . . 3 2 . 1 . 060 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -92.9 45.68 1.19 Allowed 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 118.179 -2.826 . . . . 0.0 116.137 175.633 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.07 138.85 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 117.753 -1.117 . . . . 0.0 108.88 166.428 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -154.12 -178.46 7.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.541 1.937 . . . . 0.0 109.779 -164.438 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -50.3 115.57 1.5 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.177 1.791 . . . . 0.0 109.301 171.478 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 55.78 33.57 21.71 Favored 'General case' 0 N--CA 1.452 -0.337 1 C-N-CA 133.619 4.768 . . . . 0.0 113.491 -178.064 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 138.8 56.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.313 1.845 . . . . 0.0 108.812 158.046 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.4 m -103.93 136.61 43.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.628 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.53 HD12 HD11 ' A' ' 50' ' ' LEU . 2.4 mm? -107.97 139.54 42.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 130.251 3.42 . . . . 0.0 116.771 156.202 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -97.34 124.26 41.43 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 113.219 -3.277 . . . . 0.0 107.145 -175.552 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.7 tp -93.87 124.14 37.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 128.242 3.464 . . . . 0.0 109.664 -179.248 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.2 116.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 130.194 3.398 . . . . 0.0 106.26 -177.563 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 87.4 mt -95.78 -12.21 25.7 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 126.116 2.135 . . . . 0.0 111.736 -166.854 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.296 6.6 tmm_? 95.66 -21.57 0.05 Allowed 'General case' 0 N--CA 1.454 -0.263 1 C-N-CA 134.554 5.141 . . . . 0.0 114.025 -173.287 . . . . . . . . 3 2 . 1 . 060 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.45 120.2 38.75 Favored 'General case' 0 N--CA 1.448 -0.55 1 CA-C-O 129.537 4.494 . . . . 0.0 110.113 179.677 . . . . . . . . 2 2 . 1 . 060 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -154.25 161.33 41.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 101.518 -3.512 . . . . 0.0 101.518 160.208 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.82 35.22 4.28 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 120.324 1.42 . . . . 0.0 114.031 -177.862 . . . . . . . . 1 1 . 1 . 060 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.412 0 CA-C-O 115.663 -2.743 . . . . 0.0 111.669 -168.379 . . . . . . . . 0 0 . 1 . 061 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.625 0 CA-C-O 117.73 -1.128 . . . . 0.0 109.155 . . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -88.65 125.72 34.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.19 2.196 . . . . 0.0 113.676 -179.494 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -109.76 164.12 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 124.13 3.15 . . . . 0.0 111.054 177.984 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -117.83 145.56 44.49 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 117.53 -3.231 . . . . 0.0 110.07 170.66 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.3 t -122.18 127.51 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 174.055 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -73.78 111.76 9.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 111.671 -2.513 . . . . 0.0 106.422 168.896 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 m -108.61 126.97 53.54 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -178.755 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.651 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -55.14 -6.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 1 N-CA-C 122.133 4.123 . . . . 0.0 122.133 178.124 . . . . . . . . 4 4 . 1 . 061 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -83.01 3.35 30.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 123.878 0.736 . . . . 0.0 109.589 175.9 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.62 21.81 30.49 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 123.705 1.725 . . . . 0.0 114.793 -178.704 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -123.78 135.56 53.88 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 116.645 -1.645 . . . . 0.0 109.102 -162.665 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.9 m -114.79 85.09 2.18 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.981 1.848 . . . . 0.0 111.32 177.695 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 13' ' ' ILE . 9.6 pt -77.11 161.63 4.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 O-C-N 119.1 -2.25 . . . . 0.0 106.812 -167.031 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -128.5 136.41 50.76 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 125.308 1.63 . . . . 0.0 109.774 178.582 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.331 0.3 OUTLIER -141.04 146.84 37.73 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 129.866 3.266 . . . . 0.0 114.036 -179.778 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -92.6 120.03 32.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 129.464 3.106 . . . . 0.0 105.599 -171.05 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 16.0 m -127.37 162.85 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 116.364 -3.96 . . . . 0.0 109.732 177.756 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.61 159.96 69.53 Favored Pre-proline 0 N--CA 1.451 -0.414 1 O-C-N 115.485 -4.509 . . . . 0.0 107.053 164.882 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -53.48 -46.84 30.85 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 N-CA-C 118.595 2.498 . . . . 0.0 118.595 -167.172 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.1 m -79.0 5.55 11.44 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 128.653 2.781 . . . . 0.0 112.56 -169.051 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.266 89.9 m-20 -77.66 140.61 39.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.73 -1.231 . . . . 0.0 109.494 176.658 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -86.0 146.62 26.59 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 129.08 3.988 . . . . 0.0 107.605 -179.522 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.77 -23.9 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 128.646 2.779 . . . . 0.0 111.762 -175.544 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -61.82 -38.83 89.64 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.974 2.91 . . . . 0.0 111.452 166.963 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.13 -35.61 78.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 125.756 2.693 . . . . 0.0 113.421 179.81 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -82.7 -37.71 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 112.44 -2.164 . . . . 0.0 109.3 176.425 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.363 61.8 mttt -48.72 -50.27 34.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.031 2.933 . . . . 0.0 111.665 168.143 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.3 56.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 116.056 -1.926 . . . . 0.0 109.928 -173.292 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -63.58 -45.2 91.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 122.474 2.397 . . . . 0.0 116.89 165.955 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -55.51 -40.54 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 114.822 -2.513 . . . . 0.0 110.223 167.713 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -61.5 -42.12 98.32 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 113.535 -3.126 . . . . 0.0 112.906 171.302 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.444 29.9 t70 -57.08 -27.83 62.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 122.627 2.467 . . . . 0.0 116.292 173.124 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -94.58 -55.7 3.05 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 126.485 2.366 . . . . 0.0 111.039 -174.298 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -117.31 -21.34 8.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.465 1.506 . . . . 0.0 113.835 -165.087 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.63 12.03 45.51 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 115.67 -2.739 . . . . 0.0 111.668 168.296 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 36' ' ' ILE . 39.3 mt -82.95 132.24 51.59 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 118.87 1.335 . . . . 0.0 112.608 171.434 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.21 121.79 8.61 Favored 'Trans proline' 0 N--CA 1.456 -0.692 1 C-N-CA 129.153 6.569 . . . . 0.0 113.758 178.222 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.297 32.3 Cg_exo -40.78 -35.23 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 1 C-N-CA 126.296 4.664 . . . . 0.0 117.43 170.908 . . . . . . . . 3 2 . 1 . 061 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.75 -35.09 78.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 -175.871 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -77.62 -42.11 36.11 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 130.48 3.512 . . . . 0.0 115.387 170.049 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.27 146.97 53.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.612 1.165 . . . . 0.0 114.029 -173.723 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.429 ' HB3' HG23 ' A' ' 70' ' ' VAL . 2.4 ttt180 -141.98 154.34 44.96 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 131.693 3.997 . . . . 0.0 109.88 -177.143 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.7 mt -130.11 159.61 36.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 116.72 -3.737 . . . . 0.0 115.865 177.532 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.03 136.51 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 130.004 3.322 . . . . 0.0 115.74 165.01 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 65' ' ' SER . 91.3 t80 -140.18 145.59 37.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 167.672 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.21 33.09 19.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.705 2.802 . . . . 0.0 112.086 168.007 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.26 -24.19 12.46 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.851 -1.527 . . . . 0.0 113.978 -175.033 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -87.41 141.74 28.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 121.499 2.65 . . . . 0.0 105.461 -169.889 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.61 122.68 27.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 166.05 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -75.47 137.74 41.14 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -173.983 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 2.5 mp0 -89.43 159.78 17.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 125.228 1.58 . . . . 0.0 106.91 176.607 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.11 121.89 30.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 126.203 2.189 . . . . 0.0 107.234 172.746 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.32 -33.24 3.06 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-O 124.523 2.18 . . . . 0.0 113.165 -178.398 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.437 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 4.1 mtt-85 -82.52 167.87 17.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 112.777 -1.711 . . . . 0.0 112.698 177.821 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.0 p -109.64 167.75 9.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -176.747 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.411 HD23 HD12 ' A' ' 61' ' ' ILE . 83.4 mt -56.11 -48.96 75.17 Favored 'General case' 0 N--CA 1.45 -0.44 1 C-N-CA 131.98 4.112 . . . . 0.0 105.885 172.833 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -43.98 17.01 Favored 'General case' 0 N--CA 1.444 -0.765 1 C-N-CA 131.747 4.019 . . . . 0.0 108.518 174.052 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.69 -16.38 48.47 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 124.365 3.257 . . . . 0.0 114.067 178.962 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -114.17 2.66 14.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 114.803 -2.522 . . . . 0.0 111.544 -174.661 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.305 67.3 m-80 74.85 16.33 2.99 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.794 2.438 . . . . 0.0 111.686 173.655 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.411 HD12 HD23 ' A' ' 56' ' ' LEU . 74.8 mt -68.39 128.05 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 O-C-N 117.521 -3.237 . . . . 0.0 113.905 -174.22 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -123.41 -163.45 1.12 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.152 2.581 . . . . 0.0 107.64 -178.854 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -50.81 119.26 3.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 123.375 1.56 . . . . 0.0 113.768 169.899 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.321 50.8 mt-10 74.94 21.38 2.03 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.024 -1.672 . . . . 0.0 111.576 163.171 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 45.8 m -53.7 126.28 21.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 115.96 -1.971 . . . . 0.0 110.223 160.663 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -97.38 112.38 24.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.163 2.185 . . . . 0.0 109.314 171.856 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.314 8.7 mp -97.82 167.26 11.04 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.399 1.88 . . . . 0.0 108.864 176.144 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -116.59 124.17 49.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.822 2.849 . . . . 0.0 104.605 -176.118 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -97.78 132.19 43.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.978 2.911 . . . . 0.0 110.574 -177.229 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 42' ' ' ARG 0.292 4.1 m -142.32 171.29 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 112.921 -1.945 . . . . 0.0 110.752 -176.538 . . . . . . . . 3 3 . 1 . 061 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.65 138.65 22.28 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 172.519 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.416 14.8 ttt85 85.97 -54.72 0.07 Allowed 'General case' 0 C--N 1.321 -0.658 1 C-N-CA 132.14 4.176 . . . . 0.0 113.016 164.903 . . . . . . . . 3 2 . 1 . 061 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.4 mt -95.97 144.66 26.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 128.275 2.63 . . . . 0.0 112.167 -160.667 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.3 135.88 39.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 124.242 0.964 . . . . 0.0 112.0 -176.852 . . . . . . . . 2 2 . 1 . 061 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.13 169.32 18.08 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 128.651 3.024 . . . . 0.0 109.303 176.853 . . . . . . . . 1 1 . 1 . 061 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.515 0 CA-C-O 115.848 -2.64 . . . . 0.0 110.419 178.064 . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 ptt? . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 116.878 -1.534 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 062 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.411 49.4 mm-40 -109.15 146.39 34.18 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 116.717 -1.611 . . . . 0.0 108.166 -170.609 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 pt -145.33 156.86 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 121.208 1.822 . . . . 0.0 109.038 170.473 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -99.84 141.29 32.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 178.668 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 30' ' ' ILE . 52.9 t -107.58 133.71 51.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 156.513 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -91.34 117.6 29.8 Favored 'General case' 0 C--N 1.325 -0.474 1 C-N-CA 132.743 4.417 . . . . 0.0 110.26 170.298 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -82.65 162.46 21.84 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.342 1.857 . . . . 0.0 110.07 176.821 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pp -78.76 -24.47 44.7 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 127.384 2.274 . . . . 0.0 110.179 172.024 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -87.84 -18.02 30.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 119.867 -1.77 . . . . 0.0 114.136 -178.275 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.17 7.67 3.16 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 128.506 2.955 . . . . 0.0 115.903 144.576 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -90.62 163.34 14.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 125.36 2.505 . . . . 0.0 107.71 174.817 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.3 m -128.29 117.23 21.11 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.942 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.32 129.75 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 128.458 2.703 . . . . 0.0 103.837 -167.426 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -91.57 107.73 19.41 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -177.033 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.316 48.7 mt -102.91 152.52 21.2 Favored 'General case' 0 N--CA 1.449 -0.517 1 CA-C-N 126.341 4.155 . . . . 0.0 107.935 175.581 . . . . . . . . 3 2 . 1 . 062 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -113.78 119.93 39.04 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 114.68 -2.581 . . . . 0.0 106.15 175.313 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -124.7 149.68 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 125.003 1.439 . . . . 0.0 114.661 -175.309 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -81.61 130.61 60.81 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-O 114.991 -2.433 . . . . 0.0 104.556 167.309 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -38.71 -25.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.379 1 N-CA-C 123.163 4.255 . . . . 0.0 123.163 165.69 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.1 p -115.06 18.54 16.26 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 126.147 2.154 . . . . 0.0 114.466 178.99 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -59.46 111.33 1.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 128.822 2.849 . . . . 0.0 112.636 156.806 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -72.06 169.53 15.8 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 123.256 2.753 . . . . 0.0 111.192 -177.528 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.321 18.7 mm -51.11 -32.16 11.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 125.773 1.629 . . . . 0.0 113.782 -179.916 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -87.15 -20.86 26.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 122.179 2.263 . . . . 0.0 106.893 -175.314 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -79.39 -39.18 33.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.622 1.169 . . . . 0.0 112.482 179.839 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.3 t -43.07 -39.13 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 128.497 2.719 . . . . 0.0 113.157 161.884 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -75.01 -37.66 61.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 119.512 -1.992 . . . . 0.0 112.939 -171.818 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.285 . . -68.28 -16.69 64.05 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.974 2.509 . . . . 0.0 114.444 172.298 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.25 -38.42 17.59 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.572 2.349 . . . . 0.0 112.316 171.329 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 5' ' ' VAL . 71.9 mt -58.19 -42.41 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 114.449 -2.691 . . . . 0.0 114.451 157.445 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -48.63 -62.87 1.28 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.193 2.197 . . . . 0.0 112.471 165.283 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -33.0 -40.59 0.06 Allowed 'General case' 0 N--CA 1.448 -0.57 1 CA-C-O 111.589 -4.053 . . . . 0.0 119.709 170.656 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.48 -53.1 3.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 128.202 3.439 . . . . 0.0 111.473 176.865 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -112.97 -3.75 14.01 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -167.657 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.0 -8.94 77.54 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 116.895 -2.058 . . . . 0.0 115.683 160.5 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -66.21 130.0 94.25 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 129.045 2.938 . . . . 0.0 109.035 -172.454 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -71.22 143.15 43.2 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 N-CA-C 107.975 -1.587 . . . . 0.0 107.975 172.599 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.3 46.7 Cg_exo -28.86 -60.74 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 1 C-N-CA 126.369 4.712 . . . . 0.0 117.741 163.593 . . . . . . . . 3 2 . 1 . 062 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.401 ' CG ' HH21 ' A' ' 74' ' ' ARG . 28.5 t70 -55.41 -25.49 36.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 122.082 2.219 . . . . 0.0 115.568 -172.463 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -89.89 -9.89 47.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 176.211 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -94.75 154.76 17.14 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 131.599 3.96 . . . . 0.0 107.085 -175.838 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -143.47 152.38 41.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 113.853 -2.975 . . . . 0.0 104.821 163.634 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.267 76.5 mt -123.79 119.64 30.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.5 1.955 . . . . 0.0 107.385 -173.106 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -107.52 143.13 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 127.758 2.423 . . . . 0.0 110.005 -179.131 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -155.29 143.97 20.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.421 2.288 . . . . 0.0 109.304 172.343 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.66 31.88 13.52 Favored 'General case' 0 C--N 1.328 -0.331 3 O-C-N 114.566 -5.084 . . . . 0.0 114.217 161.483 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.27 2.56 62.01 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.645 2.069 . . . . 0.0 116.449 171.386 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.338 41.5 pttt -136.1 150.4 49.1 Favored 'General case' 0 N--CA 1.445 -0.717 1 C-N-CA 133.225 4.61 . . . . 0.0 114.966 -169.271 . . . . . . . . 3 2 . 1 . 062 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 48.8 tt0 -76.54 140.73 41.24 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.704 2.002 . . . . 0.0 106.996 162.455 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 mt -71.6 129.49 38.86 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 114.764 -2.541 . . . . 0.0 112.992 171.714 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.82 139.68 30.22 Favored 'General case' 0 N--CA 1.447 -0.581 1 C-N-CA 131.814 4.046 . . . . 0.0 105.057 -173.446 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.83 117.86 24.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 127.628 2.371 . . . . 0.0 115.856 -174.126 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.46 11.44 1.73 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.391 1.948 . . . . 0.0 112.836 179.684 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -141.11 163.65 32.39 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -174.058 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -123.73 -179.29 4.31 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 119.226 -2.171 . . . . 0.0 109.728 -162.994 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -58.84 -33.75 70.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 118.464 -2.648 . . . . 0.0 114.601 172.192 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 p -76.27 -34.61 59.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 120.94 1.7 . . . . 0.0 107.056 179.582 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -74.08 -42.61 59.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 125.5 1.75 . . . . 0.0 109.537 -173.237 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -76.44 4.04 9.93 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 118.762 -2.461 . . . . 0.0 115.215 166.892 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 75.8 18.0 2.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 131.529 3.932 . . . . 0.0 114.483 168.268 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.4 mt -69.97 132.98 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 O-C-N 119.295 -2.128 . . . . 0.0 108.681 -174.233 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -124.27 153.4 41.75 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 112.859 -3.448 . . . . 0.0 109.98 -173.861 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.27 135.02 27.17 Favored 'General case' 0 N--CA 1.443 -0.802 1 O-C-N 129.111 4.007 . . . . 0.0 113.049 -177.048 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.588 80.8 mt-10 84.93 11.17 0.31 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 128.247 2.619 . . . . 0.0 116.505 172.645 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.308 27.9 m -86.65 159.9 19.06 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 116.229 -1.843 . . . . 0.0 110.964 170.978 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.8 m -130.95 113.34 13.88 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.276 1.83 . . . . 0.0 107.143 -158.948 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.7 163.32 12.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 130.575 3.55 . . . . 0.0 113.906 -179.885 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -122.17 154.86 36.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -161.31 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.257 39.1 tp -145.58 117.93 8.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 125.619 2.628 . . . . 0.0 105.913 -167.853 . . . . . . . . 2 2 . 1 . 062 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 t -110.17 119.39 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 110.588 -3.006 . . . . 0.0 108.142 169.433 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.84 145.49 40.57 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 119.427 -2.045 . . . . 0.0 110.294 167.157 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -100.42 173.5 6.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 102.009 -3.33 . . . . 0.0 102.009 177.197 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.6 mt -73.86 175.2 7.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.566 -1.334 . . . . 0.0 113.49 165.646 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.401 HH21 ' CG ' ' A' ' 39' ' ' ASP . 58.1 ttp180 65.1 121.89 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.828 1 C-N-CA 134.207 5.003 . . . . 0.0 117.331 -167.342 . . . . . . . . 3 3 . 1 . 062 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.25 144.5 6.78 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.016 -1.991 . . . . 0.0 110.852 179.903 . . . . . . . . 1 1 . 1 . 062 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.122 0 CA-C-O 113.799 -3.778 . . . . 0.0 111.946 -161.174 . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttm . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 063 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -87.31 117.5 26.12 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.93 2.892 . . . . 0.0 112.728 -175.513 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.57 167.5 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.428 1.491 . . . . 0.0 109.742 170.961 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -140.6 115.21 9.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 125.327 2.489 . . . . 0.0 105.651 -168.912 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 15' ' ' LEU . 15.5 t -101.55 109.23 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.663 -2.062 . . . . 0.0 111.807 -179.239 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -93.99 121.11 35.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 115.549 -2.167 . . . . 0.0 113.489 -174.528 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.0 p -73.48 179.32 4.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 128.246 2.618 . . . . 0.0 111.259 -177.453 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.52 -32.16 60.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.19 2.196 . . . . 0.0 108.274 172.2 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.42 -21.71 59.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.155 2.182 . . . . 0.0 109.852 179.741 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.11 -4.56 58.86 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 117.244 -1.865 . . . . 0.0 114.92 177.511 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -65.92 143.9 57.13 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.9 1.0 . . . . 0.0 110.889 170.615 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -138.15 99.93 4.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.137 -2.227 . . . . 0.0 106.011 -158.844 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.5 mm -95.72 131.78 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.226 -169.946 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 m -94.75 105.49 17.43 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 119.628 -1.92 . . . . 0.0 107.64 -171.486 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.542 HD12 HG21 ' A' ' 5' ' ' VAL . 47.8 mt -93.98 127.23 39.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 125.143 2.402 . . . . 0.0 105.594 179.401 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -95.79 110.47 22.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 119.786 -1.821 . . . . 0.0 107.506 174.071 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.14 170.57 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.598 2.759 . . . . 0.0 107.596 -174.68 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -114.39 162.41 23.49 Favored Pre-proline 0 N--CA 1.449 -0.509 1 O-C-N 129.19 4.056 . . . . 0.0 108.892 150.195 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -57.88 -14.62 18.78 Favored 'Trans proline' 0 N--CA 1.447 -1.252 1 C-N-CA 125.716 4.277 . . . . 0.0 115.486 -175.555 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.1 p -90.74 0.32 57.47 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 116.912 -3.617 . . . . 0.0 114.853 -179.383 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.74 137.91 44.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 127.983 3.302 . . . . 0.0 106.396 -176.57 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -83.39 170.69 14.26 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.171 1.35 . . . . 0.0 112.512 173.264 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 50' ' ' LEU . 47.1 mt -58.7 -42.82 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 129.26 3.024 . . . . 0.0 108.018 170.816 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -49.57 -46.99 49.53 Favored 'General case' 0 C--N 1.329 -0.294 1 C-N-CA 132.535 4.334 . . . . 0.0 109.854 166.909 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -73.61 -45.65 51.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 120.448 1.476 . . . . 0.0 110.067 -177.925 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -53.57 -48.87 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 117.315 -1.326 . . . . 0.0 108.497 171.181 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -67.39 -36.28 81.0 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 120.086 1.312 . . . . 0.0 110.368 -178.668 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.53 -40.37 78.64 Favored 'General case' 0 C--O 1.217 -0.624 1 O-C-N 115.923 -4.235 . . . . 0.0 110.703 171.238 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.319 39.2 mttp -62.14 -49.74 74.66 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.253 3.421 . . . . 0.0 117.432 -179.389 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.92 -33.94 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 128.683 3.739 . . . . 0.0 110.462 164.479 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -75.34 -37.89 60.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 121.599 2.0 . . . . 0.0 115.014 -178.903 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -55.21 -37.99 67.85 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 126.89 2.076 . . . . 0.0 113.842 172.849 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -80.99 -83.1 0.11 Allowed 'General case' 0 N--CA 1.442 -0.87 1 C-N-CA 132.108 4.163 . . . . 0.0 114.022 -176.966 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -92.37 -0.27 57.39 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 116.884 -1.531 . . . . 0.0 110.975 -174.922 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.23 11.58 82.05 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 122.652 2.478 . . . . 0.0 114.239 175.961 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.9 mm -67.77 126.8 93.08 Favored Pre-proline 0 N--CA 1.446 -0.628 1 C-N-CA 132.313 4.245 . . . . 0.0 110.808 -177.103 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -64.14 149.39 90.46 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.542 3.494 . . . . 0.0 113.4 171.519 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -68.44 -55.69 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.212 2.608 . . . . 0.0 114.422 178.044 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -52.44 -25.21 9.4 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 127.305 2.878 . . . . 0.0 113.066 -173.12 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -79.2 -10.91 59.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.077 178.857 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -111.85 152.91 27.39 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 130.206 3.402 . . . . 0.0 116.609 -168.398 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -137.96 138.69 39.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 118.712 -2.493 . . . . 0.0 106.295 166.473 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 69' ' ' LEU . 41.2 mt -107.63 148.5 29.26 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.244 3.018 . . . . 0.0 112.026 -171.819 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.4 mt -147.74 118.69 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 126.811 2.044 . . . . 0.0 107.757 -164.982 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CD1' HG12 ' A' ' 61' ' ' ILE . 45.3 t80 -146.56 140.69 26.31 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 126.018 1.727 . . . . 0.0 106.997 169.993 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 74.9 21.07 2.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.987 2.515 . . . . 0.0 116.123 169.542 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.75 3.01 61.07 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 120.413 -1.43 . . . . 0.0 112.299 179.705 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.315 16.7 ptpt -127.96 133.93 49.25 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -171.406 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -75.21 132.76 41.34 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 102.029 -3.322 . . . . 0.0 102.029 163.539 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.447 ' HB3' HD11 ' A' ' 23' ' ' ILE . 29.4 mt -86.29 137.91 32.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 112.94 -1.936 . . . . 0.0 108.415 -179.69 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -111.86 147.41 35.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -178.877 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.01 139.78 58.8 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 128.802 2.841 . . . . 0.0 111.635 -162.9 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.48 20.74 10.56 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.373 1.463 . . . . 0.0 114.486 178.701 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -131.99 147.35 52.45 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 123.923 1.82 . . . . 0.0 109.755 175.386 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -95.46 154.08 17.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 111.283 -2.69 . . . . 0.0 111.767 179.264 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 53.9 mt -51.41 -33.64 31.28 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 119.229 -2.169 . . . . 0.0 115.683 -179.105 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -10.52 59.53 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 120.415 -1.428 . . . . 0.0 114.319 177.195 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -77.76 -27.93 50.49 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.586 175.18 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.366 67.8 m-85 -104.96 -0.04 27.32 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 130.986 3.714 . . . . 0.0 113.878 170.585 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.338 0.7 OUTLIER 59.06 39.82 22.84 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 128.813 2.845 . . . . 0.0 113.962 -179.079 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 90.0 mt -70.31 112.08 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 118.758 0.708 . . . . 0.0 109.811 168.634 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -112.37 -170.12 1.6 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 113.187 -1.824 . . . . 0.0 112.751 -170.813 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.443 36.1 pttt -50.65 120.18 4.49 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 120.378 3.473 . . . . 0.0 120.378 179.674 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 67.77 54.15 0.65 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.855 2.862 . . . . 0.0 109.241 177.731 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.7 m -107.43 141.31 39.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.309 175.238 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.276 36.3 m -108.9 144.95 36.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 126.233 2.921 . . . . 0.0 107.651 168.393 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.11 -178.03 4.72 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 103.355 -2.832 . . . . 0.0 103.355 173.976 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -151.68 -179.59 7.56 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 111.986 -2.37 . . . . 0.0 105.155 -171.898 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' HB3' HD23 ' A' ' 43' ' ' LEU . 1.5 pp -147.15 168.46 21.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 123.345 1.545 . . . . 0.0 112.923 175.865 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.0 p -128.74 133.42 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 131.574 3.95 . . . . 0.0 110.057 -178.225 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.572 ' O ' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -47.05 136.59 8.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 164.394 . . . . . . . . 3 3 . 1 . 063 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.318 3.9 ttm180 -122.78 129.55 51.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.902 2.881 . . . . 0.0 105.701 171.087 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.407 HD21 HD23 ' A' ' 71' ' ' LEU . 96.3 mt -95.86 -26.31 15.67 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 127.48 2.987 . . . . 0.0 113.124 -157.339 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -97.34 140.06 32.37 Favored 'General case' 0 CA--C 1.535 0.367 1 C-N-CA 132.81 4.444 . . . . 0.0 103.765 176.939 . . . . . . . . 2 2 . 1 . 063 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.73 124.11 3.36 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 127.74 2.591 . . . . 0.0 115.127 175.401 . . . . . . . . 1 1 . 1 . 063 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 N-CA-C 104.534 -3.426 . . . . 0.0 104.534 -175.978 . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 ttp . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 115.691 -2.1 . . . . 0.0 106.17 . . . . . . . . . 0 0 . 1 . 064 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.253 27.0 mp0 -97.0 131.24 44.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -175.127 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -114.63 177.64 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 116.955 -3.59 . . . . 0.0 105.577 158.926 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -127.25 141.76 51.64 Favored 'General case' 0 N--CA 1.447 -0.618 1 C-N-CA 131.978 4.111 . . . . 0.0 108.515 175.904 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.2 106.36 17.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 -178.344 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -89.37 166.53 13.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 117.762 -3.086 . . . . 0.0 104.489 166.695 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -127.5 149.34 50.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 109.38 -3.554 . . . . 0.0 104.04 176.08 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.21 1.68 20.69 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 128.003 3.315 . . . . 0.0 112.607 175.274 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -102.84 -21.32 14.04 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.645 2.378 . . . . 0.0 116.68 167.275 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.5 13.16 9.03 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-O 113.567 -3.907 . . . . 0.0 110.805 153.721 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -72.23 131.62 42.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 123.291 3.546 . . . . 0.0 112.597 155.182 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.8 m -108.22 133.17 52.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 172.714 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.6 mt -115.24 144.0 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 129.308 3.043 . . . . 0.0 106.784 167.884 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.293 28.4 m -107.31 130.63 54.75 Favored 'General case' 0 N--CA 1.448 -0.532 1 N-CA-C 97.453 -5.017 . . . . 0.0 97.453 164.708 . . . . . . . . 3 2 . 1 . 064 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tp -130.56 138.37 50.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.857 1.348 . . . . 0.0 111.603 179.288 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.27 118.16 35.99 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 -173.225 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.289 17.1 m -120.94 160.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 122.548 1.166 . . . . 0.0 109.574 -176.095 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -96.58 141.34 22.95 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 113.305 -3.236 . . . . 0.0 113.26 173.581 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -45.0 -50.9 8.21 Favored 'Trans proline' 0 N--CA 1.444 -1.385 1 C-N-CA 131.593 8.195 . . . . 0.0 108.245 169.102 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -60.24 -15.46 24.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.703 2.001 . . . . 0.0 112.101 -179.299 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -68.94 127.95 34.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 122.469 2.395 . . . . 0.0 114.505 -168.832 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.1 p -68.33 138.49 55.47 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 125.391 1.682 . . . . 0.0 107.065 160.845 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mm -53.45 -19.83 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -177.406 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.67 -36.24 80.26 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 122.225 2.284 . . . . 0.0 112.821 166.261 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -78.42 -10.14 59.57 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 123.271 2.76 . . . . 0.0 110.19 -178.814 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -92.88 -28.82 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 118.163 -2.836 . . . . 0.0 106.447 174.383 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -84.43 -20.31 32.02 Favored 'General case' 0 CA--C 1.539 0.523 1 O-C-N 114.977 -4.827 . . . . 0.0 110.062 177.83 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.69 -26.38 59.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 117.537 -1.22 . . . . 0.0 113.5 159.752 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -78.38 -17.02 57.04 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 171.772 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.2 mt -80.18 -34.51 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 114.309 -2.758 . . . . 0.0 110.685 162.952 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -50.69 -35.81 32.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 123.078 2.672 . . . . 0.0 116.019 168.656 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.253 27.5 t70 -91.74 -5.37 53.72 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 119.148 -2.22 . . . . 0.0 111.321 -172.631 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -121.99 -36.57 2.98 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 113.175 -3.297 . . . . 0.0 111.233 -169.511 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -125.65 -26.44 3.53 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 123.648 2.931 . . . . 0.0 109.195 176.901 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.72 17.35 12.16 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 117.016 -3.553 . . . . 0.0 112.746 174.588 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mt -86.82 125.94 65.15 Favored Pre-proline 0 N--CA 1.445 -0.711 0 N-CA-C 100.821 -3.77 . . . . 0.0 100.821 -175.735 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.47 144.49 25.65 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 CA-C-O 115.47 -1.971 . . . . 0.0 112.742 165.785 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -9.71 26.89 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 124.471 3.447 . . . . 0.0 114.754 -162.994 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.77 -17.01 64.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 123.429 2.831 . . . . 0.0 117.334 169.291 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -119.82 27.19 8.85 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 117.134 -3.479 . . . . 0.0 116.285 -162.157 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -113.56 165.66 12.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.257 2.623 . . . . 0.0 111.892 178.675 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -127.15 150.79 49.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.012 3.725 . . . . 0.0 102.983 141.902 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.67 105.59 11.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 112.317 -2.219 . . . . 0.0 110.946 165.114 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.97 134.77 27.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 125.688 2.661 . . . . 0.0 105.206 174.301 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -140.76 115.08 9.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 108.603 -3.908 . . . . 0.0 112.532 176.905 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.69 37.84 1.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 128.687 2.795 . . . . 0.0 112.75 -175.052 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.6 -35.34 4.78 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 121.253 -0.905 . . . . 0.0 113.075 171.173 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.313 97.7 mttt -83.57 165.09 19.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.971 2.908 . . . . 0.0 107.247 -173.947 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -116.5 119.72 36.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.685 2.394 . . . . 0.0 108.779 177.497 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.1 mt -80.59 124.38 28.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 123.379 1.561 . . . . 0.0 109.057 -161.125 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.21 130.84 35.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 -174.38 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.95 -37.11 30.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 127.59 3.056 . . . . 0.0 118.704 -170.952 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.19 5.02 41.4 Favored Glycine 0 CA--C 1.526 0.777 1 O-C-N 116.079 -4.138 . . . . 0.0 115.026 -170.381 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -88.57 146.72 24.97 Favored 'General case' 0 C--N 1.327 -0.413 1 O-C-N 116.226 -4.103 . . . . 0.0 107.024 170.195 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -86.47 134.64 33.67 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 127.858 3.224 . . . . 0.0 111.573 -173.678 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.309 10.8 tp -22.42 -76.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 1 C-N-CA 134.036 4.935 . . . . 0.0 114.243 177.656 . . . . . . . . 3 2 . 1 . 064 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.1 -37.29 85.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 125.397 2.522 . . . . 0.0 110.217 -170.135 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.3 -21.26 42.78 Favored 'General case' 0 CA--C 1.536 0.43 1 O-C-N 113.793 -5.567 . . . . 0.0 113.201 178.584 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -22.37 66.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 162.913 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.809 6.5 t-20 105.85 24.13 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 129.534 3.134 . . . . 0.0 117.96 175.512 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -99.82 73.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 126.708 2.003 . . . . 0.0 109.672 -177.524 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -89.84 169.79 10.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 124.72 2.2 . . . . 0.0 105.955 -179.506 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -31.54 115.79 0.16 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.283 2.697 . . . . 0.0 118.283 -174.298 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 77.51 29.8 0.52 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 129.067 2.947 . . . . 0.0 113.427 174.945 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -72.44 148.47 45.12 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 126.165 2.888 . . . . 0.0 114.133 169.986 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 m -104.73 107.48 18.45 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 117.062 -3.524 . . . . 0.0 105.811 -173.288 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.36 149.17 25.22 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 128.084 3.365 . . . . 0.0 108.649 162.275 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -107.59 110.84 22.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 127.971 3.294 . . . . 0.0 114.609 155.821 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.273 6.4 tt -74.19 139.41 44.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.083 -1.636 . . . . 0.0 107.635 168.763 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.02 145.99 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 164.97 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 71' ' ' LEU . 5.6 mp -97.84 123.48 41.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 -177.573 . . . . . . . . 2 2 . 1 . 064 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -79.27 69.49 5.5 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 171.442 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 74' ' ' ARG 0.494 0.5 OUTLIER -155.49 -82.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.904 2.482 . . . . 0.0 108.858 171.444 . . . . . . . . 4 4 . 1 . 064 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -149.31 139.28 22.02 Favored 'General case' 0 N--CA 1.449 -0.525 1 C-N-CA 132.433 4.293 . . . . 0.0 102.131 171.389 . . . . . . . . 4 4 . 1 . 064 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.42 106.22 2.38 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 104.832 -3.307 . . . . 0.0 104.832 179.78 . . . . . . . . 1 1 . 1 . 064 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.499 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -154.423 . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptt? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 117.392 -1.29 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 065 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -100.2 161.61 13.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 169.272 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.9 pt -146.74 158.46 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 130.322 3.449 . . . . 0.0 103.137 168.71 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -107.11 140.31 40.15 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 127.057 2.143 . . . . 0.0 107.734 174.075 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -121.05 117.79 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 127.258 3.409 . . . . 0.0 105.808 170.009 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HZ2' ' HG1' ' A' ' 12' ' ' THR . 13.9 tptt -78.79 114.93 18.14 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 116.455 -3.903 . . . . 0.0 105.182 167.069 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.4 p -86.22 159.25 19.53 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 127.996 3.31 . . . . 0.0 108.469 168.544 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.76 -30.72 71.74 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.265 -1.789 . . . . 0.0 114.009 178.834 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.4 p -72.79 4.52 3.99 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.759 2.424 . . . . 0.0 114.806 165.913 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.86 17.08 77.92 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 114.045 -3.642 . . . . 0.0 113.839 173.013 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -85.42 121.32 27.97 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 122.819 3.309 . . . . 0.0 104.844 173.607 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.416 ' HG1' ' HZ2' ' A' ' 6' ' ' LYS . 11.3 m -85.86 63.68 8.18 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.791 2.436 . . . . 0.0 107.194 173.447 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mm -50.72 120.9 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 126.702 2.001 . . . . 0.0 111.948 173.82 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.9 m -88.67 136.66 32.88 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 174.346 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 mt -121.65 139.6 53.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.034 1.733 . . . . 0.0 106.992 177.629 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -86.97 129.22 34.97 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 167.418 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.381 18.5 m -140.75 154.48 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 128.936 2.894 . . . . 0.0 114.165 -179.416 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -117.4 171.42 4.97 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-O 114.186 -2.816 . . . . 0.0 110.596 171.63 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.97 -27.73 3.64 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 N-CA-C 118.393 2.42 . . . . 0.0 118.393 -170.171 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -86.61 -5.96 59.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 119.056 -2.277 . . . . 0.0 116.463 178.661 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.16 122.65 11.49 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 127.605 2.362 . . . . 0.0 108.996 178.224 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 p -85.87 169.77 13.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 117.222 -3.424 . . . . 0.0 110.883 -179.402 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 52' ' ' ASP . 18.4 mt -61.79 -27.81 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 O-C-N 126.299 2.249 . . . . 0.0 111.049 179.253 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.94 -43.36 79.29 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.491 -1.38 . . . . 0.0 107.372 174.326 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.315 30.0 m-20 -54.36 -41.53 69.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 118.736 -2.477 . . . . 0.0 117.344 168.6 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.5 t -73.56 -52.81 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 125.107 1.504 . . . . 0.0 109.082 176.135 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -44.64 -37.44 3.65 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 117.556 -3.215 . . . . 0.0 117.348 168.095 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.65 -37.86 55.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 126.826 2.579 . . . . 0.0 111.766 177.037 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -56.72 -50.15 73.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 127.424 2.952 . . . . 0.0 110.376 175.929 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.61 -31.29 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 117.469 -1.253 . . . . 0.0 109.322 -178.509 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -68.29 -48.63 64.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 121.104 1.775 . . . . 0.0 110.706 174.357 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.279 32.2 t70 -43.72 -40.77 4.45 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 128.624 3.703 . . . . 0.0 114.117 169.261 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -77.88 -60.1 2.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.459 1.904 . . . . 0.0 114.714 172.464 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -101.3 -21.19 14.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -162.071 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.0 -11.4 65.92 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 117.079 1.592 . . . . 0.0 117.079 -177.4 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.281 73.5 mt -77.58 126.33 84.68 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 123.915 3.857 . . . . 0.0 112.584 -174.875 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.98 168.37 24.95 Favored 'Trans proline' 0 N--CA 1.44 -1.638 0 N-CA-C 116.731 1.781 . . . . 0.0 116.731 -174.007 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.26 -22.78 9.42 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 CA-C-O 124.999 2.0 . . . . 0.0 115.817 -162.88 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.56 -20.36 59.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 111.983 -3.865 . . . . 0.0 110.58 179.778 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.64 -16.62 44.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 128.773 3.796 . . . . 0.0 109.001 -174.737 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -98.84 137.63 37.14 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.994 1.854 . . . . 0.0 113.472 -171.493 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -116.15 141.91 47.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 153.13 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.82 138.85 48.68 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.081 0.943 . . . . 0.0 108.636 179.893 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.453 HG13 ' HG3' ' A' ' 49' ' ' GLN . 3.7 mt -129.09 135.04 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 124.002 0.921 . . . . 0.0 109.564 -168.693 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -90.66 -175.94 4.57 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.365 2.266 . . . . 0.0 107.598 176.521 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -20.34 -57.22 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 1 C-N-CA 138.361 6.664 . . . . 0.0 111.826 -176.537 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.89 9.69 1.81 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.333 -1.815 . . . . 0.0 114.823 172.759 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -141.82 129.6 21.69 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -165.313 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.453 ' HG3' HG13 ' A' ' 44' ' ' ILE . 42.0 tt0 -75.35 139.82 42.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 126.22 2.2 . . . . 0.0 109.053 179.926 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -97.59 157.88 15.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 121.202 1.819 . . . . 0.0 110.692 179.003 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -148.64 138.96 22.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 123.013 1.387 . . . . 0.0 108.627 -176.517 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HA ' HD12 ' A' ' 23' ' ' ILE . 16.3 m-20 -59.42 144.3 47.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.008 2.923 . . . . 0.0 112.969 -163.526 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.6 11.88 11.11 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 126.366 2.291 . . . . 0.0 117.011 168.205 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -136.47 159.24 42.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.684 2.794 . . . . 0.0 109.072 179.487 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.0 p -85.96 176.68 7.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 124.854 2.264 . . . . 0.0 110.709 177.016 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.5 mt -62.94 -47.99 80.83 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 119.293 -2.13 . . . . 0.0 109.331 169.904 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -46.58 -38.17 9.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.892 2.877 . . . . 0.0 114.399 173.505 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -78.17 -31.61 49.72 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 115.051 -2.405 . . . . 0.0 104.803 -174.575 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -95.12 -1.38 52.09 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.817 1.323 . . . . 0.0 107.749 -173.361 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 60.0 m-80 77.83 27.72 0.57 Allowed 'General case' 0 N--CA 1.45 -0.471 1 O-C-N 115.429 -4.545 . . . . 0.0 117.931 171.605 . . . . . . . . 3 2 . 1 . 065 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -103.15 123.21 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 -170.249 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -123.28 171.0 9.71 Favored 'General case' 0 N--CA 1.445 -0.679 1 C-N-CA 131.737 4.015 . . . . 0.0 113.317 176.126 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -57.78 135.65 56.83 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 128.155 2.582 . . . . 0.0 111.478 -168.092 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.337 0.7 OUTLIER 81.51 7.24 1.13 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.656 2.782 . . . . 0.0 118.178 -177.896 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -68.67 139.61 55.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 124.83 2.252 . . . . 0.0 110.579 169.849 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.0 m -97.08 125.78 41.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 111.182 -2.735 . . . . 0.0 106.831 170.72 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.3 mt -96.36 150.51 20.5 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 128.759 2.824 . . . . 0.0 106.809 166.913 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -126.38 130.91 51.67 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 129.098 2.959 . . . . 0.0 110.703 171.685 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tp -86.4 141.84 28.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.685 1.994 . . . . 0.0 111.865 -178.543 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -130.91 133.02 63.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 101.872 -3.381 . . . . 0.0 101.872 177.098 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.1 mt -103.03 129.67 49.88 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 119.042 2.979 . . . . 0.0 119.042 175.668 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -82.94 90.33 6.97 Favored 'General case' 0 C--N 1.323 -0.572 1 O-C-N 130.1 4.625 . . . . 0.0 105.341 -176.763 . . . . . . . . 2 2 . 1 . 065 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.492 ' HG ' ' H ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -97.53 141.19 30.89 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 131.446 3.898 . . . . 0.0 108.941 173.915 . . . . . . . . 3 3 . 1 . 065 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -113.27 141.45 46.98 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 103.398 -2.815 . . . . 0.0 103.398 -166.68 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.66 -94.06 0.17 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 127.883 2.659 . . . . 0.0 112.778 163.906 . . . . . . . . 1 1 . 1 . 065 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 174.41 . . . . . . . . 0 0 . 1 . 066 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 113.855 -2.974 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 066 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -98.7 149.88 22.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 121.111 1.778 . . . . 0.0 107.267 -176.997 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 pt -152.01 157.02 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.184 1.793 . . . . 0.0 107.934 174.129 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -110.1 142.86 40.99 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 130.275 3.43 . . . . 0.0 105.79 -175.176 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t -113.97 138.46 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 168.873 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -100.96 144.72 29.57 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 118.134 -2.854 . . . . 0.0 110.757 162.348 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.1 m -113.63 142.37 46.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.523 2.729 . . . . 0.0 104.956 -175.951 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 3.2 tm? -47.35 -49.28 24.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.33 2.252 . . . . 0.0 111.569 -171.769 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.3 p -80.29 5.7 14.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 -177.871 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.34 -9.83 10.89 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 121.723 3.449 . . . . 0.0 121.723 157.47 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -79.61 149.0 31.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.883 1.673 . . . . 0.0 109.736 -179.544 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m -119.09 124.29 46.52 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 129.612 3.165 . . . . 0.0 108.572 178.811 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.286 1.5 pp -119.33 -173.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.095 1.358 . . . . 0.0 111.559 176.049 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 t -154.2 144.17 21.88 Favored 'General case' 0 C--N 1.321 -0.647 1 O-C-N 116.0 -4.187 . . . . 0.0 110.345 177.267 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.34 0.3 OUTLIER -138.42 150.97 47.03 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.77 2.828 . . . . 0.0 109.168 -175.159 . . . . . . . . 3 3 . 1 . 066 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.371 13.1 mp0 -97.49 119.89 36.87 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 126.66 2.475 . . . . 0.0 111.233 175.444 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.275 34.2 m -142.89 -179.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -163.145 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -141.84 143.37 28.48 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 127.568 2.347 . . . . 0.0 111.788 174.409 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.258 2.2 Cg_endo -58.73 -28.18 85.8 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 CA-C-N 127.279 3.635 . . . . 0.0 116.318 -175.073 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.9 m -85.2 19.59 2.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 112.375 -3.678 . . . . 0.0 109.144 178.524 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 55' ' ' THR . 12.0 m-20 -88.18 148.54 24.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 -178.982 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -87.47 154.08 20.92 Favored 'General case' 0 N--CA 1.446 -0.642 1 O-C-N 130.604 4.94 . . . . 0.0 113.244 177.489 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mm -53.17 -30.93 17.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 123.108 2.685 . . . . 0.0 118.069 -175.187 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.29 10.5 tt0 -70.62 -41.52 72.14 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 116.769 -1.586 . . . . 0.0 109.812 -176.315 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -72.95 -20.56 61.03 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 128.425 2.69 . . . . 0.0 112.152 -174.125 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.488 HG21 HD21 ' A' ' 56' ' ' LEU . 61.2 t -79.14 -50.06 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 128.054 2.541 . . . . 0.0 110.796 165.128 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -62.02 -24.06 66.83 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 120.745 1.612 . . . . 0.0 114.992 174.984 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.94 -37.57 53.21 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 128.67 2.788 . . . . 0.0 113.54 170.701 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -81.56 -23.35 37.25 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 126.038 2.086 . . . . 0.0 112.879 -176.649 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.85 -42.63 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 129.072 2.949 . . . . 0.0 104.357 179.669 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -51.03 -54.17 27.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.09 2.556 . . . . 0.0 113.83 164.294 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.66 -44.02 85.4 Favored 'General case' 0 N--CA 1.44 -0.96 1 C-N-CA 131.962 4.105 . . . . 0.0 117.54 -178.364 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -78.15 -81.85 0.1 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.646 1.979 . . . . 0.0 110.128 168.617 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -76.85 -35.11 57.72 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 127.015 2.697 . . . . 0.0 116.596 -162.663 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.85 11.1 23.47 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 119.19 -2.194 . . . . 0.0 117.139 177.024 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mt -88.72 134.54 33.68 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 116.258 -1.83 . . . . 0.0 106.548 -177.125 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -70.38 142.97 46.5 Favored 'Trans proline' 0 N--CA 1.447 -1.241 1 C-N-CA 125.454 4.103 . . . . 0.0 112.646 174.217 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.85 -20.31 68.17 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.698 1.599 . . . . 0.0 112.167 174.815 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -72.0 -5.52 35.58 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 118.231 -2.793 . . . . 0.0 112.179 172.478 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -126.01 0.71 7.25 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.827 2.451 . . . . 0.0 116.312 -176.607 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.262 50.6 mt-30 -101.72 149.01 24.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 122.256 2.298 . . . . 0.0 105.026 -175.219 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -133.06 130.96 40.06 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 158.998 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.8 mt -98.47 133.82 42.31 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.831 2.853 . . . . 0.0 107.019 175.255 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.35 148.07 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 176.319 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -156.7 119.4 4.04 Favored 'General case' 0 C--O 1.24 0.568 1 C-N-CA 132.212 4.205 . . . . 0.0 110.869 167.437 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 74.5 13.67 3.68 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.541 1.936 . . . . 0.0 115.205 177.724 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.9 -28.11 7.16 Favored Glycine 0 CA--C 1.531 1.065 1 CA-C-O 112.282 -4.621 . . . . 0.0 107.272 179.907 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -99.85 134.04 43.33 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 128.022 2.837 . . . . 0.0 110.937 -157.224 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' HB3' ' HA3' ' A' ' 76' ' ' GLY . 1.8 pt20 -62.93 129.99 42.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.384 1.053 . . . . 0.0 109.289 163.908 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.78 111.84 6.53 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 125.41 1.484 . . . . 0.0 111.828 171.224 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.473 15.9 tt0 -91.85 148.03 22.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -172.51 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.75 142.77 35.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 120.481 1.491 . . . . 0.0 112.365 -164.877 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.34 -33.94 5.43 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 125.803 2.891 . . . . 0.0 112.86 -177.629 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -80.43 170.69 16.04 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 111.514 -2.343 . . . . 0.0 111.053 -175.886 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 21' ' ' ASP . 70.6 p -115.38 159.28 21.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.994 2.518 . . . . 0.0 108.769 -172.368 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 26' ' ' VAL . 77.2 mt -62.1 -26.43 68.29 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 116.393 -3.942 . . . . 0.0 109.756 179.566 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.0 t -54.23 -50.89 66.12 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.799 2.44 . . . . 0.0 113.353 175.317 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -48.09 -16.56 0.09 Allowed 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 127.476 2.31 . . . . 0.0 117.145 173.535 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -124.96 -4.28 7.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 118.058 -2.901 . . . . 0.0 111.95 179.689 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 93.17 31.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 125.573 1.795 . . . . 0.0 108.073 163.442 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 63.5 mt -89.6 121.2 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 -172.397 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -113.37 176.16 5.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 112.902 -1.953 . . . . 0.0 112.066 -175.675 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -39.14 124.54 1.49 Allowed 'General case' 0 CA--C 1.536 0.42 1 C-N-CA 132.47 4.308 . . . . 0.0 111.643 164.526 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 80.14 0.22 2.03 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.997 3.719 . . . . 0.0 113.808 175.559 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -62.44 135.26 57.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 121.591 1.996 . . . . 0.0 108.733 -171.709 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.9 m -95.72 118.63 32.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.439 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -92.19 155.74 17.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 129.028 2.931 . . . . 0.0 108.067 177.394 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -105.68 133.08 50.99 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 163.607 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.7 tp -101.39 130.94 47.7 Favored 'General case' 0 C--N 1.322 -0.62 1 C-N-CA 132.633 4.373 . . . . 0.0 115.286 162.424 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.5 t -127.24 130.27 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 131.237 3.815 . . . . 0.0 104.041 -179.43 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.48 160.68 27.71 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 115.249 -2.31 . . . . 0.0 113.163 -177.687 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 74.77 -25.75 0.2 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 127.087 2.742 . . . . 0.0 109.392 164.486 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 pp -128.85 172.03 11.7 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 169.481 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt-85 -82.05 146.3 29.75 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.737 1.215 . . . . 0.0 109.709 -173.325 . . . . . . . . 1 1 . 1 . 066 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -137.7 121.13 2.19 Favored Glycine 0 CA--C 1.531 1.047 1 CA-C-O 113.097 -4.168 . . . . 0.0 103.835 -168.391 . . . . . . . . 2 2 . 1 . 066 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 49' ' ' GLN . . . . . . . . 0 C--O 1.256 1.505 0 N-CA-C 104.237 -3.545 . . . . 0.0 104.237 -170.972 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttp . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 . . . . . . . . . 0 0 . 1 . 067 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -87.09 131.91 33.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.188 0.995 . . . . 0.0 108.411 -175.064 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.268 30.6 pt -110.67 142.21 23.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 154.322 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -88.24 129.72 35.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 160.783 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.19 115.63 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 O-C-N 127.705 3.128 . . . . 0.0 112.812 161.241 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -67.04 118.22 10.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 127.721 2.408 . . . . 0.0 111.415 173.208 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.8 p -86.59 163.95 17.14 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 120.004 3.335 . . . . 0.0 120.004 170.918 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 mp -84.86 -18.14 35.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 129.076 2.951 . . . . 0.0 112.776 179.344 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.93 -37.07 86.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 128.228 2.611 . . . . 0.0 111.804 172.756 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.1 -159.81 24.45 Favored Glycine 0 CA--C 1.533 1.186 1 C-N-CA 132.357 4.789 . . . . 0.0 108.356 -163.165 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 mttt 41.14 -163.47 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 1 N-CA-C 123.397 4.591 . . . . 0.0 123.397 167.28 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.0 p -128.76 157.75 40.57 Favored 'General case' 0 N--CA 1.444 -0.738 2 O-C-N 115.511 -4.493 . . . . 0.0 110.106 164.079 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.8 mm -95.73 130.91 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 161.434 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 m -94.55 120.68 35.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.556 1.17 . . . . 0.0 108.945 163.027 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -100.18 144.53 29.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 131.078 3.751 . . . . 0.0 106.418 -178.455 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.92 141.21 28.67 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 121.521 1.964 . . . . 0.0 108.76 152.908 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.24 153.98 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 O-C-N 124.697 1.248 . . . . 0.0 108.782 172.582 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -90.36 156.94 45.48 Favored Pre-proline 0 C--N 1.322 -0.619 0 O-C-N 118.005 -2.934 . . . . 0.0 104.209 163.542 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.7 -4.34 13.42 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 O-C-N 116.843 -2.241 . . . . 0.0 112.336 -176.776 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.8 p -97.71 7.47 46.37 Favored 'General case' 0 N--CA 1.448 -0.56 1 C-N-CA 135.67 5.588 . . . . 0.0 116.808 173.992 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -82.05 158.13 23.89 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 165.234 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -90.76 161.96 15.08 Favored 'General case' 0 C--N 1.326 -0.435 1 C-N-CA 132.218 4.207 . . . . 0.0 109.524 171.187 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mt -69.28 -20.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 127.572 2.349 . . . . 0.0 110.144 175.556 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.19 -26.14 65.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.088 -1.633 . . . . 0.0 114.009 164.999 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -34.93 69.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 120.858 1.663 . . . . 0.0 111.379 164.558 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.67 -54.45 32.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 122.767 2.53 . . . . 0.0 109.09 174.238 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -48.24 -50.83 28.08 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 118.799 -2.438 . . . . 0.0 115.569 177.788 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.27 -11.24 59.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 116.444 -1.741 . . . . 0.0 113.394 -176.438 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -81.62 -35.25 30.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 122.022 2.192 . . . . 0.0 111.416 166.7 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.24 -44.3 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 126.204 1.802 . . . . 0.0 109.183 169.045 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.32 44.6 tt0 -69.25 -40.05 78.1 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 117.372 -3.33 . . . . 0.0 110.018 -175.907 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -52.25 -49.46 63.99 Favored 'General case' 0 N--CA 1.445 -0.7 1 C-N-CA 134.669 5.187 . . . . 0.0 110.27 169.092 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.275 35.3 mttm -76.03 -57.9 3.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 114.023 -2.894 . . . . 0.0 110.345 177.804 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -113.07 -12.87 13.13 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 121.674 2.034 . . . . 0.0 106.564 -157.992 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.45 1.49 60.61 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 125.369 3.713 . . . . 0.0 114.934 160.732 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.9 mm -74.49 133.77 76.92 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 125.897 1.587 . . . . 0.0 108.545 -174.519 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -66.92 144.85 72.16 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 N-CA-C 116.432 1.666 . . . . 0.0 116.432 176.393 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.16 -25.31 13.84 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 CA-C-O 116.247 -1.647 . . . . 0.0 110.784 -162.467 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.63 -12.06 59.95 Favored 'General case' 0 N--CA 1.442 -0.836 1 C-N-CA 133.298 4.639 . . . . 0.0 105.47 -176.358 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -104.59 -15.13 15.4 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 125.305 1.628 . . . . 0.0 112.321 174.159 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -83.53 95.48 8.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 116.624 -3.797 . . . . 0.0 109.642 -178.597 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -87.89 92.75 9.24 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 121.919 2.145 . . . . 0.0 108.437 175.824 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.57 130.35 34.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 112.085 -2.325 . . . . 0.0 109.606 -179.021 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.9 mt -116.45 143.33 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 111.47 -2.604 . . . . 0.0 108.348 -170.452 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -144.16 129.85 19.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.107 1.363 . . . . 0.0 110.362 161.56 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.286 . . 57.15 15.88 2.7 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 119.613 3.19 . . . . 0.0 119.613 174.752 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.72 -32.88 5.78 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 117.989 -1.45 . . . . 0.0 112.279 -172.552 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.8 tttm -92.47 127.93 38.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.793 1.797 . . . . 0.0 108.121 -170.784 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 104.94 13.39 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 128.85 3.844 . . . . 0.0 106.348 168.095 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 50' ' ' LEU . 44.1 mt -71.84 125.19 26.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 111.438 -2.619 . . . . 0.0 113.964 -157.632 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.59 161.57 29.02 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 124.704 2.192 . . . . 0.0 105.25 -166.368 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.93 154.73 31.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.06 1.744 . . . . 0.0 112.836 163.541 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.81 -4.81 24.27 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.303 2.382 . . . . 0.0 114.949 165.466 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -136.1 168.93 18.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -171.66 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.8 p -107.44 173.76 6.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 119.324 -2.11 . . . . 0.0 113.163 -175.353 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mt -76.64 -18.34 58.65 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 116.867 -3.645 . . . . 0.0 108.527 -164.312 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.2 t -76.93 -31.27 56.52 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 129.398 3.079 . . . . 0.0 105.644 177.782 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 35.0 m-20 -78.22 -44.25 26.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 102.41 -3.181 . . . . 0.0 102.41 -173.809 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -72.64 1.93 7.43 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 127.539 2.336 . . . . 0.0 114.832 174.556 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t30 72.15 5.46 5.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.73 2.012 . . . . 0.0 113.042 171.199 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.417 HD13 HD21 ' A' ' 67' ' ' LEU . 5.4 mt -70.54 129.61 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 125.004 3.547 . . . . 0.0 106.701 -168.814 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.325 95.6 mm-40 -103.69 166.58 10.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 125.958 2.036 . . . . 0.0 108.9 174.466 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -42.65 123.1 2.53 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 130.725 3.61 . . . . 0.0 114.744 170.772 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.404 8.0 mp0 85.66 8.28 0.35 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 129.446 3.098 . . . . 0.0 112.87 170.161 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -64.86 137.72 57.94 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 119.756 -1.84 . . . . 0.0 110.22 177.034 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -93.74 107.38 19.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 119.688 -1.883 . . . . 0.0 109.475 174.094 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.417 HD21 HD13 ' A' ' 61' ' ' ILE . 9.5 mp -98.95 148.82 23.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 100.378 -3.934 . . . . 0.0 100.378 178.226 . . . . . . . . 2 2 . 1 . 067 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -92.52 141.23 28.73 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 116.341 -3.975 . . . . 0.0 109.008 171.509 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.355 14.1 tp -107.77 131.35 54.55 Favored 'General case' 0 N--CA 1.451 -0.413 1 N-CA-C 98.36 -4.682 . . . . 0.0 98.36 158.05 . . . . . . . . 3 2 . 1 . 067 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.66 139.55 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 126.598 2.436 . . . . 0.0 105.387 169.465 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.2 mt -102.72 150.4 23.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 111.982 -2.372 . . . . 0.0 105.905 176.576 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -119.47 77.74 1.24 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.272 -1.331 . . . . 0.0 113.437 172.49 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 mt -76.5 -27.11 55.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 125.228 1.58 . . . . 0.0 113.462 -158.39 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -91.32 -57.92 2.62 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 116.71 -3.743 . . . . 0.0 111.288 171.233 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.91 -131.58 10.71 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 116.071 -2.516 . . . . 0.0 110.958 -173.675 . . . . . . . . 1 1 . 1 . 067 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 1 CA-C-N 124.847 4.323 . . . . 0.0 111.031 176.089 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 ttp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 0 0 . 1 . 068 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -87.15 152.08 22.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 102.842 -3.021 . . . . 0.0 102.842 -175.032 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 pt -150.65 164.33 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 131.538 3.935 . . . . 0.0 107.04 169.689 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -118.04 141.15 48.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 130.379 3.472 . . . . 0.0 112.351 166.568 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m -104.4 151.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 111.464 -2.607 . . . . 0.0 108.671 162.134 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -140.67 156.42 46.24 Favored 'General case' 0 C--N 1.327 -0.377 1 O-C-N 115.266 -4.646 . . . . 0.0 106.848 176.679 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.347 4.8 t -142.21 152.5 43.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.475 2.71 . . . . 0.0 107.512 -176.671 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.97 -8.26 4.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 130.825 3.65 . . . . 0.0 118.388 -170.962 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.2 p -79.61 -20.0 47.9 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 123.891 3.041 . . . . 0.0 108.492 166.675 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.35 -1.17 23.75 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 128.676 3.036 . . . . 0.0 112.562 -175.733 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.269 75.3 tttt -72.78 143.45 47.92 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 118.449 -2.795 . . . . 0.0 110.318 -173.828 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.4 p -135.27 143.43 46.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.859 2.064 . . . . 0.0 114.344 179.727 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -139.19 143.35 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 1 C-N-CA 131.71 4.004 . . . . 0.0 109.963 -178.916 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 t -101.74 139.89 36.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.611 1.82 . . . . 0.0 113.215 171.015 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mt -129.85 151.25 50.62 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.235 1.414 . . . . 0.0 109.219 177.667 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -109.19 118.06 35.73 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.833 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.43 139.37 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -170.039 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -76.62 142.72 70.79 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-O 124.37 2.033 . . . . 0.0 106.195 177.044 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -58.81 -36.49 96.93 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 125.016 3.811 . . . . 0.0 116.546 178.051 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 p -72.72 -12.99 61.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.495 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -72.09 140.75 49.08 Favored 'General case' 0 N--CA 1.45 -0.455 1 O-C-N 115.303 -4.623 . . . . 0.0 113.026 -176.831 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 26' ' ' VAL . 77.3 p -73.14 134.98 44.64 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 179.447 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.251 26.6 mm -47.34 -38.24 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 129.704 3.202 . . . . 0.0 110.48 179.431 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -36.35 76.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 172.05 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -77.2 -40.52 44.83 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 129.249 3.02 . . . . 0.0 107.3 -177.777 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 22' ' ' THR . 44.0 t -70.94 -31.04 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 130.565 3.546 . . . . 0.0 112.331 -177.75 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -64.86 -32.66 74.47 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 116.709 -3.744 . . . . 0.0 108.559 179.39 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.37 69.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 117.232 -3.417 . . . . 0.0 113.138 172.502 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -74.54 -5.98 45.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 119.859 1.209 . . . . 0.0 111.666 -171.186 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.21 -35.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 123.695 1.712 . . . . 0.0 114.432 156.454 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -72.72 -38.0 67.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 118.232 -2.792 . . . . 0.0 110.053 -166.818 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.67 -36.81 83.42 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.09 171.055 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -90.14 -33.57 16.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 113.982 -2.913 . . . . 0.0 112.084 -175.35 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -126.25 -30.25 2.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 122.037 2.199 . . . . 0.0 112.373 -171.999 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.81 -8.35 42.84 Favored Glycine 0 CA--C 1.522 0.507 1 CA-C-O 112.157 -4.691 . . . . 0.0 113.153 176.935 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -74.21 125.58 89.88 Favored Pre-proline 0 C--N 1.328 -0.347 1 O-C-N 131.361 4.8 . . . . 0.0 108.025 -175.914 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 83.3 Cg_endo -68.06 138.28 43.36 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 N-CA-C 117.525 2.086 . . . . 0.0 117.525 166.007 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 9.3 Cg_endo -61.42 -31.95 88.64 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.901 3.067 . . . . 0.0 115.521 -170.656 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.61 -17.93 64.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 111.911 -3.899 . . . . 0.0 108.293 -171.467 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -78.09 -13.22 59.95 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 117.97 2.581 . . . . 0.0 117.97 172.151 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -116.13 151.46 35.6 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 120.328 -1.482 . . . . 0.0 111.344 -154.27 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -141.33 123.67 15.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 116.556 -3.84 . . . . 0.0 113.283 175.616 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.3 148.6 28.24 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 117.132 -3.48 . . . . 0.0 115.862 171.807 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.32 45.7 mt -131.11 138.6 53.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 127.955 2.502 . . . . 0.0 110.481 179.528 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' HB3' HD21 ' A' ' 50' ' ' LEU . 36.0 t80 -135.85 -176.98 4.48 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 179.52 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.41 85.75 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.226 3.01 . . . . 0.0 116.565 -164.931 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.41 -36.46 3.96 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 118.806 -2.434 . . . . 0.0 117.359 -174.492 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.355 86.1 tttt -151.87 159.6 43.8 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 125.955 2.788 . . . . 0.0 111.081 -160.401 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -80.61 144.31 32.46 Favored 'General case' 0 C--N 1.323 -0.545 1 CA-C-N 107.405 -4.452 . . . . 0.0 108.202 178.723 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 45' ' ' PHE . 18.3 mt -94.72 133.23 38.63 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 115.812 -2.355 . . . . 0.0 109.91 -175.397 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.2 132.13 48.3 Favored 'General case' 0 C--N 1.326 -0.454 1 O-C-N 115.694 -4.378 . . . . 0.0 118.624 168.229 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -76.46 93.28 3.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 128.7 3.75 . . . . 0.0 111.021 -168.649 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.55 -0.23 2.74 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 118.495 2.158 . . . . 0.0 118.495 -170.919 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -102.81 175.15 5.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.065 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.333 78.8 p -105.38 164.13 12.09 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.651 2.781 . . . . 0.0 110.56 -172.033 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -41.04 -51.66 3.28 Favored 'General case' 0 N--CA 1.446 -0.644 1 C-N-CA 132.109 4.164 . . . . 0.0 110.699 164.646 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 m -86.04 -6.96 58.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.253 -164.787 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -69.24 -38.62 78.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 124.911 2.291 . . . . 0.0 112.21 171.115 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.444 ' CD2' HD22 ' A' ' 50' ' ' LEU . 75.5 m-85 -103.55 -5.18 22.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 128.121 2.568 . . . . 0.0 112.812 -175.559 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.521 0.7 OUTLIER 75.61 37.62 0.41 Allowed 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 128.098 3.374 . . . . 0.0 113.584 175.539 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.402 HG23 ' CB ' ' A' ' 65' ' ' SER . 85.0 mt -70.81 137.28 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 173.129 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -131.69 -178.06 4.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.147 -168.797 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -42.21 110.62 0.18 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.926 2.491 . . . . 0.0 113.77 176.274 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 73.88 25.24 1.95 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.514 1.926 . . . . 0.0 111.829 172.458 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.402 ' CB ' HG23 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -62.14 128.76 37.65 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 119.182 -2.199 . . . . 0.0 110.262 179.722 . . . . . . . . 3 3 . 1 . 068 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.9 m -91.12 107.6 19.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.216 1.006 . . . . 0.0 111.017 172.486 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.5 mt -97.01 147.56 23.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.432 1.893 . . . . 0.0 107.23 179.481 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -101.55 147.83 25.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 117.117 -1.42 . . . . 0.0 107.595 -174.181 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.19 142.97 46.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 125.095 2.379 . . . . 0.0 107.983 -179.631 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -138.42 159.59 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 O-C-N 119.353 -2.092 . . . . 0.0 105.468 173.191 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.85 134.78 57.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 112.528 -3.606 . . . . 0.0 118.151 151.24 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -82.54 128.81 34.65 Favored 'General case' 0 N--CA 1.448 -0.554 2 C-N-CA 132.93 4.492 . . . . 0.0 106.663 168.861 . . . . . . . . 2 2 . 1 . 068 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 mt -108.2 30.41 6.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 131.008 3.723 . . . . 0.0 112.708 -170.646 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.272 7.5 ttt180 86.93 34.66 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.33 1 C-N-CA 135.64 5.576 . . . . 0.0 108.008 166.071 . . . . . . . . 3 2 . 1 . 068 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.18 -173.16 13.24 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.441 170.644 . . . . . . . . 1 1 . 1 . 068 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 CA-C-O 116.923 -2.043 . . . . 0.0 115.168 174.875 . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttp . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 . . . . . . . . . 0 0 . 1 . 069 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -101.41 137.27 39.96 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 -177.369 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.492 9.7 pt -142.67 149.79 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 1 C-N-CA 133.08 4.552 . . . . 0.0 110.259 174.913 . . . . . . . . 3 2 . 1 . 069 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -108.96 141.35 41.19 Favored 'General case' 0 C--O 1.223 -0.312 1 N-CA-C 99.909 -4.108 . . . . 0.0 99.909 -175.602 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.15 119.57 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 124.249 1.02 . . . . 0.0 113.526 156.689 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -91.5 111.3 22.75 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 -178.971 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -65.95 162.55 18.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 124.644 2.164 . . . . 0.0 115.26 171.758 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -68.53 -7.0 28.49 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 118.515 -2.615 . . . . 0.0 115.832 176.882 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -123.08 14.01 9.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 118.668 -2.52 . . . . 0.0 109.671 -176.826 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.16 -31.87 7.53 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 115.772 -2.682 . . . . 0.0 112.49 154.492 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -61.85 147.49 46.4 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 179.257 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.9 m -105.39 149.1 26.4 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 115.483 -2.199 . . . . 0.0 112.98 175.236 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.23 124.91 72.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 100.647 -3.834 . . . . 0.0 100.647 -179.623 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -78.14 134.18 37.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 117.227 -3.421 . . . . 0.0 110.525 162.612 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.4 mt -115.17 132.23 56.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 125.268 1.605 . . . . 0.0 109.141 167.892 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -97.38 117.21 31.09 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 127.42 2.95 . . . . 0.0 105.298 168.017 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.46 ' HB ' ' H ' ' A' ' 18' ' ' GLU . 16.3 m -141.41 -171.52 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 125.054 1.342 . . . . 0.0 112.167 -175.32 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' H ' ' HB ' ' A' ' 17' ' ' VAL . 1.2 tm-20 -136.88 146.8 56.55 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-O 115.673 -2.108 . . . . 0.0 108.246 -165.175 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.53 -29.05 83.55 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.645 2.897 . . . . 0.0 118.425 178.346 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.4 p -92.76 1.13 57.44 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 127.614 3.071 . . . . 0.0 114.248 -175.692 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.73 118.34 22.18 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -173.273 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.286 17.0 p -52.03 142.68 15.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 117.658 -3.151 . . . . 0.0 116.181 164.108 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.358 2.5 mm -31.23 -56.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 128.001 2.52 . . . . 0.0 114.977 174.405 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.252 12.9 mm-40 -53.71 -43.77 69.29 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.035 2.534 . . . . 0.0 117.573 172.588 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.417 6.6 m120 -59.95 -14.67 16.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 118.503 2.779 . . . . 0.0 118.503 165.296 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.352 61.7 t -97.7 -33.36 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.159 1.784 . . . . 0.0 110.18 174.696 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -75.55 -27.72 58.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.346 -1.788 . . . . 0.0 109.997 178.68 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.93 -56.67 18.64 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 129.578 3.151 . . . . 0.0 112.414 167.643 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.297 88.5 mttt -44.19 -29.92 0.71 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 164.272 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -77.72 -28.69 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 O-C-N 118.407 -2.683 . . . . 0.0 112.018 171.037 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -77.2 -35.02 56.08 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 122.576 2.443 . . . . 0.0 107.392 -174.388 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.57 -31.86 66.57 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 126.005 2.066 . . . . 0.0 108.886 177.735 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -92.85 -50.56 5.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 113.113 -3.327 . . . . 0.0 110.844 -177.136 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -112.54 -19.05 12.25 Favored 'General case' 0 N--CA 1.439 -0.983 1 O-C-N 130.346 4.779 . . . . 0.0 111.129 -155.806 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.34 -4.63 58.56 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 125.631 1.832 . . . . 0.0 116.183 174.083 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.54 112.89 35.18 Favored Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 130.926 3.691 . . . . 0.0 111.06 -172.642 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.57 150.77 87.67 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 O-C-N 123.377 1.198 . . . . 0.0 111.711 -173.677 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.422 50.8 Cg_exo -41.58 -50.67 4.65 Favored 'Trans proline' 0 N--CA 1.457 -0.639 1 C-N-CA 125.648 4.232 . . . . 0.0 116.939 167.833 . . . . . . . . 3 2 . 1 . 069 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.405 ' CG ' HH21 ' A' ' 74' ' ' ARG 0.271 33.9 t70 -56.67 -22.92 38.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -178.681 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -95.52 -13.15 24.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 117.542 -3.224 . . . . 0.0 110.222 -173.807 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.261 77.7 mt-30 -94.19 136.26 34.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.957 -164.282 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.617 ' HG2' HE22 ' A' ' 49' ' ' GLN . 70.9 mtp180 -115.67 127.42 55.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 102.237 -3.245 . . . . 0.0 102.237 165.408 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.1 mt -102.62 119.79 39.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 124.525 1.141 . . . . 0.0 113.216 168.006 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 17.6 mm -114.63 152.72 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 128.947 2.899 . . . . 0.0 105.715 -170.016 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -168.0 127.04 1.25 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 112.013 -2.358 . . . . 0.0 106.556 176.532 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.417 . . 75.78 15.28 2.59 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 122.398 2.363 . . . . 0.0 116.044 167.068 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.49 17.44 31.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.856 2.646 . . . . 0.0 118.318 177.793 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 pttt -160.66 149.49 16.74 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -156.801 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.617 HE22 ' HG2' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -75.1 143.04 43.56 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 125.309 1.631 . . . . 0.0 108.021 178.094 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.45 117.2 18.69 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.462 -1.399 . . . . 0.0 107.757 169.755 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -81.57 150.92 27.94 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 131.145 3.778 . . . . 0.0 113.657 -166.422 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -64.86 120.56 12.76 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.781 2.033 . . . . 0.0 107.647 -171.956 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.56 15.25 3.7 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.394 1.949 . . . . 0.0 113.172 165.139 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.337 20.1 mtt180 -133.68 146.71 51.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 123.071 1.415 . . . . 0.0 113.881 -161.438 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -107.85 149.86 27.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 124.077 1.894 . . . . 0.0 107.505 178.043 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 mt -34.19 -48.09 0.31 Allowed 'General case' 0 N--CA 1.448 -0.525 1 C-N-CA 132.419 4.288 . . . . 0.0 116.124 176.778 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.4 p -83.88 -6.39 59.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -179.432 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.352 31.1 t0 -101.17 -10.7 20.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.765 2.026 . . . . 0.0 107.713 176.372 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.88 -14.36 17.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 129.412 3.085 . . . . 0.0 111.703 173.974 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 73.23 39.58 0.59 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 127.238 2.836 . . . . 0.0 110.578 -175.412 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.66 HD13 HD21 ' A' ' 67' ' ' LEU . 8.6 mt -87.05 96.64 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 121.988 2.176 . . . . 0.0 111.075 172.062 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.84 169.51 17.77 Favored 'General case' 0 C--N 1.325 -0.498 1 C-N-CA 134.848 5.259 . . . . 0.0 112.442 177.32 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.291 0.0 OUTLIER -51.3 140.19 17.5 Favored 'General case' 0 N--CA 1.439 -0.988 1 C-N-CA 131.739 4.016 . . . . 0.0 111.539 175.915 . . . . . . . . 4 3 . 1 . 069 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 37.34 43.58 0.39 Allowed 'General case' 0 C--N 1.324 -0.518 1 C-N-CA 133.654 4.781 . . . . 0.0 112.699 -176.917 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -59.6 147.51 36.97 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.97 1.708 . . . . 0.0 113.34 154.964 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.4 m -112.61 126.04 54.94 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 128.387 3.554 . . . . 0.0 103.798 169.7 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -124.64 160.05 29.36 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 127.696 3.123 . . . . 0.0 106.173 171.355 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 28.0 m80 -126.54 113.39 16.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 101.696 -3.446 . . . . 0.0 101.696 -155.523 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.3 tp -92.22 120.95 33.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 111.893 -2.412 . . . . 0.0 111.22 175.733 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.27 12.1 m -127.32 154.52 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 127.172 2.189 . . . . 0.0 107.818 173.435 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.258 2.3 pp -125.48 148.58 48.8 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 120.372 1.442 . . . . 0.0 112.505 -172.282 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -87.08 -171.49 3.53 Favored 'General case' 0 N--CA 1.445 -0.692 1 C-N-CA 132.056 4.142 . . . . 0.0 111.168 172.683 . . . . . . . . 2 2 . 1 . 069 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.2 mt -81.61 178.66 8.21 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.139 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 74' ' ' ARG 0.376 25.1 ttp-105 91.0 36.87 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 127.63 2.372 . . . . 0.0 112.163 175.858 . . . . . . . . 3 3 . 1 . 069 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.36 -0.1 5.88 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 122.702 1.168 . . . . 0.0 111.73 165.226 . . . . . . . . 1 1 . 1 . 069 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 O-C-N 117.918 -3.107 . . . . 0.0 109.999 -155.803 . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 . . . . . . . . . 0 0 . 1 . 070 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -86.64 131.16 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.008 1.323 . . . . 0.0 111.481 -172.174 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.566 HD12 HD13 ' A' ' 67' ' ' LEU . 19.4 pt -125.59 150.32 30.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 -175.536 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.273 2.2 m-85 -92.32 130.57 37.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.276 1.43 . . . . 0.0 108.764 168.29 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.37 96.93 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 O-C-N 127.639 3.087 . . . . 0.0 105.67 -177.093 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -85.22 123.69 31.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.01 -2.931 . . . . 0.0 104.499 -170.835 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -76.23 150.31 37.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 165.192 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.8 tp -59.88 -24.51 64.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -173.707 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -89.16 0.28 56.87 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 120.391 -1.443 . . . . 0.0 113.182 -179.696 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.5 -5.93 18.89 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 115.093 -3.06 . . . . 0.0 117.967 166.149 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -86.14 131.73 34.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 128.339 3.023 . . . . 0.0 106.633 -174.534 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -113.66 104.1 11.89 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.062 -172.274 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.2 mt -88.09 126.38 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -172.555 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 9.5 m -93.06 121.33 34.3 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 177.326 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.281 55.8 tp -144.61 144.24 31.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 119.991 -1.693 . . . . 0.0 111.16 -165.511 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.5 134.45 42.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 122.073 0.939 . . . . 0.0 109.103 -177.341 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.34 169.2 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 174.251 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -109.9 160.98 26.07 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 127.641 2.376 . . . . 0.0 110.374 164.531 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.64 -23.31 17.08 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 125.194 3.929 . . . . 0.0 115.283 -176.353 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -83.91 -1.21 54.07 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.856 -2.403 . . . . 0.0 114.644 -179.731 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -79.62 121.14 24.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.727 2.011 . . . . 0.0 107.306 -177.618 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.4 p -48.63 148.49 2.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 164.616 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' CD1' HD23 ' A' ' 56' ' ' LEU 0.393 8.6 mm -38.3 -15.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 130.089 3.355 . . . . 0.0 118.382 173.46 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -94.21 -49.8 5.57 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 123.695 2.952 . . . . 0.0 107.4 -159.256 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -51.33 -32.7 26.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.898 2.079 . . . . 0.0 114.677 -155.239 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -73.03 -21.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 1 CA-C-O 129.67 4.557 . . . . 0.0 119.359 -178.993 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -69.81 -40.31 76.02 Favored 'General case' 0 N--CA 1.442 -0.85 1 O-C-N 114.41 -5.181 . . . . 0.0 115.091 -171.413 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.58 -23.34 49.99 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 112.453 -3.641 . . . . 0.0 111.34 170.764 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -63.18 -48.39 78.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.458 2.349 . . . . 0.0 113.382 166.087 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 mm -62.23 -42.12 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 126.28 1.832 . . . . 0.0 112.309 173.204 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -47.86 -43.75 28.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 166.996 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.42 -47.2 50.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.652 -173.836 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.28 -30.11 16.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 127.317 2.886 . . . . 0.0 115.706 -176.565 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -120.99 -0.73 9.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 121.682 2.037 . . . . 0.0 110.329 179.676 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.85 -0.05 87.7 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 118.258 -2.776 . . . . 0.0 116.494 166.692 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 71' ' ' LEU . 11.6 mt -99.65 128.54 31.06 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 -170.768 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.84 155.0 58.59 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 121.818 3.738 . . . . 0.0 121.818 175.898 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -59.4 -32.17 96.08 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 124.868 3.712 . . . . 0.0 117.083 176.104 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.46 1.6 t0 -52.51 -21.48 3.83 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 163.311 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -106.28 -18.42 14.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.705 2.002 . . . . 0.0 111.755 -179.519 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -98.94 100.87 12.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 116.774 -3.704 . . . . 0.0 103.264 -172.321 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -108.73 138.6 44.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 110.352 -3.113 . . . . 0.0 104.135 166.672 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -148.51 161.72 41.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 121.654 2.025 . . . . 0.0 114.81 -168.612 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mp -129.28 131.54 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 1 C-N-CA 134.667 5.187 . . . . 0.0 112.31 -169.822 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -98.35 -50.06 4.46 Favored 'General case' 0 N--CA 1.449 -0.475 1 CA-C-O 111.577 -4.059 . . . . 0.0 114.574 161.613 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -162.35 43.36 0.13 Allowed 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 128.158 3.411 . . . . 0.0 108.054 -161.217 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.43 -69.85 0.49 Allowed Glycine 0 CA--C 1.531 1.048 0 CA-C-O 124.002 1.89 . . . . 0.0 116.686 163.778 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -54.66 132.93 46.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 162.011 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 145.58 42.58 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 116.737 -1.985 . . . . 0.0 111.955 154.933 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 59' ' ' TYR . 23.2 mt -91.08 116.98 29.23 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 123.567 1.651 . . . . 0.0 113.297 -175.498 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.271 32.1 tt0 -84.49 156.37 21.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 112.437 -2.165 . . . . 0.0 116.156 -167.67 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -65.59 141.89 58.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.281 1.832 . . . . 0.0 109.689 175.083 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.58 -42.44 1.91 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-O 115.474 -2.848 . . . . 0.0 111.585 -178.181 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 mmp_? -72.98 173.5 9.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 121.67 2.735 . . . . 0.0 117.111 -173.289 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -120.71 155.82 33.09 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 126.67 2.481 . . . . 0.0 104.925 174.868 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 ' CD1' ' A' ' 23' ' ' ILE . 49.7 mt -59.37 -29.86 68.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 125.382 2.515 . . . . 0.0 113.071 -176.882 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -47.57 -46.05 27.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 118.373 -2.704 . . . . 0.0 116.228 163.905 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -68.32 -12.32 60.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.406 -175.622 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.479 ' CE2' HD22 ' A' ' 50' ' ' LEU . 55.8 m-85 -106.67 1.37 25.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 128.169 2.587 . . . . 0.0 112.742 178.746 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 2.4 t-20 66.14 39.16 4.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.173 1.389 . . . . 0.0 110.262 175.24 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -88.33 131.28 36.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 120.75 1.614 . . . . 0.0 110.289 -176.708 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.0 mp0 -100.44 -176.14 3.12 Favored 'General case' 0 C--O 1.221 -0.406 1 O-C-N 116.235 -4.04 . . . . 0.0 110.403 -176.982 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -55.8 146.7 20.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.617 1.967 . . . . 0.0 112.084 149.837 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 66.1 14.82 9.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.062 1.745 . . . . 0.0 112.317 176.418 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.0 m -71.02 155.85 40.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.508 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.6 m -113.5 120.87 42.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 129.461 3.105 . . . . 0.0 105.371 176.871 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.566 HD13 HD12 ' A' ' 3' ' ' ILE . 4.9 mp -110.86 140.73 45.07 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 114.274 -2.774 . . . . 0.0 106.089 170.481 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -129.49 138.95 51.67 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.224 1.81 . . . . 0.0 106.484 -174.691 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.59 151.51 22.26 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.819 177.53 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -105.85 109.49 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 131.388 3.875 . . . . 0.0 102.287 170.432 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -81.23 96.4 7.24 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 129.929 3.292 . . . . 0.0 104.446 -179.972 . . . . . . . . 3 3 . 1 . 070 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 90.98 -71.28 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 131.102 3.761 . . . . 0.0 108.541 162.757 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mt -144.35 158.58 43.67 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 127.6 3.062 . . . . 0.0 105.071 -178.528 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -74.63 143.26 44.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.588 175.321 . . . . . . . . 1 1 . 1 . 070 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.7 79.81 0.31 Allowed Glycine 0 CA--C 1.534 1.234 1 C-N-CA 134.143 5.639 . . . . 0.0 109.407 -177.014 . . . . . . . . 2 2 . 1 . 070 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.991 2 C-N-CA 130.963 4.125 . . . . 0.0 105.42 -163.778 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 116.714 -1.612 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -109.03 139.44 43.9 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.032 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.11 152.19 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 128.461 2.704 . . . . 0.0 106.624 -172.76 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -105.51 140.98 37.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 124.531 2.11 . . . . 0.0 110.657 179.012 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.309 1.7 p -145.76 107.79 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.146 -178.823 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -84.23 137.2 33.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 126.038 2.086 . . . . 0.0 113.404 -173.395 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -78.91 170.68 16.3 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 113.803 -2.999 . . . . 0.0 111.615 -176.303 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 9.4 tp -60.43 -13.78 15.4 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 126.936 2.648 . . . . 0.0 118.041 -175.759 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 p -107.74 -6.34 16.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.997 1.319 . . . . 0.0 110.808 -178.681 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.0 1.81 31.8 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 120.379 -1.451 . . . . 0.0 112.745 168.161 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 tttt -84.32 119.86 25.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 130.113 3.365 . . . . 0.0 102.127 -168.343 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 3.4 m -88.71 134.89 33.77 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 -167.104 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.5 mt -120.48 152.89 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.808 2.043 . . . . 0.0 110.061 169.254 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.286 1.5 m -118.58 123.1 44.22 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 169.955 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.9 mt -116.6 140.86 48.92 Favored 'General case' 0 N--CA 1.447 -0.59 1 C-N-CA 133.587 4.755 . . . . 0.0 111.348 -176.622 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.326 0.4 OUTLIER -99.27 120.01 38.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 101.387 -3.561 . . . . 0.0 101.387 167.228 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.88 -19.45 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 113.473 -3.156 . . . . 0.0 110.666 -168.769 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 0.1 OUTLIER 90.81 127.54 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-O 115.557 -2.163 . . . . 0.0 106.651 177.426 . . . . . . . . 3 3 . 1 . 071 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -74.72 -29.26 8.92 Favored 'Trans proline' 0 N--CA 1.452 -0.966 1 C-N-CA 125.688 4.259 . . . . 0.0 113.514 178.345 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -84.54 -7.73 59.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.448 3.099 . . . . 0.0 110.606 -178.342 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.5 -177.86 3.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 122.372 2.351 . . . . 0.0 109.355 178.645 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -130.43 167.79 18.03 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -173.321 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -66.57 -38.02 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.636 1.575 . . . . 0.0 110.479 -164.735 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -56.66 -34.66 67.57 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 122.132 2.242 . . . . 0.0 109.902 -178.272 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -82.38 -2.11 52.01 Favored 'General case' 0 N--CA 1.445 -0.688 1 O-C-N 114.061 -5.4 . . . . 0.0 115.166 -178.498 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -88.98 -46.37 15.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 176.632 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HA ' HD12 ' A' ' 30' ' ' ILE . 58.1 mtmt -65.97 -29.77 70.21 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.169 0.988 . . . . 0.0 112.717 177.86 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.81 -41.11 79.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.932 2.493 . . . . 0.0 107.885 174.279 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -72.98 -30.08 63.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 173.958 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 27' ' ' LYS . 16.2 mt -67.48 -46.86 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 122.279 2.309 . . . . 0.0 111.533 169.019 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -49.75 -51.85 36.01 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 117.478 -3.264 . . . . 0.0 119.062 169.831 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -53.26 -38.05 62.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 128.602 2.761 . . . . 0.0 117.117 168.854 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -57.03 -62.81 1.49 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.46 1.504 . . . . 0.0 111.836 172.917 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.309 5.9 mm-40 -131.56 -8.7 3.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 125.493 2.568 . . . . 0.0 113.778 -157.361 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.82 32.85 6.32 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 119.955 -1.716 . . . . 0.0 115.993 178.022 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mm -82.58 130.04 60.29 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 127.889 2.476 . . . . 0.0 107.975 -167.495 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.88 127.9 15.16 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.312 2.008 . . . . 0.0 112.062 172.923 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.91 -34.99 7.88 Favored 'Trans proline' 0 N--CA 1.447 -1.219 1 C-N-CA 127.391 5.394 . . . . 0.0 112.518 -169.315 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -68.73 -19.97 64.37 Favored 'General case' 0 C--N 1.321 -0.633 1 C-N-CA 135.418 5.487 . . . . 0.0 110.244 -172.869 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -94.97 -3.74 47.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.893 1.677 . . . . 0.0 108.495 -176.914 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 10.2 mm100 -96.1 107.49 19.8 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 130.261 3.424 . . . . 0.0 111.446 -172.296 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -94.16 101.66 13.67 Favored 'General case' 0 N--CA 1.444 -0.761 1 C-N-CA 132.759 4.424 . . . . 0.0 107.24 167.919 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.488 ' CD1' ' HB3' ' A' ' 41' ' ' GLN . 11.2 mp -103.5 101.93 11.82 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 127.536 2.334 . . . . 0.0 111.4 -174.332 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.6 mm -108.69 142.3 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 123.704 1.716 . . . . 0.0 107.225 179.209 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -124.79 105.17 9.07 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 112.529 -2.123 . . . . 0.0 109.508 173.671 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.84 42.1 15.45 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 127.12 3.343 . . . . 0.0 117.048 176.791 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.9 -14.5 52.65 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 109.401 -3.545 . . . . 0.0 118.735 178.325 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.25 77.3 mttt -115.1 130.34 56.9 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -166.374 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.33 48.3 tt0 -48.33 142.34 5.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 121.345 3.832 . . . . 0.0 121.345 162.319 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 50' ' ' LEU . 87.8 mt -98.02 105.49 17.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 172.481 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -88.07 140.81 29.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 -175.706 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -81.09 141.64 34.11 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 124.161 3.164 . . . . 0.0 103.047 173.269 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.16 -29.67 6.66 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -175.664 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.39 150.4 23.83 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 127.31 2.418 . . . . 0.0 113.202 176.475 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -77.9 156.92 30.03 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.398 -1.273 . . . . 0.0 109.537 166.151 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.4 mt -74.6 -31.94 62.19 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.553 1.941 . . . . 0.0 109.589 -178.033 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.1 t -75.33 -12.67 60.32 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 120.414 -1.428 . . . . 0.0 112.572 175.917 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -66.05 -34.32 77.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 123.679 2.945 . . . . 0.0 112.65 169.518 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -91.59 7.08 43.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 127.234 2.834 . . . . 0.0 116.283 172.889 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.368 81.1 m-20 76.53 36.2 0.38 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.977 1.711 . . . . 0.0 113.304 171.285 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.4 mt -82.03 99.32 5.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 171.019 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -110.07 -172.92 2.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 129.978 3.311 . . . . 0.0 113.926 179.48 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.05 140.86 0.99 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 128.317 2.647 . . . . 0.0 117.202 173.71 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 6.7 tm-20 73.62 4.19 4.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 122.439 2.382 . . . . 0.0 114.449 162.823 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.2 m -72.54 132.14 43.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.572 -1.649 . . . . 0.0 107.913 -173.217 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.0 p -105.68 142.36 35.55 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 125.071 1.482 . . . . 0.0 108.109 167.198 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.29 165.91 26.18 Favored 'General case' 0 N--CA 1.446 -0.636 1 C-N-CA 131.838 4.055 . . . . 0.0 105.692 167.261 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -99.54 161.58 13.53 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 126.022 2.82 . . . . 0.0 104.486 165.894 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.2 tp -148.11 132.56 17.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 118.762 -2.461 . . . . 0.0 110.224 -179.56 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -68.34 89.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 127.023 3.296 . . . . 0.0 104.529 163.812 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp -153.72 148.93 26.96 Favored 'General case' 0 N--CA 1.443 -0.812 1 N-CA-C 98.601 -4.592 . . . . 0.0 98.601 175.427 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -77.75 157.46 30.02 Favored 'General case' 0 N--CA 1.441 -0.9 1 C-N-CA 133.251 4.621 . . . . 0.0 107.367 -175.1 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -12.28 61.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 125.774 2.702 . . . . 0.0 115.468 -176.004 . . . . . . . . 2 2 . 1 . 071 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -82.62 100.81 10.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 118.964 -2.335 . . . . 0.0 110.057 -175.651 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.73 -73.09 0.21 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 127.875 2.655 . . . . 0.0 111.841 161.348 . . . . . . . . 1 1 . 1 . 071 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 N-CA-C 103.23 -3.948 . . . . 0.0 103.23 169.059 . . . . . . . . 0 0 . 1 . 072 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ttp . . . . . 0 C--O 1.24 0.568 1 N-CA-C 99.492 -4.262 . . . . 0.0 99.492 . . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -94.37 136.15 34.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 123.082 2.674 . . . . 0.0 110.694 167.966 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.27 161.25 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 102.902 -2.999 . . . . 0.0 102.902 170.401 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -117.25 149.76 39.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.045 1.738 . . . . 0.0 113.481 -171.67 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' HB2' ' A' ' 67' ' ' LEU 0.343 16.3 m -141.69 165.0 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 128.681 2.792 . . . . 0.0 112.41 169.062 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -149.78 142.17 24.29 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -169.367 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -136.72 -145.21 0.21 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 129.08 2.952 . . . . 0.0 108.604 175.246 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -96.29 -55.01 3.08 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 121.357 1.889 . . . . 0.0 108.254 -169.036 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -84.98 -27.1 26.71 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.295 1.838 . . . . 0.0 114.276 -179.917 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.94 123.95 7.15 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 106.505 -2.638 . . . . 0.0 106.505 175.269 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -102.86 -29.04 11.69 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.011 2.524 . . . . 0.0 107.383 -174.683 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -137.28 96.37 3.26 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 114.283 -2.77 . . . . 0.0 104.497 -177.233 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.9 mt -103.29 109.32 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 1 N-CA-C 98.541 -4.614 . . . . 0.0 98.541 165.009 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.271 62.8 p -86.77 131.48 34.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 173.922 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -128.61 120.72 27.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.436 -2.802 . . . . 0.0 103.436 -175.603 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -96.01 120.39 36.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.611 3.564 . . . . 0.0 105.681 -178.435 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 m -143.4 159.01 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 O-C-N 117.482 -3.261 . . . . 0.0 108.057 -170.07 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.71 151.29 37.37 Favored Pre-proline 0 N--CA 1.447 -0.606 1 C-N-CA 132.618 4.367 . . . . 0.0 100.764 163.644 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.281 73.1 Cg_endo -64.47 8.7 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.966 2.444 . . . . 0.0 116.443 -179.927 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.3 p -128.34 16.87 6.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 129.345 3.058 . . . . 0.0 115.93 168.753 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.263 1.0 OUTLIER -41.0 117.21 0.82 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 158.813 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 p -73.68 151.18 40.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.947 2.899 . . . . 0.0 108.823 179.687 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.31 1.1 mm -50.77 -41.03 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 126.779 2.032 . . . . 0.0 109.501 176.438 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -57.9 -41.48 82.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 171.143 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -65.15 -50.42 66.07 Favored 'General case' 0 N--CA 1.45 -0.452 1 O-C-N 116.159 -4.088 . . . . 0.0 113.962 171.342 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.84 -54.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 122.684 2.493 . . . . 0.0 112.426 168.649 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -53.04 -47.57 68.29 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.029 2.932 . . . . 0.0 115.904 170.68 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.47 -52.96 33.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 117.141 -3.474 . . . . 0.0 118.791 159.012 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -62.05 -33.36 74.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 128.882 2.873 . . . . 0.0 110.268 -176.508 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.4 mt -76.39 -48.55 27.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 129.014 2.926 . . . . 0.0 106.842 173.227 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -49.85 -49.5 49.0 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 128.94 2.896 . . . . 0.0 113.144 176.94 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -49.3 -31.95 10.08 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 128.919 2.888 . . . . 0.0 114.883 -174.054 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -105.0 -64.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 127.782 3.176 . . . . 0.0 111.196 178.353 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -81.45 -27.87 34.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -159.118 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.61 0.65 43.1 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 170.797 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.5 mm -80.61 122.05 81.92 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 120.869 2.335 . . . . 0.0 107.764 -170.806 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -76.53 156.02 36.16 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 CA-C-O 114.356 -2.435 . . . . 0.0 112.95 175.402 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.26 -21.42 1.18 Allowed 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 122.522 2.148 . . . . 0.0 115.525 170.915 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -81.26 -22.14 38.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 117.845 -3.034 . . . . 0.0 116.814 -175.623 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -105.61 3.43 29.18 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -166.525 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.537 ' HB2' HD21 ' A' ' 69' ' ' LEU . 19.5 pt20 -128.47 128.9 45.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.346 2.258 . . . . 0.0 105.052 -171.237 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 mtt85 -90.41 170.22 10.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 124.952 2.311 . . . . 0.0 105.121 158.006 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.386 30.7 tp -138.19 112.02 8.35 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 112.71 -2.041 . . . . 0.0 107.783 176.606 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.31 140.99 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 127.445 3.498 . . . . 0.0 105.189 173.714 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.54 145.17 22.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 119.247 -2.158 . . . . 0.0 105.41 151.592 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.67 22.46 5.36 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 125.778 1.924 . . . . 0.0 111.3 175.43 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.8 -12.89 61.0 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 116.414 -2.325 . . . . 0.0 108.325 174.408 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -108.69 127.35 53.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 120.849 2.324 . . . . 0.0 106.157 -159.04 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -61.58 93.58 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.907 2.883 . . . . 0.0 105.069 165.713 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.8 mt -64.94 130.51 43.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 119.389 -2.069 . . . . 0.0 113.571 172.3 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -86.65 146.45 26.31 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 125.718 1.886 . . . . 0.0 114.562 -176.732 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.305 14.5 m-20 -68.33 112.85 5.45 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 126.975 2.672 . . . . 0.0 115.103 168.703 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.15 -23.59 2.41 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.253 -1.304 . . . . 0.0 114.862 -169.559 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -110.06 162.57 14.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 -161.796 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -101.73 165.98 10.92 Favored 'General case' 0 N--CA 1.448 -0.561 1 C-N-CA 132.583 4.353 . . . . 0.0 113.313 168.525 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.9 mt -42.03 -45.51 3.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 116.237 -1.84 . . . . 0.0 113.909 168.833 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -64.68 -14.95 60.48 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 130.199 3.4 . . . . 0.0 113.972 -176.532 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -75.92 -35.47 59.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.711 0.404 . . . . 0.0 110.518 172.809 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -114.26 12.5 17.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 -173.193 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 9.2 m120 65.27 28.94 11.86 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 126.665 1.986 . . . . 0.0 115.306 161.977 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -93.29 137.43 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 128.496 3.998 . . . . 0.0 103.841 -160.384 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -111.4 -168.75 1.35 Allowed 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 116.928 -3.608 . . . . 0.0 109.993 176.97 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -78.48 149.86 33.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 118.876 -2.39 . . . . 0.0 113.18 -170.233 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 31.4 mt-10 66.52 9.35 6.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 130.75 3.62 . . . . 0.0 112.963 174.889 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -72.51 165.75 24.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.919 1.688 . . . . 0.0 108.075 174.81 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 m -121.86 130.26 53.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.067 2.947 . . . . 0.0 109.683 176.414 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 67' ' ' LEU . 3.1 mp -104.8 169.48 8.43 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 119.543 -1.973 . . . . 0.0 111.26 158.057 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -119.77 126.5 51.2 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.6 2.36 . . . . 0.0 113.623 177.088 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 41' ' ' GLN 0.288 3.9 tt -98.85 131.39 44.99 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -177.131 . . . . . . . . 3 3 . 1 . 072 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.9 123.9 71.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 174.893 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 mt -89.23 164.95 14.74 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.774 2.43 . . . . 0.0 110.148 179.42 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -120.62 50.87 1.28 Allowed 'General case' 0 N--CA 1.447 -0.625 1 C-N-CA 135.714 5.605 . . . . 0.0 109.33 177.968 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.3 mt -80.76 -34.71 34.06 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.659 1.983 . . . . 0.0 106.546 167.168 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.274 34.1 ptt85 -154.54 116.36 4.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.348 2.659 . . . . 0.0 108.285 179.427 . . . . . . . . 2 2 . 1 . 072 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.77 -144.37 8.17 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 123.735 1.742 . . . . 0.0 116.058 -175.202 . . . . . . . . 1 1 . 1 . 072 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 C-N-CA 128.627 3.013 . . . . 0.0 112.335 -174.971 . . . . . . . . 0 0 . 1 . 073 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 6.4 ptm . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 124.935 2.302 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -85.84 121.87 29.1 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 117.603 -3.186 . . . . 0.0 109.268 170.054 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pt -137.44 117.93 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 128.338 2.655 . . . . 0.0 104.59 170.871 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -83.16 112.92 20.27 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 117.803 -3.061 . . . . 0.0 109.213 -173.259 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.4 t -85.05 100.55 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 O-C-N 117.999 -2.938 . . . . 0.0 106.89 170.797 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -103.5 119.52 39.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.3 1.44 . . . . 0.0 107.245 -167.955 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m -81.57 144.6 31.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.245 1.818 . . . . 0.0 109.437 174.89 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -37.8 -51.11 1.27 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -178.648 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 p -62.07 -10.49 10.27 Favored 'General case' 0 N--CA 1.444 -0.728 1 O-C-N 129.366 4.166 . . . . 0.0 114.751 -178.057 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.2 -24.14 16.86 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.755 1.862 . . . . 0.0 117.755 179.752 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -62.59 123.02 17.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 127.329 2.252 . . . . 0.0 109.374 -177.253 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.278 8.4 m -114.8 113.28 24.04 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.976 2.11 . . . . 0.0 115.652 -174.108 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.7 mt -90.44 148.0 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 O-C-N 126.495 2.372 . . . . 0.0 106.528 -172.445 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.318 4.7 t -155.19 100.04 2.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 -163.906 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -140.78 127.98 20.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.635 -2.075 . . . . 0.0 110.653 -161.101 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.79 93.61 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.456 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -125.84 169.81 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 126.689 1.995 . . . . 0.0 107.815 169.799 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' OE2' ' HB3' ' A' ' 1' ' ' MET . 26.7 mm-40 -138.17 158.9 70.16 Favored Pre-proline 0 N--CA 1.445 -0.713 1 C-N-CA 132.035 4.134 . . . . 0.0 107.068 -176.24 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.16 -9.03 14.12 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 O-C-N 125.58 2.358 . . . . 0.0 117.992 -168.605 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 t -92.74 4.42 53.79 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.455 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -73.18 134.23 44.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 117.267 -3.396 . . . . 0.0 111.428 175.902 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -76.29 157.25 32.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 125.03 2.348 . . . . 0.0 112.926 175.902 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.268 2.7 mm -64.52 -31.5 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 O-C-N 117.207 -3.433 . . . . 0.0 118.315 -172.12 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.03 -35.85 25.45 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.926 2.091 . . . . 0.0 111.557 178.137 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.367 10.3 t-20 -51.72 -48.94 63.4 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 127.037 2.711 . . . . 0.0 113.669 158.651 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.87 -40.43 85.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 121.898 2.136 . . . . 0.0 113.067 171.681 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.261 44.7 mtpt -64.84 -36.33 83.99 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.153 1.781 . . . . 0.0 110.833 -178.376 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.14 -14.25 62.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.449 2.299 . . . . 0.0 112.527 -176.308 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -83.13 -27.81 29.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 123.633 0.583 . . . . 0.0 111.594 173.953 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 30' ' ' ILE . 75.3 mt -82.57 -18.65 10.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.907 -164.967 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -77.26 -30.14 54.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 125.14 1.525 . . . . 0.0 112.484 176.362 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -70.91 -57.41 4.62 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 119.367 -2.083 . . . . 0.0 110.979 165.886 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -82.66 -28.59 30.56 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.157 1.783 . . . . 0.0 114.327 -161.438 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -118.23 -5.99 10.86 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 124.403 1.064 . . . . 0.0 110.601 178.733 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.22 -0.08 26.09 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 129.733 3.54 . . . . 0.0 117.923 -175.677 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.6 mm -82.8 138.88 43.34 Favored Pre-proline 0 N--CA 1.447 -0.597 1 O-C-N 115.376 -4.602 . . . . 0.0 104.165 -172.275 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -86.03 167.29 9.56 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 125.027 3.818 . . . . 0.0 105.589 176.254 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.98 -22.16 5.32 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.64 2.227 . . . . 0.0 116.237 168.507 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.37 0.0 OUTLIER -54.52 -49.73 69.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 129.747 3.219 . . . . 0.0 109.668 -179.459 . . . . . . . . 3 3 . 1 . 073 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.29 71.0 mm-40 -78.8 -22.26 46.55 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 120.458 1.481 . . . . 0.0 114.943 178.116 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.307 62.4 tt0 -86.21 154.46 21.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.488 1.915 . . . . 0.0 113.542 -156.527 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.319 23.6 ttm105 -153.35 140.4 19.32 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 128.381 2.672 . . . . 0.0 112.75 -178.247 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.3 mt -125.0 131.96 53.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 116.85 -1.548 . . . . 0.0 111.708 -177.937 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.53 120.67 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.282 1.833 . . . . 0.0 112.742 179.234 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.294 22.6 t80 -120.7 119.84 33.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 115.992 -1.956 . . . . 0.0 108.078 176.908 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.46 25.41 9.63 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 126.239 2.212 . . . . 0.0 116.928 -178.967 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.27 -15.28 63.29 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.739 1.637 . . . . 0.0 112.406 -174.73 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.13 113.76 26.11 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 124.025 3.912 . . . . 0.0 105.494 -173.444 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -66.77 136.7 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 126.338 2.97 . . . . 0.0 107.77 168.189 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -84.97 134.95 34.23 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 118.608 -2.558 . . . . 0.0 113.168 179.134 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.24 158.27 16.68 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -178.733 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -73.16 155.08 39.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.984 2.514 . . . . 0.0 111.902 177.829 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.13 -15.56 62.61 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.767 2.127 . . . . 0.0 116.303 171.213 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -91.21 161.0 15.25 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -167.821 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -84.77 166.78 16.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.923 0.868 . . . . 0.0 108.945 170.499 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.0 -41.37 91.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 118.978 -2.326 . . . . 0.0 116.905 168.088 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 t -53.92 -23.91 14.49 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 130.04 3.336 . . . . 0.0 116.069 170.307 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -74.27 -18.06 60.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 115.38 -2.248 . . . . 0.0 115.23 172.266 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -103.45 5.83 37.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.243 1.383 . . . . 0.0 110.979 172.401 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 73.72 33.73 1.0 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.119 1.368 . . . . 0.0 110.007 175.137 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -90.57 136.91 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 119.342 -2.099 . . . . 0.0 112.071 -170.608 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -130.69 174.05 10.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.013 1.725 . . . . 0.0 112.669 -162.786 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -58.26 121.23 10.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.154 2.181 . . . . 0.0 111.56 -177.995 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.368 12.4 mt-10 61.57 34.03 18.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 130.807 3.643 . . . . 0.0 113.77 178.454 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.258 24.4 m -83.76 157.72 22.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 159.481 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -126.4 135.46 51.45 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.468 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.254 3.9 mp -98.68 143.1 29.43 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 128.332 2.653 . . . . 0.0 107.51 172.081 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -72.43 148.87 44.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 124.674 2.178 . . . . 0.0 109.405 159.534 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -135.23 131.16 36.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.422 169.376 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.37 152.65 36.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 128.336 2.654 . . . . 0.0 110.922 170.49 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.41 120.88 33.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 130.309 3.444 . . . . 0.0 109.496 178.489 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.646 14.2 ttt85 93.36 -10.07 0.15 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.12 2.168 . . . . 0.0 116.227 162.918 . . . . . . . . 2 2 . 1 . 073 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.384 4.6 pp -140.18 156.05 46.68 Favored 'General case' 0 N--CA 1.448 -0.535 1 CA-C-O 111.54 -4.076 . . . . 0.0 116.875 -177.955 . . . . . . . . 3 2 . 1 . 073 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -108.56 64.46 0.61 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 127.711 3.132 . . . . 0.0 115.801 -177.71 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.28 127.9 5.63 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 127.948 2.689 . . . . 0.0 107.939 178.868 . . . . . . . . 1 1 . 1 . 073 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.684 1 N-CA-C 101.457 -4.657 . . . . 0.0 101.457 158.621 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttp . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 . . . . . . . . . 0 0 . 1 . 074 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -95.08 140.87 29.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.514 -1.675 . . . . 0.0 110.111 -178.49 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -145.09 159.58 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 128.075 2.55 . . . . 0.0 107.174 167.313 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -106.43 153.3 22.46 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 117.409 -3.307 . . . . 0.0 105.946 171.806 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.8 t -118.85 130.01 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 166.827 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -111.01 138.35 47.52 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.418 1.087 . . . . 0.0 108.128 173.789 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.7 p -88.35 140.51 29.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 164.557 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -60.47 -17.76 47.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 117.03 -3.544 . . . . 0.0 115.88 -177.15 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -80.49 -5.84 57.25 Favored 'General case' 0 C--N 1.322 -0.589 2 C-N-CA 131.97 4.108 . . . . 0.0 112.716 165.724 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.37 -7.95 43.86 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 118.306 2.082 . . . . 0.0 118.306 165.142 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -58.15 152.27 17.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 117.916 -3.108 . . . . 0.0 112.547 163.583 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.0 p -134.15 161.31 35.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.628 1.204 . . . . 0.0 109.776 161.948 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.54 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -142.42 154.8 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 102.173 -3.269 . . . . 0.0 102.173 169.385 . . . . . . . . 3 3 . 1 . 074 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -97.54 126.38 42.79 Favored 'General case' 0 N--CA 1.444 -0.773 1 C-N-CA 132.116 4.167 . . . . 0.0 103.36 -175.038 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.15 101.35 8.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 131.386 3.874 . . . . 0.0 111.687 -176.8 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.3 pm0 -76.47 126.16 30.5 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 127.174 2.796 . . . . 0.0 105.473 163.539 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.432 31.5 m -135.84 165.01 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 1 C-N-CA 133.368 4.667 . . . . 0.0 116.468 -175.674 . . . . . . . . 3 2 . 1 . 074 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.67 159.78 37.42 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 125.879 1.671 . . . . 0.0 111.124 166.686 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.352 97.7 Cg_endo -58.62 -40.59 72.22 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 N-CA-C 120.26 3.139 . . . . 0.0 120.26 177.256 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -73.15 -14.74 61.43 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 130.24 3.416 . . . . 0.0 109.89 -171.644 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -65.55 127.3 31.31 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 124.98 2.324 . . . . 0.0 112.74 -175.725 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.9 p -70.06 156.09 39.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.376 175.244 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.76 -37.0 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.577 1.151 . . . . 0.0 111.506 166.101 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -48.06 -48.61 33.22 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.691 1.996 . . . . 0.0 114.338 166.749 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -73.32 -43.3 61.12 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 118.006 -2.934 . . . . 0.0 112.774 174.59 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.315 29.9 t -58.57 -31.47 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 118.012 -2.93 . . . . 0.0 112.022 170.653 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -64.95 -39.27 93.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 123.145 2.702 . . . . 0.0 111.339 169.302 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.46 -31.36 53.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 111.944 -3.884 . . . . 0.0 114.704 175.491 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -62.95 -50.97 68.7 Favored 'General case' 0 N--CA 1.452 -0.357 1 O-C-N 132.857 6.348 . . . . 0.0 109.659 167.443 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mt -53.05 -46.18 53.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 1 O-C-N 115.517 -4.489 . . . . 0.0 109.424 173.442 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -34.64 77.8 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 112.741 -3.504 . . . . 0.0 111.51 -179.964 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.67 -32.37 69.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 128.457 3.598 . . . . 0.0 109.851 176.058 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -78.43 -34.48 47.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 121.754 2.07 . . . . 0.0 113.5 173.759 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -145.98 -19.46 0.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -151.818 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.39 -4.68 54.73 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 128.374 2.892 . . . . 0.0 114.003 158.279 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mt -65.19 115.48 21.77 Favored Pre-proline 0 N--CA 1.445 -0.701 0 O-C-N 119.027 -2.455 . . . . 0.0 111.979 173.942 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.1 153.42 62.69 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 CA-C-O 112.085 -3.381 . . . . 0.0 117.425 -178.198 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.68 -34.96 55.72 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 125.134 3.889 . . . . 0.0 118.727 -166.7 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.01 -23.81 35.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.464 0.649 . . . . 0.0 109.846 -168.338 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.397 12.3 mm100 -87.01 -0.69 57.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.922 2.489 . . . . 0.0 111.203 178.748 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -95.22 145.67 24.89 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.482 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -138.3 134.61 34.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.547 2.739 . . . . 0.0 104.359 161.232 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mt -114.89 139.02 50.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 113.401 -3.19 . . . . 0.0 107.943 -177.234 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mm -129.87 131.88 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 129.623 3.169 . . . . 0.0 106.516 -174.718 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -113.11 -38.0 4.6 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 158.767 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.257 . . -124.95 -120.34 0.27 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 118.034 -2.916 . . . . 0.0 107.831 -172.641 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.52 13.96 42.8 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 125.982 3.992 . . . . 0.0 111.668 -177.014 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -145.01 -175.86 4.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 115.098 -2.382 . . . . 0.0 109.742 -176.967 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -78.73 156.32 28.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 126.187 2.179 . . . . 0.0 111.831 169.946 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.8 mt -95.45 144.52 25.88 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 163.836 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.92 129.21 46.74 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.211 2.204 . . . . 0.0 110.825 -168.941 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -42.52 -52.62 4.66 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 120.822 3.638 . . . . 0.0 120.822 -171.161 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.71 5.19 73.13 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 114.091 -3.616 . . . . 0.0 111.131 -175.212 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 54' ' ' ARG . 14.7 mtt180 -92.6 150.8 20.49 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 119.866 1.833 . . . . 0.0 111.287 159.813 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.342 7.1 p -91.1 156.73 17.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 129.622 3.169 . . . . 0.0 113.389 -177.764 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -43.11 -49.22 6.35 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.55 3.14 . . . . 0.0 112.516 164.761 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.378 45.3 p -55.91 -40.36 72.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 172.895 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -58.52 -47.72 83.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 118.348 -2.72 . . . . 0.0 110.762 -176.091 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.393 40.3 m-85 -90.06 4.14 51.15 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.061 177.887 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 74.8 33.84 0.75 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.306 2.242 . . . . 0.0 114.017 156.51 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.1 mm -72.23 127.81 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 100.902 -3.74 . . . . 0.0 100.902 -171.802 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -92.34 155.66 17.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.063 1.745 . . . . 0.0 107.354 175.761 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.03 146.12 2.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.74 2.416 . . . . 0.0 115.372 173.892 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.373 1.6 tt0 58.0 19.1 5.62 Favored 'General case' 0 N--CA 1.443 -0.793 1 C-N-CA 133.112 4.565 . . . . 0.0 118.534 -174.741 . . . . . . . . 3 2 . 1 . 074 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.9 m -70.57 145.14 50.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.392 2.368 . . . . 0.0 117.392 169.216 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 m -90.26 140.27 29.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 103.186 -2.894 . . . . 0.0 103.186 179.157 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.4 mt -108.78 145.53 35.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 128.393 2.677 . . . . 0.0 110.525 154.699 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -104.73 137.92 41.81 Favored 'General case' 0 N--CA 1.45 -0.466 1 N-CA-C 100.091 -4.04 . . . . 0.0 100.091 174.992 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.4 tp -124.53 113.54 18.23 Favored 'General case' 0 N--CA 1.445 -0.677 1 C-N-CA 134.757 5.223 . . . . 0.0 107.436 -174.459 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.7 t -78.07 129.61 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 102.284 -3.228 . . . . 0.0 102.284 163.032 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.27 112.22 14.24 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 124.405 2.05 . . . . 0.0 106.195 171.768 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 mtm105 -80.23 48.75 1.04 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 117.641 2.459 . . . . 0.0 117.641 -170.482 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -153.34 19.36 0.56 Allowed 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 127.953 3.283 . . . . 0.0 114.567 -176.256 . . . . . . . . 1 1 . 1 . 074 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -42.46 19.6 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 117.497 -1.239 . . . . 0.0 108.682 -179.686 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.08 -14.1 19.18 Favored Glycine 0 CA--C 1.528 0.898 1 C-N-CA 131.783 4.516 . . . . 0.0 115.437 176.078 . . . . . . . . 2 2 . 1 . 074 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.333 0 N-CA-C 104.87 -3.292 . . . . 0.0 104.87 -172.403 . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ptt? . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 116.628 -1.653 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 075 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -112.67 145.53 40.28 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 123.516 2.871 . . . . 0.0 113.75 -177.835 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -135.53 155.19 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 128.03 2.532 . . . . 0.0 109.299 167.524 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -111.86 132.05 54.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 131.315 3.846 . . . . 0.0 108.787 -176.901 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 67' ' ' LEU . 93.3 t -121.67 128.79 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 172.732 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.324 59.2 mmtt -97.98 140.94 31.57 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 117.596 -3.19 . . . . 0.0 110.464 163.436 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.5 p -86.67 -176.72 5.92 Favored 'General case' 0 N--CA 1.44 -0.936 1 C-N-CA 131.914 4.086 . . . . 0.0 105.069 179.911 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.08 -46.4 57.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.236 2.615 . . . . 0.0 105.262 -178.701 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -78.58 -12.24 60.01 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.678 1.591 . . . . 0.0 112.29 -173.189 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.77 9.23 26.95 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 106.116 -2.794 . . . . 0.0 106.116 160.532 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -71.48 136.28 47.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 121.85 2.825 . . . . 0.0 110.223 170.54 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.2 m -97.23 119.76 36.34 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 128.054 3.346 . . . . 0.0 106.705 179.349 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mt -103.32 125.14 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 O-C-N 126.532 2.395 . . . . 0.0 106.915 178.358 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.2 p -109.81 124.56 51.5 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 119.948 1.249 . . . . 0.0 109.268 170.608 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.24 150.67 28.36 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.441 1.897 . . . . 0.0 107.23 175.741 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -85.37 109.4 18.38 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 131.022 3.729 . . . . 0.0 102.83 166.962 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.24 159.76 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 175.451 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -121.48 159.59 49.71 Favored Pre-proline 0 N--CA 1.45 -0.457 0 C-N-CA 131.58 3.952 . . . . 0.0 111.903 166.34 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.263 22.5 Cg_exo -61.15 -19.37 63.19 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 N-CA-C 118.019 2.276 . . . . 0.0 118.019 -172.459 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.27 0.2 OUTLIER -90.57 -2.36 57.88 Favored 'General case' 0 N--CA 1.446 -0.653 1 C-N-CA 131.877 4.071 . . . . 0.0 115.328 178.724 . . . . . . . . 4 3 . 1 . 075 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -71.43 135.37 47.18 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 118.639 -2.538 . . . . 0.0 112.549 168.675 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.1 p -82.07 164.6 21.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 177.464 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.8 mm -56.81 -36.82 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 116.878 -3.639 . . . . 0.0 113.341 -178.41 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.253 13.1 tp10 -67.63 -37.54 82.6 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 127.106 2.754 . . . . 0.0 111.188 178.395 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.09 -48.65 79.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.352 2.261 . . . . 0.0 111.658 177.833 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 t -60.39 -38.9 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 127.056 2.723 . . . . 0.0 112.271 178.156 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -80.69 -20.78 42.18 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 118.717 -2.49 . . . . 0.0 110.207 -177.551 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.91 -29.67 39.86 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 115.207 -2.33 . . . . 0.0 111.485 172.986 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -72.97 -23.74 60.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 168.317 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -73.28 -42.8 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 129.833 3.253 . . . . 0.0 111.03 170.286 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -64.42 -42.34 96.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 116.636 -1.649 . . . . 0.0 109.692 172.704 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.59 -56.2 24.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 121.827 2.103 . . . . 0.0 113.254 173.306 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -77.54 -31.97 53.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 112.993 -1.912 . . . . 0.0 115.597 -172.989 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -142.9 -7.41 0.83 Allowed 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 117.947 -2.971 . . . . 0.0 110.977 -167.51 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.95 13.07 54.43 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 126.553 2.025 . . . . 0.0 112.405 156.212 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 36' ' ' ILE . 16.9 mt -88.76 127.05 57.62 Favored Pre-proline 0 N--CA 1.446 -0.646 0 O-C-N 117.704 -3.233 . . . . 0.0 108.955 -178.616 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.73 154.97 20.57 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 N-CA-C 106.945 -1.983 . . . . 0.0 106.945 -165.612 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -68.97 -29.62 27.41 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 CA-C-O 115.359 -2.017 . . . . 0.0 112.34 176.553 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.43 118.17 9.01 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 113.731 -3.033 . . . . 0.0 115.014 171.527 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 81.45 1.63 1.57 Allowed 'General case' 0 C--N 1.321 -0.634 1 C-N-CA 132.116 4.166 . . . . 0.0 112.955 179.414 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -99.49 121.31 40.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 100.797 -3.779 . . . . 0.0 100.797 173.191 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -105.04 152.05 23.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 111.866 -2.424 . . . . 0.0 107.42 169.796 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -121.28 110.93 16.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 126.917 2.636 . . . . 0.0 113.188 174.661 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.2 mt -94.27 148.07 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 124.892 2.282 . . . . 0.0 110.01 173.427 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -126.83 107.45 10.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 100.426 -3.916 . . . . 0.0 100.426 173.108 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 76.0 -104.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 101.916 -3.364 . . . . 0.0 101.916 178.969 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.97 8.5 6.78 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 129.419 3.39 . . . . 0.0 112.707 173.617 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -86.23 105.59 16.71 Favored 'General case' 0 C--N 1.325 -0.471 1 C-N-CA 132.9 4.48 . . . . 0.0 112.056 173.204 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -66.32 134.02 51.73 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 115.421 -2.228 . . . . 0.0 114.044 158.784 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.8 mt -107.01 111.18 23.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 127.65 3.094 . . . . 0.0 109.45 -162.755 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -68.06 123.26 20.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 130.92 3.688 . . . . 0.0 111.955 176.991 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.2 -18.11 3.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 119.644 3.201 . . . . 0.0 119.644 -157.057 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.87 -1.22 56.21 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 -175.583 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -92.81 166.69 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.933 2.093 . . . . 0.0 113.898 -173.475 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -109.75 166.3 11.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 124.816 1.323 . . . . 0.0 110.11 178.84 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mt -61.93 -34.87 76.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.415 1.486 . . . . 0.0 110.426 167.656 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.7 t -53.32 -41.26 65.52 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 117.728 -3.107 . . . . 0.0 117.898 160.823 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -75.84 -41.36 52.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 112.872 -3.442 . . . . 0.0 114.255 -178.206 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -86.68 -21.0 26.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 122.013 2.188 . . . . 0.0 106.787 -174.414 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 38.6 t30 81.07 62.24 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 119.005 -2.31 . . . . 0.0 108.181 179.718 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mt -110.08 110.01 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 100.25 -3.981 . . . . 0.0 100.25 177.935 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -104.13 165.15 11.24 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 127.597 2.359 . . . . 0.0 110.66 -168.241 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.447 7.7 pttp -44.52 125.16 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 118.449 -2.657 . . . . 0.0 115.971 172.395 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.409 2.7 tt0 84.18 9.2 0.49 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 119.12 3.008 . . . . 0.0 119.12 179.34 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -59.46 147.17 37.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.454 -3.279 . . . . 0.0 114.66 172.502 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.5 p -123.94 110.69 15.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 127.093 2.746 . . . . 0.0 106.384 -171.064 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 5' ' ' VAL . 5.7 mp -111.48 158.81 18.7 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 128.798 2.839 . . . . 0.0 109.178 -173.042 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -121.55 139.37 53.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.994 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -104.11 132.63 50.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.561 -2.755 . . . . 0.0 103.561 177.875 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.331 76.7 t -113.77 132.31 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 129.504 3.121 . . . . 0.0 111.298 174.928 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.5 mt -91.01 113.95 26.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 126.115 2.134 . . . . 0.0 107.932 168.391 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -12.5 60.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.214 3.006 . . . . 0.0 111.149 179.408 . . . . . . . . 2 2 . 1 . 075 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 tp -150.72 158.37 44.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 117.192 -3.443 . . . . 0.0 104.2 158.234 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -68.68 165.4 19.49 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 121.111 1.778 . . . . 0.0 112.787 -174.948 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.73 21.21 23.66 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 129.605 3.478 . . . . 0.0 119.102 166.212 . . . . . . . . 1 1 . 1 . 075 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 1 C-N-CA 132.806 5.003 . . . . 0.0 117.415 -166.915 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 101.213 -3.625 . . . . 0.0 101.213 . . . . . . . . . 0 0 . 1 . 076 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.307 8.5 mt-30 -104.51 156.3 18.07 Favored 'General case' 0 N--CA 1.455 -0.205 1 O-C-N 112.643 -6.286 . . . . 0.0 105.895 175.256 . . . . . . . . 3 2 . 1 . 076 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.559 HD12 HD13 ' A' ' 67' ' ' LEU . 16.9 pt -125.8 140.5 48.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 110.942 -2.845 . . . . 0.0 110.541 156.143 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -81.17 138.73 35.84 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 101.044 -3.687 . . . . 0.0 101.044 171.648 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' CG2' HD23 ' A' ' 15' ' ' LEU . 39.5 t -123.12 123.3 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 166.385 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -86.22 131.65 34.18 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 -178.149 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -93.67 167.24 11.79 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.674 -1.266 . . . . 0.0 111.738 179.662 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.54 -24.36 61.93 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.427 2.691 . . . . 0.0 108.977 172.067 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.2 p -94.39 3.47 55.14 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 121.974 2.17 . . . . 0.0 110.39 -177.273 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.02 -38.94 2.53 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 158.928 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -83.54 158.78 21.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.167 -1.196 . . . . 0.0 111.008 -167.742 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -106.82 101.24 10.7 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 128.542 2.737 . . . . 0.0 103.969 177.453 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 pt -68.16 140.54 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.268 163.194 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 m -97.65 121.02 39.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 118.011 -2.93 . . . . 0.0 105.486 173.067 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD23 ' CG2' ' A' ' 5' ' ' VAL . 3.8 mm? -87.23 145.34 26.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 122.003 2.183 . . . . 0.0 105.649 166.752 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -100.65 113.18 25.81 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.078 2.151 . . . . 0.0 109.309 169.891 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.252 11.9 m -136.76 154.08 31.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 117.735 -3.103 . . . . 0.0 114.137 -164.722 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -118.24 149.31 45.55 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 127.914 2.486 . . . . 0.0 110.786 172.749 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.383 36.6 Cg_endo -57.18 -40.35 83.61 Favored 'Trans proline' 0 N--CA 1.447 -1.239 2 C-N-CA 127.461 5.441 . . . . 0.0 123.098 -174.886 . . . . . . . . 3 2 . 1 . 076 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.288 23.0 p -80.17 -2.08 43.16 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 178.836 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.69 138.97 37.51 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.831 -174.95 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -84.76 126.97 33.88 Favored 'General case' 0 C--N 1.323 -0.544 1 C-N-CA 132.134 4.174 . . . . 0.0 106.761 -171.645 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 50' ' ' LEU 0.262 5.4 mm -30.59 -41.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 120.897 3.665 . . . . 0.0 120.897 174.427 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -61.72 -34.42 75.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 114.972 -2.442 . . . . 0.0 110.693 172.669 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -72.8 -15.87 61.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 125.424 3.738 . . . . 0.0 113.119 171.116 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.2 t -86.28 -35.3 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 115.907 -1.996 . . . . 0.0 110.612 175.975 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -62.76 -45.25 93.56 Favored 'General case' 0 N--CA 1.447 -0.623 1 O-C-N 129.548 4.28 . . . . 0.0 109.667 171.362 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.56 -33.9 68.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 167.077 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -73.77 -40.82 63.19 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 116.403 -1.761 . . . . 0.0 109.815 -178.843 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.52 -33.83 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 126.682 1.993 . . . . 0.0 114.972 171.956 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -69.5 -44.92 70.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 101.887 -3.375 . . . . 0.0 101.887 177.843 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.357 2.5 t70 -63.59 -5.34 3.8 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 130.321 3.448 . . . . 0.0 114.689 179.075 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -116.85 -75.44 0.58 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.846 2.858 . . . . 0.0 111.33 178.491 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -95.91 -1.96 48.21 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.267 1.827 . . . . 0.0 114.046 -174.721 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.93 3.5 68.06 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 123.401 2.818 . . . . 0.0 114.982 164.98 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.2 mt -76.45 111.71 17.21 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 126.673 1.989 . . . . 0.0 110.216 -176.822 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -51.86 131.32 37.82 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 CA-C-O 115.696 -1.877 . . . . 0.0 113.825 168.97 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -38.58 -35.95 0.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 124.983 3.789 . . . . 0.0 119.816 175.625 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.49 -12.98 62.1 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.885 0.85 . . . . 0.0 113.129 -178.285 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -92.12 -5.7 52.21 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 117.243 -3.41 . . . . 0.0 112.161 172.423 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 65.6 mt-30 -108.3 107.38 17.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 119.439 -2.038 . . . . 0.0 108.975 -171.423 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -92.06 133.43 35.75 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 125.584 1.803 . . . . 0.0 106.668 156.492 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 69' ' ' LEU . 93.3 mt -113.4 144.81 42.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.837 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.268 11.3 mm -132.12 136.43 56.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 112.062 -2.335 . . . . 0.0 105.948 -165.767 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.423 ' CE2' HG12 ' A' ' 61' ' ' ILE . 75.8 t80 -145.35 117.4 8.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 127.097 2.748 . . . . 0.0 106.322 177.152 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.327 . . 63.76 -98.6 0.07 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.812 1.245 . . . . 0.0 111.38 -160.191 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.19 11.23 5.32 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 127.231 2.832 . . . . 0.0 119.37 161.844 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -87.03 127.04 35.11 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.417 2.687 . . . . 0.0 105.728 -163.421 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -75.12 102.94 5.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 118.967 -2.333 . . . . 0.0 108.322 170.329 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 23' ' ' ILE . 65.0 mt -62.46 117.99 6.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.401 3.08 . . . . 0.0 109.309 177.632 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -89.74 145.49 25.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 117.512 -3.242 . . . . 0.0 114.39 -174.571 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.98 118.12 16.57 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 126.551 3.072 . . . . 0.0 112.902 176.267 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.1 -17.42 19.63 Favored Glycine 0 CA--C 1.524 0.625 1 C-N-CA 132.24 4.733 . . . . 0.0 111.429 -178.431 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -86.98 149.47 24.75 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 122.089 2.944 . . . . 0.0 109.68 176.026 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.6 p -95.78 169.27 10.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 126.511 3.053 . . . . 0.0 112.964 -178.685 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.78 -36.1 80.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 116.5 -3.875 . . . . 0.0 111.384 173.638 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -67.84 -37.77 82.3 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 118.709 -2.494 . . . . 0.0 108.336 -178.775 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.4 -48.83 77.99 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 126.228 2.205 . . . . 0.0 110.789 176.742 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -81.65 7.85 11.31 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.617 3.167 . . . . 0.0 118.572 170.71 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 63.03 21.31 12.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.406 1.882 . . . . 0.0 110.789 170.489 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.423 HG12 ' CE2' ' A' ' 45' ' ' PHE . 47.1 mt -76.8 145.11 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 124.124 1.916 . . . . 0.0 108.521 175.018 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -134.44 -177.38 4.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.41 1.484 . . . . 0.0 110.631 -167.248 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -57.13 132.56 53.33 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 114.455 -2.688 . . . . 0.0 114.36 173.763 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 70.44 48.1 0.48 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 126.11 2.862 . . . . 0.0 115.825 172.888 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -117.88 152.74 34.8 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 118.698 -2.502 . . . . 0.0 106.77 -178.548 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.4 m -108.34 117.01 33.05 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 129.242 3.017 . . . . 0.0 108.746 -176.514 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.559 HD13 HD12 ' A' ' 3' ' ' ILE 0.311 7.6 mp -105.63 158.33 16.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 167.541 . . . . . . . . 3 3 . 1 . 076 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -103.27 123.87 47.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 129.762 3.225 . . . . 0.0 109.868 168.3 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 43' ' ' LEU . 36.8 tp -81.71 113.63 19.83 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 129.411 3.084 . . . . 0.0 107.921 164.101 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.85 150.71 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 128.161 2.584 . . . . 0.0 112.684 -176.977 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.2 mt -78.16 135.39 37.64 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 129.48 3.112 . . . . 0.0 103.173 -178.984 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -91.63 135.67 33.71 Favored 'General case' 0 N--CA 1.446 -0.668 1 C-N-CA 135.221 5.409 . . . . 0.0 104.596 148.083 . . . . . . . . 2 2 . 1 . 076 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -125.93 -13.83 6.24 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.395 1.684 . . . . 0.0 110.292 -168.939 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -124.7 118.89 27.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.722 2.009 . . . . 0.0 111.925 164.787 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.59 157.36 17.16 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 104.42 -3.472 . . . . 0.0 104.42 -168.957 . . . . . . . . 1 1 . 1 . 076 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 1 O-C-N 115.495 -4.532 . . . . 0.0 106.875 -176.62 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 4.3 tmm? . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 117.166 -1.397 . . . . 0.0 108.952 . . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -75.82 133.7 40.57 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.261 1.824 . . . . 0.0 110.064 -177.708 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -147.29 173.26 2.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 122.554 2.434 . . . . 0.0 113.353 162.508 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.69 148.62 39.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 128.678 2.791 . . . . 0.0 104.236 -177.951 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.06 125.08 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 126.946 2.099 . . . . 0.0 105.384 169.185 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.51 140.12 40.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.6 171.966 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -111.62 145.54 39.0 Favored 'General case' 0 C--N 1.327 -0.394 1 O-C-N 129.289 4.118 . . . . 0.0 112.636 177.965 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 tp -77.34 -13.29 59.96 Favored 'General case' 0 C--O 1.239 0.549 1 O-C-N 115.821 -4.299 . . . . 0.0 109.1 -177.269 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -88.04 -16.76 32.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 113.642 -3.075 . . . . 0.0 113.037 171.54 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.6 17.17 2.39 Favored Glycine 0 CA--C 1.54 1.633 0 O-C-N 128.892 3.87 . . . . 0.0 112.348 142.872 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -96.86 147.65 23.74 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.64 3.576 . . . . 0.0 107.552 178.808 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 m -125.07 147.24 49.07 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 122.127 2.239 . . . . 0.0 108.134 164.933 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 pt -129.51 153.83 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 126.614 1.965 . . . . 0.0 108.497 173.958 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 140.32 29.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 150.963 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.6 tp -137.8 166.12 24.78 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 129.818 3.247 . . . . 0.0 106.782 -173.638 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -132.3 128.85 38.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 100.624 -3.843 . . . . 0.0 100.624 173.122 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.514 HG21 ' CD1' ' A' ' 56' ' ' LEU . 3.5 m -127.21 166.23 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 128.521 2.728 . . . . 0.0 105.921 175.075 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.553 ' HG3' ' H ' ' A' ' 20' ' ' SER . 14.6 tp10 -86.12 155.58 57.75 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 101.443 -3.54 . . . . 0.0 101.443 166.726 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 50.7 Cg_endo -59.75 -33.27 96.39 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 CA-C-N 122.176 1.813 . . . . 0.0 114.358 157.581 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.553 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 2.9 m -93.5 19.64 8.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 109.898 -3.319 . . . . 0.0 107.568 -168.252 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -82.66 133.04 35.17 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.729 1.212 . . . . 0.0 108.57 160.927 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 54' ' ' ARG 0.357 20.3 p -77.22 163.53 26.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.794 1.238 . . . . 0.0 111.59 165.458 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 24.9 mm -38.62 -51.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 128.374 2.67 . . . . 0.0 112.307 166.411 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.58 -39.41 91.09 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 118.184 2.661 . . . . 0.0 118.184 174.67 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -83.22 -26.62 30.61 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 114.091 -2.861 . . . . 0.0 110.535 -178.608 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 22' ' ' THR . 64.0 t -44.47 -76.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 130.74 3.616 . . . . 0.0 109.958 156.991 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -31.47 -38.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 1 C-N-CA 133.693 4.797 . . . . 0.0 114.52 170.743 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.55 -22.12 61.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 128.366 2.666 . . . . 0.0 114.652 -175.615 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -101.55 -16.09 16.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.499 1.92 . . . . 0.0 109.996 -176.114 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -80.68 -25.42 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 119.297 -2.127 . . . . 0.0 114.203 158.934 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -67.53 -47.12 70.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.625 1.57 . . . . 0.0 109.707 -176.487 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -48.75 -48.59 40.7 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 127.261 2.224 . . . . 0.0 111.383 168.783 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.22 -24.26 54.61 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 119.441 -2.037 . . . . 0.0 109.265 -171.314 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.513 6.7 tp10 -128.09 -34.5 2.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 -159.024 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.79 -4.78 79.2 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 123.088 2.676 . . . . 0.0 118.249 -170.21 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.7 mt -84.3 124.31 74.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.245 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.28 153.11 45.42 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.656 3.571 . . . . 0.0 105.165 173.691 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -57.31 -42.35 63.27 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.808 3.005 . . . . 0.0 115.542 -174.128 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -49.98 -20.99 1.06 Allowed 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 119.075 2.991 . . . . 0.0 119.075 168.895 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -108.09 -9.34 15.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 122.387 2.358 . . . . 0.0 111.13 176.77 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -78.11 137.1 38.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.524 1.14 . . . . 0.0 110.806 172.237 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -126.74 111.2 13.96 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 174.932 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.8 mt -100.41 122.61 43.44 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 125.713 1.883 . . . . 0.0 108.205 -178.797 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.59 139.56 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 125.965 2.04 . . . . 0.0 112.622 171.722 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -147.77 120.96 8.9 Favored 'General case' 0 N--CA 1.448 -0.543 1 C-N-CA 131.823 4.049 . . . . 0.0 113.519 175.182 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.91 33.53 14.71 Favored 'General case' 0 N--CA 1.443 -0.801 1 C-N-CA 133.162 4.585 . . . . 0.0 111.999 -178.137 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.5 -17.63 56.42 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 128.235 2.826 . . . . 0.0 117.923 173.63 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -92.52 135.77 33.78 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 116.439 -1.744 . . . . 0.0 113.719 173.39 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -72.27 133.4 45.02 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 126.87 2.606 . . . . 0.0 110.349 156.091 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.0 mt -99.21 155.04 17.69 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 118.472 -2.642 . . . . 0.0 109.972 -155.971 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -92.63 139.12 30.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 175.968 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.266 17.0 m-20 -43.08 -58.45 2.45 Favored 'General case' 0 N--CA 1.447 -0.609 1 C-N-CA 137.54 6.336 . . . . 0.0 109.173 -160.199 . . . . . . . . 3 2 . 1 . 077 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.74 18.82 43.03 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 117.594 1.798 . . . . 0.0 117.594 -159.763 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 22' ' ' THR 0.321 22.0 mmm180 -101.49 143.06 31.96 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 179.478 . . . . . . . . 3 3 . 1 . 077 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -72.24 165.03 25.25 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.374 2.269 . . . . 0.0 106.401 -179.099 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.514 ' CD1' HG21 ' A' ' 17' ' ' VAL . 73.4 mt -65.51 -22.61 66.74 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 116.42 -3.925 . . . . 0.0 117.452 168.751 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -72.17 -24.92 61.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 167.485 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -72.47 -21.6 61.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 117.97 -2.957 . . . . 0.0 116.474 166.083 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -98.72 -2.85 37.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.051 1.341 . . . . 0.0 111.88 172.834 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 73.55 29.04 1.62 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.368 1.867 . . . . 0.0 113.905 176.82 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 11.0 mt -92.47 113.49 27.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.012 1.725 . . . . 0.0 109.231 -175.572 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.263 57.5 tp60 -142.63 83.55 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.933 2.093 . . . . 0.0 109.834 -171.739 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.369 3.9 tmtt? 91.39 108.54 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 O-C-N 116.774 -3.703 . . . . 0.0 113.538 139.523 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.69 26.4 mt-10 78.41 17.12 1.15 Allowed 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 117.595 -3.191 . . . . 0.0 118.901 -178.108 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.266 19.2 p -85.71 155.95 20.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -178.839 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.4 m -109.86 110.39 21.35 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 174.217 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.68 130.29 35.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.553 1.941 . . . . 0.0 109.405 168.64 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -94.44 128.53 41.05 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 115.471 -2.492 . . . . 0.0 104.861 -168.906 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -109.61 123.53 49.6 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -171.071 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.34 164.08 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 125.431 1.492 . . . . 0.0 107.818 174.7 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -105.99 132.47 52.05 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 123.64 1.686 . . . . 0.0 106.608 -169.961 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -78.01 85.43 4.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 125.502 2.572 . . . . 0.0 104.754 -157.693 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.09 -174.59 4.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 129.053 2.941 . . . . 0.0 103.433 175.159 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -59.61 51.06 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 129.09 2.956 . . . . 0.0 114.638 173.367 . . . . . . . . 1 1 . 1 . 077 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.94 -179.56 16.52 Favored Glycine 0 CA--C 1.533 1.18 1 C-N-CA 133.864 5.507 . . . . 0.0 111.033 174.173 . . . . . . . . 2 2 . 1 . 077 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.508 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 -163.826 . . . . . . . . 0 0 . 1 . 078 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 37.7 ttp . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 . . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -86.3 144.73 27.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 118.8 -2.438 . . . . 0.0 114.455 170.449 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 3' ' ' ILE . 42.3 pt -132.21 165.5 31.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 117.163 -3.461 . . . . 0.0 107.026 169.538 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -112.49 140.13 47.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.509 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.398 60.9 t -124.84 84.39 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 129.571 3.149 . . . . 0.0 109.686 -172.272 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -75.16 121.82 22.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 121.211 -0.93 . . . . 0.0 111.582 -179.159 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 32.1 m -90.18 154.88 19.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 118.461 -2.649 . . . . 0.0 110.783 -175.471 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.287 3.0 tm? -33.46 -38.84 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 117.221 -3.425 . . . . 0.0 118.886 168.931 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.2 p -77.71 -18.17 56.85 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.344 3.458 . . . . 0.0 114.014 179.594 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.38 14.47 38.27 Favored Glycine 0 CA--C 1.523 0.574 1 C-N-CA 132.568 4.889 . . . . 0.0 109.612 177.254 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -79.48 116.88 19.96 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.563 -1.551 . . . . 0.0 109.394 173.811 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.5 m -75.07 109.55 8.64 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.664 1.986 . . . . 0.0 107.547 163.826 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.504 HD13 HG21 ' A' ' 13' ' ' ILE 0.254 86.1 mt -90.58 148.14 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 1 N-CA-C 97.05 -5.167 . . . . 0.0 97.05 165.045 . . . . . . . . 4 3 . 1 . 078 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -135.78 139.25 43.38 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 117.217 -3.427 . . . . 0.0 108.781 163.97 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.53 149.52 42.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.432 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -83.62 136.97 34.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.969 1.308 . . . . 0.0 109.642 167.325 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.46 165.2 30.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 130.765 3.626 . . . . 0.0 108.447 173.487 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -96.67 156.42 36.64 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-O 116.75 -1.595 . . . . 0.0 113.859 167.614 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.3 -43.34 59.6 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 N-CA-C 121.755 3.714 . . . . 0.0 121.755 175.408 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -10.38 57.9 Favored 'General case' 0 N--CA 1.452 -0.337 1 N-CA-C 122.145 4.128 . . . . 0.0 122.145 -178.506 . . . . . . . . 3 3 . 1 . 078 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -49.22 139.47 11.07 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 128.056 2.543 . . . . 0.0 114.532 177.552 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -97.03 141.85 29.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 110.323 -3.126 . . . . 0.0 105.08 -174.155 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.09 -28.61 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 118.282 -2.761 . . . . 0.0 112.402 -166.325 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.31 -26.3 65.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 173.852 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -78.89 -24.71 44.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 118.762 -2.461 . . . . 0.0 107.038 -177.724 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.4 -33.86 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 122.888 2.586 . . . . 0.0 113.045 -177.345 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -68.39 -39.09 81.81 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.819 2.447 . . . . 0.0 109.548 -177.801 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.29 -28.72 68.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.761 -2.462 . . . . 0.0 112.789 176.315 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -84.58 -30.64 24.86 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 124.825 1.328 . . . . 0.0 110.893 -174.242 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mt -71.95 -41.16 68.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 127.032 2.707 . . . . 0.0 104.706 171.234 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.38 -43.14 96.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 119.009 -2.307 . . . . 0.0 108.379 176.966 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -64.99 -45.12 86.94 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 121.212 1.824 . . . . 0.0 113.789 -178.561 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -99.02 -25.33 14.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 111.895 -3.907 . . . . 0.0 111.624 -167.874 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -117.33 -22.98 7.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 123.214 2.734 . . . . 0.0 111.679 177.035 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.3 42.43 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 128.418 2.913 . . . . 0.0 113.799 166.088 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.2 mt -90.69 120.47 68.84 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 127.578 2.351 . . . . 0.0 107.133 -179.115 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -58.09 154.76 37.57 Favored 'Trans proline' 0 N--CA 1.444 -1.409 1 C-N-CA 128.009 5.806 . . . . 0.0 112.251 -179.972 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -78.52 -18.07 12.39 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 122.469 2.113 . . . . 0.0 116.531 -162.986 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.09 -10.88 51.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 167.673 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -93.7 -15.82 24.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.715 1.606 . . . . 0.0 111.229 -171.992 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 41' ' ' GLN . 18.5 pt20 -98.11 143.81 28.25 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.184 1.794 . . . . 0.0 111.451 170.24 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.88 128.64 42.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 129.003 2.921 . . . . 0.0 106.096 166.373 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -95.37 123.24 38.79 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.704 1.24 . . . . 0.0 109.993 179.413 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.463 10.3 mt -108.64 124.48 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 130.209 3.404 . . . . 0.0 114.16 178.096 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -139.6 133.97 31.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 115.763 -2.065 . . . . 0.0 112.614 171.124 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.71 36.37 23.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.938 2.095 . . . . 0.0 115.218 173.934 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.26 -16.24 30.02 Favored Glycine 0 N--CA 1.442 -0.933 1 CA-C-O 112.271 -4.627 . . . . 0.0 113.476 -171.771 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -89.48 138.63 31.28 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 122.19 2.995 . . . . 0.0 105.361 -171.208 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.38 136.26 33.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.919 -1.946 . . . . 0.0 109.355 157.119 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.493 HD22 ' CG ' ' A' ' 59' ' ' TYR 0.269 15.5 mt -90.38 139.71 30.41 Favored 'General case' 0 C--O 1.221 -0.432 1 CA-C-O 111.415 -4.136 . . . . 0.0 108.858 -165.222 . . . . . . . . 4 3 . 1 . 078 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -99.99 145.65 27.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 124.246 3.203 . . . . 0.0 113.345 173.77 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.94 139.18 52.86 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 125.083 1.489 . . . . 0.0 108.626 162.61 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.18 11.39 13.71 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 103.777 -3.729 . . . . 0.0 103.777 -179.249 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -139.5 176.8 8.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 123.572 1.653 . . . . 0.0 108.62 176.754 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.4 p -108.46 177.56 4.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.542 1.537 . . . . 0.0 112.178 178.089 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.307 85.2 mt -50.36 -55.84 13.93 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.667 3.187 . . . . 0.0 110.66 164.079 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -67.03 -24.56 66.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -173.663 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -57.39 -40.1 77.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 128.833 2.853 . . . . 0.0 112.361 176.639 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CG ' HD22 ' A' ' 50' ' ' LEU . 44.4 m-85 -103.82 0.7 30.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.654 1.982 . . . . 0.0 112.551 -177.469 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.9 m120 81.23 32.71 0.12 Allowed 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 125.038 1.461 . . . . 0.0 113.348 168.262 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -95.19 94.97 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 125.856 1.972 . . . . 0.0 106.811 -177.915 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -101.76 -158.87 0.7 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.005 0.431 . . . . 0.0 111.319 172.923 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -58.7 134.7 57.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.284 -2.135 . . . . 0.0 111.684 168.87 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 25.0 tt0 85.11 40.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.061 -1.025 . . . . 0.0 110.058 170.364 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -120.36 137.8 54.08 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.565 1.946 . . . . 0.0 108.215 -179.936 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -120.23 123.47 43.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 115.993 -1.956 . . . . 0.0 108.67 176.739 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.23 160.82 15.06 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -178.209 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -118.66 139.35 51.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 125.002 1.439 . . . . 0.0 108.226 176.711 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.332 4.0 tt -125.24 119.71 29.24 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 101.787 -3.412 . . . . 0.0 101.787 -166.764 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.282 20.9 m -111.23 144.25 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 101.74 -3.43 . . . . 0.0 101.74 174.417 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.2 mt -101.52 141.74 33.94 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 109.307 -3.588 . . . . 0.0 107.185 174.792 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.493 3.7 tpt180 71.93 -37.75 0.4 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 118.827 2.899 . . . . 0.0 118.827 174.102 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.331 1.3 pt? -148.47 167.34 25.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 118.74 -2.475 . . . . 0.0 110.687 -164.46 . . . . . . . . 2 2 . 1 . 078 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -96.06 77.78 3.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.309 1.844 . . . . 0.0 107.202 -174.812 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.08 -128.43 3.31 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.767 1.651 . . . . 0.0 114.275 173.812 . . . . . . . . 1 1 . 1 . 078 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -168.04 . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptt? . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 079 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.377 84.2 mt-30 -97.44 124.23 41.57 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.665 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.4 160.21 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 127.715 2.406 . . . . 0.0 112.82 170.239 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -113.51 136.47 52.77 Favored 'General case' 0 N--CA 1.452 -0.344 1 O-C-N 112.289 -6.507 . . . . 0.0 114.416 -176.086 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.9 t -111.25 121.64 64.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 128.171 2.588 . . . . 0.0 110.387 164.512 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -100.95 117.0 34.12 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 101.479 -3.526 . . . . 0.0 101.479 -172.21 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -73.38 155.67 39.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.977 2.511 . . . . 0.0 111.962 172.542 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.99 -30.82 68.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 124.855 2.265 . . . . 0.0 115.108 170.914 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 p -75.15 0.76 15.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 128.039 2.535 . . . . 0.0 112.881 177.293 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.57 -18.35 25.02 Favored Glycine 0 CA--C 1.526 0.778 1 C-N-CA 131.402 4.334 . . . . 0.0 118.689 166.345 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -94.54 155.05 17.09 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.827 2.451 . . . . 0.0 109.907 -160.142 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.3 m -114.04 132.55 55.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 124.724 2.202 . . . . 0.0 110.888 -176.182 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.37 126.59 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 1 O-C-N 116.219 -4.051 . . . . 0.0 106.609 178.357 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.412 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 98.8 m -90.2 128.49 36.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -171.065 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.97 123.95 51.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 116.468 -1.729 . . . . 0.0 106.816 -179.107 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -103.59 101.73 11.59 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 130.524 3.53 . . . . 0.0 110.977 177.797 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.39 166.35 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 N-CA-C 99.921 -4.103 . . . . 0.0 99.921 -157.204 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.358 48.7 mm-40 -108.08 167.99 8.52 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 115.576 -2.154 . . . . 0.0 106.3 158.951 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.15 -6.48 18.01 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 CA-C-N 123.32 2.221 . . . . 0.0 110.239 179.031 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.6 p -96.32 13.5 27.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 131.209 3.804 . . . . 0.0 113.737 177.875 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.81 135.7 38.93 Favored 'General case' 0 C--N 1.32 -0.687 1 C-N-CA 133.299 4.64 . . . . 0.0 102.684 174.036 . . . . . . . . 3 3 . 1 . 079 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -77.24 172.63 12.96 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.039 0.935 . . . . 0.0 110.856 166.915 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.288 1.4 mp -59.29 -42.09 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 125.767 1.627 . . . . 0.0 108.886 163.97 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -65.56 -39.83 92.12 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 125.647 1.842 . . . . 0.0 109.067 -172.909 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -64.45 -40.68 96.18 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.119 1.368 . . . . 0.0 107.403 177.52 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 t -69.5 -39.96 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 O-C-N 117.752 -3.093 . . . . 0.0 117.872 174.845 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -66.98 -29.51 69.37 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.905 -2.372 . . . . 0.0 114.493 168.724 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.08 59.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 170.97 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -59.11 -32.0 69.42 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.889 173.428 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.8 mt -65.14 -47.45 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 121.884 2.129 . . . . 0.0 109.37 169.386 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -74.89 -39.09 61.69 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.688 1.595 . . . . 0.0 107.912 -168.886 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.74 -31.15 72.24 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 122.866 2.576 . . . . 0.0 109.203 177.28 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 14' ' ' THR . 82.0 mttt -87.87 -66.94 0.86 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 115.355 -2.259 . . . . 0.0 107.927 177.633 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -96.79 -20.6 18.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 120.372 1.442 . . . . 0.0 110.568 -156.534 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.73 -19.12 21.72 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 168.718 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 36' ' ' ILE . 28.1 mt -69.14 139.06 89.88 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 127.64 2.376 . . . . 0.0 113.265 -170.573 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -75.06 147.73 34.11 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 CA-C-O 113.412 -2.828 . . . . 0.0 115.209 -179.778 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.32 -45.41 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.276 3.317 . . . . 0.0 115.066 -158.046 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.24 -3.6 11.29 Favored 'General case' 0 N--CA 1.452 -0.354 1 C-N-CA 132.999 4.52 . . . . 0.0 116.641 178.087 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -87.76 -23.57 24.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 126.275 2.234 . . . . 0.0 107.728 173.324 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -90.56 115.97 28.1 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.119 -3.488 . . . . 0.0 110.87 -169.289 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -99.51 126.13 45.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 123.473 1.606 . . . . 0.0 107.706 161.8 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.62 110.15 22.27 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.798 2.439 . . . . 0.0 110.767 -175.866 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.1 mt -105.03 145.96 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 O-C-N 119.823 -1.798 . . . . 0.0 111.233 -179.211 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -160.46 139.61 10.65 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.1 1.76 . . . . 0.0 112.998 165.687 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.58 28.49 15.71 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 130.763 3.625 . . . . 0.0 112.246 168.144 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.69 1.49 58.81 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 116.724 -2.153 . . . . 0.0 113.122 176.223 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -120.94 151.97 39.07 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 131.391 3.877 . . . . 0.0 114.767 176.632 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -94.93 116.65 28.98 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 128.509 3.631 . . . . 0.0 107.398 168.382 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.92 112.88 3.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.293 -2.754 . . . . 0.0 112.401 -178.905 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.272 74.4 tt0 -89.01 147.3 24.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 114.904 -2.475 . . . . 0.0 106.922 -164.619 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.92 132.86 50.49 Favored 'General case' 0 C--N 1.326 -0.423 1 O-C-N 130.442 4.839 . . . . 0.0 114.551 175.565 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.06 -9.29 54.66 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 128.196 2.808 . . . . 0.0 117.003 -176.682 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.7 mtt-85 -101.83 157.53 16.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.383 2.673 . . . . 0.0 108.27 -174.488 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.8 p -102.69 155.41 18.32 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 102.216 -3.254 . . . . 0.0 102.216 173.23 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.6 mt -35.54 -36.44 0.07 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 129.564 3.146 . . . . 0.0 118.619 162.134 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.6 t -64.6 -21.93 66.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 111.564 -2.562 . . . . 0.0 115.791 179.343 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.45 -22.88 46.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 120.531 -1.356 . . . . 0.0 111.705 -178.324 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -106.96 -0.83 22.82 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.169 2.188 . . . . 0.0 106.507 -176.262 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 m120 56.28 50.56 13.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 126.063 2.839 . . . . 0.0 112.816 173.998 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.0 mt -80.15 115.82 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 112.483 -2.144 . . . . 0.0 108.112 -178.613 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -76.57 167.02 22.57 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 165.91 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -54.09 143.81 21.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 118.633 2.827 . . . . 0.0 118.633 159.57 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 73.89 6.56 4.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 115.318 -2.277 . . . . 0.0 113.367 172.971 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -66.39 154.96 38.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.965 3.706 . . . . 0.0 111.272 172.084 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -114.47 111.72 21.86 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -177.342 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.43 169.64 8.57 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 179.917 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -130.62 141.67 50.44 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 119.708 1.14 . . . . 0.0 109.247 -163.383 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -114.85 129.47 56.71 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 126.22 2.2 . . . . 0.0 115.661 167.106 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.0 t -132.31 136.15 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 170.629 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.2 mt -97.97 159.49 14.9 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.097 -171.665 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -153.92 129.84 10.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -174.347 . . . . . . . . 1 1 . 1 . 079 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.21 69.31 1.01 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.911 2.885 . . . . 0.0 110.094 -174.483 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 75' ' ' GLY . 1.6 ttt180 -131.81 159.32 38.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 101.909 -3.367 . . . . 0.0 101.909 171.472 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.416 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . -128.45 63.09 0.62 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 130.365 3.84 . . . . 0.0 111.311 177.43 . . . . . . . . 2 2 . 1 . 079 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 104.247 -3.541 . . . . 0.0 104.247 177.261 . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 ttp . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 115.348 -2.263 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 080 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.28 92.9 mt-30 -108.51 133.53 52.54 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 125.055 3.57 . . . . 0.0 110.559 -171.241 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -127.44 174.67 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 155.113 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -117.42 156.52 27.8 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.012 1.725 . . . . 0.0 108.693 172.614 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.72 130.06 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.9 157.59 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -90.73 130.13 36.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 112.173 -2.285 . . . . 0.0 111.801 173.567 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -98.63 136.86 38.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 167.853 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.31 -0.02 1.14 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.268 1.827 . . . . 0.0 114.667 -156.323 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.8 p -86.43 -25.89 25.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 129.969 3.308 . . . . 0.0 105.68 -178.805 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.81 3.17 18.45 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.636 1.112 . . . . 0.0 113.889 -178.685 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -79.48 135.13 36.57 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.711 3.204 . . . . 0.0 109.42 170.722 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.4 p -123.48 136.25 54.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.919 1.688 . . . . 0.0 111.229 -170.041 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mt -118.7 113.0 40.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.352 -2.832 . . . . 0.0 103.352 179.833 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -67.86 119.13 12.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 162.317 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.267 0.2 OUTLIER -114.62 126.97 55.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -171.126 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -104.56 115.04 29.66 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.223 1.809 . . . . 0.0 109.844 -164.101 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.305 34.1 m -129.82 -177.83 2.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 C-N-CA 123.914 0.886 . . . . 0.0 112.351 -171.29 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.43 163.02 51.66 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-O 114.831 -2.509 . . . . 0.0 106.786 148.083 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -48.14 -16.86 0.7 Allowed 'Trans proline' 0 N--CA 1.442 -1.531 0 N-CA-C 122.149 3.865 . . . . 0.0 122.149 -176.337 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.1 m -88.15 -8.7 55.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 114.112 -2.851 . . . . 0.0 113.542 178.697 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.53 121.24 12.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.04 2.136 . . . . 0.0 106.558 -175.479 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -77.17 137.5 38.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.075 2.95 . . . . 0.0 107.874 176.274 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.285 1.5 mp -54.79 -30.93 23.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 127.637 2.375 . . . . 0.0 113.61 179.454 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -71.77 -22.49 61.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 121.54 1.973 . . . . 0.0 109.643 174.721 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.6 -31.0 21.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 115.126 -2.369 . . . . 0.0 105.969 178.987 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.48 -41.5 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 126.291 2.244 . . . . 0.0 106.931 178.129 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 30' ' ' ILE . 27.8 mtmt -56.8 -37.99 71.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 115.821 -2.037 . . . . 0.0 113.085 174.16 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.57 85.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 121.719 2.054 . . . . 0.0 111.461 175.78 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -65.78 -33.77 76.63 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 130.182 3.393 . . . . 0.0 111.933 177.723 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 27' ' ' LYS . 20.5 mt -71.96 -40.74 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 115.315 -2.278 . . . . 0.0 106.25 169.607 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -60.11 -40.43 89.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 124.273 3.215 . . . . 0.0 109.694 171.193 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.87 -30.44 67.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.062 2.545 . . . . 0.0 116.1 179.789 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -93.75 -57.04 2.68 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 128.743 2.817 . . . . 0.0 111.172 -174.707 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -118.05 -13.1 9.99 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -164.549 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.14 -11.7 55.42 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 115.339 -2.923 . . . . 0.0 117.111 156.579 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 36' ' ' ILE . 2.5 mp -77.19 123.15 87.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 111.713 -3.994 . . . . 0.0 107.687 -172.377 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -63.48 138.28 64.43 Favored 'Trans proline' 0 N--CA 1.449 -1.142 1 O-C-N 129.198 4.262 . . . . 0.0 111.565 -179.855 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -59.85 -21.91 66.1 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 120.603 3.27 . . . . 0.0 120.603 -164.724 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.39 -13.36 58.48 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 124.917 1.385 . . . . 0.0 114.089 -175.304 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -98.11 -7.5 29.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.116 1.766 . . . . 0.0 113.768 175.652 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.39 147.86 33.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.519 1.528 . . . . 0.0 112.677 165.897 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.372 35.9 ttm105 -134.83 132.42 38.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 114.511 -2.661 . . . . 0.0 107.685 161.913 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.37 107.04 14.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.619 2.768 . . . . 0.0 107.162 -179.118 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.0 mt -122.34 144.69 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 1 O-C-N 115.509 -4.494 . . . . 0.0 107.349 171.234 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.465 ' CD1' HD11 ' A' ' 50' ' ' LEU 0.38 0.1 OUTLIER -142.08 110.89 6.21 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 132.898 4.479 . . . . 0.0 114.988 167.967 . . . . . . . . 5 4 . 1 . 080 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.34 32.44 3.53 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.717 2.807 . . . . 0.0 111.337 177.582 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 -19.36 23.98 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 128.35 2.881 . . . . 0.0 116.222 -177.322 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -76.98 117.51 18.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.649 2.38 . . . . 0.0 107.996 177.165 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -77.33 122.03 24.56 Favored 'General case' 0 N--CA 1.445 -0.722 1 C-N-CA 133.986 4.914 . . . . 0.0 108.399 175.241 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.465 HD11 ' CD1' ' A' ' 45' ' ' PHE . 6.4 mp -87.1 120.84 28.79 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 126.271 2.232 . . . . 0.0 108.646 -176.922 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.46 151.16 22.63 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.516 -156.392 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.8 104.0 1.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 131.01 3.724 . . . . 0.0 108.782 -174.15 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.88 -14.6 26.57 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.277 174.211 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -71.09 147.38 48.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 122.787 3.293 . . . . 0.0 106.971 160.451 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -105.91 -178.2 3.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 118.98 -2.325 . . . . 0.0 108.408 -173.951 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -66.1 -33.37 75.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 113.829 -2.986 . . . . 0.0 108.209 175.286 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.355 21.3 m -72.59 -29.4 63.49 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 127.455 2.972 . . . . 0.0 109.378 -179.105 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -67.22 -34.95 78.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.96 1.413 . . . . 0.0 113.725 173.573 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 55.2 m-85 -97.67 9.38 42.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.48 2.312 . . . . 0.0 112.085 -178.704 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.39 74.5 m-20 73.17 13.81 4.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 173.0 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.8 mm -91.94 114.98 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 -159.298 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -88.57 168.44 12.56 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 111.67 -2.514 . . . . 0.0 112.183 163.482 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.289 30.5 pttt -29.27 137.79 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 121.345 3.831 . . . . 0.0 121.345 169.867 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.273 4.9 tt0 71.76 4.28 4.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 164.867 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -62.2 158.71 16.38 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 118.639 -2.538 . . . . 0.0 112.615 159.986 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.306 15.2 t -129.4 137.18 50.77 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 129.084 3.99 . . . . 0.0 108.764 -175.129 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -120.62 135.08 55.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 121.555 1.98 . . . . 0.0 111.998 -176.131 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -96.55 137.68 35.26 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 115.173 -2.346 . . . . 0.0 110.018 170.536 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -117.53 166.33 12.49 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 127.678 3.111 . . . . 0.0 111.212 173.489 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.95 147.22 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 O-C-N 127.477 2.985 . . . . 0.0 107.544 165.148 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 36' ' ' ILE . 32.1 mt -112.5 123.83 51.17 Favored 'General case' 0 N--CA 1.445 -0.707 1 C-N-CA 134.567 5.147 . . . . 0.0 110.553 170.595 . . . . . . . . 3 3 . 1 . 080 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -91.89 -11.19 37.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 127.583 3.052 . . . . 0.0 111.334 -167.744 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -107.88 117.04 33.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.826 1.648 . . . . 0.0 113.972 167.759 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.288 29.1 ttp180 81.02 50.58 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.26 2.224 . . . . 0.0 110.212 -174.174 . . . . . . . . 2 2 . 1 . 080 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.8 157.43 17.37 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 126.067 3.037 . . . . 0.0 111.382 174.419 . . . . . . . . 1 1 . 1 . 080 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.364 0 C-N-CA 127.364 2.411 . . . . 0.0 109.667 167.431 . . . . . . . . 0 0 . 1 . 081 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 ttp . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 . . . . . . . . . 0 0 . 1 . 081 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -96.18 155.47 16.75 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 119.569 -1.957 . . . . 0.0 106.735 -177.796 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 pt -135.84 160.29 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 129.236 3.014 . . . . 0.0 113.127 165.369 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -101.59 151.95 21.38 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 125.534 1.771 . . . . 0.0 108.509 162.338 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.5 t -125.7 132.19 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 166.368 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -89.95 119.68 30.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 117.862 -3.024 . . . . 0.0 105.593 157.954 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -100.48 136.34 40.51 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -178.137 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -44.12 -42.53 6.37 Favored 'General case' 0 C--N 1.324 -0.514 1 O-C-N 130.515 4.884 . . . . 0.0 113.53 -174.48 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.1 p -58.72 -12.08 3.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 130.859 3.664 . . . . 0.0 117.095 174.208 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.07 -16.27 10.1 Favored Glycine 0 CA--C 1.527 0.804 1 C-N-CA 130.731 4.015 . . . . 0.0 110.843 176.071 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -80.73 142.07 34.2 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 120.473 2.137 . . . . 0.0 112.117 -165.361 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.6 m -96.91 130.0 44.28 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 164.071 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.269 43.9 pt -135.69 153.97 33.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 127.623 2.369 . . . . 0.0 106.289 -177.55 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.256 11.8 t -129.03 133.05 47.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 112.657 -3.545 . . . . 0.0 110.632 -177.915 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -130.82 151.44 51.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 122.74 2.518 . . . . 0.0 111.181 -172.309 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -97.16 117.4 31.27 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 131.338 3.855 . . . . 0.0 106.394 172.882 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.18 171.81 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 1 N-CA-C 100.093 -4.04 . . . . 0.0 100.093 179.714 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -111.36 142.85 27.26 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 131.273 3.829 . . . . 0.0 101.357 159.574 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 57' ' ' SER . 53.6 Cg_endo -63.07 -13.89 38.19 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.086 3.19 . . . . 0.0 114.078 174.475 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -86.38 -7.81 58.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 126.962 3.268 . . . . 0.0 112.736 176.939 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -74.5 132.69 42.08 Favored 'General case' 0 N--CA 1.451 -0.405 1 O-C-N 114.552 -5.092 . . . . 0.0 109.361 179.521 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -63.32 162.87 11.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.343 2.657 . . . . 0.0 113.695 169.955 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mm -66.14 -36.4 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.207 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -19.55 64.59 Favored 'General case' 0 N--CA 1.449 -0.504 1 O-C-N 115.003 -4.811 . . . . 0.0 116.972 172.878 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -80.25 -24.44 40.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 125.473 1.733 . . . . 0.0 109.579 174.024 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 t -73.58 -30.89 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.662 1.185 . . . . 0.0 108.755 168.111 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -73.29 -41.11 63.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 118.168 -2.833 . . . . 0.0 113.99 175.958 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.9 -47.12 43.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 129.985 3.314 . . . . 0.0 113.372 170.162 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -73.76 -30.19 62.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 114.823 -2.513 . . . . 0.0 112.54 179.085 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -75.36 -39.89 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 O-C-N 125.821 1.95 . . . . 0.0 109.316 168.854 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -50.02 -46.36 52.78 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 128.152 2.581 . . . . 0.0 110.642 174.875 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.254 5.6 t70 -58.51 -44.18 89.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.388 1.875 . . . . 0.0 114.571 175.58 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -85.85 -51.3 6.49 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 115.91 -1.995 . . . . 0.0 110.25 -176.166 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -99.91 -23.04 15.06 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 114.131 -2.842 . . . . 0.0 111.572 -164.58 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.17 -12.98 28.79 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 128.65 3.719 . . . . 0.0 117.696 172.724 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.305 70.8 mt -75.27 132.13 76.86 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 113.715 -3.041 . . . . 0.0 111.067 -163.327 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.86 146.1 82.24 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 O-C-N 126.608 2.899 . . . . 0.0 114.206 173.014 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.56 -34.18 43.22 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 CA-C-N 120.959 1.378 . . . . 0.0 115.119 176.27 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.308 0.1 OUTLIER -42.19 -37.79 1.56 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.054 2.542 . . . . 0.0 113.853 174.793 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -108.88 -8.45 15.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.396 1.879 . . . . 0.0 111.915 -171.182 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -104.78 119.03 38.02 Favored 'General case' 0 N--CA 1.452 -0.334 1 C-N-CA 134.203 5.001 . . . . 0.0 113.343 -169.434 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -127.38 133.46 50.02 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 177.43 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.274 3.8 mt -104.42 152.4 22.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.974 1.71 . . . . 0.0 110.969 -169.302 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mt -137.04 146.09 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 1 C-N-CA 132.929 4.492 . . . . 0.0 107.324 -169.397 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -152.41 123.8 7.72 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 131.638 3.975 . . . . 0.0 107.918 169.358 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.4 38.05 25.76 Favored 'General case' 0 N--CA 1.445 -0.687 1 C-N-CA 132.355 4.262 . . . . 0.0 112.302 166.507 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.28 -14.89 63.1 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 120.149 -1.594 . . . . 0.0 116.925 -179.382 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -107.1 125.89 51.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 -171.785 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.92 127.81 32.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 169.704 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.11 137.46 34.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.289 1.859 . . . . 0.0 106.613 -168.683 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -82.21 123.63 29.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 109.55 -3.477 . . . . 0.0 105.333 -164.563 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -69.96 112.18 6.18 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 127.726 2.41 . . . . 0.0 106.033 -167.814 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.89 0.04 22.87 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 115.77 -2.683 . . . . 0.0 117.594 -157.722 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -114.16 178.71 4.18 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.981 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -125.59 160.42 29.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.958 2.503 . . . . 0.0 107.411 -174.264 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.45 -41.27 98.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.579 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 42.2 t -53.03 -38.71 62.61 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.285 -1.509 . . . . 0.0 110.227 175.575 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.47 -48.5 81.41 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 116.266 -1.826 . . . . 0.0 112.343 -173.171 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -84.95 11.89 8.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 121.503 1.956 . . . . 0.0 115.187 172.406 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.36 4.1 t-20 76.84 33.33 0.47 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 123.179 1.466 . . . . 0.0 108.566 160.363 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.99 120.09 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 118.7 -2.5 . . . . 0.0 111.345 -177.95 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -99.72 172.0 7.54 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.225 2.21 . . . . 0.0 111.642 173.414 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -59.69 133.33 55.99 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.928 2.491 . . . . 0.0 115.661 179.911 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 4.2 tt0 75.19 20.95 1.98 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.359 2.664 . . . . 0.0 115.772 -175.314 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -63.5 136.84 57.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 131.407 3.883 . . . . 0.0 109.595 165.439 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.6 m -101.05 107.0 18.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 124.781 1.301 . . . . 0.0 112.662 169.23 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.94 162.0 20.62 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.477 1.911 . . . . 0.0 110.94 172.938 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -135.41 117.06 14.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 130.381 3.472 . . . . 0.0 105.755 -168.616 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tp -98.52 140.46 32.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 115.456 -2.212 . . . . 0.0 110.925 -174.002 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.29 163.71 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 127.179 2.191 . . . . 0.0 108.657 171.908 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.485 0.7 OUTLIER -144.08 146.15 32.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -173.193 . . . . . . . . 3 3 . 1 . 081 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 82.63 -13.12 0.85 Allowed 'General case' 0 N--CA 1.45 -0.473 1 C-N-CA 132.545 4.338 . . . . 0.0 114.589 -179.036 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.486 3.5 pp -149.85 156.86 42.52 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.918 2.887 . . . . 0.0 116.137 -170.416 . . . . . . . . 2 2 . 1 . 081 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -78.43 129.01 34.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 113.515 -1.675 . . . . 0.0 107.947 157.874 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.55 158.87 14.59 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 114.275 -3.514 . . . . 0.0 114.499 155.935 . . . . . . . . 1 1 . 1 . 081 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.91 0 CA-C-N 122.145 2.972 . . . . 0.0 109.533 178.403 . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 . . . . . . . . . 0 0 . 1 . 082 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -91.91 145.19 24.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 -172.324 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.85 163.54 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 128.842 2.857 . . . . 0.0 109.147 162.731 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -104.38 151.12 23.87 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 114.638 -2.601 . . . . 0.0 105.002 177.01 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.9 105.15 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 1 C-N-CA 132.69 4.396 . . . . 0.0 104.328 172.272 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -97.91 107.36 19.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.312 2.245 . . . . 0.0 111.263 -173.905 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 p -86.11 166.49 15.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -168.422 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -86.63 -20.76 27.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.528 -2.177 . . . . 0.0 115.923 166.905 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 p -69.44 -23.76 63.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 125.32 1.638 . . . . 0.0 113.321 176.154 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.53 -14.09 5.33 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 119.494 -2.004 . . . . 0.0 115.746 156.145 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -80.6 172.54 13.62 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 120.075 -1.838 . . . . 0.0 112.892 173.556 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 m -136.67 132.1 34.49 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 117.544 -3.222 . . . . 0.0 107.2 177.297 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.22 148.1 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.63 1.572 . . . . 0.0 107.807 172.881 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 p -97.22 131.35 44.03 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.978 2.911 . . . . 0.0 110.178 165.762 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.82 133.6 53.06 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 115.411 -2.233 . . . . 0.0 111.073 -172.527 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -84.23 125.8 32.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 101.256 -3.609 . . . . 0.0 101.256 164.837 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 26' ' ' VAL . 17.1 m -132.38 147.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 176.035 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 2.1 tm-20 -97.59 135.8 21.52 Favored Pre-proline 0 N--CA 1.448 -0.526 0 O-C-N 119.274 -2.141 . . . . 0.0 108.608 158.027 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.82 -24.81 2.26 Favored 'Trans proline' 0 N--CA 1.443 -1.451 1 C-N-CA 126.817 5.012 . . . . 0.0 116.317 173.951 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -98.29 1.55 47.25 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 129.796 3.238 . . . . 0.0 109.991 177.194 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -72.03 140.46 49.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 121.799 2.09 . . . . 0.0 106.935 167.731 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.0 p -90.58 178.92 5.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 118.916 -2.365 . . . . 0.0 108.381 -175.928 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.469 HG23 HD12 ' A' ' 43' ' ' LEU . 11.0 mm -67.24 -33.23 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 120.01 1.277 . . . . 0.0 113.457 179.469 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.69 -37.27 83.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.752 2.821 . . . . 0.0 116.672 168.293 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -77.58 -35.44 53.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 115.629 -2.129 . . . . 0.0 107.233 -179.722 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.449 HG22 HG12 ' A' ' 17' ' ' VAL . 8.9 t -65.8 -48.52 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 124.856 3.48 . . . . 0.0 111.606 170.992 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -50.99 -49.99 59.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 169.719 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.05 -49.46 41.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.946 2.098 . . . . 0.0 114.889 165.157 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -65.14 -25.46 67.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 119.606 -1.934 . . . . 0.0 110.574 -179.864 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -80.92 -13.76 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 O-C-N 119.276 -2.14 . . . . 0.0 114.677 175.269 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -76.59 -41.9 44.5 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 118.593 -2.567 . . . . 0.0 110.255 168.034 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -57.72 -43.38 85.2 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 127.248 2.219 . . . . 0.0 112.314 178.903 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -69.19 -55.03 11.85 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 115.268 -2.301 . . . . 0.0 115.255 174.198 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -122.94 -19.59 6.07 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 125.837 1.96 . . . . 0.0 111.65 -155.638 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.1 9.53 63.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.282 1.896 . . . . 0.0 111.716 167.679 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.433 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.8 mt -67.52 130.45 93.27 Favored Pre-proline 0 N--CA 1.444 -0.744 0 O-C-N 118.924 -2.515 . . . . 0.0 112.841 171.754 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -79.14 123.17 5.52 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.862 3.041 . . . . 0.0 109.108 -176.467 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.458 17.4 Cg_exo -25.93 -43.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.123 1 C-N-CA 129.736 6.957 . . . . 0.0 121.94 -177.91 . . . . . . . . 3 2 . 1 . 082 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.97 -15.19 63.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 113.602 -3.094 . . . . 0.0 113.389 177.403 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -86.71 -15.0 40.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 124.034 3.106 . . . . 0.0 109.673 177.574 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -90.11 153.03 20.85 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -166.753 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -142.32 120.13 11.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 121.85 2.114 . . . . 0.0 109.32 170.084 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.469 HD12 HG23 ' A' ' 23' ' ' ILE . 12.4 mt -89.45 144.0 26.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 125.034 3.561 . . . . 0.0 107.27 -178.059 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mm -127.41 153.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 125.69 2.662 . . . . 0.0 106.634 169.522 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.566 ' HB3' HD21 ' A' ' 50' ' ' LEU . 20.2 t80 -150.46 108.67 3.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.004 2.522 . . . . 0.0 108.985 174.725 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.02 22.21 12.92 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 131.567 3.947 . . . . 0.0 112.207 167.261 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.95 -4.01 25.7 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 119.239 -2.163 . . . . 0.0 116.977 178.409 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.22 143.98 48.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 172.225 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -91.89 135.17 34.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -172.618 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 45' ' ' PHE . 5.3 mt -89.99 138.39 31.54 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.23 -1.544 . . . . 0.0 108.925 176.733 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -145.58 140.68 27.58 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -159.889 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -35.85 128.9 0.65 Allowed 'General case' 0 N--CA 1.452 -0.326 1 C-N-CA 134.633 5.173 . . . . 0.0 113.65 -179.371 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.69 -16.25 23.78 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 118.092 -2.88 . . . . 0.0 117.223 167.253 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.334 32.9 mtt85 -100.49 166.77 10.77 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 125.713 2.673 . . . . 0.0 107.065 167.766 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -87.83 167.63 13.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 119.509 -1.994 . . . . 0.0 108.755 173.115 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.306 22.2 mt -59.93 -38.43 82.36 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 172.7 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.7 p -69.03 -27.75 65.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.413 1.885 . . . . 0.0 112.917 -179.254 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.53 -44.26 96.26 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.581 1.952 . . . . 0.0 108.278 171.803 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -81.4 10.55 5.52 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 128.341 2.656 . . . . 0.0 114.142 175.488 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.268 1.9 t-20 65.87 24.1 11.31 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 172.934 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 mt -86.69 132.62 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 O-C-N 120.194 -1.567 . . . . 0.0 106.941 -173.8 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -114.05 -179.56 3.67 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 127.073 2.733 . . . . 0.0 112.121 170.224 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 138.24 24.91 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.08 0.952 . . . . 0.0 111.201 175.253 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 42.6 mt-10 74.84 13.59 3.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 125.349 1.655 . . . . 0.0 109.735 163.603 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.4 m -54.52 157.53 2.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 157.252 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.93 105.25 14.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 111.51 -2.586 . . . . 0.0 106.084 177.102 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -102.08 138.89 38.43 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 176.535 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.257 41.4 m80 -95.88 135.77 37.18 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.637 1.575 . . . . 0.0 112.254 175.766 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.23 100.91 10.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 179.426 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -96.51 151.91 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.031 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.41 148.0 26.43 Favored 'General case' 0 N--CA 1.446 -0.652 1 C-N-CA 135.776 5.631 . . . . 0.0 117.857 174.726 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -112.18 -174.74 2.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.427 2.691 . . . . 0.0 105.767 173.501 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.46 160.69 14.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 102.199 -3.26 . . . . 0.0 102.199 160.755 . . . . . . . . 2 2 . 1 . 082 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.325 2.4 ttp180 91.61 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.528 1 C-N-CA 133.705 4.802 . . . . 0.0 106.114 172.525 . . . . . . . . 3 2 . 1 . 082 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.78 -150.28 21.84 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 127.991 2.71 . . . . 0.0 117.098 179.794 . . . . . . . . 1 1 . 1 . 082 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.923 1 N-CA-C 101.707 -4.557 . . . . 0.0 101.707 -170.894 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 ttp . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 115.309 -2.281 . . . . 0.0 106.214 . . . . . . . . . 0 0 . 1 . 083 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -104.53 130.53 52.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.855 2.57 . . . . 0.0 111.388 -179.933 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.293 20.4 pt -119.22 122.03 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 114.25 -2.786 . . . . 0.0 109.617 165.336 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -73.77 151.97 40.47 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 124.15 3.159 . . . . 0.0 108.434 178.243 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -126.44 155.16 36.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 1 O-C-N 129.301 4.126 . . . . 0.0 106.794 161.438 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.25 42.3 tttt -120.63 152.87 37.61 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 128.909 2.884 . . . . 0.0 113.342 169.205 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.432 HG22 HD21 ' A' ' 69' ' ' LEU . 24.3 p -107.23 159.06 16.63 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 130.591 3.556 . . . . 0.0 106.422 -170.573 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 mt -63.64 -19.97 65.31 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.608 1.563 . . . . 0.0 111.895 -179.163 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.5 p -85.31 -15.25 43.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 176.235 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.63 5.59 41.95 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 113.777 -3.79 . . . . 0.0 114.129 177.695 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -82.58 132.67 35.19 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 121.885 2.843 . . . . 0.0 110.381 176.911 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.6 m -90.0 124.59 34.88 Favored 'General case' 0 C--N 1.325 -0.463 1 C-N-CA 134.339 5.055 . . . . 0.0 104.799 176.227 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -113.59 139.4 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 130.93 3.692 . . . . 0.0 107.809 -179.34 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.4 m -96.73 130.66 43.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 121.886 2.13 . . . . 0.0 112.128 170.854 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.2 mt -107.63 129.54 54.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.559 2.344 . . . . 0.0 113.004 173.805 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -80.37 118.7 22.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 123.69 1.71 . . . . 0.0 108.646 169.983 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.04 156.46 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 O-C-N 117.537 -3.227 . . . . 0.0 115.243 173.882 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -74.61 154.29 87.5 Favored Pre-proline 0 N--CA 1.451 -0.404 0 O-C-N 117.843 -3.036 . . . . 0.0 108.979 162.826 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -76.81 15.84 1.03 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 1 C-N-CA 125.568 4.179 . . . . 0.0 114.543 179.648 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 p -131.38 3.16 4.24 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 129.288 3.035 . . . . 0.0 117.786 171.914 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.54 137.93 57.86 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 126.588 2.43 . . . . 0.0 107.941 179.506 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.298 44.6 p -102.56 170.47 8.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 126.957 3.265 . . . . 0.0 107.709 -174.09 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mm -66.01 -30.72 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 1 O-C-N 114.642 -5.036 . . . . 0.0 115.506 -173.962 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.14 -26.25 68.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 121.031 1.741 . . . . 0.0 111.648 175.661 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.05 -28.12 29.8 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.441 2.296 . . . . 0.0 112.652 176.429 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.8 t -81.58 -29.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 122.382 2.355 . . . . 0.0 108.275 178.732 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -51.45 -49.39 61.82 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.251 2.22 . . . . 0.0 115.347 160.062 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.11 -46.11 68.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.677 1.591 . . . . 0.0 108.563 -178.695 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.254 57.2 mttm -52.09 -50.11 62.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 172.633 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.335 91.5 mt -54.52 -38.07 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 123.61 1.671 . . . . 0.0 114.992 171.902 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.88 -42.62 94.65 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 117.165 -3.459 . . . . 0.0 111.233 170.846 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -52.45 -42.5 64.22 Favored 'General case' 0 N--CA 1.445 -0.702 1 O-C-N 116.206 -4.059 . . . . 0.0 114.278 172.007 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -90.51 -47.34 7.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -167.538 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -120.15 -15.15 8.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 124.803 2.24 . . . . 0.0 113.528 -157.26 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.34 1.42 44.19 Favored Glycine 0 CA--C 1.522 0.518 1 C-N-CA 134.309 5.719 . . . . 0.0 117.352 166.818 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -88.99 119.98 69.89 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 128.181 2.592 . . . . 0.0 104.667 -153.2 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.3 142.84 55.75 Favored 'Trans proline' 0 N--CA 1.447 -1.229 1 C-N-CA 126.459 4.772 . . . . 0.0 114.659 178.164 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.02 -46.78 7.64 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 124.603 3.535 . . . . 0.0 111.267 -177.789 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.439 0.0 OUTLIER -32.95 -40.4 0.05 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 118.608 2.818 . . . . 0.0 118.608 167.49 . . . . . . . . 3 3 . 1 . 083 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.302 11.5 mm-40 -101.34 -5.25 25.65 Favored 'General case' 0 N--CA 1.448 -0.556 1 C-N-CA 132.312 4.245 . . . . 0.0 114.626 -161.56 . . . . . . . . 3 2 . 1 . 083 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -99.7 157.21 16.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.931 2.093 . . . . 0.0 106.929 -178.664 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -142.59 129.13 20.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 130.017 3.327 . . . . 0.0 110.364 160.14 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -117.04 120.26 37.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 120.357 1.435 . . . . 0.0 107.428 174.784 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mm -106.32 152.75 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 130.148 3.379 . . . . 0.0 107.801 -177.329 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -152.08 107.16 3.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 130.161 3.384 . . . . 0.0 105.582 178.271 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.439 . . 72.25 23.23 3.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 127.887 3.708 . . . . 0.0 117.679 169.383 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.03 -12.75 45.12 Favored Glycine 0 CA--C 1.529 0.958 1 O-C-N 114.574 -5.079 . . . . 0.0 110.086 171.901 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -112.69 142.24 45.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.559 3.544 . . . . 0.0 111.963 -179.969 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -91.65 141.89 28.21 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 110.473 -3.058 . . . . 0.0 105.218 -175.765 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -88.18 113.91 24.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 130.217 3.407 . . . . 0.0 106.824 -175.285 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -103.28 164.66 11.5 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 129.832 3.253 . . . . 0.0 113.346 -169.904 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -68.42 132.03 46.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 128.81 3.819 . . . . 0.0 112.745 -177.297 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.8 0.88 58.83 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.694 1.616 . . . . 0.0 112.647 173.769 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -88.81 164.53 15.18 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.866 2.066 . . . . 0.0 108.678 177.001 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -111.71 161.68 16.03 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 169.399 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -55.67 -39.41 70.91 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.675 1.19 . . . . 0.0 110.762 176.538 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 m -61.31 -34.1 74.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 116.113 -1.898 . . . . 0.0 115.214 177.885 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -60.85 -38.54 85.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 116.211 -1.852 . . . . 0.0 114.852 172.237 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -97.95 14.68 26.43 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 116.717 -1.611 . . . . 0.0 110.943 173.894 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.363 12.6 p30 74.54 14.95 3.44 Favored 'General case' 0 N--CA 1.439 -0.978 1 C-N-CA 135.111 5.364 . . . . 0.0 114.208 166.608 . . . . . . . . 3 2 . 1 . 083 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -72.33 111.57 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.181 2.192 . . . . 0.0 109.297 -170.414 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -96.57 164.84 12.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 127.019 2.699 . . . . 0.0 107.811 -173.18 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -48.26 117.76 2.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.961 3.704 . . . . 0.0 110.483 179.27 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.722 2.1 mp0 78.01 18.97 1.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 117.898 2.555 . . . . 0.0 117.898 -178.707 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.6 m -77.27 154.11 33.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 170.466 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.2 m -107.21 129.26 54.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.205 1.802 . . . . 0.0 106.949 173.232 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -99.81 156.1 17.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 163.622 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -98.94 149.38 23.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 115.496 -2.193 . . . . 0.0 108.352 160.281 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.432 HD21 HG22 ' A' ' 7' ' ' THR . 3.5 pp -97.37 151.89 19.48 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 124.752 1.283 . . . . 0.0 110.866 164.157 . . . . . . . . 2 2 . 1 . 083 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.6 t -142.72 125.35 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -179.203 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 98.6 mt -80.32 173.04 13.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.795 -1.815 . . . . 0.0 110.249 -176.002 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 -66.95 126.67 29.84 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.956 152.567 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.5 mt -126.85 143.89 51.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.626 173.322 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -73.6 145.52 45.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.221 1.808 . . . . 0.0 110.351 162.733 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.02 13.38 45.09 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 116.435 -2.314 . . . . 0.0 117.018 -157.857 . . . . . . . . 1 1 . 1 . 083 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 O-C-N 126.762 2.095 . . . . 0.0 110.116 -163.009 . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 . . . . . . . . . 0 0 . 1 . 084 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -97.04 144.79 26.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 -178.201 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 67' ' ' LEU 0.382 0.9 OUTLIER -125.54 157.55 34.76 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 C-N-CA 129.469 3.108 . . . . 0.0 107.158 167.428 . . . . . . . . 4 4 . 1 . 084 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -113.17 139.39 48.8 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.739 2.015 . . . . 0.0 105.746 179.757 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.9 t -117.25 113.45 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 171.077 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -102.16 135.14 44.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 173.084 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -83.48 164.28 19.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 118.007 -2.933 . . . . 0.0 112.105 172.394 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 70' ' ' VAL . 1.2 mt -60.3 -27.75 67.55 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.699 2.0 . . . . 0.0 108.67 179.577 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -14.44 58.93 Favored 'General case' 0 N--CA 1.448 -0.567 1 C-N-CA 134.362 5.065 . . . . 0.0 115.558 176.794 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.8 -9.0 37.19 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 118.736 -2.478 . . . . 0.0 113.047 166.448 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.262 79.0 tttt -89.95 128.25 36.2 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 -177.106 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.3 m -117.83 120.2 37.19 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 110.857 -2.883 . . . . 0.0 112.116 -174.681 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -112.54 155.51 13.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 126.895 3.236 . . . . 0.0 110.337 174.795 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.3 6.8 m -103.1 120.53 40.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.538 -1.976 . . . . 0.0 107.396 -173.785 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -115.2 126.71 54.89 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.259 2.224 . . . . 0.0 109.898 -168.177 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -90.39 114.24 26.31 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 125.099 1.499 . . . . 0.0 108.29 -176.655 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.47 165.32 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 126.308 1.843 . . . . 0.0 114.465 179.908 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -125.34 153.15 72.09 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 114.921 -2.466 . . . . 0.0 109.408 165.505 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.17 -30.85 26.78 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.449 3.433 . . . . 0.0 117.921 -177.521 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -75.97 -1.47 25.79 Favored 'General case' 0 N--CA 1.446 -0.652 1 C-N-CA 135.424 5.489 . . . . 0.0 117.707 178.534 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.65 137.71 33.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 117.246 -3.409 . . . . 0.0 109.023 -175.155 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -84.63 159.14 20.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 122.004 2.184 . . . . 0.0 113.528 175.356 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -65.76 -21.41 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.098 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.74 -36.0 81.61 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 130.396 3.479 . . . . 0.0 112.23 174.736 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -73.82 -34.42 64.57 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 125.373 1.671 . . . . 0.0 110.27 175.683 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -80.72 -42.63 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.83 2.452 . . . . 0.0 111.578 -175.093 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -53.92 -46.51 71.51 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 121.231 3.789 . . . . 0.0 121.231 161.929 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.76 -43.03 98.51 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 126.883 2.614 . . . . 0.0 113.08 174.48 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -52.02 -39.44 59.49 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 115.022 -2.418 . . . . 0.0 112.73 174.737 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.7 mt -57.12 -46.46 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 125.456 1.722 . . . . 0.0 109.599 179.292 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -66.61 -45.94 77.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.298 1.839 . . . . 0.0 108.777 178.254 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -55.38 -43.49 75.2 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 117.568 -3.208 . . . . 0.0 115.266 177.065 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.94 -80.74 0.14 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 130.055 3.342 . . . . 0.0 113.937 174.976 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -89.19 -10.17 48.11 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 122.024 2.193 . . . . 0.0 115.069 -170.214 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.71 40.61 37.03 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 119.946 2.738 . . . . 0.0 119.946 -177.753 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 mt -119.18 95.82 49.59 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 119.957 -1.908 . . . . 0.0 109.86 178.407 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -69.13 158.03 59.32 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 O-C-N 122.805 0.898 . . . . 0.0 111.735 -177.953 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.292 63.1 Cg_exo -42.09 -34.88 2.94 Favored 'Trans proline' 0 N--CA 1.444 -1.407 1 C-N-CA 126.269 4.646 . . . . 0.0 120.186 176.858 . . . . . . . . 3 2 . 1 . 084 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.97 -35.55 0.54 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 129.488 3.115 . . . . 0.0 112.997 163.942 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -110.08 -7.69 14.89 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.208 1.803 . . . . 0.0 110.851 -170.618 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.253 81.1 mt-30 -100.06 155.09 17.91 Favored 'General case' 0 C--O 1.226 -0.141 0 O-C-N 118.945 -2.347 . . . . 0.0 112.266 179.256 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -150.08 105.61 3.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 100.962 -3.718 . . . . 0.0 100.962 169.052 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD13 HD12 ' A' ' 50' ' ' LEU . 84.1 mt -81.69 72.74 8.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.565 1.546 . . . . 0.0 109.905 165.301 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 tt -71.24 92.95 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.226 154.843 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CD1' HD23 ' A' ' 50' ' ' LEU . 29.0 p90 -73.26 -28.71 62.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -172.252 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.62 -80.93 0.12 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 114.882 -2.485 . . . . 0.0 108.401 175.1 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.67 -12.88 9.12 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 115.3 -2.945 . . . . 0.0 110.042 -179.315 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -136.28 163.46 30.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 121.253 2.526 . . . . 0.0 105.077 -169.478 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -77.02 155.64 32.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.333 -1.479 . . . . 0.0 113.662 172.14 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.46 HD23 ' CD1' ' A' ' 45' ' ' PHE . 39.8 mt -68.61 152.24 45.63 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 124.62 1.2 . . . . 0.0 109.793 172.346 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -108.64 129.78 55.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 120.811 1.642 . . . . 0.0 109.114 178.791 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -45.59 105.25 0.06 Allowed 'General case' 0 N--CA 1.444 -0.739 1 C-N-CA 132.717 4.407 . . . . 0.0 116.109 166.419 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.51 -3.96 13.5 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.659 2.552 . . . . 0.0 116.373 174.961 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -98.4 158.87 15.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 -177.525 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -111.65 169.65 8.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 110.208 -3.178 . . . . 0.0 103.778 -179.925 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 3.5 mp -52.59 -34.32 50.14 Favored 'General case' 0 N--CA 1.445 -0.714 1 C-N-CA 132.111 4.164 . . . . 0.0 112.445 172.0 . . . . . . . . 3 3 . 1 . 084 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.9 m -72.15 -21.24 61.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 175.407 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -72.89 -30.62 64.08 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.443 1.497 . . . . 0.0 113.713 169.97 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -101.85 2.15 37.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.529 1.532 . . . . 0.0 111.164 173.767 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 49.1 m-80 67.94 14.55 9.4 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 117.794 -3.066 . . . . 0.0 118.726 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.0 mt -65.85 154.27 7.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -163.188 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -128.39 179.16 5.79 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 130.98 3.712 . . . . 0.0 114.319 -170.165 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 tttt -65.16 135.43 55.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 113.818 -2.992 . . . . 0.0 109.725 -177.833 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.351 15.4 mt-10 78.72 0.55 2.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.515 2.726 . . . . 0.0 113.187 167.904 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.62 141.63 54.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.936 2.494 . . . . 0.0 112.047 178.656 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.1 m -109.81 132.27 54.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -177.412 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.588 HD12 HD13 ' A' ' 3' ' ' ILE . 67.6 mt -114.7 152.34 32.15 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 125.61 1.819 . . . . 0.0 108.743 173.738 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.368 15.4 m80 -105.1 149.3 25.97 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.038 2.135 . . . . 0.0 107.092 -168.274 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -129.9 136.81 49.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 121.168 1.804 . . . . 0.0 112.631 169.598 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.491 ' HA ' HD12 ' A' ' 8' ' ' LEU . 73.0 t -124.57 139.07 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 129.768 3.227 . . . . 0.0 107.72 -176.326 . . . . . . . . 2 2 . 1 . 084 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 tp -104.25 119.26 38.57 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 -158.142 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -67.68 126.87 30.73 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 127.366 2.916 . . . . 0.0 110.847 166.218 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.1 tp -107.15 135.38 48.79 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 174.616 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -61.08 150.21 34.67 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.605 2.762 . . . . 0.0 110.238 -176.612 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.55 -178.66 15.97 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 125.989 1.757 . . . . 0.0 112.125 -161.964 . . . . . . . . 1 1 . 1 . 084 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.986 0 C-N-CA 129.312 3.339 . . . . 0.0 109.86 -174.054 . . . . . . . . 0 0 . 1 . 085 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 ttp . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 085 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -75.11 132.95 41.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 126.928 2.643 . . . . 0.0 113.644 170.275 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 3' ' ' ILE . 4.4 pt -130.54 146.56 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 1 C-N-CA 131.757 4.023 . . . . 0.0 106.917 160.414 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.29 141.53 34.03 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 129.112 2.965 . . . . 0.0 105.733 171.548 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -128.7 126.34 64.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 115.954 -1.974 . . . . 0.0 105.758 163.923 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -84.41 114.15 21.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 127.425 2.953 . . . . 0.0 110.908 174.722 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -64.13 160.67 17.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 128.5 4.0 . . . . 0.0 111.711 170.657 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -60.46 -12.59 10.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 117.274 -3.391 . . . . 0.0 118.571 -176.663 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 p -95.04 -8.0 38.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 109.894 -3.321 . . . . 0.0 111.222 175.766 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.82 -20.15 36.97 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 124.072 3.124 . . . . 0.0 112.827 -179.88 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -78.35 141.57 38.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 113.619 -3.086 . . . . 0.0 114.767 -176.219 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 p -92.77 132.05 37.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 125.926 3.966 . . . . 0.0 116.871 168.8 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.9 pt -102.91 129.37 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.536 161.005 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.2 m -88.54 129.14 35.54 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 103.452 -2.795 . . . . 0.0 103.452 -175.001 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.7 mt -114.89 131.16 56.95 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 178.624 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.15 98.72 9.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.553 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -112.98 167.99 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 124.662 2.172 . . . . 0.0 113.173 -176.221 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.371 26.4 mm-40 -93.46 149.25 36.95 Favored Pre-proline 0 N--CA 1.449 -0.511 0 O-C-N 118.204 -2.81 . . . . 0.0 105.593 167.104 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.28 15.4 Cg_endo -73.02 -16.03 25.77 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.952 2.434 . . . . 0.0 115.192 -176.61 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 p -86.61 -5.65 59.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.697 2.399 . . . . 0.0 112.07 -179.353 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -75.27 153.83 37.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -173.32 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.8 p -97.34 173.15 7.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 117.942 -2.974 . . . . 0.0 110.932 176.219 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.7 mm -85.97 -24.64 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 127.805 2.442 . . . . 0.0 109.121 -164.112 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -68.25 -30.58 69.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 129.929 3.292 . . . . 0.0 109.211 174.632 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -86.04 -17.67 34.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 124.319 3.236 . . . . 0.0 113.225 170.422 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.91 -50.93 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 102.75 -3.056 . . . . 0.0 102.75 168.908 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.22 -30.0 61.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 121.101 1.773 . . . . 0.0 108.756 -171.134 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.24 -27.4 67.94 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 117.497 -3.252 . . . . 0.0 115.465 168.317 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -67.02 -38.13 85.4 Favored 'General case' 0 C--N 1.325 -0.494 1 O-C-N 115.862 -4.274 . . . . 0.0 116.733 169.604 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.4 mt -74.3 -20.25 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 O-C-N 126.89 2.619 . . . . 0.0 113.173 171.433 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -66.61 -30.77 71.13 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 119.635 -1.915 . . . . 0.0 115.663 154.659 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -83.79 -57.71 3.1 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 121.496 1.953 . . . . 0.0 106.106 -174.765 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.323 64.7 mttm -45.04 -71.47 0.08 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 119.53 3.159 . . . . 0.0 119.53 168.073 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -102.77 -28.52 12.04 Favored 'General case' 0 N--CA 1.448 -0.526 1 CA-C-O 128.901 4.191 . . . . 0.0 115.979 -164.7 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.11 -9.12 50.18 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 118.777 -2.452 . . . . 0.0 118.955 167.211 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.4 mm -82.5 124.62 77.62 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 129.347 3.059 . . . . 0.0 104.825 -167.556 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.27 147.05 36.78 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 123.822 3.015 . . . . 0.0 112.829 -173.134 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -67.19 -13.19 38.74 Favored 'Trans proline' 0 N--CA 1.442 -1.507 1 C-N-CA 126.953 5.102 . . . . 0.0 114.072 -171.672 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -83.46 -5.7 59.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 118.213 -1.395 . . . . 0.0 113.927 173.688 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.431 2.5 tp-100 -108.98 -8.45 15.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.266 1.826 . . . . 0.0 111.408 168.885 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -92.91 123.74 36.39 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 126.859 3.219 . . . . 0.0 107.687 179.498 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.354 32.2 mtt180 -126.0 138.77 53.76 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 111.61 -2.541 . . . . 0.0 108.157 172.292 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.405 HD13 HD13 ' A' ' 67' ' ' LEU . 16.5 mt -105.49 150.96 24.85 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 174.176 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.286 68.4 mt -100.53 143.84 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 1 C-N-CA 133.383 4.673 . . . . 0.0 109.685 152.219 . . . . . . . . 3 2 . 1 . 085 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -151.59 119.68 6.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 111.025 -2.807 . . . . 0.0 115.055 162.635 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.8 39.07 24.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.758 2.423 . . . . 0.0 115.08 176.677 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.43 -10.39 16.88 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 163.15 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -134.09 136.23 43.78 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -159.867 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.359 6.0 tt0 -73.99 130.37 39.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 162.525 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -73.92 133.6 43.09 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -172.787 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.22 -39.31 94.26 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.585 1.954 . . . . 0.0 112.125 175.182 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.391 24.8 t0 106.38 160.31 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 131.701 4.0 . . . . 0.0 113.419 170.585 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.98 21.94 12.94 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 128.609 3.004 . . . . 0.0 114.518 153.608 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -113.62 176.37 5.06 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 124.724 2.202 . . . . 0.0 106.666 175.034 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.2 p -90.41 154.22 19.83 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.274 -2.141 . . . . 0.0 108.438 172.623 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.346 8.0 mp -41.79 -61.25 1.15 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 110.261 -3.154 . . . . 0.0 115.686 175.596 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -45.24 -52.88 9.01 Favored 'General case' 0 N--CA 1.448 -0.536 1 C-N-CA 132.921 4.488 . . . . 0.0 112.601 176.103 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -64.45 -43.66 93.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.66 178.216 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.75 -14.4 60.71 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 119.359 -2.088 . . . . 0.0 111.733 -173.402 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.475 0.9 OUTLIER 91.61 24.03 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 130.801 3.641 . . . . 0.0 115.643 179.323 . . . . . . . . 3 3 . 1 . 085 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.7 mt -95.59 115.47 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 119.934 1.243 . . . . 0.0 111.99 176.139 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -116.2 -156.49 0.62 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.831 1.652 . . . . 0.0 114.344 -178.876 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -56.28 112.11 1.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 127.416 2.286 . . . . 0.0 112.997 178.407 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 76.52 21.96 1.27 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.065 2.146 . . . . 0.0 108.968 168.461 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -63.68 127.31 30.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 117.195 -1.383 . . . . 0.0 108.471 175.297 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 13.5 m -90.16 111.61 22.82 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 121.33 1.877 . . . . 0.0 111.687 169.664 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.405 HD13 HD13 ' A' ' 43' ' ' LEU . 31.3 mt -91.87 152.19 20.2 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.823 1.249 . . . . 0.0 110.263 166.673 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -107.96 141.25 39.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 173.164 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -104.35 145.46 30.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -179.556 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 m -142.72 153.11 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 129.146 2.978 . . . . 0.0 107.095 -178.023 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 mt -97.82 155.41 17.06 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 127.094 2.158 . . . . 0.0 108.393 167.131 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -96.06 79.4 3.21 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 120.896 1.68 . . . . 0.0 108.691 167.89 . . . . . . . . 1 1 . 1 . 085 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.343 12.5 mt -88.68 -33.94 17.39 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 -174.084 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 74' ' ' ARG . 25.8 ttm105 -91.59 -42.81 10.01 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 115.735 -2.386 . . . . 0.0 113.815 -165.795 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.72 -141.19 11.41 Favored Glycine 0 CA--C 1.534 1.28 1 C-N-CA 131.343 4.306 . . . . 0.0 104.401 -158.486 . . . . . . . . 2 2 . 1 . 085 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.322 0 N-CA-C 104.787 -3.325 . . . . 0.0 104.787 165.599 . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 115.401 -2.238 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 086 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -72.42 152.58 41.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 129.525 3.13 . . . . 0.0 108.926 177.595 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pp -145.29 158.95 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 160.63 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -119.22 117.82 29.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.463 1.505 . . . . 0.0 108.989 -174.085 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 t -100.88 117.52 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 1 N-CA-C 99.253 -4.351 . . . . 0.0 99.253 175.886 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -109.42 136.52 48.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 125.465 1.728 . . . . 0.0 109.624 -171.917 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -84.97 174.27 9.9 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.125 -1.609 . . . . 0.0 108.969 -177.137 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.5 mt -91.64 0.65 57.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 116.84 -1.552 . . . . 0.0 107.085 179.595 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -107.19 0.89 23.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.305 1.842 . . . . 0.0 110.481 174.453 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.99 -27.48 8.6 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 115.049 -3.084 . . . . 0.0 111.912 154.625 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -62.6 144.31 56.32 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 129.826 3.898 . . . . 0.0 108.906 179.066 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -118.52 123.0 44.02 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 127.683 3.114 . . . . 0.0 103.791 -169.057 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mt -94.24 134.36 32.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 117.039 -1.457 . . . . 0.0 108.329 174.602 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.6 m -103.07 110.23 22.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 114.296 -2.764 . . . . 0.0 110.716 177.848 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -107.6 160.37 15.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 127.152 2.782 . . . . 0.0 109.648 167.668 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.394 0.0 OUTLIER -127.87 116.06 19.56 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.732 3.213 . . . . 0.0 110.568 -178.017 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.19 162.61 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 O-C-N 117.725 -3.109 . . . . 0.0 106.974 -169.387 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -102.07 154.56 37.28 Favored Pre-proline 0 N--CA 1.441 -0.901 0 O-C-N 118.975 -2.328 . . . . 0.0 106.815 164.638 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.251 67.0 Cg_endo -66.77 -29.32 42.58 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 124.496 3.464 . . . . 0.0 115.765 175.757 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.256 27.9 p -63.05 -2.28 1.21 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 114.927 -2.463 . . . . 0.0 117.366 160.814 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -70.1 136.14 49.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 123.484 2.856 . . . . 0.0 108.542 -175.517 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 p -77.99 170.83 15.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.76 2.424 . . . . 0.0 109.128 170.241 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.3 mt -72.66 -46.07 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -177.987 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -41.72 -44.1 3.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 122.668 2.485 . . . . 0.0 116.024 162.561 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -63.96 -42.97 97.13 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 124.687 1.242 . . . . 0.0 109.87 179.461 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.607 HG21 HD21 ' A' ' 56' ' ' LEU . 35.1 t -79.83 -27.88 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.353 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -68.69 -34.07 75.04 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 114.607 -2.616 . . . . 0.0 114.445 167.541 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.35 -26.12 42.15 Favored 'General case' 0 N--CA 1.45 -0.445 1 CA-C-N 126.881 4.401 . . . . 0.0 115.057 169.382 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -71.55 -39.61 70.55 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 124.688 1.242 . . . . 0.0 109.777 172.271 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.8 mt -73.36 -37.76 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 O-C-N 116.664 -3.773 . . . . 0.0 113.695 173.406 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -58.56 -45.49 88.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 119.999 1.272 . . . . 0.0 112.623 175.551 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.09 -35.51 69.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.766 2.426 . . . . 0.0 111.495 -179.612 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -86.73 -39.04 16.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -177.312 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -120.53 -25.31 5.59 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.311 1.844 . . . . 0.0 111.466 -172.259 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.77 -11.97 67.72 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 114.641 -3.311 . . . . 0.0 116.138 -178.682 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.6 mt -64.84 118.52 49.46 Favored Pre-proline 0 N--CA 1.45 -0.456 1 CA-C-N 124.434 4.117 . . . . 0.0 115.678 177.469 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -76.44 141.49 22.67 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 CA-C-N 124.533 2.655 . . . . 0.0 118.035 -173.767 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -30.21 -50.33 0.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 N-CA-C 121.089 3.457 . . . . 0.0 121.089 177.839 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.93 -40.74 63.83 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 117.446 -3.284 . . . . 0.0 114.591 172.93 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -84.51 -25.79 28.55 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 118.535 -1.266 . . . . 0.0 113.733 -174.376 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -63.81 121.48 14.13 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 128.218 2.607 . . . . 0.0 108.117 171.882 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' CZ ' ' HD2' ' A' ' 72' ' ' ARG . 65.0 mtt180 -101.54 131.83 47.5 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 123.316 2.78 . . . . 0.0 109.65 147.739 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.9 mt -104.95 139.09 40.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 125.846 1.966 . . . . 0.0 108.222 167.72 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 44' ' ' ILE . 34.7 mt -129.37 125.93 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 110.793 -2.912 . . . . 0.0 108.148 -173.912 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.362 33.1 t80 -149.54 131.18 14.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.654 1.115 . . . . 0.0 108.908 176.086 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.38 34.51 15.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -178.711 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.01 -23.05 5.42 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 119.233 2.453 . . . . 0.0 119.233 -173.05 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -79.2 139.23 38.01 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 127.566 2.568 . . . . 0.0 111.405 -174.724 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -87.67 124.83 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 164.352 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.95 135.61 33.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 126.169 1.788 . . . . 0.0 113.395 -162.175 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -83.4 134.72 34.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 116.822 -3.674 . . . . 0.0 113.437 176.643 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.92 141.48 51.14 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 127.523 3.014 . . . . 0.0 111.173 -174.577 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.76 -16.16 26.12 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 111.725 -2.489 . . . . 0.0 114.141 177.854 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -87.25 145.82 26.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.886 2.074 . . . . 0.0 112.189 177.037 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 p -85.69 157.81 20.21 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 126.037 2.086 . . . . 0.0 111.904 179.02 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.607 HD21 HG21 ' A' ' 26' ' ' VAL . 60.2 mt -53.62 -53.97 44.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.883 2.073 . . . . 0.0 114.464 177.23 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.252 22.1 t -39.68 -35.05 0.28 Allowed 'General case' 0 C--N 1.326 -0.437 1 N-CA-C 122.927 4.417 . . . . 0.0 122.927 165.925 . . . . . . . . 3 2 . 1 . 086 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -70.28 -44.25 68.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.224 2.61 . . . . 0.0 114.858 176.739 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -94.93 6.28 49.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 111.795 -2.457 . . . . 0.0 106.642 -173.286 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.9 t30 86.11 21.39 0.08 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 126.482 3.039 . . . . 0.0 113.065 151.976 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.297 82.3 mt -77.84 98.37 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 1 O-C-N 115.782 -4.324 . . . . 0.0 102.542 -178.316 . . . . . . . . 3 2 . 1 . 086 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -82.03 161.88 22.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 130.523 3.529 . . . . 0.0 107.51 -179.9 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -49.14 133.69 18.55 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 126.179 2.174 . . . . 0.0 112.913 176.242 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 65.05 20.92 12.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.125 2.97 . . . . 0.0 118.876 169.305 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -65.97 149.9 49.5 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 112.045 -3.836 . . . . 0.0 115.965 174.518 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 m -107.32 128.48 54.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 128.438 3.586 . . . . 0.0 110.265 170.332 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.251 0.7 OUTLIER -144.56 -177.9 5.72 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.361 2.264 . . . . 0.0 108.376 -170.771 . . . . . . . . 3 3 . 1 . 086 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.629 2.1 p80 -128.96 167.12 17.9 Favored 'General case' 0 N--CA 1.448 -0.537 1 C-N-CA 134.144 4.977 . . . . 0.0 118.117 177.79 . . . . . . . . 3 2 . 1 . 086 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 tp -135.86 126.72 27.54 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 110.6 -3.0 . . . . 0.0 115.713 175.267 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.14 104.77 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 130.44 3.496 . . . . 0.0 108.346 -179.303 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.53 78.06 0.07 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 130.958 3.703 . . . . 0.0 108.863 165.528 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HD2' ' CZ ' ' A' ' 42' ' ' ARG . 35.2 ttt-85 -74.6 76.04 2.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 125.325 3.693 . . . . 0.0 112.767 165.201 . . . . . . . . 2 2 . 1 . 086 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -80.61 12.49 3.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 129.368 3.067 . . . . 0.0 114.365 -177.165 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -90.61 133.18 35.3 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 102.094 -3.298 . . . . 0.0 102.094 157.694 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.2 83.13 0.35 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -165.616 . . . . . . . . 1 1 . 1 . 086 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.829 0 CA-C-O 115.168 -3.018 . . . . 0.0 108.113 179.629 . . . . . . . . 0 0 . 1 . 087 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 . . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.95 139.16 44.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 116.833 -1.556 . . . . 0.0 112.728 158.913 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -128.75 173.79 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 167.509 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.19 160.41 37.33 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 125.612 1.82 . . . . 0.0 109.421 179.946 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.541 HG21 HD11 ' A' ' 30' ' ' ILE . 73.9 t -136.37 116.22 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 127.654 2.382 . . . . 0.0 109.256 172.671 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -76.3 130.67 38.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 121.277 1.853 . . . . 0.0 111.196 156.588 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 p -100.73 168.17 9.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 116.168 -1.872 . . . . 0.0 114.592 -174.71 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 mt -58.6 -32.93 69.44 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 127.181 2.192 . . . . 0.0 113.089 -175.87 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -71.57 -22.62 61.71 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.679 1.991 . . . . 0.0 115.363 174.418 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.56 -18.22 13.41 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 128.925 3.155 . . . . 0.0 108.658 -176.793 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.68 148.09 52.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 113.839 -2.981 . . . . 0.0 109.111 -172.738 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.3 m -120.52 130.94 54.46 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 125.853 1.971 . . . . 0.0 112.429 174.966 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 mm -103.69 147.65 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 128.591 2.756 . . . . 0.0 105.597 179.471 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.3 m -106.84 122.9 47.32 Favored 'General case' 0 N--CA 1.452 -0.337 1 N-CA-C 99.472 -4.27 . . . . 0.0 99.472 174.743 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.14 160.69 25.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.87 1.668 . . . . 0.0 109.302 173.436 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -114.01 125.91 54.53 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.39 -1.732 . . . . 0.0 115.167 166.224 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.42 161.99 13.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 O-C-N 119.613 -1.929 . . . . 0.0 112.135 176.152 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -107.57 160.57 26.17 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 127.456 2.302 . . . . 0.0 107.335 161.304 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -40.38 -42.16 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.891 1 C-N-CA 127.477 5.451 . . . . 0.0 114.815 175.218 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 p -77.57 -3.01 38.58 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.772 -3.08 . . . . 0.0 117.005 -172.88 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.25 123.81 29.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 123.641 1.686 . . . . 0.0 109.841 -178.631 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.3 p -81.71 179.85 7.66 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 129.319 3.048 . . . . 0.0 106.399 -179.403 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.583 HG22 ' HE2' ' A' ' 27' ' ' LYS . 9.2 mm -64.77 -35.89 76.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 115.941 -1.98 . . . . 0.0 109.376 179.325 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -55.24 -47.15 75.82 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 126.458 1.903 . . . . 0.0 114.318 173.771 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -64.81 -34.95 79.57 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.899 3.679 . . . . 0.0 109.474 177.236 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.0 t -71.05 -42.5 76.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.454 1.902 . . . . 0.0 107.0 177.177 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HE2' HG22 ' A' ' 23' ' ' ILE . 45.0 mtmt -73.0 -31.08 64.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 119.24 -2.162 . . . . 0.0 115.61 -178.019 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.29 78.03 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.766 3.226 . . . . 0.0 112.492 170.053 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -74.46 -30.09 61.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.323 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.541 HD11 HG21 ' A' ' 5' ' ' VAL . 64.7 mt -73.39 -35.96 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 128.982 2.913 . . . . 0.0 109.916 -176.957 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -61.94 -42.74 99.45 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 119.133 -2.229 . . . . 0.0 109.515 172.931 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -61.67 -19.28 62.15 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 119.671 3.212 . . . . 0.0 119.671 178.358 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -101.11 -40.36 7.23 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 116.874 -1.536 . . . . 0.0 109.095 172.404 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.328 16.8 tp10 -125.05 -4.68 7.44 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.529 -1.357 . . . . 0.0 114.023 -157.616 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.23 9.23 28.64 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 119.176 2.43 . . . . 0.0 119.176 174.762 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 36' ' ' ILE . 7.2 mt -75.89 133.12 73.22 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 130.655 3.582 . . . . 0.0 105.484 174.842 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.55 145.67 59.1 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 CA-C-O 113.926 -2.614 . . . . 0.0 114.285 -175.193 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.08 -39.17 19.43 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.504 2.803 . . . . 0.0 119.29 -177.469 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.476 ' CG ' HH12 ' A' ' 72' ' ' ARG 0.265 38.4 t70 -48.64 -48.79 39.29 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 130.378 3.471 . . . . 0.0 114.145 179.73 . . . . . . . . 3 3 . 1 . 087 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -72.22 -25.62 61.71 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 131.092 3.757 . . . . 0.0 113.278 173.3 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.84 128.76 35.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 123.759 2.981 . . . . 0.0 109.945 -175.014 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -109.98 161.8 15.15 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 118.862 -2.399 . . . . 0.0 108.675 165.49 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -124.81 106.65 10.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 164.111 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -92.77 128.65 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 101.008 -3.701 . . . . 0.0 101.008 164.641 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -157.13 117.67 3.56 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 128.29 2.636 . . . . 0.0 110.277 -173.727 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.94 28.74 18.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.217 2.607 . . . . 0.0 110.652 -172.427 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.23 -25.49 28.05 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 125.413 1.696 . . . . 0.0 109.861 177.678 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 tttt -92.62 135.01 34.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.988 -0.713 . . . . 0.0 111.227 -162.804 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.67 119.51 14.92 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 115.885 -2.007 . . . . 0.0 109.115 171.824 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.2 mt -81.36 123.82 28.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -177.953 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -81.29 137.59 35.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.457 -1.402 . . . . 0.0 110.365 -175.414 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.73 114.71 5.21 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.486 169.747 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.24 -21.32 2.95 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 130.327 3.822 . . . . 0.0 112.752 177.932 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mtp85 -97.31 155.67 16.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -176.861 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -94.74 171.05 9.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.364 1.866 . . . . 0.0 108.09 177.619 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.13 -47.24 77.79 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.962 1.305 . . . . 0.0 111.41 176.085 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.5 p -44.89 -40.26 6.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 118.591 2.812 . . . . 0.0 118.591 159.863 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -61.57 -34.17 75.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 124.218 1.961 . . . . 0.0 116.133 168.654 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.94 11.16 21.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.033 -2.292 . . . . 0.0 115.927 168.813 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.451 8.5 p30 54.36 46.6 24.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 124.442 2.067 . . . . 0.0 111.662 177.515 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -103.85 108.25 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 128.662 2.785 . . . . 0.0 109.158 173.599 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -105.27 169.28 8.54 Favored 'General case' 0 C--N 1.325 -0.482 1 O-C-N 130.147 4.654 . . . . 0.0 112.749 -173.875 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.325 51.7 tttm -12.52 107.0 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 129.372 3.069 . . . . 0.0 117.446 168.969 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 76.49 17.87 1.85 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 129.386 3.074 . . . . 0.0 115.013 168.694 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -67.93 139.12 56.42 Favored 'General case' 0 CA--C 1.532 0.283 1 O-C-N 115.567 -4.458 . . . . 0.0 113.512 171.109 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.1 m -98.08 112.06 24.15 Favored 'General case' 0 N--CA 1.449 -0.48 1 C-N-CA 133.641 4.776 . . . . 0.0 103.579 178.137 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -87.09 161.51 18.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 128.824 2.85 . . . . 0.0 109.538 169.21 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -123.15 118.7 28.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 130.12 3.368 . . . . 0.0 111.348 -172.73 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.1 tp -89.77 111.09 21.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 116.32 -1.8 . . . . 0.0 114.649 -166.167 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.95 165.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 125.142 1.526 . . . . 0.0 107.875 -179.539 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tp -112.37 162.59 15.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.921 1.688 . . . . 0.0 109.045 -176.469 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.476 HH12 ' CG ' ' A' ' 39' ' ' ASP . 51.0 ttp180 -85.51 124.16 31.76 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 127.139 2.176 . . . . 0.0 108.078 178.602 . . . . . . . . 2 2 . 1 . 087 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.97 163.2 13.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.885 2.874 . . . . 0.0 106.991 172.327 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.374 5.1 ptp180 -147.33 152.59 38.47 Favored 'General case' 0 N--CA 1.452 -0.335 1 C-N-CA 132.664 4.385 . . . . 0.0 109.991 -176.78 . . . . . . . . 3 2 . 1 . 087 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.62 -116.18 2.4 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 103.916 -3.674 . . . . 0.0 103.916 154.488 . . . . . . . . 1 1 . 1 . 087 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.698 0 C-N-CA 129.002 3.191 . . . . 0.0 109.502 -176.604 . . . . . . . . 0 0 . 1 . 088 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -72.19 134.78 45.87 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.299 1.84 . . . . 0.0 112.864 171.592 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.5 pt -147.04 141.04 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.489 2.316 . . . . 0.0 107.958 168.935 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.04 151.28 25.07 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 119.125 -2.234 . . . . 0.0 107.54 -179.223 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -110.88 129.39 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 117.733 -3.104 . . . . 0.0 104.33 160.61 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -109.07 120.36 42.31 Favored 'General case' 0 N--CA 1.45 -0.433 1 O-C-N 116.268 -4.02 . . . . 0.0 101.406 167.707 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -85.95 126.79 34.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 158.547 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.307 6.0 mp -88.83 -12.65 41.35 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 125.318 1.636 . . . . 0.0 108.88 -167.686 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.5 p -90.33 -14.02 33.98 Favored 'General case' 0 N--CA 1.442 -0.869 1 O-C-N 115.919 -4.238 . . . . 0.0 113.198 164.281 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.64 -104.89 1.28 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.319 1.914 . . . . 0.0 108.532 -156.0 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -159.67 151.73 20.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 117.85 -3.147 . . . . 0.0 108.884 -159.071 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.4 p -70.96 127.19 31.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.553 -2.112 . . . . 0.0 110.222 161.336 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.98 137.6 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 131.324 3.85 . . . . 0.0 102.779 -175.386 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.3 p -92.51 112.55 24.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.227 -1.351 . . . . 0.0 107.662 173.935 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.35 171.74 7.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 174.533 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -141.8 127.36 18.98 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 103.147 -2.908 . . . . 0.0 103.147 -175.823 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.2 m -132.8 177.78 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 O-C-N 119.295 -2.128 . . . . 0.0 111.833 177.666 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -97.27 143.18 25.71 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 125.581 1.552 . . . . 0.0 109.605 178.611 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -63.73 -24.34 68.96 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-O 115.727 -1.864 . . . . 0.0 115.44 172.911 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.3 p -99.75 10.45 41.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 130.016 3.326 . . . . 0.0 114.132 -178.398 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.71 145.97 48.48 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 125.764 1.915 . . . . 0.0 107.187 -179.339 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.1 p -91.94 150.63 20.92 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 115.582 -2.151 . . . . 0.0 113.677 164.809 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -54.46 -34.07 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 123.868 3.031 . . . . 0.0 116.49 -176.172 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.33 -39.54 76.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 124.53 3.332 . . . . 0.0 115.963 172.974 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -83.16 -26.17 31.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.897 2.079 . . . . 0.0 115.675 175.4 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.287 99.3 t -50.47 -52.69 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 O-C-N 119.007 -2.308 . . . . 0.0 115.109 157.712 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -60.41 -34.48 74.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 126.46 2.35 . . . . 0.0 115.444 174.691 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.1 63.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 131.311 3.844 . . . . 0.0 113.04 165.561 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.289 49.1 mttp -59.33 -41.28 88.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.662 1.585 . . . . 0.0 111.592 -178.784 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.296 18.0 mt -78.22 -23.15 13.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 127.597 2.359 . . . . 0.0 110.996 -176.939 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -73.81 -43.16 59.67 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 165.444 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.296 25.8 t70 -69.08 -36.96 78.19 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 125.735 2.683 . . . . 0.0 116.675 -178.416 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -36.8 65.48 Favored 'General case' 0 CA--C 1.536 0.433 1 O-C-N 113.395 -5.816 . . . . 0.0 115.982 177.296 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -128.98 -10.43 4.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 117.372 2.36 . . . . 0.0 117.372 -168.189 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.22 10.39 77.97 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 129.794 3.569 . . . . 0.0 112.97 179.804 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.9 mt -81.92 129.1 66.0 Favored Pre-proline 0 N--CA 1.443 -0.814 1 CA-C-N 124.701 4.251 . . . . 0.0 110.288 -166.426 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.02 144.58 64.48 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 123.491 2.794 . . . . 0.0 118.084 -170.887 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -74.62 -30.06 8.26 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.411 2.741 . . . . 0.0 117.735 -168.978 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -70.89 -17.15 62.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.266 1.031 . . . . 0.0 110.196 172.446 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -102.85 -8.76 20.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 117.869 -3.02 . . . . 0.0 113.398 -171.683 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -83.33 135.39 34.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 122.074 2.215 . . . . 0.0 107.876 -178.764 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -120.05 112.73 19.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 119.414 -2.054 . . . . 0.0 107.585 148.306 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mt -84.84 147.1 26.98 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 126.128 2.142 . . . . 0.0 109.393 170.37 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 68' ' ' HIS 0.296 0.0 OUTLIER -143.36 131.99 19.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 115.45 -2.214 . . . . 0.0 111.79 -174.288 . . . . . . . . 4 4 . 1 . 088 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -137.16 121.74 18.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 102.726 -3.065 . . . . 0.0 102.726 175.393 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 79.56 2.39 2.21 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 127.768 3.167 . . . . 0.0 113.719 165.671 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.75 -17.87 20.13 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 118.07 -2.894 . . . . 0.0 108.519 -174.622 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -85.82 109.56 18.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.167 2.187 . . . . 0.0 108.955 179.993 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.7 119.87 13.15 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.042 166.83 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -91.16 116.92 29.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 117.935 -2.978 . . . . 0.0 106.361 -151.222 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -92.84 145.98 23.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 123.252 1.501 . . . . 0.0 107.045 -166.642 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.24 145.19 43.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 112.375 -2.193 . . . . 0.0 107.67 171.131 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.38 -26.03 25.0 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.783 2.135 . . . . 0.0 112.635 175.169 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -96.49 168.61 10.44 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.552 2.341 . . . . 0.0 114.955 179.2 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.7 p -119.14 176.72 5.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 112.792 -2.003 . . . . 0.0 112.256 -166.752 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.2 mt -77.21 -28.98 54.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.905 -179.782 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.2 t -76.21 -25.76 55.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 115.128 -2.368 . . . . 0.0 110.03 177.76 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -59.78 -61.66 2.45 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 131.058 3.743 . . . . 0.0 105.41 176.622 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -89.67 -7.28 54.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 128.341 2.656 . . . . 0.0 111.908 -169.596 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.384 2.3 t-20 86.03 31.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.226 2.61 . . . . 0.0 111.954 166.01 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.252 5.4 mt -80.24 107.99 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 126.247 1.819 . . . . 0.0 111.002 -174.744 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -100.7 -179.86 4.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 127.215 2.822 . . . . 0.0 112.731 179.13 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -61.86 129.93 43.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 129.712 3.205 . . . . 0.0 112.391 -176.135 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.535 1.1 tt0 79.2 4.59 2.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 159.764 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.9 p -57.12 157.58 5.92 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 127.512 3.007 . . . . 0.0 115.893 158.423 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 m -102.77 126.56 49.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 119.821 -1.8 . . . . 0.0 111.952 156.27 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 mp -91.26 146.69 23.61 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 120.721 -1.237 . . . . 0.0 107.705 160.173 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.409 ' HB2' HG23 ' A' ' 44' ' ' ILE . 30.6 m170 -94.66 145.93 24.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 117.108 -1.425 . . . . 0.0 108.188 177.73 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.13 122.02 40.09 Favored 'General case' 0 C--N 1.322 -0.589 1 C-N-CA 132.547 4.339 . . . . 0.0 104.908 177.544 . . . . . . . . 3 3 . 1 . 088 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.326 2.8 m -121.11 115.61 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 109.074 -3.694 . . . . 0.0 101.427 -178.274 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.1 mt -77.69 119.3 21.03 Favored 'General case' 0 N--CA 1.451 -0.378 1 O-C-N 115.94 -4.225 . . . . 0.0 113.4 -174.844 . . . . . . . . 2 2 . 1 . 088 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.1 ttt-85 -81.19 74.78 8.18 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 119.993 -1.692 . . . . 0.0 107.564 176.652 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.5 mt -78.45 -31.03 47.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -169.19 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -106.09 -22.35 12.89 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 127.828 3.205 . . . . 0.0 107.246 -171.838 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.71 42.26 2.17 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 115.578 -2.79 . . . . 0.0 112.721 -172.762 . . . . . . . . 1 1 . 1 . 088 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.331 0 O-C-N 125.164 1.155 . . . . 0.0 112.93 179.873 . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 ttp . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 101.511 -3.514 . . . . 0.0 101.511 . . . . . . . . . 0 0 . 1 . 089 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -89.63 150.91 22.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.857 1.263 . . . . 0.0 110.432 161.676 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.294 47.4 pt -135.13 175.06 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 129.778 3.231 . . . . 0.0 109.978 163.264 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.417 ' HE1' ' HG1' ' A' ' 14' ' ' THR 0.291 97.9 m-85 -116.38 126.17 53.1 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.101 2.96 . . . . 0.0 110.93 163.732 . . . . . . . . 3 3 . 1 . 089 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.19 140.34 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 151.807 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -118.97 146.73 44.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 126.85 2.594 . . . . 0.0 105.54 167.564 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.2 p -98.65 161.21 13.78 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.49 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt -50.6 -29.64 11.38 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 118.892 -2.38 . . . . 0.0 116.09 -175.223 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.2 p -104.77 9.47 34.93 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.544 2.737 . . . . 0.0 108.749 -162.909 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.85 -23.68 30.38 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 119.605 -1.934 . . . . 0.0 116.231 164.981 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -69.76 126.2 29.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 125.753 1.502 . . . . 0.0 108.503 -179.939 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 p -106.47 150.73 25.79 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.304 1.841 . . . . 0.0 108.654 175.658 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.7 pt -129.75 131.67 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 1 C-N-CA 133.477 4.711 . . . . 0.0 113.8 168.999 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.417 ' HG1' ' HE1' ' A' ' 4' ' ' PHE . 2.6 m -87.95 118.58 27.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.854 2.061 . . . . 0.0 106.875 177.893 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.63 134.2 50.14 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 129.183 2.993 . . . . 0.0 112.164 178.796 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.66 138.24 36.12 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.533 1.933 . . . . 0.0 113.171 172.419 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.306 7.0 m -157.16 142.99 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-O 117.295 -1.336 . . . . 0.0 107.625 -163.229 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -91.96 148.01 36.05 Favored Pre-proline 0 C--O 1.221 -0.401 0 C-N-CA 124.783 1.233 . . . . 0.0 110.814 -178.296 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 31.8 Cg_exo -47.06 -0.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.434 1 N-CA-C 122.616 4.045 . . . . 0.0 122.616 170.627 . . . . . . . . 3 2 . 1 . 089 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 p -134.32 16.24 3.75 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 118.782 -2.449 . . . . 0.0 111.715 -174.154 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -85.93 150.79 24.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -179.53 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -102.34 149.98 23.79 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 128.457 2.703 . . . . 0.0 106.369 177.509 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -49.65 -27.25 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.605 2.362 . . . . 0.0 114.546 177.269 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -50.42 -44.31 55.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.882 2.073 . . . . 0.0 115.103 161.376 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -62.1 -42.1 98.87 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 128.425 2.69 . . . . 0.0 110.891 177.735 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 26' ' ' VAL . 2.0 t -58.81 -38.45 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 176.936 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -66.51 -40.44 89.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 128.484 2.714 . . . . 0.0 114.25 175.246 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -68.65 -40.06 80.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 117.739 -1.124 . . . . 0.0 110.714 176.03 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.437 25.1 mttt -53.82 -45.58 70.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 175.538 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.279 50.8 mt -52.67 -49.4 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 117.019 -1.467 . . . . 0.0 112.686 170.565 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 9.2 tm0? -42.87 -55.21 3.8 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 129.36 3.064 . . . . 0.0 111.578 167.32 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.98 -29.86 62.2 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.002 -1.475 . . . . 0.0 111.134 -171.651 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -83.66 -47.56 11.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 120.697 1.589 . . . . 0.0 112.267 172.107 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -116.41 -20.66 9.6 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 115.575 -2.155 . . . . 0.0 113.829 -159.154 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.15 0.24 25.32 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 125.135 1.522 . . . . 0.0 115.152 172.599 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.0 mt -96.26 136.68 21.86 Favored Pre-proline 0 N--CA 1.45 -0.429 0 O-C-N 126.573 1.984 . . . . 0.0 109.607 -160.365 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -89.31 142.19 4.3 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 124.726 2.723 . . . . 0.0 111.471 -163.422 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.07 -45.77 36.83 Favored 'Trans proline' 0 N--CA 1.452 -0.95 1 C-N-CA 126.607 4.871 . . . . 0.0 114.778 -177.95 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -48.49 -23.3 0.92 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 130.13 3.372 . . . . 0.0 115.774 171.271 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -120.93 14.15 11.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 127.504 3.002 . . . . 0.0 112.941 -176.171 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 72.8 mt-30 -102.86 162.39 12.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 169.891 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.3 ttp-105 -144.52 131.88 20.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 131.209 3.804 . . . . 0.0 105.637 162.74 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.1 mt -111.25 134.76 52.6 Favored 'General case' 0 N--CA 1.444 -0.759 1 O-C-N 115.85 -4.281 . . . . 0.0 110.241 -174.747 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 41.7 mt -126.8 149.52 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 118.293 -2.755 . . . . 0.0 108.841 179.201 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -112.9 -44.11 3.34 Favored 'General case' 0 C--N 1.325 -0.48 1 C-N-CA 132.031 4.132 . . . . 0.0 111.118 161.374 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.09 -103.98 0.29 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 -175.685 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.48 -32.55 0.52 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 118.254 2.062 . . . . 0.0 118.254 -150.196 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -93.14 -178.91 4.92 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 130.125 3.37 . . . . 0.0 112.56 153.394 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -97.12 151.96 19.26 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.651 1.58 . . . . 0.0 109.725 177.475 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.23 135.74 40.99 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.34 1.856 . . . . 0.0 109.365 -177.2 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -77.58 112.65 14.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.033 -2.917 . . . . 0.0 109.448 169.16 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.92 -19.84 46.28 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 129.982 3.313 . . . . 0.0 119.132 -165.788 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.56 14.43 35.52 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.789 2.138 . . . . 0.0 110.05 -177.482 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -90.85 166.57 13.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 124.349 2.023 . . . . 0.0 108.496 157.51 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -90.53 166.02 13.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.663 -1.608 . . . . 0.0 113.687 173.758 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.409 11.8 mt -45.08 -31.86 1.53 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 129.086 2.955 . . . . 0.0 118.371 163.994 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.7 p -93.05 -11.66 32.5 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 119.474 -2.016 . . . . 0.0 111.183 179.143 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -90.59 -4.95 56.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 114.838 -2.506 . . . . 0.0 109.257 177.603 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -118.7 -10.01 10.09 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 166.555 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t30 87.0 40.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 119.479 -2.013 . . . . 0.0 111.334 171.973 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.5 mm -87.55 106.95 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 113.088 -1.869 . . . . 0.0 108.103 175.514 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -87.03 179.88 6.6 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 131.337 3.855 . . . . 0.0 106.532 -172.939 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.3 51.2 pttt -58.4 136.54 57.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 166.794 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 58.9 26.74 15.28 Favored 'General case' 0 N--CA 1.45 -0.472 1 C-N-CA 133.506 4.722 . . . . 0.0 112.344 169.03 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 m -73.8 149.96 41.35 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 129.96 3.304 . . . . 0.0 113.587 -176.844 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -98.45 119.29 36.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 178.26 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -100.23 154.19 18.66 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.397 152.735 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -116.1 119.61 36.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.794 1.638 . . . . 0.0 107.896 -172.167 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.262 52.2 tp -98.94 122.79 42.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 124.118 1.913 . . . . 0.0 113.158 -179.112 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.88 145.06 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 126.513 1.925 . . . . 0.0 110.107 161.52 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.26 136.37 41.62 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 127.982 2.513 . . . . 0.0 110.651 172.898 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.2 mtm105 -101.84 24.83 9.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.335 -175.83 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.67 79.07 1.24 Allowed 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 119.392 -2.067 . . . . 0.0 105.491 177.049 . . . . . . . . 2 2 . 1 . 089 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -153.2 -52.95 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -174.293 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.83 44.14 0.21 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 128.173 2.797 . . . . 0.0 111.369 173.384 . . . . . . . . 1 1 . 1 . 089 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.428 0 CA-C-O 115.956 -2.58 . . . . 0.0 109.452 -158.946 . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 . . . . . . . . . 0 0 . 1 . 090 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -83.24 139.63 32.99 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 129.512 3.125 . . . . 0.0 105.162 -175.747 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 14' ' ' THR 0.266 30.0 pt -141.53 149.33 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 127.124 2.17 . . . . 0.0 111.968 -176.37 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -89.13 146.43 24.81 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.224 164.036 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD12 ' A' ' 15' ' ' LEU . 2.7 t -127.76 118.09 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 126.838 2.586 . . . . 0.0 106.133 169.656 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -94.83 116.81 29.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -177.993 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.2 p -70.75 164.9 24.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 124.441 2.067 . . . . 0.0 112.955 174.982 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.25 -37.82 60.84 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 120.528 -1.358 . . . . 0.0 112.094 -177.45 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 p -54.56 -29.86 52.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 130.993 3.717 . . . . 0.0 116.242 161.844 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.68 -19.77 5.84 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 119.677 -1.889 . . . . 0.0 113.146 161.843 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -73.5 136.57 44.14 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.965 2.506 . . . . 0.0 111.024 175.059 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m -112.32 130.11 56.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 125.265 1.603 . . . . 0.0 110.019 178.273 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.416 HD13 ' HG3' ' A' ' 34' ' ' GLU . 9.3 pt -110.9 177.61 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 112.376 -2.193 . . . . 0.0 108.592 -178.513 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 5.2 t -140.83 141.64 34.68 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.404 1.881 . . . . 0.0 107.077 170.36 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.471 HD12 HG21 ' A' ' 5' ' ' VAL . 22.6 mt -129.11 159.02 37.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.647 2.779 . . . . 0.0 107.051 177.754 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -91.58 138.12 31.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 157.31 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.01 175.76 8.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 CA-C-N 122.416 2.371 . . . . 0.0 107.448 170.113 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -111.87 156.68 41.31 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 162.146 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -58.65 -28.17 85.35 Favored 'Trans proline' 0 N--CA 1.444 -1.412 1 C-N-CA 126.186 4.591 . . . . 0.0 120.538 173.042 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -98.1 21.92 10.14 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 124.939 1.399 . . . . 0.0 112.321 173.97 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.83 153.86 38.54 Favored 'General case' 0 N--CA 1.453 -0.32 1 O-C-N 115.085 -4.759 . . . . 0.0 108.089 174.319 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.293 86.7 m -100.24 157.81 16.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.27 2.228 . . . . 0.0 108.272 168.823 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.1 mm -58.47 -9.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 119.261 3.06 . . . . 0.0 119.261 -178.835 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -87.46 -4.72 59.0 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 118.832 -2.417 . . . . 0.0 113.136 -178.422 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -91.78 -34.63 14.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.717 -2.038 . . . . 0.0 111.717 164.977 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.26 -51.52 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 O-C-N 119.638 -1.914 . . . . 0.0 108.625 179.773 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -51.05 -56.14 14.05 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 128.921 3.888 . . . . 0.0 113.075 -178.532 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.97 80.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.269 2.628 . . . . 0.0 117.034 176.738 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -68.44 -40.52 81.11 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 173.044 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.357 75.8 mt -47.65 -49.29 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 128.811 2.844 . . . . 0.0 112.692 160.665 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -63.61 -45.89 88.26 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.61 2.364 . . . . 0.0 112.556 -179.259 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.51 -64.6 0.79 Allowed 'General case' 0 C--O 1.238 0.46 1 C-N-CA 132.487 4.315 . . . . 0.0 107.222 173.167 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -63.51 -57.03 11.48 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 128.094 3.371 . . . . 0.0 118.22 -174.254 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' HG3' HD13 ' A' ' 13' ' ' ILE 0.279 22.2 mm-40 -111.94 -2.07 15.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.176 2.19 . . . . 0.0 113.741 -168.173 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.85 -19.41 41.3 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 117.543 -3.223 . . . . 0.0 113.132 160.635 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -83.56 127.3 68.6 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 117.962 -3.081 . . . . 0.0 112.506 -157.483 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.22 133.85 31.93 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 CA-C-N 123.885 2.423 . . . . 0.0 113.112 168.653 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.337 17.9 Cg_endo -58.94 -30.31 92.84 Favored 'Trans proline' 0 N--CA 1.452 -0.959 1 C-N-CA 127.691 5.594 . . . . 0.0 117.211 -171.255 . . . . . . . . 3 2 . 1 . 090 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.286 26.6 t70 -76.3 -26.47 55.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 119.967 -1.708 . . . . 0.0 111.327 -163.728 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -73.14 -7.84 53.13 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 172.033 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB3' HD12 ' A' ' 71' ' ' LEU 0.455 1.2 pp0? -132.63 162.22 31.89 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.964 1.364 . . . . 0.0 113.428 -179.532 . . . . . . . . 3 3 . 1 . 090 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -126.0 148.89 49.17 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 128.573 2.749 . . . . 0.0 111.512 171.343 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mt -99.37 118.73 36.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.802 2.841 . . . . 0.0 105.475 -178.357 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 mm -107.71 144.66 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 128.613 2.765 . . . . 0.0 104.922 179.18 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -141.82 132.57 25.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 125.221 1.576 . . . . 0.0 108.506 162.087 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.07 22.77 0.15 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 129.891 3.276 . . . . 0.0 114.644 -177.216 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.44 -7.07 36.62 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 119.398 -2.064 . . . . 0.0 112.948 177.398 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -113.29 141.01 47.52 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 121.564 -0.962 . . . . 0.0 113.298 -168.033 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -63.61 137.01 57.94 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 126.667 2.479 . . . . 0.0 115.565 171.975 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -105.54 108.53 20.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.673 3.189 . . . . 0.0 106.679 179.716 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -91.61 166.45 12.81 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 120.567 1.531 . . . . 0.0 112.38 -168.608 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.31 129.19 37.33 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.371 2.668 . . . . 0.0 107.803 171.107 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.93 -20.19 29.3 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 130.009 3.671 . . . . 0.0 114.933 165.086 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -89.45 153.08 21.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.077 2.551 . . . . 0.0 106.404 179.753 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -104.18 142.19 34.95 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 129.163 2.985 . . . . 0.0 111.276 -169.642 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.28 -55.35 25.33 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 126.906 2.628 . . . . 0.0 117.342 -170.042 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.331 41.2 t -65.0 -18.94 65.73 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 118.335 -2.728 . . . . 0.0 110.255 -172.913 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -78.69 -22.41 46.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 131.377 3.871 . . . . 0.0 115.817 171.333 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -81.37 -10.07 59.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.985 1.714 . . . . 0.0 113.14 163.665 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.349 58.8 t30 80.32 47.69 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 131.546 3.938 . . . . 0.0 108.349 173.882 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD13 HD21 ' A' ' 67' ' ' LEU . 14.3 mt -104.76 146.52 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 C-N-CA 125.814 1.646 . . . . 0.0 107.357 171.652 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -139.52 -158.86 0.9 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 129.663 3.185 . . . . 0.0 112.656 -179.175 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.11 135.34 36.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.873 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 70.69 30.31 3.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 129.509 3.124 . . . . 0.0 106.506 177.979 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.1 m -74.46 149.9 40.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 117.858 -3.026 . . . . 0.0 106.347 160.403 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.8 m -113.21 101.01 9.02 Favored 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 133.336 4.655 . . . . 0.0 101.481 179.166 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.415 HD21 HD13 ' A' ' 61' ' ' ILE . 7.8 mp -92.92 157.08 16.53 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 118.847 -2.408 . . . . 0.0 106.311 166.374 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -123.47 148.58 46.06 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 116.486 -1.721 . . . . 0.0 106.693 -175.644 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tt -103.02 139.35 38.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 103.155 -2.905 . . . . 0.0 103.155 177.096 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.351 29.1 m -134.27 137.73 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 1 C-N-CA 132.77 4.428 . . . . 0.0 112.479 175.782 . . . . . . . . 3 2 . 1 . 090 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 41' ' ' GLN . 10.6 mp -104.37 145.89 29.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 116.824 -1.56 . . . . 0.0 108.371 168.368 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 61.17 -34.36 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 1 N-CA-C 122.182 4.142 . . . . 0.0 122.182 173.466 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.61 152.83 35.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 129.77 3.228 . . . . 0.0 114.45 -171.274 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.279 44.6 ttt-85 -123.07 134.87 54.23 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 -176.303 . . . . . . . . 2 2 . 1 . 090 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.95 72.49 0.21 Allowed Glycine 0 N--CA 1.441 -1.014 0 CA-C-O 126.149 3.083 . . . . 0.0 108.753 166.87 . . . . . . . . 1 1 . 1 . 090 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.285 0 C-N-CA 127.683 2.564 . . . . 0.0 109.789 -161.63 . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptt? . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 091 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -80.02 146.19 32.11 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 124.933 1.396 . . . . 0.0 110.529 -174.23 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.515 HD12 HD13 ' A' ' 67' ' ' LEU 0.418 2.4 pt -142.63 128.77 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 130.385 3.474 . . . . 0.0 108.974 175.642 . . . . . . . . 3 3 . 1 . 091 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.259 62.1 m-85 -98.78 67.13 1.68 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 131.21 3.804 . . . . 0.0 110.57 -159.463 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.267 24.2 t -62.96 113.71 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.772 2 O-C-N 115.669 -4.395 . . . . 0.0 108.651 174.721 . . . . . . . . 3 2 . 1 . 091 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.273 11.8 tppt? -102.45 139.93 37.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 101.987 -3.338 . . . . 0.0 101.987 -170.868 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -106.84 169.88 8.27 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 124.219 0.949 . . . . 0.0 109.04 167.741 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.25 -41.45 63.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 118.825 -2.422 . . . . 0.0 110.345 167.386 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.292 52.7 p -50.84 -34.25 27.08 Favored 'General case' 0 N--CA 1.448 -0.549 1 C-N-CA 131.796 4.039 . . . . 0.0 116.526 174.991 . . . . . . . . 3 2 . 1 . 091 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.66 27.48 3.28 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 128.958 3.171 . . . . 0.0 116.482 157.613 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.383 56.7 mttt -100.5 128.69 46.48 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 167.775 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.2 m -89.28 101.95 14.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 166.285 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.9 mm -53.75 -48.69 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 116.44 -1.743 . . . . 0.0 115.076 -177.052 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.6 m 74.4 50.42 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 129.459 3.103 . . . . 0.0 108.265 176.45 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tp -75.65 126.86 31.84 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -169.598 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -81.16 115.43 20.57 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 125.171 2.415 . . . . 0.0 110.854 163.171 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -108.9 162.17 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 1 C-N-CA 132.679 4.392 . . . . 0.0 113.387 176.853 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -116.07 155.38 48.11 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.98 166.215 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -78.37 -3.63 13.54 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 O-C-N 117.228 -2.038 . . . . 0.0 112.647 -172.923 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 p -81.66 -14.78 56.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.845 2.058 . . . . 0.0 111.694 167.426 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -65.33 122.67 17.67 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.234 2.214 . . . . 0.0 106.918 -179.818 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -85.65 158.09 20.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 172.918 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 21.8 mm -43.19 -43.6 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 O-C-N 118.069 -2.894 . . . . 0.0 113.941 177.438 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.13 -37.09 83.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 125.301 2.476 . . . . 0.0 114.52 176.642 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.58 -34.95 53.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.971 -179.671 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.353 41.0 t -59.48 -44.47 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 118.037 -2.914 . . . . 0.0 108.078 168.829 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -64.71 -38.83 92.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.318 -2.114 . . . . 0.0 113.458 -177.506 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -51.68 66.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 127.136 2.174 . . . . 0.0 113.016 166.569 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -60.15 -26.24 66.14 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 127.929 2.492 . . . . 0.0 113.9 172.602 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.8 mt -86.97 -42.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 120.979 1.718 . . . . 0.0 111.084 171.29 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.44 -24.76 61.08 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.16 1.784 . . . . 0.0 111.797 -175.78 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -52.98 -53.89 43.23 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 130.079 3.352 . . . . 0.0 110.184 165.52 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -85.46 -48.51 8.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 115.855 -2.021 . . . . 0.0 110.503 -170.973 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -110.18 -19.13 13.13 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 128.46 2.704 . . . . 0.0 115.202 -162.409 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.94 -10.57 73.68 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 121.789 3.476 . . . . 0.0 121.789 162.308 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.57 121.13 73.59 Favored Pre-proline 0 N--CA 1.442 -0.839 0 C-N-CA 129.893 3.277 . . . . 0.0 110.384 -163.201 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -63.45 141.89 82.75 Favored 'Trans proline' 0 N--CA 1.452 -0.931 1 C-N-CA 126.152 4.568 . . . . 0.0 113.969 179.596 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.263 50.0 Cg_exo -48.47 -41.65 36.09 Favored 'Trans proline' 0 N--CA 1.448 -1.162 1 C-N-CA 127.759 5.639 . . . . 0.0 117.458 -170.524 . . . . . . . . 3 2 . 1 . 091 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.76 -30.97 40.9 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.524 2.73 . . . . 0.0 107.709 179.908 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -72.12 -3.38 22.85 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.347 2.259 . . . . 0.0 116.233 173.374 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.55 122.77 41.32 Favored 'General case' 0 N--CA 1.446 -0.659 1 C-N-CA 133.736 4.814 . . . . 0.0 110.826 -173.492 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -134.82 137.61 43.48 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 128.324 2.65 . . . . 0.0 105.654 175.431 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.63 112.63 24.29 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 128.129 2.572 . . . . 0.0 108.314 -174.308 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.53 139.52 20.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.45 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.362 59.1 t80 -144.78 92.5 2.29 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 129.693 3.197 . . . . 0.0 109.777 -166.246 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.28 24.79 2.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 121.415 3.857 . . . . 0.0 121.415 176.277 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.58 -12.73 46.99 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 128.293 2.854 . . . . 0.0 114.57 -173.017 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.282 38.9 ttmt -120.07 139.55 52.38 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 126.206 1.768 . . . . 0.0 109.995 -163.698 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 24.3 mt-30 -80.96 130.94 35.27 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.727 2.011 . . . . 0.0 106.315 170.99 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -84.5 136.52 33.78 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.65 177.891 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.33 144.05 36.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 125.743 2.687 . . . . 0.0 106.988 -171.487 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -87.52 145.83 26.07 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.072 -2.892 . . . . 0.0 110.004 -166.629 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.23 -21.56 37.2 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 124.173 1.985 . . . . 0.0 113.909 -175.002 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -89.7 -177.08 5.18 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -162.451 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 p -107.47 168.07 9.49 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.96 171.737 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.74 -24.4 62.61 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 128.568 2.747 . . . . 0.0 109.381 165.831 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 m -75.54 -15.22 60.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.165 -1.834 . . . . 0.0 112.995 177.137 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.35 -36.53 71.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.348 1.859 . . . . 0.0 111.27 -177.065 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -100.18 -9.77 22.13 Favored 'General case' 0 N--CA 1.442 -0.857 1 C-N-CA 135.133 5.373 . . . . 0.0 110.692 -176.97 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.487 13.6 t30 82.86 18.25 0.28 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 119.685 3.217 . . . . 0.0 119.685 177.291 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mt -72.16 121.53 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.329 1.851 . . . . 0.0 107.193 -172.786 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -122.58 177.69 5.32 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 128.697 2.799 . . . . 0.0 112.027 170.734 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -46.11 136.9 6.42 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 130.732 3.613 . . . . 0.0 111.075 -164.462 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.434 2.8 tt0 85.41 15.69 0.15 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 113.935 -2.936 . . . . 0.0 114.558 170.416 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 t -93.58 133.5 36.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 130.589 3.555 . . . . 0.0 110.76 -179.573 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.4 p -92.89 135.69 33.91 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 174.526 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.515 HD13 HD12 ' A' ' 3' ' ' ILE . 6.1 mp -115.51 -176.24 2.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 164.756 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -138.6 139.75 38.71 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 128.025 2.53 . . . . 0.0 107.014 179.269 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.1 tt -111.35 123.39 50.12 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 124.466 1.104 . . . . 0.0 108.341 -174.676 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 m -124.5 137.44 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.472 -179.112 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.259 5.0 mt -88.65 160.42 17.39 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 102.687 -3.079 . . . . 0.0 102.687 -172.613 . . . . . . . . 2 2 . 1 . 091 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -72.63 -42.75 64.1 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 124.239 1.971 . . . . 0.0 107.195 -165.993 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -82.86 114.93 21.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.299 -2.751 . . . . 0.0 112.403 178.105 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 mtp-105 -73.35 153.5 40.47 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -171.506 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.44 -157.19 15.39 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 170.312 . . . . . . . . 1 1 . 1 . 091 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.349 1 C-N-CA 131.535 4.398 . . . . 0.0 110.707 -176.397 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 092 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -105.89 140.74 38.45 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.206 -2.183 . . . . 0.0 110.025 -160.046 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.8 pt -139.67 160.67 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 128.167 2.587 . . . . 0.0 108.596 178.517 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -108.93 159.45 16.8 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.468 1.907 . . . . 0.0 106.296 175.578 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.92 150.69 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 158.513 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -87.26 149.76 24.35 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.966 2.906 . . . . 0.0 114.568 155.89 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.256 9.0 t -138.24 151.93 48.12 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.959 1.304 . . . . 0.0 108.315 173.171 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.282 4.8 tp -70.44 0.04 7.41 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 127.98 2.512 . . . . 0.0 116.191 -163.679 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.0 p -85.43 -20.07 30.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.418 -2.676 . . . . 0.0 109.738 165.61 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.63 -6.21 26.18 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 129.082 3.229 . . . . 0.0 117.804 176.884 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.82 157.46 27.68 Favored 'General case' 0 C--O 1.235 0.318 1 O-C-N 132.577 5.516 . . . . 0.0 111.812 179.269 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.554 36.1 p -123.35 107.21 11.39 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 129.04 2.936 . . . . 0.0 114.088 -177.351 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 mt -104.99 136.21 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 130.042 3.337 . . . . 0.0 108.127 -171.128 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 t -108.25 121.34 44.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.865 3.266 . . . . 0.0 106.516 -178.621 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -110.95 156.02 21.82 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 129.003 2.921 . . . . 0.0 110.736 -176.15 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -118.61 116.75 27.27 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 130.831 3.653 . . . . 0.0 108.562 174.683 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -136.81 166.55 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 131.198 3.799 . . . . 0.0 110.323 -169.944 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -125.44 159.62 59.39 Favored Pre-proline 0 C--N 1.322 -0.629 0 O-C-N 118.907 -2.371 . . . . 0.0 105.993 161.828 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.42 -46.03 28.15 Favored 'Trans proline' 0 N--CA 1.452 -0.943 1 C-N-CA 125.353 4.036 . . . . 0.0 118.759 175.5 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 p -69.77 1.74 4.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 176.884 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.71 134.62 45.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 116.104 -1.903 . . . . 0.0 114.838 179.533 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.4 p -83.37 148.75 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 123.687 2.949 . . . . 0.0 112.467 -179.406 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -50.01 -37.27 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 126.258 1.823 . . . . 0.0 113.826 178.356 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.18 -39.48 79.02 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 121.201 1.819 . . . . 0.0 114.258 170.221 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -68.78 -36.46 78.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 126.821 2.576 . . . . 0.0 109.777 172.611 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.03 -57.18 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 121.383 1.902 . . . . 0.0 106.723 173.107 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.294 86.7 mttt -38.55 -40.65 0.6 Allowed 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 130.495 3.518 . . . . 0.0 116.809 171.661 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.48 -20.64 33.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.188 -2.278 . . . . 0.0 111.28 -175.006 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -87.58 -14.21 40.77 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.942 1.297 . . . . 0.0 109.777 176.881 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.31 -51.79 22.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 126.418 1.887 . . . . 0.0 107.904 162.407 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -65.4 -25.64 67.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 131.107 3.763 . . . . 0.0 109.567 -175.928 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.4 -46.1 62.74 Favored 'General case' 0 CA--C 1.533 0.307 1 C-N-CA 132.103 4.161 . . . . 0.0 113.514 170.023 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -114.16 -32.17 6.09 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 127.556 3.035 . . . . 0.0 114.798 -174.309 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -91.91 -33.28 14.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -179.291 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.18 11.32 64.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 113.583 -3.898 . . . . 0.0 113.398 171.375 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -92.15 139.31 24.25 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 100.975 -3.713 . . . . 0.0 100.975 -172.046 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.93 160.39 21.09 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 120.67 0.914 . . . . 0.0 112.552 -173.787 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.26 56.7 Cg_endo -57.9 -40.89 74.55 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 N-CA-C 117.895 2.229 . . . . 0.0 117.895 -170.868 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.92 -11.07 60.59 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.141 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -93.68 -17.43 23.24 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 172.265 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -89.39 143.13 27.06 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 123.21 1.481 . . . . 0.0 109.09 -174.644 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.26 96.29 2.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 -171.551 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.76 131.57 46.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 115.779 -2.058 . . . . 0.0 107.463 -169.389 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.48 145.21 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 129.762 3.225 . . . . 0.0 110.689 -174.424 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -128.47 -169.03 2.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.887 3.275 . . . . 0.0 110.291 179.456 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.59 49.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.481 2 C-N-CA 132.558 4.343 . . . . 0.0 121.941 -177.055 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.11 -12.97 19.55 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 127.305 2.383 . . . . 0.0 109.063 -179.403 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.403 85.4 mttt -109.29 126.41 53.33 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.346 2.258 . . . . 0.0 116.171 -176.62 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -85.19 129.53 34.79 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 130.36 3.464 . . . . 0.0 106.512 167.867 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.423 HD11 HD22 ' A' ' 67' ' ' LEU . 69.6 mt -107.19 127.76 53.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 111.799 -3.953 . . . . 0.0 106.165 -162.349 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -104.21 137.0 42.77 Favored 'General case' 0 C--N 1.324 -0.52 1 O-C-N 130.847 5.092 . . . . 0.0 110.54 -173.084 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.344 1.2 m-20 -27.91 -45.9 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.408 2 N-CA-C 123.723 4.712 . . . . 0.0 123.723 173.983 . . . . . . . . 3 2 . 1 . 092 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.84 33.94 4.56 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 117.545 -3.222 . . . . 0.0 111.681 -169.828 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -122.03 162.82 20.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.841 2.857 . . . . 0.0 105.595 165.169 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -85.17 158.24 20.43 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.553 2.341 . . . . 0.0 114.762 178.069 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.4 mt -57.76 -28.36 63.88 Favored 'General case' 0 C--N 1.326 -0.447 1 O-C-N 114.569 -5.082 . . . . 0.0 114.963 165.269 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.412 0.2 OUTLIER -61.16 -39.63 90.82 Favored 'General case' 0 N--CA 1.448 -0.546 1 C-N-CA 132.125 4.17 . . . . 0.0 113.848 163.87 . . . . . . . . 4 3 . 1 . 092 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -69.43 -11.12 60.56 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 118.269 -2.77 . . . . 0.0 111.434 170.796 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -110.41 5.92 21.83 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 114.149 -2.834 . . . . 0.0 114.753 164.105 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.347 3.9 p-10 34.76 58.27 0.71 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.182 2.993 . . . . 0.0 112.732 -171.113 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mm -67.56 131.62 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 131.674 3.99 . . . . 0.0 111.967 174.986 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.388 26.9 mt-30 -102.6 152.46 21.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 127.266 2.226 . . . . 0.0 108.098 -179.678 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -48.97 150.62 1.48 Allowed 'General case' 0 C--N 1.325 -0.492 1 O-C-N 115.444 -4.535 . . . . 0.0 116.247 176.132 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.319 7.6 tt0 70.84 8.56 6.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.768 2.827 . . . . 0.0 116.237 176.495 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 m -63.31 138.69 58.62 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.682 1.593 . . . . 0.0 108.531 178.248 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.268 16.6 m -103.82 138.84 39.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 118.567 -2.583 . . . . 0.0 104.741 165.316 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.423 HD22 HD11 ' A' ' 50' ' ' LEU . 68.6 mt -95.78 148.1 22.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 130.404 3.482 . . . . 0.0 105.506 175.609 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -88.68 125.7 34.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 117.075 -3.516 . . . . 0.0 110.767 168.401 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tt -121.02 133.4 55.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 118.359 -2.713 . . . . 0.0 104.978 -171.609 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -132.34 -173.92 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.918 1.287 . . . . 0.0 112.48 163.583 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.3 tp -85.12 144.24 28.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.912 168.819 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -78.18 115.87 18.22 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.226 -1.546 . . . . 0.0 110.842 166.802 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.4 mt -107.23 88.13 2.66 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 112.572 -2.104 . . . . 0.0 106.448 176.463 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.355 30.2 ttt85 78.81 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 112.239 -3.743 . . . . 0.0 113.885 -173.824 . . . . . . . . 2 2 . 1 . 092 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.0 155.33 20.94 Favored Glycine 0 CA--C 1.522 0.517 0 O-C-N 127.869 3.23 . . . . 0.0 109.525 -166.67 . . . . . . . . 1 1 . 1 . 092 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 1 C-N-CA 130.866 4.079 . . . . 0.0 107.139 175.344 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 ttp . . . . . 0 CA--C 1.537 0.472 1 N-CA-C 99.49 -4.263 . . . . 0.0 99.49 . . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -96.99 137.44 36.07 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 123.786 2.993 . . . . 0.0 107.226 164.794 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -107.49 170.3 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 129.817 3.247 . . . . 0.0 110.74 161.21 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -116.9 156.82 26.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 118.305 -2.747 . . . . 0.0 106.704 152.326 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.81 133.79 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 1 C-N-CA 132.517 4.327 . . . . 0.0 102.722 156.713 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -122.36 122.83 39.95 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -179.848 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 99.9 m -83.77 124.82 31.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 160.284 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.264 0.0 OUTLIER -63.2 -8.69 8.68 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 119.596 3.184 . . . . 0.0 119.596 -162.839 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -84.85 -3.6 58.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.349 2.26 . . . . 0.0 112.331 -179.529 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 32.93 0.78 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 123.396 1.553 . . . . 0.0 115.017 154.249 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -128.36 123.28 33.5 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.09 2.156 . . . . 0.0 109.964 -171.965 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 m -113.21 127.85 56.3 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.493 1.117 . . . . 0.0 108.3 -178.727 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.66 133.46 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 127.311 2.245 . . . . 0.0 106.15 164.161 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -109.66 125.42 52.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.859 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.1 tp -133.94 139.81 46.38 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.273 -0.892 . . . . 0.0 111.725 -178.171 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.7 mp0 -95.93 116.57 29.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 131.46 3.904 . . . . 0.0 102.266 179.508 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -146.66 159.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 114.507 -2.664 . . . . 0.0 105.053 -163.141 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -111.63 145.94 33.67 Favored Pre-proline 0 N--CA 1.452 -0.349 0 O-C-N 128.747 3.78 . . . . 0.0 108.024 171.925 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.88 -29.23 14.69 Favored 'Trans proline' 0 N--CA 1.452 -0.958 1 C-N-CA 129.97 7.113 . . . . 0.0 115.687 -178.59 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t -90.16 6.9 40.67 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 117.849 -3.032 . . . . 0.0 116.109 -179.758 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -78.72 149.5 32.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.332 -1.318 . . . . 0.0 110.78 -175.436 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.9 p -87.45 155.27 20.09 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 124.67 2.176 . . . . 0.0 111.089 -175.875 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.66 -27.43 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 173.379 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -85.54 -38.35 18.62 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -168.733 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -60.75 -38.93 86.83 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 115.707 -2.092 . . . . 0.0 111.379 164.063 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.324 28.2 t -55.99 -58.42 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 123.521 2.873 . . . . 0.0 117.776 167.32 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.313 37.8 ttmt -68.36 -18.01 64.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.338 1.455 . . . . 0.0 114.849 -173.267 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.12 -35.66 21.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 125.182 1.552 . . . . 0.0 111.526 170.219 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -71.56 -24.08 61.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.091 -1.044 . . . . 0.0 113.21 -175.828 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.07 -20.64 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 125.762 1.914 . . . . 0.0 110.392 170.187 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -82.01 -38.99 24.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 116.862 -3.649 . . . . 0.0 107.761 179.564 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.63 -41.5 83.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.687 2.795 . . . . 0.0 111.792 178.605 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -96.69 -22.12 17.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 130.122 3.369 . . . . 0.0 112.945 -169.565 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.492 2.3 mm-40 -136.83 -23.02 1.2 Allowed 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 118.69 -2.506 . . . . 0.0 112.228 -169.235 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.39 1.9 40.96 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 165.558 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.21 125.68 33.66 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 114.915 -2.469 . . . . 0.0 108.192 -170.522 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.07 149.09 76.64 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.906 3.071 . . . . 0.0 114.991 175.972 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.39 -38.27 54.5 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 O-C-N 126.292 2.733 . . . . 0.0 113.545 179.726 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -41.91 -42.25 2.7 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 173.226 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -94.62 -2.29 51.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 131.242 3.817 . . . . 0.0 115.062 -179.488 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -111.18 114.83 28.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.029 -3.544 . . . . 0.0 104.858 -162.627 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 ttm105 -102.24 128.47 48.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 128.607 2.763 . . . . 0.0 109.242 165.765 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 mt -115.51 137.24 52.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 111.65 -2.523 . . . . 0.0 105.8 -177.042 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.6 mt -115.22 129.43 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 128.421 2.688 . . . . 0.0 109.025 -174.521 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -132.47 134.07 44.6 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 115.231 -2.587 . . . . 0.0 111.202 156.632 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.28 0.2 3.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 172.913 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.22 -11.69 19.7 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 129.887 3.613 . . . . 0.0 108.13 -175.367 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -95.8 125.57 40.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 126.001 1.648 . . . . 0.0 110.318 -174.34 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.17 111.24 1.88 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.383 2.273 . . . . 0.0 108.115 167.866 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.254 45.6 mt -87.09 131.3 34.17 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 115.035 -2.666 . . . . 0.0 113.549 -167.715 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -119.39 156.47 30.06 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 129.96 3.304 . . . . 0.0 110.097 -179.035 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.66 142.38 35.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 130.482 3.513 . . . . 0.0 113.146 177.306 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.02 -25.61 7.82 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 126.917 2.636 . . . . 0.0 113.272 -159.231 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -121.77 133.88 54.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.435 1.894 . . . . 0.0 106.22 176.042 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.5 p -81.26 -175.31 5.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 123.86 1.79 . . . . 0.0 113.837 172.305 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.2 -38.31 90.58 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 118.532 -2.605 . . . . 0.0 110.656 176.082 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 m -63.9 -47.21 81.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 171.23 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -47.03 -39.02 11.9 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 117.11 -3.494 . . . . 0.0 117.1 166.539 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -91.12 -3.81 56.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 123.283 2.765 . . . . 0.0 117.861 170.24 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 48.0 m-80 81.92 38.29 0.06 Allowed 'General case' 0 N--CA 1.445 -0.721 1 C-N-CA 133.933 4.893 . . . . 0.0 113.082 170.846 . . . . . . . . 3 2 . 1 . 093 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.5 mt -91.29 142.65 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 -167.481 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -138.66 -169.66 2.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.436 -154.474 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -59.54 124.79 21.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.377 1.071 . . . . 0.0 111.248 173.042 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 70.96 8.98 6.69 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.297 -2.752 . . . . 0.0 115.185 172.496 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -85.29 148.0 26.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 116.953 -3.592 . . . . 0.0 106.402 -171.39 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.4 m -122.94 124.33 42.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 -173.27 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.01 141.32 28.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 130.793 3.637 . . . . 0.0 104.708 178.487 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.28 58.2 m80 -101.65 115.6 30.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 113.693 -3.051 . . . . 0.0 107.498 -177.607 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 70' ' ' VAL . 4.5 tt -90.29 125.16 35.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 171.057 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.471 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -125.78 104.57 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.102 -0.999 . . . . 0.0 112.695 170.17 . . . . . . . . 3 3 . 1 . 093 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.296 56.4 tp -79.32 128.0 32.78 Favored 'General case' 0 N--CA 1.448 -0.547 1 O-C-N 114.282 -5.262 . . . . 0.0 111.49 -170.12 . . . . . . . . 3 2 . 1 . 093 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.284 22.6 ttt180 62.91 -46.33 0.2 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 130.609 3.564 . . . . 0.0 117.001 178.146 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.55 149.82 48.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 128.765 2.826 . . . . 0.0 109.772 -172.583 . . . . . . . . 2 2 . 1 . 093 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -79.47 126.24 30.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.617 -1.302 . . . . 0.0 111.43 -172.684 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.1 176.59 17.73 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 129.464 3.411 . . . . 0.0 105.622 175.284 . . . . . . . . 1 1 . 1 . 093 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.475 0 CA-C-O 114.972 -3.127 . . . . 0.0 111.832 -163.843 . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 123.335 1.54 . . . . 0.0 107.203 . . . . . . . . . 0 0 . 1 . 094 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.257 72.1 mt-30 -104.34 149.5 25.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 111.965 -2.38 . . . . 0.0 109.59 174.527 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 pt -137.33 156.03 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 126.092 2.12 . . . . 0.0 110.056 170.727 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -107.25 132.29 53.25 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.396 172.7 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.42 116.86 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 128.406 2.682 . . . . 0.0 112.95 175.159 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -92.83 138.69 31.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.942 1.829 . . . . 0.0 108.939 -179.055 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -88.61 167.4 13.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 108.623 -3.899 . . . . 0.0 108.955 177.33 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.4 pt? -69.34 -23.46 63.78 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 119.127 -2.233 . . . . 0.0 113.189 160.991 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -90.1 -13.81 35.02 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 115.951 -1.976 . . . . 0.0 113.806 -175.343 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.37 -0.26 8.78 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 121.423 1.919 . . . . 0.0 113.042 163.695 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -92.62 149.64 21.21 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.051 1.425 . . . . 0.0 110.592 177.522 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -106.47 115.85 30.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 130.767 3.627 . . . . 0.0 104.513 165.442 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.0 mt -97.45 140.22 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 1 N-CA-C 97.95 -4.833 . . . . 0.0 97.95 177.858 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.3 m -101.41 98.73 9.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -179.639 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.09 156.12 18.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 117.409 -3.307 . . . . 0.0 109.445 175.001 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -121.16 119.87 33.62 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 130.742 3.617 . . . . 0.0 108.722 172.864 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 m -152.68 154.87 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 129.591 3.156 . . . . 0.0 104.887 175.545 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.351 76.0 mm-40 -100.41 166.73 12.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 111.348 -2.66 . . . . 0.0 112.371 174.279 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.288 2.6 Cg_exo -49.67 -34.02 33.65 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.043 3.162 . . . . 0.0 119.669 -178.848 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -85.91 -5.57 59.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 119.35 -2.094 . . . . 0.0 112.688 -172.814 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.395 65.7 m-20 -85.13 142.72 29.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 125.097 1.498 . . . . 0.0 109.092 -167.348 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.3 p -79.03 161.19 26.76 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 115.599 -2.143 . . . . 0.0 109.894 175.989 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.8 mm -42.22 -34.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 130.468 3.507 . . . . 0.0 111.172 165.499 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -66.75 -21.65 66.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 124.308 3.231 . . . . 0.0 111.908 -174.876 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -72.13 -52.01 18.68 Favored 'General case' 0 N--CA 1.44 -0.938 1 C-N-CA 131.809 4.044 . . . . 0.0 114.768 169.13 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.9 t -53.46 -59.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 126.428 1.891 . . . . 0.0 111.563 174.37 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -56.03 -33.71 65.19 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 127.455 2.972 . . . . 0.0 107.98 -179.855 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.76 -39.19 57.52 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 124.08 3.127 . . . . 0.0 118.665 -175.904 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -63.7 -40.3 96.45 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.644 1.978 . . . . 0.0 114.795 162.338 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.1 mt -59.21 -42.99 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 116.626 -1.654 . . . . 0.0 109.246 174.917 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.7 tm0? -59.07 -44.96 91.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 128.984 3.927 . . . . 0.0 113.976 171.977 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.41 -19.21 60.5 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 121.323 1.874 . . . . 0.0 112.594 -175.514 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -98.91 -53.08 3.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.084 1.754 . . . . 0.0 111.135 -166.885 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.254 36.5 tp10 -112.91 -3.48 14.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.846 -173.773 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.76 28.62 20.9 Favored Glycine 0 CA--C 1.527 0.829 1 CA-C-O 128.371 4.317 . . . . 0.0 115.093 163.836 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -105.22 118.0 56.99 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 109.983 -3.108 . . . . 0.0 111.675 -165.437 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -72.73 133.01 19.51 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 CA-C-O 111.724 -3.532 . . . . 0.0 112.692 -175.725 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -74.76 -19.62 18.3 Favored 'Trans proline' 0 N--CA 1.448 -1.169 1 O-C-N 130.087 4.73 . . . . 0.0 112.202 -163.167 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -82.46 -14.6 54.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 121.852 2.115 . . . . 0.0 108.306 177.139 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.45 -15.33 35.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.356 2.262 . . . . 0.0 109.485 178.385 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -88.18 154.94 20.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 120.64 1.564 . . . . 0.0 110.994 -177.837 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.445 ' C ' HD12 ' A' ' 43' ' ' LEU . 12.3 ttm180 -148.22 122.95 9.9 Favored 'General case' 0 C--N 1.324 -0.521 1 C-N-CA 132.985 4.514 . . . . 0.0 104.149 -175.028 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.445 HD12 ' C ' ' A' ' 42' ' ' ARG . 3.7 mp -122.13 131.59 54.04 Favored 'General case' 0 N--CA 1.446 -0.664 1 C-N-CA 132.281 4.232 . . . . 0.0 114.109 -165.231 . . . . . . . . 3 3 . 1 . 094 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.421 1.8 tt -134.63 144.66 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 126.315 2.26 . . . . 0.0 111.851 -172.309 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -156.34 142.45 18.15 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 126.552 3.072 . . . . 0.0 104.007 165.018 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 29.37 2.88 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 109.33 -3.577 . . . . 0.0 118.08 175.394 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.41 -17.67 36.61 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 127.149 2.78 . . . . 0.0 113.68 175.572 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -103.27 120.04 40.01 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 130.921 3.689 . . . . 0.0 110.979 -168.871 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -72.74 135.4 45.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.243 1.417 . . . . 0.0 107.23 164.873 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.1 mt -92.61 121.09 33.69 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.877 -163.266 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -81.5 124.8 29.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 125.729 1.893 . . . . 0.0 108.187 -169.497 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.76 108.22 2.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.271 3.028 . . . . 0.0 111.144 173.448 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.75 4.65 12.85 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 126.205 2.19 . . . . 0.0 115.615 177.2 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -105.89 144.84 32.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 116.47 -3.959 . . . . 0.0 109.92 168.418 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.6 p -84.79 145.07 28.07 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 127.123 2.764 . . . . 0.0 112.155 176.059 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 tp -41.71 -48.7 4.22 Favored 'General case' 0 N--CA 1.448 -0.538 1 C-N-CA 131.905 4.082 . . . . 0.0 109.149 179.537 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -54.25 -31.85 54.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 130.852 3.661 . . . . 0.0 113.171 176.349 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -67.53 -32.33 73.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.81 0.844 . . . . 0.0 112.955 177.139 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -88.46 -7.23 56.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 115.572 -2.156 . . . . 0.0 109.534 175.385 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 51.17 40.14 25.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 125.914 3.961 . . . . 0.0 112.971 -178.121 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.97 134.48 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.538 -2.119 . . . . 0.0 105.426 166.937 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -119.57 169.62 9.91 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 -173.834 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -49.13 126.37 12.52 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 131.687 3.995 . . . . 0.0 113.493 178.93 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 71.02 5.54 5.52 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 114.649 -2.596 . . . . 0.0 116.608 -178.887 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.5 m -59.3 128.96 39.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 164.78 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -83.22 123.77 29.9 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.337 1.055 . . . . 0.0 110.335 -177.949 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -124.23 156.59 36.56 Favored 'General case' 0 N--CA 1.452 -0.374 1 C-N-CA 134.213 5.005 . . . . 0.0 108.191 -177.549 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -124.49 148.15 47.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 120.835 -1.166 . . . . 0.0 111.934 -168.867 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tp -117.76 127.73 54.19 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.225 2.21 . . . . 0.0 108.855 -174.208 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.594 35.3 m -119.92 165.07 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 129.385 3.074 . . . . 0.0 112.493 169.847 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 71' ' ' LEU . 27.0 mt -99.74 141.12 32.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 119.794 -1.816 . . . . 0.0 106.723 175.908 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.5 ttt-85 -152.76 119.04 5.54 Favored 'General case' 0 N--CA 1.443 -0.783 1 N-CA-C 99.683 -4.191 . . . . 0.0 99.683 165.128 . . . . . . . . 2 2 . 1 . 094 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 mp -92.38 54.94 2.41 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.286 -1.779 . . . . 0.0 106.273 -172.088 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -169.12 130.85 1.18 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 119.772 -1.83 . . . . 0.0 106.519 -163.953 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.36 84.72 0.37 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.404 1.954 . . . . 0.0 112.918 171.669 . . . . . . . . 1 1 . 1 . 094 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 175.243 . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttp . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 . . . . . . . . . 0 0 . 1 . 095 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -78.59 148.39 33.32 Favored 'General case' 0 C--N 1.324 -0.537 1 O-C-N 115.481 -4.512 . . . . 0.0 110.262 169.598 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 3' ' ' ILE . 37.5 pt -136.88 163.71 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 101.93 -3.359 . . . . 0.0 101.93 164.988 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -121.51 151.2 40.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 124.338 2.018 . . . . 0.0 110.165 -178.34 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 t -127.1 130.02 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 O-C-N 119.156 -2.215 . . . . 0.0 110.58 171.741 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -85.74 167.74 14.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.008 1.723 . . . . 0.0 111.978 157.875 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -126.06 177.2 6.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.728 1.268 . . . . 0.0 111.388 -176.58 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.83 -34.42 78.1 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 115.608 1.706 . . . . 0.0 115.608 174.468 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -63.25 -50.69 69.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.662 2.385 . . . . 0.0 112.45 165.84 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.54 13.54 8.04 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 116.686 -2.174 . . . . 0.0 111.113 168.238 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -69.31 135.4 50.36 Favored 'General case' 0 N--CA 1.451 -0.398 1 C-N-CA 135.718 5.607 . . . . 0.0 102.815 174.254 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 47.6 m -89.28 140.79 29.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 113.928 -1.487 . . . . 0.0 107.785 -174.741 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -116.59 148.92 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 130.16 3.384 . . . . 0.0 106.854 164.111 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 t -134.6 139.59 45.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 128.128 3.393 . . . . 0.0 108.973 170.798 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mt -141.72 160.94 39.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 125.255 2.455 . . . . 0.0 105.759 -171.711 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -109.9 127.04 54.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 125.884 2.754 . . . . 0.0 110.065 162.358 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.6 -178.65 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 131.548 3.939 . . . . 0.0 109.925 -177.107 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 19' ' ' PRO 0.275 6.1 mt-10 -130.89 148.82 71.72 Favored Pre-proline 0 N--CA 1.444 -0.731 0 O-C-N 116.359 -3.963 . . . . 0.0 112.068 168.824 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 72.2 Cg_exo -48.51 -43.98 31.54 Favored 'Trans proline' 0 N--CA 1.453 -0.863 1 C-N-CA 125.488 4.125 . . . . 0.0 118.58 -169.968 . . . . . . . . 3 3 . 1 . 095 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 t -86.29 8.48 21.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.655 -2.066 . . . . 0.0 116.449 -179.587 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.93 154.19 31.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.305 2.253 . . . . 0.0 116.505 173.827 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.305 81.1 p -92.64 149.55 21.26 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 125.128 1.518 . . . . 0.0 108.144 178.346 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.9 mm -45.55 -44.06 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 126.632 1.973 . . . . 0.0 115.874 176.787 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -51.19 -53.97 29.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 128.77 2.828 . . . . 0.0 112.897 173.383 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -63.59 -30.39 71.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.94 1.352 . . . . 0.0 111.846 -172.142 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.47 -40.01 76.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 127.236 2.214 . . . . 0.0 109.778 169.949 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -68.98 -28.0 66.22 Favored 'General case' 0 C--N 1.328 -0.34 1 O-C-N 115.054 -4.779 . . . . 0.0 111.324 -173.797 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -31.86 66.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.576 -1.647 . . . . 0.0 112.536 172.833 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -75.08 -41.02 59.66 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -178.556 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.74 -28.97 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 119.789 1.177 . . . . 0.0 113.026 175.565 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -62.45 -44.62 95.98 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 127.84 2.456 . . . . 0.0 113.111 171.736 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -72.63 -16.55 61.71 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.091 -2.255 . . . . 0.0 113.112 -175.586 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -107.75 -53.47 2.62 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 -172.674 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -112.93 -9.32 13.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 114.471 -2.681 . . . . 0.0 112.232 -173.602 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.21 39.28 72.07 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 115.014 -3.103 . . . . 0.0 113.007 -177.181 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.2 mt -96.16 116.31 66.11 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 178.235 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.67 145.9 65.15 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 N-CA-C 118.422 2.432 . . . . 0.0 118.422 -179.032 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.297 39.7 Cg_endo -70.89 -21.41 28.27 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 125.198 3.932 . . . . 0.0 118.696 -160.045 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.49 -30.95 16.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 123.844 3.02 . . . . 0.0 110.527 -179.036 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -71.14 -37.01 72.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 177.978 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -63.74 125.02 22.96 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 112.67 -3.538 . . . . 0.0 116.487 179.262 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.281 32.4 ttm105 -128.33 121.46 29.25 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 122.872 2.578 . . . . 0.0 108.906 176.235 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.5 132.72 41.78 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 128.049 2.54 . . . . 0.0 107.625 -179.156 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.1 mt -119.87 161.14 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.742 2.017 . . . . 0.0 110.408 167.648 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -158.83 128.6 5.72 Favored 'General case' 0 N--CA 1.449 -0.494 1 N-CA-C 98.241 -4.726 . . . . 0.0 98.241 173.157 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.92 23.34 13.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.455 2.302 . . . . 0.0 113.542 162.369 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.1 0.01 54.64 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 178.03 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -120.78 129.65 53.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -167.643 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -70.77 151.82 44.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 166.221 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.93 113.95 27.37 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 101.601 -3.481 . . . . 0.0 101.601 -179.772 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -101.12 139.42 36.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 125.086 1.491 . . . . 0.0 108.428 -173.564 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -28.8 129.2 0.08 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 129.325 3.05 . . . . 0.0 116.982 167.911 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.49 -11.35 71.63 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 159.687 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -103.68 156.12 18.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.504 1.922 . . . . 0.0 106.435 -178.164 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.7 p -111.81 149.83 31.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.964 2.506 . . . . 0.0 115.778 -164.577 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.4 mt -60.81 -46.35 90.85 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 112.72 -2.037 . . . . 0.0 114.871 -164.974 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -75.8 -33.31 60.12 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.462 -171.165 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.54 -31.85 71.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 112.881 -3.438 . . . . 0.0 118.817 166.32 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -73.54 -21.92 60.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 127.916 3.26 . . . . 0.0 112.486 164.789 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t30 89.58 45.04 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.446 2 C-N-CA 134.076 4.951 . . . . 0.0 107.895 175.558 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mm -79.36 145.87 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 118.027 -2.921 . . . . 0.0 104.564 172.63 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -132.76 -178.48 4.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 121.946 2.157 . . . . 0.0 106.742 178.347 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -72.87 112.8 9.23 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 130.793 3.637 . . . . 0.0 109.036 -171.784 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 75.85 31.82 0.69 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 130.236 3.414 . . . . 0.0 111.95 -172.937 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -70.5 140.75 51.94 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 115.97 -1.967 . . . . 0.0 112.008 166.581 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.8 m -102.37 129.89 48.97 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -179.218 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.71 154.2 31.01 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.893 3.277 . . . . 0.0 108.46 -177.993 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.268 20.8 t-160 -109.04 118.28 36.38 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.013 0.925 . . . . 0.0 109.877 -171.256 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tt -93.83 127.75 39.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.224 1.81 . . . . 0.0 109.248 173.498 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.34 138.59 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 1 O-C-N 129.103 4.002 . . . . 0.0 104.039 162.399 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 tt -101.75 122.61 44.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 118.639 -2.538 . . . . 0.0 109.669 167.339 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.548 54.7 ttt180 77.02 -35.44 0.23 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 124.985 2.326 . . . . 0.0 115.58 171.861 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.25 88.1 mt -57.71 150.83 18.74 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 117.578 -3.201 . . . . 0.0 114.67 -179.204 . . . . . . . . 2 2 . 1 . 095 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -72.15 140.68 48.94 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 129.319 3.048 . . . . 0.0 107.843 -175.535 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.43 1.27 6.51 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 111.423 -2.626 . . . . 0.0 114.056 179.912 . . . . . . . . 1 1 . 1 . 095 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.373 0 N-CA-C 104.976 -3.249 . . . . 0.0 104.976 -154.354 . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 C--O 1.236 0.381 0 N-CA-C 110.88 -0.044 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 096 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.49 133.91 51.29 Favored 'General case' 0 N--CA 1.448 -0.54 1 C-N-CA 131.997 4.119 . . . . 0.0 108.242 -179.029 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.286 0.9 OUTLIER -129.93 169.9 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 117.217 -1.373 . . . . 0.0 112.114 163.701 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -110.03 152.16 26.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 125.139 3.609 . . . . 0.0 105.632 172.149 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.292 2.6 t -135.34 113.88 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 128.883 2.873 . . . . 0.0 107.148 172.1 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -97.31 126.04 42.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 129.931 3.292 . . . . 0.0 106.137 -177.789 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.0 p -86.41 178.03 7.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.247 1.819 . . . . 0.0 114.117 160.54 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -79.03 -33.8 44.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 117.144 -1.408 . . . . 0.0 110.696 -169.904 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -93.18 0.99 57.31 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -178.873 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.42 -8.31 5.92 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 126.53 2.014 . . . . 0.0 111.188 151.97 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -71.04 110.55 5.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -171.717 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -87.35 113.34 22.98 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 101.728 -3.434 . . . . 0.0 101.728 172.927 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.0 mt -86.34 126.69 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 N-CA-C 99.625 -4.213 . . . . 0.0 99.625 166.905 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.5 m -99.82 109.06 21.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 129.339 3.056 . . . . 0.0 105.16 173.891 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 tp -105.39 135.23 47.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -161.688 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 17' ' ' VAL 0.285 31.1 tt0 -86.12 134.71 33.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 110.823 -2.899 . . . . 0.0 113.142 160.351 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -148.2 164.44 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 123.807 1.765 . . . . 0.0 107.672 174.278 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -95.69 160.01 31.24 Favored Pre-proline 0 N--CA 1.444 -0.729 2 C-N-CA 133.018 4.527 . . . . 0.0 109.884 145.825 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.89 -25.16 74.29 Favored 'Trans proline' 0 N--CA 1.45 -1.03 1 C-N-CA 125.715 4.277 . . . . 0.0 113.487 -173.657 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -83.03 -11.03 58.43 Favored 'General case' 0 N--CA 1.444 -0.747 1 C-N-CA 137.275 6.23 . . . . 0.0 110.214 -175.175 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.03 114.7 8.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.734 2.014 . . . . 0.0 107.438 160.18 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.253 71.3 p -89.57 -162.54 0.89 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 115.793 -2.051 . . . . 0.0 114.857 -170.725 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.4 mm -60.9 -33.9 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 122.722 2.51 . . . . 0.0 113.811 172.262 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -78.56 -45.68 21.24 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 129.47 3.108 . . . . 0.0 114.801 174.466 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -67.6 -25.24 65.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 113.759 -3.176 . . . . 0.0 112.577 -179.517 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.5 t -57.5 -58.05 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.712 2.405 . . . . 0.0 116.841 157.06 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -58.51 -26.13 63.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 174.82 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.33 -37.81 43.69 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 127.078 3.323 . . . . 0.0 117.409 170.979 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -60.11 -39.18 85.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 117.092 -3.505 . . . . 0.0 113.635 164.249 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.0 mt -53.42 -47.91 58.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 129.166 2.986 . . . . 0.0 111.569 172.678 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -60.94 -50.57 72.86 Favored 'General case' 0 N--CA 1.45 -0.446 1 C-N-CA 132.121 4.169 . . . . 0.0 109.819 177.39 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.0 -48.05 61.47 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 171.364 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -84.82 -52.83 5.75 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 115.788 -2.053 . . . . 0.0 112.868 -171.988 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -123.4 -2.85 8.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 122.041 2.2 . . . . 0.0 110.237 -155.502 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.17 7.89 67.26 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.901 1.715 . . . . 0.0 112.328 163.104 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -73.27 124.18 90.28 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 129.347 3.059 . . . . 0.0 106.675 -170.589 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.76 110.51 1.63 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 125.002 3.802 . . . . 0.0 113.16 173.425 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.36 -15.06 12.8 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 N-CA-C 118.754 2.559 . . . . 0.0 118.754 -167.898 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.365 0.0 OUTLIER -25.54 -35.26 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 130.697 3.599 . . . . 0.0 120.252 174.778 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -126.79 25.41 6.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.502 1.921 . . . . 0.0 111.21 -165.837 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -131.24 126.88 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.272 1.829 . . . . 0.0 111.096 -168.634 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -123.68 157.56 33.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 109.586 -3.461 . . . . 0.0 109.701 176.455 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.11 138.59 53.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 114.133 -2.841 . . . . 0.0 108.659 -166.253 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mm -110.04 148.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 127.952 3.283 . . . . 0.0 115.568 165.272 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -149.24 125.64 10.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 114.687 -2.578 . . . . 0.0 105.519 166.565 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.57 15.24 10.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 130.471 3.508 . . . . 0.0 113.539 172.637 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.47 -34.93 5.38 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 128.654 3.026 . . . . 0.0 108.737 -169.425 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -78.11 136.02 37.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 122.133 2.967 . . . . 0.0 108.339 -156.946 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -80.27 106.13 12.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 113.611 -3.09 . . . . 0.0 113.31 164.572 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.3 136.96 57.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 128.098 3.374 . . . . 0.0 115.155 -178.014 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -91.98 116.07 28.6 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.166 2.186 . . . . 0.0 105.106 -165.43 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.49 116.27 3.86 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 115.298 -2.287 . . . . 0.0 112.607 -177.271 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.28 3.96 7.85 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 129.908 3.623 . . . . 0.0 112.896 -178.331 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -109.36 159.13 17.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 122.008 2.904 . . . . 0.0 108.93 -170.932 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.6 p -90.6 173.13 8.22 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 129.859 3.264 . . . . 0.0 110.551 176.981 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.78 -18.09 59.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.197 -0.939 . . . . 0.0 110.591 173.647 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.0 m -70.05 -20.52 63.23 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.43 -1.419 . . . . 0.0 112.841 177.367 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -86.12 -6.29 59.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.485 2.714 . . . . 0.0 112.154 -177.073 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -130.44 -7.21 4.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 114.495 -2.669 . . . . 0.0 113.196 178.954 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 57.05 51.07 10.97 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 127.084 2.74 . . . . 0.0 112.733 178.807 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.46 125.86 62.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 -178.417 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -114.09 -166.66 1.12 Allowed 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 112.284 -2.235 . . . . 0.0 108.502 177.88 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -65.25 149.74 49.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 129.116 2.966 . . . . 0.0 112.219 -170.004 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.542 12.6 pt-20 73.45 16.89 3.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.541 170.056 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 m -84.26 155.65 22.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.221 1.808 . . . . 0.0 111.173 -177.015 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.9 m -116.78 137.47 52.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.798 -2.439 . . . . 0.0 111.884 174.576 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -105.0 149.53 25.69 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 156.224 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -102.97 133.58 47.84 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 169.338 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 70' ' ' VAL 0.351 1.8 tm? -96.97 144.88 26.45 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 115.142 -2.361 . . . . 0.0 111.458 -178.23 . . . . . . . . 3 3 . 1 . 096 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.429 ' N ' HD13 ' A' ' 69' ' ' LEU . 48.6 t -127.83 133.14 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 128.696 2.798 . . . . 0.0 107.567 179.074 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mp -88.47 137.95 31.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 130.289 3.435 . . . . 0.0 107.745 173.207 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -73.14 -24.74 60.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 176.455 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.11 135.14 54.2 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.406 -168.89 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.359 57.3 ttt-85 -116.09 -35.16 4.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 115.629 -2.129 . . . . 0.0 115.575 167.687 . . . . . . . . 2 2 . 1 . 096 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.44 -176.56 16.16 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 120.035 2.774 . . . . 0.0 120.035 167.678 . . . . . . . . 1 1 . 1 . 096 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.431 0 N-CA-C 103.464 -3.855 . . . . 0.0 103.464 -177.039 . . . . . . . . 0 0 . 1 . 097 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.252 9.2 tpp . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 124.011 1.862 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.348 4.9 tt0 -85.54 156.85 20.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 118.203 -2.811 . . . . 0.0 115.284 177.089 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 3' ' ' ILE 0.332 17.1 pt -133.06 134.9 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 117.067 -3.521 . . . . 0.0 106.799 162.349 . . . . . . . . 3 3 . 1 . 097 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -94.13 144.55 25.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.583 166.116 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG11 HD12 ' A' ' 30' ' ' ILE . 3.8 t -128.3 133.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 127.403 2.281 . . . . 0.0 106.368 -179.975 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -133.11 145.87 51.11 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 -176.076 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -129.23 -90.75 0.48 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 116.353 -1.784 . . . . 0.0 110.704 159.847 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -142.54 -42.44 0.32 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 128.239 2.616 . . . . 0.0 114.282 169.088 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.57 114.02 21.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.116 1.366 . . . . 0.0 108.232 174.721 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.12 142.37 10.52 Favored Glycine 0 CA--C 1.536 1.392 0 N-CA-C 106.69 -2.564 . . . . 0.0 106.69 -169.426 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -54.51 -67.37 0.27 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.967 2.107 . . . . 0.0 110.267 156.402 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 p -155.57 174.53 15.14 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.916 2.486 . . . . 0.0 106.575 178.674 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.09 144.4 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 C-N-CA 127.226 2.21 . . . . 0.0 105.297 164.418 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.8 p -104.53 129.11 52.6 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.337 1.455 . . . . 0.0 112.352 -175.32 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 mt -123.42 145.98 48.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 117.349 -3.344 . . . . 0.0 108.024 176.681 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.03 121.17 37.49 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 126.132 2.145 . . . . 0.0 110.073 162.602 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -122.5 -161.6 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 O-C-N 120.223 -1.548 . . . . 0.0 112.936 -178.693 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.278 4.3 tm-20 -142.52 147.78 44.29 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 164.244 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -65.47 -21.56 60.18 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 CA-C-O 115.124 -2.115 . . . . 0.0 115.328 -178.642 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.75 14.81 6.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 120.798 1.635 . . . . 0.0 114.449 173.548 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -75.09 121.68 22.41 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 127.496 2.318 . . . . 0.0 107.124 167.233 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.8 p -66.6 155.28 38.25 Favored 'General case' 0 N--CA 1.449 -0.491 1 O-C-N 129.17 4.044 . . . . 0.0 109.028 160.782 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 80.5 mt -68.04 -27.94 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 124.249 1.976 . . . . 0.0 111.917 178.736 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -47.15 -41.39 17.59 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 112.741 -2.027 . . . . 0.0 111.689 170.517 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -75.15 -38.48 60.96 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.236 1.414 . . . . 0.0 112.351 178.56 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.71 -31.28 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 126.448 2.343 . . . . 0.0 112.712 179.03 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -51.94 -37.4 52.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 173.053 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.312 . . -79.2 -32.01 43.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 125.739 2.685 . . . . 0.0 111.163 -176.144 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -56.04 -53.09 61.14 Favored 'General case' 0 N--CA 1.452 -0.372 1 O-C-N 115.686 -4.384 . . . . 0.0 112.371 164.2 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.637 ' CG2' HD12 ' A' ' 36' ' ' ILE . 46.2 mm -59.27 -39.54 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 119.576 -1.952 . . . . 0.0 109.82 -178.301 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -51.95 -49.34 63.37 Favored 'General case' 0 N--CA 1.452 -0.34 1 N-CA-C 122.622 4.304 . . . . 0.0 122.622 161.899 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.09 -34.91 74.11 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 170.685 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.31 -23.98 14.99 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.881 1.672 . . . . 0.0 114.437 -174.869 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -143.09 -12.43 0.73 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 124.812 2.244 . . . . 0.0 115.252 -165.954 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.81 -17.4 32.82 Favored Glycine 0 CA--C 1.536 1.373 1 O-C-N 115.282 -4.636 . . . . 0.0 114.137 159.715 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.637 HD12 ' CG2' ' A' ' 30' ' ' ILE . 2.4 mt -74.32 126.31 89.09 Favored Pre-proline 0 N--CA 1.45 -0.447 0 O-C-N 120.023 -1.869 . . . . 0.0 112.714 -170.52 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -64.88 141.06 69.57 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 CA-C-O 114.846 -2.231 . . . . 0.0 117.864 173.031 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -43.87 -41.4 11.94 Favored 'Trans proline' 0 N--CA 1.449 -1.111 1 C-N-CA 125.301 4.001 . . . . 0.0 116.98 178.934 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.98 -26.1 59.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.191 2.996 . . . . 0.0 111.471 179.341 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -97.25 -15.29 20.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 127.058 2.143 . . . . 0.0 115.024 -173.761 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -90.58 132.57 35.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -169.728 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -114.24 111.9 22.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 129.23 3.012 . . . . 0.0 109.511 169.111 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -97.36 109.64 22.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.139 -1.601 . . . . 0.0 108.345 -176.855 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mt -119.08 136.66 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 1 N-CA-C 98.267 -4.716 . . . . 0.0 98.267 -174.991 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -168.66 143.16 3.24 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.997 2.519 . . . . 0.0 107.366 173.341 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.303 . . 65.51 27.21 11.69 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.261 2.224 . . . . 0.0 113.208 173.77 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.3 -8.74 59.01 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 129.016 3.198 . . . . 0.0 108.3 163.817 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -129.24 147.01 51.04 Favored 'General case' 0 C--O 1.241 0.641 0 O-C-N 116.928 -3.689 . . . . 0.0 113.194 176.82 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -60.89 104.94 0.41 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.87 3.268 . . . . 0.0 111.79 165.306 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -60.16 144.42 49.95 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -173.082 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -77.36 134.52 38.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 125.188 1.555 . . . . 0.0 110.55 161.988 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.04 -31.76 68.3 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 131.204 3.802 . . . . 0.0 117.587 -166.101 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.83 9.56 56.85 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 126.943 2.652 . . . . 0.0 110.026 -175.286 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 159.29 16.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 123.813 1.768 . . . . 0.0 110.696 162.398 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 37.3 p -102.2 163.96 11.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 111.678 -2.51 . . . . 0.0 109.923 -171.5 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.08 -59.12 4.73 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.213 2.205 . . . . 0.0 108.539 172.642 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 82.3 p -44.2 -46.12 8.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.236 2.614 . . . . 0.0 115.655 171.923 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 55' ' ' THR . 44.6 m-20 -51.38 -34.09 32.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.486 1.514 . . . . 0.0 114.812 173.244 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -104.27 0.01 28.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.559 -1.338 . . . . 0.0 112.555 -175.151 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m120 81.75 23.47 0.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.849 2.059 . . . . 0.0 111.689 -176.056 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.0 mt -84.59 102.89 11.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -174.169 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -70.8 162.3 29.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 172.958 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -42.17 138.31 1.68 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.895 2.078 . . . . 0.0 114.005 155.8 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.257 7.6 mm-40 77.07 17.91 1.55 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 129.028 2.931 . . . . 0.0 111.84 170.302 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -96.44 155.81 16.61 Favored 'General case' 0 CA--C 1.537 0.454 1 CA-C-O 130.108 4.766 . . . . 0.0 109.333 -177.053 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.4 m -96.92 140.84 30.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 110.001 -3.272 . . . . 0.0 106.51 176.704 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.54 162.7 13.89 Favored 'General case' 0 CA--C 1.537 0.465 1 N-CA-C 98.586 -4.598 . . . . 0.0 98.586 157.602 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -120.01 141.79 49.39 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 167.401 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 70' ' ' VAL . 7.5 tp -116.89 148.79 41.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 130.584 3.553 . . . . 0.0 112.808 -172.509 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.523 ' H ' HD12 ' A' ' 69' ' ' LEU . 58.0 t -133.92 130.36 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 130.304 3.441 . . . . 0.0 109.931 -176.294 . . . . . . . . 2 2 . 1 . 097 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.75 144.13 41.63 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 120.06 -1.65 . . . . 0.0 107.362 164.99 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -88.08 -34.13 18.05 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.477 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.2 mt -141.5 168.22 20.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 126.668 2.48 . . . . 0.0 109.938 168.148 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -91.54 -15.06 29.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 115.516 -2.183 . . . . 0.0 113.51 -178.296 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.05 -177.03 28.42 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 128.389 2.9 . . . . 0.0 107.119 177.929 . . . . . . . . 1 1 . 1 . 097 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.361 0 CA-C-O 114.887 -3.174 . . . . 0.0 110.877 -160.086 . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttp . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 098 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -82.78 122.76 28.62 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.387 1.875 . . . . 0.0 113.723 172.452 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -112.52 163.39 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 1 C-N-CA 132.779 4.431 . . . . 0.0 103.914 167.632 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -117.06 153.85 32.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.507 1.523 . . . . 0.0 108.497 168.151 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.97 136.24 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.216 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.365 14.9 ttmt -133.49 151.35 51.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.51 1.924 . . . . 0.0 113.596 172.632 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -110.42 151.01 28.0 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.867 1.317 . . . . 0.0 108.053 178.9 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.311 27.7 mt -61.25 -31.02 70.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.75 -2.469 . . . . 0.0 113.11 179.727 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.1 p -70.49 -3.35 17.41 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 131.466 3.906 . . . . 0.0 114.41 172.107 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.28 29.1 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 124.978 1.424 . . . . 0.0 113.024 153.211 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -62.83 127.25 30.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 118.893 -2.534 . . . . 0.0 111.603 176.966 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 m -116.85 144.41 44.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.511 2.724 . . . . 0.0 107.659 177.522 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.8 tt -146.05 132.8 14.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -175.735 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -70.04 150.27 46.8 Favored 'General case' 0 C--N 1.327 -0.388 1 O-C-N 115.693 -4.38 . . . . 0.0 108.156 166.192 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -133.11 155.62 48.92 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 172.211 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -112.38 129.78 56.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 119.64 -1.913 . . . . 0.0 107.751 172.194 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -146.77 154.81 11.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 130.11 3.364 . . . . 0.0 109.471 -174.346 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -102.11 143.52 26.77 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 171.245 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.53 -16.1 49.85 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.837 3.024 . . . . 0.0 116.214 -173.069 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.5 p -85.6 -7.31 58.92 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 121.586 1.994 . . . . 0.0 116.35 165.126 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -58.61 142.99 47.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 117.575 -3.203 . . . . 0.0 110.345 173.361 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 26' ' ' VAL . 44.7 p -80.11 157.05 26.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.869 2.067 . . . . 0.0 112.193 174.684 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.2 -29.57 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.355 1.462 . . . . 0.0 107.768 -178.143 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -64.72 -48.82 73.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.55 1.14 . . . . 0.0 108.346 172.734 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.35 -37.09 64.53 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 120.273 -1.517 . . . . 0.0 113.798 166.316 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 22' ' ' THR 0.257 3.5 t -64.34 -30.58 50.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 118.904 -2.372 . . . . 0.0 114.808 172.224 . . . . . . . . 3 3 . 1 . 098 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -76.82 -28.34 55.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 168.934 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.34 -36.0 63.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 122.424 1.107 . . . . 0.0 110.398 -179.248 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -68.01 -25.31 65.34 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.183 -1.573 . . . . 0.0 113.108 171.604 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -80.7 -38.04 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 171.562 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -30.51 4.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 116.389 -3.945 . . . . 0.0 111.396 176.922 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -73.8 -29.45 62.17 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.702 1.601 . . . . 0.0 111.969 179.338 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -103.02 -50.99 3.36 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 117.17 -3.457 . . . . 0.0 110.324 -169.12 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -122.25 -2.93 9.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.435 1.894 . . . . 0.0 113.054 -168.345 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.4 -32.16 6.75 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 114.235 -3.536 . . . . 0.0 115.251 155.493 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.5 mt -55.3 128.75 67.5 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 128.729 2.811 . . . . 0.0 110.708 -170.722 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.86 139.99 64.85 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 128.253 5.969 . . . . 0.0 109.213 179.84 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -38.23 -40.99 1.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 1 C-N-CA 130.329 7.353 . . . . 0.0 115.821 176.648 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -61.6 -30.4 70.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 117.773 -3.08 . . . . 0.0 115.348 176.706 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -83.02 -26.65 31.01 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.377 1.444 . . . . 0.0 110.677 -176.738 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.274 77.5 mt-30 -91.37 137.26 32.51 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.966 1.416 . . . . 0.0 109.848 -178.526 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.262 3.8 mtt85 -107.42 146.26 31.91 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 111.208 -2.723 . . . . 0.0 110.773 155.439 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.97 120.5 42.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.868 1.213 . . . . 0.0 108.156 167.174 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.44 146.99 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 125.22 1.575 . . . . 0.0 108.599 -179.041 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -139.86 127.46 21.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.701 2.8 . . . . 0.0 104.078 166.112 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.252 . . 61.73 33.44 17.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 119.804 -1.81 . . . . 0.0 111.948 170.765 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.85 -19.58 11.49 Favored Glycine 0 CA--C 1.538 1.517 0 O-C-N 118.495 -2.628 . . . . 0.0 111.776 -179.662 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -76.98 113.64 14.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 123.571 3.685 . . . . 0.0 107.032 -177.771 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -74.41 110.73 8.94 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 104.06 -2.57 . . . . 0.0 104.06 162.276 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.6 mt -59.36 129.25 41.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.839 1.656 . . . . 0.0 108.608 168.485 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -92.32 138.95 31.09 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.891 0.876 . . . . 0.0 110.464 -179.998 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -64.73 138.14 58.21 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 125.873 1.983 . . . . 0.0 110.466 -175.306 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.79 -30.81 6.65 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 127.929 2.681 . . . . 0.0 115.989 -175.784 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -91.69 147.93 22.63 Favored 'General case' 0 CA--C 1.535 0.394 1 C-N-CA 132.889 4.475 . . . . 0.0 110.731 -178.209 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 p -102.03 170.49 8.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 125.145 1.528 . . . . 0.0 112.513 -171.438 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -51.88 -42.91 63.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 128.618 3.699 . . . . 0.0 109.196 170.033 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -79.65 -28.16 40.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 120.02 -1.675 . . . . 0.0 114.645 -171.23 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -78.33 -40.06 37.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.045 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -83.07 0.19 46.12 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 117.852 -3.03 . . . . 0.0 109.951 -179.046 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.421 5.2 p-10 46.08 64.52 1.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.391 2.276 . . . . 0.0 113.161 -179.326 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 mm -83.89 -43.99 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 118.563 -1.255 . . . . 0.0 109.875 -166.176 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.415 52.9 mm-40 97.04 153.81 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.689 2.395 . . . . 0.0 111.774 166.747 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.39 131.51 45.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 119.044 -2.285 . . . . 0.0 108.008 177.07 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.282 3.4 mp0 81.41 10.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 127.194 2.809 . . . . 0.0 110.063 166.684 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.8 t -75.2 139.1 42.4 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 130.817 3.647 . . . . 0.0 107.82 172.992 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -100.15 126.72 46.45 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 103.031 -2.952 . . . . 0.0 103.031 -177.302 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 67' ' ' LEU . 2.2 mp -101.11 147.27 26.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.795 164.617 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -88.31 127.23 35.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.209 2.604 . . . . 0.0 107.537 -176.781 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.3 tp -114.22 123.82 50.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 -175.711 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.3 135.59 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -175.617 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.5 mt -89.48 158.69 17.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 125.228 2.442 . . . . 0.0 106.633 -163.159 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 ttt-85 -144.2 104.7 4.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.731 -2.031 . . . . 0.0 107.251 156.265 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.337 8.5 mp 88.76 148.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 1 C-N-CA 134.538 5.135 . . . . 0.0 111.621 179.683 . . . . . . . . 3 2 . 1 . 098 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.289 23.9 ttt180 -130.58 -52.2 1.08 Allowed 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 126.765 2.54 . . . . 0.0 108.96 177.36 . . . . . . . . 2 2 . 1 . 098 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.17 148.56 10.77 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 104.643 -3.383 . . . . 0.0 104.643 -172.965 . . . . . . . . 1 1 . 1 . 098 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -174.451 . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttp . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 099 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -79.66 133.93 36.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 173.975 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.9 pt -138.1 171.73 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 169.818 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -115.69 122.11 44.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 118.07 -2.894 . . . . 0.0 113.36 175.625 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -93.72 102.99 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 122.786 2.539 . . . . 0.0 111.193 166.701 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 21.3 tptt -80.49 122.98 27.67 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 128.039 2.535 . . . . 0.0 111.846 165.216 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.8 p -102.99 156.63 17.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.747 -176.256 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.781 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -53.77 -26.19 22.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 130.068 3.347 . . . . 0.0 118.267 -175.946 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -86.78 -10.65 53.07 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 127.245 2.841 . . . . 0.0 112.144 -177.8 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.89 -3.99 57.46 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 130.275 3.798 . . . . 0.0 117.761 -178.992 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -71.69 143.0 49.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 120.147 1.973 . . . . 0.0 111.411 175.402 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 154.17 33.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.002 173.538 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -135.23 143.18 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 129.341 3.056 . . . . 0.0 108.682 -176.826 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -119.73 102.02 8.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.313 179.949 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.2 mt -96.02 170.05 9.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 -177.203 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -121.57 90.94 3.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 123.265 1.507 . . . . 0.0 112.149 167.926 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -99.49 172.5 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 117.595 -3.191 . . . . 0.0 109.912 -177.536 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -131.94 130.8 22.29 Favored Pre-proline 0 N--CA 1.447 -0.624 2 O-C-N 114.672 -5.017 . . . . 0.0 107.223 -164.39 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -42.94 -29.82 1.65 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 1 CA-C-N 129.146 4.302 . . . . 0.0 116.937 167.408 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -75.73 -13.99 60.32 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 129.0 2.92 . . . . 0.0 114.869 176.871 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.463 ' HB2' HD13 ' A' ' 56' ' ' LEU . 66.1 m-20 -79.87 129.29 34.36 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 124.47 2.081 . . . . 0.0 109.989 -170.682 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -73.21 163.04 28.68 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 125.482 2.563 . . . . 0.0 105.57 177.896 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -55.28 -36.23 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 117.82 -3.05 . . . . 0.0 112.631 172.028 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.48 -30.38 69.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 117.494 -3.254 . . . . 0.0 113.346 169.568 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 13.2 m120 -59.82 -43.76 94.37 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 170.63 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -52.74 -50.09 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 O-C-N 127.707 3.13 . . . . 0.0 114.279 174.591 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -54.01 -46.37 71.78 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 129.075 3.984 . . . . 0.0 109.229 172.609 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -63.73 -39.16 93.62 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.827 2.051 . . . . 0.0 115.386 174.252 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -58.23 -41.82 84.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.353 2.261 . . . . 0.0 116.032 165.423 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -67.09 -45.52 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 120.388 -1.445 . . . . 0.0 110.976 176.56 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -45.26 -59.79 2.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 127.51 3.006 . . . . 0.0 111.761 173.099 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -52.42 -34.95 50.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.786 -175.059 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -98.17 -37.57 9.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 126.17 2.168 . . . . 0.0 116.687 -168.682 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -128.3 6.15 5.82 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.291 2.237 . . . . 0.0 116.07 -173.606 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.8 11.51 63.07 Favored Glycine 0 CA--C 1.532 1.142 1 O-C-N 116.178 -4.076 . . . . 0.0 119.887 174.678 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.3 mt -83.4 130.66 55.56 Favored Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-N 120.734 2.267 . . . . 0.0 105.238 177.274 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 40' ' ' GLN 0.264 73.7 Cg_endo -80.66 159.45 21.92 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 O-C-N 116.098 -2.632 . . . . 0.0 113.371 174.103 . . . . . . . . 3 3 . 1 . 099 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.83 -40.63 16.33 Favored 'Trans proline' 0 N--CA 1.443 -1.467 1 C-N-CA 125.395 4.063 . . . . 0.0 110.559 -170.882 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.26 24.7 t70 -55.96 -22.57 27.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 113.335 -3.221 . . . . 0.0 116.379 176.622 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 37.6 tt0 -86.34 -10.09 55.11 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 128.401 3.563 . . . . 0.0 110.009 -178.142 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -100.49 161.15 13.79 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.791 1.636 . . . . 0.0 107.136 -157.389 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -157.04 126.19 5.96 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 125.351 2.5 . . . . 0.0 107.713 162.142 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -99.59 126.02 45.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.74 -2.475 . . . . 0.0 106.738 -174.757 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.2 mm -111.45 143.64 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 129.879 3.271 . . . . 0.0 110.267 179.469 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -146.81 137.12 23.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.27 3.028 . . . . 0.0 108.666 166.626 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.281 . . 53.33 42.0 32.08 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 131.186 3.794 . . . . 0.0 112.454 172.648 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.27 10.18 85.72 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 114.429 -3.428 . . . . 0.0 114.708 -174.864 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -147.98 163.0 38.19 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 123.723 3.761 . . . . 0.0 115.305 179.172 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -63.64 133.78 54.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 131.655 3.982 . . . . 0.0 110.316 171.017 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 mt -99.31 126.73 45.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 163.609 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.93 156.85 20.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 126.324 2.265 . . . . 0.0 113.315 -174.007 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.19 155.28 11.6 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.567 -169.075 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.85 0.04 48.67 Favored Glycine 0 CA--C 1.525 0.665 1 O-C-N 130.388 4.805 . . . . 0.0 113.266 150.438 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -120.17 169.5 10.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 131.008 3.723 . . . . 0.0 112.321 179.336 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 p -105.92 163.87 12.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 116.557 -1.687 . . . . 0.0 113.916 -173.504 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.506 HD12 ' H ' ' A' ' 56' ' ' LEU . 5.9 mp -41.72 -37.83 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 112.645 -3.55 . . . . 0.0 115.108 156.94 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -71.58 -38.37 70.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 124.721 3.419 . . . . 0.0 117.94 170.531 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.95 -29.37 66.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 122.163 2.256 . . . . 0.0 115.319 173.761 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -87.68 8.84 23.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 118.68 -2.512 . . . . 0.0 108.132 173.112 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 63.26 24.47 14.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 124.211 3.187 . . . . 0.0 117.183 171.32 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.6 mt -76.87 127.71 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 118.636 -2.54 . . . . 0.0 116.749 -175.217 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.278 4.3 tp-100 -110.6 165.16 12.04 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.835 2.454 . . . . 0.0 109.896 -170.335 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.2 155.83 2.51 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 117.086 -3.509 . . . . 0.0 115.556 178.532 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 57.06 1.03 0.09 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.434 2.294 . . . . 0.0 116.509 170.435 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -60.12 151.31 27.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 130.48 3.512 . . . . 0.0 110.5 173.893 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.9 m -103.47 115.69 31.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 177.632 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.38 148.01 24.45 Favored 'General case' 0 N--CA 1.445 -0.68 1 C-N-CA 132.618 4.367 . . . . 0.0 107.784 160.402 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -113.68 148.4 36.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 122.312 2.324 . . . . 0.0 109.597 176.467 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -119.28 136.63 54.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.259 2.623 . . . . 0.0 107.274 178.996 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.97 167.99 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 O-C-N 125.222 1.576 . . . . 0.0 111.476 157.048 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.593 1.1 pp -127.41 137.28 52.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 120.573 1.533 . . . . 0.0 113.821 171.176 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -89.32 -171.96 3.44 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 111.757 -2.474 . . . . 0.0 108.796 178.319 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mt -90.68 164.56 14.11 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.381 2.673 . . . . 0.0 112.568 169.899 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.44 36.7 ttp180 81.36 127.02 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 128.179 2.591 . . . . 0.0 111.839 -177.079 . . . . . . . . 2 2 . 1 . 099 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.98 157.09 10.49 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 104.698 -3.361 . . . . 0.0 104.698 178.715 . . . . . . . . 1 1 . 1 . 099 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.349 0 N-CA-C 106.953 -2.459 . . . . 0.0 106.953 -179.815 . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 ttp . . . . . 0 C--O 1.234 0.248 0 CA-C-O 115.737 -2.078 . . . . 0.0 106.554 . . . . . . . . . 0 0 . 1 . 100 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -90.75 138.96 31.17 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 121.383 1.901 . . . . 0.0 108.748 173.331 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 pt -125.96 159.76 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 130.081 3.352 . . . . 0.0 109.372 159.908 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.46 ' HB2' ' HA ' ' A' ' 66' ' ' THR 0.279 73.4 m-85 -95.47 144.0 26.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 165.726 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.8 t -116.14 149.07 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 127.878 2.471 . . . . 0.0 108.768 163.987 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -136.79 150.07 48.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 130.488 3.515 . . . . 0.0 104.243 177.721 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.5 p -106.79 -170.97 1.8 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 111.731 -2.486 . . . . 0.0 106.189 -179.786 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.1 mt -106.67 -11.75 15.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 126.548 3.071 . . . . 0.0 112.951 -176.318 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -89.15 -6.02 57.3 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 119.077 -2.265 . . . . 0.0 110.994 173.859 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.8 -28.47 5.43 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 129.263 3.316 . . . . 0.0 111.107 171.572 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -73.12 142.48 47.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.067 -158.509 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.5 p -113.02 136.73 52.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.465 1.906 . . . . 0.0 109.897 -179.171 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 pt -117.78 143.6 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 131.4 3.88 . . . . 0.0 102.191 168.297 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.427 78.5 m -97.58 141.23 30.88 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 169.559 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.291 0.0 OUTLIER -131.23 125.28 32.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.068 2.147 . . . . 0.0 109.042 -176.649 . . . . . . . . 3 3 . 1 . 100 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.4 132.2 37.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 129.238 3.015 . . . . 0.0 112.203 156.162 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.99 160.35 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 127.235 2.214 . . . . 0.0 111.689 -177.81 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -121.19 154.87 58.73 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 100.724 -3.806 . . . . 0.0 100.724 173.976 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.82 -17.91 17.44 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.775 1.65 . . . . 0.0 115.865 -171.575 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 p -84.42 5.14 28.42 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 117.381 -1.295 . . . . 0.0 111.642 -175.064 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.03 139.51 39.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.431 2.693 . . . . 0.0 114.646 178.903 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 p -94.61 134.88 36.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.265 2.226 . . . . 0.0 114.664 -177.067 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.442 5.0 mt -42.14 -40.61 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -177.006 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.39 -13.95 59.61 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 117.156 -3.465 . . . . 0.0 113.5 176.429 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -89.64 -23.32 21.93 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 116.158 -1.877 . . . . 0.0 114.056 162.815 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.84 -36.18 73.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 116.343 -1.789 . . . . 0.0 110.129 168.034 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -60.2 -39.69 87.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 122.457 2.389 . . . . 0.0 113.487 170.078 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -36.5 79.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 115.583 -2.151 . . . . 0.0 113.664 169.694 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 tttt -61.81 -38.05 86.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 123.379 2.809 . . . . 0.0 110.349 169.606 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.366 66.4 mt -62.19 -32.66 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 O-C-N 117.7 -3.125 . . . . 0.0 117.416 169.96 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -65.29 -27.24 68.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.708 1.203 . . . . 0.0 113.774 175.947 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -84.11 -33.98 24.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 126.139 2.15 . . . . 0.0 107.371 -176.726 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -73.75 -43.45 59.02 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 177.469 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.302 47.8 tp10 -142.02 -5.2 1.01 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 123.383 1.563 . . . . 0.0 108.135 -152.855 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.24 -9.17 69.81 Favored Glycine 0 N--CA 1.443 -0.877 1 O-C-N 115.975 -4.203 . . . . 0.0 122.558 162.497 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -79.03 124.02 84.83 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-O 114.389 -2.719 . . . . 0.0 105.241 -171.2 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.303 58.9 Cg_endo -54.48 149.78 37.26 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.46 2.107 . . . . 0.0 115.394 172.221 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -84.29 -25.62 2.08 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 107.28 -1.854 . . . . 0.0 107.28 -162.165 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -48.84 -47.62 42.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 177.73 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -95.78 13.65 25.87 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.497 1.519 . . . . 0.0 108.029 -175.51 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -92.78 145.44 24.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 122.144 2.247 . . . . 0.0 109.919 171.192 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -147.63 124.23 11.1 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 130.005 3.322 . . . . 0.0 109.015 -177.261 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mp -101.39 139.01 37.64 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.875 1.67 . . . . 0.0 110.823 -177.161 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.9 mt -121.84 140.67 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 131.372 3.869 . . . . 0.0 110.292 168.761 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -116.54 -32.02 5.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 119.245 -2.159 . . . . 0.0 113.917 166.254 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.7 -107.16 0.38 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-O 115.43 -2.224 . . . . 0.0 106.312 175.961 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.95 2.77 13.19 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 117.931 1.932 . . . . 0.0 117.931 166.569 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -113.11 151.62 30.59 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 118.999 -2.471 . . . . 0.0 107.495 -160.707 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -66.41 144.65 56.39 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.676 163.912 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.4 mt -98.05 147.41 24.56 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.873 2.469 . . . . 0.0 106.534 172.729 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -66.96 114.59 5.88 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 157.677 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -53.35 -30.32 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 119.915 3.302 . . . . 0.0 119.915 -176.38 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.68 18.44 52.95 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -168.753 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -94.02 168.69 10.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 125.572 1.395 . . . . 0.0 109.913 167.232 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.1 p -96.08 166.93 11.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 130.628 3.571 . . . . 0.0 116.53 175.29 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.79 -38.41 69.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 114.492 -2.671 . . . . 0.0 115.538 168.6 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 p -76.1 -31.27 58.6 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.555 2.742 . . . . 0.0 106.702 -171.397 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -57.42 -35.01 69.53 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 120.083 1.311 . . . . 0.0 111.809 173.999 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -108.39 -3.57 18.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -170.741 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.419 36.9 t-20 67.16 53.47 0.79 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 127.324 2.89 . . . . 0.0 111.904 178.8 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.1 mm -79.11 115.68 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 127.94 2.496 . . . . 0.0 104.491 168.494 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -93.15 156.88 16.58 Favored 'General case' 0 N--CA 1.448 -0.534 1 C-N-CA 132.014 4.126 . . . . 0.0 111.438 177.047 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -67.4 149.01 50.84 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 119.645 -1.91 . . . . 0.0 111.78 -177.245 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.393 19.2 mt-10 80.67 -2.4 1.86 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 114.09 -2.862 . . . . 0.0 113.219 172.78 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.8 m -66.58 159.63 27.03 Favored 'General case' 0 N--CA 1.449 -0.494 1 O-C-N 130.016 4.573 . . . . 0.0 112.616 -177.229 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 53.5 m -103.74 121.29 42.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 175.083 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 tt -110.31 154.45 23.46 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 117.803 -3.061 . . . . 0.0 106.486 -179.347 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -120.95 119.77 33.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 116.507 -3.871 . . . . 0.0 110.415 -167.826 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.1 tp -98.4 142.57 29.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.582 2.353 . . . . 0.0 110.178 178.983 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 71' ' ' LEU . 96.1 t -124.3 162.98 24.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 129.187 2.995 . . . . 0.0 109.687 177.217 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.49 ' N ' HG12 ' A' ' 70' ' ' VAL . 2.4 pt? -153.46 163.58 39.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.455 1.121 . . . . 0.0 109.227 177.685 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.3 mtm105 -126.94 52.96 1.74 Allowed 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 118.848 -2.407 . . . . 0.0 108.802 -173.104 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.47 4.2 pp -135.05 -2.64 2.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 120.059 1.3 . . . . 0.0 109.72 -179.755 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.513 ' HE ' ' C ' ' A' ' 76' ' ' GLY . 2.8 tmm_? -94.44 -28.1 15.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -168.026 . . . . . . . . 2 2 . 1 . 100 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.66 18.32 5.72 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 121.591 1.996 . . . . 0.0 112.911 -171.358 . . . . . . . . 1 1 . 1 . 100 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.513 ' C ' ' HE ' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 129.69 3.519 . . . . 0.0 104.939 -167.633 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.4 ttm . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 116.982 -1.485 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 101 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -106.11 122.49 46.29 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -166.209 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -132.8 174.1 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 O-C-N 125.723 1.889 . . . . 0.0 109.086 167.832 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.283 7.6 p90 -150.62 149.06 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 117.033 -3.542 . . . . 0.0 109.509 -171.457 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 67' ' ' LEU . 4.7 m -114.58 150.42 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 179.909 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -109.26 123.42 49.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 175.624 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -68.51 172.88 5.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 128.538 2.735 . . . . 0.0 110.584 176.861 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.76 -26.5 66.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.805 167.43 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -88.92 -4.27 58.5 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 179.978 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.91 -4.29 57.55 Favored Glycine 0 CA--C 1.528 0.898 1 CA-C-O 112.379 -4.567 . . . . 0.0 111.823 166.128 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -84.62 141.5 30.61 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 123.922 3.861 . . . . 0.0 110.885 178.139 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.276 53.9 m -104.15 148.62 26.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 121.658 2.026 . . . . 0.0 105.906 -168.433 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mt -128.48 121.08 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.824 2.05 . . . . 0.0 107.936 176.951 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.8 m -92.67 129.77 38.5 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.561 1.945 . . . . 0.0 106.63 -177.244 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.91 139.4 47.43 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 127.147 2.779 . . . . 0.0 106.403 -175.48 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.294 22.3 tp10 -96.22 127.18 42.0 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 118.442 -2.661 . . . . 0.0 107.211 159.635 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.63 161.81 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 103.503 -2.776 . . . . 0.0 103.503 177.823 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -107.85 121.56 43.61 Favored Pre-proline 0 N--CA 1.446 -0.667 1 C-N-CA 133.366 4.666 . . . . 0.0 104.877 160.63 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 10.4 Cg_endo -65.19 -2.57 5.99 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 127.188 5.258 . . . . 0.0 117.483 -160.22 . . . . . . . . 3 2 . 1 . 101 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -96.85 3.4 52.21 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.86 -177.331 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.12 157.04 31.23 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.694 1.597 . . . . 0.0 111.523 174.932 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -100.53 149.93 23.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 -172.338 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.443 ' H ' HG12 ' A' ' 23' ' ' ILE . 5.5 mm -51.96 -31.86 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 112.609 -3.567 . . . . 0.0 116.477 -178.005 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -65.38 -26.54 68.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 123.079 2.672 . . . . 0.0 113.136 174.188 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -81.69 -21.24 38.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.506 1.503 . . . . 0.0 112.744 178.495 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 t -71.4 -52.53 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 1 C-N-CA 133.804 4.842 . . . . 0.0 110.082 167.716 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -53.6 -34.13 57.35 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 116.555 -3.84 . . . . 0.0 118.12 168.299 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.74 -18.85 39.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 120.395 -1.441 . . . . 0.0 112.06 -178.439 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -69.95 -17.23 63.3 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 116.844 -3.66 . . . . 0.0 117.026 167.293 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mm -84.83 -35.56 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 116.736 -1.602 . . . . 0.0 108.733 -174.743 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -52.14 -43.41 64.03 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 129.618 3.167 . . . . 0.0 111.863 -166.783 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.85 -29.3 65.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 122.767 2.53 . . . . 0.0 113.272 179.701 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -75.18 -56.77 4.4 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.393 -2.692 . . . . 0.0 109.914 173.294 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -134.29 137.63 44.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 -165.524 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.48 40.87 2.32 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 -149.71 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 71' ' ' LEU . 43.6 mt -91.93 119.66 68.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 130.066 3.347 . . . . 0.0 113.807 -174.781 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.97 138.94 23.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 121.273 1.49 . . . . 0.0 113.024 -168.273 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.08 -18.75 7.66 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-O 111.452 -3.645 . . . . 0.0 116.18 177.59 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -88.61 12.15 15.42 Favored 'General case' 0 C--O 1.238 0.491 1 CA-C-N 127.076 4.489 . . . . 0.0 112.314 175.078 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.336 8.2 tt0 -127.01 -18.86 4.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.511 -1.993 . . . . 0.0 111.222 -176.858 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 77.3 mt-30 -92.66 156.64 16.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.254 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -144.8 147.69 33.18 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.212 -2.885 . . . . 0.0 103.212 170.49 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.8 mt -117.76 136.06 53.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.526 2.331 . . . . 0.0 110.078 -176.591 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 44' ' ' ILE . 56.2 mt -122.15 143.18 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 172.892 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -118.03 106.45 12.92 Favored 'General case' 0 C--N 1.33 -0.273 2 CA-C-N 105.312 -5.404 . . . . 0.0 112.332 154.675 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.462 . . 87.18 4.22 0.36 Allowed 'General case' 0 CA--C 1.532 0.265 1 O-C-N 111.987 -6.696 . . . . 0.0 116.69 157.537 . . . . . . . . 3 2 . 1 . 101 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.7 2.22 46.47 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.714 -171.794 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -92.23 124.07 36.03 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 128.349 2.659 . . . . 0.0 111.276 165.012 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -77.18 128.46 34.42 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 168.788 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.279 11.9 mt -68.15 126.54 29.84 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 118.336 2.717 . . . . 0.0 118.336 170.388 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -98.75 139.09 34.95 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -173.625 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.45 142.83 57.7 Favored 'General case' 0 C--O 1.22 -0.457 0 O-C-N 117.996 -2.94 . . . . 0.0 109.013 176.787 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.68 -19.04 56.34 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 119.108 -2.245 . . . . 0.0 108.126 171.519 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -81.09 157.97 25.2 Favored 'General case' 0 N--CA 1.453 -0.319 1 O-C-N 115.072 -4.781 . . . . 0.0 106.538 173.123 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.1 p -92.03 165.93 12.94 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 120.558 -1.339 . . . . 0.0 109.967 165.689 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 mt -51.7 -45.79 63.65 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.451 2.7 . . . . 0.0 113.286 163.075 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -53.45 -28.84 32.51 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 170.082 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.01 -23.65 48.2 Favored 'General case' 0 N--CA 1.447 -0.597 1 O-C-N 115.068 -4.77 . . . . 0.0 115.857 178.356 . . . . . . . . 3 3 . 1 . 101 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.28 45.9 m-85 -97.99 -9.05 26.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.309 1.444 . . . . 0.0 114.303 172.497 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.377 26.5 t30 72.54 47.18 0.26 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 130.324 3.45 . . . . 0.0 111.405 -178.233 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -82.57 103.58 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.943 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -90.09 -175.06 4.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 130.02 3.328 . . . . 0.0 115.901 170.458 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.76 138.58 41.85 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.613 3.165 . . . . 0.0 112.933 173.498 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.454 62.8 tt0 83.93 2.24 0.91 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 126.867 2.067 . . . . 0.0 114.657 167.53 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -77.88 134.1 38.0 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.23 -1.544 . . . . 0.0 111.104 -169.195 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -85.19 115.55 23.04 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 126.662 2.476 . . . . 0.0 104.733 174.44 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.469 ' HB2' HG12 ' A' ' 5' ' ' VAL . 51.3 mt -94.83 171.03 9.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 128.208 3.443 . . . . 0.0 107.262 161.839 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -130.96 139.13 50.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.721 -179.029 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -101.95 120.87 41.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 -171.006 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.37 172.95 13.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 127.497 2.319 . . . . 0.0 105.973 -175.287 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD11 HG21 ' A' ' 36' ' ' ILE . 2.3 mp -129.0 142.78 50.81 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 122.816 0.446 . . . . 0.0 110.687 -165.576 . . . . . . . . 2 2 . 1 . 101 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 ttt85 -161.11 114.1 1.94 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 130.096 3.358 . . . . 0.0 105.846 174.218 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.7 mt -51.86 126.61 18.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 161.635 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -66.19 134.18 52.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 130.932 3.693 . . . . 0.0 109.174 178.689 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.37 22.16 11.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 116.259 -2.412 . . . . 0.0 118.231 176.704 . . . . . . . . 1 1 . 1 . 101 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 N-CA-C 106.564 -2.614 . . . . 0.0 106.564 -176.501 . . . . . . . . 0 0 . 1 . 102 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttp . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 116.654 -1.641 . . . . 0.0 107.281 . . . . . . . . . 0 0 . 1 . 102 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -93.95 138.59 31.9 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 124.041 1.877 . . . . 0.0 111.164 170.842 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -136.74 167.71 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.704 2.001 . . . . 0.0 107.897 162.289 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -119.87 135.2 54.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -177.144 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 15' ' ' LEU . 88.0 t -121.43 89.58 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 126.674 2.484 . . . . 0.0 104.907 178.747 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -77.83 121.32 23.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.456 3.902 . . . . 0.0 107.018 -175.542 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.8 p -84.61 155.05 22.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 175.373 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 mt -50.44 -16.81 0.39 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 131.415 3.886 . . . . 0.0 115.664 176.558 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -97.81 6.35 47.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.18 0.992 . . . . 0.0 111.731 172.706 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.08 -36.32 4.47 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 120.007 -1.683 . . . . 0.0 109.951 167.515 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -60.24 127.68 33.0 Favored 'General case' 0 C--N 1.33 -0.255 1 C-N-CA 132.369 4.268 . . . . 0.0 106.69 -174.718 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.253 20.6 m -119.19 123.81 45.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.102 2.561 . . . . 0.0 109.071 -166.014 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mm -82.48 120.37 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 168.235 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.8 m -74.35 134.8 42.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.88 1.363 . . . . 0.0 109.27 166.735 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.468 HD12 HG21 ' A' ' 5' ' ' VAL . 2.3 mt -125.44 129.91 50.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 120.645 1.566 . . . . 0.0 113.259 179.593 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.48 90.77 7.69 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.133 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -98.99 164.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.321 177.996 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.265 30.5 tp10 -107.81 156.21 38.49 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-O 113.612 -3.09 . . . . 0.0 105.017 162.3 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -59.93 -25.07 78.49 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 124.127 3.218 . . . . 0.0 118.073 170.557 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -88.57 1.65 54.53 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 119.439 3.125 . . . . 0.0 119.439 -179.732 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -72.43 149.18 44.47 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 114.439 -2.696 . . . . 0.0 115.891 -177.605 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 p -65.95 151.67 46.26 Favored 'General case' 0 C--N 1.325 -0.459 1 O-C-N 129.62 4.325 . . . . 0.0 110.475 167.04 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -61.02 -29.01 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 116.591 -1.671 . . . . 0.0 110.412 173.251 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -70.3 -50.61 37.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.045 2.538 . . . . 0.0 111.379 -173.056 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -50.3 -45.04 54.3 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.132 2.573 . . . . 0.0 112.629 170.93 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.4 -45.85 67.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.856 1.662 . . . . 0.0 108.158 -176.28 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -63.61 -31.19 72.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.251 1.42 . . . . 0.0 114.397 178.101 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.71 -14.87 35.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.38 3.472 . . . . 0.0 113.56 177.084 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.04 -31.2 27.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 119.119 -2.238 . . . . 0.0 107.083 174.571 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.2 mm -81.51 -6.99 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 117.348 -1.31 . . . . 0.0 109.961 176.907 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -76.54 -28.99 56.51 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 118.104 -2.873 . . . . 0.0 109.102 163.37 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.55 -47.21 12.41 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -163.292 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -73.18 -73.77 0.2 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.332 2.653 . . . . 0.0 112.214 178.437 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -85.45 -16.57 39.24 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.736 2.414 . . . . 0.0 117.183 -166.942 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.97 -7.84 67.53 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 117.142 -1.921 . . . . 0.0 112.786 -179.777 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.261 37.9 mm -80.29 115.03 51.91 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 123.141 3.471 . . . . 0.0 112.248 -163.485 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -55.67 160.22 9.91 Favored 'Trans proline' 0 N--CA 1.445 -1.354 1 C-N-CA 126.126 4.551 . . . . 0.0 113.941 171.011 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.63 5.82 3.59 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 N-CA-C 120.028 3.049 . . . . 0.0 120.028 -176.509 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.378 82.8 m-20 -104.72 -6.37 20.43 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 126.312 2.958 . . . . 0.0 117.929 174.451 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -97.82 -6.47 32.55 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 119.304 -2.122 . . . . 0.0 114.703 160.992 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -85.25 85.93 7.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 169.51 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -93.85 97.22 10.25 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 -171.421 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 mt -93.06 139.15 30.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -163.654 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 44' ' ' ILE . 24.3 mt -136.47 135.55 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.31 1.844 . . . . 0.0 110.039 177.754 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -129.38 107.13 9.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.07 3.348 . . . . 0.0 105.465 -178.465 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.39 42.0 31.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.426 2.291 . . . . 0.0 115.176 167.634 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.2 -25.29 28.81 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 119.707 -1.87 . . . . 0.0 114.199 -178.449 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -93.77 114.22 26.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 -171.227 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.292 7.8 tt0 -82.28 140.78 33.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 169.1 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.56 135.75 40.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 130.576 3.551 . . . . 0.0 109.362 -174.159 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -104.5 -4.01 23.22 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.203 2.601 . . . . 0.0 109.113 -172.013 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.323 7.5 m-20 84.38 168.35 0.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.278 170.247 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.62 -16.89 36.93 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 123.812 0.695 . . . . 0.0 113.881 169.232 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -120.98 -171.69 2.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.976 2.111 . . . . 0.0 105.366 -171.05 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.261 7.0 p -111.66 167.66 10.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.233 -0.917 . . . . 0.0 110.894 -165.463 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.284 9.3 mp -56.32 -28.86 60.28 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 169.249 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -77.06 -34.33 57.11 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 116.572 -2.051 . . . . 0.0 114.489 179.087 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.64 -40.39 76.54 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 127.924 3.265 . . . . 0.0 113.143 -177.685 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -79.44 0.56 28.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 117.519 -3.238 . . . . 0.0 109.341 171.045 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.366 1.6 t-20 70.6 49.13 0.42 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 126.277 2.942 . . . . 0.0 115.647 169.903 . . . . . . . . 2 2 . 1 . 102 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -101.79 123.45 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 112.538 -2.119 . . . . 0.0 107.336 -174.736 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -111.72 -164.96 0.95 Allowed 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 124.96 1.413 . . . . 0.0 113.696 -168.104 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -69.97 114.72 8.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 119.44 -2.037 . . . . 0.0 107.619 174.611 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.312 5.7 tt0 89.4 12.3 0.07 Allowed 'General case' 0 C--O 1.236 0.374 1 O-C-N 115.915 -4.241 . . . . 0.0 112.746 167.307 . . . . . . . . 3 2 . 1 . 102 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -49.76 152.23 1.55 Allowed 'General case' 0 C--N 1.327 -0.381 0 O-C-N 117.661 -3.149 . . . . 0.0 112.179 167.953 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.1 m -116.15 130.54 56.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.637 167.928 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.92 123.56 46.05 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.078 1.751 . . . . 0.0 112.4 166.13 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -84.65 110.32 18.65 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 173.004 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.1 tp -89.2 103.76 16.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.727 2.411 . . . . 0.0 108.933 172.413 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 t -81.36 116.75 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 127.63 2.372 . . . . 0.0 109.292 163.502 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.5 116.38 26.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 115.112 -2.375 . . . . 0.0 104.682 175.202 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -72.11 146.65 47.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 127.754 3.159 . . . . 0.0 109.503 159.798 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 mt -94.49 13.43 23.99 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 165.699 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -148.27 -163.71 1.84 Allowed 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 128.323 3.514 . . . . 0.0 103.681 -175.335 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.43 159.6 13.93 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 115.618 -2.768 . . . . 0.0 110.015 174.515 . . . . . . . . 1 1 . 1 . 102 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.952 0 O-C-N 129.257 3.563 . . . . 0.0 111.497 172.411 . . . . . . . . 0 0 . 1 . 103 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tmm? . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 . . . . . . . . . 0 0 . 1 . 103 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -94.01 154.31 17.72 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -174.665 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.461 HD13 HG21 ' A' ' 3' ' ' ILE . 4.8 pt -135.74 144.26 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 171.421 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -102.96 94.29 5.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 111.207 -2.724 . . . . 0.0 104.439 -179.235 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.4 t -80.88 112.68 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.598 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -96.14 127.91 42.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -170.142 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -95.49 136.83 35.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.317 2.247 . . . . 0.0 109.087 160.055 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.12 -32.33 71.65 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 113.871 -2.966 . . . . 0.0 112.575 166.997 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.276 33.1 p -76.37 -16.52 59.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 114.707 -2.568 . . . . 0.0 109.456 -178.805 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.36 48.15 0.09 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 117.052 -2.499 . . . . 0.0 113.665 123.301 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.304 0.6 OUTLIER -139.19 153.05 47.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.76 1.267 . . . . 0.0 108.84 164.555 . . . . . . . . 3 3 . 1 . 103 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -95.35 129.98 42.29 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.157 2.183 . . . . 0.0 107.03 164.585 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.2 mt -108.92 132.68 56.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 128.975 2.91 . . . . 0.0 106.322 177.625 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.5 m -93.78 126.33 38.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 167.133 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.87 138.17 50.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 125.944 2.028 . . . . 0.0 106.845 166.634 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.74 137.04 39.66 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 173.048 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 m -150.44 179.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.571 1 C-N-CA 132.866 4.467 . . . . 0.0 106.165 -166.779 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.262 48.4 mm-40 -130.89 159.35 71.77 Favored Pre-proline 0 N--CA 1.446 -0.658 0 C-N-CA 127.824 2.45 . . . . 0.0 105.345 155.167 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -61.47 -9.15 12.4 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.026 2.484 . . . . 0.0 116.82 179.543 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.269 26.4 p -88.58 -3.73 58.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.665 -1.16 . . . . 0.0 113.27 173.98 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.67 126.81 28.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.794 0.725 . . . . 0.0 110.457 171.147 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.398 4.7 p -67.05 155.07 39.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 173.775 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.4 -35.67 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 131.176 3.79 . . . . 0.0 107.629 171.395 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.46 -40.45 50.4 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 119.454 -2.029 . . . . 0.0 110.774 -174.204 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -56.56 -59.66 4.68 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 124.994 1.434 . . . . 0.0 113.419 168.38 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.321 96.6 t -51.72 -51.25 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 O-C-N 116.705 -3.747 . . . . 0.0 115.849 -177.387 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -48.8 -44.09 38.75 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 127.456 2.973 . . . . 0.0 116.433 169.927 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.24 -34.2 23.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 129.772 3.229 . . . . 0.0 110.361 -179.425 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -62.06 -33.54 74.58 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 125.853 1.971 . . . . 0.0 110.862 169.256 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.2 mt -63.95 -50.38 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 127.77 2.428 . . . . 0.0 113.239 165.965 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -57.91 -41.34 82.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.92 2.088 . . . . 0.0 112.856 -175.984 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -54.37 -26.22 28.89 Favored 'General case' 0 N--CA 1.447 -0.594 1 C-N-CA 131.811 4.045 . . . . 0.0 113.741 173.601 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -98.78 -62.25 1.26 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 120.645 1.566 . . . . 0.0 113.514 -178.874 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -106.78 -17.41 14.22 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 126.368 2.292 . . . . 0.0 114.265 -167.523 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.95 1.43 42.18 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 117.696 -3.127 . . . . 0.0 118.053 168.049 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mt -80.75 130.16 65.24 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 123.279 3.54 . . . . 0.0 115.511 -172.43 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.285 36.9 Cg_endo -68.3 135.37 33.95 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.996 2.464 . . . . 0.0 110.745 179.419 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -43.79 -40.63 11.36 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.532 2.821 . . . . 0.0 116.556 175.925 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -55.75 -30.28 60.97 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.698 1.199 . . . . 0.0 112.986 -176.139 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -101.15 -12.5 18.72 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 128.314 2.646 . . . . 0.0 115.216 -171.606 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.26 73.3 mt-30 -81.14 152.61 27.69 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 111.932 -2.394 . . . . 0.0 108.419 179.413 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -132.45 126.83 33.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.847 2.459 . . . . 0.0 108.246 157.13 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 mt -115.96 131.2 57.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 177.684 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.72 143.11 32.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 110.789 -2.914 . . . . 0.0 108.085 -173.031 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -139.38 118.02 12.26 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.566 2.347 . . . . 0.0 109.011 160.083 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.65 48.87 6.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 128.36 3.538 . . . . 0.0 109.688 170.152 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.66 -19.94 51.14 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.578 1.085 . . . . 0.0 112.019 166.631 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.262 74.5 mttt -96.83 144.81 26.44 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.083 1.942 . . . . 0.0 114.447 -174.568 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.319 77.8 mm-40 -76.88 169.1 18.93 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 116.895 -1.922 . . . . 0.0 109.131 160.908 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.25 43.4 mt -120.34 119.35 32.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 117.84 -3.038 . . . . 0.0 106.141 -170.571 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -86.08 146.65 26.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 123.194 1.473 . . . . 0.0 113.274 -170.243 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -68.44 122.39 18.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 111.97 -2.377 . . . . 0.0 104.916 -175.403 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.07 9.25 10.83 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 127.581 3.051 . . . . 0.0 119.336 179.698 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.277 90.2 mtt-85 -132.35 179.34 6.18 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.953 2.101 . . . . 0.0 107.244 -172.579 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -126.46 178.62 5.75 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.113 -171.184 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -73.62 -28.93 62.06 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 127.45 2.969 . . . . 0.0 110.909 175.389 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.1 t -59.81 -27.58 66.71 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 129.521 3.129 . . . . 0.0 110.692 172.49 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.89 -44.16 27.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.748 2.419 . . . . 0.0 108.796 178.528 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -99.99 20.93 13.5 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -179.622 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 3.9 t-20 83.7 25.38 0.11 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 119.147 3.017 . . . . 0.0 119.147 164.169 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mt -104.04 81.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -172.679 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -92.28 -23.49 19.28 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 129.09 2.956 . . . . 0.0 114.491 -170.362 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -168.39 130.13 1.36 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.881 1.672 . . . . 0.0 109.535 -170.881 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 7.99 86.95 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 130.906 3.683 . . . . 0.0 116.944 167.049 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.284 5.3 t -143.98 -160.52 1.13 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 115.115 -2.374 . . . . 0.0 107.301 173.788 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.5 m -125.7 132.07 52.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 122.074 2.215 . . . . 0.0 106.334 -167.265 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.77 143.54 29.01 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 156.373 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -89.96 128.84 36.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 119.521 -1.987 . . . . 0.0 109.114 166.904 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 tp -92.45 117.67 30.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 131.69 3.996 . . . . 0.0 103.511 176.833 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.5 143.69 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -176.968 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.28 124.04 31.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 119.3 -2.125 . . . . 0.0 111.044 -171.097 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.49 -29.61 66.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 114.393 -2.718 . . . . 0.0 112.854 178.95 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.296 50.7 tp -72.46 123.21 22.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 128.842 3.838 . . . . 0.0 109.085 171.395 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.323 1.2 ttp85 -84.14 125.67 32.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 102.921 -2.992 . . . . 0.0 102.921 -174.023 . . . . . . . . 2 2 . 1 . 103 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.83 -92.96 0.53 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 130.065 3.698 . . . . 0.0 106.524 -175.9 . . . . . . . . 1 1 . 1 . 103 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 C-N-CA 129.617 3.484 . . . . 0.0 110.609 -170.423 . . . . . . . . 0 0 . 1 . 104 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ptt? . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 . . . . . . . . . 0 0 . 1 . 104 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -82.71 152.32 25.84 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 115.208 -2.33 . . . . 0.0 112.678 -179.701 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.8 pt -139.82 149.5 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 121.777 2.08 . . . . 0.0 109.449 162.539 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -105.27 126.22 51.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 -172.355 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.272 93.0 t -99.4 112.14 30.9 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 C-N-CA 127.979 2.511 . . . . 0.0 108.076 171.929 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -70.32 148.8 48.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 111.565 -2.561 . . . . 0.0 111.314 166.352 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -120.75 -167.07 1.41 Allowed 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.083 -1.635 . . . . 0.0 109.534 176.442 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.14 42.17 1.53 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 164.294 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -139.74 26.54 2.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.715 2.406 . . . . 0.0 107.786 176.985 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.98 16.52 35.4 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 116.865 -3.647 . . . . 0.0 117.883 152.997 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -154.49 171.73 18.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 124.427 2.061 . . . . 0.0 110.116 177.664 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.5 m -112.89 127.57 56.23 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 131.313 3.845 . . . . 0.0 108.918 175.887 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.439 HD13 HG21 ' A' ' 13' ' ' ILE . 87.3 mt -106.47 129.37 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 O-C-N 126.78 2.55 . . . . 0.0 107.011 175.018 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.1 m -107.04 136.9 46.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 102.411 -3.181 . . . . 0.0 102.411 169.829 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tp -129.57 160.83 32.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 128.314 2.645 . . . . 0.0 105.496 -179.665 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -102.19 139.27 38.03 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 130.653 3.581 . . . . 0.0 103.19 172.968 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -151.03 166.36 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 119.314 -2.116 . . . . 0.0 108.644 -178.903 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -138.27 142.71 36.16 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 126.152 1.781 . . . . 0.0 108.469 -173.189 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.343 11.5 Cg_exo -50.72 -34.83 45.59 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 N-CA-C 121.369 3.565 . . . . 0.0 121.369 -179.887 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.5 p -93.43 -2.27 54.77 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 127.47 2.981 . . . . 0.0 112.134 -174.24 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -74.33 141.14 45.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 125.868 2.747 . . . . 0.0 109.091 170.327 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 p -76.32 172.81 12.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 119.221 -2.174 . . . . 0.0 111.408 175.933 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -53.15 -46.96 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 C-N-CA 133.875 4.87 . . . . 0.0 113.397 171.097 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -47.47 -42.16 22.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 113.295 -3.24 . . . . 0.0 112.33 170.089 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.281 4.7 m120 -59.14 -32.13 69.59 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.536 2.734 . . . . 0.0 116.135 175.392 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.79 -54.62 25.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 120.121 -1.612 . . . . 0.0 110.769 165.419 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -71.81 -23.88 61.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 125.675 2.655 . . . . 0.0 113.637 -171.952 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.6 -46.98 51.55 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 118.785 -2.447 . . . . 0.0 110.043 173.534 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.68 -27.91 60.61 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.729 2.412 . . . . 0.0 109.757 -176.487 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.36 -47.92 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 O-C-N 118.933 -2.355 . . . . 0.0 106.463 169.77 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -50.86 -51.86 47.29 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 124.426 3.284 . . . . 0.0 107.851 175.924 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.301 5.1 t70 -46.56 -50.03 17.91 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 179.094 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -83.64 -48.99 9.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 128.905 3.878 . . . . 0.0 108.55 -173.195 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -106.26 -14.74 15.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 123.493 2.861 . . . . 0.0 110.012 -161.754 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.21 0.99 84.63 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 129.851 3.595 . . . . 0.0 118.976 -178.623 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -83.86 126.42 70.58 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 119.855 1.827 . . . . 0.0 111.817 -165.827 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.09 145.92 31.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 O-C-N 124.245 1.655 . . . . 0.0 110.394 -175.063 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.27 38.0 Cg_endo -72.94 -16.23 25.93 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.494 3.463 . . . . 0.0 119.823 -163.6 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -72.07 -26.73 62.28 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 125.461 1.726 . . . . 0.0 110.337 174.335 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -83.02 -30.24 28.26 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.41 1.484 . . . . 0.0 112.507 -174.355 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -80.87 142.54 33.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 129.459 3.104 . . . . 0.0 109.375 175.747 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -145.62 119.36 9.22 Favored 'General case' 0 N--CA 1.449 -0.502 1 N-CA-C 99.217 -4.364 . . . . 0.0 99.217 175.733 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.14 124.53 29.95 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 114.64 -2.6 . . . . 0.0 115.81 177.062 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mm -102.17 129.13 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 101.197 -3.631 . . . . 0.0 101.197 173.552 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -137.31 125.98 23.81 Favored 'General case' 0 N--CA 1.451 -0.405 1 N-CA-C 97.139 -5.134 . . . . 0.0 97.139 175.607 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.75 24.18 14.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.864 2.866 . . . . 0.0 114.822 160.577 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.81 -25.92 25.8 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.873 -1.515 . . . . 0.0 112.566 -175.349 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -99.29 164.43 12.13 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 128.079 2.552 . . . . 0.0 109.159 -171.577 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.28 7.3 mt-30 -118.64 145.79 45.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.537 1.935 . . . . 0.0 106.339 166.445 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.44 139.26 30.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.77 -166.58 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.267 7.7 tp10 -85.44 140.34 30.8 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 131.671 3.989 . . . . 0.0 107.174 167.581 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -73.98 136.06 43.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 114.134 -2.841 . . . . 0.0 112.917 -177.667 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.01 -14.16 26.37 Favored Glycine 0 CA--C 1.535 1.327 1 CA-C-N 127.707 4.776 . . . . 0.0 113.775 166.028 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.295 3.1 mpt_? -81.06 161.05 24.34 Favored 'General case' 0 C--N 1.322 -0.624 1 O-C-N 130.925 4.544 . . . . 0.0 105.553 176.385 . . . . . . . . 3 2 . 1 . 104 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -89.59 172.69 8.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 125.282 1.614 . . . . 0.0 109.056 -177.457 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mt -63.04 -52.64 62.07 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 128.932 2.893 . . . . 0.0 110.443 169.961 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.0 p -41.96 -41.27 2.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 117.222 2.305 . . . . 0.0 117.222 162.501 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -62.14 -24.29 67.08 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 118.317 -2.739 . . . . 0.0 116.704 177.34 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -99.52 -6.86 26.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.738 3.215 . . . . 0.0 117.78 179.387 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.308 0.7 OUTLIER 69.85 48.13 0.58 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 130.491 3.517 . . . . 0.0 113.413 174.509 . . . . . . . . 3 3 . 1 . 104 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -93.25 139.69 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -172.998 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.274 7.0 tp60 -148.97 156.36 42.16 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 112.334 -2.212 . . . . 0.0 107.791 -176.18 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.374 23.9 ttpp -31.98 114.43 0.14 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.553 2.741 . . . . 0.0 113.541 -179.974 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 83.4 21.65 0.17 Allowed 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 128.148 3.405 . . . . 0.0 115.007 176.357 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 m -65.65 134.67 53.75 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.688 171.77 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.406 ' C ' HD12 ' A' ' 67' ' ' LEU . 85.1 m -94.71 122.4 37.28 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -178.989 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.406 HD12 ' C ' ' A' ' 66' ' ' THR . 1.7 mp -122.77 160.24 26.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.227 1.011 . . . . 0.0 109.398 166.21 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -127.88 124.36 37.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 118.493 -2.63 . . . . 0.0 111.979 -175.547 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.4 tp -82.57 101.45 10.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 115.337 -2.268 . . . . 0.0 111.086 -179.861 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.31 151.7 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 O-C-N 125.42 1.7 . . . . 0.0 107.326 163.545 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 mt -109.24 153.01 24.44 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.633 1.973 . . . . 0.0 111.3 178.77 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -80.93 146.59 30.69 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.646 154.697 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.8 141.92 30.2 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 126.831 3.205 . . . . 0.0 105.911 168.77 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -155.64 -40.71 0.08 Allowed 'General case' 0 C--O 1.234 0.264 0 O-C-N 117.479 -3.263 . . . . 0.0 113.243 -166.255 . . . . . . . . 1 1 . 1 . 104 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.25 130.91 4.89 Favored Glycine 0 CA--C 1.531 1.041 1 C-N-CA 131.273 4.273 . . . . 0.0 116.389 176.224 . . . . . . . . 2 2 . 1 . 104 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.528 0 O-C-N 125.811 1.536 . . . . 0.0 109.542 -170.824 . . . . . . . . 0 0 . 1 . 105 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptt? . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 . . . . . . . . . 0 0 . 1 . 105 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -60.7 125.16 22.66 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 117.553 -1.213 . . . . 0.0 113.248 174.231 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.365 26.8 pt -128.91 166.48 26.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 O-C-N 125.209 1.568 . . . . 0.0 112.127 162.253 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -112.38 154.11 26.26 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.567 2.747 . . . . 0.0 106.916 176.674 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.87 130.66 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 168.682 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -101.72 128.32 48.1 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 122.835 2.561 . . . . 0.0 109.285 167.708 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.6 p -91.59 163.75 14.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.855 2.462 . . . . 0.0 108.386 -173.19 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.41 -47.71 47.7 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 128.286 2.634 . . . . 0.0 109.076 176.22 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.9 p -68.58 -16.94 64.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 128.011 2.524 . . . . 0.0 111.575 -174.743 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.01 -14.06 37.46 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 125.044 3.566 . . . . 0.0 115.498 169.652 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -69.73 147.26 50.75 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.794 1.637 . . . . 0.0 115.074 172.481 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -93.28 137.8 32.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.597 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.3 mt -119.68 137.88 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 170.269 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.4 t -100.86 142.0 32.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.328 1.851 . . . . 0.0 109.941 166.198 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 mt -135.73 142.93 45.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 171.134 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -88.03 115.48 25.54 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 161.787 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 t -123.93 132.41 71.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 127.75 2.42 . . . . 0.0 108.583 -174.985 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -91.3 148.6 38.05 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 114.866 -2.492 . . . . 0.0 110.0 -172.811 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -43.17 -46.0 9.4 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 123.596 2.864 . . . . 0.0 114.955 171.957 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -91.99 15.68 12.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.095 0.861 . . . . 0.0 112.624 -178.428 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -78.46 132.98 37.5 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 118.601 -2.562 . . . . 0.0 105.241 162.818 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.8 p -84.97 179.32 7.32 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 109.86 177.564 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.323 1.1 mp -71.15 -37.36 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 124.192 1.949 . . . . 0.0 108.989 -178.062 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -57.1 -39.01 74.21 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 117.456 -3.278 . . . . 0.0 114.332 173.03 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -53.17 -50.85 63.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 126.007 2.067 . . . . 0.0 115.158 177.739 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 t -65.85 -48.03 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 1 C-N-CA 132.377 4.271 . . . . 0.0 111.094 171.123 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -64.86 -35.94 82.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 115.998 -1.953 . . . . 0.0 111.731 179.11 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.83 -37.03 70.67 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.035 2.134 . . . . 0.0 114.164 174.987 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -84.51 -29.74 25.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 111.068 -2.787 . . . . 0.0 103.67 -170.676 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.8 mt -73.91 -46.24 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 121.503 1.956 . . . . 0.0 112.562 165.368 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -52.98 -48.42 67.46 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 129.532 3.133 . . . . 0.0 110.557 -178.571 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -56.28 -42.63 77.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 169.854 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -86.8 -55.06 4.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -175.867 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -100.01 -18.53 16.99 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 129.532 3.133 . . . . 0.0 113.289 -171.583 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.09 -1.51 70.44 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 114.829 0.692 . . . . 0.0 114.829 155.641 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.63 136.1 71.23 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-O 115.252 -2.309 . . . . 0.0 112.845 173.43 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -70.29 166.32 28.64 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 O-C-N 125.513 2.323 . . . . 0.0 116.449 173.421 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.42 -33.21 5.65 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 CA-C-O 114.901 -2.208 . . . . 0.0 111.228 -166.666 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.94 -21.8 58.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 123.712 2.96 . . . . 0.0 113.241 173.574 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -111.14 -1.08 16.33 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 128.497 2.719 . . . . 0.0 112.078 -169.454 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -96.83 109.24 21.97 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 127.717 2.407 . . . . 0.0 107.145 172.756 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -110.33 89.2 2.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -175.816 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.304 12.8 mt -79.07 127.9 32.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 129.597 3.159 . . . . 0.0 109.221 -179.918 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 8.2 mt -126.2 135.41 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 O-C-N 126.996 2.685 . . . . 0.0 113.561 -175.466 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -147.35 124.3 11.33 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.213 2.205 . . . . 0.0 112.112 172.568 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.36 44.08 9.94 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.882 2.073 . . . . 0.0 111.586 169.009 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.99 4.81 64.65 Favored Glycine 0 CA--C 1.537 1.407 1 CA-C-O 111.949 -4.806 . . . . 0.0 110.393 164.449 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -133.67 141.46 47.6 Favored 'General case' 0 N--CA 1.448 -0.565 1 O-C-N 131.147 4.675 . . . . 0.0 107.509 -170.932 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.408 HE22 ' CD ' ' A' ' 51' ' ' GLU . 4.6 tm0? -70.05 127.67 33.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 123.927 1.822 . . . . 0.0 108.957 160.381 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -83.29 125.29 31.46 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 171.068 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' CD ' HE22 ' A' ' 49' ' ' GLN . 6.2 tp10 -90.33 136.69 32.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.754 1.622 . . . . 0.0 110.008 -166.163 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -53.83 99.58 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.604 1 C-N-CA 132.29 4.236 . . . . 0.0 117.209 172.207 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.13 -3.46 6.81 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 119.221 2.448 . . . . 0.0 119.221 169.044 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -86.84 -167.66 1.96 Allowed 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 118.824 -2.574 . . . . 0.0 104.463 172.611 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 69.5 p -106.7 165.77 11.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.58 178.321 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -27.77 69.57 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 123.504 1.621 . . . . 0.0 114.626 169.013 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -67.52 -36.1 80.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.454 -1.703 . . . . 0.0 115.042 172.286 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.11 -21.41 66.17 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.702 1.601 . . . . 0.0 114.426 179.235 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -112.52 -2.17 14.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 116.868 2.174 . . . . 0.0 116.868 -167.264 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 44.28 46.6 7.66 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 171.343 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -83.98 -35.26 10.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 128.032 3.333 . . . . 0.0 113.905 -173.922 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 75.51 152.28 0.13 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 129.317 3.047 . . . . 0.0 113.357 164.413 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.95 135.88 35.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 127.031 2.133 . . . . 0.0 113.992 173.461 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.344 9.2 tt0 89.05 -1.38 0.37 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 111.311 -2.677 . . . . 0.0 111.479 173.421 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -85.77 162.69 18.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 117.863 -3.023 . . . . 0.0 109.348 -171.082 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.268 36.9 m -121.5 122.83 40.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.176 2.59 . . . . 0.0 106.641 -171.864 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.299 72.9 mt -89.44 145.36 25.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 119.424 -2.047 . . . . 0.0 107.315 167.318 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.276 74.2 m-70 -100.72 121.39 41.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.447 2.699 . . . . 0.0 108.231 174.114 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.1 tp -99.21 118.29 35.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 126.605 2.441 . . . . 0.0 105.277 -179.262 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.48 135.06 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.0 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt -72.84 122.01 20.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 112.99 -3.386 . . . . 0.0 107.312 169.68 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -69.23 83.4 0.36 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 122.957 2.617 . . . . 0.0 111.596 167.325 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.39 125.5 54.32 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.747 -177.937 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 64.2 161.47 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 1 C-N-CA 135.773 5.629 . . . . 0.0 113.181 -156.142 . . . . . . . . 2 2 . 1 . 105 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.15 -42.25 2.44 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 110.194 -3.184 . . . . 0.0 108.84 170.023 . . . . . . . . 1 1 . 1 . 105 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.448 0 O-C-N 118.383 -2.833 . . . . 0.0 111.629 169.455 . . . . . . . . 0 0 . 1 . 106 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 117.566 -1.206 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 106 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.258 77.4 mm-40 -115.7 129.35 56.44 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.431 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.8 pt -100.4 155.14 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 116.866 -1.54 . . . . 0.0 111.066 165.608 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -103.71 121.66 43.43 Favored 'General case' 0 C--O 1.219 -0.532 0 O-C-N 127.395 2.934 . . . . 0.0 105.168 178.16 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 t -115.22 123.59 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 117.213 -3.43 . . . . 0.0 107.886 -177.629 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -119.57 99.66 6.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.599 -1.313 . . . . 0.0 113.294 -173.709 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.2 p -85.04 161.37 19.74 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 119.788 -1.82 . . . . 0.0 112.62 -174.592 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.386 0.0 OUTLIER -17.39 -72.78 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 1 C-N-CA 133.592 4.757 . . . . 0.0 119.711 -172.382 . . . . . . . . 4 3 . 1 . 106 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.0 p -61.21 -10.28 6.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.469 -1.696 . . . . 0.0 114.073 171.827 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.67 -5.17 34.83 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 127.222 3.679 . . . . 0.0 117.64 176.673 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.03 110.77 1.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 129.071 2.948 . . . . 0.0 108.678 -177.894 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.1 m -99.06 139.24 35.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 127.382 2.926 . . . . 0.0 107.559 -161.519 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.4 mt -123.23 141.46 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 177.387 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 m -98.51 105.88 18.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 127.994 3.309 . . . . 0.0 110.054 153.198 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tp -99.07 133.62 43.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 -179.365 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.266 83.6 tt0 -86.27 141.57 29.18 Favored 'General case' 0 N--CA 1.45 -0.427 1 O-C-N 129.363 4.165 . . . . 0.0 106.561 174.712 . . . . . . . . 3 2 . 1 . 106 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.29 179.24 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 126.691 3.138 . . . . 0.0 109.562 174.396 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -107.79 152.99 41.8 Favored Pre-proline 0 N--CA 1.45 -0.458 0 O-C-N 116.793 -3.692 . . . . 0.0 106.491 148.578 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.5 -25.19 25.45 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 O-C-N 116.714 -2.308 . . . . 0.0 113.294 -176.575 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.2 p -77.51 -0.81 27.6 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 129.052 2.941 . . . . 0.0 114.899 174.069 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -77.34 148.96 35.33 Favored 'General case' 0 C--O 1.22 -0.457 0 O-C-N 126.256 2.222 . . . . 0.0 110.226 173.279 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -109.16 144.33 37.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 111.437 -2.619 . . . . 0.0 105.581 -163.447 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -54.07 -30.29 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 1 CA-C-O 110.342 -4.647 . . . . 0.0 115.005 -171.022 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -65.73 -33.83 76.77 Favored 'General case' 0 N--CA 1.451 -0.401 1 CA-C-N 126.006 4.003 . . . . 0.0 113.067 172.532 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -80.66 -16.42 54.07 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 126.824 2.578 . . . . 0.0 107.577 -175.741 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.25 -53.55 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 127.216 2.206 . . . . 0.0 110.649 171.244 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -60.71 -37.83 83.02 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.278 1.831 . . . . 0.0 112.26 176.611 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.59 -10.08 59.13 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 115.236 -2.316 . . . . 0.0 109.88 178.898 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -91.34 -36.93 13.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.55 2.74 . . . . 0.0 108.996 178.925 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.4 mt -65.54 -40.17 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 128.785 2.834 . . . . 0.0 108.718 170.791 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.53 -47.43 66.71 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.32 -2.737 . . . . 0.0 116.282 167.061 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.58 -41.42 92.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 120.937 1.699 . . . . 0.0 115.171 172.175 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -78.01 -37.17 47.69 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.675 1.234 . . . . 0.0 112.837 -176.726 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.35 28.8 mm-40 -124.37 -33.72 3.0 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 -169.197 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.97 39.71 1.95 Allowed Glycine 0 CA--C 1.527 0.841 1 O-C-N 115.279 -4.638 . . . . 0.0 116.127 162.709 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 mt -123.36 135.72 26.34 Favored Pre-proline 0 N--CA 1.451 -0.424 0 O-C-N 118.316 -2.873 . . . . 0.0 108.592 179.159 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 71.5 Cg_endo -76.89 137.16 17.38 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 O-C-N 125.42 2.274 . . . . 0.0 113.249 -177.967 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.2 Cg_exo -44.9 -30.24 4.3 Favored 'Trans proline' 0 N--CA 1.446 -1.292 1 C-N-CA 126.161 4.574 . . . . 0.0 118.903 -177.204 . . . . . . . . 3 3 . 1 . 106 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.2 -10.83 56.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -168.151 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -98.21 -3.19 38.03 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 129.476 3.111 . . . . 0.0 112.596 175.639 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.255 64.6 mt-30 -107.94 132.9 53.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 123.63 2.923 . . . . 0.0 104.332 -172.191 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -113.96 129.95 56.56 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 119.921 -1.737 . . . . 0.0 109.842 149.965 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.5 mt -101.36 120.58 40.48 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.586 1.955 . . . . 0.0 108.128 170.262 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mm -97.63 131.59 44.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 113.076 -3.345 . . . . 0.0 109.832 172.959 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -111.89 136.38 51.27 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 124.638 3.381 . . . . 0.0 104.795 152.897 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.0 -99.95 0.1 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.205 1.402 . . . . 0.0 112.228 -169.98 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.84 25.08 3.77 Favored Glycine 0 CA--C 1.523 0.558 1 C-N-CA 131.581 4.42 . . . . 0.0 113.341 159.646 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -93.82 111.35 23.03 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 118.144 -2.974 . . . . 0.0 107.563 175.82 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -76.17 97.17 4.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 127.693 3.121 . . . . 0.0 112.857 175.818 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.81 127.92 33.51 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 126.819 2.575 . . . . 0.0 113.234 -171.384 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -104.77 132.08 51.46 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 131.358 3.863 . . . . 0.0 113.748 -169.915 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.6 123.01 17.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 130.775 3.63 . . . . 0.0 109.116 -179.128 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.72 -6.87 20.12 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 120.359 1.436 . . . . 0.0 111.475 -177.1 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -122.16 173.62 7.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 170.821 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -115.37 175.63 5.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 117.894 -3.004 . . . . 0.0 113.635 -168.886 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.1 mt -75.6 -30.3 59.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 123.258 1.504 . . . . 0.0 111.864 172.401 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -58.98 -36.2 74.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.905 1.336 . . . . 0.0 112.288 170.727 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -69.9 -41.98 74.0 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 119.252 -2.155 . . . . 0.0 108.788 -174.179 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -84.85 10.89 10.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 175.552 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 58.96 35.58 24.16 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 129.058 2.943 . . . . 0.0 111.418 172.051 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.2 mt -88.78 142.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 -173.816 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.304 3.4 pm0 -137.63 -166.22 1.91 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.811 2.045 . . . . 0.0 114.104 -162.677 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -60.81 131.83 51.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 128.861 2.864 . . . . 0.0 110.392 174.255 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.397 0.8 OUTLIER 86.36 17.06 0.11 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 127.614 3.578 . . . . 0.0 115.648 175.926 . . . . . . . . 3 3 . 1 . 106 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.8 p -83.58 127.94 34.13 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 118.216 -2.803 . . . . 0.0 112.099 -178.346 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.1 m -107.1 114.65 28.86 Favored 'General case' 0 N--CA 1.445 -0.716 1 C-N-CA 132.383 4.273 . . . . 0.0 108.697 172.724 . . . . . . . . 2 2 . 1 . 106 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -100.48 130.26 46.54 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.627 1.571 . . . . 0.0 109.016 174.895 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -102.3 127.97 49.05 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 128.852 2.861 . . . . 0.0 107.155 -170.399 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -93.69 150.72 20.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 122.22 2.282 . . . . 0.0 105.889 175.321 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.4 p -141.32 141.61 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 130.088 3.355 . . . . 0.0 107.37 163.894 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt -77.4 154.95 32.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 121.092 1.769 . . . . 0.0 110.615 175.358 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -97.57 117.97 33.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 103.044 -2.947 . . . . 0.0 103.044 168.714 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.7 mt -135.82 -5.19 2.19 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 125.176 1.547 . . . . 0.0 114.249 -171.267 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -153.25 136.55 15.75 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.844 3.257 . . . . 0.0 117.96 168.083 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.17 -168.36 14.76 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 106.248 -2.741 . . . . 0.0 106.248 175.318 . . . . . . . . 1 1 . 1 . 106 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.463 1 O-C-N 116.177 -4.131 . . . . 0.0 103.5 168.166 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 123.465 1.602 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 107 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -101.32 134.45 44.36 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.922 -1.111 . . . . 0.0 113.823 163.753 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.312 2.1 pp -124.82 146.96 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.774 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -105.73 133.83 49.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 123.797 1.76 . . . . 0.0 108.898 177.004 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.09 133.97 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 174.632 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -108.38 122.24 46.6 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 111.848 -2.433 . . . . 0.0 109.843 178.026 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -80.42 153.25 28.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 123.557 1.646 . . . . 0.0 110.161 179.627 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.36 -25.66 63.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.45 2.3 . . . . 0.0 112.383 -174.738 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.3 p -100.63 19.64 16.59 Favored 'General case' 0 CA--C 1.538 0.494 1 C-N-CA 132.943 4.497 . . . . 0.0 115.692 173.374 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.93 21.61 11.83 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-O 115.136 -3.036 . . . . 0.0 117.535 137.457 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.353 55.2 mttt -103.78 171.11 7.53 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 128.356 2.663 . . . . 0.0 115.966 169.623 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -128.22 103.92 7.45 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 130.366 3.466 . . . . 0.0 108.92 169.931 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.4 mm -81.11 117.51 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 128.629 2.771 . . . . 0.0 112.469 177.469 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.269 22.9 m -93.97 105.52 17.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.102 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -88.78 159.33 17.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 172.183 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -107.35 133.89 51.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 124.422 2.058 . . . . 0.0 107.224 165.253 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 m -139.51 -179.09 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 119.895 -1.753 . . . . 0.0 110.795 178.537 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -140.05 155.11 70.86 Favored Pre-proline 0 N--CA 1.451 -0.407 0 C-N-CA 130.208 3.403 . . . . 0.0 104.195 171.955 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.47 -38.33 53.22 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-O 115.538 -1.942 . . . . 0.0 116.39 -175.851 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -77.75 -9.42 59.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 124.542 1.151 . . . . 0.0 111.494 -170.877 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.67 135.9 52.09 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 125.041 2.353 . . . . 0.0 109.743 179.304 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.0 p -78.38 153.94 31.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 129.737 3.215 . . . . 0.0 111.257 -168.22 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.3 -17.59 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.33 -0.856 . . . . 0.0 108.934 -178.54 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -78.04 -44.15 27.26 Favored 'General case' 0 N--CA 1.448 -0.549 1 O-C-N 116.254 -4.029 . . . . 0.0 108.021 -179.506 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -62.86 -50.26 71.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 112.93 -3.414 . . . . 0.0 114.552 166.351 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 22' ' ' THR . 70.9 t -52.99 -40.65 37.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 121.828 2.104 . . . . 0.0 111.375 177.032 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -42.04 -35.78 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 115.98 1.845 . . . . 0.0 115.98 166.182 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.73 -28.06 14.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 120.363 1.438 . . . . 0.0 108.69 -177.207 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -60.92 -31.69 71.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 117.887 -3.008 . . . . 0.0 118.29 168.264 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.285 1.5 tt -70.87 -40.76 76.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 167.993 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.26 -36.41 75.45 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 175.54 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -74.19 -10.69 59.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.902 0.774 . . . . 0.0 112.626 -170.928 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -77.7 0.22 Allowed 'General case' 0 C--O 1.235 0.338 1 C-N-CA 132.385 4.274 . . . . 0.0 116.603 159.699 . . . . . . . . 3 3 . 1 . 107 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -98.54 -3.38 36.56 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.265 -0.897 . . . . 0.0 113.259 -162.777 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.01 7.95 86.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 117.906 -2.092 . . . . 0.0 117.36 171.14 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.5 mt -74.71 120.65 82.58 Favored Pre-proline 0 N--CA 1.454 -0.237 1 C-N-CA 132.704 4.402 . . . . 0.0 109.206 178.65 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -74.51 141.0 27.61 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 CA-C-O 115.164 -2.098 . . . . 0.0 112.989 -175.203 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.23 -7.14 20.47 Favored 'Trans proline' 0 N--CA 1.447 -1.264 1 C-N-CA 127.443 5.429 . . . . 0.0 116.531 -178.408 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -74.34 -9.82 58.98 Favored 'General case' 0 N--CA 1.446 -0.644 1 O-C-N 115.13 -4.731 . . . . 0.0 113.424 168.779 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -119.47 -8.49 10.01 Favored 'General case' 0 C--N 1.323 -0.56 1 C-N-CA 134.56 5.144 . . . . 0.0 114.146 -175.468 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 11.4 mt-30 -90.35 152.79 20.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 119.989 -1.694 . . . . 0.0 111.598 168.638 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttp-105 -128.05 122.09 31.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 115.028 -2.415 . . . . 0.0 109.849 156.794 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.522 ' HB3' HD13 ' A' ' 50' ' ' LEU . 3.0 mm? -80.84 115.51 20.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.635 1.561 . . . . 0.0 106.949 172.117 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.3 mt -116.26 134.85 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 116.418 -1.754 . . . . 0.0 106.7 167.299 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -88.29 -49.88 6.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.277 1.399 . . . . 0.0 108.299 -175.653 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.51 -44.32 0.1 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.221 -1.371 . . . . 0.0 114.566 -177.213 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.3 -11.21 4.75 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 118.685 2.234 . . . . 0.0 118.685 152.443 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -143.18 160.22 40.85 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.961 1.304 . . . . 0.0 112.686 -161.85 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -78.96 142.87 36.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 125.462 1.726 . . . . 0.0 113.646 -159.366 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.522 HD13 ' HB3' ' A' ' 43' ' ' LEU . 6.8 mp -85.83 109.32 18.61 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.174 -3.454 . . . . 0.0 106.652 170.496 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -71.44 128.55 36.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.592 2.757 . . . . 0.0 111.126 -175.438 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -52.68 122.42 9.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 124.836 2.255 . . . . 0.0 112.647 166.328 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.1 19.48 5.92 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 118.683 -2.51 . . . . 0.0 110.815 173.848 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.323 26.8 mtt-85 -127.21 170.89 11.94 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 130.643 3.577 . . . . 0.0 113.992 -179.652 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -118.03 162.9 17.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 130.051 3.341 . . . . 0.0 117.893 174.939 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.69 -41.69 56.12 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 122.659 2.481 . . . . 0.0 113.012 173.974 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 t -60.82 -22.24 63.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 118.502 2.778 . . . . 0.0 118.502 -178.739 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -69.23 -37.93 78.25 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 120.792 -1.192 . . . . 0.0 113.677 168.999 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -98.54 -1.38 41.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.972 2.109 . . . . 0.0 112.564 -175.264 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 74.31 14.19 3.74 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 129.454 3.102 . . . . 0.0 112.149 168.217 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.267 90.1 mt -55.41 125.45 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 124.082 0.953 . . . . 0.0 113.102 178.743 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -131.89 167.49 19.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.794 2.838 . . . . 0.0 112.271 -176.191 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.326 41.3 pttt -34.57 119.03 0.43 Allowed 'General case' 0 N--CA 1.447 -0.605 1 C-N-CA 132.999 4.52 . . . . 0.0 116.114 -178.122 . . . . . . . . 3 2 . 1 . 107 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 63.94 25.44 13.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 179.507 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 m -70.46 121.41 17.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 115.305 -2.283 . . . . 0.0 107.752 160.189 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -95.87 119.37 34.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 125.725 1.891 . . . . 0.0 107.532 174.896 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.21 147.0 26.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 128.683 2.793 . . . . 0.0 105.574 179.858 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -95.49 154.37 17.24 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 101.374 -3.565 . . . . 0.0 101.374 174.557 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.82 114.55 20.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 125.37 2.51 . . . . 0.0 112.875 161.35 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.7 t -79.86 152.47 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 129.905 3.282 . . . . 0.0 111.391 165.724 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -116.21 147.22 41.66 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 124.022 1.868 . . . . 0.0 106.848 -174.062 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -72.09 115.86 11.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.109 -1.86 . . . . 0.0 108.77 166.148 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.306 30.0 tp -143.47 140.89 30.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 118.406 -2.684 . . . . 0.0 104.881 -173.738 . . . . . . . . 2 2 . 1 . 107 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -107.7 133.77 51.64 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.709 2.404 . . . . 0.0 112.8 179.422 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.47 177.42 25.92 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 130.138 3.732 . . . . 0.0 109.592 175.703 . . . . . . . . 1 1 . 1 . 107 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.804 1 C-N-CA 134.239 5.685 . . . . 0.0 108.779 172.67 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptt? . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 . . . . . . . . . 0 0 . 1 . 108 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -86.5 157.4 19.79 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 124.404 1.065 . . . . 0.0 110.487 166.294 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.24 158.64 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 128.504 2.722 . . . . 0.0 106.531 155.142 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -113.54 138.13 50.59 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.694 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.4 115.75 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 1 C-N-CA 133.857 4.863 . . . . 0.0 107.738 170.08 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -84.56 135.32 34.26 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.563 1.545 . . . . 0.0 108.863 170.997 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -82.55 169.08 16.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 126.93 2.644 . . . . 0.0 108.118 158.615 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.99 -21.25 24.94 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.062 2.145 . . . . 0.0 109.569 178.848 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 p -68.9 -30.92 69.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 116.329 -3.982 . . . . 0.0 114.764 163.285 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.11 5.96 5.5 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 125.723 3.874 . . . . 0.0 113.639 161.653 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -88.85 130.32 35.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 117.79 -3.182 . . . . 0.0 107.391 175.353 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.8 m -89.17 128.52 35.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 124.962 2.315 . . . . 0.0 107.85 160.997 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.71 135.31 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 1 O-C-N 114.751 -4.968 . . . . 0.0 103.004 173.836 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.4 m -99.9 138.1 37.44 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 127.926 3.266 . . . . 0.0 104.023 176.18 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.441 HD13 HG13 ' A' ' 26' ' ' VAL . 53.9 mt -131.28 142.38 50.11 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.652 1.981 . . . . 0.0 110.432 178.005 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -124.5 110.6 14.68 Favored 'General case' 0 C--N 1.322 -0.622 2 O-C-N 115.748 -4.345 . . . . 0.0 110.35 -170.601 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.44 158.82 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 110.424 -3.08 . . . . 0.0 114.485 -163.022 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -96.39 153.5 38.91 Favored Pre-proline 0 N--CA 1.447 -0.598 0 O-C-N 127.53 3.019 . . . . 0.0 106.946 160.334 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -76.46 -6.66 17.27 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 118.72 2.546 . . . . 0.0 118.72 -170.616 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 m -94.44 7.14 46.57 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.484 1.514 . . . . 0.0 107.624 174.405 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.435 ' CG ' HD22 ' A' ' 25' ' ' ASN . 16.4 t0 -80.95 137.37 36.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 116.986 -3.571 . . . . 0.0 109.76 171.829 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -92.13 149.41 21.5 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 118.185 -2.822 . . . . 0.0 106.839 -156.351 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mp -46.86 -31.92 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 127.684 2.394 . . . . 0.0 114.569 169.673 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.27 -28.29 66.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.495 -1.378 . . . . 0.0 111.342 179.676 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.435 HD22 ' CG ' ' A' ' 21' ' ' ASP . 63.6 t30 -81.32 -33.82 32.28 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 119.534 -1.979 . . . . 0.0 114.42 170.451 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.441 HG13 HD13 ' A' ' 15' ' ' LEU 0.301 39.5 t -59.24 -44.98 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 116.592 -1.67 . . . . 0.0 108.518 170.117 . . . . . . . . 3 3 . 1 . 108 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HA ' HD12 ' A' ' 30' ' ' ILE . 69.9 mttt -50.66 -38.74 48.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.176 2.658 . . . . 0.0 118.176 172.793 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.9 -23.89 31.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 123.623 0.577 . . . . 0.0 112.096 -168.507 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 30.9 mttm -73.08 -29.43 62.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 118.96 -2.338 . . . . 0.0 111.698 175.441 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 27' ' ' LYS . 62.8 mt -70.64 -52.69 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 129.512 3.125 . . . . 0.0 105.943 178.301 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.372 1.1 tp-100 -34.23 -45.24 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 1 O-C-N 115.008 -4.807 . . . . 0.0 119.386 162.088 . . . . . . . . 3 2 . 1 . 108 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -73.71 -44.96 54.99 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 131.289 3.836 . . . . 0.0 109.953 -178.584 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -74.02 -47.35 37.56 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 119.833 3.272 . . . . 0.0 119.833 -177.275 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -135.6 11.8 3.45 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 117.906 -1.045 . . . . 0.0 113.701 -177.205 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.71 -8.38 75.74 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 157.485 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.6 mt -58.71 131.74 85.97 Favored Pre-proline 0 N--CA 1.449 -0.497 1 C-N-CA 134.744 5.218 . . . . 0.0 107.404 173.544 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -80.3 150.51 19.91 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.947 1.098 . . . . 0.0 112.392 -178.574 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.18 -30.83 10.14 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 124.211 3.274 . . . . 0.0 116.985 -175.997 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.38 -3.58 31.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -166.549 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -99.99 -31.15 11.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -173.483 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -75.76 118.01 18.11 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.699 1.6 . . . . 0.0 112.631 -159.407 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -102.11 113.43 26.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 130.77 3.628 . . . . 0.0 105.976 158.407 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.82 150.36 24.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 121.615 2.007 . . . . 0.0 106.932 166.929 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.28 15.2 mt -126.63 139.62 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.905 176.187 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -139.82 115.73 10.27 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 128.101 2.56 . . . . 0.0 109.412 177.659 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 74.56 20.86 2.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.961 2.504 . . . . 0.0 108.262 167.587 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.84 -3.17 73.67 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 130.323 3.821 . . . . 0.0 110.413 -175.141 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -96.66 134.2 40.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 121.516 2.658 . . . . 0.0 106.54 -170.411 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.5 pm0 -80.56 132.07 35.61 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 126.356 2.285 . . . . 0.0 108.843 172.312 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 59' ' ' TYR . 25.6 mt -95.57 155.42 16.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 125.206 2.432 . . . . 0.0 112.209 -172.921 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -118.16 157.01 27.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 112.784 -2.007 . . . . 0.0 109.088 -178.215 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -77.59 137.97 38.87 Favored 'General case' 0 N--CA 1.444 -0.726 1 O-C-N 129.996 4.56 . . . . 0.0 112.589 -172.804 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.67 -21.23 46.97 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 177.905 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -84.78 169.93 13.71 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 127.179 2.191 . . . . 0.0 112.239 168.83 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.7 p -110.55 163.52 13.63 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.179 1.792 . . . . 0.0 110.461 -162.159 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.418 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 5.7 mt -43.48 -47.51 7.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.867 1.667 . . . . 0.0 111.937 152.899 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -63.78 -38.95 93.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.532 1.933 . . . . 0.0 113.109 -170.682 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.53 -45.15 88.42 Favored 'General case' 0 C--N 1.327 -0.376 1 C-N-CA 133.589 4.756 . . . . 0.0 109.123 -178.992 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.421 ' CD2' HD22 ' A' ' 50' ' ' LEU . 35.5 m-85 -96.26 12.13 32.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 124.157 1.932 . . . . 0.0 109.328 -174.654 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.19 42.62 27.9 Favored 'General case' 0 N--CA 1.444 -0.739 2 C-N-CA 132.492 4.317 . . . . 0.0 114.903 175.858 . . . . . . . . 3 3 . 1 . 108 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 mt -93.71 101.7 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 -172.349 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -94.77 177.93 5.75 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.166 -1.379 . . . . 0.0 113.54 -176.604 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -49.01 142.04 7.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.306 3.042 . . . . 0.0 117.136 -174.77 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 88.3 mt-10 63.76 11.38 5.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 120.17 3.396 . . . . 0.0 120.17 179.005 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -73.52 143.77 46.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.445 -177.586 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.8 m -92.29 139.34 30.71 Favored 'General case' 0 N--CA 1.442 -0.848 1 C-N-CA 132.193 4.197 . . . . 0.0 108.194 178.043 . . . . . . . . 2 2 . 1 . 108 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.68 158.05 42.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 130.236 3.415 . . . . 0.0 111.56 169.215 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -126.01 148.54 49.26 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 128.231 2.612 . . . . 0.0 109.409 163.618 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 0.6 OUTLIER -98.41 130.37 45.04 Favored 'General case' 0 N--CA 1.451 -0.378 1 C-N-CA 132.329 4.252 . . . . 0.0 109.494 167.383 . . . . . . . . 4 3 . 1 . 108 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -103.44 136.37 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.045 164.749 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 mt -93.67 122.97 36.67 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 129.682 3.193 . . . . 0.0 110.638 178.506 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -161.24 112.73 1.79 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.997 172.513 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.76 147.21 39.45 Favored 'General case' 0 CA--C 1.535 0.381 1 C-N-CA 132.185 4.194 . . . . 0.0 109.683 177.062 . . . . . . . . 3 3 . 1 . 108 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.4 ttm105 -72.77 113.09 9.41 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 127.837 2.455 . . . . 0.0 112.228 -175.779 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.67 158.52 14.24 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 118.738 -2.476 . . . . 0.0 109.855 175.868 . . . . . . . . 1 1 . 1 . 108 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.327 0 CA-C-O 114.499 -3.389 . . . . 0.0 104.687 -175.493 . . . . . . . . 0 0 . 1 . 109 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 . . . . . . . . . 0 0 . 1 . 109 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.298 8.8 tt0 -88.62 144.15 26.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 125.718 2.675 . . . . 0.0 108.393 -175.092 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.26 149.38 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 111.214 -2.721 . . . . 0.0 108.848 -179.154 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -88.66 144.15 26.47 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 127.843 2.457 . . . . 0.0 113.965 168.102 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.09 99.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 118.187 -2.821 . . . . 0.0 104.147 -174.154 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -77.05 99.62 5.39 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 167.789 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.4 p -72.04 173.15 8.83 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 126.553 2.408 . . . . 0.0 114.47 166.447 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -40.19 -40.68 1.16 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 129.494 3.118 . . . . 0.0 118.815 -168.352 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.1 p -80.83 -6.43 58.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 171.864 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.71 0.6 60.54 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 123.85 1.806 . . . . 0.0 113.764 -170.369 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -69.22 106.58 2.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.919 -1.641 . . . . 0.0 108.014 -173.848 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.7 m -79.39 112.38 16.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 110.19 -3.187 . . . . 0.0 111.844 -178.304 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mt -110.75 137.27 43.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 1 CA-C-N 106.954 -4.657 . . . . 0.0 109.485 173.214 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.8 m -100.41 125.09 46.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 179.912 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tp -133.73 159.94 39.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 128.665 2.786 . . . . 0.0 110.408 -172.845 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -128.46 155.72 44.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 175.247 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.22 151.3 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 O-C-N 126.336 2.273 . . . . 0.0 107.599 -175.02 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -100.13 136.78 20.02 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 100.953 -3.721 . . . . 0.0 100.953 173.189 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -34.36 -42.01 0.27 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 1 C-N-CA 128.003 5.802 . . . . 0.0 119.326 174.228 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 p -79.3 -13.24 59.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 114.257 -2.782 . . . . 0.0 116.036 179.562 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -47.94 125.52 9.08 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.796 2.038 . . . . 0.0 112.354 -179.468 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.412 HG22 HG22 ' A' ' 55' ' ' THR . 81.9 p -69.39 151.7 45.82 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.911 2.485 . . . . 0.0 111.917 163.067 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.6 mm -63.31 -32.72 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 124.029 3.104 . . . . 0.0 119.151 -174.445 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -54.9 -33.05 61.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.057 2.143 . . . . 0.0 113.339 158.104 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -79.56 -15.67 57.27 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.662 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -82.72 -48.92 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 118.941 -2.349 . . . . 0.0 109.364 169.159 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -60.29 -27.93 67.69 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.275 0.984 . . . . 0.0 113.575 176.309 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.37 -23.43 43.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 118.786 -2.446 . . . . 0.0 116.963 176.699 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -78.24 -47.4 18.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.151 175.725 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.263 26.2 mt -51.02 -40.45 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 O-C-N 128.45 3.594 . . . . 0.0 109.977 169.367 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.62 -62.43 1.86 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.623 1.969 . . . . 0.0 114.024 179.441 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -43.38 -23.7 0.07 Allowed 'General case' 0 N--CA 1.45 -0.436 1 C-N-CA 136.039 5.735 . . . . 0.0 116.699 -178.385 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -96.78 -12.23 23.93 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 131.526 3.931 . . . . 0.0 117.513 179.194 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -160.16 -16.83 0.06 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 122.948 2.613 . . . . 0.0 110.346 -179.082 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.66 11.87 22.19 Favored Glycine 0 CA--C 1.524 0.644 1 C-N-CA 113.679 -4.105 . . . . 0.0 111.401 162.477 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.59 127.61 28.16 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 121.35 2.575 . . . . 0.0 108.457 -170.352 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -68.13 147.3 72.81 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 CA-C-O 114.644 -2.315 . . . . 0.0 111.792 -172.154 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.252 71.3 Cg_exo -44.67 -38.4 12.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 O-C-N 126.711 2.953 . . . . 0.0 117.409 167.887 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.98 -24.79 55.96 Favored 'General case' 0 C--N 1.325 -0.469 1 C-N-CA 131.896 4.078 . . . . 0.0 113.433 179.439 . . . . . . . . 3 3 . 1 . 109 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -110.29 -28.38 8.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 125.709 1.881 . . . . 0.0 110.136 -178.258 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -60.49 104.58 0.35 Allowed 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 119.942 -1.724 . . . . 0.0 111.557 177.668 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -110.56 128.57 55.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 130.205 3.402 . . . . 0.0 102.689 179.885 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 99.29 3.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -157.929 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.8 mm -99.2 128.04 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 -166.153 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.48 ' CE2' HG12 ' A' ' 61' ' ' ILE . 61.7 t80 -146.5 109.66 4.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 -177.928 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 79.99 35.21 0.15 Allowed 'General case' 0 CA--C 1.53 0.178 0 O-C-N 125.496 1.748 . . . . 0.0 109.779 178.355 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.67 -10.51 70.68 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 114.784 -3.579 . . . . 0.0 109.572 169.46 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.259 19.6 pttt -143.89 145.36 32.24 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.723 -2.633 . . . . 0.0 106.208 -161.796 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -72.2 135.25 46.05 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.701 2.4 . . . . 0.0 107.632 -175.977 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.76 107.65 19.07 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.842 1.657 . . . . 0.0 110.464 -179.445 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -114.75 161.57 17.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.412 -2.055 . . . . 0.0 105.862 -159.751 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.0 149.94 30.58 Favored 'General case' 0 N--CA 1.447 -0.61 1 C-N-CA 133.458 4.703 . . . . 0.0 107.423 -178.216 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.86 -21.71 31.39 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 169.584 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -101.49 157.58 16.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.715 2.806 . . . . 0.0 108.577 -172.513 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.412 HG22 HG22 ' A' ' 22' ' ' THR . 22.0 p -113.83 174.94 5.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.991 0.9 . . . . 0.0 109.43 163.662 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.0 mt -53.27 -38.01 62.66 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 176.753 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -60.82 -22.98 64.73 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 167.915 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -86.71 -0.23 55.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 118.446 -2.659 . . . . 0.0 113.94 -178.557 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -138.0 -6.54 1.64 Allowed 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 117.867 -3.021 . . . . 0.0 110.976 172.735 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 67.12 71.37 0.37 Allowed 'General case' 0 N--CA 1.442 -0.855 1 C-N-CA 133.467 4.707 . . . . 0.0 110.3 -177.987 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.48 HG12 ' CE2' ' A' ' 45' ' ' PHE . 70.4 mt -120.18 135.54 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 -177.95 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.264 11.9 pt20 -152.27 -166.61 2.53 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 126.005 2.066 . . . . 0.0 109.936 173.15 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -50.53 142.13 11.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.787 1.635 . . . . 0.0 114.034 -174.373 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 11.4 tp10 89.15 -8.35 0.43 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.543 1.537 . . . . 0.0 114.004 164.404 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -62.84 151.55 38.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 118.24 2.682 . . . . 0.0 118.24 170.128 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -106.8 118.01 35.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 171.802 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.5 mt -89.5 143.93 26.43 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 128.53 2.732 . . . . 0.0 105.592 167.596 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.37 25.6 p80 -133.78 135.76 44.08 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 116.261 -1.828 . . . . 0.0 109.274 -174.457 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.5 154.51 40.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 124.566 1.166 . . . . 0.0 112.561 -164.727 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.48 -179.8 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 131.422 3.889 . . . . 0.0 110.358 169.013 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.311 4.4 mp -93.92 144.17 25.69 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.288 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -89.65 129.81 36.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.405 163.618 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.5 mt -136.39 37.25 2.71 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 -169.824 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -136.97 -74.29 0.43 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 -179.348 . . . . . . . . 1 1 . 1 . 109 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.3 152.8 8.85 Favored Glycine 0 CA--C 1.525 0.681 1 C-N-CA 130.845 4.069 . . . . 0.0 112.01 -177.973 . . . . . . . . 2 2 . 1 . 109 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.329 0 C-N-CA 126.279 1.895 . . . . 0.0 112.252 -172.762 . . . . . . . . 0 0 . 1 . 110 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 115.283 -2.294 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 110 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -81.46 142.22 33.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 123.538 1.637 . . . . 0.0 107.079 167.401 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pt -127.91 152.63 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 116.268 -1.825 . . . . 0.0 107.466 161.675 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -94.11 142.71 27.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 115.627 -2.429 . . . . 0.0 111.897 172.648 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.29 53.1 t -114.68 83.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 1 C-N-CA 132.829 4.452 . . . . 0.0 108.204 169.2 . . . . . . . . 3 2 . 1 . 110 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -64.03 130.83 45.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 110.071 -3.24 . . . . 0.0 109.812 172.255 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -132.65 154.26 50.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.783 0.833 . . . . 0.0 110.306 -176.868 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.571 HD12 ' H ' ' A' ' 8' ' ' LEU . 5.8 mp -42.2 -27.2 0.13 Allowed 'General case' 0 N--CA 1.444 -0.74 1 C-N-CA 133.295 4.638 . . . . 0.0 121.031 -170.271 . . . . . . . . 3 3 . 1 . 110 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 39.1 p -119.17 17.01 13.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.229 -161.147 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.33 24.56 23.9 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 130.312 3.815 . . . . 0.0 112.217 171.127 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -105.4 160.2 15.32 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.932 1.366 . . . . 0.0 107.604 173.62 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -127.89 113.86 16.44 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.515 2.326 . . . . 0.0 113.493 174.681 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -90.67 133.86 31.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 116.466 -3.896 . . . . 0.0 103.843 -179.137 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 t -141.72 83.09 1.84 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 127.508 3.528 . . . . 0.0 112.698 -170.534 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.57 150.38 20.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.011 -2.359 . . . . 0.0 111.488 179.216 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -94.93 118.55 31.99 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 101.88 -3.378 . . . . 0.0 101.88 179.015 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -135.18 152.21 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 123.713 0.805 . . . . 0.0 109.085 -176.146 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -106.51 160.0 27.82 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 173.343 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.328 40.9 Cg_endo -66.92 -24.38 46.1 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.388 2.726 . . . . 0.0 115.269 -168.186 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.1 p -84.57 -4.97 59.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 120.608 3.558 . . . . 0.0 120.608 -174.483 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -69.77 132.25 45.79 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 126.414 2.321 . . . . 0.0 109.624 176.727 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -69.82 147.92 49.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 126.857 3.218 . . . . 0.0 105.996 171.727 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mm -59.58 -34.42 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 110.059 -3.246 . . . . 0.0 114.208 179.8 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.65 -30.66 65.99 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 121.897 2.135 . . . . 0.0 111.16 178.605 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -74.81 -26.54 59.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 125.469 1.731 . . . . 0.0 113.736 174.026 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.5 t -78.42 -24.83 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 121.251 1.841 . . . . 0.0 108.399 173.149 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -67.6 -39.8 84.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 123.562 2.892 . . . . 0.0 112.146 164.896 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.64 -31.7 70.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.71 2.004 . . . . 0.0 110.907 179.244 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -71.04 -10.72 60.24 Favored 'General case' 0 N--CA 1.451 -0.42 1 C-N-CA 134.574 5.149 . . . . 0.0 114.183 176.026 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.1 -27.61 4.36 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 127.563 2.345 . . . . 0.0 108.664 176.375 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -54.74 -27.09 38.43 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 123.064 2.666 . . . . 0.0 115.072 174.287 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -33.82 65.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 123.94 1.829 . . . . 0.0 108.474 179.078 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mmtm -96.49 -51.63 4.27 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.547 2.739 . . . . 0.0 107.085 -164.268 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -113.79 -12.17 12.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -173.45 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.42 -16.45 58.97 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 120.562 1.528 . . . . 0.0 111.584 173.11 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.2 mt -87.51 123.21 69.94 Favored Pre-proline 0 N--CA 1.449 -0.521 0 O-C-N 117.328 -3.454 . . . . 0.0 109.191 -159.209 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.03 154.78 38.0 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 O-C-N 116.349 -2.501 . . . . 0.0 108.057 179.206 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -44.73 -34.21 8.0 Favored 'Trans proline' 0 N--CA 1.441 -1.598 1 C-N-CA 126.738 4.959 . . . . 0.0 119.364 177.174 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.11 -38.26 76.13 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.62 2.768 . . . . 0.0 115.223 178.743 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.8 -8.77 57.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 103.914 -2.625 . . . . 0.0 103.914 -172.967 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -100.75 163.7 12.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 123.28 2.764 . . . . 0.0 112.356 178.324 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -144.7 160.45 41.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 109.989 -3.278 . . . . 0.0 108.547 158.338 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 mt -118.48 126.42 52.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.521 2.328 . . . . 0.0 111.623 169.748 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.4 mm -100.76 139.64 21.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 130.788 3.635 . . . . 0.0 106.952 168.296 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 61' ' ' ILE . 12.2 t80 -122.89 -146.12 0.36 Allowed 'General case' 0 C--N 1.332 -0.196 0 O-C-N 126.705 2.503 . . . . 0.0 110.466 173.654 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.11 54.18 1.58 Allowed 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.32 -1.488 . . . . 0.0 110.227 -171.543 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.64 -19.04 19.45 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 117.498 -1.723 . . . . 0.0 110.987 178.451 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -112.8 138.76 49.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 126.559 3.076 . . . . 0.0 107.063 -168.831 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -88.75 123.35 33.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.04 -1.891 . . . . 0.0 108.26 165.281 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 mt -82.22 141.09 33.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 120.9 -1.125 . . . . 0.0 113.201 -174.532 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -98.25 147.62 24.44 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.774 -0.578 . . . . 0.0 110.756 -176.488 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.04 123.52 29.55 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 125.153 1.533 . . . . 0.0 106.909 -177.71 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.1 -29.65 4.08 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 128.178 2.799 . . . . 0.0 114.194 -179.692 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -84.43 154.73 22.61 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 128.408 3.064 . . . . 0.0 106.395 172.484 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -78.6 169.82 17.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 112.226 -2.261 . . . . 0.0 110.918 175.888 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.8 -17.28 63.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 119.793 -1.817 . . . . 0.0 111.467 168.684 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.5 t -92.23 -13.93 29.73 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 118.377 -2.702 . . . . 0.0 111.472 -169.653 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -50.19 -46.04 54.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 130.988 3.715 . . . . 0.0 106.217 168.413 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -101.21 16.47 25.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 123.383 1.563 . . . . 0.0 111.016 -172.159 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.342 10.9 p-10 52.21 40.84 29.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 129.338 3.055 . . . . 0.0 114.183 177.943 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.527 HG12 ' CE2' ' A' ' 45' ' ' PHE . 19.0 mt -76.72 128.64 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 125.599 2.619 . . . . 0.0 106.786 -177.619 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -105.07 167.64 9.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 109.073 -3.694 . . . . 0.0 111.013 -177.064 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.283 36.0 pttt -40.62 129.68 2.49 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 118.719 2.859 . . . . 0.0 118.719 162.965 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 58.65 3.03 0.26 Allowed 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 126.782 2.551 . . . . 0.0 117.71 173.189 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 t -63.16 152.9 36.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.029 1.732 . . . . 0.0 114.009 174.723 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -102.14 120.41 40.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -160.995 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.83 152.68 22.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.509 2.724 . . . . 0.0 106.502 164.477 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -123.93 137.4 54.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 126.029 2.081 . . . . 0.0 109.638 -175.472 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -118.71 132.77 56.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 119.732 -1.855 . . . . 0.0 108.006 -159.838 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 m -137.64 165.2 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 1 CA-C-N 126.181 4.082 . . . . 0.0 107.384 -170.438 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.1 tp -86.82 134.48 33.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 124.027 1.87 . . . . 0.0 109.619 -179.818 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.281 40.0 ttt180 -102.74 140.0 37.58 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 116.363 -3.96 . . . . 0.0 102.89 -179.994 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.1 mt -124.91 49.25 1.88 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 129.764 3.226 . . . . 0.0 111.492 -170.334 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 90.41 2.45 0.17 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 130.874 3.67 . . . . 0.0 105.93 167.491 . . . . . . . . 1 1 . 1 . 110 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.05 136.63 9.97 Favored Glycine 0 CA--C 1.536 1.394 1 O-C-N 115.286 -4.634 . . . . 0.0 106.634 -167.852 . . . . . . . . 2 2 . 1 . 110 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.369 1 C-N-CA 130.972 4.129 . . . . 0.0 114.823 -167.441 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 . . . . . . . . . 0 0 . 1 . 111 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -77.09 143.9 38.91 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 122.725 2.512 . . . . 0.0 112.973 -179.975 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.263 46.7 pt -140.13 168.49 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 125.756 1.91 . . . . 0.0 106.997 173.045 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.94 133.52 31.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 118.326 -2.734 . . . . 0.0 110.569 159.429 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.4 t -93.04 105.58 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 101.194 -3.632 . . . . 0.0 101.194 174.117 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -97.65 104.11 16.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 118.631 -2.543 . . . . 0.0 110.198 171.542 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -86.47 146.58 26.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 126.464 3.03 . . . . 0.0 113.74 -162.876 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 9' ' ' THR . 3.4 pp -70.64 -28.74 65.04 Favored 'General case' 0 N--CA 1.446 -0.64 1 O-C-N 113.3 -5.875 . . . . 0.0 109.443 179.145 . . . . . . . . 3 3 . 1 . 111 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.418 HG23 HD12 ' A' ' 8' ' ' LEU 0.358 30.2 p -62.52 -7.46 4.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 119.667 3.21 . . . . 0.0 119.667 162.282 . . . . . . . . 3 3 . 1 . 111 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.96 -5.63 11.25 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-O 114.685 -3.286 . . . . 0.0 118.4 150.489 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -120.66 160.59 22.97 Favored 'General case' 0 N--CA 1.446 -0.661 1 CA-C-N 125.422 4.611 . . . . 0.0 111.259 -177.568 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -100.39 136.9 39.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 125.441 1.713 . . . . 0.0 109.591 177.174 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mt -113.59 119.09 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.278 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -75.85 126.73 31.56 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 130.652 3.581 . . . . 0.0 106.099 169.948 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.26 160.85 39.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 124.177 1.942 . . . . 0.0 105.904 -173.481 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -125.87 131.47 52.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.076 2.151 . . . . 0.0 109.244 -178.184 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 m -137.27 169.83 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 O-C-N 127.382 2.926 . . . . 0.0 110.715 178.238 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.283 0.7 OUTLIER -112.08 146.72 35.41 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 168.382 . . . . . . . . 3 3 . 1 . 111 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -47.99 -33.39 20.29 Favored 'Trans proline' 0 N--CA 1.447 -1.233 1 C-N-CA 129.3 6.667 . . . . 0.0 115.37 158.632 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.9 p -74.47 -6.81 50.45 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 119.516 3.154 . . . . 0.0 119.516 174.279 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -73.02 130.53 40.53 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 129.204 3.002 . . . . 0.0 104.378 179.714 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -77.28 155.85 31.79 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 111.962 -2.381 . . . . 0.0 112.852 163.376 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.367 35.5 mm -49.88 -38.1 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -178.359 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.29 -29.85 62.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.216 2.606 . . . . 0.0 113.632 177.934 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -75.94 -34.62 59.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 114.562 -2.637 . . . . 0.0 108.342 172.565 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.11 -42.69 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 120.673 1.579 . . . . 0.0 111.029 175.058 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -63.59 -27.09 69.01 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 118.441 -2.662 . . . . 0.0 111.755 179.484 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.32 . . -80.21 -22.09 42.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 116.312 -1.804 . . . . 0.0 111.727 179.962 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -80.08 -23.09 41.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 113.99 -2.909 . . . . 0.0 104.903 173.617 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 69' ' ' LEU . 96.2 mt -74.6 -37.4 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 166.717 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.356 51.1 tt0 -63.66 -32.29 73.73 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -178.412 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -70.65 -32.31 69.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.391 -2.186 . . . . 0.0 112.187 -177.626 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -98.7 -49.76 4.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 -169.738 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -105.43 -17.6 14.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 120.721 -1.237 . . . . 0.0 107.839 -165.148 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.52 4.73 57.1 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 120.769 -1.207 . . . . 0.0 114.178 171.208 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.1 mm -91.4 124.41 61.21 Favored Pre-proline 0 C--O 1.236 0.384 0 O-C-N 119.51 -2.171 . . . . 0.0 110.83 -169.904 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -66.5 141.69 62.18 Favored 'Trans proline' 0 N--CA 1.446 -1.274 1 C-N-CA 128.618 6.212 . . . . 0.0 107.077 -175.202 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.42 -35.48 39.26 Favored 'Trans proline' 0 N--CA 1.445 -1.379 1 C-N-CA 129.286 6.657 . . . . 0.0 108.884 -174.089 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -41.55 -46.83 3.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 166.032 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -79.28 -34.38 42.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 125.891 1.994 . . . . 0.0 113.893 -178.678 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -69.79 145.24 52.31 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 -179.027 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.09 150.82 39.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.022 -1.942 . . . . 0.0 110.008 165.814 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.0 tp -117.75 123.51 46.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 124.351 3.25 . . . . 0.0 103.916 -177.977 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mm -125.25 129.34 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 -168.462 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.413 ' HB3' HD11 ' A' ' 50' ' ' LEU 0.294 64.8 t80 -151.14 109.78 3.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 116.153 -1.88 . . . . 0.0 115.608 172.112 . . . . . . . . 3 3 . 1 . 111 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.529 . . 90.52 42.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 124.772 2.225 . . . . 0.0 113.033 171.903 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.88 -0.09 89.11 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 117.097 -3.502 . . . . 0.0 119.261 179.458 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -142.58 150.13 39.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 110.598 -2.801 . . . . 0.0 113.135 -165.127 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 0.0 OUTLIER -73.94 126.77 31.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 115.267 -2.301 . . . . 0.0 110.958 170.136 . . . . . . . . 3 3 . 1 . 111 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 45' ' ' PHE . 31.6 mt -78.04 126.48 30.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.462 2.705 . . . . 0.0 104.874 167.246 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -103.35 156.95 17.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 110.793 -2.912 . . . . 0.0 111.495 -170.706 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.39 161.24 20.19 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.407 2.283 . . . . 0.0 113.671 -178.286 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.14 -33.29 6.57 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 130.184 3.754 . . . . 0.0 112.359 173.038 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.279 88.6 mtt180 -98.59 153.4 18.69 Favored 'General case' 0 N--CA 1.451 -0.418 1 C-N-CA 135.343 5.457 . . . . 0.0 106.318 -164.037 . . . . . . . . 3 2 . 1 . 111 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.1 p -100.24 163.59 12.33 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 125.739 1.9 . . . . 0.0 108.094 175.763 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mt -49.46 -31.18 9.38 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.029 2.532 . . . . 0.0 117.632 157.25 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.7 p -71.56 -33.64 69.28 Favored 'General case' 0 N--CA 1.449 -0.494 1 O-C-N 114.955 -4.841 . . . . 0.0 107.694 175.186 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -76.46 -32.94 58.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 123.821 3.01 . . . . 0.0 107.042 -176.235 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -79.32 -19.76 49.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 115.156 -2.354 . . . . 0.0 109.147 170.178 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 72.6 43.13 0.48 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.287 2.635 . . . . 0.0 107.464 176.043 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -80.91 143.62 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 117.63 -3.169 . . . . 0.0 111.021 175.797 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -133.74 159.71 39.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 129.117 2.967 . . . . 0.0 115.66 -178.196 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.16 139.25 1.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 120.124 3.379 . . . . 0.0 120.124 -175.647 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 32.5 mt-10 69.76 28.11 4.46 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 129.574 3.15 . . . . 0.0 115.731 174.164 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.26 70.9 m -81.66 154.08 26.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 111.92 -2.4 . . . . 0.0 106.382 170.047 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.7 p -98.86 131.91 44.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 126.222 2.915 . . . . 0.0 103.32 166.915 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.03 150.52 38.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 129.654 3.181 . . . . 0.0 102.813 175.979 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.32 140.47 52.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 121.586 1.994 . . . . 0.0 113.412 -166.87 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 30' ' ' ILE 0.287 5.9 mt -91.19 139.87 30.33 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 118.76 -2.462 . . . . 0.0 112.422 165.937 . . . . . . . . 3 3 . 1 . 111 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.25 145.04 33.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 129.291 3.036 . . . . 0.0 106.635 163.229 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -116.42 119.28 35.15 Favored 'General case' 0 N--CA 1.452 -0.361 1 C-N-CA 132.559 4.343 . . . . 0.0 108.916 -167.522 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -72.71 168.2 19.23 Favored 'General case' 0 C--N 1.326 -0.448 1 C-N-CA 132.293 4.237 . . . . 0.0 106.137 172.146 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.0 mt -83.75 140.07 32.32 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 111.234 -2.712 . . . . 0.0 104.263 164.33 . . . . . . . . 1 1 . 1 . 111 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 91.8 130.95 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 1 C-N-CA 132.72 4.408 . . . . 0.0 109.138 -172.88 . . . . . . . . 3 3 . 1 . 111 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.61 166.55 20.07 Favored Glycine 0 CA--C 1.522 0.516 1 C-N-CA 134.183 5.658 . . . . 0.0 108.758 -177.858 . . . . . . . . 2 2 . 1 . 111 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.262 0 CA-C-O 116.678 -2.179 . . . . 0.0 109.694 -179.568 . . . . . . . . 0 0 . 1 . 112 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 125.78 2.705 . . . . 0.0 114.836 . . . . . . . . . 0 0 . 1 . 112 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.266 12.4 mt-30 -85.49 152.79 22.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 119.549 -1.969 . . . . 0.0 110.925 167.769 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.252 18.2 pt -134.24 167.42 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 101.007 -3.701 . . . . 0.0 101.007 162.979 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -131.8 93.4 3.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.429 1.492 . . . . 0.0 108.94 -167.678 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t -90.75 110.47 22.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 101.605 -3.48 . . . . 0.0 101.605 -172.057 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -109.34 137.63 46.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.45 2.3 . . . . 0.0 112.841 177.669 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -86.14 152.45 22.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 103.228 -2.879 . . . . 0.0 103.228 179.291 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -55.06 -19.05 6.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.517 2.727 . . . . 0.0 113.357 174.514 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -94.88 2.22 55.4 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 115.548 -2.168 . . . . 0.0 115.625 170.337 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.84 -12.37 57.74 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 120.769 1.622 . . . . 0.0 114.202 163.861 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -81.45 134.44 35.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -176.234 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -125.99 122.81 36.97 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 119.803 -1.81 . . . . 0.0 108.192 -159.283 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mt -95.39 122.6 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 120.229 -1.544 . . . . 0.0 110.04 169.014 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.6 m -96.55 112.68 24.33 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 125.04 2.352 . . . . 0.0 105.613 -178.242 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.52 116.42 31.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.982 1.713 . . . . 0.0 109.242 -170.244 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -77.02 127.92 33.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 127.302 2.877 . . . . 0.0 110.129 160.785 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.262 34.5 m -138.86 157.73 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 1 C-N-CA 133.454 4.702 . . . . 0.0 115.419 -178.393 . . . . . . . . 3 2 . 1 . 112 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.285 27.1 mm-40 -112.56 158.13 38.28 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 102.844 -3.021 . . . . 0.0 102.844 156.551 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -60.6 -23.08 74.73 Favored 'Trans proline' 0 N--CA 1.447 -1.225 1 C-N-CA 126.873 5.049 . . . . 0.0 116.845 -175.919 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -83.05 -2.58 55.69 Favored 'General case' 0 N--CA 1.44 -0.944 1 C-N-CA 132.062 4.145 . . . . 0.0 113.484 -175.146 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.67 136.2 38.18 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 -174.156 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.4 p -88.89 172.64 9.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.466 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.431 HG22 ' HD2' ' A' ' 27' ' ' LYS . 19.3 mm -70.63 -34.42 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 117.5 -1.238 . . . . 0.0 108.204 -178.616 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -42.52 -46.42 4.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.838 3.255 . . . . 0.0 113.652 170.911 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -70.95 -40.31 72.07 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.984 2.113 . . . . 0.0 116.207 173.833 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -82.36 -21.54 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 O-C-N 117.974 -2.954 . . . . 0.0 108.667 -176.016 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HD2' HG22 ' A' ' 23' ' ' ILE . 30.0 mttt -69.39 -42.22 75.43 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 118.749 -2.469 . . . . 0.0 115.769 170.283 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -35.21 58.22 Favored 'General case' 0 CA--C 1.535 0.403 1 O-C-N 132.228 5.955 . . . . 0.0 113.1 -179.009 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -60.28 -52.44 65.27 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 125.721 1.888 . . . . 0.0 110.403 165.594 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.344 35.9 mt -59.29 -46.13 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 114.993 -2.432 . . . . 0.0 112.917 175.969 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.377 20.1 tm0? -40.07 -63.05 0.65 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 126.296 2.951 . . . . 0.0 115.243 166.3 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.296 37.0 t70 -46.86 -47.46 21.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 110.396 -3.093 . . . . 0.0 118.584 173.314 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -84.56 -39.42 18.79 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.546 1.938 . . . . 0.0 111.29 -165.574 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.63 -14.21 6.33 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 128.301 3.501 . . . . 0.0 115.735 -166.187 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.96 22.05 40.16 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.971 2.7 . . . . 0.0 112.373 176.19 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -97.35 130.53 29.3 Favored Pre-proline 0 N--CA 1.442 -0.852 0 CA-C-N 120.488 2.144 . . . . 0.0 109.83 -178.286 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -76.36 165.12 29.83 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.738 2.292 . . . . 0.0 110.23 -173.845 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.52 -47.24 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 N-CA-C 116.41 1.658 . . . . 0.0 116.41 -174.86 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -61.28 -5.07 1.41 Allowed 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 117.946 2.573 . . . . 0.0 117.946 -175.58 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -99.62 -16.68 18.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.886 1.274 . . . . 0.0 110.245 -169.919 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -88.84 132.07 34.81 Favored 'General case' 0 N--CA 1.44 -0.934 1 C-N-CA 133.171 4.588 . . . . 0.0 110.034 -166.151 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -135.93 147.75 48.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 118.003 -2.936 . . . . 0.0 105.87 163.045 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.1 mt -104.88 128.1 52.97 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 130.668 3.587 . . . . 0.0 110.958 169.768 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 mt -124.78 130.11 73.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 128.151 2.58 . . . . 0.0 107.552 165.423 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -142.46 113.46 7.56 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 119.084 -2.26 . . . . 0.0 105.928 174.331 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.17 36.02 1.16 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 120.431 1.469 . . . . 0.0 110.536 157.872 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.88 -47.18 1.41 Allowed Glycine 0 CA--C 1.523 0.571 0 CA-C-O 126.131 3.073 . . . . 0.0 116.095 -167.146 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -76.64 126.63 31.32 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 120.159 -1.789 . . . . 0.0 113.097 -166.995 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -71.52 132.83 45.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 124.928 2.299 . . . . 0.0 106.94 154.961 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.455 HD22 ' CD2' ' A' ' 59' ' ' TYR 0.291 0.2 OUTLIER -91.92 124.88 36.36 Favored 'General case' 0 C--O 1.237 0.414 1 O-C-N 115.824 -4.297 . . . . 0.0 108.056 172.213 . . . . . . . . 5 4 . 1 . 112 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -78.15 156.19 30.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.397 2.279 . . . . 0.0 115.58 174.582 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.376 26.6 m-20 -71.44 133.49 45.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 124.345 2.021 . . . . 0.0 113.106 167.921 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.3 -11.38 39.92 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 128.544 2.973 . . . . 0.0 114.019 176.398 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -71.52 153.09 42.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 126.202 1.766 . . . . 0.0 112.217 170.78 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -99.74 143.42 29.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.291 1.837 . . . . 0.0 107.332 170.278 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.57 -33.67 76.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 -166.395 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -84.31 -23.33 30.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.008 -1.472 . . . . 0.0 114.485 -173.47 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -54.01 -36.78 63.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 126.077 2.846 . . . . 0.0 112.55 168.695 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CD2' HD22 ' A' ' 50' ' ' LEU . 10.5 m-85 -85.59 -6.6 59.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 128.745 2.818 . . . . 0.0 114.769 176.595 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.489 17.2 m120 89.81 15.18 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.613 1 C-N-CA 132.994 4.518 . . . . 0.0 118.116 177.719 . . . . . . . . 3 2 . 1 . 112 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.8 mt -81.96 112.82 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 116.174 -2.21 . . . . 0.0 108.296 -177.298 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -124.1 170.84 10.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 124.733 1.271 . . . . 0.0 108.144 -167.589 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.327 44.4 pttt -43.03 122.02 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.902 2.481 . . . . 0.0 115.668 -169.126 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 66.97 24.72 9.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 178.285 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.275 56.7 m -75.71 125.27 28.73 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 124.017 1.865 . . . . 0.0 110.56 170.258 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 m -84.81 131.59 34.52 Favored 'General case' 0 C--N 1.323 -0.562 1 C-N-CA 132.158 4.183 . . . . 0.0 100.831 173.487 . . . . . . . . 2 2 . 1 . 112 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -142.61 112.41 6.89 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 -164.911 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -46.13 103.52 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 113.746 -3.026 . . . . 0.0 115.407 159.446 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -96.1 102.5 14.3 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 121.531 1.969 . . . . 0.0 112.43 176.392 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.7 t -69.08 109.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 128.578 2.751 . . . . 0.0 108.909 -176.433 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 mt -81.71 110.24 16.87 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.566 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -111.41 136.48 50.5 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 130.302 3.441 . . . . 0.0 108.998 177.828 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -90.4 4.01 52.15 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -176.963 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -144.58 157.65 44.12 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 131.273 3.829 . . . . 0.0 106.917 -178.198 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.02 -12.84 11.67 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 111.842 -2.435 . . . . 0.0 111.054 -173.969 . . . . . . . . 1 1 . 1 . 112 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 1 C-N-CA 133.5 5.333 . . . . 0.0 103.546 -177.877 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptm . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 113 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -84.5 134.81 34.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 114.602 -2.618 . . . . 0.0 106.643 179.117 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.314 28.0 pt -125.86 171.53 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 1 O-C-N 129.138 4.024 . . . . 0.0 108.134 173.774 . . . . . . . . 3 2 . 1 . 113 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -132.75 143.1 49.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 163.04 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.44 113.28 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 126.307 1.843 . . . . 0.0 108.878 169.268 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -83.02 134.38 35.05 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -177.437 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.29 36.9 m -87.11 149.89 24.37 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 116.765 -1.588 . . . . 0.0 112.279 168.427 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -19.6 16.49 Favored 'General case' 0 C--N 1.324 -0.527 1 C-N-CA 132.772 4.429 . . . . 0.0 112.469 -174.734 . . . . . . . . 3 3 . 1 . 113 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 p -81.54 -15.78 53.78 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.493 1.917 . . . . 0.0 115.428 166.45 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.25 -9.86 10.96 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 114.289 -3.506 . . . . 0.0 107.302 175.821 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -80.32 122.59 27.1 Favored 'General case' 0 N--CA 1.45 -0.447 1 CA-C-N 124.951 4.375 . . . . 0.0 110.859 -175.044 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -84.7 107.65 17.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 175.96 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.07 126.76 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 120.188 -1.57 . . . . 0.0 110.37 179.093 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.3 p -89.67 133.31 34.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 121.485 1.948 . . . . 0.0 108.09 -179.544 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.5 tp -149.06 136.87 20.54 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.759 2.824 . . . . 0.0 106.444 -165.817 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -116.17 132.8 56.56 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.225 2.21 . . . . 0.0 105.56 -177.824 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -137.44 -177.96 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 129.346 3.058 . . . . 0.0 111.862 -178.745 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -119.24 153.14 53.23 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 124.97 1.308 . . . . 0.0 109.711 163.275 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.297 28.4 Cg_endo -55.52 -34.62 90.33 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 N-CA-C 121.452 3.597 . . . . 0.0 121.452 -179.929 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -75.28 -8.65 57.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 112.588 -2.097 . . . . 0.0 115.716 173.507 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.77 120.42 7.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 120.645 1.566 . . . . 0.0 110.345 174.369 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -61.76 150.26 37.44 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 120.126 -1.609 . . . . 0.0 108.511 161.711 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -59.99 -19.02 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.79 2.036 . . . . 0.0 112.99 179.731 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.14 -23.49 41.09 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.711 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -89.87 -22.11 22.2 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.085 0.954 . . . . 0.0 109.381 178.547 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.78 -40.91 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 O-C-N 126.912 2.632 . . . . 0.0 108.733 166.57 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -69.16 -20.76 64.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 114.048 -2.882 . . . . 0.0 112.77 172.093 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.82 -40.47 47.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 131.541 3.936 . . . . 0.0 111.415 174.611 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -71.34 -28.67 64.24 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.657 3.583 . . . . 0.0 109.708 178.106 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.83 -65.03 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 113.247 -3.264 . . . . 0.0 110.854 157.232 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -46.0 -31.41 2.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 126.563 2.414 . . . . 0.0 115.851 -179.457 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.72 -32.6 43.88 Favored 'General case' 0 C--N 1.329 -0.322 1 C-N-CA 131.79 4.036 . . . . 0.0 111.036 178.23 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -116.27 -39.2 3.43 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -176.823 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -83.56 -31.16 26.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 116.973 -3.579 . . . . 0.0 117.052 -169.953 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.96 -6.5 83.63 Favored Glycine 0 CA--C 1.531 1.094 0 O-C-N 120.944 -1.097 . . . . 0.0 111.126 171.478 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.251 77.1 mt -98.2 129.05 31.64 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-O 115.104 -2.379 . . . . 0.0 105.924 -175.072 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.56 155.69 68.12 Favored 'Trans proline' 0 N--CA 1.449 -1.104 1 C-N-CA 127.153 5.235 . . . . 0.0 117.807 -174.745 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.303 51.3 Cg_exo -42.21 -35.28 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.567 3.511 . . . . 0.0 117.319 170.026 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -43.17 -41.2 3.63 Favored 'General case' 0 CA--C 1.535 0.4 1 O-C-N 114.003 -5.435 . . . . 0.0 117.723 168.555 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -96.55 -6.44 36.96 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 118.244 -2.785 . . . . 0.0 114.363 -170.098 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -102.01 122.93 45.02 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.408 2.683 . . . . 0.0 110.321 175.03 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -120.49 131.42 54.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 173.153 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -118.76 129.07 55.05 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 128.716 2.807 . . . . 0.0 110.364 -175.532 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.36 148.19 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 127.689 2.396 . . . . 0.0 116.144 163.582 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -141.06 114.28 8.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 127.781 3.176 . . . . 0.0 107.509 172.925 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.71 41.37 12.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.789 -1.101 . . . . 0.0 109.626 176.891 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.75 -16.86 34.03 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 117.976 1.95 . . . . 0.0 117.976 177.118 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.365 69.1 mttt -94.5 129.17 41.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.886 1.327 . . . . 0.0 108.301 179.55 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.54 87.49 7.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 131.443 3.897 . . . . 0.0 102.444 178.887 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.5 mt -50.05 136.5 18.84 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 128.346 2.659 . . . . 0.0 115.186 -165.208 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -65.12 114.51 4.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 125.013 1.446 . . . . 0.0 112.89 171.798 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.349 0.0 OUTLIER -66.7 -4.53 9.13 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.972 2.109 . . . . 0.0 116.168 -172.942 . . . . . . . . 3 3 . 1 . 113 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.16 -0.09 16.76 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.221 1.391 . . . . 0.0 111.666 178.434 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -93.23 160.04 15.01 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 159.382 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.8 p -107.28 171.23 7.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 125.166 2.412 . . . . 0.0 108.053 -172.555 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.04 -30.54 62.46 Favored 'General case' 0 C--N 1.326 -0.45 1 O-C-N 114.698 -5.001 . . . . 0.0 109.316 -178.059 . . . . . . . . 3 3 . 1 . 113 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 t -67.06 -33.26 75.12 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 173.561 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -71.93 -23.02 61.4 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.958 2.503 . . . . 0.0 111.515 178.098 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -91.54 -3.79 56.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 170.755 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 t30 58.71 36.57 24.99 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 131.589 3.956 . . . . 0.0 114.77 179.784 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -77.08 125.33 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 O-C-N 124.955 1.409 . . . . 0.0 114.506 -173.889 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -98.51 176.24 5.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 125.082 2.372 . . . . 0.0 107.852 -170.769 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.94 117.05 3.89 Favored 'General case' 0 N--CA 1.441 -0.897 1 C-N-CA 131.708 4.003 . . . . 0.0 110.055 -177.787 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 68.79 44.23 1.15 Allowed 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 127.593 3.058 . . . . 0.0 111.944 163.491 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.1 p -100.27 157.7 16.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 125.708 2.67 . . . . 0.0 111.652 160.695 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -106.73 127.02 53.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 116.43 -3.919 . . . . 0.0 110.33 -166.766 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.36 172.38 8.79 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 129.294 3.037 . . . . 0.0 104.295 164.918 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -133.64 136.72 44.98 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.731 2.012 . . . . 0.0 109.169 -179.199 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -127.09 108.11 10.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 101.452 -3.536 . . . . 0.0 101.452 -163.907 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.34 116.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 1 O-C-N 130.375 4.797 . . . . 0.0 110.656 163.639 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -103.87 154.77 19.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 101.498 -3.519 . . . . 0.0 101.498 177.37 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.266 7.5 ttp180 -94.16 67.0 3.55 Favored 'General case' 0 C--N 1.328 -0.367 1 CA-C-N 108.209 -4.087 . . . . 0.0 101.945 159.109 . . . . . . . . 3 2 . 1 . 113 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 73' ' ' LEU 0.334 1.8 pt? -57.93 93.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 118.601 -2.562 . . . . 0.0 116.679 -170.534 . . . . . . . . 3 3 . 1 . 113 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.96 -33.15 0.42 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.869 1.267 . . . . 0.0 113.788 173.886 . . . . . . . . 2 2 . 1 . 113 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.41 -177.31 17.53 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 118.13 2.012 . . . . 0.0 118.13 175.116 . . . . . . . . 1 1 . 1 . 113 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.329 0 C-N-CA 128.112 2.768 . . . . 0.0 106.473 -178.716 . . . . . . . . 0 0 . 1 . 114 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 123.322 1.534 . . . . 0.0 108.764 . . . . . . . . . 0 0 . 1 . 114 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.256 43.6 mt-30 -113.76 128.72 56.53 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 111.373 -2.649 . . . . 0.0 112.859 -179.046 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.358 17.2 pt -144.7 138.36 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 128.286 3.491 . . . . 0.0 110.084 -175.39 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -106.28 121.23 43.79 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 127.377 2.923 . . . . 0.0 110.781 -163.823 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.65 87.46 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 172.202 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -86.88 149.0 25.12 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 117.338 -3.351 . . . . 0.0 107.268 -172.462 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.277 42.4 m -103.7 140.29 37.8 Favored 'General case' 0 N--CA 1.447 -0.595 1 C-N-CA 133.097 4.559 . . . . 0.0 105.565 175.863 . . . . . . . . 3 2 . 1 . 114 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.309 0.4 OUTLIER -46.29 -24.76 0.52 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 120.006 3.336 . . . . 0.0 120.006 -179.423 . . . . . . . . 3 3 . 1 . 114 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.29 6.9 p -94.82 5.72 51.07 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.836 2.454 . . . . 0.0 108.395 -174.982 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.19 0.18 44.3 Favored Glycine 0 CA--C 1.531 1.049 1 C-N-CA 134.76 5.933 . . . . 0.0 111.172 158.292 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -65.83 138.79 58.14 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 116.488 -3.948 . . . . 0.0 111.275 170.997 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.353 12.0 m -124.31 112.1 16.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.975 2.11 . . . . 0.0 111.553 -170.258 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 mm -100.99 148.87 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 173.313 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.353 7.1 p -129.22 128.88 44.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 111.641 -2.527 . . . . 0.0 111.151 -164.084 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.43 HD13 HG22 ' A' ' 26' ' ' VAL . 86.7 mt -106.38 125.56 51.15 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.849 1.26 . . . . 0.0 111.114 176.656 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -88.51 93.03 9.41 Favored 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 132.886 4.474 . . . . 0.0 107.235 162.943 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.18 162.18 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 O-C-N 118.364 -2.71 . . . . 0.0 111.06 -176.184 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.265 3.4 tp10 -115.91 135.36 22.72 Favored Pre-proline 0 N--CA 1.447 -0.6 0 N-CA-C 101.286 -3.598 . . . . 0.0 101.286 176.119 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -34.16 -40.55 0.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 1 C-N-CA 128.135 5.89 . . . . 0.0 115.148 -176.918 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -80.06 -1.37 39.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.323 2.249 . . . . 0.0 114.585 -171.505 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -65.25 135.9 55.95 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 130.746 3.618 . . . . 0.0 107.73 174.707 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -65.03 159.69 22.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.029 2.932 . . . . 0.0 112.902 171.771 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 23' ' ' ILE . 3.5 mm -74.39 -31.84 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 124.777 1.298 . . . . 0.0 110.392 178.456 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.79 -30.5 71.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 128.496 2.718 . . . . 0.0 112.203 172.965 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -80.9 -24.56 38.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 119.367 -2.083 . . . . 0.0 109.611 173.101 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG22 HD13 ' A' ' 15' ' ' LEU 0.255 1.0 OUTLIER -72.28 -20.11 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 122.5 1.143 . . . . 0.0 111.913 175.978 . . . . . . . . 4 4 . 1 . 114 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -73.4 -43.89 59.57 Favored 'General case' 0 C--N 1.323 -0.553 1 C-N-CA 133.335 4.654 . . . . 0.0 114.031 173.854 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.62 89.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.213 2.205 . . . . 0.0 111.908 174.384 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -69.3 -10.32 57.33 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.354 2.661 . . . . 0.0 116.8 173.434 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.27 58.1 mt -94.24 -40.45 11.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 O-C-N 127.509 3.005 . . . . 0.0 109.809 163.859 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -61.48 -62.93 1.47 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 130.567 3.547 . . . . 0.0 110.333 -174.917 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -41.72 -37.92 1.32 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.109 2.564 . . . . 0.0 116.673 170.307 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -79.16 -70.6 0.49 Allowed 'General case' 0 C--N 1.32 -0.683 0 O-C-N 128.32 3.513 . . . . 0.0 118.88 167.349 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -98.24 -5.5 33.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.432 -161.342 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.11 0.32 74.37 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 126.56 2.029 . . . . 0.0 114.814 166.995 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.1 mt -79.6 133.38 59.43 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-O 113.15 -3.309 . . . . 0.0 106.41 -165.283 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.83 162.65 23.86 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 CA-C-N 126.691 3.425 . . . . 0.0 111.538 -173.586 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.83 -51.46 0.38 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 123.876 3.051 . . . . 0.0 116.573 -166.034 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.95 -11.23 55.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 126.39 2.995 . . . . 0.0 113.914 -163.984 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -96.57 -17.59 20.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 113.689 -3.053 . . . . 0.0 110.165 -172.483 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.25 139.2 30.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 126.161 2.886 . . . . 0.0 107.72 -176.332 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.26 71.2 mtt180 -131.42 142.01 49.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 128.67 2.788 . . . . 0.0 112.985 162.028 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.55 0.6 OUTLIER -133.99 139.95 46.41 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 -164.755 . . . . . . . . 3 3 . 1 . 114 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.297 68.1 mt -132.52 130.14 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.209 1.804 . . . . 0.0 109.707 -160.988 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -159.27 133.88 7.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.077 2.151 . . . . 0.0 112.609 179.037 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.53 34.61 15.88 Favored 'General case' 0 N--CA 1.439 -0.986 1 C-N-CA 133.398 4.679 . . . . 0.0 112.78 -176.916 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.48 -30.05 7.51 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 115.514 -2.826 . . . . 0.0 112.21 174.478 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -120.12 148.04 44.12 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 120.502 2.151 . . . . 0.0 111.002 -159.939 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -71.83 129.28 38.24 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.998 2.119 . . . . 0.0 108.04 171.151 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mp -75.05 109.69 8.73 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 129.826 3.25 . . . . 0.0 108.853 -176.295 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -73.25 130.06 39.39 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 129.635 3.174 . . . . 0.0 110.217 -172.927 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.293 73.4 m-20 -46.24 129.7 10.3 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 129.394 3.078 . . . . 0.0 112.991 166.811 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.54 20.49 47.82 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 124.963 2.424 . . . . 0.0 111.317 172.733 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.23 177.18 4.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.598 2.359 . . . . 0.0 113.672 170.161 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.406 ' H ' ' CG ' ' A' ' 58' ' ' ASP . 43.5 p -118.29 163.83 16.11 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 125.209 2.433 . . . . 0.0 110.503 162.561 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.9 mt -53.93 -37.67 64.09 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 117.128 -3.482 . . . . 0.0 113.899 169.87 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.2 t -58.45 -31.97 68.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 124.725 2.202 . . . . 0.0 114.073 172.173 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 55' ' ' THR . 19.7 m-20 -63.46 -30.22 71.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 119.329 -2.107 . . . . 0.0 115.291 177.426 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -96.78 7.57 46.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 130.615 3.566 . . . . 0.0 109.245 178.456 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.8 t30 35.7 47.61 0.4 Allowed 'General case' 0 N--CA 1.448 -0.53 2 O-C-N 113.535 -5.728 . . . . 0.0 114.558 -172.51 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -88.91 110.75 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 128.114 2.566 . . . . 0.0 106.844 178.677 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -111.31 170.01 8.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.853 3.261 . . . . 0.0 112.682 -173.738 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -49.89 131.61 22.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 112.457 -177.475 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.453 5.4 pt-20 65.98 39.09 4.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.048 2.939 . . . . 0.0 118.146 178.511 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.7 p -87.18 140.73 29.25 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.411 1.884 . . . . 0.0 107.292 165.454 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 79.7 m -96.22 130.82 43.2 Favored 'General case' 0 N--CA 1.442 -0.858 2 C-N-CA 133.509 4.723 . . . . 0.0 107.108 164.333 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -123.67 175.49 6.81 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.941 1.696 . . . . 0.0 108.743 -176.7 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -111.38 149.88 30.57 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 118.457 -2.652 . . . . 0.0 112.335 178.21 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -121.85 138.55 54.34 Favored 'General case' 0 N--CA 1.448 -0.529 1 C-N-CA 134.395 5.078 . . . . 0.0 109.907 178.995 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 t -133.41 104.12 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 1 CA-C-O 130.104 4.764 . . . . 0.0 104.937 176.913 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.99 142.94 28.35 Favored 'General case' 0 N--CA 1.451 -0.406 1 O-C-N 113.14 -5.975 . . . . 0.0 105.495 179.286 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -94.67 167.76 11.26 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 131.633 3.973 . . . . 0.0 109.304 150.758 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.07 151.32 48.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 119.184 -2.198 . . . . 0.0 107.068 171.394 . . . . . . . . 2 2 . 1 . 114 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -108.11 -19.54 13.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 130.642 3.577 . . . . 0.0 110.097 177.582 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.04 128.99 5.22 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 128.255 2.836 . . . . 0.0 106.902 176.365 . . . . . . . . 1 1 . 1 . 114 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.844 1 N-CA-C 99.904 -5.278 . . . . 0.0 99.904 -157.565 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.2 ttp . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 113.947 -2.93 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 115 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -88.11 130.28 35.06 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 124.175 1.941 . . . . 0.0 115.491 -179.387 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 pt -115.42 174.86 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 111.421 -2.627 . . . . 0.0 111.222 155.391 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.278 52.0 p90 -147.33 143.4 28.02 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 169.143 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.63 99.04 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 130.398 3.479 . . . . 0.0 105.395 -156.487 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -83.7 133.07 34.82 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.975 2.11 . . . . 0.0 105.513 176.236 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.283 45.1 p -99.77 -171.56 2.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.043 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.77 -6.61 57.62 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 130.602 3.561 . . . . 0.0 115.325 170.373 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -117.11 -163.9 0.95 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 112.214 -2.266 . . . . 0.0 106.984 -179.723 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.03 50.7 0.77 Allowed Glycine 0 CA--C 1.524 0.656 0 O-C-N 124.757 1.285 . . . . 0.0 112.139 -178.087 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.343 66.9 tttt -119.69 139.1 52.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.48 3.912 . . . . 0.0 106.853 167.696 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.6 m -131.71 117.88 19.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 115.563 -2.161 . . . . 0.0 106.896 179.888 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.6 mt -100.46 129.32 51.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 -170.448 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -92.86 146.65 23.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 177.117 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.92 127.03 27.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 -170.801 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -108.18 98.05 7.65 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 126.407 3.003 . . . . 0.0 114.291 175.424 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.3 164.08 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 117.606 -3.184 . . . . 0.0 114.515 -166.411 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.98 137.09 31.62 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 117.085 -1.436 . . . . 0.0 110.028 171.587 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -85.01 -3.92 9.68 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.516 2.811 . . . . 0.0 113.682 -172.822 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.4 p -80.72 -2.11 45.53 Favored 'General case' 0 C--N 1.33 -0.264 1 CA-C-O 108.846 -5.359 . . . . 0.0 112.523 167.435 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -89.1 152.81 21.44 Favored 'General case' 0 N--CA 1.447 -0.59 1 O-C-N 130.172 4.67 . . . . 0.0 110.709 177.45 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -83.42 151.35 25.53 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.98 1.712 . . . . 0.0 107.427 -175.718 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.496 HD11 HD23 ' A' ' 56' ' ' LEU . 22.8 mm -53.62 -33.39 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.812 174.639 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -62.41 -52.08 64.98 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 129.387 3.075 . . . . 0.0 108.243 -173.63 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -77.57 -23.2 50.06 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 109.441 -3.527 . . . . 0.0 113.572 -174.323 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.34 35.2 t -58.4 -50.34 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 129.952 3.301 . . . . 0.0 110.916 162.452 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HE2' HG22 ' A' ' 23' ' ' ILE . 55.1 mtmt -67.15 -38.46 85.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 127.203 2.814 . . . . 0.0 114.182 175.452 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.68 -4.58 16.2 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 117.841 -3.037 . . . . 0.0 117.404 163.329 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -92.82 -42.67 9.42 Favored 'General case' 0 C--N 1.328 -0.351 1 O-C-N 115.691 -4.381 . . . . 0.0 105.093 175.407 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -49.2 -39.48 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 1 C-N-CA 132.228 4.211 . . . . 0.0 114.267 165.6 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.257 46.3 tt0 -46.1 -45.11 16.17 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.309 2.243 . . . . 0.0 116.752 175.288 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.34 -41.25 98.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 112.858 -1.974 . . . . 0.0 111.077 173.585 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -76.4 -54.17 7.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.079 -169.787 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -101.77 -5.33 25.02 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 126.251 2.219 . . . . 0.0 114.657 -172.659 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.21 6.16 89.02 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 121.487 3.355 . . . . 0.0 121.487 165.293 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.473 HD12 ' HD2' ' A' ' 37' ' ' PRO 0.266 4.0 tp -100.61 141.62 23.03 Favored Pre-proline 0 N--CA 1.454 -0.273 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -167.085 . . . . . . . . 4 3 . 1 . 115 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HD2' HD12 ' A' ' 36' ' ' ILE . 97.6 Cg_endo -70.6 161.11 47.21 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.969 2.446 . . . . 0.0 113.909 169.565 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.88 -9.43 10.85 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 N-CA-C 117.795 2.19 . . . . 0.0 117.795 -162.198 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -95.55 8.15 44.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 117.731 -3.105 . . . . 0.0 113.188 -178.175 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -119.89 -4.15 10.17 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 112.384 -2.189 . . . . 0.0 115.614 -175.207 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.302 78.4 mt-30 -99.59 138.0 37.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 128.454 2.702 . . . . 0.0 104.618 175.182 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -129.99 102.95 6.5 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 103.184 -2.895 . . . . 0.0 103.184 174.146 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.7 mt -81.61 128.41 33.9 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 119.899 -1.751 . . . . 0.0 107.47 169.119 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mt -113.46 119.89 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 1 C-N-CA 132.275 4.23 . . . . 0.0 106.963 175.894 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -105.18 128.86 53.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 101.082 -3.673 . . . . 0.0 101.082 153.152 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 73.0 -108.28 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 129.071 2.948 . . . . 0.0 110.495 171.166 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.54 22.69 4.11 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.159 1.361 . . . . 0.0 112.111 164.689 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -98.23 108.37 21.06 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.208 3.003 . . . . 0.0 109.929 166.723 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -80.88 108.7 14.77 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 173.86 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.8 mt -67.29 146.3 54.27 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.05 -159.914 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -101.39 134.5 44.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.691 1.596 . . . . 0.0 108.539 -168.299 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 1.9 m-20 -57.33 -37.69 72.93 Favored 'General case' 0 N--CA 1.442 -0.852 1 C-N-CA 132.58 4.352 . . . . 0.0 115.25 -155.489 . . . . . . . . 3 3 . 1 . 115 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.01 -13.72 24.53 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 119.018 -2.301 . . . . 0.0 112.051 -169.38 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -69.7 152.8 44.25 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 118.998 -2.472 . . . . 0.0 107.948 166.832 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.4 p -78.5 179.3 7.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 127.362 2.265 . . . . 0.0 111.902 171.319 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.496 HD23 HD11 ' A' ' 23' ' ' ILE . 43.7 mt -84.51 -26.6 27.99 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 120.165 -1.584 . . . . 0.0 109.273 166.273 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.8 p -69.84 -22.64 63.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 130.203 3.401 . . . . 0.0 110.427 173.923 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -75.88 -29.6 58.56 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 121.783 2.083 . . . . 0.0 111.116 168.954 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -90.85 -2.63 57.74 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.249 1.42 . . . . 0.0 107.912 178.549 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 5.0 t-20 59.53 38.39 22.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.99 2.916 . . . . 0.0 116.087 -179.705 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.6 mm -76.63 105.48 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 126.848 2.059 . . . . 0.0 108.624 -176.643 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 63' ' ' LYS . 2.4 tp-100 -84.67 166.77 16.79 Favored 'General case' 0 C--O 1.238 0.481 1 C-N-CA 133.517 4.727 . . . . 0.0 109.811 178.478 . . . . . . . . 3 3 . 1 . 115 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' N ' ' HG3' ' A' ' 62' ' ' GLN . 20.5 pttt -61.6 135.68 57.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 115.684 -2.103 . . . . 0.0 110.245 -173.346 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 68.79 26.76 5.94 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 131.445 3.898 . . . . 0.0 115.087 177.577 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 m -79.54 115.5 19.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 102.242 -3.244 . . . . 0.0 102.242 -177.966 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -73.36 137.62 44.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 129.23 3.012 . . . . 0.0 107.904 173.49 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.83 176.97 8.23 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 167.234 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -122.65 122.63 39.27 Favored 'General case' 0 N--CA 1.45 -0.474 1 O-C-N 116.165 -4.085 . . . . 0.0 106.301 -173.634 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.451 ' CD2' HD22 ' A' ' 71' ' ' LEU . 55.0 tp -97.91 133.06 42.9 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 124.154 1.93 . . . . 0.0 107.019 171.747 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.34 128.77 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 163.944 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 69' ' ' LEU . 2.5 pt? -141.07 173.18 11.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.675 2.034 . . . . 0.0 109.167 165.701 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -84.98 149.17 25.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 100.416 -3.92 . . . . 0.0 100.416 175.185 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.4 mt -110.25 157.05 19.87 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 125.141 2.4 . . . . 0.0 112.85 155.39 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.32 -35.97 6.14 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 128.017 2.527 . . . . 0.0 109.651 167.576 . . . . . . . . 2 2 . 1 . 115 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.55 -148.12 17.7 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 107.965 -2.054 . . . . 0.0 107.965 -177.546 . . . . . . . . 1 1 . 1 . 115 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 C-N-CA 124.888 1.232 . . . . 0.0 110.249 -179.383 . . . . . . . . 0 0 . 1 . 116 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 . . . . . . . . . 0 0 . 1 . 116 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.84 151.67 19.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 124.076 0.86 . . . . 0.0 110.403 -177.207 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.303 49.2 pt -141.61 155.62 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 1 C-N-CA 131.802 4.041 . . . . 0.0 110.996 162.278 . . . . . . . . 3 2 . 1 . 116 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -110.93 156.42 21.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 127.664 3.102 . . . . 0.0 110.902 179.058 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.328 82.0 t -136.67 128.13 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 100.763 -3.792 . . . . 0.0 100.763 174.246 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -82.41 125.58 31.22 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 118.404 -2.685 . . . . 0.0 105.63 161.496 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -80.68 167.87 19.52 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.158 1.456 . . . . 0.0 110.213 168.321 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.96 -29.96 69.95 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 117.855 -3.028 . . . . 0.0 113.278 -178.696 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 p -77.54 -25.07 49.85 Favored 'General case' 0 N--CA 1.447 -0.597 1 C-N-CA 132.877 4.471 . . . . 0.0 115.559 171.076 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.46 -2.09 9.54 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 126.799 2.562 . . . . 0.0 110.633 154.301 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -78.37 137.1 37.85 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.503 2.721 . . . . 0.0 105.795 -179.485 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -92.96 123.1 35.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.112 2.165 . . . . 0.0 107.085 -174.422 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.7 mm -111.27 129.61 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 127.863 2.465 . . . . 0.0 105.963 -174.376 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -95.58 120.57 36.06 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.676 2.79 . . . . 0.0 110.564 172.039 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -112.28 131.76 55.33 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.169 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -96.33 116.03 28.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 129.0 3.938 . . . . 0.0 110.008 160.598 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.38 160.7 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 131.511 3.925 . . . . 0.0 109.247 -165.378 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -71.23 152.75 94.43 Favored Pre-proline 0 N--CA 1.446 -0.668 0 O-C-N 117.408 -3.307 . . . . 0.0 108.163 163.197 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -71.11 -18.68 30.59 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 121.703 1.602 . . . . 0.0 112.339 173.793 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.377 63.6 p -125.54 36.44 4.55 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 127.031 2.132 . . . . 0.0 113.748 176.547 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.92 157.6 37.13 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.346 1.458 . . . . 0.0 108.845 173.486 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.259 40.8 p -99.49 168.06 10.21 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 126.782 2.551 . . . . 0.0 109.993 172.941 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.257 33.5 mm -76.88 -15.09 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 119.546 -1.971 . . . . 0.0 110.55 -178.541 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.4 -60.6 2.6 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 127.382 2.273 . . . . 0.0 112.738 174.112 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.95 -31.18 72.3 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 179.501 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.293 78.9 t -53.64 -41.69 47.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 115.373 -2.251 . . . . 0.0 113.415 163.445 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -55.02 -42.55 72.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 123.244 2.747 . . . . 0.0 109.963 176.811 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.75 -37.75 76.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 123.687 1.708 . . . . 0.0 111.635 -177.918 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -71.15 -31.12 67.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.483 -2.011 . . . . 0.0 108.498 176.562 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.303 86.3 mt -74.81 -32.86 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 1 O-C-N 115.756 -4.34 . . . . 0.0 110.842 177.605 . . . . . . . . 3 2 . 1 . 116 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -64.28 -53.2 52.64 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 130.738 3.615 . . . . 0.0 107.638 171.413 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -55.23 -51.7 65.74 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 118.783 2.882 . . . . 0.0 118.783 174.534 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -66.24 -43.48 86.46 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 115.083 -2.389 . . . . 0.0 111.482 177.679 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.342 69.3 mm-40 -128.98 -15.96 4.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 114.563 -2.637 . . . . 0.0 116.338 -166.819 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.58 -22.49 7.35 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 125.628 1.83 . . . . 0.0 111.348 156.192 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mt -73.39 124.79 90.83 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 126.375 1.87 . . . . 0.0 108.728 -162.186 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -70.04 157.51 59.61 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.25 1.967 . . . . 0.0 109.621 173.247 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.17 -29.03 22.54 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 124.805 3.67 . . . . 0.0 111.279 -168.355 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.267 5.4 t70 -40.11 -55.59 2.07 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 126.28 2.943 . . . . 0.0 117.743 158.141 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 82.0 mt-30 -81.66 -6.71 59.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 111.774 -2.466 . . . . 0.0 111.66 -175.392 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -89.06 166.76 13.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 124.184 3.174 . . . . 0.0 113.871 174.972 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.367 6.7 ptt180 -154.66 128.87 8.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 128.112 2.565 . . . . 0.0 108.213 164.594 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 mt -102.57 91.93 4.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 129.656 3.182 . . . . 0.0 110.022 174.781 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.1 mm -96.09 120.86 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 127.156 2.785 . . . . 0.0 105.168 -175.836 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -130.91 116.12 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 130.245 3.418 . . . . 0.0 109.217 -176.116 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.75 42.16 11.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 128.503 2.721 . . . . 0.0 112.516 -176.343 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.01 -2.78 55.43 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.058 1.313 . . . . 0.0 114.515 166.417 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -132.98 158.29 43.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.815 0.846 . . . . 0.0 110.769 -179.476 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.16 130.28 35.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 126.747 3.165 . . . . 0.0 114.761 173.811 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.53 128.29 35.98 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 116.865 -3.647 . . . . 0.0 109.886 163.1 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -117.38 -179.07 3.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 119.512 -1.992 . . . . 0.0 114.08 -171.031 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.28 129.6 35.85 Favored 'General case' 0 N--CA 1.449 -0.52 1 C-N-CA 133.725 4.81 . . . . 0.0 113.026 165.255 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.81 -28.41 7.38 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 118.269 -2.769 . . . . 0.0 110.518 151.18 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.256 75.1 mtt85 -97.77 124.45 42.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.905 2.082 . . . . 0.0 106.709 171.359 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.3 p -62.56 174.3 1.03 Allowed 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 125.254 1.597 . . . . 0.0 114.624 170.23 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -42.07 -53.34 3.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 176.579 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 t -64.69 -29.77 70.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.138 1.375 . . . . 0.0 111.165 -173.632 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -91.21 2.03 56.66 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 119.274 -2.141 . . . . 0.0 110.297 -176.159 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -101.9 20.36 16.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 123.057 2.662 . . . . 0.0 109.419 156.29 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.361 19.4 p30 59.19 22.32 10.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -176.727 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.8 mt -75.7 123.56 31.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 O-C-N 118.18 -2.825 . . . . 0.0 111.292 178.233 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -106.82 -176.01 2.96 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -173.559 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -67.76 125.15 25.33 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.778 1.631 . . . . 0.0 108.203 177.996 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 69.79 20.94 6.63 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 126.208 2.192 . . . . 0.0 114.025 178.016 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.7 m -73.16 140.04 46.76 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 131.163 3.785 . . . . 0.0 114.108 177.173 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.8 m -105.13 143.87 32.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.035 -1.666 . . . . 0.0 111.376 -172.521 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.3 mt -121.84 157.8 30.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.124 1.37 . . . . 0.0 113.834 172.016 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -109.71 155.03 22.06 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 177.441 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -128.53 124.64 36.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 110.426 -3.079 . . . . 0.0 107.35 -179.619 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.25 148.24 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 128.268 2.627 . . . . 0.0 107.055 162.727 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -134.37 152.4 51.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 127.284 2.865 . . . . 0.0 110.552 -177.642 . . . . . . . . 3 3 . 1 . 116 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -71.28 124.88 25.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 126.776 3.179 . . . . 0.0 106.242 176.017 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.0 mt -134.72 173.26 11.88 Favored 'General case' 0 N--CA 1.447 -0.609 1 C-N-CA 133.86 4.864 . . . . 0.0 107.972 175.827 . . . . . . . . 2 2 . 1 . 116 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -98.47 142.29 30.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 154.596 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.81 -95.64 2.07 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 156.7 . . . . . . . . 1 1 . 1 . 116 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.263 0 C-N-CA 129.887 3.613 . . . . 0.0 111.521 -173.836 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 ttp . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 113.645 -3.074 . . . . 0.0 108.144 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -72.09 134.17 45.64 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 102.607 -3.108 . . . . 0.0 102.607 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -132.79 157.62 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 130.605 3.562 . . . . 0.0 105.749 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -120.96 151.02 40.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 129.129 2.972 . . . . 0.0 107.771 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.17 135.34 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 167.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -103.62 120.3 40.62 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 126.648 2.468 . . . . 0.0 110.612 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -97.33 137.23 36.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.414 38.0 mt -27.04 -43.12 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.568 1 C-N-CA 132.996 4.518 . . . . 0.0 111.611 172.044 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.351 80.9 p -83.03 -16.32 47.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.086 -1.634 . . . . 0.0 110.438 -168.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.22 -4.48 23.65 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.477 -1.179 . . . . 0.0 112.116 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -80.61 132.62 35.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 129.449 3.1 . . . . 0.0 113.224 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -105.14 128.31 53.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 102.103 -3.295 . . . . 0.0 102.103 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 13' ' ' ILE . 59.4 mt -129.44 135.3 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 -174.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.456 1.8 t -127.18 147.03 50.2 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -143.23 129.93 20.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 118.167 -2.833 . . . . 0.0 107.21 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 16' ' ' GLU . 14.7 mp0 -75.53 123.74 25.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 165.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -137.24 173.81 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 125.996 2.808 . . . . 0.0 104.847 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.49 154.37 39.14 Favored Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 102.149 -3.278 . . . . 0.0 102.149 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.06 -29.36 22.57 Favored 'Trans proline' 0 N--CA 1.447 -1.23 1 C-N-CA 130.228 7.285 . . . . 0.0 114.352 170.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.3 m -71.89 -16.6 62.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 122.456 2.389 . . . . 0.0 115.693 173.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -65.37 132.92 50.22 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 122.644 2.474 . . . . 0.0 107.817 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.295 70.6 p -43.75 149.23 0.31 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 156.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -66.42 -39.69 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 O-C-N 121.439 -0.788 . . . . 0.0 108.953 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.324 63.4 tt0 -54.92 -37.93 67.02 Favored 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 134.272 5.029 . . . . 0.0 115.229 177.42 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -53.69 -49.29 68.36 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 161.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.35 -13.94 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 126.755 2.022 . . . . 0.0 112.578 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -78.16 -32.45 50.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.749 2.82 . . . . 0.0 108.362 168.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.94 -29.21 22.24 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 117.361 -3.337 . . . . 0.0 110.242 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -63.6 -32.2 73.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 114.612 -2.613 . . . . 0.0 108.33 168.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.361 17.6 mt -65.97 -28.72 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 124.825 3.466 . . . . 0.0 112.315 166.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -73.94 -38.74 64.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 122.054 2.206 . . . . 0.0 106.89 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -52.91 -48.82 66.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 131.203 3.801 . . . . 0.0 113.463 165.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -88.99 -37.15 15.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 126.765 2.54 . . . . 0.0 116.156 -170.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -136.76 -14.71 1.62 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.699 1.714 . . . . 0.0 110.646 -162.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.06 8.34 34.08 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 155.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.258 13.7 mt -101.59 133.08 21.04 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-N 123.367 3.583 . . . . 0.0 107.924 -162.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.21 150.92 37.95 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 CA-C-N 123.027 2.117 . . . . 0.0 114.223 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -46.85 -40.16 24.86 Favored 'Trans proline' 0 N--CA 1.443 -1.499 1 C-N-CA 126.861 5.041 . . . . 0.0 119.73 166.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.3 -44.42 88.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 128.504 3.627 . . . . 0.0 116.27 -170.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.301 74.0 mm-40 -100.37 -1.41 36.12 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 113.457 -1.701 . . . . 0.0 112.103 -173.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -95.65 125.76 40.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 126.571 2.419 . . . . 0.0 113.081 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.348 31.4 ttm105 -124.26 132.84 53.61 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 128.509 2.724 . . . . 0.0 108.579 172.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.81 151.21 29.31 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 117.498 -1.239 . . . . 0.0 108.89 -172.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.409 34.8 mt -129.95 131.53 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.912 1.685 . . . . 0.0 106.988 -167.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -142.31 118.42 10.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 130.67 3.588 . . . . 0.0 110.666 169.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.58 27.12 11.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.101 2.16 . . . . 0.0 110.228 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.53 -20.45 44.36 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.108 -1.62 . . . . 0.0 113.101 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.362 45.2 mtmt -94.71 143.41 26.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -165.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -71.35 137.4 48.41 Favored 'General case' 0 C--O 1.223 -0.294 0 O-C-N 121.644 -0.66 . . . . 0.0 110.992 159.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.2 mt -104.62 140.44 38.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -128.98 157.26 42.18 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 -147.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.256 5.9 p-10 -59.2 140.19 56.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.124 172.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.13 -47.1 1.05 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 105.673 -2.971 . . . . 0.0 105.673 162.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.86 175.92 5.46 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.225 -1.488 . . . . 0.0 111.053 -165.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 p -122.52 161.41 23.68 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.163 2.585 . . . . 0.0 113.496 -164.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mt -55.02 -35.45 64.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.5 t -57.75 -46.23 84.78 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 128.79 2.836 . . . . 0.0 109.825 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -59.91 -37.4 79.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 119.892 -1.755 . . . . 0.0 114.294 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -90.11 15.13 10.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 115.091 -2.385 . . . . 0.0 115.008 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 m120 71.52 10.87 6.54 Favored 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 132.89 4.476 . . . . 0.0 110.246 161.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.0 mt -52.61 134.54 14.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 1 C-N-CA 133.864 4.866 . . . . 0.0 110.179 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -145.06 -177.55 5.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 130.822 3.649 . . . . 0.0 111.331 -159.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.378 72.6 tttt -51.81 104.83 0.09 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 129.999 3.32 . . . . 0.0 114.278 170.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 70.92 21.49 5.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 118.143 -2.848 . . . . 0.0 113.565 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 m -58.16 119.79 7.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 121.915 2.143 . . . . 0.0 107.059 173.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.5 m -92.89 122.5 35.33 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 129.407 3.083 . . . . 0.0 107.769 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -113.82 170.99 7.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 125.279 1.612 . . . . 0.0 109.103 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.22 144.33 44.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.154 2.182 . . . . 0.0 111.128 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.06 103.2 7.32 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -160.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 m -87.54 128.6 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 124.875 2.274 . . . . 0.0 109.86 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.307 31.8 tp . . . . . 0 N--CA 1.446 -0.64 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -98.64 133.56 42.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 121.051 1.751 . . . . 0.0 109.029 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.284 1.1 pt -129.6 168.09 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.27 161.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -132.24 146.45 52.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.89 94.92 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 1 N-CA-C 98.661 -4.57 . . . . 0.0 98.661 -161.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -77.53 137.9 38.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 124.857 2.265 . . . . 0.0 110.891 170.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.582 HG22 HD23 ' A' ' 69' ' ' LEU . 44.5 p -94.61 168.52 10.8 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 124.375 2.035 . . . . 0.0 106.667 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.18 -16.53 62.53 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 118.431 -2.668 . . . . 0.0 111.137 163.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.0 p -91.23 -7.15 52.11 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 115.724 -2.084 . . . . 0.0 113.344 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.99 -17.71 17.12 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.408 1.48 . . . . 0.0 115.953 161.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -76.93 145.63 38.07 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.413 2.285 . . . . 0.0 107.674 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.2 p -105.82 121.86 44.91 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.51 2.724 . . . . 0.0 108.982 172.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.273 35.6 mm -89.26 146.82 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 173.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 22.1 m -109.52 137.64 47.06 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 119.826 -1.796 . . . . 0.0 109.86 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -122.87 100.13 6.74 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -160.24 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.5 106.35 17.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.944 3.697 . . . . 0.0 109.195 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -158.88 161.07 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 120.777 1.626 . . . . 0.0 112.26 -160.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -97.42 152.95 38.51 Favored Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 118.466 -2.646 . . . . 0.0 110.143 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.309 2.7 Cg_exo -51.77 -30.42 37.75 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 N-CA-C 119.355 2.791 . . . . 0.0 119.355 167.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 p -88.16 2.39 52.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.997 2.119 . . . . 0.0 112.019 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -81.39 140.93 34.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 120.021 1.282 . . . . 0.0 109.361 166.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -80.41 159.58 25.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.994 2.518 . . . . 0.0 109.604 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 54' ' ' ARG 0.293 8.7 mt -72.08 -14.23 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 126.219 1.808 . . . . 0.0 115.011 170.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -87.06 -18.48 30.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 170.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.279 13.3 t30 -66.56 -45.58 78.86 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 111.591 -2.549 . . . . 0.0 106.466 165.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.1 t -56.8 -40.76 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 1 C-N-CA 132.205 4.202 . . . . 0.0 108.805 170.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 90.6 mttt -73.46 -38.76 65.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 116.42 -2.112 . . . . 0.0 110.185 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -31.57 72.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -57.43 -44.72 84.91 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 125.003 1.44 . . . . 0.0 112.933 163.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.416 21.7 mt -55.88 -45.27 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 127.914 2.486 . . . . 0.0 114.703 -176.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -48.83 -67.11 0.3 Allowed 'General case' 0 C--N 1.33 -0.24 1 O-C-N 129.493 4.245 . . . . 0.0 113.815 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -50.3 -32.04 15.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -87.02 -58.27 2.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.173 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.284 18.2 tp10 -112.45 -8.66 13.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 121.105 3.743 . . . . 0.0 121.105 -166.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.56 1.2 55.44 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 117.146 -1.919 . . . . 0.0 111.749 162.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 36' ' ' ILE . 18.6 mt -98.42 110.45 56.61 Favored Pre-proline 0 N--CA 1.452 -0.359 0 C-N-CA 125.284 1.434 . . . . 0.0 110.073 -171.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -56.77 142.97 91.84 Favored 'Trans proline' 0 C--N 1.323 -0.776 1 CA-C-O 110.438 -4.068 . . . . 0.0 118.062 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HB3' ' HB3' ' A' ' 27' ' ' LYS 0.277 28.7 Cg_exo -45.1 -31.23 5.54 Favored 'Trans proline' 0 N--CA 1.452 -0.915 1 O-C-N 129.638 4.494 . . . . 0.0 119.543 -178.737 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.68 -35.2 72.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.289 79.7 mt-30 -90.07 13.37 15.11 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.652 -1.613 . . . . 0.0 113.363 -177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -106.13 156.9 17.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 172.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -138.68 116.52 11.54 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 127.271 2.228 . . . . 0.0 112.093 149.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.93 107.23 19.61 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 131.19 3.796 . . . . 0.0 105.946 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 pt -110.52 158.18 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 129.235 3.014 . . . . 0.0 109.5 169.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -115.62 -0.57 12.97 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 130.263 3.425 . . . . 0.0 108.9 161.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.552 . . -142.43 -110.68 0.13 Allowed 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 119.135 -2.228 . . . . 0.0 114.617 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.06 -19.8 2.88 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 122.473 2.397 . . . . 0.0 110.629 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -117.54 154.8 30.88 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 127.552 2.56 . . . . 0.0 112.361 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.05 165.25 11.4 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 124.122 0.889 . . . . 0.0 108.855 -172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.314 38.6 mt -96.25 128.08 42.84 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 110.954 -2.839 . . . . 0.0 106.744 164.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -69.18 125.14 25.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 116.306 -1.807 . . . . 0.0 115.551 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.278 0.0 OUTLIER -46.27 -28.66 1.35 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 128.824 3.828 . . . . 0.0 117.789 -170.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.11 10.87 60.27 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 125.57 1.794 . . . . 0.0 116.548 -168.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.511 ' O ' HD12 ' A' ' 23' ' ' ILE . 50.5 mtt180 -111.33 179.83 3.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.949 1.699 . . . . 0.0 107.504 168.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -120.45 172.09 8.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 104.583 -2.376 . . . . 0.0 104.583 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.392 6.9 mp -40.21 -51.55 2.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 130.919 3.688 . . . . 0.0 110.309 157.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 p -63.02 -37.92 89.12 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.843 2.057 . . . . 0.0 114.868 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.43 -46.42 66.81 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.835 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -79.15 -5.3 53.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 125.952 2.787 . . . . 0.0 114.699 -175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.65 44.43 17.46 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 117.977 -2.952 . . . . 0.0 115.937 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.7 mm -91.2 98.06 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -77.87 166.49 22.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.304 2.642 . . . . 0.0 109.556 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.36 129.79 1.76 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 167.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 70.79 38.83 1.15 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.455 2.302 . . . . 0.0 113.367 167.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.4 m -92.03 130.42 37.77 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 130.639 3.575 . . . . 0.0 108.449 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.3 m -88.36 111.95 22.32 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 127.435 2.959 . . . . 0.0 109.189 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.9 mt -94.85 136.43 35.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.927 1.291 . . . . 0.0 108.678 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -95.2 125.44 39.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.298 -1.501 . . . . 0.0 110.551 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.582 HD23 HG22 ' A' ' 7' ' ' THR . 27.0 tp -101.01 108.96 20.8 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.179 1.792 . . . . 0.0 108.123 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.6 147.76 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 123.343 1.544 . . . . 0.0 109.502 153.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 pp . . . . . 0 N--CA 1.449 -0.516 0 C-N-CA 127.943 2.497 . . . . 0.0 111.355 -171.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 53.8 ttp . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 117.459 -1.258 . . . . 0.0 107.756 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -77.42 134.52 38.39 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 126.244 2.215 . . . . 0.0 114.494 168.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -137.43 161.6 34.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.5 3.52 . . . . 0.0 102.337 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -112.54 144.25 42.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 111.015 -2.811 . . . . 0.0 114.764 168.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -132.77 112.78 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 O-C-N 125.738 1.899 . . . . 0.0 108.053 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -72.57 125.19 26.84 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 114.106 -2.854 . . . . 0.0 106.434 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -90.12 162.98 15.04 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 114.948 -2.453 . . . . 0.0 114.686 155.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pp -77.54 -12.37 59.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 125.283 1.614 . . . . 0.0 110.092 171.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -79.31 -10.4 59.8 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 129.937 3.295 . . . . 0.0 112.188 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.34 10.06 37.14 Favored Glycine 0 CA--C 1.539 1.554 0 O-C-N 117.991 -2.943 . . . . 0.0 114.275 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -104.51 140.97 37.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -115.16 100.83 8.44 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.934 2.894 . . . . 0.0 103.339 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.3 mt -81.16 123.66 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.8 m -104.84 123.74 48.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 121.401 1.91 . . . . 0.0 107.525 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.4 mt -126.23 130.41 50.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.117 2.567 . . . . 0.0 111.811 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.26 116.45 12.71 Favored 'General case' 0 C--N 1.327 -0.377 1 O-C-N 130.072 4.607 . . . . 0.0 109.137 154.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.0 172.72 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 113.29 -3.243 . . . . 0.0 114.793 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -97.11 144.65 28.25 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 124.37 3.259 . . . . 0.0 105.214 159.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -52.77 -28.38 38.01 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 CA-C-N 127.301 3.643 . . . . 0.0 115.475 163.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.9 p -81.46 4.32 21.48 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 127.493 2.996 . . . . 0.0 116.191 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -70.75 156.75 39.12 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.564 1.146 . . . . 0.0 108.268 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -111.42 166.56 11.02 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.352 1.861 . . . . 0.0 110.499 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.437 HG12 ' H ' ' A' ' 23' ' ' ILE . 4.0 mm -52.79 -42.64 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 127.722 2.409 . . . . 0.0 111.651 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -49.49 -34.98 18.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 115.358 -2.258 . . . . 0.0 116.322 171.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -85.0 -15.31 44.62 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 126.809 2.568 . . . . 0.0 109.089 -167.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -81.44 -52.52 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 126.307 2.956 . . . . 0.0 103.59 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -62.66 -33.17 74.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 131.058 3.743 . . . . 0.0 110.949 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.8 66.6 Favored 'General case' 0 N--CA 1.443 -0.786 1 O-C-N 114.529 -5.107 . . . . 0.0 109.377 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -67.11 -29.04 68.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 113.922 -2.942 . . . . 0.0 110.505 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 69' ' ' LEU 0.259 42.0 mt -72.44 -42.06 64.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 123.751 2.978 . . . . 0.0 104.722 176.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -53.95 -40.18 66.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 118.602 -2.561 . . . . 0.0 116.294 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.261 2.3 t70 -67.88 -19.89 65.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 116.232 -1.842 . . . . 0.0 112.171 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -94.22 -61.81 1.45 Allowed 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 124.61 1.194 . . . . 0.0 111.351 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -91.92 -28.51 17.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.443 2.697 . . . . 0.0 113.431 -166.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.22 -24.58 24.31 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 121.046 -1.034 . . . . 0.0 112.5 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 mt -60.32 118.18 31.14 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 111.737 -2.232 . . . . 0.0 107.097 -169.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.263 98.0 Cg_endo -67.74 158.04 59.05 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 CA-C-N 122.446 1.909 . . . . 0.0 116.563 175.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.312 14.9 Cg_exo -57.27 -33.11 95.49 Favored 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 128.635 6.223 . . . . 0.0 112.954 -179.282 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -86.53 -9.89 55.2 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 122.561 2.437 . . . . 0.0 111.581 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -94.77 -23.3 17.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.517 1.136 . . . . 0.0 113.724 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.46 122.15 21.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 113.722 -3.037 . . . . 0.0 108.751 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -100.4 119.47 38.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 121.428 1.922 . . . . 0.0 107.888 164.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 tp -121.18 104.06 9.47 Favored 'General case' 0 N--CA 1.445 -0.719 1 C-N-CA 132.458 4.303 . . . . 0.0 109.912 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.297 47.8 mm -96.6 151.18 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 128.359 3.537 . . . . 0.0 112.067 174.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -150.47 108.74 3.76 Favored 'General case' 0 CA--C 1.535 0.382 1 C-N-CA 132.038 4.135 . . . . 0.0 111.669 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.27 29.5 3.63 Favored 'General case' 0 C--N 1.325 -0.47 1 C-N-CA 132.269 4.228 . . . . 0.0 117.168 157.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.24 -10.11 20.18 Favored Glycine 0 CA--C 1.527 0.833 1 C-N-CA 133.765 5.459 . . . . 0.0 107.607 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -123.44 162.99 21.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 121.752 2.776 . . . . 0.0 105.908 -168.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -79.71 149.6 31.13 Favored 'General case' 0 N--CA 1.449 -0.488 1 C-N-CA 132.986 4.514 . . . . 0.0 108.588 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.0 mt -112.86 104.87 12.87 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.599 1.56 . . . . 0.0 108.479 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -94.35 149.82 20.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 102.181 -3.266 . . . . 0.0 102.181 -171.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -76.49 152.42 36.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 127.01 2.124 . . . . 0.0 114.195 -165.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.33 -23.04 33.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 119.457 2.543 . . . . 0.0 119.457 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -70.57 162.48 28.8 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 p -100.79 165.06 11.56 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.117 -1.615 . . . . 0.0 107.146 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.7 mt -60.9 -47.37 86.69 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 113.053 -1.885 . . . . 0.0 115.709 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.4 p -43.06 -45.23 5.17 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 129.081 2.952 . . . . 0.0 114.854 162.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.81 -52.5 59.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 131.416 3.886 . . . . 0.0 110.448 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -74.12 -14.3 60.95 Favored 'General case' 0 N--CA 1.449 -0.494 1 C-N-CA 132.465 4.306 . . . . 0.0 111.802 172.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.48 19.5 t30 87.37 20.74 0.06 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 165.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.9 mt -78.44 144.07 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -168.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -142.64 172.54 12.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.285 1.834 . . . . 0.0 108.996 -155.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -62.54 119.76 9.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 125.591 1.807 . . . . 0.0 109.85 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.506 15.2 mt-10 85.29 15.26 0.16 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -176.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -71.68 141.17 49.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.704 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.3 m -108.56 117.57 34.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.13 142.15 32.0 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.376 2.271 . . . . 0.0 109.304 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -108.69 125.48 51.94 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 125.275 2.464 . . . . 0.0 111.936 169.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.442 HD21 HG21 ' A' ' 30' ' ' ILE . 23.1 tp -96.16 132.96 41.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 110.341 -3.118 . . . . 0.0 109.307 174.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.12 158.14 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 131.001 3.72 . . . . 0.0 108.138 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.303 83.3 mt . . . . . 0 N--CA 1.441 -0.882 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.935 162.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 117.348 -1.31 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -89.14 140.86 29.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.424 1.489 . . . . 0.0 113.348 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.8 pt -134.45 161.02 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 127.35 2.26 . . . . 0.0 107.742 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.527 ' CE1' HG23 ' A' ' 14' ' ' THR . 57.3 m-85 -123.46 112.37 17.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 119.783 -1.823 . . . . 0.0 109.809 -169.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.75 128.8 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 100.201 -4.0 . . . . 0.0 100.201 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -90.29 136.1 33.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 110.949 -2.841 . . . . 0.0 107.004 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.255 26.8 p -114.86 132.3 56.56 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 124.465 1.103 . . . . 0.0 109.77 167.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.4 mt -72.86 -3.98 28.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 116.995 -3.566 . . . . 0.0 113.958 -151.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.5 p -76.65 -5.91 49.87 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 121.874 2.125 . . . . 0.0 115.935 159.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.6 -6.12 7.05 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 118.426 -2.671 . . . . 0.0 110.805 160.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -85.37 127.36 34.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 104.138 -2.541 . . . . 0.0 104.138 -165.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -96.2 101.4 13.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 126.629 2.456 . . . . 0.0 111.448 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.41 114.41 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 125.84 2.733 . . . . 0.0 105.305 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.527 HG23 ' CE1' ' A' ' 4' ' ' PHE . 11.2 m -99.29 113.61 26.0 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.492 HD11 HG13 ' A' ' 30' ' ' ILE . 46.7 mt -105.95 154.21 20.9 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.932 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -93.55 137.34 32.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.591 1.663 . . . . 0.0 106.677 165.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.309 11.8 m -145.05 175.78 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 128.466 2.706 . . . . 0.0 111.968 -174.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -139.3 152.99 70.58 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 128.823 2.849 . . . . 0.0 109.613 164.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.37 -30.3 92.37 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.493 2.795 . . . . 0.0 117.055 -173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 p -91.77 20.66 5.39 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 121.72 2.055 . . . . 0.0 110.752 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -100.82 140.75 34.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 119.728 -1.858 . . . . 0.0 109.046 -169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.2 p -70.24 157.91 36.81 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 127.951 3.282 . . . . 0.0 110.937 -168.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.439 HG22 ' HD2' ' A' ' 27' ' ' LYS 0.286 26.9 mt -61.67 -27.97 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 116.487 -1.72 . . . . 0.0 111.654 165.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.252 9.4 tp10 -62.06 -47.59 84.04 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 123.248 2.749 . . . . 0.0 106.052 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -68.71 -38.09 79.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 123.011 2.641 . . . . 0.0 111.645 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -55.62 -58.34 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 127.332 2.253 . . . . 0.0 114.389 166.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HE3' HD11 ' A' ' 43' ' ' LEU . 14.0 mttt -53.38 -35.44 60.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 128.423 2.689 . . . . 0.0 110.096 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.24 -32.34 70.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 125.157 2.408 . . . . 0.0 112.028 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.64 -7.18 58.98 Favored 'General case' 0 N--CA 1.451 -0.388 1 O-C-N 115.614 -4.428 . . . . 0.0 107.987 -170.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.492 HG13 HD11 ' A' ' 15' ' ' LEU . 35.2 mt -87.5 -33.41 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 119.649 1.113 . . . . 0.0 108.264 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -64.47 -39.1 93.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.23 -51.1 65.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.66 1.584 . . . . 0.0 114.536 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -83.22 -52.45 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -95.17 -15.63 23.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 119.834 3.272 . . . . 0.0 119.834 -171.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.33 4.46 62.61 Favored Glycine 0 CA--C 1.531 1.046 1 O-C-N 130.132 4.645 . . . . 0.0 116.035 170.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 36' ' ' ILE . 41.3 mt -86.98 123.16 70.73 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 121.485 2.642 . . . . 0.0 105.653 -155.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -62.65 133.43 42.3 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 CA-C-O 115.982 -1.758 . . . . 0.0 111.401 169.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.4 35.1 Cg_exo -41.55 -24.42 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 1 C-N-CA 128.664 6.243 . . . . 0.0 121.318 175.806 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -52.53 -50.43 62.86 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.971 1.708 . . . . 0.0 114.974 165.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -83.93 -18.25 37.97 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.162 2.985 . . . . 0.0 110.368 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -76.83 99.36 5.14 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.939 1.696 . . . . 0.0 110.526 169.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -102.47 107.81 18.91 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 119.693 -1.88 . . . . 0.0 107.988 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.466 HD11 ' HE3' ' A' ' 27' ' ' LYS . 19.2 mt -73.77 60.43 0.71 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 129.921 3.288 . . . . 0.0 110.184 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mm -87.79 107.68 17.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 115.646 -2.121 . . . . 0.0 108.732 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.379 23.3 t80 -133.3 118.85 19.02 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 129.467 3.107 . . . . 0.0 111.187 -168.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.86 43.88 26.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 129.163 2.985 . . . . 0.0 116.274 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.23 -28.9 9.6 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.034 2.254 . . . . 0.0 114.865 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.301 54.6 mttt -92.21 164.77 13.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -171.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -81.32 117.84 22.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 151.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.24 143.62 26.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.345 8.5 mt-10 -96.31 164.92 12.45 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 125.789 3.904 . . . . 0.0 111.635 -163.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -72.54 145.4 47.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 129.404 3.082 . . . . 0.0 110.325 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.75 6.5 12.79 Favored Glycine 0 CA--C 1.523 0.536 0 O-C-N 118.183 -2.823 . . . . 0.0 115.473 158.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -122.67 170.12 10.36 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.319 1.848 . . . . 0.0 110.226 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.4 p -99.7 165.3 11.67 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 130.959 3.703 . . . . 0.0 109.875 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.325 37.6 mt -41.21 -45.9 2.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.657 2.783 . . . . 0.0 113.623 170.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.4 m -84.45 -21.8 30.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 122.545 2.429 . . . . 0.0 112.281 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.263 20.0 m-20 -68.4 -18.59 64.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 115.981 -1.961 . . . . 0.0 113.457 173.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -108.33 11.7 26.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 126.564 2.415 . . . . 0.0 113.012 164.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 10.7 p30 64.47 28.04 13.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 167.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mt -78.6 131.29 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 121.025 -1.047 . . . . 0.0 110.647 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -106.88 163.83 12.63 Favored 'General case' 0 N--CA 1.444 -0.742 1 C-N-CA 132.078 4.151 . . . . 0.0 108.586 -177.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -53.67 144.32 18.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 111.209 -2.723 . . . . 0.0 113.237 171.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.433 44.9 mt-10 57.81 10.82 1.19 Allowed 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 118.393 -2.692 . . . . 0.0 117.432 -172.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 m -73.03 147.65 44.89 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.7 m -105.69 139.57 40.07 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 129.405 3.082 . . . . 0.0 107.969 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.84 179.97 8.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 114.657 -2.592 . . . . 0.0 111.365 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -125.41 131.13 52.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 127.29 2.869 . . . . 0.0 111.981 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 tp -102.43 147.08 27.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.379 1.872 . . . . 0.0 106.695 167.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -121.42 151.04 24.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 125.299 2.476 . . . . 0.0 108.897 168.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 N--CA 1.45 -0.434 0 CA-C-N 108.804 -3.816 . . . . 0.0 110.755 176.271 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.584 0.707 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -100.25 145.54 27.96 Favored 'General case' 0 N--CA 1.442 -0.83 2 O-C-N 113.477 -5.764 . . . . 0.0 107.722 -171.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 3' ' ' ILE . 8.1 pt -127.85 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 1 O-C-N 115.78 -4.325 . . . . 0.0 107.526 151.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -88.55 136.67 32.88 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.075 -1.421 . . . . 0.0 107.697 166.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.25 10.9 t -123.59 122.33 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 117.3 -3.375 . . . . 0.0 109.448 170.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -94.01 107.14 19.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.4 6.2 p -56.41 160.45 3.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 128.196 3.435 . . . . 0.0 117.386 170.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 70' ' ' VAL . 2.0 tm? -74.63 -24.18 58.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.395 1.078 . . . . 0.0 109.032 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.67 -1.92 56.78 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 123.144 1.449 . . . . 0.0 114.174 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.44 -26.79 15.35 Favored Glycine 0 CA--C 1.526 0.761 0 O-C-N 119.371 -2.081 . . . . 0.0 115.762 165.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -70.01 130.25 41.67 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 116.929 -3.689 . . . . 0.0 107.731 -172.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.5 m -88.77 109.94 20.6 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 118.895 -2.378 . . . . 0.0 108.089 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 pt -93.31 141.48 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 124.291 1.037 . . . . 0.0 112.551 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 t -81.95 143.94 31.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 161.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.09 121.14 22.23 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 131.543 3.937 . . . . 0.0 107.363 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.31 13.1 mp0 -86.12 134.39 33.81 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 117.598 -1.641 . . . . 0.0 110.375 172.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.274 27.4 m -137.38 170.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 116.471 -1.728 . . . . 0.0 109.37 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -112.94 158.88 36.52 Favored Pre-proline 0 N--CA 1.444 -0.739 0 C-N-CA 128.668 2.787 . . . . 0.0 105.258 162.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.79 -28.35 25.23 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.935 2.423 . . . . 0.0 117.21 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -76.85 4.22 10.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 126.127 2.142 . . . . 0.0 116.596 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -84.43 141.15 31.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.361 1.864 . . . . 0.0 107.853 -164.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -78.86 140.09 38.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.336 1.455 . . . . 0.0 110.235 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.441 HD12 ' HB2' ' A' ' 54' ' ' ARG 0.29 8.3 mt -47.09 -35.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 119.979 -1.701 . . . . 0.0 114.939 171.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -53.79 -49.31 68.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.306 2.242 . . . . 0.0 111.095 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 7.9 t-20 -64.78 -43.25 93.84 Favored 'General case' 0 N--CA 1.441 -0.91 1 C-N-CA 132.665 4.386 . . . . 0.0 111.752 176.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.12 -50.63 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 115.208 -2.33 . . . . 0.0 113.351 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -61.6 -41.19 97.09 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 127.261 2.224 . . . . 0.0 112.259 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.73 -40.53 84.03 Favored 'General case' 0 N--CA 1.448 -0.543 1 C-N-CA 132.165 4.186 . . . . 0.0 109.235 177.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.32 79.8 mttt -79.33 -19.46 50.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 119.043 -2.286 . . . . 0.0 114.794 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mt -76.82 -32.34 20.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 118.887 -2.383 . . . . 0.0 107.413 172.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.82 -38.46 86.48 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 116.667 -3.77 . . . . 0.0 114.005 163.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -67.14 -23.03 65.75 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 113.007 -3.378 . . . . 0.0 109.641 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -98.55 -66.94 0.87 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 121.455 1.934 . . . . 0.0 113.733 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -111.32 -9.78 14.27 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 117.108 -3.495 . . . . 0.0 109.235 -164.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.53 2.37 50.26 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.145 -1.364 . . . . 0.0 114.479 158.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -77.0 125.13 87.26 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 125.02 1.328 . . . . 0.0 107.782 -171.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.59 129.55 19.09 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.826 3.684 . . . . 0.0 115.637 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -41.85 -33.07 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 1 C-N-CA 127.55 5.5 . . . . 0.0 117.502 175.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -51.11 -64.17 0.9 Allowed 'General case' 0 N--CA 1.445 -0.678 1 C-N-CA 132.174 4.189 . . . . 0.0 112.925 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -73.18 -26.27 61.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 128.661 2.784 . . . . 0.0 117.524 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -73.22 128.4 35.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.104 2.562 . . . . 0.0 107.351 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 ttm105 -120.73 129.37 53.61 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.977 1.711 . . . . 0.0 108.468 158.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -97.48 161.94 13.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.365 -1.779 . . . . 0.0 110.822 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -136.07 138.0 47.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 126.428 2.33 . . . . 0.0 108.062 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -130.8 116.53 18.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.602 2.361 . . . . 0.0 107.518 162.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.293 . . 57.86 34.15 24.03 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 129.034 2.934 . . . . 0.0 114.106 168.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.1 10.81 84.24 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 129.253 3.311 . . . . 0.0 117.778 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -98.61 134.63 41.28 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.917 2.487 . . . . 0.0 106.957 173.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -84.63 124.71 31.77 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.99 130.19 38.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 116.222 -1.847 . . . . 0.0 109.839 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' OE1' ' NE ' ' A' ' 54' ' ' ARG . 1.1 tt0 -91.93 126.01 36.85 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.949 1.704 . . . . 0.0 109.273 -166.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -46.18 115.34 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 129.831 3.252 . . . . 0.0 111.836 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.24 -9.85 31.19 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 116.762 -2.132 . . . . 0.0 112.962 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HB2' HD12 ' A' ' 23' ' ' ILE 0.352 17.7 mmt180 -86.26 154.13 21.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 121.075 2.437 . . . . 0.0 111.383 174.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 p -71.57 161.2 31.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 160.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.49 -21.32 66.18 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 122.257 2.299 . . . . 0.0 113.796 169.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 t -77.53 -16.56 58.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 117.217 -3.427 . . . . 0.0 108.226 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -76.66 4.16 10.06 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 123.192 2.724 . . . . 0.0 113.336 167.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -138.45 9.33 2.68 Favored 'General case' 0 C--N 1.327 -0.405 1 O-C-N 115.085 -4.759 . . . . 0.0 112.523 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 t30 62.3 26.92 16.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 130.054 3.342 . . . . 0.0 116.679 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.36 128.42 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -124.32 -160.07 0.91 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.171 -1.377 . . . . 0.0 107.461 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.66 135.57 51.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -165.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 81.96 10.08 0.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 129.013 2.925 . . . . 0.0 115.12 163.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -70.06 152.19 44.66 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 126.049 2.093 . . . . 0.0 113.432 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.7 m -110.39 125.46 53.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.87 155.47 20.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 169.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -110.92 150.75 28.77 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.663 1.985 . . . . 0.0 106.999 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -125.9 135.55 52.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.705 2.402 . . . . 0.0 109.841 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.408 ' HA ' HD23 ' A' ' 8' ' ' LEU . 19.2 m -135.58 140.45 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 127.928 2.491 . . . . 0.0 108.043 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.277 1.1 pp . . . . . 0 C--N 1.325 -0.474 0 C-N-CA 128.107 2.563 . . . . 0.0 112.087 176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttp . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -104.67 128.92 52.88 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 101.537 -3.505 . . . . 0.0 101.537 -169.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 pt -138.14 170.97 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 129.727 3.211 . . . . 0.0 106.84 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -114.4 149.3 36.38 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -121.8 121.4 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.271 1.828 . . . . 0.0 106.206 161.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -110.1 178.49 4.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 109.248 -3.614 . . . . 0.0 110.465 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -138.08 155.96 48.26 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 128.238 2.615 . . . . 0.0 108.538 -168.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.4 mt -75.76 -14.52 60.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 112.939 -3.41 . . . . 0.0 111.245 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -92.95 -4.03 53.44 Favored 'General case' 0 C--N 1.324 -0.525 1 CA-C-N 126.255 4.116 . . . . 0.0 108.86 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.12 7.13 31.27 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 120.313 2.885 . . . . 0.0 120.313 162.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -60.76 154.26 22.17 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 118.595 -2.709 . . . . 0.0 108.82 169.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.281 4.3 m -141.92 107.0 4.94 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.427 1.891 . . . . 0.0 108.743 170.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mm -100.43 142.24 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 111.997 -2.365 . . . . 0.0 106.315 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -94.42 143.2 26.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.643 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.6 123.44 37.65 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 122.604 2.456 . . . . 0.0 107.853 -173.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -99.43 109.56 22.13 Favored 'General case' 0 C--N 1.329 -0.283 1 N-CA-C 97.181 -5.118 . . . . 0.0 97.181 175.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 m -118.76 150.21 21.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 119.711 -1.868 . . . . 0.0 108.009 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -89.45 161.29 40.09 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 116.479 -1.724 . . . . 0.0 111.078 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.02 -19.76 13.55 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.504 2.803 . . . . 0.0 111.664 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 p -73.06 -17.93 61.37 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 128.709 2.804 . . . . 0.0 111.7 173.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -69.86 123.94 22.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 124.934 2.302 . . . . 0.0 112.02 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.6 p -76.67 166.11 23.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 111.893 -2.412 . . . . 0.0 110.098 162.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.2 -21.51 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 O-C-N 124.945 1.403 . . . . 0.0 108.641 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -73.59 -28.88 62.06 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.34 -29.82 53.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -83.18 -27.88 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 119.969 -1.707 . . . . 0.0 107.505 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -69.19 -42.22 76.1 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.78 -38.49 78.64 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 133.056 4.542 . . . . 0.0 114.158 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -77.36 -38.5 50.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 127.369 3.462 . . . . 0.0 114.877 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.1 mt -61.11 -35.81 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 1 O-C-N 113.05 -6.031 . . . . 0.0 105.788 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -32.96 71.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.184 1.794 . . . . 0.0 109.756 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.03 -32.19 73.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.99 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -91.65 -36.67 13.5 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.56 1.944 . . . . 0.0 113.943 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -129.16 -23.53 2.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -173.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.04 2.03 57.06 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 126.996 2.685 . . . . 0.0 116.611 165.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.2 mm -72.8 121.42 84.97 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 120.095 1.948 . . . . 0.0 111.048 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -39.27 129.11 1.56 Allowed 'Trans proline' 0 N--CA 1.443 -1.498 0 N-CA-C 119.225 2.74 . . . . 0.0 119.225 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.29 26.4 Cg_exo -47.76 -29.99 12.17 Favored 'Trans proline' 0 N--CA 1.453 -0.901 1 C-N-CA 129.227 6.618 . . . . 0.0 115.825 178.296 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -79.28 -4.27 49.93 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 128.0 2.52 . . . . 0.0 112.381 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -118.36 -15.67 9.68 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.486 1.915 . . . . 0.0 110.349 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.304 79.9 mt-30 -90.05 115.22 27.15 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 116.317 -2.153 . . . . 0.0 108.235 -170.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -103.96 129.55 51.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 100.712 -3.81 . . . . 0.0 100.712 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 mt -132.63 93.78 3.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.423 -2.673 . . . . 0.0 106.278 -162.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -89.56 128.16 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -128.86 107.71 9.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 128.728 2.811 . . . . 0.0 106.398 166.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.331 . . 60.71 16.53 6.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 130.52 3.528 . . . . 0.0 117.706 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.82 -13.47 57.73 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.314 1.912 . . . . 0.0 110.722 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.54 105.45 14.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.998 2.119 . . . . 0.0 105.568 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -61.05 107.64 0.76 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 111.742 -2.481 . . . . 0.0 114.652 152.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.6 mt -65.7 123.06 18.73 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 128.115 3.384 . . . . 0.0 107.974 -172.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.19 131.27 34.8 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 126.884 2.615 . . . . 0.0 111.267 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.97 119.39 4.24 Favored 'General case' 0 N--CA 1.449 -0.485 1 CA-C-O 129.272 4.367 . . . . 0.0 111.849 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.18 -19.74 31.76 Favored Glycine 0 CA--C 1.523 0.559 1 O-C-N 115.195 -4.691 . . . . 0.0 119.234 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -83.56 175.83 9.48 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 118.473 -1.291 . . . . 0.0 111.433 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.3 p -114.16 162.06 17.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 121.216 1.825 . . . . 0.0 110.842 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 8.9 mt -36.71 -50.56 0.83 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.104 2.962 . . . . 0.0 116.654 172.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 p -81.29 0.27 37.73 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 109.485 -3.507 . . . . 0.0 112.995 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -97.04 -18.77 19.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 116.647 -3.783 . . . . 0.0 109.249 170.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -98.99 -17.4 18.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 118.588 -2.57 . . . . 0.0 116.832 167.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 74.72 42.59 0.28 Allowed 'General case' 0 N--CA 1.452 -0.349 1 C-N-CA 132.456 4.303 . . . . 0.0 108.517 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.9 mt -68.21 106.3 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 O-C-N 119.892 -1.755 . . . . 0.0 107.853 156.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -76.88 169.9 17.47 Favored 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 133.628 4.771 . . . . 0.0 112.254 166.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.268 17.9 pttm -69.1 148.94 49.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 174.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 73.2 mt-10 57.34 13.72 1.87 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.7 m -81.58 169.6 16.86 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.467 2.307 . . . . 0.0 108.298 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -143.51 131.51 21.69 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.233 -153.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.22 145.64 35.87 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.158 -1.589 . . . . 0.0 111.159 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.281 24.6 m80 -97.1 117.91 32.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -170.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.31 128.43 34.69 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.602 1.961 . . . . 0.0 110.668 169.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.06 146.96 30.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 1 C-N-CA 131.795 4.038 . . . . 0.0 108.688 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.291 1.2 mm? . . . . . 0 C--N 1.32 -0.694 0 O-C-N 118.961 -2.337 . . . . 0.0 109.394 175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -84.68 152.1 23.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 125.027 2.346 . . . . 0.0 114.235 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 3' ' ' ILE . 42.1 pt -134.16 137.14 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 129.783 3.233 . . . . 0.0 104.633 165.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -94.56 121.35 36.03 Favored 'General case' 0 N--CA 1.449 -0.504 1 C-N-CA 132.196 4.198 . . . . 0.0 105.219 166.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.56 130.8 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 101.306 -3.59 . . . . 0.0 101.306 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 23.2 mttm -90.9 116.57 28.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 129.547 3.139 . . . . 0.0 106.866 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 p -74.96 162.85 28.23 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 120.252 1.387 . . . . 0.0 110.176 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -70.56 -36.9 73.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.198 1.399 . . . . 0.0 107.823 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.8 p -80.71 -2.65 47.69 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.958 2.103 . . . . 0.0 116.273 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.49 20.34 8.24 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 161.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -107.35 158.07 17.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 126.47 3.033 . . . . 0.0 106.403 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.258 10.9 m -129.49 91.85 3.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 131.538 3.935 . . . . 0.0 108.854 -172.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mm -79.69 111.96 17.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 O-C-N 128.623 3.702 . . . . 0.0 104.71 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.257 85.1 m -86.52 107.73 18.23 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.816 1.647 . . . . 0.0 112.903 173.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mp -97.9 164.82 12.21 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 126.15 2.156 . . . . 0.0 112.888 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -113.08 146.59 38.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 127.196 3.379 . . . . 0.0 107.79 162.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.48 178.8 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 131.035 3.734 . . . . 0.0 107.5 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -120.9 150.42 52.99 Favored Pre-proline 0 N--CA 1.45 -0.432 0 C-N-CA 130.969 3.708 . . . . 0.0 103.109 154.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -47.02 -19.47 0.85 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 120.396 3.191 . . . . 0.0 120.396 164.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.7 m -58.92 -33.17 70.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 130.61 3.564 . . . . 0.0 114.276 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.09 126.49 20.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.891 2.476 . . . . 0.0 107.052 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.5 p -79.89 147.51 31.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 127.609 3.068 . . . . 0.0 104.809 162.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 8.2 mm -46.4 -51.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 111.921 -2.399 . . . . 0.0 114.439 169.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -35.78 -42.15 0.25 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 160.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -74.31 -35.42 63.66 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 117.491 -3.255 . . . . 0.0 115.371 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.85 -42.69 79.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 120.079 -1.638 . . . . 0.0 109.006 170.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -56.72 -36.98 70.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 123.686 1.708 . . . . 0.0 113.543 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.67 -34.02 62.6 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 130.665 3.586 . . . . 0.0 111.05 -175.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -75.44 -44.02 46.63 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 128.578 2.751 . . . . 0.0 106.924 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 mt -60.83 -33.71 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 119.352 -2.092 . . . . 0.0 113.553 162.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.262 12.8 tt0 -60.1 -38.64 83.56 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 123.048 1.404 . . . . 0.0 112.58 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.75 -61.45 2.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 119.492 3.145 . . . . 0.0 119.492 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -63.65 -43.78 95.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 108.452 -3.977 . . . . 0.0 110.443 -168.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -119.46 -18.32 8.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 120.238 1.381 . . . . 0.0 112.336 -167.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.75 -8.66 54.72 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 117.418 -1.768 . . . . 0.0 111.224 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -67.4 115.0 22.02 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 120.196 1.998 . . . . 0.0 111.207 -164.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -74.36 156.65 45.87 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.466 2.11 . . . . 0.0 108.592 -168.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -68.57 -35.46 17.17 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 117.079 1.915 . . . . 0.0 117.079 -172.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.02 -27.06 68.61 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 118.806 2.891 . . . . 0.0 118.806 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -83.73 -30.58 26.58 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 119.236 -2.165 . . . . 0.0 112.746 173.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -67.32 133.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 123.075 1.417 . . . . 0.0 113.719 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -128.19 141.55 51.44 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 130.505 3.522 . . . . 0.0 103.376 161.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.67 136.4 53.94 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 129.488 3.115 . . . . 0.0 106.337 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.2 mt -123.75 156.58 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 110.023 -3.262 . . . . 0.0 112.699 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -158.19 127.53 5.77 Favored 'General case' 0 N--CA 1.45 -0.453 1 O-C-N 129.355 4.16 . . . . 0.0 102.984 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.08 26.27 11.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 165.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.64 -9.6 41.13 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 128.7 3.048 . . . . 0.0 113.331 169.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -121.37 142.54 49.89 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 126.744 2.085 . . . . 0.0 111.371 -166.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -90.44 116.67 28.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 128.236 2.614 . . . . 0.0 107.978 -172.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.68 136.02 34.87 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.416 1.487 . . . . 0.0 107.99 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.253 4.3 mm-40 -92.33 124.29 36.28 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 110.667 -2.97 . . . . 0.0 107.915 -163.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -53.93 -22.18 9.6 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 119.38 3.104 . . . . 0.0 119.38 -160.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.74 -5.39 55.3 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 128.567 2.984 . . . . 0.0 119.197 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -90.15 156.39 18.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.935 1.694 . . . . 0.0 108.045 173.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -95.98 167.16 11.4 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.75 2.82 . . . . 0.0 108.704 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -70.38 -31.21 68.35 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 125.854 2.74 . . . . 0.0 108.663 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.353 14.1 t -50.71 -38.68 48.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 112.815 -3.469 . . . . 0.0 115.5 164.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.263 0.4 OUTLIER -74.03 -26.84 60.63 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 126.564 2.415 . . . . 0.0 109.578 -168.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.522 40.8 m-85 -102.08 10.15 39.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 125.279 1.612 . . . . 0.0 114.328 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.412 3.7 p-10 60.86 33.25 20.02 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 128.028 2.531 . . . . 0.0 116.563 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.7 mt -90.52 114.48 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.291 0.3 OUTLIER -143.86 81.35 1.69 Allowed 'General case' 0 N--CA 1.45 -0.47 1 C-N-CA 131.724 4.01 . . . . 0.0 117.011 -177.106 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.406 22.3 ttpt 84.51 131.95 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.799 3.64 . . . . 0.0 117.73 171.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 72.53 41.38 0.58 Allowed 'General case' 0 N--CA 1.443 -0.785 1 C-N-CA 134.504 5.122 . . . . 0.0 109.306 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.0 m -85.93 144.36 27.69 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 130.753 3.621 . . . . 0.0 111.439 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.9 m -100.33 109.63 21.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.127 2.571 . . . . 0.0 105.748 164.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -111.94 151.09 29.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.107 -1.901 . . . . 0.0 109.911 171.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -120.79 140.54 51.56 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 131.276 3.83 . . . . 0.0 112.06 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -98.67 135.61 39.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 116.053 -1.927 . . . . 0.0 110.954 157.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.33 148.52 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 1 O-C-N 129.345 4.153 . . . . 0.0 109.248 160.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 N--CA 1.447 -0.592 0 O-C-N 117.767 -3.083 . . . . 0.0 108.054 -173.031 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 123.284 1.516 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -134.26 150.22 51.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 108.729 -3.85 . . . . 0.0 116.608 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -136.46 144.69 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 112.8 -2.0 . . . . 0.0 113.454 166.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -90.08 122.24 32.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 116.906 -3.621 . . . . 0.0 109.138 163.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.8 t -82.82 125.24 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 101.244 -3.613 . . . . 0.0 101.244 157.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -103.98 104.58 14.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 110.14 -3.209 . . . . 0.0 104.914 162.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -72.48 137.93 46.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.645 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.36 -39.58 46.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 119.728 3.233 . . . . 0.0 119.728 -171.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.389 2.0 t -35.46 -30.76 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.704 1 C-N-CA 133.465 4.706 . . . . 0.0 117.044 156.75 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.99 -20.22 7.21 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 124.935 2.408 . . . . 0.0 110.444 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.26 73.4 tttt -71.35 139.48 49.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 119.304 -2.292 . . . . 0.0 108.712 -168.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 m -118.15 111.95 19.52 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 126.016 2.073 . . . . 0.0 114.562 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.263 13.8 mm -104.71 131.36 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.002 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.308 2.8 m -94.01 123.58 37.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 117.786 -3.071 . . . . 0.0 108.816 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mp -111.14 132.26 54.43 Favored 'General case' 0 C--O 1.217 -0.605 0 O-C-N 119.629 -1.92 . . . . 0.0 107.795 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -82.98 131.66 35.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 170.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -144.25 -174.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.807 0.843 . . . . 0.0 112.848 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -140.28 143.58 33.99 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 127.672 3.108 . . . . 0.0 108.916 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.68 -15.4 24.28 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 CA-C-N 125.105 2.859 . . . . 0.0 115.625 -167.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -75.32 1.8 12.81 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 117.41 -3.306 . . . . 0.0 116.938 165.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -93.76 150.77 20.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.499 2.319 . . . . 0.0 109.057 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 24' ' ' GLU . 7.4 p -71.36 161.0 31.78 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -175.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.63 HG23 HD13 ' A' ' 43' ' ' LEU 0.305 16.5 mm -49.76 -41.93 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 131.677 3.991 . . . . 0.0 111.174 146.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' H ' ' HB ' ' A' ' 22' ' ' THR . 27.8 tt0 -59.35 -45.82 90.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 116.232 -2.187 . . . . 0.0 113.159 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -71.8 -23.3 61.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.472 1.107 . . . . 0.0 113.459 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.294 91.7 t -48.88 -62.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 150.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -68.64 -38.16 80.26 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.927 -1.733 . . . . 0.0 115.086 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.82 -38.26 75.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 129.591 3.157 . . . . 0.0 116.233 172.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -50.26 -37.64 36.84 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 163.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -69.84 -12.92 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 O-C-N 119.837 -1.789 . . . . 0.0 107.675 -172.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -62.45 -43.38 98.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 116.591 -3.818 . . . . 0.0 112.895 171.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -83.32 -32.87 26.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.382 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -75.05 -67.55 0.64 Allowed 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 119.515 -1.991 . . . . 0.0 108.663 168.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -103.58 -23.58 13.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 116.902 -3.624 . . . . 0.0 115.814 -155.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.63 25.74 10.51 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 116.83 -2.095 . . . . 0.0 108.569 172.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 mm -107.68 129.39 24.26 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.36 165.63 31.02 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.292 1.995 . . . . 0.0 111.767 170.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.63 -38.02 6.39 Favored 'Trans proline' 0 N--CA 1.453 -0.897 1 C-N-CA 127.551 5.501 . . . . 0.0 117.007 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.86 -21.11 26.83 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.922 2.489 . . . . 0.0 113.968 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -95.51 -9.53 32.22 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.928 2.891 . . . . 0.0 116.297 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -95.88 133.51 39.97 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 115.193 -2.337 . . . . 0.0 108.793 -172.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -119.13 104.39 10.4 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.702 2.001 . . . . 0.0 107.953 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.63 HD13 HG23 ' A' ' 23' ' ' ILE . 1.4 tt -98.37 118.75 35.73 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 126.499 2.374 . . . . 0.0 105.487 -171.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -117.35 149.91 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -170.76 137.73 1.32 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 124.057 1.884 . . . . 0.0 107.725 166.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.36 28.95 11.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 117.434 2.383 . . . . 0.0 117.434 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.84 -5.39 69.23 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 116.454 -2.303 . . . . 0.0 114.061 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -125.76 147.36 49.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 127.404 2.473 . . . . 0.0 112.613 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -68.04 135.02 51.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.36 1.864 . . . . 0.0 113.46 163.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.625 HD22 HD22 ' A' ' 43' ' ' LEU . 9.9 mp -93.47 101.45 13.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.16 -16.63 59.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -173.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.594 26.5 t0 103.72 145.67 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 127.623 2.369 . . . . 0.0 112.136 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.3 -8.02 2.89 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 172.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.347 48.3 mtp180 -145.17 152.53 40.16 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.782 1.277 . . . . 0.0 109.812 -168.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.7 p -83.08 168.48 16.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 112.777 -2.01 . . . . 0.0 114.835 -168.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.5 mt -47.56 -40.69 19.66 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.3 p -60.1 -56.09 25.84 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.899 2.48 . . . . 0.0 116.594 167.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -46.01 -57.59 4.3 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.512 1.925 . . . . 0.0 114.117 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -74.82 -16.69 60.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 126.901 2.081 . . . . 0.0 115.168 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.274 25.5 t-20 90.33 64.28 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 129.951 3.3 . . . . 0.0 111.498 164.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -118.85 131.0 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.275 73.7 mm-40 -128.06 165.19 20.81 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 126.09 2.119 . . . . 0.0 106.606 -160.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -60.67 147.57 41.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 116.876 -1.535 . . . . 0.0 110.524 -167.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 59.92 19.62 8.62 Favored 'General case' 0 N--CA 1.444 -0.736 1 C-N-CA 131.957 4.103 . . . . 0.0 111.73 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.4 m -81.04 149.66 29.16 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 123.146 2.703 . . . . 0.0 113.287 170.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.3 m -93.08 131.76 37.81 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.879 2.872 . . . . 0.0 107.376 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.9 mt -103.52 130.03 50.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.63 2.772 . . . . 0.0 111.865 159.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -90.6 139.4 30.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.285 43.2 tp -122.29 129.58 52.32 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 117.129 -1.829 . . . . 0.0 109.116 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.254 83.6 t -95.45 139.33 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 126.354 2.284 . . . . 0.0 105.085 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.447 -0.618 0 CA-C-O 121.869 0.842 . . . . 0.0 111.813 176.095 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 112.891 -3.433 . . . . 0.0 107.742 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -91.38 134.51 34.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.386 3.074 . . . . 0.0 112.376 167.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 pt -125.19 167.51 19.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 124.836 2.255 . . . . 0.0 106.915 160.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -106.35 144.43 33.05 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.409 2.284 . . . . 0.0 108.037 162.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.486 HG21 HD11 ' A' ' 30' ' ' ILE . 43.8 t -118.42 108.34 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 168.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -86.19 132.36 34.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 123.236 1.494 . . . . 0.0 111.443 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.7 p -98.08 159.2 15.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 117.189 -3.445 . . . . 0.0 106.079 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -58.7 -45.64 89.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.218 2.207 . . . . 0.0 109.077 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -73.43 3.04 6.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 130.569 3.548 . . . . 0.0 115.772 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.06 -8.99 50.27 Favored Glycine 0 N--CA 1.442 -0.901 2 O-C-N 114.099 -5.376 . . . . 0.0 113.102 162.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -79.15 150.6 31.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 121.73 2.765 . . . . 0.0 111.797 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 p -105.87 131.35 53.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 126.345 2.278 . . . . 0.0 111.643 161.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.455 HG13 ' HB ' ' A' ' 5' ' ' VAL . 1.9 pt -104.28 162.74 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 1 O-C-N 114.611 -5.055 . . . . 0.0 105.469 168.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.53 110.27 14.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.635 2.374 . . . . 0.0 106.011 -172.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.282 0.4 OUTLIER -104.48 138.93 40.12 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 128.316 2.646 . . . . 0.0 109.803 -173.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 pm0 -90.15 135.81 33.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 126.821 2.576 . . . . 0.0 108.769 159.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 m -150.37 149.41 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.15 3.38 . . . . 0.0 107.418 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -101.87 141.88 23.47 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 127.939 2.496 . . . . 0.0 105.249 163.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -39.04 -42.76 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 N-CA-C 119.759 2.946 . . . . 0.0 119.759 167.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 p -88.15 14.75 8.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.422 2.689 . . . . 0.0 109.934 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -88.71 150.92 22.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 124.987 2.327 . . . . 0.0 105.661 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -86.99 146.74 26.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 110.442 -3.072 . . . . 0.0 110.206 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 23' ' ' ILE . 69.5 mt -57.17 -24.81 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 124.864 1.353 . . . . 0.0 112.145 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 6.9 tt0 -69.64 -34.16 73.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 128.239 2.616 . . . . 0.0 110.336 172.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -72.04 -31.85 66.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 114.103 -2.856 . . . . 0.0 107.305 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.4 t -79.46 -33.63 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 123.895 3.043 . . . . 0.0 107.68 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -54.85 -49.59 70.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 112.519 -3.61 . . . . 0.0 110.576 168.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.45 -52.33 6.11 Favored 'General case' 0 CA--C 1.537 0.468 1 CA-C-N 126.396 4.18 . . . . 0.0 119.426 156.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -74.09 -22.8 59.35 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 117.038 -3.539 . . . . 0.0 116.511 -169.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.486 HD11 HG21 ' A' ' 5' ' ' VAL . 14.0 mt -66.44 -39.0 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 130.951 3.701 . . . . 0.0 113.373 158.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.44 -26.82 64.79 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 122.841 2.564 . . . . 0.0 109.171 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.49 -42.38 74.87 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 128.436 3.585 . . . . 0.0 110.11 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -76.39 -42.63 43.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 176.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 13.8 tp10 -130.19 5.77 4.9 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.491 -1.38 . . . . 0.0 109.972 -159.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.09 -0.93 35.99 Favored Glycine 0 CA--C 1.532 1.109 1 N-CA-C 123.598 4.199 . . . . 0.0 123.598 165.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 mt -78.05 114.97 46.76 Favored Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 129.696 3.198 . . . . 0.0 105.325 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.264 4.9 Cg_exo -48.52 134.67 26.72 Favored 'Trans proline' 0 N--CA 1.455 -0.768 1 C-N-CA 125.413 4.076 . . . . 0.0 111.554 172.517 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.21 -37.01 26.28 Favored 'Trans proline' 0 N--CA 1.44 -1.656 1 C-N-CA 129.156 6.571 . . . . 0.0 115.15 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -39.49 -31.89 0.11 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 129.65 3.18 . . . . 0.0 115.756 159.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.387 85.5 mt-30 -98.26 -13.42 20.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 118.989 -2.319 . . . . 0.0 114.78 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -81.6 143.08 32.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.2 ttp-105 -127.77 129.66 47.43 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 155.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.4 mt -96.23 132.98 41.11 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 116.672 -3.767 . . . . 0.0 107.297 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mt -125.44 149.57 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -113.64 -25.84 8.52 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 118.203 -2.811 . . . . 0.0 113.076 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.683 . . -143.43 -123.86 0.09 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 112.266 -2.243 . . . . 0.0 110.773 -170.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.93 18.41 19.22 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.666 0.592 . . . . 0.0 112.436 -166.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -151.65 154.77 37.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 118.182 -2.952 . . . . 0.0 110.383 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -57.73 156.33 8.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.802 1.641 . . . . 0.0 112.537 166.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.19 162.72 18.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 118.811 -2.43 . . . . 0.0 108.195 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -104.62 140.86 37.4 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.95 1.357 . . . . 0.0 109.132 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 6.1 m-20 -67.97 -24.2 65.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 130.01 3.324 . . . . 0.0 114.594 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.12 40.77 2.43 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.539 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 11.1 mtt180 -130.37 151.17 51.16 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 165.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -96.6 162.27 13.53 Favored 'General case' 0 N--CA 1.45 -0.428 1 O-C-N 116.253 -4.03 . . . . 0.0 111.424 -167.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -54.67 -44.0 72.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.034 1.733 . . . . 0.0 110.617 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -61.27 -40.98 96.13 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 170.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -54.17 -33.13 57.32 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 131.296 3.838 . . . . 0.0 114.807 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 97.1 m-85 -100.13 0.04 39.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.276 -1.515 . . . . 0.0 111.732 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.7 t30 56.63 36.19 27.26 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 129.28 3.032 . . . . 0.0 117.588 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mt -79.28 116.21 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 103.204 -2.888 . . . . 0.0 103.204 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -103.44 169.35 8.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.598 1.959 . . . . 0.0 109.204 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.385 53.7 pttt -50.22 133.4 23.7 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.343 1.857 . . . . 0.0 113.42 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 24.0 mt-10 72.12 12.35 5.93 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 130.339 3.455 . . . . 0.0 115.488 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.9 m -60.86 145.31 50.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 113.97 -2.919 . . . . 0.0 112.864 162.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -102.39 131.26 49.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 127.698 3.124 . . . . 0.0 105.154 170.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.75 151.73 25.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.634 -2.541 . . . . 0.0 108.621 161.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -109.47 128.48 55.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 117.917 -2.99 . . . . 0.0 105.595 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.0 tp -106.21 103.07 12.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 112.11 -2.313 . . . . 0.0 109.673 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.1 t -83.23 137.17 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 124.498 2.095 . . . . 0.0 110.574 169.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 126.313 1.845 . . . . 0.0 107.274 -157.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.32 135.83 33.17 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 119.547 -1.971 . . . . 0.0 106.81 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.44 164.08 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 123.961 0.904 . . . . 0.0 112.018 166.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -90.57 129.94 36.65 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 126.092 1.757 . . . . 0.0 110.347 155.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.03 110.51 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 150.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -99.1 134.12 42.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 127.222 3.391 . . . . 0.0 110.926 170.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 p -89.15 141.36 28.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 111.706 -2.497 . . . . 0.0 108.759 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.06 -11.08 35.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 163.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -78.91 -15.55 58.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 118.212 -2.805 . . . . 0.0 115.069 169.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.19 -12.09 6.09 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 120.211 1.369 . . . . 0.0 113.64 159.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -82.95 137.19 34.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.522 1.529 . . . . 0.0 110.612 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -97.67 125.97 42.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 125.201 2.429 . . . . 0.0 106.507 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 mm -112.8 106.06 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 1 O-C-N 115.646 -4.409 . . . . 0.0 101.567 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.4 m -59.91 137.11 58.15 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 122.868 1.318 . . . . 0.0 111.618 158.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.29 140.54 43.47 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 128.584 2.754 . . . . 0.0 109.168 177.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -111.66 121.71 45.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.0 162.54 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 128.864 2.866 . . . . 0.0 104.787 -177.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -111.3 162.53 20.5 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 160.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -88.72 -21.71 1.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 121.735 1.623 . . . . 0.0 109.386 -164.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -69.09 -6.13 26.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 159.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -71.57 137.24 47.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 119.82 -1.8 . . . . 0.0 112.593 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.315 42.7 p -60.44 142.71 54.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 128.414 2.685 . . . . 0.0 112.74 169.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.444 62.6 mt -46.79 -29.58 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 163.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -53.83 -56.27 19.14 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 131.699 4.0 . . . . 0.0 108.013 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -74.75 -28.47 60.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 116.527 -1.701 . . . . 0.0 112.018 -171.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 t -71.01 -51.13 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 128.381 2.672 . . . . 0.0 111.743 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 38' ' ' PRO . 76.3 mttt -55.37 -45.37 76.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 113.456 -3.164 . . . . 0.0 113.317 168.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.5 -17.03 63.5 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 131.291 3.837 . . . . 0.0 115.324 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -77.55 -32.54 53.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 112.946 -3.407 . . . . 0.0 107.317 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.51 -21.81 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 O-C-N 127.062 2.726 . . . . 0.0 108.097 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -67.57 -35.64 79.42 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 128.534 2.734 . . . . 0.0 112.864 164.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.66 -33.13 60.4 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.277 1.031 . . . . 0.0 111.646 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -81.55 -77.33 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 119.725 -1.86 . . . . 0.0 109.391 -172.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.269 15.9 mm-40 -100.9 -15.4 17.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 115.034 -2.412 . . . . 0.0 114.604 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.05 -1.72 40.95 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 121.749 2.068 . . . . 0.0 110.331 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -76.22 130.63 77.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 114.953 -2.451 . . . . 0.0 106.641 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.53 149.73 16.69 Favored 'Trans proline' 0 N--CA 1.446 -1.319 1 C-N-CA 125.991 4.461 . . . . 0.0 111.317 -174.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 19.5 Cg_exo -40.01 -37.42 1.68 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 N-CA-C 119.475 2.837 . . . . 0.0 119.475 165.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -45.7 -49.06 14.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.153 1.781 . . . . 0.0 114.292 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -99.72 -3.4 32.99 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 127.47 2.308 . . . . 0.0 116.976 -169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -80.23 127.56 32.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 125.144 2.402 . . . . 0.0 108.979 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.533 ' CZ ' HG12 ' A' ' 70' ' ' VAL . 36.4 mtm180 -112.79 127.06 56.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 119.418 -2.051 . . . . 0.0 105.824 165.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.02 124.8 50.72 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 131.331 3.852 . . . . 0.0 107.577 -163.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 mm -124.89 128.82 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 117.12 -3.488 . . . . 0.0 109.445 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -153.68 136.99 15.73 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 118.529 -2.607 . . . . 0.0 109.701 163.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.385 . . 66.35 32.07 7.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 124.339 2.019 . . . . 0.0 115.123 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 -12.33 32.6 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 112.38 -2.191 . . . . 0.0 116.199 -174.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.261 9.9 ttpt -100.84 136.63 40.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.45 -1.617 . . . . 0.0 109.175 -167.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -92.82 116.47 29.06 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 171.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 mt -81.09 143.19 32.62 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 126.446 2.341 . . . . 0.0 105.239 -163.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.98 150.43 29.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.018 2.927 . . . . 0.0 109.356 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.67 155.33 33.47 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 117.988 -2.945 . . . . 0.0 111.361 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.77 48.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 127.111 2.291 . . . . 0.0 114.821 162.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -94.71 160.62 14.53 Favored 'General case' 0 N--CA 1.446 -0.664 1 C-N-CA 135.444 5.498 . . . . 0.0 113.878 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.4 p -103.91 170.8 7.71 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -72.51 -18.3 61.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 123.828 1.775 . . . . 0.0 108.305 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -78.68 -22.45 46.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.316 -2.115 . . . . 0.0 112.118 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -83.98 4.22 30.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -118.33 -7.38 10.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 118.091 -2.88 . . . . 0.0 108.529 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 10.8 p30 59.71 37.65 22.12 Favored 'General case' 0 N--CA 1.449 -0.511 1 C-N-CA 134.402 5.081 . . . . 0.0 114.149 -172.224 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -69.49 137.46 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 O-C-N 120.646 -1.284 . . . . 0.0 112.298 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -127.74 169.87 13.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.323 3.049 . . . . 0.0 109.48 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -42.33 131.89 3.56 Favored 'General case' 0 N--CA 1.45 -0.437 1 C-N-CA 136.415 5.886 . . . . 0.0 107.938 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.328 2.2 tt0 69.37 12.97 8.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 172.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.5 m -65.27 149.21 50.34 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.786 2.435 . . . . 0.0 108.145 166.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.4 m -101.63 120.84 40.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.238 -3.414 . . . . 0.0 102.557 166.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.37 37.8 mt -101.35 158.48 16.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.053 1.406 . . . . 0.0 110.435 162.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.301 79.2 m80 -117.41 133.5 55.9 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 119.279 -2.138 . . . . 0.0 108.947 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.28 120.18 39.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 124.876 2.274 . . . . 0.0 107.089 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.533 HG12 ' CZ ' ' A' ' 42' ' ' ARG . 96.4 t -99.99 136.76 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.498 171.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.1 tp . . . . . 0 C--N 1.329 -0.321 0 N-CA-C 101.062 -3.681 . . . . 0.0 101.062 -177.159 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 ttp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 102.016 -3.327 . . . . 0.0 102.016 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -99.47 145.32 27.58 Favored 'General case' 0 N--CA 1.444 -0.738 2 CA-C-O 111.552 -4.071 . . . . 0.0 108.103 170.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -120.33 159.02 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 115.653 -2.118 . . . . 0.0 110.956 150.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -99.41 132.01 45.03 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 128.719 3.762 . . . . 0.0 107.298 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.45 145.36 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 O-C-N 126.674 2.484 . . . . 0.0 105.257 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -114.56 140.32 48.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 127.904 2.481 . . . . 0.0 108.616 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -100.27 170.63 8.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 125.995 2.807 . . . . 0.0 105.116 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.5 mt -57.07 -32.11 65.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.126 -2.306 . . . . 0.0 109.918 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.0 p -86.6 -9.36 56.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 117.575 -3.203 . . . . 0.0 110.343 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.75 11.31 38.13 Favored Glycine 0 CA--C 1.532 1.134 1 C-N-CA 135.108 6.099 . . . . 0.0 114.762 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -82.54 129.26 34.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 -162.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 48.1 m -96.47 126.06 41.39 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.088 0.955 . . . . 0.0 110.718 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -120.03 151.46 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 119.605 -1.934 . . . . 0.0 106.574 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.271 4.8 m -118.0 91.21 3.51 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 128.021 2.528 . . . . 0.0 106.579 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -83.0 150.19 26.51 Favored 'General case' 0 N--CA 1.444 -0.736 1 CA-C-N 107.991 -4.186 . . . . 0.0 112.053 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.88 108.07 18.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.446 1.898 . . . . 0.0 108.121 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.61 -176.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 1 C-N-CA 134.168 4.987 . . . . 0.0 116.492 173.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -152.12 159.83 32.34 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 103.007 -2.96 . . . . 0.0 103.007 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 75.1 Cg_exo -41.89 -24.42 0.29 Allowed 'Trans proline' 0 N--CA 1.443 -1.498 1 C-N-CA 128.004 5.803 . . . . 0.0 121.697 174.824 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.9 p -78.6 1.92 21.05 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 129.853 3.261 . . . . 0.0 115.182 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.45 130.01 45.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -76.98 178.71 6.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 113.916 -2.945 . . . . 0.0 112.298 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 mm -76.19 -24.62 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 113.956 -2.926 . . . . 0.0 109.197 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -72.99 -41.6 64.16 Favored 'General case' 0 C--O 1.242 0.691 1 C-N-CA 132.697 4.399 . . . . 0.0 105.062 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -65.29 -30.41 71.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.684 -2.51 . . . . 0.0 115.623 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -87.71 -35.9 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 1 CA-C-O 108.545 -5.502 . . . . 0.0 108.219 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.03 -29.57 70.48 Favored 'General case' 0 C--N 1.324 -0.51 1 CA-C-N 126.71 4.323 . . . . 0.0 114.45 169.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.87 80.78 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 125.502 2.572 . . . . 0.0 114.079 167.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -72.9 -37.2 67.33 Favored 'General case' 0 C--N 1.326 -0.414 1 O-C-N 115.117 -4.739 . . . . 0.0 108.967 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.2 mt -50.81 -65.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 128.019 2.528 . . . . 0.0 114.459 160.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -35.99 -43.58 0.33 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.206 2.202 . . . . 0.0 112.423 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -60.32 -42.02 94.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.918 3.287 . . . . 0.0 118.219 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -102.61 -29.31 11.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.011 -2.359 . . . . 0.0 114.776 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -119.08 -13.01 9.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 118.299 2.704 . . . . 0.0 118.299 -169.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.79 -12.56 68.47 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 114.278 -3.512 . . . . 0.0 118.655 162.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mt -73.12 123.2 89.29 Favored Pre-proline 0 N--CA 1.451 -0.403 1 O-C-N 130.414 4.244 . . . . 0.0 104.957 -162.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.14 145.72 33.29 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 123.79 2.994 . . . . 0.0 113.786 170.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.06 -30.33 21.06 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 N-CA-C 117.033 1.897 . . . . 0.0 117.033 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.23 -35.34 36.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 124.156 1.932 . . . . 0.0 109.109 -158.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -80.53 -19.38 45.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.83 144.98 31.65 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 117.994 -1.003 . . . . 0.0 111.542 -172.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -142.01 150.94 41.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 114.165 -2.826 . . . . 0.0 111.449 172.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.45 121.07 41.62 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 128.277 3.486 . . . . 0.0 108.084 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.4 mm -103.36 141.58 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 1 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' HB3' HD21 ' A' ' 50' ' ' LEU . 36.9 t80 -139.11 127.55 22.94 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 100.94 -3.726 . . . . 0.0 100.94 171.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.71 46.13 17.81 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 129.5 3.12 . . . . 0.0 107.831 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.07 -12.44 1.69 Allowed Glycine 0 CA--C 1.535 1.343 0 O-C-N 116.73 -3.731 . . . . 0.0 120.577 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -97.46 137.35 36.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.219 2.608 . . . . 0.0 108.711 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.13 140.08 57.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.909 1.381 . . . . 0.0 108.269 165.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 45' ' ' PHE . 92.8 mt -81.42 109.75 16.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 131.052 3.741 . . . . 0.0 104.548 164.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -94.45 136.68 34.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.459 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -47.77 141.26 5.69 Favored 'General case' 0 C--N 1.328 -0.347 1 C-N-CA 132.846 4.459 . . . . 0.0 116.241 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.66 -30.66 7.95 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.498 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -100.78 161.82 13.33 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 117.092 -3.593 . . . . 0.0 107.542 -173.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -102.65 -176.17 3.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.535 -1.666 . . . . 0.0 108.009 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.97 -34.25 77.98 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 119.041 -2.287 . . . . 0.0 113.155 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.5 m -62.39 -37.51 86.02 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -62.92 -20.06 64.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.619 1.968 . . . . 0.0 116.055 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -114.87 -5.34 12.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.143 2.177 . . . . 0.0 111.904 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 t30 55.53 54.54 8.32 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.799 1.937 . . . . 0.0 114.684 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.0 mt -88.8 132.38 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.8 0.809 . . . . 0.0 109.168 -176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -98.32 150.89 21.09 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.383 2.273 . . . . 0.0 109.317 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -46.13 135.2 7.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 127.795 3.184 . . . . 0.0 109.799 154.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.417 0.0 OUTLIER 84.6 -6.21 0.99 Allowed 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 125.877 1.986 . . . . 0.0 115.207 166.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 t -88.17 140.2 29.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 128.004 3.315 . . . . 0.0 108.085 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.1 m -92.89 129.35 38.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -164.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.08 128.97 54.85 Favored 'General case' 0 N--CA 1.447 -0.621 1 C-N-CA 133.744 4.818 . . . . 0.0 111.659 171.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.14 141.0 29.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 123.999 3.091 . . . . 0.0 107.669 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -116.02 92.17 3.82 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 126.762 3.173 . . . . 0.0 103.154 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -93.46 158.25 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 112.653 -2.067 . . . . 0.0 110.435 170.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 129.805 3.242 . . . . 0.0 106.482 169.554 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 ttp . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.264 19.2 tm0? -109.78 123.91 50.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 125.732 2.682 . . . . 0.0 107.397 -172.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 pt -110.46 155.47 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 129.144 2.977 . . . . 0.0 108.261 155.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -110.81 160.55 16.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 125.088 2.375 . . . . 0.0 106.652 171.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 t -123.17 134.35 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 110.087 -3.233 . . . . 0.0 108.505 166.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 tttt -115.83 157.4 24.47 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 127.894 3.246 . . . . 0.0 110.406 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.312 7.9 t -147.72 161.06 41.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.754 2.821 . . . . 0.0 108.751 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 7.6 mt -28.13 -45.94 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.445 1 C-N-CA 135.863 5.665 . . . . 0.0 119.859 -176.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -79.33 -16.89 55.61 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.708 2.803 . . . . 0.0 114.24 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.61 -12.17 58.05 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 117.489 -1.728 . . . . 0.0 113.673 -171.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -55.33 150.34 11.55 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.336 22.7 p -130.44 149.91 51.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 117.801 -3.062 . . . . 0.0 115.3 168.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.403 HD11 ' OE2' ' A' ' 34' ' ' GLU . 61.9 mt -118.38 117.55 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 100.818 -3.771 . . . . 0.0 100.818 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.283 9.0 t -106.07 122.23 45.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.151 3.38 . . . . 0.0 107.954 170.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.285 42.1 mt -113.29 134.95 54.34 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.292 3.037 . . . . 0.0 108.306 162.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -81.17 109.89 16.14 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 100.887 -3.746 . . . . 0.0 100.887 168.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 56' ' ' LEU . 5.4 m -114.8 145.21 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 125.746 2.689 . . . . 0.0 111.713 -172.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.296 3.8 tt0 -103.35 116.87 61.44 Favored Pre-proline 0 C--N 1.324 -0.532 1 C-N-CA 131.745 4.018 . . . . 0.0 106.451 -176.033 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.318 50.5 Cg_exo -32.6 -42.56 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 1 N-CA-C 122.762 4.101 . . . . 0.0 122.762 -178.283 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.6 p -80.14 -7.74 59.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 131.1 3.76 . . . . 0.0 120.357 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -68.72 126.71 30.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 124.383 1.052 . . . . 0.0 113.204 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.4 p -70.28 146.83 50.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.346 20.2 mm -51.84 -31.18 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.462 1.905 . . . . 0.0 112.439 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.69 -33.63 18.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 123.15 1.452 . . . . 0.0 109.711 -170.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.18 -36.27 83.51 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 118.923 -2.361 . . . . 0.0 117.009 165.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.0 t -63.55 -49.01 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 116.646 -1.645 . . . . 0.0 111.466 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -57.75 -29.05 64.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 118.374 2.731 . . . . 0.0 118.374 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.63 -18.09 30.41 Favored 'General case' 0 CA--C 1.537 0.456 1 C-N-CA 132.257 4.223 . . . . 0.0 108.309 -176.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -90.44 -26.94 19.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.374 1.443 . . . . 0.0 110.646 169.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 30' ' ' ILE . 95.1 mt -71.0 -31.37 45.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 129.491 3.117 . . . . 0.0 108.114 172.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -56.42 -44.54 80.48 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 126.896 2.622 . . . . 0.0 113.705 172.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.39 -47.7 84.95 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.105 2.162 . . . . 0.0 109.958 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -67.84 -69.18 0.33 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 128.167 2.587 . . . . 0.0 108.646 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.403 ' OE2' HD11 ' A' ' 13' ' ' ILE . 44.6 mm-40 -88.08 -32.83 18.53 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 121.176 3.769 . . . . 0.0 121.176 -172.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.27 5.05 35.08 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 127.79 2.614 . . . . 0.0 114.384 172.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -93.63 135.07 25.54 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 101.289 -3.597 . . . . 0.0 101.289 -174.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.8 Cg_endo -78.89 148.01 21.87 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 O-C-N 125.122 2.117 . . . . 0.0 110.817 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 47.0 Cg_exo -53.99 -30.37 58.83 Favored 'Trans proline' 0 N--CA 1.447 -1.263 1 C-N-CA 128.597 6.198 . . . . 0.0 118.427 -170.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -61.77 -27.01 68.43 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 130.585 3.554 . . . . 0.0 110.105 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -91.34 -12.95 33.47 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 117.159 -1.4 . . . . 0.0 113.008 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -89.12 121.71 31.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 122.722 2.51 . . . . 0.0 111.703 -174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -88.15 110.06 20.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 151.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.7 mt -91.92 92.01 8.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 153.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mt -96.88 137.02 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 128.914 2.886 . . . . 0.0 105.23 -173.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -116.56 -149.85 0.45 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 115.214 -2.327 . . . . 0.0 107.764 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 66.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 131.233 3.813 . . . . 0.0 115.465 171.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.99 -22.51 0.75 Allowed Glycine 0 CA--C 1.533 1.171 1 C-N-CA 130.906 4.098 . . . . 0.0 117.343 -164.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -82.92 128.93 34.9 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 120.718 -1.46 . . . . 0.0 113.494 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.306 19.9 mp0 -90.73 107.99 19.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 126.078 2.111 . . . . 0.0 105.711 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.61 107.44 1.4 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.913 2.485 . . . . 0.0 113.123 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.45 142.18 32.12 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.966 2.906 . . . . 0.0 110.884 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -67.92 109.94 3.65 Favored 'General case' 0 N--CA 1.45 -0.466 1 C-N-CA 133.431 4.692 . . . . 0.0 109.616 -172.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.43 -8.59 58.7 Favored Glycine 0 CA--C 1.528 0.845 1 CA-C-O 112.669 -4.406 . . . . 0.0 113.039 -171.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.72 153.65 38.75 Favored 'General case' 0 C--N 1.323 -0.553 1 CA-C-N 125.18 4.49 . . . . 0.0 110.258 165.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.259 67.7 p -77.38 -178.56 5.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 124.253 1.977 . . . . 0.0 106.475 169.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.428 HD11 ' HB ' ' A' ' 17' ' ' VAL 0.293 26.0 mt -77.15 -38.46 51.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.383 164.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.8 t -62.42 -23.24 66.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 112.191 -3.766 . . . . 0.0 111.609 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.96 -35.43 74.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 122.011 2.187 . . . . 0.0 109.215 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -100.66 8.4 43.37 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 128.327 2.651 . . . . 0.0 108.911 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.32 2.3 p-10 52.96 46.32 27.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.152 1.781 . . . . 0.0 115.614 170.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.447 HG21 HD13 ' A' ' 61' ' ' ILE 0.251 24.9 mt -92.46 117.52 35.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 123.662 1.696 . . . . 0.0 110.06 -167.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -98.85 169.01 9.76 Favored 'General case' 0 N--CA 1.45 -0.448 1 O-C-N 116.138 -4.101 . . . . 0.0 112.776 -176.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.291 20.6 pttt -37.88 152.18 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 115.512 -2.185 . . . . 0.0 115.283 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 77.05 -9.91 1.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.3 m -62.58 132.09 51.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 119.406 -2.059 . . . . 0.0 116.184 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.4 m -109.31 111.13 22.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.8 mp -83.53 146.39 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.622 3.569 . . . . 0.0 107.825 170.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.265 50.0 t60 -103.75 111.03 23.36 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 117.364 -3.335 . . . . 0.0 111.975 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.3 1.3 tt -90.78 131.43 36.44 Favored 'General case' 0 N--CA 1.45 -0.468 1 O-C-N 131.093 5.246 . . . . 0.0 104.907 -175.402 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.343 16.7 m -147.19 169.28 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 128.515 2.726 . . . . 0.0 111.236 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.284 10.9 tp . . . . . 0 N--CA 1.446 -0.646 0 C-N-CA 128.931 2.892 . . . . 0.0 107.42 -172.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -113.82 140.29 48.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 124.082 1.896 . . . . 0.0 108.528 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 pt -146.44 160.01 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 100.428 -3.915 . . . . 0.0 100.428 172.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.387 31.3 m-85 -105.36 134.74 47.97 Favored 'General case' 0 N--CA 1.445 -0.694 1 CA-C-N 107.749 -4.296 . . . . 0.0 105.13 -173.116 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 t -106.45 132.09 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 119.706 -1.872 . . . . 0.0 107.549 166.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -84.78 123.69 30.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 159.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.0 p -80.27 167.74 19.91 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.675 2.39 . . . . 0.0 116.297 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.414 ' HB3' HD22 ' A' ' 69' ' ' LEU . 1.4 pt? -60.67 -10.97 6.02 Favored 'General case' 0 C--N 1.321 -0.646 1 C-N-CA 133.211 4.605 . . . . 0.0 113.742 175.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -122.62 2.41 9.54 Favored 'General case' 0 C--N 1.33 -0.249 1 O-C-N 114.033 -5.417 . . . . 0.0 117.205 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.24 -14.02 28.33 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 117.9 1.92 . . . . 0.0 117.9 166.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -82.28 167.18 18.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.591 2.356 . . . . 0.0 110.471 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.5 m -111.98 121.38 44.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 129.728 3.211 . . . . 0.0 105.476 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.31 19.4 pt -103.57 146.19 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 128.786 2.834 . . . . 0.0 103.987 163.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 m -78.54 153.3 31.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 129.074 2.95 . . . . 0.0 109.963 149.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.83 159.63 43.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 126.87 3.224 . . . . 0.0 105.755 161.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.66 112.56 19.03 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 126.782 3.182 . . . . 0.0 107.513 -171.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.41 165.19 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 116.774 -3.704 . . . . 0.0 107.648 -173.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.283 1.6 tm-20 -103.85 149.29 37.01 Favored Pre-proline 0 N--CA 1.44 -0.967 0 O-C-N 118.387 -2.695 . . . . 0.0 108.613 161.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -53.64 -18.65 12.35 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 125.191 3.927 . . . . 0.0 114.344 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.9 p -77.22 -7.77 56.45 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 119.321 3.082 . . . . 0.0 119.321 170.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -60.36 126.97 29.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.601 1.191 . . . . 0.0 110.833 164.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.5 p -89.41 163.91 15.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 117.331 -1.748 . . . . 0.0 108.953 170.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.325 0.9 OUTLIER -34.77 -51.53 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 113.09 -3.338 . . . . 0.0 113.481 173.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.262 3.5 tp10 -67.07 -23.71 65.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 129.34 3.056 . . . . 0.0 114.696 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -74.11 -40.33 62.75 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 166.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.51 -40.89 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 O-C-N 118.716 -2.49 . . . . 0.0 106.11 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -43.28 -45.69 5.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 129.471 3.109 . . . . 0.0 118.173 172.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.81 -37.48 48.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.769 2.028 . . . . 0.0 109.828 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP 0.371 78.0 mttt -61.2 -43.6 98.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 124.85 2.262 . . . . 0.0 111.475 177.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.45 -53.3 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 127.94 2.496 . . . . 0.0 107.262 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -49.35 -48.55 46.53 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 117.632 -3.168 . . . . 0.0 116.003 165.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.12 -33.4 70.81 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 116.834 -1.555 . . . . 0.0 110.888 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -97.29 -51.47 4.17 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 123.449 2.84 . . . . 0.0 107.648 -172.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -102.81 -31.08 10.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 127.561 2.344 . . . . 0.0 113.347 -167.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.76 9.87 24.0 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 163.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mt -90.11 127.11 54.78 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 118.756 1.278 . . . . 0.0 107.997 -162.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.75 130.22 33.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 125.289 3.992 . . . . 0.0 114.42 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.25 2.4 Cg_endo -72.63 -2.82 12.41 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.239 1.959 . . . . 0.0 113.564 173.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -79.42 -14.17 59.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 160.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -98.6 -25.97 14.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.212 1.805 . . . . 0.0 108.551 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -86.05 111.56 20.43 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 115.476 -2.202 . . . . 0.0 108.89 -172.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -105.5 148.5 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 128.164 3.415 . . . . 0.0 106.489 154.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.56 113.68 26.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 131.308 3.843 . . . . 0.0 110.597 157.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mm -122.49 119.85 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -143.32 111.53 6.19 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.898 -1.955 . . . . 0.0 107.501 -167.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 73.49 24.87 2.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 129.583 3.153 . . . . 0.0 112.408 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.65 7.58 50.78 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-O 115.347 -2.919 . . . . 0.0 114.797 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -138.69 150.72 46.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 123.686 3.743 . . . . 0.0 108.216 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -66.16 135.49 54.6 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 111.237 -2.71 . . . . 0.0 111.793 161.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.4 mt -91.62 149.54 21.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 117.638 -1.173 . . . . 0.0 107.96 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.254 10.1 tp10 -142.07 166.78 23.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.39 2.276 . . . . 0.0 115.378 -149.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.72 122.61 18.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.265 2.226 . . . . 0.0 115.053 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.71 -21.9 17.85 Favored Glycine 0 CA--C 1.537 1.418 0 O-C-N 120.337 -1.477 . . . . 0.0 111.289 163.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.535 ' H ' ' HD2' ' A' ' 54' ' ' ARG 0.319 0.3 OUTLIER -78.69 138.31 38.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.841 1.656 . . . . 0.0 108.038 169.163 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.8 p -84.1 156.79 21.98 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.2 mt -42.94 -39.54 2.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 160.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.416 3.8 p -54.49 -46.33 73.41 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 117.426 -3.296 . . . . 0.0 117.223 161.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -65.04 -13.24 57.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 122.665 2.484 . . . . 0.0 114.029 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -104.5 10.0 35.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 119.527 -1.983 . . . . 0.0 111.681 172.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 60.46 18.74 8.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 130.312 3.445 . . . . 0.0 115.77 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.9 mt -72.92 122.63 26.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -115.5 143.5 45.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.147 3.379 . . . . 0.0 112.474 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -30.2 131.73 0.08 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.441 2.697 . . . . 0.0 116.116 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 78.57 23.74 0.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.963 2.905 . . . . 0.0 111.128 164.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.6 m -97.97 161.06 13.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 129.137 2.975 . . . . 0.0 113.301 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -102.9 118.56 37.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 112.751 -3.5 . . . . 0.0 111.017 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 mt -93.17 162.86 13.85 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 125.806 1.941 . . . . 0.0 108.138 160.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -125.54 158.74 33.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.972 2.509 . . . . 0.0 109.097 171.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 8' ' ' LEU 0.316 4.8 tt -115.08 149.57 37.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 131.356 3.862 . . . . 0.0 112.244 176.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.4 t -124.89 118.2 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.537 0.454 0 CA-C-O 116.51 -1.709 . . . . 0.0 111.844 171.032 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttp . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 116.739 -1.6 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -100.49 134.17 43.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 -154.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.3 pt -117.32 150.01 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.93 158.07 15.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 118.667 -2.521 . . . . 0.0 108.835 162.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 58.9 t -140.34 138.25 36.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -112.13 128.23 56.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.546 2.338 . . . . 0.0 104.72 172.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.284 21.8 m -94.89 140.21 30.24 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 111.215 -2.721 . . . . 0.0 104.573 169.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tt -24.14 -39.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 131.204 3.802 . . . . 0.0 118.952 165.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -67.32 -10.55 51.99 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 118.913 -2.367 . . . . 0.0 117.122 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.78 14.41 55.17 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 118.908 -2.37 . . . . 0.0 109.193 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -90.9 121.44 32.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 130.755 3.622 . . . . 0.0 106.062 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.2 m -103.72 138.94 39.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.066 2.546 . . . . 0.0 105.312 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.1 172.27 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 128.313 2.645 . . . . 0.0 104.661 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 t -139.8 139.66 36.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 118.137 -2.852 . . . . 0.0 112.864 172.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 mp -132.08 132.55 43.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 128.275 3.484 . . . . 0.0 105.749 -177.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -76.55 122.71 24.98 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 127.455 2.302 . . . . 0.0 109.456 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.34 -174.88 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -128.05 160.14 63.16 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 165.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.93 -39.01 94.55 Favored 'Trans proline' 0 N--CA 1.445 -1.343 1 C-N-CA 126.355 4.703 . . . . 0.0 112.593 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.3 m -78.91 6.78 8.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -78.29 129.04 34.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 117.271 -3.393 . . . . 0.0 107.61 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -52.55 151.48 4.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 129.269 3.028 . . . . 0.0 110.832 168.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -54.91 -39.43 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.717 2.407 . . . . 0.0 111.664 158.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -50.24 -53.23 29.65 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.531 1.932 . . . . 0.0 114.405 171.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -54.62 -35.67 63.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 165.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -75.75 -42.11 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 119.707 -1.87 . . . . 0.0 111.977 -175.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -63.81 -35.75 81.64 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 125.724 1.89 . . . . 0.0 113.655 168.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.43 58.14 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.702 1.601 . . . . 0.0 107.133 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -83.48 -44.2 14.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 118.347 -2.721 . . . . 0.0 109.847 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.374 82.3 mt -42.46 -44.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 129.975 3.31 . . . . 0.0 114.59 164.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -57.24 -43.57 83.05 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.683 1.993 . . . . 0.0 116.226 172.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.19 -41.51 63.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -63.98 -49.08 73.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 131.696 3.998 . . . . 0.0 115.674 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -144.13 -7.15 0.72 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -171.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.12 -1.15 21.01 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 119.054 -2.279 . . . . 0.0 115.313 164.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 36' ' ' ILE . 4.9 mt -78.86 118.88 74.99 Favored Pre-proline 0 C--O 1.22 -0.472 0 CA-C-O 114.385 -2.721 . . . . 0.0 108.024 -162.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.7 149.19 78.83 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 O-C-N 125.783 2.465 . . . . 0.0 114.985 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.24 -32.36 1.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.447 1.432 . . . . 0.0 113.835 -165.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -86.05 7.02 26.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 129.62 3.168 . . . . 0.0 111.587 -169.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -132.38 -9.24 3.3 Favored 'General case' 0 C--N 1.325 -0.488 1 C-N-CA 132.103 4.161 . . . . 0.0 111.759 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.269 4.5 tt0 -103.03 139.24 38.84 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 128.43 2.692 . . . . 0.0 107.29 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -146.6 132.19 18.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 101.94 -3.355 . . . . 0.0 101.94 -171.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 67' ' ' LEU . 11.2 mp -114.68 141.64 47.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.796 -163.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.278 77.7 mt -128.96 138.67 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 1 C-N-CA 133.049 4.54 . . . . 0.0 109.784 -178.605 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -150.61 111.14 4.22 Favored 'General case' 0 N--CA 1.448 -0.566 1 C-N-CA 131.739 4.015 . . . . 0.0 109.309 176.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.312 . . 68.56 31.06 4.91 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.85 -23.34 9.25 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.32 1.438 . . . . 0.0 111.526 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -74.3 126.67 31.15 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 110.65 6.75 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 129.304 3.042 . . . . 0.0 106.717 160.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.9 mt -82.41 128.87 34.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -78.15 159.41 28.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.578 1.551 . . . . 0.0 111.31 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -73.91 133.19 43.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.493 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.59 -15.48 55.82 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 115.11 -3.05 . . . . 0.0 111.733 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -77.21 159.7 29.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 123.043 3.421 . . . . 0.0 114.692 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -106.44 -177.77 3.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 127.935 3.272 . . . . 0.0 110.785 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.34 -18.21 46.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 128.58 2.752 . . . . 0.0 109.095 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.83 -28.41 50.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.788 2.035 . . . . 0.0 110.815 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -64.6 -31.11 72.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 126.445 3.021 . . . . 0.0 115.675 172.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.96 8.61 13.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 124.636 2.16 . . . . 0.0 115.46 -173.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.291 36.3 m-20 67.16 39.16 3.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 120.906 3.669 . . . . 0.0 120.906 163.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.2 mt -88.75 128.24 41.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.596 -164.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -98.23 165.12 12.02 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 124.824 2.25 . . . . 0.0 115.314 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -63.88 127.8 33.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.96 -2.963 . . . . 0.0 107.491 -168.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.468 0.0 OUTLIER 93.28 3.98 0.06 Allowed 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 126.297 2.248 . . . . 0.0 113.666 175.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.9 m -61.05 144.02 54.26 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 117.029 -3.544 . . . . 0.0 109.854 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -92.55 117.34 29.85 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 118.441 -2.662 . . . . 0.0 114.047 170.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.426 HD21 HD23 ' A' ' 43' ' ' LEU 0.25 23.4 tp -107.12 134.42 50.27 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 125.131 1.519 . . . . 0.0 109.094 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -107.73 152.47 24.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.9 155.23 42.73 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 126.021 2.819 . . . . 0.0 107.575 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.93 137.44 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 131.439 3.896 . . . . 0.0 103.471 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.447 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.506 0 CA-C-O 114.839 -2.505 . . . . 0.0 111.391 176.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 ttp . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 101.966 -3.346 . . . . 0.0 101.966 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -88.5 135.96 33.22 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 121.701 2.046 . . . . 0.0 114.27 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 3' ' ' ILE 0.279 44.4 pt -119.42 148.02 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 128.626 2.77 . . . . 0.0 113.771 168.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -99.55 115.89 30.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.701 2.4 . . . . 0.0 111.365 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.277 6.5 t -89.1 100.29 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 129.086 2.954 . . . . 0.0 103.053 172.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -74.11 156.83 36.98 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.242 -1.536 . . . . 0.0 114.721 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.445 13.0 t -150.71 164.46 36.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.57 171.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 tp -46.23 -39.98 10.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 121.37 3.841 . . . . 0.0 121.37 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.8 p -82.15 -1.26 48.28 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 123.849 1.785 . . . . 0.0 111.425 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.37 8.94 55.95 Favored Glycine 0 N--CA 1.443 -0.852 0 O-C-N 116.71 -3.744 . . . . 0.0 116.539 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -76.32 132.45 39.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.027 2.931 . . . . 0.0 106.733 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 p -112.94 132.6 55.28 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 108.832 -3.803 . . . . 0.0 103.261 161.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 mt -102.03 135.12 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 159.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 t -81.88 115.89 21.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 125.587 1.804 . . . . 0.0 111.511 160.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.3 tp -116.81 129.68 56.24 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -80.4 143.94 33.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.786 1.755 . . . . 0.0 110.754 170.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.97 167.86 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 128.554 2.742 . . . . 0.0 109.822 164.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.263 9.0 tt0 -105.55 147.45 34.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 110.277 -3.147 . . . . 0.0 105.713 153.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -74.88 -25.21 12.34 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.075 1.85 . . . . 0.0 110.533 -172.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -63.97 -9.34 15.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 173.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -68.04 164.03 21.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 130.036 3.334 . . . . 0.0 111.286 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 p -124.09 148.09 47.39 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 128.822 2.849 . . . . 0.0 104.949 -164.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.92 -48.41 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 110.584 -3.007 . . . . 0.0 112.988 -171.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -67.17 -36.93 82.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -66.48 -39.71 88.91 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.27 86.9 t -70.47 -39.52 76.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 125.707 1.603 . . . . 0.0 110.405 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -56.67 -29.28 62.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 168.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.82 -41.21 62.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 166.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -64.49 -31.88 73.28 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 119.861 -1.774 . . . . 0.0 109.42 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.325 55.1 mt -62.48 -35.03 67.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.313 3.445 . . . . 0.0 110.614 165.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.26 -38.86 65.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 115.071 -2.395 . . . . 0.0 106.642 -174.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.45 1.5 t70 -37.95 -41.59 0.56 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.992 2.96 . . . . 0.0 118.992 166.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -81.46 -72.16 0.44 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.072 -1.876 . . . . 0.0 115.153 171.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -84.62 -19.87 32.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 116.535 -1.697 . . . . 0.0 115.179 -170.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.08 -9.47 56.42 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 116.867 -2.074 . . . . 0.0 111.036 159.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.09 137.31 37.47 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 123.001 1.381 . . . . 0.0 108.891 -169.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -55.95 139.96 85.26 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.292 2.661 . . . . 0.0 113.579 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.63 -26.47 12.92 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.067 2.512 . . . . 0.0 117.527 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -45.0 -38.65 4.91 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 130.812 3.645 . . . . 0.0 113.607 174.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.09 -4.11 36.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.25 2.22 . . . . 0.0 109.877 -171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -98.17 117.82 33.39 Favored 'General case' 0 N--CA 1.451 -0.393 1 O-C-N 115.656 -4.403 . . . . 0.0 114.837 -170.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.258 16.4 ttm-85 -112.39 113.94 26.4 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.172 1.789 . . . . 0.0 110.881 163.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -83.21 143.51 30.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 120.59 -1.319 . . . . 0.0 109.473 163.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 tt -133.73 143.67 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 119.531 -1.981 . . . . 0.0 106.04 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -136.99 84.3 2.06 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -170.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 84.37 24.87 0.1 Allowed 'General case' 0 N--CA 1.448 -0.547 1 C-N-CA 133.205 4.602 . . . . 0.0 113.984 165.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.12 -1.85 26.92 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 119.184 -2.198 . . . . 0.0 113.674 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.353 40.8 ttmt -121.43 137.14 54.84 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.097 2.159 . . . . 0.0 107.017 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -73.04 128.09 34.46 Favored 'General case' 0 N--CA 1.442 -0.826 1 C-N-CA 135.108 5.363 . . . . 0.0 108.618 177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.463 HD22 ' CG ' ' A' ' 59' ' ' TYR . 86.2 mt -93.41 132.27 37.81 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -134.42 145.86 49.29 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 131.101 3.761 . . . . 0.0 109.532 -162.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.29 144.93 29.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.075 -2.329 . . . . 0.0 110.418 -163.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.52 4.59 23.28 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 116.951 -2.027 . . . . 0.0 116.194 -166.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.337 11.7 mtm180 -125.51 177.5 6.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.004 1.402 . . . . 0.0 113.367 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.3 p -95.95 175.25 6.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 119.339 -2.101 . . . . 0.0 110.927 158.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -57.91 -30.98 66.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 159.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 t -66.75 -25.67 66.61 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 113.093 -3.337 . . . . 0.0 114.115 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.73 -19.99 54.26 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 127.39 2.931 . . . . 0.0 109.494 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CG ' HD22 ' A' ' 50' ' ' LEU 0.295 23.3 m-85 -108.04 6.74 27.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.11 -2.244 . . . . 0.0 110.548 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.397 0.4 OUTLIER 68.86 30.73 4.59 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.849 2.059 . . . . 0.0 112.698 163.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mt -79.16 122.47 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 O-C-N 119.293 -2.13 . . . . 0.0 110.075 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -111.62 165.57 11.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.176 1.79 . . . . 0.0 112.607 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -46.85 143.96 2.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 119.643 -1.911 . . . . 0.0 115.719 171.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 63.72 21.44 12.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 128.981 2.912 . . . . 0.0 112.254 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 m -82.89 152.67 25.46 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.12 1.768 . . . . 0.0 107.476 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.6 m -109.91 105.84 15.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 127.714 3.134 . . . . 0.0 107.862 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -82.79 154.78 24.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 163.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -117.63 148.08 42.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 118.502 -2.624 . . . . 0.0 108.436 166.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.3 tp -109.28 147.55 32.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 124.829 2.252 . . . . 0.0 105.256 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.85 175.25 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 113.683 -3.056 . . . . 0.0 107.044 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.25 13.3 tp . . . . . 0 N--CA 1.45 -0.447 0 O-C-N 128.402 3.564 . . . . 0.0 103.813 -170.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 ttp . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -94.48 144.82 25.25 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 115.279 -2.296 . . . . 0.0 106.689 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.419 HD11 HG11 ' A' ' 17' ' ' VAL . 3.2 pt -146.57 172.66 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.842 2.457 . . . . 0.0 106.193 165.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -135.26 118.6 16.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 128.057 3.348 . . . . 0.0 107.987 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.27 129.1 44.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 131.199 3.799 . . . . 0.0 101.975 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -126.2 125.45 42.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 126.241 2.924 . . . . 0.0 111.812 172.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.3 p -84.55 151.56 24.47 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.301 80.7 mt -56.65 -10.34 0.98 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 131.105 3.762 . . . . 0.0 115.984 175.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 p -93.4 -24.3 18.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 128.724 2.81 . . . . 0.0 109.269 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.06 43.18 1.81 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.148 1.832 . . . . 0.0 116.276 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -115.56 110.11 18.76 Favored 'General case' 0 C--N 1.321 -0.641 2 C-N-CA 132.118 4.167 . . . . 0.0 110.727 169.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.6 m -85.72 111.94 20.59 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 124.44 2.067 . . . . 0.0 110.281 173.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.0 mt -100.02 116.15 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 128.089 3.804 . . . . 0.0 101.741 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.325 52.7 m -91.46 134.05 34.96 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 102.274 -3.232 . . . . 0.0 102.274 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tp -130.47 155.28 46.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.112 2.965 . . . . 0.0 110.116 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 126.31 53.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 3' ' ' ILE . 11.6 m -134.53 163.77 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -101.17 148.17 34.76 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 114.305 -2.76 . . . . 0.0 106.575 174.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.95 6.77 3.98 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 CA-C-N 126.251 3.268 . . . . 0.0 113.675 -171.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -118.05 -2.95 11.16 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 114.595 -2.621 . . . . 0.0 105.666 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.97 122.87 11.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.636 2.774 . . . . 0.0 105.942 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -66.77 158.38 30.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 127.784 3.178 . . . . 0.0 116.61 161.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mm -58.46 -33.44 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 123.341 2.791 . . . . 0.0 114.36 171.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -45.29 -49.59 12.55 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 164.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -70.76 -39.06 73.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.368 71.1 t -52.3 -37.84 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 127.59 2.356 . . . . 0.0 114.021 169.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -66.92 -31.38 71.93 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 116.791 -3.693 . . . . 0.0 115.832 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.47 -36.78 32.99 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.851 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.77 -29.7 70.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 116.801 -1.571 . . . . 0.0 114.833 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.99 -43.78 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 116.398 -1.763 . . . . 0.0 111.478 166.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -59.7 -39.66 85.33 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 114.125 -2.845 . . . . 0.0 110.583 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.14 -21.48 22.78 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.515 1.134 . . . . 0.0 113.72 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.251 18.3 mmtm -109.54 -49.91 3.05 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 117.358 -3.339 . . . . 0.0 107.025 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -103.24 -9.67 19.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 113.788 -3.006 . . . . 0.0 113.661 -165.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.98 -17.7 49.32 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 121.701 2.046 . . . . 0.0 112.69 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.41 HD13 HD21 ' A' ' 71' ' ' LEU . 1.8 pt -81.2 140.22 49.18 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 117.408 0.604 . . . . 0.0 111.184 -175.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.41 140.85 30.82 Favored 'Trans proline' 0 N--CA 1.453 -0.882 1 C-N-CA 126.731 4.954 . . . . 0.0 114.971 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -40.81 -31.08 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.316 1 C-N-CA 127.373 5.382 . . . . 0.0 119.453 173.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.83 -54.81 42.13 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 131.471 3.908 . . . . 0.0 113.839 -174.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -80.02 -7.18 58.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 126.323 2.963 . . . . 0.0 114.549 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.62 145.78 25.01 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 117.573 -3.205 . . . . 0.0 111.103 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -123.67 130.95 53.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.503 1.521 . . . . 0.0 108.814 151.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.669 HD12 HD22 ' A' ' 67' ' ' LEU . 1.7 mm? -89.54 130.88 35.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 172.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -122.34 123.93 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 112.398 -2.183 . . . . 0.0 115.424 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.456 ' HB2' HD23 ' A' ' 67' ' ' LEU . 87.0 t80 -147.47 144.38 28.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 130.008 3.323 . . . . 0.0 113.848 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.62 24.68 14.04 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.938 2.495 . . . . 0.0 112.816 168.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.98 -2.32 69.02 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 114.909 0.723 . . . . 0.0 114.909 -177.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -134.64 155.82 49.82 Favored 'General case' 0 N--CA 1.447 -0.619 2 O-C-N 115.031 -4.805 . . . . 0.0 112.906 -170.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -79.12 133.6 36.75 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 125.435 2.541 . . . . 0.0 106.052 164.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 mt -80.47 136.39 36.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.769 -2.014 . . . . 0.0 114.565 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -76.89 144.05 39.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 116.884 -1.926 . . . . 0.0 111.464 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -66.67 -33.07 74.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.236 -168.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.28 -5.0 49.96 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 126.33 1.919 . . . . 0.0 111.564 -165.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.306 11.4 mmt180 -74.18 149.56 40.86 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.772 2.029 . . . . 0.0 114.616 161.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -103.87 159.76 15.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 127.215 3.388 . . . . 0.0 109.489 -172.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.2 mt -48.28 -47.45 36.35 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 110.025 -3.261 . . . . 0.0 111.915 162.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -59.8 -49.88 76.0 Favored 'General case' 0 N--CA 1.443 -0.805 1 O-C-N 129.694 4.371 . . . . 0.0 119.952 167.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 50.6 m-20 -50.06 -43.72 51.26 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 121.408 3.855 . . . . 0.0 121.408 165.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -93.28 1.28 57.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 73.57 50.8 0.12 Allowed 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 119.113 -2.242 . . . . 0.0 104.976 168.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.1 69.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 118.459 -2.65 . . . . 0.0 104.932 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -127.52 72.97 1.41 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.357 -147.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.416 10.9 tmtt? 89.03 90.87 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 O-C-N 125.285 1.616 . . . . 0.0 112.363 171.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 86.41 47.3 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 110.665 -2.971 . . . . 0.0 110.693 158.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 p -117.05 159.06 23.12 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.746 1.26 . . . . 0.0 108.733 171.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.5 m -108.8 137.46 46.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 125.495 2.569 . . . . 0.0 109.118 -172.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.669 HD22 HD12 ' A' ' 43' ' ' LEU 0.256 0.9 OUTLIER -113.84 143.57 44.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 111.711 -2.495 . . . . 0.0 107.306 -173.923 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -90.49 136.85 32.8 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 130.481 3.512 . . . . 0.0 107.47 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.3 tp -121.32 113.9 20.57 Favored 'General case' 0 N--CA 1.451 -0.405 1 C-N-CA 131.754 4.022 . . . . 0.0 107.486 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -117.56 133.16 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 129.288 3.035 . . . . 0.0 104.388 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 36' ' ' ILE . 3.5 mp . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 125.811 2.72 . . . . 0.0 111.454 -166.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 113.788 -3.006 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.253 59.2 tt0 -104.57 164.82 11.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 125.586 1.804 . . . . 0.0 109.522 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -145.51 164.91 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 1 C-N-CA 134.746 5.219 . . . . 0.0 107.053 168.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.2 147.08 41.79 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 118.922 -2.361 . . . . 0.0 111.782 175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.68 113.66 28.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 113.333 -3.222 . . . . 0.0 106.558 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -87.74 143.73 27.0 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 126.522 2.388 . . . . 0.0 110.123 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -117.09 158.73 23.7 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 126.192 2.182 . . . . 0.0 109.49 -171.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.512 HD21 HG12 ' A' ' 70' ' ' VAL . 74.6 mt -50.44 -50.29 52.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 116.826 -3.671 . . . . 0.0 116.973 -175.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -138.11 34.14 2.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.21 -123.84 2.52 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 -172.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -138.47 -167.85 2.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.677 1.991 . . . . 0.0 111.204 -166.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 p -89.75 119.99 30.62 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.083 0.856 . . . . 0.0 110.909 149.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.2 mt -80.55 143.45 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 167.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.264 71.9 p -114.68 122.31 46.06 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 113.931 -2.937 . . . . 0.0 108.221 -169.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.4 HD21 HG12 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -128.68 134.22 48.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 122.3 2.318 . . . . 0.0 104.906 174.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.85 118.91 37.8 Favored 'General case' 0 N--CA 1.44 -0.962 1 N-CA-C 99.909 -4.108 . . . . 0.0 99.909 172.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.45 149.64 33.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 130.102 3.361 . . . . 0.0 107.478 -167.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -74.19 137.02 75.47 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -62.64 -5.48 7.26 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 CA-C-O 115.817 -1.826 . . . . 0.0 115.921 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.4 p -115.18 23.45 12.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -81.36 160.92 23.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 126.717 2.51 . . . . 0.0 115.498 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 p -102.28 140.79 36.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 131.595 3.958 . . . . 0.0 107.23 -162.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.3 mt -47.96 -47.1 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 125.803 1.641 . . . . 0.0 112.979 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.75 -38.59 89.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.989 1.722 . . . . 0.0 112.025 -173.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -72.45 -12.73 61.22 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.114 2.166 . . . . 0.0 110.797 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 t -99.42 -27.39 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 1 CA-C-O 110.642 -4.504 . . . . 0.0 106.288 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -56.73 -42.97 80.17 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 128.28 3.488 . . . . 0.0 109.907 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.17 -42.41 77.03 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.717 3.607 . . . . 0.0 112.001 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -64.26 -35.36 80.58 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.4 HG12 HD21 ' A' ' 15' ' ' LEU . 61.5 mt -72.91 -28.07 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.461 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -52.49 35.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 117.105 -3.497 . . . . 0.0 114.681 166.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.94 -30.17 63.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -101.31 -33.16 10.15 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.401 1.455 . . . . 0.0 112.647 -173.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.327 78.8 mm-40 -125.28 -19.14 5.17 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.12 2.73 51.55 Favored Glycine 0 N--CA 1.44 -1.098 0 O-C-N 117.559 -3.213 . . . . 0.0 115.719 170.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.3 mt -77.66 120.67 82.32 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 122.584 3.192 . . . . 0.0 109.945 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.47 159.11 49.34 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 N-CA-C 118.037 2.283 . . . . 0.0 118.037 169.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.47 -19.83 11.34 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 124.556 3.504 . . . . 0.0 114.529 -169.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -82.4 -12.2 58.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -76.41 -42.84 42.89 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.647 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -74.77 110.73 9.31 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 127.917 3.261 . . . . 0.0 107.934 -156.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -108.54 112.1 24.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 100.388 -3.93 . . . . 0.0 100.388 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.38 124.3 44.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.538 0.0 OUTLIER -127.3 137.31 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 117.637 -3.164 . . . . 0.0 113.259 -175.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.476 ' CE2' HG13 ' A' ' 61' ' ' ILE 0.275 24.9 t80 -149.59 108.15 3.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.817 -1.538 . . . . 0.0 109.207 -165.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.4 23.34 6.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 127.043 3.306 . . . . 0.0 115.172 164.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.02 -17.86 47.54 Favored Glycine 0 CA--C 1.531 1.09 1 C-N-CA 136.234 6.635 . . . . 0.0 111.628 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -80.6 120.0 23.98 Favored 'General case' 0 N--CA 1.447 -0.607 1 C-N-CA 131.808 4.043 . . . . 0.0 107.824 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -73.06 131.59 42.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 115.417 -2.23 . . . . 0.0 114.604 159.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.364 39.2 mt -110.45 132.64 54.0 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 125.892 2.758 . . . . 0.0 107.264 -163.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -105.46 124.96 50.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 111.399 -2.637 . . . . 0.0 113.33 -169.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.267 0.0 OUTLIER -61.43 139.88 58.14 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 111.908 -2.405 . . . . 0.0 110.619 -172.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.81 -38.18 2.09 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 104.243 -3.543 . . . . 0.0 104.243 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -94.38 -178.37 4.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 -175.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.257 46.7 p -119.68 -175.84 3.04 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.753 -166.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.2 -41.87 96.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.154 1.381 . . . . 0.0 114.278 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 t -71.93 -32.91 67.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 131.011 3.725 . . . . 0.0 107.681 -170.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -71.46 -13.36 61.8 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 130.824 3.65 . . . . 0.0 112.698 -172.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -128.97 0.97 5.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.069 2.547 . . . . 0.0 111.466 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t30 57.41 53.89 7.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 128.815 2.846 . . . . 0.0 110.401 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.476 HG13 ' CE2' ' A' ' 45' ' ' PHE . 5.0 mt -92.46 112.57 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 100.395 -3.928 . . . . 0.0 100.395 168.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -130.86 171.41 13.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.39 -167.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.74 113.79 0.92 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 129.237 3.015 . . . . 0.0 112.218 -170.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 67.88 25.17 7.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 118.201 -2.812 . . . . 0.0 117.337 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.1 m -64.32 135.22 55.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 118.233 -2.792 . . . . 0.0 117.829 156.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.267 96.5 m -110.49 128.0 55.42 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 124.479 1.112 . . . . 0.0 108.563 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.261 1.2 mp -109.67 168.73 9.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 173.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -112.35 138.37 49.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.965 3.306 . . . . 0.0 107.668 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tp -126.79 114.76 18.38 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.908 1.683 . . . . 0.0 108.138 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.512 HG12 HD21 ' A' ' 8' ' ' LEU . 25.1 m -106.1 142.56 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 175.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.3 mt . . . . . 0 N--CA 1.445 -0.718 0 CA-C-O 116.005 -1.95 . . . . 0.0 111.649 179.777 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 123.544 1.64 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -105.13 130.18 53.36 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.725 3.21 . . . . 0.0 110.977 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.293 17.6 pt -133.04 140.85 46.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 1 C-N-CA 133.731 4.812 . . . . 0.0 113.345 177.596 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 49.3 m-85 -93.21 148.88 21.65 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 125.89 2.757 . . . . 0.0 112.226 170.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.55 126.57 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 118.812 -2.43 . . . . 0.0 105.304 170.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -87.2 112.29 21.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 115.687 -2.102 . . . . 0.0 114.796 171.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 p -62.68 155.62 25.85 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 119.748 1.158 . . . . 0.0 113.03 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.62 -36.26 80.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.17 2.588 . . . . 0.0 111.242 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -93.01 0.01 57.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.824 1.193 . . . . 0.0 112.682 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.93 20.51 6.01 Favored Glycine 0 N--CA 1.445 -0.719 0 O-C-N 118.484 -2.635 . . . . 0.0 116.212 142.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -84.89 152.58 23.45 Favored 'General case' 0 CA--C 1.538 0.503 1 C-N-CA 136.016 5.726 . . . . 0.0 107.247 171.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -112.38 137.07 51.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.351 1.2 pt -115.01 131.64 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 176.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.375 32.6 m -90.95 130.51 36.87 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 166.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tp -117.25 137.29 52.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 104.446 -2.428 . . . . 0.0 104.446 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 17' ' ' VAL . 2.3 tp10 -94.16 144.5 25.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 16' ' ' GLU . 12.9 m -158.96 -177.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.257 2.223 . . . . 0.0 106.763 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -133.06 153.15 80.77 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 129.119 2.967 . . . . 0.0 106.394 166.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.34 0.1 OUTLIER -49.4 -24.33 8.6 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 N-CA-C 119.214 2.736 . . . . 0.0 119.214 167.107 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.9 p -84.57 -11.06 56.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 113.578 -3.106 . . . . 0.0 110.619 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -68.35 131.72 45.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 129.746 3.218 . . . . 0.0 113.593 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.6 p -82.45 164.62 20.85 Favored 'General case' 0 N--CA 1.449 -0.476 1 O-C-N 129.542 4.276 . . . . 0.0 111.879 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -59.64 -31.29 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 112.541 -2.118 . . . . 0.0 112.013 172.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -74.21 -16.64 60.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 124.468 2.08 . . . . 0.0 112.584 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -98.45 -28.59 13.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.12 2.568 . . . . 0.0 110.485 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.267 62.8 t -52.52 -59.48 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.823 2.449 . . . . 0.0 112.291 168.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.343 17.4 ptpt -53.87 -41.78 67.9 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 128.184 3.428 . . . . 0.0 113.456 177.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.05 -40.56 70.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 126.244 2.215 . . . . 0.0 113.013 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -77.34 -28.1 52.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.609 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.55 -34.73 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 O-C-N 119.614 -1.929 . . . . 0.0 112.261 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -58.88 -42.89 90.54 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 119.225 0.92 . . . . 0.0 113.163 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.69 -47.06 42.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.257 2.223 . . . . 0.0 112.784 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -68.46 -38.65 81.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.422 64.3 mm-40 -129.21 -18.56 3.64 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 130.093 3.357 . . . . 0.0 115.675 -154.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.77 -22.28 41.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.66 2.076 . . . . 0.0 114.686 163.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 36' ' ' ILE . 44.4 mt -86.48 119.04 71.19 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 125.883 1.673 . . . . 0.0 109.638 -163.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -45.94 149.26 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.644 1 C-N-CA 127.615 5.543 . . . . 0.0 115.73 175.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -68.02 -32.51 28.05 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 124.535 3.49 . . . . 0.0 109.995 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.258 19.7 t70 -49.96 -35.92 26.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 117.042 -1.456 . . . . 0.0 114.144 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -101.55 -5.73 24.78 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 128.679 2.791 . . . . 0.0 107.325 -160.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -85.66 141.34 29.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 119.22 -2.175 . . . . 0.0 115.772 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -128.17 95.85 4.29 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.49 111.09 18.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 114.544 -2.646 . . . . 0.0 114.472 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mt -118.77 144.24 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 125.163 3.619 . . . . 0.0 110.383 -172.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -140.37 123.18 16.41 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 163.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.83 33.12 0.92 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 111.713 -2.494 . . . . 0.0 114.022 169.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.95 -33.88 4.99 Favored Glycine 0 C--O 1.221 -0.671 0 O-C-N 118.63 -2.543 . . . . 0.0 112.898 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -79.04 121.66 25.23 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 128.199 2.941 . . . . 0.0 112.171 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -79.51 111.38 15.72 Favored 'General case' 0 N--CA 1.454 -0.251 1 N-CA-C 100.023 -4.066 . . . . 0.0 100.023 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.67 123.01 24.83 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 127.826 2.45 . . . . 0.0 108.691 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -94.85 151.12 19.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 124.927 2.299 . . . . 0.0 108.389 -163.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.94 139.32 33.43 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 109.796 -3.365 . . . . 0.0 110.524 -168.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.47 -20.09 38.0 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.738 2.59 . . . . 0.0 116.291 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.8 mmm-85 -73.38 145.05 46.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 117.759 -3.201 . . . . 0.0 109.49 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 p -75.64 144.18 41.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.447 2.699 . . . . 0.0 107.026 167.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.0 mt -47.18 -37.67 10.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 166.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -67.91 -30.74 70.15 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -77.62 -36.9 51.23 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 126.262 1.825 . . . . 0.0 110.022 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.561 ' HB3' HG12 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -68.43 -20.98 64.68 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 115.742 -2.075 . . . . 0.0 115.839 170.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.341 29.5 m120 74.58 27.01 1.39 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 120.272 3.434 . . . . 0.0 120.272 -170.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.561 HG12 ' HB3' ' A' ' 59' ' ' TYR . 39.7 mm -81.18 112.52 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 O-C-N 117.863 -3.023 . . . . 0.0 109.065 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.254 78.0 mm-40 -83.25 155.71 23.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.938 2.895 . . . . 0.0 114.319 177.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.55 127.38 15.41 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 131.343 3.857 . . . . 0.0 114.762 170.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 1.5 pt-20 65.2 33.13 9.55 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 125.685 2.659 . . . . 0.0 116.048 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -74.59 155.44 37.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 124.899 2.285 . . . . 0.0 111.746 160.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 20.6 m -116.21 104.39 11.47 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 111.537 -2.574 . . . . 0.0 105.516 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -94.86 159.77 14.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 130.77 3.628 . . . . 0.0 108.721 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.347 70.7 m80 -109.35 136.61 48.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 115.465 -2.207 . . . . 0.0 114.198 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.261 31.4 tp -108.94 117.5 34.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 126.006 2.066 . . . . 0.0 106.322 173.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -112.0 145.44 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 111.818 -2.446 . . . . 0.0 105.246 169.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--N 1.325 -0.483 0 C-N-CA 130.034 3.333 . . . . 0.0 110.538 168.032 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pm0 -96.66 143.03 28.0 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.405 3.082 . . . . 0.0 109.509 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.454 HG13 HD12 ' A' ' 15' ' ' LEU . 18.4 pt -132.72 158.09 43.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 1 C-N-CA 132.152 4.181 . . . . 0.0 105.976 152.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -100.66 138.94 37.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.596 1.958 . . . . 0.0 108.327 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.49 110.37 31.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 172.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -107.06 113.22 26.56 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 126.876 3.227 . . . . 0.0 106.28 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -79.19 148.1 32.4 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 117.399 -3.313 . . . . 0.0 105.527 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.53 -21.23 66.16 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 118.908 -2.37 . . . . 0.0 112.836 168.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 p -79.0 -1.32 34.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.003 1.721 . . . . 0.0 112.334 167.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.68 -27.09 22.12 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 115.867 -2.629 . . . . 0.0 112.251 160.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -64.32 139.6 58.78 Favored 'General case' 0 C--N 1.328 -0.352 1 C-N-CA 132.21 4.204 . . . . 0.0 108.179 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.9 m -117.26 112.72 21.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 124.524 2.107 . . . . 0.0 105.934 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.7 mt -101.16 138.03 26.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 1 C-N-CA 131.832 4.053 . . . . 0.0 106.646 176.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m -101.63 129.76 47.82 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 128.375 2.67 . . . . 0.0 107.297 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.454 HD12 HG13 ' A' ' 3' ' ' ILE 0.299 62.0 mt -103.18 168.35 9.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.24 169.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.95 115.74 10.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 128.371 3.545 . . . . 0.0 101.811 169.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.52 167.55 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 103.876 -2.639 . . . . 0.0 103.876 -161.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 4.7 mm-40 -97.91 162.02 23.66 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 169.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.81 -6.24 18.3 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 124.213 3.275 . . . . 0.0 116.194 163.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.6 p -94.17 -0.64 55.1 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.477 1.911 . . . . 0.0 110.066 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -78.47 121.15 24.18 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -65.74 145.64 55.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.387 2.675 . . . . 0.0 112.342 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -66.46 88.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 123.322 1.534 . . . . 0.0 112.421 165.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 178.42 -54.48 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 131.11 3.764 . . . . 0.0 104.69 -177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.308 22.6 t-20 -52.11 -55.76 18.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 -174.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.322 40.9 t -72.6 -20.08 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 128.456 2.702 . . . . 0.0 110.996 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -71.38 -30.21 65.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 122.995 2.634 . . . . 0.0 108.507 172.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.66 -19.57 41.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 116.357 -1.782 . . . . 0.0 113.695 171.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -76.98 -35.72 56.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 116.564 -1.684 . . . . 0.0 109.342 163.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.2 mm -65.05 -38.47 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 124.644 2.164 . . . . 0.0 111.698 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -46.45 -61.49 1.78 Allowed 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 117.732 -3.105 . . . . 0.0 110.109 164.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.8 -37.66 84.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -78.65 -59.15 2.9 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -106.89 -0.36 23.29 Favored 'General case' 0 C--O 1.222 -0.351 0 O-C-N 125.691 1.869 . . . . 0.0 111.326 -162.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.18 13.7 76.35 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 129.8 3.571 . . . . 0.0 117.985 162.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.81 113.56 64.58 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -49.74 126.3 16.18 Favored 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 128.387 6.058 . . . . 0.0 113.767 167.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -41.76 -27.84 0.61 Allowed 'Trans proline' 0 C--N 1.323 -0.81 1 C-N-CA 125.685 4.257 . . . . 0.0 117.751 -177.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.81 -22.78 65.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 171.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -98.69 4.02 47.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.381 2.672 . . . . 0.0 114.708 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -95.81 113.28 24.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 113.835 -2.983 . . . . 0.0 105.133 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -95.71 141.48 29.14 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 123.763 2.983 . . . . 0.0 112.515 150.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.29 0.8 OUTLIER -157.52 117.46 3.4 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 116.603 -1.665 . . . . 0.0 108.811 -148.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mp -145.51 144.29 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 126.487 2.367 . . . . 0.0 106.43 -150.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CD2' HG12 ' A' ' 61' ' ' ILE . 37.4 t80 -131.62 -37.98 1.18 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.27 3.028 . . . . 0.0 115.155 172.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.363 . . -148.11 56.68 1.07 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 129.177 2.991 . . . . 0.0 111.163 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.98 -3.54 77.27 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-O 113.809 -3.773 . . . . 0.0 119.499 168.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -146.06 176.27 9.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 120.466 2.133 . . . . 0.0 110.052 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.06 130.29 39.04 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.029 -1.896 . . . . 0.0 107.911 174.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -77.56 120.6 22.76 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.027 1.731 . . . . 0.0 109.349 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -67.02 123.87 21.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 125.947 2.784 . . . . 0.0 109.876 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.92 115.68 3.89 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.269 2.228 . . . . 0.0 110.751 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.79 -23.55 11.73 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 115.411 -2.883 . . . . 0.0 110.23 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -77.65 148.82 34.85 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -78.34 174.51 11.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.767 2.027 . . . . 0.0 111.956 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.1 -24.78 64.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.399 1.48 . . . . 0.0 112.095 167.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -66.33 -33.84 76.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.052 2.541 . . . . 0.0 113.216 172.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -75.87 -34.84 60.03 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 115.085 -2.388 . . . . 0.0 109.833 -175.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.7 1.92 51.5 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 128.784 3.803 . . . . 0.0 113.484 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 t30 60.45 39.66 18.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.797 2.039 . . . . 0.0 110.421 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 45' ' ' PHE . 67.9 mt -90.84 137.67 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 102.14 -3.281 . . . . 0.0 102.14 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.93 170.11 16.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -168.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -58.51 138.4 56.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 120.717 3.599 . . . . 0.0 120.717 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 4.8 tt0 75.35 22.21 1.71 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.547 2.739 . . . . 0.0 108.749 160.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.413 27.4 m -99.61 158.54 15.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 124.909 2.29 . . . . 0.0 109.149 174.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.9 m -62.44 130.9 47.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 116.508 -3.87 . . . . 0.0 111.709 161.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -117.16 143.29 46.0 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 159.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -109.23 143.19 39.01 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.708 2.403 . . . . 0.0 111.935 -169.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -128.52 128.81 45.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 129.426 3.091 . . . . 0.0 107.167 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.3 4.3 t -122.03 136.09 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 115.596 -2.145 . . . . 0.0 106.947 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.427 0 C-N-CA 129.071 2.948 . . . . 0.0 115.303 -171.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttp . . . . . 0 N--CA 1.474 0.764 0 CA-C-O 122.092 0.948 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -115.88 145.23 43.05 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 117.335 -1.746 . . . . 0.0 106.389 -169.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -132.27 177.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 126.591 1.956 . . . . 0.0 108.902 171.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -124.36 149.4 46.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.93 111.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -72.43 115.14 11.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.298 2.239 . . . . 0.0 113.409 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.493 ' HA ' HD11 ' A' ' 69' ' ' LEU . 46.9 p -94.11 170.32 9.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 124.085 1.898 . . . . 0.0 107.301 -169.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.7 -15.79 62.22 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -164.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -73.46 -31.51 63.83 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 128.247 2.619 . . . . 0.0 111.244 165.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.63 2.6 27.31 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 129.031 3.205 . . . . 0.0 110.605 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -66.75 146.41 54.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 121.328 2.564 . . . . 0.0 114.478 171.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.0 m -116.33 106.75 14.0 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 114.012 -2.899 . . . . 0.0 104.164 -165.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mm -98.59 140.65 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -79.21 136.8 37.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 124.355 2.026 . . . . 0.0 109.77 167.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.64 135.85 32.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 -169.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.27 131.02 50.66 Favored 'General case' 0 C--O 1.238 0.448 1 CA-C-O 129.62 4.533 . . . . 0.0 108.138 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.14 -165.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 129.77 3.228 . . . . 0.0 118.481 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -149.65 139.28 13.13 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 167.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -61.21 -22.87 75.9 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 124.16 3.24 . . . . 0.0 118.477 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 m -90.98 -25.14 19.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 118.863 2.912 . . . . 0.0 118.863 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.85 106.28 4.12 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 130.08 3.352 . . . . 0.0 109.841 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -48.97 148.66 2.18 Favored 'General case' 0 N--CA 1.45 -0.436 1 C-N-CA 134.346 5.058 . . . . 0.0 113.139 -155.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.24 -39.62 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.157 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -47.18 -52.18 16.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.86 1.664 . . . . 0.0 111.387 170.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -69.69 -24.93 63.65 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.393 2.277 . . . . 0.0 114.27 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.275 99.4 t -56.82 -55.36 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 1 O-C-N 113.328 -5.858 . . . . 0.0 112.586 167.261 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -43.66 -42.61 5.37 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 127.443 2.297 . . . . 0.0 115.601 167.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.9 -32.44 73.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.734 3.213 . . . . 0.0 112.43 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.12 -31.86 70.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 124.819 2.247 . . . . 0.0 114.276 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -73.22 -40.19 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 127.37 2.268 . . . . 0.0 115.114 169.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.29 -37.76 49.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 127.78 2.432 . . . . 0.0 112.63 162.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -72.07 -38.19 69.48 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.034 0.533 . . . . 0.0 111.958 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -75.78 -51.88 11.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 129.069 2.948 . . . . 0.0 111.815 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -133.63 -0.16 3.22 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.246 1.498 . . . . 0.0 111.402 -160.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.87 -23.17 35.48 Favored Glycine 0 N--CA 1.44 -1.063 0 O-C-N 117.421 -3.299 . . . . 0.0 114.482 161.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.42 120.01 78.16 Favored Pre-proline 0 N--CA 1.441 -0.891 0 O-C-N 117.058 -3.613 . . . . 0.0 112.17 -171.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -72.23 142.24 37.29 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.007 3.138 . . . . 0.0 110.719 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -35.49 -42.87 0.49 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 123.88 3.053 . . . . 0.0 119.12 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.05 -18.17 32.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -119.54 1.25 11.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.372 -170.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -86.3 151.27 23.73 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 172.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -132.54 128.91 38.29 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.562 1.545 . . . . 0.0 108.875 151.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.6 mt -108.19 129.21 55.2 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 3.2 mt -112.24 128.59 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 129.215 3.006 . . . . 0.0 109.175 165.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -81.43 -36.3 29.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 119.039 -2.288 . . . . 0.0 106.535 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.08 -67.35 0.36 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.55 -24.78 1.21 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.247 1.88 . . . . 0.0 113.766 164.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -94.26 141.21 28.83 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.88 2.472 . . . . 0.0 106.595 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -70.63 140.27 51.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.224 3.01 . . . . 0.0 113.95 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 mt -93.15 100.37 12.77 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 126.191 1.796 . . . . 0.0 108.332 171.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -93.16 142.13 27.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 126.304 2.954 . . . . 0.0 106.39 -156.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.69 132.85 55.18 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 130.881 3.672 . . . . 0.0 108.492 172.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.15 -15.16 8.83 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 128.69 3.043 . . . . 0.0 115.4 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -124.47 179.61 4.87 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 128.808 2.843 . . . . 0.0 110.958 -163.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -115.65 164.62 14.07 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 118.53 -2.607 . . . . 0.0 109.409 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.2 mt -72.46 -14.43 61.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.545 -0.722 . . . . 0.0 111.476 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -72.61 -35.39 67.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 129.21 3.004 . . . . 0.0 106.921 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.369 21.3 m-20 -51.4 -36.88 45.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.849 2.46 . . . . 0.0 113.696 172.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -103.91 3.52 33.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 112.903 -3.427 . . . . 0.0 110.162 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.27 0.5 OUTLIER 33.95 63.85 0.38 Allowed 'General case' 0 N--CA 1.45 -0.464 1 C-N-CA 134.333 5.053 . . . . 0.0 114.73 -176.081 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.4 mm -77.6 135.9 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.206 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -100.27 171.66 7.64 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.316 1.446 . . . . 0.0 107.231 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -66.73 146.06 54.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 126.211 2.194 . . . . 0.0 108.456 -170.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 65.73 17.44 10.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.354 1.888 . . . . 0.0 113.765 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -62.99 148.16 48.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 162.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -100.11 106.7 18.46 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.446 2.698 . . . . 0.0 108.399 -176.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.2 159.9 14.65 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.85 0.75 . . . . 0.0 111.275 169.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.46 154.91 29.51 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.636 1.974 . . . . 0.0 108.043 170.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' A' ' 7' ' ' THR 0.342 4.3 pp -127.93 155.28 44.46 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 130.392 3.477 . . . . 0.0 116.238 177.201 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.23 148.2 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 130.304 3.442 . . . . 0.0 108.783 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.8 mt . . . . . 0 N--CA 1.448 -0.548 0 C-N-CA 130.572 3.549 . . . . 0.0 114.32 168.475 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.59 ' HG3' HG23 ' A' ' 17' ' ' VAL . 3.6 ptt? . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.401 ' HB2' HE21 ' A' ' 2' ' ' GLN . 7.5 mt-30 -93.95 155.9 16.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 173.274 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.33 18.1 pt -133.15 158.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.922 2.489 . . . . 0.0 107.167 161.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -116.94 127.04 53.84 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 118.837 -2.414 . . . . 0.0 109.525 176.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.568 HG21 HD11 ' A' ' 15' ' ' LEU 0.293 3.2 t -107.74 96.68 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 174.846 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -93.33 127.14 38.81 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 118.942 -2.349 . . . . 0.0 116.986 -171.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.54 150.23 44.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 130.429 3.492 . . . . 0.0 109.288 174.478 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.86 -25.77 64.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 116.038 -1.935 . . . . 0.0 107.713 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -80.42 2.92 23.09 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 131.165 3.786 . . . . 0.0 116.241 174.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.61 6.19 53.06 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.296 2.379 . . . . 0.0 108.829 154.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 7' ' ' THR . 47.4 mtmt -97.48 156.48 16.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 121.575 2.687 . . . . 0.0 106.188 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -125.56 129.28 49.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 126.52 2.388 . . . . 0.0 114.328 -178.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.66 116.78 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 1 N-CA-C 98.173 -4.751 . . . . 0.0 98.173 169.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -95.0 116.96 29.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.3 0.64 . . . . 0.0 109.664 170.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.568 HD11 HG21 ' A' ' 5' ' ' VAL 0.325 32.4 mt -92.24 151.49 20.31 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.754 2.022 . . . . 0.0 106.912 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -108.23 83.03 1.72 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.098 2.959 . . . . 0.0 108.458 -173.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' A' ' 1' ' ' MET . 27.0 m -103.13 164.47 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 119.219 -2.175 . . . . 0.0 110.77 -168.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -108.28 160.09 28.31 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 130.564 3.546 . . . . 0.0 111.903 162.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.28 -20.89 27.46 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 CA-C-N 122.833 2.047 . . . . 0.0 114.126 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.2 p -94.09 1.33 56.17 Favored 'General case' 0 N--CA 1.447 -0.586 1 C-N-CA 133.659 4.784 . . . . 0.0 112.649 -176.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -61.62 139.85 58.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.312 2.245 . . . . 0.0 107.7 161.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.4 p -95.77 178.88 5.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.314 2.246 . . . . 0.0 106.462 170.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.9 mm -65.11 -34.85 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 1 C-N-CA 132.433 4.293 . . . . 0.0 106.055 170.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -64.95 -42.0 95.0 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 117.26 -3.4 . . . . 0.0 109.564 176.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -76.74 -41.51 44.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.958 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.54 -29.43 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 124.964 3.529 . . . . 0.0 111.869 176.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -52.19 -46.39 65.55 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.928 2.491 . . . . 0.0 116.557 165.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.55 -44.05 71.69 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 112.366 -2.197 . . . . 0.0 111.984 171.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -72.84 -33.19 65.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.525 -1.36 . . . . 0.0 112.082 -169.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -66.89 -41.84 88.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 120.359 -1.463 . . . . 0.0 109.311 171.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.76 84.3 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 124.868 1.355 . . . . 0.0 110.174 177.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.64 -38.53 80.56 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 119.778 -1.826 . . . . 0.0 114.021 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -68.66 -43.86 75.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 115.824 -2.036 . . . . 0.0 111.253 169.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 34' ' ' GLU 0.293 18.4 tp10 -136.21 12.04 3.3 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 117.231 -1.788 . . . . 0.0 110.453 -147.645 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 29.03 40.98 0.03 OUTLIER Glycine 0 CA--C 1.53 1.01 1 C-N-CA 132.848 5.023 . . . . 0.0 114.775 175.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -91.74 120.28 68.12 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 115.492 -2.194 . . . . 0.0 105.609 157.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 38' ' ' PRO 0.291 1.7 Cg_endo -45.87 144.62 5.6 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 O-C-N 125.693 2.417 . . . . 0.0 118.357 171.482 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.9 Cg_endo -82.76 -10.66 10.55 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 O-C-N 125.844 2.497 . . . . 0.0 112.258 -163.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.87 -16.25 54.16 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 128.699 2.8 . . . . 0.0 111.5 173.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -74.5 -27.55 60.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.954 2.501 . . . . 0.0 112.673 174.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -95.36 147.69 23.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 129.349 3.06 . . . . 0.0 114.677 -168.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -115.59 117.2 29.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 172.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.0 mt -97.11 98.13 9.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 -166.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.304 74.1 mt -100.66 145.9 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 128.81 2.844 . . . . 0.0 113.673 -175.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CE2' HG12 ' A' ' 61' ' ' ILE . 33.5 t80 -153.62 123.24 6.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 116.383 -3.948 . . . . 0.0 106.02 166.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.499 . . 74.73 25.25 1.53 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 170.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.94 7.78 67.91 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 130.049 3.69 . . . . 0.0 113.151 -174.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -134.6 150.02 50.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 123.549 3.674 . . . . 0.0 105.396 -166.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -87.86 127.82 35.35 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 128.567 2.747 . . . . 0.0 107.683 176.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.52 133.64 49.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 121.581 1.991 . . . . 0.0 113.386 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -83.24 124.74 30.86 Favored 'General case' 0 N--CA 1.447 -0.604 1 C-N-CA 133.867 4.867 . . . . 0.0 107.004 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.22 123.21 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 111.992 -2.367 . . . . 0.0 108.005 -175.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.16 31.12 3.4 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 114.924 -3.153 . . . . 0.0 115.7 -177.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -139.62 146.11 39.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 122.245 3.022 . . . . 0.0 108.555 170.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.8 p -79.46 155.7 28.18 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.6 mt -46.74 -64.05 0.87 Allowed 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.6 m -66.98 -41.7 86.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.392 1.877 . . . . 0.0 115.857 -172.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.265 11.0 t70 -51.34 -46.91 62.84 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 119.349 -2.094 . . . . 0.0 113.608 170.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.98 8.12 1.72 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 129.86 3.264 . . . . 0.0 114.857 174.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.372 3.4 t30 82.31 4.83 1.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 178.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.413 HG12 ' CE2' ' A' ' 45' ' ' PHE 0.293 1.9 mt -94.27 91.21 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 123.177 1.465 . . . . 0.0 111.33 -178.304 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.251 46.6 mm-40 -96.52 -167.14 1.52 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 112.623 -2.081 . . . . 0.0 109.08 -175.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -68.48 131.52 45.41 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.865 -175.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.347 24.9 mt-10 76.96 36.53 0.32 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 130.51 3.524 . . . . 0.0 108.864 165.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.264 37.9 m -96.25 138.48 33.79 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 -170.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.2 m -96.5 118.76 33.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -178.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 67' ' ' LEU . 3.6 mp -106.94 155.72 19.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.748 2.419 . . . . 0.0 105.708 159.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.23 139.86 46.27 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 126.415 2.322 . . . . 0.0 110.488 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 tp -82.86 121.85 27.47 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 126.371 2.295 . . . . 0.0 105.911 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -136.02 136.41 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 128.191 2.596 . . . . 0.0 104.68 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.442 -0.859 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.032 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.1 ttm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 117.224 -1.369 . . . . 0.0 107.754 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -98.55 137.64 36.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 125.374 1.671 . . . . 0.0 114.649 -174.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -133.29 177.43 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 120.134 -1.604 . . . . 0.0 113.17 171.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -125.23 133.51 52.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 130.178 3.391 . . . . 0.0 109.752 173.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.9 t -117.48 131.76 69.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 109.836 -3.347 . . . . 0.0 103.002 165.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -77.66 129.71 35.91 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 116.331 -1.795 . . . . 0.0 113.461 151.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -82.63 149.5 27.36 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.293 2.637 . . . . 0.0 104.41 172.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.22 -21.02 66.7 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.168 2.587 . . . . 0.0 111.404 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -70.73 -13.62 62.13 Favored 'General case' 0 C--N 1.326 -0.44 1 C-N-CA 132.056 4.142 . . . . 0.0 112.861 165.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.28 1.02 56.89 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.934 1.243 . . . . 0.0 115.301 165.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 155.16 18.96 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.195 -2.356 . . . . 0.0 110.435 166.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.6 m -98.07 152.39 19.36 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 100.448 -3.908 . . . . 0.0 100.448 -176.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.81 144.79 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 165.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -93.75 145.22 24.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 123.237 1.494 . . . . 0.0 107.203 165.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.414 2.1 pt? -148.25 159.5 43.91 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 120.276 3.436 . . . . 0.0 120.276 166.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -108.49 139.91 42.57 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 124.282 3.219 . . . . 0.0 109.89 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.577 HG22 ' H ' ' A' ' 18' ' ' GLU 0.266 7.5 p -138.21 178.95 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 127.967 3.292 . . . . 0.0 110.363 -177.872 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.577 ' H ' HG22 ' A' ' 17' ' ' VAL . 29.9 tp10 -134.14 138.29 30.15 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 -177.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -44.34 -37.21 10.2 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 N-CA-C 119.559 2.869 . . . . 0.0 119.559 175.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.295 13.5 p -95.08 3.34 54.92 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 113.422 -3.18 . . . . 0.0 111.2 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -73.87 160.45 31.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 123.61 2.914 . . . . 0.0 105.355 169.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -102.94 155.2 18.52 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 119.311 -2.118 . . . . 0.0 112.181 -177.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.415 HD13 HD12 ' A' ' 56' ' ' LEU . 16.6 mm -63.88 -57.69 10.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 130.061 3.345 . . . . 0.0 111.777 -168.334 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.555 1.9 tt0 -44.57 -48.54 10.33 Favored 'General case' 0 C--O 1.222 -0.349 1 C-N-CA 132.632 4.373 . . . . 0.0 114.83 176.733 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.284 26.3 t30 -49.06 -61.12 2.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 130.139 3.376 . . . . 0.0 111.666 -178.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -74.06 -39.55 50.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 128.742 2.817 . . . . 0.0 106.225 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -62.38 -28.35 69.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 112.716 -3.516 . . . . 0.0 112.196 -178.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.03 -14.39 31.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.87 2.577 . . . . 0.0 116.434 178.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -54.85 -27.34 41.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.466 2.307 . . . . 0.0 113.576 177.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tp -48.03 -22.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 1 C-N-CA 135.654 5.581 . . . . 0.0 117.382 -175.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -61.8 3.08 0.16 Allowed 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 170.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.513 32.9 t70 -19.15 -55.28 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 2 C-N-CA 135.112 5.365 . . . . 0.0 122.067 158.021 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.254 1.6 pptp? -149.15 -19.52 0.29 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 122.265 2.302 . . . . 0.0 112.22 -160.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.413 1.1 pm0 -124.85 169.3 12.18 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 147.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.81 62.11 0.33 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 105.602 -2.999 . . . . 0.0 105.602 -175.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.8 pt -86.64 148.98 47.62 Favored Pre-proline 0 N--CA 1.448 -0.572 0 C-N-CA 130.196 3.398 . . . . 0.0 109.793 178.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -76.27 136.42 17.88 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.742 2.294 . . . . 0.0 113.661 171.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -77.29 -16.1 15.61 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.997 3.131 . . . . 0.0 112.099 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.3 -15.4 62.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 124.0 3.091 . . . . 0.0 108.136 178.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -90.73 17.32 7.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.986 2.114 . . . . 0.0 115.439 176.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -142.33 160.09 40.94 Favored 'General case' 0 N--CA 1.446 -0.633 1 C-N-CA 136.984 6.114 . . . . 0.0 113.022 173.221 . . . . . . . . 4 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -149.8 146.97 27.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 131.341 3.857 . . . . 0.0 111.534 -178.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -96.57 121.81 38.8 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.959 3.304 . . . . 0.0 113.265 177.049 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.3 mt -91.96 144.58 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 156.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CG ' ' N ' ' A' ' 46' ' ' ALA 0.303 4.7 p90 -111.91 -76.37 0.6 Allowed 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 169.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.454 ' N ' ' CG ' ' A' ' 45' ' ' PHE . . . -130.5 82.93 2.08 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 100.854 -3.758 . . . . 0.0 100.854 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.24 61.33 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 112.444 -2.162 . . . . 0.0 117.084 165.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -147.83 172.79 13.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 129.21 3.004 . . . . 0.0 113.862 -171.22 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 142.89 35.95 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 128.214 2.606 . . . . 0.0 112.836 -170.177 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 43' ' ' LEU . 19.9 mt -74.34 165.9 24.4 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 129.492 3.117 . . . . 0.0 113.06 169.014 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -151.97 150.85 30.47 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 129.719 3.208 . . . . 0.0 116.59 175.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -43.8 132.48 5.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.28 -26.24 7.1 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.221 1.391 . . . . 0.0 112.979 173.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 163.64 12.47 Favored 'General case' 0 N--CA 1.444 -0.731 1 C-N-CA 133.426 4.69 . . . . 0.0 108.295 -164.916 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 p -103.68 173.17 6.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 113.545 -1.662 . . . . 0.0 106.536 167.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.415 HD12 HD13 ' A' ' 23' ' ' ILE . 3.0 mp -61.45 -34.18 74.98 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.364 175.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -78.81 -8.95 59.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.123 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -69.2 -31.62 70.34 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 125.494 1.747 . . . . 0.0 109.842 160.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -110.93 11.47 22.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.424 16.1 m120 83.4 -6.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 163.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -69.92 135.24 28.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -157.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.4 -166.79 2.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 114.183 -2.818 . . . . 0.0 110.536 -162.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.36 110.69 0.33 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 165.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 78.1 mt-10 73.35 31.79 1.33 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 131.02 3.728 . . . . 0.0 115.177 175.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 m -70.14 121.91 18.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 128.014 2.526 . . . . 0.0 107.07 172.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.4 m -97.58 114.35 26.25 Favored 'General case' 0 C--N 1.32 -0.683 1 N-CA-C 97.522 -4.992 . . . . 0.0 97.522 -178.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.465 ' HB3' HD12 ' A' ' 43' ' ' LEU . 8.2 mp -95.71 151.52 19.28 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 130.453 3.501 . . . . 0.0 107.453 171.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -118.98 134.7 55.02 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 126.581 2.426 . . . . 0.0 112.775 168.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 tp -100.93 124.88 47.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -174.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.639 HG22 ' H ' ' A' ' 71' ' ' LEU 0.353 7.5 p -140.18 -146.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 126.198 1.799 . . . . 0.0 112.027 173.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.639 ' H ' HG22 ' A' ' 70' ' ' VAL 0.542 1.8 pt? . . . . . 0 N--CA 1.45 -0.446 1 C-N-CA 132.0 4.12 . . . . 0.0 111.26 179.953 . . . . . . . . 3 2 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 117.646 -1.169 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -74.37 121.2 21.02 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -170.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -136.15 174.95 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 123.606 2.912 . . . . 0.0 113.756 170.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -123.73 155.14 38.41 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.843 2.457 . . . . 0.0 113.65 169.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.2 130.9 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 O-C-N 118.195 -2.816 . . . . 0.0 105.945 161.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.272 64.8 tttt -111.49 131.35 55.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 118.829 -2.419 . . . . 0.0 104.529 176.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.8 p -98.79 168.95 9.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.516 2.726 . . . . 0.0 105.48 -166.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 71' ' ' LEU . 15.9 mt -93.16 -0.02 57.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 130.887 3.675 . . . . 0.0 112.346 175.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 p -102.59 -23.63 13.85 Favored 'General case' 0 N--CA 1.444 -0.762 1 C-N-CA 134.187 4.995 . . . . 0.0 109.942 172.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.09 -6.71 11.97 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 116.635 -2.203 . . . . 0.0 110.594 147.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -61.45 149.92 37.13 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 157.071 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -112.45 117.84 33.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 163.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mt -101.46 133.15 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 101.756 -3.424 . . . . 0.0 101.756 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -94.46 146.78 23.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.473 1.909 . . . . 0.0 110.624 177.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.9 -177.21 3.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -176.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -149.88 117.48 6.17 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 116.536 -1.697 . . . . 0.0 107.987 170.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -131.32 148.26 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 C-N-CA 133.112 4.565 . . . . 0.0 107.237 -176.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -81.99 141.53 47.26 Favored Pre-proline 0 N--CA 1.443 -0.785 0 CA-C-O 115.747 -2.073 . . . . 0.0 107.56 172.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -45.12 -35.16 10.35 Favored 'Trans proline' 0 N--CA 1.45 -1.071 1 C-N-CA 127.821 5.681 . . . . 0.0 114.169 173.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.7 p -77.07 -19.46 57.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.611 2.764 . . . . 0.0 113.918 176.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.75 126.53 28.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.704 2.047 . . . . 0.0 109.053 -173.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -70.44 150.99 45.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.1 0.96 . . . . 0.0 112.496 170.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 15.8 mm -55.13 -26.98 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 127.901 2.481 . . . . 0.0 114.777 -178.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.259 8.4 pt-20 -61.71 -33.94 74.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 166.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -92.53 -33.14 14.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -167.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.284 75.4 t -39.85 -42.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 130.631 3.573 . . . . 0.0 113.256 158.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -74.02 -16.21 61.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.97 -37.65 54.8 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 126.856 2.062 . . . . 0.0 105.52 -173.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -75.86 -26.16 56.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 130.013 3.325 . . . . 0.0 109.047 -175.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -77.68 -22.84 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 126.795 2.559 . . . . 0.0 111.441 173.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -69.17 -43.09 74.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.977 1.311 . . . . 0.0 110.994 -175.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.429 21.8 t70 -56.93 -36.19 69.92 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 129.908 3.283 . . . . 0.0 116.161 -179.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -103.46 -27.93 12.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 109.426 -3.534 . . . . 0.0 115.402 -173.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -116.75 -13.78 10.77 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 124.812 2.244 . . . . 0.0 116.201 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.8 -0.96 56.57 Favored Glycine 0 CA--C 1.526 0.753 0 O-C-N 117.642 -3.161 . . . . 0.0 110.594 165.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.75 130.24 23.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 129.396 3.078 . . . . 0.0 111.569 -156.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.92 162.11 20.93 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 121.022 1.148 . . . . 0.0 110.223 -173.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -52.49 -21.86 15.1 Favored 'Trans proline' 0 N--CA 1.449 -1.109 1 C-N-CA 126.07 4.513 . . . . 0.0 117.718 170.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -57.32 -26.92 61.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 126.996 2.685 . . . . 0.0 117.935 164.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -97.79 -28.81 13.7 Favored 'General case' 0 C--O 1.221 -0.417 1 C-N-CA 131.848 4.059 . . . . 0.0 113.093 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.74 93.83 2.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.037 2.135 . . . . 0.0 107.522 -177.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 mtp85 -110.74 100.84 9.53 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.083 1.753 . . . . 0.0 114.667 167.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.3 mt -100.17 139.9 35.17 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 110.753 -2.931 . . . . 0.0 109.789 -165.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.48 160.72 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 174.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -149.62 124.1 9.68 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.985 2.914 . . . . 0.0 103.536 168.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.75 28.31 6.19 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 128.657 2.783 . . . . 0.0 115.664 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.29 3.23 90.62 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 128.194 3.433 . . . . 0.0 114.49 -175.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -92.2 147.55 22.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 122.771 3.286 . . . . 0.0 106.335 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.33 93.31 5.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 102.696 -3.075 . . . . 0.0 102.696 -176.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.422 ' HG ' ' H ' ' A' ' 50' ' ' LEU . 20.2 mt -54.21 115.28 1.98 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 130.785 3.634 . . . . 0.0 109.041 176.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.266 40.0 tt0 -81.44 134.7 35.58 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 102.58 -3.118 . . . . 0.0 102.58 -165.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.58 119.76 7.63 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 128.086 2.554 . . . . 0.0 106.472 167.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.49 -5.97 57.35 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 119.832 -1.792 . . . . 0.0 112.654 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -94.75 176.67 6.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 116.07 -1.919 . . . . 0.0 108.986 163.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 77.0 p -115.23 176.99 4.82 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.029 1.456 . . . . 0.0 112.012 176.237 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.97 -28.69 69.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 116.729 -1.605 . . . . 0.0 113.453 167.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.7 t -64.6 -36.34 83.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.785 2.434 . . . . 0.0 109.161 174.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.402 16.4 m-20 -57.4 -25.42 59.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 116.545 -3.847 . . . . 0.0 119.759 169.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -112.25 3.79 17.35 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 116.374 -1.774 . . . . 0.0 109.715 177.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.554 8.8 p30 57.2 31.71 20.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 129.302 3.041 . . . . 0.0 116.631 -173.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -81.38 118.34 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 -176.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -99.67 173.74 6.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.707 2.403 . . . . 0.0 112.958 -173.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -39.1 134.36 1.08 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.71 2.804 . . . . 0.0 113.11 174.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 62.67 46.14 5.53 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 128.097 2.559 . . . . 0.0 109.659 175.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -104.4 125.47 50.64 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 123.182 2.719 . . . . 0.0 104.21 172.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.8 m -85.7 134.47 33.96 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 114.649 -2.596 . . . . 0.0 108.607 178.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -107.77 154.33 21.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 101.546 -3.501 . . . . 0.0 101.546 -179.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -102.34 134.76 45.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.217 2.607 . . . . 0.0 105.639 176.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 1.7 mt -97.56 129.5 44.69 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.165 2.186 . . . . 0.0 106.267 176.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -100.24 117.71 45.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 159.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.437 ' H ' HD12 ' A' ' 8' ' ' LEU . 8.1 tp . . . . . 0 N--CA 1.447 -0.621 0 C-N-CA 127.786 2.434 . . . . 0.0 110.108 176.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 115.47 -2.205 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.274 27.7 mt-30 -99.78 154.53 18.25 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 121.323 1.874 . . . . 0.0 113.879 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -145.67 153.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -124.77 107.64 11.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 115.387 -2.244 . . . . 0.0 105.967 -161.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.25 115.72 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 119.883 1.219 . . . . 0.0 108.378 179.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -84.56 142.37 30.04 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 125.438 2.542 . . . . 0.0 108.372 176.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -127.82 148.38 50.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 110.026 -3.261 . . . . 0.0 108.879 162.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.4 mt -48.17 -17.99 0.17 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 128.053 2.541 . . . . 0.0 116.765 174.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -77.78 -37.48 48.81 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 125.516 2.579 . . . . 0.0 114.453 -169.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.73 -16.49 10.33 Favored Glycine 0 CA--C 1.538 1.502 0 O-C-N 117.04 -3.538 . . . . 0.0 108.438 -170.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -77.58 138.8 39.35 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 130.007 3.323 . . . . 0.0 106.81 174.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 m -141.3 117.93 10.96 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.731 3.212 . . . . 0.0 106.632 -171.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mm -91.09 117.47 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.344 1.857 . . . . 0.0 106.636 -173.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.9 m -83.04 118.92 23.86 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.549 1.94 . . . . 0.0 109.232 176.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -120.76 134.78 55.27 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.307 1.843 . . . . 0.0 106.547 172.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -88.25 124.63 34.06 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 128.77 3.794 . . . . 0.0 109.102 157.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.8 169.89 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 1 CA-C-N 107.66 -4.336 . . . . 0.0 105.156 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -119.76 162.76 31.23 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 128.911 2.884 . . . . 0.0 111.397 158.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.65 -23.47 15.28 Favored 'Trans proline' 0 N--CA 1.447 -1.237 1 C-N-CA 126.158 4.572 . . . . 0.0 119.687 177.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -88.3 1.58 54.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 115.848 -2.025 . . . . 0.0 113.423 175.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.01 115.41 3.13 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 122.039 2.2 . . . . 0.0 113.394 -175.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.2 p -71.88 160.11 33.12 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 118.358 -2.714 . . . . 0.0 112.893 172.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.272 53.7 mt -49.17 -36.94 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 115.369 -2.253 . . . . 0.0 113.974 167.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -58.9 -31.29 68.49 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 131.397 3.879 . . . . 0.0 113.435 164.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -84.68 -32.55 23.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 121.971 2.168 . . . . 0.0 110.04 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.94 -50.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 115.284 -2.294 . . . . 0.0 109.076 169.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 70.7 mttt -43.33 -47.95 6.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.695 1.598 . . . . 0.0 114.612 177.06 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.8 -24.13 61.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 124.304 2.002 . . . . 0.0 116.148 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -86.08 -42.37 13.99 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 114.119 -2.848 . . . . 0.0 104.808 -173.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.257 78.1 mt -49.06 -59.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 112.623 -3.56 . . . . 0.0 106.337 168.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -47.24 -51.53 18.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 127.977 3.298 . . . . 0.0 117.348 171.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.37 -35.96 82.13 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.332 0.653 . . . . 0.0 112.279 -174.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -82.27 -76.03 0.28 Allowed 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 125.706 1.879 . . . . 0.0 109.902 173.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -91.54 -21.57 20.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.265 -159.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.02 -0.23 60.38 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 116.159 -2.467 . . . . 0.0 113.745 164.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -66.98 127.04 93.38 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 120.407 2.103 . . . . 0.0 109.167 165.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.44 140.26 21.47 Favored 'Trans proline' 0 N--CA 1.445 -1.358 1 C-N-CA 126.608 4.872 . . . . 0.0 110.254 175.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HG3' ' HB3' ' A' ' 27' ' ' LYS 0.257 87.3 Cg_exo -41.45 -34.4 1.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 1 C-N-CA 131.83 8.353 . . . . 0.0 118.818 169.333 . . . . . . . . 4 3 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.58 -29.0 68.96 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 125.72 1.887 . . . . 0.0 113.476 171.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -84.5 -2.79 57.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 122.346 2.339 . . . . 0.0 111.726 -170.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 26.9 mt-30 -113.83 134.4 54.81 Favored 'General case' 0 C--N 1.325 -0.495 1 CA-C-O 111.257 -4.211 . . . . 0.0 118.744 -166.694 . . . . . . . . 3 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -110.63 141.02 44.42 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 128.986 3.929 . . . . 0.0 102.05 163.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.5 mt -135.38 128.78 32.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.561 1.144 . . . . 0.0 109.396 -174.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 4.2 mt -122.42 150.77 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.083 2.553 . . . . 0.0 104.451 -174.132 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.65 -82.6 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 102.391 -3.188 . . . . 0.0 102.391 165.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.86 -52.97 1.43 Allowed 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.15 -1.594 . . . . 0.0 108.894 173.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.14 -30.68 0.78 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 106.054 -2.818 . . . . 0.0 106.054 -175.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -82.89 110.42 17.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 -175.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -60.38 127.58 32.45 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 116.526 -1.702 . . . . 0.0 111.333 159.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -75.11 151.5 38.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 125.464 2.554 . . . . 0.0 112.56 -178.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -112.66 144.86 41.45 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 119.924 -1.735 . . . . 0.0 109.833 175.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.73 153.88 42.98 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 127.257 2.848 . . . . 0.0 114.98 -172.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.85 13.03 44.85 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 128.071 2.748 . . . . 0.0 114.136 169.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.3 mtt85 -125.63 151.71 46.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.229 1.966 . . . . 0.0 108.544 -167.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.0 p -92.43 174.95 7.02 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.397 1.57 . . . . 0.0 110.799 -177.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.58 -28.26 65.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 111.833 -2.44 . . . . 0.0 111.726 174.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -71.67 -37.76 70.72 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.378 -1.451 . . . . 0.0 114.645 173.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.94 -42.02 97.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.102 0.961 . . . . 0.0 113.386 178.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.57 4.0 45.38 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 123.488 1.613 . . . . 0.0 113.01 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.316 42.7 m-80 76.49 26.77 0.86 Allowed 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 172.016 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.5 mt -99.49 107.86 21.48 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-O 125.518 2.58 . . . . 0.0 104.117 -170.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -93.34 165.11 12.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 165.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.472 39.7 pttt -30.97 125.68 0.19 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 164.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 88.43 1.98 0.32 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 130.044 3.338 . . . . 0.0 113.982 176.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -62.17 141.29 58.26 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 117.104 -3.497 . . . . 0.0 113.311 176.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.3 m -90.82 137.67 32.18 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 125.407 1.692 . . . . 0.0 108.361 170.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -119.74 172.87 7.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 164.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -136.15 110.95 8.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 126.01 2.069 . . . . 0.0 110.176 -167.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.52 126.73 42.98 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 125.383 2.516 . . . . 0.0 110.193 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.49 122.02 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 O-C-N 116.965 -3.585 . . . . 0.0 106.487 170.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.4 mt . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 129.709 3.204 . . . . 0.0 111.582 178.756 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -98.21 139.08 34.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -173.083 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.5 pt -121.91 161.58 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.99 2.116 . . . . 0.0 106.334 166.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -105.31 129.4 53.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 159.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.77 125.99 54.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 160.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -115.21 158.35 22.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 128.315 2.646 . . . . 0.0 105.651 178.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -135.43 167.94 20.14 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 118.125 -2.859 . . . . 0.0 105.565 -170.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -69.16 -27.55 65.63 Favored 'General case' 0 N--CA 1.451 -0.387 1 O-C-N 116.093 -4.129 . . . . 0.0 113.839 176.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.1 p -85.12 3.89 36.87 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 119.077 -2.264 . . . . 0.0 110.043 171.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.9 -24.19 32.19 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 117.87 -3.018 . . . . 0.0 106.961 156.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -50.23 118.79 3.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.719 3.608 . . . . 0.0 106.29 -177.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -118.76 117.06 27.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.052 0.842 . . . . 0.0 109.408 -174.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.3 mt -84.15 136.09 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 1 C-N-CA 132.471 4.308 . . . . 0.0 107.944 168.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -93.39 133.62 36.46 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 163.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.14 142.06 51.6 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 129.507 3.123 . . . . 0.0 112.436 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -113.89 136.01 53.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 168.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 m -153.76 -178.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.84 1 C-N-CA 134.695 5.198 . . . . 0.0 112.07 -165.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -139.79 147.91 53.33 Favored Pre-proline 0 N--CA 1.448 -0.542 0 O-C-N 117.979 -2.95 . . . . 0.0 110.701 175.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -49.75 -41.67 45.67 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 123.566 2.844 . . . . 0.0 114.337 -177.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 p -51.05 -26.26 6.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 165.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -70.18 126.81 30.76 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 122.517 2.417 . . . . 0.0 108.257 -170.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.8 p -66.14 149.77 49.78 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.984 1.714 . . . . 0.0 113.796 -178.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 mm -84.6 89.56 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 1 N-CA-C 99.4 -4.296 . . . . 0.0 99.4 159.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -175.08 -60.91 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 130.325 3.45 . . . . 0.0 103.695 173.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -70.46 -39.51 74.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 114.853 -2.499 . . . . 0.0 116.454 -175.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.15 -44.35 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.692 1.997 . . . . 0.0 114.317 160.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.22 -16.49 62.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 112.318 -3.706 . . . . 0.0 111.407 -176.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.36 -35.88 30.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 123.888 3.04 . . . . 0.0 105.266 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -68.55 -35.92 78.09 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 125.076 2.369 . . . . 0.0 110.491 -176.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 mm -70.36 -46.91 69.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.276 176.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -56.11 -45.82 79.32 Favored 'General case' 0 N--CA 1.453 -0.296 1 O-C-N 116.274 -4.016 . . . . 0.0 107.223 -178.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.371 4.9 t70 -47.82 -55.9 8.68 Favored 'General case' 0 N--CA 1.444 -0.742 1 C-N-CA 133.901 4.88 . . . . 0.0 112.491 169.235 . . . . . . . . 3 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -65.97 -47.63 73.93 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 124.651 1.22 . . . . 0.0 109.925 176.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -125.14 -15.84 6.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 117.936 -2.978 . . . . 0.0 116.259 -148.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.21 6.57 53.44 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 153.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.7 mt -99.47 121.53 54.62 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-O 114.39 -2.719 . . . . 0.0 105.455 -163.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.77 135.33 62.98 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-N 124.63 2.689 . . . . 0.0 113.755 173.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.292 67.4 Cg_exo -33.1 -37.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.56 1 C-N-CA 129.644 6.896 . . . . 0.0 118.246 174.476 . . . . . . . . 3 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -80.69 -31.85 36.09 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 117.985 -2.947 . . . . 0.0 106.752 -172.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -90.94 -10.91 40.69 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 115.206 -2.331 . . . . 0.0 105.11 -172.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -77.87 94.79 4.6 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 130.687 3.595 . . . . 0.0 104.545 169.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -91.26 120.55 32.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.685 176.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mt -126.5 123.97 39.0 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -163.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -138.34 133.87 43.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -164.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.361 0.3 OUTLIER -124.6 -28.25 3.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.082 -2.327 . . . . 0.0 115.287 159.662 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.291 . . -153.02 43.59 0.63 Allowed 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 125.405 1.691 . . . . 0.0 108.912 -166.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.96 -7.67 49.04 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 128.709 3.052 . . . . 0.0 117.921 159.083 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.44 32.0 pttt -151.97 147.49 26.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 131.488 3.915 . . . . 0.0 110.918 -170.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.7 139.95 48.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.151 1.78 . . . . 0.0 112.705 173.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 mt -82.11 136.35 35.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 114.949 -2.453 . . . . 0.0 107.884 -174.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -82.68 139.84 33.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 126.237 2.211 . . . . 0.0 110.371 -170.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -45.3 113.78 0.63 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 118.679 2.844 . . . . 0.0 118.679 169.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.09 -7.19 40.67 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 164.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.259 13.3 mmp_? -93.69 142.12 27.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -172.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.9 p -86.47 163.86 17.3 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.333 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -41.05 -52.89 3.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 124.798 3.454 . . . . 0.0 115.704 163.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 t -51.84 -37.64 52.72 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 114.115 -2.85 . . . . 0.0 115.156 168.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -68.0 -18.57 64.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 178.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -97.36 -13.49 21.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 114.132 -2.842 . . . . 0.0 112.308 161.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.8 t30 72.14 31.8 1.87 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 125.626 3.83 . . . . 0.0 113.104 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -70.55 112.84 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 1 O-C-N 115.927 -4.233 . . . . 0.0 109.845 -175.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.291 22.9 mt-30 -94.03 162.68 13.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.269 1.428 . . . . 0.0 110.539 -165.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.266 26.8 pttt -42.16 115.26 0.66 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 117.168 2.284 . . . . 0.0 117.168 161.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.5 2.6 tt0 87.16 30.35 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.785 170.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.31 68.6 m -90.01 132.69 35.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 172.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -82.27 125.82 31.41 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.433 2.293 . . . . 0.0 112.456 169.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mp -116.36 124.36 49.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 172.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.285 11.8 t60 -83.64 120.09 25.56 Favored 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 131.876 4.07 . . . . 0.0 112.275 165.508 . . . . . . . . 3 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -94.5 130.59 40.83 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 117.373 -3.329 . . . . 0.0 108.337 174.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.79 153.01 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 O-C-N 117.98 -2.95 . . . . 0.0 114.125 170.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.518 -0.272 1 N-CA-C 98.125 -4.769 . . . . 0.0 98.125 -161.43 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pm0 -104.92 140.72 37.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.543 1.937 . . . . 0.0 107.93 178.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -124.72 151.8 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 128.644 2.777 . . . . 0.0 106.607 165.272 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.253 60.3 m-85 -93.11 151.58 19.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 122.577 1.179 . . . . 0.0 113.217 168.702 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.1 144.67 28.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 114.293 -2.765 . . . . 0.0 107.245 167.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 52.3 tttt -126.48 127.46 45.4 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 128.75 3.781 . . . . 0.0 118.196 170.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 p -82.36 166.18 19.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.743 2.417 . . . . 0.0 111.448 -169.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.35 -37.0 66.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 129.974 3.31 . . . . 0.0 116.604 172.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.8 p -73.89 -33.25 63.95 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.589 2.756 . . . . 0.0 113.967 173.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.17 16.43 7.23 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 116.518 1.367 . . . . 0.0 116.518 177.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -86.47 134.99 33.64 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.898 1.679 . . . . 0.0 106.984 178.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -100.59 113.24 25.89 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 130.091 3.357 . . . . 0.0 105.315 -176.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -100.38 114.51 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 100.666 -3.827 . . . . 0.0 100.666 174.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -66.25 131.75 46.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.954 -2.966 . . . . 0.0 109.261 154.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.14 128.45 38.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 119.418 -2.051 . . . . 0.0 108.297 -172.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -91.92 115.79 28.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 125.696 1.872 . . . . 0.0 110.26 178.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.51 22.6 m -121.07 -68.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 113.45 -3.166 . . . . 0.0 118.052 -163.271 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 80.48 131.74 0.04 OUTLIER Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 129.709 3.204 . . . . 0.0 107.176 -155.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.3 -16.81 15.21 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 CA-C-N 120.316 1.149 . . . . 0.0 114.976 -175.294 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 m -86.23 18.03 3.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 172.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -76.79 152.63 35.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.056 1.342 . . . . 0.0 110.002 158.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -88.71 148.5 23.95 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.999 1.319 . . . . 0.0 107.952 174.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.279 5.8 mm -46.13 -37.63 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 127.546 2.338 . . . . 0.0 113.477 174.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -82.27 -14.18 55.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 116.506 -3.871 . . . . 0.0 113.343 -175.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -94.86 -24.94 16.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 123.805 1.764 . . . . 0.0 110.692 174.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.45 -41.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 1 O-C-N 115.452 -4.53 . . . . 0.0 108.857 167.343 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -69.83 -34.05 73.14 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 124.525 1.141 . . . . 0.0 112.811 176.106 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.255 . . -77.45 -13.27 59.96 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 120.604 1.547 . . . . 0.0 110.808 173.126 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -69.1 -37.06 78.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 118.314 -2.742 . . . . 0.0 111.13 172.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 mm -69.15 -31.39 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 127.572 2.349 . . . . 0.0 108.291 175.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.58 -37.12 76.82 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 172.326 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.12 -51.2 40.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.254 -1.529 . . . . 0.0 114.152 172.092 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -87.57 -27.65 22.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -171.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -122.89 -21.23 5.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 115.282 -2.294 . . . . 0.0 115.441 175.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.63 -14.6 42.12 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 116.446 -2.308 . . . . 0.0 111.558 172.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.5 mt -78.38 121.23 83.49 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 120.394 2.097 . . . . 0.0 109.238 -154.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -55.27 143.27 76.51 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 CA-C-N 123.214 2.184 . . . . 0.0 117.029 -174.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.43 -28.86 3.33 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 O-C-N 116.965 -2.177 . . . . 0.0 116.396 -166.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 0.0 OUTLIER -51.92 -29.21 19.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 121.291 3.811 . . . . 0.0 121.291 172.127 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -92.7 -18.47 22.94 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 128.492 3.62 . . . . 0.0 111.723 -177.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -83.24 129.41 35.01 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 126.168 2.167 . . . . 0.0 116.282 -175.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -103.47 119.64 39.28 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 114.488 -2.673 . . . . 0.0 105.048 160.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -88.6 120.8 30.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.788 1.631 . . . . 0.0 109.075 168.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mm -114.57 135.28 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 126.52 1.928 . . . . 0.0 112.635 -177.025 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.262 49.5 t80 -148.61 113.33 5.38 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 128.383 2.673 . . . . 0.0 109.103 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.92 50.71 0.81 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 128.159 2.583 . . . . 0.0 111.451 163.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.15 4.5 66.63 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 117.82 -2.134 . . . . 0.0 117.264 174.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -161.2 144.75 12.97 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -160.391 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -87.92 140.32 29.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 125.352 2.501 . . . . 0.0 107.648 173.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.61 113.2 24.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 118.84 -2.413 . . . . 0.0 108.514 179.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -79.2 137.22 37.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 118.395 -2.691 . . . . 0.0 111.634 -163.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -45.65 112.38 0.45 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 129.146 2.978 . . . . 0.0 114.733 156.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.62 -15.6 9.76 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 128.972 3.177 . . . . 0.0 113.896 -173.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -105.69 178.26 4.61 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 120.84 2.32 . . . . 0.0 105.797 -175.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -110.7 170.0 8.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 118.473 -2.642 . . . . 0.0 108.545 176.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.46 -35.72 63.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 117.195 -1.802 . . . . 0.0 109.983 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 p -53.95 -27.75 33.07 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 128.2 2.6 . . . . 0.0 112.91 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -58.68 -26.35 63.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 167.158 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -120.33 23.04 11.1 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 118.209 -2.807 . . . . 0.0 108.287 -170.132 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.344 13.5 m120 78.73 10.01 1.82 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 126.379 2.299 . . . . 0.0 111.978 171.12 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -77.81 120.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 121.124 1.784 . . . . 0.0 111.544 -160.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -106.37 -177.4 3.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.643 1.211 . . . . 0.0 111.185 176.13 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -69.49 126.48 29.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.074 2.149 . . . . 0.0 110.46 -178.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 61.85 29.68 17.98 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 129.392 3.077 . . . . 0.0 114.34 -176.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.5 m -62.34 126.79 28.56 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.613 2.365 . . . . 0.0 111.963 154.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -82.97 119.98 25.12 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 127.141 2.177 . . . . 0.0 107.219 173.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -89.74 154.89 19.58 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.438 -2.164 . . . . 0.0 107.607 159.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -119.24 139.72 51.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -112.41 132.3 55.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 124.564 2.126 . . . . 0.0 110.559 -167.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 m -130.53 133.07 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 113.09 -1.868 . . . . 0.0 110.04 175.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.448 -0.571 0 O-C-N 126.234 2.209 . . . . 0.0 107.499 -177.567 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 mtt . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 116.59 -1.671 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 149.17 23.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 121.29 1.859 . . . . 0.0 107.43 177.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -136.06 -177.33 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 C-N-CA 127.931 2.493 . . . . 0.0 107.986 160.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -128.44 138.63 52.4 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 119.21 -2.181 . . . . 0.0 113.064 174.011 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.9 t -110.73 114.84 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 164.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 83.8 tttt -104.26 140.31 38.04 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.296 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.4 p -102.35 117.53 34.92 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 118.165 -2.835 . . . . 0.0 104.654 166.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.09 -32.69 7.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 117.184 -3.448 . . . . 0.0 117.681 177.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 p -88.0 -9.68 52.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.903 2.881 . . . . 0.0 109.072 -176.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.73 -111.86 1.07 Allowed Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.276 -1.291 . . . . 0.0 113.233 -170.35 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.353 7.4 pttp -142.66 164.1 31.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.305 1.842 . . . . 0.0 115.387 -168.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.313 0.6 OUTLIER -81.3 115.16 20.54 Favored 'General case' 0 C--N 1.325 -0.473 1 C-N-CA 134.0 4.92 . . . . 0.0 109.603 -179.836 . . . . . . . . 4 3 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 mt -108.94 124.72 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -173.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 p -72.34 124.69 25.64 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 112.71 -2.041 . . . . 0.0 111.678 -179.027 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 16' ' ' GLU 0.261 1.7 tm? -130.06 152.22 49.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.082 -2.261 . . . . 0.0 109.907 -175.66 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.521 ' H ' HD13 ' A' ' 15' ' ' LEU . 68.1 tt0 -129.75 123.33 30.78 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 123.873 1.797 . . . . 0.0 107.936 -170.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.73 152.63 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 131.37 3.868 . . . . 0.0 113.206 178.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -93.73 156.98 38.97 Favored Pre-proline 0 N--CA 1.446 -0.66 0 C-N-CA 127.048 2.139 . . . . 0.0 105.611 171.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.14 -7.93 18.69 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 N-CA-C 118.44 2.438 . . . . 0.0 118.44 -171.091 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.6 p -108.16 5.26 25.7 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 130.95 3.7 . . . . 0.0 117.49 176.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.03 139.73 36.83 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 126.213 2.196 . . . . 0.0 107.736 -167.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -87.21 166.6 14.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 125.427 1.704 . . . . 0.0 108.588 174.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mp -69.02 -40.3 80.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 130.079 3.352 . . . . 0.0 108.049 -176.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -53.16 -34.76 58.26 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 113.431 -3.176 . . . . 0.0 112.75 168.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -82.76 -13.38 56.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 125.147 1.529 . . . . 0.0 109.752 -174.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 30' ' ' ILE . 80.3 t -70.9 -57.89 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 131.127 3.771 . . . . 0.0 106.727 168.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.316 38.7 mtmt -53.51 -38.66 63.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 125.281 2.467 . . . . 0.0 116.953 173.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -43.77 65.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 112.406 -2.179 . . . . 0.0 111.189 175.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -55.66 -51.92 65.59 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 118.79 -2.444 . . . . 0.0 109.1 171.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 26' ' ' VAL . 62.9 mt -51.78 -31.56 13.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 122.535 2.425 . . . . 0.0 109.587 169.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -78.55 -48.66 14.77 Favored 'General case' 0 N--CA 1.447 -0.61 1 O-C-N 113.851 -5.53 . . . . 0.0 108.148 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.383 18.3 t70 -46.95 -33.48 4.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 128.957 2.903 . . . . 0.0 117.841 165.614 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -100.46 -53.68 3.04 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 118.079 -2.888 . . . . 0.0 114.238 -174.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -108.47 -27.81 9.71 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -173.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.85 19.79 60.78 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 125.625 2.792 . . . . 0.0 117.269 175.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.409 HG22 ' HG2' ' A' ' 41' ' ' GLN . 49.9 mt -77.18 109.67 9.89 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-O 113.067 -3.349 . . . . 0.0 105.663 179.319 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -64.58 148.35 90.44 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 CA-C-N 126.912 3.504 . . . . 0.0 107.853 -166.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.84 -23.85 74.35 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 118.626 2.51 . . . . 0.0 118.626 -172.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -94.65 -12.23 27.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 115.461 -2.209 . . . . 0.0 111.913 -172.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -86.81 -19.41 29.04 Favored 'General case' 0 N--CA 1.448 -0.56 1 C-N-CA 132.536 4.334 . . . . 0.0 111.724 173.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.409 ' HG2' HG22 ' A' ' 36' ' ' ILE . 74.8 mt-30 -80.97 144.99 31.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.334 70.5 mtm180 -119.79 153.14 36.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 117.126 -3.484 . . . . 0.0 104.809 144.059 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.9 mt -119.35 140.98 49.46 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 114.303 -2.761 . . . . 0.0 107.255 176.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.497 0.0 OUTLIER -136.96 146.45 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 125.169 3.622 . . . . 0.0 110.778 172.482 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -159.09 110.47 2.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 116.542 -1.695 . . . . 0.0 108.875 -169.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.34 21.2 5.84 Favored 'General case' 0 N--CA 1.449 -0.487 1 O-C-N 129.525 4.265 . . . . 0.0 115.643 168.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.0 -18.16 29.01 Favored Glycine 0 CA--C 1.532 1.145 0 O-C-N 118.077 -2.89 . . . . 0.0 116.531 -169.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 126.71 52.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 129.465 3.685 . . . . 0.0 112.535 -162.361 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.78 97.6 0.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 129.2 3.0 . . . . 0.0 110.009 173.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.467 HD22 HD11 ' A' ' 61' ' ' ILE . 17.9 mt -67.63 118.69 11.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 127.757 2.423 . . . . 0.0 109.641 -178.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.51 128.96 55.26 Favored 'General case' 0 N--CA 1.451 -0.391 1 O-C-N 130.676 4.985 . . . . 0.0 112.19 175.109 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -52.85 131.46 35.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 119.255 -2.153 . . . . 0.0 112.466 156.44 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.74 2.14 14.68 Favored Glycine 0 CA--C 1.53 1.023 1 CA-C-O 110.766 -5.463 . . . . 0.0 113.367 -171.03 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -129.21 163.08 26.37 Favored 'General case' 0 N--CA 1.449 -0.506 1 CA-C-N 124.287 4.044 . . . . 0.0 107.577 -176.37 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 p -88.26 159.71 17.99 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 101.707 -3.442 . . . . 0.0 101.707 -176.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 56' ' ' LEU . 6.6 tt -34.23 -53.52 0.49 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 129.834 3.254 . . . . 0.0 111.138 153.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.6 m -72.27 -14.78 61.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 128.433 2.693 . . . . 0.0 115.233 -173.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.268 17.6 m-20 -65.09 -41.25 95.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 164.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -107.63 -28.46 9.73 Favored 'General case' 0 C--N 1.324 -0.504 1 O-C-N 114.891 -4.881 . . . . 0.0 108.136 -170.262 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.494 20.2 t30 96.06 41.72 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.324 2.25 . . . . 0.0 115.745 -175.024 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.467 HD11 HD22 ' A' ' 50' ' ' LEU . 12.1 mt -84.35 89.6 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 125.49 1.744 . . . . 0.0 110.191 176.682 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -91.09 175.13 7.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 125.82 1.95 . . . . 0.0 108.203 -168.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 149.06 30.07 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 170.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 64.78 2.96 1.85 Allowed 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 125.784 1.928 . . . . 0.0 114.421 177.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -69.06 156.17 39.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.026 -1.671 . . . . 0.0 111.442 176.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.3 m -125.17 132.27 53.08 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 117.334 -3.354 . . . . 0.0 104.746 -174.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.53 137.4 47.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -85.72 143.34 28.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.841 -1.787 . . . . 0.0 106.343 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tp -107.42 131.5 54.21 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 168.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.85 89.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.941 2.096 . . . . 0.0 114.419 -163.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mp . . . . . 0 C--N 1.323 -0.572 0 O-C-N 119.403 -2.06 . . . . 0.0 109.062 -147.89 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 117.464 -1.255 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.274 50.0 mt-30 -95.43 125.87 40.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 127.324 3.44 . . . . 0.0 107.031 -175.57 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -113.07 144.71 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.315 171.083 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -100.7 106.5 17.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.267 -178.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.3 t -88.34 106.81 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 124.028 1.871 . . . . 0.0 110.487 170.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.294 5.4 tppt? -84.75 135.76 33.99 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.029 -1.669 . . . . 0.0 109.469 173.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -78.17 165.19 24.24 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.967 1.707 . . . . 0.0 115.107 165.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.35 0.4 OUTLIER -83.1 -12.49 57.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.581 163.665 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -66.65 -41.58 88.02 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 171.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.82 38.23 1.31 Allowed Glycine 0 CA--C 1.536 1.397 0 O-C-N 118.081 -2.887 . . . . 0.0 110.218 -172.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.283 59.4 pttt -130.76 168.77 16.67 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.525 2.33 . . . . 0.0 105.593 167.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.305 1.8 m -115.3 171.21 7.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 159.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 pt -138.61 145.69 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 131.411 3.885 . . . . 0.0 109.091 161.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 m -107.58 105.88 15.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 118.787 -2.446 . . . . 0.0 110.623 -175.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.21 131.73 40.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 115.185 -2.341 . . . . 0.0 109.209 176.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -74.66 119.62 19.1 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.04 2.536 . . . . 0.0 109.041 156.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.22 157.59 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 177.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.301 1.7 tm-20 -85.53 153.04 58.33 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 169.7 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.96 -22.98 75.33 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.482 1.455 . . . . 0.0 115.846 168.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.0 p -94.86 11.68 30.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 119.021 -2.3 . . . . 0.0 113.314 171.109 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.22 134.96 48.57 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 124.518 3.327 . . . . 0.0 107.819 159.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p -89.51 155.17 19.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 112.519 -2.128 . . . . 0.0 114.029 174.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 23' ' ' ILE . 11.7 mm -40.23 -56.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.418 2.287 . . . . 0.0 114.996 -172.222 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -39.66 65.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -69.87 -33.25 71.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.164 -1.585 . . . . 0.0 110.613 176.184 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 t -59.71 -45.27 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 O-C-N 116.633 -3.792 . . . . 0.0 108.129 171.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -53.78 -49.74 67.6 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 125.426 1.704 . . . . 0.0 108.448 175.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.43 -34.95 78.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 126.828 3.204 . . . . 0.0 114.099 -178.158 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -78.44 -24.53 46.06 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 117.309 -3.369 . . . . 0.0 108.791 177.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 mt -70.24 -40.36 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 123.544 2.884 . . . . 0.0 108.935 162.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -67.92 -39.38 83.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 114.467 -2.682 . . . . 0.0 112.097 -168.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -53.66 -39.54 65.15 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 127.487 2.315 . . . . 0.0 115.112 165.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.311 65.8 mmtt -89.7 -44.86 9.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 117.755 -1.578 . . . . 0.0 113.007 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -97.87 -19.88 17.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 116.124 -1.893 . . . . 0.0 113.055 -173.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.3 -15.26 63.35 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 173.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.0 mt -70.94 113.3 17.79 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-O 114.343 -2.741 . . . . 0.0 110.043 -177.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -65.35 153.77 76.7 Favored 'Trans proline' 0 N--CA 1.449 -1.116 1 C-N-CA 126.238 4.625 . . . . 0.0 110.385 -173.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.47 -34.16 97.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.825 3.017 . . . . 0.0 113.991 -178.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -60.52 -2.91 0.57 Allowed 'General case' 0 N--CA 1.445 -0.683 1 C-N-CA 133.883 4.873 . . . . 0.0 115.85 172.899 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.39 0.0 OUTLIER -135.59 14.93 3.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 169.289 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -105.79 161.35 14.5 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 171.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.295 15.9 ttm180 -157.62 139.27 13.92 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 131.386 3.874 . . . . 0.0 108.454 169.448 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.9 118.23 22.32 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.486 2.314 . . . . 0.0 109.985 -162.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.4 mm -101.75 139.33 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.689 1.596 . . . . 0.0 109.173 -174.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -148.03 140.48 24.43 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 115.82 -2.038 . . . . 0.0 110.376 158.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.301 . . 69.97 8.09 6.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 -177.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.89 -13.84 22.03 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.189 1.852 . . . . 0.0 108.786 171.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -112.45 163.86 13.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 116.497 -3.943 . . . . 0.0 111.776 -174.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -79.1 118.44 21.08 Favored 'General case' 0 N--CA 1.441 -0.913 1 C-N-CA 132.018 4.127 . . . . 0.0 111.315 166.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.85 129.12 34.36 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 127.53 3.019 . . . . 0.0 106.769 169.782 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -92.23 156.32 17.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 130.529 3.531 . . . . 0.0 114.004 -171.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -49.11 130.69 19.09 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.447 2.299 . . . . 0.0 111.545 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.73 -27.53 14.68 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.088 1.804 . . . . 0.0 116.418 163.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.81 149.98 26.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 120.537 2.169 . . . . 0.0 108.178 176.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -79.31 164.99 23.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 128.909 2.884 . . . . 0.0 109.285 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 56' ' ' LEU . 80.1 mt -67.64 -27.0 66.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.665 170.179 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.257 1.2 p -72.32 -20.36 61.5 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 112.281 -3.723 . . . . 0.0 115.402 163.579 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.61 -17.63 62.27 Favored 'General case' 0 N--CA 1.447 -0.615 1 CA-C-O 129.295 4.379 . . . . 0.0 109.225 178.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.264 50.2 m-85 -112.05 1.67 16.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 117.649 -3.157 . . . . 0.0 110.931 177.596 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.4 t30 53.57 44.43 29.83 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.8 2.44 . . . . 0.0 115.16 168.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.275 2.9 mt -66.56 131.57 32.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 1 C-N-CA 133.825 4.85 . . . . 0.0 112.875 160.636 . . . . . . . . 3 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.0 169.29 12.26 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 114.837 -2.506 . . . . 0.0 113.537 171.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.14 127.17 3.47 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 119.452 3.13 . . . . 0.0 119.452 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 65.45 30.61 10.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.358 2.263 . . . . 0.0 115.392 174.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -81.87 151.02 27.5 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.2 m -97.48 116.71 30.21 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 119.615 -1.928 . . . . 0.0 107.565 -174.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -100.43 145.14 28.59 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 128.513 2.725 . . . . 0.0 111.49 171.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -112.55 107.5 16.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 124.39 2.043 . . . . 0.0 110.202 -167.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tp -80.49 134.75 36.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 119.214 -2.179 . . . . 0.0 109.22 -173.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.5 t -125.01 136.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.911 -1.118 . . . . 0.0 111.099 174.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 N--CA 1.45 -0.446 0 C-N-CA 130.533 3.533 . . . . 0.0 106.875 176.92 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -102.1 150.78 22.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 118.294 -2.754 . . . . 0.0 105.847 176.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.374 16.4 pt -140.56 157.51 24.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 131.203 3.801 . . . . 0.0 106.693 164.585 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -112.05 139.83 47.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -175.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 t -115.08 126.31 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 128.276 2.631 . . . . 0.0 107.83 166.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -93.29 125.59 37.97 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 127.925 3.266 . . . . 0.0 110.838 169.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.271 72.5 p -79.11 -165.18 0.71 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -179.632 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mt -77.28 -43.21 34.08 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 118.042 -2.911 . . . . 0.0 111.898 163.401 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.7 p -74.74 -6.28 47.99 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -169.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.59 0.87 43.23 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 117.253 1.661 . . . . 0.0 117.253 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -84.59 147.88 26.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.909 1.283 . . . . 0.0 111.713 173.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.6 m -110.52 109.29 19.57 Favored 'General case' 0 C--N 1.326 -0.441 1 C-N-CA 132.416 4.286 . . . . 0.0 100.314 173.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -95.31 142.42 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 127.257 2.223 . . . . 0.0 106.246 166.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.5 m -96.2 133.31 40.67 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -117.63 140.36 49.74 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -177.149 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -101.86 130.88 48.43 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 100.666 -3.828 . . . . 0.0 100.666 -177.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.482 HG21 HD23 ' A' ' 56' ' ' LEU . 34.3 m -137.34 163.14 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.177 176.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.366 71.2 mm-40 -116.48 145.83 36.09 Favored Pre-proline 0 N--CA 1.445 -0.675 0 N-CA-C 101.758 -3.423 . . . . 0.0 101.758 163.425 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -73.01 -3.6 13.92 Favored 'Trans proline' 0 N--CA 1.447 -1.261 1 C-N-CA 125.964 4.442 . . . . 0.0 113.911 -174.343 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 p -80.5 -20.91 42.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 128.755 2.822 . . . . 0.0 115.615 164.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -61.6 141.58 57.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.441 1.591 . . . . 0.0 113.565 175.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -70.56 159.12 34.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.1 1.76 . . . . 0.0 109.459 167.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 mm -45.24 -39.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 130.131 3.372 . . . . 0.0 113.973 162.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -76.61 -34.83 58.36 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.358 0.981 . . . . 0.0 110.761 179.533 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.288 18.8 m-80 -53.33 -44.29 68.32 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 116.722 -1.608 . . . . 0.0 112.014 174.381 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.28 1.9 t -51.55 -49.37 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 167.133 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -54.65 -52.15 63.21 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 125.586 1.804 . . . . 0.0 115.145 175.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.8 -39.02 4.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 131.306 3.842 . . . . 0.0 119.661 166.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -86.26 -38.92 17.07 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 110.867 -2.879 . . . . 0.0 105.841 -179.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 30' ' ' ILE 0.304 83.6 mt -54.47 -37.03 36.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 O-C-N 117.806 -3.059 . . . . 0.0 114.05 166.745 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -44.83 66.89 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 128.053 2.541 . . . . 0.0 115.718 175.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.39 -51.94 67.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.348 1.859 . . . . 0.0 111.637 168.089 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -82.67 -16.86 46.58 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 118.444 2.757 . . . . 0.0 118.444 -168.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -154.79 2.37 0.2 Allowed 'General case' 0 N--CA 1.449 -0.52 1 O-C-N 115.962 -4.211 . . . . 0.0 109.405 -173.594 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.37 -20.09 48.52 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 117.598 -3.189 . . . . 0.0 114.933 161.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mt -83.25 131.55 52.93 Favored Pre-proline 0 N--CA 1.442 -0.854 0 O-C-N 119.258 -2.319 . . . . 0.0 107.671 -167.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -59.92 151.06 74.38 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 118.824 2.586 . . . . 0.0 118.824 165.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.396 29.9 Cg_exo -47.17 -40.91 27.44 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 124.685 3.59 . . . . 0.0 117.718 173.488 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.27 2.76 38.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 124.811 1.319 . . . . 0.0 110.295 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -118.93 6.08 11.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 123.388 2.813 . . . . 0.0 112.494 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 70.1 mt-30 -99.2 156.24 17.07 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 118.704 0.684 . . . . 0.0 109.768 175.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -129.84 114.92 16.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 101.56 -3.496 . . . . 0.0 101.56 160.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 mt -86.66 146.45 26.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 125.735 3.88 . . . . 0.0 109.151 176.467 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.27 20.3 mm -135.14 156.17 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 129.722 3.209 . . . . 0.0 106.418 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -159.55 147.55 17.34 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 127.001 2.688 . . . . 0.0 109.789 159.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.347 . . 52.59 20.11 1.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 131.117 3.767 . . . . 0.0 112.51 175.354 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.29 -0.06 59.92 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 128.659 3.028 . . . . 0.0 110.168 175.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.275 28.3 mttm -100.66 148.06 25.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 116.127 -1.892 . . . . 0.0 112.689 -178.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.714 HE21 ' H ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -73.41 132.38 42.93 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 161.425 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 118.67 5.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.501 172.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.95 99.36 3.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.177 2.191 . . . . 0.0 111.25 174.463 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -39.3 135.07 1.08 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 151.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.96 2.53 7.82 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.132 -1.371 . . . . 0.0 116.412 171.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -129.25 -167.57 1.81 Allowed 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 127.371 2.453 . . . . 0.0 111.193 -163.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -125.21 165.18 18.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.824 1.65 . . . . 0.0 110.19 161.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -58.4 -40.09 81.43 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 118.081 -2.887 . . . . 0.0 111.042 -176.535 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.0 t -64.48 -33.45 75.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.719 2.008 . . . . 0.0 109.797 175.467 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.251 28.1 t70 -82.37 -32.36 29.26 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 117.667 -3.146 . . . . 0.0 115.07 -176.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -91.51 -2.75 57.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 116.012 -1.947 . . . . 0.0 109.177 173.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 71.74 40.04 0.81 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 129.988 3.315 . . . . 0.0 114.47 169.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.4 mt -79.88 109.81 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 102.003 -3.332 . . . . 0.0 102.003 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -83.51 164.98 19.5 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.274 1.83 . . . . 0.0 112.193 172.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.74 156.78 39.08 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.346 2.659 . . . . 0.0 108.951 -177.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 62.75 7.2 2.42 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.386 2.274 . . . . 0.0 112.278 175.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -74.61 148.44 40.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.2 -2.188 . . . . 0.0 111.385 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.2 m -108.4 111.91 24.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 118.361 -1.336 . . . . 0.0 112.741 -178.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.3 mp -88.62 176.02 7.3 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 129.905 3.282 . . . . 0.0 109.944 171.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -134.36 154.03 51.57 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 116.619 -3.801 . . . . 0.0 110.811 -175.263 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.321 0.7 OUTLIER -118.16 150.57 39.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.11 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.65 147.74 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 130.735 3.614 . . . . 0.0 105.597 163.02 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.9 tp . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.625 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -96.75 166.7 11.52 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -164.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 pt -114.68 134.41 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 153.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -87.12 112.06 21.56 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.53 1.532 . . . . 0.0 113.41 165.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.48 117.46 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 113.379 -3.201 . . . . 0.0 108.182 -176.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -119.29 152.28 36.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 130.005 3.322 . . . . 0.0 107.322 -169.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -155.45 170.57 21.63 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.933 1.693 . . . . 0.0 112.817 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 -23.34 48.34 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 128.608 3.693 . . . . 0.0 114.588 -165.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -76.67 -7.42 55.27 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 169.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.3 -23.5 8.05 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 118.026 -2.921 . . . . 0.0 114.108 167.113 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -59.55 133.05 55.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 118.06 2.615 . . . . 0.0 118.06 -175.853 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 m -112.86 103.67 11.66 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 170.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 mt -96.85 115.3 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 129.589 3.156 . . . . 0.0 106.484 175.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.8 p -89.6 109.94 20.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 114.046 -2.883 . . . . 0.0 111.932 168.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -112.21 140.11 47.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 125.076 3.58 . . . . 0.0 105.028 172.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -88.64 135.76 33.34 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.19 2.196 . . . . 0.0 107.599 176.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.51 173.6 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 127.879 2.472 . . . . 0.0 110.991 -161.623 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 44.7 mm-40 -132.88 166.56 28.33 Favored Pre-proline 0 N--CA 1.441 -0.925 1 O-C-N 129.572 4.295 . . . . 0.0 108.517 151.648 . . . . . . . . 3 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -37.74 -21.63 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 124.324 3.349 . . . . 0.0 120.229 163.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.7 p -94.07 -20.59 19.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.914 2.886 . . . . 0.0 113.667 -173.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -69.1 145.3 53.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.188 0.994 . . . . 0.0 112.502 176.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.5 p -90.0 165.25 14.16 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.93 -1.941 . . . . 0.0 112.108 -173.167 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -74.08 -49.72 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 114.902 -2.475 . . . . 0.0 110.382 170.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -58.62 -10.28 2.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 125.705 3.866 . . . . 0.0 119.605 172.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -74.91 -38.66 61.77 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 119.628 1.104 . . . . 0.0 112.26 161.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 30' ' ' ILE . 22.7 t -71.89 -34.63 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 O-C-N 116.817 -3.677 . . . . 0.0 109.419 -168.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -71.43 -39.53 70.98 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.692 1.997 . . . . 0.0 109.251 -175.109 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.73 89.32 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.983 3.313 . . . . 0.0 116.505 161.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -82.79 -21.04 34.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 125.62 1.825 . . . . 0.0 113.729 -177.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 26' ' ' VAL . 96.2 mt -55.76 -50.67 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.646 2.378 . . . . 0.0 109.252 161.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -67.35 -28.52 68.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -173.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.334 36.5 t70 -52.41 -46.43 66.32 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 130.882 3.673 . . . . 0.0 117.093 162.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -92.08 -48.62 6.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.688 -1.596 . . . . 0.0 108.907 -175.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.438 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS 0.318 20.8 tp10 -108.13 -15.79 14.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 128.065 2.546 . . . . 0.0 116.37 -166.78 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.26 -26.01 26.0 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 124.497 3.317 . . . . 0.0 111.949 158.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 tp -67.95 127.91 93.33 Favored Pre-proline 0 C--O 1.223 -0.33 0 CA-C-O 113.917 -2.944 . . . . 0.0 107.782 -170.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.67 137.07 17.76 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 124.519 3.48 . . . . 0.0 118.137 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -34.53 -37.95 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.441 3.427 . . . . 0.0 117.623 178.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.481 13.1 t70 -44.07 -40.47 4.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 171.214 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -108.23 12.39 26.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 112.836 -1.984 . . . . 0.0 111.426 -176.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -100.95 135.86 41.72 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.195 1.798 . . . . 0.0 107.88 174.06 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -130.26 140.07 50.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 128.09 2.556 . . . . 0.0 111.816 172.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.03 118.79 30.7 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 126.542 2.401 . . . . 0.0 108.666 -160.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.444 HG12 HG23 ' A' ' 70' ' ' VAL . 38.3 mm -120.03 138.35 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 127.599 2.359 . . . . 0.0 111.197 -173.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -133.55 100.67 4.87 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.226 2.211 . . . . 0.0 112.232 171.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.49 -94.36 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.386 -162.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.08 4.57 9.0 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 115.973 -2.57 . . . . 0.0 114.437 168.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -87.3 131.23 34.32 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 120.703 2.252 . . . . 0.0 105.067 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -85.0 124.27 31.5 Favored 'General case' 0 N--CA 1.442 -0.842 1 C-N-CA 134.445 5.098 . . . . 0.0 105.599 176.241 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 mt -101.27 157.27 16.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 125.46 1.725 . . . . 0.0 109.879 -173.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -130.18 134.04 47.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.468 1.507 . . . . 0.0 107.313 170.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.256 3.1 p30 -70.12 -168.62 0.23 Allowed 'General case' 0 C--O 1.221 -0.402 0 O-C-N 128.684 3.74 . . . . 0.0 112.141 -174.153 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.55 1.75 58.92 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 120.89 3.116 . . . . 0.0 120.89 -175.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.3 mtt-85 -147.86 159.34 43.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 128.586 2.754 . . . . 0.0 110.747 -150.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.3 p -83.19 176.73 8.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 129.972 3.309 . . . . 0.0 111.036 -179.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.66 -33.49 76.01 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 129.36 3.064 . . . . 0.0 111.232 168.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 41.1 t -85.49 -10.52 55.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 119.39 -2.069 . . . . 0.0 112.115 176.634 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.03 -28.46 68.88 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 125.612 1.82 . . . . 0.0 109.979 169.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.287 41.3 m-85 -122.73 17.15 10.28 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 119.53 -1.981 . . . . 0.0 113.562 -175.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 t30 53.8 40.61 31.72 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -174.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.2 mt -85.62 80.58 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 173.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -102.77 36.55 2.16 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.613 2.365 . . . . 0.0 111.428 -161.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm 96.45 132.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 1 C-N-CA 132.212 4.205 . . . . 0.0 105.774 156.069 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.435 9.9 mp0 73.49 23.53 2.46 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 130.6 3.56 . . . . 0.0 109.87 176.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.9 m -69.48 142.27 53.78 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 129.045 2.938 . . . . 0.0 109.308 171.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.5 m -94.86 119.08 32.84 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 126.103 2.127 . . . . 0.0 106.105 168.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.38 137.12 47.72 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 175.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -104.9 120.57 41.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.569 2.348 . . . . 0.0 107.253 178.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -92.49 115.52 28.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 110.71 -2.95 . . . . 0.0 109.089 166.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.444 HG23 HG12 ' A' ' 44' ' ' ILE . 82.8 t -74.38 109.87 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 159.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.218 -0.576 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 165.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 115.765 -2.064 . . . . 0.0 107.739 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -86.5 140.44 29.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -167.803 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.398 7.4 pt -131.77 172.97 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 128.686 2.794 . . . . 0.0 115.561 162.576 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -126.85 135.45 51.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 127.164 2.79 . . . . 0.0 103.679 -175.317 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.275 79.6 t -126.92 121.47 58.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.978 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 68' ' ' HIS 0.255 35.1 tttp -97.47 156.05 16.66 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 129.583 3.153 . . . . 0.0 103.8 -172.918 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -134.48 146.2 49.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.183 -178.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.7 mt -68.52 -22.59 64.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 117.906 -2.996 . . . . 0.0 111.403 -176.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 p -82.04 -18.49 43.04 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.504 2.322 . . . . 0.0 109.002 -172.654 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.47 31.45 0.78 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-O 116.624 -2.209 . . . . 0.0 112.981 151.14 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.311 41.5 pttt -133.43 160.87 36.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.039 3.336 . . . . 0.0 110.212 -179.399 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -122.08 135.53 54.82 Favored 'General case' 0 N--CA 1.449 -0.514 1 N-CA-C 99.739 -4.171 . . . . 0.0 99.739 164.73 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 pt -97.99 152.43 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 118.806 -2.434 . . . . 0.0 105.165 168.616 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.1 m -96.83 150.14 21.06 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 128.741 3.776 . . . . 0.0 107.656 166.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.85 157.36 46.94 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.009 2.123 . . . . 0.0 107.288 179.816 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -134.27 101.4 5.0 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.475 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.44 145.31 25.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 129.458 3.103 . . . . 0.0 112.646 -172.773 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -85.29 135.18 39.31 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.768 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.83 -37.62 2.45 Favored 'Trans proline' 0 N--CA 1.454 -0.841 1 C-N-CA 126.971 5.114 . . . . 0.0 117.639 -178.334 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 p -103.13 9.61 38.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 119.566 3.172 . . . . 0.0 119.566 -179.494 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -72.55 137.71 46.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 118.138 -2.851 . . . . 0.0 104.035 170.194 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -75.95 162.03 28.44 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 129.693 3.197 . . . . 0.0 113.809 172.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.1 mm -53.12 -36.45 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.258 2.223 . . . . 0.0 113.891 -174.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.305 4.8 tp10 -55.89 -38.6 70.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.83 2.052 . . . . 0.0 115.526 173.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -66.99 -43.66 82.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 125.932 2.02 . . . . 0.0 112.756 176.225 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.263 22.8 t -52.84 -52.76 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.836 2.054 . . . . 0.0 110.2 174.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -58.79 -42.08 88.22 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 125.667 1.854 . . . . 0.0 111.916 -179.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.48 72.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 116.462 -1.732 . . . . 0.0 112.572 177.371 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -76.41 -33.48 58.82 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 122.784 2.538 . . . . 0.0 111.457 178.586 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.58 -43.43 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 129.895 3.278 . . . . 0.0 110.698 174.394 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.48 -52.9 62.59 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 125.309 1.443 . . . . 0.0 112.416 175.722 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -52.71 -39.43 62.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 131.237 3.815 . . . . 0.0 111.977 -179.082 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -87.83 -50.69 6.29 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 127.688 3.117 . . . . 0.0 115.808 -178.894 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.3 -6.29 12.96 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 128.075 2.55 . . . . 0.0 115.357 -166.237 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.0 -16.6 35.98 Favored Glycine 0 CA--C 1.533 1.158 1 C-N-CA 130.821 4.058 . . . . 0.0 110.181 156.453 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.08 121.94 86.34 Favored Pre-proline 0 N--CA 1.444 -0.763 0 O-C-N 119.468 -2.195 . . . . 0.0 110.388 -164.089 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.26 148.94 56.54 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 122.994 2.463 . . . . 0.0 111.244 179.164 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.68 -32.14 95.33 Favored 'Trans proline' 0 N--CA 1.447 -1.238 1 C-N-CA 125.363 4.042 . . . . 0.0 116.614 -163.065 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.253 51.3 m-20 -73.18 -4.34 32.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.007 2.123 . . . . 0.0 115.49 176.165 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -108.82 -12.16 14.94 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 171.613 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.83 162.37 21.66 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.699 -0.8 . . . . 0.0 113.027 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.276 0.1 OUTLIER -151.71 102.93 2.9 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 118.308 -2.745 . . . . 0.0 106.475 175.21 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.2 mt -87.04 113.55 22.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 127.576 3.048 . . . . 0.0 114.732 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.8 mt -120.56 138.89 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 131.551 3.941 . . . . 0.0 106.558 -168.102 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -155.34 -176.68 6.07 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.098 -2.876 . . . . 0.0 105.97 -172.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.04 112.67 1.41 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 124.638 2.161 . . . . 0.0 110.026 -168.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.82 -78.54 0.3 Allowed Glycine 0 CA--C 1.532 1.137 0 N-CA-C 107.03 -2.428 . . . . 0.0 107.03 -175.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -165.74 -171.99 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.965 2.506 . . . . 0.0 104.959 -161.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.81 148.85 45.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 130.994 3.718 . . . . 0.0 110.034 -177.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.37 147.39 22.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 122.863 1.316 . . . . 0.0 111.907 176.148 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -111.55 157.72 20.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 111.663 -2.517 . . . . 0.0 115.556 -175.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -72.98 135.53 44.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 130.84 3.656 . . . . 0.0 112.381 -171.68 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.5 -28.35 10.96 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 169.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -71.74 159.26 34.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 116.605 -1.664 . . . . 0.0 110.36 -179.006 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 p -113.28 -178.46 3.38 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.358 2.263 . . . . 0.0 109.567 171.148 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.0 -31.25 68.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 125.192 1.557 . . . . 0.0 114.255 179.197 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.3 p -77.42 -33.31 54.97 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.15 -37.83 75.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 124.508 1.13 . . . . 0.0 110.883 177.261 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.73 -0.58 57.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.026 -1.046 . . . . 0.0 113.627 -175.076 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 77.94 42.83 0.1 Allowed 'General case' 0 C--N 1.324 -0.51 1 C-N-CA 134.045 4.938 . . . . 0.0 109.072 167.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -100.03 95.35 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 103.258 -2.868 . . . . 0.0 103.258 -175.34 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.66 163.74 26.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.624 -1.298 . . . . 0.0 110.162 160.459 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -45.41 147.3 0.83 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 131.095 3.758 . . . . 0.0 114.04 175.37 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 59.41 33.84 22.5 Favored 'General case' 0 N--CA 1.448 -0.566 1 C-N-CA 132.847 4.459 . . . . 0.0 106.901 172.29 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -93.68 152.21 19.13 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 117.511 -3.243 . . . . 0.0 106.861 175.739 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.6 m -99.67 130.28 45.88 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.932 1.395 . . . . 0.0 110.56 175.177 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mp -102.78 161.49 13.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 102.088 -3.301 . . . . 0.0 102.088 163.434 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -114.83 123.42 49.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 172.752 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -90.14 122.0 32.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 118.677 -2.514 . . . . 0.0 111.57 167.302 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.67 156.4 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.925 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.268 16.0 mt . . . . . 0 N--CA 1.444 -0.739 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.399 -169.807 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptt? . . . . . 0 C--O 1.223 -0.317 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -88.45 148.69 24.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 117.518 -3.239 . . . . 0.0 105.705 -177.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -127.2 143.29 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 128.925 2.89 . . . . 0.0 107.268 159.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -104.07 134.41 47.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.197 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.23 126.93 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 117.74 -1.124 . . . . 0.0 109.413 -168.047 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -116.68 116.45 27.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 122.162 2.256 . . . . 0.0 112.853 -165.703 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 p -74.06 158.59 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.201 1.4 . . . . 0.0 109.98 -178.88 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.5 tp -59.78 -40.47 88.37 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.682 1.993 . . . . 0.0 107.223 -166.792 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.6 p -80.7 2.2 26.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.89 -3.007 . . . . 0.0 118.607 176.408 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.91 -7.7 16.96 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 119.157 2.423 . . . . 0.0 119.157 152.815 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -75.67 122.86 24.61 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.281 1.433 . . . . 0.0 107.251 -177.086 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.321 73.1 m -81.86 138.16 35.11 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.19 0.995 . . . . 0.0 109.754 170.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -122.12 141.86 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 129.807 3.243 . . . . 0.0 103.379 172.917 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 m -96.88 120.05 36.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.943 2.497 . . . . 0.0 112.307 170.165 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.2 mt -106.17 136.27 46.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.084 1.754 . . . . 0.0 110.437 171.158 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -92.17 140.28 29.78 Favored 'General case' 0 CA--C 1.535 0.401 1 O-C-N 129.863 4.477 . . . . 0.0 104.235 172.058 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -153.9 168.66 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 129.256 3.022 . . . . 0.0 105.278 -174.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.9 mt-10 -116.45 159.69 39.08 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 129.094 2.958 . . . . 0.0 107.81 172.769 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 18' ' ' GLU 0.297 86.7 Cg_endo -57.86 -29.58 86.69 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.568 3.512 . . . . 0.0 116.515 172.237 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -95.88 11.18 34.67 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 130.769 3.628 . . . . 0.0 108.398 -166.889 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.29 2.6 m-20 -92.92 146.8 23.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 115.835 -2.031 . . . . 0.0 111.533 -176.038 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 24' ' ' GLU . 2.4 t -86.13 151.83 23.35 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 120.338 1.427 . . . . 0.0 112.262 173.72 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.258 62.6 mt -65.12 -31.24 53.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 118.367 -2.708 . . . . 0.0 108.826 -171.069 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 22' ' ' THR . 1.0 OUTLIER -63.15 -40.44 97.57 Favored 'General case' 0 N--CA 1.452 -0.366 2 O-C-N 114.325 -5.234 . . . . 0.0 113.824 176.515 . . . . . . . . 4 4 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -68.44 -31.0 70.01 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 128.532 2.733 . . . . 0.0 111.8 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 t -59.64 -51.94 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 122.496 2.407 . . . . 0.0 110.278 163.448 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -68.03 -40.55 82.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.973 2.909 . . . . 0.0 112.051 -164.053 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -17.94 64.8 Favored 'General case' 0 N--CA 1.446 -0.655 1 C-N-CA 132.765 4.426 . . . . 0.0 113.982 177.45 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -65.08 -31.64 72.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 130.554 3.542 . . . . 0.0 110.661 176.399 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 mm -74.05 -16.74 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 O-C-N 124.948 1.405 . . . . 0.0 114.164 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.281 6.1 tp60 -66.89 -38.12 85.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 117.251 -3.406 . . . . 0.0 111.441 169.723 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.66 -47.67 74.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.811 1.244 . . . . 0.0 110.708 168.612 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.85 -75.33 0.16 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 115.577 -2.154 . . . . 0.0 114.498 -175.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -101.24 -20.06 15.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 127.944 3.278 . . . . 0.0 115.171 -161.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.96 6.34 26.34 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 130.345 3.831 . . . . 0.0 114.51 162.811 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.59 124.02 54.32 Favored Pre-proline 0 N--CA 1.448 -0.555 0 O-C-N 126.728 2.075 . . . . 0.0 105.854 -164.176 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -68.24 172.81 10.49 Favored 'Trans proline' 0 N--CA 1.451 -1.003 1 C-N-CA 126.424 4.75 . . . . 0.0 116.16 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.85 -42.59 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 1 C-N-CA 126.943 5.096 . . . . 0.0 107.622 177.266 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.88 -15.32 62.62 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 130.725 3.61 . . . . 0.0 115.978 -174.57 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.257 38.0 tt0 -103.59 -34.57 8.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 118.101 -1.439 . . . . 0.0 113.887 171.572 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.05 135.01 21.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.745 1.618 . . . . 0.0 115.329 169.017 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -136.14 158.34 44.65 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 119.158 -2.214 . . . . 0.0 107.702 168.44 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.8 mt -129.63 152.24 49.36 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 127.87 3.231 . . . . 0.0 108.952 -167.602 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 mt -135.94 129.49 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 127.797 2.439 . . . . 0.0 107.142 169.871 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -120.28 118.33 30.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 130.359 3.464 . . . . 0.0 105.338 173.205 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.87 50.64 11.09 Favored 'General case' 0 C--O 1.22 -0.472 1 C-N-CA 133.797 4.839 . . . . 0.0 111.568 170.983 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.46 -13.92 60.93 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.787 -1.007 . . . . 0.0 111.591 173.344 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 mtmt -105.93 119.75 39.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 130.988 3.715 . . . . 0.0 109.06 -172.812 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -76.36 151.83 36.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 128.526 2.731 . . . . 0.0 104.559 172.164 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.282 0.8 OUTLIER -140.15 132.3 28.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.669 2.787 . . . . 0.0 111.11 177.768 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.258 71.9 mm-40 -87.61 162.3 17.23 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 125.188 2.423 . . . . 0.0 110.116 172.222 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.35 162.06 18.37 Favored 'General case' 0 N--CA 1.45 -0.468 1 C-N-CA 134.882 5.273 . . . . 0.0 109.02 173.898 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.57 14.46 32.28 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 119.687 2.635 . . . . 0.0 119.687 173.591 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -157.55 163.95 37.84 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.876 2.07 . . . . 0.0 111.958 177.797 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.6 p -85.47 149.43 25.4 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 130.354 3.462 . . . . 0.0 108.456 -173.106 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.543 HD22 HD13 ' A' ' 61' ' ' ILE . 20.0 mt -65.2 -34.93 79.55 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.522 1.529 . . . . 0.0 109.556 -171.334 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.29 66.5 p -36.59 -56.98 0.8 Allowed 'General case' 0 N--CA 1.449 -0.513 1 C-N-CA 133.966 4.906 . . . . 0.0 113.8 173.944 . . . . . . . . 3 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.86 -27.25 66.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 130.713 3.605 . . . . 0.0 116.156 -177.563 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -101.14 2.73 40.49 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.412 2.285 . . . . 0.0 110.846 179.603 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.362 24.3 p30 69.13 29.43 4.7 Favored 'General case' 0 N--CA 1.444 -0.772 1 C-N-CA 131.819 4.047 . . . . 0.0 113.161 168.332 . . . . . . . . 3 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.543 HD13 HD22 ' A' ' 56' ' ' LEU . 25.8 mt -83.68 127.14 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.446 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -115.57 178.83 4.16 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 130.255 3.422 . . . . 0.0 107.304 -174.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.56 135.26 46.39 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 128.689 2.796 . . . . 0.0 111.261 168.132 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 61.49 27.6 17.11 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 129.552 3.141 . . . . 0.0 116.683 176.766 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -62.98 147.86 49.33 Favored 'General case' 0 C--N 1.328 -0.369 1 O-C-N 115.423 -4.548 . . . . 0.0 109.959 171.608 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.8 p -113.69 108.3 16.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.554 1.941 . . . . 0.0 107.383 -176.688 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.57 150.64 28.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 123.817 1.77 . . . . 0.0 112.738 177.894 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -87.77 139.95 30.01 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 128.956 2.902 . . . . 0.0 104.654 169.281 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.68 120.9 40.06 Favored 'General case' 0 C--N 1.325 -0.493 1 N-CA-C 96.73 -5.285 . . . . 0.0 96.73 170.544 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 m -132.67 165.97 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 128.222 2.609 . . . . 0.0 108.367 170.176 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 C--N 1.324 -0.539 0 C-N-CA 127.805 2.442 . . . . 0.0 116.025 -174.491 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttm . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.446 HE21 ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -111.77 144.9 40.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.233 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.372 34.2 pt -132.37 162.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 130.189 3.396 . . . . 0.0 116.57 169.376 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -107.89 131.58 54.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.647 1.979 . . . . 0.0 109.858 178.41 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 30' ' ' ILE . 19.2 t -100.32 118.0 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 129.031 2.933 . . . . 0.0 105.866 159.724 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.391 71.9 tttt -112.48 123.25 49.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 -174.437 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -88.74 151.56 22.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 110.113 -3.221 . . . . 0.0 107.968 174.652 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mt -67.88 -24.21 65.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 127.172 2.795 . . . . 0.0 109.869 172.37 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -81.24 -18.43 46.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 118.526 -2.609 . . . . 0.0 111.104 -171.332 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.31 -6.17 7.18 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 128.129 2.776 . . . . 0.0 115.11 156.427 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.251 17.1 pttt -82.36 143.21 31.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.349 1.46 . . . . 0.0 111.203 -175.743 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 p -97.26 143.42 28.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 125.796 2.712 . . . . 0.0 107.671 164.629 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.6 mt -122.75 143.03 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 110.347 -3.115 . . . . 0.0 103.171 172.804 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 m -100.22 132.64 45.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.081 2.552 . . . . 0.0 110.875 172.996 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -120.38 133.08 55.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.222 3.009 . . . . 0.0 110.406 170.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -93.75 112.73 24.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.278 1.831 . . . . 0.0 109.063 170.287 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.79 175.64 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 127.975 2.51 . . . . 0.0 109.627 -176.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -132.13 159.33 72.61 Favored Pre-proline 0 N--CA 1.451 -0.399 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 159.178 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 46.0 Cg_endo -74.93 -8.94 20.62 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 123.214 2.609 . . . . 0.0 114.228 -170.652 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 p -68.64 -31.35 70.42 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.884 2.873 . . . . 0.0 114.627 167.577 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.9 131.93 41.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 117.181 -3.449 . . . . 0.0 113.978 174.489 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.0 p -73.06 157.37 37.46 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 127.085 2.154 . . . . 0.0 112.301 173.406 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.295 1.9 mp -36.2 -42.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 129.414 3.086 . . . . 0.0 115.202 154.804 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -73.03 -37.68 66.81 Favored 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 133.557 4.743 . . . . 0.0 116.561 169.517 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -63.18 -36.38 83.44 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.794 2.088 . . . . 0.0 110.89 165.862 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.1 t -69.65 -39.4 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 1 O-C-N 115.034 -4.791 . . . . 0.0 114.292 178.134 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -61.04 -38.71 87.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.914 1.686 . . . . 0.0 115.058 168.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.25 -54.51 14.37 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 130.626 3.571 . . . . 0.0 107.581 174.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -55.35 -42.38 73.79 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 5' ' ' VAL . 46.1 mt -64.08 -43.95 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.512 1.125 . . . . 0.0 111.173 169.205 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -58.59 -32.61 69.12 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.965 2.506 . . . . 0.0 112.446 178.3 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.268 0.9 OUTLIER -58.21 -37.79 75.52 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 119.536 -1.977 . . . . 0.0 111.357 169.941 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -87.5 -45.41 10.51 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.151 2.581 . . . . 0.0 106.833 -169.854 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.16 -17.51 13.2 Favored 'General case' 0 N--CA 1.451 -0.4 1 N-CA-C 124.846 5.128 . . . . 0.0 124.846 -174.516 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.79 -2.09 81.06 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 125.534 1.54 . . . . 0.0 114.489 172.693 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.7 mt -76.04 138.49 68.91 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 127.446 2.298 . . . . 0.0 109.846 -174.554 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.36 133.73 41.7 Favored 'Trans proline' 0 N--CA 1.45 -1.061 1 C-N-CA 126.363 4.709 . . . . 0.0 116.611 179.117 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -43.54 -44.74 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.698 1 C-N-CA 131.883 8.389 . . . . 0.0 111.502 173.825 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.358 2.4 t70 -38.7 -44.12 0.97 Allowed 'General case' 0 C--O 1.234 0.275 1 C-N-CA 133.826 4.85 . . . . 0.0 113.087 169.117 . . . . . . . . 3 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -96.66 -25.71 15.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.649 1.98 . . . . 0.0 108.926 -171.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -81.41 111.75 18.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -166.181 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -102.81 124.94 49.28 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 100.94 -3.726 . . . . 0.0 100.94 177.812 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.57 120.06 34.72 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 127.23 2.831 . . . . 0.0 107.435 175.032 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mt -122.35 154.12 27.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 126.273 2.233 . . . . 0.0 105.347 -169.064 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.283 67.8 t80 -143.32 128.21 18.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 115.26 -2.305 . . . . 0.0 110.472 160.716 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.36 20.3 6.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.145 2.178 . . . . 0.0 112.674 167.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.02 -8.6 63.22 Favored Glycine 0 CA--C 1.526 0.741 1 O-C-N 115.853 -4.279 . . . . 0.0 111.667 -178.59 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -102.66 155.23 18.44 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 124.988 2.328 . . . . 0.0 115.357 173.388 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -94.04 129.81 40.41 Favored 'General case' 0 N--CA 1.446 -0.643 1 N-CA-C 100.123 -4.028 . . . . 0.0 100.123 174.759 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.58 133.88 53.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 127.074 2.15 . . . . 0.0 107.701 167.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -69.86 134.62 48.67 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 115.298 -2.287 . . . . 0.0 112.796 177.836 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.294 5.6 t0 -93.21 132.99 36.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 126.224 2.916 . . . . 0.0 109.135 168.569 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.58 8.06 23.3 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 119.059 -2.275 . . . . 0.0 112.925 -159.721 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt-85 -136.98 178.19 7.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 120.476 2.138 . . . . 0.0 106.677 -177.575 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.8 p -110.78 172.42 6.88 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 129.808 3.243 . . . . 0.0 112.509 -176.901 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 5.4 mt -61.32 -46.78 88.87 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 119.178 -2.202 . . . . 0.0 109.113 168.164 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -56.32 -31.58 63.85 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 174.441 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.71 -29.72 70.29 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.87 2.068 . . . . 0.0 109.885 -178.323 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -102.16 12.23 37.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 124.106 1.908 . . . . 0.0 112.827 177.13 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.338 0.6 OUTLIER 84.14 1.7 0.9 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.728 2.011 . . . . 0.0 113.982 172.039 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.14 71.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.98 2.112 . . . . 0.0 108.8 179.28 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -81.07 -32.51 33.95 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.997 2.519 . . . . 0.0 113.902 166.565 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -149.54 118.45 6.67 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 118.779 -2.45 . . . . 0.0 114.022 -179.798 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 47.47 99.92 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.891 1 C-N-CA 135.198 5.399 . . . . 0.0 113.295 157.579 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -143.17 174.39 10.74 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 117.06 -3.525 . . . . 0.0 108.942 -177.235 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -121.81 147.88 45.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 116.758 -3.714 . . . . 0.0 104.527 171.78 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.5 mt -115.11 144.01 44.32 Favored 'General case' 0 N--CA 1.447 -0.578 1 C-N-CA 131.976 4.11 . . . . 0.0 111.354 174.42 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -100.89 117.08 34.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 101.069 -3.678 . . . . 0.0 101.069 -175.711 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.5 tp -100.87 129.48 46.74 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.463 1.105 . . . . 0.0 108.997 167.58 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.405 0.2 OUTLIER -131.02 156.94 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 O-C-N 125.996 2.06 . . . . 0.0 109.284 165.547 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.1 tp . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 127.297 3.427 . . . . 0.0 107.495 174.769 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 123.52 1.629 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -94.79 124.73 39.0 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 117.584 -3.197 . . . . 0.0 106.051 175.57 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -108.08 161.88 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 102.981 -2.97 . . . . 0.0 102.981 164.542 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -101.9 141.75 34.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 116.0 -1.952 . . . . 0.0 114.073 157.777 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 t -110.31 115.36 49.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 163.746 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -83.16 107.0 15.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.227 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.285 1.2 p -74.0 156.13 37.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.768 2.827 . . . . 0.0 109.476 174.748 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.5 tp -54.62 -37.67 65.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 130.152 3.381 . . . . 0.0 116.449 -159.986 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -66.62 -24.05 66.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 113.006 -3.378 . . . . 0.0 115.235 177.303 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.22 -35.25 3.01 Favored Glycine 0 CA--C 1.531 1.036 1 CA-C-O 112.101 -4.722 . . . . 0.0 111.415 -164.397 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.21 139.01 58.72 Favored 'General case' 0 N--CA 1.448 -0.566 1 O-C-N 131.292 4.76 . . . . 0.0 104.679 -175.423 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -116.65 129.73 56.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 128.165 2.586 . . . . 0.0 109.255 173.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 pt -113.77 143.78 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.503 167.472 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.9 m -90.65 130.38 36.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 128.337 2.655 . . . . 0.0 106.68 176.373 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.35 109.57 18.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.985 2.114 . . . . 0.0 106.871 179.086 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -71.84 112.45 7.95 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 128.945 3.903 . . . . 0.0 107.832 168.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 m -135.4 166.25 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 128.231 2.612 . . . . 0.0 109.085 -177.197 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -116.48 161.57 31.06 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 116.456 -1.735 . . . . 0.0 108.762 168.674 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -65.13 -19.49 63.03 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 124.682 3.588 . . . . 0.0 113.224 178.333 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.6 p -69.8 -26.16 64.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 113.379 -3.2 . . . . 0.0 112.3 172.068 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.93 133.85 26.42 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 128.948 2.899 . . . . 0.0 112.222 -177.717 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 p -83.61 148.65 27.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 116.055 -1.926 . . . . 0.0 111.509 175.375 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 23' ' ' ILE . 6.0 mm -48.11 -42.77 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 125.388 3.722 . . . . 0.0 111.274 168.404 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -40.98 -65.76 0.4 Allowed 'General case' 0 N--CA 1.445 -0.686 1 C-N-CA 131.703 4.001 . . . . 0.0 112.884 163.107 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -35.43 80.23 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 123.239 0.337 . . . . 0.0 110.613 179.653 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.29 68.7 t -57.04 -48.34 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 116.79 -1.576 . . . . 0.0 115.153 168.908 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -46.71 -34.37 5.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 125.559 3.8 . . . . 0.0 117.543 161.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -28.04 59.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 123.792 1.758 . . . . 0.0 112.725 177.628 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -79.7 -44.45 20.8 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 118.564 -2.585 . . . . 0.0 112.709 172.479 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mt -48.67 -49.17 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 120.732 1.605 . . . . 0.0 111.25 170.5 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -54.98 -53.77 51.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 167.2 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.88 -41.28 91.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 123.229 2.74 . . . . 0.0 109.65 -175.164 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -76.17 -27.78 57.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 118.34 2.719 . . . . 0.0 118.34 179.916 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.294 21.0 mm-40 -140.11 2.96 1.95 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 122.903 2.592 . . . . 0.0 109.97 -175.734 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.42 -3.54 86.44 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 117.937 -2.977 . . . . 0.0 116.495 162.925 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.61 146.65 61.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 115.568 -2.158 . . . . 0.0 107.136 -167.396 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -78.11 132.27 11.44 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.062 3.175 . . . . 0.0 103.932 -178.081 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.77 -18.34 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 CA-C-N 124.098 2.499 . . . . 0.0 112.84 -170.413 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.34 -22.42 44.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 118.006 -1.477 . . . . 0.0 114.831 -170.111 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -82.76 -16.67 47.02 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.633 1.973 . . . . 0.0 114.432 172.396 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -73.87 130.22 39.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.623 1.969 . . . . 0.0 111.967 174.418 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -96.16 144.81 26.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.927 2.491 . . . . 0.0 107.323 155.585 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.1 tp -142.93 115.03 8.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 130.538 3.535 . . . . 0.0 111.088 -164.946 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 46.5 pt -134.74 142.83 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 1 C-N-CA 132.336 4.254 . . . . 0.0 114.045 -159.052 . . . . . . . . 3 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -138.02 96.55 3.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.199 2.6 . . . . 0.0 105.79 178.451 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 77.25 21.66 1.05 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.12 -1.612 . . . . 0.0 107.716 162.064 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.36 -40.4 2.46 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 119.642 -1.266 . . . . 0.0 113.883 -175.157 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.319 51.1 mttm -82.04 132.53 35.25 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 119.257 -2.319 . . . . 0.0 110.916 -171.883 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -82.01 128.27 33.93 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.296 0.953 . . . . 0.0 109.422 170.992 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -82.19 115.92 21.51 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 178.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -75.96 135.95 40.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.143 -3.473 . . . . 0.0 107.511 -177.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.0 119.9 7.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.24 2.216 . . . . 0.0 111.652 178.363 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.47 6.51 41.28 Favored Glycine 0 CA--C 1.525 0.685 1 C-N-CA 130.906 4.098 . . . . 0.0 114.617 171.146 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -86.32 154.11 21.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 125.423 1.307 . . . . 0.0 110.421 169.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.7 p -76.86 145.02 38.62 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 127.027 2.704 . . . . 0.0 115.522 171.438 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.6 mt -59.51 -29.96 68.25 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.947 2.499 . . . . 0.0 112.473 172.602 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.7 t -52.44 -59.04 4.91 Favored 'General case' 0 N--CA 1.446 -0.626 1 C-N-CA 132.821 4.448 . . . . 0.0 110.515 168.503 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -50.55 -41.69 54.38 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 118.827 2.899 . . . . 0.0 118.827 170.093 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -88.53 -0.62 57.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.136 0.88 . . . . 0.0 109.951 -179.859 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m120 62.26 39.1 12.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 129.316 3.046 . . . . 0.0 115.155 -175.442 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 mm -85.81 121.84 37.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -171.425 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -103.75 169.01 8.77 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 111.593 -2.549 . . . . 0.0 114.556 -176.179 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -58.73 135.1 57.35 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 112.37 -3.681 . . . . 0.0 113.065 -176.333 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.1 19.12 11.73 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.521 3.129 . . . . 0.0 116.253 -178.559 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -70.17 141.66 52.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.725 3.21 . . . . 0.0 109.485 160.729 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.3 m -107.52 129.33 54.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 175.804 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -97.69 154.18 17.74 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 129.525 3.13 . . . . 0.0 106.846 171.049 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -125.27 163.85 21.61 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.801 2.04 . . . . 0.0 110.861 -175.158 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -134.72 160.09 39.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.103 -2.317 . . . . 0.0 116.326 -176.216 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.413 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 23.0 t -151.83 150.68 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 128.387 3.554 . . . . 0.0 105.982 166.512 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.259 53.2 mt . . . . . 0 N--CA 1.443 -0.811 0 O-C-N 119.121 -2.237 . . . . 0.0 111.453 176.483 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' OE2' ' A' ' 16' ' ' GLU 0.251 45.7 ttp . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -81.55 156.68 25.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 178.535 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 pt -146.24 174.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 1 O-C-N 129.204 4.065 . . . . 0.0 105.944 174.173 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -131.06 153.38 49.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 117.167 -1.397 . . . . 0.0 110.309 164.024 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -130.12 114.74 30.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 101.699 -3.445 . . . . 0.0 101.699 172.001 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -80.99 133.96 35.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.166 2.186 . . . . 0.0 106.244 174.452 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 p -75.13 175.48 8.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 129.977 3.311 . . . . 0.0 111.772 164.944 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.88 -9.21 49.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 118.151 -2.843 . . . . 0.0 110.671 172.044 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 p -99.57 4.31 45.79 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.777 -179.441 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.74 -25.34 7.64 Favored Glycine 0 CA--C 1.531 1.061 1 C-N-CA 131.902 4.573 . . . . 0.0 109.389 159.148 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 pttt -82.71 134.0 35.15 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 -153.502 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 m -95.36 110.63 22.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.275 1.83 . . . . 0.0 114.55 -178.333 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.74 120.82 35.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 118.648 -2.532 . . . . 0.0 105.738 -176.39 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -77.47 121.24 23.56 Favored 'General case' 0 C--N 1.324 -0.519 1 O-C-N 114.558 -5.089 . . . . 0.0 103.508 175.91 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.299 69.3 mt -125.02 152.58 44.06 Favored 'General case' 0 N--CA 1.446 -0.645 1 CA-C-N 126.294 4.134 . . . . 0.0 108.059 169.97 . . . . . . . . 3 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.444 ' OE2' ' N ' ' A' ' 1' ' ' MET . 32.0 tp10 -99.88 132.43 45.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 173.353 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.77 167.0 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 127.426 3.489 . . . . 0.0 105.72 172.512 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.41 140.13 28.71 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 110.747 -2.933 . . . . 0.0 106.408 155.518 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.363 46.3 Cg_endo -59.93 -4.48 2.88 Favored 'Trans proline' 0 N--CA 1.45 -1.032 1 C-N-CA 126.742 4.961 . . . . 0.0 117.005 -173.052 . . . . . . . . 3 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 p -88.58 -6.34 57.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 113.239 -3.267 . . . . 0.0 114.591 165.468 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.47 140.44 55.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 125.971 2.045 . . . . 0.0 106.777 179.691 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.6 p -73.93 163.37 28.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 116.527 -1.701 . . . . 0.0 109.631 170.891 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.0 mm -60.93 -37.14 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 124.211 1.958 . . . . 0.0 107.086 175.508 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.395 0.0 OUTLIER -46.2 -45.03 16.63 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 118.322 -2.736 . . . . 0.0 115.348 171.357 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -67.88 -33.89 75.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.041 2.536 . . . . 0.0 109.126 -179.909 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.258 89.0 t -67.88 -52.92 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 126.169 1.787 . . . . 0.0 113.079 166.707 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -48.67 -41.14 30.51 Favored 'General case' 0 N--CA 1.442 -0.842 1 N-CA-C 122.123 4.119 . . . . 0.0 122.123 171.398 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.25 -35.32 66.21 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.721 2.008 . . . . 0.0 112.506 176.429 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.3 mttt -67.56 -30.8 70.52 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 176.784 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -70.92 -43.49 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 130.359 3.464 . . . . 0.0 109.655 170.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -51.83 -55.34 20.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 125.806 2.717 . . . . 0.0 113.566 168.114 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.19 -27.49 62.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.552 3.141 . . . . 0.0 113.925 -173.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -97.7 -66.52 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 119.45 -2.032 . . . . 0.0 110.993 172.51 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -92.01 -17.85 24.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 120.935 1.698 . . . . 0.0 113.392 -165.381 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.83 -10.95 32.3 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 116.765 -3.709 . . . . 0.0 119.33 172.276 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 73.6 mt -86.07 129.39 54.18 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 117.541 -3.329 . . . . 0.0 112.043 -160.428 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 20.4 Cg_endo -76.95 137.96 18.03 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 125.281 3.987 . . . . 0.0 111.719 -166.761 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -39.56 -53.47 2.23 Favored 'Trans proline' 0 N--CA 1.446 -1.318 1 C-N-CA 126.863 5.042 . . . . 0.0 111.985 172.408 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.37 10.06 2.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 124.558 3.344 . . . . 0.0 113.464 -172.335 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -103.85 -28.8 11.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.602 1.191 . . . . 0.0 113.367 162.318 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.38 149.74 30.09 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 120.295 -1.503 . . . . 0.0 113.658 -168.13 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -135.04 118.91 17.29 Favored 'General case' 0 N--CA 1.451 -0.388 1 C-N-CA 132.164 4.186 . . . . 0.0 109.131 164.552 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.266 59.9 mt -100.0 132.16 45.52 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.692 0.797 . . . . 0.0 112.462 167.597 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.2 mm -109.63 124.75 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 101.068 -3.678 . . . . 0.0 101.068 -175.586 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -117.79 113.89 22.48 Favored 'General case' 0 N--CA 1.444 -0.761 1 N-CA-C 98.63 -4.582 . . . . 0.0 98.63 174.557 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.22 52.36 8.68 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 111.353 -2.658 . . . . 0.0 117.376 170.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -0.88 81.22 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 116.883 -2.065 . . . . 0.0 111.673 167.183 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -126.96 154.12 44.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.0 1.32 . . . . 0.0 111.166 177.996 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -91.89 118.47 30.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 110.137 -3.21 . . . . 0.0 105.001 -175.077 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -67.18 123.91 21.6 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.202 2.201 . . . . 0.0 107.472 172.719 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -85.65 143.19 28.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -71.66 155.66 40.25 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 126.107 2.129 . . . . 0.0 110.635 -171.299 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.29 -2.98 85.48 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 128.187 2.803 . . . . 0.0 114.507 174.414 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.376 0.9 OUTLIER -99.8 164.76 11.9 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.506 1.522 . . . . 0.0 109.615 173.893 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 64.8 p -99.66 171.49 7.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 126.852 3.215 . . . . 0.0 110.371 169.473 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mp -42.73 -51.98 5.12 Favored 'General case' 0 N--CA 1.446 -0.657 1 C-N-CA 131.772 4.029 . . . . 0.0 114.951 163.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 p -75.17 -12.44 60.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.498 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -80.85 -42.33 21.74 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 119.224 -2.172 . . . . 0.0 107.339 172.888 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.29 10.12 41.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.557 1.943 . . . . 0.0 112.705 -166.352 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.362 71.0 m-80 91.1 12.08 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.192 1.797 . . . . 0.0 114.612 159.843 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.27 55.3 mt -71.33 135.73 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 -171.198 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.523 0.4 OUTLIER -122.86 162.91 21.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.568 2.347 . . . . 0.0 114.404 175.175 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -49.6 126.84 14.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 121.468 1.94 . . . . 0.0 114.46 171.547 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.355 16.3 tt0 81.78 0.42 1.52 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 130.985 3.714 . . . . 0.0 113.212 176.94 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -61.55 145.74 51.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 119.719 -1.863 . . . . 0.0 113.638 166.823 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.3 m -125.79 109.27 12.34 Favored 'General case' 0 N--CA 1.451 -0.417 1 O-C-N 132.394 6.059 . . . . 0.0 110.614 -160.525 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.326 10.9 mp -106.04 170.71 7.75 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 -176.622 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -121.92 142.39 50.33 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.407 3.083 . . . . 0.0 105.641 177.487 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.6 tp -102.51 128.42 49.16 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 -178.043 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -111.88 150.7 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 124.407 1.067 . . . . 0.0 109.204 163.626 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.6 mt . . . . . 0 N--CA 1.444 -0.75 0 O-C-N 117.054 -3.529 . . . . 0.0 114.928 168.984 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 103.593 -2.744 . . . . 0.0 103.593 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -90.47 128.23 36.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 115.658 -2.115 . . . . 0.0 110.241 -172.316 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -116.25 148.74 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 1 CA-C-N 126.012 4.006 . . . . 0.0 109.262 168.596 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -105.76 113.32 26.8 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -172.48 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.8 t -95.14 115.65 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 1 N-CA-C 99.574 -4.232 . . . . 0.0 99.574 168.308 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -99.19 133.03 44.06 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.904 174.111 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p -121.47 140.2 52.49 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -171.882 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 mt -62.66 -40.9 98.5 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.577 2.351 . . . . 0.0 109.994 171.253 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.265 23.8 p -71.53 8.63 1.03 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 176.453 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.58 18.02 2.27 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 117.112 -1.938 . . . . 0.0 112.424 118.581 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -138.42 153.92 48.88 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 129.373 3.069 . . . . 0.0 111.458 -176.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.2 p -99.61 106.16 18.09 Favored 'General case' 0 N--CA 1.446 -0.653 1 C-N-CA 135.148 5.379 . . . . 0.0 109.799 174.935 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 mt -101.84 105.76 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 2 N-CA-C 98.685 -4.561 . . . . 0.0 98.685 -167.75 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 p -92.96 89.25 6.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 119.377 -2.077 . . . . 0.0 113.015 -176.469 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tp -73.54 133.86 43.67 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 131.603 3.961 . . . . 0.0 104.063 -178.211 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -96.33 122.45 39.23 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 129.375 3.07 . . . . 0.0 104.515 168.336 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.3 135.59 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 128.805 2.842 . . . . 0.0 115.761 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.59 149.11 90.71 Favored Pre-proline 0 N--CA 1.45 -0.469 0 O-C-N 119.535 -1.978 . . . . 0.0 106.884 175.532 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.03 15.77 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.87 2.38 . . . . 0.0 113.123 -172.455 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.268 67.4 p -135.41 18.11 3.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 120.867 1.667 . . . . 0.0 113.58 175.575 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -81.04 118.03 22.14 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.747 -167.026 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -88.01 148.4 24.55 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 122.084 2.22 . . . . 0.0 107.427 -165.034 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.429 6.0 mt -45.03 -39.92 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 113.405 -3.188 . . . . 0.0 118.175 -174.395 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.95 -45.08 93.8 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 125.508 1.755 . . . . 0.0 112.739 170.82 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -71.75 -9.16 57.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.848 1.659 . . . . 0.0 110.594 -176.736 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.89 -29.07 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 127.104 2.161 . . . . 0.0 111.88 172.584 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -68.85 -32.36 71.98 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 118.91 -2.369 . . . . 0.0 113.854 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.01 -21.1 47.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 111.982 -2.372 . . . . 0.0 108.519 -176.055 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.31 -39.24 17.91 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 113.039 -3.362 . . . . 0.0 105.925 174.29 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 mt -58.36 -34.46 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 1 CA-C-N 127.394 4.633 . . . . 0.0 115.288 169.358 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -83.6 -3.31 57.59 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.935 2.494 . . . . 0.0 110.018 -176.521 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -101.63 -45.25 5.32 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.184 1.793 . . . . 0.0 106.691 166.164 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.27 48.5 tptt -74.46 -37.58 63.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 117.137 -1.411 . . . . 0.0 110.519 -167.361 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -121.41 -24.85 5.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 123.679 2.945 . . . . 0.0 108.787 -179.923 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.02 14.01 65.36 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 121.994 2.179 . . . . 0.0 110.901 175.025 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -74.04 131.84 80.68 Favored Pre-proline 0 N--CA 1.44 -0.949 0 C-N-CA 128.482 2.713 . . . . 0.0 108.329 169.487 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -78.2 162.65 28.39 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 N-CA-C 116.549 1.711 . . . . 0.0 116.549 -177.492 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.47 -16.54 47.66 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 N-CA-C 119.364 2.794 . . . . 0.0 119.364 -177.084 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -95.95 -2.89 46.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.435 -179.559 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -117.26 -15.39 10.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 112.467 -3.635 . . . . 0.0 115.038 177.517 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -67.55 138.03 56.19 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 130.536 3.534 . . . . 0.0 108.694 174.457 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -127.63 150.96 49.51 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 146.939 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.401 0.8 OUTLIER -139.8 133.78 30.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 173.675 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.55 144.4 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 -165.981 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -125.28 137.9 54.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.019 162.211 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.289 . . 56.92 28.45 14.67 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 169.084 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.71 -17.64 58.74 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 128.919 3.152 . . . . 0.0 112.707 -171.499 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -103.87 122.27 44.8 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 121.522 2.661 . . . . 0.0 109.717 -161.351 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 113.12 6.55 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.421 1.889 . . . . 0.0 107.781 166.0 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.3 mt -71.27 131.55 43.64 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 131.692 3.997 . . . . 0.0 108.198 -172.194 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -106.33 129.35 54.36 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 112.545 -3.597 . . . . 0.0 109.587 176.453 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.66 146.8 24.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 127.405 2.94 . . . . 0.0 109.316 179.029 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.31 -21.01 22.66 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 128.073 2.749 . . . . 0.0 114.762 173.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -88.99 153.77 20.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.418 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.4 p -86.25 175.8 8.28 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 126.251 2.22 . . . . 0.0 112.282 168.993 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.48 -39.9 81.23 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.48 2.712 . . . . 0.0 111.108 176.757 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.3 t -53.05 -51.41 61.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.308 1.843 . . . . 0.0 112.241 179.65 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -46.39 -34.53 4.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 129.546 3.138 . . . . 0.0 115.285 -179.065 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -111.77 -12.42 13.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 125.32 1.638 . . . . 0.0 108.284 -170.989 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.542 ' HA ' HE21 ' A' ' 62' ' ' GLN . 14.1 t-20 82.77 46.11 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.671 1 C-N-CA 131.951 4.1 . . . . 0.0 108.404 166.568 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.262 19.8 mt -98.63 91.54 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 174.617 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.542 HE21 ' HA ' ' A' ' 60' ' ' ASN . 91.1 mm-40 -98.96 -4.12 33.43 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 114.652 -2.594 . . . . 0.0 112.11 -169.762 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER 134.42 161.06 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.862 1 C-N-CA 134.338 5.055 . . . . 0.0 105.702 176.948 . . . . . . . . 4 3 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 71.57 -31.71 0.23 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 114.964 -2.446 . . . . 0.0 113.505 172.29 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.8 m -27.3 133.24 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.547 1 C-N-CA 135.366 5.466 . . . . 0.0 111.872 173.928 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.2 m -89.64 108.52 19.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.613 -1.305 . . . . 0.0 111.159 172.457 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -87.86 154.72 20.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.04 2.536 . . . . 0.0 114.838 162.967 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -125.14 121.17 33.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.817 2.047 . . . . 0.0 106.421 -179.566 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tp -86.96 136.86 32.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 115.872 -2.013 . . . . 0.0 109.522 171.596 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.24 166.59 19.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 126.463 2.352 . . . . 0.0 108.13 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.238 0.456 0 CA-C-N 119.995 1.27 . . . . 0.0 113.655 174.293 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 115.24 -2.314 . . . . 0.0 107.819 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.62 125.56 36.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 128.34 3.525 . . . . 0.0 110.104 179.926 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -122.03 136.87 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 119.422 -2.048 . . . . 0.0 111.935 158.433 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -90.53 133.13 35.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 172.235 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.55 110.64 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 174.269 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -97.77 143.65 28.18 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 128.115 3.384 . . . . 0.0 106.136 -177.572 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -112.97 149.51 33.16 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 129.166 2.987 . . . . 0.0 114.428 177.254 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.87 -34.81 1.02 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.612 2.765 . . . . 0.0 117.869 -171.519 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -74.3 -24.83 59.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 125.329 1.643 . . . . 0.0 112.969 179.398 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.85 -7.68 15.09 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.362 2.41 . . . . 0.0 118.362 -175.172 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.77 145.54 56.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.749 2.02 . . . . 0.0 106.481 173.863 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 m -137.19 132.68 34.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 112.63 -2.077 . . . . 0.0 105.679 -172.079 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mt -93.41 109.42 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 129.904 3.282 . . . . 0.0 107.717 162.494 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -74.75 119.42 18.92 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 128.171 2.588 . . . . 0.0 106.603 162.743 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -128.17 158.43 38.08 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -177.156 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -124.96 121.12 33.53 Favored 'General case' 0 C--O 1.221 -0.424 1 N-CA-C 99.756 -4.164 . . . . 0.0 99.756 -178.009 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -152.18 147.9 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.572 1.949 . . . . 0.0 108.585 -165.325 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' A' ' 21' ' ' ASP 0.263 1.6 tm-20 -84.3 135.94 40.97 Favored Pre-proline 0 C--O 1.219 -0.516 0 O-C-N 125.817 1.948 . . . . 0.0 107.342 173.142 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -56.37 -26.81 64.4 Favored 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 126.384 4.722 . . . . 0.0 110.92 179.386 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.2 p -95.34 6.47 48.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 116.503 -3.873 . . . . 0.0 114.083 -177.497 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 66.1 m-20 -68.18 132.35 47.01 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 111.662 -2.517 . . . . 0.0 111.248 160.704 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -95.52 157.4 15.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 116.635 -1.65 . . . . 0.0 107.335 -173.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.3 mm -36.62 -54.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 112.243 -3.742 . . . . 0.0 109.863 173.786 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -68.93 -23.13 64.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 125.611 3.823 . . . . 0.0 111.248 -170.713 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -77.7 -44.64 27.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 128.185 2.594 . . . . 0.0 110.722 -179.748 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.35 -46.59 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 170.511 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.361 37.9 mtpt -46.73 -49.79 19.05 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 112.912 -1.949 . . . . 0.0 116.105 173.363 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.68 68.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 129.042 2.937 . . . . 0.0 113.223 175.742 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -67.82 -37.51 82.03 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.545 1.938 . . . . 0.0 109.354 173.257 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.91 -30.31 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 121.842 2.11 . . . . 0.0 110.254 168.042 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.72 -35.56 75.14 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 116.769 -1.972 . . . . 0.0 111.705 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.26 -43.85 76.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.565 2.346 . . . . 0.0 109.334 178.787 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.324 12.6 mmtt -66.09 -42.04 89.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 117.037 -3.539 . . . . 0.0 115.451 178.532 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -140.87 -19.49 0.82 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 116.632 -1.652 . . . . 0.0 113.278 -156.372 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.79 5.89 83.41 Favored Glycine 0 CA--C 1.524 0.654 1 CA-C-O 112.78 -4.344 . . . . 0.0 109.314 172.515 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.2 mt -69.08 128.25 92.74 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 123.445 3.623 . . . . 0.0 108.771 174.41 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -54.59 144.87 61.71 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.57 2.18 . . . . 0.0 113.911 173.138 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -72.35 -55.2 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 CA-C-N 123.423 2.258 . . . . 0.0 109.381 -170.006 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.16 -29.64 23.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.621 2.368 . . . . 0.0 112.17 -176.341 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -68.31 -31.86 71.59 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 114.432 -2.699 . . . . 0.0 110.223 179.182 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -73.81 138.9 44.78 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 123.597 2.908 . . . . 0.0 112.474 -173.055 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.42 52.6 mtt180 -104.73 134.08 48.48 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 119.563 -1.961 . . . . 0.0 112.557 141.691 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mp -88.28 114.23 24.68 Favored 'General case' 0 N--CA 1.443 -0.8 1 C-N-CA 134.14 4.976 . . . . 0.0 107.134 174.237 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.8 mt -111.76 140.09 32.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 126.602 1.961 . . . . 0.0 111.551 168.331 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -152.06 148.24 27.45 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 131.421 3.888 . . . . 0.0 105.635 160.829 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.398 . . 69.48 30.28 4.12 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 130.382 3.473 . . . . 0.0 112.773 163.689 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.64 12.9 60.31 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-N 109.678 -3.419 . . . . 0.0 116.148 168.43 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -148.29 164.53 33.73 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 -168.257 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -76.25 130.87 38.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 124.936 2.303 . . . . 0.0 105.726 162.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.45 147.62 35.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.288 -1.778 . . . . 0.0 106.792 165.748 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.82 136.63 43.95 Favored 'General case' 0 C--N 1.324 -0.538 1 C-N-CA 134.624 5.17 . . . . 0.0 110.798 -178.185 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.55 126.16 26.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 130.789 3.635 . . . . 0.0 116.653 -179.361 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.32 -24.89 7.18 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 119.337 -2.102 . . . . 0.0 113.295 -178.288 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -95.09 140.57 29.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 -172.866 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.6 p -70.2 157.15 38.16 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 167.841 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.3 mt -54.57 -33.67 60.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 116.88 -1.533 . . . . 0.0 112.881 168.892 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 p -64.21 -37.59 88.01 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.244 2.218 . . . . 0.0 111.957 174.523 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.66 -29.39 70.39 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.678 2.791 . . . . 0.0 109.723 179.052 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.93 -5.77 30.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.361 1.465 . . . . 0.0 112.852 -173.74 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.378 68.1 m-80 97.31 9.82 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 O-C-N 127.029 2.706 . . . . 0.0 110.738 165.791 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.9 mt -85.83 117.57 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 118.906 -2.371 . . . . 0.0 106.926 -154.171 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.41 23.4 tt0 -90.29 172.27 8.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 112.317 -2.22 . . . . 0.0 111.77 175.569 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.95 140.03 2.83 Favored 'General case' 0 N--CA 1.445 -0.685 1 O-C-N 129.467 4.229 . . . . 0.0 114.603 174.739 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 56.57 38.85 29.93 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.796 2.838 . . . . 0.0 111.696 170.61 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 m -81.69 139.17 35.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 110.044 -3.253 . . . . 0.0 103.263 169.687 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.4 m -103.98 112.46 25.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 114.786 -2.531 . . . . 0.0 105.363 174.662 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.57 159.41 24.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.67 3.188 . . . . 0.0 110.865 -177.041 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -116.82 152.99 33.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -156.485 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tp -137.68 136.47 37.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 119.936 1.243 . . . . 0.0 110.29 179.307 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.1 t -123.31 119.26 57.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 126.244 1.818 . . . . 0.0 109.991 174.583 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 CA--C 1.53 0.195 0 O-C-N 118.946 -2.346 . . . . 0.0 105.089 -179.231 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptt? . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -88.14 154.72 20.23 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 119.691 -1.88 . . . . 0.0 110.412 171.766 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 pt -139.53 159.19 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 130.681 3.592 . . . . 0.0 109.786 160.873 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.51 116.61 29.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 118.486 -2.634 . . . . 0.0 108.42 174.61 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -92.91 136.08 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.798 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -117.8 112.61 20.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.953 1.701 . . . . 0.0 109.564 -173.741 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -62.65 175.68 0.77 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 124.542 2.115 . . . . 0.0 109.176 -178.321 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tt -70.0 -31.69 69.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 117.785 -3.072 . . . . 0.0 114.004 174.519 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.317 18.4 p -81.09 -16.52 52.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 129.845 3.258 . . . . 0.0 109.506 -178.493 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.92 -1.16 30.17 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 117.076 -3.515 . . . . 0.0 111.285 167.259 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.257 70.8 tttt -69.05 156.25 38.97 Favored 'General case' 0 N--CA 1.45 -0.47 2 C-N-CA 132.308 4.243 . . . . 0.0 108.009 173.275 . . . . . . . . 3 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -133.01 130.77 39.89 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 113.632 -3.08 . . . . 0.0 111.339 -170.902 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.1 pt -131.93 139.28 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 129.548 3.139 . . . . 0.0 106.972 173.243 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.4 m -89.51 114.21 25.7 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 173.381 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -95.19 153.7 17.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 126.235 2.209 . . . . 0.0 105.599 167.643 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -116.44 132.29 56.72 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 113.395 -3.193 . . . . 0.0 111.078 169.39 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -153.34 -178.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 102.887 -3.005 . . . . 0.0 102.887 -162.266 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -144.28 156.49 57.55 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 131.218 3.807 . . . . 0.0 102.676 166.542 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -49.14 -28.48 14.4 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 116.147 1.557 . . . . 0.0 116.147 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 p -68.82 -18.98 64.26 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 128.816 2.846 . . . . 0.0 115.726 178.414 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS 0.275 2.0 m-20 -51.29 121.93 7.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 122.567 2.439 . . . . 0.0 112.637 173.386 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 p -65.97 156.49 33.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.632 3.173 . . . . 0.0 109.465 168.684 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.2 mm -61.83 -40.6 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 O-C-N 125.034 1.459 . . . . 0.0 110.637 171.902 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.36 -25.83 60.76 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 122.25 2.295 . . . . 0.0 109.039 -172.771 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.267 16.8 t-20 -71.77 -44.33 64.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 117.168 -3.458 . . . . 0.0 109.501 173.909 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -68.25 -27.58 37.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 O-C-N 117.585 -3.197 . . . . 0.0 110.738 179.439 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -66.09 -24.45 66.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 122.575 1.179 . . . . 0.0 114.072 169.07 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.8 -38.42 58.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 115.151 -2.357 . . . . 0.0 111.019 167.595 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP . 43.1 mttp -64.26 -42.87 96.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 129.897 3.279 . . . . 0.0 110.558 178.85 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.63 -27.88 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 O-C-N 126.268 2.23 . . . . 0.0 109.112 177.114 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -74.17 -44.94 51.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 124.273 1.987 . . . . 0.0 108.733 172.272 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.59 -40.14 74.76 Favored 'General case' 0 N--CA 1.446 -0.654 1 O-C-N 112.911 -6.118 . . . . 0.0 120.869 168.235 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -70.68 -53.32 16.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.497 2.319 . . . . 0.0 110.381 -178.178 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -133.63 6.12 3.74 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 117.627 -3.171 . . . . 0.0 112.895 -166.117 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.67 12.54 77.99 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 118.273 -2.767 . . . . 0.0 118.002 177.643 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.66 120.65 76.95 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 122.971 3.385 . . . . 0.0 112.301 174.19 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.32 147.77 94.67 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 106.208 -2.266 . . . . 0.0 106.208 -179.775 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.23 -48.73 7.84 Favored 'Trans proline' 0 N--CA 1.441 -1.601 1 C-N-CA 125.949 4.433 . . . . 0.0 117.601 170.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -77.02 -13.0 60.01 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -170.552 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -93.76 10.09 34.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.441 1.497 . . . . 0.0 113.225 -176.659 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -130.05 165.92 21.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 116.421 -3.925 . . . . 0.0 114.355 -176.557 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -143.84 129.7 19.4 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 125.376 1.673 . . . . 0.0 112.99 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.7 mt -110.92 145.26 38.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 113.381 -1.736 . . . . 0.0 115.126 -165.843 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 pt -147.71 143.87 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 1 N-CA-C 99.113 -4.403 . . . . 0.0 99.113 -157.735 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -165.63 126.16 1.84 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 161.728 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.56 36.32 13.88 Favored 'General case' 0 N--CA 1.444 -0.733 1 C-N-CA 132.827 4.451 . . . . 0.0 116.036 165.646 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.44 -11.5 65.1 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.558 -1.134 . . . . 0.0 113.513 175.348 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -111.61 133.52 53.81 Favored 'General case' 0 N--CA 1.449 -0.502 1 C-N-CA 133.682 4.793 . . . . 0.0 107.165 -173.616 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -84.82 124.58 31.74 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 128.396 3.56 . . . . 0.0 110.348 170.782 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.06 115.66 27.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 123.706 1.717 . . . . 0.0 112.61 -168.175 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.83 141.23 28.75 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 129.969 3.308 . . . . 0.0 115.033 -173.698 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -75.7 135.88 40.38 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 114.645 -2.598 . . . . 0.0 108.613 -173.921 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.96 -6.84 21.82 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 120.808 1.64 . . . . 0.0 111.225 -176.609 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -106.82 154.89 20.36 Favored 'General case' 0 N--CA 1.452 -0.367 1 C-N-CA 132.71 4.404 . . . . 0.0 107.862 177.32 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 p -101.93 162.14 13.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.865 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.5 mt -61.97 -26.76 68.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 128.252 2.621 . . . . 0.0 112.459 -172.084 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -71.25 -24.87 62.26 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.147 2.579 . . . . 0.0 110.199 179.9 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.47 -50.19 72.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.573 3.149 . . . . 0.0 109.378 -178.223 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.92 12.86 18.22 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 128.266 3.479 . . . . 0.0 113.274 178.382 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 55.16 37.99 29.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.737 2.815 . . . . 0.0 115.881 -178.277 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.01 121.36 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 122.651 2.478 . . . . 0.0 106.129 -175.198 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -88.1 164.93 15.48 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 124.378 2.037 . . . . 0.0 113.681 176.319 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 163.81 16.29 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 119.975 -1.703 . . . . 0.0 110.329 -174.372 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 46.47 10.47 0.01 OUTLIER 'General case' 0 C--O 1.236 0.359 0 N-CA-C 120.354 3.465 . . . . 0.0 120.354 176.183 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.285 71.0 m -75.49 154.49 36.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 119.394 -2.066 . . . . 0.0 107.842 174.524 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 m -95.68 110.06 22.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 176.306 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.17 125.56 43.26 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 173.716 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -82.14 148.76 28.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.869 3.268 . . . . 0.0 109.196 174.027 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.307 1.6 pp -131.55 167.43 19.4 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 166.32 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t -123.88 140.66 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 -175.634 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 163.917 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -81.69 144.26 31.29 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 123.382 1.563 . . . . 0.0 112.322 -177.906 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 11.2 pt -132.56 157.45 43.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 115.026 -2.416 . . . . 0.0 107.251 166.897 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -98.52 144.0 28.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 114.939 -2.458 . . . . 0.0 106.617 165.177 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.14 122.71 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 100.431 -3.914 . . . . 0.0 100.431 176.443 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -123.66 117.83 25.89 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 -170.799 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -80.66 144.86 31.96 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 118.644 -2.535 . . . . 0.0 106.208 -175.016 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.27 -34.43 0.49 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 118.033 2.605 . . . . 0.0 118.033 172.981 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -50.59 -37.87 42.36 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 118.239 -2.788 . . . . 0.0 116.841 164.811 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.85 9.68 8.11 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 127.188 2.328 . . . . 0.0 109.503 176.652 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -84.24 103.12 13.17 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.908 2.483 . . . . 0.0 104.725 -170.765 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.2 m -96.37 119.59 35.14 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.269 1.827 . . . . 0.0 112.874 -178.612 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mm -130.79 145.78 35.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 111.238 -2.71 . . . . 0.0 109.826 -169.334 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.5 p -81.57 165.73 20.87 Favored 'General case' 0 C--O 1.237 0.42 1 O-C-N 114.777 -4.952 . . . . 0.0 114.922 172.929 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.265 2.4 tp -152.65 142.81 22.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.132 2.973 . . . . 0.0 109.441 172.042 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -95.23 117.52 30.4 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.282 2.633 . . . . 0.0 109.528 166.687 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.272 13.9 m -120.75 148.85 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.236 2.215 . . . . 0.0 108.909 179.136 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -91.45 136.14 27.19 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 179.666 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.262 71.5 Cg_exo -41.4 -30.88 0.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 1 N-CA-C 124.084 4.609 . . . . 0.0 124.084 166.53 . . . . . . . . 3 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -103.64 14.34 31.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.992 1.717 . . . . 0.0 113.678 176.241 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.408 ' OD1' ' ND2' ' A' ' 25' ' ' ASN 0.279 24.5 m-20 -66.91 139.77 57.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 128.704 2.802 . . . . 0.0 110.99 170.886 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -73.05 154.54 40.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.091 2.556 . . . . 0.0 107.124 168.185 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mp -69.73 -29.61 41.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 130.252 3.421 . . . . 0.0 105.344 175.466 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -67.71 -36.48 80.7 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 116.85 -3.656 . . . . 0.0 112.989 164.574 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.408 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 5.4 t30 -67.92 -19.07 64.95 Favored 'General case' 0 N--CA 1.444 -0.774 1 CA-C-N 128.254 5.024 . . . . 0.0 113.14 164.285 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.76 -34.68 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 126.048 2.832 . . . . 0.0 114.633 172.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -70.18 -35.33 73.9 Favored 'General case' 0 CA--C 1.537 0.451 1 O-C-N 115.931 -4.231 . . . . 0.0 107.273 174.024 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -33.05 71.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 169.046 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -79.52 -27.54 41.35 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 116.02 -1.943 . . . . 0.0 108.658 179.765 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -77.54 -38.74 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 125.046 1.467 . . . . 0.0 109.216 171.87 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -59.89 -30.29 68.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 118.524 -2.61 . . . . 0.0 111.291 176.535 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . 29.4 t70 -53.04 -37.41 61.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 127.041 2.136 . . . . 0.0 108.149 174.603 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.484 ' HD2' ' HB3' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -115.36 -44.64 2.97 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.982 1.713 . . . . 0.0 107.326 -169.336 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -94.34 -23.52 17.77 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 118.005 -2.934 . . . . 0.0 112.143 -172.521 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.07 27.9 47.66 Favored Glycine 0 CA--C 1.525 0.685 0 O-C-N 119.569 -1.957 . . . . 0.0 113.935 175.892 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.84 124.25 37.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 113.728 -3.034 . . . . 0.0 107.45 -176.921 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.16 137.92 64.11 Favored 'Trans proline' 0 N--CA 1.451 -1.025 1 C-N-CA 125.582 4.188 . . . . 0.0 116.236 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -45.28 -30.48 5.34 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 O-C-N 125.553 2.344 . . . . 0.0 117.834 177.766 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.374 5.8 t70 -46.92 -43.31 18.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 119.09 -2.256 . . . . 0.0 116.075 178.276 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -110.24 -13.35 14.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.315 2.246 . . . . 0.0 105.558 -161.43 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -66.69 139.25 57.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.018 -1.676 . . . . 0.0 112.91 161.29 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -121.63 150.87 41.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.332 1.453 . . . . 0.0 113.217 157.612 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.356 5.8 mt -127.08 138.33 53.18 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 116.634 -3.791 . . . . 0.0 112.733 -179.283 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.366 98.4 mt -139.4 128.36 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 127.18 2.8 . . . . 0.0 112.07 -157.678 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -150.1 147.54 27.91 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.513 1.133 . . . . 0.0 108.945 152.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.365 . . 65.87 21.15 11.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 130.28 3.432 . . . . 0.0 112.537 177.478 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.35 -3.84 85.35 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.004 1.288 . . . . 0.0 113.477 -173.819 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -99.98 159.27 15.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 119.899 1.85 . . . . 0.0 107.229 -176.45 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.9 135.39 54.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 101.689 -3.448 . . . . 0.0 101.689 -178.072 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.7 mt -89.42 159.36 17.34 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 119.22 -2.175 . . . . 0.0 114.349 -179.058 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -104.01 141.2 36.61 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 119.219 -2.175 . . . . 0.0 107.068 -165.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.283 11.2 m-20 -72.27 123.51 23.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 126.247 2.927 . . . . 0.0 115.221 167.798 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.81 -28.61 9.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 129.496 3.427 . . . . 0.0 113.369 -177.876 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -69.43 167.73 15.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.476 -2.191 . . . . 0.0 112.543 170.999 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -115.0 166.46 11.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -163.722 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 mt -54.29 -44.87 72.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.328 1.451 . . . . 0.0 111.023 164.01 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -63.75 -27.65 69.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.944 1.702 . . . . 0.0 109.766 -174.002 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.37 -37.88 88.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.764 1.626 . . . . 0.0 109.696 -171.263 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -99.08 -5.0 31.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 111.723 -2.49 . . . . 0.0 107.236 -176.888 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 71.96 23.46 3.51 Favored 'General case' 0 N--CA 1.442 -0.845 1 O-C-N 114.643 -5.036 . . . . 0.0 116.408 165.221 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -90.68 130.66 39.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 130.54 3.536 . . . . 0.0 107.949 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -115.65 -173.83 2.41 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 131.143 3.777 . . . . 0.0 109.993 -167.673 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -74.17 133.26 42.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 129.577 3.151 . . . . 0.0 106.315 -159.887 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.301 35.7 mt-10 76.03 26.63 0.98 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.045 2.538 . . . . 0.0 113.28 -179.524 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.4 p -84.01 145.84 28.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.308 170.11 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.7 m -103.01 118.77 37.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 -177.23 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 tp -100.07 151.04 21.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 173.947 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -113.07 119.7 38.77 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 128.557 2.743 . . . . 0.0 109.69 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -89.16 137.05 32.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 128.642 3.714 . . . . 0.0 107.111 -176.569 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 t -105.41 116.51 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.832 166.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.446 -0.651 0 C-N-CA 125.7 1.6 . . . . 0.0 107.217 -169.681 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -89.8 112.41 23.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 128.657 2.783 . . . . 0.0 108.074 -170.29 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -109.66 143.09 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 169.121 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -87.97 150.95 23.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.061 0.944 . . . . 0.0 111.79 161.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.4 121.14 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 130.296 3.438 . . . . 0.0 108.309 168.641 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -108.95 133.73 52.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.766 2.427 . . . . 0.0 113.889 176.434 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -105.87 173.4 6.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 117.55 -3.218 . . . . 0.0 109.856 -170.963 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tt -91.84 -35.68 13.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 131.535 3.934 . . . . 0.0 111.667 -176.57 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.7 p -65.03 -6.3 8.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 166.011 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.04 -28.77 5.76 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 117.006 1.562 . . . . 0.0 117.006 160.658 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -79.21 138.35 37.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 116.197 -1.859 . . . . 0.0 111.836 -172.182 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -99.51 118.92 37.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 113.798 -3.001 . . . . 0.0 104.522 172.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.9 mt -96.91 152.92 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 126.663 2.477 . . . . 0.0 107.121 179.302 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -125.14 142.03 51.74 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 165.357 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 131.47 49.78 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 111.656 -2.52 . . . . 0.0 113.162 -178.311 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -99.46 110.73 23.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 115.824 -2.036 . . . . 0.0 106.636 174.806 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 1.7 m -131.99 -174.84 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 119.748 1.158 . . . . 0.0 108.844 175.947 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -111.88 156.09 42.24 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 125.111 1.364 . . . . 0.0 109.887 174.713 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.08 -6.96 12.18 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-O 114.249 -2.479 . . . . 0.0 113.821 -171.704 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m -106.02 2.94 27.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 121.338 1.881 . . . . 0.0 110.64 179.992 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -75.72 152.74 37.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 118.646 -2.534 . . . . 0.0 111.724 170.478 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.333 74.8 p -94.33 169.52 10.16 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.253 1.021 . . . . 0.0 109.97 -165.547 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -71.6 -22.88 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 115.946 -1.978 . . . . 0.0 106.661 -178.47 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -69.19 -19.69 63.99 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 125.072 3.578 . . . . 0.0 107.204 173.537 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -73.94 -48.05 33.29 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 119.144 0.884 . . . . 0.0 111.23 -178.101 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -67.33 -44.37 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 111.997 -2.365 . . . . 0.0 113.404 175.306 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.29 30.1 mtpt -48.64 -36.56 16.16 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 119.898 3.296 . . . . 0.0 119.898 160.15 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.83 -39.87 42.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 120.912 1.687 . . . . 0.0 110.519 -179.572 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -69.88 -33.04 71.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.109 2.163 . . . . 0.0 111.232 178.753 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.22 -46.13 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 113.139 -3.315 . . . . 0.0 114.18 162.788 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -58.44 -45.86 87.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 123.056 2.662 . . . . 0.0 115.451 168.23 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.444 24.1 t70 -47.67 -64.5 0.77 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.006 1.722 . . . . 0.0 114.431 173.326 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -98.81 -20.69 16.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -165.191 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -127.46 13.01 7.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.185 2.194 . . . . 0.0 113.894 -176.539 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.06 20.58 62.77 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.078 2.275 . . . . 0.0 117.462 159.184 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mt -91.91 132.8 31.84 Favored Pre-proline 0 N--CA 1.444 -0.752 0 O-C-N 118.275 -2.897 . . . . 0.0 105.365 -172.491 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.84 112.13 2.14 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 114.694 -2.294 . . . . 0.0 114.581 169.627 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.66 -10.59 23.63 Favored 'Trans proline' 0 N--CA 1.457 -0.626 1 C-N-CA 125.447 4.098 . . . . 0.0 114.305 -167.625 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.361 25.7 t0 -65.3 -27.85 68.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 125.528 2.585 . . . . 0.0 111.904 167.504 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -114.97 51.61 0.9 Allowed 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 116.893 -3.63 . . . . 0.0 103.257 -167.432 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -160.64 147.12 15.29 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.997 2.119 . . . . 0.0 105.839 -170.736 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -149.65 126.26 10.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 102.173 -3.269 . . . . 0.0 102.173 172.183 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.334 78.2 mt -93.46 150.14 20.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 125.052 2.358 . . . . 0.0 109.518 169.695 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.7 mt -126.61 135.07 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 1 C-N-CA 133.249 4.62 . . . . 0.0 111.471 -177.219 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 65' ' ' SER . 52.8 t80 -150.66 133.17 15.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 118.7 -2.5 . . . . 0.0 111.853 178.115 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.22 21.31 1.59 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 118.831 2.9 . . . . 0.0 118.831 -178.583 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.65 -5.35 47.56 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 127.571 2.51 . . . . 0.0 113.038 -176.681 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -119.56 123.05 42.99 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.574 2.75 . . . . 0.0 109.239 -161.246 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -54.18 124.11 14.75 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 118.669 -2.519 . . . . 0.0 110.963 164.829 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -71.51 108.46 4.91 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.853 2.061 . . . . 0.0 109.645 174.359 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.287 29.8 tt0 -91.31 151.04 21.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -166.472 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -73.83 128.4 35.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.67 2.388 . . . . 0.0 106.773 -174.66 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.97 18.16 12.88 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 128.659 3.028 . . . . 0.0 116.709 175.217 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -121.86 168.11 12.25 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.876 1.67 . . . . 0.0 107.978 -177.472 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.4 p -124.32 146.21 48.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 -173.219 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 61' ' ' ILE 0.285 5.7 mt -48.15 -41.76 27.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.936 1.694 . . . . 0.0 112.053 -171.936 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -36.61 -44.96 0.48 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 129.846 3.258 . . . . 0.0 117.342 161.493 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -73.07 -7.65 52.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.761 2.024 . . . . 0.0 112.701 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -117.01 -12.56 10.65 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.35 1.86 . . . . 0.0 112.72 170.331 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.1 t30 78.05 33.7 0.33 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.8 2.04 . . . . 0.0 111.003 171.861 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 52.9 mt -69.14 119.15 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 127.118 2.167 . . . . 0.0 106.211 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.277 4.0 pp0? -119.65 175.48 5.84 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 128.943 2.897 . . . . 0.0 108.71 -168.25 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -48.56 111.33 0.44 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 117.007 -3.558 . . . . 0.0 115.452 -175.338 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 73.46 29.32 1.62 Allowed 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 119.294 -2.128 . . . . 0.0 109.658 176.284 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 73.4 m -84.25 125.77 32.54 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 117.108 -3.495 . . . . 0.0 103.263 175.225 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.1 m -95.41 110.1 22.18 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 116.946 -3.596 . . . . 0.0 108.426 -169.191 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -79.75 157.26 27.16 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 130.766 3.626 . . . . 0.0 110.4 174.736 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -121.39 142.4 50.04 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 129.533 3.133 . . . . 0.0 104.448 -177.808 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.22 127.29 48.4 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 131.242 3.817 . . . . 0.0 105.057 -173.223 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.31 142.37 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 118.761 -2.462 . . . . 0.0 113.506 163.74 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.32 -0.674 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 -170.113 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 CA--C 1.534 0.361 1 CA-C-O 129.783 4.611 . . . . 0.0 105.297 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -71.02 144.58 50.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 110.671 -2.968 . . . . 0.0 113.389 -173.786 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.3 pt -146.12 174.95 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 116.441 -1.742 . . . . 0.0 106.691 177.998 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -128.31 117.35 21.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.063 2.545 . . . . 0.0 108.178 172.121 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -82.29 116.55 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 118.946 -2.346 . . . . 0.0 105.665 158.446 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -95.06 146.77 24.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 115.417 -2.23 . . . . 0.0 111.735 160.903 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -95.54 159.8 14.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 129.386 3.074 . . . . 0.0 104.697 164.62 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 tp -63.5 -21.41 66.31 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 111.526 -2.579 . . . . 0.0 110.534 177.037 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.1 p -95.63 -6.79 39.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 127.674 3.109 . . . . 0.0 112.708 178.134 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.5 -24.94 6.06 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.198 -1.334 . . . . 0.0 112.704 158.472 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -55.58 118.53 4.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 129.228 3.011 . . . . 0.0 109.086 -177.573 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.0 m -100.34 132.89 45.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 126.83 2.581 . . . . 0.0 109.711 179.084 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 mm -109.05 130.41 62.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.589 1.955 . . . . 0.0 106.911 173.614 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.7 m -85.36 144.1 28.24 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.907 2.483 . . . . 0.0 105.17 174.631 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.68 151.63 49.49 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 120.267 -1.521 . . . . 0.0 107.675 171.615 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -103.3 125.67 50.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 153.79 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -137.79 171.25 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 131.496 3.919 . . . . 0.0 112.677 163.73 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -130.14 144.29 52.55 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -178.411 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -57.81 -28.71 83.38 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 CA-C-O 111.843 -3.482 . . . . 0.0 115.286 -169.598 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.9 p -77.2 2.4 15.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 124.81 3.459 . . . . 0.0 115.52 172.25 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -77.83 148.78 34.55 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 118.968 -2.332 . . . . 0.0 107.358 -179.443 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.3 p -78.4 155.1 30.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 116.739 -1.601 . . . . 0.0 112.648 -172.12 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.254 10.6 mm -81.9 50.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 125.327 2.489 . . . . 0.0 109.794 161.175 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -153.72 -54.66 0.11 Allowed 'General case' 0 CA--C 1.532 0.288 0 O-C-N 117.39 -3.319 . . . . 0.0 109.066 -173.44 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -59.71 -57.37 13.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 120.698 1.59 . . . . 0.0 113.517 -175.394 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.37 -8.03 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.65 2.38 . . . . 0.0 111.188 -163.568 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -49.01 -40.29 30.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.322 2.649 . . . . 0.0 116.291 162.338 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.91 -27.69 8.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 119.722 -1.861 . . . . 0.0 115.527 172.033 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -89.01 -2.26 58.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 118.541 -1.263 . . . . 0.0 111.511 -172.096 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.9 mm -89.71 -37.75 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 127.67 2.388 . . . . 0.0 108.581 165.543 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.08 -43.24 99.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.361 -1.291 . . . . 0.0 114.225 176.476 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.25 -16.34 8.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.816 2.447 . . . . 0.0 115.704 170.934 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -108.94 -52.26 2.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.566 1.546 . . . . 0.0 110.979 -173.246 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -115.01 -19.06 11.07 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 118.801 -2.437 . . . . 0.0 112.331 -173.628 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.27 15.79 20.39 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 115.161 -3.022 . . . . 0.0 112.41 177.908 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -90.75 121.63 67.93 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 121.773 2.787 . . . . 0.0 112.172 -176.987 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.4 158.06 59.18 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.538 2.159 . . . . 0.0 113.656 179.028 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.36 -40.17 60.61 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.273 2.649 . . . . 0.0 115.465 -173.614 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -41.6 -54.87 3.09 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 131.225 3.81 . . . . 0.0 114.015 166.144 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -80.23 -13.23 59.39 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.607 2.363 . . . . 0.0 113.868 -170.481 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -83.91 106.44 15.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 129.482 3.113 . . . . 0.0 106.676 -179.058 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -113.28 137.28 51.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.728 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.284 1.7 pt? -134.02 131.37 38.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 120.707 1.594 . . . . 0.0 112.497 -172.378 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.8 mt -109.68 132.22 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 -174.533 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -131.74 -85.4 0.49 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 130.546 3.538 . . . . 0.0 114.233 168.528 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.61 55.01 0.69 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 125.961 3.982 . . . . 0.0 114.584 -170.474 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.71 -9.48 48.06 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 161.805 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -139.33 156.01 47.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 119.764 3.246 . . . . 0.0 119.764 176.536 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.86 116.17 18.16 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.988 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.5 mt -58.68 135.53 57.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.769 -2.457 . . . . 0.0 113.932 -175.251 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -84.07 143.77 29.51 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.531 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.54 132.92 46.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.323 1.449 . . . . 0.0 112.261 169.937 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.23 -24.44 10.6 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 124.671 2.262 . . . . 0.0 112.241 171.565 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -73.61 166.87 22.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 111.978 -2.111 . . . . 0.0 105.316 -179.903 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.9 p -100.81 163.59 12.24 Favored 'General case' 0 N--CA 1.45 -0.436 1 O-C-N 115.583 -4.448 . . . . 0.0 108.269 169.013 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -51.59 -36.98 47.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.233 2.213 . . . . 0.0 113.439 171.501 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -79.6 -17.84 52.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 177.235 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -62.97 -17.33 61.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 121.294 1.861 . . . . 0.0 109.411 164.847 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -118.05 7.18 12.17 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 130.389 3.476 . . . . 0.0 112.484 -178.212 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 62.96 32.39 15.61 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 131.453 3.901 . . . . 0.0 112.0 174.291 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.89 132.0 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 126.607 1.963 . . . . 0.0 105.84 -172.002 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -127.34 165.77 19.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.319 2.248 . . . . 0.0 111.678 -179.902 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -48.03 137.28 10.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 131.286 3.835 . . . . 0.0 112.494 179.577 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 84.67 4.15 0.67 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.461 1.905 . . . . 0.0 108.454 165.541 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 m -83.61 142.69 30.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 175.374 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.8 m -97.29 129.52 44.58 Favored 'General case' 0 N--CA 1.451 -0.408 1 C-N-CA 132.431 4.292 . . . . 0.0 112.749 179.485 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.62 143.18 50.71 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -169.99 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -115.1 102.68 10.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 101.621 -3.474 . . . . 0.0 101.621 -160.72 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -71.07 144.45 50.34 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 128.843 2.857 . . . . 0.0 108.649 166.1 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.85 156.29 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 130.134 3.373 . . . . 0.0 106.66 170.414 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.28 48.1 mt . . . . . 0 N--CA 1.447 -0.615 0 CA-C-O 126.55 3.072 . . . . 0.0 108.89 -178.483 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttp . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -125.13 139.59 53.63 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.007 2.523 . . . . 0.0 114.18 -175.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 3' ' ' ILE 0.296 45.6 pt -133.55 -179.48 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 128.893 2.877 . . . . 0.0 104.869 173.935 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -133.17 160.65 36.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 167.291 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.6 t -129.52 141.04 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 166.694 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -109.16 127.05 53.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.129 1.771 . . . . 0.0 106.638 176.814 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.5 p -79.74 173.14 12.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 124.154 1.931 . . . . 0.0 112.305 165.852 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.7 mt -78.71 -31.45 46.47 Favored 'General case' 0 C--O 1.24 0.602 0 O-C-N 118.188 -2.82 . . . . 0.0 111.921 173.708 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 t -64.0 -21.11 66.36 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 167.642 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.54 6.63 40.92 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 125.825 1.953 . . . . 0.0 109.275 168.769 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -65.77 119.06 10.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 122.377 3.088 . . . . 0.0 109.113 167.998 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.5 m -102.46 94.83 5.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 122.948 2.613 . . . . 0.0 104.652 -178.914 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.86 144.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 1 C-N-CA 132.212 4.205 . . . . 0.0 109.41 170.11 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.9 m -103.22 142.42 34.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.752 1.621 . . . . 0.0 109.912 169.109 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -125.12 132.53 53.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 157.819 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.84 128.4 35.48 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 154.638 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.67 157.99 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 120.402 -1.436 . . . . 0.0 111.403 -178.056 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.76 149.55 38.6 Favored Pre-proline 0 N--CA 1.442 -0.869 0 C-N-CA 127.016 2.127 . . . . 0.0 106.382 174.882 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.295 52.8 Cg_endo -70.41 -15.17 34.6 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 124.767 3.645 . . . . 0.0 116.476 -179.254 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -98.52 1.27 46.43 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.986 2.514 . . . . 0.0 113.632 -178.643 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -77.64 153.63 32.97 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.394 -1.441 . . . . 0.0 111.539 -169.863 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.5 p -89.42 158.14 17.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 128.047 2.539 . . . . 0.0 106.005 177.256 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.11 -29.74 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 114.049 -2.882 . . . . 0.0 107.59 175.964 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -59.63 -38.04 80.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 124.629 3.377 . . . . 0.0 108.316 168.921 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -76.38 -21.54 55.91 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 118.368 -2.707 . . . . 0.0 109.604 176.309 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.29 -37.02 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 124.609 3.368 . . . . 0.0 111.7 172.933 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -64.64 -30.07 71.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.484 1.914 . . . . 0.0 111.971 176.566 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.265 . . -75.25 -30.24 60.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.621 2.368 . . . . 0.0 111.928 179.867 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -79.51 -25.43 41.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 125.108 2.385 . . . . 0.0 112.014 174.707 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 30' ' ' ILE 0.34 32.1 mm -82.3 -33.68 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 113.412 -1.722 . . . . 0.0 108.883 173.241 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -36.32 66.5 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 123.013 2.642 . . . . 0.0 114.063 161.595 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.05 -59.85 2.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 128.433 2.693 . . . . 0.0 106.531 177.718 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.322 68.1 mmtt -51.39 -64.94 0.65 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.695 2.398 . . . . 0.0 110.567 -177.309 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -120.49 -9.88 9.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 112.914 -3.422 . . . . 0.0 107.437 -150.451 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.49 -1.9 62.42 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 127.875 3.234 . . . . 0.0 116.826 166.933 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.3 mm -95.09 132.14 28.67 Favored Pre-proline 0 N--CA 1.452 -0.368 0 O-C-N 117.335 -3.45 . . . . 0.0 111.722 -159.231 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -47.44 122.95 7.31 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 126.914 5.076 . . . . 0.0 108.657 168.352 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -35.36 -47.43 0.81 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 1 C-N-CA 129.698 6.932 . . . . 0.0 118.52 174.711 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.5 -16.3 64.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 114.913 -2.47 . . . . 0.0 115.422 -178.697 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.24 -7.36 42.29 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 126.186 2.179 . . . . 0.0 109.125 179.542 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -86.91 130.19 34.56 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 128.338 2.655 . . . . 0.0 109.269 179.906 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -116.86 141.06 48.72 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 128.868 2.867 . . . . 0.0 107.334 179.823 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.9 mt -119.44 111.18 17.82 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.551 2.34 . . . . 0.0 110.797 173.886 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.3 mt -105.12 118.6 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 161.23 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -126.69 130.79 51.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 175.212 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.42 19.5 10.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.658 169.514 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.17 -17.55 59.08 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 128.453 2.93 . . . . 0.0 115.678 -169.728 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.288 11.6 mmmt -93.19 146.48 23.65 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 119.404 1.602 . . . . 0.0 111.971 -176.931 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -94.54 112.47 24.23 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 130.892 3.677 . . . . 0.0 105.07 -176.246 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HG ' ' CD1' ' A' ' 59' ' ' TYR . 6.2 mp -80.2 111.2 16.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 114.455 -2.688 . . . . 0.0 105.778 -179.259 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -83.83 -15.05 49.73 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 126.769 2.543 . . . . 0.0 115.705 -173.052 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.298 5.3 t0 93.64 153.66 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 128.694 2.798 . . . . 0.0 111.49 -175.932 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.01 30.98 5.82 Favored Glycine 0 N--CA 1.438 -1.21 0 O-C-N 117.394 -3.316 . . . . 0.0 114.335 161.322 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -153.4 160.48 42.63 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 131.586 3.954 . . . . 0.0 106.83 172.276 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.6 p -98.34 176.66 5.62 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 117.013 -3.555 . . . . 0.0 111.506 -167.269 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.53 -37.13 84.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 126.312 1.845 . . . . 0.0 111.96 -173.82 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 p -64.39 -33.6 76.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.017 1.727 . . . . 0.0 115.12 166.189 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -71.74 -56.44 5.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.99 2.116 . . . . 0.0 107.416 179.634 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.498 ' CD1' ' HG ' ' A' ' 50' ' ' LEU 0.277 42.9 m-85 -64.52 0.99 0.89 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 130.548 3.539 . . . . 0.0 116.312 -178.756 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.311 1.5 t-20 78.42 18.32 1.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 124.131 3.15 . . . . 0.0 113.836 163.659 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.8 mt -94.01 105.02 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 117.306 -3.371 . . . . 0.0 106.409 179.92 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -99.83 -170.79 1.94 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 116.601 -3.812 . . . . 0.0 101.483 -166.541 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -64.99 120.23 12.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 114.669 -2.586 . . . . 0.0 112.125 -170.044 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.555 2.4 mp0 77.59 24.77 0.75 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 117.427 2.381 . . . . 0.0 117.427 179.144 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.9 m -71.23 148.02 47.65 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 112.42 -2.173 . . . . 0.0 106.157 175.221 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.321 99.1 m -114.83 128.9 56.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 169.579 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.1 mt -92.65 151.24 20.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 108.824 -3.807 . . . . 0.0 107.811 170.305 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -98.68 127.35 44.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.904 0.882 . . . . 0.0 113.374 162.112 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -107.46 118.46 36.79 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 -178.396 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.52 160.78 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.306 1.842 . . . . 0.0 110.253 172.992 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.1 mt . . . . . 0 N--CA 1.448 -0.53 0 O-C-N 118.868 -2.395 . . . . 0.0 112.623 176.523 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ttt . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 116.409 -1.758 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -77.82 131.53 37.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 123.716 2.962 . . . . 0.0 112.309 173.629 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 3' ' ' ILE . 46.4 pt -130.37 136.9 57.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 126.88 2.613 . . . . 0.0 107.202 170.457 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.52 123.01 35.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 172.045 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 46.6 t -96.27 124.88 49.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 166.682 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.261 49.3 tttm -106.87 121.31 44.15 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -174.292 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 69' ' ' LEU 0.294 5.1 p -113.13 -171.34 1.85 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 128.009 2.523 . . . . 0.0 108.099 175.466 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.301 74.3 mt -82.26 -28.41 31.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 126.625 3.107 . . . . 0.0 113.649 176.006 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 p -123.87 68.02 1.04 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.87 3.268 . . . . 0.0 107.024 -175.848 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.53 101.67 1.22 Allowed Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 104.198 -3.561 . . . . 0.0 104.198 178.653 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -79.06 -33.23 44.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 129.014 3.42 . . . . 0.0 111.363 -179.425 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m -117.71 59.57 0.78 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 126.44 3.019 . . . . 0.0 106.396 -167.634 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 2.2 mt -80.81 116.01 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 118.558 -2.589 . . . . 0.0 106.613 170.102 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.86 119.59 39.23 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 118.293 -2.754 . . . . 0.0 105.902 -169.986 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.447 HD23 ' CG1' ' A' ' 17' ' ' VAL . 8.7 tp -115.81 136.15 53.32 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 129.744 3.218 . . . . 0.0 108.746 172.657 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.259 10.1 tp10 -92.17 114.41 26.94 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 167.169 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG1' HD23 ' A' ' 15' ' ' LEU . 18.1 m -108.75 -167.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 126.18 1.792 . . . . 0.0 110.854 168.999 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -139.47 140.65 26.12 Favored Pre-proline 0 N--CA 1.45 -0.462 1 C-N-CA 131.92 4.088 . . . . 0.0 107.578 171.62 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -43.54 -47.4 9.39 Favored 'Trans proline' 0 N--CA 1.445 -1.334 1 C-N-CA 126.079 4.519 . . . . 0.0 118.876 171.282 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.264 77.9 p -91.75 18.72 7.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.304 1.842 . . . . 0.0 107.2 -176.828 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -79.0 144.94 34.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 123.439 2.836 . . . . 0.0 114.102 169.978 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -92.77 153.48 18.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 117.421 -3.299 . . . . 0.0 111.038 -178.884 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 6.3 mm -57.99 -26.1 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 118.675 -2.516 . . . . 0.0 114.713 -176.046 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -82.22 -18.31 43.03 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.787 1.635 . . . . 0.0 108.31 -170.395 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -83.78 -35.28 24.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.582 2.353 . . . . 0.0 107.948 178.905 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.95 -51.63 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 128.495 2.718 . . . . 0.0 107.538 177.288 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 38.4 mtmt -59.01 -39.28 81.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 120.075 3.361 . . . . 0.0 120.075 173.526 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -26.9 68.5 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.705 3.602 . . . . 0.0 113.331 160.792 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -77.58 -47.49 19.28 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 121.681 2.037 . . . . 0.0 113.011 172.768 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 30' ' ' ILE 0.321 92.1 mt -54.15 -46.19 66.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 131.009 3.723 . . . . 0.0 112.811 174.264 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -60.25 -20.23 58.09 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 118.753 -2.467 . . . . 0.0 116.138 -177.75 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.278 3.7 t70 -94.2 -36.89 11.83 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 -178.546 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -70.95 -55.1 9.09 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.506 178.364 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -117.47 -21.43 8.63 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 118.355 -2.716 . . . . 0.0 108.662 -166.352 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.4 10.7 28.87 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 117.183 -3.448 . . . . 0.0 114.014 164.379 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.92 120.89 57.54 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 -165.709 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -77.98 154.19 29.41 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 O-C-N 116.322 -2.515 . . . . 0.0 112.402 -173.119 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -73.98 -33.27 6.28 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.076 1.851 . . . . 0.0 112.557 -153.921 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -73.91 -19.7 60.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 124.739 1.274 . . . . 0.0 112.932 177.532 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -90.89 -16.49 28.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.638 2.375 . . . . 0.0 110.572 -179.404 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -89.11 129.45 35.72 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 129.124 2.969 . . . . 0.0 112.452 -179.704 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -119.78 155.78 31.86 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 173.791 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.06 144.33 51.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 120.15 -1.594 . . . . 0.0 111.739 178.074 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 44' ' ' ILE . 84.9 mt -131.43 143.76 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 122.844 2.565 . . . . 0.0 113.881 176.048 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -151.9 123.58 7.93 Favored 'General case' 0 N--CA 1.451 -0.388 1 C-N-CA 132.087 4.155 . . . . 0.0 113.461 171.541 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.27 37.56 4.21 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 119.651 3.204 . . . . 0.0 119.651 -175.784 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.75 -0.24 57.84 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 117.038 -3.539 . . . . 0.0 112.607 171.425 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -113.53 138.72 49.73 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 122.976 3.388 . . . . 0.0 105.15 -178.767 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.293 24.3 tt0 -98.0 125.07 42.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.308 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.14 131.14 44.87 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.89 -168.392 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -104.31 154.72 19.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 127.008 3.29 . . . . 0.0 113.726 -172.93 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -45.75 127.75 8.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 117.438 -3.289 . . . . 0.0 115.505 177.509 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.16 -2.38 61.33 Favored Glycine 0 CA--C 1.536 1.368 1 CA-C-N 127.362 4.619 . . . . 0.0 112.485 163.636 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.263 25.9 mmt-85 -100.06 172.88 6.92 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 127.188 3.375 . . . . 0.0 106.931 -173.138 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -119.69 -178.63 3.67 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 116.551 -3.843 . . . . 0.0 113.02 168.394 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.537 HD22 ' H ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -50.83 -44.42 59.32 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 131.032 3.733 . . . . 0.0 112.825 162.811 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.5 m -72.22 -33.68 67.77 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.367 2.667 . . . . 0.0 111.404 -170.897 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -66.98 -38.9 86.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 124.731 2.205 . . . . 0.0 111.34 -178.264 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -91.15 0.62 57.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 117.146 -3.471 . . . . 0.0 116.042 176.425 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.256 13.3 m120 71.52 53.13 0.23 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 130.383 3.473 . . . . 0.0 110.638 -178.206 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.9 mt -103.03 140.41 21.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 -174.306 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -106.84 149.0 27.85 Favored 'General case' 0 N--CA 1.451 -0.397 1 C-N-CA 131.936 4.094 . . . . 0.0 115.674 -169.074 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.77 128.53 30.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 124.351 1.032 . . . . 0.0 112.705 162.065 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.277 29.3 tt0 87.05 21.89 0.06 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.839 2.856 . . . . 0.0 110.209 174.253 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.9 m -71.63 141.84 49.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.216 1.806 . . . . 0.0 114.475 175.716 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.279 97.6 m -100.69 126.74 47.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 115.279 -2.296 . . . . 0.0 104.89 165.58 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.08 173.47 13.36 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 130.781 3.632 . . . . 0.0 107.2 177.651 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -127.45 134.13 49.87 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.443 2.297 . . . . 0.0 112.991 -156.548 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.425 ' HB3' HG22 ' A' ' 7' ' ' THR . 3.6 tt -108.29 139.28 43.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 125.336 2.493 . . . . 0.0 107.752 173.621 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 t -130.55 134.53 62.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 129.846 3.258 . . . . 0.0 106.722 -178.144 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.438 -1.063 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 172.338 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.374 0.6 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 . . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -91.82 129.28 37.81 Favored 'General case' 0 N--CA 1.447 -0.591 1 C-N-CA 133.927 4.891 . . . . 0.0 107.213 -179.622 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.629 HD12 HD22 ' A' ' 67' ' ' LEU . 28.5 pt -119.08 156.69 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 128.01 3.319 . . . . 0.0 106.167 154.01 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -95.35 133.86 38.8 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.579 1.552 . . . . 0.0 107.239 166.279 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.57 125.55 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 1 N-CA-C 97.321 -5.066 . . . . 0.0 97.321 175.293 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -103.04 127.05 50.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 127.059 3.314 . . . . 0.0 107.707 173.977 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -89.76 145.03 25.48 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 126.021 2.82 . . . . 0.0 106.102 -176.178 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.35 -27.89 68.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.706 -2.043 . . . . 0.0 116.241 178.561 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 p -76.72 -7.47 55.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.081 2.553 . . . . 0.0 116.94 173.274 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.05 10.15 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 129.922 3.629 . . . . 0.0 114.694 166.303 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 47.1 tttt -70.39 149.57 47.16 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 121.939 2.869 . . . . 0.0 110.758 -178.556 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.1 m -104.24 141.75 35.74 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.717 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.401 0.1 OUTLIER -125.08 135.17 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 126.516 3.055 . . . . 0.0 112.789 163.173 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 m -75.66 137.5 40.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 117.65 -3.156 . . . . 0.0 104.482 174.085 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -138.41 120.14 15.22 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 175.833 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.286 25.4 mt-10 -70.39 131.92 44.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 126.949 2.656 . . . . 0.0 111.724 170.527 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 m -148.99 164.34 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 127.886 2.474 . . . . 0.0 106.787 -173.794 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -123.47 155.99 64.78 Favored Pre-proline 0 N--CA 1.449 -0.52 0 O-C-N 117.624 -3.173 . . . . 0.0 109.419 165.49 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.72 -37.67 35.67 Favored 'Trans proline' 0 N--CA 1.451 -0.997 1 C-N-CA 127.152 5.235 . . . . 0.0 116.008 179.203 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.8 p -81.27 -13.46 58.45 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 112.563 -2.108 . . . . 0.0 112.757 -179.624 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -67.02 155.84 37.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 121.103 1.774 . . . . 0.0 109.951 170.663 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -121.8 139.86 53.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 130.287 3.435 . . . . 0.0 111.248 -161.178 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -46.23 -24.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 O-C-N 116.595 -3.816 . . . . 0.0 116.895 176.243 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -68.74 -54.4 16.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.904 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -62.42 -37.43 85.79 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 119.593 3.183 . . . . 0.0 119.593 -173.353 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.282 76.1 t -50.71 -43.98 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 129.498 3.119 . . . . 0.0 113.804 170.605 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.355 40.0 mtmt -50.78 -43.69 58.59 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.766 2.027 . . . . 0.0 112.598 172.251 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.32 -33.65 28.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 125.982 2.051 . . . . 0.0 114.649 -176.619 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -55.41 -31.9 62.23 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 125.334 2.492 . . . . 0.0 115.215 173.003 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.8 mt -75.63 -21.11 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 113.421 -1.718 . . . . 0.0 113.156 172.147 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -70.56 -43.34 69.68 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 122.572 2.442 . . . . 0.0 107.715 173.225 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.53 -29.04 67.61 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 118.926 -2.358 . . . . 0.0 112.417 176.942 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -97.19 -57.21 2.32 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 175.617 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 11' ' ' LYS . 28.6 mm-40 -92.64 -22.7 19.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.151 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.62 -18.39 22.54 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 130.672 3.987 . . . . 0.0 112.326 171.426 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.3 mt -71.2 122.98 88.59 Favored Pre-proline 0 N--CA 1.445 -0.686 0 C-N-CA 127.882 2.473 . . . . 0.0 106.185 -159.604 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.0 137.8 27.22 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.872 2.382 . . . . 0.0 109.973 172.423 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -40.73 -45.29 4.76 Favored 'Trans proline' 0 N--CA 1.454 -0.804 1 C-N-CA 126.442 4.761 . . . . 0.0 114.786 -175.654 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.257 12.6 t70 -31.76 -41.75 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 127.104 2.752 . . . . 0.0 117.943 170.762 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -96.84 -16.76 20.6 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -170.349 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -97.49 140.88 31.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 127.479 2.987 . . . . 0.0 111.746 -178.593 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -125.23 128.21 47.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 116.74 -1.6 . . . . 0.0 108.325 174.146 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.78 140.82 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.085 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.3 pt -141.91 144.36 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 131.587 3.955 . . . . 0.0 111.114 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -146.16 130.34 17.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 111.566 -2.561 . . . . 0.0 107.627 172.265 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.79 17.91 8.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.264 1.826 . . . . 0.0 115.308 168.694 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.39 -26.66 12.76 Favored Glycine 0 CA--C 1.528 0.88 1 C-N-CA 131.95 4.595 . . . . 0.0 112.501 -169.253 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.303 38.4 mttt -68.24 129.89 41.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.807 0.804 . . . . 0.0 111.278 -170.982 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.316 78.0 mt-30 -66.06 115.05 5.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 163.708 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.97 121.96 29.34 Favored 'General case' 0 C--O 1.239 0.52 1 O-C-N 116.156 -4.09 . . . . 0.0 110.139 -175.746 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.47 148.15 24.31 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 129.702 3.201 . . . . 0.0 111.293 -165.08 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -74.93 123.72 25.61 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.667 2.387 . . . . 0.0 108.323 -166.606 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.06 60.33 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 128.814 3.102 . . . . 0.0 116.215 174.1 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -80.58 143.61 33.05 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 128.214 2.606 . . . . 0.0 109.511 173.663 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -77.0 151.81 35.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 128.589 2.755 . . . . 0.0 110.655 177.977 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -59.71 -25.29 64.68 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 127.522 2.329 . . . . 0.0 114.678 161.546 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -74.46 -23.05 58.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 130.2 3.4 . . . . 0.0 112.812 166.229 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -89.53 -16.92 29.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 121.655 2.025 . . . . 0.0 109.387 178.806 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -96.81 -3.51 42.08 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 115.886 -2.007 . . . . 0.0 111.512 171.731 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 t30 62.35 37.86 13.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 171.835 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.7 mt -94.57 127.99 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 -172.19 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -99.44 175.56 5.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.789 2.036 . . . . 0.0 111.224 -176.247 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 144.0 57.45 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 130.97 3.708 . . . . 0.0 110.708 179.057 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.323 3.0 pt-20 60.68 13.17 4.12 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 131.562 3.945 . . . . 0.0 116.874 -179.374 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.0 m -67.33 144.77 55.67 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 126.709 2.506 . . . . 0.0 111.701 166.084 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.0 m -86.31 108.81 18.58 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.257 1.423 . . . . 0.0 109.074 174.788 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.629 HD22 HD12 ' A' ' 3' ' ' ILE . 11.0 mp -83.89 150.43 25.72 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 123.029 1.395 . . . . 0.0 113.36 156.785 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.265 75.2 m80 -104.02 144.07 32.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.443 -1.411 . . . . 0.0 111.303 176.714 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 tt -128.55 120.99 27.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 113.61 -3.09 . . . . 0.0 109.51 -177.813 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.99 133.34 44.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 127.782 2.433 . . . . 0.0 106.718 -175.532 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.274 73.6 mt . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 125.841 1.657 . . . . 0.0 111.678 171.895 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ttt . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 116.021 1.859 . . . . 0.0 116.021 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.426 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 96.1 mt-30 -106.61 165.96 10.91 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.103 1.761 . . . . 0.0 113.241 -176.831 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -122.75 165.02 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 127.531 2.332 . . . . 0.0 108.858 152.662 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -112.18 125.44 54.14 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 126.646 2.466 . . . . 0.0 112.414 -172.253 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.74 91.35 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 101.664 -3.458 . . . . 0.0 101.664 176.869 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -68.27 145.8 53.91 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 114.277 -2.773 . . . . 0.0 112.855 167.32 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -155.06 171.5 19.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 124.963 3.528 . . . . 0.0 111.792 170.526 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 mt -68.75 -17.49 64.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 130.057 3.343 . . . . 0.0 116.913 -164.585 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.6 p -74.14 -7.77 53.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 173.588 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.71 -20.81 44.71 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 116.674 1.43 . . . . 0.0 116.674 -179.147 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -76.9 152.71 35.26 Favored 'General case' 0 N--CA 1.447 -0.585 1 C-N-CA 132.25 4.22 . . . . 0.0 104.348 -176.21 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.289 75.7 m -122.68 147.79 46.05 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 118.937 -2.352 . . . . 0.0 112.3 161.765 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mt -120.88 154.39 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 131.685 3.994 . . . . 0.0 107.056 -178.013 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 p -127.47 135.9 51.03 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 128.174 2.59 . . . . 0.0 110.721 -165.682 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.7 mt -130.6 117.43 19.52 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 126.418 2.324 . . . . 0.0 107.679 -179.668 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HG3' ' HG2' ' A' ' 2' ' ' GLN . 31.5 mp0 -90.66 108.77 20.02 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.131 2.172 . . . . 0.0 106.26 169.117 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.0 161.33 32.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 1 C-N-CA 134.413 5.085 . . . . 0.0 108.77 -170.326 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 53.9 mm-40 -126.16 152.32 73.25 Favored Pre-proline 0 N--CA 1.442 -0.867 0 C-N-CA 131.589 3.956 . . . . 0.0 110.045 175.486 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 66.3 Cg_exo -47.35 -48.97 13.91 Favored 'Trans proline' 0 N--CA 1.456 -0.685 1 C-N-CA 126.523 4.815 . . . . 0.0 114.232 -167.368 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -61.66 -15.77 42.87 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 119.104 3.001 . . . . 0.0 119.104 -176.879 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.42 120.58 9.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.942 170.797 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 p -65.79 136.28 55.99 Favored 'General case' 0 N--CA 1.447 -0.578 1 C-N-CA 135.521 5.528 . . . . 0.0 110.266 161.377 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mm -59.99 -31.7 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 114.882 -2.485 . . . . 0.0 114.527 -174.71 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -48.7 -36.48 16.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.103 2.561 . . . . 0.0 114.73 169.743 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -82.79 -39.28 21.98 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 125.343 1.652 . . . . 0.0 108.937 -172.866 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.32 4.5 t -67.95 -36.58 76.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 112.982 -3.39 . . . . 0.0 115.678 172.705 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -58.94 -46.84 87.02 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 129.6 3.16 . . . . 0.0 107.301 177.889 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.91 -18.69 61.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.867 3.267 . . . . 0.0 118.184 172.351 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -49.57 63.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 118.24 -2.787 . . . . 0.0 113.112 160.551 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -68.32 -38.66 79.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 127.832 2.453 . . . . 0.0 107.397 -169.667 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.41 -65.61 0.53 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.489 1.115 . . . . 0.0 111.071 160.529 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.253 35.0 t70 -43.28 -38.29 2.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 129.612 3.165 . . . . 0.0 114.086 179.68 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -80.28 -45.64 17.54 Favored 'General case' 0 CA--C 1.535 0.39 1 C-N-CA 131.964 4.106 . . . . 0.0 120.658 171.619 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -123.69 -20.43 5.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 126.057 2.837 . . . . 0.0 112.988 -166.468 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.73 28.8 22.99 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 118.035 -2.916 . . . . 0.0 115.983 170.035 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 tt -106.27 111.6 64.2 Favored Pre-proline 0 N--CA 1.446 -0.654 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 -175.213 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.32 151.87 23.34 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 125.163 3.909 . . . . 0.0 109.512 -174.789 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -47.86 -38.2 30.12 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 112.135 -3.36 . . . . 0.0 115.182 -166.795 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -13.91 2.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 127.676 3.11 . . . . 0.0 116.579 175.919 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -116.72 -7.4 11.52 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.039 2.535 . . . . 0.0 110.418 -176.2 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.277 80.0 mt-30 -87.67 145.36 26.2 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 117.866 -3.021 . . . . 0.0 105.656 175.709 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -124.64 128.13 48.39 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 129.037 2.935 . . . . 0.0 106.747 161.711 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -119.92 104.57 10.29 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 112.405 -3.664 . . . . 0.0 110.002 -160.941 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.65 131.52 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 1 CA-C-N 126.011 4.005 . . . . 0.0 108.798 -163.26 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -111.43 113.41 25.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.435 1.894 . . . . 0.0 112.202 164.207 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.8 -92.1 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 131.051 3.74 . . . . 0.0 110.51 -166.068 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.16 1.63 5.4 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 113.85 -1.523 . . . . 0.0 116.044 169.961 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -95.98 128.87 43.26 Favored 'General case' 0 CA--C 1.541 0.6 1 C-N-CA 132.031 4.132 . . . . 0.0 104.951 -174.168 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.371 18.6 mp0 -77.77 138.87 39.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.451 3.901 . . . . 0.0 107.903 178.178 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.455 ' HG ' ' CE2' ' A' ' 59' ' ' TYR . 8.1 mp -94.42 153.98 17.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.317 2.008 . . . . 0.0 107.315 172.544 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -135.23 144.25 46.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 112.257 -2.247 . . . . 0.0 108.648 164.555 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -49.15 146.88 3.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.671 2.388 . . . . 0.0 115.649 169.468 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.94 16.49 28.1 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-O 116.092 -2.504 . . . . 0.0 111.292 -169.289 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -145.92 158.26 43.87 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 127.512 3.53 . . . . 0.0 102.759 171.599 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -103.21 173.99 6.06 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 116.671 -3.768 . . . . 0.0 110.27 177.678 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.98 -36.46 83.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 117.994 -2.941 . . . . 0.0 106.83 176.59 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 t -64.91 -45.18 86.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.691 0.62 . . . . 0.0 112.444 175.95 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.63 -46.43 70.48 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.809 178.239 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 39.7 m-85 -75.41 -10.51 59.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 123.454 1.597 . . . . 0.0 113.629 -175.894 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.4 t30 66.32 45.95 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.516 3.526 . . . . 0.0 114.412 -173.069 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -90.21 142.82 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 O-C-N 126.577 2.423 . . . . 0.0 106.469 -178.264 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -137.12 177.99 7.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 178.196 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -49.03 116.85 1.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.665 2.386 . . . . 0.0 112.547 -176.0 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.457 21.4 mp0 79.74 23.52 0.47 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 130.298 3.439 . . . . 0.0 112.759 168.732 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 m -71.19 150.05 45.72 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.225 1.81 . . . . 0.0 111.012 169.175 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 m -98.9 130.52 45.3 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 119.161 -2.212 . . . . 0.0 109.429 162.386 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -109.62 141.05 42.7 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 114.914 -2.47 . . . . 0.0 108.876 167.441 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.355 23.2 t60 -100.94 164.06 12.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 121.603 2.001 . . . . 0.0 115.711 178.67 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.253 0.4 OUTLIER -141.11 136.7 32.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 129.14 2.976 . . . . 0.0 107.544 -175.841 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.65 118.69 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 O-C-N 126.791 2.557 . . . . 0.0 105.717 -176.492 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.446 -0.663 0 O-C-N 128.682 3.738 . . . . 0.0 108.222 171.886 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.259 9.5 ptt? . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -74.36 146.31 43.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 118.45 -2.656 . . . . 0.0 117.196 169.187 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.336 44.5 pt -130.85 133.92 62.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 115.256 -2.307 . . . . 0.0 107.846 166.788 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -117.64 107.83 14.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -177.644 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 67' ' ' LEU . 22.0 t -108.28 120.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.972 2.509 . . . . 0.0 105.046 -170.132 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -96.08 150.12 20.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 128.67 3.731 . . . . 0.0 112.502 178.327 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -113.96 138.14 50.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 160.667 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -53.37 -36.13 61.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -174.864 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.9 p -73.48 -11.4 60.44 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 130.038 3.335 . . . . 0.0 113.263 -175.587 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.92 54.08 0.32 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 126.992 2.234 . . . . 0.0 113.973 168.872 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -141.27 143.93 34.38 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 121.372 2.586 . . . . 0.0 111.052 166.355 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -123.97 117.07 23.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 167.323 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.9 mm -80.74 118.23 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 160.779 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -92.36 128.39 38.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 164.368 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -125.07 140.32 53.0 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.066 -2.271 . . . . 0.0 107.327 178.488 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -92.75 131.36 37.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 126.898 2.624 . . . . 0.0 110.905 162.112 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.5 m -134.97 160.02 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 127.522 2.329 . . . . 0.0 111.153 179.25 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.281 20.5 mm-40 -76.18 149.34 82.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 115.778 -2.058 . . . . 0.0 111.869 156.465 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -24.56 72.26 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 CA-C-N 123.915 2.434 . . . . 0.0 114.796 176.418 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -101.61 20.85 15.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.871 2.868 . . . . 0.0 112.354 177.617 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 11.2 t0 -82.92 155.35 24.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 118.117 -2.864 . . . . 0.0 110.699 169.142 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 p -81.01 152.74 27.79 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.966 -169.744 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.9 mm -67.11 -12.68 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 120.483 -1.386 . . . . 0.0 111.2 167.843 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -71.22 -45.89 62.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 120.725 -1.234 . . . . 0.0 111.374 169.398 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -53.17 -34.05 55.21 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 175.403 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.95 -40.57 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 117.827 -1.083 . . . . 0.0 108.543 179.242 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -70.63 -37.87 73.83 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 121.867 2.121 . . . . 0.0 111.12 -179.91 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.52 87.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 115.265 -2.303 . . . . 0.0 111.814 178.153 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.372 54.6 mttm -76.83 -31.21 56.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.472 1.509 . . . . 0.0 113.056 172.925 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.42 ' CG2' HD11 ' A' ' 36' ' ' ILE . 34.8 mt -70.77 -37.89 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 1 O-C-N 115.737 -4.352 . . . . 0.0 109.292 174.117 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -54.56 -37.8 65.88 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 122.759 2.527 . . . . 0.0 117.744 160.572 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.44 -39.75 94.42 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.16 -2.291 . . . . 0.0 115.416 -179.95 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -86.68 -69.11 0.7 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.38 2.272 . . . . 0.0 107.157 -174.225 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -83.42 -15.82 48.24 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 125.945 2.028 . . . . 0.0 114.341 -161.554 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.25 8.62 68.3 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 117.276 -3.39 . . . . 0.0 115.8 175.708 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.42 HD11 ' CG2' ' A' ' 30' ' ' ILE . 5.2 pt -99.8 123.61 46.94 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-O 113.426 -3.178 . . . . 0.0 112.455 -168.844 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.72 137.27 71.99 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 127.587 3.745 . . . . 0.0 110.968 -179.136 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -64.78 -8.91 19.1 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.801 2.334 . . . . 0.0 113.608 177.683 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -75.73 -12.5 60.2 Favored 'General case' 0 N--CA 1.452 -0.341 1 CA-C-N 127.09 4.495 . . . . 0.0 109.086 172.246 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -87.99 -22.02 24.5 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 127.661 2.384 . . . . 0.0 112.909 -178.85 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HB3' HD11 ' A' ' 69' ' ' LEU . 56.9 mt-30 -95.81 131.47 42.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 130.717 3.607 . . . . 0.0 103.232 -165.234 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.287 17.1 mtp180 -126.46 111.01 13.93 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.915 2.086 . . . . 0.0 108.432 170.993 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -94.4 133.16 38.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 117.205 -3.434 . . . . 0.0 114.698 -172.652 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 tt -144.37 136.74 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 128.768 2.827 . . . . 0.0 110.254 -155.288 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -140.79 138.23 33.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.631 1.832 . . . . 0.0 112.24 172.832 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.59 35.01 7.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.049 2.939 . . . . 0.0 115.276 170.184 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.42 -23.88 31.71 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.875 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -103.07 125.11 49.65 Favored 'General case' 0 C--N 1.324 -0.52 1 O-C-N 115.655 -4.438 . . . . 0.0 109.026 -160.849 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.446 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 2.4 pm0 -85.04 126.65 33.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 127.291 2.87 . . . . 0.0 105.644 174.929 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -96.25 128.05 42.81 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 125.565 1.791 . . . . 0.0 109.463 -163.062 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -72.46 130.23 40.2 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -178.29 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -62.12 123.57 18.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 129.797 3.239 . . . . 0.0 112.299 -173.362 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.97 -6.06 51.05 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 112.117 -2.31 . . . . 0.0 114.807 173.239 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -72.77 163.81 27.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.25 1.025 . . . . 0.0 112.539 167.003 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -99.43 154.09 18.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 123.848 1.785 . . . . 0.0 114.433 174.311 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.375 11.5 mt -53.99 -48.87 69.95 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 116.775 -3.703 . . . . 0.0 110.53 -173.953 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.279 33.0 t -57.62 -47.07 83.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.782 2.033 . . . . 0.0 110.401 -177.719 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -70.37 -22.59 62.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.141 0.976 . . . . 0.0 110.733 -169.976 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.29 -3.09 54.17 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 131.131 3.772 . . . . 0.0 113.631 170.06 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.443 11.8 m120 80.94 21.86 0.38 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 130.191 3.396 . . . . 0.0 116.314 173.695 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.9 mt -83.07 112.73 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 117.02 -3.55 . . . . 0.0 106.949 171.757 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.84 178.57 5.73 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.563 2.745 . . . . 0.0 112.646 -178.692 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -54.63 137.13 44.44 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.929 1.292 . . . . 0.0 111.995 171.048 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 69.12 23.1 6.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 131.694 3.998 . . . . 0.0 112.521 175.575 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.3 m -82.63 138.14 34.28 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 117.332 -3.355 . . . . 0.0 105.804 -169.38 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.74 133.36 42.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.469 -179.664 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.4 ' CD2' HG22 ' A' ' 5' ' ' VAL 0.3 0.0 OUTLIER -149.77 -155.54 0.64 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.556 1.071 . . . . 0.0 110.538 172.603 . . . . . . . . 4 4 . 1 . 046 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -158.17 170.21 22.79 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -168.912 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 41' ' ' GLN . 22.2 tp -129.32 144.81 51.37 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 128.541 3.65 . . . . 0.0 105.059 -178.173 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -119.58 124.39 72.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 127.961 3.288 . . . . 0.0 109.691 168.591 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 mt . . . . . 0 C--N 1.322 -0.59 0 C-N-CA 126.8 2.04 . . . . 0.0 108.506 172.209 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.1 ttp . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 113.298 -3.239 . . . . 0.0 107.17 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.18 133.04 52.99 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 126.357 2.285 . . . . 0.0 114.266 170.552 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.54 -176.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 119.162 -2.211 . . . . 0.0 109.083 159.109 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -135.38 162.93 31.22 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.107 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.457 ' HB ' HD23 ' A' ' 15' ' ' LEU . 12.3 t -134.57 112.44 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 130.023 3.329 . . . . 0.0 106.228 -176.319 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -94.98 120.97 36.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 171.186 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -67.82 167.18 13.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 112.65 -2.068 . . . . 0.0 110.816 172.645 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.611 HD21 ' H ' ' A' ' 71' ' ' LEU . 4.3 mp -64.57 -35.42 80.92 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 119.297 -2.127 . . . . 0.0 113.76 176.891 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.319 17.7 p -67.73 -51.14 52.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.433 2.293 . . . . 0.0 109.383 173.544 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.89 31.15 0.6 Allowed Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.333 -1.26 . . . . 0.0 115.364 174.7 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -86.21 131.51 34.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 122.736 3.268 . . . . 0.0 109.929 160.883 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -105.1 85.47 2.28 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.104 1.361 . . . . 0.0 108.862 -175.458 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.275 3.9 mt -87.48 141.13 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 -174.216 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 m -74.63 143.4 44.35 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 169.987 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.457 HD23 ' HB ' ' A' ' 5' ' ' VAL . 2.4 mm? -125.52 127.76 46.93 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 118.057 -2.902 . . . . 0.0 104.636 -175.089 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -80.86 115.05 20.15 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 130.974 3.71 . . . . 0.0 107.829 172.465 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.9 172.77 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.669 1.188 . . . . 0.0 108.58 -176.446 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -133.05 148.7 70.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 131.5 3.92 . . . . 0.0 113.75 148.895 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.32 93.5 Cg_endo -51.03 -15.78 2.17 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 O-C-N 124.904 2.002 . . . . 0.0 116.324 -177.444 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -92.4 -1.82 56.75 Favored 'General case' 0 N--CA 1.452 -0.336 1 O-C-N 115.539 -4.476 . . . . 0.0 115.599 174.327 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.253 72.0 m-20 -81.05 131.18 35.29 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.176 -1.41 . . . . 0.0 111.451 177.176 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -69.51 160.33 31.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.838 0.855 . . . . 0.0 111.044 179.664 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.512 HD12 HD13 ' A' ' 50' ' ' LEU . 17.6 mm -61.08 -34.74 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 129.036 2.934 . . . . 0.0 106.766 175.99 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.81 -58.98 5.53 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 127.969 2.508 . . . . 0.0 111.499 175.224 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -51.77 -45.93 63.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.712 2.508 . . . . 0.0 113.931 169.367 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.58 -48.07 88.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 O-C-N 124.988 1.43 . . . . 0.0 112.838 174.644 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HG3' HD12 ' A' ' 43' ' ' LEU . 20.1 mtmt -57.43 -35.6 70.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.858 -3.026 . . . . 0.0 113.678 170.282 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.57 81.29 Favored 'General case' 0 N--CA 1.452 -0.355 1 CA-C-O 111.302 -4.19 . . . . 0.0 109.976 174.433 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -67.59 -29.76 69.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 124.042 3.11 . . . . 0.0 111.568 -179.834 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 mt -81.48 -16.21 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 126.928 2.091 . . . . 0.0 110.912 -175.67 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -70.01 -49.0 55.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 117.52 -3.238 . . . . 0.0 115.488 156.525 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -49.17 -61.29 2.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.573 1.949 . . . . 0.0 115.785 170.374 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -63.23 -46.27 87.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 130.388 3.475 . . . . 0.0 114.758 -177.189 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -138.87 -21.82 0.97 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.079 1.752 . . . . 0.0 111.019 -154.99 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.99 1.34 54.96 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 122.091 2.223 . . . . 0.0 109.458 166.972 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -81.55 117.27 67.55 Favored Pre-proline 0 N--CA 1.445 -0.675 0 O-C-N 117.163 -3.551 . . . . 0.0 103.909 179.887 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -74.13 164.29 34.67 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.433 2.089 . . . . 0.0 112.0 -172.023 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.252 37.9 Cg_endo -73.67 -37.94 2.73 Favored 'Trans proline' 0 N--CA 1.446 -1.309 1 C-N-CA 126.275 4.65 . . . . 0.0 109.835 -177.401 . . . . . . . . 3 2 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 40' ' ' GLN . 48.2 t0 -80.12 143.75 33.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.501 2.321 . . . . 0.0 108.873 170.518 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 90.05 -31.04 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.206 1.002 . . . . 0.0 109.247 179.304 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -91.1 141.63 28.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.07 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -119.95 129.69 54.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 128.134 2.573 . . . . 0.0 110.989 172.243 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.448 HD12 ' HG3' ' A' ' 27' ' ' LYS . 94.1 mt -99.24 151.09 21.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 117.656 -3.152 . . . . 0.0 111.341 164.854 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mt -127.11 156.2 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 170.302 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -126.07 136.97 53.56 Favored 'General case' 0 N--CA 1.447 -0.625 1 C-N-CA 133.836 4.855 . . . . 0.0 108.789 157.043 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.49 -100.49 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 128.904 3.877 . . . . 0.0 108.776 179.021 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.37 -2.07 3.38 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 105.704 -2.958 . . . . 0.0 105.704 168.691 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -79.93 114.98 19.26 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 118.208 -2.936 . . . . 0.0 105.134 -173.348 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -64.93 126.36 27.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 122.982 1.372 . . . . 0.0 109.08 159.907 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.512 HD13 HD12 ' A' ' 23' ' ' ILE . 16.9 mt -90.79 141.8 28.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 124.167 1.937 . . . . 0.0 109.846 177.152 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -91.74 143.59 26.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.975 2.51 . . . . 0.0 109.342 170.75 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -49.51 -44.05 45.97 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 129.732 3.213 . . . . 0.0 112.836 -172.619 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.21 4.25 40.99 Favored Glycine 0 CA--C 1.531 1.062 1 O-C-N 115.423 -4.548 . . . . 0.0 112.788 -163.837 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -76.84 160.17 29.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 120.176 1.988 . . . . 0.0 112.103 164.096 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -97.93 162.35 13.29 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 127.174 2.796 . . . . 0.0 104.811 175.007 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 18.7 mt -42.5 -42.9 3.47 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.651 1.98 . . . . 0.0 109.721 157.736 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.3 t -69.02 -28.14 66.3 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 127.455 2.302 . . . . 0.0 110.035 -169.989 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -75.9 -9.07 58.3 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 175.127 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -118.9 11.74 12.65 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.416 1.886 . . . . 0.0 114.052 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.91 29.02 18.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.808 2.043 . . . . 0.0 115.679 179.9 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.2 mt -96.33 105.04 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 124.25 1.976 . . . . 0.0 108.541 -170.077 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -89.43 178.55 6.29 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 120.01 -1.681 . . . . 0.0 113.074 163.482 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -60.46 161.45 7.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 129.936 3.295 . . . . 0.0 115.999 -167.426 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 74.96 2.89 4.09 Favored 'General case' 0 N--CA 1.443 -0.815 1 C-N-CA 133.559 4.743 . . . . 0.0 112.946 175.931 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -71.31 132.46 44.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.149 1.78 . . . . 0.0 113.232 -177.093 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 p -97.95 113.0 24.72 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 125.443 1.714 . . . . 0.0 108.343 -176.74 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.82 156.2 20.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.967 1.307 . . . . 0.0 110.66 173.193 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -127.19 119.72 27.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 124.389 2.043 . . . . 0.0 106.166 -174.581 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tt -91.2 120.31 32.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.518 3.127 . . . . 0.0 103.871 -174.728 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.32 131.02 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 112.302 -2.227 . . . . 0.0 106.371 170.459 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.611 ' H ' HD21 ' A' ' 8' ' ' LEU . 12.3 mt . . . . . 0 C--N 1.329 -0.287 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 175.181 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 116.482 -1.723 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -65.77 132.38 48.6 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 125.01 1.444 . . . . 0.0 113.14 -171.487 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 pt -135.56 171.34 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 O-C-N 118.876 -2.39 . . . . 0.0 109.144 174.282 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -114.29 126.06 54.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 126.073 2.108 . . . . 0.0 109.156 170.848 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -110.26 147.61 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 163.777 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.274 62.4 tttt -126.6 125.02 41.24 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 131.439 3.896 . . . . 0.0 113.849 -174.286 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -102.74 162.79 12.64 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.81 1.644 . . . . 0.0 108.589 -173.599 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.873 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -77.83 -16.16 58.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 129.756 3.222 . . . . 0.0 116.891 -167.598 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 p -83.81 -0.9 52.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 164.035 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.3 27.4 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 127.432 2.444 . . . . 0.0 111.609 171.097 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -67.62 136.2 54.05 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 123.377 3.588 . . . . 0.0 115.935 -173.55 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 m -113.57 147.89 37.16 Favored 'General case' 0 C--N 1.325 -0.462 1 CA-C-O 129.069 4.271 . . . . 0.0 104.029 174.829 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.276 19.2 pt -127.64 114.8 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 109.367 -3.561 . . . . 0.0 110.102 178.451 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.4 p -84.94 108.84 17.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 101.807 -3.405 . . . . 0.0 101.807 177.283 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 pp -139.78 154.52 47.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 123.409 1.576 . . . . 0.0 111.28 170.011 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -84.47 133.57 34.47 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.518 2.327 . . . . 0.0 112.467 177.958 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.16 -153.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 168.399 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -151.08 158.83 34.5 Favored Pre-proline 0 N--CA 1.443 -0.794 0 C-N-CA 127.418 2.287 . . . . 0.0 106.556 -173.002 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.81 -32.91 35.69 Favored 'Trans proline' 0 N--CA 1.445 -1.333 1 C-N-CA 126.298 4.665 . . . . 0.0 115.951 174.871 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -99.11 3.99 46.8 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.885 2.874 . . . . 0.0 112.124 -171.981 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.64 145.73 29.5 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 121.311 1.869 . . . . 0.0 110.761 -179.081 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.7 p -85.6 162.68 18.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.577 2.351 . . . . 0.0 111.034 169.295 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.334 81.2 mt -53.16 -44.03 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 O-C-N 127.253 2.845 . . . . 0.0 115.871 178.501 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -49.67 -36.11 23.86 Favored 'General case' 0 C--N 1.33 -0.275 1 C-N-CA 132.255 4.222 . . . . 0.0 115.003 166.974 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -82.92 -11.97 57.73 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 126.462 1.905 . . . . 0.0 114.275 176.407 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -98.79 -41.07 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.006 1.322 . . . . 0.0 111.392 174.648 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -53.68 -45.01 70.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 128.991 2.916 . . . . 0.0 109.56 173.793 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.79 89.19 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 126.428 3.014 . . . . 0.0 111.78 -175.845 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -60.14 -44.33 95.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 131.629 3.972 . . . . 0.0 112.8 177.171 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.12 -37.56 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 179.764 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -65.35 -38.95 91.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 124.171 3.169 . . . . 0.0 112.919 179.43 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -59.53 -26.3 65.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 112.923 -3.418 . . . . 0.0 115.017 171.241 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -115.18 -28.18 7.03 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 122.117 2.235 . . . . 0.0 111.255 -163.191 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -126.06 -19.28 4.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.719 2.408 . . . . 0.0 114.605 -177.215 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.91 16.34 61.46 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 115.909 -2.606 . . . . 0.0 114.362 178.94 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.6 mt -87.73 123.7 68.75 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 123.066 3.433 . . . . 0.0 109.469 -163.213 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 13.9 Cg_endo -73.31 127.63 12.09 Favored 'Trans proline' 0 N--CA 1.453 -0.901 1 O-C-N 128.871 4.09 . . . . 0.0 111.334 -176.523 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 98.6 Cg_endo -82.36 -19.05 6.79 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.16 2.573 . . . . 0.0 115.047 -157.249 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.85 -28.28 65.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 115.829 -2.034 . . . . 0.0 110.858 176.604 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.77 9.39 16.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 127.77 3.169 . . . . 0.0 107.453 -164.577 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -110.9 142.34 43.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 123.394 1.569 . . . . 0.0 109.476 -170.403 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -126.67 122.36 34.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 130.593 3.557 . . . . 0.0 109.786 162.35 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.8 mt -110.05 115.59 30.04 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.643 3.177 . . . . 0.0 107.074 -168.399 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 49' ' ' GLN . 30.5 mm -97.88 129.35 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 127.823 2.449 . . . . 0.0 115.123 -178.653 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.257 63.8 t80 -143.41 128.68 18.82 Favored 'General case' 0 C--N 1.327 -0.394 1 O-C-N 114.484 -5.135 . . . . 0.0 110.428 168.945 . . . . . . . . 3 2 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.1 38.5 24.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 165.457 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.53 -11.39 7.99 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 116.762 -2.132 . . . . 0.0 115.016 164.069 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -149.47 170.98 17.33 Favored 'General case' 0 C--N 1.324 -0.513 1 C-N-CA 131.865 4.066 . . . . 0.0 114.466 -176.119 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.485 ' HA ' HD13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -54.61 132.73 45.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 128.91 2.884 . . . . 0.0 107.498 154.275 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 tp -66.75 138.44 57.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 112.067 -2.333 . . . . 0.0 106.394 165.787 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -51.13 145.92 7.13 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.438 1.895 . . . . 0.0 110.659 163.192 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -103.02 109.49 21.05 Favored 'General case' 0 N--CA 1.448 -0.568 1 N-CA-C 96.562 -5.347 . . . . 0.0 96.562 170.504 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.62 35.07 1.94 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.783 2.611 . . . . 0.0 116.694 178.707 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -133.09 132.74 42.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 115.927 -1.987 . . . . 0.0 110.043 171.014 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.0 p -75.67 150.57 37.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 125.154 2.406 . . . . 0.0 113.351 168.165 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -56.74 -35.68 68.87 Favored 'General case' 0 N--CA 1.441 -0.907 1 O-C-N 115.774 -4.329 . . . . 0.0 118.005 -159.428 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -75.85 -4.93 43.5 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 129.946 3.298 . . . . 0.0 112.628 176.64 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -77.11 -11.0 59.75 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 120.948 1.704 . . . . 0.0 111.758 169.774 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -113.09 159.12 19.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 129.296 3.038 . . . . 0.0 105.04 168.134 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -80.5 55.36 2.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.61 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -73.1 104.97 2.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 159.51 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.265 71.1 mm-40 -96.37 169.8 9.68 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 125.604 1.815 . . . . 0.0 114.35 170.49 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -46.84 130.88 12.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 119.946 -1.721 . . . . 0.0 112.372 166.251 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.31 8.1 mt-10 77.54 18.85 1.28 Allowed 'General case' 0 N--CA 1.451 -0.383 1 C-N-CA 133.484 4.714 . . . . 0.0 112.185 170.417 . . . . . . . . 3 2 . 1 . 048 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -74.26 148.03 41.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.958 179.165 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.9 m -95.9 104.44 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 102.183 -3.265 . . . . 0.0 102.183 -168.22 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.2 143.69 27.17 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.314 2.646 . . . . 0.0 108.057 166.944 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -124.29 136.65 54.29 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -174.878 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.93 121.59 45.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.908 2.083 . . . . 0.0 105.41 178.863 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 t -108.15 146.97 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.487 2.315 . . . . 0.0 106.443 170.984 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 tp . . . . . 0 N--CA 1.447 -0.62 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 -175.11 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 122.407 1.098 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -79.12 135.24 36.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.528 -2.124 . . . . 0.0 110.517 -178.999 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -128.46 172.7 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.964 2.905 . . . . 0.0 109.709 173.636 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -116.79 153.37 32.55 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.363 2.665 . . . . 0.0 108.32 173.228 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.508 9.1 p -133.36 133.88 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 C-N-CA 129.045 2.938 . . . . 0.0 107.454 177.863 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -88.0 118.81 27.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 156.458 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -64.79 162.54 15.87 Favored 'General case' 0 C--N 1.324 -0.542 1 C-N-CA 132.924 4.49 . . . . 0.0 107.788 167.545 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.98 -11.56 60.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 123.749 1.738 . . . . 0.0 114.248 -173.141 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -91.99 -14.69 29.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.288 1.435 . . . . 0.0 111.575 173.753 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.62 -2.3 15.55 Favored Glycine 0 CA--C 1.535 1.31 1 O-C-N 113.447 -5.783 . . . . 0.0 111.491 165.994 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -88.27 134.39 33.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.744 2.418 . . . . 0.0 108.611 -172.682 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.09 146.91 52.25 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.34 166.083 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.533 57.2 mt -125.81 130.77 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 O-C-N 126.595 2.434 . . . . 0.0 109.223 152.901 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 90.8 m -83.73 130.57 34.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 171.845 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.1 tp -135.77 142.35 44.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 115.912 -1.994 . . . . 0.0 113.95 -174.42 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -94.28 128.23 40.63 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 131.211 3.804 . . . . 0.0 106.904 175.244 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -139.52 144.22 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 O-C-N 120.089 -1.632 . . . . 0.0 111.902 172.362 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.439 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -76.56 148.74 80.35 Favored Pre-proline 0 N--CA 1.447 -0.601 0 C-N-CA 126.305 1.842 . . . . 0.0 109.583 173.217 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.52 -41.82 18.61 Favored 'Trans proline' 0 N--CA 1.447 -1.215 1 C-N-CA 128.543 6.162 . . . . 0.0 109.731 159.057 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.9 p -66.54 -5.91 13.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.566 2.746 . . . . 0.0 117.898 170.668 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 3.0 t0 -88.61 145.94 25.4 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 117.434 -3.291 . . . . 0.0 105.097 -175.841 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -98.67 145.56 26.76 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.628 2.371 . . . . 0.0 115.901 -177.625 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.331 44.6 mm -42.0 -49.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 -176.575 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -75.87 -31.34 59.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 126.456 3.027 . . . . 0.0 114.306 -175.997 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.68 -35.37 65.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 116.499 -3.876 . . . . 0.0 113.085 172.637 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.0 t -72.21 -36.07 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 1 CA-C-O 111.127 -4.273 . . . . 0.0 112.252 169.817 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -61.47 -29.06 69.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 124.184 3.175 . . . . 0.0 114.39 162.68 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.334 . . -68.61 -31.21 70.22 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 126.77 2.544 . . . . 0.0 110.526 175.249 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -74.25 -19.32 60.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 122.458 2.39 . . . . 0.0 114.573 174.322 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.4 mm -76.71 -27.89 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 125.767 1.627 . . . . 0.0 114.047 161.629 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -63.28 -37.82 88.73 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -176.378 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.34 -53.9 3.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.477 1.511 . . . . 0.0 113.495 166.273 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -91.04 -46.32 8.2 Favored 'General case' 0 N--CA 1.45 -0.449 1 O-C-N 129.138 4.024 . . . . 0.0 107.038 -159.482 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -96.11 -32.63 12.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 119.092 -2.255 . . . . 0.0 113.503 -172.754 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.13 -31.33 8.67 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 116.857 -2.08 . . . . 0.0 108.654 175.264 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.271 8.3 mm -47.98 116.76 4.97 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 175.38 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.8 152.2 81.7 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 CA-C-N 124.032 2.476 . . . . 0.0 108.223 176.784 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.67 -36.61 72.87 Favored 'Trans proline' 0 N--CA 1.453 -0.864 1 C-N-CA 128.596 6.197 . . . . 0.0 116.023 175.274 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.18 -17.59 58.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.831 2.852 . . . . 0.0 113.938 177.804 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.265 9.3 mm-40 -91.64 -9.72 42.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 115.641 -2.123 . . . . 0.0 112.722 166.539 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -108.81 130.13 55.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -167.244 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -118.2 -176.18 3.01 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 119.863 -1.773 . . . . 0.0 109.242 156.365 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.87 123.63 3.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 177.216 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mm -108.86 122.4 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 -176.917 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -138.66 108.39 6.26 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.434 3.894 . . . . 0.0 109.434 -167.407 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.07 27.2 7.05 Favored 'General case' 0 N--CA 1.443 -0.821 1 C-N-CA 131.743 4.017 . . . . 0.0 115.972 177.665 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.37 17.13 20.79 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 106.448 -2.661 . . . . 0.0 106.448 170.05 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.302 65.6 pttt -150.71 159.46 44.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.911 2.084 . . . . 0.0 115.687 -171.698 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -79.62 148.2 31.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 131.344 3.858 . . . . 0.0 116.711 162.593 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.9 mt -100.24 118.45 36.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 128.354 3.534 . . . . 0.0 101.728 174.237 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.283 7.8 tp10 -87.3 157.15 19.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.226 -0.921 . . . . 0.0 109.052 -175.621 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.07 155.31 39.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.984 2.114 . . . . 0.0 110.675 -177.626 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.11 -14.38 57.48 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.991 175.229 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -90.65 149.34 22.13 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -176.342 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.8 p -79.19 174.29 11.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 117.326 -3.359 . . . . 0.0 109.154 167.135 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mp -76.61 -22.88 53.58 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 117.039 -3.538 . . . . 0.0 112.587 174.309 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 t -70.26 -29.14 65.85 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 127.517 2.327 . . . . 0.0 112.689 171.321 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.47 -32.32 73.86 Favored 'General case' 0 C--N 1.322 -0.6 1 O-C-N 115.843 -4.286 . . . . 0.0 111.934 173.174 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.86 6.21 21.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 119.841 -1.787 . . . . 0.0 106.738 -169.687 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.361 1.6 p-10 57.21 41.44 26.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 124.701 2.191 . . . . 0.0 113.878 167.838 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 mt -90.56 122.38 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 129.991 3.316 . . . . 0.0 106.241 -176.599 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.287 21.3 mm-40 -115.27 -176.6 2.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 130.537 3.535 . . . . 0.0 116.22 176.242 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -51.42 161.88 0.41 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 123.277 2.762 . . . . 0.0 116.065 159.83 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 85.16 1.37 0.74 Allowed 'General case' 0 C--N 1.325 -0.496 1 C-N-CA 133.301 4.64 . . . . 0.0 111.214 171.136 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -82.04 107.46 14.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 -177.373 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -84.37 110.66 18.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.553 2.341 . . . . 0.0 111.279 157.158 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.1 mt -76.46 162.67 27.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.118 -1.614 . . . . 0.0 115.16 170.019 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -119.94 147.56 44.6 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.961 2.104 . . . . 0.0 110.369 150.687 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.68 149.4 21.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 129.104 2.962 . . . . 0.0 111.947 171.317 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -133.74 155.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 O-C-N 117.839 -3.038 . . . . 0.0 115.452 168.722 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.5 mt . . . . . 0 N--CA 1.452 -0.365 0 CA-C-N 122.633 2.47 . . . . 0.0 105.712 -170.923 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 ttp . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 100.425 -3.917 . . . . 0.0 100.425 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -72.14 137.46 47.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 111.648 -2.524 . . . . 0.0 110.999 -175.108 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.305 10.9 pt -141.17 170.74 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 O-C-N 125.678 1.861 . . . . 0.0 111.268 173.106 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -122.37 138.95 54.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 107.132 177.428 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.64 117.66 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 101.875 -3.38 . . . . 0.0 101.875 173.298 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -78.87 135.38 37.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 125.327 2.489 . . . . 0.0 112.838 165.395 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 p -80.16 -169.43 2.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 118.746 -2.471 . . . . 0.0 110.023 -179.398 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.5 mt -61.82 -40.41 95.2 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -165.909 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.8 p -103.04 9.01 38.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 111.338 -2.665 . . . . 0.0 112.739 -176.266 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.64 -0.73 59.67 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 128.655 3.026 . . . . 0.0 117.841 170.469 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -73.4 129.29 37.69 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 119.949 1.874 . . . . 0.0 110.771 177.199 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 t -81.04 136.37 35.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.785 2.034 . . . . 0.0 113.72 -177.945 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 pt -114.15 120.14 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 102.671 -3.085 . . . . 0.0 102.671 168.681 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.8 m -86.66 112.88 22.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.04 2.536 . . . . 0.0 108.86 -179.836 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.83 170.07 8.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.153 2.981 . . . . 0.0 104.346 -170.698 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.484 1.1 pm0 -132.79 124.39 27.94 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 131.297 3.839 . . . . 0.0 118.965 162.99 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.334 0.0 OUTLIER -143.85 154.14 15.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 113.909 -1.496 . . . . 0.0 113.898 -175.345 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -88.97 151.08 46.63 Favored Pre-proline 0 N--CA 1.452 -0.367 0 O-C-N 119.67 -1.894 . . . . 0.0 108.828 176.919 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.29 -30.09 10.54 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 124.907 3.738 . . . . 0.0 117.53 165.835 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.303 16.8 p -96.99 12.84 31.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 129.201 3.001 . . . . 0.0 112.714 170.799 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.81 142.35 31.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 123.421 2.828 . . . . 0.0 108.104 167.513 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -81.8 177.9 8.62 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 131.565 3.946 . . . . 0.0 111.285 -177.573 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -89.21 -18.96 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 O-C-N 116.575 -3.828 . . . . 0.0 111.321 -170.803 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.76 -37.66 74.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.102 157.432 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -85.11 5.26 30.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 123.71 1.719 . . . . 0.0 110.425 -172.616 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.25 -37.41 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 O-C-N 118.08 -2.887 . . . . 0.0 110.06 156.475 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -56.78 -52.65 64.21 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 116.571 -3.831 . . . . 0.0 110.083 174.846 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.3 46.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 118.086 2.625 . . . . 0.0 118.086 179.502 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -83.18 -26.54 30.77 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 111.553 -2.567 . . . . 0.0 116.126 178.443 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.0 mt -68.38 -38.96 80.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 115.758 -2.067 . . . . 0.0 108.838 160.666 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.15 -34.19 77.51 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 117.832 -1.08 . . . . 0.0 109.921 174.457 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.44 -34.67 77.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -179.091 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -102.24 -25.21 13.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 127.651 3.094 . . . . 0.0 117.937 -176.713 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -141.15 -16.24 0.85 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.627 2.371 . . . . 0.0 112.352 -171.599 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.06 -3.89 67.31 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 120.217 -1.552 . . . . 0.0 113.699 152.157 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.3 mt -73.3 132.65 81.65 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 114.055 -2.879 . . . . 0.0 106.037 -176.953 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.6 132.56 22.21 Favored 'Trans proline' 0 N--CA 1.454 -0.81 1 C-N-CA 127.118 5.212 . . . . 0.0 106.856 -171.274 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -40.2 -30.68 0.46 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 1 C-N-CA 130.445 7.43 . . . . 0.0 119.604 177.503 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.76 -39.07 84.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.448 2.299 . . . . 0.0 113.725 175.744 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.32 -16.15 55.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 115.248 -2.311 . . . . 0.0 112.64 -175.707 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.46 130.89 35.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.76 2.824 . . . . 0.0 111.638 -172.696 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -121.47 131.93 54.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 103.354 -2.832 . . . . 0.0 103.354 168.688 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 mt -103.0 137.82 40.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 119.914 1.234 . . . . 0.0 110.488 166.649 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mm -122.61 148.66 26.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 129.925 3.29 . . . . 0.0 107.862 177.341 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -153.88 127.58 8.75 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.177 1.791 . . . . 0.0 110.038 173.919 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.37 40.39 10.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.048 2.139 . . . . 0.0 115.08 -172.536 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.64 -13.08 68.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 117.638 1.815 . . . . 0.0 117.638 177.559 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.399 55.3 pttt -123.78 148.34 46.75 Favored 'General case' 0 C--N 1.326 -0.437 1 C-N-CA 133.353 4.661 . . . . 0.0 108.212 -161.691 . . . . . . . . 3 2 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -71.3 155.33 40.8 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 118.388 -2.695 . . . . 0.0 109.245 -169.277 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -136.23 114.08 11.2 Favored 'General case' 0 N--CA 1.451 -0.388 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 177.885 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -123.31 155.49 37.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 126.335 2.969 . . . . 0.0 111.895 -169.186 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.26 145.28 55.34 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.013 -2.929 . . . . 0.0 108.668 -178.246 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.07 -6.7 19.43 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 127.148 2.78 . . . . 0.0 113.977 -173.756 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -135.35 -175.56 3.98 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.414 1.486 . . . . 0.0 113.032 -179.509 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.6 p -128.39 175.17 8.71 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.288 1.035 . . . . 0.0 109.787 -178.856 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -55.05 -36.44 65.56 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.532 1.933 . . . . 0.0 113.703 171.423 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.328 13.0 m -75.6 -25.61 57.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 115.622 -2.431 . . . . 0.0 113.6 177.159 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -70.46 -41.61 72.54 Favored 'General case' 0 N--CA 1.45 -0.451 2 CA-C-N 126.516 4.235 . . . . 0.0 112.817 173.196 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -82.09 -12.63 58.12 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 124.742 1.276 . . . . 0.0 110.8 -176.212 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.5 m120 72.76 58.91 0.12 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.554 3.542 . . . . 0.0 114.984 175.836 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -100.69 159.05 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 112.504 -2.134 . . . . 0.0 109.814 -177.933 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -130.52 -151.73 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.684 1.194 . . . . 0.0 112.188 -176.614 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -90.34 144.64 25.64 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.427 2.291 . . . . 0.0 107.444 175.874 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 77.01 19.75 1.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 125.213 2.435 . . . . 0.0 111.073 161.895 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.7 m -87.78 133.42 33.87 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.97 2.508 . . . . 0.0 115.278 -178.025 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.1 m -111.93 125.36 53.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 123.608 2.913 . . . . 0.0 104.24 -170.787 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mt -103.05 166.32 10.51 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.313 2.245 . . . . 0.0 111.281 173.518 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -109.43 134.01 52.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 118.669 -2.52 . . . . 0.0 105.282 164.99 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 1.5 tm? -90.01 140.22 29.85 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.088 1.355 . . . . 0.0 109.696 154.033 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.92 156.22 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 128.869 2.868 . . . . 0.0 111.616 164.012 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 125.908 1.683 . . . . 0.0 108.812 171.529 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 123.732 1.729 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -103.4 120.45 40.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 119.613 -1.93 . . . . 0.0 107.175 178.3 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -121.92 131.22 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.056 170.42 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -86.86 81.44 8.15 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.629 2.372 . . . . 0.0 109.166 -174.358 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -65.41 132.54 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 125.981 1.713 . . . . 0.0 108.682 169.246 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -123.24 152.78 40.97 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 119.972 -1.705 . . . . 0.0 109.562 172.923 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -117.73 -177.44 3.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 126.478 3.037 . . . . 0.0 109.585 -165.296 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -77.68 -42.4 34.71 Favored 'General case' 0 N--CA 1.446 -0.656 1 O-C-N 115.899 -4.251 . . . . 0.0 104.669 174.38 . . . . . . . . 4 4 . 1 . 051 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -69.89 -19.08 63.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 123.22 2.736 . . . . 0.0 112.772 -176.316 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.38 32.16 2.62 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.044 0.83 . . . . 0.0 113.112 156.982 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -110.68 146.27 36.52 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 114.22 -2.8 . . . . 0.0 110.088 -167.113 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.261 43.1 m -99.57 89.71 4.24 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 173.802 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mm -52.47 -57.93 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 120.757 1.617 . . . . 0.0 112.209 -173.848 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.317 75.5 m 79.3 81.91 0.06 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -178.675 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 tp -99.15 138.65 35.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 124.984 2.326 . . . . 0.0 106.61 -178.877 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -91.35 121.52 33.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.223 -1.548 . . . . 0.0 107.916 170.896 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.401 4.8 t -121.56 152.24 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 103.831 -2.655 . . . . 0.0 103.831 -175.547 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -104.36 136.0 19.25 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-O 114.624 -2.608 . . . . 0.0 109.384 170.909 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -57.7 -18.09 31.94 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 N-CA-C 118.609 2.503 . . . . 0.0 118.609 -174.773 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.7 p -74.08 -15.07 61.07 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.655 2.382 . . . . 0.0 114.427 168.93 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 25' ' ' ASN . 92.8 m-20 -66.39 129.01 38.39 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 122.72 2.509 . . . . 0.0 110.698 -176.026 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.6 p -85.37 174.67 9.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.971 1.714 . . . . 0.0 108.389 163.243 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.255 27.4 mm -46.7 -39.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 128.707 2.803 . . . . 0.0 115.899 176.592 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -59.02 -43.27 91.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 115.716 -2.088 . . . . 0.0 111.058 174.996 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 29.7 m120 -73.23 -36.06 66.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 127.476 2.31 . . . . 0.0 109.561 -172.513 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.29 -55.13 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 124.467 1.107 . . . . 0.0 110.512 172.989 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.263 78.7 mttt -43.5 -44.47 6.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.239 2.216 . . . . 0.0 113.512 169.718 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.22 -53.26 59.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.298 2.239 . . . . 0.0 110.097 177.506 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -62.37 -33.26 74.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 179.976 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -68.02 -44.72 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 126.946 2.654 . . . . 0.0 109.873 165.878 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -46.15 91.84 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 125.368 1.667 . . . . 0.0 114.106 -178.977 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.446 27.8 t70 -34.45 -61.32 0.39 Allowed 'General case' 0 N--CA 1.448 -0.549 1 N-CA-C 124.403 4.964 . . . . 0.0 124.403 152.451 . . . . . . . . 3 2 . 1 . 051 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -95.19 -30.23 14.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 119.892 -1.755 . . . . 0.0 111.405 -156.764 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -109.25 -27.79 9.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 128.806 2.843 . . . . 0.0 110.709 -179.978 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.58 -3.15 61.0 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 121.428 3.331 . . . . 0.0 121.428 167.674 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -85.15 145.19 42.5 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 114.054 -2.879 . . . . 0.0 109.715 -179.88 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.23 161.59 33.48 Favored 'Trans proline' 0 N--CA 1.45 -1.039 1 C-N-CA 126.781 4.987 . . . . 0.0 109.986 174.039 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.82 -13.07 8.28 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.724 3.616 . . . . 0.0 115.242 -171.949 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.55 -36.21 63.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 160.586 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' ' 40' ' ' GLN . 2.5 tt0 -67.78 -23.48 65.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.286 -1.34 . . . . 0.0 113.508 179.57 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -85.23 129.1 34.87 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 113.839 -2.981 . . . . 0.0 106.042 -168.484 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -110.68 160.05 17.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 155.165 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.519 0.2 OUTLIER -136.44 135.51 38.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 119.112 -2.243 . . . . 0.0 114.98 176.686 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 mt -127.47 108.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -159.469 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -124.19 130.98 53.46 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.858 1.663 . . . . 0.0 110.369 171.787 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.09 50.54 13.96 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 130.398 3.479 . . . . 0.0 110.68 175.304 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.1 -34.3 3.99 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.841 2.162 . . . . 0.0 117.173 178.839 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -89.04 132.05 34.94 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -164.134 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.259 24.5 mt-30 -88.71 104.31 16.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 123.835 1.778 . . . . 0.0 108.949 168.373 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 mt -55.86 138.35 48.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 110.426 -3.079 . . . . 0.0 113.298 -166.529 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -88.64 152.49 21.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 116.423 -1.751 . . . . 0.0 106.851 -172.121 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.59 134.76 50.46 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 114.58 -2.629 . . . . 0.0 114.885 -173.671 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.83 16.92 80.35 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 117.384 1.713 . . . . 0.0 117.384 172.614 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.0 mmm-85 -99.21 176.98 5.35 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.887 2.075 . . . . 0.0 107.583 178.448 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.5 p -100.05 141.24 33.14 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 102.371 -3.196 . . . . 0.0 102.371 -172.622 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 21.7 mt -66.26 -30.81 71.32 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 127.529 2.332 . . . . 0.0 113.071 179.661 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.3 m -87.17 -22.13 25.5 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.321 -166.802 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.02 -15.89 60.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 124.864 1.352 . . . . 0.0 114.314 173.658 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -92.84 5.62 50.62 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.847 2.059 . . . . 0.0 109.299 168.135 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 75.94 21.74 1.54 Allowed 'General case' 0 N--CA 1.444 -0.765 1 C-N-CA 134.007 4.923 . . . . 0.0 118.322 170.164 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 mt -82.33 103.69 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 C-N-CA 128.144 2.578 . . . . 0.0 107.543 -169.069 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -89.5 170.44 10.5 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.059 2.143 . . . . 0.0 109.63 177.084 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -66.76 159.01 28.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 116.991 -1.48 . . . . 0.0 113.586 159.632 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 68.35 18.88 9.07 Favored 'General case' 0 N--CA 1.453 -0.318 1 C-N-CA 132.913 4.485 . . . . 0.0 111.032 179.359 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.1 t -95.94 178.39 5.44 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 128.731 3.769 . . . . 0.0 112.182 -176.433 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.2 p -131.85 133.71 44.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 125.798 1.936 . . . . 0.0 111.072 -171.971 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.19 150.91 51.94 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 126.279 2.237 . . . . 0.0 105.468 -171.704 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -108.2 119.67 40.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 117.942 -2.974 . . . . 0.0 110.953 171.663 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.3 tp -82.4 133.78 35.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 173.43 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.291 68.7 t -108.61 141.28 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 125.149 3.613 . . . . 0.0 107.495 163.257 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.437 HD13 HD23 ' A' ' 8' ' ' LEU . 4.8 mp . . . . . 0 N--CA 1.444 -0.759 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 167.113 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 ttp . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 116.627 -1.654 . . . . 0.0 108.069 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -73.12 133.1 44.0 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 122.407 2.367 . . . . 0.0 115.765 176.167 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.446 HD12 HD23 ' A' ' 67' ' ' LEU . 42.0 pt -122.3 155.3 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 115.647 -2.12 . . . . 0.0 112.551 165.084 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -102.5 128.37 49.17 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 126.046 2.091 . . . . 0.0 105.658 179.262 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -100.54 109.6 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 118.047 -2.908 . . . . 0.0 103.383 166.066 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -102.95 150.3 23.67 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.447 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.283 14.8 t -145.48 160.32 41.77 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 125.27 2.462 . . . . 0.0 109.217 158.243 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.453 HD13 ' CE1' ' A' ' 68' ' ' HIS . 2.0 mp -67.71 -39.71 84.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 109.114 -3.675 . . . . 0.0 114.365 -161.914 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 p -52.48 -5.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 1 C-N-CA 133.435 4.694 . . . . 0.0 115.728 171.486 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.27 2.09 54.11 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 119.911 -1.743 . . . . 0.0 112.772 167.228 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -79.7 126.46 30.96 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.185 1.993 . . . . 0.0 110.096 164.308 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 m -128.2 101.96 6.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 103.244 -2.872 . . . . 0.0 103.244 171.031 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.266 2.8 mp -80.26 150.07 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 130.741 3.616 . . . . 0.0 110.457 -177.462 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 t -135.91 122.1 20.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.636 1.575 . . . . 0.0 108.241 -175.885 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -123.14 147.52 46.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.773 1.229 . . . . 0.0 113.845 175.221 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -97.43 121.23 39.09 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 131.093 3.757 . . . . 0.0 105.605 177.162 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -131.04 166.72 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 118.494 -2.629 . . . . 0.0 114.481 178.474 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -95.69 156.71 37.08 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 155.65 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.28 -20.04 69.68 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.64 2.893 . . . . 0.0 113.15 -179.891 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 13.6 p -91.78 0.33 57.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.945 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -66.33 142.85 57.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 176.562 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.33 147.49 26.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 125.216 2.436 . . . . 0.0 109.043 178.356 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.2 mt -55.75 -26.46 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 118.903 -2.373 . . . . 0.0 113.149 179.603 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.287 31.9 mt-10 -74.07 -42.66 59.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 109.422 -178.535 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.01 -50.4 70.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.513 175.499 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.1 t -55.57 -31.1 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 115.612 -2.137 . . . . 0.0 111.835 166.029 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -76.71 -17.56 59.03 Favored 'General case' 0 N--CA 1.442 -0.834 2 CA-C-N 128.092 4.951 . . . . 0.0 109.66 -177.267 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.42 -19.99 22.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.516 1.126 . . . . 0.0 113.215 172.273 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -73.76 -29.72 62.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 170.785 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 30' ' ' ILE . 56.9 mt -64.79 -30.78 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 128.834 2.854 . . . . 0.0 115.148 160.309 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -65.71 -53.51 39.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.62 1.1 . . . . 0.0 111.776 173.094 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.401 22.9 t70 -36.99 -34.16 0.07 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 131.514 3.926 . . . . 0.0 112.485 168.283 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -93.78 -57.99 2.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 120.582 1.537 . . . . 0.0 115.038 171.816 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.26 -21.14 23.35 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -161.268 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.99 1.95 62.81 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 119.312 2.485 . . . . 0.0 119.312 -174.905 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.0 mt -95.86 140.87 22.49 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 128.191 2.596 . . . . 0.0 110.874 -163.234 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.59 136.53 10.98 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.765 2.977 . . . . 0.0 115.604 172.774 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -66.47 -21.21 53.62 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 124.562 3.508 . . . . 0.0 116.093 -158.047 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.31 4.78 9.91 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 117.907 -2.996 . . . . 0.0 110.94 -176.884 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -95.36 -18.96 20.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 113.172 -3.299 . . . . 0.0 109.083 168.062 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.284 13.4 mm-40 -98.0 125.05 42.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 124.678 3.399 . . . . 0.0 112.319 -160.835 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 127.5 42.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 100.635 -3.839 . . . . 0.0 100.635 -178.772 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.7 mt -101.89 134.78 44.54 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 128.683 2.793 . . . . 0.0 115.096 179.688 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -128.74 156.65 41.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 126.458 1.903 . . . . 0.0 107.209 167.753 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.491 ' HB3' HD21 ' A' ' 50' ' ' LEU 0.368 6.7 t80 -126.61 -126.65 0.23 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 109.711 -3.404 . . . . 0.0 107.945 -157.76 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.75 44.57 1.07 Allowed 'General case' 0 C--N 1.324 -0.54 1 C-N-CA 132.243 4.217 . . . . 0.0 110.777 169.994 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.9 -22.22 34.13 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 128.328 2.87 . . . . 0.0 114.493 -177.715 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.93 126.01 34.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -171.268 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -76.21 119.86 20.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.123 0.963 . . . . 0.0 108.78 171.967 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 45' ' ' PHE . 18.5 mt -92.23 127.43 37.71 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -169.957 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.91 149.5 34.21 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 123.399 1.571 . . . . 0.0 114.872 174.005 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -64.6 126.75 28.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 129.619 3.168 . . . . 0.0 109.748 178.115 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.1 -20.08 51.59 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 116.705 -2.664 . . . . 0.0 114.847 172.279 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.32 156.35 38.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.72 1.26 . . . . 0.0 110.091 159.394 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.1 p -87.94 -179.95 6.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 119.327 -2.108 . . . . 0.0 109.152 -175.668 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 12.8 mt -77.08 -22.39 52.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 116.772 -1.585 . . . . 0.0 110.443 165.618 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.2 t -64.82 -41.02 96.09 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 117.608 2.448 . . . . 0.0 117.608 168.492 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -51.88 -53.83 36.21 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.703 -178.26 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -94.67 3.33 55.2 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.697 1.999 . . . . 0.0 110.824 -171.124 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.49 1.3 p-10 64.68 28.73 13.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 118.711 2.856 . . . . 0.0 118.711 175.11 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.411 HD13 HD11 ' A' ' 67' ' ' LEU . 30.6 mt -75.16 131.37 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.343 170.023 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -124.17 176.7 6.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 125.929 2.018 . . . . 0.0 108.936 -168.254 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -52.99 127.27 23.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.418 1.487 . . . . 0.0 108.555 175.148 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 62.95 15.52 8.43 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 120.372 3.471 . . . . 0.0 120.372 -171.373 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -76.72 123.41 26.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 116.888 -3.633 . . . . 0.0 106.402 168.496 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -87.15 129.34 34.98 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.698 2.799 . . . . 0.0 108.523 179.469 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.446 HD23 HD12 ' A' ' 3' ' ' ILE . 2.5 mm? -100.97 134.15 44.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.547 2.339 . . . . 0.0 109.363 163.72 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.453 ' CE1' HD13 ' A' ' 8' ' ' LEU . 6.9 t60 -86.03 151.29 23.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 103.552 -2.758 . . . . 0.0 103.552 164.657 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -134.23 112.8 11.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 127.871 2.468 . . . . 0.0 109.824 -173.774 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.84 -177.58 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.179 2.591 . . . . 0.0 110.965 -178.347 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.445 -0.691 0 CA-C-O 113.737 -3.03 . . . . 0.0 110.637 -177.088 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 . . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.36 144.02 33.06 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.491 1.916 . . . . 0.0 112.536 -175.148 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.611 HG22 ' H ' ' A' ' 65' ' ' SER . 22.9 pt -127.44 161.33 35.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 120.237 -1.539 . . . . 0.0 111.073 155.764 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -92.27 163.57 13.85 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 172.739 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.32 155.67 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 129.436 3.094 . . . . 0.0 110.608 148.422 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -152.12 142.39 22.42 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 122.858 2.572 . . . . 0.0 105.233 -162.308 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.27 66.7 p -100.19 170.75 8.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.049 1.34 . . . . 0.0 110.965 179.284 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.542 HD11 HG22 ' A' ' 70' ' ' VAL . 43.8 mt -93.0 18.88 8.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 117.856 -3.027 . . . . 0.0 110.22 177.324 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.371 0.6 OUTLIER -153.46 22.37 0.54 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 125.563 3.801 . . . . 0.0 109.412 -164.442 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.88 -11.36 29.68 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 122.688 3.835 . . . . 0.0 122.688 164.752 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -112.73 170.69 8.01 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 121.159 2.479 . . . . 0.0 109.193 -171.001 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.4 p -140.03 169.2 18.13 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.52 3.128 . . . . 0.0 110.503 170.579 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.7 mm -140.99 132.86 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 126.097 2.123 . . . . 0.0 110.377 168.851 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 m -80.88 116.53 20.91 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 126.621 2.45 . . . . 0.0 110.125 168.399 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.8 mt -102.74 146.08 28.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 123.773 1.749 . . . . 0.0 113.304 179.041 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.9 107.88 10.49 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.877 168.881 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -142.58 -41.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.837 1.655 . . . . 0.0 111.441 -157.067 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 75.74 140.97 0.08 OUTLIER Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 131.07 3.748 . . . . 0.0 110.726 -171.339 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 87.3 Cg_exo -46.58 -24.08 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 124.474 3.449 . . . . 0.0 119.979 172.308 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 p -64.07 -34.21 77.5 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 116.365 -3.959 . . . . 0.0 113.178 174.931 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.98 144.87 11.02 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -177.846 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.257 10.7 t -117.56 130.68 56.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 116.84 -1.552 . . . . 0.0 108.483 -165.514 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.409 24.7 mm -40.69 -43.72 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 129.774 3.23 . . . . 0.0 114.755 -159.6 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -65.48 -29.47 70.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 121.214 1.825 . . . . 0.0 113.19 179.648 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.77 -16.61 28.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 -176.825 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.43 -40.33 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 114.809 -2.519 . . . . 0.0 105.518 172.702 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -71.5 -30.04 65.5 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 125.035 1.459 . . . . 0.0 112.235 175.324 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.25 -18.65 60.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.53 2.332 . . . . 0.0 115.869 173.74 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.28 -18.41 55.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 119.724 3.231 . . . . 0.0 119.724 161.416 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.6 mt -87.97 -38.19 11.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 127.27 2.856 . . . . 0.0 107.733 170.655 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.295 38.6 tt0 -45.9 -56.28 5.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 162.01 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -51.56 -38.2 53.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 111.397 -2.638 . . . . 0.0 110.704 171.363 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -87.7 -53.71 4.63 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -179.991 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -103.46 -21.56 13.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 -170.932 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.76 -17.09 28.06 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 116.42 -2.322 . . . . 0.0 110.394 175.156 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.79 120.19 78.62 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 129.288 3.035 . . . . 0.0 110.292 -174.127 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -77.23 148.72 27.38 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 C-N-CA 123.924 3.083 . . . . 0.0 110.973 -171.146 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.293 47.2 Cg_exo -47.53 -37.39 26.21 Favored 'Trans proline' 0 N--CA 1.442 -1.532 1 C-N-CA 126.382 4.721 . . . . 0.0 116.096 -176.814 . . . . . . . . 3 2 . 1 . 053 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.75 -13.71 61.0 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -171.737 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.317 20.2 mt-30 -100.88 -7.82 23.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 178.715 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -89.23 95.03 10.13 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.247 2.219 . . . . 0.0 115.996 173.353 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.291 51.4 ttt180 -88.44 105.7 17.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.293 -1.504 . . . . 0.0 107.639 172.821 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB3' HD12 ' A' ' 50' ' ' LEU 0.295 97.1 mt -97.07 120.11 36.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.984 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.0 mt -110.85 126.24 68.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 130.179 3.392 . . . . 0.0 105.91 -172.53 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.261 89.9 t80 -119.95 -138.27 0.34 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.869 2.868 . . . . 0.0 105.019 -172.422 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.26 57.19 4.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.302 2.641 . . . . 0.0 114.146 -163.284 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.78 -3.17 80.99 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 127.198 2.333 . . . . 0.0 114.449 -166.679 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -123.96 141.01 52.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.37 2.268 . . . . 0.0 110.98 -170.381 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -77.44 140.04 39.77 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.656 -0.687 . . . . 0.0 110.989 153.309 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.443 HD12 ' HB3' ' A' ' 43' ' ' LEU . 73.4 mt -67.97 123.5 20.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 126.232 2.208 . . . . 0.0 109.156 174.01 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -85.09 138.93 32.1 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 126.554 2.409 . . . . 0.0 107.519 -177.376 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.276 96.8 m-20 -73.56 127.27 32.29 Favored 'General case' 0 N--CA 1.445 -0.724 1 CA-C-N 107.303 -4.498 . . . . 0.0 104.707 171.74 . . . . . . . . 3 2 . 1 . 053 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.32 -19.79 26.46 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.708 1.255 . . . . 0.0 116.148 -173.147 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -100.02 163.3 12.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 124.1 1.905 . . . . 0.0 110.007 176.136 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -92.87 164.8 13.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 117.377 -3.327 . . . . 0.0 111.667 179.492 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 18.2 mt -62.11 -45.07 95.1 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 117.31 -3.369 . . . . 0.0 113.482 171.644 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.535 47.5 t -29.95 -36.12 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.215 1 C-N-CA 134.838 5.255 . . . . 0.0 120.511 156.203 . . . . . . . . 3 2 . 1 . 053 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.318 34.5 m-20 -80.49 -10.03 59.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 114.38 -2.724 . . . . 0.0 110.738 177.184 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -104.86 -7.71 19.2 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 126.864 2.602 . . . . 0.0 114.199 168.15 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 7.0 t-20 55.08 59.42 4.03 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.253 2.221 . . . . 0.0 113.232 -171.909 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -101.16 126.94 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 1 O-C-N 114.621 -5.05 . . . . 0.0 103.599 179.468 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -109.9 -170.28 1.62 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.918 1.687 . . . . 0.0 112.347 -168.827 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -50.83 139.15 17.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.047 -1.033 . . . . 0.0 113.01 171.269 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.278 4.4 tt0 70.56 32.26 2.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 128.879 3.862 . . . . 0.0 109.923 163.395 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.611 ' H ' HG22 ' A' ' 3' ' ' ILE . 69.6 m -83.1 153.23 24.96 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 117.777 -3.077 . . . . 0.0 114.509 -178.335 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m -113.52 137.82 51.01 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 125.234 2.445 . . . . 0.0 111.018 168.902 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.69 125.86 27.91 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 176.468 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -92.09 143.86 26.02 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 127.619 3.075 . . . . 0.0 108.491 177.584 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tt -115.64 122.23 44.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.159 -172.724 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.542 HG22 HD11 ' A' ' 8' ' ' LEU . 11.7 t -100.91 141.82 16.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 127.981 2.512 . . . . 0.0 108.347 176.529 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt . . . . . 0 N--CA 1.447 -0.612 0 CA-C-O 126.355 2.979 . . . . 0.0 109.492 -174.118 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.9 ttp . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 115.818 -2.039 . . . . 0.0 107.086 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -90.87 146.17 24.14 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 126.036 2.085 . . . . 0.0 109.469 -169.134 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 6.0 pt -145.88 164.78 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 175.376 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -127.53 145.39 50.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 124.385 2.041 . . . . 0.0 107.937 -174.917 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -137.53 106.87 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 1 O-C-N 115.246 -4.659 . . . . 0.0 104.382 -177.908 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -77.34 126.67 31.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 124.567 2.127 . . . . 0.0 112.991 162.896 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -78.48 156.8 29.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.511 1.924 . . . . 0.0 109.266 177.468 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mt -50.47 -34.65 25.71 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 164.467 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.2 p -78.66 -11.91 59.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.735 2.014 . . . . 0.0 112.713 -176.086 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.25 -8.39 26.83 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 115.657 -2.746 . . . . 0.0 111.087 174.243 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -91.73 159.66 15.73 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.29 1.436 . . . . 0.0 109.765 -174.947 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -126.17 136.41 52.82 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 -178.127 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mt -102.79 159.81 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 1 C-N-CA 132.337 4.255 . . . . 0.0 106.647 163.956 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.33 3.3 t -135.4 149.98 49.78 Favored 'General case' 0 C--N 1.328 -0.34 1 C-N-CA 134.117 4.967 . . . . 0.0 112.526 168.831 . . . . . . . . 3 2 . 1 . 054 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mp -141.27 144.35 34.61 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -173.342 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.274 4.0 tp10 -99.71 128.04 45.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 125.322 1.639 . . . . 0.0 108.613 161.559 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.72 173.3 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 129.216 3.007 . . . . 0.0 114.976 173.05 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -103.2 148.19 35.29 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 128.148 2.579 . . . . 0.0 106.796 151.812 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -64.63 -14.13 42.83 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-O 116.499 -1.542 . . . . 0.0 112.006 172.457 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.5 m -86.98 1.53 52.47 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 127.782 3.176 . . . . 0.0 111.194 177.817 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -89.97 143.76 26.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 126.203 2.189 . . . . 0.0 106.959 175.075 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -82.76 162.56 21.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 126.245 2.926 . . . . 0.0 104.174 -168.548 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.27 -45.85 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 120.002 -1.686 . . . . 0.0 109.109 168.622 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.8 -33.58 10.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 124.266 1.984 . . . . 0.0 114.209 173.518 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.89 -34.96 67.0 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 117.106 -3.497 . . . . 0.0 112.282 176.174 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.62 -37.18 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 O-C-N 120.54 -1.35 . . . . 0.0 111.136 169.682 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -68.03 -39.8 83.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.766 -1.833 . . . . 0.0 113.449 172.922 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.35 77.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 172.689 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -72.32 -33.91 67.7 Favored 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 131.806 4.042 . . . . 0.0 111.756 175.457 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.6 mt -80.09 -39.82 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 118.502 -2.624 . . . . 0.0 116.582 169.1 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -44.03 -47.39 8.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 119.39 -2.068 . . . . 0.0 114.955 150.725 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -53.97 -45.0 71.26 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 178.085 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -107.58 -49.99 3.15 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 126.245 2.216 . . . . 0.0 107.924 -160.31 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -90.01 -38.35 13.67 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.099 1.76 . . . . 0.0 112.04 -174.172 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.2 9.38 24.06 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 116.622 -2.21 . . . . 0.0 112.865 169.641 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.64 124.53 69.28 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 119.99 1.895 . . . . 0.0 112.687 -170.722 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -54.19 135.78 65.84 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 124.316 3.344 . . . . 0.0 109.828 175.509 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.262 71.6 Cg_exo -41.59 -52.5 3.73 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.132 2.555 . . . . 0.0 117.858 170.083 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -40.82 -17.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 129.658 3.183 . . . . 0.0 114.834 167.39 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -136.04 30.71 3.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -167.068 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.297 13.1 pt20 -141.23 138.12 33.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 130.711 3.604 . . . . 0.0 110.648 168.671 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -138.34 120.92 16.19 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 118.377 -2.702 . . . . 0.0 104.282 175.507 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.59 150.35 23.1 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 119.835 -1.791 . . . . 0.0 109.706 177.037 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.8 mt -137.33 128.0 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -179.412 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -131.5 118.91 20.81 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 127.279 2.862 . . . . 0.0 108.214 179.107 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.21 13.34 7.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 130.754 3.622 . . . . 0.0 118.588 167.4 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.87 3.39 36.66 Favored Glycine 0 CA--C 1.536 1.379 1 C-N-CA 130.881 4.086 . . . . 0.0 114.581 -171.65 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -106.83 100.98 10.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 113.211 -3.28 . . . . 0.0 111.037 -177.517 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -63.29 108.56 1.33 Allowed 'General case' 0 C--N 1.325 -0.479 1 O-C-N 129.695 4.372 . . . . 0.0 106.445 169.122 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.14 147.88 46.21 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 125.789 1.931 . . . . 0.0 112.054 179.399 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 54' ' ' ARG . 3.8 mt-10 -116.39 137.61 52.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.04 2.136 . . . . 0.0 105.657 -178.502 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -43.89 136.46 3.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 138.179 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.44 -10.34 33.14 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 129.845 3.593 . . . . 0.0 115.832 -176.023 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 39.8 mtt-85 -123.58 -177.72 3.81 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 127.21 2.359 . . . . 0.0 109.385 -178.805 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -128.73 168.34 15.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.277 -175.174 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.5 mt -59.02 -29.29 67.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -178.873 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -65.45 -47.19 77.0 Favored 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 135.489 5.515 . . . . 0.0 115.659 172.736 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -47.13 -25.56 0.9 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 120.053 3.353 . . . . 0.0 120.053 170.855 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.466 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 72.3 m-85 -117.17 1.73 12.53 Favored 'General case' 0 C--O 1.238 0.473 1 C-N-CA 132.866 4.466 . . . . 0.0 115.291 177.958 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.374 4.0 t30 66.89 49.13 1.21 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.375 1.47 . . . . 0.0 113.377 176.782 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mt -101.3 125.39 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 118.243 -2.786 . . . . 0.0 104.568 177.043 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -115.02 -166.7 1.14 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.243 -2.253 . . . . 0.0 111.152 172.635 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.257 58.9 tttt -41.84 125.78 2.95 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 118.939 2.941 . . . . 0.0 118.939 170.496 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.45 44.4 mt-10 75.84 18.1 2.16 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 165.776 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 m -83.67 147.04 27.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.53 1.132 . . . . 0.0 108.782 -175.832 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -120.67 131.75 54.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 -174.466 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -111.7 162.09 15.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.084 2.553 . . . . 0.0 109.608 171.87 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -115.01 142.49 46.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 124.462 2.077 . . . . 0.0 110.496 162.537 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.3 133.52 52.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 119.374 -2.079 . . . . 0.0 106.232 -178.703 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.76 153.86 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.356 1.862 . . . . 0.0 110.897 161.507 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.442 -0.856 0 CA-C-O 116.735 -1.602 . . . . 0.0 107.975 -173.778 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttm . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -91.39 136.82 32.84 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.629 0.771 . . . . 0.0 111.639 175.382 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.478 HD11 HG11 ' A' ' 17' ' ' VAL . 16.6 pt -117.41 170.01 7.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 119.895 -1.753 . . . . 0.0 110.799 145.539 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.77 138.21 48.66 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 164.824 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 t -121.91 124.76 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 O-C-N 120.922 -1.111 . . . . 0.0 109.397 168.133 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -88.45 115.69 26.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.268 1.027 . . . . 0.0 111.89 -179.482 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 34.9 p -78.71 161.02 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 125.528 2.585 . . . . 0.0 109.378 171.675 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.04 -27.74 66.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.576 1.95 . . . . 0.0 113.634 -171.853 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p -69.0 -8.86 48.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 119.692 -1.88 . . . . 0.0 114.687 168.459 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.28 -6.09 30.27 Favored Glycine 0 N--CA 1.44 -1.039 0 O-C-N 120.179 -1.576 . . . . 0.0 112.106 172.197 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -73.85 125.28 27.8 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.36 2.264 . . . . 0.0 114.61 -176.423 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.3 57.0 m -95.69 106.19 18.26 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 101.029 -3.693 . . . . 0.0 101.029 176.906 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.9 mt -87.16 130.65 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 125.385 1.474 . . . . 0.0 110.265 173.036 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -90.26 105.63 17.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 127.697 3.123 . . . . 0.0 107.835 176.411 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.252 7.7 tp -108.51 152.31 24.9 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.827 2.051 . . . . 0.0 111.71 -178.147 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -95.93 143.15 27.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 163.3 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.478 HG11 HD11 ' A' ' 3' ' ' ILE . 16.0 m -134.05 150.94 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 129.586 3.154 . . . . 0.0 107.198 166.23 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.271 12.7 tp10 -89.39 141.92 29.3 Favored Pre-proline 0 N--CA 1.446 -0.649 0 O-C-N 127.649 3.093 . . . . 0.0 105.287 154.024 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.26 -19.73 6.91 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 N-CA-C 121.033 3.436 . . . . 0.0 121.033 170.837 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.276 20.7 p -99.2 1.57 44.97 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.664 -174.391 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 39.6 t0 -85.74 144.83 27.56 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 179.939 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.3 p -90.86 162.6 14.74 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.587 -2.571 . . . . 0.0 115.026 -174.278 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mm -52.69 -53.54 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 128.847 2.859 . . . . 0.0 107.89 -165.035 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -79.58 -21.12 45.44 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 114.129 -2.843 . . . . 0.0 112.053 -169.316 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -66.67 -47.68 71.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 123.52 2.873 . . . . 0.0 111.924 166.354 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.24 -34.52 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 130.889 3.676 . . . . 0.0 110.04 177.015 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -67.78 -35.67 79.09 Favored 'General case' 0 N--CA 1.451 -0.387 1 O-C-N 114.435 -5.166 . . . . 0.0 113.23 169.053 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.7 -22.22 46.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 130.408 3.483 . . . . 0.0 110.424 -179.22 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP . 43.9 mttp -64.46 -20.65 66.31 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 118.45 -2.656 . . . . 0.0 109.168 173.096 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mm -68.78 -19.71 24.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 117.361 -3.337 . . . . 0.0 117.243 167.279 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -74.65 -35.81 62.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 113.664 -3.065 . . . . 0.0 107.911 -165.175 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.307 27.9 t70 -30.69 -53.58 0.19 Allowed 'General case' 0 N--CA 1.441 -0.902 1 C-N-CA 132.099 4.159 . . . . 0.0 110.421 154.715 . . . . . . . . 3 2 . 1 . 055 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -89.02 -48.17 7.61 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 127.294 2.871 . . . . 0.0 116.842 -178.066 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -102.79 -36.03 8.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 125.221 1.576 . . . . 0.0 108.617 -160.891 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.15 13.47 58.79 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 115.21 -2.994 . . . . 0.0 117.529 171.28 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mm -97.55 142.55 24.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 112.516 -3.611 . . . . 0.0 108.411 -172.985 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -60.6 139.38 85.64 Favored 'Trans proline' 0 N--CA 1.453 -0.897 1 C-N-CA 126.522 4.815 . . . . 0.0 116.853 170.153 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.76 -27.81 37.5 Favored 'Trans proline' 0 N--CA 1.456 -0.729 1 C-N-CA 126.544 4.829 . . . . 0.0 113.31 -172.978 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.18 -38.23 82.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 119.916 -1.74 . . . . 0.0 115.052 166.167 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -73.99 -29.67 62.09 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 118.178 -2.826 . . . . 0.0 117.029 176.886 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -75.44 149.44 38.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.106 2.562 . . . . 0.0 114.557 164.173 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -131.44 150.01 52.31 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 128.234 2.614 . . . . 0.0 104.661 157.05 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.496 ' CD1' HD12 ' A' ' 50' ' ' LEU 0.465 0.4 OUTLIER -120.46 148.62 43.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 124.327 2.013 . . . . 0.0 112.73 158.66 . . . . . . . . 4 4 . 1 . 055 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -104.62 154.29 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 1 C-N-CA 134.504 5.122 . . . . 0.0 108.924 176.601 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -162.6 135.0 5.55 Favored 'General case' 0 C--N 1.321 -0.638 1 C-N-CA 132.313 4.245 . . . . 0.0 103.589 163.015 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 76.37 43.21 0.15 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.012 1.325 . . . . 0.0 109.554 163.504 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.51 22.63 46.23 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 129.754 3.55 . . . . 0.0 118.481 -176.655 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.322 37.4 pttt -162.06 170.13 19.76 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.658 1.583 . . . . 0.0 112.128 -179.397 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.306 27.2 mp0 -93.77 139.73 30.5 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.386 -161.563 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.496 HD12 ' CD1' ' A' ' 43' ' ' LEU . 14.2 mt -94.46 162.14 13.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.639 1.975 . . . . 0.0 109.513 179.01 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -150.93 151.3 31.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 119.294 -2.128 . . . . 0.0 110.366 -173.374 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -44.77 133.98 5.82 Favored 'General case' 0 C--N 1.327 -0.413 1 C-N-CA 134.039 4.936 . . . . 0.0 112.267 -177.341 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.35 -19.94 28.61 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 114.084 -3.62 . . . . 0.0 111.354 151.718 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -94.07 155.86 16.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 127.572 2.572 . . . . 0.0 107.518 172.361 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -76.2 163.98 26.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.801 2.44 . . . . 0.0 112.739 -178.514 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.9 mt -43.85 -43.47 6.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 130.178 3.391 . . . . 0.0 109.229 159.897 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -71.35 -37.67 71.67 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 118.701 -2.5 . . . . 0.0 114.889 -175.525 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -59.71 -36.19 76.05 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 127.139 2.176 . . . . 0.0 107.877 178.891 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.282 13.9 m-85 -97.83 11.94 35.59 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.591 1.556 . . . . 0.0 110.995 175.907 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.623 0.1 OUTLIER 67.56 25.97 8.22 Favored 'General case' 0 C--O 1.222 -0.374 1 O-C-N 115.566 -4.458 . . . . 0.0 121.512 165.016 . . . . . . . . 4 3 . 1 . 055 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -76.61 93.29 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 128.628 2.771 . . . . 0.0 104.973 174.305 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.302 8.3 mm-40 -99.4 -169.67 1.79 Allowed 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 128.089 3.368 . . . . 0.0 102.344 174.938 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.419 16.1 ptpt -43.64 122.23 2.63 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 130.808 3.643 . . . . 0.0 116.729 169.601 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 4.2 tp10 83.13 33.98 0.06 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.946 2.099 . . . . 0.0 112.493 175.198 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -96.91 138.38 34.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.125 2.97 . . . . 0.0 108.237 -176.6 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -118.26 141.19 48.77 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 173.865 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.0 158.82 16.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 116.9 -3.625 . . . . 0.0 111.718 166.171 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -135.07 136.11 41.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 175.195 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 mt -86.64 154.7 20.82 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 178.106 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 t -141.39 133.55 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 128.713 2.805 . . . . 0.0 106.525 -178.734 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.446 -0.67 0 CA-C-N 123.027 2.649 . . . . 0.0 108.438 -179.637 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.309 14.2 ptt? . . . . . 0 N--CA 1.471 0.579 0 CA-C-O 117.872 -1.061 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -79.3 153.25 30.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 115.739 -2.077 . . . . 0.0 111.602 163.896 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.291 31.4 pt -134.22 -177.39 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 129.292 3.037 . . . . 0.0 103.934 164.417 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -142.0 139.44 32.39 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 128.631 2.773 . . . . 0.0 104.544 170.954 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.29 109.31 25.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 131.266 3.826 . . . . 0.0 101.59 179.45 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -87.51 122.29 31.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 101.057 -3.683 . . . . 0.0 101.057 170.221 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.5 p -65.72 160.26 23.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 128.384 2.673 . . . . 0.0 111.119 161.967 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tt -44.84 -39.55 5.43 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 120.169 3.396 . . . . 0.0 120.169 172.941 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 p -90.87 -9.69 45.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.811 2.044 . . . . 0.0 111.715 -176.075 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.72 7.39 17.89 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.775 0.702 . . . . 0.0 111.675 165.847 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -76.5 130.92 38.63 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.808 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -112.87 146.76 38.35 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.625 2.37 . . . . 0.0 106.023 -174.071 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 pt -143.89 146.6 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 127.091 2.745 . . . . 0.0 105.737 173.158 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.9 m -89.14 132.59 34.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 129.702 3.201 . . . . 0.0 104.635 168.876 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 mt -108.86 153.27 23.76 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.047 1.739 . . . . 0.0 109.659 151.966 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -103.21 111.57 24.01 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 111.684 -2.507 . . . . 0.0 111.47 164.873 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.23 138.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.512 1.525 . . . . 0.0 106.89 -174.944 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -77.77 147.01 73.64 Favored Pre-proline 0 N--CA 1.446 -0.645 0 O-C-N 118.753 -2.467 . . . . 0.0 109.61 154.361 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.06 -22.35 74.43 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 N-CA-C 119.651 2.904 . . . . 0.0 119.651 -174.25 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 0.3 OUTLIER -81.18 -12.5 59.17 Favored 'General case' 0 N--CA 1.442 -0.861 1 C-N-CA 131.792 4.037 . . . . 0.0 112.226 177.889 . . . . . . . . 4 3 . 1 . 056 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.06 119.65 17.59 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 119.614 -1.929 . . . . 0.0 107.196 -172.65 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.5 p -66.3 167.83 9.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 121.524 1.965 . . . . 0.0 106.245 -167.797 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -54.18 -37.72 36.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -177.876 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -71.02 -28.66 64.57 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.182 0.992 . . . . 0.0 112.626 -174.92 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.41 -22.35 66.77 Favored 'General case' 0 N--CA 1.451 -0.416 1 CA-C-O 110.544 -4.55 . . . . 0.0 112.802 175.855 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.39 -45.32 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 131.139 3.776 . . . . 0.0 109.749 177.622 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.286 37.5 pttt -75.34 -23.65 57.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 123.904 1.811 . . . . 0.0 113.332 -178.504 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -34.2 75.3 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.159 2.584 . . . . 0.0 108.337 -179.549 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -73.58 -53.87 9.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 127.777 3.173 . . . . 0.0 107.277 176.011 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.43 65.4 mt -38.81 -54.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 125.807 2.718 . . . . 0.0 117.821 -179.675 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -65.08 -20.72 66.61 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 118.586 -2.571 . . . . 0.0 116.253 -179.385 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.256 36.0 t70 -90.37 -24.87 20.69 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 121.672 2.033 . . . . 0.0 107.517 175.492 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -97.33 -50.64 4.47 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 113.646 -3.073 . . . . 0.0 107.371 -164.17 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -129.18 12.21 6.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 115.647 -2.12 . . . . 0.0 109.929 -179.929 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.74 -3.19 86.08 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 126.674 2.083 . . . . 0.0 116.523 154.292 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -72.69 107.64 3.37 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 130.347 3.459 . . . . 0.0 106.439 177.352 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.97 160.61 36.8 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.47 2.113 . . . . 0.0 116.545 -177.711 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.317 5.6 Cg_endo -50.69 -35.34 47.12 Favored 'Trans proline' 0 N--CA 1.44 -1.668 1 C-N-CA 130.13 7.22 . . . . 0.0 114.027 167.845 . . . . . . . . 3 2 . 1 . 056 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.67 -18.98 63.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 116.185 1.921 . . . . 0.0 116.185 175.312 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -123.38 14.32 9.6 Favored 'General case' 0 N--CA 1.443 -0.791 1 O-C-N 115.598 -4.439 . . . . 0.0 110.037 -176.083 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.343 0.3 OUTLIER -101.85 126.29 48.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 118.814 -2.429 . . . . 0.0 107.364 -161.967 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -131.74 108.02 9.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 168.657 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.8 mt -93.21 126.66 38.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.002 -1.475 . . . . 0.0 108.392 179.572 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 pt -128.9 144.25 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 119.454 1.025 . . . . 0.0 113.046 -178.004 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -137.08 133.74 35.72 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 169.116 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.11 20.59 11.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 120.873 1.67 . . . . 0.0 111.488 166.681 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.49 -21.12 42.58 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.305 0.957 . . . . 0.0 112.723 -174.483 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -80.63 146.16 31.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -176.324 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -99.99 123.99 44.84 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 175.822 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mt -71.4 115.82 11.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 124.663 2.173 . . . . 0.0 109.951 -171.022 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -82.84 133.31 35.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.421 2.688 . . . . 0.0 112.767 175.317 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -41.89 143.29 0.56 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 130.893 3.677 . . . . 0.0 115.474 174.009 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.96 50.27 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 111.789 -2.459 . . . . 0.0 112.809 164.729 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -74.35 140.45 44.82 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 118.367 -2.843 . . . . 0.0 107.28 175.206 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -68.43 139.47 55.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 126.503 2.377 . . . . 0.0 109.048 160.947 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.2 mt -53.11 -30.08 34.57 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.666 1.586 . . . . 0.0 113.974 174.451 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 t -74.68 -35.82 62.78 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.911 2.085 . . . . 0.0 112.383 -176.992 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -60.35 -17.77 45.62 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 167.799 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.06 12.66 35.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 120.037 3.347 . . . . 0.0 120.037 167.434 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 73.64 21.22 2.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 124.811 2.243 . . . . 0.0 115.375 169.542 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.2 mm -78.32 135.01 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -179.517 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -112.89 170.54 8.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.008 178.347 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.3 140.4 17.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 118.469 -2.644 . . . . 0.0 111.246 169.364 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.494 0.6 OUTLIER 68.89 1.29 3.07 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 117.122 2.268 . . . . 0.0 117.122 163.708 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -54.98 146.04 18.8 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 118.853 2.908 . . . . 0.0 118.853 169.048 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.5 m -102.24 105.66 16.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -179.547 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.69 162.19 13.16 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.121 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -113.24 132.87 55.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 127.542 3.026 . . . . 0.0 109.116 -178.383 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -105.59 110.97 23.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 129.044 2.938 . . . . 0.0 104.979 169.716 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.38 118.82 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 O-C-N 118.74 -2.475 . . . . 0.0 104.744 172.6 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.7 mt . . . . . 0 N--CA 1.445 -0.691 0 C-N-CA 128.629 2.772 . . . . 0.0 110.861 163.728 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -102.1 141.29 35.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.775 2.43 . . . . 0.0 111.343 176.26 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 pt -133.38 144.62 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 110.964 -2.834 . . . . 0.0 108.305 164.506 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -93.84 141.03 28.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 173.556 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.1 t -120.99 122.66 68.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 123.067 2.667 . . . . 0.0 105.039 170.165 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -89.17 124.49 34.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 122.146 2.248 . . . . 0.0 106.941 176.891 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.328 82.7 p -99.59 -166.84 1.39 Allowed 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 118.201 -2.812 . . . . 0.0 114.715 -172.855 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.443 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 7.5 mp -43.27 -33.62 1.01 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 119.695 3.22 . . . . 0.0 119.695 -177.745 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -110.26 -4.82 15.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.175 2.19 . . . . 0.0 112.493 -178.549 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.34 -1.72 67.28 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 179.585 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.59 127.44 31.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 129.305 3.042 . . . . 0.0 104.616 173.352 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -90.76 131.91 36.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.943 1.402 . . . . 0.0 108.236 -179.841 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.577 HD13 ' HB2' ' A' ' 34' ' ' GLU . 12.1 pt -117.49 136.07 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 123.739 1.733 . . . . 0.0 107.038 170.302 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.9 m -88.81 112.02 22.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 113.07 -3.348 . . . . 0.0 111.376 179.895 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.03 129.27 49.76 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 101.725 -3.435 . . . . 0.0 101.725 -175.987 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -82.93 133.68 35.1 Favored 'General case' 0 C--O 1.222 -0.361 1 C-N-CA 132.324 4.25 . . . . 0.0 103.925 164.262 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.91 169.06 8.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 109.832 -3.349 . . . . 0.0 108.687 -176.739 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -128.27 157.65 73.78 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.858 169.401 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -69.45 -6.73 19.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 125.115 3.876 . . . . 0.0 114.953 -174.629 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.7 p -86.31 -13.41 46.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 129.006 2.922 . . . . 0.0 112.804 167.223 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -69.29 131.72 45.31 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 122.419 2.372 . . . . 0.0 115.069 -179.149 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 p -91.36 169.2 11.0 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.066 1.746 . . . . 0.0 113.285 172.003 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.2 -17.78 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.733 178.531 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -62.75 -47.08 85.09 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 118.146 -2.846 . . . . 0.0 112.756 160.91 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -70.03 -26.12 63.89 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.786 -178.459 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -90.49 -33.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 113.02 -3.372 . . . . 0.0 107.399 -172.656 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -43.0 -44.55 4.72 Favored 'General case' 0 C--N 1.322 -0.629 1 C-N-CA 132.681 4.392 . . . . 0.0 112.841 167.795 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.08 -17.39 55.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 114.788 -2.529 . . . . 0.0 115.727 178.295 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -90.64 -22.47 21.18 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 121.54 1.973 . . . . 0.0 107.554 172.27 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.7 mt -67.21 -37.96 80.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.432 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -42.8 61.08 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.581 2.752 . . . . 0.0 114.509 169.746 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.61 -55.24 25.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 163.982 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -80.77 -17.91 49.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -170.643 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.577 ' HB2' HD13 ' A' ' 13' ' ' ILE 0.427 25.7 tp10 -135.62 -8.7 2.17 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 121.61 3.93 . . . . 0.0 121.61 171.361 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.69 7.68 68.56 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 116.496 -3.877 . . . . 0.0 117.208 173.842 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mm -91.37 123.45 63.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 C-N-CA 130.051 3.34 . . . . 0.0 106.524 -170.985 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.324 72.9 Cg_endo -67.32 154.0 75.32 Favored 'Trans proline' 0 N--CA 1.454 -0.852 1 C-N-CA 128.095 5.863 . . . . 0.0 109.725 170.663 . . . . . . . . 3 2 . 1 . 057 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.18 -22.59 53.78 Favored 'Trans proline' 0 N--CA 1.448 -1.192 1 C-N-CA 125.313 4.009 . . . . 0.0 115.833 -164.046 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.02 -8.0 52.61 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 124.405 1.066 . . . . 0.0 110.317 -164.061 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -110.41 -9.85 14.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 118.128 -2.858 . . . . 0.0 113.573 -172.33 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.263 73.4 mt-30 -88.17 121.75 30.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.829 1.652 . . . . 0.0 106.869 -172.222 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -102.59 100.21 10.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 112.632 -2.076 . . . . 0.0 108.594 170.395 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.6 mt -90.63 126.31 35.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 119.589 -1.944 . . . . 0.0 111.842 177.443 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.1 mt -132.35 139.7 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.217 2.207 . . . . 0.0 110.853 -168.382 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -162.65 112.8 1.45 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 129.316 3.046 . . . . 0.0 112.39 -174.242 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.09 36.19 14.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 128.426 3.965 . . . . 0.0 118.496 177.292 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.08 -10.12 43.6 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 108.508 -3.951 . . . . 0.0 109.638 167.233 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -92.41 120.06 32.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 130.351 3.46 . . . . 0.0 111.448 -178.749 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -79.16 119.27 22.02 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.997 2.519 . . . . 0.0 109.055 165.028 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -79.01 129.18 34.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -158.86 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -82.77 153.44 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -172.425 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -80.47 126.57 31.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.475 170.982 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.35 -3.97 18.07 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-O 115.722 -2.71 . . . . 0.0 110.433 -172.507 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -103.14 155.85 18.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 120.652 2.226 . . . . 0.0 108.547 -167.931 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.2 p -95.98 141.43 29.4 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.61 2.364 . . . . 0.0 109.346 168.017 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.4 mt -51.23 -38.56 53.19 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 129.919 3.288 . . . . 0.0 111.696 -178.567 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -74.83 -20.44 59.76 Favored 'General case' 0 C--O 1.217 -0.624 0 O-C-N 120.103 -1.623 . . . . 0.0 111.573 -176.666 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -79.8 -25.47 40.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.371 2.268 . . . . 0.0 110.001 -178.463 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -85.86 -17.67 34.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 123.204 1.478 . . . . 0.0 114.895 166.453 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 83.17 48.45 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.867 1.667 . . . . 0.0 111.112 173.923 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.9 mt -107.18 102.97 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 1 N-CA-C 99.844 -4.132 . . . . 0.0 99.844 -174.943 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.94 154.39 24.57 Favored 'General case' 0 CA--C 1.54 0.592 1 O-C-N 130.168 4.667 . . . . 0.0 113.28 167.136 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.397 0.0 OUTLIER -38.15 133.36 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 130.896 3.678 . . . . 0.0 118.069 170.438 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.449 15.0 mt-10 80.58 1.49 1.86 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 125.331 3.696 . . . . 0.0 112.381 -179.866 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.2 m -67.81 145.42 54.68 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 126.284 2.24 . . . . 0.0 112.385 172.428 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -108.51 114.83 28.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 101.673 -3.454 . . . . 0.0 101.673 179.132 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -98.56 155.14 17.43 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.435 1.494 . . . . 0.0 108.009 177.136 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -105.83 146.57 29.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 114.817 -2.516 . . . . 0.0 108.467 178.767 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -125.81 134.73 51.59 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.011 1.725 . . . . 0.0 108.745 177.065 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -129.59 164.46 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 1 C-N-CA 132.445 4.298 . . . . 0.0 105.642 179.719 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 114.271 -2.776 . . . . 0.0 105.85 -171.35 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptt? . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -104.12 137.03 42.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 118.553 -2.592 . . . . 0.0 106.825 177.2 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 3' ' ' ILE . 4.2 pt -132.41 155.11 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 129.898 3.279 . . . . 0.0 105.908 174.709 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -118.77 143.89 46.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.296 2.238 . . . . 0.0 111.737 176.8 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -126.94 115.83 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 112.069 -3.824 . . . . 0.0 108.64 178.529 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -90.78 120.91 32.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 113.596 -3.097 . . . . 0.0 114.031 175.704 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.758 HG22 HD12 ' A' ' 69' ' ' LEU . 81.8 p -80.99 160.91 24.46 Favored 'General case' 0 N--CA 1.448 -0.552 1 O-C-N 129.15 4.031 . . . . 0.0 112.815 164.039 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -45.21 93.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 -172.53 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.261 55.7 p -59.49 -17.18 29.45 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 166.931 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.07 -0.99 6.68 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.291 1.9 . . . . 0.0 108.88 154.048 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -74.58 141.67 44.72 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 119.272 -2.311 . . . . 0.0 111.31 -167.727 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.9 m -120.11 121.63 39.26 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 125.343 1.652 . . . . 0.0 111.019 -166.437 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.65 156.63 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 114.847 -2.502 . . . . 0.0 108.284 175.055 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.388 6.6 t -126.17 124.99 41.73 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 127.47 2.981 . . . . 0.0 111.095 174.693 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.84 150.11 43.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 124.441 2.067 . . . . 0.0 106.269 -171.676 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -106.82 110.98 23.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.012 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.9 136.69 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 109.16 -3.655 . . . . 0.0 109.902 -173.114 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -95.38 139.35 21.95 Favored Pre-proline 0 N--CA 1.445 -0.714 0 CA-C-O 113.78 -3.009 . . . . 0.0 106.323 169.844 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.258 23.5 Cg_exo -53.75 -29.93 54.34 Favored 'Trans proline' 0 N--CA 1.454 -0.837 1 C-N-CA 125.63 4.22 . . . . 0.0 115.103 -173.325 . . . . . . . . 3 2 . 1 . 058 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -78.94 -4.05 47.92 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 123.314 2.779 . . . . 0.0 112.627 177.873 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.61 147.13 39.82 Favored 'General case' 0 C--N 1.328 -0.354 1 O-C-N 114.749 -4.97 . . . . 0.0 110.999 -175.585 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -92.03 162.17 14.48 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.346 1.058 . . . . 0.0 108.635 -171.195 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 mm -56.52 -26.72 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 O-C-N 126.684 2.49 . . . . 0.0 113.821 -174.589 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.367 9.4 pt-20 -65.32 -34.76 79.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.375 2.67 . . . . 0.0 114.463 172.663 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -77.95 -29.49 49.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 125.545 2.593 . . . . 0.0 108.866 -176.271 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.357 31.2 m -82.47 -35.11 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 O-C-N 116.738 -3.727 . . . . 0.0 106.934 178.622 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -55.26 -46.19 76.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 116.548 -3.845 . . . . 0.0 114.0 170.816 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.281 . . -77.27 -18.77 57.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 126.382 2.991 . . . . 0.0 114.279 -174.62 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -82.35 -43.62 17.2 Favored 'General case' 0 C--N 1.322 -0.625 1 O-C-N 116.11 -4.119 . . . . 0.0 107.257 -179.476 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.423 12.1 mt -45.51 -46.78 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 128.076 2.55 . . . . 0.0 113.205 160.389 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -59.69 -50.23 74.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 117.901 -2.999 . . . . 0.0 116.794 172.71 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.452 34.7 t70 -53.08 -33.03 50.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.706 2.802 . . . . 0.0 110.721 178.099 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -80.74 -65.71 0.98 Allowed 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 113.204 -3.284 . . . . 0.0 113.621 172.707 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -97.45 -27.15 14.58 Favored 'General case' 0 N--CA 1.445 -0.724 1 O-C-N 129.645 4.34 . . . . 0.0 118.965 -165.757 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.24 7.65 59.31 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 128.531 2.967 . . . . 0.0 114.962 -179.539 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.529 HD12 HD21 ' A' ' 71' ' ' LEU . 10.7 mm -82.1 122.35 79.56 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 116.999 -3.647 . . . . 0.0 110.474 -174.394 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 96.8 Cg_endo -70.88 120.9 7.41 Favored 'Trans proline' 0 N--CA 1.443 -1.494 1 C-N-CA 128.6 6.2 . . . . 0.0 113.346 -174.95 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 37' ' ' PRO 0.278 77.5 Cg_exo -34.49 -46.79 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.688 1 C-N-CA 128.468 6.112 . . . . 0.0 116.037 -169.545 . . . . . . . . 4 3 . 1 . 058 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.289 0.5 OUTLIER -55.63 -42.59 75.16 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 116.306 -3.996 . . . . 0.0 116.258 178.609 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -79.45 -2.88 43.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.233 0.613 . . . . 0.0 112.63 -177.196 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -85.97 141.71 29.33 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 116.662 -3.774 . . . . 0.0 108.852 173.427 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -145.29 104.6 3.95 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 111.18 -2.736 . . . . 0.0 106.071 -172.375 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -96.43 112.37 24.14 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 119.31 -2.119 . . . . 0.0 107.561 -173.373 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mt -85.47 141.9 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.011 -1.681 . . . . 0.0 110.82 168.905 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.482 ' CE2' HG23 ' A' ' 61' ' ' ILE . 14.1 t80 -147.1 119.01 8.12 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 102.253 -3.24 . . . . 0.0 102.253 164.035 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.2 22.43 11.0 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 120.957 3.688 . . . . 0.0 120.957 164.056 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.41 -22.7 38.8 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 127.414 2.435 . . . . 0.0 112.581 -175.065 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -97.1 147.26 24.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 118.189 -2.948 . . . . 0.0 107.866 -177.559 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.38 133.32 35.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 126.762 2.539 . . . . 0.0 104.216 163.674 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -70.11 109.9 4.85 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 118.189 -2.819 . . . . 0.0 114.801 168.862 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -74.02 147.23 43.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.297 2.639 . . . . 0.0 112.234 -176.754 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -81.26 147.96 29.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 126.8 2.562 . . . . 0.0 104.585 -166.23 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.46 -36.79 3.94 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 116.739 -2.145 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -76.26 169.99 17.18 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 127.057 3.313 . . . . 0.0 107.939 -174.849 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -103.25 174.75 5.73 Favored 'General case' 0 N--CA 1.452 -0.349 2 O-C-N 112.911 -6.118 . . . . 0.0 113.141 163.003 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.36 -29.04 41.98 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.865 1.666 . . . . 0.0 110.273 -177.336 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -71.13 -32.6 69.18 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 117.526 -1.226 . . . . 0.0 110.009 -177.579 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.09 -22.79 55.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 115.364 -2.255 . . . . 0.0 110.537 174.85 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -86.9 0.32 55.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.056 171.974 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t30 28.62 61.95 0.12 Allowed 'General case' 0 N--CA 1.445 -0.723 1 C-N-CA 138.845 6.858 . . . . 0.0 112.253 175.114 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.482 HG23 ' CE2' ' A' ' 45' ' ' PHE . 13.8 mt -98.55 -34.96 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 128.348 2.659 . . . . 0.0 105.433 -170.707 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.463 13.1 mm-40 82.12 -158.77 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.531 1.133 . . . . 0.0 112.608 178.109 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -81.65 158.33 24.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.311 3.045 . . . . 0.0 115.14 -176.077 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.309 4.1 tt0 66.52 11.75 8.28 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 128.634 2.774 . . . . 0.0 118.457 161.254 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -105.23 144.47 31.97 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 116.979 -1.486 . . . . 0.0 112.155 -162.515 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -103.41 106.72 17.3 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 122.228 2.286 . . . . 0.0 108.229 -166.726 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -75.64 153.68 37.08 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.264 164.864 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -117.3 95.05 4.8 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 129.102 2.961 . . . . 0.0 107.707 -172.096 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 7' ' ' THR . 1.2 tm? -63.85 118.16 7.97 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.253 2.221 . . . . 0.0 106.918 166.645 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -125.66 150.9 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 167.21 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.529 HD21 HD12 ' A' ' 36' ' ' ILE . 2.4 mp . . . . . 0 C--N 1.324 -0.5 0 CA-C-O 117.017 -1.468 . . . . 0.0 110.871 -172.051 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttp . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -96.18 142.17 28.68 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.854 2.462 . . . . 0.0 108.598 -174.744 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.5 pt -130.82 177.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 128.748 2.819 . . . . 0.0 111.32 161.944 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -100.71 144.68 29.39 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.253 1.421 . . . . 0.0 109.618 163.177 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.9 t -116.76 150.47 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 121.765 2.075 . . . . 0.0 105.494 158.791 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -137.85 145.87 42.77 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 128.476 2.71 . . . . 0.0 111.438 -178.363 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -106.85 163.84 12.62 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 126.797 2.561 . . . . 0.0 112.197 173.183 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.55 -33.77 75.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 122.071 2.214 . . . . 0.0 110.964 171.351 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -75.2 -17.09 60.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 121.721 2.055 . . . . 0.0 111.553 167.153 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.68 36.45 6.46 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 118.145 2.018 . . . . 0.0 118.145 156.129 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -77.54 116.65 18.27 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 117.604 -3.292 . . . . 0.0 104.116 158.93 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.257 12.8 m -93.93 157.86 15.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 114.548 -2.644 . . . . 0.0 111.298 167.939 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -154.68 152.66 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 126.076 2.11 . . . . 0.0 113.34 177.508 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.9 m -83.28 131.47 35.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 130.581 3.552 . . . . 0.0 107.113 166.033 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.86 121.53 21.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 119.065 -2.272 . . . . 0.0 110.309 -177.362 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.348 3.5 tt0 -99.35 128.8 45.5 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 -172.06 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.2 t -140.82 137.09 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 114.138 -2.839 . . . . 0.0 107.414 -171.446 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -90.32 138.47 27.11 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 126.745 2.528 . . . . 0.0 106.383 171.644 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.264 94.2 Cg_exo -45.09 -23.1 0.91 Allowed 'Trans proline' 0 N--CA 1.439 -1.703 1 C-N-CA 126.001 4.467 . . . . 0.0 120.906 167.303 . . . . . . . . 3 2 . 1 . 059 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 15.2 m -77.52 -13.84 59.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.77 1.628 . . . . 0.0 111.413 176.324 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.2 130.89 34.94 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 120.763 1.619 . . . . 0.0 107.82 179.265 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -69.73 174.73 4.81 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.94 162.369 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 23' ' ' ILE 0.25 24.7 mt -61.42 -44.76 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 128.426 2.69 . . . . 0.0 109.62 169.731 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.81 -38.33 64.45 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 128.858 2.863 . . . . 0.0 110.212 175.997 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -73.15 -34.6 66.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 116.422 -1.751 . . . . 0.0 113.276 177.165 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 57.9 t -62.29 -37.42 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 125.185 3.63 . . . . 0.0 108.79 168.683 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 74.5 mttt -66.1 -40.61 90.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.507 1.754 . . . . 0.0 115.158 171.41 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.4 87.53 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.554 1.942 . . . . 0.0 112.88 171.251 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 48.9 mttp -67.81 -41.49 83.04 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 123.628 1.68 . . . . 0.0 111.041 173.567 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.273 94.2 mt -55.55 -58.07 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 1 O-C-N 115.622 -4.424 . . . . 0.0 110.141 168.526 . . . . . . . . 3 2 . 1 . 059 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -45.37 -37.61 5.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 165.278 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.13 -45.14 42.92 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.727 2.011 . . . . 0.0 113.786 177.504 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 mmtm -107.51 -35.03 6.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -166.214 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.3 -30.56 18.36 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.868 2.867 . . . . 0.0 110.411 179.495 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.13 52.73 6.6 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 125.885 1.707 . . . . 0.0 111.479 174.012 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.62 145.43 33.86 Favored Pre-proline 0 N--CA 1.447 -0.595 0 C-N-CA 129.913 3.285 . . . . 0.0 112.31 -178.782 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.09 128.29 12.1 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 124.92 3.747 . . . . 0.0 116.788 162.572 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 4.9 Cg_endo -75.33 -46.9 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.791 3.661 . . . . 0.0 108.734 -165.522 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.261 23.6 t70 -34.25 -33.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.452 1 C-N-CA 132.391 4.276 . . . . 0.0 119.518 -176.256 . . . . . . . . 3 2 . 1 . 059 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -85.89 -22.27 27.59 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.028 1.731 . . . . 0.0 114.26 175.418 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -98.82 145.79 26.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -160.627 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -118.16 154.39 32.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 118.244 -2.785 . . . . 0.0 110.296 172.625 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HB3' HD11 ' A' ' 67' ' ' LEU . 2.3 mp -108.29 135.45 49.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 167.056 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.1 mm -122.41 129.41 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 128.304 2.641 . . . . 0.0 106.51 175.457 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.497 ' CE1' HG12 ' A' ' 61' ' ' ILE . 44.6 t80 -138.44 131.3 29.57 Favored 'General case' 0 C--O 1.221 -0.421 1 C-N-CA 132.371 4.268 . . . . 0.0 108.057 172.365 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.78 31.96 21.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 130.115 3.366 . . . . 0.0 115.404 -166.895 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.79 15.0 81.01 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 128.419 2.914 . . . . 0.0 111.413 179.204 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -144.37 156.66 44.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 124.112 3.956 . . . . 0.0 113.565 -171.496 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.83 120.35 20.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 126.077 2.846 . . . . 0.0 104.369 -173.345 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.45 66.9 mt -86.05 157.2 20.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 111.366 -2.652 . . . . 0.0 108.769 -178.6 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -91.79 132.99 36.02 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.274 -1.517 . . . . 0.0 107.653 -168.899 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.01 114.57 14.8 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.738 -1.226 . . . . 0.0 109.926 -166.961 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.83 -6.75 11.15 Favored Glycine 0 CA--C 1.522 0.483 0 O-C-N 117.968 -2.958 . . . . 0.0 110.47 -173.733 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -79.21 161.42 26.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 124.509 2.1 . . . . 0.0 112.31 174.67 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 p -91.25 176.87 6.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 114.012 -2.899 . . . . 0.0 112.747 167.472 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.3 tp -75.05 -28.88 60.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.613 2.365 . . . . 0.0 111.542 -173.743 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -80.11 -23.84 40.95 Favored 'General case' 0 N--CA 1.449 -0.501 1 O-C-N 115.822 -4.299 . . . . 0.0 117.138 174.2 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -67.44 -26.07 66.22 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 172.221 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -93.76 -9.22 38.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.72 2.008 . . . . 0.0 112.647 159.185 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 p30 50.99 51.7 16.53 Favored 'General case' 0 N--CA 1.45 -0.468 1 C-N-CA 131.82 4.048 . . . . 0.0 112.019 -177.997 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.497 HG12 ' CE1' ' A' ' 45' ' ' PHE . 21.5 mt -71.25 110.43 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 127.912 2.485 . . . . 0.0 109.675 162.067 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -96.34 174.41 6.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.866 -1.97 . . . . 0.0 107.981 -171.744 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -37.46 137.97 0.37 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 120.077 3.362 . . . . 0.0 120.077 162.825 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 9.4 tt0 57.25 35.01 25.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.908 3.283 . . . . 0.0 114.461 179.755 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -91.07 158.96 16.37 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.451 1.5 . . . . 0.0 111.31 174.595 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.6 m -112.35 115.63 29.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 123.036 1.398 . . . . 0.0 110.026 171.991 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.461 HD11 ' HB3' ' A' ' 43' ' ' LEU . 19.3 tp -89.43 141.32 28.67 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 127.152 3.358 . . . . 0.0 102.848 162.187 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -108.1 136.56 47.58 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 -177.819 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.292 13.7 tp -115.17 95.3 5.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.206 -172.997 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.13 110.22 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 126.81 2.044 . . . . 0.0 108.203 171.171 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.299 2.9 mm? . . . . . 0 N--CA 1.448 -0.539 0 CA-C-N 121.108 1.776 . . . . 0.0 109.237 179.327 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -82.52 146.45 29.21 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.003 2.121 . . . . 0.0 107.154 -174.812 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -142.23 161.7 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 121.798 2.09 . . . . 0.0 108.702 166.553 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -100.85 144.1 30.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.981 1.426 . . . . 0.0 113.757 162.305 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.9 t -110.19 115.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 159.091 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -89.32 137.04 32.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 155.358 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -86.9 146.66 26.09 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 165.089 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 8' ' ' LEU . 2.6 mm? -62.19 4.7 0.12 Allowed 'General case' 0 N--CA 1.445 -0.68 1 C-N-CA 132.463 4.305 . . . . 0.0 112.936 165.814 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -106.46 12.1 30.02 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 119.373 -2.079 . . . . 0.0 113.693 171.489 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.4 -20.19 35.42 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 115.645 -2.753 . . . . 0.0 116.281 169.118 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.315 74.9 tttt -101.0 130.59 47.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 126.635 3.112 . . . . 0.0 105.373 -166.203 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 m -107.91 125.25 51.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 124.717 2.198 . . . . 0.0 108.932 177.781 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.8 mt -110.31 120.75 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 -172.288 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 m -97.19 131.3 44.07 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 118.027 -2.92 . . . . 0.0 106.932 -178.682 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.29 154.06 35.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.965 2.906 . . . . 0.0 111.501 -176.412 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -109.4 137.85 46.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 123.424 1.583 . . . . 0.0 108.148 161.944 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.325 21.0 m -128.02 149.78 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 119.946 3.313 . . . . 0.0 119.946 -178.582 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -85.26 156.54 59.85 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 128.069 2.548 . . . . 0.0 105.807 172.785 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.356 60.0 Cg_endo -70.19 -33.94 14.05 Favored 'Trans proline' 0 N--CA 1.447 -1.207 2 C-N-CA 129.276 6.65 . . . . 0.0 114.165 -179.915 . . . . . . . . 3 2 . 1 . 060 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.6 m -115.73 17.44 16.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 118.674 -2.516 . . . . 0.0 104.311 -167.935 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -84.01 161.27 20.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 125.322 2.487 . . . . 0.0 109.336 178.923 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.41 49.8 p -93.6 147.86 22.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 -163.146 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.305 12.4 mm -44.44 -43.92 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 121.569 3.914 . . . . 0.0 121.569 165.478 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 pm0 -79.69 -15.95 56.6 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 113.434 -3.175 . . . . 0.0 108.571 -174.239 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -74.45 -33.15 62.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 122.412 2.369 . . . . 0.0 106.921 172.299 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.431 ' H ' HG23 ' A' ' 26' ' ' VAL . 39.2 t -49.97 -48.4 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 124.378 3.263 . . . . 0.0 114.373 167.77 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -64.5 -37.35 87.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 114.704 -2.57 . . . . 0.0 111.906 -176.519 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.06 70.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 128.082 2.553 . . . . 0.0 111.358 171.502 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -80.75 -25.69 37.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.677 -1.89 . . . . 0.0 110.497 -176.65 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 30' ' ' ILE 0.264 30.3 mm -65.94 -45.49 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 116.351 -1.785 . . . . 0.0 106.832 169.858 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -62.3 -50.52 71.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 121.504 1.956 . . . . 0.0 114.89 -179.713 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -39.74 -39.66 0.82 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.299 2.24 . . . . 0.0 114.549 172.934 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.2 tttt -98.04 -41.48 7.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 117.845 -3.034 . . . . 0.0 108.006 177.34 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -113.05 -23.03 10.26 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 124.463 3.302 . . . . 0.0 111.869 -149.639 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.96 -1.63 85.12 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-O 116.799 -2.112 . . . . 0.0 116.603 174.709 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.0 mm -78.99 118.92 75.21 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 121.8 2.8 . . . . 0.0 104.303 176.342 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.69 165.35 16.12 Favored 'Trans proline' 0 N--CA 1.45 -1.053 1 C-N-CA 126.543 4.829 . . . . 0.0 113.934 179.106 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.53 -27.27 39.47 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.608 2.205 . . . . 0.0 115.246 178.53 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -69.77 1.4 4.35 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 117.466 -3.271 . . . . 0.0 111.57 -178.634 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -121.04 -14.91 8.34 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 128.598 2.759 . . . . 0.0 109.214 -169.989 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -106.47 114.07 27.96 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 128.575 3.672 . . . . 0.0 106.825 -172.198 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -108.87 141.23 41.23 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.661 2.785 . . . . 0.0 108.17 161.248 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.28 1.5 mp -116.08 139.97 49.75 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -177.51 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 mt -112.24 151.57 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 O-C-N 127.23 2.831 . . . . 0.0 103.63 169.54 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -128.16 124.41 36.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 161.451 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.326 . . 58.57 -81.88 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 128.796 2.838 . . . . 0.0 115.467 -172.743 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.63 1.34 4.35 Favored Glycine 0 CA--C 1.533 1.176 2 O-C-N 130.294 4.747 . . . . 0.0 112.534 171.565 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -122.37 151.33 41.31 Favored 'General case' 0 C--N 1.322 -0.606 1 CA-C-N 125.352 4.576 . . . . 0.0 106.643 -169.542 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 22.8 mt-30 -72.56 138.35 46.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.533 -174.601 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.53 HD11 HD12 ' A' ' 67' ' ' LEU . 82.3 mt -95.98 120.91 37.1 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 117.079 -1.848 . . . . 0.0 112.695 171.059 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -92.63 154.02 18.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -176.446 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.87 154.9 29.38 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 131.576 3.95 . . . . 0.0 110.625 178.976 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.89 0.34 83.63 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 122.773 1.207 . . . . 0.0 115.505 171.786 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -124.75 145.85 49.5 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 131.403 3.881 . . . . 0.0 105.731 -167.006 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.41 30.5 p -79.94 159.47 26.31 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 112.225 -2.261 . . . . 0.0 115.389 -171.745 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -51.9 14.13 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 126.672 2.483 . . . . 0.0 109.919 -172.104 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -78.0 -0.37 27.56 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.431 2.692 . . . . 0.0 106.41 -168.347 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.4 -31.01 70.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 124.639 2.161 . . . . 0.0 107.127 175.576 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.353 8.3 m-85 -107.84 -179.44 3.9 Favored 'General case' 0 N--CA 1.449 -0.505 1 O-C-N 115.998 -4.189 . . . . 0.0 107.87 175.572 . . . . . . . . 3 2 . 1 . 060 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -92.9 45.68 1.19 Allowed 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 118.179 -2.826 . . . . 0.0 116.137 175.633 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.07 138.85 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 117.753 -1.117 . . . . 0.0 108.88 166.428 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -154.12 -178.46 7.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.541 1.937 . . . . 0.0 109.779 -164.438 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -50.3 115.57 1.5 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.177 1.791 . . . . 0.0 109.301 171.478 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 55.78 33.57 21.71 Favored 'General case' 0 N--CA 1.452 -0.337 1 C-N-CA 133.619 4.768 . . . . 0.0 113.491 -178.064 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 138.8 56.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.313 1.845 . . . . 0.0 108.812 158.046 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.4 m -103.93 136.61 43.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.628 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.53 HD12 HD11 ' A' ' 50' ' ' LEU . 2.4 mm? -107.97 139.54 42.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 130.251 3.42 . . . . 0.0 116.771 156.202 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -97.34 124.26 41.43 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 113.219 -3.277 . . . . 0.0 107.145 -175.552 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.7 tp -93.87 124.14 37.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 128.242 3.464 . . . . 0.0 109.664 -179.248 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.2 116.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 130.194 3.398 . . . . 0.0 106.26 -177.563 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 87.4 mt . . . . . 0 C--N 1.324 -0.536 0 O-C-N 126.116 2.135 . . . . 0.0 111.736 -166.854 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.625 0 CA-C-O 117.73 -1.128 . . . . 0.0 109.155 . . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -88.65 125.72 34.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.19 2.196 . . . . 0.0 113.676 -179.494 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -109.76 164.12 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 124.13 3.15 . . . . 0.0 111.054 177.984 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -117.83 145.56 44.49 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 117.53 -3.231 . . . . 0.0 110.07 170.66 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.3 t -122.18 127.51 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 174.055 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -73.78 111.76 9.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 111.671 -2.513 . . . . 0.0 106.422 168.896 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 m -108.61 126.97 53.54 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -178.755 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.651 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -55.14 -6.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 1 N-CA-C 122.133 4.123 . . . . 0.0 122.133 178.124 . . . . . . . . 4 4 . 1 . 061 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -83.01 3.35 30.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 123.878 0.736 . . . . 0.0 109.589 175.9 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.62 21.81 30.49 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 123.705 1.725 . . . . 0.0 114.793 -178.704 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -123.78 135.56 53.88 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 116.645 -1.645 . . . . 0.0 109.102 -162.665 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.9 m -114.79 85.09 2.18 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.981 1.848 . . . . 0.0 111.32 177.695 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 13' ' ' ILE . 9.6 pt -77.11 161.63 4.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 O-C-N 119.1 -2.25 . . . . 0.0 106.812 -167.031 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -128.5 136.41 50.76 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 125.308 1.63 . . . . 0.0 109.774 178.582 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.331 0.3 OUTLIER -141.04 146.84 37.73 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 129.866 3.266 . . . . 0.0 114.036 -179.778 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -92.6 120.03 32.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 129.464 3.106 . . . . 0.0 105.599 -171.05 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 16.0 m -127.37 162.85 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 116.364 -3.96 . . . . 0.0 109.732 177.756 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.61 159.96 69.53 Favored Pre-proline 0 N--CA 1.451 -0.414 1 O-C-N 115.485 -4.509 . . . . 0.0 107.053 164.882 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -53.48 -46.84 30.85 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 N-CA-C 118.595 2.498 . . . . 0.0 118.595 -167.172 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.1 m -79.0 5.55 11.44 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 128.653 2.781 . . . . 0.0 112.56 -169.051 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.266 89.9 m-20 -77.66 140.61 39.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.73 -1.231 . . . . 0.0 109.494 176.658 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -86.0 146.62 26.59 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 129.08 3.988 . . . . 0.0 107.605 -179.522 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.77 -23.9 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 128.646 2.779 . . . . 0.0 111.762 -175.544 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -61.82 -38.83 89.64 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.974 2.91 . . . . 0.0 111.452 166.963 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.13 -35.61 78.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 125.756 2.693 . . . . 0.0 113.421 179.81 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -82.7 -37.71 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 112.44 -2.164 . . . . 0.0 109.3 176.425 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.363 61.8 mttt -48.72 -50.27 34.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.031 2.933 . . . . 0.0 111.665 168.143 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.3 56.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 116.056 -1.926 . . . . 0.0 109.928 -173.292 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -63.58 -45.2 91.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 122.474 2.397 . . . . 0.0 116.89 165.955 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -55.51 -40.54 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 114.822 -2.513 . . . . 0.0 110.223 167.713 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -61.5 -42.12 98.32 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 113.535 -3.126 . . . . 0.0 112.906 171.302 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.444 29.9 t70 -57.08 -27.83 62.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 122.627 2.467 . . . . 0.0 116.292 173.124 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -94.58 -55.7 3.05 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 126.485 2.366 . . . . 0.0 111.039 -174.298 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -117.31 -21.34 8.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.465 1.506 . . . . 0.0 113.835 -165.087 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.63 12.03 45.51 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 115.67 -2.739 . . . . 0.0 111.668 168.296 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 36' ' ' ILE . 39.3 mt -82.95 132.24 51.59 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 118.87 1.335 . . . . 0.0 112.608 171.434 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.21 121.79 8.61 Favored 'Trans proline' 0 N--CA 1.456 -0.692 1 C-N-CA 129.153 6.569 . . . . 0.0 113.758 178.222 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.297 32.3 Cg_exo -40.78 -35.23 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 1 C-N-CA 126.296 4.664 . . . . 0.0 117.43 170.908 . . . . . . . . 3 2 . 1 . 061 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.75 -35.09 78.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 -175.871 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -77.62 -42.11 36.11 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 130.48 3.512 . . . . 0.0 115.387 170.049 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.27 146.97 53.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.612 1.165 . . . . 0.0 114.029 -173.723 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.429 ' HB3' HG23 ' A' ' 70' ' ' VAL . 2.4 ttt180 -141.98 154.34 44.96 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 131.693 3.997 . . . . 0.0 109.88 -177.143 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.7 mt -130.11 159.61 36.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 116.72 -3.737 . . . . 0.0 115.865 177.532 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.03 136.51 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 130.004 3.322 . . . . 0.0 115.74 165.01 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 65' ' ' SER . 91.3 t80 -140.18 145.59 37.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 167.672 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.21 33.09 19.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.705 2.802 . . . . 0.0 112.086 168.007 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.26 -24.19 12.46 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.851 -1.527 . . . . 0.0 113.978 -175.033 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -87.41 141.74 28.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 121.499 2.65 . . . . 0.0 105.461 -169.889 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.61 122.68 27.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 166.05 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -75.47 137.74 41.14 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -173.983 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.437 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 2.5 mp0 -89.43 159.78 17.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 125.228 1.58 . . . . 0.0 106.91 176.607 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.11 121.89 30.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 126.203 2.189 . . . . 0.0 107.234 172.746 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.32 -33.24 3.06 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-O 124.523 2.18 . . . . 0.0 113.165 -178.398 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.437 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 4.1 mtt-85 -82.52 167.87 17.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 112.777 -1.711 . . . . 0.0 112.698 177.821 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.0 p -109.64 167.75 9.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -176.747 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.411 HD23 HD12 ' A' ' 61' ' ' ILE . 83.4 mt -56.11 -48.96 75.17 Favored 'General case' 0 N--CA 1.45 -0.44 1 C-N-CA 131.98 4.112 . . . . 0.0 105.885 172.833 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -43.98 17.01 Favored 'General case' 0 N--CA 1.444 -0.765 1 C-N-CA 131.747 4.019 . . . . 0.0 108.518 174.052 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.69 -16.38 48.47 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 124.365 3.257 . . . . 0.0 114.067 178.962 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -114.17 2.66 14.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 114.803 -2.522 . . . . 0.0 111.544 -174.661 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.305 67.3 m-80 74.85 16.33 2.99 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.794 2.438 . . . . 0.0 111.686 173.655 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.411 HD12 HD23 ' A' ' 56' ' ' LEU . 74.8 mt -68.39 128.05 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 O-C-N 117.521 -3.237 . . . . 0.0 113.905 -174.22 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -123.41 -163.45 1.12 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.152 2.581 . . . . 0.0 107.64 -178.854 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -50.81 119.26 3.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 123.375 1.56 . . . . 0.0 113.768 169.899 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.321 50.8 mt-10 74.94 21.38 2.03 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.024 -1.672 . . . . 0.0 111.576 163.171 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 45.8 m -53.7 126.28 21.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 115.96 -1.971 . . . . 0.0 110.223 160.663 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -97.38 112.38 24.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.163 2.185 . . . . 0.0 109.314 171.856 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.314 8.7 mp -97.82 167.26 11.04 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.399 1.88 . . . . 0.0 108.864 176.144 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -116.59 124.17 49.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.822 2.849 . . . . 0.0 104.605 -176.118 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -97.78 132.19 43.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.978 2.911 . . . . 0.0 110.574 -177.229 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 42' ' ' ARG 0.292 4.1 m -142.32 171.29 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 112.921 -1.945 . . . . 0.0 110.752 -176.538 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 172.519 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 ptt? . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 116.878 -1.534 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.411 49.4 mm-40 -109.15 146.39 34.18 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 116.717 -1.611 . . . . 0.0 108.166 -170.609 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 pt -145.33 156.86 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 121.208 1.822 . . . . 0.0 109.038 170.473 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -99.84 141.29 32.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 178.668 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 30' ' ' ILE . 52.9 t -107.58 133.71 51.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 156.513 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -91.34 117.6 29.8 Favored 'General case' 0 C--N 1.325 -0.474 1 C-N-CA 132.743 4.417 . . . . 0.0 110.26 170.298 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -82.65 162.46 21.84 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.342 1.857 . . . . 0.0 110.07 176.821 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pp -78.76 -24.47 44.7 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 127.384 2.274 . . . . 0.0 110.179 172.024 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -87.84 -18.02 30.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 119.867 -1.77 . . . . 0.0 114.136 -178.275 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.17 7.67 3.16 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 128.506 2.955 . . . . 0.0 115.903 144.576 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -90.62 163.34 14.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 125.36 2.505 . . . . 0.0 107.71 174.817 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.3 m -128.29 117.23 21.11 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.942 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.32 129.75 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 128.458 2.703 . . . . 0.0 103.837 -167.426 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -91.57 107.73 19.41 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -177.033 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.316 48.7 mt -102.91 152.52 21.2 Favored 'General case' 0 N--CA 1.449 -0.517 1 CA-C-N 126.341 4.155 . . . . 0.0 107.935 175.581 . . . . . . . . 3 2 . 1 . 062 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -113.78 119.93 39.04 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 114.68 -2.581 . . . . 0.0 106.15 175.313 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -124.7 149.68 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 125.003 1.439 . . . . 0.0 114.661 -175.309 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -81.61 130.61 60.81 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-O 114.991 -2.433 . . . . 0.0 104.556 167.309 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -38.71 -25.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.379 1 N-CA-C 123.163 4.255 . . . . 0.0 123.163 165.69 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.1 p -115.06 18.54 16.26 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 126.147 2.154 . . . . 0.0 114.466 178.99 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -59.46 111.33 1.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 128.822 2.849 . . . . 0.0 112.636 156.806 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -72.06 169.53 15.8 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 123.256 2.753 . . . . 0.0 111.192 -177.528 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.321 18.7 mm -51.11 -32.16 11.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 125.773 1.629 . . . . 0.0 113.782 -179.916 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -87.15 -20.86 26.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 122.179 2.263 . . . . 0.0 106.893 -175.314 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -79.39 -39.18 33.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.622 1.169 . . . . 0.0 112.482 179.839 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.3 t -43.07 -39.13 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 128.497 2.719 . . . . 0.0 113.157 161.884 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -75.01 -37.66 61.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 119.512 -1.992 . . . . 0.0 112.939 -171.818 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.285 . . -68.28 -16.69 64.05 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.974 2.509 . . . . 0.0 114.444 172.298 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.25 -38.42 17.59 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.572 2.349 . . . . 0.0 112.316 171.329 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 5' ' ' VAL . 71.9 mt -58.19 -42.41 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 114.449 -2.691 . . . . 0.0 114.451 157.445 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -48.63 -62.87 1.28 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.193 2.197 . . . . 0.0 112.471 165.283 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -33.0 -40.59 0.06 Allowed 'General case' 0 N--CA 1.448 -0.57 1 CA-C-O 111.589 -4.053 . . . . 0.0 119.709 170.656 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.48 -53.1 3.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 128.202 3.439 . . . . 0.0 111.473 176.865 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -112.97 -3.75 14.01 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -167.657 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.0 -8.94 77.54 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 116.895 -2.058 . . . . 0.0 115.683 160.5 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -66.21 130.0 94.25 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 129.045 2.938 . . . . 0.0 109.035 -172.454 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -71.22 143.15 43.2 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 N-CA-C 107.975 -1.587 . . . . 0.0 107.975 172.599 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.3 46.7 Cg_exo -28.86 -60.74 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 1 C-N-CA 126.369 4.712 . . . . 0.0 117.741 163.593 . . . . . . . . 3 2 . 1 . 062 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -55.41 -25.49 36.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 122.082 2.219 . . . . 0.0 115.568 -172.463 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -89.89 -9.89 47.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 176.211 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -94.75 154.76 17.14 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 131.599 3.96 . . . . 0.0 107.085 -175.838 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -143.47 152.38 41.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 113.853 -2.975 . . . . 0.0 104.821 163.634 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.267 76.5 mt -123.79 119.64 30.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.5 1.955 . . . . 0.0 107.385 -173.106 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -107.52 143.13 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 127.758 2.423 . . . . 0.0 110.005 -179.131 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -155.29 143.97 20.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.421 2.288 . . . . 0.0 109.304 172.343 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.66 31.88 13.52 Favored 'General case' 0 C--N 1.328 -0.331 3 O-C-N 114.566 -5.084 . . . . 0.0 114.217 161.483 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.27 2.56 62.01 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.645 2.069 . . . . 0.0 116.449 171.386 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.338 41.5 pttt -136.1 150.4 49.1 Favored 'General case' 0 N--CA 1.445 -0.717 1 C-N-CA 133.225 4.61 . . . . 0.0 114.966 -169.271 . . . . . . . . 3 2 . 1 . 062 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 48.8 tt0 -76.54 140.73 41.24 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.704 2.002 . . . . 0.0 106.996 162.455 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 mt -71.6 129.49 38.86 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 114.764 -2.541 . . . . 0.0 112.992 171.714 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.82 139.68 30.22 Favored 'General case' 0 N--CA 1.447 -0.581 1 C-N-CA 131.814 4.046 . . . . 0.0 105.057 -173.446 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.83 117.86 24.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 127.628 2.371 . . . . 0.0 115.856 -174.126 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.46 11.44 1.73 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.391 1.948 . . . . 0.0 112.836 179.684 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -141.11 163.65 32.39 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -174.058 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -123.73 -179.29 4.31 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 119.226 -2.171 . . . . 0.0 109.728 -162.994 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -58.84 -33.75 70.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 118.464 -2.648 . . . . 0.0 114.601 172.192 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 p -76.27 -34.61 59.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 120.94 1.7 . . . . 0.0 107.056 179.582 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -74.08 -42.61 59.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 125.5 1.75 . . . . 0.0 109.537 -173.237 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -76.44 4.04 9.93 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 118.762 -2.461 . . . . 0.0 115.215 166.892 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 75.8 18.0 2.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 131.529 3.932 . . . . 0.0 114.483 168.268 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.4 mt -69.97 132.98 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 O-C-N 119.295 -2.128 . . . . 0.0 108.681 -174.233 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -124.27 153.4 41.75 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 112.859 -3.448 . . . . 0.0 109.98 -173.861 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.27 135.02 27.17 Favored 'General case' 0 N--CA 1.443 -0.802 1 O-C-N 129.111 4.007 . . . . 0.0 113.049 -177.048 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.588 80.8 mt-10 84.93 11.17 0.31 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 128.247 2.619 . . . . 0.0 116.505 172.645 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.308 27.9 m -86.65 159.9 19.06 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 116.229 -1.843 . . . . 0.0 110.964 170.978 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.8 m -130.95 113.34 13.88 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.276 1.83 . . . . 0.0 107.143 -158.948 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.7 163.32 12.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 130.575 3.55 . . . . 0.0 113.906 -179.885 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -122.17 154.86 36.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -161.31 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.257 39.1 tp -145.58 117.93 8.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 125.619 2.628 . . . . 0.0 105.913 -167.853 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 t -110.17 119.39 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 110.588 -3.006 . . . . 0.0 108.142 169.433 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 C--N 1.326 -0.426 0 O-C-N 119.427 -2.045 . . . . 0.0 110.294 167.157 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttm . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -87.31 117.5 26.12 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.93 2.892 . . . . 0.0 112.728 -175.513 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.57 167.5 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.428 1.491 . . . . 0.0 109.742 170.961 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -140.6 115.21 9.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 125.327 2.489 . . . . 0.0 105.651 -168.912 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 15' ' ' LEU . 15.5 t -101.55 109.23 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.663 -2.062 . . . . 0.0 111.807 -179.239 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -93.99 121.11 35.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 115.549 -2.167 . . . . 0.0 113.489 -174.528 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.0 p -73.48 179.32 4.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 128.246 2.618 . . . . 0.0 111.259 -177.453 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.52 -32.16 60.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.19 2.196 . . . . 0.0 108.274 172.2 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.42 -21.71 59.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.155 2.182 . . . . 0.0 109.852 179.741 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.11 -4.56 58.86 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 117.244 -1.865 . . . . 0.0 114.92 177.511 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -65.92 143.9 57.13 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.9 1.0 . . . . 0.0 110.889 170.615 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -138.15 99.93 4.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.137 -2.227 . . . . 0.0 106.011 -158.844 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.5 mm -95.72 131.78 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.226 -169.946 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 m -94.75 105.49 17.43 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 119.628 -1.92 . . . . 0.0 107.64 -171.486 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.542 HD12 HG21 ' A' ' 5' ' ' VAL . 47.8 mt -93.98 127.23 39.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 125.143 2.402 . . . . 0.0 105.594 179.401 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -95.79 110.47 22.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 119.786 -1.821 . . . . 0.0 107.506 174.071 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.14 170.57 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.598 2.759 . . . . 0.0 107.596 -174.68 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -114.39 162.41 23.49 Favored Pre-proline 0 N--CA 1.449 -0.509 1 O-C-N 129.19 4.056 . . . . 0.0 108.892 150.195 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -57.88 -14.62 18.78 Favored 'Trans proline' 0 N--CA 1.447 -1.252 1 C-N-CA 125.716 4.277 . . . . 0.0 115.486 -175.555 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.1 p -90.74 0.32 57.47 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 116.912 -3.617 . . . . 0.0 114.853 -179.383 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.74 137.91 44.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 127.983 3.302 . . . . 0.0 106.396 -176.57 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -83.39 170.69 14.26 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.171 1.35 . . . . 0.0 112.512 173.264 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 50' ' ' LEU . 47.1 mt -58.7 -42.82 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 129.26 3.024 . . . . 0.0 108.018 170.816 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -49.57 -46.99 49.53 Favored 'General case' 0 C--N 1.329 -0.294 1 C-N-CA 132.535 4.334 . . . . 0.0 109.854 166.909 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -73.61 -45.65 51.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 120.448 1.476 . . . . 0.0 110.067 -177.925 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -53.57 -48.87 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 117.315 -1.326 . . . . 0.0 108.497 171.181 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -67.39 -36.28 81.0 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 120.086 1.312 . . . . 0.0 110.368 -178.668 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.53 -40.37 78.64 Favored 'General case' 0 C--O 1.217 -0.624 1 O-C-N 115.923 -4.235 . . . . 0.0 110.703 171.238 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.319 39.2 mttp -62.14 -49.74 74.66 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.253 3.421 . . . . 0.0 117.432 -179.389 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.92 -33.94 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 128.683 3.739 . . . . 0.0 110.462 164.479 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -75.34 -37.89 60.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 121.599 2.0 . . . . 0.0 115.014 -178.903 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -55.21 -37.99 67.85 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 126.89 2.076 . . . . 0.0 113.842 172.849 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -80.99 -83.1 0.11 Allowed 'General case' 0 N--CA 1.442 -0.87 1 C-N-CA 132.108 4.163 . . . . 0.0 114.022 -176.966 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -92.37 -0.27 57.39 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 116.884 -1.531 . . . . 0.0 110.975 -174.922 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.23 11.58 82.05 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 122.652 2.478 . . . . 0.0 114.239 175.961 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.9 mm -67.77 126.8 93.08 Favored Pre-proline 0 N--CA 1.446 -0.628 1 C-N-CA 132.313 4.245 . . . . 0.0 110.808 -177.103 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -64.14 149.39 90.46 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.542 3.494 . . . . 0.0 113.4 171.519 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -68.44 -55.69 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.212 2.608 . . . . 0.0 114.422 178.044 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -52.44 -25.21 9.4 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 127.305 2.878 . . . . 0.0 113.066 -173.12 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -79.2 -10.91 59.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.077 178.857 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -111.85 152.91 27.39 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 130.206 3.402 . . . . 0.0 116.609 -168.398 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -137.96 138.69 39.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 118.712 -2.493 . . . . 0.0 106.295 166.473 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 69' ' ' LEU . 41.2 mt -107.63 148.5 29.26 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.244 3.018 . . . . 0.0 112.026 -171.819 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.4 mt -147.74 118.69 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 126.811 2.044 . . . . 0.0 107.757 -164.982 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CD1' HG12 ' A' ' 61' ' ' ILE . 45.3 t80 -146.56 140.69 26.31 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 126.018 1.727 . . . . 0.0 106.997 169.993 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 74.9 21.07 2.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.987 2.515 . . . . 0.0 116.123 169.542 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.75 3.01 61.07 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 120.413 -1.43 . . . . 0.0 112.299 179.705 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.315 16.7 ptpt -127.96 133.93 49.25 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -171.406 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -75.21 132.76 41.34 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 102.029 -3.322 . . . . 0.0 102.029 163.539 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.447 ' HB3' HD11 ' A' ' 23' ' ' ILE . 29.4 mt -86.29 137.91 32.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 112.94 -1.936 . . . . 0.0 108.415 -179.69 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -111.86 147.41 35.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -178.877 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.01 139.78 58.8 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 128.802 2.841 . . . . 0.0 111.635 -162.9 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.48 20.74 10.56 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.373 1.463 . . . . 0.0 114.486 178.701 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -131.99 147.35 52.45 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 123.923 1.82 . . . . 0.0 109.755 175.386 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -95.46 154.08 17.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 111.283 -2.69 . . . . 0.0 111.767 179.264 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 53.9 mt -51.41 -33.64 31.28 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 119.229 -2.169 . . . . 0.0 115.683 -179.105 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -10.52 59.53 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 120.415 -1.428 . . . . 0.0 114.319 177.195 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -77.76 -27.93 50.49 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.586 175.18 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.366 67.8 m-85 -104.96 -0.04 27.32 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 130.986 3.714 . . . . 0.0 113.878 170.585 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.338 0.7 OUTLIER 59.06 39.82 22.84 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 128.813 2.845 . . . . 0.0 113.962 -179.079 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 90.0 mt -70.31 112.08 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 118.758 0.708 . . . . 0.0 109.811 168.634 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -112.37 -170.12 1.6 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 113.187 -1.824 . . . . 0.0 112.751 -170.813 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.443 36.1 pttt -50.65 120.18 4.49 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 120.378 3.473 . . . . 0.0 120.378 179.674 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 67.77 54.15 0.65 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.855 2.862 . . . . 0.0 109.241 177.731 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.7 m -107.43 141.31 39.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.309 175.238 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.276 36.3 m -108.9 144.95 36.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 126.233 2.921 . . . . 0.0 107.651 168.393 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.11 -178.03 4.72 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 103.355 -2.832 . . . . 0.0 103.355 173.976 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -151.68 -179.59 7.56 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 111.986 -2.37 . . . . 0.0 105.155 -171.898 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.429 ' HB3' HD23 ' A' ' 43' ' ' LEU . 1.5 pp -147.15 168.46 21.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 123.345 1.545 . . . . 0.0 112.923 175.865 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.0 p -128.74 133.42 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 131.574 3.95 . . . . 0.0 110.057 -178.225 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.572 ' O ' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 164.394 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 ttp . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 115.691 -2.1 . . . . 0.0 106.17 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.253 27.0 mp0 -97.0 131.24 44.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -175.127 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -114.63 177.64 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 116.955 -3.59 . . . . 0.0 105.577 158.926 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -127.25 141.76 51.64 Favored 'General case' 0 N--CA 1.447 -0.618 1 C-N-CA 131.978 4.111 . . . . 0.0 108.515 175.904 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.2 106.36 17.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 -178.344 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -89.37 166.53 13.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 117.762 -3.086 . . . . 0.0 104.489 166.695 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -127.5 149.34 50.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 109.38 -3.554 . . . . 0.0 104.04 176.08 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.21 1.68 20.69 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 128.003 3.315 . . . . 0.0 112.607 175.274 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -102.84 -21.32 14.04 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.645 2.378 . . . . 0.0 116.68 167.275 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.5 13.16 9.03 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-O 113.567 -3.907 . . . . 0.0 110.805 153.721 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -72.23 131.62 42.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 123.291 3.546 . . . . 0.0 112.597 155.182 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.8 m -108.22 133.17 52.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 172.714 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.6 mt -115.24 144.0 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 129.308 3.043 . . . . 0.0 106.784 167.884 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.293 28.4 m -107.31 130.63 54.75 Favored 'General case' 0 N--CA 1.448 -0.532 1 N-CA-C 97.453 -5.017 . . . . 0.0 97.453 164.708 . . . . . . . . 3 2 . 1 . 064 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tp -130.56 138.37 50.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.857 1.348 . . . . 0.0 111.603 179.288 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.27 118.16 35.99 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 -173.225 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.289 17.1 m -120.94 160.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 122.548 1.166 . . . . 0.0 109.574 -176.095 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -96.58 141.34 22.95 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 113.305 -3.236 . . . . 0.0 113.26 173.581 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -45.0 -50.9 8.21 Favored 'Trans proline' 0 N--CA 1.444 -1.385 1 C-N-CA 131.593 8.195 . . . . 0.0 108.245 169.102 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -60.24 -15.46 24.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.703 2.001 . . . . 0.0 112.101 -179.299 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -68.94 127.95 34.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 122.469 2.395 . . . . 0.0 114.505 -168.832 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.1 p -68.33 138.49 55.47 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 125.391 1.682 . . . . 0.0 107.065 160.845 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mm -53.45 -19.83 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -177.406 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.67 -36.24 80.26 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 122.225 2.284 . . . . 0.0 112.821 166.261 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -78.42 -10.14 59.57 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 123.271 2.76 . . . . 0.0 110.19 -178.814 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -92.88 -28.82 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 118.163 -2.836 . . . . 0.0 106.447 174.383 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -84.43 -20.31 32.02 Favored 'General case' 0 CA--C 1.539 0.523 1 O-C-N 114.977 -4.827 . . . . 0.0 110.062 177.83 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.69 -26.38 59.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 117.537 -1.22 . . . . 0.0 113.5 159.752 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -78.38 -17.02 57.04 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 171.772 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.2 mt -80.18 -34.51 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 114.309 -2.758 . . . . 0.0 110.685 162.952 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -50.69 -35.81 32.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 123.078 2.672 . . . . 0.0 116.019 168.656 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.253 27.5 t70 -91.74 -5.37 53.72 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 119.148 -2.22 . . . . 0.0 111.321 -172.631 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -121.99 -36.57 2.98 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 113.175 -3.297 . . . . 0.0 111.233 -169.511 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -125.65 -26.44 3.53 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 123.648 2.931 . . . . 0.0 109.195 176.901 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.72 17.35 12.16 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 117.016 -3.553 . . . . 0.0 112.746 174.588 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mt -86.82 125.94 65.15 Favored Pre-proline 0 N--CA 1.445 -0.711 0 N-CA-C 100.821 -3.77 . . . . 0.0 100.821 -175.735 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.47 144.49 25.65 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 CA-C-O 115.47 -1.971 . . . . 0.0 112.742 165.785 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -9.71 26.89 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 124.471 3.447 . . . . 0.0 114.754 -162.994 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.77 -17.01 64.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 123.429 2.831 . . . . 0.0 117.334 169.291 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -119.82 27.19 8.85 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 117.134 -3.479 . . . . 0.0 116.285 -162.157 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -113.56 165.66 12.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.257 2.623 . . . . 0.0 111.892 178.675 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -127.15 150.79 49.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.012 3.725 . . . . 0.0 102.983 141.902 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.67 105.59 11.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 112.317 -2.219 . . . . 0.0 110.946 165.114 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.97 134.77 27.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 125.688 2.661 . . . . 0.0 105.206 174.301 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -140.76 115.08 9.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 108.603 -3.908 . . . . 0.0 112.532 176.905 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.69 37.84 1.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 128.687 2.795 . . . . 0.0 112.75 -175.052 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.6 -35.34 4.78 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 121.253 -0.905 . . . . 0.0 113.075 171.173 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.313 97.7 mttt -83.57 165.09 19.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.971 2.908 . . . . 0.0 107.247 -173.947 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -116.5 119.72 36.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.685 2.394 . . . . 0.0 108.779 177.497 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.1 mt -80.59 124.38 28.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 123.379 1.561 . . . . 0.0 109.057 -161.125 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.21 130.84 35.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 -174.38 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.95 -37.11 30.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 127.59 3.056 . . . . 0.0 118.704 -170.952 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.19 5.02 41.4 Favored Glycine 0 CA--C 1.526 0.777 1 O-C-N 116.079 -4.138 . . . . 0.0 115.026 -170.381 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -88.57 146.72 24.97 Favored 'General case' 0 C--N 1.327 -0.413 1 O-C-N 116.226 -4.103 . . . . 0.0 107.024 170.195 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -86.47 134.64 33.67 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 127.858 3.224 . . . . 0.0 111.573 -173.678 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.309 10.8 tp -22.42 -76.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 1 C-N-CA 134.036 4.935 . . . . 0.0 114.243 177.656 . . . . . . . . 3 2 . 1 . 064 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.1 -37.29 85.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 125.397 2.522 . . . . 0.0 110.217 -170.135 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.3 -21.26 42.78 Favored 'General case' 0 CA--C 1.536 0.43 1 O-C-N 113.793 -5.567 . . . . 0.0 113.201 178.584 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -22.37 66.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 162.913 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.809 6.5 t-20 105.85 24.13 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 129.534 3.134 . . . . 0.0 117.96 175.512 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -99.82 73.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 126.708 2.003 . . . . 0.0 109.672 -177.524 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -89.84 169.79 10.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 124.72 2.2 . . . . 0.0 105.955 -179.506 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -31.54 115.79 0.16 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.283 2.697 . . . . 0.0 118.283 -174.298 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 77.51 29.8 0.52 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 129.067 2.947 . . . . 0.0 113.427 174.945 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -72.44 148.47 45.12 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 126.165 2.888 . . . . 0.0 114.133 169.986 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 m -104.73 107.48 18.45 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 117.062 -3.524 . . . . 0.0 105.811 -173.288 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.36 149.17 25.22 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 128.084 3.365 . . . . 0.0 108.649 162.275 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -107.59 110.84 22.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 127.971 3.294 . . . . 0.0 114.609 155.821 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.273 6.4 tt -74.19 139.41 44.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.083 -1.636 . . . . 0.0 107.635 168.763 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.02 145.99 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 164.97 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 71' ' ' LEU . 5.6 mp . . . . . 0 C--N 1.325 -0.495 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 -177.573 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptt? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 117.392 -1.29 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -100.2 161.61 13.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 169.272 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.9 pt -146.74 158.46 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 130.322 3.449 . . . . 0.0 103.137 168.71 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -107.11 140.31 40.15 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 127.057 2.143 . . . . 0.0 107.734 174.075 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -121.05 117.79 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 127.258 3.409 . . . . 0.0 105.808 170.009 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HZ2' ' HG1' ' A' ' 12' ' ' THR . 13.9 tptt -78.79 114.93 18.14 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 116.455 -3.903 . . . . 0.0 105.182 167.069 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.4 p -86.22 159.25 19.53 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 127.996 3.31 . . . . 0.0 108.469 168.544 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.76 -30.72 71.74 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.265 -1.789 . . . . 0.0 114.009 178.834 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.4 p -72.79 4.52 3.99 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.759 2.424 . . . . 0.0 114.806 165.913 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.86 17.08 77.92 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 114.045 -3.642 . . . . 0.0 113.839 173.013 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -85.42 121.32 27.97 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 122.819 3.309 . . . . 0.0 104.844 173.607 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.416 ' HG1' ' HZ2' ' A' ' 6' ' ' LYS . 11.3 m -85.86 63.68 8.18 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.791 2.436 . . . . 0.0 107.194 173.447 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mm -50.72 120.9 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 126.702 2.001 . . . . 0.0 111.948 173.82 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.9 m -88.67 136.66 32.88 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 174.346 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 mt -121.65 139.6 53.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.034 1.733 . . . . 0.0 106.992 177.629 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -86.97 129.22 34.97 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 167.418 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.381 18.5 m -140.75 154.48 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 128.936 2.894 . . . . 0.0 114.165 -179.416 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -117.4 171.42 4.97 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-O 114.186 -2.816 . . . . 0.0 110.596 171.63 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.97 -27.73 3.64 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 N-CA-C 118.393 2.42 . . . . 0.0 118.393 -170.171 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -86.61 -5.96 59.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 119.056 -2.277 . . . . 0.0 116.463 178.661 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.16 122.65 11.49 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 127.605 2.362 . . . . 0.0 108.996 178.224 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 p -85.87 169.77 13.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 117.222 -3.424 . . . . 0.0 110.883 -179.402 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 52' ' ' ASP . 18.4 mt -61.79 -27.81 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 O-C-N 126.299 2.249 . . . . 0.0 111.049 179.253 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.94 -43.36 79.29 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.491 -1.38 . . . . 0.0 107.372 174.326 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.315 30.0 m-20 -54.36 -41.53 69.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 118.736 -2.477 . . . . 0.0 117.344 168.6 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.5 t -73.56 -52.81 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 125.107 1.504 . . . . 0.0 109.082 176.135 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -44.64 -37.44 3.65 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 117.556 -3.215 . . . . 0.0 117.348 168.095 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.65 -37.86 55.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 126.826 2.579 . . . . 0.0 111.766 177.037 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -56.72 -50.15 73.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 127.424 2.952 . . . . 0.0 110.376 175.929 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.61 -31.29 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 117.469 -1.253 . . . . 0.0 109.322 -178.509 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -68.29 -48.63 64.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 121.104 1.775 . . . . 0.0 110.706 174.357 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.279 32.2 t70 -43.72 -40.77 4.45 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 128.624 3.703 . . . . 0.0 114.117 169.261 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -77.88 -60.1 2.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.459 1.904 . . . . 0.0 114.714 172.464 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -101.3 -21.19 14.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -162.071 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.0 -11.4 65.92 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 117.079 1.592 . . . . 0.0 117.079 -177.4 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.281 73.5 mt -77.58 126.33 84.68 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 123.915 3.857 . . . . 0.0 112.584 -174.875 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.98 168.37 24.95 Favored 'Trans proline' 0 N--CA 1.44 -1.638 0 N-CA-C 116.731 1.781 . . . . 0.0 116.731 -174.007 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.26 -22.78 9.42 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 CA-C-O 124.999 2.0 . . . . 0.0 115.817 -162.88 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.56 -20.36 59.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 111.983 -3.865 . . . . 0.0 110.58 179.778 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.64 -16.62 44.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 128.773 3.796 . . . . 0.0 109.001 -174.737 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -98.84 137.63 37.14 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.994 1.854 . . . . 0.0 113.472 -171.493 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -116.15 141.91 47.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 153.13 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.82 138.85 48.68 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.081 0.943 . . . . 0.0 108.636 179.893 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.453 HG13 ' HG3' ' A' ' 49' ' ' GLN . 3.7 mt -129.09 135.04 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 124.002 0.921 . . . . 0.0 109.564 -168.693 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -90.66 -175.94 4.57 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.365 2.266 . . . . 0.0 107.598 176.521 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -20.34 -57.22 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 1 C-N-CA 138.361 6.664 . . . . 0.0 111.826 -176.537 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.89 9.69 1.81 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.333 -1.815 . . . . 0.0 114.823 172.759 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -141.82 129.6 21.69 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -165.313 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.453 ' HG3' HG13 ' A' ' 44' ' ' ILE . 42.0 tt0 -75.35 139.82 42.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 126.22 2.2 . . . . 0.0 109.053 179.926 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -97.59 157.88 15.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 121.202 1.819 . . . . 0.0 110.692 179.003 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -148.64 138.96 22.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 123.013 1.387 . . . . 0.0 108.627 -176.517 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HA ' HD12 ' A' ' 23' ' ' ILE . 16.3 m-20 -59.42 144.3 47.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.008 2.923 . . . . 0.0 112.969 -163.526 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.6 11.88 11.11 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 126.366 2.291 . . . . 0.0 117.011 168.205 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -136.47 159.24 42.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.684 2.794 . . . . 0.0 109.072 179.487 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.0 p -85.96 176.68 7.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 124.854 2.264 . . . . 0.0 110.709 177.016 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.5 mt -62.94 -47.99 80.83 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 119.293 -2.13 . . . . 0.0 109.331 169.904 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -46.58 -38.17 9.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.892 2.877 . . . . 0.0 114.399 173.505 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -78.17 -31.61 49.72 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 115.051 -2.405 . . . . 0.0 104.803 -174.575 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -95.12 -1.38 52.09 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.817 1.323 . . . . 0.0 107.749 -173.361 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 60.0 m-80 77.83 27.72 0.57 Allowed 'General case' 0 N--CA 1.45 -0.471 1 O-C-N 115.429 -4.545 . . . . 0.0 117.931 171.605 . . . . . . . . 3 2 . 1 . 065 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -103.15 123.21 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 -170.249 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -123.28 171.0 9.71 Favored 'General case' 0 N--CA 1.445 -0.679 1 C-N-CA 131.737 4.015 . . . . 0.0 113.317 176.126 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -57.78 135.65 56.83 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 128.155 2.582 . . . . 0.0 111.478 -168.092 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.337 0.7 OUTLIER 81.51 7.24 1.13 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.656 2.782 . . . . 0.0 118.178 -177.896 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -68.67 139.61 55.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 124.83 2.252 . . . . 0.0 110.579 169.849 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.0 m -97.08 125.78 41.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 111.182 -2.735 . . . . 0.0 106.831 170.72 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.3 mt -96.36 150.51 20.5 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 128.759 2.824 . . . . 0.0 106.809 166.913 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -126.38 130.91 51.67 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 129.098 2.959 . . . . 0.0 110.703 171.685 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tp -86.4 141.84 28.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.685 1.994 . . . . 0.0 111.865 -178.543 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -130.91 133.02 63.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 101.872 -3.381 . . . . 0.0 101.872 177.098 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.1 mt . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 119.042 2.979 . . . . 0.0 119.042 175.668 . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 113.855 -2.974 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -98.7 149.88 22.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 121.111 1.778 . . . . 0.0 107.267 -176.997 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 pt -152.01 157.02 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.184 1.793 . . . . 0.0 107.934 174.129 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -110.1 142.86 40.99 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 130.275 3.43 . . . . 0.0 105.79 -175.176 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t -113.97 138.46 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 168.873 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -100.96 144.72 29.57 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 118.134 -2.854 . . . . 0.0 110.757 162.348 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.1 m -113.63 142.37 46.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.523 2.729 . . . . 0.0 104.956 -175.951 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 3.2 tm? -47.35 -49.28 24.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.33 2.252 . . . . 0.0 111.569 -171.769 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.3 p -80.29 5.7 14.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 -177.871 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.34 -9.83 10.89 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 121.723 3.449 . . . . 0.0 121.723 157.47 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -79.61 149.0 31.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.883 1.673 . . . . 0.0 109.736 -179.544 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m -119.09 124.29 46.52 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 129.612 3.165 . . . . 0.0 108.572 178.811 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.286 1.5 pp -119.33 -173.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.095 1.358 . . . . 0.0 111.559 176.049 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 t -154.2 144.17 21.88 Favored 'General case' 0 C--N 1.321 -0.647 1 O-C-N 116.0 -4.187 . . . . 0.0 110.345 177.267 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.34 0.3 OUTLIER -138.42 150.97 47.03 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.77 2.828 . . . . 0.0 109.168 -175.159 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.371 13.1 mp0 -97.49 119.89 36.87 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 126.66 2.475 . . . . 0.0 111.233 175.444 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.275 34.2 m -142.89 -179.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -163.145 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -141.84 143.37 28.48 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 127.568 2.347 . . . . 0.0 111.788 174.409 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.258 2.2 Cg_endo -58.73 -28.18 85.8 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 CA-C-N 127.279 3.635 . . . . 0.0 116.318 -175.073 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.9 m -85.2 19.59 2.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 112.375 -3.678 . . . . 0.0 109.144 178.524 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 55' ' ' THR . 12.0 m-20 -88.18 148.54 24.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 -178.982 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -87.47 154.08 20.92 Favored 'General case' 0 N--CA 1.446 -0.642 1 O-C-N 130.604 4.94 . . . . 0.0 113.244 177.489 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mm -53.17 -30.93 17.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 123.108 2.685 . . . . 0.0 118.069 -175.187 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.29 10.5 tt0 -70.62 -41.52 72.14 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 116.769 -1.586 . . . . 0.0 109.812 -176.315 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -72.95 -20.56 61.03 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 128.425 2.69 . . . . 0.0 112.152 -174.125 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.488 HG21 HD21 ' A' ' 56' ' ' LEU . 61.2 t -79.14 -50.06 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 128.054 2.541 . . . . 0.0 110.796 165.128 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -62.02 -24.06 66.83 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 120.745 1.612 . . . . 0.0 114.992 174.984 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.94 -37.57 53.21 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 128.67 2.788 . . . . 0.0 113.54 170.701 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -81.56 -23.35 37.25 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 126.038 2.086 . . . . 0.0 112.879 -176.649 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.85 -42.63 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 129.072 2.949 . . . . 0.0 104.357 179.669 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -51.03 -54.17 27.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.09 2.556 . . . . 0.0 113.83 164.294 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.66 -44.02 85.4 Favored 'General case' 0 N--CA 1.44 -0.96 1 C-N-CA 131.962 4.105 . . . . 0.0 117.54 -178.364 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -78.15 -81.85 0.1 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.646 1.979 . . . . 0.0 110.128 168.617 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -76.85 -35.11 57.72 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 127.015 2.697 . . . . 0.0 116.596 -162.663 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.85 11.1 23.47 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 119.19 -2.194 . . . . 0.0 117.139 177.024 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mt -88.72 134.54 33.68 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 116.258 -1.83 . . . . 0.0 106.548 -177.125 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -70.38 142.97 46.5 Favored 'Trans proline' 0 N--CA 1.447 -1.241 1 C-N-CA 125.454 4.103 . . . . 0.0 112.646 174.217 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.85 -20.31 68.17 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.698 1.599 . . . . 0.0 112.167 174.815 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -72.0 -5.52 35.58 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 118.231 -2.793 . . . . 0.0 112.179 172.478 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -126.01 0.71 7.25 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.827 2.451 . . . . 0.0 116.312 -176.607 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.262 50.6 mt-30 -101.72 149.01 24.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 122.256 2.298 . . . . 0.0 105.026 -175.219 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -133.06 130.96 40.06 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 158.998 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.8 mt -98.47 133.82 42.31 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.831 2.853 . . . . 0.0 107.019 175.255 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.35 148.07 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 176.319 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -156.7 119.4 4.04 Favored 'General case' 0 C--O 1.24 0.568 1 C-N-CA 132.212 4.205 . . . . 0.0 110.869 167.437 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 74.5 13.67 3.68 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.541 1.936 . . . . 0.0 115.205 177.724 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.9 -28.11 7.16 Favored Glycine 0 CA--C 1.531 1.065 1 CA-C-O 112.282 -4.621 . . . . 0.0 107.272 179.907 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -99.85 134.04 43.33 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 128.022 2.837 . . . . 0.0 110.937 -157.224 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -62.93 129.99 42.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.384 1.053 . . . . 0.0 109.289 163.908 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.78 111.84 6.53 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 125.41 1.484 . . . . 0.0 111.828 171.224 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.473 15.9 tt0 -91.85 148.03 22.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -172.51 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.75 142.77 35.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 120.481 1.491 . . . . 0.0 112.365 -164.877 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.34 -33.94 5.43 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 125.803 2.891 . . . . 0.0 112.86 -177.629 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -80.43 170.69 16.04 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 111.514 -2.343 . . . . 0.0 111.053 -175.886 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 21' ' ' ASP . 70.6 p -115.38 159.28 21.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.994 2.518 . . . . 0.0 108.769 -172.368 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 26' ' ' VAL . 77.2 mt -62.1 -26.43 68.29 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 116.393 -3.942 . . . . 0.0 109.756 179.566 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.0 t -54.23 -50.89 66.12 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.799 2.44 . . . . 0.0 113.353 175.317 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -48.09 -16.56 0.09 Allowed 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 127.476 2.31 . . . . 0.0 117.145 173.535 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -124.96 -4.28 7.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 118.058 -2.901 . . . . 0.0 111.95 179.689 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 93.17 31.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 125.573 1.795 . . . . 0.0 108.073 163.442 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 63.5 mt -89.6 121.2 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 -172.397 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -113.37 176.16 5.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 112.902 -1.953 . . . . 0.0 112.066 -175.675 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -39.14 124.54 1.49 Allowed 'General case' 0 CA--C 1.536 0.42 1 C-N-CA 132.47 4.308 . . . . 0.0 111.643 164.526 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 80.14 0.22 2.03 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.997 3.719 . . . . 0.0 113.808 175.559 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -62.44 135.26 57.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 121.591 1.996 . . . . 0.0 108.733 -171.709 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.9 m -95.72 118.63 32.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.439 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -92.19 155.74 17.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 129.028 2.931 . . . . 0.0 108.067 177.394 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -105.68 133.08 50.99 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 163.607 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.7 tp -101.39 130.94 47.7 Favored 'General case' 0 C--N 1.322 -0.62 1 C-N-CA 132.633 4.373 . . . . 0.0 115.286 162.424 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.5 t -127.24 130.27 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 131.237 3.815 . . . . 0.0 104.041 -179.43 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.445 -0.684 0 CA-C-O 115.249 -2.31 . . . . 0.0 113.163 -177.687 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttp . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -87.09 131.91 33.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.188 0.995 . . . . 0.0 108.411 -175.064 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.268 30.6 pt -110.67 142.21 23.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 154.322 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -88.24 129.72 35.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 160.783 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.19 115.63 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 O-C-N 127.705 3.128 . . . . 0.0 112.812 161.241 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -67.04 118.22 10.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 127.721 2.408 . . . . 0.0 111.415 173.208 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.8 p -86.59 163.95 17.14 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 120.004 3.335 . . . . 0.0 120.004 170.918 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 mp -84.86 -18.14 35.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 129.076 2.951 . . . . 0.0 112.776 179.344 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.93 -37.07 86.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 128.228 2.611 . . . . 0.0 111.804 172.756 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.1 -159.81 24.45 Favored Glycine 0 CA--C 1.533 1.186 1 C-N-CA 132.357 4.789 . . . . 0.0 108.356 -163.165 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 mttt 41.14 -163.47 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 1 N-CA-C 123.397 4.591 . . . . 0.0 123.397 167.28 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.0 p -128.76 157.75 40.57 Favored 'General case' 0 N--CA 1.444 -0.738 2 O-C-N 115.511 -4.493 . . . . 0.0 110.106 164.079 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.8 mm -95.73 130.91 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 161.434 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 m -94.55 120.68 35.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.556 1.17 . . . . 0.0 108.945 163.027 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -100.18 144.53 29.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 131.078 3.751 . . . . 0.0 106.418 -178.455 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.92 141.21 28.67 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 121.521 1.964 . . . . 0.0 108.76 152.908 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.24 153.98 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 O-C-N 124.697 1.248 . . . . 0.0 108.782 172.582 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -90.36 156.94 45.48 Favored Pre-proline 0 C--N 1.322 -0.619 0 O-C-N 118.005 -2.934 . . . . 0.0 104.209 163.542 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.7 -4.34 13.42 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 O-C-N 116.843 -2.241 . . . . 0.0 112.336 -176.776 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.8 p -97.71 7.47 46.37 Favored 'General case' 0 N--CA 1.448 -0.56 1 C-N-CA 135.67 5.588 . . . . 0.0 116.808 173.992 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -82.05 158.13 23.89 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 165.234 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -90.76 161.96 15.08 Favored 'General case' 0 C--N 1.326 -0.435 1 C-N-CA 132.218 4.207 . . . . 0.0 109.524 171.187 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mt -69.28 -20.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 127.572 2.349 . . . . 0.0 110.144 175.556 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.19 -26.14 65.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.088 -1.633 . . . . 0.0 114.009 164.999 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -34.93 69.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 120.858 1.663 . . . . 0.0 111.379 164.558 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.67 -54.45 32.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 122.767 2.53 . . . . 0.0 109.09 174.238 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -48.24 -50.83 28.08 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 118.799 -2.438 . . . . 0.0 115.569 177.788 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.27 -11.24 59.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 116.444 -1.741 . . . . 0.0 113.394 -176.438 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -81.62 -35.25 30.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 122.022 2.192 . . . . 0.0 111.416 166.7 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.24 -44.3 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 126.204 1.802 . . . . 0.0 109.183 169.045 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.32 44.6 tt0 -69.25 -40.05 78.1 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 117.372 -3.33 . . . . 0.0 110.018 -175.907 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -52.25 -49.46 63.99 Favored 'General case' 0 N--CA 1.445 -0.7 1 C-N-CA 134.669 5.187 . . . . 0.0 110.27 169.092 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.275 35.3 mttm -76.03 -57.9 3.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 114.023 -2.894 . . . . 0.0 110.345 177.804 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -113.07 -12.87 13.13 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 121.674 2.034 . . . . 0.0 106.564 -157.992 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.45 1.49 60.61 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 125.369 3.713 . . . . 0.0 114.934 160.732 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.9 mm -74.49 133.77 76.92 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 125.897 1.587 . . . . 0.0 108.545 -174.519 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -66.92 144.85 72.16 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 N-CA-C 116.432 1.666 . . . . 0.0 116.432 176.393 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.16 -25.31 13.84 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 CA-C-O 116.247 -1.647 . . . . 0.0 110.784 -162.467 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.63 -12.06 59.95 Favored 'General case' 0 N--CA 1.442 -0.836 1 C-N-CA 133.298 4.639 . . . . 0.0 105.47 -176.358 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -104.59 -15.13 15.4 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 125.305 1.628 . . . . 0.0 112.321 174.159 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -83.53 95.48 8.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 116.624 -3.797 . . . . 0.0 109.642 -178.597 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -87.89 92.75 9.24 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 121.919 2.145 . . . . 0.0 108.437 175.824 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.57 130.35 34.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 112.085 -2.325 . . . . 0.0 109.606 -179.021 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.9 mt -116.45 143.33 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 111.47 -2.604 . . . . 0.0 108.348 -170.452 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -144.16 129.85 19.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.107 1.363 . . . . 0.0 110.362 161.56 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.286 . . 57.15 15.88 2.7 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 119.613 3.19 . . . . 0.0 119.613 174.752 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.72 -32.88 5.78 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 117.989 -1.45 . . . . 0.0 112.279 -172.552 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.8 tttm -92.47 127.93 38.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.793 1.797 . . . . 0.0 108.121 -170.784 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 104.94 13.39 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 128.85 3.844 . . . . 0.0 106.348 168.095 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 50' ' ' LEU . 44.1 mt -71.84 125.19 26.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 111.438 -2.619 . . . . 0.0 113.964 -157.632 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.59 161.57 29.02 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 124.704 2.192 . . . . 0.0 105.25 -166.368 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.93 154.73 31.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.06 1.744 . . . . 0.0 112.836 163.541 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.81 -4.81 24.27 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.303 2.382 . . . . 0.0 114.949 165.466 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -136.1 168.93 18.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -171.66 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.8 p -107.44 173.76 6.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 119.324 -2.11 . . . . 0.0 113.163 -175.353 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mt -76.64 -18.34 58.65 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 116.867 -3.645 . . . . 0.0 108.527 -164.312 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.2 t -76.93 -31.27 56.52 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 129.398 3.079 . . . . 0.0 105.644 177.782 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 35.0 m-20 -78.22 -44.25 26.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 102.41 -3.181 . . . . 0.0 102.41 -173.809 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -72.64 1.93 7.43 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 127.539 2.336 . . . . 0.0 114.832 174.556 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t30 72.15 5.46 5.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.73 2.012 . . . . 0.0 113.042 171.199 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.417 HD13 HD21 ' A' ' 67' ' ' LEU . 5.4 mt -70.54 129.61 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 125.004 3.547 . . . . 0.0 106.701 -168.814 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.325 95.6 mm-40 -103.69 166.58 10.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 125.958 2.036 . . . . 0.0 108.9 174.466 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -42.65 123.1 2.53 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 130.725 3.61 . . . . 0.0 114.744 170.772 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.404 8.0 mp0 85.66 8.28 0.35 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 129.446 3.098 . . . . 0.0 112.87 170.161 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -64.86 137.72 57.94 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 119.756 -1.84 . . . . 0.0 110.22 177.034 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -93.74 107.38 19.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 119.688 -1.883 . . . . 0.0 109.475 174.094 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.417 HD21 HD13 ' A' ' 61' ' ' ILE . 9.5 mp -98.95 148.82 23.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 100.378 -3.934 . . . . 0.0 100.378 178.226 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -92.52 141.23 28.73 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 116.341 -3.975 . . . . 0.0 109.008 171.509 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.355 14.1 tp -107.77 131.35 54.55 Favored 'General case' 0 N--CA 1.451 -0.413 1 N-CA-C 98.36 -4.682 . . . . 0.0 98.36 158.05 . . . . . . . . 3 2 . 1 . 067 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.66 139.55 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 126.598 2.436 . . . . 0.0 105.387 169.465 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.2 mt . . . . . 0 N--CA 1.451 -0.42 0 CA-C-N 111.982 -2.372 . . . . 0.0 105.905 176.576 . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 ttp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -87.15 152.08 22.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 102.842 -3.021 . . . . 0.0 102.842 -175.032 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 pt -150.65 164.33 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 131.538 3.935 . . . . 0.0 107.04 169.689 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -118.04 141.15 48.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 130.379 3.472 . . . . 0.0 112.351 166.568 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m -104.4 151.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 111.464 -2.607 . . . . 0.0 108.671 162.134 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -140.67 156.42 46.24 Favored 'General case' 0 C--N 1.327 -0.377 1 O-C-N 115.266 -4.646 . . . . 0.0 106.848 176.679 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.347 4.8 t -142.21 152.5 43.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.475 2.71 . . . . 0.0 107.512 -176.671 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.97 -8.26 4.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 130.825 3.65 . . . . 0.0 118.388 -170.962 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.2 p -79.61 -20.0 47.9 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 123.891 3.041 . . . . 0.0 108.492 166.675 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.35 -1.17 23.75 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 128.676 3.036 . . . . 0.0 112.562 -175.733 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.269 75.3 tttt -72.78 143.45 47.92 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 118.449 -2.795 . . . . 0.0 110.318 -173.828 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.4 p -135.27 143.43 46.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.859 2.064 . . . . 0.0 114.344 179.727 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -139.19 143.35 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 1 C-N-CA 131.71 4.004 . . . . 0.0 109.963 -178.916 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 t -101.74 139.89 36.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.611 1.82 . . . . 0.0 113.215 171.015 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mt -129.85 151.25 50.62 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.235 1.414 . . . . 0.0 109.219 177.667 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -109.19 118.06 35.73 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.833 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.43 139.37 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -170.039 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -76.62 142.72 70.79 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-O 124.37 2.033 . . . . 0.0 106.195 177.044 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -58.81 -36.49 96.93 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 125.016 3.811 . . . . 0.0 116.546 178.051 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 p -72.72 -12.99 61.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.495 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -72.09 140.75 49.08 Favored 'General case' 0 N--CA 1.45 -0.455 1 O-C-N 115.303 -4.623 . . . . 0.0 113.026 -176.831 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 26' ' ' VAL . 77.3 p -73.14 134.98 44.64 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 179.447 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.251 26.6 mm -47.34 -38.24 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 129.704 3.202 . . . . 0.0 110.48 179.431 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -36.35 76.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 172.05 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -77.2 -40.52 44.83 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 129.249 3.02 . . . . 0.0 107.3 -177.777 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 22' ' ' THR . 44.0 t -70.94 -31.04 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 130.565 3.546 . . . . 0.0 112.331 -177.75 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -64.86 -32.66 74.47 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 116.709 -3.744 . . . . 0.0 108.559 179.39 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.37 69.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 117.232 -3.417 . . . . 0.0 113.138 172.502 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -74.54 -5.98 45.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 119.859 1.209 . . . . 0.0 111.666 -171.186 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.21 -35.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 123.695 1.712 . . . . 0.0 114.432 156.454 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -72.72 -38.0 67.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 118.232 -2.792 . . . . 0.0 110.053 -166.818 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.67 -36.81 83.42 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.09 171.055 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -90.14 -33.57 16.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 113.982 -2.913 . . . . 0.0 112.084 -175.35 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -126.25 -30.25 2.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 122.037 2.199 . . . . 0.0 112.373 -171.999 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.81 -8.35 42.84 Favored Glycine 0 CA--C 1.522 0.507 1 CA-C-O 112.157 -4.691 . . . . 0.0 113.153 176.935 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -74.21 125.58 89.88 Favored Pre-proline 0 C--N 1.328 -0.347 1 O-C-N 131.361 4.8 . . . . 0.0 108.025 -175.914 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 83.3 Cg_endo -68.06 138.28 43.36 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 N-CA-C 117.525 2.086 . . . . 0.0 117.525 166.007 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 9.3 Cg_endo -61.42 -31.95 88.64 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.901 3.067 . . . . 0.0 115.521 -170.656 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.61 -17.93 64.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 111.911 -3.899 . . . . 0.0 108.293 -171.467 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.09 -13.22 59.95 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 117.97 2.581 . . . . 0.0 117.97 172.151 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -116.13 151.46 35.6 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 120.328 -1.482 . . . . 0.0 111.344 -154.27 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -141.33 123.67 15.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 116.556 -3.84 . . . . 0.0 113.283 175.616 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.3 148.6 28.24 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 117.132 -3.48 . . . . 0.0 115.862 171.807 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.32 45.7 mt -131.11 138.6 53.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 127.955 2.502 . . . . 0.0 110.481 179.528 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' HB3' HD21 ' A' ' 50' ' ' LEU . 36.0 t80 -135.85 -176.98 4.48 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 179.52 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.41 85.75 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.226 3.01 . . . . 0.0 116.565 -164.931 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.41 -36.46 3.96 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 118.806 -2.434 . . . . 0.0 117.359 -174.492 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.355 86.1 tttt -151.87 159.6 43.8 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 125.955 2.788 . . . . 0.0 111.081 -160.401 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -80.61 144.31 32.46 Favored 'General case' 0 C--N 1.323 -0.545 1 CA-C-N 107.405 -4.452 . . . . 0.0 108.202 178.723 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 45' ' ' PHE . 18.3 mt -94.72 133.23 38.63 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 115.812 -2.355 . . . . 0.0 109.91 -175.397 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.2 132.13 48.3 Favored 'General case' 0 C--N 1.326 -0.454 1 O-C-N 115.694 -4.378 . . . . 0.0 118.624 168.229 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -76.46 93.28 3.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 128.7 3.75 . . . . 0.0 111.021 -168.649 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.55 -0.23 2.74 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 118.495 2.158 . . . . 0.0 118.495 -170.919 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -102.81 175.15 5.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.065 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.333 78.8 p -105.38 164.13 12.09 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.651 2.781 . . . . 0.0 110.56 -172.033 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -41.04 -51.66 3.28 Favored 'General case' 0 N--CA 1.446 -0.644 1 C-N-CA 132.109 4.164 . . . . 0.0 110.699 164.646 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 m -86.04 -6.96 58.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.253 -164.787 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -69.24 -38.62 78.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 124.911 2.291 . . . . 0.0 112.21 171.115 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.444 ' CD2' HD22 ' A' ' 50' ' ' LEU . 75.5 m-85 -103.55 -5.18 22.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 128.121 2.568 . . . . 0.0 112.812 -175.559 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.521 0.7 OUTLIER 75.61 37.62 0.41 Allowed 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 128.098 3.374 . . . . 0.0 113.584 175.539 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.402 HG23 ' CB ' ' A' ' 65' ' ' SER . 85.0 mt -70.81 137.28 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 173.129 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -131.69 -178.06 4.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.147 -168.797 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -42.21 110.62 0.18 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.926 2.491 . . . . 0.0 113.77 176.274 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 73.88 25.24 1.95 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.514 1.926 . . . . 0.0 111.829 172.458 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.402 ' CB ' HG23 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -62.14 128.76 37.65 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 119.182 -2.199 . . . . 0.0 110.262 179.722 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.9 m -91.12 107.6 19.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.216 1.006 . . . . 0.0 111.017 172.486 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.5 mt -97.01 147.56 23.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.432 1.893 . . . . 0.0 107.23 179.481 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -101.55 147.83 25.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 117.117 -1.42 . . . . 0.0 107.595 -174.181 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.19 142.97 46.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 125.095 2.379 . . . . 0.0 107.983 -179.631 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -138.42 159.59 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 O-C-N 119.353 -2.092 . . . . 0.0 105.468 173.191 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 112.528 -3.606 . . . . 0.0 118.151 151.24 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttp . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -101.41 137.27 39.96 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 -177.369 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.492 9.7 pt -142.67 149.79 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 1 C-N-CA 133.08 4.552 . . . . 0.0 110.259 174.913 . . . . . . . . 3 2 . 1 . 069 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -108.96 141.35 41.19 Favored 'General case' 0 C--O 1.223 -0.312 1 N-CA-C 99.909 -4.108 . . . . 0.0 99.909 -175.602 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.15 119.57 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 124.249 1.02 . . . . 0.0 113.526 156.689 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -91.5 111.3 22.75 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 -178.971 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -65.95 162.55 18.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 124.644 2.164 . . . . 0.0 115.26 171.758 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -68.53 -7.0 28.49 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 118.515 -2.615 . . . . 0.0 115.832 176.882 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -123.08 14.01 9.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 118.668 -2.52 . . . . 0.0 109.671 -176.826 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.16 -31.87 7.53 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 115.772 -2.682 . . . . 0.0 112.49 154.492 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -61.85 147.49 46.4 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 179.257 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.9 m -105.39 149.1 26.4 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 115.483 -2.199 . . . . 0.0 112.98 175.236 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.23 124.91 72.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 100.647 -3.834 . . . . 0.0 100.647 -179.623 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -78.14 134.18 37.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 117.227 -3.421 . . . . 0.0 110.525 162.612 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.4 mt -115.17 132.23 56.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 125.268 1.605 . . . . 0.0 109.141 167.892 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -97.38 117.21 31.09 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 127.42 2.95 . . . . 0.0 105.298 168.017 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.46 ' HB ' ' H ' ' A' ' 18' ' ' GLU . 16.3 m -141.41 -171.52 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 125.054 1.342 . . . . 0.0 112.167 -175.32 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' H ' ' HB ' ' A' ' 17' ' ' VAL . 1.2 tm-20 -136.88 146.8 56.55 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-O 115.673 -2.108 . . . . 0.0 108.246 -165.175 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.53 -29.05 83.55 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.645 2.897 . . . . 0.0 118.425 178.346 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.4 p -92.76 1.13 57.44 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 127.614 3.071 . . . . 0.0 114.248 -175.692 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.73 118.34 22.18 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -173.273 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.286 17.0 p -52.03 142.68 15.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 117.658 -3.151 . . . . 0.0 116.181 164.108 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.358 2.5 mm -31.23 -56.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 128.001 2.52 . . . . 0.0 114.977 174.405 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.252 12.9 mm-40 -53.71 -43.77 69.29 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.035 2.534 . . . . 0.0 117.573 172.588 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.417 6.6 m120 -59.95 -14.67 16.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 118.503 2.779 . . . . 0.0 118.503 165.296 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.352 61.7 t -97.7 -33.36 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.159 1.784 . . . . 0.0 110.18 174.696 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -75.55 -27.72 58.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.346 -1.788 . . . . 0.0 109.997 178.68 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.93 -56.67 18.64 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 129.578 3.151 . . . . 0.0 112.414 167.643 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.297 88.5 mttt -44.19 -29.92 0.71 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 164.272 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -77.72 -28.69 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 O-C-N 118.407 -2.683 . . . . 0.0 112.018 171.037 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -77.2 -35.02 56.08 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 122.576 2.443 . . . . 0.0 107.392 -174.388 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.57 -31.86 66.57 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 126.005 2.066 . . . . 0.0 108.886 177.735 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -92.85 -50.56 5.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 113.113 -3.327 . . . . 0.0 110.844 -177.136 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -112.54 -19.05 12.25 Favored 'General case' 0 N--CA 1.439 -0.983 1 O-C-N 130.346 4.779 . . . . 0.0 111.129 -155.806 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.34 -4.63 58.56 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 125.631 1.832 . . . . 0.0 116.183 174.083 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.54 112.89 35.18 Favored Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 130.926 3.691 . . . . 0.0 111.06 -172.642 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.57 150.77 87.67 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 O-C-N 123.377 1.198 . . . . 0.0 111.711 -173.677 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.422 50.8 Cg_exo -41.58 -50.67 4.65 Favored 'Trans proline' 0 N--CA 1.457 -0.639 1 C-N-CA 125.648 4.232 . . . . 0.0 116.939 167.833 . . . . . . . . 3 2 . 1 . 069 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.271 33.9 t70 -56.67 -22.92 38.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -178.681 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -95.52 -13.15 24.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 117.542 -3.224 . . . . 0.0 110.222 -173.807 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.261 77.7 mt-30 -94.19 136.26 34.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.957 -164.282 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.617 ' HG2' HE22 ' A' ' 49' ' ' GLN . 70.9 mtp180 -115.67 127.42 55.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 102.237 -3.245 . . . . 0.0 102.237 165.408 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.1 mt -102.62 119.79 39.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 124.525 1.141 . . . . 0.0 113.216 168.006 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 17.6 mm -114.63 152.72 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 128.947 2.899 . . . . 0.0 105.715 -170.016 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -168.0 127.04 1.25 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 112.013 -2.358 . . . . 0.0 106.556 176.532 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.417 . . 75.78 15.28 2.59 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 122.398 2.363 . . . . 0.0 116.044 167.068 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.49 17.44 31.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.856 2.646 . . . . 0.0 118.318 177.793 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 pttt -160.66 149.49 16.74 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -156.801 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.617 HE22 ' HG2' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -75.1 143.04 43.56 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 125.309 1.631 . . . . 0.0 108.021 178.094 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.45 117.2 18.69 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.462 -1.399 . . . . 0.0 107.757 169.755 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -81.57 150.92 27.94 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 131.145 3.778 . . . . 0.0 113.657 -166.422 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -64.86 120.56 12.76 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.781 2.033 . . . . 0.0 107.647 -171.956 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.56 15.25 3.7 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.394 1.949 . . . . 0.0 113.172 165.139 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.337 20.1 mtt180 -133.68 146.71 51.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 123.071 1.415 . . . . 0.0 113.881 -161.438 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -107.85 149.86 27.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 124.077 1.894 . . . . 0.0 107.505 178.043 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 mt -34.19 -48.09 0.31 Allowed 'General case' 0 N--CA 1.448 -0.525 1 C-N-CA 132.419 4.288 . . . . 0.0 116.124 176.778 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.4 p -83.88 -6.39 59.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -179.432 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.352 31.1 t0 -101.17 -10.7 20.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.765 2.026 . . . . 0.0 107.713 176.372 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.88 -14.36 17.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 129.412 3.085 . . . . 0.0 111.703 173.974 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 73.23 39.58 0.59 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 127.238 2.836 . . . . 0.0 110.578 -175.412 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.66 HD13 HD21 ' A' ' 67' ' ' LEU . 8.6 mt -87.05 96.64 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 121.988 2.176 . . . . 0.0 111.075 172.062 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.84 169.51 17.77 Favored 'General case' 0 C--N 1.325 -0.498 1 C-N-CA 134.848 5.259 . . . . 0.0 112.442 177.32 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.291 0.0 OUTLIER -51.3 140.19 17.5 Favored 'General case' 0 N--CA 1.439 -0.988 1 C-N-CA 131.739 4.016 . . . . 0.0 111.539 175.915 . . . . . . . . 4 3 . 1 . 069 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 37.34 43.58 0.39 Allowed 'General case' 0 C--N 1.324 -0.518 1 C-N-CA 133.654 4.781 . . . . 0.0 112.699 -176.917 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -59.6 147.51 36.97 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.97 1.708 . . . . 0.0 113.34 154.964 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.4 m -112.61 126.04 54.94 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 128.387 3.554 . . . . 0.0 103.798 169.7 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -124.64 160.05 29.36 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 127.696 3.123 . . . . 0.0 106.173 171.355 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 28.0 m80 -126.54 113.39 16.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 101.696 -3.446 . . . . 0.0 101.696 -155.523 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.3 tp -92.22 120.95 33.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 111.893 -2.412 . . . . 0.0 111.22 175.733 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.27 12.1 m -127.32 154.52 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 127.172 2.189 . . . . 0.0 107.818 173.435 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.258 2.3 pp . . . . . 0 N--CA 1.451 -0.418 0 CA-C-N 120.372 1.442 . . . . 0.0 112.505 -172.282 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -86.64 131.16 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.008 1.323 . . . . 0.0 111.481 -172.174 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.566 HD12 HD13 ' A' ' 67' ' ' LEU . 19.4 pt -125.59 150.32 30.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 -175.536 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.273 2.2 m-85 -92.32 130.57 37.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.276 1.43 . . . . 0.0 108.764 168.29 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.37 96.93 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 O-C-N 127.639 3.087 . . . . 0.0 105.67 -177.093 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -85.22 123.69 31.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.01 -2.931 . . . . 0.0 104.499 -170.835 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -76.23 150.31 37.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 165.192 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.8 tp -59.88 -24.51 64.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -173.707 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -89.16 0.28 56.87 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 120.391 -1.443 . . . . 0.0 113.182 -179.696 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.5 -5.93 18.89 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 115.093 -3.06 . . . . 0.0 117.967 166.149 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -86.14 131.73 34.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 128.339 3.023 . . . . 0.0 106.633 -174.534 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -113.66 104.1 11.89 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.062 -172.274 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.2 mt -88.09 126.38 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -172.555 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 9.5 m -93.06 121.33 34.3 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 177.326 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.281 55.8 tp -144.61 144.24 31.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 119.991 -1.693 . . . . 0.0 111.16 -165.511 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.5 134.45 42.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 122.073 0.939 . . . . 0.0 109.103 -177.341 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.34 169.2 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 174.251 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -109.9 160.98 26.07 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 127.641 2.376 . . . . 0.0 110.374 164.531 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.64 -23.31 17.08 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 125.194 3.929 . . . . 0.0 115.283 -176.353 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -83.91 -1.21 54.07 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.856 -2.403 . . . . 0.0 114.644 -179.731 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -79.62 121.14 24.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.727 2.011 . . . . 0.0 107.306 -177.618 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.4 p -48.63 148.49 2.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 164.616 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.407 ' CD1' HD23 ' A' ' 56' ' ' LEU 0.393 8.6 mm -38.3 -15.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 130.089 3.355 . . . . 0.0 118.382 173.46 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -94.21 -49.8 5.57 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 123.695 2.952 . . . . 0.0 107.4 -159.256 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -51.33 -32.7 26.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.898 2.079 . . . . 0.0 114.677 -155.239 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -73.03 -21.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 1 CA-C-O 129.67 4.557 . . . . 0.0 119.359 -178.993 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -69.81 -40.31 76.02 Favored 'General case' 0 N--CA 1.442 -0.85 1 O-C-N 114.41 -5.181 . . . . 0.0 115.091 -171.413 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.58 -23.34 49.99 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 112.453 -3.641 . . . . 0.0 111.34 170.764 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -63.18 -48.39 78.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.458 2.349 . . . . 0.0 113.382 166.087 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 mm -62.23 -42.12 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 126.28 1.832 . . . . 0.0 112.309 173.204 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -47.86 -43.75 28.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 166.996 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.42 -47.2 50.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.652 -173.836 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.28 -30.11 16.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 127.317 2.886 . . . . 0.0 115.706 -176.565 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -120.99 -0.73 9.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 121.682 2.037 . . . . 0.0 110.329 179.676 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.85 -0.05 87.7 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 118.258 -2.776 . . . . 0.0 116.494 166.692 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 71' ' ' LEU . 11.6 mt -99.65 128.54 31.06 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 -170.768 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.84 155.0 58.59 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 121.818 3.738 . . . . 0.0 121.818 175.898 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -59.4 -32.17 96.08 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 124.868 3.712 . . . . 0.0 117.083 176.104 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.46 1.6 t0 -52.51 -21.48 3.83 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 163.311 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -106.28 -18.42 14.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.705 2.002 . . . . 0.0 111.755 -179.519 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -98.94 100.87 12.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 116.774 -3.704 . . . . 0.0 103.264 -172.321 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -108.73 138.6 44.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 110.352 -3.113 . . . . 0.0 104.135 166.672 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -148.51 161.72 41.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 121.654 2.025 . . . . 0.0 114.81 -168.612 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mp -129.28 131.54 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 1 C-N-CA 134.667 5.187 . . . . 0.0 112.31 -169.822 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -98.35 -50.06 4.46 Favored 'General case' 0 N--CA 1.449 -0.475 1 CA-C-O 111.577 -4.059 . . . . 0.0 114.574 161.613 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -162.35 43.36 0.13 Allowed 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 128.158 3.411 . . . . 0.0 108.054 -161.217 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.43 -69.85 0.49 Allowed Glycine 0 CA--C 1.531 1.048 0 CA-C-O 124.002 1.89 . . . . 0.0 116.686 163.778 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -54.66 132.93 46.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 162.011 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 145.58 42.58 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 116.737 -1.985 . . . . 0.0 111.955 154.933 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 59' ' ' TYR . 23.2 mt -91.08 116.98 29.23 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 123.567 1.651 . . . . 0.0 113.297 -175.498 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.271 32.1 tt0 -84.49 156.37 21.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 112.437 -2.165 . . . . 0.0 116.156 -167.67 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -65.59 141.89 58.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.281 1.832 . . . . 0.0 109.689 175.083 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.58 -42.44 1.91 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-O 115.474 -2.848 . . . . 0.0 111.585 -178.181 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 mmp_? -72.98 173.5 9.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 121.67 2.735 . . . . 0.0 117.111 -173.289 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -120.71 155.82 33.09 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 126.67 2.481 . . . . 0.0 104.925 174.868 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 ' CD1' ' A' ' 23' ' ' ILE . 49.7 mt -59.37 -29.86 68.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 125.382 2.515 . . . . 0.0 113.071 -176.882 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -47.57 -46.05 27.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 118.373 -2.704 . . . . 0.0 116.228 163.905 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -68.32 -12.32 60.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.406 -175.622 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.479 ' CE2' HD22 ' A' ' 50' ' ' LEU . 55.8 m-85 -106.67 1.37 25.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 128.169 2.587 . . . . 0.0 112.742 178.746 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 1.7 t30 66.14 39.16 4.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.173 1.389 . . . . 0.0 110.262 175.24 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -88.33 131.28 36.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 120.75 1.614 . . . . 0.0 110.289 -176.708 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.44 -176.14 3.12 Favored 'General case' 0 C--O 1.221 -0.406 1 O-C-N 116.235 -4.04 . . . . 0.0 110.403 -176.982 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -55.8 146.7 20.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.617 1.967 . . . . 0.0 112.084 149.837 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 66.1 14.82 9.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.062 1.745 . . . . 0.0 112.317 176.418 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.0 m -71.02 155.85 40.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.508 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.6 m -113.5 120.87 42.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 129.461 3.105 . . . . 0.0 105.371 176.871 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.566 HD13 HD12 ' A' ' 3' ' ' ILE . 4.9 mp -110.86 140.73 45.07 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 114.274 -2.774 . . . . 0.0 106.089 170.481 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -129.49 138.95 51.67 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.224 1.81 . . . . 0.0 106.484 -174.691 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.59 151.51 22.26 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.819 177.53 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -105.85 109.49 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 131.388 3.875 . . . . 0.0 102.287 170.432 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 36' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 C-N-CA 129.929 3.292 . . . . 0.0 104.446 -179.972 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 116.714 -1.612 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -109.03 139.44 43.9 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.032 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.11 152.19 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 128.461 2.704 . . . . 0.0 106.624 -172.76 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -105.51 140.98 37.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 124.531 2.11 . . . . 0.0 110.657 179.012 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.309 1.7 p -145.76 107.79 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.146 -178.823 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -84.23 137.2 33.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 126.038 2.086 . . . . 0.0 113.404 -173.395 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -78.91 170.68 16.3 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 113.803 -2.999 . . . . 0.0 111.615 -176.303 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 9.4 tp -60.43 -13.78 15.4 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 126.936 2.648 . . . . 0.0 118.041 -175.759 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 p -107.74 -6.34 16.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.997 1.319 . . . . 0.0 110.808 -178.681 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.0 1.81 31.8 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 120.379 -1.451 . . . . 0.0 112.745 168.161 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 tttt -84.32 119.86 25.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 130.113 3.365 . . . . 0.0 102.127 -168.343 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 3.4 m -88.71 134.89 33.77 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 -167.104 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.5 mt -120.48 152.89 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.808 2.043 . . . . 0.0 110.061 169.254 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.286 1.5 m -118.58 123.1 44.22 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 169.955 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.9 mt -116.6 140.86 48.92 Favored 'General case' 0 N--CA 1.447 -0.59 1 C-N-CA 133.587 4.755 . . . . 0.0 111.348 -176.622 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.326 0.4 OUTLIER -99.27 120.01 38.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 101.387 -3.561 . . . . 0.0 101.387 167.228 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.88 -19.45 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 113.473 -3.156 . . . . 0.0 110.666 -168.769 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 0.1 OUTLIER 90.81 127.54 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-O 115.557 -2.163 . . . . 0.0 106.651 177.426 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -74.72 -29.26 8.92 Favored 'Trans proline' 0 N--CA 1.452 -0.966 1 C-N-CA 125.688 4.259 . . . . 0.0 113.514 178.345 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -84.54 -7.73 59.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.448 3.099 . . . . 0.0 110.606 -178.342 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.5 -177.86 3.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 122.372 2.351 . . . . 0.0 109.355 178.645 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -130.43 167.79 18.03 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -173.321 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -66.57 -38.02 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.636 1.575 . . . . 0.0 110.479 -164.735 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -56.66 -34.66 67.57 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 122.132 2.242 . . . . 0.0 109.902 -178.272 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -82.38 -2.11 52.01 Favored 'General case' 0 N--CA 1.445 -0.688 1 O-C-N 114.061 -5.4 . . . . 0.0 115.166 -178.498 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -88.98 -46.37 15.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 176.632 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HA ' HD12 ' A' ' 30' ' ' ILE . 58.1 mtmt -65.97 -29.77 70.21 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.169 0.988 . . . . 0.0 112.717 177.86 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.81 -41.11 79.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.932 2.493 . . . . 0.0 107.885 174.279 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -72.98 -30.08 63.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 173.958 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 27' ' ' LYS . 16.2 mt -67.48 -46.86 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 122.279 2.309 . . . . 0.0 111.533 169.019 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -49.75 -51.85 36.01 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 117.478 -3.264 . . . . 0.0 119.062 169.831 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -53.26 -38.05 62.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 128.602 2.761 . . . . 0.0 117.117 168.854 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -57.03 -62.81 1.49 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.46 1.504 . . . . 0.0 111.836 172.917 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.309 5.9 mm-40 -131.56 -8.7 3.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 125.493 2.568 . . . . 0.0 113.778 -157.361 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.82 32.85 6.32 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 119.955 -1.716 . . . . 0.0 115.993 178.022 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mm -82.58 130.04 60.29 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 127.889 2.476 . . . . 0.0 107.975 -167.495 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.88 127.9 15.16 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.312 2.008 . . . . 0.0 112.062 172.923 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.91 -34.99 7.88 Favored 'Trans proline' 0 N--CA 1.447 -1.219 1 C-N-CA 127.391 5.394 . . . . 0.0 112.518 -169.315 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -68.73 -19.97 64.37 Favored 'General case' 0 C--N 1.321 -0.633 1 C-N-CA 135.418 5.487 . . . . 0.0 110.244 -172.869 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -94.97 -3.74 47.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.893 1.677 . . . . 0.0 108.495 -176.914 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 10.2 mm100 -96.1 107.49 19.8 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 130.261 3.424 . . . . 0.0 111.446 -172.296 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -94.16 101.66 13.67 Favored 'General case' 0 N--CA 1.444 -0.761 1 C-N-CA 132.759 4.424 . . . . 0.0 107.24 167.919 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.488 ' CD1' ' HB3' ' A' ' 41' ' ' GLN . 11.2 mp -103.5 101.93 11.82 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 127.536 2.334 . . . . 0.0 111.4 -174.332 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.6 mm -108.69 142.3 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 123.704 1.716 . . . . 0.0 107.225 179.209 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -124.79 105.17 9.07 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 112.529 -2.123 . . . . 0.0 109.508 173.671 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.84 42.1 15.45 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 127.12 3.343 . . . . 0.0 117.048 176.791 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.9 -14.5 52.65 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 109.401 -3.545 . . . . 0.0 118.735 178.325 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.25 77.3 mttt -115.1 130.34 56.9 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -166.374 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.33 48.3 tt0 -48.33 142.34 5.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 121.345 3.832 . . . . 0.0 121.345 162.319 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 50' ' ' LEU . 87.8 mt -98.02 105.49 17.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 172.481 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -88.07 140.81 29.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 -175.706 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -81.09 141.64 34.11 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 124.161 3.164 . . . . 0.0 103.047 173.269 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.16 -29.67 6.66 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -175.664 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.39 150.4 23.83 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 127.31 2.418 . . . . 0.0 113.202 176.475 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -77.9 156.92 30.03 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.398 -1.273 . . . . 0.0 109.537 166.151 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.4 mt -74.6 -31.94 62.19 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.553 1.941 . . . . 0.0 109.589 -178.033 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.1 t -75.33 -12.67 60.32 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 120.414 -1.428 . . . . 0.0 112.572 175.917 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -66.05 -34.32 77.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 123.679 2.945 . . . . 0.0 112.65 169.518 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -91.59 7.08 43.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 127.234 2.834 . . . . 0.0 116.283 172.889 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.368 81.1 m-20 76.53 36.2 0.38 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.977 1.711 . . . . 0.0 113.304 171.285 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.4 mt -82.03 99.32 5.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 171.019 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -110.07 -172.92 2.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 129.978 3.311 . . . . 0.0 113.926 179.48 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.05 140.86 0.99 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 128.317 2.647 . . . . 0.0 117.202 173.71 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 6.7 tm-20 73.62 4.19 4.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 122.439 2.382 . . . . 0.0 114.449 162.823 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.2 m -72.54 132.14 43.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.572 -1.649 . . . . 0.0 107.913 -173.217 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.0 p -105.68 142.36 35.55 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 125.071 1.482 . . . . 0.0 108.109 167.198 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.29 165.91 26.18 Favored 'General case' 0 N--CA 1.446 -0.636 1 C-N-CA 131.838 4.055 . . . . 0.0 105.692 167.261 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -99.54 161.58 13.53 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 126.022 2.82 . . . . 0.0 104.486 165.894 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.2 tp -148.11 132.56 17.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 118.762 -2.461 . . . . 0.0 110.224 -179.56 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -68.34 89.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 127.023 3.296 . . . . 0.0 104.529 163.812 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp . . . . . 0 N--CA 1.443 -0.812 1 N-CA-C 98.601 -4.592 . . . . 0.0 98.601 175.427 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ttp . . . . . 0 C--O 1.24 0.568 1 N-CA-C 99.492 -4.262 . . . . 0.0 99.492 . . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -94.37 136.15 34.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 123.082 2.674 . . . . 0.0 110.694 167.966 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.27 161.25 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 102.902 -2.999 . . . . 0.0 102.902 170.401 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -117.25 149.76 39.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.045 1.738 . . . . 0.0 113.481 -171.67 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' HB2' ' A' ' 67' ' ' LEU 0.343 16.3 m -141.69 165.0 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 128.681 2.792 . . . . 0.0 112.41 169.062 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -149.78 142.17 24.29 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -169.367 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -136.72 -145.21 0.21 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 129.08 2.952 . . . . 0.0 108.604 175.246 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -96.29 -55.01 3.08 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 121.357 1.889 . . . . 0.0 108.254 -169.036 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -84.98 -27.1 26.71 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.295 1.838 . . . . 0.0 114.276 -179.917 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.94 123.95 7.15 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 106.505 -2.638 . . . . 0.0 106.505 175.269 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -102.86 -29.04 11.69 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.011 2.524 . . . . 0.0 107.383 -174.683 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -137.28 96.37 3.26 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 114.283 -2.77 . . . . 0.0 104.497 -177.233 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.9 mt -103.29 109.32 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 1 N-CA-C 98.541 -4.614 . . . . 0.0 98.541 165.009 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.271 62.8 p -86.77 131.48 34.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 173.922 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -128.61 120.72 27.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.436 -2.802 . . . . 0.0 103.436 -175.603 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -96.01 120.39 36.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.611 3.564 . . . . 0.0 105.681 -178.435 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 m -143.4 159.01 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 O-C-N 117.482 -3.261 . . . . 0.0 108.057 -170.07 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.71 151.29 37.37 Favored Pre-proline 0 N--CA 1.447 -0.606 1 C-N-CA 132.618 4.367 . . . . 0.0 100.764 163.644 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.281 73.1 Cg_endo -64.47 8.7 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.966 2.444 . . . . 0.0 116.443 -179.927 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.3 p -128.34 16.87 6.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 129.345 3.058 . . . . 0.0 115.93 168.753 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.263 1.0 OUTLIER -41.0 117.21 0.82 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 158.813 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 p -73.68 151.18 40.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.947 2.899 . . . . 0.0 108.823 179.687 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.31 1.1 mm -50.77 -41.03 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 126.779 2.032 . . . . 0.0 109.501 176.438 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -57.9 -41.48 82.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 171.143 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -65.15 -50.42 66.07 Favored 'General case' 0 N--CA 1.45 -0.452 1 O-C-N 116.159 -4.088 . . . . 0.0 113.962 171.342 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.84 -54.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 122.684 2.493 . . . . 0.0 112.426 168.649 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -53.04 -47.57 68.29 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.029 2.932 . . . . 0.0 115.904 170.68 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.47 -52.96 33.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 117.141 -3.474 . . . . 0.0 118.791 159.012 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -62.05 -33.36 74.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 128.882 2.873 . . . . 0.0 110.268 -176.508 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.4 mt -76.39 -48.55 27.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 129.014 2.926 . . . . 0.0 106.842 173.227 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -49.85 -49.5 49.0 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 128.94 2.896 . . . . 0.0 113.144 176.94 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -49.3 -31.95 10.08 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 128.919 2.888 . . . . 0.0 114.883 -174.054 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -105.0 -64.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 127.782 3.176 . . . . 0.0 111.196 178.353 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -81.45 -27.87 34.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -159.118 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.61 0.65 43.1 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 170.797 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.5 mm -80.61 122.05 81.92 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 120.869 2.335 . . . . 0.0 107.764 -170.806 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD2' HE21 ' A' ' 40' ' ' GLN . 18.6 Cg_endo -76.53 156.02 36.16 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 CA-C-O 114.356 -2.435 . . . . 0.0 112.95 175.402 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.26 -21.42 1.18 Allowed 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 122.522 2.148 . . . . 0.0 115.525 170.915 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -81.26 -22.14 38.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 117.845 -3.034 . . . . 0.0 116.814 -175.623 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.422 HE21 ' HD2' ' A' ' 37' ' ' PRO . 9.3 tt0 -105.61 3.43 29.18 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -166.525 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.537 ' HB2' HD21 ' A' ' 69' ' ' LEU . 19.5 pt20 -128.47 128.9 45.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.346 2.258 . . . . 0.0 105.052 -171.237 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 mtt85 -90.41 170.22 10.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 124.952 2.311 . . . . 0.0 105.121 158.006 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.386 30.7 tp -138.19 112.02 8.35 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 112.71 -2.041 . . . . 0.0 107.783 176.606 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.31 140.99 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 127.445 3.498 . . . . 0.0 105.189 173.714 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.54 145.17 22.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 119.247 -2.158 . . . . 0.0 105.41 151.592 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.67 22.46 5.36 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 125.778 1.924 . . . . 0.0 111.3 175.43 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.8 -12.89 61.0 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 116.414 -2.325 . . . . 0.0 108.325 174.408 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -108.69 127.35 53.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 120.849 2.324 . . . . 0.0 106.157 -159.04 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -61.58 93.58 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.907 2.883 . . . . 0.0 105.069 165.713 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.8 mt -64.94 130.51 43.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 119.389 -2.069 . . . . 0.0 113.571 172.3 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -86.65 146.45 26.31 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 125.718 1.886 . . . . 0.0 114.562 -176.732 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.305 14.5 m-20 -68.33 112.85 5.45 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 126.975 2.672 . . . . 0.0 115.103 168.703 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.15 -23.59 2.41 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.253 -1.304 . . . . 0.0 114.862 -169.559 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -110.06 162.57 14.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 -161.796 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -101.73 165.98 10.92 Favored 'General case' 0 N--CA 1.448 -0.561 1 C-N-CA 132.583 4.353 . . . . 0.0 113.313 168.525 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.9 mt -42.03 -45.51 3.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 116.237 -1.84 . . . . 0.0 113.909 168.833 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -64.68 -14.95 60.48 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 130.199 3.4 . . . . 0.0 113.972 -176.532 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -75.92 -35.47 59.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.711 0.404 . . . . 0.0 110.518 172.809 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -114.26 12.5 17.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 -173.193 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 9.2 m120 65.27 28.94 11.86 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 126.665 1.986 . . . . 0.0 115.306 161.977 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -93.29 137.43 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 128.496 3.998 . . . . 0.0 103.841 -160.384 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -111.4 -168.75 1.35 Allowed 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 116.928 -3.608 . . . . 0.0 109.993 176.97 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -78.48 149.86 33.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 118.876 -2.39 . . . . 0.0 113.18 -170.233 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 31.4 mt-10 66.52 9.35 6.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 130.75 3.62 . . . . 0.0 112.963 174.889 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -72.51 165.75 24.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.919 1.688 . . . . 0.0 108.075 174.81 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 m -121.86 130.26 53.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.067 2.947 . . . . 0.0 109.683 176.414 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 67' ' ' LEU . 3.1 mp -104.8 169.48 8.43 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 119.543 -1.973 . . . . 0.0 111.26 158.057 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -119.77 126.5 51.2 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.6 2.36 . . . . 0.0 113.623 177.088 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 41' ' ' GLN 0.288 3.9 tt -98.85 131.39 44.99 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -177.131 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.9 123.9 71.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 174.893 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 mt . . . . . 0 C--N 1.33 -0.272 0 C-N-CA 127.774 2.43 . . . . 0.0 110.148 179.42 . . . . . . . . 0 0 . 1 . 073 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.435 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 6.4 ptm . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 124.935 2.302 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -85.84 121.87 29.1 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 117.603 -3.186 . . . . 0.0 109.268 170.054 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pt -137.44 117.93 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 128.338 2.655 . . . . 0.0 104.59 170.871 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -83.16 112.92 20.27 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 117.803 -3.061 . . . . 0.0 109.213 -173.259 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.4 t -85.05 100.55 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 O-C-N 117.999 -2.938 . . . . 0.0 106.89 170.797 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -103.5 119.52 39.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.3 1.44 . . . . 0.0 107.245 -167.955 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m -81.57 144.6 31.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.245 1.818 . . . . 0.0 109.437 174.89 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -37.8 -51.11 1.27 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -178.648 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 p -62.07 -10.49 10.27 Favored 'General case' 0 N--CA 1.444 -0.728 1 O-C-N 129.366 4.166 . . . . 0.0 114.751 -178.057 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.2 -24.14 16.86 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.755 1.862 . . . . 0.0 117.755 179.752 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -62.59 123.02 17.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 127.329 2.252 . . . . 0.0 109.374 -177.253 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.278 8.4 m -114.8 113.28 24.04 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.976 2.11 . . . . 0.0 115.652 -174.108 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.7 mt -90.44 148.0 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 O-C-N 126.495 2.372 . . . . 0.0 106.528 -172.445 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.318 4.7 t -155.19 100.04 2.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 -163.906 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -140.78 127.98 20.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.635 -2.075 . . . . 0.0 110.653 -161.101 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.79 93.61 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.456 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -125.84 169.81 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 126.689 1.995 . . . . 0.0 107.815 169.799 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' OE2' ' HB3' ' A' ' 1' ' ' MET . 26.7 mm-40 -138.17 158.9 70.16 Favored Pre-proline 0 N--CA 1.445 -0.713 1 C-N-CA 132.035 4.134 . . . . 0.0 107.068 -176.24 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.16 -9.03 14.12 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 O-C-N 125.58 2.358 . . . . 0.0 117.992 -168.605 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 t -92.74 4.42 53.79 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.455 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -73.18 134.23 44.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 117.267 -3.396 . . . . 0.0 111.428 175.902 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -76.29 157.25 32.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 125.03 2.348 . . . . 0.0 112.926 175.902 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.268 2.7 mm -64.52 -31.5 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 O-C-N 117.207 -3.433 . . . . 0.0 118.315 -172.12 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.03 -35.85 25.45 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.926 2.091 . . . . 0.0 111.557 178.137 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.367 10.3 t-20 -51.72 -48.94 63.4 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 127.037 2.711 . . . . 0.0 113.669 158.651 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.87 -40.43 85.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 121.898 2.136 . . . . 0.0 113.067 171.681 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.261 44.7 mtpt -64.84 -36.33 83.99 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.153 1.781 . . . . 0.0 110.833 -178.376 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.14 -14.25 62.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.449 2.299 . . . . 0.0 112.527 -176.308 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -83.13 -27.81 29.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 123.633 0.583 . . . . 0.0 111.594 173.953 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 30' ' ' ILE . 75.3 mt -82.57 -18.65 10.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.907 -164.967 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -77.26 -30.14 54.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 125.14 1.525 . . . . 0.0 112.484 176.362 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -70.91 -57.41 4.62 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 119.367 -2.083 . . . . 0.0 110.979 165.886 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -82.66 -28.59 30.56 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.157 1.783 . . . . 0.0 114.327 -161.438 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -118.23 -5.99 10.86 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 124.403 1.064 . . . . 0.0 110.601 178.733 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.22 -0.08 26.09 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 129.733 3.54 . . . . 0.0 117.923 -175.677 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.6 mm -82.8 138.88 43.34 Favored Pre-proline 0 N--CA 1.447 -0.597 1 O-C-N 115.376 -4.602 . . . . 0.0 104.165 -172.275 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -86.03 167.29 9.56 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 125.027 3.818 . . . . 0.0 105.589 176.254 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.98 -22.16 5.32 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.64 2.227 . . . . 0.0 116.237 168.507 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.37 0.0 OUTLIER -54.52 -49.73 69.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 129.747 3.219 . . . . 0.0 109.668 -179.459 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.29 71.0 mm-40 -78.8 -22.26 46.55 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 120.458 1.481 . . . . 0.0 114.943 178.116 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.307 7.1 tt0 -86.21 154.46 21.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.488 1.915 . . . . 0.0 113.542 -156.527 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.319 23.6 ttm105 -153.35 140.4 19.32 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 128.381 2.672 . . . . 0.0 112.75 -178.247 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.3 mt -125.0 131.96 53.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 116.85 -1.548 . . . . 0.0 111.708 -177.937 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.53 120.67 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.282 1.833 . . . . 0.0 112.742 179.234 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.294 22.6 t80 -120.7 119.84 33.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 115.992 -1.956 . . . . 0.0 108.078 176.908 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.46 25.41 9.63 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 126.239 2.212 . . . . 0.0 116.928 -178.967 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.27 -15.28 63.29 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.739 1.637 . . . . 0.0 112.406 -174.73 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.13 113.76 26.11 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 124.025 3.912 . . . . 0.0 105.494 -173.444 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -66.77 136.7 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 126.338 2.97 . . . . 0.0 107.77 168.189 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -84.97 134.95 34.23 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 118.608 -2.558 . . . . 0.0 113.168 179.134 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.24 158.27 16.68 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -178.733 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -73.16 155.08 39.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.984 2.514 . . . . 0.0 111.902 177.829 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.13 -15.56 62.61 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.767 2.127 . . . . 0.0 116.303 171.213 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -91.21 161.0 15.25 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -167.821 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -84.77 166.78 16.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.923 0.868 . . . . 0.0 108.945 170.499 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.0 -41.37 91.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 118.978 -2.326 . . . . 0.0 116.905 168.088 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 t -53.92 -23.91 14.49 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 130.04 3.336 . . . . 0.0 116.069 170.307 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -74.27 -18.06 60.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 115.38 -2.248 . . . . 0.0 115.23 172.266 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -103.45 5.83 37.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.243 1.383 . . . . 0.0 110.979 172.401 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 73.72 33.73 1.0 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.119 1.368 . . . . 0.0 110.007 175.137 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -90.57 136.91 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 119.342 -2.099 . . . . 0.0 112.071 -170.608 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -130.69 174.05 10.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.013 1.725 . . . . 0.0 112.669 -162.786 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -58.26 121.23 10.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.154 2.181 . . . . 0.0 111.56 -177.995 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.368 12.4 mt-10 61.57 34.03 18.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 130.807 3.643 . . . . 0.0 113.77 178.454 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.258 24.4 m -83.76 157.72 22.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 159.481 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -126.4 135.46 51.45 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.468 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.254 3.9 mp -98.68 143.1 29.43 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 128.332 2.653 . . . . 0.0 107.51 172.081 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -72.43 148.87 44.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 124.674 2.178 . . . . 0.0 109.405 159.534 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -135.23 131.16 36.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.422 169.376 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.37 152.65 36.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 128.336 2.654 . . . . 0.0 110.922 170.49 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.445 -0.685 0 C-N-CA 130.309 3.444 . . . . 0.0 109.496 178.489 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttp . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -95.08 140.87 29.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.514 -1.675 . . . . 0.0 110.111 -178.49 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -145.09 159.58 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 128.075 2.55 . . . . 0.0 107.174 167.313 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -106.43 153.3 22.46 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 117.409 -3.307 . . . . 0.0 105.946 171.806 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.8 t -118.85 130.01 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 166.827 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -111.01 138.35 47.52 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.418 1.087 . . . . 0.0 108.128 173.789 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.7 p -88.35 140.51 29.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 164.557 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -60.47 -17.76 47.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 117.03 -3.544 . . . . 0.0 115.88 -177.15 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -80.49 -5.84 57.25 Favored 'General case' 0 C--N 1.322 -0.589 2 C-N-CA 131.97 4.108 . . . . 0.0 112.716 165.724 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.37 -7.95 43.86 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 118.306 2.082 . . . . 0.0 118.306 165.142 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -58.15 152.27 17.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 117.916 -3.108 . . . . 0.0 112.547 163.583 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.0 p -134.15 161.31 35.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.628 1.204 . . . . 0.0 109.776 161.948 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.54 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -142.42 154.8 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 102.173 -3.269 . . . . 0.0 102.173 169.385 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -97.54 126.38 42.79 Favored 'General case' 0 N--CA 1.444 -0.773 1 C-N-CA 132.116 4.167 . . . . 0.0 103.36 -175.038 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.15 101.35 8.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 131.386 3.874 . . . . 0.0 111.687 -176.8 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.3 pm0 -76.47 126.16 30.5 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 127.174 2.796 . . . . 0.0 105.473 163.539 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.432 31.5 m -135.84 165.01 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 1 C-N-CA 133.368 4.667 . . . . 0.0 116.468 -175.674 . . . . . . . . 3 2 . 1 . 074 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.67 159.78 37.42 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 125.879 1.671 . . . . 0.0 111.124 166.686 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.352 97.7 Cg_endo -58.62 -40.59 72.22 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 N-CA-C 120.26 3.139 . . . . 0.0 120.26 177.256 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -73.15 -14.74 61.43 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 130.24 3.416 . . . . 0.0 109.89 -171.644 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -65.55 127.3 31.31 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 124.98 2.324 . . . . 0.0 112.74 -175.725 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.9 p -70.06 156.09 39.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.376 175.244 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.76 -37.0 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.577 1.151 . . . . 0.0 111.506 166.101 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -48.06 -48.61 33.22 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.691 1.996 . . . . 0.0 114.338 166.749 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -73.32 -43.3 61.12 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 118.006 -2.934 . . . . 0.0 112.774 174.59 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.315 29.9 t -58.57 -31.47 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 118.012 -2.93 . . . . 0.0 112.022 170.653 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -64.95 -39.27 93.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 123.145 2.702 . . . . 0.0 111.339 169.302 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.46 -31.36 53.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 111.944 -3.884 . . . . 0.0 114.704 175.491 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -62.95 -50.97 68.7 Favored 'General case' 0 N--CA 1.452 -0.357 1 O-C-N 132.857 6.348 . . . . 0.0 109.659 167.443 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mt -53.05 -46.18 53.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 1 O-C-N 115.517 -4.489 . . . . 0.0 109.424 173.442 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -34.64 77.8 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 112.741 -3.504 . . . . 0.0 111.51 -179.964 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.67 -32.37 69.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 128.457 3.598 . . . . 0.0 109.851 176.058 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -78.43 -34.48 47.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 121.754 2.07 . . . . 0.0 113.5 173.759 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -145.98 -19.46 0.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -151.818 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.39 -4.68 54.73 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 128.374 2.892 . . . . 0.0 114.003 158.279 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mt -65.19 115.48 21.77 Favored Pre-proline 0 N--CA 1.445 -0.701 0 O-C-N 119.027 -2.455 . . . . 0.0 111.979 173.942 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.1 153.42 62.69 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 CA-C-O 112.085 -3.381 . . . . 0.0 117.425 -178.198 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.68 -34.96 55.72 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 125.134 3.889 . . . . 0.0 118.727 -166.7 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.01 -23.81 35.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.464 0.649 . . . . 0.0 109.846 -168.338 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.397 12.3 mm100 -87.01 -0.69 57.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.922 2.489 . . . . 0.0 111.203 178.748 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -95.22 145.67 24.89 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.482 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -138.3 134.61 34.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.547 2.739 . . . . 0.0 104.359 161.232 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mt -114.89 139.02 50.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 113.401 -3.19 . . . . 0.0 107.943 -177.234 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mm -129.87 131.88 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 129.623 3.169 . . . . 0.0 106.516 -174.718 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -113.11 -38.0 4.6 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 158.767 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.257 . . -124.95 -120.34 0.27 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 118.034 -2.916 . . . . 0.0 107.831 -172.641 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.52 13.96 42.8 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 125.982 3.992 . . . . 0.0 111.668 -177.014 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -145.01 -175.86 4.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 115.098 -2.382 . . . . 0.0 109.742 -176.967 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -78.73 156.32 28.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 126.187 2.179 . . . . 0.0 111.831 169.946 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.8 mt -95.45 144.52 25.88 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 163.836 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.92 129.21 46.74 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.211 2.204 . . . . 0.0 110.825 -168.941 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -42.52 -52.62 4.66 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 120.822 3.638 . . . . 0.0 120.822 -171.161 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.71 5.19 73.13 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 114.091 -3.616 . . . . 0.0 111.131 -175.212 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 54' ' ' ARG . 14.7 mtt180 -92.6 150.8 20.49 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 119.866 1.833 . . . . 0.0 111.287 159.813 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.342 7.1 p -91.1 156.73 17.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 129.622 3.169 . . . . 0.0 113.389 -177.764 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -43.11 -49.22 6.35 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.55 3.14 . . . . 0.0 112.516 164.761 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.378 45.3 p -55.91 -40.36 72.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 172.895 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -58.52 -47.72 83.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 118.348 -2.72 . . . . 0.0 110.762 -176.091 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.393 40.3 m-85 -90.06 4.14 51.15 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.061 177.887 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 t30 74.8 33.84 0.75 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.306 2.242 . . . . 0.0 114.017 156.51 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.1 mm -72.23 127.81 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 100.902 -3.74 . . . . 0.0 100.902 -171.802 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -92.34 155.66 17.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.063 1.745 . . . . 0.0 107.354 175.761 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.03 146.12 2.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.74 2.416 . . . . 0.0 115.372 173.892 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.373 1.6 tt0 58.0 19.1 5.62 Favored 'General case' 0 N--CA 1.443 -0.793 1 C-N-CA 133.112 4.565 . . . . 0.0 118.534 -174.741 . . . . . . . . 3 2 . 1 . 074 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.9 m -70.57 145.14 50.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.392 2.368 . . . . 0.0 117.392 169.216 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 m -90.26 140.27 29.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 103.186 -2.894 . . . . 0.0 103.186 179.157 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.4 mt -108.78 145.53 35.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 128.393 2.677 . . . . 0.0 110.525 154.699 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -104.73 137.92 41.81 Favored 'General case' 0 N--CA 1.45 -0.466 1 N-CA-C 100.091 -4.04 . . . . 0.0 100.091 174.992 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.4 tp -124.53 113.54 18.23 Favored 'General case' 0 N--CA 1.445 -0.677 1 C-N-CA 134.757 5.223 . . . . 0.0 107.436 -174.459 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.7 t -78.07 129.61 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 102.284 -3.228 . . . . 0.0 102.284 163.032 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 124.405 2.05 . . . . 0.0 106.195 171.768 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ptt? . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 116.628 -1.653 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -112.67 145.53 40.28 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 123.516 2.871 . . . . 0.0 113.75 -177.835 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -135.53 155.19 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 128.03 2.532 . . . . 0.0 109.299 167.524 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -111.86 132.05 54.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 131.315 3.846 . . . . 0.0 108.787 -176.901 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 67' ' ' LEU . 93.3 t -121.67 128.79 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 172.732 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.324 59.2 mmtt -97.98 140.94 31.57 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 117.596 -3.19 . . . . 0.0 110.464 163.436 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.5 p -86.67 -176.72 5.92 Favored 'General case' 0 N--CA 1.44 -0.936 1 C-N-CA 131.914 4.086 . . . . 0.0 105.069 179.911 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.08 -46.4 57.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.236 2.615 . . . . 0.0 105.262 -178.701 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -78.58 -12.24 60.01 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.678 1.591 . . . . 0.0 112.29 -173.189 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.77 9.23 26.95 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 106.116 -2.794 . . . . 0.0 106.116 160.532 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -71.48 136.28 47.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 121.85 2.825 . . . . 0.0 110.223 170.54 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.2 m -97.23 119.76 36.34 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 128.054 3.346 . . . . 0.0 106.705 179.349 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mt -103.32 125.14 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 O-C-N 126.532 2.395 . . . . 0.0 106.915 178.358 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.2 p -109.81 124.56 51.5 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 119.948 1.249 . . . . 0.0 109.268 170.608 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.24 150.67 28.36 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.441 1.897 . . . . 0.0 107.23 175.741 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -85.37 109.4 18.38 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 131.022 3.729 . . . . 0.0 102.83 166.962 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.24 159.76 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 175.451 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -121.48 159.59 49.71 Favored Pre-proline 0 N--CA 1.45 -0.457 0 C-N-CA 131.58 3.952 . . . . 0.0 111.903 166.34 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.263 22.5 Cg_exo -61.15 -19.37 63.19 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 N-CA-C 118.019 2.276 . . . . 0.0 118.019 -172.459 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.27 0.2 OUTLIER -90.57 -2.36 57.88 Favored 'General case' 0 N--CA 1.446 -0.653 1 C-N-CA 131.877 4.071 . . . . 0.0 115.328 178.724 . . . . . . . . 4 3 . 1 . 075 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -71.43 135.37 47.18 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 118.639 -2.538 . . . . 0.0 112.549 168.675 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.1 p -82.07 164.6 21.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 177.464 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.8 mm -56.81 -36.82 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 116.878 -3.639 . . . . 0.0 113.341 -178.41 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.253 13.1 tp10 -67.63 -37.54 82.6 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 127.106 2.754 . . . . 0.0 111.188 178.395 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.09 -48.65 79.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.352 2.261 . . . . 0.0 111.658 177.833 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 t -60.39 -38.9 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 127.056 2.723 . . . . 0.0 112.271 178.156 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -80.69 -20.78 42.18 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 118.717 -2.49 . . . . 0.0 110.207 -177.551 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.91 -29.67 39.86 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 115.207 -2.33 . . . . 0.0 111.485 172.986 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -72.97 -23.74 60.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 168.317 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -73.28 -42.8 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 129.833 3.253 . . . . 0.0 111.03 170.286 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -64.42 -42.34 96.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 116.636 -1.649 . . . . 0.0 109.692 172.704 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.59 -56.2 24.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 121.827 2.103 . . . . 0.0 113.254 173.306 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -77.54 -31.97 53.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 112.993 -1.912 . . . . 0.0 115.597 -172.989 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -142.9 -7.41 0.83 Allowed 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 117.947 -2.971 . . . . 0.0 110.977 -167.51 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.95 13.07 54.43 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 126.553 2.025 . . . . 0.0 112.405 156.212 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 36' ' ' ILE . 16.9 mt -88.76 127.05 57.62 Favored Pre-proline 0 N--CA 1.446 -0.646 0 O-C-N 117.704 -3.233 . . . . 0.0 108.955 -178.616 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.73 154.97 20.57 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 N-CA-C 106.945 -1.983 . . . . 0.0 106.945 -165.612 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -68.97 -29.62 27.41 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 CA-C-O 115.359 -2.017 . . . . 0.0 112.34 176.553 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.43 118.17 9.01 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 113.731 -3.033 . . . . 0.0 115.014 171.527 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 81.45 1.63 1.57 Allowed 'General case' 0 C--N 1.321 -0.634 1 C-N-CA 132.116 4.166 . . . . 0.0 112.955 179.414 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -99.49 121.31 40.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 100.797 -3.779 . . . . 0.0 100.797 173.191 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -105.04 152.05 23.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 111.866 -2.424 . . . . 0.0 107.42 169.796 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -121.28 110.93 16.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 126.917 2.636 . . . . 0.0 113.188 174.661 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.2 mt -94.27 148.07 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 124.892 2.282 . . . . 0.0 110.01 173.427 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -126.83 107.45 10.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 100.426 -3.916 . . . . 0.0 100.426 173.108 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 76.0 -104.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 101.916 -3.364 . . . . 0.0 101.916 178.969 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.97 8.5 6.78 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 129.419 3.39 . . . . 0.0 112.707 173.617 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -86.23 105.59 16.71 Favored 'General case' 0 C--N 1.325 -0.471 1 C-N-CA 132.9 4.48 . . . . 0.0 112.056 173.204 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -66.32 134.02 51.73 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 115.421 -2.228 . . . . 0.0 114.044 158.784 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.8 mt -107.01 111.18 23.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 127.65 3.094 . . . . 0.0 109.45 -162.755 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -68.06 123.26 20.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 130.92 3.688 . . . . 0.0 111.955 176.991 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.2 -18.11 3.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 119.644 3.201 . . . . 0.0 119.644 -157.057 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.87 -1.22 56.21 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 -175.583 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -92.81 166.69 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.933 2.093 . . . . 0.0 113.898 -173.475 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -109.75 166.3 11.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 124.816 1.323 . . . . 0.0 110.11 178.84 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mt -61.93 -34.87 76.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.415 1.486 . . . . 0.0 110.426 167.656 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.7 t -53.32 -41.26 65.52 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 117.728 -3.107 . . . . 0.0 117.898 160.823 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -75.84 -41.36 52.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 112.872 -3.442 . . . . 0.0 114.255 -178.206 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -86.68 -21.0 26.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 122.013 2.188 . . . . 0.0 106.787 -174.414 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 38.6 t30 81.07 62.24 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 119.005 -2.31 . . . . 0.0 108.181 179.718 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mt -110.08 110.01 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 100.25 -3.981 . . . . 0.0 100.25 177.935 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -104.13 165.15 11.24 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 127.597 2.359 . . . . 0.0 110.66 -168.241 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.447 7.7 pttp -44.52 125.16 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 118.449 -2.657 . . . . 0.0 115.971 172.395 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.409 2.7 tt0 84.18 9.2 0.49 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 119.12 3.008 . . . . 0.0 119.12 179.34 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -59.46 147.17 37.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.454 -3.279 . . . . 0.0 114.66 172.502 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.5 p -123.94 110.69 15.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 127.093 2.746 . . . . 0.0 106.384 -171.064 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 5' ' ' VAL . 5.7 mp -111.48 158.81 18.7 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 128.798 2.839 . . . . 0.0 109.178 -173.042 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -121.55 139.37 53.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.994 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -104.11 132.63 50.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.561 -2.755 . . . . 0.0 103.561 177.875 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.331 76.7 t -113.77 132.31 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 129.504 3.121 . . . . 0.0 111.298 174.928 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.5 mt . . . . . 0 N--CA 1.449 -0.48 0 O-C-N 126.115 2.134 . . . . 0.0 107.932 168.391 . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 101.213 -3.625 . . . . 0.0 101.213 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.307 8.5 mt-30 -104.51 156.3 18.07 Favored 'General case' 0 N--CA 1.455 -0.205 1 O-C-N 112.643 -6.286 . . . . 0.0 105.895 175.256 . . . . . . . . 3 2 . 1 . 076 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.559 HD12 HD13 ' A' ' 67' ' ' LEU . 16.9 pt -125.8 140.5 48.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 110.942 -2.845 . . . . 0.0 110.541 156.143 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -81.17 138.73 35.84 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 101.044 -3.687 . . . . 0.0 101.044 171.648 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' CG2' HD23 ' A' ' 15' ' ' LEU . 39.5 t -123.12 123.3 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 166.385 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -86.22 131.65 34.18 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 -178.149 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -93.67 167.24 11.79 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.674 -1.266 . . . . 0.0 111.738 179.662 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.54 -24.36 61.93 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.427 2.691 . . . . 0.0 108.977 172.067 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.2 p -94.39 3.47 55.14 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 121.974 2.17 . . . . 0.0 110.39 -177.273 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.02 -38.94 2.53 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 158.928 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -83.54 158.78 21.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.167 -1.196 . . . . 0.0 111.008 -167.742 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -106.82 101.24 10.7 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 128.542 2.737 . . . . 0.0 103.969 177.453 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 pt -68.16 140.54 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.268 163.194 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 m -97.65 121.02 39.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 118.011 -2.93 . . . . 0.0 105.486 173.067 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD23 ' CG2' ' A' ' 5' ' ' VAL . 3.8 mm? -87.23 145.34 26.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 122.003 2.183 . . . . 0.0 105.649 166.752 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -100.65 113.18 25.81 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.078 2.151 . . . . 0.0 109.309 169.891 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.252 11.9 m -136.76 154.08 31.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 117.735 -3.103 . . . . 0.0 114.137 -164.722 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -118.24 149.31 45.55 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 127.914 2.486 . . . . 0.0 110.786 172.749 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.383 36.6 Cg_endo -57.18 -40.35 83.61 Favored 'Trans proline' 0 N--CA 1.447 -1.239 2 C-N-CA 127.461 5.441 . . . . 0.0 123.098 -174.886 . . . . . . . . 3 2 . 1 . 076 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.288 23.0 p -80.17 -2.08 43.16 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 178.836 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.69 138.97 37.51 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.831 -174.95 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -84.76 126.97 33.88 Favored 'General case' 0 C--N 1.323 -0.544 1 C-N-CA 132.134 4.174 . . . . 0.0 106.761 -171.645 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 50' ' ' LEU 0.262 5.4 mm -30.59 -41.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 120.897 3.665 . . . . 0.0 120.897 174.427 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -61.72 -34.42 75.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 114.972 -2.442 . . . . 0.0 110.693 172.669 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -72.8 -15.87 61.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 125.424 3.738 . . . . 0.0 113.119 171.116 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.2 t -86.28 -35.3 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 115.907 -1.996 . . . . 0.0 110.612 175.975 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -62.76 -45.25 93.56 Favored 'General case' 0 N--CA 1.447 -0.623 1 O-C-N 129.548 4.28 . . . . 0.0 109.667 171.362 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.56 -33.9 68.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 167.077 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -73.77 -40.82 63.19 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 116.403 -1.761 . . . . 0.0 109.815 -178.843 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.52 -33.83 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 126.682 1.993 . . . . 0.0 114.972 171.956 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -69.5 -44.92 70.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 101.887 -3.375 . . . . 0.0 101.887 177.843 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.357 2.5 t70 -63.59 -5.34 3.8 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 130.321 3.448 . . . . 0.0 114.689 179.075 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -116.85 -75.44 0.58 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.846 2.858 . . . . 0.0 111.33 178.491 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -95.91 -1.96 48.21 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.267 1.827 . . . . 0.0 114.046 -174.721 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.93 3.5 68.06 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 123.401 2.818 . . . . 0.0 114.982 164.98 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.2 mt -76.45 111.71 17.21 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 126.673 1.989 . . . . 0.0 110.216 -176.822 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -51.86 131.32 37.82 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 CA-C-O 115.696 -1.877 . . . . 0.0 113.825 168.97 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -38.58 -35.95 0.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 124.983 3.789 . . . . 0.0 119.816 175.625 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.49 -12.98 62.1 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.885 0.85 . . . . 0.0 113.129 -178.285 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -92.12 -5.7 52.21 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 117.243 -3.41 . . . . 0.0 112.161 172.423 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 65.6 mt-30 -108.3 107.38 17.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 119.439 -2.038 . . . . 0.0 108.975 -171.423 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -92.06 133.43 35.75 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 125.584 1.803 . . . . 0.0 106.668 156.492 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 69' ' ' LEU . 93.3 mt -113.4 144.81 42.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.837 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.268 11.3 mm -132.12 136.43 56.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 112.062 -2.335 . . . . 0.0 105.948 -165.767 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.423 ' CE2' HG12 ' A' ' 61' ' ' ILE . 75.8 t80 -145.35 117.4 8.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 127.097 2.748 . . . . 0.0 106.322 177.152 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.327 . . 63.76 -98.6 0.07 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.812 1.245 . . . . 0.0 111.38 -160.191 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.19 11.23 5.32 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 127.231 2.832 . . . . 0.0 119.37 161.844 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -87.03 127.04 35.11 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.417 2.687 . . . . 0.0 105.728 -163.421 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -75.12 102.94 5.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 118.967 -2.333 . . . . 0.0 108.322 170.329 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 23' ' ' ILE . 65.0 mt -62.46 117.99 6.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.401 3.08 . . . . 0.0 109.309 177.632 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -89.74 145.49 25.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 117.512 -3.242 . . . . 0.0 114.39 -174.571 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.98 118.12 16.57 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 126.551 3.072 . . . . 0.0 112.902 176.267 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.1 -17.42 19.63 Favored Glycine 0 CA--C 1.524 0.625 1 C-N-CA 132.24 4.733 . . . . 0.0 111.429 -178.431 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -86.98 149.47 24.75 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 122.089 2.944 . . . . 0.0 109.68 176.026 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.6 p -95.78 169.27 10.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 126.511 3.053 . . . . 0.0 112.964 -178.685 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.78 -36.1 80.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 116.5 -3.875 . . . . 0.0 111.384 173.638 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -67.84 -37.77 82.3 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 118.709 -2.494 . . . . 0.0 108.336 -178.775 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.4 -48.83 77.99 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 126.228 2.205 . . . . 0.0 110.789 176.742 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -81.65 7.85 11.31 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.617 3.167 . . . . 0.0 118.572 170.71 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 63.03 21.31 12.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.406 1.882 . . . . 0.0 110.789 170.489 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.423 HG12 ' CE2' ' A' ' 45' ' ' PHE . 47.1 mt -76.8 145.11 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 124.124 1.916 . . . . 0.0 108.521 175.018 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -134.44 -177.38 4.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.41 1.484 . . . . 0.0 110.631 -167.248 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -57.13 132.56 53.33 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 114.455 -2.688 . . . . 0.0 114.36 173.763 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 70.44 48.1 0.48 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 126.11 2.862 . . . . 0.0 115.825 172.888 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -117.88 152.74 34.8 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 118.698 -2.502 . . . . 0.0 106.77 -178.548 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.4 m -108.34 117.01 33.05 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 129.242 3.017 . . . . 0.0 108.746 -176.514 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.559 HD13 HD12 ' A' ' 3' ' ' ILE 0.311 7.6 mp -105.63 158.33 16.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 167.541 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -103.27 123.87 47.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 129.762 3.225 . . . . 0.0 109.868 168.3 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 43' ' ' LEU . 36.8 tp -81.71 113.63 19.83 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 129.411 3.084 . . . . 0.0 107.921 164.101 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.85 150.71 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 128.161 2.584 . . . . 0.0 112.684 -176.977 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.2 mt . . . . . 0 N--CA 1.44 -0.965 0 C-N-CA 129.48 3.112 . . . . 0.0 103.173 -178.984 . . . . . . . . 0 0 . 1 . 077 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.426 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 4.3 tmm? . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 117.166 -1.397 . . . . 0.0 108.952 . . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -75.82 133.7 40.57 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.261 1.824 . . . . 0.0 110.064 -177.708 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -147.29 173.26 2.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 122.554 2.434 . . . . 0.0 113.353 162.508 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.69 148.62 39.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 128.678 2.791 . . . . 0.0 104.236 -177.951 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.06 125.08 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 126.946 2.099 . . . . 0.0 105.384 169.185 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.51 140.12 40.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.6 171.966 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -111.62 145.54 39.0 Favored 'General case' 0 C--N 1.327 -0.394 1 O-C-N 129.289 4.118 . . . . 0.0 112.636 177.965 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 tp -77.34 -13.29 59.96 Favored 'General case' 0 C--O 1.239 0.549 1 O-C-N 115.821 -4.299 . . . . 0.0 109.1 -177.269 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -88.04 -16.76 32.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 113.642 -3.075 . . . . 0.0 113.037 171.54 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.6 17.17 2.39 Favored Glycine 0 CA--C 1.54 1.633 0 O-C-N 128.892 3.87 . . . . 0.0 112.348 142.872 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -96.86 147.65 23.74 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.64 3.576 . . . . 0.0 107.552 178.808 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 m -125.07 147.24 49.07 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 122.127 2.239 . . . . 0.0 108.134 164.933 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 pt -129.51 153.83 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 126.614 1.965 . . . . 0.0 108.497 173.958 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 140.32 29.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 150.963 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.6 tp -137.8 166.12 24.78 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 129.818 3.247 . . . . 0.0 106.782 -173.638 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -132.3 128.85 38.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 100.624 -3.843 . . . . 0.0 100.624 173.122 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.514 HG21 ' CD1' ' A' ' 56' ' ' LEU . 3.5 m -127.21 166.23 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 128.521 2.728 . . . . 0.0 105.921 175.075 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.553 ' HG3' ' H ' ' A' ' 20' ' ' SER . 14.6 tp10 -86.12 155.58 57.75 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 101.443 -3.54 . . . . 0.0 101.443 166.726 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 50.7 Cg_endo -59.75 -33.27 96.39 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 CA-C-N 122.176 1.813 . . . . 0.0 114.358 157.581 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.553 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 2.9 m -93.5 19.64 8.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 109.898 -3.319 . . . . 0.0 107.568 -168.252 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -82.66 133.04 35.17 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.729 1.212 . . . . 0.0 108.57 160.927 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 54' ' ' ARG 0.357 20.3 p -77.22 163.53 26.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.794 1.238 . . . . 0.0 111.59 165.458 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 24.9 mm -38.62 -51.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 128.374 2.67 . . . . 0.0 112.307 166.411 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.58 -39.41 91.09 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 118.184 2.661 . . . . 0.0 118.184 174.67 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -83.22 -26.62 30.61 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 114.091 -2.861 . . . . 0.0 110.535 -178.608 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 22' ' ' THR . 64.0 t -44.47 -76.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 130.74 3.616 . . . . 0.0 109.958 156.991 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -31.47 -38.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 1 C-N-CA 133.693 4.797 . . . . 0.0 114.52 170.743 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.55 -22.12 61.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 128.366 2.666 . . . . 0.0 114.652 -175.615 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -101.55 -16.09 16.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.499 1.92 . . . . 0.0 109.996 -176.114 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -80.68 -25.42 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 119.297 -2.127 . . . . 0.0 114.203 158.934 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -67.53 -47.12 70.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.625 1.57 . . . . 0.0 109.707 -176.487 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -48.75 -48.59 40.7 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 127.261 2.224 . . . . 0.0 111.383 168.783 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.22 -24.26 54.61 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 119.441 -2.037 . . . . 0.0 109.265 -171.314 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.513 6.7 tp10 -128.09 -34.5 2.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 -159.024 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.79 -4.78 79.2 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 123.088 2.676 . . . . 0.0 118.249 -170.21 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.7 mt -84.3 124.31 74.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.245 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.28 153.11 45.42 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.656 3.571 . . . . 0.0 105.165 173.691 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -57.31 -42.35 63.27 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.808 3.005 . . . . 0.0 115.542 -174.128 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -49.98 -20.99 1.06 Allowed 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 119.075 2.991 . . . . 0.0 119.075 168.895 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -108.09 -9.34 15.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 122.387 2.358 . . . . 0.0 111.13 176.77 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -78.11 137.1 38.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.524 1.14 . . . . 0.0 110.806 172.237 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -126.74 111.2 13.96 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 174.932 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.8 mt -100.41 122.61 43.44 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 125.713 1.883 . . . . 0.0 108.205 -178.797 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.59 139.56 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 125.965 2.04 . . . . 0.0 112.622 171.722 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -147.77 120.96 8.9 Favored 'General case' 0 N--CA 1.448 -0.543 1 C-N-CA 131.823 4.049 . . . . 0.0 113.519 175.182 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.91 33.53 14.71 Favored 'General case' 0 N--CA 1.443 -0.801 1 C-N-CA 133.162 4.585 . . . . 0.0 111.999 -178.137 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.5 -17.63 56.42 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 128.235 2.826 . . . . 0.0 117.923 173.63 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -92.52 135.77 33.78 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 116.439 -1.744 . . . . 0.0 113.719 173.39 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 133.4 45.02 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 126.87 2.606 . . . . 0.0 110.349 156.091 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.0 mt -99.21 155.04 17.69 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 118.472 -2.642 . . . . 0.0 109.972 -155.971 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -92.63 139.12 30.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 175.968 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.266 17.0 m-20 -43.08 -58.45 2.45 Favored 'General case' 0 N--CA 1.447 -0.609 1 C-N-CA 137.54 6.336 . . . . 0.0 109.173 -160.199 . . . . . . . . 3 2 . 1 . 077 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.74 18.82 43.03 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 117.594 1.798 . . . . 0.0 117.594 -159.763 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 22' ' ' THR 0.321 22.0 mmm180 -101.49 143.06 31.96 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 179.478 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -72.24 165.03 25.25 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.374 2.269 . . . . 0.0 106.401 -179.099 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.514 ' CD1' HG21 ' A' ' 17' ' ' VAL . 73.4 mt -65.51 -22.61 66.74 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 116.42 -3.925 . . . . 0.0 117.452 168.751 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -72.17 -24.92 61.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 167.485 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -72.47 -21.6 61.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 117.97 -2.957 . . . . 0.0 116.474 166.083 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -98.72 -2.85 37.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.051 1.341 . . . . 0.0 111.88 172.834 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 73.55 29.04 1.62 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.368 1.867 . . . . 0.0 113.905 176.82 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 11.0 mt -92.47 113.49 27.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.012 1.725 . . . . 0.0 109.231 -175.572 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.263 57.5 tp60 -142.63 83.55 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.933 2.093 . . . . 0.0 109.834 -171.739 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.369 3.9 tmtt? 91.39 108.54 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 O-C-N 116.774 -3.703 . . . . 0.0 113.538 139.523 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.69 26.4 mt-10 78.41 17.12 1.15 Allowed 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 117.595 -3.191 . . . . 0.0 118.901 -178.108 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.266 19.2 p -85.71 155.95 20.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -178.839 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.4 m -109.86 110.39 21.35 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 174.217 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.68 130.29 35.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.553 1.941 . . . . 0.0 109.405 168.64 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -94.44 128.53 41.05 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 115.471 -2.492 . . . . 0.0 104.861 -168.906 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -109.61 123.53 49.6 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -171.071 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.34 164.08 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 125.431 1.492 . . . . 0.0 107.818 174.7 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 123.64 1.686 . . . . 0.0 106.608 -169.961 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 37.7 ttp . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 . . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -86.3 144.73 27.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 118.8 -2.438 . . . . 0.0 114.455 170.449 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 3' ' ' ILE . 42.3 pt -132.21 165.5 31.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 117.163 -3.461 . . . . 0.0 107.026 169.538 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -112.49 140.13 47.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.509 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.398 60.9 t -124.84 84.39 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 129.571 3.149 . . . . 0.0 109.686 -172.272 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -75.16 121.82 22.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 121.211 -0.93 . . . . 0.0 111.582 -179.159 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 32.1 m -90.18 154.88 19.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 118.461 -2.649 . . . . 0.0 110.783 -175.471 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.287 3.0 tm? -33.46 -38.84 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 117.221 -3.425 . . . . 0.0 118.886 168.931 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.2 p -77.71 -18.17 56.85 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.344 3.458 . . . . 0.0 114.014 179.594 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.38 14.47 38.27 Favored Glycine 0 CA--C 1.523 0.574 1 C-N-CA 132.568 4.889 . . . . 0.0 109.612 177.254 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -79.48 116.88 19.96 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.563 -1.551 . . . . 0.0 109.394 173.811 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.5 m -75.07 109.55 8.64 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.664 1.986 . . . . 0.0 107.547 163.826 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.504 HD13 HG21 ' A' ' 13' ' ' ILE 0.254 86.1 mt -90.58 148.14 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 1 N-CA-C 97.05 -5.167 . . . . 0.0 97.05 165.045 . . . . . . . . 4 3 . 1 . 078 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -135.78 139.25 43.38 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 117.217 -3.427 . . . . 0.0 108.781 163.97 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.53 149.52 42.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.432 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -83.62 136.97 34.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.969 1.308 . . . . 0.0 109.642 167.325 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.46 165.2 30.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 130.765 3.626 . . . . 0.0 108.447 173.487 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -96.67 156.42 36.64 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-O 116.75 -1.595 . . . . 0.0 113.859 167.614 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.3 -43.34 59.6 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 N-CA-C 121.755 3.714 . . . . 0.0 121.755 175.408 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -10.38 57.9 Favored 'General case' 0 N--CA 1.452 -0.337 1 N-CA-C 122.145 4.128 . . . . 0.0 122.145 -178.506 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -49.22 139.47 11.07 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 128.056 2.543 . . . . 0.0 114.532 177.552 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -97.03 141.85 29.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 110.323 -3.126 . . . . 0.0 105.08 -174.155 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.09 -28.61 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 118.282 -2.761 . . . . 0.0 112.402 -166.325 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.31 -26.3 65.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 173.852 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -78.89 -24.71 44.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 118.762 -2.461 . . . . 0.0 107.038 -177.724 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.4 -33.86 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 122.888 2.586 . . . . 0.0 113.045 -177.345 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -68.39 -39.09 81.81 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.819 2.447 . . . . 0.0 109.548 -177.801 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.29 -28.72 68.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.761 -2.462 . . . . 0.0 112.789 176.315 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -84.58 -30.64 24.86 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 124.825 1.328 . . . . 0.0 110.893 -174.242 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mt -71.95 -41.16 68.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 127.032 2.707 . . . . 0.0 104.706 171.234 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.38 -43.14 96.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 119.009 -2.307 . . . . 0.0 108.379 176.966 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -64.99 -45.12 86.94 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 121.212 1.824 . . . . 0.0 113.789 -178.561 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -99.02 -25.33 14.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 111.895 -3.907 . . . . 0.0 111.624 -167.874 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -117.33 -22.98 7.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 123.214 2.734 . . . . 0.0 111.679 177.035 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.3 42.43 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 128.418 2.913 . . . . 0.0 113.799 166.088 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.2 mt -90.69 120.47 68.84 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 127.578 2.351 . . . . 0.0 107.133 -179.115 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -58.09 154.76 37.57 Favored 'Trans proline' 0 N--CA 1.444 -1.409 1 C-N-CA 128.009 5.806 . . . . 0.0 112.251 -179.972 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -78.52 -18.07 12.39 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 122.469 2.113 . . . . 0.0 116.531 -162.986 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.09 -10.88 51.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 167.673 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -93.7 -15.82 24.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.715 1.606 . . . . 0.0 111.229 -171.992 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 41' ' ' GLN . 18.5 pt20 -98.11 143.81 28.25 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.184 1.794 . . . . 0.0 111.451 170.24 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.88 128.64 42.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 129.003 2.921 . . . . 0.0 106.096 166.373 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -95.37 123.24 38.79 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.704 1.24 . . . . 0.0 109.993 179.413 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.463 10.3 mt -108.64 124.48 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 130.209 3.404 . . . . 0.0 114.16 178.096 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -139.6 133.97 31.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 115.763 -2.065 . . . . 0.0 112.614 171.124 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.71 36.37 23.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.938 2.095 . . . . 0.0 115.218 173.934 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.26 -16.24 30.02 Favored Glycine 0 N--CA 1.442 -0.933 1 CA-C-O 112.271 -4.627 . . . . 0.0 113.476 -171.771 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -89.48 138.63 31.28 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 122.19 2.995 . . . . 0.0 105.361 -171.208 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.38 136.26 33.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.919 -1.946 . . . . 0.0 109.355 157.119 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.493 HD22 ' CG ' ' A' ' 59' ' ' TYR 0.269 15.5 mt -90.38 139.71 30.41 Favored 'General case' 0 C--O 1.221 -0.432 1 CA-C-O 111.415 -4.136 . . . . 0.0 108.858 -165.222 . . . . . . . . 4 3 . 1 . 078 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -99.99 145.65 27.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 124.246 3.203 . . . . 0.0 113.345 173.77 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.94 139.18 52.86 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 125.083 1.489 . . . . 0.0 108.626 162.61 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.18 11.39 13.71 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 103.777 -3.729 . . . . 0.0 103.777 -179.249 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -139.5 176.8 8.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 123.572 1.653 . . . . 0.0 108.62 176.754 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.4 p -108.46 177.56 4.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.542 1.537 . . . . 0.0 112.178 178.089 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.307 85.2 mt -50.36 -55.84 13.93 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.667 3.187 . . . . 0.0 110.66 164.079 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -67.03 -24.56 66.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -173.663 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -57.39 -40.1 77.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 128.833 2.853 . . . . 0.0 112.361 176.639 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CG ' HD22 ' A' ' 50' ' ' LEU . 44.4 m-85 -103.82 0.7 30.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.654 1.982 . . . . 0.0 112.551 -177.469 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.9 m120 81.23 32.71 0.12 Allowed 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 125.038 1.461 . . . . 0.0 113.348 168.262 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -95.19 94.97 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 125.856 1.972 . . . . 0.0 106.811 -177.915 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -101.76 -158.87 0.7 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.005 0.431 . . . . 0.0 111.319 172.923 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -58.7 134.7 57.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.284 -2.135 . . . . 0.0 111.684 168.87 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 25.0 tt0 85.11 40.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.061 -1.025 . . . . 0.0 110.058 170.364 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -120.36 137.8 54.08 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.565 1.946 . . . . 0.0 108.215 -179.936 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -120.23 123.47 43.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 115.993 -1.956 . . . . 0.0 108.67 176.739 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.23 160.82 15.06 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -178.209 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -118.66 139.35 51.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 125.002 1.439 . . . . 0.0 108.226 176.711 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.332 4.0 tt -125.24 119.71 29.24 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 101.787 -3.412 . . . . 0.0 101.787 -166.764 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.282 20.9 m -111.23 144.25 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 101.74 -3.43 . . . . 0.0 101.74 174.417 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.2 mt . . . . . 0 N--CA 1.447 -0.586 0 CA-C-N 109.307 -3.588 . . . . 0.0 107.185 174.792 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptt? . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.377 26.7 mt-30 -97.44 124.23 41.57 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.665 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.4 160.21 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 127.715 2.406 . . . . 0.0 112.82 170.239 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -113.51 136.47 52.77 Favored 'General case' 0 N--CA 1.452 -0.344 1 O-C-N 112.289 -6.507 . . . . 0.0 114.416 -176.086 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.9 t -111.25 121.64 64.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 128.171 2.588 . . . . 0.0 110.387 164.512 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -100.95 117.0 34.12 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 101.479 -3.526 . . . . 0.0 101.479 -172.21 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -73.38 155.67 39.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.977 2.511 . . . . 0.0 111.962 172.542 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.99 -30.82 68.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 124.855 2.265 . . . . 0.0 115.108 170.914 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 p -75.15 0.76 15.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 128.039 2.535 . . . . 0.0 112.881 177.293 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.57 -18.35 25.02 Favored Glycine 0 CA--C 1.526 0.778 1 C-N-CA 131.402 4.334 . . . . 0.0 118.689 166.345 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -94.54 155.05 17.09 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.827 2.451 . . . . 0.0 109.907 -160.142 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.3 m -114.04 132.55 55.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 124.724 2.202 . . . . 0.0 110.888 -176.182 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.37 126.59 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 1 O-C-N 116.219 -4.051 . . . . 0.0 106.609 178.357 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.412 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 98.8 m -90.2 128.49 36.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -171.065 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.97 123.95 51.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 116.468 -1.729 . . . . 0.0 106.816 -179.107 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -103.59 101.73 11.59 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 130.524 3.53 . . . . 0.0 110.977 177.797 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.39 166.35 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 N-CA-C 99.921 -4.103 . . . . 0.0 99.921 -157.204 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.358 48.7 mm-40 -108.08 167.99 8.52 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 115.576 -2.154 . . . . 0.0 106.3 158.951 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.15 -6.48 18.01 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 CA-C-N 123.32 2.221 . . . . 0.0 110.239 179.031 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.6 p -96.32 13.5 27.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 131.209 3.804 . . . . 0.0 113.737 177.875 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.81 135.7 38.93 Favored 'General case' 0 C--N 1.32 -0.687 1 C-N-CA 133.299 4.64 . . . . 0.0 102.684 174.036 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -77.24 172.63 12.96 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.039 0.935 . . . . 0.0 110.856 166.915 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.288 1.4 mp -59.29 -42.09 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 125.767 1.627 . . . . 0.0 108.886 163.97 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -65.56 -39.83 92.12 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 125.647 1.842 . . . . 0.0 109.067 -172.909 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -64.45 -40.68 96.18 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.119 1.368 . . . . 0.0 107.403 177.52 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 t -69.5 -39.96 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 O-C-N 117.752 -3.093 . . . . 0.0 117.872 174.845 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -66.98 -29.51 69.37 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.905 -2.372 . . . . 0.0 114.493 168.724 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.08 59.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 170.97 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -59.11 -32.0 69.42 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.889 173.428 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.8 mt -65.14 -47.45 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 121.884 2.129 . . . . 0.0 109.37 169.386 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -74.89 -39.09 61.69 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.688 1.595 . . . . 0.0 107.912 -168.886 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.74 -31.15 72.24 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 122.866 2.576 . . . . 0.0 109.203 177.28 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 14' ' ' THR . 82.0 mttt -87.87 -66.94 0.86 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 115.355 -2.259 . . . . 0.0 107.927 177.633 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -96.79 -20.6 18.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 120.372 1.442 . . . . 0.0 110.568 -156.534 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.73 -19.12 21.72 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 168.718 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 36' ' ' ILE . 28.1 mt -69.14 139.06 89.88 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 127.64 2.376 . . . . 0.0 113.265 -170.573 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -75.06 147.73 34.11 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 CA-C-O 113.412 -2.828 . . . . 0.0 115.209 -179.778 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.32 -45.41 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.276 3.317 . . . . 0.0 115.066 -158.046 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.24 -3.6 11.29 Favored 'General case' 0 N--CA 1.452 -0.354 1 C-N-CA 132.999 4.52 . . . . 0.0 116.641 178.087 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -87.76 -23.57 24.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 126.275 2.234 . . . . 0.0 107.728 173.324 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -90.56 115.97 28.1 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.119 -3.488 . . . . 0.0 110.87 -169.289 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -99.51 126.13 45.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 123.473 1.606 . . . . 0.0 107.706 161.8 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.62 110.15 22.27 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.798 2.439 . . . . 0.0 110.767 -175.866 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.1 mt -105.03 145.96 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 O-C-N 119.823 -1.798 . . . . 0.0 111.233 -179.211 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -160.46 139.61 10.65 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.1 1.76 . . . . 0.0 112.998 165.687 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.58 28.49 15.71 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 130.763 3.625 . . . . 0.0 112.246 168.144 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.69 1.49 58.81 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 116.724 -2.153 . . . . 0.0 113.122 176.223 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -120.94 151.97 39.07 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 131.391 3.877 . . . . 0.0 114.767 176.632 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -94.93 116.65 28.98 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 128.509 3.631 . . . . 0.0 107.398 168.382 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.92 112.88 3.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.293 -2.754 . . . . 0.0 112.401 -178.905 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.272 74.4 tt0 -89.01 147.3 24.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 114.904 -2.475 . . . . 0.0 106.922 -164.619 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.92 132.86 50.49 Favored 'General case' 0 C--N 1.326 -0.423 1 O-C-N 130.442 4.839 . . . . 0.0 114.551 175.565 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.06 -9.29 54.66 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 128.196 2.808 . . . . 0.0 117.003 -176.682 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.7 mtt-85 -101.83 157.53 16.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.383 2.673 . . . . 0.0 108.27 -174.488 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.8 p -102.69 155.41 18.32 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 102.216 -3.254 . . . . 0.0 102.216 173.23 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.6 mt -35.54 -36.44 0.07 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 129.564 3.146 . . . . 0.0 118.619 162.134 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.6 t -64.6 -21.93 66.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 111.564 -2.562 . . . . 0.0 115.791 179.343 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.45 -22.88 46.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 120.531 -1.356 . . . . 0.0 111.705 -178.324 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -106.96 -0.83 22.82 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.169 2.188 . . . . 0.0 106.507 -176.262 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 m120 56.28 50.56 13.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 126.063 2.839 . . . . 0.0 112.816 173.998 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.0 mt -80.15 115.82 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 112.483 -2.144 . . . . 0.0 108.112 -178.613 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -76.57 167.02 22.57 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 165.91 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -54.09 143.81 21.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 118.633 2.827 . . . . 0.0 118.633 159.57 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 73.89 6.56 4.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 115.318 -2.277 . . . . 0.0 113.367 172.971 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -66.39 154.96 38.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.965 3.706 . . . . 0.0 111.272 172.084 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -114.47 111.72 21.86 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -177.342 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.43 169.64 8.57 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 179.917 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -130.62 141.67 50.44 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 119.708 1.14 . . . . 0.0 109.247 -163.383 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -114.85 129.47 56.71 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 126.22 2.2 . . . . 0.0 115.661 167.106 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.0 t -132.31 136.15 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 170.629 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.2 mt . . . . . 0 N--CA 1.453 -0.309 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.097 -171.665 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 ttp . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 115.348 -2.263 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.28 92.9 mt-30 -108.51 133.53 52.54 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 125.055 3.57 . . . . 0.0 110.559 -171.241 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -127.44 174.67 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 155.113 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -117.42 156.52 27.8 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.012 1.725 . . . . 0.0 108.693 172.614 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.72 130.06 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.9 157.59 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -90.73 130.13 36.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 112.173 -2.285 . . . . 0.0 111.801 173.567 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -98.63 136.86 38.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 167.853 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.31 -0.02 1.14 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.268 1.827 . . . . 0.0 114.667 -156.323 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.8 p -86.43 -25.89 25.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 129.969 3.308 . . . . 0.0 105.68 -178.805 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.81 3.17 18.45 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.636 1.112 . . . . 0.0 113.889 -178.685 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -79.48 135.13 36.57 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.711 3.204 . . . . 0.0 109.42 170.722 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.4 p -123.48 136.25 54.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.919 1.688 . . . . 0.0 111.229 -170.041 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mt -118.7 113.0 40.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.352 -2.832 . . . . 0.0 103.352 179.833 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -67.86 119.13 12.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 162.317 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.267 0.2 OUTLIER -114.62 126.97 55.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -171.126 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -104.56 115.04 29.66 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.223 1.809 . . . . 0.0 109.844 -164.101 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.305 34.1 m -129.82 -177.83 2.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 C-N-CA 123.914 0.886 . . . . 0.0 112.351 -171.29 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.43 163.02 51.66 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-O 114.831 -2.509 . . . . 0.0 106.786 148.083 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -48.14 -16.86 0.7 Allowed 'Trans proline' 0 N--CA 1.442 -1.531 0 N-CA-C 122.149 3.865 . . . . 0.0 122.149 -176.337 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.1 m -88.15 -8.7 55.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 114.112 -2.851 . . . . 0.0 113.542 178.697 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.53 121.24 12.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.04 2.136 . . . . 0.0 106.558 -175.479 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -77.17 137.5 38.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.075 2.95 . . . . 0.0 107.874 176.274 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.285 1.5 mp -54.79 -30.93 23.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 127.637 2.375 . . . . 0.0 113.61 179.454 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -71.77 -22.49 61.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 121.54 1.973 . . . . 0.0 109.643 174.721 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.6 -31.0 21.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 115.126 -2.369 . . . . 0.0 105.969 178.987 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.48 -41.5 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 126.291 2.244 . . . . 0.0 106.931 178.129 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 30' ' ' ILE . 27.8 mtmt -56.8 -37.99 71.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 115.821 -2.037 . . . . 0.0 113.085 174.16 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.57 85.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 121.719 2.054 . . . . 0.0 111.461 175.78 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -65.78 -33.77 76.63 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 130.182 3.393 . . . . 0.0 111.933 177.723 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 27' ' ' LYS . 20.5 mt -71.96 -40.74 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 115.315 -2.278 . . . . 0.0 106.25 169.607 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -60.11 -40.43 89.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 124.273 3.215 . . . . 0.0 109.694 171.193 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.87 -30.44 67.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.062 2.545 . . . . 0.0 116.1 179.789 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -93.75 -57.04 2.68 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 128.743 2.817 . . . . 0.0 111.172 -174.707 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -118.05 -13.1 9.99 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -164.549 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.14 -11.7 55.42 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 115.339 -2.923 . . . . 0.0 117.111 156.579 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 36' ' ' ILE . 2.5 mp -77.19 123.15 87.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 111.713 -3.994 . . . . 0.0 107.687 -172.377 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -63.48 138.28 64.43 Favored 'Trans proline' 0 N--CA 1.449 -1.142 1 O-C-N 129.198 4.262 . . . . 0.0 111.565 -179.855 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -59.85 -21.91 66.1 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 120.603 3.27 . . . . 0.0 120.603 -164.724 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.39 -13.36 58.48 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 124.917 1.385 . . . . 0.0 114.089 -175.304 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -98.11 -7.5 29.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.116 1.766 . . . . 0.0 113.768 175.652 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.39 147.86 33.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.519 1.528 . . . . 0.0 112.677 165.897 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.372 35.9 ttm105 -134.83 132.42 38.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 114.511 -2.661 . . . . 0.0 107.685 161.913 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.37 107.04 14.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.619 2.768 . . . . 0.0 107.162 -179.118 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.0 mt -122.34 144.69 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 1 O-C-N 115.509 -4.494 . . . . 0.0 107.349 171.234 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.465 ' CD1' HD11 ' A' ' 50' ' ' LEU 0.38 0.1 OUTLIER -142.08 110.89 6.21 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 132.898 4.479 . . . . 0.0 114.988 167.967 . . . . . . . . 5 4 . 1 . 080 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.34 32.44 3.53 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.717 2.807 . . . . 0.0 111.337 177.582 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 -19.36 23.98 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 128.35 2.881 . . . . 0.0 116.222 -177.322 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -76.98 117.51 18.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.649 2.38 . . . . 0.0 107.996 177.165 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -77.33 122.03 24.56 Favored 'General case' 0 N--CA 1.445 -0.722 1 C-N-CA 133.986 4.914 . . . . 0.0 108.399 175.241 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.465 HD11 ' CD1' ' A' ' 45' ' ' PHE . 6.4 mp -87.1 120.84 28.79 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 126.271 2.232 . . . . 0.0 108.646 -176.922 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.46 151.16 22.63 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.516 -156.392 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.8 104.0 1.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 131.01 3.724 . . . . 0.0 108.782 -174.15 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.88 -14.6 26.57 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.277 174.211 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -71.09 147.38 48.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 122.787 3.293 . . . . 0.0 106.971 160.451 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -105.91 -178.2 3.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 118.98 -2.325 . . . . 0.0 108.408 -173.951 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -66.1 -33.37 75.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 113.829 -2.986 . . . . 0.0 108.209 175.286 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.355 21.3 m -72.59 -29.4 63.49 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 127.455 2.972 . . . . 0.0 109.378 -179.105 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -67.22 -34.95 78.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.96 1.413 . . . . 0.0 113.725 173.573 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 55.2 m-85 -97.67 9.38 42.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.48 2.312 . . . . 0.0 112.085 -178.704 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.39 74.5 m-20 73.17 13.81 4.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 173.0 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.8 mm -91.94 114.98 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 -159.298 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -88.57 168.44 12.56 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 111.67 -2.514 . . . . 0.0 112.183 163.482 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.289 30.5 pttt -29.27 137.79 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 121.345 3.831 . . . . 0.0 121.345 169.867 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.273 4.9 tt0 71.76 4.28 4.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 164.867 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -62.2 158.71 16.38 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 118.639 -2.538 . . . . 0.0 112.615 159.986 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.306 15.2 t -129.4 137.18 50.77 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 129.084 3.99 . . . . 0.0 108.764 -175.129 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -120.62 135.08 55.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 121.555 1.98 . . . . 0.0 111.998 -176.131 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -96.55 137.68 35.26 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 115.173 -2.346 . . . . 0.0 110.018 170.536 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -117.53 166.33 12.49 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 127.678 3.111 . . . . 0.0 111.212 173.489 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.95 147.22 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 O-C-N 127.477 2.985 . . . . 0.0 107.544 165.148 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 36' ' ' ILE . 32.1 mt . . . . . 0 N--CA 1.445 -0.707 1 C-N-CA 134.567 5.147 . . . . 0.0 110.553 170.595 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 ttp . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -96.18 155.47 16.75 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 119.569 -1.957 . . . . 0.0 106.735 -177.796 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 pt -135.84 160.29 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 129.236 3.014 . . . . 0.0 113.127 165.369 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -101.59 151.95 21.38 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 125.534 1.771 . . . . 0.0 108.509 162.338 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.5 t -125.7 132.19 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 166.368 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -89.95 119.68 30.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 117.862 -3.024 . . . . 0.0 105.593 157.954 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -100.48 136.34 40.51 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -178.137 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -44.12 -42.53 6.37 Favored 'General case' 0 C--N 1.324 -0.514 1 O-C-N 130.515 4.884 . . . . 0.0 113.53 -174.48 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.1 p -58.72 -12.08 3.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 130.859 3.664 . . . . 0.0 117.095 174.208 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.07 -16.27 10.1 Favored Glycine 0 CA--C 1.527 0.804 1 C-N-CA 130.731 4.015 . . . . 0.0 110.843 176.071 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -80.73 142.07 34.2 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 120.473 2.137 . . . . 0.0 112.117 -165.361 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.6 m -96.91 130.0 44.28 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 164.071 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.269 43.9 pt -135.69 153.97 33.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 127.623 2.369 . . . . 0.0 106.289 -177.55 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.256 11.8 t -129.03 133.05 47.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 112.657 -3.545 . . . . 0.0 110.632 -177.915 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -130.82 151.44 51.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 122.74 2.518 . . . . 0.0 111.181 -172.309 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -97.16 117.4 31.27 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 131.338 3.855 . . . . 0.0 106.394 172.882 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.18 171.81 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 1 N-CA-C 100.093 -4.04 . . . . 0.0 100.093 179.714 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -111.36 142.85 27.26 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 131.273 3.829 . . . . 0.0 101.357 159.574 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 57' ' ' SER . 53.6 Cg_endo -63.07 -13.89 38.19 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.086 3.19 . . . . 0.0 114.078 174.475 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -86.38 -7.81 58.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 126.962 3.268 . . . . 0.0 112.736 176.939 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -74.5 132.69 42.08 Favored 'General case' 0 N--CA 1.451 -0.405 1 O-C-N 114.552 -5.092 . . . . 0.0 109.361 179.521 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -63.32 162.87 11.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.343 2.657 . . . . 0.0 113.695 169.955 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mm -66.14 -36.4 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.207 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -19.55 64.59 Favored 'General case' 0 N--CA 1.449 -0.504 1 O-C-N 115.003 -4.811 . . . . 0.0 116.972 172.878 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -80.25 -24.44 40.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 125.473 1.733 . . . . 0.0 109.579 174.024 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 t -73.58 -30.89 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.662 1.185 . . . . 0.0 108.755 168.111 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -73.29 -41.11 63.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 118.168 -2.833 . . . . 0.0 113.99 175.958 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.9 -47.12 43.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 129.985 3.314 . . . . 0.0 113.372 170.162 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -73.76 -30.19 62.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 114.823 -2.513 . . . . 0.0 112.54 179.085 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -75.36 -39.89 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 O-C-N 125.821 1.95 . . . . 0.0 109.316 168.854 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -50.02 -46.36 52.78 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 128.152 2.581 . . . . 0.0 110.642 174.875 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.254 5.6 t70 -58.51 -44.18 89.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.388 1.875 . . . . 0.0 114.571 175.58 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -85.85 -51.3 6.49 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 115.91 -1.995 . . . . 0.0 110.25 -176.166 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -99.91 -23.04 15.06 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 114.131 -2.842 . . . . 0.0 111.572 -164.58 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.17 -12.98 28.79 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 128.65 3.719 . . . . 0.0 117.696 172.724 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.305 70.8 mt -75.27 132.13 76.86 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 113.715 -3.041 . . . . 0.0 111.067 -163.327 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.86 146.1 82.24 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 O-C-N 126.608 2.899 . . . . 0.0 114.206 173.014 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.56 -34.18 43.22 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 CA-C-N 120.959 1.378 . . . . 0.0 115.119 176.27 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.308 0.1 OUTLIER -42.19 -37.79 1.56 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.054 2.542 . . . . 0.0 113.853 174.793 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -108.88 -8.45 15.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.396 1.879 . . . . 0.0 111.915 -171.182 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -104.78 119.03 38.02 Favored 'General case' 0 N--CA 1.452 -0.334 1 C-N-CA 134.203 5.001 . . . . 0.0 113.343 -169.434 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -127.38 133.46 50.02 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 177.43 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.274 3.8 mt -104.42 152.4 22.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.974 1.71 . . . . 0.0 110.969 -169.302 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mt -137.04 146.09 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 1 C-N-CA 132.929 4.492 . . . . 0.0 107.324 -169.397 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -152.41 123.8 7.72 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 131.638 3.975 . . . . 0.0 107.918 169.358 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.4 38.05 25.76 Favored 'General case' 0 N--CA 1.445 -0.687 1 C-N-CA 132.355 4.262 . . . . 0.0 112.302 166.507 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.28 -14.89 63.1 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 120.149 -1.594 . . . . 0.0 116.925 -179.382 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -107.1 125.89 51.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 -171.785 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.92 127.81 32.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 169.704 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.11 137.46 34.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.289 1.859 . . . . 0.0 106.613 -168.683 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -82.21 123.63 29.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 109.55 -3.477 . . . . 0.0 105.333 -164.563 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -69.96 112.18 6.18 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 127.726 2.41 . . . . 0.0 106.033 -167.814 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.89 0.04 22.87 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 115.77 -2.683 . . . . 0.0 117.594 -157.722 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -114.16 178.71 4.18 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.981 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -125.59 160.42 29.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.958 2.503 . . . . 0.0 107.411 -174.264 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.45 -41.27 98.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.579 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 42.2 t -53.03 -38.71 62.61 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.285 -1.509 . . . . 0.0 110.227 175.575 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.47 -48.5 81.41 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 116.266 -1.826 . . . . 0.0 112.343 -173.171 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -84.95 11.89 8.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 121.503 1.956 . . . . 0.0 115.187 172.406 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.36 4.1 t-20 76.84 33.33 0.47 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 123.179 1.466 . . . . 0.0 108.566 160.363 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.99 120.09 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 118.7 -2.5 . . . . 0.0 111.345 -177.95 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -99.72 172.0 7.54 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.225 2.21 . . . . 0.0 111.642 173.414 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -59.69 133.33 55.99 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.928 2.491 . . . . 0.0 115.661 179.911 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 4.2 tt0 75.19 20.95 1.98 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.359 2.664 . . . . 0.0 115.772 -175.314 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -63.5 136.84 57.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 131.407 3.883 . . . . 0.0 109.595 165.439 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.6 m -101.05 107.0 18.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 124.781 1.301 . . . . 0.0 112.662 169.23 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.94 162.0 20.62 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.477 1.911 . . . . 0.0 110.94 172.938 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -135.41 117.06 14.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 130.381 3.472 . . . . 0.0 105.755 -168.616 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tp -98.52 140.46 32.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 115.456 -2.212 . . . . 0.0 110.925 -174.002 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.29 163.71 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 127.179 2.191 . . . . 0.0 108.657 171.908 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.485 0.7 OUTLIER . . . . . 0 C--N 1.322 -0.588 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -173.193 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -91.91 145.19 24.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 -172.324 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.85 163.54 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 128.842 2.857 . . . . 0.0 109.147 162.731 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -104.38 151.12 23.87 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 114.638 -2.601 . . . . 0.0 105.002 177.01 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.9 105.15 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 1 C-N-CA 132.69 4.396 . . . . 0.0 104.328 172.272 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -97.91 107.36 19.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.312 2.245 . . . . 0.0 111.263 -173.905 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 p -86.11 166.49 15.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -168.422 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -86.63 -20.76 27.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.528 -2.177 . . . . 0.0 115.923 166.905 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 p -69.44 -23.76 63.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 125.32 1.638 . . . . 0.0 113.321 176.154 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.53 -14.09 5.33 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 119.494 -2.004 . . . . 0.0 115.746 156.145 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -80.6 172.54 13.62 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 120.075 -1.838 . . . . 0.0 112.892 173.556 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 m -136.67 132.1 34.49 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 117.544 -3.222 . . . . 0.0 107.2 177.297 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.22 148.1 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.63 1.572 . . . . 0.0 107.807 172.881 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 p -97.22 131.35 44.03 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.978 2.911 . . . . 0.0 110.178 165.762 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.82 133.6 53.06 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 115.411 -2.233 . . . . 0.0 111.073 -172.527 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -84.23 125.8 32.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 101.256 -3.609 . . . . 0.0 101.256 164.837 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 26' ' ' VAL . 17.1 m -132.38 147.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 176.035 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 2.1 tm-20 -97.59 135.8 21.52 Favored Pre-proline 0 N--CA 1.448 -0.526 0 O-C-N 119.274 -2.141 . . . . 0.0 108.608 158.027 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.82 -24.81 2.26 Favored 'Trans proline' 0 N--CA 1.443 -1.451 1 C-N-CA 126.817 5.012 . . . . 0.0 116.317 173.951 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -98.29 1.55 47.25 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 129.796 3.238 . . . . 0.0 109.991 177.194 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -72.03 140.46 49.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 121.799 2.09 . . . . 0.0 106.935 167.731 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.0 p -90.58 178.92 5.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 118.916 -2.365 . . . . 0.0 108.381 -175.928 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.469 HG23 HD12 ' A' ' 43' ' ' LEU . 11.0 mm -67.24 -33.23 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 120.01 1.277 . . . . 0.0 113.457 179.469 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.69 -37.27 83.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.752 2.821 . . . . 0.0 116.672 168.293 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -77.58 -35.44 53.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 115.629 -2.129 . . . . 0.0 107.233 -179.722 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.449 HG22 HG12 ' A' ' 17' ' ' VAL . 8.9 t -65.8 -48.52 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 124.856 3.48 . . . . 0.0 111.606 170.992 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -50.99 -49.99 59.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 169.719 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.05 -49.46 41.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.946 2.098 . . . . 0.0 114.889 165.157 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -65.14 -25.46 67.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 119.606 -1.934 . . . . 0.0 110.574 -179.864 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -80.92 -13.76 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 O-C-N 119.276 -2.14 . . . . 0.0 114.677 175.269 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -76.59 -41.9 44.5 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 118.593 -2.567 . . . . 0.0 110.255 168.034 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -57.72 -43.38 85.2 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 127.248 2.219 . . . . 0.0 112.314 178.903 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -69.19 -55.03 11.85 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 115.268 -2.301 . . . . 0.0 115.255 174.198 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -122.94 -19.59 6.07 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 125.837 1.96 . . . . 0.0 111.65 -155.638 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.1 9.53 63.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.282 1.896 . . . . 0.0 111.716 167.679 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.433 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.8 mt -67.52 130.45 93.27 Favored Pre-proline 0 N--CA 1.444 -0.744 0 O-C-N 118.924 -2.515 . . . . 0.0 112.841 171.754 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -79.14 123.17 5.52 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.862 3.041 . . . . 0.0 109.108 -176.467 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.458 17.4 Cg_exo -25.93 -43.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.123 1 C-N-CA 129.736 6.957 . . . . 0.0 121.94 -177.91 . . . . . . . . 3 2 . 1 . 082 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.97 -15.19 63.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 113.602 -3.094 . . . . 0.0 113.389 177.403 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -86.71 -15.0 40.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 124.034 3.106 . . . . 0.0 109.673 177.574 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -90.11 153.03 20.85 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -166.753 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -142.32 120.13 11.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 121.85 2.114 . . . . 0.0 109.32 170.084 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.469 HD12 HG23 ' A' ' 23' ' ' ILE . 12.4 mt -89.45 144.0 26.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 125.034 3.561 . . . . 0.0 107.27 -178.059 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mm -127.41 153.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 125.69 2.662 . . . . 0.0 106.634 169.522 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.566 ' HB3' HD21 ' A' ' 50' ' ' LEU . 20.2 t80 -150.46 108.67 3.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.004 2.522 . . . . 0.0 108.985 174.725 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.02 22.21 12.92 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 131.567 3.947 . . . . 0.0 112.207 167.261 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.95 -4.01 25.7 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 119.239 -2.163 . . . . 0.0 116.977 178.409 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.22 143.98 48.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 172.225 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -91.89 135.17 34.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -172.618 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 45' ' ' PHE . 5.3 mt -89.99 138.39 31.54 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.23 -1.544 . . . . 0.0 108.925 176.733 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -145.58 140.68 27.58 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -159.889 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -35.85 128.9 0.65 Allowed 'General case' 0 N--CA 1.452 -0.326 1 C-N-CA 134.633 5.173 . . . . 0.0 113.65 -179.371 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.69 -16.25 23.78 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 118.092 -2.88 . . . . 0.0 117.223 167.253 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.334 32.9 mtt85 -100.49 166.77 10.77 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 125.713 2.673 . . . . 0.0 107.065 167.766 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -87.83 167.63 13.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 119.509 -1.994 . . . . 0.0 108.755 173.115 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.306 22.2 mt -59.93 -38.43 82.36 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 172.7 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.7 p -69.03 -27.75 65.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.413 1.885 . . . . 0.0 112.917 -179.254 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.53 -44.26 96.26 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.581 1.952 . . . . 0.0 108.278 171.803 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -81.4 10.55 5.52 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 128.341 2.656 . . . . 0.0 114.142 175.488 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.268 1.9 t-20 65.87 24.1 11.31 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 172.934 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 mt -86.69 132.62 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 O-C-N 120.194 -1.567 . . . . 0.0 106.941 -173.8 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -114.05 -179.56 3.67 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 127.073 2.733 . . . . 0.0 112.121 170.224 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 138.24 24.91 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.08 0.952 . . . . 0.0 111.201 175.253 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 42.6 mt-10 74.84 13.59 3.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 125.349 1.655 . . . . 0.0 109.735 163.603 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.4 m -54.52 157.53 2.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 157.252 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.93 105.25 14.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 111.51 -2.586 . . . . 0.0 106.084 177.102 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -102.08 138.89 38.43 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 176.535 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.257 41.4 m80 -95.88 135.77 37.18 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.637 1.575 . . . . 0.0 112.254 175.766 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.23 100.91 10.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 179.426 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -96.51 151.91 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.031 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.5 mt . . . . . 0 N--CA 1.446 -0.652 1 C-N-CA 135.776 5.631 . . . . 0.0 117.857 174.726 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 ttp . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 115.309 -2.281 . . . . 0.0 106.214 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -104.53 130.53 52.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.855 2.57 . . . . 0.0 111.388 -179.933 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.293 20.4 pt -119.22 122.03 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 114.25 -2.786 . . . . 0.0 109.617 165.336 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -73.77 151.97 40.47 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 124.15 3.159 . . . . 0.0 108.434 178.243 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -126.44 155.16 36.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 1 O-C-N 129.301 4.126 . . . . 0.0 106.794 161.438 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.25 42.3 tttt -120.63 152.87 37.61 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 128.909 2.884 . . . . 0.0 113.342 169.205 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.432 HG22 HD21 ' A' ' 69' ' ' LEU . 24.3 p -107.23 159.06 16.63 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 130.591 3.556 . . . . 0.0 106.422 -170.573 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 mt -63.64 -19.97 65.31 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.608 1.563 . . . . 0.0 111.895 -179.163 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.5 p -85.31 -15.25 43.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 176.235 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.63 5.59 41.95 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 113.777 -3.79 . . . . 0.0 114.129 177.695 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -82.58 132.67 35.19 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 121.885 2.843 . . . . 0.0 110.381 176.911 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.6 m -90.0 124.59 34.88 Favored 'General case' 0 C--N 1.325 -0.463 1 C-N-CA 134.339 5.055 . . . . 0.0 104.799 176.227 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -113.59 139.4 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 130.93 3.692 . . . . 0.0 107.809 -179.34 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.4 m -96.73 130.66 43.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 121.886 2.13 . . . . 0.0 112.128 170.854 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.2 mt -107.63 129.54 54.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.559 2.344 . . . . 0.0 113.004 173.805 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -80.37 118.7 22.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 123.69 1.71 . . . . 0.0 108.646 169.983 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.04 156.46 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 O-C-N 117.537 -3.227 . . . . 0.0 115.243 173.882 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -74.61 154.29 87.5 Favored Pre-proline 0 N--CA 1.451 -0.404 0 O-C-N 117.843 -3.036 . . . . 0.0 108.979 162.826 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -76.81 15.84 1.03 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 1 C-N-CA 125.568 4.179 . . . . 0.0 114.543 179.648 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 p -131.38 3.16 4.24 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 129.288 3.035 . . . . 0.0 117.786 171.914 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.54 137.93 57.86 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 126.588 2.43 . . . . 0.0 107.941 179.506 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.298 44.6 p -102.56 170.47 8.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 126.957 3.265 . . . . 0.0 107.709 -174.09 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mm -66.01 -30.72 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 1 O-C-N 114.642 -5.036 . . . . 0.0 115.506 -173.962 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.14 -26.25 68.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 121.031 1.741 . . . . 0.0 111.648 175.661 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.05 -28.12 29.8 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.441 2.296 . . . . 0.0 112.652 176.429 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.8 t -81.58 -29.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 122.382 2.355 . . . . 0.0 108.275 178.732 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -51.45 -49.39 61.82 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.251 2.22 . . . . 0.0 115.347 160.062 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.11 -46.11 68.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.677 1.591 . . . . 0.0 108.563 -178.695 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.254 57.2 mttm -52.09 -50.11 62.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 172.633 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.335 91.5 mt -54.52 -38.07 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 123.61 1.671 . . . . 0.0 114.992 171.902 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.88 -42.62 94.65 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 117.165 -3.459 . . . . 0.0 111.233 170.846 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -52.45 -42.5 64.22 Favored 'General case' 0 N--CA 1.445 -0.702 1 O-C-N 116.206 -4.059 . . . . 0.0 114.278 172.007 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -90.51 -47.34 7.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -167.538 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -120.15 -15.15 8.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 124.803 2.24 . . . . 0.0 113.528 -157.26 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.34 1.42 44.19 Favored Glycine 0 CA--C 1.522 0.518 1 C-N-CA 134.309 5.719 . . . . 0.0 117.352 166.818 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -88.99 119.98 69.89 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 128.181 2.592 . . . . 0.0 104.667 -153.2 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.3 142.84 55.75 Favored 'Trans proline' 0 N--CA 1.447 -1.229 1 C-N-CA 126.459 4.772 . . . . 0.0 114.659 178.164 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.02 -46.78 7.64 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 124.603 3.535 . . . . 0.0 111.267 -177.789 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.439 0.0 OUTLIER -32.95 -40.4 0.05 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 118.608 2.818 . . . . 0.0 118.608 167.49 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.302 11.5 mm-40 -101.34 -5.25 25.65 Favored 'General case' 0 N--CA 1.448 -0.556 1 C-N-CA 132.312 4.245 . . . . 0.0 114.626 -161.56 . . . . . . . . 3 2 . 1 . 083 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -99.7 157.21 16.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.931 2.093 . . . . 0.0 106.929 -178.664 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -142.59 129.13 20.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 130.017 3.327 . . . . 0.0 110.364 160.14 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -117.04 120.26 37.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 120.357 1.435 . . . . 0.0 107.428 174.784 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mm -106.32 152.75 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 130.148 3.379 . . . . 0.0 107.801 -177.329 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -152.08 107.16 3.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 130.161 3.384 . . . . 0.0 105.582 178.271 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.439 . . 72.25 23.23 3.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 127.887 3.708 . . . . 0.0 117.679 169.383 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.03 -12.75 45.12 Favored Glycine 0 CA--C 1.529 0.958 1 O-C-N 114.574 -5.079 . . . . 0.0 110.086 171.901 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -112.69 142.24 45.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.559 3.544 . . . . 0.0 111.963 -179.969 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -91.65 141.89 28.21 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 110.473 -3.058 . . . . 0.0 105.218 -175.765 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -88.18 113.91 24.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 130.217 3.407 . . . . 0.0 106.824 -175.285 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -103.28 164.66 11.5 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 129.832 3.253 . . . . 0.0 113.346 -169.904 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -68.42 132.03 46.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 128.81 3.819 . . . . 0.0 112.745 -177.297 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.8 0.88 58.83 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.694 1.616 . . . . 0.0 112.647 173.769 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -88.81 164.53 15.18 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.866 2.066 . . . . 0.0 108.678 177.001 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -111.71 161.68 16.03 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 169.399 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -55.67 -39.41 70.91 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.675 1.19 . . . . 0.0 110.762 176.538 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 m -61.31 -34.1 74.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 116.113 -1.898 . . . . 0.0 115.214 177.885 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -60.85 -38.54 85.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 116.211 -1.852 . . . . 0.0 114.852 172.237 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -97.95 14.68 26.43 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 116.717 -1.611 . . . . 0.0 110.943 173.894 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.363 12.6 p30 74.54 14.95 3.44 Favored 'General case' 0 N--CA 1.439 -0.978 1 C-N-CA 135.111 5.364 . . . . 0.0 114.208 166.608 . . . . . . . . 3 2 . 1 . 083 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -72.33 111.57 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.181 2.192 . . . . 0.0 109.297 -170.414 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -96.57 164.84 12.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 127.019 2.699 . . . . 0.0 107.811 -173.18 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -48.26 117.76 2.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.961 3.704 . . . . 0.0 110.483 179.27 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.722 2.1 mp0 78.01 18.97 1.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 117.898 2.555 . . . . 0.0 117.898 -178.707 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.6 m -77.27 154.11 33.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 170.466 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.2 m -107.21 129.26 54.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.205 1.802 . . . . 0.0 106.949 173.232 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -99.81 156.1 17.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 163.622 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -98.94 149.38 23.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 115.496 -2.193 . . . . 0.0 108.352 160.281 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.432 HD21 HG22 ' A' ' 7' ' ' THR . 3.5 pp -97.37 151.89 19.48 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 124.752 1.283 . . . . 0.0 110.866 164.157 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.6 t -142.72 125.35 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -179.203 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 98.6 mt . . . . . 0 N--CA 1.449 -0.487 0 O-C-N 119.795 -1.815 . . . . 0.0 110.249 -176.002 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -97.04 144.79 26.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 -178.201 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 67' ' ' LEU 0.382 0.9 OUTLIER -125.54 157.55 34.76 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 C-N-CA 129.469 3.108 . . . . 0.0 107.158 167.428 . . . . . . . . 4 4 . 1 . 084 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -113.17 139.39 48.8 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.739 2.015 . . . . 0.0 105.746 179.757 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.9 t -117.25 113.45 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 171.077 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -102.16 135.14 44.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 173.084 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -83.48 164.28 19.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 118.007 -2.933 . . . . 0.0 112.105 172.394 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 70' ' ' VAL . 1.2 mt -60.3 -27.75 67.55 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.699 2.0 . . . . 0.0 108.67 179.577 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -14.44 58.93 Favored 'General case' 0 N--CA 1.448 -0.567 1 C-N-CA 134.362 5.065 . . . . 0.0 115.558 176.794 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.8 -9.0 37.19 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 118.736 -2.478 . . . . 0.0 113.047 166.448 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.262 79.0 tttt -89.95 128.25 36.2 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 -177.106 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.3 m -117.83 120.2 37.19 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 110.857 -2.883 . . . . 0.0 112.116 -174.681 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -112.54 155.51 13.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 126.895 3.236 . . . . 0.0 110.337 174.795 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.3 6.8 m -103.1 120.53 40.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.538 -1.976 . . . . 0.0 107.396 -173.785 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -115.2 126.71 54.89 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.259 2.224 . . . . 0.0 109.898 -168.177 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -90.39 114.24 26.31 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 125.099 1.499 . . . . 0.0 108.29 -176.655 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.47 165.32 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 126.308 1.843 . . . . 0.0 114.465 179.908 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -125.34 153.15 72.09 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 114.921 -2.466 . . . . 0.0 109.408 165.505 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.17 -30.85 26.78 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.449 3.433 . . . . 0.0 117.921 -177.521 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -75.97 -1.47 25.79 Favored 'General case' 0 N--CA 1.446 -0.652 1 C-N-CA 135.424 5.489 . . . . 0.0 117.707 178.534 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.65 137.71 33.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 117.246 -3.409 . . . . 0.0 109.023 -175.155 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -84.63 159.14 20.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 122.004 2.184 . . . . 0.0 113.528 175.356 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -65.76 -21.41 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.098 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.74 -36.0 81.61 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 130.396 3.479 . . . . 0.0 112.23 174.736 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -73.82 -34.42 64.57 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 125.373 1.671 . . . . 0.0 110.27 175.683 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -80.72 -42.63 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.83 2.452 . . . . 0.0 111.578 -175.093 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -53.92 -46.51 71.51 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 121.231 3.789 . . . . 0.0 121.231 161.929 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.76 -43.03 98.51 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 126.883 2.614 . . . . 0.0 113.08 174.48 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -52.02 -39.44 59.49 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 115.022 -2.418 . . . . 0.0 112.73 174.737 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.7 mt -57.12 -46.46 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 125.456 1.722 . . . . 0.0 109.599 179.292 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -66.61 -45.94 77.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.298 1.839 . . . . 0.0 108.777 178.254 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -55.38 -43.49 75.2 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 117.568 -3.208 . . . . 0.0 115.266 177.065 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.94 -80.74 0.14 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 130.055 3.342 . . . . 0.0 113.937 174.976 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -89.19 -10.17 48.11 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 122.024 2.193 . . . . 0.0 115.069 -170.214 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.71 40.61 37.03 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 119.946 2.738 . . . . 0.0 119.946 -177.753 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 mt -119.18 95.82 49.59 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 119.957 -1.908 . . . . 0.0 109.86 178.407 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -69.13 158.03 59.32 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 O-C-N 122.805 0.898 . . . . 0.0 111.735 -177.953 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.292 63.1 Cg_exo -42.09 -34.88 2.94 Favored 'Trans proline' 0 N--CA 1.444 -1.407 1 C-N-CA 126.269 4.646 . . . . 0.0 120.186 176.858 . . . . . . . . 3 2 . 1 . 084 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.97 -35.55 0.54 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 129.488 3.115 . . . . 0.0 112.997 163.942 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -110.08 -7.69 14.89 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.208 1.803 . . . . 0.0 110.851 -170.618 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.253 81.1 mt-30 -100.06 155.09 17.91 Favored 'General case' 0 C--O 1.226 -0.141 0 O-C-N 118.945 -2.347 . . . . 0.0 112.266 179.256 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -150.08 105.61 3.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 100.962 -3.718 . . . . 0.0 100.962 169.052 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.44 HD13 HD12 ' A' ' 50' ' ' LEU . 84.1 mt -81.69 72.74 8.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.565 1.546 . . . . 0.0 109.905 165.301 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 tt -71.24 92.95 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.226 154.843 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CD1' HD23 ' A' ' 50' ' ' LEU . 29.0 p90 -73.26 -28.71 62.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -172.252 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.62 -80.93 0.12 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 114.882 -2.485 . . . . 0.0 108.401 175.1 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.67 -12.88 9.12 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 115.3 -2.945 . . . . 0.0 110.042 -179.315 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -136.28 163.46 30.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 121.253 2.526 . . . . 0.0 105.077 -169.478 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.02 155.64 32.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.333 -1.479 . . . . 0.0 113.662 172.14 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.46 HD23 ' CD1' ' A' ' 45' ' ' PHE . 39.8 mt -68.61 152.24 45.63 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 124.62 1.2 . . . . 0.0 109.793 172.346 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -108.64 129.78 55.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 120.811 1.642 . . . . 0.0 109.114 178.791 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -45.59 105.25 0.06 Allowed 'General case' 0 N--CA 1.444 -0.739 1 C-N-CA 132.717 4.407 . . . . 0.0 116.109 166.419 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.51 -3.96 13.5 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.659 2.552 . . . . 0.0 116.373 174.961 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -98.4 158.87 15.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 -177.525 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -111.65 169.65 8.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 110.208 -3.178 . . . . 0.0 103.778 -179.925 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 3.5 mp -52.59 -34.32 50.14 Favored 'General case' 0 N--CA 1.445 -0.714 1 C-N-CA 132.111 4.164 . . . . 0.0 112.445 172.0 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.9 m -72.15 -21.24 61.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 175.407 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -72.89 -30.62 64.08 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.443 1.497 . . . . 0.0 113.713 169.97 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -101.85 2.15 37.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.529 1.532 . . . . 0.0 111.164 173.767 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 49.1 m-80 67.94 14.55 9.4 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 117.794 -3.066 . . . . 0.0 118.726 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.0 mt -65.85 154.27 7.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -163.188 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -128.39 179.16 5.79 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 130.98 3.712 . . . . 0.0 114.319 -170.165 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 tttt -65.16 135.43 55.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 113.818 -2.992 . . . . 0.0 109.725 -177.833 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.351 15.4 mt-10 78.72 0.55 2.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.515 2.726 . . . . 0.0 113.187 167.904 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.62 141.63 54.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.936 2.494 . . . . 0.0 112.047 178.656 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.1 m -109.81 132.27 54.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -177.412 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.588 HD12 HD13 ' A' ' 3' ' ' ILE . 67.6 mt -114.7 152.34 32.15 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 125.61 1.819 . . . . 0.0 108.743 173.738 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.368 15.4 m80 -105.1 149.3 25.97 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.038 2.135 . . . . 0.0 107.092 -168.274 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -129.9 136.81 49.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 121.168 1.804 . . . . 0.0 112.631 169.598 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.491 ' HA ' HD12 ' A' ' 8' ' ' LEU . 73.0 t -124.57 139.07 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 129.768 3.227 . . . . 0.0 107.72 -176.326 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 tp . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 -158.142 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 ttp . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -75.11 132.95 41.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 126.928 2.643 . . . . 0.0 113.644 170.275 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 3' ' ' ILE . 4.4 pt -130.54 146.56 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 1 C-N-CA 131.757 4.023 . . . . 0.0 106.917 160.414 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.29 141.53 34.03 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 129.112 2.965 . . . . 0.0 105.733 171.548 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -128.7 126.34 64.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 115.954 -1.974 . . . . 0.0 105.758 163.923 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -84.41 114.15 21.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 127.425 2.953 . . . . 0.0 110.908 174.722 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -64.13 160.67 17.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 128.5 4.0 . . . . 0.0 111.711 170.657 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -60.46 -12.59 10.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 117.274 -3.391 . . . . 0.0 118.571 -176.663 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 p -95.04 -8.0 38.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 109.894 -3.321 . . . . 0.0 111.222 175.766 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.82 -20.15 36.97 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 124.072 3.124 . . . . 0.0 112.827 -179.88 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -78.35 141.57 38.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 113.619 -3.086 . . . . 0.0 114.767 -176.219 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 p -92.77 132.05 37.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 125.926 3.966 . . . . 0.0 116.871 168.8 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.9 pt -102.91 129.37 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.536 161.005 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.2 m -88.54 129.14 35.54 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 103.452 -2.795 . . . . 0.0 103.452 -175.001 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.7 mt -114.89 131.16 56.95 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 178.624 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.15 98.72 9.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.553 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -112.98 167.99 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 124.662 2.172 . . . . 0.0 113.173 -176.221 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.371 26.4 mm-40 -93.46 149.25 36.95 Favored Pre-proline 0 N--CA 1.449 -0.511 0 O-C-N 118.204 -2.81 . . . . 0.0 105.593 167.104 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.28 15.4 Cg_endo -73.02 -16.03 25.77 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.952 2.434 . . . . 0.0 115.192 -176.61 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 p -86.61 -5.65 59.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.697 2.399 . . . . 0.0 112.07 -179.353 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -75.27 153.83 37.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -173.32 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.8 p -97.34 173.15 7.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 117.942 -2.974 . . . . 0.0 110.932 176.219 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.7 mm -85.97 -24.64 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 127.805 2.442 . . . . 0.0 109.121 -164.112 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -68.25 -30.58 69.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 129.929 3.292 . . . . 0.0 109.211 174.632 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -86.04 -17.67 34.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 124.319 3.236 . . . . 0.0 113.225 170.422 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.91 -50.93 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 102.75 -3.056 . . . . 0.0 102.75 168.908 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.22 -30.0 61.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 121.101 1.773 . . . . 0.0 108.756 -171.134 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.24 -27.4 67.94 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 117.497 -3.252 . . . . 0.0 115.465 168.317 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -67.02 -38.13 85.4 Favored 'General case' 0 C--N 1.325 -0.494 1 O-C-N 115.862 -4.274 . . . . 0.0 116.733 169.604 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.4 mt -74.3 -20.25 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 O-C-N 126.89 2.619 . . . . 0.0 113.173 171.433 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -66.61 -30.77 71.13 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 119.635 -1.915 . . . . 0.0 115.663 154.659 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -83.79 -57.71 3.1 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 121.496 1.953 . . . . 0.0 106.106 -174.765 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.323 64.7 mttm -45.04 -71.47 0.08 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 119.53 3.159 . . . . 0.0 119.53 168.073 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -102.77 -28.52 12.04 Favored 'General case' 0 N--CA 1.448 -0.526 1 CA-C-O 128.901 4.191 . . . . 0.0 115.979 -164.7 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.11 -9.12 50.18 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 118.777 -2.452 . . . . 0.0 118.955 167.211 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.4 mm -82.5 124.62 77.62 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 129.347 3.059 . . . . 0.0 104.825 -167.556 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.27 147.05 36.78 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 123.822 3.015 . . . . 0.0 112.829 -173.134 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -67.19 -13.19 38.74 Favored 'Trans proline' 0 N--CA 1.442 -1.507 1 C-N-CA 126.953 5.102 . . . . 0.0 114.072 -171.672 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -83.46 -5.7 59.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 118.213 -1.395 . . . . 0.0 113.927 173.688 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.431 2.5 tp-100 -108.98 -8.45 15.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.266 1.826 . . . . 0.0 111.408 168.885 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -92.91 123.74 36.39 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 126.859 3.219 . . . . 0.0 107.687 179.498 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.354 32.2 mtt180 -126.0 138.77 53.76 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 111.61 -2.541 . . . . 0.0 108.157 172.292 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.405 HD13 HD13 ' A' ' 67' ' ' LEU . 16.5 mt -105.49 150.96 24.85 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 174.176 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.286 68.4 mt -100.53 143.84 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 1 C-N-CA 133.383 4.673 . . . . 0.0 109.685 152.219 . . . . . . . . 3 2 . 1 . 085 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -151.59 119.68 6.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 111.025 -2.807 . . . . 0.0 115.055 162.635 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.8 39.07 24.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.758 2.423 . . . . 0.0 115.08 176.677 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.43 -10.39 16.88 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 163.15 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -134.09 136.23 43.78 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -159.867 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.359 6.0 tt0 -73.99 130.37 39.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 162.525 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -73.92 133.6 43.09 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -172.787 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.22 -39.31 94.26 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.585 1.954 . . . . 0.0 112.125 175.182 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.391 24.8 t0 106.38 160.31 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 131.701 4.0 . . . . 0.0 113.419 170.585 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.98 21.94 12.94 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 128.609 3.004 . . . . 0.0 114.518 153.608 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -113.62 176.37 5.06 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 124.724 2.202 . . . . 0.0 106.666 175.034 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.2 p -90.41 154.22 19.83 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.274 -2.141 . . . . 0.0 108.438 172.623 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.346 8.0 mp -41.79 -61.25 1.15 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 110.261 -3.154 . . . . 0.0 115.686 175.596 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -45.24 -52.88 9.01 Favored 'General case' 0 N--CA 1.448 -0.536 1 C-N-CA 132.921 4.488 . . . . 0.0 112.601 176.103 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -64.45 -43.66 93.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.66 178.216 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.75 -14.4 60.71 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 119.359 -2.088 . . . . 0.0 111.733 -173.402 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.475 0.9 OUTLIER 91.61 24.03 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 130.801 3.641 . . . . 0.0 115.643 179.323 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.7 mt -95.59 115.47 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 119.934 1.243 . . . . 0.0 111.99 176.139 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -116.2 -156.49 0.62 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.831 1.652 . . . . 0.0 114.344 -178.876 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -56.28 112.11 1.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 127.416 2.286 . . . . 0.0 112.997 178.407 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 76.52 21.96 1.27 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.065 2.146 . . . . 0.0 108.968 168.461 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -63.68 127.31 30.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 117.195 -1.383 . . . . 0.0 108.471 175.297 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 13.5 m -90.16 111.61 22.82 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 121.33 1.877 . . . . 0.0 111.687 169.664 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.405 HD13 HD13 ' A' ' 43' ' ' LEU . 31.3 mt -91.87 152.19 20.2 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.823 1.249 . . . . 0.0 110.263 166.673 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -107.96 141.25 39.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 173.164 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -104.35 145.46 30.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -179.556 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 m -142.72 153.11 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 129.146 2.978 . . . . 0.0 107.095 -178.023 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 mt . . . . . 0 C--N 1.323 -0.549 0 C-N-CA 127.094 2.158 . . . . 0.0 108.393 167.131 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 115.401 -2.238 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -72.42 152.58 41.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 129.525 3.13 . . . . 0.0 108.926 177.595 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pp -145.29 158.95 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 160.63 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -119.22 117.82 29.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.463 1.505 . . . . 0.0 108.989 -174.085 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 t -100.88 117.52 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 1 N-CA-C 99.253 -4.351 . . . . 0.0 99.253 175.886 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -109.42 136.52 48.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 125.465 1.728 . . . . 0.0 109.624 -171.917 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -84.97 174.27 9.9 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.125 -1.609 . . . . 0.0 108.969 -177.137 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.5 mt -91.64 0.65 57.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 116.84 -1.552 . . . . 0.0 107.085 179.595 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -107.19 0.89 23.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.305 1.842 . . . . 0.0 110.481 174.453 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.99 -27.48 8.6 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 115.049 -3.084 . . . . 0.0 111.912 154.625 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -62.6 144.31 56.32 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 129.826 3.898 . . . . 0.0 108.906 179.066 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -118.52 123.0 44.02 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 127.683 3.114 . . . . 0.0 103.791 -169.057 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mt -94.24 134.36 32.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 117.039 -1.457 . . . . 0.0 108.329 174.602 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.6 m -103.07 110.23 22.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 114.296 -2.764 . . . . 0.0 110.716 177.848 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -107.6 160.37 15.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 127.152 2.782 . . . . 0.0 109.648 167.668 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.394 0.0 OUTLIER -127.87 116.06 19.56 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.732 3.213 . . . . 0.0 110.568 -178.017 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.19 162.61 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 O-C-N 117.725 -3.109 . . . . 0.0 106.974 -169.387 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -102.07 154.56 37.28 Favored Pre-proline 0 N--CA 1.441 -0.901 0 O-C-N 118.975 -2.328 . . . . 0.0 106.815 164.638 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.251 67.0 Cg_endo -66.77 -29.32 42.58 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 124.496 3.464 . . . . 0.0 115.765 175.757 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.256 27.9 p -63.05 -2.28 1.21 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 114.927 -2.463 . . . . 0.0 117.366 160.814 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -70.1 136.14 49.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 123.484 2.856 . . . . 0.0 108.542 -175.517 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 p -77.99 170.83 15.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.76 2.424 . . . . 0.0 109.128 170.241 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.3 mt -72.66 -46.07 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -177.987 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -41.72 -44.1 3.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 122.668 2.485 . . . . 0.0 116.024 162.561 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -63.96 -42.97 97.13 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 124.687 1.242 . . . . 0.0 109.87 179.461 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.607 HG21 HD21 ' A' ' 56' ' ' LEU . 35.1 t -79.83 -27.88 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.353 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -68.69 -34.07 75.04 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 114.607 -2.616 . . . . 0.0 114.445 167.541 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.35 -26.12 42.15 Favored 'General case' 0 N--CA 1.45 -0.445 1 CA-C-N 126.881 4.401 . . . . 0.0 115.057 169.382 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -71.55 -39.61 70.55 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 124.688 1.242 . . . . 0.0 109.777 172.271 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.8 mt -73.36 -37.76 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 O-C-N 116.664 -3.773 . . . . 0.0 113.695 173.406 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -45.49 88.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 119.999 1.272 . . . . 0.0 112.623 175.551 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.09 -35.51 69.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.766 2.426 . . . . 0.0 111.495 -179.612 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -86.73 -39.04 16.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -177.312 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -120.53 -25.31 5.59 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.311 1.844 . . . . 0.0 111.466 -172.259 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.77 -11.97 67.72 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 114.641 -3.311 . . . . 0.0 116.138 -178.682 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.6 mt -64.84 118.52 49.46 Favored Pre-proline 0 N--CA 1.45 -0.456 1 CA-C-N 124.434 4.117 . . . . 0.0 115.678 177.469 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -76.44 141.49 22.67 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 CA-C-N 124.533 2.655 . . . . 0.0 118.035 -173.767 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -30.21 -50.33 0.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 N-CA-C 121.089 3.457 . . . . 0.0 121.089 177.839 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.93 -40.74 63.83 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 117.446 -3.284 . . . . 0.0 114.591 172.93 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -84.51 -25.79 28.55 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 118.535 -1.266 . . . . 0.0 113.733 -174.376 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -63.81 121.48 14.13 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 128.218 2.607 . . . . 0.0 108.117 171.882 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 65.0 mtt180 -101.54 131.83 47.5 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 123.316 2.78 . . . . 0.0 109.65 147.739 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.9 mt -104.95 139.09 40.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 125.846 1.966 . . . . 0.0 108.222 167.72 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 44' ' ' ILE . 34.7 mt -129.37 125.93 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 110.793 -2.912 . . . . 0.0 108.148 -173.912 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.362 33.1 t80 -149.54 131.18 14.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.654 1.115 . . . . 0.0 108.908 176.086 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.38 34.51 15.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -178.711 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.01 -23.05 5.42 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 119.233 2.453 . . . . 0.0 119.233 -173.05 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -79.2 139.23 38.01 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 127.566 2.568 . . . . 0.0 111.405 -174.724 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -87.67 124.83 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 164.352 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.95 135.61 33.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 126.169 1.788 . . . . 0.0 113.395 -162.175 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -83.4 134.72 34.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 116.822 -3.674 . . . . 0.0 113.437 176.643 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.92 141.48 51.14 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 127.523 3.014 . . . . 0.0 111.173 -174.577 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.76 -16.16 26.12 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 111.725 -2.489 . . . . 0.0 114.141 177.854 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -87.25 145.82 26.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.886 2.074 . . . . 0.0 112.189 177.037 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 p -85.69 157.81 20.21 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 126.037 2.086 . . . . 0.0 111.904 179.02 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.607 HD21 HG21 ' A' ' 26' ' ' VAL . 60.2 mt -53.62 -53.97 44.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.883 2.073 . . . . 0.0 114.464 177.23 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.252 22.1 t -39.68 -35.05 0.28 Allowed 'General case' 0 C--N 1.326 -0.437 1 N-CA-C 122.927 4.417 . . . . 0.0 122.927 165.925 . . . . . . . . 3 2 . 1 . 086 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -70.28 -44.25 68.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.224 2.61 . . . . 0.0 114.858 176.739 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -94.93 6.28 49.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 111.795 -2.457 . . . . 0.0 106.642 -173.286 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.9 t30 86.11 21.39 0.08 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 126.482 3.039 . . . . 0.0 113.065 151.976 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.297 82.3 mt -77.84 98.37 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 1 O-C-N 115.782 -4.324 . . . . 0.0 102.542 -178.316 . . . . . . . . 3 2 . 1 . 086 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -82.03 161.88 22.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 130.523 3.529 . . . . 0.0 107.51 -179.9 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -49.14 133.69 18.55 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 126.179 2.174 . . . . 0.0 112.913 176.242 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 65.05 20.92 12.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.125 2.97 . . . . 0.0 118.876 169.305 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -65.97 149.9 49.5 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 112.045 -3.836 . . . . 0.0 115.965 174.518 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 m -107.32 128.48 54.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 128.438 3.586 . . . . 0.0 110.265 170.332 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.251 0.7 OUTLIER -144.56 -177.9 5.72 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.361 2.264 . . . . 0.0 108.376 -170.771 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.629 2.1 p80 -128.96 167.12 17.9 Favored 'General case' 0 N--CA 1.448 -0.537 1 C-N-CA 134.144 4.977 . . . . 0.0 118.117 177.79 . . . . . . . . 3 2 . 1 . 086 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 tp -135.86 126.72 27.54 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 110.6 -3.0 . . . . 0.0 115.713 175.267 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.14 104.77 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 130.44 3.496 . . . . 0.0 108.346 -179.303 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 N--CA 1.448 -0.563 0 C-N-CA 130.958 3.703 . . . . 0.0 108.863 165.528 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 . . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.95 139.16 44.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 116.833 -1.556 . . . . 0.0 112.728 158.913 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -128.75 173.79 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 167.509 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.19 160.41 37.33 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 125.612 1.82 . . . . 0.0 109.421 179.946 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.541 HG21 HD11 ' A' ' 30' ' ' ILE . 73.9 t -136.37 116.22 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 127.654 2.382 . . . . 0.0 109.256 172.671 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -76.3 130.67 38.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 121.277 1.853 . . . . 0.0 111.196 156.588 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 p -100.73 168.17 9.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 116.168 -1.872 . . . . 0.0 114.592 -174.71 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 mt -58.6 -32.93 69.44 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 127.181 2.192 . . . . 0.0 113.089 -175.87 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -71.57 -22.62 61.71 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.679 1.991 . . . . 0.0 115.363 174.418 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.56 -18.22 13.41 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 128.925 3.155 . . . . 0.0 108.658 -176.793 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.68 148.09 52.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 113.839 -2.981 . . . . 0.0 109.111 -172.738 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.3 m -120.52 130.94 54.46 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 125.853 1.971 . . . . 0.0 112.429 174.966 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 mm -103.69 147.65 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 128.591 2.756 . . . . 0.0 105.597 179.471 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.3 m -106.84 122.9 47.32 Favored 'General case' 0 N--CA 1.452 -0.337 1 N-CA-C 99.472 -4.27 . . . . 0.0 99.472 174.743 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.14 160.69 25.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.87 1.668 . . . . 0.0 109.302 173.436 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -114.01 125.91 54.53 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.39 -1.732 . . . . 0.0 115.167 166.224 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.42 161.99 13.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 O-C-N 119.613 -1.929 . . . . 0.0 112.135 176.152 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -107.57 160.57 26.17 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 127.456 2.302 . . . . 0.0 107.335 161.304 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -40.38 -42.16 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.891 1 C-N-CA 127.477 5.451 . . . . 0.0 114.815 175.218 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 p -77.57 -3.01 38.58 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.772 -3.08 . . . . 0.0 117.005 -172.88 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.25 123.81 29.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 123.641 1.686 . . . . 0.0 109.841 -178.631 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.3 p -81.71 179.85 7.66 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 129.319 3.048 . . . . 0.0 106.399 -179.403 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.583 HG22 ' HE2' ' A' ' 27' ' ' LYS . 9.2 mm -64.77 -35.89 76.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 115.941 -1.98 . . . . 0.0 109.376 179.325 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -55.24 -47.15 75.82 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 126.458 1.903 . . . . 0.0 114.318 173.771 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -64.81 -34.95 79.57 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.899 3.679 . . . . 0.0 109.474 177.236 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.0 t -71.05 -42.5 76.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.454 1.902 . . . . 0.0 107.0 177.177 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HE2' HG22 ' A' ' 23' ' ' ILE . 45.0 mtmt -73.0 -31.08 64.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 119.24 -2.162 . . . . 0.0 115.61 -178.019 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.29 78.03 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.766 3.226 . . . . 0.0 112.492 170.053 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -74.46 -30.09 61.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.323 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.541 HD11 HG21 ' A' ' 5' ' ' VAL . 64.7 mt -73.39 -35.96 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 128.982 2.913 . . . . 0.0 109.916 -176.957 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -61.94 -42.74 99.45 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 119.133 -2.229 . . . . 0.0 109.515 172.931 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -61.67 -19.28 62.15 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 119.671 3.212 . . . . 0.0 119.671 178.358 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -101.11 -40.36 7.23 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 116.874 -1.536 . . . . 0.0 109.095 172.404 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.328 16.8 tp10 -125.05 -4.68 7.44 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.529 -1.357 . . . . 0.0 114.023 -157.616 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.23 9.23 28.64 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 119.176 2.43 . . . . 0.0 119.176 174.762 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 36' ' ' ILE . 7.2 mt -75.89 133.12 73.22 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 130.655 3.582 . . . . 0.0 105.484 174.842 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.55 145.67 59.1 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 CA-C-O 113.926 -2.614 . . . . 0.0 114.285 -175.193 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.08 -39.17 19.43 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.504 2.803 . . . . 0.0 119.29 -177.469 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 38.4 t70 -48.64 -48.79 39.29 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 130.378 3.471 . . . . 0.0 114.145 179.73 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -72.22 -25.62 61.71 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 131.092 3.757 . . . . 0.0 113.278 173.3 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.84 128.76 35.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 123.759 2.981 . . . . 0.0 109.945 -175.014 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -109.98 161.8 15.15 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 118.862 -2.399 . . . . 0.0 108.675 165.49 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -124.81 106.65 10.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 164.111 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -92.77 128.65 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 101.008 -3.701 . . . . 0.0 101.008 164.641 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -157.13 117.67 3.56 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 128.29 2.636 . . . . 0.0 110.277 -173.727 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.94 28.74 18.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.217 2.607 . . . . 0.0 110.652 -172.427 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.23 -25.49 28.05 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 125.413 1.696 . . . . 0.0 109.861 177.678 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 tttt -92.62 135.01 34.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.988 -0.713 . . . . 0.0 111.227 -162.804 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.67 119.51 14.92 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 115.885 -2.007 . . . . 0.0 109.115 171.824 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.2 mt -81.36 123.82 28.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -177.953 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -81.29 137.59 35.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.457 -1.402 . . . . 0.0 110.365 -175.414 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.73 114.71 5.21 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.486 169.747 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.24 -21.32 2.95 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 130.327 3.822 . . . . 0.0 112.752 177.932 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mtp85 -97.31 155.67 16.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -176.861 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -94.74 171.05 9.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.364 1.866 . . . . 0.0 108.09 177.619 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.13 -47.24 77.79 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.962 1.305 . . . . 0.0 111.41 176.085 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.5 p -44.89 -40.26 6.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 118.591 2.812 . . . . 0.0 118.591 159.863 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -61.57 -34.17 75.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 124.218 1.961 . . . . 0.0 116.133 168.654 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.94 11.16 21.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.033 -2.292 . . . . 0.0 115.927 168.813 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.451 8.5 p30 54.36 46.6 24.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 124.442 2.067 . . . . 0.0 111.662 177.515 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -103.85 108.25 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 128.662 2.785 . . . . 0.0 109.158 173.599 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -105.27 169.28 8.54 Favored 'General case' 0 C--N 1.325 -0.482 1 O-C-N 130.147 4.654 . . . . 0.0 112.749 -173.875 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.325 51.7 tttm -12.52 107.0 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 129.372 3.069 . . . . 0.0 117.446 168.969 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 76.49 17.87 1.85 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 129.386 3.074 . . . . 0.0 115.013 168.694 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -67.93 139.12 56.42 Favored 'General case' 0 CA--C 1.532 0.283 1 O-C-N 115.567 -4.458 . . . . 0.0 113.512 171.109 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.1 m -98.08 112.06 24.15 Favored 'General case' 0 N--CA 1.449 -0.48 1 C-N-CA 133.641 4.776 . . . . 0.0 103.579 178.137 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -87.09 161.51 18.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 128.824 2.85 . . . . 0.0 109.538 169.21 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -123.15 118.7 28.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 130.12 3.368 . . . . 0.0 111.348 -172.73 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.1 tp -89.77 111.09 21.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 116.32 -1.8 . . . . 0.0 114.649 -166.167 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.95 165.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 125.142 1.526 . . . . 0.0 107.875 -179.539 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tp . . . . . 0 N--CA 1.449 -0.477 0 C-N-CA 125.921 1.688 . . . . 0.0 109.045 -176.469 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -72.19 134.78 45.87 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.299 1.84 . . . . 0.0 112.864 171.592 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.5 pt -147.04 141.04 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.489 2.316 . . . . 0.0 107.958 168.935 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.04 151.28 25.07 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 119.125 -2.234 . . . . 0.0 107.54 -179.223 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -110.88 129.39 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 117.733 -3.104 . . . . 0.0 104.33 160.61 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -109.07 120.36 42.31 Favored 'General case' 0 N--CA 1.45 -0.433 1 O-C-N 116.268 -4.02 . . . . 0.0 101.406 167.707 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -85.95 126.79 34.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 158.547 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.307 6.0 mp -88.83 -12.65 41.35 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 125.318 1.636 . . . . 0.0 108.88 -167.686 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.5 p -90.33 -14.02 33.98 Favored 'General case' 0 N--CA 1.442 -0.869 1 O-C-N 115.919 -4.238 . . . . 0.0 113.198 164.281 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.64 -104.89 1.28 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.319 1.914 . . . . 0.0 108.532 -156.0 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -159.67 151.73 20.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 117.85 -3.147 . . . . 0.0 108.884 -159.071 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.4 p -70.96 127.19 31.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.553 -2.112 . . . . 0.0 110.222 161.336 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.98 137.6 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 131.324 3.85 . . . . 0.0 102.779 -175.386 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.3 p -92.51 112.55 24.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.227 -1.351 . . . . 0.0 107.662 173.935 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.35 171.74 7.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 174.533 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -141.8 127.36 18.98 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 103.147 -2.908 . . . . 0.0 103.147 -175.823 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.2 m -132.8 177.78 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 O-C-N 119.295 -2.128 . . . . 0.0 111.833 177.666 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -97.27 143.18 25.71 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 125.581 1.552 . . . . 0.0 109.605 178.611 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -63.73 -24.34 68.96 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-O 115.727 -1.864 . . . . 0.0 115.44 172.911 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.3 p -99.75 10.45 41.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 130.016 3.326 . . . . 0.0 114.132 -178.398 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.71 145.97 48.48 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 125.764 1.915 . . . . 0.0 107.187 -179.339 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.1 p -91.94 150.63 20.92 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 115.582 -2.151 . . . . 0.0 113.677 164.809 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -54.46 -34.07 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 123.868 3.031 . . . . 0.0 116.49 -176.172 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.33 -39.54 76.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 124.53 3.332 . . . . 0.0 115.963 172.974 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -83.16 -26.17 31.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.897 2.079 . . . . 0.0 115.675 175.4 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.287 99.3 t -50.47 -52.69 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 O-C-N 119.007 -2.308 . . . . 0.0 115.109 157.712 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -60.41 -34.48 74.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 126.46 2.35 . . . . 0.0 115.444 174.691 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.1 63.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 131.311 3.844 . . . . 0.0 113.04 165.561 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.289 49.1 mttp -59.33 -41.28 88.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.662 1.585 . . . . 0.0 111.592 -178.784 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.296 18.0 mt -78.22 -23.15 13.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 127.597 2.359 . . . . 0.0 110.996 -176.939 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.81 -43.16 59.67 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 165.444 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.296 25.8 t70 -69.08 -36.96 78.19 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 125.735 2.683 . . . . 0.0 116.675 -178.416 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -36.8 65.48 Favored 'General case' 0 CA--C 1.536 0.433 1 O-C-N 113.395 -5.816 . . . . 0.0 115.982 177.296 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -128.98 -10.43 4.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 117.372 2.36 . . . . 0.0 117.372 -168.189 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.22 10.39 77.97 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 129.794 3.569 . . . . 0.0 112.97 179.804 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.9 mt -81.92 129.1 66.0 Favored Pre-proline 0 N--CA 1.443 -0.814 1 CA-C-N 124.701 4.251 . . . . 0.0 110.288 -166.426 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.02 144.58 64.48 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 123.491 2.794 . . . . 0.0 118.084 -170.887 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -74.62 -30.06 8.26 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.411 2.741 . . . . 0.0 117.735 -168.978 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -70.89 -17.15 62.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.266 1.031 . . . . 0.0 110.196 172.446 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -102.85 -8.76 20.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 117.869 -3.02 . . . . 0.0 113.398 -171.683 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -83.33 135.39 34.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 122.074 2.215 . . . . 0.0 107.876 -178.764 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -120.05 112.73 19.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 119.414 -2.054 . . . . 0.0 107.585 148.306 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mt -84.84 147.1 26.98 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 126.128 2.142 . . . . 0.0 109.393 170.37 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 68' ' ' HIS 0.296 0.0 OUTLIER -143.36 131.99 19.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 115.45 -2.214 . . . . 0.0 111.79 -174.288 . . . . . . . . 4 4 . 1 . 088 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -137.16 121.74 18.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 102.726 -3.065 . . . . 0.0 102.726 175.393 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 79.56 2.39 2.21 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 127.768 3.167 . . . . 0.0 113.719 165.671 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.75 -17.87 20.13 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 118.07 -2.894 . . . . 0.0 108.519 -174.622 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -85.82 109.56 18.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.167 2.187 . . . . 0.0 108.955 179.993 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.7 119.87 13.15 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.042 166.83 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -91.16 116.92 29.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 117.935 -2.978 . . . . 0.0 106.361 -151.222 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -92.84 145.98 23.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 123.252 1.501 . . . . 0.0 107.045 -166.642 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.24 145.19 43.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 112.375 -2.193 . . . . 0.0 107.67 171.131 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.38 -26.03 25.0 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.783 2.135 . . . . 0.0 112.635 175.169 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -96.49 168.61 10.44 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.552 2.341 . . . . 0.0 114.955 179.2 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.7 p -119.14 176.72 5.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 112.792 -2.003 . . . . 0.0 112.256 -166.752 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.2 mt -77.21 -28.98 54.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.905 -179.782 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.2 t -76.21 -25.76 55.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 115.128 -2.368 . . . . 0.0 110.03 177.76 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -59.78 -61.66 2.45 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 131.058 3.743 . . . . 0.0 105.41 176.622 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -89.67 -7.28 54.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 128.341 2.656 . . . . 0.0 111.908 -169.596 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.384 2.3 t-20 86.03 31.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.226 2.61 . . . . 0.0 111.954 166.01 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.252 5.4 mt -80.24 107.99 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 126.247 1.819 . . . . 0.0 111.002 -174.744 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -100.7 -179.86 4.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 127.215 2.822 . . . . 0.0 112.731 179.13 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -61.86 129.93 43.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 129.712 3.205 . . . . 0.0 112.391 -176.135 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.535 1.1 tt0 79.2 4.59 2.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 159.764 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.9 p -57.12 157.58 5.92 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 127.512 3.007 . . . . 0.0 115.893 158.423 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 m -102.77 126.56 49.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 119.821 -1.8 . . . . 0.0 111.952 156.27 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 mp -91.26 146.69 23.61 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 120.721 -1.237 . . . . 0.0 107.705 160.173 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.409 ' HB2' HG23 ' A' ' 44' ' ' ILE . 30.6 m170 -94.66 145.93 24.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 117.108 -1.425 . . . . 0.0 108.188 177.73 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.13 122.02 40.09 Favored 'General case' 0 C--N 1.322 -0.589 1 C-N-CA 132.547 4.339 . . . . 0.0 104.908 177.544 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.326 2.8 m -121.11 115.61 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 109.074 -3.694 . . . . 0.0 101.427 -178.274 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.1 mt . . . . . 0 N--CA 1.451 -0.378 1 O-C-N 115.94 -4.225 . . . . 0.0 113.4 -174.844 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 ttp . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 101.511 -3.514 . . . . 0.0 101.511 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -89.63 150.91 22.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.857 1.263 . . . . 0.0 110.432 161.676 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.294 47.4 pt -135.13 175.06 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 129.778 3.231 . . . . 0.0 109.978 163.264 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.417 ' HE1' ' HG1' ' A' ' 14' ' ' THR 0.291 97.9 m-85 -116.38 126.17 53.1 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.101 2.96 . . . . 0.0 110.93 163.732 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.19 140.34 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 151.807 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -118.97 146.73 44.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 126.85 2.594 . . . . 0.0 105.54 167.564 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.2 p -98.65 161.21 13.78 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.49 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt -50.6 -29.64 11.38 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 118.892 -2.38 . . . . 0.0 116.09 -175.223 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.2 p -104.77 9.47 34.93 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.544 2.737 . . . . 0.0 108.749 -162.909 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.85 -23.68 30.38 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 119.605 -1.934 . . . . 0.0 116.231 164.981 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -69.76 126.2 29.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 125.753 1.502 . . . . 0.0 108.503 -179.939 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 p -106.47 150.73 25.79 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.304 1.841 . . . . 0.0 108.654 175.658 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.7 pt -129.75 131.67 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 1 C-N-CA 133.477 4.711 . . . . 0.0 113.8 168.999 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.417 ' HG1' ' HE1' ' A' ' 4' ' ' PHE . 2.6 m -87.95 118.58 27.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.854 2.061 . . . . 0.0 106.875 177.893 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.63 134.2 50.14 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 129.183 2.993 . . . . 0.0 112.164 178.796 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.66 138.24 36.12 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.533 1.933 . . . . 0.0 113.171 172.419 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.306 7.0 m -157.16 142.99 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-O 117.295 -1.336 . . . . 0.0 107.625 -163.229 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -91.96 148.01 36.05 Favored Pre-proline 0 C--O 1.221 -0.401 0 C-N-CA 124.783 1.233 . . . . 0.0 110.814 -178.296 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 31.8 Cg_exo -47.06 -0.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.434 1 N-CA-C 122.616 4.045 . . . . 0.0 122.616 170.627 . . . . . . . . 3 2 . 1 . 089 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 p -134.32 16.24 3.75 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 118.782 -2.449 . . . . 0.0 111.715 -174.154 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -85.93 150.79 24.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -179.53 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -102.34 149.98 23.79 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 128.457 2.703 . . . . 0.0 106.369 177.509 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -49.65 -27.25 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.605 2.362 . . . . 0.0 114.546 177.269 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -50.42 -44.31 55.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.882 2.073 . . . . 0.0 115.103 161.376 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -62.1 -42.1 98.87 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 128.425 2.69 . . . . 0.0 110.891 177.735 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 26' ' ' VAL . 2.0 t -58.81 -38.45 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 176.936 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -66.51 -40.44 89.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 128.484 2.714 . . . . 0.0 114.25 175.246 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -68.65 -40.06 80.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 117.739 -1.124 . . . . 0.0 110.714 176.03 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.437 25.1 mttt -53.82 -45.58 70.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 175.538 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.279 50.8 mt -52.67 -49.4 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 117.019 -1.467 . . . . 0.0 112.686 170.565 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -42.87 -55.21 3.8 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 129.36 3.064 . . . . 0.0 111.578 167.32 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.98 -29.86 62.2 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.002 -1.475 . . . . 0.0 111.134 -171.651 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -83.66 -47.56 11.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 120.697 1.589 . . . . 0.0 112.267 172.107 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -116.41 -20.66 9.6 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 115.575 -2.155 . . . . 0.0 113.829 -159.154 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.15 0.24 25.32 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 125.135 1.522 . . . . 0.0 115.152 172.599 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.0 mt -96.26 136.68 21.86 Favored Pre-proline 0 N--CA 1.45 -0.429 0 O-C-N 126.573 1.984 . . . . 0.0 109.607 -160.365 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -89.31 142.19 4.3 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 124.726 2.723 . . . . 0.0 111.471 -163.422 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.07 -45.77 36.83 Favored 'Trans proline' 0 N--CA 1.452 -0.95 1 C-N-CA 126.607 4.871 . . . . 0.0 114.778 -177.95 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -48.49 -23.3 0.92 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 130.13 3.372 . . . . 0.0 115.774 171.271 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -120.93 14.15 11.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 127.504 3.002 . . . . 0.0 112.941 -176.171 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 72.8 mt-30 -102.86 162.39 12.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 169.891 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.3 ttp-105 -144.52 131.88 20.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 131.209 3.804 . . . . 0.0 105.637 162.74 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.1 mt -111.25 134.76 52.6 Favored 'General case' 0 N--CA 1.444 -0.759 1 O-C-N 115.85 -4.281 . . . . 0.0 110.241 -174.747 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 41.7 mt -126.8 149.52 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 118.293 -2.755 . . . . 0.0 108.841 179.201 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -112.9 -44.11 3.34 Favored 'General case' 0 C--N 1.325 -0.48 1 C-N-CA 132.031 4.132 . . . . 0.0 111.118 161.374 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.09 -103.98 0.29 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 -175.685 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.48 -32.55 0.52 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 118.254 2.062 . . . . 0.0 118.254 -150.196 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -93.14 -178.91 4.92 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 130.125 3.37 . . . . 0.0 112.56 153.394 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -97.12 151.96 19.26 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.651 1.58 . . . . 0.0 109.725 177.475 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.23 135.74 40.99 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.34 1.856 . . . . 0.0 109.365 -177.2 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -77.58 112.65 14.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.033 -2.917 . . . . 0.0 109.448 169.16 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.92 -19.84 46.28 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 129.982 3.313 . . . . 0.0 119.132 -165.788 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.56 14.43 35.52 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.789 2.138 . . . . 0.0 110.05 -177.482 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -90.85 166.57 13.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 124.349 2.023 . . . . 0.0 108.496 157.51 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -90.53 166.02 13.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.663 -1.608 . . . . 0.0 113.687 173.758 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.409 11.8 mt -45.08 -31.86 1.53 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 129.086 2.955 . . . . 0.0 118.371 163.994 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.7 p -93.05 -11.66 32.5 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 119.474 -2.016 . . . . 0.0 111.183 179.143 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -90.59 -4.95 56.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 114.838 -2.506 . . . . 0.0 109.257 177.603 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -118.7 -10.01 10.09 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 166.555 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t30 87.0 40.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 119.479 -2.013 . . . . 0.0 111.334 171.973 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.5 mm -87.55 106.95 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 113.088 -1.869 . . . . 0.0 108.103 175.514 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -87.03 179.88 6.6 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 131.337 3.855 . . . . 0.0 106.532 -172.939 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.3 51.2 pttt -58.4 136.54 57.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 166.794 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 58.9 26.74 15.28 Favored 'General case' 0 N--CA 1.45 -0.472 1 C-N-CA 133.506 4.722 . . . . 0.0 112.344 169.03 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 m -73.8 149.96 41.35 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 129.96 3.304 . . . . 0.0 113.587 -176.844 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -98.45 119.29 36.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 178.26 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -100.23 154.19 18.66 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.397 152.735 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -116.1 119.61 36.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.794 1.638 . . . . 0.0 107.896 -172.167 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.262 52.2 tp -98.94 122.79 42.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 124.118 1.913 . . . . 0.0 113.158 -179.112 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.88 145.06 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 126.513 1.925 . . . . 0.0 110.107 161.52 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 127.982 2.513 . . . . 0.0 110.651 172.898 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -83.24 139.63 32.99 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 129.512 3.125 . . . . 0.0 105.162 -175.747 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 14' ' ' THR 0.266 30.0 pt -141.53 149.33 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 127.124 2.17 . . . . 0.0 111.968 -176.37 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -89.13 146.43 24.81 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.224 164.036 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD12 ' A' ' 15' ' ' LEU . 2.7 t -127.76 118.09 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 126.838 2.586 . . . . 0.0 106.133 169.656 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -94.83 116.81 29.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -177.993 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.2 p -70.75 164.9 24.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 124.441 2.067 . . . . 0.0 112.955 174.982 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.25 -37.82 60.84 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 120.528 -1.358 . . . . 0.0 112.094 -177.45 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 p -54.56 -29.86 52.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 130.993 3.717 . . . . 0.0 116.242 161.844 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.68 -19.77 5.84 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 119.677 -1.889 . . . . 0.0 113.146 161.843 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -73.5 136.57 44.14 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.965 2.506 . . . . 0.0 111.024 175.059 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m -112.32 130.11 56.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 125.265 1.603 . . . . 0.0 110.019 178.273 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.416 HD13 ' HG3' ' A' ' 34' ' ' GLU . 9.3 pt -110.9 177.61 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 112.376 -2.193 . . . . 0.0 108.592 -178.513 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 5.2 t -140.83 141.64 34.68 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.404 1.881 . . . . 0.0 107.077 170.36 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.471 HD12 HG21 ' A' ' 5' ' ' VAL . 22.6 mt -129.11 159.02 37.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.647 2.779 . . . . 0.0 107.051 177.754 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -91.58 138.12 31.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 157.31 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.01 175.76 8.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 CA-C-N 122.416 2.371 . . . . 0.0 107.448 170.113 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -111.87 156.68 41.31 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 162.146 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -58.65 -28.17 85.35 Favored 'Trans proline' 0 N--CA 1.444 -1.412 1 C-N-CA 126.186 4.591 . . . . 0.0 120.538 173.042 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -98.1 21.92 10.14 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 124.939 1.399 . . . . 0.0 112.321 173.97 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.83 153.86 38.54 Favored 'General case' 0 N--CA 1.453 -0.32 1 O-C-N 115.085 -4.759 . . . . 0.0 108.089 174.319 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.293 86.7 m -100.24 157.81 16.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.27 2.228 . . . . 0.0 108.272 168.823 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.1 mm -58.47 -9.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 119.261 3.06 . . . . 0.0 119.261 -178.835 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -87.46 -4.72 59.0 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 118.832 -2.417 . . . . 0.0 113.136 -178.422 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -91.78 -34.63 14.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.717 -2.038 . . . . 0.0 111.717 164.977 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.26 -51.52 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 O-C-N 119.638 -1.914 . . . . 0.0 108.625 179.773 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -51.05 -56.14 14.05 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 128.921 3.888 . . . . 0.0 113.075 -178.532 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.97 80.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.269 2.628 . . . . 0.0 117.034 176.738 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -68.44 -40.52 81.11 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 173.044 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.357 75.8 mt -47.65 -49.29 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 128.811 2.844 . . . . 0.0 112.692 160.665 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -63.61 -45.89 88.26 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.61 2.364 . . . . 0.0 112.556 -179.259 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.51 -64.6 0.79 Allowed 'General case' 0 C--O 1.238 0.46 1 C-N-CA 132.487 4.315 . . . . 0.0 107.222 173.167 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -63.51 -57.03 11.48 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 128.094 3.371 . . . . 0.0 118.22 -174.254 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' HG3' HD13 ' A' ' 13' ' ' ILE 0.279 22.2 mm-40 -111.94 -2.07 15.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.176 2.19 . . . . 0.0 113.741 -168.173 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.85 -19.41 41.3 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 117.543 -3.223 . . . . 0.0 113.132 160.635 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -83.56 127.3 68.6 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 117.962 -3.081 . . . . 0.0 112.506 -157.483 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.22 133.85 31.93 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 CA-C-N 123.885 2.423 . . . . 0.0 113.112 168.653 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.337 17.9 Cg_endo -58.94 -30.31 92.84 Favored 'Trans proline' 0 N--CA 1.452 -0.959 1 C-N-CA 127.691 5.594 . . . . 0.0 117.211 -171.255 . . . . . . . . 3 2 . 1 . 090 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.286 26.6 t70 -76.3 -26.47 55.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 119.967 -1.708 . . . . 0.0 111.327 -163.728 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -73.14 -7.84 53.13 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 172.033 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB3' HD12 ' A' ' 71' ' ' LEU 0.455 1.2 pp0? -132.63 162.22 31.89 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.964 1.364 . . . . 0.0 113.428 -179.532 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -126.0 148.89 49.17 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 128.573 2.749 . . . . 0.0 111.512 171.343 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mt -99.37 118.73 36.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.802 2.841 . . . . 0.0 105.475 -178.357 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 mm -107.71 144.66 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 128.613 2.765 . . . . 0.0 104.922 179.18 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -141.82 132.57 25.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 125.221 1.576 . . . . 0.0 108.506 162.087 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.07 22.77 0.15 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 129.891 3.276 . . . . 0.0 114.644 -177.216 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.44 -7.07 36.62 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 119.398 -2.064 . . . . 0.0 112.948 177.398 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -113.29 141.01 47.52 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 121.564 -0.962 . . . . 0.0 113.298 -168.033 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -63.61 137.01 57.94 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 126.667 2.479 . . . . 0.0 115.565 171.975 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -105.54 108.53 20.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.673 3.189 . . . . 0.0 106.679 179.716 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -91.61 166.45 12.81 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 120.567 1.531 . . . . 0.0 112.38 -168.608 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.31 129.19 37.33 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.371 2.668 . . . . 0.0 107.803 171.107 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.93 -20.19 29.3 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 130.009 3.671 . . . . 0.0 114.933 165.086 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -89.45 153.08 21.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.077 2.551 . . . . 0.0 106.404 179.753 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -104.18 142.19 34.95 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 129.163 2.985 . . . . 0.0 111.276 -169.642 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.28 -55.35 25.33 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 126.906 2.628 . . . . 0.0 117.342 -170.042 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.331 41.2 t -65.0 -18.94 65.73 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 118.335 -2.728 . . . . 0.0 110.255 -172.913 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -78.69 -22.41 46.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 131.377 3.871 . . . . 0.0 115.817 171.333 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -81.37 -10.07 59.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.985 1.714 . . . . 0.0 113.14 163.665 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.349 58.8 t30 80.32 47.69 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 131.546 3.938 . . . . 0.0 108.349 173.882 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.415 HD13 HD21 ' A' ' 67' ' ' LEU . 14.3 mt -104.76 146.52 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 C-N-CA 125.814 1.646 . . . . 0.0 107.357 171.652 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -139.52 -158.86 0.9 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 129.663 3.185 . . . . 0.0 112.656 -179.175 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.11 135.34 36.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.873 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 70.69 30.31 3.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 129.509 3.124 . . . . 0.0 106.506 177.979 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.1 m -74.46 149.9 40.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 117.858 -3.026 . . . . 0.0 106.347 160.403 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.8 m -113.21 101.01 9.02 Favored 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 133.336 4.655 . . . . 0.0 101.481 179.166 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.415 HD21 HD13 ' A' ' 61' ' ' ILE . 7.8 mp -92.92 157.08 16.53 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 118.847 -2.408 . . . . 0.0 106.311 166.374 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -123.47 148.58 46.06 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 116.486 -1.721 . . . . 0.0 106.693 -175.644 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tt -103.02 139.35 38.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 103.155 -2.905 . . . . 0.0 103.155 177.096 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.351 29.1 m -134.27 137.73 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 1 C-N-CA 132.77 4.428 . . . . 0.0 112.479 175.782 . . . . . . . . 3 2 . 1 . 090 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 41' ' ' GLN . 10.6 mp . . . . . 0 N--CA 1.45 -0.431 0 CA-C-O 116.824 -1.56 . . . . 0.0 108.371 168.368 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptt? . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -80.02 146.19 32.11 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 124.933 1.396 . . . . 0.0 110.529 -174.23 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.515 HD12 HD13 ' A' ' 67' ' ' LEU 0.418 2.4 pt -142.63 128.77 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 130.385 3.474 . . . . 0.0 108.974 175.642 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.259 62.1 m-85 -98.78 67.13 1.68 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 131.21 3.804 . . . . 0.0 110.57 -159.463 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.267 24.2 t -62.96 113.71 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.772 2 O-C-N 115.669 -4.395 . . . . 0.0 108.651 174.721 . . . . . . . . 3 2 . 1 . 091 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.273 11.8 tppt? -102.45 139.93 37.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 101.987 -3.338 . . . . 0.0 101.987 -170.868 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -106.84 169.88 8.27 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 124.219 0.949 . . . . 0.0 109.04 167.741 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.25 -41.45 63.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 118.825 -2.422 . . . . 0.0 110.345 167.386 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.292 52.7 p -50.84 -34.25 27.08 Favored 'General case' 0 N--CA 1.448 -0.549 1 C-N-CA 131.796 4.039 . . . . 0.0 116.526 174.991 . . . . . . . . 3 2 . 1 . 091 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.66 27.48 3.28 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 128.958 3.171 . . . . 0.0 116.482 157.613 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.383 56.7 mttt -100.5 128.69 46.48 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 167.775 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.2 m -89.28 101.95 14.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 166.285 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.9 mm -53.75 -48.69 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 116.44 -1.743 . . . . 0.0 115.076 -177.052 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.6 m 74.4 50.42 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 129.459 3.103 . . . . 0.0 108.265 176.45 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tp -75.65 126.86 31.84 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -169.598 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -81.16 115.43 20.57 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 125.171 2.415 . . . . 0.0 110.854 163.171 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -108.9 162.17 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 1 C-N-CA 132.679 4.392 . . . . 0.0 113.387 176.853 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -116.07 155.38 48.11 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.98 166.215 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -78.37 -3.63 13.54 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 O-C-N 117.228 -2.038 . . . . 0.0 112.647 -172.923 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 p -81.66 -14.78 56.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.845 2.058 . . . . 0.0 111.694 167.426 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -65.33 122.67 17.67 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.234 2.214 . . . . 0.0 106.918 -179.818 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -85.65 158.09 20.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 172.918 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 21.8 mm -43.19 -43.6 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 O-C-N 118.069 -2.894 . . . . 0.0 113.941 177.438 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.13 -37.09 83.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 125.301 2.476 . . . . 0.0 114.52 176.642 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.58 -34.95 53.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.971 -179.671 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.353 41.0 t -59.48 -44.47 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 118.037 -2.914 . . . . 0.0 108.078 168.829 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -64.71 -38.83 92.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.318 -2.114 . . . . 0.0 113.458 -177.506 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -51.68 66.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 127.136 2.174 . . . . 0.0 113.016 166.569 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -60.15 -26.24 66.14 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 127.929 2.492 . . . . 0.0 113.9 172.602 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.8 mt -86.97 -42.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 120.979 1.718 . . . . 0.0 111.084 171.29 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.44 -24.76 61.08 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.16 1.784 . . . . 0.0 111.797 -175.78 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -52.98 -53.89 43.23 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 130.079 3.352 . . . . 0.0 110.184 165.52 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -85.46 -48.51 8.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 115.855 -2.021 . . . . 0.0 110.503 -170.973 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -110.18 -19.13 13.13 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 128.46 2.704 . . . . 0.0 115.202 -162.409 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.94 -10.57 73.68 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 121.789 3.476 . . . . 0.0 121.789 162.308 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.57 121.13 73.59 Favored Pre-proline 0 N--CA 1.442 -0.839 0 C-N-CA 129.893 3.277 . . . . 0.0 110.384 -163.201 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -63.45 141.89 82.75 Favored 'Trans proline' 0 N--CA 1.452 -0.931 1 C-N-CA 126.152 4.568 . . . . 0.0 113.969 179.596 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.263 50.0 Cg_exo -48.47 -41.65 36.09 Favored 'Trans proline' 0 N--CA 1.448 -1.162 1 C-N-CA 127.759 5.639 . . . . 0.0 117.458 -170.524 . . . . . . . . 3 2 . 1 . 091 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.76 -30.97 40.9 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.524 2.73 . . . . 0.0 107.709 179.908 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -72.12 -3.38 22.85 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.347 2.259 . . . . 0.0 116.233 173.374 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.55 122.77 41.32 Favored 'General case' 0 N--CA 1.446 -0.659 1 C-N-CA 133.736 4.814 . . . . 0.0 110.826 -173.492 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -134.82 137.61 43.48 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 128.324 2.65 . . . . 0.0 105.654 175.431 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.63 112.63 24.29 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 128.129 2.572 . . . . 0.0 108.314 -174.308 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.53 139.52 20.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.45 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.362 59.1 t80 -144.78 92.5 2.29 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 129.693 3.197 . . . . 0.0 109.777 -166.246 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.28 24.79 2.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 121.415 3.857 . . . . 0.0 121.415 176.277 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.58 -12.73 46.99 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 128.293 2.854 . . . . 0.0 114.57 -173.017 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.282 38.9 ttmt -120.07 139.55 52.38 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 126.206 1.768 . . . . 0.0 109.995 -163.698 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 24.3 mt-30 -80.96 130.94 35.27 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.727 2.011 . . . . 0.0 106.315 170.99 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -84.5 136.52 33.78 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.65 177.891 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.33 144.05 36.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 125.743 2.687 . . . . 0.0 106.988 -171.487 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -87.52 145.83 26.07 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.072 -2.892 . . . . 0.0 110.004 -166.629 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.23 -21.56 37.2 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 124.173 1.985 . . . . 0.0 113.909 -175.002 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -89.7 -177.08 5.18 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -162.451 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 p -107.47 168.07 9.49 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.96 171.737 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.74 -24.4 62.61 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 128.568 2.747 . . . . 0.0 109.381 165.831 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 m -75.54 -15.22 60.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.165 -1.834 . . . . 0.0 112.995 177.137 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.35 -36.53 71.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.348 1.859 . . . . 0.0 111.27 -177.065 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -100.18 -9.77 22.13 Favored 'General case' 0 N--CA 1.442 -0.857 1 C-N-CA 135.133 5.373 . . . . 0.0 110.692 -176.97 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.487 13.6 t30 82.86 18.25 0.28 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 119.685 3.217 . . . . 0.0 119.685 177.291 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mt -72.16 121.53 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.329 1.851 . . . . 0.0 107.193 -172.786 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -122.58 177.69 5.32 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 128.697 2.799 . . . . 0.0 112.027 170.734 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -46.11 136.9 6.42 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 130.732 3.613 . . . . 0.0 111.075 -164.462 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.434 2.8 tt0 85.41 15.69 0.15 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 113.935 -2.936 . . . . 0.0 114.558 170.416 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 t -93.58 133.5 36.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 130.589 3.555 . . . . 0.0 110.76 -179.573 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.4 p -92.89 135.69 33.91 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 174.526 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.515 HD13 HD12 ' A' ' 3' ' ' ILE . 6.1 mp -115.51 -176.24 2.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 164.756 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -138.6 139.75 38.71 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 128.025 2.53 . . . . 0.0 107.014 179.269 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.1 tt -111.35 123.39 50.12 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 124.466 1.104 . . . . 0.0 108.341 -174.676 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 m -124.5 137.44 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.472 -179.112 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.259 5.0 mt . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 102.687 -3.079 . . . . 0.0 102.687 -172.613 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -105.89 140.74 38.45 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.206 -2.183 . . . . 0.0 110.025 -160.046 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.8 pt -139.67 160.67 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 128.167 2.587 . . . . 0.0 108.596 178.517 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -108.93 159.45 16.8 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.468 1.907 . . . . 0.0 106.296 175.578 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.92 150.69 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 158.513 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -87.26 149.76 24.35 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.966 2.906 . . . . 0.0 114.568 155.89 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.256 9.0 t -138.24 151.93 48.12 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.959 1.304 . . . . 0.0 108.315 173.171 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.282 4.8 tp -70.44 0.04 7.41 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 127.98 2.512 . . . . 0.0 116.191 -163.679 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.0 p -85.43 -20.07 30.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.418 -2.676 . . . . 0.0 109.738 165.61 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.63 -6.21 26.18 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 129.082 3.229 . . . . 0.0 117.804 176.884 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.82 157.46 27.68 Favored 'General case' 0 C--O 1.235 0.318 1 O-C-N 132.577 5.516 . . . . 0.0 111.812 179.269 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.554 36.1 p -123.35 107.21 11.39 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 129.04 2.936 . . . . 0.0 114.088 -177.351 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 mt -104.99 136.21 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 130.042 3.337 . . . . 0.0 108.127 -171.128 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 t -108.25 121.34 44.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.865 3.266 . . . . 0.0 106.516 -178.621 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -110.95 156.02 21.82 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 129.003 2.921 . . . . 0.0 110.736 -176.15 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -118.61 116.75 27.27 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 130.831 3.653 . . . . 0.0 108.562 174.683 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -136.81 166.55 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 131.198 3.799 . . . . 0.0 110.323 -169.944 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -125.44 159.62 59.39 Favored Pre-proline 0 C--N 1.322 -0.629 0 O-C-N 118.907 -2.371 . . . . 0.0 105.993 161.828 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.42 -46.03 28.15 Favored 'Trans proline' 0 N--CA 1.452 -0.943 1 C-N-CA 125.353 4.036 . . . . 0.0 118.759 175.5 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 p -69.77 1.74 4.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 176.884 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.71 134.62 45.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 116.104 -1.903 . . . . 0.0 114.838 179.533 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.4 p -83.37 148.75 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 123.687 2.949 . . . . 0.0 112.467 -179.406 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -50.01 -37.27 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 126.258 1.823 . . . . 0.0 113.826 178.356 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.18 -39.48 79.02 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 121.201 1.819 . . . . 0.0 114.258 170.221 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -68.78 -36.46 78.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 126.821 2.576 . . . . 0.0 109.777 172.611 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.03 -57.18 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 121.383 1.902 . . . . 0.0 106.723 173.107 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.294 86.7 mttt -38.55 -40.65 0.6 Allowed 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 130.495 3.518 . . . . 0.0 116.809 171.661 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.48 -20.64 33.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.188 -2.278 . . . . 0.0 111.28 -175.006 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -87.58 -14.21 40.77 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.942 1.297 . . . . 0.0 109.777 176.881 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.31 -51.79 22.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 126.418 1.887 . . . . 0.0 107.904 162.407 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -65.4 -25.64 67.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 131.107 3.763 . . . . 0.0 109.567 -175.928 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.4 -46.1 62.74 Favored 'General case' 0 CA--C 1.533 0.307 1 C-N-CA 132.103 4.161 . . . . 0.0 113.514 170.023 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -114.16 -32.17 6.09 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 127.556 3.035 . . . . 0.0 114.798 -174.309 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -91.91 -33.28 14.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -179.291 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.18 11.32 64.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 113.583 -3.898 . . . . 0.0 113.398 171.375 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -92.15 139.31 24.25 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 100.975 -3.713 . . . . 0.0 100.975 -172.046 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.93 160.39 21.09 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 120.67 0.914 . . . . 0.0 112.552 -173.787 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.26 56.7 Cg_endo -57.9 -40.89 74.55 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 N-CA-C 117.895 2.229 . . . . 0.0 117.895 -170.868 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.92 -11.07 60.59 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.141 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -93.68 -17.43 23.24 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 172.265 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -89.39 143.13 27.06 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 123.21 1.481 . . . . 0.0 109.09 -174.644 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.26 96.29 2.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 -171.551 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.76 131.57 46.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 115.779 -2.058 . . . . 0.0 107.463 -169.389 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.48 145.21 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 129.762 3.225 . . . . 0.0 110.689 -174.424 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -128.47 -169.03 2.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.887 3.275 . . . . 0.0 110.291 179.456 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.59 49.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.481 2 C-N-CA 132.558 4.343 . . . . 0.0 121.941 -177.055 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.11 -12.97 19.55 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 127.305 2.383 . . . . 0.0 109.063 -179.403 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.403 85.4 mttt -109.29 126.41 53.33 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.346 2.258 . . . . 0.0 116.171 -176.62 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -85.19 129.53 34.79 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 130.36 3.464 . . . . 0.0 106.512 167.867 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.423 HD11 HD22 ' A' ' 67' ' ' LEU . 69.6 mt -107.19 127.76 53.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 111.799 -3.953 . . . . 0.0 106.165 -162.349 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -104.21 137.0 42.77 Favored 'General case' 0 C--N 1.324 -0.52 1 O-C-N 130.847 5.092 . . . . 0.0 110.54 -173.084 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.344 1.2 m-20 -27.91 -45.9 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.408 2 N-CA-C 123.723 4.712 . . . . 0.0 123.723 173.983 . . . . . . . . 3 2 . 1 . 092 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.84 33.94 4.56 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 117.545 -3.222 . . . . 0.0 111.681 -169.828 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -122.03 162.82 20.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.841 2.857 . . . . 0.0 105.595 165.169 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -85.17 158.24 20.43 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.553 2.341 . . . . 0.0 114.762 178.069 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.4 mt -57.76 -28.36 63.88 Favored 'General case' 0 C--N 1.326 -0.447 1 O-C-N 114.569 -5.082 . . . . 0.0 114.963 165.269 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.412 0.2 OUTLIER -61.16 -39.63 90.82 Favored 'General case' 0 N--CA 1.448 -0.546 1 C-N-CA 132.125 4.17 . . . . 0.0 113.848 163.87 . . . . . . . . 4 3 . 1 . 092 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -69.43 -11.12 60.56 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 118.269 -2.77 . . . . 0.0 111.434 170.796 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -110.41 5.92 21.83 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 114.149 -2.834 . . . . 0.0 114.753 164.105 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.347 3.9 p-10 34.76 58.27 0.71 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.182 2.993 . . . . 0.0 112.732 -171.113 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mm -67.56 131.62 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 131.674 3.99 . . . . 0.0 111.967 174.986 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.388 26.9 mt-30 -102.6 152.46 21.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 127.266 2.226 . . . . 0.0 108.098 -179.678 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -48.97 150.62 1.48 Allowed 'General case' 0 C--N 1.325 -0.492 1 O-C-N 115.444 -4.535 . . . . 0.0 116.247 176.132 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.319 7.6 tt0 70.84 8.56 6.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.768 2.827 . . . . 0.0 116.237 176.495 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 m -63.31 138.69 58.62 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.682 1.593 . . . . 0.0 108.531 178.248 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.268 16.6 m -103.82 138.84 39.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 118.567 -2.583 . . . . 0.0 104.741 165.316 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.423 HD22 HD11 ' A' ' 50' ' ' LEU . 68.6 mt -95.78 148.1 22.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 130.404 3.482 . . . . 0.0 105.506 175.609 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -88.68 125.7 34.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 117.075 -3.516 . . . . 0.0 110.767 168.401 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tt -121.02 133.4 55.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 118.359 -2.713 . . . . 0.0 104.978 -171.609 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -132.34 -173.92 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.918 1.287 . . . . 0.0 112.48 163.583 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.3 tp . . . . . 0 N--CA 1.445 -0.7 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.912 168.819 . . . . . . . . 0 0 . 1 . 093 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 ttp . . . . . 0 CA--C 1.537 0.472 1 N-CA-C 99.49 -4.263 . . . . 0.0 99.49 . . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -96.99 137.44 36.07 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 123.786 2.993 . . . . 0.0 107.226 164.794 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -107.49 170.3 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 129.817 3.247 . . . . 0.0 110.74 161.21 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -116.9 156.82 26.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 118.305 -2.747 . . . . 0.0 106.704 152.326 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.81 133.79 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 1 C-N-CA 132.517 4.327 . . . . 0.0 102.722 156.713 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -122.36 122.83 39.95 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -179.848 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 99.9 m -83.77 124.82 31.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 160.284 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.264 0.0 OUTLIER -63.2 -8.69 8.68 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 119.596 3.184 . . . . 0.0 119.596 -162.839 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -84.85 -3.6 58.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.349 2.26 . . . . 0.0 112.331 -179.529 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 32.93 0.78 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 123.396 1.553 . . . . 0.0 115.017 154.249 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -128.36 123.28 33.5 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.09 2.156 . . . . 0.0 109.964 -171.965 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 m -113.21 127.85 56.3 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.493 1.117 . . . . 0.0 108.3 -178.727 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.66 133.46 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 127.311 2.245 . . . . 0.0 106.15 164.161 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -109.66 125.42 52.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.859 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.1 tp -133.94 139.81 46.38 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.273 -0.892 . . . . 0.0 111.725 -178.171 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.7 mp0 -95.93 116.57 29.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 131.46 3.904 . . . . 0.0 102.266 179.508 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -146.66 159.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 114.507 -2.664 . . . . 0.0 105.053 -163.141 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -111.63 145.94 33.67 Favored Pre-proline 0 N--CA 1.452 -0.349 0 O-C-N 128.747 3.78 . . . . 0.0 108.024 171.925 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.88 -29.23 14.69 Favored 'Trans proline' 0 N--CA 1.452 -0.958 1 C-N-CA 129.97 7.113 . . . . 0.0 115.687 -178.59 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t -90.16 6.9 40.67 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 117.849 -3.032 . . . . 0.0 116.109 -179.758 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -78.72 149.5 32.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.332 -1.318 . . . . 0.0 110.78 -175.436 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.9 p -87.45 155.27 20.09 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 124.67 2.176 . . . . 0.0 111.089 -175.875 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.66 -27.43 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 173.379 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -85.54 -38.35 18.62 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -168.733 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -60.75 -38.93 86.83 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 115.707 -2.092 . . . . 0.0 111.379 164.063 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.324 28.2 t -55.99 -58.42 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 123.521 2.873 . . . . 0.0 117.776 167.32 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.313 37.8 ttmt -68.36 -18.01 64.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.338 1.455 . . . . 0.0 114.849 -173.267 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.12 -35.66 21.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 125.182 1.552 . . . . 0.0 111.526 170.219 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -71.56 -24.08 61.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.091 -1.044 . . . . 0.0 113.21 -175.828 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.07 -20.64 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 125.762 1.914 . . . . 0.0 110.392 170.187 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -82.01 -38.99 24.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 116.862 -3.649 . . . . 0.0 107.761 179.564 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.63 -41.5 83.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.687 2.795 . . . . 0.0 111.792 178.605 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -96.69 -22.12 17.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 130.122 3.369 . . . . 0.0 112.945 -169.565 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.492 2.3 mm-40 -136.83 -23.02 1.2 Allowed 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 118.69 -2.506 . . . . 0.0 112.228 -169.235 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.39 1.9 40.96 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 165.558 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.21 125.68 33.66 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 114.915 -2.469 . . . . 0.0 108.192 -170.522 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.07 149.09 76.64 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.906 3.071 . . . . 0.0 114.991 175.972 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.39 -38.27 54.5 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 O-C-N 126.292 2.733 . . . . 0.0 113.545 179.726 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -41.91 -42.25 2.7 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 173.226 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -94.62 -2.29 51.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 131.242 3.817 . . . . 0.0 115.062 -179.488 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -111.18 114.83 28.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.029 -3.544 . . . . 0.0 104.858 -162.627 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 ttm105 -102.24 128.47 48.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 128.607 2.763 . . . . 0.0 109.242 165.765 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 mt -115.51 137.24 52.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 111.65 -2.523 . . . . 0.0 105.8 -177.042 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.6 mt -115.22 129.43 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 128.421 2.688 . . . . 0.0 109.025 -174.521 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -132.47 134.07 44.6 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 115.231 -2.587 . . . . 0.0 111.202 156.632 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.28 0.2 3.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 172.913 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.22 -11.69 19.7 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 129.887 3.613 . . . . 0.0 108.13 -175.367 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -95.8 125.57 40.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 126.001 1.648 . . . . 0.0 110.318 -174.34 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.17 111.24 1.88 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.383 2.273 . . . . 0.0 108.115 167.866 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.254 45.6 mt -87.09 131.3 34.17 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 115.035 -2.666 . . . . 0.0 113.549 -167.715 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -119.39 156.47 30.06 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 129.96 3.304 . . . . 0.0 110.097 -179.035 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.66 142.38 35.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 130.482 3.513 . . . . 0.0 113.146 177.306 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.02 -25.61 7.82 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 126.917 2.636 . . . . 0.0 113.272 -159.231 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -121.77 133.88 54.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.435 1.894 . . . . 0.0 106.22 176.042 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.5 p -81.26 -175.31 5.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 123.86 1.79 . . . . 0.0 113.837 172.305 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.2 -38.31 90.58 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 118.532 -2.605 . . . . 0.0 110.656 176.082 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 m -63.9 -47.21 81.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 171.23 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -47.03 -39.02 11.9 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 117.11 -3.494 . . . . 0.0 117.1 166.539 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -91.12 -3.81 56.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 123.283 2.765 . . . . 0.0 117.861 170.24 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 48.0 m-80 81.92 38.29 0.06 Allowed 'General case' 0 N--CA 1.445 -0.721 1 C-N-CA 133.933 4.893 . . . . 0.0 113.082 170.846 . . . . . . . . 3 2 . 1 . 093 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.5 mt -91.29 142.65 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 -167.481 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -138.66 -169.66 2.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.436 -154.474 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -59.54 124.79 21.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.377 1.071 . . . . 0.0 111.248 173.042 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 70.96 8.98 6.69 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.297 -2.752 . . . . 0.0 115.185 172.496 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -85.29 148.0 26.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 116.953 -3.592 . . . . 0.0 106.402 -171.39 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.4 m -122.94 124.33 42.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 -173.27 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.01 141.32 28.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 130.793 3.637 . . . . 0.0 104.708 178.487 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.28 58.2 m80 -101.65 115.6 30.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 113.693 -3.051 . . . . 0.0 107.498 -177.607 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 70' ' ' VAL . 4.5 tt -90.29 125.16 35.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 171.057 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.471 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -125.78 104.57 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.102 -0.999 . . . . 0.0 112.695 170.17 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.296 56.4 tp . . . . . 0 N--CA 1.448 -0.547 1 O-C-N 114.282 -5.262 . . . . 0.0 111.49 -170.12 . . . . . . . . 2 1 . 1 . 094 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 123.335 1.54 . . . . 0.0 107.203 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.257 20.9 mt-30 -104.34 149.5 25.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 111.965 -2.38 . . . . 0.0 109.59 174.527 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 pt -137.33 156.03 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 126.092 2.12 . . . . 0.0 110.056 170.727 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -107.25 132.29 53.25 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.396 172.7 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.42 116.86 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 128.406 2.682 . . . . 0.0 112.95 175.159 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -92.83 138.69 31.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.942 1.829 . . . . 0.0 108.939 -179.055 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -88.61 167.4 13.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 108.623 -3.899 . . . . 0.0 108.955 177.33 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.4 pt? -69.34 -23.46 63.78 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 119.127 -2.233 . . . . 0.0 113.189 160.991 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -90.1 -13.81 35.02 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 115.951 -1.976 . . . . 0.0 113.806 -175.343 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.37 -0.26 8.78 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 121.423 1.919 . . . . 0.0 113.042 163.695 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -92.62 149.64 21.21 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.051 1.425 . . . . 0.0 110.592 177.522 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -106.47 115.85 30.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 130.767 3.627 . . . . 0.0 104.513 165.442 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.0 mt -97.45 140.22 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 1 N-CA-C 97.95 -4.833 . . . . 0.0 97.95 177.858 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.3 m -101.41 98.73 9.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -179.639 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.09 156.12 18.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 117.409 -3.307 . . . . 0.0 109.445 175.001 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -121.16 119.87 33.62 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 130.742 3.617 . . . . 0.0 108.722 172.864 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 m -152.68 154.87 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 129.591 3.156 . . . . 0.0 104.887 175.545 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.351 76.0 mm-40 -100.41 166.73 12.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 111.348 -2.66 . . . . 0.0 112.371 174.279 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.288 2.6 Cg_exo -49.67 -34.02 33.65 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.043 3.162 . . . . 0.0 119.669 -178.848 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -85.91 -5.57 59.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 119.35 -2.094 . . . . 0.0 112.688 -172.814 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.395 65.7 m-20 -85.13 142.72 29.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 125.097 1.498 . . . . 0.0 109.092 -167.348 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.3 p -79.03 161.19 26.76 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 115.599 -2.143 . . . . 0.0 109.894 175.989 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.8 mm -42.22 -34.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 130.468 3.507 . . . . 0.0 111.172 165.499 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -66.75 -21.65 66.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 124.308 3.231 . . . . 0.0 111.908 -174.876 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -72.13 -52.01 18.68 Favored 'General case' 0 N--CA 1.44 -0.938 1 C-N-CA 131.809 4.044 . . . . 0.0 114.768 169.13 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.9 t -53.46 -59.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 126.428 1.891 . . . . 0.0 111.563 174.37 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -56.03 -33.71 65.19 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 127.455 2.972 . . . . 0.0 107.98 -179.855 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.76 -39.19 57.52 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 124.08 3.127 . . . . 0.0 118.665 -175.904 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -63.7 -40.3 96.45 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.644 1.978 . . . . 0.0 114.795 162.338 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.1 mt -59.21 -42.99 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 116.626 -1.654 . . . . 0.0 109.246 174.917 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -44.96 91.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 128.984 3.927 . . . . 0.0 113.976 171.977 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.41 -19.21 60.5 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 121.323 1.874 . . . . 0.0 112.594 -175.514 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -98.91 -53.08 3.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.084 1.754 . . . . 0.0 111.135 -166.885 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.254 36.5 tp10 -112.91 -3.48 14.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.846 -173.773 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.76 28.62 20.9 Favored Glycine 0 CA--C 1.527 0.829 1 CA-C-O 128.371 4.317 . . . . 0.0 115.093 163.836 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -105.22 118.0 56.99 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 109.983 -3.108 . . . . 0.0 111.675 -165.437 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -72.73 133.01 19.51 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 CA-C-O 111.724 -3.532 . . . . 0.0 112.692 -175.725 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -74.76 -19.62 18.3 Favored 'Trans proline' 0 N--CA 1.448 -1.169 1 O-C-N 130.087 4.73 . . . . 0.0 112.202 -163.167 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -82.46 -14.6 54.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 121.852 2.115 . . . . 0.0 108.306 177.139 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.45 -15.33 35.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.356 2.262 . . . . 0.0 109.485 178.385 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -88.18 154.94 20.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 120.64 1.564 . . . . 0.0 110.994 -177.837 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.445 ' C ' HD12 ' A' ' 43' ' ' LEU . 12.3 ttm180 -148.22 122.95 9.9 Favored 'General case' 0 C--N 1.324 -0.521 1 C-N-CA 132.985 4.514 . . . . 0.0 104.149 -175.028 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.445 HD12 ' C ' ' A' ' 42' ' ' ARG . 3.7 mp -122.13 131.59 54.04 Favored 'General case' 0 N--CA 1.446 -0.664 1 C-N-CA 132.281 4.232 . . . . 0.0 114.109 -165.231 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.421 1.8 tt -134.63 144.66 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 126.315 2.26 . . . . 0.0 111.851 -172.309 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -156.34 142.45 18.15 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 126.552 3.072 . . . . 0.0 104.007 165.018 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 29.37 2.88 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 109.33 -3.577 . . . . 0.0 118.08 175.394 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.41 -17.67 36.61 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 127.149 2.78 . . . . 0.0 113.68 175.572 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -103.27 120.04 40.01 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 130.921 3.689 . . . . 0.0 110.979 -168.871 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -72.74 135.4 45.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.243 1.417 . . . . 0.0 107.23 164.873 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.1 mt -92.61 121.09 33.69 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.877 -163.266 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -81.5 124.8 29.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 125.729 1.893 . . . . 0.0 108.187 -169.497 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.76 108.22 2.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.271 3.028 . . . . 0.0 111.144 173.448 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.75 4.65 12.85 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 126.205 2.19 . . . . 0.0 115.615 177.2 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -105.89 144.84 32.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 116.47 -3.959 . . . . 0.0 109.92 168.418 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.6 p -84.79 145.07 28.07 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 127.123 2.764 . . . . 0.0 112.155 176.059 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 tp -41.71 -48.7 4.22 Favored 'General case' 0 N--CA 1.448 -0.538 1 C-N-CA 131.905 4.082 . . . . 0.0 109.149 179.537 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -54.25 -31.85 54.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 130.852 3.661 . . . . 0.0 113.171 176.349 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -67.53 -32.33 73.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.81 0.844 . . . . 0.0 112.955 177.139 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -88.46 -7.23 56.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 115.572 -2.156 . . . . 0.0 109.534 175.385 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 51.17 40.14 25.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 125.914 3.961 . . . . 0.0 112.971 -178.121 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.97 134.48 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.538 -2.119 . . . . 0.0 105.426 166.937 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -119.57 169.62 9.91 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 -173.834 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -49.13 126.37 12.52 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 131.687 3.995 . . . . 0.0 113.493 178.93 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 71.02 5.54 5.52 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 114.649 -2.596 . . . . 0.0 116.608 -178.887 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.5 m -59.3 128.96 39.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 164.78 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -83.22 123.77 29.9 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.337 1.055 . . . . 0.0 110.335 -177.949 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -124.23 156.59 36.56 Favored 'General case' 0 N--CA 1.452 -0.374 1 C-N-CA 134.213 5.005 . . . . 0.0 108.191 -177.549 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -124.49 148.15 47.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 120.835 -1.166 . . . . 0.0 111.934 -168.867 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tp -117.76 127.73 54.19 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.225 2.21 . . . . 0.0 108.855 -174.208 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.594 35.3 m -119.92 165.07 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 129.385 3.074 . . . . 0.0 112.493 169.847 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 71' ' ' LEU . 27.0 mt . . . . . 0 N--CA 1.442 -0.843 0 O-C-N 119.794 -1.816 . . . . 0.0 106.723 175.908 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttp . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -78.59 148.39 33.32 Favored 'General case' 0 C--N 1.324 -0.537 1 O-C-N 115.481 -4.512 . . . . 0.0 110.262 169.598 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 3' ' ' ILE . 37.5 pt -136.88 163.71 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 101.93 -3.359 . . . . 0.0 101.93 164.988 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -121.51 151.2 40.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 124.338 2.018 . . . . 0.0 110.165 -178.34 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 t -127.1 130.02 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 O-C-N 119.156 -2.215 . . . . 0.0 110.58 171.741 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -85.74 167.74 14.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.008 1.723 . . . . 0.0 111.978 157.875 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -126.06 177.2 6.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.728 1.268 . . . . 0.0 111.388 -176.58 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.83 -34.42 78.1 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 115.608 1.706 . . . . 0.0 115.608 174.468 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -63.25 -50.69 69.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.662 2.385 . . . . 0.0 112.45 165.84 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.54 13.54 8.04 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 116.686 -2.174 . . . . 0.0 111.113 168.238 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -69.31 135.4 50.36 Favored 'General case' 0 N--CA 1.451 -0.398 1 C-N-CA 135.718 5.607 . . . . 0.0 102.815 174.254 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 47.6 m -89.28 140.79 29.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 113.928 -1.487 . . . . 0.0 107.785 -174.741 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -116.59 148.92 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 130.16 3.384 . . . . 0.0 106.854 164.111 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 t -134.6 139.59 45.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 128.128 3.393 . . . . 0.0 108.973 170.798 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mt -141.72 160.94 39.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 125.255 2.455 . . . . 0.0 105.759 -171.711 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -109.9 127.04 54.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 125.884 2.754 . . . . 0.0 110.065 162.358 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.6 -178.65 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 131.548 3.939 . . . . 0.0 109.925 -177.107 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 19' ' ' PRO 0.275 6.1 mt-10 -130.89 148.82 71.72 Favored Pre-proline 0 N--CA 1.444 -0.731 0 O-C-N 116.359 -3.963 . . . . 0.0 112.068 168.824 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 72.2 Cg_exo -48.51 -43.98 31.54 Favored 'Trans proline' 0 N--CA 1.453 -0.863 1 C-N-CA 125.488 4.125 . . . . 0.0 118.58 -169.968 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 t -86.29 8.48 21.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.655 -2.066 . . . . 0.0 116.449 -179.587 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.93 154.19 31.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.305 2.253 . . . . 0.0 116.505 173.827 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.305 81.1 p -92.64 149.55 21.26 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 125.128 1.518 . . . . 0.0 108.144 178.346 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.9 mm -45.55 -44.06 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 126.632 1.973 . . . . 0.0 115.874 176.787 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -51.19 -53.97 29.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 128.77 2.828 . . . . 0.0 112.897 173.383 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -63.59 -30.39 71.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.94 1.352 . . . . 0.0 111.846 -172.142 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.47 -40.01 76.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 127.236 2.214 . . . . 0.0 109.778 169.949 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -68.98 -28.0 66.22 Favored 'General case' 0 C--N 1.328 -0.34 1 O-C-N 115.054 -4.779 . . . . 0.0 111.324 -173.797 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -31.86 66.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.576 -1.647 . . . . 0.0 112.536 172.833 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -75.08 -41.02 59.66 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -178.556 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.74 -28.97 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 119.789 1.177 . . . . 0.0 113.026 175.565 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -62.45 -44.62 95.98 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 127.84 2.456 . . . . 0.0 113.111 171.736 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -72.63 -16.55 61.71 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.091 -2.255 . . . . 0.0 113.112 -175.586 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -107.75 -53.47 2.62 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 -172.674 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -112.93 -9.32 13.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 114.471 -2.681 . . . . 0.0 112.232 -173.602 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.21 39.28 72.07 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 115.014 -3.103 . . . . 0.0 113.007 -177.181 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.2 mt -96.16 116.31 66.11 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 178.235 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.67 145.9 65.15 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 N-CA-C 118.422 2.432 . . . . 0.0 118.422 -179.032 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.297 39.7 Cg_endo -70.89 -21.41 28.27 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 125.198 3.932 . . . . 0.0 118.696 -160.045 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.49 -30.95 16.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 123.844 3.02 . . . . 0.0 110.527 -179.036 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -71.14 -37.01 72.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 177.978 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -63.74 125.02 22.96 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 112.67 -3.538 . . . . 0.0 116.487 179.262 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.281 32.4 ttm105 -128.33 121.46 29.25 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 122.872 2.578 . . . . 0.0 108.906 176.235 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.5 132.72 41.78 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 128.049 2.54 . . . . 0.0 107.625 -179.156 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.1 mt -119.87 161.14 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.742 2.017 . . . . 0.0 110.408 167.648 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -158.83 128.6 5.72 Favored 'General case' 0 N--CA 1.449 -0.494 1 N-CA-C 98.241 -4.726 . . . . 0.0 98.241 173.157 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.92 23.34 13.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.455 2.302 . . . . 0.0 113.542 162.369 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.1 0.01 54.64 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 178.03 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -120.78 129.65 53.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -167.643 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -70.77 151.82 44.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 166.221 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.93 113.95 27.37 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 101.601 -3.481 . . . . 0.0 101.601 -179.772 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -101.12 139.42 36.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 125.086 1.491 . . . . 0.0 108.428 -173.564 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -28.8 129.2 0.08 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 129.325 3.05 . . . . 0.0 116.982 167.911 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.49 -11.35 71.63 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 159.687 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -103.68 156.12 18.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.504 1.922 . . . . 0.0 106.435 -178.164 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.7 p -111.81 149.83 31.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.964 2.506 . . . . 0.0 115.778 -164.577 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.4 mt -60.81 -46.35 90.85 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 112.72 -2.037 . . . . 0.0 114.871 -164.974 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -75.8 -33.31 60.12 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.462 -171.165 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.54 -31.85 71.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 112.881 -3.438 . . . . 0.0 118.817 166.32 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -73.54 -21.92 60.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 127.916 3.26 . . . . 0.0 112.486 164.789 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t30 89.58 45.04 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.446 2 C-N-CA 134.076 4.951 . . . . 0.0 107.895 175.558 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mm -79.36 145.87 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 118.027 -2.921 . . . . 0.0 104.564 172.63 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -132.76 -178.48 4.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 121.946 2.157 . . . . 0.0 106.742 178.347 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -72.87 112.8 9.23 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 130.793 3.637 . . . . 0.0 109.036 -171.784 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 75.85 31.82 0.69 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 130.236 3.414 . . . . 0.0 111.95 -172.937 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -70.5 140.75 51.94 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 115.97 -1.967 . . . . 0.0 112.008 166.581 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.8 m -102.37 129.89 48.97 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -179.218 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.71 154.2 31.01 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.893 3.277 . . . . 0.0 108.46 -177.993 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.268 20.8 t-160 -109.04 118.28 36.38 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.013 0.925 . . . . 0.0 109.877 -171.256 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tt -93.83 127.75 39.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.224 1.81 . . . . 0.0 109.248 173.498 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.34 138.59 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 1 O-C-N 129.103 4.002 . . . . 0.0 104.039 162.399 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 tt . . . . . 0 N--CA 1.448 -0.566 0 O-C-N 118.639 -2.538 . . . . 0.0 109.669 167.339 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 C--O 1.236 0.381 0 N-CA-C 110.88 -0.044 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.49 133.91 51.29 Favored 'General case' 0 N--CA 1.448 -0.54 1 C-N-CA 131.997 4.119 . . . . 0.0 108.242 -179.029 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.286 0.9 OUTLIER -129.93 169.9 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 117.217 -1.373 . . . . 0.0 112.114 163.701 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -110.03 152.16 26.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 125.139 3.609 . . . . 0.0 105.632 172.149 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.292 2.6 t -135.34 113.88 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 128.883 2.873 . . . . 0.0 107.148 172.1 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -97.31 126.04 42.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 129.931 3.292 . . . . 0.0 106.137 -177.789 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.0 p -86.41 178.03 7.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.247 1.819 . . . . 0.0 114.117 160.54 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -79.03 -33.8 44.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 117.144 -1.408 . . . . 0.0 110.696 -169.904 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -93.18 0.99 57.31 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -178.873 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.42 -8.31 5.92 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 126.53 2.014 . . . . 0.0 111.188 151.97 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -71.04 110.55 5.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -171.717 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -87.35 113.34 22.98 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 101.728 -3.434 . . . . 0.0 101.728 172.927 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.0 mt -86.34 126.69 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 N-CA-C 99.625 -4.213 . . . . 0.0 99.625 166.905 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.5 m -99.82 109.06 21.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 129.339 3.056 . . . . 0.0 105.16 173.891 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 tp -105.39 135.23 47.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -161.688 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 17' ' ' VAL 0.285 31.1 tt0 -86.12 134.71 33.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 110.823 -2.899 . . . . 0.0 113.142 160.351 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -148.2 164.44 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 123.807 1.765 . . . . 0.0 107.672 174.278 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -95.69 160.01 31.24 Favored Pre-proline 0 N--CA 1.444 -0.729 2 C-N-CA 133.018 4.527 . . . . 0.0 109.884 145.825 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.89 -25.16 74.29 Favored 'Trans proline' 0 N--CA 1.45 -1.03 1 C-N-CA 125.715 4.277 . . . . 0.0 113.487 -173.657 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -83.03 -11.03 58.43 Favored 'General case' 0 N--CA 1.444 -0.747 1 C-N-CA 137.275 6.23 . . . . 0.0 110.214 -175.175 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.03 114.7 8.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.734 2.014 . . . . 0.0 107.438 160.18 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.253 71.3 p -89.57 -162.54 0.89 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 115.793 -2.051 . . . . 0.0 114.857 -170.725 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.4 mm -60.9 -33.9 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 122.722 2.51 . . . . 0.0 113.811 172.262 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -78.56 -45.68 21.24 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 129.47 3.108 . . . . 0.0 114.801 174.466 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -67.6 -25.24 65.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 113.759 -3.176 . . . . 0.0 112.577 -179.517 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.5 t -57.5 -58.05 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.712 2.405 . . . . 0.0 116.841 157.06 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -58.51 -26.13 63.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 174.82 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.33 -37.81 43.69 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 127.078 3.323 . . . . 0.0 117.409 170.979 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -60.11 -39.18 85.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 117.092 -3.505 . . . . 0.0 113.635 164.249 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.0 mt -53.42 -47.91 58.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 129.166 2.986 . . . . 0.0 111.569 172.678 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -60.94 -50.57 72.86 Favored 'General case' 0 N--CA 1.45 -0.446 1 C-N-CA 132.121 4.169 . . . . 0.0 109.819 177.39 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.0 -48.05 61.47 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 171.364 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -84.82 -52.83 5.75 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 115.788 -2.053 . . . . 0.0 112.868 -171.988 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -123.4 -2.85 8.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 122.041 2.2 . . . . 0.0 110.237 -155.502 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.17 7.89 67.26 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.901 1.715 . . . . 0.0 112.328 163.104 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -73.27 124.18 90.28 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 129.347 3.059 . . . . 0.0 106.675 -170.589 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.76 110.51 1.63 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 125.002 3.802 . . . . 0.0 113.16 173.425 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.36 -15.06 12.8 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 N-CA-C 118.754 2.559 . . . . 0.0 118.754 -167.898 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.365 0.0 OUTLIER -25.54 -35.26 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 130.697 3.599 . . . . 0.0 120.252 174.778 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -126.79 25.41 6.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.502 1.921 . . . . 0.0 111.21 -165.837 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -131.24 126.88 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.272 1.829 . . . . 0.0 111.096 -168.634 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -123.68 157.56 33.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 109.586 -3.461 . . . . 0.0 109.701 176.455 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.11 138.59 53.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 114.133 -2.841 . . . . 0.0 108.659 -166.253 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mm -110.04 148.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 127.952 3.283 . . . . 0.0 115.568 165.272 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -149.24 125.64 10.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 114.687 -2.578 . . . . 0.0 105.519 166.565 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.57 15.24 10.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 130.471 3.508 . . . . 0.0 113.539 172.637 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.47 -34.93 5.38 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 128.654 3.026 . . . . 0.0 108.737 -169.425 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -78.11 136.02 37.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 122.133 2.967 . . . . 0.0 108.339 -156.946 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -80.27 106.13 12.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 113.611 -3.09 . . . . 0.0 113.31 164.572 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.3 136.96 57.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 128.098 3.374 . . . . 0.0 115.155 -178.014 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -91.98 116.07 28.6 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.166 2.186 . . . . 0.0 105.106 -165.43 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.49 116.27 3.86 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 115.298 -2.287 . . . . 0.0 112.607 -177.271 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.28 3.96 7.85 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 129.908 3.623 . . . . 0.0 112.896 -178.331 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -109.36 159.13 17.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 122.008 2.904 . . . . 0.0 108.93 -170.932 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.6 p -90.6 173.13 8.22 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 129.859 3.264 . . . . 0.0 110.551 176.981 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.78 -18.09 59.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.197 -0.939 . . . . 0.0 110.591 173.647 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.0 m -70.05 -20.52 63.23 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.43 -1.419 . . . . 0.0 112.841 177.367 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -86.12 -6.29 59.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.485 2.714 . . . . 0.0 112.154 -177.073 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -130.44 -7.21 4.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 114.495 -2.669 . . . . 0.0 113.196 178.954 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.1 t30 57.05 51.07 10.97 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 127.084 2.74 . . . . 0.0 112.733 178.807 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.46 125.86 62.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 -178.417 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -114.09 -166.66 1.12 Allowed 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 112.284 -2.235 . . . . 0.0 108.502 177.88 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -65.25 149.74 49.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 129.116 2.966 . . . . 0.0 112.219 -170.004 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.542 12.6 pt-20 73.45 16.89 3.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.541 170.056 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 m -84.26 155.65 22.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.221 1.808 . . . . 0.0 111.173 -177.015 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.9 m -116.78 137.47 52.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.798 -2.439 . . . . 0.0 111.884 174.576 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -105.0 149.53 25.69 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 156.224 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -102.97 133.58 47.84 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 169.338 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 70' ' ' VAL 0.351 1.8 tm? -96.97 144.88 26.45 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 115.142 -2.361 . . . . 0.0 111.458 -178.23 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.429 ' N ' HD13 ' A' ' 69' ' ' LEU . 48.6 t -127.83 133.14 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 128.696 2.798 . . . . 0.0 107.567 179.074 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mp . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 130.289 3.435 . . . . 0.0 107.745 173.207 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.252 9.2 tpp . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 124.011 1.862 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.348 4.9 tt0 -85.54 156.85 20.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 118.203 -2.811 . . . . 0.0 115.284 177.089 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 3' ' ' ILE 0.332 17.1 pt -133.06 134.9 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 117.067 -3.521 . . . . 0.0 106.799 162.349 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -94.13 144.55 25.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.583 166.116 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.416 HG11 HD12 ' A' ' 30' ' ' ILE . 3.8 t -128.3 133.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 127.403 2.281 . . . . 0.0 106.368 -179.975 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -133.11 145.87 51.11 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 -176.076 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -129.23 -90.75 0.48 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 116.353 -1.784 . . . . 0.0 110.704 159.847 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -142.54 -42.44 0.32 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 128.239 2.616 . . . . 0.0 114.282 169.088 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.57 114.02 21.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.116 1.366 . . . . 0.0 108.232 174.721 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.12 142.37 10.52 Favored Glycine 0 CA--C 1.536 1.392 0 N-CA-C 106.69 -2.564 . . . . 0.0 106.69 -169.426 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -54.51 -67.37 0.27 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.967 2.107 . . . . 0.0 110.267 156.402 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 p -155.57 174.53 15.14 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.916 2.486 . . . . 0.0 106.575 178.674 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.09 144.4 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 C-N-CA 127.226 2.21 . . . . 0.0 105.297 164.418 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.8 p -104.53 129.11 52.6 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.337 1.455 . . . . 0.0 112.352 -175.32 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 mt -123.42 145.98 48.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 117.349 -3.344 . . . . 0.0 108.024 176.681 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.03 121.17 37.49 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 126.132 2.145 . . . . 0.0 110.073 162.602 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -122.5 -161.6 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 O-C-N 120.223 -1.548 . . . . 0.0 112.936 -178.693 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.278 4.3 tm-20 -142.52 147.78 44.29 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 164.244 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -65.47 -21.56 60.18 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 CA-C-O 115.124 -2.115 . . . . 0.0 115.328 -178.642 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.75 14.81 6.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 120.798 1.635 . . . . 0.0 114.449 173.548 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -75.09 121.68 22.41 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 127.496 2.318 . . . . 0.0 107.124 167.233 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.8 p -66.6 155.28 38.25 Favored 'General case' 0 N--CA 1.449 -0.491 1 O-C-N 129.17 4.044 . . . . 0.0 109.028 160.782 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 80.5 mt -68.04 -27.94 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 124.249 1.976 . . . . 0.0 111.917 178.736 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -47.15 -41.39 17.59 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 112.741 -2.027 . . . . 0.0 111.689 170.517 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -75.15 -38.48 60.96 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.236 1.414 . . . . 0.0 112.351 178.56 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.71 -31.28 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 126.448 2.343 . . . . 0.0 112.712 179.03 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -51.94 -37.4 52.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 173.053 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.312 . . -79.2 -32.01 43.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 125.739 2.685 . . . . 0.0 111.163 -176.144 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -56.04 -53.09 61.14 Favored 'General case' 0 N--CA 1.452 -0.372 1 O-C-N 115.686 -4.384 . . . . 0.0 112.371 164.2 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.637 ' CG2' HD12 ' A' ' 36' ' ' ILE . 46.2 mm -59.27 -39.54 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 119.576 -1.952 . . . . 0.0 109.82 -178.301 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -51.95 -49.34 63.37 Favored 'General case' 0 N--CA 1.452 -0.34 1 N-CA-C 122.622 4.304 . . . . 0.0 122.622 161.899 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.09 -34.91 74.11 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 170.685 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.31 -23.98 14.99 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.881 1.672 . . . . 0.0 114.437 -174.869 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -143.09 -12.43 0.73 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 124.812 2.244 . . . . 0.0 115.252 -165.954 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.81 -17.4 32.82 Favored Glycine 0 CA--C 1.536 1.373 1 O-C-N 115.282 -4.636 . . . . 0.0 114.137 159.715 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.637 HD12 ' CG2' ' A' ' 30' ' ' ILE . 2.4 mt -74.32 126.31 89.09 Favored Pre-proline 0 N--CA 1.45 -0.447 0 O-C-N 120.023 -1.869 . . . . 0.0 112.714 -170.52 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -64.88 141.06 69.57 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 CA-C-O 114.846 -2.231 . . . . 0.0 117.864 173.031 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -43.87 -41.4 11.94 Favored 'Trans proline' 0 N--CA 1.449 -1.111 1 C-N-CA 125.301 4.001 . . . . 0.0 116.98 178.934 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.98 -26.1 59.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.191 2.996 . . . . 0.0 111.471 179.341 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -97.25 -15.29 20.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 127.058 2.143 . . . . 0.0 115.024 -173.761 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -90.58 132.57 35.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -169.728 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -114.24 111.9 22.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 129.23 3.012 . . . . 0.0 109.511 169.111 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -97.36 109.64 22.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.139 -1.601 . . . . 0.0 108.345 -176.855 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mt -119.08 136.66 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 1 N-CA-C 98.267 -4.716 . . . . 0.0 98.267 -174.991 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -168.66 143.16 3.24 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.997 2.519 . . . . 0.0 107.366 173.341 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.303 . . 65.51 27.21 11.69 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.261 2.224 . . . . 0.0 113.208 173.77 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.3 -8.74 59.01 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 129.016 3.198 . . . . 0.0 108.3 163.817 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -129.24 147.01 51.04 Favored 'General case' 0 C--O 1.241 0.641 0 O-C-N 116.928 -3.689 . . . . 0.0 113.194 176.82 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -60.89 104.94 0.41 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.87 3.268 . . . . 0.0 111.79 165.306 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -60.16 144.42 49.95 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -173.082 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -77.36 134.52 38.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 125.188 1.555 . . . . 0.0 110.55 161.988 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.04 -31.76 68.3 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 131.204 3.802 . . . . 0.0 117.587 -166.101 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.83 9.56 56.85 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 126.943 2.652 . . . . 0.0 110.026 -175.286 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 159.29 16.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 123.813 1.768 . . . . 0.0 110.696 162.398 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 37.3 p -102.2 163.96 11.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 111.678 -2.51 . . . . 0.0 109.923 -171.5 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.08 -59.12 4.73 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.213 2.205 . . . . 0.0 108.539 172.642 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 82.3 p -44.2 -46.12 8.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.236 2.614 . . . . 0.0 115.655 171.923 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 55' ' ' THR . 44.6 m-20 -51.38 -34.09 32.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.486 1.514 . . . . 0.0 114.812 173.244 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -104.27 0.01 28.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.559 -1.338 . . . . 0.0 112.555 -175.151 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m120 81.75 23.47 0.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.849 2.059 . . . . 0.0 111.689 -176.056 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.0 mt -84.59 102.89 11.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -174.169 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -70.8 162.3 29.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 172.958 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -42.17 138.31 1.68 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.895 2.078 . . . . 0.0 114.005 155.8 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.257 7.6 mm-40 77.07 17.91 1.55 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 129.028 2.931 . . . . 0.0 111.84 170.302 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -96.44 155.81 16.61 Favored 'General case' 0 CA--C 1.537 0.454 1 CA-C-O 130.108 4.766 . . . . 0.0 109.333 -177.053 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.4 m -96.92 140.84 30.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 110.001 -3.272 . . . . 0.0 106.51 176.704 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.54 162.7 13.89 Favored 'General case' 0 CA--C 1.537 0.465 1 N-CA-C 98.586 -4.598 . . . . 0.0 98.586 157.602 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -120.01 141.79 49.39 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 167.401 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 70' ' ' VAL . 7.5 tp -116.89 148.79 41.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 130.584 3.553 . . . . 0.0 112.808 -172.509 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.523 ' H ' HD12 ' A' ' 69' ' ' LEU . 58.0 t -133.92 130.36 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 130.304 3.441 . . . . 0.0 109.931 -176.294 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--N 1.327 -0.405 0 O-C-N 120.06 -1.65 . . . . 0.0 107.362 164.99 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttp . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -82.78 122.76 28.62 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.387 1.875 . . . . 0.0 113.723 172.452 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -112.52 163.39 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 1 C-N-CA 132.779 4.431 . . . . 0.0 103.914 167.632 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -117.06 153.85 32.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.507 1.523 . . . . 0.0 108.497 168.151 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.97 136.24 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.216 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.365 14.9 ttmt -133.49 151.35 51.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.51 1.924 . . . . 0.0 113.596 172.632 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -110.42 151.01 28.0 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.867 1.317 . . . . 0.0 108.053 178.9 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.311 27.7 mt -61.25 -31.02 70.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.75 -2.469 . . . . 0.0 113.11 179.727 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.1 p -70.49 -3.35 17.41 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 131.466 3.906 . . . . 0.0 114.41 172.107 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.28 29.1 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 124.978 1.424 . . . . 0.0 113.024 153.211 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -62.83 127.25 30.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 118.893 -2.534 . . . . 0.0 111.603 176.966 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 m -116.85 144.41 44.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.511 2.724 . . . . 0.0 107.659 177.522 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.8 tt -146.05 132.8 14.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -175.735 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -70.04 150.27 46.8 Favored 'General case' 0 C--N 1.327 -0.388 1 O-C-N 115.693 -4.38 . . . . 0.0 108.156 166.192 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -133.11 155.62 48.92 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 172.211 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -112.38 129.78 56.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 119.64 -1.913 . . . . 0.0 107.751 172.194 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -146.77 154.81 11.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 130.11 3.364 . . . . 0.0 109.471 -174.346 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -102.11 143.52 26.77 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 171.245 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.53 -16.1 49.85 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.837 3.024 . . . . 0.0 116.214 -173.069 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.5 p -85.6 -7.31 58.92 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 121.586 1.994 . . . . 0.0 116.35 165.126 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -58.61 142.99 47.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 117.575 -3.203 . . . . 0.0 110.345 173.361 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 26' ' ' VAL . 44.7 p -80.11 157.05 26.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.869 2.067 . . . . 0.0 112.193 174.684 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.2 -29.57 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.355 1.462 . . . . 0.0 107.768 -178.143 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -64.72 -48.82 73.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.55 1.14 . . . . 0.0 108.346 172.734 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.35 -37.09 64.53 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 120.273 -1.517 . . . . 0.0 113.798 166.316 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 22' ' ' THR 0.257 3.5 t -64.34 -30.58 50.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 118.904 -2.372 . . . . 0.0 114.808 172.224 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -76.82 -28.34 55.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 168.934 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.34 -36.0 63.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 122.424 1.107 . . . . 0.0 110.398 -179.248 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -68.01 -25.31 65.34 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.183 -1.573 . . . . 0.0 113.108 171.604 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -80.7 -38.04 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 171.562 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -30.51 4.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 116.389 -3.945 . . . . 0.0 111.396 176.922 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -73.8 -29.45 62.17 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.702 1.601 . . . . 0.0 111.969 179.338 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -103.02 -50.99 3.36 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 117.17 -3.457 . . . . 0.0 110.324 -169.12 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -122.25 -2.93 9.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.435 1.894 . . . . 0.0 113.054 -168.345 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.4 -32.16 6.75 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 114.235 -3.536 . . . . 0.0 115.251 155.493 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.5 mt -55.3 128.75 67.5 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 128.729 2.811 . . . . 0.0 110.708 -170.722 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.86 139.99 64.85 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 128.253 5.969 . . . . 0.0 109.213 179.84 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -38.23 -40.99 1.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 1 C-N-CA 130.329 7.353 . . . . 0.0 115.821 176.648 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -61.6 -30.4 70.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 117.773 -3.08 . . . . 0.0 115.348 176.706 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -83.02 -26.65 31.01 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.377 1.444 . . . . 0.0 110.677 -176.738 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.274 77.5 mt-30 -91.37 137.26 32.51 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.966 1.416 . . . . 0.0 109.848 -178.526 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.262 3.8 mtt85 -107.42 146.26 31.91 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 111.208 -2.723 . . . . 0.0 110.773 155.439 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.97 120.5 42.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.868 1.213 . . . . 0.0 108.156 167.174 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.44 146.99 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 125.22 1.575 . . . . 0.0 108.599 -179.041 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -139.86 127.46 21.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.701 2.8 . . . . 0.0 104.078 166.112 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.252 . . 61.73 33.44 17.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 119.804 -1.81 . . . . 0.0 111.948 170.765 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.85 -19.58 11.49 Favored Glycine 0 CA--C 1.538 1.517 0 O-C-N 118.495 -2.628 . . . . 0.0 111.776 -179.662 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -76.98 113.64 14.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 123.571 3.685 . . . . 0.0 107.032 -177.771 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.41 110.73 8.94 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 104.06 -2.57 . . . . 0.0 104.06 162.276 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.6 mt -59.36 129.25 41.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.839 1.656 . . . . 0.0 108.608 168.485 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -92.32 138.95 31.09 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.891 0.876 . . . . 0.0 110.464 -179.998 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -64.73 138.14 58.21 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 125.873 1.983 . . . . 0.0 110.466 -175.306 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.79 -30.81 6.65 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 127.929 2.681 . . . . 0.0 115.989 -175.784 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -91.69 147.93 22.63 Favored 'General case' 0 CA--C 1.535 0.394 1 C-N-CA 132.889 4.475 . . . . 0.0 110.731 -178.209 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 p -102.03 170.49 8.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 125.145 1.528 . . . . 0.0 112.513 -171.438 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -51.88 -42.91 63.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 128.618 3.699 . . . . 0.0 109.196 170.033 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -79.65 -28.16 40.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 120.02 -1.675 . . . . 0.0 114.645 -171.23 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -78.33 -40.06 37.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.045 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -83.07 0.19 46.12 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 117.852 -3.03 . . . . 0.0 109.951 -179.046 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.421 5.2 p-10 46.08 64.52 1.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.391 2.276 . . . . 0.0 113.161 -179.326 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 mm -83.89 -43.99 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 118.563 -1.255 . . . . 0.0 109.875 -166.176 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.415 52.9 mm-40 97.04 153.81 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.689 2.395 . . . . 0.0 111.774 166.747 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.39 131.51 45.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 119.044 -2.285 . . . . 0.0 108.008 177.07 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.282 3.4 mp0 81.41 10.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 127.194 2.809 . . . . 0.0 110.063 166.684 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.8 t -75.2 139.1 42.4 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 130.817 3.647 . . . . 0.0 107.82 172.992 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -100.15 126.72 46.45 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 103.031 -2.952 . . . . 0.0 103.031 -177.302 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 67' ' ' LEU . 2.2 mp -101.11 147.27 26.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.795 164.617 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -88.31 127.23 35.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.209 2.604 . . . . 0.0 107.537 -176.781 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.3 tp -114.22 123.82 50.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 -175.711 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.3 135.59 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -175.617 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 125.228 2.442 . . . . 0.0 106.633 -163.159 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttp . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -79.66 133.93 36.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 173.975 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.9 pt -138.1 171.73 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 169.818 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -115.69 122.11 44.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 118.07 -2.894 . . . . 0.0 113.36 175.625 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -93.72 102.99 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 122.786 2.539 . . . . 0.0 111.193 166.701 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 21.3 tptt -80.49 122.98 27.67 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 128.039 2.535 . . . . 0.0 111.846 165.216 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.8 p -102.99 156.63 17.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.747 -176.256 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.781 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -53.77 -26.19 22.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 130.068 3.347 . . . . 0.0 118.267 -175.946 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -86.78 -10.65 53.07 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 127.245 2.841 . . . . 0.0 112.144 -177.8 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.89 -3.99 57.46 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 130.275 3.798 . . . . 0.0 117.761 -178.992 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -71.69 143.0 49.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 120.147 1.973 . . . . 0.0 111.411 175.402 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 154.17 33.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.002 173.538 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -135.23 143.18 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 129.341 3.056 . . . . 0.0 108.682 -176.826 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -119.73 102.02 8.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.313 179.949 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.2 mt -96.02 170.05 9.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 -177.203 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -121.57 90.94 3.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 123.265 1.507 . . . . 0.0 112.149 167.926 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -99.49 172.5 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 117.595 -3.191 . . . . 0.0 109.912 -177.536 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -131.94 130.8 22.29 Favored Pre-proline 0 N--CA 1.447 -0.624 2 O-C-N 114.672 -5.017 . . . . 0.0 107.223 -164.39 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -42.94 -29.82 1.65 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 1 CA-C-N 129.146 4.302 . . . . 0.0 116.937 167.408 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -75.73 -13.99 60.32 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 129.0 2.92 . . . . 0.0 114.869 176.871 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.463 ' HB2' HD13 ' A' ' 56' ' ' LEU . 66.1 m-20 -79.87 129.29 34.36 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 124.47 2.081 . . . . 0.0 109.989 -170.682 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -73.21 163.04 28.68 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 125.482 2.563 . . . . 0.0 105.57 177.896 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -55.28 -36.23 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 117.82 -3.05 . . . . 0.0 112.631 172.028 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.48 -30.38 69.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 117.494 -3.254 . . . . 0.0 113.346 169.568 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 13.2 m120 -59.82 -43.76 94.37 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 170.63 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -52.74 -50.09 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 O-C-N 127.707 3.13 . . . . 0.0 114.279 174.591 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -54.01 -46.37 71.78 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 129.075 3.984 . . . . 0.0 109.229 172.609 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -63.73 -39.16 93.62 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.827 2.051 . . . . 0.0 115.386 174.252 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -58.23 -41.82 84.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.353 2.261 . . . . 0.0 116.032 165.423 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -67.09 -45.52 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 120.388 -1.445 . . . . 0.0 110.976 176.56 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -45.26 -59.79 2.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 127.51 3.006 . . . . 0.0 111.761 173.099 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -52.42 -34.95 50.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.786 -175.059 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -98.17 -37.57 9.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 126.17 2.168 . . . . 0.0 116.687 -168.682 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -128.3 6.15 5.82 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.291 2.237 . . . . 0.0 116.07 -173.606 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.8 11.51 63.07 Favored Glycine 0 CA--C 1.532 1.142 1 O-C-N 116.178 -4.076 . . . . 0.0 119.887 174.678 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.3 mt -83.4 130.66 55.56 Favored Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-N 120.734 2.267 . . . . 0.0 105.238 177.274 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 40' ' ' GLN 0.264 73.7 Cg_endo -80.66 159.45 21.92 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 O-C-N 116.098 -2.632 . . . . 0.0 113.371 174.103 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.83 -40.63 16.33 Favored 'Trans proline' 0 N--CA 1.443 -1.467 1 C-N-CA 125.395 4.063 . . . . 0.0 110.559 -170.882 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.26 24.7 t70 -55.96 -22.57 27.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 113.335 -3.221 . . . . 0.0 116.379 176.622 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 37.6 tt0 -86.34 -10.09 55.11 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 128.401 3.563 . . . . 0.0 110.009 -178.142 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -100.49 161.15 13.79 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.791 1.636 . . . . 0.0 107.136 -157.389 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -157.04 126.19 5.96 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 125.351 2.5 . . . . 0.0 107.713 162.142 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -99.59 126.02 45.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.74 -2.475 . . . . 0.0 106.738 -174.757 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.2 mm -111.45 143.64 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 129.879 3.271 . . . . 0.0 110.267 179.469 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -146.81 137.12 23.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.27 3.028 . . . . 0.0 108.666 166.626 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.281 . . 53.33 42.0 32.08 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 131.186 3.794 . . . . 0.0 112.454 172.648 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.27 10.18 85.72 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 114.429 -3.428 . . . . 0.0 114.708 -174.864 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -147.98 163.0 38.19 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 123.723 3.761 . . . . 0.0 115.305 179.172 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -63.64 133.78 54.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 131.655 3.982 . . . . 0.0 110.316 171.017 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 mt -99.31 126.73 45.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 163.609 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.93 156.85 20.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 126.324 2.265 . . . . 0.0 113.315 -174.007 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.19 155.28 11.6 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.567 -169.075 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.85 0.04 48.67 Favored Glycine 0 CA--C 1.525 0.665 1 O-C-N 130.388 4.805 . . . . 0.0 113.266 150.438 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -120.17 169.5 10.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 131.008 3.723 . . . . 0.0 112.321 179.336 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 p -105.92 163.87 12.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 116.557 -1.687 . . . . 0.0 113.916 -173.504 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.506 HD12 ' H ' ' A' ' 56' ' ' LEU . 5.9 mp -41.72 -37.83 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 112.645 -3.55 . . . . 0.0 115.108 156.94 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -71.58 -38.37 70.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 124.721 3.419 . . . . 0.0 117.94 170.531 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.95 -29.37 66.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 122.163 2.256 . . . . 0.0 115.319 173.761 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -87.68 8.84 23.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 118.68 -2.512 . . . . 0.0 108.132 173.112 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 63.26 24.47 14.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 124.211 3.187 . . . . 0.0 117.183 171.32 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.6 mt -76.87 127.71 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 118.636 -2.54 . . . . 0.0 116.749 -175.217 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.278 4.3 tp-100 -110.6 165.16 12.04 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.835 2.454 . . . . 0.0 109.896 -170.335 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.2 155.83 2.51 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 117.086 -3.509 . . . . 0.0 115.556 178.532 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 57.06 1.03 0.09 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.434 2.294 . . . . 0.0 116.509 170.435 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -60.12 151.31 27.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 130.48 3.512 . . . . 0.0 110.5 173.893 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.9 m -103.47 115.69 31.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 177.632 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.38 148.01 24.45 Favored 'General case' 0 N--CA 1.445 -0.68 1 C-N-CA 132.618 4.367 . . . . 0.0 107.784 160.402 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -113.68 148.4 36.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 122.312 2.324 . . . . 0.0 109.597 176.467 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -119.28 136.63 54.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.259 2.623 . . . . 0.0 107.274 178.996 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.97 167.99 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 O-C-N 125.222 1.576 . . . . 0.0 111.476 157.048 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.593 1.1 pp . . . . . 0 N--CA 1.447 -0.598 0 CA-C-N 120.573 1.533 . . . . 0.0 113.821 171.176 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 ttp . . . . . 0 C--O 1.234 0.248 0 CA-C-O 115.737 -2.078 . . . . 0.0 106.554 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.472 HE21 HG23 ' A' ' 14' ' ' THR . 57.9 tt0 -90.75 138.96 31.17 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 121.383 1.901 . . . . 0.0 108.748 173.331 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 pt -125.96 159.76 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 130.081 3.352 . . . . 0.0 109.372 159.908 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.46 ' HB2' ' HA ' ' A' ' 66' ' ' THR 0.279 73.4 m-85 -95.47 144.0 26.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 165.726 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.8 t -116.14 149.07 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 127.878 2.471 . . . . 0.0 108.768 163.987 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -136.79 150.07 48.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 130.488 3.515 . . . . 0.0 104.243 177.721 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.5 p -106.79 -170.97 1.8 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 111.731 -2.486 . . . . 0.0 106.189 -179.786 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.1 mt -106.67 -11.75 15.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 126.548 3.071 . . . . 0.0 112.951 -176.318 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -89.15 -6.02 57.3 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 119.077 -2.265 . . . . 0.0 110.994 173.859 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.8 -28.47 5.43 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 129.263 3.316 . . . . 0.0 111.107 171.572 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -73.12 142.48 47.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.067 -158.509 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.5 p -113.02 136.73 52.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.465 1.906 . . . . 0.0 109.897 -179.171 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 pt -117.78 143.6 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 131.4 3.88 . . . . 0.0 102.191 168.297 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.472 HG23 HE21 ' A' ' 2' ' ' GLN 0.427 78.5 m -97.58 141.23 30.88 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 169.559 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.291 0.0 OUTLIER -131.23 125.28 32.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.068 2.147 . . . . 0.0 109.042 -176.649 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.4 132.2 37.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 129.238 3.015 . . . . 0.0 112.203 156.162 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.99 160.35 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 127.235 2.214 . . . . 0.0 111.689 -177.81 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -121.19 154.87 58.73 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 100.724 -3.806 . . . . 0.0 100.724 173.976 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.82 -17.91 17.44 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.775 1.65 . . . . 0.0 115.865 -171.575 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 p -84.42 5.14 28.42 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 117.381 -1.295 . . . . 0.0 111.642 -175.064 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.03 139.51 39.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.431 2.693 . . . . 0.0 114.646 178.903 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 p -94.61 134.88 36.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.265 2.226 . . . . 0.0 114.664 -177.067 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.442 5.0 mt -42.14 -40.61 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -177.006 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.39 -13.95 59.61 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 117.156 -3.465 . . . . 0.0 113.5 176.429 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -89.64 -23.32 21.93 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 116.158 -1.877 . . . . 0.0 114.056 162.815 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.84 -36.18 73.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 116.343 -1.789 . . . . 0.0 110.129 168.034 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -60.2 -39.69 87.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 122.457 2.389 . . . . 0.0 113.487 170.078 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -36.5 79.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 115.583 -2.151 . . . . 0.0 113.664 169.694 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 tttt -61.81 -38.05 86.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 123.379 2.809 . . . . 0.0 110.349 169.606 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.366 66.4 mt -62.19 -32.66 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 O-C-N 117.7 -3.125 . . . . 0.0 117.416 169.96 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -27.24 68.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.708 1.203 . . . . 0.0 113.774 175.947 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -84.11 -33.98 24.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 126.139 2.15 . . . . 0.0 107.371 -176.726 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -73.75 -43.45 59.02 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 177.469 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.302 47.8 tp10 -142.02 -5.2 1.01 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 123.383 1.563 . . . . 0.0 108.135 -152.855 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.24 -9.17 69.81 Favored Glycine 0 N--CA 1.443 -0.877 1 O-C-N 115.975 -4.203 . . . . 0.0 122.558 162.497 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -79.03 124.02 84.83 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-O 114.389 -2.719 . . . . 0.0 105.241 -171.2 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.303 58.9 Cg_endo -54.48 149.78 37.26 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.46 2.107 . . . . 0.0 115.394 172.221 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -84.29 -25.62 2.08 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 107.28 -1.854 . . . . 0.0 107.28 -162.165 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -48.84 -47.62 42.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 177.73 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -95.78 13.65 25.87 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.497 1.519 . . . . 0.0 108.029 -175.51 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -92.78 145.44 24.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 122.144 2.247 . . . . 0.0 109.919 171.192 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -147.63 124.23 11.1 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 130.005 3.322 . . . . 0.0 109.015 -177.261 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mp -101.39 139.01 37.64 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.875 1.67 . . . . 0.0 110.823 -177.161 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.9 mt -121.84 140.67 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 131.372 3.869 . . . . 0.0 110.292 168.761 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -116.54 -32.02 5.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 119.245 -2.159 . . . . 0.0 113.917 166.254 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.7 -107.16 0.38 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-O 115.43 -2.224 . . . . 0.0 106.312 175.961 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.95 2.77 13.19 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 117.931 1.932 . . . . 0.0 117.931 166.569 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -113.11 151.62 30.59 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 118.999 -2.471 . . . . 0.0 107.495 -160.707 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -66.41 144.65 56.39 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.676 163.912 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.4 mt -98.05 147.41 24.56 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.873 2.469 . . . . 0.0 106.534 172.729 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -66.96 114.59 5.88 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 157.677 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -53.35 -30.32 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 119.915 3.302 . . . . 0.0 119.915 -176.38 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.68 18.44 52.95 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -168.753 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -94.02 168.69 10.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 125.572 1.395 . . . . 0.0 109.913 167.232 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.1 p -96.08 166.93 11.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 130.628 3.571 . . . . 0.0 116.53 175.29 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.79 -38.41 69.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 114.492 -2.671 . . . . 0.0 115.538 168.6 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 p -76.1 -31.27 58.6 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.555 2.742 . . . . 0.0 106.702 -171.397 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -57.42 -35.01 69.53 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 120.083 1.311 . . . . 0.0 111.809 173.999 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -108.39 -3.57 18.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -170.741 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.419 36.9 t-20 67.16 53.47 0.79 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 127.324 2.89 . . . . 0.0 111.904 178.8 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.1 mm -79.11 115.68 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 127.94 2.496 . . . . 0.0 104.491 168.494 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -93.15 156.88 16.58 Favored 'General case' 0 N--CA 1.448 -0.534 1 C-N-CA 132.014 4.126 . . . . 0.0 111.438 177.047 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -67.4 149.01 50.84 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 119.645 -1.91 . . . . 0.0 111.78 -177.245 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.393 19.2 mt-10 80.67 -2.4 1.86 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 114.09 -2.862 . . . . 0.0 113.219 172.78 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.8 m -66.58 159.63 27.03 Favored 'General case' 0 N--CA 1.449 -0.494 1 O-C-N 130.016 4.573 . . . . 0.0 112.616 -177.229 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 53.5 m -103.74 121.29 42.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 175.083 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 tt -110.31 154.45 23.46 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 117.803 -3.061 . . . . 0.0 106.486 -179.347 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -120.95 119.77 33.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 116.507 -3.871 . . . . 0.0 110.415 -167.826 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.1 tp -98.4 142.57 29.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.582 2.353 . . . . 0.0 110.178 178.983 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 71' ' ' LEU . 96.1 t -124.3 162.98 24.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 129.187 2.995 . . . . 0.0 109.687 177.217 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.49 ' N ' HG12 ' A' ' 70' ' ' VAL . 2.4 pt? . . . . . 0 C--N 1.325 -0.482 0 CA-C-O 122.455 1.121 . . . . 0.0 109.227 177.685 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.4 ttm . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 116.982 -1.485 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 101 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -106.11 122.49 46.29 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -166.209 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -132.8 174.1 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 O-C-N 125.723 1.889 . . . . 0.0 109.086 167.832 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.283 7.6 p90 -150.62 149.06 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 117.033 -3.542 . . . . 0.0 109.509 -171.457 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 67' ' ' LEU . 4.7 m -114.58 150.42 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 179.909 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -109.26 123.42 49.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 175.624 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -68.51 172.88 5.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 128.538 2.735 . . . . 0.0 110.584 176.861 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.76 -26.5 66.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.805 167.43 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -88.92 -4.27 58.5 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 179.978 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.91 -4.29 57.55 Favored Glycine 0 CA--C 1.528 0.898 1 CA-C-O 112.379 -4.567 . . . . 0.0 111.823 166.128 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -84.62 141.5 30.61 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 123.922 3.861 . . . . 0.0 110.885 178.139 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.276 53.9 m -104.15 148.62 26.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 121.658 2.026 . . . . 0.0 105.906 -168.433 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mt -128.48 121.08 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.824 2.05 . . . . 0.0 107.936 176.951 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.8 m -92.67 129.77 38.5 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.561 1.945 . . . . 0.0 106.63 -177.244 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.91 139.4 47.43 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 127.147 2.779 . . . . 0.0 106.403 -175.48 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.294 22.3 tp10 -96.22 127.18 42.0 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 118.442 -2.661 . . . . 0.0 107.211 159.635 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.63 161.81 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 103.503 -2.776 . . . . 0.0 103.503 177.823 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -107.85 121.56 43.61 Favored Pre-proline 0 N--CA 1.446 -0.667 1 C-N-CA 133.366 4.666 . . . . 0.0 104.877 160.63 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 10.4 Cg_endo -65.19 -2.57 5.99 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 127.188 5.258 . . . . 0.0 117.483 -160.22 . . . . . . . . 3 2 . 1 . 101 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -96.85 3.4 52.21 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.86 -177.331 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.12 157.04 31.23 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.694 1.597 . . . . 0.0 111.523 174.932 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -100.53 149.93 23.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 -172.338 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.443 ' H ' HG12 ' A' ' 23' ' ' ILE . 5.5 mm -51.96 -31.86 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 112.609 -3.567 . . . . 0.0 116.477 -178.005 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -65.38 -26.54 68.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 123.079 2.672 . . . . 0.0 113.136 174.188 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -81.69 -21.24 38.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.506 1.503 . . . . 0.0 112.744 178.495 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 t -71.4 -52.53 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 1 C-N-CA 133.804 4.842 . . . . 0.0 110.082 167.716 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -53.6 -34.13 57.35 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 116.555 -3.84 . . . . 0.0 118.12 168.299 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.74 -18.85 39.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 120.395 -1.441 . . . . 0.0 112.06 -178.439 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -69.95 -17.23 63.3 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 116.844 -3.66 . . . . 0.0 117.026 167.293 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mm -84.83 -35.56 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 116.736 -1.602 . . . . 0.0 108.733 -174.743 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -52.14 -43.41 64.03 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 129.618 3.167 . . . . 0.0 111.863 -166.783 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.85 -29.3 65.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 122.767 2.53 . . . . 0.0 113.272 179.701 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -75.18 -56.77 4.4 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.393 -2.692 . . . . 0.0 109.914 173.294 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -134.29 137.63 44.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 -165.524 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.48 40.87 2.32 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 -149.71 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 71' ' ' LEU . 43.6 mt -91.93 119.66 68.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 130.066 3.347 . . . . 0.0 113.807 -174.781 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.97 138.94 23.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 121.273 1.49 . . . . 0.0 113.024 -168.273 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.08 -18.75 7.66 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-O 111.452 -3.645 . . . . 0.0 116.18 177.59 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -88.61 12.15 15.42 Favored 'General case' 0 C--O 1.238 0.491 1 CA-C-N 127.076 4.489 . . . . 0.0 112.314 175.078 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.336 8.2 tt0 -127.01 -18.86 4.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.511 -1.993 . . . . 0.0 111.222 -176.858 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 77.3 mt-30 -92.66 156.64 16.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.254 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -144.8 147.69 33.18 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.212 -2.885 . . . . 0.0 103.212 170.49 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.8 mt -117.76 136.06 53.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.526 2.331 . . . . 0.0 110.078 -176.591 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 44' ' ' ILE . 56.2 mt -122.15 143.18 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 172.892 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -118.03 106.45 12.92 Favored 'General case' 0 C--N 1.33 -0.273 2 CA-C-N 105.312 -5.404 . . . . 0.0 112.332 154.675 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.462 . . 87.18 4.22 0.36 Allowed 'General case' 0 CA--C 1.532 0.265 1 O-C-N 111.987 -6.696 . . . . 0.0 116.69 157.537 . . . . . . . . 3 2 . 1 . 101 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.7 2.22 46.47 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.714 -171.794 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -92.23 124.07 36.03 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 128.349 2.659 . . . . 0.0 111.276 165.012 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -77.18 128.46 34.42 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 168.788 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.279 11.9 mt -68.15 126.54 29.84 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 118.336 2.717 . . . . 0.0 118.336 170.388 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -98.75 139.09 34.95 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -173.625 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.45 142.83 57.7 Favored 'General case' 0 C--O 1.22 -0.457 0 O-C-N 117.996 -2.94 . . . . 0.0 109.013 176.787 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.68 -19.04 56.34 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 119.108 -2.245 . . . . 0.0 108.126 171.519 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -81.09 157.97 25.2 Favored 'General case' 0 N--CA 1.453 -0.319 1 O-C-N 115.072 -4.781 . . . . 0.0 106.538 173.123 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.1 p -92.03 165.93 12.94 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 120.558 -1.339 . . . . 0.0 109.967 165.689 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 mt -51.7 -45.79 63.65 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.451 2.7 . . . . 0.0 113.286 163.075 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -53.45 -28.84 32.51 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 170.082 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.01 -23.65 48.2 Favored 'General case' 0 N--CA 1.447 -0.597 1 O-C-N 115.068 -4.77 . . . . 0.0 115.857 178.356 . . . . . . . . 3 3 . 1 . 101 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.28 45.9 m-85 -97.99 -9.05 26.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.309 1.444 . . . . 0.0 114.303 172.497 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.377 26.5 t30 72.54 47.18 0.26 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 130.324 3.45 . . . . 0.0 111.405 -178.233 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -82.57 103.58 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.943 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -90.09 -175.06 4.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 130.02 3.328 . . . . 0.0 115.901 170.458 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.76 138.58 41.85 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.613 3.165 . . . . 0.0 112.933 173.498 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.454 62.8 tt0 83.93 2.24 0.91 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 126.867 2.067 . . . . 0.0 114.657 167.53 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -77.88 134.1 38.0 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.23 -1.544 . . . . 0.0 111.104 -169.195 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -85.19 115.55 23.04 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 126.662 2.476 . . . . 0.0 104.733 174.44 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.469 ' HB2' HG12 ' A' ' 5' ' ' VAL . 51.3 mt -94.83 171.03 9.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 128.208 3.443 . . . . 0.0 107.262 161.839 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -130.96 139.13 50.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.721 -179.029 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -101.95 120.87 41.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 -171.006 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.37 172.95 13.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 127.497 2.319 . . . . 0.0 105.973 -175.287 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD11 HG21 ' A' ' 36' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.443 -0.818 0 C-N-CA 122.816 0.446 . . . . 0.0 110.687 -165.576 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttp . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 116.654 -1.641 . . . . 0.0 107.281 . . . . . . . . . 0 0 . 1 . 102 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -93.95 138.59 31.9 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 124.041 1.877 . . . . 0.0 111.164 170.842 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -136.74 167.71 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.704 2.001 . . . . 0.0 107.897 162.289 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -119.87 135.2 54.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -177.144 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 15' ' ' LEU . 88.0 t -121.43 89.58 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 126.674 2.484 . . . . 0.0 104.907 178.747 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -77.83 121.32 23.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.456 3.902 . . . . 0.0 107.018 -175.542 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.8 p -84.61 155.05 22.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 175.373 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 mt -50.44 -16.81 0.39 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 131.415 3.886 . . . . 0.0 115.664 176.558 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -97.81 6.35 47.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.18 0.992 . . . . 0.0 111.731 172.706 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.08 -36.32 4.47 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 120.007 -1.683 . . . . 0.0 109.951 167.515 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -60.24 127.68 33.0 Favored 'General case' 0 C--N 1.33 -0.255 1 C-N-CA 132.369 4.268 . . . . 0.0 106.69 -174.718 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.253 20.6 m -119.19 123.81 45.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.102 2.561 . . . . 0.0 109.071 -166.014 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mm -82.48 120.37 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 168.235 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.8 m -74.35 134.8 42.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.88 1.363 . . . . 0.0 109.27 166.735 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.468 HD12 HG21 ' A' ' 5' ' ' VAL . 2.3 mt -125.44 129.91 50.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 120.645 1.566 . . . . 0.0 113.259 179.593 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.48 90.77 7.69 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.133 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -98.99 164.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.321 177.996 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.265 30.5 tp10 -107.81 156.21 38.49 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-O 113.612 -3.09 . . . . 0.0 105.017 162.3 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -59.93 -25.07 78.49 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 124.127 3.218 . . . . 0.0 118.073 170.557 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -88.57 1.65 54.53 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 119.439 3.125 . . . . 0.0 119.439 -179.732 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -72.43 149.18 44.47 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 114.439 -2.696 . . . . 0.0 115.891 -177.605 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 p -65.95 151.67 46.26 Favored 'General case' 0 C--N 1.325 -0.459 1 O-C-N 129.62 4.325 . . . . 0.0 110.475 167.04 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -61.02 -29.01 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 116.591 -1.671 . . . . 0.0 110.412 173.251 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -70.3 -50.61 37.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.045 2.538 . . . . 0.0 111.379 -173.056 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.3 -45.04 54.3 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.132 2.573 . . . . 0.0 112.629 170.93 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.4 -45.85 67.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.856 1.662 . . . . 0.0 108.158 -176.28 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -63.61 -31.19 72.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.251 1.42 . . . . 0.0 114.397 178.101 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.71 -14.87 35.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.38 3.472 . . . . 0.0 113.56 177.084 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.04 -31.2 27.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 119.119 -2.238 . . . . 0.0 107.083 174.571 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.2 mm -81.51 -6.99 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 117.348 -1.31 . . . . 0.0 109.961 176.907 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -76.54 -28.99 56.51 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 118.104 -2.873 . . . . 0.0 109.102 163.37 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.55 -47.21 12.41 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -163.292 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -73.18 -73.77 0.2 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.332 2.653 . . . . 0.0 112.214 178.437 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -85.45 -16.57 39.24 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.736 2.414 . . . . 0.0 117.183 -166.942 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.97 -7.84 67.53 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 117.142 -1.921 . . . . 0.0 112.786 -179.777 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.261 37.9 mm -80.29 115.03 51.91 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 123.141 3.471 . . . . 0.0 112.248 -163.485 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -55.67 160.22 9.91 Favored 'Trans proline' 0 N--CA 1.445 -1.354 1 C-N-CA 126.126 4.551 . . . . 0.0 113.941 171.011 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.63 5.82 3.59 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 N-CA-C 120.028 3.049 . . . . 0.0 120.028 -176.509 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.378 82.8 m-20 -104.72 -6.37 20.43 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 126.312 2.958 . . . . 0.0 117.929 174.451 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -97.82 -6.47 32.55 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 119.304 -2.122 . . . . 0.0 114.703 160.992 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -85.25 85.93 7.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 169.51 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -93.85 97.22 10.25 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 -171.421 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 mt -93.06 139.15 30.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -163.654 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 44' ' ' ILE . 24.3 mt -136.47 135.55 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.31 1.844 . . . . 0.0 110.039 177.754 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -129.38 107.13 9.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.07 3.348 . . . . 0.0 105.465 -178.465 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.39 42.0 31.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.426 2.291 . . . . 0.0 115.176 167.634 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.2 -25.29 28.81 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 119.707 -1.87 . . . . 0.0 114.199 -178.449 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -93.77 114.22 26.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 -171.227 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.292 7.8 tt0 -82.28 140.78 33.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 169.1 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.56 135.75 40.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 130.576 3.551 . . . . 0.0 109.362 -174.159 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -104.5 -4.01 23.22 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.203 2.601 . . . . 0.0 109.113 -172.013 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.323 7.5 m-20 84.38 168.35 0.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.278 170.247 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.62 -16.89 36.93 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 123.812 0.695 . . . . 0.0 113.881 169.232 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -120.98 -171.69 2.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.976 2.111 . . . . 0.0 105.366 -171.05 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.261 7.0 p -111.66 167.66 10.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.233 -0.917 . . . . 0.0 110.894 -165.463 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.284 9.3 mp -56.32 -28.86 60.28 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 169.249 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -77.06 -34.33 57.11 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 116.572 -2.051 . . . . 0.0 114.489 179.087 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.64 -40.39 76.54 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 127.924 3.265 . . . . 0.0 113.143 -177.685 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -79.44 0.56 28.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 117.519 -3.238 . . . . 0.0 109.341 171.045 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.366 1.6 t-20 70.6 49.13 0.42 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 126.277 2.942 . . . . 0.0 115.647 169.903 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -101.79 123.45 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 112.538 -2.119 . . . . 0.0 107.336 -174.736 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -111.72 -164.96 0.95 Allowed 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 124.96 1.413 . . . . 0.0 113.696 -168.104 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -69.97 114.72 8.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 119.44 -2.037 . . . . 0.0 107.619 174.611 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.312 5.7 tt0 89.4 12.3 0.07 Allowed 'General case' 0 C--O 1.236 0.374 1 O-C-N 115.915 -4.241 . . . . 0.0 112.746 167.307 . . . . . . . . 3 2 . 1 . 102 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -49.76 152.23 1.55 Allowed 'General case' 0 C--N 1.327 -0.381 0 O-C-N 117.661 -3.149 . . . . 0.0 112.179 167.953 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.1 m -116.15 130.54 56.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.637 167.928 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.92 123.56 46.05 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.078 1.751 . . . . 0.0 112.4 166.13 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -84.65 110.32 18.65 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 173.004 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.1 tp -89.2 103.76 16.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.727 2.411 . . . . 0.0 108.933 172.413 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 t -81.36 116.75 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 127.63 2.372 . . . . 0.0 109.292 163.502 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 mp . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 115.112 -2.375 . . . . 0.0 104.682 175.202 . . . . . . . . 0 0 . 1 . 103 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tmm? . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 . . . . . . . . . 0 0 . 1 . 103 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -94.01 154.31 17.72 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -174.665 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.461 HD13 HG21 ' A' ' 3' ' ' ILE . 4.8 pt -135.74 144.26 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 171.421 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -102.96 94.29 5.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 111.207 -2.724 . . . . 0.0 104.439 -179.235 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.4 t -80.88 112.68 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.598 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -96.14 127.91 42.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -170.142 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -95.49 136.83 35.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.317 2.247 . . . . 0.0 109.087 160.055 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.12 -32.33 71.65 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 113.871 -2.966 . . . . 0.0 112.575 166.997 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.276 33.1 p -76.37 -16.52 59.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 114.707 -2.568 . . . . 0.0 109.456 -178.805 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.36 48.15 0.09 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 117.052 -2.499 . . . . 0.0 113.665 123.301 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.304 0.6 OUTLIER -139.19 153.05 47.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.76 1.267 . . . . 0.0 108.84 164.555 . . . . . . . . 3 3 . 1 . 103 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -95.35 129.98 42.29 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.157 2.183 . . . . 0.0 107.03 164.585 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.2 mt -108.92 132.68 56.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 128.975 2.91 . . . . 0.0 106.322 177.625 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.5 m -93.78 126.33 38.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 167.133 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.87 138.17 50.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 125.944 2.028 . . . . 0.0 106.845 166.634 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.74 137.04 39.66 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 173.048 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 m -150.44 179.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.571 1 C-N-CA 132.866 4.467 . . . . 0.0 106.165 -166.779 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.262 48.4 mm-40 -130.89 159.35 71.77 Favored Pre-proline 0 N--CA 1.446 -0.658 0 C-N-CA 127.824 2.45 . . . . 0.0 105.345 155.167 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -61.47 -9.15 12.4 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.026 2.484 . . . . 0.0 116.82 179.543 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.269 26.4 p -88.58 -3.73 58.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.665 -1.16 . . . . 0.0 113.27 173.98 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.67 126.81 28.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.794 0.725 . . . . 0.0 110.457 171.147 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.398 4.7 p -67.05 155.07 39.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 173.775 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.4 -35.67 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 131.176 3.79 . . . . 0.0 107.629 171.395 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.46 -40.45 50.4 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 119.454 -2.029 . . . . 0.0 110.774 -174.204 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -56.56 -59.66 4.68 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 124.994 1.434 . . . . 0.0 113.419 168.38 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.321 96.6 t -51.72 -51.25 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 O-C-N 116.705 -3.747 . . . . 0.0 115.849 -177.387 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -48.8 -44.09 38.75 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 127.456 2.973 . . . . 0.0 116.433 169.927 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.24 -34.2 23.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 129.772 3.229 . . . . 0.0 110.361 -179.425 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -62.06 -33.54 74.58 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 125.853 1.971 . . . . 0.0 110.862 169.256 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.2 mt -63.95 -50.38 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 127.77 2.428 . . . . 0.0 113.239 165.965 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -41.34 82.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.92 2.088 . . . . 0.0 112.856 -175.984 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -54.37 -26.22 28.89 Favored 'General case' 0 N--CA 1.447 -0.594 1 C-N-CA 131.811 4.045 . . . . 0.0 113.741 173.601 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -98.78 -62.25 1.26 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 120.645 1.566 . . . . 0.0 113.514 -178.874 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -106.78 -17.41 14.22 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 126.368 2.292 . . . . 0.0 114.265 -167.523 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.95 1.43 42.18 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 117.696 -3.127 . . . . 0.0 118.053 168.049 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mt -80.75 130.16 65.24 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 123.279 3.54 . . . . 0.0 115.511 -172.43 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.285 36.9 Cg_endo -68.3 135.37 33.95 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.996 2.464 . . . . 0.0 110.745 179.419 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -43.79 -40.63 11.36 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.532 2.821 . . . . 0.0 116.556 175.925 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -55.75 -30.28 60.97 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.698 1.199 . . . . 0.0 112.986 -176.139 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -101.15 -12.5 18.72 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 128.314 2.646 . . . . 0.0 115.216 -171.606 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.26 73.3 mt-30 -81.14 152.61 27.69 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 111.932 -2.394 . . . . 0.0 108.419 179.413 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -132.45 126.83 33.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.847 2.459 . . . . 0.0 108.246 157.13 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 mt -115.96 131.2 57.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 177.684 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.72 143.11 32.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 110.789 -2.914 . . . . 0.0 108.085 -173.031 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -139.38 118.02 12.26 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.566 2.347 . . . . 0.0 109.011 160.083 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.65 48.87 6.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 128.36 3.538 . . . . 0.0 109.688 170.152 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.66 -19.94 51.14 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.578 1.085 . . . . 0.0 112.019 166.631 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.262 74.5 mttt -96.83 144.81 26.44 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.083 1.942 . . . . 0.0 114.447 -174.568 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.319 77.8 mm-40 -76.88 169.1 18.93 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 116.895 -1.922 . . . . 0.0 109.131 160.908 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.25 43.4 mt -120.34 119.35 32.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 117.84 -3.038 . . . . 0.0 106.141 -170.571 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -86.08 146.65 26.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 123.194 1.473 . . . . 0.0 113.274 -170.243 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -68.44 122.39 18.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 111.97 -2.377 . . . . 0.0 104.916 -175.403 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.07 9.25 10.83 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 127.581 3.051 . . . . 0.0 119.336 179.698 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.277 90.2 mtt-85 -132.35 179.34 6.18 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.953 2.101 . . . . 0.0 107.244 -172.579 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -126.46 178.62 5.75 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.113 -171.184 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -73.62 -28.93 62.06 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 127.45 2.969 . . . . 0.0 110.909 175.389 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.1 t -59.81 -27.58 66.71 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 129.521 3.129 . . . . 0.0 110.692 172.49 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.89 -44.16 27.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.748 2.419 . . . . 0.0 108.796 178.528 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -99.99 20.93 13.5 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -179.622 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 3.9 t-20 83.7 25.38 0.11 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 119.147 3.017 . . . . 0.0 119.147 164.169 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mt -104.04 81.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -172.679 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -92.28 -23.49 19.28 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 129.09 2.956 . . . . 0.0 114.491 -170.362 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -168.39 130.13 1.36 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.881 1.672 . . . . 0.0 109.535 -170.881 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 7.99 86.95 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 130.906 3.683 . . . . 0.0 116.944 167.049 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.284 5.3 t -143.98 -160.52 1.13 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 115.115 -2.374 . . . . 0.0 107.301 173.788 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.5 m -125.7 132.07 52.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 122.074 2.215 . . . . 0.0 106.334 -167.265 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.77 143.54 29.01 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 156.373 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -89.96 128.84 36.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 119.521 -1.987 . . . . 0.0 109.114 166.904 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 tp -92.45 117.67 30.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 131.69 3.996 . . . . 0.0 103.511 176.833 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.5 143.69 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -176.968 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.625 0 O-C-N 119.3 -2.125 . . . . 0.0 111.044 -171.097 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ptt? . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 . . . . . . . . . 0 0 . 1 . 104 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -82.71 152.32 25.84 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 115.208 -2.33 . . . . 0.0 112.678 -179.701 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.8 pt -139.82 149.5 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 121.777 2.08 . . . . 0.0 109.449 162.539 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -105.27 126.22 51.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 -172.355 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.272 93.0 t -99.4 112.14 30.9 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 C-N-CA 127.979 2.511 . . . . 0.0 108.076 171.929 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -70.32 148.8 48.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 111.565 -2.561 . . . . 0.0 111.314 166.352 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -120.75 -167.07 1.41 Allowed 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.083 -1.635 . . . . 0.0 109.534 176.442 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.14 42.17 1.53 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 164.294 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -139.74 26.54 2.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.715 2.406 . . . . 0.0 107.786 176.985 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.98 16.52 35.4 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 116.865 -3.647 . . . . 0.0 117.883 152.997 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -154.49 171.73 18.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 124.427 2.061 . . . . 0.0 110.116 177.664 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.5 m -112.89 127.57 56.23 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 131.313 3.845 . . . . 0.0 108.918 175.887 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.439 HD13 HG21 ' A' ' 13' ' ' ILE . 87.3 mt -106.47 129.37 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 O-C-N 126.78 2.55 . . . . 0.0 107.011 175.018 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.1 m -107.04 136.9 46.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 102.411 -3.181 . . . . 0.0 102.411 169.829 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tp -129.57 160.83 32.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 128.314 2.645 . . . . 0.0 105.496 -179.665 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -102.19 139.27 38.03 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 130.653 3.581 . . . . 0.0 103.19 172.968 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -151.03 166.36 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 119.314 -2.116 . . . . 0.0 108.644 -178.903 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -138.27 142.71 36.16 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 126.152 1.781 . . . . 0.0 108.469 -173.189 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.343 11.5 Cg_exo -50.72 -34.83 45.59 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 N-CA-C 121.369 3.565 . . . . 0.0 121.369 -179.887 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.5 p -93.43 -2.27 54.77 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 127.47 2.981 . . . . 0.0 112.134 -174.24 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -74.33 141.14 45.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 125.868 2.747 . . . . 0.0 109.091 170.327 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 p -76.32 172.81 12.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 119.221 -2.174 . . . . 0.0 111.408 175.933 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -53.15 -46.96 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 C-N-CA 133.875 4.87 . . . . 0.0 113.397 171.097 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -47.47 -42.16 22.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 113.295 -3.24 . . . . 0.0 112.33 170.089 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.281 4.7 m120 -59.14 -32.13 69.59 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.536 2.734 . . . . 0.0 116.135 175.392 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.79 -54.62 25.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 120.121 -1.612 . . . . 0.0 110.769 165.419 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -71.81 -23.88 61.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 125.675 2.655 . . . . 0.0 113.637 -171.952 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.6 -46.98 51.55 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 118.785 -2.447 . . . . 0.0 110.043 173.534 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.68 -27.91 60.61 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.729 2.412 . . . . 0.0 109.757 -176.487 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.36 -47.92 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 O-C-N 118.933 -2.355 . . . . 0.0 106.463 169.77 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -50.86 -51.86 47.29 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 124.426 3.284 . . . . 0.0 107.851 175.924 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.301 5.1 t70 -46.56 -50.03 17.91 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 179.094 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -83.64 -48.99 9.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 128.905 3.878 . . . . 0.0 108.55 -173.195 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -106.26 -14.74 15.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 123.493 2.861 . . . . 0.0 110.012 -161.754 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.21 0.99 84.63 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 129.851 3.595 . . . . 0.0 118.976 -178.623 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -83.86 126.42 70.58 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 119.855 1.827 . . . . 0.0 111.817 -165.827 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.09 145.92 31.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 O-C-N 124.245 1.655 . . . . 0.0 110.394 -175.063 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.27 38.0 Cg_endo -72.94 -16.23 25.93 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.494 3.463 . . . . 0.0 119.823 -163.6 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -72.07 -26.73 62.28 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 125.461 1.726 . . . . 0.0 110.337 174.335 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -83.02 -30.24 28.26 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.41 1.484 . . . . 0.0 112.507 -174.355 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -80.87 142.54 33.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 129.459 3.104 . . . . 0.0 109.375 175.747 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -145.62 119.36 9.22 Favored 'General case' 0 N--CA 1.449 -0.502 1 N-CA-C 99.217 -4.364 . . . . 0.0 99.217 175.733 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.14 124.53 29.95 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 114.64 -2.6 . . . . 0.0 115.81 177.062 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mm -102.17 129.13 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 101.197 -3.631 . . . . 0.0 101.197 173.552 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -137.31 125.98 23.81 Favored 'General case' 0 N--CA 1.451 -0.405 1 N-CA-C 97.139 -5.134 . . . . 0.0 97.139 175.607 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.75 24.18 14.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.864 2.866 . . . . 0.0 114.822 160.577 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.81 -25.92 25.8 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.873 -1.515 . . . . 0.0 112.566 -175.349 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -99.29 164.43 12.13 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 128.079 2.552 . . . . 0.0 109.159 -171.577 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.28 7.3 mt-30 -118.64 145.79 45.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.537 1.935 . . . . 0.0 106.339 166.445 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.44 139.26 30.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.77 -166.58 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.267 7.7 tp10 -85.44 140.34 30.8 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 131.671 3.989 . . . . 0.0 107.174 167.581 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -73.98 136.06 43.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 114.134 -2.841 . . . . 0.0 112.917 -177.667 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.01 -14.16 26.37 Favored Glycine 0 CA--C 1.535 1.327 1 CA-C-N 127.707 4.776 . . . . 0.0 113.775 166.028 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.295 3.1 mpt_? -81.06 161.05 24.34 Favored 'General case' 0 C--N 1.322 -0.624 1 O-C-N 130.925 4.544 . . . . 0.0 105.553 176.385 . . . . . . . . 3 2 . 1 . 104 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -89.59 172.69 8.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 125.282 1.614 . . . . 0.0 109.056 -177.457 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mt -63.04 -52.64 62.07 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 128.932 2.893 . . . . 0.0 110.443 169.961 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.0 p -41.96 -41.27 2.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 117.222 2.305 . . . . 0.0 117.222 162.501 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -62.14 -24.29 67.08 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 118.317 -2.739 . . . . 0.0 116.704 177.34 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -99.52 -6.86 26.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.738 3.215 . . . . 0.0 117.78 179.387 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.308 0.7 OUTLIER 69.85 48.13 0.58 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 130.491 3.517 . . . . 0.0 113.413 174.509 . . . . . . . . 3 3 . 1 . 104 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -93.25 139.69 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -172.998 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.274 7.0 tp60 -148.97 156.36 42.16 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 112.334 -2.212 . . . . 0.0 107.791 -176.18 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.374 23.9 ttpp -31.98 114.43 0.14 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.553 2.741 . . . . 0.0 113.541 -179.974 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 83.4 21.65 0.17 Allowed 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 128.148 3.405 . . . . 0.0 115.007 176.357 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 m -65.65 134.67 53.75 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.688 171.77 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.406 ' C ' HD12 ' A' ' 67' ' ' LEU . 85.1 m -94.71 122.4 37.28 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -178.989 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.406 HD12 ' C ' ' A' ' 66' ' ' THR . 1.7 mp -122.77 160.24 26.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.227 1.011 . . . . 0.0 109.398 166.21 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -127.88 124.36 37.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 118.493 -2.63 . . . . 0.0 111.979 -175.547 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.4 tp -82.57 101.45 10.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 115.337 -2.268 . . . . 0.0 111.086 -179.861 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.31 151.7 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 O-C-N 125.42 1.7 . . . . 0.0 107.326 163.545 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 mt . . . . . 0 C--N 1.325 -0.459 0 C-N-CA 126.633 1.973 . . . . 0.0 111.3 178.77 . . . . . . . . 0 0 . 1 . 105 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptt? . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 . . . . . . . . . 0 0 . 1 . 105 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -60.7 125.16 22.66 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 117.553 -1.213 . . . . 0.0 113.248 174.231 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.365 26.8 pt -128.91 166.48 26.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 O-C-N 125.209 1.568 . . . . 0.0 112.127 162.253 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -112.38 154.11 26.26 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.567 2.747 . . . . 0.0 106.916 176.674 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.87 130.66 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 168.682 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -101.72 128.32 48.1 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 122.835 2.561 . . . . 0.0 109.285 167.708 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.6 p -91.59 163.75 14.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.855 2.462 . . . . 0.0 108.386 -173.19 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.41 -47.71 47.7 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 128.286 2.634 . . . . 0.0 109.076 176.22 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.9 p -68.58 -16.94 64.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 128.011 2.524 . . . . 0.0 111.575 -174.743 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.01 -14.06 37.46 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 125.044 3.566 . . . . 0.0 115.498 169.652 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -69.73 147.26 50.75 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.794 1.637 . . . . 0.0 115.074 172.481 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -93.28 137.8 32.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.597 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.3 mt -119.68 137.88 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 170.269 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.4 t -100.86 142.0 32.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.328 1.851 . . . . 0.0 109.941 166.198 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 mt -135.73 142.93 45.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 171.134 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -88.03 115.48 25.54 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 161.787 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 t -123.93 132.41 71.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 127.75 2.42 . . . . 0.0 108.583 -174.985 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -91.3 148.6 38.05 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 114.866 -2.492 . . . . 0.0 110.0 -172.811 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -43.17 -46.0 9.4 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 123.596 2.864 . . . . 0.0 114.955 171.957 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -91.99 15.68 12.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.095 0.861 . . . . 0.0 112.624 -178.428 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -78.46 132.98 37.5 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 118.601 -2.562 . . . . 0.0 105.241 162.818 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.8 p -84.97 179.32 7.32 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 109.86 177.564 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.323 1.1 mp -71.15 -37.36 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 124.192 1.949 . . . . 0.0 108.989 -178.062 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -57.1 -39.01 74.21 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 117.456 -3.278 . . . . 0.0 114.332 173.03 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -53.17 -50.85 63.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 126.007 2.067 . . . . 0.0 115.158 177.739 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 t -65.85 -48.03 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 1 C-N-CA 132.377 4.271 . . . . 0.0 111.094 171.123 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -64.86 -35.94 82.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 115.998 -1.953 . . . . 0.0 111.731 179.11 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.83 -37.03 70.67 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.035 2.134 . . . . 0.0 114.164 174.987 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -84.51 -29.74 25.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 111.068 -2.787 . . . . 0.0 103.67 -170.676 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.8 mt -73.91 -46.24 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 121.503 1.956 . . . . 0.0 112.562 165.368 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -52.98 -48.42 67.46 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 129.532 3.133 . . . . 0.0 110.557 -178.571 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -56.28 -42.63 77.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 169.854 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -86.8 -55.06 4.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -175.867 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -100.01 -18.53 16.99 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 129.532 3.133 . . . . 0.0 113.289 -171.583 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.09 -1.51 70.44 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 114.829 0.692 . . . . 0.0 114.829 155.641 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.63 136.1 71.23 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-O 115.252 -2.309 . . . . 0.0 112.845 173.43 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -70.29 166.32 28.64 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 O-C-N 125.513 2.323 . . . . 0.0 116.449 173.421 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.42 -33.21 5.65 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 CA-C-O 114.901 -2.208 . . . . 0.0 111.228 -166.666 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.94 -21.8 58.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 123.712 2.96 . . . . 0.0 113.241 173.574 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -111.14 -1.08 16.33 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 128.497 2.719 . . . . 0.0 112.078 -169.454 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -96.83 109.24 21.97 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 127.717 2.407 . . . . 0.0 107.145 172.756 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -110.33 89.2 2.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -175.816 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.304 12.8 mt -79.07 127.9 32.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 129.597 3.159 . . . . 0.0 109.221 -179.918 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 8.2 mt -126.2 135.41 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 O-C-N 126.996 2.685 . . . . 0.0 113.561 -175.466 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -147.35 124.3 11.33 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.213 2.205 . . . . 0.0 112.112 172.568 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.36 44.08 9.94 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.882 2.073 . . . . 0.0 111.586 169.009 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.99 4.81 64.65 Favored Glycine 0 CA--C 1.537 1.407 1 CA-C-O 111.949 -4.806 . . . . 0.0 110.393 164.449 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -133.67 141.46 47.6 Favored 'General case' 0 N--CA 1.448 -0.565 1 O-C-N 131.147 4.675 . . . . 0.0 107.509 -170.932 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.408 HE22 ' CD ' ' A' ' 51' ' ' GLU . 4.6 tm0? -70.05 127.67 33.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 123.927 1.822 . . . . 0.0 108.957 160.381 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -83.29 125.29 31.46 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 171.068 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' CD ' HE22 ' A' ' 49' ' ' GLN . 6.2 tp10 -90.33 136.69 32.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.754 1.622 . . . . 0.0 110.008 -166.163 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -53.83 99.58 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.604 1 C-N-CA 132.29 4.236 . . . . 0.0 117.209 172.207 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.13 -3.46 6.81 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 119.221 2.448 . . . . 0.0 119.221 169.044 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -86.84 -167.66 1.96 Allowed 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 118.824 -2.574 . . . . 0.0 104.463 172.611 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 69.5 p -106.7 165.77 11.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.58 178.321 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -27.77 69.57 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 123.504 1.621 . . . . 0.0 114.626 169.013 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -67.52 -36.1 80.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.454 -1.703 . . . . 0.0 115.042 172.286 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.11 -21.41 66.17 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.702 1.601 . . . . 0.0 114.426 179.235 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -112.52 -2.17 14.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 116.868 2.174 . . . . 0.0 116.868 -167.264 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 44.28 46.6 7.66 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 171.343 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -83.98 -35.26 10.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 128.032 3.333 . . . . 0.0 113.905 -173.922 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 75.51 152.28 0.13 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 129.317 3.047 . . . . 0.0 113.357 164.413 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.95 135.88 35.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 127.031 2.133 . . . . 0.0 113.992 173.461 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.344 9.2 tt0 89.05 -1.38 0.37 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 111.311 -2.677 . . . . 0.0 111.479 173.421 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -85.77 162.69 18.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 117.863 -3.023 . . . . 0.0 109.348 -171.082 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.268 36.9 m -121.5 122.83 40.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.176 2.59 . . . . 0.0 106.641 -171.864 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.299 72.9 mt -89.44 145.36 25.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 119.424 -2.047 . . . . 0.0 107.315 167.318 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.276 74.2 m-70 -100.72 121.39 41.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.447 2.699 . . . . 0.0 108.231 174.114 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.1 tp -99.21 118.29 35.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 126.605 2.441 . . . . 0.0 105.277 -179.262 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.48 135.06 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.0 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 112.99 -3.386 . . . . 0.0 107.312 169.68 . . . . . . . . 0 0 . 1 . 106 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 117.566 -1.206 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 106 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.258 77.4 mm-40 -115.7 129.35 56.44 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.431 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.8 pt -100.4 155.14 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 116.866 -1.54 . . . . 0.0 111.066 165.608 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -103.71 121.66 43.43 Favored 'General case' 0 C--O 1.219 -0.532 0 O-C-N 127.395 2.934 . . . . 0.0 105.168 178.16 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 t -115.22 123.59 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 117.213 -3.43 . . . . 0.0 107.886 -177.629 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -119.57 99.66 6.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.599 -1.313 . . . . 0.0 113.294 -173.709 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.2 p -85.04 161.37 19.74 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 119.788 -1.82 . . . . 0.0 112.62 -174.592 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.386 0.0 OUTLIER -17.39 -72.78 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 1 C-N-CA 133.592 4.757 . . . . 0.0 119.711 -172.382 . . . . . . . . 4 3 . 1 . 106 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.0 p -61.21 -10.28 6.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.469 -1.696 . . . . 0.0 114.073 171.827 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.67 -5.17 34.83 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 127.222 3.679 . . . . 0.0 117.64 176.673 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.03 110.77 1.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 129.071 2.948 . . . . 0.0 108.678 -177.894 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.1 m -99.06 139.24 35.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 127.382 2.926 . . . . 0.0 107.559 -161.519 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.4 mt -123.23 141.46 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 177.387 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 m -98.51 105.88 18.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 127.994 3.309 . . . . 0.0 110.054 153.198 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tp -99.07 133.62 43.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 -179.365 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.266 83.6 tt0 -86.27 141.57 29.18 Favored 'General case' 0 N--CA 1.45 -0.427 1 O-C-N 129.363 4.165 . . . . 0.0 106.561 174.712 . . . . . . . . 3 2 . 1 . 106 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.29 179.24 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 126.691 3.138 . . . . 0.0 109.562 174.396 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -107.79 152.99 41.8 Favored Pre-proline 0 N--CA 1.45 -0.458 0 O-C-N 116.793 -3.692 . . . . 0.0 106.491 148.578 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.5 -25.19 25.45 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 O-C-N 116.714 -2.308 . . . . 0.0 113.294 -176.575 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.2 p -77.51 -0.81 27.6 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 129.052 2.941 . . . . 0.0 114.899 174.069 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -77.34 148.96 35.33 Favored 'General case' 0 C--O 1.22 -0.457 0 O-C-N 126.256 2.222 . . . . 0.0 110.226 173.279 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -109.16 144.33 37.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 111.437 -2.619 . . . . 0.0 105.581 -163.447 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -54.07 -30.29 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 1 CA-C-O 110.342 -4.647 . . . . 0.0 115.005 -171.022 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -65.73 -33.83 76.77 Favored 'General case' 0 N--CA 1.451 -0.401 1 CA-C-N 126.006 4.003 . . . . 0.0 113.067 172.532 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -80.66 -16.42 54.07 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 126.824 2.578 . . . . 0.0 107.577 -175.741 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.25 -53.55 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 127.216 2.206 . . . . 0.0 110.649 171.244 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -60.71 -37.83 83.02 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.278 1.831 . . . . 0.0 112.26 176.611 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.59 -10.08 59.13 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 115.236 -2.316 . . . . 0.0 109.88 178.898 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -91.34 -36.93 13.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.55 2.74 . . . . 0.0 108.996 178.925 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.4 mt -65.54 -40.17 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 128.785 2.834 . . . . 0.0 108.718 170.791 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.53 -47.43 66.71 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.32 -2.737 . . . . 0.0 116.282 167.061 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.58 -41.42 92.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 120.937 1.699 . . . . 0.0 115.171 172.175 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -78.01 -37.17 47.69 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.675 1.234 . . . . 0.0 112.837 -176.726 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.35 28.8 mm-40 -124.37 -33.72 3.0 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 -169.197 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.97 39.71 1.95 Allowed Glycine 0 CA--C 1.527 0.841 1 O-C-N 115.279 -4.638 . . . . 0.0 116.127 162.709 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 mt -123.36 135.72 26.34 Favored Pre-proline 0 N--CA 1.451 -0.424 0 O-C-N 118.316 -2.873 . . . . 0.0 108.592 179.159 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 71.5 Cg_endo -76.89 137.16 17.38 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 O-C-N 125.42 2.274 . . . . 0.0 113.249 -177.967 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.2 Cg_exo -44.9 -30.24 4.3 Favored 'Trans proline' 0 N--CA 1.446 -1.292 1 C-N-CA 126.161 4.574 . . . . 0.0 118.903 -177.204 . . . . . . . . 3 3 . 1 . 106 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.2 -10.83 56.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -168.151 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -98.21 -3.19 38.03 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 129.476 3.111 . . . . 0.0 112.596 175.639 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.255 64.6 mt-30 -107.94 132.9 53.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 123.63 2.923 . . . . 0.0 104.332 -172.191 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -113.96 129.95 56.56 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 119.921 -1.737 . . . . 0.0 109.842 149.965 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.5 mt -101.36 120.58 40.48 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.586 1.955 . . . . 0.0 108.128 170.262 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mm -97.63 131.59 44.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 113.076 -3.345 . . . . 0.0 109.832 172.959 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -111.89 136.38 51.27 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 124.638 3.381 . . . . 0.0 104.795 152.897 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.0 -99.95 0.1 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.205 1.402 . . . . 0.0 112.228 -169.98 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.84 25.08 3.77 Favored Glycine 0 CA--C 1.523 0.558 1 C-N-CA 131.581 4.42 . . . . 0.0 113.341 159.646 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -93.82 111.35 23.03 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 118.144 -2.974 . . . . 0.0 107.563 175.82 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -76.17 97.17 4.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 127.693 3.121 . . . . 0.0 112.857 175.818 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.81 127.92 33.51 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 126.819 2.575 . . . . 0.0 113.234 -171.384 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -104.77 132.08 51.46 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 131.358 3.863 . . . . 0.0 113.748 -169.915 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.6 123.01 17.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 130.775 3.63 . . . . 0.0 109.116 -179.128 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.72 -6.87 20.12 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 120.359 1.436 . . . . 0.0 111.475 -177.1 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -122.16 173.62 7.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 170.821 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -115.37 175.63 5.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 117.894 -3.004 . . . . 0.0 113.635 -168.886 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.1 mt -75.6 -30.3 59.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 123.258 1.504 . . . . 0.0 111.864 172.401 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -58.98 -36.2 74.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.905 1.336 . . . . 0.0 112.288 170.727 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -69.9 -41.98 74.0 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 119.252 -2.155 . . . . 0.0 108.788 -174.179 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -84.85 10.89 10.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 175.552 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 58.96 35.58 24.16 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 129.058 2.943 . . . . 0.0 111.418 172.051 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.2 mt -88.78 142.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 -173.816 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.304 3.4 pm0 -137.63 -166.22 1.91 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.811 2.045 . . . . 0.0 114.104 -162.677 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -60.81 131.83 51.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 128.861 2.864 . . . . 0.0 110.392 174.255 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.397 0.8 OUTLIER 86.36 17.06 0.11 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 127.614 3.578 . . . . 0.0 115.648 175.926 . . . . . . . . 3 3 . 1 . 106 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.8 p -83.58 127.94 34.13 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 118.216 -2.803 . . . . 0.0 112.099 -178.346 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.1 m -107.1 114.65 28.86 Favored 'General case' 0 N--CA 1.445 -0.716 1 C-N-CA 132.383 4.273 . . . . 0.0 108.697 172.724 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -100.48 130.26 46.54 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.627 1.571 . . . . 0.0 109.016 174.895 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -102.3 127.97 49.05 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 128.852 2.861 . . . . 0.0 107.155 -170.399 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -93.69 150.72 20.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 122.22 2.282 . . . . 0.0 105.889 175.321 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.4 p -141.32 141.61 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 130.088 3.355 . . . . 0.0 107.37 163.894 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt . . . . . 0 N--CA 1.448 -0.559 0 CA-C-N 121.092 1.769 . . . . 0.0 110.615 175.358 . . . . . . . . 0 0 . 1 . 107 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 123.465 1.602 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 107 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -101.32 134.45 44.36 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.922 -1.111 . . . . 0.0 113.823 163.753 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.312 2.1 pp -124.82 146.96 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.774 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -105.73 133.83 49.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 123.797 1.76 . . . . 0.0 108.898 177.004 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.09 133.97 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 174.632 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -108.38 122.24 46.6 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 111.848 -2.433 . . . . 0.0 109.843 178.026 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -80.42 153.25 28.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 123.557 1.646 . . . . 0.0 110.161 179.627 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.36 -25.66 63.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.45 2.3 . . . . 0.0 112.383 -174.738 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.3 p -100.63 19.64 16.59 Favored 'General case' 0 CA--C 1.538 0.494 1 C-N-CA 132.943 4.497 . . . . 0.0 115.692 173.374 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.93 21.61 11.83 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-O 115.136 -3.036 . . . . 0.0 117.535 137.457 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.353 55.2 mttt -103.78 171.11 7.53 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 128.356 2.663 . . . . 0.0 115.966 169.623 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -128.22 103.92 7.45 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 130.366 3.466 . . . . 0.0 108.92 169.931 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.4 mm -81.11 117.51 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 128.629 2.771 . . . . 0.0 112.469 177.469 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.269 22.9 m -93.97 105.52 17.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.102 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -88.78 159.33 17.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 172.183 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -107.35 133.89 51.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 124.422 2.058 . . . . 0.0 107.224 165.253 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 m -139.51 -179.09 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 119.895 -1.753 . . . . 0.0 110.795 178.537 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -140.05 155.11 70.86 Favored Pre-proline 0 N--CA 1.451 -0.407 0 C-N-CA 130.208 3.403 . . . . 0.0 104.195 171.955 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.47 -38.33 53.22 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-O 115.538 -1.942 . . . . 0.0 116.39 -175.851 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -77.75 -9.42 59.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 124.542 1.151 . . . . 0.0 111.494 -170.877 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.67 135.9 52.09 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 125.041 2.353 . . . . 0.0 109.743 179.304 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.0 p -78.38 153.94 31.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 129.737 3.215 . . . . 0.0 111.257 -168.22 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.3 -17.59 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.33 -0.856 . . . . 0.0 108.934 -178.54 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -78.04 -44.15 27.26 Favored 'General case' 0 N--CA 1.448 -0.549 1 O-C-N 116.254 -4.029 . . . . 0.0 108.021 -179.506 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -62.86 -50.26 71.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 112.93 -3.414 . . . . 0.0 114.552 166.351 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 22' ' ' THR . 70.9 t -52.99 -40.65 37.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 121.828 2.104 . . . . 0.0 111.375 177.032 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -42.04 -35.78 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 115.98 1.845 . . . . 0.0 115.98 166.182 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.73 -28.06 14.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 120.363 1.438 . . . . 0.0 108.69 -177.207 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -60.92 -31.69 71.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 117.887 -3.008 . . . . 0.0 118.29 168.264 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.285 1.5 tt -70.87 -40.76 76.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 167.993 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.26 -36.41 75.45 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 175.54 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -74.19 -10.69 59.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.902 0.774 . . . . 0.0 112.626 -170.928 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -77.7 0.22 Allowed 'General case' 0 C--O 1.235 0.338 1 C-N-CA 132.385 4.274 . . . . 0.0 116.603 159.699 . . . . . . . . 3 3 . 1 . 107 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -98.54 -3.38 36.56 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.265 -0.897 . . . . 0.0 113.259 -162.777 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.01 7.95 86.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 117.906 -2.092 . . . . 0.0 117.36 171.14 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.5 mt -74.71 120.65 82.58 Favored Pre-proline 0 N--CA 1.454 -0.237 1 C-N-CA 132.704 4.402 . . . . 0.0 109.206 178.65 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -74.51 141.0 27.61 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 CA-C-O 115.164 -2.098 . . . . 0.0 112.989 -175.203 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.23 -7.14 20.47 Favored 'Trans proline' 0 N--CA 1.447 -1.264 1 C-N-CA 127.443 5.429 . . . . 0.0 116.531 -178.408 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -74.34 -9.82 58.98 Favored 'General case' 0 N--CA 1.446 -0.644 1 O-C-N 115.13 -4.731 . . . . 0.0 113.424 168.779 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -119.47 -8.49 10.01 Favored 'General case' 0 C--N 1.323 -0.56 1 C-N-CA 134.56 5.144 . . . . 0.0 114.146 -175.468 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 11.4 mt-30 -90.35 152.79 20.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 119.989 -1.694 . . . . 0.0 111.598 168.638 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttp-105 -128.05 122.09 31.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 115.028 -2.415 . . . . 0.0 109.849 156.794 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.522 ' HB3' HD13 ' A' ' 50' ' ' LEU . 3.0 mm? -80.84 115.51 20.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.635 1.561 . . . . 0.0 106.949 172.117 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.3 mt -116.26 134.85 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 116.418 -1.754 . . . . 0.0 106.7 167.299 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -88.29 -49.88 6.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.277 1.399 . . . . 0.0 108.299 -175.653 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.51 -44.32 0.1 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.221 -1.371 . . . . 0.0 114.566 -177.213 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.3 -11.21 4.75 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 118.685 2.234 . . . . 0.0 118.685 152.443 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -143.18 160.22 40.85 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.961 1.304 . . . . 0.0 112.686 -161.85 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -78.96 142.87 36.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 125.462 1.726 . . . . 0.0 113.646 -159.366 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.522 HD13 ' HB3' ' A' ' 43' ' ' LEU . 6.8 mp -85.83 109.32 18.61 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.174 -3.454 . . . . 0.0 106.652 170.496 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -71.44 128.55 36.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.592 2.757 . . . . 0.0 111.126 -175.438 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -52.68 122.42 9.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 124.836 2.255 . . . . 0.0 112.647 166.328 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.1 19.48 5.92 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 118.683 -2.51 . . . . 0.0 110.815 173.848 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.323 26.8 mtt-85 -127.21 170.89 11.94 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 130.643 3.577 . . . . 0.0 113.992 -179.652 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -118.03 162.9 17.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 130.051 3.341 . . . . 0.0 117.893 174.939 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.69 -41.69 56.12 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 122.659 2.481 . . . . 0.0 113.012 173.974 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 t -60.82 -22.24 63.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 118.502 2.778 . . . . 0.0 118.502 -178.739 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -69.23 -37.93 78.25 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 120.792 -1.192 . . . . 0.0 113.677 168.999 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -98.54 -1.38 41.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.972 2.109 . . . . 0.0 112.564 -175.264 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 74.31 14.19 3.74 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 129.454 3.102 . . . . 0.0 112.149 168.217 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.267 90.1 mt -55.41 125.45 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 124.082 0.953 . . . . 0.0 113.102 178.743 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -131.89 167.49 19.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.794 2.838 . . . . 0.0 112.271 -176.191 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.326 41.3 pttt -34.57 119.03 0.43 Allowed 'General case' 0 N--CA 1.447 -0.605 1 C-N-CA 132.999 4.52 . . . . 0.0 116.114 -178.122 . . . . . . . . 3 2 . 1 . 107 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 63.94 25.44 13.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 179.507 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 m -70.46 121.41 17.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 115.305 -2.283 . . . . 0.0 107.752 160.189 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -95.87 119.37 34.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 125.725 1.891 . . . . 0.0 107.532 174.896 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.21 147.0 26.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 128.683 2.793 . . . . 0.0 105.574 179.858 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -95.49 154.37 17.24 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 101.374 -3.565 . . . . 0.0 101.374 174.557 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.82 114.55 20.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 125.37 2.51 . . . . 0.0 112.875 161.35 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.7 t -79.86 152.47 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 129.905 3.282 . . . . 0.0 111.391 165.724 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 124.022 1.868 . . . . 0.0 106.848 -174.062 . . . . . . . . 0 0 . 1 . 108 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptt? . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 . . . . . . . . . 0 0 . 1 . 108 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -86.5 157.4 19.79 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 124.404 1.065 . . . . 0.0 110.487 166.294 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.24 158.64 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 128.504 2.722 . . . . 0.0 106.531 155.142 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -113.54 138.13 50.59 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.694 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.4 115.75 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 1 C-N-CA 133.857 4.863 . . . . 0.0 107.738 170.08 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -84.56 135.32 34.26 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.563 1.545 . . . . 0.0 108.863 170.997 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -82.55 169.08 16.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 126.93 2.644 . . . . 0.0 108.118 158.615 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.99 -21.25 24.94 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.062 2.145 . . . . 0.0 109.569 178.848 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 p -68.9 -30.92 69.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 116.329 -3.982 . . . . 0.0 114.764 163.285 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.11 5.96 5.5 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 125.723 3.874 . . . . 0.0 113.639 161.653 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -88.85 130.32 35.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 117.79 -3.182 . . . . 0.0 107.391 175.353 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.8 m -89.17 128.52 35.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 124.962 2.315 . . . . 0.0 107.85 160.997 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.71 135.31 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 1 O-C-N 114.751 -4.968 . . . . 0.0 103.004 173.836 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.4 m -99.9 138.1 37.44 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 127.926 3.266 . . . . 0.0 104.023 176.18 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.441 HD13 HG13 ' A' ' 26' ' ' VAL . 53.9 mt -131.28 142.38 50.11 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.652 1.981 . . . . 0.0 110.432 178.005 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -124.5 110.6 14.68 Favored 'General case' 0 C--N 1.322 -0.622 2 O-C-N 115.748 -4.345 . . . . 0.0 110.35 -170.601 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.44 158.82 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 110.424 -3.08 . . . . 0.0 114.485 -163.022 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -96.39 153.5 38.91 Favored Pre-proline 0 N--CA 1.447 -0.598 0 O-C-N 127.53 3.019 . . . . 0.0 106.946 160.334 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -76.46 -6.66 17.27 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 118.72 2.546 . . . . 0.0 118.72 -170.616 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 m -94.44 7.14 46.57 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.484 1.514 . . . . 0.0 107.624 174.405 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.435 ' CG ' HD22 ' A' ' 25' ' ' ASN . 16.4 t0 -80.95 137.37 36.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 116.986 -3.571 . . . . 0.0 109.76 171.829 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -92.13 149.41 21.5 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 118.185 -2.822 . . . . 0.0 106.839 -156.351 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mp -46.86 -31.92 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 127.684 2.394 . . . . 0.0 114.569 169.673 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.27 -28.29 66.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.495 -1.378 . . . . 0.0 111.342 179.676 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.435 HD22 ' CG ' ' A' ' 21' ' ' ASP . 63.6 t30 -81.32 -33.82 32.28 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 119.534 -1.979 . . . . 0.0 114.42 170.451 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.441 HG13 HD13 ' A' ' 15' ' ' LEU 0.301 39.5 t -59.24 -44.98 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 116.592 -1.67 . . . . 0.0 108.518 170.117 . . . . . . . . 3 3 . 1 . 108 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HA ' HD12 ' A' ' 30' ' ' ILE . 69.9 mttt -50.66 -38.74 48.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.176 2.658 . . . . 0.0 118.176 172.793 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.9 -23.89 31.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 123.623 0.577 . . . . 0.0 112.096 -168.507 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 30.9 mttm -73.08 -29.43 62.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 118.96 -2.338 . . . . 0.0 111.698 175.441 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 27' ' ' LYS . 62.8 mt -70.64 -52.69 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 129.512 3.125 . . . . 0.0 105.943 178.301 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.372 1.1 tp-100 -34.23 -45.24 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 1 O-C-N 115.008 -4.807 . . . . 0.0 119.386 162.088 . . . . . . . . 3 2 . 1 . 108 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -73.71 -44.96 54.99 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 131.289 3.836 . . . . 0.0 109.953 -178.584 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -74.02 -47.35 37.56 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 119.833 3.272 . . . . 0.0 119.833 -177.275 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -135.6 11.8 3.45 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 117.906 -1.045 . . . . 0.0 113.701 -177.205 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.71 -8.38 75.74 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 157.485 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.6 mt -58.71 131.74 85.97 Favored Pre-proline 0 N--CA 1.449 -0.497 1 C-N-CA 134.744 5.218 . . . . 0.0 107.404 173.544 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -80.3 150.51 19.91 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.947 1.098 . . . . 0.0 112.392 -178.574 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.18 -30.83 10.14 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 124.211 3.274 . . . . 0.0 116.985 -175.997 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.38 -3.58 31.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -166.549 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -99.99 -31.15 11.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -173.483 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -75.76 118.01 18.11 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.699 1.6 . . . . 0.0 112.631 -159.407 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -102.11 113.43 26.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 130.77 3.628 . . . . 0.0 105.976 158.407 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.82 150.36 24.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 121.615 2.007 . . . . 0.0 106.932 166.929 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.28 15.2 mt -126.63 139.62 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.905 176.187 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -139.82 115.73 10.27 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 128.101 2.56 . . . . 0.0 109.412 177.659 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 74.56 20.86 2.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.961 2.504 . . . . 0.0 108.262 167.587 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.84 -3.17 73.67 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 130.323 3.821 . . . . 0.0 110.413 -175.141 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -96.66 134.2 40.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 121.516 2.658 . . . . 0.0 106.54 -170.411 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.5 pm0 -80.56 132.07 35.61 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 126.356 2.285 . . . . 0.0 108.843 172.312 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 59' ' ' TYR . 25.6 mt -95.57 155.42 16.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 125.206 2.432 . . . . 0.0 112.209 -172.921 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -118.16 157.01 27.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 112.784 -2.007 . . . . 0.0 109.088 -178.215 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -77.59 137.97 38.87 Favored 'General case' 0 N--CA 1.444 -0.726 1 O-C-N 129.996 4.56 . . . . 0.0 112.589 -172.804 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.67 -21.23 46.97 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 177.905 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -84.78 169.93 13.71 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 127.179 2.191 . . . . 0.0 112.239 168.83 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.7 p -110.55 163.52 13.63 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.179 1.792 . . . . 0.0 110.461 -162.159 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.418 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 5.7 mt -43.48 -47.51 7.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.867 1.667 . . . . 0.0 111.937 152.899 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -63.78 -38.95 93.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.532 1.933 . . . . 0.0 113.109 -170.682 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.53 -45.15 88.42 Favored 'General case' 0 C--N 1.327 -0.376 1 C-N-CA 133.589 4.756 . . . . 0.0 109.123 -178.992 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.421 ' CD2' HD22 ' A' ' 50' ' ' LEU . 35.5 m-85 -96.26 12.13 32.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 124.157 1.932 . . . . 0.0 109.328 -174.654 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.19 42.62 27.9 Favored 'General case' 0 N--CA 1.444 -0.739 2 C-N-CA 132.492 4.317 . . . . 0.0 114.903 175.858 . . . . . . . . 3 3 . 1 . 108 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 mt -93.71 101.7 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 -172.349 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -94.77 177.93 5.75 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.166 -1.379 . . . . 0.0 113.54 -176.604 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -49.01 142.04 7.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.306 3.042 . . . . 0.0 117.136 -174.77 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 88.3 mt-10 63.76 11.38 5.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 120.17 3.396 . . . . 0.0 120.17 179.005 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -73.52 143.77 46.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.445 -177.586 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.8 m -92.29 139.34 30.71 Favored 'General case' 0 N--CA 1.442 -0.848 1 C-N-CA 132.193 4.197 . . . . 0.0 108.194 178.043 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.68 158.05 42.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 130.236 3.415 . . . . 0.0 111.56 169.215 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -126.01 148.54 49.26 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 128.231 2.612 . . . . 0.0 109.409 163.618 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 0.6 OUTLIER -98.41 130.37 45.04 Favored 'General case' 0 N--CA 1.451 -0.378 1 C-N-CA 132.329 4.252 . . . . 0.0 109.494 167.383 . . . . . . . . 4 3 . 1 . 108 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -103.44 136.37 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.045 164.749 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 mt . . . . . 0 N--CA 1.446 -0.64 0 C-N-CA 129.682 3.193 . . . . 0.0 110.638 178.506 . . . . . . . . 0 0 . 1 . 109 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 . . . . . . . . . 0 0 . 1 . 109 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.298 8.8 tt0 -88.62 144.15 26.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 125.718 2.675 . . . . 0.0 108.393 -175.092 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.26 149.38 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 111.214 -2.721 . . . . 0.0 108.848 -179.154 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -88.66 144.15 26.47 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 127.843 2.457 . . . . 0.0 113.965 168.102 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.09 99.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 118.187 -2.821 . . . . 0.0 104.147 -174.154 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -77.05 99.62 5.39 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 167.789 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.4 p -72.04 173.15 8.83 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 126.553 2.408 . . . . 0.0 114.47 166.447 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -40.19 -40.68 1.16 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 129.494 3.118 . . . . 0.0 118.815 -168.352 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.1 p -80.83 -6.43 58.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 171.864 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.71 0.6 60.54 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 123.85 1.806 . . . . 0.0 113.764 -170.369 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -69.22 106.58 2.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.919 -1.641 . . . . 0.0 108.014 -173.848 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.7 m -79.39 112.38 16.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 110.19 -3.187 . . . . 0.0 111.844 -178.304 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mt -110.75 137.27 43.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 1 CA-C-N 106.954 -4.657 . . . . 0.0 109.485 173.214 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.8 m -100.41 125.09 46.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 179.912 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tp -133.73 159.94 39.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 128.665 2.786 . . . . 0.0 110.408 -172.845 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -128.46 155.72 44.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 175.247 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.22 151.3 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 O-C-N 126.336 2.273 . . . . 0.0 107.599 -175.02 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -100.13 136.78 20.02 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 100.953 -3.721 . . . . 0.0 100.953 173.189 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -34.36 -42.01 0.27 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 1 C-N-CA 128.003 5.802 . . . . 0.0 119.326 174.228 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 p -79.3 -13.24 59.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 114.257 -2.782 . . . . 0.0 116.036 179.562 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -47.94 125.52 9.08 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.796 2.038 . . . . 0.0 112.354 -179.468 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.412 HG22 HG22 ' A' ' 55' ' ' THR . 81.9 p -69.39 151.7 45.82 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.911 2.485 . . . . 0.0 111.917 163.067 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.6 mm -63.31 -32.72 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 124.029 3.104 . . . . 0.0 119.151 -174.445 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -54.9 -33.05 61.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.057 2.143 . . . . 0.0 113.339 158.104 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -79.56 -15.67 57.27 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.662 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -82.72 -48.92 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 118.941 -2.349 . . . . 0.0 109.364 169.159 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -60.29 -27.93 67.69 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.275 0.984 . . . . 0.0 113.575 176.309 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.37 -23.43 43.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 118.786 -2.446 . . . . 0.0 116.963 176.699 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -78.24 -47.4 18.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.151 175.725 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.263 26.2 mt -51.02 -40.45 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 O-C-N 128.45 3.594 . . . . 0.0 109.977 169.367 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.62 -62.43 1.86 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.623 1.969 . . . . 0.0 114.024 179.441 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -43.38 -23.7 0.07 Allowed 'General case' 0 N--CA 1.45 -0.436 1 C-N-CA 136.039 5.735 . . . . 0.0 116.699 -178.385 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -96.78 -12.23 23.93 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 131.526 3.931 . . . . 0.0 117.513 179.194 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -160.16 -16.83 0.06 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 122.948 2.613 . . . . 0.0 110.346 -179.082 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.66 11.87 22.19 Favored Glycine 0 CA--C 1.524 0.644 1 C-N-CA 113.679 -4.105 . . . . 0.0 111.401 162.477 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.59 127.61 28.16 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 121.35 2.575 . . . . 0.0 108.457 -170.352 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -68.13 147.3 72.81 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 CA-C-O 114.644 -2.315 . . . . 0.0 111.792 -172.154 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.252 71.3 Cg_exo -44.67 -38.4 12.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 O-C-N 126.711 2.953 . . . . 0.0 117.409 167.887 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.98 -24.79 55.96 Favored 'General case' 0 C--N 1.325 -0.469 1 C-N-CA 131.896 4.078 . . . . 0.0 113.433 179.439 . . . . . . . . 3 3 . 1 . 109 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -110.29 -28.38 8.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 125.709 1.881 . . . . 0.0 110.136 -178.258 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -60.49 104.58 0.35 Allowed 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 119.942 -1.724 . . . . 0.0 111.557 177.668 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -110.56 128.57 55.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 130.205 3.402 . . . . 0.0 102.689 179.885 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 99.29 3.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -157.929 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.8 mm -99.2 128.04 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 -166.153 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.48 ' CE2' HG12 ' A' ' 61' ' ' ILE . 61.7 t80 -146.5 109.66 4.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 -177.928 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 79.99 35.21 0.15 Allowed 'General case' 0 CA--C 1.53 0.178 0 O-C-N 125.496 1.748 . . . . 0.0 109.779 178.355 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.67 -10.51 70.68 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 114.784 -3.579 . . . . 0.0 109.572 169.46 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.259 19.6 pttt -143.89 145.36 32.24 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.723 -2.633 . . . . 0.0 106.208 -161.796 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -72.2 135.25 46.05 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.701 2.4 . . . . 0.0 107.632 -175.977 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.76 107.65 19.07 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.842 1.657 . . . . 0.0 110.464 -179.445 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -114.75 161.57 17.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.412 -2.055 . . . . 0.0 105.862 -159.751 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.0 149.94 30.58 Favored 'General case' 0 N--CA 1.447 -0.61 1 C-N-CA 133.458 4.703 . . . . 0.0 107.423 -178.216 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.86 -21.71 31.39 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 169.584 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -101.49 157.58 16.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.715 2.806 . . . . 0.0 108.577 -172.513 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.412 HG22 HG22 ' A' ' 22' ' ' THR . 22.0 p -113.83 174.94 5.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.991 0.9 . . . . 0.0 109.43 163.662 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.0 mt -53.27 -38.01 62.66 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 176.753 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -60.82 -22.98 64.73 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 167.915 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -86.71 -0.23 55.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 118.446 -2.659 . . . . 0.0 113.94 -178.557 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -138.0 -6.54 1.64 Allowed 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 117.867 -3.021 . . . . 0.0 110.976 172.735 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 67.12 71.37 0.37 Allowed 'General case' 0 N--CA 1.442 -0.855 1 C-N-CA 133.467 4.707 . . . . 0.0 110.3 -177.987 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.48 HG12 ' CE2' ' A' ' 45' ' ' PHE . 70.4 mt -120.18 135.54 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 -177.95 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.264 11.9 pt20 -152.27 -166.61 2.53 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 126.005 2.066 . . . . 0.0 109.936 173.15 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -50.53 142.13 11.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.787 1.635 . . . . 0.0 114.034 -174.373 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 11.4 tp10 89.15 -8.35 0.43 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.543 1.537 . . . . 0.0 114.004 164.404 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -62.84 151.55 38.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 118.24 2.682 . . . . 0.0 118.24 170.128 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -106.8 118.01 35.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 171.802 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.5 mt -89.5 143.93 26.43 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 128.53 2.732 . . . . 0.0 105.592 167.596 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.37 25.6 p80 -133.78 135.76 44.08 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 116.261 -1.828 . . . . 0.0 109.274 -174.457 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.5 154.51 40.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 124.566 1.166 . . . . 0.0 112.561 -164.727 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.48 -179.8 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 131.422 3.889 . . . . 0.0 110.358 169.013 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.311 4.4 mp . . . . . 0 C--O 1.239 0.516 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.288 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 115.283 -2.294 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 110 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -81.46 142.22 33.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 123.538 1.637 . . . . 0.0 107.079 167.401 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pt -127.91 152.63 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 116.268 -1.825 . . . . 0.0 107.466 161.675 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -94.11 142.71 27.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 115.627 -2.429 . . . . 0.0 111.897 172.648 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.29 53.1 t -114.68 83.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 1 C-N-CA 132.829 4.452 . . . . 0.0 108.204 169.2 . . . . . . . . 3 2 . 1 . 110 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -64.03 130.83 45.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 110.071 -3.24 . . . . 0.0 109.812 172.255 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -132.65 154.26 50.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.783 0.833 . . . . 0.0 110.306 -176.868 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.571 HD12 ' H ' ' A' ' 8' ' ' LEU . 5.8 mp -42.2 -27.2 0.13 Allowed 'General case' 0 N--CA 1.444 -0.74 1 C-N-CA 133.295 4.638 . . . . 0.0 121.031 -170.271 . . . . . . . . 3 3 . 1 . 110 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 39.1 p -119.17 17.01 13.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.229 -161.147 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.33 24.56 23.9 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 130.312 3.815 . . . . 0.0 112.217 171.127 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -105.4 160.2 15.32 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.932 1.366 . . . . 0.0 107.604 173.62 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -127.89 113.86 16.44 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.515 2.326 . . . . 0.0 113.493 174.681 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -90.67 133.86 31.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 116.466 -3.896 . . . . 0.0 103.843 -179.137 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 t -141.72 83.09 1.84 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 127.508 3.528 . . . . 0.0 112.698 -170.534 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.57 150.38 20.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.011 -2.359 . . . . 0.0 111.488 179.216 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -94.93 118.55 31.99 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 101.88 -3.378 . . . . 0.0 101.88 179.015 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -135.18 152.21 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 123.713 0.805 . . . . 0.0 109.085 -176.146 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -106.51 160.0 27.82 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 173.343 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.328 40.9 Cg_endo -66.92 -24.38 46.1 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.388 2.726 . . . . 0.0 115.269 -168.186 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.1 p -84.57 -4.97 59.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 120.608 3.558 . . . . 0.0 120.608 -174.483 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -69.77 132.25 45.79 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 126.414 2.321 . . . . 0.0 109.624 176.727 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -69.82 147.92 49.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 126.857 3.218 . . . . 0.0 105.996 171.727 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mm -59.58 -34.42 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 110.059 -3.246 . . . . 0.0 114.208 179.8 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.65 -30.66 65.99 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 121.897 2.135 . . . . 0.0 111.16 178.605 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -74.81 -26.54 59.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 125.469 1.731 . . . . 0.0 113.736 174.026 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.5 t -78.42 -24.83 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 121.251 1.841 . . . . 0.0 108.399 173.149 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -67.6 -39.8 84.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 123.562 2.892 . . . . 0.0 112.146 164.896 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.64 -31.7 70.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.71 2.004 . . . . 0.0 110.907 179.244 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -71.04 -10.72 60.24 Favored 'General case' 0 N--CA 1.451 -0.42 1 C-N-CA 134.574 5.149 . . . . 0.0 114.183 176.026 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.1 -27.61 4.36 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 127.563 2.345 . . . . 0.0 108.664 176.375 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -54.74 -27.09 38.43 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 123.064 2.666 . . . . 0.0 115.072 174.287 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -33.82 65.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 123.94 1.829 . . . . 0.0 108.474 179.078 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mmtm -96.49 -51.63 4.27 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.547 2.739 . . . . 0.0 107.085 -164.268 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -113.79 -12.17 12.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -173.45 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.42 -16.45 58.97 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 120.562 1.528 . . . . 0.0 111.584 173.11 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.2 mt -87.51 123.21 69.94 Favored Pre-proline 0 N--CA 1.449 -0.521 0 O-C-N 117.328 -3.454 . . . . 0.0 109.191 -159.209 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.03 154.78 38.0 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 O-C-N 116.349 -2.501 . . . . 0.0 108.057 179.206 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -44.73 -34.21 8.0 Favored 'Trans proline' 0 N--CA 1.441 -1.598 1 C-N-CA 126.738 4.959 . . . . 0.0 119.364 177.174 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.11 -38.26 76.13 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.62 2.768 . . . . 0.0 115.223 178.743 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.8 -8.77 57.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 103.914 -2.625 . . . . 0.0 103.914 -172.967 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -100.75 163.7 12.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 123.28 2.764 . . . . 0.0 112.356 178.324 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -144.7 160.45 41.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 109.989 -3.278 . . . . 0.0 108.547 158.338 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 mt -118.48 126.42 52.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.521 2.328 . . . . 0.0 111.623 169.748 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.4 mm -100.76 139.64 21.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 130.788 3.635 . . . . 0.0 106.952 168.296 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 61' ' ' ILE . 12.2 t80 -122.89 -146.12 0.36 Allowed 'General case' 0 C--N 1.332 -0.196 0 O-C-N 126.705 2.503 . . . . 0.0 110.466 173.654 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.11 54.18 1.58 Allowed 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.32 -1.488 . . . . 0.0 110.227 -171.543 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.64 -19.04 19.45 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 117.498 -1.723 . . . . 0.0 110.987 178.451 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -112.8 138.76 49.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 126.559 3.076 . . . . 0.0 107.063 -168.831 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -88.75 123.35 33.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.04 -1.891 . . . . 0.0 108.26 165.281 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 mt -82.22 141.09 33.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 120.9 -1.125 . . . . 0.0 113.201 -174.532 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -98.25 147.62 24.44 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.774 -0.578 . . . . 0.0 110.756 -176.488 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.04 123.52 29.55 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 125.153 1.533 . . . . 0.0 106.909 -177.71 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.1 -29.65 4.08 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 128.178 2.799 . . . . 0.0 114.194 -179.692 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -84.43 154.73 22.61 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 128.408 3.064 . . . . 0.0 106.395 172.484 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -78.6 169.82 17.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 112.226 -2.261 . . . . 0.0 110.918 175.888 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.8 -17.28 63.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 119.793 -1.817 . . . . 0.0 111.467 168.684 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.5 t -92.23 -13.93 29.73 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 118.377 -2.702 . . . . 0.0 111.472 -169.653 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -50.19 -46.04 54.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 130.988 3.715 . . . . 0.0 106.217 168.413 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -101.21 16.47 25.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 123.383 1.563 . . . . 0.0 111.016 -172.159 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.342 10.9 p-10 52.21 40.84 29.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 129.338 3.055 . . . . 0.0 114.183 177.943 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.527 HG12 ' CE2' ' A' ' 45' ' ' PHE . 19.0 mt -76.72 128.64 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 125.599 2.619 . . . . 0.0 106.786 -177.619 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.07 167.64 9.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 109.073 -3.694 . . . . 0.0 111.013 -177.064 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.283 36.0 pttt -40.62 129.68 2.49 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 118.719 2.859 . . . . 0.0 118.719 162.965 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 58.65 3.03 0.26 Allowed 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 126.782 2.551 . . . . 0.0 117.71 173.189 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 t -63.16 152.9 36.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.029 1.732 . . . . 0.0 114.009 174.723 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -102.14 120.41 40.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -160.995 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.83 152.68 22.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.509 2.724 . . . . 0.0 106.502 164.477 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -123.93 137.4 54.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 126.029 2.081 . . . . 0.0 109.638 -175.472 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -118.71 132.77 56.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 119.732 -1.855 . . . . 0.0 108.006 -159.838 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 m -137.64 165.2 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 1 CA-C-N 126.181 4.082 . . . . 0.0 107.384 -170.438 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.1 tp . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 124.027 1.87 . . . . 0.0 109.619 -179.818 . . . . . . . . 0 0 . 1 . 111 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 . . . . . . . . . 0 0 . 1 . 111 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -77.09 143.9 38.91 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 122.725 2.512 . . . . 0.0 112.973 -179.975 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.263 46.7 pt -140.13 168.49 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 125.756 1.91 . . . . 0.0 106.997 173.045 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.94 133.52 31.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 118.326 -2.734 . . . . 0.0 110.569 159.429 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.4 t -93.04 105.58 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 101.194 -3.632 . . . . 0.0 101.194 174.117 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -97.65 104.11 16.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 118.631 -2.543 . . . . 0.0 110.198 171.542 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -86.47 146.58 26.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 126.464 3.03 . . . . 0.0 113.74 -162.876 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 9' ' ' THR . 3.4 pp -70.64 -28.74 65.04 Favored 'General case' 0 N--CA 1.446 -0.64 1 O-C-N 113.3 -5.875 . . . . 0.0 109.443 179.145 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.418 HG23 HD12 ' A' ' 8' ' ' LEU 0.358 30.2 p -62.52 -7.46 4.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 119.667 3.21 . . . . 0.0 119.667 162.282 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.96 -5.63 11.25 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-O 114.685 -3.286 . . . . 0.0 118.4 150.489 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -120.66 160.59 22.97 Favored 'General case' 0 N--CA 1.446 -0.661 1 CA-C-N 125.422 4.611 . . . . 0.0 111.259 -177.568 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -100.39 136.9 39.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 125.441 1.713 . . . . 0.0 109.591 177.174 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mt -113.59 119.09 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.278 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -75.85 126.73 31.56 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 130.652 3.581 . . . . 0.0 106.099 169.948 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.26 160.85 39.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 124.177 1.942 . . . . 0.0 105.904 -173.481 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -125.87 131.47 52.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.076 2.151 . . . . 0.0 109.244 -178.184 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 m -137.27 169.83 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 O-C-N 127.382 2.926 . . . . 0.0 110.715 178.238 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.283 0.7 OUTLIER -112.08 146.72 35.41 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 168.382 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -47.99 -33.39 20.29 Favored 'Trans proline' 0 N--CA 1.447 -1.233 1 C-N-CA 129.3 6.667 . . . . 0.0 115.37 158.632 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.9 p -74.47 -6.81 50.45 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 119.516 3.154 . . . . 0.0 119.516 174.279 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -73.02 130.53 40.53 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 129.204 3.002 . . . . 0.0 104.378 179.714 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -77.28 155.85 31.79 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 111.962 -2.381 . . . . 0.0 112.852 163.376 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.367 35.5 mm -49.88 -38.1 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -178.359 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.29 -29.85 62.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.216 2.606 . . . . 0.0 113.632 177.934 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -75.94 -34.62 59.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 114.562 -2.637 . . . . 0.0 108.342 172.565 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.11 -42.69 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 120.673 1.579 . . . . 0.0 111.029 175.058 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -63.59 -27.09 69.01 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 118.441 -2.662 . . . . 0.0 111.755 179.484 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.32 . . -80.21 -22.09 42.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 116.312 -1.804 . . . . 0.0 111.727 179.962 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -80.08 -23.09 41.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 113.99 -2.909 . . . . 0.0 104.903 173.617 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 69' ' ' LEU . 96.2 mt -74.6 -37.4 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 166.717 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.356 51.1 tt0 -63.66 -32.29 73.73 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -178.412 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -70.65 -32.31 69.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.391 -2.186 . . . . 0.0 112.187 -177.626 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -98.7 -49.76 4.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 -169.738 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -105.43 -17.6 14.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 120.721 -1.237 . . . . 0.0 107.839 -165.148 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.52 4.73 57.1 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 120.769 -1.207 . . . . 0.0 114.178 171.208 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.1 mm -91.4 124.41 61.21 Favored Pre-proline 0 C--O 1.236 0.384 0 O-C-N 119.51 -2.171 . . . . 0.0 110.83 -169.904 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -66.5 141.69 62.18 Favored 'Trans proline' 0 N--CA 1.446 -1.274 1 C-N-CA 128.618 6.212 . . . . 0.0 107.077 -175.202 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.42 -35.48 39.26 Favored 'Trans proline' 0 N--CA 1.445 -1.379 1 C-N-CA 129.286 6.657 . . . . 0.0 108.884 -174.089 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -41.55 -46.83 3.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 166.032 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -79.28 -34.38 42.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 125.891 1.994 . . . . 0.0 113.893 -178.678 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -69.79 145.24 52.31 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 -179.027 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.09 150.82 39.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.022 -1.942 . . . . 0.0 110.008 165.814 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.0 tp -117.75 123.51 46.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 124.351 3.25 . . . . 0.0 103.916 -177.977 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mm -125.25 129.34 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 -168.462 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.413 ' HB3' HD11 ' A' ' 50' ' ' LEU 0.294 64.8 t80 -151.14 109.78 3.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 116.153 -1.88 . . . . 0.0 115.608 172.112 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.529 . . 90.52 42.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 124.772 2.225 . . . . 0.0 113.033 171.903 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.88 -0.09 89.11 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 117.097 -3.502 . . . . 0.0 119.261 179.458 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -142.58 150.13 39.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 110.598 -2.801 . . . . 0.0 113.135 -165.127 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 0.0 OUTLIER -73.94 126.77 31.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 115.267 -2.301 . . . . 0.0 110.958 170.136 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 45' ' ' PHE . 31.6 mt -78.04 126.48 30.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.462 2.705 . . . . 0.0 104.874 167.246 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -103.35 156.95 17.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 110.793 -2.912 . . . . 0.0 111.495 -170.706 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.39 161.24 20.19 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.407 2.283 . . . . 0.0 113.671 -178.286 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.14 -33.29 6.57 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 130.184 3.754 . . . . 0.0 112.359 173.038 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.279 88.6 mtt180 -98.59 153.4 18.69 Favored 'General case' 0 N--CA 1.451 -0.418 1 C-N-CA 135.343 5.457 . . . . 0.0 106.318 -164.037 . . . . . . . . 3 2 . 1 . 111 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.1 p -100.24 163.59 12.33 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 125.739 1.9 . . . . 0.0 108.094 175.763 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mt -49.46 -31.18 9.38 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.029 2.532 . . . . 0.0 117.632 157.25 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.7 p -71.56 -33.64 69.28 Favored 'General case' 0 N--CA 1.449 -0.494 1 O-C-N 114.955 -4.841 . . . . 0.0 107.694 175.186 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -76.46 -32.94 58.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 123.821 3.01 . . . . 0.0 107.042 -176.235 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -79.32 -19.76 49.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 115.156 -2.354 . . . . 0.0 109.147 170.178 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 72.6 43.13 0.48 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.287 2.635 . . . . 0.0 107.464 176.043 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -80.91 143.62 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 117.63 -3.169 . . . . 0.0 111.021 175.797 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -133.74 159.71 39.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 129.117 2.967 . . . . 0.0 115.66 -178.196 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.16 139.25 1.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 120.124 3.379 . . . . 0.0 120.124 -175.647 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 32.5 mt-10 69.76 28.11 4.46 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 129.574 3.15 . . . . 0.0 115.731 174.164 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.26 70.9 m -81.66 154.08 26.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 111.92 -2.4 . . . . 0.0 106.382 170.047 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.7 p -98.86 131.91 44.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 126.222 2.915 . . . . 0.0 103.32 166.915 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.03 150.52 38.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 129.654 3.181 . . . . 0.0 102.813 175.979 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.32 140.47 52.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 121.586 1.994 . . . . 0.0 113.412 -166.87 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 30' ' ' ILE 0.287 5.9 mt -91.19 139.87 30.33 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 118.76 -2.462 . . . . 0.0 112.422 165.937 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.25 145.04 33.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 129.291 3.036 . . . . 0.0 106.635 163.229 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.452 -0.361 1 C-N-CA 132.559 4.343 . . . . 0.0 108.916 -167.522 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 125.78 2.705 . . . . 0.0 114.836 . . . . . . . . . 0 0 . 1 . 112 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.266 12.4 mt-30 -85.49 152.79 22.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 119.549 -1.969 . . . . 0.0 110.925 167.769 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.252 18.2 pt -134.24 167.42 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 101.007 -3.701 . . . . 0.0 101.007 162.979 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -131.8 93.4 3.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.429 1.492 . . . . 0.0 108.94 -167.678 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t -90.75 110.47 22.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 101.605 -3.48 . . . . 0.0 101.605 -172.057 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -109.34 137.63 46.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.45 2.3 . . . . 0.0 112.841 177.669 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -86.14 152.45 22.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 103.228 -2.879 . . . . 0.0 103.228 179.291 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -55.06 -19.05 6.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.517 2.727 . . . . 0.0 113.357 174.514 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -94.88 2.22 55.4 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 115.548 -2.168 . . . . 0.0 115.625 170.337 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.84 -12.37 57.74 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 120.769 1.622 . . . . 0.0 114.202 163.861 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -81.45 134.44 35.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -176.234 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -125.99 122.81 36.97 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 119.803 -1.81 . . . . 0.0 108.192 -159.283 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mt -95.39 122.6 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 120.229 -1.544 . . . . 0.0 110.04 169.014 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.6 m -96.55 112.68 24.33 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 125.04 2.352 . . . . 0.0 105.613 -178.242 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.52 116.42 31.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.982 1.713 . . . . 0.0 109.242 -170.244 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -77.02 127.92 33.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 127.302 2.877 . . . . 0.0 110.129 160.785 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.262 34.5 m -138.86 157.73 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 1 C-N-CA 133.454 4.702 . . . . 0.0 115.419 -178.393 . . . . . . . . 3 2 . 1 . 112 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.285 27.1 mm-40 -112.56 158.13 38.28 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 102.844 -3.021 . . . . 0.0 102.844 156.551 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -60.6 -23.08 74.73 Favored 'Trans proline' 0 N--CA 1.447 -1.225 1 C-N-CA 126.873 5.049 . . . . 0.0 116.845 -175.919 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -83.05 -2.58 55.69 Favored 'General case' 0 N--CA 1.44 -0.944 1 C-N-CA 132.062 4.145 . . . . 0.0 113.484 -175.146 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.67 136.2 38.18 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 -174.156 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.4 p -88.89 172.64 9.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.466 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.431 HG22 ' HD2' ' A' ' 27' ' ' LYS . 19.3 mm -70.63 -34.42 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 117.5 -1.238 . . . . 0.0 108.204 -178.616 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -42.52 -46.42 4.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.838 3.255 . . . . 0.0 113.652 170.911 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -70.95 -40.31 72.07 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.984 2.113 . . . . 0.0 116.207 173.833 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -82.36 -21.54 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 O-C-N 117.974 -2.954 . . . . 0.0 108.667 -176.016 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HD2' HG22 ' A' ' 23' ' ' ILE . 30.0 mttt -69.39 -42.22 75.43 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 118.749 -2.469 . . . . 0.0 115.769 170.283 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -35.21 58.22 Favored 'General case' 0 CA--C 1.535 0.403 1 O-C-N 132.228 5.955 . . . . 0.0 113.1 -179.009 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -60.28 -52.44 65.27 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 125.721 1.888 . . . . 0.0 110.403 165.594 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.344 35.9 mt -59.29 -46.13 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 114.993 -2.432 . . . . 0.0 112.917 175.969 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.442 ' HB3' HE21 ' A' ' 31' ' ' GLN 0.377 0.0 OUTLIER -40.07 -63.05 0.65 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 126.296 2.951 . . . . 0.0 115.243 166.3 . . . . . . . . 4 4 . 1 . 112 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.296 37.0 t70 -46.86 -47.46 21.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 110.396 -3.093 . . . . 0.0 118.584 173.314 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -84.56 -39.42 18.79 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.546 1.938 . . . . 0.0 111.29 -165.574 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.63 -14.21 6.33 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 128.301 3.501 . . . . 0.0 115.735 -166.187 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.96 22.05 40.16 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.971 2.7 . . . . 0.0 112.373 176.19 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -97.35 130.53 29.3 Favored Pre-proline 0 N--CA 1.442 -0.852 0 CA-C-N 120.488 2.144 . . . . 0.0 109.83 -178.286 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -76.36 165.12 29.83 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.738 2.292 . . . . 0.0 110.23 -173.845 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.52 -47.24 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 N-CA-C 116.41 1.658 . . . . 0.0 116.41 -174.86 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -61.28 -5.07 1.41 Allowed 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 117.946 2.573 . . . . 0.0 117.946 -175.58 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -99.62 -16.68 18.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.886 1.274 . . . . 0.0 110.245 -169.919 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -88.84 132.07 34.81 Favored 'General case' 0 N--CA 1.44 -0.934 1 C-N-CA 133.171 4.588 . . . . 0.0 110.034 -166.151 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -135.93 147.75 48.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 118.003 -2.936 . . . . 0.0 105.87 163.045 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.1 mt -104.88 128.1 52.97 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 130.668 3.587 . . . . 0.0 110.958 169.768 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 mt -124.78 130.11 73.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 128.151 2.58 . . . . 0.0 107.552 165.423 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -142.46 113.46 7.56 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 119.084 -2.26 . . . . 0.0 105.928 174.331 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.17 36.02 1.16 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 120.431 1.469 . . . . 0.0 110.536 157.872 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.88 -47.18 1.41 Allowed Glycine 0 CA--C 1.523 0.571 0 CA-C-O 126.131 3.073 . . . . 0.0 116.095 -167.146 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -76.64 126.63 31.32 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 120.159 -1.789 . . . . 0.0 113.097 -166.995 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -71.52 132.83 45.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 124.928 2.299 . . . . 0.0 106.94 154.961 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.455 HD22 ' CD2' ' A' ' 59' ' ' TYR 0.291 0.2 OUTLIER -91.92 124.88 36.36 Favored 'General case' 0 C--O 1.237 0.414 1 O-C-N 115.824 -4.297 . . . . 0.0 108.056 172.213 . . . . . . . . 5 4 . 1 . 112 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -78.15 156.19 30.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.397 2.279 . . . . 0.0 115.58 174.582 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.376 26.6 m-20 -71.44 133.49 45.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 124.345 2.021 . . . . 0.0 113.106 167.921 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.3 -11.38 39.92 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 128.544 2.973 . . . . 0.0 114.019 176.398 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -71.52 153.09 42.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 126.202 1.766 . . . . 0.0 112.217 170.78 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -99.74 143.42 29.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.291 1.837 . . . . 0.0 107.332 170.278 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.57 -33.67 76.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 -166.395 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -84.31 -23.33 30.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.008 -1.472 . . . . 0.0 114.485 -173.47 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -54.01 -36.78 63.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 126.077 2.846 . . . . 0.0 112.55 168.695 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CD2' HD22 ' A' ' 50' ' ' LEU . 10.5 m-85 -85.59 -6.6 59.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 128.745 2.818 . . . . 0.0 114.769 176.595 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.489 17.2 m120 89.81 15.18 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.613 1 C-N-CA 132.994 4.518 . . . . 0.0 118.116 177.719 . . . . . . . . 3 2 . 1 . 112 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.8 mt -81.96 112.82 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 116.174 -2.21 . . . . 0.0 108.296 -177.298 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -124.1 170.84 10.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 124.733 1.271 . . . . 0.0 108.144 -167.589 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.327 44.4 pttt -43.03 122.02 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.902 2.481 . . . . 0.0 115.668 -169.126 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 66.97 24.72 9.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 178.285 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.275 56.7 m -75.71 125.27 28.73 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 124.017 1.865 . . . . 0.0 110.56 170.258 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 m -84.81 131.59 34.52 Favored 'General case' 0 C--N 1.323 -0.562 1 C-N-CA 132.158 4.183 . . . . 0.0 100.831 173.487 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -142.61 112.41 6.89 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 -164.911 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -46.13 103.52 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 113.746 -3.026 . . . . 0.0 115.407 159.446 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -96.1 102.5 14.3 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 121.531 1.969 . . . . 0.0 112.43 176.392 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.7 t -69.08 109.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 128.578 2.751 . . . . 0.0 108.909 -176.433 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 mt . . . . . 0 N--CA 1.44 -0.959 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.566 . . . . . . . . 0 0 . 1 . 113 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptm . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 113 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -84.5 134.81 34.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 114.602 -2.618 . . . . 0.0 106.643 179.117 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.314 28.0 pt -125.86 171.53 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 1 O-C-N 129.138 4.024 . . . . 0.0 108.134 173.774 . . . . . . . . 3 2 . 1 . 113 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -132.75 143.1 49.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 163.04 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.44 113.28 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 126.307 1.843 . . . . 0.0 108.878 169.268 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -83.02 134.38 35.05 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -177.437 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.29 36.9 m -87.11 149.89 24.37 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 116.765 -1.588 . . . . 0.0 112.279 168.427 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -19.6 16.49 Favored 'General case' 0 C--N 1.324 -0.527 1 C-N-CA 132.772 4.429 . . . . 0.0 112.469 -174.734 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 p -81.54 -15.78 53.78 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.493 1.917 . . . . 0.0 115.428 166.45 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.25 -9.86 10.96 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 114.289 -3.506 . . . . 0.0 107.302 175.821 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -80.32 122.59 27.1 Favored 'General case' 0 N--CA 1.45 -0.447 1 CA-C-N 124.951 4.375 . . . . 0.0 110.859 -175.044 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -84.7 107.65 17.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 175.96 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.07 126.76 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 120.188 -1.57 . . . . 0.0 110.37 179.093 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.3 p -89.67 133.31 34.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 121.485 1.948 . . . . 0.0 108.09 -179.544 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.5 tp -149.06 136.87 20.54 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.759 2.824 . . . . 0.0 106.444 -165.817 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -116.17 132.8 56.56 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.225 2.21 . . . . 0.0 105.56 -177.824 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -137.44 -177.96 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 129.346 3.058 . . . . 0.0 111.862 -178.745 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -119.24 153.14 53.23 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 124.97 1.308 . . . . 0.0 109.711 163.275 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.297 28.4 Cg_endo -55.52 -34.62 90.33 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 N-CA-C 121.452 3.597 . . . . 0.0 121.452 -179.929 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -75.28 -8.65 57.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 112.588 -2.097 . . . . 0.0 115.716 173.507 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.77 120.42 7.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 120.645 1.566 . . . . 0.0 110.345 174.369 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -61.76 150.26 37.44 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 120.126 -1.609 . . . . 0.0 108.511 161.711 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -59.99 -19.02 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.79 2.036 . . . . 0.0 112.99 179.731 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.14 -23.49 41.09 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.711 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -89.87 -22.11 22.2 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.085 0.954 . . . . 0.0 109.381 178.547 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.78 -40.91 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 O-C-N 126.912 2.632 . . . . 0.0 108.733 166.57 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -69.16 -20.76 64.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 114.048 -2.882 . . . . 0.0 112.77 172.093 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.82 -40.47 47.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 131.541 3.936 . . . . 0.0 111.415 174.611 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -71.34 -28.67 64.24 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.657 3.583 . . . . 0.0 109.708 178.106 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.83 -65.03 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 113.247 -3.264 . . . . 0.0 110.854 157.232 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -46.0 -31.41 2.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 126.563 2.414 . . . . 0.0 115.851 -179.457 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.72 -32.6 43.88 Favored 'General case' 0 C--N 1.329 -0.322 1 C-N-CA 131.79 4.036 . . . . 0.0 111.036 178.23 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -116.27 -39.2 3.43 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -176.823 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -83.56 -31.16 26.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 116.973 -3.579 . . . . 0.0 117.052 -169.953 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.96 -6.5 83.63 Favored Glycine 0 CA--C 1.531 1.094 0 O-C-N 120.944 -1.097 . . . . 0.0 111.126 171.478 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.251 77.1 mt -98.2 129.05 31.64 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-O 115.104 -2.379 . . . . 0.0 105.924 -175.072 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.56 155.69 68.12 Favored 'Trans proline' 0 N--CA 1.449 -1.104 1 C-N-CA 127.153 5.235 . . . . 0.0 117.807 -174.745 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.303 51.3 Cg_exo -42.21 -35.28 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.567 3.511 . . . . 0.0 117.319 170.026 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -43.17 -41.2 3.63 Favored 'General case' 0 CA--C 1.535 0.4 1 O-C-N 114.003 -5.435 . . . . 0.0 117.723 168.555 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -96.55 -6.44 36.96 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 118.244 -2.785 . . . . 0.0 114.363 -170.098 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -102.01 122.93 45.02 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.408 2.683 . . . . 0.0 110.321 175.03 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -120.49 131.42 54.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 173.153 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -118.76 129.07 55.05 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 128.716 2.807 . . . . 0.0 110.364 -175.532 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.36 148.19 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 127.689 2.396 . . . . 0.0 116.144 163.582 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -141.06 114.28 8.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 127.781 3.176 . . . . 0.0 107.509 172.925 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.71 41.37 12.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.789 -1.101 . . . . 0.0 109.626 176.891 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.75 -16.86 34.03 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 117.976 1.95 . . . . 0.0 117.976 177.118 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.365 69.1 mttt -94.5 129.17 41.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.886 1.327 . . . . 0.0 108.301 179.55 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.54 87.49 7.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 131.443 3.897 . . . . 0.0 102.444 178.887 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.5 mt -50.05 136.5 18.84 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 128.346 2.659 . . . . 0.0 115.186 -165.208 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -65.12 114.51 4.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 125.013 1.446 . . . . 0.0 112.89 171.798 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.349 0.0 OUTLIER -66.7 -4.53 9.13 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.972 2.109 . . . . 0.0 116.168 -172.942 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.16 -0.09 16.76 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.221 1.391 . . . . 0.0 111.666 178.434 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -93.23 160.04 15.01 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 159.382 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.8 p -107.28 171.23 7.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 125.166 2.412 . . . . 0.0 108.053 -172.555 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.04 -30.54 62.46 Favored 'General case' 0 C--N 1.326 -0.45 1 O-C-N 114.698 -5.001 . . . . 0.0 109.316 -178.059 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 t -67.06 -33.26 75.12 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 173.561 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -71.93 -23.02 61.4 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.958 2.503 . . . . 0.0 111.515 178.098 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -91.54 -3.79 56.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 170.755 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 t30 58.71 36.57 24.99 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 131.589 3.956 . . . . 0.0 114.77 179.784 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -77.08 125.33 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 O-C-N 124.955 1.409 . . . . 0.0 114.506 -173.889 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -98.51 176.24 5.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 125.082 2.372 . . . . 0.0 107.852 -170.769 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.94 117.05 3.89 Favored 'General case' 0 N--CA 1.441 -0.897 1 C-N-CA 131.708 4.003 . . . . 0.0 110.055 -177.787 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 68.79 44.23 1.15 Allowed 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 127.593 3.058 . . . . 0.0 111.944 163.491 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.1 p -100.27 157.7 16.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 125.708 2.67 . . . . 0.0 111.652 160.695 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -106.73 127.02 53.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 116.43 -3.919 . . . . 0.0 110.33 -166.766 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.36 172.38 8.79 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 129.294 3.037 . . . . 0.0 104.295 164.918 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -133.64 136.72 44.98 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.731 2.012 . . . . 0.0 109.169 -179.199 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -127.09 108.11 10.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 101.452 -3.536 . . . . 0.0 101.452 -163.907 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.34 116.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 1 O-C-N 130.375 4.797 . . . . 0.0 110.656 163.639 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 101.498 -3.519 . . . . 0.0 101.498 177.37 . . . . . . . . 0 0 . 1 . 114 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 123.322 1.534 . . . . 0.0 108.764 . . . . . . . . . 0 0 . 1 . 114 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.256 43.6 mt-30 -113.76 128.72 56.53 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 111.373 -2.649 . . . . 0.0 112.859 -179.046 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.358 17.2 pt -144.7 138.36 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 128.286 3.491 . . . . 0.0 110.084 -175.39 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -106.28 121.23 43.79 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 127.377 2.923 . . . . 0.0 110.781 -163.823 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.65 87.46 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 172.202 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -86.88 149.0 25.12 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 117.338 -3.351 . . . . 0.0 107.268 -172.462 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.277 42.4 m -103.7 140.29 37.8 Favored 'General case' 0 N--CA 1.447 -0.595 1 C-N-CA 133.097 4.559 . . . . 0.0 105.565 175.863 . . . . . . . . 3 2 . 1 . 114 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.309 0.4 OUTLIER -46.29 -24.76 0.52 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 120.006 3.336 . . . . 0.0 120.006 -179.423 . . . . . . . . 3 3 . 1 . 114 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.29 6.9 p -94.82 5.72 51.07 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.836 2.454 . . . . 0.0 108.395 -174.982 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.19 0.18 44.3 Favored Glycine 0 CA--C 1.531 1.049 1 C-N-CA 134.76 5.933 . . . . 0.0 111.172 158.292 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -65.83 138.79 58.14 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 116.488 -3.948 . . . . 0.0 111.275 170.997 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.353 12.0 m -124.31 112.1 16.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.975 2.11 . . . . 0.0 111.553 -170.258 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 mm -100.99 148.87 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 173.313 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.353 7.1 p -129.22 128.88 44.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 111.641 -2.527 . . . . 0.0 111.151 -164.084 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.43 HD13 HG22 ' A' ' 26' ' ' VAL . 86.7 mt -106.38 125.56 51.15 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.849 1.26 . . . . 0.0 111.114 176.656 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -88.51 93.03 9.41 Favored 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 132.886 4.474 . . . . 0.0 107.235 162.943 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.18 162.18 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 O-C-N 118.364 -2.71 . . . . 0.0 111.06 -176.184 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.265 3.4 tp10 -115.91 135.36 22.72 Favored Pre-proline 0 N--CA 1.447 -0.6 0 N-CA-C 101.286 -3.598 . . . . 0.0 101.286 176.119 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -34.16 -40.55 0.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 1 C-N-CA 128.135 5.89 . . . . 0.0 115.148 -176.918 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -80.06 -1.37 39.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.323 2.249 . . . . 0.0 114.585 -171.505 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -65.25 135.9 55.95 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 130.746 3.618 . . . . 0.0 107.73 174.707 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -65.03 159.69 22.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.029 2.932 . . . . 0.0 112.902 171.771 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 23' ' ' ILE . 3.5 mm -74.39 -31.84 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 124.777 1.298 . . . . 0.0 110.392 178.456 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.79 -30.5 71.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 128.496 2.718 . . . . 0.0 112.203 172.965 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -80.9 -24.56 38.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 119.367 -2.083 . . . . 0.0 109.611 173.101 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.43 HG22 HD13 ' A' ' 15' ' ' LEU 0.255 1.0 OUTLIER -72.28 -20.11 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 122.5 1.143 . . . . 0.0 111.913 175.978 . . . . . . . . 4 4 . 1 . 114 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -73.4 -43.89 59.57 Favored 'General case' 0 C--N 1.323 -0.553 1 C-N-CA 133.335 4.654 . . . . 0.0 114.031 173.854 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.62 89.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.213 2.205 . . . . 0.0 111.908 174.384 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -69.3 -10.32 57.33 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.354 2.661 . . . . 0.0 116.8 173.434 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.27 58.1 mt -94.24 -40.45 11.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 O-C-N 127.509 3.005 . . . . 0.0 109.809 163.859 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -61.48 -62.93 1.47 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 130.567 3.547 . . . . 0.0 110.333 -174.917 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -41.72 -37.92 1.32 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.109 2.564 . . . . 0.0 116.673 170.307 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -79.16 -70.6 0.49 Allowed 'General case' 0 C--N 1.32 -0.683 0 O-C-N 128.32 3.513 . . . . 0.0 118.88 167.349 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -98.24 -5.5 33.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.432 -161.342 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.11 0.32 74.37 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 126.56 2.029 . . . . 0.0 114.814 166.995 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.1 mt -79.6 133.38 59.43 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-O 113.15 -3.309 . . . . 0.0 106.41 -165.283 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.83 162.65 23.86 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 CA-C-N 126.691 3.425 . . . . 0.0 111.538 -173.586 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.83 -51.46 0.38 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 123.876 3.051 . . . . 0.0 116.573 -166.034 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.95 -11.23 55.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 126.39 2.995 . . . . 0.0 113.914 -163.984 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -96.57 -17.59 20.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 113.689 -3.053 . . . . 0.0 110.165 -172.483 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.25 139.2 30.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 126.161 2.886 . . . . 0.0 107.72 -176.332 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.26 71.2 mtt180 -131.42 142.01 49.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 128.67 2.788 . . . . 0.0 112.985 162.028 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.55 0.6 OUTLIER -133.99 139.95 46.41 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 -164.755 . . . . . . . . 3 3 . 1 . 114 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.297 68.1 mt -132.52 130.14 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.209 1.804 . . . . 0.0 109.707 -160.988 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -159.27 133.88 7.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.077 2.151 . . . . 0.0 112.609 179.037 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.53 34.61 15.88 Favored 'General case' 0 N--CA 1.439 -0.986 1 C-N-CA 133.398 4.679 . . . . 0.0 112.78 -176.916 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.48 -30.05 7.51 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 115.514 -2.826 . . . . 0.0 112.21 174.478 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -120.12 148.04 44.12 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 120.502 2.151 . . . . 0.0 111.002 -159.939 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -71.83 129.28 38.24 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.998 2.119 . . . . 0.0 108.04 171.151 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mp -75.05 109.69 8.73 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 129.826 3.25 . . . . 0.0 108.853 -176.295 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -73.25 130.06 39.39 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 129.635 3.174 . . . . 0.0 110.217 -172.927 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.293 73.4 m-20 -46.24 129.7 10.3 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 129.394 3.078 . . . . 0.0 112.991 166.811 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.54 20.49 47.82 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 124.963 2.424 . . . . 0.0 111.317 172.733 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.23 177.18 4.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.598 2.359 . . . . 0.0 113.672 170.161 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.406 ' H ' ' CG ' ' A' ' 58' ' ' ASP . 43.5 p -118.29 163.83 16.11 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 125.209 2.433 . . . . 0.0 110.503 162.561 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.9 mt -53.93 -37.67 64.09 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 117.128 -3.482 . . . . 0.0 113.899 169.87 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.2 t -58.45 -31.97 68.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 124.725 2.202 . . . . 0.0 114.073 172.173 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 55' ' ' THR . 19.7 m-20 -63.46 -30.22 71.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 119.329 -2.107 . . . . 0.0 115.291 177.426 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -96.78 7.57 46.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 130.615 3.566 . . . . 0.0 109.245 178.456 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.8 t30 35.7 47.61 0.4 Allowed 'General case' 0 N--CA 1.448 -0.53 2 O-C-N 113.535 -5.728 . . . . 0.0 114.558 -172.51 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -88.91 110.75 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 128.114 2.566 . . . . 0.0 106.844 178.677 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -111.31 170.01 8.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.853 3.261 . . . . 0.0 112.682 -173.738 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -49.89 131.61 22.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 112.457 -177.475 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.453 5.4 pt-20 65.98 39.09 4.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.048 2.939 . . . . 0.0 118.146 178.511 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.7 p -87.18 140.73 29.25 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.411 1.884 . . . . 0.0 107.292 165.454 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 79.7 m -96.22 130.82 43.2 Favored 'General case' 0 N--CA 1.442 -0.858 2 C-N-CA 133.509 4.723 . . . . 0.0 107.108 164.333 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -123.67 175.49 6.81 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.941 1.696 . . . . 0.0 108.743 -176.7 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -111.38 149.88 30.57 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 118.457 -2.652 . . . . 0.0 112.335 178.21 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -121.85 138.55 54.34 Favored 'General case' 0 N--CA 1.448 -0.529 1 C-N-CA 134.395 5.078 . . . . 0.0 109.907 178.995 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 t -133.41 104.12 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 1 CA-C-O 130.104 4.764 . . . . 0.0 104.937 176.913 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.0 mt . . . . . 0 N--CA 1.451 -0.406 1 O-C-N 113.14 -5.975 . . . . 0.0 105.495 179.286 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.2 ttp . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 113.947 -2.93 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 115 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -88.11 130.28 35.06 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 124.175 1.941 . . . . 0.0 115.491 -179.387 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 pt -115.42 174.86 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 111.421 -2.627 . . . . 0.0 111.222 155.391 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.278 52.0 p90 -147.33 143.4 28.02 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 169.143 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.63 99.04 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 130.398 3.479 . . . . 0.0 105.395 -156.487 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -83.7 133.07 34.82 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.975 2.11 . . . . 0.0 105.513 176.236 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.283 45.1 p -99.77 -171.56 2.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.043 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.77 -6.61 57.62 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 130.602 3.561 . . . . 0.0 115.325 170.373 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -117.11 -163.9 0.95 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 112.214 -2.266 . . . . 0.0 106.984 -179.723 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.03 50.7 0.77 Allowed Glycine 0 CA--C 1.524 0.656 0 O-C-N 124.757 1.285 . . . . 0.0 112.139 -178.087 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.343 66.9 tttt -119.69 139.1 52.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.48 3.912 . . . . 0.0 106.853 167.696 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.6 m -131.71 117.88 19.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 115.563 -2.161 . . . . 0.0 106.896 179.888 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.6 mt -100.46 129.32 51.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 -170.448 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -92.86 146.65 23.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 177.117 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.92 127.03 27.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 -170.801 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -108.18 98.05 7.65 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 126.407 3.003 . . . . 0.0 114.291 175.424 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.3 164.08 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 117.606 -3.184 . . . . 0.0 114.515 -166.411 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.98 137.09 31.62 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 117.085 -1.436 . . . . 0.0 110.028 171.587 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -85.01 -3.92 9.68 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.516 2.811 . . . . 0.0 113.682 -172.822 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.4 p -80.72 -2.11 45.53 Favored 'General case' 0 C--N 1.33 -0.264 1 CA-C-O 108.846 -5.359 . . . . 0.0 112.523 167.435 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -89.1 152.81 21.44 Favored 'General case' 0 N--CA 1.447 -0.59 1 O-C-N 130.172 4.67 . . . . 0.0 110.709 177.45 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -83.42 151.35 25.53 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.98 1.712 . . . . 0.0 107.427 -175.718 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.496 HD11 HD23 ' A' ' 56' ' ' LEU . 22.8 mm -53.62 -33.39 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.812 174.639 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -62.41 -52.08 64.98 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 129.387 3.075 . . . . 0.0 108.243 -173.63 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -77.57 -23.2 50.06 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 109.441 -3.527 . . . . 0.0 113.572 -174.323 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.34 35.2 t -58.4 -50.34 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 129.952 3.301 . . . . 0.0 110.916 162.452 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HE2' HG22 ' A' ' 23' ' ' ILE . 55.1 mtmt -67.15 -38.46 85.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 127.203 2.814 . . . . 0.0 114.182 175.452 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.68 -4.58 16.2 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 117.841 -3.037 . . . . 0.0 117.404 163.329 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -92.82 -42.67 9.42 Favored 'General case' 0 C--N 1.328 -0.351 1 O-C-N 115.691 -4.381 . . . . 0.0 105.093 175.407 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -49.2 -39.48 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 1 C-N-CA 132.228 4.211 . . . . 0.0 114.267 165.6 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.257 46.3 tt0 -46.1 -45.11 16.17 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.309 2.243 . . . . 0.0 116.752 175.288 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.34 -41.25 98.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 112.858 -1.974 . . . . 0.0 111.077 173.585 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -76.4 -54.17 7.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.079 -169.787 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -101.77 -5.33 25.02 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 126.251 2.219 . . . . 0.0 114.657 -172.659 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.21 6.16 89.02 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 121.487 3.355 . . . . 0.0 121.487 165.293 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.473 HD12 ' HD2' ' A' ' 37' ' ' PRO 0.266 4.0 tp -100.61 141.62 23.03 Favored Pre-proline 0 N--CA 1.454 -0.273 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -167.085 . . . . . . . . 4 3 . 1 . 115 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HD2' HD12 ' A' ' 36' ' ' ILE . 97.6 Cg_endo -70.6 161.11 47.21 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.969 2.446 . . . . 0.0 113.909 169.565 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.88 -9.43 10.85 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 N-CA-C 117.795 2.19 . . . . 0.0 117.795 -162.198 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -95.55 8.15 44.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 117.731 -3.105 . . . . 0.0 113.188 -178.175 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -119.89 -4.15 10.17 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 112.384 -2.189 . . . . 0.0 115.614 -175.207 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.302 78.4 mt-30 -99.59 138.0 37.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 128.454 2.702 . . . . 0.0 104.618 175.182 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -129.99 102.95 6.5 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 103.184 -2.895 . . . . 0.0 103.184 174.146 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.7 mt -81.61 128.41 33.9 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 119.899 -1.751 . . . . 0.0 107.47 169.119 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mt -113.46 119.89 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 1 C-N-CA 132.275 4.23 . . . . 0.0 106.963 175.894 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -105.18 128.86 53.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 101.082 -3.673 . . . . 0.0 101.082 153.152 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 73.0 -108.28 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 129.071 2.948 . . . . 0.0 110.495 171.166 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.54 22.69 4.11 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.159 1.361 . . . . 0.0 112.111 164.689 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -98.23 108.37 21.06 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.208 3.003 . . . . 0.0 109.929 166.723 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -80.88 108.7 14.77 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 173.86 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.8 mt -67.29 146.3 54.27 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.05 -159.914 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -101.39 134.5 44.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.691 1.596 . . . . 0.0 108.539 -168.299 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 1.9 m-20 -57.33 -37.69 72.93 Favored 'General case' 0 N--CA 1.442 -0.852 1 C-N-CA 132.58 4.352 . . . . 0.0 115.25 -155.489 . . . . . . . . 3 3 . 1 . 115 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.01 -13.72 24.53 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 119.018 -2.301 . . . . 0.0 112.051 -169.38 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -69.7 152.8 44.25 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 118.998 -2.472 . . . . 0.0 107.948 166.832 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.4 p -78.5 179.3 7.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 127.362 2.265 . . . . 0.0 111.902 171.319 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.496 HD23 HD11 ' A' ' 23' ' ' ILE . 43.7 mt -84.51 -26.6 27.99 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 120.165 -1.584 . . . . 0.0 109.273 166.273 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.8 p -69.84 -22.64 63.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 130.203 3.401 . . . . 0.0 110.427 173.923 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -75.88 -29.6 58.56 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 121.783 2.083 . . . . 0.0 111.116 168.954 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -90.85 -2.63 57.74 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.249 1.42 . . . . 0.0 107.912 178.549 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 5.0 t-20 59.53 38.39 22.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.99 2.916 . . . . 0.0 116.087 -179.705 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.6 mm -76.63 105.48 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 126.848 2.059 . . . . 0.0 108.624 -176.643 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 63' ' ' LYS . 2.4 tp-100 -84.67 166.77 16.79 Favored 'General case' 0 C--O 1.238 0.481 1 C-N-CA 133.517 4.727 . . . . 0.0 109.811 178.478 . . . . . . . . 3 3 . 1 . 115 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.45 ' N ' ' HG3' ' A' ' 62' ' ' GLN . 20.5 pttt -61.6 135.68 57.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 115.684 -2.103 . . . . 0.0 110.245 -173.346 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 68.79 26.76 5.94 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 131.445 3.898 . . . . 0.0 115.087 177.577 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 m -79.54 115.5 19.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 102.242 -3.244 . . . . 0.0 102.242 -177.966 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -73.36 137.62 44.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 129.23 3.012 . . . . 0.0 107.904 173.49 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.83 176.97 8.23 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 167.234 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -122.65 122.63 39.27 Favored 'General case' 0 N--CA 1.45 -0.474 1 O-C-N 116.165 -4.085 . . . . 0.0 106.301 -173.634 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.451 ' CD2' HD22 ' A' ' 71' ' ' LEU . 55.0 tp -97.91 133.06 42.9 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 124.154 1.93 . . . . 0.0 107.019 171.747 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.34 128.77 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 163.944 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 69' ' ' LEU . 2.5 pt? . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 121.675 2.034 . . . . 0.0 109.167 165.701 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 . . . . . . . . . 0 0 . 1 . 116 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.84 151.67 19.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 124.076 0.86 . . . . 0.0 110.403 -177.207 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.303 49.2 pt -141.61 155.62 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 1 C-N-CA 131.802 4.041 . . . . 0.0 110.996 162.278 . . . . . . . . 3 2 . 1 . 116 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -110.93 156.42 21.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 127.664 3.102 . . . . 0.0 110.902 179.058 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.328 82.0 t -136.67 128.13 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 100.763 -3.792 . . . . 0.0 100.763 174.246 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -82.41 125.58 31.22 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 118.404 -2.685 . . . . 0.0 105.63 161.496 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -80.68 167.87 19.52 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.158 1.456 . . . . 0.0 110.213 168.321 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.96 -29.96 69.95 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 117.855 -3.028 . . . . 0.0 113.278 -178.696 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 p -77.54 -25.07 49.85 Favored 'General case' 0 N--CA 1.447 -0.597 1 C-N-CA 132.877 4.471 . . . . 0.0 115.559 171.076 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.46 -2.09 9.54 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 126.799 2.562 . . . . 0.0 110.633 154.301 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -78.37 137.1 37.85 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.503 2.721 . . . . 0.0 105.795 -179.485 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -92.96 123.1 35.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.112 2.165 . . . . 0.0 107.085 -174.422 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.7 mm -111.27 129.61 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 127.863 2.465 . . . . 0.0 105.963 -174.376 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -95.58 120.57 36.06 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.676 2.79 . . . . 0.0 110.564 172.039 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -112.28 131.76 55.33 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.169 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -96.33 116.03 28.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 129.0 3.938 . . . . 0.0 110.008 160.598 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.38 160.7 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 131.511 3.925 . . . . 0.0 109.247 -165.378 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -71.23 152.75 94.43 Favored Pre-proline 0 N--CA 1.446 -0.668 0 O-C-N 117.408 -3.307 . . . . 0.0 108.163 163.197 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -71.11 -18.68 30.59 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 121.703 1.602 . . . . 0.0 112.339 173.793 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.377 63.6 p -125.54 36.44 4.55 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 127.031 2.132 . . . . 0.0 113.748 176.547 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.92 157.6 37.13 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.346 1.458 . . . . 0.0 108.845 173.486 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.259 40.8 p -99.49 168.06 10.21 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 126.782 2.551 . . . . 0.0 109.993 172.941 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.257 33.5 mm -76.88 -15.09 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 119.546 -1.971 . . . . 0.0 110.55 -178.541 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.4 -60.6 2.6 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 127.382 2.273 . . . . 0.0 112.738 174.112 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.95 -31.18 72.3 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 179.501 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.293 78.9 t -53.64 -41.69 47.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 115.373 -2.251 . . . . 0.0 113.415 163.445 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -55.02 -42.55 72.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 123.244 2.747 . . . . 0.0 109.963 176.811 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.75 -37.75 76.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 123.687 1.708 . . . . 0.0 111.635 -177.918 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -71.15 -31.12 67.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.483 -2.011 . . . . 0.0 108.498 176.562 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.303 86.3 mt -74.81 -32.86 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 1 O-C-N 115.756 -4.34 . . . . 0.0 110.842 177.605 . . . . . . . . 3 2 . 1 . 116 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -64.28 -53.2 52.64 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 130.738 3.615 . . . . 0.0 107.638 171.413 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -55.23 -51.7 65.74 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 118.783 2.882 . . . . 0.0 118.783 174.534 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -66.24 -43.48 86.46 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 115.083 -2.389 . . . . 0.0 111.482 177.679 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.342 69.3 mm-40 -128.98 -15.96 4.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 114.563 -2.637 . . . . 0.0 116.338 -166.819 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.58 -22.49 7.35 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 125.628 1.83 . . . . 0.0 111.348 156.192 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mt -73.39 124.79 90.83 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 126.375 1.87 . . . . 0.0 108.728 -162.186 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -70.04 157.51 59.61 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.25 1.967 . . . . 0.0 109.621 173.247 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.17 -29.03 22.54 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 124.805 3.67 . . . . 0.0 111.279 -168.355 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.267 5.4 t70 -40.11 -55.59 2.07 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 126.28 2.943 . . . . 0.0 117.743 158.141 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 82.0 mt-30 -81.66 -6.71 59.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 111.774 -2.466 . . . . 0.0 111.66 -175.392 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -89.06 166.76 13.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 124.184 3.174 . . . . 0.0 113.871 174.972 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.367 6.7 ptt180 -154.66 128.87 8.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 128.112 2.565 . . . . 0.0 108.213 164.594 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 mt -102.57 91.93 4.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 129.656 3.182 . . . . 0.0 110.022 174.781 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.1 mm -96.09 120.86 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 127.156 2.785 . . . . 0.0 105.168 -175.836 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -130.91 116.12 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 130.245 3.418 . . . . 0.0 109.217 -176.116 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.75 42.16 11.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 128.503 2.721 . . . . 0.0 112.516 -176.343 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.01 -2.78 55.43 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.058 1.313 . . . . 0.0 114.515 166.417 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -132.98 158.29 43.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.815 0.846 . . . . 0.0 110.769 -179.476 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.16 130.28 35.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 126.747 3.165 . . . . 0.0 114.761 173.811 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.53 128.29 35.98 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 116.865 -3.647 . . . . 0.0 109.886 163.1 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -117.38 -179.07 3.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 119.512 -1.992 . . . . 0.0 114.08 -171.031 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.28 129.6 35.85 Favored 'General case' 0 N--CA 1.449 -0.52 1 C-N-CA 133.725 4.81 . . . . 0.0 113.026 165.255 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.81 -28.41 7.38 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 118.269 -2.769 . . . . 0.0 110.518 151.18 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.256 75.1 mtt85 -97.77 124.45 42.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.905 2.082 . . . . 0.0 106.709 171.359 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.3 p -62.56 174.3 1.03 Allowed 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 125.254 1.597 . . . . 0.0 114.624 170.23 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -42.07 -53.34 3.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 176.579 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 t -64.69 -29.77 70.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.138 1.375 . . . . 0.0 111.165 -173.632 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -91.21 2.03 56.66 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 119.274 -2.141 . . . . 0.0 110.297 -176.159 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -101.9 20.36 16.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 123.057 2.662 . . . . 0.0 109.419 156.29 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.361 19.4 p30 59.19 22.32 10.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -176.727 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.8 mt -75.7 123.56 31.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 O-C-N 118.18 -2.825 . . . . 0.0 111.292 178.233 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -106.82 -176.01 2.96 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -173.559 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -67.76 125.15 25.33 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.778 1.631 . . . . 0.0 108.203 177.996 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 69.79 20.94 6.63 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 126.208 2.192 . . . . 0.0 114.025 178.016 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.7 m -73.16 140.04 46.76 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 131.163 3.785 . . . . 0.0 114.108 177.173 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.8 m -105.13 143.87 32.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.035 -1.666 . . . . 0.0 111.376 -172.521 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.3 mt -121.84 157.8 30.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.124 1.37 . . . . 0.0 113.834 172.016 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -109.71 155.03 22.06 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 177.441 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -128.53 124.64 36.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 110.426 -3.079 . . . . 0.0 107.35 -179.619 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.25 148.24 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 128.268 2.627 . . . . 0.0 107.055 162.727 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.478 0 O-C-N 127.284 2.865 . . . . 0.0 110.552 -177.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.3 ttp . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 113.645 -3.074 . . . . 0.0 108.144 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -72.09 134.17 45.64 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 102.607 -3.108 . . . . 0.0 102.607 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -132.79 157.62 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 130.605 3.562 . . . . 0.0 105.749 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -120.96 151.02 40.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 129.129 2.972 . . . . 0.0 107.771 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 t -132.17 135.34 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 167.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -103.62 120.3 40.62 Favored 'General case' 0 N--CA 1.444 -0.73 0 O-C-N 126.648 2.468 . . . . 0.0 110.612 172.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m -97.33 137.23 36.65 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 -175.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.414 38.0 mt -27.04 -43.12 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.568 1 C-N-CA 132.996 4.518 . . . . 0.0 111.611 172.044 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.351 80.9 p -83.03 -16.32 47.56 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 120.086 -1.634 . . . . 0.0 110.438 -168.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.22 -4.48 23.65 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.477 -1.179 . . . . 0.0 112.116 175.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -80.61 132.62 35.64 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 129.449 3.1 . . . . 0.0 113.224 178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 90.9 m -105.14 128.31 53.31 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 102.103 -3.295 . . . . 0.0 102.103 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 13' ' ' ILE . 59.4 mt -129.44 135.3 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 -174.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.456 1.8 t -127.18 147.03 50.2 Favored 'General case' 0 C--O 1.222 -0.387 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 mp -143.23 129.93 20.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 118.167 -2.833 . . . . 0.0 107.21 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.475 ' H ' ' CD ' ' A' ' 16' ' ' GLU . 14.7 mp0 -75.53 123.74 25.98 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.442 -2.059 . . . . 0.0 105.442 165.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.5 m -137.24 173.81 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 125.996 2.808 . . . . 0.0 104.847 -176.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -105.49 154.37 39.14 Favored Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 102.149 -3.278 . . . . 0.0 102.149 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -70.06 -29.36 22.57 Favored 'Trans proline' 0 N--CA 1.447 -1.23 1 C-N-CA 130.228 7.285 . . . . 0.0 114.352 170.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.3 m -71.89 -16.6 62.13 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 122.456 2.389 . . . . 0.0 115.693 173.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -65.37 132.92 50.22 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 122.644 2.474 . . . . 0.0 107.817 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.295 70.6 p -43.75 149.23 0.31 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 117.296 2.332 . . . . 0.0 117.296 156.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.6 mm -66.42 -39.69 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 O-C-N 121.439 -0.788 . . . . 0.0 108.953 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.324 63.4 tt0 -54.92 -37.93 67.02 Favored 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 134.272 5.029 . . . . 0.0 115.229 177.42 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -53.69 -49.29 68.36 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 117.966 2.58 . . . . 0.0 117.966 161.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.35 -13.94 15.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 126.755 2.022 . . . . 0.0 112.578 -176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mtpt -78.16 -32.45 50.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.749 2.82 . . . . 0.0 108.362 168.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -86.94 -29.21 22.24 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 117.361 -3.337 . . . . 0.0 110.242 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -63.6 -32.2 73.6 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 114.612 -2.613 . . . . 0.0 108.33 168.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.361 17.6 mt -65.97 -28.72 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 CA-C-N 124.825 3.466 . . . . 0.0 112.315 166.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -73.94 -38.74 64.17 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 122.054 2.206 . . . . 0.0 106.89 -174.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -52.91 -48.82 66.95 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 131.203 3.801 . . . . 0.0 113.463 165.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -88.99 -37.15 15.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 126.765 2.54 . . . . 0.0 116.156 -170.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -136.76 -14.71 1.62 Allowed 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 123.699 1.714 . . . . 0.0 110.646 -162.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.06 8.34 34.08 Favored Glycine 0 CA--C 1.532 1.145 0 N-CA-C 107.419 -2.272 . . . . 0.0 107.419 155.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.258 13.7 mt -101.59 133.08 21.04 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-N 123.367 3.583 . . . . 0.0 107.924 -162.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -75.21 150.92 37.95 Favored 'Trans proline' 0 N--CA 1.444 -1.412 0 CA-C-N 123.027 2.117 . . . . 0.0 114.223 -178.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -46.85 -40.16 24.86 Favored 'Trans proline' 0 N--CA 1.443 -1.499 1 C-N-CA 126.861 5.041 . . . . 0.0 119.73 166.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -58.3 -44.42 88.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 128.504 3.627 . . . . 0.0 116.27 -170.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.301 74.0 mm-40 -100.37 -1.41 36.12 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-N 113.457 -1.701 . . . . 0.0 112.103 -173.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -95.65 125.76 40.46 Favored 'General case' 0 N--CA 1.447 -0.595 0 O-C-N 126.571 2.419 . . . . 0.0 113.081 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.348 31.4 ttm105 -124.26 132.84 53.61 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 128.509 2.724 . . . . 0.0 108.579 172.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.8 mt -111.81 151.21 29.31 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 117.498 -1.239 . . . . 0.0 108.89 -172.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.409 34.8 mt -129.95 131.53 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.912 1.685 . . . . 0.0 106.988 -167.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -142.31 118.42 10.7 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 130.67 3.588 . . . . 0.0 110.666 169.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.58 27.12 11.58 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.101 2.16 . . . . 0.0 110.228 171.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.53 -20.45 44.36 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 120.108 -1.62 . . . . 0.0 113.101 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.362 45.2 mtmt -94.71 143.41 26.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 -165.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -71.35 137.4 48.41 Favored 'General case' 0 C--O 1.223 -0.294 0 O-C-N 121.644 -0.66 . . . . 0.0 110.992 159.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.2 mt -104.62 140.44 38.01 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -128.98 157.26 42.18 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 102.71 -3.07 . . . . 0.0 102.71 -147.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.256 5.9 p-10 -59.2 140.19 56.18 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.124 172.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.13 -47.1 1.05 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 105.673 -2.971 . . . . 0.0 105.673 162.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.86 175.92 5.46 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.225 -1.488 . . . . 0.0 111.053 -165.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 p -122.52 161.41 23.68 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 128.163 2.585 . . . . 0.0 113.496 -164.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 mt -55.02 -35.45 64.44 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.5 t -57.75 -46.23 84.78 Favored 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 128.79 2.836 . . . . 0.0 109.825 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -59.91 -37.4 79.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 119.892 -1.755 . . . . 0.0 114.294 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -90.11 15.13 10.76 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 115.091 -2.385 . . . . 0.0 115.008 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 m120 71.52 10.87 6.54 Favored 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 132.89 4.476 . . . . 0.0 110.246 161.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.0 mt -52.61 134.54 14.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 1 C-N-CA 133.864 4.866 . . . . 0.0 110.179 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -145.06 -177.55 5.6 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 130.822 3.649 . . . . 0.0 111.331 -159.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.378 72.6 tttt -51.81 104.83 0.09 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 129.999 3.32 . . . . 0.0 114.278 170.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 70.92 21.49 5.0 Favored 'General case' 0 N--CA 1.449 -0.49 0 O-C-N 118.143 -2.848 . . . . 0.0 113.565 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.0 m -58.16 119.79 7.47 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 121.915 2.143 . . . . 0.0 107.059 173.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.5 m -92.89 122.5 35.33 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 129.407 3.083 . . . . 0.0 107.769 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -113.82 170.99 7.86 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 125.279 1.612 . . . . 0.0 109.103 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.22 144.33 44.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.154 2.182 . . . . 0.0 111.128 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.5 tt -127.06 103.2 7.32 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -160.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 m -87.54 128.6 39.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 124.875 2.274 . . . . 0.0 109.86 171.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.307 31.8 tp -93.43 114.0 26.29 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 173.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.304 37.6 ttt85 80.42 -52.65 0.35 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 129.162 2.985 . . . . 0.0 115.408 162.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 tp -72.44 138.46 47.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.714 2.806 . . . . 0.0 105.375 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.282 40.5 ttt-85 -110.6 134.31 52.53 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 102.297 -3.223 . . . . 0.0 102.297 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.0 -122.56 6.2 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 116.566 -2.731 . . . . 0.0 107.36 -164.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.193 0 CA-C-O 115.531 -2.816 . . . . 0.0 112.164 -175.574 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.475 0.817 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -98.64 133.56 42.81 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 121.051 1.751 . . . . 0.0 109.029 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.284 1.1 pt -129.6 168.09 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-O 118.085 -0.96 . . . . 0.0 110.27 161.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -132.24 146.45 52.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -172.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.5 t -132.89 94.92 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 1 N-CA-C 98.661 -4.57 . . . . 0.0 98.661 -161.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -77.53 137.9 38.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 124.857 2.265 . . . . 0.0 110.891 170.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.582 HG22 HD23 ' A' ' 69' ' ' LEU . 44.5 p -94.61 168.52 10.8 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 124.375 2.035 . . . . 0.0 106.667 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.9 mt -71.18 -16.53 62.53 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 118.431 -2.668 . . . . 0.0 111.137 163.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.0 p -91.23 -7.15 52.11 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-O 115.724 -2.084 . . . . 0.0 113.344 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.99 -17.71 17.12 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 125.408 1.48 . . . . 0.0 115.953 161.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -76.93 145.63 38.07 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.413 2.285 . . . . 0.0 107.674 -177.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.2 p -105.82 121.86 44.91 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.51 2.724 . . . . 0.0 108.982 172.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.273 35.6 mm -89.26 146.82 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 173.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 22.1 m -109.52 137.64 47.06 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 119.826 -1.796 . . . . 0.0 109.86 175.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -122.87 100.13 6.74 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -160.24 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.5 106.35 17.44 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 130.944 3.697 . . . . 0.0 109.195 -174.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.9 m -158.88 161.07 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-N 120.777 1.626 . . . . 0.0 112.26 -160.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -97.42 152.95 38.51 Favored Pre-proline 0 C--N 1.322 -0.608 0 O-C-N 118.466 -2.646 . . . . 0.0 110.143 176.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.309 2.7 Cg_exo -51.77 -30.42 37.75 Favored 'Trans proline' 0 N--CA 1.444 -1.398 0 N-CA-C 119.355 2.791 . . . . 0.0 119.355 167.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 33.4 p -88.16 2.39 52.24 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.997 2.119 . . . . 0.0 112.019 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -81.39 140.93 34.42 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 120.021 1.282 . . . . 0.0 109.361 166.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.4 p -80.41 159.58 25.63 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.994 2.518 . . . . 0.0 109.604 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.511 HD12 ' O ' ' A' ' 54' ' ' ARG 0.293 8.7 mt -72.08 -14.23 17.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 126.219 1.808 . . . . 0.0 115.011 170.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -87.06 -18.48 30.46 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 117.679 2.474 . . . . 0.0 117.679 170.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.279 13.3 t30 -66.56 -45.58 78.86 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 111.591 -2.549 . . . . 0.0 106.466 165.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.1 t -56.8 -40.76 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 1 C-N-CA 132.205 4.202 . . . . 0.0 108.805 170.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.567 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 90.6 mttt -73.46 -38.76 65.36 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 116.42 -2.112 . . . . 0.0 110.185 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.52 -31.57 72.38 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 117.621 2.452 . . . . 0.0 117.621 172.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -57.43 -44.72 84.91 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 125.003 1.44 . . . . 0.0 112.933 163.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.416 21.7 mt -55.88 -45.27 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 127.914 2.486 . . . . 0.0 114.703 -176.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -48.83 -67.11 0.3 Allowed 'General case' 0 C--N 1.33 -0.24 1 O-C-N 129.493 4.245 . . . . 0.0 113.815 172.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -50.3 -32.04 15.93 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.7 mttm -87.02 -58.27 2.65 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.173 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.284 18.2 tp10 -112.45 -8.66 13.87 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 121.105 3.743 . . . . 0.0 121.105 -166.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.56 1.2 55.44 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 117.146 -1.919 . . . . 0.0 111.749 162.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.432 HD13 HG21 ' A' ' 36' ' ' ILE . 18.6 mt -98.42 110.45 56.61 Favored Pre-proline 0 N--CA 1.452 -0.359 0 C-N-CA 125.284 1.434 . . . . 0.0 110.073 -171.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -56.77 142.97 91.84 Favored 'Trans proline' 0 C--N 1.323 -0.776 1 CA-C-O 110.438 -4.068 . . . . 0.0 118.062 171.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HB3' ' HB3' ' A' ' 27' ' ' LYS 0.277 28.7 Cg_exo -45.1 -31.23 5.54 Favored 'Trans proline' 0 N--CA 1.452 -0.915 1 O-C-N 129.638 4.494 . . . . 0.0 119.543 -178.737 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -70.68 -35.2 72.7 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.289 79.7 mt-30 -90.07 13.37 15.11 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.652 -1.613 . . . . 0.0 113.363 -177.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -106.13 156.9 17.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 172.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttp-105 -138.68 116.52 11.54 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 127.271 2.228 . . . . 0.0 112.093 149.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.7 mt -98.93 107.23 19.61 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 131.19 3.796 . . . . 0.0 105.946 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 pt -110.52 158.18 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 129.235 3.014 . . . . 0.0 109.5 169.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -115.62 -0.57 12.97 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 130.263 3.425 . . . . 0.0 108.9 161.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.552 . . -142.43 -110.68 0.13 Allowed 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 119.135 -2.228 . . . . 0.0 114.617 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -123.06 -19.8 2.88 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 122.473 2.397 . . . . 0.0 110.629 178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -117.54 154.8 30.88 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 127.552 2.56 . . . . 0.0 112.361 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -65.05 165.25 11.4 Favored 'General case' 0 N--CA 1.44 -0.941 0 O-C-N 124.122 0.889 . . . . 0.0 108.855 -172.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.314 38.6 mt -96.25 128.08 42.84 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 110.954 -2.839 . . . . 0.0 106.744 164.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -69.18 125.14 25.75 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 116.306 -1.807 . . . . 0.0 115.551 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.278 0.0 OUTLIER -46.27 -28.66 1.35 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 128.824 3.828 . . . . 0.0 117.789 -170.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -100.11 10.87 60.27 Favored Glycine 0 CA--C 1.532 1.149 0 O-C-N 125.57 1.794 . . . . 0.0 116.548 -168.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.511 ' O ' HD12 ' A' ' 23' ' ' ILE . 50.5 mtt180 -111.33 179.83 3.92 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.949 1.699 . . . . 0.0 107.504 168.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.2 p -120.45 172.09 8.07 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 104.583 -2.376 . . . . 0.0 104.583 -170.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.392 6.9 mp -40.21 -51.55 2.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 130.919 3.688 . . . . 0.0 110.309 157.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.1 p -63.02 -37.92 89.12 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.843 2.057 . . . . 0.0 114.868 -178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -69.43 -46.42 66.81 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.835 -177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -79.15 -5.3 53.86 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 125.952 2.787 . . . . 0.0 114.699 -175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 58.65 44.43 17.46 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 117.977 -2.952 . . . . 0.0 115.937 -177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 30.7 mm -91.2 98.06 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -77.87 166.49 22.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.304 2.642 . . . . 0.0 109.556 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -39.36 129.79 1.76 Allowed 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 167.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 70.79 38.83 1.15 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 127.455 2.302 . . . . 0.0 113.367 167.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.4 m -92.03 130.42 37.77 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 130.639 3.575 . . . . 0.0 108.449 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.3 m -88.36 111.95 22.32 Favored 'General case' 0 N--CA 1.441 -0.891 0 O-C-N 127.435 2.959 . . . . 0.0 109.189 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.9 mt -94.85 136.43 35.16 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.927 1.291 . . . . 0.0 108.678 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -95.2 125.44 39.84 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 120.298 -1.501 . . . . 0.0 110.551 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.582 HD23 HG22 ' A' ' 7' ' ' THR . 27.0 tp -101.01 108.96 20.8 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.179 1.792 . . . . 0.0 108.123 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -77.6 147.76 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 123.343 1.544 . . . . 0.0 109.502 153.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 pp -138.18 141.05 40.06 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 127.943 2.497 . . . . 0.0 111.355 -171.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.8 mtm105 -91.34 12.45 20.4 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 117.391 2.367 . . . . 0.0 117.391 174.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.264 2.0 pp -122.74 37.27 4.44 Favored 'General case' 0 N--CA 1.452 -0.331 0 O-C-N 128.044 3.34 . . . . 0.0 111.77 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.403 HH21 ' C ' ' A' ' 76' ' ' GLY . 1.7 tmm_? -63.76 -43.43 96.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.255 3.422 . . . . 0.0 113.887 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.02 23.53 7.69 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 130.244 3.783 . . . . 0.0 114.117 -166.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.403 ' C ' HH21 ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.25 1.097 0 CA-C-O 115.624 -2.765 . . . . 0.0 106.935 167.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 53.8 ttp . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 117.459 -1.258 . . . . 0.0 107.756 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -77.42 134.52 38.39 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 126.244 2.215 . . . . 0.0 114.494 168.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.1 pt -137.43 161.6 34.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.5 3.52 . . . . 0.0 102.337 174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -112.54 144.25 42.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 111.015 -2.811 . . . . 0.0 114.764 168.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 55.6 t -132.77 112.78 19.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 O-C-N 125.738 1.899 . . . . 0.0 108.053 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 tptt -72.57 125.19 26.84 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 114.106 -2.854 . . . . 0.0 106.434 178.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.6 p -90.12 162.98 15.04 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 114.948 -2.453 . . . . 0.0 114.686 155.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pp -77.54 -12.37 59.96 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 125.283 1.614 . . . . 0.0 110.092 171.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.3 p -79.31 -10.4 59.8 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 129.937 3.295 . . . . 0.0 112.188 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.34 10.06 37.14 Favored Glycine 0 CA--C 1.539 1.554 0 O-C-N 117.991 -2.943 . . . . 0.0 114.275 174.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 tttt -104.51 140.97 37.2 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.424 -1.695 . . . . 0.0 106.424 -174.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 m -115.16 100.83 8.44 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.934 2.894 . . . . 0.0 103.339 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 68.3 mt -81.16 123.66 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 102.843 -3.021 . . . . 0.0 102.843 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.8 m -104.84 123.74 48.23 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 121.401 1.91 . . . . 0.0 107.525 174.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.4 mt -126.23 130.41 50.88 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 128.117 2.567 . . . . 0.0 111.811 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -72.26 116.45 12.71 Favored 'General case' 0 C--N 1.327 -0.377 1 O-C-N 130.072 4.607 . . . . 0.0 109.137 154.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -106.0 172.72 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 CA-C-O 113.29 -3.243 . . . . 0.0 114.793 171.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -97.11 144.65 28.25 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 124.37 3.259 . . . . 0.0 105.214 159.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -52.77 -28.38 38.01 Favored 'Trans proline' 0 N--CA 1.449 -1.102 0 CA-C-N 127.301 3.643 . . . . 0.0 115.475 163.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 80.9 p -81.46 4.32 21.48 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 127.493 2.996 . . . . 0.0 116.191 179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -70.75 156.75 39.12 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.564 1.146 . . . . 0.0 108.268 176.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.2 p -111.42 166.56 11.02 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 126.352 1.861 . . . . 0.0 110.499 170.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.437 HG12 ' H ' ' A' ' 23' ' ' ILE . 4.0 mm -52.79 -42.64 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 127.722 2.409 . . . . 0.0 111.651 -174.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -49.49 -34.98 18.44 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 115.358 -2.258 . . . . 0.0 116.322 171.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -85.0 -15.31 44.62 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 126.809 2.568 . . . . 0.0 109.089 -167.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.3 t -81.44 -52.52 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 126.307 2.956 . . . . 0.0 103.59 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.5 mttt -62.66 -33.17 74.5 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 131.058 3.743 . . . . 0.0 110.949 -176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.2 -36.8 66.6 Favored 'General case' 0 N--CA 1.443 -0.786 1 O-C-N 114.529 -5.107 . . . . 0.0 109.377 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -67.11 -29.04 68.68 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 113.922 -2.942 . . . . 0.0 110.505 171.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.442 HG21 HD21 ' A' ' 69' ' ' LEU 0.259 42.0 mt -72.44 -42.06 64.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 123.751 2.978 . . . . 0.0 104.722 176.034 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -53.95 -40.18 66.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 118.602 -2.561 . . . . 0.0 116.294 175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.261 2.3 t70 -67.88 -19.89 65.07 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 116.232 -1.842 . . . . 0.0 112.171 176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -94.22 -61.81 1.45 Allowed 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 124.61 1.194 . . . . 0.0 111.351 175.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -91.92 -28.51 17.22 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 128.443 2.697 . . . . 0.0 113.431 -166.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.22 -24.58 24.31 Favored Glycine 0 CA--C 1.533 1.179 0 O-C-N 121.046 -1.034 . . . . 0.0 112.5 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 mt -60.32 118.18 31.14 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 111.737 -2.232 . . . . 0.0 107.097 -169.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.263 98.0 Cg_endo -67.74 158.04 59.05 Favored 'Trans proline' 0 N--CA 1.449 -1.088 0 CA-C-N 122.446 1.909 . . . . 0.0 116.563 175.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.312 14.9 Cg_exo -57.27 -33.11 95.49 Favored 'Trans proline' 0 N--CA 1.449 -1.145 1 C-N-CA 128.635 6.223 . . . . 0.0 112.954 -179.282 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -86.53 -9.89 55.2 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 122.561 2.437 . . . . 0.0 111.581 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -94.77 -23.3 17.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.517 1.136 . . . . 0.0 113.724 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -73.46 122.15 21.68 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 113.722 -3.037 . . . . 0.0 108.751 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -100.4 119.47 38.5 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 121.428 1.922 . . . . 0.0 107.888 164.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 tp -121.18 104.06 9.47 Favored 'General case' 0 N--CA 1.445 -0.719 1 C-N-CA 132.458 4.303 . . . . 0.0 109.912 -171.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.297 47.8 mm -96.6 151.18 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 O-C-N 128.359 3.537 . . . . 0.0 112.067 174.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -150.47 108.74 3.76 Favored 'General case' 0 CA--C 1.535 0.382 1 C-N-CA 132.038 4.135 . . . . 0.0 111.669 177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.27 29.5 3.63 Favored 'General case' 0 C--N 1.325 -0.47 1 C-N-CA 132.269 4.228 . . . . 0.0 117.168 157.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.24 -10.11 20.18 Favored Glycine 0 CA--C 1.527 0.833 1 C-N-CA 133.765 5.459 . . . . 0.0 107.607 170.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.7 pttt -123.44 162.99 21.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 121.752 2.776 . . . . 0.0 105.908 -168.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -79.71 149.6 31.13 Favored 'General case' 0 N--CA 1.449 -0.488 1 C-N-CA 132.986 4.514 . . . . 0.0 108.588 173.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.0 mt -112.86 104.87 12.87 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.599 1.56 . . . . 0.0 108.479 -175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -94.35 149.82 20.87 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 102.181 -3.266 . . . . 0.0 102.181 -171.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -76.49 152.42 36.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 127.01 2.124 . . . . 0.0 114.195 -165.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.33 -23.04 33.69 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 119.457 2.543 . . . . 0.0 119.457 173.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.9 mpt_? -70.57 162.48 28.8 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 118.52 2.785 . . . . 0.0 118.52 169.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.8 p -100.79 165.06 11.56 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 120.117 -1.615 . . . . 0.0 107.146 -178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 31.7 mt -60.9 -47.37 86.69 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 113.053 -1.885 . . . . 0.0 115.709 170.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.4 p -43.06 -45.23 5.17 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 129.081 2.952 . . . . 0.0 114.854 162.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -63.81 -52.5 59.94 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 131.416 3.886 . . . . 0.0 110.448 -176.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -74.12 -14.3 60.95 Favored 'General case' 0 N--CA 1.449 -0.494 1 C-N-CA 132.465 4.306 . . . . 0.0 111.802 172.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.48 19.5 t30 87.37 20.74 0.06 Allowed 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 165.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.9 mt -78.44 144.07 11.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 103.576 -2.75 . . . . 0.0 103.576 -168.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -142.64 172.54 12.55 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.285 1.834 . . . . 0.0 108.996 -155.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.3 tttp -62.54 119.76 9.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 125.591 1.807 . . . . 0.0 109.85 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.506 15.2 mt-10 85.29 15.26 0.16 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 -176.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.7 m -71.68 141.17 49.87 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 117.545 -1.217 . . . . 0.0 113.704 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.3 m -108.56 117.57 34.51 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 115.088 1.514 . . . . 0.0 115.088 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -100.13 142.15 32.0 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 127.376 2.271 . . . . 0.0 109.304 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -108.69 125.48 51.94 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 125.275 2.464 . . . . 0.0 111.936 169.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.442 HD21 HG21 ' A' ' 30' ' ' ILE . 23.1 tp -96.16 132.96 41.03 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 110.341 -3.118 . . . . 0.0 109.307 174.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.8 t -121.12 158.14 23.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 131.001 3.72 . . . . 0.0 108.138 175.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.303 83.3 mt -101.34 143.86 30.86 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 118.313 -0.851 . . . . 0.0 112.935 162.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -84.79 134.76 34.3 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 129.121 2.969 . . . . 0.0 107.605 150.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.6 mt -114.67 133.86 55.53 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.365 18.0 ptt180 -137.23 -9.12 1.74 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 116.46 2.022 . . . . 0.0 116.46 -165.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.35 -40.77 1.75 Allowed Glycine 0 CA--C 1.528 0.859 0 O-C-N 128.34 3.525 . . . . 0.0 114.474 -165.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.748 0 C-N-CA 126.049 1.785 . . . . 0.0 109.19 -169.112 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 ptt? . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 117.348 -1.31 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 39.9 mm-40 -89.14 140.86 29.03 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.424 1.489 . . . . 0.0 113.348 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.8 pt -134.45 161.02 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 127.35 2.26 . . . . 0.0 107.742 172.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.527 ' CE1' HG23 ' A' ' 14' ' ' THR . 57.3 m-85 -123.46 112.37 17.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 119.783 -1.823 . . . . 0.0 109.809 -169.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.75 128.8 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 100.201 -4.0 . . . . 0.0 100.201 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -90.29 136.1 33.26 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 110.949 -2.841 . . . . 0.0 107.004 172.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.255 26.8 p -114.86 132.3 56.56 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 124.465 1.103 . . . . 0.0 109.77 167.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.4 mt -72.86 -3.98 28.99 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 116.995 -3.566 . . . . 0.0 113.958 -151.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.5 p -76.65 -5.91 49.87 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 121.874 2.125 . . . . 0.0 115.935 159.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.6 -6.12 7.05 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 118.426 -2.671 . . . . 0.0 110.805 160.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -85.37 127.36 34.34 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 104.138 -2.541 . . . . 0.0 104.138 -165.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -96.2 101.4 13.05 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 126.629 2.456 . . . . 0.0 111.448 174.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.41 114.41 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 CA-C-O 125.84 2.733 . . . . 0.0 105.305 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.527 HG23 ' CE1' ' A' ' 4' ' ' PHE . 11.2 m -99.29 113.61 26.0 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.492 HD11 HG13 ' A' ' 30' ' ' ILE . 46.7 mt -105.95 154.21 20.9 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.932 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -93.55 137.34 32.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.591 1.663 . . . . 0.0 106.677 165.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.309 11.8 m -145.05 175.78 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 128.466 2.706 . . . . 0.0 111.968 -174.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -139.3 152.99 70.58 Favored Pre-proline 0 C--N 1.32 -0.677 0 C-N-CA 128.823 2.849 . . . . 0.0 109.613 164.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -59.37 -30.3 92.37 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 123.493 2.795 . . . . 0.0 117.055 -173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 p -91.77 20.66 5.39 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 121.72 2.055 . . . . 0.0 110.752 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -100.82 140.75 34.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 119.728 -1.858 . . . . 0.0 109.046 -169.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.2 p -70.24 157.91 36.81 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 127.951 3.282 . . . . 0.0 110.937 -168.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.439 HG22 ' HD2' ' A' ' 27' ' ' LYS 0.286 26.9 mt -61.67 -27.97 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 116.487 -1.72 . . . . 0.0 111.654 165.2 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.252 9.4 tp10 -62.06 -47.59 84.04 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 123.248 2.749 . . . . 0.0 106.052 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -68.71 -38.09 79.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 123.011 2.641 . . . . 0.0 111.645 -178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -55.62 -58.34 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 127.332 2.253 . . . . 0.0 114.389 166.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.466 ' HE3' HD11 ' A' ' 43' ' ' LEU . 14.0 mttt -53.38 -35.44 60.32 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 128.423 2.689 . . . . 0.0 110.096 172.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -70.24 -32.34 70.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 125.157 2.408 . . . . 0.0 112.028 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -85.64 -7.18 58.98 Favored 'General case' 0 N--CA 1.451 -0.388 1 O-C-N 115.614 -4.428 . . . . 0.0 107.987 -170.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.492 HG13 HD11 ' A' ' 15' ' ' LEU . 35.2 mt -87.5 -33.41 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 119.649 1.113 . . . . 0.0 108.264 170.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -64.47 -39.1 93.17 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 174.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -54.23 -51.1 65.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.66 1.584 . . . . 0.0 114.536 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 40.9 mmtt -83.22 -52.45 6.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -95.17 -15.63 23.16 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 119.834 3.272 . . . . 0.0 119.834 -171.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.33 4.46 62.61 Favored Glycine 0 CA--C 1.531 1.046 1 O-C-N 130.132 4.645 . . . . 0.0 116.035 170.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.426 HG21 HD13 ' A' ' 36' ' ' ILE . 41.3 mt -86.98 123.16 70.73 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 121.485 2.642 . . . . 0.0 105.653 -155.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -62.65 133.43 42.3 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 CA-C-O 115.982 -1.758 . . . . 0.0 111.401 169.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.4 35.1 Cg_exo -41.55 -24.42 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 1 C-N-CA 128.664 6.243 . . . . 0.0 121.318 175.806 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -52.53 -50.43 62.86 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.971 1.708 . . . . 0.0 114.974 165.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -83.93 -18.25 37.97 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.162 2.985 . . . . 0.0 110.368 -175.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -76.83 99.36 5.14 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.939 1.696 . . . . 0.0 110.526 169.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 mtm180 -102.47 107.81 18.91 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 119.693 -1.88 . . . . 0.0 107.988 -174.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.466 HD11 ' HE3' ' A' ' 27' ' ' LYS . 19.2 mt -73.77 60.43 0.71 Allowed 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 129.921 3.288 . . . . 0.0 110.184 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.8 mm -87.79 107.68 17.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 115.646 -2.121 . . . . 0.0 108.732 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.379 23.3 t80 -133.3 118.85 19.02 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 129.467 3.107 . . . . 0.0 111.187 -168.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.86 43.88 26.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 129.163 2.985 . . . . 0.0 116.274 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.23 -28.9 9.6 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 127.034 2.254 . . . . 0.0 114.865 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.301 54.6 mttt -92.21 164.77 13.43 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -171.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.3 tp60 -81.32 117.84 22.13 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 102.794 -3.039 . . . . 0.0 102.794 151.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.24 143.62 26.71 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.345 8.5 mt-10 -96.31 164.92 12.45 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 125.789 3.904 . . . . 0.0 111.635 -163.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -72.54 145.4 47.48 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 129.404 3.082 . . . . 0.0 110.325 167.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.75 6.5 12.79 Favored Glycine 0 CA--C 1.523 0.536 0 O-C-N 118.183 -2.823 . . . . 0.0 115.473 158.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -122.67 170.12 10.36 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 126.319 1.848 . . . . 0.0 110.226 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.4 p -99.7 165.3 11.67 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 130.959 3.703 . . . . 0.0 109.875 179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.325 37.6 mt -41.21 -45.9 2.98 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 128.657 2.783 . . . . 0.0 113.623 170.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 18.4 m -84.45 -21.8 30.57 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 122.545 2.429 . . . . 0.0 112.281 -177.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.263 20.0 m-20 -68.4 -18.59 64.48 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 115.981 -1.961 . . . . 0.0 113.457 173.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -108.33 11.7 26.96 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 126.564 2.415 . . . . 0.0 113.012 164.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.257 10.7 p30 64.47 28.04 13.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 167.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mt -78.6 131.29 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 O-C-N 121.025 -1.047 . . . . 0.0 110.647 -179.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -106.88 163.83 12.63 Favored 'General case' 0 N--CA 1.444 -0.742 1 C-N-CA 132.078 4.151 . . . . 0.0 108.586 -177.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.3 pttt -53.67 144.32 18.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 111.209 -2.723 . . . . 0.0 113.237 171.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.433 44.9 mt-10 57.81 10.82 1.19 Allowed 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 118.393 -2.692 . . . . 0.0 117.432 -172.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 m -73.03 147.65 44.89 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.7 m -105.69 139.57 40.07 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 129.405 3.082 . . . . 0.0 107.969 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 pp -154.84 179.97 8.6 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 114.657 -2.592 . . . . 0.0 111.365 174.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -125.41 131.13 52.98 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 127.29 2.869 . . . . 0.0 111.981 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.8 tp -102.43 147.08 27.17 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.379 1.872 . . . . 0.0 106.695 167.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -121.42 151.04 24.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 125.299 2.476 . . . . 0.0 108.897 168.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -111.57 143.75 41.93 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 108.804 -3.816 . . . . 0.0 110.755 176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -58.89 124.61 20.42 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.92 2.488 . . . . 0.0 110.036 156.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.4 mt -91.29 136.39 33.14 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 130.587 3.555 . . . . 0.0 109.858 -176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.3 ptt180 -80.01 -20.05 46.29 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 112.473 -3.632 . . . . 0.0 112.254 -170.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.03 40.99 1.25 Allowed Glycine 0 CA--C 1.538 1.509 0 CA-C-N 122.125 2.239 . . . . 0.0 113.406 -165.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 N-CA-C 103.31 -3.916 . . . . 0.0 103.31 177.26 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 ptt? . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.584 0.707 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -100.25 145.54 27.96 Favored 'General case' 0 N--CA 1.442 -0.83 2 O-C-N 113.477 -5.764 . . . . 0.0 107.722 -171.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 3' ' ' ILE . 8.1 pt -127.85 143.39 40.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 1 O-C-N 115.78 -4.325 . . . . 0.0 107.526 151.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -88.55 136.67 32.88 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.075 -1.421 . . . . 0.0 107.697 166.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.25 10.9 t -123.59 122.33 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 O-C-N 117.3 -3.375 . . . . 0.0 109.448 170.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -94.01 107.14 19.08 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 103.308 -2.849 . . . . 0.0 103.308 -172.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.4 6.2 p -56.41 160.45 3.11 Favored 'General case' 0 N--CA 1.448 -0.548 0 O-C-N 128.196 3.435 . . . . 0.0 117.386 170.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 70' ' ' VAL . 2.0 tm? -74.63 -24.18 58.8 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.395 1.078 . . . . 0.0 109.032 -175.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.67 -1.92 56.78 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 123.144 1.449 . . . . 0.0 114.174 169.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.44 -26.79 15.35 Favored Glycine 0 CA--C 1.526 0.761 0 O-C-N 119.371 -2.081 . . . . 0.0 115.762 165.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -70.01 130.25 41.67 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 116.929 -3.689 . . . . 0.0 107.731 -172.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.5 m -88.77 109.94 20.6 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 118.895 -2.378 . . . . 0.0 108.089 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.3 pt -93.31 141.48 14.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 124.291 1.037 . . . . 0.0 112.551 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 t -81.95 143.94 31.27 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 161.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -133.09 121.14 22.23 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 131.543 3.937 . . . . 0.0 107.363 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.31 13.1 mp0 -86.12 134.39 33.81 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 117.598 -1.641 . . . . 0.0 110.375 172.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.274 27.4 m -137.38 170.31 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-O 116.471 -1.728 . . . . 0.0 109.37 -176.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -112.94 158.88 36.52 Favored Pre-proline 0 N--CA 1.444 -0.739 0 C-N-CA 128.668 2.787 . . . . 0.0 105.258 162.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.79 -28.35 25.23 Favored 'Trans proline' 0 N--CA 1.451 -1.012 0 C-N-CA 122.935 2.423 . . . . 0.0 117.21 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.8 p -76.85 4.22 10.27 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 126.127 2.142 . . . . 0.0 116.596 177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -84.43 141.15 31.02 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.361 1.864 . . . . 0.0 107.853 -164.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.1 p -78.86 140.09 38.22 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.336 1.455 . . . . 0.0 110.235 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.441 HD12 ' HB2' ' A' ' 54' ' ' ARG 0.29 8.3 mt -47.09 -35.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 O-C-N 119.979 -1.701 . . . . 0.0 114.939 171.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.0 tp10 -53.79 -49.31 68.56 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.306 2.242 . . . . 0.0 111.095 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.404 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 7.9 t-20 -64.78 -43.25 93.84 Favored 'General case' 0 N--CA 1.441 -0.91 1 C-N-CA 132.665 4.386 . . . . 0.0 111.752 176.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -52.12 -50.63 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 CA-C-O 115.208 -2.33 . . . . 0.0 113.351 171.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -61.6 -41.19 97.09 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 127.261 2.224 . . . . 0.0 112.259 176.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -58.73 -40.53 84.03 Favored 'General case' 0 N--CA 1.448 -0.543 1 C-N-CA 132.165 4.186 . . . . 0.0 109.235 177.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.32 79.8 mttt -79.33 -19.46 50.27 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 119.043 -2.286 . . . . 0.0 114.794 175.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.4 mt -76.82 -32.34 20.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 118.887 -2.383 . . . . 0.0 107.413 172.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -66.82 -38.46 86.48 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 116.667 -3.77 . . . . 0.0 114.005 163.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -67.14 -23.03 65.75 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 113.007 -3.378 . . . . 0.0 109.641 173.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -98.55 -66.94 0.87 Allowed 'General case' 0 N--CA 1.444 -0.752 0 CA-C-N 121.455 1.934 . . . . 0.0 113.733 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -111.32 -9.78 14.27 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 117.108 -3.495 . . . . 0.0 109.235 -164.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.53 2.37 50.26 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.145 -1.364 . . . . 0.0 114.479 158.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.0 mt -77.0 125.13 87.26 Favored Pre-proline 0 C--O 1.238 0.493 0 C-N-CA 125.02 1.328 . . . . 0.0 107.782 -171.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.59 129.55 19.09 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.826 3.684 . . . . 0.0 115.637 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -41.85 -33.07 1.89 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 1 C-N-CA 127.55 5.5 . . . . 0.0 117.502 175.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -51.11 -64.17 0.9 Allowed 'General case' 0 N--CA 1.445 -0.678 1 C-N-CA 132.174 4.189 . . . . 0.0 112.925 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -73.18 -26.27 61.1 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 128.661 2.784 . . . . 0.0 117.524 175.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -73.22 128.4 35.38 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.104 2.562 . . . . 0.0 107.351 -177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 ttm105 -120.73 129.37 53.61 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.977 1.711 . . . . 0.0 108.468 158.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -97.48 161.94 13.55 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 116.365 -1.779 . . . . 0.0 110.822 175.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.2 mt -136.07 138.0 47.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 126.428 2.33 . . . . 0.0 108.062 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -130.8 116.53 18.09 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 127.602 2.361 . . . . 0.0 107.518 162.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.293 . . 57.86 34.15 24.03 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 129.034 2.934 . . . . 0.0 114.106 168.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.1 10.81 84.24 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 129.253 3.311 . . . . 0.0 117.778 -176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -98.61 134.63 41.28 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.917 2.487 . . . . 0.0 106.957 173.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -84.63 124.71 31.77 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 175.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.2 mt -74.99 130.19 38.94 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 116.222 -1.847 . . . . 0.0 109.839 -173.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' OE1' ' NE ' ' A' ' 54' ' ' ARG . 1.1 tt0 -91.93 126.01 36.85 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 120.949 1.704 . . . . 0.0 109.273 -166.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -46.18 115.34 0.98 Allowed 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 129.831 3.252 . . . . 0.0 111.836 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.24 -9.85 31.19 Favored Glycine 0 CA--C 1.535 1.329 0 CA-C-O 116.762 -2.132 . . . . 0.0 112.962 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.441 ' HB2' HD12 ' A' ' 23' ' ' ILE 0.352 17.7 mmt180 -86.26 154.13 21.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 121.075 2.437 . . . . 0.0 111.383 174.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.4 p -71.57 161.2 31.39 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 117.435 2.383 . . . . 0.0 117.435 160.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.1 mt -66.49 -21.32 66.18 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 122.257 2.299 . . . . 0.0 113.796 169.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.3 t -77.53 -16.56 58.6 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 117.217 -3.427 . . . . 0.0 108.226 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -76.66 4.16 10.06 Favored 'General case' 0 C--O 1.221 -0.421 0 CA-C-N 123.192 2.724 . . . . 0.0 113.336 167.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -138.45 9.33 2.68 Favored 'General case' 0 C--N 1.327 -0.405 1 O-C-N 115.085 -4.759 . . . . 0.0 112.523 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.9 t30 62.3 26.92 16.12 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 130.054 3.342 . . . . 0.0 116.679 169.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.6 mt -87.36 128.42 39.95 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 -177.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -124.32 -160.07 0.91 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.171 -1.377 . . . . 0.0 107.461 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -68.66 135.57 51.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -165.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 81.96 10.08 0.79 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 129.013 2.925 . . . . 0.0 115.12 163.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.5 m -70.06 152.19 44.66 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 126.049 2.093 . . . . 0.0 113.432 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.7 m -110.39 125.46 53.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -107.87 155.47 20.24 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 103.551 -2.759 . . . . 0.0 103.551 169.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 64.0 m170 -110.92 150.75 28.77 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.663 1.985 . . . . 0.0 106.999 174.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 tt -125.9 135.55 52.04 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 127.705 2.402 . . . . 0.0 109.841 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.408 ' HA ' HD23 ' A' ' 8' ' ' LEU . 19.2 m -135.58 140.45 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 C-N-CA 127.928 2.491 . . . . 0.0 108.043 -176.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.277 1.1 pp -136.83 178.48 7.04 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.107 2.563 . . . . 0.0 112.087 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 73.42 -53.36 0.7 Allowed 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.697 2.399 . . . . 0.0 113.342 174.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.352 0.8 OUTLIER -131.71 151.22 51.8 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 -175.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.7 ttt-85 -72.39 112.74 8.72 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.93 -2.356 . . . . 0.0 107.16 171.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.04 172.76 14.54 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-O 115.737 -2.702 . . . . 0.0 111.061 163.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 127.078 3.599 . . . . 0.0 109.124 -156.683 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttp . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -104.67 128.92 52.88 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 101.537 -3.505 . . . . 0.0 101.537 -169.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.1 pt -138.14 170.97 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 129.727 3.211 . . . . 0.0 106.84 179.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -114.4 149.3 36.38 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.7 t -121.8 121.4 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 126.271 1.828 . . . . 0.0 106.206 161.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -110.1 178.49 4.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 109.248 -3.614 . . . . 0.0 110.465 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.4 p -138.08 155.96 48.26 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 128.238 2.615 . . . . 0.0 108.538 -168.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 71.4 mt -75.76 -14.52 60.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 112.939 -3.41 . . . . 0.0 111.245 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -92.95 -4.03 53.44 Favored 'General case' 0 C--N 1.324 -0.525 1 CA-C-N 126.255 4.116 . . . . 0.0 108.86 177.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.12 7.13 31.27 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 120.313 2.885 . . . . 0.0 120.313 162.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 31.3 tttt -60.76 154.26 22.17 Favored 'General case' 0 N--CA 1.44 -0.927 0 O-C-N 118.595 -2.709 . . . . 0.0 108.82 169.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.281 4.3 m -141.92 107.0 4.94 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 126.427 1.891 . . . . 0.0 108.743 170.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mm -100.43 142.24 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 111.997 -2.365 . . . . 0.0 106.315 175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 m -94.42 143.2 26.61 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.152 -1.386 . . . . 0.0 111.643 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.6 123.44 37.65 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 122.604 2.456 . . . . 0.0 107.853 -173.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.0 mp0 -99.43 109.56 22.13 Favored 'General case' 0 C--N 1.329 -0.283 1 N-CA-C 97.181 -5.118 . . . . 0.0 97.181 175.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.8 m -118.76 150.21 21.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 119.711 -1.868 . . . . 0.0 108.009 173.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -89.45 161.29 40.09 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 116.479 -1.724 . . . . 0.0 111.078 170.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -77.02 -19.76 13.55 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 123.504 2.803 . . . . 0.0 111.664 -178.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.4 p -73.06 -17.93 61.37 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 128.709 2.804 . . . . 0.0 111.7 173.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -69.86 123.94 22.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 124.934 2.302 . . . . 0.0 112.02 -173.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.6 p -76.67 166.11 23.82 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 111.893 -2.412 . . . . 0.0 110.098 162.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -66.2 -21.51 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 O-C-N 124.945 1.403 . . . . 0.0 108.641 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -73.59 -28.88 62.06 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 114.854 1.428 . . . . 0.0 114.854 174.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -77.34 -29.82 53.67 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 170.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.5 t -83.18 -27.88 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 119.969 -1.707 . . . . 0.0 107.505 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -69.19 -42.22 76.1 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.78 -38.49 78.64 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 133.056 4.542 . . . . 0.0 114.158 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -77.36 -38.5 50.05 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 127.369 3.462 . . . . 0.0 114.877 173.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.1 mt -61.11 -35.81 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 1 O-C-N 113.05 -6.031 . . . . 0.0 105.788 174.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.62 -32.96 71.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.184 1.794 . . . . 0.0 109.756 176.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -67.03 -32.19 73.22 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 119.502 -0.879 . . . . 0.0 109.99 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -91.65 -36.67 13.5 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.56 1.944 . . . . 0.0 113.943 -166.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.7 tp10 -129.16 -23.53 2.99 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -173.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.04 2.03 57.06 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 126.996 2.685 . . . . 0.0 116.611 165.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 24.2 mm -72.8 121.42 84.97 Favored Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-N 120.095 1.948 . . . . 0.0 111.048 -177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -39.27 129.11 1.56 Allowed 'Trans proline' 0 N--CA 1.443 -1.498 0 N-CA-C 119.225 2.74 . . . . 0.0 119.225 166.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.29 26.4 Cg_exo -47.76 -29.99 12.17 Favored 'Trans proline' 0 N--CA 1.453 -0.901 1 C-N-CA 129.227 6.618 . . . . 0.0 115.825 178.296 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -79.28 -4.27 49.93 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 128.0 2.52 . . . . 0.0 112.381 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -118.36 -15.67 9.68 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 126.486 1.915 . . . . 0.0 110.349 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.304 79.9 mt-30 -90.05 115.22 27.15 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 116.317 -2.153 . . . . 0.0 108.235 -170.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -103.96 129.55 51.53 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 100.712 -3.81 . . . . 0.0 100.712 170.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.2 mt -132.63 93.78 3.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.423 -2.673 . . . . 0.0 106.278 -162.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.1 mt -89.56 128.16 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -128.86 107.71 9.86 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 128.728 2.811 . . . . 0.0 106.398 166.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.331 . . 60.71 16.53 6.75 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 130.52 3.528 . . . . 0.0 117.706 -177.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.82 -13.47 57.73 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 126.314 1.912 . . . . 0.0 110.722 -175.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.54 105.45 14.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.998 2.119 . . . . 0.0 105.568 176.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 33.5 tp60 -61.05 107.64 0.76 Allowed 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 111.742 -2.481 . . . . 0.0 114.652 152.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 40.6 mt -65.7 123.06 18.73 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 128.115 3.384 . . . . 0.0 107.974 -172.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -88.19 131.27 34.8 Favored 'General case' 0 N--CA 1.446 -0.626 0 O-C-N 126.884 2.615 . . . . 0.0 111.267 -178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.97 119.39 4.24 Favored 'General case' 0 N--CA 1.449 -0.485 1 CA-C-O 129.272 4.367 . . . . 0.0 111.849 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.18 -19.74 31.76 Favored Glycine 0 CA--C 1.523 0.559 1 O-C-N 115.195 -4.691 . . . . 0.0 119.234 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.1 mtt-85 -83.56 175.83 9.48 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 118.473 -1.291 . . . . 0.0 111.433 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.3 p -114.16 162.06 17.0 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 121.216 1.825 . . . . 0.0 110.842 -174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 8.9 mt -36.71 -50.56 0.83 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 129.104 2.962 . . . . 0.0 116.654 172.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.3 p -81.29 0.27 37.73 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 109.485 -3.507 . . . . 0.0 112.995 -177.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -97.04 -18.77 19.18 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 116.647 -3.783 . . . . 0.0 109.249 170.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -98.99 -17.4 18.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 118.588 -2.57 . . . . 0.0 116.832 167.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 74.72 42.59 0.28 Allowed 'General case' 0 N--CA 1.452 -0.349 1 C-N-CA 132.456 4.303 . . . . 0.0 108.517 -177.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.9 mt -68.21 106.3 1.04 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.269 0 O-C-N 119.892 -1.755 . . . . 0.0 107.853 156.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -76.88 169.9 17.47 Favored 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 133.628 4.771 . . . . 0.0 112.254 166.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.268 17.9 pttm -69.1 148.94 49.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 174.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 73.2 mt-10 57.34 13.72 1.87 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.7 m -81.58 169.6 16.86 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 127.467 2.307 . . . . 0.0 108.298 177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -143.51 131.51 21.69 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.108 -1.405 . . . . 0.0 108.233 -153.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 pp -141.22 145.64 35.87 Favored 'General case' 0 N--CA 1.445 -0.693 0 O-C-N 120.158 -1.589 . . . . 0.0 111.159 -175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.281 24.6 m80 -97.1 117.91 32.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -170.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.2 tp -85.31 128.43 34.69 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.602 1.961 . . . . 0.0 110.668 169.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -134.06 146.96 30.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 1 C-N-CA 131.795 4.038 . . . . 0.0 108.688 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.291 1.2 mm? -84.72 126.56 33.5 Favored 'General case' 0 C--N 1.32 -0.694 0 O-C-N 118.961 -2.337 . . . . 0.0 109.394 175.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -148.79 105.59 3.58 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 119.438 -2.039 . . . . 0.0 106.55 171.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.9 mt -53.78 93.95 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.336 3.054 . . . . 0.0 103.107 175.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -150.97 121.56 7.44 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 124.754 2.216 . . . . 0.0 110.153 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.63 -0.99 9.19 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 113.175 -1.83 . . . . 0.0 114.906 -175.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.207 0 C-N-CA 127.965 2.698 . . . . 0.0 110.004 173.276 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 ttp . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -84.68 152.1 23.99 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 125.027 2.346 . . . . 0.0 114.235 171.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.418 HD13 HG21 ' A' ' 3' ' ' ILE . 42.1 pt -134.16 137.14 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 129.783 3.233 . . . . 0.0 104.633 165.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -94.56 121.35 36.03 Favored 'General case' 0 N--CA 1.449 -0.504 1 C-N-CA 132.196 4.198 . . . . 0.0 105.219 166.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.56 130.8 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 N-CA-C 101.306 -3.59 . . . . 0.0 101.306 170.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 23.2 mttm -90.9 116.57 28.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 129.547 3.139 . . . . 0.0 106.866 -177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.0 p -74.96 162.85 28.23 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 120.252 1.387 . . . . 0.0 110.176 172.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -70.56 -36.9 73.89 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.198 1.399 . . . . 0.0 107.823 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 38.8 p -80.71 -2.65 47.69 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.958 2.103 . . . . 0.0 116.273 -178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.49 20.34 8.24 Favored Glycine 0 CA--C 1.527 0.782 0 N-CA-C 117.05 1.58 . . . . 0.0 117.05 161.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -107.35 158.07 17.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 126.47 3.033 . . . . 0.0 106.403 174.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.258 10.9 m -129.49 91.85 3.24 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 131.538 3.935 . . . . 0.0 108.854 -172.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.1 mm -79.69 111.96 17.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 O-C-N 128.623 3.702 . . . . 0.0 104.71 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.257 85.1 m -86.52 107.73 18.23 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.816 1.647 . . . . 0.0 112.903 173.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mp -97.9 164.82 12.21 Favored 'General case' 0 N--CA 1.443 -0.786 0 O-C-N 126.15 2.156 . . . . 0.0 112.888 174.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -113.08 146.59 38.89 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 127.196 3.379 . . . . 0.0 107.79 162.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 11.0 m -143.48 178.8 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 131.035 3.734 . . . . 0.0 107.5 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -120.9 150.42 52.99 Favored Pre-proline 0 N--CA 1.45 -0.432 0 C-N-CA 130.969 3.708 . . . . 0.0 103.109 154.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -47.02 -19.47 0.85 Allowed 'Trans proline' 0 N--CA 1.448 -1.164 0 N-CA-C 120.396 3.191 . . . . 0.0 120.396 164.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.7 m -58.92 -33.17 70.27 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 130.61 3.564 . . . . 0.0 114.276 172.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.09 126.49 20.88 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.891 2.476 . . . . 0.0 107.052 -177.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.5 p -79.89 147.51 31.66 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 127.609 3.068 . . . . 0.0 104.809 162.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.5 ' HB ' ' HA ' ' A' ' 52' ' ' ASP . 8.2 mm -46.4 -51.51 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-N 111.921 -2.399 . . . . 0.0 114.439 169.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -35.78 -42.15 0.25 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 160.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -74.31 -35.42 63.66 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 117.491 -3.255 . . . . 0.0 115.371 174.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.85 -42.69 79.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 120.079 -1.638 . . . . 0.0 109.006 170.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -56.72 -36.98 70.32 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 123.686 1.708 . . . . 0.0 113.543 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.67 -34.02 62.6 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 130.665 3.586 . . . . 0.0 111.05 -175.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -75.44 -44.02 46.63 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 128.578 2.751 . . . . 0.0 106.924 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.6 mt -60.83 -33.71 56.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 O-C-N 119.352 -2.092 . . . . 0.0 113.553 162.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.262 12.8 tt0 -60.1 -38.64 83.56 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 123.048 1.404 . . . . 0.0 112.58 176.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -57.75 -61.45 2.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 119.492 3.145 . . . . 0.0 119.492 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -63.65 -43.78 95.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 108.452 -3.977 . . . . 0.0 110.443 -168.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -119.46 -18.32 8.53 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 120.238 1.381 . . . . 0.0 112.336 -167.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.75 -8.66 54.72 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 117.418 -1.768 . . . . 0.0 111.224 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.8 mt -67.4 115.0 22.02 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 120.196 1.998 . . . . 0.0 111.207 -164.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -74.36 156.65 45.87 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 122.466 2.11 . . . . 0.0 108.592 -168.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -68.57 -35.46 17.17 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 117.079 1.915 . . . . 0.0 117.079 -172.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -62.02 -27.06 68.61 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 118.806 2.891 . . . . 0.0 118.806 -176.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -83.73 -30.58 26.58 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 119.236 -2.165 . . . . 0.0 112.746 173.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -67.32 133.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 123.075 1.417 . . . . 0.0 113.719 -178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -128.19 141.55 51.44 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 130.505 3.522 . . . . 0.0 103.376 161.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.67 136.4 53.94 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 129.488 3.115 . . . . 0.0 106.337 -174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.2 mt -123.75 156.58 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 CA-C-N 110.023 -3.262 . . . . 0.0 112.699 175.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -158.19 127.53 5.77 Favored 'General case' 0 N--CA 1.45 -0.453 1 O-C-N 129.355 4.16 . . . . 0.0 102.984 174.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.08 26.27 11.82 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 117.129 2.27 . . . . 0.0 117.129 165.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.64 -9.6 41.13 Favored Glycine 0 CA--C 1.525 0.656 0 C-N-CA 128.7 3.048 . . . . 0.0 113.331 169.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 pttt -121.37 142.54 49.89 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 126.744 2.085 . . . . 0.0 111.371 -166.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -90.44 116.67 28.55 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 128.236 2.614 . . . . 0.0 107.978 -172.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.5 mt -82.68 136.02 34.87 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 125.416 1.487 . . . . 0.0 107.99 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.253 4.3 mm-40 -92.33 124.29 36.28 Favored 'General case' 0 C--O 1.22 -0.461 0 CA-C-N 110.667 -2.97 . . . . 0.0 107.915 -163.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -53.93 -22.18 9.6 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 119.38 3.104 . . . . 0.0 119.38 -160.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.74 -5.39 55.3 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 128.567 2.984 . . . . 0.0 119.197 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.4 mmt180 -90.15 156.39 18.37 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.935 1.694 . . . . 0.0 108.045 173.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -95.98 167.16 11.4 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.75 2.82 . . . . 0.0 108.704 -177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.7 mt -70.38 -31.21 68.35 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 125.854 2.74 . . . . 0.0 108.663 175.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.353 14.1 t -50.71 -38.68 48.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 112.815 -3.469 . . . . 0.0 115.5 164.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.263 0.4 OUTLIER -74.03 -26.84 60.63 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 126.564 2.415 . . . . 0.0 109.578 -168.198 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.522 40.8 m-85 -102.08 10.15 39.74 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 125.279 1.612 . . . . 0.0 114.328 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.412 3.7 p-10 60.86 33.25 20.02 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 128.028 2.531 . . . . 0.0 116.563 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.7 mt -90.52 114.48 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.291 0.3 OUTLIER -143.86 81.35 1.69 Allowed 'General case' 0 N--CA 1.45 -0.47 1 C-N-CA 131.724 4.01 . . . . 0.0 117.011 -177.106 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.406 22.3 ttpt 84.51 131.95 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.799 3.64 . . . . 0.0 117.73 171.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 25.1 tp10 72.53 41.38 0.58 Allowed 'General case' 0 N--CA 1.443 -0.785 1 C-N-CA 134.504 5.122 . . . . 0.0 109.306 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.0 m -85.93 144.36 27.69 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 130.753 3.621 . . . . 0.0 111.439 -175.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.9 m -100.33 109.63 21.83 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.127 2.571 . . . . 0.0 105.748 164.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -111.94 151.09 29.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.107 -1.901 . . . . 0.0 109.911 171.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -120.79 140.54 51.56 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 131.276 3.83 . . . . 0.0 112.06 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.7 tp -98.67 135.61 39.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 116.053 -1.927 . . . . 0.0 110.954 157.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.33 148.52 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 1 O-C-N 129.345 4.153 . . . . 0.0 109.248 160.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -165.31 -174.6 3.27 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 117.767 -3.083 . . . . 0.0 108.054 -173.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -107.56 123.0 47.8 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 128.524 2.73 . . . . 0.0 107.201 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -131.57 153.45 49.85 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-O 123.541 1.639 . . . . 0.0 110.988 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 45.3 ttp85 -104.91 146.82 28.49 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.086 -2.19 . . . . 0.0 105.086 171.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.69 165.24 18.96 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 127.978 2.704 . . . . 0.0 111.75 171.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 168.88 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 ptt? . . . . . 0 N--CA 1.47 0.57 0 CA-C-O 123.284 1.516 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -134.26 150.22 51.0 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 108.729 -3.85 . . . . 0.0 116.608 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.0 pt -136.46 144.69 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 112.8 -2.0 . . . . 0.0 113.454 166.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -90.08 122.24 32.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 116.906 -3.621 . . . . 0.0 109.138 163.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.8 t -82.82 125.24 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 101.244 -3.613 . . . . 0.0 101.244 157.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -103.98 104.58 14.56 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 110.14 -3.209 . . . . 0.0 104.914 162.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.9 p -72.48 137.93 46.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.645 171.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.36 -39.58 46.83 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 119.728 3.233 . . . . 0.0 119.728 -171.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.389 2.0 t -35.46 -30.76 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.704 1 C-N-CA 133.465 4.706 . . . . 0.0 117.044 156.75 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.99 -20.22 7.21 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-O 124.935 2.408 . . . . 0.0 110.444 175.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.26 73.4 tttt -71.35 139.48 49.86 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 119.304 -2.292 . . . . 0.0 108.712 -168.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 m -118.15 111.95 19.52 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 126.016 2.073 . . . . 0.0 114.562 -174.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.263 13.8 mm -104.71 131.36 53.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.002 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.308 2.8 m -94.01 123.58 37.47 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 117.786 -3.071 . . . . 0.0 108.816 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mp -111.14 132.26 54.43 Favored 'General case' 0 C--O 1.217 -0.605 0 O-C-N 119.629 -1.92 . . . . 0.0 107.795 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.7 mp0 -82.98 131.66 35.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 170.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.8 m -144.25 -174.21 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 123.807 0.843 . . . . 0.0 112.848 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -140.28 143.58 33.99 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 127.672 3.108 . . . . 0.0 108.916 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -73.68 -15.4 24.28 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 CA-C-N 125.105 2.859 . . . . 0.0 115.625 -167.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.9 p -75.32 1.8 12.81 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 117.41 -3.306 . . . . 0.0 116.938 165.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -93.76 150.77 20.12 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 127.499 2.319 . . . . 0.0 109.057 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.444 ' HB ' ' H ' ' A' ' 24' ' ' GLU . 7.4 p -71.36 161.0 31.78 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 104.363 -2.458 . . . . 0.0 104.363 -175.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.63 HG23 HD13 ' A' ' 43' ' ' LEU 0.305 16.5 mm -49.76 -41.93 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 131.677 3.991 . . . . 0.0 111.174 146.197 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' H ' ' HB ' ' A' ' 22' ' ' THR . 27.8 tt0 -59.35 -45.82 90.32 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 116.232 -2.187 . . . . 0.0 113.159 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -71.8 -23.3 61.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 124.472 1.107 . . . . 0.0 113.459 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.294 91.7 t -48.88 -62.78 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 150.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -68.64 -38.16 80.26 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.927 -1.733 . . . . 0.0 115.086 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.82 -38.26 75.27 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 129.591 3.157 . . . . 0.0 116.233 172.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -50.26 -37.64 36.84 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 163.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.2 mm -69.84 -12.92 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 O-C-N 119.837 -1.789 . . . . 0.0 107.675 -172.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -62.45 -43.38 98.96 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 116.591 -3.818 . . . . 0.0 112.895 171.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -83.32 -32.87 26.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.126 -1.397 . . . . 0.0 110.382 -175.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -75.05 -67.55 0.64 Allowed 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 119.515 -1.991 . . . . 0.0 108.663 168.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -103.58 -23.58 13.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 116.902 -3.624 . . . . 0.0 115.814 -155.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.63 25.74 10.51 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 116.83 -2.095 . . . . 0.0 108.569 172.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 mm -107.68 129.39 24.26 Favored Pre-proline 0 N--CA 1.438 -1.026 0 N-CA-C 105.658 -1.979 . . . . 0.0 105.658 -173.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.36 165.63 31.02 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 122.292 1.995 . . . . 0.0 111.767 170.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.63 -38.02 6.39 Favored 'Trans proline' 0 N--CA 1.453 -0.897 1 C-N-CA 127.551 5.501 . . . . 0.0 117.007 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.86 -21.11 26.83 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.922 2.489 . . . . 0.0 113.968 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -95.51 -9.53 32.22 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 128.928 2.891 . . . . 0.0 116.297 -176.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -95.88 133.51 39.97 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 115.193 -2.337 . . . . 0.0 108.793 -172.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -119.13 104.39 10.4 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 126.702 2.001 . . . . 0.0 107.953 -178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.63 HD13 HG23 ' A' ' 23' ' ' ILE . 1.4 tt -98.37 118.75 35.73 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 126.499 2.374 . . . . 0.0 105.487 -171.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mt -117.35 149.91 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 103.925 -2.62 . . . . 0.0 103.925 178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -170.76 137.73 1.32 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 124.057 1.884 . . . . 0.0 107.725 166.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 65.36 28.95 11.69 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 117.434 2.383 . . . . 0.0 117.434 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.84 -5.39 69.23 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 116.454 -2.303 . . . . 0.0 114.061 175.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.7 mttt -125.76 147.36 49.41 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 127.404 2.473 . . . . 0.0 112.613 -175.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -68.04 135.02 51.62 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.36 1.864 . . . . 0.0 113.46 163.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.625 HD22 HD22 ' A' ' 43' ' ' LEU . 9.9 mp -93.47 101.45 13.64 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -77.16 -16.63 59.05 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 115.713 1.746 . . . . 0.0 115.713 -173.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.594 26.5 t0 103.72 145.67 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 127.623 2.369 . . . . 0.0 112.136 178.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 140.3 -8.02 2.89 Favored Glycine 0 CA--C 1.528 0.881 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 172.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.347 48.3 mtp180 -145.17 152.53 40.16 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 122.782 1.277 . . . . 0.0 109.812 -168.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 66.7 p -83.08 168.48 16.86 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 112.777 -2.01 . . . . 0.0 114.835 -168.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.5 mt -47.56 -40.69 19.66 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.3 p -60.1 -56.09 25.84 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 127.899 2.48 . . . . 0.0 116.594 167.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -46.01 -57.59 4.3 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 126.512 1.925 . . . . 0.0 114.117 176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -74.82 -16.69 60.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 126.901 2.081 . . . . 0.0 115.168 175.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.274 25.5 t-20 90.33 64.28 0.0 OUTLIER 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 129.951 3.3 . . . . 0.0 111.498 164.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -118.85 131.0 72.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.275 73.7 mm-40 -128.06 165.19 20.81 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 126.09 2.119 . . . . 0.0 106.606 -160.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -60.67 147.57 41.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 116.876 -1.535 . . . . 0.0 110.524 -167.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 59.92 19.62 8.62 Favored 'General case' 0 N--CA 1.444 -0.736 1 C-N-CA 131.957 4.103 . . . . 0.0 111.73 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.4 m -81.04 149.66 29.16 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 123.146 2.703 . . . . 0.0 113.287 170.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.3 m -93.08 131.76 37.81 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 128.879 2.872 . . . . 0.0 107.376 176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.9 mt -103.52 130.03 50.83 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 128.63 2.772 . . . . 0.0 111.865 159.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -90.6 139.4 30.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 172.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.285 43.2 tp -122.29 129.58 52.32 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 117.129 -1.829 . . . . 0.0 109.116 176.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.254 83.6 t -95.45 139.33 19.08 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 126.354 2.284 . . . . 0.0 105.085 171.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 mp -115.01 148.77 38.41 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 121.869 0.842 . . . . 0.0 111.813 176.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -112.24 163.24 14.6 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 124.275 1.988 . . . . 0.0 106.202 175.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.2 mt -102.17 22.43 13.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 127.363 2.265 . . . . 0.0 111.615 -173.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -163.87 154.14 15.21 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.099 -2.25 . . . . 0.0 107.584 -176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.88 94.2 0.36 Allowed Glycine 0 N--CA 1.444 -0.817 1 C-N-CA 131.382 4.325 . . . . 0.0 110.691 155.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.984 0 CA-C-O 115.564 -2.798 . . . . 0.0 112.665 -171.566 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 ptt? . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 112.891 -3.433 . . . . 0.0 107.742 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -91.38 134.51 34.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.386 3.074 . . . . 0.0 112.376 167.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.6 pt -125.19 167.51 19.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 124.836 2.255 . . . . 0.0 106.915 160.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -106.35 144.43 33.05 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 127.409 2.284 . . . . 0.0 108.037 162.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.486 HG21 HD11 ' A' ' 30' ' ' ILE . 43.8 t -118.42 108.34 24.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 N-CA-C 104.715 -2.328 . . . . 0.0 104.715 168.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -86.19 132.36 34.03 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 123.236 1.494 . . . . 0.0 111.443 175.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.7 p -98.08 159.2 15.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 117.189 -3.445 . . . . 0.0 106.079 -174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.7 tp -58.7 -45.64 89.06 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.218 2.207 . . . . 0.0 109.077 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 p -73.43 3.04 6.53 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 130.569 3.548 . . . . 0.0 115.772 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.06 -8.99 50.27 Favored Glycine 0 N--CA 1.442 -0.901 2 O-C-N 114.099 -5.376 . . . . 0.0 113.102 162.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -79.15 150.6 31.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 121.73 2.765 . . . . 0.0 111.797 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.6 p -105.87 131.35 53.3 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 126.345 2.278 . . . . 0.0 111.643 161.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.455 HG13 ' HB ' ' A' ' 5' ' ' VAL . 1.9 pt -104.28 162.74 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 1 O-C-N 114.611 -5.055 . . . . 0.0 105.469 168.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.53 110.27 14.84 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 127.635 2.374 . . . . 0.0 106.011 -172.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.282 0.4 OUTLIER -104.48 138.93 40.12 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 128.316 2.646 . . . . 0.0 109.803 -173.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 pm0 -90.15 135.81 33.43 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 126.821 2.576 . . . . 0.0 108.769 159.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 m -150.37 149.41 14.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.15 3.38 . . . . 0.0 107.418 -171.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -101.87 141.88 23.47 Favored Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 127.939 2.496 . . . . 0.0 105.249 163.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -39.04 -42.76 2.18 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 N-CA-C 119.759 2.946 . . . . 0.0 119.759 167.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.4 p -88.15 14.75 8.59 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 128.422 2.689 . . . . 0.0 109.934 -172.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -88.71 150.92 22.74 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 124.987 2.327 . . . . 0.0 105.661 175.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.7 p -86.99 146.74 26.02 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 110.442 -3.072 . . . . 0.0 110.206 175.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 23' ' ' ILE . 69.5 mt -57.17 -24.81 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 124.864 1.353 . . . . 0.0 112.145 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 52' ' ' ASP . 6.9 tt0 -69.64 -34.16 73.63 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 128.239 2.616 . . . . 0.0 110.336 172.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -72.04 -31.85 66.56 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 114.103 -2.856 . . . . 0.0 107.305 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.4 t -79.46 -33.63 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-N 123.895 3.043 . . . . 0.0 107.68 -178.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -54.85 -49.59 70.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 112.519 -3.61 . . . . 0.0 110.576 168.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.45 -52.33 6.11 Favored 'General case' 0 CA--C 1.537 0.468 1 CA-C-N 126.396 4.18 . . . . 0.0 119.426 156.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 15.2 mtpp -74.09 -22.8 59.35 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 117.038 -3.539 . . . . 0.0 116.511 -169.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.486 HD11 HG21 ' A' ' 5' ' ' VAL . 14.0 mt -66.44 -39.0 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 130.951 3.701 . . . . 0.0 113.373 158.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.44 -26.82 64.79 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 122.841 2.564 . . . . 0.0 109.171 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -69.49 -42.38 74.87 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 128.436 3.585 . . . . 0.0 110.11 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.9 mmtt -76.39 -42.63 43.77 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 176.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.26 13.8 tp10 -130.19 5.77 4.9 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 120.491 -1.38 . . . . 0.0 109.972 -159.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.09 -0.93 35.99 Favored Glycine 0 CA--C 1.532 1.109 1 N-CA-C 123.598 4.199 . . . . 0.0 123.598 165.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.0 mt -78.05 114.97 46.76 Favored Pre-proline 0 N--CA 1.443 -0.799 0 C-N-CA 129.696 3.198 . . . . 0.0 105.325 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.264 4.9 Cg_exo -48.52 134.67 26.72 Favored 'Trans proline' 0 N--CA 1.455 -0.768 1 C-N-CA 125.413 4.076 . . . . 0.0 111.554 172.517 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -66.21 -37.01 26.28 Favored 'Trans proline' 0 N--CA 1.44 -1.656 1 C-N-CA 129.156 6.571 . . . . 0.0 115.15 -173.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -39.49 -31.89 0.11 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 129.65 3.18 . . . . 0.0 115.756 159.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.387 85.5 mt-30 -98.26 -13.42 20.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 118.989 -2.319 . . . . 0.0 114.78 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -81.6 143.08 32.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -174.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.2 ttp-105 -127.77 129.66 47.43 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 155.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 31.4 mt -96.23 132.98 41.11 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 116.672 -3.767 . . . . 0.0 107.297 169.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.2 mt -125.44 149.57 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 102.836 -3.024 . . . . 0.0 102.836 176.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -113.64 -25.84 8.52 Favored 'General case' 0 N--CA 1.446 -0.665 0 O-C-N 118.203 -2.811 . . . . 0.0 113.076 171.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.683 . . -143.43 -123.86 0.09 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 112.266 -2.243 . . . . 0.0 110.773 -170.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -113.93 18.41 19.22 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.666 0.592 . . . . 0.0 112.436 -166.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -151.65 154.77 37.02 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 118.182 -2.952 . . . . 0.0 110.383 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -57.73 156.33 8.81 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.802 1.641 . . . . 0.0 112.537 166.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.1 mt -120.19 162.72 18.89 Favored 'General case' 0 N--CA 1.452 -0.361 0 O-C-N 118.811 -2.43 . . . . 0.0 108.195 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -104.62 140.86 37.4 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 122.95 1.357 . . . . 0.0 109.132 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 6.1 m-20 -67.97 -24.2 65.12 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 130.01 3.324 . . . . 0.0 114.594 -175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.12 40.77 2.43 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.539 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . 11.1 mtt180 -130.37 151.17 51.16 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 165.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.7 p -96.6 162.27 13.53 Favored 'General case' 0 N--CA 1.45 -0.428 1 O-C-N 116.253 -4.03 . . . . 0.0 111.424 -167.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -54.67 -44.0 72.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 126.034 1.733 . . . . 0.0 110.617 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.4 p -61.27 -40.98 96.13 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 170.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -54.17 -33.13 57.32 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 131.296 3.838 . . . . 0.0 114.807 174.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.539 ' CE2' ' HB2' ' A' ' 54' ' ' ARG . 97.1 m-85 -100.13 0.04 39.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.276 -1.515 . . . . 0.0 111.732 173.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.7 t30 56.63 36.19 27.26 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 129.28 3.032 . . . . 0.0 117.588 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mt -79.28 116.21 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 103.204 -2.888 . . . . 0.0 103.204 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.3 mm-40 -103.44 169.35 8.59 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.598 1.959 . . . . 0.0 109.204 -172.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.385 53.7 pttt -50.22 133.4 23.7 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.343 1.857 . . . . 0.0 113.42 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.268 24.0 mt-10 72.12 12.35 5.93 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 130.339 3.455 . . . . 0.0 115.488 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.9 m -60.86 145.31 50.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 113.97 -2.919 . . . . 0.0 112.864 162.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.0 m -102.39 131.26 49.14 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 127.698 3.124 . . . . 0.0 105.154 170.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -108.75 151.73 25.81 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.634 -2.541 . . . . 0.0 108.621 161.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -109.47 128.48 55.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 117.917 -2.99 . . . . 0.0 105.595 -173.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.0 tp -106.21 103.07 12.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 112.11 -2.313 . . . . 0.0 109.673 -171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.1 t -83.23 137.17 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 CA-C-O 124.498 2.095 . . . . 0.0 110.574 169.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.62 149.68 51.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 126.313 1.845 . . . . 0.0 107.274 -157.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 mtm105 -108.78 55.32 0.64 Allowed 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 129.139 2.975 . . . . 0.0 113.65 166.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.488 1.0 OUTLIER -138.09 15.16 2.84 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 117.434 2.383 . . . . 0.0 117.434 163.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 -45.23 48.52 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 127.518 2.327 . . . . 0.0 113.76 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 111.98 7.03 23.92 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 127.109 2.29 . . . . 0.0 111.599 171.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 O-C-N 120.267 -1.725 . . . . 0.0 109.855 -157.495 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptt? . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -87.32 135.83 33.17 Favored 'General case' 0 C--O 1.237 0.433 0 O-C-N 119.547 -1.971 . . . . 0.0 106.81 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.9 pt -134.44 164.08 35.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 123.961 0.904 . . . . 0.0 112.018 166.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -90.57 129.94 36.65 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 126.092 1.757 . . . . 0.0 110.347 155.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -95.03 110.51 24.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 101.95 -3.352 . . . . 0.0 101.95 150.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.5 mttt -99.1 134.12 42.4 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 127.222 3.391 . . . . 0.0 110.926 170.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.9 p -89.15 141.36 28.58 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 111.706 -2.497 . . . . 0.0 108.759 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.06 -11.08 35.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 115.894 1.812 . . . . 0.0 115.894 163.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.4 p -78.91 -15.55 58.17 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 118.212 -2.805 . . . . 0.0 115.069 169.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.19 -12.09 6.09 Favored Glycine 0 CA--C 1.526 0.772 0 CA-C-N 120.211 1.369 . . . . 0.0 113.64 159.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -82.95 137.19 34.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 125.522 1.529 . . . . 0.0 110.612 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 100.0 m -97.67 125.97 42.74 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 125.201 2.429 . . . . 0.0 106.507 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 mm -112.8 106.06 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 1 O-C-N 115.646 -4.409 . . . . 0.0 101.567 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.4 m -59.91 137.11 58.15 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 122.868 1.318 . . . . 0.0 111.618 158.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.29 140.54 43.47 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 128.584 2.754 . . . . 0.0 109.168 177.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -111.66 121.71 45.87 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 m -134.0 162.54 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 128.864 2.866 . . . . 0.0 104.787 -177.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -111.3 162.53 20.5 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 160.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -88.72 -21.71 1.32 Allowed 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 121.735 1.623 . . . . 0.0 109.386 -164.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -69.09 -6.13 26.48 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 117.718 2.488 . . . . 0.0 117.718 159.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -71.57 137.24 47.87 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 119.82 -1.8 . . . . 0.0 112.593 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.315 42.7 p -60.44 142.71 54.73 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 128.414 2.685 . . . . 0.0 112.74 169.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.444 62.6 mt -46.79 -29.58 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 117.693 2.479 . . . . 0.0 117.693 163.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -53.83 -56.27 19.14 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 131.699 4.0 . . . . 0.0 108.013 168.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -74.75 -28.47 60.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-O 116.527 -1.701 . . . . 0.0 112.018 -171.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 18.3 t -71.01 -51.13 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 C-N-CA 128.381 2.672 . . . . 0.0 111.743 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 38' ' ' PRO . 76.3 mttt -55.37 -45.37 76.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 113.456 -3.164 . . . . 0.0 113.317 168.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.5 -17.03 63.5 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 131.291 3.837 . . . . 0.0 115.324 -174.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.2 mttt -77.55 -32.54 53.96 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 112.946 -3.407 . . . . 0.0 107.317 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 4.5 mt -80.51 -21.81 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 O-C-N 127.062 2.726 . . . . 0.0 108.097 -169.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -67.57 -35.64 79.42 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 128.534 2.734 . . . . 0.0 112.864 164.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -75.66 -33.13 60.4 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.277 1.031 . . . . 0.0 111.646 172.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.7 mmtt -81.55 -77.33 0.22 Allowed 'General case' 0 N--CA 1.442 -0.848 0 O-C-N 119.725 -1.86 . . . . 0.0 109.391 -172.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.269 15.9 mm-40 -100.9 -15.4 17.57 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 115.034 -2.412 . . . . 0.0 114.604 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.05 -1.72 40.95 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 121.749 2.068 . . . . 0.0 110.331 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -76.22 130.63 77.14 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 114.953 -2.451 . . . . 0.0 106.641 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.53 149.73 16.69 Favored 'Trans proline' 0 N--CA 1.446 -1.319 1 C-N-CA 125.991 4.461 . . . . 0.0 111.317 -174.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 19.5 Cg_exo -40.01 -37.42 1.68 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 N-CA-C 119.475 2.837 . . . . 0.0 119.475 165.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -45.7 -49.06 14.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.153 1.781 . . . . 0.0 114.292 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -99.72 -3.4 32.99 Favored 'General case' 0 C--O 1.223 -0.316 0 C-N-CA 127.47 2.308 . . . . 0.0 116.976 -169.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -80.23 127.56 32.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 125.144 2.402 . . . . 0.0 108.979 171.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.533 ' CZ ' HG12 ' A' ' 70' ' ' VAL . 36.4 mtm180 -112.79 127.06 56.05 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 119.418 -2.051 . . . . 0.0 105.824 165.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.02 124.8 50.72 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 131.331 3.852 . . . . 0.0 107.577 -163.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.1 mm -124.89 128.82 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 117.12 -3.488 . . . . 0.0 109.445 179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -153.68 136.99 15.73 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 118.529 -2.607 . . . . 0.0 109.701 163.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.385 . . 66.35 32.07 7.92 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 124.339 2.019 . . . . 0.0 115.123 173.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 -12.33 32.6 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-N 112.38 -2.191 . . . . 0.0 116.199 -174.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.261 9.9 ttpt -100.84 136.63 40.4 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 120.45 -1.617 . . . . 0.0 109.175 -167.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -92.82 116.47 29.06 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.164 -2.162 . . . . 0.0 105.164 171.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.1 mt -81.09 143.19 32.62 Favored 'General case' 0 C--N 1.33 -0.245 0 O-C-N 126.446 2.341 . . . . 0.0 105.239 -163.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.98 150.43 29.27 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.018 2.927 . . . . 0.0 109.356 -171.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -76.67 155.33 33.47 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 117.988 -2.945 . . . . 0.0 111.361 -175.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.5 -5.77 48.62 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 127.111 2.291 . . . . 0.0 114.821 162.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 57.6 mtt85 -94.71 160.62 14.53 Favored 'General case' 0 N--CA 1.446 -0.664 1 C-N-CA 135.444 5.498 . . . . 0.0 113.878 172.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 46.4 p -103.91 170.8 7.71 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 26.8 mt -72.51 -18.3 61.67 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 123.828 1.775 . . . . 0.0 108.305 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 t -78.68 -22.45 46.73 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 119.316 -2.115 . . . . 0.0 112.118 175.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -83.98 4.22 30.76 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -118.33 -7.38 10.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 118.091 -2.88 . . . . 0.0 108.529 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.33 10.8 p30 59.71 37.65 22.12 Favored 'General case' 0 N--CA 1.449 -0.511 1 C-N-CA 134.402 5.081 . . . . 0.0 114.149 -172.224 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 6.7 mt -69.49 137.46 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 O-C-N 120.646 -1.284 . . . . 0.0 112.298 174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -127.74 169.87 13.36 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.323 3.049 . . . . 0.0 109.48 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -42.33 131.89 3.56 Favored 'General case' 0 N--CA 1.45 -0.437 1 C-N-CA 136.415 5.886 . . . . 0.0 107.938 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.328 2.2 tt0 69.37 12.97 8.44 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 117.806 2.521 . . . . 0.0 117.806 172.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.5 m -65.27 149.21 50.34 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 127.786 2.435 . . . . 0.0 108.145 166.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.4 m -101.63 120.84 40.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.238 -3.414 . . . . 0.0 102.557 166.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.37 37.8 mt -101.35 158.48 16.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 123.053 1.406 . . . . 0.0 110.435 162.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.301 79.2 m80 -117.41 133.5 55.9 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 119.279 -2.138 . . . . 0.0 108.947 -170.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 tt -114.28 120.18 39.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-O 124.876 2.274 . . . . 0.0 107.089 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.533 HG12 ' CZ ' ' A' ' 42' ' ' ARG . 96.4 t -99.99 136.76 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.498 171.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.1 tp -95.01 155.62 16.65 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 101.062 -3.681 . . . . 0.0 101.062 -177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -87.98 104.27 16.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 128.876 2.87 . . . . 0.0 108.125 167.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.6 mt -95.72 -176.01 3.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 113.011 -1.904 . . . . 0.0 110.733 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -106.52 12.77 29.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 174.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.95 -173.95 13.85 Favored Glycine 0 CA--C 1.528 0.87 1 C-N-CA 130.862 4.077 . . . . 0.0 105.885 167.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.893 0 C-N-CA 129.591 3.472 . . . . 0.0 109.603 179.244 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.7 ttp . . . . . 0 N--CA 1.474 0.746 0 N-CA-C 102.016 -3.327 . . . . 0.0 102.016 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -99.47 145.32 27.58 Favored 'General case' 0 N--CA 1.444 -0.738 2 CA-C-O 111.552 -4.071 . . . . 0.0 108.103 170.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -120.33 159.02 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 115.653 -2.118 . . . . 0.0 110.956 150.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -99.41 132.01 45.03 Favored 'General case' 0 C--O 1.225 -0.231 0 O-C-N 128.719 3.762 . . . . 0.0 107.298 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.45 145.36 35.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 O-C-N 126.674 2.484 . . . . 0.0 105.257 171.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -114.56 140.32 48.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 127.904 2.481 . . . . 0.0 108.616 175.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 p -100.27 170.63 8.31 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-O 125.995 2.807 . . . . 0.0 105.116 177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.5 mt -57.07 -32.11 65.91 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.126 -2.306 . . . . 0.0 109.918 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 26.0 p -86.6 -9.36 56.23 Favored 'General case' 0 N--CA 1.449 -0.512 0 O-C-N 117.575 -3.203 . . . . 0.0 110.343 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.75 11.31 38.13 Favored Glycine 0 CA--C 1.532 1.134 1 C-N-CA 135.108 6.099 . . . . 0.0 114.762 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.5 tttt -82.54 129.26 34.89 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 -162.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.271 48.1 m -96.47 126.06 41.39 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.088 0.955 . . . . 0.0 110.718 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -120.03 151.46 22.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 119.605 -1.934 . . . . 0.0 106.574 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.271 4.8 m -118.0 91.21 3.51 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 128.021 2.528 . . . . 0.0 106.579 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.7 tp -83.0 150.19 26.51 Favored 'General case' 0 N--CA 1.444 -0.736 1 CA-C-N 107.991 -4.186 . . . . 0.0 112.053 178.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -108.88 108.07 18.7 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.446 1.898 . . . . 0.0 108.121 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -120.61 -176.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 1 C-N-CA 134.168 4.987 . . . . 0.0 116.492 173.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -152.12 159.83 32.34 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 103.007 -2.96 . . . . 0.0 103.007 172.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 75.1 Cg_exo -41.89 -24.42 0.29 Allowed 'Trans proline' 0 N--CA 1.443 -1.498 1 C-N-CA 128.004 5.803 . . . . 0.0 121.697 174.824 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 58.9 p -78.6 1.92 21.05 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 129.853 3.261 . . . . 0.0 115.182 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -98.45 130.01 45.06 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -76.98 178.71 6.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 113.916 -2.945 . . . . 0.0 112.298 172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 mm -76.19 -24.62 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 113.956 -2.926 . . . . 0.0 109.197 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -72.99 -41.6 64.16 Favored 'General case' 0 C--O 1.242 0.691 1 C-N-CA 132.697 4.399 . . . . 0.0 105.062 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -65.29 -30.41 71.27 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.684 -2.51 . . . . 0.0 115.623 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.1 t -87.71 -35.9 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 1 CA-C-O 108.545 -5.502 . . . . 0.0 108.219 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -65.03 -29.57 70.48 Favored 'General case' 0 C--N 1.324 -0.51 1 CA-C-N 126.71 4.323 . . . . 0.0 114.45 169.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.65 -38.87 80.78 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-O 125.502 2.572 . . . . 0.0 114.079 167.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -72.9 -37.2 67.33 Favored 'General case' 0 C--N 1.326 -0.414 1 O-C-N 115.117 -4.739 . . . . 0.0 108.967 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.2 mt -50.81 -65.42 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 128.019 2.528 . . . . 0.0 114.459 160.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -35.99 -43.58 0.33 Allowed 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.206 2.202 . . . . 0.0 112.423 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -60.32 -42.02 94.73 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 129.918 3.287 . . . . 0.0 118.219 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -102.61 -29.31 11.62 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 112.011 -2.359 . . . . 0.0 114.776 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -119.08 -13.01 9.41 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 118.299 2.704 . . . . 0.0 118.299 -169.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.79 -12.56 68.47 Favored Glycine 0 CA--C 1.536 1.366 0 CA-C-O 114.278 -3.512 . . . . 0.0 118.655 162.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 mt -73.12 123.2 89.29 Favored Pre-proline 0 N--CA 1.451 -0.403 1 O-C-N 130.414 4.244 . . . . 0.0 104.957 -162.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -52.14 145.72 33.29 Favored 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 123.79 2.994 . . . . 0.0 113.786 170.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -70.06 -30.33 21.06 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 N-CA-C 117.033 1.897 . . . . 0.0 117.033 -176.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -80.23 -35.34 36.28 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 124.156 1.932 . . . . 0.0 109.109 -158.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -80.53 -19.38 45.87 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -80.83 144.98 31.65 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 117.994 -1.003 . . . . 0.0 111.542 -172.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -142.01 150.94 41.97 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 114.165 -2.826 . . . . 0.0 111.449 172.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.45 121.07 41.62 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 128.277 3.486 . . . . 0.0 108.084 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.4 mm -103.36 141.58 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 1 N-CA-C 100.032 -4.062 . . . . 0.0 100.032 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' HB3' HD21 ' A' ' 50' ' ' LEU . 36.9 t80 -139.11 127.55 22.94 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 100.94 -3.726 . . . . 0.0 100.94 171.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.71 46.13 17.81 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 129.5 3.12 . . . . 0.0 107.831 174.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 70.07 -12.44 1.69 Allowed Glycine 0 CA--C 1.535 1.343 0 O-C-N 116.73 -3.731 . . . . 0.0 120.577 -177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -97.46 137.35 36.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 128.219 2.608 . . . . 0.0 108.711 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -61.13 140.08 57.96 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.909 1.381 . . . . 0.0 108.269 165.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.453 HD21 ' HB3' ' A' ' 45' ' ' PHE . 92.8 mt -81.42 109.75 16.2 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 131.052 3.741 . . . . 0.0 104.548 164.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -94.45 136.68 34.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 113.354 -1.748 . . . . 0.0 108.459 -172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -47.77 141.26 5.69 Favored 'General case' 0 C--N 1.328 -0.347 1 C-N-CA 132.846 4.459 . . . . 0.0 116.241 176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.66 -30.66 7.95 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.498 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -100.78 161.82 13.33 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 117.092 -3.593 . . . . 0.0 107.542 -173.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -102.65 -176.17 3.02 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.535 -1.666 . . . . 0.0 108.009 -176.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.97 -34.25 77.98 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 119.041 -2.287 . . . . 0.0 113.155 169.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.5 m -62.39 -37.51 86.02 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -62.92 -20.06 64.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 126.619 1.968 . . . . 0.0 116.055 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -114.87 -5.34 12.59 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.143 2.177 . . . . 0.0 111.904 -177.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 62.7 t30 55.53 54.54 8.32 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 125.799 1.937 . . . . 0.0 114.684 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.0 mt -88.8 132.38 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-O 121.8 0.809 . . . . 0.0 109.168 -176.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mp0 -98.32 150.89 21.09 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 127.383 2.273 . . . . 0.0 109.317 169.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -46.13 135.2 7.86 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 127.795 3.184 . . . . 0.0 109.799 154.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.417 0.0 OUTLIER 84.6 -6.21 0.99 Allowed 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 125.877 1.986 . . . . 0.0 115.207 166.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.5 t -88.17 140.2 29.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 128.004 3.315 . . . . 0.0 108.085 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 35.1 m -92.89 129.35 38.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -164.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -107.08 128.97 54.85 Favored 'General case' 0 N--CA 1.447 -0.621 1 C-N-CA 133.744 4.818 . . . . 0.0 111.659 171.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.14 141.0 29.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 123.999 3.091 . . . . 0.0 107.669 176.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -116.02 92.17 3.82 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 126.762 3.173 . . . . 0.0 103.154 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 54.8 t -93.46 158.25 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 CA-C-N 112.653 -2.067 . . . . 0.0 110.435 170.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.0 mp -97.53 128.6 44.41 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.805 3.242 . . . . 0.0 106.482 169.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.8 ttt180 -68.78 -30.37 68.94 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 115.629 -2.129 . . . . 0.0 110.16 174.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.41 116.63 8.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 130.578 3.551 . . . . 0.0 101.667 174.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.85 -25.74 15.35 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 128.629 2.772 . . . . 0.0 109.784 -175.085 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 105.25 -105.07 2.43 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-N 114.847 -1.069 . . . . 0.0 112.878 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.395 0 C-N-CA 128.333 2.873 . . . . 0.0 106.023 161.396 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 ttp . . . . . 0 N--CA 1.472 0.673 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.264 19.2 tm0? -109.78 123.91 50.36 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 125.732 2.682 . . . . 0.0 107.397 -172.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.8 pt -110.46 155.47 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 129.144 2.977 . . . . 0.0 108.261 155.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -110.81 160.55 16.64 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 125.088 2.375 . . . . 0.0 106.652 171.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 t -123.17 134.35 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 CA-C-N 110.087 -3.233 . . . . 0.0 108.505 166.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 tttt -115.83 157.4 24.47 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 127.894 3.246 . . . . 0.0 110.406 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.312 7.9 t -147.72 161.06 41.98 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.754 2.821 . . . . 0.0 108.751 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.418 ' HG ' ' H ' ' A' ' 8' ' ' LEU . 7.6 mt -28.13 -45.94 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.445 1 C-N-CA 135.863 5.665 . . . . 0.0 119.859 -176.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -79.33 -16.89 55.61 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 128.708 2.803 . . . . 0.0 114.24 -171.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.61 -12.17 58.05 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 117.489 -1.728 . . . . 0.0 113.673 -171.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -55.33 150.34 11.55 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 106.117 -1.809 . . . . 0.0 106.117 176.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.336 22.7 p -130.44 149.91 51.9 Favored 'General case' 0 N--CA 1.449 -0.504 0 O-C-N 117.801 -3.062 . . . . 0.0 115.3 168.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.403 HD11 ' OE2' ' A' ' 34' ' ' GLU . 61.9 mt -118.38 117.55 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 N-CA-C 100.818 -3.771 . . . . 0.0 100.818 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.283 9.0 t -106.07 122.23 45.75 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.151 3.38 . . . . 0.0 107.954 170.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.285 42.1 mt -113.29 134.95 54.34 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 129.292 3.037 . . . . 0.0 108.306 162.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -81.17 109.89 16.14 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 100.887 -3.746 . . . . 0.0 100.887 168.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 56' ' ' LEU . 5.4 m -114.8 145.21 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-O 125.746 2.689 . . . . 0.0 111.713 -172.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.296 3.8 tt0 -103.35 116.87 61.44 Favored Pre-proline 0 C--N 1.324 -0.532 1 C-N-CA 131.745 4.018 . . . . 0.0 106.451 -176.033 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.318 50.5 Cg_exo -32.6 -42.56 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 1 N-CA-C 122.762 4.101 . . . . 0.0 122.762 -178.283 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.6 p -80.14 -7.74 59.07 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 131.1 3.76 . . . . 0.0 120.357 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -68.72 126.71 30.58 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 124.383 1.052 . . . . 0.0 113.204 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 60.4 p -70.28 146.83 50.34 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.346 20.2 mm -51.84 -31.18 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 126.462 1.905 . . . . 0.0 112.439 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -87.69 -33.63 18.69 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 123.15 1.452 . . . . 0.0 109.711 -170.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -64.18 -36.27 83.51 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 118.923 -2.361 . . . . 0.0 117.009 165.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.0 t -63.55 -49.01 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-O 116.646 -1.645 . . . . 0.0 111.466 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -57.75 -29.05 64.48 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 118.374 2.731 . . . . 0.0 118.374 172.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -87.63 -18.09 30.41 Favored 'General case' 0 CA--C 1.537 0.456 1 C-N-CA 132.257 4.223 . . . . 0.0 108.309 -176.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -90.44 -26.94 19.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 120.374 1.443 . . . . 0.0 110.646 169.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 30' ' ' ILE . 95.1 mt -71.0 -31.37 45.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 C-N-CA 129.491 3.117 . . . . 0.0 108.114 172.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -56.42 -44.54 80.48 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 126.896 2.622 . . . . 0.0 113.705 172.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.39 -47.7 84.95 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 127.105 2.162 . . . . 0.0 109.958 -179.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -67.84 -69.18 0.33 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 128.167 2.587 . . . . 0.0 108.646 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.403 ' OE2' HD11 ' A' ' 13' ' ' ILE . 44.6 mm-40 -88.08 -32.83 18.53 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 121.176 3.769 . . . . 0.0 121.176 -172.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.27 5.05 35.08 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 127.79 2.614 . . . . 0.0 114.384 172.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.2 mt -93.63 135.07 25.54 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 101.289 -3.597 . . . . 0.0 101.289 -174.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.8 Cg_endo -78.89 148.01 21.87 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 O-C-N 125.122 2.117 . . . . 0.0 110.817 174.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 47.0 Cg_exo -53.99 -30.37 58.83 Favored 'Trans proline' 0 N--CA 1.447 -1.263 1 C-N-CA 128.597 6.198 . . . . 0.0 118.427 -170.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -61.77 -27.01 68.43 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 130.585 3.554 . . . . 0.0 110.105 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -91.34 -12.95 33.47 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 117.159 -1.4 . . . . 0.0 113.008 176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -89.12 121.71 31.71 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 122.722 2.51 . . . . 0.0 111.703 -174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -88.15 110.06 20.38 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 151.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.7 mt -91.92 92.01 8.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 153.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 29.5 mt -96.88 137.02 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 C-N-CA 128.914 2.886 . . . . 0.0 105.23 -173.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -116.56 -149.85 0.45 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 115.214 -2.327 . . . . 0.0 107.764 -175.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.14 66.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 131.233 3.813 . . . . 0.0 115.465 171.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.99 -22.51 0.75 Allowed Glycine 0 CA--C 1.533 1.171 1 C-N-CA 130.906 4.098 . . . . 0.0 117.343 -164.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -82.92 128.93 34.9 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 120.718 -1.46 . . . . 0.0 113.494 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.306 19.9 mp0 -90.73 107.99 19.53 Favored 'General case' 0 N--CA 1.447 -0.597 0 O-C-N 126.078 2.111 . . . . 0.0 105.711 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 37.7 mt -64.61 107.44 1.4 Allowed 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 127.913 2.485 . . . . 0.0 113.123 178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -82.45 142.18 32.12 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 128.966 2.906 . . . . 0.0 110.884 -175.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -67.92 109.94 3.65 Favored 'General case' 0 N--CA 1.45 -0.466 1 C-N-CA 133.431 4.692 . . . . 0.0 109.616 -172.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.43 -8.59 58.7 Favored Glycine 0 CA--C 1.528 0.845 1 CA-C-O 112.669 -4.406 . . . . 0.0 113.039 -171.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.72 153.65 38.75 Favored 'General case' 0 C--N 1.323 -0.553 1 CA-C-N 125.18 4.49 . . . . 0.0 110.258 165.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.259 67.7 p -77.38 -178.56 5.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 124.253 1.977 . . . . 0.0 106.475 169.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.428 HD11 ' HB ' ' A' ' 17' ' ' VAL 0.293 26.0 mt -77.15 -38.46 51.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 112.807 -1.997 . . . . 0.0 113.383 164.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.8 t -62.42 -23.24 66.75 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 112.191 -3.766 . . . . 0.0 111.609 174.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -69.96 -35.43 74.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 122.011 2.187 . . . . 0.0 109.215 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -100.66 8.4 43.37 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 128.327 2.651 . . . . 0.0 108.911 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.32 2.3 p-10 52.96 46.32 27.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.152 1.781 . . . . 0.0 115.614 170.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.447 HG21 HD13 ' A' ' 61' ' ' ILE 0.251 24.9 mt -92.46 117.52 35.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 123.662 1.696 . . . . 0.0 110.06 -167.664 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -98.85 169.01 9.76 Favored 'General case' 0 N--CA 1.45 -0.448 1 O-C-N 116.138 -4.101 . . . . 0.0 112.776 -176.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.291 20.6 pttt -37.88 152.18 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 115.512 -2.185 . . . . 0.0 115.283 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 77.05 -9.91 1.44 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 167.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.3 m -62.58 132.09 51.24 Favored 'General case' 0 N--CA 1.452 -0.37 0 O-C-N 119.406 -2.059 . . . . 0.0 116.184 179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.4 m -109.31 111.13 22.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.124 -2.917 . . . . 0.0 103.124 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.8 mp -83.53 146.39 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 130.622 3.569 . . . . 0.0 107.825 170.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.265 50.0 t60 -103.75 111.03 23.36 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 117.364 -3.335 . . . . 0.0 111.975 -179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.3 1.3 tt -90.78 131.43 36.44 Favored 'General case' 0 N--CA 1.45 -0.468 1 O-C-N 131.093 5.246 . . . . 0.0 104.907 -175.402 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.343 16.7 m -147.19 169.28 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 128.515 2.726 . . . . 0.0 111.236 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.284 10.9 tp -92.79 129.49 38.7 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 128.931 2.892 . . . . 0.0 107.42 -172.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -69.46 97.04 0.95 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 130.414 3.486 . . . . 0.0 106.567 174.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.6 mt -96.42 102.2 13.95 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 152.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.409 27.2 ttt180 91.57 -64.4 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 128.991 2.916 . . . . 0.0 108.12 176.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.54 -174.17 44.61 Favored Glycine 0 CA--C 1.526 0.754 1 C-N-CA 132.338 4.78 . . . . 0.0 112.625 174.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.479 2 N-CA-C 101.356 -4.698 . . . . 0.0 101.356 -172.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ptt? . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 104.23 -2.508 . . . . 0.0 104.23 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -113.82 140.29 48.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 124.082 1.896 . . . . 0.0 108.528 -169.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.2 pt -146.44 160.01 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.708 0 N-CA-C 100.428 -3.915 . . . . 0.0 100.428 172.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.387 31.3 m-85 -105.36 134.74 47.97 Favored 'General case' 0 N--CA 1.445 -0.694 1 CA-C-N 107.749 -4.296 . . . . 0.0 105.13 -173.116 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 t -106.45 132.09 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 O-C-N 119.706 -1.872 . . . . 0.0 107.549 166.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -84.78 123.69 30.72 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 102.254 -3.239 . . . . 0.0 102.254 159.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.0 p -80.27 167.74 19.91 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 127.675 2.39 . . . . 0.0 116.297 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.414 ' HB3' HD22 ' A' ' 69' ' ' LEU . 1.4 pt? -60.67 -10.97 6.02 Favored 'General case' 0 C--N 1.321 -0.646 1 C-N-CA 133.211 4.605 . . . . 0.0 113.742 175.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 49.4 p -122.62 2.41 9.54 Favored 'General case' 0 C--N 1.33 -0.249 1 O-C-N 114.033 -5.417 . . . . 0.0 117.205 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.24 -14.02 28.33 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 117.9 1.92 . . . . 0.0 117.9 166.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -82.28 167.18 18.87 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 127.591 2.356 . . . . 0.0 110.471 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.5 m -111.98 121.38 44.84 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 129.728 3.211 . . . . 0.0 105.476 -178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.31 19.4 pt -103.57 146.19 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 128.786 2.834 . . . . 0.0 103.987 163.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.0 m -78.54 153.3 31.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 129.074 2.95 . . . . 0.0 109.963 149.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.83 159.63 43.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 126.87 3.224 . . . . 0.0 105.755 161.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -120.66 112.56 19.03 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 126.782 3.182 . . . . 0.0 107.513 -171.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -138.41 165.19 25.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 O-C-N 116.774 -3.704 . . . . 0.0 107.648 -173.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.283 1.6 tm-20 -103.85 149.29 37.01 Favored Pre-proline 0 N--CA 1.44 -0.967 0 O-C-N 118.387 -2.695 . . . . 0.0 108.613 161.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -53.64 -18.65 12.35 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 125.191 3.927 . . . . 0.0 114.344 178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.9 p -77.22 -7.77 56.45 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 119.321 3.082 . . . . 0.0 119.321 170.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.408 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -60.36 126.97 29.51 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 122.601 1.191 . . . . 0.0 110.833 164.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 58.5 p -89.41 163.91 15.08 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 117.331 -1.748 . . . . 0.0 108.953 170.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.325 0.9 OUTLIER -34.77 -51.53 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-O 113.09 -3.338 . . . . 0.0 113.481 173.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.262 3.5 tp10 -67.07 -23.71 65.89 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 129.34 3.056 . . . . 0.0 114.696 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -74.11 -40.33 62.75 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 166.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.51 -40.89 82.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 O-C-N 118.716 -2.49 . . . . 0.0 106.11 -176.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -43.28 -45.69 5.96 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 129.471 3.109 . . . . 0.0 118.173 172.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.81 -37.48 48.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.769 2.028 . . . . 0.0 109.828 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.408 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP 0.371 78.0 mttt -61.2 -43.6 98.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 124.85 2.262 . . . . 0.0 111.475 177.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.45 -53.3 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 C-N-CA 127.94 2.496 . . . . 0.0 107.262 174.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -49.35 -48.55 46.53 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 117.632 -3.168 . . . . 0.0 116.003 165.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -59.12 -33.4 70.81 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 116.834 -1.555 . . . . 0.0 110.888 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -97.29 -51.47 4.17 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 123.449 2.84 . . . . 0.0 107.648 -172.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -102.81 -31.08 10.48 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 127.561 2.344 . . . . 0.0 113.347 -167.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.76 9.87 24.0 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 163.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.8 mt -90.11 127.11 54.78 Favored Pre-proline 0 CA--C 1.533 0.294 0 CA-C-N 118.756 1.278 . . . . 0.0 107.997 -162.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.75 130.22 33.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 125.289 3.992 . . . . 0.0 114.42 176.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.25 2.4 Cg_endo -72.63 -2.82 12.41 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.239 1.959 . . . . 0.0 113.564 173.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -79.42 -14.17 59.11 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 160.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -98.6 -25.97 14.55 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 126.212 1.805 . . . . 0.0 108.551 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -86.05 111.56 20.43 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 115.476 -2.202 . . . . 0.0 108.89 -172.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 38.6 mtp180 -105.5 148.5 27.15 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 128.164 3.415 . . . . 0.0 106.489 154.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.1 mt -100.56 113.68 26.69 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 131.308 3.843 . . . . 0.0 110.597 157.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mm -122.49 119.85 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 102.55 -3.13 . . . . 0.0 102.55 172.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -143.32 111.53 6.19 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.898 -1.955 . . . . 0.0 107.501 -167.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 73.49 24.87 2.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 129.583 3.153 . . . . 0.0 112.408 170.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.65 7.58 50.78 Favored Glycine 0 CA--C 1.525 0.679 0 CA-C-O 115.347 -2.919 . . . . 0.0 114.797 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -138.69 150.72 46.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 123.686 3.743 . . . . 0.0 108.216 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -66.16 135.49 54.6 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 111.237 -2.71 . . . . 0.0 111.793 161.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.4 mt -91.62 149.54 21.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 117.638 -1.173 . . . . 0.0 107.96 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.254 10.1 tp10 -142.07 166.78 23.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 127.39 2.276 . . . . 0.0 115.378 -149.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -68.72 122.61 18.9 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 127.265 2.226 . . . . 0.0 115.053 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.71 -21.9 17.85 Favored Glycine 0 CA--C 1.537 1.418 0 O-C-N 120.337 -1.477 . . . . 0.0 111.289 163.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.535 ' H ' ' HD2' ' A' ' 54' ' ' ARG 0.319 0.3 OUTLIER -78.69 138.31 38.22 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.841 1.656 . . . . 0.0 108.038 169.163 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 67.8 p -84.1 156.79 21.98 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 72.2 mt -42.94 -39.54 2.62 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 160.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.416 3.8 p -54.49 -46.33 73.41 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 117.426 -3.296 . . . . 0.0 117.223 161.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -65.04 -13.24 57.41 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 122.665 2.484 . . . . 0.0 114.029 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -104.5 10.0 35.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 119.527 -1.983 . . . . 0.0 111.681 172.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 60.46 18.74 8.49 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 130.312 3.445 . . . . 0.0 115.77 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.9 mt -72.92 122.63 26.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 103.66 -2.719 . . . . 0.0 103.66 -175.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -115.5 143.5 45.22 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 130.147 3.379 . . . . 0.0 112.474 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -30.2 131.73 0.08 Allowed 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 128.441 2.697 . . . . 0.0 116.116 174.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 78.57 23.74 0.63 Allowed 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.963 2.905 . . . . 0.0 111.128 164.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.6 m -97.97 161.06 13.92 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 129.137 2.975 . . . . 0.0 113.301 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -102.9 118.56 37.1 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 112.751 -3.5 . . . . 0.0 111.017 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 mt -93.17 162.86 13.85 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 125.806 1.941 . . . . 0.0 108.138 160.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -125.54 158.74 33.79 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.972 2.509 . . . . 0.0 109.097 171.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.414 HD22 ' HB3' ' A' ' 8' ' ' LEU 0.316 4.8 tt -115.08 149.57 37.31 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 131.356 3.862 . . . . 0.0 112.244 176.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 49.4 t -124.89 118.2 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 -177.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pp -71.02 155.02 41.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 116.51 -1.709 . . . . 0.0 111.844 171.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 ptp85 -103.17 148.95 25.14 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 124.021 3.101 . . . . 0.0 104.927 148.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.6 mp -100.6 34.63 2.37 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 104.659 -2.349 . . . . 0.0 104.659 -164.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.5 ttp85 -89.61 118.91 29.58 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 123.029 2.65 . . . . 0.0 107.67 161.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.35 -137.06 13.33 Favored Glycine 0 CA--C 1.529 0.96 0 O-C-N 118.661 -2.525 . . . . 0.0 107.799 172.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 115.77 -2.683 . . . . 0.0 106.918 -177.063 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ttp . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 116.739 -1.6 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.4 mp0 -100.49 134.17 43.84 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 -154.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.3 pt -117.32 150.01 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 177.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -98.93 158.07 15.89 Favored 'General case' 0 N--CA 1.445 -0.699 0 O-C-N 118.667 -2.521 . . . . 0.0 108.835 162.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' LEU . 58.9 t -140.34 138.25 36.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 173.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -112.13 128.23 56.16 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.546 2.338 . . . . 0.0 104.72 172.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.284 21.8 m -94.89 140.21 30.24 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 111.215 -2.721 . . . . 0.0 104.573 169.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.1 tt -24.14 -39.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 131.204 3.802 . . . . 0.0 118.952 165.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.0 p -67.32 -10.55 51.99 Favored 'General case' 0 C--N 1.321 -0.633 0 O-C-N 118.913 -2.367 . . . . 0.0 117.122 170.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.78 14.41 55.17 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 118.908 -2.37 . . . . 0.0 109.193 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -90.9 121.44 32.75 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 130.755 3.622 . . . . 0.0 106.062 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.2 m -103.72 138.94 39.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.066 2.546 . . . . 0.0 105.312 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.1 pt -144.1 172.27 6.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 C-N-CA 128.313 2.645 . . . . 0.0 104.661 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.6 t -139.8 139.66 36.45 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 118.137 -2.852 . . . . 0.0 112.864 172.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.9 mp -132.08 132.55 43.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 128.275 3.484 . . . . 0.0 105.749 -177.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -76.55 122.71 24.98 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 127.455 2.302 . . . . 0.0 109.456 170.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.3 m -134.34 -174.88 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -128.05 160.14 63.16 Favored Pre-proline 0 N--CA 1.45 -0.467 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 165.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -56.93 -39.01 94.55 Favored 'Trans proline' 0 N--CA 1.445 -1.343 1 C-N-CA 126.355 4.703 . . . . 0.0 112.593 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 72.3 m -78.91 6.78 8.4 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -175.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -78.29 129.04 34.57 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 117.271 -3.393 . . . . 0.0 107.61 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.4 p -52.55 151.48 4.21 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 129.269 3.028 . . . . 0.0 110.832 168.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mm -54.91 -39.43 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 C-N-CA 127.717 2.407 . . . . 0.0 111.664 158.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -50.24 -53.23 29.65 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.531 1.932 . . . . 0.0 114.405 171.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -54.62 -35.67 63.67 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 165.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.6 t -75.75 -42.11 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 O-C-N 119.707 -1.87 . . . . 0.0 111.977 -175.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -63.81 -35.75 81.64 Favored 'General case' 0 N--CA 1.447 -0.593 0 O-C-N 125.724 1.89 . . . . 0.0 113.655 168.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.01 -29.43 58.14 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.702 1.601 . . . . 0.0 107.133 178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.3 mtpt -83.48 -44.2 14.97 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 118.347 -2.721 . . . . 0.0 109.847 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.374 82.3 mt -42.46 -44.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 129.975 3.31 . . . . 0.0 114.59 164.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -57.24 -43.57 83.05 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 126.683 1.993 . . . . 0.0 116.226 172.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -73.19 -41.51 63.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 -178.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? -63.98 -49.08 73.92 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 131.696 3.998 . . . . 0.0 115.674 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -144.13 -7.15 0.72 Allowed 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -171.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.12 -1.15 21.01 Favored Glycine 0 CA--C 1.525 0.696 0 O-C-N 119.054 -2.279 . . . . 0.0 115.313 164.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.444 HD13 HG21 ' A' ' 36' ' ' ILE . 4.9 mt -78.86 118.88 74.99 Favored Pre-proline 0 C--O 1.22 -0.472 0 CA-C-O 114.385 -2.721 . . . . 0.0 108.024 -162.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.7 149.19 78.83 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 O-C-N 125.783 2.465 . . . . 0.0 114.985 175.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -79.24 -32.36 1.8 Allowed 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 121.447 1.432 . . . . 0.0 113.835 -165.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -86.05 7.02 26.26 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 129.62 3.168 . . . . 0.0 111.587 -169.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -132.38 -9.24 3.3 Favored 'General case' 0 C--N 1.325 -0.488 1 C-N-CA 132.103 4.161 . . . . 0.0 111.759 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.269 4.5 tt0 -103.03 139.24 38.84 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 128.43 2.692 . . . . 0.0 107.29 -176.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.9 ttm105 -146.6 132.19 18.8 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 101.94 -3.355 . . . . 0.0 101.94 -171.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 67' ' ' LEU . 11.2 mp -114.68 141.64 47.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.796 -163.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.278 77.7 mt -128.96 138.67 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 1 C-N-CA 133.049 4.54 . . . . 0.0 109.784 -178.605 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -150.61 111.14 4.22 Favored 'General case' 0 N--CA 1.448 -0.566 1 C-N-CA 131.739 4.015 . . . . 0.0 109.309 176.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.312 . . 68.56 31.06 4.91 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 173.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.85 -23.34 9.25 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.32 1.438 . . . . 0.0 111.526 -176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -74.3 126.67 31.15 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.14 110.65 6.75 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 129.304 3.042 . . . . 0.0 106.717 160.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 62.9 mt -82.41 128.87 34.67 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 -179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -78.15 159.41 28.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.578 1.551 . . . . 0.0 111.31 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -73.91 133.19 43.06 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.493 172.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.59 -15.48 55.82 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 115.11 -3.05 . . . . 0.0 111.733 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -77.21 159.7 29.49 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 123.043 3.421 . . . . 0.0 114.692 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.6 p -106.44 -177.77 3.46 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 127.935 3.272 . . . . 0.0 110.785 173.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.34 -18.21 46.46 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 128.58 2.752 . . . . 0.0 109.095 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.4 t -77.83 -28.41 50.2 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.788 2.035 . . . . 0.0 110.815 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -64.6 -31.11 72.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 126.445 3.021 . . . . 0.0 115.675 172.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -116.96 8.61 13.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 124.636 2.16 . . . . 0.0 115.46 -173.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.291 36.3 m-20 67.16 39.16 3.18 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 120.906 3.669 . . . . 0.0 120.906 163.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 5.2 mt -88.75 128.24 41.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 113.562 -1.654 . . . . 0.0 111.596 -164.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -98.23 165.12 12.02 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 124.824 2.25 . . . . 0.0 115.314 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -63.88 127.8 33.02 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.96 -2.963 . . . . 0.0 107.491 -168.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.468 0.0 OUTLIER 93.28 3.98 0.06 Allowed 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 126.297 2.248 . . . . 0.0 113.666 175.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.9 m -61.05 144.02 54.26 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 117.029 -3.544 . . . . 0.0 109.854 -177.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -92.55 117.34 29.85 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 118.441 -2.662 . . . . 0.0 114.047 170.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.426 HD21 HD23 ' A' ' 43' ' ' LEU 0.25 23.4 tp -107.12 134.42 50.27 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 125.131 1.519 . . . . 0.0 109.094 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -107.73 152.47 24.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -171.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.0 pp -145.9 155.23 42.73 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 126.021 2.819 . . . . 0.0 107.575 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.2 m -116.93 137.44 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 131.439 3.896 . . . . 0.0 103.471 -178.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.447 0.7 OUTLIER -119.8 125.3 48.25 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 114.839 -2.505 . . . . 0.0 111.391 176.097 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.411 3.6 ttt180 96.72 -4.4 0.06 Allowed 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 127.375 2.922 . . . . 0.0 115.289 164.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 pp -143.03 158.67 43.39 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.713 1.605 . . . . 0.0 108.842 177.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.0 ttt-85 -76.37 90.79 3.23 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 176.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.25 157.34 15.17 Favored Glycine 0 CA--C 1.536 1.375 0 CA-C-O 116.482 -2.288 . . . . 0.0 116.132 171.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 O-C-N 127.744 2.673 . . . . 0.0 106.769 -168.367 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 ttp . . . . . 0 N--CA 1.472 0.644 0 N-CA-C 101.966 -3.346 . . . . 0.0 101.966 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.8 tm0? -88.5 135.96 33.22 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 121.701 2.046 . . . . 0.0 114.27 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 3' ' ' ILE 0.279 44.4 pt -119.42 148.02 22.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 128.626 2.77 . . . . 0.0 113.771 168.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -99.55 115.89 30.42 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.701 2.4 . . . . 0.0 111.365 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.277 6.5 t -89.1 100.29 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 129.086 2.954 . . . . 0.0 103.053 172.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.0 tttt -74.11 156.83 36.98 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.242 -1.536 . . . . 0.0 114.721 164.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.445 13.0 t -150.71 164.46 36.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.57 171.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.8 tp -46.23 -39.98 10.69 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 121.37 3.841 . . . . 0.0 121.37 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.8 p -82.15 -1.26 48.28 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 123.849 1.785 . . . . 0.0 111.425 -171.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.37 8.94 55.95 Favored Glycine 0 N--CA 1.443 -0.852 0 O-C-N 116.71 -3.744 . . . . 0.0 116.539 176.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -76.32 132.45 39.8 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 129.027 2.931 . . . . 0.0 106.733 175.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 p -112.94 132.6 55.28 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 108.832 -3.803 . . . . 0.0 103.261 161.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.1 mt -102.03 135.12 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 159.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.0 t -81.88 115.89 21.28 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 125.587 1.804 . . . . 0.0 111.511 160.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.3 tp -116.81 129.68 56.24 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 117.616 2.45 . . . . 0.0 117.616 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -80.4 143.94 33.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 123.786 1.755 . . . . 0.0 110.754 170.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.97 167.86 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 128.554 2.742 . . . . 0.0 109.822 164.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.263 9.0 tt0 -105.55 147.45 34.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 110.277 -3.147 . . . . 0.0 105.713 153.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -74.88 -25.21 12.34 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 122.075 1.85 . . . . 0.0 110.533 -172.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 p -63.97 -9.34 15.13 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 118.569 2.803 . . . . 0.0 118.569 173.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -68.04 164.03 21.03 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 130.036 3.334 . . . . 0.0 111.286 170.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.8 p -124.09 148.09 47.39 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 128.822 2.849 . . . . 0.0 104.949 -164.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.5 mm -55.92 -48.41 78.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 110.584 -3.007 . . . . 0.0 112.988 -171.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -67.17 -36.93 82.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -66.48 -39.71 88.91 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.27 86.9 t -70.47 -39.52 76.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 125.707 1.603 . . . . 0.0 110.405 178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -56.67 -29.28 62.16 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 168.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.82 -41.21 62.64 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 166.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -64.49 -31.88 73.28 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 119.861 -1.774 . . . . 0.0 109.42 175.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.325 55.1 mt -62.48 -35.03 67.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 130.313 3.445 . . . . 0.0 110.614 165.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.26 -38.86 65.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 115.071 -2.395 . . . . 0.0 106.642 -174.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.45 1.5 t70 -37.95 -41.59 0.56 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.992 2.96 . . . . 0.0 118.992 166.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -81.46 -72.16 0.44 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.072 -1.876 . . . . 0.0 115.153 171.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -84.62 -19.87 32.29 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 116.535 -1.697 . . . . 0.0 115.179 -170.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.08 -9.47 56.42 Favored Glycine 0 CA--C 1.526 0.722 0 CA-C-O 116.867 -2.074 . . . . 0.0 111.036 159.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -85.09 137.31 37.47 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 123.001 1.381 . . . . 0.0 108.891 -169.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -55.95 139.96 85.26 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 123.292 2.661 . . . . 0.0 113.579 172.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.63 -26.47 12.92 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.067 2.512 . . . . 0.0 117.527 175.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -45.0 -38.65 4.91 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 130.812 3.645 . . . . 0.0 113.607 174.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -98.09 -4.11 36.53 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.25 2.22 . . . . 0.0 109.877 -171.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -98.17 117.82 33.39 Favored 'General case' 0 N--CA 1.451 -0.393 1 O-C-N 115.656 -4.403 . . . . 0.0 114.837 -170.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.438 HH12 ' C ' ' A' ' 76' ' ' GLY 0.258 16.4 ttm-85 -112.39 113.94 26.4 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 126.172 1.789 . . . . 0.0 110.881 163.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.9 mt -83.21 143.51 30.41 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 120.59 -1.319 . . . . 0.0 109.473 163.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.0 tt -133.73 143.67 38.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 119.531 -1.981 . . . . 0.0 106.04 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -136.99 84.3 2.06 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 -170.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 84.37 24.87 0.1 Allowed 'General case' 0 N--CA 1.448 -0.547 1 C-N-CA 133.205 4.602 . . . . 0.0 113.984 165.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.12 -1.85 26.92 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 119.184 -2.198 . . . . 0.0 113.674 -176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.353 40.8 ttmt -121.43 137.14 54.84 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 127.097 2.159 . . . . 0.0 107.017 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.1 mp0 -73.04 128.09 34.46 Favored 'General case' 0 N--CA 1.442 -0.826 1 C-N-CA 135.108 5.363 . . . . 0.0 108.618 177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.463 HD22 ' CG ' ' A' ' 59' ' ' TYR . 86.2 mt -93.41 132.27 37.81 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 168.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -134.42 145.86 49.29 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 131.101 3.761 . . . . 0.0 109.532 -162.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.29 144.93 29.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 112.075 -2.329 . . . . 0.0 110.418 -163.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.52 4.59 23.28 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 116.951 -2.027 . . . . 0.0 116.194 -166.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.337 11.7 mtm180 -125.51 177.5 6.17 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 119.004 1.402 . . . . 0.0 113.367 179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.3 p -95.95 175.25 6.56 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 119.339 -2.101 . . . . 0.0 110.927 158.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.2 mp -57.91 -30.98 66.35 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 118.031 2.604 . . . . 0.0 118.031 159.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.6 t -66.75 -25.67 66.61 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 113.093 -3.337 . . . . 0.0 114.115 174.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -77.73 -19.99 54.26 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 127.39 2.931 . . . . 0.0 109.494 175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.463 ' CG ' HD22 ' A' ' 50' ' ' LEU 0.295 23.3 m-85 -108.04 6.74 27.32 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 119.11 -2.244 . . . . 0.0 110.548 179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.397 0.4 OUTLIER 68.86 30.73 4.59 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 126.849 2.059 . . . . 0.0 112.698 163.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.5 mt -79.16 122.47 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 O-C-N 119.293 -2.13 . . . . 0.0 110.075 -177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -111.62 165.57 11.9 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.176 1.79 . . . . 0.0 112.607 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -46.85 143.96 2.63 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 119.643 -1.911 . . . . 0.0 115.719 171.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 63.72 21.44 12.69 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 128.981 2.912 . . . . 0.0 112.254 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.1 m -82.89 152.67 25.46 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.12 1.768 . . . . 0.0 107.476 175.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.6 m -109.91 105.84 15.17 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 127.714 3.134 . . . . 0.0 107.862 177.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mt -82.79 154.78 24.56 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 163.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -117.63 148.08 42.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 O-C-N 118.502 -2.624 . . . . 0.0 108.436 166.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.3 tp -109.28 147.55 32.46 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 124.829 2.252 . . . . 0.0 105.256 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -136.85 175.25 10.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 113.683 -3.056 . . . . 0.0 107.044 172.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.25 13.3 tp -106.73 149.35 27.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 128.402 3.564 . . . . 0.0 103.813 -170.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.0 ttp180 -116.89 87.2 2.65 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 -167.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.8 mt -96.8 131.07 43.9 Favored 'General case' 0 C--O 1.24 0.571 0 O-C-N 119.317 -2.114 . . . . 0.0 106.7 -178.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 82.84 -32.26 0.09 Allowed 'General case' 0 N--CA 1.444 -0.747 1 C-N-CA 136.215 5.806 . . . . 0.0 112.15 148.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.23 -171.47 15.29 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 128.374 2.892 . . . . 0.0 106.825 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.438 ' C ' HH12 ' A' ' 42' ' ' ARG . . . . . . . . 0 C--O 1.251 1.198 0 CA-C-N 112.56 -1.82 . . . . 0.0 112.318 177.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 ttp . . . . . 0 N--CA 1.469 0.513 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -94.48 144.82 25.25 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 115.279 -2.296 . . . . 0.0 106.689 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.419 HD11 HG11 ' A' ' 17' ' ' VAL . 3.2 pt -146.57 172.66 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.842 2.457 . . . . 0.0 106.193 165.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -135.26 118.6 16.73 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 128.057 3.348 . . . . 0.0 107.987 178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.3 t -93.27 129.1 44.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 131.199 3.799 . . . . 0.0 101.975 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -126.2 125.45 42.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 126.241 2.924 . . . . 0.0 111.812 172.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.3 p -84.55 151.56 24.47 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 174.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.301 80.7 mt -56.65 -10.34 0.98 Allowed 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 131.105 3.762 . . . . 0.0 115.984 175.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.3 p -93.4 -24.3 18.12 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 128.724 2.81 . . . . 0.0 109.269 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.06 43.18 1.81 Allowed Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.148 1.832 . . . . 0.0 116.276 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -115.56 110.11 18.76 Favored 'General case' 0 C--N 1.321 -0.641 2 C-N-CA 132.118 4.167 . . . . 0.0 110.727 169.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 92.6 m -85.72 111.94 20.59 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 124.44 2.067 . . . . 0.0 110.281 173.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.0 mt -100.02 116.15 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 128.089 3.804 . . . . 0.0 101.741 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.325 52.7 m -91.46 134.05 34.96 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 102.274 -3.232 . . . . 0.0 102.274 178.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 tp -130.47 155.28 46.7 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 129.112 2.965 . . . . 0.0 110.116 -172.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 126.31 53.38 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 104.205 -2.517 . . . . 0.0 104.205 172.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.419 HG11 HD11 ' A' ' 3' ' ' ILE . 11.6 m -134.53 163.77 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 103.249 -2.871 . . . . 0.0 103.249 -176.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -101.17 148.17 34.76 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 114.305 -2.76 . . . . 0.0 106.575 174.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.95 6.77 3.98 Favored 'Trans proline' 0 N--CA 1.448 -1.169 0 CA-C-N 126.251 3.268 . . . . 0.0 113.675 -171.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.1 p -118.05 -2.95 11.16 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-O 114.595 -2.621 . . . . 0.0 105.666 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -53.97 122.87 11.01 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.636 2.774 . . . . 0.0 105.942 174.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -66.77 158.38 30.49 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 127.784 3.178 . . . . 0.0 116.61 161.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.2 mm -58.46 -33.44 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-N 123.341 2.791 . . . . 0.0 114.36 171.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -45.29 -49.59 12.55 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 164.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -70.76 -39.06 73.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -177.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.368 71.1 t -52.3 -37.84 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 127.59 2.356 . . . . 0.0 114.021 169.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -66.92 -31.38 71.93 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 116.791 -3.693 . . . . 0.0 115.832 173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -80.47 -36.78 32.99 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.179 -1.391 . . . . 0.0 110.851 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -63.77 -29.7 70.88 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 116.801 -1.571 . . . . 0.0 114.833 168.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.9 mt -66.99 -43.78 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 116.398 -1.763 . . . . 0.0 111.478 166.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -59.7 -39.66 85.33 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-O 114.125 -2.845 . . . . 0.0 110.583 177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -56.14 -21.48 22.78 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.515 1.134 . . . . 0.0 113.72 175.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.251 18.3 mmtm -109.54 -49.91 3.05 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 117.358 -3.339 . . . . 0.0 107.025 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 tp10 -103.24 -9.67 19.38 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 113.788 -3.006 . . . . 0.0 113.661 -165.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.98 -17.7 49.32 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-N 121.701 2.046 . . . . 0.0 112.69 167.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.41 HD13 HD21 ' A' ' 71' ' ' LEU . 1.8 pt -81.2 140.22 49.18 Favored Pre-proline 0 N--CA 1.443 -0.812 0 CA-C-N 117.408 0.604 . . . . 0.0 111.184 -175.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.41 140.85 30.82 Favored 'Trans proline' 0 N--CA 1.453 -0.882 1 C-N-CA 126.731 4.954 . . . . 0.0 114.971 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -40.81 -31.08 0.64 Allowed 'Trans proline' 0 N--CA 1.446 -1.316 1 C-N-CA 127.373 5.382 . . . . 0.0 119.453 173.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -56.83 -54.81 42.13 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 131.471 3.908 . . . . 0.0 113.839 -174.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -80.02 -7.18 58.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 126.323 2.963 . . . . 0.0 114.549 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -89.62 145.78 25.01 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 117.573 -3.205 . . . . 0.0 111.103 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.0 mtt180 -123.67 130.95 53.44 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.503 1.521 . . . . 0.0 108.814 151.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.669 HD12 HD22 ' A' ' 67' ' ' LEU . 1.7 mm? -89.54 130.88 35.8 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 172.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 28.0 mm -122.34 123.93 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 112.398 -2.183 . . . . 0.0 115.424 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.456 ' HB2' HD23 ' A' ' 67' ' ' LEU . 87.0 t80 -147.47 144.38 28.55 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 130.008 3.323 . . . . 0.0 113.848 -174.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 63.62 24.68 14.04 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.938 2.495 . . . . 0.0 112.816 168.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.98 -2.32 69.02 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 114.909 0.723 . . . . 0.0 114.909 -177.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -134.64 155.82 49.82 Favored 'General case' 0 N--CA 1.447 -0.619 2 O-C-N 115.031 -4.805 . . . . 0.0 112.906 -170.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -79.12 133.6 36.75 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 125.435 2.541 . . . . 0.0 106.052 164.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.4 mt -80.47 136.39 36.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 112.769 -2.014 . . . . 0.0 114.565 -174.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -76.89 144.05 39.2 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 116.884 -1.926 . . . . 0.0 111.464 168.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -66.67 -33.07 74.84 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.236 -168.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -102.28 -5.0 49.96 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 126.33 1.919 . . . . 0.0 111.564 -165.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.306 11.4 mmt180 -74.18 149.56 40.86 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.772 2.029 . . . . 0.0 114.616 161.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -103.87 159.76 15.38 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 127.215 3.388 . . . . 0.0 109.489 -172.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 16.2 mt -48.28 -47.45 36.35 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 110.025 -3.261 . . . . 0.0 111.915 162.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -59.8 -49.88 76.0 Favored 'General case' 0 N--CA 1.443 -0.805 1 O-C-N 129.694 4.371 . . . . 0.0 119.952 167.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.27 50.6 m-20 -50.06 -43.72 51.26 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 121.408 3.855 . . . . 0.0 121.408 165.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -93.28 1.28 57.08 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 73.57 50.8 0.12 Allowed 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 119.113 -2.242 . . . . 0.0 104.976 168.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -109.1 69.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 118.459 -2.65 . . . . 0.0 104.932 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -127.52 72.97 1.41 Allowed 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.302 -0.856 . . . . 0.0 109.357 -147.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.416 10.9 tmtt? 89.03 90.87 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 O-C-N 125.285 1.616 . . . . 0.0 112.363 171.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 86.41 47.3 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 110.665 -2.971 . . . . 0.0 110.693 158.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 p -117.05 159.06 23.12 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 122.746 1.26 . . . . 0.0 108.733 171.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.5 m -108.8 137.46 46.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 125.495 2.569 . . . . 0.0 109.118 -172.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.669 HD22 HD12 ' A' ' 43' ' ' LEU 0.256 0.9 OUTLIER -113.84 143.57 44.45 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 111.711 -2.495 . . . . 0.0 107.306 -173.923 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.7 m80 -90.49 136.85 32.8 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 130.481 3.512 . . . . 0.0 107.47 167.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 49.3 tp -121.32 113.9 20.57 Favored 'General case' 0 N--CA 1.451 -0.405 1 C-N-CA 131.754 4.022 . . . . 0.0 107.486 174.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -117.56 133.16 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 129.288 3.035 . . . . 0.0 104.388 -171.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.41 HD21 HD13 ' A' ' 36' ' ' ILE . 3.5 mp -122.38 150.43 42.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 125.811 2.72 . . . . 0.0 111.454 -166.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.269 34.8 ttt180 -92.69 44.27 1.15 Allowed 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 127.767 2.427 . . . . 0.0 108.606 -176.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.302 2.3 pp -143.18 155.48 44.55 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.198 0.999 . . . . 0.0 108.374 -177.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -86.05 118.16 25.34 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 128.156 3.41 . . . . 0.0 107.216 -170.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.82 86.18 1.77 Allowed Glycine 0 CA--C 1.528 0.889 0 CA-C-N 123.123 2.692 . . . . 0.0 109.937 -159.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.314 0 CA-C-O 116.821 -2.099 . . . . 0.0 108.619 -174.392 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 tpt . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 113.788 -3.006 . . . . 0.0 112.23 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.253 59.2 tt0 -104.57 164.82 11.48 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 125.586 1.804 . . . . 0.0 109.522 -177.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.3 pt -145.51 164.91 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 1 C-N-CA 134.746 5.219 . . . . 0.0 107.053 168.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -116.2 147.08 41.79 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 118.922 -2.361 . . . . 0.0 111.782 175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.7 t -129.68 113.66 28.0 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 CA-C-O 113.333 -3.222 . . . . 0.0 106.558 168.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -87.74 143.73 27.0 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 126.522 2.388 . . . . 0.0 110.123 -177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.0 p -117.09 158.73 23.7 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 126.192 2.182 . . . . 0.0 109.49 -171.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.512 HD21 HG12 ' A' ' 70' ' ' VAL . 74.6 mt -50.44 -50.29 52.55 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 116.826 -3.671 . . . . 0.0 116.973 -175.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.6 p -138.11 34.14 2.35 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -169.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -131.21 -123.84 2.52 Favored Glycine 0 CA--C 1.533 1.175 0 N-CA-C 116.1 1.2 . . . . 0.0 116.1 -172.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.3 pttt -138.47 -167.85 2.27 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 126.677 1.991 . . . . 0.0 111.204 -166.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.5 p -89.75 119.99 30.62 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 119.083 0.856 . . . . 0.0 110.909 149.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.2 mt -80.55 143.45 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 167.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.264 71.9 p -114.68 122.31 46.06 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 113.931 -2.937 . . . . 0.0 108.221 -169.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.4 HD21 HG12 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -128.68 134.22 48.43 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 122.3 2.318 . . . . 0.0 104.906 174.119 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -103.85 118.91 37.8 Favored 'General case' 0 N--CA 1.44 -0.962 1 N-CA-C 99.909 -4.108 . . . . 0.0 99.909 172.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 m -131.45 149.64 33.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 C-N-CA 130.102 3.361 . . . . 0.0 107.478 -167.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -74.19 137.02 75.47 Favored Pre-proline 0 N--CA 1.447 -0.621 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -62.64 -5.48 7.26 Favored 'Trans proline' 0 N--CA 1.442 -1.527 0 CA-C-O 115.817 -1.826 . . . . 0.0 115.921 -176.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 88.4 p -115.18 23.45 12.47 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 170.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -81.36 160.92 23.99 Favored 'General case' 0 N--CA 1.452 -0.343 0 O-C-N 126.717 2.51 . . . . 0.0 115.498 174.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 p -102.28 140.79 36.09 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 131.595 3.958 . . . . 0.0 107.23 -162.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 49.3 mt -47.96 -47.1 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.705 0 C-N-CA 125.803 1.641 . . . . 0.0 112.979 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -65.75 -38.59 89.51 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 120.989 1.722 . . . . 0.0 112.025 -173.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -72.45 -12.73 61.22 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.114 2.166 . . . . 0.0 110.797 -176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 t -99.42 -27.39 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 1 CA-C-O 110.642 -4.504 . . . . 0.0 106.288 176.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -56.73 -42.97 80.17 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 128.28 3.488 . . . . 0.0 109.907 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.17 -42.41 77.03 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.717 3.607 . . . . 0.0 112.001 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -64.26 -35.36 80.58 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 118.686 2.847 . . . . 0.0 118.686 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.4 HG12 HD21 ' A' ' 15' ' ' LEU . 61.5 mt -72.91 -28.07 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.461 172.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.94 -52.49 35.47 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 117.105 -3.497 . . . . 0.0 114.681 166.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -56.94 -30.17 63.78 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 117.035 2.235 . . . . 0.0 117.035 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -101.31 -33.16 10.15 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.401 1.455 . . . . 0.0 112.647 -173.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.327 78.8 mm-40 -125.28 -19.14 5.17 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.12 2.73 51.55 Favored Glycine 0 N--CA 1.44 -1.098 0 O-C-N 117.559 -3.213 . . . . 0.0 115.719 170.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.3 mt -77.66 120.67 82.32 Favored Pre-proline 0 N--CA 1.446 -0.658 0 CA-C-N 122.584 3.192 . . . . 0.0 109.945 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -65.47 159.11 49.34 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 N-CA-C 118.037 2.283 . . . . 0.0 118.037 169.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -78.47 -19.83 11.34 Favored 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 124.556 3.504 . . . . 0.0 114.529 -169.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -82.4 -12.2 58.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 174.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -76.41 -42.84 42.89 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.647 171.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -74.77 110.73 9.31 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 127.917 3.261 . . . . 0.0 107.934 -156.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 69.2 mtm180 -108.54 112.1 24.3 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 100.388 -3.93 . . . . 0.0 100.388 174.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.38 124.3 44.39 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.538 0.0 OUTLIER -127.3 137.31 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 117.637 -3.164 . . . . 0.0 113.259 -175.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.476 ' CE2' HG13 ' A' ' 61' ' ' ILE 0.275 24.9 t80 -149.59 108.15 3.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 113.817 -1.538 . . . . 0.0 109.207 -165.427 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.4 23.34 6.16 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-O 127.043 3.306 . . . . 0.0 115.172 164.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.02 -17.86 47.54 Favored Glycine 0 CA--C 1.531 1.09 1 C-N-CA 136.234 6.635 . . . . 0.0 111.628 177.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.4 mttp -80.6 120.0 23.98 Favored 'General case' 0 N--CA 1.447 -0.607 1 C-N-CA 131.808 4.043 . . . . 0.0 107.824 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mm100 -73.06 131.59 42.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 115.417 -2.23 . . . . 0.0 114.604 159.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.364 39.2 mt -110.45 132.64 54.0 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 125.892 2.758 . . . . 0.0 107.264 -163.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -105.46 124.96 50.42 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 111.399 -2.637 . . . . 0.0 113.33 -169.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.267 0.0 OUTLIER -61.43 139.88 58.14 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 111.908 -2.405 . . . . 0.0 110.619 -172.435 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.81 -38.18 2.09 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 104.243 -3.543 . . . . 0.0 104.243 178.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -94.38 -178.37 4.56 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 104.345 -2.465 . . . . 0.0 104.345 -175.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.257 46.7 p -119.68 -175.84 3.04 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.775 -2.011 . . . . 0.0 107.753 -166.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.7 mt -64.2 -41.87 96.88 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.154 1.381 . . . . 0.0 114.278 -176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 t -71.93 -32.91 67.82 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 131.011 3.725 . . . . 0.0 107.681 -170.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -71.46 -13.36 61.8 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 130.824 3.65 . . . . 0.0 112.698 -172.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -128.97 0.97 5.3 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.069 2.547 . . . . 0.0 111.466 174.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t30 57.41 53.89 7.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 128.815 2.846 . . . . 0.0 110.401 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.476 HG13 ' CE2' ' A' ' 45' ' ' PHE . 5.0 mt -92.46 112.57 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 N-CA-C 100.395 -3.928 . . . . 0.0 100.395 168.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -130.86 171.41 13.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 111.574 -2.557 . . . . 0.0 107.39 -167.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.74 113.79 0.92 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 129.237 3.015 . . . . 0.0 112.218 -170.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 67.88 25.17 7.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 118.201 -2.812 . . . . 0.0 117.337 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.1 m -64.32 135.22 55.98 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 118.233 -2.792 . . . . 0.0 117.829 156.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.267 96.5 m -110.49 128.0 55.42 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 124.479 1.112 . . . . 0.0 108.563 178.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.261 1.2 mp -109.67 168.73 9.19 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 103.459 -2.793 . . . . 0.0 103.459 173.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -112.35 138.37 49.18 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 129.965 3.306 . . . . 0.0 107.668 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 tp -126.79 114.76 18.38 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 125.908 1.683 . . . . 0.0 108.138 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.512 HG12 HD21 ' A' ' 8' ' ' LEU . 25.1 m -106.1 142.56 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 102.724 -3.065 . . . . 0.0 102.724 175.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.3 mt -101.19 150.91 22.47 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 116.005 -1.95 . . . . 0.0 111.649 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.6 ttt-85 -103.86 101.97 11.78 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 129.114 2.966 . . . . 0.0 103.35 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 mt -118.3 -23.14 7.38 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 130.166 3.387 . . . . 0.0 114.655 -178.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -112.36 4.97 17.94 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 -169.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.09 -27.65 19.44 Favored Glycine 0 CA--C 1.53 0.985 1 C-N-CA 132.011 4.624 . . . . 0.0 110.784 169.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.58 -2.233 . . . . 0.0 111.107 157.276 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.465 0.286 0 CA-C-O 123.544 1.64 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -105.13 130.18 53.36 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.725 3.21 . . . . 0.0 110.977 167.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.293 17.6 pt -133.04 140.85 46.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 1 C-N-CA 133.731 4.812 . . . . 0.0 113.345 177.596 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.416 ' HB2' ' HA ' ' A' ' 66' ' ' THR . 49.3 m-85 -93.21 148.88 21.65 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 125.89 2.757 . . . . 0.0 112.226 170.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 t -137.55 126.57 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 118.812 -2.43 . . . . 0.0 105.304 170.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 37.9 mmtt -87.2 112.29 21.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 115.687 -2.102 . . . . 0.0 114.796 171.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.8 p -62.68 155.62 25.85 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 119.748 1.158 . . . . 0.0 113.03 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.1 tp -61.62 -36.26 80.24 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 128.17 2.588 . . . . 0.0 111.242 -178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.8 p -93.01 0.01 57.29 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 119.824 1.193 . . . . 0.0 112.682 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.93 20.51 6.01 Favored Glycine 0 N--CA 1.445 -0.719 0 O-C-N 118.484 -2.635 . . . . 0.0 116.212 142.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -84.89 152.58 23.45 Favored 'General case' 0 CA--C 1.538 0.503 1 C-N-CA 136.016 5.726 . . . . 0.0 107.247 171.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.2 m -112.38 137.07 51.07 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.351 1.2 pt -115.01 131.64 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 103.326 -2.842 . . . . 0.0 103.326 176.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.375 32.6 m -90.95 130.51 36.87 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 166.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tp -117.25 137.29 52.49 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 104.446 -2.428 . . . . 0.0 104.446 -171.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 17' ' ' VAL . 2.3 tp10 -94.16 144.5 25.45 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 16' ' ' GLU . 12.9 m -158.96 -177.12 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 127.257 2.223 . . . . 0.0 106.763 -177.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -133.06 153.15 80.77 Favored Pre-proline 0 C--N 1.321 -0.669 0 C-N-CA 129.119 2.967 . . . . 0.0 106.394 166.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.34 0.1 OUTLIER -49.4 -24.33 8.6 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 N-CA-C 119.214 2.736 . . . . 0.0 119.214 167.107 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 26.9 p -84.57 -11.06 56.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 113.578 -3.106 . . . . 0.0 110.619 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -68.35 131.72 45.82 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 129.746 3.218 . . . . 0.0 113.593 173.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.6 p -82.45 164.62 20.85 Favored 'General case' 0 N--CA 1.449 -0.476 1 O-C-N 129.542 4.276 . . . . 0.0 111.879 178.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.0 mm -59.64 -31.29 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 CA-C-N 112.541 -2.118 . . . . 0.0 112.013 172.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -74.21 -16.64 60.97 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 124.468 2.08 . . . . 0.0 112.584 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -98.45 -28.59 13.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 128.12 2.568 . . . . 0.0 110.485 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.267 62.8 t -52.52 -59.48 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 127.823 2.449 . . . . 0.0 112.291 168.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.343 17.4 ptpt -53.87 -41.78 67.9 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 128.184 3.428 . . . . 0.0 113.456 177.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.05 -40.56 70.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 126.244 2.215 . . . . 0.0 113.013 175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttt -77.34 -28.1 52.95 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 118.38 -1.328 . . . . 0.0 112.609 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.1 mt -62.55 -34.73 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 O-C-N 119.614 -1.929 . . . . 0.0 112.261 169.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -58.88 -42.89 90.54 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 119.225 0.92 . . . . 0.0 113.163 169.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -73.69 -47.06 42.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.257 2.223 . . . . 0.0 112.784 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -68.46 -38.65 81.29 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.422 64.3 mm-40 -129.21 -18.56 3.64 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 130.093 3.357 . . . . 0.0 115.675 -154.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.77 -22.28 41.67 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.66 2.076 . . . . 0.0 114.686 163.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 36' ' ' ILE . 44.4 mt -86.48 119.04 71.19 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 125.883 1.673 . . . . 0.0 109.638 -163.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -45.94 149.26 2.3 Favored 'Trans proline' 0 N--CA 1.457 -0.644 1 C-N-CA 127.615 5.543 . . . . 0.0 115.73 175.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -68.02 -32.51 28.05 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 124.535 3.49 . . . . 0.0 109.995 -171.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.258 19.7 t70 -49.96 -35.92 26.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 117.042 -1.456 . . . . 0.0 114.144 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -101.55 -5.73 24.78 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 128.679 2.791 . . . . 0.0 107.325 -160.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -85.66 141.34 29.84 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 119.22 -2.175 . . . . 0.0 115.772 177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -128.17 95.85 4.29 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 101.308 -3.59 . . . . 0.0 101.308 176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.2 mt -82.49 111.09 18.19 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 114.544 -2.646 . . . . 0.0 114.472 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 16.6 mt -118.77 144.24 27.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 125.163 3.619 . . . . 0.0 110.383 -172.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -140.37 123.18 16.41 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 102.439 -3.171 . . . . 0.0 102.439 163.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 44.83 33.12 0.92 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 111.713 -2.494 . . . . 0.0 114.022 169.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.95 -33.88 4.99 Favored Glycine 0 C--O 1.221 -0.671 0 O-C-N 118.63 -2.543 . . . . 0.0 112.898 173.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -79.04 121.66 25.23 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 128.199 2.941 . . . . 0.0 112.171 -178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -79.51 111.38 15.72 Favored 'General case' 0 N--CA 1.454 -0.251 1 N-CA-C 100.023 -4.066 . . . . 0.0 100.023 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 71.6 mt -75.67 123.01 24.83 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 127.826 2.45 . . . . 0.0 108.691 -173.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 -94.85 151.12 19.49 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 124.927 2.299 . . . . 0.0 108.389 -163.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.94 139.32 33.43 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-N 109.796 -3.365 . . . . 0.0 110.524 -168.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.47 -20.09 38.0 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 127.738 2.59 . . . . 0.0 116.291 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 10.8 mmm-85 -73.38 145.05 46.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 117.759 -3.201 . . . . 0.0 109.49 176.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 p -75.64 144.18 41.85 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.447 2.699 . . . . 0.0 107.026 167.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.0 mt -47.18 -37.67 10.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 166.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 t -67.91 -30.74 70.15 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -77.62 -36.9 51.23 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 126.262 1.825 . . . . 0.0 110.022 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.561 ' HB3' HG12 ' A' ' 61' ' ' ILE . 0.7 OUTLIER -68.43 -20.98 64.68 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-O 115.742 -2.075 . . . . 0.0 115.839 170.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.341 29.5 m120 74.58 27.01 1.39 Allowed 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 120.272 3.434 . . . . 0.0 120.272 -170.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.561 HG12 ' HB3' ' A' ' 59' ' ' TYR . 39.7 mm -81.18 112.52 19.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 O-C-N 117.863 -3.023 . . . . 0.0 109.065 -179.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.254 78.0 mm-40 -83.25 155.71 23.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.938 2.895 . . . . 0.0 114.319 177.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.55 127.38 15.41 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 131.343 3.857 . . . . 0.0 114.762 170.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 1.5 pt-20 65.2 33.13 9.55 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 125.685 2.659 . . . . 0.0 116.048 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 m -74.59 155.44 37.86 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 124.899 2.285 . . . . 0.0 111.746 160.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.416 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 20.6 m -116.21 104.39 11.47 Favored 'General case' 0 C--O 1.23 0.066 0 CA-C-N 111.537 -2.574 . . . . 0.0 105.516 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -94.86 159.77 14.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 130.77 3.628 . . . . 0.0 108.721 175.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.347 70.7 m80 -109.35 136.61 48.5 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 115.465 -2.207 . . . . 0.0 114.198 177.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.261 31.4 tp -108.94 117.5 34.35 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 126.006 2.066 . . . . 0.0 106.322 173.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 92.1 t -112.0 145.44 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 111.818 -2.446 . . . . 0.0 105.246 169.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.78 121.04 24.27 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 130.034 3.333 . . . . 0.0 110.538 168.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -68.07 -19.14 64.84 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.318 2.647 . . . . 0.0 111.033 172.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.336 0.0 OUTLIER -144.68 159.4 42.9 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 122.778 2.535 . . . . 0.0 116.689 157.158 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 mtt180 -123.38 -26.42 4.26 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.365 1.466 . . . . 0.0 111.708 166.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.9 147.16 7.9 Favored Glycine 0 CA--C 1.536 1.373 0 N-CA-C 107.307 -2.317 . . . . 0.0 107.307 162.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.258 1.653 1 CA-C-O 112.987 -4.229 . . . . 0.0 111.904 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptt? . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.1 pm0 -96.66 143.03 28.0 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.405 3.082 . . . . 0.0 109.509 -174.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.454 HG13 HD12 ' A' ' 15' ' ' LEU . 18.4 pt -132.72 158.09 43.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 1 C-N-CA 132.152 4.181 . . . . 0.0 105.976 152.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -100.66 138.94 37.04 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 126.596 1.958 . . . . 0.0 108.327 176.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.1 t -106.49 110.37 31.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 1 N-CA-C 100.188 -4.004 . . . . 0.0 100.188 172.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -107.06 113.22 26.56 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 126.876 3.227 . . . . 0.0 106.28 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -79.19 148.1 32.4 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 117.399 -3.313 . . . . 0.0 105.527 -173.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 37.4 tp -66.53 -21.23 66.16 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 118.908 -2.37 . . . . 0.0 112.836 168.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 p -79.0 -1.32 34.93 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.003 1.721 . . . . 0.0 112.334 167.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.68 -27.09 22.12 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-O 115.867 -2.629 . . . . 0.0 112.251 160.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.7 tttt -64.32 139.6 58.78 Favored 'General case' 0 C--N 1.328 -0.352 1 C-N-CA 132.21 4.204 . . . . 0.0 108.179 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 60.9 m -117.26 112.72 21.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 124.524 2.107 . . . . 0.0 105.934 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.7 mt -101.16 138.03 26.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 1 C-N-CA 131.832 4.053 . . . . 0.0 106.646 176.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 m -101.63 129.76 47.82 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 128.375 2.67 . . . . 0.0 107.297 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.454 HD12 HG13 ' A' ' 3' ' ' ILE 0.299 62.0 mt -103.18 168.35 9.24 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 117.826 -1.083 . . . . 0.0 109.24 169.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.95 115.74 10.76 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 128.371 3.545 . . . . 0.0 101.811 169.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.52 167.55 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 103.876 -2.639 . . . . 0.0 103.876 -161.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 4.7 mm-40 -97.91 162.02 23.66 Favored Pre-proline 0 N--CA 1.447 -0.59 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 169.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.81 -6.24 18.3 Favored 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 124.213 3.275 . . . . 0.0 116.194 163.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.6 p -94.17 -0.64 55.1 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.477 1.911 . . . . 0.0 110.066 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -78.47 121.15 24.18 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 102.912 -2.995 . . . . 0.0 102.912 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -65.74 145.64 55.76 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.387 2.675 . . . . 0.0 112.342 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.4 mm -66.46 88.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-O 123.322 1.534 . . . . 0.0 112.421 165.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 178.42 -54.48 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 131.11 3.764 . . . . 0.0 104.69 -177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.308 22.6 t-20 -52.11 -55.76 18.79 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 -174.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.322 40.9 t -72.6 -20.08 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 C-N-CA 128.456 2.702 . . . . 0.0 110.996 178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -71.38 -30.21 65.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 122.995 2.634 . . . . 0.0 108.507 172.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.66 -19.57 41.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 116.357 -1.782 . . . . 0.0 113.695 171.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -76.98 -35.72 56.97 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 116.564 -1.684 . . . . 0.0 109.342 163.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 17.2 mm -65.05 -38.47 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 124.644 2.164 . . . . 0.0 111.698 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -46.45 -61.49 1.78 Allowed 'General case' 0 N--CA 1.451 -0.419 0 O-C-N 117.732 -3.105 . . . . 0.0 110.109 164.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -66.8 -37.66 84.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.0 mmtm -78.65 -59.15 2.9 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -106.89 -0.36 23.29 Favored 'General case' 0 C--O 1.222 -0.351 0 O-C-N 125.691 1.869 . . . . 0.0 111.326 -162.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.18 13.7 76.35 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 129.8 3.571 . . . . 0.0 117.985 162.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.4 mt -98.81 113.56 64.58 Favored Pre-proline 0 CA--C 1.531 0.213 0 N-CA-C 104.049 -2.574 . . . . 0.0 104.049 -167.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -49.74 126.3 16.18 Favored 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 128.387 6.058 . . . . 0.0 113.767 167.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -41.76 -27.84 0.61 Allowed 'Trans proline' 0 C--N 1.323 -0.81 1 C-N-CA 125.685 4.257 . . . . 0.0 117.751 -177.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -67.81 -22.78 65.15 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 116.065 1.876 . . . . 0.0 116.065 171.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 69.4 mt-30 -98.69 4.02 47.81 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.381 2.672 . . . . 0.0 114.708 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -95.81 113.28 24.9 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 113.835 -2.983 . . . . 0.0 105.133 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.1 mtt180 -95.71 141.48 29.14 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 123.763 2.983 . . . . 0.0 112.515 150.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.29 0.8 OUTLIER -157.52 117.46 3.4 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 116.603 -1.665 . . . . 0.0 108.811 -148.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.3 mp -145.51 144.29 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 O-C-N 126.487 2.367 . . . . 0.0 106.43 -150.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' CD2' HG12 ' A' ' 61' ' ' ILE . 37.4 t80 -131.62 -37.98 1.18 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.27 3.028 . . . . 0.0 115.155 172.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.363 . . -148.11 56.68 1.07 Allowed 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 129.177 2.991 . . . . 0.0 111.163 -175.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.98 -3.54 77.27 Favored Glycine 0 CA--C 1.536 1.384 0 CA-C-O 113.809 -3.773 . . . . 0.0 119.499 168.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -146.06 176.27 9.84 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 120.466 2.133 . . . . 0.0 110.052 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.06 130.29 39.04 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 113.029 -1.896 . . . . 0.0 107.911 174.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.4 mt -77.56 120.6 22.76 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.027 1.731 . . . . 0.0 109.349 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.5 tt0 -67.02 123.87 21.44 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 125.947 2.784 . . . . 0.0 109.876 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -60.92 115.68 3.89 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 127.269 2.228 . . . . 0.0 110.751 -178.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.79 -23.55 11.73 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 115.411 -2.883 . . . . 0.0 110.23 176.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.1 mmp_? -77.65 148.82 34.85 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -78.34 174.51 11.17 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.767 2.027 . . . . 0.0 111.956 171.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -69.1 -24.78 64.17 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.399 1.48 . . . . 0.0 112.095 167.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -66.33 -33.84 76.64 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.052 2.541 . . . . 0.0 113.216 172.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -75.87 -34.84 60.03 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 115.085 -2.388 . . . . 0.0 109.833 -175.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.7 1.92 51.5 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 128.784 3.803 . . . . 0.0 113.484 -176.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 t30 60.45 39.66 18.12 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.797 2.039 . . . . 0.0 110.421 175.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.405 HG12 ' CD2' ' A' ' 45' ' ' PHE . 67.9 mt -90.84 137.67 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 102.14 -3.281 . . . . 0.0 102.14 -178.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -140.93 170.11 16.36 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -168.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 12.5 pttp -58.51 138.4 56.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 120.717 3.599 . . . . 0.0 120.717 -173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.264 4.8 tt0 75.35 22.21 1.71 Allowed 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 128.547 2.739 . . . . 0.0 108.749 160.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.413 27.4 m -99.61 158.54 15.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 124.909 2.29 . . . . 0.0 109.149 174.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.9 m -62.44 130.9 47.31 Favored 'General case' 0 N--CA 1.455 -0.193 0 O-C-N 116.508 -3.87 . . . . 0.0 111.709 161.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tt -117.16 143.29 46.0 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 100.715 -3.809 . . . . 0.0 100.715 159.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.4 t60 -109.23 143.19 39.01 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.708 2.403 . . . . 0.0 111.935 -169.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -128.52 128.81 45.03 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 129.426 3.091 . . . . 0.0 107.167 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.3 4.3 t -122.03 136.09 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-O 115.596 -2.145 . . . . 0.0 106.947 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -110.02 121.48 45.35 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 129.071 2.948 . . . . 0.0 115.303 -171.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 40.76 -28.25 0.0 OUTLIER 'General case' 0 N--CA 1.441 -0.891 1 C-N-CA 135.623 5.569 . . . . 0.0 119.899 -174.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 71.3 mt -117.58 149.48 40.59 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 101.528 -3.508 . . . . 0.0 101.528 -168.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -57.63 135.14 56.67 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 128.431 2.692 . . . . 0.0 111.572 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.31 47.26 1.04 Allowed Glycine 0 CA--C 1.529 0.918 0 C-N-CA 127.442 2.449 . . . . 0.0 114.352 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.486 0 CA-C-O 114.492 -3.393 . . . . 0.0 110.805 -168.586 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 ttp . . . . . 0 N--CA 1.474 0.764 0 CA-C-O 122.092 0.948 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -115.88 145.23 43.05 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 117.335 -1.746 . . . . 0.0 106.389 -169.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.2 pt -132.27 177.99 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 C-N-CA 126.591 1.956 . . . . 0.0 108.902 171.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -124.36 149.4 46.69 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 105.229 -2.137 . . . . 0.0 105.229 178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.93 111.43 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 104.84 -2.282 . . . . 0.0 104.84 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -72.43 115.14 11.34 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 127.298 2.239 . . . . 0.0 113.409 167.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.493 ' HA ' HD11 ' A' ' 69' ' ' LEU . 46.9 p -94.11 170.32 9.61 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 124.085 1.898 . . . . 0.0 107.301 -169.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 mp -71.7 -15.79 62.22 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -164.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.9 p -73.46 -31.51 63.83 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 128.247 2.619 . . . . 0.0 111.244 165.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.63 2.6 27.31 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 129.031 3.205 . . . . 0.0 110.605 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -66.75 146.41 54.48 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 121.328 2.564 . . . . 0.0 114.478 171.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.0 m -116.33 106.75 14.0 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 114.012 -2.899 . . . . 0.0 104.164 -165.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 25.8 mm -98.59 140.65 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 104.535 -2.395 . . . . 0.0 104.535 -176.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 m -79.21 136.8 37.18 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 124.355 2.026 . . . . 0.0 109.77 167.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.64 135.85 32.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 101.121 -3.659 . . . . 0.0 101.121 -169.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.27 131.02 50.66 Favored 'General case' 0 C--O 1.238 0.448 1 CA-C-O 129.62 4.533 . . . . 0.0 108.138 174.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.14 -165.62 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 129.77 3.228 . . . . 0.0 118.481 176.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -149.65 139.28 13.13 Favored Pre-proline 0 N--CA 1.444 -0.767 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 167.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -61.21 -22.87 75.9 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 124.16 3.24 . . . . 0.0 118.477 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.9 m -90.98 -25.14 19.87 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 118.863 2.912 . . . . 0.0 118.863 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -71.85 106.28 4.12 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 130.08 3.352 . . . . 0.0 109.841 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -48.97 148.66 2.18 Favored 'General case' 0 N--CA 1.45 -0.436 1 C-N-CA 134.346 5.058 . . . . 0.0 113.139 -155.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 60.2 mt -58.24 -39.62 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.157 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -47.18 -52.18 16.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.86 1.664 . . . . 0.0 111.387 170.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -69.69 -24.93 63.65 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 127.393 2.277 . . . . 0.0 114.27 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.275 99.4 t -56.82 -55.36 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 1 O-C-N 113.328 -5.858 . . . . 0.0 112.586 167.261 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -43.66 -42.61 5.37 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 127.443 2.297 . . . . 0.0 115.601 167.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.9 -32.44 73.94 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.734 3.213 . . . . 0.0 112.43 -178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -69.12 -31.86 70.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 124.819 2.247 . . . . 0.0 114.276 170.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.1 mt -73.22 -40.19 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 127.37 2.268 . . . . 0.0 115.114 169.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -51.29 -37.76 49.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 127.78 2.432 . . . . 0.0 112.63 162.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -72.07 -38.19 69.48 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.034 0.533 . . . . 0.0 111.958 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -75.78 -51.88 11.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 129.069 2.948 . . . . 0.0 111.815 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -133.63 -0.16 3.22 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 123.246 1.498 . . . . 0.0 111.402 -160.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.87 -23.17 35.48 Favored Glycine 0 N--CA 1.44 -1.063 0 O-C-N 117.421 -3.299 . . . . 0.0 114.482 161.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.3 mt -72.42 120.01 78.16 Favored Pre-proline 0 N--CA 1.441 -0.891 0 O-C-N 117.058 -3.613 . . . . 0.0 112.17 -171.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -72.23 142.24 37.29 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 124.007 3.138 . . . . 0.0 110.719 -174.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -35.49 -42.87 0.49 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 C-N-CA 123.88 3.053 . . . . 0.0 119.12 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -59.05 -18.17 32.34 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 116.591 2.071 . . . . 0.0 116.591 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -119.54 1.25 11.15 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.372 -170.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -86.3 151.27 23.73 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 172.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.2 mtt180 -132.54 128.91 38.29 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.562 1.545 . . . . 0.0 108.875 151.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.6 mt -108.19 129.21 55.2 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 3.2 mt -112.24 128.59 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 129.215 3.006 . . . . 0.0 109.175 165.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -81.43 -36.3 29.6 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 119.039 -2.288 . . . . 0.0 106.535 -177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -143.08 -67.35 0.36 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 119.54 3.163 . . . . 0.0 119.54 173.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.55 -24.78 1.21 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 126.247 1.88 . . . . 0.0 113.766 164.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -94.26 141.21 28.83 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.88 2.472 . . . . 0.0 106.595 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -70.63 140.27 51.55 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.224 3.01 . . . . 0.0 113.95 174.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 mt -93.15 100.37 12.77 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 126.191 1.796 . . . . 0.0 108.332 171.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -93.16 142.13 27.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 126.304 2.954 . . . . 0.0 106.39 -156.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.69 132.85 55.18 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 130.881 3.672 . . . . 0.0 108.492 172.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 122.15 -15.16 8.83 Favored Glycine 0 CA--C 1.539 1.535 0 C-N-CA 128.69 3.043 . . . . 0.0 115.4 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -124.47 179.61 4.87 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 128.808 2.843 . . . . 0.0 110.958 -163.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -115.65 164.62 14.07 Favored 'General case' 0 N--CA 1.442 -0.832 0 O-C-N 118.53 -2.607 . . . . 0.0 109.409 -179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 36.2 mt -72.46 -14.43 61.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.545 -0.722 . . . . 0.0 111.476 174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -72.61 -35.39 67.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 129.21 3.004 . . . . 0.0 106.921 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.369 21.3 m-20 -51.4 -36.88 45.56 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 127.849 2.46 . . . . 0.0 113.696 172.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -103.91 3.52 33.75 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 112.903 -3.427 . . . . 0.0 110.162 179.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.27 0.5 OUTLIER 33.95 63.85 0.38 Allowed 'General case' 0 N--CA 1.45 -0.464 1 C-N-CA 134.333 5.053 . . . . 0.0 114.73 -176.081 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.4 mm -77.6 135.9 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 113.556 -1.656 . . . . 0.0 107.206 -177.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -100.27 171.66 7.64 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.316 1.446 . . . . 0.0 107.231 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -66.73 146.06 54.87 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 126.211 2.194 . . . . 0.0 108.456 -170.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 65.73 17.44 10.87 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.354 1.888 . . . . 0.0 113.765 171.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.5 m -62.99 148.16 48.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 162.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -100.11 106.7 18.46 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 128.446 2.698 . . . . 0.0 108.399 -176.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.2 159.9 14.65 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.85 0.75 . . . . 0.0 111.275 169.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.46 154.91 29.51 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.636 1.974 . . . . 0.0 108.043 170.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.493 HD11 ' HA ' ' A' ' 7' ' ' THR 0.342 4.3 pp -127.93 155.28 44.46 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 130.392 3.477 . . . . 0.0 116.238 177.201 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -153.23 148.2 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 130.304 3.442 . . . . 0.0 108.783 174.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.8 mt -54.13 129.3 34.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 130.572 3.549 . . . . 0.0 114.32 168.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -108.44 52.22 0.72 Allowed 'General case' 0 CA--C 1.534 0.332 0 O-C-N 125.526 1.766 . . . . 0.0 108.268 163.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.35 -176.11 2.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 117.731 -1.588 . . . . 0.0 114.257 152.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.6 ttm105 -146.53 -26.22 0.42 Allowed 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 122.814 2.552 . . . . 0.0 109.12 176.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.56 165.78 24.39 Favored Glycine 0 C--N 1.34 0.752 0 CA-C-O 124.541 2.189 . . . . 0.0 112.688 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.01 1 CA-C-O 111.623 -4.987 . . . . 0.0 113.405 -178.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.59 ' HG3' HG23 ' A' ' 17' ' ' VAL . 3.6 ptt? . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.401 ' HB2' HE21 ' A' ' 2' ' ' GLN . 7.5 mt-30 -93.95 155.9 16.9 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 173.274 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.33 18.1 pt -133.15 158.02 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 C-N-CA 127.922 2.489 . . . . 0.0 107.167 161.187 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -116.94 127.04 53.84 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 118.837 -2.414 . . . . 0.0 109.525 176.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.568 HG21 HD11 ' A' ' 15' ' ' LEU 0.293 3.2 t -107.74 96.68 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 103.317 -2.845 . . . . 0.0 103.317 174.846 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -93.33 127.14 38.81 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 118.942 -2.349 . . . . 0.0 116.986 -171.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -71.54 150.23 44.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 C-N-CA 130.429 3.492 . . . . 0.0 109.288 174.478 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.3 mt -68.86 -25.77 64.8 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 116.038 -1.935 . . . . 0.0 107.713 175.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -80.42 2.92 23.09 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 131.165 3.786 . . . . 0.0 116.241 174.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.61 6.19 53.06 Favored Glycine 0 CA--C 1.536 1.362 0 C-N-CA 127.296 2.379 . . . . 0.0 108.829 154.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 7' ' ' THR . 47.4 mtmt -97.48 156.48 16.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 121.575 2.687 . . . . 0.0 106.188 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.3 m -125.56 129.28 49.39 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 126.52 2.388 . . . . 0.0 114.328 -178.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.2 mp -99.66 116.78 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 1 N-CA-C 98.173 -4.751 . . . . 0.0 98.173 169.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.7 m -95.0 116.96 29.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.3 0.64 . . . . 0.0 109.664 170.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.568 HD11 HG21 ' A' ' 5' ' ' VAL 0.325 32.4 mt -92.24 151.49 20.31 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 126.754 2.022 . . . . 0.0 106.912 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -108.23 83.03 1.72 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.098 2.959 . . . . 0.0 108.458 -173.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' A' ' 1' ' ' MET . 27.0 m -103.13 164.47 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 119.219 -2.175 . . . . 0.0 110.77 -168.059 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -108.28 160.09 28.31 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 130.564 3.546 . . . . 0.0 111.903 162.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.28 -20.89 27.46 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 CA-C-N 122.833 2.047 . . . . 0.0 114.126 -176.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.2 p -94.09 1.33 56.17 Favored 'General case' 0 N--CA 1.447 -0.586 1 C-N-CA 133.659 4.784 . . . . 0.0 112.649 -176.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -61.62 139.85 58.23 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 127.312 2.245 . . . . 0.0 107.7 161.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.4 p -95.77 178.88 5.3 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.314 2.246 . . . . 0.0 106.462 170.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.9 mm -65.11 -34.85 73.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 1 C-N-CA 132.433 4.293 . . . . 0.0 106.055 170.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -64.95 -42.0 95.0 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 117.26 -3.4 . . . . 0.0 109.564 176.007 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -76.74 -41.51 44.72 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 115.497 -2.192 . . . . 0.0 110.958 179.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.54 -29.43 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 124.964 3.529 . . . . 0.0 111.869 176.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -52.19 -46.39 65.55 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.928 2.491 . . . . 0.0 116.557 165.339 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.55 -44.05 71.69 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 112.366 -2.197 . . . . 0.0 111.984 171.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -72.84 -33.19 65.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 120.525 -1.36 . . . . 0.0 112.082 -169.426 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -66.89 -41.84 88.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 O-C-N 120.359 -1.463 . . . . 0.0 109.311 171.229 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -36.76 84.3 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 124.868 1.355 . . . . 0.0 110.174 177.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -68.64 -38.53 80.56 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 119.778 -1.826 . . . . 0.0 114.021 179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 41.1 mmtt -68.66 -43.86 75.32 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-O 115.824 -2.036 . . . . 0.0 111.253 169.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 34' ' ' GLU 0.293 18.4 tp10 -136.21 12.04 3.3 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 117.231 -1.788 . . . . 0.0 110.453 -147.645 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 29.03 40.98 0.03 OUTLIER Glycine 0 CA--C 1.53 1.01 1 C-N-CA 132.848 5.023 . . . . 0.0 114.775 175.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -91.74 120.28 68.12 Favored Pre-proline 0 N--CA 1.447 -0.596 0 CA-C-O 115.492 -2.194 . . . . 0.0 105.609 157.771 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 38' ' ' PRO 0.291 1.7 Cg_endo -45.87 144.62 5.6 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 O-C-N 125.693 2.417 . . . . 0.0 118.357 171.482 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 87.9 Cg_endo -82.76 -10.66 10.55 Favored 'Trans proline' 0 N--CA 1.446 -1.309 0 O-C-N 125.844 2.497 . . . . 0.0 112.258 -163.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.87 -16.25 54.16 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 128.699 2.8 . . . . 0.0 111.5 173.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -74.5 -27.55 60.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 127.954 2.501 . . . . 0.0 112.673 174.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -95.36 147.69 23.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 129.349 3.06 . . . . 0.0 114.677 -168.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 78.0 mtp180 -115.59 117.2 29.66 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 103.162 -2.903 . . . . 0.0 103.162 172.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.0 mt -97.11 98.13 9.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 103.773 -2.677 . . . . 0.0 103.773 -166.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.304 74.1 mt -100.66 145.9 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 128.81 2.844 . . . . 0.0 113.673 -175.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CE2' HG12 ' A' ' 61' ' ' ILE . 33.5 t80 -153.62 123.24 6.72 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 116.383 -3.948 . . . . 0.0 106.02 166.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.499 . . 74.73 25.25 1.53 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 170.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.94 7.78 67.91 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 130.049 3.69 . . . . 0.0 113.151 -174.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -134.6 150.02 50.65 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 123.549 3.674 . . . . 0.0 105.396 -166.19 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -87.86 127.82 35.35 Favored 'General case' 0 C--O 1.221 -0.433 0 C-N-CA 128.567 2.747 . . . . 0.0 107.683 176.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 63.5 mt -67.52 133.64 49.84 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 121.581 1.991 . . . . 0.0 113.386 -179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -83.24 124.74 30.86 Favored 'General case' 0 N--CA 1.447 -0.604 1 C-N-CA 133.867 4.867 . . . . 0.0 107.004 -178.079 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -75.22 123.21 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 111.992 -2.367 . . . . 0.0 108.005 -175.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.16 31.12 3.4 Favored Glycine 0 CA--C 1.528 0.847 0 CA-C-O 114.924 -3.153 . . . . 0.0 115.7 -177.3 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.9 mtt-85 -139.62 146.11 39.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 122.245 3.022 . . . . 0.0 108.555 170.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.8 p -79.46 155.7 28.18 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -178.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 27.6 mt -46.74 -64.05 0.87 Allowed 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.6 m -66.98 -41.7 86.36 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.392 1.877 . . . . 0.0 115.857 -172.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.265 11.0 t70 -51.34 -46.91 62.84 Favored 'General case' 0 C--N 1.328 -0.362 0 O-C-N 119.349 -2.094 . . . . 0.0 113.608 170.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.98 8.12 1.72 Allowed 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 129.86 3.264 . . . . 0.0 114.857 174.66 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.372 3.4 t30 82.31 4.83 1.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 118.08 2.622 . . . . 0.0 118.08 178.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.413 HG12 ' CE2' ' A' ' 45' ' ' PHE 0.293 1.9 mt -94.27 91.21 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-O 123.177 1.465 . . . . 0.0 111.33 -178.304 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.251 46.6 mm-40 -96.52 -167.14 1.52 Allowed 'General case' 0 C--O 1.238 0.466 0 CA-C-N 112.623 -2.081 . . . . 0.0 109.08 -175.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.0 pttt -68.48 131.52 45.41 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.865 -175.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.347 24.9 mt-10 76.96 36.53 0.32 Allowed 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 130.51 3.524 . . . . 0.0 108.864 165.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.264 37.9 m -96.25 138.48 33.79 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 102.649 -3.093 . . . . 0.0 102.649 -170.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.2 m -96.5 118.76 33.67 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 -178.758 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 67' ' ' LEU . 3.6 mp -106.94 155.72 19.47 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 127.748 2.419 . . . . 0.0 105.708 159.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -111.23 139.86 46.27 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 126.415 2.322 . . . . 0.0 110.488 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.8 tp -82.86 121.85 27.47 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 126.371 2.295 . . . . 0.0 105.911 179.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -136.02 136.41 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 128.191 2.596 . . . . 0.0 104.68 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mt -116.18 163.66 15.64 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 179.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.26 43.6 ttt-85 -137.22 131.9 33.08 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.7 2.8 . . . . 0.0 107.684 170.482 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.267 34.1 mt -84.43 28.85 0.62 Allowed 'General case' 0 N--CA 1.454 -0.244 1 C-N-CA 135.294 5.437 . . . . 0.0 113.568 -168.783 . . . . . . . . 3 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -153.94 131.35 11.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.391 2.676 . . . . 0.0 108.037 178.271 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.88 -24.21 7.41 Favored Glycine 0 CA--C 1.537 1.458 0 CA-C-N 111.121 -2.763 . . . . 0.0 117.738 -174.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 129.997 3.665 . . . . 0.0 104.131 175.851 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.1 ttm . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 117.224 -1.369 . . . . 0.0 107.754 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -98.55 137.64 36.91 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 125.374 1.671 . . . . 0.0 114.649 -174.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.5 pt -133.29 177.43 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 O-C-N 120.134 -1.604 . . . . 0.0 113.17 171.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -125.23 133.51 52.69 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 130.178 3.391 . . . . 0.0 109.752 173.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 73.9 t -117.48 131.76 69.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-N 109.836 -3.347 . . . . 0.0 103.002 165.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 87.2 mttt -77.66 129.71 35.91 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 116.331 -1.795 . . . . 0.0 113.461 151.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.7 p -82.63 149.5 27.36 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 128.293 2.637 . . . . 0.0 104.41 172.518 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.22 -21.02 66.7 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.168 2.587 . . . . 0.0 111.404 -179.304 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.2 p -70.73 -13.62 62.13 Favored 'General case' 0 C--N 1.326 -0.44 1 C-N-CA 132.056 4.142 . . . . 0.0 112.861 165.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.28 1.02 56.89 Favored Glycine 0 CA--C 1.534 1.279 0 CA-C-N 119.934 1.243 . . . . 0.0 115.301 165.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 155.16 18.96 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.195 -2.356 . . . . 0.0 110.435 166.848 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.6 m -98.07 152.39 19.36 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 100.448 -3.908 . . . . 0.0 100.448 -176.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 pt -126.81 144.79 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 165.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.3 m -93.75 145.22 24.74 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 123.237 1.494 . . . . 0.0 107.203 165.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.414 2.1 pt? -148.25 159.5 43.91 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 120.276 3.436 . . . . 0.0 120.276 166.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -108.49 139.91 42.57 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 124.282 3.219 . . . . 0.0 109.89 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.577 HG22 ' H ' ' A' ' 18' ' ' GLU 0.266 7.5 p -138.21 178.95 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 O-C-N 127.967 3.292 . . . . 0.0 110.363 -177.872 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.577 ' H ' HG22 ' A' ' 17' ' ' VAL . 29.9 tp10 -134.14 138.29 30.15 Favored Pre-proline 0 N--CA 1.447 -0.58 0 N-CA-C 103.895 -2.631 . . . . 0.0 103.895 -177.508 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -44.34 -37.21 10.2 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 N-CA-C 119.559 2.869 . . . . 0.0 119.559 175.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.295 13.5 p -95.08 3.34 54.92 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 113.422 -3.18 . . . . 0.0 111.2 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -73.87 160.45 31.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 123.61 2.914 . . . . 0.0 105.355 169.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.0 p -102.94 155.2 18.52 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 119.311 -2.118 . . . . 0.0 112.181 -177.519 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.415 HD13 HD12 ' A' ' 56' ' ' LEU . 16.6 mm -63.88 -57.69 10.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 130.061 3.345 . . . . 0.0 111.777 -168.334 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.555 1.9 tt0 -44.57 -48.54 10.33 Favored 'General case' 0 C--O 1.222 -0.349 1 C-N-CA 132.632 4.373 . . . . 0.0 114.83 176.733 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.284 26.3 t30 -49.06 -61.12 2.24 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 130.139 3.376 . . . . 0.0 111.666 -178.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -74.06 -39.55 50.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 128.742 2.817 . . . . 0.0 106.225 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 59.2 tttm -62.38 -28.35 69.71 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 112.716 -3.516 . . . . 0.0 112.196 -178.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.03 -14.39 31.47 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.87 2.577 . . . . 0.0 116.434 178.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -54.85 -27.34 41.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 127.466 2.307 . . . . 0.0 113.576 177.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.2 tp -48.03 -22.56 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.024 1 C-N-CA 135.654 5.581 . . . . 0.0 117.382 -175.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -61.8 3.08 0.16 Allowed 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 116.267 1.951 . . . . 0.0 116.267 170.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.513 32.9 t70 -19.15 -55.28 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.487 2 C-N-CA 135.112 5.365 . . . . 0.0 122.067 158.021 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.254 1.6 pptp? -149.15 -19.52 0.29 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 122.265 2.302 . . . . 0.0 112.22 -160.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.413 1.1 pm0 -124.85 169.3 12.18 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 147.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.81 62.11 0.33 Allowed Glycine 0 CA--C 1.53 0.983 0 N-CA-C 105.602 -2.999 . . . . 0.0 105.602 -175.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.8 pt -86.64 148.98 47.62 Favored Pre-proline 0 N--CA 1.448 -0.572 0 C-N-CA 130.196 3.398 . . . . 0.0 109.793 178.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -76.27 136.42 17.88 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.742 2.294 . . . . 0.0 113.661 171.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -77.29 -16.1 15.61 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.997 3.131 . . . . 0.0 112.099 -176.461 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -70.3 -15.4 62.88 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 124.0 3.091 . . . . 0.0 108.136 178.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.1 mm-40 -90.73 17.32 7.79 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.986 2.114 . . . . 0.0 115.439 176.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.264 0.0 OUTLIER -142.33 160.09 40.94 Favored 'General case' 0 N--CA 1.446 -0.633 1 C-N-CA 136.984 6.114 . . . . 0.0 113.022 173.221 . . . . . . . . 4 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -149.8 146.97 27.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 131.341 3.857 . . . . 0.0 111.534 -178.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.465 HD12 ' HB3' ' A' ' 67' ' ' LEU . 1.0 OUTLIER -96.57 121.81 38.8 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 129.959 3.304 . . . . 0.0 113.265 177.049 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 96.3 mt -91.96 144.58 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 156.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' CG ' ' N ' ' A' ' 46' ' ' ALA 0.303 4.7 p90 -111.91 -76.37 0.6 Allowed 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 116.742 2.127 . . . . 0.0 116.742 169.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.454 ' N ' ' CG ' ' A' ' 45' ' ' PHE . . . -130.5 82.93 2.08 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 100.854 -3.758 . . . . 0.0 100.854 178.576 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.24 61.33 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-N 112.444 -2.162 . . . . 0.0 117.084 165.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -147.83 172.79 13.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 129.21 3.004 . . . . 0.0 113.862 -171.22 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.04 142.89 35.95 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 128.214 2.606 . . . . 0.0 112.836 -170.177 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.419 HD12 ' HB3' ' A' ' 43' ' ' LEU . 19.9 mt -74.34 165.9 24.4 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 129.492 3.117 . . . . 0.0 113.06 169.014 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -151.97 150.85 30.47 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 129.719 3.208 . . . . 0.0 116.59 175.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -43.8 132.48 5.13 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 117.547 2.425 . . . . 0.0 117.547 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.28 -26.24 7.1 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 125.221 1.391 . . . . 0.0 112.979 173.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.23 163.64 12.47 Favored 'General case' 0 N--CA 1.444 -0.731 1 C-N-CA 133.426 4.69 . . . . 0.0 108.295 -164.916 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.2 p -103.68 173.17 6.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 113.545 -1.662 . . . . 0.0 106.536 167.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.415 HD12 HD13 ' A' ' 23' ' ' ILE . 3.0 mp -61.45 -34.18 74.98 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 113.673 -1.603 . . . . 0.0 112.364 175.55 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -78.81 -8.95 59.26 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.123 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -69.2 -31.62 70.34 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 125.494 1.747 . . . . 0.0 109.842 160.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -110.93 11.47 22.26 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.424 16.1 m120 83.4 -6.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 116.992 2.219 . . . . 0.0 116.992 163.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.2 mt -69.92 135.24 28.65 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -157.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.4 -166.79 2.06 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 114.183 -2.818 . . . . 0.0 110.536 -162.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.36 110.69 0.33 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 120.061 3.356 . . . . 0.0 120.061 165.015 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.252 78.1 mt-10 73.35 31.79 1.33 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 131.02 3.728 . . . . 0.0 115.177 175.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 m -70.14 121.91 18.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 128.014 2.526 . . . . 0.0 107.07 172.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.4 m -97.58 114.35 26.25 Favored 'General case' 0 C--N 1.32 -0.683 1 N-CA-C 97.522 -4.992 . . . . 0.0 97.522 -178.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.465 ' HB3' HD12 ' A' ' 43' ' ' LEU . 8.2 mp -95.71 151.52 19.28 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 130.453 3.501 . . . . 0.0 107.453 171.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -118.98 134.7 55.02 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 126.581 2.426 . . . . 0.0 112.775 168.795 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.0 tp -100.93 124.88 47.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -174.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.639 HG22 ' H ' ' A' ' 71' ' ' LEU 0.353 7.5 p -140.18 -146.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 126.198 1.799 . . . . 0.0 112.027 173.959 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.639 ' H ' HG22 ' A' ' 70' ' ' VAL 0.542 1.8 pt? -150.09 165.75 31.86 Favored 'General case' 0 N--CA 1.45 -0.446 1 C-N-CA 132.0 4.12 . . . . 0.0 111.26 179.953 . . . . . . . . 4 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -67.66 121.0 14.96 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.388 177.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.349 5.2 mp -122.19 51.62 1.35 Allowed 'General case' 0 CA--C 1.534 0.341 1 C-N-CA 132.705 4.402 . . . . 0.0 108.307 179.777 . . . . . . . . 3 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -144.34 131.39 20.5 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 127.613 3.071 . . . . 0.0 105.119 173.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.75 -8.93 19.97 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 130.13 3.729 . . . . 0.0 109.402 -178.005 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.238 0 N-CA-C 105.525 -3.03 . . . . 0.0 105.525 164.968 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 117.646 -1.169 . . . . 0.0 108.831 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -74.37 121.2 21.02 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 -170.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.9 pt -136.15 174.95 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 123.606 2.912 . . . . 0.0 113.756 170.682 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -123.73 155.14 38.41 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 127.843 2.457 . . . . 0.0 113.65 169.336 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.2 130.9 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 O-C-N 118.195 -2.816 . . . . 0.0 105.945 161.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.272 64.8 tttt -111.49 131.35 55.29 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 118.829 -2.419 . . . . 0.0 104.529 176.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.8 p -98.79 168.95 9.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.516 2.726 . . . . 0.0 105.48 -166.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.437 HD12 ' H ' ' A' ' 71' ' ' LEU . 15.9 mt -93.16 -0.02 57.04 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 130.887 3.675 . . . . 0.0 112.346 175.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.2 p -102.59 -23.63 13.85 Favored 'General case' 0 N--CA 1.444 -0.762 1 C-N-CA 134.187 4.995 . . . . 0.0 109.942 172.707 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.09 -6.71 11.97 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 116.635 -2.203 . . . . 0.0 110.594 147.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -61.45 149.92 37.13 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 117.297 2.332 . . . . 0.0 117.297 157.071 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.5 m -112.45 117.84 33.52 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 102.52 -3.141 . . . . 0.0 102.52 163.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.6 mt -101.46 133.15 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 101.756 -3.424 . . . . 0.0 101.756 -179.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 t -94.46 146.78 23.84 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 126.473 1.909 . . . . 0.0 110.624 177.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -126.9 -177.21 3.95 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 -176.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -149.88 117.48 6.17 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 116.536 -1.697 . . . . 0.0 107.987 170.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -131.32 148.26 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 C-N-CA 133.112 4.565 . . . . 0.0 107.237 -176.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -81.99 141.53 47.26 Favored Pre-proline 0 N--CA 1.443 -0.785 0 CA-C-O 115.747 -2.073 . . . . 0.0 107.56 172.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -45.12 -35.16 10.35 Favored 'Trans proline' 0 N--CA 1.45 -1.071 1 C-N-CA 127.821 5.681 . . . . 0.0 114.169 173.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.7 p -77.07 -19.46 57.07 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 128.611 2.764 . . . . 0.0 113.918 176.71 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -65.75 126.53 28.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.704 2.047 . . . . 0.0 109.053 -173.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -70.44 150.99 45.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 124.1 0.96 . . . . 0.0 112.496 170.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 15.8 mm -55.13 -26.98 18.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 127.901 2.481 . . . . 0.0 114.777 -178.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.259 8.4 pt-20 -61.71 -33.94 74.9 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 116.711 2.115 . . . . 0.0 116.711 166.079 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -92.53 -33.14 14.58 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -167.527 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.284 75.4 t -39.85 -42.25 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 130.631 3.573 . . . . 0.0 113.256 158.479 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -74.02 -16.21 61.06 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 117.322 2.341 . . . . 0.0 117.322 -178.589 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.97 -37.65 54.8 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 126.856 2.062 . . . . 0.0 105.52 -173.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 43.3 mttp -75.86 -26.16 56.86 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 130.013 3.325 . . . . 0.0 109.047 -175.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.6 mt -77.68 -22.84 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 O-C-N 126.795 2.559 . . . . 0.0 111.441 173.236 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -69.17 -43.09 74.94 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.977 1.311 . . . . 0.0 110.994 -175.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.429 21.8 t70 -56.93 -36.19 69.92 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 129.908 3.283 . . . . 0.0 116.161 -179.373 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -103.46 -27.93 12.1 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 109.426 -3.534 . . . . 0.0 115.402 -173.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.6 mm-40 -116.75 -13.78 10.77 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 124.812 2.244 . . . . 0.0 116.201 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.8 -0.96 56.57 Favored Glycine 0 CA--C 1.526 0.753 0 O-C-N 117.642 -3.161 . . . . 0.0 110.594 165.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.1 pt -112.75 130.24 23.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 129.396 3.078 . . . . 0.0 111.569 -156.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -80.92 162.11 20.93 Favored 'Trans proline' 0 N--CA 1.446 -1.285 0 C-N-CA 121.022 1.148 . . . . 0.0 110.223 -173.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -52.49 -21.86 15.1 Favored 'Trans proline' 0 N--CA 1.449 -1.109 1 C-N-CA 126.07 4.513 . . . . 0.0 117.718 170.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -57.32 -26.92 61.69 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 126.996 2.685 . . . . 0.0 117.935 164.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -97.79 -28.81 13.7 Favored 'General case' 0 C--O 1.221 -0.417 1 C-N-CA 131.848 4.059 . . . . 0.0 113.093 -179.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.74 93.83 2.64 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.037 2.135 . . . . 0.0 107.522 -177.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 mtp85 -110.74 100.84 9.53 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.083 1.753 . . . . 0.0 114.667 167.734 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.3 mt -100.17 139.9 35.17 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 110.753 -2.931 . . . . 0.0 109.789 -165.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.4 pt -131.48 160.72 42.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 174.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -149.62 124.1 9.68 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.985 2.914 . . . . 0.0 103.536 168.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.75 28.31 6.19 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 128.657 2.783 . . . . 0.0 115.664 179.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.29 3.23 90.62 Favored Glycine 0 CA--C 1.533 1.173 0 O-C-N 128.194 3.433 . . . . 0.0 114.49 -175.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -92.2 147.55 22.84 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 122.771 3.286 . . . . 0.0 106.335 -179.699 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.33 93.31 5.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 102.696 -3.075 . . . . 0.0 102.696 -176.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.422 ' HG ' ' H ' ' A' ' 50' ' ' LEU . 20.2 mt -54.21 115.28 1.98 Allowed 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 130.785 3.634 . . . . 0.0 109.041 176.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.266 40.0 tt0 -81.44 134.7 35.58 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 102.58 -3.118 . . . . 0.0 102.58 -165.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -58.58 119.76 7.63 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 128.086 2.554 . . . . 0.0 106.472 167.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.49 -5.97 57.35 Favored Glycine 0 CA--C 1.526 0.748 0 O-C-N 119.832 -1.792 . . . . 0.0 112.654 177.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -94.75 176.67 6.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 116.07 -1.919 . . . . 0.0 108.986 163.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.31 77.0 p -115.23 176.99 4.82 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 125.029 1.456 . . . . 0.0 112.012 176.237 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.97 -28.69 69.08 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-O 116.729 -1.605 . . . . 0.0 113.453 167.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.7 t -64.6 -36.34 83.93 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.785 2.434 . . . . 0.0 109.161 174.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.402 16.4 m-20 -57.4 -25.42 59.51 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 116.545 -3.847 . . . . 0.0 119.759 169.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -112.25 3.79 17.35 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 116.374 -1.774 . . . . 0.0 109.715 177.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.554 8.8 p30 57.2 31.71 20.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 129.302 3.041 . . . . 0.0 116.631 -173.212 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.1 mt -81.38 118.34 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 -176.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -99.67 173.74 6.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.707 2.403 . . . . 0.0 112.958 -173.104 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -39.1 134.36 1.08 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.71 2.804 . . . . 0.0 113.11 174.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 62.67 46.14 5.53 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 128.097 2.559 . . . . 0.0 109.659 175.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.7 m -104.4 125.47 50.64 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 123.182 2.719 . . . . 0.0 104.21 172.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.8 m -85.7 134.47 33.96 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 114.649 -2.596 . . . . 0.0 108.607 178.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -107.77 154.33 21.67 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 101.546 -3.501 . . . . 0.0 101.546 -179.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -102.34 134.76 45.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 128.217 2.607 . . . . 0.0 105.639 176.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 1.7 mt -97.56 129.5 44.69 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.165 2.186 . . . . 0.0 106.267 176.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.7 t -100.24 117.71 45.84 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 159.386 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.437 ' H ' HD12 ' A' ' 8' ' ' LEU . 8.1 tp -119.04 168.82 10.46 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 127.786 2.434 . . . . 0.0 110.108 176.127 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 29.3 ttt180 -124.01 113.39 18.36 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 129.604 3.162 . . . . 0.0 112.123 155.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.253 0.2 OUTLIER -134.52 -158.41 0.88 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 117.382 -3.324 . . . . 0.0 105.995 158.625 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.4 mtm-85 -63.45 -64.51 0.88 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 130.246 3.418 . . . . 0.0 108.559 175.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.98 -10.26 3.9 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 107.501 -2.239 . . . . 0.0 107.501 177.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 0 C-N-CA 127.239 2.352 . . . . 0.0 108.338 -178.3 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.468 0.443 0 CA-C-O 115.47 -2.205 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.274 27.7 mt-30 -99.78 154.53 18.25 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 121.323 1.874 . . . . 0.0 113.879 -179.347 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -145.67 153.32 13.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 168.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -124.77 107.64 11.14 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 115.387 -2.244 . . . . 0.0 105.967 -161.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.25 115.72 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 119.883 1.219 . . . . 0.0 108.378 179.42 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -84.56 142.37 30.04 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 125.438 2.542 . . . . 0.0 108.372 176.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -127.82 148.38 50.45 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 110.026 -3.261 . . . . 0.0 108.879 162.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.4 mt -48.17 -17.99 0.17 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 128.053 2.541 . . . . 0.0 116.765 174.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.9 p -77.78 -37.48 48.81 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 125.516 2.579 . . . . 0.0 114.453 -169.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.73 -16.49 10.33 Favored Glycine 0 CA--C 1.538 1.502 0 O-C-N 117.04 -3.538 . . . . 0.0 108.438 -170.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -77.58 138.8 39.35 Favored 'General case' 0 N--CA 1.442 -0.856 0 C-N-CA 130.007 3.323 . . . . 0.0 106.81 174.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.4 m -141.3 117.93 10.96 Favored 'General case' 0 N--CA 1.44 -0.949 0 C-N-CA 129.731 3.212 . . . . 0.0 106.632 -171.106 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mm -91.09 117.47 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 C-N-CA 126.344 1.857 . . . . 0.0 106.636 -173.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 59.9 m -83.04 118.92 23.86 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 126.549 1.94 . . . . 0.0 109.232 176.391 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.4 mt -120.76 134.78 55.27 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 126.307 1.843 . . . . 0.0 106.547 172.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -88.25 124.63 34.06 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 128.77 3.794 . . . . 0.0 109.102 157.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -131.8 169.89 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 1 CA-C-N 107.66 -4.336 . . . . 0.0 105.156 -177.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -119.76 162.76 31.23 Favored Pre-proline 0 N--CA 1.447 -0.586 0 C-N-CA 128.911 2.884 . . . . 0.0 111.397 158.185 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.65 -23.47 15.28 Favored 'Trans proline' 0 N--CA 1.447 -1.237 1 C-N-CA 126.158 4.572 . . . . 0.0 119.687 177.625 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.1 t -88.3 1.58 54.27 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 115.848 -2.025 . . . . 0.0 113.423 175.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.01 115.41 3.13 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 122.039 2.2 . . . . 0.0 113.394 -175.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.2 p -71.88 160.11 33.12 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 118.358 -2.714 . . . . 0.0 112.893 172.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.272 53.7 mt -49.17 -36.94 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-O 115.369 -2.253 . . . . 0.0 113.974 167.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -58.9 -31.29 68.49 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 131.397 3.879 . . . . 0.0 113.435 164.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -84.68 -32.55 23.54 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 121.971 2.168 . . . . 0.0 110.04 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.9 t -70.94 -50.49 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-O 115.284 -2.294 . . . . 0.0 109.076 169.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 70.7 mttt -43.33 -47.95 6.79 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 125.695 1.598 . . . . 0.0 114.612 177.06 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.8 -24.13 61.68 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 124.304 2.002 . . . . 0.0 116.148 178.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -86.08 -42.37 13.99 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 114.119 -2.848 . . . . 0.0 104.808 -173.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.257 78.1 mt -49.06 -59.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-O 112.623 -3.56 . . . . 0.0 106.337 168.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.0 tt0 -47.24 -51.53 18.51 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 127.977 3.298 . . . . 0.0 117.348 171.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -63.37 -35.96 82.13 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.332 0.653 . . . . 0.0 112.279 -174.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -82.27 -76.03 0.28 Allowed 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 125.706 1.879 . . . . 0.0 109.902 173.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -91.54 -21.57 20.8 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 117.658 -1.163 . . . . 0.0 111.265 -159.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.02 -0.23 60.38 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 116.159 -2.467 . . . . 0.0 113.745 164.865 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.1 mt -66.98 127.04 93.38 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-N 120.407 2.103 . . . . 0.0 109.167 165.129 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -76.44 140.26 21.47 Favored 'Trans proline' 0 N--CA 1.445 -1.358 1 C-N-CA 126.608 4.872 . . . . 0.0 110.254 175.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HG3' ' HB3' ' A' ' 27' ' ' LYS 0.257 87.3 Cg_exo -41.45 -34.4 1.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.952 1 C-N-CA 131.83 8.353 . . . . 0.0 118.818 169.333 . . . . . . . . 4 3 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -66.58 -29.0 68.96 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 125.72 1.887 . . . . 0.0 113.476 171.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -84.5 -2.79 57.84 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 122.346 2.339 . . . . 0.0 111.726 -170.613 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 26.9 mt-30 -113.83 134.4 54.81 Favored 'General case' 0 C--N 1.325 -0.495 1 CA-C-O 111.257 -4.211 . . . . 0.0 118.744 -166.694 . . . . . . . . 3 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -110.63 141.02 44.42 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 128.986 3.929 . . . . 0.0 102.05 163.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.5 mt -135.38 128.78 32.26 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.561 1.144 . . . . 0.0 109.396 -174.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 4.2 mt -122.42 150.77 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 128.083 2.553 . . . . 0.0 104.451 -174.132 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -70.65 -82.6 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 102.391 -3.188 . . . . 0.0 102.391 165.324 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -126.86 -52.97 1.43 Allowed 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 120.15 -1.594 . . . . 0.0 108.894 173.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.14 -30.68 0.78 Allowed Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 106.054 -2.818 . . . . 0.0 106.054 -175.314 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.5 tttt -82.89 110.42 17.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 -175.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.4 tp60 -60.38 127.58 32.45 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 116.526 -1.702 . . . . 0.0 111.333 159.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.9 mt -75.11 151.5 38.59 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 125.464 2.554 . . . . 0.0 112.56 -178.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -112.66 144.86 41.45 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 119.924 -1.735 . . . . 0.0 109.833 175.04 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.73 153.88 42.98 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 127.257 2.848 . . . . 0.0 114.98 -172.336 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.85 13.03 44.85 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 128.071 2.748 . . . . 0.0 114.136 169.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.3 mtt85 -125.63 151.71 46.15 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 124.229 1.966 . . . . 0.0 108.544 -167.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.0 p -92.43 174.95 7.02 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 123.397 1.57 . . . . 0.0 110.799 -177.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.5 mt -69.58 -28.26 65.81 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 111.833 -2.44 . . . . 0.0 111.726 174.611 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.8 t -71.67 -37.76 70.72 Favored 'General case' 0 C--O 1.239 0.503 0 O-C-N 120.378 -1.451 . . . . 0.0 114.645 173.311 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -63.94 -42.02 97.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.102 0.961 . . . . 0.0 113.386 178.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -87.57 4.0 45.38 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-O 123.488 1.613 . . . . 0.0 113.01 -179.641 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.316 42.7 m-80 76.49 26.77 0.86 Allowed 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 172.016 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 41.5 mt -99.49 107.86 21.48 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.511 0 CA-C-O 125.518 2.58 . . . . 0.0 104.117 -170.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -93.34 165.11 12.95 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 165.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.472 39.7 pttt -30.97 125.68 0.19 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 164.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 88.43 1.98 0.32 Allowed 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 130.044 3.338 . . . . 0.0 113.982 176.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -62.17 141.29 58.26 Favored 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 117.104 -3.497 . . . . 0.0 113.311 176.766 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.3 m -90.82 137.67 32.18 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 125.407 1.692 . . . . 0.0 108.361 170.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.6 mt -119.74 172.87 7.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 164.472 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -136.15 110.95 8.73 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 126.01 2.069 . . . . 0.0 110.176 -167.302 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.52 126.73 42.98 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 125.383 2.516 . . . . 0.0 110.193 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 t -124.49 122.02 62.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 O-C-N 116.965 -3.585 . . . . 0.0 106.487 170.387 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.4 mt -70.01 145.9 51.44 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.709 3.204 . . . . 0.0 111.582 178.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -82.48 48.11 1.25 Allowed 'General case' 0 C--O 1.237 0.441 0 C-N-CA 127.702 2.401 . . . . 0.0 116.583 173.578 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 24.1 mt -54.94 130.67 42.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 109.156 -3.656 . . . . 0.0 114.01 174.275 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.265 5.2 mpt_? -108.08 123.61 48.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.159 177.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.73 158.38 23.03 Favored Glycine 0 CA--C 1.535 1.325 0 N-CA-C 105.361 -3.096 . . . . 0.0 105.361 179.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.682 0 CA-C-O 115.39 -2.894 . . . . 0.0 107.285 164.165 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 ttp . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -98.21 139.08 34.54 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 118.409 2.744 . . . . 0.0 118.409 -173.083 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 35.5 pt -121.91 161.58 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 C-N-CA 126.99 2.116 . . . . 0.0 106.334 166.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -105.31 129.4 53.66 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 159.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 71.3 t -100.77 125.99 54.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 160.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -115.21 158.35 22.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 128.315 2.646 . . . . 0.0 105.651 178.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -135.43 167.94 20.14 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 118.125 -2.859 . . . . 0.0 105.565 -170.028 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.3 tp -69.16 -27.55 65.63 Favored 'General case' 0 N--CA 1.451 -0.387 1 O-C-N 116.093 -4.129 . . . . 0.0 113.839 176.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.1 p -85.12 3.89 36.87 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 119.077 -2.264 . . . . 0.0 110.043 171.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.9 -24.19 32.19 Favored Glycine 0 CA--C 1.534 1.272 0 O-C-N 117.87 -3.018 . . . . 0.0 106.961 156.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.4 tttt -50.23 118.79 3.18 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.719 3.608 . . . . 0.0 106.29 -177.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.4 m -118.76 117.06 27.89 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 119.052 0.842 . . . . 0.0 109.408 -174.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 63.3 mt -84.15 136.09 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.843 1 C-N-CA 132.471 4.308 . . . . 0.0 107.944 168.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.2 m -93.39 133.62 36.46 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 163.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.14 142.06 51.6 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 129.507 3.123 . . . . 0.0 112.436 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -113.89 136.01 53.35 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.836 -1.912 . . . . 0.0 105.836 168.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 m -153.76 -178.64 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.84 1 C-N-CA 134.695 5.198 . . . . 0.0 112.07 -165.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -139.79 147.91 53.33 Favored Pre-proline 0 N--CA 1.448 -0.542 0 O-C-N 117.979 -2.95 . . . . 0.0 110.701 175.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -49.75 -41.67 45.67 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 123.566 2.844 . . . . 0.0 114.337 -177.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 59.0 p -51.05 -26.26 6.02 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 165.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -70.18 126.81 30.76 Favored 'General case' 0 C--O 1.219 -0.548 0 CA-C-N 122.517 2.417 . . . . 0.0 108.257 -170.502 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.8 p -66.14 149.77 49.78 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.984 1.714 . . . . 0.0 113.796 -178.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 mm -84.6 89.56 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 1 N-CA-C 99.4 -4.296 . . . . 0.0 99.4 159.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -175.08 -60.91 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 130.325 3.45 . . . . 0.0 103.695 173.144 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -70.46 -39.51 74.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 114.853 -2.499 . . . . 0.0 116.454 -175.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.1 t -48.15 -44.35 12.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.692 1.997 . . . . 0.0 114.317 160.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -71.22 -16.49 62.5 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 112.318 -3.706 . . . . 0.0 111.407 -176.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -81.36 -35.88 30.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 123.888 3.04 . . . . 0.0 105.266 -178.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.3 mttt -68.55 -35.92 78.09 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 125.076 2.369 . . . . 0.0 110.491 -176.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 mm -70.36 -46.91 69.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 112.466 -2.152 . . . . 0.0 109.276 176.297 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -56.11 -45.82 79.32 Favored 'General case' 0 N--CA 1.453 -0.296 1 O-C-N 116.274 -4.016 . . . . 0.0 107.223 -178.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.371 4.9 t70 -47.82 -55.9 8.68 Favored 'General case' 0 N--CA 1.444 -0.742 1 C-N-CA 133.901 4.88 . . . . 0.0 112.491 169.235 . . . . . . . . 3 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 60.2 mttm -65.97 -47.63 73.93 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 124.651 1.22 . . . . 0.0 109.925 176.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -125.14 -15.84 6.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 117.936 -2.978 . . . . 0.0 116.259 -148.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.21 6.57 53.44 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 153.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.7 mt -99.47 121.53 54.62 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-O 114.39 -2.719 . . . . 0.0 105.455 -163.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -59.77 135.33 62.98 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 CA-C-N 124.63 2.689 . . . . 0.0 113.755 173.022 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.292 67.4 Cg_exo -33.1 -37.66 0.09 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.56 1 C-N-CA 129.644 6.896 . . . . 0.0 118.246 174.476 . . . . . . . . 3 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -80.69 -31.85 36.09 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 117.985 -2.947 . . . . 0.0 106.752 -172.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -90.94 -10.91 40.69 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 115.206 -2.331 . . . . 0.0 105.11 -172.192 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.9 mt-30 -77.87 94.79 4.6 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 130.687 3.595 . . . . 0.0 104.545 169.563 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -91.26 120.55 32.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 117.48 -1.248 . . . . 0.0 107.685 176.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mt -126.5 123.97 39.0 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -163.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.8 mp -138.34 133.87 43.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 -164.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.361 0.3 OUTLIER -124.6 -28.25 3.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 112.082 -2.327 . . . . 0.0 115.287 159.662 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.291 . . -153.02 43.59 0.63 Allowed 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 125.405 1.691 . . . . 0.0 108.912 -166.217 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.96 -7.67 49.04 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 128.709 3.052 . . . . 0.0 117.921 159.083 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.44 32.0 pttt -151.97 147.49 26.61 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 131.488 3.915 . . . . 0.0 110.918 -170.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.7 139.95 48.87 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.151 1.78 . . . . 0.0 112.705 173.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.7 mt -82.11 136.35 35.18 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 114.949 -2.453 . . . . 0.0 107.884 -174.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.6 tt0 -82.68 139.84 33.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 126.237 2.211 . . . . 0.0 110.371 -170.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -45.3 113.78 0.63 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 118.679 2.844 . . . . 0.0 118.679 169.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.09 -7.19 40.67 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 164.448 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.259 13.3 mmp_? -93.69 142.12 27.71 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 -172.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.9 p -86.47 163.86 17.3 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.333 -178.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.2 mp -41.05 -52.89 3.13 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 124.798 3.454 . . . . 0.0 115.704 163.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 t -51.84 -37.64 52.72 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-O 114.115 -2.85 . . . . 0.0 115.156 168.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -68.0 -18.57 64.76 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 178.627 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -97.36 -13.49 21.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 114.132 -2.842 . . . . 0.0 112.308 161.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.8 t30 72.14 31.8 1.87 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 125.626 3.83 . . . . 0.0 113.104 -176.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 77.5 mt -70.55 112.84 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 1 O-C-N 115.927 -4.233 . . . . 0.0 109.845 -175.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.291 22.9 mt-30 -94.03 162.68 13.79 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.269 1.428 . . . . 0.0 110.539 -165.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.266 26.8 pttt -42.16 115.26 0.66 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 117.168 2.284 . . . . 0.0 117.168 161.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.5 2.6 tt0 87.16 30.35 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.545 -1.207 . . . . 0.0 112.785 170.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.31 68.6 m -90.01 132.69 35.23 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 172.519 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 94.1 m -82.27 125.82 31.41 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.433 2.293 . . . . 0.0 112.456 169.566 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.5 mp -116.36 124.36 49.88 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 172.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.285 11.8 t60 -83.64 120.09 25.56 Favored 'General case' 0 N--CA 1.447 -0.606 1 C-N-CA 131.876 4.07 . . . . 0.0 112.275 165.508 . . . . . . . . 3 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tt -94.5 130.59 40.83 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 117.373 -3.329 . . . . 0.0 108.337 174.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 35.5 m -123.79 153.01 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 O-C-N 117.98 -2.95 . . . . 0.0 114.125 170.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -137.73 95.28 3.02 Favored 'General case' 0 CA--C 1.518 -0.272 1 N-CA-C 98.125 -4.769 . . . . 0.0 98.125 -161.43 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 73.52 11.66 4.76 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 117.456 -3.277 . . . . 0.0 114.487 168.086 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.8 mp -110.63 139.39 45.94 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 129.032 2.933 . . . . 0.0 103.885 176.202 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 mtp180 -93.04 163.39 13.67 Favored 'General case' 0 C--O 1.221 -0.396 0 CA-C-O 126.707 3.146 . . . . 0.0 111.472 166.835 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.01 49.74 0.84 Allowed Glycine 0 CA--C 1.536 1.372 0 O-C-N 118.37 -2.706 . . . . 0.0 107.896 178.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 128.997 3.189 . . . . 0.0 106.415 -176.706 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 pm0 -104.92 140.72 37.74 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.543 1.937 . . . . 0.0 107.93 178.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.1 pt -124.72 151.8 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 C-N-CA 128.644 2.777 . . . . 0.0 106.607 165.272 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.253 60.3 m-85 -93.11 151.58 19.77 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 122.577 1.179 . . . . 0.0 113.217 168.702 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -120.1 144.67 28.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 114.293 -2.765 . . . . 0.0 107.245 167.548 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 52.3 tttt -126.48 127.46 45.4 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 128.75 3.781 . . . . 0.0 118.196 170.091 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.4 p -82.36 166.18 19.67 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 127.743 2.417 . . . . 0.0 111.448 -169.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.6 mt -55.35 -37.0 66.91 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 129.974 3.31 . . . . 0.0 116.604 172.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.8 p -73.89 -33.25 63.95 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 128.589 2.756 . . . . 0.0 113.967 173.607 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.17 16.43 7.23 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 116.518 1.367 . . . . 0.0 116.518 177.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -86.47 134.99 33.64 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 125.898 1.679 . . . . 0.0 106.984 178.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -100.59 113.24 25.89 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 130.091 3.357 . . . . 0.0 105.315 -176.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 8.8 mt -100.38 114.51 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 100.666 -3.827 . . . . 0.0 100.666 174.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -66.25 131.75 46.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.954 -2.966 . . . . 0.0 109.261 154.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.14 128.45 38.11 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 119.418 -2.051 . . . . 0.0 108.297 -172.29 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -91.92 115.79 28.36 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 125.696 1.872 . . . . 0.0 110.26 178.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.51 22.6 m -121.07 -68.34 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-O 113.45 -3.166 . . . . 0.0 118.052 -163.271 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 80.48 131.74 0.04 OUTLIER Pre-proline 0 N--CA 1.448 -0.527 0 C-N-CA 129.709 3.204 . . . . 0.0 107.176 -155.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -77.3 -16.81 15.21 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 CA-C-N 120.316 1.149 . . . . 0.0 114.976 -175.294 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 m -86.23 18.03 3.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 115.819 1.785 . . . . 0.0 115.819 172.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -76.79 152.63 35.49 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.056 1.342 . . . . 0.0 110.002 158.359 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.3 p -88.71 148.5 23.95 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 124.999 1.319 . . . . 0.0 107.952 174.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.279 5.8 mm -46.13 -37.63 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.731 0 C-N-CA 127.546 2.338 . . . . 0.0 113.477 174.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 67.1 mt-10 -82.27 -14.18 55.85 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 116.506 -3.871 . . . . 0.0 113.343 -175.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -94.86 -24.94 16.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 123.805 1.764 . . . . 0.0 110.692 174.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 96.1 t -58.45 -41.66 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 1 O-C-N 115.452 -4.53 . . . . 0.0 108.857 167.343 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -69.83 -34.05 73.14 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 124.525 1.141 . . . . 0.0 112.811 176.106 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.255 . . -77.45 -13.27 59.96 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 120.604 1.547 . . . . 0.0 110.808 173.126 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.9 mttt -69.1 -37.06 78.21 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 118.314 -2.742 . . . . 0.0 111.13 172.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 19.9 mm -69.15 -31.39 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 127.572 2.349 . . . . 0.0 108.291 175.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.58 -37.12 76.82 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 172.326 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -69.12 -51.2 40.91 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 120.254 -1.529 . . . . 0.0 114.152 172.092 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 tttt -87.57 -27.65 22.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 117.982 2.586 . . . . 0.0 117.982 -171.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -122.89 -21.23 5.59 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 115.282 -2.294 . . . . 0.0 115.441 175.119 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.63 -14.6 42.12 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 116.446 -2.308 . . . . 0.0 111.558 172.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 25.5 mt -78.38 121.23 83.49 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 120.394 2.097 . . . . 0.0 109.238 -154.348 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -55.27 143.27 76.51 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 CA-C-N 123.214 2.184 . . . . 0.0 117.029 -174.848 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -79.43 -28.86 3.33 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 O-C-N 116.965 -2.177 . . . . 0.0 116.396 -166.628 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.265 0.0 OUTLIER -51.92 -29.21 19.2 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 121.291 3.811 . . . . 0.0 121.291 172.127 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -92.7 -18.47 22.94 Favored 'General case' 0 N--CA 1.452 -0.351 0 O-C-N 128.492 3.62 . . . . 0.0 111.723 -177.103 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -83.24 129.41 35.01 Favored 'General case' 0 C--O 1.22 -0.466 0 O-C-N 126.168 2.167 . . . . 0.0 116.282 -175.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.9 mtm180 -103.47 119.64 39.28 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-O 114.488 -2.673 . . . . 0.0 105.048 160.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 84.9 mt -88.6 120.8 30.32 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.788 1.631 . . . . 0.0 109.075 168.993 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.5 mm -114.57 135.28 54.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 126.52 1.928 . . . . 0.0 112.635 -177.025 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.262 49.5 t80 -148.61 113.33 5.38 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 128.383 2.673 . . . . 0.0 109.103 -179.515 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 67.92 50.71 0.81 Allowed 'General case' 0 C--O 1.237 0.397 0 C-N-CA 128.159 2.583 . . . . 0.0 111.451 163.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.15 4.5 66.63 Favored Glycine 0 N--CA 1.441 -0.979 0 C-N-CA 117.82 -2.134 . . . . 0.0 117.264 174.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -161.2 144.75 12.97 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -160.391 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -87.92 140.32 29.62 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 125.352 2.501 . . . . 0.0 107.648 173.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.7 mt -89.61 113.2 24.61 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 118.84 -2.413 . . . . 0.0 108.514 179.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -79.2 137.22 37.34 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 118.395 -2.691 . . . . 0.0 111.634 -163.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -45.65 112.38 0.45 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 129.146 2.978 . . . . 0.0 114.733 156.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.62 -15.6 9.76 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 128.972 3.177 . . . . 0.0 113.896 -173.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -105.69 178.26 4.61 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 120.84 2.32 . . . . 0.0 105.797 -175.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.1 p -110.7 170.0 8.38 Favored 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 118.473 -2.642 . . . . 0.0 108.545 176.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.4 mt -74.46 -35.72 63.31 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 117.195 -1.802 . . . . 0.0 109.983 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 p -53.95 -27.75 33.07 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 128.2 2.6 . . . . 0.0 112.91 175.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -58.68 -26.35 63.74 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 167.158 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -120.33 23.04 11.1 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 118.209 -2.807 . . . . 0.0 108.287 -170.132 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.344 13.5 m120 78.73 10.01 1.82 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 126.379 2.299 . . . . 0.0 111.978 171.12 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 44.6 mm -77.81 120.95 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 121.124 1.784 . . . . 0.0 111.544 -160.361 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.1 mm100 -106.37 -177.4 3.35 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 122.643 1.211 . . . . 0.0 111.185 176.13 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -69.49 126.48 29.87 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.074 2.149 . . . . 0.0 110.46 -178.174 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 78.8 mt-10 61.85 29.68 17.98 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 129.392 3.077 . . . . 0.0 114.34 -176.583 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.5 m -62.34 126.79 28.56 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 127.613 2.365 . . . . 0.0 111.963 154.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.4 p -82.97 119.98 25.12 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 127.141 2.177 . . . . 0.0 107.219 173.586 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.7 mt -89.74 154.89 19.58 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 112.438 -2.164 . . . . 0.0 107.607 159.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -119.24 139.72 51.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 168.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -112.41 132.3 55.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 124.564 2.126 . . . . 0.0 110.559 -167.374 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.4 m -130.53 133.07 64.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 113.09 -1.868 . . . . 0.0 110.04 175.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -94.97 133.78 38.35 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 126.234 2.209 . . . . 0.0 107.499 -177.567 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 47.8 ttp180 -123.93 119.88 30.9 Favored 'General case' 0 N--CA 1.448 -0.534 1 CA-C-O 111.281 -4.199 . . . . 0.0 109.505 -172.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -104.12 143.56 32.75 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 123.365 2.802 . . . . 0.0 104.682 171.029 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.252 25.6 ttp85 86.53 -96.8 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.185 2.594 . . . . 0.0 107.588 170.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -143.31 -166.91 11.4 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 128.153 2.787 . . . . 0.0 110.012 167.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.874 0 CA-C-N 123.962 3.881 . . . . 0.0 115.792 -171.415 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 mtt . . . . . 0 CA--C 1.538 0.482 0 CA-C-O 116.59 -1.671 . . . . 0.0 109.127 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.75 149.17 23.14 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 121.29 1.859 . . . . 0.0 107.43 177.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.5 pt -136.06 -177.33 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 C-N-CA 127.931 2.493 . . . . 0.0 107.986 160.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -128.44 138.63 52.4 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 119.21 -2.181 . . . . 0.0 113.064 174.011 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.9 t -110.73 114.84 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 164.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.254 83.8 tttt -104.26 140.31 38.04 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -177.296 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.4 p -102.35 117.53 34.92 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 118.165 -2.835 . . . . 0.0 104.654 166.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.09 -32.69 7.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 117.184 -3.448 . . . . 0.0 117.681 177.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.3 p -88.0 -9.68 52.7 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 128.903 2.881 . . . . 0.0 109.072 -176.61 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.73 -111.86 1.07 Allowed Glycine 0 CA--C 1.532 1.122 0 CA-C-O 118.276 -1.291 . . . . 0.0 113.233 -170.35 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.353 7.4 pttp -142.66 164.1 31.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.305 1.842 . . . . 0.0 115.387 -168.158 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.313 0.6 OUTLIER -81.3 115.16 20.54 Favored 'General case' 0 C--N 1.325 -0.473 1 C-N-CA 134.0 4.92 . . . . 0.0 109.603 -179.836 . . . . . . . . 4 3 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 42.6 mt -108.94 124.72 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 102.964 -2.976 . . . . 0.0 102.964 -173.642 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.2 p -72.34 124.69 25.64 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 112.71 -2.041 . . . . 0.0 111.678 -179.027 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.521 HD13 ' H ' ' A' ' 16' ' ' GLU 0.261 1.7 tm? -130.06 152.22 49.75 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.082 -2.261 . . . . 0.0 109.907 -175.66 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.521 ' H ' HD13 ' A' ' 15' ' ' LEU . 68.1 tt0 -129.75 123.33 30.78 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 123.873 1.797 . . . . 0.0 107.936 -170.801 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -125.73 152.63 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 131.37 3.868 . . . . 0.0 113.206 178.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -93.73 156.98 38.97 Favored Pre-proline 0 N--CA 1.446 -0.66 0 C-N-CA 127.048 2.139 . . . . 0.0 105.611 171.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -66.14 -7.93 18.69 Favored 'Trans proline' 0 N--CA 1.444 -1.396 0 N-CA-C 118.44 2.438 . . . . 0.0 118.44 -171.091 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 83.6 p -108.16 5.26 25.7 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 130.95 3.7 . . . . 0.0 117.49 176.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.03 139.73 36.83 Favored 'General case' 0 N--CA 1.442 -0.825 0 O-C-N 126.213 2.196 . . . . 0.0 107.736 -167.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.7 p -87.21 166.6 14.82 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 125.427 1.704 . . . . 0.0 108.588 174.809 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mp -69.02 -40.3 80.7 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 130.079 3.352 . . . . 0.0 108.049 -176.473 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -53.16 -34.76 58.26 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 113.431 -3.176 . . . . 0.0 112.75 168.315 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -82.76 -13.38 56.4 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 125.147 1.529 . . . . 0.0 109.752 -174.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 30' ' ' ILE . 80.3 t -70.9 -57.89 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 131.127 3.771 . . . . 0.0 106.727 168.535 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.316 38.7 mtmt -53.51 -38.66 63.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 125.281 2.467 . . . . 0.0 116.953 173.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -43.77 65.01 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 112.406 -2.179 . . . . 0.0 111.189 175.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -55.66 -51.92 65.59 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 118.79 -2.444 . . . . 0.0 109.1 171.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 26' ' ' VAL . 62.9 mt -51.78 -31.56 13.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 122.535 2.425 . . . . 0.0 109.587 169.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -78.55 -48.66 14.77 Favored 'General case' 0 N--CA 1.447 -0.61 1 O-C-N 113.851 -5.53 . . . . 0.0 108.148 -178.751 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.383 18.3 t70 -46.95 -33.48 4.67 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 128.957 2.903 . . . . 0.0 117.841 165.614 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.3 tptt -100.46 -53.68 3.04 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 118.079 -2.888 . . . . 0.0 114.238 -174.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 57.9 mm-40 -108.47 -27.81 9.71 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -173.295 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.85 19.79 60.78 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 125.625 2.792 . . . . 0.0 117.269 175.363 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.409 HG22 ' HG2' ' A' ' 41' ' ' GLN . 49.9 mt -77.18 109.67 9.89 Favored Pre-proline 0 N--CA 1.447 -0.622 0 CA-C-O 113.067 -3.349 . . . . 0.0 105.663 179.319 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -64.58 148.35 90.44 Favored 'Trans proline' 0 N--CA 1.445 -1.357 0 CA-C-N 126.912 3.504 . . . . 0.0 107.853 -166.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -62.84 -23.85 74.35 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 N-CA-C 118.626 2.51 . . . . 0.0 118.626 -172.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -94.65 -12.23 27.77 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 115.461 -2.209 . . . . 0.0 111.913 -172.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -86.81 -19.41 29.04 Favored 'General case' 0 N--CA 1.448 -0.56 1 C-N-CA 132.536 4.334 . . . . 0.0 111.724 173.746 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.409 ' HG2' HG22 ' A' ' 36' ' ' ILE . 74.8 mt-30 -80.97 144.99 31.43 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 103.207 -2.886 . . . . 0.0 103.207 -179.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.334 70.5 mtm180 -119.79 153.14 36.17 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 117.126 -3.484 . . . . 0.0 104.809 144.059 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 64.9 mt -119.35 140.98 49.46 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 114.303 -2.761 . . . . 0.0 107.255 176.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.497 0.0 OUTLIER -136.96 146.45 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-N 125.169 3.622 . . . . 0.0 110.778 172.482 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -159.09 110.47 2.09 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 116.542 -1.695 . . . . 0.0 108.875 -169.626 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.34 21.2 5.84 Favored 'General case' 0 N--CA 1.449 -0.487 1 O-C-N 129.525 4.265 . . . . 0.0 115.643 168.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.0 -18.16 29.01 Favored Glycine 0 CA--C 1.532 1.145 0 O-C-N 118.077 -2.89 . . . . 0.0 116.531 -169.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.02 126.71 52.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 129.465 3.685 . . . . 0.0 112.535 -162.361 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.78 97.6 0.48 Allowed 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 129.2 3.0 . . . . 0.0 110.009 173.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.467 HD22 HD11 ' A' ' 61' ' ' ILE . 17.9 mt -67.63 118.69 11.25 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 127.757 2.423 . . . . 0.0 109.641 -178.704 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -108.51 128.96 55.26 Favored 'General case' 0 N--CA 1.451 -0.391 1 O-C-N 130.676 4.985 . . . . 0.0 112.19 175.109 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -52.85 131.46 35.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 O-C-N 119.255 -2.153 . . . . 0.0 112.466 156.44 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.74 2.14 14.68 Favored Glycine 0 CA--C 1.53 1.023 1 CA-C-O 110.766 -5.463 . . . . 0.0 113.367 -171.03 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -129.21 163.08 26.37 Favored 'General case' 0 N--CA 1.449 -0.506 1 CA-C-N 124.287 4.044 . . . . 0.0 107.577 -176.37 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.6 p -88.26 159.71 17.99 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 101.707 -3.442 . . . . 0.0 101.707 -176.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.43 HD23 ' C ' ' A' ' 56' ' ' LEU . 6.6 tt -34.23 -53.52 0.49 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 129.834 3.254 . . . . 0.0 111.138 153.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 74.6 m -72.27 -14.78 61.85 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 128.433 2.693 . . . . 0.0 115.233 -173.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.268 17.6 m-20 -65.09 -41.25 95.18 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 164.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -107.63 -28.46 9.73 Favored 'General case' 0 C--N 1.324 -0.504 1 O-C-N 114.891 -4.881 . . . . 0.0 108.136 -170.262 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.494 20.2 t30 96.06 41.72 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.324 2.25 . . . . 0.0 115.745 -175.024 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.467 HD11 HD22 ' A' ' 50' ' ' LEU . 12.1 mt -84.35 89.6 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 O-C-N 125.49 1.744 . . . . 0.0 110.191 176.682 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -91.09 175.13 7.06 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 125.82 1.95 . . . . 0.0 108.203 -168.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.34 149.06 30.07 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 170.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 64.78 2.96 1.85 Allowed 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 125.784 1.928 . . . . 0.0 114.421 177.606 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.5 m -69.06 156.17 39.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 120.026 -1.671 . . . . 0.0 111.442 176.484 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.3 m -125.17 132.27 53.08 Favored 'General case' 0 C--N 1.33 -0.279 0 O-C-N 117.334 -3.354 . . . . 0.0 104.746 -174.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.4 pp -132.53 137.4 47.14 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 -179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -85.72 143.34 28.41 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.841 -1.787 . . . . 0.0 106.343 -179.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.6 tp -107.42 131.5 54.21 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 103.108 -2.923 . . . . 0.0 103.108 168.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 m -149.85 89.45 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 126.941 2.096 . . . . 0.0 114.419 -163.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.7 mp -80.14 156.66 26.89 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 119.403 -2.06 . . . . 0.0 109.062 -147.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 mtt-85 -94.09 87.0 5.15 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 163.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.259 18.7 mt -91.87 -45.87 8.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 118.709 -0.663 . . . . 0.0 110.45 168.458 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.6 ttp180 -82.18 -38.23 24.93 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 124.774 1.23 . . . . 0.0 112.756 169.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.8 12.1 8.07 Favored Glycine 0 CA--C 1.523 0.563 0 O-C-N 126.244 2.215 . . . . 0.0 116.218 -172.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 115.172 -3.016 . . . . 0.0 112.132 -166.803 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 ttp . . . . . 0 CA--C 1.533 0.324 0 CA-C-O 117.464 -1.255 . . . . 0.0 108.717 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.274 50.0 mt-30 -95.43 125.87 40.34 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 127.324 3.44 . . . . 0.0 107.031 -175.57 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.0 pt -113.07 144.71 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 111.886 -2.415 . . . . 0.0 106.315 171.083 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -100.7 106.5 17.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.04 -1.436 . . . . 0.0 108.267 -178.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.3 t -88.34 106.81 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 124.028 1.871 . . . . 0.0 110.487 170.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.294 5.4 tppt? -84.75 135.76 33.99 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 120.029 -1.669 . . . . 0.0 109.469 173.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.9 p -78.17 165.19 24.24 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.967 1.707 . . . . 0.0 115.107 165.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.35 0.4 OUTLIER -83.1 -12.49 57.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 118.396 -0.812 . . . . 0.0 110.581 163.665 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.1 p -66.65 -41.58 88.02 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 171.43 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.82 38.23 1.31 Allowed Glycine 0 CA--C 1.536 1.397 0 O-C-N 118.081 -2.887 . . . . 0.0 110.218 -172.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.283 59.4 pttt -130.76 168.77 16.67 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 127.525 2.33 . . . . 0.0 105.593 167.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.305 1.8 m -115.3 171.21 7.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 159.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.4 pt -138.61 145.69 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 131.411 3.885 . . . . 0.0 109.091 161.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.1 m -107.58 105.88 15.98 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 118.787 -2.446 . . . . 0.0 110.623 -175.88 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -95.21 131.73 40.94 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 115.185 -2.341 . . . . 0.0 109.209 176.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -74.66 119.62 19.1 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 128.04 2.536 . . . . 0.0 109.041 156.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.4 m -141.22 157.59 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 177.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.301 1.7 tm-20 -85.53 153.04 58.33 Favored Pre-proline 0 N--CA 1.445 -0.705 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 169.7 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -61.96 -22.98 75.33 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.482 1.455 . . . . 0.0 115.846 168.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.0 p -94.86 11.68 30.79 Favored 'General case' 0 N--CA 1.449 -0.497 0 O-C-N 119.021 -2.3 . . . . 0.0 113.314 171.109 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -70.22 134.96 48.57 Favored 'General case' 0 C--O 1.222 -0.388 0 CA-C-N 124.518 3.327 . . . . 0.0 107.819 159.181 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p -89.51 155.17 19.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 112.519 -2.128 . . . . 0.0 114.029 174.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.419 ' H ' HG12 ' A' ' 23' ' ' ILE . 11.7 mm -40.23 -56.01 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 127.418 2.287 . . . . 0.0 114.996 -172.222 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.64 -39.66 65.18 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 179.735 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -69.87 -33.25 71.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 120.164 -1.585 . . . . 0.0 110.613 176.184 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.4 t -59.71 -45.27 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 O-C-N 116.633 -3.792 . . . . 0.0 108.129 171.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -53.78 -49.74 67.6 Favored 'General case' 0 C--O 1.221 -0.435 0 O-C-N 125.426 1.704 . . . . 0.0 108.448 175.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.43 -34.95 78.88 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 126.828 3.204 . . . . 0.0 114.099 -178.158 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -78.44 -24.53 46.06 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 117.309 -3.369 . . . . 0.0 108.791 177.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 12.1 mt -70.24 -40.36 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 CA-C-N 123.544 2.884 . . . . 0.0 108.935 162.54 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.5 tt0 -67.92 -39.38 83.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 114.467 -2.682 . . . . 0.0 112.097 -168.391 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -53.66 -39.54 65.15 Favored 'General case' 0 C--O 1.221 -0.444 0 C-N-CA 127.487 2.315 . . . . 0.0 115.112 165.478 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.311 65.8 mmtt -89.7 -44.86 9.73 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 117.755 -1.578 . . . . 0.0 113.007 -179.553 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -97.87 -19.88 17.84 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-O 116.124 -1.893 . . . . 0.0 113.055 -173.747 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.3 -15.26 63.35 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 108.524 -1.83 . . . . 0.0 108.524 173.601 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 67.0 mt -70.94 113.3 17.79 Favored Pre-proline 0 N--CA 1.449 -0.496 0 CA-C-O 114.343 -2.741 . . . . 0.0 110.043 -177.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -65.35 153.77 76.7 Favored 'Trans proline' 0 N--CA 1.449 -1.116 1 C-N-CA 126.238 4.625 . . . . 0.0 110.385 -173.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.47 -34.16 97.2 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.825 3.017 . . . . 0.0 113.991 -178.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -60.52 -2.91 0.57 Allowed 'General case' 0 N--CA 1.445 -0.683 1 C-N-CA 133.883 4.873 . . . . 0.0 115.85 172.899 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.39 0.0 OUTLIER -135.59 14.93 3.42 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 116.719 2.118 . . . . 0.0 116.719 169.289 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -105.79 161.35 14.5 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 171.477 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.295 15.9 ttm180 -157.62 139.27 13.92 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 131.386 3.874 . . . . 0.0 108.454 169.448 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.9 118.23 22.32 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.486 2.314 . . . . 0.0 109.985 -162.569 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.4 mm -101.75 139.33 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 125.689 1.596 . . . . 0.0 109.173 -174.418 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -148.03 140.48 24.43 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 115.82 -2.038 . . . . 0.0 110.376 158.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.301 . . 69.97 8.09 6.53 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 117.286 2.328 . . . . 0.0 117.286 -177.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.89 -13.84 22.03 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 126.189 1.852 . . . . 0.0 108.786 171.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -112.45 163.86 13.96 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 116.497 -3.943 . . . . 0.0 111.776 -174.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -79.1 118.44 21.08 Favored 'General case' 0 N--CA 1.441 -0.913 1 C-N-CA 132.018 4.127 . . . . 0.0 111.315 166.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.85 129.12 34.36 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 127.53 3.019 . . . . 0.0 106.769 169.782 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -92.23 156.32 17.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 130.529 3.531 . . . . 0.0 114.004 -171.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -49.11 130.69 19.09 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.447 2.299 . . . . 0.0 111.545 175.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.73 -27.53 14.68 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 126.088 1.804 . . . . 0.0 116.418 163.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.81 149.98 26.06 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 120.537 2.169 . . . . 0.0 108.178 176.403 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.8 p -79.31 164.99 23.64 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 128.909 2.884 . . . . 0.0 109.285 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 56' ' ' LEU . 80.1 mt -67.64 -27.0 66.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 113.661 -1.609 . . . . 0.0 112.665 170.179 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.257 1.2 p -72.32 -20.36 61.5 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 112.281 -3.723 . . . . 0.0 115.402 163.579 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.61 -17.63 62.27 Favored 'General case' 0 N--CA 1.447 -0.615 1 CA-C-O 129.295 4.379 . . . . 0.0 109.225 178.527 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.264 50.2 m-85 -112.05 1.67 16.46 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 117.649 -3.157 . . . . 0.0 110.931 177.596 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.4 t30 53.57 44.43 29.83 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 127.8 2.44 . . . . 0.0 115.16 168.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.275 2.9 mt -66.56 131.57 32.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 1 C-N-CA 133.825 4.85 . . . . 0.0 112.875 160.636 . . . . . . . . 3 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.0 169.29 12.26 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-O 114.837 -2.506 . . . . 0.0 113.537 171.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -42.14 127.17 3.47 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 119.452 3.13 . . . . 0.0 119.452 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 65.45 30.61 10.75 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.358 2.263 . . . . 0.0 115.392 174.784 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.6 m -81.87 151.02 27.5 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 103.697 -2.705 . . . . 0.0 103.697 176.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.2 m -97.48 116.71 30.21 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 119.615 -1.928 . . . . 0.0 107.565 -174.259 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mp -100.43 145.14 28.59 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 128.513 2.725 . . . . 0.0 111.49 171.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -112.55 107.5 16.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 124.39 2.043 . . . . 0.0 110.202 -167.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 tp -80.49 134.75 36.0 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 119.214 -2.179 . . . . 0.0 109.22 -173.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.5 t -125.01 136.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 O-C-N 120.911 -1.118 . . . . 0.0 111.099 174.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -93.42 134.92 35.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 130.533 3.533 . . . . 0.0 106.875 176.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.2 mtp-105 -120.38 175.08 6.15 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 102.447 -3.168 . . . . 0.0 102.447 159.305 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.8 mt -84.04 162.97 20.18 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 128.947 2.899 . . . . 0.0 111.694 168.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.475 6.1 ttp180 108.8 78.71 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 130.484 3.514 . . . . 0.0 109.994 -177.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.03 -145.46 15.94 Favored Glycine 0 CA--C 1.536 1.368 1 C-N-CA 131.084 4.183 . . . . 0.0 109.021 173.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.774 0 C-N-CA 128.772 3.082 . . . . 0.0 111.536 -172.654 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ptt? . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -102.1 150.78 22.91 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 118.294 -2.754 . . . . 0.0 105.847 176.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.374 16.4 pt -140.56 157.51 24.14 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 C-N-CA 131.203 3.801 . . . . 0.0 106.693 164.585 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -112.05 139.83 47.23 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -175.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.3 t -115.08 126.31 72.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 C-N-CA 128.276 2.631 . . . . 0.0 107.83 166.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppt? -93.29 125.59 37.97 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 127.925 3.266 . . . . 0.0 110.838 169.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.271 72.5 p -79.11 -165.18 0.71 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 118.335 2.717 . . . . 0.0 118.335 -179.632 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.3 mt -77.28 -43.21 34.08 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 118.042 -2.911 . . . . 0.0 111.898 163.401 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 81.7 p -74.74 -6.28 47.99 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 -169.614 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.59 0.87 43.23 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 117.253 1.661 . . . . 0.0 117.253 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -84.59 147.88 26.77 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 124.909 1.283 . . . . 0.0 111.713 173.866 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.6 m -110.52 109.29 19.57 Favored 'General case' 0 C--N 1.326 -0.441 1 C-N-CA 132.416 4.286 . . . . 0.0 100.314 173.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.7 mt -95.31 142.42 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 C-N-CA 127.257 2.223 . . . . 0.0 106.246 166.552 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.5 m -96.2 133.31 40.67 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 105.626 -1.991 . . . . 0.0 105.626 -179.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -117.63 140.36 49.74 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -177.149 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.1 mp0 -101.86 130.88 48.43 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 100.666 -3.828 . . . . 0.0 100.666 -177.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.482 HG21 HD23 ' A' ' 56' ' ' LEU . 34.3 m -137.34 163.14 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 113.421 -1.718 . . . . 0.0 109.177 176.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.366 71.2 mm-40 -116.48 145.83 36.09 Favored Pre-proline 0 N--CA 1.445 -0.675 0 N-CA-C 101.758 -3.423 . . . . 0.0 101.758 163.425 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -73.01 -3.6 13.92 Favored 'Trans proline' 0 N--CA 1.447 -1.261 1 C-N-CA 125.964 4.442 . . . . 0.0 113.911 -174.343 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.7 p -80.5 -20.91 42.56 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 128.755 2.822 . . . . 0.0 115.615 164.836 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -61.6 141.58 57.68 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 123.441 1.591 . . . . 0.0 113.565 175.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.5 p -70.56 159.12 34.91 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.1 1.76 . . . . 0.0 109.459 167.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.9 mm -45.24 -39.91 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 130.131 3.372 . . . . 0.0 113.973 162.593 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 51.9 tt0 -76.61 -34.83 58.36 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.358 0.981 . . . . 0.0 110.761 179.533 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.288 18.8 m-80 -53.33 -44.29 68.32 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 116.722 -1.608 . . . . 0.0 112.014 174.381 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.28 1.9 t -51.55 -49.37 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 167.133 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -54.65 -52.15 63.21 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 125.586 1.804 . . . . 0.0 115.145 175.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -44.8 -39.02 4.92 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 131.306 3.842 . . . . 0.0 119.661 166.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -86.26 -38.92 17.07 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 110.867 -2.879 . . . . 0.0 105.841 -179.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 30' ' ' ILE 0.304 83.6 mt -54.47 -37.03 36.63 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 O-C-N 117.806 -3.059 . . . . 0.0 114.05 166.745 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.8 -44.83 66.89 Favored 'General case' 0 C--O 1.22 -0.473 0 C-N-CA 128.053 2.541 . . . . 0.0 115.718 175.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -57.39 -51.94 67.37 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.348 1.859 . . . . 0.0 111.637 168.089 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -82.67 -16.86 46.58 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 118.444 2.757 . . . . 0.0 118.444 -168.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -154.79 2.37 0.2 Allowed 'General case' 0 N--CA 1.449 -0.52 1 O-C-N 115.962 -4.211 . . . . 0.0 109.405 -173.594 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.37 -20.09 48.52 Favored Glycine 0 CA--C 1.533 1.185 0 O-C-N 117.598 -3.189 . . . . 0.0 114.933 161.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 45.9 mt -83.25 131.55 52.93 Favored Pre-proline 0 N--CA 1.442 -0.854 0 O-C-N 119.258 -2.319 . . . . 0.0 107.671 -167.11 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -59.92 151.06 74.38 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 N-CA-C 118.824 2.586 . . . . 0.0 118.824 165.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.396 29.9 Cg_exo -47.17 -40.91 27.44 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 124.685 3.59 . . . . 0.0 117.718 173.488 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.27 2.76 38.56 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 124.811 1.319 . . . . 0.0 110.295 -179.584 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.426 ' HB3' HD23 ' A' ' 73' ' ' LEU . 72.3 mt-30 -118.93 6.08 11.39 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 123.388 2.813 . . . . 0.0 112.494 170.671 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 70.1 mt-30 -99.2 156.24 17.07 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 118.704 0.684 . . . . 0.0 109.768 175.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -129.84 114.92 16.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 101.56 -3.496 . . . . 0.0 101.56 160.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.8 mt -86.66 146.45 26.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 125.735 3.88 . . . . 0.0 109.151 176.467 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.27 20.3 mm -135.14 156.17 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 C-N-CA 129.722 3.209 . . . . 0.0 106.418 179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -159.55 147.55 17.34 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 127.001 2.688 . . . . 0.0 109.789 159.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.347 . . 52.59 20.11 1.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 131.117 3.767 . . . . 0.0 112.51 175.354 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.29 -0.06 59.92 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 128.659 3.028 . . . . 0.0 110.168 175.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.275 28.3 mttm -100.66 148.06 25.29 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 116.127 -1.892 . . . . 0.0 112.689 -178.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.714 HE21 ' H ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -73.41 132.38 42.93 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.223 -2.51 . . . . 0.0 104.223 161.425 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.62 118.67 5.9 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.501 172.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -74.95 99.36 3.82 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 127.177 2.191 . . . . 0.0 111.25 174.463 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -39.3 135.07 1.08 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 151.782 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.96 2.53 7.82 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.132 -1.371 . . . . 0.0 116.412 171.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.3 mtt-85 -129.25 -167.57 1.81 Allowed 'General case' 0 N--CA 1.445 -0.698 0 O-C-N 127.371 2.453 . . . . 0.0 111.193 -163.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.4 p -125.21 165.18 18.75 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.824 1.65 . . . . 0.0 110.19 161.183 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.482 HD23 HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -58.4 -40.09 81.43 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 118.081 -2.887 . . . . 0.0 111.042 -176.535 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.0 t -64.48 -33.45 75.9 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.719 2.008 . . . . 0.0 109.797 175.467 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.251 28.1 t70 -82.37 -32.36 29.26 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 117.667 -3.146 . . . . 0.0 115.07 -176.77 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -91.51 -2.75 57.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 116.012 -1.947 . . . . 0.0 109.177 173.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 71.74 40.04 0.81 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 129.988 3.315 . . . . 0.0 114.47 169.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.4 mt -79.88 109.81 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 102.003 -3.332 . . . . 0.0 102.003 179.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.7 mm-40 -83.51 164.98 19.5 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 126.274 1.83 . . . . 0.0 112.193 172.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.1 pttt -70.74 156.78 39.08 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 128.346 2.659 . . . . 0.0 108.951 -177.07 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 62.75 7.2 2.42 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 127.386 2.274 . . . . 0.0 112.278 175.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.0 m -74.61 148.44 40.73 Favored 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 119.2 -2.188 . . . . 0.0 111.385 179.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.2 m -108.4 111.91 24.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 118.361 -1.336 . . . . 0.0 112.741 -178.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 67' ' ' LEU . 5.3 mp -88.62 176.02 7.3 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 129.905 3.282 . . . . 0.0 109.944 171.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.9 m80 -134.36 154.03 51.57 Favored 'General case' 0 C--O 1.225 -0.207 0 O-C-N 116.619 -3.801 . . . . 0.0 110.811 -175.263 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.321 0.7 OUTLIER -118.16 150.57 39.17 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.11 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -133.65 147.74 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 130.735 3.614 . . . . 0.0 105.597 163.02 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 26.9 tp -92.5 140.83 29.16 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 179.625 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -149.79 113.04 4.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 100.519 -3.882 . . . . 0.0 100.519 174.865 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.426 HD23 ' HB3' ' A' ' 40' ' ' GLN . 49.7 mt -86.75 53.81 2.95 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 103.141 -2.911 . . . . 0.0 103.141 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -160.84 131.8 5.45 Favored 'General case' 0 N--CA 1.45 -0.47 1 C-N-CA 134.872 5.269 . . . . 0.0 106.715 178.292 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -117.51 6.19 16.58 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-O 125.864 2.924 . . . . 0.0 110.767 -178.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.029 0 O-C-N 118.191 -2.946 . . . . 0.0 111.205 -177.083 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttt . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -96.75 166.7 11.52 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 -164.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.3 pt -114.68 134.41 57.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 101.553 -3.499 . . . . 0.0 101.553 153.61 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -87.12 112.06 21.56 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.53 1.532 . . . . 0.0 113.41 165.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.8 t -104.48 117.46 50.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 CA-C-O 113.379 -3.201 . . . . 0.0 108.182 -176.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.6 mttt -119.29 152.28 36.99 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 130.005 3.322 . . . . 0.0 107.322 -169.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 t -155.45 170.57 21.63 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.933 1.693 . . . . 0.0 112.817 179.623 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.0 -23.34 48.34 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 128.608 3.693 . . . . 0.0 114.588 -165.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.0 p -76.67 -7.42 55.27 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 169.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.3 -23.5 8.05 Favored Glycine 0 CA--C 1.531 1.052 0 O-C-N 118.026 -2.921 . . . . 0.0 114.108 167.113 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' NZ ' ' OE1' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -59.55 133.05 55.74 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 118.06 2.615 . . . . 0.0 118.06 -175.853 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 m -112.86 103.67 11.66 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 170.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.7 mt -96.85 115.3 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 129.589 3.156 . . . . 0.0 106.484 175.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.8 p -89.6 109.94 20.85 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 114.046 -2.883 . . . . 0.0 111.932 168.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -112.21 140.11 47.18 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 125.076 3.58 . . . . 0.0 105.028 172.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.0 mp0 -88.64 135.76 33.34 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.19 2.196 . . . . 0.0 107.599 176.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.51 173.6 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 127.879 2.472 . . . . 0.0 110.991 -161.623 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.276 44.7 mm-40 -132.88 166.56 28.33 Favored Pre-proline 0 N--CA 1.441 -0.925 1 O-C-N 129.572 4.295 . . . . 0.0 108.517 151.648 . . . . . . . . 3 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_exo -37.74 -21.63 0.05 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.561 0 C-N-CA 124.324 3.349 . . . . 0.0 120.229 163.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.7 p -94.07 -20.59 19.79 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.914 2.886 . . . . 0.0 113.667 -173.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -69.1 145.3 53.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.188 0.994 . . . . 0.0 112.502 176.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.5 p -90.0 165.25 14.16 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.93 -1.941 . . . . 0.0 112.108 -173.167 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.1 mm -74.08 -49.72 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-O 114.902 -2.475 . . . . 0.0 110.382 170.28 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -58.62 -10.28 2.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 125.705 3.866 . . . . 0.0 119.605 172.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -74.91 -38.66 61.77 Favored 'General case' 0 N--CA 1.442 -0.863 0 CA-C-N 119.628 1.104 . . . . 0.0 112.26 161.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 30' ' ' ILE . 22.7 t -71.89 -34.63 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 O-C-N 116.817 -3.677 . . . . 0.0 109.419 -168.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.3 mtpt -71.43 -39.53 70.98 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.692 1.997 . . . . 0.0 109.251 -175.109 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.71 -42.73 89.32 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 129.983 3.313 . . . . 0.0 116.505 161.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -82.79 -21.04 34.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 125.62 1.825 . . . . 0.0 113.729 -177.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 26' ' ' VAL . 96.2 mt -55.76 -50.67 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 C-N-CA 127.646 2.378 . . . . 0.0 109.252 161.111 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -67.35 -28.52 68.03 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 118.479 2.77 . . . . 0.0 118.479 -173.506 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.334 36.5 t70 -52.41 -46.43 66.32 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 130.882 3.673 . . . . 0.0 117.093 162.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -92.08 -48.62 6.63 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.688 -1.596 . . . . 0.0 108.907 -175.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.438 ' OE1' ' NZ ' ' A' ' 11' ' ' LYS 0.318 20.8 tp10 -108.13 -15.79 14.42 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 128.065 2.546 . . . . 0.0 116.37 -166.78 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.26 -26.01 26.0 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 124.497 3.317 . . . . 0.0 111.949 158.061 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 tp -67.95 127.91 93.33 Favored Pre-proline 0 C--O 1.223 -0.33 0 CA-C-O 113.917 -2.944 . . . . 0.0 107.782 -170.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -76.67 137.07 17.76 Favored 'Trans proline' 0 N--CA 1.445 -1.371 0 C-N-CA 124.519 3.48 . . . . 0.0 118.137 179.069 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -34.53 -37.95 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.441 3.427 . . . . 0.0 117.623 178.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.481 13.1 t70 -44.07 -40.47 4.89 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 117.568 2.433 . . . . 0.0 117.568 171.214 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -108.23 12.39 26.61 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 112.836 -1.984 . . . . 0.0 111.426 -176.265 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -100.95 135.86 41.72 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.195 1.798 . . . . 0.0 107.88 174.06 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.5 mtm180 -130.26 140.07 50.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 128.09 2.556 . . . . 0.0 111.816 172.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.7 mp -121.03 118.79 30.7 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 126.542 2.401 . . . . 0.0 108.666 -160.262 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.444 HG12 HG23 ' A' ' 70' ' ' VAL . 38.3 mm -120.03 138.35 50.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 127.599 2.359 . . . . 0.0 111.197 -173.916 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -133.55 100.67 4.87 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 127.226 2.211 . . . . 0.0 112.232 171.447 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.49 -94.36 0.04 OUTLIER 'General case' 0 C--O 1.226 -0.166 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.386 -162.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.08 4.57 9.0 Favored Glycine 0 CA--C 1.529 0.926 0 CA-C-O 115.973 -2.57 . . . . 0.0 114.437 168.643 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -87.3 131.23 34.32 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 120.703 2.252 . . . . 0.0 105.067 -175.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -85.0 124.27 31.5 Favored 'General case' 0 N--CA 1.442 -0.842 1 C-N-CA 134.445 5.098 . . . . 0.0 105.599 176.241 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.4 mt -101.27 157.27 16.91 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 125.46 1.725 . . . . 0.0 109.879 -173.011 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -130.18 134.04 47.01 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.468 1.507 . . . . 0.0 107.313 170.261 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.256 3.1 p30 -70.12 -168.62 0.23 Allowed 'General case' 0 C--O 1.221 -0.402 0 O-C-N 128.684 3.74 . . . . 0.0 112.141 -174.153 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.55 1.75 58.92 Favored Glycine 0 CA--C 1.521 0.406 0 N-CA-C 120.89 3.116 . . . . 0.0 120.89 -175.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.3 mtt-85 -147.86 159.34 43.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 128.586 2.754 . . . . 0.0 110.747 -150.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.3 p -83.19 176.73 8.96 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 129.972 3.309 . . . . 0.0 111.036 -179.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.66 -33.49 76.01 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 129.36 3.064 . . . . 0.0 111.232 168.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 41.1 t -85.49 -10.52 55.96 Favored 'General case' 0 N--CA 1.444 -0.759 0 O-C-N 119.39 -2.069 . . . . 0.0 112.115 176.634 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.03 -28.46 68.88 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 125.612 1.82 . . . . 0.0 109.979 169.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.287 41.3 m-85 -122.73 17.15 10.28 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 119.53 -1.981 . . . . 0.0 113.562 -175.914 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.6 t30 53.8 40.61 31.72 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 119.303 3.075 . . . . 0.0 119.303 -174.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.2 mt -85.62 80.58 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 173.157 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.3 mm-40 -102.77 36.55 2.16 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 127.613 2.365 . . . . 0.0 111.428 -161.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm 96.45 132.27 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 1 C-N-CA 132.212 4.205 . . . . 0.0 105.774 156.069 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.435 9.9 mp0 73.49 23.53 2.46 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 130.6 3.56 . . . . 0.0 109.87 176.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.9 m -69.48 142.27 53.78 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 129.045 2.938 . . . . 0.0 109.308 171.339 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.5 m -94.86 119.08 32.84 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 126.103 2.127 . . . . 0.0 106.105 168.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -109.38 137.12 47.72 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 175.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -104.9 120.57 41.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 127.569 2.348 . . . . 0.0 107.253 178.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 19.5 tp -92.49 115.52 28.17 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 110.71 -2.95 . . . . 0.0 109.089 166.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.444 HG23 HG12 ' A' ' 44' ' ' ILE . 82.8 t -74.38 109.87 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 105.432 -2.062 . . . . 0.0 105.432 159.853 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.02 136.43 37.94 Favored 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 165.84 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -76.57 120.82 22.3 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 125.819 1.95 . . . . 0.0 109.547 172.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.8 mt -144.01 140.06 29.37 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.935 3.294 . . . . 0.0 106.707 -171.695 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.9 ttm105 -95.85 -27.9 14.98 Favored 'General case' 0 C--N 1.325 -0.472 1 CA-C-O 129.008 4.242 . . . . 0.0 110.35 179.055 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.24 -124.36 3.17 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-N 110.036 -3.257 . . . . 0.0 108.111 168.507 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 130.075 3.702 . . . . 0.0 110.318 -164.437 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.838 0 CA-C-O 115.765 -2.064 . . . . 0.0 107.739 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -86.5 140.44 29.93 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -167.803 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.398 7.4 pt -131.77 172.97 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 128.686 2.794 . . . . 0.0 115.561 162.576 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -126.85 135.45 51.0 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 127.164 2.79 . . . . 0.0 103.679 -175.317 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.275 79.6 t -126.92 121.47 58.21 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.477 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 175.978 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.427 ' HB3' ' HA ' ' A' ' 68' ' ' HIS 0.255 35.1 tttp -97.47 156.05 16.66 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 129.583 3.153 . . . . 0.0 103.8 -172.918 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.8 p -134.48 146.2 49.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.183 -178.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.7 mt -68.52 -22.59 64.51 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 117.906 -2.996 . . . . 0.0 111.403 -176.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.0 p -82.04 -18.49 43.04 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 127.504 2.322 . . . . 0.0 109.002 -172.654 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.47 31.45 0.78 Allowed Glycine 0 CA--C 1.53 1.005 0 CA-C-O 116.624 -2.209 . . . . 0.0 112.981 151.14 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.311 41.5 pttt -133.43 160.87 36.1 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.039 3.336 . . . . 0.0 110.212 -179.399 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.0 m -122.08 135.53 54.82 Favored 'General case' 0 N--CA 1.449 -0.514 1 N-CA-C 99.739 -4.171 . . . . 0.0 99.739 164.73 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.1 pt -97.99 152.43 4.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 O-C-N 118.806 -2.434 . . . . 0.0 105.165 168.616 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.1 m -96.83 150.14 21.06 Favored 'General case' 0 C--N 1.332 -0.188 0 O-C-N 128.741 3.776 . . . . 0.0 107.656 166.428 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.85 157.36 46.94 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 127.009 2.123 . . . . 0.0 107.288 179.816 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -134.27 101.4 5.0 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -176.475 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 m -119.44 145.31 25.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 129.458 3.103 . . . . 0.0 112.646 -172.773 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -85.29 135.18 39.31 Favored Pre-proline 0 N--CA 1.444 -0.752 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.768 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -40.83 -37.62 2.45 Favored 'Trans proline' 0 N--CA 1.454 -0.841 1 C-N-CA 126.971 5.114 . . . . 0.0 117.639 -178.334 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.9 p -103.13 9.61 38.29 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 119.566 3.172 . . . . 0.0 119.566 -179.494 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -72.55 137.71 46.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 118.138 -2.851 . . . . 0.0 104.035 170.194 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.9 p -75.95 162.03 28.44 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 129.693 3.197 . . . . 0.0 113.809 172.714 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.1 mm -53.12 -36.45 24.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 127.258 2.223 . . . . 0.0 113.891 -174.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.305 4.8 tp10 -55.89 -38.6 70.39 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.83 2.052 . . . . 0.0 115.526 173.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -66.99 -43.66 82.37 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 125.932 2.02 . . . . 0.0 112.756 176.225 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.263 22.8 t -52.84 -52.76 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.836 2.054 . . . . 0.0 110.2 174.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -58.79 -42.08 88.22 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 125.667 1.854 . . . . 0.0 111.916 -179.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.24 -31.48 72.66 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 116.462 -1.732 . . . . 0.0 112.572 177.371 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttt -76.41 -33.48 58.82 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 122.784 2.538 . . . . 0.0 111.457 178.586 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.8 mt -64.58 -43.43 96.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 129.895 3.278 . . . . 0.0 110.698 174.394 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -61.48 -52.9 62.59 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 125.309 1.443 . . . . 0.0 112.416 175.722 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -52.71 -39.43 62.04 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 131.237 3.815 . . . . 0.0 111.977 -179.082 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -87.83 -50.69 6.29 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 127.688 3.117 . . . . 0.0 115.808 -178.894 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -114.3 -6.29 12.96 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 128.075 2.55 . . . . 0.0 115.357 -166.237 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.0 -16.6 35.98 Favored Glycine 0 CA--C 1.533 1.158 1 C-N-CA 130.821 4.058 . . . . 0.0 110.181 156.453 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.4 mp -75.08 121.94 86.34 Favored Pre-proline 0 N--CA 1.444 -0.763 0 O-C-N 119.468 -2.195 . . . . 0.0 110.388 -164.089 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -71.26 148.94 56.54 Favored 'Trans proline' 0 N--CA 1.45 -1.029 0 C-N-CA 122.994 2.463 . . . . 0.0 111.244 179.164 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.68 -32.14 95.33 Favored 'Trans proline' 0 N--CA 1.447 -1.238 1 C-N-CA 125.363 4.042 . . . . 0.0 116.614 -163.065 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.253 51.3 m-20 -73.18 -4.34 32.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.007 2.123 . . . . 0.0 115.49 176.165 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -108.82 -12.16 14.94 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 171.613 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.83 162.37 21.66 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 119.699 -0.8 . . . . 0.0 113.027 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.276 0.1 OUTLIER -151.71 102.93 2.9 Favored 'General case' 0 C--O 1.236 0.364 0 O-C-N 118.308 -2.745 . . . . 0.0 106.475 175.21 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 49.2 mt -87.04 113.55 22.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 127.576 3.048 . . . . 0.0 114.732 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.8 mt -120.56 138.89 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 131.551 3.941 . . . . 0.0 106.558 -168.102 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -155.34 -176.68 6.07 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.098 -2.876 . . . . 0.0 105.97 -172.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.04 112.67 1.41 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 124.638 2.161 . . . . 0.0 110.026 -168.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 118.82 -78.54 0.3 Allowed Glycine 0 CA--C 1.532 1.137 0 N-CA-C 107.03 -2.428 . . . . 0.0 107.03 -175.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -165.74 -171.99 2.24 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.965 2.506 . . . . 0.0 104.959 -161.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -62.81 148.85 45.73 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 130.994 3.718 . . . . 0.0 110.034 -177.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.5 mt -93.37 147.39 22.97 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 122.863 1.316 . . . . 0.0 111.907 176.148 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -111.55 157.72 20.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 111.663 -2.517 . . . . 0.0 115.556 -175.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -72.98 135.53 44.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 130.84 3.656 . . . . 0.0 112.381 -171.68 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.5 -28.35 10.96 Favored Glycine 0 CA--C 1.531 1.086 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 169.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -71.74 159.26 34.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 116.605 -1.664 . . . . 0.0 110.36 -179.006 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 p -113.28 -178.46 3.38 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 127.358 2.263 . . . . 0.0 109.567 171.148 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.2 mp -70.0 -31.25 68.84 Favored 'General case' 0 N--CA 1.45 -0.472 0 O-C-N 125.192 1.557 . . . . 0.0 114.255 179.197 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.3 p -77.42 -33.31 54.97 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -70.15 -37.83 75.32 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 124.508 1.13 . . . . 0.0 110.883 177.261 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -91.73 -0.58 57.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 121.026 -1.046 . . . . 0.0 113.627 -175.076 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 77.94 42.83 0.1 Allowed 'General case' 0 C--N 1.324 -0.51 1 C-N-CA 134.045 4.938 . . . . 0.0 109.072 167.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -100.03 95.35 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 N-CA-C 103.258 -2.868 . . . . 0.0 103.258 -175.34 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -70.66 163.74 26.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.624 -1.298 . . . . 0.0 110.162 160.459 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -45.41 147.3 0.83 Allowed 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 131.095 3.758 . . . . 0.0 114.04 175.37 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 59.41 33.84 22.5 Favored 'General case' 0 N--CA 1.448 -0.566 1 C-N-CA 132.847 4.459 . . . . 0.0 106.901 172.29 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.3 m -93.68 152.21 19.13 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 117.511 -3.243 . . . . 0.0 106.861 175.739 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.6 m -99.67 130.28 45.88 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.932 1.395 . . . . 0.0 110.56 175.177 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.0 mp -102.78 161.49 13.7 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 102.088 -3.301 . . . . 0.0 102.088 163.434 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -114.83 123.42 49.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 103.64 -2.726 . . . . 0.0 103.64 172.752 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -90.14 122.0 32.7 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 118.677 -2.514 . . . . 0.0 111.57 167.302 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.7 t -116.67 156.4 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 179.925 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.268 16.0 mt -114.84 147.92 39.21 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.467 -1.242 . . . . 0.0 110.399 -169.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -95.03 160.86 14.37 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 127.986 3.304 . . . . 0.0 108.779 156.449 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -95.26 115.54 27.57 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 165.994 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.265 21.7 ttt180 -140.05 -80.86 0.28 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 112.952 -1.931 . . . . 0.0 106.416 177.305 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.29 -179.68 16.45 Favored Glycine 0 CA--C 1.534 1.236 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 178.985 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.551 1 N-CA-C 102.321 -4.312 . . . . 0.0 102.321 168.54 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptt? . . . . . 0 C--O 1.223 -0.317 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -88.45 148.69 24.06 Favored 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 117.518 -3.239 . . . . 0.0 105.705 -177.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.4 pt -127.2 143.29 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 128.925 2.89 . . . . 0.0 107.268 159.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -104.07 134.41 47.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 176.197 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.9 t -135.23 126.93 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 117.74 -1.124 . . . . 0.0 109.413 -168.047 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -116.68 116.45 27.56 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 122.162 2.256 . . . . 0.0 112.853 -165.703 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.0 p -74.06 158.59 34.0 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.201 1.4 . . . . 0.0 109.98 -178.88 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.5 tp -59.78 -40.47 88.37 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.682 1.993 . . . . 0.0 107.223 -166.792 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 36.6 p -80.7 2.2 26.96 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 117.89 -3.007 . . . . 0.0 118.607 176.408 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.91 -7.7 16.96 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 119.157 2.423 . . . . 0.0 119.157 152.815 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.2 tttt -75.67 122.86 24.61 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.281 1.433 . . . . 0.0 107.251 -177.086 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.321 73.1 m -81.86 138.16 35.11 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 122.19 0.995 . . . . 0.0 109.754 170.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.0 mp -122.12 141.86 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 129.807 3.243 . . . . 0.0 103.379 172.917 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 m -96.88 120.05 36.49 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.943 2.497 . . . . 0.0 112.307 170.165 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 65.2 mt -106.17 136.27 46.17 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.084 1.754 . . . . 0.0 110.437 171.158 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -92.17 140.28 29.78 Favored 'General case' 0 CA--C 1.535 0.401 1 O-C-N 129.863 4.477 . . . . 0.0 104.235 172.058 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.8 m -153.9 168.66 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 C-N-CA 129.256 3.022 . . . . 0.0 105.278 -174.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.9 mt-10 -116.45 159.69 39.08 Favored Pre-proline 0 N--CA 1.445 -0.716 0 C-N-CA 129.094 2.958 . . . . 0.0 107.81 172.769 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 18' ' ' GLU 0.297 86.7 Cg_endo -57.86 -29.58 86.69 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 124.568 3.512 . . . . 0.0 116.515 172.237 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.4 p -95.88 11.18 34.67 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 130.769 3.628 . . . . 0.0 108.398 -166.889 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.29 2.6 m-20 -92.92 146.8 23.36 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 115.835 -2.031 . . . . 0.0 111.533 -176.038 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.45 HG23 ' HG2' ' A' ' 24' ' ' GLU . 2.4 t -86.13 151.83 23.35 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 120.338 1.427 . . . . 0.0 112.262 173.72 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.258 62.6 mt -65.12 -31.24 53.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 118.367 -2.708 . . . . 0.0 108.826 -171.069 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 22' ' ' THR . 1.0 OUTLIER -63.15 -40.44 97.57 Favored 'General case' 0 N--CA 1.452 -0.366 2 O-C-N 114.325 -5.234 . . . . 0.0 113.824 176.515 . . . . . . . . 4 4 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -68.44 -31.0 70.01 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 128.532 2.733 . . . . 0.0 111.8 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.6 t -59.64 -51.94 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 122.496 2.407 . . . . 0.0 110.278 163.448 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.4 mtpt -68.03 -40.55 82.87 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 128.973 2.909 . . . . 0.0 112.051 -164.053 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -17.94 64.8 Favored 'General case' 0 N--CA 1.446 -0.655 1 C-N-CA 132.765 4.426 . . . . 0.0 113.982 177.45 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.8 mttt -65.08 -31.64 72.95 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 130.554 3.542 . . . . 0.0 110.661 176.399 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 10.0 mm -74.05 -16.74 16.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 O-C-N 124.948 1.405 . . . . 0.0 114.164 -179.71 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.281 6.1 tp60 -66.89 -38.12 85.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 117.251 -3.406 . . . . 0.0 111.441 169.723 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -65.66 -47.67 74.75 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 124.811 1.244 . . . . 0.0 110.708 168.612 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.0 mptt -73.85 -75.33 0.16 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 115.577 -2.154 . . . . 0.0 114.498 -175.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -101.24 -20.06 15.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 127.944 3.278 . . . . 0.0 115.171 -161.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.96 6.34 26.34 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 130.345 3.831 . . . . 0.0 114.51 162.811 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 56.1 mt -95.59 124.02 54.32 Favored Pre-proline 0 N--CA 1.448 -0.555 0 O-C-N 126.728 2.075 . . . . 0.0 105.854 -164.176 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -68.24 172.81 10.49 Favored 'Trans proline' 0 N--CA 1.451 -1.003 1 C-N-CA 126.424 4.75 . . . . 0.0 116.16 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.85 -42.59 0.41 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 1 C-N-CA 126.943 5.096 . . . . 0.0 107.622 177.266 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.88 -15.32 62.62 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 130.725 3.61 . . . . 0.0 115.978 -174.57 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.257 38.0 tt0 -103.59 -34.57 8.6 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 118.101 -1.439 . . . . 0.0 113.887 171.572 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -50.05 135.01 21.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.745 1.618 . . . . 0.0 115.329 169.017 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -136.14 158.34 44.65 Favored 'General case' 0 N--CA 1.443 -0.824 0 O-C-N 119.158 -2.214 . . . . 0.0 107.702 168.44 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 77.8 mt -129.63 152.24 49.36 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 127.87 3.231 . . . . 0.0 108.952 -167.602 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.8 mt -135.94 129.49 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 C-N-CA 127.797 2.439 . . . . 0.0 107.142 169.871 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -120.28 118.33 30.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 130.359 3.464 . . . . 0.0 105.338 173.205 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.87 50.64 11.09 Favored 'General case' 0 C--O 1.22 -0.472 1 C-N-CA 133.797 4.839 . . . . 0.0 111.568 170.983 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.46 -13.92 60.93 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.787 -1.007 . . . . 0.0 111.591 173.344 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 48' ' ' LYS . 33.0 mtmt -105.93 119.75 39.99 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 130.988 3.715 . . . . 0.0 109.06 -172.812 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -76.36 151.83 36.51 Favored 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 128.526 2.731 . . . . 0.0 104.559 172.164 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.282 0.8 OUTLIER -140.15 132.3 28.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 128.669 2.787 . . . . 0.0 111.11 177.768 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.258 71.9 mm-40 -87.61 162.3 17.23 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 125.188 2.423 . . . . 0.0 110.116 172.222 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -65.35 162.06 18.37 Favored 'General case' 0 N--CA 1.45 -0.468 1 C-N-CA 134.882 5.273 . . . . 0.0 109.02 173.898 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.57 14.46 32.28 Favored Glycine 0 CA--C 1.531 1.055 0 N-CA-C 119.687 2.635 . . . . 0.0 119.687 173.591 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.5 tpp180 -157.55 163.95 37.84 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 126.876 2.07 . . . . 0.0 111.958 177.797 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.6 p -85.47 149.43 25.4 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 130.354 3.462 . . . . 0.0 108.456 -173.106 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.543 HD22 HD13 ' A' ' 61' ' ' ILE . 20.0 mt -65.2 -34.93 79.55 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 125.522 1.529 . . . . 0.0 109.556 -171.334 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.29 66.5 p -36.59 -56.98 0.8 Allowed 'General case' 0 N--CA 1.449 -0.513 1 C-N-CA 133.966 4.906 . . . . 0.0 113.8 173.944 . . . . . . . . 3 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -67.86 -27.25 66.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 130.713 3.605 . . . . 0.0 116.156 -177.563 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -101.14 2.73 40.49 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 127.412 2.285 . . . . 0.0 110.846 179.603 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.362 24.3 p30 69.13 29.43 4.7 Favored 'General case' 0 N--CA 1.444 -0.772 1 C-N-CA 131.819 4.047 . . . . 0.0 113.161 168.332 . . . . . . . . 3 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.543 HD13 HD22 ' A' ' 56' ' ' LEU . 25.8 mt -83.68 127.14 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 175.446 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -115.57 178.83 4.16 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 130.255 3.422 . . . . 0.0 107.304 -174.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.56 135.26 46.39 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 128.689 2.796 . . . . 0.0 111.261 168.132 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 61.49 27.6 17.11 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 129.552 3.141 . . . . 0.0 116.683 176.766 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.9 m -62.98 147.86 49.33 Favored 'General case' 0 C--N 1.328 -0.369 1 O-C-N 115.423 -4.548 . . . . 0.0 109.959 171.608 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.8 p -113.69 108.3 16.94 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 126.554 1.941 . . . . 0.0 107.383 -176.688 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -110.57 150.64 28.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 123.817 1.77 . . . . 0.0 112.738 177.894 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -87.77 139.95 30.01 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 128.956 2.902 . . . . 0.0 104.654 169.281 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.3 tt -116.68 120.9 40.06 Favored 'General case' 0 C--N 1.325 -0.493 1 N-CA-C 96.73 -5.285 . . . . 0.0 96.73 170.544 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.0 m -132.67 165.97 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 128.222 2.609 . . . . 0.0 108.367 170.176 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.8 mp -107.83 137.64 45.48 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.805 2.442 . . . . 0.0 116.025 -174.491 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -84.78 119.31 25.15 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 100.662 -3.829 . . . . 0.0 100.662 165.176 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.9 mt -95.98 114.26 25.96 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.3 2.64 . . . . 0.0 112.904 167.066 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.2 mtm180 -104.9 144.25 32.04 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 131.494 3.917 . . . . 0.0 113.238 -173.083 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.78 51.64 0.81 Allowed Glycine 0 CA--C 1.53 0.971 0 CA-C-O 122.902 1.279 . . . . 0.0 111.756 166.964 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.472 0 C-N-CA 128.083 2.754 . . . . 0.0 110.576 -175.106 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttm . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.446 HE21 ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -111.77 144.9 40.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 169.233 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.372 34.2 pt -132.37 162.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 130.189 3.396 . . . . 0.0 116.57 169.376 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -107.89 131.58 54.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.647 1.979 . . . . 0.0 109.858 178.41 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.422 HG21 HD11 ' A' ' 30' ' ' ILE . 19.2 t -100.32 118.0 46.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 129.031 2.933 . . . . 0.0 105.866 159.724 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.391 71.9 tttt -112.48 123.25 49.86 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 102.863 -3.014 . . . . 0.0 102.863 -174.437 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.7 p -88.74 151.56 22.34 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 110.113 -3.221 . . . . 0.0 107.968 174.652 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.5 mt -67.88 -24.21 65.21 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 127.172 2.795 . . . . 0.0 109.869 172.37 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -81.24 -18.43 46.06 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 118.526 -2.609 . . . . 0.0 111.104 -171.332 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.31 -6.17 7.18 Favored Glycine 0 CA--C 1.522 0.508 0 C-N-CA 128.129 2.776 . . . . 0.0 115.11 156.427 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.251 17.1 pttt -82.36 143.21 31.39 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.349 1.46 . . . . 0.0 111.203 -175.743 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.6 p -97.26 143.42 28.05 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 125.796 2.712 . . . . 0.0 107.671 164.629 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 45.6 mt -122.75 143.03 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 110.347 -3.115 . . . . 0.0 103.171 172.804 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 m -100.22 132.64 45.48 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 128.081 2.552 . . . . 0.0 110.875 172.996 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.7 tp -120.38 133.08 55.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.222 3.009 . . . . 0.0 110.406 170.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -93.75 112.73 24.65 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 126.278 1.831 . . . . 0.0 109.063 170.287 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 m -128.79 175.64 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 127.975 2.51 . . . . 0.0 109.627 -176.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -132.13 159.33 72.61 Favored Pre-proline 0 N--CA 1.451 -0.399 0 N-CA-C 104.164 -2.532 . . . . 0.0 104.164 159.178 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.454 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 46.0 Cg_endo -74.93 -8.94 20.62 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 123.214 2.609 . . . . 0.0 114.228 -170.652 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.3 p -68.64 -31.35 70.42 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 128.884 2.873 . . . . 0.0 114.627 167.577 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.9 131.93 41.0 Favored 'General case' 0 N--CA 1.453 -0.323 0 O-C-N 117.181 -3.449 . . . . 0.0 113.978 174.489 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 55' ' ' THR . 34.0 p -73.06 157.37 37.46 Favored 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 127.085 2.154 . . . . 0.0 112.301 173.406 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.295 1.9 mp -36.2 -42.21 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 129.414 3.086 . . . . 0.0 115.202 154.804 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -73.03 -37.68 66.81 Favored 'General case' 0 N--CA 1.447 -0.579 1 C-N-CA 133.557 4.743 . . . . 0.0 116.561 169.517 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -63.18 -36.38 83.44 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 121.794 2.088 . . . . 0.0 110.89 165.862 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.1 t -69.65 -39.4 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 1 O-C-N 115.034 -4.791 . . . . 0.0 114.292 178.134 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -61.04 -38.71 87.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.914 1.686 . . . . 0.0 115.058 168.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.25 -54.51 14.37 Favored 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 130.626 3.571 . . . . 0.0 107.581 174.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -55.35 -42.38 73.79 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 118.066 2.617 . . . . 0.0 118.066 173.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD11 HG21 ' A' ' 5' ' ' VAL . 46.1 mt -64.08 -43.95 97.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.512 1.125 . . . . 0.0 111.173 169.205 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -58.59 -32.61 69.12 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 127.965 2.506 . . . . 0.0 112.446 178.3 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.268 0.9 OUTLIER -58.21 -37.79 75.52 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 119.536 -1.977 . . . . 0.0 111.357 169.941 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -87.5 -45.41 10.51 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 128.151 2.581 . . . . 0.0 106.833 -169.854 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -111.16 -17.51 13.2 Favored 'General case' 0 N--CA 1.451 -0.4 1 N-CA-C 124.846 5.128 . . . . 0.0 124.846 -174.516 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.79 -2.09 81.06 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 125.534 1.54 . . . . 0.0 114.489 172.693 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 75.7 mt -76.04 138.49 68.91 Favored Pre-proline 0 N--CA 1.448 -0.546 0 C-N-CA 127.446 2.298 . . . . 0.0 109.846 -174.554 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.36 133.73 41.7 Favored 'Trans proline' 0 N--CA 1.45 -1.061 1 C-N-CA 126.363 4.709 . . . . 0.0 116.611 179.117 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -43.54 -44.74 10.84 Favored 'Trans proline' 0 N--CA 1.456 -0.698 1 C-N-CA 131.883 8.389 . . . . 0.0 111.502 173.825 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.358 2.4 t70 -38.7 -44.12 0.97 Allowed 'General case' 0 C--O 1.234 0.275 1 C-N-CA 133.826 4.85 . . . . 0.0 113.087 169.117 . . . . . . . . 3 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -96.66 -25.71 15.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 126.649 1.98 . . . . 0.0 108.926 -171.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -81.41 111.75 18.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -166.181 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -102.81 124.94 49.28 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 100.94 -3.726 . . . . 0.0 100.94 177.812 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.3 mt -120.57 120.06 34.72 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 127.23 2.831 . . . . 0.0 107.435 175.032 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.3 mt -122.35 154.12 27.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 O-C-N 126.273 2.233 . . . . 0.0 105.347 -169.064 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.283 67.8 t80 -143.32 128.21 18.38 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 115.26 -2.305 . . . . 0.0 110.472 160.716 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 70.36 20.3 6.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.145 2.178 . . . . 0.0 112.674 167.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.02 -8.6 63.22 Favored Glycine 0 CA--C 1.526 0.741 1 O-C-N 115.853 -4.279 . . . . 0.0 111.667 -178.59 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -102.66 155.23 18.44 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 124.988 2.328 . . . . 0.0 115.357 173.388 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -94.04 129.81 40.41 Favored 'General case' 0 N--CA 1.446 -0.643 1 N-CA-C 100.123 -4.028 . . . . 0.0 100.123 174.759 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.58 133.88 53.22 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 127.074 2.15 . . . . 0.0 107.701 167.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -69.86 134.62 48.67 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 115.298 -2.287 . . . . 0.0 112.796 177.836 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.294 5.6 t0 -93.21 132.99 36.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 126.224 2.916 . . . . 0.0 109.135 168.569 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.58 8.06 23.3 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 119.059 -2.275 . . . . 0.0 112.925 -159.721 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.8 mmt-85 -136.98 178.19 7.27 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 120.476 2.138 . . . . 0.0 106.677 -177.575 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 30.8 p -110.78 172.42 6.88 Favored 'General case' 0 C--O 1.22 -0.487 0 C-N-CA 129.808 3.243 . . . . 0.0 112.509 -176.901 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.454 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 5.4 mt -61.32 -46.78 88.87 Favored 'General case' 0 N--CA 1.445 -0.712 0 O-C-N 119.178 -2.202 . . . . 0.0 109.113 168.164 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.3 t -56.32 -31.58 63.85 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 174.441 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -65.71 -29.72 70.29 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.87 2.068 . . . . 0.0 109.885 -178.323 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -102.16 12.23 37.07 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 124.106 1.908 . . . . 0.0 112.827 177.13 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.338 0.6 OUTLIER 84.14 1.7 0.9 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.728 2.011 . . . . 0.0 113.982 172.039 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.0 mt -72.14 71.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 C-N-CA 126.98 2.112 . . . . 0.0 108.8 179.28 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -81.07 -32.51 33.95 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 127.997 2.519 . . . . 0.0 113.902 166.565 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 45.1 pttt -149.54 118.45 6.67 Favored 'General case' 0 N--CA 1.441 -0.888 0 O-C-N 118.779 -2.45 . . . . 0.0 114.022 -179.798 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 47.47 99.92 0.01 OUTLIER 'General case' 0 N--CA 1.441 -0.891 1 C-N-CA 135.198 5.399 . . . . 0.0 113.295 157.579 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.0 m -143.17 174.39 10.74 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 117.06 -3.525 . . . . 0.0 108.942 -177.235 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.4 m -121.81 147.88 45.39 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 116.758 -3.714 . . . . 0.0 104.527 171.78 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 89.5 mt -115.11 144.01 44.32 Favored 'General case' 0 N--CA 1.447 -0.578 1 C-N-CA 131.976 4.11 . . . . 0.0 111.354 174.42 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -100.89 117.08 34.24 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 101.069 -3.678 . . . . 0.0 101.069 -175.711 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.5 tp -100.87 129.48 46.74 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 124.463 1.105 . . . . 0.0 108.997 167.58 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.405 0.2 OUTLIER -131.02 156.94 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 O-C-N 125.996 2.06 . . . . 0.0 109.284 165.547 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 72' ' ' ARG . 5.1 tp -85.77 -160.03 0.5 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 127.297 3.427 . . . . 0.0 107.495 174.769 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.402 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -96.88 -20.69 17.97 Favored 'General case' 0 N--CA 1.45 -0.451 1 O-C-N 114.544 -5.097 . . . . 0.0 108.477 176.936 . . . . . . . . 4 4 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.9 mt -118.49 161.68 19.61 Favored 'General case' 0 N--CA 1.455 -0.18 1 C-N-CA 132.657 4.383 . . . . 0.0 104.444 -174.594 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.09 126.75 51.45 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-O 125.07 2.367 . . . . 0.0 105.475 170.294 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 165.35 -151.36 20.08 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 106.841 -2.504 . . . . 0.0 106.841 -168.671 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 116.357 -2.357 . . . . 0.0 114.535 179.861 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.5 ptt? . . . . . 0 N--CA 1.466 0.359 0 CA-C-O 123.52 1.629 . . . . 0.0 111.454 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -94.79 124.73 39.0 Favored 'General case' 0 C--O 1.223 -0.341 0 O-C-N 117.584 -3.197 . . . . 0.0 106.051 175.57 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.1 pt -108.08 161.88 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 102.981 -2.97 . . . . 0.0 102.981 164.542 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -101.9 141.75 34.27 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 116.0 -1.952 . . . . 0.0 114.073 157.777 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.2 t -110.31 115.36 49.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 105.606 -1.998 . . . . 0.0 105.606 163.746 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -83.16 107.0 15.41 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 169.227 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.285 1.2 p -74.0 156.13 37.87 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 128.768 2.827 . . . . 0.0 109.476 174.748 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.5 tp -54.62 -37.67 65.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 130.152 3.381 . . . . 0.0 116.449 -159.986 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.2 p -66.62 -24.05 66.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 113.006 -3.378 . . . . 0.0 115.235 177.303 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.22 -35.25 3.01 Favored Glycine 0 CA--C 1.531 1.036 1 CA-C-O 112.101 -4.722 . . . . 0.0 111.415 -164.397 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -64.21 139.01 58.72 Favored 'General case' 0 N--CA 1.448 -0.566 1 O-C-N 131.292 4.76 . . . . 0.0 104.679 -175.423 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -116.65 129.73 56.32 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 128.165 2.586 . . . . 0.0 109.255 173.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 pt -113.77 143.78 22.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 113.584 -1.644 . . . . 0.0 108.503 167.472 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.9 m -90.65 130.38 36.67 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 128.337 2.655 . . . . 0.0 106.68 176.373 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.35 109.57 18.55 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 126.985 2.114 . . . . 0.0 106.871 179.086 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -71.84 112.45 7.95 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 128.945 3.903 . . . . 0.0 107.832 168.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 m -135.4 166.25 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 128.231 2.612 . . . . 0.0 109.085 -177.197 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -116.48 161.57 31.06 Favored Pre-proline 0 N--CA 1.445 -0.684 0 CA-C-O 116.456 -1.735 . . . . 0.0 108.762 168.674 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -65.13 -19.49 63.03 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 124.682 3.588 . . . . 0.0 113.224 178.333 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 98.6 p -69.8 -26.16 64.13 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 113.379 -3.2 . . . . 0.0 112.3 172.068 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.93 133.85 26.42 Favored 'General case' 0 C--O 1.219 -0.514 0 C-N-CA 128.948 2.899 . . . . 0.0 112.222 -177.717 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.7 p -83.61 148.65 27.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 116.055 -1.926 . . . . 0.0 111.509 175.375 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.409 ' N ' HD13 ' A' ' 23' ' ' ILE . 6.0 mm -48.11 -42.77 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-N 125.388 3.722 . . . . 0.0 111.274 168.404 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -40.98 -65.76 0.4 Allowed 'General case' 0 N--CA 1.445 -0.686 1 C-N-CA 131.703 4.001 . . . . 0.0 112.884 163.107 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.07 -35.43 80.23 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 123.239 0.337 . . . . 0.0 110.613 179.653 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.29 68.7 t -57.04 -48.34 81.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 116.79 -1.576 . . . . 0.0 115.153 168.908 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 mtmt -46.71 -34.37 5.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 125.559 3.8 . . . . 0.0 117.543 161.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.5 -28.04 59.01 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 123.792 1.758 . . . . 0.0 112.725 177.628 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -79.7 -44.45 20.8 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 118.564 -2.585 . . . . 0.0 112.709 172.479 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mt -48.67 -49.17 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 120.732 1.605 . . . . 0.0 111.25 170.5 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -54.98 -53.77 51.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 167.2 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.88 -41.28 91.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 123.229 2.74 . . . . 0.0 109.65 -175.164 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -76.17 -27.78 57.09 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 118.34 2.719 . . . . 0.0 118.34 179.916 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.294 21.0 mm-40 -140.11 2.96 1.95 Allowed 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 122.903 2.592 . . . . 0.0 109.97 -175.734 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.42 -3.54 86.44 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 117.937 -2.977 . . . . 0.0 116.495 162.925 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.61 146.65 61.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-O 115.568 -2.158 . . . . 0.0 107.136 -167.396 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -78.11 132.27 11.44 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.062 3.175 . . . . 0.0 103.932 -178.081 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -80.77 -18.34 9.22 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 CA-C-N 124.098 2.499 . . . . 0.0 112.84 -170.413 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.34 -22.42 44.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 118.006 -1.477 . . . . 0.0 114.831 -170.111 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -82.76 -16.67 47.02 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 126.633 1.973 . . . . 0.0 114.432 172.396 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -73.87 130.22 39.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 126.623 1.969 . . . . 0.0 111.967 174.418 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -96.16 144.81 26.06 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.927 2.491 . . . . 0.0 107.323 155.585 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.1 tp -142.93 115.03 8.33 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 130.538 3.535 . . . . 0.0 111.088 -164.946 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.25 46.5 pt -134.74 142.83 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 1 C-N-CA 132.336 4.254 . . . . 0.0 114.045 -159.052 . . . . . . . . 3 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -138.02 96.55 3.23 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.199 2.6 . . . . 0.0 105.79 178.451 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 77.25 21.66 1.05 Allowed 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.12 -1.612 . . . . 0.0 107.716 162.064 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.36 -40.4 2.46 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 119.642 -1.266 . . . . 0.0 113.883 -175.157 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.319 51.1 mttm -82.04 132.53 35.25 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 119.257 -2.319 . . . . 0.0 110.916 -171.883 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -82.01 128.27 33.93 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 119.296 0.953 . . . . 0.0 109.422 170.992 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -82.19 115.92 21.51 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 103.79 -2.67 . . . . 0.0 103.79 178.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -75.96 135.95 40.04 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.143 -3.473 . . . . 0.0 107.511 -177.902 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -58.0 119.9 7.59 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.24 2.216 . . . . 0.0 111.652 178.363 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.47 6.51 41.28 Favored Glycine 0 CA--C 1.525 0.685 1 C-N-CA 130.906 4.098 . . . . 0.0 114.617 171.146 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -86.32 154.11 21.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 125.423 1.307 . . . . 0.0 110.421 169.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.7 p -76.86 145.02 38.62 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 127.027 2.704 . . . . 0.0 115.522 171.438 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.6 mt -59.51 -29.96 68.25 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 127.947 2.499 . . . . 0.0 112.473 172.602 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.7 t -52.44 -59.04 4.91 Favored 'General case' 0 N--CA 1.446 -0.626 1 C-N-CA 132.821 4.448 . . . . 0.0 110.515 168.503 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -50.55 -41.69 54.38 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 118.827 2.899 . . . . 0.0 118.827 170.093 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -88.53 -0.62 57.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 119.136 0.88 . . . . 0.0 109.951 -179.859 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m120 62.26 39.1 12.85 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 129.316 3.046 . . . . 0.0 115.155 -175.442 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 8.8 mm -85.81 121.84 37.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -171.425 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.8 mm100 -103.75 169.01 8.77 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 111.593 -2.549 . . . . 0.0 114.556 -176.179 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 16.8 pttp -58.73 135.1 57.35 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 112.37 -3.681 . . . . 0.0 113.065 -176.333 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 65.1 19.12 11.73 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.521 3.129 . . . . 0.0 116.253 -178.559 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.9 m -70.17 141.66 52.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.725 3.21 . . . . 0.0 109.485 160.729 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.3 m -107.52 129.33 54.98 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 103.705 -2.702 . . . . 0.0 103.705 175.804 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.7 mp -97.69 154.18 17.74 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 129.525 3.13 . . . . 0.0 106.846 171.049 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -125.27 163.85 21.61 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 126.801 2.04 . . . . 0.0 110.861 -175.158 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.413 ' HG ' ' H ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -134.72 160.09 39.24 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.103 -2.317 . . . . 0.0 116.326 -176.216 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.413 ' H ' ' HG ' ' A' ' 69' ' ' LEU . 23.0 t -151.83 150.68 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 O-C-N 128.387 3.554 . . . . 0.0 105.982 166.512 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.259 53.2 mt -107.11 151.35 25.5 Favored 'General case' 0 N--CA 1.443 -0.811 0 O-C-N 119.121 -2.237 . . . . 0.0 111.453 176.483 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -46.19 -52.42 12.37 Favored 'General case' 0 C--N 1.325 -0.497 1 CA-C-O 129.833 4.635 . . . . 0.0 109.511 175.556 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.4 147.35 36.05 Favored 'General case' 0 N--CA 1.447 -0.61 2 C-N-CA 134.39 5.076 . . . . 0.0 110.555 170.366 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -110.81 -30.98 7.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.47 1.908 . . . . 0.0 110.695 164.215 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.55 126.23 4.6 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 127.118 2.761 . . . . 0.0 109.571 179.584 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.231 0 CA-C-O 116.372 -2.349 . . . . 0.0 108.911 172.434 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' N ' ' OE2' ' A' ' 16' ' ' GLU 0.251 45.7 ttp . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -81.55 156.68 25.1 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 178.535 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.9 pt -146.24 174.46 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 1 O-C-N 129.204 4.065 . . . . 0.0 105.944 174.173 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -131.06 153.38 49.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 117.167 -1.397 . . . . 0.0 110.309 164.024 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -130.12 114.74 30.36 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 101.699 -3.445 . . . . 0.0 101.699 172.001 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -80.99 133.96 35.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 127.166 2.186 . . . . 0.0 106.244 174.452 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 60.8 p -75.13 175.48 8.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 129.977 3.311 . . . . 0.0 111.772 164.944 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.88 -9.21 49.85 Favored 'General case' 0 N--CA 1.441 -0.897 0 O-C-N 118.151 -2.843 . . . . 0.0 110.671 172.044 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.5 p -99.57 4.31 45.79 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-O 117.023 -1.465 . . . . 0.0 111.777 -179.441 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.74 -25.34 7.64 Favored Glycine 0 CA--C 1.531 1.061 1 C-N-CA 131.902 4.573 . . . . 0.0 109.389 159.148 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.4 pttt -82.71 134.0 35.15 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 -153.502 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 m -95.36 110.63 22.62 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.275 1.83 . . . . 0.0 114.55 -178.333 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mt -84.74 120.82 35.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 O-C-N 118.648 -2.532 . . . . 0.0 105.738 -176.39 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -77.47 121.24 23.56 Favored 'General case' 0 C--N 1.324 -0.519 1 O-C-N 114.558 -5.089 . . . . 0.0 103.508 175.91 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.299 69.3 mt -125.02 152.58 44.06 Favored 'General case' 0 N--CA 1.446 -0.645 1 CA-C-N 126.294 4.134 . . . . 0.0 108.059 169.97 . . . . . . . . 3 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.444 ' OE2' ' N ' ' A' ' 1' ' ' MET . 32.0 tp10 -99.88 132.43 45.23 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 173.353 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.77 167.0 24.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 127.426 3.489 . . . . 0.0 105.72 172.512 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.41 140.13 28.71 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 110.747 -2.933 . . . . 0.0 106.408 155.518 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.363 46.3 Cg_endo -59.93 -4.48 2.88 Favored 'Trans proline' 0 N--CA 1.45 -1.032 1 C-N-CA 126.742 4.961 . . . . 0.0 117.005 -173.052 . . . . . . . . 3 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 53.4 p -88.58 -6.34 57.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 113.239 -3.267 . . . . 0.0 114.591 165.468 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -68.47 140.44 55.73 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 125.971 2.045 . . . . 0.0 106.777 179.691 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 78.6 p -73.93 163.37 28.01 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 116.527 -1.701 . . . . 0.0 109.631 170.891 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.0 mm -60.93 -37.14 76.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 CA-C-O 124.211 1.958 . . . . 0.0 107.086 175.508 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.395 0.0 OUTLIER -46.2 -45.03 16.63 Favored 'General case' 0 N--CA 1.448 -0.525 0 O-C-N 118.322 -2.736 . . . . 0.0 115.348 171.357 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -67.88 -33.89 75.6 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 128.041 2.536 . . . . 0.0 109.126 -179.909 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.258 89.0 t -67.88 -52.92 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 C-N-CA 126.169 1.787 . . . . 0.0 113.079 166.707 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -48.67 -41.14 30.51 Favored 'General case' 0 N--CA 1.442 -0.842 1 N-CA-C 122.123 4.119 . . . . 0.0 122.123 171.398 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -73.25 -35.32 66.21 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.721 2.008 . . . . 0.0 112.506 176.429 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.3 mttt -67.56 -30.8 70.52 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 176.784 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 72.6 mt -70.92 -43.49 76.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 130.359 3.464 . . . . 0.0 109.655 170.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -51.83 -55.34 20.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 125.806 2.717 . . . . 0.0 113.566 168.114 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -57.19 -27.49 62.0 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.552 3.141 . . . . 0.0 113.925 -173.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -97.7 -66.52 0.9 Allowed 'General case' 0 C--N 1.33 -0.255 0 O-C-N 119.45 -2.032 . . . . 0.0 110.993 172.51 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -92.01 -17.85 24.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 120.935 1.698 . . . . 0.0 113.392 -165.381 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.83 -10.95 32.3 Favored Glycine 0 CA--C 1.535 1.328 0 O-C-N 116.765 -3.709 . . . . 0.0 119.33 172.276 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 73.6 mt -86.07 129.39 54.18 Favored Pre-proline 0 C--N 1.324 -0.541 0 O-C-N 117.541 -3.329 . . . . 0.0 112.043 -160.428 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 20.4 Cg_endo -76.95 137.96 18.03 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 125.281 3.987 . . . . 0.0 111.719 -166.761 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -39.56 -53.47 2.23 Favored 'Trans proline' 0 N--CA 1.446 -1.318 1 C-N-CA 126.863 5.042 . . . . 0.0 111.985 172.408 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -76.37 10.06 2.27 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 124.558 3.344 . . . . 0.0 113.464 -172.335 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -103.85 -28.8 11.39 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 122.602 1.191 . . . . 0.0 113.367 162.318 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -80.38 149.74 30.09 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 120.295 -1.503 . . . . 0.0 113.658 -168.13 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -135.04 118.91 17.29 Favored 'General case' 0 N--CA 1.451 -0.388 1 C-N-CA 132.164 4.186 . . . . 0.0 109.131 164.552 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.266 59.9 mt -100.0 132.16 45.52 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.692 0.797 . . . . 0.0 112.462 167.597 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.2 mm -109.63 124.75 66.59 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 101.068 -3.678 . . . . 0.0 101.068 -175.586 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -117.79 113.89 22.48 Favored 'General case' 0 N--CA 1.444 -0.761 1 N-CA-C 98.63 -4.582 . . . . 0.0 98.63 174.557 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 45.22 52.36 8.68 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 111.353 -2.658 . . . . 0.0 117.376 170.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.48 -0.88 81.22 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 116.883 -2.065 . . . . 0.0 111.673 167.183 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.6 pttt -126.96 154.12 44.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 125.0 1.32 . . . . 0.0 111.166 177.996 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -91.89 118.47 30.76 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 110.137 -3.21 . . . . 0.0 105.001 -175.077 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 48.4 mt -67.18 123.91 21.6 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 127.202 2.201 . . . . 0.0 107.472 172.719 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -85.65 143.19 28.55 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 175.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -71.66 155.66 40.25 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 126.107 2.129 . . . . 0.0 110.635 -171.299 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.29 -2.98 85.48 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 128.187 2.803 . . . . 0.0 114.507 174.414 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.376 0.9 OUTLIER -99.8 164.76 11.9 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 125.506 1.522 . . . . 0.0 109.615 173.893 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.263 64.8 p -99.66 171.49 7.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 126.852 3.215 . . . . 0.0 110.371 169.473 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mp -42.73 -51.98 5.12 Favored 'General case' 0 N--CA 1.446 -0.657 1 C-N-CA 131.772 4.029 . . . . 0.0 114.951 163.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 p -75.17 -12.44 60.3 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 176.498 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -80.85 -42.33 21.74 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 119.224 -2.172 . . . . 0.0 107.339 172.888 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.29 10.12 41.42 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.557 1.943 . . . . 0.0 112.705 -166.352 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.362 71.0 m-80 91.1 12.08 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.192 1.797 . . . . 0.0 114.612 159.843 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.27 55.3 mt -71.33 135.73 27.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 -171.198 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.523 0.4 OUTLIER -122.86 162.91 21.29 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.568 2.347 . . . . 0.0 114.404 175.175 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -49.6 126.84 14.42 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 121.468 1.94 . . . . 0.0 114.46 171.547 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.355 16.3 tt0 81.78 0.42 1.52 Allowed 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 130.985 3.714 . . . . 0.0 113.212 176.94 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 m -61.55 145.74 51.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 119.719 -1.863 . . . . 0.0 113.638 166.823 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.3 m -125.79 109.27 12.34 Favored 'General case' 0 N--CA 1.451 -0.417 1 O-C-N 132.394 6.059 . . . . 0.0 110.614 -160.525 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.326 10.9 mp -106.04 170.71 7.75 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 -176.622 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -121.92 142.39 50.33 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.407 3.083 . . . . 0.0 105.641 177.487 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.6 tp -102.51 128.42 49.16 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 -178.043 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -111.88 150.7 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 O-C-N 124.407 1.067 . . . . 0.0 109.204 163.626 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.6 mt -113.47 157.38 22.05 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 117.054 -3.529 . . . . 0.0 114.928 168.984 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.1 ttm-85 -95.92 155.89 16.56 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.54 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 tt -86.46 132.72 33.86 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.528 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.258 42.8 ttt85 -134.6 -48.91 0.76 Allowed 'General case' 0 CA--C 1.534 0.338 0 O-C-N 127.122 2.764 . . . . 0.0 112.663 -174.653 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.87 9.17 7.66 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.923 1.725 . . . . 0.0 113.044 164.862 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.197 0 CA-C-O 118.022 -1.432 . . . . 0.0 113.692 179.228 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.47 0.559 0 N-CA-C 103.593 -2.744 . . . . 0.0 103.593 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -90.47 128.23 36.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 115.658 -2.115 . . . . 0.0 110.241 -172.316 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.1 pp -116.25 148.74 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 1 CA-C-N 126.012 4.006 . . . . 0.0 109.262 168.596 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -105.76 113.32 26.8 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -172.48 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 79.8 t -95.14 115.65 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 1 N-CA-C 99.574 -4.232 . . . . 0.0 99.574 168.308 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -99.19 133.03 44.06 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.904 174.111 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 47.2 p -121.47 140.2 52.49 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 -171.882 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 mt -62.66 -40.9 98.5 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.577 2.351 . . . . 0.0 109.994 171.253 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.265 23.8 p -71.53 8.63 1.03 Allowed 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 176.453 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.58 18.02 2.27 Favored Glycine 0 CA--C 1.537 1.42 0 CA-C-O 117.112 -1.938 . . . . 0.0 112.424 118.581 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 39.8 pttt -138.42 153.92 48.88 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 129.373 3.069 . . . . 0.0 111.458 -176.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 44.2 p -99.61 106.16 18.09 Favored 'General case' 0 N--CA 1.446 -0.653 1 C-N-CA 135.148 5.379 . . . . 0.0 109.799 174.935 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.0 mt -101.84 105.76 18.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 2 N-CA-C 98.685 -4.561 . . . . 0.0 98.685 -167.75 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.2 p -92.96 89.25 6.47 Favored 'General case' 0 N--CA 1.452 -0.35 0 O-C-N 119.377 -2.077 . . . . 0.0 113.015 -176.469 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.1 tp -73.54 133.86 43.67 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 131.603 3.961 . . . . 0.0 104.063 -178.211 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -96.33 122.45 39.23 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 129.375 3.07 . . . . 0.0 104.515 168.336 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.3 135.59 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 128.805 2.842 . . . . 0.0 115.761 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -72.59 149.11 90.71 Favored Pre-proline 0 N--CA 1.45 -0.469 0 O-C-N 119.535 -1.978 . . . . 0.0 106.884 175.532 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.03 15.77 0.18 Allowed 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.87 2.38 . . . . 0.0 113.123 -172.455 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.268 67.4 p -135.41 18.11 3.37 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 120.867 1.667 . . . . 0.0 113.58 175.575 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -81.04 118.03 22.14 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-O 115.813 -2.041 . . . . 0.0 112.747 -167.026 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.2 p -88.01 148.4 24.55 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 122.084 2.22 . . . . 0.0 107.427 -165.034 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.429 6.0 mt -45.03 -39.92 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 113.405 -3.188 . . . . 0.0 118.175 -174.395 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -59.95 -45.08 93.8 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 125.508 1.755 . . . . 0.0 112.739 170.82 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -71.75 -9.16 57.87 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 125.848 1.659 . . . . 0.0 110.594 -176.736 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -86.89 -29.07 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 127.104 2.161 . . . . 0.0 111.88 172.584 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -68.85 -32.36 71.98 Favored 'General case' 0 N--CA 1.452 -0.354 0 O-C-N 118.91 -2.369 . . . . 0.0 113.854 -179.77 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.01 -21.1 47.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 111.982 -2.372 . . . . 0.0 108.519 -176.055 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.31 -39.24 17.91 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 113.039 -3.362 . . . . 0.0 105.925 174.29 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 8.6 mt -58.36 -34.46 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 1 CA-C-N 127.394 4.633 . . . . 0.0 115.288 169.358 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -83.6 -3.31 57.59 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 127.935 2.494 . . . . 0.0 110.018 -176.521 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -101.63 -45.25 5.32 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 126.184 1.793 . . . . 0.0 106.691 166.164 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.27 48.5 tptt -74.46 -37.58 63.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 117.137 -1.411 . . . . 0.0 110.519 -167.361 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -121.41 -24.85 5.31 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 123.679 2.945 . . . . 0.0 108.787 -179.923 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.02 14.01 65.36 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 121.994 2.179 . . . . 0.0 110.901 175.025 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.3 mt -74.04 131.84 80.68 Favored Pre-proline 0 N--CA 1.44 -0.949 0 C-N-CA 128.482 2.713 . . . . 0.0 108.329 169.487 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -78.2 162.65 28.39 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 N-CA-C 116.549 1.711 . . . . 0.0 116.549 -177.492 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -67.47 -16.54 47.66 Favored 'Trans proline' 0 N--CA 1.442 -1.525 0 N-CA-C 119.364 2.794 . . . . 0.0 119.364 -177.084 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -95.95 -2.89 46.18 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.435 -179.559 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -117.26 -15.39 10.42 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 112.467 -3.635 . . . . 0.0 115.038 177.517 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -67.55 138.03 56.19 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 130.536 3.534 . . . . 0.0 108.694 174.457 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -127.63 150.96 49.51 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 104.003 -2.591 . . . . 0.0 104.003 146.939 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.401 0.8 OUTLIER -139.8 133.78 30.86 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 173.675 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -127.55 144.4 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 104.564 -2.384 . . . . 0.0 104.564 -165.981 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -125.28 137.9 54.09 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.019 162.211 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.289 . . 56.92 28.45 14.67 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 118.797 2.888 . . . . 0.0 118.797 169.084 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.71 -17.64 58.74 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 128.919 3.152 . . . . 0.0 112.707 -171.499 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -103.87 122.27 44.8 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 121.522 2.661 . . . . 0.0 109.717 -161.351 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 113.12 6.55 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.421 1.889 . . . . 0.0 107.781 166.0 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 60.3 mt -71.27 131.55 43.64 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 131.692 3.997 . . . . 0.0 108.198 -172.194 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -106.33 129.35 54.36 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 112.545 -3.597 . . . . 0.0 109.587 176.453 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.66 146.8 24.34 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 127.405 2.94 . . . . 0.0 109.316 179.029 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.31 -21.01 22.66 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 128.073 2.749 . . . . 0.0 114.762 173.798 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -88.99 153.77 20.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 178.418 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 63.4 p -86.25 175.8 8.28 Favored 'General case' 0 N--CA 1.443 -0.783 0 O-C-N 126.251 2.22 . . . . 0.0 112.282 168.993 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 34.7 mt -58.48 -39.9 81.23 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 128.48 2.712 . . . . 0.0 111.108 176.757 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.3 t -53.05 -51.41 61.85 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 126.308 1.843 . . . . 0.0 112.241 179.65 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -46.39 -34.53 4.71 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 129.546 3.138 . . . . 0.0 115.285 -179.065 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -111.77 -12.42 13.84 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 125.32 1.638 . . . . 0.0 108.284 -170.989 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.542 ' HA ' HE21 ' A' ' 62' ' ' GLN . 14.1 t-20 82.77 46.11 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.671 1 C-N-CA 131.951 4.1 . . . . 0.0 108.404 166.568 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.262 19.8 mt -98.63 91.54 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 102.288 -3.227 . . . . 0.0 102.288 174.617 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.542 HE21 ' HA ' ' A' ' 60' ' ' ASN . 91.1 mm-40 -98.96 -4.12 33.43 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 114.652 -2.594 . . . . 0.0 112.11 -169.762 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.292 0.0 OUTLIER 134.42 161.06 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.862 1 C-N-CA 134.338 5.055 . . . . 0.0 105.702 176.948 . . . . . . . . 4 3 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 71.57 -31.71 0.23 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 114.964 -2.446 . . . . 0.0 113.505 172.29 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.8 m -27.3 133.24 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.547 1 C-N-CA 135.366 5.466 . . . . 0.0 111.872 173.928 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.2 m -89.64 108.52 19.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 120.613 -1.305 . . . . 0.0 111.159 172.457 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.6 mp -87.86 154.72 20.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.04 2.536 . . . . 0.0 114.838 162.967 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -125.14 121.17 33.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.817 2.047 . . . . 0.0 106.421 -179.566 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.7 tp -86.96 136.86 32.78 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 115.872 -2.013 . . . . 0.0 109.522 171.596 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 m -140.24 166.59 19.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 126.463 2.352 . . . . 0.0 108.13 -179.583 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.14 149.15 23.83 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 119.995 1.27 . . . . 0.0 113.655 174.293 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.4 ttt180 -76.93 84.43 3.48 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.789 2.436 . . . . 0.0 109.018 173.04 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 55.8 mt -86.04 -2.33 58.21 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 124.866 2.27 . . . . 0.0 115.743 -165.197 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -139.04 -56.51 0.6 Allowed 'General case' 0 N--CA 1.451 -0.413 0 O-C-N 117.241 -3.412 . . . . 0.0 110.527 -167.262 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 114.07 48.78 0.56 Allowed Glycine 0 CA--C 1.532 1.097 0 N-CA-C 107.501 -2.24 . . . . 0.0 107.501 -176.753 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.284 0 N-CA-C 104.046 -3.622 . . . . 0.0 104.046 -174.524 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.0 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 115.24 -2.314 . . . . 0.0 107.819 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -91.62 125.56 36.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 128.34 3.525 . . . . 0.0 110.104 179.926 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -122.03 136.87 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 O-C-N 119.422 -2.048 . . . . 0.0 111.935 158.433 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -90.53 133.13 35.28 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 104.219 -2.511 . . . . 0.0 104.219 172.235 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.2 t -117.55 110.64 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 102.631 -3.1 . . . . 0.0 102.631 174.269 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 tttp -97.77 143.65 28.18 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 128.115 3.384 . . . . 0.0 106.136 -177.572 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 49.5 p -112.97 149.51 33.16 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 129.166 2.987 . . . . 0.0 114.428 177.254 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -42.87 -34.81 1.02 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.612 2.765 . . . . 0.0 117.869 -171.519 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 43.6 p -74.3 -24.83 59.28 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 125.329 1.643 . . . . 0.0 112.969 179.398 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.85 -7.68 15.09 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.362 2.41 . . . . 0.0 118.362 -175.172 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -64.77 145.54 56.1 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.749 2.02 . . . . 0.0 106.481 173.863 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.5 m -137.19 132.68 34.23 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 112.63 -2.077 . . . . 0.0 105.679 -172.079 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.3 mt -93.41 109.42 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 129.904 3.282 . . . . 0.0 107.717 162.494 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.3 m -74.75 119.42 18.92 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 128.171 2.588 . . . . 0.0 106.603 162.743 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -128.17 158.43 38.08 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -177.156 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -124.96 121.12 33.53 Favored 'General case' 0 C--O 1.221 -0.424 1 N-CA-C 99.756 -4.164 . . . . 0.0 99.756 -178.009 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.8 m -152.18 147.9 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 126.572 1.949 . . . . 0.0 108.585 -165.325 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.599 ' O ' ' HB2' ' A' ' 21' ' ' ASP 0.263 1.6 tm-20 -84.3 135.94 40.97 Favored Pre-proline 0 C--O 1.219 -0.516 0 O-C-N 125.817 1.948 . . . . 0.0 107.342 173.142 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -56.37 -26.81 64.4 Favored 'Trans proline' 0 N--CA 1.444 -1.43 1 C-N-CA 126.384 4.722 . . . . 0.0 110.92 179.386 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.2 p -95.34 6.47 48.92 Favored 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 116.503 -3.873 . . . . 0.0 114.083 -177.497 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 18' ' ' GLU . 66.1 m-20 -68.18 132.35 47.01 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 111.662 -2.517 . . . . 0.0 111.248 160.704 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.6 p -95.52 157.4 15.91 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 116.635 -1.65 . . . . 0.0 107.335 -173.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.3 mm -36.62 -54.25 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 112.243 -3.742 . . . . 0.0 109.863 173.786 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -68.93 -23.13 64.13 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 125.611 3.823 . . . . 0.0 111.248 -170.713 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -77.7 -44.64 27.28 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 128.185 2.594 . . . . 0.0 110.722 -179.748 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.0 t -60.35 -46.59 94.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 117.709 2.485 . . . . 0.0 117.709 170.511 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.361 37.9 mtpt -46.73 -49.79 19.05 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 112.912 -1.949 . . . . 0.0 116.105 173.363 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.12 -31.68 68.06 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 129.042 2.937 . . . . 0.0 113.223 175.742 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.4 mttt -67.82 -37.51 82.03 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 126.545 1.938 . . . . 0.0 109.354 173.257 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.3 mt -65.91 -30.31 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-N 121.842 2.11 . . . . 0.0 110.254 168.042 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -69.72 -35.56 75.14 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 116.769 -1.972 . . . . 0.0 111.705 179.728 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -68.26 -43.85 76.91 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 127.565 2.346 . . . . 0.0 109.334 178.787 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.324 12.6 mmtt -66.09 -42.04 89.85 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 117.037 -3.539 . . . . 0.0 115.451 178.532 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -140.87 -19.49 0.82 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 116.632 -1.652 . . . . 0.0 113.278 -156.372 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.79 5.89 83.41 Favored Glycine 0 CA--C 1.524 0.654 1 CA-C-O 112.78 -4.344 . . . . 0.0 109.314 172.515 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.2 mt -69.08 128.25 92.74 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-N 123.445 3.623 . . . . 0.0 108.771 174.41 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -54.59 144.87 61.71 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.57 2.18 . . . . 0.0 113.911 173.138 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -72.35 -55.2 0.12 Allowed 'Trans proline' 0 N--CA 1.446 -1.293 0 CA-C-N 123.423 2.258 . . . . 0.0 109.381 -170.006 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.16 -29.64 23.08 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 127.621 2.368 . . . . 0.0 112.17 -176.341 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 tt0 -68.31 -31.86 71.59 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 114.432 -2.699 . . . . 0.0 110.223 179.182 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -73.81 138.9 44.78 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 123.597 2.908 . . . . 0.0 112.474 -173.055 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.42 52.6 mtt180 -104.73 134.08 48.48 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 119.563 -1.961 . . . . 0.0 112.557 141.691 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mp -88.28 114.23 24.68 Favored 'General case' 0 N--CA 1.443 -0.8 1 C-N-CA 134.14 4.976 . . . . 0.0 107.134 174.237 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 23.8 mt -111.76 140.09 32.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 126.602 1.961 . . . . 0.0 111.551 168.331 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -152.06 148.24 27.45 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 131.421 3.888 . . . . 0.0 105.635 160.829 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.398 . . 69.48 30.28 4.12 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 130.382 3.473 . . . . 0.0 112.773 163.689 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.64 12.9 60.31 Favored Glycine 0 CA--C 1.539 1.553 0 CA-C-N 109.678 -3.419 . . . . 0.0 116.148 168.43 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -148.29 164.53 33.73 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 103.295 -2.854 . . . . 0.0 103.295 -168.257 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -76.25 130.87 38.82 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 124.936 2.303 . . . . 0.0 105.726 162.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -77.45 147.62 35.84 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 113.288 -1.778 . . . . 0.0 106.792 165.748 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -104.82 136.63 43.95 Favored 'General case' 0 C--N 1.324 -0.538 1 C-N-CA 134.624 5.17 . . . . 0.0 110.798 -178.185 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -62.55 126.16 26.4 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 130.789 3.635 . . . . 0.0 116.653 -179.361 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 121.32 -24.89 7.18 Favored Glycine 0 CA--C 1.526 0.746 0 O-C-N 119.337 -2.102 . . . . 0.0 113.295 -178.288 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.0 mtt180 -95.09 140.57 29.84 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 105.351 -2.092 . . . . 0.0 105.351 -172.866 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.6 p -70.2 157.15 38.16 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 117.354 2.353 . . . . 0.0 117.354 167.841 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.3 mt -54.57 -33.67 60.64 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 116.88 -1.533 . . . . 0.0 112.881 168.892 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 47.3 p -64.21 -37.59 88.01 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 127.244 2.218 . . . . 0.0 111.957 174.523 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -64.66 -29.39 70.39 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 128.678 2.791 . . . . 0.0 109.723 179.052 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.93 -5.77 30.06 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.361 1.465 . . . . 0.0 112.852 -173.74 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.378 68.1 m-80 97.31 9.82 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 O-C-N 127.029 2.706 . . . . 0.0 110.738 165.791 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 19.9 mt -85.83 117.57 30.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 118.906 -2.371 . . . . 0.0 106.926 -154.171 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.41 23.4 tt0 -90.29 172.27 8.89 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 112.317 -2.22 . . . . 0.0 111.77 175.569 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.95 140.03 2.83 Favored 'General case' 0 N--CA 1.445 -0.685 1 O-C-N 129.467 4.229 . . . . 0.0 114.603 174.739 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 56.57 38.85 29.93 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 128.796 2.838 . . . . 0.0 111.696 170.61 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 11.0 m -81.69 139.17 35.08 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 110.044 -3.253 . . . . 0.0 103.263 169.687 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.4 m -103.98 112.46 25.45 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 114.786 -2.531 . . . . 0.0 105.363 174.662 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.57 159.41 24.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.67 3.188 . . . . 0.0 110.865 -177.041 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -116.82 152.99 33.27 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -156.485 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.3 tp -137.68 136.47 37.45 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 119.936 1.243 . . . . 0.0 110.29 179.307 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 20.1 t -123.31 119.26 57.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 C-N-CA 126.244 1.818 . . . . 0.0 109.991 174.583 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 74.0 mt -89.73 126.42 35.65 Favored 'General case' 0 CA--C 1.53 0.195 0 O-C-N 118.946 -2.346 . . . . 0.0 105.089 -179.231 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.5 mtp180 -83.31 -176.07 6.14 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 128.494 2.718 . . . . 0.0 108.206 177.292 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' O ' ' CB ' ' A' ' 74' ' ' ARG . 44.3 mt -97.32 132.02 43.45 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 116.606 -3.809 . . . . 0.0 110.465 168.871 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.444 ' CB ' ' O ' ' A' ' 73' ' ' LEU . 39.4 ttp180 124.68 106.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 1 C-N-CA 134.245 5.018 . . . . 0.0 108.828 -174.186 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.46 148.66 8.78 Favored Glycine 0 CA--C 1.526 0.763 2 C-N-CA 132.619 4.914 . . . . 0.0 113.444 -168.478 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.755 1 N-CA-C 101.034 -4.826 . . . . 0.0 101.034 169.651 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ptt? . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mp0 -88.14 154.72 20.23 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 119.691 -1.88 . . . . 0.0 110.412 171.766 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 pt -139.53 159.19 28.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 130.681 3.592 . . . . 0.0 109.786 160.873 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.51 116.61 29.84 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 118.486 -2.634 . . . . 0.0 108.42 174.61 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -92.91 136.08 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 176.798 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -117.8 112.61 20.63 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.953 1.701 . . . . 0.0 109.564 -173.741 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -62.65 175.68 0.77 Allowed 'General case' 0 N--CA 1.441 -0.876 0 CA-C-O 124.542 2.115 . . . . 0.0 109.176 -178.321 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tt -70.0 -31.69 69.49 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 117.785 -3.072 . . . . 0.0 114.004 174.519 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.317 18.4 p -81.09 -16.52 52.9 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 129.845 3.258 . . . . 0.0 109.506 -178.493 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.92 -1.16 30.17 Favored Glycine 0 CA--C 1.534 1.25 0 O-C-N 117.076 -3.515 . . . . 0.0 111.285 167.259 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.257 70.8 tttt -69.05 156.25 38.97 Favored 'General case' 0 N--CA 1.45 -0.47 2 C-N-CA 132.308 4.243 . . . . 0.0 108.009 173.275 . . . . . . . . 3 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.3 m -133.01 130.77 39.89 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 113.632 -3.08 . . . . 0.0 111.339 -170.902 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.1 pt -131.93 139.28 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 129.548 3.139 . . . . 0.0 106.972 173.243 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.4 m -89.51 114.21 25.7 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 104.683 -2.339 . . . . 0.0 104.683 173.381 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mp -95.19 153.7 17.54 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 126.235 2.209 . . . . 0.0 105.599 167.643 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -116.44 132.29 56.72 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 113.395 -3.193 . . . . 0.0 111.078 169.39 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -153.34 -178.09 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 102.887 -3.005 . . . . 0.0 102.887 -162.266 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -144.28 156.49 57.55 Favored Pre-proline 0 C--N 1.327 -0.386 0 C-N-CA 131.218 3.807 . . . . 0.0 102.676 166.542 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -49.14 -28.48 14.4 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 N-CA-C 116.147 1.557 . . . . 0.0 116.147 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 p -68.82 -18.98 64.26 Favored 'General case' 0 C--O 1.242 0.687 0 C-N-CA 128.816 2.846 . . . . 0.0 115.726 178.414 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.413 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS 0.275 2.0 m-20 -51.29 121.93 7.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 122.567 2.439 . . . . 0.0 112.637 173.386 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.1 p -65.97 156.49 33.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.632 3.173 . . . . 0.0 109.465 168.684 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.2 mm -61.83 -40.6 87.6 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 O-C-N 125.034 1.459 . . . . 0.0 110.637 171.902 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -73.36 -25.83 60.76 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 122.25 2.295 . . . . 0.0 109.039 -172.771 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.267 16.8 t-20 -71.77 -44.33 64.21 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 117.168 -3.458 . . . . 0.0 109.501 173.909 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.7 m -68.25 -27.58 37.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 O-C-N 117.585 -3.197 . . . . 0.0 110.738 179.439 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -66.09 -24.45 66.71 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 122.575 1.179 . . . . 0.0 114.072 169.07 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.8 -38.42 58.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 115.151 -2.357 . . . . 0.0 111.019 167.595 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.413 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP . 43.1 mttp -64.26 -42.87 96.28 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 129.897 3.279 . . . . 0.0 110.558 178.85 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.63 -27.88 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 O-C-N 126.268 2.23 . . . . 0.0 109.112 177.114 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -74.17 -44.94 51.53 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 124.273 1.987 . . . . 0.0 108.733 172.272 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.59 -40.14 74.76 Favored 'General case' 0 N--CA 1.446 -0.654 1 O-C-N 112.911 -6.118 . . . . 0.0 120.869 168.235 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.7 mmtm -70.68 -53.32 16.17 Favored 'General case' 0 N--CA 1.446 -0.666 0 C-N-CA 127.497 2.319 . . . . 0.0 110.381 -178.178 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -133.63 6.12 3.74 Favored 'General case' 0 C--N 1.32 -0.688 0 O-C-N 117.627 -3.171 . . . . 0.0 112.895 -166.117 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.67 12.54 77.99 Favored Glycine 0 CA--C 1.531 1.081 0 O-C-N 118.273 -2.767 . . . . 0.0 118.002 177.643 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.9 mt -82.66 120.65 76.95 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 122.971 3.385 . . . . 0.0 112.301 174.19 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -61.32 147.77 94.67 Favored 'Trans proline' 0 N--CA 1.443 -1.473 0 N-CA-C 106.208 -2.266 . . . . 0.0 106.208 -179.775 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -43.23 -48.73 7.84 Favored 'Trans proline' 0 N--CA 1.441 -1.601 1 C-N-CA 125.949 4.433 . . . . 0.0 117.601 170.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -77.02 -13.0 60.01 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 116.566 2.062 . . . . 0.0 116.566 -170.552 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 mm100 -93.76 10.09 34.42 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 125.441 1.497 . . . . 0.0 113.225 -176.659 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -130.05 165.92 21.22 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 116.421 -3.925 . . . . 0.0 114.355 -176.557 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -143.84 129.7 19.4 Favored 'General case' 0 C--O 1.238 0.476 0 O-C-N 125.376 1.673 . . . . 0.0 112.99 176.571 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 33.7 mt -110.92 145.26 38.64 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 113.381 -1.736 . . . . 0.0 115.126 -165.843 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 pt -147.71 143.87 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 1 N-CA-C 99.113 -4.403 . . . . 0.0 99.113 -157.735 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -165.63 126.16 1.84 Allowed 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 161.728 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.56 36.32 13.88 Favored 'General case' 0 N--CA 1.444 -0.733 1 C-N-CA 132.827 4.451 . . . . 0.0 116.036 165.646 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.44 -11.5 65.1 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 118.558 -1.134 . . . . 0.0 113.513 175.348 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 24.6 mttt -111.61 133.52 53.81 Favored 'General case' 0 N--CA 1.449 -0.502 1 C-N-CA 133.682 4.793 . . . . 0.0 107.165 -173.616 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -84.82 124.58 31.74 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 128.396 3.56 . . . . 0.0 110.348 170.782 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.9 mt -90.06 115.66 27.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 123.706 1.717 . . . . 0.0 112.61 -168.175 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -87.83 141.23 28.75 Favored 'General case' 0 C--O 1.224 -0.264 0 C-N-CA 129.969 3.308 . . . . 0.0 115.033 -173.698 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -75.7 135.88 40.38 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-O 114.645 -2.598 . . . . 0.0 108.613 -173.921 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.96 -6.84 21.82 Favored Glycine 0 CA--C 1.534 1.278 0 CA-C-N 120.808 1.64 . . . . 0.0 111.225 -176.609 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 22.2 mmm-85 -106.82 154.89 20.36 Favored 'General case' 0 N--CA 1.452 -0.367 1 C-N-CA 132.71 4.404 . . . . 0.0 107.862 177.32 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 62.1 p -101.93 162.14 13.13 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 173.865 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.5 mt -61.97 -26.76 68.4 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 128.252 2.621 . . . . 0.0 112.459 -172.084 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -71.25 -24.87 62.26 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 128.147 2.579 . . . . 0.0 110.199 179.9 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.47 -50.19 72.44 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.573 3.149 . . . . 0.0 109.378 -178.223 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -90.92 12.86 18.22 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 128.266 3.479 . . . . 0.0 113.274 178.382 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 55.16 37.99 29.75 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 128.737 2.815 . . . . 0.0 115.881 -178.277 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.9 mt -74.01 121.36 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 122.651 2.478 . . . . 0.0 106.129 -175.198 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -88.1 164.93 15.48 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 124.378 2.037 . . . . 0.0 113.681 176.319 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.92 163.81 16.29 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 119.975 -1.703 . . . . 0.0 110.329 -174.372 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 46.47 10.47 0.01 OUTLIER 'General case' 0 C--O 1.236 0.359 0 N-CA-C 120.354 3.465 . . . . 0.0 120.354 176.183 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.285 71.0 m -75.49 154.49 36.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 119.394 -2.066 . . . . 0.0 107.842 174.524 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.4 m -95.68 110.06 22.24 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 104.258 -2.497 . . . . 0.0 104.258 176.306 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.17 125.56 43.26 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 173.716 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.2 m170 -82.14 148.76 28.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 129.869 3.268 . . . . 0.0 109.196 174.027 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.307 1.6 pp -131.55 167.43 19.4 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 166.32 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 78.2 t -123.88 140.66 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 103.126 -2.916 . . . . 0.0 103.126 -175.634 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.8 tp -86.68 121.22 28.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 104.62 -2.363 . . . . 0.0 104.62 163.917 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -72.12 -21.42 61.48 Favored 'General case' 0 N--CA 1.446 -0.668 1 C-N-CA 132.375 4.27 . . . . 0.0 111.411 -170.427 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.573 ' N ' HD13 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -142.18 145.82 34.59 Favored 'General case' 0 N--CA 1.451 -0.376 0 O-C-N 117.514 -3.241 . . . . 0.0 103.507 170.899 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 -144.34 111.72 6.0 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.598 1.159 . . . . 0.0 112.684 170.243 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 130.77 121.7 2.33 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 118.05 -2.024 . . . . 0.0 113.957 -175.26 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 1 C-N-CA 133.185 5.183 . . . . 0.0 110.668 171.461 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 ptt? . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 116.214 1.931 . . . . 0.0 116.214 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -81.69 144.26 31.29 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-O 123.382 1.563 . . . . 0.0 112.322 -177.906 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 11.2 pt -132.56 157.45 43.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 115.026 -2.416 . . . . 0.0 107.251 166.897 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -98.52 144.0 28.33 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 114.939 -2.458 . . . . 0.0 106.617 165.177 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.14 122.71 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 100.431 -3.914 . . . . 0.0 100.431 176.443 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -123.66 117.83 25.89 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 104.153 -2.536 . . . . 0.0 104.153 -170.799 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.9 m -80.66 144.86 31.96 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 118.644 -2.535 . . . . 0.0 106.208 -175.016 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -41.27 -34.43 0.49 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 118.033 2.605 . . . . 0.0 118.033 172.981 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -50.59 -37.87 42.36 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 118.239 -2.788 . . . . 0.0 116.841 164.811 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.85 9.68 8.11 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 127.188 2.328 . . . . 0.0 109.503 176.652 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -84.24 103.12 13.17 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.908 2.483 . . . . 0.0 104.725 -170.765 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 46.2 m -96.37 119.59 35.14 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.269 1.827 . . . . 0.0 112.874 -178.612 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.3 mm -130.79 145.78 35.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 111.238 -2.71 . . . . 0.0 109.826 -169.334 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.5 p -81.57 165.73 20.87 Favored 'General case' 0 C--O 1.237 0.42 1 O-C-N 114.777 -4.952 . . . . 0.0 114.922 172.929 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.265 2.4 tp -152.65 142.81 22.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.132 2.973 . . . . 0.0 109.441 172.042 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -95.23 117.52 30.4 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 128.282 2.633 . . . . 0.0 109.528 166.687 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.272 13.9 m -120.75 148.85 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 127.236 2.215 . . . . 0.0 108.909 179.136 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -91.45 136.14 27.19 Favored Pre-proline 0 C--O 1.233 0.234 0 N-CA-C 102.659 -3.089 . . . . 0.0 102.659 179.666 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.262 71.5 Cg_exo -41.4 -30.88 0.93 Allowed 'Trans proline' 0 N--CA 1.448 -1.199 1 N-CA-C 124.084 4.609 . . . . 0.0 124.084 166.53 . . . . . . . . 3 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -103.64 14.34 31.31 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.992 1.717 . . . . 0.0 113.678 176.241 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.408 ' OD1' ' ND2' ' A' ' 25' ' ' ASN 0.279 24.5 m-20 -66.91 139.77 57.74 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 128.704 2.802 . . . . 0.0 110.99 170.886 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -73.05 154.54 40.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.091 2.556 . . . . 0.0 107.124 168.185 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mp -69.73 -29.61 41.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 C-N-CA 130.252 3.421 . . . . 0.0 105.344 175.466 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 63.7 mt-10 -67.71 -36.48 80.7 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 116.85 -3.656 . . . . 0.0 112.989 164.574 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.408 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 5.4 t30 -67.92 -19.07 64.95 Favored 'General case' 0 N--CA 1.444 -0.774 1 CA-C-N 128.254 5.024 . . . . 0.0 113.14 164.285 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.4 t -77.76 -34.68 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-O 126.048 2.832 . . . . 0.0 114.633 172.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -70.18 -35.33 73.9 Favored 'General case' 0 CA--C 1.537 0.451 1 O-C-N 115.931 -4.231 . . . . 0.0 107.273 174.024 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.19 -33.05 71.68 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 115.699 1.741 . . . . 0.0 115.699 169.046 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -79.52 -27.54 41.35 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 116.02 -1.943 . . . . 0.0 108.658 179.765 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.6 mt -77.54 -38.74 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 125.046 1.467 . . . . 0.0 109.216 171.87 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -59.89 -30.29 68.9 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 118.524 -2.61 . . . . 0.0 111.291 176.535 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 33' ' ' LYS . 29.4 t70 -53.04 -37.41 61.53 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 127.041 2.136 . . . . 0.0 108.149 174.603 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.484 ' HD2' ' HB3' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -115.36 -44.64 2.97 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 125.982 1.713 . . . . 0.0 107.326 -169.336 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -94.34 -23.52 17.77 Favored 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 118.005 -2.934 . . . . 0.0 112.143 -172.521 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.07 27.9 47.66 Favored Glycine 0 CA--C 1.525 0.685 0 O-C-N 119.569 -1.957 . . . . 0.0 113.935 175.892 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.6 mt -104.84 124.25 37.4 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 113.728 -3.034 . . . . 0.0 107.45 -176.921 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.16 137.92 64.11 Favored 'Trans proline' 0 N--CA 1.451 -1.025 1 C-N-CA 125.582 4.188 . . . . 0.0 116.236 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -45.28 -30.48 5.34 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 O-C-N 125.553 2.344 . . . . 0.0 117.834 177.766 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.374 5.8 t70 -46.92 -43.31 18.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 119.09 -2.256 . . . . 0.0 116.075 178.276 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -110.24 -13.35 14.35 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 127.315 2.246 . . . . 0.0 105.558 -161.43 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -66.69 139.25 57.83 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 120.018 -1.676 . . . . 0.0 112.91 161.29 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -121.63 150.87 41.1 Favored 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.332 1.453 . . . . 0.0 113.217 157.612 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.356 5.8 mt -127.08 138.33 53.18 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 116.634 -3.791 . . . . 0.0 112.733 -179.283 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.366 98.4 mt -139.4 128.36 28.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 O-C-N 127.18 2.8 . . . . 0.0 112.07 -157.678 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -150.1 147.54 27.91 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.513 1.133 . . . . 0.0 108.945 152.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.365 . . 65.87 21.15 11.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 130.28 3.432 . . . . 0.0 112.537 177.478 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.35 -3.84 85.35 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.004 1.288 . . . . 0.0 113.477 -173.819 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -99.98 159.27 15.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 119.899 1.85 . . . . 0.0 107.229 -176.45 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.9 135.39 54.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 101.689 -3.448 . . . . 0.0 101.689 -178.072 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.7 mt -89.42 159.36 17.34 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 119.22 -2.175 . . . . 0.0 114.349 -179.058 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -104.01 141.2 36.61 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 119.219 -2.175 . . . . 0.0 107.068 -165.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.283 11.2 m-20 -72.27 123.51 23.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 126.247 2.927 . . . . 0.0 115.221 167.798 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.81 -28.61 9.24 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 129.496 3.427 . . . . 0.0 113.369 -177.876 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -69.43 167.73 15.98 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.476 -2.191 . . . . 0.0 112.543 170.999 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.5 p -115.0 166.46 11.78 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -163.722 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.8 mt -54.29 -44.87 72.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.328 1.451 . . . . 0.0 111.023 164.01 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -63.75 -27.65 69.34 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.944 1.702 . . . . 0.0 109.766 -174.002 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.37 -37.88 88.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.764 1.626 . . . . 0.0 109.696 -171.263 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -99.08 -5.0 31.07 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 111.723 -2.49 . . . . 0.0 107.236 -176.888 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 71.96 23.46 3.51 Favored 'General case' 0 N--CA 1.442 -0.845 1 O-C-N 114.643 -5.036 . . . . 0.0 116.408 165.221 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.9 pt -90.68 130.66 39.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 130.54 3.536 . . . . 0.0 107.949 -179.91 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.8 mm-40 -115.65 -173.83 2.41 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 131.143 3.777 . . . . 0.0 109.993 -167.673 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.6 tttt -74.17 133.26 42.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 129.577 3.151 . . . . 0.0 106.315 -159.887 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.301 35.7 mt-10 76.03 26.63 0.98 Allowed 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 128.045 2.538 . . . . 0.0 113.28 -179.524 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 81.4 p -84.01 145.84 28.29 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.009 -1.905 . . . . 0.0 110.308 170.11 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.7 m -103.01 118.77 37.56 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 -177.23 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 41.3 tp -100.07 151.04 21.84 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 173.947 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -113.07 119.7 38.77 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 128.557 2.743 . . . . 0.0 109.69 179.703 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.8 tp -89.16 137.05 32.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 128.642 3.714 . . . . 0.0 107.111 -176.569 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.8 t -105.41 116.51 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 113.872 -1.513 . . . . 0.0 110.832 166.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.31 142.84 28.22 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.7 1.6 . . . . 0.0 107.217 -169.681 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -132.38 138.54 47.75 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 114.601 -2.619 . . . . 0.0 110.492 160.416 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -158.0 164.9 36.31 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 127.349 2.905 . . . . 0.0 104.916 178.005 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -116.61 -28.07 6.51 Favored 'General case' 0 N--CA 1.452 -0.341 1 C-N-CA 133.187 4.595 . . . . 0.0 108.13 -174.399 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.07 -119.48 6.48 Favored Glycine 0 CA--C 1.526 0.781 0 O-C-N 128.965 3.916 . . . . 0.0 114.306 -171.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 O-C-N 119.342 -2.269 . . . . 0.0 112.31 -173.659 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.472 0.635 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -89.8 112.41 23.72 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 128.657 2.783 . . . . 0.0 108.074 -170.29 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.4 pt -109.66 143.09 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 169.121 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -87.97 150.95 23.15 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 124.061 0.944 . . . . 0.0 111.79 161.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -132.4 121.14 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 130.296 3.438 . . . . 0.0 108.309 168.641 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 tttm -108.95 133.73 52.57 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 127.766 2.427 . . . . 0.0 113.889 176.434 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 34.5 p -105.87 173.4 6.33 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 117.55 -3.218 . . . . 0.0 109.856 -170.963 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 tt -91.84 -35.68 13.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 131.535 3.934 . . . . 0.0 111.667 -176.57 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.7 p -65.03 -6.3 8.38 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 166.011 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.04 -28.77 5.76 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 117.006 1.562 . . . . 0.0 117.006 160.658 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -79.21 138.35 37.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 116.197 -1.859 . . . . 0.0 111.836 -172.182 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -99.51 118.92 37.14 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 113.798 -3.001 . . . . 0.0 104.522 172.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 53.9 mt -96.91 152.92 3.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 126.663 2.477 . . . . 0.0 107.121 179.302 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.8 t -125.14 142.03 51.74 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 165.357 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.68 131.47 49.78 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 111.656 -2.52 . . . . 0.0 113.162 -178.311 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -99.46 110.73 23.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 115.824 -2.036 . . . . 0.0 106.636 174.806 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 1.7 m -131.99 -174.84 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 119.748 1.158 . . . . 0.0 108.844 175.947 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -111.88 156.09 42.24 Favored Pre-proline 0 N--CA 1.449 -0.476 0 C-N-CA 125.111 1.364 . . . . 0.0 109.887 174.713 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -82.08 -6.96 12.18 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-O 114.249 -2.479 . . . . 0.0 113.821 -171.704 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.7 m -106.02 2.94 27.74 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 121.338 1.881 . . . . 0.0 110.64 179.992 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -75.72 152.74 37.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 O-C-N 118.646 -2.534 . . . . 0.0 111.724 170.478 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.333 74.8 p -94.33 169.52 10.16 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 124.253 1.021 . . . . 0.0 109.97 -165.547 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -71.6 -22.88 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 115.946 -1.978 . . . . 0.0 106.661 -178.47 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -69.19 -19.69 63.99 Favored 'General case' 0 N--CA 1.437 -1.091 0 CA-C-N 125.072 3.578 . . . . 0.0 107.204 173.537 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -73.94 -48.05 33.29 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 119.144 0.884 . . . . 0.0 111.23 -178.101 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.0 t -67.33 -44.37 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 111.997 -2.365 . . . . 0.0 113.404 175.306 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.29 30.1 mtpt -48.64 -36.56 16.16 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 119.898 3.296 . . . . 0.0 119.898 160.15 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.83 -39.87 42.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 120.912 1.687 . . . . 0.0 110.519 -179.572 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.7 mttm -69.88 -33.04 71.7 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.109 2.163 . . . . 0.0 111.232 178.753 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -64.22 -46.13 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 113.139 -3.315 . . . . 0.0 114.18 162.788 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -58.44 -45.86 87.69 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 123.056 2.662 . . . . 0.0 115.451 168.23 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.444 24.1 t70 -47.67 -64.5 0.77 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 126.006 1.722 . . . . 0.0 114.431 173.326 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.2 mmtp -98.81 -20.69 16.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -165.191 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -127.46 13.01 7.03 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.185 2.194 . . . . 0.0 113.894 -176.539 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.06 20.58 62.77 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.078 2.275 . . . . 0.0 117.462 159.184 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mt -91.91 132.8 31.84 Favored Pre-proline 0 N--CA 1.444 -0.752 0 O-C-N 118.275 -2.897 . . . . 0.0 105.365 -172.491 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.84 112.13 2.14 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 114.694 -2.294 . . . . 0.0 114.581 169.627 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -73.66 -10.59 23.63 Favored 'Trans proline' 0 N--CA 1.457 -0.626 1 C-N-CA 125.447 4.098 . . . . 0.0 114.305 -167.625 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.361 25.7 t0 -65.3 -27.85 68.91 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 125.528 2.585 . . . . 0.0 111.904 167.504 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.6 mm-40 -114.97 51.61 0.9 Allowed 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 116.893 -3.63 . . . . 0.0 103.257 -167.432 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -160.64 147.12 15.29 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.997 2.119 . . . . 0.0 105.839 -170.736 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.8 mtt85 -149.65 126.26 10.97 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 102.173 -3.269 . . . . 0.0 102.173 172.183 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.334 78.2 mt -93.46 150.14 20.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 125.052 2.358 . . . . 0.0 109.518 169.695 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 41.7 mt -126.61 135.07 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 1 C-N-CA 133.249 4.62 . . . . 0.0 111.471 -177.219 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 65' ' ' SER . 52.8 t80 -150.66 133.17 15.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 118.7 -2.5 . . . . 0.0 111.853 178.115 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.22 21.31 1.59 Allowed 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 118.831 2.9 . . . . 0.0 118.831 -178.583 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.65 -5.35 47.56 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 127.571 2.51 . . . . 0.0 113.038 -176.681 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -119.56 123.05 42.99 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.574 2.75 . . . . 0.0 109.239 -161.246 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -54.18 124.11 14.75 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 118.669 -2.519 . . . . 0.0 110.963 164.829 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 80.0 mt -71.51 108.46 4.91 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 126.853 2.061 . . . . 0.0 109.645 174.359 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.287 29.8 tt0 -91.31 151.04 21.04 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -166.472 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -73.83 128.4 35.43 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 127.67 2.388 . . . . 0.0 106.773 -174.66 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.97 18.16 12.88 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 128.659 3.028 . . . . 0.0 116.709 175.217 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -121.86 168.11 12.25 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.876 1.67 . . . . 0.0 107.978 -177.472 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.4 p -124.32 146.21 48.94 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 103.304 -2.85 . . . . 0.0 103.304 -173.219 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB3' ' HB ' ' A' ' 61' ' ' ILE 0.285 5.7 mt -48.15 -41.76 27.62 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.936 1.694 . . . . 0.0 112.053 -171.936 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.2 t -36.61 -44.96 0.48 Allowed 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 129.846 3.258 . . . . 0.0 117.342 161.493 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -73.07 -7.65 52.21 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.761 2.024 . . . . 0.0 112.701 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -117.01 -12.56 10.65 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.35 1.86 . . . . 0.0 112.72 170.331 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.1 t30 78.05 33.7 0.33 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 126.8 2.04 . . . . 0.0 111.003 171.861 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.409 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 52.9 mt -69.14 119.15 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 127.118 2.167 . . . . 0.0 106.211 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.277 4.0 pp0? -119.65 175.48 5.84 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 128.943 2.897 . . . . 0.0 108.71 -168.25 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -48.56 111.33 0.44 Allowed 'General case' 0 C--N 1.323 -0.575 0 O-C-N 117.007 -3.558 . . . . 0.0 115.452 -175.338 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 58.4 mt-10 73.46 29.32 1.62 Allowed 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 119.294 -2.128 . . . . 0.0 109.658 176.284 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.423 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 73.4 m -84.25 125.77 32.54 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 117.108 -3.495 . . . . 0.0 103.263 175.225 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.1 m -95.41 110.1 22.18 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 116.946 -3.596 . . . . 0.0 108.426 -169.191 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -79.75 157.26 27.16 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 130.766 3.626 . . . . 0.0 110.4 174.736 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -121.39 142.4 50.04 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 129.533 3.133 . . . . 0.0 104.448 -177.808 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -123.22 127.29 48.4 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 131.242 3.817 . . . . 0.0 105.057 -173.223 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.31 142.37 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 O-C-N 118.761 -2.462 . . . . 0.0 113.506 163.74 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.98 114.91 27.2 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 105.947 -1.872 . . . . 0.0 105.947 -170.113 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 20.5 ttp180 55.5 -25.03 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.099 2.16 . . . . 0.0 116.771 -179.158 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.2 mt -51.05 139.87 16.94 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 131.127 3.771 . . . . 0.0 112.848 -176.652 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.258 42.5 ttt180 -86.95 137.94 31.94 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.232 -173.287 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.6 -156.23 11.94 Favored Glycine 0 CA--C 1.524 0.639 0 C-N-CA 128.868 3.128 . . . . 0.0 118.713 -178.005 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.811 0 C-N-CA 126.467 1.984 . . . . 0.0 108.271 171.365 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.4 ptt? . . . . . 0 CA--C 1.534 0.361 1 CA-C-O 129.783 4.611 . . . . 0.0 105.297 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -71.02 144.58 50.38 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 110.671 -2.968 . . . . 0.0 113.389 -173.786 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.3 pt -146.12 174.95 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 116.441 -1.742 . . . . 0.0 106.691 177.998 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -128.31 117.35 21.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.063 2.545 . . . . 0.0 108.178 172.121 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.2 t -82.29 116.55 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 O-C-N 118.946 -2.346 . . . . 0.0 105.665 158.446 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 69.5 mttt -95.06 146.77 24.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 115.417 -2.23 . . . . 0.0 111.735 160.903 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -95.54 159.8 14.82 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 129.386 3.074 . . . . 0.0 104.697 164.62 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.3 tp -63.5 -21.41 66.31 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 111.526 -2.579 . . . . 0.0 110.534 177.037 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.1 p -95.63 -6.79 39.35 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 127.674 3.109 . . . . 0.0 112.708 178.134 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.5 -24.94 6.06 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 118.198 -1.334 . . . . 0.0 112.704 158.472 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -55.58 118.53 4.58 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 129.228 3.011 . . . . 0.0 109.086 -177.573 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.0 m -100.34 132.89 45.46 Favored 'General case' 0 N--CA 1.451 -0.418 0 O-C-N 126.83 2.581 . . . . 0.0 109.711 179.084 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.0 mm -109.05 130.41 62.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.589 1.955 . . . . 0.0 106.911 173.614 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.7 m -85.36 144.1 28.24 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 127.907 2.483 . . . . 0.0 105.17 174.631 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.7 mt -136.68 151.63 49.49 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 120.267 -1.521 . . . . 0.0 107.675 171.615 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -103.3 125.67 50.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 103.434 -2.802 . . . . 0.0 103.434 153.79 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.5 m -137.79 171.25 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 C-N-CA 131.496 3.919 . . . . 0.0 112.677 163.73 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -130.14 144.29 52.55 Favored Pre-proline 0 N--CA 1.449 -0.488 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 -178.411 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -57.81 -28.71 83.38 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 CA-C-O 111.843 -3.482 . . . . 0.0 115.286 -169.598 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 79.9 p -77.2 2.4 15.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 124.81 3.459 . . . . 0.0 115.52 172.25 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -77.83 148.78 34.55 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 118.968 -2.332 . . . . 0.0 107.358 -179.443 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.3 p -78.4 155.1 30.17 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 116.739 -1.601 . . . . 0.0 112.648 -172.12 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.254 10.6 mm -81.9 50.14 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-O 125.327 2.489 . . . . 0.0 109.794 161.175 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -153.72 -54.66 0.11 Allowed 'General case' 0 CA--C 1.532 0.288 0 O-C-N 117.39 -3.319 . . . . 0.0 109.066 -173.44 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -59.71 -57.37 13.2 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 120.698 1.59 . . . . 0.0 113.517 -175.394 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -78.37 -8.03 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.65 2.38 . . . . 0.0 111.188 -163.568 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -49.01 -40.29 30.26 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.322 2.649 . . . . 0.0 116.291 162.338 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.91 -27.69 8.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 O-C-N 119.722 -1.861 . . . . 0.0 115.527 172.033 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.3 ttmt -89.01 -2.26 58.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 118.541 -1.263 . . . . 0.0 111.511 -172.096 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.9 mm -89.71 -37.75 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 127.67 2.388 . . . . 0.0 108.581 165.543 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.08 -43.24 99.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.361 -1.291 . . . . 0.0 114.225 176.476 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -57.25 -16.34 8.18 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 127.816 2.447 . . . . 0.0 115.704 170.934 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -108.94 -52.26 2.78 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.566 1.546 . . . . 0.0 110.979 -173.246 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -115.01 -19.06 11.07 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 118.801 -2.437 . . . . 0.0 112.331 -173.628 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.27 15.79 20.39 Favored Glycine 0 CA--C 1.529 0.931 0 CA-C-O 115.161 -3.022 . . . . 0.0 112.41 177.908 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.2 mt -90.75 121.63 67.93 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 121.773 2.787 . . . . 0.0 112.172 -176.987 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.4 158.06 59.18 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 122.538 2.159 . . . . 0.0 113.656 179.028 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -60.36 -40.17 60.61 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 C-N-CA 123.273 2.649 . . . . 0.0 115.465 -173.614 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 37.8 t0 -41.6 -54.87 3.09 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 131.225 3.81 . . . . 0.0 114.015 166.144 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -80.23 -13.23 59.39 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.607 2.363 . . . . 0.0 113.868 -170.481 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -83.91 106.44 15.59 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 129.482 3.113 . . . . 0.0 106.676 -179.058 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -113.28 137.28 51.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.728 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.284 1.7 pt? -134.02 131.37 38.81 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 120.707 1.594 . . . . 0.0 112.497 -172.378 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 21.8 mt -109.68 132.22 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 103.463 -2.792 . . . . 0.0 103.463 -174.533 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.0 t80 -131.74 -85.4 0.49 Allowed 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 130.546 3.538 . . . . 0.0 114.233 168.528 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.61 55.01 0.69 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 125.961 3.982 . . . . 0.0 114.584 -170.474 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.71 -9.48 48.06 Favored Glycine 0 CA--C 1.53 0.981 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 161.805 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -139.33 156.01 47.31 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 119.764 3.246 . . . . 0.0 119.764 176.536 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.86 116.17 18.16 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 177.988 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.5 mt -58.68 135.53 57.43 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 118.769 -2.457 . . . . 0.0 113.932 -175.251 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -84.07 143.77 29.51 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -178.531 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.54 132.92 46.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.323 1.449 . . . . 0.0 112.261 169.937 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.23 -24.44 10.6 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 124.671 2.262 . . . . 0.0 112.241 171.565 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 12.5 mmp_? -73.61 166.87 22.48 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 111.978 -2.111 . . . . 0.0 105.316 -179.903 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.9 p -100.81 163.59 12.24 Favored 'General case' 0 N--CA 1.45 -0.436 1 O-C-N 115.583 -4.448 . . . . 0.0 108.269 169.013 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.5 mt -51.59 -36.98 47.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.233 2.213 . . . . 0.0 113.439 171.501 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 t -79.6 -17.84 52.97 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 117.256 2.317 . . . . 0.0 117.256 177.235 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -62.97 -17.33 61.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 121.294 1.861 . . . . 0.0 109.411 164.847 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -118.05 7.18 12.17 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 130.389 3.476 . . . . 0.0 112.484 -178.212 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 62.96 32.39 15.61 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 131.453 3.901 . . . . 0.0 112.0 174.291 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.3 mt -74.89 132.0 34.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 C-N-CA 126.607 1.963 . . . . 0.0 105.84 -172.002 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -127.34 165.77 19.1 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 127.319 2.248 . . . . 0.0 111.678 -179.902 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.6 pttt -48.03 137.28 10.48 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 131.286 3.835 . . . . 0.0 112.494 179.577 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 84.67 4.15 0.67 Allowed 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.461 1.905 . . . . 0.0 108.454 165.541 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.0 m -83.61 142.69 30.64 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 175.374 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.8 m -97.29 129.52 44.58 Favored 'General case' 0 N--CA 1.451 -0.408 1 C-N-CA 132.431 4.292 . . . . 0.0 112.749 179.485 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -129.62 143.18 50.71 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 -169.99 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -115.1 102.68 10.15 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 101.621 -3.474 . . . . 0.0 101.621 -160.72 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 26.9 tp -71.07 144.45 50.34 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 128.843 2.857 . . . . 0.0 108.649 166.1 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.1 m -145.85 156.29 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 130.134 3.373 . . . . 0.0 106.66 170.414 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.28 48.1 mt -108.05 126.77 53.13 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 126.55 3.072 . . . . 0.0 108.89 -178.483 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.438 5.4 ttt180 93.39 -54.81 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 131.209 3.804 . . . . 0.0 118.255 164.12 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 mt -110.51 146.08 36.61 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 110.55 -3.023 . . . . 0.0 105.645 -161.539 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 74' ' ' ARG . 23.3 ttp180 -65.68 145.95 55.4 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 128.972 2.909 . . . . 0.0 111.309 171.059 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -119.6 117.66 3.68 Favored Glycine 0 CA--C 1.532 1.103 0 O-C-N 125.406 1.691 . . . . 0.0 111.347 163.881 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.385 0 CA-C-O 124.481 2.156 . . . . 0.0 115.256 -172.099 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttp . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -125.13 139.59 53.63 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.007 2.523 . . . . 0.0 114.18 -175.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 3' ' ' ILE 0.296 45.6 pt -133.55 -179.48 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 128.893 2.877 . . . . 0.0 104.869 173.935 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -133.17 160.65 36.61 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 167.291 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.6 t -129.52 141.04 47.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 166.694 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -109.16 127.05 53.88 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.129 1.771 . . . . 0.0 106.638 176.814 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 79.5 p -79.74 173.14 12.88 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-O 124.154 1.931 . . . . 0.0 112.305 165.852 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.7 mt -78.71 -31.45 46.47 Favored 'General case' 0 C--O 1.24 0.602 0 O-C-N 118.188 -2.82 . . . . 0.0 111.921 173.708 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 t -64.0 -21.11 66.36 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 167.642 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.54 6.63 40.92 Favored Glycine 0 CA--C 1.529 0.907 0 O-C-N 125.825 1.953 . . . . 0.0 109.275 168.769 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.6 ttmt -65.77 119.06 10.56 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 122.377 3.088 . . . . 0.0 109.113 167.998 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 17.5 m -102.46 94.83 5.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 122.948 2.613 . . . . 0.0 104.652 -178.914 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 49.4 mm -59.86 144.99 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 1 C-N-CA 132.212 4.205 . . . . 0.0 109.41 170.11 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.9 m -103.22 142.42 34.21 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.752 1.621 . . . . 0.0 109.912 169.109 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.9 mt -125.12 132.53 53.1 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 157.819 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -74.84 128.4 35.48 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 154.638 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -140.67 157.99 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 O-C-N 120.402 -1.436 . . . . 0.0 111.403 -178.056 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -106.76 149.55 38.6 Favored Pre-proline 0 N--CA 1.442 -0.869 0 C-N-CA 127.016 2.127 . . . . 0.0 106.382 174.882 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.295 52.8 Cg_endo -70.41 -15.17 34.6 Favored 'Trans proline' 0 N--CA 1.441 -1.594 0 C-N-CA 124.767 3.645 . . . . 0.0 116.476 -179.254 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.3 p -98.52 1.27 46.43 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 127.986 2.514 . . . . 0.0 113.632 -178.643 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -77.64 153.63 32.97 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 120.394 -1.441 . . . . 0.0 111.539 -169.863 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.5 p -89.42 158.14 17.86 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 128.047 2.539 . . . . 0.0 106.005 177.256 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.0 mm -72.11 -29.74 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 114.049 -2.882 . . . . 0.0 107.59 175.964 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -59.63 -38.04 80.3 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 124.629 3.377 . . . . 0.0 108.316 168.921 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -76.38 -21.54 55.91 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 118.368 -2.707 . . . . 0.0 109.604 176.309 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.2 t -79.29 -37.02 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 CA-C-N 124.609 3.368 . . . . 0.0 111.7 172.933 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -64.64 -30.07 71.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.484 1.914 . . . . 0.0 111.971 176.566 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.265 . . -75.25 -30.24 60.44 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 127.621 2.368 . . . . 0.0 111.928 179.867 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.0 mttt -79.51 -25.43 41.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 125.108 2.385 . . . . 0.0 112.014 174.707 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 30' ' ' ILE 0.34 32.1 mm -82.3 -33.68 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 113.412 -1.722 . . . . 0.0 108.883 173.241 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.48 -36.32 66.5 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 123.013 2.642 . . . . 0.0 114.063 161.595 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.05 -59.85 2.55 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 128.433 2.693 . . . . 0.0 106.531 177.718 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.322 68.1 mmtt -51.39 -64.94 0.65 Allowed 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 127.695 2.398 . . . . 0.0 110.567 -177.309 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -120.49 -9.88 9.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 112.914 -3.422 . . . . 0.0 107.437 -150.451 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.49 -1.9 62.42 Favored Glycine 0 CA--C 1.531 1.064 0 O-C-N 127.875 3.234 . . . . 0.0 116.826 166.933 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.3 mm -95.09 132.14 28.67 Favored Pre-proline 0 N--CA 1.452 -0.368 0 O-C-N 117.335 -3.45 . . . . 0.0 111.722 -159.231 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -47.44 122.95 7.31 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 126.914 5.076 . . . . 0.0 108.657 168.352 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -35.36 -47.43 0.81 Allowed 'Trans proline' 0 N--CA 1.447 -1.243 1 C-N-CA 129.698 6.932 . . . . 0.0 118.52 174.711 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.5 -16.3 64.13 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 114.913 -2.47 . . . . 0.0 115.422 -178.697 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -94.24 -7.36 42.29 Favored 'General case' 0 N--CA 1.445 -0.692 0 O-C-N 126.186 2.179 . . . . 0.0 109.125 179.542 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -86.91 130.19 34.56 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 128.338 2.655 . . . . 0.0 109.269 179.906 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -116.86 141.06 48.72 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 128.868 2.867 . . . . 0.0 107.334 179.823 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 91.9 mt -119.44 111.18 17.82 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 127.551 2.34 . . . . 0.0 110.797 173.886 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 84.3 mt -105.12 118.6 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 N-CA-C 105.72 -1.956 . . . . 0.0 105.72 161.23 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -126.69 130.79 51.09 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 175.212 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.42 19.5 10.31 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 111.748 -2.478 . . . . 0.0 113.658 169.514 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.17 -17.55 59.08 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 128.453 2.93 . . . . 0.0 115.678 -169.728 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.288 11.6 mmmt -93.19 146.48 23.65 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 119.404 1.602 . . . . 0.0 111.971 -176.931 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.9 tp60 -94.54 112.47 24.23 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 130.892 3.677 . . . . 0.0 105.07 -176.246 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.498 ' HG ' ' CD1' ' A' ' 59' ' ' TYR . 6.2 mp -80.2 111.2 16.34 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 114.455 -2.688 . . . . 0.0 105.778 -179.259 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -83.83 -15.05 49.73 Favored 'General case' 0 C--N 1.323 -0.581 0 O-C-N 126.769 2.543 . . . . 0.0 115.705 -173.052 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.298 5.3 t0 93.64 153.66 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 128.694 2.798 . . . . 0.0 111.49 -175.932 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.01 30.98 5.82 Favored Glycine 0 N--CA 1.438 -1.21 0 O-C-N 117.394 -3.316 . . . . 0.0 114.335 161.322 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -153.4 160.48 42.63 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 131.586 3.954 . . . . 0.0 106.83 172.276 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.6 p -98.34 176.66 5.62 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 117.013 -3.555 . . . . 0.0 111.506 -167.269 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.6 tp -62.53 -37.13 84.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 126.312 1.845 . . . . 0.0 111.96 -173.82 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.0 p -64.39 -33.6 76.24 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 126.017 1.727 . . . . 0.0 115.12 166.189 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -71.74 -56.44 5.79 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 126.99 2.116 . . . . 0.0 107.416 179.634 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.498 ' CD1' ' HG ' ' A' ' 50' ' ' LEU 0.277 42.9 m-85 -64.52 0.99 0.89 Allowed 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 130.548 3.539 . . . . 0.0 116.312 -178.756 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.311 1.5 t-20 78.42 18.32 1.05 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 124.131 3.15 . . . . 0.0 113.836 163.659 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.8 mt -94.01 105.02 16.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 117.306 -3.371 . . . . 0.0 106.409 179.92 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 -99.83 -170.79 1.94 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 116.601 -3.812 . . . . 0.0 101.483 -166.541 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -64.99 120.23 12.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 114.669 -2.586 . . . . 0.0 112.125 -170.044 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.555 2.4 mp0 77.59 24.77 0.75 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 117.427 2.381 . . . . 0.0 117.427 179.144 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.9 m -71.23 148.02 47.65 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 112.42 -2.173 . . . . 0.0 106.157 175.221 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.321 99.1 m -114.83 128.9 56.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 102.192 -3.262 . . . . 0.0 102.192 169.579 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.1 mt -92.65 151.24 20.21 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 108.824 -3.807 . . . . 0.0 107.811 170.305 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 18.2 t-160 -98.68 127.35 44.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.904 0.882 . . . . 0.0 113.374 162.112 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tp -107.46 118.46 36.79 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 103.356 -2.831 . . . . 0.0 103.356 -178.396 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.52 160.78 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 126.306 1.842 . . . . 0.0 110.253 172.992 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 42.1 mt -92.55 153.39 19.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 118.868 -2.395 . . . . 0.0 112.623 176.523 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.7 mtt-85 -91.51 146.1 24.07 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 127.91 2.484 . . . . 0.0 108.002 150.514 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.8 mt -93.67 -22.38 18.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 126.779 3.181 . . . . 0.0 111.806 170.319 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 26.4 tpt85 -149.32 135.66 19.21 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 129.753 3.221 . . . . 0.0 116.223 -177.5 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.08 149.98 16.68 Favored Glycine 0 CA--C 1.533 1.176 1 O-C-N 115.459 -4.526 . . . . 0.0 104.939 168.89 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 C-N-CA 127.731 2.586 . . . . 0.0 108.467 -175.33 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ttt . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 116.409 -1.758 . . . . 0.0 112.15 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 73.5 mm-40 -77.82 131.53 37.61 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 123.716 2.962 . . . . 0.0 112.309 173.629 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.406 HG21 HD13 ' A' ' 3' ' ' ILE . 46.4 pt -130.37 136.9 57.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 126.88 2.613 . . . . 0.0 107.202 170.457 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -92.52 123.01 35.52 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 172.045 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.42 ' HB ' ' HB ' ' A' ' 13' ' ' ILE . 46.6 t -96.27 124.88 49.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 166.682 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.261 49.3 tttm -106.87 121.31 44.15 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.476 -2.046 . . . . 0.0 105.476 -174.292 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 69' ' ' LEU 0.294 5.1 p -113.13 -171.34 1.85 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 128.009 2.523 . . . . 0.0 108.099 175.466 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.301 74.3 mt -82.26 -28.41 31.84 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 126.625 3.107 . . . . 0.0 113.649 176.006 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.9 p -123.87 68.02 1.04 Allowed 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 129.87 3.268 . . . . 0.0 107.024 -175.848 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.53 101.67 1.22 Allowed Glycine 0 N--CA 1.442 -0.953 0 N-CA-C 104.198 -3.561 . . . . 0.0 104.198 178.653 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 pttt -79.06 -33.23 44.82 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 129.014 3.42 . . . . 0.0 111.363 -179.425 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m -117.71 59.57 0.78 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 126.44 3.019 . . . . 0.0 106.396 -167.634 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 5' ' ' VAL . 2.2 mt -80.81 116.01 24.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 O-C-N 118.558 -2.589 . . . . 0.0 106.613 170.102 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.86 119.59 39.23 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 118.293 -2.754 . . . . 0.0 105.902 -169.986 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.447 HD23 ' CG1' ' A' ' 17' ' ' VAL . 8.7 tp -115.81 136.15 53.32 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 129.744 3.218 . . . . 0.0 108.746 172.657 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.259 10.1 tp10 -92.17 114.41 26.94 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 101.97 -3.344 . . . . 0.0 101.97 167.169 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.447 ' CG1' HD23 ' A' ' 15' ' ' LEU . 18.1 m -108.75 -167.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 126.18 1.792 . . . . 0.0 110.854 168.999 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -139.47 140.65 26.12 Favored Pre-proline 0 N--CA 1.45 -0.462 1 C-N-CA 131.92 4.088 . . . . 0.0 107.578 171.62 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -43.54 -47.4 9.39 Favored 'Trans proline' 0 N--CA 1.445 -1.334 1 C-N-CA 126.079 4.519 . . . . 0.0 118.876 171.282 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.264 77.9 p -91.75 18.72 7.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 126.304 1.842 . . . . 0.0 107.2 -176.828 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -79.0 144.94 34.21 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 123.439 2.836 . . . . 0.0 114.102 169.978 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.7 p -92.77 153.48 18.86 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 117.421 -3.299 . . . . 0.0 111.038 -178.884 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 6.3 mm -57.99 -26.1 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 O-C-N 118.675 -2.516 . . . . 0.0 114.713 -176.046 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.3 tp10 -82.22 -18.31 43.03 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.787 1.635 . . . . 0.0 108.31 -170.395 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 t30 -83.78 -35.28 24.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 127.582 2.353 . . . . 0.0 107.948 178.905 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.95 -51.63 64.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 C-N-CA 128.495 2.718 . . . . 0.0 107.538 177.288 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 23' ' ' ILE . 38.4 mtmt -59.01 -39.28 81.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 120.075 3.361 . . . . 0.0 120.075 173.526 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.94 -26.9 68.5 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.705 3.602 . . . . 0.0 113.331 160.792 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -77.58 -47.49 19.28 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 121.681 2.037 . . . . 0.0 113.011 172.768 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 30' ' ' ILE 0.321 92.1 mt -54.15 -46.19 66.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 131.009 3.723 . . . . 0.0 112.811 174.264 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -60.25 -20.23 58.09 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 118.753 -2.467 . . . . 0.0 116.138 -177.75 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.278 3.7 t70 -94.2 -36.89 11.83 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 -178.546 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mptt -70.95 -55.1 9.09 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.506 178.364 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -117.47 -21.43 8.63 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 118.355 -2.716 . . . . 0.0 108.662 -166.352 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.4 10.7 28.87 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 117.183 -3.448 . . . . 0.0 114.014 164.379 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.92 120.89 57.54 Favored Pre-proline 0 C--N 1.33 -0.258 0 N-CA-C 106.228 -1.768 . . . . 0.0 106.228 -165.709 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -77.98 154.19 29.41 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 O-C-N 116.322 -2.515 . . . . 0.0 112.402 -173.119 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -73.98 -33.27 6.28 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.076 1.851 . . . . 0.0 112.557 -153.921 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -73.91 -19.7 60.62 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 124.739 1.274 . . . . 0.0 112.932 177.532 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -90.89 -16.49 28.08 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 127.638 2.375 . . . . 0.0 110.572 -179.404 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -89.11 129.45 35.72 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 129.124 2.969 . . . . 0.0 112.452 -179.704 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -119.78 155.78 31.86 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 102.477 -3.157 . . . . 0.0 102.477 173.791 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.06 144.33 51.28 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 120.15 -1.594 . . . . 0.0 111.739 178.074 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 44' ' ' ILE . 84.9 mt -131.43 143.76 39.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 122.844 2.565 . . . . 0.0 113.881 176.048 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -151.9 123.58 7.93 Favored 'General case' 0 N--CA 1.451 -0.388 1 C-N-CA 132.087 4.155 . . . . 0.0 113.461 171.541 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.27 37.56 4.21 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 119.651 3.204 . . . . 0.0 119.651 -175.784 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.75 -0.24 57.84 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 117.038 -3.539 . . . . 0.0 112.607 171.425 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -113.53 138.72 49.73 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 122.976 3.388 . . . . 0.0 105.15 -178.767 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.293 24.3 tt0 -98.0 125.07 42.78 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -178.308 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.2 mt -68.14 131.14 44.87 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.1 -1.409 . . . . 0.0 111.89 -168.392 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -104.31 154.72 19.47 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 127.008 3.29 . . . . 0.0 113.726 -172.93 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -45.75 127.75 8.13 Favored 'General case' 0 N--CA 1.447 -0.587 0 O-C-N 117.438 -3.289 . . . . 0.0 115.505 177.509 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.16 -2.38 61.33 Favored Glycine 0 CA--C 1.536 1.368 1 CA-C-N 127.362 4.619 . . . . 0.0 112.485 163.636 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.263 25.9 mmt-85 -100.06 172.88 6.92 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 127.188 3.375 . . . . 0.0 106.931 -173.138 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.9 p -119.69 -178.63 3.67 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 116.551 -3.843 . . . . 0.0 113.02 168.394 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.537 HD22 ' H ' ' A' ' 56' ' ' LEU . 1.0 OUTLIER -50.83 -44.42 59.32 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 131.032 3.733 . . . . 0.0 112.825 162.811 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 72.5 m -72.22 -33.68 67.77 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 128.367 2.667 . . . . 0.0 111.404 -170.897 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -66.98 -38.9 86.9 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 124.731 2.205 . . . . 0.0 111.34 -178.264 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -91.15 0.62 57.5 Favored 'General case' 0 N--CA 1.444 -0.773 0 O-C-N 117.146 -3.471 . . . . 0.0 116.042 176.425 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.256 13.3 m120 71.52 53.13 0.23 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 130.383 3.473 . . . . 0.0 110.638 -178.206 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 23.9 mt -103.03 140.41 21.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 -174.306 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -106.84 149.0 27.85 Favored 'General case' 0 N--CA 1.451 -0.397 1 C-N-CA 131.936 4.094 . . . . 0.0 115.674 -169.074 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.77 128.53 30.09 Favored 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 124.351 1.032 . . . . 0.0 112.705 162.065 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.277 29.3 tt0 87.05 21.89 0.06 Allowed 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 128.839 2.856 . . . . 0.0 110.209 174.253 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.9 m -71.63 141.84 49.95 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.216 1.806 . . . . 0.0 114.475 175.716 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.279 97.6 m -100.69 126.74 47.23 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 115.279 -2.296 . . . . 0.0 104.89 165.58 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -149.08 173.47 13.36 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 130.781 3.632 . . . . 0.0 107.2 177.651 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.7 m80 -127.45 134.13 49.87 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.443 2.297 . . . . 0.0 112.991 -156.548 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.425 ' HB3' HG22 ' A' ' 7' ' ' THR . 3.6 tt -108.29 139.28 43.22 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 125.336 2.493 . . . . 0.0 107.752 173.621 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.3 t -130.55 134.53 62.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 129.846 3.258 . . . . 0.0 106.722 -178.144 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.3 mp -97.14 134.43 40.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 101.729 -3.434 . . . . 0.0 101.729 172.338 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -95.7 81.19 3.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 125.812 2.72 . . . . 0.0 109.807 -174.761 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -89.11 -22.81 22.69 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 109.864 -3.335 . . . . 0.0 113.77 167.575 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.1 ptt-85 -136.57 167.13 21.97 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 126.411 1.884 . . . . 0.0 115.038 167.874 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.25 169.19 14.35 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 128.637 3.711 . . . . 0.0 110.066 167.541 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 1 CA-C-O 112.726 -4.374 . . . . 0.0 116.905 165.6 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.374 0.6 OUTLIER . . . . . 0 C--O 1.234 0.281 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 . . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -91.82 129.28 37.81 Favored 'General case' 0 N--CA 1.447 -0.591 1 C-N-CA 133.927 4.891 . . . . 0.0 107.213 -179.622 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.629 HD12 HD22 ' A' ' 67' ' ' LEU . 28.5 pt -119.08 156.69 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 O-C-N 128.01 3.319 . . . . 0.0 106.167 154.01 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -95.35 133.86 38.8 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.579 1.552 . . . . 0.0 107.239 166.279 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.2 t -117.57 125.55 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 1 N-CA-C 97.321 -5.066 . . . . 0.0 97.321 175.293 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 mttt -103.04 127.05 50.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-O 127.059 3.314 . . . . 0.0 107.707 173.977 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.4 p -89.76 145.03 25.48 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 126.021 2.82 . . . . 0.0 106.102 -176.178 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 63.0 tp -61.35 -27.89 68.83 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.706 -2.043 . . . . 0.0 116.241 178.561 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.2 p -76.72 -7.47 55.41 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.081 2.553 . . . . 0.0 116.94 173.274 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.78 -20.05 10.15 Favored Glycine 0 CA--C 1.541 1.669 0 C-N-CA 129.922 3.629 . . . . 0.0 114.694 166.303 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 34' ' ' GLU . 47.1 tttt -70.39 149.57 47.16 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 121.939 2.869 . . . . 0.0 110.758 -178.556 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.1 m -104.24 141.75 35.74 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.717 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.401 0.1 OUTLIER -125.08 135.17 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 CA-C-O 126.516 3.055 . . . . 0.0 112.789 163.173 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.5 m -75.66 137.5 40.73 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 117.65 -3.156 . . . . 0.0 104.482 174.085 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -138.41 120.14 15.22 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 175.833 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.286 25.4 mt-10 -70.39 131.92 44.83 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 126.949 2.656 . . . . 0.0 111.724 170.527 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 m -148.99 164.34 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 127.886 2.474 . . . . 0.0 106.787 -173.794 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -123.47 155.99 64.78 Favored Pre-proline 0 N--CA 1.449 -0.52 0 O-C-N 117.624 -3.173 . . . . 0.0 109.419 165.49 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.72 -37.67 35.67 Favored 'Trans proline' 0 N--CA 1.451 -0.997 1 C-N-CA 127.152 5.235 . . . . 0.0 116.008 179.203 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.8 p -81.27 -13.46 58.45 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 112.563 -2.108 . . . . 0.0 112.757 -179.624 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -67.02 155.84 37.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 121.103 1.774 . . . . 0.0 109.951 170.663 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -121.8 139.86 53.09 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 130.287 3.435 . . . . 0.0 111.248 -161.178 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -46.23 -24.5 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 O-C-N 116.595 -3.816 . . . . 0.0 116.895 176.243 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -68.74 -54.4 16.25 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 176.904 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -62.42 -37.43 85.79 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 119.593 3.183 . . . . 0.0 119.593 -173.353 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.282 76.1 t -50.71 -43.98 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 129.498 3.119 . . . . 0.0 113.804 170.605 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.355 40.0 mtmt -50.78 -43.69 58.59 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.766 2.027 . . . . 0.0 112.598 172.251 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.32 -33.65 28.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 125.982 2.051 . . . . 0.0 114.649 -176.619 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.5 mttp -55.41 -31.9 62.23 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 125.334 2.492 . . . . 0.0 115.215 173.003 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 70.8 mt -75.63 -21.11 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 113.421 -1.718 . . . . 0.0 113.156 172.147 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -70.56 -43.34 69.68 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 122.572 2.442 . . . . 0.0 107.715 173.225 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.53 -29.04 67.61 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 118.926 -2.358 . . . . 0.0 112.417 176.942 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -97.19 -57.21 2.32 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 117.552 2.427 . . . . 0.0 117.552 175.617 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 11' ' ' LYS . 28.6 mm-40 -92.64 -22.7 19.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 -172.151 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.62 -18.39 22.54 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 130.672 3.987 . . . . 0.0 112.326 171.426 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 95.3 mt -71.2 122.98 88.59 Favored Pre-proline 0 N--CA 1.445 -0.686 0 C-N-CA 127.882 2.473 . . . . 0.0 106.185 -159.604 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.0 137.8 27.22 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.872 2.382 . . . . 0.0 109.973 172.423 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -40.73 -45.29 4.76 Favored 'Trans proline' 0 N--CA 1.454 -0.804 1 C-N-CA 126.442 4.761 . . . . 0.0 114.786 -175.654 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.257 12.6 t70 -31.76 -41.75 0.05 OUTLIER 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 127.104 2.752 . . . . 0.0 117.943 170.762 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -96.84 -16.76 20.6 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 -170.349 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -97.49 140.88 31.27 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 127.479 2.987 . . . . 0.0 111.746 -178.593 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -125.23 128.21 47.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 116.74 -1.6 . . . . 0.0 108.325 174.146 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -102.78 140.82 36.55 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 115.798 1.777 . . . . 0.0 115.798 -178.085 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.3 pt -141.91 144.36 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 131.587 3.955 . . . . 0.0 111.114 179.757 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -146.16 130.34 17.5 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 111.566 -2.561 . . . . 0.0 107.627 172.265 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.79 17.91 8.72 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.264 1.826 . . . . 0.0 115.308 168.694 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.39 -26.66 12.76 Favored Glycine 0 CA--C 1.528 0.88 1 C-N-CA 131.95 4.595 . . . . 0.0 112.501 -169.253 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.303 38.4 mttt -68.24 129.89 41.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.807 0.804 . . . . 0.0 111.278 -170.982 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.316 78.0 mt-30 -66.06 115.05 5.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 103.581 -2.748 . . . . 0.0 103.581 163.708 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 86.6 mt -85.97 121.96 29.34 Favored 'General case' 0 C--O 1.239 0.52 1 O-C-N 116.156 -4.09 . . . . 0.0 110.139 -175.746 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -88.47 148.15 24.31 Favored 'General case' 0 C--N 1.319 -0.739 0 C-N-CA 129.702 3.201 . . . . 0.0 111.293 -165.08 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -74.93 123.72 25.61 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 127.667 2.387 . . . . 0.0 108.323 -166.606 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.47 -5.06 60.33 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 128.814 3.102 . . . . 0.0 116.215 174.1 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.7 mmm-85 -80.58 143.61 33.05 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 128.214 2.606 . . . . 0.0 109.511 173.663 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.6 p -77.0 151.81 35.46 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 128.589 2.755 . . . . 0.0 110.655 177.977 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 60.2 mt -59.71 -25.29 64.68 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 127.522 2.329 . . . . 0.0 114.678 161.546 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -74.46 -23.05 58.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 130.2 3.4 . . . . 0.0 112.812 166.229 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -89.53 -16.92 29.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 121.655 2.025 . . . . 0.0 109.387 178.806 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -96.81 -3.51 42.08 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 115.886 -2.007 . . . . 0.0 111.512 171.731 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 t30 62.35 37.86 13.49 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 171.835 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.7 mt -94.57 127.99 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 -172.19 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -99.44 175.56 5.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 126.789 2.036 . . . . 0.0 111.224 -176.247 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.24 144.0 57.45 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 130.97 3.708 . . . . 0.0 110.708 179.057 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.323 3.0 pt-20 60.68 13.17 4.12 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 131.562 3.945 . . . . 0.0 116.874 -179.374 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.0 m -67.33 144.77 55.67 Favored 'General case' 0 C--O 1.218 -0.578 0 O-C-N 126.709 2.506 . . . . 0.0 111.701 166.084 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 99.0 m -86.31 108.81 18.58 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 125.257 1.423 . . . . 0.0 109.074 174.788 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.629 HD22 HD12 ' A' ' 3' ' ' ILE . 11.0 mp -83.89 150.43 25.72 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 123.029 1.395 . . . . 0.0 113.36 156.785 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.265 75.2 m80 -104.02 144.07 32.04 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 120.443 -1.411 . . . . 0.0 111.303 176.714 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.1 tt -128.55 120.99 27.78 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 113.61 -3.09 . . . . 0.0 109.51 -177.813 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.5 t -100.99 133.34 44.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 C-N-CA 127.782 2.433 . . . . 0.0 106.718 -175.532 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.274 73.6 mt -80.63 148.92 30.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.841 1.657 . . . . 0.0 111.678 171.895 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -81.52 -15.29 55.35 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 115.122 -2.37 . . . . 0.0 108.762 171.106 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.82 147.95 39.82 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 123.026 2.648 . . . . 0.0 110.888 -175.681 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.82 -54.46 0.93 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 121.329 1.877 . . . . 0.0 107.077 169.272 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 113.72 136.66 6.46 Favored Glycine 0 CA--C 1.531 1.068 1 C-N-CA 130.986 4.136 . . . . 0.0 109.781 -166.228 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.083 0 C-N-CA 120.182 -1.008 . . . . 0.0 111.404 176.13 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.7 ttt . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 116.021 1.859 . . . . 0.0 116.021 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.426 ' HG2' ' HG3' ' A' ' 16' ' ' GLU . 96.1 mt-30 -106.61 165.96 10.91 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.103 1.761 . . . . 0.0 113.241 -176.831 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.9 pt -122.75 165.02 19.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 127.531 2.332 . . . . 0.0 108.858 152.662 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -112.18 125.44 54.14 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 126.646 2.466 . . . . 0.0 112.414 -172.253 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.3 t -96.74 91.35 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 101.664 -3.458 . . . . 0.0 101.664 176.869 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -68.27 145.8 53.91 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 114.277 -2.773 . . . . 0.0 112.855 167.32 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 14.1 t -155.06 171.5 19.67 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 124.963 3.528 . . . . 0.0 111.792 170.526 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.1 mt -68.75 -17.49 64.06 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 130.057 3.343 . . . . 0.0 116.913 -164.585 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.6 p -74.14 -7.77 53.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 114.976 1.473 . . . . 0.0 114.976 173.588 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.71 -20.81 44.71 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 116.674 1.43 . . . . 0.0 116.674 -179.147 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -76.9 152.71 35.26 Favored 'General case' 0 N--CA 1.447 -0.585 1 C-N-CA 132.25 4.22 . . . . 0.0 104.348 -176.21 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.289 75.7 m -122.68 147.79 46.05 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 118.937 -2.352 . . . . 0.0 112.3 161.765 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.9 mt -120.88 154.39 24.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 131.685 3.994 . . . . 0.0 107.056 -178.013 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.0 p -127.47 135.9 51.03 Favored 'General case' 0 C--O 1.241 0.609 0 C-N-CA 128.174 2.59 . . . . 0.0 110.721 -165.682 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 33.7 mt -130.6 117.43 19.52 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 126.418 2.324 . . . . 0.0 107.679 -179.668 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.426 ' HG3' ' HG2' ' A' ' 2' ' ' GLN . 31.5 mp0 -90.66 108.77 20.02 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 127.131 2.172 . . . . 0.0 106.26 169.117 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.2 m -138.0 161.33 32.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 1 C-N-CA 134.413 5.085 . . . . 0.0 108.77 -170.326 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 53.9 mm-40 -126.16 152.32 73.25 Favored Pre-proline 0 N--CA 1.442 -0.867 0 C-N-CA 131.589 3.956 . . . . 0.0 110.045 175.486 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 66.3 Cg_exo -47.35 -48.97 13.91 Favored 'Trans proline' 0 N--CA 1.456 -0.685 1 C-N-CA 126.523 4.815 . . . . 0.0 114.232 -167.368 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.6 m -61.66 -15.77 42.87 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 119.104 3.001 . . . . 0.0 119.104 -176.879 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -59.42 120.58 9.61 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 114.931 -1.031 . . . . 0.0 112.942 170.797 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 p -65.79 136.28 55.99 Favored 'General case' 0 N--CA 1.447 -0.578 1 C-N-CA 135.521 5.528 . . . . 0.0 110.266 161.377 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mm -59.99 -31.7 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-O 114.882 -2.485 . . . . 0.0 114.527 -174.71 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -48.7 -36.48 16.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 128.103 2.561 . . . . 0.0 114.73 169.743 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.9 t30 -82.79 -39.28 21.98 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 125.343 1.652 . . . . 0.0 108.937 -172.866 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.32 4.5 t -67.95 -36.58 76.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 112.982 -3.39 . . . . 0.0 115.678 172.705 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -58.94 -46.84 87.02 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 129.6 3.16 . . . . 0.0 107.301 177.889 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.91 -18.69 61.13 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.867 3.267 . . . . 0.0 118.184 172.351 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.45 -49.57 63.05 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 118.24 -2.787 . . . . 0.0 113.112 160.551 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.8 mt -68.32 -38.66 79.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 127.832 2.453 . . . . 0.0 107.397 -169.667 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -50.41 -65.61 0.53 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 124.489 1.115 . . . . 0.0 111.071 160.529 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.253 35.0 t70 -43.28 -38.29 2.55 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 129.612 3.165 . . . . 0.0 114.086 179.68 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -80.28 -45.64 17.54 Favored 'General case' 0 CA--C 1.535 0.39 1 C-N-CA 131.964 4.106 . . . . 0.0 120.658 171.619 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -123.69 -20.43 5.49 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 126.057 2.837 . . . . 0.0 112.988 -166.468 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.73 28.8 22.99 Favored Glycine 0 CA--C 1.524 0.641 0 O-C-N 118.035 -2.916 . . . . 0.0 115.983 170.035 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.1 tt -106.27 111.6 64.2 Favored Pre-proline 0 N--CA 1.446 -0.654 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 -175.213 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -79.32 151.87 23.34 Favored 'Trans proline' 0 N--CA 1.442 -1.508 0 C-N-CA 125.163 3.909 . . . . 0.0 109.512 -174.789 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -47.86 -38.2 30.12 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 CA-C-O 112.135 -3.36 . . . . 0.0 115.182 -166.795 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.25 -13.91 2.45 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 127.676 3.11 . . . . 0.0 116.579 175.919 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -116.72 -7.4 11.52 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.039 2.535 . . . . 0.0 110.418 -176.2 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.277 80.0 mt-30 -87.67 145.36 26.2 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 117.866 -3.021 . . . . 0.0 105.656 175.709 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -124.64 128.13 48.39 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 129.037 2.935 . . . . 0.0 106.747 161.711 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.4 mp -119.92 104.57 10.29 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 112.405 -3.664 . . . . 0.0 110.002 -160.941 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -116.65 131.52 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 1 CA-C-N 126.011 4.005 . . . . 0.0 108.798 -163.26 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -111.43 113.41 25.83 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 126.435 1.894 . . . . 0.0 112.202 164.207 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.8 -92.1 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 131.051 3.74 . . . . 0.0 110.51 -166.068 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -131.16 1.63 5.4 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 113.85 -1.523 . . . . 0.0 116.044 169.961 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.2 mttt -95.98 128.87 43.26 Favored 'General case' 0 CA--C 1.541 0.6 1 C-N-CA 132.031 4.132 . . . . 0.0 104.951 -174.168 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.371 18.6 mp0 -77.77 138.87 39.24 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 131.451 3.901 . . . . 0.0 107.903 178.178 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.455 ' HG ' ' CE2' ' A' ' 59' ' ' TYR . 8.1 mp -94.42 153.98 17.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 124.317 2.008 . . . . 0.0 107.315 172.544 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -135.23 144.25 46.79 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 112.257 -2.247 . . . . 0.0 108.648 164.555 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -49.15 146.88 3.29 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 127.671 2.388 . . . . 0.0 115.649 169.468 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.94 16.49 28.1 Favored Glycine 0 N--CA 1.442 -0.939 0 CA-C-O 116.092 -2.504 . . . . 0.0 111.292 -169.289 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.4 mtt-85 -145.92 158.26 43.87 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 127.512 3.53 . . . . 0.0 102.759 171.599 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.4 p -103.21 173.99 6.06 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 116.671 -3.768 . . . . 0.0 110.27 177.678 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mt -62.98 -36.46 83.58 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 117.994 -2.941 . . . . 0.0 106.83 176.59 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.5 t -64.91 -45.18 86.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 123.691 0.62 . . . . 0.0 112.444 175.95 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -53.63 -46.43 70.48 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.809 178.239 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 39.7 m-85 -75.41 -10.51 59.51 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-O 123.454 1.597 . . . . 0.0 113.629 -175.894 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.4 t30 66.32 45.95 2.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.516 3.526 . . . . 0.0 114.412 -173.069 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.5 mt -90.21 142.82 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 O-C-N 126.577 2.423 . . . . 0.0 106.469 -178.264 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -137.12 177.99 7.43 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 117.524 2.416 . . . . 0.0 117.524 178.196 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -49.03 116.85 1.82 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.665 2.386 . . . . 0.0 112.547 -176.0 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.457 21.4 mp0 79.74 23.52 0.47 Allowed 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 130.298 3.439 . . . . 0.0 112.759 168.732 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.3 m -71.19 150.05 45.72 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.225 1.81 . . . . 0.0 111.012 169.175 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.6 m -98.9 130.52 45.3 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 119.161 -2.212 . . . . 0.0 109.429 162.386 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -109.62 141.05 42.7 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-O 114.914 -2.47 . . . . 0.0 108.876 167.441 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.355 23.2 t60 -100.94 164.06 12.0 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 121.603 2.001 . . . . 0.0 115.711 178.67 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.253 0.4 OUTLIER -141.11 136.7 32.18 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 129.14 2.976 . . . . 0.0 107.544 -175.841 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -102.65 118.69 49.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 O-C-N 126.791 2.557 . . . . 0.0 105.717 -176.492 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.89 145.03 26.84 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 128.682 3.738 . . . . 0.0 108.222 171.886 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -77.59 119.15 20.74 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 126.609 2.443 . . . . 0.0 105.876 171.257 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 88.7 mt -82.8 163.98 20.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 178.252 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -104.36 -37.69 7.13 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.866 -171.775 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 123.42 -168.94 15.58 Favored Glycine 0 CA--C 1.531 1.091 0 O-C-N 126.337 2.273 . . . . 0.0 110.363 -177.683 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.924 0 N-CA-C 107.852 -2.099 . . . . 0.0 107.852 -166.417 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.259 9.5 ptt? . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 -74.36 146.31 43.13 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 118.45 -2.656 . . . . 0.0 117.196 169.187 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.336 44.5 pt -130.85 133.92 62.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 115.256 -2.307 . . . . 0.0 107.846 166.788 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -117.64 107.83 14.7 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 -177.644 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 67' ' ' LEU . 22.0 t -108.28 120.97 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.972 2.509 . . . . 0.0 105.046 -170.132 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -96.08 150.12 20.85 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 128.67 3.731 . . . . 0.0 112.502 178.327 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.2 p -113.96 138.14 50.75 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 160.667 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 17.1 mt -53.37 -36.13 61.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -174.864 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 68.9 p -73.48 -11.4 60.44 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 130.038 3.335 . . . . 0.0 113.263 -175.587 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.92 54.08 0.32 Allowed Glycine 0 N--CA 1.441 -1.009 0 C-N-CA 126.992 2.234 . . . . 0.0 113.973 168.872 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -141.27 143.93 34.38 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 121.372 2.586 . . . . 0.0 111.052 166.355 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.6 m -123.97 117.07 23.92 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 167.323 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.9 mm -80.74 118.23 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 160.779 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 m -92.36 128.39 38.19 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 100.594 -3.854 . . . . 0.0 100.594 164.368 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -125.07 140.32 53.0 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 119.066 -2.271 . . . . 0.0 107.327 178.488 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -92.75 131.36 37.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 126.898 2.624 . . . . 0.0 110.905 162.112 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.5 m -134.97 160.02 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 127.522 2.329 . . . . 0.0 111.153 179.25 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.281 20.5 mm-40 -76.18 149.34 82.05 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 115.778 -2.058 . . . . 0.0 111.869 156.465 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.24 -24.56 72.26 Favored 'Trans proline' 0 N--CA 1.442 -1.555 0 CA-C-N 123.915 2.434 . . . . 0.0 114.796 176.418 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.6 t -101.61 20.85 15.37 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 128.871 2.868 . . . . 0.0 112.354 177.617 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.27 11.2 t0 -82.92 155.35 24.1 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 118.117 -2.864 . . . . 0.0 110.699 169.142 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.3 p -81.01 152.74 27.79 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.966 -169.744 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.9 mm -67.11 -12.68 15.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 120.483 -1.386 . . . . 0.0 111.2 167.843 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -71.22 -45.89 62.36 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 120.725 -1.234 . . . . 0.0 111.374 169.398 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -53.17 -34.05 55.21 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 175.403 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.2 t -72.95 -40.57 59.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 117.827 -1.083 . . . . 0.0 108.543 179.242 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -70.63 -37.87 73.83 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 121.867 2.121 . . . . 0.0 111.12 -179.91 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.41 -42.52 87.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 115.265 -2.303 . . . . 0.0 111.814 178.153 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.372 54.6 mttm -76.83 -31.21 56.73 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.472 1.509 . . . . 0.0 113.056 172.925 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.42 ' CG2' HD11 ' A' ' 36' ' ' ILE . 34.8 mt -70.77 -37.89 70.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 1 O-C-N 115.737 -4.352 . . . . 0.0 109.292 174.117 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -54.56 -37.8 65.88 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 122.759 2.527 . . . . 0.0 117.744 160.572 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -64.44 -39.75 94.42 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 112.16 -2.291 . . . . 0.0 115.416 -179.95 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -86.68 -69.11 0.7 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 127.38 2.272 . . . . 0.0 107.157 -174.225 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -83.42 -15.82 48.24 Favored 'General case' 0 C--N 1.32 -0.712 0 O-C-N 125.945 2.028 . . . . 0.0 114.341 -161.554 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.25 8.62 68.3 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 117.276 -3.39 . . . . 0.0 115.8 175.708 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.42 HD11 ' CG2' ' A' ' 30' ' ' ILE . 5.2 pt -99.8 123.61 46.94 Favored Pre-proline 0 N--CA 1.446 -0.65 0 CA-C-O 113.426 -3.178 . . . . 0.0 112.455 -168.844 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -60.72 137.27 71.99 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 CA-C-N 127.587 3.745 . . . . 0.0 110.968 -179.136 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -64.78 -8.91 19.1 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.801 2.334 . . . . 0.0 113.608 177.683 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -75.73 -12.5 60.2 Favored 'General case' 0 N--CA 1.452 -0.341 1 CA-C-N 127.09 4.495 . . . . 0.0 109.086 172.246 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -87.99 -22.02 24.5 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 127.661 2.384 . . . . 0.0 112.909 -178.85 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.444 ' HB3' HD11 ' A' ' 69' ' ' LEU . 56.9 mt-30 -95.81 131.47 42.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 130.717 3.607 . . . . 0.0 103.232 -165.234 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.287 17.1 mtp180 -126.46 111.01 13.93 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 126.915 2.086 . . . . 0.0 108.432 170.993 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.2 mt -94.4 133.16 38.27 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 117.205 -3.434 . . . . 0.0 114.698 -172.652 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.7 tt -144.37 136.74 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 128.768 2.827 . . . . 0.0 110.254 -155.288 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -140.79 138.23 33.93 Favored 'General case' 0 N--CA 1.446 -0.632 0 O-C-N 125.631 1.832 . . . . 0.0 112.24 172.832 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.59 35.01 7.76 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.049 2.939 . . . . 0.0 115.276 170.184 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.42 -23.88 31.71 Favored Glycine 0 CA--C 1.532 1.119 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.875 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -103.07 125.11 49.65 Favored 'General case' 0 C--N 1.324 -0.52 1 O-C-N 115.655 -4.438 . . . . 0.0 109.026 -160.849 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.446 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 2.4 pm0 -85.04 126.65 33.74 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 127.291 2.87 . . . . 0.0 105.644 174.929 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 mt -96.25 128.05 42.81 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 125.565 1.791 . . . . 0.0 109.463 -163.062 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -72.46 130.23 40.2 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -178.29 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -62.12 123.57 18.5 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 129.797 3.239 . . . . 0.0 112.299 -173.362 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.97 -6.06 51.05 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 112.117 -2.31 . . . . 0.0 114.807 173.239 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmp_? -72.77 163.81 27.53 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 118.25 1.025 . . . . 0.0 112.539 167.003 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.0 p -99.43 154.09 18.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 123.848 1.785 . . . . 0.0 114.433 174.311 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.375 11.5 mt -53.99 -48.87 69.95 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 116.775 -3.703 . . . . 0.0 110.53 -173.953 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.279 33.0 t -57.62 -47.07 83.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.782 2.033 . . . . 0.0 110.401 -177.719 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -70.37 -22.59 62.75 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.141 0.976 . . . . 0.0 110.733 -169.976 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.29 -3.09 54.17 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 131.131 3.772 . . . . 0.0 113.631 170.06 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.443 11.8 m120 80.94 21.86 0.38 Allowed 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 130.191 3.396 . . . . 0.0 116.314 173.695 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 66.9 mt -83.07 112.73 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 117.02 -3.55 . . . . 0.0 106.949 171.757 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -92.84 178.57 5.73 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.563 2.745 . . . . 0.0 112.646 -178.692 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -54.63 137.13 44.44 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.929 1.292 . . . . 0.0 111.995 171.048 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 69.12 23.1 6.57 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 131.694 3.998 . . . . 0.0 112.521 175.575 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 14.3 m -82.63 138.14 34.28 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 117.332 -3.355 . . . . 0.0 105.804 -169.38 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.74 133.36 42.37 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 112.672 -2.058 . . . . 0.0 106.469 -179.664 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.4 ' CD2' HG22 ' A' ' 5' ' ' VAL 0.3 0.0 OUTLIER -149.77 -155.54 0.64 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 119.556 1.071 . . . . 0.0 110.538 172.603 . . . . . . . . 4 4 . 1 . 046 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -158.17 170.21 22.79 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 -168.912 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.444 HD11 ' HB3' ' A' ' 41' ' ' GLN . 22.2 tp -129.32 144.81 51.37 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 128.541 3.65 . . . . 0.0 105.059 -178.173 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.5 t -119.58 124.39 72.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 O-C-N 127.961 3.288 . . . . 0.0 109.691 168.591 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.3 mt -87.32 128.18 35.18 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 126.8 2.04 . . . . 0.0 108.506 172.209 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.251 18.6 tpt180 -158.02 126.93 5.65 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 130.158 3.383 . . . . 0.0 108.425 -166.315 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.2 tp -83.77 144.86 29.04 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 127.292 2.237 . . . . 0.0 106.254 171.65 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 41.1 ttm105 -77.54 145.39 36.95 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 128.636 2.774 . . . . 0.0 110.115 175.787 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.02 -153.1 15.32 Favored Glycine 0 CA--C 1.53 1.023 0 O-C-N 118.404 -2.685 . . . . 0.0 110.271 -178.081 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.883 0 C-N-CA 118.205 -1.95 . . . . 0.0 109.003 -179.666 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.1 ttp . . . . . 0 N--CA 1.468 0.447 0 CA-C-O 113.298 -3.239 . . . . 0.0 107.17 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.18 133.04 52.99 Favored 'General case' 0 N--CA 1.45 -0.442 0 O-C-N 126.357 2.285 . . . . 0.0 114.266 170.552 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -120.54 -176.44 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 119.162 -2.211 . . . . 0.0 109.083 159.109 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -135.38 162.93 31.22 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 177.107 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.457 ' HB ' HD23 ' A' ' 15' ' ' LEU . 12.3 t -134.57 112.44 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 130.023 3.329 . . . . 0.0 106.228 -176.319 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.8 tttt -94.98 120.97 36.1 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 103.946 -2.612 . . . . 0.0 103.946 171.186 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.8 p -67.82 167.18 13.96 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 112.65 -2.068 . . . . 0.0 110.816 172.645 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.611 HD21 ' H ' ' A' ' 71' ' ' LEU . 4.3 mp -64.57 -35.42 80.92 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 119.297 -2.127 . . . . 0.0 113.76 176.891 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.319 17.7 p -67.73 -51.14 52.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 127.433 2.293 . . . . 0.0 109.383 173.544 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.89 31.15 0.6 Allowed Glycine 0 CA--C 1.535 1.329 0 CA-C-O 118.333 -1.26 . . . . 0.0 115.364 174.7 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.1 tttt -86.21 131.51 34.22 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 122.736 3.268 . . . . 0.0 109.929 160.883 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.5 m -105.1 85.47 2.28 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 125.104 1.361 . . . . 0.0 108.862 -175.458 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.275 3.9 mt -87.48 141.13 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 104.174 -2.528 . . . . 0.0 104.174 -174.216 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.2 m -74.63 143.4 44.35 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 169.987 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.457 HD23 ' HB ' ' A' ' 5' ' ' VAL . 2.4 mm? -125.52 127.76 46.93 Favored 'General case' 0 CA--C 1.542 0.635 0 O-C-N 118.057 -2.902 . . . . 0.0 104.636 -175.089 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.8 mp0 -80.86 115.05 20.15 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 130.974 3.71 . . . . 0.0 107.829 172.465 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.5 m -139.9 172.77 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.669 1.188 . . . . 0.0 108.58 -176.446 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -133.05 148.7 70.4 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 131.5 3.92 . . . . 0.0 113.75 148.895 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.32 93.5 Cg_endo -51.03 -15.78 2.17 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 O-C-N 124.904 2.002 . . . . 0.0 116.324 -177.444 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.1 p -92.4 -1.82 56.75 Favored 'General case' 0 N--CA 1.452 -0.336 1 O-C-N 115.539 -4.476 . . . . 0.0 115.599 174.327 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.253 72.0 m-20 -81.05 131.18 35.29 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 118.176 -1.41 . . . . 0.0 111.451 177.176 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.4 p -69.51 160.33 31.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 123.838 0.855 . . . . 0.0 111.044 179.664 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.512 HD12 HD13 ' A' ' 50' ' ' LEU . 17.6 mm -61.08 -34.74 61.38 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 129.036 2.934 . . . . 0.0 106.766 175.99 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.81 -58.98 5.53 Favored 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 127.969 2.508 . . . . 0.0 111.499 175.224 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -51.77 -45.93 63.96 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.712 2.508 . . . . 0.0 113.931 169.367 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.58 -48.07 88.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 O-C-N 124.988 1.43 . . . . 0.0 112.838 174.644 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.448 ' HG3' HD12 ' A' ' 43' ' ' LEU . 20.1 mtmt -57.43 -35.6 70.29 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.858 -3.026 . . . . 0.0 113.678 170.282 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.57 81.29 Favored 'General case' 0 N--CA 1.452 -0.355 1 CA-C-O 111.302 -4.19 . . . . 0.0 109.976 174.433 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -67.59 -29.76 69.19 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 124.042 3.11 . . . . 0.0 111.568 -179.834 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 18.1 mt -81.48 -16.21 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 C-N-CA 126.928 2.091 . . . . 0.0 110.912 -175.67 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -70.01 -49.0 55.75 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 117.52 -3.238 . . . . 0.0 115.488 156.525 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -49.17 -61.29 2.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.573 1.949 . . . . 0.0 115.785 170.374 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.1 tttt -63.23 -46.27 87.71 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 130.388 3.475 . . . . 0.0 114.758 -177.189 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -138.87 -21.82 0.97 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.079 1.752 . . . . 0.0 111.019 -154.99 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.99 1.34 54.96 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 122.091 2.223 . . . . 0.0 109.458 166.972 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.5 mt -81.55 117.27 67.55 Favored Pre-proline 0 N--CA 1.445 -0.675 0 O-C-N 117.163 -3.551 . . . . 0.0 103.909 179.887 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -74.13 164.29 34.67 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.433 2.089 . . . . 0.0 112.0 -172.023 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.252 37.9 Cg_endo -73.67 -37.94 2.73 Favored 'Trans proline' 0 N--CA 1.446 -1.309 1 C-N-CA 126.275 4.65 . . . . 0.0 109.835 -177.401 . . . . . . . . 3 2 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 40' ' ' GLN . 48.2 t0 -80.12 143.75 33.66 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.501 2.321 . . . . 0.0 108.873 170.518 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 39' ' ' ASP . 0.0 OUTLIER 90.05 -31.04 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.206 1.002 . . . . 0.0 109.247 179.304 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -91.1 141.63 28.62 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.07 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -119.95 129.69 54.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 128.134 2.573 . . . . 0.0 110.989 172.243 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.448 HD12 ' HG3' ' A' ' 27' ' ' LYS . 94.1 mt -99.24 151.09 21.41 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 117.656 -3.152 . . . . 0.0 111.341 164.854 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.6 mt -127.11 156.2 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 170.302 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -126.07 136.97 53.56 Favored 'General case' 0 N--CA 1.447 -0.625 1 C-N-CA 133.836 4.855 . . . . 0.0 108.789 157.043 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.49 -100.49 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 128.904 3.877 . . . . 0.0 108.776 179.021 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -134.37 -2.07 3.38 Favored Glycine 0 CA--C 1.527 0.797 0 N-CA-C 105.704 -2.958 . . . . 0.0 105.704 168.691 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -79.93 114.98 19.26 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 118.208 -2.936 . . . . 0.0 105.134 -173.348 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -64.93 126.36 27.74 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 122.982 1.372 . . . . 0.0 109.08 159.907 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.512 HD13 HD12 ' A' ' 23' ' ' ILE . 16.9 mt -90.79 141.8 28.43 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 124.167 1.937 . . . . 0.0 109.846 177.152 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -91.74 143.59 26.38 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 127.975 2.51 . . . . 0.0 109.342 170.75 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -49.51 -44.05 45.97 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 129.732 3.213 . . . . 0.0 112.836 -172.619 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.21 4.25 40.99 Favored Glycine 0 CA--C 1.531 1.062 1 O-C-N 115.423 -4.548 . . . . 0.0 112.788 -163.837 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 61.3 mtt85 -76.84 160.17 29.47 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 120.176 1.988 . . . . 0.0 112.103 164.096 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.8 p -97.93 162.35 13.29 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 127.174 2.796 . . . . 0.0 104.811 175.007 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.415 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 18.7 mt -42.5 -42.9 3.47 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.651 1.98 . . . . 0.0 109.721 157.736 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.3 t -69.02 -28.14 66.3 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 127.455 2.302 . . . . 0.0 110.035 -169.989 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -75.9 -9.07 58.3 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 115.834 1.79 . . . . 0.0 115.834 175.127 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -118.9 11.74 12.65 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.416 1.886 . . . . 0.0 114.052 -179.972 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 60.91 29.02 18.76 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 126.808 2.043 . . . . 0.0 115.679 179.9 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 24.2 mt -96.33 105.04 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 124.25 1.976 . . . . 0.0 108.541 -170.077 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -89.43 178.55 6.29 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 120.01 -1.681 . . . . 0.0 113.074 163.482 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.3 pttp -60.46 161.45 7.45 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 129.936 3.295 . . . . 0.0 115.999 -167.426 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 74.96 2.89 4.09 Favored 'General case' 0 N--CA 1.443 -0.815 1 C-N-CA 133.559 4.743 . . . . 0.0 112.946 175.931 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -71.31 132.46 44.92 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.149 1.78 . . . . 0.0 113.232 -177.093 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 p -97.95 113.0 24.72 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 125.443 1.714 . . . . 0.0 108.343 -176.74 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.8 mp -85.82 156.2 20.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.967 1.307 . . . . 0.0 110.66 173.193 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -127.19 119.72 27.08 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 124.389 2.043 . . . . 0.0 106.166 -174.581 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.9 tt -91.2 120.31 32.01 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.518 3.127 . . . . 0.0 103.871 -174.728 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 22.1 t -114.32 131.02 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-N 112.302 -2.227 . . . . 0.0 106.371 170.459 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.611 ' H ' HD21 ' A' ' 8' ' ' LEU . 12.3 mt -98.33 126.26 43.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 175.181 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -63.4 -48.72 76.65 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 128.69 2.796 . . . . 0.0 113.759 172.448 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 53.0 mt -145.04 173.5 11.84 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 130.05 3.34 . . . . 0.0 105.816 177.833 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -69.33 134.99 49.77 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 126.087 1.755 . . . . 0.0 107.451 178.076 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.49 -34.8 0.48 Allowed Glycine 0 CA--C 1.529 0.962 0 CA-C-O 115.565 -2.797 . . . . 0.0 111.999 179.693 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.195 0 CA-C-O 116.407 -2.329 . . . . 0.0 114.604 179.393 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 ttp . . . . . 0 N--CA 1.466 0.333 0 CA-C-O 116.482 -1.723 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -65.77 132.38 48.6 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 125.01 1.444 . . . . 0.0 113.14 -171.487 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.2 pt -135.56 171.34 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 O-C-N 118.876 -2.39 . . . . 0.0 109.144 174.282 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -114.29 126.06 54.59 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 126.073 2.108 . . . . 0.0 109.156 170.848 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -110.26 147.61 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 105.09 -2.189 . . . . 0.0 105.09 163.777 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.274 62.4 tttt -126.6 125.02 41.24 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 131.439 3.896 . . . . 0.0 113.849 -174.286 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -102.74 162.79 12.64 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 125.81 1.644 . . . . 0.0 108.589 -173.599 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.873 HD13 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -77.83 -16.16 58.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 129.756 3.222 . . . . 0.0 116.891 -167.598 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.2 p -83.81 -0.9 52.98 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 164.035 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.3 27.4 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 127.432 2.444 . . . . 0.0 111.609 171.097 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -67.62 136.2 54.05 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-N 123.377 3.588 . . . . 0.0 115.935 -173.55 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.2 m -113.57 147.89 37.16 Favored 'General case' 0 C--N 1.325 -0.462 1 CA-C-O 129.069 4.271 . . . . 0.0 104.029 174.829 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.276 19.2 pt -127.64 114.8 37.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 109.367 -3.561 . . . . 0.0 110.102 178.451 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 67.4 p -84.94 108.84 17.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 101.807 -3.405 . . . . 0.0 101.807 177.283 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 pp -139.78 154.52 47.41 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 123.409 1.576 . . . . 0.0 111.28 170.011 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.7 tp10 -84.47 133.57 34.47 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.518 2.327 . . . . 0.0 112.467 177.958 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.6 m -123.16 -153.41 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 102.69 -3.078 . . . . 0.0 102.69 168.399 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -151.08 158.83 34.5 Favored Pre-proline 0 N--CA 1.443 -0.794 0 C-N-CA 127.418 2.287 . . . . 0.0 106.556 -173.002 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.81 -32.91 35.69 Favored 'Trans proline' 0 N--CA 1.445 -1.333 1 C-N-CA 126.298 4.665 . . . . 0.0 115.951 174.871 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.8 p -99.11 3.99 46.8 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.885 2.874 . . . . 0.0 112.124 -171.981 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -82.64 145.73 29.5 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 121.311 1.869 . . . . 0.0 110.761 -179.081 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.7 p -85.6 162.68 18.74 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.577 2.351 . . . . 0.0 111.034 169.295 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.334 81.2 mt -53.16 -44.03 51.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 O-C-N 127.253 2.845 . . . . 0.0 115.871 178.501 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 tp10 -49.67 -36.11 23.86 Favored 'General case' 0 C--N 1.33 -0.275 1 C-N-CA 132.255 4.222 . . . . 0.0 115.003 166.974 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -82.92 -11.97 57.73 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 126.462 1.905 . . . . 0.0 114.275 176.407 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -98.79 -41.07 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 C-N-CA 125.006 1.322 . . . . 0.0 111.392 174.648 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mttt -53.68 -45.01 70.18 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 128.991 2.916 . . . . 0.0 109.56 173.793 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.65 -42.79 89.19 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-O 126.428 3.014 . . . . 0.0 111.78 -175.845 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -60.14 -44.33 95.04 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 131.629 3.972 . . . . 0.0 112.8 177.171 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 6.3 mt -79.12 -37.56 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 N-CA-C 104.004 -2.591 . . . . 0.0 104.004 179.764 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 64.5 mt-30 -65.35 -38.95 91.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 124.171 3.169 . . . . 0.0 112.919 179.43 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -59.53 -26.3 65.22 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 112.923 -3.418 . . . . 0.0 115.017 171.241 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.1 mttp -115.18 -28.18 7.03 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 122.117 2.235 . . . . 0.0 111.255 -163.191 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -126.06 -19.28 4.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 127.719 2.408 . . . . 0.0 114.605 -177.215 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.91 16.34 61.46 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 115.909 -2.606 . . . . 0.0 114.362 178.94 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 51.6 mt -87.73 123.7 68.75 Favored Pre-proline 0 N--CA 1.447 -0.625 0 CA-C-N 123.066 3.433 . . . . 0.0 109.469 -163.213 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.449 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 13.9 Cg_endo -73.31 127.63 12.09 Favored 'Trans proline' 0 N--CA 1.453 -0.901 1 O-C-N 128.871 4.09 . . . . 0.0 111.334 -176.523 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 98.6 Cg_endo -82.36 -19.05 6.79 Favored 'Trans proline' 0 N--CA 1.446 -1.321 0 C-N-CA 123.16 2.573 . . . . 0.0 115.047 -157.249 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -69.85 -28.28 65.54 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 115.829 -2.034 . . . . 0.0 110.858 176.604 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.77 9.39 16.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 127.77 3.169 . . . . 0.0 107.453 -164.577 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -110.9 142.34 43.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 123.394 1.569 . . . . 0.0 109.476 -170.403 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.5 ttt180 -126.67 122.36 34.73 Favored 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 130.593 3.557 . . . . 0.0 109.786 162.35 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.8 mt -110.05 115.59 30.04 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 129.643 3.177 . . . . 0.0 107.074 -168.399 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.485 HD13 ' HA ' ' A' ' 49' ' ' GLN . 30.5 mm -97.88 129.35 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 127.823 2.449 . . . . 0.0 115.123 -178.653 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.257 63.8 t80 -143.41 128.68 18.82 Favored 'General case' 0 C--N 1.327 -0.394 1 O-C-N 114.484 -5.135 . . . . 0.0 110.428 168.945 . . . . . . . . 3 2 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.1 38.5 24.34 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 118.19 2.663 . . . . 0.0 118.19 165.457 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.53 -11.39 7.99 Favored Glycine 0 CA--C 1.525 0.712 0 CA-C-O 116.762 -2.132 . . . . 0.0 115.016 164.069 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -149.47 170.98 17.33 Favored 'General case' 0 C--N 1.324 -0.513 1 C-N-CA 131.865 4.066 . . . . 0.0 114.466 -176.119 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.485 ' HA ' HD13 ' A' ' 44' ' ' ILE . 0.3 OUTLIER -54.61 132.73 45.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 128.91 2.884 . . . . 0.0 107.498 154.275 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.3 tp -66.75 138.44 57.38 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 112.067 -2.333 . . . . 0.0 106.394 165.787 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -51.13 145.92 7.13 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.438 1.895 . . . . 0.0 110.659 163.192 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -103.02 109.49 21.05 Favored 'General case' 0 N--CA 1.448 -0.568 1 N-CA-C 96.562 -5.347 . . . . 0.0 96.562 170.504 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.62 35.07 1.94 Allowed Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.783 2.611 . . . . 0.0 116.694 178.707 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? -133.09 132.74 42.09 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 115.927 -1.987 . . . . 0.0 110.043 171.014 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.0 p -75.67 150.57 37.89 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 125.154 2.406 . . . . 0.0 113.351 168.165 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -56.74 -35.68 68.87 Favored 'General case' 0 N--CA 1.441 -0.907 1 O-C-N 115.774 -4.329 . . . . 0.0 118.005 -159.428 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.9 t -75.85 -4.93 43.5 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 129.946 3.298 . . . . 0.0 112.628 176.64 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -77.11 -11.0 59.75 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 120.948 1.704 . . . . 0.0 111.758 169.774 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -113.09 159.12 19.53 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 129.296 3.038 . . . . 0.0 105.04 168.134 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 25.0 t30 -80.5 55.36 2.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 173.61 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -73.1 104.97 2.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.248 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 159.51 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.265 71.1 mm-40 -96.37 169.8 9.68 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 125.604 1.815 . . . . 0.0 114.35 170.49 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 6.1 ptmt -46.84 130.88 12.01 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 119.946 -1.721 . . . . 0.0 112.372 166.251 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.31 8.1 mt-10 77.54 18.85 1.28 Allowed 'General case' 0 N--CA 1.451 -0.383 1 C-N-CA 133.484 4.714 . . . . 0.0 112.185 170.417 . . . . . . . . 3 2 . 1 . 048 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.0 m -74.26 148.03 41.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 117.804 -1.093 . . . . 0.0 112.958 179.165 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.9 m -95.9 104.44 16.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 102.183 -3.265 . . . . 0.0 102.183 -168.22 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.9 tp -87.2 143.69 27.17 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.314 2.646 . . . . 0.0 108.057 166.944 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -124.29 136.65 54.29 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -174.878 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.7 tt -112.93 121.59 45.1 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 126.908 2.083 . . . . 0.0 105.41 178.863 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 t -108.15 146.97 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 C-N-CA 127.487 2.315 . . . . 0.0 106.443 170.984 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.6 tp -77.9 138.51 38.94 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 103.851 -2.648 . . . . 0.0 103.851 -175.11 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? -90.28 113.62 25.5 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 119.732 -1.855 . . . . 0.0 107.361 163.846 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.7 pp -61.86 159.59 13.64 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.89 2.476 . . . . 0.0 111.158 -175.712 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.4 mmt-85 -123.47 48.87 1.77 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 124.632 2.158 . . . . 0.0 108.498 173.241 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -108.97 12.37 34.5 Favored Glycine 0 CA--C 1.532 1.111 1 C-N-CA 131.661 4.458 . . . . 0.0 111.536 172.008 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.487 0 CA-C-O 114.656 -3.302 . . . . 0.0 111.311 -163.252 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.473 0.698 0 CA-C-O 122.407 1.098 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -79.12 135.24 36.78 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 112.528 -2.124 . . . . 0.0 110.517 -178.999 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -128.46 172.7 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 128.964 2.905 . . . . 0.0 109.709 173.636 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -116.79 153.37 32.55 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.363 2.665 . . . . 0.0 108.32 173.228 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.508 9.1 p -133.36 133.88 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 C-N-CA 129.045 2.938 . . . . 0.0 107.454 177.863 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -88.0 118.81 27.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 156.458 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -64.79 162.54 15.87 Favored 'General case' 0 C--N 1.324 -0.542 1 C-N-CA 132.924 4.49 . . . . 0.0 107.788 167.545 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 75.1 mt -78.98 -11.56 60.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 123.749 1.738 . . . . 0.0 114.248 -173.141 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.1 p -91.99 -14.69 29.05 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.288 1.435 . . . . 0.0 111.575 173.753 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 118.62 -2.3 15.55 Favored Glycine 0 CA--C 1.535 1.31 1 O-C-N 113.447 -5.783 . . . . 0.0 111.491 165.994 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -88.27 134.39 33.81 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 127.744 2.418 . . . . 0.0 108.611 -172.682 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.09 146.91 52.25 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.34 166.083 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.533 57.2 mt -125.81 130.77 72.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 O-C-N 126.595 2.434 . . . . 0.0 109.223 152.901 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.26 90.8 m -83.73 130.57 34.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 103.67 -2.715 . . . . 0.0 103.67 171.845 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.1 tp -135.77 142.35 44.94 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 115.912 -1.994 . . . . 0.0 113.95 -174.42 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -94.28 128.23 40.63 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 131.211 3.804 . . . . 0.0 106.904 175.244 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -139.52 144.22 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 O-C-N 120.089 -1.632 . . . . 0.0 111.902 172.362 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.439 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.4 OUTLIER -76.56 148.74 80.35 Favored Pre-proline 0 N--CA 1.447 -0.601 0 C-N-CA 126.305 1.842 . . . . 0.0 109.583 173.217 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.52 -41.82 18.61 Favored 'Trans proline' 0 N--CA 1.447 -1.215 1 C-N-CA 128.543 6.162 . . . . 0.0 109.731 159.057 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 95.9 p -66.54 -5.91 13.07 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 128.566 2.746 . . . . 0.0 117.898 170.668 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 18' ' ' GLU . 3.0 t0 -88.61 145.94 25.4 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 117.434 -3.291 . . . . 0.0 105.097 -175.841 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.0 p -98.67 145.56 26.76 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 127.628 2.371 . . . . 0.0 115.901 -177.625 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.331 44.6 mm -42.0 -49.72 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 118.181 2.66 . . . . 0.0 118.181 -176.575 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -75.87 -31.34 59.21 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 126.456 3.027 . . . . 0.0 114.306 -175.997 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -73.68 -35.37 65.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 116.499 -3.876 . . . . 0.0 113.085 172.637 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 87.0 t -72.21 -36.07 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 1 CA-C-O 111.127 -4.273 . . . . 0.0 112.252 169.817 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -61.47 -29.06 69.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 124.184 3.175 . . . . 0.0 114.39 162.68 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.334 . . -68.61 -31.21 70.22 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 126.77 2.544 . . . . 0.0 110.526 175.249 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -74.25 -19.32 60.55 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 122.458 2.39 . . . . 0.0 114.573 174.322 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 26.4 mm -76.71 -27.89 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 125.767 1.627 . . . . 0.0 114.047 161.629 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -63.28 -37.82 88.73 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -176.378 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -41.34 -53.9 3.16 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.477 1.511 . . . . 0.0 113.495 166.273 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -91.04 -46.32 8.2 Favored 'General case' 0 N--CA 1.45 -0.449 1 O-C-N 129.138 4.024 . . . . 0.0 107.038 -159.482 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -96.11 -32.63 12.42 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 119.092 -2.255 . . . . 0.0 113.503 -172.754 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.13 -31.33 8.67 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 116.857 -2.08 . . . . 0.0 108.654 175.264 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.271 8.3 mm -47.98 116.76 4.97 Favored Pre-proline 0 N--CA 1.452 -0.369 0 N-CA-C 119.419 3.118 . . . . 0.0 119.419 175.38 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -63.8 152.2 81.7 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 CA-C-N 124.032 2.476 . . . . 0.0 108.223 176.784 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -52.67 -36.61 72.87 Favored 'Trans proline' 0 N--CA 1.453 -0.864 1 C-N-CA 128.596 6.197 . . . . 0.0 116.023 175.274 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -77.18 -17.59 58.43 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 128.831 2.852 . . . . 0.0 113.938 177.804 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.265 9.3 mm-40 -91.64 -9.72 42.99 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 115.641 -2.123 . . . . 0.0 112.722 166.539 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -108.81 130.13 55.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 -167.244 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -118.2 -176.18 3.01 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 119.863 -1.773 . . . . 0.0 109.242 156.365 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.87 123.63 3.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 N-CA-C 102.127 -3.286 . . . . 0.0 102.127 177.216 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 10.4 mm -108.86 122.4 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 N-CA-C 102.64 -3.096 . . . . 0.0 102.64 -176.917 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -138.66 108.39 6.26 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.434 3.894 . . . . 0.0 109.434 -167.407 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 68.07 27.2 7.05 Favored 'General case' 0 N--CA 1.443 -0.821 1 C-N-CA 131.743 4.017 . . . . 0.0 115.972 177.665 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.37 17.13 20.79 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 106.448 -2.661 . . . . 0.0 106.448 170.05 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.302 65.6 pttt -150.71 159.46 44.5 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 126.911 2.084 . . . . 0.0 115.687 -171.698 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -79.62 148.2 31.76 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 131.344 3.858 . . . . 0.0 116.711 162.593 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 78.9 mt -100.24 118.45 36.57 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 128.354 3.534 . . . . 0.0 101.728 174.237 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.283 7.8 tp10 -87.3 157.15 19.36 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 121.226 -0.921 . . . . 0.0 109.052 -175.621 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.07 155.31 39.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 126.984 2.114 . . . . 0.0 110.675 -177.626 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.11 -14.38 57.48 Favored Glycine 0 N--CA 1.443 -0.897 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.991 175.229 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -90.65 149.34 22.13 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -176.342 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.8 p -79.19 174.29 11.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 117.326 -3.359 . . . . 0.0 109.154 167.135 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mp -76.61 -22.88 53.58 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 117.039 -3.538 . . . . 0.0 112.587 174.309 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 t -70.26 -29.14 65.85 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 127.517 2.327 . . . . 0.0 112.689 171.321 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -65.47 -32.32 73.86 Favored 'General case' 0 C--N 1.322 -0.6 1 O-C-N 115.843 -4.286 . . . . 0.0 111.934 173.174 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -110.86 6.21 21.12 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 119.841 -1.787 . . . . 0.0 106.738 -169.687 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.361 1.6 p-10 57.21 41.44 26.95 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 124.701 2.191 . . . . 0.0 113.878 167.838 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.2 mt -90.56 122.38 41.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 129.991 3.316 . . . . 0.0 106.241 -176.599 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.287 21.3 mm-40 -115.27 -176.6 2.95 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 130.537 3.535 . . . . 0.0 116.22 176.242 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.9 pttt -51.42 161.88 0.41 Allowed 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 123.277 2.762 . . . . 0.0 116.065 159.83 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 85.16 1.37 0.74 Allowed 'General case' 0 C--N 1.325 -0.496 1 C-N-CA 133.301 4.64 . . . . 0.0 111.214 171.136 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.2 m -82.04 107.46 14.76 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 -177.373 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -84.37 110.66 18.78 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 127.553 2.341 . . . . 0.0 111.279 157.158 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.1 mt -76.46 162.67 27.64 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 120.118 -1.614 . . . . 0.0 115.16 170.019 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 -119.94 147.56 44.6 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.961 2.104 . . . . 0.0 110.369 150.687 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.68 149.4 21.84 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 129.104 2.962 . . . . 0.0 111.947 171.317 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.4 m -133.74 155.96 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 O-C-N 117.839 -3.038 . . . . 0.0 115.452 168.722 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.5 mt -99.2 141.46 31.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 122.633 2.47 . . . . 0.0 105.712 -170.923 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 mtp180 -84.81 153.87 22.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 125.447 3.749 . . . . 0.0 111.709 149.578 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.256 18.8 tp -84.38 -44.53 13.66 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 118.286 -2.759 . . . . 0.0 113.994 166.906 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -77.85 144.12 37.27 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 127.504 2.322 . . . . 0.0 107.748 -174.331 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.81 -127.77 4.21 Favored Glycine 0 CA--C 1.534 1.267 0 N-CA-C 106.992 -2.443 . . . . 0.0 106.992 174.004 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.936 0 CA-C-O 124.997 2.443 . . . . 0.0 112.097 -168.349 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 ttp . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 100.425 -3.917 . . . . 0.0 100.425 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -72.14 137.46 47.01 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 111.648 -2.524 . . . . 0.0 110.999 -175.108 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.305 10.9 pt -141.17 170.74 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.654 0 O-C-N 125.678 1.861 . . . . 0.0 111.268 173.106 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -122.37 138.95 54.35 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 107.132 177.428 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.5 t -124.64 117.66 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 101.875 -3.38 . . . . 0.0 101.875 173.298 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -78.87 135.38 37.0 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 125.327 2.489 . . . . 0.0 112.838 165.395 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 p -80.16 -169.43 2.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 118.746 -2.471 . . . . 0.0 110.023 -179.398 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.5 mt -61.82 -40.41 95.2 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -165.909 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.8 p -103.04 9.01 38.78 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 111.338 -2.665 . . . . 0.0 112.739 -176.266 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.64 -0.73 59.67 Favored Glycine 0 CA--C 1.535 1.32 0 C-N-CA 128.655 3.026 . . . . 0.0 117.841 170.469 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.8 tttm -73.4 129.29 37.69 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 119.949 1.874 . . . . 0.0 110.771 177.199 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.6 t -81.04 136.37 35.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 126.785 2.034 . . . . 0.0 113.72 -177.945 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 pt -114.15 120.14 63.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 N-CA-C 102.671 -3.085 . . . . 0.0 102.671 168.681 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 46.8 m -86.66 112.88 22.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.04 2.536 . . . . 0.0 108.86 -179.836 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.83 170.07 8.14 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 129.153 2.981 . . . . 0.0 104.346 -170.698 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.484 1.1 pm0 -132.79 124.39 27.94 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 131.297 3.839 . . . . 0.0 118.965 162.99 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.334 0.0 OUTLIER -143.85 154.14 15.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 113.909 -1.496 . . . . 0.0 113.898 -175.345 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -88.97 151.08 46.63 Favored Pre-proline 0 N--CA 1.452 -0.367 0 O-C-N 119.67 -1.894 . . . . 0.0 108.828 176.919 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.29 -30.09 10.54 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 124.907 3.738 . . . . 0.0 117.53 165.835 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.303 16.8 p -96.99 12.84 31.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 129.201 3.001 . . . . 0.0 112.714 170.799 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -82.81 142.35 31.61 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 123.421 2.828 . . . . 0.0 108.104 167.513 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 p -81.8 177.9 8.62 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 131.565 3.946 . . . . 0.0 111.285 -177.573 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -89.21 -18.96 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 O-C-N 116.575 -3.828 . . . . 0.0 111.321 -170.803 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -57.76 -37.66 74.04 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 118.795 -0.621 . . . . 0.0 112.102 157.432 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 m-20 -85.11 5.26 30.5 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 123.71 1.719 . . . . 0.0 110.425 -172.616 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.25 -37.41 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 O-C-N 118.08 -2.887 . . . . 0.0 110.06 156.475 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -56.78 -52.65 64.21 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 116.571 -3.831 . . . . 0.0 110.083 174.846 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.7 -33.3 46.99 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 118.086 2.625 . . . . 0.0 118.086 179.502 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -83.18 -26.54 30.77 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 111.553 -2.567 . . . . 0.0 116.126 178.443 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.0 mt -68.38 -38.96 80.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 115.758 -2.067 . . . . 0.0 108.838 160.666 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -64.15 -34.19 77.51 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 117.832 -1.08 . . . . 0.0 109.921 174.457 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.44 -34.67 77.68 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 116.767 2.136 . . . . 0.0 116.767 -179.091 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -102.24 -25.21 13.77 Favored 'General case' 0 N--CA 1.45 -0.462 0 O-C-N 127.651 3.094 . . . . 0.0 117.937 -176.713 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -141.15 -16.24 0.85 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.627 2.371 . . . . 0.0 112.352 -171.599 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.06 -3.89 67.31 Favored Glycine 0 CA--C 1.531 1.04 0 O-C-N 120.217 -1.552 . . . . 0.0 113.699 152.157 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.3 mt -73.3 132.65 81.65 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-O 114.055 -2.879 . . . . 0.0 106.037 -176.953 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -70.6 132.56 22.21 Favored 'Trans proline' 0 N--CA 1.454 -0.81 1 C-N-CA 127.118 5.212 . . . . 0.0 106.856 -171.274 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -40.2 -30.68 0.46 Allowed 'Trans proline' 0 N--CA 1.449 -1.137 1 C-N-CA 130.445 7.43 . . . . 0.0 119.604 177.503 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.76 -39.07 84.2 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 127.448 2.299 . . . . 0.0 113.725 175.744 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.32 -16.15 55.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 115.248 -2.311 . . . . 0.0 112.64 -175.707 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -81.46 130.89 35.22 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.76 2.824 . . . . 0.0 111.638 -172.696 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -121.47 131.93 54.44 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 103.354 -2.832 . . . . 0.0 103.354 168.688 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 mt -103.0 137.82 40.69 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 119.914 1.234 . . . . 0.0 110.488 166.649 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mm -122.61 148.66 26.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 129.925 3.29 . . . . 0.0 107.862 177.341 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -153.88 127.58 8.75 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.177 1.791 . . . . 0.0 110.038 173.919 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.37 40.39 10.72 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 127.048 2.139 . . . . 0.0 115.08 -172.536 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.64 -13.08 68.32 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 117.638 1.815 . . . . 0.0 117.638 177.559 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.399 55.3 pttt -123.78 148.34 46.75 Favored 'General case' 0 C--N 1.326 -0.437 1 C-N-CA 133.353 4.661 . . . . 0.0 108.212 -161.691 . . . . . . . . 3 2 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -71.3 155.33 40.8 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 118.388 -2.695 . . . . 0.0 109.245 -169.277 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.1 mt -136.23 114.08 11.2 Favored 'General case' 0 N--CA 1.451 -0.388 1 N-CA-C 99.523 -4.251 . . . . 0.0 99.523 177.885 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -123.31 155.49 37.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 126.335 2.969 . . . . 0.0 111.895 -169.186 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -67.26 145.28 55.34 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.013 -2.929 . . . . 0.0 108.668 -178.246 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.07 -6.7 19.43 Favored Glycine 0 CA--C 1.528 0.886 0 O-C-N 127.148 2.78 . . . . 0.0 113.977 -173.756 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -135.35 -175.56 3.98 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.414 1.486 . . . . 0.0 113.032 -179.509 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.6 p -128.39 175.17 8.71 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.288 1.035 . . . . 0.0 109.787 -178.856 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.9 mp -55.05 -36.44 65.56 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 126.532 1.933 . . . . 0.0 113.703 171.423 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.328 13.0 m -75.6 -25.61 57.14 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 115.622 -2.431 . . . . 0.0 113.6 177.159 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -70.46 -41.61 72.54 Favored 'General case' 0 N--CA 1.45 -0.451 2 CA-C-N 126.516 4.235 . . . . 0.0 112.817 173.196 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -82.09 -12.63 58.12 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 124.742 1.276 . . . . 0.0 110.8 -176.212 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.5 m120 72.76 58.91 0.12 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 130.554 3.542 . . . . 0.0 114.984 175.836 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -100.69 159.05 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 112.504 -2.134 . . . . 0.0 109.814 -177.933 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -130.52 -151.73 0.48 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.684 1.194 . . . . 0.0 112.188 -176.614 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -90.34 144.64 25.64 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.427 2.291 . . . . 0.0 107.444 175.874 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 77.01 19.75 1.33 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 125.213 2.435 . . . . 0.0 111.073 161.895 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.7 m -87.78 133.42 33.87 Favored 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 127.97 2.508 . . . . 0.0 115.278 -178.025 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.1 m -111.93 125.36 53.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 123.608 2.913 . . . . 0.0 104.24 -170.787 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mt -103.05 166.32 10.51 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.313 2.245 . . . . 0.0 111.281 173.518 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -109.43 134.01 52.37 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 118.669 -2.52 . . . . 0.0 105.282 164.99 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.288 1.5 tm? -90.01 140.22 29.85 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 125.088 1.355 . . . . 0.0 109.696 154.033 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.92 156.22 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 128.869 2.868 . . . . 0.0 111.616 164.012 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.0 124.77 30.07 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.908 1.683 . . . . 0.0 108.812 171.529 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -173.44 97.88 0.11 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 111.63 -2.532 . . . . 0.0 109.865 -176.148 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.66 112.63 4.27 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 118.242 -2.786 . . . . 0.0 106.719 179.663 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.35 -55.4 0.44 Allowed 'General case' 0 N--CA 1.452 -0.372 1 N-CA-C 97.11 -5.144 . . . . 0.0 97.11 170.814 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.06 -142.24 15.56 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 117.302 -3.374 . . . . 0.0 111.538 -175.905 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.863 0 CA-C-N 121.397 2.598 . . . . 0.0 110.686 -174.149 . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.9 ptm . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 123.732 1.729 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 051 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -103.4 120.45 40.83 Favored 'General case' 0 N--CA 1.445 -0.71 0 O-C-N 119.613 -1.93 . . . . 0.0 107.175 178.3 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.9 pt -121.92 131.22 73.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.715 -1.13 . . . . 0.0 113.056 170.42 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -86.86 81.44 8.15 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.629 2.372 . . . . 0.0 109.166 -174.358 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -65.41 132.54 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 C-N-CA 125.981 1.713 . . . . 0.0 108.682 169.246 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -123.24 152.78 40.97 Favored 'General case' 0 N--CA 1.446 -0.651 0 O-C-N 119.972 -1.705 . . . . 0.0 109.562 172.923 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.3 p -117.73 -177.44 3.25 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 126.478 3.037 . . . . 0.0 109.585 -165.296 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -77.68 -42.4 34.71 Favored 'General case' 0 N--CA 1.446 -0.656 1 O-C-N 115.899 -4.251 . . . . 0.0 104.669 174.38 . . . . . . . . 4 4 . 1 . 051 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.0 p -69.89 -19.08 63.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 123.22 2.736 . . . . 0.0 112.772 -176.316 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.38 32.16 2.62 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.044 0.83 . . . . 0.0 113.112 156.982 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.8 mptt -110.68 146.27 36.52 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 114.22 -2.8 . . . . 0.0 110.088 -167.113 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.261 43.1 m -99.57 89.71 4.24 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 173.802 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mm -52.47 -57.93 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 120.757 1.617 . . . . 0.0 112.209 -173.848 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.317 75.5 m 79.3 81.91 0.06 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -178.675 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 tp -99.15 138.65 35.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 124.984 2.326 . . . . 0.0 106.61 -178.877 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -91.35 121.52 33.15 Favored 'General case' 0 N--CA 1.451 -0.395 0 O-C-N 120.223 -1.548 . . . . 0.0 107.916 170.896 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.401 4.8 t -121.56 152.24 25.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 103.831 -2.655 . . . . 0.0 103.831 -175.547 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -104.36 136.0 19.25 Favored Pre-proline 0 N--CA 1.452 -0.357 0 CA-C-O 114.624 -2.608 . . . . 0.0 109.384 170.909 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -57.7 -18.09 31.94 Favored 'Trans proline' 0 N--CA 1.449 -1.137 0 N-CA-C 118.609 2.503 . . . . 0.0 118.609 -174.773 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.7 p -74.08 -15.07 61.07 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 127.655 2.382 . . . . 0.0 114.427 168.93 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 25' ' ' ASN . 92.8 m-20 -66.39 129.01 38.39 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 122.72 2.509 . . . . 0.0 110.698 -176.026 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.6 p -85.37 174.67 9.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 120.971 1.714 . . . . 0.0 108.389 163.243 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.255 27.4 mm -46.7 -39.02 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 128.707 2.803 . . . . 0.0 115.899 176.592 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -59.02 -43.27 91.56 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-O 115.716 -2.088 . . . . 0.0 111.058 174.996 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.486 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 29.7 m120 -73.23 -36.06 66.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 127.476 2.31 . . . . 0.0 109.561 -172.513 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.29 -55.13 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 C-N-CA 124.467 1.107 . . . . 0.0 110.512 172.989 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.263 78.7 mttt -43.5 -44.47 6.0 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 127.239 2.216 . . . . 0.0 113.512 169.718 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.22 -53.26 59.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.298 2.239 . . . . 0.0 110.097 177.506 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.5 mttp -62.37 -33.26 74.4 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 116.705 2.113 . . . . 0.0 116.705 179.976 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 77.8 mt -68.02 -44.72 84.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 O-C-N 126.946 2.654 . . . . 0.0 109.873 165.878 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -46.15 91.84 Favored 'General case' 0 N--CA 1.441 -0.909 0 O-C-N 125.368 1.667 . . . . 0.0 114.106 -178.977 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.446 27.8 t70 -34.45 -61.32 0.39 Allowed 'General case' 0 N--CA 1.448 -0.549 1 N-CA-C 124.403 4.964 . . . . 0.0 124.403 152.451 . . . . . . . . 3 2 . 1 . 051 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -95.19 -30.23 14.12 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 119.892 -1.755 . . . . 0.0 111.405 -156.764 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -109.25 -27.79 9.35 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 128.806 2.843 . . . . 0.0 110.709 -179.978 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.58 -3.15 61.0 Favored Glycine 0 CA--C 1.533 1.21 0 N-CA-C 121.428 3.331 . . . . 0.0 121.428 167.674 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -85.15 145.19 42.5 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-O 114.054 -2.879 . . . . 0.0 109.715 -179.88 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -64.23 161.59 33.48 Favored 'Trans proline' 0 N--CA 1.45 -1.039 1 C-N-CA 126.781 4.987 . . . . 0.0 109.986 174.039 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -83.82 -13.07 8.28 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 124.724 3.616 . . . . 0.0 115.242 -171.949 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.55 -36.21 63.11 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 116.699 2.111 . . . . 0.0 116.699 160.586 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' ' 40' ' ' GLN . 2.5 tt0 -67.78 -23.48 65.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 117.286 -1.34 . . . . 0.0 113.508 179.57 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -85.23 129.1 34.87 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 113.839 -2.981 . . . . 0.0 106.042 -168.484 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 89.4 mtt180 -110.68 160.05 17.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.375 -2.454 . . . . 0.0 104.375 155.165 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.519 0.2 OUTLIER -136.44 135.51 38.72 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 119.112 -2.243 . . . . 0.0 114.98 176.686 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 14.0 mt -127.47 108.64 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -159.469 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -124.19 130.98 53.46 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 125.858 1.663 . . . . 0.0 110.369 171.787 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.09 50.54 13.96 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 130.398 3.479 . . . . 0.0 110.68 175.304 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.1 -34.3 3.99 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 126.841 2.162 . . . . 0.0 117.173 178.839 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -89.04 132.05 34.94 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -164.134 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.259 24.5 mt-30 -88.71 104.31 16.76 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 123.835 1.778 . . . . 0.0 108.949 168.373 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.5 mt -55.86 138.35 48.52 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 110.426 -3.079 . . . . 0.0 113.298 -166.529 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -88.64 152.49 21.79 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 116.423 -1.751 . . . . 0.0 106.851 -172.121 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -68.59 134.76 50.46 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 114.58 -2.629 . . . . 0.0 114.885 -173.671 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 76.83 16.92 80.35 Favored Glycine 0 CA--C 1.534 1.245 0 N-CA-C 117.384 1.713 . . . . 0.0 117.384 172.614 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.0 mmm-85 -99.21 176.98 5.35 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 126.887 2.075 . . . . 0.0 107.583 178.448 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.5 p -100.05 141.24 33.14 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 102.371 -3.196 . . . . 0.0 102.371 -172.622 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.448 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 21.7 mt -66.26 -30.81 71.32 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 127.529 2.332 . . . . 0.0 113.071 179.661 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.3 m -87.17 -22.13 25.5 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.321 -166.802 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -76.02 -15.89 60.05 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 124.864 1.352 . . . . 0.0 114.314 173.658 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -92.84 5.62 50.62 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 126.847 2.059 . . . . 0.0 109.299 168.135 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 75.94 21.74 1.54 Allowed 'General case' 0 N--CA 1.444 -0.765 1 C-N-CA 134.007 4.923 . . . . 0.0 118.322 170.164 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 mt -82.33 103.69 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 C-N-CA 128.144 2.578 . . . . 0.0 107.543 -169.069 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.3 mm-40 -89.5 170.44 10.5 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.059 2.143 . . . . 0.0 109.63 177.084 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.3 pttt -66.76 159.01 28.87 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 116.991 -1.48 . . . . 0.0 113.586 159.632 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 68.35 18.88 9.07 Favored 'General case' 0 N--CA 1.453 -0.318 1 C-N-CA 132.913 4.485 . . . . 0.0 111.032 179.359 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 33.1 t -95.94 178.39 5.44 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 128.731 3.769 . . . . 0.0 112.182 -176.433 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.2 p -131.85 133.71 44.95 Favored 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 125.798 1.936 . . . . 0.0 111.072 -171.971 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.0 mp -131.19 150.91 51.94 Favored 'General case' 0 N--CA 1.445 -0.715 0 O-C-N 126.279 2.237 . . . . 0.0 105.468 -171.704 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -108.2 119.67 40.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 117.942 -2.974 . . . . 0.0 110.953 171.663 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.3 tp -82.4 133.78 35.22 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 173.43 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.291 68.7 t -108.61 141.28 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 125.149 3.613 . . . . 0.0 107.495 163.257 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.437 HD13 HD23 ' A' ' 8' ' ' LEU . 4.8 mp -83.8 149.02 26.69 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 167.113 . . . . . . . . 2 2 . 1 . 051 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.36 0.0 OUTLIER -58.02 -7.82 0.88 Allowed 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 129.972 3.309 . . . . 0.0 116.259 171.235 . . . . . . . . 3 3 . 1 . 051 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.24 155.77 19.57 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.655 1.982 . . . . 0.0 109.971 177.354 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.1 mtt180 -99.41 130.99 45.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 125.471 2.558 . . . . 0.0 105.99 -167.963 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 124.18 -172.31 16.61 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 113.989 -1.459 . . . . 0.0 112.49 179.63 . . . . . . . . 1 1 . 1 . 051 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 113.405 -3.997 . . . . 0.0 106.835 174.511 . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.0 ttp . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 116.627 -1.654 . . . . 0.0 108.069 . . . . . . . . . 0 0 . 1 . 052 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.3 tm0? -73.12 133.1 44.0 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 122.407 2.367 . . . . 0.0 115.765 176.167 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.446 HD12 HD23 ' A' ' 67' ' ' LEU . 42.0 pt -122.3 155.3 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 115.647 -2.12 . . . . 0.0 112.551 165.084 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -102.5 128.37 49.17 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 126.046 2.091 . . . . 0.0 105.658 179.262 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.1 t -100.54 109.6 25.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 118.047 -2.908 . . . . 0.0 103.383 166.066 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.5 tttm -102.95 150.3 23.67 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.447 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.283 14.8 t -145.48 160.32 41.77 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-O 125.27 2.462 . . . . 0.0 109.217 158.243 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.453 HD13 ' CE1' ' A' ' 68' ' ' HIS . 2.0 mp -67.71 -39.71 84.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 109.114 -3.675 . . . . 0.0 114.365 -161.914 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.3 p -52.48 -5.17 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 1 C-N-CA 133.435 4.694 . . . . 0.0 115.728 171.486 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.27 2.09 54.11 Favored Glycine 0 CA--C 1.53 0.996 0 O-C-N 119.911 -1.743 . . . . 0.0 112.772 167.228 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -79.7 126.46 30.96 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 120.185 1.993 . . . . 0.0 110.096 164.308 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 m -128.2 101.96 6.49 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 103.244 -2.872 . . . . 0.0 103.244 171.031 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.266 2.8 mp -80.26 150.07 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 130.741 3.616 . . . . 0.0 110.457 -177.462 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.7 t -135.91 122.1 20.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.636 1.575 . . . . 0.0 108.241 -175.885 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 94.5 mt -123.14 147.52 46.72 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.773 1.229 . . . . 0.0 113.845 175.221 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -97.43 121.23 39.09 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 131.093 3.757 . . . . 0.0 105.605 177.162 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.2 m -131.04 166.72 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 O-C-N 118.494 -2.629 . . . . 0.0 114.481 178.474 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -95.69 156.71 37.08 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 102.513 -3.143 . . . . 0.0 102.513 155.65 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.28 -20.04 69.68 Favored 'Trans proline' 0 N--CA 1.446 -1.279 0 C-N-CA 123.64 2.893 . . . . 0.0 113.15 -179.891 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 13.6 p -91.78 0.33 57.49 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -175.945 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -66.33 142.85 57.49 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 176.562 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -86.33 147.49 26.03 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 125.216 2.436 . . . . 0.0 109.043 178.356 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.2 mt -55.75 -26.46 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 O-C-N 118.903 -2.373 . . . . 0.0 113.149 179.603 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.287 31.9 mt-10 -74.07 -42.66 59.84 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.463 1.105 . . . . 0.0 109.422 -178.535 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -63.01 -50.4 70.88 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 116.733 -1.603 . . . . 0.0 111.513 175.499 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.1 t -55.57 -31.1 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-O 115.612 -2.137 . . . . 0.0 111.835 166.029 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.9 mttt -76.71 -17.56 59.03 Favored 'General case' 0 N--CA 1.442 -0.834 2 CA-C-N 128.092 4.951 . . . . 0.0 109.66 -177.267 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -91.42 -19.99 22.27 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.516 1.126 . . . . 0.0 113.215 172.273 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -73.76 -29.72 62.37 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 170.785 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 30' ' ' ILE . 56.9 mt -64.79 -30.78 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 128.834 2.854 . . . . 0.0 115.148 160.309 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -65.71 -53.51 39.92 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.62 1.1 . . . . 0.0 111.776 173.094 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.401 22.9 t70 -36.99 -34.16 0.07 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 131.514 3.926 . . . . 0.0 112.485 168.283 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -93.78 -57.99 2.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 120.582 1.537 . . . . 0.0 115.038 171.816 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -89.26 -21.14 23.35 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 115.151 1.537 . . . . 0.0 115.151 -161.268 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.99 1.95 62.81 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 119.312 2.485 . . . . 0.0 119.312 -174.905 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 88.0 mt -95.86 140.87 22.49 Favored Pre-proline 0 C--O 1.234 0.258 0 C-N-CA 128.191 2.596 . . . . 0.0 110.874 -163.234 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -80.59 136.53 10.98 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.765 2.977 . . . . 0.0 115.604 172.774 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -66.47 -21.21 53.62 Favored 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 124.562 3.508 . . . . 0.0 116.093 -158.047 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -77.31 4.78 9.91 Favored 'General case' 0 N--CA 1.442 -0.836 0 O-C-N 117.907 -2.996 . . . . 0.0 110.94 -176.884 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -95.36 -18.96 20.32 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 113.172 -3.299 . . . . 0.0 109.083 168.062 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.284 13.4 mm-40 -98.0 125.05 42.77 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 124.678 3.399 . . . . 0.0 112.319 -160.835 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 127.5 42.78 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 100.635 -3.839 . . . . 0.0 100.635 -178.772 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 72.7 mt -101.89 134.78 44.54 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 128.683 2.793 . . . . 0.0 115.096 179.688 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mt -128.74 156.65 41.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 126.458 1.903 . . . . 0.0 107.209 167.753 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.491 ' HB3' HD21 ' A' ' 50' ' ' LEU 0.368 6.7 t80 -126.61 -126.65 0.23 Allowed 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 109.711 -3.404 . . . . 0.0 107.945 -157.76 . . . . . . . . 3 3 . 1 . 052 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.75 44.57 1.07 Allowed 'General case' 0 C--N 1.324 -0.54 1 C-N-CA 132.243 4.217 . . . . 0.0 110.777 169.994 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 104.9 -22.22 34.13 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 128.328 2.87 . . . . 0.0 114.493 -177.715 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -86.93 126.01 34.42 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -171.268 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 mp0 -76.21 119.86 20.69 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 122.123 0.963 . . . . 0.0 108.78 171.967 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 45' ' ' PHE . 18.5 mt -92.23 127.43 37.71 Favored 'General case' 0 C--O 1.223 -0.336 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -169.957 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -77.91 149.5 34.21 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 123.399 1.571 . . . . 0.0 114.872 174.005 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -64.6 126.75 28.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 129.619 3.168 . . . . 0.0 109.748 178.115 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.1 -20.08 51.59 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 116.705 -2.664 . . . . 0.0 114.847 172.279 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.32 156.35 38.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.72 1.26 . . . . 0.0 110.091 159.394 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.1 p -87.94 -179.95 6.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 119.327 -2.108 . . . . 0.0 109.152 -175.668 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.42 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 12.8 mt -77.08 -22.39 52.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 116.772 -1.585 . . . . 0.0 110.443 165.618 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.2 t -64.82 -41.02 96.09 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 117.608 2.448 . . . . 0.0 117.608 168.492 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -51.88 -53.83 36.21 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.703 -178.26 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -94.67 3.33 55.2 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.697 1.999 . . . . 0.0 110.824 -171.124 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.49 1.3 p-10 64.68 28.73 13.08 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 118.711 2.856 . . . . 0.0 118.711 175.11 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.411 HD13 HD11 ' A' ' 67' ' ' LEU . 30.6 mt -75.16 131.37 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 CA-C-N 114.091 -1.413 . . . . 0.0 110.343 170.023 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -124.17 176.7 6.23 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 125.929 2.018 . . . . 0.0 108.936 -168.254 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.6 pttt -52.99 127.27 23.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.418 1.487 . . . . 0.0 108.555 175.148 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 62.95 15.52 8.43 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 120.372 3.471 . . . . 0.0 120.372 -171.373 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 74.6 m -76.72 123.41 26.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 116.888 -3.633 . . . . 0.0 106.402 168.496 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.6 m -87.15 129.34 34.98 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 128.698 2.799 . . . . 0.0 108.523 179.469 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.446 HD23 HD12 ' A' ' 3' ' ' ILE . 2.5 mm? -100.97 134.15 44.39 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.547 2.339 . . . . 0.0 109.363 163.72 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.453 ' CE1' HD13 ' A' ' 8' ' ' LEU . 6.9 t60 -86.03 151.29 23.83 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 103.552 -2.758 . . . . 0.0 103.552 164.657 . . . . . . . . 2 2 . 1 . 052 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 11.6 tp -134.23 112.8 11.37 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 127.871 2.468 . . . . 0.0 109.824 -173.774 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.84 -177.58 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.179 2.591 . . . . 0.0 110.965 -178.347 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.8 mt -87.47 138.87 31.11 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-O 113.737 -3.03 . . . . 0.0 110.637 -177.088 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -76.81 124.91 28.4 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 120.959 1.709 . . . . 0.0 107.866 174.59 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 77.2 mt -126.55 91.84 3.44 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 122.828 1.299 . . . . 0.0 111.74 -173.898 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 88.02 -74.88 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.794 2.437 . . . . 0.0 109.618 -175.81 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.64 -179.37 15.84 Favored Glycine 0 CA--C 1.533 1.159 0 CA-C-O 118.953 -0.915 . . . . 0.0 112.11 -177.011 . . . . . . . . 1 1 . 1 . 052 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.837 0 CA-C-O 117.961 -1.466 . . . . 0.0 109.708 172.454 . . . . . . . . 0 0 . 1 . 053 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 116.479 2.029 . . . . 0.0 116.479 . . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.36 144.02 33.06 Favored 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 126.491 1.916 . . . . 0.0 112.536 -175.148 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.611 HG22 ' H ' ' A' ' 65' ' ' SER . 22.9 pt -127.44 161.33 35.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 O-C-N 120.237 -1.539 . . . . 0.0 111.073 155.764 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -92.27 163.57 13.85 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 172.739 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.32 155.67 37.61 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 C-N-CA 129.436 3.094 . . . . 0.0 110.608 148.422 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -152.12 142.39 22.42 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 122.858 2.572 . . . . 0.0 105.233 -162.308 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.27 66.7 p -100.19 170.75 8.24 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.049 1.34 . . . . 0.0 110.965 179.284 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.542 HD11 HG22 ' A' ' 70' ' ' VAL . 43.8 mt -93.0 18.88 8.48 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 117.856 -3.027 . . . . 0.0 110.22 177.324 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.371 0.6 OUTLIER -153.46 22.37 0.54 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 125.563 3.801 . . . . 0.0 109.412 -164.442 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.88 -11.36 29.68 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 122.688 3.835 . . . . 0.0 122.688 164.752 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.1 tttt -112.73 170.69 8.01 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 121.159 2.479 . . . . 0.0 109.193 -171.001 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.4 p -140.03 169.2 18.13 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 129.52 3.128 . . . . 0.0 110.503 170.579 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.7 mm -140.99 132.86 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.65 0 O-C-N 126.097 2.123 . . . . 0.0 110.377 168.851 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.6 m -80.88 116.53 20.91 Favored 'General case' 0 C--N 1.319 -0.739 0 O-C-N 126.621 2.45 . . . . 0.0 110.125 168.399 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.8 mt -102.74 146.08 28.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 123.773 1.749 . . . . 0.0 113.304 179.041 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.9 107.88 10.49 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.877 168.881 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -142.58 -41.02 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.837 1.655 . . . . 0.0 111.441 -157.067 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 75.74 140.97 0.08 OUTLIER Pre-proline 0 N--CA 1.452 -0.37 0 C-N-CA 131.07 3.748 . . . . 0.0 110.726 -171.339 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' A' ' 56' ' ' LEU . 87.3 Cg_exo -46.58 -24.08 2.63 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 124.474 3.449 . . . . 0.0 119.979 172.308 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 p -64.07 -34.21 77.5 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 116.365 -3.959 . . . . 0.0 113.178 174.931 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.98 144.87 11.02 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -177.846 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.257 10.7 t -117.56 130.68 56.56 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 116.84 -1.552 . . . . 0.0 108.483 -165.514 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.409 24.7 mm -40.69 -43.72 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 129.774 3.23 . . . . 0.0 114.755 -159.6 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -65.48 -29.47 70.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 121.214 1.825 . . . . 0.0 113.19 179.648 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.77 -16.61 28.08 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 -176.825 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.9 t -72.43 -40.33 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-O 114.809 -2.519 . . . . 0.0 105.518 172.702 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.8 mttt -71.5 -30.04 65.5 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 125.035 1.459 . . . . 0.0 112.235 175.324 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.25 -18.65 60.71 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 127.53 2.332 . . . . 0.0 115.869 173.74 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -78.28 -18.41 55.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 119.724 3.231 . . . . 0.0 119.724 161.416 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.6 mt -87.97 -38.19 11.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 127.27 2.856 . . . . 0.0 107.733 170.655 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.295 38.6 tt0 -45.9 -56.28 5.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 119.391 3.108 . . . . 0.0 119.391 162.01 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -51.56 -38.2 53.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 111.397 -2.638 . . . . 0.0 110.704 171.363 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.5 mmtt -87.7 -53.71 4.63 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -179.991 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -103.46 -21.56 13.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 116.462 2.023 . . . . 0.0 116.462 -170.932 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.76 -17.09 28.06 Favored Glycine 0 CA--C 1.538 1.47 0 CA-C-O 116.42 -2.322 . . . . 0.0 110.394 175.156 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.79 120.19 78.62 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 129.288 3.035 . . . . 0.0 110.292 -174.127 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -77.23 148.72 27.38 Favored 'Trans proline' 0 N--CA 1.441 -1.604 0 C-N-CA 123.924 3.083 . . . . 0.0 110.973 -171.146 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.293 47.2 Cg_exo -47.53 -37.39 26.21 Favored 'Trans proline' 0 N--CA 1.442 -1.532 1 C-N-CA 126.382 4.721 . . . . 0.0 116.096 -176.814 . . . . . . . . 3 2 . 1 . 053 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.75 -13.71 61.0 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -171.737 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.404 ' HA ' ' HG3' ' A' ' 72' ' ' ARG 0.317 20.2 mt-30 -100.88 -7.82 23.14 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 178.715 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -89.23 95.03 10.13 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 127.247 2.219 . . . . 0.0 115.996 173.353 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.291 51.4 ttt180 -88.44 105.7 17.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 120.293 -1.504 . . . . 0.0 107.639 172.821 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB3' HD12 ' A' ' 50' ' ' LEU 0.295 97.1 mt -97.07 120.11 36.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 177.984 . . . . . . . . 3 3 . 1 . 053 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.0 mt -110.85 126.24 68.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 130.179 3.392 . . . . 0.0 105.91 -172.53 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.261 89.9 t80 -119.95 -138.27 0.34 Allowed 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 128.869 2.868 . . . . 0.0 105.019 -172.422 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.26 57.19 4.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.302 2.641 . . . . 0.0 114.146 -163.284 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.78 -3.17 80.99 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 127.198 2.333 . . . . 0.0 114.449 -166.679 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.5 mmtt -123.96 141.01 52.42 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.37 2.268 . . . . 0.0 110.98 -170.381 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -77.44 140.04 39.77 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.656 -0.687 . . . . 0.0 110.989 153.309 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.443 HD12 ' HB3' ' A' ' 43' ' ' LEU . 73.4 mt -67.97 123.5 20.78 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 126.232 2.208 . . . . 0.0 109.156 174.01 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -85.09 138.93 32.1 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 126.554 2.409 . . . . 0.0 107.519 -177.376 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.276 96.8 m-20 -73.56 127.27 32.29 Favored 'General case' 0 N--CA 1.445 -0.724 1 CA-C-N 107.303 -4.498 . . . . 0.0 104.707 171.74 . . . . . . . . 3 2 . 1 . 053 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.32 -19.79 26.46 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.708 1.255 . . . . 0.0 116.148 -173.147 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -100.02 163.3 12.49 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 124.1 1.905 . . . . 0.0 110.007 176.136 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -92.87 164.8 13.19 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 117.377 -3.327 . . . . 0.0 111.667 179.492 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 19' ' ' PRO . 18.2 mt -62.11 -45.07 95.1 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 117.31 -3.369 . . . . 0.0 113.482 171.644 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.535 47.5 t -29.95 -36.12 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.215 1 C-N-CA 134.838 5.255 . . . . 0.0 120.511 156.203 . . . . . . . . 3 2 . 1 . 053 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.318 34.5 m-20 -80.49 -10.03 59.75 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 114.38 -2.724 . . . . 0.0 110.738 177.184 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -104.86 -7.71 19.2 Favored 'General case' 0 N--CA 1.447 -0.615 0 O-C-N 126.864 2.602 . . . . 0.0 114.199 168.15 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.322 7.0 t-20 55.08 59.42 4.03 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 127.253 2.221 . . . . 0.0 113.232 -171.909 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -101.16 126.94 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 1 O-C-N 114.621 -5.05 . . . . 0.0 103.599 179.468 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -109.9 -170.28 1.62 Allowed 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.918 1.687 . . . . 0.0 112.347 -168.827 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -50.83 139.15 17.42 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 121.047 -1.033 . . . . 0.0 113.01 171.269 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.278 4.4 tt0 70.56 32.26 2.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 128.879 3.862 . . . . 0.0 109.923 163.395 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.611 ' H ' HG22 ' A' ' 3' ' ' ILE . 69.6 m -83.1 153.23 24.96 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 117.777 -3.077 . . . . 0.0 114.509 -178.335 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 52.7 m -113.52 137.82 51.01 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 125.234 2.445 . . . . 0.0 111.018 168.902 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.69 125.86 27.91 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 103.024 -2.954 . . . . 0.0 103.024 176.468 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 34.3 p-80 -92.09 143.86 26.02 Favored 'General case' 0 C--N 1.33 -0.239 0 O-C-N 127.619 3.075 . . . . 0.0 108.491 177.584 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.4 tt -115.64 122.23 44.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.757 -1.565 . . . . 0.0 109.159 -172.724 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.542 HG22 HD11 ' A' ' 8' ' ' LEU . 11.7 t -100.91 141.82 16.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 C-N-CA 127.981 2.512 . . . . 0.0 108.347 176.529 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt -89.92 149.35 22.64 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 126.355 2.979 . . . . 0.0 109.492 -174.118 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' HG3' ' HA ' ' A' ' 40' ' ' GLN . 22.4 ptt180 -154.85 -179.39 7.98 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 131.428 3.891 . . . . 0.0 105.497 174.421 . . . . . . . . 2 2 . 1 . 053 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -134.38 118.69 17.73 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 100.758 -3.793 . . . . 0.0 100.758 151.259 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.0 ttp180 -81.23 -34.45 32.16 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.827 1.251 . . . . 0.0 110.464 171.756 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 126.56 4.9 6.14 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 117.875 -2.107 . . . . 0.0 114.189 177.072 . . . . . . . . 1 1 . 1 . 053 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 C-N-CA 125.68 1.61 . . . . 0.0 113.824 -151.936 . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.9 ttp . . . . . 0 N--CA 1.471 0.603 0 CA-C-O 115.818 -2.039 . . . . 0.0 107.086 . . . . . . . . . 0 0 . 1 . 054 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -90.87 146.17 24.14 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 126.036 2.085 . . . . 0.0 109.469 -169.134 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.265 6.0 pt -145.88 164.78 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 114.39 1.255 . . . . 0.0 114.39 175.376 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -127.53 145.39 50.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 124.385 2.041 . . . . 0.0 107.937 -174.917 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -137.53 106.87 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 1 O-C-N 115.246 -4.659 . . . . 0.0 104.382 -177.908 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -77.34 126.67 31.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 124.567 2.127 . . . . 0.0 112.991 162.896 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 m -78.48 156.8 29.14 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.511 1.924 . . . . 0.0 109.266 177.468 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 mt -50.47 -34.65 25.71 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 164.467 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.2 p -78.66 -11.91 59.99 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.735 2.014 . . . . 0.0 112.713 -176.086 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.25 -8.39 26.83 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 115.657 -2.746 . . . . 0.0 111.087 174.243 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -91.73 159.66 15.73 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 125.29 1.436 . . . . 0.0 109.765 -174.947 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.3 m -126.17 136.41 52.82 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 -178.127 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.4 mt -102.79 159.81 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 1 C-N-CA 132.337 4.255 . . . . 0.0 106.647 163.956 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.33 3.3 t -135.4 149.98 49.78 Favored 'General case' 0 C--N 1.328 -0.34 1 C-N-CA 134.117 4.967 . . . . 0.0 112.526 168.831 . . . . . . . . 3 2 . 1 . 054 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mp -141.27 144.35 34.61 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -173.342 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.274 4.0 tp10 -99.71 128.04 45.82 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 125.322 1.639 . . . . 0.0 108.613 161.559 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.72 173.3 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 129.216 3.007 . . . . 0.0 114.976 173.05 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.5 mm-40 -103.2 148.19 35.29 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 128.148 2.579 . . . . 0.0 106.796 151.812 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -64.63 -14.13 42.83 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-O 116.499 -1.542 . . . . 0.0 112.006 172.457 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.5 m -86.98 1.53 52.47 Favored 'General case' 0 C--O 1.242 0.69 0 O-C-N 127.782 3.176 . . . . 0.0 111.194 177.817 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -89.97 143.76 26.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 126.203 2.189 . . . . 0.0 106.959 175.075 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -82.76 162.56 21.69 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 126.245 2.926 . . . . 0.0 104.174 -168.548 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.2 mm -62.27 -45.85 97.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 O-C-N 120.002 -1.686 . . . . 0.0 109.109 168.622 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.8 -33.58 10.72 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 124.266 1.984 . . . . 0.0 114.209 173.518 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -72.89 -34.96 67.0 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 117.106 -3.497 . . . . 0.0 112.282 176.174 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.62 -37.18 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 O-C-N 120.54 -1.35 . . . . 0.0 111.136 169.682 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -68.03 -39.8 83.04 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.766 -1.833 . . . . 0.0 113.449 172.922 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.35 77.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 119.302 3.075 . . . . 0.0 119.302 172.689 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -72.32 -33.91 67.7 Favored 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 131.806 4.042 . . . . 0.0 111.756 175.457 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.6 mt -80.09 -39.82 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 O-C-N 118.502 -2.624 . . . . 0.0 116.582 169.1 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -44.03 -47.39 8.73 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 119.39 -2.068 . . . . 0.0 114.955 150.725 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -53.97 -45.0 71.26 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 178.085 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.8 tttt -107.58 -49.99 3.15 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 126.245 2.216 . . . . 0.0 107.924 -160.31 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -90.01 -38.35 13.67 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.099 1.76 . . . . 0.0 112.04 -174.172 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.2 9.38 24.06 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-O 116.622 -2.21 . . . . 0.0 112.865 169.641 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.8 mt -86.64 124.53 69.28 Favored Pre-proline 0 N--CA 1.453 -0.301 0 CA-C-N 119.99 1.895 . . . . 0.0 112.687 -170.722 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -54.19 135.78 65.84 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 124.316 3.344 . . . . 0.0 109.828 175.509 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.262 71.6 Cg_exo -41.59 -52.5 3.73 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.132 2.555 . . . . 0.0 117.858 170.083 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -40.82 -17.83 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 129.658 3.183 . . . . 0.0 114.834 167.39 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.1 mm-40 -136.04 30.71 3.02 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 -167.068 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.297 13.1 pt20 -141.23 138.12 33.07 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 130.711 3.604 . . . . 0.0 110.648 168.671 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 -138.34 120.92 16.19 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 118.377 -2.702 . . . . 0.0 104.282 175.507 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.4 mt -88.59 150.35 23.1 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 119.835 -1.791 . . . . 0.0 109.706 177.037 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 52.8 mt -137.33 128.0 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 -179.412 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -131.5 118.91 20.81 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 127.279 2.862 . . . . 0.0 108.214 179.107 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 64.21 13.34 7.81 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 130.754 3.622 . . . . 0.0 118.588 167.4 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.87 3.39 36.66 Favored Glycine 0 CA--C 1.536 1.379 1 C-N-CA 130.881 4.086 . . . . 0.0 114.581 -171.65 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -106.83 100.98 10.45 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 113.211 -3.28 . . . . 0.0 111.037 -177.517 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -63.29 108.56 1.33 Allowed 'General case' 0 C--N 1.325 -0.479 1 O-C-N 129.695 4.372 . . . . 0.0 106.445 169.122 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.6 mt -62.14 147.88 46.21 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 125.789 1.931 . . . . 0.0 112.054 179.399 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' CD ' HH21 ' A' ' 54' ' ' ARG . 3.8 mt-10 -116.39 137.61 52.02 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.04 2.136 . . . . 0.0 105.657 -178.502 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -43.89 136.46 3.62 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 116.136 1.902 . . . . 0.0 116.136 138.179 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.44 -10.34 33.14 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 129.845 3.593 . . . . 0.0 115.832 -176.023 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 39.8 mtt-85 -123.58 -177.72 3.81 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 127.21 2.359 . . . . 0.0 109.385 -178.805 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.6 p -128.73 168.34 15.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.277 -175.174 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.5 mt -59.02 -29.29 67.16 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 116.145 1.906 . . . . 0.0 116.145 -178.873 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.1 t -65.45 -47.19 77.0 Favored 'General case' 0 N--CA 1.449 -0.477 1 C-N-CA 135.489 5.515 . . . . 0.0 115.659 172.736 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -47.13 -25.56 0.9 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 120.053 3.353 . . . . 0.0 120.053 170.855 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.466 ' CZ ' ' HD2' ' A' ' 54' ' ' ARG . 72.3 m-85 -117.17 1.73 12.53 Favored 'General case' 0 C--O 1.238 0.473 1 C-N-CA 132.866 4.466 . . . . 0.0 115.291 177.958 . . . . . . . . 3 3 . 1 . 054 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.374 4.0 t30 66.89 49.13 1.21 Allowed 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 125.375 1.47 . . . . 0.0 113.377 176.782 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mt -101.3 125.39 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 118.243 -2.786 . . . . 0.0 104.568 177.043 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -115.02 -166.7 1.14 Allowed 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 112.243 -2.253 . . . . 0.0 111.152 172.635 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.257 58.9 tttt -41.84 125.78 2.95 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 118.939 2.941 . . . . 0.0 118.939 170.496 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.45 44.4 mt-10 75.84 18.1 2.16 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 165.776 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 10.8 m -83.67 147.04 27.91 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.53 1.132 . . . . 0.0 108.782 -175.832 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -120.67 131.75 54.74 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 -174.466 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mp -111.7 162.09 15.58 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 128.084 2.553 . . . . 0.0 109.608 171.87 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -115.01 142.49 46.56 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 124.462 2.077 . . . . 0.0 110.496 162.537 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.3 133.52 52.41 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 119.374 -2.079 . . . . 0.0 106.232 -178.703 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 29.6 m -114.76 153.86 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 126.356 1.862 . . . . 0.0 110.897 161.507 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -130.35 110.14 11.28 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-O 116.735 -1.602 . . . . 0.0 107.975 -173.778 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 70.54 -49.69 0.66 Allowed 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 128.735 2.814 . . . . 0.0 117.685 177.51 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.85 148.79 21.74 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 128.693 2.797 . . . . 0.0 108.203 165.183 . . . . . . . . 2 2 . 1 . 054 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -93.72 139.41 30.86 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 112.691 -2.05 . . . . 0.0 110.126 171.947 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.95 108.28 1.15 Allowed Glycine 0 CA--C 1.528 0.89 0 O-C-N 119.731 -1.855 . . . . 0.0 114.552 163.787 . . . . . . . . 1 1 . 1 . 054 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.655 1 C-N-CA 134.629 5.871 . . . . 0.0 103.226 163.1 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttm . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 . . . . . . . . . 0 0 . 1 . 055 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -91.39 136.82 32.84 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 123.629 0.771 . . . . 0.0 111.639 175.382 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.478 HD11 HG11 ' A' ' 17' ' ' VAL . 16.6 pt -117.41 170.01 7.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 O-C-N 119.895 -1.753 . . . . 0.0 110.799 145.539 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -111.77 138.21 48.66 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 105.544 -2.021 . . . . 0.0 105.544 164.824 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.5 t -121.91 124.76 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 O-C-N 120.922 -1.111 . . . . 0.0 109.397 168.133 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -88.45 115.69 26.14 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.268 1.027 . . . . 0.0 111.89 -179.482 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 34.9 p -78.71 161.02 27.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 125.528 2.585 . . . . 0.0 109.378 171.675 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.04 -27.74 66.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 126.576 1.95 . . . . 0.0 113.634 -171.853 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.6 p -69.0 -8.86 48.8 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 119.692 -1.88 . . . . 0.0 114.687 168.459 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 110.28 -6.09 30.27 Favored Glycine 0 N--CA 1.44 -1.039 0 O-C-N 120.179 -1.576 . . . . 0.0 112.106 172.197 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -73.85 125.28 27.8 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 127.36 2.264 . . . . 0.0 114.61 -176.423 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.3 57.0 m -95.69 106.19 18.26 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 101.029 -3.693 . . . . 0.0 101.029 176.906 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 89.9 mt -87.16 130.65 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 C-N-CA 125.385 1.474 . . . . 0.0 110.265 173.036 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -90.26 105.63 17.94 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 127.697 3.123 . . . . 0.0 107.835 176.411 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.252 7.7 tp -108.51 152.31 24.9 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.827 2.051 . . . . 0.0 111.71 -178.147 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -95.93 143.15 27.37 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 163.3 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.478 HG11 HD11 ' A' ' 3' ' ' ILE . 16.0 m -134.05 150.94 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 129.586 3.154 . . . . 0.0 107.198 166.23 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.271 12.7 tp10 -89.39 141.92 29.3 Favored Pre-proline 0 N--CA 1.446 -0.649 0 O-C-N 127.649 3.093 . . . . 0.0 105.287 154.024 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.26 -19.73 6.91 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 N-CA-C 121.033 3.436 . . . . 0.0 121.033 170.837 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.276 20.7 p -99.2 1.57 44.97 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 112.676 -2.056 . . . . 0.0 112.664 -174.391 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.419 ' OD2' ' NZ ' ' A' ' 29' ' ' LYS . 39.6 t0 -85.74 144.83 27.56 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 104.342 -2.466 . . . . 0.0 104.342 179.939 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.3 p -90.86 162.6 14.74 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.587 -2.571 . . . . 0.0 115.026 -174.278 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mm -52.69 -53.54 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 128.847 2.859 . . . . 0.0 107.89 -165.035 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -79.58 -21.12 45.44 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 114.129 -2.843 . . . . 0.0 112.053 -169.316 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -66.67 -47.68 71.69 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 123.52 2.873 . . . . 0.0 111.924 166.354 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -67.24 -34.52 69.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 130.889 3.676 . . . . 0.0 110.04 177.015 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -67.78 -35.67 79.09 Favored 'General case' 0 N--CA 1.451 -0.387 1 O-C-N 114.435 -5.166 . . . . 0.0 113.23 169.053 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.7 -22.22 46.99 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 130.408 3.483 . . . . 0.0 110.424 -179.22 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' NZ ' ' OD2' ' A' ' 21' ' ' ASP . 43.9 mttp -64.46 -20.65 66.31 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 118.45 -2.656 . . . . 0.0 109.168 173.096 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.3 mm -68.78 -19.71 24.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 O-C-N 117.361 -3.337 . . . . 0.0 117.243 167.279 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -74.65 -35.81 62.85 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 113.664 -3.065 . . . . 0.0 107.911 -165.175 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.307 27.9 t70 -30.69 -53.58 0.19 Allowed 'General case' 0 N--CA 1.441 -0.902 1 C-N-CA 132.099 4.159 . . . . 0.0 110.421 154.715 . . . . . . . . 3 2 . 1 . 055 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -89.02 -48.17 7.61 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 127.294 2.871 . . . . 0.0 116.842 -178.066 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -102.79 -36.03 8.42 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 125.221 1.576 . . . . 0.0 108.617 -160.891 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.15 13.47 58.79 Favored Glycine 0 CA--C 1.526 0.72 0 CA-C-O 115.21 -2.994 . . . . 0.0 117.529 171.28 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 mm -97.55 142.55 24.72 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 112.516 -3.611 . . . . 0.0 108.411 -172.985 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -60.6 139.38 85.64 Favored 'Trans proline' 0 N--CA 1.453 -0.897 1 C-N-CA 126.522 4.815 . . . . 0.0 116.853 170.153 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -67.76 -27.81 37.5 Favored 'Trans proline' 0 N--CA 1.456 -0.729 1 C-N-CA 126.544 4.829 . . . . 0.0 113.31 -172.978 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -60.18 -38.23 82.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 119.916 -1.74 . . . . 0.0 115.052 166.167 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -73.99 -29.67 62.09 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 118.178 -2.826 . . . . 0.0 117.029 176.886 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -75.44 149.44 38.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.106 2.562 . . . . 0.0 114.557 164.173 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.4 ttt180 -131.44 150.01 52.31 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 128.234 2.614 . . . . 0.0 104.661 157.05 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.496 ' CD1' HD12 ' A' ' 50' ' ' LEU 0.465 0.4 OUTLIER -120.46 148.62 43.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 124.327 2.013 . . . . 0.0 112.73 158.66 . . . . . . . . 4 4 . 1 . 055 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.8 mm -104.62 154.29 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 1 C-N-CA 134.504 5.122 . . . . 0.0 108.924 176.601 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -162.6 135.0 5.55 Favored 'General case' 0 C--N 1.321 -0.638 1 C-N-CA 132.313 4.245 . . . . 0.0 103.589 163.015 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 76.37 43.21 0.15 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.012 1.325 . . . . 0.0 109.554 163.504 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 57.51 22.63 46.23 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 129.754 3.55 . . . . 0.0 118.481 -176.655 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.322 37.4 pttt -162.06 170.13 19.76 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 125.658 1.583 . . . . 0.0 112.128 -179.397 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.306 27.2 mp0 -93.77 139.73 30.5 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.386 -161.563 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.496 HD12 ' CD1' ' A' ' 43' ' ' LEU . 14.2 mt -94.46 162.14 13.94 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 126.639 1.975 . . . . 0.0 109.513 179.01 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -150.93 151.3 31.95 Favored 'General case' 0 N--CA 1.45 -0.433 0 O-C-N 119.294 -2.128 . . . . 0.0 110.366 -173.374 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -44.77 133.98 5.82 Favored 'General case' 0 C--N 1.327 -0.413 1 C-N-CA 134.039 4.936 . . . . 0.0 112.267 -177.341 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 109.35 -19.94 28.61 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-O 114.084 -3.62 . . . . 0.0 111.354 151.718 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -94.07 155.86 16.88 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 127.572 2.572 . . . . 0.0 107.518 172.361 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.7 p -76.2 163.98 26.53 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.801 2.44 . . . . 0.0 112.739 -178.514 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.9 mt -43.85 -43.47 6.31 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 130.178 3.391 . . . . 0.0 109.229 159.897 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.4 t -71.35 -37.67 71.67 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 118.701 -2.5 . . . . 0.0 114.889 -175.525 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -59.71 -36.19 76.05 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 127.139 2.176 . . . . 0.0 107.877 178.891 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.282 13.9 m-85 -97.83 11.94 35.59 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.591 1.556 . . . . 0.0 110.995 175.907 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.623 0.1 OUTLIER 67.56 25.97 8.22 Favored 'General case' 0 C--O 1.222 -0.374 1 O-C-N 115.566 -4.458 . . . . 0.0 121.512 165.016 . . . . . . . . 4 3 . 1 . 055 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.7 mt -76.61 93.29 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 128.628 2.771 . . . . 0.0 104.973 174.305 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.302 8.3 mm-40 -99.4 -169.67 1.79 Allowed 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 128.089 3.368 . . . . 0.0 102.344 174.938 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.419 16.1 ptpt -43.64 122.23 2.63 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 130.808 3.643 . . . . 0.0 116.729 169.601 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 4.2 tp10 83.13 33.98 0.06 Allowed 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.946 2.099 . . . . 0.0 112.493 175.198 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.3 m -96.91 138.38 34.55 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.125 2.97 . . . . 0.0 108.237 -176.6 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.1 m -118.26 141.19 48.77 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 173.865 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.4 mt -107.0 158.82 16.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 116.9 -3.625 . . . . 0.0 111.718 166.171 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -135.07 136.11 41.77 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 175.195 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.3 mt -86.64 154.7 20.82 Favored 'General case' 0 C--O 1.222 -0.391 0 N-CA-C 104.578 -2.378 . . . . 0.0 104.578 178.106 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 33.2 t -141.39 133.55 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 C-N-CA 128.713 2.805 . . . . 0.0 106.525 -178.734 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 15.3 mt -92.09 136.21 33.36 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 123.027 2.649 . . . . 0.0 108.438 -179.637 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 mtp180 -93.27 113.61 25.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 103.114 -2.921 . . . . 0.0 103.114 163.924 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.8 mt -99.48 58.38 1.07 Allowed 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.001 2.52 . . . . 0.0 104.961 -167.481 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.25 13.6 mmm180 -104.07 164.86 11.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 113.009 -1.905 . . . . 0.0 112.591 -177.134 . . . . . . . . 2 2 . 1 . 055 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.41 -136.1 6.16 Favored Glycine 0 CA--C 1.536 1.363 0 N-CA-C 104.197 -3.561 . . . . 0.0 104.197 -176.155 . . . . . . . . 1 1 . 1 . 055 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.26 1.723 0 N-CA-C 103.36 -3.896 . . . . 0.0 103.36 -175.618 . . . . . . . . 0 0 . 1 . 056 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.309 14.2 ptt? . . . . . 0 N--CA 1.471 0.579 0 CA-C-O 117.872 -1.061 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -79.3 153.25 30.01 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 115.739 -2.077 . . . . 0.0 111.602 163.896 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.291 31.4 pt -134.22 -177.39 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 C-N-CA 129.292 3.037 . . . . 0.0 103.934 164.417 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -142.0 139.44 32.39 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 128.631 2.773 . . . . 0.0 104.544 170.954 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -120.29 109.31 25.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 131.266 3.826 . . . . 0.0 101.59 179.45 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -87.51 122.29 31.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 101.057 -3.683 . . . . 0.0 101.057 170.221 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 59.5 p -65.72 160.26 23.25 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 128.384 2.673 . . . . 0.0 111.119 161.967 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tt -44.84 -39.55 5.43 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 120.169 3.396 . . . . 0.0 120.169 172.941 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.3 p -90.87 -9.69 45.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.811 2.044 . . . . 0.0 111.715 -176.075 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.72 7.39 17.89 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 123.775 0.702 . . . . 0.0 111.675 165.847 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -76.5 130.92 38.63 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 172.808 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.8 m -112.87 146.76 38.35 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 127.625 2.37 . . . . 0.0 106.023 -174.071 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.2 pt -143.89 146.6 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 O-C-N 127.091 2.745 . . . . 0.0 105.737 173.158 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.9 m -89.14 132.59 34.75 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 129.702 3.201 . . . . 0.0 104.635 168.876 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 59.8 mt -108.86 153.27 23.76 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 126.047 1.739 . . . . 0.0 109.659 151.966 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -103.21 111.57 24.01 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 111.684 -2.507 . . . . 0.0 111.47 164.873 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.2 m -123.23 138.86 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 C-N-CA 125.512 1.525 . . . . 0.0 106.89 -174.944 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -77.77 147.01 73.64 Favored Pre-proline 0 N--CA 1.446 -0.645 0 O-C-N 118.753 -2.467 . . . . 0.0 109.61 154.361 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -61.06 -22.35 74.43 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 N-CA-C 119.651 2.904 . . . . 0.0 119.651 -174.25 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.265 0.3 OUTLIER -81.18 -12.5 59.17 Favored 'General case' 0 N--CA 1.442 -0.861 1 C-N-CA 131.792 4.037 . . . . 0.0 112.226 177.889 . . . . . . . . 4 3 . 1 . 056 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.06 119.65 17.59 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 119.614 -1.929 . . . . 0.0 107.196 -172.65 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.5 p -66.3 167.83 9.75 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 121.524 1.965 . . . . 0.0 106.245 -167.797 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -54.18 -37.72 36.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 N-CA-C 116.883 2.179 . . . . 0.0 116.883 -177.876 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -71.02 -28.66 64.57 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.182 0.992 . . . . 0.0 112.626 -174.92 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -65.41 -22.35 66.77 Favored 'General case' 0 N--CA 1.451 -0.416 1 CA-C-O 110.544 -4.55 . . . . 0.0 112.802 175.855 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.9 t -83.39 -45.32 18.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 131.139 3.776 . . . . 0.0 109.749 177.622 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.286 37.5 pttt -75.34 -23.65 57.26 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 123.904 1.811 . . . . 0.0 113.332 -178.504 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.66 -34.2 75.3 Favored 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.159 2.584 . . . . 0.0 108.337 -179.549 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -73.58 -53.87 9.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 127.777 3.173 . . . . 0.0 107.277 176.011 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.43 65.4 mt -38.81 -54.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 125.807 2.718 . . . . 0.0 117.821 -179.675 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -65.08 -20.72 66.61 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 118.586 -2.571 . . . . 0.0 116.253 -179.385 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.256 36.0 t70 -90.37 -24.87 20.69 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 121.672 2.033 . . . . 0.0 107.517 175.492 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -97.33 -50.64 4.47 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 113.646 -3.073 . . . . 0.0 107.371 -164.17 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -129.18 12.21 6.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 115.647 -2.12 . . . . 0.0 109.929 -179.929 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.74 -3.19 86.08 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 126.674 2.083 . . . . 0.0 116.523 154.292 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 54.4 mt -72.69 107.64 3.37 Favored Pre-proline 0 CA--C 1.535 0.402 0 C-N-CA 130.347 3.459 . . . . 0.0 106.439 177.352 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.97 160.61 36.8 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.47 2.113 . . . . 0.0 116.545 -177.711 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.317 5.6 Cg_endo -50.69 -35.34 47.12 Favored 'Trans proline' 0 N--CA 1.44 -1.668 1 C-N-CA 130.13 7.22 . . . . 0.0 114.027 167.845 . . . . . . . . 3 2 . 1 . 056 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -62.67 -18.98 63.37 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 116.185 1.921 . . . . 0.0 116.185 175.312 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -123.38 14.32 9.6 Favored 'General case' 0 N--CA 1.443 -0.791 1 O-C-N 115.598 -4.439 . . . . 0.0 110.037 -176.083 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.343 0.3 OUTLIER -101.85 126.29 48.71 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 118.814 -2.429 . . . . 0.0 107.364 -161.967 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -131.74 108.02 9.18 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 103.83 -2.656 . . . . 0.0 103.83 168.657 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.8 mt -93.21 126.66 38.43 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.002 -1.475 . . . . 0.0 108.392 179.572 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 pt -128.9 144.25 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 119.454 1.025 . . . . 0.0 113.046 -178.004 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -137.08 133.74 35.72 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 169.116 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.11 20.59 11.2 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 120.873 1.67 . . . . 0.0 111.488 166.681 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.49 -21.12 42.58 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 119.305 0.957 . . . . 0.0 112.723 -174.483 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -80.63 146.16 31.32 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -176.324 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -99.99 123.99 44.84 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 175.822 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.2 mt -71.4 115.82 11.01 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 124.663 2.173 . . . . 0.0 109.951 -171.022 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -82.84 133.31 35.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.421 2.688 . . . . 0.0 112.767 175.317 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -41.89 143.29 0.56 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 130.893 3.677 . . . . 0.0 115.474 174.009 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.2 -16.96 50.27 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 111.789 -2.459 . . . . 0.0 112.809 164.729 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mmm-85 -74.35 140.45 44.82 Favored 'General case' 0 CA--C 1.535 0.366 0 O-C-N 118.367 -2.843 . . . . 0.0 107.28 175.206 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.7 p -68.43 139.47 55.75 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 126.503 2.377 . . . . 0.0 109.048 160.947 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 52.2 mt -53.11 -30.08 34.57 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 125.666 1.586 . . . . 0.0 113.974 174.451 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 t -74.68 -35.82 62.78 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.911 2.085 . . . . 0.0 112.383 -176.992 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -60.35 -17.77 45.62 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 167.799 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -99.06 12.66 35.38 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 120.037 3.347 . . . . 0.0 120.037 167.434 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 12.8 m120 73.64 21.22 2.87 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 124.811 2.243 . . . . 0.0 115.375 169.542 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 52.2 mm -78.32 135.01 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -179.517 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -112.89 170.54 8.12 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.128 -2.305 . . . . 0.0 111.008 178.347 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.3 140.4 17.08 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 118.469 -2.644 . . . . 0.0 111.246 169.364 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.494 0.6 OUTLIER 68.89 1.29 3.07 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 117.122 2.268 . . . . 0.0 117.122 163.708 . . . . . . . . 3 3 . 1 . 056 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -54.98 146.04 18.8 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 118.853 2.908 . . . . 0.0 118.853 169.048 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.5 m -102.24 105.66 16.35 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 -179.547 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.8 mp -99.69 162.19 13.16 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 174.121 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -113.24 132.87 55.35 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 127.542 3.026 . . . . 0.0 109.116 -178.383 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.9 tp -105.59 110.97 23.49 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 129.044 2.938 . . . . 0.0 104.979 169.716 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.5 t -76.38 118.82 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 O-C-N 118.74 -2.475 . . . . 0.0 104.744 172.6 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 50.7 mt -67.12 99.08 0.64 Allowed 'General case' 0 N--CA 1.445 -0.691 0 C-N-CA 128.629 2.772 . . . . 0.0 110.861 163.728 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -75.24 -16.12 60.49 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.823 2.849 . . . . 0.0 110.917 -157.221 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.404 ' N ' HD13 ' A' ' 73' ' ' LEU 0.366 0.0 OUTLIER -138.38 174.14 10.86 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 119.986 -1.696 . . . . 0.0 113.051 153.584 . . . . . . . . 4 4 . 1 . 056 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.506 23.1 ttt180 -139.67 -69.32 0.41 Allowed 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 126.477 3.037 . . . . 0.0 114.262 -178.054 . . . . . . . . 2 2 . 1 . 056 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.82 148.17 8.84 Favored Glycine 0 CA--C 1.523 0.584 0 CA-C-N 109.12 -3.673 . . . . 0.0 108.29 -165.207 . . . . . . . . 1 1 . 1 . 056 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.295 0 O-C-N 117.742 -3.211 . . . . 0.0 120.088 178.799 . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptt? . . . . . 0 N--CA 1.469 0.478 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 057 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -102.1 141.29 35.18 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 127.775 2.43 . . . . 0.0 111.343 176.26 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 pt -133.38 144.62 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 110.964 -2.834 . . . . 0.0 108.305 164.506 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -93.84 141.03 28.97 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 173.556 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.1 t -120.99 122.66 68.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 123.067 2.667 . . . . 0.0 105.039 170.165 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -89.17 124.49 34.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 122.146 2.248 . . . . 0.0 106.941 176.891 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.328 82.7 p -99.59 -166.84 1.39 Allowed 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 118.201 -2.812 . . . . 0.0 114.715 -172.855 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 7.5 mp -43.27 -33.62 1.01 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 119.695 3.22 . . . . 0.0 119.695 -177.745 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.2 p -110.26 -4.82 15.48 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 127.175 2.19 . . . . 0.0 112.493 -178.549 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.34 -1.72 67.28 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 116.078 1.191 . . . . 0.0 116.078 179.585 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -63.59 127.44 31.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 129.305 3.042 . . . . 0.0 104.616 173.352 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -90.76 131.91 36.15 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.943 1.402 . . . . 0.0 108.236 -179.841 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.577 HD13 ' HB2' ' A' ' 34' ' ' GLU . 12.1 pt -117.49 136.07 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 123.739 1.733 . . . . 0.0 107.038 170.302 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.9 m -88.81 112.02 22.72 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 113.07 -3.348 . . . . 0.0 111.376 179.895 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -103.03 129.27 49.76 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 101.725 -3.435 . . . . 0.0 101.725 -175.987 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -82.93 133.68 35.1 Favored 'General case' 0 C--O 1.222 -0.361 1 C-N-CA 132.324 4.25 . . . . 0.0 103.925 164.262 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.91 169.06 8.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 109.832 -3.349 . . . . 0.0 108.687 -176.739 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -128.27 157.65 73.78 Favored Pre-proline 0 N--CA 1.447 -0.609 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.858 169.401 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -69.45 -6.73 19.16 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 125.115 3.876 . . . . 0.0 114.953 -174.629 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 55.7 p -86.31 -13.41 46.66 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 129.006 2.922 . . . . 0.0 112.804 167.223 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -69.29 131.72 45.31 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 122.419 2.372 . . . . 0.0 115.069 -179.149 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 44.1 p -91.36 169.2 11.0 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.066 1.746 . . . . 0.0 113.285 172.003 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.2 -17.78 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-O 117.493 -1.241 . . . . 0.0 109.733 178.531 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -62.75 -47.08 85.09 Favored 'General case' 0 C--O 1.221 -0.422 0 O-C-N 118.146 -2.846 . . . . 0.0 112.756 160.91 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -70.03 -26.12 63.89 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.786 -178.459 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.4 t -90.49 -33.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 113.02 -3.372 . . . . 0.0 107.399 -172.656 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.1 mttt -43.0 -44.55 4.72 Favored 'General case' 0 C--N 1.322 -0.629 1 C-N-CA 132.681 4.392 . . . . 0.0 112.841 167.795 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.08 -17.39 55.27 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 114.788 -2.529 . . . . 0.0 115.727 178.295 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -90.64 -22.47 21.18 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 121.54 1.973 . . . . 0.0 107.554 172.27 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.7 mt -67.21 -37.96 80.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.432 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -42.8 61.08 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 128.581 2.752 . . . . 0.0 114.509 169.746 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -63.61 -55.24 25.17 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 163.982 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.1 mmtt -80.77 -17.91 49.36 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 -170.643 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.577 ' HB2' HD13 ' A' ' 13' ' ' ILE 0.427 25.7 tp10 -135.62 -8.7 2.17 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 121.61 3.93 . . . . 0.0 121.61 171.361 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.69 7.68 68.56 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 116.496 -3.877 . . . . 0.0 117.208 173.842 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.9 mm -91.37 123.45 63.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 C-N-CA 130.051 3.34 . . . . 0.0 106.524 -170.985 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.324 72.9 Cg_endo -67.32 154.0 75.32 Favored 'Trans proline' 0 N--CA 1.454 -0.852 1 C-N-CA 128.095 5.863 . . . . 0.0 109.725 170.663 . . . . . . . . 3 2 . 1 . 057 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -66.18 -22.59 53.78 Favored 'Trans proline' 0 N--CA 1.448 -1.192 1 C-N-CA 125.313 4.009 . . . . 0.0 115.833 -164.046 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -90.02 -8.0 52.61 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 124.405 1.066 . . . . 0.0 110.317 -164.061 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -110.41 -9.85 14.59 Favored 'General case' 0 N--CA 1.449 -0.485 0 O-C-N 118.128 -2.858 . . . . 0.0 113.573 -172.33 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.263 73.4 mt-30 -88.17 121.75 30.93 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.829 1.652 . . . . 0.0 106.869 -172.222 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 -102.59 100.21 10.27 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 112.632 -2.076 . . . . 0.0 108.594 170.395 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.6 mt -90.63 126.31 35.92 Favored 'General case' 0 N--CA 1.441 -0.923 0 O-C-N 119.589 -1.944 . . . . 0.0 111.842 177.443 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.1 mt -132.35 139.7 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 127.217 2.207 . . . . 0.0 110.853 -168.382 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 46.2 t80 -162.65 112.8 1.45 Allowed 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 129.316 3.046 . . . . 0.0 112.39 -174.242 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.09 36.19 14.87 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 128.426 3.965 . . . . 0.0 118.496 177.292 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.08 -10.12 43.6 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-N 108.508 -3.951 . . . . 0.0 109.638 167.233 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -92.41 120.06 32.55 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 130.351 3.46 . . . . 0.0 111.448 -178.749 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -79.16 119.27 22.02 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 127.997 2.519 . . . . 0.0 109.055 165.028 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -79.01 129.18 34.17 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -158.86 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -82.77 153.44 25.25 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -172.425 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -80.47 126.57 31.38 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.475 170.982 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.35 -3.97 18.07 Favored Glycine 0 N--CA 1.446 -0.639 0 CA-C-O 115.722 -2.71 . . . . 0.0 110.433 -172.507 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -103.14 155.85 18.11 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 120.652 2.226 . . . . 0.0 108.547 -167.931 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.2 p -95.98 141.43 29.4 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.61 2.364 . . . . 0.0 109.346 168.017 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.4 mt -51.23 -38.56 53.19 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 129.919 3.288 . . . . 0.0 111.696 -178.567 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.5 m -74.83 -20.44 59.76 Favored 'General case' 0 C--O 1.217 -0.624 0 O-C-N 120.103 -1.623 . . . . 0.0 111.573 -176.666 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -79.8 -25.47 40.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.371 2.268 . . . . 0.0 110.001 -178.463 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -85.86 -17.67 34.95 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 123.204 1.478 . . . . 0.0 114.895 166.453 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 83.17 48.45 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.867 1.667 . . . . 0.0 111.112 173.923 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 18.9 mt -107.18 102.97 14.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 1 N-CA-C 99.844 -4.132 . . . . 0.0 99.844 -174.943 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -82.94 154.39 24.57 Favored 'General case' 0 CA--C 1.54 0.592 1 O-C-N 130.168 4.667 . . . . 0.0 113.28 167.136 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.397 0.0 OUTLIER -38.15 133.36 0.93 Allowed 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 130.896 3.678 . . . . 0.0 118.069 170.438 . . . . . . . . 3 3 . 1 . 057 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.449 15.0 mt-10 80.58 1.49 1.86 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 125.331 3.696 . . . . 0.0 112.381 -179.866 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.2 m -67.81 145.42 54.68 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 126.284 2.24 . . . . 0.0 112.385 172.428 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 m -108.51 114.83 28.97 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 101.673 -3.454 . . . . 0.0 101.673 179.132 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 mp -98.56 155.14 17.43 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.435 1.494 . . . . 0.0 108.009 177.136 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -105.83 146.57 29.73 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 114.817 -2.516 . . . . 0.0 108.467 178.767 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.4 tt -125.81 134.73 51.59 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 126.011 1.725 . . . . 0.0 108.745 177.065 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.6 t -129.59 164.46 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 1 C-N-CA 132.445 4.298 . . . . 0.0 105.642 179.719 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.84 126.43 50.95 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 114.271 -2.776 . . . . 0.0 105.85 -171.35 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.9 ttt180 -142.53 121.86 13.12 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 128.793 3.808 . . . . 0.0 108.415 165.532 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -79.11 124.06 27.95 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 133.498 4.719 . . . . 0.0 106.793 167.916 . . . . . . . . 2 2 . 1 . 057 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -154.99 100.81 2.22 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 102.059 -3.311 . . . . 0.0 102.059 171.756 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.99 116.07 1.68 Allowed Glycine 0 CA--C 1.528 0.848 0 C-N-CA 128.565 2.983 . . . . 0.0 110.37 178.732 . . . . . . . . 1 1 . 1 . 057 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.149 0 CA-C-O 116.129 -2.484 . . . . 0.0 117.924 162.978 . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 ptt? . . . . . 0 N--CA 1.471 0.579 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 . . . . . . . . . 0 0 . 1 . 058 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -104.12 137.03 42.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 118.553 -2.592 . . . . 0.0 106.825 177.2 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 3' ' ' ILE . 4.2 pt -132.41 155.11 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 C-N-CA 129.898 3.279 . . . . 0.0 105.908 174.709 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -118.77 143.89 46.63 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.296 2.238 . . . . 0.0 111.737 176.8 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 86.3 t -126.94 115.83 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 112.069 -3.824 . . . . 0.0 108.64 178.529 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.3 tttt -90.78 120.91 32.21 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 113.596 -3.097 . . . . 0.0 114.031 175.704 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.758 HG22 HD12 ' A' ' 69' ' ' LEU . 81.8 p -80.99 160.91 24.46 Favored 'General case' 0 N--CA 1.448 -0.552 1 O-C-N 129.15 4.031 . . . . 0.0 112.815 164.039 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -45.21 93.61 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 118.263 2.69 . . . . 0.0 118.263 -172.53 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.261 55.7 p -59.49 -17.18 29.45 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 117.046 2.239 . . . . 0.0 117.046 166.931 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.07 -0.99 6.68 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 126.291 1.9 . . . . 0.0 108.88 154.048 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -74.58 141.67 44.72 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 119.272 -2.311 . . . . 0.0 111.31 -167.727 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.9 m -120.11 121.63 39.26 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 125.343 1.652 . . . . 0.0 111.019 -166.437 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 58.5 mt -91.65 156.63 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-O 114.847 -2.502 . . . . 0.0 108.284 175.055 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.388 6.6 t -126.17 124.99 41.73 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 127.47 2.981 . . . . 0.0 111.095 174.693 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.2 mt -122.84 150.11 43.29 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 124.441 2.067 . . . . 0.0 106.269 -171.676 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -106.82 110.98 23.29 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 104.628 -2.36 . . . . 0.0 104.628 176.012 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 58.5 t -122.9 136.69 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 109.16 -3.655 . . . . 0.0 109.902 -173.114 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -95.38 139.35 21.95 Favored Pre-proline 0 N--CA 1.445 -0.714 0 CA-C-O 113.78 -3.009 . . . . 0.0 106.323 169.844 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.258 23.5 Cg_exo -53.75 -29.93 54.34 Favored 'Trans proline' 0 N--CA 1.454 -0.837 1 C-N-CA 125.63 4.22 . . . . 0.0 115.103 -173.325 . . . . . . . . 3 2 . 1 . 058 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 69.1 m -78.94 -4.05 47.92 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 123.314 2.779 . . . . 0.0 112.627 177.873 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -75.61 147.13 39.82 Favored 'General case' 0 C--N 1.328 -0.354 1 O-C-N 114.749 -4.97 . . . . 0.0 110.999 -175.585 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.4 p -92.03 162.17 14.48 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.346 1.058 . . . . 0.0 108.635 -171.195 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.8 mm -56.52 -26.72 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 O-C-N 126.684 2.49 . . . . 0.0 113.821 -174.589 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.367 9.4 pt-20 -65.32 -34.76 79.09 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 128.375 2.67 . . . . 0.0 114.463 172.663 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -77.95 -29.49 49.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 125.545 2.593 . . . . 0.0 108.866 -176.271 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.357 31.2 m -82.47 -35.11 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 O-C-N 116.738 -3.727 . . . . 0.0 106.934 178.622 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.5 mttt -55.26 -46.19 76.11 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 116.548 -3.845 . . . . 0.0 114.0 170.816 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.281 . . -77.27 -18.77 57.31 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 126.382 2.991 . . . . 0.0 114.279 -174.62 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -82.35 -43.62 17.2 Favored 'General case' 0 C--N 1.322 -0.625 1 O-C-N 116.11 -4.119 . . . . 0.0 107.257 -179.476 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.423 12.1 mt -45.51 -46.78 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 C-N-CA 128.076 2.55 . . . . 0.0 113.205 160.389 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -59.69 -50.23 74.67 Favored 'General case' 0 N--CA 1.445 -0.683 0 O-C-N 117.901 -2.999 . . . . 0.0 116.794 172.71 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.452 34.7 t70 -53.08 -33.03 50.27 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 128.706 2.802 . . . . 0.0 110.721 178.099 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.8 mmtt -80.74 -65.71 0.98 Allowed 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 113.204 -3.284 . . . . 0.0 113.621 172.707 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -97.45 -27.15 14.58 Favored 'General case' 0 N--CA 1.445 -0.724 1 O-C-N 129.645 4.34 . . . . 0.0 118.965 -165.757 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.24 7.65 59.31 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 128.531 2.967 . . . . 0.0 114.962 -179.539 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.529 HD12 HD21 ' A' ' 71' ' ' LEU . 10.7 mm -82.1 122.35 79.56 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 116.999 -3.647 . . . . 0.0 110.474 -174.394 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 96.8 Cg_endo -70.88 120.9 7.41 Favored 'Trans proline' 0 N--CA 1.443 -1.494 1 C-N-CA 128.6 6.2 . . . . 0.0 113.346 -174.95 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 37' ' ' PRO 0.278 77.5 Cg_exo -34.49 -46.79 0.55 Allowed 'Trans proline' 0 N--CA 1.439 -1.688 1 C-N-CA 128.468 6.112 . . . . 0.0 116.037 -169.545 . . . . . . . . 4 3 . 1 . 058 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.289 0.5 OUTLIER -55.63 -42.59 75.16 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 116.306 -3.996 . . . . 0.0 116.258 178.609 . . . . . . . . 3 3 . 1 . 058 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -79.45 -2.88 43.97 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.233 0.613 . . . . 0.0 112.63 -177.196 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -85.97 141.71 29.33 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 116.662 -3.774 . . . . 0.0 108.852 173.427 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 21.5 ttt180 -145.29 104.6 3.95 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 111.18 -2.736 . . . . 0.0 106.071 -172.375 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.1 mt -96.43 112.37 24.14 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 119.31 -2.119 . . . . 0.0 107.561 -173.373 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mt -85.47 141.9 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 120.011 -1.681 . . . . 0.0 110.82 168.905 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.482 ' CE2' HG23 ' A' ' 61' ' ' ILE . 14.1 t80 -147.1 119.01 8.12 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 102.253 -3.24 . . . . 0.0 102.253 164.035 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.2 22.43 11.0 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 120.957 3.688 . . . . 0.0 120.957 164.056 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.41 -22.7 38.8 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 127.414 2.435 . . . . 0.0 112.581 -175.065 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 pttm -97.1 147.26 24.23 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 118.189 -2.948 . . . . 0.0 107.866 -177.559 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.38 133.32 35.99 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 126.762 2.539 . . . . 0.0 104.216 163.674 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -70.11 109.9 4.85 Favored 'General case' 0 N--CA 1.447 -0.614 0 O-C-N 118.189 -2.819 . . . . 0.0 114.801 168.862 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -74.02 147.23 43.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 128.297 2.639 . . . . 0.0 112.234 -176.754 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -81.26 147.96 29.68 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 126.8 2.562 . . . . 0.0 104.585 -166.23 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.46 -36.79 3.94 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 116.739 -2.145 . . . . 0.0 110.972 179.986 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -76.26 169.99 17.18 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 127.057 3.313 . . . . 0.0 107.939 -174.849 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.2 p -103.25 174.75 5.73 Favored 'General case' 0 N--CA 1.452 -0.349 2 O-C-N 112.911 -6.118 . . . . 0.0 113.141 163.003 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.36 -29.04 41.98 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.865 1.666 . . . . 0.0 110.273 -177.336 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.2 t -71.13 -32.6 69.18 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 117.526 -1.226 . . . . 0.0 110.009 -177.579 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.09 -22.79 55.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 115.364 -2.255 . . . . 0.0 110.537 174.85 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -86.9 0.32 55.21 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 117.61 -1.186 . . . . 0.0 113.056 171.974 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t30 28.62 61.95 0.12 Allowed 'General case' 0 N--CA 1.445 -0.723 1 C-N-CA 138.845 6.858 . . . . 0.0 112.253 175.114 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.482 HG23 ' CE2' ' A' ' 45' ' ' PHE . 13.8 mt -98.55 -34.96 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 128.348 2.659 . . . . 0.0 105.433 -170.707 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.463 13.1 mm-40 82.12 -158.77 0.02 OUTLIER 'General case' 0 C--O 1.225 -0.232 0 C-N-CA 124.531 1.133 . . . . 0.0 112.608 178.109 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -81.65 158.33 24.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 129.311 3.045 . . . . 0.0 115.14 -176.077 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.309 4.1 tt0 66.52 11.75 8.28 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 128.634 2.774 . . . . 0.0 118.457 161.254 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -105.23 144.47 31.97 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 116.979 -1.486 . . . . 0.0 112.155 -162.515 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.8 m -103.41 106.72 17.3 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 122.228 2.286 . . . . 0.0 108.229 -166.726 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.5 mp -75.64 153.68 37.08 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.264 164.864 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -117.3 95.05 4.8 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 129.102 2.961 . . . . 0.0 107.707 -172.096 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.758 HD12 HG22 ' A' ' 7' ' ' THR . 1.2 tm? -63.85 118.16 7.97 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.253 2.221 . . . . 0.0 106.918 166.645 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -125.66 150.9 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 167.21 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.529 HD21 HD12 ' A' ' 36' ' ' ILE . 2.4 mp -100.61 160.81 14.05 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 117.017 -1.468 . . . . 0.0 110.871 -172.051 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.9 ttp180 -110.1 104.73 13.64 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.584 1.177 . . . . 0.0 113.941 169.086 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -94.9 122.27 37.36 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.207 -3.257 . . . . 0.0 102.207 -178.349 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.443 51.0 mtp180 89.79 -84.28 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 125.071 2.367 . . . . 0.0 109.062 164.635 . . . . . . . . 2 2 . 1 . 058 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.1 -29.26 0.74 Allowed Glycine 0 CA--C 1.533 1.21 0 CA-C-O 116.847 -2.085 . . . . 0.0 116.091 -178.034 . . . . . . . . 1 1 . 1 . 058 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 N-CA-C 107.846 -2.101 . . . . 0.0 107.846 -169.244 . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.9 ttp . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 . . . . . . . . . 0 0 . 1 . 059 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -96.18 142.17 28.68 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.854 2.462 . . . . 0.0 108.598 -174.744 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.5 pt -130.82 177.56 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 128.748 2.819 . . . . 0.0 111.32 161.944 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -100.71 144.68 29.39 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.253 1.421 . . . . 0.0 109.618 163.177 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.9 t -116.76 150.47 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 121.765 2.075 . . . . 0.0 105.494 158.791 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.8 tttt -137.85 145.87 42.77 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 128.476 2.71 . . . . 0.0 111.438 -178.363 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 p -106.85 163.84 12.62 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 126.797 2.561 . . . . 0.0 112.197 173.183 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.5 mt -67.55 -33.77 75.72 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 122.071 2.214 . . . . 0.0 110.964 171.351 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.7 p -75.2 -17.09 60.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 121.721 2.055 . . . . 0.0 111.553 167.153 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.68 36.45 6.46 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 118.145 2.018 . . . . 0.0 118.145 156.129 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.7 tttt -77.54 116.65 18.27 Favored 'General case' 0 N--CA 1.442 -0.868 0 O-C-N 117.604 -3.292 . . . . 0.0 104.116 158.93 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.257 12.8 m -93.93 157.86 15.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 114.548 -2.644 . . . . 0.0 111.298 167.939 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.1 pt -154.68 152.66 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 126.076 2.11 . . . . 0.0 113.34 177.508 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.9 m -83.28 131.47 35.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 130.581 3.552 . . . . 0.0 107.113 166.033 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.86 121.53 21.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 119.065 -2.272 . . . . 0.0 110.309 -177.362 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.348 3.5 tt0 -99.35 128.8 45.5 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 -172.06 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.2 t -140.82 137.09 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 114.138 -2.839 . . . . 0.0 107.414 -171.446 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -90.32 138.47 27.11 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 126.745 2.528 . . . . 0.0 106.383 171.644 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.264 94.2 Cg_exo -45.09 -23.1 0.91 Allowed 'Trans proline' 0 N--CA 1.439 -1.703 1 C-N-CA 126.001 4.467 . . . . 0.0 120.906 167.303 . . . . . . . . 3 2 . 1 . 059 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.28 15.2 m -77.52 -13.84 59.82 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.77 1.628 . . . . 0.0 111.413 176.324 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -88.2 130.89 34.94 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 120.763 1.619 . . . . 0.0 107.82 179.265 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.1 p -69.73 174.73 4.81 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.94 162.369 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 23' ' ' ILE 0.25 24.7 mt -61.42 -44.76 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 128.426 2.69 . . . . 0.0 109.62 169.731 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.81 -38.33 64.45 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 128.858 2.863 . . . . 0.0 110.212 175.997 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -73.15 -34.6 66.16 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 116.422 -1.751 . . . . 0.0 113.276 177.165 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.255 57.9 t -62.29 -37.42 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 125.185 3.63 . . . . 0.0 108.79 168.683 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 38' ' ' PRO . 74.5 mttt -66.1 -40.61 90.91 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.507 1.754 . . . . 0.0 115.158 171.41 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.99 -41.4 87.53 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 126.554 1.942 . . . . 0.0 112.88 171.251 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.265 48.9 mttp -67.81 -41.49 83.04 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 123.628 1.68 . . . . 0.0 111.041 173.567 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.273 94.2 mt -55.55 -58.07 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 1 O-C-N 115.622 -4.424 . . . . 0.0 110.141 168.526 . . . . . . . . 3 2 . 1 . 059 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -45.37 -37.61 5.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 165.278 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.13 -45.14 42.92 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.727 2.011 . . . . 0.0 113.786 177.504 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 mmtm -107.51 -35.03 6.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -166.214 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -89.3 -30.56 18.36 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.868 2.867 . . . . 0.0 110.411 179.495 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.13 52.73 6.6 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 125.885 1.707 . . . . 0.0 111.479 174.012 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mt -114.62 145.43 33.86 Favored Pre-proline 0 N--CA 1.447 -0.595 0 C-N-CA 129.913 3.285 . . . . 0.0 112.31 -178.782 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -74.09 128.29 12.1 Favored 'Trans proline' 0 C--N 1.319 -1.013 0 C-N-CA 124.92 3.747 . . . . 0.0 116.788 162.572 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 4.9 Cg_endo -75.33 -46.9 0.2 Allowed 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 124.791 3.661 . . . . 0.0 108.734 -165.522 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.261 23.6 t70 -34.25 -33.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.452 1 C-N-CA 132.391 4.276 . . . . 0.0 119.518 -176.256 . . . . . . . . 3 2 . 1 . 059 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -85.89 -22.27 27.59 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 126.028 1.731 . . . . 0.0 114.26 175.418 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 41.5 mm-40 -98.82 145.79 26.6 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 -160.627 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 67.6 mtt180 -118.16 154.39 32.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 118.244 -2.785 . . . . 0.0 110.296 172.625 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.461 ' HB3' HD11 ' A' ' 67' ' ' LEU . 2.3 mp -108.29 135.45 49.59 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 167.056 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.1 mm -122.41 129.41 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 128.304 2.641 . . . . 0.0 106.51 175.457 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.497 ' CE1' HG12 ' A' ' 61' ' ' ILE . 44.6 t80 -138.44 131.3 29.57 Favored 'General case' 0 C--O 1.221 -0.421 1 C-N-CA 132.371 4.268 . . . . 0.0 108.057 172.365 . . . . . . . . 3 3 . 1 . 059 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.78 31.96 21.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 130.115 3.366 . . . . 0.0 115.404 -166.895 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.79 15.0 81.01 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 128.419 2.914 . . . . 0.0 111.413 179.204 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.1 pttt -144.37 156.66 44.33 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 124.112 3.956 . . . . 0.0 113.565 -171.496 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.83 120.35 20.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 126.077 2.846 . . . . 0.0 104.369 -173.345 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.45 66.9 mt -86.05 157.2 20.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 111.366 -2.652 . . . . 0.0 108.769 -178.6 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -91.79 132.99 36.02 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.274 -1.517 . . . . 0.0 107.653 -168.899 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -76.01 114.57 14.8 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 120.738 -1.226 . . . . 0.0 109.926 -166.961 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.83 -6.75 11.15 Favored Glycine 0 CA--C 1.522 0.483 0 O-C-N 117.968 -2.958 . . . . 0.0 110.47 -173.733 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -79.21 161.42 26.39 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 124.509 2.1 . . . . 0.0 112.31 174.67 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.3 p -91.25 176.87 6.42 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 114.012 -2.899 . . . . 0.0 112.747 167.472 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.3 tp -75.05 -28.88 60.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.613 2.365 . . . . 0.0 111.542 -173.743 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -80.11 -23.84 40.95 Favored 'General case' 0 N--CA 1.449 -0.501 1 O-C-N 115.822 -4.299 . . . . 0.0 117.138 174.2 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -67.44 -26.07 66.22 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 172.221 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -93.76 -9.22 38.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.72 2.008 . . . . 0.0 112.647 159.185 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 p30 50.99 51.7 16.53 Favored 'General case' 0 N--CA 1.45 -0.468 1 C-N-CA 131.82 4.048 . . . . 0.0 112.019 -177.997 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.497 HG12 ' CE1' ' A' ' 45' ' ' PHE . 21.5 mt -71.25 110.43 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 127.912 2.485 . . . . 0.0 109.675 162.067 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -96.34 174.41 6.89 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 112.866 -1.97 . . . . 0.0 107.981 -171.744 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -37.46 137.97 0.37 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 120.077 3.362 . . . . 0.0 120.077 162.825 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.288 9.4 tt0 57.25 35.01 25.62 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 129.908 3.283 . . . . 0.0 114.461 179.755 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.4 m -91.07 158.96 16.37 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.451 1.5 . . . . 0.0 111.31 174.595 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.6 m -112.35 115.63 29.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 123.036 1.398 . . . . 0.0 110.026 171.991 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.461 HD11 ' HB3' ' A' ' 43' ' ' LEU . 19.3 tp -89.43 141.32 28.67 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 127.152 3.358 . . . . 0.0 102.848 162.187 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -108.1 136.56 47.58 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 -177.819 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.292 13.7 tp -115.17 95.3 5.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.504 -1.68 . . . . 0.0 108.206 -172.997 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.13 110.22 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 126.81 2.044 . . . . 0.0 108.203 171.171 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.299 2.9 mm? -93.33 155.42 17.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 121.108 1.776 . . . . 0.0 109.237 179.327 . . . . . . . . 2 2 . 1 . 059 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -145.94 114.18 6.64 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 103.139 -2.911 . . . . 0.0 103.139 165.416 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 82.4 mt -122.33 127.48 49.85 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.937 2.095 . . . . 0.0 110.114 -171.984 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.8 ttp-105 -94.0 -45.67 7.49 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 116.628 -3.795 . . . . 0.0 104.856 178.0 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -97.06 170.47 26.17 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-N 122.435 2.379 . . . . 0.0 108.939 173.818 . . . . . . . . 1 1 . 1 . 059 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 C-N-CA 126.418 1.961 . . . . 0.0 110.145 173.463 . . . . . . . . 0 0 . 1 . 060 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -82.52 146.45 29.21 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 127.003 2.121 . . . . 0.0 107.154 -174.812 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -142.23 161.7 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 121.798 2.09 . . . . 0.0 108.702 166.553 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -100.85 144.1 30.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 124.981 1.426 . . . . 0.0 113.757 162.305 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.9 t -110.19 115.34 49.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 159.091 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.6 tttt -89.32 137.04 32.68 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 155.358 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -86.9 146.66 26.09 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 165.089 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.505 HD22 ' N ' ' A' ' 8' ' ' LEU . 2.6 mm? -62.19 4.7 0.12 Allowed 'General case' 0 N--CA 1.445 -0.68 1 C-N-CA 132.463 4.305 . . . . 0.0 112.936 165.814 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.9 p -106.46 12.1 30.02 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 119.373 -2.079 . . . . 0.0 113.693 171.489 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.4 -20.19 35.42 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 115.645 -2.753 . . . . 0.0 116.281 169.118 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.315 74.9 tttt -101.0 130.59 47.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 126.635 3.112 . . . . 0.0 105.373 -166.203 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.1 m -107.91 125.25 51.26 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 124.717 2.198 . . . . 0.0 108.932 177.781 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 59.8 mt -110.31 120.75 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 -172.288 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.7 m -97.19 131.3 44.07 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 118.027 -2.92 . . . . 0.0 106.932 -178.682 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tp -120.29 154.06 35.51 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.965 2.906 . . . . 0.0 111.501 -176.412 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -109.4 137.85 46.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 123.424 1.583 . . . . 0.0 108.148 161.944 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.325 21.0 m -128.02 149.78 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 119.946 3.313 . . . . 0.0 119.946 -178.582 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -85.26 156.54 59.85 Favored Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 128.069 2.548 . . . . 0.0 105.807 172.785 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.356 60.0 Cg_endo -70.19 -33.94 14.05 Favored 'Trans proline' 0 N--CA 1.447 -1.207 2 C-N-CA 129.276 6.65 . . . . 0.0 114.165 -179.915 . . . . . . . . 3 2 . 1 . 060 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.6 m -115.73 17.44 16.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 118.674 -2.516 . . . . 0.0 104.311 -167.935 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -84.01 161.27 20.79 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 125.322 2.487 . . . . 0.0 109.336 178.923 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.41 49.8 p -93.6 147.86 22.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 103.503 -2.777 . . . . 0.0 103.503 -163.146 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.305 12.4 mm -44.44 -43.92 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 121.569 3.914 . . . . 0.0 121.569 165.478 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 pm0 -79.69 -15.95 56.6 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 113.434 -3.175 . . . . 0.0 108.571 -174.239 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -74.45 -33.15 62.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 122.412 2.369 . . . . 0.0 106.921 172.299 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.431 ' H ' HG23 ' A' ' 26' ' ' VAL . 39.2 t -49.97 -48.4 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 124.378 3.263 . . . . 0.0 114.373 167.77 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -64.5 -37.35 87.24 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 114.704 -2.57 . . . . 0.0 111.906 -176.519 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.84 -39.06 70.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 128.082 2.553 . . . . 0.0 111.358 171.502 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -80.75 -25.69 37.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 119.677 -1.89 . . . . 0.0 110.497 -176.65 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.468 HD13 ' HA ' ' A' ' 30' ' ' ILE 0.264 30.3 mm -65.94 -45.49 90.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 116.351 -1.785 . . . . 0.0 106.832 169.858 . . . . . . . . 3 3 . 1 . 060 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -62.3 -50.52 71.34 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 121.504 1.956 . . . . 0.0 114.89 -179.713 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -39.74 -39.66 0.82 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 127.299 2.24 . . . . 0.0 114.549 172.934 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.2 tttt -98.04 -41.48 7.94 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 117.845 -3.034 . . . . 0.0 108.006 177.34 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -113.05 -23.03 10.26 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 124.463 3.302 . . . . 0.0 111.869 -149.639 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.96 -1.63 85.12 Favored Glycine 0 CA--C 1.524 0.652 0 CA-C-O 116.799 -2.112 . . . . 0.0 116.603 174.709 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.0 mm -78.99 118.92 75.21 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 121.8 2.8 . . . . 0.0 104.303 176.342 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.69 165.35 16.12 Favored 'Trans proline' 0 N--CA 1.45 -1.053 1 C-N-CA 126.543 4.829 . . . . 0.0 113.934 179.106 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -67.53 -27.27 39.47 Favored 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 122.608 2.205 . . . . 0.0 115.246 178.53 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -69.77 1.4 4.35 Favored 'General case' 0 N--CA 1.439 -1.019 0 O-C-N 117.466 -3.271 . . . . 0.0 111.57 -178.634 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -121.04 -14.91 8.34 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 128.598 2.759 . . . . 0.0 109.214 -169.989 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -106.47 114.07 27.96 Favored 'General case' 0 N--CA 1.449 -0.486 0 O-C-N 128.575 3.672 . . . . 0.0 106.825 -172.198 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -108.87 141.23 41.23 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 128.661 2.785 . . . . 0.0 108.17 161.248 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.28 1.5 mp -116.08 139.97 49.75 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 117.463 2.394 . . . . 0.0 117.463 -177.51 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.8 mt -112.24 151.57 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 O-C-N 127.23 2.831 . . . . 0.0 103.63 169.54 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -128.16 124.41 36.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 161.451 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.326 . . 58.57 -81.88 0.02 OUTLIER 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 128.796 2.838 . . . . 0.0 115.467 -172.743 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -133.63 1.34 4.35 Favored Glycine 0 CA--C 1.533 1.176 2 O-C-N 130.294 4.747 . . . . 0.0 112.534 171.565 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -122.37 151.33 41.31 Favored 'General case' 0 C--N 1.322 -0.606 1 CA-C-N 125.352 4.576 . . . . 0.0 106.643 -169.542 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 22.8 mt-30 -72.56 138.35 46.82 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.49 -1.232 . . . . 0.0 111.533 -174.601 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.53 HD11 HD12 ' A' ' 67' ' ' LEU . 82.3 mt -95.98 120.91 37.1 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 117.079 -1.848 . . . . 0.0 112.695 171.059 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -92.63 154.02 18.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -176.446 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -78.87 154.9 29.38 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 131.576 3.95 . . . . 0.0 110.625 178.976 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.89 0.34 83.63 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 122.773 1.207 . . . . 0.0 115.505 171.786 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.9 mtp85 -124.75 145.85 49.5 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 131.403 3.881 . . . . 0.0 105.731 -167.006 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.41 30.5 p -79.94 159.47 26.31 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 112.225 -2.261 . . . . 0.0 115.389 -171.745 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -51.9 14.13 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 126.672 2.483 . . . . 0.0 109.919 -172.104 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.5 m -78.0 -0.37 27.56 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 128.431 2.692 . . . . 0.0 106.41 -168.347 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -67.4 -31.01 70.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 124.639 2.161 . . . . 0.0 107.127 175.576 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.353 8.3 m-85 -107.84 -179.44 3.9 Favored 'General case' 0 N--CA 1.449 -0.505 1 O-C-N 115.998 -4.189 . . . . 0.0 107.87 175.572 . . . . . . . . 3 2 . 1 . 060 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -92.9 45.68 1.19 Allowed 'General case' 0 N--CA 1.448 -0.536 0 O-C-N 118.179 -2.826 . . . . 0.0 116.137 175.633 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.3 mt -76.07 138.85 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 117.753 -1.117 . . . . 0.0 108.88 166.428 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -154.12 -178.46 7.11 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.541 1.937 . . . . 0.0 109.779 -164.438 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -50.3 115.57 1.5 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 126.177 1.791 . . . . 0.0 109.301 171.478 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 55.78 33.57 21.71 Favored 'General case' 0 N--CA 1.452 -0.337 1 C-N-CA 133.619 4.768 . . . . 0.0 113.491 -178.064 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 138.8 56.77 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.313 1.845 . . . . 0.0 108.812 158.046 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.4 m -103.93 136.61 43.27 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.628 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.53 HD12 HD11 ' A' ' 50' ' ' LEU . 2.4 mm? -107.97 139.54 42.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 130.251 3.42 . . . . 0.0 116.771 156.202 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 59.4 m80 -97.34 124.26 41.43 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 113.219 -3.277 . . . . 0.0 107.145 -175.552 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.7 tp -93.87 124.14 37.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 128.242 3.464 . . . . 0.0 109.664 -179.248 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.5 t -101.2 116.56 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 130.194 3.398 . . . . 0.0 106.26 -177.563 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.265 87.4 mt -95.78 -12.21 25.7 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 126.116 2.135 . . . . 0.0 111.736 -166.854 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.296 6.6 tmm_? 95.66 -21.57 0.05 Allowed 'General case' 0 N--CA 1.454 -0.263 1 C-N-CA 134.554 5.141 . . . . 0.0 114.025 -173.287 . . . . . . . . 3 2 . 1 . 060 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.6 tt -115.45 120.2 38.75 Favored 'General case' 0 N--CA 1.448 -0.55 1 CA-C-O 129.537 4.494 . . . . 0.0 110.113 179.677 . . . . . . . . 2 2 . 1 . 060 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -154.25 161.33 41.87 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 101.518 -3.512 . . . . 0.0 101.518 160.208 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.82 35.22 4.28 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 120.324 1.42 . . . . 0.0 114.031 -177.862 . . . . . . . . 1 1 . 1 . 060 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.412 0 CA-C-O 115.663 -2.743 . . . . 0.0 111.669 -168.379 . . . . . . . . 0 0 . 1 . 061 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.625 0 CA-C-O 117.73 -1.128 . . . . 0.0 109.155 . . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -88.65 125.72 34.96 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.19 2.196 . . . . 0.0 113.676 -179.494 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.7 pt -109.76 164.12 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 124.13 3.15 . . . . 0.0 111.054 177.984 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -117.83 145.56 44.49 Favored 'General case' 0 N--CA 1.444 -0.745 0 O-C-N 117.53 -3.231 . . . . 0.0 110.07 170.66 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 80.3 t -122.18 127.51 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 104.102 -2.555 . . . . 0.0 104.102 174.055 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -73.78 111.76 9.25 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 111.671 -2.513 . . . . 0.0 106.422 168.896 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 61.0 m -108.61 126.97 53.54 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 -178.755 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.651 ' H ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -55.14 -6.31 0.14 Allowed 'General case' 0 C--N 1.324 -0.524 1 N-CA-C 122.133 4.123 . . . . 0.0 122.133 178.124 . . . . . . . . 4 4 . 1 . 061 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 p -83.01 3.35 30.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 123.878 0.736 . . . . 0.0 109.589 175.9 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.62 21.81 30.49 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-O 123.705 1.725 . . . . 0.0 114.793 -178.704 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -123.78 135.56 53.88 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 116.645 -1.645 . . . . 0.0 109.102 -162.665 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.9 m -114.79 85.09 2.18 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.981 1.848 . . . . 0.0 111.32 177.695 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.457 HD13 HG21 ' A' ' 13' ' ' ILE . 9.6 pt -77.11 161.63 4.49 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.359 0 O-C-N 119.1 -2.25 . . . . 0.0 106.812 -167.031 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.5 t -128.5 136.41 50.76 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 125.308 1.63 . . . . 0.0 109.774 178.582 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.331 0.3 OUTLIER -141.04 146.84 37.73 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 129.866 3.266 . . . . 0.0 114.036 -179.778 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.7 mp0 -92.6 120.03 32.63 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 129.464 3.106 . . . . 0.0 105.599 -171.05 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.273 16.0 m -127.37 162.85 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 O-C-N 116.364 -3.96 . . . . 0.0 109.732 177.756 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.61 159.96 69.53 Favored Pre-proline 0 N--CA 1.451 -0.414 1 O-C-N 115.485 -4.509 . . . . 0.0 107.053 164.882 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -53.48 -46.84 30.85 Favored 'Trans proline' 0 N--CA 1.446 -1.267 0 N-CA-C 118.595 2.498 . . . . 0.0 118.595 -167.172 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.1 m -79.0 5.55 11.44 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 128.653 2.781 . . . . 0.0 112.56 -169.051 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.266 89.9 m-20 -77.66 140.61 39.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.73 -1.231 . . . . 0.0 109.494 176.658 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.2 p -86.0 146.62 26.59 Favored 'General case' 0 C--N 1.319 -0.72 0 O-C-N 129.08 3.988 . . . . 0.0 107.605 -179.522 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.8 mm -60.77 -23.9 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 128.646 2.779 . . . . 0.0 111.762 -175.544 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -61.82 -38.83 89.64 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 128.974 2.91 . . . . 0.0 111.452 166.963 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -68.13 -35.61 78.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 125.756 2.693 . . . . 0.0 113.421 179.81 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 81.3 t -82.7 -37.71 14.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 112.44 -2.164 . . . . 0.0 109.3 176.425 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.363 61.8 mttt -48.72 -50.27 34.34 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.031 2.933 . . . . 0.0 111.665 168.143 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.44 -27.3 56.15 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 116.056 -1.926 . . . . 0.0 109.928 -173.292 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -63.58 -45.2 91.48 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 122.474 2.397 . . . . 0.0 116.89 165.955 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 58.0 mt -55.51 -40.54 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 114.822 -2.513 . . . . 0.0 110.223 167.713 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -61.5 -42.12 98.32 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 113.535 -3.126 . . . . 0.0 112.906 171.302 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.444 29.9 t70 -57.08 -27.83 62.09 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 122.627 2.467 . . . . 0.0 116.292 173.124 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.6 tppt? -94.58 -55.7 3.05 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 126.485 2.366 . . . . 0.0 111.039 -174.298 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -117.31 -21.34 8.77 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.465 1.506 . . . . 0.0 113.835 -165.087 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.63 12.03 45.51 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 115.67 -2.739 . . . . 0.0 111.668 168.296 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 36' ' ' ILE . 39.3 mt -82.95 132.24 51.59 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 118.87 1.335 . . . . 0.0 112.608 171.434 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.21 121.79 8.61 Favored 'Trans proline' 0 N--CA 1.456 -0.692 1 C-N-CA 129.153 6.569 . . . . 0.0 113.758 178.222 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.297 32.3 Cg_exo -40.78 -35.23 1.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 1 C-N-CA 126.296 4.664 . . . . 0.0 117.43 170.908 . . . . . . . . 3 2 . 1 . 061 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -67.75 -35.09 78.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 -175.871 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -77.62 -42.11 36.11 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 130.48 3.512 . . . . 0.0 115.387 170.049 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -64.27 146.97 53.47 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.612 1.165 . . . . 0.0 114.029 -173.723 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.429 ' HB3' HG23 ' A' ' 70' ' ' VAL . 2.4 ttt180 -141.98 154.34 44.96 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 131.693 3.997 . . . . 0.0 109.88 -177.143 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.7 mt -130.11 159.61 36.26 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 116.72 -3.737 . . . . 0.0 115.865 177.532 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.03 136.51 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 C-N-CA 130.004 3.322 . . . . 0.0 115.74 165.01 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CE1' ' HB3' ' A' ' 65' ' ' SER . 91.3 t80 -140.18 145.59 37.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 167.672 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.21 33.09 19.83 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 128.705 2.802 . . . . 0.0 112.086 168.007 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.26 -24.19 12.46 Favored Glycine 0 CA--C 1.53 0.993 0 CA-C-O 117.851 -1.527 . . . . 0.0 113.978 -175.033 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -87.41 141.74 28.4 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 121.499 2.65 . . . . 0.0 105.461 -169.889 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -81.61 122.68 27.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.713 -2.329 . . . . 0.0 104.713 166.05 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.4 mt -75.47 137.74 41.14 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -173.983 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' CD ' ' HE ' ' A' ' 54' ' ' ARG . 2.5 mp0 -89.43 159.78 17.12 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 125.228 1.58 . . . . 0.0 106.91 176.607 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -87.11 121.89 30.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 126.203 2.189 . . . . 0.0 107.234 172.746 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.32 -33.24 3.06 Favored Glycine 0 N--CA 1.44 -1.066 0 CA-C-O 124.523 2.18 . . . . 0.0 113.165 -178.398 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.437 ' HE ' ' CD ' ' A' ' 51' ' ' GLU . 4.1 mtt-85 -82.52 167.87 17.96 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 112.777 -1.711 . . . . 0.0 112.698 177.821 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.0 p -109.64 167.75 9.91 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 -176.747 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.411 HD23 HD12 ' A' ' 61' ' ' ILE . 83.4 mt -56.11 -48.96 75.17 Favored 'General case' 0 N--CA 1.45 -0.44 1 C-N-CA 131.98 4.112 . . . . 0.0 105.885 172.833 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.45 -43.98 17.01 Favored 'General case' 0 N--CA 1.444 -0.765 1 C-N-CA 131.747 4.019 . . . . 0.0 108.518 174.052 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -61.69 -16.38 48.47 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 124.365 3.257 . . . . 0.0 114.067 178.962 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -114.17 2.66 14.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 114.803 -2.522 . . . . 0.0 111.544 -174.661 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.305 67.3 m-80 74.85 16.33 2.99 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.794 2.438 . . . . 0.0 111.686 173.655 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.411 HD12 HD23 ' A' ' 56' ' ' LEU . 74.8 mt -68.39 128.05 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 O-C-N 117.521 -3.237 . . . . 0.0 113.905 -174.22 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -123.41 -163.45 1.12 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 128.152 2.581 . . . . 0.0 107.64 -178.854 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -50.81 119.26 3.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 123.375 1.56 . . . . 0.0 113.768 169.899 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.321 50.8 mt-10 74.94 21.38 2.03 Favored 'General case' 0 N--CA 1.446 -0.628 0 O-C-N 120.024 -1.672 . . . . 0.0 111.576 163.171 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.413 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 45.8 m -53.7 126.28 21.38 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 115.96 -1.971 . . . . 0.0 110.223 160.663 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 m -97.38 112.38 24.23 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 127.163 2.185 . . . . 0.0 109.314 171.856 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.314 8.7 mp -97.82 167.26 11.04 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.399 1.88 . . . . 0.0 108.864 176.144 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.8 m80 -116.59 124.17 49.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 128.822 2.849 . . . . 0.0 104.605 -176.118 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.1 tp -97.78 132.19 43.62 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 128.978 2.911 . . . . 0.0 110.574 -177.229 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.429 HG23 ' HB3' ' A' ' 42' ' ' ARG 0.292 4.1 m -142.32 171.29 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 112.921 -1.945 . . . . 0.0 110.752 -176.538 . . . . . . . . 3 3 . 1 . 061 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.65 138.65 22.28 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 102.416 -3.179 . . . . 0.0 102.416 172.519 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.416 14.8 ttt85 85.97 -54.72 0.07 Allowed 'General case' 0 C--N 1.321 -0.658 1 C-N-CA 132.14 4.176 . . . . 0.0 113.016 164.903 . . . . . . . . 3 2 . 1 . 061 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 26.4 mt -95.97 144.66 26.08 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 128.275 2.63 . . . . 0.0 112.167 -160.667 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.3 135.88 39.6 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 124.242 0.964 . . . . 0.0 112.0 -176.852 . . . . . . . . 2 2 . 1 . 061 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -126.13 169.32 18.08 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 128.651 3.024 . . . . 0.0 109.303 176.853 . . . . . . . . 1 1 . 1 . 061 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.515 0 CA-C-O 115.848 -2.64 . . . . 0.0 110.419 178.064 . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 ptt? . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 116.878 -1.534 . . . . 0.0 112.088 . . . . . . . . . 0 0 . 1 . 062 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.411 49.4 mm-40 -109.15 146.39 34.18 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 116.717 -1.611 . . . . 0.0 108.166 -170.609 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.9 pt -145.33 156.86 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 121.208 1.822 . . . . 0.0 109.038 170.473 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -99.84 141.29 32.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 105.118 -2.178 . . . . 0.0 105.118 178.668 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.406 HG21 HD11 ' A' ' 30' ' ' ILE . 52.9 t -107.58 133.71 51.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 105.92 -1.881 . . . . 0.0 105.92 156.513 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -91.34 117.6 29.8 Favored 'General case' 0 C--N 1.325 -0.474 1 C-N-CA 132.743 4.417 . . . . 0.0 110.26 170.298 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -82.65 162.46 21.84 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.342 1.857 . . . . 0.0 110.07 176.821 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pp -78.76 -24.47 44.7 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 127.384 2.274 . . . . 0.0 110.179 172.024 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -87.84 -18.02 30.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 O-C-N 119.867 -1.77 . . . . 0.0 114.136 -178.275 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.17 7.67 3.16 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 128.506 2.955 . . . . 0.0 115.903 144.576 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -90.62 163.34 14.59 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 125.36 2.505 . . . . 0.0 107.71 174.817 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.3 m -128.29 117.23 21.11 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.942 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 55.0 mt -100.32 129.75 50.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 128.458 2.703 . . . . 0.0 103.837 -167.426 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 96.8 m -91.57 107.73 19.41 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -177.033 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.316 48.7 mt -102.91 152.52 21.2 Favored 'General case' 0 N--CA 1.449 -0.517 1 CA-C-N 126.341 4.155 . . . . 0.0 107.935 175.581 . . . . . . . . 3 2 . 1 . 062 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -113.78 119.93 39.04 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 114.68 -2.581 . . . . 0.0 106.15 175.313 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -124.7 149.68 29.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 125.003 1.439 . . . . 0.0 114.661 -175.309 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -81.61 130.61 60.81 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-O 114.991 -2.433 . . . . 0.0 104.556 167.309 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -38.71 -25.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.379 1 N-CA-C 123.163 4.255 . . . . 0.0 123.163 165.69 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 97.1 p -115.06 18.54 16.26 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 126.147 2.154 . . . . 0.0 114.466 178.99 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -59.46 111.33 1.35 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 128.822 2.849 . . . . 0.0 112.636 156.806 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 p -72.06 169.53 15.8 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 123.256 2.753 . . . . 0.0 111.192 -177.528 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.321 18.7 mm -51.11 -32.16 11.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 125.773 1.629 . . . . 0.0 113.782 -179.916 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 19.0 tp10 -87.15 -20.86 26.42 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 122.179 2.263 . . . . 0.0 106.893 -175.314 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -79.39 -39.18 33.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.622 1.169 . . . . 0.0 112.482 179.839 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.3 t -43.07 -39.13 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 128.497 2.719 . . . . 0.0 113.157 161.884 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -75.01 -37.66 61.75 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 119.512 -1.992 . . . . 0.0 112.939 -171.818 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.285 . . -68.28 -16.69 64.05 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 127.974 2.509 . . . . 0.0 114.444 172.298 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.25 -38.42 17.59 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 127.572 2.349 . . . . 0.0 112.316 171.329 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.406 HD11 HG21 ' A' ' 5' ' ' VAL . 71.9 mt -58.19 -42.41 83.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 114.449 -2.691 . . . . 0.0 114.451 157.445 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -48.63 -62.87 1.28 Allowed 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.193 2.197 . . . . 0.0 112.471 165.283 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -33.0 -40.59 0.06 Allowed 'General case' 0 N--CA 1.448 -0.57 1 CA-C-O 111.589 -4.053 . . . . 0.0 119.709 170.656 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.4 mptt -96.48 -53.1 3.7 Favored 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 128.202 3.439 . . . . 0.0 111.473 176.865 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -112.97 -3.75 14.01 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 115.289 1.589 . . . . 0.0 115.289 -167.657 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.0 -8.94 77.54 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-O 116.895 -2.058 . . . . 0.0 115.683 160.5 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -66.21 130.0 94.25 Favored Pre-proline 0 N--CA 1.45 -0.445 0 C-N-CA 129.045 2.938 . . . . 0.0 109.035 -172.454 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -71.22 143.15 43.2 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 N-CA-C 107.975 -1.587 . . . . 0.0 107.975 172.599 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.3 46.7 Cg_exo -28.86 -60.74 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 1 C-N-CA 126.369 4.712 . . . . 0.0 117.741 163.593 . . . . . . . . 3 2 . 1 . 062 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.401 ' CG ' HH21 ' A' ' 74' ' ' ARG . 28.5 t70 -55.41 -25.49 36.2 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 122.082 2.219 . . . . 0.0 115.568 -172.463 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -89.89 -9.89 47.26 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 176.211 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 -94.75 154.76 17.14 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 131.599 3.96 . . . . 0.0 107.085 -175.838 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -143.47 152.38 41.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 113.853 -2.975 . . . . 0.0 104.821 163.634 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.267 76.5 mt -123.79 119.64 30.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 121.5 1.955 . . . . 0.0 107.385 -173.106 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -107.52 143.13 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 127.758 2.423 . . . . 0.0 110.005 -179.131 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -155.29 143.97 20.55 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.421 2.288 . . . . 0.0 109.304 172.343 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.66 31.88 13.52 Favored 'General case' 0 C--N 1.328 -0.331 3 O-C-N 114.566 -5.084 . . . . 0.0 114.217 161.483 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.27 2.56 62.01 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 126.645 2.069 . . . . 0.0 116.449 171.386 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.338 41.5 pttt -136.1 150.4 49.1 Favored 'General case' 0 N--CA 1.445 -0.717 1 C-N-CA 133.225 4.61 . . . . 0.0 114.966 -169.271 . . . . . . . . 3 2 . 1 . 062 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 48.8 tt0 -76.54 140.73 41.24 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.704 2.002 . . . . 0.0 106.996 162.455 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.9 mt -71.6 129.49 38.86 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 114.764 -2.541 . . . . 0.0 112.992 171.714 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.82 139.68 30.22 Favored 'General case' 0 N--CA 1.447 -0.581 1 C-N-CA 131.814 4.046 . . . . 0.0 105.057 -173.446 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -84.83 117.86 24.13 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 127.628 2.371 . . . . 0.0 115.856 -174.126 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 133.46 11.44 1.73 Allowed Glycine 0 CA--C 1.532 1.131 0 C-N-CA 126.391 1.948 . . . . 0.0 112.836 179.684 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -141.11 163.65 32.39 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 105.83 -1.915 . . . . 0.0 105.83 -174.058 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -123.73 -179.29 4.31 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 119.226 -2.171 . . . . 0.0 109.728 -162.994 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 mp -58.84 -33.75 70.78 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 118.464 -2.648 . . . . 0.0 114.601 172.192 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 p -76.27 -34.61 59.12 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 120.94 1.7 . . . . 0.0 107.056 179.582 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -74.08 -42.61 59.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 125.5 1.75 . . . . 0.0 109.537 -173.237 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -76.44 4.04 9.93 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 118.762 -2.461 . . . . 0.0 115.215 166.892 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 75.8 18.0 2.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 131.529 3.932 . . . . 0.0 114.483 168.268 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.4 mt -69.97 132.98 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 O-C-N 119.295 -2.128 . . . . 0.0 108.681 -174.233 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -124.27 153.4 41.75 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 112.859 -3.448 . . . . 0.0 109.98 -173.861 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -51.27 135.02 27.17 Favored 'General case' 0 N--CA 1.443 -0.802 1 O-C-N 129.111 4.007 . . . . 0.0 113.049 -177.048 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.588 80.8 mt-10 84.93 11.17 0.31 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 128.247 2.619 . . . . 0.0 116.505 172.645 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.308 27.9 m -86.65 159.9 19.06 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 116.229 -1.843 . . . . 0.0 110.964 170.978 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 88.8 m -130.95 113.34 13.88 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.276 1.83 . . . . 0.0 107.143 -158.948 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.0 mp -105.7 163.32 12.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 130.575 3.55 . . . . 0.0 113.906 -179.885 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 38.7 m80 -122.17 154.86 36.89 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -161.31 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.257 39.1 tp -145.58 117.93 8.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 125.619 2.628 . . . . 0.0 105.913 -167.853 . . . . . . . . 2 2 . 1 . 062 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.6 t -110.17 119.39 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 110.588 -3.006 . . . . 0.0 108.142 169.433 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -75.84 145.49 40.57 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 119.427 -2.045 . . . . 0.0 110.294 167.157 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.0 mtp180 -100.42 173.5 6.55 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 102.009 -3.33 . . . . 0.0 102.009 177.197 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.6 mt -73.86 175.2 7.51 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.566 -1.334 . . . . 0.0 113.49 165.646 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.401 HH21 ' CG ' ' A' ' 39' ' ' ASP . 58.1 ttp180 65.1 121.89 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.828 1 C-N-CA 134.207 5.003 . . . . 0.0 117.331 -167.342 . . . . . . . . 3 3 . 1 . 062 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.25 144.5 6.78 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-O 117.016 -1.991 . . . . 0.0 110.852 179.903 . . . . . . . . 1 1 . 1 . 062 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.122 0 CA-C-O 113.799 -3.778 . . . . 0.0 111.946 -161.174 . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.9 ttm . . . . . 0 N--CA 1.466 0.354 0 CA-C-O 117.962 -1.018 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 063 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 pm0 -87.31 117.5 26.12 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 128.93 2.892 . . . . 0.0 112.728 -175.513 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.6 pt -126.57 167.5 21.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 125.428 1.491 . . . . 0.0 109.742 170.961 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -140.6 115.21 9.49 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 125.327 2.489 . . . . 0.0 105.651 -168.912 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.542 HG21 HD12 ' A' ' 15' ' ' LEU . 15.5 t -101.55 109.23 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 CA-C-N 112.663 -2.062 . . . . 0.0 111.807 -179.239 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.1 tttt -93.99 121.11 35.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 115.549 -2.167 . . . . 0.0 113.489 -174.528 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 36.0 p -73.48 179.32 4.1 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 128.246 2.618 . . . . 0.0 111.259 -177.453 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.52 -32.16 60.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 127.19 2.196 . . . . 0.0 108.274 172.2 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.42 -21.71 59.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 127.155 2.182 . . . . 0.0 109.852 179.741 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.11 -4.56 58.86 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 117.244 -1.865 . . . . 0.0 114.92 177.511 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -65.92 143.9 57.13 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 124.9 1.0 . . . . 0.0 110.889 170.615 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -138.15 99.93 4.0 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 119.137 -2.227 . . . . 0.0 106.011 -158.844 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.5 mm -95.72 131.78 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.226 -169.946 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 m -94.75 105.49 17.43 Favored 'General case' 0 N--CA 1.442 -0.87 0 O-C-N 119.628 -1.92 . . . . 0.0 107.64 -171.486 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.542 HD12 HG21 ' A' ' 5' ' ' VAL . 47.8 mt -93.98 127.23 39.64 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 125.143 2.402 . . . . 0.0 105.594 179.401 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -95.79 110.47 22.62 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 119.786 -1.821 . . . . 0.0 107.506 174.071 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -116.14 170.57 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 128.598 2.759 . . . . 0.0 107.596 -174.68 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -114.39 162.41 23.49 Favored Pre-proline 0 N--CA 1.449 -0.509 1 O-C-N 129.19 4.056 . . . . 0.0 108.892 150.195 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -57.88 -14.62 18.78 Favored 'Trans proline' 0 N--CA 1.447 -1.252 1 C-N-CA 125.716 4.277 . . . . 0.0 115.486 -175.555 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 60.1 p -90.74 0.32 57.47 Favored 'General case' 0 N--CA 1.449 -0.477 0 O-C-N 116.912 -3.617 . . . . 0.0 114.853 -179.383 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.74 137.91 44.28 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 127.983 3.302 . . . . 0.0 106.396 -176.57 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.8 p -83.39 170.69 14.26 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 120.171 1.35 . . . . 0.0 112.512 173.264 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.447 HD11 ' HB3' ' A' ' 50' ' ' LEU . 47.1 mt -58.7 -42.82 86.22 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 C-N-CA 129.26 3.024 . . . . 0.0 108.018 170.816 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -49.57 -46.99 49.53 Favored 'General case' 0 C--N 1.329 -0.294 1 C-N-CA 132.535 4.334 . . . . 0.0 109.854 166.909 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -73.61 -45.65 51.74 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 120.448 1.476 . . . . 0.0 110.067 -177.925 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.7 t -53.57 -48.87 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 CA-C-O 117.315 -1.326 . . . . 0.0 108.497 171.181 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -67.39 -36.28 81.0 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 120.086 1.312 . . . . 0.0 110.368 -178.668 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.53 -40.37 78.64 Favored 'General case' 0 C--O 1.217 -0.624 1 O-C-N 115.923 -4.235 . . . . 0.0 110.703 171.238 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.319 39.2 mttp -62.14 -49.74 74.66 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 130.253 3.421 . . . . 0.0 117.432 -179.389 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 51.8 mt -55.92 -33.94 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 O-C-N 128.683 3.739 . . . . 0.0 110.462 164.479 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -75.34 -37.89 60.46 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 121.599 2.0 . . . . 0.0 115.014 -178.903 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -55.21 -37.99 67.85 Favored 'General case' 0 C--O 1.224 -0.248 0 C-N-CA 126.89 2.076 . . . . 0.0 113.842 172.849 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.4 mptt -80.99 -83.1 0.11 Allowed 'General case' 0 N--CA 1.442 -0.87 1 C-N-CA 132.108 4.163 . . . . 0.0 114.022 -176.966 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -92.37 -0.27 57.39 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 116.884 -1.531 . . . . 0.0 110.975 -174.922 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.23 11.58 82.05 Favored Glycine 0 CA--C 1.53 0.979 0 CA-C-N 122.652 2.478 . . . . 0.0 114.239 175.961 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.9 mm -67.77 126.8 93.08 Favored Pre-proline 0 N--CA 1.446 -0.628 1 C-N-CA 132.313 4.245 . . . . 0.0 110.808 -177.103 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -64.14 149.39 90.46 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 124.542 3.494 . . . . 0.0 113.4 171.519 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -68.44 -55.69 0.22 Allowed 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 123.212 2.608 . . . . 0.0 114.422 178.044 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -52.44 -25.21 9.4 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 127.305 2.878 . . . . 0.0 113.066 -173.12 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -79.2 -10.91 59.94 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 114.721 -2.561 . . . . 0.0 114.077 178.857 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 -111.85 152.91 27.39 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 130.206 3.402 . . . . 0.0 116.609 -168.398 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 -137.96 138.69 39.2 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 118.712 -2.493 . . . . 0.0 106.295 166.473 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.429 HD23 ' HB3' ' A' ' 69' ' ' LEU . 41.2 mt -107.63 148.5 29.26 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 129.244 3.018 . . . . 0.0 112.026 -171.819 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 31.4 mt -147.74 118.69 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 126.811 2.044 . . . . 0.0 107.757 -164.982 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.429 ' CD1' HG12 ' A' ' 61' ' ' ILE . 45.3 t80 -146.56 140.69 26.31 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 126.018 1.727 . . . . 0.0 106.997 169.993 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 74.9 21.07 2.11 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.987 2.515 . . . . 0.0 116.123 169.542 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.75 3.01 61.07 Favored Glycine 0 CA--C 1.526 0.745 0 O-C-N 120.413 -1.43 . . . . 0.0 112.299 179.705 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.315 16.7 ptpt -127.96 133.93 49.25 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 -171.406 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -75.21 132.76 41.34 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 102.029 -3.322 . . . . 0.0 102.029 163.539 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.447 ' HB3' HD11 ' A' ' 23' ' ' ILE . 29.4 mt -86.29 137.91 32.25 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 112.94 -1.936 . . . . 0.0 108.415 -179.69 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -111.86 147.41 35.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.226 -2.139 . . . . 0.0 105.226 -178.877 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.01 139.78 58.8 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 128.802 2.841 . . . . 0.0 111.635 -162.9 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.48 20.74 10.56 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 125.373 1.463 . . . . 0.0 114.486 178.701 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -131.99 147.35 52.45 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 123.923 1.82 . . . . 0.0 109.755 175.386 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.6 p -95.46 154.08 17.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 111.283 -2.69 . . . . 0.0 111.767 179.264 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 61' ' ' ILE . 53.9 mt -51.41 -33.64 31.28 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 119.229 -2.169 . . . . 0.0 115.683 -179.105 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -10.52 59.53 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 120.415 -1.428 . . . . 0.0 114.319 177.195 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -77.76 -27.93 50.49 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.586 175.18 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.366 67.8 m-85 -104.96 -0.04 27.32 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 130.986 3.714 . . . . 0.0 113.878 170.585 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.338 0.7 OUTLIER 59.06 39.82 22.84 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 128.813 2.845 . . . . 0.0 113.962 -179.079 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 90.0 mt -70.31 112.08 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 118.758 0.708 . . . . 0.0 109.811 168.634 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -112.37 -170.12 1.6 Allowed 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 113.187 -1.824 . . . . 0.0 112.751 -170.813 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.443 36.1 pttt -50.65 120.18 4.49 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 120.378 3.473 . . . . 0.0 120.378 179.674 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 67.77 54.15 0.65 Allowed 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 128.855 2.862 . . . . 0.0 109.241 177.731 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.7 m -107.43 141.31 39.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 117.602 -1.19 . . . . 0.0 112.309 175.238 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.276 36.3 m -108.9 144.95 36.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 126.233 2.921 . . . . 0.0 107.651 168.393 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.7 pp -132.11 -178.03 4.72 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 103.355 -2.832 . . . . 0.0 103.355 173.976 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -151.68 -179.59 7.56 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 111.986 -2.37 . . . . 0.0 105.155 -171.898 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.429 ' HB3' HD23 ' A' ' 43' ' ' LEU . 1.5 pp -147.15 168.46 21.58 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 123.345 1.545 . . . . 0.0 112.923 175.865 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.0 p -128.74 133.42 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 131.574 3.95 . . . . 0.0 110.057 -178.225 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.572 ' O ' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -47.05 136.59 8.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 120.016 3.339 . . . . 0.0 120.016 164.394 . . . . . . . . 3 3 . 1 . 063 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.318 3.9 ttm180 -122.78 129.55 51.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.902 2.881 . . . . 0.0 105.701 171.087 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.407 HD21 HD23 ' A' ' 71' ' ' LEU . 96.3 mt -95.86 -26.31 15.67 Favored 'General case' 0 N--CA 1.442 -0.844 0 O-C-N 127.48 2.987 . . . . 0.0 113.124 -157.339 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.8 ttt-85 -97.34 140.06 32.37 Favored 'General case' 0 CA--C 1.535 0.367 1 C-N-CA 132.81 4.444 . . . . 0.0 103.765 176.939 . . . . . . . . 2 2 . 1 . 063 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -134.73 124.11 3.36 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 127.74 2.591 . . . . 0.0 115.127 175.401 . . . . . . . . 1 1 . 1 . 063 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 N-CA-C 104.534 -3.426 . . . . 0.0 104.534 -175.978 . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.6 ttp . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 115.691 -2.1 . . . . 0.0 106.17 . . . . . . . . . 0 0 . 1 . 064 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.253 27.0 mp0 -97.0 131.24 44.02 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 -175.127 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 16.6 pt -114.63 177.64 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 116.955 -3.59 . . . . 0.0 105.577 158.926 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -127.25 141.76 51.64 Favored 'General case' 0 N--CA 1.447 -0.618 1 C-N-CA 131.978 4.111 . . . . 0.0 108.515 175.904 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -122.2 106.36 17.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 N-CA-C 103.404 -2.813 . . . . 0.0 103.404 -178.344 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -89.37 166.53 13.67 Favored 'General case' 0 N--CA 1.446 -0.669 0 O-C-N 117.762 -3.086 . . . . 0.0 104.489 166.695 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.6 p -127.5 149.34 50.17 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 109.38 -3.554 . . . . 0.0 104.04 176.08 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.21 1.68 20.69 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 128.003 3.315 . . . . 0.0 112.607 175.274 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.7 p -102.84 -21.32 14.04 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 127.645 2.378 . . . . 0.0 116.68 167.275 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 115.5 13.16 9.03 Favored Glycine 0 CA--C 1.521 0.41 0 CA-C-O 113.567 -3.907 . . . . 0.0 110.805 153.721 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -72.23 131.62 42.99 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 123.291 3.546 . . . . 0.0 112.597 155.182 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.8 m -108.22 133.17 52.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 172.714 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.6 mt -115.24 144.0 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 C-N-CA 129.308 3.043 . . . . 0.0 106.784 167.884 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.293 28.4 m -107.31 130.63 54.75 Favored 'General case' 0 N--CA 1.448 -0.532 1 N-CA-C 97.453 -5.017 . . . . 0.0 97.453 164.708 . . . . . . . . 3 2 . 1 . 064 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 tp -130.56 138.37 50.14 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 124.857 1.348 . . . . 0.0 111.603 179.288 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.27 118.16 35.99 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 102.457 -3.164 . . . . 0.0 102.457 -173.225 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.289 17.1 m -120.94 160.96 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 CA-C-O 122.548 1.166 . . . . 0.0 109.574 -176.095 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.1 tp10 -96.58 141.34 22.95 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-O 113.305 -3.236 . . . . 0.0 113.26 173.581 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -45.0 -50.9 8.21 Favored 'Trans proline' 0 N--CA 1.444 -1.385 1 C-N-CA 131.593 8.195 . . . . 0.0 108.245 169.102 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.1 m -60.24 -15.46 24.83 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.703 2.001 . . . . 0.0 112.101 -179.299 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -68.94 127.95 34.94 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 122.469 2.395 . . . . 0.0 114.505 -168.832 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.1 p -68.33 138.49 55.47 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 125.391 1.682 . . . . 0.0 107.065 160.845 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.7 mm -53.45 -19.83 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 -177.406 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.67 -36.24 80.26 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 122.225 2.284 . . . . 0.0 112.821 166.261 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -78.42 -10.14 59.57 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 123.271 2.76 . . . . 0.0 110.19 -178.814 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 79.5 t -92.88 -28.82 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 O-C-N 118.163 -2.836 . . . . 0.0 106.447 174.383 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -84.43 -20.31 32.02 Favored 'General case' 0 CA--C 1.539 0.523 1 O-C-N 114.977 -4.827 . . . . 0.0 110.062 177.83 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.69 -26.38 59.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 117.537 -1.22 . . . . 0.0 113.5 159.752 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -78.38 -17.02 57.04 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 171.772 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 53.2 mt -80.18 -34.51 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 114.309 -2.758 . . . . 0.0 110.685 162.952 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -50.69 -35.81 32.83 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 123.078 2.672 . . . . 0.0 116.019 168.656 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.253 27.5 t70 -91.74 -5.37 53.72 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 119.148 -2.22 . . . . 0.0 111.321 -172.631 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.9 mmtt -121.99 -36.57 2.98 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 113.175 -3.297 . . . . 0.0 111.233 -169.511 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -125.65 -26.44 3.53 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 123.648 2.931 . . . . 0.0 109.195 176.901 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.72 17.35 12.16 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 117.016 -3.553 . . . . 0.0 112.746 174.588 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 50.7 mt -86.82 125.94 65.15 Favored Pre-proline 0 N--CA 1.445 -0.711 0 N-CA-C 100.821 -3.77 . . . . 0.0 100.821 -175.735 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.47 144.49 25.65 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 CA-C-O 115.47 -1.971 . . . . 0.0 112.742 165.785 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -69.51 -9.71 26.89 Favored 'Trans proline' 0 N--CA 1.445 -1.326 0 C-N-CA 124.471 3.447 . . . . 0.0 114.754 -162.994 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -67.77 -17.01 64.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 123.429 2.831 . . . . 0.0 117.334 169.291 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -119.82 27.19 8.85 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 117.134 -3.479 . . . . 0.0 116.285 -162.157 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -113.56 165.66 12.29 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 128.257 2.623 . . . . 0.0 111.892 178.675 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -127.15 150.79 49.34 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.012 3.725 . . . . 0.0 102.983 141.902 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -118.67 105.59 11.74 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 112.317 -2.219 . . . . 0.0 110.946 165.114 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mt -87.97 134.77 27.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 125.688 2.661 . . . . 0.0 105.206 174.301 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -140.76 115.08 9.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 108.603 -3.908 . . . . 0.0 112.532 176.905 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 43.69 37.84 1.74 Allowed 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 128.687 2.795 . . . . 0.0 112.75 -175.052 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.6 -35.34 4.78 Favored Glycine 0 CA--C 1.527 0.799 0 O-C-N 121.253 -0.905 . . . . 0.0 113.075 171.173 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.313 97.7 mttt -83.57 165.09 19.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 128.971 2.908 . . . . 0.0 107.247 -173.947 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -116.5 119.72 36.5 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.685 2.394 . . . . 0.0 108.779 177.497 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 52.1 mt -80.59 124.38 28.92 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 123.379 1.561 . . . . 0.0 109.057 -161.125 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.21 130.84 35.89 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 -174.38 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.95 -37.11 30.52 Favored 'General case' 0 N--CA 1.452 -0.353 0 O-C-N 127.59 3.056 . . . . 0.0 118.704 -170.952 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.19 5.02 41.4 Favored Glycine 0 CA--C 1.526 0.777 1 O-C-N 116.079 -4.138 . . . . 0.0 115.026 -170.381 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.0 mmm180 -88.57 146.72 24.97 Favored 'General case' 0 C--N 1.327 -0.413 1 O-C-N 116.226 -4.103 . . . . 0.0 107.024 170.195 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -86.47 134.64 33.67 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 127.858 3.224 . . . . 0.0 111.573 -173.678 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.309 10.8 tp -22.42 -76.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.508 1 C-N-CA 134.036 4.935 . . . . 0.0 114.243 177.656 . . . . . . . . 3 2 . 1 . 064 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -66.1 -37.29 85.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 125.397 2.522 . . . . 0.0 110.217 -170.135 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -80.3 -21.26 42.78 Favored 'General case' 0 CA--C 1.536 0.43 1 O-C-N 113.793 -5.567 . . . . 0.0 113.201 178.584 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.86 -22.37 66.89 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 162.913 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.809 6.5 t-20 105.85 24.13 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 129.534 3.134 . . . . 0.0 117.96 175.512 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.6 mt -99.82 73.42 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 126.708 2.003 . . . . 0.0 109.672 -177.524 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -89.84 169.79 10.95 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 124.72 2.2 . . . . 0.0 105.955 -179.506 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -31.54 115.79 0.16 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.283 2.697 . . . . 0.0 118.283 -174.298 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 77.51 29.8 0.52 Allowed 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 129.067 2.947 . . . . 0.0 113.427 174.945 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.1 m -72.44 148.47 45.12 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 126.165 2.888 . . . . 0.0 114.133 169.986 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.8 m -104.73 107.48 18.45 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 117.062 -3.524 . . . . 0.0 105.811 -173.288 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 68.6 mt -86.36 149.17 25.22 Favored 'General case' 0 N--CA 1.443 -0.804 0 O-C-N 128.084 3.365 . . . . 0.0 108.649 162.275 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -107.59 110.84 22.83 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 127.971 3.294 . . . . 0.0 114.609 155.821 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.273 6.4 tt -74.19 139.41 44.4 Favored 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 120.083 -1.636 . . . . 0.0 107.635 168.763 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.8 t -127.02 145.99 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 164.97 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.526 ' N ' HD12 ' A' ' 71' ' ' LEU . 5.6 mp -97.84 123.48 41.82 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 -177.573 . . . . . . . . 2 2 . 1 . 064 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.8 ttt180 -79.27 69.49 5.5 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 171.442 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' HG ' ' H ' ' A' ' 74' ' ' ARG 0.494 0.5 OUTLIER -155.49 -82.63 0.07 Allowed 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.904 2.482 . . . . 0.0 108.858 171.444 . . . . . . . . 4 4 . 1 . 064 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.41 ' H ' ' HG ' ' A' ' 73' ' ' LEU . 0.4 OUTLIER -149.31 139.28 22.02 Favored 'General case' 0 N--CA 1.449 -0.525 1 C-N-CA 132.433 4.293 . . . . 0.0 102.131 171.389 . . . . . . . . 4 4 . 1 . 064 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.42 106.22 2.38 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 104.832 -3.307 . . . . 0.0 104.832 179.78 . . . . . . . . 1 1 . 1 . 064 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.499 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -154.423 . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptt? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 117.392 -1.29 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 065 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -100.2 161.61 13.5 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 116.946 2.202 . . . . 0.0 116.946 169.272 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.9 pt -146.74 158.46 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 130.322 3.449 . . . . 0.0 103.137 168.71 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -107.11 140.31 40.15 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 127.057 2.143 . . . . 0.0 107.734 174.075 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.0 t -121.05 117.79 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-O 127.258 3.409 . . . . 0.0 105.808 170.009 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.416 ' HZ2' ' HG1' ' A' ' 12' ' ' THR . 13.9 tptt -78.79 114.93 18.14 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 116.455 -3.903 . . . . 0.0 105.182 167.069 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.4 p -86.22 159.25 19.53 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 127.996 3.31 . . . . 0.0 108.469 168.544 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 tp -64.76 -30.72 71.74 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 113.265 -1.789 . . . . 0.0 114.009 178.834 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.4 p -72.79 4.52 3.99 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 127.759 2.424 . . . . 0.0 114.806 165.913 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.86 17.08 77.92 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 114.045 -3.642 . . . . 0.0 113.839 173.013 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -85.42 121.32 27.97 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 122.819 3.309 . . . . 0.0 104.844 173.607 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.416 ' HG1' ' HZ2' ' A' ' 6' ' ' LYS . 11.3 m -85.86 63.68 8.18 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.791 2.436 . . . . 0.0 107.194 173.447 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 12.9 mm -50.72 120.9 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 126.702 2.001 . . . . 0.0 111.948 173.82 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.9 m -88.67 136.66 32.88 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 174.346 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 38.9 mt -121.65 139.6 53.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 126.034 1.733 . . . . 0.0 106.992 177.629 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.5 mp0 -86.97 129.22 34.97 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 167.418 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.381 18.5 m -140.75 154.48 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 C-N-CA 128.936 2.894 . . . . 0.0 114.165 -179.416 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -117.4 171.42 4.97 Favored Pre-proline 0 N--CA 1.445 -0.712 0 CA-C-O 114.186 -2.816 . . . . 0.0 110.596 171.63 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -79.97 -27.73 3.64 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 N-CA-C 118.393 2.42 . . . . 0.0 118.393 -170.171 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.8 t -86.61 -5.96 59.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 119.056 -2.277 . . . . 0.0 116.463 178.661 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.16 122.65 11.49 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 127.605 2.362 . . . . 0.0 108.996 178.224 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.0 p -85.87 169.77 13.0 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 117.222 -3.424 . . . . 0.0 110.883 -179.402 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.44 HD12 ' HA ' ' A' ' 52' ' ' ASP . 18.4 mt -61.79 -27.81 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 O-C-N 126.299 2.249 . . . . 0.0 111.049 179.253 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -67.94 -43.36 79.29 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.491 -1.38 . . . . 0.0 107.372 174.326 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.315 30.0 m-20 -54.36 -41.53 69.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 118.736 -2.477 . . . . 0.0 117.344 168.6 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 76.5 t -73.56 -52.81 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 O-C-N 125.107 1.504 . . . . 0.0 109.082 176.135 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -44.64 -37.44 3.65 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 117.556 -3.215 . . . . 0.0 117.348 168.095 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.65 -37.86 55.56 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 126.826 2.579 . . . . 0.0 111.766 177.037 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -56.72 -50.15 73.05 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 127.424 2.952 . . . . 0.0 110.376 175.929 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.9 mt -66.61 -31.29 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 CA-C-O 117.469 -1.253 . . . . 0.0 109.322 -178.509 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -68.29 -48.63 64.47 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 121.104 1.775 . . . . 0.0 110.706 174.357 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.279 32.2 t70 -43.72 -40.77 4.45 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 128.624 3.703 . . . . 0.0 114.117 169.261 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -77.88 -60.1 2.51 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 126.459 1.904 . . . . 0.0 114.714 172.464 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -101.3 -21.19 14.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 117.617 2.451 . . . . 0.0 117.617 -162.071 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.0 -11.4 65.92 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 117.079 1.592 . . . . 0.0 117.079 -177.4 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.281 73.5 mt -77.58 126.33 84.68 Favored Pre-proline 0 N--CA 1.446 -0.653 0 CA-C-N 123.915 3.857 . . . . 0.0 112.584 -174.875 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.98 168.37 24.95 Favored 'Trans proline' 0 N--CA 1.44 -1.638 0 N-CA-C 116.731 1.781 . . . . 0.0 116.731 -174.007 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.26 -22.78 9.42 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 CA-C-O 124.999 2.0 . . . . 0.0 115.817 -162.88 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.56 -20.36 59.98 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 111.983 -3.865 . . . . 0.0 110.58 179.778 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.64 -16.62 44.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 128.773 3.796 . . . . 0.0 109.001 -174.737 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -98.84 137.63 37.14 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-O 123.994 1.854 . . . . 0.0 113.472 -171.493 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.7 mtt-85 -116.15 141.91 47.51 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 153.13 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.82 138.85 48.68 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 122.081 0.943 . . . . 0.0 108.636 179.893 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.453 HG13 ' HG3' ' A' ' 49' ' ' GLN . 3.7 mt -129.09 135.04 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 124.002 0.921 . . . . 0.0 109.564 -168.693 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -90.66 -175.94 4.57 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.365 2.266 . . . . 0.0 107.598 176.521 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -20.34 -57.22 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.482 1 C-N-CA 138.361 6.664 . . . . 0.0 111.826 -176.537 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -144.89 9.69 1.81 Allowed Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.333 -1.815 . . . . 0.0 114.823 172.759 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -141.82 129.6 21.69 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -165.313 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.453 ' HG3' HG13 ' A' ' 44' ' ' ILE . 42.0 tt0 -75.35 139.82 42.65 Favored 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 126.22 2.2 . . . . 0.0 109.053 179.926 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.9 mt -97.59 157.88 15.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 121.202 1.819 . . . . 0.0 110.692 179.003 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -148.64 138.96 22.5 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 123.013 1.387 . . . . 0.0 108.627 -176.517 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' HA ' HD12 ' A' ' 23' ' ' ILE . 16.3 m-20 -59.42 144.3 47.29 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 129.008 2.923 . . . . 0.0 112.969 -163.526 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.6 11.88 11.11 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 126.366 2.291 . . . . 0.0 117.011 168.205 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -136.47 159.24 42.39 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.684 2.794 . . . . 0.0 109.072 179.487 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.0 p -85.96 176.68 7.92 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 124.854 2.264 . . . . 0.0 110.709 177.016 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.5 mt -62.94 -47.99 80.83 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 119.293 -2.13 . . . . 0.0 109.331 169.904 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.0 t -46.58 -38.17 9.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.892 2.877 . . . . 0.0 114.399 173.505 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -78.17 -31.61 49.72 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 115.051 -2.405 . . . . 0.0 104.803 -174.575 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -95.12 -1.38 52.09 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.817 1.323 . . . . 0.0 107.749 -173.361 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 60.0 m-80 77.83 27.72 0.57 Allowed 'General case' 0 N--CA 1.45 -0.471 1 O-C-N 115.429 -4.545 . . . . 0.0 117.931 171.605 . . . . . . . . 3 2 . 1 . 065 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 80.6 mt -103.15 123.21 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 102.198 -3.26 . . . . 0.0 102.198 -170.249 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -123.28 171.0 9.71 Favored 'General case' 0 N--CA 1.445 -0.679 1 C-N-CA 131.737 4.015 . . . . 0.0 113.317 176.126 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.8 tttt -57.78 135.65 56.83 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 128.155 2.582 . . . . 0.0 111.478 -168.092 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.337 0.7 OUTLIER 81.51 7.24 1.13 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.656 2.782 . . . . 0.0 118.178 -177.896 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.8 m -68.67 139.61 55.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 124.83 2.252 . . . . 0.0 110.579 169.849 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.0 m -97.08 125.78 41.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 111.182 -2.735 . . . . 0.0 106.831 170.72 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 87.3 mt -96.36 150.51 20.5 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 128.759 2.824 . . . . 0.0 106.809 166.913 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -126.38 130.91 51.67 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 129.098 2.959 . . . . 0.0 110.703 171.685 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.1 tp -86.4 141.84 28.87 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.685 1.994 . . . . 0.0 111.865 -178.543 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.5 t -130.91 133.02 63.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 101.872 -3.381 . . . . 0.0 101.872 177.098 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 38.1 mt -103.03 129.67 49.88 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 119.042 2.979 . . . . 0.0 119.042 175.668 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -82.94 90.33 6.97 Favored 'General case' 0 C--N 1.323 -0.572 1 O-C-N 130.1 4.625 . . . . 0.0 105.341 -176.763 . . . . . . . . 2 2 . 1 . 065 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.492 ' HG ' ' H ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -97.53 141.19 30.89 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 131.446 3.898 . . . . 0.0 108.941 173.915 . . . . . . . . 3 3 . 1 . 065 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -113.27 141.45 46.98 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 103.398 -2.815 . . . . 0.0 103.398 -166.68 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.66 -94.06 0.17 Allowed Glycine 0 CA--C 1.54 1.612 0 C-N-CA 127.883 2.659 . . . . 0.0 112.778 163.906 . . . . . . . . 1 1 . 1 . 065 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.222 0 N-CA-C 104.09 -3.604 . . . . 0.0 104.09 174.41 . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.474 0.75 0 CA-C-O 113.855 -2.974 . . . . 0.0 112.145 . . . . . . . . . 0 0 . 1 . 066 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -98.7 149.88 22.37 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 121.111 1.778 . . . . 0.0 107.267 -176.997 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.1 pt -152.01 157.02 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 C-N-CA 126.184 1.793 . . . . 0.0 107.934 174.129 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -110.1 142.86 40.99 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 130.275 3.43 . . . . 0.0 105.79 -175.176 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.7 t -113.97 138.46 43.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 168.873 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -100.96 144.72 29.57 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 118.134 -2.854 . . . . 0.0 110.757 162.348 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 98.1 m -113.63 142.37 46.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 128.523 2.729 . . . . 0.0 104.956 -175.951 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.279 3.2 tm? -47.35 -49.28 24.7 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 127.33 2.252 . . . . 0.0 111.569 -171.769 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.3 p -80.29 5.7 14.0 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 -177.871 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.34 -9.83 10.89 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 121.723 3.449 . . . . 0.0 121.723 157.47 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -79.61 149.0 31.46 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.883 1.673 . . . . 0.0 109.736 -179.544 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.3 m -119.09 124.29 46.52 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 129.612 3.165 . . . . 0.0 108.572 178.811 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.286 1.5 pp -119.33 -173.83 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.095 1.358 . . . . 0.0 111.559 176.049 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.9 t -154.2 144.17 21.88 Favored 'General case' 0 C--N 1.321 -0.647 1 O-C-N 116.0 -4.187 . . . . 0.0 110.345 177.267 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.34 0.3 OUTLIER -138.42 150.97 47.03 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.77 2.828 . . . . 0.0 109.168 -175.159 . . . . . . . . 3 3 . 1 . 066 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.371 13.1 mp0 -97.49 119.89 36.87 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 126.66 2.475 . . . . 0.0 111.233 175.444 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.275 34.2 m -142.89 -179.49 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -163.145 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -141.84 143.37 28.48 Favored Pre-proline 0 C--N 1.325 -0.463 0 C-N-CA 127.568 2.347 . . . . 0.0 111.788 174.409 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.258 2.2 Cg_endo -58.73 -28.18 85.8 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 CA-C-N 127.279 3.635 . . . . 0.0 116.318 -175.073 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.9 m -85.2 19.59 2.19 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 112.375 -3.678 . . . . 0.0 109.144 178.524 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 55' ' ' THR . 12.0 m-20 -88.18 148.54 24.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 103.578 -2.749 . . . . 0.0 103.578 -178.982 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.5 p -87.47 154.08 20.92 Favored 'General case' 0 N--CA 1.446 -0.642 1 O-C-N 130.604 4.94 . . . . 0.0 113.244 177.489 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 mm -53.17 -30.93 17.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 123.108 2.685 . . . . 0.0 118.069 -175.187 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.29 10.5 tt0 -70.62 -41.52 72.14 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 116.769 -1.586 . . . . 0.0 109.812 -176.315 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -72.95 -20.56 61.03 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 128.425 2.69 . . . . 0.0 112.152 -174.125 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.488 HG21 HD21 ' A' ' 56' ' ' LEU . 61.2 t -79.14 -50.06 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 128.054 2.541 . . . . 0.0 110.796 165.128 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -62.02 -24.06 66.83 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 120.745 1.612 . . . . 0.0 114.992 174.984 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.94 -37.57 53.21 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 128.67 2.788 . . . . 0.0 113.54 170.701 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -81.56 -23.35 37.25 Favored 'General case' 0 N--CA 1.446 -0.65 0 O-C-N 126.038 2.086 . . . . 0.0 112.879 -176.649 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 57.9 mt -84.85 -42.63 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 C-N-CA 129.072 2.949 . . . . 0.0 104.357 179.669 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -51.03 -54.17 27.03 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 128.09 2.556 . . . . 0.0 113.83 164.294 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -57.66 -44.02 85.4 Favored 'General case' 0 N--CA 1.44 -0.96 1 C-N-CA 131.962 4.105 . . . . 0.0 117.54 -178.364 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -78.15 -81.85 0.1 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.646 1.979 . . . . 0.0 110.128 168.617 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -76.85 -35.11 57.72 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 127.015 2.697 . . . . 0.0 116.596 -162.663 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.85 11.1 23.47 Favored Glycine 0 CA--C 1.525 0.686 0 O-C-N 119.19 -2.194 . . . . 0.0 117.139 177.024 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.8 mt -88.72 134.54 33.68 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-O 116.258 -1.83 . . . . 0.0 106.548 -177.125 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -70.38 142.97 46.5 Favored 'Trans proline' 0 N--CA 1.447 -1.241 1 C-N-CA 125.454 4.103 . . . . 0.0 112.646 174.217 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -63.85 -20.31 68.17 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 121.698 1.599 . . . . 0.0 112.167 174.815 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -72.0 -5.52 35.58 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 118.231 -2.793 . . . . 0.0 112.179 172.478 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -126.01 0.71 7.25 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 127.827 2.451 . . . . 0.0 116.312 -176.607 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.262 50.6 mt-30 -101.72 149.01 24.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 122.256 2.298 . . . . 0.0 105.026 -175.219 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -133.06 130.96 40.06 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 158.998 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.8 mt -98.47 133.82 42.31 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.831 2.853 . . . . 0.0 107.019 175.255 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mp -126.35 148.07 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 176.319 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -156.7 119.4 4.04 Favored 'General case' 0 C--O 1.24 0.568 1 C-N-CA 132.212 4.205 . . . . 0.0 110.869 167.437 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.268 . . 74.5 13.67 3.68 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.541 1.936 . . . . 0.0 115.205 177.724 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.9 -28.11 7.16 Favored Glycine 0 CA--C 1.531 1.065 1 CA-C-O 112.282 -4.621 . . . . 0.0 107.272 179.907 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -99.85 134.04 43.33 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 128.022 2.837 . . . . 0.0 110.937 -157.224 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' HB3' ' HA3' ' A' ' 76' ' ' GLY . 1.8 pt20 -62.93 129.99 42.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 124.384 1.053 . . . . 0.0 109.289 163.908 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.78 111.84 6.53 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 125.41 1.484 . . . . 0.0 111.828 171.224 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.473 15.9 tt0 -91.85 148.03 22.54 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 114.247 1.203 . . . . 0.0 114.247 -172.51 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.75 142.77 35.11 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 120.481 1.491 . . . . 0.0 112.365 -164.877 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.34 -33.94 5.43 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-O 125.803 2.891 . . . . 0.0 112.86 -177.629 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 84.4 mtt-85 -80.43 170.69 16.04 Favored 'General case' 0 N--CA 1.441 -0.909 0 CA-C-N 111.514 -2.343 . . . . 0.0 111.053 -175.886 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 21' ' ' ASP . 70.6 p -115.38 159.28 21.3 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 127.994 2.518 . . . . 0.0 108.769 -172.368 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.488 HD21 HG21 ' A' ' 26' ' ' VAL . 77.2 mt -62.1 -26.43 68.29 Favored 'General case' 0 N--CA 1.444 -0.726 0 O-C-N 116.393 -3.942 . . . . 0.0 109.756 179.566 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.0 t -54.23 -50.89 66.12 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.799 2.44 . . . . 0.0 113.353 175.317 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -48.09 -16.56 0.09 Allowed 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 127.476 2.31 . . . . 0.0 117.145 173.535 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -124.96 -4.28 7.54 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 118.058 -2.901 . . . . 0.0 111.95 179.689 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 93.17 31.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 125.573 1.795 . . . . 0.0 108.073 163.442 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.4 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 63.5 mt -89.6 121.2 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 -172.397 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -113.37 176.16 5.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 112.902 -1.953 . . . . 0.0 112.066 -175.675 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.6 tmtt? -39.14 124.54 1.49 Allowed 'General case' 0 CA--C 1.536 0.42 1 C-N-CA 132.47 4.308 . . . . 0.0 111.643 164.526 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 80.14 0.22 2.03 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 130.997 3.719 . . . . 0.0 113.808 175.559 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -62.44 135.26 57.35 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 121.591 1.996 . . . . 0.0 108.733 -171.709 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.9 m -95.72 118.63 32.75 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 177.439 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -92.19 155.74 17.8 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 129.028 2.931 . . . . 0.0 108.067 177.394 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -105.68 133.08 50.99 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 163.607 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 13.7 tp -101.39 130.94 47.7 Favored 'General case' 0 C--N 1.322 -0.62 1 C-N-CA 132.633 4.373 . . . . 0.0 115.286 162.424 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.5 t -127.24 130.27 70.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 131.237 3.815 . . . . 0.0 104.041 -179.43 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.48 160.68 27.71 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 115.249 -2.31 . . . . 0.0 113.163 -177.687 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 74.77 -25.75 0.2 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 127.087 2.742 . . . . 0.0 109.392 164.486 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.0 pp -128.85 172.03 11.7 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 104.248 -2.501 . . . . 0.0 104.248 169.481 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.5 ttt-85 -82.05 146.3 29.75 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.737 1.215 . . . . 0.0 109.709 -173.325 . . . . . . . . 1 1 . 1 . 066 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -137.7 121.13 2.19 Favored Glycine 0 CA--C 1.531 1.047 1 CA-C-O 113.097 -4.168 . . . . 0.0 103.835 -168.391 . . . . . . . . 2 2 . 1 . 066 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 49' ' ' GLN . . . . . . . . 0 C--O 1.256 1.505 0 N-CA-C 104.237 -3.545 . . . . 0.0 104.237 -170.972 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttp . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 . . . . . . . . . 0 0 . 1 . 067 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -87.09 131.91 33.99 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.188 0.995 . . . . 0.0 108.411 -175.064 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.268 30.6 pt -110.67 142.21 23.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 154.322 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -88.24 129.72 35.28 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 104.556 -2.387 . . . . 0.0 104.556 160.783 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -101.19 115.63 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 O-C-N 127.705 3.128 . . . . 0.0 112.812 161.241 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tttt -67.04 118.22 10.18 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 127.721 2.408 . . . . 0.0 111.415 173.208 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.8 p -86.59 163.95 17.14 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 120.004 3.335 . . . . 0.0 120.004 170.918 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 mp -84.86 -18.14 35.78 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 129.076 2.951 . . . . 0.0 112.776 179.344 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.93 -37.07 86.05 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 128.228 2.611 . . . . 0.0 111.804 172.756 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.1 -159.81 24.45 Favored Glycine 0 CA--C 1.533 1.186 1 C-N-CA 132.357 4.789 . . . . 0.0 108.356 -163.165 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.9 mttt 41.14 -163.47 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.448 1 N-CA-C 123.397 4.591 . . . . 0.0 123.397 167.28 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.0 p -128.76 157.75 40.57 Favored 'General case' 0 N--CA 1.444 -0.738 2 O-C-N 115.511 -4.493 . . . . 0.0 110.106 164.079 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.8 mm -95.73 130.91 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 161.434 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.9 m -94.55 120.68 35.15 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 122.556 1.17 . . . . 0.0 108.945 163.027 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 tp -100.18 144.53 29.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 131.078 3.751 . . . . 0.0 106.418 -178.455 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -92.92 141.21 28.67 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 121.521 1.964 . . . . 0.0 108.76 152.908 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -153.24 153.98 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 O-C-N 124.697 1.248 . . . . 0.0 108.782 172.582 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -90.36 156.94 45.48 Favored Pre-proline 0 C--N 1.322 -0.619 0 O-C-N 118.005 -2.934 . . . . 0.0 104.209 163.542 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.7 -4.34 13.42 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 O-C-N 116.843 -2.241 . . . . 0.0 112.336 -176.776 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 30.8 p -97.71 7.47 46.37 Favored 'General case' 0 N--CA 1.448 -0.56 1 C-N-CA 135.67 5.588 . . . . 0.0 116.808 173.992 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -82.05 158.13 23.89 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 165.234 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -90.76 161.96 15.08 Favored 'General case' 0 C--N 1.326 -0.435 1 C-N-CA 132.218 4.207 . . . . 0.0 109.524 171.187 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 40.1 mt -69.28 -20.35 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 127.572 2.349 . . . . 0.0 110.144 175.556 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.19 -26.14 65.59 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 120.088 -1.633 . . . . 0.0 114.009 164.999 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.87 -34.93 69.61 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 120.858 1.663 . . . . 0.0 111.379 164.558 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -63.67 -54.45 32.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.367 0 CA-C-N 122.767 2.53 . . . . 0.0 109.09 174.238 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -48.24 -50.83 28.08 Favored 'General case' 0 N--CA 1.451 -0.404 0 O-C-N 118.799 -2.438 . . . . 0.0 115.569 177.788 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.27 -11.24 59.92 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-O 116.444 -1.741 . . . . 0.0 113.394 -176.438 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -81.62 -35.25 30.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 122.022 2.192 . . . . 0.0 111.416 166.7 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.9 mt -69.24 -44.3 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 126.204 1.802 . . . . 0.0 109.183 169.045 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.32 44.6 tt0 -69.25 -40.05 78.1 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 117.372 -3.33 . . . . 0.0 110.018 -175.907 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -52.25 -49.46 63.99 Favored 'General case' 0 N--CA 1.445 -0.7 1 C-N-CA 134.669 5.187 . . . . 0.0 110.27 169.092 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.275 35.3 mttm -76.03 -57.9 3.6 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 114.023 -2.894 . . . . 0.0 110.345 177.804 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -113.07 -12.87 13.13 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 121.674 2.034 . . . . 0.0 106.564 -157.992 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.45 1.49 60.61 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-N 125.369 3.713 . . . . 0.0 114.934 160.732 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 27.9 mm -74.49 133.77 76.92 Favored Pre-proline 0 N--CA 1.444 -0.739 0 O-C-N 125.897 1.587 . . . . 0.0 108.545 -174.519 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -66.92 144.85 72.16 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 N-CA-C 116.432 1.666 . . . . 0.0 116.432 176.393 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.16 -25.31 13.84 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 CA-C-O 116.247 -1.647 . . . . 0.0 110.784 -162.467 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.63 -12.06 59.95 Favored 'General case' 0 N--CA 1.442 -0.836 1 C-N-CA 133.298 4.639 . . . . 0.0 105.47 -176.358 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -104.59 -15.13 15.4 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 125.305 1.628 . . . . 0.0 112.321 174.159 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -83.53 95.48 8.32 Favored 'General case' 0 N--CA 1.445 -0.714 0 O-C-N 116.624 -3.797 . . . . 0.0 109.642 -178.597 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -87.89 92.75 9.24 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 121.919 2.145 . . . . 0.0 108.437 175.824 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -86.57 130.35 34.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 112.085 -2.325 . . . . 0.0 109.606 -179.021 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.9 mt -116.45 143.33 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 111.47 -2.604 . . . . 0.0 108.348 -170.452 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -144.16 129.85 19.19 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.107 1.363 . . . . 0.0 110.362 161.56 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.286 . . 57.15 15.88 2.7 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 119.613 3.19 . . . . 0.0 119.613 174.752 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.72 -32.88 5.78 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-O 117.989 -1.45 . . . . 0.0 112.279 -172.552 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.8 tttm -92.47 127.93 38.14 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 119.793 1.797 . . . . 0.0 108.121 -170.784 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.78 104.94 13.39 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 128.85 3.844 . . . . 0.0 106.348 168.095 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 50' ' ' LEU . 44.1 mt -71.84 125.19 26.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 111.438 -2.619 . . . . 0.0 113.964 -157.632 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -75.59 161.57 29.02 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-O 124.704 2.192 . . . . 0.0 105.25 -166.368 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -77.93 154.73 31.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.06 1.744 . . . . 0.0 112.836 163.541 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.81 -4.81 24.27 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 127.303 2.382 . . . . 0.0 114.949 165.466 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -136.1 168.93 18.45 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -171.66 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 47.8 p -107.44 173.76 6.18 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 119.324 -2.11 . . . . 0.0 113.163 -175.353 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.5 mt -76.64 -18.34 58.65 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 116.867 -3.645 . . . . 0.0 108.527 -164.312 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.2 t -76.93 -31.27 56.52 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 129.398 3.079 . . . . 0.0 105.644 177.782 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.257 35.0 m-20 -78.22 -44.25 26.16 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 102.41 -3.181 . . . . 0.0 102.41 -173.809 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -72.64 1.93 7.43 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 127.539 2.336 . . . . 0.0 114.832 174.556 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 t30 72.15 5.46 5.31 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 126.73 2.012 . . . . 0.0 113.042 171.199 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.417 HD13 HD21 ' A' ' 67' ' ' LEU . 5.4 mt -70.54 129.61 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 CA-C-N 125.004 3.547 . . . . 0.0 106.701 -168.814 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.325 95.6 mm-40 -103.69 166.58 10.33 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 125.958 2.036 . . . . 0.0 108.9 174.466 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -42.65 123.1 2.53 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 130.725 3.61 . . . . 0.0 114.744 170.772 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.404 8.0 mp0 85.66 8.28 0.35 Allowed 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 129.446 3.098 . . . . 0.0 112.87 170.161 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -64.86 137.72 57.94 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 119.756 -1.84 . . . . 0.0 110.22 177.034 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.9 m -93.74 107.38 19.26 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 119.688 -1.883 . . . . 0.0 109.475 174.094 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.417 HD21 HD13 ' A' ' 61' ' ' ILE . 9.5 mp -98.95 148.82 23.59 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 100.378 -3.934 . . . . 0.0 100.378 178.226 . . . . . . . . 2 2 . 1 . 067 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -92.52 141.23 28.73 Favored 'General case' 0 N--CA 1.441 -0.925 0 O-C-N 116.341 -3.975 . . . . 0.0 109.008 171.509 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.355 14.1 tp -107.77 131.35 54.55 Favored 'General case' 0 N--CA 1.451 -0.413 1 N-CA-C 98.36 -4.682 . . . . 0.0 98.36 158.05 . . . . . . . . 3 2 . 1 . 067 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.66 139.55 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 O-C-N 126.598 2.436 . . . . 0.0 105.387 169.465 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.2 mt -102.72 150.4 23.5 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 111.982 -2.372 . . . . 0.0 105.905 176.576 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.5 ttt-85 -119.47 77.74 1.24 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.272 -1.331 . . . . 0.0 113.437 172.49 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.2 mt -76.5 -27.11 55.92 Favored 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 125.228 1.58 . . . . 0.0 113.462 -158.39 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.1 mtt180 -91.32 -57.92 2.62 Favored 'General case' 0 C--N 1.319 -0.727 0 O-C-N 116.71 -3.743 . . . . 0.0 111.288 171.233 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.91 -131.58 10.71 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 116.071 -2.516 . . . . 0.0 110.958 -173.675 . . . . . . . . 1 1 . 1 . 067 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.1 1 CA-C-N 124.847 4.323 . . . . 0.0 111.031 176.089 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 ttp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 . . . . . . . . . 0 0 . 1 . 068 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -87.15 152.08 22.64 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 102.842 -3.021 . . . . 0.0 102.842 -175.032 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 pt -150.65 164.33 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 C-N-CA 131.538 3.935 . . . . 0.0 107.04 169.689 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -118.04 141.15 48.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 130.379 3.472 . . . . 0.0 112.351 166.568 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 m -104.4 151.22 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 111.464 -2.607 . . . . 0.0 108.671 162.134 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 75.5 tttt -140.67 156.42 46.24 Favored 'General case' 0 C--N 1.327 -0.377 1 O-C-N 115.266 -4.646 . . . . 0.0 106.848 176.679 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.347 4.8 t -142.21 152.5 43.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.475 2.71 . . . . 0.0 107.512 -176.671 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 58.4 mt -61.97 -8.26 4.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 130.825 3.65 . . . . 0.0 118.388 -170.962 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.2 p -79.61 -20.0 47.9 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 123.891 3.041 . . . . 0.0 108.492 166.675 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.35 -1.17 23.75 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 128.676 3.036 . . . . 0.0 112.562 -175.733 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.269 75.3 tttt -72.78 143.45 47.92 Favored 'General case' 0 N--CA 1.446 -0.655 0 O-C-N 118.449 -2.795 . . . . 0.0 110.318 -173.828 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.4 p -135.27 143.43 46.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.859 2.064 . . . . 0.0 114.344 179.727 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 4.4 mt -139.19 143.35 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 1 C-N-CA 131.71 4.004 . . . . 0.0 109.963 -178.916 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.2 t -101.74 139.89 36.76 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 125.611 1.82 . . . . 0.0 113.215 171.015 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.8 mt -129.85 151.25 50.62 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.235 1.414 . . . . 0.0 109.219 177.667 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -109.19 118.06 35.73 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 174.833 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.43 139.37 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.524 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -170.039 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -76.62 142.72 70.79 Favored Pre-proline 0 N--CA 1.445 -0.686 0 CA-C-O 124.37 2.033 . . . . 0.0 106.195 177.044 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -58.81 -36.49 96.93 Favored 'Trans proline' 0 N--CA 1.443 -1.466 0 C-N-CA 125.016 3.811 . . . . 0.0 116.546 178.051 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.8 p -72.72 -12.99 61.23 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 177.495 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -72.09 140.75 49.08 Favored 'General case' 0 N--CA 1.45 -0.455 1 O-C-N 115.303 -4.623 . . . . 0.0 113.026 -176.831 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 26' ' ' VAL . 77.3 p -73.14 134.98 44.64 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 113.526 0.936 . . . . 0.0 113.526 179.447 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.251 26.6 mm -47.34 -38.24 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 129.704 3.202 . . . . 0.0 110.48 179.431 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.79 -36.35 76.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 117.615 2.45 . . . . 0.0 117.615 172.05 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -77.2 -40.52 44.83 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 129.249 3.02 . . . . 0.0 107.3 -177.777 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 22' ' ' THR . 44.0 t -70.94 -31.04 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 130.565 3.546 . . . . 0.0 112.331 -177.75 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -64.86 -32.66 74.47 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 116.709 -3.744 . . . . 0.0 108.559 179.39 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.52 -28.37 69.8 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 117.232 -3.417 . . . . 0.0 113.138 172.502 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -74.54 -5.98 45.88 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 119.859 1.209 . . . . 0.0 111.666 -171.186 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.21 -35.12 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-O 123.695 1.712 . . . . 0.0 114.432 156.454 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -72.72 -38.0 67.59 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 118.232 -2.792 . . . . 0.0 110.053 -166.818 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -66.67 -36.81 83.42 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 116.988 -1.482 . . . . 0.0 113.09 171.055 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.7 mmtt -90.14 -33.57 16.19 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-O 113.982 -2.913 . . . . 0.0 112.084 -175.35 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 31.2 mm-40 -126.25 -30.25 2.92 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 122.037 2.199 . . . . 0.0 112.373 -171.999 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.81 -8.35 42.84 Favored Glycine 0 CA--C 1.522 0.507 1 CA-C-O 112.157 -4.691 . . . . 0.0 113.153 176.935 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.0 mt -74.21 125.58 89.88 Favored Pre-proline 0 C--N 1.328 -0.347 1 O-C-N 131.361 4.8 . . . . 0.0 108.025 -175.914 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.462 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 83.3 Cg_endo -68.06 138.28 43.36 Favored 'Trans proline' 0 C--N 1.317 -1.094 0 N-CA-C 117.525 2.086 . . . . 0.0 117.525 166.007 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 9.3 Cg_endo -61.42 -31.95 88.64 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 123.901 3.067 . . . . 0.0 115.521 -170.656 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -64.61 -17.93 64.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 111.911 -3.899 . . . . 0.0 108.293 -171.467 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.09 -13.22 59.95 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 117.97 2.581 . . . . 0.0 117.97 172.151 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -116.13 151.46 35.6 Favored 'General case' 0 C--N 1.322 -0.629 0 O-C-N 120.328 -1.482 . . . . 0.0 111.344 -154.27 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -141.33 123.67 15.73 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 116.556 -3.84 . . . . 0.0 113.283 175.616 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -82.3 148.6 28.24 Favored 'General case' 0 N--CA 1.445 -0.701 0 O-C-N 117.132 -3.48 . . . . 0.0 115.862 171.807 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.32 45.7 mt -131.11 138.6 53.02 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 127.955 2.502 . . . . 0.0 110.481 179.528 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' HB3' HD21 ' A' ' 50' ' ' LEU . 36.0 t80 -135.85 -176.98 4.48 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 104.848 -2.279 . . . . 0.0 104.848 179.52 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.41 85.75 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.693 0 C-N-CA 129.226 3.01 . . . . 0.0 116.565 -164.931 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.41 -36.46 3.96 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 118.806 -2.434 . . . . 0.0 117.359 -174.492 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.355 86.1 tttt -151.87 159.6 43.8 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 125.955 2.788 . . . . 0.0 111.081 -160.401 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -80.61 144.31 32.46 Favored 'General case' 0 C--N 1.323 -0.545 1 CA-C-N 107.405 -4.452 . . . . 0.0 108.202 178.723 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' A' ' 45' ' ' PHE . 18.3 mt -94.72 133.23 38.63 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 115.812 -2.355 . . . . 0.0 109.91 -175.397 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.2 132.13 48.3 Favored 'General case' 0 C--N 1.326 -0.454 1 O-C-N 115.694 -4.378 . . . . 0.0 118.624 168.229 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -76.46 93.28 3.5 Favored 'General case' 0 N--CA 1.443 -0.813 0 O-C-N 128.7 3.75 . . . . 0.0 111.021 -168.649 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 137.55 -0.23 2.74 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 118.495 2.158 . . . . 0.0 118.495 -170.919 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -102.81 175.15 5.58 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 170.065 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.333 78.8 p -105.38 164.13 12.09 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 128.651 2.781 . . . . 0.0 110.56 -172.033 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.2 mp -41.04 -51.66 3.28 Favored 'General case' 0 N--CA 1.446 -0.644 1 C-N-CA 132.109 4.164 . . . . 0.0 110.699 164.646 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 m -86.04 -6.96 58.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.398 -1.728 . . . . 0.0 112.253 -164.787 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -69.24 -38.62 78.57 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 124.911 2.291 . . . . 0.0 112.21 171.115 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.444 ' CD2' HD22 ' A' ' 50' ' ' LEU . 75.5 m-85 -103.55 -5.18 22.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 128.121 2.568 . . . . 0.0 112.812 -175.559 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.521 0.7 OUTLIER 75.61 37.62 0.41 Allowed 'General case' 0 N--CA 1.448 -0.533 0 O-C-N 128.098 3.374 . . . . 0.0 113.584 175.539 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.402 HG23 ' CB ' ' A' ' 65' ' ' SER . 85.0 mt -70.81 137.28 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 173.129 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -131.69 -178.06 4.7 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 112.415 -2.175 . . . . 0.0 110.147 -168.797 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -42.21 110.62 0.18 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 127.926 2.491 . . . . 0.0 113.77 176.274 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 73.88 25.24 1.95 Allowed 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 126.514 1.926 . . . . 0.0 111.829 172.458 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.402 ' CB ' HG23 ' A' ' 61' ' ' ILE . 1.0 OUTLIER -62.14 128.76 37.65 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 119.182 -2.199 . . . . 0.0 110.262 179.722 . . . . . . . . 3 3 . 1 . 068 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.9 m -91.12 107.6 19.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 124.216 1.006 . . . . 0.0 111.017 172.486 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.5 mt -97.01 147.56 23.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.432 1.893 . . . . 0.0 107.23 179.481 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -101.55 147.83 25.93 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 117.117 -1.42 . . . . 0.0 107.595 -174.181 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.1 mp -117.19 142.97 46.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 125.095 2.379 . . . . 0.0 107.983 -179.631 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 m -138.42 159.59 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 O-C-N 119.353 -2.092 . . . . 0.0 105.468 173.191 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.85 134.78 57.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 112.528 -3.606 . . . . 0.0 118.151 151.24 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -82.54 128.81 34.65 Favored 'General case' 0 N--CA 1.448 -0.554 2 C-N-CA 132.93 4.492 . . . . 0.0 106.663 168.861 . . . . . . . . 2 2 . 1 . 068 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.3 mt -108.2 30.41 6.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 131.008 3.723 . . . . 0.0 112.708 -170.646 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.272 7.5 ttt180 86.93 34.66 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.33 1 C-N-CA 135.64 5.576 . . . . 0.0 108.008 166.071 . . . . . . . . 3 2 . 1 . 068 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.18 -173.16 13.24 Favored Glycine 0 CA--C 1.531 1.038 0 CA-C-N 113.949 -1.478 . . . . 0.0 110.441 170.644 . . . . . . . . 1 1 . 1 . 068 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 CA-C-O 116.923 -2.043 . . . . 0.0 115.168 174.875 . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttp . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 . . . . . . . . . 0 0 . 1 . 069 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -101.41 137.27 39.96 Favored 'General case' 0 C--O 1.22 -0.499 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 -177.369 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.492 9.7 pt -142.67 149.79 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 1 C-N-CA 133.08 4.552 . . . . 0.0 110.259 174.913 . . . . . . . . 3 2 . 1 . 069 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -108.96 141.35 41.19 Favored 'General case' 0 C--O 1.223 -0.312 1 N-CA-C 99.909 -4.108 . . . . 0.0 99.909 -175.602 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 70.9 t -110.15 119.57 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 C-N-CA 124.249 1.02 . . . . 0.0 113.526 156.689 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.1 tttt -91.5 111.3 22.75 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 -178.971 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -65.95 162.55 18.99 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 124.644 2.164 . . . . 0.0 115.26 171.758 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -68.53 -7.0 28.49 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 118.515 -2.615 . . . . 0.0 115.832 176.882 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -123.08 14.01 9.78 Favored 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 118.668 -2.52 . . . . 0.0 109.671 -176.826 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.16 -31.87 7.53 Favored Glycine 0 CA--C 1.526 0.724 0 CA-C-O 115.772 -2.682 . . . . 0.0 112.49 154.492 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -61.85 147.49 46.4 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 179.257 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.9 m -105.39 149.1 26.4 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-O 115.483 -2.199 . . . . 0.0 112.98 175.236 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 1.8 mp -122.23 124.91 72.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 100.647 -3.834 . . . . 0.0 100.647 -179.623 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.5 m -78.14 134.18 37.71 Favored 'General case' 0 N--CA 1.44 -0.929 0 O-C-N 117.227 -3.421 . . . . 0.0 110.525 162.612 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 58.4 mt -115.17 132.23 56.67 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 125.268 1.605 . . . . 0.0 109.141 167.892 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -97.38 117.21 31.09 Favored 'General case' 0 N--CA 1.441 -0.894 0 O-C-N 127.42 2.95 . . . . 0.0 105.298 168.017 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.46 ' HB ' ' H ' ' A' ' 18' ' ' GLU . 16.3 m -141.41 -171.52 0.53 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.41 0 C-N-CA 125.054 1.342 . . . . 0.0 112.167 -175.32 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' H ' ' HB ' ' A' ' 17' ' ' VAL . 1.2 tm-20 -136.88 146.8 56.55 Favored Pre-proline 0 N--CA 1.455 -0.222 0 CA-C-O 115.673 -2.108 . . . . 0.0 108.246 -165.175 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -57.53 -29.05 83.55 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.645 2.897 . . . . 0.0 118.425 178.346 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.4 p -92.76 1.13 57.44 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 127.614 3.071 . . . . 0.0 114.248 -175.692 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.73 118.34 22.18 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 -173.273 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.286 17.0 p -52.03 142.68 15.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 117.658 -3.151 . . . . 0.0 116.181 164.108 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.358 2.5 mm -31.23 -56.15 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 128.001 2.52 . . . . 0.0 114.977 174.405 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.252 12.9 mm-40 -53.71 -43.77 69.29 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.035 2.534 . . . . 0.0 117.573 172.588 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.417 6.6 m120 -59.95 -14.67 16.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 118.503 2.779 . . . . 0.0 118.503 165.296 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.352 61.7 t -97.7 -33.36 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 C-N-CA 126.159 1.784 . . . . 0.0 110.18 174.696 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -75.55 -27.72 58.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.346 -1.788 . . . . 0.0 109.997 178.68 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.93 -56.67 18.64 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 129.578 3.151 . . . . 0.0 112.414 167.643 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.297 88.5 mttt -44.19 -29.92 0.71 Allowed 'General case' 0 C--O 1.234 0.285 0 N-CA-C 118.627 2.825 . . . . 0.0 118.627 164.272 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 85.7 mt -77.72 -28.69 15.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 O-C-N 118.407 -2.683 . . . . 0.0 112.018 171.037 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -77.2 -35.02 56.08 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 122.576 2.443 . . . . 0.0 107.392 -174.388 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -57.57 -31.86 66.57 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 126.005 2.066 . . . . 0.0 108.886 177.735 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.1 mmtt -92.85 -50.56 5.5 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 113.113 -3.327 . . . . 0.0 110.844 -177.136 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -112.54 -19.05 12.25 Favored 'General case' 0 N--CA 1.439 -0.983 1 O-C-N 130.346 4.779 . . . . 0.0 111.129 -155.806 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.34 -4.63 58.56 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 125.631 1.832 . . . . 0.0 116.183 174.083 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.9 mt -80.54 112.89 35.18 Favored Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 130.926 3.691 . . . . 0.0 111.06 -172.642 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.57 150.77 87.67 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 O-C-N 123.377 1.198 . . . . 0.0 111.711 -173.677 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.422 50.8 Cg_exo -41.58 -50.67 4.65 Favored 'Trans proline' 0 N--CA 1.457 -0.639 1 C-N-CA 125.648 4.232 . . . . 0.0 116.939 167.833 . . . . . . . . 3 2 . 1 . 069 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.405 ' CG ' HH21 ' A' ' 74' ' ' ARG 0.271 33.9 t70 -56.67 -22.92 38.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 116.052 1.871 . . . . 0.0 116.052 -178.681 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -95.52 -13.15 24.74 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 117.542 -3.224 . . . . 0.0 110.222 -173.807 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.261 77.7 mt-30 -94.19 136.26 34.68 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.957 -164.282 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.617 ' HG2' HE22 ' A' ' 49' ' ' GLN . 70.9 mtp180 -115.67 127.42 55.16 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 102.237 -3.245 . . . . 0.0 102.237 165.408 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.1 mt -102.62 119.79 39.43 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 124.525 1.141 . . . . 0.0 113.216 168.006 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 68' ' ' HIS . 17.6 mm -114.63 152.72 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 C-N-CA 128.947 2.899 . . . . 0.0 105.715 -170.016 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -168.0 127.04 1.25 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 112.013 -2.358 . . . . 0.0 106.556 176.532 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.417 . . 75.78 15.28 2.59 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 122.398 2.363 . . . . 0.0 116.044 167.068 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.49 17.44 31.2 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 127.856 2.646 . . . . 0.0 118.318 177.793 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.3 pttt -160.66 149.49 16.74 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -156.801 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.617 HE22 ' HG2' ' A' ' 42' ' ' ARG . 1.0 OUTLIER -75.1 143.04 43.56 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 125.309 1.631 . . . . 0.0 108.021 178.094 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 88.6 mt -77.45 117.2 18.69 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 120.462 -1.399 . . . . 0.0 107.757 169.755 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -81.57 150.92 27.94 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 131.145 3.778 . . . . 0.0 113.657 -166.422 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -64.86 120.56 12.76 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.781 2.033 . . . . 0.0 107.647 -171.956 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 123.56 15.25 3.7 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.394 1.949 . . . . 0.0 113.172 165.139 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.337 20.1 mtt180 -133.68 146.71 51.1 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 123.071 1.415 . . . . 0.0 113.881 -161.438 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.1 p -107.85 149.86 27.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 124.077 1.894 . . . . 0.0 107.505 178.043 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.7 mt -34.19 -48.09 0.31 Allowed 'General case' 0 N--CA 1.448 -0.525 1 C-N-CA 132.419 4.288 . . . . 0.0 116.124 176.778 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 94.4 p -83.88 -6.39 59.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -179.432 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . 0.352 31.1 t0 -101.17 -10.7 20.17 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.765 2.026 . . . . 0.0 107.713 176.372 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.88 -14.36 17.98 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 129.412 3.085 . . . . 0.0 111.703 173.974 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 73.23 39.58 0.59 Allowed 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 127.238 2.836 . . . . 0.0 110.578 -175.412 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.66 HD13 HD21 ' A' ' 67' ' ' LEU . 8.6 mt -87.05 96.64 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-N 121.988 2.176 . . . . 0.0 111.075 172.062 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.84 169.51 17.77 Favored 'General case' 0 C--N 1.325 -0.498 1 C-N-CA 134.848 5.259 . . . . 0.0 112.442 177.32 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.291 0.0 OUTLIER -51.3 140.19 17.5 Favored 'General case' 0 N--CA 1.439 -0.988 1 C-N-CA 131.739 4.016 . . . . 0.0 111.539 175.915 . . . . . . . . 4 3 . 1 . 069 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 37.34 43.58 0.39 Allowed 'General case' 0 C--N 1.324 -0.518 1 C-N-CA 133.654 4.781 . . . . 0.0 112.699 -176.917 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.6 m -59.6 147.51 36.97 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 125.97 1.708 . . . . 0.0 113.34 154.964 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.4 m -112.61 126.04 54.94 Favored 'General case' 0 C--O 1.24 0.559 0 O-C-N 128.387 3.554 . . . . 0.0 103.798 169.7 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.66 HD21 HD13 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -124.64 160.05 29.36 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 127.696 3.123 . . . . 0.0 106.173 171.355 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.405 ' HB2' ' HB ' ' A' ' 44' ' ' ILE . 28.0 m80 -126.54 113.39 16.72 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 101.696 -3.446 . . . . 0.0 101.696 -155.523 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 23.3 tp -92.22 120.95 33.28 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 111.893 -2.412 . . . . 0.0 111.22 175.733 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.27 12.1 m -127.32 154.52 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 127.172 2.189 . . . . 0.0 107.818 173.435 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.258 2.3 pp -125.48 148.58 48.8 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 120.372 1.442 . . . . 0.0 112.505 -172.282 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -87.08 -171.49 3.53 Favored 'General case' 0 N--CA 1.445 -0.692 1 C-N-CA 132.056 4.142 . . . . 0.0 111.168 172.683 . . . . . . . . 2 2 . 1 . 069 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 68.2 mt -81.61 178.66 8.21 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 170.139 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 74' ' ' ARG 0.376 25.1 ttp-105 91.0 36.87 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 127.63 2.372 . . . . 0.0 112.163 175.858 . . . . . . . . 3 3 . 1 . 069 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.36 -0.1 5.88 Favored Glycine 0 CA--C 1.527 0.83 0 CA-C-O 122.702 1.168 . . . . 0.0 111.73 165.226 . . . . . . . . 1 1 . 1 . 069 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 O-C-N 117.918 -3.107 . . . . 0.0 109.999 -155.803 . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.472 0.66 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 . . . . . . . . . 0 0 . 1 . 070 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -86.64 131.16 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 125.008 1.323 . . . . 0.0 111.481 -172.174 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.566 HD12 HD13 ' A' ' 67' ' ' LEU . 19.4 pt -125.59 150.32 30.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 -175.536 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.273 2.2 m-85 -92.32 130.57 37.98 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.276 1.43 . . . . 0.0 108.764 168.29 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.6 t -119.37 96.93 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 O-C-N 127.639 3.087 . . . . 0.0 105.67 -177.093 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -85.22 123.69 31.0 Favored 'General case' 0 N--CA 1.441 -0.914 0 O-C-N 118.01 -2.931 . . . . 0.0 104.499 -170.835 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.4 p -76.23 150.31 37.06 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 165.192 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.8 tp -59.88 -24.51 64.32 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 114.828 1.418 . . . . 0.0 114.828 -173.707 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 44.8 p -89.16 0.28 56.87 Favored 'General case' 0 N--CA 1.44 -0.936 0 O-C-N 120.391 -1.443 . . . . 0.0 113.182 -179.696 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.5 -5.93 18.89 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 115.093 -3.06 . . . . 0.0 117.967 166.149 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -86.14 131.73 34.18 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 128.339 3.023 . . . . 0.0 106.633 -174.534 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 m -113.66 104.1 11.89 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 114.249 -1.341 . . . . 0.0 111.062 -172.274 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.2 mt -88.09 126.38 41.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 N-CA-C 104.439 -2.43 . . . . 0.0 104.439 -172.555 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.254 9.5 m -93.06 121.33 34.3 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 177.326 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.281 55.8 tp -144.61 144.24 31.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 119.991 -1.693 . . . . 0.0 111.16 -165.511 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.5 134.45 42.36 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 122.073 0.939 . . . . 0.0 109.103 -177.341 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.34 169.2 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 174.251 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -109.9 160.98 26.07 Favored Pre-proline 0 N--CA 1.447 -0.624 0 C-N-CA 127.641 2.376 . . . . 0.0 110.374 164.531 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.64 -23.31 17.08 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 125.194 3.929 . . . . 0.0 115.283 -176.353 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 7.5 p -83.91 -1.21 54.07 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.856 -2.403 . . . . 0.0 114.644 -179.731 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -79.62 121.14 24.9 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.727 2.011 . . . . 0.0 107.306 -177.618 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.4 p -48.63 148.49 2.07 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 164.616 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.407 ' CD1' HD23 ' A' ' 56' ' ' LEU 0.393 8.6 mm -38.3 -15.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 130.089 3.355 . . . . 0.0 118.382 173.46 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.2 tp10 -94.21 -49.8 5.57 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 123.695 2.952 . . . . 0.0 107.4 -159.256 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -51.33 -32.7 26.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 126.898 2.079 . . . . 0.0 114.677 -155.239 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -73.03 -21.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 1 CA-C-O 129.67 4.557 . . . . 0.0 119.359 -178.993 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -69.81 -40.31 76.02 Favored 'General case' 0 N--CA 1.442 -0.85 1 O-C-N 114.41 -5.181 . . . . 0.0 115.091 -171.413 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.58 -23.34 49.99 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 112.453 -3.641 . . . . 0.0 111.34 170.764 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -63.18 -48.39 78.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.458 2.349 . . . . 0.0 113.382 166.087 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 16.1 mm -62.23 -42.12 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 126.28 1.832 . . . . 0.0 112.309 173.204 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -47.86 -43.75 28.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 117.442 2.386 . . . . 0.0 117.442 166.996 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -72.42 -47.2 50.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.959 -1.473 . . . . 0.0 111.652 -173.836 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.28 -30.11 16.79 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 127.317 2.886 . . . . 0.0 115.706 -176.565 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -120.99 -0.73 9.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 121.682 2.037 . . . . 0.0 110.329 179.676 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.85 -0.05 87.7 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 118.258 -2.776 . . . . 0.0 116.494 166.692 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 71' ' ' LEU . 11.6 mt -99.65 128.54 31.06 Favored Pre-proline 0 N--CA 1.45 -0.458 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 -170.768 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.84 155.0 58.59 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 N-CA-C 121.818 3.738 . . . . 0.0 121.818 175.898 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -59.4 -32.17 96.08 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 C-N-CA 124.868 3.712 . . . . 0.0 117.083 176.104 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.46 1.6 t0 -52.51 -21.48 3.83 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 163.311 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -106.28 -18.42 14.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 126.705 2.002 . . . . 0.0 111.755 -179.519 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -98.94 100.87 12.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 116.774 -3.704 . . . . 0.0 103.264 -172.321 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -108.73 138.6 44.8 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 110.352 -3.113 . . . . 0.0 104.135 166.672 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -148.51 161.72 41.08 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 121.654 2.025 . . . . 0.0 114.81 -168.612 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.1 mp -129.28 131.54 67.49 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 1 C-N-CA 134.667 5.187 . . . . 0.0 112.31 -169.822 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -98.35 -50.06 4.46 Favored 'General case' 0 N--CA 1.449 -0.475 1 CA-C-O 111.577 -4.059 . . . . 0.0 114.574 161.613 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -162.35 43.36 0.13 Allowed 'General case' 0 N--CA 1.446 -0.675 0 O-C-N 128.158 3.411 . . . . 0.0 108.054 -161.217 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.43 -69.85 0.49 Allowed Glycine 0 CA--C 1.531 1.048 0 CA-C-O 124.002 1.89 . . . . 0.0 116.686 163.778 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -54.66 132.93 46.5 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 118.516 2.784 . . . . 0.0 118.516 162.011 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.28 145.58 42.58 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 116.737 -1.985 . . . . 0.0 111.955 154.933 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 59' ' ' TYR . 23.2 mt -91.08 116.98 29.23 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 123.567 1.651 . . . . 0.0 113.297 -175.498 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.271 32.1 tt0 -84.49 156.37 21.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 112.437 -2.165 . . . . 0.0 116.156 -167.67 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -65.59 141.89 58.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 126.281 1.832 . . . . 0.0 109.689 175.083 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.58 -42.44 1.91 Allowed Glycine 0 CA--C 1.53 1.024 0 CA-C-O 115.474 -2.848 . . . . 0.0 111.585 -178.181 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 13.0 mmp_? -72.98 173.5 9.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 121.67 2.735 . . . . 0.0 117.111 -173.289 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.8 p -120.71 155.82 33.09 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 126.67 2.481 . . . . 0.0 104.925 174.868 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 ' CD1' ' A' ' 23' ' ' ILE . 49.7 mt -59.37 -29.86 68.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 125.382 2.515 . . . . 0.0 113.071 -176.882 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.5 t -47.57 -46.05 27.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 118.373 -2.704 . . . . 0.0 116.228 163.905 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -68.32 -12.32 60.88 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.406 -175.622 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.479 ' CE2' HD22 ' A' ' 50' ' ' LEU . 55.8 m-85 -106.67 1.37 25.04 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 128.169 2.587 . . . . 0.0 112.742 178.746 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.258 1.7 t30 66.14 39.16 4.39 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.173 1.389 . . . . 0.0 110.262 175.24 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.5 mt -88.33 131.28 36.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 120.75 1.614 . . . . 0.0 110.289 -176.708 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -100.44 -176.14 3.12 Favored 'General case' 0 C--O 1.221 -0.406 1 O-C-N 116.235 -4.04 . . . . 0.0 110.403 -176.982 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -55.8 146.7 20.81 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.617 1.967 . . . . 0.0 112.084 149.837 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 66.1 14.82 9.82 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 126.062 1.745 . . . . 0.0 112.317 176.418 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.0 m -71.02 155.85 40.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.508 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.6 m -113.5 120.87 42.48 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 129.461 3.105 . . . . 0.0 105.371 176.871 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.566 HD13 HD12 ' A' ' 3' ' ' ILE . 4.9 mp -110.86 140.73 45.07 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 114.274 -2.774 . . . . 0.0 106.089 170.481 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -129.49 138.95 51.67 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.224 1.81 . . . . 0.0 106.484 -174.691 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.4 mp -102.59 151.51 22.26 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.819 177.53 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.1 t -105.85 109.49 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 131.388 3.875 . . . . 0.0 102.287 170.432 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.468 HD11 HD13 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -81.23 96.4 7.24 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 129.929 3.292 . . . . 0.0 104.446 -179.972 . . . . . . . . 3 3 . 1 . 070 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 ttt-85 90.98 -71.28 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 131.102 3.761 . . . . 0.0 108.541 162.757 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.4 mt -144.35 158.58 43.67 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 127.6 3.062 . . . . 0.0 105.071 -178.528 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -74.63 143.26 44.41 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.588 175.321 . . . . . . . . 1 1 . 1 . 070 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.7 79.81 0.31 Allowed Glycine 0 CA--C 1.534 1.234 1 C-N-CA 134.143 5.639 . . . . 0.0 109.407 -177.014 . . . . . . . . 2 2 . 1 . 070 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.991 2 C-N-CA 130.963 4.125 . . . . 0.0 105.42 -163.778 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 116.714 -1.612 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -109.03 139.44 43.9 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 178.032 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.5 pp -139.11 152.19 23.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 128.461 2.704 . . . . 0.0 106.624 -172.76 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -105.51 140.98 37.78 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 124.531 2.11 . . . . 0.0 110.657 179.012 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.309 1.7 p -145.76 107.79 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 114.091 -1.413 . . . . 0.0 112.146 -178.823 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -84.23 137.2 33.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 126.038 2.086 . . . . 0.0 113.404 -173.395 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.3 p -78.91 170.68 16.3 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 113.803 -2.999 . . . . 0.0 111.615 -176.303 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' A' ' 8' ' ' LEU . 9.4 tp -60.43 -13.78 15.4 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 126.936 2.648 . . . . 0.0 118.041 -175.759 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 p -107.74 -6.34 16.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.997 1.319 . . . . 0.0 110.808 -178.681 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.0 1.81 31.8 Favored Glycine 0 CA--C 1.526 0.735 0 O-C-N 120.379 -1.451 . . . . 0.0 112.745 168.161 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.7 tttt -84.32 119.86 25.57 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 130.113 3.365 . . . . 0.0 102.127 -168.343 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 3.4 m -88.71 134.89 33.77 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 -167.104 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 27.5 mt -120.48 152.89 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 C-N-CA 126.808 2.043 . . . . 0.0 110.061 169.254 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.286 1.5 m -118.58 123.1 44.22 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 169.955 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 37.9 mt -116.6 140.86 48.92 Favored 'General case' 0 N--CA 1.447 -0.59 1 C-N-CA 133.587 4.755 . . . . 0.0 111.348 -176.622 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.326 0.4 OUTLIER -99.27 120.01 38.84 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 101.387 -3.561 . . . . 0.0 101.387 167.228 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -126.88 -19.45 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 CA-C-O 113.473 -3.156 . . . . 0.0 110.666 -168.769 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 0.1 OUTLIER 90.81 127.54 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-O 115.557 -2.163 . . . . 0.0 106.651 177.426 . . . . . . . . 3 3 . 1 . 071 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -74.72 -29.26 8.92 Favored 'Trans proline' 0 N--CA 1.452 -0.966 1 C-N-CA 125.688 4.259 . . . . 0.0 113.514 178.345 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p -84.54 -7.73 59.16 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.448 3.099 . . . . 0.0 110.606 -178.342 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.5 -177.86 3.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 122.372 2.351 . . . . 0.0 109.355 178.645 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -130.43 167.79 18.03 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 -173.321 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -66.57 -38.02 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 125.636 1.575 . . . . 0.0 110.479 -164.735 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -56.66 -34.66 67.57 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 122.132 2.242 . . . . 0.0 109.902 -178.272 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -82.38 -2.11 52.01 Favored 'General case' 0 N--CA 1.445 -0.688 1 O-C-N 114.061 -5.4 . . . . 0.0 115.166 -178.498 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -88.98 -46.37 15.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 176.632 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HA ' HD12 ' A' ' 30' ' ' ILE . 58.1 mtmt -65.97 -29.77 70.21 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.169 0.988 . . . . 0.0 112.717 177.86 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.81 -41.11 79.1 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 127.932 2.493 . . . . 0.0 107.885 174.279 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -72.98 -30.08 63.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 116.501 2.037 . . . . 0.0 116.501 173.958 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 27' ' ' LYS . 16.2 mt -67.48 -46.86 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 122.279 2.309 . . . . 0.0 111.533 169.019 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -49.75 -51.85 36.01 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 117.478 -3.264 . . . . 0.0 119.062 169.831 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -53.26 -38.05 62.68 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 128.602 2.761 . . . . 0.0 117.117 168.854 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -57.03 -62.81 1.49 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 125.46 1.504 . . . . 0.0 111.836 172.917 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.309 5.9 mm-40 -131.56 -8.7 3.65 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 125.493 2.568 . . . . 0.0 113.778 -157.361 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.82 32.85 6.32 Favored Glycine 0 CA--C 1.533 1.163 0 O-C-N 119.955 -1.716 . . . . 0.0 115.993 178.022 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 mm -82.58 130.04 60.29 Favored Pre-proline 0 N--CA 1.446 -0.652 0 C-N-CA 127.889 2.476 . . . . 0.0 107.975 -167.495 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.88 127.9 15.16 Favored 'Trans proline' 0 N--CA 1.446 -1.288 0 C-N-CA 122.312 2.008 . . . . 0.0 112.062 172.923 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -71.91 -34.99 7.88 Favored 'Trans proline' 0 N--CA 1.447 -1.219 1 C-N-CA 127.391 5.394 . . . . 0.0 112.518 -169.315 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -68.73 -19.97 64.37 Favored 'General case' 0 C--N 1.321 -0.633 1 C-N-CA 135.418 5.487 . . . . 0.0 110.244 -172.869 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.0 tp60 -94.97 -3.74 47.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.893 1.677 . . . . 0.0 108.495 -176.914 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 10.2 mm100 -96.1 107.49 19.8 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 130.261 3.424 . . . . 0.0 111.446 -172.296 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -94.16 101.66 13.67 Favored 'General case' 0 N--CA 1.444 -0.761 1 C-N-CA 132.759 4.424 . . . . 0.0 107.24 167.919 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.488 ' CD1' ' HB3' ' A' ' 41' ' ' GLN . 11.2 mp -103.5 101.93 11.82 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 127.536 2.334 . . . . 0.0 111.4 -174.332 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.6 mm -108.69 142.3 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-O 123.704 1.716 . . . . 0.0 107.225 179.209 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -124.79 105.17 9.07 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 112.529 -2.123 . . . . 0.0 109.508 173.671 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.84 42.1 15.45 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 127.12 3.343 . . . . 0.0 117.048 176.791 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.9 -14.5 52.65 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 109.401 -3.545 . . . . 0.0 118.735 178.325 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.25 77.3 mttt -115.1 130.34 56.9 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 -166.374 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.33 48.3 tt0 -48.33 142.34 5.68 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 121.345 3.832 . . . . 0.0 121.345 162.319 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 50' ' ' LEU . 87.8 mt -98.02 105.49 17.64 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 102.779 -3.045 . . . . 0.0 102.779 172.481 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -88.07 140.81 29.11 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 -175.706 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -81.09 141.64 34.11 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 124.161 3.164 . . . . 0.0 103.047 173.269 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.16 -29.67 6.66 Favored Glycine 0 CA--C 1.534 1.241 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 -175.664 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -87.39 150.4 23.83 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 127.31 2.418 . . . . 0.0 113.202 176.475 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.2 p -77.9 156.92 30.03 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.398 -1.273 . . . . 0.0 109.537 166.151 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 19.4 mt -74.6 -31.94 62.19 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.553 1.941 . . . . 0.0 109.589 -178.033 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.1 t -75.33 -12.67 60.32 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 120.414 -1.428 . . . . 0.0 112.572 175.917 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -66.05 -34.32 77.8 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 123.679 2.945 . . . . 0.0 112.65 169.518 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -91.59 7.08 43.17 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 127.234 2.834 . . . . 0.0 116.283 172.889 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.368 81.1 m-20 76.53 36.2 0.38 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.977 1.711 . . . . 0.0 113.304 171.285 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.4 mt -82.03 99.32 5.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 171.019 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -110.07 -172.92 2.13 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 129.978 3.311 . . . . 0.0 113.926 179.48 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.05 140.86 0.99 Allowed 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 128.317 2.647 . . . . 0.0 117.202 173.71 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.271 6.7 tm-20 73.62 4.19 4.69 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 122.439 2.382 . . . . 0.0 114.449 162.823 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.2 m -72.54 132.14 43.43 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.572 -1.649 . . . . 0.0 107.913 -173.217 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.0 p -105.68 142.36 35.55 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 125.071 1.482 . . . . 0.0 108.109 167.198 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 pp -143.29 165.91 26.18 Favored 'General case' 0 N--CA 1.446 -0.636 1 C-N-CA 131.838 4.055 . . . . 0.0 105.692 167.261 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -99.54 161.58 13.53 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-O 126.022 2.82 . . . . 0.0 104.486 165.894 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.2 tp -148.11 132.56 17.64 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 118.762 -2.461 . . . . 0.0 110.224 -179.56 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 m -68.34 89.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 127.023 3.296 . . . . 0.0 104.529 163.812 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.0 tp -153.72 148.93 26.96 Favored 'General case' 0 N--CA 1.443 -0.812 1 N-CA-C 98.601 -4.592 . . . . 0.0 98.601 175.427 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.1 mmt-85 -77.75 157.46 30.02 Favored 'General case' 0 N--CA 1.441 -0.9 1 C-N-CA 133.251 4.621 . . . . 0.0 107.367 -175.1 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.14 -12.28 61.12 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 125.774 2.702 . . . . 0.0 115.468 -176.004 . . . . . . . . 2 2 . 1 . 071 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -82.62 100.81 10.4 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 118.964 -2.335 . . . . 0.0 110.057 -175.651 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.73 -73.09 0.21 Allowed Glycine 0 CA--C 1.532 1.094 0 C-N-CA 127.875 2.655 . . . . 0.0 111.841 161.348 . . . . . . . . 1 1 . 1 . 071 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.876 0 N-CA-C 103.23 -3.948 . . . . 0.0 103.23 169.059 . . . . . . . . 0 0 . 1 . 072 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.2 ttp . . . . . 0 C--O 1.24 0.568 1 N-CA-C 99.492 -4.262 . . . . 0.0 99.492 . . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -94.37 136.15 34.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 123.082 2.674 . . . . 0.0 110.694 167.966 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 pt -135.27 161.25 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 102.902 -2.999 . . . . 0.0 102.902 170.401 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -117.25 149.76 39.89 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.045 1.738 . . . . 0.0 113.481 -171.67 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' HB2' ' A' ' 67' ' ' LEU 0.343 16.3 m -141.69 165.0 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 128.681 2.792 . . . . 0.0 112.41 169.062 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.0 tttt -149.78 142.17 24.29 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 -169.367 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 p -136.72 -145.21 0.21 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 129.08 2.952 . . . . 0.0 108.604 175.246 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.9 mt -96.29 -55.01 3.08 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 121.357 1.889 . . . . 0.0 108.254 -169.036 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 71.7 p -84.98 -27.1 26.71 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.295 1.838 . . . . 0.0 114.276 -179.917 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.94 123.95 7.15 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 106.505 -2.638 . . . . 0.0 106.505 175.269 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -102.86 -29.04 11.69 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 128.011 2.524 . . . . 0.0 107.383 -174.683 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.0 m -137.28 96.37 3.26 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 114.283 -2.77 . . . . 0.0 104.497 -177.233 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 50.9 mt -103.29 109.32 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 1 N-CA-C 98.541 -4.614 . . . . 0.0 98.541 165.009 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.271 62.8 p -86.77 131.48 34.12 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 100.387 -3.931 . . . . 0.0 100.387 173.922 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.6 tp -128.61 120.72 27.17 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 103.436 -2.802 . . . . 0.0 103.436 -175.603 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -96.01 120.39 36.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 130.611 3.564 . . . . 0.0 105.681 -178.435 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 m -143.4 159.01 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 O-C-N 117.482 -3.261 . . . . 0.0 108.057 -170.07 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -98.71 151.29 37.37 Favored Pre-proline 0 N--CA 1.447 -0.606 1 C-N-CA 132.618 4.367 . . . . 0.0 100.764 163.644 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.281 73.1 Cg_endo -64.47 8.7 0.17 Allowed 'Trans proline' 0 N--CA 1.447 -1.259 0 C-N-CA 122.966 2.444 . . . . 0.0 116.443 -179.927 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 12.3 p -128.34 16.87 6.57 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 129.345 3.058 . . . . 0.0 115.93 168.753 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.263 1.0 OUTLIER -41.0 117.21 0.82 Allowed 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 158.813 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.7 p -73.68 151.18 40.84 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 128.947 2.899 . . . . 0.0 108.823 179.687 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.31 1.1 mm -50.77 -41.03 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 126.779 2.032 . . . . 0.0 109.501 176.438 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.6 tp10 -57.9 -41.48 82.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 117.254 2.316 . . . . 0.0 117.254 171.143 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -65.15 -50.42 66.07 Favored 'General case' 0 N--CA 1.45 -0.452 1 O-C-N 116.159 -4.088 . . . . 0.0 113.962 171.342 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.84 -54.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 122.684 2.493 . . . . 0.0 112.426 168.649 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -53.04 -47.57 68.29 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 129.029 2.932 . . . . 0.0 115.904 170.68 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.47 -52.96 33.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 117.141 -3.474 . . . . 0.0 118.791 159.012 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -62.05 -33.36 74.24 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 128.882 2.873 . . . . 0.0 110.268 -176.508 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 75.4 mt -76.39 -48.55 27.1 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 C-N-CA 129.014 2.926 . . . . 0.0 106.842 173.227 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -49.85 -49.5 49.0 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 128.94 2.896 . . . . 0.0 113.144 176.94 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -49.3 -31.95 10.08 Favored 'General case' 0 C--O 1.221 -0.434 0 C-N-CA 128.919 2.888 . . . . 0.0 114.883 -174.054 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.0 mptt -105.0 -64.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 O-C-N 127.782 3.176 . . . . 0.0 111.196 178.353 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -81.45 -27.87 34.45 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -159.118 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.61 0.65 43.1 Favored Glycine 0 CA--C 1.529 0.931 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 170.797 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.5 mm -80.61 122.05 81.92 Favored Pre-proline 0 N--CA 1.449 -0.475 0 CA-C-N 120.869 2.335 . . . . 0.0 107.764 -170.806 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.422 ' HD2' HE21 ' A' ' 40' ' ' GLN . 18.6 Cg_endo -76.53 156.02 36.16 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 CA-C-O 114.356 -2.435 . . . . 0.0 112.95 175.402 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.26 -21.42 1.18 Allowed 'Trans proline' 0 N--CA 1.438 -1.747 0 C-N-CA 122.522 2.148 . . . . 0.0 115.525 170.915 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -81.26 -22.14 38.91 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 117.845 -3.034 . . . . 0.0 116.814 -175.623 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.422 HE21 ' HD2' ' A' ' 37' ' ' PRO . 9.3 tt0 -105.61 3.43 29.18 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -166.525 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.537 ' HB2' HD21 ' A' ' 69' ' ' LEU . 19.5 pt20 -128.47 128.9 45.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 127.346 2.258 . . . . 0.0 105.052 -171.237 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.4 mtt85 -90.41 170.22 10.41 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 124.952 2.311 . . . . 0.0 105.121 158.006 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.386 30.7 tp -138.19 112.02 8.35 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 112.71 -2.041 . . . . 0.0 107.783 176.606 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.3 mm -96.31 140.99 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 CA-C-O 127.445 3.498 . . . . 0.0 105.189 173.714 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -154.54 145.17 22.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 119.247 -2.158 . . . . 0.0 105.41 151.592 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.67 22.46 5.36 Favored 'General case' 0 N--CA 1.444 -0.763 0 O-C-N 125.778 1.924 . . . . 0.0 111.3 175.43 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.8 -12.89 61.0 Favored Glycine 0 CA--C 1.531 1.042 0 CA-C-O 116.414 -2.325 . . . . 0.0 108.325 174.408 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -108.69 127.35 53.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 120.849 2.324 . . . . 0.0 106.157 -159.04 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.2 mp0 -61.58 93.58 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.907 2.883 . . . . 0.0 105.069 165.713 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.8 mt -64.94 130.51 43.66 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 119.389 -2.069 . . . . 0.0 113.571 172.3 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.3 tp10 -86.65 146.45 26.31 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 125.718 1.886 . . . . 0.0 114.562 -176.732 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.305 14.5 m-20 -68.33 112.85 5.45 Favored 'General case' 0 C--O 1.238 0.489 0 O-C-N 126.975 2.672 . . . . 0.0 115.103 168.703 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.15 -23.59 2.41 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 118.253 -1.304 . . . . 0.0 114.862 -169.559 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -110.06 162.57 14.42 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.591 -2.374 . . . . 0.0 104.591 -161.796 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -101.73 165.98 10.92 Favored 'General case' 0 N--CA 1.448 -0.561 1 C-N-CA 132.583 4.353 . . . . 0.0 113.313 168.525 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 17.9 mt -42.03 -45.51 3.91 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 116.237 -1.84 . . . . 0.0 113.909 168.833 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -64.68 -14.95 60.48 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 130.199 3.4 . . . . 0.0 113.972 -176.532 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -75.92 -35.47 59.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.711 0.404 . . . . 0.0 110.518 172.809 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -114.26 12.5 17.68 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 -173.193 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.312 9.2 m120 65.27 28.94 11.86 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 126.665 1.986 . . . . 0.0 115.306 161.977 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.9 mt -93.29 137.43 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 CA-C-O 128.496 3.998 . . . . 0.0 103.841 -160.384 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -111.4 -168.75 1.35 Allowed 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 116.928 -3.608 . . . . 0.0 109.993 176.97 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -78.48 149.86 33.08 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 118.876 -2.39 . . . . 0.0 113.18 -170.233 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 31.4 mt-10 66.52 9.35 6.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 130.75 3.62 . . . . 0.0 112.963 174.889 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.6 m -72.51 165.75 24.02 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 125.919 1.688 . . . . 0.0 108.075 174.81 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.5 m -121.86 130.26 53.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 129.067 2.947 . . . . 0.0 109.683 176.414 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.416 ' N ' HD12 ' A' ' 67' ' ' LEU . 3.1 mp -104.8 169.48 8.43 Favored 'General case' 0 N--CA 1.443 -0.822 0 O-C-N 119.543 -1.973 . . . . 0.0 111.26 158.057 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -119.77 126.5 51.2 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.6 2.36 . . . . 0.0 113.623 177.088 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.537 HD21 ' HB2' ' A' ' 41' ' ' GLN 0.288 3.9 tt -98.85 131.39 44.99 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -177.131 . . . . . . . . 3 3 . 1 . 072 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 55.8 t -119.9 123.9 71.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 174.893 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.4 mt -89.23 164.95 14.74 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 127.774 2.43 . . . . 0.0 110.148 179.42 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.3 ttp180 -120.62 50.87 1.28 Allowed 'General case' 0 N--CA 1.447 -0.625 1 C-N-CA 135.714 5.605 . . . . 0.0 109.33 177.968 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.3 mt -80.76 -34.71 34.06 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 126.659 1.983 . . . . 0.0 106.546 167.168 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.274 34.1 ptt85 -154.54 116.36 4.18 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 128.348 2.659 . . . . 0.0 108.285 179.427 . . . . . . . . 2 2 . 1 . 072 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -115.77 -144.37 8.17 Favored Glycine 0 CA--C 1.524 0.622 0 CA-C-O 123.735 1.742 . . . . 0.0 116.058 -175.202 . . . . . . . . 1 1 . 1 . 072 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 C-N-CA 128.627 3.013 . . . . 0.0 112.335 -174.971 . . . . . . . . 0 0 . 1 . 073 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HB3' ' OE2' ' A' ' 18' ' ' GLU . 6.4 ptm . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 124.935 2.302 . . . . 0.0 109.786 . . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -85.84 121.87 29.1 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 117.603 -3.186 . . . . 0.0 109.268 170.054 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pt -137.44 117.93 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 128.338 2.655 . . . . 0.0 104.59 170.871 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -83.16 112.92 20.27 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 117.803 -3.061 . . . . 0.0 109.213 -173.259 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.4 t -85.05 100.55 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 O-C-N 117.999 -2.938 . . . . 0.0 106.89 170.797 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.1 ttpp -103.5 119.52 39.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 125.3 1.44 . . . . 0.0 107.245 -167.955 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m -81.57 144.6 31.16 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 126.245 1.818 . . . . 0.0 109.437 174.89 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -37.8 -51.11 1.27 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 -178.648 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.6 p -62.07 -10.49 10.27 Favored 'General case' 0 N--CA 1.444 -0.728 1 O-C-N 129.366 4.166 . . . . 0.0 114.751 -178.057 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.2 -24.14 16.86 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 117.755 1.862 . . . . 0.0 117.755 179.752 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -62.59 123.02 17.26 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 127.329 2.252 . . . . 0.0 109.374 -177.253 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.278 8.4 m -114.8 113.28 24.04 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.976 2.11 . . . . 0.0 115.652 -174.108 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.7 mt -90.44 148.0 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 O-C-N 126.495 2.372 . . . . 0.0 106.528 -172.445 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.318 4.7 t -155.19 100.04 2.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 -163.906 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 tp -140.78 127.98 20.96 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 112.635 -2.075 . . . . 0.0 110.653 -161.101 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -59.79 93.61 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 175.456 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.9 m -125.84 169.81 16.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 C-N-CA 126.689 1.995 . . . . 0.0 107.815 169.799 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' OE2' ' HB3' ' A' ' 1' ' ' MET . 26.7 mm-40 -138.17 158.9 70.16 Favored Pre-proline 0 N--CA 1.445 -0.713 1 C-N-CA 132.035 4.134 . . . . 0.0 107.068 -176.24 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.16 -9.03 14.12 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 O-C-N 125.58 2.358 . . . . 0.0 117.992 -168.605 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.7 t -92.74 4.42 53.79 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 176.455 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -73.18 134.23 44.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 117.267 -3.396 . . . . 0.0 111.428 175.902 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.3 p -76.29 157.25 32.71 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 125.03 2.348 . . . . 0.0 112.926 175.902 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.268 2.7 mm -64.52 -31.5 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 O-C-N 117.207 -3.433 . . . . 0.0 118.315 -172.12 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -83.03 -35.85 25.45 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.926 2.091 . . . . 0.0 111.557 178.137 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.367 10.3 t-20 -51.72 -48.94 63.4 Favored 'General case' 0 N--CA 1.441 -0.88 0 O-C-N 127.037 2.711 . . . . 0.0 113.669 158.651 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.1 t -66.87 -40.43 85.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 121.898 2.136 . . . . 0.0 113.067 171.681 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.261 44.7 mtpt -64.84 -36.33 83.99 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 126.153 1.781 . . . . 0.0 110.833 -178.376 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.14 -14.25 62.89 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 127.449 2.299 . . . . 0.0 112.527 -176.308 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -83.13 -27.81 29.86 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 123.633 0.583 . . . . 0.0 111.594 173.953 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.428 HD13 HG21 ' A' ' 30' ' ' ILE . 75.3 mt -82.57 -18.65 10.72 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.269 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.907 -164.967 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -77.26 -30.14 54.28 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 125.14 1.525 . . . . 0.0 112.484 176.362 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -70.91 -57.41 4.62 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 119.367 -2.083 . . . . 0.0 110.979 165.886 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.6 mttp -82.66 -28.59 30.56 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.157 1.783 . . . . 0.0 114.327 -161.438 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -118.23 -5.99 10.86 Favored 'General case' 0 N--CA 1.443 -0.821 0 O-C-N 124.403 1.064 . . . . 0.0 110.601 178.733 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.22 -0.08 26.09 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 129.733 3.54 . . . . 0.0 117.923 -175.677 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.6 mm -82.8 138.88 43.34 Favored Pre-proline 0 N--CA 1.447 -0.597 1 O-C-N 115.376 -4.602 . . . . 0.0 104.165 -172.275 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -86.03 167.29 9.56 Favored 'Trans proline' 0 N--CA 1.449 -1.125 0 C-N-CA 125.027 3.818 . . . . 0.0 105.589 176.254 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.98 -22.16 5.32 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 122.64 2.227 . . . . 0.0 116.237 168.507 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.37 0.0 OUTLIER -54.52 -49.73 69.54 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 129.747 3.219 . . . . 0.0 109.668 -179.459 . . . . . . . . 3 3 . 1 . 073 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.29 71.0 mm-40 -78.8 -22.26 46.55 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 120.458 1.481 . . . . 0.0 114.943 178.116 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.307 7.1 tt0 -86.21 154.46 21.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.488 1.915 . . . . 0.0 113.542 -156.527 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.319 23.6 ttm105 -153.35 140.4 19.32 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 128.381 2.672 . . . . 0.0 112.75 -178.247 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.3 mt -125.0 131.96 53.33 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 116.85 -1.548 . . . . 0.0 111.708 -177.937 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -117.53 120.67 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.282 1.833 . . . . 0.0 112.742 179.234 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.294 22.6 t80 -120.7 119.84 33.95 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 115.992 -1.956 . . . . 0.0 108.078 176.908 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 56.46 25.41 9.63 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 126.239 2.212 . . . . 0.0 116.928 -178.967 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 93.27 -15.28 63.29 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.739 1.637 . . . . 0.0 112.406 -174.73 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -91.13 113.76 26.11 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 124.025 3.912 . . . . 0.0 105.494 -173.444 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.7 pp0? -66.77 136.7 55.86 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 126.338 2.97 . . . . 0.0 107.77 168.189 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -84.97 134.95 34.23 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 118.608 -2.558 . . . . 0.0 113.168 179.134 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -91.24 158.27 16.68 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 -178.733 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -73.16 155.08 39.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 127.984 2.514 . . . . 0.0 111.902 177.829 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.13 -15.56 62.61 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 126.767 2.127 . . . . 0.0 116.303 171.213 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -91.21 161.0 15.25 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -167.821 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.7 p -84.77 166.78 16.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.923 0.868 . . . . 0.0 108.945 170.499 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.0 -41.37 91.94 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 118.978 -2.326 . . . . 0.0 116.905 168.088 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.1 t -53.92 -23.91 14.49 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 130.04 3.336 . . . . 0.0 116.069 170.307 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -74.27 -18.06 60.78 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 115.38 -2.248 . . . . 0.0 115.23 172.266 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -103.45 5.83 37.21 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 120.243 1.383 . . . . 0.0 110.979 172.401 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 73.72 33.73 1.0 Allowed 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.119 1.368 . . . . 0.0 110.007 175.137 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -90.57 136.91 22.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 O-C-N 119.342 -2.099 . . . . 0.0 112.071 -170.608 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mm-40 -130.69 174.05 10.31 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.013 1.725 . . . . 0.0 112.669 -162.786 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -58.26 121.23 10.26 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.154 2.181 . . . . 0.0 111.56 -177.995 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.368 12.4 mt-10 61.57 34.03 18.02 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 130.807 3.643 . . . . 0.0 113.77 178.454 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.258 24.4 m -83.76 157.72 22.01 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 102.62 -3.104 . . . . 0.0 102.62 159.481 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -126.4 135.46 51.45 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.468 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.254 3.9 mp -98.68 143.1 29.43 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 128.332 2.653 . . . . 0.0 107.51 172.081 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -72.43 148.87 44.76 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 124.674 2.178 . . . . 0.0 109.405 159.534 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.5 tt -135.23 131.16 36.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 113.122 -1.854 . . . . 0.0 107.422 169.376 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.4 m -132.37 152.65 36.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 C-N-CA 128.336 2.654 . . . . 0.0 110.922 170.49 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.41 120.88 33.38 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 130.309 3.444 . . . . 0.0 109.496 178.489 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.646 14.2 ttt85 93.36 -10.07 0.15 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.12 2.168 . . . . 0.0 116.227 162.918 . . . . . . . . 2 2 . 1 . 073 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.384 4.6 pp -140.18 156.05 46.68 Favored 'General case' 0 N--CA 1.448 -0.535 1 CA-C-O 111.54 -4.076 . . . . 0.0 116.875 -177.955 . . . . . . . . 3 2 . 1 . 073 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 22.7 ttt180 -108.56 64.46 0.61 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 127.711 3.132 . . . . 0.0 115.801 -177.71 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -129.28 127.9 5.63 Favored Glycine 0 CA--C 1.527 0.794 0 C-N-CA 127.948 2.689 . . . . 0.0 107.939 178.868 . . . . . . . . 1 1 . 1 . 073 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.684 1 N-CA-C 101.457 -4.657 . . . . 0.0 101.457 158.621 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.2 ttp . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 . . . . . . . . . 0 0 . 1 . 074 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -95.08 140.87 29.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.514 -1.675 . . . . 0.0 110.111 -178.49 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.6 pt -145.09 159.58 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 128.075 2.55 . . . . 0.0 107.174 167.313 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -106.43 153.3 22.46 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 117.409 -3.307 . . . . 0.0 105.946 171.806 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.8 t -118.85 130.01 74.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 166.827 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.0 tttt -111.01 138.35 47.52 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.418 1.087 . . . . 0.0 108.128 173.789 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.7 p -88.35 140.51 29.4 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 164.557 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 67.0 mt -60.47 -17.76 47.03 Favored 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 117.03 -3.544 . . . . 0.0 115.88 -177.15 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -80.49 -5.84 57.25 Favored 'General case' 0 C--N 1.322 -0.589 2 C-N-CA 131.97 4.108 . . . . 0.0 112.716 165.724 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.37 -7.95 43.86 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 118.306 2.082 . . . . 0.0 118.306 165.142 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.1 tttt -58.15 152.27 17.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 117.916 -3.108 . . . . 0.0 112.547 163.583 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.0 p -134.15 161.31 35.26 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.628 1.204 . . . . 0.0 109.776 161.948 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.54 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -142.42 154.8 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 102.173 -3.269 . . . . 0.0 102.173 169.385 . . . . . . . . 3 3 . 1 . 074 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -97.54 126.38 42.79 Favored 'General case' 0 N--CA 1.444 -0.773 1 C-N-CA 132.116 4.167 . . . . 0.0 103.36 -175.038 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -118.15 101.35 8.16 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 131.386 3.874 . . . . 0.0 111.687 -176.8 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.3 pm0 -76.47 126.16 30.5 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 127.174 2.796 . . . . 0.0 105.473 163.539 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.432 31.5 m -135.84 165.01 30.85 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 1 C-N-CA 133.368 4.667 . . . . 0.0 116.468 -175.674 . . . . . . . . 3 2 . 1 . 074 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.67 159.78 37.42 Favored Pre-proline 0 N--CA 1.45 -0.436 0 C-N-CA 125.879 1.671 . . . . 0.0 111.124 166.686 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.352 97.7 Cg_endo -58.62 -40.59 72.22 Favored 'Trans proline' 0 N--CA 1.441 -1.565 0 N-CA-C 120.26 3.139 . . . . 0.0 120.26 177.256 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.5 p -73.15 -14.74 61.43 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 130.24 3.416 . . . . 0.0 109.89 -171.644 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -65.55 127.3 31.31 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 124.98 2.324 . . . . 0.0 112.74 -175.725 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.9 p -70.06 156.09 39.67 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 113.46 -1.7 . . . . 0.0 109.376 175.244 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.9 mp -54.76 -37.0 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 C-N-CA 124.577 1.151 . . . . 0.0 111.506 166.101 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -48.06 -48.61 33.22 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.691 1.996 . . . . 0.0 114.338 166.749 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -73.32 -43.3 61.12 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 118.006 -2.934 . . . . 0.0 112.774 174.59 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.315 29.9 t -58.57 -31.47 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 118.012 -2.93 . . . . 0.0 112.022 170.653 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mttt -64.95 -39.27 93.24 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 123.145 2.702 . . . . 0.0 111.339 169.302 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.46 -31.36 53.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 111.944 -3.884 . . . . 0.0 114.704 175.491 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -62.95 -50.97 68.7 Favored 'General case' 0 N--CA 1.452 -0.357 1 O-C-N 132.857 6.348 . . . . 0.0 109.659 167.443 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.5 mt -53.05 -46.18 53.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 1 O-C-N 115.517 -4.489 . . . . 0.0 109.424 173.442 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.86 -34.64 77.8 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 112.741 -3.504 . . . . 0.0 111.51 -179.964 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.67 -32.37 69.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 128.457 3.598 . . . . 0.0 109.851 176.058 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -78.43 -34.48 47.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 121.754 2.07 . . . . 0.0 113.5 173.759 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -145.98 -19.46 0.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 118.138 2.644 . . . . 0.0 118.138 -151.818 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 101.39 -4.68 54.73 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 128.374 2.892 . . . . 0.0 114.003 158.279 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.6 mt -65.19 115.48 21.77 Favored Pre-proline 0 N--CA 1.445 -0.701 0 O-C-N 119.027 -2.455 . . . . 0.0 111.979 173.942 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.1 153.42 62.69 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 CA-C-O 112.085 -3.381 . . . . 0.0 117.425 -178.198 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.68 -34.96 55.72 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 125.134 3.889 . . . . 0.0 118.727 -166.7 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.01 -23.81 35.76 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.464 0.649 . . . . 0.0 109.846 -168.338 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.397 12.3 mm100 -87.01 -0.69 57.04 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.922 2.489 . . . . 0.0 111.203 178.748 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -95.22 145.67 24.89 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 178.482 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -138.3 134.61 34.52 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.547 2.739 . . . . 0.0 104.359 161.232 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 9.0 mt -114.89 139.02 50.13 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 113.401 -3.19 . . . . 0.0 107.943 -177.234 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.0 mm -129.87 131.88 66.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 129.623 3.169 . . . . 0.0 106.516 -174.718 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -113.11 -38.0 4.6 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 158.767 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.257 . . -124.95 -120.34 0.27 Allowed 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 118.034 -2.916 . . . . 0.0 107.831 -172.641 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -106.52 13.96 42.8 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 125.982 3.992 . . . . 0.0 111.668 -177.014 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -145.01 -175.86 4.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 115.098 -2.382 . . . . 0.0 109.742 -176.967 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -78.73 156.32 28.96 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 126.187 2.179 . . . . 0.0 111.831 169.946 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 66.8 mt -95.45 144.52 25.88 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 102.834 -3.024 . . . . 0.0 102.834 163.836 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -100.92 129.21 46.74 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.211 2.204 . . . . 0.0 110.825 -168.941 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -42.52 -52.62 4.66 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 120.822 3.638 . . . . 0.0 120.822 -171.161 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -93.71 5.19 73.13 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 114.091 -3.616 . . . . 0.0 111.131 -175.212 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 54' ' ' ARG . 14.7 mtt180 -92.6 150.8 20.49 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 119.866 1.833 . . . . 0.0 111.287 159.813 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.342 7.1 p -91.1 156.73 17.68 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 129.622 3.169 . . . . 0.0 113.389 -177.764 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.4 mt -43.11 -49.22 6.35 Favored 'General case' 0 N--CA 1.442 -0.834 0 C-N-CA 129.55 3.14 . . . . 0.0 112.516 164.761 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.378 45.3 p -55.91 -40.36 72.97 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 172.895 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -58.52 -47.72 83.2 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 118.348 -2.72 . . . . 0.0 110.762 -176.091 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.393 40.3 m-85 -90.06 4.14 51.15 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 114.236 -1.347 . . . . 0.0 110.061 177.887 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.2 t30 74.8 33.84 0.75 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 127.306 2.242 . . . . 0.0 114.017 156.51 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.1 mm -72.23 127.81 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 100.902 -3.74 . . . . 0.0 100.902 -171.802 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.5 mm-40 -92.34 155.66 17.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.063 1.745 . . . . 0.0 107.354 175.761 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.03 146.12 2.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.74 2.416 . . . . 0.0 115.372 173.892 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.373 1.6 tt0 58.0 19.1 5.62 Favored 'General case' 0 N--CA 1.443 -0.793 1 C-N-CA 133.112 4.565 . . . . 0.0 118.534 -174.741 . . . . . . . . 3 2 . 1 . 074 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.9 m -70.57 145.14 50.97 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 117.392 2.368 . . . . 0.0 117.392 169.216 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 m -90.26 140.27 29.84 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 103.186 -2.894 . . . . 0.0 103.186 179.157 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 40.4 mt -108.78 145.53 35.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 128.393 2.677 . . . . 0.0 110.525 154.699 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -104.73 137.92 41.81 Favored 'General case' 0 N--CA 1.45 -0.466 1 N-CA-C 100.091 -4.04 . . . . 0.0 100.091 174.992 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.4 tp -124.53 113.54 18.23 Favored 'General case' 0 N--CA 1.445 -0.677 1 C-N-CA 134.757 5.223 . . . . 0.0 107.436 -174.459 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.7 t -78.07 129.61 37.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 102.284 -3.228 . . . . 0.0 102.284 163.032 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.27 112.22 14.24 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 124.405 2.05 . . . . 0.0 106.195 171.768 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 mtm105 -80.23 48.75 1.04 Allowed 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 117.641 2.459 . . . . 0.0 117.641 -170.482 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -153.34 19.36 0.56 Allowed 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 127.953 3.283 . . . . 0.0 114.567 -176.256 . . . . . . . . 1 1 . 1 . 074 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -42.46 19.6 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 117.497 -1.239 . . . . 0.0 108.682 -179.686 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.08 -14.1 19.18 Favored Glycine 0 CA--C 1.528 0.898 1 C-N-CA 131.783 4.516 . . . . 0.0 115.437 176.078 . . . . . . . . 2 2 . 1 . 074 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.333 0 N-CA-C 104.87 -3.292 . . . . 0.0 104.87 -172.403 . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.5 ptt? . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 116.628 -1.653 . . . . 0.0 108.883 . . . . . . . . . 0 0 . 1 . 075 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -112.67 145.53 40.28 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 123.516 2.871 . . . . 0.0 113.75 -177.835 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.3 pt -135.53 155.19 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 C-N-CA 128.03 2.532 . . . . 0.0 109.299 167.524 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -111.86 132.05 54.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 131.315 3.846 . . . . 0.0 108.787 -176.901 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.448 HG22 ' HB2' ' A' ' 67' ' ' LEU . 93.3 t -121.67 128.79 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 172.732 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.324 59.2 mmtt -97.98 140.94 31.57 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 117.596 -3.19 . . . . 0.0 110.464 163.436 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.5 p -86.67 -176.72 5.92 Favored 'General case' 0 N--CA 1.44 -0.936 1 C-N-CA 131.914 4.086 . . . . 0.0 105.069 179.911 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.4 mp -72.08 -46.4 57.0 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 128.236 2.615 . . . . 0.0 105.262 -178.701 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -78.58 -12.24 60.01 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 125.678 1.591 . . . . 0.0 112.29 -173.189 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.77 9.23 26.95 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 106.116 -2.794 . . . . 0.0 106.116 160.532 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -71.48 136.28 47.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 121.85 2.825 . . . . 0.0 110.223 170.54 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 79.2 m -97.23 119.76 36.34 Favored 'General case' 0 N--CA 1.45 -0.449 0 O-C-N 128.054 3.346 . . . . 0.0 106.705 179.349 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.9 mt -103.32 125.14 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 O-C-N 126.532 2.395 . . . . 0.0 106.915 178.358 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 30.2 p -109.81 124.56 51.5 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 119.948 1.249 . . . . 0.0 109.268 170.608 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -110.24 150.67 28.36 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 126.441 1.897 . . . . 0.0 107.23 175.741 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -85.37 109.4 18.38 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 131.022 3.729 . . . . 0.0 102.83 166.962 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.24 159.76 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 175.451 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -121.48 159.59 49.71 Favored Pre-proline 0 N--CA 1.45 -0.457 0 C-N-CA 131.58 3.952 . . . . 0.0 111.903 166.34 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.263 22.5 Cg_exo -61.15 -19.37 63.19 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 N-CA-C 118.019 2.276 . . . . 0.0 118.019 -172.459 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.27 0.2 OUTLIER -90.57 -2.36 57.88 Favored 'General case' 0 N--CA 1.446 -0.653 1 C-N-CA 131.877 4.071 . . . . 0.0 115.328 178.724 . . . . . . . . 4 3 . 1 . 075 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -71.43 135.37 47.18 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 118.639 -2.538 . . . . 0.0 112.549 168.675 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.1 p -82.07 164.6 21.27 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 177.464 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.8 mm -56.81 -36.82 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 O-C-N 116.878 -3.639 . . . . 0.0 113.341 -178.41 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . 0.253 13.1 tp10 -67.63 -37.54 82.6 Favored 'General case' 0 N--CA 1.45 -0.439 0 O-C-N 127.106 2.754 . . . . 0.0 111.188 178.395 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -58.09 -48.65 79.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 127.352 2.261 . . . . 0.0 111.658 177.833 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.5 t -60.39 -38.9 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 O-C-N 127.056 2.723 . . . . 0.0 112.271 178.156 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 mtmt -80.69 -20.78 42.18 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 118.717 -2.49 . . . . 0.0 110.207 -177.551 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.91 -29.67 39.86 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 115.207 -2.33 . . . . 0.0 111.485 172.986 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -72.97 -23.74 60.69 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 168.317 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 95.4 mt -73.28 -42.8 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 C-N-CA 129.833 3.253 . . . . 0.0 111.03 170.286 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.8 tm0? -64.42 -42.34 96.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 116.636 -1.649 . . . . 0.0 109.692 172.704 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -56.59 -56.2 24.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 121.827 2.103 . . . . 0.0 113.254 173.306 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.3 tttt -77.54 -31.97 53.67 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 112.993 -1.912 . . . . 0.0 115.597 -172.989 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -142.9 -7.41 0.83 Allowed 'General case' 0 N--CA 1.453 -0.278 0 O-C-N 117.947 -2.971 . . . . 0.0 110.977 -167.51 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.95 13.07 54.43 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 126.553 2.025 . . . . 0.0 112.405 156.212 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.41 HD13 HG21 ' A' ' 36' ' ' ILE . 16.9 mt -88.76 127.05 57.62 Favored Pre-proline 0 N--CA 1.446 -0.646 0 O-C-N 117.704 -3.233 . . . . 0.0 108.955 -178.616 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -80.73 154.97 20.57 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 N-CA-C 106.945 -1.983 . . . . 0.0 106.945 -165.612 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -68.97 -29.62 27.41 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 CA-C-O 115.359 -2.017 . . . . 0.0 112.34 176.553 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -65.43 118.17 9.01 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 113.731 -3.033 . . . . 0.0 115.014 171.527 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 81.45 1.63 1.57 Allowed 'General case' 0 C--N 1.321 -0.634 1 C-N-CA 132.116 4.166 . . . . 0.0 112.955 179.414 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -99.49 121.31 40.97 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 100.797 -3.779 . . . . 0.0 100.797 173.191 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -105.04 152.05 23.21 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 111.866 -2.424 . . . . 0.0 107.42 169.796 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.1 mt -121.28 110.93 16.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 O-C-N 126.917 2.636 . . . . 0.0 113.188 174.661 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 83.2 mt -94.27 148.07 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-O 124.892 2.282 . . . . 0.0 110.01 173.427 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -126.83 107.45 10.13 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 100.426 -3.916 . . . . 0.0 100.426 173.108 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 76.0 -104.39 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 101.916 -3.364 . . . . 0.0 101.916 178.969 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -127.97 8.5 6.78 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 129.419 3.39 . . . . 0.0 112.707 173.617 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.4 mtmt -86.23 105.59 16.71 Favored 'General case' 0 C--N 1.325 -0.471 1 C-N-CA 132.9 4.48 . . . . 0.0 112.056 173.204 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -66.32 134.02 51.73 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-O 115.421 -2.228 . . . . 0.0 114.044 158.784 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.8 mt -107.01 111.18 23.54 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 127.65 3.094 . . . . 0.0 109.45 -162.755 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -68.06 123.26 20.16 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 130.92 3.688 . . . . 0.0 111.955 176.991 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.2 -18.11 3.53 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 119.644 3.201 . . . . 0.0 119.644 -157.057 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -99.87 -1.22 56.21 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 119.488 2.555 . . . . 0.0 119.488 -175.583 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 -92.81 166.69 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.933 2.093 . . . . 0.0 113.898 -173.475 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -109.75 166.3 11.02 Favored 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 124.816 1.323 . . . . 0.0 110.11 178.84 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mt -61.93 -34.87 76.88 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.415 1.486 . . . . 0.0 110.426 167.656 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 10.7 t -53.32 -41.26 65.52 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 117.728 -3.107 . . . . 0.0 117.898 160.823 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -75.84 -41.36 52.69 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 112.872 -3.442 . . . . 0.0 114.255 -178.206 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -86.68 -21.0 26.93 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 122.013 2.188 . . . . 0.0 106.787 -174.414 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 38.6 t30 81.07 62.24 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 119.005 -2.31 . . . . 0.0 108.181 179.718 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.5 mt -110.08 110.01 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 100.25 -3.981 . . . . 0.0 100.25 177.935 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -104.13 165.15 11.24 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 127.597 2.359 . . . . 0.0 110.66 -168.241 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.447 7.7 pttp -44.52 125.16 4.59 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 118.449 -2.657 . . . . 0.0 115.971 172.395 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.409 2.7 tt0 84.18 9.2 0.49 Allowed 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 119.12 3.008 . . . . 0.0 119.12 179.34 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 73.6 m -59.46 147.17 37.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.454 -3.279 . . . . 0.0 114.66 172.502 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.5 p -123.94 110.69 15.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 O-C-N 127.093 2.746 . . . . 0.0 106.384 -171.064 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.448 ' HB2' HG22 ' A' ' 5' ' ' VAL . 5.7 mp -111.48 158.81 18.7 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 128.798 2.839 . . . . 0.0 109.178 -173.042 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 36.9 t60 -121.55 139.37 53.59 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 179.994 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.1 tt -104.11 132.63 50.17 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 103.561 -2.755 . . . . 0.0 103.561 177.875 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.331 76.7 t -113.77 132.31 63.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 129.504 3.121 . . . . 0.0 111.298 174.928 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 14.5 mt -91.01 113.95 26.35 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 126.115 2.134 . . . . 0.0 107.932 168.391 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.58 -12.5 60.48 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 129.214 3.006 . . . . 0.0 111.149 179.408 . . . . . . . . 2 2 . 1 . 075 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.7 tp -150.72 158.37 44.07 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 117.192 -3.443 . . . . 0.0 104.2 158.234 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.9 mtm105 -68.68 165.4 19.49 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 121.111 1.778 . . . . 0.0 112.787 -174.948 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -110.73 21.21 23.66 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 129.605 3.478 . . . . 0.0 119.102 166.212 . . . . . . . . 1 1 . 1 . 075 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 1 C-N-CA 132.806 5.003 . . . . 0.0 117.415 -166.915 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.0 ptt? . . . . . 0 N--CA 1.473 0.725 0 N-CA-C 101.213 -3.625 . . . . 0.0 101.213 . . . . . . . . . 0 0 . 1 . 076 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.307 8.5 mt-30 -104.51 156.3 18.07 Favored 'General case' 0 N--CA 1.455 -0.205 1 O-C-N 112.643 -6.286 . . . . 0.0 105.895 175.256 . . . . . . . . 3 2 . 1 . 076 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.559 HD12 HD13 ' A' ' 67' ' ' LEU . 16.9 pt -125.8 140.5 48.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 110.942 -2.845 . . . . 0.0 110.541 156.143 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -81.17 138.73 35.84 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 101.044 -3.687 . . . . 0.0 101.044 171.648 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' CG2' HD23 ' A' ' 15' ' ' LEU . 39.5 t -123.12 123.3 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 166.385 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -86.22 131.65 34.18 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 -178.149 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.0 p -93.67 167.24 11.79 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 120.674 -1.266 . . . . 0.0 111.738 179.662 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.0 mt -71.54 -24.36 61.93 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 128.427 2.691 . . . . 0.0 108.977 172.067 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.2 p -94.39 3.47 55.14 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 121.974 2.17 . . . . 0.0 110.39 -177.273 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.02 -38.94 2.53 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 158.928 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 42.5 pttt -83.54 158.78 21.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 121.167 -1.196 . . . . 0.0 111.008 -167.742 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -106.82 101.24 10.7 Favored 'General case' 0 C--O 1.221 -0.42 0 C-N-CA 128.542 2.737 . . . . 0.0 103.969 177.453 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.5 pt -68.16 140.54 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.268 163.194 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.6 m -97.65 121.02 39.07 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 118.011 -2.93 . . . . 0.0 105.486 173.067 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD23 ' CG2' ' A' ' 5' ' ' VAL . 3.8 mm? -87.23 145.34 26.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 122.003 2.183 . . . . 0.0 105.649 166.752 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 -100.65 113.18 25.81 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.078 2.151 . . . . 0.0 109.309 169.891 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.252 11.9 m -136.76 154.08 31.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 O-C-N 117.735 -3.103 . . . . 0.0 114.137 -164.722 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -118.24 149.31 45.55 Favored Pre-proline 0 N--CA 1.449 -0.518 0 C-N-CA 127.914 2.486 . . . . 0.0 110.786 172.749 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.383 36.6 Cg_endo -57.18 -40.35 83.61 Favored 'Trans proline' 0 N--CA 1.447 -1.239 2 C-N-CA 127.461 5.441 . . . . 0.0 123.098 -174.886 . . . . . . . . 3 2 . 1 . 076 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.288 23.0 p -80.17 -2.08 43.16 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 178.836 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -79.69 138.97 37.51 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 113.723 -1.58 . . . . 0.0 108.831 -174.95 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.7 t -84.76 126.97 33.88 Favored 'General case' 0 C--N 1.323 -0.544 1 C-N-CA 132.134 4.174 . . . . 0.0 106.761 -171.645 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 50' ' ' LEU 0.262 5.4 mm -30.59 -41.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 120.897 3.665 . . . . 0.0 120.897 174.427 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -61.72 -34.42 75.77 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 114.972 -2.442 . . . . 0.0 110.693 172.669 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -72.8 -15.87 61.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 125.424 3.738 . . . . 0.0 113.119 171.116 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 72.2 t -86.28 -35.3 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-O 115.907 -1.996 . . . . 0.0 110.612 175.975 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -62.76 -45.25 93.56 Favored 'General case' 0 N--CA 1.447 -0.623 1 O-C-N 129.548 4.28 . . . . 0.0 109.667 171.362 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.56 -33.9 68.62 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 116.934 2.198 . . . . 0.0 116.934 167.077 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 ttmt -73.77 -40.82 63.19 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 116.403 -1.761 . . . . 0.0 109.815 -178.843 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.52 -33.83 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 126.682 1.993 . . . . 0.0 114.972 171.956 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -69.5 -44.92 70.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 101.887 -3.375 . . . . 0.0 101.887 177.843 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.357 2.5 t70 -63.59 -5.34 3.8 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 130.321 3.448 . . . . 0.0 114.689 179.075 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 36.7 mttm -116.85 -75.44 0.58 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.846 2.858 . . . . 0.0 111.33 178.491 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -95.91 -1.96 48.21 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.267 1.827 . . . . 0.0 114.046 -174.721 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.93 3.5 68.06 Favored Glycine 0 CA--C 1.528 0.877 0 CA-C-N 123.401 2.818 . . . . 0.0 114.982 164.98 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.2 mt -76.45 111.71 17.21 Favored Pre-proline 0 N--CA 1.449 -0.502 0 C-N-CA 126.673 1.989 . . . . 0.0 110.216 -176.822 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -51.86 131.32 37.82 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 CA-C-O 115.696 -1.877 . . . . 0.0 113.825 168.97 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -38.58 -35.95 0.54 Allowed 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 124.983 3.789 . . . . 0.0 119.816 175.625 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -69.49 -12.98 62.1 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.885 0.85 . . . . 0.0 113.129 -178.285 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -92.12 -5.7 52.21 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 117.243 -3.41 . . . . 0.0 112.161 172.423 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.266 65.6 mt-30 -108.3 107.38 17.94 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 119.439 -2.038 . . . . 0.0 108.975 -171.423 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -92.06 133.43 35.75 Favored 'General case' 0 C--O 1.218 -0.561 0 O-C-N 125.584 1.803 . . . . 0.0 106.668 156.492 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 69' ' ' LEU . 93.3 mt -113.4 144.81 42.16 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.837 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.268 11.3 mm -132.12 136.43 56.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 112.062 -2.335 . . . . 0.0 105.948 -165.767 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.423 ' CE2' HG12 ' A' ' 61' ' ' ILE . 75.8 t80 -145.35 117.4 8.32 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 127.097 2.748 . . . . 0.0 106.322 177.152 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.327 . . 63.76 -98.6 0.07 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 124.812 1.245 . . . . 0.0 111.38 -160.191 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.19 11.23 5.32 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 127.231 2.832 . . . . 0.0 119.37 161.844 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -87.03 127.04 35.11 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 128.417 2.687 . . . . 0.0 105.728 -163.421 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -75.12 102.94 5.1 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 118.967 -2.333 . . . . 0.0 108.322 170.329 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 23' ' ' ILE . 65.0 mt -62.46 117.99 6.93 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 129.401 3.08 . . . . 0.0 109.309 177.632 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -89.74 145.49 25.16 Favored 'General case' 0 N--CA 1.45 -0.465 0 O-C-N 117.512 -3.242 . . . . 0.0 114.39 -174.571 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.98 118.12 16.57 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-O 126.551 3.072 . . . . 0.0 112.902 176.267 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.1 -17.42 19.63 Favored Glycine 0 CA--C 1.524 0.625 1 C-N-CA 132.24 4.733 . . . . 0.0 111.429 -178.431 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.8 mtt-85 -86.98 149.47 24.75 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 122.089 2.944 . . . . 0.0 109.68 176.026 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.6 p -95.78 169.27 10.12 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 126.511 3.053 . . . . 0.0 112.964 -178.685 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.78 -36.1 80.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 116.5 -3.875 . . . . 0.0 111.384 173.638 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.7 t -67.84 -37.77 82.3 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 118.709 -2.494 . . . . 0.0 108.336 -178.775 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -62.4 -48.83 77.99 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 126.228 2.205 . . . . 0.0 110.789 176.742 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -81.65 7.85 11.31 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.617 3.167 . . . . 0.0 118.572 170.71 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 63.03 21.31 12.82 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.406 1.882 . . . . 0.0 110.789 170.489 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.423 HG12 ' CE2' ' A' ' 45' ' ' PHE . 47.1 mt -76.8 145.11 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-O 124.124 1.916 . . . . 0.0 108.521 175.018 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -134.44 -177.38 4.57 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.41 1.484 . . . . 0.0 110.631 -167.248 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.6 pttt -57.13 132.56 53.33 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-O 114.455 -2.688 . . . . 0.0 114.36 173.763 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.6 tt0 70.44 48.1 0.48 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 126.11 2.862 . . . . 0.0 115.825 172.888 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.1 m -117.88 152.74 34.8 Favored 'General case' 0 C--N 1.319 -0.757 0 O-C-N 118.698 -2.502 . . . . 0.0 106.77 -178.548 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.4 m -108.34 117.01 33.05 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 129.242 3.017 . . . . 0.0 108.746 -176.514 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.559 HD13 HD12 ' A' ' 3' ' ' ILE 0.311 7.6 mp -105.63 158.33 16.77 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 167.541 . . . . . . . . 3 3 . 1 . 076 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -103.27 123.87 47.58 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 129.762 3.225 . . . . 0.0 109.868 168.3 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 43' ' ' LEU . 36.8 tp -81.71 113.63 19.83 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 129.411 3.084 . . . . 0.0 107.921 164.101 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -135.85 150.71 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 C-N-CA 128.161 2.584 . . . . 0.0 112.684 -176.977 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.2 mt -78.16 135.39 37.64 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 129.48 3.112 . . . . 0.0 103.173 -178.984 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.5 ttt180 -91.63 135.67 33.71 Favored 'General case' 0 N--CA 1.446 -0.668 1 C-N-CA 135.221 5.409 . . . . 0.0 104.596 148.083 . . . . . . . . 2 2 . 1 . 076 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.5 mt -125.93 -13.83 6.24 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 125.395 1.684 . . . . 0.0 110.292 -168.939 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 46.7 ptt85 -124.7 118.89 27.45 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.722 2.009 . . . . 0.0 111.925 164.787 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.59 157.36 17.16 Favored Glycine 0 CA--C 1.533 1.176 0 N-CA-C 104.42 -3.472 . . . . 0.0 104.42 -168.957 . . . . . . . . 1 1 . 1 . 076 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.988 1 O-C-N 115.495 -4.532 . . . . 0.0 106.875 -176.62 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.426 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 4.3 tmm? . . . . . 0 N--CA 1.467 0.409 0 CA-C-O 117.166 -1.397 . . . . 0.0 108.952 . . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -75.82 133.7 40.57 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.261 1.824 . . . . 0.0 110.064 -177.708 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -147.29 173.26 2.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 122.554 2.434 . . . . 0.0 113.353 162.508 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -115.69 148.62 39.52 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 128.678 2.791 . . . . 0.0 104.236 -177.951 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.06 125.08 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 C-N-CA 126.946 2.099 . . . . 0.0 105.384 169.185 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -107.51 140.12 40.97 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 115.921 -1.99 . . . . 0.0 107.6 171.966 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -111.62 145.54 39.0 Favored 'General case' 0 C--N 1.327 -0.394 1 O-C-N 129.289 4.118 . . . . 0.0 112.636 177.965 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 tp -77.34 -13.29 59.96 Favored 'General case' 0 C--O 1.239 0.549 1 O-C-N 115.821 -4.299 . . . . 0.0 109.1 -177.269 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -88.04 -16.76 32.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 113.642 -3.075 . . . . 0.0 113.037 171.54 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 126.6 17.17 2.39 Favored Glycine 0 CA--C 1.54 1.633 0 O-C-N 128.892 3.87 . . . . 0.0 112.348 142.872 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -96.86 147.65 23.74 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.64 3.576 . . . . 0.0 107.552 178.808 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 m -125.07 147.24 49.07 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 122.127 2.239 . . . . 0.0 108.134 164.933 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 pt -129.51 153.83 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 126.614 1.965 . . . . 0.0 108.497 173.958 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.87 140.32 29.8 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 150.963 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.6 tp -137.8 166.12 24.78 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 129.818 3.247 . . . . 0.0 106.782 -173.638 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -132.3 128.85 38.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 100.624 -3.843 . . . . 0.0 100.624 173.122 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.514 HG21 ' CD1' ' A' ' 56' ' ' LEU . 3.5 m -127.21 166.23 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 128.521 2.728 . . . . 0.0 105.921 175.075 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.553 ' HG3' ' H ' ' A' ' 20' ' ' SER . 14.6 tp10 -86.12 155.58 57.75 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 101.443 -3.54 . . . . 0.0 101.443 166.726 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 50.7 Cg_endo -59.75 -33.27 96.39 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 CA-C-N 122.176 1.813 . . . . 0.0 114.358 157.581 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.553 ' H ' ' HG3' ' A' ' 18' ' ' GLU . 2.9 m -93.5 19.64 8.22 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 109.898 -3.319 . . . . 0.0 107.568 -168.252 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -82.66 133.04 35.17 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.729 1.212 . . . . 0.0 108.57 160.927 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 54' ' ' ARG 0.357 20.3 p -77.22 163.53 26.45 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.794 1.238 . . . . 0.0 111.59 165.458 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 24.9 mm -38.62 -51.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 C-N-CA 128.374 2.67 . . . . 0.0 112.307 166.411 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -61.58 -39.41 91.09 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 118.184 2.661 . . . . 0.0 118.184 174.67 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -83.22 -26.62 30.61 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 114.091 -2.861 . . . . 0.0 110.535 -178.608 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 22' ' ' THR . 64.0 t -44.47 -76.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 C-N-CA 130.74 3.616 . . . . 0.0 109.958 156.991 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -31.47 -38.89 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.45 1 C-N-CA 133.693 4.797 . . . . 0.0 114.52 170.743 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.55 -22.12 61.06 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 128.366 2.666 . . . . 0.0 114.652 -175.615 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.7 mttt -101.55 -16.09 16.89 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.499 1.92 . . . . 0.0 109.996 -176.114 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.7 mt -80.68 -25.42 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 119.297 -2.127 . . . . 0.0 114.203 158.934 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -67.53 -47.12 70.81 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 125.625 1.57 . . . . 0.0 109.707 -176.487 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -48.75 -48.59 40.7 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 127.261 2.224 . . . . 0.0 111.383 168.783 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.22 -24.26 54.61 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 119.441 -2.037 . . . . 0.0 109.265 -171.314 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.513 6.7 tp10 -128.09 -34.5 2.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 118.039 2.607 . . . . 0.0 118.039 -159.024 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.79 -4.78 79.2 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-N 123.088 2.676 . . . . 0.0 118.249 -170.21 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.7 mt -84.3 124.31 74.02 Favored Pre-proline 0 CA--C 1.538 0.496 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 179.245 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.28 153.11 45.42 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 124.656 3.571 . . . . 0.0 105.165 173.691 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -57.31 -42.35 63.27 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.808 3.005 . . . . 0.0 115.542 -174.128 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -49.98 -20.99 1.06 Allowed 'General case' 0 C--O 1.222 -0.375 0 N-CA-C 119.075 2.991 . . . . 0.0 119.075 168.895 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -108.09 -9.34 15.62 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 122.387 2.358 . . . . 0.0 111.13 176.77 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -78.11 137.1 38.03 Favored 'General case' 0 N--CA 1.448 -0.55 0 O-C-N 124.524 1.14 . . . . 0.0 110.806 172.237 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -126.74 111.2 13.96 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 105.037 -2.209 . . . . 0.0 105.037 174.932 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 57.8 mt -100.41 122.61 43.44 Favored 'General case' 0 N--CA 1.44 -0.96 0 O-C-N 125.713 1.883 . . . . 0.0 108.205 -178.797 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.59 139.56 25.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 O-C-N 125.965 2.04 . . . . 0.0 112.622 171.722 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -147.77 120.96 8.9 Favored 'General case' 0 N--CA 1.448 -0.543 1 C-N-CA 131.823 4.049 . . . . 0.0 113.519 175.182 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.91 33.53 14.71 Favored 'General case' 0 N--CA 1.443 -0.801 1 C-N-CA 133.162 4.585 . . . . 0.0 111.999 -178.137 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.5 -17.63 56.42 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 128.235 2.826 . . . . 0.0 117.923 173.63 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -92.52 135.77 33.78 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 116.439 -1.744 . . . . 0.0 113.719 173.39 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.27 133.4 45.02 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 126.87 2.606 . . . . 0.0 110.349 156.091 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 79.0 mt -99.21 155.04 17.69 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 118.472 -2.642 . . . . 0.0 109.972 -155.971 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -92.63 139.12 30.89 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 175.968 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.266 17.0 m-20 -43.08 -58.45 2.45 Favored 'General case' 0 N--CA 1.447 -0.609 1 C-N-CA 137.54 6.336 . . . . 0.0 109.173 -160.199 . . . . . . . . 3 2 . 1 . 077 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -104.74 18.82 43.03 Favored Glycine 0 CA--C 1.534 1.234 0 N-CA-C 117.594 1.798 . . . . 0.0 117.594 -159.763 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 22' ' ' THR 0.321 22.0 mmm180 -101.49 143.06 31.96 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 179.478 . . . . . . . . 3 3 . 1 . 077 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -72.24 165.03 25.25 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.374 2.269 . . . . 0.0 106.401 -179.099 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.514 ' CD1' HG21 ' A' ' 17' ' ' VAL . 73.4 mt -65.51 -22.61 66.74 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 116.42 -3.925 . . . . 0.0 117.452 168.751 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.8 m -72.17 -24.92 61.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 117.791 2.515 . . . . 0.0 117.791 167.485 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 -72.47 -21.6 61.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 117.97 -2.957 . . . . 0.0 116.474 166.083 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -98.72 -2.85 37.18 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.051 1.341 . . . . 0.0 111.88 172.834 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 73.55 29.04 1.62 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 126.368 1.867 . . . . 0.0 113.905 176.82 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 56' ' ' LEU . 11.0 mt -92.47 113.49 27.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 C-N-CA 126.012 1.725 . . . . 0.0 109.231 -175.572 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.263 57.5 tp60 -142.63 83.55 1.82 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 126.933 2.093 . . . . 0.0 109.834 -171.739 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.369 3.9 tmtt? 91.39 108.54 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 O-C-N 116.774 -3.703 . . . . 0.0 113.538 139.523 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.69 26.4 mt-10 78.41 17.12 1.15 Allowed 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 117.595 -3.191 . . . . 0.0 118.901 -178.108 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.266 19.2 p -85.71 155.95 20.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -178.839 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.4 m -109.86 110.39 21.35 Favored 'General case' 0 N--CA 1.439 -0.979 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 174.217 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.68 130.29 35.34 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.553 1.941 . . . . 0.0 109.405 168.64 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -94.44 128.53 41.05 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 115.471 -2.492 . . . . 0.0 104.861 -168.906 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 14.7 tp -109.61 123.53 49.6 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 -171.071 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 m -126.34 164.08 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 125.431 1.492 . . . . 0.0 107.818 174.7 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 mp -105.99 132.47 52.05 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 123.64 1.686 . . . . 0.0 106.608 -169.961 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -78.01 85.43 4.24 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 125.502 2.572 . . . . 0.0 104.754 -157.693 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -158.09 -174.59 4.9 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 129.053 2.941 . . . . 0.0 103.433 175.159 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 29.8 ptt85 -59.61 51.06 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 129.09 2.956 . . . . 0.0 114.638 173.367 . . . . . . . . 1 1 . 1 . 077 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -133.94 -179.56 16.52 Favored Glycine 0 CA--C 1.533 1.18 1 C-N-CA 133.864 5.507 . . . . 0.0 111.033 174.173 . . . . . . . . 2 2 . 1 . 077 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.508 0 N-CA-C 106.603 -2.599 . . . . 0.0 106.603 -163.826 . . . . . . . . 0 0 . 1 . 078 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 37.7 ttp . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 . . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -86.3 144.73 27.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 118.8 -2.438 . . . . 0.0 114.455 170.449 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.434 HD13 HG21 ' A' ' 3' ' ' ILE . 42.3 pt -132.21 165.5 31.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 O-C-N 117.163 -3.461 . . . . 0.0 107.026 169.538 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -112.49 140.13 47.5 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.509 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.398 60.9 t -124.84 84.39 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 129.571 3.149 . . . . 0.0 109.686 -172.272 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -75.16 121.82 22.68 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 121.211 -0.93 . . . . 0.0 111.582 -179.159 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.295 32.1 m -90.18 154.88 19.42 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 118.461 -2.649 . . . . 0.0 110.783 -175.471 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.287 3.0 tm? -33.46 -38.84 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 O-C-N 117.221 -3.425 . . . . 0.0 118.886 168.931 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.2 p -77.71 -18.17 56.85 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 130.344 3.458 . . . . 0.0 114.014 179.594 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.38 14.47 38.27 Favored Glycine 0 CA--C 1.523 0.574 1 C-N-CA 132.568 4.889 . . . . 0.0 109.612 177.254 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.6 ttpt -79.48 116.88 19.96 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.563 -1.551 . . . . 0.0 109.394 173.811 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.5 m -75.07 109.55 8.64 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 126.664 1.986 . . . . 0.0 107.547 163.826 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.504 HD13 HG21 ' A' ' 13' ' ' ILE 0.254 86.1 mt -90.58 148.14 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 1 N-CA-C 97.05 -5.167 . . . . 0.0 97.05 165.045 . . . . . . . . 4 3 . 1 . 078 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 6.4 t -135.78 139.25 43.38 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 117.217 -3.427 . . . . 0.0 108.781 163.97 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.53 149.52 42.54 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.432 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.6 mp0 -83.62 136.97 34.03 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 124.969 1.308 . . . . 0.0 109.642 167.325 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.46 165.2 30.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 C-N-CA 130.765 3.626 . . . . 0.0 108.447 173.487 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -96.67 156.42 36.64 Favored Pre-proline 0 N--CA 1.451 -0.402 0 CA-C-O 116.75 -1.595 . . . . 0.0 113.859 167.614 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -55.3 -43.34 59.6 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 N-CA-C 121.755 3.714 . . . . 0.0 121.755 175.408 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.56 -10.38 57.9 Favored 'General case' 0 N--CA 1.452 -0.337 1 N-CA-C 122.145 4.128 . . . . 0.0 122.145 -178.506 . . . . . . . . 3 3 . 1 . 078 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -49.22 139.47 11.07 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 128.056 2.543 . . . . 0.0 114.532 177.552 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 74.4 p -97.03 141.85 29.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 110.323 -3.126 . . . . 0.0 105.08 -174.155 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 28.3 mm -62.09 -28.61 44.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 118.282 -2.761 . . . . 0.0 112.402 -166.325 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.31 -26.3 65.56 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 173.852 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -78.89 -24.71 44.02 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 118.762 -2.461 . . . . 0.0 107.038 -177.724 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.6 t -68.4 -33.86 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-N 122.888 2.586 . . . . 0.0 113.045 -177.345 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.5 mtmt -68.39 -39.09 81.81 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.819 2.447 . . . . 0.0 109.548 -177.801 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.29 -28.72 68.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 118.761 -2.462 . . . . 0.0 112.789 176.315 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -84.58 -30.64 24.86 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 124.825 1.328 . . . . 0.0 110.893 -174.242 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 mt -71.95 -41.16 68.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 127.032 2.707 . . . . 0.0 104.706 171.234 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -60.38 -43.14 96.88 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 119.009 -2.307 . . . . 0.0 108.379 176.966 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -64.99 -45.12 86.94 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 121.212 1.824 . . . . 0.0 113.789 -178.561 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -99.02 -25.33 14.59 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 111.895 -3.907 . . . . 0.0 111.624 -167.874 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -117.33 -22.98 7.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 123.214 2.734 . . . . 0.0 111.679 177.035 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.05 22.3 42.43 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 128.418 2.913 . . . . 0.0 113.799 166.088 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.2 mt -90.69 120.47 68.84 Favored Pre-proline 0 N--CA 1.448 -0.543 0 C-N-CA 127.578 2.351 . . . . 0.0 107.133 -179.115 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -58.09 154.76 37.57 Favored 'Trans proline' 0 N--CA 1.444 -1.409 1 C-N-CA 128.009 5.806 . . . . 0.0 112.251 -179.972 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -78.52 -18.07 12.39 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 122.469 2.113 . . . . 0.0 116.531 -162.986 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -87.09 -10.88 51.8 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 117.732 2.493 . . . . 0.0 117.732 167.673 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -93.7 -15.82 24.87 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.715 1.606 . . . . 0.0 111.229 -171.992 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.408 ' HG2' ' H ' ' A' ' 41' ' ' GLN . 18.5 pt20 -98.11 143.81 28.25 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 126.184 1.794 . . . . 0.0 111.451 170.24 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -129.88 128.64 42.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 129.003 2.921 . . . . 0.0 106.096 166.373 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.6 mt -95.37 123.24 38.79 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 122.704 1.24 . . . . 0.0 109.993 179.413 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.463 10.3 mt -108.64 124.48 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 130.209 3.404 . . . . 0.0 114.16 178.096 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -139.6 133.97 31.46 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 115.763 -2.065 . . . . 0.0 112.614 171.124 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.71 36.37 23.6 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.938 2.095 . . . . 0.0 115.218 173.934 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.26 -16.24 30.02 Favored Glycine 0 N--CA 1.442 -0.933 1 CA-C-O 112.271 -4.627 . . . . 0.0 113.476 -171.771 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -89.48 138.63 31.28 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 122.19 2.995 . . . . 0.0 105.361 -171.208 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -88.38 136.26 33.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 112.919 -1.946 . . . . 0.0 109.355 157.119 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.493 HD22 ' CG ' ' A' ' 59' ' ' TYR 0.269 15.5 mt -90.38 139.71 30.41 Favored 'General case' 0 C--O 1.221 -0.432 1 CA-C-O 111.415 -4.136 . . . . 0.0 108.858 -165.222 . . . . . . . . 4 3 . 1 . 078 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -99.99 145.65 27.62 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 124.246 3.203 . . . . 0.0 113.345 173.77 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.94 139.18 52.86 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 125.083 1.489 . . . . 0.0 108.626 162.61 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.18 11.39 13.71 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 103.777 -3.729 . . . . 0.0 103.777 -179.249 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 58.7 mtm-85 -139.5 176.8 8.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-O 123.572 1.653 . . . . 0.0 108.62 176.754 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.4 p -108.46 177.56 4.75 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.542 1.537 . . . . 0.0 112.178 178.089 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.307 85.2 mt -50.36 -55.84 13.93 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 129.667 3.187 . . . . 0.0 110.66 164.079 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.3 m -67.03 -24.56 66.01 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 116.72 2.119 . . . . 0.0 116.72 -173.663 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -57.39 -40.1 77.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 128.833 2.853 . . . . 0.0 112.361 176.639 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.493 ' CG ' HD22 ' A' ' 50' ' ' LEU . 44.4 m-85 -103.82 0.7 30.64 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 126.654 1.982 . . . . 0.0 112.551 -177.469 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.9 m120 81.23 32.71 0.12 Allowed 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 125.038 1.461 . . . . 0.0 113.348 168.262 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.0 mt -95.19 94.97 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 125.856 1.972 . . . . 0.0 106.811 -177.915 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.6 mm-40 -101.76 -158.87 0.7 Allowed 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.005 0.431 . . . . 0.0 111.319 172.923 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -58.7 134.7 57.04 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.284 -2.135 . . . . 0.0 111.684 168.87 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 25.0 tt0 85.11 40.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.061 -1.025 . . . . 0.0 110.058 170.364 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -120.36 137.8 54.08 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.565 1.946 . . . . 0.0 108.215 -179.936 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -120.23 123.47 43.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 115.993 -1.956 . . . . 0.0 108.67 176.739 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.23 160.82 15.06 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -178.209 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -118.66 139.35 51.67 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 125.002 1.439 . . . . 0.0 108.226 176.711 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.332 4.0 tt -125.24 119.71 29.24 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 101.787 -3.412 . . . . 0.0 101.787 -166.764 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.282 20.9 m -111.23 144.25 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 101.74 -3.43 . . . . 0.0 101.74 174.417 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.2 mt -101.52 141.74 33.94 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 109.307 -3.588 . . . . 0.0 107.185 174.792 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.493 3.7 tpt180 71.93 -37.75 0.4 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 118.827 2.899 . . . . 0.0 118.827 174.102 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.331 1.3 pt? -148.47 167.34 25.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 118.74 -2.475 . . . . 0.0 110.687 -164.46 . . . . . . . . 2 2 . 1 . 078 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -96.06 77.78 3.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 126.309 1.844 . . . . 0.0 107.202 -174.812 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -124.08 -128.43 3.31 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.767 1.651 . . . . 0.0 114.275 173.812 . . . . . . . . 1 1 . 1 . 078 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.166 0 N-CA-C 108.745 -1.742 . . . . 0.0 108.745 -168.04 . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 ptt? . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 . . . . . . . . . 0 0 . 1 . 079 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.377 26.7 mt-30 -97.44 124.23 41.57 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -177.665 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.4 160.21 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 127.715 2.406 . . . . 0.0 112.82 170.239 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -113.51 136.47 52.77 Favored 'General case' 0 N--CA 1.452 -0.344 1 O-C-N 112.289 -6.507 . . . . 0.0 114.416 -176.086 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.9 t -111.25 121.64 64.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 128.171 2.588 . . . . 0.0 110.387 164.512 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.9 tttp -100.95 117.0 34.12 Favored 'General case' 0 C--O 1.22 -0.455 0 N-CA-C 101.479 -3.526 . . . . 0.0 101.479 -172.21 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 69.3 p -73.38 155.67 39.12 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 127.977 2.511 . . . . 0.0 111.962 172.542 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.2 tt -58.99 -30.82 68.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 124.855 2.265 . . . . 0.0 115.108 170.914 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 p -75.15 0.76 15.19 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 128.039 2.535 . . . . 0.0 112.881 177.293 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.57 -18.35 25.02 Favored Glycine 0 CA--C 1.526 0.778 1 C-N-CA 131.402 4.334 . . . . 0.0 118.689 166.345 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -94.54 155.05 17.09 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 127.827 2.451 . . . . 0.0 109.907 -160.142 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.3 m -114.04 132.55 55.97 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 124.724 2.202 . . . . 0.0 110.888 -176.182 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.3 mt -120.37 126.59 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 1 O-C-N 116.219 -4.051 . . . . 0.0 106.609 178.357 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.412 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 98.8 m -90.2 128.49 36.39 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -171.065 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -111.97 123.95 51.34 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 116.468 -1.729 . . . . 0.0 106.816 -179.107 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -103.59 101.73 11.59 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 130.524 3.53 . . . . 0.0 110.977 177.797 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.39 166.35 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 1 N-CA-C 99.921 -4.103 . . . . 0.0 99.921 -157.204 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.358 48.7 mm-40 -108.08 167.99 8.52 Favored Pre-proline 0 N--CA 1.448 -0.539 0 CA-C-O 115.576 -2.154 . . . . 0.0 106.3 158.951 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -75.15 -6.48 18.01 Favored 'Trans proline' 0 N--CA 1.449 -1.118 0 CA-C-N 123.32 2.221 . . . . 0.0 110.239 179.031 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 71.6 p -96.32 13.5 27.42 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 131.209 3.804 . . . . 0.0 113.737 177.875 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.81 135.7 38.93 Favored 'General case' 0 C--N 1.32 -0.687 1 C-N-CA 133.299 4.64 . . . . 0.0 102.684 174.036 . . . . . . . . 3 3 . 1 . 079 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -77.24 172.63 12.96 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.039 0.935 . . . . 0.0 110.856 166.915 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.288 1.4 mp -59.29 -42.09 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 125.767 1.627 . . . . 0.0 108.886 163.97 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -65.56 -39.83 92.12 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 125.647 1.842 . . . . 0.0 109.067 -172.909 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -64.45 -40.68 96.18 Favored 'General case' 0 N--CA 1.448 -0.534 0 C-N-CA 125.119 1.368 . . . . 0.0 107.403 177.52 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 t -69.5 -39.96 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 O-C-N 117.752 -3.093 . . . . 0.0 117.872 174.845 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.6 mttt -66.98 -29.51 69.37 Favored 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 118.905 -2.372 . . . . 0.0 114.493 168.724 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.74 -46.08 59.65 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 170.97 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -59.11 -32.0 69.42 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 113.612 -1.631 . . . . 0.0 111.889 173.428 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.8 mt -65.14 -47.45 87.59 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 121.884 2.129 . . . . 0.0 109.37 169.386 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -74.89 -39.09 61.69 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.688 1.595 . . . . 0.0 107.912 -168.886 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.74 -31.15 72.24 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 122.866 2.576 . . . . 0.0 109.203 177.28 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.412 ' NZ ' ' O ' ' A' ' 14' ' ' THR . 82.0 mttt -87.87 -66.94 0.86 Allowed 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 115.355 -2.259 . . . . 0.0 107.927 177.633 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -96.79 -20.6 18.09 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 120.372 1.442 . . . . 0.0 110.568 -156.534 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.73 -19.12 21.72 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 118.366 2.106 . . . . 0.0 118.366 168.718 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 36' ' ' ILE . 28.1 mt -69.14 139.06 89.88 Favored Pre-proline 0 N--CA 1.449 -0.478 0 C-N-CA 127.64 2.376 . . . . 0.0 113.265 -170.573 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -75.06 147.73 34.11 Favored 'Trans proline' 0 N--CA 1.447 -1.259 0 CA-C-O 113.412 -2.828 . . . . 0.0 115.209 -179.778 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -73.32 -45.41 0.43 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.276 3.317 . . . . 0.0 115.066 -158.046 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -68.24 -3.6 11.29 Favored 'General case' 0 N--CA 1.452 -0.354 1 C-N-CA 132.999 4.52 . . . . 0.0 116.641 178.087 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -87.76 -23.57 24.07 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 126.275 2.234 . . . . 0.0 107.728 173.324 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -90.56 115.97 28.1 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.119 -3.488 . . . . 0.0 110.87 -169.289 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -99.51 126.13 45.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 123.473 1.606 . . . . 0.0 107.706 161.8 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 92.2 mt -100.62 110.15 22.27 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 127.798 2.439 . . . . 0.0 110.767 -175.866 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.1 mt -105.03 145.96 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 O-C-N 119.823 -1.798 . . . . 0.0 111.233 -179.211 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -160.46 139.61 10.65 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 126.1 1.76 . . . . 0.0 112.998 165.687 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 57.58 28.49 15.71 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 130.763 3.625 . . . . 0.0 112.246 168.144 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.69 1.49 58.81 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 116.724 -2.153 . . . . 0.0 113.122 176.223 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 mttt -120.94 151.97 39.07 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 131.391 3.877 . . . . 0.0 114.767 176.632 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -94.93 116.65 28.98 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 128.509 3.631 . . . . 0.0 107.398 168.382 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.0 mt -63.92 112.88 3.12 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.293 -2.754 . . . . 0.0 112.401 -178.905 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.272 74.4 tt0 -89.01 147.3 24.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 114.904 -2.475 . . . . 0.0 106.922 -164.619 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -64.92 132.86 50.49 Favored 'General case' 0 C--N 1.326 -0.423 1 O-C-N 130.442 4.839 . . . . 0.0 114.551 175.565 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.06 -9.29 54.66 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 128.196 2.808 . . . . 0.0 117.003 -176.682 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 63.7 mtt-85 -101.83 157.53 16.78 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.383 2.673 . . . . 0.0 108.27 -174.488 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.8 p -102.69 155.41 18.32 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 102.216 -3.254 . . . . 0.0 102.216 173.23 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.6 mt -35.54 -36.44 0.07 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 129.564 3.146 . . . . 0.0 118.619 162.134 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.6 t -64.6 -21.93 66.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 111.564 -2.562 . . . . 0.0 115.791 179.343 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -78.45 -22.88 46.93 Favored 'General case' 0 N--CA 1.453 -0.291 0 O-C-N 120.531 -1.356 . . . . 0.0 111.705 -178.324 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -106.96 -0.83 22.82 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.169 2.188 . . . . 0.0 106.507 -176.262 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 m120 56.28 50.56 13.11 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-O 126.063 2.839 . . . . 0.0 112.816 173.998 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.0 mt -80.15 115.82 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 112.483 -2.144 . . . . 0.0 108.112 -178.613 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -76.57 167.02 22.57 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 165.91 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 36.7 pttt -54.09 143.81 21.28 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 118.633 2.827 . . . . 0.0 118.633 159.57 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 71.8 mt-10 73.89 6.56 4.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 115.318 -2.277 . . . . 0.0 113.367 172.971 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.5 m -66.39 154.96 38.74 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 130.965 3.706 . . . . 0.0 111.272 172.084 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.0 m -114.47 111.72 21.86 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 106.02 -1.845 . . . . 0.0 106.02 -177.342 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 mp -109.43 169.64 8.57 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.905 -2.628 . . . . 0.0 103.905 179.917 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -130.62 141.67 50.44 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 119.708 1.14 . . . . 0.0 109.247 -163.383 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 20.6 tp -114.85 129.47 56.71 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 126.22 2.2 . . . . 0.0 115.661 167.106 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.0 t -132.31 136.15 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 103.212 -2.884 . . . . 0.0 103.212 170.629 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.2 mt -97.97 159.49 14.9 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.097 -171.665 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -153.92 129.84 10.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -174.347 . . . . . . . . 1 1 . 1 . 079 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.21 69.31 1.01 Allowed 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.911 2.885 . . . . 0.0 110.094 -174.483 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.416 ' HG3' ' H ' ' A' ' 75' ' ' GLY . 1.6 ttt180 -131.81 159.32 38.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 101.909 -3.367 . . . . 0.0 101.909 171.472 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.416 ' H ' ' HG3' ' A' ' 74' ' ' ARG . . . -128.45 63.09 0.62 Allowed Glycine 0 CA--C 1.534 1.243 0 C-N-CA 130.365 3.84 . . . . 0.0 111.311 177.43 . . . . . . . . 2 2 . 1 . 079 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 N-CA-C 104.247 -3.541 . . . . 0.0 104.247 177.261 . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.6 ttp . . . . . 0 N--CA 1.471 0.59 0 CA-C-O 115.348 -2.263 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 080 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.28 92.9 mt-30 -108.51 133.53 52.54 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 125.055 3.57 . . . . 0.0 110.559 -171.241 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.3 pt -127.44 174.67 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.792 0 N-CA-C 101.859 -3.386 . . . . 0.0 101.859 155.113 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -117.42 156.52 27.8 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 126.012 1.725 . . . . 0.0 108.693 172.614 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.3 p -128.72 130.06 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 CA-C-N 114.099 -1.41 . . . . 0.0 109.9 157.59 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.0 mttt -90.73 130.13 36.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 112.173 -2.285 . . . . 0.0 111.801 173.567 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 p -98.63 136.86 38.1 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 167.853 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 92.3 mt -64.31 -0.02 1.14 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.268 1.827 . . . . 0.0 114.667 -156.323 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.8 p -86.43 -25.89 25.01 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 129.969 3.308 . . . . 0.0 105.68 -178.805 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.81 3.17 18.45 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.636 1.112 . . . . 0.0 113.889 -178.685 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -79.48 135.13 36.57 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 129.711 3.204 . . . . 0.0 109.42 170.722 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.4 p -123.48 136.25 54.49 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 125.919 1.688 . . . . 0.0 111.229 -170.041 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mt -118.7 113.0 40.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 103.352 -2.832 . . . . 0.0 103.352 179.833 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.5 m -67.86 119.13 12.04 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 162.317 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.267 0.2 OUTLIER -114.62 126.97 55.51 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 -171.126 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -104.56 115.04 29.66 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.223 1.809 . . . . 0.0 109.844 -164.101 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.305 34.1 m -129.82 -177.83 2.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.475 0 C-N-CA 123.914 0.886 . . . . 0.0 112.351 -171.29 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -137.43 163.02 51.66 Favored Pre-proline 0 N--CA 1.45 -0.432 0 CA-C-O 114.831 -2.509 . . . . 0.0 106.786 148.083 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -48.14 -16.86 0.7 Allowed 'Trans proline' 0 N--CA 1.442 -1.531 0 N-CA-C 122.149 3.865 . . . . 0.0 122.149 -176.337 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 57.1 m -88.15 -8.7 55.0 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 114.112 -2.851 . . . . 0.0 113.542 178.697 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.53 121.24 12.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 127.04 2.136 . . . . 0.0 106.558 -175.479 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.7 p -77.17 137.5 38.91 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.075 2.95 . . . . 0.0 107.874 176.274 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.285 1.5 mp -54.79 -30.93 23.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 127.637 2.375 . . . . 0.0 113.61 179.454 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -71.77 -22.49 61.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 121.54 1.973 . . . . 0.0 109.643 174.721 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -86.6 -31.0 21.39 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 115.126 -2.369 . . . . 0.0 105.969 178.987 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.48 -41.5 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 O-C-N 126.291 2.244 . . . . 0.0 106.931 178.129 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' HA ' HD12 ' A' ' 30' ' ' ILE . 27.8 mtmt -56.8 -37.99 71.92 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 115.821 -2.037 . . . . 0.0 113.085 174.16 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.16 -38.57 85.67 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 121.719 2.054 . . . . 0.0 111.461 175.78 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.2 mttt -65.78 -33.77 76.63 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 130.182 3.393 . . . . 0.0 111.933 177.723 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.484 HD12 ' HA ' ' A' ' 27' ' ' LYS . 20.5 mt -71.96 -40.74 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-O 115.315 -2.278 . . . . 0.0 106.25 169.607 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -60.11 -40.43 89.66 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 124.273 3.215 . . . . 0.0 109.694 171.193 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -58.87 -30.44 67.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 128.062 2.545 . . . . 0.0 116.1 179.789 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.7 mmtm -93.75 -57.04 2.68 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 128.743 2.817 . . . . 0.0 111.172 -174.707 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -118.05 -13.1 9.99 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 116.837 2.162 . . . . 0.0 116.837 -164.549 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.14 -11.7 55.42 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 115.339 -2.923 . . . . 0.0 117.111 156.579 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.481 HD12 ' N ' ' A' ' 36' ' ' ILE . 2.5 mp -77.19 123.15 87.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 111.713 -3.994 . . . . 0.0 107.687 -172.377 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -63.48 138.28 64.43 Favored 'Trans proline' 0 N--CA 1.449 -1.142 1 O-C-N 129.198 4.262 . . . . 0.0 111.565 -179.855 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -59.85 -21.91 66.1 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 N-CA-C 120.603 3.27 . . . . 0.0 120.603 -164.724 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.39 -13.36 58.48 Favored 'General case' 0 N--CA 1.444 -0.756 0 O-C-N 124.917 1.385 . . . . 0.0 114.089 -175.304 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -98.11 -7.5 29.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 126.116 1.766 . . . . 0.0 113.768 175.652 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.39 147.86 33.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.519 1.528 . . . . 0.0 112.677 165.897 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.372 35.9 ttm105 -134.83 132.42 38.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 114.511 -2.661 . . . . 0.0 107.685 161.913 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.2 mt -115.37 107.04 14.71 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 128.619 2.768 . . . . 0.0 107.162 -179.118 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 34.0 mt -122.34 144.69 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 1 O-C-N 115.509 -4.494 . . . . 0.0 107.349 171.234 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.465 ' CD1' HD11 ' A' ' 50' ' ' LEU 0.38 0.1 OUTLIER -142.08 110.89 6.21 Favored 'General case' 0 N--CA 1.448 -0.53 1 C-N-CA 132.898 4.479 . . . . 0.0 114.988 167.967 . . . . . . . . 5 4 . 1 . 080 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 69.34 32.44 3.53 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.717 2.807 . . . . 0.0 111.337 177.582 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.43 -19.36 23.98 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 128.35 2.881 . . . . 0.0 116.222 -177.322 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -76.98 117.51 18.65 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.649 2.38 . . . . 0.0 107.996 177.165 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -77.33 122.03 24.56 Favored 'General case' 0 N--CA 1.445 -0.722 1 C-N-CA 133.986 4.914 . . . . 0.0 108.399 175.241 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.465 HD11 ' CD1' ' A' ' 45' ' ' PHE . 6.4 mp -87.1 120.84 28.79 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 126.271 2.232 . . . . 0.0 108.646 -176.922 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.46 151.16 22.63 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 113.752 -1.567 . . . . 0.0 111.516 -156.392 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -66.8 104.0 1.24 Allowed 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 131.01 3.724 . . . . 0.0 108.782 -174.15 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.88 -14.6 26.57 Favored Glycine 0 CA--C 1.537 1.452 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.277 174.211 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -71.09 147.38 48.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 122.787 3.293 . . . . 0.0 106.971 160.451 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 43.5 p -105.91 -178.2 3.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 118.98 -2.325 . . . . 0.0 108.408 -173.951 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.5 mt -66.1 -33.37 75.64 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 113.829 -2.986 . . . . 0.0 108.209 175.286 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.355 21.3 m -72.59 -29.4 63.49 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 127.455 2.972 . . . . 0.0 109.378 -179.105 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -67.22 -34.95 78.56 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 124.96 1.413 . . . . 0.0 113.725 173.573 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 50' ' ' LEU . 55.2 m-85 -97.67 9.38 42.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 127.48 2.312 . . . . 0.0 112.085 -178.704 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.39 74.5 m-20 73.17 13.81 4.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 173.0 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 38.8 mm -91.94 114.98 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 -159.298 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -88.57 168.44 12.56 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 111.67 -2.514 . . . . 0.0 112.183 163.482 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.289 30.5 pttt -29.27 137.79 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 121.345 3.831 . . . . 0.0 121.345 169.867 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.273 4.9 tt0 71.76 4.28 4.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 164.867 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 t -62.2 158.71 16.38 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 118.639 -2.538 . . . . 0.0 112.615 159.986 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.306 15.2 t -129.4 137.18 50.77 Favored 'General case' 0 N--CA 1.454 -0.228 0 O-C-N 129.084 3.99 . . . . 0.0 108.764 -175.129 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -120.62 135.08 55.2 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 121.555 1.98 . . . . 0.0 111.998 -176.131 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -96.55 137.68 35.26 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 115.173 -2.346 . . . . 0.0 110.018 170.536 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.2 pp -117.53 166.33 12.49 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 127.678 3.111 . . . . 0.0 111.212 173.489 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 37.2 t -117.95 147.22 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 O-C-N 127.477 2.985 . . . . 0.0 107.544 165.148 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.42 HD22 HG21 ' A' ' 36' ' ' ILE . 32.1 mt -112.5 123.83 51.17 Favored 'General case' 0 N--CA 1.445 -0.707 1 C-N-CA 134.567 5.147 . . . . 0.0 110.553 170.595 . . . . . . . . 3 3 . 1 . 080 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -91.89 -11.19 37.02 Favored 'General case' 0 N--CA 1.451 -0.414 0 O-C-N 127.583 3.052 . . . . 0.0 111.334 -167.744 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -107.88 117.04 33.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 120.826 1.648 . . . . 0.0 113.972 167.759 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.288 29.1 ttp180 81.02 50.58 0.02 OUTLIER 'General case' 0 N--CA 1.444 -0.775 0 C-N-CA 127.26 2.224 . . . . 0.0 110.212 -174.174 . . . . . . . . 2 2 . 1 . 080 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.8 157.43 17.37 Favored Glycine 0 CA--C 1.533 1.184 0 CA-C-O 126.067 3.037 . . . . 0.0 111.382 174.419 . . . . . . . . 1 1 . 1 . 080 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.364 0 C-N-CA 127.364 2.411 . . . . 0.0 109.667 167.431 . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.5 ttp . . . . . 0 N--CA 1.468 0.43 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 . . . . . . . . . 0 0 . 1 . 081 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -96.18 155.47 16.75 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 119.569 -1.957 . . . . 0.0 106.735 -177.796 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.4 pt -135.84 160.29 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 129.236 3.014 . . . . 0.0 113.127 165.369 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -101.59 151.95 21.38 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 125.534 1.771 . . . . 0.0 108.509 162.338 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 51.5 t -125.7 132.19 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 166.368 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -89.95 119.68 30.53 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 117.862 -3.024 . . . . 0.0 105.593 157.954 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.8 m -100.48 136.34 40.51 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -178.137 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -44.12 -42.53 6.37 Favored 'General case' 0 C--N 1.324 -0.514 1 O-C-N 130.515 4.884 . . . . 0.0 113.53 -174.48 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.1 p -58.72 -12.08 3.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 130.859 3.664 . . . . 0.0 117.095 174.208 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.07 -16.27 10.1 Favored Glycine 0 CA--C 1.527 0.804 1 C-N-CA 130.731 4.015 . . . . 0.0 110.843 176.071 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -80.73 142.07 34.2 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 120.473 2.137 . . . . 0.0 112.117 -165.361 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.6 m -96.91 130.0 44.28 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.105 -1.442 . . . . 0.0 107.105 164.071 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . 0.269 43.9 pt -135.69 153.97 33.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 127.623 2.369 . . . . 0.0 106.289 -177.55 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.256 11.8 t -129.03 133.05 47.57 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 112.657 -3.545 . . . . 0.0 110.632 -177.915 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.2 mp -130.82 151.44 51.24 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 122.74 2.518 . . . . 0.0 111.181 -172.309 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -97.16 117.4 31.27 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 131.338 3.855 . . . . 0.0 106.394 172.882 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.18 171.81 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 1 N-CA-C 100.093 -4.04 . . . . 0.0 100.093 179.714 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -111.36 142.85 27.26 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 131.273 3.829 . . . . 0.0 101.357 159.574 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 57' ' ' SER . 53.6 Cg_endo -63.07 -13.89 38.19 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 124.086 3.19 . . . . 0.0 114.078 174.475 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.0 m -86.38 -7.81 58.16 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 126.962 3.268 . . . . 0.0 112.736 176.939 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -74.5 132.69 42.08 Favored 'General case' 0 N--CA 1.451 -0.405 1 O-C-N 114.552 -5.092 . . . . 0.0 109.361 179.521 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.8 p -63.32 162.87 11.48 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 128.343 2.657 . . . . 0.0 113.695 169.955 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.3 mm -66.14 -36.4 77.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -177.207 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.43 -19.55 64.59 Favored 'General case' 0 N--CA 1.449 -0.504 1 O-C-N 115.003 -4.811 . . . . 0.0 116.972 172.878 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -80.25 -24.44 40.13 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 125.473 1.733 . . . . 0.0 109.579 174.024 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.1 t -73.58 -30.89 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 124.662 1.185 . . . . 0.0 108.755 168.111 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -73.29 -41.11 63.98 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 118.168 -2.833 . . . . 0.0 113.99 175.958 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.9 -47.12 43.48 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 129.985 3.314 . . . . 0.0 113.372 170.162 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -73.76 -30.19 62.65 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 114.823 -2.513 . . . . 0.0 112.54 179.085 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.7 mt -75.36 -39.89 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 O-C-N 125.821 1.95 . . . . 0.0 109.316 168.854 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -50.02 -46.36 52.78 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 128.152 2.581 . . . . 0.0 110.642 174.875 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.254 5.6 t70 -58.51 -44.18 89.38 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.388 1.875 . . . . 0.0 114.571 175.58 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 tppm? -85.85 -51.3 6.49 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 115.91 -1.995 . . . . 0.0 110.25 -176.166 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -99.91 -23.04 15.06 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-O 114.131 -2.842 . . . . 0.0 111.572 -164.58 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.17 -12.98 28.79 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 128.65 3.719 . . . . 0.0 117.696 172.724 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.305 70.8 mt -75.27 132.13 76.86 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 113.715 -3.041 . . . . 0.0 111.067 -163.327 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -65.86 146.1 82.24 Favored 'Trans proline' 0 N--CA 1.441 -1.564 0 O-C-N 126.608 2.899 . . . . 0.0 114.206 173.014 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.56 -34.18 43.22 Favored 'Trans proline' 0 N--CA 1.449 -1.089 0 CA-C-N 120.959 1.378 . . . . 0.0 115.119 176.27 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.308 0.1 OUTLIER -42.19 -37.79 1.56 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 128.054 2.542 . . . . 0.0 113.853 174.793 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -108.88 -8.45 15.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 126.396 1.879 . . . . 0.0 111.915 -171.182 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -104.78 119.03 38.02 Favored 'General case' 0 N--CA 1.452 -0.334 1 C-N-CA 134.203 5.001 . . . . 0.0 113.343 -169.434 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.8 mtp85 -127.38 133.46 50.02 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 117.998 2.592 . . . . 0.0 117.998 177.43 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.274 3.8 mt -104.42 152.4 22.36 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.974 1.71 . . . . 0.0 110.969 -169.302 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 mt -137.04 146.09 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 1 C-N-CA 132.929 4.492 . . . . 0.0 107.324 -169.397 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -152.41 123.8 7.72 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 131.638 3.975 . . . . 0.0 107.918 169.358 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.4 38.05 25.76 Favored 'General case' 0 N--CA 1.445 -0.687 1 C-N-CA 132.355 4.262 . . . . 0.0 112.302 166.507 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.28 -14.89 63.1 Favored Glycine 0 CA--C 1.523 0.573 0 O-C-N 120.149 -1.594 . . . . 0.0 116.925 -179.382 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 74.4 mttt -107.1 125.89 51.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 -171.785 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.92 127.81 32.94 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 169.704 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mt -95.11 137.46 34.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.289 1.859 . . . . 0.0 106.613 -168.683 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -82.21 123.63 29.19 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 109.55 -3.477 . . . . 0.0 105.333 -164.563 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -69.96 112.18 6.18 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 127.726 2.41 . . . . 0.0 106.033 -167.814 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.89 0.04 22.87 Favored Glycine 0 CA--C 1.533 1.204 0 CA-C-O 115.77 -2.683 . . . . 0.0 117.594 -157.722 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.8 mtt-85 -114.16 178.71 4.18 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -179.981 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -125.59 160.42 29.64 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.958 2.503 . . . . 0.0 107.411 -174.264 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.1 mt -63.45 -41.27 98.65 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 179.579 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 42.2 t -53.03 -38.71 62.61 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 120.285 -1.509 . . . . 0.0 110.227 175.575 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.47 -48.5 81.41 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 116.266 -1.826 . . . . 0.0 112.343 -173.171 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -84.95 11.89 8.58 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 121.503 1.956 . . . . 0.0 115.187 172.406 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.36 4.1 t-20 76.84 33.33 0.47 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 123.179 1.466 . . . . 0.0 108.566 160.363 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.2 mt -72.99 120.09 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 118.7 -2.5 . . . . 0.0 111.345 -177.95 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -99.72 172.0 7.54 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 127.225 2.21 . . . . 0.0 111.642 173.414 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -59.69 133.33 55.99 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 127.928 2.491 . . . . 0.0 115.661 179.911 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.285 4.2 tt0 75.19 20.95 1.98 Allowed 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 128.359 2.664 . . . . 0.0 115.772 -175.314 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.9 m -63.5 136.84 57.86 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 131.407 3.883 . . . . 0.0 109.595 165.439 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 83.6 m -101.05 107.0 18.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 124.781 1.301 . . . . 0.0 112.662 169.23 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.94 162.0 20.62 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 126.477 1.911 . . . . 0.0 110.94 172.938 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -135.41 117.06 14.94 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 130.381 3.472 . . . . 0.0 105.755 -168.616 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.9 tp -98.52 140.46 32.73 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 115.456 -2.212 . . . . 0.0 110.925 -174.002 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 17.8 m -136.29 163.71 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 C-N-CA 127.179 2.191 . . . . 0.0 108.657 171.908 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.485 0.7 OUTLIER -144.08 146.15 32.63 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -173.193 . . . . . . . . 3 3 . 1 . 081 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 82.63 -13.12 0.85 Allowed 'General case' 0 N--CA 1.45 -0.473 1 C-N-CA 132.545 4.338 . . . . 0.0 114.589 -179.036 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.486 3.5 pp -149.85 156.86 42.52 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 128.918 2.887 . . . . 0.0 116.137 -170.416 . . . . . . . . 2 2 . 1 . 081 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.4 ttt-85 -78.43 129.01 34.43 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 113.515 -1.675 . . . . 0.0 107.947 157.874 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -118.55 158.87 14.59 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 114.275 -3.514 . . . . 0.0 114.499 155.935 . . . . . . . . 1 1 . 1 . 081 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.91 0 CA-C-N 122.145 2.972 . . . . 0.0 109.533 178.403 . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.469 0.509 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 . . . . . . . . . 0 0 . 1 . 082 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -91.91 145.19 24.74 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 -172.324 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.85 163.54 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 C-N-CA 128.842 2.857 . . . . 0.0 109.147 162.731 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -104.38 151.12 23.87 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 114.638 -2.601 . . . . 0.0 105.002 177.01 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.9 105.15 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 1 C-N-CA 132.69 4.396 . . . . 0.0 104.328 172.272 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -97.91 107.36 19.83 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.312 2.245 . . . . 0.0 111.263 -173.905 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 p -86.11 166.49 15.76 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -168.422 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -86.63 -20.76 27.37 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 115.528 -2.177 . . . . 0.0 115.923 166.905 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.1 p -69.44 -23.76 63.72 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 125.32 1.638 . . . . 0.0 113.321 176.154 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.53 -14.09 5.33 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 119.494 -2.004 . . . . 0.0 115.746 156.145 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -80.6 172.54 13.62 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 120.075 -1.838 . . . . 0.0 112.892 173.556 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.6 m -136.67 132.1 34.49 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 117.544 -3.222 . . . . 0.0 107.2 177.297 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.2 mp -100.22 148.1 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 C-N-CA 125.63 1.572 . . . . 0.0 107.807 172.881 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.2 p -97.22 131.35 44.03 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 128.978 2.911 . . . . 0.0 110.178 165.762 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -124.82 133.6 53.06 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 115.411 -2.233 . . . . 0.0 111.073 -172.527 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -84.23 125.8 32.55 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 101.256 -3.609 . . . . 0.0 101.256 164.837 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.449 HG12 HG22 ' A' ' 26' ' ' VAL . 17.1 m -132.38 147.08 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 176.035 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.254 2.1 tm-20 -97.59 135.8 21.52 Favored Pre-proline 0 N--CA 1.448 -0.526 0 O-C-N 119.274 -2.141 . . . . 0.0 108.608 158.027 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -45.82 -24.81 2.26 Favored 'Trans proline' 0 N--CA 1.443 -1.451 1 C-N-CA 126.817 5.012 . . . . 0.0 116.317 173.951 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 64.5 p -98.29 1.55 47.25 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 129.796 3.238 . . . . 0.0 109.991 177.194 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -72.03 140.46 49.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 121.799 2.09 . . . . 0.0 106.935 167.731 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.0 p -90.58 178.92 5.96 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 118.916 -2.365 . . . . 0.0 108.381 -175.928 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.469 HG23 HD12 ' A' ' 43' ' ' LEU . 11.0 mm -67.24 -33.23 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 120.01 1.277 . . . . 0.0 113.457 179.469 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.69 -37.27 83.5 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.752 2.821 . . . . 0.0 116.672 168.293 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -77.58 -35.44 53.0 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 115.629 -2.129 . . . . 0.0 107.233 -179.722 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.449 HG22 HG12 ' A' ' 17' ' ' VAL . 8.9 t -65.8 -48.52 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 124.856 3.48 . . . . 0.0 111.606 170.992 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -50.99 -49.99 59.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 169.719 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.05 -49.46 41.25 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.946 2.098 . . . . 0.0 114.889 165.157 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -65.14 -25.46 67.76 Favored 'General case' 0 N--CA 1.441 -0.876 0 O-C-N 119.606 -1.934 . . . . 0.0 110.574 -179.864 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.2 mt -80.92 -13.76 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 O-C-N 119.276 -2.14 . . . . 0.0 114.677 175.269 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -76.59 -41.9 44.5 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 118.593 -2.567 . . . . 0.0 110.255 168.034 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -57.72 -43.38 85.2 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 127.248 2.219 . . . . 0.0 112.314 178.903 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.7 mmtm -69.19 -55.03 11.85 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 115.268 -2.301 . . . . 0.0 115.255 174.198 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -122.94 -19.59 6.07 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 125.837 1.96 . . . . 0.0 111.65 -155.638 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.1 9.53 63.55 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 126.282 1.896 . . . . 0.0 111.716 167.679 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.433 ' H ' HG13 ' A' ' 36' ' ' ILE . 2.8 mt -67.52 130.45 93.27 Favored Pre-proline 0 N--CA 1.444 -0.744 0 O-C-N 118.924 -2.515 . . . . 0.0 112.841 171.754 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -79.14 123.17 5.52 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.862 3.041 . . . . 0.0 109.108 -176.467 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.458 17.4 Cg_exo -25.93 -43.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.123 1 C-N-CA 129.736 6.957 . . . . 0.0 121.94 -177.91 . . . . . . . . 3 2 . 1 . 082 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.97 -15.19 63.0 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 113.602 -3.094 . . . . 0.0 113.389 177.403 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -86.71 -15.0 40.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 124.034 3.106 . . . . 0.0 109.673 177.574 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -90.11 153.03 20.85 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -166.753 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -142.32 120.13 11.93 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 121.85 2.114 . . . . 0.0 109.32 170.084 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.469 HD12 HG23 ' A' ' 23' ' ' ILE . 12.4 mt -89.45 144.0 26.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 125.034 3.561 . . . . 0.0 107.27 -178.059 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.8 mm -127.41 153.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 125.69 2.662 . . . . 0.0 106.634 169.522 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.566 ' HB3' HD21 ' A' ' 50' ' ' LEU . 20.2 t80 -150.46 108.67 3.75 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 128.004 2.522 . . . . 0.0 108.985 174.725 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.02 22.21 12.92 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 131.567 3.947 . . . . 0.0 112.207 167.261 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.95 -4.01 25.7 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 119.239 -2.163 . . . . 0.0 116.977 178.409 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.22 143.98 48.85 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 172.225 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -91.89 135.17 34.14 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -172.618 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.566 HD21 ' HB3' ' A' ' 45' ' ' PHE . 5.3 mt -89.99 138.39 31.54 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 120.23 -1.544 . . . . 0.0 108.925 176.733 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -145.58 140.68 27.58 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 105.18 -2.155 . . . . 0.0 105.18 -159.889 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -35.85 128.9 0.65 Allowed 'General case' 0 N--CA 1.452 -0.326 1 C-N-CA 134.633 5.173 . . . . 0.0 113.65 -179.371 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.69 -16.25 23.78 Favored Glycine 0 CA--C 1.527 0.809 0 O-C-N 118.092 -2.88 . . . . 0.0 117.223 167.253 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.334 32.9 mtt85 -100.49 166.77 10.77 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 125.713 2.673 . . . . 0.0 107.065 167.766 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 61.6 p -87.83 167.63 13.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 119.509 -1.994 . . . . 0.0 108.755 173.115 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.306 22.2 mt -59.93 -38.43 82.36 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 172.7 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.7 p -69.03 -27.75 65.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.413 1.885 . . . . 0.0 112.917 -179.254 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -60.53 -44.26 96.26 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 126.581 1.952 . . . . 0.0 108.278 171.803 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -81.4 10.55 5.52 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 128.341 2.656 . . . . 0.0 114.142 175.488 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.268 1.9 t-20 65.87 24.1 11.31 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 172.934 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.6 mt -86.69 132.62 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.788 0 O-C-N 120.194 -1.567 . . . . 0.0 106.941 -173.8 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.5 tp60 -114.05 -179.56 3.67 Favored 'General case' 0 N--CA 1.451 -0.38 0 O-C-N 127.073 2.733 . . . . 0.0 112.121 170.224 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.92 138.24 24.91 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.08 0.952 . . . . 0.0 111.201 175.253 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.303 42.6 mt-10 74.84 13.59 3.41 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 125.349 1.655 . . . . 0.0 109.735 163.603 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.4 m -54.52 157.53 2.86 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 157.252 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.93 105.25 14.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 111.51 -2.586 . . . . 0.0 106.084 177.102 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.2 mp -102.08 138.89 38.43 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 103.815 -2.661 . . . . 0.0 103.815 176.535 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.257 41.4 m80 -95.88 135.77 37.18 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.637 1.575 . . . . 0.0 112.254 175.766 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.23 100.91 10.65 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 179.426 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 87.0 t -96.51 151.91 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 166.031 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 53.5 mt -103.41 148.0 26.43 Favored 'General case' 0 N--CA 1.446 -0.652 1 C-N-CA 135.776 5.631 . . . . 0.0 117.857 174.726 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.4 mtp180 -112.18 -174.74 2.53 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 128.427 2.691 . . . . 0.0 105.767 173.501 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.46 160.69 14.33 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 102.199 -3.26 . . . . 0.0 102.199 160.755 . . . . . . . . 2 2 . 1 . 082 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.325 2.4 ttp180 91.61 130.49 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.528 1 C-N-CA 133.705 4.802 . . . . 0.0 106.114 172.525 . . . . . . . . 3 2 . 1 . 082 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.78 -150.28 21.84 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 127.991 2.71 . . . . 0.0 117.098 179.794 . . . . . . . . 1 1 . 1 . 082 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.923 1 N-CA-C 101.707 -4.557 . . . . 0.0 101.707 -170.894 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.6 ttp . . . . . 0 N--CA 1.469 0.505 0 CA-C-O 115.309 -2.281 . . . . 0.0 106.214 . . . . . . . . . 0 0 . 1 . 083 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -104.53 130.53 52.48 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 122.855 2.57 . . . . 0.0 111.388 -179.933 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.293 20.4 pt -119.22 122.03 68.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 CA-C-O 114.25 -2.786 . . . . 0.0 109.617 165.336 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -73.77 151.97 40.47 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 124.15 3.159 . . . . 0.0 108.434 178.243 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 p -126.44 155.16 36.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 1 O-C-N 129.301 4.126 . . . . 0.0 106.794 161.438 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.25 42.3 tttt -120.63 152.87 37.61 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 128.909 2.884 . . . . 0.0 113.342 169.205 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.432 HG22 HD21 ' A' ' 69' ' ' LEU . 24.3 p -107.23 159.06 16.63 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 130.591 3.556 . . . . 0.0 106.422 -170.573 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 mt -63.64 -19.97 65.31 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.608 1.563 . . . . 0.0 111.895 -179.163 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 66.5 p -85.31 -15.25 43.94 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 176.235 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.63 5.59 41.95 Favored Glycine 0 CA--C 1.539 1.567 0 CA-C-O 113.777 -3.79 . . . . 0.0 114.129 177.695 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -82.58 132.67 35.19 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 121.885 2.843 . . . . 0.0 110.381 176.911 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.6 m -90.0 124.59 34.88 Favored 'General case' 0 C--N 1.325 -0.463 1 C-N-CA 134.339 5.055 . . . . 0.0 104.799 176.227 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -113.59 139.4 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 130.93 3.692 . . . . 0.0 107.809 -179.34 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 52.4 m -96.73 130.66 43.93 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 121.886 2.13 . . . . 0.0 112.128 170.854 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 36.2 mt -107.63 129.54 54.99 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 127.559 2.344 . . . . 0.0 113.004 173.805 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -80.37 118.7 22.24 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 123.69 1.71 . . . . 0.0 108.646 169.983 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.3 m -128.04 156.46 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 O-C-N 117.537 -3.227 . . . . 0.0 115.243 173.882 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -74.61 154.29 87.5 Favored Pre-proline 0 N--CA 1.451 -0.404 0 O-C-N 117.843 -3.036 . . . . 0.0 108.979 162.826 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -76.81 15.84 1.03 Allowed 'Trans proline' 0 N--CA 1.448 -1.195 1 C-N-CA 125.568 4.179 . . . . 0.0 114.543 179.648 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.8 p -131.38 3.16 4.24 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 129.288 3.035 . . . . 0.0 117.786 171.914 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.54 137.93 57.86 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 126.588 2.43 . . . . 0.0 107.941 179.506 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.298 44.6 p -102.56 170.47 8.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 126.957 3.265 . . . . 0.0 107.709 -174.09 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 mm -66.01 -30.72 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 1 O-C-N 114.642 -5.036 . . . . 0.0 115.506 -173.962 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -65.14 -26.25 68.1 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 121.031 1.741 . . . . 0.0 111.648 175.661 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.05 -28.12 29.8 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 127.441 2.296 . . . . 0.0 112.652 176.429 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.8 t -81.58 -29.26 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 122.382 2.355 . . . . 0.0 108.275 178.732 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -51.45 -49.39 61.82 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 127.251 2.22 . . . . 0.0 115.347 160.062 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.11 -46.11 68.52 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 125.677 1.591 . . . . 0.0 108.563 -178.695 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.254 57.2 mttm -52.09 -50.11 62.24 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 172.633 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.335 91.5 mt -54.52 -38.07 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 123.61 1.671 . . . . 0.0 114.992 171.902 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.88 -42.62 94.65 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 117.165 -3.459 . . . . 0.0 111.233 170.846 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -52.45 -42.5 64.22 Favored 'General case' 0 N--CA 1.445 -0.702 1 O-C-N 116.206 -4.059 . . . . 0.0 114.278 172.007 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -90.51 -47.34 7.77 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 -167.538 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -120.15 -15.15 8.75 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 124.803 2.24 . . . . 0.0 113.528 -157.26 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.34 1.42 44.19 Favored Glycine 0 CA--C 1.522 0.518 1 C-N-CA 134.309 5.719 . . . . 0.0 117.352 166.818 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 71.3 mt -88.99 119.98 69.89 Favored Pre-proline 0 N--CA 1.444 -0.745 0 C-N-CA 128.181 2.592 . . . . 0.0 104.667 -153.2 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.3 142.84 55.75 Favored 'Trans proline' 0 N--CA 1.447 -1.229 1 C-N-CA 126.459 4.772 . . . . 0.0 114.659 178.164 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -64.02 -46.78 7.64 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 124.603 3.535 . . . . 0.0 111.267 -177.789 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.439 0.0 OUTLIER -32.95 -40.4 0.05 Allowed 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 118.608 2.818 . . . . 0.0 118.608 167.49 . . . . . . . . 3 3 . 1 . 083 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.302 11.5 mm-40 -101.34 -5.25 25.65 Favored 'General case' 0 N--CA 1.448 -0.556 1 C-N-CA 132.312 4.245 . . . . 0.0 114.626 -161.56 . . . . . . . . 3 2 . 1 . 083 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.9 mt-30 -99.7 157.21 16.64 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.931 2.093 . . . . 0.0 106.929 -178.664 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -142.59 129.13 20.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 130.017 3.327 . . . . 0.0 110.364 160.14 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 32.7 mt -117.04 120.26 37.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 120.357 1.435 . . . . 0.0 107.428 174.784 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.9 mm -106.32 152.75 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 C-N-CA 130.148 3.379 . . . . 0.0 107.801 -177.329 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -152.08 107.16 3.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 130.161 3.384 . . . . 0.0 105.582 178.271 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.439 . . 72.25 23.23 3.35 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 127.887 3.708 . . . . 0.0 117.679 169.383 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.03 -12.75 45.12 Favored Glycine 0 CA--C 1.529 0.958 1 O-C-N 114.574 -5.079 . . . . 0.0 110.086 171.901 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -112.69 142.24 45.53 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 130.559 3.544 . . . . 0.0 111.963 -179.969 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -91.65 141.89 28.21 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 110.473 -3.058 . . . . 0.0 105.218 -175.765 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -88.18 113.91 24.27 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 130.217 3.407 . . . . 0.0 106.824 -175.285 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -103.28 164.66 11.5 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 129.832 3.253 . . . . 0.0 113.346 -169.904 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -68.42 132.03 46.32 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 128.81 3.819 . . . . 0.0 112.745 -177.297 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.8 0.88 58.83 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.694 1.616 . . . . 0.0 112.647 173.769 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.6 mmt85 -88.81 164.53 15.18 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 126.866 2.066 . . . . 0.0 108.678 177.001 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 72.2 p -111.71 161.68 16.03 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 105.85 -1.908 . . . . 0.0 105.85 169.399 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 70.4 mt -55.67 -39.41 70.91 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.675 1.19 . . . . 0.0 110.762 176.538 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.8 m -61.31 -34.1 74.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 116.113 -1.898 . . . . 0.0 115.214 177.885 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -60.85 -38.54 85.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 116.211 -1.852 . . . . 0.0 114.852 172.237 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -97.95 14.68 26.43 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 116.717 -1.611 . . . . 0.0 110.943 173.894 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.363 12.6 p30 74.54 14.95 3.44 Favored 'General case' 0 N--CA 1.439 -0.978 1 C-N-CA 135.111 5.364 . . . . 0.0 114.208 166.608 . . . . . . . . 3 2 . 1 . 083 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.1 mt -72.33 111.57 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 127.181 2.192 . . . . 0.0 109.297 -170.414 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.5 mm-40 -96.57 164.84 12.43 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 127.019 2.699 . . . . 0.0 107.811 -173.18 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -48.26 117.76 2.11 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 130.961 3.704 . . . . 0.0 110.483 179.27 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.722 2.1 mp0 78.01 18.97 1.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 117.898 2.555 . . . . 0.0 117.898 -178.707 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 64.6 m -77.27 154.11 33.28 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 170.466 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.2 m -107.21 129.26 54.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.205 1.802 . . . . 0.0 106.949 173.232 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -99.81 156.1 17.29 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 163.622 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -98.94 149.38 23.02 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 115.496 -2.193 . . . . 0.0 108.352 160.281 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.432 HD21 HG22 ' A' ' 7' ' ' THR . 3.5 pp -97.37 151.89 19.48 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 124.752 1.283 . . . . 0.0 110.866 164.157 . . . . . . . . 2 2 . 1 . 083 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.6 t -142.72 125.35 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -179.203 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 98.6 mt -80.32 173.04 13.0 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 119.795 -1.815 . . . . 0.0 110.249 -176.002 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 ttp-105 -66.95 126.67 29.84 Favored 'General case' 0 C--O 1.221 -0.423 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.956 152.567 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.5 mt -126.85 143.89 51.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 113.502 -1.681 . . . . 0.0 109.626 173.322 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -73.6 145.52 45.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 126.221 1.808 . . . . 0.0 110.351 162.733 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -106.02 13.38 45.09 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 116.435 -2.314 . . . . 0.0 117.018 -157.857 . . . . . . . . 1 1 . 1 . 083 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 O-C-N 126.762 2.095 . . . . 0.0 110.116 -163.009 . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.4 ptt? . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 . . . . . . . . . 0 0 . 1 . 084 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -97.04 144.79 26.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 104.986 -2.228 . . . . 0.0 104.986 -178.201 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 67' ' ' LEU 0.382 0.9 OUTLIER -125.54 157.55 34.76 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 C-N-CA 129.469 3.108 . . . . 0.0 107.158 167.428 . . . . . . . . 4 4 . 1 . 084 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -113.17 139.39 48.8 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 126.739 2.015 . . . . 0.0 105.746 179.757 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 91.9 t -117.25 113.45 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 171.077 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 55.6 tttt -102.16 135.14 44.27 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 173.084 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.6 p -83.48 164.28 19.96 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 118.007 -2.933 . . . . 0.0 112.105 172.394 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.491 HD12 ' HA ' ' A' ' 70' ' ' VAL . 1.2 mt -60.3 -27.75 67.55 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 126.699 2.0 . . . . 0.0 108.67 179.577 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 -14.44 58.93 Favored 'General case' 0 N--CA 1.448 -0.567 1 C-N-CA 134.362 5.065 . . . . 0.0 115.558 176.794 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.8 -9.0 37.19 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 118.736 -2.478 . . . . 0.0 113.047 166.448 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.262 79.0 tttt -89.95 128.25 36.2 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 102.39 -3.189 . . . . 0.0 102.39 -177.106 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.3 m -117.83 120.2 37.19 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 110.857 -2.883 . . . . 0.0 112.116 -174.681 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.5 pt -112.54 155.51 13.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 126.895 3.236 . . . . 0.0 110.337 174.795 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.3 6.8 m -103.1 120.53 40.86 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 119.538 -1.976 . . . . 0.0 107.396 -173.785 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 tp -115.2 126.71 54.89 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 127.259 2.224 . . . . 0.0 109.898 -168.177 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -90.39 114.24 26.31 Favored 'General case' 0 N--CA 1.447 -0.583 0 O-C-N 125.099 1.499 . . . . 0.0 108.29 -176.655 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.47 165.32 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 C-N-CA 126.308 1.843 . . . . 0.0 114.465 179.908 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -125.34 153.15 72.09 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 114.921 -2.466 . . . . 0.0 109.408 165.505 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.17 -30.85 26.78 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 124.449 3.433 . . . . 0.0 117.921 -177.521 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.4 t -75.97 -1.47 25.79 Favored 'General case' 0 N--CA 1.446 -0.652 1 C-N-CA 135.424 5.489 . . . . 0.0 117.707 178.534 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -84.65 137.71 33.11 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 117.246 -3.409 . . . . 0.0 109.023 -175.155 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 61.1 p -84.63 159.14 20.66 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 122.004 2.184 . . . . 0.0 113.528 175.356 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.8 mm -65.76 -21.41 28.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.098 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -62.74 -36.0 81.61 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 130.396 3.479 . . . . 0.0 112.23 174.736 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -73.82 -34.42 64.57 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 125.373 1.671 . . . . 0.0 110.27 175.683 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.1 t -80.72 -42.63 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.83 2.452 . . . . 0.0 111.578 -175.093 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.2 mtmt -53.92 -46.51 71.51 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 121.231 3.789 . . . . 0.0 121.231 161.929 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.76 -43.03 98.51 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 126.883 2.614 . . . . 0.0 113.08 174.48 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -52.02 -39.44 59.49 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 115.022 -2.418 . . . . 0.0 112.73 174.737 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 69.7 mt -57.12 -46.46 84.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 O-C-N 125.456 1.722 . . . . 0.0 109.599 179.292 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -66.61 -45.94 77.5 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.298 1.839 . . . . 0.0 108.777 178.254 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -55.38 -43.49 75.2 Favored 'General case' 0 N--CA 1.447 -0.618 0 O-C-N 117.568 -3.208 . . . . 0.0 115.266 177.065 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.94 -80.74 0.14 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 130.055 3.342 . . . . 0.0 113.937 174.976 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -89.19 -10.17 48.11 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 122.024 2.193 . . . . 0.0 115.069 -170.214 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.71 40.61 37.03 Favored Glycine 0 CA--C 1.538 1.493 0 N-CA-C 119.946 2.738 . . . . 0.0 119.946 -177.753 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.5 mt -119.18 95.82 49.59 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 119.957 -1.908 . . . . 0.0 109.86 178.407 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -69.13 158.03 59.32 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 O-C-N 122.805 0.898 . . . . 0.0 111.735 -177.953 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.292 63.1 Cg_exo -42.09 -34.88 2.94 Favored 'Trans proline' 0 N--CA 1.444 -1.407 1 C-N-CA 126.269 4.646 . . . . 0.0 120.186 176.858 . . . . . . . . 3 2 . 1 . 084 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.97 -35.55 0.54 Allowed 'General case' 0 N--CA 1.444 -0.768 0 C-N-CA 129.488 3.115 . . . . 0.0 112.997 163.942 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -110.08 -7.69 14.89 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.208 1.803 . . . . 0.0 110.851 -170.618 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.253 81.1 mt-30 -100.06 155.09 17.91 Favored 'General case' 0 C--O 1.226 -0.141 0 O-C-N 118.945 -2.347 . . . . 0.0 112.266 179.256 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -150.08 105.61 3.4 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 100.962 -3.718 . . . . 0.0 100.962 169.052 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.44 HD13 HD12 ' A' ' 50' ' ' LEU . 84.1 mt -81.69 72.74 8.74 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 125.565 1.546 . . . . 0.0 109.905 165.301 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.7 tt -71.24 92.95 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 113.517 -1.674 . . . . 0.0 107.226 154.843 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CD1' HD23 ' A' ' 50' ' ' LEU . 29.0 p90 -73.26 -28.71 62.29 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -172.252 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -149.62 -80.93 0.12 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 114.882 -2.485 . . . . 0.0 108.401 175.1 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -115.67 -12.88 9.12 Favored Glycine 0 CA--C 1.524 0.606 0 CA-C-O 115.3 -2.945 . . . . 0.0 110.042 -179.315 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 ttmt -136.28 163.46 30.36 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 121.253 2.526 . . . . 0.0 105.077 -169.478 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -77.02 155.64 32.41 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 120.333 -1.479 . . . . 0.0 113.662 172.14 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.46 HD23 ' CD1' ' A' ' 45' ' ' PHE . 39.8 mt -68.61 152.24 45.63 Favored 'General case' 0 N--CA 1.445 -0.706 0 O-C-N 124.62 1.2 . . . . 0.0 109.793 172.346 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -108.64 129.78 55.33 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 120.811 1.642 . . . . 0.0 109.114 178.791 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -45.59 105.25 0.06 Allowed 'General case' 0 N--CA 1.444 -0.739 1 C-N-CA 132.717 4.407 . . . . 0.0 116.109 166.419 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.51 -3.96 13.5 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 127.659 2.552 . . . . 0.0 116.373 174.961 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 -98.4 158.87 15.32 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 103.286 -2.857 . . . . 0.0 103.286 -177.525 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -111.65 169.65 8.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 110.208 -3.178 . . . . 0.0 103.778 -179.925 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 56' ' ' LEU . 3.5 mp -52.59 -34.32 50.14 Favored 'General case' 0 N--CA 1.445 -0.714 1 C-N-CA 132.111 4.164 . . . . 0.0 112.445 172.0 . . . . . . . . 3 3 . 1 . 084 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.9 m -72.15 -21.24 61.48 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 175.407 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -72.89 -30.62 64.08 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 125.443 1.497 . . . . 0.0 113.713 169.97 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -101.85 2.15 37.88 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.529 1.532 . . . . 0.0 111.164 173.767 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.3 49.1 m-80 67.94 14.55 9.4 Favored 'General case' 0 N--CA 1.445 -0.704 0 O-C-N 117.794 -3.066 . . . . 0.0 118.726 180.0 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.0 mt -65.85 154.27 7.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -163.188 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -128.39 179.16 5.79 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 130.98 3.712 . . . . 0.0 114.319 -170.165 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.7 tttt -65.16 135.43 55.47 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-O 113.818 -2.992 . . . . 0.0 109.725 -177.833 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.351 15.4 mt-10 78.72 0.55 2.5 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 128.515 2.726 . . . . 0.0 113.187 167.904 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.62 141.63 54.58 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 127.936 2.494 . . . . 0.0 112.047 178.656 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 55.1 m -109.81 132.27 54.3 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 -177.412 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.588 HD12 HD13 ' A' ' 3' ' ' ILE . 67.6 mt -114.7 152.34 32.15 Favored 'General case' 0 C--O 1.24 0.556 0 O-C-N 125.61 1.819 . . . . 0.0 108.743 173.738 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.368 15.4 m80 -105.1 149.3 25.97 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.038 2.135 . . . . 0.0 107.092 -168.274 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 10.5 tt -129.9 136.81 49.94 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 121.168 1.804 . . . . 0.0 112.631 169.598 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.491 ' HA ' HD12 ' A' ' 8' ' ' LEU . 73.0 t -124.57 139.07 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 C-N-CA 129.768 3.227 . . . . 0.0 107.72 -176.326 . . . . . . . . 2 2 . 1 . 084 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.6 tp -104.25 119.26 38.57 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 103.331 -2.84 . . . . 0.0 103.331 -158.142 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -67.68 126.87 30.73 Favored 'General case' 0 C--N 1.328 -0.342 0 O-C-N 127.366 2.916 . . . . 0.0 110.847 166.218 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 43.1 tp -107.15 135.38 48.79 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 174.616 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -61.08 150.21 34.67 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 128.605 2.762 . . . . 0.0 110.238 -176.612 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.55 -178.66 15.97 Favored Glycine 0 CA--C 1.541 1.698 0 C-N-CA 125.989 1.757 . . . . 0.0 112.125 -161.964 . . . . . . . . 1 1 . 1 . 084 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.986 0 C-N-CA 129.312 3.339 . . . . 0.0 109.86 -174.054 . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 ttp . . . . . 0 N--CA 1.468 0.45 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 085 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -75.11 132.95 41.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 126.928 2.643 . . . . 0.0 113.644 170.275 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.495 HD13 HG21 ' A' ' 3' ' ' ILE . 4.4 pt -130.54 146.56 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 1 C-N-CA 131.757 4.023 . . . . 0.0 106.917 160.414 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.29 141.53 34.03 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 129.112 2.965 . . . . 0.0 105.733 171.548 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -128.7 126.34 64.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 115.954 -1.974 . . . . 0.0 105.758 163.923 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.0 mttt -84.41 114.15 21.69 Favored 'General case' 0 N--CA 1.447 -0.576 0 O-C-N 127.425 2.953 . . . . 0.0 110.908 174.722 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.6 m -64.13 160.67 17.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 128.5 4.0 . . . . 0.0 111.711 170.657 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -60.46 -12.59 10.02 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 117.274 -3.391 . . . . 0.0 118.571 -176.663 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.7 p -95.04 -8.0 38.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 109.894 -3.321 . . . . 0.0 111.222 175.766 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.82 -20.15 36.97 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 124.072 3.124 . . . . 0.0 112.827 -179.88 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -78.35 141.57 38.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 113.619 -3.086 . . . . 0.0 114.767 -176.219 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.8 p -92.77 132.05 37.3 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 125.926 3.966 . . . . 0.0 116.871 168.8 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 44.9 pt -102.91 129.37 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 114.786 -1.097 . . . . 0.0 112.536 161.005 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.2 m -88.54 129.14 35.54 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 103.452 -2.795 . . . . 0.0 103.452 -175.001 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.7 mt -114.89 131.16 56.95 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 178.624 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.15 98.72 9.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 177.553 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 m -112.98 167.99 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-O 124.662 2.172 . . . . 0.0 113.173 -176.221 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.371 26.4 mm-40 -93.46 149.25 36.95 Favored Pre-proline 0 N--CA 1.449 -0.511 0 O-C-N 118.204 -2.81 . . . . 0.0 105.593 167.104 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.28 15.4 Cg_endo -73.02 -16.03 25.77 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.952 2.434 . . . . 0.0 115.192 -176.61 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 16.2 p -86.61 -5.65 59.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 127.697 2.399 . . . . 0.0 112.07 -179.353 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -75.27 153.83 37.76 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 -173.32 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.8 p -97.34 173.15 7.34 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 117.942 -2.974 . . . . 0.0 110.932 176.219 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.7 mm -85.97 -24.64 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 127.805 2.442 . . . . 0.0 109.121 -164.112 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -68.25 -30.58 69.65 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 129.929 3.292 . . . . 0.0 109.211 174.632 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -86.04 -17.67 34.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 124.319 3.236 . . . . 0.0 113.225 170.422 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 t -70.91 -50.93 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 102.75 -3.056 . . . . 0.0 102.75 168.908 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -74.22 -30.0 61.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 121.101 1.773 . . . . 0.0 108.756 -171.134 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.24 -27.4 67.94 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 117.497 -3.252 . . . . 0.0 115.465 168.317 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -67.02 -38.13 85.4 Favored 'General case' 0 C--N 1.325 -0.494 1 O-C-N 115.862 -4.274 . . . . 0.0 116.733 169.604 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 13.4 mt -74.3 -20.25 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 O-C-N 126.89 2.619 . . . . 0.0 113.173 171.433 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -66.61 -30.77 71.13 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 119.635 -1.915 . . . . 0.0 115.663 154.659 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -83.79 -57.71 3.1 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 121.496 1.953 . . . . 0.0 106.106 -174.765 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.323 64.7 mttm -45.04 -71.47 0.08 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 119.53 3.159 . . . . 0.0 119.53 168.073 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -102.77 -28.52 12.04 Favored 'General case' 0 N--CA 1.448 -0.526 1 CA-C-O 128.901 4.191 . . . . 0.0 115.979 -164.7 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.11 -9.12 50.18 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 118.777 -2.452 . . . . 0.0 118.955 167.211 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 34.4 mm -82.5 124.62 77.62 Favored Pre-proline 0 N--CA 1.447 -0.619 0 C-N-CA 129.347 3.059 . . . . 0.0 104.825 -167.556 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.27 147.05 36.78 Favored 'Trans proline' 0 N--CA 1.443 -1.482 0 C-N-CA 123.822 3.015 . . . . 0.0 112.829 -173.134 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -67.19 -13.19 38.74 Favored 'Trans proline' 0 N--CA 1.442 -1.507 1 C-N-CA 126.953 5.102 . . . . 0.0 114.072 -171.672 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -83.46 -5.7 59.24 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 118.213 -1.395 . . . . 0.0 113.927 173.688 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.431 2.5 tp-100 -108.98 -8.45 15.21 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.266 1.826 . . . . 0.0 111.408 168.885 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -92.91 123.74 36.39 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 126.859 3.219 . . . . 0.0 107.687 179.498 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.354 32.2 mtt180 -126.0 138.77 53.76 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 111.61 -2.541 . . . . 0.0 108.157 172.292 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.405 HD13 HD13 ' A' ' 67' ' ' LEU . 16.5 mt -105.49 150.96 24.85 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 174.176 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.286 68.4 mt -100.53 143.84 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 1 C-N-CA 133.383 4.673 . . . . 0.0 109.685 152.219 . . . . . . . . 3 2 . 1 . 085 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -151.59 119.68 6.28 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 111.025 -2.807 . . . . 0.0 115.055 162.635 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.8 39.07 24.52 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.758 2.423 . . . . 0.0 115.08 176.677 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.43 -10.39 16.88 Favored Glycine 0 CA--C 1.53 0.994 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 163.15 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.0 tttt -134.09 136.23 43.78 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 -159.867 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.359 6.0 tt0 -73.99 130.37 39.72 Favored 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 162.525 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -73.92 133.6 43.09 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -172.787 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -63.22 -39.31 94.26 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 126.585 1.954 . . . . 0.0 112.125 175.182 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.391 24.8 t0 106.38 160.31 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 131.701 4.0 . . . . 0.0 113.419 170.585 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.98 21.94 12.94 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 128.609 3.004 . . . . 0.0 114.518 153.608 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 38.1 mtt180 -113.62 176.37 5.06 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 124.724 2.202 . . . . 0.0 106.666 175.034 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 77.2 p -90.41 154.22 19.83 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.274 -2.141 . . . . 0.0 108.438 172.623 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.346 8.0 mp -41.79 -61.25 1.15 Allowed 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 110.261 -3.154 . . . . 0.0 115.686 175.596 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 27.5 t -45.24 -52.88 9.01 Favored 'General case' 0 N--CA 1.448 -0.536 1 C-N-CA 132.921 4.488 . . . . 0.0 112.601 176.103 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -64.45 -43.66 93.55 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 113.495 -1.684 . . . . 0.0 111.66 178.216 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.75 -14.4 60.71 Favored 'General case' 0 N--CA 1.442 -0.856 0 O-C-N 119.359 -2.088 . . . . 0.0 111.733 -173.402 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.475 0.9 OUTLIER 91.61 24.03 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 130.801 3.641 . . . . 0.0 115.643 179.323 . . . . . . . . 3 3 . 1 . 085 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.7 mt -95.59 115.47 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 119.934 1.243 . . . . 0.0 111.99 176.139 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -116.2 -156.49 0.62 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 125.831 1.652 . . . . 0.0 114.344 -178.876 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -56.28 112.11 1.15 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 127.416 2.286 . . . . 0.0 112.997 178.407 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 76.52 21.96 1.27 Allowed 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 127.065 2.146 . . . . 0.0 108.968 168.461 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 53.7 m -63.68 127.31 30.8 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 117.195 -1.383 . . . . 0.0 108.471 175.297 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.281 13.5 m -90.16 111.61 22.82 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 121.33 1.877 . . . . 0.0 111.687 169.664 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.405 HD13 HD13 ' A' ' 43' ' ' LEU . 31.3 mt -91.87 152.19 20.2 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 124.823 1.249 . . . . 0.0 110.263 166.673 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -107.96 141.25 39.89 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 173.164 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.0 tp -104.35 145.46 30.22 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 -179.556 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.7 m -142.72 153.11 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 C-N-CA 129.146 2.978 . . . . 0.0 107.095 -178.023 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 25.5 mt -97.82 155.41 17.06 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 127.094 2.158 . . . . 0.0 108.393 167.131 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -96.06 79.4 3.21 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 120.896 1.68 . . . . 0.0 108.691 167.89 . . . . . . . . 1 1 . 1 . 085 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.343 12.5 mt -88.68 -33.94 17.39 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 -174.084 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 74' ' ' ARG . 25.8 ttm105 -91.59 -42.81 10.01 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 115.735 -2.386 . . . . 0.0 113.815 -165.795 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.72 -141.19 11.41 Favored Glycine 0 CA--C 1.534 1.28 1 C-N-CA 131.343 4.306 . . . . 0.0 104.401 -158.486 . . . . . . . . 2 2 . 1 . 085 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.322 0 N-CA-C 104.787 -3.325 . . . . 0.0 104.787 165.599 . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.47 0.572 0 CA-C-O 115.401 -2.238 . . . . 0.0 112.661 . . . . . . . . . 0 0 . 1 . 086 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -72.42 152.58 41.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 129.525 3.13 . . . . 0.0 108.926 177.595 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.1 pp -145.29 158.95 13.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 160.63 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -119.22 117.82 29.66 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.463 1.505 . . . . 0.0 108.989 -174.085 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 t -100.88 117.52 46.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 1 N-CA-C 99.253 -4.351 . . . . 0.0 99.253 175.886 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.4 tptt -109.42 136.52 48.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 125.465 1.728 . . . . 0.0 109.624 -171.917 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.4 p -84.97 174.27 9.9 Favored 'General case' 0 N--CA 1.441 -0.892 0 O-C-N 120.125 -1.609 . . . . 0.0 108.969 -177.137 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.5 mt -91.64 0.65 57.48 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 116.84 -1.552 . . . . 0.0 107.085 179.595 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.6 p -107.19 0.89 23.63 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 126.305 1.842 . . . . 0.0 110.481 174.453 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.99 -27.48 8.6 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 115.049 -3.084 . . . . 0.0 111.912 154.625 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.3 mttt -62.6 144.31 56.32 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 129.826 3.898 . . . . 0.0 108.906 179.066 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 91.7 m -118.52 123.0 44.02 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 127.683 3.114 . . . . 0.0 103.791 -169.057 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mt -94.24 134.36 32.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 117.039 -1.457 . . . . 0.0 108.329 174.602 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.6 m -103.07 110.23 22.08 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-O 114.296 -2.764 . . . . 0.0 110.716 177.848 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -107.6 160.37 15.73 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 127.152 2.782 . . . . 0.0 109.648 167.668 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.394 0.0 OUTLIER -127.87 116.06 19.56 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.732 3.213 . . . . 0.0 110.568 -178.017 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.1 m -131.19 162.61 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 O-C-N 117.725 -3.109 . . . . 0.0 106.974 -169.387 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -102.07 154.56 37.28 Favored Pre-proline 0 N--CA 1.441 -0.901 0 O-C-N 118.975 -2.328 . . . . 0.0 106.815 164.638 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.251 67.0 Cg_endo -66.77 -29.32 42.58 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 C-N-CA 124.496 3.464 . . . . 0.0 115.765 175.757 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.256 27.9 p -63.05 -2.28 1.21 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 114.927 -2.463 . . . . 0.0 117.366 160.814 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -70.1 136.14 49.91 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 123.484 2.856 . . . . 0.0 108.542 -175.517 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 p -77.99 170.83 15.94 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.76 2.424 . . . . 0.0 109.128 170.241 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.3 mt -72.66 -46.07 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 104.607 -2.368 . . . . 0.0 104.607 -177.987 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -41.72 -44.1 3.09 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 122.668 2.485 . . . . 0.0 116.024 162.561 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -63.96 -42.97 97.13 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 124.687 1.242 . . . . 0.0 109.87 179.461 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.607 HG21 HD21 ' A' ' 56' ' ' LEU . 35.1 t -79.83 -27.88 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -179.353 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -68.69 -34.07 75.04 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 114.607 -2.616 . . . . 0.0 114.445 167.541 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.35 -26.12 42.15 Favored 'General case' 0 N--CA 1.45 -0.445 1 CA-C-N 126.881 4.401 . . . . 0.0 115.057 169.382 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.2 mttt -71.55 -39.61 70.55 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 124.688 1.242 . . . . 0.0 109.777 172.271 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 28.8 mt -73.36 -37.76 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 O-C-N 116.664 -3.773 . . . . 0.0 113.695 173.406 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -45.49 88.87 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 119.999 1.272 . . . . 0.0 112.623 175.551 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.09 -35.51 69.48 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 127.766 2.426 . . . . 0.0 111.495 -179.612 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 33.4 mmtt -86.73 -39.04 16.36 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 117.817 2.525 . . . . 0.0 117.817 -177.312 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -120.53 -25.31 5.59 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.311 1.844 . . . . 0.0 111.466 -172.259 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.77 -11.97 67.72 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 114.641 -3.311 . . . . 0.0 116.138 -178.682 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.6 mt -64.84 118.52 49.46 Favored Pre-proline 0 N--CA 1.45 -0.456 1 CA-C-N 124.434 4.117 . . . . 0.0 115.678 177.469 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -76.44 141.49 22.67 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 CA-C-N 124.533 2.655 . . . . 0.0 118.035 -173.767 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -30.21 -50.33 0.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.364 0 N-CA-C 121.089 3.457 . . . . 0.0 121.089 177.839 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.93 -40.74 63.83 Favored 'General case' 0 C--N 1.329 -0.318 0 O-C-N 117.446 -3.284 . . . . 0.0 114.591 172.93 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -84.51 -25.79 28.55 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 118.535 -1.266 . . . . 0.0 113.733 -174.376 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -63.81 121.48 14.13 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 128.218 2.607 . . . . 0.0 108.117 171.882 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.422 ' CZ ' ' HD2' ' A' ' 72' ' ' ARG . 65.0 mtt180 -101.54 131.83 47.5 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 123.316 2.78 . . . . 0.0 109.65 147.739 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 36.9 mt -104.95 139.09 40.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 125.846 1.966 . . . . 0.0 108.222 167.72 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.442 HD13 HG21 ' A' ' 44' ' ' ILE . 34.7 mt -129.37 125.93 62.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 110.793 -2.912 . . . . 0.0 108.148 -173.912 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.362 33.1 t80 -149.54 131.18 14.93 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 119.654 1.115 . . . . 0.0 108.908 176.086 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.38 34.51 15.6 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -178.711 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.01 -23.05 5.42 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 119.233 2.453 . . . . 0.0 119.233 -173.05 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -79.2 139.23 38.01 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 127.566 2.568 . . . . 0.0 111.405 -174.724 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -87.67 124.83 33.95 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 164.352 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.95 135.61 33.23 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 126.169 1.788 . . . . 0.0 113.395 -162.175 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -83.4 134.72 34.87 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 116.822 -3.674 . . . . 0.0 113.437 176.643 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.92 141.48 51.14 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 127.523 3.014 . . . . 0.0 111.173 -174.577 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.76 -16.16 26.12 Favored Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 111.725 -2.489 . . . . 0.0 114.141 177.854 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.1 mtt180 -87.25 145.82 26.22 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.886 2.074 . . . . 0.0 112.189 177.037 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 22.8 p -85.69 157.81 20.21 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 126.037 2.086 . . . . 0.0 111.904 179.02 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.607 HD21 HG21 ' A' ' 26' ' ' VAL . 60.2 mt -53.62 -53.97 44.19 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 126.883 2.073 . . . . 0.0 114.464 177.23 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.252 22.1 t -39.68 -35.05 0.28 Allowed 'General case' 0 C--N 1.326 -0.437 1 N-CA-C 122.927 4.417 . . . . 0.0 122.927 165.925 . . . . . . . . 3 2 . 1 . 086 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -70.28 -44.25 68.78 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 128.224 2.61 . . . . 0.0 114.858 176.739 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -94.93 6.28 49.49 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 111.795 -2.457 . . . . 0.0 106.642 -173.286 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.9 t30 86.11 21.39 0.08 Allowed 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 126.482 3.039 . . . . 0.0 113.065 151.976 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.297 82.3 mt -77.84 98.37 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 1 O-C-N 115.782 -4.324 . . . . 0.0 102.542 -178.316 . . . . . . . . 3 2 . 1 . 086 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -82.03 161.88 22.81 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 130.523 3.529 . . . . 0.0 107.51 -179.9 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -49.14 133.69 18.55 Favored 'General case' 0 N--CA 1.446 -0.672 0 O-C-N 126.179 2.174 . . . . 0.0 112.913 176.242 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 65.05 20.92 12.18 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.125 2.97 . . . . 0.0 118.876 169.305 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.9 m -65.97 149.9 49.5 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 112.045 -3.836 . . . . 0.0 115.965 174.518 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.0 m -107.32 128.48 54.48 Favored 'General case' 0 N--CA 1.449 -0.511 0 O-C-N 128.438 3.586 . . . . 0.0 110.265 170.332 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.251 0.7 OUTLIER -144.56 -177.9 5.72 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 127.361 2.264 . . . . 0.0 108.376 -170.771 . . . . . . . . 3 3 . 1 . 086 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.629 2.1 p80 -128.96 167.12 17.9 Favored 'General case' 0 N--CA 1.448 -0.537 1 C-N-CA 134.144 4.977 . . . . 0.0 118.117 177.79 . . . . . . . . 3 2 . 1 . 086 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.4 tp -135.86 126.72 27.54 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 110.6 -3.0 . . . . 0.0 115.713 175.267 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.0 t -99.14 104.77 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 C-N-CA 130.44 3.496 . . . . 0.0 108.346 -179.303 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.2 mp -65.53 78.06 0.07 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 130.958 3.703 . . . . 0.0 108.863 165.528 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.422 ' HD2' ' CZ ' ' A' ' 42' ' ' ARG . 35.2 ttt-85 -74.6 76.04 2.0 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 125.325 3.693 . . . . 0.0 112.767 165.201 . . . . . . . . 2 2 . 1 . 086 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -80.61 12.49 3.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 129.368 3.067 . . . . 0.0 114.365 -177.165 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.2 ttt85 -90.61 133.18 35.3 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 102.094 -3.298 . . . . 0.0 102.094 157.694 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.2 83.13 0.35 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -165.616 . . . . . . . . 1 1 . 1 . 086 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.829 0 CA-C-O 115.168 -3.018 . . . . 0.0 108.113 179.629 . . . . . . . . 0 0 . 1 . 087 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 . . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -73.95 139.16 44.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 116.833 -1.556 . . . . 0.0 112.728 158.913 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -128.75 173.79 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 104.502 -2.407 . . . . 0.0 104.502 167.509 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.19 160.41 37.33 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 125.612 1.82 . . . . 0.0 109.421 179.946 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.541 HG21 HD11 ' A' ' 30' ' ' ILE . 73.9 t -136.37 116.22 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 127.654 2.382 . . . . 0.0 109.256 172.671 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -76.3 130.67 38.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 121.277 1.853 . . . . 0.0 111.196 156.588 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.9 p -100.73 168.17 9.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 116.168 -1.872 . . . . 0.0 114.592 -174.71 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 19.1 mt -58.6 -32.93 69.44 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 127.181 2.192 . . . . 0.0 113.089 -175.87 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -71.57 -22.62 61.71 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.679 1.991 . . . . 0.0 115.363 174.418 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.56 -18.22 13.41 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 128.925 3.155 . . . . 0.0 108.658 -176.793 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.68 148.09 52.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-O 113.839 -2.981 . . . . 0.0 109.111 -172.738 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.3 m -120.52 130.94 54.46 Favored 'General case' 0 N--CA 1.449 -0.516 0 O-C-N 125.853 1.971 . . . . 0.0 112.429 174.966 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.1 mm -103.69 147.65 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 128.591 2.756 . . . . 0.0 105.597 179.471 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 75.3 m -106.84 122.9 47.32 Favored 'General case' 0 N--CA 1.452 -0.337 1 N-CA-C 99.472 -4.27 . . . . 0.0 99.472 174.743 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 mt -123.14 160.69 25.93 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.87 1.668 . . . . 0.0 109.302 173.436 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -114.01 125.91 54.53 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 113.39 -1.732 . . . . 0.0 115.167 166.224 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.42 161.99 13.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 O-C-N 119.613 -1.929 . . . . 0.0 112.135 176.152 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -107.57 160.57 26.17 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 127.456 2.302 . . . . 0.0 107.335 161.304 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_exo -40.38 -42.16 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.891 1 C-N-CA 127.477 5.451 . . . . 0.0 114.815 175.218 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.6 p -77.57 -3.01 38.58 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 117.772 -3.08 . . . . 0.0 117.005 -172.88 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -82.25 123.81 29.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 123.641 1.686 . . . . 0.0 109.841 -178.631 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.3 p -81.71 179.85 7.66 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 129.319 3.048 . . . . 0.0 106.399 -179.403 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.583 HG22 ' HE2' ' A' ' 27' ' ' LYS . 9.2 mm -64.77 -35.89 76.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 115.941 -1.98 . . . . 0.0 109.376 179.325 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -55.24 -47.15 75.82 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 126.458 1.903 . . . . 0.0 114.318 173.771 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -64.81 -34.95 79.57 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 130.899 3.679 . . . . 0.0 109.474 177.236 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.0 t -71.05 -42.5 76.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 126.454 1.902 . . . . 0.0 107.0 177.177 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.583 ' HE2' HG22 ' A' ' 23' ' ' ILE . 45.0 mtmt -73.0 -31.08 64.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 119.24 -2.162 . . . . 0.0 115.61 -178.019 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.29 78.03 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.766 3.226 . . . . 0.0 112.492 170.053 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -74.46 -30.09 61.72 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 176.323 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.541 HD11 HG21 ' A' ' 5' ' ' VAL . 64.7 mt -73.39 -35.96 47.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 128.982 2.913 . . . . 0.0 109.916 -176.957 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -61.94 -42.74 99.45 Favored 'General case' 0 CA--C 1.536 0.435 0 O-C-N 119.133 -2.229 . . . . 0.0 109.515 172.931 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -61.67 -19.28 62.15 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 119.671 3.212 . . . . 0.0 119.671 178.358 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -101.11 -40.36 7.23 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 116.874 -1.536 . . . . 0.0 109.095 172.404 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.328 16.8 tp10 -125.05 -4.68 7.44 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 120.529 -1.357 . . . . 0.0 114.023 -157.616 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.23 9.23 28.64 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 119.176 2.43 . . . . 0.0 119.176 174.762 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 36' ' ' ILE . 7.2 mt -75.89 133.12 73.22 Favored Pre-proline 0 N--CA 1.45 -0.471 0 C-N-CA 130.655 3.582 . . . . 0.0 105.484 174.842 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -69.55 145.67 59.1 Favored 'Trans proline' 0 N--CA 1.445 -1.341 0 CA-C-O 113.926 -2.614 . . . . 0.0 114.285 -175.193 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -66.08 -39.17 19.43 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 123.504 2.803 . . . . 0.0 119.29 -177.469 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.476 ' CG ' HH12 ' A' ' 72' ' ' ARG 0.265 38.4 t70 -48.64 -48.79 39.29 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 130.378 3.471 . . . . 0.0 114.145 179.73 . . . . . . . . 3 3 . 1 . 087 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -72.22 -25.62 61.71 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 131.092 3.757 . . . . 0.0 113.278 173.3 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.84 128.76 35.19 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 123.759 2.981 . . . . 0.0 109.945 -175.014 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.8 mtm180 -109.98 161.8 15.15 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 118.862 -2.399 . . . . 0.0 108.675 165.49 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 67.7 mt -124.81 106.65 10.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 164.111 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mm -92.77 128.65 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 101.008 -3.701 . . . . 0.0 101.008 164.641 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -157.13 117.67 3.56 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 128.29 2.636 . . . . 0.0 110.277 -173.727 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.94 28.74 18.01 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 128.217 2.607 . . . . 0.0 110.652 -172.427 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.23 -25.49 28.05 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 125.413 1.696 . . . . 0.0 109.861 177.678 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 tttt -92.62 135.01 34.45 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 121.988 -0.713 . . . . 0.0 111.227 -162.804 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.67 119.51 14.92 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 115.885 -2.007 . . . . 0.0 109.115 171.824 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.2 mt -81.36 123.82 28.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 -177.953 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -81.29 137.59 35.78 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 120.457 -1.402 . . . . 0.0 110.365 -175.414 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.73 114.71 5.21 Favored 'General case' 0 N--CA 1.442 -0.838 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.486 169.747 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 139.24 -21.32 2.95 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 130.327 3.822 . . . . 0.0 112.752 177.932 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.5 mtp85 -97.31 155.67 16.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 -176.861 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 42.0 p -94.74 171.05 9.02 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.364 1.866 . . . . 0.0 108.09 177.619 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.13 -47.24 77.79 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.962 1.305 . . . . 0.0 111.41 176.085 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.5 p -44.89 -40.26 6.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 118.591 2.812 . . . . 0.0 118.591 159.863 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -61.57 -34.17 75.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 124.218 1.961 . . . . 0.0 116.133 168.654 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -89.94 11.16 21.28 Favored 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 119.033 -2.292 . . . . 0.0 115.927 168.813 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.451 8.5 p30 54.36 46.6 24.74 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 124.442 2.067 . . . . 0.0 111.662 177.515 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.6 mt -103.85 108.25 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 128.662 2.785 . . . . 0.0 109.158 173.599 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.1 mm-40 -105.27 169.28 8.54 Favored 'General case' 0 C--N 1.325 -0.482 1 O-C-N 130.147 4.654 . . . . 0.0 112.749 -173.875 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.325 51.7 tttm -12.52 107.0 0.02 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 129.372 3.069 . . . . 0.0 117.446 168.969 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 76.49 17.87 1.85 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 129.386 3.074 . . . . 0.0 115.013 168.694 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 67.7 m -67.93 139.12 56.42 Favored 'General case' 0 CA--C 1.532 0.283 1 O-C-N 115.567 -4.458 . . . . 0.0 113.512 171.109 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.1 m -98.08 112.06 24.15 Favored 'General case' 0 N--CA 1.449 -0.48 1 C-N-CA 133.641 4.776 . . . . 0.0 103.579 178.137 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.4 mt -87.09 161.51 18.08 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 128.824 2.85 . . . . 0.0 109.538 169.21 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -123.15 118.7 28.26 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 130.12 3.368 . . . . 0.0 111.348 -172.73 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.1 tp -89.77 111.09 21.99 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 116.32 -1.8 . . . . 0.0 114.649 -166.167 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.3 t -107.95 165.48 4.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 125.142 1.526 . . . . 0.0 107.875 -179.539 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 tp -112.37 162.59 15.39 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.921 1.688 . . . . 0.0 109.045 -176.469 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.476 HH12 ' CG ' ' A' ' 39' ' ' ASP . 51.0 ttp180 -85.51 124.16 31.76 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 127.139 2.176 . . . . 0.0 108.078 178.602 . . . . . . . . 2 2 . 1 . 087 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -94.97 163.2 13.42 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.885 2.874 . . . . 0.0 106.991 172.327 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.374 5.1 ptp180 -147.33 152.59 38.47 Favored 'General case' 0 N--CA 1.452 -0.335 1 C-N-CA 132.664 4.385 . . . . 0.0 109.991 -176.78 . . . . . . . . 3 2 . 1 . 087 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.62 -116.18 2.4 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 103.916 -3.674 . . . . 0.0 103.916 154.488 . . . . . . . . 1 1 . 1 . 087 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.698 0 C-N-CA 129.002 3.191 . . . . 0.0 109.502 -176.604 . . . . . . . . 0 0 . 1 . 088 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.467 0.417 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 . . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -72.19 134.78 45.87 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 126.299 1.84 . . . . 0.0 112.864 171.592 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.5 pt -147.04 141.04 20.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.489 2.316 . . . . 0.0 107.958 168.935 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -84.04 151.28 25.07 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 119.125 -2.234 . . . . 0.0 107.54 -179.223 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.6 t -110.88 129.39 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 O-C-N 117.733 -3.104 . . . . 0.0 104.33 160.61 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -109.07 120.36 42.31 Favored 'General case' 0 N--CA 1.45 -0.433 1 O-C-N 116.268 -4.02 . . . . 0.0 101.406 167.707 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -85.95 126.79 34.37 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 158.547 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.307 6.0 mp -88.83 -12.65 41.35 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 125.318 1.636 . . . . 0.0 108.88 -167.686 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.5 p -90.33 -14.02 33.98 Favored 'General case' 0 N--CA 1.442 -0.869 1 O-C-N 115.919 -4.238 . . . . 0.0 113.198 164.281 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -127.64 -104.89 1.28 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.319 1.914 . . . . 0.0 108.532 -156.0 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.7 pttt -159.67 151.73 20.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 117.85 -3.147 . . . . 0.0 108.884 -159.071 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.4 p -70.96 127.19 31.73 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 112.553 -2.112 . . . . 0.0 110.222 161.336 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mt -117.98 137.6 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 C-N-CA 131.324 3.85 . . . . 0.0 102.779 -175.386 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.3 p -92.51 112.55 24.54 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.227 -1.351 . . . . 0.0 107.662 173.935 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -111.35 171.74 7.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 174.533 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -141.8 127.36 18.98 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 103.147 -2.908 . . . . 0.0 103.147 -175.823 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.2 m -132.8 177.78 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 O-C-N 119.295 -2.128 . . . . 0.0 111.833 177.666 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -97.27 143.18 25.71 Favored Pre-proline 0 N--CA 1.448 -0.561 0 C-N-CA 125.581 1.552 . . . . 0.0 109.605 178.611 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -63.73 -24.34 68.96 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 CA-C-O 115.727 -1.864 . . . . 0.0 115.44 172.911 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 27.3 p -99.75 10.45 41.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 130.016 3.326 . . . . 0.0 114.132 -178.398 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.71 145.97 48.48 Favored 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 125.764 1.915 . . . . 0.0 107.187 -179.339 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.1 p -91.94 150.63 20.92 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 115.582 -2.151 . . . . 0.0 113.677 164.809 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.8 mm -54.46 -34.07 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 CA-C-N 123.868 3.031 . . . . 0.0 116.49 -176.172 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -57.33 -39.54 76.1 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 124.53 3.332 . . . . 0.0 115.963 172.974 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 t30 -83.16 -26.17 31.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 126.897 2.079 . . . . 0.0 115.675 175.4 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.287 99.3 t -50.47 -52.69 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 O-C-N 119.007 -2.308 . . . . 0.0 115.109 157.712 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -60.41 -34.48 74.0 Favored 'General case' 0 N--CA 1.45 -0.463 0 O-C-N 126.46 2.35 . . . . 0.0 115.444 174.691 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.43 -50.1 63.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 131.311 3.844 . . . . 0.0 113.04 165.561 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.289 49.1 mttp -59.33 -41.28 88.74 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 125.662 1.585 . . . . 0.0 111.592 -178.784 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.296 18.0 mt -78.22 -23.15 13.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 127.597 2.359 . . . . 0.0 110.996 -176.939 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.81 -43.16 59.67 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 165.444 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.296 25.8 t70 -69.08 -36.96 78.19 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 125.735 2.683 . . . . 0.0 116.675 -178.416 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.63 -36.8 65.48 Favored 'General case' 0 CA--C 1.536 0.433 1 O-C-N 113.395 -5.816 . . . . 0.0 115.982 177.296 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mm-40 -128.98 -10.43 4.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 117.372 2.36 . . . . 0.0 117.372 -168.189 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.22 10.39 77.97 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 129.794 3.569 . . . . 0.0 112.97 179.804 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.9 mt -81.92 129.1 66.0 Favored Pre-proline 0 N--CA 1.443 -0.814 1 CA-C-N 124.701 4.251 . . . . 0.0 110.288 -166.426 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.02 144.58 64.48 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 123.491 2.794 . . . . 0.0 118.084 -170.887 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -74.62 -30.06 8.26 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.411 2.741 . . . . 0.0 117.735 -168.978 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -70.89 -17.15 62.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 122.266 1.031 . . . . 0.0 110.196 172.446 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -102.85 -8.76 20.48 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 117.869 -3.02 . . . . 0.0 113.398 -171.683 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -83.33 135.39 34.74 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 122.074 2.215 . . . . 0.0 107.876 -178.764 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -120.05 112.73 19.5 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 119.414 -2.054 . . . . 0.0 107.585 148.306 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.6 mt -84.84 147.1 26.98 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 126.128 2.142 . . . . 0.0 109.393 170.37 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 68' ' ' HIS 0.296 0.0 OUTLIER -143.36 131.99 19.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 115.45 -2.214 . . . . 0.0 111.79 -174.288 . . . . . . . . 4 4 . 1 . 088 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -137.16 121.74 18.45 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 102.726 -3.065 . . . . 0.0 102.726 175.393 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 79.56 2.39 2.21 Favored 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 127.768 3.167 . . . . 0.0 113.719 165.671 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.75 -17.87 20.13 Favored Glycine 0 CA--C 1.526 0.764 0 O-C-N 118.07 -2.894 . . . . 0.0 108.519 -174.622 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -85.82 109.56 18.77 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.167 2.187 . . . . 0.0 108.955 179.993 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.7 119.87 13.15 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.027 -1.897 . . . . 0.0 111.042 166.83 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.3 mt -91.16 116.92 29.19 Favored 'General case' 0 N--CA 1.446 -0.633 0 O-C-N 117.935 -2.978 . . . . 0.0 106.361 -151.222 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -92.84 145.98 23.99 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 123.252 1.501 . . . . 0.0 107.045 -166.642 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.24 145.19 43.82 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 112.375 -2.193 . . . . 0.0 107.67 171.131 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.38 -26.03 25.0 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 126.783 2.135 . . . . 0.0 112.635 175.169 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -96.49 168.61 10.44 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.552 2.341 . . . . 0.0 114.955 179.2 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.7 p -119.14 176.72 5.17 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 112.792 -2.003 . . . . 0.0 112.256 -166.752 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.2 mt -77.21 -28.98 54.01 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 112.687 -2.051 . . . . 0.0 109.905 -179.782 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.2 t -76.21 -25.76 55.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 115.128 -2.368 . . . . 0.0 110.03 177.76 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -59.78 -61.66 2.45 Favored 'General case' 0 N--CA 1.443 -0.825 0 C-N-CA 131.058 3.743 . . . . 0.0 105.41 176.622 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -89.67 -7.28 54.99 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 128.341 2.656 . . . . 0.0 111.908 -169.596 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.384 2.3 t-20 86.03 31.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 128.226 2.61 . . . . 0.0 111.954 166.01 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.252 5.4 mt -80.24 107.99 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 126.247 1.819 . . . . 0.0 111.002 -174.744 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.4 mm-40 -100.7 -179.86 4.2 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 127.215 2.822 . . . . 0.0 112.731 179.13 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.0 tttm -61.86 129.93 43.28 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 129.712 3.205 . . . . 0.0 112.391 -176.135 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.535 1.1 tt0 79.2 4.59 2.27 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 159.764 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.9 p -57.12 157.58 5.92 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 127.512 3.007 . . . . 0.0 115.893 158.423 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 13.0 m -102.77 126.56 49.94 Favored 'General case' 0 N--CA 1.446 -0.635 0 O-C-N 119.821 -1.8 . . . . 0.0 111.952 156.27 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.6 mp -91.26 146.69 23.61 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 120.721 -1.237 . . . . 0.0 107.705 160.173 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.409 ' HB2' HG23 ' A' ' 44' ' ' ILE . 30.6 m170 -94.66 145.93 24.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 117.108 -1.425 . . . . 0.0 108.188 177.73 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.13 122.02 40.09 Favored 'General case' 0 C--N 1.322 -0.589 1 C-N-CA 132.547 4.339 . . . . 0.0 104.908 177.544 . . . . . . . . 3 3 . 1 . 088 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.326 2.8 m -121.11 115.61 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 109.074 -3.694 . . . . 0.0 101.427 -178.274 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.1 mt -77.69 119.3 21.03 Favored 'General case' 0 N--CA 1.451 -0.378 1 O-C-N 115.94 -4.225 . . . . 0.0 113.4 -174.844 . . . . . . . . 2 2 . 1 . 088 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 33.1 ttt-85 -81.19 74.78 8.18 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 119.993 -1.692 . . . . 0.0 107.564 176.652 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.5 mt -78.45 -31.03 47.82 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 -169.19 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -106.09 -22.35 12.89 Favored 'General case' 0 N--CA 1.445 -0.697 0 O-C-N 127.828 3.205 . . . . 0.0 107.246 -171.838 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.71 42.26 2.17 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 115.578 -2.79 . . . . 0.0 112.721 -172.762 . . . . . . . . 1 1 . 1 . 088 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.331 0 O-C-N 125.164 1.155 . . . . 0.0 112.93 179.873 . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 ttp . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 101.511 -3.514 . . . . 0.0 101.511 . . . . . . . . . 0 0 . 1 . 089 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -89.63 150.91 22.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.857 1.263 . . . . 0.0 110.432 161.676 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.294 47.4 pt -135.13 175.06 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 C-N-CA 129.778 3.231 . . . . 0.0 109.978 163.264 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.417 ' HE1' ' HG1' ' A' ' 14' ' ' THR 0.291 97.9 m-85 -116.38 126.17 53.1 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.101 2.96 . . . . 0.0 110.93 163.732 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.19 140.34 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 104.186 -2.524 . . . . 0.0 104.186 151.807 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -118.97 146.73 44.76 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 126.85 2.594 . . . . 0.0 105.54 167.564 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 42.2 p -98.65 161.21 13.78 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.49 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 87.9 mt -50.6 -29.64 11.38 Favored 'General case' 0 C--N 1.321 -0.668 0 O-C-N 118.892 -2.38 . . . . 0.0 116.09 -175.223 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.2 p -104.77 9.47 34.93 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.544 2.737 . . . . 0.0 108.749 -162.909 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.85 -23.68 30.38 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 119.605 -1.934 . . . . 0.0 116.231 164.981 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -69.76 126.2 29.0 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 125.753 1.502 . . . . 0.0 108.503 -179.939 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 p -106.47 150.73 25.79 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 126.304 1.841 . . . . 0.0 108.654 175.658 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 31.7 pt -129.75 131.67 66.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 1 C-N-CA 133.477 4.711 . . . . 0.0 113.8 168.999 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.417 ' HG1' ' HE1' ' A' ' 4' ' ' PHE . 2.6 m -87.95 118.58 27.59 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 126.854 2.061 . . . . 0.0 106.875 177.893 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -106.63 134.2 50.14 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 129.183 2.993 . . . . 0.0 112.164 178.796 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.66 138.24 36.12 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.533 1.933 . . . . 0.0 113.171 172.419 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.306 7.0 m -157.16 142.99 9.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-O 117.295 -1.336 . . . . 0.0 107.625 -163.229 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -91.96 148.01 36.05 Favored Pre-proline 0 C--O 1.221 -0.401 0 C-N-CA 124.783 1.233 . . . . 0.0 110.814 -178.296 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 31.8 Cg_exo -47.06 -0.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.434 1 N-CA-C 122.616 4.045 . . . . 0.0 122.616 170.627 . . . . . . . . 3 2 . 1 . 089 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 68.2 p -134.32 16.24 3.75 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 118.782 -2.449 . . . . 0.0 111.715 -174.154 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -85.93 150.79 24.26 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 -179.53 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -102.34 149.98 23.79 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 128.457 2.703 . . . . 0.0 106.369 177.509 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mp -49.65 -27.25 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 127.605 2.362 . . . . 0.0 114.546 177.269 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -50.42 -44.31 55.14 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.882 2.073 . . . . 0.0 115.103 161.376 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -62.1 -42.1 98.87 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 128.425 2.69 . . . . 0.0 110.891 177.735 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 26' ' ' VAL . 2.0 t -58.81 -38.45 72.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 176.936 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -66.51 -40.44 89.22 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 128.484 2.714 . . . . 0.0 114.25 175.246 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 31' ' ' GLN . . . -68.65 -40.06 80.41 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 117.739 -1.124 . . . . 0.0 110.714 176.03 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.437 25.1 mttt -53.82 -45.58 70.87 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 118.024 2.601 . . . . 0.0 118.024 175.538 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.279 50.8 mt -52.67 -49.4 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 CA-C-O 117.019 -1.467 . . . . 0.0 112.686 170.565 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.468 ' HB3' ' O ' ' A' ' 28' ' ' ALA . 0.5 OUTLIER -42.87 -55.21 3.8 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 129.36 3.064 . . . . 0.0 111.578 167.32 . . . . . . . . 3 3 . 1 . 089 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -73.98 -29.86 62.2 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 117.002 -1.475 . . . . 0.0 111.134 -171.651 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -83.66 -47.56 11.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 120.697 1.589 . . . . 0.0 112.267 172.107 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -116.41 -20.66 9.6 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 115.575 -2.155 . . . . 0.0 113.829 -159.154 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.15 0.24 25.32 Favored Glycine 0 CA--C 1.532 1.144 0 O-C-N 125.135 1.522 . . . . 0.0 115.152 172.599 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 93.0 mt -96.26 136.68 21.86 Favored Pre-proline 0 N--CA 1.45 -0.429 0 O-C-N 126.573 1.984 . . . . 0.0 109.607 -160.365 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -89.31 142.19 4.3 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 CA-C-N 124.726 2.723 . . . . 0.0 111.471 -163.422 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -52.07 -45.77 36.83 Favored 'Trans proline' 0 N--CA 1.452 -0.95 1 C-N-CA 126.607 4.871 . . . . 0.0 114.778 -177.95 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -48.49 -23.3 0.92 Allowed 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 130.13 3.372 . . . . 0.0 115.774 171.271 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -120.93 14.15 11.51 Favored 'General case' 0 N--CA 1.449 -0.476 0 O-C-N 127.504 3.002 . . . . 0.0 112.941 -176.171 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 72.8 mt-30 -102.86 162.39 12.97 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 104.967 -2.235 . . . . 0.0 104.967 169.891 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.3 ttp-105 -144.52 131.88 20.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 131.209 3.804 . . . . 0.0 105.637 162.74 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.1 mt -111.25 134.76 52.6 Favored 'General case' 0 N--CA 1.444 -0.759 1 O-C-N 115.85 -4.281 . . . . 0.0 110.241 -174.747 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.251 41.7 mt -126.8 149.52 31.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 O-C-N 118.293 -2.755 . . . . 0.0 108.841 179.201 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -112.9 -44.11 3.34 Favored 'General case' 0 C--N 1.325 -0.48 1 C-N-CA 132.031 4.132 . . . . 0.0 111.118 161.374 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.09 -103.98 0.29 Allowed 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 103.91 -2.626 . . . . 0.0 103.91 -175.685 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -130.48 -32.55 0.52 Allowed Glycine 0 CA--C 1.529 0.909 0 N-CA-C 118.254 2.062 . . . . 0.0 118.254 -150.196 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.7 mttt -93.14 -178.91 4.92 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 130.125 3.37 . . . . 0.0 112.56 153.394 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -97.12 151.96 19.26 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.651 1.58 . . . . 0.0 109.725 177.475 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.23 135.74 40.99 Favored 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 126.34 1.856 . . . . 0.0 109.365 -177.2 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -77.58 112.65 14.6 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.033 -2.917 . . . . 0.0 109.448 169.16 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.92 -19.84 46.28 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 129.982 3.313 . . . . 0.0 119.132 -165.788 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.56 14.43 35.52 Favored Glycine 0 CA--C 1.539 1.568 0 C-N-CA 126.789 2.138 . . . . 0.0 110.05 -177.482 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -90.85 166.57 13.0 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 124.349 2.023 . . . . 0.0 108.496 157.51 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.8 p -90.53 166.02 13.45 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 113.663 -1.608 . . . . 0.0 113.687 173.758 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.409 11.8 mt -45.08 -31.86 1.53 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 129.086 2.955 . . . . 0.0 118.371 163.994 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.7 p -93.05 -11.66 32.5 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 119.474 -2.016 . . . . 0.0 111.183 179.143 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -90.59 -4.95 56.48 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 114.838 -2.506 . . . . 0.0 109.257 177.603 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -118.7 -10.01 10.09 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 117.861 2.541 . . . . 0.0 117.861 166.555 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t30 87.0 40.36 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 O-C-N 119.479 -2.013 . . . . 0.0 111.334 171.973 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.5 mm -87.55 106.95 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-N 113.088 -1.869 . . . . 0.0 108.103 175.514 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 -87.03 179.88 6.6 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 131.337 3.855 . . . . 0.0 106.532 -172.939 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.3 51.2 pttt -58.4 136.54 57.47 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 116.307 1.966 . . . . 0.0 116.307 166.794 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 58.9 26.74 15.28 Favored 'General case' 0 N--CA 1.45 -0.472 1 C-N-CA 133.506 4.722 . . . . 0.0 112.344 169.03 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.4 m -73.8 149.96 41.35 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 129.96 3.304 . . . . 0.0 113.587 -176.844 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.7 m -98.45 119.29 36.91 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 105.814 -1.921 . . . . 0.0 105.814 178.26 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mp -100.23 154.19 18.66 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.397 152.735 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.3 m-70 -116.1 119.61 36.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 125.794 1.638 . . . . 0.0 107.896 -172.167 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.262 52.2 tp -98.94 122.79 42.65 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 124.118 1.913 . . . . 0.0 113.158 -179.112 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.9 t -83.88 145.06 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 126.513 1.925 . . . . 0.0 110.107 161.52 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.26 136.37 41.62 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 127.982 2.513 . . . . 0.0 110.651 172.898 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.2 mtm105 -101.84 24.83 9.36 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.962 -1.472 . . . . 0.0 110.335 -175.83 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.67 79.07 1.24 Allowed 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 119.392 -2.067 . . . . 0.0 105.491 177.049 . . . . . . . . 2 2 . 1 . 089 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -153.2 -52.95 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 115.837 1.792 . . . . 0.0 115.837 -174.293 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.83 44.14 0.21 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 128.173 2.797 . . . . 0.0 111.369 173.384 . . . . . . . . 1 1 . 1 . 089 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.428 0 CA-C-O 115.956 -2.58 . . . . 0.0 109.452 -158.946 . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.47 0.555 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 . . . . . . . . . 0 0 . 1 . 090 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -83.24 139.63 32.99 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 129.512 3.125 . . . . 0.0 105.162 -175.747 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 14' ' ' THR 0.266 30.0 pt -141.53 149.33 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 C-N-CA 127.124 2.17 . . . . 0.0 111.968 -176.37 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -89.13 146.43 24.81 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 118.24 -0.886 . . . . 0.0 111.224 164.036 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG21 HD12 ' A' ' 15' ' ' LEU . 2.7 t -127.76 118.09 48.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 O-C-N 126.838 2.586 . . . . 0.0 106.133 169.656 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -94.83 116.81 29.18 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 105.213 -2.143 . . . . 0.0 105.213 -177.993 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.2 p -70.75 164.9 24.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 124.441 2.067 . . . . 0.0 112.955 174.982 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.25 -37.82 60.84 Favored 'General case' 0 N--CA 1.438 -1.044 0 O-C-N 120.528 -1.358 . . . . 0.0 112.094 -177.45 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.9 p -54.56 -29.86 52.38 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 130.993 3.717 . . . . 0.0 116.242 161.844 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.68 -19.77 5.84 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 119.677 -1.889 . . . . 0.0 113.146 161.843 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -73.5 136.57 44.14 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 127.965 2.506 . . . . 0.0 111.024 175.059 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.3 m -112.32 130.11 56.06 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 125.265 1.603 . . . . 0.0 110.019 178.273 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.416 HD13 ' HG3' ' A' ' 34' ' ' GLU . 9.3 pt -110.9 177.61 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 CA-C-N 112.376 -2.193 . . . . 0.0 108.592 -178.513 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 3' ' ' ILE . 5.2 t -140.83 141.64 34.68 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.404 1.881 . . . . 0.0 107.077 170.36 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.471 HD12 HG21 ' A' ' 5' ' ' VAL . 22.6 mt -129.11 159.02 37.32 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.647 2.779 . . . . 0.0 107.051 177.754 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -91.58 138.12 31.82 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 157.31 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 m -127.01 175.76 8.39 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.502 0 CA-C-N 122.416 2.371 . . . . 0.0 107.448 170.113 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.3 mm-40 -111.87 156.68 41.31 Favored Pre-proline 0 N--CA 1.449 -0.484 0 N-CA-C 106.198 -1.778 . . . . 0.0 106.198 162.146 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -58.65 -28.17 85.35 Favored 'Trans proline' 0 N--CA 1.444 -1.412 1 C-N-CA 126.186 4.591 . . . . 0.0 120.538 173.042 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.3 t -98.1 21.92 10.14 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 124.939 1.399 . . . . 0.0 112.321 173.97 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.83 153.86 38.54 Favored 'General case' 0 N--CA 1.453 -0.32 1 O-C-N 115.085 -4.759 . . . . 0.0 108.089 174.319 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.293 86.7 m -100.24 157.81 16.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 127.27 2.228 . . . . 0.0 108.272 168.823 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.1 mm -58.47 -9.58 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 119.261 3.06 . . . . 0.0 119.261 -178.835 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -87.46 -4.72 59.0 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 118.832 -2.417 . . . . 0.0 113.136 -178.422 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -91.78 -34.63 14.51 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 112.717 -2.038 . . . . 0.0 111.717 164.977 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.26 -51.52 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 O-C-N 119.638 -1.914 . . . . 0.0 108.625 179.773 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -51.05 -56.14 14.05 Favored 'General case' 0 N--CA 1.446 -0.64 0 O-C-N 128.921 3.888 . . . . 0.0 113.075 -178.532 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.97 80.21 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 128.269 2.628 . . . . 0.0 117.034 176.738 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.6 mttt -68.44 -40.52 81.11 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 173.044 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.357 75.8 mt -47.65 -49.29 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 C-N-CA 128.811 2.844 . . . . 0.0 112.692 160.665 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -63.61 -45.89 88.26 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.61 2.364 . . . . 0.0 112.556 -179.259 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.51 -64.6 0.79 Allowed 'General case' 0 C--O 1.238 0.46 1 C-N-CA 132.487 4.315 . . . . 0.0 107.222 173.167 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -63.51 -57.03 11.48 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 128.094 3.371 . . . . 0.0 118.22 -174.254 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' HG3' HD13 ' A' ' 13' ' ' ILE 0.279 22.2 mm-40 -111.94 -2.07 15.26 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.176 2.19 . . . . 0.0 113.741 -168.173 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.85 -19.41 41.3 Favored Glycine 0 CA--C 1.529 0.918 0 O-C-N 117.543 -3.223 . . . . 0.0 113.132 160.635 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.3 mt -83.56 127.3 68.6 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 117.962 -3.081 . . . . 0.0 112.506 -157.483 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.22 133.85 31.93 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 CA-C-N 123.885 2.423 . . . . 0.0 113.112 168.653 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.337 17.9 Cg_endo -58.94 -30.31 92.84 Favored 'Trans proline' 0 N--CA 1.452 -0.959 1 C-N-CA 127.691 5.594 . . . . 0.0 117.211 -171.255 . . . . . . . . 3 2 . 1 . 090 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.286 26.6 t70 -76.3 -26.47 55.88 Favored 'General case' 0 N--CA 1.446 -0.666 0 O-C-N 119.967 -1.708 . . . . 0.0 111.327 -163.728 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -73.14 -7.84 53.13 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 118.82 2.896 . . . . 0.0 118.82 172.033 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.446 ' HB3' HD12 ' A' ' 71' ' ' LEU 0.455 1.2 pp0? -132.63 162.22 31.89 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.964 1.364 . . . . 0.0 113.428 -179.532 . . . . . . . . 3 3 . 1 . 090 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -126.0 148.89 49.17 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 128.573 2.749 . . . . 0.0 111.512 171.343 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.9 mt -99.37 118.73 36.66 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 128.802 2.841 . . . . 0.0 105.475 -178.357 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.1 mm -107.71 144.66 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 128.613 2.765 . . . . 0.0 104.922 179.18 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -141.82 132.57 25.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 125.221 1.576 . . . . 0.0 108.506 162.087 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.07 22.77 0.15 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 129.891 3.276 . . . . 0.0 114.644 -177.216 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.44 -7.07 36.62 Favored Glycine 0 CA--C 1.526 0.777 0 O-C-N 119.398 -2.064 . . . . 0.0 112.948 177.398 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -113.29 141.01 47.52 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 121.564 -0.962 . . . . 0.0 113.298 -168.033 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -63.61 137.01 57.94 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 126.667 2.479 . . . . 0.0 115.565 171.975 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.9 mt -105.54 108.53 20.1 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.673 3.189 . . . . 0.0 106.679 179.716 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -91.61 166.45 12.81 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 120.567 1.531 . . . . 0.0 112.38 -168.608 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -74.31 129.19 37.33 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 128.371 2.668 . . . . 0.0 107.803 171.107 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.93 -20.19 29.3 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 130.009 3.671 . . . . 0.0 114.933 165.086 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 -89.45 153.08 21.11 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 128.077 2.551 . . . . 0.0 106.404 179.753 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.1 p -104.18 142.19 34.95 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 129.163 2.985 . . . . 0.0 111.276 -169.642 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.28 -55.35 25.33 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 126.906 2.628 . . . . 0.0 117.342 -170.042 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.331 41.2 t -65.0 -18.94 65.73 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 118.335 -2.728 . . . . 0.0 110.255 -172.913 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -78.69 -22.41 46.73 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 131.377 3.871 . . . . 0.0 115.817 171.333 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -81.37 -10.07 59.61 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.985 1.714 . . . . 0.0 113.14 163.665 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.349 58.8 t30 80.32 47.69 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 131.546 3.938 . . . . 0.0 108.349 173.882 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.415 HD13 HD21 ' A' ' 67' ' ' LEU . 14.3 mt -104.76 146.52 11.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 C-N-CA 125.814 1.646 . . . . 0.0 107.357 171.652 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -139.52 -158.86 0.9 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 129.663 3.185 . . . . 0.0 112.656 -179.175 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -79.11 135.34 36.81 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.873 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 70.69 30.31 3.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 129.509 3.124 . . . . 0.0 106.506 177.979 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.1 m -74.46 149.9 40.14 Favored 'General case' 0 N--CA 1.45 -0.43 0 O-C-N 117.858 -3.026 . . . . 0.0 106.347 160.403 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.8 m -113.21 101.01 9.02 Favored 'General case' 0 N--CA 1.444 -0.734 1 C-N-CA 133.336 4.655 . . . . 0.0 101.481 179.166 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.415 HD21 HD13 ' A' ' 61' ' ' ILE . 7.8 mp -92.92 157.08 16.53 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 118.847 -2.408 . . . . 0.0 106.311 166.374 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -123.47 148.58 46.06 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 116.486 -1.721 . . . . 0.0 106.693 -175.644 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 9.2 tt -103.02 139.35 38.69 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 103.155 -2.905 . . . . 0.0 103.155 177.096 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.351 29.1 m -134.27 137.73 51.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 1 C-N-CA 132.77 4.428 . . . . 0.0 112.479 175.782 . . . . . . . . 3 2 . 1 . 090 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.446 HD12 ' HB3' ' A' ' 41' ' ' GLN . 10.6 mp -104.37 145.89 29.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 116.824 -1.56 . . . . 0.0 108.371 168.368 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 61.17 -34.36 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 1 N-CA-C 122.182 4.142 . . . . 0.0 122.182 173.466 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -76.61 152.83 35.74 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 129.77 3.228 . . . . 0.0 114.45 -171.274 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.279 44.6 ttt-85 -123.07 134.87 54.23 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 103.11 -2.922 . . . . 0.0 103.11 -176.303 . . . . . . . . 2 2 . 1 . 090 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -111.95 72.49 0.21 Allowed Glycine 0 N--CA 1.441 -1.014 0 CA-C-O 126.149 3.083 . . . . 0.0 108.753 166.87 . . . . . . . . 1 1 . 1 . 090 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.285 0 C-N-CA 127.683 2.564 . . . . 0.0 109.789 -161.63 . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.4 ptt? . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 . . . . . . . . . 0 0 . 1 . 091 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -80.02 146.19 32.11 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 124.933 1.396 . . . . 0.0 110.529 -174.23 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.515 HD12 HD13 ' A' ' 67' ' ' LEU 0.418 2.4 pt -142.63 128.77 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 130.385 3.474 . . . . 0.0 108.974 175.642 . . . . . . . . 3 3 . 1 . 091 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.259 62.1 m-85 -98.78 67.13 1.68 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 131.21 3.804 . . . . 0.0 110.57 -159.463 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.267 24.2 t -62.96 113.71 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.772 2 O-C-N 115.669 -4.395 . . . . 0.0 108.651 174.721 . . . . . . . . 3 2 . 1 . 091 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.273 11.8 tppt? -102.45 139.93 37.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 101.987 -3.338 . . . . 0.0 101.987 -170.868 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 23.9 p -106.84 169.88 8.27 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 124.219 0.949 . . . . 0.0 109.04 167.741 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -73.25 -41.45 63.68 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 118.825 -2.422 . . . . 0.0 110.345 167.386 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.292 52.7 p -50.84 -34.25 27.08 Favored 'General case' 0 N--CA 1.448 -0.549 1 C-N-CA 131.796 4.039 . . . . 0.0 116.526 174.991 . . . . . . . . 3 2 . 1 . 091 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.66 27.48 3.28 Favored Glycine 0 CA--C 1.536 1.381 0 C-N-CA 128.958 3.171 . . . . 0.0 116.482 157.613 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.383 56.7 mttt -100.5 128.69 46.48 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 104.625 -2.361 . . . . 0.0 104.625 167.775 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 82.2 m -89.28 101.95 14.62 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 103.287 -2.857 . . . . 0.0 103.287 166.285 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.9 mm -53.75 -48.69 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-O 116.44 -1.743 . . . . 0.0 115.076 -177.052 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.6 m 74.4 50.42 0.1 Allowed 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 129.459 3.103 . . . . 0.0 108.265 176.45 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 tp -75.65 126.86 31.84 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -169.598 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 -81.16 115.43 20.57 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-O 125.171 2.415 . . . . 0.0 110.854 163.171 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.4 m -108.9 162.17 6.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 1 C-N-CA 132.679 4.392 . . . . 0.0 113.387 176.853 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -116.07 155.38 48.11 Favored Pre-proline 0 N--CA 1.449 -0.513 0 CA-C-N 113.86 -1.518 . . . . 0.0 110.98 166.215 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -78.37 -3.63 13.54 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 O-C-N 117.228 -2.038 . . . . 0.0 112.647 -172.923 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 p -81.66 -14.78 56.21 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 126.845 2.058 . . . . 0.0 111.694 167.426 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -65.33 122.67 17.67 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.234 2.214 . . . . 0.0 106.918 -179.818 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.8 p -85.65 158.09 20.17 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 172.918 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.407 21.8 mm -43.19 -43.6 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 O-C-N 118.069 -2.894 . . . . 0.0 113.941 177.438 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -62.13 -37.09 83.84 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 125.301 2.476 . . . . 0.0 114.52 176.642 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -77.58 -34.95 53.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 113.085 -1.871 . . . . 0.0 109.971 -179.671 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.353 41.0 t -59.48 -44.47 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 118.037 -2.914 . . . . 0.0 108.078 168.829 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -64.71 -38.83 92.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 O-C-N 119.318 -2.114 . . . . 0.0 113.458 -177.506 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.56 -51.68 66.26 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 127.136 2.174 . . . . 0.0 113.016 166.569 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -60.15 -26.24 66.14 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 127.929 2.492 . . . . 0.0 113.9 172.602 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.8 mt -86.97 -42.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 120.979 1.718 . . . . 0.0 111.084 171.29 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.44 -24.76 61.08 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.16 1.784 . . . . 0.0 111.797 -175.78 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -52.98 -53.89 43.23 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 130.079 3.352 . . . . 0.0 110.184 165.52 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -85.46 -48.51 8.91 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 115.855 -2.021 . . . . 0.0 110.503 -170.973 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -110.18 -19.13 13.13 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 128.46 2.704 . . . . 0.0 115.202 -162.409 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.94 -10.57 73.68 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 121.789 3.476 . . . . 0.0 121.789 162.308 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.1 mm -65.57 121.13 73.59 Favored Pre-proline 0 N--CA 1.442 -0.839 0 C-N-CA 129.893 3.277 . . . . 0.0 110.384 -163.201 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -63.45 141.89 82.75 Favored 'Trans proline' 0 N--CA 1.452 -0.931 1 C-N-CA 126.152 4.568 . . . . 0.0 113.969 179.596 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.263 50.0 Cg_exo -48.47 -41.65 36.09 Favored 'Trans proline' 0 N--CA 1.448 -1.162 1 C-N-CA 127.759 5.639 . . . . 0.0 117.458 -170.524 . . . . . . . . 3 2 . 1 . 091 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.76 -30.97 40.9 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 128.524 2.73 . . . . 0.0 107.709 179.908 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -72.12 -3.38 22.85 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.347 2.259 . . . . 0.0 116.233 173.374 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -120.55 122.77 41.32 Favored 'General case' 0 N--CA 1.446 -0.659 1 C-N-CA 133.736 4.814 . . . . 0.0 110.826 -173.492 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 35.6 mtt180 -134.82 137.61 43.48 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 128.324 2.65 . . . . 0.0 105.654 175.431 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 17.9 mt -112.63 112.63 24.29 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 128.129 2.572 . . . . 0.0 108.314 -174.308 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.9 mt -98.53 139.52 20.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 176.45 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . 0.362 59.1 t80 -144.78 92.5 2.29 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 129.693 3.197 . . . . 0.0 109.777 -166.246 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.28 24.79 2.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 121.415 3.857 . . . . 0.0 121.415 176.277 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.58 -12.73 46.99 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 128.293 2.854 . . . . 0.0 114.57 -173.017 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.282 38.9 ttmt -120.07 139.55 52.38 Favored 'General case' 0 N--CA 1.444 -0.755 0 O-C-N 126.206 1.768 . . . . 0.0 109.995 -163.698 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.288 24.3 mt-30 -80.96 130.94 35.27 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.727 2.011 . . . . 0.0 106.315 170.99 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.2 mt -84.5 136.52 33.78 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 112.57 -2.105 . . . . 0.0 106.65 177.891 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -78.33 144.05 36.4 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 125.743 2.687 . . . . 0.0 106.988 -171.487 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -87.52 145.83 26.07 Favored 'General case' 0 N--CA 1.444 -0.74 0 O-C-N 118.072 -2.892 . . . . 0.0 110.004 -166.629 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.23 -21.56 37.2 Favored Glycine 0 CA--C 1.536 1.362 0 CA-C-O 124.173 1.985 . . . . 0.0 113.909 -175.002 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 48.6 mmm-85 -89.7 -177.08 5.18 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 103.982 -2.599 . . . . 0.0 103.982 -162.451 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.4 p -107.47 168.07 9.49 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 113.442 -1.708 . . . . 0.0 112.96 171.737 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 20.3 mt -70.74 -24.4 62.61 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 128.568 2.747 . . . . 0.0 109.381 165.831 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.2 m -75.54 -15.22 60.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 113.165 -1.834 . . . . 0.0 112.995 177.137 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.35 -36.53 71.54 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 126.348 1.859 . . . . 0.0 111.27 -177.065 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -100.18 -9.77 22.13 Favored 'General case' 0 N--CA 1.442 -0.857 1 C-N-CA 135.133 5.373 . . . . 0.0 110.692 -176.97 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.487 13.6 t30 82.86 18.25 0.28 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 119.685 3.217 . . . . 0.0 119.685 177.291 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.0 mt -72.16 121.53 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.329 1.851 . . . . 0.0 107.193 -172.786 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -122.58 177.69 5.32 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 128.697 2.799 . . . . 0.0 112.027 170.734 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.7 pttt -46.11 136.9 6.42 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 130.732 3.613 . . . . 0.0 111.075 -164.462 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.434 2.8 tt0 85.41 15.69 0.15 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 113.935 -2.936 . . . . 0.0 114.558 170.416 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.2 t -93.58 133.5 36.84 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 130.589 3.555 . . . . 0.0 110.76 -179.573 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.4 p -92.89 135.69 33.91 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 174.526 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.515 HD13 HD12 ' A' ' 3' ' ' ILE . 6.1 mp -115.51 -176.24 2.88 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 164.756 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -138.6 139.75 38.71 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 128.025 2.53 . . . . 0.0 107.014 179.269 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 8.1 tt -111.35 123.39 50.12 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 124.466 1.104 . . . . 0.0 108.341 -174.676 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.2 m -124.5 137.44 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.9 -1.046 . . . . 0.0 112.472 -179.112 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.259 5.0 mt -88.65 160.42 17.39 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 102.687 -3.079 . . . . 0.0 102.687 -172.613 . . . . . . . . 2 2 . 1 . 091 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.2 ttt-85 -72.63 -42.75 64.1 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-O 124.239 1.971 . . . . 0.0 107.195 -165.993 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -82.86 114.93 21.5 Favored 'General case' 0 N--CA 1.446 -0.661 0 O-C-N 118.299 -2.751 . . . . 0.0 112.403 178.105 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 21.4 mtp-105 -73.35 153.5 40.47 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 -171.506 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 108.44 -157.19 15.39 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 106.61 -2.596 . . . . 0.0 106.61 170.312 . . . . . . . . 1 1 . 1 . 091 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.349 1 C-N-CA 131.535 4.398 . . . . 0.0 110.707 -176.397 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.471 0.591 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 092 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.6 tm0? -105.89 140.74 38.45 Favored 'General case' 0 C--N 1.329 -0.31 0 O-C-N 119.206 -2.183 . . . . 0.0 110.025 -160.046 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 40.8 pt -139.67 160.67 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 C-N-CA 128.167 2.587 . . . . 0.0 108.596 178.517 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -108.93 159.45 16.8 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 126.468 1.907 . . . . 0.0 106.296 175.578 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.92 150.69 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 158.513 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -87.26 149.76 24.35 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.966 2.906 . . . . 0.0 114.568 155.89 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.256 9.0 t -138.24 151.93 48.12 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.959 1.304 . . . . 0.0 108.315 173.171 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.282 4.8 tp -70.44 0.04 7.41 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 127.98 2.512 . . . . 0.0 116.191 -163.679 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.0 p -85.43 -20.07 30.36 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 118.418 -2.676 . . . . 0.0 109.738 165.61 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.63 -6.21 26.18 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 129.082 3.229 . . . . 0.0 117.804 176.884 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.82 157.46 27.68 Favored 'General case' 0 C--O 1.235 0.318 1 O-C-N 132.577 5.516 . . . . 0.0 111.812 179.269 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.554 36.1 p -123.35 107.21 11.39 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 129.04 2.936 . . . . 0.0 114.088 -177.351 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.9 mt -104.99 136.21 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 130.042 3.337 . . . . 0.0 108.127 -171.128 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 t -108.25 121.34 44.69 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 129.865 3.266 . . . . 0.0 106.516 -178.621 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -110.95 156.02 21.82 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 129.003 2.921 . . . . 0.0 110.736 -176.15 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.7 tp10 -118.61 116.75 27.27 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 130.831 3.653 . . . . 0.0 108.562 174.683 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.4 m -136.81 166.55 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 131.198 3.799 . . . . 0.0 110.323 -169.944 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -125.44 159.62 59.39 Favored Pre-proline 0 C--N 1.322 -0.629 0 O-C-N 118.907 -2.371 . . . . 0.0 105.993 161.828 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.42 -46.03 28.15 Favored 'Trans proline' 0 N--CA 1.452 -0.943 1 C-N-CA 125.353 4.036 . . . . 0.0 118.759 175.5 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.8 p -69.77 1.74 4.02 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 176.884 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -72.71 134.62 45.11 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 116.104 -1.903 . . . . 0.0 114.838 179.533 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.4 p -83.37 148.75 27.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 123.687 2.949 . . . . 0.0 112.467 -179.406 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.9 mm -50.01 -37.27 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 C-N-CA 126.258 1.823 . . . . 0.0 113.826 178.356 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -58.18 -39.48 79.02 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 121.201 1.819 . . . . 0.0 114.258 170.221 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.8 t30 -68.78 -36.46 78.33 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 126.821 2.576 . . . . 0.0 109.777 172.611 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.1 t -63.03 -57.18 13.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 121.383 1.902 . . . . 0.0 106.723 173.107 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.294 86.7 mttt -38.55 -40.65 0.6 Allowed 'General case' 0 C--O 1.22 -0.456 0 C-N-CA 130.495 3.518 . . . . 0.0 116.809 171.661 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.48 -20.64 33.62 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 112.188 -2.278 . . . . 0.0 111.28 -175.006 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 mtmt -87.58 -14.21 40.77 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 124.942 1.297 . . . . 0.0 109.777 176.881 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.31 -51.79 22.19 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.373 0 C-N-CA 126.418 1.887 . . . . 0.0 107.904 162.407 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -65.4 -25.64 67.64 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 131.107 3.763 . . . . 0.0 109.567 -175.928 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.4 -46.1 62.74 Favored 'General case' 0 CA--C 1.533 0.307 1 C-N-CA 132.103 4.161 . . . . 0.0 113.514 170.023 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -114.16 -32.17 6.09 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 127.556 3.035 . . . . 0.0 114.798 -174.309 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -91.91 -33.28 14.96 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -179.291 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.18 11.32 64.96 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-O 113.583 -3.898 . . . . 0.0 113.398 171.375 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -92.15 139.31 24.25 Favored Pre-proline 0 N--CA 1.445 -0.703 0 N-CA-C 100.975 -3.713 . . . . 0.0 100.975 -172.046 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -80.93 160.39 21.09 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 120.67 0.914 . . . . 0.0 112.552 -173.787 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.26 56.7 Cg_endo -57.9 -40.89 74.55 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 N-CA-C 117.895 2.229 . . . . 0.0 117.895 -170.868 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.92 -11.07 60.59 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -175.141 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 mt-30 -93.68 -17.43 23.24 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 116.948 2.203 . . . . 0.0 116.948 172.265 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -89.39 143.13 27.06 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 123.21 1.481 . . . . 0.0 109.09 -174.644 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.26 96.29 2.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 103.534 -2.765 . . . . 0.0 103.534 -171.551 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.4 mt -100.76 131.57 46.59 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 115.779 -2.058 . . . . 0.0 107.463 -169.389 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 2.4 mt -136.48 145.21 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 129.762 3.225 . . . . 0.0 110.689 -174.424 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -128.47 -169.03 2.0 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 129.887 3.275 . . . . 0.0 110.291 179.456 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -50.59 49.07 0.0 OUTLIER 'General case' 0 N--CA 1.449 -0.481 2 C-N-CA 132.558 4.343 . . . . 0.0 121.941 -177.055 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.11 -12.97 19.55 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 127.305 2.383 . . . . 0.0 109.063 -179.403 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.403 85.4 mttt -109.29 126.41 53.33 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 127.346 2.258 . . . . 0.0 116.171 -176.62 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -85.19 129.53 34.79 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 130.36 3.464 . . . . 0.0 106.512 167.867 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.423 HD11 HD22 ' A' ' 67' ' ' LEU . 69.6 mt -107.19 127.76 53.81 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 111.799 -3.953 . . . . 0.0 106.165 -162.349 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -104.21 137.0 42.77 Favored 'General case' 0 C--N 1.324 -0.52 1 O-C-N 130.847 5.092 . . . . 0.0 110.54 -173.084 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.344 1.2 m-20 -27.91 -45.9 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.408 2 N-CA-C 123.723 4.712 . . . . 0.0 123.723 173.983 . . . . . . . . 3 2 . 1 . 092 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.84 33.94 4.56 Favored Glycine 0 CA--C 1.526 0.737 0 O-C-N 117.545 -3.222 . . . . 0.0 111.681 -169.828 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -122.03 162.82 20.47 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.841 2.857 . . . . 0.0 105.595 165.169 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.0 p -85.17 158.24 20.43 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 127.553 2.341 . . . . 0.0 114.762 178.069 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.4 mt -57.76 -28.36 63.88 Favored 'General case' 0 C--N 1.326 -0.447 1 O-C-N 114.569 -5.082 . . . . 0.0 114.963 165.269 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.412 0.2 OUTLIER -61.16 -39.63 90.82 Favored 'General case' 0 N--CA 1.448 -0.546 1 C-N-CA 132.125 4.17 . . . . 0.0 113.848 163.87 . . . . . . . . 4 3 . 1 . 092 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -69.43 -11.12 60.56 Favored 'General case' 0 N--CA 1.445 -0.709 0 O-C-N 118.269 -2.77 . . . . 0.0 111.434 170.796 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -110.41 5.92 21.83 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 114.149 -2.834 . . . . 0.0 114.753 164.105 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.347 3.9 p-10 34.76 58.27 0.71 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 129.182 2.993 . . . . 0.0 112.732 -171.113 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.1 mm -67.56 131.62 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 C-N-CA 131.674 3.99 . . . . 0.0 111.967 174.986 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.388 26.9 mt-30 -102.6 152.46 21.15 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 127.266 2.226 . . . . 0.0 108.098 -179.678 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -48.97 150.62 1.48 Allowed 'General case' 0 C--N 1.325 -0.492 1 O-C-N 115.444 -4.535 . . . . 0.0 116.247 176.132 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.319 7.6 tt0 70.84 8.56 6.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 128.768 2.827 . . . . 0.0 116.237 176.495 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 66.4 m -63.31 138.69 58.62 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.682 1.593 . . . . 0.0 108.531 178.248 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.268 16.6 m -103.82 138.84 39.86 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 118.567 -2.583 . . . . 0.0 104.741 165.316 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.423 HD22 HD11 ' A' ' 50' ' ' LEU . 68.6 mt -95.78 148.1 22.94 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 130.404 3.482 . . . . 0.0 105.506 175.609 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -88.68 125.7 34.96 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 117.075 -3.516 . . . . 0.0 110.767 168.401 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 5.7 tt -121.02 133.4 55.26 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 118.359 -2.713 . . . . 0.0 104.978 -171.609 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 26.7 m -132.34 -173.92 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 C-N-CA 124.918 1.287 . . . . 0.0 112.48 163.583 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.3 tp -85.12 144.24 28.33 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.839 -1.528 . . . . 0.0 108.912 168.819 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.4 ttt85 -78.18 115.87 18.22 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 120.226 -1.546 . . . . 0.0 110.842 166.802 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.4 mt -107.23 88.13 2.66 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 112.572 -2.104 . . . . 0.0 106.448 176.463 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.355 30.2 ttt85 78.81 -82.74 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 112.239 -3.743 . . . . 0.0 113.885 -173.824 . . . . . . . . 2 2 . 1 . 092 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -130.0 155.33 20.94 Favored Glycine 0 CA--C 1.522 0.517 0 O-C-N 127.869 3.23 . . . . 0.0 109.525 -166.67 . . . . . . . . 1 1 . 1 . 092 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 1 C-N-CA 130.866 4.079 . . . . 0.0 107.139 175.344 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.6 ttp . . . . . 0 CA--C 1.537 0.472 1 N-CA-C 99.49 -4.263 . . . . 0.0 99.49 . . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -96.99 137.44 36.07 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 123.786 2.993 . . . . 0.0 107.226 164.794 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 11.0 pt -107.49 170.3 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 129.817 3.247 . . . . 0.0 110.74 161.21 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -116.9 156.82 26.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 118.305 -2.747 . . . . 0.0 106.704 152.326 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -116.81 133.79 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 1 C-N-CA 132.517 4.327 . . . . 0.0 102.722 156.713 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.0 tttt -122.36 122.83 39.95 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 -179.848 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 99.9 m -83.77 124.82 31.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.874 -1.899 . . . . 0.0 105.874 160.284 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.264 0.0 OUTLIER -63.2 -8.69 8.68 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 119.596 3.184 . . . . 0.0 119.596 -162.839 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.2 p -84.85 -3.6 58.74 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.349 2.26 . . . . 0.0 112.331 -179.529 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 32.93 0.78 Allowed Glycine 0 CA--C 1.526 0.762 0 CA-C-O 123.396 1.553 . . . . 0.0 115.017 154.249 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -128.36 123.28 33.5 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 127.09 2.156 . . . . 0.0 109.964 -171.965 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.7 m -113.21 127.85 56.3 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 124.493 1.117 . . . . 0.0 108.3 -178.727 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.4 mp -98.66 133.46 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 C-N-CA 127.311 2.245 . . . . 0.0 106.15 164.161 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.2 t -109.66 125.42 52.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 179.859 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.1 tp -133.94 139.81 46.38 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.273 -0.892 . . . . 0.0 111.725 -178.171 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 60.7 mp0 -95.93 116.57 29.14 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 131.46 3.904 . . . . 0.0 102.266 179.508 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -146.66 159.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 114.507 -2.664 . . . . 0.0 105.053 -163.141 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -111.63 145.94 33.67 Favored Pre-proline 0 N--CA 1.452 -0.349 0 O-C-N 128.747 3.78 . . . . 0.0 108.024 171.925 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -48.88 -29.23 14.69 Favored 'Trans proline' 0 N--CA 1.452 -0.958 1 C-N-CA 129.97 7.113 . . . . 0.0 115.687 -178.59 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 45.0 t -90.16 6.9 40.67 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 117.849 -3.032 . . . . 0.0 116.109 -179.758 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.0 m-20 -78.72 149.5 32.72 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 117.332 -1.318 . . . . 0.0 110.78 -175.436 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 79.9 p -87.45 155.27 20.09 Favored 'General case' 0 C--O 1.22 -0.453 0 CA-C-O 124.67 2.176 . . . . 0.0 111.089 -175.875 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.5 mm -57.66 -27.43 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 115.937 1.828 . . . . 0.0 115.937 173.379 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -85.54 -38.35 18.62 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -168.733 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -60.75 -38.93 86.83 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-O 115.707 -2.092 . . . . 0.0 111.379 164.063 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.324 28.2 t -55.99 -58.42 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 CA-C-N 123.521 2.873 . . . . 0.0 117.776 167.32 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . 0.313 37.8 ttmt -68.36 -18.01 64.38 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 125.338 1.455 . . . . 0.0 114.849 -173.267 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.12 -35.66 21.63 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 125.182 1.552 . . . . 0.0 111.526 170.219 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -71.56 -24.08 61.86 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.091 -1.044 . . . . 0.0 113.21 -175.828 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -70.07 -20.64 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 O-C-N 125.762 1.914 . . . . 0.0 110.392 170.187 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -82.01 -38.99 24.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 116.862 -3.649 . . . . 0.0 107.761 179.564 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -67.63 -41.5 83.83 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.687 2.795 . . . . 0.0 111.792 178.605 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -96.69 -22.12 17.18 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 130.122 3.369 . . . . 0.0 112.945 -169.565 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.492 2.3 mm-40 -136.83 -23.02 1.2 Allowed 'General case' 0 N--CA 1.444 -0.758 0 O-C-N 118.69 -2.506 . . . . 0.0 112.228 -169.235 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.39 1.9 40.96 Favored Glycine 0 CA--C 1.536 1.35 0 N-CA-C 118.341 2.096 . . . . 0.0 118.341 165.558 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 mt -104.21 125.68 33.66 Favored Pre-proline 0 N--CA 1.447 -0.579 0 CA-C-O 114.915 -2.469 . . . . 0.0 108.192 -170.522 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -68.07 149.09 76.64 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.906 3.071 . . . . 0.0 114.991 175.972 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.39 -38.27 54.5 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 O-C-N 126.292 2.733 . . . . 0.0 113.545 179.726 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -41.91 -42.25 2.7 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 116.511 2.041 . . . . 0.0 116.511 173.226 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -94.62 -2.29 51.65 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 131.242 3.817 . . . . 0.0 115.062 -179.488 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -111.18 114.83 28.35 Favored 'General case' 0 N--CA 1.445 -0.677 0 O-C-N 117.029 -3.544 . . . . 0.0 104.858 -162.627 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.8 ttm105 -102.24 128.47 48.76 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 128.607 2.763 . . . . 0.0 109.242 165.765 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 mt -115.51 137.24 52.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 111.65 -2.523 . . . . 0.0 105.8 -177.042 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.6 mt -115.22 129.43 71.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.935 0 C-N-CA 128.421 2.688 . . . . 0.0 109.025 -174.521 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -132.47 134.07 44.6 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 115.231 -2.587 . . . . 0.0 111.202 156.632 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 71.28 0.2 3.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 172.913 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.22 -11.69 19.7 Favored Glycine 0 CA--C 1.54 1.646 0 C-N-CA 129.887 3.613 . . . . 0.0 108.13 -175.367 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.4 mptt -95.8 125.57 40.46 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 126.001 1.648 . . . . 0.0 110.318 -174.34 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.17 111.24 1.88 Allowed 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 127.383 2.273 . . . . 0.0 108.115 167.866 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.254 45.6 mt -87.09 131.3 34.17 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 115.035 -2.666 . . . . 0.0 113.549 -167.715 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -119.39 156.47 30.06 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 129.96 3.304 . . . . 0.0 110.097 -179.035 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.66 142.38 35.6 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 130.482 3.513 . . . . 0.0 113.146 177.306 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.02 -25.61 7.82 Favored Glycine 0 N--CA 1.446 -0.686 0 O-C-N 126.917 2.636 . . . . 0.0 113.272 -159.231 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.4 mtm-85 -121.77 133.88 54.92 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 126.435 1.894 . . . . 0.0 106.22 176.042 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 82.5 p -81.26 -175.31 5.39 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 123.86 1.79 . . . . 0.0 113.837 172.305 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.2 -38.31 90.58 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 118.532 -2.605 . . . . 0.0 110.656 176.082 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.9 m -63.9 -47.21 81.51 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 116.418 2.007 . . . . 0.0 116.418 171.23 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -47.03 -39.02 11.9 Favored 'General case' 0 C--O 1.238 0.453 0 O-C-N 117.11 -3.494 . . . . 0.0 117.1 166.539 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -91.12 -3.81 56.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 123.283 2.765 . . . . 0.0 117.861 170.24 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.251 48.0 m-80 81.92 38.29 0.06 Allowed 'General case' 0 N--CA 1.445 -0.721 1 C-N-CA 133.933 4.893 . . . . 0.0 113.082 170.846 . . . . . . . . 3 2 . 1 . 093 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.5 mt -91.29 142.65 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 102.543 -3.132 . . . . 0.0 102.543 -167.481 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -138.66 -169.66 2.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 113.024 -1.898 . . . . 0.0 111.436 -154.474 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -59.54 124.79 21.21 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.377 1.071 . . . . 0.0 111.248 173.042 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 70.96 8.98 6.69 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.297 -2.752 . . . . 0.0 115.185 172.496 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 60.4 m -85.29 148.0 26.27 Favored 'General case' 0 N--CA 1.45 -0.45 0 O-C-N 116.953 -3.592 . . . . 0.0 106.402 -171.39 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.4 m -122.94 124.33 42.96 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 -173.27 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.01 141.32 28.75 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 130.793 3.637 . . . . 0.0 104.708 178.487 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.28 58.2 m80 -101.65 115.6 30.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 113.693 -3.051 . . . . 0.0 107.498 -177.607 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 70' ' ' VAL . 4.5 tt -90.29 125.16 35.41 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 171.057 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.471 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -125.78 104.57 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.102 -0.999 . . . . 0.0 112.695 170.17 . . . . . . . . 3 3 . 1 . 093 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.296 56.4 tp -79.32 128.0 32.78 Favored 'General case' 0 N--CA 1.448 -0.547 1 O-C-N 114.282 -5.262 . . . . 0.0 111.49 -170.12 . . . . . . . . 3 2 . 1 . 093 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.284 22.6 ttt180 62.91 -46.33 0.2 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 130.609 3.564 . . . . 0.0 117.001 178.146 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -136.55 149.82 48.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 128.765 2.826 . . . . 0.0 109.772 -172.583 . . . . . . . . 2 2 . 1 . 093 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -79.47 126.24 30.6 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 120.617 -1.302 . . . . 0.0 111.43 -172.684 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.1 176.59 17.73 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 129.464 3.411 . . . . 0.0 105.622 175.284 . . . . . . . . 1 1 . 1 . 093 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.475 0 CA-C-O 114.972 -3.127 . . . . 0.0 111.832 -163.843 . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ptt? . . . . . 0 N--CA 1.475 0.79 0 CA-C-O 123.335 1.54 . . . . 0.0 107.203 . . . . . . . . . 0 0 . 1 . 094 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.257 20.9 mt-30 -104.34 149.5 25.31 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 111.965 -2.38 . . . . 0.0 109.59 174.527 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 pt -137.33 156.03 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 O-C-N 126.092 2.12 . . . . 0.0 110.056 170.727 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -107.25 132.29 53.25 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 118.038 -0.982 . . . . 0.0 108.396 172.7 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.1 t -117.42 116.86 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 128.406 2.682 . . . . 0.0 112.95 175.159 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 30.2 mttt -92.83 138.69 31.27 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 123.942 1.829 . . . . 0.0 108.939 -179.055 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.6 p -88.61 167.4 13.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 108.623 -3.899 . . . . 0.0 108.955 177.33 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.512 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.4 pt? -69.34 -23.46 63.78 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 119.127 -2.233 . . . . 0.0 113.189 160.991 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -90.1 -13.81 35.02 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 115.951 -1.976 . . . . 0.0 113.806 -175.343 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.37 -0.26 8.78 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-N 121.423 1.919 . . . . 0.0 113.042 163.695 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -92.62 149.64 21.21 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 119.051 1.425 . . . . 0.0 110.592 177.522 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -106.47 115.85 30.92 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 130.767 3.627 . . . . 0.0 104.513 165.442 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.0 mt -97.45 140.22 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 1 N-CA-C 97.95 -4.833 . . . . 0.0 97.95 177.858 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 80.3 m -101.41 98.73 9.05 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 -179.639 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -90.09 156.12 18.59 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 117.409 -3.307 . . . . 0.0 109.445 175.001 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -121.16 119.87 33.62 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 130.742 3.617 . . . . 0.0 108.722 172.864 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.7 m -152.68 154.87 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 C-N-CA 129.591 3.156 . . . . 0.0 104.887 175.545 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.351 76.0 mm-40 -100.41 166.73 12.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 111.348 -2.66 . . . . 0.0 112.371 174.279 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.288 2.6 Cg_exo -49.67 -34.02 33.65 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 124.043 3.162 . . . . 0.0 119.669 -178.848 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -85.91 -5.57 59.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 119.35 -2.094 . . . . 0.0 112.688 -172.814 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . 0.395 65.7 m-20 -85.13 142.72 29.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 125.097 1.498 . . . . 0.0 109.092 -167.348 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.3 p -79.03 161.19 26.76 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 115.599 -2.143 . . . . 0.0 109.894 175.989 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.8 mm -42.22 -34.01 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 130.468 3.507 . . . . 0.0 111.172 165.499 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -66.75 -21.65 66.06 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 124.308 3.231 . . . . 0.0 111.908 -174.876 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -72.13 -52.01 18.68 Favored 'General case' 0 N--CA 1.44 -0.938 1 C-N-CA 131.809 4.044 . . . . 0.0 114.768 169.13 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 80.9 t -53.46 -59.03 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 C-N-CA 126.428 1.891 . . . . 0.0 111.563 174.37 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 41.4 mttt -56.03 -33.71 65.19 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 127.455 2.972 . . . . 0.0 107.98 -179.855 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.76 -39.19 57.52 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 124.08 3.127 . . . . 0.0 118.665 -175.904 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.7 mttt -63.7 -40.3 96.45 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 126.644 1.978 . . . . 0.0 114.795 162.338 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.1 mt -59.21 -42.99 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-O 116.626 -1.654 . . . . 0.0 109.246 174.917 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -44.96 91.91 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 128.984 3.927 . . . . 0.0 113.976 171.977 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -74.41 -19.21 60.5 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 121.323 1.874 . . . . 0.0 112.594 -175.514 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 27.8 mttm -98.91 -53.08 3.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.084 1.754 . . . . 0.0 111.135 -166.885 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.254 36.5 tp10 -112.91 -3.48 14.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.641 -1.163 . . . . 0.0 113.846 -173.773 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.76 28.62 20.9 Favored Glycine 0 CA--C 1.527 0.829 1 CA-C-O 128.371 4.317 . . . . 0.0 115.093 163.836 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 11.4 mt -105.22 118.0 56.99 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 109.983 -3.108 . . . . 0.0 111.675 -165.437 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -72.73 133.01 19.51 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 CA-C-O 111.724 -3.532 . . . . 0.0 112.692 -175.725 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -74.76 -19.62 18.3 Favored 'Trans proline' 0 N--CA 1.448 -1.169 1 O-C-N 130.087 4.73 . . . . 0.0 112.202 -163.167 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -82.46 -14.6 54.8 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 121.852 2.115 . . . . 0.0 108.306 177.139 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -88.45 -15.33 35.66 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 127.356 2.262 . . . . 0.0 109.485 178.385 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -88.18 154.94 20.04 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 120.64 1.564 . . . . 0.0 110.994 -177.837 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.445 ' C ' HD12 ' A' ' 43' ' ' LEU . 12.3 ttm180 -148.22 122.95 9.9 Favored 'General case' 0 C--N 1.324 -0.521 1 C-N-CA 132.985 4.514 . . . . 0.0 104.149 -175.028 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.445 HD12 ' C ' ' A' ' 42' ' ' ARG . 3.7 mp -122.13 131.59 54.04 Favored 'General case' 0 N--CA 1.446 -0.664 1 C-N-CA 132.281 4.232 . . . . 0.0 114.109 -165.231 . . . . . . . . 3 3 . 1 . 094 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.421 1.8 tt -134.63 144.66 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 126.315 2.26 . . . . 0.0 111.851 -172.309 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -156.34 142.45 18.15 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-O 126.552 3.072 . . . . 0.0 104.007 165.018 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.49 29.37 2.88 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 109.33 -3.577 . . . . 0.0 118.08 175.394 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.41 -17.67 36.61 Favored Glycine 0 CA--C 1.528 0.892 0 O-C-N 127.149 2.78 . . . . 0.0 113.68 175.572 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -103.27 120.04 40.01 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 130.921 3.689 . . . . 0.0 110.979 -168.871 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -72.74 135.4 45.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.243 1.417 . . . . 0.0 107.23 164.873 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.1 mt -92.61 121.09 33.69 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.877 -163.266 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -81.5 124.8 29.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 125.729 1.893 . . . . 0.0 108.187 -169.497 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -66.76 108.22 2.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 129.271 3.028 . . . . 0.0 111.144 173.448 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.75 4.65 12.85 Favored Glycine 0 CA--C 1.526 0.72 0 O-C-N 126.205 2.19 . . . . 0.0 115.615 177.2 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -105.89 144.84 32.05 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 116.47 -3.959 . . . . 0.0 109.92 168.418 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.6 p -84.79 145.07 28.07 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 127.123 2.764 . . . . 0.0 112.155 176.059 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 tp -41.71 -48.7 4.22 Favored 'General case' 0 N--CA 1.448 -0.538 1 C-N-CA 131.905 4.082 . . . . 0.0 109.149 179.537 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 38.3 t -54.25 -31.85 54.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 130.852 3.661 . . . . 0.0 113.171 176.349 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -67.53 -32.33 73.04 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.81 0.844 . . . . 0.0 112.955 177.139 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -88.46 -7.23 56.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 115.572 -2.156 . . . . 0.0 109.534 175.385 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 51.17 40.14 25.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 125.914 3.961 . . . . 0.0 112.971 -178.121 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -79.97 134.48 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-N 112.538 -2.119 . . . . 0.0 105.426 166.937 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -119.57 169.62 9.91 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.24 -2.504 . . . . 0.0 104.24 -173.834 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.8 pttt -49.13 126.37 12.52 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 131.687 3.995 . . . . 0.0 113.493 178.93 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 71.02 5.54 5.52 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-O 114.649 -2.596 . . . . 0.0 116.608 -178.887 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.5 m -59.3 128.96 39.7 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 117.917 2.562 . . . . 0.0 117.917 164.78 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -83.22 123.77 29.9 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 124.337 1.055 . . . . 0.0 110.335 -177.949 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 mt -124.23 156.59 36.56 Favored 'General case' 0 N--CA 1.452 -0.374 1 C-N-CA 134.213 5.005 . . . . 0.0 108.191 -177.549 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -124.49 148.15 47.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 120.835 -1.166 . . . . 0.0 111.934 -168.867 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 7.3 tp -117.76 127.73 54.19 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 127.225 2.21 . . . . 0.0 108.855 -174.208 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . 0.594 35.3 m -119.92 165.07 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 129.385 3.074 . . . . 0.0 112.493 169.847 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 71' ' ' LEU . 27.0 mt -99.74 141.12 32.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 O-C-N 119.794 -1.816 . . . . 0.0 106.723 175.908 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.5 ttt-85 -152.76 119.04 5.54 Favored 'General case' 0 N--CA 1.443 -0.783 1 N-CA-C 99.683 -4.191 . . . . 0.0 99.683 165.128 . . . . . . . . 2 2 . 1 . 094 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.6 mp -92.38 54.94 2.41 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 113.286 -1.779 . . . . 0.0 106.273 -172.088 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 23.8 ttt180 -169.12 130.85 1.18 Allowed 'General case' 0 N--CA 1.448 -0.563 0 O-C-N 119.772 -1.83 . . . . 0.0 106.519 -163.953 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.36 84.72 0.37 Allowed Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.404 1.954 . . . . 0.0 112.918 171.669 . . . . . . . . 1 1 . 1 . 094 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.161 0 N-CA-C 107.542 -2.223 . . . . 0.0 107.542 175.243 . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttp . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 102.058 -3.312 . . . . 0.0 102.058 . . . . . . . . . 0 0 . 1 . 095 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -78.59 148.39 33.32 Favored 'General case' 0 C--N 1.324 -0.537 1 O-C-N 115.481 -4.512 . . . . 0.0 110.262 169.598 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.403 HG21 HD13 ' A' ' 3' ' ' ILE . 37.5 pt -136.88 163.71 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 101.93 -3.359 . . . . 0.0 101.93 164.988 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -121.51 151.2 40.56 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 124.338 2.018 . . . . 0.0 110.165 -178.34 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 t -127.1 130.02 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 O-C-N 119.156 -2.215 . . . . 0.0 110.58 171.741 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -85.74 167.74 14.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.008 1.723 . . . . 0.0 111.978 157.875 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 p -126.06 177.2 6.5 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.728 1.268 . . . . 0.0 111.388 -176.58 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.83 -34.42 78.1 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 115.608 1.706 . . . . 0.0 115.608 174.468 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 70.3 p -63.25 -50.69 69.2 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 127.662 2.385 . . . . 0.0 112.45 165.84 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.54 13.54 8.04 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-O 116.686 -2.174 . . . . 0.0 111.113 168.238 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.7 tttt -69.31 135.4 50.36 Favored 'General case' 0 N--CA 1.451 -0.398 1 C-N-CA 135.718 5.607 . . . . 0.0 102.815 174.254 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 47.6 m -89.28 140.79 29.13 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 113.928 -1.487 . . . . 0.0 107.785 -174.741 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.5 mt -116.59 148.92 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 130.16 3.384 . . . . 0.0 106.854 164.111 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 t -134.6 139.59 45.45 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 128.128 3.393 . . . . 0.0 108.973 170.798 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 mt -141.72 160.94 39.15 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 125.255 2.455 . . . . 0.0 105.759 -171.711 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 mp0 -109.9 127.04 54.49 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 125.884 2.754 . . . . 0.0 110.065 162.358 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.6 -178.65 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 131.548 3.939 . . . . 0.0 109.925 -177.107 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 19' ' ' PRO 0.275 6.1 mt-10 -130.89 148.82 71.72 Favored Pre-proline 0 N--CA 1.444 -0.731 0 O-C-N 116.359 -3.963 . . . . 0.0 112.068 168.824 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 18' ' ' GLU . 72.2 Cg_exo -48.51 -43.98 31.54 Favored 'Trans proline' 0 N--CA 1.453 -0.863 1 C-N-CA 125.488 4.125 . . . . 0.0 118.58 -169.968 . . . . . . . . 3 3 . 1 . 095 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 15.7 t -86.29 8.48 21.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 112.655 -2.066 . . . . 0.0 116.449 -179.587 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.93 154.19 31.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 126.305 2.253 . . . . 0.0 116.505 173.827 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.305 81.1 p -92.64 149.55 21.26 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 125.128 1.518 . . . . 0.0 108.144 178.346 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.9 mm -45.55 -44.06 3.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 126.632 1.973 . . . . 0.0 115.874 176.787 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -51.19 -53.97 29.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 128.77 2.828 . . . . 0.0 112.897 173.383 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -63.59 -30.39 71.51 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 122.94 1.352 . . . . 0.0 111.846 -172.142 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.3 t -70.47 -40.01 76.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 127.236 2.214 . . . . 0.0 109.778 169.949 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -68.98 -28.0 66.22 Favored 'General case' 0 C--N 1.328 -0.34 1 O-C-N 115.054 -4.779 . . . . 0.0 111.324 -173.797 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -71.83 -31.86 66.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 113.576 -1.647 . . . . 0.0 112.536 172.833 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -75.08 -41.02 59.66 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -178.556 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.2 mt -64.74 -28.97 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 119.789 1.177 . . . . 0.0 113.026 175.565 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -62.45 -44.62 95.98 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 127.84 2.456 . . . . 0.0 113.111 171.736 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -72.63 -16.55 61.71 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 119.091 -2.255 . . . . 0.0 113.112 -175.586 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.7 mptt -107.75 -53.47 2.62 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 105.674 -1.972 . . . . 0.0 105.674 -172.674 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 56.8 mm-40 -112.93 -9.32 13.63 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 114.471 -2.681 . . . . 0.0 112.232 -173.602 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.21 39.28 72.07 Favored Glycine 0 CA--C 1.533 1.199 0 CA-C-O 115.014 -3.103 . . . . 0.0 113.007 -177.181 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.2 mt -96.16 116.31 66.11 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 102.859 -3.015 . . . . 0.0 102.859 178.235 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -68.67 145.9 65.15 Favored 'Trans proline' 0 N--CA 1.445 -1.374 0 N-CA-C 118.422 2.432 . . . . 0.0 118.422 -179.032 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.297 39.7 Cg_endo -70.89 -21.41 28.27 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 125.198 3.932 . . . . 0.0 118.696 -160.045 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -91.49 -30.95 16.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 123.844 3.02 . . . . 0.0 110.527 -179.036 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -71.14 -37.01 72.27 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 177.978 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -63.74 125.02 22.96 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 112.67 -3.538 . . . . 0.0 116.487 179.262 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.281 32.4 ttm105 -128.33 121.46 29.25 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 122.872 2.578 . . . . 0.0 108.906 176.235 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -96.5 132.72 41.78 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 128.049 2.54 . . . . 0.0 107.625 -179.156 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.1 mt -119.87 161.14 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 126.742 2.017 . . . . 0.0 110.408 167.648 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -158.83 128.6 5.72 Favored 'General case' 0 N--CA 1.449 -0.494 1 N-CA-C 98.241 -4.726 . . . . 0.0 98.241 173.157 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.92 23.34 13.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.455 2.302 . . . . 0.0 113.542 162.369 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.1 0.01 54.64 Favored Glycine 0 CA--C 1.534 1.273 0 N-CA-C 111.865 -0.494 . . . . 0.0 111.865 178.03 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.9 mttt -120.78 129.65 53.68 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -167.643 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -70.77 151.82 44.44 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 166.221 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -100.93 113.95 27.37 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 101.601 -3.481 . . . . 0.0 101.601 -179.772 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -101.12 139.42 36.82 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 125.086 1.491 . . . . 0.0 108.428 -173.564 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -28.8 129.2 0.08 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 129.325 3.05 . . . . 0.0 116.982 167.911 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.49 -11.35 71.63 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 159.687 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -103.68 156.12 18.04 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.504 1.922 . . . . 0.0 106.435 -178.164 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 76.7 p -111.81 149.83 31.19 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.964 2.506 . . . . 0.0 115.778 -164.577 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 42.4 mt -60.81 -46.35 90.85 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 112.72 -2.037 . . . . 0.0 114.871 -164.974 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.6 t -75.8 -33.31 60.12 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.462 -171.165 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -61.54 -31.85 71.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 112.881 -3.438 . . . . 0.0 118.817 166.32 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -73.54 -21.92 60.24 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 127.916 3.26 . . . . 0.0 112.486 164.789 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.4 t30 89.58 45.04 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.446 2 C-N-CA 134.076 4.951 . . . . 0.0 107.895 175.558 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 16.6 mm -79.36 145.87 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 O-C-N 118.027 -2.921 . . . . 0.0 104.564 172.63 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -132.76 -178.48 4.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 121.946 2.157 . . . . 0.0 106.742 178.347 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -72.87 112.8 9.23 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 130.793 3.637 . . . . 0.0 109.036 -171.784 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 75.85 31.82 0.69 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 130.236 3.414 . . . . 0.0 111.95 -172.937 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 m -70.5 140.75 51.94 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 115.97 -1.967 . . . . 0.0 112.008 166.581 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.8 m -102.37 129.89 48.97 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -179.218 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 mp -116.71 154.2 31.01 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 129.893 3.277 . . . . 0.0 108.46 -177.993 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.268 20.8 t-160 -109.04 118.28 36.38 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.013 0.925 . . . . 0.0 109.877 -171.256 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.1 tt -93.83 127.75 39.74 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 126.224 1.81 . . . . 0.0 109.248 173.498 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 34.1 m -110.34 138.59 37.55 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 1 O-C-N 129.103 4.002 . . . . 0.0 104.039 162.399 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.3 tt -101.75 122.61 44.26 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 118.639 -2.538 . . . . 0.0 109.669 167.339 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.548 54.7 ttt180 77.02 -35.44 0.23 Allowed 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 124.985 2.326 . . . . 0.0 115.58 171.861 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.25 88.1 mt -57.71 150.83 18.74 Favored 'General case' 0 C--O 1.222 -0.365 0 O-C-N 117.578 -3.201 . . . . 0.0 114.67 -179.204 . . . . . . . . 2 2 . 1 . 095 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -72.15 140.68 48.94 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 129.319 3.048 . . . . 0.0 107.843 -175.535 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -128.43 1.27 6.51 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-N 111.423 -2.626 . . . . 0.0 114.056 179.912 . . . . . . . . 1 1 . 1 . 095 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.373 0 N-CA-C 104.976 -3.249 . . . . 0.0 104.976 -154.354 . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 C--O 1.236 0.381 0 N-CA-C 110.88 -0.044 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 096 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -107.49 133.91 51.29 Favored 'General case' 0 N--CA 1.448 -0.54 1 C-N-CA 131.997 4.119 . . . . 0.0 108.242 -179.029 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.286 0.9 OUTLIER -129.93 169.9 20.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 117.217 -1.373 . . . . 0.0 112.114 163.701 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -110.03 152.16 26.27 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 125.139 3.609 . . . . 0.0 105.632 172.149 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.292 2.6 t -135.34 113.88 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 C-N-CA 128.883 2.873 . . . . 0.0 107.148 172.1 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 mttt -97.31 126.04 42.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 129.931 3.292 . . . . 0.0 106.137 -177.789 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.0 p -86.41 178.03 7.25 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 126.247 1.819 . . . . 0.0 114.117 160.54 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -79.03 -33.8 44.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 117.144 -1.408 . . . . 0.0 110.696 -169.904 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -93.18 0.99 57.31 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -178.873 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.42 -8.31 5.92 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 126.53 2.014 . . . . 0.0 111.188 151.97 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -71.04 110.55 5.8 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 -171.717 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.2 m -87.35 113.34 22.98 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 101.728 -3.434 . . . . 0.0 101.728 172.927 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 75.0 mt -86.34 126.69 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 N-CA-C 99.625 -4.213 . . . . 0.0 99.625 166.905 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 48.5 m -99.82 109.06 21.48 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 129.339 3.056 . . . . 0.0 105.16 173.891 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 tp -105.39 135.23 47.15 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -161.688 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.408 ' O ' HG13 ' A' ' 17' ' ' VAL 0.285 31.1 tt0 -86.12 134.71 33.79 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 110.823 -2.899 . . . . 0.0 113.142 160.351 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 16' ' ' GLU . 0.2 OUTLIER -148.2 164.44 5.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 123.807 1.765 . . . . 0.0 107.672 174.278 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 24.6 mm-40 -95.69 160.01 31.24 Favored Pre-proline 0 N--CA 1.444 -0.729 2 C-N-CA 133.018 4.527 . . . . 0.0 109.884 145.825 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -62.89 -25.16 74.29 Favored 'Trans proline' 0 N--CA 1.45 -1.03 1 C-N-CA 125.715 4.277 . . . . 0.0 113.487 -173.657 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p -83.03 -11.03 58.43 Favored 'General case' 0 N--CA 1.444 -0.747 1 C-N-CA 137.275 6.23 . . . . 0.0 110.214 -175.175 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -70.03 114.7 8.45 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.734 2.014 . . . . 0.0 107.438 160.18 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.253 71.3 p -89.57 -162.54 0.89 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 115.793 -2.051 . . . . 0.0 114.857 -170.725 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.4 mm -60.9 -33.9 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 CA-C-N 122.722 2.51 . . . . 0.0 113.811 172.262 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -78.56 -45.68 21.24 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 129.47 3.108 . . . . 0.0 114.801 174.466 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -67.6 -25.24 65.67 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 113.759 -3.176 . . . . 0.0 112.577 -179.517 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 37.5 t -57.5 -58.05 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.712 2.405 . . . . 0.0 116.841 157.06 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -58.51 -26.13 63.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 117.901 2.556 . . . . 0.0 117.901 174.82 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.33 -37.81 43.69 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 127.078 3.323 . . . . 0.0 117.409 170.979 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.3 mttp -60.11 -39.18 85.3 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 117.092 -3.505 . . . . 0.0 113.635 164.249 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.0 mt -53.42 -47.91 58.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 C-N-CA 129.166 2.986 . . . . 0.0 111.569 172.678 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -60.94 -50.57 72.86 Favored 'General case' 0 N--CA 1.45 -0.446 1 C-N-CA 132.121 4.169 . . . . 0.0 109.819 177.39 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -51.0 -48.05 61.47 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 171.364 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 47.0 mttm -84.82 -52.83 5.75 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 115.788 -2.053 . . . . 0.0 112.868 -171.988 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -123.4 -2.85 8.45 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 122.041 2.2 . . . . 0.0 110.237 -155.502 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.17 7.89 67.26 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 125.901 1.715 . . . . 0.0 112.328 163.104 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 69.8 mt -73.27 124.18 90.28 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 129.347 3.059 . . . . 0.0 106.675 -170.589 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -83.76 110.51 1.63 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 125.002 3.802 . . . . 0.0 113.16 173.425 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.36 -15.06 12.8 Favored 'Trans proline' 0 N--CA 1.442 -1.506 0 N-CA-C 118.754 2.559 . . . . 0.0 118.754 -167.898 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.365 0.0 OUTLIER -25.54 -35.26 0.0 OUTLIER 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 130.697 3.599 . . . . 0.0 120.252 174.778 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.252 0.0 OUTLIER -126.79 25.41 6.37 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.502 1.921 . . . . 0.0 111.21 -165.837 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -131.24 126.88 36.62 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 126.272 1.829 . . . . 0.0 111.096 -168.634 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -123.68 157.56 33.6 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 109.586 -3.461 . . . . 0.0 109.701 176.455 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.11 138.59 53.47 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 114.133 -2.841 . . . . 0.0 108.659 -166.253 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 11.9 mm -110.04 148.11 13.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 127.952 3.283 . . . . 0.0 115.568 165.272 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -149.24 125.64 10.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 114.687 -2.578 . . . . 0.0 105.519 166.565 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 66.57 15.24 10.06 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 130.471 3.508 . . . . 0.0 113.539 172.637 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.47 -34.93 5.38 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 128.654 3.026 . . . . 0.0 108.737 -169.425 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -78.11 136.02 37.8 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 122.133 2.967 . . . . 0.0 108.339 -156.946 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -80.27 106.13 12.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 113.611 -3.09 . . . . 0.0 113.31 164.572 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.3 136.96 57.21 Favored 'General case' 0 N--CA 1.446 -0.627 0 O-C-N 128.098 3.374 . . . . 0.0 115.155 -178.014 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -91.98 116.07 28.6 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 127.166 2.186 . . . . 0.0 105.106 -165.43 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.49 116.27 3.86 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 115.298 -2.287 . . . . 0.0 112.607 -177.271 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.28 3.96 7.85 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 129.908 3.623 . . . . 0.0 112.896 -178.331 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -109.36 159.13 17.25 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 122.008 2.904 . . . . 0.0 108.93 -170.932 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.6 p -90.6 173.13 8.22 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 129.859 3.264 . . . . 0.0 110.551 176.981 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -75.78 -18.09 59.65 Favored 'General case' 0 N--CA 1.45 -0.444 0 O-C-N 121.197 -0.939 . . . . 0.0 110.591 173.647 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.0 m -70.05 -20.52 63.23 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 120.43 -1.419 . . . . 0.0 112.841 177.367 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -86.12 -6.29 59.04 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 128.485 2.714 . . . . 0.0 112.154 -177.073 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -130.44 -7.21 4.2 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 114.495 -2.669 . . . . 0.0 113.196 178.954 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.1 t30 57.05 51.07 10.97 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 127.084 2.74 . . . . 0.0 112.733 178.807 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.7 mt -106.46 125.86 62.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 104.489 -2.412 . . . . 0.0 104.489 -178.417 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -114.09 -166.66 1.12 Allowed 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 112.284 -2.235 . . . . 0.0 108.502 177.88 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 15.4 pttt -65.25 149.74 49.43 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 129.116 2.966 . . . . 0.0 112.219 -170.004 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.542 12.6 pt-20 73.45 16.89 3.95 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.541 170.056 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.0 m -84.26 155.65 22.35 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.221 1.808 . . . . 0.0 111.173 -177.015 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.9 m -116.78 137.47 52.17 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 118.798 -2.439 . . . . 0.0 111.884 174.576 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 37.4 mt -105.0 149.53 25.69 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 103.74 -2.689 . . . . 0.0 103.74 156.224 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -102.97 133.58 47.84 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 169.338 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.429 HD13 ' N ' ' A' ' 70' ' ' VAL 0.351 1.8 tm? -96.97 144.88 26.45 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-O 115.142 -2.361 . . . . 0.0 111.458 -178.23 . . . . . . . . 3 3 . 1 . 096 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.429 ' N ' HD13 ' A' ' 69' ' ' LEU . 48.6 t -127.83 133.14 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 C-N-CA 128.696 2.798 . . . . 0.0 107.567 179.074 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 mp -88.47 137.95 31.86 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 130.289 3.435 . . . . 0.0 107.745 173.207 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -73.14 -24.74 60.64 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 176.455 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.11 135.14 54.2 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 113.396 -1.729 . . . . 0.0 109.406 -168.89 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.359 57.3 ttt-85 -116.09 -35.16 4.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 115.629 -2.129 . . . . 0.0 115.575 167.687 . . . . . . . . 2 2 . 1 . 096 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.44 -176.56 16.16 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 120.035 2.774 . . . . 0.0 120.035 167.678 . . . . . . . . 1 1 . 1 . 096 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.431 0 N-CA-C 103.464 -3.855 . . . . 0.0 103.464 -177.039 . . . . . . . . 0 0 . 1 . 097 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.252 9.2 tpp . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 124.011 1.862 . . . . 0.0 110.274 . . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.348 4.9 tt0 -85.54 156.85 20.59 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 118.203 -2.811 . . . . 0.0 115.284 177.089 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 3' ' ' ILE 0.332 17.1 pt -133.06 134.9 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 O-C-N 117.067 -3.521 . . . . 0.0 106.799 162.349 . . . . . . . . 3 3 . 1 . 097 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -94.13 144.55 25.4 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 113.936 -1.484 . . . . 0.0 109.583 166.116 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG11 HD12 ' A' ' 30' ' ' ILE . 3.8 t -128.3 133.16 67.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 127.403 2.281 . . . . 0.0 106.368 -179.975 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -133.11 145.87 51.11 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 103.816 -2.661 . . . . 0.0 103.816 -176.076 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.5 p -129.23 -90.75 0.48 Allowed 'General case' 0 N--CA 1.45 -0.471 0 CA-C-O 116.353 -1.784 . . . . 0.0 110.704 159.847 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.7 pp -142.54 -42.44 0.32 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 128.239 2.616 . . . . 0.0 114.282 169.088 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.57 114.02 21.67 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.116 1.366 . . . . 0.0 108.232 174.721 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.12 142.37 10.52 Favored Glycine 0 CA--C 1.536 1.392 0 N-CA-C 106.69 -2.564 . . . . 0.0 106.69 -169.426 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -54.51 -67.37 0.27 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 126.967 2.107 . . . . 0.0 110.267 156.402 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.2 p -155.57 174.53 15.14 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 127.916 2.486 . . . . 0.0 106.575 178.674 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -130.09 144.4 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 C-N-CA 127.226 2.21 . . . . 0.0 105.297 164.418 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.8 p -104.53 129.11 52.6 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 125.337 1.455 . . . . 0.0 112.352 -175.32 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.9 mt -123.42 145.98 48.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 117.349 -3.344 . . . . 0.0 108.024 176.681 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.03 121.17 37.49 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 126.132 2.145 . . . . 0.0 110.073 162.602 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.3 m -122.5 -161.6 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 O-C-N 120.223 -1.548 . . . . 0.0 112.936 -178.693 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.278 4.3 tm-20 -142.52 147.78 44.29 Favored Pre-proline 0 N--CA 1.447 -0.596 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 164.244 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -65.47 -21.56 60.18 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 CA-C-O 115.124 -2.115 . . . . 0.0 115.328 -178.642 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.75 14.81 6.47 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 120.798 1.635 . . . . 0.0 114.449 173.548 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -75.09 121.68 22.41 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 127.496 2.318 . . . . 0.0 107.124 167.233 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.8 p -66.6 155.28 38.25 Favored 'General case' 0 N--CA 1.449 -0.491 1 O-C-N 129.17 4.044 . . . . 0.0 109.028 160.782 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 80.5 mt -68.04 -27.94 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 124.249 1.976 . . . . 0.0 111.917 178.736 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -47.15 -41.39 17.59 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 112.741 -2.027 . . . . 0.0 111.689 170.517 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -75.15 -38.48 60.96 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 125.236 1.414 . . . . 0.0 112.351 178.56 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.7 t -66.71 -31.28 52.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 O-C-N 126.448 2.343 . . . . 0.0 112.712 179.03 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 88.5 mttt -51.94 -37.4 52.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 114.837 1.421 . . . . 0.0 114.837 173.053 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.312 . . -79.2 -32.01 43.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 125.739 2.685 . . . . 0.0 111.163 -176.144 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -56.04 -53.09 61.14 Favored 'General case' 0 N--CA 1.452 -0.372 1 O-C-N 115.686 -4.384 . . . . 0.0 112.371 164.2 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.637 ' CG2' HD12 ' A' ' 36' ' ' ILE . 46.2 mm -59.27 -39.54 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 O-C-N 119.576 -1.952 . . . . 0.0 109.82 -178.301 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -51.95 -49.34 63.37 Favored 'General case' 0 N--CA 1.452 -0.34 1 N-CA-C 122.622 4.304 . . . . 0.0 122.622 161.899 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.09 -34.91 74.11 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 119.106 3.002 . . . . 0.0 119.106 170.685 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.31 -23.98 14.99 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 125.881 1.672 . . . . 0.0 114.437 -174.869 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -143.09 -12.43 0.73 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 124.812 2.244 . . . . 0.0 115.252 -165.954 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.81 -17.4 32.82 Favored Glycine 0 CA--C 1.536 1.373 1 O-C-N 115.282 -4.636 . . . . 0.0 114.137 159.715 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.637 HD12 ' CG2' ' A' ' 30' ' ' ILE . 2.4 mt -74.32 126.31 89.09 Favored Pre-proline 0 N--CA 1.45 -0.447 0 O-C-N 120.023 -1.869 . . . . 0.0 112.714 -170.52 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -64.88 141.06 69.57 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 CA-C-O 114.846 -2.231 . . . . 0.0 117.864 173.031 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -43.87 -41.4 11.94 Favored 'Trans proline' 0 N--CA 1.449 -1.111 1 C-N-CA 125.301 4.001 . . . . 0.0 116.98 178.934 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -56.98 -26.1 59.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 129.191 2.996 . . . . 0.0 111.471 179.341 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -97.25 -15.29 20.89 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 127.058 2.143 . . . . 0.0 115.024 -173.761 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -90.58 132.57 35.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -169.728 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -114.24 111.9 22.27 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 129.23 3.012 . . . . 0.0 109.511 169.111 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -97.36 109.64 22.35 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 120.139 -1.601 . . . . 0.0 108.345 -176.855 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mt -119.08 136.66 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 1 N-CA-C 98.267 -4.716 . . . . 0.0 98.267 -174.991 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -168.66 143.16 3.24 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.997 2.519 . . . . 0.0 107.366 173.341 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.303 . . 65.51 27.21 11.69 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.261 2.224 . . . . 0.0 113.208 173.77 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.3 -8.74 59.01 Favored Glycine 0 CA--C 1.526 0.722 0 C-N-CA 129.016 3.198 . . . . 0.0 108.3 163.817 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -129.24 147.01 51.04 Favored 'General case' 0 C--O 1.241 0.641 0 O-C-N 116.928 -3.689 . . . . 0.0 113.194 176.82 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -60.89 104.94 0.41 Allowed 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 129.87 3.268 . . . . 0.0 111.79 165.306 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.3 mt -60.16 144.42 49.95 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -173.082 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -77.36 134.52 38.45 Favored 'General case' 0 N--CA 1.448 -0.56 0 O-C-N 125.188 1.555 . . . . 0.0 110.55 161.988 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -71.04 -31.76 68.3 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 131.204 3.802 . . . . 0.0 117.587 -166.101 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.83 9.56 56.85 Favored Glycine 0 CA--C 1.525 0.67 0 O-C-N 126.943 2.652 . . . . 0.0 110.026 -175.286 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.49 159.29 16.59 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 123.813 1.768 . . . . 0.0 110.696 162.398 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.435 ' O ' ' HB2' ' A' ' 58' ' ' ASP . 37.3 p -102.2 163.96 11.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 111.678 -2.51 . . . . 0.0 109.923 -171.5 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.8 mp -52.08 -59.12 4.73 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.213 2.205 . . . . 0.0 108.539 172.642 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . 0.312 82.3 p -44.2 -46.12 8.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 128.236 2.614 . . . . 0.0 115.655 171.923 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.435 ' HB2' ' O ' ' A' ' 55' ' ' THR . 44.6 m-20 -51.38 -34.09 32.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 125.486 1.514 . . . . 0.0 114.812 173.244 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -104.27 0.01 28.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 120.559 -1.338 . . . . 0.0 112.555 -175.151 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.4 m120 81.75 23.47 0.26 Allowed 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.849 2.059 . . . . 0.0 111.689 -176.056 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.0 mt -84.59 102.89 11.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 103.176 -2.898 . . . . 0.0 103.176 -174.169 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -70.8 162.3 29.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 117.475 2.398 . . . . 0.0 117.475 172.958 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.4 pttt -42.17 138.31 1.68 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 126.895 2.078 . . . . 0.0 114.005 155.8 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.257 7.6 mm-40 77.07 17.91 1.55 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 129.028 2.931 . . . . 0.0 111.84 170.302 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.4 m -96.44 155.81 16.61 Favored 'General case' 0 CA--C 1.537 0.454 1 CA-C-O 130.108 4.766 . . . . 0.0 109.333 -177.053 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.4 m -96.92 140.84 30.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 110.001 -3.272 . . . . 0.0 106.51 176.704 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -108.54 162.7 13.89 Favored 'General case' 0 CA--C 1.537 0.465 1 N-CA-C 98.586 -4.598 . . . . 0.0 98.586 157.602 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -120.01 141.79 49.39 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 103.634 -2.728 . . . . 0.0 103.634 167.401 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.523 HD12 ' H ' ' A' ' 70' ' ' VAL . 7.5 tp -116.89 148.79 41.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 130.584 3.553 . . . . 0.0 112.808 -172.509 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.523 ' H ' HD12 ' A' ' 69' ' ' LEU . 58.0 t -133.92 130.36 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 130.304 3.441 . . . . 0.0 109.931 -176.294 . . . . . . . . 2 2 . 1 . 097 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.9 mp -75.75 144.13 41.63 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 120.06 -1.65 . . . . 0.0 107.362 164.99 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -88.08 -34.13 18.05 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.477 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.2 mt -141.5 168.22 20.28 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 126.668 2.48 . . . . 0.0 109.938 168.148 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 90.9 mtt180 -91.54 -15.06 29.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 115.516 -2.183 . . . . 0.0 113.51 -178.296 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 150.05 -177.03 28.42 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 128.389 2.9 . . . . 0.0 107.119 177.929 . . . . . . . . 1 1 . 1 . 097 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.361 0 CA-C-O 114.887 -3.174 . . . . 0.0 110.877 -160.086 . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.5 ttp . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 098 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.2 mp0 -82.78 122.76 28.62 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 126.387 1.875 . . . . 0.0 113.723 172.452 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -112.52 163.39 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 1 C-N-CA 132.779 4.431 . . . . 0.0 103.914 167.632 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -117.06 153.85 32.0 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.507 1.523 . . . . 0.0 108.497 168.151 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.3 t -130.97 136.24 58.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 175.216 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.365 14.9 ttmt -133.49 151.35 51.75 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 126.51 1.924 . . . . 0.0 113.596 172.632 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 p -110.42 151.01 28.0 Favored 'General case' 0 N--CA 1.443 -0.799 0 CA-C-O 122.867 1.317 . . . . 0.0 108.053 178.9 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.311 27.7 mt -61.25 -31.02 70.82 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 118.75 -2.469 . . . . 0.0 113.11 179.727 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.1 p -70.49 -3.35 17.41 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 131.466 3.906 . . . . 0.0 114.41 172.107 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.92 -18.28 29.1 Favored Glycine 0 CA--C 1.528 0.904 0 O-C-N 124.978 1.424 . . . . 0.0 113.024 153.211 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -62.83 127.25 30.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 118.893 -2.534 . . . . 0.0 111.603 176.966 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.2 m -116.85 144.41 44.53 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 128.511 2.724 . . . . 0.0 107.659 177.522 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.8 tt -146.05 132.8 14.41 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -175.735 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.9 m -70.04 150.27 46.8 Favored 'General case' 0 C--N 1.327 -0.388 1 O-C-N 115.693 -4.38 . . . . 0.0 108.156 166.192 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 tp -133.11 155.62 48.92 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 102.643 -3.095 . . . . 0.0 102.643 172.211 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -112.38 129.78 56.19 Favored 'General case' 0 N--CA 1.442 -0.854 0 O-C-N 119.64 -1.913 . . . . 0.0 107.751 172.194 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 m -146.77 154.81 11.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 130.11 3.364 . . . . 0.0 109.471 -174.346 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 62.6 tt0 -102.11 143.52 26.77 Favored Pre-proline 0 N--CA 1.446 -0.673 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 171.245 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -66.53 -16.1 49.85 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.837 3.024 . . . . 0.0 116.214 -173.069 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 52.5 p -85.6 -7.31 58.92 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 121.586 1.994 . . . . 0.0 116.35 165.126 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -58.61 142.99 47.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 O-C-N 117.575 -3.203 . . . . 0.0 110.345 173.361 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 26' ' ' VAL . 44.7 p -80.11 157.05 26.76 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 126.869 2.067 . . . . 0.0 112.193 174.684 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 mp -67.2 -29.57 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.355 1.462 . . . . 0.0 107.768 -178.143 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -64.72 -48.82 73.22 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.55 1.14 . . . . 0.0 108.346 172.734 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -54.35 -37.09 64.53 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 120.273 -1.517 . . . . 0.0 113.798 166.316 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 22' ' ' THR 0.257 3.5 t -64.34 -30.58 50.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 118.904 -2.372 . . . . 0.0 114.808 172.224 . . . . . . . . 3 3 . 1 . 098 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -76.82 -28.34 55.53 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 168.934 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.34 -36.0 63.62 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 122.424 1.107 . . . . 0.0 110.398 -179.248 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -68.01 -25.31 65.34 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 120.183 -1.573 . . . . 0.0 113.108 171.604 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -80.7 -38.04 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 171.562 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.21 -30.51 4.77 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 116.389 -3.945 . . . . 0.0 111.396 176.922 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -73.8 -29.45 62.17 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 125.702 1.601 . . . . 0.0 111.969 179.338 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -103.02 -50.99 3.36 Favored 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 117.17 -3.457 . . . . 0.0 110.324 -169.12 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -122.25 -2.93 9.01 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 126.435 1.894 . . . . 0.0 113.054 -168.345 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 96.4 -32.16 6.75 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 114.235 -3.536 . . . . 0.0 115.251 155.493 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.5 mt -55.3 128.75 67.5 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 128.729 2.811 . . . . 0.0 110.708 -170.722 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -64.86 139.99 64.85 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 128.253 5.969 . . . . 0.0 109.213 179.84 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -38.23 -40.99 1.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 1 C-N-CA 130.329 7.353 . . . . 0.0 115.821 176.648 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -61.6 -30.4 70.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 O-C-N 117.773 -3.08 . . . . 0.0 115.348 176.706 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -83.02 -26.65 31.01 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.377 1.444 . . . . 0.0 110.677 -176.738 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.274 77.5 mt-30 -91.37 137.26 32.51 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 124.966 1.416 . . . . 0.0 109.848 -178.526 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.262 3.8 mtt85 -107.42 146.26 31.91 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 111.208 -2.723 . . . . 0.0 110.773 155.439 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.2 mt -111.97 120.5 42.09 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 119.868 1.213 . . . . 0.0 108.156 167.174 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 22.0 mt -116.44 146.99 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 O-C-N 125.22 1.575 . . . . 0.0 108.599 -179.041 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -139.86 127.46 21.69 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 128.701 2.8 . . . . 0.0 104.078 166.112 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.252 . . 61.73 33.44 17.92 Favored 'General case' 0 N--CA 1.452 -0.34 0 O-C-N 119.804 -1.81 . . . . 0.0 111.948 170.765 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.85 -19.58 11.49 Favored Glycine 0 CA--C 1.538 1.517 0 O-C-N 118.495 -2.628 . . . . 0.0 111.776 -179.662 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -76.98 113.64 14.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 123.571 3.685 . . . . 0.0 107.032 -177.771 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.41 110.73 8.94 Favored 'General case' 0 C--O 1.221 -0.412 0 N-CA-C 104.06 -2.57 . . . . 0.0 104.06 162.276 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.6 mt -59.36 129.25 41.13 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 125.839 1.656 . . . . 0.0 108.608 168.485 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -92.32 138.95 31.09 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.891 0.876 . . . . 0.0 110.464 -179.998 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 -64.73 138.14 58.21 Favored 'General case' 0 CA--C 1.541 0.608 0 O-C-N 125.873 1.983 . . . . 0.0 110.466 -175.306 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.79 -30.81 6.65 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 127.929 2.681 . . . . 0.0 115.989 -175.784 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 -91.69 147.93 22.63 Favored 'General case' 0 CA--C 1.535 0.394 1 C-N-CA 132.889 4.475 . . . . 0.0 110.731 -178.209 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.5 p -102.03 170.49 8.09 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 125.145 1.528 . . . . 0.0 112.513 -171.438 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 mt -51.88 -42.91 63.03 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 128.618 3.699 . . . . 0.0 109.196 170.033 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -79.65 -28.16 40.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 120.02 -1.675 . . . . 0.0 114.645 -171.23 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -78.33 -40.06 37.74 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 173.045 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -83.07 0.19 46.12 Favored 'General case' 0 C--O 1.222 -0.367 0 O-C-N 117.852 -3.03 . . . . 0.0 109.951 -179.046 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.421 5.2 p-10 46.08 64.52 1.45 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.391 2.276 . . . . 0.0 113.161 -179.326 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.6 mm -83.89 -43.99 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 118.563 -1.255 . . . . 0.0 109.875 -166.176 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.415 52.9 mm-40 97.04 153.81 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.689 2.395 . . . . 0.0 111.774 166.747 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.39 131.51 45.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 O-C-N 119.044 -2.285 . . . . 0.0 108.008 177.07 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.282 3.4 mp0 81.41 10.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 127.194 2.809 . . . . 0.0 110.063 166.684 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.8 t -75.2 139.1 42.4 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 130.817 3.647 . . . . 0.0 107.82 172.992 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -100.15 126.72 46.45 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 103.031 -2.952 . . . . 0.0 103.031 -177.302 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.417 ' N ' HD12 ' A' ' 67' ' ' LEU . 2.2 mp -101.11 147.27 26.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.583 -1.189 . . . . 0.0 111.795 164.617 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -88.31 127.23 35.47 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 128.209 2.604 . . . . 0.0 107.537 -176.781 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 40.3 tp -114.22 123.82 50.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 103.253 -2.869 . . . . 0.0 103.253 -175.711 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.1 p -146.3 135.59 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -175.617 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 33.5 mt -89.48 158.69 17.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 125.228 2.442 . . . . 0.0 106.633 -163.159 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.7 ttt-85 -144.2 104.7 4.14 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 112.731 -2.031 . . . . 0.0 107.251 156.265 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.337 8.5 mp 88.76 148.39 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.345 1 C-N-CA 134.538 5.135 . . . . 0.0 111.621 179.683 . . . . . . . . 3 2 . 1 . 098 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.289 23.9 ttt180 -130.58 -52.2 1.08 Allowed 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 126.765 2.54 . . . . 0.0 108.96 177.36 . . . . . . . . 2 2 . 1 . 098 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.17 148.56 10.77 Favored Glycine 0 CA--C 1.536 1.376 0 N-CA-C 104.643 -3.383 . . . . 0.0 104.643 -172.965 . . . . . . . . 1 1 . 1 . 098 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 N-CA-C 110.356 -1.098 . . . . 0.0 110.356 -174.451 . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ttp . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 . . . . . . . . . 0 0 . 1 . 099 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -79.66 133.93 36.4 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 173.975 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.9 pt -138.1 171.73 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 N-CA-C 103.522 -2.77 . . . . 0.0 103.522 169.818 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -115.69 122.11 44.55 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 118.07 -2.894 . . . . 0.0 113.36 175.625 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.1 t -93.72 102.99 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 122.786 2.539 . . . . 0.0 111.193 166.701 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . 0.268 21.3 tptt -80.49 122.98 27.67 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 128.039 2.535 . . . . 0.0 111.846 165.216 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 73.8 p -102.99 156.63 17.54 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 114.711 -1.131 . . . . 0.0 110.747 -176.256 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.781 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -53.77 -26.19 22.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 130.068 3.347 . . . . 0.0 118.267 -175.946 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -86.78 -10.65 53.07 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 127.245 2.841 . . . . 0.0 112.144 -177.8 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.89 -3.99 57.46 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 130.275 3.798 . . . . 0.0 117.761 -178.992 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -71.69 143.0 49.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 120.147 1.973 . . . . 0.0 111.411 175.402 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 154.17 33.04 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.002 173.538 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 9.4 mt -135.23 143.18 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 129.341 3.056 . . . . 0.0 108.682 -176.826 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -119.73 102.02 8.31 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.313 179.949 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 40.2 mt -96.02 170.05 9.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 117.854 2.539 . . . . 0.0 117.854 -177.203 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -121.57 90.94 3.41 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 123.265 1.507 . . . . 0.0 112.149 167.926 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.9 m -99.49 172.5 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 O-C-N 117.595 -3.191 . . . . 0.0 109.912 -177.536 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -131.94 130.8 22.29 Favored Pre-proline 0 N--CA 1.447 -0.624 2 O-C-N 114.672 -5.017 . . . . 0.0 107.223 -164.39 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -42.94 -29.82 1.65 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 1 CA-C-N 129.146 4.302 . . . . 0.0 116.937 167.408 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 99.2 p -75.73 -13.99 60.32 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 129.0 2.92 . . . . 0.0 114.869 176.871 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.463 ' HB2' HD13 ' A' ' 56' ' ' LEU . 66.1 m-20 -79.87 129.29 34.36 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 124.47 2.081 . . . . 0.0 109.989 -170.682 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.1 p -73.21 163.04 28.68 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 125.482 2.563 . . . . 0.0 105.57 177.896 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 32.5 mm -55.28 -36.23 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 O-C-N 117.82 -3.05 . . . . 0.0 112.631 172.028 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -68.48 -30.38 69.21 Favored 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 117.494 -3.254 . . . . 0.0 113.346 169.568 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.439 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 13.2 m120 -59.82 -43.76 94.37 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 119.397 3.11 . . . . 0.0 119.397 170.63 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -52.74 -50.09 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 O-C-N 127.707 3.13 . . . . 0.0 114.279 174.591 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -54.01 -46.37 71.78 Favored 'General case' 0 N--CA 1.448 -0.574 0 O-C-N 129.075 3.984 . . . . 0.0 109.229 172.609 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -63.73 -39.16 93.62 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.827 2.051 . . . . 0.0 115.386 174.252 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -58.23 -41.82 84.98 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.353 2.261 . . . . 0.0 116.032 165.423 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.8 mt -67.09 -45.52 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 O-C-N 120.388 -1.445 . . . . 0.0 110.976 176.56 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -45.26 -59.79 2.47 Favored 'General case' 0 N--CA 1.449 -0.522 0 O-C-N 127.51 3.006 . . . . 0.0 111.761 173.099 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -52.42 -34.95 50.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 113.284 -1.78 . . . . 0.0 111.786 -175.059 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 mmtt -98.17 -37.57 9.65 Favored 'General case' 0 N--CA 1.446 -0.637 0 O-C-N 126.17 2.168 . . . . 0.0 116.687 -168.682 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -128.3 6.15 5.82 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 127.291 2.237 . . . . 0.0 116.07 -173.606 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.8 11.51 63.07 Favored Glycine 0 CA--C 1.532 1.142 1 O-C-N 116.178 -4.076 . . . . 0.0 119.887 174.678 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 63.3 mt -83.4 130.66 55.56 Favored Pre-proline 0 N--CA 1.442 -0.839 0 CA-C-N 120.734 2.267 . . . . 0.0 105.238 177.274 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 40' ' ' GLN 0.264 73.7 Cg_endo -80.66 159.45 21.92 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 O-C-N 116.098 -2.632 . . . . 0.0 113.371 174.103 . . . . . . . . 3 3 . 1 . 099 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -65.83 -40.63 16.33 Favored 'Trans proline' 0 N--CA 1.443 -1.467 1 C-N-CA 125.395 4.063 . . . . 0.0 110.559 -170.882 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.26 24.7 t70 -55.96 -22.57 27.17 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 113.335 -3.221 . . . . 0.0 116.379 176.622 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' HB2' ' HG2' ' A' ' 37' ' ' PRO . 37.6 tt0 -86.34 -10.09 55.11 Favored 'General case' 0 N--CA 1.445 -0.711 0 O-C-N 128.401 3.563 . . . . 0.0 110.009 -178.142 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 -100.49 161.15 13.79 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 125.791 1.636 . . . . 0.0 107.136 -157.389 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -157.04 126.19 5.96 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 125.351 2.5 . . . . 0.0 107.713 162.142 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.2 mt -99.59 126.02 45.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 118.74 -2.475 . . . . 0.0 106.738 -174.757 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 26.2 mm -111.45 143.64 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 C-N-CA 129.879 3.271 . . . . 0.0 110.267 179.469 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -146.81 137.12 23.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.27 3.028 . . . . 0.0 108.666 166.626 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.281 . . 53.33 42.0 32.08 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 131.186 3.794 . . . . 0.0 112.454 172.648 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.27 10.18 85.72 Favored Glycine 0 CA--C 1.536 1.387 0 CA-C-O 114.429 -3.428 . . . . 0.0 114.708 -174.864 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -147.98 163.0 38.19 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 123.723 3.761 . . . . 0.0 115.305 179.172 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.5 tm0? -63.64 133.78 54.27 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 131.655 3.982 . . . . 0.0 110.316 171.017 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 31.4 mt -99.31 126.73 45.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 163.609 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.93 156.85 20.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 O-C-N 126.324 2.265 . . . . 0.0 113.315 -174.007 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -58.19 155.28 11.6 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 113.704 -1.589 . . . . 0.0 113.567 -169.075 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.85 0.04 48.67 Favored Glycine 0 CA--C 1.525 0.665 1 O-C-N 130.388 4.805 . . . . 0.0 113.266 150.438 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 80.5 mtt180 -120.17 169.5 10.18 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 131.008 3.723 . . . . 0.0 112.321 179.336 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.3 p -105.92 163.87 12.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 116.557 -1.687 . . . . 0.0 113.916 -173.504 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.506 HD12 ' H ' ' A' ' 56' ' ' LEU . 5.9 mp -41.72 -37.83 1.3 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 112.645 -3.55 . . . . 0.0 115.108 156.94 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 87.9 p -71.58 -38.37 70.94 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 124.721 3.419 . . . . 0.0 117.94 170.531 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -69.95 -29.37 66.48 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 122.163 2.256 . . . . 0.0 115.319 173.761 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -87.68 8.84 23.61 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 118.68 -2.512 . . . . 0.0 108.132 173.112 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 63.26 24.47 14.31 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 124.211 3.187 . . . . 0.0 117.183 171.32 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 29.6 mt -76.87 127.71 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 O-C-N 118.636 -2.54 . . . . 0.0 116.749 -175.217 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.278 4.3 tp-100 -110.6 165.16 12.04 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 127.835 2.454 . . . . 0.0 109.896 -170.335 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.2 155.83 2.51 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 117.086 -3.509 . . . . 0.0 115.556 178.532 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 57.06 1.03 0.09 Allowed 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 127.434 2.294 . . . . 0.0 116.509 170.435 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.5 m -60.12 151.31 27.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 130.48 3.512 . . . . 0.0 110.5 173.893 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 39.9 m -103.47 115.69 31.0 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 177.632 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.38 148.01 24.45 Favored 'General case' 0 N--CA 1.445 -0.68 1 C-N-CA 132.618 4.367 . . . . 0.0 107.784 160.402 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -113.68 148.4 36.42 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 122.312 2.324 . . . . 0.0 109.597 176.467 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 30.5 tp -119.28 136.63 54.14 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 128.259 2.623 . . . . 0.0 107.274 178.996 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 t -110.97 167.99 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 O-C-N 125.222 1.576 . . . . 0.0 111.476 157.048 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.593 1.1 pp -127.41 137.28 52.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 120.573 1.533 . . . . 0.0 113.821 171.176 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -89.32 -171.96 3.44 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 111.757 -2.474 . . . . 0.0 108.796 178.319 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.9 mt -90.68 164.56 14.11 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 128.381 2.673 . . . . 0.0 112.568 169.899 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.44 36.7 ttp180 81.36 127.02 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 128.179 2.591 . . . . 0.0 111.839 -177.079 . . . . . . . . 2 2 . 1 . 099 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 117.98 157.09 10.49 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 104.698 -3.361 . . . . 0.0 104.698 178.715 . . . . . . . . 1 1 . 1 . 099 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.349 0 N-CA-C 106.953 -2.459 . . . . 0.0 106.953 -179.815 . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.0 ttp . . . . . 0 C--O 1.234 0.248 0 CA-C-O 115.737 -2.078 . . . . 0.0 106.554 . . . . . . . . . 0 0 . 1 . 100 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.472 HE21 HG23 ' A' ' 14' ' ' THR . 57.9 tt0 -90.75 138.96 31.17 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 121.383 1.901 . . . . 0.0 108.748 173.331 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 pt -125.96 159.76 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 130.081 3.352 . . . . 0.0 109.372 159.908 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.46 ' HB2' ' HA ' ' A' ' 66' ' ' THR 0.279 73.4 m-85 -95.47 144.0 26.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 165.726 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 52.8 t -116.14 149.07 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 127.878 2.471 . . . . 0.0 108.768 163.987 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -136.79 150.07 48.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 130.488 3.515 . . . . 0.0 104.243 177.721 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 52.5 p -106.79 -170.97 1.8 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 111.731 -2.486 . . . . 0.0 106.189 -179.786 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 46.1 mt -106.67 -11.75 15.74 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 126.548 3.071 . . . . 0.0 112.951 -176.318 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 p -89.15 -6.02 57.3 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 119.077 -2.265 . . . . 0.0 110.994 173.859 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.8 -28.47 5.43 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 129.263 3.316 . . . . 0.0 111.107 171.572 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 47.3 tttt -73.12 142.48 47.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 118.438 -0.791 . . . . 0.0 110.067 -158.509 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.5 p -113.02 136.73 52.37 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.465 1.906 . . . . 0.0 109.897 -179.171 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.7 pt -117.78 143.6 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 131.4 3.88 . . . . 0.0 102.191 168.297 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.472 HG23 HE21 ' A' ' 2' ' ' GLN 0.427 78.5 m -97.58 141.23 30.88 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 104.045 -2.576 . . . . 0.0 104.045 169.559 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.291 0.0 OUTLIER -131.23 125.28 32.49 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 127.068 2.147 . . . . 0.0 109.042 -176.649 . . . . . . . . 3 3 . 1 . 100 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.4 132.2 37.25 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 129.238 3.015 . . . . 0.0 112.203 156.162 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -147.99 160.35 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 127.235 2.214 . . . . 0.0 111.689 -177.81 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -121.19 154.87 58.73 Favored Pre-proline 0 N--CA 1.445 -0.707 0 N-CA-C 100.724 -3.806 . . . . 0.0 100.724 173.976 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.82 -17.91 17.44 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 121.775 1.65 . . . . 0.0 115.865 -171.575 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.0 p -84.42 5.14 28.42 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 117.381 -1.295 . . . . 0.0 111.642 -175.064 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.03 139.51 39.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 128.431 2.693 . . . . 0.0 114.646 178.903 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 p -94.61 134.88 36.7 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 127.265 2.226 . . . . 0.0 114.664 -177.067 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.442 5.0 mt -42.14 -40.61 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -177.006 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -78.39 -13.95 59.61 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 117.156 -3.465 . . . . 0.0 113.5 176.429 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -89.64 -23.32 21.93 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 116.158 -1.877 . . . . 0.0 114.056 162.815 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.84 -36.18 73.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 116.343 -1.789 . . . . 0.0 110.129 168.034 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -60.2 -39.69 87.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 122.457 2.389 . . . . 0.0 113.487 170.078 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.12 -36.5 79.83 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 115.583 -2.151 . . . . 0.0 113.664 169.694 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.1 tttt -61.81 -38.05 86.69 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 123.379 2.809 . . . . 0.0 110.349 169.606 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.366 66.4 mt -62.19 -32.66 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 O-C-N 117.7 -3.125 . . . . 0.0 117.416 169.96 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -27.24 68.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.708 1.203 . . . . 0.0 113.774 175.947 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -84.11 -33.98 24.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 126.139 2.15 . . . . 0.0 107.371 -176.726 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -73.75 -43.45 59.02 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 116.004 1.853 . . . . 0.0 116.004 177.469 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.302 47.8 tp10 -142.02 -5.2 1.01 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 123.383 1.563 . . . . 0.0 108.135 -152.855 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.24 -9.17 69.81 Favored Glycine 0 N--CA 1.443 -0.877 1 O-C-N 115.975 -4.203 . . . . 0.0 122.558 162.497 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 68.0 mt -79.03 124.02 84.83 Favored Pre-proline 0 N--CA 1.45 -0.431 0 CA-C-O 114.389 -2.719 . . . . 0.0 105.241 -171.2 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.303 58.9 Cg_endo -54.48 149.78 37.26 Favored 'Trans proline' 0 N--CA 1.451 -0.998 0 C-N-CA 122.46 2.107 . . . . 0.0 115.394 172.221 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -84.29 -25.62 2.08 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 N-CA-C 107.28 -1.854 . . . . 0.0 107.28 -162.165 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -48.84 -47.62 42.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 117.708 2.484 . . . . 0.0 117.708 177.73 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -95.78 13.65 25.87 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.497 1.519 . . . . 0.0 108.029 -175.51 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -92.78 145.44 24.4 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 122.144 2.247 . . . . 0.0 109.919 171.192 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -147.63 124.23 11.1 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 130.005 3.322 . . . . 0.0 109.015 -177.261 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.2 mp -101.39 139.01 37.64 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 125.875 1.67 . . . . 0.0 110.823 -177.161 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.9 mt -121.84 140.67 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 131.372 3.869 . . . . 0.0 110.292 168.761 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -116.54 -32.02 5.35 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 119.245 -2.159 . . . . 0.0 113.917 166.254 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -114.7 -107.16 0.38 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-O 115.43 -2.224 . . . . 0.0 106.312 175.961 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -119.95 2.77 13.19 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 117.931 1.932 . . . . 0.0 117.931 166.569 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -113.11 151.62 30.59 Favored 'General case' 0 C--O 1.218 -0.573 0 O-C-N 118.999 -2.471 . . . . 0.0 107.495 -160.707 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -66.41 144.65 56.39 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.676 163.912 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 41.4 mt -98.05 147.41 24.56 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 127.873 2.469 . . . . 0.0 106.534 172.729 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -66.96 114.59 5.88 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 157.677 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -53.35 -30.32 38.86 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 119.915 3.302 . . . . 0.0 119.915 -176.38 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -101.68 18.44 52.95 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 108.87 -1.692 . . . . 0.0 108.87 -168.753 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -94.02 168.69 10.79 Favored 'General case' 0 N--CA 1.45 -0.454 0 O-C-N 125.572 1.395 . . . . 0.0 109.913 167.232 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.1 p -96.08 166.93 11.52 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 130.628 3.571 . . . . 0.0 116.53 175.29 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.9 mp -55.79 -38.41 69.88 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 114.492 -2.671 . . . . 0.0 115.538 168.6 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.8 p -76.1 -31.27 58.6 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 128.555 2.742 . . . . 0.0 106.702 -171.397 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 53.2 m-20 -57.42 -35.01 69.53 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 120.083 1.311 . . . . 0.0 111.809 173.999 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -108.39 -3.57 18.15 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 -170.741 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.419 36.9 t-20 67.16 53.47 0.79 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 127.324 2.89 . . . . 0.0 111.904 178.8 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 12.1 mm -79.11 115.68 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 127.94 2.496 . . . . 0.0 104.491 168.494 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 -93.15 156.88 16.58 Favored 'General case' 0 N--CA 1.448 -0.534 1 C-N-CA 132.014 4.126 . . . . 0.0 111.438 177.047 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -67.4 149.01 50.84 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 119.645 -1.91 . . . . 0.0 111.78 -177.245 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.393 19.2 mt-10 80.67 -2.4 1.86 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 114.09 -2.862 . . . . 0.0 113.219 172.78 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.8 m -66.58 159.63 27.03 Favored 'General case' 0 N--CA 1.449 -0.494 1 O-C-N 130.016 4.573 . . . . 0.0 112.616 -177.229 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.46 ' HA ' ' HB2' ' A' ' 4' ' ' PHE . 53.5 m -103.74 121.29 42.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 104.418 -2.438 . . . . 0.0 104.418 175.083 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.7 tt -110.31 154.45 23.46 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 117.803 -3.061 . . . . 0.0 106.486 -179.347 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -120.95 119.77 33.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 O-C-N 116.507 -3.871 . . . . 0.0 110.415 -167.826 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.1 tp -98.4 142.57 29.86 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.582 2.353 . . . . 0.0 110.178 178.983 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.49 HG12 ' N ' ' A' ' 71' ' ' LEU . 96.1 t -124.3 162.98 24.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 129.187 2.995 . . . . 0.0 109.687 177.217 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.49 ' N ' HG12 ' A' ' 70' ' ' VAL . 2.4 pt? -153.46 163.58 39.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 122.455 1.121 . . . . 0.0 109.227 177.685 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.3 mtm105 -126.94 52.96 1.74 Allowed 'General case' 0 N--CA 1.447 -0.62 0 O-C-N 118.848 -2.407 . . . . 0.0 108.802 -173.104 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.47 4.2 pp -135.05 -2.64 2.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 120.059 1.3 . . . . 0.0 109.72 -179.755 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.513 ' HE ' ' C ' ' A' ' 76' ' ' GLY . 2.8 tmm_? -94.44 -28.1 15.66 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 -168.026 . . . . . . . . 2 2 . 1 . 100 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.66 18.32 5.72 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 121.591 1.996 . . . . 0.0 112.911 -171.358 . . . . . . . . 1 1 . 1 . 100 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.513 ' C ' ' HE ' ' A' ' 74' ' ' ARG . . . . . . . . 0 C--O 1.249 1.062 0 C-N-CA 129.69 3.519 . . . . 0.0 104.939 -167.633 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.4 ttm . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 116.982 -1.485 . . . . 0.0 110.509 . . . . . . . . . 0 0 . 1 . 101 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -106.11 122.49 46.29 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 -166.209 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 29.1 pt -132.8 174.1 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 O-C-N 125.723 1.889 . . . . 0.0 109.086 167.832 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.283 7.6 p90 -150.62 149.06 29.39 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 117.033 -3.542 . . . . 0.0 109.509 -171.457 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.469 HG12 ' HB2' ' A' ' 67' ' ' LEU . 4.7 m -114.58 150.42 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 179.909 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.1 tptt -109.26 123.42 49.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 175.624 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.8 p -68.51 172.88 5.55 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 128.538 2.735 . . . . 0.0 110.584 176.861 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.76 -26.5 66.15 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.805 167.43 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.0 p -88.92 -4.27 58.5 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 114.395 1.257 . . . . 0.0 114.395 179.978 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.91 -4.29 57.55 Favored Glycine 0 CA--C 1.528 0.898 1 CA-C-O 112.379 -4.567 . . . . 0.0 111.823 166.128 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -84.62 141.5 30.61 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 123.922 3.861 . . . . 0.0 110.885 178.139 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.276 53.9 m -104.15 148.62 26.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 121.658 2.026 . . . . 0.0 105.906 -168.433 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.3 mt -128.48 121.08 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 126.824 2.05 . . . . 0.0 107.936 176.951 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.8 m -92.67 129.77 38.5 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 126.561 1.945 . . . . 0.0 106.63 -177.244 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -111.91 139.4 47.43 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 127.147 2.779 . . . . 0.0 106.403 -175.48 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.294 22.3 tp10 -96.22 127.18 42.0 Favored 'General case' 0 N--CA 1.445 -0.694 0 O-C-N 118.442 -2.661 . . . . 0.0 107.211 159.635 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.63 161.81 35.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 103.503 -2.776 . . . . 0.0 103.503 177.823 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -107.85 121.56 43.61 Favored Pre-proline 0 N--CA 1.446 -0.667 1 C-N-CA 133.366 4.666 . . . . 0.0 104.877 160.63 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.25 10.4 Cg_endo -65.19 -2.57 5.99 Favored 'Trans proline' 0 N--CA 1.447 -1.226 1 C-N-CA 127.188 5.258 . . . . 0.0 117.483 -160.22 . . . . . . . . 3 2 . 1 . 101 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.5 p -96.85 3.4 52.21 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 117.895 -1.05 . . . . 0.0 109.86 -177.331 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -77.12 157.04 31.23 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.694 1.597 . . . . 0.0 111.523 174.932 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.7 p -100.53 149.93 23.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 -172.338 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.443 ' H ' HG12 ' A' ' 23' ' ' ILE . 5.5 mm -51.96 -31.86 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 112.609 -3.567 . . . . 0.0 116.477 -178.005 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -65.38 -26.54 68.05 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 123.079 2.672 . . . . 0.0 113.136 174.188 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -81.69 -21.24 38.17 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.506 1.503 . . . . 0.0 112.744 178.495 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 12.6 t -71.4 -52.53 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 1 C-N-CA 133.804 4.842 . . . . 0.0 110.082 167.716 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -53.6 -34.13 57.35 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 116.555 -3.84 . . . . 0.0 118.12 168.299 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.74 -18.85 39.31 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 120.395 -1.441 . . . . 0.0 112.06 -178.439 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.0 mttp -69.95 -17.23 63.3 Favored 'General case' 0 N--CA 1.446 -0.659 0 O-C-N 116.844 -3.66 . . . . 0.0 117.026 167.293 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.5 mm -84.83 -35.56 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-O 116.736 -1.602 . . . . 0.0 108.733 -174.743 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -52.14 -43.41 64.03 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 129.618 3.167 . . . . 0.0 111.863 -166.783 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -70.85 -29.3 65.39 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 122.767 2.53 . . . . 0.0 113.272 179.701 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 34.7 mmtt -75.18 -56.77 4.4 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 118.393 -2.692 . . . . 0.0 109.914 173.294 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -134.29 137.63 44.39 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 103.379 -2.823 . . . . 0.0 103.379 -165.524 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -105.48 40.87 2.32 Favored Glycine 0 CA--C 1.532 1.126 0 N-CA-C 107.43 -2.268 . . . . 0.0 107.43 -149.71 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 71' ' ' LEU . 43.6 mt -91.93 119.66 68.24 Favored Pre-proline 0 C--N 1.328 -0.346 0 C-N-CA 130.066 3.347 . . . . 0.0 113.807 -174.781 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.97 138.94 23.78 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 121.273 1.49 . . . . 0.0 113.024 -168.273 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -52.08 -18.75 7.66 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 CA-C-O 111.452 -3.645 . . . . 0.0 116.18 177.59 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -88.61 12.15 15.42 Favored 'General case' 0 C--O 1.238 0.491 1 CA-C-N 127.076 4.489 . . . . 0.0 112.314 175.078 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . 0.336 8.2 tt0 -127.01 -18.86 4.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 119.511 -1.993 . . . . 0.0 111.222 -176.858 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.273 77.3 mt-30 -92.66 156.64 16.95 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 179.254 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -144.8 147.69 33.18 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.212 -2.885 . . . . 0.0 103.212 170.49 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.8 mt -117.76 136.06 53.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 127.526 2.331 . . . . 0.0 110.078 -176.591 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 44' ' ' ILE . 56.2 mt -122.15 143.18 35.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 102.12 -3.289 . . . . 0.0 102.12 172.892 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -118.03 106.45 12.92 Favored 'General case' 0 C--N 1.33 -0.273 2 CA-C-N 105.312 -5.404 . . . . 0.0 112.332 154.675 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.462 . . 87.18 4.22 0.36 Allowed 'General case' 0 CA--C 1.532 0.265 1 O-C-N 111.987 -6.696 . . . . 0.0 116.69 157.537 . . . . . . . . 3 2 . 1 . 101 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.7 2.22 46.47 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.714 -171.794 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -92.23 124.07 36.03 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 128.349 2.659 . . . . 0.0 111.276 165.012 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -77.18 128.46 34.42 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 168.788 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.279 11.9 mt -68.15 126.54 29.84 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 118.336 2.717 . . . . 0.0 118.336 170.388 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -98.75 139.09 34.95 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 -173.625 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.45 142.83 57.7 Favored 'General case' 0 C--O 1.22 -0.457 0 O-C-N 117.996 -2.94 . . . . 0.0 109.013 176.787 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.68 -19.04 56.34 Favored Glycine 0 CA--C 1.524 0.626 0 O-C-N 119.108 -2.245 . . . . 0.0 108.126 171.519 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -81.09 157.97 25.2 Favored 'General case' 0 N--CA 1.453 -0.319 1 O-C-N 115.072 -4.781 . . . . 0.0 106.538 173.123 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 59.1 p -92.03 165.93 12.94 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 120.558 -1.339 . . . . 0.0 109.967 165.689 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 21.4 mt -51.7 -45.79 63.65 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 128.451 2.7 . . . . 0.0 113.286 163.075 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.1 t -53.45 -28.84 32.51 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 118.563 2.801 . . . . 0.0 118.563 170.082 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.01 -23.65 48.2 Favored 'General case' 0 N--CA 1.447 -0.597 1 O-C-N 115.068 -4.77 . . . . 0.0 115.857 178.356 . . . . . . . . 3 3 . 1 . 101 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . 0.28 45.9 m-85 -97.99 -9.05 26.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.309 1.444 . . . . 0.0 114.303 172.497 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.377 26.5 t30 72.54 47.18 0.26 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 130.324 3.45 . . . . 0.0 111.405 -178.233 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.2 mt -82.57 103.58 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 167.943 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -90.09 -175.06 4.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 130.02 3.328 . . . . 0.0 115.901 170.458 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.76 138.58 41.85 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 129.613 3.165 . . . . 0.0 112.933 173.498 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.454 62.8 tt0 83.93 2.24 0.91 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 126.867 2.067 . . . . 0.0 114.657 167.53 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 55.0 m -77.88 134.1 38.0 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.23 -1.544 . . . . 0.0 111.104 -169.195 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -85.19 115.55 23.04 Favored 'General case' 0 N--CA 1.447 -0.606 0 O-C-N 126.662 2.476 . . . . 0.0 104.733 174.44 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.469 ' HB2' HG12 ' A' ' 5' ' ' VAL . 51.3 mt -94.83 171.03 9.02 Favored 'General case' 0 N--CA 1.444 -0.732 0 O-C-N 128.208 3.443 . . . . 0.0 107.262 161.839 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -130.96 139.13 50.0 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.781 -1.1 . . . . 0.0 110.721 -179.029 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.3 tp -101.95 120.87 41.1 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 103.477 -2.786 . . . . 0.0 103.477 -171.006 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.1 m -137.37 172.95 13.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 127.497 2.319 . . . . 0.0 105.973 -175.287 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD11 HG21 ' A' ' 36' ' ' ILE . 2.3 mp -129.0 142.78 50.81 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 122.816 0.446 . . . . 0.0 110.687 -165.576 . . . . . . . . 2 2 . 1 . 101 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.8 ttt85 -161.11 114.1 1.94 Allowed 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 130.096 3.358 . . . . 0.0 105.846 174.218 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 58.7 mt -51.86 126.61 18.59 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 161.635 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -66.19 134.18 52.19 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 130.932 3.693 . . . . 0.0 109.174 178.689 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -116.37 22.16 11.3 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 116.259 -2.412 . . . . 0.0 118.231 176.704 . . . . . . . . 1 1 . 1 . 101 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 N-CA-C 106.564 -2.614 . . . . 0.0 106.564 -176.501 . . . . . . . . 0 0 . 1 . 102 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.1 ttp . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 116.654 -1.641 . . . . 0.0 107.281 . . . . . . . . . 0 0 . 1 . 102 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -93.95 138.59 31.9 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 124.041 1.877 . . . . 0.0 111.164 170.842 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.0 pt -136.74 167.71 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 126.704 2.001 . . . . 0.0 107.897 162.289 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -119.87 135.2 54.97 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 -177.144 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.468 HG21 HD12 ' A' ' 15' ' ' LEU . 88.0 t -121.43 89.58 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 126.674 2.484 . . . . 0.0 104.907 178.747 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -77.83 121.32 23.94 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.456 3.902 . . . . 0.0 107.018 -175.542 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 78.8 p -84.61 155.05 22.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 104.461 -2.422 . . . . 0.0 104.461 175.373 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 38.7 mt -50.44 -16.81 0.39 Allowed 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 131.415 3.886 . . . . 0.0 115.664 176.558 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 t -97.81 6.35 47.95 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.18 0.992 . . . . 0.0 111.731 172.706 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.08 -36.32 4.47 Favored Glycine 0 CA--C 1.526 0.731 0 O-C-N 120.007 -1.683 . . . . 0.0 109.951 167.515 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -60.24 127.68 33.0 Favored 'General case' 0 C--N 1.33 -0.255 1 C-N-CA 132.369 4.268 . . . . 0.0 106.69 -174.718 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.253 20.6 m -119.19 123.81 45.25 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.102 2.561 . . . . 0.0 109.071 -166.014 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.1 mm -82.48 120.37 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 168.235 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.8 m -74.35 134.8 42.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 124.88 1.363 . . . . 0.0 109.27 166.735 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.468 HD12 HG21 ' A' ' 5' ' ' VAL . 2.3 mt -125.44 129.91 50.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 120.645 1.566 . . . . 0.0 113.259 179.593 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.48 90.77 7.69 Favored 'General case' 0 C--O 1.222 -0.37 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 170.133 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -98.99 164.58 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.321 177.996 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.265 30.5 tp10 -107.81 156.21 38.49 Favored Pre-proline 0 N--CA 1.447 -0.597 0 CA-C-O 113.612 -3.09 . . . . 0.0 105.017 162.3 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -59.93 -25.07 78.49 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 124.127 3.218 . . . . 0.0 118.073 170.557 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 84.5 p -88.57 1.65 54.53 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 119.439 3.125 . . . . 0.0 119.439 -179.732 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -72.43 149.18 44.47 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 114.439 -2.696 . . . . 0.0 115.891 -177.605 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 p -65.95 151.67 46.26 Favored 'General case' 0 C--N 1.325 -0.459 1 O-C-N 129.62 4.325 . . . . 0.0 110.475 167.04 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -61.02 -29.01 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 116.591 -1.671 . . . . 0.0 110.412 173.251 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -70.3 -50.61 37.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 128.045 2.538 . . . . 0.0 111.379 -173.056 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -50.3 -45.04 54.3 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.132 2.573 . . . . 0.0 112.629 170.93 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 44.8 t -71.4 -45.85 67.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 125.856 1.662 . . . . 0.0 108.158 -176.28 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -63.61 -31.19 72.28 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.251 1.42 . . . . 0.0 114.397 178.101 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -61.71 -14.87 35.6 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 130.38 3.472 . . . . 0.0 113.56 177.084 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.04 -31.2 27.51 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 119.119 -2.238 . . . . 0.0 107.083 174.571 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.2 mm -81.51 -6.99 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 117.348 -1.31 . . . . 0.0 109.961 176.907 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -76.54 -28.99 56.51 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 118.104 -2.873 . . . . 0.0 109.102 163.37 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.55 -47.21 12.41 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -163.292 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mttm -73.18 -73.77 0.2 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 128.332 2.653 . . . . 0.0 112.214 178.437 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -85.45 -16.57 39.24 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.736 2.414 . . . . 0.0 117.183 -166.942 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.97 -7.84 67.53 Favored Glycine 0 CA--C 1.535 1.313 0 CA-C-O 117.142 -1.921 . . . . 0.0 112.786 -179.777 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.261 37.9 mm -80.29 115.03 51.91 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-N 123.141 3.471 . . . . 0.0 112.248 -163.485 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -55.67 160.22 9.91 Favored 'Trans proline' 0 N--CA 1.445 -1.354 1 C-N-CA 126.126 4.551 . . . . 0.0 113.941 171.011 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -74.63 5.82 3.59 Favored 'Trans proline' 0 N--CA 1.443 -1.468 0 N-CA-C 120.028 3.049 . . . . 0.0 120.028 -176.509 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.378 82.8 m-20 -104.72 -6.37 20.43 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 126.312 2.958 . . . . 0.0 117.929 174.451 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -97.82 -6.47 32.55 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 119.304 -2.122 . . . . 0.0 114.703 160.992 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -85.25 85.93 7.42 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 118.042 2.608 . . . . 0.0 118.042 169.51 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -93.85 97.22 10.25 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 102.862 -3.014 . . . . 0.0 102.862 -171.421 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 6.0 mt -93.06 139.15 30.85 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 -163.654 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 44' ' ' ILE . 24.3 mt -136.47 135.55 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 126.31 1.844 . . . . 0.0 110.039 177.754 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -129.38 107.13 9.27 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.07 3.348 . . . . 0.0 105.465 -178.465 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.39 42.0 31.65 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 127.426 2.291 . . . . 0.0 115.176 167.634 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 99.2 -25.29 28.81 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 119.707 -1.87 . . . . 0.0 114.199 -178.449 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -93.77 114.22 26.45 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 -171.227 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.292 7.8 tt0 -82.28 140.78 33.41 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 104.206 -2.516 . . . . 0.0 104.206 169.1 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.7 mp -99.56 135.75 40.51 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 130.576 3.551 . . . . 0.0 109.362 -174.159 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -104.5 -4.01 23.22 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 128.203 2.601 . . . . 0.0 109.113 -172.013 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.323 7.5 m-20 84.38 168.35 0.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 118.105 -0.95 . . . . 0.0 111.278 170.247 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.62 -16.89 36.93 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 123.812 0.695 . . . . 0.0 113.881 169.232 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -120.98 -171.69 2.24 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.976 2.111 . . . . 0.0 105.366 -171.05 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.261 7.0 p -111.66 167.66 10.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 121.233 -0.917 . . . . 0.0 110.894 -165.463 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . 0.284 9.3 mp -56.32 -28.86 60.28 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 169.249 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 97.7 p -77.06 -34.33 57.11 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 116.572 -2.051 . . . . 0.0 114.489 179.087 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -69.64 -40.39 76.54 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 127.924 3.265 . . . . 0.0 113.143 -177.685 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -79.44 0.56 28.91 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 117.519 -3.238 . . . . 0.0 109.341 171.045 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.366 1.6 t-20 70.6 49.13 0.42 Allowed 'General case' 0 N--CA 1.439 -1.013 0 CA-C-O 126.277 2.942 . . . . 0.0 115.647 169.903 . . . . . . . . 2 2 . 1 . 102 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -101.79 123.45 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 112.538 -2.119 . . . . 0.0 107.336 -174.736 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -111.72 -164.96 0.95 Allowed 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 124.96 1.413 . . . . 0.0 113.696 -168.104 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 76.6 mttt -69.97 114.72 8.41 Favored 'General case' 0 N--CA 1.448 -0.557 0 O-C-N 119.44 -2.037 . . . . 0.0 107.619 174.611 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.312 5.7 tt0 89.4 12.3 0.07 Allowed 'General case' 0 C--O 1.236 0.374 1 O-C-N 115.915 -4.241 . . . . 0.0 112.746 167.307 . . . . . . . . 3 2 . 1 . 102 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.7 m -49.76 152.23 1.55 Allowed 'General case' 0 C--N 1.327 -0.381 0 O-C-N 117.661 -3.149 . . . . 0.0 112.179 167.953 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.1 m -116.15 130.54 56.85 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.637 167.928 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 8.3 mt -101.92 123.56 46.05 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 126.078 1.751 . . . . 0.0 112.4 166.13 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -84.65 110.32 18.65 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 104.63 -2.359 . . . . 0.0 104.63 173.004 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 21.1 tp -89.2 103.76 16.36 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 127.727 2.411 . . . . 0.0 108.933 172.413 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.2 t -81.36 116.75 26.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 127.63 2.372 . . . . 0.0 109.292 163.502 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.8 mp -88.5 116.38 26.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 115.112 -2.375 . . . . 0.0 104.682 175.202 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 75.6 mtt-85 -72.11 146.65 47.36 Favored 'General case' 0 N--CA 1.442 -0.851 0 O-C-N 127.754 3.159 . . . . 0.0 109.503 159.798 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.3 mt -94.49 13.43 23.99 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 165.699 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -148.27 -163.71 1.84 Allowed 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 128.323 3.514 . . . . 0.0 103.681 -175.335 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -109.43 159.6 13.93 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-O 115.618 -2.768 . . . . 0.0 110.015 174.515 . . . . . . . . 1 1 . 1 . 102 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.952 0 O-C-N 129.257 3.563 . . . . 0.0 111.497 172.411 . . . . . . . . 0 0 . 1 . 103 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 tmm? . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 . . . . . . . . . 0 0 . 1 . 103 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -94.01 154.31 17.72 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -174.665 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.461 HD13 HG21 ' A' ' 3' ' ' ILE . 4.8 pt -135.74 144.26 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 101.778 -3.416 . . . . 0.0 101.778 171.421 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -102.96 94.29 5.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 111.207 -2.724 . . . . 0.0 104.439 -179.235 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.4 t -80.88 112.68 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 -179.598 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -96.14 127.91 42.57 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -170.142 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 p -95.49 136.83 35.37 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.317 2.247 . . . . 0.0 109.087 160.055 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -69.12 -32.33 71.65 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 113.871 -2.966 . . . . 0.0 112.575 166.997 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.276 33.1 p -76.37 -16.52 59.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 114.707 -2.568 . . . . 0.0 109.456 -178.805 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 134.36 48.15 0.09 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 117.052 -2.499 . . . . 0.0 113.665 123.301 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.304 0.6 OUTLIER -139.19 153.05 47.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 122.76 1.267 . . . . 0.0 108.84 164.555 . . . . . . . . 3 3 . 1 . 103 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 87.3 m -95.35 129.98 42.29 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 127.157 2.183 . . . . 0.0 107.03 164.585 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.2 mt -108.92 132.68 56.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 C-N-CA 128.975 2.91 . . . . 0.0 106.322 177.625 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.5 m -93.78 126.33 38.9 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 104.034 -2.58 . . . . 0.0 104.034 167.133 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -113.87 138.17 50.67 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 125.944 2.028 . . . . 0.0 106.845 166.634 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -100.74 137.04 39.66 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 173.048 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 m -150.44 179.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.571 1 C-N-CA 132.866 4.467 . . . . 0.0 106.165 -166.779 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.262 48.4 mm-40 -130.89 159.35 71.77 Favored Pre-proline 0 N--CA 1.446 -0.658 0 C-N-CA 127.824 2.45 . . . . 0.0 105.345 155.167 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -61.47 -9.15 12.4 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 123.026 2.484 . . . . 0.0 116.82 179.543 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.269 26.4 p -88.58 -3.73 58.73 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 117.665 -1.16 . . . . 0.0 113.27 173.98 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.67 126.81 28.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.794 0.725 . . . . 0.0 110.457 171.147 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.398 4.7 p -67.05 155.07 39.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 117.959 2.577 . . . . 0.0 117.959 173.775 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mp -49.4 -35.67 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 131.176 3.79 . . . . 0.0 107.629 171.395 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -76.46 -40.45 50.4 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 119.454 -2.029 . . . . 0.0 110.774 -174.204 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 31.1 m120 -56.56 -59.66 4.68 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 124.994 1.434 . . . . 0.0 113.419 168.38 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.321 96.6 t -51.72 -51.25 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 O-C-N 116.705 -3.747 . . . . 0.0 115.849 -177.387 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -48.8 -44.09 38.75 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 127.456 2.973 . . . . 0.0 116.433 169.927 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.24 -34.2 23.91 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 129.772 3.229 . . . . 0.0 110.361 -179.425 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -62.06 -33.54 74.58 Favored 'General case' 0 C--O 1.222 -0.394 0 O-C-N 125.853 1.971 . . . . 0.0 110.862 169.256 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 7.2 mt -63.95 -50.38 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 C-N-CA 127.77 2.428 . . . . 0.0 113.239 165.965 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.91 -41.34 82.46 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.92 2.088 . . . . 0.0 112.856 -175.984 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -54.37 -26.22 28.89 Favored 'General case' 0 N--CA 1.447 -0.594 1 C-N-CA 131.811 4.045 . . . . 0.0 113.741 173.601 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.5 mttm -98.78 -62.25 1.26 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 120.645 1.566 . . . . 0.0 113.514 -178.874 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -106.78 -17.41 14.22 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 126.368 2.292 . . . . 0.0 114.265 -167.523 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.95 1.43 42.18 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 117.696 -3.127 . . . . 0.0 118.053 168.049 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 mt -80.75 130.16 65.24 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 123.279 3.54 . . . . 0.0 115.511 -172.43 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . 0.285 36.9 Cg_endo -68.3 135.37 33.95 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.996 2.464 . . . . 0.0 110.745 179.419 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -43.79 -40.63 11.36 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.532 2.821 . . . . 0.0 116.556 175.925 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -55.75 -30.28 60.97 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.698 1.199 . . . . 0.0 112.986 -176.139 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -101.15 -12.5 18.72 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 128.314 2.646 . . . . 0.0 115.216 -171.606 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.26 73.3 mt-30 -81.14 152.61 27.69 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 111.932 -2.394 . . . . 0.0 108.419 179.413 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.9 mtt180 -132.45 126.83 33.95 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 127.847 2.459 . . . . 0.0 108.246 157.13 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.4 mt -115.96 131.2 57.01 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 177.684 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.72 143.11 32.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 110.789 -2.914 . . . . 0.0 108.085 -173.031 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -139.38 118.02 12.26 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.566 2.347 . . . . 0.0 109.011 160.083 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 60.65 48.87 6.86 Favored 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 128.36 3.538 . . . . 0.0 109.688 170.152 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.66 -19.94 51.14 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.578 1.085 . . . . 0.0 112.019 166.631 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.262 74.5 mttt -96.83 144.81 26.44 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 120.083 1.942 . . . . 0.0 114.447 -174.568 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.319 77.8 mm-40 -76.88 169.1 18.93 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 116.895 -1.922 . . . . 0.0 109.131 160.908 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . 0.25 43.4 mt -120.34 119.35 32.86 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 117.84 -3.038 . . . . 0.0 106.141 -170.571 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -86.08 146.65 26.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 123.194 1.473 . . . . 0.0 113.274 -170.243 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -68.44 122.39 18.32 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 111.97 -2.377 . . . . 0.0 104.916 -175.403 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.07 9.25 10.83 Favored Glycine 0 CA--C 1.534 1.24 0 O-C-N 127.581 3.051 . . . . 0.0 119.336 179.698 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.277 90.2 mtt-85 -132.35 179.34 6.18 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 126.953 2.101 . . . . 0.0 107.244 -172.579 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.9 p -126.46 178.62 5.75 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 113.218 -1.81 . . . . 0.0 108.113 -171.184 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 73.3 mt -73.62 -28.93 62.06 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 127.45 2.969 . . . . 0.0 110.909 175.389 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.1 t -59.81 -27.58 66.71 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 129.521 3.129 . . . . 0.0 110.692 172.49 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.89 -44.16 27.9 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.748 2.419 . . . . 0.0 108.796 178.528 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -99.99 20.93 13.5 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 118.059 2.614 . . . . 0.0 118.059 -179.622 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.402 3.9 t-20 83.7 25.38 0.11 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 119.147 3.017 . . . . 0.0 119.147 164.169 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.8 mt -104.04 81.15 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 -172.679 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -92.28 -23.49 19.28 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 129.09 2.956 . . . . 0.0 114.491 -170.362 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.2 pttt -168.39 130.13 1.36 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.881 1.672 . . . . 0.0 109.535 -170.881 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 20.3 mp0 7.99 86.95 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 130.906 3.683 . . . . 0.0 116.944 167.049 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.284 5.3 t -143.98 -160.52 1.13 Allowed 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 115.115 -2.374 . . . . 0.0 107.301 173.788 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 62.5 m -125.7 132.07 52.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 122.074 2.215 . . . . 0.0 106.334 -167.265 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.77 143.54 29.01 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 156.373 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 9.4 m80 -89.96 128.84 36.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 O-C-N 119.521 -1.987 . . . . 0.0 109.114 166.904 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 1.4 tp -92.45 117.67 30.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 131.69 3.996 . . . . 0.0 103.511 176.833 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.2 t -124.5 143.69 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 -176.968 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.28 124.04 31.48 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 119.3 -2.125 . . . . 0.0 111.044 -171.097 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -58.49 -29.61 66.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 114.393 -2.718 . . . . 0.0 112.854 178.95 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.296 50.7 tp -72.46 123.21 22.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 128.842 3.838 . . . . 0.0 109.085 171.395 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.323 1.2 ttp85 -84.14 125.67 32.38 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 102.921 -2.992 . . . . 0.0 102.921 -174.023 . . . . . . . . 2 2 . 1 . 103 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 119.83 -92.96 0.53 Allowed Glycine 0 CA--C 1.534 1.249 0 C-N-CA 130.065 3.698 . . . . 0.0 106.524 -175.9 . . . . . . . . 1 1 . 1 . 103 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.004 0 C-N-CA 129.617 3.484 . . . . 0.0 110.609 -170.423 . . . . . . . . 0 0 . 1 . 104 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.5 ptt? . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 . . . . . . . . . 0 0 . 1 . 104 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -82.71 152.32 25.84 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 115.208 -2.33 . . . . 0.0 112.678 -179.701 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 22.8 pt -139.82 149.5 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 121.777 2.08 . . . . 0.0 109.449 162.539 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.0 m-30 -105.27 126.22 51.85 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 103.441 -2.8 . . . . 0.0 103.441 -172.355 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.272 93.0 t -99.4 112.14 30.9 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 C-N-CA 127.979 2.511 . . . . 0.0 108.076 171.929 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -70.32 148.8 48.05 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 111.565 -2.561 . . . . 0.0 111.314 166.352 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 30.1 p -120.75 -167.07 1.41 Allowed 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 120.083 -1.635 . . . . 0.0 109.534 176.442 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.14 42.17 1.53 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 164.294 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.6 p -139.74 26.54 2.29 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.715 2.406 . . . . 0.0 107.786 176.985 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.98 16.52 35.4 Favored Glycine 0 CA--C 1.532 1.12 0 O-C-N 116.865 -3.647 . . . . 0.0 117.883 152.997 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -154.49 171.73 18.92 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 124.427 2.061 . . . . 0.0 110.116 177.664 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.5 m -112.89 127.57 56.23 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 131.313 3.845 . . . . 0.0 108.918 175.887 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.439 HD13 HG21 ' A' ' 13' ' ' ILE . 87.3 mt -106.47 129.37 59.99 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 O-C-N 126.78 2.55 . . . . 0.0 107.011 175.018 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 57.1 m -107.04 136.9 46.1 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 102.411 -3.181 . . . . 0.0 102.411 169.829 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.9 tp -129.57 160.83 32.04 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 128.314 2.645 . . . . 0.0 105.496 -179.665 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -102.19 139.27 38.03 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 130.653 3.581 . . . . 0.0 103.19 172.968 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.9 m -151.03 166.36 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 O-C-N 119.314 -2.116 . . . . 0.0 108.644 -178.903 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -138.27 142.71 36.16 Favored Pre-proline 0 N--CA 1.446 -0.635 0 C-N-CA 126.152 1.781 . . . . 0.0 108.469 -173.189 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.343 11.5 Cg_exo -50.72 -34.83 45.59 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 N-CA-C 121.369 3.565 . . . . 0.0 121.369 -179.887 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 61.5 p -93.43 -2.27 54.77 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 127.47 2.981 . . . . 0.0 112.134 -174.24 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -74.33 141.14 45.23 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 125.868 2.747 . . . . 0.0 109.091 170.327 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.9 p -76.32 172.81 12.28 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 119.221 -2.174 . . . . 0.0 111.408 175.933 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.7 mm -53.15 -46.96 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 1 C-N-CA 133.875 4.87 . . . . 0.0 113.397 171.097 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 35.6 tp10 -47.47 -42.16 22.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 113.295 -3.24 . . . . 0.0 112.33 170.089 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . 0.281 4.7 m120 -59.14 -32.13 69.59 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 128.536 2.734 . . . . 0.0 116.135 175.392 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -65.79 -54.62 25.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 O-C-N 120.121 -1.612 . . . . 0.0 110.769 165.419 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -71.81 -23.88 61.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 125.675 2.655 . . . . 0.0 113.637 -171.952 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.6 -46.98 51.55 Favored 'General case' 0 N--CA 1.44 -0.943 0 O-C-N 118.785 -2.447 . . . . 0.0 110.043 173.534 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -74.68 -27.91 60.61 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 127.729 2.412 . . . . 0.0 109.757 -176.487 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.36 -47.92 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 O-C-N 118.933 -2.355 . . . . 0.0 106.463 169.77 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -50.86 -51.86 47.29 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 124.426 3.284 . . . . 0.0 107.851 175.924 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.301 5.1 t70 -46.56 -50.03 17.91 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 116.333 1.975 . . . . 0.0 116.333 179.094 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -83.64 -48.99 9.61 Favored 'General case' 0 N--CA 1.451 -0.417 0 O-C-N 128.905 3.878 . . . . 0.0 108.55 -173.195 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -106.26 -14.74 15.03 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 123.493 2.861 . . . . 0.0 110.012 -161.754 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.21 0.99 84.63 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 129.851 3.595 . . . . 0.0 118.976 -178.623 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.3 mt -83.86 126.42 70.58 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 119.855 1.827 . . . . 0.0 111.817 -165.827 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.09 145.92 31.72 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 O-C-N 124.245 1.655 . . . . 0.0 110.394 -175.063 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.27 38.0 Cg_endo -72.94 -16.23 25.93 Favored 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 124.494 3.463 . . . . 0.0 119.823 -163.6 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -72.07 -26.73 62.28 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 125.461 1.726 . . . . 0.0 110.337 174.335 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -83.02 -30.24 28.26 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.41 1.484 . . . . 0.0 112.507 -174.355 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -80.87 142.54 33.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 129.459 3.104 . . . . 0.0 109.375 175.747 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 36.0 ttp-105 -145.62 119.36 9.22 Favored 'General case' 0 N--CA 1.449 -0.502 1 N-CA-C 99.217 -4.364 . . . . 0.0 99.217 175.733 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.7 mp -82.14 124.53 29.95 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 114.64 -2.6 . . . . 0.0 115.81 177.062 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.7 mm -102.17 129.13 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 101.197 -3.631 . . . . 0.0 101.197 173.552 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -137.31 125.98 23.81 Favored 'General case' 0 N--CA 1.451 -0.405 1 N-CA-C 97.139 -5.134 . . . . 0.0 97.139 175.607 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 62.75 24.18 14.4 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 128.864 2.866 . . . . 0.0 114.822 160.577 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 102.81 -25.92 25.8 Favored Glycine 0 CA--C 1.531 1.062 0 CA-C-O 117.873 -1.515 . . . . 0.0 112.566 -175.349 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -99.29 164.43 12.13 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 128.079 2.552 . . . . 0.0 109.159 -171.577 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.28 7.3 mt-30 -118.64 145.79 45.17 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.537 1.935 . . . . 0.0 106.339 166.445 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 94.5 mt -91.44 139.26 30.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 112.165 -2.289 . . . . 0.0 109.77 -166.58 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . 0.267 7.7 tp10 -85.44 140.34 30.8 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 131.671 3.989 . . . . 0.0 107.174 167.581 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -73.98 136.06 43.19 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 114.134 -2.841 . . . . 0.0 112.917 -177.667 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.01 -14.16 26.37 Favored Glycine 0 CA--C 1.535 1.327 1 CA-C-N 127.707 4.776 . . . . 0.0 113.775 166.028 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.295 3.1 mpt_? -81.06 161.05 24.34 Favored 'General case' 0 C--N 1.322 -0.624 1 O-C-N 130.925 4.544 . . . . 0.0 105.553 176.385 . . . . . . . . 3 2 . 1 . 104 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.4 p -89.59 172.69 8.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 125.282 1.614 . . . . 0.0 109.056 -177.457 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mt -63.04 -52.64 62.07 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 128.932 2.893 . . . . 0.0 110.443 169.961 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.0 p -41.96 -41.27 2.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 117.222 2.305 . . . . 0.0 117.222 162.501 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -62.14 -24.29 67.08 Favored 'General case' 0 N--CA 1.444 -0.741 0 O-C-N 118.317 -2.739 . . . . 0.0 116.704 177.34 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -99.52 -6.86 26.77 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 129.738 3.215 . . . . 0.0 117.78 179.387 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.308 0.7 OUTLIER 69.85 48.13 0.58 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 130.491 3.517 . . . . 0.0 113.413 174.509 . . . . . . . . 3 3 . 1 . 104 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.4 mt -93.25 139.69 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 100.741 -3.8 . . . . 0.0 100.741 -172.998 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.274 7.0 tp60 -148.97 156.36 42.16 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 112.334 -2.212 . . . . 0.0 107.791 -176.18 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.374 23.9 ttpp -31.98 114.43 0.14 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 128.553 2.741 . . . . 0.0 113.541 -179.974 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 83.4 21.65 0.17 Allowed 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 128.148 3.405 . . . . 0.0 115.007 176.357 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.7 m -65.65 134.67 53.75 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.688 171.77 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.406 ' C ' HD12 ' A' ' 67' ' ' LEU . 85.1 m -94.71 122.4 37.28 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 -178.989 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.406 HD12 ' C ' ' A' ' 66' ' ' THR . 1.7 mp -122.77 160.24 26.36 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 124.227 1.011 . . . . 0.0 109.398 166.21 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -127.88 124.36 37.28 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 118.493 -2.63 . . . . 0.0 111.979 -175.547 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 56.4 tp -82.57 101.45 10.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 115.337 -2.268 . . . . 0.0 111.086 -179.861 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.31 151.7 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 O-C-N 125.42 1.7 . . . . 0.0 107.326 163.545 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.7 mt -109.24 153.01 24.44 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.633 1.973 . . . . 0.0 111.3 178.77 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.7 mmt180 -80.93 146.59 30.69 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 114.136 -1.393 . . . . 0.0 111.646 154.697 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.8 141.92 30.2 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 126.831 3.205 . . . . 0.0 105.911 168.77 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -155.64 -40.71 0.08 Allowed 'General case' 0 C--O 1.234 0.264 0 O-C-N 117.479 -3.263 . . . . 0.0 113.243 -166.255 . . . . . . . . 1 1 . 1 . 104 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 115.25 130.91 4.89 Favored Glycine 0 CA--C 1.531 1.041 1 C-N-CA 131.273 4.273 . . . . 0.0 116.389 176.224 . . . . . . . . 2 2 . 1 . 104 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.528 0 O-C-N 125.811 1.536 . . . . 0.0 109.542 -170.824 . . . . . . . . 0 0 . 1 . 105 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ptt? . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 . . . . . . . . . 0 0 . 1 . 105 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -60.7 125.16 22.66 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-O 117.553 -1.213 . . . . 0.0 113.248 174.231 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.365 26.8 pt -128.91 166.48 26.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 O-C-N 125.209 1.568 . . . . 0.0 112.127 162.253 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -112.38 154.11 26.26 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 128.567 2.747 . . . . 0.0 106.916 176.674 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.87 130.66 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 168.682 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -101.72 128.32 48.1 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 122.835 2.561 . . . . 0.0 109.285 167.708 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.6 p -91.59 163.75 14.01 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.855 2.462 . . . . 0.0 108.386 -173.19 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -49.41 -47.71 47.7 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 128.286 2.634 . . . . 0.0 109.076 176.22 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 61.9 p -68.58 -16.94 64.02 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 128.011 2.524 . . . . 0.0 111.575 -174.743 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.01 -14.06 37.46 Favored Glycine 0 CA--C 1.528 0.904 0 CA-C-N 125.044 3.566 . . . . 0.0 115.498 169.652 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -69.73 147.26 50.75 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 125.794 1.637 . . . . 0.0 115.074 172.481 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 m -93.28 137.8 32.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 177.597 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.3 mt -119.68 137.88 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 170.269 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.4 t -100.86 142.0 32.95 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.328 1.851 . . . . 0.0 109.941 166.198 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.5 mt -135.73 142.93 45.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 103.848 -2.649 . . . . 0.0 103.848 171.134 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -88.03 115.48 25.54 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 161.787 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 t -123.93 132.41 71.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 C-N-CA 127.75 2.42 . . . . 0.0 108.583 -174.985 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -91.3 148.6 38.05 Favored Pre-proline 0 C--O 1.236 0.347 0 CA-C-O 114.866 -2.492 . . . . 0.0 110.0 -172.811 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -43.17 -46.0 9.4 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 123.596 2.864 . . . . 0.0 114.955 171.957 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.3 t -91.99 15.68 12.72 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 119.095 0.861 . . . . 0.0 112.624 -178.428 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -78.46 132.98 37.5 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 118.601 -2.562 . . . . 0.0 105.241 162.818 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.8 p -84.97 179.32 7.32 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 109.86 177.564 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.323 1.1 mp -71.15 -37.36 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 124.192 1.949 . . . . 0.0 108.989 -178.062 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -57.1 -39.01 74.21 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 117.456 -3.278 . . . . 0.0 114.332 173.03 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -53.17 -50.85 63.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 O-C-N 126.007 2.067 . . . . 0.0 115.158 177.739 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.5 t -65.85 -48.03 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 1 C-N-CA 132.377 4.271 . . . . 0.0 111.094 171.123 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.9 mttt -64.86 -35.94 82.73 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 115.998 -1.953 . . . . 0.0 111.731 179.11 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.83 -37.03 70.67 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 127.035 2.134 . . . . 0.0 114.164 174.987 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -84.51 -29.74 25.73 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 111.068 -2.787 . . . . 0.0 103.67 -170.676 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 68.8 mt -73.91 -46.24 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 121.503 1.956 . . . . 0.0 112.562 165.368 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -52.98 -48.42 67.46 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 129.532 3.133 . . . . 0.0 110.557 -178.571 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -56.28 -42.63 77.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 117.512 2.412 . . . . 0.0 117.512 169.854 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.4 mmtm -86.8 -55.06 4.02 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 -175.867 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -100.01 -18.53 16.99 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 129.532 3.133 . . . . 0.0 113.289 -171.583 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.09 -1.51 70.44 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 114.829 0.692 . . . . 0.0 114.829 155.641 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 22.5 mm -75.63 136.1 71.23 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-O 115.252 -2.309 . . . . 0.0 112.845 173.43 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -70.29 166.32 28.64 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 O-C-N 125.513 2.323 . . . . 0.0 116.449 173.421 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -74.42 -33.21 5.65 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 CA-C-O 114.901 -2.208 . . . . 0.0 111.228 -166.666 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -58.94 -21.8 58.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 123.712 2.96 . . . . 0.0 113.241 173.574 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -111.14 -1.08 16.33 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 128.497 2.719 . . . . 0.0 112.078 -169.454 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -96.83 109.24 21.97 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 127.717 2.407 . . . . 0.0 107.145 172.756 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.6 ttm180 -110.33 89.2 2.96 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 -175.816 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.304 12.8 mt -79.07 127.9 32.58 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 129.597 3.159 . . . . 0.0 109.221 -179.918 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.322 8.2 mt -126.2 135.41 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 O-C-N 126.996 2.685 . . . . 0.0 113.561 -175.466 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -147.35 124.3 11.33 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 127.213 2.205 . . . . 0.0 112.112 172.568 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.36 44.08 9.94 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.882 2.073 . . . . 0.0 111.586 169.009 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.99 4.81 64.65 Favored Glycine 0 CA--C 1.537 1.407 1 CA-C-O 111.949 -4.806 . . . . 0.0 110.393 164.449 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -133.67 141.46 47.6 Favored 'General case' 0 N--CA 1.448 -0.565 1 O-C-N 131.147 4.675 . . . . 0.0 107.509 -170.932 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.408 HE22 ' CD ' ' A' ' 51' ' ' GLU . 4.6 tm0? -70.05 127.67 33.65 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-O 123.927 1.822 . . . . 0.0 108.957 160.381 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.1 mt -83.29 125.29 31.46 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 171.068 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' CD ' HE22 ' A' ' 49' ' ' GLN . 6.2 tp10 -90.33 136.69 32.9 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.754 1.622 . . . . 0.0 110.008 -166.163 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 -53.83 99.58 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.604 1 C-N-CA 132.29 4.236 . . . . 0.0 117.209 172.207 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.13 -3.46 6.81 Favored Glycine 0 CA--C 1.532 1.118 0 N-CA-C 119.221 2.448 . . . . 0.0 119.221 169.044 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.3 mtt180 -86.84 -167.66 1.96 Allowed 'General case' 0 N--CA 1.446 -0.664 0 O-C-N 118.824 -2.574 . . . . 0.0 104.463 172.611 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . 0.256 69.5 p -106.7 165.77 11.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.58 178.321 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.85 -27.77 69.57 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 123.504 1.621 . . . . 0.0 114.626 169.013 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.7 t -67.52 -36.1 80.38 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.454 -1.703 . . . . 0.0 115.042 172.286 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -63.11 -21.41 66.17 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.702 1.601 . . . . 0.0 114.426 179.235 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 32.3 m-85 -112.52 -2.17 14.72 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 116.868 2.174 . . . . 0.0 116.868 -167.264 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 44.28 46.6 7.66 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 117.9 2.555 . . . . 0.0 117.9 171.343 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -83.98 -35.26 10.91 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.323 0 O-C-N 128.032 3.333 . . . . 0.0 113.905 -173.922 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 75.51 152.28 0.13 Allowed 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 129.317 3.047 . . . . 0.0 113.357 164.413 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.95 135.88 35.79 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 127.031 2.133 . . . . 0.0 113.992 173.461 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.344 9.2 tt0 89.05 -1.38 0.37 Allowed 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 111.311 -2.677 . . . . 0.0 111.479 173.421 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.3 m -85.77 162.69 18.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 O-C-N 117.863 -3.023 . . . . 0.0 109.348 -171.082 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . 0.268 36.9 m -121.5 122.83 40.6 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 128.176 2.59 . . . . 0.0 106.641 -171.864 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.299 72.9 mt -89.44 145.36 25.37 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 119.424 -2.047 . . . . 0.0 107.315 167.318 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.276 74.2 m-70 -100.72 121.39 41.58 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 128.447 2.699 . . . . 0.0 108.231 174.114 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 27.1 tp -99.21 118.29 35.58 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 126.605 2.441 . . . . 0.0 105.277 -179.262 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.4 t -108.48 135.06 48.45 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.0 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 48.6 mt -72.84 122.01 20.89 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 112.99 -3.386 . . . . 0.0 107.312 169.68 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -69.23 83.4 0.36 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 122.957 2.617 . . . . 0.0 111.596 167.325 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -113.39 125.5 54.32 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.747 -177.937 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 64.2 161.47 0.11 Allowed 'General case' 0 C--N 1.322 -0.591 1 C-N-CA 135.773 5.629 . . . . 0.0 113.181 -156.142 . . . . . . . . 2 2 . 1 . 105 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -101.15 -42.25 2.44 Favored Glycine 0 CA--C 1.533 1.18 0 CA-C-N 110.194 -3.184 . . . . 0.0 108.84 170.023 . . . . . . . . 1 1 . 1 . 105 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.448 0 O-C-N 118.383 -2.833 . . . . 0.0 111.629 169.455 . . . . . . . . 0 0 . 1 . 106 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 ttt . . . . . 0 N--CA 1.473 0.71 0 CA-C-O 117.566 -1.206 . . . . 0.0 108.663 . . . . . . . . . 0 0 . 1 . 106 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.258 77.4 mm-40 -115.7 129.35 56.44 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.431 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.8 pt -100.4 155.14 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 116.866 -1.54 . . . . 0.0 111.066 165.608 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -103.71 121.66 43.43 Favored 'General case' 0 C--O 1.219 -0.532 0 O-C-N 127.395 2.934 . . . . 0.0 105.168 178.16 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.4 t -115.22 123.59 70.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 117.213 -3.43 . . . . 0.0 107.886 -177.629 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.9 tttp -119.57 99.66 6.8 Favored 'General case' 0 N--CA 1.449 -0.507 0 O-C-N 120.599 -1.313 . . . . 0.0 113.294 -173.709 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 56.2 p -85.04 161.37 19.74 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 119.788 -1.82 . . . . 0.0 112.62 -174.592 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.386 0.0 OUTLIER -17.39 -72.78 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.489 1 C-N-CA 133.592 4.757 . . . . 0.0 119.711 -172.382 . . . . . . . . 4 3 . 1 . 106 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.0 p -61.21 -10.28 6.41 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.469 -1.696 . . . . 0.0 114.073 171.827 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.67 -5.17 34.83 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 127.222 3.679 . . . . 0.0 117.64 176.673 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.03 110.77 1.91 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 129.071 2.948 . . . . 0.0 108.678 -177.894 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.1 m -99.06 139.24 35.0 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 127.382 2.926 . . . . 0.0 107.559 -161.519 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.4 mt -123.23 141.46 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 104.539 -2.393 . . . . 0.0 104.539 177.387 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 m -98.51 105.88 18.08 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 127.994 3.309 . . . . 0.0 110.054 153.198 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.1 tp -99.07 133.62 43.08 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 105.115 -2.18 . . . . 0.0 105.115 -179.365 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . 0.266 83.6 tt0 -86.27 141.57 29.18 Favored 'General case' 0 N--CA 1.45 -0.427 1 O-C-N 129.363 4.165 . . . . 0.0 106.561 174.712 . . . . . . . . 3 2 . 1 . 106 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.6 m -144.29 179.24 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-O 126.691 3.138 . . . . 0.0 109.562 174.396 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -107.79 152.99 41.8 Favored Pre-proline 0 N--CA 1.45 -0.458 0 O-C-N 116.793 -3.692 . . . . 0.0 106.491 148.578 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.5 -25.19 25.45 Favored 'Trans proline' 0 N--CA 1.443 -1.452 0 O-C-N 116.714 -2.308 . . . . 0.0 113.294 -176.575 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 35.2 p -77.51 -0.81 27.6 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 129.052 2.941 . . . . 0.0 114.899 174.069 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -77.34 148.96 35.33 Favored 'General case' 0 C--O 1.22 -0.457 0 O-C-N 126.256 2.222 . . . . 0.0 110.226 173.279 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 11.3 t -109.16 144.33 37.39 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 111.437 -2.619 . . . . 0.0 105.581 -163.447 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.1 mm -54.07 -30.29 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 1 CA-C-O 110.342 -4.647 . . . . 0.0 115.005 -171.022 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -65.73 -33.83 76.77 Favored 'General case' 0 N--CA 1.451 -0.401 1 CA-C-N 126.006 4.003 . . . . 0.0 113.067 172.532 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -80.66 -16.42 54.07 Favored 'General case' 0 N--CA 1.442 -0.85 0 O-C-N 126.824 2.578 . . . . 0.0 107.577 -175.741 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 46.9 t -79.25 -53.55 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 C-N-CA 127.216 2.206 . . . . 0.0 110.649 171.244 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -60.71 -37.83 83.02 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 126.278 1.831 . . . . 0.0 112.26 176.611 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.59 -10.08 59.13 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 115.236 -2.316 . . . . 0.0 109.88 178.898 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.3 tttt -91.34 -36.93 13.56 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 128.55 2.74 . . . . 0.0 108.996 178.925 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.4 mt -65.54 -40.17 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 C-N-CA 128.785 2.834 . . . . 0.0 108.718 170.791 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -52.53 -47.43 66.71 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 118.32 -2.737 . . . . 0.0 116.282 167.061 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.58 -41.42 92.88 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 120.937 1.699 . . . . 0.0 115.171 172.175 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -78.01 -37.17 47.69 Favored 'General case' 0 N--CA 1.448 -0.562 0 O-C-N 124.675 1.234 . . . . 0.0 112.837 -176.726 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.35 28.8 mm-40 -124.37 -33.72 3.0 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 117.797 2.517 . . . . 0.0 117.797 -169.197 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.97 39.71 1.95 Allowed Glycine 0 CA--C 1.527 0.841 1 O-C-N 115.279 -4.638 . . . . 0.0 116.127 162.709 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.4 mt -123.36 135.72 26.34 Favored Pre-proline 0 N--CA 1.451 -0.424 0 O-C-N 118.316 -2.873 . . . . 0.0 108.592 179.159 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 71.5 Cg_endo -76.89 137.16 17.38 Favored 'Trans proline' 0 N--CA 1.448 -1.163 0 O-C-N 125.42 2.274 . . . . 0.0 113.249 -177.967 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 37' ' ' PRO . 88.2 Cg_exo -44.9 -30.24 4.3 Favored 'Trans proline' 0 N--CA 1.446 -1.292 1 C-N-CA 126.161 4.574 . . . . 0.0 118.903 -177.204 . . . . . . . . 3 3 . 1 . 106 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -85.2 -10.83 56.16 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -168.151 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -98.21 -3.19 38.03 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 129.476 3.111 . . . . 0.0 112.596 175.639 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.255 64.6 mt-30 -107.94 132.9 53.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 123.63 2.923 . . . . 0.0 104.332 -172.191 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.7 mtt180 -113.96 129.95 56.56 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 119.921 -1.737 . . . . 0.0 109.842 149.965 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 52.5 mt -101.36 120.58 40.48 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 126.586 1.955 . . . . 0.0 108.128 170.262 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.7 mm -97.63 131.59 44.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 113.076 -3.345 . . . . 0.0 109.832 172.959 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -111.89 136.38 51.27 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 124.638 3.381 . . . . 0.0 104.795 152.897 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.0 -99.95 0.1 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 125.205 1.402 . . . . 0.0 112.228 -169.98 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.84 25.08 3.77 Favored Glycine 0 CA--C 1.523 0.558 1 C-N-CA 131.581 4.42 . . . . 0.0 113.341 159.646 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -93.82 111.35 23.03 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 118.144 -2.974 . . . . 0.0 107.563 175.82 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -76.17 97.17 4.05 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 127.693 3.121 . . . . 0.0 112.857 175.818 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 49.6 mt -63.81 127.92 33.51 Favored 'General case' 0 C--O 1.239 0.517 0 O-C-N 126.819 2.575 . . . . 0.0 113.234 -171.384 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -104.77 132.08 51.46 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 131.358 3.863 . . . . 0.0 113.748 -169.915 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.6 123.01 17.73 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 130.775 3.63 . . . . 0.0 109.116 -179.128 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.72 -6.87 20.12 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 120.359 1.436 . . . . 0.0 111.475 -177.1 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 70.7 mtm180 -122.16 173.62 7.47 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 170.821 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.0 p -115.37 175.63 5.43 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 117.894 -3.004 . . . . 0.0 113.635 -168.886 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 45.1 mt -75.6 -30.3 59.54 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 123.258 1.504 . . . . 0.0 111.864 172.401 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.3 t -58.98 -36.2 74.46 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 122.905 1.336 . . . . 0.0 112.288 170.727 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -69.9 -41.98 74.0 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 119.252 -2.155 . . . . 0.0 108.788 -174.179 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -84.85 10.89 10.37 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 115.447 1.647 . . . . 0.0 115.447 175.552 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 58.96 35.58 24.16 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 129.058 2.943 . . . . 0.0 111.418 172.051 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.2 mt -88.78 142.76 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 102.579 -3.119 . . . . 0.0 102.579 -173.816 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.304 3.4 pm0 -137.63 -166.22 1.91 Allowed 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 126.811 2.045 . . . . 0.0 114.104 -162.677 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.0 tttm -60.81 131.83 51.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 128.861 2.864 . . . . 0.0 110.392 174.255 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.397 0.8 OUTLIER 86.36 17.06 0.11 Allowed 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 127.614 3.578 . . . . 0.0 115.648 175.926 . . . . . . . . 3 3 . 1 . 106 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.8 p -83.58 127.94 34.13 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 118.216 -2.803 . . . . 0.0 112.099 -178.346 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.1 m -107.1 114.65 28.86 Favored 'General case' 0 N--CA 1.445 -0.716 1 C-N-CA 132.383 4.273 . . . . 0.0 108.697 172.724 . . . . . . . . 2 2 . 1 . 106 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.7 mp -100.48 130.26 46.54 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.627 1.571 . . . . 0.0 109.016 174.895 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -102.3 127.97 49.05 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 128.852 2.861 . . . . 0.0 107.155 -170.399 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.7 tp -93.69 150.72 20.18 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 122.22 2.282 . . . . 0.0 105.889 175.321 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.4 p -141.32 141.61 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 130.088 3.355 . . . . 0.0 107.37 163.894 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 17.8 mt -77.4 154.95 32.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 121.092 1.769 . . . . 0.0 110.615 175.358 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -97.57 117.97 33.02 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 103.044 -2.947 . . . . 0.0 103.044 168.714 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 70.7 mt -135.82 -5.19 2.19 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 125.176 1.547 . . . . 0.0 114.249 -171.267 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 ttt180 -153.25 136.55 15.75 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 129.844 3.257 . . . . 0.0 117.96 168.083 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 122.17 -168.36 14.76 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 106.248 -2.741 . . . . 0.0 106.248 175.318 . . . . . . . . 1 1 . 1 . 106 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.463 1 O-C-N 116.177 -4.131 . . . . 0.0 103.5 168.166 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ptp . . . . . 0 N--CA 1.471 0.61 0 CA-C-O 123.465 1.602 . . . . 0.0 108.559 . . . . . . . . . 0 0 . 1 . 107 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -101.32 134.45 44.36 Favored 'General case' 0 N--CA 1.443 -0.797 0 O-C-N 120.922 -1.111 . . . . 0.0 113.823 163.753 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.312 2.1 pp -124.82 146.96 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 170.774 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -105.73 133.83 49.83 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 123.797 1.76 . . . . 0.0 108.898 177.004 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.09 133.97 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 174.632 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -108.38 122.24 46.6 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 111.848 -2.433 . . . . 0.0 109.843 178.026 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 43.4 p -80.42 153.25 28.37 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 123.557 1.646 . . . . 0.0 110.161 179.627 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.36 -25.66 63.38 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 127.45 2.3 . . . . 0.0 112.383 -174.738 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 39.3 p -100.63 19.64 16.59 Favored 'General case' 0 CA--C 1.538 0.494 1 C-N-CA 132.943 4.497 . . . . 0.0 115.692 173.374 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.93 21.61 11.83 Favored Glycine 0 CA--C 1.54 1.633 0 CA-C-O 115.136 -3.036 . . . . 0.0 117.535 137.457 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.353 55.2 mttt -103.78 171.11 7.53 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 128.356 2.663 . . . . 0.0 115.966 169.623 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.5 m -128.22 103.92 7.45 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 130.366 3.466 . . . . 0.0 108.92 169.931 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.4 mm -81.11 117.51 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 128.629 2.771 . . . . 0.0 112.469 177.469 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.269 22.9 m -93.97 105.52 17.53 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 178.102 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.7 mt -88.78 159.33 17.81 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 103.962 -2.607 . . . . 0.0 103.962 172.183 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -107.35 133.89 51.22 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 124.422 2.058 . . . . 0.0 107.224 165.253 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 m -139.51 -179.09 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 119.895 -1.753 . . . . 0.0 110.795 178.537 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -140.05 155.11 70.86 Favored Pre-proline 0 N--CA 1.451 -0.407 0 C-N-CA 130.208 3.403 . . . . 0.0 104.195 171.955 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -62.47 -38.33 53.22 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 CA-C-O 115.538 -1.942 . . . . 0.0 116.39 -175.851 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 50.0 m -77.75 -9.42 59.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 O-C-N 124.542 1.151 . . . . 0.0 111.494 -170.877 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -68.67 135.9 52.09 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 125.041 2.353 . . . . 0.0 109.743 179.304 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.43 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.0 p -78.38 153.94 31.16 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 129.737 3.215 . . . . 0.0 111.257 -168.22 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.9 mm -79.3 -17.59 13.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 O-C-N 121.33 -0.856 . . . . 0.0 108.934 -178.54 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -78.04 -44.15 27.26 Favored 'General case' 0 N--CA 1.448 -0.549 1 O-C-N 116.254 -4.029 . . . . 0.0 108.021 -179.506 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -62.86 -50.26 71.61 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 112.93 -3.414 . . . . 0.0 114.552 166.351 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 22' ' ' THR . 70.9 t -52.99 -40.65 37.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 121.828 2.104 . . . . 0.0 111.375 177.032 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -42.04 -35.78 0.97 Allowed 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 115.98 1.845 . . . . 0.0 115.98 166.182 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -96.73 -28.06 14.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 120.363 1.438 . . . . 0.0 108.69 -177.207 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.7 mttt -60.92 -31.69 71.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 117.887 -3.008 . . . . 0.0 118.29 168.264 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.285 1.5 tt -70.87 -40.76 76.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 167.993 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -59.26 -36.41 75.45 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 175.54 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -74.19 -10.69 59.86 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 118.902 0.774 . . . . 0.0 112.626 -170.928 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.46 -77.7 0.22 Allowed 'General case' 0 C--O 1.235 0.338 1 C-N-CA 132.385 4.274 . . . . 0.0 116.603 159.699 . . . . . . . . 3 3 . 1 . 107 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -98.54 -3.38 36.56 Favored 'General case' 0 C--N 1.322 -0.621 0 O-C-N 121.265 -0.897 . . . . 0.0 113.259 -162.777 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.01 7.95 86.42 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 117.906 -2.092 . . . . 0.0 117.36 171.14 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.5 mt -74.71 120.65 82.58 Favored Pre-proline 0 N--CA 1.454 -0.237 1 C-N-CA 132.704 4.402 . . . . 0.0 109.206 178.65 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -74.51 141.0 27.61 Favored 'Trans proline' 0 N--CA 1.447 -1.24 0 CA-C-O 115.164 -2.098 . . . . 0.0 112.989 -175.203 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.23 -7.14 20.47 Favored 'Trans proline' 0 N--CA 1.447 -1.264 1 C-N-CA 127.443 5.429 . . . . 0.0 116.531 -178.408 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -74.34 -9.82 58.98 Favored 'General case' 0 N--CA 1.446 -0.644 1 O-C-N 115.13 -4.731 . . . . 0.0 113.424 168.779 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -119.47 -8.49 10.01 Favored 'General case' 0 C--N 1.323 -0.56 1 C-N-CA 134.56 5.144 . . . . 0.0 114.146 -175.468 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.275 11.4 mt-30 -90.35 152.79 20.86 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 119.989 -1.694 . . . . 0.0 111.598 168.638 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 13.4 ttp-105 -128.05 122.09 31.32 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 115.028 -2.415 . . . . 0.0 109.849 156.794 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.522 ' HB3' HD13 ' A' ' 50' ' ' LEU . 3.0 mm? -80.84 115.51 20.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.635 1.561 . . . . 0.0 106.949 172.117 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 39.3 mt -116.26 134.85 58.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 116.418 -1.754 . . . . 0.0 106.7 167.299 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -88.29 -49.88 6.69 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 120.277 1.399 . . . . 0.0 108.299 -175.653 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -152.51 -44.32 0.1 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 117.221 -1.371 . . . . 0.0 114.566 -177.213 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -124.3 -11.21 4.75 Favored Glycine 0 CA--C 1.529 0.914 0 N-CA-C 118.685 2.234 . . . . 0.0 118.685 152.443 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -143.18 160.22 40.85 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.961 1.304 . . . . 0.0 112.686 -161.85 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -78.96 142.87 36.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 O-C-N 125.462 1.726 . . . . 0.0 113.646 -159.366 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.522 HD13 ' HB3' ' A' ' 43' ' ' LEU . 6.8 mp -85.83 109.32 18.61 Favored 'General case' 0 N--CA 1.443 -0.788 0 O-C-N 117.174 -3.454 . . . . 0.0 106.652 170.496 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -71.44 128.55 36.24 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 128.592 2.757 . . . . 0.0 111.126 -175.438 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -52.68 122.42 9.01 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 124.836 2.255 . . . . 0.0 112.647 166.328 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.1 19.48 5.92 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 118.683 -2.51 . . . . 0.0 110.815 173.848 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.323 26.8 mtt-85 -127.21 170.89 11.94 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 130.643 3.577 . . . . 0.0 113.992 -179.652 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 30.1 p -118.03 162.9 17.41 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 130.051 3.341 . . . . 0.0 117.893 174.939 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 mp -50.69 -41.69 56.12 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 122.659 2.481 . . . . 0.0 113.012 173.974 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.7 t -60.82 -22.24 63.98 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 118.502 2.778 . . . . 0.0 118.502 -178.739 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -69.23 -37.93 78.25 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 120.792 -1.192 . . . . 0.0 113.677 168.999 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 50.1 m-85 -98.54 -1.38 41.25 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.972 2.109 . . . . 0.0 112.564 -175.264 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 74.31 14.19 3.74 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 129.454 3.102 . . . . 0.0 112.149 168.217 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . 0.267 90.1 mt -55.41 125.45 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 C-N-CA 124.082 0.953 . . . . 0.0 113.102 178.743 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -131.89 167.49 19.51 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 128.794 2.838 . . . . 0.0 112.271 -176.191 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.326 41.3 pttt -34.57 119.03 0.43 Allowed 'General case' 0 N--CA 1.447 -0.605 1 C-N-CA 132.999 4.52 . . . . 0.0 116.114 -178.122 . . . . . . . . 3 2 . 1 . 107 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 63.94 25.44 13.94 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 179.507 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 37.2 m -70.46 121.41 17.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 115.305 -2.283 . . . . 0.0 107.752 160.189 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.5 m -95.87 119.37 34.24 Favored 'General case' 0 N--CA 1.447 -0.619 0 O-C-N 125.725 1.891 . . . . 0.0 107.532 174.896 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.21 147.0 26.77 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 128.683 2.793 . . . . 0.0 105.574 179.858 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -95.49 154.37 17.24 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 101.374 -3.565 . . . . 0.0 101.374 174.557 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -122.82 114.55 20.66 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 125.37 2.51 . . . . 0.0 112.875 161.35 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.7 t -79.86 152.47 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 C-N-CA 129.905 3.282 . . . . 0.0 111.391 165.724 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -116.21 147.22 41.66 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 124.022 1.868 . . . . 0.0 106.848 -174.062 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -72.09 115.86 11.83 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 113.109 -1.86 . . . . 0.0 108.77 166.148 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . 0.306 30.0 tp -143.47 140.89 30.57 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 118.406 -2.684 . . . . 0.0 104.881 -173.738 . . . . . . . . 2 2 . 1 . 107 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -107.7 133.77 51.64 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.709 2.404 . . . . 0.0 112.8 179.422 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.47 177.42 25.92 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 130.138 3.732 . . . . 0.0 109.592 175.703 . . . . . . . . 1 1 . 1 . 107 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.261 1.804 1 C-N-CA 134.239 5.685 . . . . 0.0 108.779 172.67 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptt? . . . . . 0 N--CA 1.466 0.332 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 . . . . . . . . . 0 0 . 1 . 108 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -86.5 157.4 19.79 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 124.404 1.065 . . . . 0.0 110.487 166.294 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 37.5 pt -127.24 158.64 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 C-N-CA 128.504 2.722 . . . . 0.0 106.531 155.142 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -113.54 138.13 50.59 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 172.694 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.8 t -117.4 115.75 49.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 1 C-N-CA 133.857 4.863 . . . . 0.0 107.738 170.08 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -84.56 135.32 34.26 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.563 1.545 . . . . 0.0 108.863 170.997 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.7 p -82.55 169.08 16.72 Favored 'General case' 0 N--CA 1.446 -0.656 0 O-C-N 126.93 2.644 . . . . 0.0 108.118 158.615 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.7 mt -87.99 -21.25 24.94 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 127.062 2.145 . . . . 0.0 109.569 178.848 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.2 p -68.9 -30.92 69.51 Favored 'General case' 0 N--CA 1.448 -0.573 0 O-C-N 116.329 -3.982 . . . . 0.0 114.764 163.285 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 127.11 5.96 5.5 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 125.723 3.874 . . . . 0.0 113.639 161.653 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -88.85 130.32 35.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 117.79 -3.182 . . . . 0.0 107.391 175.353 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.8 m -89.17 128.52 35.8 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 124.962 2.315 . . . . 0.0 107.85 160.997 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.2 mm -98.71 135.31 34.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 1 O-C-N 114.751 -4.968 . . . . 0.0 103.004 173.836 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.4 m -99.9 138.1 37.44 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 127.926 3.266 . . . . 0.0 104.023 176.18 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.441 HD13 HG13 ' A' ' 26' ' ' VAL . 53.9 mt -131.28 142.38 50.11 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.652 1.981 . . . . 0.0 110.432 178.005 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -124.5 110.6 14.68 Favored 'General case' 0 C--N 1.322 -0.622 2 O-C-N 115.748 -4.345 . . . . 0.0 110.35 -170.601 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -139.44 158.82 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 110.424 -3.08 . . . . 0.0 114.485 -163.022 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -96.39 153.5 38.91 Favored Pre-proline 0 N--CA 1.447 -0.598 0 O-C-N 127.53 3.019 . . . . 0.0 106.946 160.334 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -76.46 -6.66 17.27 Favored 'Trans proline' 0 N--CA 1.446 -1.315 0 N-CA-C 118.72 2.546 . . . . 0.0 118.72 -170.616 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.2 m -94.44 7.14 46.57 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.484 1.514 . . . . 0.0 107.624 174.405 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.435 ' CG ' HD22 ' A' ' 25' ' ' ASN . 16.4 t0 -80.95 137.37 36.11 Favored 'General case' 0 N--CA 1.452 -0.349 0 O-C-N 116.986 -3.571 . . . . 0.0 109.76 171.829 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.6 p -92.13 149.41 21.5 Favored 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 118.185 -2.822 . . . . 0.0 106.839 -156.351 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 mp -46.86 -31.92 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 127.684 2.394 . . . . 0.0 114.569 169.673 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -69.27 -28.29 66.17 Favored 'General case' 0 N--CA 1.449 -0.494 0 O-C-N 120.495 -1.378 . . . . 0.0 111.342 179.676 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.435 HD22 ' CG ' ' A' ' 21' ' ' ASP . 63.6 t30 -81.32 -33.82 32.28 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 119.534 -1.979 . . . . 0.0 114.42 170.451 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.441 HG13 HD13 ' A' ' 15' ' ' LEU 0.301 39.5 t -59.24 -44.98 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 116.592 -1.67 . . . . 0.0 108.518 170.117 . . . . . . . . 3 3 . 1 . 108 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HA ' HD12 ' A' ' 30' ' ' ILE . 69.9 mttt -50.66 -38.74 48.14 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 118.176 2.658 . . . . 0.0 118.176 172.793 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.9 -23.89 31.01 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 123.623 0.577 . . . . 0.0 112.096 -168.507 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . 0.275 30.9 mttm -73.08 -29.43 62.94 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 118.96 -2.338 . . . . 0.0 111.698 175.441 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 27' ' ' LYS . 62.8 mt -70.64 -52.69 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 129.512 3.125 . . . . 0.0 105.943 178.301 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.372 1.1 tp-100 -34.23 -45.24 0.21 Allowed 'General case' 0 C--N 1.325 -0.46 1 O-C-N 115.008 -4.807 . . . . 0.0 119.386 162.088 . . . . . . . . 3 2 . 1 . 108 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -73.71 -44.96 54.99 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 131.289 3.836 . . . . 0.0 109.953 -178.584 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -74.02 -47.35 37.56 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 119.833 3.272 . . . . 0.0 119.833 -177.275 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -135.6 11.8 3.45 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 117.906 -1.045 . . . . 0.0 113.701 -177.205 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.71 -8.38 75.74 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 115.973 1.149 . . . . 0.0 115.973 157.485 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 29.6 mt -58.71 131.74 85.97 Favored Pre-proline 0 N--CA 1.449 -0.497 1 C-N-CA 134.744 5.218 . . . . 0.0 107.404 173.544 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -80.3 150.51 19.91 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 120.947 1.098 . . . . 0.0 112.392 -178.574 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -73.18 -30.83 10.14 Favored 'Trans proline' 0 C--N 1.323 -0.815 0 C-N-CA 124.211 3.274 . . . . 0.0 116.985 -175.997 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.38 -3.58 31.25 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -166.549 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -99.99 -31.15 11.6 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 -173.483 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -75.76 118.01 18.11 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 125.699 1.6 . . . . 0.0 112.631 -159.407 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -102.11 113.43 26.68 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 130.77 3.628 . . . . 0.0 105.976 158.407 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.5 mp -86.82 150.36 24.18 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 121.615 2.007 . . . . 0.0 106.932 166.929 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.28 15.2 mt -126.63 139.62 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 CA-C-N 114.18 -1.373 . . . . 0.0 110.905 176.187 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -139.82 115.73 10.27 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 128.101 2.56 . . . . 0.0 109.412 177.659 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 74.56 20.86 2.36 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 127.961 2.504 . . . . 0.0 108.262 167.587 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 92.84 -3.17 73.67 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 130.323 3.821 . . . . 0.0 110.413 -175.141 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -96.66 134.2 40.22 Favored 'General case' 0 N--CA 1.444 -0.734 0 CA-C-N 121.516 2.658 . . . . 0.0 106.54 -170.411 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.5 pm0 -80.56 132.07 35.61 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 126.356 2.285 . . . . 0.0 108.843 172.312 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 59' ' ' TYR . 25.6 mt -95.57 155.42 16.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 125.206 2.432 . . . . 0.0 112.209 -172.921 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -118.16 157.01 27.72 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 112.784 -2.007 . . . . 0.0 109.088 -178.215 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -77.59 137.97 38.87 Favored 'General case' 0 N--CA 1.444 -0.726 1 O-C-N 129.996 4.56 . . . . 0.0 112.589 -172.804 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 98.67 -21.23 46.97 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 116.784 1.474 . . . . 0.0 116.784 177.905 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -84.78 169.93 13.71 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 127.179 2.191 . . . . 0.0 112.239 168.83 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 52.7 p -110.55 163.52 13.63 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.179 1.792 . . . . 0.0 110.461 -162.159 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.418 ' H ' ' HG ' ' A' ' 56' ' ' LEU . 5.7 mt -43.48 -47.51 7.15 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.867 1.667 . . . . 0.0 111.937 152.899 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.5 t -63.78 -38.95 93.0 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.532 1.933 . . . . 0.0 113.109 -170.682 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -64.53 -45.15 88.42 Favored 'General case' 0 C--N 1.327 -0.376 1 C-N-CA 133.589 4.756 . . . . 0.0 109.123 -178.992 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.421 ' CD2' HD22 ' A' ' 50' ' ' LEU . 35.5 m-85 -96.26 12.13 32.11 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 124.157 1.932 . . . . 0.0 109.328 -174.654 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 56.19 42.62 27.9 Favored 'General case' 0 N--CA 1.444 -0.739 2 C-N-CA 132.492 4.317 . . . . 0.0 114.903 175.858 . . . . . . . . 3 3 . 1 . 108 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 mt -93.71 101.7 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 102.32 -3.215 . . . . 0.0 102.32 -172.349 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -94.77 177.93 5.75 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.166 -1.379 . . . . 0.0 113.54 -176.604 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -49.01 142.04 7.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.306 3.042 . . . . 0.0 117.136 -174.77 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.343 88.3 mt-10 63.76 11.38 5.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 120.17 3.396 . . . . 0.0 120.17 179.005 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 58.7 m -73.52 143.77 46.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 113.532 -1.667 . . . . 0.0 113.445 -177.586 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 57.8 m -92.29 139.34 30.71 Favored 'General case' 0 N--CA 1.442 -0.848 1 C-N-CA 132.193 4.197 . . . . 0.0 108.194 178.043 . . . . . . . . 2 2 . 1 . 108 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.4 mp -131.68 158.05 42.12 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 130.236 3.415 . . . . 0.0 111.56 169.215 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 p-80 -126.01 148.54 49.26 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 128.231 2.612 . . . . 0.0 109.409 163.618 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . 0.251 0.6 OUTLIER -98.41 130.37 45.04 Favored 'General case' 0 N--CA 1.451 -0.378 1 C-N-CA 132.329 4.252 . . . . 0.0 109.494 167.383 . . . . . . . . 4 3 . 1 . 108 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.3 t -103.44 136.37 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 113.497 -1.683 . . . . 0.0 109.045 164.749 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 mt -93.67 122.97 36.67 Favored 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 129.682 3.193 . . . . 0.0 110.638 178.506 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -161.24 112.73 1.79 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 112.764 -2.016 . . . . 0.0 109.997 172.513 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.76 147.21 39.45 Favored 'General case' 0 CA--C 1.535 0.381 1 C-N-CA 132.185 4.194 . . . . 0.0 109.683 177.062 . . . . . . . . 3 3 . 1 . 108 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 27.4 ttm105 -72.77 113.09 9.41 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 127.837 2.455 . . . . 0.0 112.228 -175.779 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.67 158.52 14.24 Favored Glycine 0 CA--C 1.529 0.953 0 O-C-N 118.738 -2.476 . . . . 0.0 109.855 175.868 . . . . . . . . 1 1 . 1 . 108 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.327 0 CA-C-O 114.499 -3.389 . . . . 0.0 104.687 -175.493 . . . . . . . . 0 0 . 1 . 109 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 . . . . . . . . . 0 0 . 1 . 109 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.298 8.8 tt0 -88.62 144.15 26.48 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 125.718 2.675 . . . . 0.0 108.393 -175.092 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.0 pt -142.26 149.38 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 111.214 -2.721 . . . . 0.0 108.848 -179.154 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -88.66 144.15 26.47 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 127.843 2.457 . . . . 0.0 113.965 168.102 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.8 t -135.09 99.14 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 O-C-N 118.187 -2.821 . . . . 0.0 104.147 -174.154 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 22.5 mttp -77.05 99.62 5.39 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 167.789 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.4 p -72.04 173.15 8.83 Favored 'General case' 0 C--N 1.322 -0.607 0 O-C-N 126.553 2.408 . . . . 0.0 114.47 166.447 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -40.19 -40.68 1.16 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 129.494 3.118 . . . . 0.0 118.815 -168.352 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 46.1 p -80.83 -6.43 58.55 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 117.958 2.577 . . . . 0.0 117.958 171.864 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.71 0.6 60.54 Favored Glycine 0 CA--C 1.527 0.784 0 CA-C-O 123.85 1.806 . . . . 0.0 113.764 -170.369 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.5 tttt -69.22 106.58 2.91 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.919 -1.641 . . . . 0.0 108.014 -173.848 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.7 m -79.39 112.38 16.57 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 110.19 -3.187 . . . . 0.0 111.844 -178.304 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mt -110.75 137.27 43.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 1 CA-C-N 106.954 -4.657 . . . . 0.0 109.485 173.214 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.8 m -100.41 125.09 46.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 179.912 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 tp -133.73 159.94 39.04 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 128.665 2.786 . . . . 0.0 110.408 -172.845 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -128.46 155.72 44.35 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 175.247 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.8 m -143.22 151.3 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 O-C-N 126.336 2.273 . . . . 0.0 107.599 -175.02 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -100.13 136.78 20.02 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 100.953 -3.721 . . . . 0.0 100.953 173.189 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -34.36 -42.01 0.27 Allowed 'Trans proline' 0 N--CA 1.443 -1.465 1 C-N-CA 128.003 5.802 . . . . 0.0 119.326 174.228 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 3.0 p -79.3 -13.24 59.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 114.257 -2.782 . . . . 0.0 116.036 179.562 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -47.94 125.52 9.08 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.796 2.038 . . . . 0.0 112.354 -179.468 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.412 HG22 HG22 ' A' ' 55' ' ' THR . 81.9 p -69.39 151.7 45.82 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 127.911 2.485 . . . . 0.0 111.917 163.067 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.6 mm -63.31 -32.72 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 124.029 3.104 . . . . 0.0 119.151 -174.445 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -54.9 -33.05 61.67 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 127.057 2.143 . . . . 0.0 113.339 158.104 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -79.56 -15.67 57.27 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.662 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 20.2 t -82.72 -48.92 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 O-C-N 118.941 -2.349 . . . . 0.0 109.364 169.159 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -60.29 -27.93 67.69 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.275 0.984 . . . . 0.0 113.575 176.309 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -79.37 -23.43 43.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 118.786 -2.446 . . . . 0.0 116.963 176.699 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -78.24 -47.4 18.03 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.178 -1.373 . . . . 0.0 110.151 175.725 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.263 26.2 mt -51.02 -40.45 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 O-C-N 128.45 3.594 . . . . 0.0 109.977 169.367 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -58.62 -62.43 1.86 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 126.623 1.969 . . . . 0.0 114.024 179.441 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -43.38 -23.7 0.07 Allowed 'General case' 0 N--CA 1.45 -0.436 1 C-N-CA 136.039 5.735 . . . . 0.0 116.699 -178.385 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 mmtt -96.78 -12.23 23.93 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 131.526 3.931 . . . . 0.0 117.513 179.194 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -160.16 -16.83 0.06 Allowed 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 122.948 2.613 . . . . 0.0 110.346 -179.082 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 108.66 11.87 22.19 Favored Glycine 0 CA--C 1.524 0.644 1 C-N-CA 113.679 -4.105 . . . . 0.0 111.401 162.477 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.6 mt -105.59 127.61 28.16 Favored Pre-proline 0 N--CA 1.45 -0.442 0 CA-C-N 121.35 2.575 . . . . 0.0 108.457 -170.352 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -68.13 147.3 72.81 Favored 'Trans proline' 0 N--CA 1.452 -0.912 0 CA-C-O 114.644 -2.315 . . . . 0.0 111.792 -172.154 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.252 71.3 Cg_exo -44.67 -38.4 12.44 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 O-C-N 126.711 2.953 . . . . 0.0 117.409 167.887 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.98 -24.79 55.96 Favored 'General case' 0 C--N 1.325 -0.469 1 C-N-CA 131.896 4.078 . . . . 0.0 113.433 179.439 . . . . . . . . 3 3 . 1 . 109 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -110.29 -28.38 8.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 125.709 1.881 . . . . 0.0 110.136 -178.258 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -60.49 104.58 0.35 Allowed 'General case' 0 N--CA 1.446 -0.663 0 O-C-N 119.942 -1.724 . . . . 0.0 111.557 177.668 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.0 ttt85 -110.56 128.57 55.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 130.205 3.402 . . . . 0.0 102.689 179.885 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.98 99.29 3.43 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -157.929 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 5.8 mm -99.2 128.04 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 N-CA-C 103.442 -2.799 . . . . 0.0 103.442 -166.153 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.48 ' CE2' HG12 ' A' ' 61' ' ' ILE . 61.7 t80 -146.5 109.66 4.71 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 -177.928 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 79.99 35.21 0.15 Allowed 'General case' 0 CA--C 1.53 0.178 0 O-C-N 125.496 1.748 . . . . 0.0 109.779 178.355 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.67 -10.51 70.68 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 114.784 -3.579 . . . . 0.0 109.572 169.46 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.259 19.6 pttt -143.89 145.36 32.24 Favored 'General case' 0 N--CA 1.448 -0.568 0 O-C-N 118.723 -2.633 . . . . 0.0 106.208 -161.796 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 tp60 -72.2 135.25 46.05 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 127.701 2.4 . . . . 0.0 107.632 -175.977 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 55.1 mt -88.76 107.65 19.07 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.842 1.657 . . . . 0.0 110.464 -179.445 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -114.75 161.57 17.99 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 119.412 -2.055 . . . . 0.0 105.862 -159.751 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.0 149.94 30.58 Favored 'General case' 0 N--CA 1.447 -0.61 1 C-N-CA 133.458 4.703 . . . . 0.0 107.423 -178.216 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.86 -21.71 31.39 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.618 -0.993 . . . . 0.0 110.618 169.584 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -101.49 157.58 16.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 128.715 2.806 . . . . 0.0 108.577 -172.513 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.412 HG22 HG22 ' A' ' 22' ' ' THR . 22.0 p -113.83 174.94 5.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.991 0.9 . . . . 0.0 109.43 163.662 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.0 mt -53.27 -38.01 62.66 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 117.114 2.264 . . . . 0.0 117.114 176.753 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.7 t -60.82 -22.98 64.73 Favored 'General case' 0 C--O 1.222 -0.364 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 167.915 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -86.71 -0.23 55.9 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 118.446 -2.659 . . . . 0.0 113.94 -178.557 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -138.0 -6.54 1.64 Allowed 'General case' 0 N--CA 1.45 -0.455 0 O-C-N 117.867 -3.021 . . . . 0.0 110.976 172.735 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 67.12 71.37 0.37 Allowed 'General case' 0 N--CA 1.442 -0.855 1 C-N-CA 133.467 4.707 . . . . 0.0 110.3 -177.987 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.48 HG12 ' CE2' ' A' ' 45' ' ' PHE . 70.4 mt -120.18 135.54 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.771 0 N-CA-C 102.276 -3.231 . . . . 0.0 102.276 -177.95 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . 0.264 11.9 pt20 -152.27 -166.61 2.53 Favored 'General case' 0 N--CA 1.446 -0.662 0 O-C-N 126.005 2.066 . . . . 0.0 109.936 173.15 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.9 pttt -50.53 142.13 11.23 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 125.787 1.635 . . . . 0.0 114.034 -174.373 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.477 11.4 tp10 89.15 -8.35 0.43 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.543 1.537 . . . . 0.0 114.004 164.404 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 m -62.84 151.55 38.7 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 118.24 2.682 . . . . 0.0 118.24 170.128 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.1 m -106.8 118.01 35.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 104.304 -2.48 . . . . 0.0 104.304 171.802 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.5 mt -89.5 143.93 26.43 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 128.53 2.732 . . . . 0.0 105.592 167.596 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . 0.37 25.6 p80 -133.78 135.76 44.08 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-O 116.261 -1.828 . . . . 0.0 109.274 -174.457 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 6.0 mp -124.5 154.51 40.44 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 124.566 1.166 . . . . 0.0 112.561 -164.727 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.48 -179.8 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 131.422 3.889 . . . . 0.0 110.358 169.013 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . 0.311 4.4 mp -93.92 144.17 25.69 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -179.288 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -89.65 129.81 36.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.405 163.618 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 85.5 mt -136.39 37.25 2.71 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 -169.824 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -136.97 -74.29 0.43 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 103.392 -2.818 . . . . 0.0 103.392 -179.348 . . . . . . . . 1 1 . 1 . 109 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 121.3 152.8 8.85 Favored Glycine 0 CA--C 1.525 0.681 1 C-N-CA 130.845 4.069 . . . . 0.0 112.01 -177.973 . . . . . . . . 2 2 . 1 . 109 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.329 0 C-N-CA 126.279 1.895 . . . . 0.0 112.252 -172.762 . . . . . . . . 0 0 . 1 . 110 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ptt? . . . . . 0 N--CA 1.472 0.664 0 CA-C-O 115.283 -2.294 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 110 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -81.46 142.22 33.14 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 123.538 1.637 . . . . 0.0 107.079 167.401 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.6 pt -127.91 152.63 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 116.268 -1.825 . . . . 0.0 107.466 161.675 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -94.11 142.71 27.08 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 115.627 -2.429 . . . . 0.0 111.897 172.648 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.29 53.1 t -114.68 83.38 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 1 C-N-CA 132.829 4.452 . . . . 0.0 108.204 169.2 . . . . . . . . 3 2 . 1 . 110 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.6 tttt -64.03 130.83 45.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 110.071 -3.24 . . . . 0.0 109.812 172.255 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -132.65 154.26 50.28 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.783 0.833 . . . . 0.0 110.306 -176.868 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.571 HD12 ' H ' ' A' ' 8' ' ' LEU . 5.8 mp -42.2 -27.2 0.13 Allowed 'General case' 0 N--CA 1.444 -0.74 1 C-N-CA 133.295 4.638 . . . . 0.0 121.031 -170.271 . . . . . . . . 3 3 . 1 . 110 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.25 39.1 p -119.17 17.01 13.22 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 117.747 -1.12 . . . . 0.0 111.229 -161.147 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.33 24.56 23.9 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 130.312 3.815 . . . . 0.0 112.217 171.127 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -105.4 160.2 15.32 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 118.932 1.366 . . . . 0.0 107.604 173.62 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -127.89 113.86 16.44 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 127.515 2.326 . . . . 0.0 113.493 174.681 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.6 mt -90.67 133.86 31.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 116.466 -3.896 . . . . 0.0 103.843 -179.137 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 t -141.72 83.09 1.84 Allowed 'General case' 0 N--CA 1.446 -0.67 0 CA-C-O 127.508 3.528 . . . . 0.0 112.698 -170.534 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 61.8 mt -93.57 150.38 20.48 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 112.011 -2.359 . . . . 0.0 111.488 179.216 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -94.93 118.55 31.99 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 101.88 -3.378 . . . . 0.0 101.88 179.015 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.0 m -135.18 152.21 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 C-N-CA 123.713 0.805 . . . . 0.0 109.085 -176.146 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -106.51 160.0 27.82 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 173.343 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.328 40.9 Cg_endo -66.92 -24.38 46.1 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.388 2.726 . . . . 0.0 115.269 -168.186 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 87.1 p -84.57 -4.97 59.25 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 120.608 3.558 . . . . 0.0 120.608 -174.483 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -69.77 132.25 45.79 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 126.414 2.321 . . . . 0.0 109.624 176.727 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.6 p -69.82 147.92 49.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 126.857 3.218 . . . . 0.0 105.996 171.727 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.7 mm -59.58 -34.42 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 CA-C-N 110.059 -3.246 . . . . 0.0 114.208 179.8 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -71.65 -30.66 65.99 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 121.897 2.135 . . . . 0.0 111.16 178.605 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.5 t30 -74.81 -26.54 59.8 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 125.469 1.731 . . . . 0.0 113.736 174.026 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.5 t -78.42 -24.83 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 121.251 1.841 . . . . 0.0 108.399 173.149 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -67.6 -39.8 84.79 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 123.562 2.892 . . . . 0.0 112.146 164.896 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.64 -31.7 70.89 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 126.71 2.004 . . . . 0.0 110.907 179.244 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -71.04 -10.72 60.24 Favored 'General case' 0 N--CA 1.451 -0.42 1 C-N-CA 134.574 5.149 . . . . 0.0 114.183 176.026 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.9 mt -94.1 -27.61 4.36 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 C-N-CA 127.563 2.345 . . . . 0.0 108.664 176.375 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -54.74 -27.09 38.43 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 123.064 2.666 . . . . 0.0 115.072 174.287 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.31 -33.82 65.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 123.94 1.829 . . . . 0.0 108.474 179.078 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.8 mmtm -96.49 -51.63 4.27 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 128.547 2.739 . . . . 0.0 107.085 -164.268 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -113.79 -12.17 12.79 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 -173.45 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.42 -16.45 58.97 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 120.562 1.528 . . . . 0.0 111.584 173.11 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.2 mt -87.51 123.21 69.94 Favored Pre-proline 0 N--CA 1.449 -0.521 0 O-C-N 117.328 -3.454 . . . . 0.0 109.191 -159.209 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -76.03 154.78 38.0 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 O-C-N 116.349 -2.501 . . . . 0.0 108.057 179.206 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -44.73 -34.21 8.0 Favored 'Trans proline' 0 N--CA 1.441 -1.598 1 C-N-CA 126.738 4.959 . . . . 0.0 119.364 177.174 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -58.11 -38.26 76.13 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 128.62 2.768 . . . . 0.0 115.223 178.743 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -85.8 -8.77 57.9 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 103.914 -2.625 . . . . 0.0 103.914 -172.967 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -100.75 163.7 12.2 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 123.28 2.764 . . . . 0.0 112.356 178.324 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 24.5 ttm-85 -144.7 160.45 41.19 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 109.989 -3.278 . . . . 0.0 108.547 158.338 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 16.9 mt -118.48 126.42 52.0 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 127.521 2.328 . . . . 0.0 111.623 169.748 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.4 mm -100.76 139.64 21.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 130.788 3.635 . . . . 0.0 106.952 168.296 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.527 ' CE2' HG12 ' A' ' 61' ' ' ILE . 12.2 t80 -122.89 -146.12 0.36 Allowed 'General case' 0 C--N 1.332 -0.196 0 O-C-N 126.705 2.503 . . . . 0.0 110.466 173.654 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -79.11 54.18 1.58 Allowed 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.32 -1.488 . . . . 0.0 110.227 -171.543 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.64 -19.04 19.45 Favored Glycine 0 CA--C 1.534 1.274 0 CA-C-O 117.498 -1.723 . . . . 0.0 110.987 178.451 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -112.8 138.76 49.14 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 126.559 3.076 . . . . 0.0 107.063 -168.831 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -88.75 123.35 33.09 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 113.04 -1.891 . . . . 0.0 108.26 165.281 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 30.1 mt -82.22 141.09 33.29 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 120.9 -1.125 . . . . 0.0 113.201 -174.532 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -98.25 147.62 24.44 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.774 -0.578 . . . . 0.0 110.756 -176.488 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.04 123.52 29.55 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 125.153 1.533 . . . . 0.0 106.909 -177.71 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 128.1 -29.65 4.08 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 128.178 2.799 . . . . 0.0 114.194 -179.692 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -84.43 154.73 22.61 Favored 'General case' 0 N--CA 1.446 -0.644 0 O-C-N 128.408 3.064 . . . . 0.0 106.395 172.484 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.3 p -78.6 169.82 17.64 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 112.226 -2.261 . . . . 0.0 110.918 175.888 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 14.9 mt -69.8 -17.28 63.4 Favored 'General case' 0 N--CA 1.443 -0.777 0 O-C-N 119.793 -1.817 . . . . 0.0 111.467 168.684 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.5 t -92.23 -13.93 29.73 Favored 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 118.377 -2.702 . . . . 0.0 111.472 -169.653 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -50.19 -46.04 54.06 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 130.988 3.715 . . . . 0.0 106.217 168.413 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -101.21 16.47 25.38 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 123.383 1.563 . . . . 0.0 111.016 -172.159 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.342 10.9 p-10 52.21 40.84 29.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 129.338 3.055 . . . . 0.0 114.183 177.943 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.527 HG12 ' CE2' ' A' ' 45' ' ' PHE . 19.0 mt -76.72 128.64 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 CA-C-O 125.599 2.619 . . . . 0.0 106.786 -177.619 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -105.07 167.64 9.58 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 109.073 -3.694 . . . . 0.0 111.013 -177.064 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.283 36.0 pttt -40.62 129.68 2.49 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 118.719 2.859 . . . . 0.0 118.719 162.965 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 58.65 3.03 0.26 Allowed 'General case' 0 N--CA 1.448 -0.554 0 O-C-N 126.782 2.551 . . . . 0.0 117.71 173.189 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.6 t -63.16 152.9 36.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 126.029 1.732 . . . . 0.0 114.009 174.723 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -102.14 120.41 40.4 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -160.995 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -104.83 152.68 22.3 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 128.509 2.724 . . . . 0.0 106.502 164.477 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.7 t60 -123.93 137.4 54.63 Favored 'General case' 0 N--CA 1.445 -0.716 0 O-C-N 126.029 2.081 . . . . 0.0 109.638 -175.472 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 48.5 tp -118.71 132.77 56.16 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 119.732 -1.855 . . . . 0.0 108.006 -159.838 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 m -137.64 165.2 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 1 CA-C-N 126.181 4.082 . . . . 0.0 107.384 -170.438 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.1 tp -86.82 134.48 33.55 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 124.027 1.87 . . . . 0.0 109.619 -179.818 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.281 40.0 ttt180 -102.74 140.0 37.58 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 116.363 -3.96 . . . . 0.0 102.89 -179.994 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.1 mt -124.91 49.25 1.88 Allowed 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 129.764 3.226 . . . . 0.0 111.492 -170.334 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 36.2 ttt-85 90.41 2.45 0.17 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 130.874 3.67 . . . . 0.0 105.93 167.491 . . . . . . . . 1 1 . 1 . 110 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -125.05 136.63 9.97 Favored Glycine 0 CA--C 1.536 1.394 1 O-C-N 115.286 -4.634 . . . . 0.0 106.634 -167.852 . . . . . . . . 2 2 . 1 . 110 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.369 1 C-N-CA 130.972 4.129 . . . . 0.0 114.823 -167.441 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 ttp . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 104.462 -2.422 . . . . 0.0 104.462 . . . . . . . . . 0 0 . 1 . 111 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -77.09 143.9 38.91 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 122.725 2.512 . . . . 0.0 112.973 -179.975 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.263 46.7 pt -140.13 168.49 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 O-C-N 125.756 1.91 . . . . 0.0 106.997 173.045 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.94 133.52 31.92 Favored 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 118.326 -2.734 . . . . 0.0 110.569 159.429 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.4 t -93.04 105.58 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 N-CA-C 101.194 -3.632 . . . . 0.0 101.194 174.117 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -97.65 104.11 16.11 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 118.631 -2.543 . . . . 0.0 110.198 171.542 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -86.47 146.58 26.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 126.464 3.03 . . . . 0.0 113.74 -162.876 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.418 HD12 HG23 ' A' ' 9' ' ' THR . 3.4 pp -70.64 -28.74 65.04 Favored 'General case' 0 N--CA 1.446 -0.64 1 O-C-N 113.3 -5.875 . . . . 0.0 109.443 179.145 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.418 HG23 HD12 ' A' ' 8' ' ' LEU 0.358 30.2 p -62.52 -7.46 4.66 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 119.667 3.21 . . . . 0.0 119.667 162.282 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.96 -5.63 11.25 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-O 114.685 -3.286 . . . . 0.0 118.4 150.489 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -120.66 160.59 22.97 Favored 'General case' 0 N--CA 1.446 -0.661 1 CA-C-N 125.422 4.611 . . . . 0.0 111.259 -177.568 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.3 m -100.39 136.9 39.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 O-C-N 125.441 1.713 . . . . 0.0 109.591 177.174 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 2.0 mt -113.59 119.09 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 162.278 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -75.85 126.73 31.56 Favored 'General case' 0 C--O 1.24 0.598 0 C-N-CA 130.652 3.581 . . . . 0.0 106.099 169.948 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.26 160.85 39.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 124.177 1.942 . . . . 0.0 105.904 -173.481 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -125.87 131.47 52.37 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.076 2.151 . . . . 0.0 109.244 -178.184 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 m -137.27 169.83 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 O-C-N 127.382 2.926 . . . . 0.0 110.715 178.238 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.283 0.7 OUTLIER -112.08 146.72 35.41 Favored Pre-proline 0 N--CA 1.448 -0.553 0 N-CA-C 103.137 -2.912 . . . . 0.0 103.137 168.382 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -47.99 -33.39 20.29 Favored 'Trans proline' 0 N--CA 1.447 -1.233 1 C-N-CA 129.3 6.667 . . . . 0.0 115.37 158.632 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 92.9 p -74.47 -6.81 50.45 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 119.516 3.154 . . . . 0.0 119.516 174.279 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -73.02 130.53 40.53 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 129.204 3.002 . . . . 0.0 104.378 179.714 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -77.28 155.85 31.79 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 111.962 -2.381 . . . . 0.0 112.852 163.376 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.367 35.5 mm -49.88 -38.1 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -178.359 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -73.29 -29.85 62.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 128.216 2.606 . . . . 0.0 113.632 177.934 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -75.94 -34.62 59.86 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-O 114.562 -2.637 . . . . 0.0 108.342 172.565 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.7 t -66.11 -42.69 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 CA-C-N 120.673 1.579 . . . . 0.0 111.029 175.058 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -63.59 -27.09 69.01 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 118.441 -2.662 . . . . 0.0 111.755 179.484 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . 0.32 . . -80.21 -22.09 42.21 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 116.312 -1.804 . . . . 0.0 111.727 179.962 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -80.08 -23.09 41.54 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 113.99 -2.909 . . . . 0.0 104.903 173.617 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.412 HG21 HD21 ' A' ' 69' ' ' LEU . 96.2 mt -74.6 -37.4 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 116.474 2.027 . . . . 0.0 116.474 166.717 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.356 51.1 tt0 -63.66 -32.29 73.73 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -178.412 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -70.65 -32.31 69.55 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 112.391 -2.186 . . . . 0.0 112.187 -177.626 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -98.7 -49.76 4.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 -169.738 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -105.43 -17.6 14.38 Favored 'General case' 0 N--CA 1.443 -0.795 0 O-C-N 120.721 -1.237 . . . . 0.0 107.839 -165.148 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.52 4.73 57.1 Favored Glycine 0 CA--C 1.529 0.909 0 O-C-N 120.769 -1.207 . . . . 0.0 114.178 171.208 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.1 mm -91.4 124.41 61.21 Favored Pre-proline 0 C--O 1.236 0.384 0 O-C-N 119.51 -2.171 . . . . 0.0 110.83 -169.904 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -66.5 141.69 62.18 Favored 'Trans proline' 0 N--CA 1.446 -1.274 1 C-N-CA 128.618 6.212 . . . . 0.0 107.077 -175.202 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.42 -35.48 39.26 Favored 'Trans proline' 0 N--CA 1.445 -1.379 1 C-N-CA 129.286 6.657 . . . . 0.0 108.884 -174.089 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -41.55 -46.83 3.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 115.912 1.819 . . . . 0.0 115.912 166.032 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -79.28 -34.38 42.54 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 125.891 1.994 . . . . 0.0 113.893 -178.678 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -69.79 145.24 52.31 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 118.661 2.837 . . . . 0.0 118.661 -179.027 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.09 150.82 39.97 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 116.022 -1.942 . . . . 0.0 110.008 165.814 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 13.0 tp -117.75 123.51 46.19 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 124.351 3.25 . . . . 0.0 103.916 -177.977 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.3 mm -125.25 129.34 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 102.575 -3.12 . . . . 0.0 102.575 -168.462 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.413 ' HB3' HD11 ' A' ' 50' ' ' LEU 0.294 64.8 t80 -151.14 109.78 3.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 116.153 -1.88 . . . . 0.0 115.608 172.112 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.529 . . 90.52 42.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 124.772 2.225 . . . . 0.0 113.033 171.903 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.88 -0.09 89.11 Favored Glycine 0 CA--C 1.528 0.898 0 O-C-N 117.097 -3.502 . . . . 0.0 119.261 179.458 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -142.58 150.13 39.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 110.598 -2.801 . . . . 0.0 113.135 -165.127 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . 0.27 0.0 OUTLIER -73.94 126.77 31.21 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 115.267 -2.301 . . . . 0.0 110.958 170.136 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.413 HD11 ' HB3' ' A' ' 45' ' ' PHE . 31.6 mt -78.04 126.48 30.88 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 128.462 2.705 . . . . 0.0 104.874 167.246 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -103.35 156.95 17.36 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 110.793 -2.912 . . . . 0.0 111.495 -170.706 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -65.39 161.24 20.19 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.407 2.283 . . . . 0.0 113.671 -178.286 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.14 -33.29 6.57 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 130.184 3.754 . . . . 0.0 112.359 173.038 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.279 88.6 mtt180 -98.59 153.4 18.69 Favored 'General case' 0 N--CA 1.451 -0.418 1 C-N-CA 135.343 5.457 . . . . 0.0 106.318 -164.037 . . . . . . . . 3 2 . 1 . 111 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 34.1 p -100.24 163.59 12.33 Favored 'General case' 0 N--CA 1.447 -0.584 0 O-C-N 125.739 1.9 . . . . 0.0 108.094 175.763 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mt -49.46 -31.18 9.38 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 128.029 2.532 . . . . 0.0 117.632 157.25 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 84.7 p -71.56 -33.64 69.28 Favored 'General case' 0 N--CA 1.449 -0.494 1 O-C-N 114.955 -4.841 . . . . 0.0 107.694 175.186 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -76.46 -32.94 58.7 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 123.821 3.01 . . . . 0.0 107.042 -176.235 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -79.32 -19.76 49.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 115.156 -2.354 . . . . 0.0 109.147 170.178 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 72.6 43.13 0.48 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 128.287 2.635 . . . . 0.0 107.464 176.043 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.9 mt -80.91 143.62 12.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 117.63 -3.169 . . . . 0.0 111.021 175.797 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -133.74 159.71 39.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 129.117 2.967 . . . . 0.0 115.66 -178.196 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.16 139.25 1.43 Allowed 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 120.124 3.379 . . . . 0.0 120.124 -175.647 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.261 32.5 mt-10 69.76 28.11 4.46 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 129.574 3.15 . . . . 0.0 115.731 174.164 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.26 70.9 m -81.66 154.08 26.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 111.92 -2.4 . . . . 0.0 106.382 170.047 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.7 p -98.86 131.91 44.6 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 126.222 2.915 . . . . 0.0 103.32 166.915 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.03 150.52 38.49 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 129.654 3.181 . . . . 0.0 102.813 175.979 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -122.32 140.47 52.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 121.586 1.994 . . . . 0.0 113.412 -166.87 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.412 HD21 HG21 ' A' ' 30' ' ' ILE 0.287 5.9 mt -91.19 139.87 30.33 Favored 'General case' 0 N--CA 1.446 -0.636 0 O-C-N 118.76 -2.462 . . . . 0.0 112.422 165.937 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.5 t -134.25 145.04 33.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 C-N-CA 129.291 3.036 . . . . 0.0 106.635 163.229 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -116.42 119.28 35.15 Favored 'General case' 0 N--CA 1.452 -0.361 1 C-N-CA 132.559 4.343 . . . . 0.0 108.916 -167.522 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.8 mtp180 -72.71 168.2 19.23 Favored 'General case' 0 C--N 1.326 -0.448 1 C-N-CA 132.293 4.237 . . . . 0.0 106.137 172.146 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.0 mt -83.75 140.07 32.32 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 111.234 -2.712 . . . . 0.0 104.263 164.33 . . . . . . . . 1 1 . 1 . 111 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 91.8 130.95 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.479 1 C-N-CA 132.72 4.408 . . . . 0.0 109.138 -172.88 . . . . . . . . 3 3 . 1 . 111 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.61 166.55 20.07 Favored Glycine 0 CA--C 1.522 0.516 1 C-N-CA 134.183 5.658 . . . . 0.0 108.758 -177.858 . . . . . . . . 2 2 . 1 . 111 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.262 0 CA-C-O 116.678 -2.179 . . . . 0.0 109.694 -179.568 . . . . . . . . 0 0 . 1 . 112 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.481 1.095 0 CA-C-O 125.78 2.705 . . . . 0.0 114.836 . . . . . . . . . 0 0 . 1 . 112 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.266 12.4 mt-30 -85.49 152.79 22.91 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 119.549 -1.969 . . . . 0.0 110.925 167.769 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.252 18.2 pt -134.24 167.42 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 N-CA-C 101.007 -3.701 . . . . 0.0 101.007 162.979 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -131.8 93.4 3.31 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 125.429 1.492 . . . . 0.0 108.94 -167.678 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 63.8 t -90.75 110.47 22.27 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.406 0 N-CA-C 101.605 -3.48 . . . . 0.0 101.605 -172.057 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.2 tttt -109.34 137.63 46.91 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.45 2.3 . . . . 0.0 112.841 177.669 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.2 p -86.14 152.45 22.84 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 103.228 -2.879 . . . . 0.0 103.228 179.291 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -55.06 -19.05 6.25 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 128.517 2.727 . . . . 0.0 113.357 174.514 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -94.88 2.22 55.4 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 115.548 -2.168 . . . . 0.0 115.625 170.337 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.84 -12.37 57.74 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-N 120.769 1.622 . . . . 0.0 114.202 163.861 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 63.1 mttt -81.45 134.44 35.54 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.459 -2.423 . . . . 0.0 104.459 -176.234 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 89.3 m -125.99 122.81 36.97 Favored 'General case' 0 N--CA 1.441 -0.887 0 O-C-N 119.803 -1.81 . . . . 0.0 108.192 -159.283 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 6.0 mt -95.39 122.6 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 O-C-N 120.229 -1.544 . . . . 0.0 110.04 169.014 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 83.6 m -96.55 112.68 24.33 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 125.04 2.352 . . . . 0.0 105.613 -178.242 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -110.52 116.42 31.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.982 1.713 . . . . 0.0 109.242 -170.244 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -77.02 127.92 33.57 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 127.302 2.877 . . . . 0.0 110.129 160.785 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.262 34.5 m -138.86 157.73 29.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 1 C-N-CA 133.454 4.702 . . . . 0.0 115.419 -178.393 . . . . . . . . 3 2 . 1 . 112 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.285 27.1 mm-40 -112.56 158.13 38.28 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 102.844 -3.021 . . . . 0.0 102.844 156.551 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -60.6 -23.08 74.73 Favored 'Trans proline' 0 N--CA 1.447 -1.225 1 C-N-CA 126.873 5.049 . . . . 0.0 116.845 -175.919 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.1 p -83.05 -2.58 55.69 Favored 'General case' 0 N--CA 1.44 -0.944 1 C-N-CA 132.062 4.145 . . . . 0.0 113.484 -175.146 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.67 136.2 38.18 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 -174.156 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 28.4 p -88.89 172.64 9.02 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 179.466 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.431 HG22 ' HD2' ' A' ' 27' ' ' LYS . 19.3 mm -70.63 -34.42 56.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 CA-C-O 117.5 -1.238 . . . . 0.0 108.204 -178.616 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -42.52 -46.42 4.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 129.838 3.255 . . . . 0.0 113.652 170.911 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -70.95 -40.31 72.07 Favored 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.984 2.113 . . . . 0.0 116.207 173.833 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 55.0 t -82.36 -21.54 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 O-C-N 117.974 -2.954 . . . . 0.0 108.667 -176.016 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HD2' HG22 ' A' ' 23' ' ' ILE . 30.0 mttt -69.39 -42.22 75.43 Favored 'General case' 0 N--CA 1.451 -0.402 0 O-C-N 118.749 -2.469 . . . . 0.0 115.769 170.283 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.61 -35.21 58.22 Favored 'General case' 0 CA--C 1.535 0.403 1 O-C-N 132.228 5.955 . . . . 0.0 113.1 -179.009 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -60.28 -52.44 65.27 Favored 'General case' 0 C--N 1.327 -0.398 0 O-C-N 125.721 1.888 . . . . 0.0 110.403 165.594 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.344 35.9 mt -59.29 -46.13 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 114.993 -2.432 . . . . 0.0 112.917 175.969 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.442 ' HB3' HE21 ' A' ' 31' ' ' GLN 0.377 0.0 OUTLIER -40.07 -63.05 0.65 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 126.296 2.951 . . . . 0.0 115.243 166.3 . . . . . . . . 4 4 . 1 . 112 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . 0.296 37.0 t70 -46.86 -47.46 21.26 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 110.396 -3.093 . . . . 0.0 118.584 173.314 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -84.56 -39.42 18.79 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 126.546 1.938 . . . . 0.0 111.29 -165.574 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -125.63 -14.21 6.33 Favored 'General case' 0 N--CA 1.445 -0.68 0 O-C-N 128.301 3.501 . . . . 0.0 115.735 -166.187 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.96 22.05 40.16 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 127.971 2.7 . . . . 0.0 112.373 176.19 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.3 mt -97.35 130.53 29.3 Favored Pre-proline 0 N--CA 1.442 -0.852 0 CA-C-N 120.488 2.144 . . . . 0.0 109.83 -178.286 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -76.36 165.12 29.83 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.738 2.292 . . . . 0.0 110.23 -173.845 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.52 -47.24 0.39 Allowed 'Trans proline' 0 N--CA 1.448 -1.189 0 N-CA-C 116.41 1.658 . . . . 0.0 116.41 -174.86 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -61.28 -5.07 1.41 Allowed 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 117.946 2.573 . . . . 0.0 117.946 -175.58 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -99.62 -16.68 18.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 124.886 1.274 . . . . 0.0 110.245 -169.919 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -88.84 132.07 34.81 Favored 'General case' 0 N--CA 1.44 -0.934 1 C-N-CA 133.171 4.588 . . . . 0.0 110.034 -166.151 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 -135.93 147.75 48.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 O-C-N 118.003 -2.936 . . . . 0.0 105.87 163.045 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.1 mt -104.88 128.1 52.97 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 130.668 3.587 . . . . 0.0 110.958 169.768 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.8 mt -124.78 130.11 73.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 128.151 2.58 . . . . 0.0 107.552 165.423 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -142.46 113.46 7.56 Favored 'General case' 0 N--CA 1.444 -0.749 0 O-C-N 119.084 -2.26 . . . . 0.0 105.928 174.331 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 72.17 36.02 1.16 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 120.431 1.469 . . . . 0.0 110.536 157.872 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 98.88 -47.18 1.41 Allowed Glycine 0 CA--C 1.523 0.571 0 CA-C-O 126.131 3.073 . . . . 0.0 116.095 -167.146 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 22.5 mttt -76.64 126.63 31.32 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 120.159 -1.789 . . . . 0.0 113.097 -166.995 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -71.52 132.83 45.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 124.928 2.299 . . . . 0.0 106.94 154.961 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.455 HD22 ' CD2' ' A' ' 59' ' ' TYR 0.291 0.2 OUTLIER -91.92 124.88 36.36 Favored 'General case' 0 C--O 1.237 0.414 1 O-C-N 115.824 -4.297 . . . . 0.0 108.056 172.213 . . . . . . . . 5 4 . 1 . 112 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -78.15 156.19 30.04 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.397 2.279 . . . . 0.0 115.58 174.582 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.376 26.6 m-20 -71.44 133.49 45.94 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 124.345 2.021 . . . . 0.0 113.106 167.921 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.3 -11.38 39.92 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 128.544 2.973 . . . . 0.0 114.019 176.398 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.0 mmt180 -71.52 153.09 42.44 Favored 'General case' 0 N--CA 1.448 -0.558 0 O-C-N 126.202 1.766 . . . . 0.0 112.217 170.78 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 71.0 p -99.74 143.42 29.99 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 126.291 1.837 . . . . 0.0 107.332 170.278 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.57 -33.67 76.45 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 116.848 2.166 . . . . 0.0 116.848 -166.395 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.5 t -84.31 -23.33 30.32 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 117.008 -1.472 . . . . 0.0 114.485 -173.47 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -54.01 -36.78 63.34 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 126.077 2.846 . . . . 0.0 112.55 168.695 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.455 ' CD2' HD22 ' A' ' 50' ' ' LEU . 10.5 m-85 -85.59 -6.6 59.14 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 128.745 2.818 . . . . 0.0 114.769 176.595 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.489 17.2 m120 89.81 15.18 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.613 1 C-N-CA 132.994 4.518 . . . . 0.0 118.116 177.719 . . . . . . . . 3 2 . 1 . 112 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.8 mt -81.96 112.82 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 116.174 -2.21 . . . . 0.0 108.296 -177.298 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -124.1 170.84 10.29 Favored 'General case' 0 N--CA 1.45 -0.428 0 O-C-N 124.733 1.271 . . . . 0.0 108.144 -167.589 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . 0.327 44.4 pttt -43.03 122.02 2.31 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 127.902 2.481 . . . . 0.0 115.668 -169.126 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 66.97 24.72 9.52 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 116.967 2.21 . . . . 0.0 116.967 178.285 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . 0.275 56.7 m -75.71 125.27 28.73 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-O 124.017 1.865 . . . . 0.0 110.56 170.258 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 m -84.81 131.59 34.52 Favored 'General case' 0 C--N 1.323 -0.562 1 C-N-CA 132.158 4.183 . . . . 0.0 100.831 173.487 . . . . . . . . 2 2 . 1 . 112 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -142.61 112.41 6.89 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 102.408 -3.182 . . . . 0.0 102.408 -164.911 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -46.13 103.52 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-O 113.746 -3.026 . . . . 0.0 115.407 159.446 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 tp -96.1 102.5 14.3 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 121.531 1.969 . . . . 0.0 112.43 176.392 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.7 t -69.08 109.58 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 128.578 2.751 . . . . 0.0 108.909 -176.433 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 mt -81.71 110.24 16.87 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 176.566 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -111.41 136.48 50.5 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 130.302 3.441 . . . . 0.0 108.998 177.828 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.9 mt -90.4 4.01 52.15 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 116.777 2.14 . . . . 0.0 116.777 -176.963 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -144.58 157.65 44.12 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 131.273 3.829 . . . . 0.0 106.917 -178.198 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -113.02 -12.84 11.67 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 111.842 -2.435 . . . . 0.0 111.054 -173.969 . . . . . . . . 1 1 . 1 . 112 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.04 1 C-N-CA 133.5 5.333 . . . . 0.0 103.546 -177.877 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ptm . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 0 0 . 1 . 113 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -84.5 134.81 34.42 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 114.602 -2.618 . . . . 0.0 106.643 179.117 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.314 28.0 pt -125.86 171.53 14.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 1 O-C-N 129.138 4.024 . . . . 0.0 108.134 173.774 . . . . . . . . 3 2 . 1 . 113 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -132.75 143.1 49.37 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 163.04 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.44 113.28 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 126.307 1.843 . . . . 0.0 108.878 169.268 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -83.02 134.38 35.05 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 -177.437 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.29 36.9 m -87.11 149.89 24.37 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 116.765 -1.588 . . . . 0.0 112.279 168.427 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.54 -19.6 16.49 Favored 'General case' 0 C--N 1.324 -0.527 1 C-N-CA 132.772 4.429 . . . . 0.0 112.469 -174.734 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 73.1 p -81.54 -15.78 53.78 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 126.493 1.917 . . . . 0.0 115.428 166.45 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 120.25 -9.86 10.96 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 114.289 -3.506 . . . . 0.0 107.302 175.821 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -80.32 122.59 27.1 Favored 'General case' 0 N--CA 1.45 -0.447 1 CA-C-N 124.951 4.375 . . . . 0.0 110.859 -175.044 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.8 m -84.7 107.65 17.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 175.96 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 3.6 mm -87.07 126.76 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 O-C-N 120.188 -1.57 . . . . 0.0 110.37 179.093 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.3 p -89.67 133.31 34.72 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 121.485 1.948 . . . . 0.0 108.09 -179.544 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.5 tp -149.06 136.87 20.54 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 128.759 2.824 . . . . 0.0 106.444 -165.817 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -116.17 132.8 56.56 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 127.225 2.21 . . . . 0.0 105.56 -177.824 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 m -137.44 -177.96 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 129.346 3.058 . . . . 0.0 111.862 -178.745 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -119.24 153.14 53.23 Favored Pre-proline 0 N--CA 1.449 -0.486 0 C-N-CA 124.97 1.308 . . . . 0.0 109.711 163.275 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . 0.297 28.4 Cg_endo -55.52 -34.62 90.33 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 N-CA-C 121.452 3.597 . . . . 0.0 121.452 -179.929 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.0 p -75.28 -8.65 57.22 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 112.588 -2.097 . . . . 0.0 115.716 173.507 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -56.77 120.42 7.84 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 120.645 1.566 . . . . 0.0 110.345 174.369 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 72.9 p -61.76 150.26 37.44 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 120.126 -1.609 . . . . 0.0 108.511 161.711 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -59.99 -19.02 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.79 2.036 . . . . 0.0 112.99 179.731 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -80.14 -23.49 41.09 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.711 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -89.87 -22.11 22.2 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.085 0.954 . . . . 0.0 109.381 178.547 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.78 -40.91 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 O-C-N 126.912 2.632 . . . . 0.0 108.733 166.57 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -69.16 -20.76 64.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 114.048 -2.882 . . . . 0.0 112.77 172.093 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -76.82 -40.47 47.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 131.541 3.936 . . . . 0.0 111.415 174.611 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -71.34 -28.67 64.24 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 130.657 3.583 . . . . 0.0 109.708 178.106 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.5 mt -69.83 -65.03 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-O 113.247 -3.264 . . . . 0.0 110.854 157.232 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -46.0 -31.41 2.24 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 126.563 2.414 . . . . 0.0 115.851 -179.457 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.72 -32.6 43.88 Favored 'General case' 0 C--N 1.329 -0.322 1 C-N-CA 131.79 4.036 . . . . 0.0 111.036 178.23 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.8 ttpt -116.27 -39.2 3.43 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 -176.823 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 61.9 mm-40 -83.56 -31.16 26.51 Favored 'General case' 0 N--CA 1.447 -0.601 0 O-C-N 116.973 -3.579 . . . . 0.0 117.052 -169.953 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.96 -6.5 83.63 Favored Glycine 0 CA--C 1.531 1.094 0 O-C-N 120.944 -1.097 . . . . 0.0 111.126 171.478 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . 0.251 77.1 mt -98.2 129.05 31.64 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-O 115.104 -2.379 . . . . 0.0 105.924 -175.072 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.56 155.69 68.12 Favored 'Trans proline' 0 N--CA 1.449 -1.104 1 C-N-CA 127.153 5.235 . . . . 0.0 117.807 -174.745 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.303 51.3 Cg_exo -42.21 -35.28 3.35 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 124.567 3.511 . . . . 0.0 117.319 170.026 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -43.17 -41.2 3.63 Favored 'General case' 0 CA--C 1.535 0.4 1 O-C-N 114.003 -5.435 . . . . 0.0 117.723 168.555 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -96.55 -6.44 36.96 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 118.244 -2.785 . . . . 0.0 114.363 -170.098 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -102.01 122.93 45.02 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 128.408 2.683 . . . . 0.0 110.321 175.03 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -120.49 131.42 54.72 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 173.153 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 mt -118.76 129.07 55.05 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 128.716 2.807 . . . . 0.0 110.364 -175.532 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 1.5 mp -118.36 148.19 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 127.689 2.396 . . . . 0.0 116.144 163.582 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -141.06 114.28 8.62 Favored 'General case' 0 N--CA 1.444 -0.766 0 O-C-N 127.781 3.176 . . . . 0.0 107.509 172.925 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.71 41.37 12.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 117.789 -1.101 . . . . 0.0 109.626 176.891 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.75 -16.86 34.03 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 117.976 1.95 . . . . 0.0 117.976 177.118 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.365 69.1 mttt -94.5 129.17 41.39 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 122.886 1.327 . . . . 0.0 108.301 179.55 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.54 87.49 7.29 Favored 'General case' 0 N--CA 1.447 -0.624 0 C-N-CA 131.443 3.897 . . . . 0.0 102.444 178.887 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.5 mt -50.05 136.5 18.84 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 128.346 2.659 . . . . 0.0 115.186 -165.208 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -65.12 114.51 4.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 125.013 1.446 . . . . 0.0 112.89 171.798 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.349 0.0 OUTLIER -66.7 -4.53 9.13 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 126.972 2.109 . . . . 0.0 116.168 -172.942 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -118.16 -0.09 16.76 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 125.221 1.391 . . . . 0.0 111.666 178.434 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -93.23 160.04 15.01 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 159.382 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.8 p -107.28 171.23 7.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 125.166 2.412 . . . . 0.0 108.053 -172.555 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.04 -30.54 62.46 Favored 'General case' 0 C--N 1.326 -0.45 1 O-C-N 114.698 -5.001 . . . . 0.0 109.316 -178.059 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.9 t -67.06 -33.26 75.12 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 173.561 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -71.93 -23.02 61.4 Favored 'General case' 0 N--CA 1.44 -0.926 0 C-N-CA 127.958 2.503 . . . . 0.0 111.515 178.098 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -91.54 -3.79 56.11 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 118.771 2.878 . . . . 0.0 118.771 170.755 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.6 t30 58.71 36.57 24.99 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 131.589 3.956 . . . . 0.0 114.77 179.784 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 83.2 mt -77.08 125.33 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 O-C-N 124.955 1.409 . . . . 0.0 114.506 -173.889 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -98.51 176.24 5.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 125.082 2.372 . . . . 0.0 107.852 -170.769 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.94 117.05 3.89 Favored 'General case' 0 N--CA 1.441 -0.897 1 C-N-CA 131.708 4.003 . . . . 0.0 110.055 -177.787 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 68.79 44.23 1.15 Allowed 'General case' 0 N--CA 1.443 -0.792 0 O-C-N 127.593 3.058 . . . . 0.0 111.944 163.491 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.1 p -100.27 157.7 16.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 125.708 2.67 . . . . 0.0 111.652 160.695 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 92.2 m -106.73 127.02 53.03 Favored 'General case' 0 N--CA 1.445 -0.679 0 O-C-N 116.43 -3.919 . . . . 0.0 110.33 -166.766 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.36 172.38 8.79 Favored 'General case' 0 N--CA 1.445 -0.675 0 C-N-CA 129.294 3.037 . . . . 0.0 104.295 164.918 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -133.64 136.72 44.98 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 126.731 2.012 . . . . 0.0 109.169 -179.199 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 58.1 tp -127.09 108.11 10.62 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 101.452 -3.536 . . . . 0.0 101.452 -163.907 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.6 t -85.34 116.71 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 1 O-C-N 130.375 4.797 . . . . 0.0 110.656 163.639 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -103.87 154.77 19.23 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 101.498 -3.519 . . . . 0.0 101.498 177.37 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . 0.266 7.5 ttp180 -94.16 67.0 3.55 Favored 'General case' 0 C--N 1.328 -0.367 1 CA-C-N 108.209 -4.087 . . . . 0.0 101.945 159.109 . . . . . . . . 3 2 . 1 . 113 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.543 ' H ' HD23 ' A' ' 73' ' ' LEU 0.334 1.8 pt? -57.93 93.97 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.488 0 O-C-N 118.601 -2.562 . . . . 0.0 116.679 -170.534 . . . . . . . . 3 3 . 1 . 113 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -143.96 -33.15 0.42 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.869 1.267 . . . . 0.0 113.788 173.886 . . . . . . . . 2 2 . 1 . 113 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 127.41 -177.31 17.53 Favored Glycine 0 CA--C 1.531 1.032 0 N-CA-C 118.13 2.012 . . . . 0.0 118.13 175.116 . . . . . . . . 1 1 . 1 . 113 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.329 0 C-N-CA 128.112 2.768 . . . . 0.0 106.473 -178.716 . . . . . . . . 0 0 . 1 . 114 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 123.322 1.534 . . . . 0.0 108.764 . . . . . . . . . 0 0 . 1 . 114 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . 0.256 43.6 mt-30 -113.76 128.72 56.53 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 111.373 -2.649 . . . . 0.0 112.859 -179.046 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.358 17.2 pt -144.7 138.36 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 O-C-N 128.286 3.491 . . . . 0.0 110.084 -175.39 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -106.28 121.23 43.79 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 127.377 2.923 . . . . 0.0 110.781 -163.823 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -110.65 87.46 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 172.202 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -86.88 149.0 25.12 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 117.338 -3.351 . . . . 0.0 107.268 -172.462 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.277 42.4 m -103.7 140.29 37.8 Favored 'General case' 0 N--CA 1.447 -0.595 1 C-N-CA 133.097 4.559 . . . . 0.0 105.565 175.863 . . . . . . . . 3 2 . 1 . 114 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . 0.309 0.4 OUTLIER -46.29 -24.76 0.52 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 120.006 3.336 . . . . 0.0 120.006 -179.423 . . . . . . . . 3 3 . 1 . 114 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.29 6.9 p -94.82 5.72 51.07 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 127.836 2.454 . . . . 0.0 108.395 -174.982 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.19 0.18 44.3 Favored Glycine 0 CA--C 1.531 1.049 1 C-N-CA 134.76 5.933 . . . . 0.0 111.172 158.292 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -65.83 138.79 58.14 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 116.488 -3.948 . . . . 0.0 111.275 170.997 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.353 12.0 m -124.31 112.1 16.6 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.975 2.11 . . . . 0.0 111.553 -170.258 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 26.9 mm -100.99 148.87 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 173.313 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . 0.353 7.1 p -129.22 128.88 44.22 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 111.641 -2.527 . . . . 0.0 111.151 -164.084 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.43 HD13 HG22 ' A' ' 26' ' ' VAL . 86.7 mt -106.38 125.56 51.15 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 124.849 1.26 . . . . 0.0 111.114 176.656 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -88.51 93.03 9.41 Favored 'General case' 0 N--CA 1.449 -0.485 1 C-N-CA 132.886 4.474 . . . . 0.0 107.235 162.943 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.18 162.18 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 O-C-N 118.364 -2.71 . . . . 0.0 111.06 -176.184 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . 0.265 3.4 tp10 -115.91 135.36 22.72 Favored Pre-proline 0 N--CA 1.447 -0.6 0 N-CA-C 101.286 -3.598 . . . . 0.0 101.286 176.119 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -34.16 -40.55 0.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.776 1 C-N-CA 128.135 5.89 . . . . 0.0 115.148 -176.918 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.7 p -80.06 -1.37 39.6 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 127.323 2.249 . . . . 0.0 114.585 -171.505 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -65.25 135.9 55.95 Favored 'General case' 0 N--CA 1.441 -0.925 0 C-N-CA 130.746 3.618 . . . . 0.0 107.73 174.707 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.4 p -65.03 159.69 22.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 129.029 2.932 . . . . 0.0 112.902 171.771 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 23' ' ' ILE . 3.5 mm -74.39 -31.84 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 O-C-N 124.777 1.298 . . . . 0.0 110.392 178.456 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -63.79 -30.5 71.59 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 128.496 2.718 . . . . 0.0 112.203 172.965 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -80.9 -24.56 38.17 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 119.367 -2.083 . . . . 0.0 109.611 173.101 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.43 HG22 HD13 ' A' ' 15' ' ' LEU 0.255 1.0 OUTLIER -72.28 -20.11 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 CA-C-O 122.5 1.143 . . . . 0.0 111.913 175.978 . . . . . . . . 4 4 . 1 . 114 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -73.4 -43.89 59.57 Favored 'General case' 0 C--N 1.323 -0.553 1 C-N-CA 133.335 4.654 . . . . 0.0 114.031 173.854 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.95 -38.62 89.08 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 127.213 2.205 . . . . 0.0 111.908 174.384 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -69.3 -10.32 57.33 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 128.354 2.661 . . . . 0.0 116.8 173.434 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.27 58.1 mt -94.24 -40.45 11.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.249 0 O-C-N 127.509 3.005 . . . . 0.0 109.809 163.859 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -61.48 -62.93 1.47 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 130.567 3.547 . . . . 0.0 110.333 -174.917 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -41.72 -37.92 1.32 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 128.109 2.564 . . . . 0.0 116.673 170.307 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -79.16 -70.6 0.49 Allowed 'General case' 0 C--N 1.32 -0.683 0 O-C-N 128.32 3.513 . . . . 0.0 118.88 167.349 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.6 mm-40 -98.24 -5.5 33.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.432 -161.342 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.11 0.32 74.37 Favored Glycine 0 CA--C 1.523 0.548 0 C-N-CA 126.56 2.029 . . . . 0.0 114.814 166.995 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 62.1 mt -79.6 133.38 59.43 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-O 113.15 -3.309 . . . . 0.0 106.41 -165.283 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -79.83 162.65 23.86 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 CA-C-N 126.691 3.425 . . . . 0.0 111.538 -173.586 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -69.83 -51.46 0.38 Allowed 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 123.876 3.051 . . . . 0.0 116.573 -166.034 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -66.95 -11.23 55.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 126.39 2.995 . . . . 0.0 113.914 -163.984 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.2 mp0 -96.57 -17.59 20.35 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 113.689 -3.053 . . . . 0.0 110.165 -172.483 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.25 139.2 30.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 126.161 2.886 . . . . 0.0 107.72 -176.332 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.26 71.2 mtt180 -131.42 142.01 49.94 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 128.67 2.788 . . . . 0.0 112.985 162.028 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . 0.55 0.6 OUTLIER -133.99 139.95 46.41 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 -164.755 . . . . . . . . 3 3 . 1 . 114 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . 0.297 68.1 mt -132.52 130.14 59.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 126.209 1.804 . . . . 0.0 109.707 -160.988 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -159.27 133.88 7.92 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 127.077 2.151 . . . . 0.0 112.609 179.037 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.53 34.61 15.88 Favored 'General case' 0 N--CA 1.439 -0.986 1 C-N-CA 133.398 4.679 . . . . 0.0 112.78 -176.916 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.48 -30.05 7.51 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 115.514 -2.826 . . . . 0.0 112.21 174.478 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -120.12 148.04 44.12 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 120.502 2.151 . . . . 0.0 111.002 -159.939 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -71.83 129.28 38.24 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 126.998 2.119 . . . . 0.0 108.04 171.151 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.8 mp -75.05 109.69 8.73 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 129.826 3.25 . . . . 0.0 108.853 -176.295 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -73.25 130.06 39.39 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 129.635 3.174 . . . . 0.0 110.217 -172.927 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . 0.293 73.4 m-20 -46.24 129.7 10.3 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 129.394 3.078 . . . . 0.0 112.991 166.811 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.54 20.49 47.82 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-O 124.963 2.424 . . . . 0.0 111.317 172.733 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.23 177.18 4.93 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.598 2.359 . . . . 0.0 113.672 170.161 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.406 ' H ' ' CG ' ' A' ' 58' ' ' ASP . 43.5 p -118.29 163.83 16.11 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 125.209 2.433 . . . . 0.0 110.503 162.561 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 71.9 mt -53.93 -37.67 64.09 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 117.128 -3.482 . . . . 0.0 113.899 169.87 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.2 t -58.45 -31.97 68.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 124.725 2.202 . . . . 0.0 114.073 172.173 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 55' ' ' THR . 19.7 m-20 -63.46 -30.22 71.38 Favored 'General case' 0 N--CA 1.453 -0.29 0 O-C-N 119.329 -2.107 . . . . 0.0 115.291 177.426 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -96.78 7.57 46.3 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 130.615 3.566 . . . . 0.0 109.245 178.456 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 19.8 t30 35.7 47.61 0.4 Allowed 'General case' 0 N--CA 1.448 -0.53 2 O-C-N 113.535 -5.728 . . . . 0.0 114.558 -172.51 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 76.8 mt -88.91 110.75 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 128.114 2.566 . . . . 0.0 106.844 178.677 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 74.6 mm-40 -111.31 170.01 8.41 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 129.853 3.261 . . . . 0.0 112.682 -173.738 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -49.89 131.61 22.48 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.78 1.232 . . . . 0.0 112.457 -177.475 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.453 5.4 pt-20 65.98 39.09 4.63 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 129.048 2.939 . . . . 0.0 118.146 178.511 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.7 p -87.18 140.73 29.25 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 126.411 1.884 . . . . 0.0 107.292 165.454 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 79.7 m -96.22 130.82 43.2 Favored 'General case' 0 N--CA 1.442 -0.858 2 C-N-CA 133.509 4.723 . . . . 0.0 107.108 164.333 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mp -123.67 175.49 6.81 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.941 1.696 . . . . 0.0 108.743 -176.7 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -111.38 149.88 30.57 Favored 'General case' 0 C--O 1.237 0.408 0 O-C-N 118.457 -2.652 . . . . 0.0 112.335 178.21 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.1 tp -121.85 138.55 54.34 Favored 'General case' 0 N--CA 1.448 -0.529 1 C-N-CA 134.395 5.078 . . . . 0.0 109.907 178.995 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 31.0 t -133.41 104.12 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 1 CA-C-O 130.104 4.764 . . . . 0.0 104.937 176.913 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.99 142.94 28.35 Favored 'General case' 0 N--CA 1.451 -0.406 1 O-C-N 113.14 -5.975 . . . . 0.0 105.495 179.286 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -94.67 167.76 11.26 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 131.633 3.973 . . . . 0.0 109.304 150.758 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.07 151.32 48.78 Favored 'General case' 0 N--CA 1.453 -0.288 0 O-C-N 119.184 -2.198 . . . . 0.0 107.068 171.394 . . . . . . . . 2 2 . 1 . 114 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -108.11 -19.54 13.46 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 130.642 3.577 . . . . 0.0 110.097 177.582 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.04 128.99 5.22 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 128.255 2.836 . . . . 0.0 106.902 176.365 . . . . . . . . 1 1 . 1 . 114 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.844 1 N-CA-C 99.904 -5.278 . . . . 0.0 99.904 -157.565 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.2 ttp . . . . . 0 N--CA 1.478 0.951 0 CA-C-O 113.947 -2.93 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 115 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -88.11 130.28 35.06 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 124.175 1.941 . . . . 0.0 115.491 -179.387 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 pt -115.42 174.86 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 111.421 -2.627 . . . . 0.0 111.222 155.391 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . 0.278 52.0 p90 -147.33 143.4 28.02 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 169.143 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.63 99.04 7.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 130.398 3.479 . . . . 0.0 105.395 -156.487 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 50.7 tttt -83.7 133.07 34.82 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 126.975 2.11 . . . . 0.0 105.513 176.236 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . 0.283 45.1 p -99.77 -171.56 2.08 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -179.043 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.77 -6.61 57.62 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 130.602 3.561 . . . . 0.0 115.325 170.373 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 p -117.11 -163.9 0.95 Allowed 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 112.214 -2.266 . . . . 0.0 106.984 -179.723 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.03 50.7 0.77 Allowed Glycine 0 CA--C 1.524 0.656 0 O-C-N 124.757 1.285 . . . . 0.0 112.139 -178.087 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . 0.343 66.9 tttt -119.69 139.1 52.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 131.48 3.912 . . . . 0.0 106.853 167.696 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.6 m -131.71 117.88 19.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 115.563 -2.161 . . . . 0.0 106.896 179.888 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.6 mt -100.46 129.32 51.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 -170.448 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.1 m -92.86 146.65 23.47 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 177.117 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.92 127.03 27.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 -170.801 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -108.18 98.05 7.65 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-O 126.407 3.003 . . . . 0.0 114.291 175.424 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.3 164.08 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 117.606 -3.184 . . . . 0.0 114.515 -166.411 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -87.98 137.09 31.62 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-O 117.085 -1.436 . . . . 0.0 110.028 171.587 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -85.01 -3.92 9.68 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.516 2.811 . . . . 0.0 113.682 -172.822 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.4 p -80.72 -2.11 45.53 Favored 'General case' 0 C--N 1.33 -0.264 1 CA-C-O 108.846 -5.359 . . . . 0.0 112.523 167.435 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -89.1 152.81 21.44 Favored 'General case' 0 N--CA 1.447 -0.59 1 O-C-N 130.172 4.67 . . . . 0.0 110.709 177.45 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -83.42 151.35 25.53 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 125.98 1.712 . . . . 0.0 107.427 -175.718 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.496 HD11 HD23 ' A' ' 56' ' ' LEU . 22.8 mm -53.62 -33.39 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.812 174.639 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -62.41 -52.08 64.98 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 129.387 3.075 . . . . 0.0 108.243 -173.63 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.7 t30 -77.57 -23.2 50.06 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 109.441 -3.527 . . . . 0.0 113.572 -174.323 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.34 35.2 t -58.4 -50.34 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 129.952 3.301 . . . . 0.0 110.916 162.452 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.454 ' HE2' HG22 ' A' ' 23' ' ' ILE . 55.1 mtmt -67.15 -38.46 85.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 O-C-N 127.203 2.814 . . . . 0.0 114.182 175.452 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.68 -4.58 16.2 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 117.841 -3.037 . . . . 0.0 117.404 163.329 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -92.82 -42.67 9.42 Favored 'General case' 0 C--N 1.328 -0.351 1 O-C-N 115.691 -4.381 . . . . 0.0 105.093 175.407 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -49.2 -39.48 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 1 C-N-CA 132.228 4.211 . . . . 0.0 114.267 165.6 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . 0.257 46.3 tt0 -46.1 -45.11 16.17 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 127.309 2.243 . . . . 0.0 116.752 175.288 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -62.34 -41.25 98.42 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 112.858 -1.974 . . . . 0.0 111.077 173.585 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -76.4 -54.17 7.12 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.102 -1.408 . . . . 0.0 112.079 -169.787 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -101.77 -5.33 25.02 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 126.251 2.219 . . . . 0.0 114.657 -172.659 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.21 6.16 89.02 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 121.487 3.355 . . . . 0.0 121.487 165.293 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.473 HD12 ' HD2' ' A' ' 37' ' ' PRO 0.266 4.0 tp -100.61 141.62 23.03 Favored Pre-proline 0 N--CA 1.454 -0.273 1 N-CA-C 100.09 -4.041 . . . . 0.0 100.09 -167.085 . . . . . . . . 4 3 . 1 . 115 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HD2' HD12 ' A' ' 36' ' ' ILE . 97.6 Cg_endo -70.6 161.11 47.21 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.969 2.446 . . . . 0.0 113.909 169.565 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -82.88 -9.43 10.85 Favored 'Trans proline' 0 N--CA 1.449 -1.115 0 N-CA-C 117.795 2.19 . . . . 0.0 117.795 -162.198 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -95.55 8.15 44.18 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 117.731 -3.105 . . . . 0.0 113.188 -178.175 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -119.89 -4.15 10.17 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 112.384 -2.189 . . . . 0.0 115.614 -175.207 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.302 78.4 mt-30 -99.59 138.0 37.28 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 128.454 2.702 . . . . 0.0 104.618 175.182 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -129.99 102.95 6.5 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 103.184 -2.895 . . . . 0.0 103.184 174.146 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 34.7 mt -81.61 128.41 33.9 Favored 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 119.899 -1.751 . . . . 0.0 107.47 169.119 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mt -113.46 119.89 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 1 C-N-CA 132.275 4.23 . . . . 0.0 106.963 175.894 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -105.18 128.86 53.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 101.082 -3.673 . . . . 0.0 101.082 153.152 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . 0.358 . . 73.0 -108.28 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 129.071 2.948 . . . . 0.0 110.495 171.166 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -132.54 22.69 4.11 Favored Glycine 0 CA--C 1.538 1.516 0 C-N-CA 125.159 1.361 . . . . 0.0 112.111 164.689 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -98.23 108.37 21.06 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 129.208 3.003 . . . . 0.0 109.929 166.723 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -80.88 108.7 14.77 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.801 -1.925 . . . . 0.0 105.801 173.86 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 34.8 mt -67.29 146.3 54.27 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.05 -159.914 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -101.39 134.5 44.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.691 1.596 . . . . 0.0 108.539 -168.299 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 27' ' ' LYS . 1.9 m-20 -57.33 -37.69 72.93 Favored 'General case' 0 N--CA 1.442 -0.852 1 C-N-CA 132.58 4.352 . . . . 0.0 115.25 -155.489 . . . . . . . . 3 3 . 1 . 115 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -105.01 -13.72 24.53 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 119.018 -2.301 . . . . 0.0 112.051 -169.38 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -69.7 152.8 44.25 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 118.998 -2.472 . . . . 0.0 107.948 166.832 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.4 p -78.5 179.3 7.14 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 127.362 2.265 . . . . 0.0 111.902 171.319 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.496 HD23 HD11 ' A' ' 23' ' ' ILE . 43.7 mt -84.51 -26.6 27.99 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 120.165 -1.584 . . . . 0.0 109.273 166.273 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 85.8 p -69.84 -22.64 63.26 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 130.203 3.401 . . . . 0.0 110.427 173.923 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -75.88 -29.6 58.56 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 121.783 2.083 . . . . 0.0 111.116 168.954 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -90.85 -2.63 57.74 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.249 1.42 . . . . 0.0 107.912 178.549 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.309 5.0 t-20 59.53 38.39 22.4 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.99 2.916 . . . . 0.0 116.087 -179.705 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.6 mm -76.63 105.48 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 126.848 2.059 . . . . 0.0 108.624 -176.643 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 63' ' ' LYS . 2.4 tp-100 -84.67 166.77 16.79 Favored 'General case' 0 C--O 1.238 0.481 1 C-N-CA 133.517 4.727 . . . . 0.0 109.811 178.478 . . . . . . . . 3 3 . 1 . 115 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.45 ' N ' ' HG3' ' A' ' 62' ' ' GLN . 20.5 pttt -61.6 135.68 57.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 115.684 -2.103 . . . . 0.0 110.245 -173.346 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 68.79 26.76 5.94 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 131.445 3.898 . . . . 0.0 115.087 177.577 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.4 m -79.54 115.5 19.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 102.242 -3.244 . . . . 0.0 102.242 -177.966 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.4 m -73.36 137.62 44.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 129.23 3.012 . . . . 0.0 107.904 173.49 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.5 pp -137.83 176.97 8.23 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 167.234 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -122.65 122.63 39.27 Favored 'General case' 0 N--CA 1.45 -0.474 1 O-C-N 116.165 -4.085 . . . . 0.0 106.301 -173.634 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.451 ' CD2' HD22 ' A' ' 71' ' ' LEU . 55.0 tp -97.91 133.06 42.9 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 124.154 1.93 . . . . 0.0 107.019 171.747 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 89.0 t -97.34 128.77 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 163.944 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD22 ' CD2' ' A' ' 69' ' ' LEU . 2.5 pt? -141.07 173.18 11.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 121.675 2.034 . . . . 0.0 109.167 165.701 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 -84.98 149.17 25.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 100.416 -3.92 . . . . 0.0 100.416 175.185 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.4 mt -110.25 157.05 19.87 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 125.141 2.4 . . . . 0.0 112.85 155.39 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.32 -35.97 6.14 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 128.017 2.527 . . . . 0.0 109.651 167.576 . . . . . . . . 2 2 . 1 . 115 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 120.55 -148.12 17.7 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 107.965 -2.054 . . . . 0.0 107.965 -177.546 . . . . . . . . 1 1 . 1 . 115 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.081 0 C-N-CA 124.888 1.232 . . . . 0.0 110.249 -179.383 . . . . . . . . 0 0 . 1 . 116 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 . . . . . . . . . 0 0 . 1 . 116 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.84 151.67 19.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 O-C-N 124.076 0.86 . . . . 0.0 110.403 -177.207 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . 0.303 49.2 pt -141.61 155.62 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.918 1 C-N-CA 131.802 4.041 . . . . 0.0 110.996 162.278 . . . . . . . . 3 2 . 1 . 116 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -110.93 156.42 21.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 127.664 3.102 . . . . 0.0 110.902 179.058 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . 0.328 82.0 t -136.67 128.13 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 100.763 -3.792 . . . . 0.0 100.763 174.246 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -82.41 125.58 31.22 Favored 'General case' 0 N--CA 1.447 -0.611 0 O-C-N 118.404 -2.685 . . . . 0.0 105.63 161.496 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.8 p -80.68 167.87 19.52 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 123.158 1.456 . . . . 0.0 110.213 168.321 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.8 tp -66.96 -29.96 69.95 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 117.855 -3.028 . . . . 0.0 113.278 -178.696 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.8 p -77.54 -25.07 49.85 Favored 'General case' 0 N--CA 1.447 -0.597 1 C-N-CA 132.877 4.471 . . . . 0.0 115.559 171.076 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.46 -2.09 9.54 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 126.799 2.562 . . . . 0.0 110.633 154.301 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.1 tttt -78.37 137.1 37.85 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 128.503 2.721 . . . . 0.0 105.795 -179.485 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 94.6 m -92.96 123.1 35.97 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.112 2.165 . . . . 0.0 107.085 -174.422 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.7 mm -111.27 129.61 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 127.863 2.465 . . . . 0.0 105.963 -174.376 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.1 p -95.58 120.57 36.06 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 128.676 2.79 . . . . 0.0 110.564 172.039 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.0 mt -112.28 131.76 55.33 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 171.169 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.3 pm0 -96.33 116.03 28.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 129.0 3.938 . . . . 0.0 110.008 160.598 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.2 m -122.38 160.7 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 131.511 3.925 . . . . 0.0 109.247 -165.378 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -71.23 152.75 94.43 Favored Pre-proline 0 N--CA 1.446 -0.668 0 O-C-N 117.408 -3.307 . . . . 0.0 108.163 163.197 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -71.11 -18.68 30.59 Favored 'Trans proline' 0 N--CA 1.446 -1.303 0 C-N-CA 121.703 1.602 . . . . 0.0 112.339 173.793 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . 0.377 63.6 p -125.54 36.44 4.55 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 127.031 2.132 . . . . 0.0 113.748 176.547 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.92 157.6 37.13 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 125.346 1.458 . . . . 0.0 108.845 173.486 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . 0.259 40.8 p -99.49 168.06 10.21 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 126.782 2.551 . . . . 0.0 109.993 172.941 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.257 33.5 mm -76.88 -15.09 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 119.546 -1.971 . . . . 0.0 110.55 -178.541 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -66.4 -60.6 2.6 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 127.382 2.273 . . . . 0.0 112.738 174.112 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -64.95 -31.18 72.3 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 179.501 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . 0.293 78.9 t -53.64 -41.69 47.72 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.354 0 CA-C-O 115.373 -2.251 . . . . 0.0 113.415 163.445 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -55.02 -42.55 72.72 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 123.244 2.747 . . . . 0.0 109.963 176.811 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -69.75 -37.75 76.54 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 123.687 1.708 . . . . 0.0 111.635 -177.918 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -71.15 -31.12 67.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 119.483 -2.011 . . . . 0.0 108.498 176.562 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . 0.303 86.3 mt -74.81 -32.86 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 1 O-C-N 115.756 -4.34 . . . . 0.0 110.842 177.605 . . . . . . . . 3 2 . 1 . 116 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -64.28 -53.2 52.64 Favored 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 130.738 3.615 . . . . 0.0 107.638 171.413 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -55.23 -51.7 65.74 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 118.783 2.882 . . . . 0.0 118.783 174.534 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -66.24 -43.48 86.46 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 115.083 -2.389 . . . . 0.0 111.482 177.679 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.342 69.3 mm-40 -128.98 -15.96 4.18 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 114.563 -2.637 . . . . 0.0 116.338 -166.819 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.58 -22.49 7.35 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 125.628 1.83 . . . . 0.0 111.348 156.192 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mt -73.39 124.79 90.83 Favored Pre-proline 0 N--CA 1.446 -0.653 0 C-N-CA 126.375 1.87 . . . . 0.0 108.728 -162.186 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -70.04 157.51 59.61 Favored 'Trans proline' 0 N--CA 1.446 -1.306 0 C-N-CA 122.25 1.967 . . . . 0.0 109.621 173.247 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -70.17 -29.03 22.54 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 124.805 3.67 . . . . 0.0 111.279 -168.355 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . 0.267 5.4 t70 -40.11 -55.59 2.07 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 126.28 2.943 . . . . 0.0 117.743 158.141 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 71' ' ' LEU . 82.0 mt-30 -81.66 -6.71 59.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 111.774 -2.466 . . . . 0.0 111.66 -175.392 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -89.06 166.76 13.66 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 124.184 3.174 . . . . 0.0 113.871 174.972 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . 0.367 6.7 ptt180 -154.66 128.87 8.96 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 128.112 2.565 . . . . 0.0 108.213 164.594 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.6 mt -102.57 91.93 4.43 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 129.656 3.182 . . . . 0.0 110.022 174.781 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.1 mm -96.09 120.86 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 127.156 2.785 . . . . 0.0 105.168 -175.836 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -130.91 116.12 17.45 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 130.245 3.418 . . . . 0.0 109.217 -176.116 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.75 42.16 11.31 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 128.503 2.721 . . . . 0.0 112.516 -176.343 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.01 -2.78 55.43 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 125.058 1.313 . . . . 0.0 114.515 166.417 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -132.98 158.29 43.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.815 0.846 . . . . 0.0 110.769 -179.476 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -79.16 130.28 35.33 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-O 126.747 3.165 . . . . 0.0 114.761 173.811 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 64.3 mt -69.53 128.29 35.98 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 116.865 -3.647 . . . . 0.0 109.886 163.1 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -117.38 -179.07 3.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 119.512 -1.992 . . . . 0.0 114.08 -171.031 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.28 129.6 35.85 Favored 'General case' 0 N--CA 1.449 -0.52 1 C-N-CA 133.725 4.81 . . . . 0.0 113.026 165.255 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.81 -28.41 7.38 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 118.269 -2.769 . . . . 0.0 110.518 151.18 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.256 75.1 mtt85 -97.77 124.45 42.14 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.905 2.082 . . . . 0.0 106.709 171.359 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.3 p -62.56 174.3 1.03 Allowed 'General case' 0 N--CA 1.454 -0.241 0 O-C-N 125.254 1.597 . . . . 0.0 114.624 170.23 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 11.6 mt -42.07 -53.34 3.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 176.579 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.0 t -64.69 -29.77 70.77 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.138 1.375 . . . . 0.0 111.165 -173.632 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -91.21 2.03 56.66 Favored 'General case' 0 N--CA 1.443 -0.793 0 O-C-N 119.274 -2.141 . . . . 0.0 110.297 -176.159 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -101.9 20.36 16.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 123.057 2.662 . . . . 0.0 109.419 156.29 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . 0.361 19.4 p30 59.19 22.32 10.51 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 117.131 2.271 . . . . 0.0 117.131 -176.727 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 56.8 mt -75.7 123.56 31.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 O-C-N 118.18 -2.825 . . . . 0.0 111.292 178.233 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -106.82 -176.01 2.96 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -173.559 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -67.76 125.15 25.33 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.778 1.631 . . . . 0.0 108.203 177.996 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 69.79 20.94 6.63 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 126.208 2.192 . . . . 0.0 114.025 178.016 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.7 m -73.16 140.04 46.76 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 131.163 3.785 . . . . 0.0 114.108 177.173 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.8 m -105.13 143.87 32.72 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.035 -1.666 . . . . 0.0 111.376 -172.521 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 84.3 mt -121.84 157.8 30.31 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.124 1.37 . . . . 0.0 113.834 172.016 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -109.71 155.03 22.06 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 177.441 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 12.5 tp -128.53 124.64 36.52 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 110.426 -3.079 . . . . 0.0 107.35 -179.619 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.3 t -114.25 148.24 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 128.268 2.627 . . . . 0.0 107.055 162.727 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 40' ' ' GLN . 0.5 OUTLIER -134.37 152.4 51.78 Favored 'General case' 0 N--CA 1.449 -0.478 0 O-C-N 127.284 2.865 . . . . 0.0 110.552 -177.642 . . . . . . . . 3 3 . 1 . 116 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 41.7 ttp180 -71.28 124.88 25.52 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 126.776 3.179 . . . . 0.0 106.242 176.017 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 37.0 mt -134.72 173.26 11.88 Favored 'General case' 0 N--CA 1.447 -0.609 1 C-N-CA 133.86 4.864 . . . . 0.0 107.972 175.827 . . . . . . . . 2 2 . 1 . 116 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -98.47 142.29 30.27 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 154.596 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.81 -95.64 2.07 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 156.7 . . . . . . . . 1 1 . 1 . 116 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.263 0 C-N-CA 129.887 3.613 . . . . 0.0 111.521 -173.836 . . . . . . . . 0 0 . 1 stop_ save_